No/DT drug/NN ,/, nutritional/JJ supplement/NN ,/, food/NN or/CC herb/NN interactions/NNS have/VBP yet/RB been/VBN reported/VBN ./.

(ROOT (S1 (S (S (NP (DT No) (NP (NP (NN drug)) (, ,) (NP (JJ nutritional) (NN supplement)) (, ,) (NP (NN food)) (CC or) (NP (NN herb))) (NNS interactions)) (VP (VBP have) (ADVP (RB yet)) (VP (VBN been) (VP (VBN reported))))) (. .))))

det(interactions-10, No-1)
nn(interactions-10, drug-2)
amod(supplement-5, nutritional-4)
conj_or(drug-2, supplement-5)
conj_or(drug-2, food-7)
conj_or(drug-2, herb-9)
nsubjpass(reported-14, interactions-10)
aux(reported-14, have-11)
advmod(reported-14, yet-12)
auxpass(reported-14, been-13)
root(ROOT-0, reported-14)

Formal/JJ drug/NN interaction/NN studies/NNS have/VBP not/RB been/VBN conducted/VBN with/IN ORENCIA/NN ./.

(ROOT (S1 (S (S (NP (JJ Formal) (NN drug) (NN interaction) (NNS studies)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN conducted) (PP (IN with) (NP (NN ORENCIA))))))) (. .))))

amod(studies-4, Formal-1)
nn(studies-4, drug-2)
nn(studies-4, interaction-3)
nsubjpass(conducted-8, studies-4)
aux(conducted-8, have-5)
neg(conducted-8, not-6)
auxpass(conducted-8, been-7)
root(ROOT-0, conducted-8)
prep_with(conducted-8, ORENCIA-10)

Population/NN pharmacokinetic/JJ analyses/NNS revealed/VBD that/IN MTX/NN ,/, NSAIDs/NN ,/, corticosteroids/NNS ,/, and/CC TNF/NN blocking/NN agents/NNS did/VBD not/RB influence/VB abatacept/NN clearance/NN ./.

(ROOT (S1 (S (S (NP (NN Population) (JJ pharmacokinetic) (NNS analyses)) (VP (VBD revealed) (SBAR (IN that) (S (NP (NP (NP (NN MTX)) (, ,) (NP (NN NSAIDs)) (, ,) (NP (NNS corticosteroids)) (, ,) (CC and) (NP (NN TNF))) (NN blocking) (NNS agents)) (VP (VBD did) (RB not) (VP (VB influence) (NP (NN abatacept) (NN clearance)))))))) (. .))))

nn(analyses-3, Population-1)
amod(analyses-3, pharmacokinetic-2)
nsubj(revealed-4, analyses-3)
root(ROOT-0, revealed-4)
complm(influence-18, that-5)
nn(agents-15, MTX-6)
conj_and(MTX-6, NSAIDs-8)
conj_and(MTX-6, corticosteroids-10)
conj_and(MTX-6, TNF-13)
nn(agents-15, blocking-14)
nsubj(influence-18, agents-15)
aux(influence-18, did-16)
neg(influence-18, not-17)
ccomp(revealed-4, influence-18)
nn(clearance-20, abatacept-19)
dobj(influence-18, clearance-20)

The/DT majority/NN of/IN patients/NNS in/IN RA/NN clinical/JJ studies/NNS received/VBD one/CD or/CC more/JJR of/IN the/DT following/VBG concomitant/JJ medications/NNS with/IN ORENCIA/NN :/: MTX/NN ,/, NSAIDs/NNS ,/, corticosteroids/NNS ,/, TNF/NN blocking/NN agents/NNS ,/, azathioprine/NN ,/, chloroquine/NN ,/, gold/NN ,/, hydroxychloroquine/NN ,/, leflunomide/NN ,/, sulfasalazine/NN ,/, and/CC anakinra/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN majority)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN in) (NP (NN RA) (JJ clinical) (NNS studies)))))) (VP (VBD received) (NP (NP (CD one)) (CC or) (NP (ADJP (JJR more) (PP (IN of) (NP (NP (DT the) (VBG following) (JJ concomitant) (NNS medications)) (PP (IN with) (NP (NP (NN ORENCIA)) (: :) (NP (NN MTX)) (, ,) (NP (NNS NSAIDs)) (, ,) (NP (NNS corticosteroids)) (, ,) (NP (NN TNF) (NN blocking) (NNS agents)) (, ,) (NP (NN azathioprine)) (, ,) (NP (NN chloroquine)) (, ,) (NP (NN gold)) (, ,) (NP (NN hydroxychloroquine)) (, ,) (NP (NN leflunomide)) (, ,) (NP (NN sulfasalazine)) (, ,) (CC and) (NP (NN anakinra))))))))))) (. .))))

det(majority-2, The-1)
nsubj(received-9, majority-2)
prep_of(majority-2, patients-4)
nn(studies-8, RA-6)
amod(studies-8, clinical-7)
prep_in(patients-4, studies-8)
root(ROOT-0, received-9)
dobj(received-9, one-10)
conj_or(one-10, more-12)
det(medications-17, the-14)
amod(medications-17, following-15)
amod(medications-17, concomitant-16)
prep_of(more-12, medications-17)
prep_with(medications-17, ORENCIA-19)
conj_and(ORENCIA-19, MTX-21)
conj_and(ORENCIA-19, NSAIDs-23)
conj_and(ORENCIA-19, corticosteroids-25)
nn(agents-29, TNF-27)
nn(agents-29, blocking-28)
conj_and(ORENCIA-19, agents-29)
conj_and(ORENCIA-19, azathioprine-31)
conj_and(ORENCIA-19, chloroquine-33)
conj_and(ORENCIA-19, gold-35)
conj_and(ORENCIA-19, hydroxychloroquine-37)
conj_and(ORENCIA-19, leflunomide-39)
conj_and(ORENCIA-19, sulfasalazine-41)
conj_and(ORENCIA-19, anakinra-44)

Concurrent/JJ administration/NN of/IN a/DT TNF/NN antagonist/NN with/IN ORENCIA/NN has/VBZ been/VBN associated/VBN with/IN an/DT increased/VBN risk/NN of/IN serious/JJ infections/NNS and/CC no/DT significant/JJ additional/JJ efficacy/NN over/IN use/NN of/IN the/DT TNF/NN antagonists/NNS alone/RB ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN administration)) (PP (IN of) (NP (DT a) (NN TNF) (NN antagonist))) (PP (IN with) (NP (NN ORENCIA)))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (NP (JJ serious) (NNS infections)) (CC and) (NP (NP (DT no) (JJ significant) (JJ additional) (NN efficacy)) (PP (IN over) (NP (NP (NN use)) (PP (IN of) (NP (NP (DT the) (NN TNF) (NNS antagonists)) (ADVP (RB alone))))))))))))))) (. .))))

amod(administration-2, Concurrent-1)
nsubjpass(associated-11, administration-2)
det(antagonist-6, a-4)
nn(antagonist-6, TNF-5)
prep_of(administration-2, antagonist-6)
prep_with(administration-2, ORENCIA-8)
aux(associated-11, has-9)
auxpass(associated-11, been-10)
root(ROOT-0, associated-11)
det(risk-15, an-13)
amod(risk-15, increased-14)
prep_with(associated-11, risk-15)
amod(infections-18, serious-17)
prep_of(risk-15, infections-18)
det(efficacy-23, no-20)
amod(efficacy-23, significant-21)
amod(efficacy-23, additional-22)
conj_and(infections-18, efficacy-23)
prep_over(efficacy-23, use-25)
det(antagonists-29, the-27)
nn(antagonists-29, TNF-28)
prep_of(use-25, antagonists-29)
advmod(antagonists-29, alone-30)

Concurrent/JJ therapy/NN with/IN ORENCIA/NN and/CC TNF/NN antagonists/NNS is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN therapy)) (PP (IN with) (NP (NP (NN ORENCIA)) (CC and) (NP (NN TNF)) (NP (NNS antagonists))))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

amod(therapy-2, Concurrent-1)
nsubjpass(recommended-10, therapy-2)
prep_with(therapy-2, ORENCIA-4)
conj_and(ORENCIA-4, TNF-6)
dep(ORENCIA-4, antagonists-7)
auxpass(recommended-10, is-8)
neg(recommended-10, not-9)
root(ROOT-0, recommended-10)

There/EX is/VBZ insufficient/JJ experience/VBP to/TO assess/VB the/DT safety/NN and/CC efficacy/NN of/IN ORENCIA/NNS administered/VBN concurrently/RB with/IN anakinra/NN ,/, and/CC therefore/RB such/JJ use/NN is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (S (NP (EX There)) (VP (VBZ is) (ADJP (JJ insufficient) (S (VP (VBP experience) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NP (NN safety)) (CC and) (NP (NN efficacy))) (PP (IN of) (NP (NP (NNS ORENCIA)) (VP (VBN administered) (ADVP (RB concurrently)) (PP (IN with) (NP (NN anakinra))))))))))))))) (, ,) (CC and) (S (ADVP (RB therefore)) (NP (JJ such) (NN use)) (VP (VBZ is) (RB not) (VP (VBN recommended))))) (. .))))

expl(is-2, There-1)
root(ROOT-0, is-2)
acomp(is-2, insufficient-3)
dep(insufficient-3, experience-4)
aux(assess-6, to-5)
xcomp(experience-4, assess-6)
dep(safety-8, the-7)
dobj(assess-6, safety-8)
conj_and(safety-8, efficacy-10)
prep_of(safety-8, ORENCIA-12)
partmod(ORENCIA-12, administered-13)
advmod(administered-13, concurrently-14)
prep_with(administered-13, anakinra-16)
advmod(recommended-24, therefore-19)
amod(use-21, such-20)
nsubjpass(recommended-24, use-21)
auxpass(recommended-24, is-22)
neg(recommended-24, not-23)
conj_and(is-2, recommended-24)

Formal/JJ drug/NN interaction/NN studies/NNS with/IN Abciximab/NN have/VBP not/RB been/VBN conducted/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Formal) (NN drug) (NN interaction) (NNS studies)) (PP (IN with) (NP (NN Abciximab)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN conducted))))) (. .))))

amod(studies-4, Formal-1)
nn(studies-4, drug-2)
nn(studies-4, interaction-3)
nsubjpass(conducted-10, studies-4)
prep_with(studies-4, Abciximab-6)
aux(conducted-10, have-7)
neg(conducted-10, not-8)
auxpass(conducted-10, been-9)
root(ROOT-0, conducted-10)

Abciximab/NN has/VBZ been/VBN administered/VBN to/TO patients/NNS with/IN ischemic/JJ heart/NN disease/NN treated/VBN concomitantly/RB with/IN a/DT broad/JJ range/NN of/IN medications/NNS used/VBN in/IN the/DT treatment/NN of/IN angina/NN myocardial/JJ infarction/NN and/CC hypertension/NN ./.

(ROOT (S1 (S (S (NP (NN Abciximab)) (VP (VBZ has) (VP (VBN been) (VP (VBN administered) (PP (TO to) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ ischemic) (NN heart) (NN disease))) (VP (VBN treated) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (DT a) (JJ broad) (NN range)) (PP (IN of) (NP (NP (NNS medications)) (VP (VBN used) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NN angina) (JJ myocardial) (NN infarction)) (CC and) (NP (NN hypertension)))))))))))))))))) (. .))))

nsubjpass(administered-4, Abciximab-1)
aux(administered-4, has-2)
auxpass(administered-4, been-3)
root(ROOT-0, administered-4)
prep_to(administered-4, patients-6)
amod(disease-10, ischemic-8)
nn(disease-10, heart-9)
prep_with(patients-6, disease-10)
partmod(patients-6, treated-11)
advmod(treated-11, concomitantly-12)
det(range-16, a-14)
amod(range-16, broad-15)
prep_with(treated-11, range-16)
prep_of(range-16, medications-18)
partmod(medications-18, used-19)
det(treatment-22, the-21)
prep_in(used-19, treatment-22)
nn(infarction-26, angina-24)
amod(infarction-26, myocardial-25)
prep_of(treatment-22, infarction-26)
conj_and(infarction-26, hypertension-28)

These/DT medications/NNS have/VBP included/VBN heparin/NN warfarin/NN ,/, beta-adrenergic/JJ receptor/NN blockers/NNS ,/, calcium/NN channel/NN antagonists/NNS ,/, angiotensin/NN converting/NN enzyme/NN inhibitors/NNS ,/, intravenous/JJ and/CC oral/JJ nitrates/NNS ,/, ticlopidine/NN ,/, and/CC aspirin/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS medications)) (VP (VBP have) (VP (VBN included) (NP (NP (NP (NN heparin) (NN warfarin)) (, ,) (NP (NP (JJ beta-adrenergic) (NN receptor) (NNS blockers)) (, ,) (NP (NN calcium) (NN channel) (NNS antagonists)) (, ,) (NP (NN angiotensin) (NN converting) (NN enzyme) (NNS inhibitors)) (, ,) (NP (ADJP (ADJP (JJ intravenous)) (CC and) (ADJP (JJ oral))) (NNS nitrates)))) (, ,) (NP (NN ticlopidine)) (, ,) (CC and) (NP (NN aspirin)))))) (. .))))

det(medications-2, These-1)
nsubj(included-4, medications-2)
aux(included-4, have-3)
root(ROOT-0, included-4)
nn(warfarin-6, heparin-5)
dobj(included-4, warfarin-6)
amod(blockers-10, beta-adrenergic-8)
nn(blockers-10, receptor-9)
appos(warfarin-6, blockers-10)
nn(antagonists-14, calcium-12)
nn(antagonists-14, channel-13)
appos(blockers-10, antagonists-14)
nn(inhibitors-19, angiotensin-16)
nn(inhibitors-19, converting-17)
nn(inhibitors-19, enzyme-18)
appos(blockers-10, inhibitors-19)
amod(nitrates-24, intravenous-21)
conj_and(intravenous-21, oral-23)
appos(blockers-10, nitrates-24)
conj_and(warfarin-6, ticlopidine-26)
conj_and(warfarin-6, aspirin-29)

Heparin/NN ,/, other/JJ anticoagulants/NNS ,/, thrombolytic/JJ s/NNS ,/, and/CC anti/JJ platelet/NN agents/NNS are/VBP associated/VBN with/IN an/DT increase/NN in/IN bleeding/JJ ./.

(ROOT (S1 (S (S (NP (NP (NN Heparin)) (, ,) (NP (JJ other) (NNS anticoagulants)) (, ,) (NP (JJ thrombolytic) (NNS s)) (, ,) (CC and) (NP (JJ anti) (NN platelet) (NNS agents))) (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (JJ bleeding)))))))) (. .))))

nsubjpass(associated-14, Heparin-1)
amod(anticoagulants-4, other-3)
conj_and(Heparin-1, anticoagulants-4)
amod(s-7, thrombolytic-6)
conj_and(Heparin-1, s-7)
amod(agents-12, anti-10)
nn(agents-12, platelet-11)
conj_and(Heparin-1, agents-12)
auxpass(associated-14, are-13)
root(ROOT-0, associated-14)
det(increase-17, an-16)
prep_with(associated-14, increase-17)
prep_in(increase-17, bleeding-19)

Patients/NNS with/IN HACA/NN titers/NNS may/MD have/VBP allergic/JJ or/CC hypersensitivity/NN reactions/NNS when/WRB treated/VBN with/IN other/JJ diagnostic/JJ or/CC therapeutic/JJ monoclonal/JJ antibodies/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NN HACA) (NNS titers)))) (VP (MD may) (VP (VBP have) (NP (JJ allergic) (CC or) (NN hypersensitivity) (NNS reactions)) (SBAR (WHADVP (WRB when)) (S (VP (VBN treated) (PP (IN with) (NP (JJ other) (ADJP (ADJP (JJ diagnostic)) (CC or) (ADJP (JJ therapeutic))) (JJ monoclonal) (NNS antibodies))))))))) (. .))))

nsubj(have-6, Patients-1)
nn(titers-4, HACA-3)
prep_with(Patients-1, titers-4)
aux(have-6, may-5)
root(ROOT-0, have-6)
amod(reactions-10, allergic-7)
conj_or(allergic-7, hypersensitivity-9)
dobj(have-6, reactions-10)
advmod(treated-12, when-11)
advcl(have-6, treated-12)
amod(antibodies-19, other-14)
amod(antibodies-19, diagnostic-15)
conj_or(diagnostic-15, therapeutic-17)
amod(antibodies-19, monoclonal-18)
prep_with(treated-12, antibodies-19)

The/DT concomitant/JJ intake/NN of/IN alcohol/NN and/CC Acamprosate/NN does/VBZ not/RB affect/VB the/DT pharmacokinetics/NNS of/IN either/CC alcohol/NN or/CC acamprosate/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN intake)) (PP (IN of) (NP (NP (NN alcohol)) (CC and) (NP (NN Acamprosate))))) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (CC either) (NP (NN alcohol)) (CC or) (NP (NN acamprosate)))))))) (. .))))

det(intake-3, The-1)
amod(intake-3, concomitant-2)
nsubj(affect-10, intake-3)
prep_of(intake-3, alcohol-5)
conj_and(alcohol-5, Acamprosate-7)
aux(affect-10, does-8)
neg(affect-10, not-9)
root(ROOT-0, affect-10)
det(pharmacokinetics-12, the-11)
dobj(affect-10, pharmacokinetics-12)
preconj(alcohol-15, either-14)
prep_of(pharmacokinetics-12, alcohol-15)
conj_or(alcohol-15, acamprosate-17)

Pharmacokinetic/JJ studies/NNS indicate/VBP that/IN administration/NN of/IN disulfiram/NN or/CC diazepam/NN does/VBZ not/RB affect/VB the/DT pharmacokinetics/NNS of/IN acamprosate/NN ./.

(ROOT (S1 (S (S (NP (JJ Pharmacokinetic) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN administration)) (PP (IN of) (NP (NP (NN disulfiram)) (CC or) (NP (NN diazepam))))) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN acamprosate)))))))))) (. .))))

amod(studies-2, Pharmacokinetic-1)
nsubj(indicate-3, studies-2)
root(ROOT-0, indicate-3)
complm(affect-12, that-4)
nsubj(affect-12, administration-5)
prep_of(administration-5, disulfiram-7)
conj_or(disulfiram-7, diazepam-9)
aux(affect-12, does-10)
neg(affect-12, not-11)
ccomp(indicate-3, affect-12)
det(pharmacokinetics-14, the-13)
dobj(affect-12, pharmacokinetics-14)
prep_of(pharmacokinetics-14, acamprosate-16)

Co-administration/NN of/IN naltrexone/NN with/IN Acamprosate/NN produced/VBD a/DT 25/CD %/NN increase/NN in/IN AUC/NN and/CC a/DT 33/CD %/NN increase/NN in/IN the/DT Cmax/NN of/IN acamprosate/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NN naltrexone))) (PP (IN with) (NP (NN Acamprosate)))) (VP (VBD produced) (NP (NP (NP (DT a) (ADJP (CD 25) (NN %)) (NN increase)) (PP (IN in) (NP (NN AUC)))) (CC and) (NP (NP (DT a) (ADJP (CD 33) (NN %)) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN Cmax)) (PP (IN of) (NP (NN acamprosate))))))))) (. .))))

nsubj(produced-6, Co-administration-1)
prep_of(Co-administration-1, naltrexone-3)
prep_with(Co-administration-1, Acamprosate-5)
root(ROOT-0, produced-6)
det(increase-10, a-7)
number(%-9, 25-8)
amod(increase-10, %-9)
dobj(produced-6, increase-10)
prep_in(increase-10, AUC-12)
det(increase-17, a-14)
number(%-16, 33-15)
amod(increase-17, %-16)
conj_and(increase-10, increase-17)
det(Cmax-20, the-19)
prep_in(increase-17, Cmax-20)
prep_of(Cmax-20, acamprosate-22)

The/DT pharmacokinetics/NNS of/IN naltrexone/NN and/CC its/PRP$ major/JJ metabolite/NN 6-/CD beta-naltrexol/NN were/VBD unaffected/VBN following/VBG co-administration/NN with/IN Acamprosate/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (DT The) (NNS pharmacokinetics)) (PP (IN of) (NP (NN naltrexone)))) (CC and) (NP (NP (PRP$ its) (JJ major) (NN metabolite)) (ADJP (CD 6-) (NN beta-naltrexol)))) (VP (VBD were) (VP (VBN unaffected) (PP (VBG following) (NP (NP (NN co-administration)) (PP (IN with) (NP (NN Acamprosate)))))))) (. .))))

det(pharmacokinetics-2, The-1)
nsubjpass(unaffected-12, pharmacokinetics-2)
prep_of(pharmacokinetics-2, naltrexone-4)
poss(metabolite-8, its-6)
amod(metabolite-8, major-7)
conj_and(pharmacokinetics-2, metabolite-8)
number(beta-naltrexol-10, 6--9)
amod(metabolite-8, beta-naltrexol-10)
auxpass(unaffected-12, were-11)
root(ROOT-0, unaffected-12)
prep_following(unaffected-12, co-administration-14)
prep_with(co-administration-14, Acamprosate-16)

Other/JJ concomitant/JJ therapies/NNS :/: In/IN clinical/JJ trials/NNS ,/, the/DT safety/NN profile/NN in/IN subjects/NNS treated/VBN with/IN Acamprosate/NN concomitantly/RB with/IN anxiolytics/NNS ,/, hypnotics/NNS and/CC sedatives/NNS (/-LRB- including/VBG benzodiazepines/NNS )/-RRB- ,/, or/CC non-opioid/JJ analgesics/NNS was/VBD similar/JJ to/TO that/DT of/IN subjects/NNS taking/VBG placebo/NN with/IN these/DT concomitant/JJ medications/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Other) (JJ concomitant) (NNS therapies)) (: :) (S (PP (IN In) (NP (JJ clinical) (NNS trials))) (, ,) (NP (NP (DT the) (NN safety) (NN profile)) (PP (IN in) (NP (NP (NNS subjects)) (VP (VBN treated) (PP (IN with) (NP (NN Acamprosate))) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NNS anxiolytics)) (, ,) (NP (NP (NP (NNS hypnotics)) (CC and) (NP (NNS sedatives))) (PRN (-LRB- -LRB-) (VP (VBG including) (NP (NNS benzodiazepines))) (-RRB- -RRB-))) (, ,) (CC or) (NP (JJ non-opioid) (NNS analgesics)))))))) (VP (VBD was) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (NP (NNS subjects)) (VP (VBG taking) (NP (NN placebo)) (PP (IN with) (NP (DT these) (JJ concomitant) (NNS medications))))))))))) (. .)))))

amod(therapies-3, Other-1)
amod(therapies-3, concomitant-2)
root(ROOT-0, therapies-3)
amod(trials-7, clinical-6)
prep_in(similar-33, trials-7)
det(profile-11, the-9)
nn(profile-11, safety-10)
nsubj(similar-33, profile-11)
prep_in(profile-11, subjects-13)
partmod(subjects-13, treated-14)
prep_with(treated-14, Acamprosate-16)
advmod(treated-14, concomitantly-17)
prep_with(treated-14, anxiolytics-19)
conj_or(anxiolytics-19, hypnotics-21)
conj_and(hypnotics-21, sedatives-23)
dep(hypnotics-21, including-25)
dobj(including-25, benzodiazepines-26)
amod(analgesics-31, non-opioid-30)
conj_or(anxiolytics-19, analgesics-31)
cop(similar-33, was-32)
dep(therapies-3, similar-33)
prep_to(similar-33, that-35)
prep_of(that-35, subjects-37)
partmod(subjects-37, taking-38)
dobj(taking-38, placebo-39)
det(medications-43, these-41)
amod(medications-43, concomitant-42)
prep_with(taking-38, medications-43)

Patients/NNS taking/VBG Acamprosate/NN concomitantly/RB with/IN antidepressants/NNS more/RBR commonly/RB reported/VBD both/CC weight/NN gain/NN and/CC weight/NN loss/NN ,/, compared/VBN with/IN patients/NNS taking/VBG either/DT medication/NN alone/RB ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG taking) (NP (NP (NN Acamprosate)) (PP (ADVP (RB concomitantly)) (IN with) (NP (NNS antidepressants)))))) (ADVP (RBR more) (RB commonly)) (VP (VBD reported) (NP (CC both) (NP (NN weight) (NN gain)) (CC and) (NP (NN weight) (NN loss))) (, ,) (S (VP (VBN compared) (PP (IN with) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (DT either) (NN medication)) (ADVP (RB alone)))))))))) (. .))))

nsubj(reported-9, Patients-1)
partmod(Patients-1, taking-2)
dobj(taking-2, Acamprosate-3)
advmod(Acamprosate-3, concomitantly-4)
prep_with(Acamprosate-3, antidepressants-6)
advmod(commonly-8, more-7)
advmod(reported-9, commonly-8)
root(ROOT-0, reported-9)
preconj(gain-12, both-10)
nn(gain-12, weight-11)
dobj(reported-9, gain-12)
nn(loss-15, weight-14)
conj_and(gain-12, loss-15)
partmod(reported-9, compared-17)
prep_with(compared-17, patients-19)
partmod(patients-19, taking-20)
det(medication-22, either-21)
dobj(taking-20, medication-22)
advmod(medication-22, alone-23)

Concomitant/JJ use/NN with/IN iron/NN supplement/NN s/NNS may/MD result/VB in/IN the/DT reduced/VBN absorption/NN of/IN iron/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN with) (NP (NN iron) (NN supplement) (NNS s)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT the) (VBN reduced) (NN absorption)) (PP (IN of) (NP (NN iron)))))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(result-8, use-2)
nn(s-6, iron-4)
nn(s-6, supplement-5)
prep_with(use-2, s-6)
aux(result-8, may-7)
root(ROOT-0, result-8)
det(absorption-12, the-10)
amod(absorption-12, reduced-11)
prep_in(result-8, absorption-12)
prep_of(absorption-12, iron-14)

Co-administration/NN of/IN probenecid/NN with/IN acyclovir/NN has/VBZ been/VBN shown/VBN to/TO increase/VB the/DT mean/JJ half-life/NN and/CC the/DT area/NN under/IN the/DT concentration-time/JJ curve/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NN probenecid))) (PP (IN with) (NP (NN acyclovir)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (JJ mean) (NN half-life)) (CC and) (NP (NP (DT the) (NN area)) (PP (IN under) (NP (DT the) (JJ concentration-time) (NN curve)))))))))))) (. .))))

nsubjpass(shown-8, Co-administration-1)
xsubj(increase-10, Co-administration-1)
prep_of(Co-administration-1, probenecid-3)
prep_with(Co-administration-1, acyclovir-5)
aux(shown-8, has-6)
auxpass(shown-8, been-7)
root(ROOT-0, shown-8)
aux(increase-10, to-9)
xcomp(shown-8, increase-10)
det(half-life-13, the-11)
amod(half-life-13, mean-12)
dobj(increase-10, half-life-13)
det(area-16, the-15)
conj_and(half-life-13, area-16)
det(curve-20, the-18)
amod(curve-20, concentration-time-19)
prep_under(area-16, curve-20)

Ethanol/NN :/: Clinical/JJ evidence/NN has/VBZ shown/VBN that/IN etretinate/NN can/MD be/VB formed/VBN with/IN concurrent/JJ ingestion/NN of/IN acitretin/NN and/CC ethanol/NN ./.

(ROOT (S1 (S (S (NP (NN Ethanol)) (: :) (NP (JJ Clinical) (NN evidence)) (VP (VBZ has) (VP (VBN shown) (SBAR (IN that) (S (NP (NN etretinate)) (VP (MD can) (VP (VB be) (VP (VBN formed) (PP (IN with) (NP (NP (JJ concurrent) (NN ingestion)) (PP (IN of) (NP (NP (NN acitretin)) (CC and) (NP (NN ethanol)))))))))))))) (. .))))

nsubj(shown-6, Ethanol-1)
amod(evidence-4, Clinical-3)
nsubj(shown-6, evidence-4)
aux(shown-6, has-5)
root(ROOT-0, shown-6)
complm(formed-11, that-7)
nsubjpass(formed-11, etretinate-8)
aux(formed-11, can-9)
auxpass(formed-11, be-10)
ccomp(shown-6, formed-11)
amod(ingestion-14, concurrent-13)
prep_with(formed-11, ingestion-14)
prep_of(ingestion-14, acitretin-16)
conj_and(acitretin-16, ethanol-18)

Glibenclamide/NN :/: In/IN a/DT study/NN of/IN 7/CD healthy/JJ male/JJ volunteers/NNS ,/, acitretin/NN treatment/NN potentiated/VBD the/DT blood/NN glucose/NN lowering/JJ effect/NN of/IN glibenclamide/NN (/-LRB- a/DT sulfonylurea/NN similar/JJ to/TO chlorpropamide/NN )/-RRB- in/IN 3/CD of/IN the/DT 7/CD subjects/NNS ./.

(ROOT (S1 (S (S (NP (NN Glibenclamide)) (: :) (PP (IN In) (NP (NP (DT a) (NN study)) (PP (IN of) (NP (CD 7) (JJ healthy) (JJ male) (NNS volunteers))))) (, ,) (NP (NN acitretin) (NN treatment)) (VP (VBD potentiated) (NP (NP (DT the) (NN blood) (NN glucose) (JJ lowering) (NN effect)) (PP (IN of) (NP (NP (NN glibenclamide)) (PRN (-LRB- -LRB-) (NP (NP (DT a) (NN sulfonylurea)) (ADJP (JJ similar) (PP (TO to) (NP (NN chlorpropamide))))) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (CD 3)) (PP (IN of) (NP (DT the) (CD 7) (NNS subjects)))))))) (. .))))

nsubj(potentiated-14, Glibenclamide-1)
det(study-5, a-4)
prep_in(potentiated-14, study-5)
num(volunteers-10, 7-7)
amod(volunteers-10, healthy-8)
amod(volunteers-10, male-9)
prep_of(study-5, volunteers-10)
nn(treatment-13, acitretin-12)
nsubj(potentiated-14, treatment-13)
root(ROOT-0, potentiated-14)
det(effect-19, the-15)
nn(effect-19, blood-16)
nn(effect-19, glucose-17)
amod(effect-19, lowering-18)
dobj(potentiated-14, effect-19)
prep_of(effect-19, glibenclamide-21)
det(sulfonylurea-24, a-23)
dep(glibenclamide-21, sulfonylurea-24)
amod(sulfonylurea-24, similar-25)
prep_to(similar-25, chlorpropamide-27)
prep_in(effect-19, 3-30)
det(subjects-34, the-32)
num(subjects-34, 7-33)
prep_of(3-30, subjects-34)

Repeating/VBG the/DT study/NN with/IN 6/CD healthy/JJ male/JJ volunteers/NNS in/IN the/DT absence/NN of/IN glibenclamide/NN did/VBD not/RB detect/VB an/DT effect/NN of/IN acitretin/NN on/IN glucose/NN tolerance/NN ./.

(ROOT (S1 (S (S (S (VP (VBG Repeating) (NP (NP (DT the) (NN study)) (PP (IN with) (NP (CD 6) (JJ healthy) (JJ male) (NNS volunteers))) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN glibenclamide)))))))) (VP (VBD did) (RB not) (VP (VB detect) (NP (NP (DT an) (NN effect)) (PP (IN of) (NP (NN acitretin))) (PP (IN on) (NP (NN glucose) (NN tolerance))))))) (. .))))

csubj(detect-16, Repeating-1)
det(study-3, the-2)
dobj(Repeating-1, study-3)
num(volunteers-8, 6-5)
amod(volunteers-8, healthy-6)
amod(volunteers-8, male-7)
prep_with(study-3, volunteers-8)
det(absence-11, the-10)
prep_in(study-3, absence-11)
prep_of(absence-11, glibenclamide-13)
aux(detect-16, did-14)
neg(detect-16, not-15)
root(ROOT-0, detect-16)
det(effect-18, an-17)
dobj(detect-16, effect-18)
prep_of(effect-18, acitretin-20)
nn(tolerance-23, glucose-22)
prep_on(effect-18, tolerance-23)

Careful/JJ supervision/NN of/IN diabetic/JJ patients/NNS under/IN treatment/NN with/IN Soriatane/NN is/VBZ recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Careful) (NN supervision)) (PP (IN of) (NP (JJ diabetic) (NNS patients))) (PP (IN under) (NP (NP (NN treatment)) (PP (IN with) (NP (NN Soriatane)))))) (VP (VBZ is) (VP (VBN recommended)))) (. .))))

amod(supervision-2, Careful-1)
nsubjpass(recommended-11, supervision-2)
amod(patients-5, diabetic-4)
prep_of(supervision-2, patients-5)
prep_under(supervision-2, treatment-7)
prep_with(treatment-7, Soriatane-9)
auxpass(recommended-11, is-10)
root(ROOT-0, recommended-11)

Hormonal/JJ Contraceptives/NNS :/: It/PRP has/VBZ not/RB been/VBN established/VBN if/IN there/EX is/VBZ a/DT pharmacokinetic/JJ interaction/NN between/IN acitretin/NN and/CC combined/JJ oral/JJ contraceptives/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Hormonal) (NNS Contraceptives)) (: :) (S (NP (PRP It)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN established) (SBAR (IN if) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (JJ pharmacokinetic) (NN interaction)) (PP (IN between) (NP (NP (NN acitretin)) (CC and) (NP (JJ combined) (JJ oral) (NNS contraceptives)))))))))))) (. .)))))

amod(Contraceptives-2, Hormonal-1)
root(ROOT-0, Contraceptives-2)
nsubjpass(established-8, It-4)
aux(established-8, has-5)
neg(established-8, not-6)
auxpass(established-8, been-7)
dep(Contraceptives-2, established-8)
mark(is-11, if-9)
expl(is-11, there-10)
advcl(established-8, is-11)
det(interaction-14, a-12)
amod(interaction-14, pharmacokinetic-13)
nsubj(is-11, interaction-14)
prep_between(interaction-14, acitretin-16)
amod(contraceptives-20, combined-18)
amod(contraceptives-20, oral-19)
conj_and(acitretin-16, contraceptives-20)

However/RB ,/, it/PRP has/VBZ been/VBN established/VBN that/IN acitretin/NN interferes/VBZ with/IN the/DT contraceptive/JJ effect/NN of/IN microdosed/JJ progestin/NN minipill/NN preparations/NNS ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN established) (SBAR (IN that) (S (NP (NN acitretin)) (VP (VBZ interferes) (PP (IN with) (NP (NP (DT the) (JJ contraceptive) (NN effect)) (PP (IN of) (NP (JJ microdosed) (NN progestin) (NN minipill) (NNS preparations)))))))))))) (. .))))

advmod(established-6, However-1)
nsubjpass(established-6, it-3)
aux(established-6, has-4)
auxpass(established-6, been-5)
root(ROOT-0, established-6)
complm(interferes-9, that-7)
nsubj(interferes-9, acitretin-8)
ccomp(established-6, interferes-9)
det(effect-13, the-11)
amod(effect-13, contraceptive-12)
prep_with(interferes-9, effect-13)
amod(preparations-18, microdosed-15)
nn(preparations-18, progestin-16)
nn(preparations-18, minipill-17)
prep_of(effect-13, preparations-18)

Microdosed/JJ minipill/NN progestin/NN preparations/NNS are/VBP not/RB recommended/VBN for/IN use/NN with/IN Soriatane/NN ./.

(ROOT (S1 (S (S (NP (JJ Microdosed) (NN minipill) (NN progestin) (NNS preparations)) (VP (VBP are) (RB not) (VP (VBN recommended) (PP (IN for) (NP (NP (NN use)) (PP (IN with) (NP (NN Soriatane)))))))) (. .))))

amod(preparations-4, Microdosed-1)
nn(preparations-4, minipill-2)
nn(preparations-4, progestin-3)
nsubjpass(recommended-7, preparations-4)
auxpass(recommended-7, are-5)
neg(recommended-7, not-6)
root(ROOT-0, recommended-7)
prep_for(recommended-7, use-9)
prep_with(use-9, Soriatane-11)

It/PRP is/VBZ not/RB known/VBN whether/IN other/JJ progestational/JJ contraceptives/NNS ,/, such/JJ as/IN implants/NNS and/CC injectables/NNS ,/, are/VBP adequate/JJ methods/NNS of/IN contraception/NN during/IN acitretin/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (IN whether) (S (NP (NP (JJ other) (JJ progestational) (NNS contraceptives)) (, ,) (PP (JJ such) (IN as) (NP (NP (NNS implants)) (CC and) (NP (NNS injectables)))) (, ,)) (VP (VBP are) (NP (NP (JJ adequate) (NNS methods)) (PP (IN of) (NP (NN contraception)))) (PP (IN during) (NP (NN acitretin) (NN therapy))))))))) (. .))))

nsubjpass(known-4, It-1)
auxpass(known-4, is-2)
neg(known-4, not-3)
root(ROOT-0, known-4)
complm(methods-18, whether-5)
amod(contraceptives-8, other-6)
amod(contraceptives-8, progestational-7)
nsubj(methods-18, contraceptives-8)
prep_such_as(contraceptives-8, implants-12)
conj_and(implants-12, injectables-14)
cop(methods-18, are-16)
amod(methods-18, adequate-17)
ccomp(known-4, methods-18)
prep_of(methods-18, contraception-20)
nn(therapy-23, acitretin-22)
prep_during(methods-18, therapy-23)

Methotrexate/NN :/: An/DT increased/VBN risk/NN of/IN hepatitis/NN has/VBZ been/VBN reported/VBN to/TO result/VB from/IN combined/JJ use/NN of/IN methotrexate/NN and/CC etretinate/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Methotrexate)) (: :) (NP (NP (DT An) (VBN increased) (NN risk)) (PP (IN of) (NP (NN hepatitis))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB result) (PP (IN from) (NP (NP (JJ combined) (NN use)) (PP (IN of) (NP (NP (NN methotrexate)) (CC and) (NP (NN etretinate))))))))))))) (. .))))

nsubjpass(reported-10, Methotrexate-1)
xsubj(result-12, Methotrexate-1)
det(risk-5, An-3)
amod(risk-5, increased-4)
dep(Methotrexate-1, risk-5)
prep_of(risk-5, hepatitis-7)
aux(reported-10, has-8)
auxpass(reported-10, been-9)
root(ROOT-0, reported-10)
aux(result-12, to-11)
xcomp(reported-10, result-12)
amod(use-15, combined-14)
prep_from(result-12, use-15)
prep_of(use-15, methotrexate-17)
conj_and(methotrexate-17, etretinate-19)

Consequently/RB ,/, the/DT combination/NN of/IN methotrexate/NN with/IN acitretin/NN is/VBZ also/RB contraindicated/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Consequently)) (, ,) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NN methotrexate))) (PP (IN with) (NP (NN acitretin)))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN contraindicated)))) (. .))))

advmod(contraindicated-11, Consequently-1)
det(combination-4, the-3)
nsubjpass(contraindicated-11, combination-4)
prep_of(combination-4, methotrexate-6)
prep_with(combination-4, acitretin-8)
auxpass(contraindicated-11, is-9)
advmod(contraindicated-11, also-10)
root(ROOT-0, contraindicated-11)

Phenytoin/NN :/: If/IN acitretin/NN is/VBZ given/VBN concurrently/RB with/IN phenytoin/NN ,/, the/DT protein/NN binding/NN of/IN phenytoin/NN may/MD be/VB reduced/VBN ./.

(ROOT (S1 (S (NP (NP (NN Phenytoin)) (: :) (S (SBAR (IN If) (S (NP (NN acitretin)) (VP (VBZ is) (VP (VBN given) (ADVP (RB concurrently)) (PP (IN with) (NP (NN phenytoin))))))) (, ,) (NP (NP (DT the) (NN protein) (NN binding)) (PP (IN of) (NP (NN phenytoin)))) (VP (MD may) (VP (VB be) (VP (VBN reduced))))) (. .)))))

root(ROOT-0, Phenytoin-1)
mark(given-6, If-3)
nsubjpass(given-6, acitretin-4)
auxpass(given-6, is-5)
advcl(reduced-18, given-6)
advmod(given-6, concurrently-7)
prep_with(given-6, phenytoin-9)
det(binding-13, the-11)
nn(binding-13, protein-12)
nsubjpass(reduced-18, binding-13)
prep_of(binding-13, phenytoin-15)
aux(reduced-18, may-16)
auxpass(reduced-18, be-17)
dep(Phenytoin-1, reduced-18)

Tetracyclines/NN :/: Since/IN both/CC acitretin/NN and/CC tetracyclines/NN can/MD cause/VB increased/VBN intracranial/JJ pressure/NN ,/, their/PRP$ combined/JJ use/NN is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (NP (NP (NN Tetracyclines)) (: :) (S (SBAR (IN Since) (S (NP (CC both) (NP (NN acitretin)) (CC and) (NP (NN tetracyclines))) (VP (MD can) (VP (VB cause) (NP (VBN increased) (JJ intracranial) (NN pressure)))))) (, ,) (NP (PRP$ their) (JJ combined) (NN use)) (VP (VBZ is) (VP (VBN contraindicated)))) (. .)))))

root(ROOT-0, Tetracyclines-1)
mark(cause-9, Since-3)
preconj(acitretin-5, both-4)
nsubj(cause-9, acitretin-5)
conj_and(acitretin-5, tetracyclines-7)
aux(cause-9, can-8)
advcl(contraindicated-18, cause-9)
amod(pressure-12, increased-10)
amod(pressure-12, intracranial-11)
dobj(cause-9, pressure-12)
poss(use-16, their-14)
amod(use-16, combined-15)
nsubjpass(contraindicated-18, use-16)
auxpass(contraindicated-18, is-17)
dep(Tetracyclines-1, contraindicated-18)

Vitamin/NN A/NN and/CC oral/JJ retinoids/NNS :/: Concomitant/JJ administration/NN of/IN vitamin/NN A/NN and/or/CC other/JJ oral/JJ retinoids/NNS with/IN acitretin/NN must/MD be/VB avoided/VBN because/IN of/IN the/DT risk/NN of/IN hypervitaminosis/NN A/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN Vitamin) (NN A)) (CC and) (NP (JJ oral) (NNS retinoids))) (: :) (S (NP (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NN vitamin) (NN A)))) (CC and/or) (NP (NP (JJ other) (JJ oral) (NNS retinoids)) (PP (IN with) (NP (NN acitretin))))) (VP (MD must) (VP (VB be) (VP (VBN avoided) (PP (IN because) (IN of) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN hypervitaminosis) (NN A))))))))) (. .)))))

nn(A-2, Vitamin-1)
root(ROOT-0, A-2)
amod(retinoids-5, oral-4)
conj_and(A-2, retinoids-5)
amod(administration-8, Concomitant-7)
nsubjpass(avoided-20, administration-8)
nn(A-11, vitamin-10)
prep_of(administration-8, A-11)
amod(retinoids-15, other-13)
amod(retinoids-15, oral-14)
conj_and/or(administration-8, retinoids-15)
prep_with(retinoids-15, acitretin-17)
aux(avoided-20, must-18)
auxpass(avoided-20, be-19)
dep(A-2, avoided-20)
det(risk-24, the-23)
prep_because_of(avoided-20, risk-24)
nn(A-27, hypervitaminosis-26)
prep_of(risk-24, A-27)

Other/JJ :/: There/EX appears/VBZ to/TO be/VB no/DT pharmacokinetic/JJ interaction/NN between/IN acitretin/NN and/CC cimetidine/NN ,/, digoxin/NN ,/, or/CC glyburide/NN ./.

(ROOT (S1 (S (S (NP (JJ Other) (: :) (EX There)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (NP (NP (DT no) (JJ pharmacokinetic) (NN interaction)) (PP (IN between) (NP (NP (NN acitretin)) (CC and) (NP (NN cimetidine)) (, ,) (NP (NN digoxin)) (, ,) (CC or) (NP (NN glyburide)))))))))) (. .))))

expl(appears-4, Other-1)
xsubj(interaction-9, Other-1)
dep(Other-1, There-3)
root(ROOT-0, appears-4)
aux(interaction-9, to-5)
cop(interaction-9, be-6)
det(interaction-9, no-7)
amod(interaction-9, pharmacokinetic-8)
xcomp(appears-4, interaction-9)
prep_between(interaction-9, acitretin-11)
conj_and(acitretin-11, cimetidine-13)
conj_and(acitretin-11, digoxin-15)
conj_or(acitretin-11, glyburide-18)

Investigations/NNS into/IN the/DT effect/NN of/IN acitretin/NN on/IN the/DT protein/NN binding/NN of/IN anticoagulants/NNS of/IN the/DT coumarin/NN type/NN (/-LRB- warfarin/NN )/-RRB- revealed/VBD no/DT interaction/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Investigations)) (PP (IN into) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN acitretin))) (PP (IN on) (NP (NP (DT the) (NN protein) (NN binding)) (PP (IN of) (NP (NP (NNS anticoagulants)) (PP (IN of) (NP (NP (DT the) (NN coumarin) (NN type)) (PRN (-LRB- -LRB-) (NP (NN warfarin)) (-RRB- -RRB-))))))))))) (VP (VBD revealed) (NP (DT no) (NN interaction)))) (. .))))

nsubj(revealed-20, Investigations-1)
det(effect-4, the-3)
prep_into(Investigations-1, effect-4)
prep_of(effect-4, acitretin-6)
det(binding-10, the-8)
nn(binding-10, protein-9)
prep_on(effect-4, binding-10)
prep_of(binding-10, anticoagulants-12)
det(type-16, the-14)
nn(type-16, coumarin-15)
prep_of(anticoagulants-12, type-16)
appos(type-16, warfarin-18)
root(ROOT-0, revealed-20)
det(interaction-22, no-21)
dobj(revealed-20, interaction-22)

Blood/NN Sugar/NN :/: Some/DT patients/NNS receiving/VBG retinoids/NNS have/VBP experienced/VBN problems/NNS with/IN blood/NN sugar/NN control/NN ./.

(ROOT (S1 (S (NP (NP (NN Blood) (NN Sugar)) (: :) (S (NP (NP (DT Some) (NNS patients)) (VP (VBG receiving) (NP (NNS retinoids)))) (VP (VBP have) (VP (VBN experienced) (NP (NNS problems)) (PP (IN with) (NP (NN blood) (NN sugar) (NN control)))))) (. .)))))

nn(Sugar-2, Blood-1)
root(ROOT-0, Sugar-2)
det(patients-5, Some-4)
nsubj(experienced-9, patients-5)
partmod(patients-5, receiving-6)
dobj(receiving-6, retinoids-7)
aux(experienced-9, have-8)
dep(Sugar-2, experienced-9)
dobj(experienced-9, problems-10)
nn(control-14, blood-12)
nn(control-14, sugar-13)
prep_with(experienced-9, control-14)

In/IN addition/NN ,/, new/JJ cases/NNS of/IN diabetes/NNS have/VBP been/VBN diagnosed/VBN during/IN retinoid/NN therapy/NN ,/, including/VBG diabetic/JJ ketoacidosis/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (JJ new) (NNS cases)) (PP (IN of) (NP (NNS diabetes)))) (VP (VBP have) (VP (VBN been) (VP (VBN diagnosed) (PP (IN during) (NP (NN retinoid) (NN therapy))) (, ,) (PP (VBG including) (NP (JJ diabetic) (NN ketoacidosis))))))) (. .))))

prep_in(diagnosed-10, addition-2)
amod(cases-5, new-4)
nsubjpass(diagnosed-10, cases-5)
prep_of(cases-5, diabetes-7)
aux(diagnosed-10, have-8)
auxpass(diagnosed-10, been-9)
root(ROOT-0, diagnosed-10)
nn(therapy-13, retinoid-12)
prep_during(diagnosed-10, therapy-13)
amod(ketoacidosis-17, diabetic-16)
prep_including(diagnosed-10, ketoacidosis-17)

It/PRP is/VBZ recommended/VBN that/IN these/DT tests/NNS be/VB performed/VBN weekly/RB or/CC every/DT other/JJ week/NN until/IN the/DT lipid/NN response/NN to/TO Soriatane/NN has/VBZ stabilized/VBN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (S (NP (DT these) (NNS tests)) (VP (VB be) (VP (VBN performed) (ADVP (RB weekly))))) (CC or) (S (NP (NP (DT every) (JJ other) (NN week)) (PP (IN until) (NP (NP (DT the) (NN lipid) (NN response)) (PP (TO to) (NP (NN Soriatane)))))) (VP (VBZ has) (VP (VBN stabilized))))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(performed-8, that-4)
det(tests-6, these-5)
nsubjpass(performed-8, tests-6)
auxpass(performed-8, be-7)
ccomp(recommended-3, performed-8)
advmod(performed-8, weekly-9)
det(week-13, every-11)
amod(week-13, other-12)
nsubj(stabilized-21, week-13)
det(response-17, the-15)
nn(response-17, lipid-16)
prep_until(week-13, response-17)
prep_to(response-17, Soriatane-19)
aux(stabilized-21, has-20)
conj_or(performed-8, stabilized-21)

Liver/NN Function/NN Tests/NNS :/: Elevations/NNS of/IN AST/NN (/-LRB- SGOT/NN )/-RRB- ,/, ALT/NN (/-LRB- SGPT/NN )/-RRB- or/CC LDH/NN were/VBD experienced/VBN by/IN approximately/RB 1/CD in/IN 3/CD patients/NNS treated/VBN with/IN Soriatane/NN ./.

(ROOT (S1 (S (NP (NP (NN Liver) (NN Function) (NNS Tests)) (: :) (S (NP (NP (NNS Elevations)) (PP (IN of) (NP (NP (NP (NN AST)) (PRN (-LRB- -LRB-) (NP (NN SGOT)) (-RRB- -RRB-))) (, ,) (NP (NP (NN ALT)) (PRN (-LRB- -LRB-) (NP (NN SGPT)) (-RRB- -RRB-))) (CC or) (NP (NN LDH))))) (VP (VBD were) (VP (VBN experienced) (PP (IN by) (NP (NP (RB approximately) (CD 1)) (PP (IN in) (NP (NP (CD 3) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NN Soriatane))))))))))) (. .)))))

nn(Tests-3, Liver-1)
nn(Tests-3, Function-2)
root(ROOT-0, Tests-3)
nsubjpass(experienced-19, Elevations-5)
prep_of(Elevations-5, AST-7)
abbrev(AST-7, SGOT-9)
conj_or(AST-7, ALT-12)
abbrev(ALT-12, SGPT-14)
conj_or(AST-7, LDH-17)
auxpass(experienced-19, were-18)
dep(Tests-3, experienced-19)
advmod(1-22, approximately-21)
agent(experienced-19, 1-22)
num(patients-25, 3-24)
prep_in(1-22, patients-25)
partmod(patients-25, treated-26)
prep_with(treated-26, Soriatane-28)

It/PRP is/VBZ recommended/VBN that/IN these/DT tests/NNS be/VB performed/VBN prior/RB to/TO initiation/NN of/IN Soriatane/NN therapy/NN ,/, at/IN 1-/CD to/TO 2-week/JJ intervals/NNS until/IN stable/JJ and/CC thereafter/RB at/IN intervals/NNS as/IN clinically/RB indicated/VBN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (DT these) (NNS tests)) (VP (VB be) (VP (VBN performed) (ADVP (ADVP (RB prior)) (PP (TO to) (NP (NP (NN initiation)) (PP (IN of) (NP (NN Soriatane) (NN therapy)))))) (, ,) (PP (PP (IN at) (NP (NP (CD 1-) (TO to) (JJ 2-week) (NNS intervals)) (PP (IN until) (NP (JJ stable))))) (CC and) (ADVP (RB thereafter)) (PP (IN at) (NP (NNS intervals)))) (SBAR (IN as) (S (ADVP (RB clinically)) (VP (VBN indicated))))))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(performed-8, that-4)
det(tests-6, these-5)
nsubjpass(performed-8, tests-6)
auxpass(performed-8, be-7)
ccomp(recommended-3, performed-8)
prep_prior_to(performed-8, initiation-11)
nn(therapy-14, Soriatane-13)
prep_of(initiation-11, therapy-14)
num(intervals-20, 1--17)
dep(intervals-20, to-18)
amod(intervals-20, 2-week-19)
prep_at(performed-8, intervals-20)
prep_until(intervals-20, stable-22)
advmod(performed-8, thereafter-24)
conj(performed-8, thereafter-24)
conj_and(intervals-20, intervals-26)
mark(indicated-29, as-27)
advmod(indicated-29, clinically-28)
advcl(performed-8, indicated-29)

Methotrexate/NN HUMIRA/NN has/VBZ been/VBN studied/VBN in/IN rheumatoid/JJ arthritis/NN patients/NNS taking/VBG concomitant/JJ MTX/NN ./.

(ROOT (S1 (S (S (NP (NN Methotrexate) (NN HUMIRA)) (VP (VBZ has) (VP (VBN been) (VP (VBN studied) (PP (IN in) (NP (NP (JJ rheumatoid) (NN arthritis) (NNS patients)) (VP (VBG taking) (NP (JJ concomitant) (NN MTX))))))))) (. .))))

nn(HUMIRA-2, Methotrexate-1)
nsubjpass(studied-5, HUMIRA-2)
aux(studied-5, has-3)
auxpass(studied-5, been-4)
root(ROOT-0, studied-5)
amod(patients-9, rheumatoid-7)
nn(patients-9, arthritis-8)
prep_in(studied-5, patients-9)
partmod(patients-9, taking-10)
amod(MTX-12, concomitant-11)
dobj(taking-10, MTX-12)

The/DT data/NNS do/VBP not/RB suggest/VBP the/DT need/NN for/IN dose/NN adjustment/NN of/IN either/CC HUMIRA/NN or/CC MTX/NN ./.

(ROOT (S1 (S (S (NP (DT The) (NNS data)) (VP (VBP do) (RB not) (VP (VBP suggest) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (NP (NN dose) (NN adjustment)) (PP (IN of) (NP (CC either) (NP (NN HUMIRA)) (CC or) (NP (NN MTX)))))))))) (. .))))

det(data-2, The-1)
nsubj(suggest-5, data-2)
aux(suggest-5, do-3)
neg(suggest-5, not-4)
root(ROOT-0, suggest-5)
det(need-7, the-6)
dobj(suggest-5, need-7)
nn(adjustment-10, dose-9)
prep_for(need-7, adjustment-10)
preconj(HUMIRA-13, either-12)
prep_of(adjustment-10, HUMIRA-13)
conj_or(HUMIRA-13, MTX-15)

Anakinra/NN Concurrent/JJ administration/NN of/IN anakinra/NN (/-LRB- an/DT interleukin-1/NN antagonist/NN )/-RRB- and/CC another/DT TNF-blocking/JJ agent/NN has/VBZ been/VBN associated/VBN with/IN an/DT increased/VBN risk/NN of/IN serious/JJ infections/NNS ,/, an/DT increased/VBN risk/NN of/IN neutropenia/NN and/CC no/DT additional/JJ benefit/NN compared/VBN to/TO these/DT medicinal/JJ product/NN s/NN alone/RB ./.

(ROOT (S1 (S (S (NP (NP (NN Anakinra) (JJ Concurrent) (NN administration)) (PP (IN of) (NP (NP (NP (NN anakinra)) (PRN (-LRB- -LRB-) (NP (DT an) (NN interleukin-1) (NN antagonist)) (-RRB- -RRB-))) (CC and) (NP (DT another) (JJ TNF-blocking) (NN agent))))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (JJ serious) (NNS infections)))) (, ,) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (NN neutropenia)))) (CC and) (NP (NP (DT no) (JJ additional) (NN benefit)) (PP (VBN compared) (PP (TO to) (NP (NP (DT these) (JJ medicinal) (NN product) (NN s)) (ADVP (RB alone)))))))))))) (. .))))

nn(administration-3, Anakinra-1)
amod(administration-3, Concurrent-2)
nsubjpass(associated-17, administration-3)
prep_of(administration-3, anakinra-5)
det(antagonist-9, an-7)
nn(antagonist-9, interleukin-1-8)
appos(anakinra-5, antagonist-9)
det(agent-14, another-12)
amod(agent-14, TNF-blocking-13)
conj_and(anakinra-5, agent-14)
aux(associated-17, has-15)
auxpass(associated-17, been-16)
root(ROOT-0, associated-17)
det(risk-21, an-19)
amod(risk-21, increased-20)
prep_with(associated-17, risk-21)
amod(infections-24, serious-23)
prep_of(risk-21, infections-24)
det(risk-28, an-26)
amod(risk-28, increased-27)
conj_and(risk-21, risk-28)
prep_of(risk-28, neutropenia-30)
det(benefit-34, no-32)
amod(benefit-34, additional-33)
conj_and(risk-21, benefit-34)
prepc_compared_to(benefit-34, to-36)
det(s-40, these-37)
amod(s-40, medicinal-38)
nn(s-40, product-39)
pobj(benefit-34, s-40)
advmod(s-40, alone-41)

The/DT safety/NN and/CC efficacy/NN of/IN anakinra/NN used/VBN in/IN combination/NN with/IN HUMIRA/NNS has/VBZ not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NP (NN safety)) (CC and) (NP (NN efficacy))) (PP (IN of) (NP (NP (NN anakinra)) (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NNS HUMIRA))))))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

dep(safety-2, The-1)
nsubjpass(studied-15, safety-2)
conj_and(safety-2, efficacy-4)
prep_of(safety-2, anakinra-6)
partmod(anakinra-6, used-7)
prep_in(used-7, combination-9)
prep_with(combination-9, HUMIRA-11)
aux(studied-15, has-12)
neg(studied-15, not-13)
auxpass(studied-15, been-14)
root(ROOT-0, studied-15)

Therefore/RB the/DT ,/, combination/NN of/IN anakinra/NN with/IN other/JJ TNF-blocking/JJ agents/NNS ,/, including/VBG HUMIRA/NN ,/, may/MD also/RB result/VB i/NN n/NN similar/JJ toxicities/NNS ./.

(ROOT (S1 (S (S (ADJP (RB Therefore) (DT the)) (, ,) (NP (NP (NN combination)) (PP (IN of) (NP (NN anakinra))) (PP (IN with) (NP (NP (JJ other) (JJ TNF-blocking) (NNS agents)) (, ,) (PP (VBG including) (NP (NN HUMIRA))) (, ,)))) (VP (MD may) (ADVP (RB also)) (VP (VB result) (NP (ADJP (NN i) (NN n) (JJ similar)) (NNS toxicities))))) (. .))))

advmod(the-2, Therefore-1)
dep(result-17, the-2)
nsubj(result-17, combination-4)
prep_of(combination-4, anakinra-6)
amod(agents-10, other-8)
amod(agents-10, TNF-blocking-9)
prep_with(combination-4, agents-10)
prep_including(agents-10, HUMIRA-13)
aux(result-17, may-15)
advmod(result-17, also-16)
root(ROOT-0, result-17)
dep(similar-20, i-18)
dep(similar-20, n-19)
amod(toxicities-21, similar-20)
dobj(result-17, toxicities-21)

Intravenous/JJ Adenocard/NN (/-LRB- adenosine/NN )/-RRB- has/VBZ been/VBN effectively/RB administered/VBN in/IN the/DT presence/NN of/IN other/JJ cardioactive/JJ drugs/NNS ,/, such/JJ as/IN quinidine/NN ,/, beta-adrenergic/JJ blocking/NN agents/NNS ,/, calcium/NN channel/NN blocking/NN agents/NNS ,/, and/CC angiotensin/NN converting/NN enzyme/NN inhibitors/NNS ,/, without/IN any/DT change/NN in/IN the/DT adverse/JJ reaction/NN profile/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Intravenous) (NN Adenocard)) (PRN (-LRB- -LRB-) (NP (NN adenosine)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (ADVP (RB effectively)) (VP (VBN administered) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ other) (JJ cardioactive) (NNS drugs)) (, ,) (PP (JJ such) (IN as) (NP (NN quinidine))) (, ,) (NP (JJ beta-adrenergic) (NN blocking) (NNS agents)) (, ,) (NP (NN calcium) (NN channel) (NN blocking) (NNS agents)) (, ,) (CC and) (NP (NN angiotensin) (NN converting) (NN enzyme) (NNS inhibitors)))))) (, ,) (PP (IN without) (NP (NP (DT any) (NN change)) (PP (IN in) (NP (DT the) (JJ adverse) (NN reaction) (NN profile))))))))) (. .))))

amod(Adenocard-2, Intravenous-1)
nsubjpass(administered-9, Adenocard-2)
appos(Adenocard-2, adenosine-4)
aux(administered-9, has-6)
auxpass(administered-9, been-7)
advmod(administered-9, effectively-8)
root(ROOT-0, administered-9)
det(presence-12, the-11)
prep_in(administered-9, presence-12)
amod(drugs-16, other-14)
amod(drugs-16, cardioactive-15)
prep_of(presence-12, drugs-16)
conj_and(drugs-16, as-19)
prep_such_as(drugs-16, quinidine-20)
amod(agents-24, beta-adrenergic-22)
nn(agents-24, blocking-23)
conj_and(drugs-16, agents-24)
nn(agents-29, calcium-26)
nn(agents-29, channel-27)
nn(agents-29, blocking-28)
conj_and(drugs-16, agents-29)
nn(inhibitors-35, angiotensin-32)
nn(inhibitors-35, converting-33)
nn(inhibitors-35, enzyme-34)
conj_and(drugs-16, inhibitors-35)
det(change-39, any-38)
prep_without(administered-9, change-39)
det(profile-44, the-41)
amod(profile-44, adverse-42)
nn(profile-44, reaction-43)
prep_in(change-39, profile-44)

Digoxin/NN and/CC verapamil/NN use/NN may/MD be/VB rarely/RB associated/VBN with/IN ventricular/JJ fibrillation/NN when/WRB combined/VBN with/IN Adenocard/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Digoxin)) (CC and) (NP (NN verapamil))) (NN use)) (VP (MD may) (VP (VB be) (ADVP (RB rarely)) (VP (VBN associated) (PP (IN with) (NP (JJ ventricular) (NN fibrillation))) (SBAR (WHADVP (WRB when)) (S (VP (VBN combined) (PP (IN with) (NP (NN Adenocard)))))))))) (. .))))

nn(use-4, Digoxin-1)
conj_and(Digoxin-1, verapamil-3)
nsubjpass(associated-8, use-4)
aux(associated-8, may-5)
auxpass(associated-8, be-6)
advmod(associated-8, rarely-7)
root(ROOT-0, associated-8)
amod(fibrillation-11, ventricular-10)
prep_with(associated-8, fibrillation-11)
advmod(combined-13, when-12)
advcl(associated-8, combined-13)
prep_with(combined-13, Adenocard-15)

Because/IN of/IN the/DT potential/NN for/IN additive/JJ or/CC synergistic/JJ depressant/NN effects/NNS on/IN the/DT SA/NN and/CC AV/NN nodes/NNS ,/, however/RB ,/, Adenocard/NN should/MD be/VB used/VBN with/IN caution/NN in/IN the/DT presence/NN of/IN these/DT agents/NNS ./.

(ROOT (S1 (S (PP (IN Because) (PP (IN of) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (ADJP (ADJP (JJ additive)) (CC or) (ADJP (JJ synergistic))) (NN depressant) (NNS effects)) (PP (IN on) (NP (DT the) (NN SA) (CC and) (NN AV) (NNS nodes)))))))) (, ,) (ADVP (RB however)) (, ,) (NP (NN Adenocard)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN caution))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT these) (NNS agents)))))))) (. .))))

prepc_because_of(used-23, of-2)
det(potential-4, the-3)
pobj(used-23, potential-4)
amod(effects-10, additive-6)
conj_or(additive-6, synergistic-8)
nn(effects-10, depressant-9)
prep_for(potential-4, effects-10)
det(nodes-16, the-12)
nn(nodes-16, SA-13)
conj_and(SA-13, AV-15)
prep_on(effects-10, nodes-16)
advmod(used-23, however-18)
nsubjpass(used-23, Adenocard-20)
aux(used-23, should-21)
auxpass(used-23, be-22)
root(ROOT-0, used-23)
prep_with(used-23, caution-25)
det(presence-28, the-27)
prep_in(used-23, presence-28)
det(agents-31, these-30)
prep_of(presence-28, agents-31)

The/DT use/NN of/IN Adenocard/NN in/IN patients/NNS receiving/VBG digitalis/NN may/MD be/VB rarely/RB associated/VBN with/IN ventricular/JJ fibrillation/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NN Adenocard))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN digitalis)))))) (VP (MD may) (VP (VB be) (ADVP (RB rarely)) (VP (VBN associated) (PP (IN with) (NP (JJ ventricular) (NN fibrillation))))))) (. .))))

det(use-2, The-1)
nsubjpass(associated-12, use-2)
prep_of(use-2, Adenocard-4)
prep_in(use-2, patients-6)
partmod(patients-6, receiving-7)
dobj(receiving-7, digitalis-8)
aux(associated-12, may-9)
auxpass(associated-12, be-10)
advmod(associated-12, rarely-11)
root(ROOT-0, associated-12)
amod(fibrillation-15, ventricular-14)
prep_with(associated-12, fibrillation-15)

The/DT effects/NNS of/IN adenosine/NN are/VBP antagonized/VBN by/IN methylxanthines/NNS such/JJ as/IN caffeine/NN and/CC theophylline/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NN adenosine)))) (VP (VBP are) (VP (VBN antagonized) (PP (IN by) (NP (NP (NNS methylxanthines)) (PP (JJ such) (IN as) (NP (NP (NN caffeine)) (CC and) (NP (NN theophylline))))))))) (. .))))

det(effects-2, The-1)
nsubjpass(antagonized-6, effects-2)
prep_of(effects-2, adenosine-4)
auxpass(antagonized-6, are-5)
root(ROOT-0, antagonized-6)
agent(antagonized-6, methylxanthines-8)
prep_such_as(methylxanthines-8, caffeine-11)
conj_and(caffeine-11, theophylline-13)

In/IN the/DT presence/NN of/IN these/DT methylxanthines/NNS ,/, larger/JJR doses/NNS of/IN adenosine/NN may/MD be/VB required/VBN or/CC adenosine/NN may/MD not/RB be/VB effective/JJ ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT these) (NNS methylxanthines))))) (, ,) (S (NP (NP (JJR larger) (NNS doses)) (PP (IN of) (NP (NN adenosine)))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (CC or) (S (NP (NN adenosine)) (VP (MD may) (RB not) (VP (VB be) (ADJP (JJ effective)))))) (. .))))

det(presence-3, the-2)
prep_in(required-14, presence-3)
det(methylxanthines-6, these-5)
prep_of(presence-3, methylxanthines-6)
amod(doses-9, larger-8)
nsubjpass(required-14, doses-9)
prep_of(doses-9, adenosine-11)
aux(required-14, may-12)
auxpass(required-14, be-13)
root(ROOT-0, required-14)
nsubj(effective-20, adenosine-16)
aux(effective-20, may-17)
neg(effective-20, not-18)
cop(effective-20, be-19)
conj_or(required-14, effective-20)

Adenosine/NN effects/NNS are/VBP potentiated/VBN by/IN dipyridamole/NN ./.

(ROOT (S1 (S (S (NP (NN Adenosine) (NNS effects)) (VP (VBP are) (VP (VBN potentiated) (PP (IN by) (NP (NN dipyridamole)))))) (. .))))

nn(effects-2, Adenosine-1)
nsubjpass(potentiated-4, effects-2)
auxpass(potentiated-4, are-3)
root(ROOT-0, potentiated-4)
agent(potentiated-4, dipyridamole-6)

Thus/RB ,/, smaller/JJR doses/NNS of/IN adenosine/NN may/MD be/VB effective/JJ in/IN the/DT presence/NN of/IN dipyridamole/NN ./.

(ROOT (S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (JJR smaller) (NNS doses)) (PP (IN of) (NP (NN adenosine)))) (VP (MD may) (VP (VB be) (ADJP (JJ effective) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN dipyridamole))))))))) (. .))))

advmod(effective-9, Thus-1)
amod(doses-4, smaller-3)
nsubj(effective-9, doses-4)
prep_of(doses-4, adenosine-6)
aux(effective-9, may-7)
cop(effective-9, be-8)
root(ROOT-0, effective-9)
det(presence-12, the-11)
prep_in(effective-9, presence-12)
prep_of(presence-12, dipyridamole-14)

Carbamazepine/NN has/VBZ been/VBN reported/VBN to/TO increase/VB the/DT degree/NN of/IN heart/NN block/NN produced/VBN by/IN other/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (NN Carbamazepine)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NP (NN heart) (NN block)) (VP (VBN produced) (PP (IN by) (NP (JJ other) (NNS agents)))))))))))))) (. .))))

nsubjpass(reported-4, Carbamazepine-1)
xsubj(increase-6, Carbamazepine-1)
aux(reported-4, has-2)
auxpass(reported-4, been-3)
root(ROOT-0, reported-4)
aux(increase-6, to-5)
xcomp(reported-4, increase-6)
det(degree-8, the-7)
dobj(increase-6, degree-8)
nn(block-11, heart-10)
prep_of(degree-8, block-11)
partmod(block-11, produced-12)
amod(agents-15, other-14)
agent(produced-12, agents-15)

As/IN the/DT primary/JJ effect/NN of/IN adenosine/NN is/VBZ to/TO decrease/VB conduction/NN through/IN the/DT A-V/NN node/NN ,/, higher/JJR degrees/NNS of/IN heart/NN block/NN may/MD be/VB produced/VBN in/IN the/DT presence/NN of/IN carbamazepine/NN ./.

(ROOT (S1 (S (S (SBAR (IN As) (S (NP (NP (DT the) (JJ primary) (NN effect)) (PP (IN of) (NP (NN adenosine)))) (VP (VBZ is) (S (VP (TO to) (VP (VB decrease) (NP (NN conduction)) (PP (IN through) (NP (DT the) (NN A-V) (NN node))))))))) (, ,) (NP (NP (JJR higher) (NNS degrees)) (PP (IN of) (NP (NN heart) (NN block)))) (VP (MD may) (VP (VB be) (VP (VBN produced) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN carbamazepine))))))))) (. .))))

mark(is-7, As-1)
det(effect-4, the-2)
amod(effect-4, primary-3)
nsubj(is-7, effect-4)
xsubj(decrease-9, effect-4)
prep_of(effect-4, adenosine-6)
advcl(produced-23, is-7)
aux(decrease-9, to-8)
xcomp(is-7, decrease-9)
dobj(decrease-9, conduction-10)
det(node-14, the-12)
nn(node-14, A-V-13)
prep_through(decrease-9, node-14)
amod(degrees-17, higher-16)
nsubjpass(produced-23, degrees-17)
nn(block-20, heart-19)
prep_of(degrees-17, block-20)
aux(produced-23, may-21)
auxpass(produced-23, be-22)
root(ROOT-0, produced-23)
det(presence-26, the-25)
prep_in(produced-23, presence-26)
prep_of(presence-26, carbamazepine-28)

Co-administration/NN with/IN antifungal/JJ agents/NNS such/JJ as/IN ketoconazole/NN or/CC itraconazole/NN is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN with) (NP (NP (JJ antifungal) (NNS agents)) (PP (JJ such) (IN as) (NP (NP (NN ketoconazole)) (CC or) (NP (NN itraconazole))))))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

nsubjpass(recommended-12, Co-administration-1)
amod(agents-4, antifungal-3)
prep_with(Co-administration-1, agents-4)
prep_such_as(agents-4, ketoconazole-7)
conj_or(ketoconazole-7, itraconazole-9)
auxpass(recommended-12, is-10)
neg(recommended-12, not-11)
root(ROOT-0, recommended-12)

Nafazodone/NN ,/, fluvoxamine/NN ,/, cimetidine/NN (/-LRB- consider/VB Xanax/NN dose/NN reduction/NN )./CD

(ROOT (S1 (S (NP (NP (NN Nafazodone)) (, ,) (NP (NN fluvoxamine)) (, ,) (NP (NN cimetidine)) (-LRB- -LRB-) (NP (VB consider) (NP (NN Xanax) (NN dose) (NN reduction) (CD -RRB-.)))))))

root(ROOT-0, Nafazodone-1)
appos(Nafazodone-1, fluvoxamine-3)
appos(Nafazodone-1, cimetidine-5)
dep(reduction-10, consider-7)
nn(reduction-10, Xanax-8)
nn(reduction-10, dose-9)
dep(Nafazodone-1, reduction-10)
num(reduction-10, -RRB-.-11)

Fluoxetine/NN ,/, OCs/NN ,/, sertraline/NN ,/, diltiazem/NN ,/, macrolide/NN antibiotics/NNS (/-LRB- exercise/NN caution/NN )./NN

(ROOT (S1 (S (NP (NP (NN Fluoxetine)) (, ,) (NP (NN OCs)) (, ,) (NP (NN sertraline)) (, ,) (NP (NN diltiazem)) (, ,) (NP (NN macrolide) (NNS antibiotics)) (-LRB- -LRB-) (NP (NN exercise) (NN caution) (NN -RRB-.))))))

root(ROOT-0, Fluoxetine-1)
appos(Fluoxetine-1, OCs-3)
appos(Fluoxetine-1, sertraline-5)
appos(Fluoxetine-1, diltiazem-7)
nn(antibiotics-10, macrolide-9)
appos(Fluoxetine-1, antibiotics-10)
nn(-RRB-.-14, exercise-12)
nn(-RRB-.-14, caution-13)
dep(Fluoxetine-1, -RRB-.-14)

Dexamethasone/NN :/: Steady-state/JJ trough/NN concentrations/NNS of/IN albendazole/JJ sulfoxide/NN were/VBD about/RB 56/CD %/NN higher/JJR when/WRB 8/CD mg/NN dexamethasone/NN was/VBD coadministered/VBN with/IN each/DT dose/NN of/IN albendazole/NN (/-LRB- 15/CD mg/kg/day/NN )/-RRB- in/IN eight/CD neurocysticercosis/NN patients/NNS ./.

(ROOT (S1 (S (NP (NP (NN Dexamethasone)) (: :) (S (NP (NP (JJ Steady-state) (NN trough) (NNS concentrations)) (PP (IN of) (NP (JJ albendazole) (NN sulfoxide)))) (VP (VBD were) (ADJP (NP (QP (RB about) (CD 56)) (NN %)) (JJR higher)) (SBAR (WHADVP (WRB when)) (S (NP (ADJP (CD 8) (NN mg)) (NN dexamethasone)) (VP (VBD was) (VP (VBN coadministered) (PP (IN with) (NP (NP (NP (NP (DT each) (NN dose)) (PP (IN of) (NP (NN albendazole)))) (PRN (-LRB- -LRB-) (NP (CD 15) (NN mg/kg/day)) (-RRB- -RRB-))) (PP (IN in) (NP (CD eight) (NN neurocysticercosis) (NNS patients))))))))))) (. .)))))

root(ROOT-0, Dexamethasone-1)
amod(concentrations-5, Steady-state-3)
nn(concentrations-5, trough-4)
nsubj(higher-13, concentrations-5)
amod(sulfoxide-8, albendazole-7)
prep_of(concentrations-5, sulfoxide-8)
cop(higher-13, were-9)
quantmod(56-11, about-10)
num(%-12, 56-11)
npadvmod(higher-13, %-12)
dep(Dexamethasone-1, higher-13)
advmod(coadministered-19, when-14)
number(mg-16, 8-15)
amod(dexamethasone-17, mg-16)
nsubjpass(coadministered-19, dexamethasone-17)
auxpass(coadministered-19, was-18)
advcl(higher-13, coadministered-19)
det(dose-22, each-21)
prep_with(coadministered-19, dose-22)
prep_of(dose-22, albendazole-24)
num(mg/kg/day-27, 15-26)
appos(dose-22, mg/kg/day-27)
num(patients-32, eight-30)
nn(patients-32, neurocysticercosis-31)
prep_in(dose-22, patients-32)

Praziquantel/NN :/: In/IN the/DT fed/JJ state/NN ,/, praziquantel/NN (/-LRB- 40/CD mg/kg/NN )/-RRB- increased/VBD mean/NN maximum/NN plasma/NN concentration/NN and/CC area/NN under/IN the/DT curve/NN of/IN albendazole/NN sulfoxide/NN by/IN about/RB 50/CD %/NN in/IN healthy/JJ subjects/NNS (/-LRB- n=10/NN )/-RRB- compared/VBN with/IN a/DT separate/JJ group/NN of/IN subjects/NNS (/-LRB- n=6/NN )/-RRB- given/IN albendazole/NN alone/RB ./.

(ROOT (S1 (S (NP (NP (NN Praziquantel)) (: :) (S (PP (IN In) (NP (DT the) (JJ fed) (NN state))) (, ,) (NP (NP (NN praziquantel)) (PRN (-LRB- -LRB-) (NP (CD 40) (NN mg/kg)) (-RRB- -RRB-))) (VP (VBD increased) (NP (NP (NN mean) (NN maximum) (NN plasma) (NN concentration)) (CC and) (NP (NP (NN area)) (PP (IN under) (NP (NP (DT the) (NN curve)) (PP (IN of) (NP (NN albendazole) (NN sulfoxide))))))) (PP (IN by) (NP (NP (QP (RB about) (CD 50)) (NN %)) (PP (IN in) (NP (NP (JJ healthy) (NNS subjects)) (PRN (-LRB- -LRB-) (NP (NN n=10)) (-RRB- -RRB-)))))) (PP (VBN compared) (PP (IN with) (NP (NP (DT a) (JJ separate) (NN group)) (PP (IN of) (NP (NP (NP (NNS subjects)) (PRN (-LRB- -LRB-) (NP (NN n=6)) (-RRB- -RRB-))) (PP (IN given) (NP (NP (NN albendazole)) (ADVP (RB alone))))))))))) (. .)))))

root(ROOT-0, Praziquantel-1)
det(state-6, the-4)
amod(state-6, fed-5)
prep_in(increased-13, state-6)
nsubj(increased-13, praziquantel-8)
num(mg/kg-11, 40-10)
appos(praziquantel-8, mg/kg-11)
dep(Praziquantel-1, increased-13)
nn(concentration-17, mean-14)
nn(concentration-17, maximum-15)
nn(concentration-17, plasma-16)
dobj(increased-13, concentration-17)
conj_and(concentration-17, area-19)
det(curve-22, the-21)
prep_under(area-19, curve-22)
nn(sulfoxide-25, albendazole-24)
prep_of(curve-22, sulfoxide-25)
quantmod(50-28, about-27)
num(%-29, 50-28)
prep_by(increased-13, %-29)
amod(subjects-32, healthy-31)
prep_in(%-29, subjects-32)
appos(subjects-32, n=10-34)
prepc_compared_with(increased-13, with-37)
det(group-40, a-38)
amod(group-40, separate-39)
pobj(increased-13, group-40)
prep_of(group-40, subjects-42)
appos(subjects-42, n=6-44)
prep_given(subjects-42, albendazole-47)
advmod(albendazole-47, alone-48)

Mean/NN T/NN max/NN and/CC mean/NN plasma/NN elimination/NN half-life/NN of/IN albendazole/JJ sulfoxide/NN were/VBD unchanged/JJ ./.

(ROOT (S1 (S (S (NP (NP (NN Mean) (NN T) (NN max) (CC and) (NN mean) (NN plasma) (NN elimination) (NN half-life)) (PP (IN of) (NP (JJ albendazole) (NN sulfoxide)))) (VP (VBD were) (ADJP (JJ unchanged)))) (. .))))

nn(max-3, Mean-1)
nn(max-3, T-2)
nsubj(unchanged-13, max-3)
nn(half-life-8, mean-5)
nn(half-life-8, plasma-6)
nn(half-life-8, elimination-7)
conj_and(max-3, half-life-8)
amod(sulfoxide-11, albendazole-10)
prep_of(max-3, sulfoxide-11)
cop(unchanged-13, were-12)
root(ROOT-0, unchanged-13)

The/DT pharmacokinetics/NNS of/IN praziquantel/NN were/VBD unchanged/JJ following/VBG coadministration/NN with/IN albendazole/NN (/-LRB- 400/CD mg/NN )./CD

(ROOT (S1 (S (NP (NP (DT The) (NNS pharmacokinetics)) (PP (IN of) (NP (NN praziquantel)))) (VP (VBD were) (ADJP (JJ unchanged)) (PP (VBG following) (NP (NN coadministration))) (PP (IN with) (NP (NN albendazole))) (-LRB- -LRB-) (NP (CD 400) (NN mg) (CD -RRB-.))))))

det(pharmacokinetics-2, The-1)
nsubj(unchanged-6, pharmacokinetics-2)
prep_of(pharmacokinetics-2, praziquantel-4)
cop(unchanged-6, were-5)
root(ROOT-0, unchanged-6)
prep_following(unchanged-6, coadministration-8)
prep_with(unchanged-6, albendazole-10)
num(mg-13, 400-12)
attr(unchanged-6, mg-13)
num(mg-13, -RRB-.-14)

Cimetidine/NN :/: Albendazole/NN sulfoxide/NN concentrations/NNS in/IN bile/NN and/CC cystic/JJ fluid/NN were/VBD increased/VBN (/-LRB- about/RB 2-fold/RB )/-RRB- in/IN hydatid/JJ cyst/NN patients/NNS treated/VBN with/IN cimetidine/NN (/-LRB- 10/CD mg/kg/day/NN )/-RRB- (/-LRB- n=7/NN )/-RRB- compared/VBN with/IN albendazole/NN (/-LRB- 20/CD mg/kg/day/NN )/-RRB- alone/RB (/-LRB- n=12)./NN

(ROOT (S1 (S (NP (NP (NN Cimetidine)) (: :) (S (NP (NP (NN Albendazole) (NN sulfoxide) (NNS concentrations)) (PP (IN in) (NP (NP (NN bile)) (CC and) (NP (JJ cystic) (NN fluid))))) (VP (VBD were) (VP (VBN increased) (PRN (-LRB- -LRB-) (ADVP (RB about) (RB 2-fold)) (-RRB- -RRB-)) (PP (IN in) (NP (NP (JJ hydatid) (NN cyst) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (NP (NN cimetidine)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN mg/kg/day)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (NN n=7)) (-RRB- -RRB-))))))) (PP (VBN compared) (PP (IN with) (NP (NP (NP (NN albendazole)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN mg/kg/day)) (-RRB- -RRB-))) (ADVP (RB alone))))) (-LRB- -LRB-) (NP (NN n=12-RRB-.)))))))))

root(ROOT-0, Cimetidine-1)
nn(concentrations-5, Albendazole-3)
nn(concentrations-5, sulfoxide-4)
nsubjpass(increased-12, concentrations-5)
prep_in(concentrations-5, bile-7)
amod(fluid-10, cystic-9)
conj_and(bile-7, fluid-10)
auxpass(increased-12, were-11)
dep(Cimetidine-1, increased-12)
advmod(2-fold-15, about-14)
dep(increased-12, 2-fold-15)
amod(patients-20, hydatid-18)
nn(patients-20, cyst-19)
prep_in(increased-12, patients-20)
partmod(patients-20, treated-21)
prep_with(treated-21, cimetidine-23)
num(mg/kg/day-26, 10-25)
appos(cimetidine-23, mg/kg/day-26)
appos(cimetidine-23, n=7-29)
prepc_compared_with(increased-12, with-32)
pobj(increased-12, albendazole-33)
num(mg/kg/day-36, 20-35)
appos(albendazole-33, mg/kg/day-36)
advmod(albendazole-33, alone-38)
dobj(increased-12, n=12-RRB-.-40)

Albendazole/NN sulfoxide/NN plasma/NN concentrations/NNS were/VBD unchanged/JJ 4/CD hours/NNS after/IN dosing/NN ./.

(ROOT (S1 (S (S (NP (NN Albendazole) (NN sulfoxide) (NN plasma) (NNS concentrations)) (VP (VBD were) (ADJP (JJ unchanged)) (PP (NP (CD 4) (NNS hours)) (IN after) (NP (NN dosing))))) (. .))))

nn(concentrations-4, Albendazole-1)
nn(concentrations-4, sulfoxide-2)
nn(concentrations-4, plasma-3)
nsubj(unchanged-6, concentrations-4)
cop(unchanged-6, were-5)
root(ROOT-0, unchanged-6)
num(hours-8, 4-7)
npadvmod(unchanged-6, hours-8)
prep_after(unchanged-6, dosing-10)

Theophylline/NN :/: The/DT pharmacokinetics/NNS of/IN theophylline/NN (/-LRB- aminophylline/NN 5.8/CD mg/kg/NN infused/VBN over/IN 20/CD minutes/NNS )/-RRB- were/VBD unchanged/JJ following/VBG a/DT single/JJ oral/JJ dose/NN of/IN albendazole/NN (/-LRB- 400/CD mg/NN )/-RRB- in/IN 6/CD healthy/JJ subjects/NNS ./.

(ROOT (S1 (S (NP (NP (NN Theophylline)) (: :) (S (NP (NP (DT The) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN theophylline)) (PRN (-LRB- -LRB-) (NP (NP (NN aminophylline) (CD 5.8) (NN mg/kg)) (VP (VBN infused) (PP (IN over) (NP (CD 20) (NNS minutes))))) (-RRB- -RRB-))))) (VP (VBD were) (ADJP (JJ unchanged)) (PP (VBG following) (NP (NP (NP (DT a) (JJ single) (JJ oral) (NN dose)) (PP (IN of) (NP (NN albendazole)))) (PRN (-LRB- -LRB-) (NP (CD 400) (NN mg)) (-RRB- -RRB-)))) (PP (IN in) (NP (CD 6) (JJ healthy) (NNS subjects))))) (. .)))))

root(ROOT-0, Theophylline-1)
det(pharmacokinetics-4, The-3)
nsubj(unchanged-17, pharmacokinetics-4)
prep_of(pharmacokinetics-4, theophylline-6)
nn(mg/kg-10, aminophylline-8)
num(mg/kg-10, 5.8-9)
dep(theophylline-6, mg/kg-10)
partmod(mg/kg-10, infused-11)
num(minutes-14, 20-13)
prep_over(infused-11, minutes-14)
cop(unchanged-17, were-16)
dep(Theophylline-1, unchanged-17)
det(dose-22, a-19)
amod(dose-22, single-20)
amod(dose-22, oral-21)
prep_following(unchanged-17, dose-22)
prep_of(dose-22, albendazole-24)
num(mg-27, 400-26)
appos(dose-22, mg-27)
num(subjects-32, 6-30)
amod(subjects-32, healthy-31)
prep_in(unchanged-17, subjects-32)

PROLEUKIN/NN may/MD affect/VB central/JJ nervous/JJ function/NN ./.

(ROOT (S1 (S (S (NP (NN PROLEUKIN)) (VP (MD may) (VP (VB affect) (NP (JJ central) (JJ nervous) (NN function))))) (. .))))

nsubj(affect-3, PROLEUKIN-1)
aux(affect-3, may-2)
root(ROOT-0, affect-3)
amod(function-6, central-4)
amod(function-6, nervous-5)
dobj(affect-3, function-6)

Therefore/RB ,/, interactions/NNS could/MD occur/VB following/VBG concomitant/JJ administration/NN of/IN psychotropic/JJ drugs/NNS (/-LRB- e.g./FW ,/, narcotics/NNS ,/, analgesics/NNS ,/, antiemetics/NNS ,/, sedatives/NNS ,/, tranquilizers/NNS )/-RRB- ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NNS interactions)) (VP (MD could) (VP (VB occur) (PP (VBG following) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (JJ psychotropic) (NNS drugs)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NNS narcotics)) (, ,) (NP (NNS analgesics)) (, ,) (NP (NNS antiemetics)) (, ,) (NP (NNS sedatives)) (, ,) (NP (NNS tranquilizers))) (-RRB- -RRB-))))))))) (. .))))

advmod(occur-5, Therefore-1)
nsubj(occur-5, interactions-3)
aux(occur-5, could-4)
root(ROOT-0, occur-5)
amod(administration-8, concomitant-7)
prep_following(occur-5, administration-8)
amod(drugs-11, psychotropic-10)
prep_of(administration-8, drugs-11)
dep(narcotics-15, e.g.-13)
dep(drugs-11, narcotics-15)
appos(narcotics-15, analgesics-17)
appos(narcotics-15, antiemetics-19)
appos(narcotics-15, sedatives-21)
appos(narcotics-15, tranquilizers-23)

Concurrent/JJ administration/NN of/IN drugs/NNS possessing/VBG nephrotoxic/JJ (/-LRB- e.g./FW ,/, aminoglycosides/NN ,/, indomethacin/NN )/-RRB- ,/, myelotoxic/JJ (/-LRB- e.g./FW ,/, cytotoxic/JJ chemotherapy/NN )/-RRB- ,/, cardiotoxic/JJ (/-LRB- e.g./FW ,/, doxorubicin/NN )/-RRB- or/CC hepatotoxic/JJ (/-LRB- e.g./FW ,/, methotrexate/NN ,/, asparaginase/NN )/-RRB- effects/NNS with/IN PROLEUKIN/NN may/MD increase/VB toxicity/NN in/IN these/DT organ/NN systems/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Concurrent) (NN administration)) (PP (IN of) (NP (NP (NNS drugs)) (VP (VBG possessing) (NP (ADJP (ADJP (JJ nephrotoxic) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN aminoglycosides)) (, ,) (NP (NN indomethacin))) (-RRB- -RRB-))) (, ,) (ADJP (JJ myelotoxic) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (JJ cytotoxic) (NN chemotherapy)) (-RRB- -RRB-))) (, ,) (ADJP (JJ cardiotoxic) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN doxorubicin)) (-RRB- -RRB-))) (CC or) (ADJP (JJ hepatotoxic) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN methotrexate))) (, ,) (NP (NN asparaginase)) (-RRB- -RRB-)))) (NNS effects))))) (PP (IN with) (NP (NN PROLEUKIN)))) (VP (MD may) (VP (VB increase) (NP (NN toxicity)) (PP (IN in) (NP (DT these) (NN organ) (NNS systems))))) (. .))))

amod(administration-2, Concurrent-1)
nsubj(increase-42, administration-2)
prep_of(administration-2, drugs-4)
partmod(drugs-4, possessing-5)
amod(effects-38, nephrotoxic-6)
dep(aminoglycosides-10, e.g.-8)
dep(nephrotoxic-6, aminoglycosides-10)
appos(aminoglycosides-10, indomethacin-12)
conj_or(nephrotoxic-6, myelotoxic-15)
dep(chemotherapy-20, e.g.-17)
amod(chemotherapy-20, cytotoxic-19)
dep(myelotoxic-15, chemotherapy-20)
conj_or(nephrotoxic-6, cardiotoxic-23)
dep(doxorubicin-27, e.g.-25)
dep(cardiotoxic-23, doxorubicin-27)
conj_or(nephrotoxic-6, hepatotoxic-30)
dep(asparaginase-36, e.g.-32)
pobj(e.g.-32, methotrexate-34)
dep(hepatotoxic-30, asparaginase-36)
dobj(possessing-5, effects-38)
prep_with(administration-2, PROLEUKIN-40)
aux(increase-42, may-41)
root(ROOT-0, increase-42)
dobj(increase-42, toxicity-43)
det(systems-47, these-45)
nn(systems-47, organ-46)
prep_in(increase-42, systems-47)

The/DT safety/NN and/CC efficacy/NN of/IN PROLEUKIN/NN in/IN combination/NN with/IN any/DT antineoplastic/JJ agents/NNS have/VBP not/RB been/VBN established/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NP (NN safety)) (CC and) (NP (NN efficacy))) (PP (IN of) (NP (NN PROLEUKIN))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (DT any) (JJ antineoplastic) (NNS agents)))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN established))))) (. .))))

dep(safety-2, The-1)
nsubjpass(established-16, safety-2)
conj_and(safety-2, efficacy-4)
prep_of(safety-2, PROLEUKIN-6)
prep_in(safety-2, combination-8)
det(agents-12, any-10)
amod(agents-12, antineoplastic-11)
prep_with(combination-8, agents-12)
aux(established-16, have-13)
neg(established-16, not-14)
auxpass(established-16, been-15)
root(ROOT-0, established-16)

In/IN addition/NN ,/, reduced/VBN kidney/NN and/CC liver/NN function/NN secondary/JJ to/TO PROLEUKIN/NN treatment/NN may/MD delay/VB elimination/NN of/IN concomitant/JJ medications/NNS and/CC increase/VB the/DT risk/NN of/IN adverse/JJ events/NNS from/IN those/DT drugs/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (VBN reduced) (NP (NP (NN kidney)) (CC and) (NP (NN liver))) (NN function)) (ADJP (JJ secondary) (PP (TO to) (NP (NN PROLEUKIN) (NN treatment))))) (VP (MD may) (VP (VP (VB delay) (NP (NP (NN elimination)) (PP (IN of) (NP (JJ concomitant) (NNS medications))))) (CC and) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ adverse) (NNS events))) (PP (IN from) (NP (DT those) (NNS drugs)))))))) (. .))))

prep_in(delay-14, addition-2)
amod(function-8, reduced-4)
nn(function-8, kidney-5)
conj_and(kidney-5, liver-7)
nsubj(delay-14, function-8)
amod(function-8, secondary-9)
nn(treatment-12, PROLEUKIN-11)
prep_to(secondary-9, treatment-12)
aux(delay-14, may-13)
root(ROOT-0, delay-14)
dobj(delay-14, elimination-15)
amod(medications-18, concomitant-17)
prep_of(elimination-15, medications-18)
conj_and(delay-14, increase-20)
det(risk-22, the-21)
dobj(increase-20, risk-22)
amod(events-25, adverse-24)
prep_of(risk-22, events-25)
det(drugs-28, those-27)
prep_from(risk-22, drugs-28)

Hypersensitivity/NN reactions/NNS have/VBP been/VBN reported/VBN in/IN patients/NNS receiving/VBG combination/NN regimens/NNS containing/VBG sequential/JJ high/JJ dose/NN PROLEUKIN/NN and/CC antineoplastic/JJ agents/NNS ,/, specifically/RB ,/, dacarbazine/NN ,/, cis-platinum/NN ,/, tamoxifen/NN and/CC interferon-alfa/NN ./.

(ROOT (S1 (S (S (NP (NN Hypersensitivity) (NNS reactions)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN combination) (NNS regimens)) (VP (VBG containing) (NP (NP (JJ sequential) (JJ high) (NN dose) (NN PROLEUKIN)) (CC and) (NP (JJ antineoplastic) (NNS agents)) (, ,) (ADVP (RB specifically)) (, ,) (NP (NN dacarbazine)) (, ,) (NP (NN cis-platinum)) (, ,) (NP (NN tamoxifen)) (CC and) (NP (NN interferon-alfa)))))))))))) (. .))))

nn(reactions-2, Hypersensitivity-1)
nsubjpass(reported-5, reactions-2)
aux(reported-5, have-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
prep_in(reported-5, patients-7)
partmod(patients-7, receiving-8)
nn(regimens-10, combination-9)
dobj(receiving-8, regimens-10)
partmod(regimens-10, containing-11)
amod(PROLEUKIN-15, sequential-12)
amod(PROLEUKIN-15, high-13)
nn(PROLEUKIN-15, dose-14)
dobj(containing-11, PROLEUKIN-15)
amod(agents-18, antineoplastic-17)
conj_and(PROLEUKIN-15, agents-18)
advmod(PROLEUKIN-15, specifically-20)
conj_and(PROLEUKIN-15, specifically-20)
conj_and(PROLEUKIN-15, dacarbazine-22)
conj_and(PROLEUKIN-15, cis-platinum-24)
conj_and(PROLEUKIN-15, tamoxifen-26)
conj_and(PROLEUKIN-15, interferon-alfa-28)

Myocardial/JJ injury/NN ,/, including/VBG myocardial/JJ infarction/NN ,/, myocarditis/NN ,/, ventricular/JJ hypokinesia/NN ,/, and/CC severe/JJ rhabdomyolysis/NN appear/VBP to/TO be/VB increased/VBN in/IN patients/NNS receiving/VBG PROLEUKIN/NN and/CC interferon-alfa/NN concurrently/RB ./.

(ROOT (S1 (S (S (NP (NP (JJ Myocardial) (NN injury)) (, ,) (PP (VBG including) (NP (NP (JJ myocardial) (NN infarction)) (, ,) (NP (NN myocarditis)) (, ,) (NP (JJ ventricular) (NN hypokinesia)) (, ,) (CC and) (NP (JJ severe) (NN rhabdomyolysis))))) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (VP (VBN increased) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN PROLEUKIN)) (CC and) (NP (NN interferon-alfa)))))) (ADVP (RB concurrently)))))))) (. .))))

amod(injury-2, Myocardial-1)
nsubj(appear-16, injury-2)
xsubj(increased-19, injury-2)
amod(infarction-6, myocardial-5)
prep_including(injury-2, infarction-6)
conj_and(infarction-6, myocarditis-8)
amod(hypokinesia-11, ventricular-10)
conj_and(infarction-6, hypokinesia-11)
amod(rhabdomyolysis-15, severe-14)
conj_and(infarction-6, rhabdomyolysis-15)
root(ROOT-0, appear-16)
aux(increased-19, to-17)
auxpass(increased-19, be-18)
xcomp(appear-16, increased-19)
prep_in(increased-19, patients-21)
partmod(patients-21, receiving-22)
dobj(receiving-22, PROLEUKIN-23)
conj_and(PROLEUKIN-23, interferon-alfa-25)
advmod(increased-19, concurrently-26)

Exacerbation/NN or/CC the/DT initial/JJ presentation/NN of/IN a/DT number/NN of/IN autoimmune/JJ and/CC inflammatory/JJ disorders/NNS has/VBZ been/VBN observed/VBN following/VBG concurrent/JJ use/NN of/IN interferon-alfa/NN and/CC PROLEUKIN/NN ,/, including/VBG crescentic/JJ IgA/NN glomerulonephritis/NN ,/, oculo-bulbar/JJ myasthenia/NN gravis/NN ,/, inflammatory/JJ arthritis/NN ,/, thyroiditis/NN ,/, bullous/NN pemphigoid/NN ,/, and/CC Stevens-Johnson/NN syndrome/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Exacerbation)) (CC or) (NP (DT the) (JJ initial) (NN presentation))) (PP (IN of) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (ADJP (ADJP (JJ autoimmune)) (CC and) (ADJP (JJ inflammatory))) (NNS disorders)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN observed) (PP (VBG following) (NP (NP (JJ concurrent) (NN use)) (PP (IN of) (NP (NP (NP (NN interferon-alfa)) (CC and) (NP (NN PROLEUKIN))) (, ,) (PP (VBG including) (NP (NP (JJ crescentic) (NN IgA) (NN glomerulonephritis)) (, ,) (NP (JJ oculo-bulbar) (NN myasthenia) (NN gravis)) (, ,) (NP (JJ inflammatory) (NN arthritis)) (, ,) (NP (NN thyroiditis)) (, ,) (NP (NN bullous) (NN pemphigoid)) (, ,) (CC and) (NP (NN Stevens-Johnson) (NN syndrome)))))))))))) (. .))))

nsubjpass(observed-16, Exacerbation-1)
det(presentation-5, the-3)
amod(presentation-5, initial-4)
conj_or(Exacerbation-1, presentation-5)
det(number-8, a-7)
prep_of(Exacerbation-1, number-8)
amod(disorders-13, autoimmune-10)
conj_and(autoimmune-10, inflammatory-12)
prep_of(number-8, disorders-13)
aux(observed-16, has-14)
auxpass(observed-16, been-15)
root(ROOT-0, observed-16)
amod(use-19, concurrent-18)
prep_following(observed-16, use-19)
prep_of(use-19, interferon-alfa-21)
conj_and(interferon-alfa-21, PROLEUKIN-23)
amod(glomerulonephritis-28, crescentic-26)
nn(glomerulonephritis-28, IgA-27)
prep_including(interferon-alfa-21, glomerulonephritis-28)
amod(gravis-32, oculo-bulbar-30)
nn(gravis-32, myasthenia-31)
conj_and(glomerulonephritis-28, gravis-32)
amod(arthritis-35, inflammatory-34)
conj_and(glomerulonephritis-28, arthritis-35)
conj_and(glomerulonephritis-28, thyroiditis-37)
nn(pemphigoid-40, bullous-39)
conj_and(glomerulonephritis-28, pemphigoid-40)
nn(syndrome-44, Stevens-Johnson-43)
conj_and(glomerulonephritis-28, syndrome-44)

Although/IN glucocorticoids/NNS have/VBP been/VBN shown/VBN to/TO reduce/VB PROLEUKIN/NN -induced/JJ side/JJ effects/NNS including/VBG fever/NN ,/, renal/JJ insufficiency/NN ,/, hyperbilirubinemia/NN ,/, confusion/NN ,/, and/CC dyspnea/NN ,/, concomitant/JJ administration/NN of/IN these/DT agents/NNS with/IN PROLEUKIN/NN may/MD reduce/VB the/DT antitumor/JJ effectiveness/NN of/IN PROLEUKIN/NN and/CC thus/RB should/MD be/VB avoided./VBN 12/CD Beta-blockers/NN and/CC other/JJ antihypertensives/NNS may/MD potentiate/VB the/DT hypotension/NN seen/VBN with/IN PROLEUKIN/NN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NNS glucocorticoids)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB reduce) (NP (NP (NN PROLEUKIN) (JJ -induced) (JJ side) (NNS effects)) (PP (VBG including) (NP (NP (NN fever)) (, ,) (NP (JJ renal) (NN insufficiency)) (, ,) (NP (NN hyperbilirubinemia)) (, ,) (NP (NN confusion)) (, ,) (CC and) (NP (NN dyspnea))))))))))))) (, ,) (S (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (DT these) (NNS agents))) (PP (IN with) (NP (NN PROLEUKIN)))) (VP (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (JJ antitumor) (NN effectiveness)) (PP (IN of) (NP (NN PROLEUKIN)))))) (CC and) (ADVP (RB thus)) (VP (MD should) (VP (VB be) (VP (VBN avoided.) (NP (CD 12) (NN Beta-blockers))))))) (CC and) (S (NP (JJ other) (NNS antihypertensives)) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (NN hypotension)) (VP (VBN seen) (PP (IN with) (NP (NN PROLEUKIN))))))))) (. .))))

mark(shown-5, Although-1)
nsubjpass(shown-5, glucocorticoids-2)
xsubj(reduce-7, glucocorticoids-2)
aux(shown-5, have-3)
auxpass(shown-5, been-4)
advcl(reduce-33, shown-5)
aux(reduce-7, to-6)
xcomp(shown-5, reduce-7)
nn(effects-11, PROLEUKIN-8)
amod(effects-11, -induced-9)
amod(effects-11, side-10)
dobj(reduce-7, effects-11)
prep_including(effects-11, fever-13)
amod(insufficiency-16, renal-15)
conj_and(fever-13, insufficiency-16)
conj_and(fever-13, hyperbilirubinemia-18)
conj_and(fever-13, confusion-20)
conj_and(fever-13, dyspnea-23)
amod(administration-26, concomitant-25)
nsubj(reduce-33, administration-26)
det(agents-29, these-28)
prep_of(administration-26, agents-29)
prep_with(administration-26, PROLEUKIN-31)
aux(reduce-33, may-32)
root(ROOT-0, reduce-33)
det(effectiveness-36, the-34)
amod(effectiveness-36, antitumor-35)
dobj(reduce-33, effectiveness-36)
prep_of(effectiveness-36, PROLEUKIN-38)
advmod(reduce-33, thus-40)
conj_and(reduce-33, thus-40)
aux(avoided.-43, should-41)
auxpass(avoided.-43, be-42)
conj_and(reduce-33, avoided.-43)
num(Beta-blockers-45, 12-44)
dobj(avoided.-43, Beta-blockers-45)
amod(antihypertensives-48, other-47)
nsubj(potentiate-50, antihypertensives-48)
aux(potentiate-50, may-49)
conj_and(reduce-33, potentiate-50)
det(hypotension-52, the-51)
dobj(potentiate-50, hypotension-52)
partmod(hypotension-52, seen-53)
prep_with(seen-53, PROLEUKIN-55)

Delayed/VBN Adverse/JJ Reactions/NNS to/TO Iodinated/JJ Contrast/NN Media/NNS :/: A/DT review/NN of/IN the/DT literature/NN revealed/VBN that/IN 12.6/CD %/NN (/-LRB- range/NN 11-28/CD %/NN )/-RRB- of/IN 501/CD patients/NNS treated/VBN with/IN various/JJ interleukin-2/NN containing/NN regimens/NNS who/WP were/VBD subsequently/RB administered/VBN radiographic/JJ iodinated/JJ contrast/NN media/NNS experienced/VBN acute/JJ ,/, atypical/JJ adverse/JJ reactions/NNS ./.

(ROOT (S1 (S (NP (NP (NP (VBN Delayed) (JJ Adverse) (NNS Reactions)) (PP (TO to) (NP (JJ Iodinated) (NN Contrast) (NNS Media)))) (: :) (NP (NP (DT A) (NN review)) (PP (IN of) (NP (NP (DT the) (NN literature)) (VP (VBN revealed) (PP (IN that) (NP (NP (NP (CD 12.6) (NN %)) (PRN (-LRB- -LRB-) (NP (NN range) (CD 11-28) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (CD 501) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (JJ various) (NN interleukin-2) (NN containing) (NNS regimens)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (ADVP (RB subsequently)) (VP (VBN administered) (NP (NP (JJ radiographic) (JJ iodinated) (NN contrast) (NNS media)) (VP (VBN experienced) (NP (ADJP (ADJP (JJ acute)) (, ,) (ADJP (JJ atypical))) (JJ adverse) (NNS reactions))))))))))))))))))) (. .)))))

amod(Reactions-3, Delayed-1)
amod(Reactions-3, Adverse-2)
root(ROOT-0, Reactions-3)
amod(Media-7, Iodinated-5)
nn(Media-7, Contrast-6)
prep_to(Reactions-3, Media-7)
det(review-10, A-9)
dep(Reactions-3, review-10)
det(literature-13, the-12)
prep_of(review-10, literature-13)
partmod(literature-13, revealed-14)
num(%-17, 12.6-16)
prep_that(revealed-14, %-17)
nn(%-21, range-19)
num(%-21, 11-28-20)
appos(%-17, %-21)
num(patients-25, 501-24)
prep_of(%-17, patients-25)
partmod(patients-25, treated-26)
amod(regimens-31, various-28)
nn(regimens-31, interleukin-2-29)
nn(regimens-31, containing-30)
prep_with(treated-26, regimens-31)
nsubjpass(administered-35, regimens-31)
auxpass(administered-35, were-33)
advmod(administered-35, subsequently-34)
rcmod(regimens-31, administered-35)
amod(media-39, radiographic-36)
amod(media-39, iodinated-37)
nn(media-39, contrast-38)
dobj(administered-35, media-39)
partmod(media-39, experienced-40)
amod(reactions-45, acute-41)
dep(acute-41, atypical-43)
amod(reactions-45, adverse-44)
dobj(experienced-40, reactions-45)

Some/DT clinicians/NNS have/VBP noted/VBN that/IN these/DT reactions/NNS resemble/VBP the/DT immediate/JJ side/JJ effects/NNS caused/VBN by/IN interleukin-2/NN administration/NN ,/, however/RB the/DT cause/NN of/IN contrast/NN reactions/NNS after/IN interleukin-2/NN therapy/NN is/VBZ unknown/JJ ./.

(ROOT (S1 (S (S (NP (DT Some) (NNS clinicians)) (VP (VBP have) (VP (VBN noted) (SBAR (IN that) (S (S (NP (DT these) (NNS reactions)) (VP (VBP resemble) (NP (NP (DT the) (JJ immediate) (JJ side) (NNS effects)) (VP (VBN caused) (PP (IN by) (NP (NN interleukin-2) (NN administration))))))) (, ,) (S (ADVP (RB however)) (NP (NP (DT the) (NN cause)) (PP (IN of) (NP (NN contrast) (NNS reactions))) (PP (IN after) (NP (NN interleukin-2) (NN therapy)))) (VP (VBZ is) (ADJP (JJ unknown))))))))) (. .))))

det(clinicians-2, Some-1)
nsubj(noted-4, clinicians-2)
aux(noted-4, have-3)
root(ROOT-0, noted-4)
complm(effects-12, that-5)
det(reactions-7, these-6)
nsubj(effects-12, reactions-7)
cop(effects-12, resemble-8)
det(effects-12, the-9)
amod(effects-12, immediate-10)
amod(effects-12, side-11)
ccomp(noted-4, effects-12)
partmod(effects-12, caused-13)
nn(administration-16, interleukin-2-15)
agent(caused-13, administration-16)
advmod(unknown-28, however-18)
det(cause-20, the-19)
nsubj(unknown-28, cause-20)
nn(reactions-23, contrast-22)
prep_of(cause-20, reactions-23)
nn(therapy-26, interleukin-2-25)
prep_after(cause-20, therapy-26)
cop(unknown-28, is-27)
dep(effects-12, unknown-28)

Most/JJ events/NNS were/VBD reported/VBN to/TO occur/VB when/WRB contrast/NN media/NNS was/VBD given/VBN within/IN 4/CD weeks/NNS after/IN the/DT last/JJ dose/NN of/IN interleukin-2/NN ./.

(ROOT (S1 (S (S (NP (JJ Most) (NNS events)) (VP (VBD were) (VP (VBN reported) (S (VP (TO to) (VP (VB occur) (SBAR (WHADVP (WRB when)) (S (NP (NN contrast) (NNS media)) (VP (VBD was) (VP (VBN given) (PP (IN within) (NP (CD 4) (NNS weeks))) (PP (IN after) (NP (NP (DT the) (JJ last) (NN dose)) (PP (IN of) (NP (NN interleukin-2))))))))))))))) (. .))))

amod(events-2, Most-1)
nsubjpass(reported-4, events-2)
xsubj(occur-6, events-2)
auxpass(reported-4, were-3)
root(ROOT-0, reported-4)
aux(occur-6, to-5)
xcomp(reported-4, occur-6)
advmod(given-11, when-7)
nn(media-9, contrast-8)
nsubjpass(given-11, media-9)
auxpass(given-11, was-10)
advcl(occur-6, given-11)
num(weeks-14, 4-13)
prep_within(given-11, weeks-14)
det(dose-18, the-16)
amod(dose-18, last-17)
prep_after(given-11, dose-18)
prep_of(dose-18, interleukin-2-20)

These/DT events/NNS were/VBD also/RB reported/VBN to/TO occur/VB when/WRB contrast/NN media/NNS was/VBD given/VBN several/JJ months/NNS after/IN interleukin-2/NN treatment/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS events)) (VP (VBD were) (ADVP (RB also)) (VP (VBN reported) (S (VP (TO to) (VP (VB occur) (SBAR (WHADVP (WRB when)) (S (NP (NN contrast) (NNS media)) (VP (VBD was) (VP (VBN given) (NP (JJ several) (NNS months)) (PP (IN after) (NP (NN interleukin-2) (NN treatment))))))))))))) (. .))))

det(events-2, These-1)
nsubjpass(reported-5, events-2)
xsubj(occur-7, events-2)
auxpass(reported-5, were-3)
advmod(reported-5, also-4)
root(ROOT-0, reported-5)
aux(occur-7, to-6)
xcomp(reported-5, occur-7)
advmod(given-12, when-8)
nn(media-10, contrast-9)
nsubjpass(given-12, media-10)
auxpass(given-12, was-11)
advcl(occur-7, given-12)
amod(months-14, several-13)
tmod(given-12, months-14)
nn(treatment-17, interleukin-2-16)
prep_after(given-12, treatment-17)

In/IN a/DT chronic/JJ toxicity/NN study/NN ,/, cynomolgus/NN monkeys/NNS were/VBD dosed/VBN weekly/RB for/IN 52/CD weeks/NNS with/IN intravenous/JJ alefacept/NN at/IN 1/CD mg/kg/dose/NN or/CC 20/CD mg/kg/dose/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT a) (JJ chronic) (NN toxicity) (NN study))) (, ,) (NP (NN cynomolgus) (NNS monkeys)) (VP (VBD were) (VP (VBN dosed) (ADVP (RB weekly)) (PP (IN for) (NP (CD 52) (NNS weeks))) (PP (IN with) (NP (NP (JJ intravenous) (NN alefacept)) (PP (IN at) (NP (CD 1) (NN mg/kg/dose) (CC or) (CD 20) (NN mg/kg/dose)))))))) (. .))))

det(study-5, a-2)
amod(study-5, chronic-3)
nn(study-5, toxicity-4)
prep_in(dosed-10, study-5)
nn(monkeys-8, cynomolgus-7)
nsubjpass(dosed-10, monkeys-8)
auxpass(dosed-10, were-9)
root(ROOT-0, dosed-10)
advmod(dosed-10, weekly-11)
num(weeks-14, 52-13)
prep_for(dosed-10, weeks-14)
amod(alefacept-17, intravenous-16)
prep_with(dosed-10, alefacept-17)
num(mg/kg/dose-20, 1-19)
prep_at(alefacept-17, mg/kg/dose-20)
num(mg/kg/dose-23, 20-22)
conj_or(mg/kg/dose-20, mg/kg/dose-23)

In/IN a/DT separate/JJ study/NN ,/, baboons/NNS given/VBN 3/CD doses/NNS of/IN alefacept/NN at/IN 1/CD mg/kg/NN every/DT 8/CD weeks/NNS were/VBD found/VBN to/TO have/VB centroblast/JJ proliferation/NN in/IN B-cell/NN dependent/JJ areas/NNS in/IN the/DT germinal/JJ centers/NNS of/IN the/DT spleen/NN following/VBG a/DT 116-day/JJ washout/NN period/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (DT a) (JJ separate) (NN study))) (, ,) (NP (NP (NP (NNS baboons)) (VP (VBN given) (NP (NP (CD 3) (NNS doses)) (PP (IN of) (NP (NN alefacept)))) (PP (IN at) (NP (CD 1) (NN mg/kg))))) (NP (DT every) (CD 8) (NNS weeks))) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (JJ centroblast) (NN proliferation)) (PP (IN in) (NP (NP (NN B-cell) (JJ dependent) (NNS areas)) (PP (IN in) (NP (NP (DT the) (JJ germinal) (NNS centers)) (PP (IN of) (NP (DT the) (NN spleen))))))) (PP (VBG following) (NP (DT a) (JJ 116-day) (NN washout) (NN period)))))))) (. .))))

det(study-4, a-2)
amod(study-4, separate-3)
prep_in(found-19, study-4)
nsubjpass(found-19, baboons-6)
xsubj(have-21, baboons-6)
partmod(baboons-6, given-7)
num(doses-9, 3-8)
dobj(given-7, doses-9)
prep_of(doses-9, alefacept-11)
num(mg/kg-14, 1-13)
prep_at(given-7, mg/kg-14)
det(weeks-17, every-15)
num(weeks-17, 8-16)
dep(baboons-6, weeks-17)
auxpass(found-19, were-18)
root(ROOT-0, found-19)
aux(have-21, to-20)
xcomp(found-19, have-21)
amod(proliferation-23, centroblast-22)
dobj(have-21, proliferation-23)
nn(areas-27, B-cell-25)
amod(areas-27, dependent-26)
prep_in(have-21, areas-27)
det(centers-31, the-29)
amod(centers-31, germinal-30)
prep_in(areas-27, centers-31)
det(spleen-34, the-33)
prep_of(centers-31, spleen-34)
det(period-39, a-36)
amod(period-39, 116-day-37)
nn(period-39, washout-38)
prep_following(have-21, period-39)

Since/IN the/DT effect/NN of/IN AMEVIVE/JJ @/NN on/IN pregnancy/NN and/CC fetal/JJ development/NN ,/, including/VBG immune/JJ system/NN development/NN ,/, is/VBZ not/RB known/VBN ,/, health/NN care/NN providers/NNS are/VBP encouraged/VBN to/TO enroll/VBP patients/NNS currently/RB taking/VBG AMEVIVE/JJ @/NN who/WP become/VBP pregnant/JJ into/IN the/DT Biogen/NN Pregnancy/NN Registry/NN by/IN calling/VBG 1-866-/NN AMEVIVE/NN (/-LRB- 1-866-263-8483)./NN

(ROOT (S1 (S (SBAR (IN Since) (S (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ AMEVIVE) (NN @))) (PP (IN on) (NP (NP (NP (NN pregnancy)) (CC and) (NP (JJ fetal) (NN development))) (, ,) (PP (VBG including) (NP (JJ immune) (NN system) (NN development))) (, ,)))) (VP (VBZ is) (RB not) (VP (VBN known))))) (, ,) (S (NP (NN health) (NN care) (NNS providers)) (VP (VBP are) (VP (VBN encouraged) (S (VP (TO to) (VP (VBP enroll) (NP (NP (NP (NNS patients)) (VP (ADVP (RB currently)) (VBG taking) (NP (JJ AMEVIVE) (NN @)))) (SBAR (WHNP (WP who)) (S (VP (VBP become) (ADJP (JJ pregnant)) (PP (IN into) (NP (DT the) (NN Biogen) (NN Pregnancy) (NN Registry))) (PP (IN by) (S (VP (VBG calling) (NP (NN 1-866-) (NN AMEVIVE))))) (-LRB- -LRB-) (NP (NN 1-866-263-8483-RRB-.)))))))))))))))

mark(known-20, Since-1)
det(effect-3, the-2)
nsubjpass(known-20, effect-3)
amod(@-6, AMEVIVE-5)
prep_of(effect-3, @-6)
prep_on(effect-3, pregnancy-8)
amod(development-11, fetal-10)
conj_and(pregnancy-8, development-11)
amod(development-16, immune-14)
nn(development-16, system-15)
prep_including(pregnancy-8, development-16)
auxpass(known-20, is-18)
neg(known-20, not-19)
advcl(encouraged-26, known-20)
nn(providers-24, health-22)
nn(providers-24, care-23)
nsubjpass(encouraged-26, providers-24)
xsubj(enroll-28, providers-24)
auxpass(encouraged-26, are-25)
root(ROOT-0, encouraged-26)
aux(enroll-28, to-27)
xcomp(encouraged-26, enroll-28)
dobj(enroll-28, patients-29)
nsubj(pregnant-36, patients-29)
advmod(taking-31, currently-30)
partmod(patients-29, taking-31)
amod(@-33, AMEVIVE-32)
dobj(taking-31, @-33)
cop(pregnant-36, become-35)
rcmod(patients-29, pregnant-36)
det(Registry-41, the-38)
nn(Registry-41, Biogen-39)
nn(Registry-41, Pregnancy-40)
prep_into(pregnant-36, Registry-41)
prepc_by(pregnant-36, calling-43)
nn(AMEVIVE-45, 1-866--44)
dobj(calling-43, AMEVIVE-45)
attr(pregnant-36, 1-866-263-8483-RRB-.-47)

No/DT abortifacient/JJ or/CC teratogenic/JJ effects/NNS were/VBD observed/VBN in/IN cynomolgus/JJ monkeys/NNS following/VBG intravenous/JJ bolus/NN injections/NNS of/IN AMEVIVE/JJ @/NN administered/VBN weekly/RB during/IN the/DT period/NN of/IN organogenesis/NN to/TO gestation/NN ./.

(ROOT (S1 (S (S (NP (DT No) (ADJP (ADJP (JJ abortifacient)) (CC or) (ADJP (JJ teratogenic))) (NNS effects)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (JJ cynomolgus) (NNS monkeys))) (PP (VBG following) (NP (NP (JJ intravenous) (NN bolus) (NNS injections)) (PP (IN of) (NP (JJ AMEVIVE) (NN @))) (VP (VBN administered) (ADVP (RB weekly)) (PP (IN during) (NP (NP (DT the) (NN period)) (PP (IN of) (NP (NN organogenesis))) (PP (TO to) (NP (NN gestation))))))))))) (. .))))

det(effects-5, No-1)
amod(effects-5, abortifacient-2)
conj_or(abortifacient-2, teratogenic-4)
nsubjpass(observed-7, effects-5)
auxpass(observed-7, were-6)
root(ROOT-0, observed-7)
amod(monkeys-10, cynomolgus-9)
prep_in(observed-7, monkeys-10)
amod(injections-14, intravenous-12)
nn(injections-14, bolus-13)
prep_following(observed-7, injections-14)
amod(@-17, AMEVIVE-16)
prep_of(injections-14, @-17)
partmod(injections-14, administered-18)
advmod(administered-18, weekly-19)
det(period-22, the-21)
prep_during(administered-18, period-22)
prep_of(period-22, organogenesis-24)
prep_to(period-22, gestation-26)

If/IN pregnancy/NN occurs/VBZ while/IN taking/VBG AMEVIVE/JJ @/NN ,/, continued/JJ use/NN of/IN the/DT drug/NN should/MD be/VB assessed/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN pregnancy)) (VP (VBZ occurs) (SBAR (IN while) (S (VP (VBG taking) (NP (JJ AMEVIVE) (NN @)))))))) (, ,) (NP (NP (JJ continued) (NN use)) (PP (IN of) (NP (DT the) (NN drug)))) (VP (MD should) (VP (VB be) (VP (VBN assessed))))) (. .))))

mark(occurs-3, If-1)
nsubj(occurs-3, pregnancy-2)
advcl(assessed-16, occurs-3)
mark(taking-5, while-4)
advcl(occurs-3, taking-5)
amod(@-7, AMEVIVE-6)
dobj(taking-5, @-7)
amod(use-10, continued-9)
nsubjpass(assessed-16, use-10)
det(drug-13, the-12)
prep_of(use-10, drug-13)
aux(assessed-16, should-14)
auxpass(assessed-16, be-15)
root(ROOT-0, assessed-16)

Because/IN many/JJ drugs/NNS are/VBP excreted/VBN in/IN human/JJ milk/NN ,/, and/CC because/IN there/EX exists/VBZ the/DT potential/NN for/IN serious/JJ adverse/JJ reactions/NNS in/IN nursing/JJ infants/NNS from/IN AMEVIVE/JJ @/NN ,/, a/DT decision/NN should/MD be/VB made/VBN whether/IN to/TO discontinue/VBP nursing/VBG while/IN taking/VBG the/DT drug/NN or/CC to/TO discontinue/VBP the/DT use/NN of/IN the/DT drug/NN ,/, taking/VBG into/IN account/VBP the/DT importance/NN of/IN the/DT drug/NN to/TO the/DT mother/NN ./.

(ROOT (S1 (S (SBAR (IN Because) (S (NP (JJ many) (NNS drugs)) (VP (VBP are) (VP (VBN excreted) (PP (IN in) (NP (JJ human) (NN milk))))))) (, ,) (CC and) (SBAR (IN because) (S (NP (EX there)) (VP (VBZ exists) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (JJ serious) (JJ adverse) (NNS reactions)) (PP (IN in) (NP (NP (JJ nursing) (NNS infants)) (PP (IN from) (NP (JJ AMEVIVE) (NN @))))))))))) (, ,) (NP (DT a) (NN decision)) (VP (MD should) (VP (VB be) (VP (VBN made) (SBAR (IN whether) (S (VP (VP (TO to) (VP (VBP discontinue) (S (VP (VBG nursing) (SBAR (IN while) (S (VP (VBG taking) (NP (DT the) (NN drug))))))))) (CC or) (VP (TO to) (VP (VBP discontinue) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT the) (NN drug)))) (, ,) (S (VP (VBG taking) (SBAR (IN into) (S (VP (VBP account) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (DT the) (NN drug))) (PP (TO to) (NP (DT the) (NN mother))))))))))))))))) (. .))))

mark(excreted-5, Because-1)
amod(drugs-3, many-2)
nsubjpass(excreted-5, drugs-3)
auxpass(excreted-5, are-4)
advcl(made-31, excreted-5)
amod(milk-8, human-7)
prep_in(excreted-5, milk-8)
mark(exists-13, because-11)
expl(exists-13, there-12)
advcl(made-31, exists-13)
conj_and(made-31, exists-13)
det(potential-15, the-14)
dobj(exists-13, potential-15)
nsubj(exists-13, potential-15)
amod(reactions-19, serious-17)
amod(reactions-19, adverse-18)
prep_for(potential-15, reactions-19)
amod(infants-22, nursing-21)
prep_in(reactions-19, infants-22)
amod(@-25, AMEVIVE-24)
prep_from(infants-22, @-25)
det(decision-28, a-27)
conj_and(made-31, decision-28)
nsubjpass(made-31, decision-28)
aux(made-31, should-29)
auxpass(made-31, be-30)
root(ROOT-0, made-31)
complm(discontinue-34, whether-32)
aux(discontinue-34, to-33)
ccomp(made-31, discontinue-34)
xcomp(discontinue-34, nursing-35)
mark(taking-37, while-36)
advcl(nursing-35, taking-37)
det(drug-39, the-38)
dobj(taking-37, drug-39)
aux(discontinue-42, to-41)
conj_or(discontinue-34, discontinue-42)
det(use-44, the-43)
dobj(discontinue-42, use-44)
det(drug-47, the-46)
prep_of(use-44, drug-47)
partmod(discontinue-42, taking-49)
xcomp(discontinue-42, taking-49)
mark(account-51, into-50)
advcl(taking-49, account-51)
det(importance-53, the-52)
dobj(account-51, importance-53)
det(drug-56, the-55)
prep_of(importance-53, drug-56)
det(mother-59, the-58)
prep_to(importance-53, mother-59)

Pediatric/JJ Use/NN ./.

(ROOT (S1 (S (NP (NP (JJ Pediatric) (NN Use)) (. .)))))

amod(Use-2, Pediatric-1)
root(ROOT-0, Use-2)

The/DT safety/NN and/CC efficacy/NN of/IN AMEVIVE/JJ @/NN in/IN pediatric/JJ patients/NNS have/VBP not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NP (NN safety)) (CC and) (NP (NN efficacy))) (PP (IN of) (NP (JJ AMEVIVE) (NN @))) (PP (IN in) (NP (JJ pediatric) (NNS patients)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

dep(safety-2, The-1)
nsubjpass(studied-14, safety-2)
conj_and(safety-2, efficacy-4)
amod(@-7, AMEVIVE-6)
prep_of(safety-2, @-7)
amod(patients-10, pediatric-9)
prep_in(safety-2, patients-10)
aux(studied-14, have-11)
neg(studied-14, not-12)
auxpass(studied-14, been-13)
root(ROOT-0, studied-14)

AMEVIVE/JJ @/NN is/VBZ not/RB indicated/VBN for/IN pediatric/JJ patients/NNS ./.

(ROOT (S1 (S (S (NP (JJ AMEVIVE) (NN @)) (VP (VBZ is) (RB not) (VP (VBN indicated) (PP (IN for) (NP (JJ pediatric) (NNS patients)))))) (. .))))

amod(@-2, AMEVIVE-1)
nsubjpass(indicated-5, @-2)
auxpass(indicated-5, is-3)
neg(indicated-5, not-4)
root(ROOT-0, indicated-5)
amod(patients-8, pediatric-7)
prep_for(indicated-5, patients-8)

Intravenous/JJ ranitidine/NN was/VBD shown/VBN to/TO double/JJ the/DT bioavailability/NN of/IN oral/JJ alendronate/NN ./.

(ROOT (S1 (S (S (NP (JJ Intravenous) (NN ranitidine)) (VP (VBD was) (VP (VBN shown) (S (VP (TO to) (VP (JJ double) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (JJ oral) (NN alendronate)))))))))) (. .))))

amod(ranitidine-2, Intravenous-1)
nsubjpass(shown-4, ranitidine-2)
xsubj(double-6, ranitidine-2)
auxpass(shown-4, was-3)
root(ROOT-0, shown-4)
aux(double-6, to-5)
xcomp(shown-4, double-6)
det(bioavailability-8, the-7)
dobj(double-6, bioavailability-8)
amod(alendronate-11, oral-10)
prep_of(bioavailability-8, alendronate-11)

Products/NNS containing/VBG calcium/NN and/CC other/JJ multivalent/JJ cations/NNS likely/RB will/MD interfere/VB with/IN absorption/NN of/IN alendronate/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Products)) (VP (VBG containing) (NP (NN calcium)))) (CC and) (NP (JJ other) (JJ multivalent) (NNS cations))) (VP (ADVP (RB likely)) (MD will) (VP (VB interfere) (PP (IN with) (NP (NP (NN absorption)) (PP (IN of) (NP (NN alendronate)))))))) (. .))))

nsubj(interfere-10, Products-1)
partmod(Products-1, containing-2)
dobj(containing-2, calcium-3)
amod(cations-7, other-5)
amod(cations-7, multivalent-6)
conj_and(Products-1, cations-7)
advmod(interfere-10, likely-8)
aux(interfere-10, will-9)
root(ROOT-0, interfere-10)
prep_with(interfere-10, absorption-12)
prep_of(absorption-12, alendronate-14)

Both/CC the/DT magnitude/NN and/CC duration/NN of/IN central/JJ nervous/JJ system/NN and/CC cardiovascular/JJ effects/NNS may/MD be/VB enhanced/VBN when/WRB ALFENTA/NN is/VBZ administered/VBN in/IN combination/NN with/IN other/JJ CNS/NN depressants/NNS such/JJ as/IN barbiturates/NNS ,/, tranquilizers/NNS ,/, opioids/NNS ,/, or/CC inhalation/NN general/JJ anesthetics/NNS ./.

(ROOT (S1 (S (S (NP (NP (CC Both) (DT the) (NP (NN magnitude)) (CC and) (NP (NN duration))) (PP (IN of) (NP (NP (JJ central) (JJ nervous) (NN system)) (CC and) (NP (JJ cardiovascular) (NNS effects))))) (VP (MD may) (VP (VB be) (VP (VBN enhanced) (SBAR (WHADVP (WRB when)) (S (NP (NN ALFENTA)) (VP (VBZ is) (VP (VBN administered) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (JJ other) (NN CNS) (NNS depressants)) (PP (JJ such) (IN as) (NP (NP (NNS barbiturates)) (, ,) (NP (NNS tranquilizers)) (, ,) (NP (NNS opioids)) (, ,) (CC or) (NP (NN inhalation) (JJ general) (NNS anesthetics)))))))))))))))) (. .))))

preconj(magnitude-3, Both-1)
dep(magnitude-3, the-2)
nsubjpass(enhanced-15, magnitude-3)
conj_and(magnitude-3, duration-5)
amod(system-9, central-7)
amod(system-9, nervous-8)
prep_of(magnitude-3, system-9)
amod(effects-12, cardiovascular-11)
conj_and(system-9, effects-12)
aux(enhanced-15, may-13)
auxpass(enhanced-15, be-14)
root(ROOT-0, enhanced-15)
advmod(administered-19, when-16)
nsubjpass(administered-19, ALFENTA-17)
auxpass(administered-19, is-18)
advcl(enhanced-15, administered-19)
prep_in(administered-19, combination-21)
amod(depressants-25, other-23)
nn(depressants-25, CNS-24)
prep_with(combination-21, depressants-25)
prep_such_as(depressants-25, barbiturates-28)
conj_or(barbiturates-28, tranquilizers-30)
conj_or(barbiturates-28, opioids-32)
nn(anesthetics-37, inhalation-35)
amod(anesthetics-37, general-36)
conj_or(barbiturates-28, anesthetics-37)

Limited/JJ clinical/JJ experience/VBP indicates/VBZ that/IN requirements/NNS for/IN volatile/JJ inhalation/NN anesthetics/NNS are/VBP reduced/VBN by/IN 30/CD to/TO 50/CD %/NN for/IN the/DT first/JJ sixty/NN (/-LRB- 60/CD )/-RRB- minutes/NNS following/VBG ALFENTA/NN induction/NN The/DT concomitant/JJ use/NN of/IN erythromycin/NN with/IN ALFENTA/NN can/MD significantly/RB inhibit/VB ALFENTA/NN clearance/NN and/CC may/MD increase/VB the/DT risk/NN of/IN prolonged/JJ or/CC delayed/VBN respiratory/JJ depression/NN ./.

(ROOT (S1 (S (S (NP (JJ Limited) (JJ clinical) (VBP experience)) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NP (NNS requirements)) (PP (IN for) (NP (JJ volatile) (NN inhalation) (NNS anesthetics)))) (VP (VBP are) (VP (VBN reduced) (PP (IN by) (NP (NP (QP (CD 30) (TO to) (CD 50)) (NN %)) (PP (IN for) (NP (NP (DT the) (JJ first) (NN sixty) (-LRB- -LRB-) (CD 60) (-RRB- -RRB-) (NNS minutes)) (PP (VBG following) (NP (NP (NN ALFENTA) (NN induction)) (S (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (NN erythromycin))) (PP (IN with) (NP (NN ALFENTA)))) (VP (VP (MD can) (ADVP (RB significantly)) (VP (VB inhibit) (NP (NN ALFENTA) (NN clearance)))) (CC and) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (ADJP (ADJP (JJ prolonged)) (CC or) (ADJP (VBN delayed))) (JJ respiratory) (NN depression)))))))))))))))))))) (. .))))

amod(clinical-2, Limited-1)
nsubj(indicates-4, clinical-2)
dep(clinical-2, experience-3)
root(ROOT-0, indicates-4)
complm(reduced-12, that-5)
nsubjpass(reduced-12, requirements-6)
amod(anesthetics-10, volatile-8)
nn(anesthetics-10, inhalation-9)
prep_for(requirements-6, anesthetics-10)
auxpass(reduced-12, are-11)
ccomp(indicates-4, reduced-12)
number(50-16, 30-14)
dep(50-16, to-15)
num(%-17, 50-16)
agent(reduced-12, %-17)
det(minutes-25, the-19)
amod(minutes-25, first-20)
nn(minutes-25, sixty-21)
num(minutes-25, 60-23)
prep_for(%-17, minutes-25)
nn(induction-28, ALFENTA-27)
prep_following(minutes-25, induction-28)
det(use-31, The-29)
amod(use-31, concomitant-30)
nsubj(inhibit-38, use-31)
prep_of(use-31, erythromycin-33)
prep_with(use-31, ALFENTA-35)
aux(inhibit-38, can-36)
advmod(inhibit-38, significantly-37)
dep(induction-28, inhibit-38)
nn(clearance-40, ALFENTA-39)
dobj(inhibit-38, clearance-40)
aux(increase-43, may-42)
conj_and(inhibit-38, increase-43)
det(risk-45, the-44)
dobj(increase-43, risk-45)
amod(depression-51, prolonged-47)
conj_or(prolonged-47, delayed-49)
amod(depression-51, respiratory-50)
prep_of(risk-45, depression-51)

Cimetidine/NN reduces/VBZ the/DT clearance/NN of/IN ALFENTA/NN ./.

(ROOT (S1 (S (S (NP (NN Cimetidine)) (VP (VBZ reduces) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN ALFENTA)))))) (. .))))

nsubj(reduces-2, Cimetidine-1)
root(ROOT-0, reduces-2)
det(clearance-4, the-3)
dobj(reduces-2, clearance-4)
prep_of(clearance-4, ALFENTA-6)

Therefore/RB smaller/JJR ALFENTA/NN doses/NNS will/MD be/VB required/VBN with/IN prolonged/JJ administration/NN and/CC the/DT duration/NN of/IN action/NN of/IN ALFENTA/NN my/NNS be/VB extended/VBN ./.

(ROOT (S1 (S (S (NP (ADJP (RB Therefore) (JJR smaller)) (NN ALFENTA) (NNS doses)) (VP (MD will) (VP (VB be) (VP (VBN required) (PP (IN with) (NP (JJ prolonged) (NN administration))))))) (CC and) (S (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NP (NN action)) (PP (IN of) (NP (NN ALFENTA) (NNS my)))))) (VP (VB be) (VP (VBN extended)))) (. .))))

advmod(smaller-2, Therefore-1)
amod(doses-4, smaller-2)
nn(doses-4, ALFENTA-3)
nsubjpass(required-7, doses-4)
aux(required-7, will-5)
auxpass(required-7, be-6)
root(ROOT-0, required-7)
amod(administration-10, prolonged-9)
prep_with(required-7, administration-10)
det(duration-13, the-12)
nsubjpass(extended-20, duration-13)
prep_of(duration-13, action-15)
nn(my-18, ALFENTA-17)
prep_of(action-15, my-18)
auxpass(extended-20, be-19)
conj_and(required-7, extended-20)

Perioperative/JJ administration/NN of/IN drugs/NNS affecting/VBG hepatic/JJ blood/NN flow/NN or/CC enzyme/NN function/NN may/MD reduce/VB plasma/NN clearance/NN and/CC prolong/VB recovery/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Perioperative) (NN administration)) (PP (IN of) (NP (NP (NNS drugs)) (VP (VBG affecting) (NP (NP (JJ hepatic) (NN blood) (NN flow)) (CC or) (NP (NN enzyme) (NN function))))))) (VP (MD may) (VP (VP (VB reduce) (NP (NN plasma) (NN clearance))) (CC and) (VP (VB prolong) (NP (NN recovery)))))) (. .))))

amod(administration-2, Perioperative-1)
nsubj(reduce-13, administration-2)
prep_of(administration-2, drugs-4)
partmod(drugs-4, affecting-5)
amod(flow-8, hepatic-6)
nn(flow-8, blood-7)
dobj(affecting-5, flow-8)
nn(function-11, enzyme-10)
conj_or(flow-8, function-11)
aux(reduce-13, may-12)
root(ROOT-0, reduce-13)
nn(clearance-15, plasma-14)
dobj(reduce-13, clearance-15)
conj_and(reduce-13, prolong-17)
dobj(prolong-17, recovery-18)

Drug-Drug/JJ Interactions/NNS :/: The/DT pharmacokinetic/JJ and/CC pharmacodynamic/JJ interactions/NNS between/IN UROXATRAL/JJ and/CC other/JJ alpha-blockers/NNS have/VBP not/RB been/VBN determined/VBN ./.

(ROOT (S1 (S (NP (NP (JJ Drug-Drug) (NNS Interactions)) (: :) (S (NP (NP (DT The) (ADJP (ADJP (JJ pharmacokinetic)) (CC and) (ADJP (JJ pharmacodynamic))) (NNS interactions)) (PP (IN between) (NP (ADJP (ADJP (JJ UROXATRAL)) (CC and) (ADJP (JJ other))) (NNS alpha-blockers)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN determined))))) (. .)))))

amod(Interactions-2, Drug-Drug-1)
root(ROOT-0, Interactions-2)
det(interactions-8, The-4)
amod(interactions-8, pharmacokinetic-5)
conj_and(pharmacokinetic-5, pharmacodynamic-7)
nsubjpass(determined-17, interactions-8)
amod(alpha-blockers-13, UROXATRAL-10)
conj_and(UROXATRAL-10, other-12)
prep_between(interactions-8, alpha-blockers-13)
aux(determined-17, have-14)
neg(determined-17, not-15)
auxpass(determined-17, been-16)
dep(Interactions-2, determined-17)

However/RB ,/, interactions/NNS may/MD be/VB expected/VBN ,/, and/CC UROXATRAL/NN should/MD NOT/RB be/VB used/VBN in/IN combination/NN with/IN other/JJ alpha-blockers/NNS ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (S (NP (NNS interactions)) (VP (MD may) (VP (VB be) (VP (VBN expected))))) (, ,) (CC and) (S (NP (NN UROXATRAL)) (VP (MD should) (RB NOT) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ other) (NNS alpha-blockers)))))))))) (. .))))

advmod(expected-6, However-1)
nsubjpass(expected-6, interactions-3)
aux(expected-6, may-4)
auxpass(expected-6, be-5)
root(ROOT-0, expected-6)
nsubjpass(used-13, UROXATRAL-9)
aux(used-13, should-10)
neg(used-13, NOT-11)
auxpass(used-13, be-12)
conj_and(expected-6, used-13)
prep_in(used-13, combination-15)
amod(alpha-blockers-18, other-17)
prep_with(combination-15, alpha-blockers-18)

Effects/NNS of/IN Other/JJ Drugs/NNS on/IN Aliskiren/NN Based/VBN on/IN in-vitro/FW studies/NNS ,/, aliskiren/NN is/VBZ metabolized/VBN by/IN CYP/NN 3A4/NN ./.

(ROOT (S1 (S (S (S (NP (NP (NNS Effects)) (PP (IN of) (NP (JJ Other) (NNS Drugs))) (PP (IN on) (NP (NN Aliskiren)))) (VP (VBN Based) (PP (IN on) (NP (ADJP (FW in-vitro)) (NNS studies))))) (, ,) (NP (NN aliskiren)) (VP (VBZ is) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP) (NN 3A4)))))) (. .))))

nsubj(Based-7, Effects-1)
amod(Drugs-4, Other-3)
prep_of(Effects-1, Drugs-4)
prep_on(Effects-1, Aliskiren-6)
partmod(metabolized-14, Based-7)
amod(studies-10, in-vitro-9)
prep_on(Based-7, studies-10)
nsubjpass(metabolized-14, aliskiren-12)
auxpass(metabolized-14, is-13)
root(ROOT-0, metabolized-14)
nn(3A4-17, CYP-16)
agent(metabolized-14, 3A4-17)

Co-administration/NN of/IN lovastatin/NN ,/, atenolol/NN ,/, warfarin/NN ,/, furosemide/NN ,/, digoxin/NN ,/, celecoxib/NN ,/, hydrochlorothiazide/NN ,/, ramapril/NN ,/, valsartan/NN ,/, metformin/NN and/CC amlodipine/NN did/VBD not/RB result/VB in/IN clinically/RB significant/JJ increases/NNS in/IN aliskiren/NN exposure/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NP (NN lovastatin)) (, ,) (NP (NN atenolol)) (, ,) (NP (NN warfarin)) (, ,) (NP (NN furosemide)) (, ,) (NP (NN digoxin)) (, ,) (NP (NN celecoxib)) (, ,) (NP (NN hydrochlorothiazide)) (, ,) (NP (NN ramapril)) (, ,) (NP (NN valsartan)) (, ,) (NP (NN metformin)) (CC and) (NP (NN amlodipine))))) (VP (VBD did) (RB not) (VP (VB result) (PP (IN in) (NP (NP (ADJP (RB clinically) (JJ significant)) (NNS increases)) (PP (IN in) (NP (NN aliskiren) (NN exposure)))))))) (. .))))

nsubj(result-26, Co-administration-1)
prep_of(Co-administration-1, lovastatin-3)
conj_and(lovastatin-3, atenolol-5)
conj_and(lovastatin-3, warfarin-7)
conj_and(lovastatin-3, furosemide-9)
conj_and(lovastatin-3, digoxin-11)
conj_and(lovastatin-3, celecoxib-13)
conj_and(lovastatin-3, hydrochlorothiazide-15)
conj_and(lovastatin-3, ramapril-17)
conj_and(lovastatin-3, valsartan-19)
conj_and(lovastatin-3, metformin-21)
conj_and(lovastatin-3, amlodipine-23)
aux(result-26, did-24)
neg(result-26, not-25)
root(ROOT-0, result-26)
advmod(significant-29, clinically-28)
amod(increases-30, significant-29)
prep_in(result-26, increases-30)
nn(exposure-33, aliskiren-32)
prep_in(increases-30, exposure-33)

Co-administration/NN of/IN irbesartan/NN reduced/VBD aliskiren/CD Cmax/NN up/RP to/TO 50/CD %/NN after/IN multiple/JJ dosing/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NN irbesartan)))) (VP (VBD reduced) (NP (QP (CD aliskiren) (NN Cmax) (RP up) (TO to) (CD 50)) (NN %)) (PP (IN after) (NP (JJ multiple) (NN dosing))))) (. .))))

nsubj(reduced-4, Co-administration-1)
prep_of(Co-administration-1, irbesartan-3)
root(ROOT-0, reduced-4)
number(Cmax-6, aliskiren-5)
num(%-10, Cmax-6)
dep(Cmax-6, up-7)
dep(Cmax-6, to-8)
number(Cmax-6, 50-9)
dobj(reduced-4, %-10)
amod(dosing-13, multiple-12)
prep_after(reduced-4, dosing-13)

Co-administration/NN of/IN atorvastatin/NN resulted/VBD in/IN about/RB a/DT 50/CD %/NN increase/NN in/IN aliskiren/JJ Cmax/NN and/CC AUC/NN after/IN multiple/JJ dosing/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NN atorvastatin)))) (VP (VBD resulted) (PP (IN in) (NP (NP (RB about) (DT a) (ADJP (CD 50) (NN %)) (NN increase)) (PP (IN in) (NP (NP (NP (JJ aliskiren) (NN Cmax)) (CC and) (NP (NN AUC))) (PP (IN after) (NP (JJ multiple) (NN dosing))))))))) (. .))))

nsubj(resulted-4, Co-administration-1)
prep_of(Co-administration-1, atorvastatin-3)
root(ROOT-0, resulted-4)
advmod(increase-10, about-6)
det(increase-10, a-7)
number(%-9, 50-8)
amod(increase-10, %-9)
prep_in(resulted-4, increase-10)
amod(Cmax-13, aliskiren-12)
prep_in(increase-10, Cmax-13)
conj_and(Cmax-13, AUC-15)
amod(dosing-18, multiple-17)
prep_after(Cmax-13, dosing-18)

Ketoconazole/NN Co-administration/NN of/IN 200/CD mg/NN twice-daily/NN ketoconazole/NN with/IN aliskiren/NN resulted/VBD in/IN an/DT approximate/JJ 80/CD %/NN increase/NN in/IN plasma/NN levels/NNS of/IN aliskiren/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Ketoconazole) (NN Co-administration)) (PP (IN of) (NP (ADJP (CD 200) (NN mg)) (NN twice-daily) (NN ketoconazole))) (PP (IN with) (NP (NN aliskiren)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT an) (JJ approximate) (ADJP (CD 80) (NN %)) (NN increase)) (PP (IN in) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (NN aliskiren))))))))) (. .))))

nn(Co-administration-2, Ketoconazole-1)
nsubj(resulted-10, Co-administration-2)
number(mg-5, 200-4)
amod(ketoconazole-7, mg-5)
nn(ketoconazole-7, twice-daily-6)
prep_of(Co-administration-2, ketoconazole-7)
prep_with(Co-administration-2, aliskiren-9)
root(ROOT-0, resulted-10)
det(increase-16, an-12)
amod(increase-16, approximate-13)
number(%-15, 80-14)
amod(increase-16, %-15)
prep_in(resulted-10, increase-16)
nn(levels-19, plasma-18)
prep_in(increase-16, levels-19)
prep_of(levels-19, aliskiren-21)

A/DT 400/CD mg/NN once-daily/JJ dose/NN was/VBD not/RB studied/VBN but/CC would/MD be/VB expected/VBN to/TO increase/VB aliskiren/NN blood/NN levels/NNS further/RB ./.

(ROOT (S1 (S (S (NP (DT A) (ADJP (CD 400) (NN mg)) (JJ once-daily) (NN dose)) (VP (VP (VBD was) (RB not) (VP (VBN studied))) (CC but) (VP (MD would) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB increase) (NP (NN aliskiren) (NN blood) (NNS levels)) (ADVP (RB further)))))))))) (. .))))

det(dose-5, A-1)
number(mg-3, 400-2)
amod(dose-5, mg-3)
amod(dose-5, once-daily-4)
nsubjpass(studied-8, dose-5)
auxpass(studied-8, was-6)
neg(studied-8, not-7)
root(ROOT-0, studied-8)
aux(expected-12, would-10)
auxpass(expected-12, be-11)
conj_but(studied-8, expected-12)
aux(increase-14, to-13)
xcomp(expected-12, increase-14)
nn(levels-17, aliskiren-15)
nn(levels-17, blood-16)
dobj(increase-14, levels-17)
advmod(increase-14, further-18)

Effects/NNS of/IN Aliskiren/NNP on/IN Other/JJ Drugs/NNS Aliskiren/NNP does/VBZ not/RB inhibit/VB the/DT CYP450/CD isoenzymes/NNS (/-LRB- CYP1A2/NN ,/, 2C8/NN ,/, 2C9/NN ,/, 2C19/NN ,/, 2D6/NN ,/, 2E1/NN ,/, and/CC CYP/NN 3A/NN )/-RRB- or/CC induce/VB CYP/NN 3A4/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Effects)) (PP (IN of) (NP (NNP Aliskiren))) (PP (IN on) (NP (NP (JJ Other) (NNS Drugs)) (NP (NNP Aliskiren))))) (VP (VBZ does) (RB not) (VP (VP (VB inhibit) (NP (NP (DT the) (CD CYP450) (NNS isoenzymes)) (PRN (-LRB- -LRB-) (NP (NN CYP1A2)) (, ,) (NP (NP (NN 2C8)) (, ,) (NP (NN 2C9)) (, ,) (NP (NN 2C19)) (, ,) (NP (NN 2D6)) (, ,) (NP (NN 2E1)) (, ,) (CC and) (NP (NN CYP) (NN 3A))) (-RRB- -RRB-)))) (CC or) (VP (VB induce) (NP (NN CYP) (NN 3A4)))))) (. .))))

nsubj(inhibit-10, Effects-1)
prep_of(Effects-1, Aliskiren-3)
amod(Drugs-6, Other-5)
prep_on(Effects-1, Drugs-6)
dep(Drugs-6, Aliskiren-7)
aux(inhibit-10, does-8)
neg(inhibit-10, not-9)
root(ROOT-0, inhibit-10)
det(isoenzymes-13, the-11)
num(isoenzymes-13, CYP450-12)
dobj(inhibit-10, isoenzymes-13)
dep(isoenzymes-13, CYP1A2-15)
dep(CYP1A2-15, 2C8-17)
conj_and(2C8-17, 2C9-19)
conj_and(2C8-17, 2C19-21)
conj_and(2C8-17, 2D6-23)
conj_and(2C8-17, 2E1-25)
nn(3A-29, CYP-28)
conj_and(2C8-17, 3A-29)
conj_or(inhibit-10, induce-32)
nn(3A4-34, CYP-33)
dobj(induce-32, 3A4-34)

Co-administration/NN of/IN aliskiren/NN did/VBD not/RB significantly/RB affect/VB the/DT pharmacokinetics/NNS of/IN lovastatin/NN ,/, digoxin/NN ,/, valsartan/NN ,/, amlodipine/NN ,/, metformin/NN ,/, celecoxib/NN ,/, atenolol/NN ,/, atorvastatin/NN ,/, ramipril/NN or/CC hydrochlorothiazide/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NN aliskiren)))) (VP (VBD did) (RB not) (ADVP (RB significantly)) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN lovastatin)) (, ,) (NP (NN digoxin)) (, ,) (NP (NN valsartan)) (, ,) (NP (NN amlodipine)) (, ,) (NP (NN metformin)) (, ,) (NP (NN celecoxib)) (, ,) (NP (NN atenolol)) (, ,) (NP (NN atorvastatin)) (, ,) (NP (NN ramipril)) (CC or) (NP (NN hydrochlorothiazide)))))))) (. .))))

nsubj(affect-7, Co-administration-1)
prep_of(Co-administration-1, aliskiren-3)
aux(affect-7, did-4)
neg(affect-7, not-5)
advmod(affect-7, significantly-6)
root(ROOT-0, affect-7)
det(pharmacokinetics-9, the-8)
dobj(affect-7, pharmacokinetics-9)
prep_of(pharmacokinetics-9, lovastatin-11)
conj_or(lovastatin-11, digoxin-13)
conj_or(lovastatin-11, valsartan-15)
conj_or(lovastatin-11, amlodipine-17)
conj_or(lovastatin-11, metformin-19)
conj_or(lovastatin-11, celecoxib-21)
conj_or(lovastatin-11, atenolol-23)
conj_or(lovastatin-11, atorvastatin-25)
conj_or(lovastatin-11, ramipril-27)
conj_or(lovastatin-11, hydrochlorothiazide-29)

Warfarin/NN :/: The/DT effects/NNS of/IN aliskiren/NN on/IN warfarin/NN pharmacokinetics/NNS have/VBP not/RB been/VBN evaluated/VBN in/IN a/DT well-controlled/JJ clinical/JJ trial/NN ./.

(ROOT (S1 (S (NP (NP (NN Warfarin)) (: :) (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NN aliskiren))) (PP (IN on) (NP (NN warfarin) (NNS pharmacokinetics)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN evaluated) (PP (IN in) (NP (DT a) (JJ well-controlled) (JJ clinical) (NN trial))))))) (. .)))))

root(ROOT-0, Warfarin-1)
det(effects-4, The-3)
nsubjpass(evaluated-13, effects-4)
prep_of(effects-4, aliskiren-6)
nn(pharmacokinetics-9, warfarin-8)
prep_on(effects-4, pharmacokinetics-9)
aux(evaluated-13, have-10)
neg(evaluated-13, not-11)
auxpass(evaluated-13, been-12)
dep(Warfarin-1, evaluated-13)
det(trial-18, a-15)
amod(trial-18, well-controlled-16)
amod(trial-18, clinical-17)
prep_in(evaluated-13, trial-18)

Furosemide/NN :/: When/WRB aliskiren/NN was/VBD co-administered/VBN with/IN furosemide/NN ,/, the/DT AUC/NN and/CC Cmax/NN of/IN furosemide/NN were/VBD reduced/VBN by/IN about/RB 30/CD %/NN and/CC 50/CD %/NN ,/, respectively/RB ./.

(ROOT (S1 (S (NP (NP (NN Furosemide)) (: :) (S (SBAR (WHADVP (WRB When)) (S (NP (NN aliskiren)) (VP (VBD was) (VP (VBN co-administered) (PP (IN with) (NP (NN furosemide))))))) (, ,) (NP (NP (DT the) (NP (NN AUC)) (CC and) (NP (NN Cmax))) (PP (IN of) (NP (NN furosemide)))) (VP (VBD were) (VP (VBN reduced) (PP (IN by) (NP (NP (QP (RB about) (CD 30)) (NN %)) (CC and) (NP (CD 50) (NN %)) (, ,) (ADVP (RB respectively))))))) (. .)))))

root(ROOT-0, Furosemide-1)
advmod(co-administered-6, When-3)
nsubjpass(co-administered-6, aliskiren-4)
auxpass(co-administered-6, was-5)
advcl(reduced-17, co-administered-6)
prep_with(co-administered-6, furosemide-8)
dep(AUC-11, the-10)
nsubjpass(reduced-17, AUC-11)
conj_and(AUC-11, Cmax-13)
prep_of(AUC-11, furosemide-15)
auxpass(reduced-17, were-16)
dep(Furosemide-1, reduced-17)
quantmod(30-20, about-19)
num(%-21, 30-20)
agent(reduced-17, %-21)
num(%-24, 50-23)
conj_and(%-21, %-24)
advmod(%-21, respectively-26)
conj_and(%-21, respectively-26)

Patients/NNS who/WP are/VBP applying/VBG Panretin/NN @/NN gel/NN should/MD not/RB concurrently/RB use/VB products/NNS that/WDT contain/VBP DEET/NN (/-LRB- N/NN ,/, N-diethyl-m-toluamide/NN )/-RRB- ,/, a/DT common/JJ component/NN of/IN insect/NN repellent/NN products/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG applying) (NP (NN Panretin) (NN @) (NN gel))))))) (VP (MD should) (RB not) (ADVP (RB concurrently)) (VP (VB use) (NP (NP (NNS products)) (SBAR (WHNP (WDT that)) (S (VP (VBP contain) (NP (NP (NP (NN DEET)) (PRN (-LRB- -LRB-) (NP (NP (NN N)) (, ,) (NP (NN N-diethyl-m-toluamide))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ common) (NN component)) (PP (IN of) (NP (NN insect) (NN repellent) (NNS products)))))))))))) (. .))))

nsubj(applying-4, Patients-1)
nsubj(use-11, Patients-1)
aux(applying-4, are-3)
rcmod(Patients-1, applying-4)
nn(gel-7, Panretin-5)
nn(gel-7, @-6)
dobj(applying-4, gel-7)
aux(use-11, should-8)
neg(use-11, not-9)
advmod(use-11, concurrently-10)
root(ROOT-0, use-11)
dobj(use-11, products-12)
nsubj(contain-14, products-12)
rcmod(products-12, contain-14)
dobj(contain-14, DEET-15)
dep(DEET-15, N-17)
appos(N-17, N-diethyl-m-toluamide-19)
det(component-24, a-22)
amod(component-24, common-23)
appos(DEET-15, component-24)
nn(products-28, insect-26)
nn(products-28, repellent-27)
prep_of(component-24, products-28)

Animal/NN toxicology/NN studies/NNS showed/VBD increased/VBN DEET/NN toxicity/NN when/WRB DEET/NN was/VBD included/VBN as/IN proof/NN of/IN the/DT formulation/NN ./.

(ROOT (S1 (S (S (NP (NN Animal) (NN toxicology) (NNS studies)) (VP (VBD showed) (NP (VBN increased) (NN DEET) (NN toxicity)) (SBAR (WHADVP (WRB when)) (S (NP (NN DEET)) (VP (VBD was) (VP (VBN included) (PP (IN as) (NP (NP (NN proof)) (PP (IN of) (NP (DT the) (NN formulation))))))))))) (. .))))

nn(studies-3, Animal-1)
nn(studies-3, toxicology-2)
nsubj(showed-4, studies-3)
root(ROOT-0, showed-4)
amod(toxicity-7, increased-5)
nn(toxicity-7, DEET-6)
dobj(showed-4, toxicity-7)
advmod(included-11, when-8)
nsubjpass(included-11, DEET-9)
auxpass(included-11, was-10)
advcl(showed-4, included-11)
prep_as(included-11, proof-13)
det(formulation-16, the-15)
prep_of(proof-13, formulation-16)

Although/IN there/EX was/VBD no/DT clinical/JJ evidence/NN in/IN the/DT vehicle-controlled/JJ studies/NNS of/IN drug/NN interactions/NNS with/IN systemic/JJ antiretroviral/JJ agents/NNS ,/, including/VBG protease/NN inhibitors/NNS ,/, macrolide/NN antibiotics/NNS ,/, and/CC azole/JJ antifungals/NNS ,/, the/DT effect/NN of/IN Panretin/NN @/NN gel/NN on/IN the/DT steady-state/JJ concentrations/NNS of/IN these/DT drugs/NNS is/VBZ not/RB known/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (EX there)) (VP (VBD was) (NP (DT no) (JJ clinical) (NN evidence)) (PP (IN in) (NP (NP (DT the) (JJ vehicle-controlled) (NNS studies)) (PP (IN of) (NP (NP (NN drug) (NNS interactions)) (PP (IN with) (NP (NP (JJ systemic) (JJ antiretroviral) (NNS agents)) (, ,) (PP (VBG including) (NP (NP (NN protease) (NNS inhibitors)) (, ,) (NP (NN macrolide) (NNS antibiotics)) (, ,) (CC and) (NP (JJ azole) (NNS antifungals))))))))))))) (, ,) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN Panretin) (NN @) (NN gel))) (PP (IN on) (NP (NP (DT the) (JJ steady-state) (NNS concentrations)) (PP (IN of) (NP (DT these) (NNS drugs)))))) (VP (VBZ is) (RB not) (VP (VBN known)))) (. .))))

mark(was-3, Although-1)
expl(was-3, there-2)
advcl(known-45, was-3)
det(evidence-6, no-4)
amod(evidence-6, clinical-5)
nsubj(was-3, evidence-6)
det(studies-10, the-8)
amod(studies-10, vehicle-controlled-9)
prep_in(was-3, studies-10)
nn(interactions-13, drug-12)
prep_of(studies-10, interactions-13)
amod(agents-17, systemic-15)
amod(agents-17, antiretroviral-16)
prep_with(interactions-13, agents-17)
nn(inhibitors-21, protease-20)
prep_including(agents-17, inhibitors-21)
nn(antibiotics-24, macrolide-23)
conj_and(inhibitors-21, antibiotics-24)
amod(antifungals-28, azole-27)
conj_and(inhibitors-21, antifungals-28)
det(effect-31, the-30)
nsubjpass(known-45, effect-31)
nn(gel-35, Panretin-33)
nn(gel-35, @-34)
prep_of(effect-31, gel-35)
det(concentrations-39, the-37)
amod(concentrations-39, steady-state-38)
prep_on(effect-31, concentrations-39)
det(drugs-42, these-41)
prep_of(concentrations-39, drugs-42)
auxpass(known-45, is-43)
neg(known-45, not-44)
root(ROOT-0, known-45)

The/DT following/JJ drug/NN interactions/NNS were/VBD observed/VBN in/IN some/DT patients/NNS undergoing/VBG treatment/NN with/IN oral/JJ allopurinol/NN ./.

(ROOT (S1 (S (S (NP (DT The) (JJ following) (NN drug) (NNS interactions)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (DT some) (NNS patients)) (VP (VBG undergoing) (NP (NP (NN treatment)) (PP (IN with) (NP (JJ oral) (NN allopurinol)))))))))) (. .))))

det(interactions-4, The-1)
amod(interactions-4, following-2)
nn(interactions-4, drug-3)
nsubjpass(observed-6, interactions-4)
auxpass(observed-6, were-5)
root(ROOT-0, observed-6)
det(patients-9, some-8)
prep_in(observed-6, patients-9)
partmod(patients-9, undergoing-10)
dobj(undergoing-10, treatment-11)
amod(allopurinol-14, oral-13)
prep_with(treatment-11, allopurinol-14)

Although/IN the/DT pattern/NN of/IN use/NN for/IN oral/JJ allopurinol/NN includes/VBZ longer/JJR term/NN therapy/NN ,/, particularly/RB for/IN gout/NN and/CC renal/JJ calculi/NN ,/, the/DT experience/VBP gained/VBN may/MD be/VB relevant/JJ ./.

(ROOT (S1 (S (SBAR (IN Although) (S (NP (NP (DT the) (NN pattern)) (PP (IN of) (NP (NN use))) (PP (IN for) (NP (JJ oral) (NN allopurinol)))) (VP (VBZ includes) (NP (NP (JJR longer) (NN term) (NN therapy)) (, ,) (ADVP (RB particularly)) (PP (IN for) (NP (NP (NN gout)) (CC and) (NP (JJ renal) (NN calculi)))))))) (, ,) (NP (DT the)) (VP (VBP experience) (VP (VBN gained) (S (VP (MD may) (VP (VB be) (ADJP (JJ relevant))))))) (. .))))

mark(includes-9, Although-1)
det(pattern-3, the-2)
nsubj(includes-9, pattern-3)
prep_of(pattern-3, use-5)
amod(allopurinol-8, oral-7)
prep_for(pattern-3, allopurinol-8)
advcl(experience-22, includes-9)
amod(therapy-12, longer-10)
nn(therapy-12, term-11)
dobj(includes-9, therapy-12)
advmod(therapy-12, particularly-14)
prep_for(therapy-12, gout-16)
amod(calculi-19, renal-18)
conj_and(gout-16, calculi-19)
nsubj(experience-22, the-21)
root(ROOT-0, experience-22)
dep(experience-22, gained-23)
aux(relevant-26, may-24)
cop(relevant-26, be-25)
ccomp(gained-23, relevant-26)

Mercaptopurine/NN //: Azathioprine/NN :/: Allopurinol/NN inhibits/VBZ the/DT enzymatic/JJ oxidation/NN of/IN mercaptopurine/NN and/CC azathioprine/NN to/TO 6-thiouric/JJ acid/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Mercaptopurine)) (: /) (NP (NN Azathioprine)) (: :) (NP (NN Allopurinol))) (VP (VBZ inhibits) (NP (NP (DT the) (JJ enzymatic) (NN oxidation)) (PP (IN of) (NP (NP (NN mercaptopurine)) (CC and) (NP (NN azathioprine)))) (PP (TO to) (NP (JJ 6-thiouric) (NN acid)))))) (. .))))

nsubj(inhibits-6, Mercaptopurine-1)
punct(Mercaptopurine-1, /-2)
dep(Mercaptopurine-1, Azathioprine-3)
dep(Mercaptopurine-1, Allopurinol-5)
root(ROOT-0, inhibits-6)
det(oxidation-9, the-7)
amod(oxidation-9, enzymatic-8)
dobj(inhibits-6, oxidation-9)
prep_of(oxidation-9, mercaptopurine-11)
conj_and(mercaptopurine-11, azathioprine-13)
amod(acid-16, 6-thiouric-15)
prep_to(oxidation-9, acid-16)

This/DT oxidation/NN ,/, which/WDT is/VBZ catalyzed/VBN by/IN xanthine/NN oxidase/NN ,/, inactivates/VBZ mercaptopurine/NN ./.

(ROOT (S1 (S (S (NP (NP (DT This) (NN oxidation)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN catalyzed) (PP (IN by) (NP (NN xanthine) (NN oxidase))))))) (, ,)) (VP (VBZ inactivates) (NP (NN mercaptopurine)))) (. .))))

det(oxidation-2, This-1)
nsubjpass(catalyzed-6, oxidation-2)
nsubj(inactivates-11, oxidation-2)
auxpass(catalyzed-6, is-5)
rcmod(oxidation-2, catalyzed-6)
nn(oxidase-9, xanthine-8)
agent(catalyzed-6, oxidase-9)
root(ROOT-0, inactivates-11)
dobj(inactivates-11, mercaptopurine-12)

In/IN patients/NNS receiving/VBG mercaptopurine/NN (/-LRB- Purinethol/NN )/-RRB- or/CC azathioprine/NN (/-LRB- Imuran/NN )/-RRB- ,/, the/DT concomitant/JJ administration/NN of/IN 300-600/CD mg/NN of/IN allopurinol/NN per/IN day/NN will/MD require/VB a/DT reduction/NN in/IN dose/NN to/TO approximately/RB one-third/CD to/TO one-fourth/CD of/IN the/DT usual/JJ dose/NN of/IN mercaptopurine/NN or/CC azathioprine/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NP (NN mercaptopurine)) (PRN (-LRB- -LRB-) (NP (NN Purinethol)) (-RRB- -RRB-))) (CC or) (NP (NP (NN azathioprine)) (PRN (-LRB- -LRB-) (NP (NN Imuran)) (-RRB- -RRB-))))))) (, ,) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (CD 300-600) (NN mg)) (PP (IN of) (NP (NN allopurinol))) (PP (IN per) (NP (NN day)))))) (VP (MD will) (VP (VB require) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NN dose))) (PP (TO to) (NP (NP (RB approximately) (CD one-third) (TO to) (CD one-fourth)) (PP (IN of) (NP (NP (DT the) (JJ usual) (NN dose)) (PP (IN of) (NP (NP (NN mercaptopurine)) (CC or) (NP (NN azathioprine))))))))))) (. .))))

prep_in(require-25, patients-2)
partmod(patients-2, receiving-3)
dobj(receiving-3, mercaptopurine-4)
appos(mercaptopurine-4, Purinethol-6)
conj_or(mercaptopurine-4, azathioprine-9)
appos(azathioprine-9, Imuran-11)
det(administration-16, the-14)
amod(administration-16, concomitant-15)
nsubj(require-25, administration-16)
num(mg-19, 300-600-18)
prep_of(administration-16, mg-19)
prep_of(mg-19, allopurinol-21)
prep_per(mg-19, day-23)
aux(require-25, will-24)
root(ROOT-0, require-25)
det(reduction-27, a-26)
dobj(require-25, reduction-27)
prep_in(reduction-27, dose-29)
advmod(one-fourth-34, approximately-31)
num(one-fourth-34, one-third-32)
dep(one-fourth-34, to-33)
prep_to(reduction-27, one-fourth-34)
det(dose-38, the-36)
amod(dose-38, usual-37)
prep_of(one-fourth-34, dose-38)
prep_of(dose-38, mercaptopurine-40)
conj_or(mercaptopurine-40, azathioprine-42)

Subsequent/JJ adjustment/NN of/IN doses/NNS of/IN mercaptopurine/NN or/CC azathioprine/NN should/MD be/VB made/VBN on/IN the/DT basis/NN of/IN therapeutic/JJ response/NN and/CC the/DT appearance/NN of/IN toxic/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Subsequent) (NN adjustment)) (PP (IN of) (NP (NP (NNS doses)) (PP (IN of) (NP (NP (NN mercaptopurine)) (CC or) (NP (NN azathioprine))))))) (VP (MD should) (VP (VB be) (VP (VBN made) (PP (IN on) (NP (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (JJ therapeutic) (NN response)))) (CC and) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (JJ toxic) (NNS effects)))))))))) (. .))))

amod(adjustment-2, Subsequent-1)
nsubjpass(made-11, adjustment-2)
prep_of(adjustment-2, doses-4)
prep_of(doses-4, mercaptopurine-6)
conj_or(mercaptopurine-6, azathioprine-8)
aux(made-11, should-9)
auxpass(made-11, be-10)
root(ROOT-0, made-11)
det(basis-14, the-13)
prep_on(made-11, basis-14)
amod(response-17, therapeutic-16)
prep_of(basis-14, response-17)
det(appearance-20, the-19)
conj_and(basis-14, appearance-20)
amod(effects-23, toxic-22)
prep_of(appearance-20, effects-23)

Dicumarol/NN :/: It/PRP has/VBZ been/VBN reported/VBN that/IN allopurinol/NN prolongs/VBZ the/DT half-life/NN of/IN the/DT anticoagulant/JJ ,/, dicumarol/NN ./.

(ROOT (S1 (S (NP (NP (NN Dicumarol)) (: :) (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (SBAR (IN that) (S (NP (NN allopurinol)) (VP (VBZ prolongs) (NP (NP (DT the) (NN half-life)) (PP (IN of) (NP (NP (DT the) (JJ anticoagulant)) (, ,) (NP (NN dicumarol)))))))))))) (. .)))))

root(ROOT-0, Dicumarol-1)
nsubjpass(reported-6, It-3)
aux(reported-6, has-4)
auxpass(reported-6, been-5)
dep(Dicumarol-1, reported-6)
complm(prolongs-9, that-7)
nsubj(prolongs-9, allopurinol-8)
ccomp(reported-6, prolongs-9)
det(half-life-11, the-10)
dobj(prolongs-9, half-life-11)
det(anticoagulant-14, the-13)
prep_of(half-life-11, anticoagulant-14)
appos(anticoagulant-14, dicumarol-16)

The/DT clinical/JJ basis/NN of/IN this/DT drug/NN interaction/NN has/VBZ not/RB been/VBN established/VBN but/CC should/MD be/VB noted/VBN when/WRB allopurinol/NN is/VBZ given/VBN to/TO patients/NNS already/RB on/IN dicumarol/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ clinical) (NN basis)) (PP (IN of) (NP (DT this) (NN drug) (NN interaction)))) (VP (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN established)))) (CC but) (VP (MD should) (VP (VB be) (VP (VBN noted) (SBAR (WHADVP (WRB when)) (S (NP (NN allopurinol)) (VP (VBZ is) (VP (VBN given) (PP (TO to) (NP (NNS patients))) (PP (ADVP (RB already)) (IN on) (NP (NN dicumarol) (NN therapy)))))))))))) (. .))))

det(basis-3, The-1)
amod(basis-3, clinical-2)
nsubjpass(established-11, basis-3)
det(interaction-7, this-5)
nn(interaction-7, drug-6)
prep_of(basis-3, interaction-7)
aux(established-11, has-8)
neg(established-11, not-9)
auxpass(established-11, been-10)
root(ROOT-0, established-11)
aux(noted-15, should-13)
auxpass(noted-15, be-14)
conj_but(established-11, noted-15)
advmod(given-19, when-16)
nsubjpass(given-19, allopurinol-17)
auxpass(given-19, is-18)
advcl(noted-15, given-19)
prep_to(given-19, patients-21)
advmod(given-19, already-22)
nn(therapy-25, dicumarol-24)
prep_on(given-19, therapy-25)

Consequently/RB ,/, prothrombin/NN time/NN should/MD be/VB reassessed/VBN periodically/RB in/IN patients/NNS receiving/VBG both/DT drugs/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Consequently)) (, ,) (NP (NN prothrombin) (NN time)) (VP (MD should) (VP (VB be) (VP (VBN reassessed) (ADVP (RB periodically)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (DT both) (NNS drugs))))))))) (. .))))

advmod(reassessed-7, Consequently-1)
nn(time-4, prothrombin-3)
nsubjpass(reassessed-7, time-4)
aux(reassessed-7, should-5)
auxpass(reassessed-7, be-6)
root(ROOT-0, reassessed-7)
advmod(reassessed-7, periodically-8)
prep_in(reassessed-7, patients-10)
partmod(patients-10, receiving-11)
det(drugs-13, both-12)
dobj(receiving-11, drugs-13)

Uricosuric/JJ Agents/NNS :/: Since/IN the/DT excretion/NN of/IN oxipurinol/NN is/VBZ similar/JJ to/TO that/DT of/IN urate/NN ,/, uricosuric/JJ agents/NNS ,/, which/WDT increase/VBP the/DT excretion/NN of/IN urate/NN ,/, are/VBP also/RB likely/JJ to/TO increase/VB the/DT excretion/NN of/IN oxipurinol/NN and/CC thus/RB lower/JJR the/DT degree/NN of/IN inhibition/NN of/IN xanthine/NN oxidase/NN ./.

(ROOT (S1 (S (NP (NP (JJ Uricosuric) (NNS Agents)) (: :) (S (SBAR (IN Since) (S (NP (NP (DT the) (NN excretion)) (PP (IN of) (NP (NN oxipurinol)))) (VP (VBZ is) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (NN urate))))))))) (, ,) (NP (NP (JJ uricosuric) (NNS agents)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP increase) (NP (NP (DT the) (NN excretion)) (PP (IN of) (NP (NN urate))))))) (, ,)) (VP (VBP are) (ADVP (RB also)) (ADJP (JJ likely) (S (VP (TO to) (VP (VP (VB increase) (NP (NP (DT the) (NN excretion)) (PP (IN of) (NP (NN oxipurinol))))) (CC and) (VP (ADVP (RB thus)) (JJR lower) (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN xanthine) (NN oxidase))))))))))))) (. .)))))

amod(Agents-2, Uricosuric-1)
root(ROOT-0, Agents-2)
mark(similar-10, Since-4)
det(excretion-6, the-5)
nsubj(similar-10, excretion-6)
prep_of(excretion-6, oxipurinol-8)
cop(similar-10, is-9)
advcl(likely-28, similar-10)
prep_to(similar-10, that-12)
prep_of(that-12, urate-14)
amod(agents-17, uricosuric-16)
nsubj(increase-20, agents-17)
nsubj(likely-28, agents-17)
rcmod(agents-17, increase-20)
det(excretion-22, the-21)
dobj(increase-20, excretion-22)
prep_of(excretion-22, urate-24)
cop(likely-28, are-26)
advmod(likely-28, also-27)
dep(Agents-2, likely-28)
aux(increase-30, to-29)
xcomp(likely-28, increase-30)
det(excretion-32, the-31)
dobj(increase-30, excretion-32)
prep_of(excretion-32, oxipurinol-34)
advmod(degree-39, thus-36)
dep(degree-39, lower-37)
det(degree-39, the-38)
conj_and(increase-30, degree-39)
prep_of(degree-39, inhibition-41)
nn(oxidase-44, xanthine-43)
prep_of(inhibition-41, oxidase-44)

The/DT concomitant/JJ administration/NN of/IN uricosuric/JJ agents/NNS and/CC allopurinol/NN has/VBZ been/VBN associated/VBN with/IN a/DT decrease/NN in/IN the/DT excretion/NN of/IN oxypurines/NNS (/-LRB- hypoxanthine/NN and/CC xanthine/NN )/-RRB- and/CC an/DT increase/NN in/IN urinary/JJ uric/JJ acid/NN excretion/NN compared/VBN with/IN that/DT observed/VBN with/IN allopurinol/NN alone/RB ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (JJ uricosuric) (NNS agents)) (CC and) (NP (NN allopurinol))))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN excretion)) (PP (IN of) (NP (NP (NNS oxypurines)) (PRN (-LRB- -LRB-) (NP (NP (NN hypoxanthine)) (CC and) (NP (NN xanthine))) (-RRB- -RRB-))))))) (CC and) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (JJ urinary) (JJ uric) (NN acid) (NN excretion)) (PP (VBN compared) (PP (IN with) (NP (NP (DT that)) (VP (VBN observed) (PP (IN with) (NP (NP (NN allopurinol)) (ADVP (RB alone))))))))))))))))) (. .))))

det(administration-3, The-1)
amod(administration-3, concomitant-2)
nsubjpass(associated-11, administration-3)
amod(agents-6, uricosuric-5)
prep_of(administration-3, agents-6)
conj_and(agents-6, allopurinol-8)
aux(associated-11, has-9)
auxpass(associated-11, been-10)
root(ROOT-0, associated-11)
det(decrease-14, a-13)
prep_with(associated-11, decrease-14)
det(excretion-17, the-16)
prep_in(decrease-14, excretion-17)
prep_of(excretion-17, oxypurines-19)
dep(oxypurines-19, hypoxanthine-21)
conj_and(hypoxanthine-21, xanthine-23)
det(increase-27, an-26)
conj_and(decrease-14, increase-27)
amod(excretion-32, urinary-29)
amod(excretion-32, uric-30)
nn(excretion-32, acid-31)
prep_in(increase-27, excretion-32)
prepc_compared_with(excretion-32, with-34)
pobj(excretion-32, that-35)
partmod(that-35, observed-36)
prep_with(observed-36, allopurinol-38)
advmod(allopurinol-38, alone-39)

Although/IN clinical/JJ evidence/NN to/TO date/NN has/VBZ not/RB demonstrated/VBN renal/JJ precipitation/NN of/IN oxypurines/NNS in/IN patients/NNS either/CC on/IN allopurinol/NN alone/RB or/CC in/IN combination/NN with/IN uricosuric/JJ agents/NNS ,/, the/DT possibility/NN should/MD be/VB kept/VBN in/IN mind/NN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ clinical) (NN evidence)) (PP (TO to) (NP (NN date)))) (VP (VBZ has) (RB not) (VP (VBN demonstrated) (NP (NP (JJ renal) (NN precipitation)) (PP (IN of) (NP (NNS oxypurines))) (PP (PP (IN in) (NP (NNS patients))) (CC either) (PP (IN on) (NP (NN allopurinol)))) (UCP (ADVP (RB alone)) (CC or) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ uricosuric) (NNS agents))))))))))) (, ,) (NP (DT the) (NN possibility)) (VP (MD should) (VP (VB be) (VP (VBN kept) (PP (IN in) (NP (NN mind))))))) (. .))))

mark(demonstrated-8, Although-1)
amod(evidence-3, clinical-2)
nsubj(demonstrated-8, evidence-3)
prep_to(evidence-3, date-5)
aux(demonstrated-8, has-6)
neg(demonstrated-8, not-7)
advcl(kept-30, demonstrated-8)
amod(precipitation-10, renal-9)
dobj(demonstrated-8, precipitation-10)
prep_of(precipitation-10, oxypurines-12)
prep_in(precipitation-10, patients-14)
dep(precipitation-10, either-15)
conj(precipitation-10, on-16)
pobj(on-16, allopurinol-17)
dep(precipitation-10, alone-18)
conj_or(alone-18, in-20)
pobj(in-20, combination-21)
amod(agents-24, uricosuric-23)
prep_with(combination-21, agents-24)
det(possibility-27, the-26)
nsubjpass(kept-30, possibility-27)
aux(kept-30, should-28)
auxpass(kept-30, be-29)
root(ROOT-0, kept-30)
prep_in(kept-30, mind-32)

Thiazide/NN Diuretics/NNS :/: The/DT reports/NNS that/IN the/DT concomitant/JJ use/NN of/IN allopurinol/NN and/CC thiazide/NN diuretics/NNS may/MD contribute/VB to/TO the/DT enhancement/NN of/IN allopurinol/NN toxicity/NN in/IN some/DT patients/NNS have/VBP been/VBN reviewed/VBN in/IN an/DT attempt/NN to/TO establish/VB a/DT cause-and-effect/JJ relationship/NN and/CC a/DT mechanism/NN of/IN causation/NN ./.

(ROOT (S1 (S (NP (NP (NN Thiazide) (NNS Diuretics)) (: :) (S (NP (NP (DT The) (NNS reports)) (SBAR (IN that) (S (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN allopurinol)) (CC and) (NP (NN thiazide) (NNS diuretics))))) (VP (MD may) (VP (VB contribute) (PP (TO to) (NP (NP (DT the) (NN enhancement)) (PP (IN of) (NP (NN allopurinol) (NN toxicity))) (PP (IN in) (NP (DT some) (NNS patients)))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN reviewed) (PP (IN in) (NP (NP (DT an) (NN attempt)) (S (VP (TO to) (VP (VB establish) (NP (NP (DT a) (JJ cause-and-effect) (NN relationship)) (CC and) (NP (NP (DT a) (NN mechanism)) (PP (IN of) (NP (NN causation)))))))))))))) (. .)))))

nn(Diuretics-2, Thiazide-1)
root(ROOT-0, Diuretics-2)
det(reports-5, The-4)
dobj(contribute-16, reports-5)
nsubjpass(reviewed-28, reports-5)
complm(contribute-16, that-6)
det(use-9, the-7)
amod(use-9, concomitant-8)
nsubj(contribute-16, use-9)
prep_of(use-9, allopurinol-11)
nn(diuretics-14, thiazide-13)
conj_and(allopurinol-11, diuretics-14)
aux(contribute-16, may-15)
dep(reports-5, contribute-16)
det(enhancement-19, the-18)
prep_to(contribute-16, enhancement-19)
nn(toxicity-22, allopurinol-21)
prep_of(enhancement-19, toxicity-22)
det(patients-25, some-24)
prep_in(enhancement-19, patients-25)
aux(reviewed-28, have-26)
auxpass(reviewed-28, been-27)
dep(Diuretics-2, reviewed-28)
det(attempt-31, an-30)
prep_in(reviewed-28, attempt-31)
aux(establish-33, to-32)
infmod(attempt-31, establish-33)
det(relationship-36, a-34)
amod(relationship-36, cause-and-effect-35)
dobj(establish-33, relationship-36)
det(mechanism-39, a-38)
conj_and(relationship-36, mechanism-39)
prep_of(mechanism-39, causation-41)

Review/NN of/IN these/DT case/NN reports/NNS indicates/VBZ that/IN the/DT patients/NNS were/VBD mainly/RB receiving/VBG thiazide/NN diuretics/NNS for/IN hypertension/NN and/CC that/IN tests/NNS to/TO rule/NN out/IN decreased/VBN renal/JJ function/NN secondary/JJ to/TO hypertensive/NN nephropathy/NN were/VBD not/RB often/RB performed/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Review)) (PP (IN of) (NP (DT these) (NN case) (NNS reports)))) (VP (VBZ indicates) (SBAR (SBAR (IN that) (S (NP (DT the) (NNS patients)) (VP (VBD were) (ADVP (RB mainly)) (VP (VBG receiving) (NP (NP (NN thiazide) (NNS diuretics)) (PP (IN for) (NP (NN hypertension)))))))) (CC and) (SBAR (IN that) (S (NP (NP (NNS tests)) (PP (TO to) (NP (NP (NN rule)) (PP (IN out) (NP (NP (VBN decreased) (JJ renal) (NN function)) (ADJP (JJ secondary) (PP (TO to) (NP (NN hypertensive) (NN nephropathy))))))))) (VP (VBD were) (RB not) (ADVP (RB often)) (VP (VBN performed)))))))) (. .))))

nsubj(indicates-6, Review-1)
det(reports-5, these-3)
nn(reports-5, case-4)
prep_of(Review-1, reports-5)
root(ROOT-0, indicates-6)
complm(receiving-12, that-7)
det(patients-9, the-8)
nsubj(receiving-12, patients-9)
aux(receiving-12, were-10)
advmod(receiving-12, mainly-11)
ccomp(indicates-6, receiving-12)
nn(diuretics-14, thiazide-13)
dobj(receiving-12, diuretics-14)
prep_for(diuretics-14, hypertension-16)
complm(performed-33, that-18)
nsubjpass(performed-33, tests-19)
prep_to(tests-19, rule-21)
amod(function-25, decreased-23)
amod(function-25, renal-24)
prep_out(rule-21, function-25)
amod(function-25, secondary-26)
nn(nephropathy-29, hypertensive-28)
prep_to(secondary-26, nephropathy-29)
auxpass(performed-33, were-30)
neg(performed-33, not-31)
advmod(performed-33, often-32)
conj_and(receiving-12, performed-33)

In/IN those/DT patients/NNS in/IN whom/WP renal/JJ insufficiency/NN was/VBD documented/VBN ,/, however/RB ,/, the/DT recommendation/NN to/TO lower/VB the/DT dose/NN of/IN allopurinol/NN was/VBD not/RB followed/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT those) (NNS patients)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (JJ renal) (NN insufficiency)) (VP (VBD was) (VP (VBN documented))))))) (, ,) (ADVP (RB however)) (, ,) (NP (DT the) (NN recommendation) (S (VP (TO to) (VP (VB lower) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN allopurinol)))))))) (VP (VBD was) (RB not) (VP (VBN followed)))) (. .))))

det(patients-3, those-2)
prep_in(followed-23, patients-3)
rel(documented-9, whom-5)
amod(insufficiency-7, renal-6)
nsubjpass(documented-9, insufficiency-7)
auxpass(documented-9, was-8)
rcmod(patients-3, documented-9)
advmod(followed-23, however-11)
det(recommendation-14, the-13)
nsubjpass(followed-23, recommendation-14)
aux(lower-16, to-15)
infmod(recommendation-14, lower-16)
det(dose-18, the-17)
dobj(lower-16, dose-18)
prep_of(dose-18, allopurinol-20)
auxpass(followed-23, was-21)
neg(followed-23, not-22)
root(ROOT-0, followed-23)

Although/IN a/DT causal/JJ mechanism/NN and/CC a/DT cause-and-effect/JJ relationship/NN have/VBP not/RB been/VBN established/VBN ,/, current/JJ evidence/NN suggests/VBZ that/IN renal/JJ function/NN should/MD be/VB monitored/VBN in/IN patients/NNS on/IN thiazide/NN diuretics/NNS and/CC allopurinol/NN even/RB in/IN the/DT absence/NN of/IN renal/JJ failure/NN ,/, and/CC dosage/NN levels/NNS should/MD be/VB even/RB more/RBR conservatively/RB adjusted/VBN in/IN those/DT patients/NNS on/IN such/JJ combined/JJ therapy/NN if/IN diminished/VBN renal/JJ function/NN is/VBZ detected/VBN ../NN

(ROOT (S1 (S (SBAR (IN Although) (S (NP (NP (DT a) (JJ causal) (NN mechanism)) (CC and) (NP (DT a) (JJ cause-and-effect) (NN relationship))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN established)))))) (, ,) (S (NP (JJ current) (NN evidence)) (VP (VBZ suggests) (SBAR (IN that) (S (S (NP (JJ renal) (NN function)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (PP (IN in) (NP (NP (NNS patients)) (PP (IN on) (NP (NP (NN thiazide) (NNS diuretics)) (CC and) (NP (NN allopurinol)))))) (PP (ADVP (RB even)) (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (JJ renal) (NN failure))))))))) (, ,) (CC and) (S (NP (NN dosage) (NNS levels)) (VP (MD should) (VP (VB be) (ADVP (RB even) (RBR more) (RB conservatively)) (VP (VBN adjusted) (PP (IN in) (NP (NP (DT those) (NNS patients)) (PP (IN on) (NP (JJ such) (JJ combined) (NN therapy))))) (SBAR (IN if) (S (NP (VBN diminished) (JJ renal) (NN function)) (VP (VBZ is) (VP (VBN detected) (NP (NN ..)))))))))))))))))

mark(established-12, Although-1)
det(mechanism-4, a-2)
amod(mechanism-4, causal-3)
nsubjpass(established-12, mechanism-4)
det(relationship-8, a-6)
amod(relationship-8, cause-and-effect-7)
conj_and(mechanism-4, relationship-8)
aux(established-12, have-9)
neg(established-12, not-10)
auxpass(established-12, been-11)
advcl(suggests-16, established-12)
amod(evidence-15, current-14)
nsubj(suggests-16, evidence-15)
root(ROOT-0, suggests-16)
complm(monitored-22, that-17)
amod(function-19, renal-18)
nsubjpass(monitored-22, function-19)
aux(monitored-22, should-20)
auxpass(monitored-22, be-21)
ccomp(suggests-16, monitored-22)
prep_in(monitored-22, patients-24)
nn(diuretics-27, thiazide-26)
prep_on(patients-24, diuretics-27)
conj_and(diuretics-27, allopurinol-29)
advmod(monitored-22, even-30)
det(absence-33, the-32)
prep_in(monitored-22, absence-33)
amod(failure-36, renal-35)
prep_of(absence-33, failure-36)
nn(levels-40, dosage-39)
nsubjpass(adjusted-46, levels-40)
aux(adjusted-46, should-41)
auxpass(adjusted-46, be-42)
advmod(conservatively-45, even-43)
advmod(conservatively-45, more-44)
advmod(adjusted-46, conservatively-45)
conj_and(monitored-22, adjusted-46)
det(patients-49, those-48)
prep_in(adjusted-46, patients-49)
amod(therapy-53, such-51)
amod(therapy-53, combined-52)
prep_on(patients-49, therapy-53)
mark(detected-59, if-54)
amod(function-57, diminished-55)
amod(function-57, renal-56)
nsubjpass(detected-59, function-57)
auxpass(detected-59, is-58)
advcl(adjusted-46, detected-59)
dobj(detected-59, ..-60)

Ampicillin/NN //: Amoxicillin/NN :/: An/DT increase/NN in/IN the/DT frequency/NN of/IN skin/NN rash/NN has/VBZ been/VBN reported/VBN among/IN patients/NNS receiving/VBG ampicillin/NN or/CC amoxicillin/NN concurrently/RB with/IN allopurinol/NN compared/VBN to/TO patients/NNS who/WP are/VBP not/RB receiving/VBG both/DT drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Ampicillin)) (: /) (NP (NN Amoxicillin)) (: :) (NP (NP (DT An) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NN skin) (NN rash))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN among) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NP (NN ampicillin)) (CC or) (NP (NN amoxicillin))) (PP (ADVP (RB concurrently)) (IN with) (NP (NN allopurinol))) (PP (VBN compared) (PP (TO to) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (RB not) (VP (VBG receiving) (NP (DT both) (NNS drugs))))))))))))))))) (. .))))

nsubjpass(reported-15, Ampicillin-1)
punct(Ampicillin-1, /-2)
dep(Ampicillin-1, Amoxicillin-3)
det(increase-6, An-5)
dep(Ampicillin-1, increase-6)
det(frequency-9, the-8)
prep_in(increase-6, frequency-9)
nn(rash-12, skin-11)
prep_of(frequency-9, rash-12)
aux(reported-15, has-13)
auxpass(reported-15, been-14)
root(ROOT-0, reported-15)
prep_among(reported-15, patients-17)
partmod(patients-17, receiving-18)
dobj(receiving-18, ampicillin-19)
conj_or(ampicillin-19, amoxicillin-21)
advmod(ampicillin-19, concurrently-22)
prep_with(ampicillin-19, allopurinol-24)
prepc_compared_to(ampicillin-19, to-26)
pobj(ampicillin-19, patients-27)
nsubj(receiving-31, patients-27)
aux(receiving-31, are-29)
neg(receiving-31, not-30)
rcmod(patients-27, receiving-31)
det(drugs-33, both-32)
dobj(receiving-31, drugs-33)

Cytotoxic/JJ Agent/NN s/NNS :/: Enhanced/VBN bone/NN marrow/NN suppression/NN by/IN cyclophosphamide/NN and/CC other/JJ cytotoxic/JJ agent/NN s/NNS has/VBZ been/VBN reported/VBN among/IN patients/NNS with/IN neoplastic/JJ disease/NN ,/, except/IN leukemia/NN ,/, in/IN the/DT presence/NN of/IN allopurinol/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Cytotoxic) (NN Agent) (NNS s)) (: :) (NP (NP (VBN Enhanced) (NP (NN bone) (NN marrow)) (NN suppression)) (PP (IN by) (NP (NN cyclophosphamide)))) (CC and) (NP (JJ other) (JJ cytotoxic) (NN agent) (NNS s))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN among) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ neoplastic) (NN disease))))) (, ,) (PP (IN except) (NP (NN leukemia))) (, ,) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN allopurinol))))))))) (. .))))

amod(s-3, Cytotoxic-1)
nn(s-3, Agent-2)
nsubjpass(reported-18, s-3)
amod(suppression-8, Enhanced-5)
nn(marrow-7, bone-6)
nn(suppression-8, marrow-7)
conj_and(s-3, suppression-8)
prep_by(suppression-8, cyclophosphamide-10)
amod(s-15, other-12)
amod(s-15, cytotoxic-13)
nn(s-15, agent-14)
conj_and(s-3, s-15)
aux(reported-18, has-16)
auxpass(reported-18, been-17)
root(ROOT-0, reported-18)
prep_among(reported-18, patients-20)
amod(disease-23, neoplastic-22)
prep_with(patients-20, disease-23)
prep_except(reported-18, leukemia-26)
det(presence-30, the-29)
prep_in(reported-18, presence-30)
prep_of(presence-30, allopurinol-32)

However/RB ,/, in/IN a/DT well-controlled/JJ study/NN of/IN patients/NNS with/IN lymphoma/NN on/IN combination/NN therapy/NN ,/, allopurinol/NN did/VBD not/RB increase/VB the/DT marrow/NN toxicity/NN of/IN patients/NNS treated/VBN with/IN cyclophosphamide/NN ,/, doxorubicin/NN ,/, bleomycin/NN ,/, procarbazine/NN and/or/CC mechlorethamine/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (NP (DT a) (JJ well-controlled) (NN study)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NN lymphoma))))) (PP (IN on) (NP (NN combination) (NN therapy))))) (, ,) (NP (NN allopurinol)) (VP (VBD did) (RB not) (VP (VB increase) (NP (NP (DT the) (NN marrow) (NN toxicity)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (NN cyclophosphamide)) (, ,) (NP (NN doxorubicin)) (, ,) (NP (NN bleomycin)) (, ,) (NP (NN procarbazine)) (CC and/or) (NP (NN mechlorethamine))))))))))) (. .))))

advmod(increase-18, However-1)
det(study-6, a-4)
amod(study-6, well-controlled-5)
prep_in(increase-18, study-6)
prep_of(study-6, patients-8)
prep_with(patients-8, lymphoma-10)
nn(therapy-13, combination-12)
prep_on(study-6, therapy-13)
nsubj(increase-18, allopurinol-15)
aux(increase-18, did-16)
neg(increase-18, not-17)
root(ROOT-0, increase-18)
det(toxicity-21, the-19)
nn(toxicity-21, marrow-20)
dobj(increase-18, toxicity-21)
prep_of(toxicity-21, patients-23)
partmod(patients-23, treated-24)
prep_with(treated-24, cyclophosphamide-26)
conj_and/or(cyclophosphamide-26, doxorubicin-28)
conj_and/or(cyclophosphamide-26, bleomycin-30)
conj_and/or(cyclophosphamide-26, procarbazine-32)
conj_and/or(cyclophosphamide-26, mechlorethamine-34)

Chlorpropamide/NN :/: Chlorpropamide/NN s/NN plasma/NN half-life/NN may/MD be/VB prolonged/JJ by/IN allopurinol/NN ,/, since/IN allopurinol/NN and/CC chlorpropamide/NN may/MD compete/VB for/IN excretion/NN in/IN the/DT renal/JJ tubule/NN ./.

(ROOT (S1 (S (NP (NP (NN Chlorpropamide)) (: :) (S (NP (NN Chlorpropamide) (NN s) (NN plasma) (NN half-life)) (VP (MD may) (VP (VB be) (ADJP (JJ prolonged) (PP (IN by) (NP (NN allopurinol)))) (, ,) (SBAR (IN since) (S (NP (NP (NN allopurinol)) (CC and) (NP (NN chlorpropamide))) (VP (MD may) (VP (VB compete) (PP (IN for) (NP (NN excretion))) (PP (IN in) (NP (DT the) (JJ renal) (NN tubule)))))))))) (. .)))))

root(ROOT-0, Chlorpropamide-1)
nn(half-life-6, Chlorpropamide-3)
nn(half-life-6, s-4)
nn(half-life-6, plasma-5)
nsubj(prolonged-9, half-life-6)
aux(prolonged-9, may-7)
cop(prolonged-9, be-8)
dep(Chlorpropamide-1, prolonged-9)
prep_by(prolonged-9, allopurinol-11)
mark(compete-18, since-13)
nsubj(compete-18, allopurinol-14)
conj_and(allopurinol-14, chlorpropamide-16)
aux(compete-18, may-17)
advcl(prolonged-9, compete-18)
prep_for(compete-18, excretion-20)
det(tubule-24, the-22)
amod(tubule-24, renal-23)
prep_in(compete-18, tubule-24)

The/DT risk/NN of/IN hypoglycemia/NN secondary/JJ to/TO this/DT mechanism/NN may/MD be/VB increased/VBN if/IN allopurinol/NN and/CC chlorpropamide/NN are/VBP given/VBN concomitantly/RB in/IN the/DT presence/NN of/IN renal/JJ insufficiency/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN risk)) (PP (IN of) (NP (NP (NN hypoglycemia)) (ADJP (JJ secondary) (PP (TO to) (NP (DT this) (NN mechanism))))))) (VP (MD may) (VP (VB be) (VP (VBN increased) (SBAR (IN if) (S (NP (NP (NN allopurinol)) (CC and) (NP (NN chlorpropamide))) (VP (VBP are) (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ renal) (NN insufficiency))))))))))))) (. .))))

det(risk-2, The-1)
nsubjpass(increased-11, risk-2)
prep_of(risk-2, hypoglycemia-4)
amod(hypoglycemia-4, secondary-5)
det(mechanism-8, this-7)
prep_to(secondary-5, mechanism-8)
aux(increased-11, may-9)
auxpass(increased-11, be-10)
root(ROOT-0, increased-11)
mark(given-17, if-12)
nsubjpass(given-17, allopurinol-13)
conj_and(allopurinol-13, chlorpropamide-15)
auxpass(given-17, are-16)
advcl(increased-11, given-17)
advmod(given-17, concomitantly-18)
det(presence-21, the-20)
prep_in(given-17, presence-21)
amod(insufficiency-24, renal-23)
prep_of(presence-21, insufficiency-24)

Cyclosporin/NN :/: Reports/NNS indicate/VBP that/IN cyclosporine/NN levels/NNS may/MD be/VB increased/VBN during/IN concomitant/JJ treatment/NN with/IN allopurinol/NN sodium/NN for/IN injection/NN ./.

(ROOT (S1 (S (NP (NP (NN Cyclosporin)) (: :) (S (NP (NNS Reports)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN cyclosporine) (NNS levels)) (VP (MD may) (VP (VB be) (VP (VBN increased) (PP (IN during) (NP (NP (JJ concomitant) (NN treatment)) (PP (IN with) (NP (NN allopurinol) (NN sodium))) (PP (IN for) (NP (NN injection)))))))))))) (. .)))))

root(ROOT-0, Cyclosporin-1)
nsubj(indicate-4, Reports-3)
dep(Cyclosporin-1, indicate-4)
complm(increased-10, that-5)
nn(levels-7, cyclosporine-6)
nsubjpass(increased-10, levels-7)
aux(increased-10, may-8)
auxpass(increased-10, be-9)
ccomp(indicate-4, increased-10)
amod(treatment-13, concomitant-12)
prep_during(increased-10, treatment-13)
nn(sodium-16, allopurinol-15)
prep_with(treatment-13, sodium-16)
prep_for(treatment-13, injection-18)

Monitoring/NN of/IN cyclosporine/NN levels/NNS and/CC possible/JJ adjustment/NN of/IN cyclosporine/NN dosage/NN should/MD be/VB considered/VBN when/WRB these/DT drugs/NNS are/VBP co-administered/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Monitoring)) (PP (IN of) (NP (NP (NN cyclosporine) (NNS levels)) (CC and) (NP (NP (JJ possible) (NN adjustment)) (PP (IN of) (NP (NN cyclosporine) (NN dosage))))))) (VP (MD should) (VP (VB be) (VP (VBN considered) (SBAR (WHADVP (WRB when)) (S (NP (DT these) (NNS drugs)) (VP (VBP are) (VP (VBN co-administered))))))))) (. .))))

nsubjpass(considered-13, Monitoring-1)
nn(levels-4, cyclosporine-3)
prep_of(Monitoring-1, levels-4)
amod(adjustment-7, possible-6)
conj_and(levels-4, adjustment-7)
nn(dosage-10, cyclosporine-9)
prep_of(adjustment-7, dosage-10)
aux(considered-13, should-11)
auxpass(considered-13, be-12)
root(ROOT-0, considered-13)
advmod(co-administered-18, when-14)
det(drugs-16, these-15)
nsubjpass(co-administered-18, drugs-16)
auxpass(co-administered-18, are-17)
advcl(considered-13, co-administered-18)

Tolbutamide/NN s/NN conversion/NN to/TO inactive/JJ metabolites/NNS has/VBZ been/VBN shown/VBN to/TO be/VB catalyzed/VBN by/IN xanthine/NN oxidase/NN from/IN rat/NN liver/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Tolbutamide) (NN s) (NN conversion)) (PP (TO to) (NP (JJ inactive) (NNS metabolites)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (VP (VBN catalyzed) (PP (IN by) (NP (NP (NN xanthine) (NN oxidase)) (PP (IN from) (NP (NN rat) (NN liver))))))))))))) (. .))))

nn(conversion-3, Tolbutamide-1)
nn(conversion-3, s-2)
nsubjpass(shown-9, conversion-3)
xsubj(catalyzed-12, conversion-3)
amod(metabolites-6, inactive-5)
prep_to(conversion-3, metabolites-6)
aux(shown-9, has-7)
auxpass(shown-9, been-8)
root(ROOT-0, shown-9)
aux(catalyzed-12, to-10)
auxpass(catalyzed-12, be-11)
xcomp(shown-9, catalyzed-12)
nn(oxidase-15, xanthine-14)
agent(catalyzed-12, oxidase-15)
nn(liver-18, rat-17)
prep_from(oxidase-15, liver-18)

Ergot-Containing/JJ Drugs/NNS :/: These/DT drugs/NNS have/VBP been/VBN reported/VBN to/TO cause/VB prolonged/JJ vasospastic/JJ reactions/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Ergot-Containing) (NNS Drugs)) (: :) (S (NP (DT These) (NNS drugs)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB cause) (NP (JJ prolonged) (JJ vasospastic) (NNS reactions))))))))) (. .)))))

amod(Drugs-2, Ergot-Containing-1)
root(ROOT-0, Drugs-2)
det(drugs-5, These-4)
nsubjpass(reported-8, drugs-5)
xsubj(cause-10, drugs-5)
aux(reported-8, have-6)
auxpass(reported-8, been-7)
dep(Drugs-2, reported-8)
aux(cause-10, to-9)
xcomp(reported-8, cause-10)
amod(reactions-13, prolonged-11)
amod(reactions-13, vasospastic-12)
dobj(cause-10, reactions-13)

Because/IN there/EX is/VBZ a/DT theoretical/JJ basis/NN that/IN these/DT effects/NNS may/MD be/VB additive/JJ ,/, use/NN of/IN ergotamine/JJ -containing/JJ or/CC ergot-type/JJ medications/NNS (/-LRB- like/IN dihydroergotamine/NN or/CC methysergide/NN )/-RRB- and/CC AXERT/NN @/NN within/IN 24/CD hours/NNS of/IN each/DT other/JJ should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (SBAR (IN Because) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (JJ theoretical) (NN basis)) (SBAR (IN that) (S (NP (DT these) (NNS effects)) (VP (MD may) (VP (VB be) (ADJP (JJ additive)))))))))) (, ,) (NP (NP (NN use)) (PP (IN of) (NP (NP (NP (JJ ergotamine) (ADJP (ADJP (JJ -containing)) (CC or) (ADJP (JJ ergot-type))) (NNS medications)) (PRN (-LRB- -LRB-) (PP (IN like) (NP (NP (NN dihydroergotamine)) (CC or) (NP (NN methysergide)))) (-RRB- -RRB-))) (CC and) (NP (NN AXERT) (NN @)))) (PP (IN within) (NP (NP (CD 24) (NNS hours)) (PP (IN of) (NP (DT each) (JJ other)))))) (VP (MD should) (VP (VB be) (VP (VBN avoided)))) (. .))))

mark(is-3, Because-1)
expl(is-3, there-2)
advcl(avoided-38, is-3)
det(basis-6, a-4)
amod(basis-6, theoretical-5)
nsubj(is-3, basis-6)
dobj(additive-12, basis-6)
complm(additive-12, that-7)
det(effects-9, these-8)
nsubj(additive-12, effects-9)
aux(additive-12, may-10)
cop(additive-12, be-11)
dep(basis-6, additive-12)
nsubjpass(avoided-38, use-14)
amod(medications-20, ergotamine-16)
amod(medications-20, -containing-17)
conj_or(-containing-17, ergot-type-19)
prep_of(use-14, medications-20)
dep(medications-20, like-22)
pobj(like-22, dihydroergotamine-23)
conj_or(dihydroergotamine-23, methysergide-25)
nn(@-29, AXERT-28)
conj_and(medications-20, @-29)
num(hours-32, 24-31)
prep_within(use-14, hours-32)
det(other-35, each-34)
prep_of(hours-32, other-35)
aux(avoided-38, should-36)
auxpass(avoided-38, be-37)
root(ROOT-0, avoided-38)

Monoamine/NN Oxidase/NN Inhibitors/NNS Coadministration/NN of/IN moclobemide/NN resulted/VBD in/IN a/DT 27/CD %/NN decrease/NN in/IN almotriptan/NN clearance/NN and/CC an/DT increase/NN in/IN Cmax/NN of/IN approximately/RB 6/CD %./NN

(ROOT (S1 (S (NP (NP (NN Monoamine) (NN Oxidase) (NNS Inhibitors)) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN moclobemide)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (ADJP (CD 27) (NN %)) (NN decrease)) (PP (IN in) (NP (NN almotriptan) (NN clearance)))) (CC and) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN Cmax)) (PP (IN of) (NP (QP (RB approximately) (CD 6)) (NN %.))))))))))))))

nn(Inhibitors-3, Monoamine-1)
nn(Inhibitors-3, Oxidase-2)
root(ROOT-0, Inhibitors-3)
nsubj(resulted-7, Coadministration-4)
prep_of(Coadministration-4, moclobemide-6)
dep(Inhibitors-3, resulted-7)
det(decrease-12, a-9)
number(%-11, 27-10)
amod(decrease-12, %-11)
prep_in(resulted-7, decrease-12)
nn(clearance-15, almotriptan-14)
prep_in(decrease-12, clearance-15)
det(increase-18, an-17)
conj_and(decrease-12, increase-18)
prep_in(increase-18, Cmax-20)
quantmod(6-23, approximately-22)
num(%.-24, 6-23)
prep_of(Cmax-20, %.-24)

Other/JJ 5-HT1B/1D/NN Agonists/NNS Concomitant/JJ use/NN of/IN other/JJ 5-HT1B/1D/NN agonists/NNS within/IN 24/CD hours/NNS of/IN treatment/NN with/IN AXERT/NN @/NN is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Other) (NN 5-HT1B/1D) (NNS Agonists)) (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (JJ other) (NN 5-HT1B/1D) (NNS agonists)) (PP (IN within) (NP (NP (CD 24) (NNS hours)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN with) (NP (NN AXERT) (NN @)))))))))) (VP (VBZ is) (VP (VBN contraindicated)))) (. .))))

amod(Agonists-3, Other-1)
nn(Agonists-3, 5-HT1B/1D-2)
nn(use-5, Agonists-3)
amod(use-5, Concomitant-4)
nsubjpass(contraindicated-19, use-5)
amod(agonists-9, other-7)
nn(agonists-9, 5-HT1B/1D-8)
prep_of(use-5, agonists-9)
num(hours-12, 24-11)
prep_within(agonists-9, hours-12)
prep_of(hours-12, treatment-14)
nn(@-17, AXERT-16)
prep_with(treatment-14, @-17)
auxpass(contraindicated-19, is-18)
root(ROOT-0, contraindicated-19)

Propanolol/NN :/: The/DT pharmacokinetics/NNS of/IN almotriptan/NN were/VBD not/RB affected/VBN by/IN coadministration/NN of/IN propranolol/NN ./.

(ROOT (S1 (S (S (NP (NN Propanolol)) (: :) (NP (NP (DT The) (NNS pharmacokinetics)) (PP (IN of) (NP (NN almotriptan)))) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (NN coadministration)) (PP (IN of) (NP (NN propranolol)))))))) (. .))))

nsubjpass(affected-9, Propanolol-1)
det(pharmacokinetics-4, The-3)
nsubjpass(affected-9, pharmacokinetics-4)
prep_of(pharmacokinetics-4, almotriptan-6)
auxpass(affected-9, were-7)
neg(affected-9, not-8)
root(ROOT-0, affected-9)
agent(affected-9, coadministration-11)
prep_of(coadministration-11, propranolol-13)

Selective/JJ Serotonin/NN Reuptake/NN Inhibitors/NNS (/-LRB- SSRIs/NN )/-RRB- SSRIs/NN (/-LRB- e.g./FW ,/, fluoxetine/NN ,/, fluvoxamine/NN ,/, paroxetine/NN ,/, sertraline/NN )/-RRB- have/VBP been/VBN rarely/RB reported/VBN to/TO cause/VB weakness/NN ,/, hyperreflexia/NN ,/, and/CC incoordination/NN when/WRB coadministered/VBN with/IN 5-HT1/NN agonists/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Selective) (NN Serotonin) (NN Reuptake) (NNS Inhibitors)) (PRN (-LRB- -LRB-) (NP (NN SSRIs)) (-RRB- -RRB-))) (NP (NP (NN SSRIs)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN fluoxetine)) (, ,) (NP (NN fluvoxamine)) (, ,) (NP (NN paroxetine)) (, ,) (NP (NN sertraline))) (-RRB- -RRB-)))) (VP (VBP have) (VP (VBN been) (ADVP (RB rarely)) (VP (VBN reported) (S (VP (TO to) (VP (VB cause) (NP (NP (NN weakness)) (, ,) (NP (NN hyperreflexia)) (, ,) (CC and) (NP (NN incoordination))) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NN 5-HT1) (NNS agonists))))))))))))) (. .))))

amod(Inhibitors-4, Selective-1)
nn(Inhibitors-4, Serotonin-2)
nn(Inhibitors-4, Reuptake-3)
nsubjpass(reported-23, Inhibitors-4)
xsubj(cause-25, Inhibitors-4)
abbrev(Inhibitors-4, SSRIs-6)
dep(Inhibitors-4, SSRIs-8)
dep(fluoxetine-12, e.g.-10)
dep(SSRIs-8, fluoxetine-12)
appos(fluoxetine-12, fluvoxamine-14)
appos(fluoxetine-12, paroxetine-16)
appos(fluoxetine-12, sertraline-18)
aux(reported-23, have-20)
auxpass(reported-23, been-21)
advmod(reported-23, rarely-22)
root(ROOT-0, reported-23)
aux(cause-25, to-24)
xcomp(reported-23, cause-25)
dobj(cause-25, weakness-26)
conj_and(weakness-26, hyperreflexia-28)
conj_and(weakness-26, incoordination-31)
advmod(coadministered-33, when-32)
advcl(cause-25, coadministered-33)
nn(agonists-36, 5-HT1-35)
prep_with(coadministered-33, agonists-36)

If/IN concomitant/JJ treatment/NN with/IN AXERT/NN @/NN and/CC an/DT SSRI/NN is/VBZ clinically/RB warranted/VBN ,/, appropriate/JJ observation/NN of/IN the/DT patient/NN is/VBZ advised/JJ ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NP (JJ concomitant) (NN treatment)) (PP (IN with) (NP (NN AXERT) (NN @) (CC and) (DT an) (NN SSRI)))) (VP (VBZ is) (ADVP (RB clinically)) (VP (VBN warranted))))) (, ,) (NP (NP (JJ appropriate) (NN observation)) (PP (IN of) (NP (DT the) (NN patient)))) (VP (VBZ is) (ADJP (JJ advised)))) (. .))))

mark(warranted-12, If-1)
amod(treatment-3, concomitant-2)
nsubjpass(warranted-12, treatment-3)
nn(@-6, AXERT-5)
prep_with(treatment-3, @-6)
det(SSRI-9, an-8)
conj_and(@-6, SSRI-9)
auxpass(warranted-12, is-10)
advmod(warranted-12, clinically-11)
advcl(advised-20, warranted-12)
amod(observation-15, appropriate-14)
nsubj(advised-20, observation-15)
det(patient-18, the-17)
prep_of(observation-15, patient-18)
cop(advised-20, is-19)
root(ROOT-0, advised-20)

Verapamil/NN Coadministration/NN of/IN almotriptan/NN and/CC verapamil/NN resulted/VBD in/IN a/DT 24/CD %/NN increase/NN in/IN plasma/NN concentrations/NNS of/IN almotriptan/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Verapamil) (NN Coadministration)) (PP (IN of) (NP (NP (NN almotriptan)) (CC and) (NP (NN verapamil))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (ADJP (CD 24) (NN %)) (NN increase)) (PP (IN in) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN almotriptan))))))))) (. .))))

nn(Coadministration-2, Verapamil-1)
nsubj(resulted-7, Coadministration-2)
prep_of(Coadministration-2, almotriptan-4)
conj_and(almotriptan-4, verapamil-6)
root(ROOT-0, resulted-7)
det(increase-12, a-9)
number(%-11, 24-10)
amod(increase-12, %-11)
prep_in(resulted-7, increase-12)
nn(concentrations-15, plasma-14)
prep_in(increase-12, concentrations-15)
prep_of(concentrations-15, almotriptan-17)

Ketoconazole/NN and/CC Other/JJ Potent/JJ CYP3A4/JJ Inhibitors/NNS Coadministration/NN of/IN almotriptan/NN and/CC the/DT potent/JJ CYP3A4/NN inhibitor/NN ketoconazole/NN (/-LRB- 400/CD mg/NN q.d./NN for/IN 3/CD days/NNS )/-RRB- resulted/VBD in/IN an/DT approximately/RB 60/CD %/NN increase/NN in/IN the/DT area/NN under/IN the/DT plasma/NN concentration-time/NN curve/NN and/CC maximal/JJ plasma/NN concentrations/NNS of/IN almotriptan/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Ketoconazole)) (CC and) (NP (NP (JJ Other) (JJ Potent) (JJ CYP3A4) (NNS Inhibitors)) (NP (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN almotriptan)))) (CC and) (NP (NP (DT the) (JJ potent) (NN CYP3A4) (NN inhibitor) (NN ketoconazole)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 400) (NN mg)) (NN q.d.)) (PP (IN for) (NP (CD 3) (NNS days)))) (-RRB- -RRB-)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT an) (ADJP (QP (RB approximately) (CD 60)) (NN %)) (NN increase)) (PP (IN in) (NP (NP (NP (DT the) (NN area)) (PP (IN under) (NP (DT the) (NN plasma) (NN concentration-time) (NN curve)))) (CC and) (NP (NP (JJ maximal) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN almotriptan)))))))))) (. .))))

nsubj(resulted-24, Ketoconazole-1)
amod(Inhibitors-6, Other-3)
amod(Inhibitors-6, Potent-4)
amod(Inhibitors-6, CYP3A4-5)
conj_and(Ketoconazole-1, Inhibitors-6)
dep(Inhibitors-6, Coadministration-7)
prep_of(Coadministration-7, almotriptan-9)
det(ketoconazole-15, the-11)
amod(ketoconazole-15, potent-12)
nn(ketoconazole-15, CYP3A4-13)
nn(ketoconazole-15, inhibitor-14)
conj_and(Coadministration-7, ketoconazole-15)
number(mg-18, 400-17)
amod(q.d.-19, mg-18)
dep(ketoconazole-15, q.d.-19)
num(days-22, 3-21)
prep_for(q.d.-19, days-22)
root(ROOT-0, resulted-24)
det(increase-30, an-26)
quantmod(60-28, approximately-27)
dep(%-29, 60-28)
dep(increase-30, %-29)
prep_in(resulted-24, increase-30)
det(area-33, the-32)
prep_in(increase-30, area-33)
det(curve-38, the-35)
nn(curve-38, plasma-36)
nn(curve-38, concentration-time-37)
prep_under(area-33, curve-38)
amod(concentrations-42, maximal-40)
nn(concentrations-42, plasma-41)
conj_and(area-33, concentrations-42)
prep_of(concentrations-42, almotriptan-44)

Although/IN the/DT interaction/NN between/IN almotriptan/NN and/CC other/JJ potent/JJ CYP3A4/JJ inhibitors/NNS (/-LRB- e.g./FW ,/, itraconazole/NN ,/, ritonavir/NN ,/, and/CC erythromycin/NN )/-RRB- has/VBZ not/RB been/VBN studied/VBN ,/, increased/VBN exposures/NNS to/TO almotriptan/NN may/MD be/VB expected/VBN when/WRB almotriptan/NN is/VBZ used/VBN concomitantly/RB with/IN these/DT medications/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN almotriptan)) (CC and) (NP (NP (JJ other) (JJ potent) (JJ CYP3A4) (NNS inhibitors)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN itraconazole)) (, ,) (NP (NN ritonavir)) (, ,) (CC and) (NP (NN erythromycin)))) (-RRB- -RRB-)))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied)))))) (, ,) (NP (NP (VBN increased) (NNS exposures)) (PP (TO to) (NP (NN almotriptan)))) (VP (MD may) (VP (VB be) (VP (VBN expected) (SBAR (WHADVP (WRB when)) (S (NP (NN almotriptan)) (VP (VBZ is) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (DT these) (NNS medications))))))))))) (. .))))

mark(studied-24, Although-1)
det(interaction-3, the-2)
nsubjpass(studied-24, interaction-3)
prep_between(interaction-3, almotriptan-5)
amod(inhibitors-10, other-7)
amod(inhibitors-10, potent-8)
amod(inhibitors-10, CYP3A4-9)
conj_and(almotriptan-5, inhibitors-10)
dep(inhibitors-10, e.g.-12)
pobj(e.g.-12, itraconazole-14)
conj_and(itraconazole-14, ritonavir-16)
conj_and(itraconazole-14, erythromycin-19)
aux(studied-24, has-21)
neg(studied-24, not-22)
auxpass(studied-24, been-23)
advcl(expected-32, studied-24)
amod(exposures-27, increased-26)
nsubjpass(expected-32, exposures-27)
prep_to(exposures-27, almotriptan-29)
aux(expected-32, may-30)
auxpass(expected-32, be-31)
root(ROOT-0, expected-32)
advmod(used-36, when-33)
nsubjpass(used-36, almotriptan-34)
auxpass(used-36, is-35)
advcl(expected-32, used-36)
advmod(used-36, concomitantly-37)
det(medications-40, these-39)
prep_with(used-36, medications-40)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS AXERT/VBP @/NN is/VBZ not/RB known/VBN to/TO interfere/VB with/IN commonly/RB employed/VBN clinical/JJ laboratory/NN tests/NNS ./.

(ROOT (S1 (S (S (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (VP (VBP AXERT) (S (NP (NN @)) (VP (VBZ is) (RB not) (VP (VBN known) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (ADJP (RB commonly) (VBN employed)) (JJ clinical) (NN laboratory) (NNS tests))))))))))) (. .))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
nsubj(AXERT-5, Interactions-4)
root(ROOT-0, AXERT-5)
nsubjpass(known-9, @-6)
xsubj(interfere-11, @-6)
auxpass(known-9, is-7)
neg(known-9, not-8)
ccomp(AXERT-5, known-9)
aux(interfere-11, to-10)
xcomp(known-9, interfere-11)
advmod(employed-14, commonly-13)
amod(tests-17, employed-14)
amod(tests-17, clinical-15)
nn(tests-17, laboratory-16)
prep_with(interfere-11, tests-17)

The/DT benzodiazepines/NNS ,/, including/VBG alprazolam/NN ,/, produce/VBP additive/JJ CNS/NN depressant/NN effects/NNS when/WRB co-administered/VBN with/IN other/JJ psychotropic/JJ medications/NNS ,/, anticonvulsants/NNS ,/, antihistaminics/NNS ,/, ethanol/NN ,/, and/CC other/JJ drugs/NNS which/WDT themselves/PRP produce/VBP CNS/NN depression/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS benzodiazepines)) (, ,) (PP (VBG including) (NP (NN alprazolam))) (, ,)) (VP (VBP produce) (NP (JJ additive) (NN CNS) (NN depressant) (NNS effects)) (SBAR (WHADVP (WRB when)) (S (VP (VBN co-administered) (PP (IN with) (NP (NP (NP (JJ other) (JJ psychotropic) (NNS medications)) (, ,) (NP (NNS anticonvulsants)) (, ,) (NP (NNS antihistaminics)) (, ,) (NP (NN ethanol)) (, ,) (CC and) (NP (JJ other) (NNS drugs))) (SBAR (WHNP (WDT which)) (S (NP (PRP themselves)) (VP (VBP produce) (NP (NN CNS) (NN depression)))))))))))) (. .))))

det(benzodiazepines-2, The-1)
nsubj(produce-7, benzodiazepines-2)
prep_including(benzodiazepines-2, alprazolam-5)
root(ROOT-0, produce-7)
amod(effects-11, additive-8)
nn(effects-11, CNS-9)
nn(effects-11, depressant-10)
dobj(produce-7, effects-11)
advmod(co-administered-13, when-12)
advcl(produce-7, co-administered-13)
amod(medications-17, other-15)
amod(medications-17, psychotropic-16)
prep_with(co-administered-13, medications-17)
dobj(produce-30, medications-17)
conj_and(medications-17, anticonvulsants-19)
conj_and(medications-17, antihistaminics-21)
conj_and(medications-17, ethanol-23)
amod(drugs-27, other-26)
conj_and(medications-17, drugs-27)
rel(produce-30, which-28)
nsubj(produce-30, themselves-29)
rcmod(medications-17, produce-30)
nn(depression-32, CNS-31)
dobj(produce-30, depression-32)

The/DT steady/JJ state/NN plasma/NN concentrations/NNS of/IN imipramine/NN and/CC desipramine/NN have/VBP been/VBN reported/VBN to/TO be/VB increased/VBN an/DT average/NN of/IN 31/CD %/NN and/CC 20/CD %/NN ,/, respectively/RB ,/, by/IN the/DT concomitant/JJ administration/NN of/IN alprazolam/NN tablets/NNS in/IN doses/NNS up/RB to/TO 4/CD mg/day/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ steady) (NN state) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (NN imipramine)) (CC and) (NP (NN desipramine))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (VP (VBN increased) (NP (NP (DT an) (NN average)) (PP (IN of) (NP (NP (CD 31) (NN %)) (CC and) (NP (CD 20) (NN %)) (, ,) (ADVP (RB respectively))))) (, ,) (PP (IN by) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN alprazolam) (NNS tablets))) (PP (IN in) (NP (NP (NNS doses)) (ADJP (QP (RB up) (TO to) (CD 4)) (NN mg/day)))))))))))))) (. .))))

det(concentrations-5, The-1)
amod(concentrations-5, steady-2)
nn(concentrations-5, state-3)
nn(concentrations-5, plasma-4)
nsubjpass(reported-12, concentrations-5)
xsubj(increased-15, concentrations-5)
prep_of(concentrations-5, imipramine-7)
conj_and(imipramine-7, desipramine-9)
aux(reported-12, have-10)
auxpass(reported-12, been-11)
root(ROOT-0, reported-12)
aux(increased-15, to-13)
auxpass(increased-15, be-14)
xcomp(reported-12, increased-15)
det(average-17, an-16)
dobj(increased-15, average-17)
num(%-20, 31-19)
prep_of(average-17, %-20)
num(%-23, 20-22)
conj_and(%-20, %-23)
advmod(%-20, respectively-25)
conj_and(%-20, respectively-25)
det(administration-30, the-28)
amod(administration-30, concomitant-29)
agent(increased-15, administration-30)
nn(tablets-33, alprazolam-32)
prep_of(administration-30, tablets-33)
prep_in(administration-30, doses-35)
quantmod(4-38, up-36)
dep(4-38, to-37)
dep(mg/day-39, 4-38)
dep(doses-35, mg/day-39)

Drugs/NNS That/WDT Inhibit/VBP Alprazolam/NN Metabolism/NN Via/IN Cytochrome/NN P450/NN 3A/NN :/: The/DT initial/JJ step/NN in/IN alprazolam/NN metabolism/NN is/VBZ hydroxylation/NN catalyzed/VBN by/IN cytochrome/NN P450/NN 3A/NN (/-LRB- CYP/NN 3A/NN )./NN

(ROOT (S1 (S (NP (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT That)) (S (VP (VBP Inhibit) (NP (NN Alprazolam) (NN Metabolism)) (PP (IN Via) (NP (NN Cytochrome) (NN P450) (NN 3A))))))) (: :) (S (NP (NP (DT The) (JJ initial) (NN step)) (PP (IN in) (NP (NN alprazolam) (NN metabolism)))) (VP (VBZ is) (NP (NP (NN hydroxylation)) (VP (VBN catalyzed) (PP (IN by) (NP (NN cytochrome) (NN P450) (NN 3A) (-LRB- -LRB-) (NN CYP) (NN 3A) (NN -RRB-.)))))))))))

root(ROOT-0, Drugs-1)
nsubj(Inhibit-3, Drugs-1)
rcmod(Drugs-1, Inhibit-3)
nn(Metabolism-5, Alprazolam-4)
dobj(Inhibit-3, Metabolism-5)
nn(3A-9, Cytochrome-7)
nn(3A-9, P450-8)
prep_via(Inhibit-3, 3A-9)
det(step-13, The-11)
amod(step-13, initial-12)
nsubj(hydroxylation-18, step-13)
nn(metabolism-16, alprazolam-15)
prep_in(step-13, metabolism-16)
cop(hydroxylation-18, is-17)
dep(Drugs-1, hydroxylation-18)
partmod(hydroxylation-18, catalyzed-19)
nn(-RRB-.-27, cytochrome-21)
nn(-RRB-.-27, P450-22)
nn(-RRB-.-27, 3A-23)
nn(-RRB-.-27, CYP-25)
nn(-RRB-.-27, 3A-26)
agent(catalyzed-19, -RRB-.-27)

Drugs/NNS which/WDT inhibit/VBP this/DT metabolic/JJ pathway/NN may/MD have/VB a/DT profound/JJ effect/NN on/IN the/DT clearance/NN of/IN alprazolam/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT which)) (S (VP (VBP inhibit) (NP (DT this) (JJ metabolic) (NN pathway)))))) (VP (MD may) (VP (VB have) (NP (DT a) (JJ profound) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN alprazolam)))))))) (. .))))

nsubj(inhibit-3, Drugs-1)
nsubj(have-8, Drugs-1)
rcmod(Drugs-1, inhibit-3)
det(pathway-6, this-4)
amod(pathway-6, metabolic-5)
dobj(inhibit-3, pathway-6)
aux(have-8, may-7)
root(ROOT-0, have-8)
det(effect-11, a-9)
amod(effect-11, profound-10)
dobj(have-8, effect-11)
det(clearance-14, the-13)
prep_on(have-8, clearance-14)
prep_of(clearance-14, alprazolam-16)

Drugs/NNS Demonstrated/VBD to/TO be/VB CYP/NN 3A/NN Inhibitors/NNS of/IN Possible/JJ Clinical/JJ Significance/NN on/IN the/DT Basis/NN of/IN Clinical/JJ Studies/NNS Involving/VBG Alprazolam/NN (/-LRB- caution/NN is/VBZ recommended/VBN during/IN coadministration/NN with/IN alprazolam/NN )/-RRB- :/: Fluoxetine/NN :/: Coadministration/NN of/IN fluoxetine/NN with/IN alprazolam/NN increased/VBD the/DT maximum/JJ plasma/NN concentration/NN of/IN alprazolam/NN by/IN 46/CD %/NN ,/, decreased/VBD clearance/NN by/IN 21/CD %/NN ,/, increased/VBD half-life/NN by/IN 17/CD %/NN ,/, and/CC decreased/VBD measured/VBN psychomotor/NN performance/NN ./.

(ROOT (S1 (S (S (NP (NNS Drugs)) (VP (VBD Demonstrated) (S (VP (TO to) (VP (VB be) (NP (NP (NN CYP) (NN 3A) (NNS Inhibitors)) (PP (IN of) (NP (JJ Possible) (JJ Clinical) (NN Significance)))) (PP (IN on) (DT the) (NN Basis) (IN of) (NP (NP (JJ Clinical) (NNS Studies)) (VP (VBG Involving) (NP (NP (NP (NN Alprazolam)) (PRN (-LRB- -LRB-) (NP (NP (NN caution)) (VP (VBZ is) (VP (VBN recommended) (PP (IN during) (NP (NP (NN coadministration)) (PP (IN with) (NP (NN alprazolam)))))))) (-RRB- -RRB-))) (: :) (NP (NN Fluoxetine)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN fluoxetine))) (PP (IN with) (NP (NN alprazolam)))) (VP (VP (VBD increased) (NP (NP (DT the) (JJ maximum) (NN plasma) (NN concentration)) (PP (IN of) (NP (NN alprazolam)))) (PP (IN by) (NP (CD 46) (NN %)))) (, ,) (VP (VBD decreased) (NP (NN clearance)) (PP (IN by) (NP (CD 21) (NN %)))) (, ,) (VP (VBD increased) (NP (NN half-life)) (PP (IN by) (NP (CD 17) (NN %)))) (, ,) (CC and) (VP (VBD decreased) (NP (VBN measured) (NN psychomotor) (NN performance)))))))))))))) (. .))))

nsubj(Demonstrated-2, Drugs-1)
xsubj(Inhibitors-7, Drugs-1)
root(ROOT-0, Demonstrated-2)
aux(Inhibitors-7, to-3)
cop(Inhibitors-7, be-4)
nn(Inhibitors-7, CYP-5)
nn(Inhibitors-7, 3A-6)
xcomp(Demonstrated-2, Inhibitors-7)
amod(Significance-11, Possible-9)
amod(Significance-11, Clinical-10)
prep_of(Inhibitors-7, Significance-11)
dep(Inhibitors-7, on-12)
dep(Inhibitors-7, the-13)
dep(Inhibitors-7, Basis-14)
amod(Studies-17, Clinical-16)
prep_of(Inhibitors-7, Studies-17)
partmod(Studies-17, Involving-18)
dobj(Involving-18, Alprazolam-19)
dep(Alprazolam-19, caution-21)
auxpass(recommended-23, is-22)
dep(caution-21, recommended-23)
prep_during(recommended-23, coadministration-25)
prep_with(coadministration-25, alprazolam-27)
dep(Alprazolam-19, Fluoxetine-30)
nsubj(increased-37, Coadministration-32)
prep_of(Coadministration-32, fluoxetine-34)
prep_with(Coadministration-32, alprazolam-36)
dep(Alprazolam-19, increased-37)
det(concentration-41, the-38)
amod(concentration-41, maximum-39)
nn(concentration-41, plasma-40)
dobj(increased-37, concentration-41)
prep_of(concentration-41, alprazolam-43)
num(%-46, 46-45)
prep_by(increased-37, %-46)
conj_and(increased-37, decreased-48)
dobj(decreased-48, clearance-49)
num(%-52, 21-51)
prep_by(decreased-48, %-52)
conj_and(increased-37, increased-54)
dobj(increased-54, half-life-55)
num(%-58, 17-57)
prep_by(increased-54, %-58)
conj_and(increased-37, decreased-61)
amod(performance-64, measured-62)
nn(performance-64, psychomotor-63)
dobj(decreased-61, performance-64)

Propoxyphene/NN :/: Coadministration/NN of/IN propoxyphene/NN decreased/VBD the/DT maximum/JJ plasma/NN concentration/NN of/IN alprazolam/NN by/IN 6/CD %/NN ,/, decreased/VBD clearance/NN by/IN 38/CD %/NN ,/, and/CC increased/VBD half-life/NN by/IN 58/CD %./NN

(ROOT (S1 (S (NP (NP (NN Propoxyphene)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN propoxyphene)))) (VP (VP (VBD decreased) (NP (NP (DT the) (JJ maximum) (NN plasma) (NN concentration)) (PP (IN of) (NP (NN alprazolam)))) (PP (IN by) (NP (CD 6) (NN %)))) (, ,) (VP (VBD decreased) (NP (NN clearance)) (PP (IN by) (NP (CD 38) (NN %)))) (, ,) (CC and) (VP (VBD increased) (NP (NN half-life)) (PP (IN by) (NP (CD 58) (NN %.))))))))))

root(ROOT-0, Propoxyphene-1)
nsubj(decreased-6, Coadministration-3)
prep_of(Coadministration-3, propoxyphene-5)
dep(Propoxyphene-1, decreased-6)
det(concentration-10, the-7)
amod(concentration-10, maximum-8)
nn(concentration-10, plasma-9)
dobj(decreased-6, concentration-10)
prep_of(concentration-10, alprazolam-12)
num(%-15, 6-14)
prep_by(decreased-6, %-15)
conj_and(decreased-6, decreased-17)
dobj(decreased-17, clearance-18)
num(%-21, 38-20)
prep_by(decreased-17, %-21)
conj_and(decreased-6, increased-24)
dobj(increased-24, half-life-25)
num(%.-28, 58-27)
prep_by(increased-24, %.-28)

Oral/JJ Contraceptives/NNS :/: Coadministration/NN of/IN oral/JJ contraceptives/NNS increased/VBD the/DT maximum/JJ plasma/NN concentration/NN of/IN alprazolam/NN by/IN 18/CD %/NN ,/, decreased/VBD clearance/NN by/IN 22/CD %/NN ,/, and/CC increased/VBD half-life/NN by/IN 29/CD %./NN

(ROOT (S1 (S (NP (NP (JJ Oral) (NNS Contraceptives)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (JJ oral) (NNS contraceptives)))) (VP (VP (VBD increased) (NP (NP (DT the) (JJ maximum) (NN plasma) (NN concentration)) (PP (IN of) (NP (NN alprazolam)))) (PP (IN by) (NP (CD 18) (NN %)))) (, ,) (VP (VBD decreased) (NP (NN clearance)) (PP (IN by) (NP (CD 22) (NN %)))) (, ,) (CC and) (VP (VBD increased) (NP (NN half-life)) (PP (IN by) (NP (CD 29) (NN %.))))))))))

amod(Contraceptives-2, Oral-1)
root(ROOT-0, Contraceptives-2)
nsubj(increased-8, Coadministration-4)
amod(contraceptives-7, oral-6)
prep_of(Coadministration-4, contraceptives-7)
dep(Contraceptives-2, increased-8)
det(concentration-12, the-9)
amod(concentration-12, maximum-10)
nn(concentration-12, plasma-11)
dobj(increased-8, concentration-12)
prep_of(concentration-12, alprazolam-14)
num(%-17, 18-16)
prep_by(increased-8, %-17)
conj_and(increased-8, decreased-19)
dobj(decreased-19, clearance-20)
num(%-23, 22-22)
prep_by(decreased-19, %-23)
conj_and(increased-8, increased-26)
dobj(increased-26, half-life-27)
num(%.-30, 29-29)
prep_by(increased-26, %.-30)

Drugs/NNS and/CC other/JJ substances/NNS demonstrated/VBD to/TO be/VB CYP/NN 3A/NN inhibitors/NNS on/IN the/DT basis/NN of/IN clinical/JJ studies/NNS involving/VBG benzodiazepines/NNS metabolized/VBN similarly/RB to/TO alprazolam/NN or/CC on/IN the/DT basis/NN of/IN in/FW vitro/FW studies/NNS with/IN alprazolam/NN or/CC other/JJ benzodiazepines/NNS (/-LRB- caution/NN is/VBZ recommended/VBN during/IN coadministration/NN with/IN alprazolam/NN )/-RRB- :/: Available/JJ data/NNS from/IN clinical/JJ studies/NNS of/IN benzodiazepines/NNS other/JJ than/IN alprazolam/NN suggest/VBP a/DT possible/JJ drug/NN interaction/NN with/IN alprazolam/NN for/IN the/DT following/NN :/: diltiazem/NN ,/, isoniazid/NN ,/, macrolide/NN antibiotics/NNS such/JJ as/IN erythromycin/NN and/CC clarithromycin/NN ,/, and/CC grapefruit/NN juice/NN ./.

(ROOT (S1 (S (NP (NP (NNS Drugs)) (CC and) (NP (JJ other) (NNS substances))) (VP (VBD demonstrated) (S (VP (TO to) (VP (VB be) (NP (NP (NN CYP) (NN 3A) (NNS inhibitors)) (PP (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (NP (JJ clinical) (NNS studies)) (VP (VBG involving) (NP (NP (NNS benzodiazepines)) (VP (VBN metabolized) (ADVP (RB similarly)) (PP (TO to) (NP (NN alprazolam)))))))))) (CC or) (PP (IN on) (NP (NP (DT the) (NN basis)) (PP (IN of) (NP (NP (ADJP (FW in) (FW vitro)) (NNS studies)) (PP (IN with) (NP (NP (NN alprazolam)) (CC or) (NP (NP (JJ other) (NNS benzodiazepines)) (PRN (-LRB- -LRB-) (S (NP (NN caution)) (VP (VBZ is) (VP (VBN recommended) (PP (IN during) (NP (NP (NN coadministration)) (PP (IN with) (NP (NN alprazolam) (-RRB- -RRB-) (: :) (S (NP (NP (JJ Available) (NNS data)) (PP (IN from) (NP (NP (JJ clinical) (NNS studies)) (PP (IN of) (NP (NP (NNS benzodiazepines)) (ADJP (JJ other) (PP (IN than) (NP (NN alprazolam))))))))) (VP (VBP suggest) (NP (NP (DT a) (JJ possible) (NN drug) (NN interaction)) (PP (IN with) (NP (NN alprazolam))) (PP (IN for) (NP (NP (DT the) (NN following)) (: :) (NP (NN diltiazem)) (, ,) (NP (NN isoniazid)) (, ,) (NP (NP (NN macrolide) (NNS antibiotics)) (PP (JJ such) (IN as) (NP (NP (NN erythromycin)) (CC and) (NP (NN clarithromycin))))) (, ,) (CC and) (NP (NN grapefruit) (NN juice)))))))))))))))))))))))))))) (. .))))

nsubj(demonstrated-5, Drugs-1)
xsubj(inhibitors-10, Drugs-1)
amod(substances-4, other-3)
conj_and(Drugs-1, substances-4)
root(ROOT-0, demonstrated-5)
aux(inhibitors-10, to-6)
cop(inhibitors-10, be-7)
nn(inhibitors-10, CYP-8)
nn(inhibitors-10, 3A-9)
xcomp(demonstrated-5, inhibitors-10)
det(basis-13, the-12)
prep_on(inhibitors-10, basis-13)
amod(studies-16, clinical-15)
prep_of(basis-13, studies-16)
partmod(studies-16, involving-17)
dobj(involving-17, benzodiazepines-18)
partmod(benzodiazepines-18, metabolized-19)
advmod(metabolized-19, similarly-20)
prep_to(metabolized-19, alprazolam-22)
det(basis-26, the-25)
conj_or(basis-13, basis-26)
nn(vitro-29, in-28)
amod(studies-30, vitro-29)
prep_of(basis-26, studies-30)
prep_with(studies-30, alprazolam-32)
amod(benzodiazepines-35, other-34)
conj_or(alprazolam-32, benzodiazepines-35)
nsubjpass(recommended-39, caution-37)
auxpass(recommended-39, is-38)
dep(benzodiazepines-35, recommended-39)
prep_during(recommended-39, coadministration-41)
prep_with(coadministration-41, alprazolam-43)
amod(data-47, Available-46)
nsubj(suggest-56, data-47)
amod(studies-50, clinical-49)
prep_from(data-47, studies-50)
prep_of(studies-50, benzodiazepines-52)
amod(benzodiazepines-52, other-53)
prep_than(other-53, alprazolam-55)
dep(alprazolam-43, suggest-56)
det(interaction-60, a-57)
amod(interaction-60, possible-58)
nn(interaction-60, drug-59)
dobj(suggest-56, interaction-60)
prep_with(interaction-60, alprazolam-62)
det(following-65, the-64)
prep_for(interaction-60, following-65)
conj_and(following-65, diltiazem-67)
conj_and(following-65, isoniazid-69)
nn(antibiotics-72, macrolide-71)
conj_and(following-65, antibiotics-72)
prep_such_as(antibiotics-72, erythromycin-75)
conj_and(erythromycin-75, clarithromycin-77)
nn(juice-81, grapefruit-80)
conj_and(following-65, juice-81)

Data/NNS from/IN in/FW vitro/FW studies/NNS of/IN alprazolam/NN suggest/VBP a/DT possible/JJ drug/NN interaction/NN with/IN alprazolam/NNS for/IN the/DT following/NN :/: sertraline/NN and/CC paroxetine/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Data)) (PP (IN from) (NP (NP (ADJP (FW in) (FW vitro)) (NNS studies)) (PP (IN of) (NP (NN alprazolam)))))) (VP (VBP suggest) (NP (NP (DT a) (JJ possible) (NN drug) (NN interaction)) (PP (IN with) (NP (NP (NP (NNS alprazolam)) (PP (IN for) (NP (DT the) (NN following)))) (: :) (NP (NP (NN sertraline)) (CC and) (NP (NN paroxetine)))))))) (. .))))

nsubj(suggest-8, Data-1)
nn(vitro-4, in-3)
amod(studies-5, vitro-4)
prep_from(Data-1, studies-5)
prep_of(studies-5, alprazolam-7)
root(ROOT-0, suggest-8)
det(interaction-12, a-9)
amod(interaction-12, possible-10)
nn(interaction-12, drug-11)
dobj(suggest-8, interaction-12)
prep_with(interaction-12, alprazolam-14)
det(following-17, the-16)
prep_for(alprazolam-14, following-17)
dep(alprazolam-14, sertraline-19)
conj_and(sertraline-19, paroxetine-21)

Data/NNS from/IN in/FW vitro/FW studies/NNS of/IN benzodiazepines/NNS other/JJ than/IN alprazolam/NN suggest/VBP a/DT possible/JJ drug/NN interaction/NN for/IN the/DT following/NN :/: ergotamine/NN ,/, cyclosporine/NN ,/, amiodarone/NN ,/, nicardipine/NN ,/, and/CC nifedipine/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Data)) (PP (IN from) (NP (NP (ADJP (FW in) (FW vitro)) (NNS studies)) (PP (IN of) (NP (NP (NNS benzodiazepines)) (ADJP (JJ other) (PP (IN than) (NP (NN alprazolam))))))))) (VP (VBP suggest) (NP (NP (DT a) (JJ possible) (NN drug) (NN interaction)) (PP (IN for) (NP (NP (DT the) (NN following)) (: :) (NP (NN ergotamine)) (, ,) (NP (NN cyclosporine)) (, ,) (NP (NN amiodarone)) (, ,) (NP (NN nicardipine)) (, ,) (CC and) (NP (NN nifedipine))))))) (. .))))

nsubj(suggest-11, Data-1)
nn(vitro-4, in-3)
amod(studies-5, vitro-4)
prep_from(Data-1, studies-5)
prep_of(studies-5, benzodiazepines-7)
amod(benzodiazepines-7, other-8)
prep_than(other-8, alprazolam-10)
root(ROOT-0, suggest-11)
det(interaction-15, a-12)
amod(interaction-15, possible-13)
nn(interaction-15, drug-14)
dobj(suggest-11, interaction-15)
det(following-18, the-17)
prep_for(interaction-15, following-18)
conj_and(following-18, ergotamine-20)
conj_and(following-18, cyclosporine-22)
conj_and(following-18, amiodarone-24)
conj_and(following-18, nicardipine-26)
conj_and(following-18, nifedipine-29)

Caution/NN is/VBZ recommended/VBN during/IN the/DT coadministration/NN of/IN any/DT of/IN these/DT with/IN alprazolam/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (VBZ is) (VP (VBN recommended) (PP (IN during) (NP (NP (DT the) (NN coadministration)) (PP (IN of) (NP (NP (DT any)) (PP (IN of) (NP (NP (DT these)) (PP (IN with) (NP (NN alprazolam)))))))))))) (. .))))

nsubjpass(recommended-3, Caution-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
det(coadministration-6, the-5)
prep_during(recommended-3, coadministration-6)
prep_of(coadministration-6, any-8)
prep_of(any-8, these-10)
prep_with(these-10, alprazolam-12)

Prostin/NN VR/JJ Pediatric/JJ Sterile/JJ Solution/NN :/: No/DT drug/NN interactions/NNS have/VBP been/VBN reported/VBN between/IN Prostin/NN VR/NN Pediatric/JJ and/CC the/DT therapy/NN standard/JJ in/IN neonates/NNS with/IN restricted/JJ pulmonary/JJ or/CC systemic/JJ blood/NN flow/NN ./.

(ROOT (S1 (S (NP (NP (NN Prostin) (JJ VR) (JJ Pediatric) (JJ Sterile) (NN Solution)) (: :) (S (NP (DT No) (NN drug) (NNS interactions)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN between) (NP (NP (NP (ADJP (NN Prostin) (NN VR) (JJ Pediatric))) (CC and) (NP (DT the) (NN therapy) (JJ standard))) (PP (IN in) (NP (NP (NNS neonates)) (PP (IN with) (NP (JJ restricted) (ADJP (ADJP (JJ pulmonary)) (CC or) (ADJP (JJ systemic))) (NN blood) (NN flow))))))))))) (. .)))))

nn(Solution-5, Prostin-1)
amod(Solution-5, VR-2)
amod(Solution-5, Pediatric-3)
amod(Solution-5, Sterile-4)
root(ROOT-0, Solution-5)
det(interactions-9, No-7)
nn(interactions-9, drug-8)
nsubjpass(reported-12, interactions-9)
aux(reported-12, have-10)
auxpass(reported-12, been-11)
dep(Solution-5, reported-12)
dep(Pediatric-16, Prostin-14)
dep(Pediatric-16, VR-15)
prep_between(reported-12, Pediatric-16)
det(therapy-19, the-18)
conj_and(Pediatric-16, therapy-19)
amod(therapy-19, standard-20)
prep_in(Pediatric-16, neonates-22)
amod(flow-29, restricted-24)
amod(flow-29, pulmonary-25)
conj_or(pulmonary-25, systemic-27)
nn(flow-29, blood-28)
prep_with(neonates-22, flow-29)

Standard/JJ therapy/NN includes/VBZ antibiotics/NNS ,/, such/JJ as/IN penicillin/NN and/CC gentamicin/NN ;/: ./.

(ROOT (S1 (S (S (NP (JJ Standard) (NN therapy)) (VP (VBZ includes) (NP (NP (NNS antibiotics)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN penicillin)) (CC and) (NP (NN gentamicin)))))) (: ;)) (. .))))

amod(therapy-2, Standard-1)
nsubj(includes-3, therapy-2)
root(ROOT-0, includes-3)
dobj(includes-3, antibiotics-4)
prep_such_as(antibiotics-4, penicillin-8)
conj_and(penicillin-8, gentamicin-10)

vasopressor/NN s/NNS ,/, such/JJ as/IN dopamine/NN and/CC isoproterenol/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN vasopressor) (NNS s)) (, ,) (NP (NP (JJ such)) (PP (IN as) (NP (NP (NN dopamine)) (CC and) (NP (NN isoproterenol)))) (: ;)) (. .)))))

nn(s-2, vasopressor-1)
root(ROOT-0, s-2)
appos(s-2, such-4)
prep_as(such-4, dopamine-6)
conj_and(dopamine-6, isoproterenol-8)

cardiac/JJ glycosides/NNS ;/: ./.

(ROOT (S1 (S (NP (NP (JJ cardiac) (NNS glycosides) (: ;)) (. .)))))

amod(glycosides-2, cardiac-1)
root(ROOT-0, glycosides-2)

and/CC diuretics/NN ,/, such/JJ as/IN furosemide/NN ./.

(ROOT (S1 (S (S (NP (CC and) (NP (NN diuretics)) (, ,)) (VP (JJ such) (PP (IN as) (NP (NN furosemide))))) (. .))))

cc(diuretics-2, and-1)
nsubj(such-4, diuretics-2)
root(ROOT-0, such-4)
prep_as(such-4, furosemide-6)

Caverject/NN :/: The/DT potential/NN for/IN pharmacokinetic/JJ drug-drug/JJ interactions/NNS between/IN alprostadil/NN and/CC other/JJ agents/NNS has/VBZ not/RB been/VBN formally/RB studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Caverject)) (: :) (NP (NP (DT The) (NN potential)) (PP (IN for) (NP (NP (JJ pharmacokinetic) (JJ drug-drug) (NNS interactions)) (PP (IN between) (NP (NP (NN alprostadil)) (CC and) (NP (JJ other) (NNS agents)))))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB formally)) (VP (VBN studied))))) (. .))))

nsubjpass(studied-18, Caverject-1)
det(potential-4, The-3)
dep(Caverject-1, potential-4)
amod(interactions-8, pharmacokinetic-6)
amod(interactions-8, drug-drug-7)
prep_for(potential-4, interactions-8)
prep_between(interactions-8, alprostadil-10)
amod(agents-13, other-12)
conj_and(alprostadil-10, agents-13)
aux(studied-18, has-14)
neg(studied-18, not-15)
auxpass(studied-18, been-16)
advmod(studied-18, formally-17)
root(ROOT-0, studied-18)

Concurrent/JJ administration/NN of/IN HEXALEN/NN and/CC antidepressants/NNS of/IN the/DT MAO/NN inhibitor/NN class/NN may/MD cause/VB severe/JJ orthostatic/JJ hypotension./NN Cimetidine/NN ,/, an/DT inhibitor/NN of/IN microsomal/JJ drug/NN metabolism/NN ,/, increased/VBN altretamine/NN s/NN half-life/NN and/CC toxicity/NN in/IN a/DT rat/NN model/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN administration)) (PP (IN of) (NP (NP (NN HEXALEN)) (CC and) (NP (NNS antidepressants)))) (PP (IN of) (NP (DT the) (NN MAO) (NN inhibitor) (NN class)))) (VP (MD may) (VP (VB cause) (NP (NP (JJ severe) (JJ orthostatic) (NN hypotension.) (NN Cimetidine)) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NP (JJ microsomal) (NN drug) (NN metabolism)) (, ,) (NP (VBN increased) (NN altretamine) (NN s) (NN half-life)) (CC and) (NP (NN toxicity)))))) (PP (IN in) (NP (DT a) (NN rat) (NN model)))))) (. .))))

amod(administration-2, Concurrent-1)
nsubj(cause-13, administration-2)
prep_of(administration-2, HEXALEN-4)
conj_and(HEXALEN-4, antidepressants-6)
det(class-11, the-8)
nn(class-11, MAO-9)
nn(class-11, inhibitor-10)
prep_of(administration-2, class-11)
aux(cause-13, may-12)
root(ROOT-0, cause-13)
amod(Cimetidine-17, severe-14)
amod(Cimetidine-17, orthostatic-15)
nn(Cimetidine-17, hypotension.-16)
dobj(cause-13, Cimetidine-17)
det(inhibitor-20, an-19)
appos(Cimetidine-17, inhibitor-20)
amod(metabolism-24, microsomal-22)
nn(metabolism-24, drug-23)
prep_of(inhibitor-20, metabolism-24)
amod(half-life-29, increased-26)
nn(half-life-29, altretamine-27)
nn(half-life-29, s-28)
conj_and(metabolism-24, half-life-29)
conj_and(metabolism-24, toxicity-31)
det(model-35, a-33)
nn(model-35, rat-34)
prep_in(cause-13, model-35)

Data/NNS from/IN a/DT randomized/JJ trial/NN of/IN HEXALEN/NN and/CC cisplatin/NN plus/JJ or/CC minus/JJ pyridoxine/NN in/IN ovarian/JJ cancer/NN indicated/VBD that/IN pyridoxine/NN significantly/RB reduced/VBD neurotoxicity/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NNS Data)) (PP (IN from) (NP (NP (DT a) (JJ randomized) (NN trial)) (PP (IN of) (NP (NP (NN HEXALEN)) (CC and) (NP (NN cisplatin)) (NP (ADJP (ADJP (JJ plus)) (CC or) (ADJP (JJ minus))) (NN pyridoxine)))) (PP (IN in) (NP (JJ ovarian) (NN cancer)))))) (VP (VBD indicated) (SBAR (IN that) (S (NP (NN pyridoxine)) (ADVP (RB significantly)) (VP (VBD reduced) (NP (NN neurotoxicity)))))) (: ;)) (. .))))

nsubj(indicated-17, Data-1)
det(trial-5, a-3)
amod(trial-5, randomized-4)
prep_from(Data-1, trial-5)
prep_of(trial-5, HEXALEN-7)
conj_and(HEXALEN-7, cisplatin-9)
amod(pyridoxine-13, plus-10)
conj_or(plus-10, minus-12)
dep(HEXALEN-7, pyridoxine-13)
amod(cancer-16, ovarian-15)
prep_in(trial-5, cancer-16)
root(ROOT-0, indicated-17)
complm(reduced-21, that-18)
nsubj(reduced-21, pyridoxine-19)
advmod(reduced-21, significantly-20)
ccomp(indicated-17, reduced-21)
dobj(reduced-21, neurotoxicity-22)

however/RB ,/, it/PRP adversely/RB affected/VBD response/NN duration/NN suggesting/VBG that/IN pyridoxine/NN should/MD not/RB be/VB administered/VBN with/IN HEXALEN/NN and/or/CC cisplatin/NN .1/NN ./.

(ROOT (S1 (S (S (ADVP (RB however)) (, ,) (NP (PRP it)) (ADVP (RB adversely)) (VP (VBD affected) (NP (NN response) (NN duration)) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NN pyridoxine)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (NP (NN HEXALEN)) (CC and/or) (NP (NN cisplatin)) (NP (NN .1))))))))))))) (. .))))

advmod(affected-5, however-1)
nsubj(affected-5, it-3)
advmod(affected-5, adversely-4)
root(ROOT-0, affected-5)
nn(duration-7, response-6)
dobj(affected-5, duration-7)
xcomp(affected-5, suggesting-8)
complm(administered-14, that-9)
nsubjpass(administered-14, pyridoxine-10)
aux(administered-14, should-11)
neg(administered-14, not-12)
auxpass(administered-14, be-13)
ccomp(suggesting-8, administered-14)
prep_with(administered-14, HEXALEN-16)
conj_and/or(HEXALEN-16, cisplatin-18)
dep(HEXALEN-16, .1-19)

Careful/JJ observation/NN is/VBZ required/VBN when/WRB amantadine/NN is/VBZ administered/VBN concurrently/RB with/IN central/JJ nervous/JJ system/NN stimulants/NNS ./.

(ROOT (S1 (S (S (NP (JJ Careful) (NN observation)) (VP (VBZ is) (VP (VBN required) (SBAR (WHADVP (WRB when)) (S (NP (NN amantadine)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concurrently)) (PP (IN with) (NP (ADJP (JJ central) (JJ nervous) (NN system)) (NNS stimulants)))))))))) (. .))))

amod(observation-2, Careful-1)
nsubjpass(required-4, observation-2)
auxpass(required-4, is-3)
root(ROOT-0, required-4)
advmod(administered-8, when-5)
nsubjpass(administered-8, amantadine-6)
auxpass(administered-8, is-7)
advcl(required-4, administered-8)
advmod(administered-8, concurrently-9)
amod(system-13, central-11)
amod(system-13, nervous-12)
amod(stimulants-14, system-13)
prep_with(administered-8, stimulants-14)

Coadministration/NN of/IN thioridazine/NN has/VBZ been/VBN reported/VBN to/TO worsen/VB the/DT tremor/NN in/IN elderly/JJ patients/NNS with/IN Parkinsons/JJ disease/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN thioridazine)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB worsen) (NP (NP (DT the) (NN tremor)) (PP (IN in) (NP (NP (JJ elderly) (NNS patients)) (PP (IN with) (NP (JJ Parkinsons) (NN disease)))))))))))) (: ;)) (. .))))

nsubjpass(reported-6, Coadministration-1)
xsubj(worsen-8, Coadministration-1)
prep_of(Coadministration-1, thioridazine-3)
aux(reported-6, has-4)
auxpass(reported-6, been-5)
root(ROOT-0, reported-6)
aux(worsen-8, to-7)
xcomp(reported-6, worsen-8)
det(tremor-10, the-9)
dobj(worsen-8, tremor-10)
amod(patients-13, elderly-12)
prep_in(tremor-10, patients-13)
amod(disease-16, Parkinsons-15)
prep_with(patients-13, disease-16)

however/RB ,/, it/PRP is/VBZ not/RB known/VBN if/IN other/JJ phenothiazines/NNS produce/VBP a/DT similar/JJ response/NN ./.

(ROOT (S1 (S (S (ADVP (RB however)) (, ,) (NP (PRP it)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (IN if) (S (NP (JJ other) (NNS phenothiazines)) (VP (VBP produce) (NP (DT a) (JJ similar) (NN response)))))))) (. .))))

advmod(known-6, however-1)
nsubjpass(known-6, it-3)
auxpass(known-6, is-4)
neg(known-6, not-5)
root(ROOT-0, known-6)
mark(produce-10, if-7)
amod(phenothiazines-9, other-8)
nsubj(produce-10, phenothiazines-9)
advcl(known-6, produce-10)
det(response-13, a-11)
amod(response-13, similar-12)
dobj(produce-10, response-13)

Coadministration/NN of/IN triamterene/NN and/CC hydrochlorothiazide/NN capsules/NNS resulted/VBD in/IN a/DT higher/JJR plasma/NN amantadine/NN concentration/NN in/IN a/DT 61/CD year/NN old/JJ man/NN receiving/VBG amantadine/NN (/-LRB- amantadine/NN hydrochloride/NN )/-RRB- 100/CD mg/NN TID/NN for/IN Parkinsons/NNP disease.1/CD It/PRP is/VBZ not/RB known/VBN which/WDT of/IN the/DT components/NNS of/IN triamterene/NN and/CC hydrochlorothiazide/NN capsules/NNS contributed/VBD to/TO the/DT observation/NN or/CC if/IN related/JJ drugs/NNS produce/VBP a/DT similar/JJ response/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NP (NN triamterene)) (CC and) (NP (NN hydrochlorothiazide))) (NNS capsules)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJR higher) (NN plasma) (NN amantadine) (NN concentration)) (PP (IN in) (NP (NP (DT a) (ADJP (CD 61) (NN year) (JJ old)) (NN man)) (VP (VBG receiving) (NP (NP (NP (NN amantadine)) (PRN (-LRB- -LRB-) (NP (NN amantadine) (NN hydrochloride)) (-RRB- -RRB-))) (NP (CD 100) (NN mg)) (NN TID)) (PP (IN for) (NP (NP (NNP Parkinsons) (CD disease.1)) (S (NP (PRP It)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (WHNP (WHNP (WDT which)) (PP (IN of) (NP (NP (DT the) (NNS components)) (PP (IN of) (NP (NP (NP (NN triamterene)) (CC and) (NP (NN hydrochlorothiazide))) (NNS capsules)))))) (S (VP (VBD contributed) (PP (TO to) (NP (DT the) (NN observation) (SBAR (CC or) (SBAR (IN if) (S (NP (JJ related) (NNS drugs)) (VP (VBP produce) (NP (DT a) (JJ similar) (NN response))))))))))))))))))))))) (. .))))

nsubj(resulted-7, Coadministration-1)
nn(capsules-6, triamterene-3)
conj_and(triamterene-3, hydrochlorothiazide-5)
prep_of(Coadministration-1, capsules-6)
root(ROOT-0, resulted-7)
det(concentration-13, a-9)
amod(concentration-13, higher-10)
nn(concentration-13, plasma-11)
nn(concentration-13, amantadine-12)
prep_in(resulted-7, concentration-13)
det(man-19, a-15)
number(old-18, 61-16)
dep(old-18, year-17)
amod(man-19, old-18)
prep_in(concentration-13, man-19)
partmod(man-19, receiving-20)
nn(TID-28, amantadine-21)
nn(hydrochloride-24, amantadine-23)
appos(amantadine-21, hydrochloride-24)
num(mg-27, 100-26)
dobj(receiving-20, mg-27)
nn(TID-28, mg-27)
dobj(receiving-20, TID-28)
iobj(receiving-20, TID-28)
prep_for(receiving-20, Parkinsons-30)
num(Parkinsons-30, disease.1-31)
nsubjpass(known-35, It-32)
auxpass(known-35, is-33)
neg(known-35, not-34)
dep(Parkinsons-30, known-35)
nsubj(contributed-45, which-36)
det(components-39, the-38)
prep_of(which-36, components-39)
nn(capsules-44, triamterene-41)
conj_and(triamterene-41, hydrochlorothiazide-43)
prep_of(components-39, capsules-44)
ccomp(known-35, contributed-45)
det(observation-48, the-47)
prep_to(contributed-45, observation-48)
cc(produce-53, or-49)
mark(produce-53, if-50)
amod(drugs-52, related-51)
nsubj(produce-53, drugs-52)
ccomp(observation-48, produce-53)
det(response-56, a-54)
amod(response-56, similar-55)
dobj(produce-53, response-56)

Interactions/NNS can/MD occur/VB with/IN the/DT following/JJ medications/NNS :/: demecarium/NN (/-LRB- Humorsol/NN )/-RRB- ,/, echothiophate/NN (/-LRB- Phospholine/NN Iodide/NN )/-RRB- ,/, isoflurophate/NN (/-LRB- Floropryl/NN )/-RRB- ,/, malathion/NN (/-LRB- using/VBG these/DT medicines/NNS with/IN antimyasthenics/NNS may/MD result/VB in/IN serious/JJ side/JJ effects/NNS )/-RRB- ,/, guanadrel/NN (/-LRB- Hylorel/NN )/-RRB- ,/, guanethidine/NN (/-LRB- Ismelin/NN )/-RRB- ,/, mecamylamine/NN (/-LRB- Inversine/NN )/-RRB- ,/, procainamide/NN (/-LRB- Pronestyl/NN )/-RRB- ,/, and/CC trimethaphan/NN (/-LRB- the/DT effects/NNS of/IN these/DT medicines/NNS may/MD interfere/VB with/IN the/DT actions/NNS of/IN the/DT antimyasthenics/NN )./NN

(ROOT (S1 (S (S (NP (NNS Interactions)) (VP (MD can) (VP (VB occur) (PP (IN with) (NP (NP (DT the) (JJ following) (NNS medications)) (: :) (NP (NP (NP (NP (NN demecarium)) (PRN (-LRB- -LRB-) (NP (NN Humorsol)) (-RRB- -RRB-))) (, ,) (NP (NP (NN echothiophate)) (PRN (-LRB- -LRB-) (NP (NN Phospholine) (NN Iodide)) (-RRB- -RRB-))) (, ,) (NP (NP (NN isoflurophate)) (PRN (-LRB- -LRB-) (NP (NN Floropryl)) (-RRB- -RRB-))) (, ,) (NP (NN malathion))) (-LRB- -LRB-) (VP (VBG using) (NP (NP (DT these) (NNS medicines)) (PP (IN with) (NP (NP (NNS antimyasthenics)) (VP (MD may) (VP (VB result) (PP (IN in) (NP (JJ serious) (JJ side) (NNS effects))))))))) (-RRB- -RRB-) (, ,) (NP (NP (NN guanadrel)) (PRN (-LRB- -LRB-) (NP (NN Hylorel)) (-RRB- -RRB-))) (, ,) (NP (NP (NN guanethidine)) (PRN (-LRB- -LRB-) (NP (NN Ismelin)) (-RRB- -RRB-))) (, ,) (NP (NP (NN mecamylamine)) (PRN (-LRB- -LRB-) (NP (NN Inversine)) (-RRB- -RRB-))) (, ,) (NP (NP (NN procainamide)) (PRN (-LRB- -LRB-) (NP (NN Pronestyl)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN trimethaphan)))))))) (S (-LRB- -LRB-) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (DT these) (NNS medicines)))) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NNS actions)) (PP (IN of) (NP (DT the) (NN antimyasthenics) (NN -RRB-.)))))))))))

nsubj(occur-3, Interactions-1)
aux(occur-3, can-2)
root(ROOT-0, occur-3)
det(medications-7, the-5)
amod(medications-7, following-6)
prep_with(occur-3, medications-7)
dep(medications-7, demecarium-9)
appos(demecarium-9, Humorsol-11)
appos(demecarium-9, echothiophate-14)
nn(Iodide-17, Phospholine-16)
appos(echothiophate-14, Iodide-17)
appos(demecarium-9, isoflurophate-20)
appos(isoflurophate-20, Floropryl-22)
appos(demecarium-9, malathion-25)
conj_and(demecarium-9, using-27)
partmod(demecarium-9, using-27)
det(medicines-29, these-28)
dobj(using-27, medicines-29)
prep_with(medicines-29, antimyasthenics-31)
aux(result-33, may-32)
dep(antimyasthenics-31, result-33)
amod(effects-37, serious-35)
amod(effects-37, side-36)
prep_in(result-33, effects-37)
conj_and(demecarium-9, guanadrel-40)
appos(guanadrel-40, Hylorel-42)
conj_and(demecarium-9, guanethidine-45)
appos(guanethidine-45, Ismelin-47)
conj_and(demecarium-9, mecamylamine-50)
appos(mecamylamine-50, Inversine-52)
conj_and(demecarium-9, procainamide-55)
appos(procainamide-55, Pronestyl-57)
conj_and(demecarium-9, trimethaphan-61)
det(effects-64, the-63)
nsubj(interfere-69, effects-64)
det(medicines-67, these-66)
prep_of(effects-64, medicines-67)
aux(interfere-69, may-68)
dep(occur-3, interfere-69)
det(actions-72, the-71)
prep_with(interfere-69, actions-72)
det(-RRB-.-76, the-74)
nn(-RRB-.-76, antimyasthenics-75)
prep_of(actions-72, -RRB-.-76)

When/WRB amiloride/NN HCl/NN is/VBZ administered/VBN concomitantly/RB with/IN an/DT angiotensin-converting/JJ enzyme/NN inhibitor/NN ,/, the/DT risk/NN of/IN hyperkalemia/NN may/MD be/VB increased/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN amiloride) (NN HCl)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (DT an) (JJ angiotensin-converting) (NN enzyme) (NN inhibitor))))))) (, ,) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN hyperkalemia)))) (VP (MD may) (VP (VB be) (VP (VBN increased))))) (. .))))

advmod(administered-5, When-1)
nn(HCl-3, amiloride-2)
nsubjpass(administered-5, HCl-3)
auxpass(administered-5, is-4)
advcl(increased-19, administered-5)
advmod(administered-5, concomitantly-6)
det(inhibitor-11, an-8)
amod(inhibitor-11, angiotensin-converting-9)
nn(inhibitor-11, enzyme-10)
prep_with(administered-5, inhibitor-11)
det(risk-14, the-13)
nsubjpass(increased-19, risk-14)
prep_of(risk-14, hyperkalemia-16)
aux(increased-19, may-17)
auxpass(increased-19, be-18)
root(ROOT-0, increased-19)

Lithium/NN generally/RB should/MD not/RB be/VB given/VBN with/IN diuretics/NN because/IN they/PRP reduce/VBP its/PRP$ renal/JJ clearance/NN and/CC add/VBP a/DT high/JJ risk/NN of/IN lithium/NN toxicity/NN ./.

(ROOT (S1 (S (S (NP (NN Lithium)) (ADVP (RB generally)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN given) (PP (IN with) (NP (NN diuretics))) (SBAR (IN because) (S (NP (PRP they)) (VP (VP (VBP reduce) (NP (PRP$ its) (JJ renal) (NN clearance))) (CC and) (VP (VBP add) (NP (NP (DT a) (JJ high) (NN risk)) (PP (IN of) (NP (NN lithium) (NN toxicity)))))))))))) (. .))))

nsubjpass(given-6, Lithium-1)
advmod(given-6, generally-2)
aux(given-6, should-3)
neg(given-6, not-4)
auxpass(given-6, be-5)
root(ROOT-0, given-6)
prep_with(given-6, diuretics-8)
mark(reduce-11, because-9)
nsubj(reduce-11, they-10)
advcl(given-6, reduce-11)
poss(clearance-14, its-12)
amod(clearance-14, renal-13)
dobj(reduce-11, clearance-14)
conj_and(reduce-11, add-16)
det(risk-19, a-17)
amod(risk-19, high-18)
dobj(add-16, risk-19)
nn(toxicity-22, lithium-21)
prep_of(risk-19, toxicity-22)

Read/VBN circulars/VBZ for/IN lithium/NN preparation/NN s/NNS before/IN use/NN of/IN such/JJ concomitant/JJ therapy/NN ./.

(ROOT (S1 (S (S (NP (VBN Read)) (VP (VBZ circulars) (PP (IN for) (NP (NP (NN lithium) (NN preparation) (NNS s)) (PP (IN before) (NP (NP (NN use)) (PP (IN of) (NP (JJ such) (JJ concomitant) (NN therapy))))))))) (. .))))

nsubj(circulars-2, Read-1)
root(ROOT-0, circulars-2)
nn(s-6, lithium-4)
nn(s-6, preparation-5)
prep_for(circulars-2, s-6)
prep_before(s-6, use-8)
amod(therapy-12, such-10)
amod(therapy-12, concomitant-11)
prep_of(use-8, therapy-12)

In/IN some/DT patients/NNS ,/, the/DT administration/NN of/IN a/DT non-steroidal/JJ anti-inflammatory/JJ agent/NN can/MD reduce/VB the/DT diuretic/JJ ,/, natriuretic/JJ ,/, and/CC antihypertensive/JJ effects/NNS of/IN loop/NN ,/, potassium/NN -sparing/NN and/CC thiazide/NN diuretics/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT some) (NNS patients))) (, ,) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (DT a) (JJ non-steroidal) (JJ anti-inflammatory) (NN agent)))) (VP (MD can) (VP (VB reduce) (NP (NP (DT the) (ADJP (ADJP (JJ diuretic)) (, ,) (ADJP (JJ natriuretic)) (, ,) (CC and) (ADJP (JJ antihypertensive))) (NNS effects)) (PP (IN of) (NP (NP (NN loop)) (, ,) (NP (NN potassium) (NN -sparing)) (CC and) (NP (NN thiazide) (NNS diuretics)))))))) (. .))))

det(patients-3, some-2)
prep_in(reduce-13, patients-3)
det(administration-6, the-5)
nsubj(reduce-13, administration-6)
det(agent-11, a-8)
amod(agent-11, non-steroidal-9)
amod(agent-11, anti-inflammatory-10)
prep_of(administration-6, agent-11)
aux(reduce-13, can-12)
root(ROOT-0, reduce-13)
det(effects-21, the-14)
amod(effects-21, diuretic-15)
conj_and(diuretic-15, natriuretic-17)
conj_and(diuretic-15, antihypertensive-20)
dobj(reduce-13, effects-21)
prep_of(effects-21, loop-23)
nn(-sparing-26, potassium-25)
conj_and(loop-23, -sparing-26)
nn(diuretics-29, thiazide-28)
conj_and(loop-23, diuretics-29)

Therefore/RB ,/, when/WRB MIDAMOR/NN and/CC non-steroidal/JJ anti-inflammatory/JJ agents/NNS are/VBP used/VBN concomitantly/RB ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB to/TO determine/VB if/IN the/DT desired/JJ effect/NN of/IN the/DT diuretic/NN is/VBZ obtained/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN MIDAMOR)) (CC and) (NP (JJ non-steroidal) (JJ anti-inflammatory) (NNS agents))) (VP (VBP are) (VP (VBN used) (ADVP (RB concomitantly)))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (NP (DT the) (JJ desired) (NN effect)) (PP (IN of) (NP (DT the) (NN diuretic)))) (VP (VBZ is) (VP (VBN obtained)))))))))))) (. .))))

advmod(observed-17, Therefore-1)
advmod(used-10, when-3)
nsubjpass(used-10, MIDAMOR-4)
amod(agents-8, non-steroidal-6)
amod(agents-8, anti-inflammatory-7)
conj_and(MIDAMOR-4, agents-8)
auxpass(used-10, are-9)
advcl(observed-17, used-10)
advmod(used-10, concomitantly-11)
det(patient-14, the-13)
nsubjpass(observed-17, patient-14)
aux(observed-17, should-15)
auxpass(observed-17, be-16)
root(ROOT-0, observed-17)
advmod(observed-17, closely-18)
aux(determine-20, to-19)
xcomp(observed-17, determine-20)
mark(obtained-29, if-21)
det(effect-24, the-22)
amod(effect-24, desired-23)
nsubjpass(obtained-29, effect-24)
det(diuretic-27, the-26)
prep_of(effect-24, diuretic-27)
auxpass(obtained-29, is-28)
advcl(determine-20, obtained-29)

Since/IN indomethacin/NN and/CC potassium-sparing/JJ diuretics/NN ,/, including/VBG MIDAMOR/NN ,/, may/MD each/DT be/VB associated/VBN with/IN increased/VBN serum/NN potassium/NN levels/NNS ,/, the/DT potential/JJ effects/NNS on/IN potassium/NN kinetics/NNS and/CC renal/JJ function/NN should/MD be/VB considered/VBN when/WRB these/DT agents/NNS are/VBP administered/VBN concurrently/RB ./.

(ROOT (S1 (S (SBAR (IN Since) (S (NP (NP (NP (NN indomethacin)) (CC and) (NP (JJ potassium-sparing) (NN diuretics))) (, ,) (PP (VBG including) (NP (NN MIDAMOR))) (, ,)) (VP (MD may) (DT each) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (VBN increased) (NN serum) (NN potassium) (NNS levels)))))))) (, ,) (NP (NP (DT the) (JJ potential) (NNS effects)) (PP (IN on) (NP (NP (NN potassium) (NNS kinetics)) (CC and) (NP (JJ renal) (NN function))))) (VP (MD should) (VP (VB be) (VP (VBN considered) (SBAR (WHADVP (WRB when)) (S (NP (DT these) (NNS agents)) (VP (VBP are) (VP (VBN administered) (ADVP (RB concurrently))))))))) (. .))))

mark(associated-13, Since-1)
nsubjpass(associated-13, indomethacin-2)
amod(diuretics-5, potassium-sparing-4)
conj_and(indomethacin-2, diuretics-5)
prep_including(indomethacin-2, MIDAMOR-8)
aux(associated-13, may-10)
dep(associated-13, each-11)
auxpass(associated-13, be-12)
advcl(considered-31, associated-13)
amod(levels-18, increased-15)
nn(levels-18, serum-16)
nn(levels-18, potassium-17)
prep_with(associated-13, levels-18)
det(effects-22, the-20)
amod(effects-22, potential-21)
nsubjpass(considered-31, effects-22)
nn(kinetics-25, potassium-24)
prep_on(effects-22, kinetics-25)
amod(function-28, renal-27)
conj_and(kinetics-25, function-28)
aux(considered-31, should-29)
auxpass(considered-31, be-30)
root(ROOT-0, considered-31)
advmod(administered-36, when-32)
det(agents-34, these-33)
nsubjpass(administered-36, agents-34)
auxpass(administered-36, are-35)
advcl(considered-31, administered-36)
advmod(administered-36, concurrently-37)

Drug/NN Laboratory/NN Test/NN Interactions/NNS @/NN Prolongation/NN of/IN the/DT template/NN bleeding/JJ time/NN has/VBZ been/VBN reported/VBN during/IN continuous/JJ intravenous/JJ infusion/NN of/IN AMICAR/NN at/IN dosages/NNS exceeding/VBG 24/CD g/day/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Drug) (NN Laboratory) (NN Test) (NNS Interactions)) (NN @) (NN Prolongation)) (PP (IN of) (NP (DT the) (NN template) (JJ bleeding) (NN time)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN during) (NP (NP (JJ continuous) (JJ intravenous) (NN infusion)) (PP (IN of) (NP (NN AMICAR))) (PP (IN at) (NP (NP (NNS dosages)) (VP (VBG exceeding) (NP (CD 24) (NN g/day))))))))))) (. .))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, Laboratory-2)
nn(Interactions-4, Test-3)
nn(Prolongation-6, Interactions-4)
nn(Prolongation-6, @-5)
nsubjpass(reported-14, Prolongation-6)
det(time-11, the-8)
nn(time-11, template-9)
amod(time-11, bleeding-10)
prep_of(Prolongation-6, time-11)
aux(reported-14, has-12)
auxpass(reported-14, been-13)
root(ROOT-0, reported-14)
amod(infusion-18, continuous-16)
amod(infusion-18, intravenous-17)
prep_during(reported-14, infusion-18)
prep_of(infusion-18, AMICAR-20)
prep_at(infusion-18, dosages-22)
partmod(dosages-22, exceeding-23)
num(g/day-25, 24-24)
dobj(exceeding-23, g/day-25)

However/RB ,/, in/FW vitro/FW studies/NNS have/VBP shown/VBN that/IN at/IN high/JJ concentrations/NNS (/-LRB- 7.4/CD mMol/L/NN or/CC 0.97/CD mg/mL/NN and/CC greater/JJR )/-RRB- EACA/NN inhibits/VBZ ADP/NN and/CC collagen/NN -induced/JJ platelet/NN aggregation/NN ,/, the/DT release/NN of/IN ATP/NN and/CC serotonin/NN ,/, and/CC the/DT binding/NN of/IN fibrinogen/NN to/TO the/DT platelets/NNS in/IN a/DT concentration-response/JJ manner/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (ADJP (FW in) (FW vitro)) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (PP (IN at) (NP (NP (JJ high) (NNS concentrations)) (PRN (-LRB- -LRB-) (NP (CD 7.4) (NN mMol/L) (CC or) (CD 0.97) (NN mg/mL) (QP (CC and) (JJR greater))) (-RRB- -RRB-)))) (NP (NN EACA)) (VP (VBZ inhibits) (NP (NP (ADJP (NP (NP (NN ADP)) (CC and) (NP (NN collagen))) (JJ -induced)) (NN platelet) (NN aggregation)) (, ,) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (NP (NN ATP)) (CC and) (NP (NN serotonin))))) (, ,) (CC and) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NN fibrinogen))) (PP (TO to) (NP (DT the) (NNS platelets))))) (PP (IN in) (NP (DT a) (JJ concentration-response) (NN manner))))))))) (. .))))

advmod(shown-7, However-1)
nn(vitro-4, in-3)
amod(studies-5, vitro-4)
nsubj(shown-7, studies-5)
aux(shown-7, have-6)
root(ROOT-0, shown-7)
complm(inhibits-22, that-8)
amod(concentrations-11, high-10)
prep_at(inhibits-22, concentrations-11)
num(mMol/L-14, 7.4-13)
dep(concentrations-11, mMol/L-14)
num(mg/mL-17, 0.97-16)
conj_or(mMol/L-14, mg/mL-17)
cc(greater-19, and-18)
num(mg/mL-17, greater-19)
nsubj(inhibits-22, EACA-21)
ccomp(shown-7, inhibits-22)
npadvmod(-induced-26, ADP-23)
conj_and(ADP-23, collagen-25)
amod(aggregation-28, -induced-26)
nn(aggregation-28, platelet-27)
dobj(inhibits-22, aggregation-28)
det(release-31, the-30)
conj_and(aggregation-28, release-31)
prep_of(release-31, ATP-33)
conj_and(ATP-33, serotonin-35)
det(binding-39, the-38)
conj_and(aggregation-28, binding-39)
prep_of(binding-39, fibrinogen-41)
det(platelets-44, the-43)
prep_to(binding-39, platelets-44)
det(manner-48, a-46)
amod(manner-48, concentration-response-47)
prep_in(inhibits-22, manner-48)

Following/VBG a/DT 10/CD g/NN bolus/NN of/IN AMICAR/NN ,/, transient/JJ peak/NN plasma/NN concentrations/NNS of/IN 4.6/CD mMol/L/NN or/CC 0.60/CD mg/mL/NN have/VBP been/VBN obtained/VBN ./.

(ROOT (S1 (S (S (PP (VBG Following) (NP (NP (DT a) (CD 10) (NN g) (NN bolus)) (PP (IN of) (NP (NN AMICAR))))) (, ,) (NP (NP (JJ transient) (NN peak) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (QP (CD 4.6) (NN mMol/L) (CC or) (CD 0.60)) (NN mg/mL)))) (VP (VBP have) (VP (VBN been) (VP (VBN obtained))))) (. .))))

det(bolus-5, a-2)
num(bolus-5, 10-3)
nn(bolus-5, g-4)
prep_following(obtained-21, bolus-5)
prep_of(bolus-5, AMICAR-7)
amod(concentrations-12, transient-9)
nn(concentrations-12, peak-10)
nn(concentrations-12, plasma-11)
nsubjpass(obtained-21, concentrations-12)
number(mMol/L-15, 4.6-14)
num(mg/mL-18, mMol/L-15)
conj_or(mMol/L-15, 0.60-17)
prep_of(concentrations-12, mg/mL-18)
aux(obtained-21, have-19)
auxpass(obtained-21, been-20)
root(ROOT-0, obtained-21)

The/DT concentration/NN of/IN AMICAR/NN necessary/JJ to/TO maintain/VB inhibition/NN of/IN fibrinolysis/NN is/VBZ 0.99/CD mMol/L/NN or/CC 0.13/CD mg/mL/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN concentration)) (PP (IN of) (NP (NN AMICAR))) (ADJP (JJ necessary) (S (VP (TO to) (VP (VB maintain) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN fibrinolysis))))))))) (VP (VBZ is) (NP (QP (CD 0.99) (NN mMol/L) (CC or) (CD 0.13)) (NN mg/mL)))) (. .))))

det(concentration-2, The-1)
nsubj(mg/mL-16, concentration-2)
prep_of(concentration-2, AMICAR-4)
amod(concentration-2, necessary-5)
aux(maintain-7, to-6)
xcomp(necessary-5, maintain-7)
dobj(maintain-7, inhibition-8)
prep_of(inhibition-8, fibrinolysis-10)
cop(mg/mL-16, is-11)
number(mMol/L-13, 0.99-12)
num(mg/mL-16, mMol/L-13)
conj_or(mMol/L-13, 0.13-15)
root(ROOT-0, mg/mL-16)

However/RB ,/, higher/JJR plasma/NN concentrations/NNS of/IN AMICAR/NN may/MD occur/VB in/IN patients/NNS with/IN severe/JJ renal/JJ failure/NN .?/RB

(ROOT (S1 (S (ADVP (RB However)) (, ,) (NP (NP (JJR higher) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN AMICAR)))) (VP (MD may) (VP (VB occur) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ severe) (JJ renal) (NN failure))))) (ADVP (RB .?)))))))

advmod(occur-9, However-1)
amod(concentrations-5, higher-3)
nn(concentrations-5, plasma-4)
nsubj(occur-9, concentrations-5)
prep_of(concentrations-5, AMICAR-7)
aux(occur-9, may-8)
root(ROOT-0, occur-9)
prep_in(occur-9, patients-11)
amod(failure-15, severe-13)
amod(failure-15, renal-14)
prep_with(patients-11, failure-15)
advmod(occur-9, .?-16)

Cytadren/NN accelerates/VBZ the/DT metabolism/NN of/IN dexamethasone/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN Cytadren)) (VP (VBZ accelerates) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN dexamethasone))))) (: ;)) (. .))))

nsubj(accelerates-2, Cytadren-1)
root(ROOT-0, accelerates-2)
det(metabolism-4, the-3)
dobj(accelerates-2, metabolism-4)
prep_of(metabolism-4, dexamethasone-6)

therefore/RB ,/, if/IN glucocorticoid/NN replacement/NN is/VBZ needed/VBN ,/, hydrocortisone/NN should/MD be/VB prescribed/VBN ./.

(ROOT (S1 (S (S (ADVP (RB therefore)) (, ,) (SBAR (IN if) (S (NP (NN glucocorticoid) (NN replacement)) (VP (VBZ is) (VP (VBN needed))))) (, ,) (NP (NN hydrocortisone)) (VP (MD should) (VP (VB be) (VP (VBN prescribed))))) (. .))))

advmod(prescribed-12, therefore-1)
mark(needed-7, if-3)
nn(replacement-5, glucocorticoid-4)
nsubjpass(needed-7, replacement-5)
auxpass(needed-7, is-6)
advcl(prescribed-12, needed-7)
nsubjpass(prescribed-12, hydrocortisone-9)
aux(prescribed-12, should-10)
auxpass(prescribed-12, be-11)
root(ROOT-0, prescribed-12)

Aminoglutethimide/NN diminishes/VBZ the/DT effect/NN of/IN coumarin/NN and/CC warfarin/NN ./.

(ROOT (S1 (S (S (NP (NN Aminoglutethimide)) (VP (VBZ diminishes) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NN coumarin)) (CC and) (NP (NN warfarin))))))) (. .))))

nsubj(diminishes-2, Aminoglutethimide-1)
root(ROOT-0, diminishes-2)
det(effect-4, the-3)
dobj(diminishes-2, effect-4)
prep_of(effect-4, coumarin-6)
conj_and(coumarin-6, warfarin-8)

There/EX have/VBP been/VBN no/DT formal/JJ studies/NNS of/IN the/DT interaction/NN of/IN LEVULAN/NNP KERASTICK/NNP for/IN Topical/JJ Solution/NN with/IN any/DT other/JJ drugs/NNS ,/, and/CC no/DT drug-specific/JJ interactions/NNS were/VBD noted/VBN during/IN any/DT of/IN the/DT controlled/JJ clinical/JJ trials/NNS ./.

(ROOT (S1 (S (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (DT no) (JJ formal) (NNS studies)) (PP (IN of) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (NP (NNP LEVULAN) (NNP KERASTICK)) (PP (IN for) (NP (JJ Topical) (NN Solution))))) (PP (IN with) (NP (DT any) (JJ other) (NNS drugs))))))))) (, ,) (CC and) (S (NP (DT no) (JJ drug-specific) (NNS interactions)) (VP (VBD were) (VP (VBN noted) (PP (IN during) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (JJ controlled) (JJ clinical) (NNS trials))))))))) (. .))))

expl(studies-6, There-1)
aux(studies-6, have-2)
cop(studies-6, been-3)
det(studies-6, no-4)
amod(studies-6, formal-5)
root(ROOT-0, studies-6)
det(interaction-9, the-8)
prep_of(studies-6, interaction-9)
nn(KERASTICK-12, LEVULAN-11)
prep_of(interaction-9, KERASTICK-12)
amod(Solution-15, Topical-14)
prep_for(KERASTICK-12, Solution-15)
det(drugs-19, any-17)
amod(drugs-19, other-18)
prep_with(interaction-9, drugs-19)
det(interactions-24, no-22)
amod(interactions-24, drug-specific-23)
nsubjpass(noted-26, interactions-24)
auxpass(noted-26, were-25)
conj_and(studies-6, noted-26)
prep_during(noted-26, any-28)
det(trials-33, the-30)
amod(trials-33, controlled-31)
amod(trials-33, clinical-32)
prep_of(any-28, trials-33)

It/PRP is/VBZ ,/, however/RB ,/, possible/JJ that/IN concomitant/JJ use/NN of/IN other/JJ known/JJ photosensitizing/NN agents/NNS such/JJ as/IN griseofulvin/NN ,/, thiazide/NN diuretics/NNS ,/, sulfonylureas/NNS ,/, phenothiazines/NNS ,/, sulfonamides/NNS and/CC tetracyclines/NNS might/MD increase/VB the/DT photosensitivity/NN reaction/NN of/IN actinic/JJ keratoses/NNS treated/VBN with/IN the/DT LEVULAN/NNP KERASTICK/NNP for/IN Topical/JJ Solution/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (, ,) (ADVP (RB however)) (, ,) (ADJP (JJ possible)) (SBAR (IN that) (S (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (JJ other) (JJ known) (NN photosensitizing) (NNS agents)) (PP (JJ such) (IN as) (NP (NP (NN griseofulvin)) (, ,) (NP (NP (NN thiazide) (NNS diuretics)) (, ,) (NP (NNS sulfonylureas)) (, ,) (NP (NNS phenothiazines)) (, ,) (NP (NNS sulfonamides)) (CC and) (NP (NNS tetracyclines)))))))) (VP (MD might) (VP (VB increase) (NP (NP (DT the) (NN photosensitivity) (NN reaction)) (PP (IN of) (NP (NP (JJ actinic) (NNS keratoses)) (VP (VBN treated) (PP (IN with) (NP (NP (DT the) (NNP LEVULAN) (NNP KERASTICK)) (PP (IN for) (NP (JJ Topical) (NN Solution))))))))))))))) (. .))))

nsubj(possible-6, It-1)
cop(possible-6, is-2)
advmod(possible-6, however-4)
root(ROOT-0, possible-6)
complm(increase-30, that-7)
amod(use-9, concomitant-8)
nsubj(increase-30, use-9)
amod(agents-14, other-11)
amod(agents-14, known-12)
nn(agents-14, photosensitizing-13)
prep_of(use-9, agents-14)
prep_such_as(agents-14, griseofulvin-17)
nn(diuretics-20, thiazide-19)
appos(griseofulvin-17, diuretics-20)
conj_and(diuretics-20, sulfonylureas-22)
conj_and(diuretics-20, phenothiazines-24)
conj_and(diuretics-20, sulfonamides-26)
conj_and(diuretics-20, tetracyclines-28)
aux(increase-30, might-29)
ccomp(possible-6, increase-30)
det(reaction-33, the-31)
nn(reaction-33, photosensitivity-32)
dobj(increase-30, reaction-33)
amod(keratoses-36, actinic-35)
prep_of(reaction-33, keratoses-36)
partmod(keratoses-36, treated-37)
det(KERASTICK-41, the-39)
nn(KERASTICK-41, LEVULAN-40)
prep_with(treated-37, KERASTICK-41)
amod(Solution-44, Topical-43)
prep_for(KERASTICK-41, Solution-44)

Drugs/NNS Metabolized/VBN by/IN P450/NN 2D6/NN -/: The/DT biochemical/JJ activity/NN of/IN the/DT drug/NN metabolizing/NN isozyme/NN cytochrome/NN P450/NN 2D6/NN (/-LRB- debrisoquin/NN hydroxylase/NN )/-RRB- is/VBZ reduced/VBN in/IN a/DT subset/NN of/IN the/DT caucasian/NN population/NN (/-LRB- about/RB 7-10/CD %/NN of/IN caucasians/NNS are/VBP so/RB called/VBN poor/JJ metabolizers/NNS )/-RRB- ;/: ./.

(ROOT (S1 (S (S (NP (NNS Drugs)) (VP (VBN Metabolized) (PP (IN by) (NP (NN P450) (NN 2D6))))) (: -) (S (NP (NP (DT The) (JJ biochemical) (NN activity)) (PP (IN of) (NP (DT the) (NN drug) (NN metabolizing) (NN isozyme) (NP (NP (NN cytochrome) (NN P450) (NN 2D6)) (PRN (-LRB- -LRB-) (NP (NN debrisoquin) (NN hydroxylase)) (-RRB- -RRB-)))))) (VP (VBZ is) (VP (VBN reduced) (PP (IN in) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (DT the) (NN caucasian) (NN population))))) (PRN (-LRB- -LRB-) (S (NP (NP (QP (RB about) (CD 7-10)) (NN %)) (PP (IN of) (NP (NNS caucasians)))) (VP (VBP are) (NP (ADJP (RB so) (VBN called)) (JJ poor) (NNS metabolizers)))) (-RRB- -RRB-)))) (: ;)) (. .))))

nsubj(Metabolized-2, Drugs-1)
root(ROOT-0, Metabolized-2)
nn(2D6-5, P450-4)
prep_by(Metabolized-2, 2D6-5)
det(activity-9, The-7)
amod(activity-9, biochemical-8)
nsubjpass(reduced-23, activity-9)
det(isozyme-14, the-11)
nn(isozyme-14, drug-12)
nn(isozyme-14, metabolizing-13)
prep_of(activity-9, isozyme-14)
nn(2D6-17, cytochrome-15)
nn(2D6-17, P450-16)
dep(isozyme-14, 2D6-17)
nn(hydroxylase-20, debrisoquin-19)
appos(2D6-17, hydroxylase-20)
auxpass(reduced-23, is-22)
parataxis(Metabolized-2, reduced-23)
det(subset-26, a-25)
prep_in(reduced-23, subset-26)
det(population-30, the-28)
nn(population-30, caucasian-29)
prep_of(subset-26, population-30)
quantmod(7-10-33, about-32)
num(%-34, 7-10-33)
nsubj(metabolizers-41, %-34)
prep_of(%-34, caucasians-36)
cop(metabolizers-41, are-37)
advmod(called-39, so-38)
amod(metabolizers-41, called-39)
amod(metabolizers-41, poor-40)
parataxis(reduced-23, metabolizers-41)

reliable/JJ estimates/NNS of/IN the/DT prevalence/NN of/IN reduced/VBN P450/NN 2D6/NN isozyme/NN activity/NN among/IN Asian/JJ ,/, African/JJ and/CC other/JJ populations/NNS are/VBP not/RB yet/RB available/JJ ./.

(ROOT (S1 (S (S (NP (NP (JJ reliable) (NNS estimates)) (PP (IN of) (NP (NP (DT the) (NN prevalence)) (PP (IN of) (NP (VBN reduced) (NN P450) (NN 2D6) (NN isozyme) (NN activity))) (PP (IN among) (NP (ADJP (ADJP (JJ Asian)) (, ,) (ADJP (JJ African)) (CC and) (ADJP (JJ other))) (NNS populations)))))) (VP (VBP are) (RB not) (ADVP (RB yet)) (ADJP (JJ available)))) (. .))))

amod(estimates-2, reliable-1)
nsubj(available-22, estimates-2)
det(prevalence-5, the-4)
prep_of(estimates-2, prevalence-5)
amod(activity-11, reduced-7)
nn(activity-11, P450-8)
nn(activity-11, 2D6-9)
nn(activity-11, isozyme-10)
prep_of(prevalence-5, activity-11)
amod(populations-18, Asian-13)
conj_and(Asian-13, African-15)
conj_and(Asian-13, other-17)
prep_among(prevalence-5, populations-18)
cop(available-22, are-19)
neg(available-22, not-20)
advmod(available-22, yet-21)
root(ROOT-0, available-22)

Poor/JJ metabolizers/NNS have/VBP higher/JJR than/IN expected/VBN plasma/NN concentrations/NNS of/IN tricyclic/JJ antidepressants/NNS (/-LRB- TCAs/NNS )/-RRB- when/WRB given/VBN usual/JJ doses/NNS ./.

(ROOT (S1 (S (S (NP (JJ Poor) (NNS metabolizers)) (VP (VBP have) (NP (NP (JJR higher) (IN than) (VBN expected) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (JJ tricyclic) (NNS antidepressants)) (PRN (-LRB- -LRB-) (NP (NNS TCAs)) (-RRB- -RRB-))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (NP (JJ usual) (NNS doses))))))) (. .))))

amod(metabolizers-2, Poor-1)
nsubj(have-3, metabolizers-2)
root(ROOT-0, have-3)
amod(concentrations-8, higher-4)
amod(concentrations-8, than-5)
amod(concentrations-8, expected-6)
nn(concentrations-8, plasma-7)
dobj(have-3, concentrations-8)
amod(antidepressants-11, tricyclic-10)
prep_of(concentrations-8, antidepressants-11)
appos(antidepressants-11, TCAs-13)
advmod(given-16, when-15)
advcl(have-3, given-16)
amod(doses-18, usual-17)
dobj(given-16, doses-18)

Depending/VBG on/IN the/DT fraction/NN of/IN drug/NN metabolized/VBN by/IN P450/NN 2D6/NN ,/, the/DT increase/NN in/IN plasma/NN concentration/NN may/MD be/VB small/JJ ,/, or/CC quite/RB large/JJ (/-LRB- 8-fold/JJ increase/NN in/IN plasma/NN AUC/NN of/IN the/DT TCA/NN )./NN

(ROOT (S1 (S (PP (VBG Depending) (PP (IN on) (NP (NP (DT the) (NN fraction)) (PP (IN of) (NP (NP (NN drug)) (VP (VBN metabolized) (PP (IN by) (NP (NN P450) (NN 2D6))))))))) (, ,) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NN plasma) (NN concentration)))) (VP (MD may) (VP (VB be) (ADJP (ADJP (JJ small)) (, ,) (CC or) (RB quite) (ADJP (JJ large))))) (PRN (-LRB- -LRB-) (NP (NP (JJ 8-fold) (NN increase)) (PP (IN in) (NP (NP (NN plasma) (NN AUC)) (PP (IN of) (NP (DT the) (NN TCA) (NN -RRB-.))))))))))

prepc_depending_on(small-19, on-2)
det(fraction-4, the-3)
pobj(small-19, fraction-4)
prep_of(fraction-4, drug-6)
partmod(drug-6, metabolized-7)
nn(2D6-10, P450-9)
agent(metabolized-7, 2D6-10)
det(increase-13, the-12)
nsubj(small-19, increase-13)
nn(concentration-16, plasma-15)
prep_in(increase-13, concentration-16)
aux(small-19, may-17)
cop(small-19, be-18)
root(ROOT-0, small-19)
advmod(small-19, quite-22)
conj_or(small-19, quite-22)
dep(small-19, large-23)
amod(increase-26, 8-fold-25)
dep(small-19, increase-26)
nn(AUC-29, plasma-28)
prep_in(increase-26, AUC-29)
det(-RRB-.-33, the-31)
nn(-RRB-.-33, TCA-32)
prep_of(AUC-29, -RRB-.-33)

In/IN addition/NN ,/, certain/JJ drugs/NNS inhibit/VB the/DT activity/NN of/IN this/DT isozyme/NN and/CC make/VB normal/JJ metabolizers/NNS resemble/VBP poor/JJ metabolizers/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (JJ certain) (NNS drugs)) (VP (VP (VB inhibit) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT this) (NN isozyme))))) (CC and) (VP (VB make) (NP (JJ normal) (NNS metabolizers)))) (VP (VBP resemble) (NP (JJ poor) (NNS metabolizers)))) (. .))))

prep_in(inhibit-6, addition-2)
amod(drugs-5, certain-4)
nsubj(inhibit-6, drugs-5)
root(ROOT-0, inhibit-6)
det(activity-8, the-7)
dobj(inhibit-6, activity-8)
det(isozyme-11, this-10)
prep_of(activity-8, isozyme-11)
conj_and(inhibit-6, make-13)
amod(metabolizers-15, normal-14)
dobj(make-13, metabolizers-15)
cop(metabolizers-18, resemble-16)
amod(metabolizers-18, poor-17)
dep(inhibit-6, metabolizers-18)

An/DT individual/JJ who/WP is/VBZ stable/JJ on/IN a/DT given/JJ dose/NN of/IN TCA/NN may/MD become/VB abruptly/RB toxic/JJ when/WRB given/VBN one/CD of/IN these/DT inhibiting/JJ drugs/NNS as/IN concomitant/JJ therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (DT An) (JJ individual)) (SBAR (WHNP (WP who)) (S (VP (VBZ is) (ADJP (JJ stable) (PP (IN on) (NP (NP (DT a) (JJ given) (NN dose)) (PP (IN of) (NP (NN TCA)))))))))) (VP (MD may) (VP (VB become) (ADJP (RB abruptly) (JJ toxic)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT these) (JJ inhibiting) (NNS drugs)) (PP (IN as) (NP (JJ concomitant) (NN therapy)))))))))))) (. .))))

det(individual-2, An-1)
nsubj(stable-5, individual-2)
nsubj(toxic-15, individual-2)
cop(stable-5, is-4)
rcmod(individual-2, stable-5)
det(dose-9, a-7)
amod(dose-9, given-8)
prep_on(stable-5, dose-9)
prep_of(dose-9, TCA-11)
aux(toxic-15, may-12)
cop(toxic-15, become-13)
advmod(toxic-15, abruptly-14)
root(ROOT-0, toxic-15)
advmod(given-17, when-16)
advcl(toxic-15, given-17)
dobj(given-17, one-18)
det(drugs-22, these-20)
amod(drugs-22, inhibiting-21)
prep_of(one-18, drugs-22)
amod(therapy-25, concomitant-24)
prep_as(drugs-22, therapy-25)

The/DT drugs/NNS that/WDT inhibit/VBP cytochrome/NN P450/NN 2D6/NN include/VBP some/DT that/WDT are/VBP not/RB metabolized/VBN by/IN the/DT enzyme/NN (/-LRB- quinidine/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (NN cytochrome) (NN P450) (NN 2D6)))))) (VP (VBP include) (NP (NP (DT some)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (RB not) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (NN enzyme) (-LRB- -LRB-) (NN quinidine) (: ;)))))))))) (. .))))

det(drugs-2, The-1)
nsubj(inhibit-4, drugs-2)
nsubj(include-8, drugs-2)
rcmod(drugs-2, inhibit-4)
nn(2D6-7, cytochrome-5)
nn(2D6-7, P450-6)
dobj(inhibit-4, 2D6-7)
root(ROOT-0, include-8)
dobj(include-8, some-9)
nsubjpass(metabolized-13, some-9)
auxpass(metabolized-13, are-11)
neg(metabolized-13, not-12)
rcmod(some-9, metabolized-13)
det(quinidine-18, the-15)
nn(quinidine-18, enzyme-16)
agent(metabolized-13, quinidine-18)

cimetidine/NN )/-RRB- and/CC many/JJ that/WDT are/VBP substrates/NNS for/IN P450/NN 2D6/NN (/-LRB- many/JJ other/JJ antidepressants/NNS ,/, phenothiazines/NNS ,/, and/CC the/DT Type/NN 1C/NN antiarrhythmics/NNS propafenone/NN and/CC flecainide/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NP (NN cimetidine) (-RRB- -RRB-)) (CC and) (NP (NP (JJ many)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NNS substrates)) (PP (IN for) (NP (NN P450) (NN 2D6)))) (PRN (-LRB- -LRB-) (NP (NP (JJ many) (JJ other) (NNS antidepressants)) (, ,) (NP (NNS phenothiazines)) (, ,) (CC and) (NP (NP (DT the) (NN Type) (NN 1C) (NNS antiarrhythmics)) (NP (NP (NN propafenone)) (CC and) (NP (NN flecainide))))) (-RRB- -RRB-))))))) (. .)))))

root(ROOT-0, cimetidine-1)
conj_and(cimetidine-1, many-4)
nsubj(substrates-7, many-4)
cop(substrates-7, are-6)
rcmod(many-4, substrates-7)
nn(2D6-10, P450-9)
prep_for(substrates-7, 2D6-10)
amod(antidepressants-14, many-12)
amod(antidepressants-14, other-13)
dep(substrates-7, antidepressants-14)
conj_and(antidepressants-14, phenothiazines-16)
det(antiarrhythmics-22, the-19)
nn(antiarrhythmics-22, Type-20)
nn(antiarrhythmics-22, 1C-21)
conj_and(antidepressants-14, antiarrhythmics-22)
dep(antiarrhythmics-22, propafenone-23)
conj_and(propafenone-23, flecainide-25)

While/IN all/PDT the/DT selective/JJ serotonin/NN reuptake/NN inhibitors/NNS (/-LRB- SSRIs/NN )/-RRB- ,/, e.g./FW ,/, fluoxetine/NN ,/, sertraline/NN ,/, and/CC paroxetine/NN ,/, inhibit/VBP P450/NN 2D6/NN ,/, they/PRP may/MD vary/VB in/IN the/DT extent/NN of/IN inhibition/NN ./.

(ROOT (S1 (S (S (SBAR (IN While) (S (NP (NP (NP (PDT all) (DT the) (JJ selective) (NN serotonin) (NN reuptake) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NN SSRIs)) (-RRB- -RRB-))) (, ,) (PP (FW e.g.) (, ,) (NP (NP (NN fluoxetine)) (, ,) (NP (NN sertraline)) (, ,) (CC and) (NP (NN paroxetine)))) (, ,)) (VP (VBP inhibit) (NP (NN P450) (NN 2D6))))) (, ,) (NP (PRP they)) (VP (MD may) (VP (VB vary) (PP (IN in) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NN inhibition)))))))) (. .))))

mark(inhibit-21, While-1)
predet(inhibitors-7, all-2)
det(inhibitors-7, the-3)
amod(inhibitors-7, selective-4)
nn(inhibitors-7, serotonin-5)
nn(inhibitors-7, reuptake-6)
nsubj(inhibit-21, inhibitors-7)
abbrev(inhibitors-7, SSRIs-9)
prep(inhibitors-7, e.g.-12)
pobj(e.g.-12, fluoxetine-14)
conj_and(fluoxetine-14, sertraline-16)
conj_and(fluoxetine-14, paroxetine-19)
advcl(vary-27, inhibit-21)
nn(2D6-23, P450-22)
dobj(inhibit-21, 2D6-23)
nsubj(vary-27, they-25)
aux(vary-27, may-26)
root(ROOT-0, vary-27)
det(extent-30, the-29)
prep_in(vary-27, extent-30)
prep_of(extent-30, inhibition-32)

Of/IN particular/JJ importance/NN ,/, sufficient/JJ time/NN must/MD elapse/VB before/IN initiating/VBG TCA/NN treatment/NN in/IN a/DT patient/NN being/VBG withdrawn/NN from/IN fluoxetine/NN ,/, given/IN the/DT long/JJ half-life/NN of/IN the/DT parent/JJ and/CC active/JJ metabolite/NN (/-LRB- at/IN least/JJS 5/CD weeks/NNS may/MD be/VB necessary/JJ )./NN

(ROOT (S1 (S (PP (IN Of) (NP (JJ particular) (NN importance))) (, ,) (S (NP (JJ sufficient) (NN time)) (VP (MD must) (VP (VB elapse) (PP (IN before) (S (VP (VBG initiating) (NP (NN TCA) (NN treatment))))) (PP (IN in) (NP (NP (DT a) (NN patient)) (VP (VBG being) (NP (NP (NN withdrawn)) (PP (IN from) (NP (NN fluoxetine))))))) (, ,) (SBAR (IN given) (S (NP (NP (DT the) (JJ long) (NN half-life)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ parent)) (CC and) (ADJP (JJ active))) (NN metabolite) (-LRB- -LRB-) (QP (IN at) (JJS least) (CD 5)) (NNS weeks)))) (VP (MD may) (VP (VB be) (NP (JJ necessary) (NN -RRB-.))))))))))))

amod(importance-3, particular-2)
prep_of(elapse-8, importance-3)
amod(time-6, sufficient-5)
nsubj(elapse-8, time-6)
aux(elapse-8, must-7)
root(ROOT-0, elapse-8)
prepc_before(elapse-8, initiating-10)
nn(treatment-12, TCA-11)
dobj(initiating-10, treatment-12)
det(patient-15, a-14)
prep_in(elapse-8, patient-15)
cop(withdrawn-17, being-16)
partmod(patient-15, withdrawn-17)
prep_from(withdrawn-17, fluoxetine-19)
mark(-RRB-.-39, given-21)
det(half-life-24, the-22)
amod(half-life-24, long-23)
nsubj(-RRB-.-39, half-life-24)
det(weeks-35, the-26)
amod(weeks-35, parent-27)
conj_and(parent-27, active-29)
nn(weeks-35, metabolite-30)
quantmod(5-34, at-32)
mwe(at-32, least-33)
pobj(at-32, least-33)
num(weeks-35, 5-34)
prep_of(half-life-24, weeks-35)
aux(-RRB-.-39, may-36)
cop(-RRB-.-39, be-37)
amod(-RRB-.-39, necessary-38)
advcl(elapse-8, -RRB-.-39)

Concomitant/JJ use/NN of/IN tricyclic/JJ antidepressants/NNS with/IN drugs/NNS that/WDT can/MD inhibit/VB cytochrome/NN P450/NN 2D6/NN may/MD require/VB lower/JJR doses/NNS than/IN usually/RB prescribed/VBN for/IN either/CC the/DT tricyclic/JJ antidepressant/JJ or/CC the/DT other/JJ drug/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (JJ tricyclic) (NNS antidepressants)) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB inhibit) (NP (NN cytochrome) (NN P450) (NN 2D6))))))))))) (VP (MD may) (VP (VB require) (NP (NP (JJR lower) (NNS doses)) (VP (ADVP (IN than) (RB usually)) (VBN prescribed) (PP (IN for) (NP (CC either) (NP (DT the) (JJ tricyclic) (JJ antidepressant)) (CC or) (NP (DT the) (JJ other) (NN drug))))))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(require-15, use-2)
amod(antidepressants-5, tricyclic-4)
prep_of(use-2, antidepressants-5)
prep_with(antidepressants-5, drugs-7)
nsubj(inhibit-10, drugs-7)
aux(inhibit-10, can-9)
rcmod(drugs-7, inhibit-10)
nn(2D6-13, cytochrome-11)
nn(2D6-13, P450-12)
dobj(inhibit-10, 2D6-13)
aux(require-15, may-14)
root(ROOT-0, require-15)
amod(doses-17, lower-16)
dobj(require-15, doses-17)
advmod(prescribed-20, than-18)
advmod(than-18, usually-19)
partmod(doses-17, prescribed-20)
preconj(antidepressant-25, either-22)
det(antidepressant-25, the-23)
amod(antidepressant-25, tricyclic-24)
prep_for(prescribed-20, antidepressant-25)
det(drug-29, the-27)
amod(drug-29, other-28)
conj_or(antidepressant-25, drug-29)

Furthermore/RB ,/, whenever/RB one/CD of/IN these/DT other/JJ drugs/NNS is/VBZ withdrawn/VBN from/IN co-therapy/NN ,/, an/DT increased/VBN dose/NN of/IN tricyclic/JJ antidepressant/JJ may/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Furthermore)) (, ,) (S (ADVP (RB whenever)) (NP (NP (CD one)) (PP (IN of) (NP (DT these) (JJ other) (NNS drugs)))) (VP (VBZ is) (VP (VBN withdrawn) (PP (IN from) (NP (NN co-therapy)))))) (, ,) (NP (NP (DT an) (VBN increased) (NN dose)) (PP (IN of) (NP (JJ tricyclic) (JJ antidepressant)))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (. .))))

advmod(required-22, Furthermore-1)
advmod(withdrawn-10, whenever-3)
nsubjpass(withdrawn-10, one-4)
det(drugs-8, these-6)
amod(drugs-8, other-7)
prep_of(one-4, drugs-8)
auxpass(withdrawn-10, is-9)
ccomp(required-22, withdrawn-10)
prep_from(withdrawn-10, co-therapy-12)
det(dose-16, an-14)
amod(dose-16, increased-15)
nsubjpass(required-22, dose-16)
amod(antidepressant-19, tricyclic-18)
prep_of(dose-16, antidepressant-19)
aux(required-22, may-20)
auxpass(required-22, be-21)
root(ROOT-0, required-22)

It/PRP is/VBZ desirable/JJ to/TO monitor/VB TCA/NN plasma/NN levels/NNS whenever/RB a/DT TCA/NN is/VBZ going/JJ to/TO be/VB coadministered/VBN with/IN another/DT drug/NN known/VBN to/TO be/VB an/DT inhibitor/NN of/IN P450/NN 2D6/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ desirable)) (S (VP (TO to) (VP (VB monitor) (NP (NN TCA) (NN plasma) (NNS levels)) (S (ADVP (RB whenever)) (NP (DT a) (NN TCA)) (VP (VBZ is) (ADJP (JJ going) (S (VP (TO to) (VP (VB be) (VP (VBN coadministered) (PP (IN with) (NP (NP (DT another) (NN drug)) (VP (VBN known) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN P450) (NN 2D6)))))))))))))))))))))) (. .))))

nsubj(desirable-3, It-1)
xsubj(monitor-5, It-1)
cop(desirable-3, is-2)
root(ROOT-0, desirable-3)
aux(monitor-5, to-4)
xcomp(desirable-3, monitor-5)
nn(levels-8, TCA-6)
nn(levels-8, plasma-7)
dobj(monitor-5, levels-8)
advmod(going-13, whenever-9)
det(TCA-11, a-10)
nsubj(going-13, TCA-11)
cop(going-13, is-12)
dep(monitor-5, going-13)
aux(coadministered-16, to-14)
auxpass(coadministered-16, be-15)
xcomp(going-13, coadministered-16)
det(drug-19, another-18)
prep_with(coadministered-16, drug-19)
partmod(drug-19, known-20)
aux(inhibitor-24, to-21)
cop(inhibitor-24, be-22)
det(inhibitor-24, an-23)
xcomp(known-20, inhibitor-24)
nn(2D6-27, P450-26)
prep_of(inhibitor-24, 2D6-27)

Monoamine/NN Oxidase/NN Inhibitors/NNS :/: Guanethidine/NN or/CC similarly/RB acting/VBG compounds/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NP (NN Monoamine) (NN Oxidase) (NNS Inhibitors)) (: :) (NP (NP (NN Guanethidine)) (CC or) (NP (ADJP (RB similarly) (VBG acting)) (NNS compounds))) (: ;))) (. .))))

nn(Inhibitors-3, Monoamine-1)
nn(Inhibitors-3, Oxidase-2)
root(ROOT-0, Inhibitors-3)
dep(Inhibitors-3, Guanethidine-5)
advmod(acting-8, similarly-7)
amod(compounds-9, acting-8)
conj_or(Guanethidine-5, compounds-9)

thyroid/NN medication/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NP (NN thyroid) (NN medication)) (: ;)) (. .)))))

nn(medication-2, thyroid-1)
root(ROOT-0, medication-2)

alcohol/NN ,/, barbiturates/NNS and/CC other/JJ CNS/NNS depressants/VBZ ;/: ./.

(ROOT (S1 (S (S (NP (NP (NN alcohol)) (, ,) (NP (NNS barbiturates)) (CC and) (NP (JJ other) (NNS CNS))) (VP (VBZ depressants)) (: ;)) (. .))))

nsubj(depressants-7, alcohol-1)
conj_and(alcohol-1, barbiturates-3)
amod(CNS-6, other-5)
conj_and(alcohol-1, CNS-6)
root(ROOT-0, depressants-7)

and/CC disulfiram/NN When/WRB amitriptyline/NN HCl/NN is/VBZ given/VBN with/IN anticholinergic/JJ agents/NNS or/CC sympathomimetic/JJ drugs/NNS ,/, including/VBG epinephrine/NN combined/VBN with/IN local/JJ anesthetics/NNS ,/, close/JJ supervision/NN and/CC careful/JJ adjustment/NN of/IN dosages/NNS are/VBP required/VBN ./.

(ROOT (S1 (S (S (NP (CC and) (NP (NP (NP (NN disulfiram)) (SBAR (WHADVP (WRB When)) (S (NP (NN amitriptyline) (NN HCl)) (VP (VBZ is) (VP (VBN given) (PP (IN with) (NP (NP (NP (JJ anticholinergic) (NNS agents)) (CC or) (NP (JJ sympathomimetic) (NNS drugs))) (, ,) (PP (VBG including) (NP (NP (NN epinephrine)) (VP (VBN combined) (PP (IN with) (NP (JJ local) (NNS anesthetics))))))))))))) (, ,) (NP (JJ close) (NN supervision))) (CC and) (NP (NP (JJ careful) (NN adjustment)) (PP (IN of) (NP (NNS dosages))))) (VP (VBP are) (VP (VBN required)))) (. .))))

nsubjpass(required-30, disulfiram-2)
advmod(given-7, When-3)
nn(HCl-5, amitriptyline-4)
nsubjpass(given-7, HCl-5)
auxpass(given-7, is-6)
dep(disulfiram-2, given-7)
amod(agents-10, anticholinergic-9)
prep_with(given-7, agents-10)
amod(drugs-13, sympathomimetic-12)
conj_or(agents-10, drugs-13)
prep_including(agents-10, epinephrine-16)
partmod(epinephrine-16, combined-17)
amod(anesthetics-20, local-19)
prep_with(combined-17, anesthetics-20)
amod(supervision-23, close-22)
appos(disulfiram-2, supervision-23)
amod(adjustment-26, careful-25)
conj_and(disulfiram-2, adjustment-26)
prep_of(adjustment-26, dosages-28)
auxpass(required-30, are-29)
root(ROOT-0, required-30)

Hyperpyrexia/NN has/VBZ been/VBN reported/VBN when/WRB amitriptyline/NN HCl/NN is/VBZ administered/VBN with/IN anticholinergic/JJ agents/NNS or/CC with/IN neuroleptic/JJ drugs/NNS ,/, particularly/RB during/IN hot/JJ weather/NN ./.

(ROOT (S1 (S (S (NP (NN Hyperpyrexia)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (SBAR (WHADVP (WRB when)) (S (NP (NN amitriptyline) (NN HCl)) (VP (VBZ is) (VP (VBN administered) (PP (PP (IN with) (NP (JJ anticholinergic) (NNS agents))) (CC or) (PP (IN with) (NP (JJ neuroleptic) (NNS drugs)))) (, ,) (PP (ADVP (RB particularly)) (IN during) (NP (JJ hot) (NN weather))))))))))) (. .))))

nsubjpass(reported-4, Hyperpyrexia-1)
aux(reported-4, has-2)
auxpass(reported-4, been-3)
root(ROOT-0, reported-4)
advmod(administered-9, when-5)
nn(HCl-7, amitriptyline-6)
nsubjpass(administered-9, HCl-7)
auxpass(administered-9, is-8)
advcl(reported-4, administered-9)
amod(agents-12, anticholinergic-11)
prep_with(administered-9, agents-12)
amod(drugs-16, neuroleptic-15)
conj_or(agents-12, drugs-16)
advmod(administered-9, particularly-18)
amod(weather-21, hot-20)
prep_during(administered-9, weather-21)

Paralytic/JJ ileus/NN may/MD occur/VB in/IN patients/NNS taking/VBG tricyclic/JJ antidepressants/NNS in/IN combination/NN with/IN anticholinergic-type/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (JJ Paralytic) (NN ileus)) (VP (MD may) (VP (VB occur) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (JJ tricyclic) (NNS antidepressants)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ anticholinergic-type) (NNS drugs))))))))))) (. .))))

amod(ileus-2, Paralytic-1)
nsubj(occur-4, ileus-2)
aux(occur-4, may-3)
root(ROOT-0, occur-4)
prep_in(occur-4, patients-6)
partmod(patients-6, taking-7)
amod(antidepressants-9, tricyclic-8)
dobj(taking-7, antidepressants-9)
prep_in(taking-7, combination-11)
amod(drugs-14, anticholinergic-type-13)
prep_with(combination-11, drugs-14)

Cimetidine/NN is/VBZ reported/VBN to/TO reduce/VB hepatic/JJ metabolism/NN of/IN certain/JJ tricyclic/JJ antidepressants/NNS ,/, thereby/RB delaying/VBG elimination/NN and/CC increasing/VBG steady-state/JJ concentrations/NNS of/IN these/DT drugs/NNS ./.

(ROOT (S1 (S (S (NP (NN Cimetidine)) (VP (VBZ is) (VP (VBN reported) (S (VP (TO to) (VP (VB reduce) (NP (NP (JJ hepatic) (NN metabolism)) (PP (IN of) (NP (JJ certain) (JJ tricyclic) (NNS antidepressants)))))))) (, ,) (S (ADVP (RB thereby)) (VP (VP (VBG delaying) (NP (NN elimination))) (CC and) (VP (VBG increasing) (NP (NP (JJ steady-state) (NNS concentrations)) (PP (IN of) (NP (DT these) (NNS drugs))))))))) (. .))))

nsubjpass(reported-3, Cimetidine-1)
xsubj(reduce-5, Cimetidine-1)
auxpass(reported-3, is-2)
root(ROOT-0, reported-3)
aux(reduce-5, to-4)
xcomp(reported-3, reduce-5)
amod(metabolism-7, hepatic-6)
dobj(reduce-5, metabolism-7)
amod(antidepressants-11, certain-9)
amod(antidepressants-11, tricyclic-10)
prep_of(metabolism-7, antidepressants-11)
advmod(delaying-14, thereby-13)
ccomp(reported-3, delaying-14)
dobj(delaying-14, elimination-15)
conj_and(delaying-14, increasing-17)
amod(concentrations-19, steady-state-18)
dobj(increasing-17, concentrations-19)
det(drugs-22, these-21)
prep_of(concentrations-19, drugs-22)

Clinically/RB significant/JJ effects/NNS have/VBP been/VBN reported/VBN with/IN the/DT tricyclic/JJ antidepressants/NNS when/WRB used/VBN concomitantly/RB with/IN cimetidine/NN ./.

(ROOT (S1 (S (S (NP (ADJP (RB Clinically) (JJ significant)) (NNS effects)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NP (DT the) (JJ tricyclic) (NNS antidepressants)) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN cimetidine)))))))))))) (. .))))

advmod(significant-2, Clinically-1)
amod(effects-3, significant-2)
nsubjpass(reported-6, effects-3)
aux(reported-6, have-4)
auxpass(reported-6, been-5)
root(ROOT-0, reported-6)
det(antidepressants-10, the-8)
amod(antidepressants-10, tricyclic-9)
prep_with(reported-6, antidepressants-10)
advmod(used-12, when-11)
dep(antidepressants-10, used-12)
advmod(used-12, concomitantly-13)
prep_with(used-12, cimetidine-15)

Increases/NNS in/IN plasma/NN levels/NNS of/IN tricyclic/JJ antidepressants/NNS ,/, and/CC in/IN the/DT frequency/NN and/CC severity/NN of/IN side/JJ effects/NNS ,/, particularly/RB anticholinergic/JJ ,/, have/VBP been/VBN reported/VBN when/WRB cimetidine/NN was/VBD added/VBN to/TO the/DT drug/NN regimen/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Increases)) (PP (PP (IN in) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (JJ tricyclic) (NNS antidepressants))))) (, ,) (CC and) (PP (IN in) (NP (NP (DT the) (NP (NN frequency)) (CC and) (NP (NN severity))) (PP (IN of) (NP (NP (JJ side) (NNS effects)) (, ,) (ADJP (RB particularly) (JJ anticholinergic)) (, ,))))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (SBAR (WHADVP (WRB when)) (S (NP (NN cimetidine)) (VP (VBD was) (VP (VBN added) (PP (TO to) (NP (DT the) (NN drug) (NN regimen))))))))))) (. .))))

nsubjpass(reported-24, Increases-1)
nn(levels-4, plasma-3)
prep_in(Increases-1, levels-4)
amod(antidepressants-7, tricyclic-6)
prep_of(levels-4, antidepressants-7)
dep(frequency-12, the-11)
conj_and(levels-4, frequency-12)
conj_and(frequency-12, severity-14)
amod(effects-17, side-16)
prep_of(frequency-12, effects-17)
advmod(anticholinergic-20, particularly-19)
amod(effects-17, anticholinergic-20)
aux(reported-24, have-22)
auxpass(reported-24, been-23)
root(ROOT-0, reported-24)
advmod(added-28, when-25)
nsubjpass(added-28, cimetidine-26)
auxpass(added-28, was-27)
advcl(reported-24, added-28)
det(regimen-32, the-30)
nn(regimen-32, drug-31)
prep_to(added-28, regimen-32)

Discontinuation/NN of/IN cimetidine/NN in/IN well-controlled/JJ patients/NNS receiving/VBG tricyclic/JJ antidepressants/NNS and/CC cimetidine/NN may/MD decrease/VB the/DT plasma/NN levels/NNS and/CC efficacy/NN of/IN the/DT antidepressants/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Discontinuation)) (PP (IN of) (NP (NN cimetidine))) (PP (IN in) (NP (NP (JJ well-controlled) (NNS patients)) (VP (VBG receiving) (NP (NP (JJ tricyclic) (NNS antidepressants)) (CC and) (NP (NN cimetidine))))))) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NP (NN plasma) (NNS levels)) (CC and) (NP (NN efficacy))) (PP (IN of) (NP (DT the) (NNS antidepressants))))))) (. .))))

nsubj(decrease-13, Discontinuation-1)
prep_of(Discontinuation-1, cimetidine-3)
amod(patients-6, well-controlled-5)
prep_in(Discontinuation-1, patients-6)
partmod(patients-6, receiving-7)
amod(antidepressants-9, tricyclic-8)
dobj(receiving-7, antidepressants-9)
conj_and(antidepressants-9, cimetidine-11)
aux(decrease-13, may-12)
root(ROOT-0, decrease-13)
dep(levels-16, the-14)
nn(levels-16, plasma-15)
dobj(decrease-13, levels-16)
conj_and(levels-16, efficacy-18)
det(antidepressants-21, the-20)
prep_of(levels-16, antidepressants-21)

Caution/NN is/VBZ advised/VBN if/IN patients/NNS receive/VBP large/JJ doses/NNS of/IN ethchlorvynol/NN concurrently/RB ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (VBZ is) (VP (VBN advised) (SBAR (IN if) (S (NP (NNS patients)) (VP (VBP receive) (NP (NP (JJ large) (NNS doses)) (PP (IN of) (NP (NN ethchlorvynol)))) (ADVP (RB concurrently)))))))) (. .))))

nsubjpass(advised-3, Caution-1)
auxpass(advised-3, is-2)
root(ROOT-0, advised-3)
mark(receive-6, if-4)
nsubj(receive-6, patients-5)
advcl(advised-3, receive-6)
amod(doses-8, large-7)
dobj(receive-6, doses-8)
prep_of(doses-8, ethchlorvynol-10)
advmod(receive-6, concurrently-11)

Transient/JJ delirium/NN has/VBZ been/VBN reported/VBN in/IN patients/NNS who/WP were/VBD treated/VBN with/IN one/CD gram/NN of/IN ethchlorvynol/NN and/CC 75/CD -/: 150/CD mg/NN of/IN amitriptyline/NN HCl/NN ./.

(ROOT (S1 (S (S (NP (JJ Transient) (NN delirium)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (CD one) (NN gram)) (PP (IN of) (NP (NP (NN ethchlorvynol)) (CC and) (NP (NP (CD 75) (: -) (CD 150) (NN mg)) (PP (IN of) (NP (NN amitriptyline) (NN HCl)))))))))))))))))) (. .))))

amod(delirium-2, Transient-1)
nsubjpass(reported-5, delirium-2)
aux(reported-5, has-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
prep_in(reported-5, patients-7)
nsubjpass(treated-10, patients-7)
auxpass(treated-10, were-9)
rcmod(patients-7, treated-10)
num(gram-13, one-12)
prep_with(treated-10, gram-13)
prep_of(gram-13, ethchlorvynol-15)
num(mg-20, 75-17)
num(mg-20, 150-19)
conj_and(ethchlorvynol-15, mg-20)
nn(HCl-23, amitriptyline-22)
prep_of(mg-20, HCl-23)

Paralytic/JJ ileus/NN may/MD occur/VB in/IN patients/NNS taking/VBG tricyclic/JJ antidepressants/NNS in/IN combination/NN with/IN anticholinergic/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (JJ Paralytic) (NN ileus)) (VP (MD may) (VP (VB occur) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (JJ tricyclic) (NNS antidepressants)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ anticholinergic) (NNS drugs))))))))))) (. .))))

amod(ileus-2, Paralytic-1)
nsubj(occur-4, ileus-2)
aux(occur-4, may-3)
root(ROOT-0, occur-4)
prep_in(occur-4, patients-6)
partmod(patients-6, taking-7)
amod(antidepressants-9, tricyclic-8)
dobj(taking-7, antidepressants-9)
prep_in(taking-7, combination-11)
amod(drugs-14, anticholinergic-13)
prep_with(combination-11, drugs-14)

Amoxapine/NN may/MD enhance/VB the/DT response/NN to/TO alcohol/NN and/CC the/DT effects/NNS of/IN barbiturates/NNS and/CC other/JJ CNS/NN depressants/NNS ./.

(ROOT (S1 (S (S (NP (NN Amoxapine)) (VP (MD may) (VP (VB enhance) (NP (NP (NP (DT the) (NN response)) (PP (TO to) (NP (NN alcohol)))) (CC and) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NNS barbiturates)) (CC and) (NP (JJ other) (NN CNS) (NNS depressants))))))))) (. .))))

nsubj(enhance-3, Amoxapine-1)
aux(enhance-3, may-2)
root(ROOT-0, enhance-3)
det(response-5, the-4)
dobj(enhance-3, response-5)
prep_to(response-5, alcohol-7)
det(effects-10, the-9)
conj_and(response-5, effects-10)
prep_of(effects-10, barbiturates-12)
amod(depressants-16, other-14)
nn(depressants-16, CNS-15)
conj_and(barbiturates-12, depressants-16)

Serum/NN levels/NNS of/IN several/JJ tricyclic/JJ antidepressants/NNS have/VBP been/VBN reported/VBN to/TO be/VB significantly/RB increased/VBN when/WRB cimetidine/NN is/VBZ administered/VBN concurrently/RB Although/IN such/PDT an/DT interaction/NN has/VBZ not/RB been/VBN reported/VBN to/TO date/VB with/IN amoxapine/NN ,/, specific/JJ interaction/NN studies/NNS have/VBP not/RB been/VBN done/VBN ,/, and/CC the/DT possibility/NN should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Serum) (NNS levels)) (PP (IN of) (NP (JJ several) (JJ tricyclic) (NNS antidepressants)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (VP (ADVP (RB significantly)) (VBN increased) (SBAR (WHADVP (WRB when)) (S (NP (NN cimetidine)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concurrently)) (SBAR (IN Although) (S (S (NP (PDT such) (DT an) (NN interaction)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB date) (PP (IN with) (NP (NN amoxapine)))))))))) (, ,) (S (NP (JJ specific) (NN interaction) (NNS studies)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN done))))) (, ,) (CC and) (S (NP (DT the) (NN possibility)) (VP (MD should) (VP (VB be) (VP (VBN considered))))))))))))))))))) (. .))))

nn(levels-2, Serum-1)
nsubjpass(reported-9, levels-2)
xsubj(increased-13, levels-2)
amod(antidepressants-6, several-4)
amod(antidepressants-6, tricyclic-5)
prep_of(levels-2, antidepressants-6)
aux(reported-9, have-7)
auxpass(reported-9, been-8)
root(ROOT-0, reported-9)
aux(increased-13, to-10)
auxpass(increased-13, be-11)
advmod(increased-13, significantly-12)
xcomp(reported-9, increased-13)
advmod(administered-17, when-14)
nsubjpass(administered-17, cimetidine-15)
auxpass(administered-17, is-16)
advcl(increased-13, administered-17)
advmod(administered-17, concurrently-18)
mark(reported-26, Although-19)
predet(interaction-22, such-20)
det(interaction-22, an-21)
nsubjpass(reported-26, interaction-22)
aux(reported-26, has-23)
neg(reported-26, not-24)
auxpass(reported-26, been-25)
advcl(administered-17, reported-26)
aux(date-28, to-27)
xcomp(reported-26, date-28)
prep_with(date-28, amoxapine-30)
amod(studies-34, specific-32)
nn(studies-34, interaction-33)
nsubjpass(done-38, studies-34)
aux(done-38, have-35)
neg(done-38, not-36)
auxpass(done-38, been-37)
ccomp(reported-26, done-38)
conj_and(reported-26, done-38)
det(possibility-42, the-41)
nsubjpass(considered-45, possibility-42)
aux(considered-45, should-43)
auxpass(considered-45, be-44)
conj_and(reported-26, considered-45)

Drugs/NNS Metabolized/VBN by/IN P450/NN 2D6/NN ./.

(ROOT (S1 (S (S (NP (NNS Drugs)) (VP (VBN Metabolized) (PP (IN by) (NP (NN P450) (NN 2D6))))) (. .))))

nsubj(Metabolized-2, Drugs-1)
root(ROOT-0, Metabolized-2)
nn(2D6-5, P450-4)
prep_by(Metabolized-2, 2D6-5)

The/DT biochemical/JJ activity/NN of/IN the/DT drug/NN metabolizing/NN isozyme/NN cytochrome/NN P450/NN 2D6/NN (/-LRB- dehrisoquin/NN hydroxylase/NN )/-RRB- is/VBZ reduced/VBN in/IN a/DT subset/NN of/IN the/DT caucasian/NN population/NN (/-LRB- about/RB 7/CD to/TO 10/CD %/NN of/IN caucasians/NNS are/VBP so/RB called/VBN of/IN reduced/VBN P450/NN 2D6/NN isozyme/NN activity/NN among/IN p.o./NN metabolizers/NNS )/-RRB- ;/: ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ biochemical) (NN activity)) (PP (IN of) (NP (NP (DT the) (NN drug) (NN metabolizing) (NN isozyme) (NN cytochrome) (NN P450) (NN 2D6)) (PRN (-LRB- -LRB-) (NP (NN dehrisoquin) (NN hydroxylase)) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN reduced) (PP (IN in) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (DT the) (NN caucasian) (NN population))))) (PRN (-LRB- -LRB-) (S (NP (NP (QP (RB about) (CD 7) (TO to) (CD 10)) (NN %)) (PP (IN of) (NP (NNS caucasians)))) (VP (VBP are) (ADVP (RB so)) (VP (VBN called) (PP (IN of) (NP (NP (VBN reduced) (NN P450) (NN 2D6) (NN isozyme) (NN activity)) (PP (IN among) (NP (NN p.o.) (NNS metabolizers)))))))) (-RRB- -RRB-)))) (: ;)) (. .))))

det(activity-3, The-1)
amod(activity-3, biochemical-2)
nsubjpass(reduced-17, activity-3)
det(2D6-11, the-5)
nn(2D6-11, drug-6)
nn(2D6-11, metabolizing-7)
nn(2D6-11, isozyme-8)
nn(2D6-11, cytochrome-9)
nn(2D6-11, P450-10)
prep_of(activity-3, 2D6-11)
nn(hydroxylase-14, dehrisoquin-13)
appos(2D6-11, hydroxylase-14)
auxpass(reduced-17, is-16)
root(ROOT-0, reduced-17)
det(subset-20, a-19)
prep_in(reduced-17, subset-20)
det(population-24, the-22)
nn(population-24, caucasian-23)
prep_of(subset-20, population-24)
quantmod(10-29, about-26)
number(10-29, 7-27)
dep(10-29, to-28)
num(%-30, 10-29)
nsubjpass(called-35, %-30)
prep_of(%-30, caucasians-32)
auxpass(called-35, are-33)
advmod(called-35, so-34)
parataxis(reduced-17, called-35)
amod(activity-41, reduced-37)
nn(activity-41, P450-38)
nn(activity-41, 2D6-39)
nn(activity-41, isozyme-40)
prep_of(called-35, activity-41)
nn(metabolizers-44, p.o.-43)
prep_among(activity-41, metabolizers-44)

Poor/JJ metabolizers/NNS have/VBP higher/JJR than/IN expected/VBN plasma/NN concentrations/NNS tricyclic/JJ antidepressants/NNS (/-LRB- TCAs/NNS )/-RRB- when/WRB given/VBN usual/JJ doses/NNS ./.

(ROOT (S1 (S (S (NP (JJ Poor) (NNS metabolizers)) (VP (VBP have) (NP (NP (JJR higher) (IN than) (VBN expected) (NN plasma) (NNS concentrations)) (NP (NP (JJ tricyclic) (NNS antidepressants)) (PRN (-LRB- -LRB-) (NP (NNS TCAs)) (-RRB- -RRB-)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (NP (JJ usual) (NNS doses))))))) (. .))))

amod(metabolizers-2, Poor-1)
nsubj(have-3, metabolizers-2)
root(ROOT-0, have-3)
amod(concentrations-8, higher-4)
amod(concentrations-8, than-5)
amod(concentrations-8, expected-6)
nn(concentrations-8, plasma-7)
dobj(have-3, concentrations-8)
iobj(have-3, concentrations-8)
amod(antidepressants-10, tricyclic-9)
dobj(have-3, antidepressants-10)
dep(concentrations-8, antidepressants-10)
appos(antidepressants-10, TCAs-12)
advmod(given-15, when-14)
advcl(have-3, given-15)
amod(doses-17, usual-16)
dobj(given-15, doses-17)

Depending/VBG on/IN the/DT fraction/NN of/IN drug/NN metabolized/VBN by/IN P450/NN 2D6/NN ,/, the/DT increase/NN in/IN plasma/NN concentration/NN may/MD be/VB small/JJ ,/, or/CC quite/RB large/JJ (/-LRB- 8/CD fold/JJ increase/NN in/IN plasma/NN AUC/NN of/IN the/DT TCA/NN )./NN

(ROOT (S1 (S (PP (VBG Depending) (PP (IN on) (NP (NP (DT the) (NN fraction)) (PP (IN of) (NP (NP (NN drug)) (VP (VBN metabolized) (PP (IN by) (NP (NN P450) (NN 2D6))))))))) (, ,) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NN plasma) (NN concentration)))) (VP (MD may) (VP (VB be) (ADJP (ADJP (JJ small)) (, ,) (CC or) (RB quite) (ADJP (JJ large))))) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 8) (JJ fold)) (NN increase)) (PP (IN in) (NP (NP (NN plasma) (NN AUC)) (PP (IN of) (NP (DT the) (NN TCA) (NN -RRB-.))))))))))

prepc_depending_on(small-19, on-2)
det(fraction-4, the-3)
pobj(small-19, fraction-4)
prep_of(fraction-4, drug-6)
partmod(drug-6, metabolized-7)
nn(2D6-10, P450-9)
agent(metabolized-7, 2D6-10)
det(increase-13, the-12)
nsubj(small-19, increase-13)
nn(concentration-16, plasma-15)
prep_in(increase-13, concentration-16)
aux(small-19, may-17)
cop(small-19, be-18)
root(ROOT-0, small-19)
advmod(small-19, quite-22)
conj_or(small-19, quite-22)
dep(small-19, large-23)
number(fold-26, 8-25)
amod(increase-27, fold-26)
dep(small-19, increase-27)
nn(AUC-30, plasma-29)
prep_in(increase-27, AUC-30)
det(-RRB-.-34, the-32)
nn(-RRB-.-34, TCA-33)
prep_of(AUC-30, -RRB-.-34)

In/IN addition/NN certain/JJ drugs/NNS inhibit/VBP the/DT activity/NN of/IN this/DT isozyme/NN and/CC make/VBP normal/JJ metabolizers/NNS resemble/VBP p.o./NN metabolizers/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (NP (JJ certain) (NNS drugs)) (VP (VP (VBP inhibit) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT this) (NN isozyme))))) (CC and) (VP (VBP make) (NP (NP (JJ normal) (NNS metabolizers)) (VP (VBP resemble) (NP (NN p.o.) (NNS metabolizers))))))) (. .))))

prep_in(inhibit-5, addition-2)
amod(drugs-4, certain-3)
nsubj(inhibit-5, drugs-4)
root(ROOT-0, inhibit-5)
det(activity-7, the-6)
dobj(inhibit-5, activity-7)
det(isozyme-10, this-9)
prep_of(activity-7, isozyme-10)
conj_and(inhibit-5, make-12)
amod(metabolizers-14, normal-13)
dobj(make-12, metabolizers-14)
cop(metabolizers-17, resemble-15)
nn(metabolizers-17, p.o.-16)
dep(metabolizers-14, metabolizers-17)

An/DT individual/JJ who/WP is/VBZ stable/JJ on/IN a/DT given/JJ dose/NN of/IN TCA/NN may/MD become/VB abruptly/RB toxic/JJ when/WRB given/VBN one/CD of/IN these/DT inhibiting/JJ drugs/NNS as/IN concomitant/JJ therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (DT An) (JJ individual)) (SBAR (WHNP (WP who)) (S (VP (VBZ is) (ADJP (JJ stable) (PP (IN on) (NP (NP (DT a) (JJ given) (NN dose)) (PP (IN of) (NP (NN TCA)))))))))) (VP (MD may) (VP (VB become) (ADJP (RB abruptly) (JJ toxic)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT these) (JJ inhibiting) (NNS drugs)) (PP (IN as) (NP (JJ concomitant) (NN therapy)))))))))))) (. .))))

det(individual-2, An-1)
nsubj(stable-5, individual-2)
nsubj(toxic-15, individual-2)
cop(stable-5, is-4)
rcmod(individual-2, stable-5)
det(dose-9, a-7)
amod(dose-9, given-8)
prep_on(stable-5, dose-9)
prep_of(dose-9, TCA-11)
aux(toxic-15, may-12)
cop(toxic-15, become-13)
advmod(toxic-15, abruptly-14)
root(ROOT-0, toxic-15)
advmod(given-17, when-16)
advcl(toxic-15, given-17)
dobj(given-17, one-18)
det(drugs-22, these-20)
amod(drugs-22, inhibiting-21)
prep_of(one-18, drugs-22)
amod(therapy-25, concomitant-24)
prep_as(drugs-22, therapy-25)

The/DT drugs/NNS that/WDT inhibit/VBP cytochrome/NN P450/NN 2D6/NN include/VBP some/DT that/WDT are/VBP not/RB metabolized/VBN by/IN the/DT enzymes/NNS quinidine/NN ,/, cimetidine/NN ,/, and/CC many/JJ that/WDT are/VBP substrates/NNS for/IN P450/NN 2D6/NN (/-LRB- many/JJ other/JJ antidepressants/NNS ,/, phenothiazines/NNS ,/, and/CC the/DT Type/NN 1C/NN antiarrhythmics/NNS propafenone/NN and/CC flecainide/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (NN cytochrome) (NN P450) (NN 2D6)))))) (VP (VBP include) (NP (NP (DT some)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (RB not) (VP (VBN metabolized) (PP (IN by) (NP (NP (DT the) (NNS enzymes) (NP (NP (NN quinidine)) (, ,) (NP (NN cimetidine)) (, ,) (CC and) (NP (JJ many)))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NNS substrates)) (PP (IN for) (NP (NP (NN P450) (NN 2D6)) (PRN (-LRB- -LRB-) (NP (NP (JJ many) (JJ other) (NNS antidepressants)) (, ,) (NP (NNS phenothiazines)) (, ,) (CC and) (NP (DT the) (NN Type) (NN 1C) (NNS antiarrhythmics) (NP (NP (NN propafenone)) (CC and) (NP (NN flecainide))))) (-RRB- -RRB-))))))))))))))))) (. .))))

det(drugs-2, The-1)
nsubj(inhibit-4, drugs-2)
nsubj(include-8, drugs-2)
rcmod(drugs-2, inhibit-4)
nn(2D6-7, cytochrome-5)
nn(2D6-7, P450-6)
dobj(inhibit-4, 2D6-7)
root(ROOT-0, include-8)
dobj(include-8, some-9)
nsubjpass(metabolized-13, some-9)
auxpass(metabolized-13, are-11)
neg(metabolized-13, not-12)
rcmod(some-9, metabolized-13)
det(enzymes-16, the-15)
agent(metabolized-13, enzymes-16)
nsubj(substrates-25, enzymes-16)
dep(enzymes-16, quinidine-17)
conj_and(quinidine-17, cimetidine-19)
conj_and(quinidine-17, many-22)
cop(substrates-25, are-24)
rcmod(enzymes-16, substrates-25)
nn(2D6-28, P450-27)
prep_for(substrates-25, 2D6-28)
amod(antidepressants-32, many-30)
amod(antidepressants-32, other-31)
dep(2D6-28, antidepressants-32)
conj_and(antidepressants-32, phenothiazines-34)
det(antiarrhythmics-40, the-37)
nn(antiarrhythmics-40, Type-38)
nn(antiarrhythmics-40, 1C-39)
conj_and(antidepressants-32, antiarrhythmics-40)
dep(antiarrhythmics-40, propafenone-41)
conj_and(propafenone-41, flecainide-43)

While/IN all/PDT the/DT selective/JJ serotonin/NN reuptake/NN inhibitors/NNS (/-LRB- SSRls/NN )/-RRB- ,/, e.g./FW fluoxetine/NN ,/, sertraline/NN ,/, and/CC paroxetine/NN inhibit/VBP P450/NN 2D6/NN ,/, they/PRP may/MD vary/VB in/IN the/DT extent/NN of/IN inhibition/NN ./.

(ROOT (S1 (S (S (SBAR (IN While) (S (NP (NP (NP (PDT all) (DT the) (JJ selective) (NN serotonin) (NN reuptake) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NN SSRls)) (-RRB- -RRB-))) (, ,) (PP (FW e.g.) (NP (NP (NN fluoxetine)) (, ,) (NP (NN sertraline)) (, ,) (CC and) (NP (NN paroxetine))))) (VP (VBP inhibit) (NP (NN P450) (NN 2D6))))) (, ,) (NP (PRP they)) (VP (MD may) (VP (VB vary) (PP (IN in) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NN inhibition)))))))) (. .))))

mark(inhibit-19, While-1)
predet(inhibitors-7, all-2)
det(inhibitors-7, the-3)
amod(inhibitors-7, selective-4)
nn(inhibitors-7, serotonin-5)
nn(inhibitors-7, reuptake-6)
nsubj(inhibit-19, inhibitors-7)
abbrev(inhibitors-7, SSRls-9)
prep(inhibitors-7, e.g.-12)
pobj(e.g.-12, fluoxetine-13)
conj_and(fluoxetine-13, sertraline-15)
conj_and(fluoxetine-13, paroxetine-18)
advcl(vary-25, inhibit-19)
nn(2D6-21, P450-20)
dobj(inhibit-19, 2D6-21)
nsubj(vary-25, they-23)
aux(vary-25, may-24)
root(ROOT-0, vary-25)
det(extent-28, the-27)
prep_in(vary-25, extent-28)
prep_of(extent-28, inhibition-30)

Sufficient/JJ time/NN must/MD elapse/VB before/IN initiating/VBG TCA/NN treatment/NN in/IN a/DT patient/NN being/VBG withdrawn/NN from/IN fluoxetine/NN given/VBN ./.

(ROOT (S1 (S (S (NP (JJ Sufficient) (NN time)) (VP (MD must) (VP (VB elapse) (PP (IN before) (S (VP (VBG initiating) (NP (NN TCA) (NN treatment)) (PP (IN in) (NP (NP (DT a) (NN patient)) (VP (VBG being) (NP (NP (NN withdrawn)) (PP (IN from) (NP (NP (NN fluoxetine)) (VP (VBN given)))))))))))))) (. .))))

amod(time-2, Sufficient-1)
nsubj(elapse-4, time-2)
aux(elapse-4, must-3)
root(ROOT-0, elapse-4)
prepc_before(elapse-4, initiating-6)
nn(treatment-8, TCA-7)
dobj(initiating-6, treatment-8)
det(patient-11, a-10)
prep_in(initiating-6, patient-11)
cop(withdrawn-13, being-12)
partmod(patient-11, withdrawn-13)
prep_from(withdrawn-13, fluoxetine-15)
partmod(fluoxetine-15, given-16)

The/DT long/JJ half-life/NN of/IN the/DT parent/JJ and/CC active/JJ metabolite/NN (/-LRB- at/IN least/JJS 5/CD weeks/NNS may/MD be/VB necessary/JJ )./NN

(ROOT (S1 (S (NP (NP (DT The) (JJ long) (NN half-life)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ parent)) (CC and) (ADJP (JJ active))) (NN metabolite) (-LRB- -LRB-) (QP (IN at) (JJS least) (CD 5)) (NNS weeks)))) (VP (MD may) (VP (VB be) (NP (JJ necessary) (NN -RRB-.)))))))

det(half-life-3, The-1)
amod(half-life-3, long-2)
nsubj(-RRB-.-18, half-life-3)
det(weeks-14, the-5)
amod(weeks-14, parent-6)
conj_and(parent-6, active-8)
nn(weeks-14, metabolite-9)
quantmod(5-13, at-11)
mwe(at-11, least-12)
pobj(at-11, least-12)
num(weeks-14, 5-13)
prep_of(half-life-3, weeks-14)
aux(-RRB-.-18, may-15)
cop(-RRB-.-18, be-16)
amod(-RRB-.-18, necessary-17)
root(ROOT-0, -RRB-.-18)

Concomitant/JJ use/NN of/IN tricyclic/JJ antidepressants/NNS with/IN drugs/NNS that/WDT can/MD inhibit/VB cytochrome/NN P450/NN 2D6/NN may/MD require/VB lower/JJR doses/NNS than/IN usually/RB prescribed/VBN for/IN either/CC the/DT tricyclic/JJ antidepressant/JJ or/CC the/DT other/JJ drug/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (JJ tricyclic) (NNS antidepressants)) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB inhibit) (NP (NN cytochrome) (NN P450) (NN 2D6))))))))))) (VP (MD may) (VP (VB require) (NP (NP (JJR lower) (NNS doses)) (VP (ADVP (IN than) (RB usually)) (VBN prescribed) (PP (IN for) (NP (CC either) (NP (DT the) (JJ tricyclic) (JJ antidepressant)) (CC or) (NP (DT the) (JJ other) (NN drug))))))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(require-15, use-2)
amod(antidepressants-5, tricyclic-4)
prep_of(use-2, antidepressants-5)
prep_with(antidepressants-5, drugs-7)
nsubj(inhibit-10, drugs-7)
aux(inhibit-10, can-9)
rcmod(drugs-7, inhibit-10)
nn(2D6-13, cytochrome-11)
nn(2D6-13, P450-12)
dobj(inhibit-10, 2D6-13)
aux(require-15, may-14)
root(ROOT-0, require-15)
amod(doses-17, lower-16)
dobj(require-15, doses-17)
advmod(prescribed-20, than-18)
advmod(than-18, usually-19)
partmod(doses-17, prescribed-20)
preconj(antidepressant-25, either-22)
det(antidepressant-25, the-23)
amod(antidepressant-25, tricyclic-24)
prep_for(prescribed-20, antidepressant-25)
det(drug-29, the-27)
amod(drug-29, other-28)
conj_or(antidepressant-25, drug-29)

Furthermore/RB ,/, whenever/RB one/CD of/IN these/DT other/JJ drugs/NNS is/VBZ withdrawn/VBN from/IN co-therapy/NN ,/, an/DT increased/VBN dose/NN of/IN tricyclic/JJ antidepressant/JJ may/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Furthermore)) (, ,) (S (ADVP (RB whenever)) (NP (NP (CD one)) (PP (IN of) (NP (DT these) (JJ other) (NNS drugs)))) (VP (VBZ is) (VP (VBN withdrawn) (PP (IN from) (NP (NN co-therapy)))))) (, ,) (NP (NP (DT an) (VBN increased) (NN dose)) (PP (IN of) (NP (JJ tricyclic) (JJ antidepressant)))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (. .))))

advmod(required-22, Furthermore-1)
advmod(withdrawn-10, whenever-3)
nsubjpass(withdrawn-10, one-4)
det(drugs-8, these-6)
amod(drugs-8, other-7)
prep_of(one-4, drugs-8)
auxpass(withdrawn-10, is-9)
ccomp(required-22, withdrawn-10)
prep_from(withdrawn-10, co-therapy-12)
det(dose-16, an-14)
amod(dose-16, increased-15)
nsubjpass(required-22, dose-16)
amod(antidepressant-19, tricyclic-18)
prep_of(dose-16, antidepressant-19)
aux(required-22, may-20)
auxpass(required-22, be-21)
root(ROOT-0, required-22)

It/PRP is/VBZ desirable/JJ to/TO monitor/VB TCA/NN plasma/NN levels/NNS whenever/RB a/DT TCA/NN is/VBZ going/JJ to/TO be/VB co-administered/VBN with/IN another/DT drug/NN known/VBN to/TO be/VB an/DT inhibitor/NN of/IN P450/NN 2D6/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ desirable)) (S (VP (TO to) (VP (VB monitor) (NP (NN TCA) (NN plasma) (NNS levels)) (S (ADVP (RB whenever)) (NP (DT a) (NN TCA)) (VP (VBZ is) (ADJP (JJ going) (S (VP (TO to) (VP (VB be) (VP (VBN co-administered) (PP (IN with) (NP (NP (DT another) (NN drug)) (VP (VBN known) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN P450) (NN 2D6)))))))))))))))))))))) (. .))))

nsubj(desirable-3, It-1)
xsubj(monitor-5, It-1)
cop(desirable-3, is-2)
root(ROOT-0, desirable-3)
aux(monitor-5, to-4)
xcomp(desirable-3, monitor-5)
nn(levels-8, TCA-6)
nn(levels-8, plasma-7)
dobj(monitor-5, levels-8)
advmod(going-13, whenever-9)
det(TCA-11, a-10)
nsubj(going-13, TCA-11)
cop(going-13, is-12)
dep(monitor-5, going-13)
aux(co-administered-16, to-14)
auxpass(co-administered-16, be-15)
xcomp(going-13, co-administered-16)
det(drug-19, another-18)
prep_with(co-administered-16, drug-19)
partmod(drug-19, known-20)
aux(inhibitor-24, to-21)
cop(inhibitor-24, be-22)
det(inhibitor-24, an-23)
xcomp(known-20, inhibitor-24)
nn(2D6-27, P450-26)
prep_of(inhibitor-24, 2D6-27)

Acidifying/JJ agents/NNS -/CC Gastrointestinal/JJ acidifying/JJ agents/NNS (/-LRB- guanethidine/NN ,/, reserpine/NN ,/, glutamic/JJ acid/NN HCl/NN ,/, ascorbic/JJ acid/NN ,/, fruit/NN juices/NNS ,/, etc./NN )/-RRB- lower/JJR absorption/NN of/IN amphetamines/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Acidifying) (NNS agents)) (CC -) (NP (NP (JJ Gastrointestinal) (JJ acidifying) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NP (NN guanethidine)) (, ,) (NP (NN reserpine)) (, ,) (NP (NP (JJ glutamic) (NN acid)) (NN HCl)) (, ,) (NP (JJ ascorbic) (NN acid)) (, ,) (NP (NN fruit) (NNS juices)) (, ,) (NP (NN etc.))) (-RRB- -RRB-)))) (VP (JJR lower) (NP (NP (NN absorption)) (PP (IN of) (NP (NN amphetamines)))))) (. .))))

amod(agents-2, Acidifying-1)
nsubj(absorption-25, agents-2)
amod(agents-6, Gastrointestinal-4)
amod(agents-6, acidifying-5)
conj(agents-2, agents-6)
dep(agents-6, guanethidine-8)
appos(guanethidine-8, reserpine-10)
amod(acid-13, glutamic-12)
nn(HCl-14, acid-13)
appos(guanethidine-8, HCl-14)
amod(acid-17, ascorbic-16)
appos(guanethidine-8, acid-17)
nn(juices-20, fruit-19)
appos(guanethidine-8, juices-20)
appos(guanethidine-8, etc.-22)
dep(absorption-25, lower-24)
root(ROOT-0, absorption-25)
prep_of(absorption-25, amphetamines-27)

Urinary/JJ acidifying/JJ agents/NNS -/: (/-LRB- ammonium/NN chloride/NN ,/, sodium/NN acid/NN phosphate/NN ,/, etc./NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (JJ Urinary) (JJ acidifying) (NNS agents)) (: -) (S (PRN (-LRB- -LRB-) (NP (NP (NN ammonium) (NN chloride)) (, ,) (NP (NN sodium) (NN acid) (NN phosphate)) (, ,) (NP (NN etc.))) (-RRB- -RRB-)))) (. .))))

amod(agents-3, Urinary-1)
amod(agents-3, acidifying-2)
dep(chloride-7, agents-3)
nn(chloride-7, ammonium-6)
root(ROOT-0, chloride-7)
nn(phosphate-11, sodium-9)
nn(phosphate-11, acid-10)
appos(chloride-7, phosphate-11)
appos(chloride-7, etc.-13)

Increase/VBP the/DT concentration/NN of/IN the/DT ionized/VBN species/NNS of/IN the/DT amphetamine/NN ./.

(ROOT (S1 (S (S (VP (VBP Increase) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NP (DT the) (VBN ionized) (NNS species)) (PP (IN of) (NP (DT the) (NN amphetamine)))))))) (. .))))

root(ROOT-0, Increase-1)
det(concentration-3, the-2)
dobj(Increase-1, concentration-3)
det(species-7, the-5)
amod(species-7, ionized-6)
prep_of(concentration-3, species-7)
det(amphetamine-10, the-9)
prep_of(species-7, amphetamine-10)

Primary/JJ excretion/NN -/CC Both/DT Groups/NNS of/IN agents/NNS lower/JJR blood/NN levels/NNS and/CC efficacy/NN of/IN amphetamines/NN ./.

(ROOT (S1 (S (S (NP (NP (ADJP (NP (NP (JJ Primary) (NN excretion)) (CC -) (NP (NP (DT Both) (NNS Groups)) (PP (IN of) (NP (NNS agents))))) (JJR lower)) (NN blood) (NNS levels)) (CC and) (NP (NP (NN efficacy)) (PP (IN of) (NP (NN amphetamines)))))) (. .))))

amod(excretion-2, Primary-1)
npadvmod(lower-8, excretion-2)
det(Groups-5, Both-4)
conj(excretion-2, Groups-5)
prep_of(Groups-5, agents-7)
amod(levels-10, lower-8)
nn(levels-10, blood-9)
root(ROOT-0, levels-10)
conj_and(levels-10, efficacy-12)
prep_of(efficacy-12, amphetamines-14)

Adrenergic/JJ blockers/NNS -/CC Adrenergic/JJ blockers/NNS are/VBP inhibited/VBN by/IN amphetamines/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Adrenergic) (NNS blockers)) (CC -) (NP (JJ Adrenergic) (NNS blockers))) (VP (VBP are) (VP (VBN inhibited) (PP (IN by) (NP (NN amphetamines)))))) (. .))))

amod(blockers-2, Adrenergic-1)
nsubjpass(inhibited-7, blockers-2)
amod(blockers-5, Adrenergic-4)
conj(blockers-2, blockers-5)
auxpass(inhibited-7, are-6)
root(ROOT-0, inhibited-7)
agent(inhibited-7, amphetamines-9)

Alkalinizing/NN agents/NNS -Gastrointestinal/JJ alkalinizing/NN agents/NNS (/-LRB- sodium/NN bicarbonate/NN ,/, etc./NN )/-RRB- increase/VBP absorption/NN of/IN amphetamines/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Alkalinizing) (NNS agents) (JJ -Gastrointestinal) (NN alkalinizing) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NP (NN sodium) (NN bicarbonate)) (, ,) (NP (NN etc.))) (-RRB- -RRB-))) (VP (VBP increase) (NP (NP (NN absorption)) (PP (IN of) (NP (NN amphetamines)))))) (. .))))

nn(agents-5, Alkalinizing-1)
nn(agents-5, agents-2)
amod(agents-5, -Gastrointestinal-3)
nn(agents-5, alkalinizing-4)
nsubj(increase-12, agents-5)
nn(bicarbonate-8, sodium-7)
dep(agents-5, bicarbonate-8)
appos(bicarbonate-8, etc.-10)
root(ROOT-0, increase-12)
dobj(increase-12, absorption-13)
prep_of(absorption-13, amphetamines-15)

Urinary/JJ alkalinizing/NN agents/NNS (/-LRB- acetazolamide/NN ,/, some/DT thiazides/NNS )/-RRB- increase/VBP the/DT concentration/NN of/IN the/DT non-ionized/JJ species/NNS of/IN the/DT amphetamine/NN molecule/NN ,/, thereby/RB decreasing/VBG urinary/JJ excretion/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Urinary) (NN alkalinizing) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NP (NN acetazolamide)) (, ,) (NP (DT some) (NNS thiazides))) (-RRB- -RRB-))) (VP (VBP increase) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NP (DT the) (JJ non-ionized) (NNS species)) (PP (IN of) (NP (DT the) (NN amphetamine) (NN molecule)))))) (, ,) (S (ADVP (RB thereby)) (VP (VBG decreasing) (NP (JJ urinary) (NN excretion)))))) (. .))))

amod(agents-3, Urinary-1)
nn(agents-3, alkalinizing-2)
nsubj(increase-10, agents-3)
dep(agents-3, acetazolamide-5)
det(thiazides-8, some-7)
appos(acetazolamide-5, thiazides-8)
root(ROOT-0, increase-10)
det(concentration-12, the-11)
dobj(increase-10, concentration-12)
det(species-16, the-14)
amod(species-16, non-ionized-15)
prep_of(concentration-12, species-16)
det(molecule-20, the-18)
nn(molecule-20, amphetamine-19)
prep_of(species-16, molecule-20)
advmod(decreasing-23, thereby-22)
partmod(increase-10, decreasing-23)
xcomp(increase-10, decreasing-23)
amod(excretion-25, urinary-24)
dobj(decreasing-23, excretion-25)

Both/CC groups/NNS of/IN agents/NNS increase/VBP blood/NN levels/NNS and/CC therefore/RB potentate/VBP the/DT actions/NNS of/IN amphetamines/NN ./.

(ROOT (S1 (S (S (NP (NP (CC Both) (NNS groups)) (PP (IN of) (NP (NNS agents)))) (VP (VP (VBP increase) (NP (NN blood) (NNS levels))) (CC and) (ADVP (RB therefore)) (VP (VBP potentate) (NP (NP (DT the) (NNS actions)) (PP (IN of) (NP (NN amphetamines))))))) (. .))))

dep(groups-2, Both-1)
nsubj(increase-5, groups-2)
prep_of(groups-2, agents-4)
root(ROOT-0, increase-5)
nn(levels-7, blood-6)
dobj(increase-5, levels-7)
advmod(increase-5, therefore-9)
conj_and(increase-5, therefore-9)
conj_and(increase-5, potentate-10)
det(actions-12, the-11)
dobj(potentate-10, actions-12)
prep_of(actions-12, amphetamines-14)

Antidepressants/NNS ,/, tricyclic/JJ -/CC Amphetamines/NNS may/MD enhance/VB the/DT activity/NN of/IN tricyclic/JJ or/CC sympathomimetic/JJ agents/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NP (NNS Antidepressants)) (, ,) (NP (ADJP (JJ tricyclic))) (CC -) (NP (NNS Amphetamines))) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (ADJP (ADJP (JJ tricyclic)) (CC or) (ADJP (JJ sympathomimetic))) (NNS agents)))))) (: ;)) (. .))))

nsubj(enhance-7, Antidepressants-1)
conj(Antidepressants-1, tricyclic-3)
conj(Antidepressants-1, Amphetamines-5)
aux(enhance-7, may-6)
root(ROOT-0, enhance-7)
det(activity-9, the-8)
dobj(enhance-7, activity-9)
amod(agents-14, tricyclic-11)
conj_or(tricyclic-11, sympathomimetic-13)
prep_of(activity-9, agents-14)

d-amphetamine/NN with/IN desipramine/NN or/CC protriptyline/NN and/CC possibly/RB other/JJ tricyclics/NNS cause/VBP striking/JJ and/CC sustained/JJ increases/NNS in/IN the/DT concentration/NN of/IN d-amphetamine/NN in/IN the/DT brain/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NP (NN d-amphetamine)) (PP (IN with) (NP (NP (NN desipramine)) (CC or) (NP (NN protriptyline))))) (CC and) (ADVP (RB possibly)) (NP (JJ other) (NNS tricyclics))) (VP (VBP cause) (NP (NP (ADJP (ADJP (JJ striking)) (CC and) (ADJP (JJ sustained))) (NNS increases)) (PP (IN in) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NN d-amphetamine))) (PP (IN in) (NP (DT the) (NN brain))))))) (: ;)) (. .))))

nsubj(cause-10, d-amphetamine-1)
prep_with(d-amphetamine-1, desipramine-3)
conj_or(desipramine-3, protriptyline-5)
advmod(d-amphetamine-1, possibly-7)
conj_and(d-amphetamine-1, possibly-7)
amod(tricyclics-9, other-8)
conj_and(d-amphetamine-1, tricyclics-9)
root(ROOT-0, cause-10)
amod(increases-14, striking-11)
conj_and(striking-11, sustained-13)
dobj(cause-10, increases-14)
det(concentration-17, the-16)
prep_in(increases-14, concentration-17)
prep_of(concentration-17, d-amphetamine-19)
det(brain-22, the-21)
prep_in(concentration-17, brain-22)

MAO/NN inhibitors/NNS -/CC MAO/NN antidepressants/NNS ,/, as/RB well/RB as/IN a/DT metabolite/NN of/IN furazolidone/NN ,/, slow/JJ amphetamine/NN metabolism/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN MAO) (NNS inhibitors)) (CC -) (NP (NN MAO) (NNS antidepressants))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT a) (NN metabolite)) (PP (IN of) (NP (NN furazolidone)))) (, ,)) (NP (JJ slow) (NN amphetamine) (NN metabolism))) (. .))))

nn(inhibitors-2, MAO-1)
dep(metabolism-17, inhibitors-2)
nn(antidepressants-5, MAO-4)
conj_and(inhibitors-2, antidepressants-5)
det(metabolite-11, a-10)
conj_and(inhibitors-2, metabolite-11)
prep_of(metabolite-11, furazolidone-13)
amod(metabolism-17, slow-15)
nn(metabolism-17, amphetamine-16)
root(ROOT-0, metabolism-17)

This/DT slowing/NN potentiates/VBZ amphetamines/NN ,/, increasing/VBG their/PRP$ effect/NN on/IN the/DT release/NN of/IN norepinephrine/NN and/CC other/JJ monoamines/NNS from/IN adrenergic/JJ nerve/NN endings/NNS ,/, this/DT can/MD cause/VB headaches/NNS and/CC other/JJ signs/NNS of/IN hypertensive/JJ crisis/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN slowing)) (VP (VBZ potentiates) (NP (NN amphetamines)) (, ,) (S (VP (VBG increasing) (NP (NP (PRP$ their) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (NP (NN norepinephrine)) (CC and) (NP (JJ other) (NNS monoamines)))) (PP (IN from) (NP (JJ adrenergic) (NN nerve) (NNS endings)))))))))) (, ,) (S (NP (DT this)) (VP (MD can) (VP (VB cause) (NP (NP (NP (NNS headaches)) (CC and) (NP (JJ other) (NNS signs))) (PP (IN of) (NP (JJ hypertensive) (NN crisis))))))) (. .))))

det(slowing-2, This-1)
nsubj(potentiates-3, slowing-2)
root(ROOT-0, potentiates-3)
dobj(potentiates-3, amphetamines-4)
partmod(potentiates-3, increasing-6)
xcomp(potentiates-3, increasing-6)
poss(effect-8, their-7)
dobj(increasing-6, effect-8)
det(release-11, the-10)
prep_on(effect-8, release-11)
prep_of(release-11, norepinephrine-13)
amod(monoamines-16, other-15)
conj_and(norepinephrine-13, monoamines-16)
amod(endings-20, adrenergic-18)
nn(endings-20, nerve-19)
prep_from(release-11, endings-20)
nsubj(cause-24, this-22)
aux(cause-24, can-23)
ccomp(potentiates-3, cause-24)
dobj(cause-24, headaches-25)
amod(signs-28, other-27)
conj_and(headaches-25, signs-28)
amod(crisis-31, hypertensive-30)
prep_of(headaches-25, crisis-31)

Antihistamines/NNS -/CC Amphetamines/NNS may/MD counteract/VB the/DT sedative/JJ effect/NN of/IN antihistamines/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Antihistamines)) (CC -) (NP (NNS Amphetamines))) (VP (MD may) (VP (VB counteract) (NP (NP (DT the) (JJ sedative) (NN effect)) (PP (IN of) (NP (NNS antihistamines))))))) (. .))))

nsubj(counteract-5, Antihistamines-1)
conj(Antihistamines-1, Amphetamines-3)
aux(counteract-5, may-4)
root(ROOT-0, counteract-5)
det(effect-8, the-6)
amod(effect-8, sedative-7)
dobj(counteract-5, effect-8)
prep_of(effect-8, antihistamines-10)

Antihypertensives/NNS -/CC Amphetamines/NNS may/MD antagonize/VB the/DT hypotensive/JJ effects/NNS of/IN antihypertensives/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Antihypertensives)) (CC -) (NP (NNS Amphetamines))) (VP (MD may) (VP (VB antagonize) (NP (NP (DT the) (JJ hypotensive) (NNS effects)) (PP (IN of) (NP (NNS antihypertensives))))))) (. .))))

nsubj(antagonize-5, Antihypertensives-1)
conj(Antihypertensives-1, Amphetamines-3)
aux(antagonize-5, may-4)
root(ROOT-0, antagonize-5)
det(effects-8, the-6)
amod(effects-8, hypotensive-7)
dobj(antagonize-5, effects-8)
prep_of(effects-8, antihypertensives-10)

Chlorpromazine/NN -/CC Chlorpromazine/NN blocks/VBZ dopamine/NN and/CC norepinephrine/NN receptors/NNS ,/, thus/RB inhibiting/VBG the/DT central/JJ stimulant/JJ effects/NNS of/IN amphetamines/NN ,/, and/CC can/MD be/VB used/VBN to/TO treat/VB amphetamine/NN poisoning/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Chlorpromazine)) (CC -) (NP (NN Chlorpromazine))) (VP (VP (VBZ blocks) (NP (NP (NP (NN dopamine)) (CC and) (NP (NN norepinephrine))) (NNS receptors)) (, ,) (S (ADVP (RB thus)) (VP (VBG inhibiting) (NP (NP (DT the) (JJ central) (JJ stimulant) (NNS effects)) (PP (IN of) (NP (NN amphetamines))))))) (, ,) (CC and) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (NN amphetamine) (NN poisoning)))))))))) (. .))))

nsubj(blocks-4, Chlorpromazine-1)
conj(Chlorpromazine-1, Chlorpromazine-3)
root(ROOT-0, blocks-4)
nn(receptors-8, dopamine-5)
conj_and(dopamine-5, norepinephrine-7)
dobj(blocks-4, receptors-8)
advmod(inhibiting-11, thus-10)
partmod(blocks-4, inhibiting-11)
xcomp(blocks-4, inhibiting-11)
det(effects-15, the-12)
amod(effects-15, central-13)
amod(effects-15, stimulant-14)
dobj(inhibiting-11, effects-15)
prep_of(effects-15, amphetamines-17)
aux(used-22, can-20)
auxpass(used-22, be-21)
conj_and(blocks-4, used-22)
aux(treat-24, to-23)
xcomp(used-22, treat-24)
nn(poisoning-26, amphetamine-25)
dobj(treat-24, poisoning-26)

Ethosuximide/NN -/CC Amphetamines/NN may/MD delay/VB intestinal/JJ absorption/NN of/IN ethosuximide/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Ethosuximide)) (CC -) (NP (NN Amphetamines))) (VP (MD may) (VP (VB delay) (NP (NP (JJ intestinal) (NN absorption)) (PP (IN of) (NP (NN ethosuximide))))))) (. .))))

nsubj(delay-5, Ethosuximide-1)
conj(Ethosuximide-1, Amphetamines-3)
aux(delay-5, may-4)
root(ROOT-0, delay-5)
amod(absorption-7, intestinal-6)
dobj(delay-5, absorption-7)
prep_of(absorption-7, ethosuximide-9)

Haloperidol/NN -/CC Haloperidol/NN blocks/VBZ dopamine/NN receptors/NNS ,/, thus/RB inhibiting/VBG the/DT central/JJ stimulant/NN effects/NNS of/IN amphetamines/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Haloperidol)) (CC -) (NP (NN Haloperidol))) (VP (VBZ blocks) (NP (NN dopamine) (NNS receptors)) (, ,) (S (ADVP (RB thus)) (VP (VBG inhibiting) (NP (NP (DT the) (JJ central) (NN stimulant) (NNS effects)) (PP (IN of) (NP (NN amphetamines)))))))) (. .))))

nsubj(blocks-4, Haloperidol-1)
conj(Haloperidol-1, Haloperidol-3)
root(ROOT-0, blocks-4)
nn(receptors-6, dopamine-5)
dobj(blocks-4, receptors-6)
advmod(inhibiting-9, thus-8)
partmod(blocks-4, inhibiting-9)
xcomp(blocks-4, inhibiting-9)
det(effects-13, the-10)
amod(effects-13, central-11)
nn(effects-13, stimulant-12)
dobj(inhibiting-9, effects-13)
prep_of(effects-13, amphetamines-15)

Lithium/NN carbonate/NN -/CC The/DT anorectic/JJ and/CC stimulatory/JJ effects/NNS of/IN amphetamines/NN may/MD be/VB inhibited/VBN by/IN lithium/NN carbonate/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Lithium) (NN carbonate)) (CC -) (NP (NP (DT The) (ADJP (ADJP (JJ anorectic)) (CC and) (ADJP (JJ stimulatory))) (NNS effects)) (PP (IN of) (NP (NN amphetamines))))) (VP (MD may) (VP (VB be) (VP (VBN inhibited) (PP (IN by) (NP (NN lithium) (NN carbonate))))))) (. .))))

nn(carbonate-2, Lithium-1)
nsubjpass(inhibited-13, carbonate-2)
det(effects-8, The-4)
amod(effects-8, anorectic-5)
conj_and(anorectic-5, stimulatory-7)
conj(carbonate-2, effects-8)
prep_of(effects-8, amphetamines-10)
aux(inhibited-13, may-11)
auxpass(inhibited-13, be-12)
root(ROOT-0, inhibited-13)
nn(carbonate-16, lithium-15)
agent(inhibited-13, carbonate-16)

Meperidine/NN -/CC Amphetamines/NN pone/VBP the/DT analgesic/JJ effect/NN of/IN meperidine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Meperidine)) (CC -) (NP (NN Amphetamines))) (VP (VBP pone) (NP (NP (DT the) (JJ analgesic) (NN effect)) (PP (IN of) (NP (NN meperidine)))))) (. .))))

nsubj(pone-4, Meperidine-1)
conj(Meperidine-1, Amphetamines-3)
root(ROOT-0, pone-4)
det(effect-7, the-5)
amod(effect-7, analgesic-6)
dobj(pone-4, effect-7)
prep_of(effect-7, meperidine-9)

Methenamine/JJ therapy/NN -/CC Urinary/JJ excretion/NN of/IN amphetamines/NN is/VBZ increased/VBN ,/, and/CC efficacy/NN is/VBZ reduced/VBN ,/, by/IN acidifying/VBG agents/NNS used/VBN in/IN methenamine/NN therapy/NN ./.

(ROOT (S1 (S (S (S (NP (NP (NP (JJ Methenamine) (NN therapy)) (CC -) (NP (JJ Urinary) (NN excretion))) (PP (IN of) (NP (NN amphetamines)))) (VP (VBZ is) (VP (VBN increased)))) (, ,) (CC and) (S (NP (NN efficacy)) (VP (VBZ is) (VP (VBN reduced) (, ,) (PP (IN by) (S (VP (VBG acidifying) (NP (NP (NNS agents)) (VP (VBN used) (PP (IN in) (NP (NN methenamine) (NN therapy)))))))))))) (. .))))

amod(therapy-2, Methenamine-1)
nsubjpass(increased-9, therapy-2)
amod(excretion-5, Urinary-4)
conj(therapy-2, excretion-5)
prep_of(therapy-2, amphetamines-7)
auxpass(increased-9, is-8)
root(ROOT-0, increased-9)
nsubjpass(reduced-14, efficacy-12)
auxpass(reduced-14, is-13)
conj_and(increased-9, reduced-14)
agent(reduced-14, acidifying-17)
dobj(acidifying-17, agents-18)
partmod(agents-18, used-19)
nn(therapy-22, methenamine-21)
prep_in(used-19, therapy-22)

Norepinephrine/NN -/CC Amphetamines/NN enhance/VBP the/DT adrenergic/JJ effect/NN of/IN norepinephrine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Norepinephrine)) (CC -) (NP (NN Amphetamines))) (VP (VBP enhance) (NP (NP (DT the) (JJ adrenergic) (NN effect)) (PP (IN of) (NP (NN norepinephrine)))))) (. .))))

nsubj(enhance-4, Norepinephrine-1)
conj(Norepinephrine-1, Amphetamines-3)
root(ROOT-0, enhance-4)
det(effect-7, the-5)
amod(effect-7, adrenergic-6)
dobj(enhance-4, effect-7)
prep_of(effect-7, norepinephrine-9)

Phenobarbital/NN -/CC Amphetamines/NN may/MD delay/VB intestinal/JJ absorption/NN of/IN phenobarbital/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NN Phenobarbital)) (CC -) (NP (NN Amphetamines))) (VP (MD may) (VP (VB delay) (NP (NP (JJ intestinal) (NN absorption)) (PP (IN of) (NP (NN phenobarbital)))))) (: ;)) (. .))))

nsubj(delay-5, Phenobarbital-1)
conj(Phenobarbital-1, Amphetamines-3)
aux(delay-5, may-4)
root(ROOT-0, delay-5)
amod(absorption-7, intestinal-6)
dobj(delay-5, absorption-7)
prep_of(absorption-7, phenobarbital-9)

co-administration/NN of/IN phenobarbital/NN may/MD produce/VB a/DT synergistic/JJ anticonvulsant/JJ action/NN ./.

(ROOT (S1 (S (S (NP (NP (NN co-administration)) (PP (IN of) (NP (NN phenobarbital)))) (VP (MD may) (VP (VB produce) (NP (DT a) (JJ synergistic) (JJ anticonvulsant) (NN action))))) (. .))))

nsubj(produce-5, co-administration-1)
prep_of(co-administration-1, phenobarbital-3)
aux(produce-5, may-4)
root(ROOT-0, produce-5)
det(action-9, a-6)
amod(action-9, synergistic-7)
amod(action-9, anticonvulsant-8)
dobj(produce-5, action-9)

Phenytoin/NN -/CC Amphetamines/NN may/MD delay/VB intestinal/JJ absorption/NN of/IN phenytoin/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NN Phenytoin)) (CC -) (NP (NN Amphetamines))) (VP (MD may) (VP (VB delay) (NP (NP (JJ intestinal) (NN absorption)) (PP (IN of) (NP (NN phenytoin)))))) (: ;)) (. .))))

nsubj(delay-5, Phenytoin-1)
conj(Phenytoin-1, Amphetamines-3)
aux(delay-5, may-4)
root(ROOT-0, delay-5)
amod(absorption-7, intestinal-6)
dobj(delay-5, absorption-7)
prep_of(absorption-7, phenytoin-9)

co-administration/NN of/IN phenytoin/NN may/MD produce/VB a/DT synergistic/JJ anticonvulsant/JJ action/NN ./.

(ROOT (S1 (S (S (NP (NP (NN co-administration)) (PP (IN of) (NP (NN phenytoin)))) (VP (MD may) (VP (VB produce) (NP (DT a) (JJ synergistic) (JJ anticonvulsant) (NN action))))) (. .))))

nsubj(produce-5, co-administration-1)
prep_of(co-administration-1, phenytoin-3)
aux(produce-5, may-4)
root(ROOT-0, produce-5)
det(action-9, a-6)
amod(action-9, synergistic-7)
amod(action-9, anticonvulsant-8)
dobj(produce-5, action-9)

Propoxyphene/NN -/: In/IN cases/NNS of/IN propoxyphene/NN overdose/NN ,/, amphetamine/NN CNS/NN stimulation/NN is/VBZ potentiated/VBN and/CC fatal/JJ convulsions/NNS can/MD occur/VB ./.

(ROOT (S1 (S (NP (NP (NN Propoxyphene)) (: -) (S (PP (IN In) (NP (NP (NNS cases)) (PP (IN of) (NP (NN propoxyphene) (NN overdose))))) (, ,) (S (NP (NN amphetamine) (NN CNS) (NN stimulation)) (VP (VBZ is) (VP (VBN potentiated)))) (CC and) (S (NP (JJ fatal) (NNS convulsions)) (VP (MD can) (VP (VB occur))))) (. .)))))

root(ROOT-0, Propoxyphene-1)
prep_in(potentiated-13, cases-4)
nn(overdose-7, propoxyphene-6)
prep_of(cases-4, overdose-7)
nn(stimulation-11, amphetamine-9)
nn(stimulation-11, CNS-10)
nsubjpass(potentiated-13, stimulation-11)
auxpass(potentiated-13, is-12)
dep(Propoxyphene-1, potentiated-13)
amod(convulsions-16, fatal-15)
nsubj(occur-18, convulsions-16)
aux(occur-18, can-17)
conj_and(potentiated-13, occur-18)

Veratrum/NN alkaloids/NNS -/CC Amphetamines/NNS inhibit/VBP the/DT hypotensive/JJ effect/NN of/IN veratrum/NN alkaloids/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Veratrum) (NNS alkaloids)) (CC -) (NP (NNS Amphetamines))) (VP (VBP inhibit) (NP (NP (DT the) (JJ hypotensive) (NN effect)) (PP (IN of) (NP (NN veratrum) (NNS alkaloids)))))) (. .))))

nn(alkaloids-2, Veratrum-1)
nsubj(inhibit-5, alkaloids-2)
conj(alkaloids-2, Amphetamines-4)
root(ROOT-0, inhibit-5)
det(effect-8, the-6)
amod(effect-8, hypotensive-7)
dobj(inhibit-5, effect-8)
nn(alkaloids-11, veratrum-10)
prep_of(effect-8, alkaloids-11)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS Amphetamines/NN can/MD cause/VB a/DT significant/JJ elevation/NN in/IN plasma/NN corticosteroid/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (NN Amphetamines)) (VP (MD can) (VP (VB cause) (NP (NP (DT a) (JJ significant) (NN elevation)) (PP (IN in) (NP (NN plasma) (NN corticosteroid) (NNS levels))))))) (. .))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
nn(Amphetamines-5, Interactions-4)
nsubj(cause-7, Amphetamines-5)
aux(cause-7, can-6)
root(ROOT-0, cause-7)
det(elevation-10, a-8)
amod(elevation-10, significant-9)
dobj(cause-7, elevation-10)
nn(levels-14, plasma-12)
nn(levels-14, corticosteroid-13)
prep_in(elevation-10, levels-14)

Amphetamines/NN may/MD interfere/VB with/IN urinary/JJ steroid/NN determinations/NNS ./.

(ROOT (S1 (S (S (NP (NN Amphetamines)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (JJ urinary) (NN steroid) (NNS determinations)))))) (. .))))

nsubj(interfere-3, Amphetamines-1)
aux(interfere-3, may-2)
root(ROOT-0, interfere-3)
amod(determinations-7, urinary-5)
nn(determinations-7, steroid-6)
prep_with(interfere-3, determinations-7)

When/WRB administered/VBN concurrently/RB ,/, the/DT following/JJ drugs/NNS may/MD interact/VB with/IN amphotericin/NN B/NN :/: Antineoplastic/JJ agents/NNS :/: may/MD enhance/VB the/DT potential/NN for/IN renal/JJ toxicity/NN ,/, bronchospasm/NN and/CC hypotension/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN administered) (ADVP (RB concurrently))))) (, ,) (NP (DT the) (JJ following) (NNS drugs)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NN amphotericin) (NN B)))))) (: :) (S (NP (JJ Antineoplastic) (NNS agents) (: :)) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (JJ renal) (NN toxicity)) (, ,) (NP (NN bronchospasm)) (CC and) (NP (NN hypotension)))))))) (. .))))

advmod(administered-2, When-1)
advcl(interact-9, administered-2)
advmod(administered-2, concurrently-3)
det(drugs-7, the-5)
amod(drugs-7, following-6)
nsubj(interact-9, drugs-7)
aux(interact-9, may-8)
root(ROOT-0, interact-9)
nn(B-12, amphotericin-11)
prep_with(interact-9, B-12)
amod(agents-15, Antineoplastic-14)
nsubj(enhance-18, agents-15)
aux(enhance-18, may-17)
parataxis(interact-9, enhance-18)
det(potential-20, the-19)
dobj(enhance-18, potential-20)
amod(toxicity-23, renal-22)
prep_for(potential-20, toxicity-23)
conj_and(toxicity-23, bronchospasm-25)
conj_and(toxicity-23, hypotension-27)

Antineoplastic/JJ agents/NNS (/-LRB- e./FW g./FW ,/, nitrogen/NN mustard/NN ,/, etc./NN )/-RRB- should/MD be/VB given/VBN concomitantly/RB only/RB with/IN great/JJ caution/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Antineoplastic) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NP (FW e.) (FW g.)) (, ,) (NP (NN nitrogen) (NN mustard)) (, ,) (NP (NN etc.))) (-RRB- -RRB-))) (VP (MD should) (VP (VB be) (VP (VBN given) (ADVP (RB concomitantly)) (PP (ADVP (RB only)) (IN with) (NP (JJ great) (NN caution))))))) (. .))))

amod(agents-2, Antineoplastic-1)
nsubjpass(given-14, agents-2)
nn(g.-5, e.-4)
dep(agents-2, g.-5)
nn(mustard-8, nitrogen-7)
appos(g.-5, mustard-8)
appos(g.-5, etc.-10)
aux(given-14, should-12)
auxpass(given-14, be-13)
root(ROOT-0, given-14)
advmod(given-14, concomitantly-15)
advmod(given-14, only-16)
amod(caution-19, great-18)
prep_with(given-14, caution-19)

Corticosteroids/NNS and/CC Corticotropin/NN (/-LRB- ACTH/NN )/-RRB- :/: may/MD potentiate/VB amphotericin/NN B/NN -/CC induced/VBN hypokalemia/NN which/WDT may/MD predispose/VB the/DT patient/NN to/TO cardiac/JJ dysfunction/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Corticosteroids)) (CC and) (NP (NP (NN Corticotropin)) (PRN (-LRB- -LRB-) (NP (NN ACTH)) (-RRB- -RRB-)) (: :))) (VP (MD may) (VP (VB potentiate) (NP (NP (NP (NN amphotericin) (NN B)) (CC -) (NP (VBN induced) (NN hypokalemia))) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB predispose) (NP (DT the) (NN patient)) (PP (TO to) (NP (JJ cardiac) (NN dysfunction))))))))))) (. .))))

nsubj(potentiate-9, Corticosteroids-1)
conj_and(Corticosteroids-1, Corticotropin-3)
abbrev(Corticotropin-3, ACTH-5)
aux(potentiate-9, may-8)
root(ROOT-0, potentiate-9)
nn(B-11, amphotericin-10)
dobj(potentiate-9, B-11)
nsubj(predispose-17, B-11)
amod(hypokalemia-14, induced-13)
conj(B-11, hypokalemia-14)
aux(predispose-17, may-16)
rcmod(B-11, predispose-17)
det(patient-19, the-18)
dobj(predispose-17, patient-19)
amod(dysfunction-22, cardiac-21)
prep_to(predispose-17, dysfunction-22)

Avoid/VB concomitant/JJ use/NN unless/IN necessary/JJ to/TO control/JJ side/JJ effects/NNS of/IN amphotericin/NN B/NN ./.

(ROOT (S1 (S (S (VP (VB Avoid) (NP (JJ concomitant) (NN use)) (PP (IN unless) (ADJP (JJ necessary) (PP (TO to) (NP (NP (JJ control) (JJ side) (NNS effects)) (PP (IN of) (NP (NN amphotericin) (NN B))))))))) (. .))))

root(ROOT-0, Avoid-1)
amod(use-3, concomitant-2)
dobj(Avoid-1, use-3)
prep_unless(Avoid-1, necessary-5)
amod(effects-9, control-7)
amod(effects-9, side-8)
prep_to(necessary-5, effects-9)
nn(B-12, amphotericin-11)
prep_of(effects-9, B-12)

Digitalis/NN glycosides/NNS :/: amphotericin/NN B/NN -induced/JJ hypokalemia/NN may/MD potentiate/VB digitalis/NN toxicity/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Digitalis) (NNS glycosides)) (: :) (NP (ADJP (NP (NN amphotericin) (NN B)) (JJ -induced)) (NN hypokalemia))) (VP (MD may) (VP (VB potentiate) (NP (NN digitalis) (NN toxicity))))) (. .))))

nn(glycosides-2, Digitalis-1)
nsubj(potentiate-9, glycosides-2)
nn(B-5, amphotericin-4)
npadvmod(-induced-6, B-5)
amod(hypokalemia-7, -induced-6)
dep(glycosides-2, hypokalemia-7)
aux(potentiate-9, may-8)
root(ROOT-0, potentiate-9)
nn(toxicity-11, digitalis-10)
dobj(potentiate-9, toxicity-11)

Flucytosine/NN :/: while/IN a/DT synergistic/JJ relationship/NN with/IN amphotericin/NN B/NN has/VBZ been/VBN reported/VBN ,/, concomitant/JJ use/NN may/MD increase/VB the/DT toxicity/NN of/IN flucytosine/NN by/IN possibly/RB increasing/VBG its/PRP$ cellular/JJ uptake/NN and/or/CC impairing/VBG its/PRP$ renal/JJ excretion/NN ./.

(ROOT (S1 (S (NP (NP (NN Flucytosine)) (: :) (S (SBAR (IN while) (S (NP (NP (DT a) (JJ synergistic) (NN relationship)) (PP (IN with) (NP (NN amphotericin) (NN B)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported)))))) (, ,) (NP (JJ concomitant) (NN use)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN toxicity)) (PP (IN of) (NP (NN flucytosine)))) (PP (IN by) (S (ADVP (RB possibly)) (VP (VP (VBG increasing) (NP (PRP$ its) (JJ cellular) (NN uptake))) (CC and/or) (VP (VBG impairing) (NP (PRP$ its) (JJ renal) (NN excretion))))))))) (. .)))))

root(ROOT-0, Flucytosine-1)
mark(reported-12, while-3)
det(relationship-6, a-4)
amod(relationship-6, synergistic-5)
nsubjpass(reported-12, relationship-6)
nn(B-9, amphotericin-8)
prep_with(relationship-6, B-9)
aux(reported-12, has-10)
auxpass(reported-12, been-11)
advcl(increase-17, reported-12)
amod(use-15, concomitant-14)
nsubj(increase-17, use-15)
aux(increase-17, may-16)
dep(Flucytosine-1, increase-17)
det(toxicity-19, the-18)
dobj(increase-17, toxicity-19)
prep_of(toxicity-19, flucytosine-21)
advmod(increasing-24, possibly-23)
prepc_by(increase-17, increasing-24)
poss(uptake-27, its-25)
amod(uptake-27, cellular-26)
dobj(increasing-24, uptake-27)
conj_and/or(increasing-24, impairing-29)
poss(excretion-32, its-30)
amod(excretion-32, renal-31)
dobj(impairing-29, excretion-32)

Imidazoles/NNS (/-LRB- e./FW g./FW ,/, ketoconazole/NN ,/, miconazole/NN ,/, clotrimazole/NN ,/, fluconazole/NN ,/, etc./NN )/-RRB- :/: in/FW vitro/FW and/CC animal/JJ studies/NNS with/IN the/DT combination/NN of/IN amphotericin/NN B/NN and/CC imidazoles/NNS suggest/VBP that/IN imidazoles/NNS may/MD induce/VB fungal/JJ resistance/NN to/TO amphotericin/NN B/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Imidazoles)) (PRN (-LRB- -LRB-) (NP (NP (FW e.) (FW g.)) (, ,) (NP (NP (NN ketoconazole)) (, ,) (NP (NN miconazole)) (, ,) (NP (NN clotrimazole)) (, ,) (NP (NN fluconazole)) (, ,) (NP (NN etc.)))) (-RRB- -RRB-))) (: :) (NP (NP (ADJP (ADJP (FW in) (FW vitro)) (CC and) (ADJP (JJ animal))) (NNS studies)) (PP (IN with) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NN amphotericin) (NN B)))))) (CC and) (NP (NNS imidazoles))) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS imidazoles)) (VP (MD may) (VP (VB induce) (NP (NP (JJ fungal) (NN resistance)) (PP (TO to) (NP (NN amphotericin) (NN B)))))))))) (. .))))

nsubj(suggest-30, Imidazoles-1)
nn(g.-4, e.-3)
dep(Imidazoles-1, g.-4)
appos(g.-4, ketoconazole-6)
appos(ketoconazole-6, miconazole-8)
appos(ketoconazole-6, clotrimazole-10)
appos(ketoconazole-6, fluconazole-12)
appos(ketoconazole-6, etc.-14)
nn(vitro-18, in-17)
amod(studies-21, vitro-18)
conj_and(vitro-18, animal-20)
conj_and(Imidazoles-1, studies-21)
det(combination-24, the-23)
prep_with(studies-21, combination-24)
nn(B-27, amphotericin-26)
prep_of(combination-24, B-27)
conj_and(Imidazoles-1, imidazoles-29)
root(ROOT-0, suggest-30)
complm(induce-34, that-31)
nsubj(induce-34, imidazoles-32)
aux(induce-34, may-33)
ccomp(suggest-30, induce-34)
amod(resistance-36, fungal-35)
dobj(induce-34, resistance-36)
nn(B-39, amphotericin-38)
prep_to(resistance-36, B-39)

Other/JJ nephrotoxic/JJ medications/NNS :/: agents/NNS such/JJ as/IN aminoglycosides/NN ,/, cyclosporine/NN ,/, and/CC pentamidine/NN may/MD enhance/VB the/DT potential/NN for/IN drug-induced/JJ renal/JJ toxicity/NN ,/, and/CC should/MD be/VB used/VBN concomitantly/RB only/RB with/IN great/JJ caution/NN ./.

(ROOT (S1 (S (NP (NP (JJ Other) (JJ nephrotoxic) (NNS medications)) (: :) (S (NP (NP (NNS agents)) (PP (JJ such) (IN as) (NP (NP (NN aminoglycosides)) (, ,) (NP (NN cyclosporine)) (, ,) (CC and) (NP (NN pentamidine))))) (VP (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (JJ drug-induced) (JJ renal) (NN toxicity)))))) (, ,) (CC and) (VP (MD should) (VP (VB be) (VP (VBN used) (ADVP (RB concomitantly)) (PP (ADVP (RB only)) (IN with) (NP (JJ great) (NN caution)))))))) (. .)))))

amod(medications-3, Other-1)
amod(medications-3, nephrotoxic-2)
root(ROOT-0, medications-3)
nsubj(enhance-15, agents-5)
prep_such_as(agents-5, aminoglycosides-8)
conj_and(aminoglycosides-8, cyclosporine-10)
conj_and(aminoglycosides-8, pentamidine-13)
aux(enhance-15, may-14)
dep(medications-3, enhance-15)
det(potential-17, the-16)
dobj(enhance-15, potential-17)
amod(toxicity-21, drug-induced-19)
amod(toxicity-21, renal-20)
prep_for(potential-17, toxicity-21)
aux(used-26, should-24)
auxpass(used-26, be-25)
conj_and(enhance-15, used-26)
advmod(used-26, concomitantly-27)
advmod(used-26, only-28)
amod(caution-31, great-30)
prep_with(used-26, caution-31)

Intensive/JJ monitoring/NN of/IN renal/JJ function/NN is/VBZ recommended/VBN in/IN patients/NNS requiring/VBG any/DT combination/NN of/IN nephrotoxic/JJ medications/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Intensive) (NN monitoring)) (PP (IN of) (NP (JJ renal) (NN function)))) (VP (VBZ is) (VP (VBN recommended) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG requiring) (NP (NP (DT any) (NN combination)) (PP (IN of) (NP (JJ nephrotoxic) (NNS medications)))))))))) (. .))))

amod(monitoring-2, Intensive-1)
nsubjpass(recommended-7, monitoring-2)
amod(function-5, renal-4)
prep_of(monitoring-2, function-5)
auxpass(recommended-7, is-6)
root(ROOT-0, recommended-7)
prep_in(recommended-7, patients-9)
partmod(patients-9, requiring-10)
det(combination-12, any-11)
dobj(requiring-10, combination-12)
amod(medications-15, nephrotoxic-14)
prep_of(combination-12, medications-15)

Skeletal/JJ muscle/NN relaxants/NNS :/: amphotericin/NN B/NN -induced/JJ hypokalemia/NN may/MD enhance/VB the/DT curariform/JJ effect/NN of/IN skeletal/JJ muscle/NN relaxants/NNS (/-LRB- e.g./FW ,/, tubocurarine/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (JJ Skeletal) (NN muscle) (NNS relaxants)) (: :) (S (NP (ADJP (NP (NN amphotericin) (NN B)) (JJ -induced)) (NN hypokalemia)) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (JJ curariform) (NN effect)) (PP (IN of) (NP (JJ skeletal) (NN muscle) (NNS relaxants)))) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN tubocurarine)) (-RRB- -RRB-))))) (. .)))))

amod(relaxants-3, Skeletal-1)
nn(relaxants-3, muscle-2)
root(ROOT-0, relaxants-3)
nn(B-6, amphotericin-5)
npadvmod(-induced-7, B-6)
amod(hypokalemia-8, -induced-7)
nsubj(enhance-10, hypokalemia-8)
aux(enhance-10, may-9)
dep(relaxants-3, enhance-10)
det(effect-13, the-11)
amod(effect-13, curariform-12)
dobj(enhance-10, effect-13)
amod(relaxants-17, skeletal-15)
nn(relaxants-17, muscle-16)
prep_of(effect-13, relaxants-17)
dep(tubocurarine-21, e.g.-19)
dep(enhance-10, tubocurarine-21)

Leukocyte/NN transfusions/NNS :/: acute/JJ pulmonary/JJ toxicity/NN has/VBZ been/VBN reported/VBN in/IN patients/NNS receiving/VBG intravenous/JJ amphotericin/NN B/NN and/CC leukocyte/NN transfusions/NNS ./.

(ROOT (S1 (S (NP (NP (NN Leukocyte) (NNS transfusions)) (: :) (S (NP (JJ acute) (JJ pulmonary) (NN toxicity)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ intravenous) (NN amphotericin) (NN B)))) (CC and) (NP (NN leukocyte) (NNS transfusions)))))))) (. .)))))

nn(transfusions-2, Leukocyte-1)
root(ROOT-0, transfusions-2)
amod(toxicity-6, acute-4)
amod(toxicity-6, pulmonary-5)
nsubjpass(reported-9, toxicity-6)
aux(reported-9, has-7)
auxpass(reported-9, been-8)
dep(transfusions-2, reported-9)
prep_in(reported-9, patients-11)
partmod(patients-11, receiving-12)
amod(B-15, intravenous-13)
nn(B-15, amphotericin-14)
dobj(receiving-12, B-15)
nn(transfusions-18, leukocyte-17)
conj_and(patients-11, transfusions-18)

When/WRB administered/VBN concurrently/RB ,/, the/DT following/JJ drugs/NNS may/MD interact/VB with/IN ampicillin/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN administered) (ADVP (RB concurrently))))) (, ,) (NP (DT the) (JJ following) (NNS drugs)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NN ampicillin)))))) (. .))))

advmod(administered-2, When-1)
advcl(interact-9, administered-2)
advmod(administered-2, concurrently-3)
det(drugs-7, the-5)
amod(drugs-7, following-6)
nsubj(interact-9, drugs-7)
aux(interact-9, may-8)
root(ROOT-0, interact-9)
prep_with(interact-9, ampicillin-11)

Allopurinol/NN :/: Increased/VBN possibility/NN of/IN skin/NN rash/NN ,/, particularly/RB in/IN hyperuricemic/JJ patients/NNS may/MD occur/VB ./.

(ROOT (S1 (S (NP (NP (NN Allopurinol)) (: :) (S (NP (NP (VBN Increased) (NN possibility)) (PP (IN of) (NP (NN skin) (NN rash))) (, ,) (ADVP (RB particularly)) (PP (IN in) (NP (JJ hyperuricemic) (NNS patients)))) (VP (MD may) (VP (VB occur)))) (. .)))))

root(ROOT-0, Allopurinol-1)
amod(possibility-4, Increased-3)
nsubj(occur-14, possibility-4)
nn(rash-7, skin-6)
prep_of(possibility-4, rash-7)
advmod(possibility-4, particularly-9)
amod(patients-12, hyperuricemic-11)
prep_in(possibility-4, patients-12)
aux(occur-14, may-13)
dep(Allopurinol-1, occur-14)

Bacteriostat/NN ic/NN Antibiotics/NNS :/: Chloramphenicol/NN ,/, erythromycins/NN ,/, sulfonamides/NNS ,/, or/CC tetracyclines/NN may/MD interfere/VB with/IN the/DT bactericidal/JJ effect/NN of/IN penicillins/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Bacteriostat) (NN ic) (NNS Antibiotics)) (: :) (NP (NP (NN Chloramphenicol)) (, ,) (NP (NN erythromycins)) (, ,) (NP (NNS sulfonamides)) (, ,) (CC or) (NP (NN tetracyclines)))) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (JJ bactericidal) (NN effect)) (PP (IN of) (NP (NN penicillins)))))))) (. .))))

nn(Antibiotics-3, Bacteriostat-1)
nn(Antibiotics-3, ic-2)
nsubj(interfere-14, Antibiotics-3)
dep(Antibiotics-3, Chloramphenicol-5)
conj_or(Chloramphenicol-5, erythromycins-7)
conj_or(Chloramphenicol-5, sulfonamides-9)
conj_or(Chloramphenicol-5, tetracyclines-12)
aux(interfere-14, may-13)
root(ROOT-0, interfere-14)
det(effect-18, the-16)
amod(effect-18, bactericidal-17)
prep_with(interfere-14, effect-18)
prep_of(effect-18, penicillins-20)

Oral/JJ Contraceptives/NNS :/: May/MD be/VB less/RBR effective/JJ and/CC increased/VBD breakthrough/JJ bleeding/JJ may/MD occur/VB ./.

(ROOT (S1 (S (NP (NP (JJ Oral) (NNS Contraceptives)) (: :) (S (S (VP (VP (MD May) (VP (VB be) (ADJP (RBR less) (JJ effective)))) (CC and) (VP (VBD increased)))) (S (NP (JJ breakthrough) (JJ bleeding)) (VP (MD may) (VP (VB occur))))) (. .)))))

amod(Contraceptives-2, Oral-1)
root(ROOT-0, Contraceptives-2)
aux(effective-7, May-4)
cop(effective-7, be-5)
advmod(effective-7, less-6)
dep(Contraceptives-2, effective-7)
conj_and(effective-7, increased-9)
amod(bleeding-11, breakthrough-10)
nsubj(occur-13, bleeding-11)
aux(occur-13, may-12)
dep(effective-7, occur-13)

Probenecid/NN :/: May/MD decrease/VB renal/JJ tubular/JJ secretion/NN of/IN ampicillin/NN resulting/VBG in/IN increased/VBN blood/NN levels/NNS and/or/CC ampicillin/NN toxicity/NN ./.

(ROOT (S1 (S (S (NP (NN Probenecid) (: :)) (VP (MD May) (VP (VB decrease) (NP (NP (JJ renal) (JJ tubular) (NN secretion)) (PP (IN of) (NP (NP (NN ampicillin)) (VP (VBG resulting) (PP (IN in) (NP (NP (VBN increased) (NN blood) (NNS levels)) (CC and/or) (NP (NN ampicillin) (NN toxicity))))))))))) (. .))))

nsubj(decrease-4, Probenecid-1)
aux(decrease-4, May-3)
root(ROOT-0, decrease-4)
amod(secretion-7, renal-5)
amod(secretion-7, tubular-6)
dobj(decrease-4, secretion-7)
prep_of(secretion-7, ampicillin-9)
partmod(ampicillin-9, resulting-10)
amod(levels-14, increased-12)
nn(levels-14, blood-13)
prep_in(resulting-10, levels-14)
nn(toxicity-17, ampicillin-16)
conj_and/or(levels-14, toxicity-17)

Drug/NN /Laboratory/NN Test/NN Interaction/NN :/: After/IN treatment/NN with/IN ampicillin/NN ,/, a/DT false-positive/JJ reaction/NN for/IN glucose/NN in/IN the/DT urine/NN may/MD occur/VB with/IN copper/NN sulfate/NN tests/NNS (/-LRB- Benedicts/NN solution/NN ,/, Fehlings/NN solution/NN ,/, or/CC Clinitest/NN tablets/NNS )/-RRB- but/CC not/RB with/IN enzyme/NN based/NN tests/NNS such/JJ as/IN Clinistix/NN and/CC Glucose/NN Enzymatic/JJ Test/NN Strip/NN USP/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NN Interaction)) (: :) (S (PP (IN After) (NP (NP (NN treatment)) (PP (IN with) (NP (NN ampicillin))))) (, ,) (NP (NP (DT a) (JJ false-positive) (NN reaction)) (PP (IN for) (NP (NN glucose))) (PP (IN in) (NP (DT the) (NN urine)))) (VP (MD may) (VP (VB occur) (PP (PP (IN with) (NP (NP (NN copper) (NN sulfate) (NNS tests)) (PRN (-LRB- -LRB-) (NP (NP (NN Benedicts) (NN solution)) (, ,) (NP (NN Fehlings) (NN solution)) (, ,) (CC or) (NP (NN Clinitest) (NNS tablets))) (-RRB- -RRB-)))) (CC but) (PP (RB not) (IN with) (NP (NP (NN enzyme) (NN based) (NNS tests)) (PP (JJ such) (IN as) (NP (NP (NN Clinistix)) (CC and) (NP (NN Glucose) (JJ Enzymatic) (NN Test) (NN Strip) (NN USP)))))))))) (. .)))))

nn(Interaction-4, Drug-1)
nn(Interaction-4, /Laboratory-2)
nn(Interaction-4, Test-3)
root(ROOT-0, Interaction-4)
prep_after(occur-20, treatment-7)
prep_with(treatment-7, ampicillin-9)
det(reaction-13, a-11)
amod(reaction-13, false-positive-12)
nsubj(occur-20, reaction-13)
prep_for(reaction-13, glucose-15)
det(urine-18, the-17)
prep_in(reaction-13, urine-18)
aux(occur-20, may-19)
dep(Interaction-4, occur-20)
nn(tests-24, copper-22)
nn(tests-24, sulfate-23)
prep_with(occur-20, tests-24)
nn(solution-27, Benedicts-26)
dep(tests-24, solution-27)
nn(solution-30, Fehlings-29)
conj_or(solution-27, solution-30)
nn(tablets-34, Clinitest-33)
conj_or(solution-27, tablets-34)
neg(occur-20, not-37)
nn(tests-41, enzyme-39)
nn(tests-41, based-40)
conj_but(tests-24, tests-41)
prep_such_as(tests-41, Clinistix-44)
nn(USP-50, Glucose-46)
amod(USP-50, Enzymatic-47)
nn(USP-50, Test-48)
nn(USP-50, Strip-49)
conj_and(Clinistix-44, USP-50)

Amprenavir/NN is/VBZ metabolized/VBN in/IN the/DT liver/NN by/IN the/DT cytochrome/NN P450/NN enzyme/NN system/NN ./.

(ROOT (S1 (S (S (NP (NN Amprenavir)) (VP (VBZ is) (VP (VBN metabolized) (PP (IN in) (NP (DT the) (NN liver))) (PP (IN by) (NP (DT the) (NN cytochrome) (NN P450) (NN enzyme) (NN system)))))) (. .))))

nsubjpass(metabolized-3, Amprenavir-1)
auxpass(metabolized-3, is-2)
root(ROOT-0, metabolized-3)
det(liver-6, the-5)
prep_in(metabolized-3, liver-6)
det(system-12, the-8)
nn(system-12, cytochrome-9)
nn(system-12, P450-10)
nn(system-12, enzyme-11)
agent(metabolized-3, system-12)

Amprenavir/NN inhibits/VBZ CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Amprenavir)) (VP (VBZ inhibits) (NP (NN CYP3A4)))) (. .))))

nsubj(inhibits-2, Amprenavir-1)
root(ROOT-0, inhibits-2)
dobj(inhibits-2, CYP3A4-3)

Caution/NN should/MD be/VB used/VBN when/WRB coadministering/VBG medications/NNS that/WDT are/VBP substrates/NNS ,/, inhibitors/NNS ,/, or/CC inducers/NNS of/IN CYP3A4/NN ,/, or/CC potentially/RB toxic/JJ medications/NNS that/WDT are/VBP metabolized/VBN by/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN used))) (SBAR (WHADVP (WRB when)) (S (VP (VBG coadministering) (NP (NP (NNS medications)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NNS substrates)) (, ,) (NP (NP (NP (NNS inhibitors)) (, ,) (CC or) (NP (NNS inducers))) (PP (IN of) (NP (NN CYP3A4)))) (, ,) (CC or) (NP (NP (ADJP (RB potentially) (JJ toxic)) (NNS medications)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP3A4)))))))))))))))))) (. .))))

nsubjpass(used-4, Caution-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
advmod(coadministering-6, when-5)
advcl(used-4, coadministering-6)
dobj(coadministering-6, medications-7)
nsubj(substrates-10, medications-7)
cop(substrates-10, are-9)
rcmod(medications-7, substrates-10)
conj_or(substrates-10, inhibitors-12)
conj_or(inhibitors-12, inducers-15)
prep_of(inhibitors-12, CYP3A4-17)
advmod(toxic-21, potentially-20)
amod(medications-22, toxic-21)
conj_or(substrates-10, medications-22)
nsubjpass(metabolized-25, medications-22)
auxpass(metabolized-25, are-24)
rcmod(medications-22, metabolized-25)
agent(metabolized-25, CYP3A4-27)

Amprenavir/NN does/VBZ not/RB inhibit/VB CYP2D6/NN ,/, CYP1A2/NN ,/, CYP2C9/NN ,/, CYP2C19/NN ,/, CYP2E1/NN ,/, or/CC uridine/NN glucuronosyltransferase/NN (/-LRB- UDPGT/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NN Amprenavir)) (VP (VBZ does) (RB not) (VP (VB inhibit) (NP (NP (NN CYP2D6)) (, ,) (NP (NN CYP1A2)) (, ,) (NP (NN CYP2C9)) (, ,) (NP (NN CYP2C19)) (, ,) (NP (NN CYP2E1)) (, ,) (CC or) (NP (NP (NN uridine) (NN glucuronosyltransferase)) (PRN (-LRB- -LRB-) (NP (NN UDPGT)) (-RRB- -RRB-))))))) (. .))))

nsubj(inhibit-4, Amprenavir-1)
aux(inhibit-4, does-2)
neg(inhibit-4, not-3)
root(ROOT-0, inhibit-4)
dobj(inhibit-4, CYP2D6-5)
conj_or(CYP2D6-5, CYP1A2-7)
conj_or(CYP2D6-5, CYP2C9-9)
conj_or(CYP2D6-5, CYP2C19-11)
conj_or(CYP2D6-5, CYP2E1-13)
nn(glucuronosyltransferase-17, uridine-16)
conj_or(CYP2D6-5, glucuronosyltransferase-17)
abbrev(glucuronosyltransferase-17, UDPGT-19)

HIV/NN Protease/NN Inhibitors/NNS :/: The/DT effect/NN of/IN amprenavir/NN on/IN total/JJ drug/NN concentrations/NNS of/IN other/JJ HIV/NN protease/NN inhibitors/NNS in/IN subjects/NNS receiving/VBG both/DT agents/NNS was/VBD evaluated/VBN using/VBG comparisons/NNS to/TO historical/JJ data/NNS ./.

(ROOT (S1 (S (NP (NP (NN HIV) (NN Protease) (NNS Inhibitors)) (: :) (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN amprenavir))) (PP (IN on) (NP (NP (JJ total) (NN drug) (NNS concentrations)) (PP (IN of) (NP (NP (JJ other) (NN HIV) (NN protease) (NNS inhibitors)) (PP (IN in) (NP (NP (NNS subjects)) (VP (VBG receiving) (NP (DT both) (NNS agents)))))))))) (VP (VBD was) (VP (VBN evaluated) (S (VP (VBG using) (NP (NP (NNS comparisons)) (PP (TO to) (NP (JJ historical) (NNS data))))))))) (. .)))))

nn(Inhibitors-3, HIV-1)
nn(Inhibitors-3, Protease-2)
root(ROOT-0, Inhibitors-3)
det(effect-6, The-5)
nsubjpass(evaluated-24, effect-6)
prep_of(effect-6, amprenavir-8)
amod(concentrations-12, total-10)
nn(concentrations-12, drug-11)
prep_on(effect-6, concentrations-12)
amod(inhibitors-17, other-14)
nn(inhibitors-17, HIV-15)
nn(inhibitors-17, protease-16)
prep_of(concentrations-12, inhibitors-17)
prep_in(inhibitors-17, subjects-19)
partmod(subjects-19, receiving-20)
det(agents-22, both-21)
dobj(receiving-20, agents-22)
auxpass(evaluated-24, was-23)
dep(Inhibitors-3, evaluated-24)
xcomp(evaluated-24, using-25)
dobj(using-25, comparisons-26)
amod(data-29, historical-28)
prep_to(comparisons-26, data-29)

Indinavir/NN steady-state/JJ Cmax/NN ,/, A.C./NNP and/CC Cmin/NN were/VBD decreased/VBN by/IN 22/CD %/NN ,/, 38/CD %/NN ,/, and/CC 27/CD %/NN ,/, respectively/RB ,/, by/IN concomitant/JJ amprenavir/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Indinavir) (JJ steady-state) (NN Cmax)) (, ,) (NP (NNP A.C.)) (CC and) (NP (NN Cmin))) (VP (VBD were) (VP (VBN decreased) (PP (IN by) (NP (NP (CD 22) (NN %)) (, ,) (NP (CD 38) (NN %)) (, ,) (CC and) (NP (CD 27) (NN %)) (, ,) (ADVP (RB respectively)))) (, ,) (PP (IN by) (NP (JJ concomitant) (NN amprenavir)))))) (. .))))

nn(Cmax-3, Indinavir-1)
amod(Cmax-3, steady-state-2)
nsubjpass(decreased-9, Cmax-3)
conj_and(Cmax-3, A.C.-5)
conj_and(Cmax-3, Cmin-7)
auxpass(decreased-9, were-8)
root(ROOT-0, decreased-9)
num(%-12, 22-11)
agent(decreased-9, %-12)
num(%-15, 38-14)
conj_and(%-12, %-15)
num(%-19, 27-18)
conj_and(%-12, %-19)
advmod(%-12, respectively-21)
conj_and(%-12, respectively-21)
amod(amprenavir-25, concomitant-24)
agent(decreased-9, amprenavir-25)

Saquinavir/NN steady-state/JJ Cmax/NN ,/, A.C./NNP and/CC Cmin/NN were/VBD increased/VBN 21/CD %/NN ,/, decreased/VBN 19/CD %/NN ,/, and/CC decreased/VBN 48/CD %/NN ,/, respectively/RB ,/, by/IN concomitant/JJ amprenavir/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Saquinavir) (JJ steady-state) (NN Cmax)) (, ,) (NP (NNP A.C.)) (CC and) (NP (NN Cmin))) (VP (VBD were) (VP (VP (VBN increased) (NP (CD 21) (NN %))) (, ,) (VP (VBN decreased) (NP (CD 19) (NN %))) (, ,) (CC and) (VP (VBN decreased) (NP (CD 48) (NN %))) (, ,) (ADVP (RB respectively)) (, ,) (PP (IN by) (NP (JJ concomitant) (NN amprenavir)))))) (. .))))

nn(Cmax-3, Saquinavir-1)
amod(Cmax-3, steady-state-2)
nsubjpass(increased-9, Cmax-3)
conj_and(Cmax-3, A.C.-5)
conj_and(Cmax-3, Cmin-7)
auxpass(increased-9, were-8)
root(ROOT-0, increased-9)
num(%-11, 21-10)
dobj(increased-9, %-11)
conj_and(increased-9, decreased-13)
num(%-15, 19-14)
dobj(decreased-13, %-15)
conj_and(increased-9, decreased-18)
num(%-20, 48-19)
dobj(decreased-18, %-20)
advmod(increased-9, respectively-22)
conj_and(increased-9, respectively-22)
conj_and(increased-9, by-24)
amod(amprenavir-26, concomitant-25)
agent(increased-9, amprenavir-26)

Nelfinavir/NN steady-state/JJ Cmax/NN ,/, A.C./NNP and/CC Cmin/NN were/VBD increased/VBN by/IN 12/CD %/NN ,/, 15/CD %/NN ,/, and/CC 14/CD %/NN ,/, respectively/RB ,/, by/IN concomitant/JJ amprenavir/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Nelfinavir) (JJ steady-state) (NN Cmax)) (, ,) (NP (NNP A.C.)) (CC and) (NP (NN Cmin))) (VP (VBD were) (VP (VBN increased) (PP (IN by) (NP (NP (CD 12) (NN %)) (, ,) (NP (CD 15) (NN %)) (, ,) (CC and) (NP (CD 14) (NN %)) (, ,) (ADVP (RB respectively)))) (, ,) (PP (IN by) (NP (JJ concomitant) (NN amprenavir)))))) (. .))))

nn(Cmax-3, Nelfinavir-1)
amod(Cmax-3, steady-state-2)
nsubjpass(increased-9, Cmax-3)
conj_and(Cmax-3, A.C.-5)
conj_and(Cmax-3, Cmin-7)
auxpass(increased-9, were-8)
root(ROOT-0, increased-9)
num(%-12, 12-11)
agent(increased-9, %-12)
num(%-15, 15-14)
conj_and(%-12, %-15)
num(%-19, 14-18)
conj_and(%-12, %-19)
advmod(%-12, respectively-21)
conj_and(%-12, respectively-21)
amod(amprenavir-25, concomitant-24)
agent(increased-9, amprenavir-25)

Methadone/NN :/: Coadministration/NN of/IN amprenavir/NN and/CC methadone/NN can/MD decrease/VB plasma/NN levels/NNS ofmethadone/CD ./.

(ROOT (S1 (S (NP (NP (NN Methadone)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NN amprenavir)) (CC and) (NP (NN methadone))))) (VP (MD can) (VP (VB decrease) (NP (NN plasma) (NNS levels) (CD ofmethadone))))) (. .)))))

root(ROOT-0, Methadone-1)
nsubj(decrease-9, Coadministration-3)
prep_of(Coadministration-3, amprenavir-5)
conj_and(amprenavir-5, methadone-7)
aux(decrease-9, can-8)
dep(Methadone-1, decrease-9)
nn(levels-11, plasma-10)
dobj(decrease-9, levels-11)
num(levels-11, ofmethadone-12)

Coadministration/NN of/IN amprenavir/NN and/CC methadone/NN as/IN compared/VBN to/TO a/DT non-matched/JJ historicalcontrol/NN group/NN resulted/VBD in/IN a/DT 30/CD %/NN ,/, 27/CD %/NN ,/, and/CC 25/CD %/NN decrease/NN in/IN serum/NN amprenavir/NN AUC/NN ,/, Cmax/NN ,/, andCmin/NN ,/, respectively/RB ./.

(ROOT (S1 (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NN amprenavir)) (CC and) (NP (NN methadone)))) (SBAR (IN as) (S (VP (VBN compared) (PP (TO to) (NP (DT a) (JJ non-matched) (NN historicalcontrol) (NN group))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (ADJP (ADJP (CD 30) (NN %)) (, ,) (ADJP (CD 27) (NN %)) (, ,) (CC and) (ADJP (CD 25) (NN %))) (NN decrease)) (PP (IN in) (NP (NP (NN serum) (NN amprenavir) (NN AUC)) (, ,) (NP (NN Cmax)) (, ,) (NP (NN andCmin)))))) (, ,) (ADVP (RB respectively))) (. .))))

nsubj(resulted-13, Coadministration-1)
prep_of(Coadministration-1, amprenavir-3)
conj_and(amprenavir-3, methadone-5)
mark(Coadministration-1, as-6)
det(group-12, a-9)
amod(group-12, non-matched-10)
nn(group-12, historicalcontrol-11)
prep_compared_to(Coadministration-1, group-12)
root(ROOT-0, resulted-13)
det(decrease-25, a-15)
number(%-17, 30-16)
amod(decrease-25, %-17)
number(%-20, 27-19)
conj_and(%-17, %-20)
number(%-24, 25-23)
conj_and(%-17, %-24)
prep_in(resulted-13, decrease-25)
nn(AUC-29, serum-27)
nn(AUC-29, amprenavir-28)
prep_in(decrease-25, AUC-29)
appos(AUC-29, Cmax-31)
appos(AUC-29, andCmin-33)
advmod(resulted-13, respectively-35)

Amprenavir/NN is/VBZ an/DT inhibitor/NN of/IN cytochrome/NN P450/NN C.P.A./NNP metabolism/NN and/CC therefore/RB should/MD not/RB be/VB administered/VBN concurrently/RB with/IN medications/NNS with/IN narrow/JJ therapeutic/JJ windows/NNS that/WDT are/VBP substrates/NNS of/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Amprenavir)) (VP (VP (VBZ is) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NP (NN cytochrome) (NN P450)) (NNP C.P.A.) (NN metabolism))))) (CC and) (ADVP (RB therefore)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (ADVP (RB concurrently)) (PP (IN with) (NP (NP (NNS medications)) (PP (IN with) (NP (NP (ADJP (ADJP (JJ narrow)) (ADJP (JJ therapeutic))) (NNS windows)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NNS substrates)) (PP (IN of) (NP (NN CYP3A4)))))))))))))))) (. .))))

nsubj(inhibitor-4, Amprenavir-1)
cop(inhibitor-4, is-2)
det(inhibitor-4, an-3)
root(ROOT-0, inhibitor-4)
nn(P450-7, cytochrome-6)
nn(metabolism-9, P450-7)
nn(metabolism-9, C.P.A.-8)
prep_of(inhibitor-4, metabolism-9)
advmod(inhibitor-4, therefore-11)
conj_and(inhibitor-4, therefore-11)
aux(administered-15, should-12)
neg(administered-15, not-13)
auxpass(administered-15, be-14)
conj_and(inhibitor-4, administered-15)
advmod(administered-15, concurrently-16)
prep_with(administered-15, medications-18)
amod(windows-22, narrow-20)
dep(narrow-20, therapeutic-21)
prep_with(medications-18, windows-22)
nsubj(substrates-25, windows-22)
cop(substrates-25, are-24)
rcmod(windows-22, substrates-25)
prep_of(substrates-25, CYP3A4-27)

Laboratory/NN Tests/NNS :/: The/DT combination/NN of/IN Amprenavir/NN and/CC low-dose/JJ ritonavir/NN has/VBZ been/VBN associated/VBN with/IN elevations/NNS of/IN cholesterol/NN and/CC triglycerides/NNS ,/, SGOT/NN (/-LRB- AST/NN )/-RRB- ,/, and/CC SGPT/NN (/-LRB- ALT/NN )/-RRB- in/IN some/DT patients/NNS ./.

(ROOT (S1 (S (NP (NP (NN Laboratory) (NNS Tests)) (: :) (S (NP (NP (DT The) (NN combination)) (PP (IN of) (NP (NP (NN Amprenavir)) (CC and) (NP (JJ low-dose) (NN ritonavir))))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (NNS elevations)) (PP (IN of) (NP (NP (NP (NN cholesterol)) (CC and) (NP (NNS triglycerides))) (, ,) (NP (NP (NN SGOT)) (PRN (-LRB- -LRB-) (NP (NN AST)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN SGPT)) (PRN (-LRB- -LRB-) (NP (NN ALT)) (-RRB- -RRB-))))) (PP (IN in) (NP (DT some) (NNS patients))))))))) (. .)))))

nn(Tests-2, Laboratory-1)
root(ROOT-0, Tests-2)
det(combination-5, The-4)
nsubjpass(associated-13, combination-5)
prep_of(combination-5, Amprenavir-7)
amod(ritonavir-10, low-dose-9)
conj_and(Amprenavir-7, ritonavir-10)
aux(associated-13, has-11)
auxpass(associated-13, been-12)
dep(Tests-2, associated-13)
prep_with(associated-13, elevations-15)
prep_of(elevations-15, cholesterol-17)
conj_and(cholesterol-17, triglycerides-19)
conj_and(cholesterol-17, SGOT-21)
abbrev(SGOT-21, AST-23)
conj_and(cholesterol-17, SGPT-27)
abbrev(SGPT-27, ALT-29)
det(patients-33, some-32)
prep_in(elevations-15, patients-33)

Appropriate/JJ laboratory/NN testing/NN should/MD be/VB considered/VBN prior/JJ to/TO initiating/VBG combination/NN therapy/NN with/IN Amprenavir/NN and/CC ritonavir/NN and/CC at/IN periodic/JJ intervals/NNS or/CC if/IN any/DT clinical/JJ signs/NNS or/CC symptoms/NNS of/IN hyperlipidemia/NN or/CC elevated/JJ liver/NN function/NN tests/NNS occur/VBP during/IN therapy/NN ./.

(ROOT (S1 (S (NP (JJ Appropriate) (NN laboratory) (NN testing)) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (JJ prior) (TO to) (S (VP (VBG initiating) (NP (NP (NN combination) (NN therapy)) (SBAR (IN with) (S (NP (NP (NP (NN Amprenavir)) (CC and) (NP (NN ritonavir))) (PP (CC and) (PP (IN at) (NP (JJ periodic) (NNS intervals))) (CC or) (PP (IN if) (NP (NP (DT any) (NP (JJ clinical) (NNS signs)) (CC or) (NP (NNS symptoms))) (PP (IN of) (NP (NP (NN hyperlipidemia)) (CC or) (NP (JJ elevated) (NN liver) (NN function) (NNS tests)))))))) (VP (VBP occur) (PP (IN during) (NP (NN therapy))))))))))))) (. .))))

amod(testing-3, Appropriate-1)
nn(testing-3, laboratory-2)
nsubjpass(considered-6, testing-3)
aux(considered-6, should-4)
auxpass(considered-6, be-5)
root(ROOT-0, considered-6)
prepc_prior_to(considered-6, initiating-9)
nn(therapy-11, combination-10)
dobj(initiating-9, therapy-11)
dobj(occur-34, therapy-11)
mark(occur-34, with-12)
conj_or(Amprenavir-13, Amprenavir-13')
nsubj(occur-34, Amprenavir-13)
conj_and(Amprenavir-13, ritonavir-15)
amod(intervals-19, periodic-18)
prep_at(Amprenavir-13, intervals-19)
dep(signs-24, any-22)
amod(signs-24, clinical-23)
prep_if(Amprenavir-13', signs-24)
conj_or(signs-24, symptoms-26)
prep_of(signs-24, hyperlipidemia-28)
amod(tests-33, elevated-30)
nn(tests-33, liver-31)
nn(tests-33, function-32)
conj_or(hyperlipidemia-28, tests-33)
dep(therapy-11, occur-34)
prep_during(occur-34, therapy-36)

For/IN comprehensive/JJ information/NN concerning/VBG laboratory/NN test/NN alterations/NNS associated/VBN with/IN ritonavir/NN ,/, physicians/NNS should/MD refer/VBP to/TO the/DT complete/JJ prescribing/JJ information/NN for/IN NORVIR/NN (/-LRB- ritonavir/NN )/-RRB- ./.

(ROOT (S1 (S (S (PP (IN For) (NP (NP (JJ comprehensive) (NN information)) (VP (VBG concerning) (NP (NP (NN laboratory) (NN test) (NNS alterations)) (VP (VBN associated) (PP (IN with) (NP (NN ritonavir)))))))) (, ,) (NP (NNS physicians)) (VP (MD should) (VP (VBP refer) (PP (TO to) (NP (NP (DT the) (JJ complete) (JJ prescribing) (NN information)) (PP (IN for) (NP (NP (NN NORVIR)) (PRN (-LRB- -LRB-) (NP (NN ritonavir)) (-RRB- -RRB-))))))))) (. .))))

amod(information-3, comprehensive-2)
prep_for(refer-14, information-3)
partmod(information-3, concerning-4)
nn(alterations-7, laboratory-5)
nn(alterations-7, test-6)
dobj(concerning-4, alterations-7)
partmod(alterations-7, associated-8)
prep_with(associated-8, ritonavir-10)
nsubj(refer-14, physicians-12)
aux(refer-14, should-13)
root(ROOT-0, refer-14)
det(information-19, the-16)
amod(information-19, complete-17)
amod(information-19, prescribing-18)
prep_to(refer-14, information-19)
prep_for(information-19, NORVIR-21)
appos(NORVIR-21, ritonavir-23)

Taking/VBG amyl/NN nitrite/NN after/IN drinking/JJ alcohol/NN may/MD worsen/VB side/JJ effects/NNS and/CC may/MD cause/VB severe/JJ hypotension/NN and/CC cardiovascular/JJ collapse/NN ./.

(ROOT (S1 (S (S (S (VP (VBG Taking) (NP (NN amyl) (NN nitrite)) (PP (IN after) (NP (JJ drinking) (NN alcohol))))) (VP (VP (MD may) (VP (VB worsen) (NP (JJ side) (NNS effects)))) (CC and) (VP (MD may) (VP (VB cause) (NP (NP (JJ severe) (NN hypotension)) (CC and) (NP (JJ cardiovascular) (NN collapse))))))) (. .))))

csubj(worsen-8, Taking-1)
nn(nitrite-3, amyl-2)
dobj(Taking-1, nitrite-3)
amod(alcohol-6, drinking-5)
prep_after(Taking-1, alcohol-6)
aux(worsen-8, may-7)
root(ROOT-0, worsen-8)
amod(effects-10, side-9)
dobj(worsen-8, effects-10)
aux(cause-13, may-12)
conj_and(worsen-8, cause-13)
amod(hypotension-15, severe-14)
dobj(cause-13, hypotension-15)
amod(collapse-18, cardiovascular-17)
conj_and(hypotension-15, collapse-18)

Limited/JJ PK/NN and/or/CC PD/NN studies/NNS investigating/VBG possible/JJ interactions/NNS between/IN anagrelide/NN and/CC other/JJ medicinal/NN product/NN s/NNS have/VBP been/VBN conducted/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Limited) (NP (NP (NN PK)) (CC and/or) (NP (NN PD))) (NNS studies)) (VP (VBG investigating) (NP (NP (JJ possible) (NNS interactions)) (PP (IN between) (NP (NN anagrelide)))))) (CC and) (NP (JJ other) (NN medicinal) (NN product) (NNS s))) (VP (VBP have) (VP (VBN been) (VP (VBN conducted))))) (. .))))

amod(studies-5, Limited-1)
nn(studies-5, PK-2)
conj_and/or(PK-2, PD-4)
nsubjpass(conducted-18, studies-5)
partmod(studies-5, investigating-6)
amod(interactions-8, possible-7)
dobj(investigating-6, interactions-8)
prep_between(interactions-8, anagrelide-10)
amod(s-15, other-12)
nn(s-15, medicinal-13)
nn(s-15, product-14)
conj_and(studies-5, s-15)
aux(conducted-18, have-16)
auxpass(conducted-18, been-17)
root(ROOT-0, conducted-18)

In/FW vivo/FW interaction/NN studies/NNS in/IN humans/NNS have/VBP demonstrated/VBN that/IN digoxin/NN and/CC warfarin/NN do/VBP not/RB affect/VB the/DT PK/NN properties/NNS of/IN anagrelide/NN ,/, nor/CC does/VBZ anagrelide/NN affect/VB the/DT PK/NN properties/NNS of/IN digoxin/NN or/CC warfarin/NN ./.

(ROOT (S1 (S (S (NP (NP (ADJP (FW In) (FW vivo)) (NN interaction) (NNS studies)) (PP (IN in) (NP (NNS humans)))) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (S (NP (NP (NN digoxin)) (CC and) (NP (NN warfarin))) (VP (VBP do) (RB not) (VP (VB affect) (NP (NP (DT the) (NN PK) (NNS properties)) (PP (IN of) (NP (NN anagrelide))))))) (, ,) (CC nor) (SINV (VBZ does) (NP (NN anagrelide)) (VP (VB affect) (NP (NP (DT the) (NN PK) (NNS properties)) (PP (IN of) (NP (NP (NN digoxin)) (CC or) (NP (NN warfarin)))))))))))) (. .))))

nn(vivo-2, In-1)
amod(studies-4, vivo-2)
nn(studies-4, interaction-3)
nsubj(demonstrated-8, studies-4)
prep_in(studies-4, humans-6)
aux(demonstrated-8, have-7)
root(ROOT-0, demonstrated-8)
complm(affect-15, that-9)
nsubj(affect-15, digoxin-10)
conj_and(digoxin-10, warfarin-12)
aux(affect-15, do-13)
neg(affect-15, not-14)
ccomp(demonstrated-8, affect-15)
det(properties-18, the-16)
nn(properties-18, PK-17)
dobj(affect-15, properties-18)
prep_of(properties-18, anagrelide-20)
aux(affect-25, does-23)
nsubj(affect-25, anagrelide-24)
conj_nor(affect-15, affect-25)
det(properties-28, the-26)
nn(properties-28, PK-27)
dobj(affect-25, properties-28)
prep_of(properties-28, digoxin-30)
conj_or(digoxin-30, warfarin-32)

Although/IN additional/JJ drug/NN interaction/NN studies/NNS have/VBP not/RB been/VBN conducted/VBN ,/, the/DT most/RBS common/JJ medications/NNS used/VBN concomitantly/RB with/IN anagrelide/NN in/IN clinical/JJ trials/NNS were/VBD aspirin/NN ,/, acetaminophen/NN ,/, furosemide/NN ,/, iron/NN ,/, ranitidine/NN ,/, hydroxyurea/NN ,/, and/CC allopurinol/NN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (JJ additional) (NN drug) (NN interaction) (NNS studies)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN conducted)))))) (, ,) (NP (NP (DT the) (ADJP (RBS most) (JJ common)) (NNS medications)) (VP (VBN used) (PP (RB concomitantly) (IN with) (NP (NN anagrelide))) (PP (IN in) (NP (JJ clinical) (NNS trials))))) (VP (VBD were) (NP (NP (NN aspirin)) (, ,) (NP (NN acetaminophen)) (, ,) (NP (NN furosemide)) (, ,) (NP (NN iron)) (, ,) (NP (NN ranitidine)) (, ,) (NP (NN hydroxyurea)) (, ,) (CC and) (NP (NN allopurinol))))) (. .))))

mark(conducted-9, Although-1)
amod(studies-5, additional-2)
nn(studies-5, drug-3)
nn(studies-5, interaction-4)
nsubjpass(conducted-9, studies-5)
aux(conducted-9, have-6)
neg(conducted-9, not-7)
auxpass(conducted-9, been-8)
advcl(aspirin-23, conducted-9)
det(medications-14, the-11)
advmod(common-13, most-12)
amod(medications-14, common-13)
nsubj(aspirin-23, medications-14)
partmod(medications-14, used-15)
advmod(used-15, concomitantly-16)
prep_with(used-15, anagrelide-18)
amod(trials-21, clinical-20)
prep_in(used-15, trials-21)
cop(aspirin-23, were-22)
root(ROOT-0, aspirin-23)
conj_and(aspirin-23, acetaminophen-25)
conj_and(aspirin-23, furosemide-27)
conj_and(aspirin-23, iron-29)
conj_and(aspirin-23, ranitidine-31)
conj_and(aspirin-23, hydroxyurea-33)
conj_and(aspirin-23, allopurinol-36)

There/EX is/VBZ no/DT clinical/JJ evidence/NN to/TO suggest/VB that/IN anagrelide/NN interacts/VBZ with/IN any/DT of/IN these/DT compounds/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT no) (JJ clinical) (NN evidence)) (S (VP (TO to) (VP (VB suggest) (SBAR (IN that) (S (NP (NN anagrelide)) (VP (VBZ interacts) (PP (IN with) (NP (NP (DT any)) (PP (IN of) (NP (DT these) (NNS compounds)))))))))))))) (. .))))

expl(is-2, There-1)
root(ROOT-0, is-2)
det(evidence-5, no-3)
amod(evidence-5, clinical-4)
nsubj(is-2, evidence-5)
aux(suggest-7, to-6)
infmod(evidence-5, suggest-7)
complm(interacts-10, that-8)
nsubj(interacts-10, anagrelide-9)
ccomp(suggest-7, interacts-10)
prep_with(interacts-10, any-12)
det(compounds-15, these-14)
prep_of(any-12, compounds-15)

An/DT in/FW vivo/FW interaction/NN study/NN in/IN humans/NNS demonstrated/VBD that/IN a/DT single/JJ 1mg/NN dose/NN of/IN anagrelide/NN administered/VBN concomitantly/RB with/IN a/DT single/JJ 900/CD mg/NN dose/NN of/IN aspirin/NN was/VBD generally/RB well/RB tolerated/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT An) (ADJP (FW in) (FW vivo)) (NN interaction) (NN study)) (PP (IN in) (NP (NNS humans)))) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (DT a) (JJ single) (NN 1mg) (NN dose)) (PP (IN of) (NP (NN anagrelide))) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (DT a) (JJ single) (ADJP (CD 900) (NN mg)) (NN dose)) (PP (IN of) (NP (NN aspirin))))))) (VP (VBD was) (ADVP (RB generally)) (VP (ADVP (RB well)) (VBN tolerated))))))) (. .))))

det(study-5, An-1)
nn(vivo-3, in-2)
amod(study-5, vivo-3)
nn(study-5, interaction-4)
nsubj(demonstrated-8, study-5)
prep_in(study-5, humans-7)
root(ROOT-0, demonstrated-8)
complm(tolerated-29, that-9)
det(dose-13, a-10)
amod(dose-13, single-11)
nn(dose-13, 1mg-12)
nsubjpass(tolerated-29, dose-13)
prep_of(dose-13, anagrelide-15)
partmod(dose-13, administered-16)
advmod(administered-16, concomitantly-17)
det(dose-23, a-19)
amod(dose-23, single-20)
number(mg-22, 900-21)
amod(dose-23, mg-22)
prep_with(administered-16, dose-23)
prep_of(dose-23, aspirin-25)
auxpass(tolerated-29, was-26)
advmod(tolerated-29, generally-27)
advmod(tolerated-29, well-28)
ccomp(demonstrated-8, tolerated-29)

No/DT clinically/RB relevant/JJ pharmacokinetic/JJ interactions/NNS between/IN anagrelide/NN and/CC acetylsalicylic/JJ acid/NN were/VBD observed/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (ADJP (RB clinically) (JJ relevant)) (JJ pharmacokinetic) (NNS interactions)) (PP (IN between) (NP (NP (NN anagrelide)) (CC and) (NP (JJ acetylsalicylic) (NN acid))))) (VP (VBD were) (VP (VBN observed)))) (. .))))

det(interactions-5, No-1)
advmod(relevant-3, clinically-2)
amod(interactions-5, relevant-3)
amod(interactions-5, pharmacokinetic-4)
nsubjpass(observed-12, interactions-5)
prep_between(interactions-5, anagrelide-7)
amod(acid-10, acetylsalicylic-9)
conj_and(anagrelide-7, acid-10)
auxpass(observed-12, were-11)
root(ROOT-0, observed-12)

In/IN that/DT same/JJ study/NN ,/, aspirin/NN alone/RB produced/VBD a/DT marked/JJ inhibition/NN in/IN platelet/NN aggregation/NN ex/FW vivo/FW ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT that) (JJ same) (NN study))) (, ,) (NP (NN aspirin)) (ADVP (RB alone)) (VP (VBD produced) (NP (DT a) (JJ marked) (NN inhibition)) (PP (IN in) (NP (NN platelet) (NN aggregation))) (ADVP (FW ex) (FW vivo)))) (. .))))

det(study-4, that-2)
amod(study-4, same-3)
prep_in(produced-8, study-4)
nsubj(produced-8, aspirin-6)
advmod(produced-8, alone-7)
root(ROOT-0, produced-8)
det(inhibition-11, a-9)
amod(inhibition-11, marked-10)
dobj(produced-8, inhibition-11)
nn(aggregation-14, platelet-13)
prep_in(produced-8, aggregation-14)
nn(vivo-16, ex-15)
advmod(produced-8, vivo-16)

Anagrelide/NN alone/RB had/VBD no/DT effect/NN on/IN platelet/NN aggregation/NN ,/, but/CC did/VBD slightly/RB enhance/VB the/DT inhibition/NN of/IN platelet/NN aggregation/NN by/IN aspirin/NN ./.

(ROOT (S1 (S (S (NP (NN Anagrelide)) (ADVP (RB alone)) (VP (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NN platelet) (NN aggregation)))) (, ,) (CC but) (VP (VBD did) (ADVP (RB slightly)) (VP (VB enhance) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NN platelet) (NN aggregation))) (PP (IN by) (NP (NN aspirin)))))))) (. .))))

nsubj(had-3, Anagrelide-1)
advmod(had-3, alone-2)
root(ROOT-0, had-3)
det(effect-5, no-4)
dobj(had-3, effect-5)
nn(aggregation-8, platelet-7)
prep_on(had-3, aggregation-8)
aux(enhance-13, did-11)
advmod(enhance-13, slightly-12)
conj_but(had-3, enhance-13)
det(inhibition-15, the-14)
dobj(enhance-13, inhibition-15)
nn(aggregation-18, platelet-17)
prep_of(inhibition-15, aggregation-18)
prep_by(inhibition-15, aspirin-20)

Anagrelide/NN is/VBZ metabolized/VBN at/IN least/JJS in/IN part/NN by/IN CYP1A2/NN ./.

(ROOT (S1 (S (S (NP (NN Anagrelide)) (VP (VBZ is) (VP (VBN metabolized) (PP (ADVP (IN at) (JJS least)) (IN in) (NP (NN part))) (PP (IN by) (NP (NN CYP1A2)))))) (. .))))

nsubjpass(metabolized-3, Anagrelide-1)
auxpass(metabolized-3, is-2)
root(ROOT-0, metabolized-3)
advmod(metabolized-3, at-4)
pobj(at-4, least-5)
prep_in(metabolized-3, part-7)
agent(metabolized-3, CYP1A2-9)

It/PRP is/VBZ known/VBN that/IN CYP1A2/NN is/VBZ inhibited/VBN by/IN several/JJ medicinal/NN product/NN s/NNS ,/, including/VBG fluvoxamine/NN ,/, and/CC such/IN medicinal/NN product/NN s/NNS could/MD theoretically/RB adversely/RB influence/VB the/DT clearance/NN of/IN anagrelide/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN known) (SBAR (SBAR (IN that) (S (NP (NN CYP1A2)) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NP (JJ several) (NN medicinal) (NN product) (NNS s)) (, ,) (PP (VBG including) (NP (NN fluvoxamine))))))))) (, ,) (CC and) (SBAR (IN such) (S (NP (NN medicinal) (NN product) (NNS s)) (VP (MD could) (ADVP (RB theoretically)) (ADVP (RB adversely)) (VP (VB influence) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN anagrelide)))))))))))) (. .))))

nsubjpass(known-3, It-1)
auxpass(known-3, is-2)
root(ROOT-0, known-3)
complm(inhibited-7, that-4)
nsubjpass(inhibited-7, CYP1A2-5)
auxpass(inhibited-7, is-6)
ccomp(known-3, inhibited-7)
amod(s-12, several-9)
nn(s-12, medicinal-10)
nn(s-12, product-11)
agent(inhibited-7, s-12)
prep_including(s-12, fluvoxamine-15)
mark(influence-25, such-18)
nn(s-21, medicinal-19)
nn(s-21, product-20)
nsubj(influence-25, s-21)
aux(influence-25, could-22)
advmod(influence-25, theoretically-23)
advmod(influence-25, adversely-24)
conj_and(inhibited-7, influence-25)
det(clearance-27, the-26)
dobj(influence-25, clearance-27)
prep_of(clearance-27, anagrelide-29)

Anagrelide/NN demonstrates/VBZ some/DT limited/JJ inhibitory/JJ activity/NN towards/IN CYP1A2/NN which/WDT may/MD present/VBP a/DT theoretical/JJ potential/NN for/IN interaction/NN with/IN other/JJ coadministered/JJ medicinal/NN product/NN s/NNS sharing/VBG that/DT clearance/NN mechanism/NN e.g./FW ./.

(ROOT (S1 (S (S (NP (NN Anagrelide)) (VP (VBZ demonstrates) (NP (NP (DT some) (JJ limited) (JJ inhibitory) (NN activity)) (PP (IN towards) (NP (NN CYP1A2))) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VBP present) (NP (NP (DT a) (JJ theoretical) (NN potential)) (PP (IN for) (NP (NP (NN interaction)) (PP (IN with) (NP (NP (JJ other) (JJ coadministered) (NN medicinal) (NN product) (NNS s)) (VP (VBG sharing) (NP (DT that) (NN clearance) (NN mechanism))))) (ADVP (FW e.g.)))))))))))) (. .))))

nsubj(demonstrates-2, Anagrelide-1)
root(ROOT-0, demonstrates-2)
det(activity-6, some-3)
amod(activity-6, limited-4)
amod(activity-6, inhibitory-5)
dobj(demonstrates-2, activity-6)
nsubj(present-11, activity-6)
prep_towards(activity-6, CYP1A2-8)
aux(present-11, may-10)
rcmod(activity-6, present-11)
det(potential-14, a-12)
amod(potential-14, theoretical-13)
dobj(present-11, potential-14)
prep_for(potential-14, interaction-16)
amod(s-22, other-18)
amod(s-22, coadministered-19)
nn(s-22, medicinal-20)
nn(s-22, product-21)
prep_with(interaction-16, s-22)
partmod(s-22, sharing-23)
det(mechanism-26, that-24)
nn(mechanism-26, clearance-25)
dobj(sharing-23, mechanism-26)
advmod(interaction-16, e.g.-27)

theophylline/NN ./.

(ROOT (S1 (S (NP (NP (NN theophylline)) (. .)))))

root(ROOT-0, theophylline-1)

Anagrelide/NN is/VBZ an/DT inhibitor/NN of/IN cyclic/JJ AMP/NN PDE/NN III/CD ./.

(ROOT (S1 (S (S (NP (NN Anagrelide)) (VP (VBZ is) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (JJ cyclic) (NN AMP) (NN PDE) (CD III)))))) (. .))))

nsubj(inhibitor-4, Anagrelide-1)
cop(inhibitor-4, is-2)
det(inhibitor-4, an-3)
root(ROOT-0, inhibitor-4)
amod(PDE-8, cyclic-6)
nn(PDE-8, AMP-7)
prep_of(inhibitor-4, PDE-8)
num(PDE-8, III-9)

The/DT effects/NNS of/IN medicinal/NN product/NN s/NNS with/IN similar/JJ properties/NNS such/JJ as/IN inotropes/NNS milrinone/NN ,/, enoximone/NN ,/, amrinone/NN ,/, olprinone/NN and/CC cilostazol/NN may/MD be/VB exacerbated/JJ by/IN anagrelide/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NN medicinal) (NN product) (NNS s))) (PP (IN with) (NP (NP (JJ similar) (NNS properties)) (PP (JJ such) (IN as) (NP (NNS inotropes) (NP (NP (NN milrinone)) (, ,) (NP (NN enoximone)) (, ,) (NP (NN amrinone)) (, ,) (NP (NN olprinone)) (CC and) (NP (NN cilostazol)))))))) (VP (MD may) (VP (VB be) (ADJP (JJ exacerbated) (PP (IN by) (NP (NN anagrelide))))))) (. .))))

det(effects-2, The-1)
nsubj(exacerbated-24, effects-2)
nn(s-6, medicinal-4)
nn(s-6, product-5)
prep_of(effects-2, s-6)
amod(properties-9, similar-8)
prep_with(effects-2, properties-9)
prep_such_as(properties-9, inotropes-12)
dep(inotropes-12, milrinone-13)
conj_and(milrinone-13, enoximone-15)
conj_and(milrinone-13, amrinone-17)
conj_and(milrinone-13, olprinone-19)
conj_and(milrinone-13, cilostazol-21)
aux(exacerbated-24, may-22)
cop(exacerbated-24, be-23)
root(ROOT-0, exacerbated-24)
prep_by(exacerbated-24, anagrelide-26)

There/EX is/VBZ a/DT single/JJ case/NN report/NN ,/, which/WDT suggests/VBZ that/IN sucralfate/NN may/MD interfere/VB with/IN anagrelide/NN absorption/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT a) (JJ single) (NN case) (NN report)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN sucralfate)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NN anagrelide) (NN absorption))))))))))))) (. .))))

expl(is-2, There-1)
root(ROOT-0, is-2)
det(report-6, a-3)
amod(report-6, single-4)
nn(report-6, case-5)
nsubj(is-2, report-6)
nsubj(suggests-9, report-6)
rcmod(report-6, suggests-9)
complm(interfere-13, that-10)
nsubj(interfere-13, sucralfate-11)
aux(interfere-13, may-12)
ccomp(suggests-9, interfere-13)
nn(absorption-16, anagrelide-15)
prep_with(interfere-13, absorption-16)

Food/NN has/VBZ no/DT clinically/RB significant/JJ effect/NN on/IN the/DT bioavailability/NN of/IN anagrelide/NN ./.

(ROOT (S1 (S (S (NP (NN Food)) (VP (VBZ has) (NP (DT no) (ADJP (RB clinically) (JJ significant)) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (NN anagrelide))))))) (. .))))

nsubj(has-2, Food-1)
root(ROOT-0, has-2)
det(effect-6, no-3)
advmod(significant-5, clinically-4)
amod(effect-6, significant-5)
dobj(has-2, effect-6)
det(bioavailability-9, the-8)
prep_on(has-2, bioavailability-9)
prep_of(bioavailability-9, anagrelide-11)

Anastrozole/NN inhibited/VBD in/FW vitro/FW metabolic/JJ reactions/NNS catalyzed/VBN by/IN cytochromes/NN P450/NN 1A2/NN ,/, 2C8/9/NN ,/, and/CC 3A4/NN but/CC only/RB at/IN relatively/RB high/JJ concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NN Anastrozole)) (VP (VP (VBD inhibited) (NP (NP (ADJP (FW in) (FW vitro)) (JJ metabolic) (NNS reactions)) (VP (VBN catalyzed) (PP (IN by) (NP (NN cytochromes) (NN P450) (NP (NN 1A2)) (, ,) (NP (NN 2C8/9)) (, ,) (CC and) (NP (NN 3A4))))))) (CC but) (VP (ADVP (RB only)) (PP (IN at) (NP (ADJP (RB relatively) (JJ high)) (NNS concentrations)))))) (. .))))

nsubj(inhibited-2, Anastrozole-1)
root(ROOT-0, inhibited-2)
nn(vitro-4, in-3)
amod(reactions-6, vitro-4)
amod(reactions-6, metabolic-5)
dobj(inhibited-2, reactions-6)
partmod(reactions-6, catalyzed-7)
nn(P450-10, cytochromes-9)
agent(catalyzed-7, P450-10)
dep(P450-10, 1A2-11)
conj_and(P450-10, 2C8/9-13)
conj_and(P450-10, 3A4-16)
conj_but(inhibited-2, only-18)
advmod(high-21, relatively-20)
amod(concentrations-22, high-21)
prep_at(only-18, concentrations-22)

Anastrozole/NN did/VBD not/RB inhibit/VB P450/NN 2A6/NN or/CC the/DT polymorphic/JJ P450/NN 2D6/NN in/IN human/JJ liver/NN microsomes/NNS ./.

(ROOT (S1 (S (S (NP (NN Anastrozole)) (VP (VBD did) (RB not) (VP (VB inhibit) (NP (NP (NP (NN P450) (NN 2A6)) (CC or) (NP (DT the) (JJ polymorphic) (NN P450) (NN 2D6))) (PP (IN in) (NP (JJ human) (NN liver) (NNS microsomes))))))) (. .))))

nsubj(inhibit-4, Anastrozole-1)
aux(inhibit-4, did-2)
neg(inhibit-4, not-3)
root(ROOT-0, inhibit-4)
nn(2A6-6, P450-5)
dobj(inhibit-4, 2A6-6)
det(2D6-11, the-8)
amod(2D6-11, polymorphic-9)
nn(2D6-11, P450-10)
conj_or(2A6-6, 2D6-11)
amod(microsomes-15, human-13)
nn(microsomes-15, liver-14)
prep_in(2A6-6, microsomes-15)

Anastrozole/NN did/VBD not/RB alter/VB the/DT pharmacokinetics/NNS of/IN antipyrine/NN ./.

(ROOT (S1 (S (S (NP (NN Anastrozole)) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN antipyrine))))))) (. .))))

nsubj(alter-4, Anastrozole-1)
aux(alter-4, did-2)
neg(alter-4, not-3)
root(ROOT-0, alter-4)
det(pharmacokinetics-6, the-5)
dobj(alter-4, pharmacokinetics-6)
prep_of(pharmacokinetics-6, antipyrine-8)

Although/IN there/EX have/VBP been/VBN no/DT formal/JJ interaction/NN studies/NNS other/JJ than/IN with/IN antipyrine/NN ,/, based/VBN on/IN these/DT in/FW vivo/FW and/CC in/FW vitro/FW studies/NNS ,/, it/PRP is/VBZ unlikely/JJ that/IN co-administration/NN of/IN a/DT 1/CD mg/NN dose/NN of/IN ARIMIDEX/NN with/IN other/JJ drugs/NNS will/MD result/VB in/IN clinically/RB significant/JJ drug/NN inhibition/NN of/IN cytochrome/NN P450/NN -mediated/JJ metabolism/NN of/IN the/DT other/JJ drugs/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (DT no) (JJ formal) (NN interaction) (NNS studies)) (CONJP (JJ other) (IN than)) (PP (IN with) (NP (NN antipyrine)))))))) (, ,) (PP (VBN based) (PP (IN on) (NP (DT these) (ADJP (ADJP (FW in) (FW vivo)) (CC and) (ADJP (FW in) (FW vitro))) (NNS studies)))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ unlikely) (SBAR (IN that) (S (NP (NP (NN co-administration)) (PP (IN of) (NP (NP (DT a) (ADJP (CD 1) (NN mg)) (NN dose)) (PP (IN of) (NP (NN ARIMIDEX))))) (PP (IN with) (NP (JJ other) (NNS drugs)))) (VP (MD will) (VP (VB result) (PP (IN in) (NP (NP (ADJP (RB clinically) (JJ significant)) (NN drug) (NN inhibition)) (PP (IN of) (NP (NP (ADJP (NP (NN cytochrome) (NN P450)) (JJ -mediated)) (NN metabolism)) (PP (IN of) (NP (DT the) (JJ other) (NNS drugs)))))))))))))) (. .))))

mark(studies-8, Although-1)
expl(studies-8, there-2)
aux(studies-8, have-3)
cop(studies-8, been-4)
det(studies-8, no-5)
amod(studies-8, formal-6)
nn(studies-8, interaction-7)
advcl(is-25, studies-8)
conj_other(studies-8, with-11)
prep_with(studies-8, antipyrine-12)
prepc_based_on(is-25, on-15)
det(studies-22, these-16)
nn(vivo-18, in-17)
amod(studies-22, vivo-18)
nn(vitro-21, in-20)
conj_and(vivo-18, vitro-21)
pobj(is-25, studies-22)
nsubj(is-25, it-24)
root(ROOT-0, is-25)
acomp(is-25, unlikely-26)
complm(result-40, that-27)
nsubj(result-40, co-administration-28)
det(dose-33, a-30)
number(mg-32, 1-31)
amod(dose-33, mg-32)
prep_of(co-administration-28, dose-33)
prep_of(dose-33, ARIMIDEX-35)
amod(drugs-38, other-37)
prep_with(co-administration-28, drugs-38)
aux(result-40, will-39)
ccomp(unlikely-26, result-40)
advmod(significant-43, clinically-42)
amod(inhibition-45, significant-43)
nn(inhibition-45, drug-44)
prep_in(result-40, inhibition-45)
nn(P450-48, cytochrome-47)
npadvmod(-mediated-49, P450-48)
amod(metabolism-50, -mediated-49)
prep_of(inhibition-45, metabolism-50)
det(drugs-54, the-52)
amod(drugs-54, other-53)
prep_of(metabolism-50, drugs-54)

An/DT interaction/NN study/NN with/IN warfarin/NN showed/VBD no/DT clinically/RB significant/JJ effect/NN of/IN anastrozole/NN on/IN warfarin/NN pharmacokinetics/NNS or/CC anticoagulant/JJ activity/NN ./.

(ROOT (S1 (S (S (NP (NP (DT An) (NN interaction) (NN study)) (PP (IN with) (NP (NN warfarin)))) (VP (VBD showed) (NP (NP (DT no) (ADJP (RB clinically) (JJ significant)) (NN effect)) (PP (IN of) (NP (NN anastrozole))) (PP (IN on) (NP (NP (NN warfarin) (NNS pharmacokinetics)) (CC or) (NP (JJ anticoagulant) (NN activity))))))) (. .))))

det(study-3, An-1)
nn(study-3, interaction-2)
nsubj(showed-6, study-3)
prep_with(study-3, warfarin-5)
root(ROOT-0, showed-6)
det(effect-10, no-7)
advmod(significant-9, clinically-8)
amod(effect-10, significant-9)
dobj(showed-6, effect-10)
prep_of(effect-10, anastrozole-12)
nn(pharmacokinetics-15, warfarin-14)
prep_on(effect-10, pharmacokinetics-15)
amod(activity-18, anticoagulant-17)
conj_or(pharmacokinetics-15, activity-18)

At/IN a/DT median/NN follow-up/NN of/IN 33/CD months/NNS ,/, the/DT combination/NN of/IN ARIMIDEX/NN and/CC tamoxifen/NN did/VBD not/RB demonstrate/VB any/DT efficacy/NN benefit/NN when/WRB compared/VBN with/IN tamoxifen/NN in/IN all/DT patients/NNS as/RB well/RB as/IN in/IN the/DT hormone/NN receptor/NN -positive/JJ subpopulation/NN ./.

(ROOT (S1 (S (S (PP (IN At) (NP (NP (DT a) (NN median) (NN follow-up)) (PP (IN of) (NP (CD 33) (NNS months))))) (, ,) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NP (NN ARIMIDEX)) (CC and) (NP (NN tamoxifen))))) (VP (VBD did) (RB not) (VP (VB demonstrate) (NP (DT any) (NN efficacy) (NN benefit))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (IN with) (NP (NP (NN tamoxifen)) (PP (PP (IN in) (NP (DT all) (NNS patients))) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (DT the) (NN hormone) (NN receptor) (JJ -positive) (NN subpopulation))))))))))) (. .))))

det(follow-up-4, a-2)
nn(follow-up-4, median-3)
prep_at(demonstrate-17, follow-up-4)
num(months-7, 33-6)
prep_of(follow-up-4, months-7)
det(combination-10, the-9)
nsubj(demonstrate-17, combination-10)
prep_of(combination-10, ARIMIDEX-12)
conj_and(ARIMIDEX-12, tamoxifen-14)
aux(demonstrate-17, did-15)
neg(demonstrate-17, not-16)
root(ROOT-0, demonstrate-17)
det(benefit-20, any-18)
nn(benefit-20, efficacy-19)
dobj(demonstrate-17, benefit-20)
advmod(compared-22, when-21)
advcl(demonstrate-17, compared-22)
prep_with(compared-22, tamoxifen-24)
det(patients-27, all-26)
prep_in(tamoxifen-24, patients-27)
det(subpopulation-36, the-32)
nn(subpopulation-36, hormone-33)
nn(subpopulation-36, receptor-34)
amod(subpopulation-36, -positive-35)
conj_and(patients-27, subpopulation-36)

Based/VBN on/IN clinical/JJ and/CC pharmacokinetic/JJ results/NNS from/IN the/DT ATAC/NN trial/NN ,/, tamoxifen/NN should/MD not/RB be/VB administered/VBN with/IN anastrozole/NN (/-LRB- see/VB CLINICAL/JJ PHARMACOLOGY/NN @/NN Drug/NN Interactions/NNS and/CC CLINICAL/JJ PHARMACOLOGY/NN -/CC Clinical/JJ Studies/NNS -/: Adjuvant/JJ Treatment/NN of/IN Breast/NN Cancer/NN in/IN Postmenopausal/JJ Women/NNS subsections/VBZ )./NN

(ROOT (S1 (S (PP (VBN Based) (PP (IN on) (NP (NP (ADJP (ADJP (JJ clinical)) (CC and) (ADJP (JJ pharmacokinetic))) (NNS results)) (PP (IN from) (NP (DT the) (NN ATAC) (NN trial)))))) (, ,) (S (S (NP (NN tamoxifen)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (NN anastrozole))))))) (S (-LRB- -LRB-) (VP (VB see) (NP (JJ CLINICAL) (NN PHARMACOLOGY) (NP (NN @) (NN Drug) (NNS Interactions)) (CC and) (NP (NP (NP (JJ CLINICAL) (NN PHARMACOLOGY)) (CC -) (NP (JJ Clinical) (NNS Studies))) (: -) (S (NP (NP (JJ Adjuvant) (NN Treatment)) (PP (IN of) (NP (NN Breast) (NN Cancer))) (PP (IN in) (NP (JJ Postmenopausal) (NNS Women)))) (VP (VBZ subsections) (NP (NN -RRB-.))))))))))))

prepc_based_on(administered-16, on-2)
amod(results-6, clinical-3)
conj_and(clinical-3, pharmacokinetic-5)
pobj(administered-16, results-6)
det(trial-10, the-8)
nn(trial-10, ATAC-9)
prep_from(results-6, trial-10)
nsubjpass(administered-16, tamoxifen-12)
aux(administered-16, should-13)
neg(administered-16, not-14)
auxpass(administered-16, be-15)
root(ROOT-0, administered-16)
prep_with(administered-16, anastrozole-18)
dep(administered-16, see-20)
amod(PHARMACOLOGY-22, CLINICAL-21)
dobj(see-20, PHARMACOLOGY-22)
nn(Interactions-25, @-23)
nn(Interactions-25, Drug-24)
dep(PHARMACOLOGY-22, Interactions-25)
amod(PHARMACOLOGY-28, CLINICAL-27)
conj_and(PHARMACOLOGY-22, PHARMACOLOGY-28)
amod(Studies-31, Clinical-30)
conj(PHARMACOLOGY-28, Studies-31)
amod(Treatment-34, Adjuvant-33)
nsubj(subsections-41, Treatment-34)
nn(Cancer-37, Breast-36)
prep_of(Treatment-34, Cancer-37)
amod(Women-40, Postmenopausal-39)
prep_in(Treatment-34, Women-40)
dep(PHARMACOLOGY-28, subsections-41)
dobj(subsections-41, -RRB-.-42)

Co-administration/NN of/IN anastrozole/NN and/CC tamoxifen/NN resulted/VBD in/IN a/DT reduction/NN of/IN anastrozole/NN plasma/NN levels/NNS by/IN 27/CD %/NN compared/VBN with/IN those/DT achieved/VBN with/IN anastrozole/NN alone/RB ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NP (NN anastrozole)) (CC and) (NP (NN tamoxifen))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (NN reduction)) (PP (IN of) (NP (NN anastrozole) (NN plasma) (NNS levels))) (PP (IN by) (NP (CD 27) (NN %))))) (PP (VBN compared) (PP (IN with) (NP (NP (DT those)) (VP (VBN achieved) (PP (IN with) (NP (NP (NN anastrozole)) (ADVP (RB alone)))))))))) (. .))))

nsubj(resulted-6, Co-administration-1)
prep_of(Co-administration-1, anastrozole-3)
conj_and(anastrozole-3, tamoxifen-5)
root(ROOT-0, resulted-6)
det(reduction-9, a-8)
prep_in(resulted-6, reduction-9)
nn(levels-13, anastrozole-11)
nn(levels-13, plasma-12)
prep_of(reduction-9, levels-13)
num(%-16, 27-15)
prep_by(reduction-9, %-16)
prepc_compared_with(resulted-6, with-18)
pobj(resulted-6, those-19)
partmod(those-19, achieved-20)
prep_with(achieved-20, anastrozole-22)
advmod(anastrozole-22, alone-23)

Estrogen-containing/JJ therapies/NNS should/MD not/RB be/VB used/VBN with/IN ARIMIDEX/NN as/IN they/PRP may/MD diminish/VB its/PRP$ pharmacologic/JJ action/NN ./.

(ROOT (S1 (S (S (NP (JJ Estrogen-containing) (NNS therapies)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN ARIMIDEX))) (SBAR (IN as) (S (NP (PRP they)) (VP (MD may) (VP (VB diminish) (NP (PRP$ its) (JJ pharmacologic) (NN action)))))))))) (. .))))

amod(therapies-2, Estrogen-containing-1)
nsubjpass(used-6, therapies-2)
aux(used-6, should-3)
neg(used-6, not-4)
auxpass(used-6, be-5)
root(ROOT-0, used-6)
prep_with(used-6, ARIMIDEX-8)
mark(diminish-12, as-9)
nsubj(diminish-12, they-10)
aux(diminish-12, may-11)
advcl(used-6, diminish-12)
poss(action-15, its-13)
amod(action-15, pharmacologic-14)
dobj(diminish-12, action-15)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: No/DT clinically/RB significant/JJ changes/NNS in/IN the/DT results/NNS of/IN clinical/JJ laboratory/NN tests/NNS have/VBP been/VBN observed/VBN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (NP (DT No) (ADJP (RB clinically) (JJ significant)) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (JJ clinical) (NN laboratory) (NNS tests)))))) (VP (VBP have) (VP (VBN been) (VP (VBN observed))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
det(changes-9, No-6)
advmod(significant-8, clinically-7)
amod(changes-9, significant-8)
nsubjpass(observed-19, changes-9)
det(results-12, the-11)
prep_in(changes-9, results-12)
amod(tests-16, clinical-14)
nn(tests-16, laboratory-15)
prep_of(results-12, tests-16)
aux(observed-19, have-17)
auxpass(observed-19, been-18)
dep(Interactions-4, observed-19)

Addition/NN or/CC deletion/NN of/IN any/DT drug/NN from/IN the/DT therapeutic/JJ regimen/NN of/IN patients/NNS receiving/VBG oral/JJ anticoagulants/NNS may/MD affect/VB patient/NN response/NN to/TO the/DT anticoagulant/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Addition)) (CC or) (NP (NP (NN deletion)) (PP (IN of) (NP (DT any) (NN drug))) (PP (IN from) (NP (NP (DT the) (JJ therapeutic) (NN regimen)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ oral) (NNS anticoagulants))))))))) (VP (MD may) (VP (VB affect) (NP (NP (NN patient) (NN response)) (PP (TO to) (NP (DT the) (NN anticoagulant))))))) (. .))))

nsubj(affect-17, Addition-1)
conj_or(Addition-1, deletion-3)
det(drug-6, any-5)
prep_of(deletion-3, drug-6)
det(regimen-10, the-8)
amod(regimen-10, therapeutic-9)
prep_from(deletion-3, regimen-10)
prep_of(regimen-10, patients-12)
partmod(patients-12, receiving-13)
amod(anticoagulants-15, oral-14)
dobj(receiving-13, anticoagulants-15)
aux(affect-17, may-16)
root(ROOT-0, affect-17)
nn(response-19, patient-18)
dobj(affect-17, response-19)
det(anticoagulant-22, the-21)
prep_to(response-19, anticoagulant-22)

Frequent/JJ determination/NN of/IN prothrombin/NN time/NN and/CC close/JJ monitoring/NN of/IN the/DT patient/NN is/VBZ essential/JJ to/TO ascertain/VB when/WRB adjustment/NN of/IN dosage/NN of/IN anticoagulant/NN may/MD be/VB needed/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (JJ Frequent) (NN determination)) (PP (IN of) (NP (NN prothrombin) (NN time)))) (CC and) (NP (JJ close) (NN monitoring))) (PP (IN of) (NP (DT the) (NN patient)))) (VP (VBZ is) (ADJP (JJ essential) (S (VP (TO to) (VP (VB ascertain) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN adjustment)) (PP (IN of) (NP (NP (NN dosage)) (PP (IN of) (NP (NN anticoagulant)))))) (VP (MD may) (VP (VB be) (VP (VBN needed)))))))))))) (. .))))

amod(determination-2, Frequent-1)
nsubj(essential-13, determination-2)
nn(time-5, prothrombin-4)
prep_of(determination-2, time-5)
amod(monitoring-8, close-7)
conj_and(determination-2, monitoring-8)
det(patient-11, the-10)
prep_of(determination-2, patient-11)
cop(essential-13, is-12)
root(ROOT-0, essential-13)
aux(ascertain-15, to-14)
xcomp(essential-13, ascertain-15)
advmod(needed-24, when-16)
nsubjpass(needed-24, adjustment-17)
prep_of(adjustment-17, dosage-19)
prep_of(dosage-19, anticoagulant-21)
aux(needed-24, may-22)
auxpass(needed-24, be-23)
advcl(ascertain-15, needed-24)

Because/IN of/IN the/DT variability/NN of/IN individual/JJ patient/NN response/NN ,/, multiple/JJ interacting/VBG mechanisms/NNS with/IN some/DT drugs/NNS ,/, the/DT dependency/NN of/IN the/DT extent/NN of/IN the/DT interaction/NN on/IN the/DT dosage/NN and/CC duration/NN of/IN therapy/NN ,/, and/CC the/DT possible/JJ administration/NN of/IN several/JJ interacting/VBG drugs/NNS simultaneously/RB ,/, it/PRP is/VBZ difficult/JJ to/TO predict/VB the/DT direction/NN and/CC degree/NN of/IN the/DT ultimate/JJ effect/NN of/IN concomitant/JJ medications/NNS on/IN anticoagulant/JJ response/NN ./.

(ROOT (S1 (S (PP (IN Because) (PP (IN of) (NP (NP (NP (DT the) (NN variability)) (PP (IN of) (NP (JJ individual) (NN patient) (NN response)))) (, ,) (NP (NP (JJ multiple) (VBG interacting) (NNS mechanisms)) (PP (IN with) (NP (DT some) (NNS drugs)))) (, ,) (NP (NP (DT the) (NN dependency)) (PP (IN of) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NP (DT the) (NN interaction)) (PP (IN on) (NP (NP (DT the) (NP (NN dosage)) (CC and) (NP (NN duration))) (PP (IN of) (NP (NN therapy)))))))))) (, ,) (CC and) (NP (NP (DT the) (JJ possible) (NN administration)) (PP (IN of) (NP (NP (JJ several) (VBG interacting) (NNS drugs)) (ADVP (RB simultaneously)))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ difficult) (S (VP (TO to) (VP (VB predict) (NP (NP (DT the) (NP (NN direction)) (CC and) (NP (NN degree))) (PP (IN of) (NP (NP (DT the) (JJ ultimate) (NN effect)) (PP (IN of) (NP (JJ concomitant) (NNS medications))) (PP (IN on) (NP (JJ anticoagulant) (NN response))))))))))) (. .))))

prepc_because_of(difficult-45, of-2)
det(variability-4, the-3)
pobj(difficult-45, variability-4)
amod(response-8, individual-6)
nn(response-8, patient-7)
prep_of(variability-4, response-8)
amod(mechanisms-12, multiple-10)
amod(mechanisms-12, interacting-11)
conj_and(variability-4, mechanisms-12)
det(drugs-15, some-14)
prep_with(mechanisms-12, drugs-15)
det(dependency-18, the-17)
conj_and(variability-4, dependency-18)
det(extent-21, the-20)
prep_of(dependency-18, extent-21)
det(interaction-24, the-23)
prep_of(extent-21, interaction-24)
dep(dosage-27, the-26)
prep_on(interaction-24, dosage-27)
conj_and(dosage-27, duration-29)
prep_of(dosage-27, therapy-31)
det(administration-36, the-34)
amod(administration-36, possible-35)
conj_and(variability-4, administration-36)
amod(drugs-40, several-38)
amod(drugs-40, interacting-39)
prep_of(administration-36, drugs-40)
advmod(drugs-40, simultaneously-41)
nsubj(difficult-45, it-43)
cop(difficult-45, is-44)
root(ROOT-0, difficult-45)
aux(predict-47, to-46)
xcomp(difficult-45, predict-47)
dep(direction-49, the-48)
dobj(predict-47, direction-49)
conj_and(direction-49, degree-51)
det(effect-55, the-53)
amod(effect-55, ultimate-54)
prep_of(direction-49, effect-55)
amod(medications-58, concomitant-57)
prep_of(effect-55, medications-58)
amod(response-61, anticoagulant-60)
prep_on(effect-55, response-61)

For/IN example/NN ,/, since/IN cholestyramine/NN may/MD reduce/VB the/DT gastrointestinal/JJ absorption/NN of/IN both/CC the/DT oral/JJ anticoagulants/NNS and/CC vitamin/NN K/NN ,/, the/DT net/JJ effects/NNS are/VBP unpredictable/JJ ./.

(ROOT (S1 (S (S (PP (IN For) (NP (NN example))) (, ,) (SBAR (IN since) (S (NP (NN cholestyramine)) (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (JJ gastrointestinal) (NN absorption)) (PP (IN of) (NP (CC both) (NP (DT the) (JJ oral) (NNS anticoagulants)) (CC and) (NP (NN vitamin) (NN K))))))))) (, ,) (NP (DT the) (JJ net) (NNS effects)) (VP (VBP are) (ADJP (JJ unpredictable)))) (. .))))

prep_for(unpredictable-24, example-2)
mark(reduce-7, since-4)
nsubj(reduce-7, cholestyramine-5)
aux(reduce-7, may-6)
advcl(unpredictable-24, reduce-7)
det(absorption-10, the-8)
amod(absorption-10, gastrointestinal-9)
dobj(reduce-7, absorption-10)
preconj(anticoagulants-15, both-12)
det(anticoagulants-15, the-13)
amod(anticoagulants-15, oral-14)
prep_of(absorption-10, anticoagulants-15)
nn(K-18, vitamin-17)
conj_and(anticoagulants-15, K-18)
det(effects-22, the-20)
amod(effects-22, net-21)
nsubj(unpredictable-24, effects-22)
cop(unpredictable-24, are-23)
root(ROOT-0, unpredictable-24)

Chloral/JJ hydrate/NN may/MD cause/VB an/DT increased/VBN prothrombin/NN response/NN by/IN displacing/VBG the/DT anticoagulant/NN from/IN protein/NN binding/NN sites/NNS or/CC a/DT diminished/VBN prothrombin/NN response/NN through/IN increased/VBN metabolism/NN of/IN the/DT unbound/JJ drug/NN by/IN hepatic/JJ enzyme/NN induction/NN ,/, thus/RB leading/VBG to/TO inter-patient/JJ variation/NN in/IN ultimate/JJ prothrombin/NN effect/NN ./.

(ROOT (S1 (S (S (NP (JJ Chloral) (NN hydrate)) (VP (MD may) (VP (VB cause) (NP (DT an) (VBN increased) (NN prothrombin) (NN response)) (PP (IN by) (S (VP (VBG displacing) (NP (NP (DT the) (NN anticoagulant)) (PP (IN from) (NP (NP (NN protein) (NN binding) (NNS sites)) (CC or) (NP (DT a) (VBN diminished) (NN prothrombin) (NN response))))) (PP (IN through) (NP (NP (VBN increased) (NN metabolism)) (PP (IN of) (NP (DT the) (JJ unbound) (NN drug)))))))) (PP (IN by) (NP (JJ hepatic) (NN enzyme) (NN induction))) (, ,) (S (ADVP (RB thus)) (VP (VBG leading) (PP (TO to) (NP (NP (JJ inter-patient) (NN variation)) (PP (IN in) (NP (JJ ultimate) (NN prothrombin) (NN effect)))))))))) (. .))))

amod(hydrate-2, Chloral-1)
nsubj(cause-4, hydrate-2)
aux(cause-4, may-3)
root(ROOT-0, cause-4)
det(response-8, an-5)
amod(response-8, increased-6)
nn(response-8, prothrombin-7)
dobj(cause-4, response-8)
prepc_by(cause-4, displacing-10)
det(anticoagulant-12, the-11)
dobj(displacing-10, anticoagulant-12)
nn(sites-16, protein-14)
nn(sites-16, binding-15)
prep_from(anticoagulant-12, sites-16)
det(response-21, a-18)
amod(response-21, diminished-19)
nn(response-21, prothrombin-20)
conj_or(sites-16, response-21)
amod(metabolism-24, increased-23)
prep_through(displacing-10, metabolism-24)
det(drug-28, the-26)
amod(drug-28, unbound-27)
prep_of(metabolism-24, drug-28)
amod(induction-32, hepatic-30)
nn(induction-32, enzyme-31)
prep_by(cause-4, induction-32)
advmod(leading-35, thus-34)
partmod(cause-4, leading-35)
xcomp(cause-4, leading-35)
amod(variation-38, inter-patient-37)
prep_to(leading-35, variation-38)
amod(effect-42, ultimate-40)
nn(effect-42, prothrombin-41)
prep_in(variation-38, effect-42)

An/DT interacting/VBG drug/NN which/WDT leads/VBZ to/TO a/DT decrease/NN in/IN prothrombin/NN time/NN necessitating/VBG an/DT increased/VBN dose/NN of/IN oral/JJ anticoagulant/NN to/TO maintain/VB an/DT adequate/JJ degree/NN of/IN anticoagulation/NN may/MD ,/, if/IN abruptly/RB discontinued/VBN ,/, increase/VB the/DT risk/NN of/IN subsequent/JJ bleeding/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT An) (VBG interacting) (NN drug)) (SBAR (WHNP (WDT which)) (S (VP (VBZ leads) (PP (TO to) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NN prothrombin) (NN time))))) (S (VP (VBG necessitating) (NP (NP (DT an) (VBN increased) (NN dose)) (PP (IN of) (NP (JJ oral) (NN anticoagulant)))) (S (VP (TO to) (VP (VB maintain) (NP (NP (DT an) (JJ adequate) (NN degree)) (PP (IN of) (NP (NN anticoagulation))))))))))))) (VP (MD may) (, ,) (SBAR (IN if) (S (ADVP (RB abruptly)) (VP (VBN discontinued)))) (, ,) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ subsequent) (JJ bleeding))))))) (. .))))

det(drug-3, An-1)
amod(drug-3, interacting-2)
nsubj(leads-5, drug-3)
nsubj(increase-32, drug-3)
rcmod(drug-3, leads-5)
det(decrease-8, a-7)
prep_to(leads-5, decrease-8)
nn(time-11, prothrombin-10)
prep_in(decrease-8, time-11)
xcomp(leads-5, necessitating-12)
det(dose-15, an-13)
amod(dose-15, increased-14)
dobj(necessitating-12, dose-15)
amod(anticoagulant-18, oral-17)
prep_of(dose-15, anticoagulant-18)
aux(maintain-20, to-19)
xcomp(necessitating-12, maintain-20)
det(degree-23, an-21)
amod(degree-23, adequate-22)
dobj(maintain-20, degree-23)
prep_of(degree-23, anticoagulation-25)
aux(increase-32, may-26)
mark(discontinued-30, if-28)
advmod(discontinued-30, abruptly-29)
advcl(increase-32, discontinued-30)
root(ROOT-0, increase-32)
det(risk-34, the-33)
dobj(increase-32, risk-34)
amod(bleeding-37, subsequent-36)
prep_of(risk-34, bleeding-37)

Drugs/NNS that/WDT have/VBP been/VBN reported/VBN to/TO diminish/VB oral/JJ anticoagulant/NN response/NN ,/, ie/NN ,/, decreased/VBN prothrom-bin/JJ time/NN response/NN ,/, in/IN man/NN significantly/RB include/VBP :/: adrenocortical/JJ steroids/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB diminish) (NP (NP (JJ oral) (NN anticoagulant) (NN response)) (, ,) (NP (NN ie)) (, ,) (NP (VBN decreased) (JJ prothrom-bin) (NN time) (NN response)) (, ,)) (PP (IN in) (NP (NN man)))))))))))) (ADVP (RB significantly)) (VP (VBP include) (: :) (NP (JJ adrenocortical) (NNS steroids))) (: ;)) (. .))))

nsubjpass(reported-5, Drugs-1)
nsubj(include-22, Drugs-1)
aux(reported-5, have-3)
auxpass(reported-5, been-4)
rcmod(Drugs-1, reported-5)
aux(diminish-7, to-6)
xcomp(reported-5, diminish-7)
amod(response-10, oral-8)
nn(response-10, anticoagulant-9)
dobj(diminish-7, response-10)
appos(response-10, ie-12)
amod(response-17, decreased-14)
amod(response-17, prothrom-bin-15)
nn(response-17, time-16)
appos(response-10, response-17)
prep_in(diminish-7, man-20)
advmod(include-22, significantly-21)
root(ROOT-0, include-22)
amod(steroids-25, adrenocortical-24)
dobj(include-22, steroids-25)

alcohol/NN */VBZ ;/: ./.

(ROOT (S1 (S (S (NP (NN alcohol)) (VP (VBZ *)) (: ;)) (. .))))

nsubj(*-2, alcohol-1)
root(ROOT-0, *-2)

antacids/NNS ;/: ./.

(ROOT (S1 (S (NP (NP (NNS antacids) (: ;)) (. .)))))

root(ROOT-0, antacids-1)

antihistamines/NNS ;/: ./.

(ROOT (S1 (S (NP (NP (NNS antihistamines) (: ;)) (. .)))))

root(ROOT-0, antihistamines-1)

barbiturates/NNS ;/: ./.

(ROOT (S1 (S (NP (NP (NNS barbiturates) (: ;)) (. .)))))

root(ROOT-0, barbiturates-1)

carbamazepine/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN carbamazepine) (: ;)) (. .)))))

root(ROOT-0, carbamazepine-1)

chloral/JJ hydrate/NN */VBZ ;/: ./.

(ROOT (S1 (S (S (NP (JJ chloral) (NN hydrate)) (VP (VBZ *)) (: ;)) (. .))))

amod(hydrate-2, chloral-1)
nsubj(*-3, hydrate-2)
root(ROOT-0, *-3)

chlordiazepoxide/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN chlordiazepoxide) (: ;)) (. .)))))

root(ROOT-0, chlordiazepoxide-1)

cholestyramine/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN cholestyramine) (: ;)) (. .)))))

root(ROOT-0, cholestyramine-1)

diet/NN high/JJ in/IN vitamin/NN K/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN diet)) (VP (JJ high) (PP (IN in) (NP (NN vitamin) (NN K)))) (: ;)) (. .))))

nsubj(high-2, diet-1)
root(ROOT-0, high-2)
nn(K-5, vitamin-4)
prep_in(high-2, K-5)

diuretics/NN */VBZ ;/: ./.

(ROOT (S1 (S (S (NP (NN diuretics)) (VP (VBZ *)) (: ;)) (. .))))

nsubj(*-2, diuretics-1)
root(ROOT-0, *-2)

ethchlorvynol/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN ethchlorvynol) (: ;)) (. .)))))

root(ROOT-0, ethchlorvynol-1)

glu/NN -tethimide/VBP ;/: ./.

(ROOT (S1 (S (S (NP (NN glu)) (VP (VBP -tethimide)) (: ;)) (. .))))

nsubj(-tethimide-2, glu-1)
root(ROOT-0, -tethimide-2)

griseofulvin/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN griseofulvin) (: ;)) (. .)))))

root(ROOT-0, griseofulvin-1)

haloperidol/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN haloperidol) (: ;)) (. .)))))

root(ROOT-0, haloperidol-1)

meprobamate/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN meprobamate) (: ;)) (. .)))))

root(ROOT-0, meprobamate-1)

oral/JJ contraceptives/NNS ;/: ./.

(ROOT (S1 (S (NP (NP (JJ oral) (NNS contraceptives) (: ;)) (. .)))))

amod(contraceptives-2, oral-1)
root(ROOT-0, contraceptives-2)

paraldehyde/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN paraldehyde) (: ;)) (. .)))))

root(ROOT-0, paraldehyde-1)

primidone/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN primidone) (: ;)) (. .)))))

root(ROOT-0, primidone-1)

ranitidine/NN */VBZ ;/: ./.

(ROOT (S1 (S (S (NP (NN ranitidine)) (VP (VBZ *)) (: ;)) (. .))))

nsubj(*-2, ranitidine-1)
root(ROOT-0, *-2)

rifampin/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN rifampin) (: ;)) (. .)))))

root(ROOT-0, rifampin-1)

vitamin/NN C/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NP (NN vitamin) (NN C)) (: ;)) (. .)))))

nn(C-2, vitamin-1)
root(ROOT-0, C-2)

warfarin/NN sodium/NN under-dosage/JJ ./.

(ROOT (S1 (S (S (NP (NN warfarin)) (VP (NN sodium) (JJ under-dosage))) (. .))))

nsubj(sodium-2, warfarin-1)
root(ROOT-0, sodium-2)
dep(sodium-2, under-dosage-3)

Drugs/NNS that/WDT reportedly/RB may/MD increase/VB oral/JJ anticoagulant/NN response/NN ,/, ie/NN ,/, increased/VBN prothrombin/NN response/NN ,/, in/IN man/NN include/VBP :/: alcohol/NN */NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (ADVP (RB reportedly)) (VP (MD may) (VP (VB increase) (NP (NP (JJ oral) (NN anticoagulant) (NN response)) (, ,) (NP (NN ie)) (, ,) (NP (VBN increased) (NN prothrombin) (NN response)) (, ,)) (PP (IN in) (NP (NN man)))))))) (VP (VBP include) (: :) (NP (NN alcohol) (NN *))) (: ;)) (. .))))

nsubj(increase-5, Drugs-1)
nsubj(include-18, Drugs-1)
advmod(increase-5, reportedly-3)
aux(increase-5, may-4)
rcmod(Drugs-1, increase-5)
amod(response-8, oral-6)
nn(response-8, anticoagulant-7)
dobj(increase-5, response-8)
appos(response-8, ie-10)
amod(response-14, increased-12)
nn(response-14, prothrombin-13)
appos(response-8, response-14)
prep_in(increase-5, man-17)
root(ROOT-0, include-18)
nn(*-21, alcohol-20)
dobj(include-18, *-21)

allopurinol/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN allopurinol) (: ;)) (. .)))))

root(ROOT-0, allopurinol-1)

aminosalicylic/JJ acid/NN ;/: ./.

(ROOT (S1 (S (NP (NP (JJ aminosalicylic) (NN acid) (: ;)) (. .)))))

amod(acid-2, aminosalicylic-1)
root(ROOT-0, acid-2)

amiodarone/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN amiodarone) (: ;)) (. .)))))

root(ROOT-0, amiodarone-1)

anabolic/JJ steroids/NNS ;/: ./.

(ROOT (S1 (S (NP (NP (JJ anabolic) (NNS steroids) (: ;)) (. .)))))

amod(steroids-2, anabolic-1)
root(ROOT-0, steroids-2)

antibiotics/NNS ;/: ./.

(ROOT (S1 (S (NP (NP (NNS antibiotics) (: ;)) (. .)))))

root(ROOT-0, antibiotics-1)

bromelains/NNS ;/: ./.

(ROOT (S1 (S (NP (NP (NNS bromelains) (: ;)) (. .)))))

root(ROOT-0, bromelains-1)

chloral/JJ hydrate/NN */VBZ ;/: ./.

(ROOT (S1 (S (S (NP (JJ chloral) (NN hydrate)) (VP (VBZ *)) (: ;)) (. .))))

amod(hydrate-2, chloral-1)
nsubj(*-3, hydrate-2)
root(ROOT-0, *-3)

chlorpro/NN -pamide/VBP ;/: ./.

(ROOT (S1 (S (S (NP (NN chlorpro)) (VP (VBP -pamide)) (: ;)) (. .))))

nsubj(-pamide-2, chlorpro-1)
root(ROOT-0, -pamide-2)

chymotrypsin/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN chymotrypsin) (: ;)) (. .)))))

root(ROOT-0, chymotrypsin-1)

cimetidine/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN cimetidine) (: ;)) (. .)))))

root(ROOT-0, cimetidine-1)

cinchophen/NNP ;/: ./.

(ROOT (S1 (S (NP (NP (NNP cinchophen) (: ;)) (. .)))))

root(ROOT-0, cinchophen-1)

clofibrate/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN clofibrate) (: ;)) (. .)))))

root(ROOT-0, clofibrate-1)

dextran/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN dextran) (: ;)) (. .)))))

root(ROOT-0, dextran-1)

dextrothyroxine/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN dextrothyroxine) (: ;)) (. .)))))

root(ROOT-0, dextrothyroxine-1)

diazoxide/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN diazoxide) (: ;)) (. .)))))

root(ROOT-0, diazoxide-1)

diflunisal/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN diflunisal) (: ;)) (. .)))))

root(ROOT-0, diflunisal-1)

diuretics/NN */VBZ ;/: ./.

(ROOT (S1 (S (S (NP (NN diuretics)) (VP (VBZ *)) (: ;)) (. .))))

nsubj(*-2, diuretics-1)
root(ROOT-0, *-2)

disulfiram/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN disulfiram) (: ;)) (. .)))))

root(ROOT-0, disulfiram-1)

drugs/NNS affecting/VBG blood/NN elements/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NNS drugs)) (VP (VBG affecting) (NP (NN blood) (NNS elements))) (: ;)) (. .))))

nsubj(affecting-2, drugs-1)
root(ROOT-0, affecting-2)
nn(elements-4, blood-3)
dobj(affecting-2, elements-4)

ethacrynic/JJ acid/NN ;/: ./.

(ROOT (S1 (S (NP (NP (JJ ethacrynic) (NN acid) (: ;)) (. .)))))

amod(acid-2, ethacrynic-1)
root(ROOT-0, acid-2)

fenoprofen/NNP ;/: ./.

(ROOT (S1 (S (NP (NP (NNP fenoprofen) (: ;)) (. .)))))

root(ROOT-0, fenoprofen-1)

glucagon/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN glucagon) (: ;)) (. .)))))

root(ROOT-0, glucagon-1)

hepatotoxic/JJ drugs/NNS ;/: ./.

(ROOT (S1 (S (NP (NP (JJ hepatotoxic) (NNS drugs) (: ;)) (. .)))))

amod(drugs-2, hepatotoxic-1)
root(ROOT-0, drugs-2)

ibuprofen/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN ibuprofen) (: ;)) (. .)))))

root(ROOT-0, ibuprofen-1)

indomethacin/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN indomethacin) (: ;)) (. .)))))

root(ROOT-0, indomethacin-1)

influenza/NN virus/NN vaccine/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NP (NN influenza) (NN virus) (NN vaccine)) (: ;)) (. .)))))

nn(vaccine-3, influenza-1)
nn(vaccine-3, virus-2)
root(ROOT-0, vaccine-3)

inhalation/NN anesthetics/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NN inhalation)) (VP (NNS anesthetics)) (: ;)) (. .))))

nsubj(anesthetics-2, inhalation-1)
root(ROOT-0, anesthetics-2)

mefenamic/JJ acid/NN ;/: ./.

(ROOT (S1 (S (NP (NP (JJ mefenamic) (NN acid) (: ;)) (. .)))))

amod(acid-2, mefenamic-1)
root(ROOT-0, acid-2)

methyldopa/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN methyldopa) (: ;)) (. .)))))

root(ROOT-0, methyldopa-1)

methylphenidate/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN methylphenidate) (: ;)) (. .)))))

root(ROOT-0, methylphenidate-1)

metronidazole/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN metronidazole) (: ;)) (. .)))))

root(ROOT-0, metronidazole-1)

miconazole/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN miconazole) (: ;)) (. .)))))

root(ROOT-0, miconazole-1)

monoamine/NN oxidase/NN inhibitors/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NN monoamine) (NN oxidase)) (VP (NNS inhibitors)) (: ;)) (. .))))

nn(oxidase-2, monoamine-1)
nsubj(inhibitors-3, oxidase-2)
root(ROOT-0, inhibitors-3)

nalidixic/JJ acid/NN ;/: ./.

(ROOT (S1 (S (NP (NP (JJ nalidixic) (NN acid) (: ;)) (. .)))))

amod(acid-2, nalidixic-1)
root(ROOT-0, acid-2)

naproxen/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN naproxen) (: ;)) (. .)))))

root(ROOT-0, naproxen-1)

oxolinic/JJ acid/NN ;/: ./.

(ROOT (S1 (S (NP (NP (JJ oxolinic) (NN acid) (: ;)) (. .)))))

amod(acid-2, oxolinic-1)
root(ROOT-0, acid-2)

oxyphenbutazone/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN oxyphenbutazone) (: ;)) (. .)))))

root(ROOT-0, oxyphenbutazone-1)

phenylbutazone/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN phenylbutazone) (: ;)) (. .)))))

root(ROOT-0, phenylbutazone-1)

phenyramidol/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN phenyramidol) (: ;)) (. .)))))

root(ROOT-0, phenyramidol-1)

prolonged/VBD narcotics/NNS ;/: ./.

(ROOT (S1 (S (S (VP (VBD prolonged) (NP (NNS narcotics) (: ;)))) (. .))))

root(ROOT-0, prolonged-1)
dobj(prolonged-1, narcotics-2)

quinidine/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN quinidine) (: ;)) (. .)))))

root(ROOT-0, quinidine-1)

quinine/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN quinine) (: ;)) (. .)))))

root(ROOT-0, quinine-1)

ranitidine/NN */VBZ ;/: ./.

(ROOT (S1 (S (S (NP (NN ranitidine)) (VP (VBZ *)) (: ;)) (. .))))

nsubj(*-2, ranitidine-1)
root(ROOT-0, *-2)

sali-/JJ cylate/NN s/NNS ;/: sulfinpyrazone/NN ;/: ./.

(ROOT (S1 (S (S (NP (JJ sali-) (NN cylate) (NNS s)) (: ;) (NP (NN sulfinpyrazone)) (: ;)) (. .))))

amod(s-3, sali--1)
nn(s-3, cylate-2)
dep(sulfinpyrazone-5, s-3)
root(ROOT-0, sulfinpyrazone-5)

sulfonamides/NNS ,/, long/RB acting/VBG ;/: ./.

(ROOT (S1 (S (S (NP (NNS sulfonamides)) (VP (, ,) (ADVP (RB long)) (VP (VBG acting))) (: ;)) (. .))))

nsubj(acting-4, sulfonamides-1)
advmod(acting-4, long-3)
root(ROOT-0, acting-4)

sulindac/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN sulindac) (: ;)) (. .)))))

root(ROOT-0, sulindac-1)

thyroid/NN drug/NN s/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NP (NN thyroid) (NN drug) (NN s)) (: ;)) (. .)))))

nn(s-3, thyroid-1)
nn(s-3, drug-2)
root(ROOT-0, s-3)

tolbutamide/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN tolbutamide) (: ;)) (. .)))))

root(ROOT-0, tolbutamide-1)

triclofos/JJ sodium/NN ;/: ./.

(ROOT (S1 (S (S (ADJP (JJ triclofos) (NN sodium) (: ;))) (. .))))

dep(sodium-2, triclofos-1)
root(ROOT-0, sodium-2)

trimethoprim/NN //: sulfamethoxazole/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN trimethoprim)) (: /) (NP (NP (NN sulfamethoxazole)) (: ;)) (. .)))))

root(ROOT-0, trimethoprim-1)
punct(trimethoprim-1, /-2)
dep(trimethoprim-1, sulfamethoxazole-3)

warfarin/NN sodium/NN overdosage/NN ./.

(ROOT (S1 (S (NP (NP (NN warfarin) (NN sodium) (NN overdosage)) (. .)))))

nn(overdosage-3, warfarin-1)
nn(overdosage-3, sodium-2)
root(ROOT-0, overdosage-3)

Oral/JJ anticoagulants/NNS may/MD potentiate/VB the/DT hypoglycemic/JJ action/NN of/IN hypoglycemic/JJ agents/NNS ,/, eg/NN ,/, tolbut-amide/NN and/CC chlorpropamide/NN ,/, by/IN inhibiting/VBG their/PRP$ metabolism/NN in/IN the/DT liver/NN ./.

(ROOT (S1 (S (S (NP (JJ Oral) (NNS anticoagulants)) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (JJ hypoglycemic) (NN action)) (PP (IN of) (NP (NP (JJ hypoglycemic) (NNS agents)) (, ,) (NP (NP (NN eg)) (, ,) (NP (NN tolbut-amide)) (CC and) (NP (NN chlorpropamide))) (, ,)))) (PP (IN by) (S (VP (VBG inhibiting) (NP (NP (PRP$ their) (NN metabolism)) (PP (IN in) (NP (DT the) (NN liver)))))))))) (. .))))

amod(anticoagulants-2, Oral-1)
nsubj(potentiate-4, anticoagulants-2)
aux(potentiate-4, may-3)
root(ROOT-0, potentiate-4)
det(action-7, the-5)
amod(action-7, hypoglycemic-6)
dobj(potentiate-4, action-7)
amod(agents-10, hypoglycemic-9)
prep_of(action-7, agents-10)
appos(agents-10, eg-12)
conj_and(eg-12, tolbut-amide-14)
conj_and(eg-12, chlorpropamide-16)
prepc_by(potentiate-4, inhibiting-19)
poss(metabolism-21, their-20)
dobj(inhibiting-19, metabolism-21)
det(liver-24, the-23)
prep_in(metabolism-21, liver-24)

Because/IN oral/JJ anticoagulants/NNS may/MD interfere/VB with/IN the/DT hepatic/JJ metabolism/NN of/IN phenytoin/NN ,/, toxic/JJ levels/NNS of/IN the/DT anticonvulsant/JJ may/MD occur/VB when/WRB an/DT oral/JJ anticoagulant/NN and/CC pheny-toin/NN are/VBP administered/VBN concurrently/RB ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (JJ oral) (NNS anticoagulants)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (JJ hepatic) (NN metabolism)) (PP (IN of) (NP (NN phenytoin))))))))) (, ,) (NP (NP (JJ toxic) (NNS levels)) (PP (IN of) (NP (DT the) (JJ anticonvulsant)))) (VP (MD may) (VP (VB occur) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT an) (JJ oral) (NN anticoagulant)) (CC and) (NP (NN pheny-toin))) (VP (VBP are) (VP (VBN administered) (ADVP (RB concurrently))))))))) (. .))))

mark(interfere-5, Because-1)
amod(anticoagulants-3, oral-2)
nsubj(interfere-5, anticoagulants-3)
aux(interfere-5, may-4)
advcl(occur-19, interfere-5)
det(metabolism-9, the-7)
amod(metabolism-9, hepatic-8)
prep_with(interfere-5, metabolism-9)
prep_of(metabolism-9, phenytoin-11)
amod(levels-14, toxic-13)
nsubj(occur-19, levels-14)
det(anticonvulsant-17, the-16)
prep_of(levels-14, anticonvulsant-17)
aux(occur-19, may-18)
root(ROOT-0, occur-19)
advmod(administered-27, when-20)
det(anticoagulant-23, an-21)
amod(anticoagulant-23, oral-22)
nsubjpass(administered-27, anticoagulant-23)
conj_and(anticoagulant-23, pheny-toin-25)
auxpass(administered-27, are-26)
advcl(occur-19, administered-27)
advmod(administered-27, concurrently-28)

Drugs/NNS that/WDT reduce/VBP the/DT number/NN of/IN blood/NN platelets/NNS by/IN causing/VBG bone/NN marrow/NN depression/NN (/-LRB- such/JJ as/IN antineoplastic/JJ agents/NNS )/-RRB- or/CC drugs/NNS which/WDT inhibit/VBP platelet/NN function/NN (/-LRB- eg/NN ,/, aspirin/NN and/CC other/JJ non-steroidal/JJ anti-inflammatory/JJ drugs/NNS ,/, dipyridamole/NN ,/, hydrochloroquine/NN ,/, clofibrate/NN ,/, dextran/NN )/-RRB- may/MD increase/VB the/DT bleeding/JJ tendency/NN produced/VBN by/IN anticoagulants/NNS without/IN altering/VBG prothrombin/NN time/NN determinations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP reduce) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN blood) (NNS platelets)))) (PP (IN by) (S (VP (VBG causing) (NP (NP (NP (NN bone) (NN marrow)) (NN depression)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (JJ antineoplastic) (NNS agents)))) (-RRB- -RRB-)))))))))) (CC or) (NP (NNS drugs))) (SBAR (WHNP (WDT which)) (S (VP (VBP inhibit) (NP (NP (NN platelet) (NN function)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NP (NN aspirin)) (CC and) (NP (JJ other) (JJ non-steroidal) (JJ anti-inflammatory) (NNS drugs))) (, ,) (NP (NN dipyridamole)) (, ,) (NP (NN hydrochloroquine)) (, ,) (NP (NN clofibrate)) (, ,) (NP (NN dextran))) (-RRB- -RRB-))))))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (JJ bleeding) (NN tendency)) (VP (VBN produced) (PP (IN by) (NP (NP (NNS anticoagulants)) (PP (IN without) (S (VP (VBG altering) (NP (NN prothrombin) (NN time) (NNS determinations)))))))))))) (. .))))

nsubj(reduce-3, Drugs-1)
nsubj(inhibit-23, Drugs-1)
nsubj(increase-45, Drugs-1)
rcmod(Drugs-1, reduce-3)
det(number-5, the-4)
dobj(reduce-3, number-5)
nn(platelets-8, blood-7)
prep_of(number-5, platelets-8)
prepc_by(reduce-3, causing-10)
nn(marrow-12, bone-11)
nn(depression-13, marrow-12)
dobj(causing-10, depression-13)
amod(agents-18, antineoplastic-17)
prep_such_as(depression-13, agents-18)
conj_or(Drugs-1, drugs-21)
rcmod(Drugs-1, inhibit-23)
nn(function-25, platelet-24)
dobj(inhibit-23, function-25)
dep(function-25, eg-27)
appos(eg-27, aspirin-29)
amod(drugs-34, other-31)
amod(drugs-34, non-steroidal-32)
amod(drugs-34, anti-inflammatory-33)
conj_and(aspirin-29, drugs-34)
appos(eg-27, dipyridamole-36)
appos(eg-27, hydrochloroquine-38)
appos(eg-27, clofibrate-40)
appos(eg-27, dextran-42)
aux(increase-45, may-44)
root(ROOT-0, increase-45)
det(tendency-48, the-46)
amod(tendency-48, bleeding-47)
dobj(increase-45, tendency-48)
partmod(tendency-48, produced-49)
agent(produced-49, anticoagulants-51)
prepc_without(anticoagulants-51, altering-53)
nn(determinations-56, prothrombin-54)
nn(determinations-56, time-55)
dobj(altering-53, determinations-56)

The/DT beneficial/JJ effects/NNS on/IN arterial/JJ thrombus/NN formation/NN from/IN combined/JJ therapy/NN with/IN antiplatelet/JJ and/CC anticoagulant/JJ medication/NN must/MD be/VB weighed/VBN against/IN an/DT increased/VBN risk/NN of/IN inducing/NN hemorrhage/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ beneficial) (NNS effects)) (PP (IN on) (NP (JJ arterial) (NN thrombus) (NN formation))) (PP (IN from) (NP (NP (JJ combined) (NN therapy)) (PP (IN with) (NP (ADJP (ADJP (JJ antiplatelet)) (CC and) (ADJP (JJ anticoagulant))) (NN medication)))))) (VP (MD must) (VP (VB be) (VP (VBN weighed) (PP (IN against) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (NN inducing) (NN hemorrhage))))))))) (. .))))

det(effects-3, The-1)
amod(effects-3, beneficial-2)
nsubjpass(weighed-18, effects-3)
amod(formation-7, arterial-5)
nn(formation-7, thrombus-6)
prep_on(effects-3, formation-7)
amod(therapy-10, combined-9)
prep_from(effects-3, therapy-10)
amod(medication-15, antiplatelet-12)
conj_and(antiplatelet-12, anticoagulant-14)
prep_with(therapy-10, medication-15)
aux(weighed-18, must-16)
auxpass(weighed-18, be-17)
root(ROOT-0, weighed-18)
det(risk-22, an-20)
amod(risk-22, increased-21)
prep_against(weighed-18, risk-22)
nn(hemorrhage-25, inducing-24)
prep_of(risk-22, hemorrhage-25)

Drug/NN /Laboratory/NN Test/NN Interferences/NNS :/: Dicu-marol/NN and/CC indanedione/NN anticoagulant/NN s/NN ,/, including/VBG anisindione/NN ,/, or/CC their/PRP$ metabolites/NNS may/MD color/NN alkaline/NN urine/NN red-orange/JJ ,/, which/WDT may/MD interfere/VB with/IN spectrophotometrically/RB determined/VBN urinary/JJ laboratory/NN tests/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interferences)) (: :) (NP (NP (NN Dicu-marol)) (CC and) (NP (NN indanedione) (NN anticoagulant) (NN s)))) (, ,) (PP (VBG including) (NP (NN anisindione))) (, ,)) (CC or) (NP (PRP$ their) (NNS metabolites))) (VP (MD may) (VP (NN color) (NP (NP (NN alkaline) (NN urine) (JJ red-orange)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (ADJP (RB spectrophotometrically) (VBN determined)) (JJ urinary) (NN laboratory) (NNS tests))))))))))) (. .))))

nn(Interferences-4, Drug-1)
nn(Interferences-4, /Laboratory-2)
nn(Interferences-4, Test-3)
nsubj(color-19, Interferences-4)
dep(Interferences-4, Dicu-marol-6)
nn(s-10, indanedione-8)
nn(s-10, anticoagulant-9)
conj_and(Dicu-marol-6, s-10)
prep_including(Interferences-4, anisindione-13)
poss(metabolites-17, their-16)
conj_or(Interferences-4, metabolites-17)
aux(color-19, may-18)
root(ROOT-0, color-19)
nn(urine-21, alkaline-20)
dobj(color-19, urine-21)
nsubj(interfere-26, urine-21)
amod(urine-21, red-orange-22)
aux(interfere-26, may-25)
rcmod(urine-21, interfere-26)
advmod(determined-29, spectrophotometrically-28)
amod(tests-32, determined-29)
amod(tests-32, urinary-30)
nn(tests-32, laboratory-31)
prep_with(interfere-26, tests-32)

5HT3/NN Antagonists/NNS Based/VBN on/IN reports/NNS of/IN profound/JJ hypotension/NN and/CC loss/NN of/IN consciousness/NN when/WRB apomorphine/NN was/VBD administered/VBN with/IN ondansetron/NN ,/, the/DT concomitant/JJ use/NN of/IN apomorphine/NN with/IN drugs/NNS of/IN the/DT 5HT3/NN antagonist/NN class/NN (/-LRB- including/VBG ,/, for/IN example/NN ,/, ondansetron/NN ,/, granisetron/NN ,/, dolasetron/NN ,/, palonosetron/NN ,/, and/CC alosetron/NN )/-RRB- is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (S (NP (NN 5HT3) (NNS Antagonists)) (VP (VBN Based) (PP (IN on) (NP (NP (NNS reports)) (PP (IN of) (NP (NP (JJ profound) (NN hypotension)) (CC and) (NP (NP (NN loss)) (PP (IN of) (NP (NN consciousness)))))))) (SBAR (WHADVP (WRB when)) (S (NP (NN apomorphine)) (VP (VBD was) (VP (VBN administered) (PP (IN with) (NP (NN ondansetron))))))))) (, ,) (S (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (NN apomorphine))) (PP (IN with) (NP (NP (NNS drugs)) (PP (IN of) (NP (NP (DT the) (NN 5HT3) (NN antagonist) (NN class)) (PRN (-LRB- -LRB-) (S (VP (VBG including) (, ,) (PP (IN for) (NP (NP (NN example)) (, ,) (NP (NN ondansetron)) (, ,) (NP (NN granisetron)) (, ,) (NP (NN dolasetron)) (, ,) (NP (NN palonosetron)) (, ,) (CC and) (NP (NN alosetron)))))) (-RRB- -RRB-))))))) (VP (VBZ is) (VP (VBN contraindicated)))) (. .))))

nn(Antagonists-2, 5HT3-1)
nsubj(Based-3, Antagonists-2)
root(ROOT-0, Based-3)
prep_on(Based-3, reports-5)
amod(hypotension-8, profound-7)
prep_of(reports-5, hypotension-8)
conj_and(hypotension-8, loss-10)
prep_of(loss-10, consciousness-12)
advmod(administered-16, when-13)
nsubjpass(administered-16, apomorphine-14)
auxpass(administered-16, was-15)
advcl(Based-3, administered-16)
prep_with(administered-16, ondansetron-18)
det(use-22, the-20)
amod(use-22, concomitant-21)
nsubjpass(contraindicated-50, use-22)
prep_of(use-22, apomorphine-24)
prep_with(use-22, drugs-26)
det(class-31, the-28)
nn(class-31, 5HT3-29)
nn(class-31, antagonist-30)
prep_of(drugs-26, class-31)
dep(class-31, including-33)
prep_for(including-33, example-36)
conj_and(example-36, ondansetron-38)
conj_and(example-36, granisetron-40)
conj_and(example-36, dolasetron-42)
conj_and(example-36, palonosetron-44)
conj_and(example-36, alosetron-47)
auxpass(contraindicated-50, is-49)
ccomp(Based-3, contraindicated-50)

Antihypertensive/JJ Medications/NNS and/CC Vasodilators/NNS The/DT following/JJ adverse/JJ events/NNS were/VBD experienced/VBN more/RBR commonly/RB in/IN patients/NNS receiving/VBG concomitant/JJ antihypertensive/JJ medications/NNS or/CC vasodilators/NNS (/-LRB- n/NN =/JJ 94/CD )/-RRB- compared/VBN to/TO patients/NNS not/RB receiving/VBG these/DT concomitant/JJ drugs/NNS (/-LRB- n/NN =/JJ 456/CD )/-RRB- :/: hypotension/NN 10/CD %/NN vs/CC 4/CD %/NN ,/, myocardial/JJ infarction/NN 3/CD %/NN vs/CC 1/CD %/NN ,/, serious/JJ pneumonia/NN 5/CD %/NN vs/CC 3/CD %/NN ,/, serious/JJ falls/NNS 9/CD %/NN vs/CC 3/CD %/NN ,/, and/CC bone/NN and/CC joint/NN injuries/NNS 6/CD %/NN vs/CC 2/CD %./NN

(ROOT (S1 (S (NP (NP (JJ Antihypertensive) (NNS Medications)) (CC and) (NP (NNS Vasodilators)) (NP (DT The) (JJ following) (JJ adverse) (NNS events))) (VP (VBD were) (VP (VBN experienced) (ADVP (RBR more) (RB commonly)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (JJ concomitant) (JJ antihypertensive) (NNS medications)) (CC or) (NP (NP (NNS vasodilators)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 94)) (-RRB- -RRB-))))))) (PP (VBN compared) (PP (TO to) (S (NP (NNS patients)) (VP (RB not) (VBG receiving) (NP (NP (NP (DT these) (JJ concomitant) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 456)) (-RRB- -RRB-))) (: :) (NP (NP (NN hypotension) (CD 10) (NN %) (CC vs) (CD 4) (NN %)) (, ,) (NP (NP (JJ myocardial) (NN infarction) (CD 3) (NN %)) (CC vs) (NP (CD 1) (NN %))) (, ,) (NP (NP (JJ serious) (NN pneumonia) (CD 5) (NN %)) (CC vs) (NP (CD 3) (NN %))) (, ,) (NP (NP (JJ serious) (NNS falls)) (CD 9) (NN %) (CC vs) (CD 3) (NN %)) (, ,) (CC and) (NP (NN bone) (CC and) (NN joint) (NNS injuries)) (NP (CD 6) (NN %)) (CC vs) (NP (CD 2) (NN %.)))))))))))))

amod(Medications-2, Antihypertensive-1)
nsubjpass(experienced-10, Medications-2)
conj_and(Medications-2, Vasodilators-4)
det(events-8, The-5)
amod(events-8, following-6)
amod(events-8, adverse-7)
dep(Medications-2, events-8)
auxpass(experienced-10, were-9)
root(ROOT-0, experienced-10)
advmod(commonly-12, more-11)
advmod(experienced-10, commonly-12)
prep_in(experienced-10, patients-14)
partmod(patients-14, receiving-15)
amod(medications-18, concomitant-16)
amod(medications-18, antihypertensive-17)
dobj(receiving-15, medications-18)
conj_or(medications-18, vasodilators-20)
appos(vasodilators-20, n-22)
amod(n-22, =-23)
num(n-22, 94-24)
prepc_compared_to(experienced-10, to-27)
nsubj(receiving-30, patients-28)
neg(receiving-30, not-29)
pcomp(experienced-10, receiving-30)
det(drugs-33, these-31)
amod(drugs-33, concomitant-32)
dobj(receiving-30, drugs-33)
appos(drugs-33, n-35)
amod(n-35, =-36)
num(n-35, 456-37)
nn(%-42, hypotension-40)
num(%-42, 10-41)
dep(drugs-33, %-42)
num(%-45, 4-44)
conj_vs(%-42, %-45)
amod(%-50, myocardial-47)
nn(%-50, infarction-48)
num(%-50, 3-49)
conj_vs(%-42, %-50)
num(%-53, 1-52)
conj_vs(%-50, %-53)
amod(%-58, serious-55)
nn(%-58, pneumonia-56)
num(%-58, 5-57)
conj_vs(%-42, %-58)
num(%-61, 3-60)
conj_vs(%-58, %-61)
amod(falls-64, serious-63)
nn(%-66, falls-64)
num(%-66, 9-65)
conj_vs(%-42, %-66)
num(%-69, 3-68)
conj_vs(%-66, %-69)
nn(injuries-75, bone-72)
conj_and(bone-72, joint-74)
conj_and(%-42, injuries-75)
num(%-77, 6-76)
dep(%-42, %-77)
num(%.-80, 2-79)
conj_vs(%-42, %.-80)

Dopamine/NN Antagonists/NNS :/: Since/IN apomorphine/NN is/VBZ a/DT dopamine/NN agonist/NN ,/, it/PRP is/VBZ possible/JJ that/IN dopamine/NN antagonists/NNS ,/, such/JJ as/IN the/DT neuroleptics/NNS (/-LRB- phenoth-iazines/NN ,/, butyrophenones/NN ,/, thioxanthenes/NN )/-RRB- or/CC metoclopramide/NN ,/, may/MD diminish/VB the/DT effectiveness/NN of/IN APOKYN/NN ./.

(ROOT (S1 (S (NP (NP (NN Dopamine) (NNS Antagonists)) (: :) (S (SBAR (IN Since) (S (NP (NN apomorphine)) (VP (VBZ is) (NP (DT a) (NN dopamine) (NN agonist))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ possible)) (SBAR (IN that) (S (NP (NP (NN dopamine) (NNS antagonists)) (, ,) (PP (JJ such) (IN as) (NP (NP (NP (DT the) (NNS neuroleptics)) (PRN (-LRB- -LRB-) (NP (NP (NN phenoth-iazines)) (, ,) (NP (NN butyrophenones)) (, ,) (NP (NN thioxanthenes))) (-RRB- -RRB-))) (CC or) (NP (NN metoclopramide)))) (, ,)) (VP (MD may) (VP (VB diminish) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (NN APOKYN)))))))))) (. .)))))

nn(Antagonists-2, Dopamine-1)
root(ROOT-0, Antagonists-2)
mark(agonist-9, Since-4)
nsubj(agonist-9, apomorphine-5)
cop(agonist-9, is-6)
det(agonist-9, a-7)
nn(agonist-9, dopamine-8)
advcl(possible-13, agonist-9)
nsubj(possible-13, it-11)
cop(possible-13, is-12)
dep(Antagonists-2, possible-13)
complm(diminish-33, that-14)
nn(antagonists-16, dopamine-15)
nsubj(diminish-33, antagonists-16)
det(neuroleptics-21, the-20)
prep_such_as(antagonists-16, neuroleptics-21)
dep(neuroleptics-21, phenoth-iazines-23)
appos(phenoth-iazines-23, butyrophenones-25)
appos(phenoth-iazines-23, thioxanthenes-27)
conj_or(neuroleptics-21, metoclopramide-30)
aux(diminish-33, may-32)
ccomp(possible-13, diminish-33)
det(effectiveness-35, the-34)
dobj(diminish-33, effectiveness-35)
prep_of(effectiveness-35, APOKYN-37)

Patients/NNS with/IN major/JJ psychotic/JJ disorders/NNS ,/, treated/VBN with/IN neuroleptics/NNS ,/, should/MD be/VB treated/VBN with/IN dopamine/NN agonists/NNS only/RB if/IN the/DT potential/JJ benefits/NNS outweigh/VBP the/DT risks/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (PP (IN with) (NP (JJ major) (JJ psychotic) (NNS disorders))) (, ,) (VP (VBN treated) (PP (IN with) (NP (NNS neuroleptics)))) (, ,)) (VP (MD should) (VP (VB be) (VP (VBN treated) (PP (IN with) (NP (NN dopamine) (NNS agonists))) (SBAR (RB only) (IN if) (S (NP (DT the) (JJ potential) (NNS benefits)) (VP (VBP outweigh) (NP (DT the) (NNS risks))))))))) (. .))))

nsubjpass(treated-13, Patients-1)
amod(disorders-5, major-3)
amod(disorders-5, psychotic-4)
prep_with(Patients-1, disorders-5)
partmod(Patients-1, treated-7)
prep_with(treated-7, neuroleptics-9)
aux(treated-13, should-11)
auxpass(treated-13, be-12)
root(ROOT-0, treated-13)
nn(agonists-16, dopamine-15)
prep_with(treated-13, agonists-16)
advmod(outweigh-22, only-17)
dep(outweigh-22, if-18)
det(benefits-21, the-19)
amod(benefits-21, potential-20)
nsubj(outweigh-22, benefits-21)
ccomp(treated-13, outweigh-22)
det(risks-24, the-23)
dobj(outweigh-22, risks-24)

Drugs/NNS Prolonging/VBG the/DT QT/QTc/NN Interval/NN Caution/NN should/MD be/VB exercised/VBN when/WRB prescribing/VBG apomorphine/NN concomitantly/RB with/IN drugs/NNS that/WDT prolong/VBP the/DT QT/QTc/NN interval/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (VP (VBG Prolonging) (NP (DT the) (NN QT/QTc) (NN Interval) (NN Caution)))) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (VP (VBG prescribing) (NP (NP (NN apomorphine)) (PP (RB concomitantly) (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP prolong) (NP (DT the) (NN QT/QTc) (NN interval))))))))))))))) (. .))))

nsubjpass(exercised-9, Drugs-1)
partmod(Drugs-1, Prolonging-2)
det(Caution-6, the-3)
nn(Caution-6, QT/QTc-4)
nn(Caution-6, Interval-5)
dobj(Prolonging-2, Caution-6)
aux(exercised-9, should-7)
auxpass(exercised-9, be-8)
root(ROOT-0, exercised-9)
advmod(prescribing-11, when-10)
advcl(exercised-9, prescribing-11)
dobj(prescribing-11, apomorphine-12)
advmod(apomorphine-12, concomitantly-13)
prep_with(apomorphine-12, drugs-15)
nsubj(prolong-17, drugs-15)
rcmod(drugs-15, prolong-17)
det(interval-20, the-18)
nn(interval-20, QT/QTc-19)
dobj(prolong-17, interval-20)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: There/EX are/VBP no/DT known/JJ interactions/NNS between/IN APOKYN/NN and/CC laboratory/NN tests/NNS ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (EX There)) (VP (VBP are) (NP (NP (DT no) (JJ known) (NNS interactions)) (PP (IN between) (NP (NP (NN APOKYN)) (CC and) (NP (NN laboratory) (NNS tests))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
expl(are-7, There-6)
dep(Interactions-4, are-7)
det(interactions-10, no-8)
amod(interactions-10, known-9)
nsubj(are-7, interactions-10)
prep_between(interactions-10, APOKYN-12)
nn(tests-15, laboratory-14)
conj_and(APOKYN-12, tests-15)

Apraclonidine/NN should/MD not/RB be/VB used/VBN in/IN patients/NNS receiving/VBG MAO/NN inhibitors/NNS ./. ./.

(ROOT (S1 (S (S (S (NP (NN Apraclonidine)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN MAO) (NNS inhibitors))))))))) (. .)) (. .))))

nsubjpass(used-5, Apraclonidine-1)
aux(used-5, should-2)
neg(used-5, not-3)
auxpass(used-5, be-4)
root(ROOT-0, used-5)
prep_in(used-5, patients-7)
partmod(patients-7, receiving-8)
nn(inhibitors-10, MAO-9)
dobj(receiving-8, inhibitors-10)

Although/IN no/DT specific/JJ drug/NN interactions/NNS with/IN topical/JJ glaucoma/NN drugs/NNS or/CC systemic/JJ medications/NNS were/VBD identified/VBN in/IN clinical/JJ studies/NNS of/IN IOPIDINE/NN @/NN 0.5/CD %/NN Ophthalmic/JJ Solution/NN ,/, the/DT possibility/NN of/IN an/DT additive/JJ or/NN potentiating/NN effect/NN with/IN CNS/NN depressants/NNS (/-LRB- alcohol/NN ,/, barbiturates/NNS ,/, opiates/NNS ,/, sedatives/NNS ,/, anesthetics/NNS )/-RRB- should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (SBAR (IN Although) (S (NP (NP (DT no) (JJ specific) (NN drug) (NNS interactions)) (PP (IN with) (NP (NP (JJ topical) (NN glaucoma) (NNS drugs)) (CC or) (NP (JJ systemic) (NNS medications))))) (VP (VBD were) (VP (VBN identified) (PP (IN in) (NP (NP (JJ clinical) (NNS studies)) (PP (IN of) (NP (NN IOPIDINE) (NN @) (CD 0.5) (NN %) (JJ Ophthalmic) (NN Solution))))))))) (, ,) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (DT an) (JJ additive) (NN or) (NN potentiating) (NN effect)) (PP (IN with) (NP (NP (NN CNS) (NNS depressants)) (PRN (-LRB- -LRB-) (NP (NN alcohol)) (, ,) (NP (NP (NNS barbiturates)) (, ,) (NP (NNS opiates)) (, ,) (NP (NNS sedatives)) (, ,) (NP (NNS anesthetics))) (-RRB- -RRB-))))))) (VP (MD should) (VP (VB be) (VP (VBN considered)))) (. .))))

mark(identified-14, Although-1)
det(interactions-5, no-2)
amod(interactions-5, specific-3)
nn(interactions-5, drug-4)
nsubjpass(identified-14, interactions-5)
amod(drugs-9, topical-7)
nn(drugs-9, glaucoma-8)
prep_with(interactions-5, drugs-9)
amod(medications-12, systemic-11)
conj_or(drugs-9, medications-12)
auxpass(identified-14, were-13)
advcl(considered-50, identified-14)
amod(studies-17, clinical-16)
prep_in(identified-14, studies-17)
nn(Solution-24, IOPIDINE-19)
nn(Solution-24, @-20)
num(Solution-24, 0.5-21)
nn(Solution-24, %-22)
amod(Solution-24, Ophthalmic-23)
prep_of(studies-17, Solution-24)
det(possibility-27, the-26)
nsubjpass(considered-50, possibility-27)
det(effect-33, an-29)
amod(effect-33, additive-30)
nn(effect-33, or-31)
nn(effect-33, potentiating-32)
prep_of(possibility-27, effect-33)
nn(depressants-36, CNS-35)
prep_with(effect-33, depressants-36)
dep(depressants-36, alcohol-38)
dep(alcohol-38, barbiturates-40)
appos(barbiturates-40, opiates-42)
appos(barbiturates-40, sedatives-44)
appos(barbiturates-40, anesthetics-46)
aux(considered-50, should-48)
auxpass(considered-50, be-49)
root(ROOT-0, considered-50)

Tricyclic/JJ antidepressants/NNS have/VBP been/VBN reported/VBN to/TO blunt/VB the/DT hypotensive/JJ effect/NN of/IN systemic/JJ clonidine/NN ./.

(ROOT (S1 (S (S (NP (JJ Tricyclic) (NNS antidepressants)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB blunt) (NP (NP (DT the) (JJ hypotensive) (NN effect)) (PP (IN of) (NP (JJ systemic) (NN clonidine))))))))))) (. .))))

amod(antidepressants-2, Tricyclic-1)
nsubjpass(reported-5, antidepressants-2)
xsubj(blunt-7, antidepressants-2)
aux(reported-5, have-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
aux(blunt-7, to-6)
xcomp(reported-5, blunt-7)
det(effect-10, the-8)
amod(effect-10, hypotensive-9)
dobj(blunt-7, effect-10)
amod(clonidine-13, systemic-12)
prep_of(effect-10, clonidine-13)

It/PRP is/VBZ not/RB known/VBN whether/IN the/DT concurrent/JJ use/NN of/IN these/DT agents/NNS with/IN apraclonidine/NN can/MD lead/VB to/TO a/DT reduction/NN in/IN IOP/NN lowering/JJ effect/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (IN whether) (S (NP (NP (DT the) (JJ concurrent) (NN use)) (PP (IN of) (NP (DT these) (NNS agents))) (PP (IN with) (NP (NN apraclonidine)))) (VP (MD can) (VP (VB lead) (PP (TO to) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NN IOP) (JJ lowering) (NN effect)))))))))))) (. .))))

nsubjpass(known-4, It-1)
auxpass(known-4, is-2)
neg(known-4, not-3)
root(ROOT-0, known-4)
complm(lead-15, whether-5)
det(use-8, the-6)
amod(use-8, concurrent-7)
nsubj(lead-15, use-8)
det(agents-11, these-10)
prep_of(use-8, agents-11)
prep_with(use-8, apraclonidine-13)
aux(lead-15, can-14)
ccomp(known-4, lead-15)
det(reduction-18, a-17)
prep_to(lead-15, reduction-18)
nn(effect-22, IOP-20)
amod(effect-22, lowering-21)
prep_in(reduction-18, effect-22)

No/DT data/NNS on/IN the/DT level/NN of/IN circulating/JJ catecholamines/NNS after/IN apraclonidine/NN withdrawal/NN are/VBP available/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT No) (NNS data)) (PP (IN on) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (JJ circulating) (NNS catecholamines))) (PP (IN after) (NP (NN apraclonidine) (NN withdrawal)))))) (VP (VBP are) (ADJP (JJ available)))) (. .))))

det(data-2, No-1)
nsubj(available-13, data-2)
det(level-5, the-4)
prep_on(data-2, level-5)
amod(catecholamines-8, circulating-7)
prep_of(level-5, catecholamines-8)
nn(withdrawal-11, apraclonidine-10)
prep_after(level-5, withdrawal-11)
cop(available-13, are-12)
root(ROOT-0, available-13)

Caution/NN ,/, however/RB ,/, is/VBZ advised/VBN in/IN patients/NNS taking/VBG tricyclic/JJ antidepressants/NNS which/WDT can/MD affect/VB the/DT metabolism/NN and/CC uptake/NN of/IN circulating/VBG amines/NNS ./.

(ROOT (S1 (S (S (NP (NN Caution)) (, ,) (ADVP (RB however)) (, ,) (VP (VBZ is) (VP (VBN advised) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (JJ tricyclic) (NNS antidepressants)) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB affect) (NP (NP (DT the) (NP (NN metabolism)) (CC and) (NP (NN uptake))) (PP (IN of) (NP (VBG circulating) (NNS amines))))))))))))))) (. .))))

nsubjpass(advised-6, Caution-1)
advmod(advised-6, however-3)
auxpass(advised-6, is-5)
root(ROOT-0, advised-6)
prep_in(advised-6, patients-8)
partmod(patients-8, taking-9)
amod(antidepressants-11, tricyclic-10)
dobj(taking-9, antidepressants-11)
nsubj(affect-14, antidepressants-11)
aux(affect-14, can-13)
rcmod(antidepressants-11, affect-14)
dep(metabolism-16, the-15)
dobj(affect-14, metabolism-16)
conj_and(metabolism-16, uptake-18)
amod(amines-21, circulating-20)
prep_of(metabolism-16, amines-21)

An/DT additive/JJ hypotensive/JJ effect/NN has/VBZ been/VBN reported/VBN with/IN the/DT combination/NN of/IN systemic/JJ clonidine/NN and/CC neuroleptic/JJ therapy/NN ./.

(ROOT (S1 (S (S (NP (DT An) (JJ additive) (JJ hypotensive) (NN effect)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NP (JJ systemic) (NN clonidine)) (CC and) (NP (JJ neuroleptic) (NN therapy)))))))))) (. .))))

det(effect-4, An-1)
amod(effect-4, additive-2)
amod(effect-4, hypotensive-3)
nsubjpass(reported-7, effect-4)
aux(reported-7, has-5)
auxpass(reported-7, been-6)
root(ROOT-0, reported-7)
det(combination-10, the-9)
prep_with(reported-7, combination-10)
amod(clonidine-13, systemic-12)
prep_of(combination-10, clonidine-13)
amod(therapy-16, neuroleptic-15)
conj_and(clonidine-13, therapy-16)

Systemic/JJ clonidine/NN may/MD inhibit/VB the/DT production/NN of/IN catecholamines/NNS in/IN response/NN to/TO insulin-induced/JJ hypoglycemia/NN and/CC mask/VB the/DT signs/NNS and/CC symptoms/NNS of/IN hypoglycemia/NN ./.

(ROOT (S1 (S (S (NP (JJ Systemic) (NN clonidine)) (VP (MD may) (VP (VP (VB inhibit) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NNS catecholamines))) (PP (IN in) (NP (NP (NN response)) (PP (TO to) (NP (JJ insulin-induced) (NN hypoglycemia))))))) (CC and) (VP (VB mask) (NP (NP (DT the) (NP (NNS signs)) (CC and) (NP (NNS symptoms))) (PP (IN of) (NP (NN hypoglycemia)))))))) (. .))))

amod(clonidine-2, Systemic-1)
nsubj(inhibit-4, clonidine-2)
aux(inhibit-4, may-3)
root(ROOT-0, inhibit-4)
det(production-6, the-5)
dobj(inhibit-4, production-6)
prep_of(production-6, catecholamines-8)
prep_in(production-6, response-10)
amod(hypoglycemia-13, insulin-induced-12)
prep_to(response-10, hypoglycemia-13)
conj_and(inhibit-4, mask-15)
dep(signs-17, the-16)
dobj(mask-15, signs-17)
conj_and(signs-17, symptoms-19)
prep_of(signs-17, hypoglycemia-21)

Since/IN apraclonidine/NN may/MD reduce/VB pulse/NN and/CC blood/NN pressure/NN ,/, caution/NN in/IN using/VBG drugs/NNS such/JJ as/IN beta-blockers/NNS (/-LRB- ophthalmic/JJ and/CC systemic/JJ )/-RRB- ,/, antihypertensives/NNS ,/, and/CC cardiac/JJ glycosides/NNS is/VBZ advised/JJ ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NN apraclonidine)) (VP (MD may) (VP (VB reduce) (NP (NP (NN pulse)) (CC and) (NP (NN blood) (NN pressure))))))) (, ,) (NP (NP (NN caution)) (PP (IN in) (S (VP (VBG using) (NP (NP (NNS drugs)) (PP (JJ such) (IN as) (NP (NP (NP (NNS beta-blockers)) (PRN (-LRB- -LRB-) (ADJP (ADJP (JJ ophthalmic)) (CC and) (ADJP (JJ systemic))) (-RRB- -RRB-))) (, ,) (NP (NNS antihypertensives)) (, ,) (CC and) (NP (JJ cardiac) (NNS glycosides))))))))) (VP (VBZ is) (ADJP (JJ advised)))) (. .))))

mark(reduce-4, Since-1)
nsubj(reduce-4, apraclonidine-2)
aux(reduce-4, may-3)
advcl(advised-29, reduce-4)
dobj(reduce-4, pulse-5)
nn(pressure-8, blood-7)
conj_and(pulse-5, pressure-8)
nsubj(advised-29, caution-10)
prepc_in(caution-10, using-12)
dobj(using-12, drugs-13)
prep_such_as(drugs-13, beta-blockers-16)
dep(beta-blockers-16, ophthalmic-18)
conj_and(ophthalmic-18, systemic-20)
conj_and(beta-blockers-16, antihypertensives-23)
amod(glycosides-27, cardiac-26)
conj_and(beta-blockers-16, glycosides-27)
cop(advised-29, is-28)
root(ROOT-0, advised-29)

Patients/NNS using/VBG cardiovascular/JJ drugs/NNS concurrently/RB with/IN IOPIDINE/NN 0/CD .5/CD %/NN Ophthalmic/JJ Solution/NN should/MD have/VB pulse/NN and/CC blood/NN pressures/NNS frequently/RB monitored/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG using) (NP (NP (JJ cardiovascular) (NNS drugs)) (PP (ADVP (RB concurrently)) (IN with) (NP (NN IOPIDINE) (CD 0) (ADJP (CD .5) (NN %)) (JJ Ophthalmic) (NN Solution)))))) (VP (MD should) (VP (VB have) (NP (NP (NN pulse) (CC and) (NN blood) (NNS pressures)) (VP (ADVP (RB frequently)) (VBN monitored)))))) (. .))))

nsubj(have-14, Patients-1)
partmod(Patients-1, using-2)
amod(drugs-4, cardiovascular-3)
dobj(using-2, drugs-4)
advmod(drugs-4, concurrently-5)
nn(Solution-12, IOPIDINE-7)
num(Solution-12, 0-8)
number(%-10, .5-9)
amod(Solution-12, %-10)
amod(Solution-12, Ophthalmic-11)
prep_with(drugs-4, Solution-12)
aux(have-14, should-13)
root(ROOT-0, have-14)
nn(pressures-18, pulse-15)
conj_and(pulse-15, blood-17)
dobj(have-14, pressures-18)
advmod(monitored-20, frequently-19)
partmod(pressures-18, monitored-20)

Caution/NN should/MD be/VB exercised/VBN with/IN simultaneous/JJ use/NN of/IN clonidine/NN and/CC other/JJ similar/JJ pharmacologic/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (PP (IN with) (NP (NP (JJ simultaneous) (NN use)) (PP (IN of) (NP (NP (NN clonidine)) (CC and) (NP (JJ other) (JJ similar) (JJ pharmacologic) (NNS agents)))))))))) (. .))))

nsubjpass(exercised-4, Caution-1)
aux(exercised-4, should-2)
auxpass(exercised-4, be-3)
root(ROOT-0, exercised-4)
amod(use-7, simultaneous-6)
prep_with(exercised-4, use-7)
prep_of(use-7, clonidine-9)
amod(agents-14, other-11)
amod(agents-14, similar-12)
amod(agents-14, pharmacologic-13)
conj_and(clonidine-9, agents-14)

Aprepitant/NN is/VBZ a/DT substrate/NN ,/, a/DT moderate/JJ inhibitor/NN ,/, and/CC an/DT inducer/NN of/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Aprepitant)) (VP (VBZ is) (NP (NP (DT a) (NN substrate)) (, ,) (NP (DT a) (JJ moderate) (NN inhibitor)) (, ,) (CC and) (NP (NP (DT an) (NN inducer)) (PP (IN of) (NP (NN CYP3A4))))))) (. .))))

nsubj(substrate-4, Aprepitant-1)
cop(substrate-4, is-2)
det(substrate-4, a-3)
root(ROOT-0, substrate-4)
det(inhibitor-8, a-6)
amod(inhibitor-8, moderate-7)
conj_and(substrate-4, inhibitor-8)
det(inducer-12, an-11)
conj_and(substrate-4, inducer-12)
prep_of(inducer-12, CYP3A4-14)

Aprepitant/NN is/VBZ also/RB an/DT inducer/NN of/IN CYP2C9/NN ./.

(ROOT (S1 (S (S (NP (NN Aprepitant)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT an) (NN inducer)) (PP (IN of) (NP (NN CYP2C9)))))) (. .))))

nsubj(inducer-5, Aprepitant-1)
cop(inducer-5, is-2)
advmod(inducer-5, also-3)
det(inducer-5, an-4)
root(ROOT-0, inducer-5)
prep_of(inducer-5, CYP2C9-7)

Effect/NN of/IN aprepitant/NN on/IN the/DT pharmacokinetics/NNS of/IN other/JJ agents/NNS ./.

(ROOT (S1 (S (NP (NP (NN Effect)) (PP (IN of) (NP (NN aprepitant))) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (JJ other) (NNS agents))))) (. .)))))

root(ROOT-0, Effect-1)
prep_of(Effect-1, aprepitant-3)
det(pharmacokinetics-6, the-5)
prep_on(Effect-1, pharmacokinetics-6)
amod(agents-9, other-8)
prep_of(pharmacokinetics-6, agents-9)

As/IN a/DT moderate/JJ inhibitor/NN of/IN CYP3A4/NN ,/, aprepitant/NN can/MD increase/VB plasma/NN concentrations/NNS of/IN coadministered/JJ medicinal/JJ product/NN s/NNS that/WDT are/VBP metabolized/VBN through/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (PP (IN As) (NP (NP (DT a) (JJ moderate) (NN inhibitor)) (PP (IN of) (NP (NN CYP3A4))))) (, ,) (NP (NN aprepitant)) (VP (MD can) (VP (VB increase) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (JJ coadministered) (JJ medicinal) (NN product) (NNS s)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN metabolized) (PP (IN through) (NP (NN CYP3A4))))))))))))) (. .))))

det(inhibitor-4, a-2)
amod(inhibitor-4, moderate-3)
prep_as(increase-10, inhibitor-4)
prep_of(inhibitor-4, CYP3A4-6)
nsubj(increase-10, aprepitant-8)
aux(increase-10, can-9)
root(ROOT-0, increase-10)
nn(concentrations-12, plasma-11)
dobj(increase-10, concentrations-12)
amod(s-17, coadministered-14)
amod(s-17, medicinal-15)
nn(s-17, product-16)
prep_of(concentrations-12, s-17)
nsubjpass(metabolized-20, s-17)
auxpass(metabolized-20, are-19)
rcmod(s-17, metabolized-20)
prep_through(metabolized-20, CYP3A4-22)

Aprepitant/NN has/VBZ been/VBN shown/VBN to/TO induce/VB the/DT metabolism/NN of/IN S/NN (/-LRB- -/CC )/-RRB- warfarin/NN and/CC tolbutamide/NN ,/, which/WDT are/VBP metabolized/VBN through/IN CYP2C9/NN ./.

(ROOT (S1 (S (S (NP (NN Aprepitant)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB induce) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NP (NP (NN S)) (-LRB- -LRB-) (CC -) (-RRB- -RRB-) (NP (NN warfarin)) (CC and) (NP (NN tolbutamide))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN metabolized) (PP (IN through) (NP (NN CYP2C9))))))))))))))))) (. .))))

nsubjpass(shown-4, Aprepitant-1)
xsubj(induce-6, Aprepitant-1)
aux(shown-4, has-2)
auxpass(shown-4, been-3)
root(ROOT-0, shown-4)
aux(induce-6, to-5)
xcomp(shown-4, induce-6)
det(metabolism-8, the-7)
dobj(induce-6, metabolism-8)
prep_of(metabolism-8, S-10)
nsubjpass(metabolized-20, S-10)
conj_and(S-10, warfarin-14)
conj_and(S-10, tolbutamide-16)
auxpass(metabolized-20, are-19)
rcmod(S-10, metabolized-20)
prep_through(metabolized-20, CYP2C9-22)

Coadministration/NN of/IN Aprepitant/NN with/IN these/DT drugs/NNS or/CC other/JJ drugs/NNS that/WDT are/VBP known/VBN to/TO be/VB metabolized/VBN by/IN CYP2C9/NN ,/, such/JJ as/IN phenytoin/NN ,/, may/MD result/VB in/IN lower/JJR plasma/NN concentrations/NNS of/IN these/DT drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN Aprepitant))) (PP (IN with) (NP (NP (NP (DT these) (NP (NNS drugs)) (CC or) (NP (JJ other) (NNS drugs))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB be) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP2C9)))))))))))) (, ,) (PP (JJ such) (IN as) (NP (NN phenytoin))) (, ,)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (JJR lower) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (DT these) (NNS drugs)))))))) (. .))))

nsubj(result-24, Coadministration-1)
prep_of(Coadministration-1, Aprepitant-3)
dep(drugs-6, these-5)
prep_with(Coadministration-1, drugs-6)
nsubjpass(known-12, drugs-6)
amod(drugs-9, other-8)
conj_or(drugs-6, drugs-9)
auxpass(known-12, are-11)
rcmod(drugs-6, known-12)
aux(metabolized-15, to-13)
auxpass(metabolized-15, be-14)
xcomp(known-12, metabolized-15)
agent(metabolized-15, CYP2C9-17)
prep_such_as(drugs-6, phenytoin-21)
aux(result-24, may-23)
root(ROOT-0, result-24)
amod(concentrations-28, lower-26)
nn(concentrations-28, plasma-27)
prep_in(result-24, concentrations-28)
det(drugs-31, these-30)
prep_of(concentrations-28, drugs-31)

Aprepitant/NN is/VBZ unlikely/JJ to/TO interact/VB with/IN drugs/NNS that/WDT are/VBP substrates/NNS for/IN the/DT P-/NN glycoprotein/NN transporter/NN ,/, as/IN demonstrated/VBN by/IN the/DT lack/NN of/IN interaction/NN of/IN Aprepitant/NN with/IN digoxin/NN in/IN a/DT clinical/JJ drug/NN interaction/NN study/NN ./.

(ROOT (S1 (S (S (NP (NN Aprepitant)) (VP (VBZ is) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NNS substrates)) (PP (IN for) (NP (DT the) (NN P-) (NN glycoprotein) (NN transporter)))) (, ,) (SBAR (IN as) (S (VP (VBN demonstrated) (PP (IN by) (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (NP (NN interaction)) (PP (IN of) (NP (NN Aprepitant))) (PP (IN with) (NP (NN digoxin))))) (PP (IN in) (NP (DT a) (JJ clinical) (NN drug) (NN interaction) (NN study))))))))))))))))))) (. .))))

nsubj(unlikely-3, Aprepitant-1)
cop(unlikely-3, is-2)
root(ROOT-0, unlikely-3)
aux(interact-5, to-4)
xcomp(unlikely-3, interact-5)
prep_with(interact-5, drugs-7)
nsubj(substrates-10, drugs-7)
nsubj(demonstrated-18, drugs-7)
cop(substrates-10, are-9)
rcmod(drugs-7, substrates-10)
det(transporter-15, the-12)
nn(transporter-15, P--13)
nn(transporter-15, glycoprotein-14)
prep_for(substrates-10, transporter-15)
mark(demonstrated-18, as-17)
advcl(substrates-10, demonstrated-18)
det(lack-21, the-20)
prep_by(demonstrated-18, lack-21)
prep_of(lack-21, interaction-23)
prep_of(interaction-23, Aprepitant-25)
prep_with(interaction-23, digoxin-27)
det(study-33, a-29)
amod(study-33, clinical-30)
nn(study-33, drug-31)
nn(study-33, interaction-32)
prep_in(lack-21, study-33)

5-HT3/NN antagonists/NNS :/: In/IN clinical/JJ drug/NN interaction/NN studies/NNS ,/, aprepitant/NN did/VBD not/RB have/VB clinically/RB important/JJ effects/NNS on/IN the/DT pharmacokinetics/NNS of/IN ondansetron/NN or/CC granisetron/NN ./.

(ROOT (S1 (S (S (NP (NN 5-HT3) (NNS antagonists)) (: :) (PP (IN In) (NP (JJ clinical) (NN drug) (NN interaction) (NNS studies))) (, ,) (NP (NN aprepitant)) (VP (VBD did) (RB not) (VP (VB have) (NP (ADJP (RB clinically) (JJ important)) (NNS effects)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN ondansetron)) (CC or) (NP (NN granisetron))))))))) (. .))))

nn(antagonists-2, 5-HT3-1)
nsubj(have-13, antagonists-2)
amod(studies-8, clinical-5)
nn(studies-8, drug-6)
nn(studies-8, interaction-7)
prep_in(have-13, studies-8)
nsubj(have-13, aprepitant-10)
aux(have-13, did-11)
neg(have-13, not-12)
root(ROOT-0, have-13)
advmod(important-15, clinically-14)
amod(effects-16, important-15)
dobj(have-13, effects-16)
det(pharmacokinetics-19, the-18)
prep_on(have-13, pharmacokinetics-19)
prep_of(pharmacokinetics-19, ondansetron-21)
conj_or(ondansetron-21, granisetron-23)

No/DT clinical/JJ or/NN drug/NN interaction/NN study/NN was/VBD conducted/VBN with/IN dolasetron/NN ./.

(ROOT (S1 (S (S (NP (DT No) (JJ clinical) (NN or) (NN drug) (NN interaction) (NN study)) (VP (VBD was) (VP (VBN conducted) (PP (IN with) (NP (NN dolasetron)))))) (. .))))

det(study-6, No-1)
amod(study-6, clinical-2)
nn(study-6, or-3)
nn(study-6, drug-4)
nn(study-6, interaction-5)
nsubjpass(conducted-8, study-6)
auxpass(conducted-8, was-7)
root(ROOT-0, conducted-8)
prep_with(conducted-8, dolasetron-10)

Corticosteroids/NNS :/: Dexamethasone/NN :/: Aprepitant/NN ,/, when/WRB given/VBN as/IN a/DT regimen/NN of/IN 125mg/NN with/IN dexamethasone/NN coadministered/VBN orally/RB as/IN 20/CD mg/NN on/IN Day/NN 1/CD ,/, and/CC Aprepitant/NN when/WRB given/VBN as/IN 80/CD mg/day/NN with/IN dexamethasone/NN coadministered/VBN orally/RB as/IN 8/CD mg/NN on/IN Days/NNS 2/CD through/IN 5/CD ,/, increased/VBD the/DT AUC/NN of/IN dexamethasone/NN ,/, a/DT CYP3A4/NN substrate/NN by/IN 2.2-fold/NN ,/, on/IN Days/NNS 1/CD and/CC 5/CD ./.

(ROOT (S1 (S (NP (NP (NNS Corticosteroids)) (: :) (S (NP (NP (NN Dexamethasone)) (: :) (NP (NN Aprepitant)) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN as) (NP (NP (DT a) (NN regimen)) (PP (IN of) (NP (NN 125mg))))) (PP (IN with) (NP (NP (NP (NN dexamethasone)) (VP (VBN coadministered) (ADVP (RB orally)) (PP (IN as) (NP (NP (CD 20) (NN mg)) (PP (IN on) (NP (NN Day) (CD 1))))))) (, ,) (CC and) (NP (NN Aprepitant)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN as) (NP (CD 80) (NN mg/day))) (PP (IN with) (NP (NP (NN dexamethasone)) (VP (VBN coadministered) (ADVP (RB orally)) (PP (IN as) (NP (NP (CD 8) (NN mg)) (PP (IN on) (NP (NNS Days) (QP (CD 2) (IN through) (CD 5))))))))))))))) (, ,)) (VP (VBD increased) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NP (NN dexamethasone)) (, ,) (NP (NP (DT a) (NN CYP3A4) (NN substrate)) (PP (IN by) (NP (NN 2.2-fold))))))) (, ,) (PP (IN on) (NP (NNS Days) (CD 1) (CC and) (CD 5))))) (. .)))))

root(ROOT-0, Corticosteroids-1)
nsubj(increased-45, Dexamethasone-3)
dep(Dexamethasone-3, Aprepitant-5)
advmod(given-8, when-7)
dep(Dexamethasone-3, given-8)
det(regimen-11, a-10)
prep_as(given-8, regimen-11)
prep_of(regimen-11, 125mg-13)
prep_with(given-8, dexamethasone-15)
partmod(dexamethasone-15, coadministered-16)
advmod(coadministered-16, orally-17)
num(mg-20, 20-19)
prep_as(coadministered-16, mg-20)
prep_on(mg-20, Day-22)
num(Day-22, 1-23)
conj_and(dexamethasone-15, Aprepitant-26)
advmod(given-28, when-27)
advcl(given-8, given-28)
num(mg/day-31, 80-30)
prep_as(given-28, mg/day-31)
prep_with(given-28, dexamethasone-33)
partmod(dexamethasone-33, coadministered-34)
advmod(coadministered-34, orally-35)
num(mg-38, 8-37)
prep_as(coadministered-34, mg-38)
prep_on(mg-38, Days-40)
number(5-43, 2-41)
quantmod(5-43, through-42)
num(Days-40, 5-43)
dep(Corticosteroids-1, increased-45)
det(AUC-47, the-46)
dobj(increased-45, AUC-47)
prep_of(AUC-47, dexamethasone-49)
det(substrate-53, a-51)
nn(substrate-53, CYP3A4-52)
appos(dexamethasone-49, substrate-53)
prep_by(substrate-53, 2.2-fold-55)
prep_on(increased-45, Days-58)
num(Days-58, 1-59)
conj_and(Days-58, 5-61)

The/DT oral/JJ dexamethasone/NN doses/NNS should/MD be/VB reduced/VBN by/IN approximately/RB 50/CD %/NN when/WRB coadministered/VBN with/IN Aprepitant/NN ,/, to/TO achieve/VB exposures/NNS of/IN dexamethasone/NN similar/JJ to/TO those/DT obtained/VBN when/WRB it/PRP is/VBZ given/VBN without/IN Aprepitant/NN ./.

(ROOT (S1 (S (S (NP (DT The) (JJ oral) (NN dexamethasone) (NNS doses)) (VP (MD should) (VP (VB be) (VP (VBN reduced) (PP (IN by) (NP (QP (RB approximately) (CD 50)) (NN %))) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NN Aprepitant))) (, ,) (S (VP (TO to) (VP (VB achieve) (NP (NP (NNS exposures)) (PP (IN of) (NP (NN dexamethasone))) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (VP (VBN obtained) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN given) (PP (IN without) (NP (NN Aprepitant)))))))))))))))))))))) (. .))))

det(doses-4, The-1)
amod(doses-4, oral-2)
nn(doses-4, dexamethasone-3)
nsubjpass(reduced-7, doses-4)
aux(reduced-7, should-5)
auxpass(reduced-7, be-6)
root(ROOT-0, reduced-7)
quantmod(50-10, approximately-9)
num(%-11, 50-10)
agent(reduced-7, %-11)
advmod(coadministered-13, when-12)
advcl(reduced-7, coadministered-13)
prep_with(coadministered-13, Aprepitant-15)
aux(achieve-18, to-17)
xcomp(coadministered-13, achieve-18)
dobj(achieve-18, exposures-19)
prep_of(exposures-19, dexamethasone-21)
amod(exposures-19, similar-22)
prep_to(similar-22, those-24)
partmod(those-24, obtained-25)
advmod(given-29, when-26)
nsubjpass(given-29, it-27)
auxpass(given-29, is-28)
advcl(obtained-25, given-29)
prep_without(given-29, Aprepitant-31)

The/DT daily/JJ dose/NN of/IN dexamethasone/NN administered/VBN in/IN clinical/JJ studies/NNS with/IN Aprepitant/NN reflects/VBZ an/DT approximate/JJ 50/CD %/NN reduction/NN of/IN the/DT dose/NN of/IN dexamethasone/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ daily) (NN dose)) (PP (IN of) (NP (NN dexamethasone))) (VP (VBN administered) (PP (IN in) (NP (NP (JJ clinical) (NNS studies)) (PP (IN with) (NP (NN Aprepitant))))))) (VP (VBZ reflects) (NP (NP (DT an) (JJ approximate) (ADJP (CD 50) (NN %)) (NN reduction)) (PP (IN of) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN dexamethasone)))))))) (. .))))

det(dose-3, The-1)
amod(dose-3, daily-2)
nsubj(reflects-12, dose-3)
prep_of(dose-3, dexamethasone-5)
partmod(dose-3, administered-6)
amod(studies-9, clinical-8)
prep_in(administered-6, studies-9)
prep_with(studies-9, Aprepitant-11)
root(ROOT-0, reflects-12)
det(reduction-17, an-13)
amod(reduction-17, approximate-14)
number(%-16, 50-15)
amod(reduction-17, %-16)
dobj(reflects-12, reduction-17)
det(dose-20, the-19)
prep_of(reduction-17, dose-20)
prep_of(dose-20, dexamethasone-22)

Methylprednisolone/NN ./.

(ROOT (S1 (S (NP (NP (NN Methylprednisolone)) (. .)))))

root(ROOT-0, Methylprednisolone-1)

Aprepitant/NN ,/, when/WRB given/VBN as/IN a/DT regimen/NN of/IN 125/CD mg/NN on/IN Day/NN 1/CD and/CC 80/CD mg/day/NN on/IN Days/NNS 2/CD and/CC 3/CD ,/, increased/VBD the/DT AUC/NN of/IN methylprednisolone/NN ,/, a/DT CYP3A4/NN substrate/NN ,/, by/IN 1.34-fold/NN on/IN Day/NN 1/CD and/CC by/IN 2.5-fold/JJ on/IN Day/NN 3/CD ,/, when/WRB methylprednisolone/NN was/VBD coadministered/VBN intravenously/RB as/IN 125/CD mg/NN on/IN Day/NN 1/CD and/CC orally/RB as/IN 40/CD mg/NN on/IN Days/NNS 2/CD and/CC 3/CD ./.

(ROOT (S1 (S (NP (NN Aprepitant)) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN as) (NP (NP (DT a) (NN regimen)) (PP (IN of) (NP (CD 125) (NN mg))))) (PP (IN on) (NP (NP (NN Day) (CD 1)) (CC and) (NP (CD 80) (NN mg/day)))) (PP (IN on) (NP (NNS Days) (CD 2) (CC and) (CD 3)))))) (, ,) (VP (VBD increased) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NP (NN methylprednisolone)) (, ,) (NP (DT a) (NN CYP3A4) (NN substrate)) (, ,)))) (PP (IN by) (NP (NP (NN 1.34-fold)) (PP (PP (IN on) (NP (NN Day) (CD 1))) (CC and) (PP (IN by) (NP (NP (JJ 2.5-fold)) (PP (IN on) (NP (NP (NN Day) (CD 3)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NN methylprednisolone)) (VP (VBD was) (VP (VBN coadministered) (ADVP (RB intravenously)) (PP (PP (IN as) (NP (NP (CD 125) (NN mg)) (PP (IN on) (NP (NN Day) (CD 1))))) (CC and) (ADVP (RB orally)) (PP (IN as) (NP (NP (CD 40) (NN mg)) (PP (IN on) (NP (NNS Days) (CD 2) (CC and) (CD 3)))))))))))))))))) (. .))))

nsubj(increased-23, Aprepitant-1)
advmod(given-4, when-3)
advcl(increased-23, given-4)
det(regimen-7, a-6)
prep_as(given-4, regimen-7)
num(mg-10, 125-9)
prep_of(regimen-7, mg-10)
prep_on(given-4, Day-12)
num(Day-12, 1-13)
num(mg/day-16, 80-15)
conj_and(Day-12, mg/day-16)
prep_on(given-4, Days-18)
num(Days-18, 2-19)
conj_and(Days-18, 3-21)
root(ROOT-0, increased-23)
det(AUC-25, the-24)
dobj(increased-23, AUC-25)
prep_of(AUC-25, methylprednisolone-27)
det(substrate-31, a-29)
nn(substrate-31, CYP3A4-30)
appos(methylprednisolone-27, substrate-31)
prep_by(increased-23, 1.34-fold-34)
conj_and(1.34-fold-34, 1.34-fold-34')
prep_on(1.34-fold-34, Day-36)
num(Day-36, 1-37)
prep_by(1.34-fold-34', 2.5-fold-40)
prep_on(2.5-fold-40, Day-42)
tmod(coadministered-48, Day-42)
num(Day-42, 3-43)
advmod(coadministered-48, when-45)
nsubjpass(coadministered-48, methylprednisolone-46)
auxpass(coadministered-48, was-47)
dep(Day-42, coadministered-48)
advmod(coadministered-48, intravenously-49)
num(mg-52, 125-51)
prep_as(coadministered-48, mg-52)
prep_on(mg-52, Day-54)
num(Day-54, 1-55)
advmod(coadministered-48, orally-57)
conj(coadministered-48, orally-57)
num(mg-60, 40-59)
conj_and(mg-52, mg-60)
prep_on(mg-60, Days-62)
num(Days-62, 2-63)
conj_and(Days-62, 3-65)

The/DT IV/NN methylprednisolone/JJ dose/NN should/MD be/VB reduced/VBN by/IN approximately/RB 25/CD %/NN ,/, and/CC the/DT oral/JJ methylprednisolone/JJ dose/NN should/MD be/VB reduced/VBN by/IN approximately/RB 50/CD %/NN when/WRB coadministered/VBN with/IN Aprepitant/NN to/TO achieve/VB exposures/NNS of/IN methylprednisolone/NN similar/JJ to/TO those/DT obtained/VBN when/WRB it/PRP is/VBZ given/VBN without/IN Aprepitant/NN ./.

(ROOT (S1 (S (S (S (NP (DT The) (NN IV) (JJ methylprednisolone) (NN dose)) (VP (MD should) (VP (VB be) (VP (VBN reduced) (PP (IN by) (NP (QP (RB approximately) (CD 25)) (NN %))))))) (, ,) (CC and) (S (NP (DT the) (JJ oral) (JJ methylprednisolone) (NN dose)) (VP (MD should) (VP (VB be) (VP (VBN reduced) (PP (IN by) (NP (QP (RB approximately) (CD 50)) (NN %))) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NN Aprepitant))) (S (VP (TO to) (VP (VB achieve) (NP (NP (NNS exposures)) (PP (IN of) (NP (NP (NN methylprednisolone)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (VP (VBN obtained) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN given) (PP (IN without) (NP (NN Aprepitant))))))))))))))))))))))))) (. .))))

det(dose-4, The-1)
nn(dose-4, IV-2)
amod(dose-4, methylprednisolone-3)
nsubjpass(reduced-7, dose-4)
aux(reduced-7, should-5)
auxpass(reduced-7, be-6)
root(ROOT-0, reduced-7)
quantmod(25-10, approximately-9)
num(%-11, 25-10)
agent(reduced-7, %-11)
det(dose-17, the-14)
amod(dose-17, oral-15)
amod(dose-17, methylprednisolone-16)
nsubjpass(reduced-20, dose-17)
aux(reduced-20, should-18)
auxpass(reduced-20, be-19)
conj_and(reduced-7, reduced-20)
quantmod(50-23, approximately-22)
num(%-24, 50-23)
agent(reduced-20, %-24)
advmod(coadministered-26, when-25)
advcl(reduced-20, coadministered-26)
prep_with(coadministered-26, Aprepitant-28)
aux(achieve-30, to-29)
xcomp(coadministered-26, achieve-30)
dobj(achieve-30, exposures-31)
prep_of(exposures-31, methylprednisolone-33)
amod(methylprednisolone-33, similar-34)
prep_to(similar-34, those-36)
partmod(those-36, obtained-37)
advmod(given-41, when-38)
nsubjpass(given-41, it-39)
auxpass(given-41, is-40)
advcl(obtained-37, given-41)
prep_without(given-41, Aprepitant-43)

Warfarin/NN :/: A/DT single/JJ 125-mg/NN dose/NN of/IN Aprepitant/NN was/VBD administered/VBN on/IN Day/NN 1/CD and/CC 80/CD mg/day/NN on/IN Days/NNS 2/CD and/CC 3/CD to/TO healthy/JJ subjects/NNS who/WP were/VBD stabilized/VBN on/IN chronic/JJ warfarin/NN therapy/NN ./.

(ROOT (S1 (S (NP (NP (NN Warfarin)) (: :) (S (NP (NP (DT A) (JJ single) (NN 125-mg) (NN dose)) (PP (IN of) (NP (NN Aprepitant)))) (VP (VBD was) (VP (VBN administered) (PP (IN on) (NP (NP (NN Day) (CD 1)) (CC and) (NP (NP (CD 80) (NN mg/day)) (PP (IN on) (NP (NNS Days) (CD 2) (CC and) (CD 3))) (PP (TO to) (NP (NP (JJ healthy) (NNS subjects)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN stabilized) (PP (IN on) (NP (JJ chronic) (NN warfarin) (NN therapy))))))))))))))) (. .)))))

root(ROOT-0, Warfarin-1)
det(dose-6, A-3)
amod(dose-6, single-4)
nn(dose-6, 125-mg-5)
nsubjpass(administered-10, dose-6)
prep_of(dose-6, Aprepitant-8)
auxpass(administered-10, was-9)
dep(Warfarin-1, administered-10)
prep_on(administered-10, Day-12)
num(Day-12, 1-13)
num(mg/day-16, 80-15)
conj_and(Day-12, mg/day-16)
prep_on(mg/day-16, Days-18)
num(Days-18, 2-19)
conj_and(Days-18, 3-21)
amod(subjects-24, healthy-23)
prep_to(mg/day-16, subjects-24)
nsubjpass(stabilized-27, subjects-24)
auxpass(stabilized-27, were-26)
rcmod(subjects-24, stabilized-27)
amod(therapy-31, chronic-29)
nn(therapy-31, warfarin-30)
prep_on(stabilized-27, therapy-31)

Although/IN there/EX was/VBD no/DT effect/NN of/IN Aprepitant/NN on/IN the/DT plasma/NN AUC/NN of/IN R/NN (/-LRB- +/CC )/-RRB- or/CC S/NN (/-LRB- -/CC )/-RRB- warfarin/NN determined/VBN on/IN Day/NN 3/CD ,/, there/EX was/VBD a/DT 34/JJ %/NN decrease/NN in/IN S/NN (/-LRB- -/CC )/-RRB- warfarin/NN (/-LRB- a/DT CYP2C9/NN substrate/NN )/-RRB- trough/NN concentration/NN accompanied/VBN by/IN a/DT 14/CD %/NN decrease/NN in/IN the/DT prothrombin/NN time/NN (/-LRB- reported/VBN as/IN International/NNP Normalized/VBN Ratio/NN or/CC INR/NN )/-RRB- 5/CD days/NNS after/IN completion/NN of/IN dosing/NN with/IN Aprepitant/NN ./.

(ROOT (S1 (S (SBAR (IN Although) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN effect)) (PP (IN of) (NP (NP (NN Aprepitant)) (PP (IN on) (NP (NP (DT the) (NN plasma) (NN AUC)) (PP (IN of) (NP (NP (NP (NN R)) (-LRB- -LRB-) (CC +) (-RRB- -RRB-)) (CC or) (NP (NP (NN S)) (-LRB- -LRB-) (CC -) (-RRB- -RRB-)) (NP (NN warfarin)))) (VP (VBN determined) (PP (IN on) (NP (NN Day) (CD 3)))))))))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (JJ 34) (NN %) (NN decrease)) (PP (IN in) (NP (NP (NP (NP (NN S)) (-LRB- -LRB-) (CC -) (-RRB- -RRB-) (NP (NN warfarin)) (PRN (-LRB- -LRB-) (NP (DT a) (NN CYP2C9) (NN substrate)) (-RRB- -RRB-))) (NN trough) (NN concentration)) (VP (VBN accompanied) (PP (IN by) (NP (NP (DT a) (ADJP (CD 14) (NN %)) (NN decrease)) (PP (IN in) (NP (NP (NP (DT the) (NN prothrombin) (NN time)) (PRN (-LRB- -LRB-) (VP (VBN reported) (PP (IN as) (NP (NP (NP (NNP International)) (VBN Normalized) (NN Ratio)) (CC or) (NP (NN INR))))) (-RRB- -RRB-))) (NP (NP (CD 5) (NNS days)) (PP (IN after) (NP (NP (NN completion)) (PP (IN of) (NP (NP (NN dosing)) (PP (IN with) (NP (NN Aprepitant))))))))))))))))) (. .))))

mark(was-3, Although-1)
expl(was-3, there-2)
advcl(was-29, was-3)
det(effect-5, no-4)
nsubj(was-3, effect-5)
prep_of(effect-5, Aprepitant-7)
det(AUC-11, the-9)
nn(AUC-11, plasma-10)
prep_on(Aprepitant-7, AUC-11)
prep_of(AUC-11, R-13)
conj_or(R-13, S-18)
dep(R-13, warfarin-22)
partmod(AUC-11, determined-23)
prep_on(determined-23, Day-25)
num(Day-25, 3-26)
expl(was-29, there-28)
root(ROOT-0, was-29)
det(decrease-33, a-30)
amod(decrease-33, 34-31)
nn(decrease-33, %-32)
nsubj(was-29, decrease-33)
nn(concentration-46, S-35)
conj(S-35, warfarin-39)
det(substrate-43, a-41)
nn(substrate-43, CYP2C9-42)
abbrev(S-35, substrate-43)
nn(concentration-46, trough-45)
prep_in(decrease-33, concentration-46)
partmod(concentration-46, accompanied-47)
det(decrease-52, a-49)
number(%-51, 14-50)
amod(decrease-52, %-51)
agent(accompanied-47, decrease-52)
det(time-56, the-54)
nn(time-56, prothrombin-55)
prep_in(decrease-52, time-56)
dep(time-56, reported-58)
nn(Ratio-62, International-60)
amod(Ratio-62, Normalized-61)
prep_as(reported-58, Ratio-62)
conj_or(Ratio-62, INR-64)
num(days-67, 5-66)
dep(time-56, days-67)
prep_after(days-67, completion-69)
prep_of(completion-69, dosing-71)
prep_with(dosing-71, Aprepitant-73)

In/IN patients/NNS on/IN chronic/JJ warfarin/NN therapy/NN ,/, the/DT prothrombin/NN time/NN (/-LRB- INR/NN )/-RRB- should/MD be/VB closely/RB monitored/VBN in/IN the/DT 2-week/JJ period/NN ,/, particularly/RB at/IN 7/CD to/TO 10/CD days/NNS ,/, following/VBG initiation/NN of/IN the/DT 3-day/JJ regimen/NN of/IN Aprepitant/NN with/IN each/DT chemotherapy/NN cycle/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN on) (NP (JJ chronic) (NN warfarin) (NN therapy))))) (, ,) (NP (NP (DT the) (NN prothrombin) (NN time)) (PRN (-LRB- -LRB-) (NP (NN INR)) (-RRB- -RRB-))) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN monitored) (PP (IN in) (NP (DT the) (JJ 2-week) (NN period))) (, ,) (PP (ADVP (RB particularly)) (IN at) (NP (QP (CD 7) (TO to) (CD 10)) (NNS days))) (, ,) (PP (VBG following) (NP (NP (NN initiation)) (PP (IN of) (NP (NP (DT the) (JJ 3-day) (NN regimen)) (PP (IN of) (NP (NN Aprepitant))))) (PP (IN with) (NP (DT each) (NN chemotherapy) (NN cycle)))))))) (. .))))

prep_in(monitored-17, patients-2)
amod(therapy-6, chronic-4)
nn(therapy-6, warfarin-5)
prep_on(patients-2, therapy-6)
det(time-10, the-8)
nn(time-10, prothrombin-9)
nsubjpass(monitored-17, time-10)
abbrev(time-10, INR-12)
aux(monitored-17, should-14)
auxpass(monitored-17, be-15)
advmod(monitored-17, closely-16)
root(ROOT-0, monitored-17)
det(period-21, the-19)
amod(period-21, 2-week-20)
prep_in(monitored-17, period-21)
advmod(monitored-17, particularly-23)
number(10-27, 7-25)
dep(10-27, to-26)
num(days-28, 10-27)
prep_at(monitored-17, days-28)
prep_following(monitored-17, initiation-31)
det(regimen-35, the-33)
amod(regimen-35, 3-day-34)
prep_of(initiation-31, regimen-35)
prep_of(regimen-35, Aprepitant-37)
det(cycle-41, each-39)
nn(cycle-41, chemotherapy-40)
prep_with(initiation-31, cycle-41)

Tolbutamide/NN :/: Aprepitant/NN ,/, when/WRB given/VBN as/IN 125/CD mg/NN on/IN Day/NN 1/CD and/CC 80/CD mg/day/NN on/IN Days/NNS 2/CD and/CC 3/CD ,/, decreased/VBD the/DT AUC/NN of/IN tolbutamide/NN (/-LRB- a/DT CYP2C9/NN substrate/NN )/-RRB- by/IN 23/CD %/NN on/IN Day/NN 4/CD ,/, 28/CD %/NN on/IN Day/NN 8/CD ,/, and/CC 15/CD %/NN on/IN Day/NN 15/CD ,/, when/WRB a/DT single/JJ dose/NN of/IN tolbutamide/NN 500/CD mg/NN was/VBD admini/NNS ,/, stered/JJ orally/RB prior/JJ to/TO the/DT administration/NN of/IN the/DT 3-day/JJ regimen/NN of/IN Aprepitant/NN and/CC on/IN Days/NNS 4,8/CD ,/, and/CC 15/CD ./.

(ROOT (S1 (S (NP (NP (NN Tolbutamide)) (: :) (S (NP (NN Aprepitant)) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN as) (NP (NP (CD 125) (NN mg)) (PP (IN on) (NP (NP (NN Day) (CD 1)) (CC and) (NP (CD 80) (NN mg/day)))))) (PP (IN on) (NP (NNS Days) (CD 2) (CC and) (CD 3)))))) (, ,) (VP (VBD decreased) (ADJP (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NP (NP (NN tolbutamide)) (PRN (-LRB- -LRB-) (NP (DT a) (NN CYP2C9) (NN substrate)) (-RRB- -RRB-))) (PP (IN by) (NP (NP (NP (CD 23) (NN %)) (PP (IN on) (NP (NN Day) (CD 4)))) (, ,) (NP (NP (CD 28) (NN %)) (PP (IN on) (NP (NN Day) (CD 8)))) (, ,) (CC and) (NP (CD 15) (NN %)))) (PP (IN on) (NP (NN Day) (CD 15))))) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NN tolbutamide) (CD 500) (NN mg)))) (VP (VBD was) (NP (NNS admini))))) (, ,)) (JJ stered) (PP (ADVP (RB orally)) (JJ prior) (TO to) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (DT the) (JJ 3-day) (NN regimen)) (PP (IN of) (NP (NP (NN Aprepitant)) (PP (CC and) (PP (IN on) (NP (NNS Days) (QP (CD 4,8) (, ,) (CC and) (CD 15)))))))))))))) (. .)))))

root(ROOT-0, Tolbutamide-1)
nsubj(decreased-22, Aprepitant-3)
advmod(given-6, when-5)
advcl(decreased-22, given-6)
num(mg-9, 125-8)
prep_as(given-6, mg-9)
prep_on(mg-9, Day-11)
num(Day-11, 1-12)
num(mg/day-15, 80-14)
conj_and(Day-11, mg/day-15)
prep_on(given-6, Days-17)
num(Days-17, 2-18)
conj_and(Days-17, 3-20)
dep(Tolbutamide-1, decreased-22)
det(AUC-24, the-23)
npadvmod(stered-63, AUC-24)
prep_of(AUC-24, tolbutamide-26)
det(substrate-30, a-28)
nn(substrate-30, CYP2C9-29)
abbrev(tolbutamide-26, substrate-30)
num(%-34, 23-33)
prep_by(tolbutamide-26, %-34)
prep_on(%-34, Day-36)
num(Day-36, 4-37)
num(%-40, 28-39)
conj_and(%-34, %-40)
prep_on(%-40, Day-42)
num(Day-42, 8-43)
num(%-47, 15-46)
conj_and(%-34, %-47)
prep_on(tolbutamide-26, Day-49)
num(Day-49, 15-50)
advmod(admini-61, when-52)
det(dose-55, a-53)
amod(dose-55, single-54)
nsubj(admini-61, dose-55)
nn(mg-59, tolbutamide-57)
num(mg-59, 500-58)
prep_of(dose-55, mg-59)
cop(admini-61, was-60)
dep(AUC-24, admini-61)
acomp(decreased-22, stered-63)
advmod(stered-63, orally-64)
det(administration-68, the-67)
prep_prior_to(stered-63, administration-68)
det(regimen-72, the-70)
amod(regimen-72, 3-day-71)
prep_of(administration-68, regimen-72)
prep_of(regimen-72, Aprepitant-74)
cc(Aprepitant-74, and-75)
prep_on(Aprepitant-74, Days-77)
num(Days-77, 4,8-78)
conj_and(4,8-78, 15-81)

Oral/JJ contraceptives/NNS :/: Aprepitant/NN ,/, when/WRB given/VBN once/RB daily/RB for/IN 14/CD days/NNS as/IN a/DT 100-mg/JJ capsule/NN with/IN an/DT oral/JJ contraceptive/NN containing/VBG 35/CD mcg/NN of/IN ethinyl/NN estradiol/NN and/CC 1/CD mg/NN of/IN norethindrone/NN ,/, decreased/VBD the/DT AUC/NN of/IN ethinyl/NN estradiol/NN by/IN 43/CD %/NN ,/, and/CC decreased/VBD the/DT AUC/NN of/IN norethindrone/NN by/IN 8/CD %/NN ;/: ./.

(ROOT (S1 (S (NP (NP (JJ Oral) (NNS contraceptives)) (: :) (S (NP (NP (NN Aprepitant)) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (ADVP (RB once) (RB daily)) (PP (IN for) (NP (CD 14) (NNS days))) (PP (IN as) (NP (NP (DT a) (JJ 100-mg) (NN capsule)) (PP (IN with) (NP (NP (DT an) (JJ oral) (NN contraceptive)) (VP (VBG containing) (NP (NP (NP (CD 35) (NN mcg)) (PP (IN of) (NP (NN ethinyl) (NN estradiol)))) (CC and) (NP (NP (CD 1) (NN mg)) (PP (IN of) (NP (NN norethindrone))))))))))))) (, ,)) (VP (VP (VBD decreased) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NN ethinyl) (NN estradiol)))) (PP (IN by) (NP (CD 43) (NN %)))) (, ,) (CC and) (VP (VBD decreased) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NN norethindrone)))) (PP (IN by) (NP (CD 8) (NN %))))) (: ;)) (. .)))))

amod(contraceptives-2, Oral-1)
root(ROOT-0, contraceptives-2)
nsubj(decreased-33, Aprepitant-4)
advmod(given-7, when-6)
dep(Aprepitant-4, given-7)
advmod(daily-9, once-8)
advmod(given-7, daily-9)
num(days-12, 14-11)
prep_for(given-7, days-12)
det(capsule-16, a-14)
amod(capsule-16, 100-mg-15)
prep_as(given-7, capsule-16)
det(contraceptive-20, an-18)
amod(contraceptive-20, oral-19)
prep_with(capsule-16, contraceptive-20)
partmod(contraceptive-20, containing-21)
num(mcg-23, 35-22)
dobj(containing-21, mcg-23)
nn(estradiol-26, ethinyl-25)
prep_of(mcg-23, estradiol-26)
num(mg-29, 1-28)
conj_and(mcg-23, mg-29)
prep_of(mg-29, norethindrone-31)
dep(contraceptives-2, decreased-33)
det(AUC-35, the-34)
dobj(decreased-33, AUC-35)
nn(estradiol-38, ethinyl-37)
prep_of(AUC-35, estradiol-38)
num(%-41, 43-40)
prep_by(decreased-33, %-41)
conj_and(decreased-33, decreased-44)
det(AUC-46, the-45)
dobj(decreased-44, AUC-46)
prep_of(AUC-46, norethindrone-48)
num(%-51, 8-50)
prep_by(decreased-44, %-51)

therefore/RB ,/, the/DT efficacy/NN of/IN oral/JJ contraceptives/NNS during/IN administration/NN of/IN Aprepitant/NN may/MD be/VB reduced/VBN ./.

(ROOT (S1 (S (S (ADVP (RB therefore)) (, ,) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (JJ oral) (NNS contraceptives))) (PP (IN during) (NP (NP (NN administration)) (PP (IN of) (NP (NN Aprepitant)))))) (VP (MD may) (VP (VB be) (VP (VBN reduced))))) (. .))))

advmod(reduced-14, therefore-1)
det(efficacy-4, the-3)
nsubjpass(reduced-14, efficacy-4)
amod(contraceptives-7, oral-6)
prep_of(efficacy-4, contraceptives-7)
prep_during(efficacy-4, administration-9)
prep_of(administration-9, Aprepitant-11)
aux(reduced-14, may-12)
auxpass(reduced-14, be-13)
root(ROOT-0, reduced-14)

Although/IN a/DT 3-day/JJ regimen/NN of/IN Aprepitant/NN given/VBN concomitantly/RB with/IN oral/JJ contraceptives/NNS has/VBZ not/RB been/VBN studied/VBN ,/, alternative/JJ or/CC back-up/JJ methods/NNS of/IN contraception/NN should/MD be/VB used/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NP (DT a) (JJ 3-day) (NN regimen)) (PP (IN of) (NP (NN Aprepitant))) (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (JJ oral) (NNS contraceptives))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied)))))) (, ,) (NP (NP (ADJP (ADJP (JJ alternative)) (CC or) (ADJP (JJ back-up))) (NNS methods)) (PP (IN of) (NP (NN contraception)))) (VP (MD should) (VP (VB be) (VP (VBN used))))) (. .))))

mark(studied-15, Although-1)
det(regimen-4, a-2)
amod(regimen-4, 3-day-3)
nsubjpass(studied-15, regimen-4)
prep_of(regimen-4, Aprepitant-6)
partmod(regimen-4, given-7)
advmod(given-7, concomitantly-8)
amod(contraceptives-11, oral-10)
prep_with(given-7, contraceptives-11)
aux(studied-15, has-12)
neg(studied-15, not-13)
auxpass(studied-15, been-14)
advcl(used-25, studied-15)
amod(methods-20, alternative-17)
conj_or(alternative-17, back-up-19)
nsubjpass(used-25, methods-20)
prep_of(methods-20, contraception-22)
aux(used-25, should-23)
auxpass(used-25, be-24)
root(ROOT-0, used-25)

Midazolam/NNS :/: Aprepitant/NN increased/VBD the/DT AUC/NN of/IN midazolam/NN ,/, a/DT sensitive/JJ CYP3A4/NN substrate/NN ,/, by/IN 2.3-fold/NN on/IN Day/NN 1/CD and/CC 3.3-fold/RB on/IN Day/NN 5/CD ,/, when/WRB a/DT single/JJ oral/JJ dose/NN of/IN midazolam/NN 2/CD mg/NN was/VBD coadministered/VBN on/IN Day/NN 1/CD and/CC Day/NN 5/CD of/IN a/DT regimen/NN of/IN Aprepitant/NN 125/CD mg/NN on/IN Day/NN 1/CD and/CC 80/CD mg/day/NN on/IN Days/NNS 2/CD through/IN 5/CD ./.

(ROOT (S1 (S (NP (NP (NNS Midazolam)) (: :) (S (NP (NN Aprepitant)) (VP (VBD increased) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NP (NN midazolam)) (, ,) (NP (DT a) (JJ sensitive) (NN CYP3A4) (NN substrate)) (, ,)))) (PP (IN by) (NP (NN 2.3-fold))) (PP (PP (IN on) (NP (NN Day) (CD 1))) (CC and) (RB 3.3-fold) (PP (IN on) (NP (NN Day) (CD 5)))) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT a) (JJ single) (JJ oral) (NN dose)) (PP (IN of) (NP (NN midazolam) (CD 2) (NN mg)))) (VP (VBD was) (VP (VBN coadministered) (PP (IN on) (NP (NP (NP (NN Day) (CD 1)) (CC and) (NP (NN Day) (CD 5))) (PP (IN of) (NP (NP (DT a) (NN regimen)) (PP (IN of) (NP (NP (NN Aprepitant) (CD 125) (NN mg)) (PP (IN on) (NP (NP (NP (NN Day) (CD 1)) (CC and) (NP (CD 80) (NN mg/day))) (PP (IN on) (NP (NNS Days) (QP (CD 2) (IN through) (CD 5)))))))))))))))))) (. .)))))

root(ROOT-0, Midazolam-1)
nsubj(increased-4, Aprepitant-3)
dep(Midazolam-1, increased-4)
det(AUC-6, the-5)
dobj(increased-4, AUC-6)
prep_of(AUC-6, midazolam-8)
det(substrate-13, a-10)
amod(substrate-13, sensitive-11)
nn(substrate-13, CYP3A4-12)
appos(midazolam-8, substrate-13)
prep_by(increased-4, 2.3-fold-16)
prep(increased-4, on-17)
pobj(on-17, Day-18)
num(Day-18, 1-19)
advmod(on-17, 3.3-fold-21)
conj_and(on-17, 3.3-fold-21)
dep(on-17, on-22)
pobj(on-22, Day-23)
num(Day-23, 5-24)
advmod(coadministered-36, when-26)
det(dose-30, a-27)
amod(dose-30, single-28)
amod(dose-30, oral-29)
nsubjpass(coadministered-36, dose-30)
nn(mg-34, midazolam-32)
num(mg-34, 2-33)
prep_of(dose-30, mg-34)
auxpass(coadministered-36, was-35)
advcl(increased-4, coadministered-36)
prep_on(coadministered-36, Day-38)
num(Day-38, 1-39)
conj_and(Day-38, Day-41)
num(Day-41, 5-42)
det(regimen-45, a-44)
prep_of(Day-38, regimen-45)
nn(mg-49, Aprepitant-47)
num(mg-49, 125-48)
prep_of(regimen-45, mg-49)
prep_on(mg-49, Day-51)
num(Day-51, 1-52)
num(mg/day-55, 80-54)
conj_and(Day-51, mg/day-55)
prep_on(Day-51, Days-57)
number(5-60, 2-58)
quantmod(5-60, through-59)
num(Days-57, 5-60)

The/DT potential/JJ effects/NNS of/IN increased/VBN plasma/NN concentrations/NNS of/IN midazolam/NNS or/CC other/JJ benzodiazepines/NNS metabolized/VBN via/IN CYP3A4/NN (/-LRB- alprazolam/NN ,/, triazolam/NN )/-RRB- should/MD be/VB considered/VBN when/WRB coadministering/VBG these/DT agents/NNS with/IN Aprepitant/NN ./.

(ROOT (S1 (S (NP (NP (DT The) (JJ potential) (NNS effects)) (PP (IN of) (NP (NP (VBN increased) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (NP (NNS midazolam)) (CC or) (NP (JJ other) (NNS benzodiazepines))) (VP (VBN metabolized) (PP (IN via) (NP (NP (NN CYP3A4)) (PRN (-LRB- -LRB-) (NP (NP (NN alprazolam)) (, ,) (NP (NN triazolam))) (-RRB- -RRB-)))))))))) (VP (MD should) (VP (VB be) (VP (VBN considered) (SBAR (WHADVP (WRB when)) (S (VP (VBG coadministering) (NP (DT these) (NNS agents)) (PP (IN with) (NP (NN Aprepitant))))))))) (. .))))

det(effects-3, The-1)
amod(effects-3, potential-2)
nsubjpass(considered-23, effects-3)
amod(concentrations-7, increased-5)
nn(concentrations-7, plasma-6)
prep_of(effects-3, concentrations-7)
prep_of(concentrations-7, midazolam-9)
amod(benzodiazepines-12, other-11)
conj_or(midazolam-9, benzodiazepines-12)
partmod(midazolam-9, metabolized-13)
prep_via(metabolized-13, CYP3A4-15)
dep(CYP3A4-15, alprazolam-17)
appos(alprazolam-17, triazolam-19)
aux(considered-23, should-21)
auxpass(considered-23, be-22)
root(ROOT-0, considered-23)
advmod(coadministering-25, when-24)
advcl(considered-23, coadministering-25)
det(agents-27, these-26)
dobj(coadministering-25, agents-27)
prep_with(coadministering-25, Aprepitant-29)

In/IN another/DT study/NN with/IN intravenous/JJ administration/NN of/IN midazolam/NN ,/, Aprepitant/NN was/VBD given/VBN as/IN 125/CD mg/NN on/IN Day/NN 1/CD and/CC 80/CD mg/day/NN on/IN Days/NNS 2/CD and/CC 3/CD ,/, and/CC midazolam/NN 2/CD mg/NN IV/CD was/VBD given/VBN prior/JJ to/TO the/DT administration/NN of/IN the/DT 3-day/JJ regimen/NN of/IN Aprepitant/NN and/CC on/IN Days/NNS 4/CD ,/, 8/CD ,/, and/CC 15/CD ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (DT another) (NN study)) (PP (IN with) (NP (NP (JJ intravenous) (NN administration)) (PP (IN of) (NP (NN midazolam))))))) (, ,) (S (S (NP (NN Aprepitant)) (VP (VBD was) (VP (VBN given) (PP (IN as) (NP (NP (NP (CD 125) (NN mg)) (PP (IN on) (NP (NN Day) (CD 1)))) (CC and) (NP (CD 80) (NN mg/day)))) (PP (IN on) (NP (NNS Days) (CD 2) (CC and) (CD 3)))))) (, ,) (CC and) (S (NP (NN midazolam) (CD 2) (NN mg) (CD IV)) (VP (VBD was) (VP (VBN given) (PP (JJ prior) (TO to) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (DT the) (JJ 3-day) (NN regimen)) (PP (PP (IN of) (NP (NN Aprepitant))) (CC and) (PP (IN on) (NP (NNS Days) (QP (CD 4) (, ,) (CD 8) (, ,) (CC and) (CD 15))))))))))))) (. .))))

det(study-3, another-2)
prep_in(given-12, study-3)
amod(administration-6, intravenous-5)
prep_with(study-3, administration-6)
prep_of(administration-6, midazolam-8)
nsubjpass(given-12, Aprepitant-10)
auxpass(given-12, was-11)
root(ROOT-0, given-12)
num(mg-15, 125-14)
prep_as(given-12, mg-15)
prep_on(mg-15, Day-17)
num(Day-17, 1-18)
num(mg/day-21, 80-20)
conj_and(mg-15, mg/day-21)
prep_on(given-12, Days-23)
num(Days-23, 2-24)
conj_and(Days-23, 3-26)
nn(mg-31, midazolam-29)
num(mg-31, 2-30)
nsubjpass(given-34, mg-31)
num(mg-31, IV-32)
auxpass(given-34, was-33)
conj_and(given-12, given-34)
det(administration-38, the-37)
prep_prior_to(given-34, administration-38)
det(regimen-42, the-40)
amod(regimen-42, 3-day-41)
prep_of(administration-38, regimen-42)
conj_and(regimen-42, regimen-42')
prep_of(regimen-42, Aprepitant-44)
prep_on(regimen-42', Days-47)
num(Days-47, 4-48)
number(4-48, 8-50)
conj_and(4-48, 15-53)

Aprepitant/NN increased/VBD the/DT AUC/NN of/IN midazolam/NN by/IN 25/CD %/NN on/IN Day/NN 4/CD and/CC decreased/VBD the/DT AUC/NN of/IN midazolam/NN by/IN 19/CD %/NN on/IN Day/NN 8/CD relative/JJ to/TO the/DT dosing/NN of/IN Aprepitant/NN on/IN Days/NNS 1/CD through/IN 3/CD ./.

(ROOT (S1 (S (S (NP (NN Aprepitant)) (VP (VP (VBD increased) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NN midazolam)))) (PP (IN by) (NP (NP (CD 25) (NN %)) (PP (IN on) (NP (NN Day) (CD 4)))))) (CC and) (VP (VBD decreased) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NN midazolam)))) (PP (IN by) (NP (NP (CD 19) (NN %)) (PP (IN on) (NP (NN Day) (CD 8) (ADJP (JJ relative) (PP (TO to) (NP (NP (DT the) (NN dosing)) (PP (IN of) (NP (NP (NN Aprepitant)) (PP (IN on) (NP (NNS Days) (QP (CD 1) (IN through) (CD 3)))))))))))))))) (. .))))

nsubj(increased-2, Aprepitant-1)
root(ROOT-0, increased-2)
det(AUC-4, the-3)
dobj(increased-2, AUC-4)
prep_of(AUC-4, midazolam-6)
num(%-9, 25-8)
prep_by(increased-2, %-9)
prep_on(%-9, Day-11)
num(Day-11, 4-12)
conj_and(increased-2, decreased-14)
det(AUC-16, the-15)
dobj(decreased-14, AUC-16)
prep_of(AUC-16, midazolam-18)
num(%-21, 19-20)
prep_by(decreased-14, %-21)
prep_on(%-21, Day-23)
num(Day-23, 8-24)
amod(Day-23, relative-25)
det(dosing-28, the-27)
prep_to(relative-25, dosing-28)
prep_of(dosing-28, Aprepitant-30)
prep_on(Aprepitant-30, Days-32)
number(3-35, 1-33)
quantmod(3-35, through-34)
num(Days-32, 3-35)

The/DT AUC/NN of/IN midazolam/NN on/IN Day/NN 15/CD was/VBD similar/JJ to/TO that/DT observed/VBN at/IN baseline/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN AUC)) (PP (IN of) (NP (NN midazolam))) (PP (IN on) (NP (NN Day) (CD 15)))) (VP (VBD was) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (VP (VBN observed) (PP (IN at) (NP (NN baseline))))))))) (. .))))

det(AUC-2, The-1)
nsubj(similar-9, AUC-2)
prep_of(AUC-2, midazolam-4)
prep_on(AUC-2, Day-6)
num(Day-6, 15-7)
cop(similar-9, was-8)
root(ROOT-0, similar-9)
prep_to(similar-9, that-11)
partmod(that-11, observed-12)
prep_at(observed-12, baseline-14)

Effect/NN of/IN other/JJ agents/NNS on/IN the/DT pharmacokinefics/NNS of/IN aprepitant/NN ./.

(ROOT (S1 (S (NP (NP (NN Effect)) (PP (IN of) (NP (JJ other) (NNS agents))) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinefics)) (PP (IN of) (NP (NN aprepitant))))) (. .)))))

root(ROOT-0, Effect-1)
amod(agents-4, other-3)
prep_of(Effect-1, agents-4)
det(pharmacokinefics-7, the-6)
prep_on(Effect-1, pharmacokinefics-7)
prep_of(pharmacokinefics-7, aprepitant-9)

Aprepitant/NN is/VBZ a/DT substrate/NN for/IN CYP3A4/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN Aprepitant)) (VP (VBZ is) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN CYP3A4))))) (: ;)) (. .))))

nsubj(substrate-4, Aprepitant-1)
cop(substrate-4, is-2)
det(substrate-4, a-3)
root(ROOT-0, substrate-4)
prep_for(substrate-4, CYP3A4-6)

therefore/RB ,/, coadministration/NN of/IN Aprepitant/NN with/IN drugs/NNS that/WDT inhibit/VBP CYP3A4/NN activity/NN may/MD result/VB in/IN increased/VBN plasma/NN concentrations/NNS of/IN aprepitant/NN ./.

(ROOT (S1 (S (S (ADVP (RB therefore)) (, ,) (NP (NP (NN coadministration)) (PP (IN of) (NP (NN Aprepitant))) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (NN CYP3A4) (NN activity)))))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (VBN increased) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN aprepitant)))))))) (. .))))

advmod(result-13, therefore-1)
nsubj(result-13, coadministration-3)
prep_of(coadministration-3, Aprepitant-5)
prep_with(coadministration-3, drugs-7)
nsubj(inhibit-9, drugs-7)
rcmod(drugs-7, inhibit-9)
nn(activity-11, CYP3A4-10)
dobj(inhibit-9, activity-11)
aux(result-13, may-12)
root(ROOT-0, result-13)
amod(concentrations-17, increased-15)
nn(concentrations-17, plasma-16)
prep_in(result-13, concentrations-17)
prep_of(concentrations-17, aprepitant-19)

Consequently/RB ,/, concomitant/JJ administration/NN of/IN Aprepitant/NN with/IN strong/JJ CYP3A4/JJ inhibitors/NNS (/-LRB- e.g./FW ,/, ketoconazole/NN ,/, itraconazole/NN ,/, nefazodone/NN ,/, troleandomycin/NN ,/, clarithromycin/NN ,/, ritonavir/NN ,/, nelfinavir/NN )/-RRB- should/MD be/VB approached/VBN with/IN caution/NN ./.

(ROOT (S1 (S (S (ADVP (RB Consequently)) (, ,) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN Aprepitant))) (PP (IN with) (NP (NP (JJ strong) (JJ CYP3A4) (NNS inhibitors)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN ketoconazole)) (, ,) (NP (NN itraconazole)) (, ,) (NP (NN nefazodone)) (, ,) (NP (NN troleandomycin)) (, ,) (NP (NN clarithromycin)) (, ,) (NP (NN ritonavir)) (, ,) (NP (NN nelfinavir)))) (-RRB- -RRB-))))) (VP (MD should) (VP (VB be) (VP (VBN approached) (PP (IN with) (NP (NN caution))))))) (. .))))

advmod(approached-30, Consequently-1)
amod(administration-4, concomitant-3)
nsubjpass(approached-30, administration-4)
prep_of(administration-4, Aprepitant-6)
amod(inhibitors-10, strong-8)
amod(inhibitors-10, CYP3A4-9)
prep_with(administration-4, inhibitors-10)
dep(inhibitors-10, e.g.-12)
pobj(e.g.-12, ketoconazole-14)
appos(ketoconazole-14, itraconazole-16)
appos(ketoconazole-14, nefazodone-18)
appos(ketoconazole-14, troleandomycin-20)
appos(ketoconazole-14, clarithromycin-22)
appos(ketoconazole-14, ritonavir-24)
appos(ketoconazole-14, nelfinavir-26)
aux(approached-30, should-28)
auxpass(approached-30, be-29)
root(ROOT-0, approached-30)
prep_with(approached-30, caution-32)

Because/IN moderate/JJ CYP3A4/JJ inhibitors/NNS (/-LRB- e.g./FW ,/, diltiazem/NN )/-RRB- result/VBP in/IN 2-fold/JJ increase/NN in/IN plasma/NN concentrations/NNS of/IN aprepitant/NN ,/, concomitant/JJ administration/NN should/MD also/RB be/VB approached/VBN with/IN caution/NN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NP (JJ moderate) (JJ CYP3A4) (NNS inhibitors)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN diltiazem))) (-RRB- -RRB-))) (VP (VBP result) (PP (IN in) (NP (NP (JJ 2-fold) (NN increase)) (PP (IN in) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN aprepitant)))))))))) (, ,) (NP (JJ concomitant) (NN administration)) (VP (MD should) (ADVP (RB also)) (VP (VB be) (VP (VBN approached) (PP (IN with) (NP (NN caution))))))) (. .))))

mark(result-10, Because-1)
amod(inhibitors-4, moderate-2)
amod(inhibitors-4, CYP3A4-3)
nsubj(result-10, inhibitors-4)
dep(inhibitors-4, e.g.-6)
pobj(e.g.-6, diltiazem-8)
advcl(approached-25, result-10)
amod(increase-13, 2-fold-12)
prep_in(result-10, increase-13)
nn(concentrations-16, plasma-15)
prep_in(increase-13, concentrations-16)
prep_of(concentrations-16, aprepitant-18)
amod(administration-21, concomitant-20)
nsubjpass(approached-25, administration-21)
aux(approached-25, should-22)
advmod(approached-25, also-23)
auxpass(approached-25, be-24)
root(ROOT-0, approached-25)
prep_with(approached-25, caution-27)

Aprepitant/NN is/VBZ a/DT substrate/NN for/IN CYP3A4/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN Aprepitant)) (VP (VBZ is) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN CYP3A4))))) (: ;)) (. .))))

nsubj(substrate-4, Aprepitant-1)
cop(substrate-4, is-2)
det(substrate-4, a-3)
root(ROOT-0, substrate-4)
prep_for(substrate-4, CYP3A4-6)

therefore/RB ,/, coadministration/NN of/IN Aprepitant/NN with/IN drugs/NNS that/WDT strongly/RB induce/VBP CYP3A4/NN activity/NN (/-LRB- e.g./FW ,/, rifampin/NN ,/, carbamazepine/NN ,/, phenytoin/NN )/-RRB- may/MD result/VB in/IN reduced/VBN plasma/NN concentrations/NNS of/IN aprepitant/NN that/WDT may/MD result/VB in/IN decreased/VBN efficacy/NN of/IN Aprepitant/NN ./.

(ROOT (S1 (S (ADVP (RB therefore)) (, ,) (NP (NP (NN coadministration)) (PP (IN of) (NP (NN Aprepitant))) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (ADVP (RB strongly)) (VP (VBP induce) (NP (NN CYP3A4) (NN activity)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN rifampin)) (, ,) (NP (NN carbamazepine)) (, ,) (NP (NN phenytoin))) (-RRB- -RRB-)))))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (VBN reduced) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN aprepitant))) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (VBN decreased) (NN efficacy)) (PP (IN of) (NP (NN Aprepitant))))))))))))) (. .))))

advmod(result-23, therefore-1)
nsubj(result-23, coadministration-3)
prep_of(coadministration-3, Aprepitant-5)
prep_with(coadministration-3, drugs-7)
nsubj(induce-10, drugs-7)
advmod(induce-10, strongly-9)
rcmod(drugs-7, induce-10)
nn(activity-12, CYP3A4-11)
dobj(induce-10, activity-12)
dep(rifampin-16, e.g.-14)
dep(induce-10, rifampin-16)
appos(rifampin-16, carbamazepine-18)
appos(rifampin-16, phenytoin-20)
aux(result-23, may-22)
root(ROOT-0, result-23)
amod(concentrations-27, reduced-25)
nn(concentrations-27, plasma-26)
prep_in(result-23, concentrations-27)
nsubj(result-32, concentrations-27)
prep_of(concentrations-27, aprepitant-29)
aux(result-32, may-31)
rcmod(concentrations-27, result-32)
amod(efficacy-35, decreased-34)
prep_in(result-32, efficacy-35)
prep_of(efficacy-35, Aprepitant-37)

Ketoconazole/NN :/: When/IN a/DT single/JJ 125-mg/NN dose/NN of/IN Aprepitant/NN was/VBD administered/VBN on/IN Day5/NN of/IN a/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Ketoconazole) (: :)) (PP (IN When) (NP (NP (DT a) (JJ single) (NN 125-mg) (NN dose)) (PP (IN of) (NP (NN Aprepitant)))))) (VP (VBD was) (VP (VBN administered) (PP (IN on) (NP (NP (NN Day5)) (PP (IN of) (NP (NN a)))))))) (. .))))

nsubjpass(administered-11, Ketoconazole-1)
det(dose-7, a-4)
amod(dose-7, single-5)
nn(dose-7, 125-mg-6)
prep_when(Ketoconazole-1, dose-7)
prep_of(dose-7, Aprepitant-9)
auxpass(administered-11, was-10)
root(ROOT-0, administered-11)
prep_on(administered-11, Day5-13)
prep_of(Day5-13, a-15)

10-day/JJ regimen/NN of/IN 400/CD mg/day/NN of/IN ketoconazole/NN ,/, a/DT strong/JJ CYP3A4/NN inhibitor/NN ,/, the/DT AUC/NN of/IN aprepitant/NN increased/VBD approximately/RB 5-fold/RB and/CC the/DT mean/JJ terminal/JJ half-life/NN of/IN aprepitant/NN increased/VBD approximately/RB 3-fold/RB ./.

(ROOT (S1 (S (S (S (NP (NP (JJ 10-day) (NN regimen)) (PP (IN of) (NP (NP (CD 400) (NN mg/day)) (PP (IN of) (NP (NP (NN ketoconazole)) (, ,) (NP (NP (DT a) (JJ strong) (NN CYP3A4) (NN inhibitor)) (, ,) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NN aprepitant)))))))))) (VP (VBD increased) (ADVP (RB approximately) (RB 5-fold)))) (CC and) (S (NP (NP (DT the) (JJ mean) (JJ terminal) (NN half-life)) (PP (IN of) (NP (NN aprepitant)))) (VP (VBD increased) (ADVP (RB approximately) (RB 3-fold))))) (. .))))

amod(regimen-2, 10-day-1)
nsubj(increased-18, regimen-2)
num(mg/day-5, 400-4)
prep_of(regimen-2, mg/day-5)
prep_of(mg/day-5, ketoconazole-7)
det(inhibitor-12, a-9)
amod(inhibitor-12, strong-10)
nn(inhibitor-12, CYP3A4-11)
appos(ketoconazole-7, inhibitor-12)
det(AUC-15, the-14)
appos(inhibitor-12, AUC-15)
prep_of(AUC-15, aprepitant-17)
root(ROOT-0, increased-18)
advmod(5-fold-20, approximately-19)
advmod(increased-18, 5-fold-20)
det(half-life-25, the-22)
amod(half-life-25, mean-23)
amod(half-life-25, terminal-24)
nsubj(increased-28, half-life-25)
prep_of(half-life-25, aprepitant-27)
conj_and(increased-18, increased-28)
advmod(3-fold-30, approximately-29)
advmod(increased-28, 3-fold-30)

Concomitant/JJ administration/NN of/IN Aprepitant/NN with/IN strong/JJ CYP3A4/JJ inhibitors/NNS should/MD be/VB approached/VBN cautiously/RB ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NN Aprepitant))) (PP (IN with) (NP (JJ strong) (JJ CYP3A4) (NNS inhibitors)))) (VP (MD should) (VP (VB be) (VP (VBN approached) (ADVP (RB cautiously)))))) (. .))))

amod(administration-2, Concomitant-1)
nsubjpass(approached-11, administration-2)
prep_of(administration-2, Aprepitant-4)
amod(inhibitors-8, strong-6)
amod(inhibitors-8, CYP3A4-7)
prep_with(administration-2, inhibitors-8)
aux(approached-11, should-9)
auxpass(approached-11, be-10)
root(ROOT-0, approached-11)
advmod(approached-11, cautiously-12)

Rifampin/NN :/: When/WRB a/DT single/JJ 375-mg/NN dose/NN of/IN Aprepitant/NN was/VBD administered/VBN on/IN Day9/NN of/IN a/DT 14-day/JJ regimen/NN of/IN 600/CD mg/day/NN of/IN rifampin/NN ,/, a/DT strong/JJ CYP3A4/NN inducer/NN ,/, the/DT AUC/NN of/IN aprepitant/NN decreased/VBD approximately/RB 11-fold/RB and/CC the/DT mean/JJ terminal/JJ half-life/NN decreased/VBD approximately/RB 3-fold/RB ./.

(ROOT (S1 (S (NP (NP (NN Rifampin)) (: :) (S (SBAR (WHADVP (WRB When)) (S (NP (NP (DT a) (JJ single) (NN 375-mg) (NN dose)) (PP (IN of) (NP (NN Aprepitant)))) (VP (VBD was) (VP (VBN administered) (PP (IN on) (NP (NP (NN Day9)) (PP (IN of) (NP (NP (DT a) (JJ 14-day) (NN regimen)) (PP (IN of) (NP (NP (CD 600) (NN mg/day)) (PP (IN of) (NP (NP (NN rifampin)) (, ,) (NP (DT a) (JJ strong) (NN CYP3A4) (NN inducer)))))))))))))) (, ,) (S (S (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NN aprepitant)))) (VP (VBD decreased) (ADVP (RB approximately) (RB 11-fold)))) (CC and) (S (NP (DT the) (JJ mean) (JJ terminal) (NN half-life)) (VP (VBD decreased) (ADVP (RB approximately) (RB 3-fold)))))) (. .)))))

root(ROOT-0, Rifampin-1)
advmod(administered-11, When-3)
det(dose-7, a-4)
amod(dose-7, single-5)
nn(dose-7, 375-mg-6)
nsubjpass(administered-11, dose-7)
prep_of(dose-7, Aprepitant-9)
auxpass(administered-11, was-10)
advcl(decreased-33, administered-11)
prep_on(administered-11, Day9-13)
det(regimen-17, a-15)
amod(regimen-17, 14-day-16)
prep_of(Day9-13, regimen-17)
num(mg/day-20, 600-19)
prep_of(regimen-17, mg/day-20)
prep_of(mg/day-20, rifampin-22)
det(inducer-27, a-24)
amod(inducer-27, strong-25)
nn(inducer-27, CYP3A4-26)
appos(rifampin-22, inducer-27)
det(AUC-30, the-29)
nsubj(decreased-33, AUC-30)
prep_of(AUC-30, aprepitant-32)
dep(Rifampin-1, decreased-33)
advmod(11-fold-35, approximately-34)
advmod(decreased-33, 11-fold-35)
det(half-life-40, the-37)
amod(half-life-40, mean-38)
amod(half-life-40, terminal-39)
nsubj(decreased-41, half-life-40)
conj_and(decreased-33, decreased-41)
advmod(3-fold-43, approximately-42)
advmod(decreased-41, 3-fold-43)

Coadministration/NN of/IN Aprepitant/NN with/IN drugs/NNS that/WDT induce/VBP CYP3A4/NN activity/NN may/MD result/VB in/IN reduced/VBN plasma/NN concentrations/NNS and/CC decreased/VBN efficacy/NN of/IN Aprepitant/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN Aprepitant))) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP induce) (NP (NN CYP3A4) (NN activity)))))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (VBN reduced) (NN plasma) (NNS concentrations)) (CC and) (NP (NP (VBN decreased) (NN efficacy)) (PP (IN of) (NP (NN Aprepitant))))))))) (. .))))

nsubj(result-11, Coadministration-1)
prep_of(Coadministration-1, Aprepitant-3)
prep_with(Coadministration-1, drugs-5)
nsubj(induce-7, drugs-5)
rcmod(drugs-5, induce-7)
nn(activity-9, CYP3A4-8)
dobj(induce-7, activity-9)
aux(result-11, may-10)
root(ROOT-0, result-11)
amod(concentrations-15, reduced-13)
nn(concentrations-15, plasma-14)
prep_in(result-11, concentrations-15)
amod(efficacy-18, decreased-17)
conj_and(concentrations-15, efficacy-18)
prep_of(efficacy-18, Aprepitant-20)

Diltiazem/NN :/: In/IN patients/NNS with/IN mild/JJ to/TO moderate/JJ hypertension/NN ,/, administration/NN of/IN aprepitant/NN once/RB daily/RB ,/, as/IN a/DT tablet/NN formulation/NN comparable/JJ to/TO 230/CD mg/NN of/IN the/DT capsule/JJ formulation/NN ,/, with/IN diltiazem/NN 120/CD mg/NN 3/CD times/NNS daily/JJ for/IN 5/CD days/NNS ,/, resulted/VBD in/IN a/DT 2-fold/JJ increase/NN of/IN aprepitant/JJ AUC/NN and/CC a/DT simultaneous/JJ 1.7-fold/JJ increase/NN of/IN diltiazem/NN AUC/NN ./.

(ROOT (S1 (S (NP (NP (NN Diltiazem)) (: :) (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (JJ mild) (TO to) (JJ moderate)) (NN hypertension))))) (, ,) (NP (NP (NN administration)) (PP (IN of) (NP (NP (NN aprepitant)) (ADVP (RB once) (RB daily))))) (, ,) (PP (IN as) (NP (NP (DT a) (NN tablet) (NN formulation)) (ADJP (JJ comparable) (PP (TO to) (NP (NP (CD 230) (NN mg)) (PP (IN of) (NP (DT the) (JJ capsule) (NN formulation)))))))) (, ,) (PP (IN with) (NP (NP (NN diltiazem) (CD 120) (NN mg) (CD 3) (NNS times)) (ADJP (JJ daily) (PP (IN for) (NP (CD 5) (NNS days)))))) (, ,) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (JJ 2-fold) (NN increase)) (PP (IN of) (NP (JJ aprepitant) (NN AUC)))) (CC and) (NP (NP (DT a) (JJ simultaneous) (JJ 1.7-fold) (NN increase)) (PP (IN of) (NP (NN diltiazem) (NN AUC)))))))) (. .)))))

root(ROOT-0, Diltiazem-1)
prep_in(resulted-41, patients-4)
amod(moderate-8, mild-6)
dep(moderate-8, to-7)
amod(hypertension-9, moderate-8)
prep_with(patients-4, hypertension-9)
nsubj(resulted-41, administration-11)
prep_of(administration-11, aprepitant-13)
advmod(daily-15, once-14)
advmod(aprepitant-13, daily-15)
det(formulation-20, a-18)
nn(formulation-20, tablet-19)
prep_as(resulted-41, formulation-20)
amod(formulation-20, comparable-21)
num(mg-24, 230-23)
prep_to(comparable-21, mg-24)
det(formulation-28, the-26)
amod(formulation-28, capsule-27)
prep_of(mg-24, formulation-28)
nn(times-35, diltiazem-31)
num(times-35, 120-32)
nn(times-35, mg-33)
num(times-35, 3-34)
prep_with(resulted-41, times-35)
amod(times-35, daily-36)
num(days-39, 5-38)
prep_for(daily-36, days-39)
dep(Diltiazem-1, resulted-41)
det(increase-45, a-43)
amod(increase-45, 2-fold-44)
prep_in(resulted-41, increase-45)
amod(AUC-48, aprepitant-47)
prep_of(increase-45, AUC-48)
det(increase-53, a-50)
amod(increase-53, simultaneous-51)
amod(increase-53, 1.7-fold-52)
conj_and(increase-45, increase-53)
nn(AUC-56, diltiazem-55)
prep_of(increase-53, AUC-56)

These/DT pharmacokinetic/JJ effects/NNS did/VBD not/RB result/VB in/IN clinically/RB meaningful/JJ changes/NNS in/IN ECG/NN ,/, heart/NN rate/NN or/CC blood/NN pressure/NN beyond/IN those/DT changes/NNS induced/VBN by/IN diltiazem/NN alone/RB ./.

(ROOT (S1 (S (S (NP (DT These) (JJ pharmacokinetic) (NNS effects)) (VP (VBD did) (RB not) (VP (VB result) (PP (IN in) (NP (NP (ADJP (RB clinically) (JJ meaningful)) (NNS changes)) (PP (IN in) (NP (NP (NN ECG)) (, ,) (NP (NN heart) (NN rate)) (CC or) (NP (NN blood) (NN pressure)))))) (PP (IN beyond) (NP (NP (DT those) (NNS changes)) (VP (VBN induced) (PP (IN by) (NP (NP (NN diltiazem)) (ADVP (RB alone)))))))))) (. .))))

det(effects-3, These-1)
amod(effects-3, pharmacokinetic-2)
nsubj(result-6, effects-3)
aux(result-6, did-4)
neg(result-6, not-5)
root(ROOT-0, result-6)
advmod(meaningful-9, clinically-8)
amod(changes-10, meaningful-9)
prep_in(result-6, changes-10)
prep_in(changes-10, ECG-12)
nn(rate-15, heart-14)
conj_or(ECG-12, rate-15)
nn(pressure-18, blood-17)
conj_or(ECG-12, pressure-18)
det(changes-21, those-20)
prep_beyond(result-6, changes-21)
partmod(changes-21, induced-22)
agent(induced-22, diltiazem-24)
advmod(diltiazem-24, alone-25)

Paroxetine/NN :/: Coadministration/NN of/IN once/RB daily/JJ doses/NNS of/IN aprepitant/NN ,/, as/IN a/DT tablet/NN formulation/NN comparable/JJ to/TO 85/CD mg/NN or/CC 170/CD mg/NN of/IN the/DT capsule/JJ formulation/NN ,/, with/IN paroxetine/NN 20/CD mg/NN once/RB daily/JJ ,/, resulted/VBD in/IN a/DT decrease/NN in/IN AUC/NN by/IN approximately/RB 25/CD %/NN and/CC Cmax/NN ,/, by/IN approximately/RB 20/CD %/NN of/IN both/DT aprepitant/NN and/CC paroxetine/NN ./.

(ROOT (S1 (S (NP (NP (NN Paroxetine)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (ADJP (RB once) (JJ daily)) (NNS doses)) (PP (IN of) (NP (NN aprepitant))))) (, ,) (PP (IN as) (NP (NP (DT a) (NN tablet) (NN formulation)) (ADJP (JJ comparable) (PP (TO to) (NP (NP (NP (CD 85) (NN mg)) (CC or) (NP (CD 170) (NN mg))) (PP (IN of) (NP (DT the) (JJ capsule) (NN formulation)))))))) (, ,) (PP (IN with) (NP (NP (NN paroxetine) (CD 20) (NN mg)) (ADJP (RB once) (JJ daily)))) (, ,)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (NP (NN AUC)) (PP (IN by) (NP (QP (RB approximately) (CD 25)) (NN %)))) (CC and) (NP (NN Cmax)))))) (, ,) (PP (IN by) (NP (NP (NP (QP (RB approximately) (CD 20)) (NN %)) (PP (IN of) (NP (DT both) (NN aprepitant)))) (CC and) (NP (NN paroxetine)))))) (. .)))))

root(ROOT-0, Paroxetine-1)
nsubj(resulted-34, Coadministration-3)
advmod(daily-6, once-5)
amod(doses-7, daily-6)
prep_of(Coadministration-3, doses-7)
prep_of(doses-7, aprepitant-9)
det(formulation-14, a-12)
nn(formulation-14, tablet-13)
prep_as(Coadministration-3, formulation-14)
amod(formulation-14, comparable-15)
num(mg-18, 85-17)
prep_to(comparable-15, mg-18)
num(mg-21, 170-20)
conj_or(mg-18, mg-21)
det(formulation-25, the-23)
amod(formulation-25, capsule-24)
prep_of(mg-18, formulation-25)
nn(mg-30, paroxetine-28)
num(mg-30, 20-29)
prep_with(Coadministration-3, mg-30)
advmod(daily-32, once-31)
amod(mg-30, daily-32)
dep(Paroxetine-1, resulted-34)
det(decrease-37, a-36)
prep_in(resulted-34, decrease-37)
prep_in(decrease-37, AUC-39)
quantmod(25-42, approximately-41)
num(%-43, 25-42)
prep_by(AUC-39, %-43)
conj_and(AUC-39, Cmax-45)
quantmod(20-49, approximately-48)
num(%-50, 20-49)
prep_by(resulted-34, %-50)
det(aprepitant-53, both-52)
prep_of(%-50, aprepitant-53)
conj_and(%-50, paroxetine-55)

Beta-adrenergic/JJ blocking/NN agents/NNS :/: concurrent/JJ use/NN may/MD blunt/VB the/DT response/NN to/TO arbutamine/NN ./.

(ROOT (S1 (S (S (NP (JJ Beta-adrenergic) (NN blocking) (NNS agents)) (: :) (NP (JJ concurrent) (NN use)) (VP (MD may) (VP (VB blunt) (NP (NP (DT the) (NN response)) (PP (TO to) (NP (NN arbutamine))))))) (. .))))

amod(agents-3, Beta-adrenergic-1)
nn(agents-3, blocking-2)
nsubj(blunt-8, agents-3)
amod(use-6, concurrent-5)
nsubj(blunt-8, use-6)
aux(blunt-8, may-7)
root(ROOT-0, blunt-8)
det(response-10, the-9)
dobj(blunt-8, response-10)
prep_to(response-10, arbutamine-12)

Beta-adrenergic/JJ blocking/NN agents/NNS should/MD be/VB withdrawn/VBN at/IN least/JJS 48/CD hours/NNS before/IN conducting/VBG an/DT arbutamine/JJ -mediated/JJ stress/NN test/NN ./.

(ROOT (S1 (S (S (NP (JJ Beta-adrenergic) (NN blocking) (NNS agents)) (VP (MD should) (VP (VB be) (VP (VBN withdrawn) (PP (IN at) (NP (QP (JJS least) (CD 48)) (NNS hours))) (PP (IN before) (S (VP (VBG conducting) (NP (DT an) (JJ arbutamine) (JJ -mediated) (NN stress) (NN test))))))))) (. .))))

amod(agents-3, Beta-adrenergic-1)
nn(agents-3, blocking-2)
nsubjpass(withdrawn-6, agents-3)
aux(withdrawn-6, should-4)
auxpass(withdrawn-6, be-5)
root(ROOT-0, withdrawn-6)
quantmod(48-9, least-8)
num(hours-10, 48-9)
prep_at(withdrawn-6, hours-10)
prepc_before(withdrawn-6, conducting-12)
det(test-17, an-13)
amod(test-17, arbutamine-14)
amod(test-17, -mediated-15)
nn(test-17, stress-16)
dobj(conducting-12, test-17)

Antiarrhythmic/JJ agent/NN s/NNS ,/, class/NN I/NN (/-LRB- such/JJ as/IN flecainide/NN ,/, lidocaine/NN ,/, or/CC quinidine/NN )/-RRB- :/: concurrent/JJ use/NN with/IN arbutamine/NN may/MD have/VB a/DT proarrhythmic/JJ effect/NN ./.

(ROOT (S1 (S (NP (NP (NP (NP (JJ Antiarrhythmic) (NN agent) (NNS s)) (, ,) (NP (NN class) (NN I))) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NP (NN flecainide)) (, ,) (NP (NN lidocaine)) (, ,) (CC or) (NP (NN quinidine))))) (-RRB- -RRB-))) (: :) (S (NP (NP (JJ concurrent) (NN use)) (PP (IN with) (NP (NN arbutamine)))) (VP (MD may) (VP (VB have) (NP (DT a) (JJ proarrhythmic) (NN effect))))) (. .)))))

amod(s-3, Antiarrhythmic-1)
nn(s-3, agent-2)
root(ROOT-0, s-3)
nn(I-6, class-5)
appos(s-3, I-6)
prep_such_as(s-3, flecainide-10)
conj_or(flecainide-10, lidocaine-12)
conj_or(flecainide-10, quinidine-15)
amod(use-19, concurrent-18)
nsubj(have-23, use-19)
prep_with(use-19, arbutamine-21)
aux(have-23, may-22)
dep(s-3, have-23)
det(effect-26, a-24)
amod(effect-26, proarrhythmic-25)
dobj(have-23, effect-26)

Antidepressants/NNS (/-LRB- tricyclic/JJ )/-RRB- ,/, atropine/JJ or/CC other/JJ anticholinergic/JJ agents/NNS ,/, or/CC digitalis/NN glycosides/NNS :/: concurrent/JJ use/NN with/IN arbutamine/NN may/MD produce/VB additive/JJ inotropic/JJ and/or/CC chronotropic/JJ effects/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NP (NNS Antidepressants)) (PRN (-LRB- -LRB-) (NP (JJ tricyclic)) (-RRB- -RRB-))) (, ,) (NP (ADJP (ADJP (JJ atropine)) (CC or) (ADJP (JJ other))) (JJ anticholinergic) (NNS agents)) (, ,) (CC or) (NP (NN digitalis) (NNS glycosides))) (: :) (S (NP (NP (JJ concurrent) (NN use)) (PP (IN with) (NP (NN arbutamine)))) (VP (MD may) (VP (VB produce) (NP (JJ additive) (ADJP (ADJP (JJ inotropic)) (CC and/or) (ADJP (JJ chronotropic))) (NNS effects))))) (. .)))))

root(ROOT-0, Antidepressants-1)
dep(Antidepressants-1, tricyclic-3)
amod(agents-10, atropine-6)
conj_or(atropine-6, other-8)
amod(agents-10, anticholinergic-9)
conj_or(Antidepressants-1, agents-10)
nn(glycosides-14, digitalis-13)
conj_or(Antidepressants-1, glycosides-14)
amod(use-17, concurrent-16)
nsubj(produce-21, use-17)
prep_with(use-17, arbutamine-19)
aux(produce-21, may-20)
dep(Antidepressants-1, produce-21)
amod(effects-26, additive-22)
amod(effects-26, inotropic-23)
conj_and/or(inotropic-23, chronotropic-25)
dobj(produce-21, effects-26)

Anticoagulants/NNS including/VBG coumarin/NN derivatives/NNS ,/, indandione/NN derivatives/NNS ,/, and/CC platelet/NN aggregation/NN inhibitors/NNS such/JJ as/IN nonsteroidal/JJ anti-inflammatory/JJ drugs/NNS (/-LRB- NSAIDs/NNS )/-RRB- ,/, and/CC aspirin/NN may/MD increase/VB the/DT risk/NN of/IN bleeding/JJ when/WRB administered/VBN concomitantly/RB with/IN ardeparin/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Anticoagulants)) (PP (VBG including) (NP (NP (NN coumarin) (NNS derivatives)) (, ,) (NP (NN indandione) (NNS derivatives)) (, ,) (CC and) (NP (NP (NN platelet) (NN aggregation) (NNS inhibitors)) (PP (JJ such) (IN as) (NP (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NNS NSAIDs)) (-RRB- -RRB-))))) (, ,) (CC and) (NP (NN aspirin))))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ bleeding)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN ardeparin))))))))) (. .))))

nsubj(increase-25, Anticoagulants-1)
nn(derivatives-4, coumarin-3)
prep_including(Anticoagulants-1, derivatives-4)
nn(derivatives-7, indandione-6)
conj_and(derivatives-4, derivatives-7)
nn(inhibitors-12, platelet-10)
nn(inhibitors-12, aggregation-11)
conj_and(derivatives-4, inhibitors-12)
amod(drugs-17, nonsteroidal-15)
amod(drugs-17, anti-inflammatory-16)
prep_such_as(inhibitors-12, drugs-17)
appos(drugs-17, NSAIDs-19)
conj_and(derivatives-4, aspirin-23)
aux(increase-25, may-24)
root(ROOT-0, increase-25)
det(risk-27, the-26)
dobj(increase-25, risk-27)
prep_of(risk-27, bleeding-29)
advmod(administered-31, when-30)
advcl(increase-25, administered-31)
advmod(administered-31, concomitantly-32)
prep_with(administered-31, ardeparin-34)

If/IN additional/JJ adrenergic/JJ drugs/NNS are/VBP to/TO be/VB administered/VBN by/IN any/DT route/NN ,/, they/PRP should/MD be/VB used/VBN with/IN caution/NN because/IN the/DT pharmacologically/RB predictable/JJ sympathetic/JJ effects/NNS of/IN BROVANA/NN may/MD be/VB potentiated/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (JJ additional) (JJ adrenergic) (NNS drugs)) (VP (VBP are) (S (VP (TO to) (VP (VB be) (VP (VBN administered) (PP (IN by) (NP (DT any) (NN route)))))))))) (, ,) (NP (PRP they)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN caution))) (SBAR (IN because) (S (NP (NP (DT the) (ADJP (RB pharmacologically) (JJ predictable)) (JJ sympathetic) (NNS effects)) (PP (IN of) (NP (NN BROVANA)))) (VP (MD may) (VP (VB be) (VP (VBN potentiated)))))))))) (. .))))

mark(are-5, If-1)
amod(drugs-4, additional-2)
amod(drugs-4, adrenergic-3)
nsubj(are-5, drugs-4)
xsubj(administered-8, drugs-4)
advcl(used-16, are-5)
aux(administered-8, to-6)
auxpass(administered-8, be-7)
xcomp(are-5, administered-8)
det(route-11, any-10)
agent(administered-8, route-11)
nsubjpass(used-16, they-13)
aux(used-16, should-14)
auxpass(used-16, be-15)
root(ROOT-0, used-16)
prep_with(used-16, caution-18)
mark(potentiated-29, because-19)
det(effects-24, the-20)
advmod(predictable-22, pharmacologically-21)
amod(effects-24, predictable-22)
amod(effects-24, sympathetic-23)
nsubjpass(potentiated-29, effects-24)
prep_of(effects-24, BROVANA-26)
aux(potentiated-29, may-27)
auxpass(potentiated-29, be-28)
advcl(used-16, potentiated-29)

When/WRB paroxetine/NN ,/, a/DT potent/JJ inhibitor/NN of/IN CYP2D6/NN ,/, was/VBD co-administered/VBN with/IN BROVANA/NN at/IN steady-state/NN ,/, exposure/NN to/TO either/DT drug/NN was/VBD not/RB altered/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NP (NN paroxetine)) (, ,) (NP (NP (DT a) (JJ potent) (NN inhibitor)) (PP (IN of) (NP (NN CYP2D6)))) (, ,)) (VP (VBD was) (VP (VBN co-administered) (PP (IN with) (NP (NN BROVANA))) (PP (IN at) (NP (NN steady-state))))))) (, ,) (NP (NP (NN exposure)) (PP (TO to) (NP (DT either) (NN drug)))) (VP (VBD was) (RB not) (VP (VBN altered)))) (. .))))

advmod(co-administered-11, When-1)
nsubjpass(co-administered-11, paroxetine-2)
det(inhibitor-6, a-4)
amod(inhibitor-6, potent-5)
appos(paroxetine-2, inhibitor-6)
prep_of(inhibitor-6, CYP2D6-8)
auxpass(co-administered-11, was-10)
advcl(altered-23, co-administered-11)
prep_with(co-administered-11, BROVANA-13)
prep_at(co-administered-11, steady-state-15)
nsubjpass(altered-23, exposure-17)
det(drug-20, either-19)
prep_to(exposure-17, drug-20)
auxpass(altered-23, was-21)
neg(altered-23, not-22)
root(ROOT-0, altered-23)

Dosage/NN adjustments/NNS of/IN BROVANA/NN are/VBP not/RB necessary/JJ when/WRB the/DT drug/NN is/VBZ given/VBN concomitantly/RB with/IN potent/JJ CYP2D6/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Dosage) (NNS adjustments)) (PP (IN of) (NP (NN BROVANA)))) (VP (VBP are) (RB not) (ADJP (JJ necessary)) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN drug)) (VP (VBZ is) (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (JJ potent) (NN CYP2D6) (NNS inhibitors))))))))) (. .))))

nn(adjustments-2, Dosage-1)
nsubj(necessary-7, adjustments-2)
prep_of(adjustments-2, BROVANA-4)
cop(necessary-7, are-5)
neg(necessary-7, not-6)
root(ROOT-0, necessary-7)
advmod(given-12, when-8)
det(drug-10, the-9)
nsubjpass(given-12, drug-10)
auxpass(given-12, is-11)
advcl(necessary-7, given-12)
advmod(given-12, concomitantly-13)
amod(inhibitors-17, potent-15)
nn(inhibitors-17, CYP2D6-16)
prep_with(given-12, inhibitors-17)

Concomitant/JJ treatment/NN with/IN methylxanthines/NNS (/-LRB- aminophylline/NN ,/, theophylline/NN )/-RRB- ,/, steroids/NNS ,/, or/CC diuretics/NNS may/MD potentiate/VB any/DT hypokalemic/JJ effect/NN of/IN adrenergic/JJ agonists/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN treatment)) (PP (IN with) (NP (NP (NP (NNS methylxanthines)) (PRN (-LRB- -LRB-) (NP (NP (NN aminophylline)) (, ,) (NP (NN theophylline))) (-RRB- -RRB-))) (, ,) (NP (NNS steroids)) (, ,) (CC or) (NP (NNS diuretics))))) (VP (MD may) (VP (VB potentiate) (NP (NP (DT any) (JJ hypokalemic) (NN effect)) (PP (IN of) (NP (JJ adrenergic) (NNS agonists))))))) (. .))))

amod(treatment-2, Concomitant-1)
nsubj(potentiate-16, treatment-2)
prep_with(treatment-2, methylxanthines-4)
dep(methylxanthines-4, aminophylline-6)
appos(aminophylline-6, theophylline-8)
conj_or(methylxanthines-4, steroids-11)
conj_or(methylxanthines-4, diuretics-14)
aux(potentiate-16, may-15)
root(ROOT-0, potentiate-16)
det(effect-19, any-17)
amod(effect-19, hypokalemic-18)
dobj(potentiate-16, effect-19)
amod(agonists-22, adrenergic-21)
prep_of(effect-19, agonists-22)

The/DT ECG/NN changes/NNS and/or/CC hypokalemia/NN that/WDT may/MD result/VB from/IN the/DT administration/NN of/IN non-/JJ potassium/NN sparing/NN diuretics/NN (/-LRB- such/JJ as/IN loop/NN or/CC thiazide/NN diuretics/NNS )/-RRB- can/MD be/VB acutely/RB worsened/VBN by/IN beta-/NN agonists/NNS ,/, especially/RB when/WRB the/DT recommended/VBN dose/NN of/IN the/DT beta-/NN agonist/NN is/VBZ exceeded/VBD ./.

(ROOT (S1 (S (NP (NP (NP (DT The) (NN ECG) (NNS changes)) (CC and/or) (NP (NN hypokalemia))) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB result) (PP (IN from) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (JJ non-) (NN potassium) (NN sparing) (NN diuretics)) (PRN (-LRB- -LRB-) (CONJP (JJ such) (IN as)) (NP (NN loop) (CC or) (NN thiazide) (NNS diuretics)) (-RRB- -RRB-))))))))))) (VP (MD can) (VP (VB be) (VP (ADVP (RB acutely)) (VBN worsened) (PP (IN by) (NP (NN beta-) (NNS agonists))) (, ,) (SBAR (WHADVP (RB especially) (WRB when)) (S (NP (NP (DT the) (VBN recommended) (NN dose)) (PP (IN of) (NP (DT the) (NN beta-) (NN agonist)))) (VP (VBZ is) (VP (VBD exceeded)))))))) (. .))))

det(changes-3, The-1)
nn(changes-3, ECG-2)
nsubj(result-8, changes-3)
nsubjpass(worsened-28, changes-3)
conj_and/or(changes-3, hypokalemia-5)
aux(result-8, may-7)
rcmod(changes-3, result-8)
det(administration-11, the-10)
prep_from(result-8, administration-11)
amod(diuretics-16, non--13)
nn(diuretics-16, potassium-14)
nn(diuretics-16, sparing-15)
prep_of(administration-11, diuretics-16)
dep(diuretics-23, such-18)
dep(such-18, as-19)
nn(diuretics-23, loop-20)
conj_or(loop-20, thiazide-22)
appos(diuretics-16, diuretics-23)
aux(worsened-28, can-25)
auxpass(worsened-28, be-26)
advmod(worsened-28, acutely-27)
root(ROOT-0, worsened-28)
nn(agonists-31, beta--30)
agent(worsened-28, agonists-31)
advmod(when-34, especially-33)
advmod(exceeded-43, when-34)
det(dose-37, the-35)
amod(dose-37, recommended-36)
nsubjpass(exceeded-43, dose-37)
det(agonist-41, the-39)
nn(agonist-41, beta--40)
prep_of(dose-37, agonist-41)
auxpass(exceeded-43, is-42)
advcl(worsened-28, exceeded-43)

Although/IN the/DT clinical/JJ significance/NN of/IN these/DT effects/NNS is/VBZ not/RB known/VBN ,/, caution/NN is/VBZ advised/VBN in/IN the/DT co-administration/NN of/IN beta-/NN agonists/NNS with/IN non-/JJ potassium/NN sparing/NN diuretics/NNS ./.

(ROOT (S1 (S (SBAR (IN Although) (S (NP (NP (DT the) (JJ clinical) (NN significance)) (PP (IN of) (NP (DT these) (NNS effects)))) (VP (VBZ is) (RB not) (VP (VBN known))))) (, ,) (NP (NN caution)) (VP (VBZ is) (VP (VBN advised) (PP (IN in) (NP (NP (DT the) (NN co-administration)) (PP (IN of) (NP (NN beta-) (NNS agonists))) (PP (IN with) (NP (JJ non-) (NN potassium) (NN sparing) (NNS diuretics))))))) (. .))))

mark(known-10, Although-1)
det(significance-4, the-2)
amod(significance-4, clinical-3)
nsubjpass(known-10, significance-4)
det(effects-7, these-6)
prep_of(significance-4, effects-7)
auxpass(known-10, is-8)
neg(known-10, not-9)
advcl(advised-14, known-10)
nsubjpass(advised-14, caution-12)
auxpass(advised-14, is-13)
root(ROOT-0, advised-14)
det(co-administration-17, the-16)
prep_in(advised-14, co-administration-17)
nn(agonists-20, beta--19)
prep_of(co-administration-17, agonists-20)
amod(diuretics-25, non--22)
nn(diuretics-25, potassium-23)
nn(diuretics-25, sparing-24)
prep_with(co-administration-17, diuretics-25)

BROVANA/NN ,/, as/RB with/IN other/JJ beta2-/NN agonists/NNS ,/, should/MD be/VB administered/VBN with/IN extreme/JJ caution/NN to/TO patients/NNS being/VBG treated/VBN with/IN monoamine/NN oxidase/NN inhibitors/NNS ,/, tricyclic/JJ antidepressants/NNS ,/, or/CC drugs/NNS known/VBN to/TO prolong/VB the/DT QTc/NN interval/NN because/IN the/DT action/NN of/IN adrenergic/JJ agonists/NNS on/IN the/DT cardiovascular/JJ system/NN may/MD be/VB potentiated/VBN by/IN these/DT agents/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN BROVANA)) (, ,) (CONJP (RB as) (IN with)) (NP (JJ other) (NN beta2-) (NNS agonists)) (, ,)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (NP (JJ extreme) (NN caution)) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NP (NP (NN monoamine) (NN oxidase)) (NNS inhibitors)) (, ,) (NP (JJ tricyclic) (NNS antidepressants)) (, ,) (CC or) (NP (NP (NNS drugs)) (VP (VBN known) (S (VP (TO to) (VP (VB prolong) (NP (DT the) (NN QTc) (NN interval)) (SBAR (IN because) (S (NP (NP (DT the) (NN action)) (PP (IN of) (NP (JJ adrenergic) (NNS agonists))) (PP (IN on) (NP (DT the) (JJ cardiovascular) (NN system)))) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (PP (IN by) (NP (DT these) (NNS agents))))))))))))))))))))))))) (. .))))

nsubjpass(administered-11, BROVANA-1)
amod(agonists-7, other-5)
nn(agonists-7, beta2--6)
conj_as(BROVANA-1, agonists-7)
aux(administered-11, should-9)
auxpass(administered-11, be-10)
root(ROOT-0, administered-11)
amod(caution-14, extreme-13)
prep_with(administered-11, caution-14)
prep_to(caution-14, patients-16)
auxpass(treated-18, being-17)
partmod(patients-16, treated-18)
nn(oxidase-21, monoamine-20)
nn(inhibitors-22, oxidase-21)
prep_with(treated-18, inhibitors-22)
amod(antidepressants-25, tricyclic-24)
conj_or(inhibitors-22, antidepressants-25)
conj_or(inhibitors-22, drugs-28)
partmod(drugs-28, known-29)
aux(prolong-31, to-30)
xcomp(known-29, prolong-31)
det(interval-34, the-32)
nn(interval-34, QTc-33)
dobj(prolong-31, interval-34)
mark(potentiated-47, because-35)
det(action-37, the-36)
nsubjpass(potentiated-47, action-37)
amod(agonists-40, adrenergic-39)
prep_of(action-37, agonists-40)
det(system-44, the-42)
amod(system-44, cardiovascular-43)
prep_on(action-37, system-44)
aux(potentiated-47, may-45)
auxpass(potentiated-47, be-46)
advcl(prolong-31, potentiated-47)
det(agents-50, these-49)
agent(potentiated-47, agents-50)

Drugs/NNS that/WDT are/VBP known/VBN to/TO prolong/VB the/DT QTc/NN interval/NN have/VBP an/DT increased/VBN risk/NN of/IN ventricular/JJ arrhythmias/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB prolong) (NP (DT the) (NN QTc) (NN interval)))))))))) (VP (VBP have) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (JJ ventricular) (NNS arrhythmias)))))) (. .))))

nsubjpass(known-4, Drugs-1)
nsubj(have-10, Drugs-1)
auxpass(known-4, are-3)
rcmod(Drugs-1, known-4)
aux(prolong-6, to-5)
xcomp(known-4, prolong-6)
det(interval-9, the-7)
nn(interval-9, QTc-8)
dobj(prolong-6, interval-9)
root(ROOT-0, have-10)
det(risk-13, an-11)
amod(risk-13, increased-12)
dobj(have-10, risk-13)
amod(arrhythmias-16, ventricular-15)
prep_of(risk-13, arrhythmias-16)

The/DT concurrent/JJ use/NN of/IN intravenously/RB or/CC orally/RB administered/VBN methylxanthines/NNS (/-LRB- e.g./FW ,/, aminophylline/NN ,/, theophylline/NN )/-RRB- by/IN patients/NNS receiving/VBG BROVANA/NN has/VBZ not/RB been/VBN completely/RB evaluated/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concurrent) (NN use)) (PP (IN of) (NP (NP (ADJP (RB intravenously) (CC or) (RB orally) (VBN administered)) (NNS methylxanthines)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN aminophylline))) (, ,) (NP (NN theophylline)) (-RRB- -RRB-)))) (PP (IN by) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN BROVANA)))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB completely)) (VP (VBN evaluated))))) (. .))))

det(use-3, The-1)
amod(use-3, concurrent-2)
nsubjpass(evaluated-25, use-3)
advmod(administered-8, intravenously-5)
advmod(administered-8, orally-7)
conj_or(administered-8, orally-7)
amod(methylxanthines-9, administered-8)
prep_of(use-3, methylxanthines-9)
dep(theophylline-15, e.g.-11)
pobj(e.g.-11, aminophylline-13)
appos(methylxanthines-9, theophylline-15)
prep_by(use-3, patients-18)
partmod(patients-18, receiving-19)
dobj(receiving-19, BROVANA-20)
aux(evaluated-25, has-21)
neg(evaluated-25, not-22)
auxpass(evaluated-25, been-23)
advmod(evaluated-25, completely-24)
root(ROOT-0, evaluated-25)

In/IN two/CD combined/JJ 12-week/JJ placebo/NN controlled/JJ trials/NNS that/WDT included/VBD BROVANA/JJ doses/NNS of/IN 15/CD mcg/NN twice/RB daily/RB ,/, 25/CD mcg/NN twice/RB daily/RB ,/, and/CC 50/CD mcg/NN once/RB daily/RB ,/, 54/CD of/IN 873/CD BROVANA/JJ -treated/JJ subjects/NNS received/VBD concomitant/JJ theophylline/NN at/IN study/NN entry/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (CD two) (JJ combined) (JJ 12-week) (NN placebo) (JJ controlled) (NNS trials)) (SBAR (WHNP (WDT that)) (S (VP (VBD included) (NP (NP (JJ BROVANA) (NNS doses)) (PP (IN of) (NP (NP (NP (CD 15) (NN mcg)) (ADVP (RB twice) (RB daily))) (, ,) (NP (NP (CD 25) (NN mcg)) (ADVP (RB twice) (RB daily))) (, ,) (CC and) (NP (NP (CD 50) (NN mcg)) (ADVP (RB once) (RB daily))))))))))) (, ,) (NP (NP (CD 54)) (PP (IN of) (NP (CD 873) (JJ BROVANA) (JJ -treated) (NNS subjects)))) (VP (VBD received) (NP (JJ concomitant) (NN theophylline)) (PP (IN at) (NP (NN study) (NN entry)))) (. .))))

num(trials-7, two-2)
amod(trials-7, combined-3)
amod(trials-7, 12-week-4)
nn(trials-7, placebo-5)
amod(trials-7, controlled-6)
nsubj(included-9, trials-7)
prep_in(received-35, trials-7)
rcmod(trials-7, included-9)
amod(doses-11, BROVANA-10)
dobj(included-9, doses-11)
num(mcg-14, 15-13)
prep_of(doses-11, mcg-14)
advmod(daily-16, twice-15)
advmod(mcg-14, daily-16)
num(mcg-19, 25-18)
conj_and(mcg-14, mcg-19)
advmod(daily-21, twice-20)
advmod(mcg-19, daily-21)
num(mcg-25, 50-24)
conj_and(mcg-14, mcg-25)
advmod(daily-27, once-26)
advmod(mcg-25, daily-27)
nsubj(received-35, 54-29)
num(subjects-34, 873-31)
amod(subjects-34, BROVANA-32)
amod(subjects-34, -treated-33)
prep_of(54-29, subjects-34)
root(ROOT-0, received-35)
amod(theophylline-37, concomitant-36)
dobj(received-35, theophylline-37)
nn(entry-40, study-39)
prep_at(received-35, entry-40)

In/IN a/DT 12-month/JJ controlled/JJ trial/NN that/WDT included/VBD a/DT 50/CD mcg/NN once/RB daily/JJ BROVANA/NN dose/NN ,/, 30/CD of/IN the/DT 528/CD BROVANA/JJ -treated/JJ subjects/NNS received/VBD concomitant/JJ theophylline/NN at/IN study/NN entry/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT a) (JJ 12-month) (JJ controlled) (NN trial)) (SBAR (WHNP (WDT that)) (S (VP (VBD included) (NP (DT a) (CD 50) (NN mcg) (ADJP (RB once) (JJ daily)) (NN BROVANA) (NN dose))))))) (, ,) (NP (NP (CD 30)) (PP (IN of) (NP (DT the) (CD 528) (JJ BROVANA) (JJ -treated) (NNS subjects)))) (VP (VBD received) (NP (JJ concomitant) (NN theophylline)) (PP (IN at) (NP (NN study) (NN entry))))) (. .))))

det(trial-5, a-2)
amod(trial-5, 12-month-3)
amod(trial-5, controlled-4)
nsubj(included-7, trial-5)
prep_in(received-23, trial-5)
rcmod(trial-5, included-7)
det(dose-14, a-8)
num(dose-14, 50-9)
nn(dose-14, mcg-10)
advmod(daily-12, once-11)
amod(dose-14, daily-12)
nn(dose-14, BROVANA-13)
dobj(included-7, dose-14)
nsubj(received-23, 30-16)
det(subjects-22, the-18)
num(subjects-22, 528-19)
amod(subjects-22, BROVANA-20)
amod(subjects-22, -treated-21)
prep_of(30-16, subjects-22)
root(ROOT-0, received-23)
amod(theophylline-25, concomitant-24)
dobj(received-23, theophylline-25)
nn(entry-28, study-27)
prep_at(received-23, entry-28)

In/IN these/DT trials/NNS ,/, heart/NN rate/NN and/CC systolic/JJ blood/NN pressure/NN were/VBD approximately/RB 2-3/CD bpm/NN and/CC 6-8/CD mm/NN Hg/NN higher/JJR ,/, respectively/RB ,/, in/IN subjects/NNS on/IN concomitant/JJ theophylline/NN compared/VBN with/IN the/DT overall/JJ population/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (DT these) (NNS trials))) (, ,) (NP (NP (NN heart) (NN rate)) (CC and) (NP (JJ systolic) (NN blood) (NN pressure))) (VP (VBD were) (ADJP (NP (NP (ADJP (QP (RB approximately) (CD 2-3)) (NN bpm))) (CC and) (NP (ADJP (CD 6-8) (NN mm)) (NN Hg))) (JJR higher)) (, ,) (ADVP (RB respectively)) (, ,) (PP (IN in) (NP (NP (NNS subjects)) (PP (IN on) (NP (NP (JJ concomitant) (NN theophylline)) (VP (VBN compared) (PP (IN with) (NP (DT the) (JJ overall) (NN population))))))))) (. .))))

det(trials-3, these-2)
prep_in(higher-19, trials-3)
nn(rate-6, heart-5)
nsubj(higher-19, rate-6)
amod(pressure-10, systolic-8)
nn(pressure-10, blood-9)
conj_and(rate-6, pressure-10)
cop(higher-19, were-11)
quantmod(2-3-13, approximately-12)
dep(bpm-14, 2-3-13)
npadvmod(higher-19, bpm-14)
number(mm-17, 6-8-16)
amod(Hg-18, mm-17)
conj_and(bpm-14, Hg-18)
root(ROOT-0, higher-19)
advmod(higher-19, respectively-21)
prep_in(higher-19, subjects-24)
amod(theophylline-27, concomitant-26)
prep_on(subjects-24, theophylline-27)
partmod(theophylline-27, compared-28)
det(population-32, the-30)
amod(population-32, overall-31)
prep_with(compared-28, population-32)

Beta-adrenergic/JJ receptor/NN antagonists/NNS (/-LRB- beta-blockers/NNS )/-RRB- and/CC BROVANA/NNS may/MD interfere/VB with/IN the/DT effect/NN of/IN each/DT other/JJ when/WRB administered/VBN concurrently/RB ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Beta-adrenergic) (NN receptor) (NNS antagonists)) (PRN (-LRB- -LRB-) (NP (NNS beta-blockers)) (-RRB- -RRB-))) (CC and) (NP (NNS BROVANA))) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (DT each) (JJ other))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (ADVP (RB concurrently)))))))) (. .))))

amod(antagonists-3, Beta-adrenergic-1)
nn(antagonists-3, receptor-2)
nsubj(interfere-10, antagonists-3)
appos(antagonists-3, beta-blockers-5)
conj_and(antagonists-3, BROVANA-8)
aux(interfere-10, may-9)
root(ROOT-0, interfere-10)
det(effect-13, the-12)
prep_with(interfere-10, effect-13)
det(other-16, each-15)
prep_of(effect-13, other-16)
advmod(administered-18, when-17)
advcl(interfere-10, administered-18)
advmod(administered-18, concurrently-19)

Beta-blockers/NNS not/RB only/RB block/VBP the/DT therapeutic/JJ effects/NNS of/IN beta-/NN agonists/NNS ,/, but/CC may/MD produce/VB severe/JJ bronchospasm/NN in/IN COPD/NN patients/NNS ./.

(ROOT (S1 (S (S (NP (NNS Beta-blockers)) (VP (CONJP (RB not) (RB only)) (VP (VBP block) (NP (NP (DT the) (JJ therapeutic) (NNS effects)) (PP (IN of) (NP (NN beta-) (NNS agonists))))) (, ,) (CC but) (VP (MD may) (VP (VB produce) (NP (NP (JJ severe) (NN bronchospasm)) (PP (IN in) (NP (NN COPD) (NNS patients)))))))) (. .))))

nsubj(block-4, Beta-blockers-1)
neg(only-3, not-2)
preconj(block-4, only-3)
root(ROOT-0, block-4)
det(effects-7, the-5)
amod(effects-7, therapeutic-6)
dobj(block-4, effects-7)
nn(agonists-10, beta--9)
prep_of(effects-7, agonists-10)
aux(produce-14, may-13)
conj_but(block-4, produce-14)
amod(bronchospasm-16, severe-15)
dobj(produce-14, bronchospasm-16)
nn(patients-19, COPD-18)
prep_in(bronchospasm-16, patients-19)

Therefore/RB ,/, patients/NNS with/IN COPD/NN should/MD not/RB normally/RB be/VB treated/VBN with/IN beta-blockers/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NNS patients)) (PP (IN with) (NP (NN COPD)))) (VP (MD should) (RB not) (ADVP (RB normally)) (VP (VB be) (VP (VBN treated) (PP (IN with) (NP (NN beta-blockers))))))) (. .))))

advmod(treated-10, Therefore-1)
nsubjpass(treated-10, patients-3)
prep_with(patients-3, COPD-5)
aux(treated-10, should-6)
neg(treated-10, not-7)
advmod(treated-10, normally-8)
auxpass(treated-10, be-9)
root(ROOT-0, treated-10)
prep_with(treated-10, beta-blockers-12)

However/RB ,/, under/IN certain/JJ circumstances/NNS ,/, e.g./FW ,/, as/IN prophylaxis/NN after/IN myocardial/JJ infarction/NN ,/, there/EX may/MD be/VB no/DT acceptable/JJ alternatives/NNS to/TO the/DT use/NN of/IN beta-blockers/NNS in/IN patients/NNS with/IN COPD/NN ./.

(ROOT (S1 (S (ADVP (RB However)) (, ,) (PP (IN under) (NP (NP (JJ certain) (NNS circumstances)) (, ,) (PP (FW e.g.)))) (, ,) (PP (IN as) (NP (NP (NN prophylaxis)) (PP (IN after) (NP (JJ myocardial) (NN infarction))))) (, ,) (NP (EX there)) (VP (MD may) (VP (VB be) (NP (NP (DT no) (JJ acceptable) (NNS alternatives)) (PP (TO to) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NNS beta-blockers))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN COPD)))))))))) (. .))))

advmod(alternatives-20, However-1)
amod(circumstances-5, certain-4)
prep_under(alternatives-20, circumstances-5)
prep(circumstances-5, e.g.-7)
prep_as(alternatives-20, prophylaxis-10)
amod(infarction-13, myocardial-12)
prep_after(prophylaxis-10, infarction-13)
expl(alternatives-20, there-15)
aux(alternatives-20, may-16)
cop(alternatives-20, be-17)
det(alternatives-20, no-18)
amod(alternatives-20, acceptable-19)
root(ROOT-0, alternatives-20)
det(use-23, the-22)
prep_to(alternatives-20, use-23)
prep_of(use-23, beta-blockers-25)
prep_in(use-23, patients-27)
prep_with(patients-27, COPD-29)

In/IN this/DT setting/NN ,/, cardioselective/JJ beta-blockers/NNS could/MD be/VB considered/VBN ,/, although/IN they/PRP should/MD be/VB administered/VBN with/IN caution/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT this) (NN setting))) (, ,) (NP (JJ cardioselective) (NNS beta-blockers)) (VP (MD could) (VP (VB be) (VP (VBN considered) (, ,) (SBAR (IN although) (S (NP (PRP they)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (NN caution)))))))))))) (. .))))

det(setting-3, this-2)
prep_in(considered-9, setting-3)
amod(beta-blockers-6, cardioselective-5)
nsubjpass(considered-9, beta-blockers-6)
aux(considered-9, could-7)
auxpass(considered-9, be-8)
root(ROOT-0, considered-9)
mark(administered-15, although-11)
nsubjpass(administered-15, they-12)
aux(administered-15, should-13)
auxpass(administered-15, be-14)
advcl(considered-9, administered-15)
prep_with(administered-15, caution-17)

Heparin/NN :/: Since/IN heparin/NN is/VBZ contraindicated/VBN in/IN patients/NNS with/IN heparin/NN -induced/JJ thrombocytopenia/NN ,/, the/DT co-administration/NN of/IN Argatroban/NN and/CC heparin/NN is/VBZ unlikely/JJ for/IN this/DT indication/NN ./.

(ROOT (S1 (S (NP (NP (NN Heparin)) (: :) (S (SBAR (IN Since) (S (NP (NN heparin)) (VP (VBZ is) (VP (VBN contraindicated) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (NN heparin) (JJ -induced)) (NN thrombocytopenia))))))))) (, ,) (NP (NP (DT the) (NN co-administration)) (PP (IN of) (NP (NP (NN Argatroban)) (CC and) (NP (NN heparin))))) (VP (VBZ is) (ADJP (JJ unlikely) (PP (IN for) (NP (DT this) (NN indication)))))) (. .)))))

root(ROOT-0, Heparin-1)
mark(contraindicated-6, Since-3)
nsubjpass(contraindicated-6, heparin-4)
auxpass(contraindicated-6, is-5)
advcl(unlikely-21, contraindicated-6)
prep_in(contraindicated-6, patients-8)
dep(-induced-11, heparin-10)
amod(thrombocytopenia-12, -induced-11)
prep_with(patients-8, thrombocytopenia-12)
det(co-administration-15, the-14)
nsubj(unlikely-21, co-administration-15)
prep_of(co-administration-15, Argatroban-17)
conj_and(Argatroban-17, heparin-19)
cop(unlikely-21, is-20)
dep(Heparin-1, unlikely-21)
det(indication-24, this-23)
prep_for(unlikely-21, indication-24)

However/RB ,/, if/IN Argatroban/NN is/VBZ to/TO be/VB initiated/VBN after/IN cessation/NN of/IN heparin/NN therapy/NN ,/, allow/VBP sufficient/JJ time/NN for/IN heparin/NN s/NN effect/NN on/IN the/DT aPTT/NN to/TO decrease/VB prior/RB to/TO initiation/NN of/IN Argatroban/NN therapy/NN ./.

(ROOT (S1 (S (ADVP (RB However)) (, ,) (SBAR (IN if) (S (NP (NN Argatroban)) (VP (VBZ is) (S (VP (TO to) (VP (VB be) (VP (VBN initiated) (PP (IN after) (NP (NP (NN cessation)) (PP (IN of) (NP (NN heparin) (NN therapy)))))))))))) (, ,) (VP (VBP allow) (NP (JJ sufficient) (NN time)) (PP (IN for) (NP (NP (NN heparin) (NN s) (NN effect)) (PP (IN on) (NP (DT the) (NN aPTT) (S (VP (TO to) (VP (VB decrease) (ADVP (RB prior)) (PP (TO to) (NP (NP (NN initiation)) (PP (IN of) (NP (NN Argatroban) (NN therapy))))))))))))) (. .))))

advmod(allow-15, However-1)
mark(is-5, if-3)
nsubj(is-5, Argatroban-4)
xsubj(initiated-8, Argatroban-4)
dep(allow-15, is-5)
aux(initiated-8, to-6)
auxpass(initiated-8, be-7)
xcomp(is-5, initiated-8)
prep_after(initiated-8, cessation-10)
nn(therapy-13, heparin-12)
prep_of(cessation-10, therapy-13)
root(ROOT-0, allow-15)
amod(time-17, sufficient-16)
dobj(allow-15, time-17)
nn(effect-21, heparin-19)
nn(effect-21, s-20)
prep_for(allow-15, effect-21)
det(aPTT-24, the-23)
prep_on(effect-21, aPTT-24)
aux(decrease-26, to-25)
infmod(aPTT-24, decrease-26)
prep_prior_to(decrease-26, initiation-29)
nn(therapy-32, Argatroban-31)
prep_of(initiation-29, therapy-32)

Aspirin/NN //: Acetaminophen/NN :/: Pharmacokinetic/JJ or/CC pharmacodynamic/JJ drug-drug/JJ interactions/NNS have/VBP not/RB been/VBN demonstrated/VBN between/IN Argatroban/NN and/CC concomitantly/RB administered/VBN aspirin/NN (/-LRB- 162.5/CD mg/NN orally/RB given/VBN 26/CD and/CC 2/CD hours/NNS prior/JJ to/TO initiation/NN of/IN Argatroban/NN 1/CD @/NN g/kg/min./NN over/IN 4/CD hours/NNS )/-RRB- or/CC acetaminophen/NN (/-LRB- 1000/CD mg/NN orally/RB given/VBN 12/CD ,/, 6/CD and/CC 0/CD hours/NNS prior/RB to/TO ,/, and/CC 6/CD and/CC 12/CD hours/NNS subsequent/JJ to/TO ,/, initiation/NN of/IN Argatroban/NN 1.5/CD @/NN g/kg/min./NN over/IN 18/CD hours/NNS )./NN

(ROOT (S1 (S (NP (NP (NN Aspirin)) (: /) (NP (NN Acetaminophen)) (: :) (S (NP (ADJP (ADJP (JJ Pharmacokinetic)) (CC or) (ADJP (JJ pharmacodynamic))) (JJ drug-drug) (NNS interactions)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VP (VBN demonstrated) (PP (IN between) (NP (NN Argatroban)))) (CC and) (VP (ADVP (RB concomitantly)) (VBN administered) (NP (NP (NP (NP (NN aspirin)) (PRN (-LRB- -LRB-) (NP (NP (CD 162.5) (NN mg)) (VP (ADVP (RB orally)) (VBN given) (NP (QP (CD 26) (CC and) (CD 2)) (NNS hours)) (PP (JJ prior) (TO to) (NP (NP (NN initiation)) (PP (IN of) (NP (NN Argatroban) (CD 1) (NN @) (NN g/kg/min.))))) (PP (IN over) (NP (CD 4) (NNS hours))))) (-RRB- -RRB-))) (CC or) (NP (NN acetaminophen))) (-LRB- -LRB-) (NP (NP (CD 1000) (NN mg)) (VP (ADVP (RB orally)) (VP (VBN given) (ADVP (NP (QP (CD 12) (, ,) (CD 6) (CC and) (CD 0)) (NNS hours)) (RB prior) (PP (TO to) (NP (QP (, ,) (CC and) (CD 6) (CC and) (CD 12)) (NNS hours)))) (PP (JJ subsequent) (TO to))) (, ,) (NP (NP (NN initiation)) (PP (IN of) (NP (NN Argatroban) (CD 1.5) (NN @) (NN g/kg/min.))) (PP (IN over) (NP (CD 18) (NNS hours) (NN -RRB-.))))))))))))))))

root(ROOT-0, Aspirin-1)
punct(Aspirin-1, /-2)
dep(Aspirin-1, Acetaminophen-3)
amod(interactions-9, Pharmacokinetic-5)
conj_or(Pharmacokinetic-5, pharmacodynamic-7)
amod(interactions-9, drug-drug-8)
nsubjpass(demonstrated-13, interactions-9)
aux(demonstrated-13, have-10)
neg(demonstrated-13, not-11)
auxpass(demonstrated-13, been-12)
dep(Aspirin-1, demonstrated-13)
prep_between(demonstrated-13, Argatroban-15)
advmod(administered-18, concomitantly-17)
conj_and(demonstrated-13, administered-18)
dobj(administered-18, aspirin-19)
iobj(administered-18, aspirin-19)
num(mg-22, 162.5-21)
dep(aspirin-19, mg-22)
advmod(given-24, orally-23)
partmod(mg-22, given-24)
num(hours-28, 26-25)
conj_and(26-25, 2-27)
dobj(given-24, hours-28)
prep_prior_to(given-24, initiation-31)
nn(g/kg/min.-36, Argatroban-33)
num(g/kg/min.-36, 1-34)
nn(g/kg/min.-36, @-35)
prep_of(initiation-31, g/kg/min.-36)
num(hours-39, 4-38)
prep_over(given-24, hours-39)
conj_or(aspirin-19, acetaminophen-42)
num(mg-45, 1000-44)
dep(aspirin-19, mg-45)
advmod(given-47, orally-46)
dep(mg-45, given-47)
num(hours-53, 12-48)
number(12-48, 6-50)
conj_and(12-48, 0-52)
npadvmod(given-47, hours-53)
num(hours-61, 6-58)
conj_and(6-58, 12-60)
prep_prior_to(given-47, hours-61)
dep(to-63, subsequent-62)
prep(given-47, to-63)
dobj(given-47, initiation-65)
nn(g/kg/min.-70, Argatroban-67)
num(g/kg/min.-70, 1.5-68)
nn(g/kg/min.-70, @-69)
prep_of(initiation-65, g/kg/min.-70)
num(-RRB-.-74, 18-72)
nn(-RRB-.-74, hours-73)
prep_over(initiation-65, -RRB-.-74)

Oral/JJ anticoagulant/JJ agents/NNS :/: Pharmacokinetic/JJ drug-drug/JJ interactions/NNS between/IN Argatroban/NN and/CC warfarin/NN (/-LRB- 7.5/CD mg/NN single/JJ oral/JJ dose/NN )/-RRB- have/VBP not/RB been/VBN demonstrated/VBN ./.

(ROOT (S1 (S (NP (NP (JJ Oral) (JJ anticoagulant) (NNS agents)) (: :) (S (NP (NP (JJ Pharmacokinetic) (JJ drug-drug) (NNS interactions)) (PP (IN between) (NP (NP (NP (NN Argatroban)) (CC and) (NP (NN warfarin))) (PRN (-LRB- -LRB-) (NP (CD 7.5) (NN mg) (JJ single) (JJ oral) (NN dose)) (-RRB- -RRB-))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN demonstrated))))) (. .)))))

amod(agents-3, Oral-1)
amod(agents-3, anticoagulant-2)
root(ROOT-0, agents-3)
amod(interactions-7, Pharmacokinetic-5)
amod(interactions-7, drug-drug-6)
nsubjpass(demonstrated-22, interactions-7)
prep_between(interactions-7, Argatroban-9)
conj_and(Argatroban-9, warfarin-11)
num(dose-17, 7.5-13)
nn(dose-17, mg-14)
amod(dose-17, single-15)
amod(dose-17, oral-16)
appos(Argatroban-9, dose-17)
aux(demonstrated-22, have-19)
neg(demonstrated-22, not-20)
auxpass(demonstrated-22, been-21)
dep(agents-3, demonstrated-22)

However/RB ,/, the/DT concomitant/JJ use/NN of/IN Argatroban/NN and/CC warfarin/NN (/-LRB- 5-7.5/CD mg/NN initial/JJ oral/JJ dose/NN followed/VBN by/IN 2.5-6/CD mg/day/NN orally/RB for/IN 6-10/CD days/NNS )/-RRB- results/VBZ in/IN prolongation/NN of/IN the/DT prothrombin/NN time/NN (/-LRB- PT/NN )/-RRB- and/CC International/NNP Normalized/VBN Ratio/NN (/-LRB- INR)./NNP

(ROOT (S1 (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NP (NN Argatroban)) (CC and) (NP (NN warfarin))) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 5-7.5) (NN mg)) (JJ initial) (JJ oral) (NN dose)) (VP (VBN followed) (PP (IN by) (NP (NP (CD 2.5-6) (NN mg/day)) (ADVP (RB orally)))) (PP (IN for) (NP (CD 6-10) (NNS days))))) (-RRB- -RRB-))))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (NN prolongation)) (PP (IN of) (NP (NP (DT the) (NN prothrombin) (NN time)) (PRN (-LRB- -LRB-) (NP (NN PT)) (-RRB- -RRB-))))) (CC and) (NP (NP (NNP International)) (VBN Normalized) (NN Ratio))))) (PRN (-LRB- -LRB-) (NP (NNP INR-RRB-.))))))

advmod(results-25, However-1)
det(use-5, the-3)
amod(use-5, concomitant-4)
nsubj(results-25, use-5)
prep_of(use-5, Argatroban-7)
conj_and(Argatroban-7, warfarin-9)
number(mg-12, 5-7.5-11)
amod(dose-15, mg-12)
amod(dose-15, initial-13)
amod(dose-15, oral-14)
dep(Argatroban-7, dose-15)
partmod(dose-15, followed-16)
num(mg/day-19, 2.5-6-18)
agent(followed-16, mg/day-19)
advmod(mg/day-19, orally-20)
num(days-23, 6-10-22)
prep_for(followed-16, days-23)
root(ROOT-0, results-25)
prep_in(results-25, prolongation-27)
det(time-31, the-29)
nn(time-31, prothrombin-30)
prep_of(prolongation-27, time-31)
abbrev(time-31, PT-33)
nn(Ratio-38, International-36)
amod(Ratio-38, Normalized-37)
conj_and(prolongation-27, Ratio-38)
dep(results-25, INR-RRB-.-40)

Thrombolytic/JJ agents/NNS :/: The/DT safety/NN and/CC effectiveness/NN of/IN Argatroban/NN with/IN thrombolytic/JJ agents/NNS have/VBP not/RB been/VBN established/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Thrombolytic) (NNS agents)) (: :) (NP (NP (DT The) (NP (NN safety)) (CC and) (NP (NN effectiveness))) (PP (IN of) (NP (NN Argatroban))) (PP (IN with) (NP (JJ thrombolytic) (NNS agents))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN established))))) (. .))))

amod(agents-2, Thrombolytic-1)
nsubjpass(established-16, agents-2)
dep(safety-5, The-4)
dep(agents-2, safety-5)
conj_and(safety-5, effectiveness-7)
prep_of(safety-5, Argatroban-9)
amod(agents-12, thrombolytic-11)
prep_with(safety-5, agents-12)
aux(established-16, have-13)
neg(established-16, not-14)
auxpass(established-16, been-15)
root(ROOT-0, established-16)

Co-administration/NN :/: Concomitant/JJ use/NN of/IN Argatroban/NN with/IN antiplatelet/JJ agents/NNS ,/, thrombolytic/JJ s/NNS ,/, and/CC other/JJ anticoagulants/NNS may/MD increase/VB the/DT risk/NN of/IN bleeding/JJ ./.

(ROOT (S1 (S (NP (NP (NN Co-administration)) (: :) (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NN Argatroban))) (PP (IN with) (NP (NP (JJ antiplatelet) (NNS agents)) (, ,) (NP (JJ thrombolytic) (NNS s)) (, ,) (CC and) (NP (JJ other) (NNS anticoagulants))))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ bleeding))))))) (. .)))))

root(ROOT-0, Co-administration-1)
amod(use-4, Concomitant-3)
nsubj(increase-18, use-4)
prep_of(use-4, Argatroban-6)
amod(agents-9, antiplatelet-8)
prep_with(use-4, agents-9)
amod(s-12, thrombolytic-11)
conj_and(agents-9, s-12)
amod(anticoagulants-16, other-15)
conj_and(agents-9, anticoagulants-16)
aux(increase-18, may-17)
dep(Co-administration-1, increase-18)
det(risk-20, the-19)
dobj(increase-18, risk-20)
prep_of(risk-20, bleeding-22)

Drug-drug/JJ interactions/NNS have/VBP not/RB been/VBN observed/VBN between/IN Argatroban/NN and/CC digoxin/NN or/CC erythromycin/NN ./.

(ROOT (S1 (S (S (NP (JJ Drug-drug) (NNS interactions)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN observed) (PP (IN between) (NP (NP (NN Argatroban)) (CC and) (NP (NN digoxin)) (CC or) (NP (NN erythromycin)))))))) (. .))))

amod(interactions-2, Drug-drug-1)
nsubjpass(observed-6, interactions-2)
aux(observed-6, have-3)
neg(observed-6, not-4)
auxpass(observed-6, been-5)
root(ROOT-0, observed-6)
prep_between(observed-6, Argatroban-8)
conj_and(Argatroban-8, digoxin-10)
conj_or(Argatroban-8, erythromycin-12)

Drug-Drug/JJ Interactions/NNS Given/IN the/DT primary/JJ CNS/NN effects/NNS of/IN aripiprazole/NN ,/, caution/NN should/MD be/VB used/VBN when/WRB ABILIFY/NN is/VBZ taken/VBN in/IN combination/NN with/IN other/JJ centrally/RB acting/VBG drugs/NNS and/CC alcohol/NN ./.

(ROOT (S1 (S (S (NP (JJ Drug-Drug) (NNS Interactions)) (PP (IN Given) (NP (NP (DT the) (JJ primary) (NN CNS) (NNS effects)) (PP (IN of) (NP (NN aripiprazole))))) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN used))) (SBAR (WHADVP (WRB when)) (S (NP (NN ABILIFY)) (VP (VBZ is) (VP (VBN taken) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (JJ other) (ADJP (RB centrally) (VBG acting)) (NNS drugs)) (CC and) (NP (NN alcohol)))))))))))) (. .))))

amod(Interactions-2, Drug-Drug-1)
nsubjpass(used-14, Interactions-2)
det(effects-7, the-4)
amod(effects-7, primary-5)
nn(effects-7, CNS-6)
prep_given(used-14, effects-7)
prep_of(effects-7, aripiprazole-9)
nsubjpass(used-14, caution-11)
aux(used-14, should-12)
auxpass(used-14, be-13)
root(ROOT-0, used-14)
advmod(taken-18, when-15)
nsubjpass(taken-18, ABILIFY-16)
auxpass(taken-18, is-17)
advcl(used-14, taken-18)
prep_in(taken-18, combination-20)
amod(drugs-25, other-22)
advmod(acting-24, centrally-23)
amod(drugs-25, acting-24)
prep_with(combination-20, drugs-25)
conj_and(drugs-25, alcohol-27)

1-/CD adrenergic/JJ receptor/NN antagonism/NN ,/, aripiprazole/NN has/VBZ the/DT potential/NN to/TO enhance/VB the/DT effect/NN of/IN certain/JJ antihypertensive/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (NP (CD 1-) (JJ adrenergic) (NN receptor) (NN antagonism)) (, ,) (NP (NN aripiprazole))) (VP (VBZ has) (NP (DT the) (NN potential) (S (VP (TO to) (VP (VB enhance) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ certain) (JJ antihypertensive) (NNS agents)))))))))) (. .))))

num(antagonism-4, 1--1)
amod(antagonism-4, adrenergic-2)
nn(antagonism-4, receptor-3)
nsubj(has-7, antagonism-4)
appos(antagonism-4, aripiprazole-6)
root(ROOT-0, has-7)
det(potential-9, the-8)
dobj(has-7, potential-9)
aux(enhance-11, to-10)
infmod(potential-9, enhance-11)
det(effect-13, the-12)
dobj(enhance-11, effect-13)
amod(agents-17, certain-15)
amod(agents-17, antihypertensive-16)
prep_of(effect-13, agents-17)

Potential/NN for/IN Other/JJ Drugs/NNS to/TO Affect/VB ABILIFY/NN Aripiprazole/NN is/VBZ not/RB a/DT substrate/NN of/IN CYP1A1/NN ,/, CYP1A2/NN ,/, CYP2A6/NN ,/, CYP2B6/NN ,/, CYP2C8/NN ,/, CYP2C9/NN ,/, CYP2C19/NN ,/, or/CC CYP2E1/NN enzymes/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Potential)) (PP (IN for) (NP (JJ Other) (NNS Drugs))) (S (VP (TO to) (VP (VB Affect) (NP (NN ABILIFY) (NN Aripiprazole)))))) (VP (VBZ is) (RB not) (NP (NP (DT a) (NN substrate)) (PP (IN of) (NP (NP (NP (NN CYP1A1)) (, ,) (NP (NN CYP1A2)) (, ,) (NP (NN CYP2A6)) (, ,) (NP (NN CYP2B6)) (, ,) (NP (NN CYP2C8)) (, ,) (NP (NN CYP2C9)) (, ,) (NP (NN CYP2C19)) (, ,) (CC or) (NP (NN CYP2E1))) (NNS enzymes)))))) (. .))))

nsubj(substrate-12, Potential-1)
amod(Drugs-4, Other-3)
prep_for(Potential-1, Drugs-4)
aux(Affect-6, to-5)
infmod(Potential-1, Affect-6)
nn(Aripiprazole-8, ABILIFY-7)
dobj(Affect-6, Aripiprazole-8)
cop(substrate-12, is-9)
neg(substrate-12, not-10)
det(substrate-12, a-11)
root(ROOT-0, substrate-12)
nn(enzymes-30, CYP1A1-14)
conj_or(CYP1A1-14, CYP1A2-16)
conj_or(CYP1A1-14, CYP2A6-18)
conj_or(CYP1A1-14, CYP2B6-20)
conj_or(CYP1A1-14, CYP2C8-22)
conj_or(CYP1A1-14, CYP2C9-24)
conj_or(CYP1A1-14, CYP2C19-26)
conj_or(CYP1A1-14, CYP2E1-29)
prep_of(substrate-12, enzymes-30)

Aripiprazole/NN also/RB does/VBZ not/RB undergo/VB direct/JJ glucuronidation/NN ./.

(ROOT (S1 (S (S (NP (NN Aripiprazole)) (ADVP (RB also)) (VP (VBZ does) (RB not) (VP (VB undergo) (NP (JJ direct) (NN glucuronidation))))) (. .))))

nsubj(undergo-5, Aripiprazole-1)
advmod(undergo-5, also-2)
aux(undergo-5, does-3)
neg(undergo-5, not-4)
root(ROOT-0, undergo-5)
amod(glucuronidation-7, direct-6)
dobj(undergo-5, glucuronidation-7)

This/DT suggests/VBZ that/IN an/DT interaction/NN of/IN aripiprazole/NN with/IN inhibitors/NNS or/CC inducers/NNS of/IN these/DT enzymes/NNS ,/, or/CC other/JJ factors/NNS ,/, like/IN smoking/NN ,/, is/VBZ unlikely/JJ ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (DT an) (NN interaction)) (PP (IN of) (NP (NN aripiprazole))) (PP (IN with) (NP (NP (NP (NNS inhibitors)) (CC or) (NP (NNS inducers))) (PP (IN of) (NP (NP (DT these) (NNS enzymes)) (, ,) (CC or) (NP (JJ other) (NNS factors))))))) (, ,) (PP (IN like) (NP (NN smoking))) (, ,) (VP (VBZ is) (ADJP (JJ unlikely))))))) (. .))))

nsubj(suggests-2, This-1)
root(ROOT-0, suggests-2)
complm(unlikely-24, that-3)
det(interaction-5, an-4)
nsubj(unlikely-24, interaction-5)
prep_of(interaction-5, aripiprazole-7)
prep_with(interaction-5, inhibitors-9)
conj_or(inhibitors-9, inducers-11)
det(enzymes-14, these-13)
prep_of(inhibitors-9, enzymes-14)
amod(factors-18, other-17)
conj_or(enzymes-14, factors-18)
prep_like(unlikely-24, smoking-21)
cop(unlikely-24, is-23)
ccomp(suggests-2, unlikely-24)

Both/CC CYP3A4/NN and/CC CYP2D6/NN are/VBP responsible/JJ for/IN aripiprazole/NN metabolism/NN ./.

(ROOT (S1 (S (S (NP (CC Both) (NP (NN CYP3A4)) (CC and) (NP (NN CYP2D6))) (VP (VBP are) (ADJP (JJ responsible) (PP (IN for) (NP (NN aripiprazole) (NN metabolism)))))) (. .))))

preconj(CYP3A4-2, Both-1)
nsubj(responsible-6, CYP3A4-2)
conj_and(CYP3A4-2, CYP2D6-4)
cop(responsible-6, are-5)
root(ROOT-0, responsible-6)
nn(metabolism-9, aripiprazole-8)
prep_for(responsible-6, metabolism-9)

Agents/NNS that/WDT induce/VBP CYP3A4/NN (/-LRB- eg/NN ,/, carbamazepine/NN )/-RRB- could/MD cause/VB an/DT increase/NN in/IN aripiprazole/NN clearance/NN and/CC lower/JJR blood/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Agents)) (SBAR (WHNP (WDT that)) (S (VP (VBP induce) (NP (NP (NN CYP3A4)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN carbamazepine))) (-RRB- -RRB-))))))) (VP (MD could) (VP (VB cause) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN aripiprazole) (NN clearance)) (CC and) (NP (JJR lower) (NN blood) (NNS levels)))))))) (. .))))

nsubj(induce-3, Agents-1)
nsubj(cause-11, Agents-1)
rcmod(Agents-1, induce-3)
dobj(induce-3, CYP3A4-4)
dep(CYP3A4-4, eg-6)
appos(eg-6, carbamazepine-8)
aux(cause-11, could-10)
root(ROOT-0, cause-11)
det(increase-13, an-12)
dobj(cause-11, increase-13)
nn(clearance-16, aripiprazole-15)
prep_in(increase-13, clearance-16)
amod(levels-20, lower-18)
nn(levels-20, blood-19)
conj_and(clearance-16, levels-20)

Inhibitors/NNS of/IN CYP3A4/NN (/-LRB- eg/NN ,/, ketoconazole/NN )/-RRB- or/CC CYP2D6/NN (/-LRB- eg/NN ,/, quinidine/NN ,/, fluoxetine/NN ,/, or/CC paroxetine/NN )/-RRB- can/MD inhibit/VB aripiprazole/NN elimination/NN and/CC cause/VB increased/VBN blood/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Inhibitors)) (PP (IN of) (NP (NP (NP (NN CYP3A4)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN ketoconazole))) (-RRB- -RRB-))) (CC or) (NP (NP (NN CYP2D6)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN quinidine)) (, ,) (NP (NN fluoxetine)) (, ,) (CC or) (NP (NN paroxetine))) (-RRB- -RRB-)))))) (VP (MD can) (VP (VP (VB inhibit) (NP (NN aripiprazole) (NN elimination))) (CC and) (VP (VB cause) (NP (VBN increased) (NN blood) (NNS levels)))))) (. .))))

nsubj(inhibit-22, Inhibitors-1)
prep_of(Inhibitors-1, CYP3A4-3)
dep(CYP3A4-3, eg-5)
appos(eg-5, ketoconazole-7)
conj_or(CYP3A4-3, CYP2D6-10)
dep(CYP2D6-10, eg-12)
conj_or(eg-12, quinidine-14)
conj_or(eg-12, fluoxetine-16)
conj_or(eg-12, paroxetine-19)
aux(inhibit-22, can-21)
root(ROOT-0, inhibit-22)
nn(elimination-24, aripiprazole-23)
dobj(inhibit-22, elimination-24)
conj_and(inhibit-22, cause-26)
amod(levels-29, increased-27)
nn(levels-29, blood-28)
dobj(cause-26, levels-29)

Ketoconazole/NN :/: Coadministration/NN of/IN ketoconazole/NN (/-LRB- 200/CD mg/day/NN for/IN 14/CD days/NNS )/-RRB- with/IN a/DT 15-mg/JJ single/JJ dose/NN of/IN aripiprazole/NN increased/VBD the/DT AUC/NN of/IN aripiprazole/NN and/CC its/PRP$ active/JJ metabolite/NN by/IN 63/CD %/NN and/CC 77/CD %/NN ,/, respectively/RB ./.

(ROOT (S1 (S (NP (NP (NN Ketoconazole)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NN ketoconazole)) (PRN (-LRB- -LRB-) (NP (NP (CD 200) (NN mg/day)) (PP (IN for) (NP (CD 14) (NNS days)))) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (DT a) (JJ 15-mg) (JJ single) (NN dose)) (PP (IN of) (NP (NN aripiprazole)))))) (VP (VBD increased) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NP (NN aripiprazole)) (CC and) (NP (PRP$ its) (JJ active) (NN metabolite))))) (PP (IN by) (NP (NP (CD 63) (NN %)) (CC and) (NP (CD 77) (NN %)))) (, ,) (ADVP (RB respectively)))) (. .)))))

root(ROOT-0, Ketoconazole-1)
nsubj(increased-20, Coadministration-3)
prep_of(Coadministration-3, ketoconazole-5)
num(mg/day-8, 200-7)
dep(ketoconazole-5, mg/day-8)
num(days-11, 14-10)
prep_for(mg/day-8, days-11)
det(dose-17, a-14)
amod(dose-17, 15-mg-15)
amod(dose-17, single-16)
prep_with(Coadministration-3, dose-17)
prep_of(dose-17, aripiprazole-19)
dep(Ketoconazole-1, increased-20)
det(AUC-22, the-21)
dobj(increased-20, AUC-22)
prep_of(AUC-22, aripiprazole-24)
poss(metabolite-28, its-26)
amod(metabolite-28, active-27)
conj_and(aripiprazole-24, metabolite-28)
num(%-31, 63-30)
prep_by(increased-20, %-31)
num(%-34, 77-33)
conj_and(%-31, %-34)
advmod(increased-20, respectively-36)

The/DT effect/NN of/IN a/DT higher/JJR ketoconazole/NN dose/NN (/-LRB- 400/CD mg/day/NN )/-RRB- has/VBZ not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NP (DT a) (JJR higher) (NN ketoconazole) (NN dose)) (PRN (-LRB- -LRB-) (NP (CD 400) (NN mg/day)) (-RRB- -RRB-))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

det(effect-2, The-1)
nsubjpass(studied-15, effect-2)
det(dose-7, a-4)
amod(dose-7, higher-5)
nn(dose-7, ketoconazole-6)
prep_of(effect-2, dose-7)
num(mg/day-10, 400-9)
appos(dose-7, mg/day-10)
aux(studied-15, has-12)
neg(studied-15, not-13)
auxpass(studied-15, been-14)
root(ROOT-0, studied-15)

When/WRB concomitant/JJ administration/NN of/IN ketoconazole/NN with/IN aripiprazole/NN occurs/VBZ ,/, aripiprazole/NN dose/NN should/MD be/VB reduced/VBN to/TO one-half/NN of/IN its/PRP$ normal/JJ dose/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN ketoconazole))) (PP (IN with) (NP (NN aripiprazole)))) (VP (VBZ occurs)))) (, ,) (NP (NN aripiprazole) (NN dose)) (VP (MD should) (VP (VB be) (VP (VBN reduced) (PP (TO to) (NP (NP (NN one-half)) (PP (IN of) (NP (PRP$ its) (JJ normal) (NN dose))))))))) (. .))))

advmod(occurs-8, When-1)
amod(administration-3, concomitant-2)
nsubj(occurs-8, administration-3)
prep_of(administration-3, ketoconazole-5)
prep_with(administration-3, aripiprazole-7)
advcl(reduced-14, occurs-8)
nn(dose-11, aripiprazole-10)
nsubjpass(reduced-14, dose-11)
aux(reduced-14, should-12)
auxpass(reduced-14, be-13)
root(ROOT-0, reduced-14)
prep_to(reduced-14, one-half-16)
poss(dose-20, its-18)
amod(dose-20, normal-19)
prep_of(one-half-16, dose-20)

Other/JJ strong/JJ inhibitors/NNS of/IN CYP3A4/NN (/-LRB- itraconazole/NN )/-RRB- would/MD be/VB expected/VBN to/TO have/VBP similar/JJ effects/NNS and/CC need/VBP similar/JJ dose/NN reductions/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Other) (JJ strong) (NNS inhibitors)) (PP (IN of) (NP (NN CYP3A4)))) (PRN (-LRB- -LRB-) (NP (NN itraconazole)) (-RRB- -RRB-))) (VP (MD would) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VP (VBP have) (NP (JJ similar) (NNS effects))) (CC and) (VP (VBP need) (NP (JJ similar) (NN dose) (NNS reductions))))))))) (: ;)) (. .))))

amod(inhibitors-3, Other-1)
amod(inhibitors-3, strong-2)
nsubjpass(expected-11, inhibitors-3)
prep_of(inhibitors-3, CYP3A4-5)
appos(inhibitors-3, itraconazole-7)
aux(expected-11, would-9)
auxpass(expected-11, be-10)
root(ROOT-0, expected-11)
aux(have-13, to-12)
xcomp(expected-11, have-13)
amod(effects-15, similar-14)
dobj(have-13, effects-15)
conj_and(have-13, need-17)
amod(reductions-20, similar-18)
nn(reductions-20, dose-19)
dobj(need-17, reductions-20)

weaker/JJR inhibitors/NNS (/-LRB- erythromycin/NN ,/, grapefruit/NN juice/NN )/-RRB- have/VBP not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJR weaker) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NP (NN erythromycin)) (, ,) (NP (NN grapefruit) (NN juice))) (-RRB- -RRB-))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

amod(inhibitors-2, weaker-1)
nsubjpass(studied-12, inhibitors-2)
dep(inhibitors-2, erythromycin-4)
nn(juice-7, grapefruit-6)
appos(erythromycin-4, juice-7)
aux(studied-12, have-9)
neg(studied-12, not-10)
auxpass(studied-12, been-11)
root(ROOT-0, studied-12)

When/WRB the/DT CYP3A4/NN inhibitor/NN is/VBZ withdrawn/VBN from/IN the/DT combination/NN therapy/NN ,/, aripiprazole/NN dose/NN should/MD then/RB be/VB increased/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (DT the) (NN CYP3A4) (NN inhibitor)) (VP (VBZ is) (VP (VBN withdrawn) (PP (IN from) (NP (DT the) (NN combination) (NN therapy))))))) (, ,) (NP (NN aripiprazole) (NN dose)) (VP (MD should) (ADVP (RB then)) (VP (VB be) (VP (VBN increased))))) (. .))))

advmod(withdrawn-6, When-1)
det(inhibitor-4, the-2)
nn(inhibitor-4, CYP3A4-3)
nsubjpass(withdrawn-6, inhibitor-4)
auxpass(withdrawn-6, is-5)
advcl(increased-17, withdrawn-6)
det(therapy-10, the-8)
nn(therapy-10, combination-9)
prep_from(withdrawn-6, therapy-10)
nn(dose-13, aripiprazole-12)
nsubjpass(increased-17, dose-13)
aux(increased-17, should-14)
advmod(increased-17, then-15)
auxpass(increased-17, be-16)
root(ROOT-0, increased-17)

Quinidine/NN :/: Coadministration/NN of/IN a/DT 10-mg/JJ single/JJ dose/NN of/IN aripiprazole/NN with/IN quinidine/NN (/-LRB- 166/CD mg/day/NN for/IN 13/CD days/NNS )/-RRB- ,/, a/DT potent/JJ inhibitor/NN of/IN CYP2D6/NN ,/, increased/VBD the/DT AUC/NN of/IN aripiprazole/NN by/IN 112/CD %/NN but/CC decreased/VBD the/DT AUC/NN of/IN its/PRP$ active/JJ metabolite/NN ,/, dehydroaripiprazole/NN ,/, by/IN 35/CD %./NN

(ROOT (S1 (S (NP (NP (NN Quinidine)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (DT a) (JJ 10-mg) (JJ single) (NN dose)) (PP (IN of) (NP (NN aripiprazole))))) (PP (IN with) (NP (NP (NP (NN quinidine)) (PRN (-LRB- -LRB-) (NP (NP (CD 166) (NN mg/day)) (PP (IN for) (NP (CD 13) (NNS days)))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ potent) (NN inhibitor)) (PP (IN of) (NP (NN CYP2D6)))) (, ,)))) (VP (VP (VBD increased) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NN aripiprazole)))) (PP (IN by) (NP (CD 112) (NN %)))) (CC but) (VP (VBD decreased) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NP (PRP$ its) (JJ active) (NN metabolite)) (, ,) (NP (NN dehydroaripiprazole)) (, ,)))) (PP (IN by) (NP (CD 35) (NN %.))))))))))

root(ROOT-0, Quinidine-1)
nsubj(increased-27, Coadministration-3)
det(dose-8, a-5)
amod(dose-8, 10-mg-6)
amod(dose-8, single-7)
prep_of(Coadministration-3, dose-8)
prep_of(dose-8, aripiprazole-10)
prep_with(Coadministration-3, quinidine-12)
num(mg/day-15, 166-14)
dep(quinidine-12, mg/day-15)
num(days-18, 13-17)
prep_for(mg/day-15, days-18)
det(inhibitor-23, a-21)
amod(inhibitor-23, potent-22)
appos(quinidine-12, inhibitor-23)
prep_of(inhibitor-23, CYP2D6-25)
dep(Quinidine-1, increased-27)
det(AUC-29, the-28)
dobj(increased-27, AUC-29)
prep_of(AUC-29, aripiprazole-31)
num(%-34, 112-33)
prep_by(increased-27, %-34)
conj_but(increased-27, decreased-36)
det(AUC-38, the-37)
dobj(decreased-36, AUC-38)
poss(metabolite-42, its-40)
amod(metabolite-42, active-41)
prep_of(AUC-38, metabolite-42)
appos(metabolite-42, dehydroaripiprazole-44)
num(%.-48, 35-47)
prep_by(decreased-36, %.-48)

Aripiprazole/NN dose/NN should/MD be/VB reduced/VBN to/TO one-half/NN of/IN its/PRP$ normal/JJ dose/NN when/WRB concomitant/JJ administration/NN of/IN quinidine/NN with/IN aripiprazole/NN occurs/VBZ ./.

(ROOT (S1 (S (S (NP (NN Aripiprazole) (NN dose)) (VP (MD should) (VP (VB be) (VP (VBN reduced) (PP (TO to) (NP (NP (NN one-half)) (PP (IN of) (NP (PRP$ its) (JJ normal) (NN dose))))) (SBAR (WHADVP (WRB when)) (S (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN quinidine))) (PP (IN with) (NP (NN aripiprazole)))) (VP (VBZ occurs)))))))) (. .))))

nn(dose-2, Aripiprazole-1)
nsubjpass(reduced-5, dose-2)
aux(reduced-5, should-3)
auxpass(reduced-5, be-4)
root(ROOT-0, reduced-5)
prep_to(reduced-5, one-half-7)
poss(dose-11, its-9)
amod(dose-11, normal-10)
prep_of(one-half-7, dose-11)
advmod(occurs-19, when-12)
amod(administration-14, concomitant-13)
nsubj(occurs-19, administration-14)
prep_of(administration-14, quinidine-16)
prep_with(administration-14, aripiprazole-18)
advcl(reduced-5, occurs-19)

Other/JJ significant/JJ inhibitors/NNS of/IN CYP2D6/NN ,/, such/JJ as/IN fluoxetine/NN or/CC paroxetine/NN ,/, would/MD be/VB expected/VBN to/TO have/VB similar/JJ effects/NNS and/CC ,/, therefore/RB ,/, should/MD be/VB accompanied/VBN by/IN similar/JJ dose/NN reductions/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Other) (JJ significant) (NNS inhibitors)) (PP (IN of) (NP (NN CYP2D6))) (, ,) (PP (JJ such) (IN as) (NP (NP (NN fluoxetine)) (CC or) (NP (NN paroxetine)))) (, ,)) (VP (VP (MD would) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB have) (NP (JJ similar) (NNS effects)))))))) (CC and) (, ,) (ADVP (RB therefore)) (, ,) (VP (MD should) (VP (VB be) (VP (VBN accompanied) (PP (IN by) (NP (JJ similar) (NN dose) (NNS reductions)))))))) (. .))))

amod(inhibitors-3, Other-1)
amod(inhibitors-3, significant-2)
nsubjpass(expected-15, inhibitors-3)
prep_of(inhibitors-3, CYP2D6-5)
prep_such_as(inhibitors-3, fluoxetine-9)
conj_or(fluoxetine-9, paroxetine-11)
aux(expected-15, would-13)
auxpass(expected-15, be-14)
root(ROOT-0, expected-15)
aux(have-17, to-16)
xcomp(expected-15, have-17)
amod(effects-19, similar-18)
dobj(have-17, effects-19)
advmod(expected-15, therefore-22)
conj_and(expected-15, therefore-22)
aux(accompanied-26, should-24)
auxpass(accompanied-26, be-25)
conj_and(expected-15, accompanied-26)
amod(reductions-30, similar-28)
nn(reductions-30, dose-29)
agent(accompanied-26, reductions-30)

When/WRB the/DT CYP2D6/NN inhibitor/NN is/VBZ withdrawn/VBN from/IN the/DT combination/NN therapy/NN ,/, aripiprazole/NN dose/NN should/MD then/RB be/VB increased/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (DT the) (NN CYP2D6) (NN inhibitor)) (VP (VBZ is) (VP (VBN withdrawn) (PP (IN from) (NP (DT the) (NN combination) (NN therapy))))))) (, ,) (NP (NN aripiprazole) (NN dose)) (VP (MD should) (ADVP (RB then)) (VP (VB be) (VP (VBN increased))))) (. .))))

advmod(withdrawn-6, When-1)
det(inhibitor-4, the-2)
nn(inhibitor-4, CYP2D6-3)
nsubjpass(withdrawn-6, inhibitor-4)
auxpass(withdrawn-6, is-5)
advcl(increased-17, withdrawn-6)
det(therapy-10, the-8)
nn(therapy-10, combination-9)
prep_from(withdrawn-6, therapy-10)
nn(dose-13, aripiprazole-12)
nsubjpass(increased-17, dose-13)
aux(increased-17, should-14)
advmod(increased-17, then-15)
auxpass(increased-17, be-16)
root(ROOT-0, increased-17)

Carbamazepine/NN :/: Coadministration/NN of/IN carbamazepine/NN (/-LRB- 200/CD mg/NN BID/NN )/-RRB- ,/, a/DT potent/JJ CYP3A4/NN inducer/NN ,/, with/IN aripiprazole/NN (/-LRB- 30/CD mg/NN QD/NN )/-RRB- resulted/VBD in/IN an/DT approximate/JJ 70/CD %/NN decrease/NN in/IN Cmax/NN and/CC AUC/NN values/NNS of/IN both/CC aripiprazole/NN and/CC its/PRP$ active/JJ metabolite/NN ,/, dehydro-/NN aripiprazole/NN ./.

(ROOT (S1 (S (NP (NP (NN Carbamazepine)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NP (NN carbamazepine)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 200) (NN mg)) (NN BID)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ potent) (NN CYP3A4) (NN inducer)) (, ,))) (PP (IN with) (NP (NP (NN aripiprazole)) (PRN (-LRB- -LRB-) (NP (CD 30) (NN mg) (NN QD)) (-RRB- -RRB-))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT an) (JJ approximate) (ADJP (CD 70) (NN %)) (NN decrease)) (PP (IN in) (NP (NP (NP (NP (NN Cmax)) (CC and) (NP (NN AUC))) (NNS values)) (PP (IN of) (NP (CC both) (NP (NN aripiprazole)) (CC and) (NP (NP (PRP$ its) (JJ active) (NN metabolite)) (, ,) (NP (NN dehydro-) (NN aripiprazole))))))))))) (. .)))))

root(ROOT-0, Carbamazepine-1)
nsubj(resulted-24, Coadministration-3)
prep_of(Coadministration-3, carbamazepine-5)
number(mg-8, 200-7)
amod(BID-9, mg-8)
appos(carbamazepine-5, BID-9)
det(inducer-15, a-12)
amod(inducer-15, potent-13)
nn(inducer-15, CYP3A4-14)
appos(carbamazepine-5, inducer-15)
prep_with(Coadministration-3, aripiprazole-18)
num(QD-22, 30-20)
nn(QD-22, mg-21)
appos(aripiprazole-18, QD-22)
dep(Carbamazepine-1, resulted-24)
det(decrease-30, an-26)
amod(decrease-30, approximate-27)
number(%-29, 70-28)
amod(decrease-30, %-29)
prep_in(resulted-24, decrease-30)
nn(values-35, Cmax-32)
conj_and(Cmax-32, AUC-34)
prep_in(decrease-30, values-35)
preconj(aripiprazole-38, both-37)
prep_of(values-35, aripiprazole-38)
poss(metabolite-42, its-40)
amod(metabolite-42, active-41)
conj_and(aripiprazole-38, metabolite-42)
nn(aripiprazole-45, dehydro--44)
appos(metabolite-42, aripiprazole-45)

When/WRB carbamazepine/NN is/VBZ added/VBN to/TO aripiprazole/NN therapy/NN ,/, aripiprazole/NN dose/NN should/MD be/VB doubled/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN carbamazepine)) (VP (VBZ is) (VP (VBN added) (PP (TO to) (NP (NN aripiprazole) (NN therapy))))))) (, ,) (NP (NN aripiprazole) (NN dose)) (VP (MD should) (VP (VB be) (VP (VBN doubled))))) (. .))))

advmod(added-4, When-1)
nsubjpass(added-4, carbamazepine-2)
auxpass(added-4, is-3)
advcl(doubled-13, added-4)
nn(therapy-7, aripiprazole-6)
prep_to(added-4, therapy-7)
nn(dose-10, aripiprazole-9)
nsubjpass(doubled-13, dose-10)
aux(doubled-13, should-11)
auxpass(doubled-13, be-12)
root(ROOT-0, doubled-13)

When/WRB carbamazepine/NN is/VBZ withdrawn/VBN from/IN the/DT combination/NN therapy/NN ,/, aripiprazole/NN dose/NN should/MD then/RB be/VB reduced/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN carbamazepine)) (VP (VBZ is) (VP (VBN withdrawn) (PP (IN from) (NP (DT the) (NN combination) (NN therapy))))))) (, ,) (NP (NN aripiprazole) (NN dose)) (VP (MD should) (ADVP (RB then)) (VP (VB be) (VP (VBN reduced))))) (. .))))

advmod(withdrawn-4, When-1)
nsubjpass(withdrawn-4, carbamazepine-2)
auxpass(withdrawn-4, is-3)
advcl(reduced-15, withdrawn-4)
det(therapy-8, the-6)
nn(therapy-8, combination-7)
prep_from(withdrawn-4, therapy-8)
nn(dose-11, aripiprazole-10)
nsubjpass(reduced-15, dose-11)
aux(reduced-15, should-12)
advmod(reduced-15, then-13)
auxpass(reduced-15, be-14)
root(ROOT-0, reduced-15)

No/DT clinically/RB significant/JJ effect/NN of/IN famotidine/NN ,/, valproate/NN ,/, or/CC lithium/NN was/VBD seen/VBN on/IN the/DT pharmacokinetics/NNS of/IN aripiprazole/NN (/-LRB- see/VB CLINICAL/JJ PHARMACOLOGY/NN :/: Drug-/NN Drug/NN Interactions/NNS )./NN

(ROOT (S1 (S (S (NP (NP (DT No) (ADJP (RB clinically) (JJ significant)) (NN effect)) (PP (IN of) (NP (NP (NN famotidine)) (, ,) (NP (NN valproate)) (, ,) (CC or) (NP (NN lithium))))) (VP (VBD was) (VP (VBN seen) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN aripiprazole))))) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (JJ CLINICAL) (NN PHARMACOLOGY)))))))) (: :) (S (NP (NN Drug-) (NN Drug) (NNS Interactions)) (NP (NN -RRB-.))))))

det(effect-4, No-1)
advmod(significant-3, clinically-2)
amod(effect-4, significant-3)
nsubjpass(seen-13, effect-4)
prep_of(effect-4, famotidine-6)
conj_or(famotidine-6, valproate-8)
conj_or(famotidine-6, lithium-11)
auxpass(seen-13, was-12)
root(ROOT-0, seen-13)
det(pharmacokinetics-16, the-15)
prep_on(seen-13, pharmacokinetics-16)
prep_of(pharmacokinetics-16, aripiprazole-18)
parataxis(seen-13, see-20)
amod(PHARMACOLOGY-22, CLINICAL-21)
dobj(see-20, PHARMACOLOGY-22)
nn(Interactions-26, Drug--24)
nn(Interactions-26, Drug-25)
dep(-RRB-.-27, Interactions-26)
parataxis(seen-13, -RRB-.-27)

Potential/NN for/IN ABILIFY/NN to/TO Affect/VB Other/JJ Drugs/NNS Aripiprazole/NN is/VBZ unlikely/JJ to/TO cause/VB clinically/RB important/JJ pharmacokinetic/JJ interactions/NNS with/IN drugs/NNS metabolized/VBN by/IN cytochrome/NN P450/NN enzymes/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Potential)) (PP (IN for) (NP (NN ABILIFY))) (S (VP (TO to) (VP (VB Affect) (NP (NP (JJ Other) (NNS Drugs)) (NN Aripiprazole)))))) (VP (VBZ is) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB cause) (NP (NP (ADJP (RB clinically) (JJ important)) (JJ pharmacokinetic) (NNS interactions)) (PP (IN with) (NP (NP (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (NN cytochrome) (NN P450) (NNS enzymes))))))))))))) (. .))))

nsubj(unlikely-10, Potential-1)
prep_for(Potential-1, ABILIFY-3)
aux(Affect-5, to-4)
infmod(Potential-1, Affect-5)
amod(Drugs-7, Other-6)
nn(Aripiprazole-8, Drugs-7)
dobj(Affect-5, Aripiprazole-8)
cop(unlikely-10, is-9)
root(ROOT-0, unlikely-10)
aux(cause-12, to-11)
xcomp(unlikely-10, cause-12)
advmod(important-14, clinically-13)
amod(interactions-16, important-14)
amod(interactions-16, pharmacokinetic-15)
dobj(cause-12, interactions-16)
prep_with(interactions-16, drugs-18)
partmod(drugs-18, metabolized-19)
nn(enzymes-23, cytochrome-21)
nn(enzymes-23, P450-22)
agent(metabolized-19, enzymes-23)

In/IN in/FW vivo/FW studies/NNS ,/, 10-/CD to/TO 30-mg/day/JJ doses/NNS of/IN aripiprazole/NN had/VBD no/DT significant/JJ effect/NN on/IN metabolism/NN by/IN CYP2D6/NN (/-LRB- dextromethorphan/NN )/-RRB- ,/, CYP2C9/NN (/-LRB- warfarin/NN )/-RRB- ,/, CYP2C19/NN (/-LRB- omeprazole/NN ,/, warfarin/NN )/-RRB- ,/, and/CC CYP3A4/NN (/-LRB- dextromethorphan/NN )/-RRB- substrates/NNS ./.

(ROOT (S1 (S (PP (IN In) (NP (ADJP (FW in) (FW vivo)) (NNS studies))) (, ,) (NP (NP (ADJP (CD 10-) (TO to) (JJ 30-mg/day)) (NNS doses)) (PP (IN of) (NP (NN aripiprazole)))) (VP (VBD had) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (NN metabolism)) (PP (IN by) (NP (NP (NP (NN CYP2D6)) (PRN (-LRB- -LRB-) (NP (NN dextromethorphan)) (-RRB- -RRB-))) (, ,) (NP (NP (NN CYP2C9)) (PRN (-LRB- -LRB-) (NP (NN warfarin)) (-RRB- -RRB-))) (, ,) (NP (NP (NN CYP2C19)) (PRN (-LRB- -LRB-) (NP (NP (NN omeprazole)) (, ,) (NP (NN warfarin))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN CYP3A4)) (PRN (-LRB- -LRB-) (NP (NN dextromethorphan)) (-RRB- -RRB-))) (NP (NNS substrates))))))) (. .))))

nn(vivo-3, in-2)
amod(studies-4, vivo-3)
prep_in(had-12, studies-4)
number(30-mg/day-8, 10--6)
dep(30-mg/day-8, to-7)
amod(doses-9, 30-mg/day-8)
nsubj(had-12, doses-9)
prep_of(doses-9, aripiprazole-11)
root(ROOT-0, had-12)
det(effect-15, no-13)
amod(effect-15, significant-14)
dobj(had-12, effect-15)
prep_on(had-12, metabolism-17)
prep_by(metabolism-17, CYP2D6-19)
appos(CYP2D6-19, dextromethorphan-21)
conj_and(CYP2D6-19, CYP2C9-24)
appos(CYP2C9-24, warfarin-26)
conj_and(CYP2D6-19, CYP2C19-29)
dep(CYP2C19-29, omeprazole-31)
appos(omeprazole-31, warfarin-33)
conj_and(CYP2D6-19, CYP3A4-37)
appos(CYP3A4-37, dextromethorphan-39)
dep(CYP2D6-19, substrates-41)

Additionally/RB ,/, aripiprazole/NN and/CC dehydroaripiprazole/NN did/VBD not/RB show/VB potential/NN for/IN altering/VBG CYP1A2-mediated/JJ metabolism/NN in/FW vitro/FW ./.

(ROOT (S1 (S (S (ADVP (RB Additionally)) (, ,) (NP (NP (NN aripiprazole)) (CC and) (NP (NN dehydroaripiprazole))) (VP (VBD did) (RB not) (VP (VB show) (NP (NN potential)) (PP (IN for) (S (VP (VBG altering) (NP (JJ CYP1A2-mediated) (NN metabolism)) (ADVP (FW in) (FW vitro)))))))) (. .))))

advmod(show-8, Additionally-1)
nsubj(show-8, aripiprazole-3)
conj_and(aripiprazole-3, dehydroaripiprazole-5)
aux(show-8, did-6)
neg(show-8, not-7)
root(ROOT-0, show-8)
dobj(show-8, potential-9)
prepc_for(show-8, altering-11)
amod(metabolism-13, CYP1A2-mediated-12)
dobj(altering-11, metabolism-13)
nn(vitro-15, in-14)
advmod(altering-11, vitro-15)

Alcohol/NN :/: There/EX was/VBD no/DT significant/JJ difference/NN between/IN aripiprazole/NN coadministered/VBN with/IN ethanol/NN and/CC placebo/NN coadministered/VBN with/IN ethanol/NN on/IN performance/NN of/IN gross/JJ motor/NN skills/NNS or/CC stimulus/NN response/NN in/IN healthy/JJ subjects/NNS ./.

(ROOT (S1 (S (NP (NP (NN Alcohol)) (: :) (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (JJ significant) (NN difference)) (PP (IN between) (NP (NP (NN aripiprazole)) (VP (VBN coadministered) (PP (IN with) (NP (NP (NP (NN ethanol)) (CC and) (NP (NN placebo))) (VP (VBN coadministered) (PP (IN with) (NP (NN ethanol))) (PP (IN on) (NP (NP (NN performance)) (PP (IN of) (NP (NP (JJ gross) (NN motor) (NNS skills)) (CC or) (NP (NN stimulus) (NN response)))) (PP (IN in) (NP (JJ healthy) (NNS subjects)))))))))))))) (. .)))))

root(ROOT-0, Alcohol-1)
expl(was-4, There-3)
dep(Alcohol-1, was-4)
det(difference-7, no-5)
amod(difference-7, significant-6)
nsubj(was-4, difference-7)
prep_between(difference-7, aripiprazole-9)
partmod(aripiprazole-9, coadministered-10)
prep_with(coadministered-10, ethanol-12)
conj_and(ethanol-12, placebo-14)
partmod(ethanol-12, coadministered-15)
prep_with(coadministered-15, ethanol-17)
prep_on(coadministered-15, performance-19)
amod(skills-23, gross-21)
nn(skills-23, motor-22)
prep_of(performance-19, skills-23)
nn(response-26, stimulus-25)
conj_or(skills-23, response-26)
amod(subjects-29, healthy-28)
prep_in(performance-19, subjects-29)

As/IN with/IN most/JJS psychoactive/JJ medications/NNS ,/, patients/NNS should/MD be/VB advised/VBN to/TO avoid/VB alcohol/NN while/IN taking/VBG ABILIFY/NN ./.

(ROOT (S1 (S (PP (IN As) (PP (IN with) (NP (JJS most) (JJ psychoactive) (NNS medications)))) (, ,) (NP (NNS patients)) (VP (MD should) (VP (VB be) (VP (VBN advised) (S (VP (TO to) (VP (VB avoid) (NP (NN alcohol)) (SBAR (IN while) (S (VP (VBG taking) (NP (NN ABILIFY))))))))))) (. .))))

prep(advised-10, As-1)
pcomp(As-1, with-2)
amod(medications-5, most-3)
amod(medications-5, psychoactive-4)
prep_with(As-1, medications-5)
nsubjpass(advised-10, patients-7)
aux(advised-10, should-8)
auxpass(advised-10, be-9)
root(ROOT-0, advised-10)
aux(avoid-12, to-11)
xcomp(advised-10, avoid-12)
dobj(avoid-12, alcohol-13)
mark(taking-15, while-14)
advcl(avoid-12, taking-15)
dobj(taking-15, ABILIFY-16)

Caution/NN is/VBZ advised/VBN when/WRB TRISENOX/NN @/NN is/VBZ coadministered/VBN with/IN other/JJ medications/NNS that/WDT can/MD prolong/VB the/DT QT/JJ interval/NN (/-LRB- e.g./FW certain/JJ antiarrhythmics/NNS or/CC thioridazine/NN )/-RRB- or/CC lead/VB to/TO electrolyte/NN abnormalities/NNS (/-LRB- such/JJ as/IN diuretics/NN or/CC amphotericin/NN B/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (VBZ is) (VP (VBN advised) (SBAR (WHADVP (WRB when)) (S (NP (NN TRISENOX) (NN @)) (VP (VBZ is) (VP (VBN coadministered) (PP (IN with) (NP (NP (JJ other) (NNS medications)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VP (VB prolong) (NP (NP (DT the) (JJ QT) (NN interval)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (NP (NP (JJ certain) (NNS antiarrhythmics)) (CC or) (NP (NN thioridazine))) (-RRB- -RRB-)))) (CC or) (VP (VB lead) (PP (TO to) (NP (NP (NN electrolyte) (NNS abnormalities)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NP (NN diuretics)) (CC or) (NP (NN amphotericin) (NN B))))) (-RRB- -RRB-)))))))))))))))))) (. .))))

nsubjpass(advised-3, Caution-1)
auxpass(advised-3, is-2)
root(ROOT-0, advised-3)
advmod(coadministered-8, when-4)
nn(@-6, TRISENOX-5)
nsubjpass(coadministered-8, @-6)
auxpass(coadministered-8, is-7)
advcl(advised-3, coadministered-8)
amod(medications-11, other-10)
prep_with(coadministered-8, medications-11)
nsubj(prolong-14, medications-11)
aux(prolong-14, can-13)
rcmod(medications-11, prolong-14)
det(interval-17, the-15)
amod(interval-17, QT-16)
dobj(prolong-14, interval-17)
dep(antiarrhythmics-21, e.g.-19)
amod(antiarrhythmics-21, certain-20)
dep(interval-17, antiarrhythmics-21)
conj_or(antiarrhythmics-21, thioridazine-23)
conj_or(prolong-14, lead-26)
nn(abnormalities-29, electrolyte-28)
prep_to(lead-26, abnormalities-29)
prep_such_as(abnormalities-29, diuretics-33)
nn(B-36, amphotericin-35)
conj_or(diuretics-33, B-36)

Tissue/NN culture/NN and/CC animal/NN studies/NNS indicate/VBP that/IN ELSPAR/NN can/MD diminish/VB or/CC abolish/VB the/DT effect/NN of/IN methotrexate/NN on/IN malignant/JJ cells.14/NN This/DT effect/NN on/IN methotrexate/NN activity/NN persists/VBZ as/RB long/RB as/IN plasma/NN asparagine/NN levels/NNS are/VBP suppressed/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Tissue) (NN culture)) (CC and) (NP (NN animal) (NNS studies))) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN ELSPAR)) (VP (MD can) (VP (VP (VB diminish)) (CC or) (VP (VB abolish) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN methotrexate))) (PP (IN on) (NP (JJ malignant) (NN cells.14))))) (NP (DT This) (NN effect) (SBAR (IN on) (S (NP (NN methotrexate) (NN activity)) (VP (VBZ persists) (SBAR (RB as) (RB long) (IN as) (S (NP (NN plasma) (NN asparagine) (NNS levels)) (VP (VBP are) (VP (VBN suppressed))))))))))))))) (. .))))

nn(culture-2, Tissue-1)
nsubj(indicate-6, culture-2)
nn(studies-5, animal-4)
conj_and(culture-2, studies-5)
root(ROOT-0, indicate-6)
complm(diminish-10, that-7)
nsubj(diminish-10, ELSPAR-8)
aux(diminish-10, can-9)
ccomp(indicate-6, diminish-10)
conj_or(diminish-10, abolish-12)
det(effect-14, the-13)
dobj(abolish-12, effect-14)
prep_of(effect-14, methotrexate-16)
amod(cells.14-19, malignant-18)
prep_on(effect-14, cells.14-19)
det(effect-21, This-20)
dobj(diminish-10, effect-21)
mark(persists-25, on-22)
nn(activity-24, methotrexate-23)
nsubj(persists-25, activity-24)
ccomp(effect-21, persists-25)
advmod(suppressed-33, as-26)
advmod(suppressed-33, long-27)
dep(suppressed-33, as-28)
nn(levels-31, plasma-29)
nn(levels-31, asparagine-30)
nsubjpass(suppressed-33, levels-31)
auxpass(suppressed-33, are-32)
ccomp(persists-25, suppressed-33)

These/DT results/NNS would/MD seem/VB to/TO dictate/VB against/IN the/DT clinical/JJ use/NN of/IN methotrexate/NN with/IN ELSPAR/NN ,/, or/CC during/IN the/DT period/NN following/VBG ELSPAR/NN therapy/NN when/WRB plasma/NN asparagine/NN levels/NNS are/VBP below/IN normal/JJ ./.

(ROOT (S1 (S (S (NP (DT These) (NNS results)) (VP (MD would) (VP (VB seem) (S (VP (TO to) (VP (VB dictate) (PP (IN against) (NP (NP (DT the) (JJ clinical) (NN use)) (PP (IN of) (NP (NN methotrexate))))) (PP (PP (IN with) (NP (NN ELSPAR))) (, ,) (CC or) (PP (IN during) (NP (NP (DT the) (NN period)) (PP (VBG following) (NP (NN ELSPAR) (NN therapy))))))) (SBAR (WHADVP (WRB when)) (S (NP (NN plasma) (NN asparagine) (NNS levels)) (VP (VBP are) (PP (IN below) (NP (JJ normal))))))))))) (. .))))

det(results-2, These-1)
nsubj(seem-4, results-2)
xsubj(dictate-6, results-2)
aux(seem-4, would-3)
root(ROOT-0, seem-4)
aux(dictate-6, to-5)
xcomp(seem-4, dictate-6)
conj_or(dictate-6, dictate-6')
det(use-10, the-8)
amod(use-10, clinical-9)
prep_against(dictate-6, use-10)
prep_of(use-10, methotrexate-12)
prep_with(dictate-6, ELSPAR-14)
det(period-19, the-18)
prep_during(dictate-6', period-19)
nn(therapy-22, ELSPAR-21)
prep_following(period-19, therapy-22)
advmod(are-27, when-23)
nn(levels-26, plasma-24)
nn(levels-26, asparagine-25)
nsubj(are-27, levels-26)
advcl(dictate-6, are-27)
prep_below(are-27, normal-29)

Uricosuric/JJ Agents/NNS :/: Aspirin/NN may/MD decrease/VB the/DT effects/NNS of/IN probenecid/NN ,/, sulfinpyrazone/NN ,/, and/CC phenylbutazone/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Uricosuric) (NNS Agents)) (: :) (NP (NN Aspirin))) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NN probenecid)) (, ,) (NP (NN sulfinpyrazone)) (, ,) (CC and) (NP (NN phenylbutazone)))))))) (. .))))

amod(Agents-2, Uricosuric-1)
nsubj(decrease-6, Agents-2)
dep(Agents-2, Aspirin-4)
aux(decrease-6, may-5)
root(ROOT-0, decrease-6)
det(effects-8, the-7)
dobj(decrease-6, effects-8)
prep_of(effects-8, probenecid-10)
conj_and(probenecid-10, sulfinpyrazone-12)
conj_and(probenecid-10, phenylbutazone-15)

Alcohol/NN :/: Has/VBZ a/DT synergistic/JJ effect/NN with/IN aspirin/NN in/IN causing/VBG gastrointestinal/JJ bleeding/JJ ./.

(ROOT (S1 (S (S (NP (NN Alcohol) (: :)) (VP (VBZ Has) (NP (NP (DT a) (JJ synergistic) (NN effect)) (PP (IN with) (NP (NN aspirin)))) (PP (IN in) (S (VP (VBG causing) (NP (JJ gastrointestinal) (JJ bleeding))))))) (. .))))

nsubj(Has-3, Alcohol-1)
root(ROOT-0, Has-3)
det(effect-6, a-4)
amod(effect-6, synergistic-5)
dobj(Has-3, effect-6)
prep_with(effect-6, aspirin-8)
prepc_in(Has-3, causing-10)
amod(bleeding-12, gastrointestinal-11)
dobj(causing-10, bleeding-12)

Corticosteroids/NNS :/: Concomitant/JJ administration/NN with/IN aspirin/NN may/MD increase/VB the/DT risk/NN of/IN gastrointestinal/JJ ulceration/NN and/CC may/MD reduce/VB serum/NN salicylate/NN levels/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Corticosteroids)) (: :) (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN with) (NP (NN aspirin)))) (VP (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ gastrointestinal) (NN ulceration)))))) (CC and) (VP (MD may) (VP (VB reduce) (NP (NN serum) (NN salicylate) (NNS levels)))))) (. .)))))

root(ROOT-0, Corticosteroids-1)
amod(administration-4, Concomitant-3)
nsubj(increase-8, administration-4)
prep_with(administration-4, aspirin-6)
aux(increase-8, may-7)
dep(Corticosteroids-1, increase-8)
det(risk-10, the-9)
dobj(increase-8, risk-10)
amod(ulceration-13, gastrointestinal-12)
prep_of(risk-10, ulceration-13)
aux(reduce-16, may-15)
conj_and(increase-8, reduce-16)
nn(levels-19, serum-17)
nn(levels-19, salicylate-18)
dobj(reduce-16, levels-19)

Pyrazolone/NN Derivatives/NNS (/-LRB- phenylbutazone/NN ,/, oxyphenbutazone/NN ,/, and/CC possibly/RB dipyrone/NN )/-RRB- :/: Concomitant/JJ administration/NN with/IN aspirin/NN may/MD increase/VB the/DT risk/NN of/IN gastrointestinal/JJ ulceration/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN Pyrazolone) (NNS Derivatives)) (PRN (-LRB- -LRB-) (NP (NP (NN phenylbutazone)) (, ,) (NP (NN oxyphenbutazone)) (, ,) (CC and) (ADVP (RB possibly)) (NP (NN dipyrone))) (-RRB- -RRB-))) (: :) (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN with) (NP (NN aspirin)))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ gastrointestinal) (NN ulceration))))))) (. .)))))

nn(Derivatives-2, Pyrazolone-1)
root(ROOT-0, Derivatives-2)
dep(Derivatives-2, phenylbutazone-4)
conj_and(phenylbutazone-4, oxyphenbutazone-6)
advmod(phenylbutazone-4, possibly-9)
conj_and(phenylbutazone-4, possibly-9)
conj_and(phenylbutazone-4, dipyrone-10)
amod(administration-14, Concomitant-13)
nsubj(increase-18, administration-14)
prep_with(administration-14, aspirin-16)
aux(increase-18, may-17)
dep(Derivatives-2, increase-18)
det(risk-20, the-19)
dobj(increase-18, risk-20)
amod(ulceration-23, gastrointestinal-22)
prep_of(risk-20, ulceration-23)

Nonsteroidal/JJ Antiinflammatory/JJ Agents/NNS :/: Aspirin/NN is/VBZ contraindicated/VBN in/IN patients/NNS who/WP are/VBP hypersensitive/JJ to/TO nonsteroidal/JJ anti-inflammatory/JJ agents/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Nonsteroidal) (JJ Antiinflammatory) (NNS Agents)) (: :) (S (NP (NN Aspirin)) (VP (VBZ is) (VP (VBN contraindicated) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADJP (JJ hypersensitive) (PP (TO to) (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS agents)))))))))))) (. .)))))

amod(Agents-3, Nonsteroidal-1)
amod(Agents-3, Antiinflammatory-2)
root(ROOT-0, Agents-3)
nsubjpass(contraindicated-7, Aspirin-5)
auxpass(contraindicated-7, is-6)
dep(Agents-3, contraindicated-7)
prep_in(contraindicated-7, patients-9)
nsubj(hypersensitive-12, patients-9)
cop(hypersensitive-12, are-11)
rcmod(patients-9, hypersensitive-12)
amod(agents-16, nonsteroidal-14)
amod(agents-16, anti-inflammatory-15)
prep_to(hypersensitive-12, agents-16)

Urinary/JJ Alkalinizers/NNS :/: Decrease/VB aspirin/NN effectiveness/NN by/IN increasing/VBG the/DT rate/NN of/IN salicylate/NN renal/JJ excretion/NN ./.

(ROOT (S1 (S (NP (NP (JJ Urinary) (NNS Alkalinizers)) (: :) (S (VP (VB Decrease) (NP (NN aspirin) (NN effectiveness)) (PP (IN by) (S (VP (VBG increasing) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NN salicylate) (JJ renal) (NN excretion))))))))) (. .)))))

amod(Alkalinizers-2, Urinary-1)
root(ROOT-0, Alkalinizers-2)
dep(Alkalinizers-2, Decrease-4)
nn(effectiveness-6, aspirin-5)
dobj(Decrease-4, effectiveness-6)
prepc_by(Decrease-4, increasing-8)
det(rate-10, the-9)
dobj(increasing-8, rate-10)
nn(excretion-14, salicylate-12)
amod(excretion-14, renal-13)
prep_of(rate-10, excretion-14)

Phenobarbital/NN :/: Decreases/VBZ aspirin/NN effectiveness/NN by/IN enzyme/NN induction/NN ./.

(ROOT (S1 (S (S (NP (NN Phenobarbital) (: :)) (VP (VBZ Decreases) (NP (NN aspirin) (NN effectiveness)) (PP (IN by) (NP (NN enzyme) (NN induction))))) (. .))))

nsubj(Decreases-3, Phenobarbital-1)
root(ROOT-0, Decreases-3)
nn(effectiveness-5, aspirin-4)
dobj(Decreases-3, effectiveness-5)
nn(induction-8, enzyme-7)
prep_by(Decreases-3, induction-8)

Phenytoin/NN :/: Serum/NN phenytoin/NN level/NN s/NNS may/MD be/VB increased/VBN by/IN aspirin/NN ./.

(ROOT (S1 (S (S (NP (NN Phenytoin) (: :) (NN Serum) (NN phenytoin) (NN level) (NNS s)) (VP (MD may) (VP (VB be) (VP (VBN increased) (PP (IN by) (NP (NN aspirin))))))) (. .))))

nn(s-6, Phenytoin-1)
nn(s-6, Serum-3)
nn(s-6, phenytoin-4)
nn(s-6, level-5)
nsubjpass(increased-9, s-6)
aux(increased-9, may-7)
auxpass(increased-9, be-8)
root(ROOT-0, increased-9)
agent(increased-9, aspirin-11)

Propranolol/NN :/: May/MD decrease/VB aspirin/NN s/NN anti-inflammatory/JJ action/NN by/IN competing/VBG for/IN the/DT same/JJ receptors/NNS ./.

(ROOT (S1 (S (S (NP (NN Propranolol) (: :)) (VP (MD May) (VP (VB decrease) (NP (NN aspirin) (NN s) (JJ anti-inflammatory) (NN action)) (PP (IN by) (S (VP (VBG competing) (PP (IN for) (NP (DT the) (JJ same) (NNS receptors))))))))) (. .))))

nsubj(decrease-4, Propranolol-1)
aux(decrease-4, May-3)
root(ROOT-0, decrease-4)
nn(action-8, aspirin-5)
nn(action-8, s-6)
amod(action-8, anti-inflammatory-7)
dobj(decrease-4, action-8)
prepc_by(decrease-4, competing-10)
det(receptors-14, the-12)
amod(receptors-14, same-13)
prep_for(competing-10, receptors-14)

Antacids/NNS :/: Enteric/JJ Coated/JJ Aspirin/NN should/MD not/RB be/VB given/VBN concurrently/RB with/IN antacids/NNS ,/, since/IN an/DT increase/NN in/IN the/DT pH/NN of/IN the/DT stomach/NN may/MD effect/VB the/DT enteric/JJ coating/NN of/IN the/DT tablets/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Antacids)) (: :) (S (NP (JJ Enteric) (JJ Coated) (NN Aspirin)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN given) (ADVP (RB concurrently)) (PP (IN with) (NP (NNS antacids))) (, ,) (SBAR (IN since) (S (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN pH)) (PP (IN of) (NP (DT the) (NN stomach)))))) (VP (MD may) (VP (VB effect) (NP (NP (DT the) (JJ enteric) (NN coating)) (PP (IN of) (NP (DT the) (NNS tablets)))))))))))) (. .)))))

root(ROOT-0, Antacids-1)
amod(Aspirin-5, Enteric-3)
amod(Aspirin-5, Coated-4)
nsubjpass(given-9, Aspirin-5)
aux(given-9, should-6)
neg(given-9, not-7)
auxpass(given-9, be-8)
dep(Antacids-1, given-9)
advmod(given-9, concurrently-10)
prep_with(given-9, antacids-12)
mark(effect-24, since-14)
det(increase-16, an-15)
nsubj(effect-24, increase-16)
det(pH-19, the-18)
prep_in(increase-16, pH-19)
det(stomach-22, the-21)
prep_of(pH-19, stomach-22)
aux(effect-24, may-23)
advcl(given-9, effect-24)
det(coating-27, the-25)
amod(coating-27, enteric-26)
dobj(effect-24, coating-27)
det(tablets-30, the-29)
prep_of(coating-27, tablets-30)

Catecholamine-depleting/JJ drugs/NNS (/-LRB- eg/NN ,/, reserpine/NN )/-RRB- may/MD have/VB an/DT additive/JJ effect/NN when/WRB given/VBN with/IN beta-blocking/JJ agent/NN s/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Catecholamine-depleting) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN reserpine))) (-RRB- -RRB-))) (VP (MD may) (VP (VB have) (NP (DT an) (JJ additive) (NN effect)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN with) (NP (JJ beta-blocking) (NN agent) (NNS s))))))))) (. .))))

amod(drugs-2, Catecholamine-depleting-1)
nsubj(have-9, drugs-2)
dep(drugs-2, eg-4)
appos(eg-4, reserpine-6)
aux(have-9, may-8)
root(ROOT-0, have-9)
det(effect-12, an-10)
amod(effect-12, additive-11)
dobj(have-9, effect-12)
advmod(given-14, when-13)
advcl(have-9, given-14)
amod(s-18, beta-blocking-16)
nn(s-18, agent-17)
prep_with(given-14, s-18)

Patients/NNS treated/VBN with/IN TENORMIN/NN plus/CC a/DT catecholamine/NN depletor/NN should/MD therefore/RB be/VB closely/RB observed/VBN for/IN evidence/NN of/IN hypotension/NN and/or/CC marked/JJ bradycardia/NN which/WDT may/MD produce/VB vertigo/NN ,/, syncope/NN ,/, or/CC postural/JJ hypotension/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBN treated) (PP (IN with) (NP (NP (NN TENORMIN)) (CC plus) (NP (DT a) (NN catecholamine) (NN depletor)))))) (VP (MD should) (ADVP (RB therefore)) (VP (VB be) (ADVP (RB closely)) (VP (VBN observed) (PP (IN for) (NP (NP (NN evidence)) (PP (IN of) (NP (NP (NP (NN hypotension)) (CC and/or) (NP (JJ marked) (NN bradycardia))) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB produce) (NP (NP (NN vertigo)) (, ,) (NP (NN syncope)) (, ,) (CC or) (NP (JJ postural) (NN hypotension))))))))))))))) (. .))))

nsubjpass(observed-13, Patients-1)
partmod(Patients-1, treated-2)
prep_with(treated-2, TENORMIN-4)
det(depletor-8, a-6)
nn(depletor-8, catecholamine-7)
conj_plus(TENORMIN-4, depletor-8)
aux(observed-13, should-9)
advmod(observed-13, therefore-10)
auxpass(observed-13, be-11)
advmod(observed-13, closely-12)
root(ROOT-0, observed-13)
prep_for(observed-13, evidence-15)
prep_of(evidence-15, hypotension-17)
nsubj(produce-23, hypotension-17)
amod(bradycardia-20, marked-19)
conj_and/or(hypotension-17, bradycardia-20)
aux(produce-23, may-22)
rcmod(hypotension-17, produce-23)
dobj(produce-23, vertigo-24)
conj_or(vertigo-24, syncope-26)
amod(hypotension-30, postural-29)
conj_or(vertigo-24, hypotension-30)

Calcium/NN channel/NN blockers/NNS may/MD also/RB have/VB an/DT additive/JJ effect/NN when/WRB given/VBN with/IN TENORMIN/NN ./.

(ROOT (S1 (S (S (NP (NN Calcium) (NN channel) (NNS blockers)) (VP (MD may) (ADVP (RB also)) (VP (VB have) (NP (DT an) (JJ additive) (NN effect)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN with) (NP (NN TENORMIN))))))))) (. .))))

nn(blockers-3, Calcium-1)
nn(blockers-3, channel-2)
nsubj(have-6, blockers-3)
aux(have-6, may-4)
advmod(have-6, also-5)
root(ROOT-0, have-6)
det(effect-9, an-7)
amod(effect-9, additive-8)
dobj(have-6, effect-9)
advmod(given-11, when-10)
advcl(have-6, given-11)
prep_with(given-11, TENORMIN-13)

Beta/NN blockers/NNS may/MD exacerbate/VB the/DT rebound/JJ hypertension/NN which/WDT can/MD follow/VBP the/DT withdrawal/NN of/IN clonidine/NN ./.

(ROOT (S1 (S (S (NP (NN Beta) (NNS blockers)) (VP (MD may) (VP (VB exacerbate) (NP (NP (DT the) (JJ rebound) (NN hypertension)) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VBP follow) (NP (NP (DT the) (NN withdrawal)) (PP (IN of) (NP (NN clonidine)))))))))))) (. .))))

nn(blockers-2, Beta-1)
nsubj(exacerbate-4, blockers-2)
aux(exacerbate-4, may-3)
root(ROOT-0, exacerbate-4)
det(hypertension-7, the-5)
amod(hypertension-7, rebound-6)
dobj(exacerbate-4, hypertension-7)
nsubj(follow-10, hypertension-7)
aux(follow-10, can-9)
rcmod(hypertension-7, follow-10)
det(withdrawal-12, the-11)
dobj(follow-10, withdrawal-12)
prep_of(withdrawal-12, clonidine-14)

If/IN the/DT two/CD drugs/NNS are/VBP coadministered/VBN ,/, the/DT beta/NN blocker/NN should/MD be/VB withdrawn/VBN several/JJ days/NNS before/IN the/DT gradual/JJ withdrawal/NN of/IN clonidine/NN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (DT the) (CD two) (NNS drugs)) (VP (VBP are) (VP (VBN coadministered))))) (, ,) (NP (DT the) (NN beta) (NN blocker)) (VP (MD should) (VP (VB be) (VP (VBN withdrawn) (NP (JJ several) (NNS days)) (PP (IN before) (NP (NP (DT the) (JJ gradual) (NN withdrawal)) (PP (IN of) (NP (NN clonidine))))))))) (. .))))

mark(coadministered-6, If-1)
det(drugs-4, the-2)
num(drugs-4, two-3)
nsubjpass(coadministered-6, drugs-4)
auxpass(coadministered-6, are-5)
advcl(withdrawn-13, coadministered-6)
det(blocker-10, the-8)
nn(blocker-10, beta-9)
nsubjpass(withdrawn-13, blocker-10)
aux(withdrawn-13, should-11)
auxpass(withdrawn-13, be-12)
root(ROOT-0, withdrawn-13)
amod(days-15, several-14)
tmod(withdrawn-13, days-15)
det(withdrawal-19, the-17)
amod(withdrawal-19, gradual-18)
prep_before(withdrawn-13, withdrawal-19)
prep_of(withdrawal-19, clonidine-21)

If/IN replacing/VBG clonidine/NN by/IN beta-blocker/NN therapy/NN ,/, the/DT introduction/NN of/IN beta/NN blockers/NNS should/MD be/VB delayed/VBN for/IN several/JJ days/NNS after/IN clonidine/NN administration/NN has/VBZ stopped/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (VP (VBG replacing) (NP (NN clonidine)) (PP (IN by) (NP (NN beta-blocker) (NN therapy)))))) (, ,) (NP (NP (DT the) (NN introduction)) (PP (IN of) (NP (NN beta) (NNS blockers)))) (VP (MD should) (VP (VB be) (VP (VBN delayed) (PP (IN for) (NP (NP (JJ several) (NNS days)) (SBAR (IN after) (S (NP (NN clonidine) (NN administration)) (VP (VBZ has) (VP (VBN stopped))))))))))) (. .))))

mark(replacing-2, If-1)
advcl(delayed-15, replacing-2)
dobj(replacing-2, clonidine-3)
nn(therapy-6, beta-blocker-5)
prep_by(replacing-2, therapy-6)
det(introduction-9, the-8)
nsubjpass(delayed-15, introduction-9)
nn(blockers-12, beta-11)
prep_of(introduction-9, blockers-12)
aux(delayed-15, should-13)
auxpass(delayed-15, be-14)
root(ROOT-0, delayed-15)
amod(days-18, several-17)
prep_for(delayed-15, days-18)
dobj(stopped-23, days-18)
mark(stopped-23, after-19)
nn(administration-21, clonidine-20)
nsubj(stopped-23, administration-21)
aux(stopped-23, has-22)
dep(days-18, stopped-23)

Concomitant/JJ use/NN of/IN prostaglandin/NN synthase/NN inhibiting/JJ drugs/NNS ,/, eg/FW ,/, indomethacin/NN ,/, may/MD decrease/VB the/DT hypotensive/JJ effects/NNS of/IN beta/NN blockers/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (NP (NN prostaglandin) (NN synthase)) (JJ inhibiting) (NNS drugs)) (, ,) (NP (FW eg) (, ,) (NP (NN indomethacin))) (, ,)))) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (JJ hypotensive) (NNS effects)) (PP (IN of) (NP (NN beta) (NNS blockers))))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(decrease-14, use-2)
nn(synthase-5, prostaglandin-4)
nn(drugs-7, synthase-5)
amod(drugs-7, inhibiting-6)
prep_of(use-2, drugs-7)
dep(indomethacin-11, eg-9)
appos(drugs-7, indomethacin-11)
aux(decrease-14, may-13)
root(ROOT-0, decrease-14)
det(effects-17, the-15)
amod(effects-17, hypotensive-16)
dobj(decrease-14, effects-17)
nn(blockers-20, beta-19)
prep_of(effects-17, blockers-20)

Information/NN on/IN concurrent/JJ usage/NN of/IN atenolol/NN and/CC aspirin/NN is/VBZ limited/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Information)) (PP (IN on) (NP (NP (JJ concurrent) (NN usage)) (PP (IN of) (NP (NP (NN atenolol)) (CC and) (NP (NN aspirin))))))) (VP (VBZ is) (VP (VBN limited)))) (. .))))

nsubjpass(limited-10, Information-1)
amod(usage-4, concurrent-3)
prep_on(Information-1, usage-4)
prep_of(usage-4, atenolol-6)
conj_and(atenolol-6, aspirin-8)
auxpass(limited-10, is-9)
root(ROOT-0, limited-10)

Data/NNS from/IN several/JJ studies/NNS ,/, ie/NN ,/, TIMI-II/NN ,/, ISIS-2/NN ,/, currently/RB do/VBP not/RB suggest/VBP any/DT clinical/JJ interaction/NN between/IN aspirin/NN and/CC beta/NN blockers/NNS in/IN the/DT acute/JJ myocardial/JJ infarction/NN setting/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Data)) (PP (IN from) (NP (JJ several) (NNS studies)))) (, ,) (NP (NP (NN ie)) (, ,) (NP (NN TIMI-II)) (, ,) (NP (NN ISIS-2))) (, ,)) (ADVP (RB currently)) (VP (VBP do) (RB not) (VP (VBP suggest) (NP (NP (DT any) (JJ clinical) (NN interaction)) (PP (IN between) (NP (NP (NP (NP (NN aspirin)) (CC and) (NP (NN beta))) (NNS blockers)) (PP (IN in) (NP (DT the) (NP (JJ acute) (JJ myocardial) (NN infarction)) (NN setting)))))))) (. .))))

nsubj(suggest-15, Data-1)
amod(studies-4, several-3)
prep_from(Data-1, studies-4)
appos(Data-1, ie-6)
appos(ie-6, TIMI-II-8)
appos(ie-6, ISIS-2-10)
advmod(suggest-15, currently-12)
aux(suggest-15, do-13)
neg(suggest-15, not-14)
root(ROOT-0, suggest-15)
det(interaction-18, any-16)
amod(interaction-18, clinical-17)
dobj(suggest-15, interaction-18)
nn(blockers-23, aspirin-20)
conj_and(aspirin-20, beta-22)
prep_between(interaction-18, blockers-23)
det(setting-29, the-25)
amod(infarction-28, acute-26)
amod(infarction-28, myocardial-27)
nn(setting-29, infarction-28)
prep_in(blockers-23, setting-29)

While/IN taking/VBG beta/NN blockers/NNS ,/, patients/NNS with/IN a/DT history/NN of/IN anaphylactic/JJ reaction/NN to/TO a/DT variety/NN of/IN allergens/NNS may/MD have/VB a/DT more/RBR severe/JJ reaction/NN on/IN repeated/JJ challenge/NN ,/, either/CC accidental/JJ ,/, diagnostic/JJ or/CC therapeutic/JJ ./.

(ROOT (S1 (S (S (SBAR (IN While) (S (VP (VBG taking) (NP (NN beta) (NNS blockers))))) (, ,) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (JJ anaphylactic) (NN reaction)) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS allergens)))))))))) (VP (MD may) (VP (VB have) (NP (DT a) (ADJP (RBR more) (JJ severe)) (NN reaction)) (PP (IN on) (NP (NP (JJ repeated) (NN challenge)) (, ,) (UCP (CC either) (ADJP (JJ accidental)) (, ,) (ADJP (ADJP (JJ diagnostic)) (CC or) (ADJP (JJ therapeutic))))))))) (. .))))

mark(taking-2, While-1)
advcl(have-19, taking-2)
nn(blockers-4, beta-3)
dobj(taking-2, blockers-4)
nsubj(have-19, patients-6)
det(history-9, a-8)
prep_with(patients-6, history-9)
amod(reaction-12, anaphylactic-11)
prep_of(history-9, reaction-12)
det(variety-15, a-14)
prep_to(reaction-12, variety-15)
prep_of(variety-15, allergens-17)
aux(have-19, may-18)
root(ROOT-0, have-19)
det(reaction-23, a-20)
advmod(severe-22, more-21)
amod(reaction-23, severe-22)
dobj(have-19, reaction-23)
amod(challenge-26, repeated-25)
prep_on(have-19, challenge-26)
dep(challenge-26, either-28)
dep(either-28, accidental-29)
dep(either-28, diagnostic-31)
conj_or(diagnostic-31, therapeutic-33)

Such/JJ patients/NNS may/MD be/VB unresponsive/JJ to/TO the/DT usual/JJ doses/NNS of/IN epinephrine/NN used/VBN to/TO treat/VB the/DT allergic/JJ reaction/NN ./.

(ROOT (S1 (S (S (NP (JJ Such) (NNS patients)) (VP (MD may) (VP (VB be) (ADJP (JJ unresponsive) (PP (TO to) (NP (NP (DT the) (JJ usual) (NNS doses)) (PP (IN of) (NP (NN epinephrine))) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (DT the) (JJ allergic) (NN reaction)))))))))))) (. .))))

amod(patients-2, Such-1)
nsubj(unresponsive-5, patients-2)
aux(unresponsive-5, may-3)
cop(unresponsive-5, be-4)
root(ROOT-0, unresponsive-5)
det(doses-9, the-7)
amod(doses-9, usual-8)
prep_to(unresponsive-5, doses-9)
prep_of(doses-9, epinephrine-11)
partmod(doses-9, used-12)
aux(treat-14, to-13)
xcomp(used-12, treat-14)
det(reaction-17, the-15)
amod(reaction-17, allergic-16)
dobj(treat-14, reaction-17)

Drug-Drug/JJ Interactions/NNS Albuterol/NN -/CC STRATTERA/NN should/MD be/VB administered/VBN with/IN caution/NN to/TO patients/NNS being/VBG treated/VBN with/IN systemically-administered/JJ (/-LRB- oral/JJ or/CC intravenous/JJ )/-RRB- albuterol/NN (/-LRB- or/CC other/JJ beta2/NN agonists/NNS )/-RRB- because/IN the/DT action/NN of/IN albuterol/NN on/IN the/DT cardiovascular/JJ system/NN can/MD be/VB potentiated/VBN resulting/VBG in/IN increases/NNS in/IN heart/NN rate/NN and/CC blood/NN pressure/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Drug-Drug) (NNS Interactions)) (NP (NP (NN Albuterol)) (CC -) (NP (NN STRATTERA)))) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (NN caution))) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NP (ADJP (ADJP (JJ systemically-administered)) (PRN (-LRB- -LRB-) (ADJP (ADJP (JJ oral)) (CC or) (ADJP (JJ intravenous))) (-RRB- -RRB-))) (NN albuterol)) (PRN (-LRB- -LRB-) (CC or) (NP (JJ other) (NN beta2) (NNS agonists)) (-RRB- -RRB-)))))))) (SBAR (IN because) (S (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NN albuterol))) (PP (IN on) (NP (DT the) (JJ cardiovascular) (NN system)))) (VP (MD can) (VP (VB be) (VP (VBN potentiated) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (NN heart) (NN rate)) (CC and) (NP (NN blood) (NN pressure))))))))))))))))) (. .))))

amod(Interactions-2, Drug-Drug-1)
nsubjpass(administered-8, Interactions-2)
dep(Interactions-2, Albuterol-3)
conj(Albuterol-3, STRATTERA-5)
aux(administered-8, should-6)
auxpass(administered-8, be-7)
root(ROOT-0, administered-8)
prep_with(administered-8, caution-10)
prep_to(administered-8, patients-12)
auxpass(treated-14, being-13)
partmod(patients-12, treated-14)
amod(albuterol-22, systemically-administered-16)
dep(systemically-administered-16, oral-18)
conj_or(oral-18, intravenous-20)
prep_with(treated-14, albuterol-22)
dep(agonists-27, or-24)
amod(agonists-27, other-25)
nn(agonists-27, beta2-26)
appos(albuterol-22, agonists-27)
mark(potentiated-40, because-29)
det(action-31, the-30)
nsubjpass(potentiated-40, action-31)
prep_of(action-31, albuterol-33)
det(system-37, the-35)
amod(system-37, cardiovascular-36)
prep_on(action-31, system-37)
aux(potentiated-40, can-38)
auxpass(potentiated-40, be-39)
advcl(administered-8, potentiated-40)
xcomp(potentiated-40, resulting-41)
prep_in(resulting-41, increases-43)
nn(rate-46, heart-45)
prep_in(increases-43, rate-46)
nn(pressure-49, blood-48)
conj_and(rate-46, pressure-49)

CYP2D6/NN inhibitors/NNS -/CC Atomoxetine/NN is/VBZ primarily/RB metabolized/VBN by/IN the/DT CYP2D6/NN pathway/NN to/TO 4-hydroxyatomoxetine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN CYP2D6)) (NP (NNS inhibitors)) (CC -) (NP (NN Atomoxetine))) (VP (VBZ is) (ADVP (RB primarily)) (VP (VBN metabolized) (PP (IN by) (NP (NP (DT the) (NN CYP2D6) (NN pathway)) (PP (TO to) (NP (NN 4-hydroxyatomoxetine)))))))) (. .))))

nsubjpass(metabolized-7, CYP2D6-1)
dep(CYP2D6-1, inhibitors-2)
conj(CYP2D6-1, Atomoxetine-4)
auxpass(metabolized-7, is-5)
advmod(metabolized-7, primarily-6)
root(ROOT-0, metabolized-7)
det(pathway-11, the-9)
nn(pathway-11, CYP2D6-10)
agent(metabolized-7, pathway-11)
prep_to(pathway-11, 4-hydroxyatomoxetine-13)

In/IN EMs/NN ,/, selective/JJ inhibitors/NNS of/IN CYP2D6/NN increase/VBP atomoxetine/JJ steady-state/JJ plasma/NN concentrations/NNS to/TO exposures/NNS similar/JJ to/TO those/DT observed/VBN in/IN PMs/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN EMs))) (, ,) (NP (NP (JJ selective) (NNS inhibitors)) (PP (IN of) (NP (NN CYP2D6)))) (VP (VBP increase) (NP (JJ atomoxetine) (JJ steady-state) (NN plasma) (NNS concentrations)) (PP (TO to) (NP (NP (NNS exposures)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (VP (VBN observed) (PP (IN in) (NP (NN PMs))))))))))) (. .))))

prep_in(increase-8, EMs-2)
amod(inhibitors-5, selective-4)
nsubj(increase-8, inhibitors-5)
prep_of(inhibitors-5, CYP2D6-7)
root(ROOT-0, increase-8)
amod(concentrations-12, atomoxetine-9)
amod(concentrations-12, steady-state-10)
nn(concentrations-12, plasma-11)
dobj(increase-8, concentrations-12)
prep_to(increase-8, exposures-14)
amod(exposures-14, similar-15)
prep_to(similar-15, those-17)
partmod(those-17, observed-18)
prep_in(observed-18, PMs-20)

Dosage/NN adjustment/NN of/IN STRATTERA/NN may/MD be/VB necessary/JJ when/WRB coadministered/VBN with/IN CYP2D6/NN inhibitors/NNS ,/, e.g./FW ,/, paroxetine/NN ,/, fluoxetine/NN ,/, and/CC quinidine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Dosage) (NN adjustment)) (PP (IN of) (NP (NN STRATTERA)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary))) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NP (NN CYP2D6) (NNS inhibitors)) (, ,) (PP (FW e.g.) (, ,) (NP (NP (NN paroxetine)) (, ,) (NP (NN fluoxetine)) (, ,) (CC and) (NP (NN quinidine))))))))))) (. .))))

nn(adjustment-2, Dosage-1)
nsubj(necessary-7, adjustment-2)
prep_of(adjustment-2, STRATTERA-4)
aux(necessary-7, may-5)
cop(necessary-7, be-6)
root(ROOT-0, necessary-7)
advmod(coadministered-9, when-8)
advcl(necessary-7, coadministered-9)
nn(inhibitors-12, CYP2D6-11)
prep_with(coadministered-9, inhibitors-12)
prep(inhibitors-12, e.g.-14)
pobj(e.g.-14, paroxetine-16)
conj_and(paroxetine-16, fluoxetine-18)
conj_and(paroxetine-16, quinidine-21)

In/IN EM/JJ individuals/NNS treated/VBN with/IN paroxetine/NN or/CC fluoxetine/NN ,/, the/DT AUC/NN of/IN atomoxetine/NN is/VBZ approximately/RB 6-/CD to/TO 8-fold/JJ and/CC Css/NN ,/, max/NN is/VBZ about/RB 3-/CD to/TO 4-fold/RB greater/JJR than/IN atomoxetine/NN alone/RB ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (JJ EM) (NNS individuals)) (VP (VBN treated) (PP (IN with) (NP (NP (NN paroxetine)) (CC or) (NP (NN fluoxetine))))))) (, ,) (S (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NN atomoxetine)))) (VP (VBZ is) (NP (RB approximately) (CD 6-) (TO to) (JJ 8-fold)))) (CC and) (S (NP (NP (NN Css)) (, ,) (NP (NN max))) (VP (VBZ is) (ADJP (NP (RB about) (CD 3-) (TO to) (RB 4-fold)) (JJR greater) (PP (IN than) (NP (NP (NN atomoxetine)) (ADVP (RB alone)))))))) (. .))))

amod(individuals-3, EM-2)
prep_in(6--16, individuals-3)
partmod(individuals-3, treated-4)
prep_with(treated-4, paroxetine-6)
conj_or(paroxetine-6, fluoxetine-8)
det(AUC-11, the-10)
nsubj(6--16, AUC-11)
prep_of(AUC-11, atomoxetine-13)
cop(6--16, is-14)
advmod(6--16, approximately-15)
root(ROOT-0, 6--16)
dep(6--16, to-17)
amod(6--16, 8-fold-18)
nsubj(greater-28, Css-20)
appos(Css-20, max-22)
cop(greater-28, is-23)
advmod(3--25, about-24)
npadvmod(greater-28, 3--25)
dep(3--25, to-26)
advmod(3--25, 4-fold-27)
conj_and(6--16, greater-28)
prep_than(greater-28, atomoxetine-30)
advmod(atomoxetine-30, alone-31)

In/FW vitro/FW studies/NNS suggest/VBP that/IN coadministration/NN of/IN cytochrome/NN P450/NN inhibitors/NNS to/TO PMs/NN will/MD not/RB increase/VB the/DT plasma/NN concentrations/NNS of/IN atomoxetine/NN ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN coadministration)) (PP (IN of) (NP (NN cytochrome) (NN P450) (NNS inhibitors))) (PP (TO to) (NP (NN PMs)))) (VP (MD will) (RB not) (VP (VB increase) (NP (NP (DT the) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN atomoxetine)))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(suggest-4, studies-3)
root(ROOT-0, suggest-4)
complm(increase-15, that-5)
nsubj(increase-15, coadministration-6)
nn(inhibitors-10, cytochrome-8)
nn(inhibitors-10, P450-9)
prep_of(coadministration-6, inhibitors-10)
prep_to(coadministration-6, PMs-12)
aux(increase-15, will-13)
neg(increase-15, not-14)
ccomp(suggest-4, increase-15)
det(concentrations-18, the-16)
nn(concentrations-18, plasma-17)
dobj(increase-15, concentrations-18)
prep_of(concentrations-18, atomoxetine-20)

Pressor/JJ agents/NNS -/: Because/IN of/IN possible/JJ effects/NNS on/IN blood/NN pressure/NN ,/, STRATTERA/NN should/MD be/VB used/VBN cautiously/RB with/IN pressor/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (JJ Pressor) (NNS agents)) (: -) (PP (IN Because) (PP (IN of) (NP (NP (JJ possible) (NNS effects)) (PP (IN on) (NP (NN blood) (NN pressure)))))) (, ,) (NP (NN STRATTERA)) (VP (MD should) (VP (VB be) (VP (VBN used) (ADVP (RB cautiously)) (PP (IN with) (NP (JJ pressor) (NNS agents))))))) (. .))))

amod(agents-2, Pressor-1)
nsubjpass(used-15, agents-2)
prepc_because_of(used-15, of-5)
amod(effects-7, possible-6)
pobj(used-15, effects-7)
nn(pressure-10, blood-9)
prep_on(effects-7, pressure-10)
nsubjpass(used-15, STRATTERA-12)
aux(used-15, should-13)
auxpass(used-15, be-14)
root(ROOT-0, used-15)
advmod(used-15, cautiously-16)
amod(agents-19, pressor-18)
prep_with(used-15, agents-19)

The/DT risk/NN of/IN myopathy/NN during/IN treatment/NN with/IN drugs/NNS of/IN this/DT class/NN is/VBZ increased/VBN with/IN concurrent/JJ administration/NN of/IN cyclosporine/NN ,/, fibric/JJ acid/NN derivatives/NNS ,/, niacin/NN (/-LRB- nicotinic/JJ acid/NN )/-RRB- ,/, erythromycin/NN ,/, azole/JJ antifungals/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN risk)) (PP (IN of) (NP (NN myopathy))) (PP (IN during) (NP (NP (NN treatment)) (PP (IN with) (NP (NP (NNS drugs)) (PP (IN of) (NP (DT this) (NN class)))))))) (VP (VBZ is) (VP (VBN increased) (PP (IN with) (NP (NP (JJ concurrent) (NN administration)) (PP (IN of) (NP (NP (NN cyclosporine)) (, ,) (NP (JJ fibric) (NN acid) (NNS derivatives)) (, ,) (NP (NP (NN niacin)) (PRN (-LRB- -LRB-) (NP (JJ nicotinic) (NN acid)) (-RRB- -RRB-))) (, ,) (NP (NN erythromycin)) (, ,) (NP (JJ azole) (NNS antifungals))))))))) (. .))))

det(risk-2, The-1)
nsubjpass(increased-13, risk-2)
prep_of(risk-2, myopathy-4)
prep_during(risk-2, treatment-6)
prep_with(treatment-6, drugs-8)
det(class-11, this-10)
prep_of(drugs-8, class-11)
auxpass(increased-13, is-12)
root(ROOT-0, increased-13)
amod(administration-16, concurrent-15)
prep_with(increased-13, administration-16)
prep_of(administration-16, cyclosporine-18)
amod(derivatives-22, fibric-20)
nn(derivatives-22, acid-21)
appos(cyclosporine-18, derivatives-22)
appos(cyclosporine-18, niacin-24)
amod(acid-27, nicotinic-26)
appos(niacin-24, acid-27)
appos(cyclosporine-18, erythromycin-30)
amod(antifungals-33, azole-32)
appos(cyclosporine-18, antifungals-33)

Antacid/JJ :/: When/WRB atorvastatin/NN and/CC Maalox/NN @/NN TC/NN suspension/NN were/VBD coadministered/VBN ,/, plasma/NN concentrations/NNS of/IN atorvastatin/NN decreased/VBD approximately/RB 35/CD %./NN

(ROOT (S1 (S (S (ADJP (JJ Antacid))) (: :) (S (SBAR (WHADVP (WRB When)) (S (NP (NP (NN atorvastatin)) (CC and) (NP (NN Maalox) (NN @) (NN TC) (NN suspension))) (VP (VBD were) (VP (VBN coadministered))))) (, ,) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN atorvastatin)))) (VP (VBD decreased) (NP (QP (RB approximately) (CD 35)) (NN %.)))))))

root(ROOT-0, Antacid-1)
advmod(coadministered-11, When-3)
nsubjpass(coadministered-11, atorvastatin-4)
nn(suspension-9, Maalox-6)
nn(suspension-9, @-7)
nn(suspension-9, TC-8)
conj_and(atorvastatin-4, suspension-9)
auxpass(coadministered-11, were-10)
advcl(decreased-17, coadministered-11)
nn(concentrations-14, plasma-13)
nsubj(decreased-17, concentrations-14)
prep_of(concentrations-14, atorvastatin-16)
parataxis(Antacid-1, decreased-17)
quantmod(35-19, approximately-18)
num(%.-20, 35-19)
dobj(decreased-17, %.-20)

Antipyrine/NN :/: Because/IN atorvastatin/NN does/VBZ not/RB affect/VB the/DT pharmacokinetics/NNS of/IN antipyrine/NN ,/, interactions/NNS with/IN other/JJ drugs/NNS metabolized/VBN via/IN the/DT same/JJ cytochrome/NN isozymes/NNS are/VBP not/RB expected/VBN ./.

(ROOT (S1 (S (NP (NP (NN Antipyrine)) (: :) (S (SBAR (IN Because) (S (NP (NN atorvastatin)) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN antipyrine)))))))) (, ,) (NP (NP (NNS interactions)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (VP (VBN metabolized) (PP (IN via) (NP (DT the) (JJ same) (NN cytochrome) (NNS isozymes))))))) (VP (VBP are) (RB not) (VP (VBN expected)))) (. .)))))

root(ROOT-0, Antipyrine-1)
mark(affect-7, Because-3)
nsubj(affect-7, atorvastatin-4)
aux(affect-7, does-5)
neg(affect-7, not-6)
advcl(expected-25, affect-7)
det(pharmacokinetics-9, the-8)
dobj(affect-7, pharmacokinetics-9)
prep_of(pharmacokinetics-9, antipyrine-11)
nsubjpass(expected-25, interactions-13)
amod(drugs-16, other-15)
prep_with(interactions-13, drugs-16)
partmod(drugs-16, metabolized-17)
det(isozymes-22, the-19)
amod(isozymes-22, same-20)
nn(isozymes-22, cytochrome-21)
prep_via(metabolized-17, isozymes-22)
auxpass(expected-25, are-23)
neg(expected-25, not-24)
dep(Antipyrine-1, expected-25)

Colestipol/NN :/: Plasma/NN concentrations/NNS of/IN atorvastatin/NN decreased/VBD approximately/RB 25/CD %/NN when/WRB colestipol/NN and/CC atorvastatin/NN were/VBD coadministered/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Colestipol) (: :) (NN Plasma) (NNS concentrations)) (PP (IN of) (NP (NN atorvastatin)))) (VP (VBD decreased) (NP (QP (RB approximately) (CD 25)) (NN %)) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN colestipol)) (CC and) (NP (NN atorvastatin))) (VP (VBD were) (VP (VBN coadministered))))))) (. .))))

nn(concentrations-4, Colestipol-1)
nn(concentrations-4, Plasma-3)
nsubj(decreased-7, concentrations-4)
prep_of(concentrations-4, atorvastatin-6)
root(ROOT-0, decreased-7)
quantmod(25-9, approximately-8)
num(%-10, 25-9)
dobj(decreased-7, %-10)
advmod(coadministered-16, when-11)
nsubjpass(coadministered-16, colestipol-12)
conj_and(colestipol-12, atorvastatin-14)
auxpass(coadministered-16, were-15)
advcl(decreased-7, coadministered-16)

However/RB ,/, LDL-C/NN reduction/NN was/VBD greater/JJR when/WRB atorvastatin/NN and/CC colestipol/NN were/VBD coadministered/VBN than/IN when/WRB either/DT drug/NN was/VBD given/VBN alone/RB ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NN LDL-C) (NN reduction)) (VP (VBD was) (ADJP (JJR greater)) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN atorvastatin)) (CC and) (NP (NN colestipol))) (VP (VBD were) (VP (VBN coadministered) (PP (IN than) (SBAR (WHADVP (WRB when)) (S (NP (DT either) (NN drug)) (VP (VBD was) (VP (VBN given) (ADVP (RB alone))))))))))))) (. .))))

advmod(greater-6, However-1)
nn(reduction-4, LDL-C-3)
nsubj(greater-6, reduction-4)
cop(greater-6, was-5)
root(ROOT-0, greater-6)
advmod(coadministered-12, when-7)
nsubjpass(coadministered-12, atorvastatin-8)
conj_and(atorvastatin-8, colestipol-10)
auxpass(coadministered-12, were-11)
advcl(greater-6, coadministered-12)
advmod(given-18, when-14)
det(drug-16, either-15)
nsubjpass(given-18, drug-16)
auxpass(given-18, was-17)
prepc_than(coadministered-12, given-18)
advmod(given-18, alone-19)

Cimetidine/NN :/: Atorvastatin/NN plasma/NN concentrations/NNS and/CC LDL-C/JJ reduction/NN were/VBD not/RB altered/VBN by/IN coadministration/NN of/IN cimetidine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Cimetidine)) (: :) (NP (NN Atorvastatin) (NN plasma) (NNS concentrations)) (CC and) (NP (JJ LDL-C) (NN reduction))) (VP (VBD were) (RB not) (VP (VBN altered) (PP (IN by) (NP (NP (NN coadministration)) (PP (IN of) (NP (NN cimetidine)))))))) (. .))))

nsubjpass(altered-11, Cimetidine-1)
nn(concentrations-5, Atorvastatin-3)
nn(concentrations-5, plasma-4)
conj_and(Cimetidine-1, concentrations-5)
amod(reduction-8, LDL-C-7)
conj_and(Cimetidine-1, reduction-8)
auxpass(altered-11, were-9)
neg(altered-11, not-10)
root(ROOT-0, altered-11)
agent(altered-11, coadministration-13)
prep_of(coadministration-13, cimetidine-15)

Digoxin/NN :/: When/WRB multiple/JJ doses/NNS of/IN atorvastatin/NN and/CC digoxin/NN were/VBD coadministered/VBN ,/, steady-state/JJ plasma/NN digoxin/NN concentrations/NNS increased/VBD by/IN approximately/RB 20/CD %./NN

(ROOT (S1 (S (NP (NP (NN Digoxin)) (: :) (S (SBAR (WHADVP (WRB When)) (S (NP (NP (JJ multiple) (NNS doses)) (PP (IN of) (NP (NP (NN atorvastatin)) (CC and) (NP (NN digoxin))))) (VP (VBD were) (VP (VBN coadministered))))) (, ,) (NP (JJ steady-state) (NN plasma) (NN digoxin) (NNS concentrations)) (VP (VBD increased) (PP (IN by) (NP (QP (RB approximately) (CD 20)) (NN %.)))))))))

root(ROOT-0, Digoxin-1)
advmod(coadministered-11, When-3)
amod(doses-5, multiple-4)
nsubjpass(coadministered-11, doses-5)
prep_of(doses-5, atorvastatin-7)
conj_and(atorvastatin-7, digoxin-9)
auxpass(coadministered-11, were-10)
advcl(increased-17, coadministered-11)
amod(concentrations-16, steady-state-13)
nn(concentrations-16, plasma-14)
nn(concentrations-16, digoxin-15)
nsubj(increased-17, concentrations-16)
dep(Digoxin-1, increased-17)
quantmod(20-20, approximately-19)
num(%.-21, 20-20)
prep_by(increased-17, %.-21)

Patients/NNS taking/VBG digoxin/NN should/MD be/VB monitored/VBN appropriately/RB ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG taking) (NP (NN digoxin)))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB appropriately)))))) (. .))))

nsubjpass(monitored-6, Patients-1)
partmod(Patients-1, taking-2)
dobj(taking-2, digoxin-3)
aux(monitored-6, should-4)
auxpass(monitored-6, be-5)
root(ROOT-0, monitored-6)
advmod(monitored-6, appropriately-7)

Erythromycin/NN :/: In/IN healthy/JJ individuals/NNS ,/, plasma/NN concentrations/NNS of/IN atorvastatin/NN increased/VBD approximately/RB 40/CD %/NN with/IN coadministration/NN of/IN atorvastatin/NN and/CC erythromycin/NN ,/, a/DT known/JJ inhibitor/NN of/IN cytochrome/NN P450/NN 3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Erythromycin)) (: :) (PP (IN In) (NP (JJ healthy) (NNS individuals))) (, ,) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN atorvastatin)))) (VP (VBD increased) (NP (QP (RB approximately) (CD 40)) (NN %)) (PP (IN with) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NP (NN atorvastatin)) (CC and) (NP (NN erythromycin))) (, ,) (NP (NP (DT a) (JJ known) (NN inhibitor)) (PP (IN of) (NP (NN cytochrome) (NN P450) (NN 3A4)))))))))) (. .))))

nsubj(increased-11, Erythromycin-1)
amod(individuals-5, healthy-4)
prep_in(increased-11, individuals-5)
nn(concentrations-8, plasma-7)
nsubj(increased-11, concentrations-8)
prep_of(concentrations-8, atorvastatin-10)
root(ROOT-0, increased-11)
quantmod(40-13, approximately-12)
num(%-14, 40-13)
dobj(increased-11, %-14)
prep_with(increased-11, coadministration-16)
prep_of(coadministration-16, atorvastatin-18)
conj_and(atorvastatin-18, erythromycin-20)
det(inhibitor-24, a-22)
amod(inhibitor-24, known-23)
appos(atorvastatin-18, inhibitor-24)
nn(3A4-28, cytochrome-26)
nn(3A4-28, P450-27)
prep_of(inhibitor-24, 3A4-28)

Oral/JJ Contraceptives/NNS :/: Coadministration/NN of/IN atorvastatin/NN and/CC an/DT oral/JJ contraceptive/NN increased/VBD AUC/NN values/NNS for/IN norethindrone/NN and/CC ethinyl/NN estradiol/NN by/IN approximately/RB 30/CD %/NN and/CC 20/CD %./NN

(ROOT (S1 (S (NP (NP (JJ Oral) (NNS Contraceptives)) (: :) (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN atorvastatin)))) (CC and) (NP (NP (NP (DT an) (JJ oral) (NN contraceptive)) (VP (VBD increased) (NP (NP (NN AUC) (NNS values)) (PP (IN for) (NP (NP (NN norethindrone)) (CC and) (NP (NN ethinyl) (NN estradiol))))) (PP (IN by) (NP (QP (RB approximately) (CD 30)) (NN %))))) (CC and) (NP (CD 20) (NN %.)))))))

amod(Contraceptives-2, Oral-1)
root(ROOT-0, Contraceptives-2)
conj_and(Contraceptives-2, Coadministration-4)
prep_of(Coadministration-4, atorvastatin-6)
det(contraceptive-10, an-8)
amod(contraceptive-10, oral-9)
conj_and(Contraceptives-2, contraceptive-10)
partmod(contraceptive-10, increased-11)
nn(values-13, AUC-12)
dobj(increased-11, values-13)
prep_for(values-13, norethindrone-15)
nn(estradiol-18, ethinyl-17)
conj_and(norethindrone-15, estradiol-18)
quantmod(30-21, approximately-20)
num(%-22, 30-21)
agent(increased-11, %-22)
num(%.-25, 20-24)
conj_and(contraceptive-10, %.-25)

These/DT increases/NNS should/MD be/VB considered/VBN when/WRB selecting/VBG an/DT oral/JJ contraceptive/NN for/IN a/DT woman/NN taking/VBG atorvastatin/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS increases)) (VP (MD should) (VP (VB be) (VP (VBN considered) (SBAR (WHADVP (WRB when)) (S (VP (VBG selecting) (NP (NP (DT an) (JJ oral) (NN contraceptive)) (PP (IN for) (NP (NP (DT a) (NN woman)) (VP (VBG taking) (NP (NN atorvastatin))))))))))))) (. .))))

det(increases-2, These-1)
nsubjpass(considered-5, increases-2)
aux(considered-5, should-3)
auxpass(considered-5, be-4)
root(ROOT-0, considered-5)
advmod(selecting-7, when-6)
advcl(considered-5, selecting-7)
det(contraceptive-10, an-8)
amod(contraceptive-10, oral-9)
dobj(selecting-7, contraceptive-10)
det(woman-13, a-12)
prep_for(contraceptive-10, woman-13)
partmod(woman-13, taking-14)
dobj(taking-14, atorvastatin-15)

Warfarin/NN :/: Atorvastatin/NN had/VBD no/DT clinically/RB significant/JJ effect/NN on/IN prothrombin/NN time/NN when/WRB administered/VBN to/TO patients/NNS receiving/VBG chronic/JJ warfarin/NN treatment/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Warfarin)) (: :) (NP (NN Atorvastatin))) (VP (VBD had) (NP (DT no) (ADJP (RB clinically) (JJ significant)) (NN effect)) (PP (IN on) (NP (NN prothrombin) (NN time))) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ chronic) (NN warfarin) (NN treatment)))))))))) (. .))))

nsubj(had-4, Warfarin-1)
dep(Warfarin-1, Atorvastatin-3)
root(ROOT-0, had-4)
det(effect-8, no-5)
advmod(significant-7, clinically-6)
amod(effect-8, significant-7)
dobj(had-4, effect-8)
nn(time-11, prothrombin-10)
prep_on(had-4, time-11)
advmod(administered-13, when-12)
advcl(had-4, administered-13)
prep_to(administered-13, patients-15)
partmod(patients-15, receiving-16)
amod(treatment-19, chronic-17)
nn(treatment-19, warfarin-18)
dobj(receiving-16, treatment-19)

Endocrine/JJ Function/NN HMG-CoA/NN reductase/NN inhibitors/NNS interfere/VBP with/IN cholesterol/NN synthesis/NN and/CC theoretically/RB might/MD blunt/VB adrenal/JJ and/or/CC gonadal/JJ steroid/NN production/NN ./.

(ROOT (S1 (S (S (NP (JJ Endocrine) (NN Function) (NN HMG-CoA) (NN reductase) (NNS inhibitors)) (VP (VP (VBP interfere) (PP (IN with) (NP (NN cholesterol) (NN synthesis)))) (CC and) (VP (ADVP (RB theoretically)) (VP (MD might) (VP (VB blunt) (NP (ADJP (ADJP (JJ adrenal)) (CC and/or) (ADJP (JJ gonadal))) (NN steroid) (NN production))))))) (. .))))

amod(inhibitors-5, Endocrine-1)
nn(inhibitors-5, Function-2)
nn(inhibitors-5, HMG-CoA-3)
nn(inhibitors-5, reductase-4)
nsubj(interfere-6, inhibitors-5)
root(ROOT-0, interfere-6)
nn(synthesis-9, cholesterol-8)
prep_with(interfere-6, synthesis-9)
advmod(blunt-13, theoretically-11)
aux(blunt-13, might-12)
conj_and(interfere-6, blunt-13)
amod(production-18, adrenal-14)
conj_and/or(adrenal-14, gonadal-16)
nn(production-18, steroid-17)
dobj(blunt-13, production-18)

Clinical/JJ studies/NNS have/VBP shown/VBN that/IN atorvastatin/NN does/VBZ not/RB reduce/VB basal/JJ plasma/NN cortisol/NN concentration/NN or/CC impair/VB adrenal/JJ reserve/NN ./.

(ROOT (S1 (S (S (NP (JJ Clinical) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NN atorvastatin)) (VP (VBZ does) (RB not) (VP (VP (VB reduce) (NP (JJ basal) (NN plasma) (NN cortisol) (NN concentration))) (CC or) (VP (VB impair) (NP (JJ adrenal) (NN reserve)))))))))) (. .))))

amod(studies-2, Clinical-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
complm(reduce-9, that-5)
nsubj(reduce-9, atorvastatin-6)
aux(reduce-9, does-7)
neg(reduce-9, not-8)
ccomp(shown-4, reduce-9)
amod(concentration-13, basal-10)
nn(concentration-13, plasma-11)
nn(concentration-13, cortisol-12)
dobj(reduce-9, concentration-13)
conj_or(reduce-9, impair-15)
amod(reserve-17, adrenal-16)
dobj(impair-15, reserve-17)

The/DT effects/NNS of/IN HMG-CoA/NN reductase/NN inhibitors/NNS on/IN male/JJ fertility/NN have/VBP not/RB been/VBN studied/VBN in/IN adequate/JJ numbers/NNS of/IN patients/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NN HMG-CoA) (NN reductase) (NNS inhibitors))) (PP (IN on) (NP (JJ male) (NN fertility)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN studied) (PP (IN in) (NP (NP (JJ adequate) (NNS numbers)) (PP (IN of) (NP (NNS patients))))))))) (. .))))

det(effects-2, The-1)
nsubjpass(studied-13, effects-2)
nn(inhibitors-6, HMG-CoA-4)
nn(inhibitors-6, reductase-5)
prep_of(effects-2, inhibitors-6)
amod(fertility-9, male-8)
prep_on(effects-2, fertility-9)
aux(studied-13, have-10)
neg(studied-13, not-11)
auxpass(studied-13, been-12)
root(ROOT-0, studied-13)
amod(numbers-16, adequate-15)
prep_in(studied-13, numbers-16)
prep_of(numbers-16, patients-18)

Caution/NN should/MD be/VB exercised/VBN if/IN an/DT HMG-CoA/NN reductase/NN inhibitor/NN is/VBZ administered/VBN concomitantly/RB with/IN drugs/NNS that/WDT may/MD decrease/VB the/DT levels/NNS or/CC activity/NN of/IN endogenous/JJ steroid/NN hormones/NNS ,/, such/JJ as/IN ketoconazole/NN ,/, spironolactone/NN ,/, and/CC cimetidine/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (IN if) (S (NP (DT an) (NN HMG-CoA) (NN reductase) (NN inhibitor)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NP (NNS levels)) (CC or) (NP (NN activity))) (PP (IN of) (NP (JJ endogenous) (NN steroid) (NNS hormones)))))))) (, ,) (PP (JJ such) (IN as) (NP (NP (NN ketoconazole)) (, ,) (NP (NN spironolactone)) (, ,) (CC and) (NP (NN cimetidine)))))))))))))) (. .))))

nsubjpass(exercised-4, Caution-1)
aux(exercised-4, should-2)
auxpass(exercised-4, be-3)
root(ROOT-0, exercised-4)
mark(administered-11, if-5)
det(inhibitor-9, an-6)
nn(inhibitor-9, HMG-CoA-7)
nn(inhibitor-9, reductase-8)
nsubjpass(administered-11, inhibitor-9)
auxpass(administered-11, is-10)
advcl(exercised-4, administered-11)
advmod(administered-11, concomitantly-12)
prep_with(administered-11, drugs-14)
nsubj(decrease-17, drugs-14)
aux(decrease-17, may-16)
rcmod(drugs-14, decrease-17)
dep(levels-19, the-18)
dobj(decrease-17, levels-19)
conj_or(levels-19, activity-21)
amod(hormones-25, endogenous-23)
nn(hormones-25, steroid-24)
prep_of(levels-19, hormones-25)
prep_such_as(drugs-14, ketoconazole-29)
conj_and(ketoconazole-29, spironolactone-31)
conj_and(ketoconazole-29, cimetidine-34)

The/DT 120/CD mg/kg/NN dose/NN resulted/VBD in/IN a/DT systemic/JJ exposure/NN approximately/RB 16/CD times/NNS the/DT human/JJ plasma/NN area-under-the-curve/NN (/-LRB- AUC/NN ,/, 0-24/CD hours/NNS )/-RRB- based/VBN on/IN the/DT maximum/JJ human/JJ dose/NN of/IN 80/CD mg/day/NN ./.

(ROOT (S1 (S (S (NP (DT The) (CD 120) (NN mg/kg) (NN dose)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJ systemic) (NN exposure)) (NP (NP (QP (RB approximately) (CD 16)) (NNS times)) (NP (NP (NP (DT the) (JJ human) (NN plasma) (NN area-under-the-curve)) (PRN (-LRB- -LRB-) (NP (NP (NN AUC)) (, ,) (NP (CD 0-24) (NNS hours))) (-RRB- -RRB-))) (VP (VBN based) (PP (IN on) (NP (NP (DT the) (JJ maximum) (JJ human) (NN dose)) (PP (IN of) (NP (CD 80) (NN mg/day)))))))))))) (. .))))

det(dose-4, The-1)
num(dose-4, 120-2)
nn(dose-4, mg/kg-3)
nsubj(resulted-5, dose-4)
root(ROOT-0, resulted-5)
det(exposure-9, a-7)
amod(exposure-9, systemic-8)
prep_in(resulted-5, exposure-9)
quantmod(16-11, approximately-10)
num(times-12, 16-11)
dep(exposure-9, times-12)
det(area-under-the-curve-16, the-13)
amod(area-under-the-curve-16, human-14)
nn(area-under-the-curve-16, plasma-15)
dep(times-12, area-under-the-curve-16)
dep(area-under-the-curve-16, AUC-18)
num(hours-21, 0-24-20)
appos(AUC-18, hours-21)
partmod(area-under-the-curve-16, based-23)
det(dose-28, the-25)
amod(dose-28, maximum-26)
amod(dose-28, human-27)
prep_on(based-23, dose-28)
num(mg/day-31, 80-30)
prep_of(dose-28, mg/day-31)

A/DT chemically/RB similar/JJ drug/NN in/IN this/DT class/NN produced/VBD optic/JJ nerve/NN degeneration/NN (/-LRB- Wallerian/NNP degeneration/NN of/IN retinogeniculate/NN fibers/NNS )/-RRB- in/IN clinically/RB normal/JJ dogs/NNS in/IN a/DT dose-dependent/JJ fashion/NN at/IN a/DT dose/NN that/WDT produced/VBD plasma/NN drug/NN levels/NNS about/RB 30/CD times/NNS higher/JJR than/IN the/DT mean/JJ drug/NN level/NN in/IN humans/NNS taking/VBG the/DT highest/JJS recommended/VBN dose/NN ./.

(ROOT (S1 (S (S (NP (NP (DT A) (ADJP (RB chemically) (JJ similar)) (NN drug)) (PP (IN in) (NP (DT this) (NN class)))) (VP (VBD produced) (NP (NP (JJ optic) (NN nerve) (NN degeneration)) (PRN (-LRB- -LRB-) (NP (NP (NNP Wallerian) (NN degeneration)) (PP (IN of) (NP (NN retinogeniculate) (NNS fibers)))) (-RRB- -RRB-))) (PP (IN in) (NP (ADJP (RB clinically) (JJ normal)) (NNS dogs))) (PP (IN in) (NP (DT a) (JJ dose-dependent) (NN fashion))) (PP (IN at) (NP (NP (DT a) (NN dose)) (SBAR (WHNP (WDT that)) (S (VP (VBD produced) (NP (NP (NN plasma) (NN drug) (NNS levels)) (ADJP (NP (QP (RB about) (CD 30)) (NNS times)) (JJR higher) (PP (IN than) (NP (NP (DT the) (JJ mean) (NN drug) (NN level)) (PP (IN in) (NP (NP (NNS humans)) (VP (VBG taking) (NP (DT the) (JJS highest) (VBN recommended) (NN dose)))))))))))))))) (. .))))

det(drug-4, A-1)
advmod(similar-3, chemically-2)
amod(drug-4, similar-3)
nsubj(produced-8, drug-4)
det(class-7, this-6)
prep_in(drug-4, class-7)
root(ROOT-0, produced-8)
amod(degeneration-11, optic-9)
nn(degeneration-11, nerve-10)
dobj(produced-8, degeneration-11)
nn(degeneration-14, Wallerian-13)
dep(degeneration-11, degeneration-14)
nn(fibers-17, retinogeniculate-16)
prep_of(degeneration-14, fibers-17)
advmod(normal-21, clinically-20)
amod(dogs-22, normal-21)
prep_in(produced-8, dogs-22)
det(fashion-26, a-24)
amod(fashion-26, dose-dependent-25)
prep_in(produced-8, fashion-26)
det(dose-29, a-28)
prep_at(produced-8, dose-29)
nsubj(produced-31, dose-29)
rcmod(dose-29, produced-31)
nn(levels-34, plasma-32)
nn(levels-34, drug-33)
dobj(produced-31, levels-34)
quantmod(30-36, about-35)
num(times-37, 30-36)
npadvmod(higher-38, times-37)
amod(levels-34, higher-38)
det(level-43, the-40)
amod(level-43, mean-41)
nn(level-43, drug-42)
prep_than(higher-38, level-43)
prep_in(level-43, humans-45)
partmod(humans-45, taking-46)
det(dose-50, the-47)
amod(dose-50, highest-48)
amod(dose-50, recommended-49)
dobj(taking-46, dose-50)

Drugs/NNS which/WDT may/MD enhance/VB the/DT neuromuscular/JJ blocking/NN action/NN of/IN TRACRIUM/NN include/VBP :/: enflurane/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (JJ neuromuscular) (NN blocking) (NN action)) (PP (IN of) (NP (NN TRACRIUM))))))))) (VP (VBP include) (: :) (NP (NN enflurane))) (: ;)) (. .))))

nsubj(enhance-4, Drugs-1)
nsubj(include-11, Drugs-1)
aux(enhance-4, may-3)
rcmod(Drugs-1, enhance-4)
det(action-8, the-5)
amod(action-8, neuromuscular-6)
nn(action-8, blocking-7)
dobj(enhance-4, action-8)
prep_of(action-8, TRACRIUM-10)
root(ROOT-0, include-11)
dobj(include-11, enflurane-13)

isoflurane/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN isoflurane) (: ;)) (. .)))))

root(ROOT-0, isoflurane-1)

halothane/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN halothane) (: ;)) (. .)))))

root(ROOT-0, halothane-1)

certain/JJ antibiotics/NNS ,/, especially/RB the/DT aminoglycosides/NNS and/CC polymyxins/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NP (JJ certain) (NNS antibiotics)) (, ,) (ADVP (RB especially)) (NP (DT the) (NP (NNS aminoglycosides)) (CC and) (NP (NNS polymyxins)) (: ;)))) (. .))))

amod(antibiotics-2, certain-1)
root(ROOT-0, antibiotics-2)
advmod(antibiotics-2, especially-4)
dep(aminoglycosides-6, the-5)
dep(antibiotics-2, aminoglycosides-6)
conj_and(aminoglycosides-6, polymyxins-8)

lithium/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN lithium) (: ;)) (. .)))))

root(ROOT-0, lithium-1)

magnesium/NN salt/NN s/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NP (NN magnesium) (NN salt) (NN s)) (: ;)) (. .)))))

nn(s-3, magnesium-1)
nn(s-3, salt-2)
root(ROOT-0, s-3)

procainamide/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN procainamide) (: ;)) (. .)))))

root(ROOT-0, procainamide-1)

and/CC quinidine/NN ./.

(ROOT (S1 (S (S (CC and) (NP (NN quinidine))) (. .))))

cc(quinidine-2, and-1)
root(ROOT-0, quinidine-2)

If/IN other/JJ muscle/NN relaxants/NNS are/VBP used/VBN during/IN the/DT same/JJ procedure/NN ,/, the/DT possibility/NN of/IN a/DT synergistic/JJ or/NN antagonist/NN effect/NN should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (JJ other) (NN muscle) (NNS relaxants)) (VP (VBP are) (VP (VBN used) (PP (IN during) (NP (DT the) (JJ same) (NN procedure))))))) (, ,) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (DT a) (JJ synergistic) (NN or) (NN antagonist) (NN effect)))) (VP (MD should) (VP (VB be) (VP (VBN considered))))) (. .))))

mark(used-6, If-1)
amod(relaxants-4, other-2)
nn(relaxants-4, muscle-3)
nsubjpass(used-6, relaxants-4)
auxpass(used-6, are-5)
advcl(considered-22, used-6)
det(procedure-10, the-8)
amod(procedure-10, same-9)
prep_during(used-6, procedure-10)
det(possibility-13, the-12)
nsubjpass(considered-22, possibility-13)
det(effect-19, a-15)
amod(effect-19, synergistic-16)
nn(effect-19, or-17)
nn(effect-19, antagonist-18)
prep_of(possibility-13, effect-19)
aux(considered-22, should-20)
auxpass(considered-22, be-21)
root(ROOT-0, considered-22)

The/DT prior/JJ administration/NN of/IN succinylcholine/NN does/VBZ not/RB enhance/VB the/DT duration/NN ,/, but/CC quickens/VBZ the/DT onset/NN and/CC may/MD increase/VB the/DT depth/NN ,/, of/IN neuromuscular/JJ block/NN induced/VBN by/IN TRACRIUM/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ prior) (NN administration)) (PP (IN of) (NP (NN succinylcholine)))) (VP (VP (VBZ does) (RB not) (VP (VB enhance) (NP (DT the) (NN duration)))) (, ,) (CC but) (VP (VBZ quickens) (NP (DT the) (NN onset))) (CC and) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN depth)) (, ,) (PP (IN of) (NP (NP (JJ neuromuscular) (NN block)) (VP (VBN induced) (PP (IN by) (NP (NN TRACRIUM))))))))))) (. .))))

det(administration-3, The-1)
amod(administration-3, prior-2)
nsubj(enhance-8, administration-3)
prep_of(administration-3, succinylcholine-5)
aux(enhance-8, does-6)
neg(enhance-8, not-7)
root(ROOT-0, enhance-8)
det(duration-10, the-9)
dobj(enhance-8, duration-10)
conj_but(enhance-8, quickens-13)
det(onset-15, the-14)
dobj(quickens-13, onset-15)
aux(increase-18, may-17)
conj_and(enhance-8, increase-18)
det(depth-20, the-19)
dobj(increase-18, depth-20)
amod(block-24, neuromuscular-23)
prep_of(depth-20, block-24)
partmod(block-24, induced-25)
agent(induced-25, TRACRIUM-27)

TRACRIUM/NN should/MD not/RB be/VB administered/VBN until/IN a/DT patient/NN has/VBZ recovered/VBN from/IN succinylcholine/NN -induced/JJ neuromuscular/JJ block/NN ./.

(ROOT (S1 (S (S (NP (NN TRACRIUM)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (SBAR (IN until) (S (NP (DT a) (NN patient)) (VP (VBZ has) (VP (VBN recovered) (PP (IN from) (NP (NN succinylcholine) (JJ -induced) (JJ neuromuscular) (NN block))))))))))) (. .))))

nsubjpass(administered-5, TRACRIUM-1)
aux(administered-5, should-2)
neg(administered-5, not-3)
auxpass(administered-5, be-4)
root(ROOT-0, administered-5)
mark(recovered-10, until-6)
det(patient-8, a-7)
nsubj(recovered-10, patient-8)
aux(recovered-10, has-9)
advcl(administered-5, recovered-10)
nn(block-15, succinylcholine-12)
amod(block-15, -induced-13)
amod(block-15, neuromuscular-14)
prep_from(recovered-10, block-15)

Auranofin/NN should/MD be/VB avoided/VBN by/IN patients/NNS with/IN a/DT history/NN of/IN serious/JJ reaction/NN to/TO any/DT gold/JJ medication/NN ,/, including/VBG Solganal/NN and/CC Myochrysine/NN ./.

(ROOT (S1 (S (S (NP (NN Auranofin)) (VP (MD should) (VP (VB be) (VP (VBN avoided) (PP (IN by) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (JJ serious) (NN reaction))) (PP (TO to) (NP (NP (DT any) (JJ gold) (NN medication)) (, ,) (PP (VBG including) (NP (NP (NN Solganal)) (CC and) (NP (NN Myochrysine)))))))))))))) (. .))))

nsubjpass(avoided-4, Auranofin-1)
aux(avoided-4, should-2)
auxpass(avoided-4, be-3)
root(ROOT-0, avoided-4)
agent(avoided-4, patients-6)
det(history-9, a-8)
prep_with(patients-6, history-9)
amod(reaction-12, serious-11)
prep_of(history-9, reaction-12)
det(medication-16, any-14)
amod(medication-16, gold-15)
prep_to(history-9, medication-16)
prep_including(medication-16, Solganal-19)
conj_and(Solganal-19, Myochrysine-21)

Auranofin/NN should/MD not/RB be/VB used/VBN together/RB with/IN penicillamine/NN (/-LRB- Depen/NNP ,/, Cuprimine/NNP )/-RRB- ,/, another/DT arthritis/NN medication/NN ./.

(ROOT (S1 (S (S (NP (NN Auranofin)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (ADVP (RB together)) (PP (IN with) (NP (NP (NP (NN penicillamine)) (PRN (-LRB- -LRB-) (NP (NNP Depen) (, ,) (NNP Cuprimine)) (-RRB- -RRB-))) (, ,) (NP (DT another) (NN arthritis) (NN medication)))))))) (. .))))

nsubjpass(used-5, Auranofin-1)
aux(used-5, should-2)
neg(used-5, not-3)
auxpass(used-5, be-4)
root(ROOT-0, used-5)
prep_together_with(used-5, penicillamine-8)
nn(Cuprimine-12, Depen-10)
appos(penicillamine-8, Cuprimine-12)
det(medication-17, another-15)
nn(medication-17, arthritis-16)
appos(penicillamine-8, medication-17)

It/PRP should/MD also/RB be/VB avoided/VBN in/IN patients/NNS with/IN blood/NN ,/, liver/NN or/CC kidney/NN diseases/NNS ,/, recent/JJ radiation/NN treatment/NN ,/, or/CC uncontrolled/JJ diabetes/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (MD should) (ADVP (RB also)) (VP (VB be) (VP (VBN avoided) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN blood)) (, ,) (NP (NN liver)) (CC or) (NP (NN kidney) (NNS diseases)) (, ,) (NP (JJ recent) (NN radiation) (NN treatment)) (, ,) (CC or) (NP (JJ uncontrolled) (NN diabetes)))))))))) (. .))))

nsubjpass(avoided-5, It-1)
aux(avoided-5, should-2)
advmod(avoided-5, also-3)
auxpass(avoided-5, be-4)
root(ROOT-0, avoided-5)
prep_in(avoided-5, patients-7)
prep_with(patients-7, blood-9)
conj_or(blood-9, liver-11)
nn(diseases-14, kidney-13)
conj_or(blood-9, diseases-14)
amod(treatment-18, recent-16)
nn(treatment-18, radiation-17)
conj_or(blood-9, treatment-18)
amod(diabetes-22, uncontrolled-21)
conj_or(blood-9, diabetes-22)

Patients/NNS should/MD report/VBP to/TO their/PRP$ practitioners/NNS any/DT new/JJ rashes/NN ,/, itching/NN ,/, mouth/NN sores/NNS ,/, or/CC unusual/JJ taste/NN while/IN taking/VBG auranofin/NN ./.

(ROOT (S1 (S (S (NP (NNS Patients)) (VP (MD should) (VP (VBP report) (PP (TO to) (NP (NP (PRP$ their) (NNS practitioners)) (NP (NP (DT any) (JJ new) (NN rashes)) (, ,) (NP (NN itching)) (, ,) (NP (NN mouth) (NNS sores)) (, ,) (CC or) (NP (JJ unusual) (NN taste)))))) (SBAR (IN while) (S (VP (VBG taking) (NP (NN auranofin))))))) (. .))))

nsubj(report-3, Patients-1)
aux(report-3, should-2)
root(ROOT-0, report-3)
poss(practitioners-6, their-5)
prep_to(report-3, practitioners-6)
det(rashes-9, any-7)
amod(rashes-9, new-8)
dep(practitioners-6, rashes-9)
conj_or(rashes-9, itching-11)
nn(sores-14, mouth-13)
conj_or(rashes-9, sores-14)
amod(taste-18, unusual-17)
conj_or(rashes-9, taste-18)
mark(taking-20, while-19)
advcl(report-3, taking-20)
dobj(taking-20, auranofin-21)

Gold/NN is/VBZ excreted/VBN slowly/RB from/IN the/DT body/NN ./.

(ROOT (S1 (S (S (NP (NN Gold)) (VP (VBZ is) (VP (VBN excreted) (ADVP (RB slowly)) (PP (IN from) (NP (DT the) (NN body)))))) (. .))))

nsubjpass(excreted-3, Gold-1)
auxpass(excreted-3, is-2)
root(ROOT-0, excreted-3)
advmod(excreted-3, slowly-4)
det(body-7, the-6)
prep_from(excreted-3, body-7)

No/DT formal/JJ assessments/NNS of/IN drug-drug/JJ interactions/NNS between/IN Vidaza/NN and/CC other/JJ agents/NNS have/VBP been/VBN conducted/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (JJ formal) (NNS assessments)) (PP (IN of) (NP (NP (JJ drug-drug) (NNS interactions)) (PP (IN between) (NP (NP (NN Vidaza)) (CC and) (NP (JJ other) (NNS agents))))))) (VP (VBP have) (VP (VBN been) (VP (VBN conducted))))) (. .))))

det(assessments-3, No-1)
amod(assessments-3, formal-2)
nsubjpass(conducted-14, assessments-3)
amod(interactions-6, drug-drug-5)
prep_of(assessments-3, interactions-6)
prep_between(interactions-6, Vidaza-8)
amod(agents-11, other-10)
conj_and(Vidaza-8, agents-11)
aux(conducted-14, have-12)
auxpass(conducted-14, been-13)
root(ROOT-0, conducted-14)

MAO/NN inhibitors/NNS prolong/VBP and/CC intensify/VB the/DT effects/NNS of/IN antihistamines/NNS ./.

(ROOT (S1 (S (S (NP (NN MAO) (NNS inhibitors)) (VP (VP (VBP prolong)) (CC and) (VP (VB intensify) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NNS antihistamines))))))) (. .))))

nn(inhibitors-2, MAO-1)
nsubj(prolong-3, inhibitors-2)
root(ROOT-0, prolong-3)
conj_and(prolong-3, intensify-5)
det(effects-7, the-6)
dobj(intensify-5, effects-7)
prep_of(effects-7, antihistamines-9)

Concomitant/JJ use/NN of/IN antihistamines/NNS with/IN alcohol/NN ,/, tricyclic/JJ antidepressants/NNS ,/, barbiturates/NNS ,/, or/CC other/JJ central/JJ nervous/JJ system/NN depressants/NNS may/MD have/VB an/DT additive/JJ effect/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (NP (NNS antihistamines)) (PP (IN with) (NP (NN alcohol)))) (, ,) (NP (JJ tricyclic) (NNS antidepressants)) (, ,) (NP (NNS barbiturates)) (, ,) (CC or) (NP (JJ other) (NP (JJ central) (JJ nervous) (NN system)) (NNS depressants))))) (VP (MD may) (VP (VB have) (NP (DT an) (JJ additive) (NN effect))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(have-20, use-2)
prep_of(use-2, antihistamines-4)
prep_with(antihistamines-4, alcohol-6)
amod(antidepressants-9, tricyclic-8)
conj_or(antihistamines-4, antidepressants-9)
conj_or(antihistamines-4, barbiturates-11)
amod(depressants-18, other-14)
amod(system-17, central-15)
amod(system-17, nervous-16)
nn(depressants-18, system-17)
conj_or(antihistamines-4, depressants-18)
aux(have-20, may-19)
root(ROOT-0, have-20)
det(effect-23, an-21)
amod(effect-23, additive-22)
dobj(have-20, effect-23)

When/WRB sympathomimetic/JJ drugs/NNS are/VBP given/VBN to/TO patients/NNS receiving/VBG monoamine/NN oxidase/NN inhibitors/NNS ,/, hypertensive/JJ reactions/NNS ,/, including/VBG hypertensive/JJ crises/NNS ,/, may/MD occur/VB ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ sympathomimetic) (NNS drugs)) (VP (VBP are) (VP (VBN given) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN monoamine) (NN oxidase) (NNS inhibitors))))))))) (, ,) (NP (NP (JJ hypertensive) (NNS reactions)) (, ,) (PP (VBG including) (NP (JJ hypertensive) (NNS crises))) (, ,)) (VP (MD may) (VP (VB occur)))) (. .))))

advmod(given-5, When-1)
amod(drugs-3, sympathomimetic-2)
nsubjpass(given-5, drugs-3)
auxpass(given-5, are-4)
advcl(occur-21, given-5)
prep_to(given-5, patients-7)
partmod(patients-7, receiving-8)
nn(inhibitors-11, monoamine-9)
nn(inhibitors-11, oxidase-10)
dobj(receiving-8, inhibitors-11)
amod(reactions-14, hypertensive-13)
nsubj(occur-21, reactions-14)
amod(crises-18, hypertensive-17)
prep_including(reactions-14, crises-18)
aux(occur-21, may-20)
root(ROOT-0, occur-21)

The/DT antihypertensive/JJ effects/NNS of/IN methyldopa/NN ,/, mecamylamine/NN ,/, reserpine/NN ,/, and/CC veratrum/NN alkaloids/NNS may/MD be/VB reduced/VBN by/IN sympathomimetics/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ antihypertensive) (NNS effects)) (PP (IN of) (NP (NP (NN methyldopa)) (, ,) (NP (NN mecamylamine)) (, ,) (NP (NN reserpine)) (, ,) (CC and) (NP (NN veratrum)) (NP (NNS alkaloids))))) (VP (MD may) (VP (VB be) (VP (VBN reduced) (PP (IN by) (NP (NN sympathomimetics))))))) (. .))))

det(effects-3, The-1)
amod(effects-3, antihypertensive-2)
nsubjpass(reduced-16, effects-3)
prep_of(effects-3, methyldopa-5)
conj_and(methyldopa-5, mecamylamine-7)
conj_and(methyldopa-5, reserpine-9)
conj_and(methyldopa-5, veratrum-12)
dep(methyldopa-5, alkaloids-13)
aux(reduced-16, may-14)
auxpass(reduced-16, be-15)
root(ROOT-0, reduced-16)
agent(reduced-16, sympathomimetics-18)

Beta-adrenergic/JJ blocking/NN agents/NNS may/MD also/RB interact/VB with/IN sympathomimetics/NN ./.

(ROOT (S1 (S (S (NP (JJ Beta-adrenergic) (NN blocking) (NNS agents)) (VP (MD may) (ADVP (RB also)) (VP (VB interact) (PP (IN with) (NP (NN sympathomimetics)))))) (. .))))

amod(agents-3, Beta-adrenergic-1)
nn(agents-3, blocking-2)
nsubj(interact-6, agents-3)
aux(interact-6, may-4)
advmod(interact-6, also-5)
root(ROOT-0, interact-6)
prep_with(interact-6, sympathomimetics-8)

Increased/VBN ectopic/JJ pacemaker/NN activity/NN can/MD occur/VB when/WRB pseudoephedrine/NN is/VBZ used/VBN concomitantly/RB with/IN digitalis/NN ./.

(ROOT (S1 (S (S (NP (VBN Increased) (JJ ectopic) (NN pacemaker) (NN activity)) (VP (MD can) (VP (VB occur) (SBAR (WHADVP (WRB when)) (S (NP (NN pseudoephedrine)) (VP (VBZ is) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN digitalis)))))))))) (. .))))

amod(activity-4, Increased-1)
amod(activity-4, ectopic-2)
nn(activity-4, pacemaker-3)
nsubj(occur-6, activity-4)
aux(occur-6, can-5)
root(ROOT-0, occur-6)
advmod(used-10, when-7)
nsubjpass(used-10, pseudoephedrine-8)
auxpass(used-10, is-9)
advcl(occur-6, used-10)
advmod(used-10, concomitantly-11)
prep_with(used-10, digitalis-13)

Antacids/NNS increase/VBP the/DT rate/NN of/IN absorption/NN of/IN pseudoephedrine/NN ,/, while/IN kaolin/NN decreases/VBZ it/PRP ./.

(ROOT (S1 (S (S (NP (NNS Antacids)) (VP (VBP increase) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NP (NN absorption)) (PP (IN of) (NP (NN pseudoephedrine)))))) (, ,) (SBAR (IN while) (S (NP (NN kaolin)) (VP (VBZ decreases) (NP (PRP it))))))) (. .))))

nsubj(increase-2, Antacids-1)
root(ROOT-0, increase-2)
det(rate-4, the-3)
dobj(increase-2, rate-4)
prep_of(rate-4, absorption-6)
prep_of(absorption-6, pseudoephedrine-8)
mark(decreases-12, while-10)
nsubj(decreases-12, kaolin-11)
advcl(increase-2, decreases-12)
dobj(decreases-12, it-13)

Use/NN with/IN Allopurinol/NN :/: The/DT principal/JJ pathway/NN for/IN detoxification/NN of/IN azathioprine/NN is/VBZ inhibited/VBN by/IN allopurinol/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Use)) (PP (IN with) (NP (NN Allopurinol)))) (: :) (NP (NP (DT The) (JJ principal) (NN pathway)) (PP (IN for) (NP (NP (NN detoxification)) (PP (IN of) (NP (NN azathioprine)))))) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NN allopurinol)))))) (. .))))

nsubjpass(inhibited-13, Use-1)
prep_with(Use-1, Allopurinol-3)
det(pathway-7, The-5)
amod(pathway-7, principal-6)
nsubjpass(inhibited-13, pathway-7)
prep_for(pathway-7, detoxification-9)
prep_of(detoxification-9, azathioprine-11)
auxpass(inhibited-13, is-12)
root(ROOT-0, inhibited-13)
agent(inhibited-13, allopurinol-15)

Patients/NNS receiving/VBG azathioprine/NN and/CC allopurinol/NN concomitantly/RB should/MD have/VB a/DT dose/NN reduction/NN of/IN azathioprine/NN ,/, to/TO approximately/RB 1/3/CD to/TO 1/4/CD the/DT usual/JJ dose/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (NP (NP (NN azathioprine)) (CC and) (NP (NN allopurinol))) (ADVP (RB concomitantly))))) (VP (MD should) (VP (VB have) (NP (NP (DT a) (NN dose) (NN reduction)) (PP (IN of) (NP (NN azathioprine)))) (, ,) (PP (TO to) (NP (QP (RB approximately) (CD 1/3) (TO to) (CD 1/4)) (NP (DT the) (JJ usual) (NN dose))))))) (. .))))

nsubj(have-8, Patients-1)
partmod(Patients-1, receiving-2)
dobj(receiving-2, azathioprine-3)
conj_and(azathioprine-3, allopurinol-5)
advmod(azathioprine-3, concomitantly-6)
aux(have-8, should-7)
root(ROOT-0, have-8)
det(reduction-11, a-9)
nn(reduction-11, dose-10)
dobj(have-8, reduction-11)
prep_of(reduction-11, azathioprine-13)
quantmod(1/4-19, approximately-16)
number(1/4-19, 1/3-17)
dep(1/4-19, to-18)
num(dose-22, 1/4-19)
det(dose-22, the-20)
amod(dose-22, usual-21)
prep_to(have-8, dose-22)

Use/NN with/IN Other/JJ Agents/NNS Affecting/VBG Myelopoesis/NN :/: Drugs/NNS which/WDT may/MD affect/VB leukocyte/NN production/NN ,/, including/VBG co-trimoxazole/NN ,/, may/MD lead/VB to/TO exaggerated/JJ leukopenia/NN ,/, especially/RB in/IN renal/JJ transplant/NN recipients/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NN Use)) (PP (IN with) (NP (NP (JJ Other) (NNS Agents)) (VP (VBG Affecting) (NP (NN Myelopoesis)))))) (: :) (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB affect) (NP (NN leukocyte) (NN production)))))) (, ,) (PP (VBG including) (NP (NN co-trimoxazole))) (, ,)) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (JJ exaggerated) (NN leukopenia))) (, ,) (PP (ADVP (RB especially)) (IN in) (NP (JJ renal) (NN transplant) (NNS recipients)))))) (. .)))))

root(ROOT-0, Use-1)
amod(Agents-4, Other-3)
prep_with(Use-1, Agents-4)
partmod(Agents-4, Affecting-5)
dobj(Affecting-5, Myelopoesis-6)
nsubj(affect-11, Drugs-8)
nsubj(lead-19, Drugs-8)
aux(affect-11, may-10)
rcmod(Drugs-8, affect-11)
nn(production-13, leukocyte-12)
dobj(affect-11, production-13)
prep_including(Drugs-8, co-trimoxazole-16)
aux(lead-19, may-18)
dep(Use-1, lead-19)
amod(leukopenia-22, exaggerated-21)
prep_to(lead-19, leukopenia-22)
advmod(lead-19, especially-24)
amod(recipients-28, renal-26)
nn(recipients-28, transplant-27)
prep_in(lead-19, recipients-28)

Use/NN with/IN Angiotensln/NN Converting/NN Enzyme/NN Inhibitors/NNS :/: The/DT use/NN of/IN angiotensin/NN converting/NN enzyme/NN inhibitors/NNS to/TO control/VB hypertension/NN in/IN patients/NNS on/IN azathioprine/NN has/VBZ been/VBN reported/VBN to/TO induce/VB severe/JJ leukopenia/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Use)) (PP (IN with) (NP (NP (NN Angiotensln) (NN Converting) (NN Enzyme) (NNS Inhibitors)) (: :) (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NN angiotensin) (NN converting) (NN enzyme) (NNS inhibitors)))) (VP (TO to) (VP (VB control) (NP (NP (NN hypertension)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN on) (NP (NN azathioprine)))))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB induce) (NP (JJ severe) (NN leukopenia))))))))) (. .))))

nsubjpass(reported-24, Use-1)
xsubj(induce-26, Use-1)
nn(Inhibitors-6, Angiotensln-3)
nn(Inhibitors-6, Converting-4)
nn(Inhibitors-6, Enzyme-5)
prep_with(Use-1, Inhibitors-6)
det(use-9, The-8)
nsubj(control-16, use-9)
nn(inhibitors-14, angiotensin-11)
nn(inhibitors-14, converting-12)
nn(inhibitors-14, enzyme-13)
prep_of(use-9, inhibitors-14)
aux(control-16, to-15)
infmod(Inhibitors-6, control-16)
dobj(control-16, hypertension-17)
prep_in(hypertension-17, patients-19)
prep_on(patients-19, azathioprine-21)
aux(reported-24, has-22)
auxpass(reported-24, been-23)
root(ROOT-0, reported-24)
aux(induce-26, to-25)
xcomp(reported-24, induce-26)
amod(leukopenia-28, severe-27)
dobj(induce-26, leukopenia-28)

No/DT drug/NN interaction/NN studies/NNS have/VBP been/VBN conducted/VBN for/IN COLAZAL/NN ,/, however/RB the/DT use/NN of/IN orally/RB administered/VBN antibiotics/NNS could/MD ,/, theoretically/RB ,/, interfere/VB with/IN the/DT release/NN of/IN mesalamine/NN in/IN the/DT colon/NN ./.

(ROOT (S1 (S (S (S (NP (DT No) (NN drug) (NN interaction) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN conducted) (PP (IN for) (NP (NN COLAZAL))))))) (, ,) (ADVP (RB however)) (S (NP (NP (DT the) (NN use)) (PP (IN of) (NP (ADJP (RB orally) (VBN administered)) (NNS antibiotics)))) (VP (MD could) (, ,) (ADVP (RB theoretically)) (, ,) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (NN mesalamine))) (PP (IN in) (NP (DT the) (NN colon))))))))) (. .))))

det(studies-4, No-1)
nn(studies-4, drug-2)
nn(studies-4, interaction-3)
nsubjpass(conducted-7, studies-4)
aux(conducted-7, have-5)
auxpass(conducted-7, been-6)
root(ROOT-0, conducted-7)
prep_for(conducted-7, COLAZAL-9)
advmod(conducted-7, however-11)
det(use-13, the-12)
nsubj(interfere-22, use-13)
advmod(administered-16, orally-15)
amod(antibiotics-17, administered-16)
prep_of(use-13, antibiotics-17)
aux(interfere-22, could-18)
advmod(interfere-22, theoretically-20)
dep(conducted-7, interfere-22)
det(release-25, the-24)
prep_with(interfere-22, release-25)
prep_of(release-25, mesalamine-27)
det(colon-30, the-29)
prep_in(release-25, colon-30)

No/DT dose/NN adjustment/NN is/VBZ necessary/JJ when/WRB Simulect/NN @/NN is/VBZ added/VBN to/TO triple-immunosuppression/JJ regimens/NNS including/VBG cyclosporine/NN ,/, corticosteroids/NNS ,/, and/CC either/RB azathioprine/NN or/CC mycophenolate/NN mofetil/NN ./.

(ROOT (S1 (S (NP (DT No) (NN dose) (NN adjustment)) (VP (VBZ is) (ADJP (JJ necessary)) (SBAR (WHADVP (WRB when)) (S (NP (NN Simulect) (NN @)) (VP (VBZ is) (VP (VBN added) (PP (TO to) (NP (NP (JJ triple-immunosuppression) (NNS regimens)) (PP (VBG including) (NP (NP (NN cyclosporine)) (, ,) (NP (NNS corticosteroids)) (, ,) (CC and) (RB either) (NP (NN azathioprine)) (CC or) (NP (NN mycophenolate)) (NP (NN mofetil))))))))))) (. .))))

det(adjustment-3, No-1)
nn(adjustment-3, dose-2)
nsubj(necessary-5, adjustment-3)
cop(necessary-5, is-4)
root(ROOT-0, necessary-5)
advmod(added-10, when-6)
nn(@-8, Simulect-7)
nsubjpass(added-10, @-8)
auxpass(added-10, is-9)
advcl(necessary-5, added-10)
amod(regimens-13, triple-immunosuppression-12)
prep_to(added-10, regimens-13)
prep_including(regimens-13, cyclosporine-15)
conj_and(cyclosporine-15, corticosteroids-17)
advmod(cyclosporine-15, either-20)
conj_and(cyclosporine-15, either-20)
dep(cyclosporine-15, azathioprine-21)
conj_or(cyclosporine-15, mycophenolate-23)
dep(cyclosporine-15, mofetil-24)

Total/JJ body/NN clearance/NN of/IN Simulect/NN @/NN was/VBD reduced/VBN by/IN an/DT average/JJ 22/CD %/NN and/CC 51/CD %/NN when/WRB azathioprine/NN and/CC mycophenolate/NN mofetil/NN ,/, respectively/RB ,/, were/VBD added/VBN to/TO a/DT regimen/NN consisting/VBG of/IN cyclosporine/NN ,/, USP/NN (/-LRB- MODIFIED/JJ )/-RRB- and/CC corticosteroids/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Total) (NN body) (NN clearance)) (PP (IN of) (NP (NN Simulect) (NN @)))) (VP (VBD was) (VP (VBN reduced) (PP (IN by) (NP (NP (DT an) (JJ average) (CD 22) (NN %)) (CC and) (NP (CD 51) (NN %)))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN azathioprine)) (CC and) (NP (NP (NN mycophenolate) (NN mofetil)) (, ,) (ADVP (RB respectively)) (, ,))) (VP (VBD were) (VP (VBN added) (PP (TO to) (NP (NP (DT a) (NN regimen)) (VP (VBG consisting) (PP (IN of) (NP (NP (NN cyclosporine)) (, ,) (NP (NP (NN USP)) (PRN (-LRB- -LRB-) (NP (JJ MODIFIED)) (-RRB- -RRB-))) (CC and) (NP (NNS corticosteroids)))))))))))))) (. .))))

amod(clearance-3, Total-1)
nn(clearance-3, body-2)
nsubjpass(reduced-8, clearance-3)
nn(@-6, Simulect-5)
prep_of(clearance-3, @-6)
auxpass(reduced-8, was-7)
root(ROOT-0, reduced-8)
det(%-13, an-10)
amod(%-13, average-11)
num(%-13, 22-12)
agent(reduced-8, %-13)
num(%-16, 51-15)
conj_and(%-13, %-16)
advmod(added-26, when-17)
nsubjpass(added-26, azathioprine-18)
nn(mofetil-21, mycophenolate-20)
conj_and(azathioprine-18, mofetil-21)
advmod(mofetil-21, respectively-23)
auxpass(added-26, were-25)
advcl(reduced-8, added-26)
det(regimen-29, a-28)
prep_to(added-26, regimen-29)
partmod(regimen-29, consisting-30)
prep_of(consisting-30, cyclosporine-32)
conj_and(cyclosporine-32, USP-34)
dep(USP-34, MODIFIED-36)
conj_and(cyclosporine-32, corticosteroids-39)

Nonetheless/RB ,/, the/DT range/NN of/IN individual/JJ Simulect/NN @/NN clearance/NN values/NNS in/IN the/DT presence/NN of/IN azathioprine/NN (/-LRB- 12-57/CD mL/h/NN )/-RRB- or/CC mycophenolate/NN mofetil/NN (/-LRB- 7-54/CD mL/h/NN )/-RRB- did/VBD not/RB extend/VB outside/IN the/DT range/NN observed/VBN with/IN dual/JJ therapy/NN (/-LRB- 10-78/CD mL/h/NN )./CD

(ROOT (S1 (S (ADVP (RB Nonetheless)) (, ,) (NP (NP (DT the) (NN range)) (PP (IN of) (NP (NP (JJ individual) (NN Simulect) (NN @) (NN clearance) (NNS values)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NP (NN azathioprine)) (PRN (-LRB- -LRB-) (NP (CD 12-57) (NN mL/h)) (-RRB- -RRB-))) (CC or) (NP (NP (NN mycophenolate) (NN mofetil)) (PRN (-LRB- -LRB-) (NP (CD 7-54) (NN mL/h)) (-RRB- -RRB-)))))))))) (VP (VBD did) (RB not) (VP (VB extend) (PP (IN outside) (NP (NP (DT the) (NN range)) (VP (VBN observed) (PP (IN with) (NP (NP (JJ dual) (NN therapy)) (PRN (-LRB- -LRB-) (NP (CD 10-78) (NN mL/h) (CD -RRB-.)))))))))))))

advmod(extend-29, Nonetheless-1)
det(range-4, the-3)
nsubj(extend-29, range-4)
amod(values-10, individual-6)
nn(values-10, Simulect-7)
nn(values-10, @-8)
nn(values-10, clearance-9)
prep_of(range-4, values-10)
det(presence-13, the-12)
prep_in(values-10, presence-13)
prep_of(presence-13, azathioprine-15)
num(mL/h-18, 12-57-17)
appos(azathioprine-15, mL/h-18)
nn(mofetil-22, mycophenolate-21)
conj_or(azathioprine-15, mofetil-22)
num(mL/h-25, 7-54-24)
appos(mofetil-22, mL/h-25)
aux(extend-29, did-27)
neg(extend-29, not-28)
root(ROOT-0, extend-29)
det(range-32, the-31)
prep_outside(extend-29, range-32)
partmod(range-32, observed-33)
amod(therapy-36, dual-35)
prep_with(observed-33, therapy-36)
num(mL/h-39, 10-78-38)
dep(therapy-36, mL/h-39)
num(mL/h-39, -RRB-.-40)

The/DT following/JJ medications/NNS have/VBP been/VBN administered/VBN in/IN clinical/JJ trials/NNS with/IN Simulect/NN @/NN with/IN no/DT increase/NN in/IN adverse/JJ reactions/NNS :/: ATG/NN /ALG/NN ,/, azathioprine/NN ,/, corticosteroids/NNS ,/, cyclosporine/NN ,/, mycophenolate/NN mofetil/NN ,/, and/CC muromonab-CD3/NN ./.

(ROOT (S1 (S (S (NP (DT The) (JJ following) (NNS medications)) (VP (VBP have) (VP (VBN been) (VP (VBN administered) (PP (IN in) (NP (NP (NP (JJ clinical) (NNS trials)) (PP (IN with) (NP (NP (NN Simulect) (NN @)) (PP (IN with) (NP (NP (DT no) (NN increase)) (PP (IN in) (NP (JJ adverse) (NNS reactions)))))))) (: :) (NP (NP (NN ATG) (NN /ALG)) (, ,) (NP (NN azathioprine)) (, ,) (NP (NNS corticosteroids)) (, ,) (NP (NN cyclosporine)) (, ,) (NP (NN mycophenolate) (NN mofetil)) (, ,) (CC and) (NP (NN muromonab-CD3))))))))) (. .))))

det(medications-3, The-1)
amod(medications-3, following-2)
nsubjpass(administered-6, medications-3)
aux(administered-6, have-4)
auxpass(administered-6, been-5)
root(ROOT-0, administered-6)
amod(trials-9, clinical-8)
prep_in(administered-6, trials-9)
nn(@-12, Simulect-11)
prep_with(trials-9, @-12)
det(increase-15, no-14)
prep_with(@-12, increase-15)
amod(reactions-18, adverse-17)
prep_in(increase-15, reactions-18)
nn(/ALG-21, ATG-20)
dep(trials-9, /ALG-21)
conj_and(/ALG-21, azathioprine-23)
conj_and(/ALG-21, corticosteroids-25)
conj_and(/ALG-21, cyclosporine-27)
nn(mofetil-30, mycophenolate-29)
conj_and(/ALG-21, mofetil-30)
conj_and(/ALG-21, muromonab-CD3-33)

It/PRP is/VBZ not/RB known/VBN if/IN REGRANEX/NN Gel/NN interacts/VBZ with/IN other/JJ topical/JJ medications/NNS applied/VBN to/TO the/DT ulcer/NN site/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (IN if) (S (NP (NN REGRANEX) (NN Gel)) (VP (VBZ interacts) (PP (IN with) (NP (NP (JJ other) (JJ topical) (NNS medications)) (VP (VBN applied) (PP (TO to) (NP (DT the) (NN ulcer) (NN site)))))))))))) (. .))))

nsubjpass(known-4, It-1)
auxpass(known-4, is-2)
neg(known-4, not-3)
root(ROOT-0, known-4)
mark(interacts-8, if-5)
nn(Gel-7, REGRANEX-6)
nsubj(interacts-8, Gel-7)
advcl(known-4, interacts-8)
amod(medications-12, other-10)
amod(medications-12, topical-11)
prep_with(interacts-8, medications-12)
partmod(medications-12, applied-13)
det(site-17, the-15)
nn(site-17, ulcer-16)
prep_to(applied-13, site-17)

The/DT use/NN of/IN REGRANEX/NN Gel/NN with/IN other/JJ topical/JJ drugs/NNS has/VBZ not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NP (NN REGRANEX) (NN Gel)) (PP (IN with) (NP (JJ other) (JJ topical) (NNS drugs)))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

det(use-2, The-1)
nsubjpass(studied-13, use-2)
nn(Gel-5, REGRANEX-4)
prep_of(use-2, Gel-5)
amod(drugs-9, other-7)
amod(drugs-9, topical-8)
prep_with(Gel-5, drugs-9)
aux(studied-13, has-10)
neg(studied-13, not-11)
auxpass(studied-13, been-12)
root(ROOT-0, studied-13)

Albuterol/NN ,/, Antihistamines/NNS ,/, antidiabetic/JJ drugs/NNS ,/, diuretics/NN ,/, digitalis/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Albuterol)) (, ,) (NP (NNS Antihistamines)) (, ,) (NP (JJ antidiabetic) (NNS drugs)) (, ,) (NP (NN diuretics)) (, ,)) (NP (NN digitalis))) (. .))))

dep(digitalis-10, Albuterol-1)
appos(Albuterol-1, Antihistamines-3)
amod(drugs-6, antidiabetic-5)
appos(Albuterol-1, drugs-6)
appos(Albuterol-1, diuretics-8)
root(ROOT-0, digitalis-10)

Diuretics/NN Patients/NNS on/IN diuretics/NN ,/, especially/RB those/DT in/IN whom/WP diuretic/JJ therapy/NN was/VBD recently/RB instituted/VBN ,/, may/MD occasionally/RB experience/VBP an/DT excessive/JJ reduction/NN of/IN blood/NN pressure/NN after/IN initiation/NN of/IN therapy/NN with/IN Lotensin/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Diuretics) (NNS Patients)) (PP (IN on) (NP (NN diuretics)))) (, ,) (ADVP (RB especially)) (NP (NP (DT those)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (JJ diuretic) (NN therapy)) (VP (VBD was) (ADVP (RB recently)) (VP (VBN instituted)))))) (, ,)) (VP (MD may) (ADVP (RB occasionally)) (VP (VBP experience) (NP (NP (DT an) (JJ excessive) (NN reduction)) (PP (IN of) (NP (NP (NN blood) (NN pressure)) (PP (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (NP (NN therapy)) (PP (IN with) (NP (NN Lotensin))))))))))))) (. .))))

nn(Patients-2, Diuretics-1)
nsubj(experience-18, Patients-2)
prep_on(Patients-2, diuretics-4)
advmod(Patients-2, especially-6)
dep(Patients-2, those-7)
rel(instituted-14, whom-9)
amod(therapy-11, diuretic-10)
nsubjpass(instituted-14, therapy-11)
auxpass(instituted-14, was-12)
advmod(instituted-14, recently-13)
rcmod(those-7, instituted-14)
aux(experience-18, may-16)
advmod(experience-18, occasionally-17)
root(ROOT-0, experience-18)
det(reduction-21, an-19)
amod(reduction-21, excessive-20)
dobj(experience-18, reduction-21)
nn(pressure-24, blood-23)
prep_of(reduction-21, pressure-24)
prep_after(pressure-24, initiation-26)
prep_of(initiation-26, therapy-28)
prep_with(therapy-28, Lotensin-30)

The/DT possibility/NN of/IN hypotensive/JJ effects/NNS with/IN Lotensin/NN can/MD be/VB minimized/VBN by/IN either/CC discontinuing/VBG the/DT diuretic/JJ or/CC increasing/VBG the/DT salt/NN intake/NN prior/RB to/TO initiation/NN of/IN treatment/NN with/IN Lotensin/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN possibility)) (PP (IN of) (NP (NP (JJ hypotensive) (NNS effects)) (PP (IN with) (NP (NN Lotensin)))))) (VP (MD can) (VP (VB be) (VP (VBN minimized) (PP (IN by) (S (VP (CC either) (VP (VBG discontinuing) (NP (DT the) (JJ diuretic))) (CC or) (VP (VBG increasing) (NP (NP (DT the) (NN salt) (NN intake)) (ADVP (ADVP (RB prior)) (PP (TO to) (NP (NP (NN initiation)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN with) (NP (NN Lotensin))))))))))))))))) (. .))))

det(possibility-2, The-1)
nsubjpass(minimized-10, possibility-2)
amod(effects-5, hypotensive-4)
prep_of(possibility-2, effects-5)
prep_with(effects-5, Lotensin-7)
aux(minimized-10, can-8)
auxpass(minimized-10, be-9)
root(ROOT-0, minimized-10)
preconj(discontinuing-13, either-12)
agent(minimized-10, discontinuing-13)
det(diuretic-15, the-14)
dobj(discontinuing-13, diuretic-15)
conj_or(discontinuing-13, increasing-17)
det(intake-20, the-18)
nn(intake-20, salt-19)
dobj(increasing-17, intake-20)
prep_prior_to(intake-20, initiation-23)
prep_of(initiation-23, treatment-25)
prep_with(treatment-25, Lotensin-27)

Potassium/NN Supplement/NN s/NNS and/CC Potassium-Sparing/JJ Diuretics/NN Lotensin/NN can/MD attenuate/VB potassium/NN loss/NN caused/VBN by/IN thiazide/NN diuretics/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Potassium) (NN Supplement) (NNS s)) (CC and) (NP (JJ Potassium-Sparing) (NN Diuretics) (NN Lotensin))) (VP (MD can) (VP (VB attenuate) (NP (NP (NN potassium) (NN loss)) (VP (VBN caused) (PP (IN by) (NP (NN thiazide) (NNS diuretics)))))))) (. .))))

nn(s-3, Potassium-1)
nn(s-3, Supplement-2)
nsubj(attenuate-9, s-3)
amod(Lotensin-7, Potassium-Sparing-5)
nn(Lotensin-7, Diuretics-6)
conj_and(s-3, Lotensin-7)
aux(attenuate-9, can-8)
root(ROOT-0, attenuate-9)
nn(loss-11, potassium-10)
dobj(attenuate-9, loss-11)
partmod(loss-11, caused-12)
nn(diuretics-15, thiazide-14)
agent(caused-12, diuretics-15)

Potassium-sparing/JJ diuretics/NNS (/-LRB- spironolactone/NN ,/, amiloride/NN ,/, triamterene/NN ,/, and/CC others/NNS )/-RRB- or/CC potassium/NN supplement/NN s/NNS can/MD increase/VB the/DT risk/NN of/IN hyperkalemia/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Potassium-sparing) (NNS diuretics)) (PRN (-LRB- -LRB-) (NP (NP (NN spironolactone)) (, ,) (NP (NN amiloride)) (, ,) (NP (NN triamterene)) (, ,) (CC and) (NP (NNS others))) (-RRB- -RRB-))) (CC or) (NP (NN potassium) (NN supplement) (NNS s))) (VP (MD can) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN hyperkalemia))))))) (. .))))

amod(diuretics-2, Potassium-sparing-1)
nsubj(increase-18, diuretics-2)
dep(diuretics-2, spironolactone-4)
conj_and(spironolactone-4, amiloride-6)
conj_and(spironolactone-4, triamterene-8)
conj_and(spironolactone-4, others-11)
nn(s-16, potassium-14)
nn(s-16, supplement-15)
conj_or(diuretics-2, s-16)
aux(increase-18, can-17)
root(ROOT-0, increase-18)
det(risk-20, the-19)
dobj(increase-18, risk-20)
prep_of(risk-20, hyperkalemia-22)

Oral/JJ Anticoagulants/NNS Interaction/NN studies/NNS with/IN warfarin/NN and/CC acenocoumarol/NN failed/VBD to/TO identify/VB any/DT clinically/RB important/JJ effects/NNS on/IN the/DT serum/NN concentrations/NNS or/CC clinical/JJ effects/NNS of/IN these/DT anticoagulants/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Oral) (NNS Anticoagulants) (NN Interaction) (NNS studies)) (PP (IN with) (NP (NP (NN warfarin)) (CC and) (NP (NN acenocoumarol))))) (VP (VBD failed) (S (VP (TO to) (VP (VB identify) (NP (NP (DT any) (ADJP (RB clinically) (JJ important)) (NNS effects)) (PP (IN on) (NP (NP (DT the) (NP (NN serum) (NNS concentrations)) (CC or) (NP (JJ clinical) (NNS effects))) (PP (IN of) (NP (DT these) (NNS anticoagulants))))))))))) (. .))))

amod(studies-4, Oral-1)
nn(studies-4, Anticoagulants-2)
nn(studies-4, Interaction-3)
nsubj(failed-9, studies-4)
xsubj(identify-11, studies-4)
prep_with(studies-4, warfarin-6)
conj_and(warfarin-6, acenocoumarol-8)
root(ROOT-0, failed-9)
aux(identify-11, to-10)
xcomp(failed-9, identify-11)
det(effects-15, any-12)
advmod(important-14, clinically-13)
amod(effects-15, important-14)
dobj(identify-11, effects-15)
dep(concentrations-19, the-17)
nn(concentrations-19, serum-18)
prep_on(effects-15, concentrations-19)
amod(effects-22, clinical-21)
conj_or(concentrations-19, effects-22)
det(anticoagulants-25, these-24)
prep_of(concentrations-19, anticoagulants-25)

Lithium/NN Increased/VBN serum/NN lithium/NN levels/NNS and/CC symptoms/NNS of/IN lithium/NN toxicity/NN have/VBP been/VBN reported/VBN in/IN patients/NNS receiving/VBG ACE/NN inhibitors/NNS during/IN therapy/NN with/IN lithium/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (ADJP (NP (NN Lithium)) (VBN Increased)) (NN serum) (NN lithium) (NNS levels)) (CC and) (NP (NNS symptoms))) (PP (IN of) (NP (NN lithium) (NN toxicity)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN ACE) (NNS inhibitors)) (PP (IN during) (NP (NP (NN therapy)) (PP (IN with) (NP (NN lithium)))))))))))) (. .))))

dep(Increased-2, Lithium-1)
amod(levels-5, Increased-2)
nn(levels-5, serum-3)
nn(levels-5, lithium-4)
nsubjpass(reported-13, levels-5)
conj_and(levels-5, symptoms-7)
nn(toxicity-10, lithium-9)
prep_of(levels-5, toxicity-10)
aux(reported-13, have-11)
auxpass(reported-13, been-12)
root(ROOT-0, reported-13)
prep_in(reported-13, patients-15)
partmod(patients-15, receiving-16)
nn(inhibitors-18, ACE-17)
dobj(receiving-16, inhibitors-18)
prep_during(receiving-16, therapy-20)
prep_with(therapy-20, lithium-22)

These/DT drugs/NNS should/MD be/VB coadministered/VBN with/IN caution/NN ,/, and/CC frequent/JJ monitoring/NN of/IN serum/NN lithium/NN levels/NNS is/VBZ recommended/VBN ./.

(ROOT (S1 (S (S (S (NP (DT These) (NNS drugs)) (VP (MD should) (VP (VB be) (VP (VBN coadministered) (PP (IN with) (NP (NN caution))))))) (, ,) (CC and) (S (NP (NP (JJ frequent) (NN monitoring)) (PP (IN of) (NP (NN serum) (NN lithium) (NNS levels)))) (VP (VBZ is) (VP (VBN recommended))))) (. .))))

det(drugs-2, These-1)
nsubjpass(coadministered-5, drugs-2)
aux(coadministered-5, should-3)
auxpass(coadministered-5, be-4)
root(ROOT-0, coadministered-5)
prep_with(coadministered-5, caution-7)
amod(monitoring-11, frequent-10)
nsubjpass(recommended-17, monitoring-11)
nn(levels-15, serum-13)
nn(levels-15, lithium-14)
prep_of(monitoring-11, levels-15)
auxpass(recommended-17, is-16)
conj_and(coadministered-5, recommended-17)

If/IN a/DT diuretic/NN is/VBZ also/RB used/VBN ,/, the/DT risk/NN of/IN lithium/NN toxicity/NN may/MD be/VB increased/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (DT a) (NN diuretic)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN used))))) (, ,) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN lithium) (NN toxicity)))) (VP (MD may) (VP (VB be) (VP (VBN increased))))) (. .))))

mark(used-6, If-1)
det(diuretic-3, a-2)
nsubjpass(used-6, diuretic-3)
auxpass(used-6, is-4)
advmod(used-6, also-5)
advcl(increased-15, used-6)
det(risk-9, the-8)
nsubjpass(increased-15, risk-9)
nn(toxicity-12, lithium-11)
prep_of(risk-9, toxicity-12)
aux(increased-15, may-13)
auxpass(increased-15, be-14)
root(ROOT-0, increased-15)

Other/JJ :/: No/DT clinically/RB important/JJ pharmacokinetic/JJ interactions/NNS occurred/VBD when/WRB Lotensin/NN was/VBD administered/VBN concomitantly/RB with/IN hydrochlorothiazide/NN ,/, chlorthalidone/NN ,/, furosemide/NN ,/, digoxin/NN ,/, propranolol/NN ,/, atenolol/NN ,/, naproxen/NN ,/, or/CC cimetidine/NN ./.

(ROOT (S1 (S (S (NP (JJ Other)) (: :) (NP (DT No) (ADJP (RB clinically) (JJ important)) (JJ pharmacokinetic) (NNS interactions)) (VP (VBD occurred) (SBAR (WHADVP (WRB when)) (S (NP (NN Lotensin)) (VP (VBD was) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NN hydrochlorothiazide)) (, ,) (NP (NN chlorthalidone)) (, ,) (NP (NN furosemide)) (, ,) (NP (NN digoxin)) (, ,) (NP (NN propranolol)) (, ,) (NP (NN atenolol)) (, ,) (NP (NN naproxen)) (, ,) (CC or) (NP (NN cimetidine)))))))))) (. .))))

nsubj(occurred-8, Other-1)
det(interactions-7, No-3)
advmod(important-5, clinically-4)
amod(interactions-7, important-5)
amod(interactions-7, pharmacokinetic-6)
nsubj(occurred-8, interactions-7)
root(ROOT-0, occurred-8)
advmod(administered-12, when-9)
nsubjpass(administered-12, Lotensin-10)
auxpass(administered-12, was-11)
advcl(occurred-8, administered-12)
advmod(administered-12, concomitantly-13)
prep_with(administered-12, hydrochlorothiazide-15)
conj_or(hydrochlorothiazide-15, chlorthalidone-17)
conj_or(hydrochlorothiazide-15, furosemide-19)
conj_or(hydrochlorothiazide-15, digoxin-21)
conj_or(hydrochlorothiazide-15, propranolol-23)
conj_or(hydrochlorothiazide-15, atenolol-25)
conj_or(hydrochlorothiazide-15, naproxen-27)
conj_or(hydrochlorothiazide-15, cimetidine-30)

Lotensin/NN has/VBZ been/VBN used/VBN concomitantly/RB with/IN beta-adrenergic-blocking/JJ agents/NNS ,/, calcium-channel-blocking/JJ agents/NNS ,/, diuretics/NN ,/, digoxin/NN ,/, and/CC hydralazine/NN ,/, without/IN evidence/NN of/IN clinically/RB important/JJ adverse/JJ interactions/NNS ./.

(ROOT (S1 (S (S (NP (NN Lotensin)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (JJ beta-adrenergic-blocking) (NNS agents)) (, ,) (NP (JJ calcium-channel-blocking) (NNS agents)) (, ,) (NP (NP (NN diuretics)) (, ,) (NP (NN digoxin)) (, ,) (CC and) (NP (NN hydralazine))) (, ,))) (PP (IN without) (NP (NP (NN evidence)) (PP (IN of) (NP (ADJP (RB clinically) (JJ important)) (JJ adverse) (NNS interactions))))))))) (. .))))

nsubjpass(used-4, Lotensin-1)
aux(used-4, has-2)
auxpass(used-4, been-3)
root(ROOT-0, used-4)
advmod(used-4, concomitantly-5)
amod(agents-8, beta-adrenergic-blocking-7)
prep_with(used-4, agents-8)
amod(agents-11, calcium-channel-blocking-10)
appos(agents-8, agents-11)
appos(agents-8, diuretics-13)
conj_and(diuretics-13, digoxin-15)
conj_and(diuretics-13, hydralazine-18)
prep_without(used-4, evidence-21)
advmod(important-24, clinically-23)
amod(interactions-26, important-24)
amod(interactions-26, adverse-25)
prep_of(evidence-21, interactions-26)

Benazepril/NN ,/, like/IN other/JJ ACE/NN inhibitors/NNS ,/, has/VBZ had/VBD less/JJR than/IN additive/JJ effects/NNS with/IN beta-adrenergic/JJ blockers/NNS ,/, presumably/RB because/IN both/DT drugs/NNS lower/JJR blood/NN pressure/NN by/IN inhibiting/VBG parts/NNS of/IN the/DT renin-angiotensin/JJ system/NN ./.

(ROOT (S1 (S (S (NP (NN Benazepril)) (, ,) (PP (IN like) (NP (JJ other) (NN ACE) (NNS inhibitors))) (, ,) (VP (VBZ has) (VP (VBD had) (ADJP (ADJP (JJR less)) (PP (IN than) (NP (NP (JJ additive) (NNS effects)) (PP (IN with) (NP (JJ beta-adrenergic) (NNS blockers)))))) (, ,) (SBAR (ADVP (RB presumably)) (IN because) (S (NP (DT both) (NNS drugs)) (VP (JJR lower) (NP (NN blood) (NN pressure)) (PP (IN by) (S (VP (VBG inhibiting) (NP (NP (NNS parts)) (PP (IN of) (NP (DT the) (JJ renin-angiotensin) (NN system))))))))))))) (. .))))

nsubj(less-10, Benazepril-1)
amod(inhibitors-6, other-4)
nn(inhibitors-6, ACE-5)
prep_like(less-10, inhibitors-6)
aux(less-10, has-8)
dep(less-10, had-9)
root(ROOT-0, less-10)
amod(effects-13, additive-12)
prep_than(less-10, effects-13)
amod(blockers-16, beta-adrenergic-15)
prep_with(effects-13, blockers-16)
advmod(pressure-24, presumably-18)
dep(pressure-24, because-19)
det(drugs-21, both-20)
nsubj(pressure-24, drugs-21)
dep(pressure-24, lower-22)
nn(pressure-24, blood-23)
ccomp(less-10, pressure-24)
prepc_by(pressure-24, inhibiting-26)
dobj(inhibiting-26, parts-27)
det(system-31, the-29)
amod(system-31, renin-angiotensin-30)
prep_of(parts-27, system-31)

May/MD interact/VB with/IN the/DT following/NN :/: cholestyramine/NN ,/, colestipol/NN (/-LRB- use/NN with/IN thiazide/NN diuretics/NNS may/MD prevent/VB the/DT diuretic/NN from/IN working/NNP properly/RB ;/: ./.

(ROOT (S1 (S (S (VP (MD May) (VP (VB interact) (PP (IN with) (NP (NP (DT the) (NN following)) (: :) (S (NP (NP (NP (NN cholestyramine)) (, ,) (NP (NN colestipol) (-LRB- -LRB-) (NN use))) (PP (IN with) (NP (NN thiazide) (NNS diuretics)))) (VP (MD may) (VP (VB prevent) (NP (DT the) (NN diuretic)) (PP (IN from) (NP (NNP working))) (ADVP (RB properly))))) (: ;)))))) (. .))))

aux(interact-2, May-1)
root(ROOT-0, interact-2)
det(following-5, the-4)
prep_with(interact-2, following-5)
nsubj(prevent-16, cholestyramine-7)
nn(use-11, colestipol-9)
appos(cholestyramine-7, use-11)
nn(diuretics-14, thiazide-13)
prep_with(cholestyramine-7, diuretics-14)
aux(prevent-16, may-15)
dep(following-5, prevent-16)
det(diuretic-18, the-17)
dobj(prevent-16, diuretic-18)
prep_from(prevent-16, working-20)
advmod(prevent-16, properly-21)

take/VB the/DT diuretic/JJ at/IN least/JJS 1/CD hour/NN before/IN or/CC 4/CD hours/NNS after/IN cholestyramine/NN or/CC colestipol/NN )/-RRB- ,/, digitalis/NN glycosides/NNS (/-LRB- use/NN with/IN thiazide/NN diuretics/NNS may/MD cause/VB high/JJ blood/NN levels/NNS of/IN digoxin/NN ,/, which/WDT may/MD increase/VB the/DT chance/NN of/IN side/JJ effects/NNS )/-RRB- ,/, and/CC lithium/NN (/-LRB- use/NN with/IN thiazide/NN diuretics/NNS may/MD cause/VB high/JJ blood/NN levels/NNS of/IN lithium/NN ,/, which/WDT may/MD increase/VB the/DT chance/NN of/IN side/JJ effects/NNS )./RB

(ROOT (S1 (S (VP (VB take) (NP (DT the) (JJ diuretic) (QP (IN at) (JJS least) (CD 1)) (NN hour)) (PP (IN before) (NP (CC or) (NP (NP (CD 4) (NNS hours)) (PP (IN after) (NP (NP (NN cholestyramine)) (CC or) (NP (NN colestipol)))) (-RRB- -RRB-)) (, ,) (NP (NP (NN digitalis) (NNS glycosides)) (PRN (-LRB- -LRB-) (S (NP (NP (NN use)) (PP (IN with) (NP (NN thiazide) (NNS diuretics)))) (VP (MD may) (VP (VB cause) (NP (NP (JJ high) (NN blood) (NNS levels)) (PP (IN of) (NP (NN digoxin))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN chance)) (PP (IN of) (NP (JJ side) (NNS effects)))))))))))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN lithium)) (-LRB- -LRB-) (NP (NN use)) (PP (IN with) (NP (NN thiazide) (NNS diuretics))))))) (VP (MD may) (VP (VB cause) (NP (NP (JJ high) (NN blood) (NNS levels)) (PP (IN of) (NP (NN lithium))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN chance)) (PP (IN of) (NP (JJ side) (NNS effects)))) (ADVP (RB -RRB-.))))))))))))

root(ROOT-0, take-1)
det(hour-7, the-2)
amod(hour-7, diuretic-3)
quantmod(1-6, at-4)
mwe(at-4, least-5)
pobj(at-4, least-5)
num(hour-7, 1-6)
dobj(take-1, hour-7)
num(hours-11, 4-10)
prep_before(take-1, hours-11)
prep_after(hours-11, cholestyramine-13)
conj_or(cholestyramine-13, colestipol-15)
nn(glycosides-19, digitalis-18)
conj_or(hours-11, glycosides-19)
nsubj(cause-26, use-21)
nn(diuretics-24, thiazide-23)
prep_with(use-21, diuretics-24)
aux(cause-26, may-25)
dep(glycosides-19, cause-26)
amod(levels-29, high-27)
nn(levels-29, blood-28)
dobj(cause-26, levels-29)
nsubj(increase-35, levels-29)
prep_of(levels-29, digoxin-31)
aux(increase-35, may-34)
rcmod(levels-29, increase-35)
det(chance-37, the-36)
dobj(increase-35, chance-37)
amod(effects-40, side-39)
prep_of(chance-37, effects-40)
conj_and(hours-11, lithium-44)
dep(lithium-44, use-46)
nn(diuretics-49, thiazide-48)
prep_with(lithium-44, diuretics-49)
aux(cause-51, may-50)
dep(take-1, cause-51)
amod(levels-54, high-52)
nn(levels-54, blood-53)
dobj(cause-51, levels-54)
nsubj(increase-60, levels-54)
prep_of(levels-54, lithium-56)
aux(increase-60, may-59)
rcmod(levels-54, increase-60)
det(chance-62, the-61)
dobj(increase-60, chance-62)
amod(effects-65, side-64)
prep_of(chance-62, effects-65)
advmod(increase-60, -RRB-.-66)

May/MD interact/VB with/IN other/JJ creams/NNS ,/, lotions/NNS ,/, or/CC skin/NN medicines/NNS when/WRB placed/VBN on/IN the/DT same/JJ areas/NNS of/IN your/NN skin/NN that/WDT you/RB are/VBP using/VBG bentoquatam/NN ./.

(ROOT (S1 (S (S (VP (MD May) (VP (VB interact) (PP (IN with) (NP (NP (JJ other) (NNS creams)) (, ,) (NP (NNS lotions)) (, ,) (CC or) (NP (NN skin) (NNS medicines)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN placed) (PP (IN on) (NP (NP (DT the) (JJ same) (NNS areas)) (PP (IN of) (NP (NP (NN your) (NN skin)) (SBAR (WHNP (WDT that)) (S (ADVP (RB you)) (VP (VBP are) (VP (VBG using) (NP (NN bentoquatam)))))))))))))))) (. .))))

aux(interact-2, May-1)
root(ROOT-0, interact-2)
amod(creams-5, other-4)
prep_with(interact-2, creams-5)
conj_or(creams-5, lotions-7)
nn(medicines-11, skin-10)
conj_or(creams-5, medicines-11)
advmod(placed-13, when-12)
advcl(interact-2, placed-13)
det(areas-17, the-15)
amod(areas-17, same-16)
prep_on(placed-13, areas-17)
nn(skin-20, your-19)
prep_of(areas-17, skin-20)
nsubj(using-24, skin-20)
advmod(using-24, you-22)
aux(using-24, are-23)
rcmod(skin-20, using-24)
dobj(using-24, bentoquatam-25)

Antipsychotic/JJ drugs/NNS such/JJ as/IN phenothiazines/NNS or/CC haloperidol/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (JJ Antipsychotic) (NNS drugs)) (PP (JJ such) (IN as) (NP (NP (NNS phenothiazines)) (CC or) (NP (NN haloperidol)))) (: ;))) (. .))))

amod(drugs-2, Antipsychotic-1)
root(ROOT-0, drugs-2)
prep_such_as(drugs-2, phenothiazines-5)
conj_or(phenothiazines-5, haloperidol-7)

tricyclic/JJ antidepressants/NNS ./.

(ROOT (S1 (S (NP (NP (JJ tricyclic) (NNS antidepressants)) (. .)))))

amod(antidepressants-2, tricyclic-1)
root(ROOT-0, antidepressants-2)

Nitrates/NNS :/: The/DT concomitant/JJ use/NN of/IN Bepridil/NN with/IN long-/NN and/CC short-acting/JJ nitrates/NNS has/VBZ been/VBN safely/RB tolerated/VBN in/IN patients/NNS with/IN stable/JJ angina/NN pectoris/NN ./.

(ROOT (S1 (S (NP (NP (NNS Nitrates)) (: :) (S (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (NN Bepridil))) (PP (IN with) (NP (NP (NN long-)) (CC and) (NP (JJ short-acting) (NNS nitrates))))) (VP (VBZ has) (VP (VBN been) (ADVP (RB safely)) (VP (VBN tolerated) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ stable) (NN angina) (NN pectoris))))))))) (. .)))))

root(ROOT-0, Nitrates-1)
det(use-5, The-3)
amod(use-5, concomitant-4)
nsubjpass(tolerated-16, use-5)
prep_of(use-5, Bepridil-7)
prep_with(use-5, long--9)
amod(nitrates-12, short-acting-11)
conj_and(long--9, nitrates-12)
aux(tolerated-16, has-13)
auxpass(tolerated-16, been-14)
advmod(tolerated-16, safely-15)
dep(Nitrates-1, tolerated-16)
prep_in(tolerated-16, patients-18)
amod(pectoris-22, stable-20)
nn(pectoris-22, angina-21)
prep_with(patients-18, pectoris-22)

Sublingual/JJ nitroglycerin/NN may/MD be/VB taken/VBN if/IN necessary/JJ for/IN the/DT control/NN of/IN acute/JJ angina/NN attacks/NNS during/IN Bepridil/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (JJ Sublingual) (NN nitroglycerin)) (VP (MD may) (VP (VB be) (VP (VBN taken) (SBAR (IN if) (ADJP (JJ necessary) (PP (IN for) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NP (JJ acute) (NN angina) (NNS attacks)) (PP (IN during) (NP (NN Bepridil) (NN therapy))))))))))))) (. .))))

amod(nitroglycerin-2, Sublingual-1)
nsubjpass(taken-5, nitroglycerin-2)
aux(taken-5, may-3)
auxpass(taken-5, be-4)
root(ROOT-0, taken-5)
advcl(taken-5, if-6)
dep(if-6, necessary-7)
det(control-10, the-9)
prep_for(necessary-7, control-10)
amod(attacks-14, acute-12)
nn(attacks-14, angina-13)
prep_of(control-10, attacks-14)
nn(therapy-17, Bepridil-16)
prep_during(attacks-14, therapy-17)

Beta-blocking/JJ Agent/NN s/NNS :/: The/DT concomitant/JJ use/NN of/IN Bepridil/NN and/CC beta-blocking/JJ agent/NN s/NNS has/VBZ been/VBN well/RB tolerated/VBN in/IN patients/NNS with/IN stable/JJ angina/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Beta-blocking) (NN Agent) (NNS s)) (: :) (S (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN Bepridil)) (CC and) (NP (JJ beta-blocking) (NN agent) (NNS s))))) (VP (VBZ has) (VP (VBN been) (ADVP (RB well)) (VP (VBN tolerated) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ stable) (NNS angina))))))))) (. .)))))

amod(s-3, Beta-blocking-1)
nn(s-3, Agent-2)
root(ROOT-0, s-3)
det(use-7, The-5)
amod(use-7, concomitant-6)
nsubjpass(tolerated-17, use-7)
prep_of(use-7, Bepridil-9)
amod(s-13, beta-blocking-11)
nn(s-13, agent-12)
conj_and(Bepridil-9, s-13)
aux(tolerated-17, has-14)
auxpass(tolerated-17, been-15)
advmod(tolerated-17, well-16)
dep(s-3, tolerated-17)
prep_in(tolerated-17, patients-19)
amod(angina-22, stable-21)
prep_with(patients-19, angina-22)

Available/JJ data/NNS are/VBP not/RB sufficient/JJ ,/, however/RB ,/, to/TO predict/VB the/DT effects/NNS of/IN concomitant/JJ medication/NN on/IN patients/NNS with/IN impaired/JJ ventricular/JJ function/NN or/CC cardiac/JJ conduction/JJ abnormalities/NNS ./.

(ROOT (S1 (S (S (NP (JJ Available) (NNS data)) (VP (VBP are) (RB not) (ADJP (JJ sufficient) (S (, ,) (ADVP (RB however)) (, ,) (VP (TO to) (VP (VB predict) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ concomitant) (NN medication))) (PP (IN on) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ impaired) (JJ ventricular) (NN function)) (CC or) (NP (JJ cardiac) (JJ conduction) (NNS abnormalities))))))))))))) (. .))))

amod(data-2, Available-1)
nsubj(sufficient-5, data-2)
cop(sufficient-5, are-3)
neg(sufficient-5, not-4)
root(ROOT-0, sufficient-5)
advmod(predict-10, however-7)
aux(predict-10, to-9)
dep(sufficient-5, predict-10)
det(effects-12, the-11)
dobj(predict-10, effects-12)
amod(medication-15, concomitant-14)
prep_of(effects-12, medication-15)
prep_on(effects-12, patients-17)
amod(function-21, impaired-19)
amod(function-21, ventricular-20)
prep_with(patients-17, function-21)
amod(abnormalities-25, cardiac-23)
amod(abnormalities-25, conduction-24)
conj_or(function-21, abnormalities-25)

Digoxin/NN :/: In/IN controlled/JJ studies/NNS in/IN healthy/JJ volunteers/NNS ,/, bepridil/NN hydrochloride/NN either/RB had/VBD no/DT effect/NN (/-LRB- one/CD study/NN )/-RRB- or/CC was/VBD associated/VBN with/IN modest/JJ increases/NNS ,/, about/RB 30/CD %/NN (/-LRB- two/CD studies/NNS )/-RRB- in/IN steady-state/JJ serum/NN digoxin/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NN Digoxin)) (: :) (PP (IN In) (NP (NP (JJ controlled) (NNS studies)) (PP (IN in) (NP (JJ healthy) (NNS volunteers))))) (, ,) (NP (NN bepridil) (NN hydrochloride)) (ADVP (RB either)) (VP (VP (VBD had) (NP (DT no) (NN effect)) (PRN (-LRB- -LRB-) (NP (CD one) (NN study)) (-RRB- -RRB-))) (CC or) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (NP (NP (JJ modest) (NNS increases)) (, ,) (NP (QP (RB about) (CD 30)) (NN %))) (PRN (-LRB- -LRB-) (NP (CD two) (NNS studies)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ steady-state) (NN serum) (NN digoxin) (NNS concentrations))))))))) (. .))))

nsubj(had-13, Digoxin-1)
amod(studies-5, controlled-4)
prep_in(had-13, studies-5)
amod(volunteers-8, healthy-7)
prep_in(studies-5, volunteers-8)
nn(hydrochloride-11, bepridil-10)
nsubj(had-13, hydrochloride-11)
advmod(had-13, either-12)
root(ROOT-0, had-13)
det(effect-15, no-14)
dobj(had-13, effect-15)
num(study-18, one-17)
dep(had-13, study-18)
auxpass(associated-22, was-21)
conj_or(had-13, associated-22)
amod(increases-25, modest-24)
prep_with(associated-22, increases-25)
quantmod(30-28, about-27)
num(%-29, 30-28)
appos(increases-25, %-29)
num(studies-32, two-31)
appos(increases-25, studies-32)
amod(concentrations-38, steady-state-35)
nn(concentrations-38, serum-36)
nn(concentrations-38, digoxin-37)
prep_in(increases-25, concentrations-38)

Limited/JJ clinical/JJ data/NNS in/IN angina/JJ patients/NNS receiving/VBG concomitant/JJ bepridil/NN hydrochloride/NN and/CC digoxin/NN therapy/NN indicate/VBP no/DT discernible/JJ changes/NNS in/IN serum/NN digoxin/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Limited) (JJ clinical) (NNS data)) (PP (IN in) (NP (NP (JJ angina) (NNS patients)) (VP (VBG receiving) (NP (JJ concomitant) (NN bepridil) (NN hydrochloride) (CC and) (NN digoxin) (NN therapy)))))) (VP (VBP indicate) (NP (NP (DT no) (JJ discernible) (NNS changes)) (PP (IN in) (NP (NN serum) (NN digoxin) (NNS levels)))))) (. .))))

amod(data-3, Limited-1)
amod(data-3, clinical-2)
nsubj(indicate-14, data-3)
amod(patients-6, angina-5)
prep_in(data-3, patients-6)
partmod(patients-6, receiving-7)
amod(hydrochloride-10, concomitant-8)
nn(hydrochloride-10, bepridil-9)
dobj(receiving-7, hydrochloride-10)
nn(therapy-13, digoxin-12)
conj_and(hydrochloride-10, therapy-13)
root(ROOT-0, indicate-14)
det(changes-17, no-15)
amod(changes-17, discernible-16)
dobj(indicate-14, changes-17)
nn(levels-21, serum-19)
nn(levels-21, digoxin-20)
prep_in(changes-17, levels-21)

Available/JJ data/NNS are/VBP neither/CC sufficient/JJ to/TO rule/NN out/IN possible/JJ increases/NNS in/IN serum/NN digoxin/NN with/IN concomitant/JJ treatment/NN in/IN some/DT patients/NNS ,/, nor/CC other/JJ possible/JJ interactions/NNS ,/, particularly/RB in/IN patients/NNS with/IN cardiac/JJ conduction/NN abnormalities/NNS (/-LRB- Also/RB see/VB WARNINGS/NNS Congestive/JJ Heart/NN Failure/NN )./CD

(ROOT (S1 (S (NP (JJ Available) (NNS data)) (VP (VBP are) (ADJP (CC neither) (ADJP (JJ sufficient))) (PP (TO to) (NP (NP (NP (NN rule)) (PP (IN out) (NP (NP (JJ possible) (NNS increases)) (PP (IN in) (NP (NP (NN serum) (NN digoxin)) (PP (IN with) (NP (NP (JJ concomitant) (NN treatment)) (PP (IN in) (NP (DT some) (NNS patients)))))))))) (, ,) (CC nor) (NP (JJ other) (JJ possible) (NNS interactions)) (, ,) (ADVP (RB particularly)))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ cardiac) (NN conduction) (NNS abnormalities))))) (PRN (-LRB- -LRB-) (RB Also) (VP (VB see) (NP (NNS WARNINGS) (NP (JJ Congestive) (NN Heart) (NN Failure) (CD -RRB-.)))))))))

amod(data-2, Available-1)
nsubj(sufficient-5, data-2)
cop(sufficient-5, are-3)
dep(sufficient-5, neither-4)
root(ROOT-0, sufficient-5)
prep_to(sufficient-5, rule-7)
amod(increases-10, possible-9)
prep_out(rule-7, increases-10)
nn(digoxin-13, serum-12)
prep_in(increases-10, digoxin-13)
amod(treatment-16, concomitant-15)
prep_with(digoxin-13, treatment-16)
det(patients-19, some-18)
prep_in(treatment-16, patients-19)
amod(interactions-24, other-22)
amod(interactions-24, possible-23)
conj_nor(rule-7, interactions-24)
advmod(rule-7, particularly-26)
conj_nor(rule-7, particularly-26)
prep_in(sufficient-5, patients-28)
amod(abnormalities-32, cardiac-30)
nn(abnormalities-32, conduction-31)
prep_with(patients-28, abnormalities-32)
dep(see-35, Also-34)
dep(sufficient-5, see-35)
dobj(see-35, WARNINGS-36)
amod(Failure-39, Congestive-37)
nn(Failure-39, Heart-38)
dep(WARNINGS-36, Failure-39)
num(Failure-39, -RRB-.-40)

Oral/JJ Hypoglycemics/NN :/: Bepridil/NN has/VBZ been/VBN safely/RB used/VBN in/IN diabetic/JJ patients/NNS without/IN significantly/RB lowering/VBG their/PRP$ blood/NN glucose/NN levels/NNS or/CC altering/VBG their/PRP$ need/NN for/IN insulin/NN or/CC oral/JJ hypoglycemic/JJ agents/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Oral) (NN Hypoglycemics)) (: :) (S (NP (NN Bepridil)) (VP (VBZ has) (VP (VBN been) (VP (ADVP (RB safely)) (VBN used) (PP (IN in) (NP (JJ diabetic) (NNS patients))) (PP (IN without) (S (ADVP (RB significantly)) (VP (VP (VBG lowering) (NP (PRP$ their) (NN blood) (NN glucose) (NNS levels))) (CC or) (VP (VBG altering) (NP (NP (PRP$ their) (NN need)) (PP (IN for) (NP (NP (NN insulin)) (CC or) (NP (JJ oral) (JJ hypoglycemic) (NNS agents))))))))))))) (. .)))))

amod(Hypoglycemics-2, Oral-1)
root(ROOT-0, Hypoglycemics-2)
nsubjpass(used-8, Bepridil-4)
aux(used-8, has-5)
auxpass(used-8, been-6)
advmod(used-8, safely-7)
dep(Hypoglycemics-2, used-8)
amod(patients-11, diabetic-10)
prep_in(used-8, patients-11)
advmod(lowering-14, significantly-13)
prepc_without(used-8, lowering-14)
poss(levels-18, their-15)
nn(levels-18, blood-16)
nn(levels-18, glucose-17)
dobj(lowering-14, levels-18)
conj_or(lowering-14, altering-20)
poss(need-22, their-21)
dobj(altering-20, need-22)
prep_for(need-22, insulin-24)
amod(agents-28, oral-26)
amod(agents-28, hypoglycemic-27)
conj_or(insulin-24, agents-28)

General/JJ Interactions/NNS :/: Certain/JJ drugs/NNS could/MD increase/VB the/DT likelihood/NN of/IN potentially/RB serious/JJ adverse/JJ effects/NNS with/IN bepridil/NN hydrochloride/NN ./.

(ROOT (S1 (S (NP (NP (JJ General) (NNS Interactions)) (: :) (S (NP (JJ Certain) (NNS drugs)) (VP (MD could) (VP (VB increase) (NP (NP (DT the) (NN likelihood)) (PP (IN of) (NP (NP (ADJP (RB potentially) (JJ serious)) (JJ adverse) (NNS effects)) (PP (IN with) (NP (NN bepridil) (NN hydrochloride))))))))) (. .)))))

amod(Interactions-2, General-1)
root(ROOT-0, Interactions-2)
amod(drugs-5, Certain-4)
nsubj(increase-7, drugs-5)
aux(increase-7, could-6)
dep(Interactions-2, increase-7)
det(likelihood-9, the-8)
dobj(increase-7, likelihood-9)
advmod(serious-12, potentially-11)
amod(effects-14, serious-12)
amod(effects-14, adverse-13)
prep_of(likelihood-9, effects-14)
nn(hydrochloride-17, bepridil-16)
prep_with(effects-14, hydrochloride-17)

In/IN general/JJ ,/, these/DT are/VBP drugs/NNS that/WDT have/VBP one/CD or/CC more/JJR pharmacologic/JJ activities/NNS similar/JJ to/TO bepridil/NN hydrochloride/NN ,/, including/VBG anti-arrhythmic/JJ agents/NNS such/JJ as/IN quinidine/NN and/CC procainamide/NN ,/, cardiac/JJ glycosides/NNS and/CC tricyclic/JJ anti-depressants/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ general))) (, ,) (NP (DT these)) (VP (VBP are) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (NP (NP (QP (CD one) (CC or) (JJR more)) (JJ pharmacologic) (NNS activities)) (ADJP (JJ similar) (PP (TO to) (NP (NN bepridil) (NN hydrochloride)))) (, ,) (PP (VBG including) (NP (NP (JJ anti-arrhythmic) (NNS agents)) (PP (JJ such) (IN as) (NP (NP (NN quinidine)) (CC and) (NP (NN procainamide)))))) (, ,) (NP (NP (JJ cardiac) (NNS glycosides)) (CC and) (NP (JJ tricyclic) (NNS anti-depressants)))))))))) (. .))))

prep_in(drugs-6, general-2)
nsubj(drugs-6, these-4)
cop(drugs-6, are-5)
root(ROOT-0, drugs-6)
nsubj(have-8, drugs-6)
rcmod(drugs-6, have-8)
num(activities-13, one-9)
conj_or(one-9, more-11)
quantmod(one-9, more-11)
amod(activities-13, pharmacologic-12)
dobj(have-8, activities-13)
amod(activities-13, similar-14)
nn(hydrochloride-17, bepridil-16)
prep_to(similar-14, hydrochloride-17)
amod(agents-21, anti-arrhythmic-20)
prep_including(activities-13, agents-21)
prep_such_as(agents-21, quinidine-24)
conj_and(quinidine-24, procainamide-26)
amod(glycosides-29, cardiac-28)
appos(activities-13, glycosides-29)
amod(anti-depressants-32, tricyclic-31)
conj_and(glycosides-29, anti-depressants-32)

Anti-arrhythmics/NN and/CC tricyclic/JJ anti-depressants/NNS could/MD exaggerate/VB the/DT prolongation/NN of/IN the/DT QT/JJ interval/NN observed/VBN with/IN bepridil/NN hydrochloride/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Anti-arrhythmics)) (CC and) (NP (JJ tricyclic) (NNS anti-depressants))) (VP (MD could) (VP (VB exaggerate) (NP (NP (DT the) (NN prolongation)) (PP (IN of) (NP (NP (DT the) (JJ QT) (NN interval)) (VP (VBN observed) (PP (IN with) (NP (NN bepridil) (NN hydrochloride)))))))))) (. .))))

nsubj(exaggerate-6, Anti-arrhythmics-1)
amod(anti-depressants-4, tricyclic-3)
conj_and(Anti-arrhythmics-1, anti-depressants-4)
aux(exaggerate-6, could-5)
root(ROOT-0, exaggerate-6)
det(prolongation-8, the-7)
dobj(exaggerate-6, prolongation-8)
det(interval-12, the-10)
amod(interval-12, QT-11)
prep_of(prolongation-8, interval-12)
partmod(interval-12, observed-13)
nn(hydrochloride-16, bepridil-15)
prep_with(observed-13, hydrochloride-16)

Cardiac/JJ glycosides/NNS could/MD exaggerate/VB the/DT depression/NN of/IN AV/NN nodal/JJ conduction/NN observed/VBN with/IN bepridil/NN hydrochloride/NN ./.

(ROOT (S1 (S (S (NP (JJ Cardiac) (NNS glycosides)) (VP (MD could) (VP (VB exaggerate) (NP (NP (DT the) (NN depression)) (PP (IN of) (NP (NP (NN AV) (JJ nodal) (NN conduction)) (VP (VBN observed) (PP (IN with) (NP (NN bepridil) (NN hydrochloride)))))))))) (. .))))

amod(glycosides-2, Cardiac-1)
nsubj(exaggerate-4, glycosides-2)
aux(exaggerate-4, could-3)
root(ROOT-0, exaggerate-4)
det(depression-6, the-5)
dobj(exaggerate-4, depression-6)
nn(conduction-10, AV-8)
amod(conduction-10, nodal-9)
prep_of(depression-6, conduction-10)
partmod(conduction-10, observed-11)
nn(hydrochloride-14, bepridil-13)
prep_with(observed-11, hydrochloride-14)

The/DT following/JJ drugs/NNS have/VBP been/VBN coadministered/VBN with/IN Kerlone/NN and/CC have/VBP not/RB altered/VBN its/PRP$ pharmacokinetics/NNS :/: cimetidine/NN ,/, nifedipine/NN ,/, chlorthalidone/NN ,/, and/CC hydrochlorothiazide/NN ./.

(ROOT (S1 (S (S (NP (DT The) (JJ following) (NNS drugs)) (VP (VP (VBP have) (VP (VBN been) (VP (VBN coadministered) (PP (IN with) (NP (NN Kerlone)))))) (CC and) (VP (VBP have) (RB not) (VP (VBN altered) (NP (NP (PRP$ its) (NNS pharmacokinetics)) (: :) (NP (NP (NN cimetidine)) (, ,) (NP (NN nifedipine)) (, ,) (NP (NN chlorthalidone)) (, ,) (CC and) (NP (NN hydrochlorothiazide)))))))) (. .))))

det(drugs-3, The-1)
amod(drugs-3, following-2)
nsubjpass(coadministered-6, drugs-3)
aux(coadministered-6, have-4)
auxpass(coadministered-6, been-5)
root(ROOT-0, coadministered-6)
prep_with(coadministered-6, Kerlone-8)
aux(altered-12, have-10)
neg(altered-12, not-11)
conj_and(coadministered-6, altered-12)
poss(pharmacokinetics-14, its-13)
dobj(altered-12, pharmacokinetics-14)
dep(pharmacokinetics-14, cimetidine-16)
conj_and(cimetidine-16, nifedipine-18)
conj_and(cimetidine-16, chlorthalidone-20)
conj_and(cimetidine-16, hydrochlorothiazide-23)

Concomitant/JJ administration/NN of/IN Kerlone/NN with/IN the/DT oral/JJ anticoagulant/NN warfarin/NN has/VBZ been/VBN shown/VBN not/RB to/TO potentiate/VB the/DT anticoagulant/JJ effect/NN of/IN warfarin/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NN Kerlone))) (PP (IN with) (NP (DT the) (JJ oral) (NN anticoagulant) (NN warfarin)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (RB not) (TO to) (VP (VB potentiate) (NP (NP (DT the) (JJ anticoagulant) (NN effect)) (PP (IN of) (NP (NN warfarin))))))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubjpass(shown-12, administration-2)
xsubj(potentiate-15, administration-2)
prep_of(administration-2, Kerlone-4)
det(warfarin-9, the-6)
amod(warfarin-9, oral-7)
nn(warfarin-9, anticoagulant-8)
prep_with(administration-2, warfarin-9)
aux(shown-12, has-10)
auxpass(shown-12, been-11)
root(ROOT-0, shown-12)
neg(potentiate-15, not-13)
aux(potentiate-15, to-14)
ccomp(shown-12, potentiate-15)
xcomp(shown-12, potentiate-15)
det(effect-18, the-16)
amod(effect-18, anticoagulant-17)
dobj(potentiate-15, effect-18)
prep_of(effect-18, warfarin-20)

Catecholamine-depleting/JJ drugs/NNS (/-LRB- e.g./FW ,/, reserpine/NN )/-RRB- may/MD have/VB an/DT additive/JJ effect/NN when/WRB given/VBN with/IN beta-blocking/JJ agent/NN s/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Catecholamine-depleting) (NNS drugs)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN reserpine))) (-RRB- -RRB-))) (VP (MD may) (VP (VB have) (NP (DT an) (JJ additive) (NN effect)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN with) (NP (JJ beta-blocking) (NN agent) (NNS s))))))))) (. .))))

amod(drugs-2, Catecholamine-depleting-1)
nsubj(have-9, drugs-2)
dep(drugs-2, e.g.-4)
pobj(e.g.-4, reserpine-6)
aux(have-9, may-8)
root(ROOT-0, have-9)
det(effect-12, an-10)
amod(effect-12, additive-11)
dobj(have-9, effect-12)
advmod(given-14, when-13)
advcl(have-9, given-14)
amod(s-18, beta-blocking-16)
nn(s-18, agent-17)
prep_with(given-14, s-18)

Patients/NNS treated/VBN with/IN a/DT beta-adrenergic/JJ receptor/NN blocking/NN agent/NN plus/CC a/DT catecholamine/NN depletor/NN should/MD therefore/RB be/VB closely/RB observed/VBN for/IN evidence/NN of/IN hypotension/NN or/CC marked/JJ bradycardia/NN ,/, which/WDT may/MD produce/VB vertigo/NN ,/, syncope/NN ,/, or/CC postural/JJ hypotension/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBN treated) (PP (IN with) (NP (NP (DT a) (JJ beta-adrenergic) (NN receptor) (NN blocking) (NN agent)) (CC plus) (NP (DT a) (NN catecholamine) (NN depletor)))))) (VP (MD should) (ADVP (RB therefore)) (VP (VB be) (ADVP (RB closely)) (VP (VBN observed) (PP (IN for) (NP (NP (NN evidence)) (PP (IN of) (NP (NP (NP (NN hypotension)) (CC or) (NP (JJ marked) (NN bradycardia))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB produce) (NP (NP (NN vertigo)) (, ,) (NP (NN syncope)) (, ,) (CC or) (NP (JJ postural) (NN hypotension))))))))))))))) (. .))))

nsubjpass(observed-17, Patients-1)
partmod(Patients-1, treated-2)
det(agent-8, a-4)
amod(agent-8, beta-adrenergic-5)
nn(agent-8, receptor-6)
nn(agent-8, blocking-7)
prep_with(treated-2, agent-8)
det(depletor-12, a-10)
nn(depletor-12, catecholamine-11)
conj_plus(agent-8, depletor-12)
aux(observed-17, should-13)
advmod(observed-17, therefore-14)
auxpass(observed-17, be-15)
advmod(observed-17, closely-16)
root(ROOT-0, observed-17)
prep_for(observed-17, evidence-19)
prep_of(evidence-19, hypotension-21)
nsubj(produce-28, hypotension-21)
amod(bradycardia-24, marked-23)
conj_or(hypotension-21, bradycardia-24)
aux(produce-28, may-27)
rcmod(hypotension-21, produce-28)
dobj(produce-28, vertigo-29)
conj_or(vertigo-29, syncope-31)
amod(hypotension-35, postural-34)
conj_or(vertigo-29, hypotension-35)

Should/MD it/PRP be/VB decided/VBN to/TO discontinue/NN therapy/NN in/IN patients/NNS receiving/VBG beta-blockers/NN and/CC clonidine/NN concurrently/RB ,/, the/DT beta-blocker/NN should/MD be/VB discontinued/VBN slowly/RB over/IN several/JJ days/NNS before/IN the/DT gradual/JJ withdrawal/NN of/IN clonidine/NN ./.

(ROOT (S1 (S (S (SINV (MD Should) (NP (PRP it)) (VP (VB be) (VP (VBN decided) (PP (TO to) (NP (NP (NN discontinue) (NN therapy)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN beta-blockers)) (CC and) (NP (NN clonidine)))))))) (ADVP (RB concurrently))))) (, ,) (NP (DT the) (NN beta-blocker)) (VP (MD should) (VP (VB be) (VP (VBN discontinued) (ADVP (RB slowly)) (PP (IN over) (NP (NP (JJ several) (NNS days)) (PP (IN before) (NP (NP (DT the) (JJ gradual) (NN withdrawal)) (PP (IN of) (NP (NN clonidine))))))))))) (. .))))

aux(decided-4, Should-1)
nsubjpass(decided-4, it-2)
auxpass(decided-4, be-3)
dep(discontinued-20, decided-4)
nn(therapy-7, discontinue-6)
prep_to(decided-4, therapy-7)
prep_in(therapy-7, patients-9)
partmod(patients-9, receiving-10)
dobj(receiving-10, beta-blockers-11)
conj_and(beta-blockers-11, clonidine-13)
advmod(decided-4, concurrently-14)
det(beta-blocker-17, the-16)
nsubjpass(discontinued-20, beta-blocker-17)
aux(discontinued-20, should-18)
auxpass(discontinued-20, be-19)
root(ROOT-0, discontinued-20)
advmod(discontinued-20, slowly-21)
amod(days-24, several-23)
prep_over(discontinued-20, days-24)
det(withdrawal-28, the-26)
amod(withdrawal-28, gradual-27)
prep_before(days-24, withdrawal-28)
prep_of(withdrawal-28, clonidine-30)

Literature/NN reports/NNS suggest/VBP that/IN oral/JJ calcium/NN antagonist/NN s/NNS may/MD be/VB used/VBN in/IN combination/NN with/IN beta-adrenergic/JJ blocking/VBG agents/NNS when/WRB heart/NN function/NN is/VBZ normal/JJ ,/, but/CC should/MD be/VB avoided/VBN in/IN patients/NNS with/IN impaired/JJ cardiac/JJ function/NN ./.

(ROOT (S1 (S (S (NP (NN Literature) (NNS reports)) (VP (VBP suggest) (SBAR (IN that) (S (NP (JJ oral) (NN calcium) (NN antagonist) (NNS s)) (VP (VP (MD may) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ beta-adrenergic) (VBG blocking) (NNS agents))))) (SBAR (WHADVP (WRB when)) (S (NP (NN heart) (NN function)) (VP (VBZ is) (ADJP (JJ normal)))))))) (, ,) (CC but) (VP (MD should) (VP (VB be) (VP (VBN avoided) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ impaired) (JJ cardiac) (NN function))))))))))))) (. .))))

nn(reports-2, Literature-1)
nsubj(suggest-3, reports-2)
root(ROOT-0, suggest-3)
complm(used-11, that-4)
amod(s-8, oral-5)
nn(s-8, calcium-6)
nn(s-8, antagonist-7)
nsubjpass(used-11, s-8)
aux(used-11, may-9)
auxpass(used-11, be-10)
ccomp(suggest-3, used-11)
prep_in(used-11, combination-13)
amod(agents-17, beta-adrenergic-15)
amod(agents-17, blocking-16)
prep_with(combination-13, agents-17)
advmod(normal-22, when-18)
nn(function-20, heart-19)
nsubj(normal-22, function-20)
cop(normal-22, is-21)
advcl(used-11, normal-22)
aux(avoided-27, should-25)
auxpass(avoided-27, be-26)
conj_but(used-11, avoided-27)
prep_in(avoided-27, patients-29)
amod(function-33, impaired-31)
amod(function-33, cardiac-32)
prep_with(patients-29, function-33)

Hypotension/NN ,/, AV/NN conduction/NN disturbances/NNS ,/, and/CC left/JJ ventricular/JJ failure/NN have/VBP been/VBN reported/VBN in/IN some/DT patients/NNS receiving/VBG beta-adrenergic/JJ blocking/NN agents/NNS when/WRB an/DT oral/JJ calcium/NN antagonist/NN was/VBD added/VBN to/TO the/DT treatment/NN regimen/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Hypotension)) (, ,) (NP (NN AV) (NN conduction) (NNS disturbances)) (, ,) (CC and) (NP (JJ left) (JJ ventricular) (NN failure))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (DT some) (NNS patients)) (VP (VBG receiving) (NP (JJ beta-adrenergic) (NN blocking) (NNS agents))))) (SBAR (WHADVP (WRB when)) (S (NP (DT an) (JJ oral) (NN calcium) (NN antagonist)) (VP (VBD was) (VP (VBN added) (PP (TO to) (NP (DT the) (NN treatment) (NN regimen))))))))))) (. .))))

nsubjpass(reported-13, Hypotension-1)
nn(disturbances-5, AV-3)
nn(disturbances-5, conduction-4)
conj_and(Hypotension-1, disturbances-5)
amod(failure-10, left-8)
amod(failure-10, ventricular-9)
conj_and(Hypotension-1, failure-10)
aux(reported-13, have-11)
auxpass(reported-13, been-12)
root(ROOT-0, reported-13)
det(patients-16, some-15)
prep_in(reported-13, patients-16)
partmod(patients-16, receiving-17)
amod(agents-20, beta-adrenergic-18)
nn(agents-20, blocking-19)
dobj(receiving-17, agents-20)
advmod(added-27, when-21)
det(antagonist-25, an-22)
amod(antagonist-25, oral-23)
nn(antagonist-25, calcium-24)
nsubjpass(added-27, antagonist-25)
auxpass(added-27, was-26)
advcl(reported-13, added-27)
det(regimen-31, the-29)
nn(regimen-31, treatment-30)
prep_to(added-27, regimen-31)

Hypotension/NN was/VBD more/RBR likely/JJ to/TO occur/VB if/IN the/DT calcium/NN antagonist/NN were/VBD a/DT dihydropyridine/NN derivative/NN ,/, e.g./FW ,/, nifedipine/NN ,/, while/IN left/JJ ventricular/NN failure/NN and/CC AV/NN conduction/NN disturbances/NNS ,/, including/VBG complete/JJ heart/NN block/NN ,/, were/VBD more/RBR likely/JJ to/TO occur/VB with/IN either/CC verapamil/NN or/CC diltiazem/NN ./.

(ROOT (S1 (S (S (NP (NN Hypotension)) (VP (VBD was) (ADJP (RBR more) (JJ likely)) (S (VP (TO to) (VP (VB occur) (SBAR (IN if) (S (NP (DT the) (NN calcium) (NN antagonist)) (VP (VBD were) (NP (DT a) (NN dihydropyridine) (NN derivative)) (, ,) (PP (FW e.g.) (, ,) (NP (NN nifedipine))) (, ,) (SBAR (IN while) (S (NP (NP (NP (NP (JJ left) (NN ventricular)) (NN failure)) (CC and) (NP (NN AV) (NN conduction) (NNS disturbances))) (, ,) (PP (VBG including) (NP (JJ complete) (NN heart) (NN block))) (, ,)) (VP (VBD were) (ADJP (RBR more) (JJ likely)) (S (VP (TO to) (VP (VB occur) (PP (IN with) (NP (CC either) (NP (NN verapamil)) (CC or) (NP (NN diltiazem)))))))))))))))))) (. .))))

nsubj(likely-4, Hypotension-1)
xsubj(occur-6, Hypotension-1)
cop(likely-4, was-2)
advmod(likely-4, more-3)
root(ROOT-0, likely-4)
aux(occur-6, to-5)
xcomp(likely-4, occur-6)
mark(derivative-14, if-7)
det(antagonist-10, the-8)
nn(antagonist-10, calcium-9)
nsubj(derivative-14, antagonist-10)
cop(derivative-14, were-11)
det(derivative-14, a-12)
nn(derivative-14, dihydropyridine-13)
advcl(occur-6, derivative-14)
prep(derivative-14, e.g.-16)
pobj(e.g.-16, nifedipine-18)
mark(likely-36, while-20)
amod(ventricular-22, left-21)
nn(failure-23, ventricular-22)
nsubj(likely-36, failure-23)
xsubj(occur-38, failure-23)
nn(disturbances-27, AV-25)
nn(disturbances-27, conduction-26)
conj_and(failure-23, disturbances-27)
amod(block-32, complete-30)
nn(block-32, heart-31)
prep_including(failure-23, block-32)
cop(likely-36, were-34)
advmod(likely-36, more-35)
advcl(derivative-14, likely-36)
aux(occur-38, to-37)
xcomp(likely-36, occur-38)
preconj(verapamil-41, either-40)
prep_with(occur-38, verapamil-41)
conj_or(verapamil-41, diltiazem-43)

Risk/NN of/IN Anaphylactic/JJ Reaction/NN :/: Although/IN it/PRP is/VBZ known/VBN that/IN patients/NNS on/IN beta-blockers/NNS may/MD be/VB refractory/JJ to/TO epinephrine/NN in/IN the/DT treatment/NN of/IN anaphylactic/NN shock/NN ,/, beta-blockers/NNS can/MD ,/, in/IN addition/NN ,/, interfere/VB with/IN the/DT modulation/NN of/IN allergic/JJ reaction/NN and/CC lead/VB to/TO an/DT increased/VBN severity/NN and/or/CC frequency/NN of/IN attacks/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NN Risk)) (PP (IN of) (NP (JJ Anaphylactic) (NN Reaction)))) (: :) (S (SBAR (IN Although) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN known) (PP (IN that) (NP (NP (NNS patients)) (PP (IN on) (NP (NP (NNS beta-blockers)) (VP (MD may) (VP (VB be) (ADJP (JJ refractory) (PP (TO to) (NP (NP (NN epinephrine)) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN anaphylactic) (NN shock)))))))))))))))))) (, ,) (NP (NNS beta-blockers)) (VP (MD can) (, ,) (PP (IN in) (NP (NN addition))) (, ,) (VP (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN modulation)) (PP (IN of) (NP (JJ allergic) (NN reaction)))))) (CC and) (VP (VB lead) (PP (TO to) (NP (NP (DT an) (VBN increased) (NP (NP (NN severity)) (CC and/or) (NP (NN frequency)))) (PP (IN of) (NP (NNS attacks))))))))) (. .)))))

root(ROOT-0, Risk-1)
amod(Reaction-4, Anaphylactic-3)
prep_of(Risk-1, Reaction-4)
mark(known-9, Although-6)
nsubjpass(known-9, it-7)
auxpass(known-9, is-8)
advcl(interfere-32, known-9)
prep_that(known-9, patients-11)
prep_on(patients-11, beta-blockers-13)
aux(refractory-16, may-14)
cop(refractory-16, be-15)
dep(beta-blockers-13, refractory-16)
prep_to(refractory-16, epinephrine-18)
det(treatment-21, the-20)
prep_in(epinephrine-18, treatment-21)
nn(shock-24, anaphylactic-23)
prep_of(treatment-21, shock-24)
nsubj(interfere-32, beta-blockers-26)
aux(interfere-32, can-27)
prep_in(interfere-32, addition-30)
dep(Risk-1, interfere-32)
det(modulation-35, the-34)
prep_with(interfere-32, modulation-35)
amod(reaction-38, allergic-37)
prep_of(modulation-35, reaction-38)
conj_and(interfere-32, lead-40)
det(severity-44, an-42)
amod(severity-44, increased-43)
prep_to(lead-40, severity-44)
conj_and/or(severity-44, frequency-46)
prep_of(severity-44, attacks-48)

Severe/JJ allergic/JJ reactions/NNS including/VBG anaphylaxis/NN have/VBP been/VBN reported/VBN in/IN patients/NNS exposed/VBN to/TO a/DT variety/NN of/IN allergens/NNS either/CC by/IN repeated/JJ challenge/NN ,/, or/CC accidental/JJ contact/NN ,/, and/CC with/IN diagnostic/JJ or/CC therapeutic/JJ agents/NNS while/IN receiving/VBG beta-blockers/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Severe) (JJ allergic) (NNS reactions)) (PP (VBG including) (NP (NN anaphylaxis)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (PP (IN in) (NP (NP (NNS patients)) (VP (VBN exposed) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS allergens)))))))) (CC either) (PP (IN by) (NP (NP (JJ repeated) (NN challenge)) (, ,) (CC or) (NP (JJ accidental) (NN contact)))) (, ,) (CC and) (PP (IN with) (NP (ADJP (ADJP (JJ diagnostic)) (CC or) (ADJP (JJ therapeutic))) (NNS agents)))) (SBAR (IN while) (S (VP (VBG receiving) (NP (NN beta-blockers))))))))) (. .))))

amod(reactions-3, Severe-1)
amod(reactions-3, allergic-2)
nsubjpass(reported-8, reactions-3)
prep_including(reactions-3, anaphylaxis-5)
aux(reported-8, have-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
conj_and(reported-8, reported-8')
conj_and(reported-8, reported-8'')
prep_in(reported-8, patients-10)
partmod(patients-10, exposed-11)
det(variety-14, a-13)
prep_to(exposed-11, variety-14)
prep_of(variety-14, allergens-16)
preconj(reported-8, either-17)
amod(challenge-20, repeated-19)
agent(reported-8', challenge-20)
amod(contact-24, accidental-23)
conj_or(challenge-20, contact-24)
amod(agents-31, diagnostic-28)
conj_or(diagnostic-28, therapeutic-30)
prep_with(reported-8'', agents-31)
mark(receiving-33, while-32)
advcl(reported-8, receiving-33)
dobj(receiving-33, beta-blockers-34)

Such/JJ patients/NNS may/MD be/VB unresponsive/JJ to/TO the/DT usual/JJ doses/NNS of/IN epinephrine/NN used/VBN to/TO treat/VB allergic/JJ reaction/NN ./.

(ROOT (S1 (S (S (NP (JJ Such) (NNS patients)) (VP (MD may) (VP (VB be) (ADJP (JJ unresponsive) (PP (TO to) (NP (NP (DT the) (JJ usual) (NNS doses)) (PP (IN of) (NP (NN epinephrine))) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (JJ allergic) (NN reaction)))))))))))) (. .))))

amod(patients-2, Such-1)
nsubj(unresponsive-5, patients-2)
aux(unresponsive-5, may-3)
cop(unresponsive-5, be-4)
root(ROOT-0, unresponsive-5)
det(doses-9, the-7)
amod(doses-9, usual-8)
prep_to(unresponsive-5, doses-9)
prep_of(doses-9, epinephrine-11)
partmod(doses-9, used-12)
aux(treat-14, to-13)
xcomp(used-12, treat-14)
amod(reaction-16, allergic-15)
dobj(treat-14, reaction-16)

Special/JJ care/NN is/VBZ required/VBN if/IN this/DT drug/NN is/VBZ given/VBN to/TO patients/NNS receiving/VBG ganglion/NN blocking/NN compounds/NNS because/IN a/DT critical/JJ fall/VBP in/IN blood/NN pressure/NN may/MD occur/VB ./.

(ROOT (S1 (S (S (NP (JJ Special) (NN care)) (VP (VBZ is) (VP (VBN required) (SBAR (IN if) (S (NP (DT this) (NN drug)) (VP (VBZ is) (VP (VBN given) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN ganglion) (NN blocking) (NNS compounds))))) (SBAR (IN because) (S (NP (NP (DT a) (JJ critical)) (VP (VBP fall) (PP (IN in) (NP (NN blood) (NN pressure))))) (VP (MD may) (VP (VB occur)))))))))))) (. .))))

amod(care-2, Special-1)
nsubjpass(required-4, care-2)
auxpass(required-4, is-3)
root(ROOT-0, required-4)
mark(given-9, if-5)
det(drug-7, this-6)
nsubjpass(given-9, drug-7)
auxpass(given-9, is-8)
advcl(required-4, given-9)
prep_to(given-9, patients-11)
partmod(patients-11, receiving-12)
nn(compounds-15, ganglion-13)
nn(compounds-15, blocking-14)
dobj(receiving-12, compounds-15)
mark(occur-24, because-16)
det(critical-18, a-17)
nsubj(occur-24, critical-18)
dep(critical-18, fall-19)
nn(pressure-22, blood-21)
prep_in(fall-19, pressure-22)
aux(occur-24, may-23)
advcl(given-9, occur-24)

No/DT formal/JJ studies/NNS to/TO evaluate/VB drug/NN interactions/NNS with/IN bexarotene/NN have/VBP been/VBN conducted/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (JJ formal) (NNS studies)) (VP (TO to) (VP (VB evaluate) (NP (NP (NN drug) (NNS interactions)) (PP (IN with) (NP (NN bexarotene))))))) (VP (VBP have) (VP (VBN been) (VP (VBN conducted))))) (. .))))

det(studies-3, No-1)
amod(studies-3, formal-2)
nsubjpass(conducted-12, studies-3)
aux(evaluate-5, to-4)
dep(studies-3, evaluate-5)
nn(interactions-7, drug-6)
dobj(evaluate-5, interactions-7)
prep_with(interactions-7, bexarotene-9)
aux(conducted-12, have-10)
auxpass(conducted-12, been-11)
root(ROOT-0, conducted-12)

Bexarotene/JJ oxidative/JJ metabolites/NNS appear/VBP to/TO be/VB formed/VBN by/IN cytochrome/NN P450/NN 3A4/NN ./.

(ROOT (S1 (S (S (NP (JJ Bexarotene) (JJ oxidative) (NNS metabolites)) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (VP (VBN formed) (PP (IN by) (NP (NN cytochrome) (NN P450) (NN 3A4))))))))) (. .))))

amod(metabolites-3, Bexarotene-1)
amod(metabolites-3, oxidative-2)
nsubj(appear-4, metabolites-3)
xsubj(formed-7, metabolites-3)
root(ROOT-0, appear-4)
aux(formed-7, to-5)
auxpass(formed-7, be-6)
xcomp(appear-4, formed-7)
nn(3A4-11, cytochrome-9)
nn(3A4-11, P450-10)
agent(formed-7, 3A4-11)

On/IN the/DT basis/NN of/IN the/DT metabolism/NN of/IN bexarotene/NN by/IN cytochrome/NN P450/NN 3A4/NN ,/, ketoconazole/NN ,/, itraconazole/NN ,/, erythromycin/NN ,/, gemfibrozil/NN ,/, grapefruit/NN juice/NN ,/, and/CC other/JJ inhibitors/NNS of/IN cytochrome/NN P450/NN 3A4/NN would/MD be/VB expected/VBN to/TO lead/VB to/TO an/DT increase/NN in/IN plasma/NN bexarotene/NN concentrations/NNS ./.

(ROOT (S1 (S (S (PP (IN On) (DT the) (NN basis) (IN of) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN bexarotene))) (PP (IN by) (NP (NN cytochrome) (NN P450) (NN 3A4))))) (, ,) (NP (NP (NP (NN ketoconazole)) (, ,) (NP (NN itraconazole)) (, ,) (NP (NN erythromycin)) (, ,) (NP (NN gemfibrozil)) (, ,) (NP (NN grapefruit) (NN juice)) (, ,) (CC and) (NP (JJ other) (NNS inhibitors))) (PP (IN of) (NP (NN cytochrome) (NN P450) (NN 3A4)))) (VP (MD would) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB lead) (PP (TO to) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN plasma) (NN bexarotene) (NNS concentrations)))))))))))) (. .))))

dep(expected-34, On-1)
dep(expected-34, the-2)
dep(expected-34, basis-3)
det(metabolism-6, the-5)
prep_of(expected-34, metabolism-6)
prep_of(metabolism-6, bexarotene-8)
nn(3A4-12, cytochrome-10)
nn(3A4-12, P450-11)
prep_by(metabolism-6, 3A4-12)
nsubjpass(expected-34, ketoconazole-14)
conj_and(ketoconazole-14, itraconazole-16)
conj_and(ketoconazole-14, erythromycin-18)
conj_and(ketoconazole-14, gemfibrozil-20)
nn(juice-23, grapefruit-22)
conj_and(ketoconazole-14, juice-23)
amod(inhibitors-27, other-26)
conj_and(ketoconazole-14, inhibitors-27)
nn(3A4-31, cytochrome-29)
nn(3A4-31, P450-30)
prep_of(ketoconazole-14, 3A4-31)
aux(expected-34, would-32)
auxpass(expected-34, be-33)
root(ROOT-0, expected-34)
aux(lead-36, to-35)
xcomp(expected-34, lead-36)
det(increase-39, an-38)
prep_to(lead-36, increase-39)
nn(concentrations-43, plasma-41)
nn(concentrations-43, bexarotene-42)
prep_in(increase-39, concentrations-43)

Furthermore/RB ,/, rifampin/NN ,/, phenytoin/NN ,/, phenobarbital/NN ,/, and/CC other/JJ inducers/NNS of/IN cytochrome/NN P450/NN 3A4/NN may/MD cause/VB a/DT reduction/NN in/IN plasma/NN bexarotene/NN concentrations/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NP (NP (NN rifampin)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN phenobarbital)) (, ,) (CC and) (NP (JJ other) (NNS inducers))) (PP (IN of) (NP (NN cytochrome) (NN P450) (NN 3A4)))) (VP (MD may) (VP (VB cause) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NN plasma) (NN bexarotene) (NNS concentrations))))))) (. .))))

advmod(cause-17, Furthermore-1)
nsubj(cause-17, rifampin-3)
conj_and(rifampin-3, phenytoin-5)
conj_and(rifampin-3, phenobarbital-7)
amod(inducers-11, other-10)
conj_and(rifampin-3, inducers-11)
nn(3A4-15, cytochrome-13)
nn(3A4-15, P450-14)
prep_of(rifampin-3, 3A4-15)
aux(cause-17, may-16)
root(ROOT-0, cause-17)
det(reduction-19, a-18)
dobj(cause-17, reduction-19)
nn(concentrations-23, plasma-21)
nn(concentrations-23, bexarotene-22)
prep_in(reduction-19, concentrations-23)

Concomitant/JJ administration/NN of/IN Targretin/NN @/NN capsules/NNS and/CC gemfibrozil/NN resulted/VBD in/IN substantial/JJ increases/NNS in/IN plasma/NN concentrations/NNS of/IN bexarotene/NN ,/, probably/RB at/IN least/JJS partially/RB related/JJ to/TO cytochrome/NN P450/NN 3A4/NN inhibition/NN by/IN gemfibrozil/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN Targretin) (NN @) (NNS capsules)) (CC and) (NP (NN gemfibrozil))))) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ substantial) (NNS increases)) (PP (IN in) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN bexarotene))))))) (, ,) (ADVP (RB probably)) (ADJP (ADVP (ADVP (IN at) (JJS least)) (RB partially)) (JJ related) (PP (TO to) (NP (NP (NP (NN cytochrome) (NN P450) (NN 3A4)) (NN inhibition)) (PP (IN by) (NP (NN gemfibrozil)))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubj(resulted-9, administration-2)
nn(capsules-6, Targretin-4)
nn(capsules-6, @-5)
prep_of(administration-2, capsules-6)
conj_and(capsules-6, gemfibrozil-8)
root(ROOT-0, resulted-9)
amod(increases-12, substantial-11)
prep_in(resulted-9, increases-12)
nn(concentrations-15, plasma-14)
prep_in(increases-12, concentrations-15)
prep_of(concentrations-15, bexarotene-17)
advmod(resulted-9, probably-19)
advmod(related-23, at-20)
pobj(at-20, least-21)
advmod(at-20, partially-22)
acomp(resulted-9, related-23)
nn(3A4-27, cytochrome-25)
nn(3A4-27, P450-26)
nn(inhibition-28, 3A4-27)
prep_to(related-23, inhibition-28)
prep_by(inhibition-28, gemfibrozil-30)

Under/IN similar/JJ conditions/NNS ,/, bexarotene/NN concentrations/NNS were/VBD not/RB affected/VBN by/IN concomitant/JJ atorvastatin/NN administration/NN ./.

(ROOT (S1 (S (S (PP (IN Under) (NP (JJ similar) (NNS conditions))) (, ,) (NP (NN bexarotene) (NNS concentrations)) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN by) (NP (JJ concomitant) (NN atorvastatin) (NN administration)))))) (. .))))

amod(conditions-3, similar-2)
prep_under(affected-9, conditions-3)
nn(concentrations-6, bexarotene-5)
nsubjpass(affected-9, concentrations-6)
auxpass(affected-9, were-7)
neg(affected-9, not-8)
root(ROOT-0, affected-9)
amod(administration-13, concomitant-11)
nn(administration-13, atorvastatin-12)
agent(affected-9, administration-13)

Concomitant/JJ administration/NN of/IN gemfibrozil/NN with/IN Targretin/NN @/NN capsules/NNS is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NN gemfibrozil))) (PP (IN with) (NP (NN Targretin) (NN @) (NNS capsules)))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

amod(administration-2, Concomitant-1)
nsubjpass(recommended-11, administration-2)
prep_of(administration-2, gemfibrozil-4)
nn(capsules-8, Targretin-6)
nn(capsules-8, @-7)
prep_with(administration-2, capsules-8)
auxpass(recommended-11, is-9)
neg(recommended-11, not-10)
root(ROOT-0, recommended-11)

When/WRB Bezalip/NN or/CC Bezalip/NN retard/VB is/VBZ used/VBN at/IN the/DT same/JJ time/NN as/IN other/JJ medicines/NNS or/CC substances/NNS the/DT following/VBG interactions/NNS must/MD be/VB taken/VBN into/IN account/NN :/: -/CC Bezalip/NN and/CC Bezalip/NN retard/VB may/MD enhance/VB the/DT action/NN of/IN anticoagulants/NNS of/IN the/DT coumarin/NN type/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NP (NP (NN Bezalip)) (CC or) (NP (NN Bezalip))) (VP (VB retard))) (VP (VBZ is) (VP (VBN used) (PP (IN at) (NP (DT the) (JJ same) (NN time))) (PP (IN as) (NP (NP (JJ other) (NNS medicines)) (CC or) (NP (NNS substances)))))))) (NP (DT the) (VBG following) (NNS interactions)) (VP (MD must) (VP (VB be) (VP (VBN taken) (PP (IN into) (NP (NN account))))))) (: :) (S (NP (NP (CC -) (NP (NN Bezalip)) (CC and) (NP (NN Bezalip))) (VP (VB retard))) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NP (NNS anticoagulants)) (PP (IN of) (NP (DT the) (NN coumarin) (NN type))))))))) (. .))))

advmod(used-7, When-1)
nsubjpass(used-7, Bezalip-2)
conj_or(Bezalip-2, Bezalip-4)
dep(Bezalip-2, retard-5)
auxpass(used-7, is-6)
advcl(taken-22, used-7)
det(time-11, the-9)
amod(time-11, same-10)
prep_at(used-7, time-11)
amod(medicines-14, other-13)
prep_as(used-7, medicines-14)
conj_or(medicines-14, substances-16)
det(interactions-19, the-17)
amod(interactions-19, following-18)
nsubjpass(taken-22, interactions-19)
aux(taken-22, must-20)
auxpass(taken-22, be-21)
root(ROOT-0, taken-22)
prep_into(taken-22, account-24)
nsubj(enhance-32, Bezalip-27)
conj_and(Bezalip-27, Bezalip-29)
dep(Bezalip-27, retard-30)
aux(enhance-32, may-31)
parataxis(taken-22, enhance-32)
det(action-34, the-33)
dobj(enhance-32, action-34)
prep_of(action-34, anticoagulants-36)
det(type-40, the-38)
nn(type-40, coumarin-39)
prep_of(anticoagulants-36, type-40)

For/IN this/DT reason/NN ,/, the/DT dose/NN of/IN the/DT anticoagulant/NN should/MD be/VB reduced/VBN by/IN 30/CD -/TO 50/CD %/NN at/IN the/DT start/NN of/IN treatment/NN with/IN Bezalip/NNP or/CC Bezalip/NNP retard/VB and/CC then/RB titrated/VBN according/VBG to/TO the/DT blood/NN clotting/NN parameters/NNS ./.

(ROOT (S1 (S (PP (IN For) (NP (DT this) (NN reason))) (, ,) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (DT the) (NN anticoagulant)))) (VP (MD should) (VP (VB be) (VP (VP (VBN reduced) (PP (IN by) (NP (QP (CD 30) (TO -) (CD 50)) (NN %))) (PP (IN at) (NP (NP (DT the) (NN start)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN with) (NP (NP (NP (NNP Bezalip)) (CC or) (NP (NNP Bezalip))) (VP (VB retard))))))))) (CC and) (VP (ADVP (RB then)) (VBN titrated) (PP (VBG according) (PP (TO to) (NP (DT the) (NN blood) (NN clotting) (NNS parameters)))))))) (. .))))

det(reason-3, this-2)
prep_for(reduced-12, reason-3)
det(dose-6, the-5)
nsubjpass(reduced-12, dose-6)
det(anticoagulant-9, the-8)
prep_of(dose-6, anticoagulant-9)
aux(reduced-12, should-10)
auxpass(reduced-12, be-11)
root(ROOT-0, reduced-12)
number(50-16, 30-14)
num(%-17, 50-16)
agent(reduced-12, %-17)
det(start-20, the-19)
prep_at(reduced-12, start-20)
prep_of(start-20, treatment-22)
prep_with(treatment-22, Bezalip-24)
conj_or(Bezalip-24, Bezalip-26)
dep(Bezalip-24, retard-27)
advmod(titrated-30, then-29)
conj_and(reduced-12, titrated-30)
prepc_according_to(titrated-30, to-32)
det(parameters-36, the-33)
nn(parameters-36, blood-34)
nn(parameters-36, clotting-35)
pobj(titrated-30, parameters-36)

-/CC The/DT action/NN of/IN sulphonylureas/NN and/CC insulin/NN may/MD be/VB enhanced/VBN by/IN Bezalip/NNP or/CC Bezalip/NNP retard/VB ./.

(ROOT (S1 (S (S (NP (NP (CC -) (DT The) (NN action)) (PP (IN of) (NP (NP (NN sulphonylureas)) (CC and) (NP (NN insulin))))) (VP (MD may) (VP (VB be) (VP (VBN enhanced) (PP (IN by) (NP (NP (NP (NNP Bezalip)) (CC or) (NP (NNP Bezalip))) (VP (VB retard)))))))) (. .))))

det(action-3, The-2)
nsubjpass(enhanced-10, action-3)
prep_of(action-3, sulphonylureas-5)
conj_and(sulphonylureas-5, insulin-7)
aux(enhanced-10, may-8)
auxpass(enhanced-10, be-9)
root(ROOT-0, enhanced-10)
agent(enhanced-10, Bezalip-12)
conj_or(Bezalip-12, Bezalip-14)
dep(Bezalip-12, retard-15)

This/DT may/MD be/VB due/JJ to/TO an/DT improved/JJ glucose/NN utilization/NN with/IN simultaneous/JJ reduction/NN in/IN insulin/NN requirement/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (NP (DT an) (JJ improved) (NN glucose) (NN utilization)) (PP (IN with) (NP (NP (JJ simultaneous) (NN reduction)) (PP (IN in) (NP (NN insulin) (NN requirement))))))))))) (. .))))

nsubj(due-4, This-1)
aux(due-4, may-2)
cop(due-4, be-3)
root(ROOT-0, due-4)
det(utilization-9, an-6)
amod(utilization-9, improved-7)
nn(utilization-9, glucose-8)
prep_to(due-4, utilization-9)
amod(reduction-12, simultaneous-11)
prep_with(utilization-9, reduction-12)
nn(requirement-15, insulin-14)
prep_in(reduction-12, requirement-15)

-/CC In/IN isolated/VBN cases/NNS ,/, a/DT pronounced/JJ though/RB reversible/JJ ,/, impairment/NN of/IN renal/JJ function/NN (/-LRB- accompanied/VBN by/IN a/DT corresponding/JJ increase/NN in/IN the/DT serum/NN creatinine/NN level/NN )/-RRB- has/VBZ been/VBN reported/VBN in/IN organ/NN transplant/NN patients/NNS receiving/VBG immuno-suppressant/JJ therapy/NN and/CC concomitant/JJ bezafibrate/NN ./.

(ROOT (S1 (S (S (PP (CC -) (PP (IN In) (NP (VBN isolated) (NNS cases)))) (, ,) (NP (NP (DT a) (ADJP (ADJP (JJ pronounced)) (ADJP (RB though) (JJ reversible))) (, ,) (NN impairment)) (PP (IN of) (NP (JJ renal) (NN function))) (-LRB- -LRB-) (VP (VBN accompanied) (PP (IN by) (NP (NP (DT a) (JJ corresponding) (NN increase)) (PP (IN in) (NP (DT the) (NN serum) (NN creatinine) (NN level)))))) (-RRB- -RRB-)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NN organ) (NN transplant) (NNS patients)) (VP (VBG receiving) (NP (NP (JJ immuno-suppressant) (NN therapy)) (CC and) (NP (JJ concomitant) (NN bezafibrate)))))))))) (. .))))

amod(cases-4, isolated-3)
prep_in(reported-29, cases-4)
det(impairment-11, a-6)
amod(impairment-11, pronounced-7)
advmod(reversible-9, though-8)
dep(pronounced-7, reversible-9)
nsubjpass(reported-29, impairment-11)
amod(function-14, renal-13)
prep_of(impairment-11, function-14)
partmod(impairment-11, accompanied-16)
det(increase-20, a-18)
amod(increase-20, corresponding-19)
agent(accompanied-16, increase-20)
det(level-25, the-22)
nn(level-25, serum-23)
nn(level-25, creatinine-24)
prep_in(increase-20, level-25)
aux(reported-29, has-27)
auxpass(reported-29, been-28)
root(ROOT-0, reported-29)
nn(patients-33, organ-31)
nn(patients-33, transplant-32)
prep_in(reported-29, patients-33)
partmod(patients-33, receiving-34)
amod(therapy-36, immuno-suppressant-35)
dobj(receiving-34, therapy-36)
amod(bezafibrate-39, concomitant-38)
conj_and(therapy-36, bezafibrate-39)

Accordingly/RB ,/, renal/JJ function/NN should/MD be/VB closely/RB monitored/VBN in/IN these/DT patients/NNS and/CC ,/, in/IN the/DT event/NN of/IN relevant/JJ significant/JJ changes/NNS in/IN laboratory/JJ parameters/NNS ,/, bezafibrate/NN should/MD ,/, if/IN necessary/JJ ,/, be/VB discontinued/VBN ./.

(ROOT (S1 (S (S (S (ADVP (RB Accordingly)) (, ,) (NP (JJ renal) (NN function)) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN monitored) (PP (IN in) (NP (DT these) (NNS patients))))))) (CC and) (S (, ,) (PP (IN in) (DT the) (NN event) (IN of) (NP (NP (JJ relevant) (JJ significant) (NNS changes)) (PP (IN in) (NP (JJ laboratory) (NNS parameters))))) (, ,) (NP (NN bezafibrate)) (VP (MD should) (, ,) (PP (IN if) (NP (JJ necessary))) (, ,) (VP (VB be) (VP (VBN discontinued)))))) (. .))))

advmod(monitored-8, Accordingly-1)
amod(function-4, renal-3)
nsubjpass(monitored-8, function-4)
aux(monitored-8, should-5)
auxpass(monitored-8, be-6)
advmod(monitored-8, closely-7)
root(ROOT-0, monitored-8)
det(patients-11, these-10)
prep_in(monitored-8, patients-11)
dep(discontinued-32, in-14)
dep(discontinued-32, the-15)
dep(discontinued-32, event-16)
amod(changes-20, relevant-18)
amod(changes-20, significant-19)
prep_of(discontinued-32, changes-20)
amod(parameters-23, laboratory-22)
prep_in(changes-20, parameters-23)
nsubjpass(discontinued-32, bezafibrate-25)
aux(discontinued-32, should-26)
prep_if(discontinued-32, necessary-29)
auxpass(discontinued-32, be-31)
conj_and(monitored-8, discontinued-32)

-/CC When/WRB Bezalip/NN or/CC Bezalip/NN retard/VB is/VBZ used/VBN concurrently/RB with/IN anion-exchange/JJ resins/NNS (/-LRB- e.g./FW cholestryramine/NN )/-RRB- ,/, an/DT interval/NN of/IN at/IN least/JJS 2/CD hours/NNS should/MD be/VB maintained/VBN between/IN the/DT two/CD medicines/NNS ,/, since/IN the/DT absorption/NN of/IN Bezalip/NNP or/CC Bezalip/NNP retard/VB is/VBZ impaired/VBN ./.

(ROOT (S1 (S (CC -) (SBAR (WHADVP (WRB When)) (S (NP (NP (NP (NN Bezalip)) (CC or) (NP (NN Bezalip))) (VP (VB retard))) (VP (VBZ is) (VP (VBN used) (ADVP (RB concurrently)) (PP (IN with) (NP (NP (JJ anion-exchange) (NNS resins)) (PRN (-LRB- -LRB-) (NP (FW e.g.) (NN cholestryramine)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (DT an) (NN interval)) (PP (IN of) (NP (QP (IN at) (JJS least) (CD 2)) (NNS hours)))) (VP (MD should) (VP (VB be) (VP (VBN maintained) (PP (IN between) (NP (DT the) (CD two) (NNS medicines))) (, ,) (SBAR (IN since) (S (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NP (NP (NNP Bezalip)) (CC or) (NP (NNP Bezalip))) (VP (VB retard))))) (VP (VBZ is) (VP (VBN impaired)))))))) (. .))))

advmod(used-8, When-2)
nsubjpass(used-8, Bezalip-3)
conj_or(Bezalip-3, Bezalip-5)
dep(Bezalip-3, retard-6)
auxpass(used-8, is-7)
advcl(maintained-27, used-8)
advmod(used-8, concurrently-9)
amod(resins-12, anion-exchange-11)
prep_with(used-8, resins-12)
nn(cholestryramine-15, e.g.-14)
appos(resins-12, cholestryramine-15)
det(interval-19, an-18)
nsubjpass(maintained-27, interval-19)
quantmod(2-23, at-21)
mwe(at-21, least-22)
pobj(at-21, least-22)
num(hours-24, 2-23)
prep_of(interval-19, hours-24)
aux(maintained-27, should-25)
auxpass(maintained-27, be-26)
root(ROOT-0, maintained-27)
det(medicines-31, the-29)
num(medicines-31, two-30)
prep_between(maintained-27, medicines-31)
mark(impaired-42, since-33)
det(absorption-35, the-34)
nsubjpass(impaired-42, absorption-35)
prep_of(absorption-35, Bezalip-37)
conj_or(Bezalip-37, Bezalip-39)
dep(Bezalip-37, retard-40)
auxpass(impaired-42, is-41)
advcl(maintained-27, impaired-42)

-/CC Perhexiline/NN hydrogen/NN maleate/NN or/CC MAO-inhibitors/NN (/-LRB- with/IN hepatotoxic/JJ potential/NN )/-RRB- must/MD not/RB be/VB administered/VBN together/RB with/IN Bezalip/NN or/CC Bezalip/NN retard/VB ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NP (NN Perhexiline) (NN hydrogen) (NN maleate)) (CC or) (NP (NN MAO-inhibitors))) (PRN (-LRB- -LRB-) (PP (IN with) (NP (JJ hepatotoxic) (NN potential))) (-RRB- -RRB-))) (VP (MD must) (RB not) (VP (VB be) (VP (VBN administered) (ADVP (RB together)) (PP (IN with) (NP (NP (NN Bezalip)) (CC or) (NP (NP (NN Bezalip)) (VP (VB retard))))))))) (. .))))

nn(maleate-4, Perhexiline-2)
nn(maleate-4, hydrogen-3)
nsubjpass(administered-15, maleate-4)
conj_or(maleate-4, MAO-inhibitors-6)
dep(maleate-4, with-8)
amod(potential-10, hepatotoxic-9)
pobj(with-8, potential-10)
aux(administered-15, must-12)
neg(administered-15, not-13)
auxpass(administered-15, be-14)
root(ROOT-0, administered-15)
prep_together_with(administered-15, Bezalip-18)
conj_or(Bezalip-18, Bezalip-20)
dep(Bezalip-20, retard-21)

Drug/NN Interactions/NNS :/: The/DT central/JJ anticholinergic/NN syndrome/NN can/MD occur/VB when/WRB anticholinergic/JJ agents/NNS such/JJ as/IN AKINETON/NN are/VBP administered/VBN concomitantly/RB with/IN drugs/NNS that/WDT have/VBP secondary/JJ anticholinergic/JJ actions/NNS ,/, e.g./FW ,/, certain/JJ narcotic/JJ analgesics/NNS such/JJ as/IN meperidine/NN ,/, the/DT phenothiazines/NNS and/CC other/JJ antipsychotics/NNS ,/, tricyclic/JJ antidepressants/NNS ,/, certain/JJ antiarrhythmics/NNS such/JJ as/IN the/DT quinidine/NN salts/NNS ,/, and/CC antihistamines/NNS ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NNS Interactions)) (: :) (S (NP (DT The) (JJ central) (NN anticholinergic) (NN syndrome)) (VP (MD can) (VP (VB occur) (SBAR (WHADVP (WRB when)) (S (NP (NP (JJ anticholinergic) (NNS agents)) (PP (JJ such) (IN as) (NP (NN AKINETON)))) (VP (VBP are) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (NP (NP (JJ secondary) (JJ anticholinergic) (NNS actions)) (, ,) (PP (FW e.g.) (, ,) (NP (NP (JJ certain) (JJ narcotic) (NNS analgesics)) (PP (JJ such) (IN as) (NP (NP (NN meperidine)) (, ,) (NP (DT the) (NNS phenothiazines)) (CC and) (NP (NP (JJ other) (NNS antipsychotics)) (, ,) (NP (JJ tricyclic) (NNS antidepressants)) (, ,) (NP (NP (JJ certain) (NNS antiarrhythmics)) (PP (JJ such) (IN as) (NP (DT the) (NN quinidine) (NNS salts)))) (, ,) (CC and) (NP (NNS antihistamines)))))))))))))))))))) (. .)))))

nn(Interactions-2, Drug-1)
root(ROOT-0, Interactions-2)
det(syndrome-7, The-4)
amod(syndrome-7, central-5)
nn(syndrome-7, anticholinergic-6)
nsubj(occur-9, syndrome-7)
aux(occur-9, can-8)
dep(Interactions-2, occur-9)
advmod(administered-17, when-10)
amod(agents-12, anticholinergic-11)
nsubjpass(administered-17, agents-12)
mwe(agents-12, such-13)
prep_as(agents-12, AKINETON-15)
auxpass(administered-17, are-16)
advcl(occur-9, administered-17)
advmod(administered-17, concomitantly-18)
prep_with(administered-17, drugs-20)
nsubj(have-22, drugs-20)
rcmod(drugs-20, have-22)
amod(actions-25, secondary-23)
amod(actions-25, anticholinergic-24)
dobj(have-22, actions-25)
prep(actions-25, e.g.-27)
amod(analgesics-31, certain-29)
amod(analgesics-31, narcotic-30)
pobj(e.g.-27, analgesics-31)
prep_such_as(analgesics-31, meperidine-34)
det(phenothiazines-37, the-36)
conj_and(meperidine-34, phenothiazines-37)
amod(antipsychotics-40, other-39)
conj_and(meperidine-34, antipsychotics-40)
amod(antidepressants-43, tricyclic-42)
conj_and(antipsychotics-40, antidepressants-43)
amod(antiarrhythmics-46, certain-45)
conj_and(antipsychotics-40, antiarrhythmics-46)
det(salts-51, the-49)
nn(salts-51, quinidine-50)
prep_such_as(antiarrhythmics-46, salts-51)
conj_and(antipsychotics-40, antihistamines-54)

ZEBETA/NN should/MD not/RB be/VB combined/VBN with/IN other/JJ beta-blocking/JJ agent/NN s/NNS ./.

(ROOT (S1 (S (S (NP (NN ZEBETA)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN combined) (PP (IN with) (NP (JJ other) (JJ beta-blocking) (NN agent) (NNS s))))))) (. .))))

nsubjpass(combined-5, ZEBETA-1)
aux(combined-5, should-2)
neg(combined-5, not-3)
auxpass(combined-5, be-4)
root(ROOT-0, combined-5)
amod(s-10, other-7)
amod(s-10, beta-blocking-8)
nn(s-10, agent-9)
prep_with(combined-5, s-10)

Patients/NNS receiving/VBG catecholamine-depleting/JJ drugs/NNS ,/, such/JJ as/IN reserpine/NN or/CC guanethidine/NN ,/, should/MD be/VB closely/RB monitored/VBN ,/, because/IN the/DT added/VBN beta-adrenergic/JJ blocking/VBG action/NN of/IN ZEBETA/NN may/MD produce/VB excessive/JJ reduction/NN of/IN sympathetic/JJ activity/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (NP (JJ catecholamine-depleting) (NNS drugs)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN reserpine)) (CC or) (NP (NN guanethidine)))) (, ,)))) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN monitored)) (, ,) (SBAR (IN because) (S (NP (NP (DT the) (VBN added) (JJ beta-adrenergic) (VBG blocking) (NN action)) (PP (IN of) (NP (NN ZEBETA)))) (VP (MD may) (VP (VB produce) (NP (NP (JJ excessive) (NN reduction)) (PP (IN of) (NP (JJ sympathetic) (NN activity))))))))))) (. .))))

nsubjpass(monitored-15, Patients-1)
partmod(Patients-1, receiving-2)
amod(drugs-4, catecholamine-depleting-3)
dobj(receiving-2, drugs-4)
prep_such_as(drugs-4, reserpine-8)
conj_or(reserpine-8, guanethidine-10)
aux(monitored-15, should-12)
auxpass(monitored-15, be-13)
advmod(monitored-15, closely-14)
root(ROOT-0, monitored-15)
mark(produce-26, because-17)
det(action-22, the-18)
amod(action-22, added-19)
amod(action-22, beta-adrenergic-20)
amod(action-22, blocking-21)
nsubj(produce-26, action-22)
prep_of(action-22, ZEBETA-24)
aux(produce-26, may-25)
advcl(monitored-15, produce-26)
amod(reduction-28, excessive-27)
dobj(produce-26, reduction-28)
amod(activity-31, sympathetic-30)
prep_of(reduction-28, activity-31)

In/IN patients/NNS receiving/VBG concurrent/JJ therapy/NN with/IN clonidine/NN ,/, if/IN therapy/NN is/VBZ to/TO be/VB discontinued/VBN ,/, it/PRP is/VBZ suggested/VBN that/IN ZEBETA/NN be/VB discontinued/VBN for/IN several/JJ days/NNS before/IN the/DT withdrawal/NN of/IN clonidine/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (JJ concurrent) (NN therapy)) (PP (IN with) (NP (NN clonidine))))))) (, ,) (SBAR (IN if) (S (NP (NN therapy)) (VP (VBZ is) (S (VP (TO to) (VP (VB be) (VP (VBN discontinued)))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN suggested) (SBAR (IN that) (S (NP (NN ZEBETA)) (VP (VB be) (VP (VBN discontinued) (PP (IN for) (NP (NP (JJ several) (NNS days)) (PP (IN before) (NP (NP (DT the) (NN withdrawal)) (PP (IN of) (NP (NN clonidine)))))))))))))) (. .))))

prep_in(suggested-18, patients-2)
partmod(patients-2, receiving-3)
amod(therapy-5, concurrent-4)
dobj(receiving-3, therapy-5)
prep_with(therapy-5, clonidine-7)
mark(is-11, if-9)
nsubj(is-11, therapy-10)
xsubj(discontinued-14, therapy-10)
advcl(suggested-18, is-11)
aux(discontinued-14, to-12)
auxpass(discontinued-14, be-13)
xcomp(is-11, discontinued-14)
nsubjpass(suggested-18, it-16)
auxpass(suggested-18, is-17)
root(ROOT-0, suggested-18)
complm(discontinued-22, that-19)
nsubjpass(discontinued-22, ZEBETA-20)
auxpass(discontinued-22, be-21)
ccomp(suggested-18, discontinued-22)
amod(days-25, several-24)
prep_for(discontinued-22, days-25)
det(withdrawal-28, the-27)
prep_before(days-25, withdrawal-28)
prep_of(withdrawal-28, clonidine-30)

ZEBETA/NN should/MD be/VB used/VBN with/IN care/NN when/WRB myocardial/JJ depressants/NNS or/CC inhibitors/NNS of/IN AV/NN conduction/NN ,/, such/JJ as/IN certain/JJ calcium/NN antagonist/NN s/NNS (/-LRB- particularly/RB of/IN the/DT phenylalkylamine/JJ [/-LRB- verapamil/NN ]/-RRB- and/CC benzothiazepine/NN [/-LRB- diltiazem/NN ]/-RRB- classes/NNS )/-RRB- ,/, or/CC antiarrhythmic/JJ agent/NN s/NNS ,/, such/JJ as/IN disopyramide/NN ,/, are/VBP used/VBN concurrently/RB ./.

(ROOT (S1 (S (S (NP (NN ZEBETA)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN care))) (SBAR (WHADVP (WRB when)) (S (NP (NP (JJ myocardial) (NNS depressants)) (CC or) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NN AV) (NN conduction))) (, ,) (PP (JJ such) (IN as) (NP (NP (NP (JJ certain) (NN calcium) (NN antagonist) (NNS s)) (PRN (-LRB- -LRB-) (ADVP (RB particularly)) (PP (IN of) (NP (DT the) (JJ phenylalkylamine) (PRN (-LRB- -LSB-) (NP (NN verapamil)) (-RRB- -RSB-)) (CC and) (NN benzothiazepine) (PRN (-LRB- -LSB-) (NP (NN diltiazem)) (-RRB- -RSB-)) (NNS classes))) (-RRB- -RRB-))) (, ,) (CC or) (NP (JJ antiarrhythmic) (NN agent) (NNS s)))) (, ,) (PP (JJ such) (IN as) (NP (NN disopyramide))) (, ,))) (VP (VBP are) (VP (VBN used) (ADVP (RB concurrently)))))))))) (. .))))

nsubjpass(used-4, ZEBETA-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
prep_with(used-4, care-6)
advmod(used-48, when-7)
amod(depressants-9, myocardial-8)
nsubjpass(used-48, depressants-9)
conj_or(depressants-9, inhibitors-11)
nn(conduction-14, AV-13)
prep_of(inhibitors-11, conduction-14)
amod(s-21, certain-18)
nn(s-21, calcium-19)
nn(s-21, antagonist-20)
prep_such_as(inhibitors-11, s-21)
dep(of-24, particularly-23)
dep(s-21, of-24)
det(verapamil-28, the-25)
amod(verapamil-28, phenylalkylamine-26)
punct(verapamil-28, -LSB--27)
pobj(of-24, verapamil-28)
punct(verapamil-28, -RSB--29)
nn(classes-35, benzothiazepine-31)
punct(diltiazem-33, -LSB--32)
appos(classes-35, diltiazem-33)
punct(diltiazem-33, -RSB--34)
conj_and(verapamil-28, classes-35)
amod(s-41, antiarrhythmic-39)
nn(s-41, agent-40)
conj_or(s-21, s-41)
prep_such_as(inhibitors-11, disopyramide-45)
auxpass(used-48, are-47)
advcl(used-4, used-48)
advmod(used-48, concurrently-49)

Concurrent/JJ use/NN of/IN rifampin/NN increases/VBZ the/DT metabolic/JJ clearance/NN of/IN ZEBETA/NN ,/, resulting/VBG in/IN a/DT shortened/VBD elimination/NN half-life/NN of/IN ZEBETA/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN use)) (PP (IN of) (NP (NN rifampin)))) (VP (VBZ increases) (NP (NP (DT the) (JJ metabolic) (NN clearance)) (PP (IN of) (NP (NN ZEBETA)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (VBD shortened) (NN elimination) (NN half-life)) (PP (IN of) (NP (NN ZEBETA))))))))) (. .))))

amod(use-2, Concurrent-1)
nsubj(increases-5, use-2)
prep_of(use-2, rifampin-4)
root(ROOT-0, increases-5)
det(clearance-8, the-6)
amod(clearance-8, metabolic-7)
dobj(increases-5, clearance-8)
prep_of(clearance-8, ZEBETA-10)
partmod(increases-5, resulting-12)
xcomp(increases-5, resulting-12)
det(half-life-17, a-14)
amod(half-life-17, shortened-15)
nn(half-life-17, elimination-16)
prep_in(resulting-12, half-life-17)
prep_of(half-life-17, ZEBETA-19)

Pharmacokinetic/JJ studies/NNS document/VBP no/DT clinically/RB relevant/JJ interactions/NNS with/IN other/JJ agents/NNS given/VBN concomitantly/RB ,/, including/VBG thiazide/NN diuretics/NNS ,/, digoxin/NN ,/, and/CC cimetidine/NN ./.

(ROOT (S1 (S (S (NP (JJ Pharmacokinetic) (NNS studies)) (VP (VBP document) (NP (NP (DT no) (ADJP (RB clinically) (JJ relevant)) (NNS interactions)) (PP (IN with) (NP (NP (JJ other) (NNS agents)) (VP (VBN given) (ADVP (RB concomitantly))) (, ,) (PP (VBG including) (NP (NP (NN thiazide) (NNS diuretics)) (, ,) (NP (NN digoxin)) (, ,) (CC and) (NP (NN cimetidine))))))))) (. .))))

amod(studies-2, Pharmacokinetic-1)
nsubj(document-3, studies-2)
root(ROOT-0, document-3)
det(interactions-7, no-4)
advmod(relevant-6, clinically-5)
amod(interactions-7, relevant-6)
dobj(document-3, interactions-7)
amod(agents-10, other-9)
prep_with(interactions-7, agents-10)
partmod(agents-10, given-11)
advmod(given-11, concomitantly-12)
nn(diuretics-16, thiazide-15)
prep_including(agents-10, diuretics-16)
conj_and(diuretics-16, digoxin-18)
conj_and(diuretics-16, cimetidine-21)

There/EX was/VBD no/DT effect/NN of/IN ZEBETA/NN on/IN prothrombin/NN time/NN in/IN patients/NNS on/IN stable/JJ doses/NNS of/IN warfarin/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (NN effect)) (PP (IN of) (NP (NN ZEBETA))) (PP (IN on) (NP (NP (NN prothrombin) (NN time)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN on) (NP (NP (JJ stable) (NNS doses)) (PP (IN of) (NP (NN warfarin)))))))))))) (. .))))

expl(was-2, There-1)
root(ROOT-0, was-2)
det(effect-4, no-3)
nsubj(was-2, effect-4)
prep_of(effect-4, ZEBETA-6)
nn(time-9, prothrombin-8)
prep_on(effect-4, time-9)
prep_in(time-9, patients-11)
amod(doses-14, stable-13)
prep_on(patients-11, doses-14)
prep_of(doses-14, warfarin-16)

Risk/NN of/IN Anaphylactic/JJ Reaction/NN :/: While/IN taking/VBG beta-blockers/NN ,/, patients/NNS with/IN a/DT history/NN of/IN severe/JJ anaphylactic/JJ reaction/NN to/TO a/DT variety/NN of/IN allergens/NNS may/MD be/VB more/RBR reactive/JJ to/TO repeated/JJ challenge/NN ,/, either/CC accidental/JJ ,/, diagnostic/JJ ,/, or/CC therapeutic/JJ ./.

(ROOT (S1 (S (NP (NP (NP (NN Risk)) (PP (IN of) (NP (JJ Anaphylactic) (NN Reaction)))) (: :) (S (SBAR (IN While) (S (VP (VBG taking) (NP (NN beta-blockers))))) (, ,) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (JJ severe) (JJ anaphylactic) (NN reaction)) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS allergens)))))))))) (VP (MD may) (VP (VB be) (ADJP (ADJP (RBR more) (JJ reactive) (PP (TO to) (NP (JJ repeated) (NN challenge)))) (, ,) (CC either) (ADJP (JJ accidental)) (, ,) (ADJP (JJ diagnostic)) (, ,) (CC or) (ADJP (JJ therapeutic)))))) (. .)))))

root(ROOT-0, Risk-1)
amod(Reaction-4, Anaphylactic-3)
prep_of(Risk-1, Reaction-4)
mark(taking-7, While-6)
advcl(reactive-26, taking-7)
dobj(taking-7, beta-blockers-8)
nsubj(reactive-26, patients-10)
det(history-13, a-12)
prep_with(patients-10, history-13)
amod(reaction-17, severe-15)
amod(reaction-17, anaphylactic-16)
prep_of(history-13, reaction-17)
det(variety-20, a-19)
prep_to(reaction-17, variety-20)
prep_of(variety-20, allergens-22)
aux(reactive-26, may-23)
cop(reactive-26, be-24)
advmod(reactive-26, more-25)
dep(Risk-1, reactive-26)
amod(challenge-29, repeated-28)
prep_to(reactive-26, challenge-29)
preconj(reactive-26, either-31)
conj_or(reactive-26, accidental-32)
conj_or(reactive-26, diagnostic-34)
conj_or(reactive-26, therapeutic-37)

Such/JJ patients/NNS may/MD be/VB unresponsive/JJ to/TO the/DT usual/JJ doses/NNS of/IN epinephrine/NN used/VBN to/TO treat/VB allergic/JJ reactions/NNS ./.

(ROOT (S1 (S (S (NP (JJ Such) (NNS patients)) (VP (MD may) (VP (VB be) (ADJP (JJ unresponsive) (PP (TO to) (NP (NP (DT the) (JJ usual) (NNS doses)) (PP (IN of) (NP (NN epinephrine))) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (JJ allergic) (NNS reactions)))))))))))) (. .))))

amod(patients-2, Such-1)
nsubj(unresponsive-5, patients-2)
aux(unresponsive-5, may-3)
cop(unresponsive-5, be-4)
root(ROOT-0, unresponsive-5)
det(doses-9, the-7)
amod(doses-9, usual-8)
prep_to(unresponsive-5, doses-9)
prep_of(doses-9, epinephrine-11)
partmod(doses-9, used-12)
aux(treat-14, to-13)
xcomp(used-12, treat-14)
amod(reactions-16, allergic-15)
dobj(treat-14, reactions-16)

Use/NN of/IN MAO/NN inhibitors/NNS may/MD cause/VB an/DT excessive/JJ increase/NN in/IN blood/NN pressure/NN and/CC heart/NN stimulation/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Use)) (PP (IN of) (NP (NN MAO) (NNS inhibitors)))) (VP (MD may) (VP (VB cause) (NP (NP (DT an) (JJ excessive) (NN increase)) (PP (IN in) (NP (NP (NN blood) (NN pressure)) (CC and) (NP (NN heart) (NN stimulation)))))))) (. .))))

nsubj(cause-6, Use-1)
nn(inhibitors-4, MAO-3)
prep_of(Use-1, inhibitors-4)
aux(cause-6, may-5)
root(ROOT-0, cause-6)
det(increase-9, an-7)
amod(increase-9, excessive-8)
dobj(cause-6, increase-9)
nn(pressure-12, blood-11)
prep_in(increase-9, pressure-12)
nn(stimulation-15, heart-14)
conj_and(pressure-12, stimulation-15)

If/IN you/VBN are/VBP also/RB using/VBG a/DT steroid/NN inhaler/NN ,/, take/VB bitolterol/NN first/RB and/CC then/RB wait/VBP about/IN 15/CD minutes/NNS before/IN using/VBG the/DT steroid/NN inhaler/NN ./.

(ROOT (S1 (S (SBAR (IN If) (S (VP (VBN you)))) (VP (VBP are) (ADVP (RB also)) (VP (VP (VBG using) (NP (DT a) (NN steroid) (NN inhaler))) (, ,) (VP (VB take) (NP (NN bitolterol)) (ADVP (RB first))) (CC and) (ADVP (RB then)) (VP (VBP wait) (PP (IN about) (NP (CD 15) (NNS minutes))) (PP (IN before) (S (VP (VBG using) (NP (DT the) (NN steroid) (NN inhaler)))))))) (. .))))

mark(you-2, If-1)
csubj(using-5, you-2)
aux(using-5, are-3)
advmod(using-5, also-4)
root(ROOT-0, using-5)
det(inhaler-8, a-6)
nn(inhaler-8, steroid-7)
dobj(using-5, inhaler-8)
conj_and(using-5, take-10)
dobj(take-10, bitolterol-11)
advmod(take-10, first-12)
advmod(using-5, then-14)
conj_and(using-5, then-14)
conj_and(using-5, wait-15)
num(minutes-18, 15-17)
prep_about(wait-15, minutes-18)
prepc_before(wait-15, using-20)
det(inhaler-23, the-21)
nn(inhaler-23, steroid-22)
dobj(using-20, inhaler-23)

This/DT allows/VBZ bitolterol/NN to/TO open/VB air/NN passages/NNS ,/, increasing/VBG the/DT effectiveness/NN of/IN the/DT steroid/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (VBZ allows) (S (NP (NN bitolterol)) (VP (TO to) (VP (VB open) (NP (NN air) (NNS passages))))) (, ,) (S (VP (VBG increasing) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (DT the) (NN steroid)))))))) (. .))))

nsubj(allows-2, This-1)
root(ROOT-0, allows-2)
nsubj(open-5, bitolterol-3)
aux(open-5, to-4)
xcomp(allows-2, open-5)
nn(passages-7, air-6)
dobj(open-5, passages-7)
xcomp(allows-2, increasing-9)
det(effectiveness-11, the-10)
dobj(increasing-9, effectiveness-11)
det(steroid-14, the-13)
prep_of(effectiveness-11, steroid-14)

Angiomax/NN does/VBZ not/RB exhibit/VB binding/NN to/TO plasma/NN proteins/NNS (/-LRB- other/JJ than/IN thrombin/NN )/-RRB- or/CC red/JJ blood/NN cells/NNS ./.

(ROOT (S1 (S (S (NP (NN Angiomax)) (VP (VBZ does) (RB not) (VP (VB exhibit) (NP (NP (NN binding)) (PP (TO to) (NP (NP (NP (NN plasma) (NNS proteins)) (PRN (-LRB- -LRB-) (ADJP (JJ other) (PP (IN than) (NP (NN thrombin)))) (-RRB- -RRB-))) (CC or) (NP (JJ red) (NN blood) (NNS cells)))))))) (. .))))

nsubj(exhibit-4, Angiomax-1)
aux(exhibit-4, does-2)
neg(exhibit-4, not-3)
root(ROOT-0, exhibit-4)
dobj(exhibit-4, binding-5)
nn(proteins-8, plasma-7)
prep_to(binding-5, proteins-8)
dep(proteins-8, other-10)
prep_than(other-10, thrombin-12)
amod(cells-17, red-15)
nn(cells-17, blood-16)
conj_or(proteins-8, cells-17)

In/IN clinical/JJ trials/NNS in/IN patients/NNS undergoing/VBG PTCA//NN PCI/NN ,/, co-administration/NN of/IN Angiomax/NN with/IN heparin/NN ,/, warfarin/NN ,/, thrombolytic/JJ s/NN or/CC glycoprotein/NN IIb/IIIa/NN inhibitors/NNS was/VBD associated/VBN with/IN increased/VBN risks/NNS of/IN major/JJ bleeding/JJ events/NNS compared/VBD to/TO patients/NNS not/RB receiving/VBG these/DT concomitant/JJ medications/NNS ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (JJ clinical) (NNS trials)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG undergoing) (NP (NN PTCA/) (NN PCI))))))) (, ,) (NP (NP (NN co-administration)) (PP (IN of) (NP (NN Angiomax))) (PP (IN with) (NP (NP (NN heparin)) (, ,) (NP (NN warfarin)) (, ,) (NP (JJ thrombolytic) (NN s)) (CC or) (NP (NN glycoprotein) (NN IIb/IIIa) (NNS inhibitors))))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (VBN increased) (NNS risks)) (PP (IN of) (NP (NP (JJ major) (JJ bleeding) (NNS events)) (VP (VBD compared) (PP (TO to) (NP (NP (NNS patients)) (VP (RB not) (VBG receiving) (NP (DT these) (JJ concomitant) (NNS medications)))))))))))) (. .))))

amod(trials-3, clinical-2)
prep_in(associated-25, trials-3)
prep_in(trials-3, patients-5)
partmod(patients-5, undergoing-6)
nn(PCI-8, PTCA/-7)
dobj(undergoing-6, PCI-8)
nsubjpass(associated-25, co-administration-10)
prep_of(co-administration-10, Angiomax-12)
prep_with(co-administration-10, heparin-14)
conj_or(heparin-14, warfarin-16)
amod(s-19, thrombolytic-18)
conj_or(heparin-14, s-19)
nn(inhibitors-23, glycoprotein-21)
nn(inhibitors-23, IIb/IIIa-22)
conj_or(heparin-14, inhibitors-23)
auxpass(associated-25, was-24)
root(ROOT-0, associated-25)
amod(risks-28, increased-27)
prep_with(associated-25, risks-28)
amod(events-32, major-30)
amod(events-32, bleeding-31)
prep_of(risks-28, events-32)
partmod(events-32, compared-33)
prep_to(compared-33, patients-35)
neg(receiving-37, not-36)
partmod(patients-35, receiving-37)
det(medications-40, these-38)
amod(medications-40, concomitant-39)
dobj(receiving-37, medications-40)

There/EX is/VBZ no/DT experience/VBP with/IN co-administration/NN of/IN Angiomax/NN and/CC plasma/NN expander/NN s/NNS such/JJ as/IN dextran/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT no)) (VP (VBP experience) (PP (IN with) (NP (NP (NN co-administration)) (PP (IN of) (NP (NP (NP (NP (NN Angiomax)) (CC and) (NP (NN plasma) (NN expander))) (NNS s)) (PP (JJ such) (IN as) (NP (NN dextran))))))))))) (. .))))

expl(is-2, There-1)
root(ROOT-0, is-2)
nsubj(is-2, no-3)
dep(no-3, experience-4)
prep_with(experience-4, co-administration-6)
nn(s-12, Angiomax-8)
nn(expander-11, plasma-10)
conj_and(Angiomax-8, expander-11)
prep_of(co-administration-6, s-12)
prep_such_as(s-12, dextran-15)

Angiomax/NN should/MD be/VB used/VBN with/IN caution/NN in/IN patients/NNS with/IN disease/NN states/NNS associated/VBN with/IN an/DT increased/VBN risk/NN of/IN bleeding/JJ ./.

(ROOT (S1 (S (S (NP (NN Angiomax)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN caution))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN disease) (NNS states)) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (JJ bleeding)))))))))))))) (. .))))

nsubjpass(used-4, Angiomax-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
prep_with(used-4, caution-6)
prep_in(used-4, patients-8)
nn(states-11, disease-10)
prep_with(patients-8, states-11)
partmod(states-11, associated-12)
det(risk-16, an-14)
amod(risk-16, increased-15)
prep_with(associated-12, risk-16)
prep_of(risk-16, bleeding-18)

Immunogenicity/Re-exposure/NN :/: In/IN in/FW vitro/FW studies/NNS ,/, Angiomax/NN exhibited/VBD no/DT platelet/NN aggregation/NN response/NN against/IN sera/NN from/IN patients/NNS with/IN a/DT history/NN of/IN HIT/HITTS/NNS ./.

(ROOT (S1 (S (NP (NP (NN Immunogenicity/Re-exposure)) (: :) (S (PP (IN In) (NP (ADJP (FW in) (FW vitro)) (NNS studies))) (, ,) (NP (NN Angiomax)) (VP (VBD exhibited) (NP (DT no) (NN platelet) (NN aggregation) (NN response)) (PP (IN against) (NP (NP (NN sera)) (PP (IN from) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NNS HIT/HITTS))))))))))) (. .)))))

root(ROOT-0, Immunogenicity/Re-exposure-1)
nn(vitro-5, in-4)
amod(studies-6, vitro-5)
prep_in(exhibited-9, studies-6)
nsubj(exhibited-9, Angiomax-8)
dep(Immunogenicity/Re-exposure-1, exhibited-9)
det(response-13, no-10)
nn(response-13, platelet-11)
nn(response-13, aggregation-12)
dobj(exhibited-9, response-13)
prep_against(exhibited-9, sera-15)
prep_from(sera-15, patients-17)
det(history-20, a-19)
prep_with(patients-17, history-20)
prep_of(history-20, HIT/HITTS-22)

Among/IN 494/CD subjects/NNS who/WP received/VBD Angiomax/NN in/IN clinical/JJ trials/NNS and/CC were/VBD tested/VBN for/IN antibodies/NNS ,/, 2/CD subjects/NNS had/VBD treatment-emergent/JJ positive/JJ bivalirudin/NN antibody/NN tests/NNS ./.

(ROOT (S1 (S (S (PP (IN Among) (NP (NP (CD 494) (NNS subjects)) (SBAR (WHNP (WP who)) (S (VP (VP (VBD received) (NP (NN Angiomax)) (PP (IN in) (NP (JJ clinical) (NNS trials)))) (CC and) (VP (VBD were) (VP (VBN tested) (PP (IN for) (NP (NNS antibodies)))))))))) (, ,) (NP (CD 2) (NNS subjects)) (VP (VBD had) (NP (JJ treatment-emergent) (JJ positive) (NN bivalirudin) (NN antibody) (NNS tests)))) (. .))))

num(subjects-3, 494-2)
nsubj(received-5, subjects-3)
prep_among(had-18, subjects-3)
rcmod(subjects-3, received-5)
dobj(received-5, Angiomax-6)
amod(trials-9, clinical-8)
prep_in(received-5, trials-9)
auxpass(tested-12, were-11)
conj_and(received-5, tested-12)
prep_for(tested-12, antibodies-14)
num(subjects-17, 2-16)
nsubj(had-18, subjects-17)
root(ROOT-0, had-18)
amod(tests-23, treatment-emergent-19)
amod(tests-23, positive-20)
nn(tests-23, bivalirudin-21)
nn(tests-23, antibody-22)
dobj(had-18, tests-23)

Certain/JJ antibiotic/JJ ,/, cisplatin/NN ,/, cyclosporine/NN ,/, diuretic/NN ,/, foscarnet/NN ,/, and/CC vaccines/NNS ./.

(ROOT (S1 (S (S (NP (JJ Certain) (JJ antibiotic)) (, ,) (NP (NP (NN cisplatin)) (, ,) (NP (NN cyclosporine)) (, ,) (NP (NN diuretic)) (, ,) (NP (NN foscarnet)) (, ,) (CC and) (NP (NNS vaccines)))) (. .))))

amod(antibiotic-2, Certain-1)
dep(cisplatin-4, antibiotic-2)
root(ROOT-0, cisplatin-4)
conj_and(cisplatin-4, cyclosporine-6)
conj_and(cisplatin-4, diuretic-8)
conj_and(cisplatin-4, foscarnet-10)
conj_and(cisplatin-4, vaccines-13)

Bosentan/NN is/VBZ metabolized/VBN by/IN CYP2C9/NN and/CC CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Bosentan)) (VP (VBZ is) (VP (VBN metabolized) (PP (IN by) (NP (NP (NN CYP2C9)) (CC and) (NP (NN CYP3A4))))))) (. .))))

nsubjpass(metabolized-3, Bosentan-1)
auxpass(metabolized-3, is-2)
root(ROOT-0, metabolized-3)
agent(metabolized-3, CYP2C9-5)
conj_and(CYP2C9-5, CYP3A4-7)

Inhibition/NN of/IN these/DT isoenzymes/NNS may/MD increase/VB the/DT plasma/NN concentration/NN of/IN bosentan/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (DT these) (NNS isoenzymes)))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN plasma) (NN concentration)) (PP (IN of) (NP (NN bosentan))))))) (. .))))

nsubj(increase-6, Inhibition-1)
det(isoenzymes-4, these-3)
prep_of(Inhibition-1, isoenzymes-4)
aux(increase-6, may-5)
root(ROOT-0, increase-6)
det(concentration-9, the-7)
nn(concentration-9, plasma-8)
dobj(increase-6, concentration-9)
prep_of(concentration-9, bosentan-11)

Bosentan/NN is/VBZ an/DT inducer/NN of/IN CYP3A4/NN and/CC CYP2C9/NN ./.

(ROOT (S1 (S (S (NP (NN Bosentan)) (VP (VBZ is) (NP (NP (DT an) (NN inducer)) (PP (IN of) (NP (NP (NN CYP3A4)) (CC and) (NP (NN CYP2C9))))))) (. .))))

nsubj(inducer-4, Bosentan-1)
cop(inducer-4, is-2)
det(inducer-4, an-3)
root(ROOT-0, inducer-4)
prep_of(inducer-4, CYP3A4-6)
conj_and(CYP3A4-6, CYP2C9-8)

Consequently/RB ,/, plasma/NN concentrations/NNS of/IN drugs/NNS metabolized/VBN by/IN these/DT two/CD isoenzymes/NNS will/MD be/VB decreased/VBN when/WRB TRACLEER/NN @/NN is/VBZ co-administered/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Consequently)) (, ,) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (DT these) (CD two) (NNS isoenzymes))))))) (VP (MD will) (VP (VB be) (VP (VBN decreased) (SBAR (WHADVP (WRB when)) (S (NP (NN TRACLEER) (NN @)) (VP (VBZ is) (VP (VBN co-administered))))))))) (. .))))

advmod(decreased-14, Consequently-1)
nn(concentrations-4, plasma-3)
nsubjpass(decreased-14, concentrations-4)
prep_of(concentrations-4, drugs-6)
partmod(drugs-6, metabolized-7)
det(isoenzymes-11, these-9)
num(isoenzymes-11, two-10)
agent(metabolized-7, isoenzymes-11)
aux(decreased-14, will-12)
auxpass(decreased-14, be-13)
root(ROOT-0, decreased-14)
advmod(co-administered-19, when-15)
nn(@-17, TRACLEER-16)
nsubjpass(co-administered-19, @-17)
auxpass(co-administered-19, is-18)
advcl(decreased-14, co-administered-19)

Bosentan/NN had/VBD no/DT relevant/JJ inhibitory/JJ effect/NN on/IN any/DT CYP/JJ isoenzymes/NNS tested/VBN (/-LRB- CYP1A2/NN ,/, CYP2C9/NN ,/, CYP2C19/NN ,/, CYP2D6/NN ,/, CYP3A4/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NN Bosentan)) (VP (VBD had) (NP (DT no) (JJ relevant) (JJ inhibitory) (NN effect)) (PP (IN on) (NP (NP (DT any) (JJ CYP) (NNS isoenzymes)) (VP (VBN tested) (PRN (-LRB- -LRB-) (NP (NP (NN CYP1A2)) (, ,) (NP (NN CYP2C9)) (, ,) (NP (NN CYP2C19)) (, ,) (NP (NN CYP2D6)) (, ,) (NP (NN CYP3A4))) (-RRB- -RRB-))))))) (. .))))

nsubj(had-2, Bosentan-1)
root(ROOT-0, had-2)
det(effect-6, no-3)
amod(effect-6, relevant-4)
amod(effect-6, inhibitory-5)
dobj(had-2, effect-6)
det(isoenzymes-10, any-8)
amod(isoenzymes-10, CYP-9)
prep_on(had-2, isoenzymes-10)
partmod(isoenzymes-10, tested-11)
dep(tested-11, CYP1A2-13)
appos(CYP1A2-13, CYP2C9-15)
appos(CYP1A2-13, CYP2C19-17)
appos(CYP1A2-13, CYP2D6-19)
appos(CYP1A2-13, CYP3A4-21)

Consequently/RB ,/, TRACLEER/NN @/NN is/VBZ not/RB expected/VBN to/TO increase/VB the/DT plasma/NN concentrations/NNS of/IN drugs/NNS metabolized/VBN by/IN these/DT enzymes/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Consequently)) (, ,) (NP (NN TRACLEER) (NN @)) (VP (VBZ is) (RB not) (VP (VBN expected) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (DT these) (NNS enzymes))))))))))))) (. .))))

advmod(expected-7, Consequently-1)
nn(@-4, TRACLEER-3)
nsubjpass(expected-7, @-4)
xsubj(increase-9, @-4)
auxpass(expected-7, is-5)
neg(expected-7, not-6)
root(ROOT-0, expected-7)
aux(increase-9, to-8)
xcomp(expected-7, increase-9)
det(concentrations-12, the-10)
nn(concentrations-12, plasma-11)
dobj(increase-9, concentrations-12)
prep_of(concentrations-12, drugs-14)
partmod(drugs-14, metabolized-15)
det(enzymes-18, these-17)
agent(metabolized-15, enzymes-18)

Hormonal/JJ Contraceptives/NNS ,/, Including/VBG Oral/JJ ,/, Injectable/JJ ,/, Transdermal/JJ ,/, and/CC Implantable/JJ Contraceptives/NNS :/: An/DT interaction/NN study/NN demonstrated/VBD that/IN co-administration/NN of/IN bosentan/NN and/CC the/DT oral/JJ hormonal/JJ contraceptive/JJ Ortho-Novum/NN @/NN produced/VBD average/JJ decreases/NNS of/IN norethindrone/NN and/CC ethinyl/NN estradiol/NN levels/NNS of/IN 14/CD %/NN and/CC 31/CD %/NN ,/, respectively/RB ./.

(ROOT (S1 (S (NP (NP (NP (JJ Hormonal) (NNS Contraceptives)) (, ,) (PP (VBG Including) (NP (ADJP (ADJP (JJ Oral)) (, ,) (ADJP (JJ Injectable)) (, ,) (ADJP (JJ Transdermal)) (, ,) (CC and) (ADJP (JJ Implantable))) (NNS Contraceptives)))) (: :) (S (NP (DT An) (NN interaction) (NN study)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NP (NN co-administration)) (PP (IN of) (NP (NN bosentan)))) (CC and) (NP (DT the) (JJ oral) (JJ hormonal) (JJ contraceptive) (NN Ortho-Novum) (NN @))) (VP (VBD produced) (NP (NP (NP (JJ average) (NNS decreases)) (PP (IN of) (NP (NN norethindrone)))) (CC and) (NP (NP (NN ethinyl) (NN estradiol) (NNS levels)) (PP (IN of) (NP (NP (CD 14) (NN %)) (CC and) (NP (CD 31) (NN %)) (, ,) (ADVP (RB respectively))))))))))) (. .)))))

amod(Contraceptives-2, Hormonal-1)
root(ROOT-0, Contraceptives-2)
amod(Contraceptives-13, Oral-5)
conj_and(Oral-5, Injectable-7)
conj_and(Oral-5, Transdermal-9)
conj_and(Oral-5, Implantable-12)
prep_including(Contraceptives-2, Contraceptives-13)
det(study-17, An-15)
nn(study-17, interaction-16)
nsubj(demonstrated-18, study-17)
dep(Contraceptives-2, demonstrated-18)
complm(produced-30, that-19)
nsubj(produced-30, co-administration-20)
prep_of(co-administration-20, bosentan-22)
det(@-29, the-24)
amod(@-29, oral-25)
amod(@-29, hormonal-26)
amod(@-29, contraceptive-27)
nn(@-29, Ortho-Novum-28)
conj_and(co-administration-20, @-29)
ccomp(demonstrated-18, produced-30)
amod(decreases-32, average-31)
dobj(produced-30, decreases-32)
prep_of(decreases-32, norethindrone-34)
nn(levels-38, ethinyl-36)
nn(levels-38, estradiol-37)
conj_and(decreases-32, levels-38)
num(%-41, 14-40)
prep_of(levels-38, %-41)
num(%-44, 31-43)
conj_and(%-41, %-44)
advmod(%-41, respectively-46)
conj_and(%-41, respectively-46)

Therefore/RB ,/, hormonal/JJ contraceptives/NNS ,/, including/VBG oral/JJ ,/, injectable/JJ ,/, transdermal/JJ ,/, and/CC implantable/JJ forms/NNS ,/, may/MD not/RB be/VB reliable/JJ when/WRB TRACLEER/NN @/NN is/VBZ co-administered/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (JJ hormonal) (NNS contraceptives)) (, ,) (PP (VBG including) (NP (ADJP (ADJP (JJ oral)) (, ,) (ADJP (JJ injectable)) (, ,) (ADJP (JJ transdermal)) (, ,) (CC and) (ADJP (JJ implantable))) (NNS forms))) (, ,)) (VP (MD may) (RB not) (VP (VB be) (ADJP (JJ reliable) (SBAR (WHADVP (WRB when)) (S (NP (NN TRACLEER) (NN @)) (VP (VBZ is) (VP (VBN co-administered))))))))) (. .))))

advmod(reliable-20, Therefore-1)
amod(contraceptives-4, hormonal-3)
nsubj(reliable-20, contraceptives-4)
amod(forms-15, oral-7)
conj_and(oral-7, injectable-9)
conj_and(oral-7, transdermal-11)
conj_and(oral-7, implantable-14)
prep_including(contraceptives-4, forms-15)
aux(reliable-20, may-17)
neg(reliable-20, not-18)
cop(reliable-20, be-19)
root(ROOT-0, reliable-20)
advmod(co-administered-25, when-21)
nn(@-23, TRACLEER-22)
nsubjpass(co-administered-25, @-23)
auxpass(co-administered-25, is-24)
dep(reliable-20, co-administered-25)

Specific/JJ interaction/NN studies/NNS have/VBP demonstrated/VBN the/DT following/NN :/: Cyclosporine/NN A/NN :/: During/IN the/DT first/JJ day/NN of/IN concomitant/JJ administration/NN ,/, trough/NN concentrations/NNS of/IN bosentan/NN were/VBD increased/VBN by/IN about/RB 30-fold/RB ./.

(ROOT (S1 (S (S (NP (JJ Specific) (NN interaction) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT the) (NN following)) (: :) (NP (NN Cyclosporine) (NN A)) (: :) (S (PP (IN During) (NP (NP (DT the) (JJ first) (NN day)) (PP (IN of) (NP (JJ concomitant) (NN administration))))) (, ,) (NP (NP (NN trough) (NNS concentrations)) (PP (IN of) (NP (NN bosentan)))) (VP (VBD were) (VP (VBN increased) (PP (IN by) (NP (RB about) (RB 30-fold)))))))))) (. .))))

amod(studies-3, Specific-1)
nn(studies-3, interaction-2)
nsubj(demonstrated-5, studies-3)
aux(demonstrated-5, have-4)
root(ROOT-0, demonstrated-5)
det(following-7, the-6)
dobj(demonstrated-5, following-7)
nn(A-10, Cyclosporine-9)
dep(following-7, A-10)
det(day-15, the-13)
amod(day-15, first-14)
prep_during(increased-25, day-15)
amod(administration-18, concomitant-17)
prep_of(day-15, administration-18)
nn(concentrations-21, trough-20)
nsubjpass(increased-25, concentrations-21)
prep_of(concentrations-21, bosentan-23)
auxpass(increased-25, were-24)
dep(following-7, increased-25)
prep(increased-25, by-26)
advmod(30-fold-28, about-27)
pobj(by-26, 30-fold-28)

Steady-state/JJ bosentan/NN plasma/NN concentrations/NNS were/VBD 3-/CD to/TO 4-fold/RB higher/JJR than/IN in/IN the/DT absence/NN of/IN cyclosporine/NN A/NN ./.

(ROOT (S1 (S (S (NP (JJ Steady-state) (NN bosentan) (NN plasma) (NNS concentrations)) (VP (VBD were) (ADJP (ADJP (NP (CD 3-) (TO to) (RB 4-fold)) (JJR higher)) (PP (IN than) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NN cyclosporine) (NN A))))))))) (. .))))

amod(concentrations-4, Steady-state-1)
nn(concentrations-4, bosentan-2)
nn(concentrations-4, plasma-3)
nsubj(higher-9, concentrations-4)
cop(higher-9, were-5)
npadvmod(higher-9, 3--6)
dep(3--6, to-7)
advmod(3--6, 4-fold-8)
root(ROOT-0, higher-9)
prep(higher-9, than-10)
pcomp(than-10, in-11)
det(absence-13, the-12)
prep_in(than-10, absence-13)
nn(A-16, cyclosporine-15)
prep_of(absence-13, A-16)

The/DT concomitant/JJ administration/NN of/IN bosentan/NN and/CC cyclosporine/NN A/NN is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN bosentan)) (CC and) (NP (NN cyclosporine) (NN A))))) (VP (VBZ is) (VP (VBN contraindicated)))) (. .))))

det(administration-3, The-1)
amod(administration-3, concomitant-2)
nsubjpass(contraindicated-10, administration-3)
prep_of(administration-3, bosentan-5)
nn(A-8, cyclosporine-7)
conj_and(bosentan-5, A-8)
auxpass(contraindicated-10, is-9)
root(ROOT-0, contraindicated-10)

Co-administration/NN of/IN bosentan/NN decreased/VBD the/DT plasma/NN concentrations/NNS of/IN cyclosporine/NN A/NN (/-LRB- a/DT CYP3A4/NN substrate/NN )/-RRB- by/IN approximately/RB 50/CD %./NN

(ROOT (S1 (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NN bosentan)))) (VP (VBD decreased) (NP (NP (DT the) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (NN cyclosporine) (NN A)) (PRN (-LRB- -LRB-) (NP (DT a) (NN CYP3A4) (NN substrate)) (-RRB- -RRB-))))) (PP (IN by) (NP (QP (RB approximately) (CD 50)) (NN %.)))))))

nsubj(decreased-4, Co-administration-1)
prep_of(Co-administration-1, bosentan-3)
root(ROOT-0, decreased-4)
det(concentrations-7, the-5)
nn(concentrations-7, plasma-6)
dobj(decreased-4, concentrations-7)
nn(A-10, cyclosporine-9)
prep_of(concentrations-7, A-10)
det(substrate-14, a-12)
nn(substrate-14, CYP3A4-13)
abbrev(A-10, substrate-14)
quantmod(50-18, approximately-17)
num(%.-19, 50-18)
prep_by(decreased-4, %.-19)

Tacrolimus/NN :/: Co-administration/NN of/IN tacrolimus/NN and/CC bosentan/NN has/VBZ not/RB been/VBN studied/VBN in/IN man/NN ./.

(ROOT (S1 (S (NP (NP (NN Tacrolimus)) (: :) (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NP (NN tacrolimus)) (CC and) (NP (NN bosentan))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied) (PP (IN in) (NP (NN man))))))) (. .)))))

root(ROOT-0, Tacrolimus-1)
nsubjpass(studied-11, Co-administration-3)
prep_of(Co-administration-3, tacrolimus-5)
conj_and(tacrolimus-5, bosentan-7)
aux(studied-11, has-8)
neg(studied-11, not-9)
auxpass(studied-11, been-10)
dep(Tacrolimus-1, studied-11)
prep_in(studied-11, man-13)

Co-administration/NN of/IN tacrolimus/NN and/CC bosentan/NN resulted/VBD in/IN markedly/RB increased/VBN plasma/NN concentrations/NNS of/IN bosentan/NN in/IN animals/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NP (NN tacrolimus)) (CC and) (NP (NN bosentan))))) (VP (VBD resulted) (PP (IN in) (NP (NP (ADJP (RB markedly) (VBN increased)) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (NN bosentan)) (PP (IN in) (NP (NNS animals))))))))) (. .))))

nsubj(resulted-6, Co-administration-1)
prep_of(Co-administration-1, tacrolimus-3)
conj_and(tacrolimus-3, bosentan-5)
root(ROOT-0, resulted-6)
advmod(increased-9, markedly-8)
amod(concentrations-11, increased-9)
nn(concentrations-11, plasma-10)
prep_in(resulted-6, concentrations-11)
prep_of(concentrations-11, bosentan-13)
prep_in(bosentan-13, animals-15)

Caution/NN should/MD be/VB exercised/VBN if/IN tacrolimus/NN and/CC bosentan/NN are/VBP used/VBN together/RB ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (IN if) (S (NP (NP (NN tacrolimus)) (CC and) (NP (NN bosentan))) (VP (VBP are) (VP (VBN used) (ADVP (RB together)))))))))) (. .))))

nsubjpass(exercised-4, Caution-1)
aux(exercised-4, should-2)
auxpass(exercised-4, be-3)
root(ROOT-0, exercised-4)
mark(used-10, if-5)
nsubjpass(used-10, tacrolimus-6)
conj_and(tacrolimus-6, bosentan-8)
auxpass(used-10, are-9)
advcl(exercised-4, used-10)
advmod(used-10, together-11)

Glyburide/NN :/: An/DT increased/VBN risk/NN of/IN elevated/JJ liver/NN aminotransferases/NNS was/VBD observed/VBN in/IN patients/NNS receiving/VBG concomitant/JJ therapy/NN with/IN glyburide/NN ./.

(ROOT (S1 (S (S (NP (NN Glyburide)) (: :) (NP (NP (DT An) (VBN increased) (NN risk)) (PP (IN of) (NP (JJ elevated) (NN liver) (NNS aminotransferases)))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (JJ concomitant) (NN therapy)) (PP (IN with) (NP (NN glyburide)))))))))) (. .))))

nsubjpass(observed-11, Glyburide-1)
det(risk-5, An-3)
amod(risk-5, increased-4)
nsubjpass(observed-11, risk-5)
amod(aminotransferases-9, elevated-7)
nn(aminotransferases-9, liver-8)
prep_of(risk-5, aminotransferases-9)
auxpass(observed-11, was-10)
root(ROOT-0, observed-11)
prep_in(observed-11, patients-13)
partmod(patients-13, receiving-14)
amod(therapy-16, concomitant-15)
dobj(receiving-14, therapy-16)
prep_with(therapy-16, glyburide-18)

Therefore/RB ,/, the/DT concomitant/JJ administration/NN of/IN TRACLEER/NN @/NN and/CC glyburide/NN is/VBZ contraindicated/VBN ,/, and/CC alternative/JJ hypoglycemic/JJ agents/NNS should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN TRACLEER) (NP (NP (NN @)) (CC and) (NP (NN glyburide)))))) (VP (VBZ is) (VP (VBN contraindicated)))) (, ,) (CC and) (S (NP (JJ alternative) (JJ hypoglycemic) (NNS agents)) (VP (MD should) (VP (VB be) (VP (VBN considered)))))) (. .))))

advmod(contraindicated-12, Therefore-1)
det(administration-5, the-3)
amod(administration-5, concomitant-4)
nsubjpass(contraindicated-12, administration-5)
prep_of(administration-5, TRACLEER-7)
dep(TRACLEER-7, @-8)
conj_and(@-8, glyburide-10)
auxpass(contraindicated-12, is-11)
root(ROOT-0, contraindicated-12)
amod(agents-17, alternative-15)
amod(agents-17, hypoglycemic-16)
nsubjpass(considered-20, agents-17)
aux(considered-20, should-18)
auxpass(considered-20, be-19)
conj_and(contraindicated-12, considered-20)

Co-administration/NN of/IN bosentan/NN decreased/VBD the/DT plasma/NN concentrations/NNS of/IN glyburide/NN by/IN approximately/RB 40/CD %./NN

(ROOT (S1 (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NN bosentan)))) (VP (VBD decreased) (NP (NP (DT the) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN glyburide)))) (PP (IN by) (NP (QP (RB approximately) (CD 40)) (NN %.)))))))

nsubj(decreased-4, Co-administration-1)
prep_of(Co-administration-1, bosentan-3)
root(ROOT-0, decreased-4)
det(concentrations-7, the-5)
nn(concentrations-7, plasma-6)
dobj(decreased-4, concentrations-7)
prep_of(concentrations-7, glyburide-9)
quantmod(40-12, approximately-11)
num(%.-13, 40-12)
prep_by(decreased-4, %.-13)

The/DT plasma/NN concentrations/NNS of/IN bosentan/NN were/VBD also/RB decreased/VBN by/IN approximately/RB 30/CD %./NN

(ROOT (S1 (S (NP (NP (DT The) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN bosentan)))) (VP (VBD were) (ADVP (RB also)) (VP (VBN decreased) (PP (IN by) (NP (QP (RB approximately) (CD 30)) (NN %.))))))))

det(concentrations-3, The-1)
nn(concentrations-3, plasma-2)
nsubjpass(decreased-8, concentrations-3)
prep_of(concentrations-3, bosentan-5)
auxpass(decreased-8, were-6)
advmod(decreased-8, also-7)
root(ROOT-0, decreased-8)
quantmod(30-11, approximately-10)
num(%.-12, 30-11)
agent(decreased-8, %.-12)

Bosentan/NN is/VBZ also/RB expected/VBN to/TO reduce/VB plasma/NN concentrations/NNS of/IN other/JJ oral/JJ hypoglycemic/JJ agents/NNS that/WDT are/VBP predominantly/RB metabolized/VBN by/IN CYP2C9/NN or/CC CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Bosentan)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN expected) (S (VP (TO to) (VP (VB reduce) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (JJ other) (JJ oral) (JJ hypoglycemic) (NNS agents)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB predominantly)) (VP (VBN metabolized) (PP (IN by) (NP (NP (NN CYP2C9)) (CC or) (NP (NN CYP3A4))))))))))))))))) (. .))))

nsubjpass(expected-4, Bosentan-1)
xsubj(reduce-6, Bosentan-1)
auxpass(expected-4, is-2)
advmod(expected-4, also-3)
root(ROOT-0, expected-4)
aux(reduce-6, to-5)
xcomp(expected-4, reduce-6)
nn(concentrations-8, plasma-7)
dobj(reduce-6, concentrations-8)
amod(agents-13, other-10)
amod(agents-13, oral-11)
amod(agents-13, hypoglycemic-12)
prep_of(concentrations-8, agents-13)
nsubjpass(metabolized-17, agents-13)
auxpass(metabolized-17, are-15)
advmod(metabolized-17, predominantly-16)
rcmod(agents-13, metabolized-17)
agent(metabolized-17, CYP2C9-19)
conj_or(CYP2C9-19, CYP3A4-21)

Ketoconazole/NN :/: Co-administration/NN of/IN bosentan/NN 125/CD mg/NN b.i.d./NN and/CC ketoconazole/NN ,/, a/DT potent/JJ CYP3A4/NN inhibitor/NN ,/, increased/VBD the/DT plasma/NN concentrations/NNS of/IN bosentan/NN by/IN approximately/RB 2-fold/RB ./.

(ROOT (S1 (S (NP (NP (NN Ketoconazole)) (: :) (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NP (NN bosentan) (CD 125) (NN mg) (NN b.i.d.)) (CC and) (NP (NP (NN ketoconazole)) (, ,) (NP (DT a) (JJ potent) (NN CYP3A4) (NN inhibitor)) (, ,))))) (VP (VBD increased) (NP (NP (DT the) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN bosentan)))) (PP (IN by) (NP (RB approximately) (RB 2-fold))))) (. .)))))

root(ROOT-0, Ketoconazole-1)
nsubj(increased-17, Co-administration-3)
nn(b.i.d.-8, bosentan-5)
num(b.i.d.-8, 125-6)
nn(b.i.d.-8, mg-7)
prep_of(Co-administration-3, b.i.d.-8)
conj_and(b.i.d.-8, ketoconazole-10)
det(inhibitor-15, a-12)
amod(inhibitor-15, potent-13)
nn(inhibitor-15, CYP3A4-14)
appos(ketoconazole-10, inhibitor-15)
dep(Ketoconazole-1, increased-17)
det(concentrations-20, the-18)
nn(concentrations-20, plasma-19)
dobj(increased-17, concentrations-20)
prep_of(concentrations-20, bosentan-22)
prep(increased-17, by-23)
advmod(2-fold-25, approximately-24)
pobj(by-23, 2-fold-25)

No/DT dose/NN adjustment/NN of/IN bosentan/NN is/VBZ necessary/JJ ,/, but/CC increased/VBN effects/NNS of/IN bosentan/NN should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (DT No) (NN dose) (NN adjustment)) (PP (IN of) (NP (NN bosentan)))) (VP (VBZ is) (ADJP (JJ necessary)))) (, ,) (CC but) (S (NP (NP (VBN increased) (NNS effects)) (PP (IN of) (NP (NN bosentan)))) (VP (MD should) (VP (VB be) (VP (VBN considered)))))) (. .))))

det(adjustment-3, No-1)
nn(adjustment-3, dose-2)
nsubj(necessary-7, adjustment-3)
prep_of(adjustment-3, bosentan-5)
cop(necessary-7, is-6)
root(ROOT-0, necessary-7)
amod(effects-11, increased-10)
nsubjpass(considered-16, effects-11)
prep_of(effects-11, bosentan-13)
aux(considered-16, should-14)
auxpass(considered-16, be-15)
conj_but(necessary-7, considered-16)

Simvastatin/NN and/CC Other/JJ Statins/NN :/: Co-administration/NN of/IN bosentan/NN decreased/VBD the/DT plasma/NN concentrations/NNS of/IN simvastatin/NN (/-LRB- a/DT CYP3A4/NN substrate/NN )/-RRB- ,/, and/CC its/PRP$ active/JJ @/NN -hydroxy/NN acid/NN metabolite/NN ,/, by/IN approximately/RB 50/CD %./NN

(ROOT (S1 (S (NP (NP (NP (NN Simvastatin)) (CC and) (NP (JJ Other) (NN Statins))) (: :) (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NN bosentan)))) (VP (VBD decreased) (NP (NP (DT the) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (NP (NN simvastatin)) (PRN (-LRB- -LRB-) (NP (DT a) (NN CYP3A4) (NN substrate)) (-RRB- -RRB-))) (, ,) (CC and) (NP (PRP$ its) (JJ active) (NN @) (NN -hydroxy) (NN acid) (NN metabolite))))) (, ,) (PP (IN by) (NP (QP (RB approximately) (CD 50)) (NN %.)))))))))

root(ROOT-0, Simvastatin-1)
amod(Statins-4, Other-3)
conj_and(Simvastatin-1, Statins-4)
nsubj(decreased-9, Co-administration-6)
prep_of(Co-administration-6, bosentan-8)
dep(Simvastatin-1, decreased-9)
det(concentrations-12, the-10)
nn(concentrations-12, plasma-11)
dobj(decreased-9, concentrations-12)
prep_of(concentrations-12, simvastatin-14)
det(substrate-18, a-16)
nn(substrate-18, CYP3A4-17)
abbrev(simvastatin-14, substrate-18)
poss(metabolite-27, its-22)
amod(metabolite-27, active-23)
nn(metabolite-27, @-24)
nn(metabolite-27, -hydroxy-25)
nn(metabolite-27, acid-26)
conj_and(simvastatin-14, metabolite-27)
quantmod(50-31, approximately-30)
num(%.-32, 50-31)
prep_by(decreased-9, %.-32)

The/DT plasma/NN concentrations/NNS of/IN bosentan/NN were/VBD not/RB affected/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN bosentan)))) (VP (VBD were) (RB not) (VP (VBN affected)))) (. .))))

det(concentrations-3, The-1)
nn(concentrations-3, plasma-2)
nsubjpass(affected-8, concentrations-3)
prep_of(concentrations-3, bosentan-5)
auxpass(affected-8, were-6)
neg(affected-8, not-7)
root(ROOT-0, affected-8)

Bosentan/NN is/VBZ also/RB expected/VBN to/TO reduce/VB plasma/NN concentrations/NNS of/IN other/JJ statins/NNS that/WDT have/VBP significant/JJ metabolism/NN by/IN CYP3A4/NN ,/, such/JJ as/IN lovastatin/NN and/CC atorvastatin/NN ./.

(ROOT (S1 (S (S (NP (NN Bosentan)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN expected) (S (VP (TO to) (VP (VB reduce) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (JJ other) (NNS statins)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (NP (JJ significant) (NN metabolism)) (PP (IN by) (NP (NN CYP3A4)))))) (, ,) (PP (JJ such) (IN as) (NP (NP (NN lovastatin)) (CC and) (NP (NN atorvastatin))))))))))))) (. .))))

nsubjpass(expected-4, Bosentan-1)
xsubj(reduce-6, Bosentan-1)
auxpass(expected-4, is-2)
advmod(expected-4, also-3)
root(ROOT-0, expected-4)
aux(reduce-6, to-5)
xcomp(expected-4, reduce-6)
nn(concentrations-8, plasma-7)
dobj(reduce-6, concentrations-8)
amod(statins-11, other-10)
prep_of(concentrations-8, statins-11)
nsubj(have-13, statins-11)
rcmod(statins-11, have-13)
amod(metabolism-15, significant-14)
dobj(have-13, metabolism-15)
prep_by(have-13, CYP3A4-17)
prep_such_as(statins-11, lovastatin-21)
conj_and(lovastatin-21, atorvastatin-23)

Patients/NNS using/VBG CYP3A4/JJ metabolized/JJ statins/NNS should/MD have/VB cholesterol/NN levels/NNS monitored/VBN after/IN TRACLEER/NN @/NN is/VBZ initiated/VBN to/TO see/VB whether/IN the/DT statin/NN dose/NN needs/VBZ adjustment/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG using) (NP (JJ CYP3A4) (JJ metabolized) (NNS statins)))) (VP (MD should) (VP (VB have) (NP (NP (NN cholesterol) (NNS levels)) (VP (VBN monitored) (PP (IN after) (NP (NN TRACLEER) (NN @)))))))) (VP (VBZ is) (VP (VBN initiated) (S (VP (TO to) (VP (VB see) (SBAR (IN whether) (S (NP (DT the) (NN statin) (NN dose)) (VP (VBZ needs) (NP (NN adjustment)))))))))) (. .))))

nsubj(have-7, Patients-1)
partmod(Patients-1, using-2)
amod(statins-5, CYP3A4-3)
amod(statins-5, metabolized-4)
dobj(using-2, statins-5)
aux(have-7, should-6)
csubjpass(initiated-15, have-7)
nn(levels-9, cholesterol-8)
dobj(have-7, levels-9)
partmod(levels-9, monitored-10)
nn(@-13, TRACLEER-12)
prep_after(monitored-10, @-13)
auxpass(initiated-15, is-14)
root(ROOT-0, initiated-15)
aux(see-17, to-16)
xcomp(initiated-15, see-17)
complm(needs-22, whether-18)
det(dose-21, the-19)
nn(dose-21, statin-20)
nsubj(needs-22, dose-21)
ccomp(see-17, needs-22)
dobj(needs-22, adjustment-23)

Warfarin/NN :/: Co-administration/NN of/IN bosentan/NN 500/CD mg/NN b.i.d./NN for/IN 6/CD days/NNS decreased/VBD the/DT plasma/NN concentrations/NNS of/IN both/CC S-/NN warfarin/NN (/-LRB- a/DT CYP2C9/NN substrate/NN )/-RRB- and/CC R-/NN warfarin/NN (/-LRB- a/DT CYP3A4/NN substrate/NN )/-RRB- by/IN 29/CD and/CC 38/CD %/NN ,/, respectively/RB ./.

(ROOT (S1 (S (NP (NP (NN Warfarin)) (: :) (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NP (NN bosentan) (CD 500) (NN mg) (NN b.i.d.)) (PP (IN for) (NP (CD 6) (NNS days)))))) (VP (VBD decreased) (NP (NP (DT the) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (CC both) (NP (NP (NN S-) (NN warfarin)) (PRN (-LRB- -LRB-) (NP (DT a) (NN CYP2C9) (NN substrate)) (-RRB- -RRB-))) (CC and) (NP (NP (NN R-) (NN warfarin)) (PRN (-LRB- -LRB-) (NP (DT a) (NN CYP3A4) (NN substrate)) (-RRB- -RRB-)))))) (PP (IN by) (NP (QP (CD 29) (CC and) (CD 38)) (NN %))) (, ,) (ADVP (RB respectively)))) (. .)))))

root(ROOT-0, Warfarin-1)
nsubj(decreased-12, Co-administration-3)
nn(b.i.d.-8, bosentan-5)
num(b.i.d.-8, 500-6)
nn(b.i.d.-8, mg-7)
prep_of(Co-administration-3, b.i.d.-8)
num(days-11, 6-10)
prep_for(b.i.d.-8, days-11)
dep(Warfarin-1, decreased-12)
det(concentrations-15, the-13)
nn(concentrations-15, plasma-14)
dobj(decreased-12, concentrations-15)
preconj(warfarin-19, both-17)
nn(warfarin-19, S--18)
prep_of(concentrations-15, warfarin-19)
det(substrate-23, a-21)
nn(substrate-23, CYP2C9-22)
abbrev(warfarin-19, substrate-23)
nn(warfarin-27, R--26)
conj_and(warfarin-19, warfarin-27)
det(substrate-31, a-29)
nn(substrate-31, CYP3A4-30)
abbrev(warfarin-27, substrate-31)
num(%-37, 29-34)
conj_and(29-34, 38-36)
prep_by(decreased-12, %-37)
advmod(decreased-12, respectively-39)

Clinical/JJ experience/VBP with/IN concomitant/JJ administration/NN of/IN bosentan/NN and/CC warfarin/NN in/IN patients/NNS with/IN pulmonary/JJ arterial/JJ hypertension/NN did/VBD not/RB show/VB clinically/RB relevant/JJ changes/NNS in/IN INR/NN or/CC warfarin/NN dose/NN (/-LRB- baseline/NN vs./CC end/NN of/IN the/DT clinical/JJ studies/NNS )/-RRB- ,/, and/CC the/DT need/NN to/TO change/VB the/DT warfarin/NN dose/NN during/IN the/DT trials/NNS due/JJ to/TO changes/NNS in/IN INR/NN or/CC due/JJ to/TO adverse/JJ events/NNS was/VBD similar/JJ among/IN bosentan/NN -/: and/CC placebo-treated/JJ patients/NNS ./.

(ROOT (S1 (S (S (NP (JJ Clinical)) (VP (VBP experience) (SBAR (IN with) (S (S (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NP (NN bosentan)) (CC and) (NP (NN warfarin))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ pulmonary) (JJ arterial) (NN hypertension)))))))) (VP (VBD did) (RB not) (VP (VB show) (NP (NP (ADJP (RB clinically) (JJ relevant)) (NNS changes)) (PP (IN in) (NP (NP (NP (NN INR)) (CC or) (NP (NN warfarin)) (NP (NN dose))) (PRN (-LRB- -LRB-) (NP (NP (NN baseline)) (CC vs.) (NP (NP (NN end)) (PP (IN of) (NP (DT the) (JJ clinical) (NNS studies))))) (-RRB- -RRB-)))))))) (, ,) (CC and) (S (NP (DT the) (NN need) (S (VP (TO to) (VP (VB change) (NP (DT the) (NN warfarin) (NN dose)) (PP (IN during) (NP (NP (DT the) (NNS trials)) (ADJP (ADJP (JJ due) (PP (TO to) (NP (NP (NNS changes)) (PP (IN in) (NP (NN INR)))))) (CC or) (ADJP (JJ due) (PP (TO to) (NP (JJ adverse) (NNS events))))))))))) (VP (VBD was) (ADJP (JJ similar) (PP (IN among) (NP (NN bosentan)))))))))) (: -) (CC and) (NP (JJ placebo-treated) (NNS patients)) (. .))))

nsubj(experience-2, Clinical-1)
root(ROOT-0, experience-2)
mark(show-18, with-3)
amod(administration-5, concomitant-4)
nsubj(show-18, administration-5)
prep_of(administration-5, bosentan-7)
conj_and(bosentan-7, warfarin-9)
prep_in(bosentan-7, patients-11)
amod(hypertension-15, pulmonary-13)
amod(hypertension-15, arterial-14)
prep_with(patients-11, hypertension-15)
aux(show-18, did-16)
neg(show-18, not-17)
advcl(experience-2, show-18)
advmod(relevant-20, clinically-19)
amod(changes-21, relevant-20)
dobj(show-18, changes-21)
prep_in(changes-21, INR-23)
conj_or(INR-23, warfarin-25)
dep(INR-23, dose-26)
dep(INR-23, baseline-28)
conj_vs.(baseline-28, end-30)
det(studies-34, the-32)
amod(studies-34, clinical-33)
prep_of(end-30, studies-34)
det(need-39, the-38)
nsubj(similar-59, need-39)
aux(change-41, to-40)
infmod(need-39, change-41)
det(dose-44, the-42)
nn(dose-44, warfarin-43)
dobj(change-41, dose-44)
det(trials-47, the-46)
prep_during(change-41, trials-47)
amod(trials-47, due-48)
prep_to(due-48, changes-50)
prep_in(changes-50, INR-52)
conj_or(due-48, due-54)
amod(events-57, adverse-56)
prep_to(due-54, events-57)
cop(similar-59, was-58)
conj_and(show-18, similar-59)
prep_among(similar-59, bosentan-61)
amod(patients-65, placebo-treated-64)
conj_and(experience-2, patients-65)

Digoxin/NN ,/, Nimodipine/NN and/CC Losartan/NN :/: Bosentan/NN has/VBZ no/DT significant/JJ pharmacokinetic/JJ interactions/NNS with/IN digoxin/NN and/CC nimodipine/NN ,/, and/CC losartan/NN has/VBZ no/DT significant/JJ effect/NN on/IN plasma/NN levels/NNS of/IN bosentan/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN Digoxin)) (, ,) (NP (NN Nimodipine)) (CC and) (NP (NN Losartan))) (: :) (S (S (NP (NN Bosentan)) (VP (VBZ has) (NP (NP (DT no) (JJ significant) (JJ pharmacokinetic) (NNS interactions)) (PP (IN with) (NP (NP (NN digoxin)) (CC and) (NP (NN nimodipine))))))) (, ,) (CC and) (S (NP (NN losartan)) (VP (VBZ has) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (NN bosentan)))))))) (. .)))))

root(ROOT-0, Digoxin-1)
conj_and(Digoxin-1, Nimodipine-3)
conj_and(Digoxin-1, Losartan-5)
nsubj(has-8, Bosentan-7)
dep(Digoxin-1, has-8)
det(interactions-12, no-9)
amod(interactions-12, significant-10)
amod(interactions-12, pharmacokinetic-11)
dobj(has-8, interactions-12)
prep_with(interactions-12, digoxin-14)
conj_and(digoxin-14, nimodipine-16)
nsubj(has-20, losartan-19)
conj_and(has-8, has-20)
det(effect-23, no-21)
amod(effect-23, significant-22)
dobj(has-20, effect-23)
nn(levels-26, plasma-25)
prep_on(has-20, levels-26)
prep_of(levels-26, bosentan-28)

Co-administration/NN of/IN MYOBLOC/NN and/CC aminoglycosides/NNS or/CC other/JJ agents/NNS interfering/VBG with/IN neuromuscular/JJ transmission/NN (/-LRB- e.g./FW ,/, curare/NN -like/JJ compounds/NNS )/-RRB- should/MD only/RB be/VB performed/VBN with/IN caution/NN as/IN the/DT effect/NN of/IN the/DT toxin/NN may/MD be/VB potentiated/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NP (NN MYOBLOC)) (CC and) (NP (NP (NP (NNS aminoglycosides)) (CC or) (NP (NP (JJ other) (NNS agents)) (VP (VBG interfering) (PP (IN with) (NP (JJ neuromuscular) (NN transmission)))))) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN curare) (JJ -like) (NNS compounds)) (-RRB- -RRB-)))))) (VP (MD should) (ADVP (RB only)) (VP (VB be) (VP (VBN performed) (PP (IN with) (NP (NN caution))) (SBAR (IN as) (S (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (DT the) (NN toxin)))) (VP (MD may) (VP (VB be) (VP (VBN potentiated)))))))))) (. .))))

nsubjpass(performed-23, Co-administration-1)
prep_of(Co-administration-1, MYOBLOC-3)
conj_and(MYOBLOC-3, aminoglycosides-5)
amod(agents-8, other-7)
conj_or(aminoglycosides-5, agents-8)
partmod(agents-8, interfering-9)
amod(transmission-12, neuromuscular-11)
prep_with(interfering-9, transmission-12)
dep(compounds-18, e.g.-14)
nn(compounds-18, curare-16)
amod(compounds-18, -like-17)
appos(aminoglycosides-5, compounds-18)
aux(performed-23, should-20)
advmod(performed-23, only-21)
auxpass(performed-23, be-22)
root(ROOT-0, performed-23)
prep_with(performed-23, caution-25)
mark(potentiated-34, as-26)
det(effect-28, the-27)
nsubjpass(potentiated-34, effect-28)
det(toxin-31, the-30)
prep_of(effect-28, toxin-31)
aux(potentiated-34, may-32)
auxpass(potentiated-34, be-33)
advcl(performed-23, potentiated-34)

The/DT effect/NN of/IN administering/VBG different/JJ botulinum/NN neurotoxin/NN serotypes/NNS at/IN the/DT same/JJ time/NN or/CC within/IN less/JJR than/IN 4/CD months/NNS of/IN each/DT other/JJ is/VBZ unknown/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (S (VP (VBG administering) (NP (JJ different) (NN botulinum) (NN neurotoxin) (NNS serotypes)) (PP (PP (IN at) (NP (DT the) (JJ same) (NN time))) (CC or) (PP (IN within) (NP (NP (QP (JJR less) (IN than) (CD 4)) (NNS months)) (PP (IN of) (NP (DT each) (JJ other)))))))))) (VP (VBZ is) (ADJP (JJ unknown)))) (. .))))

det(effect-2, The-1)
nsubj(unknown-23, effect-2)
prepc_of(effect-2, administering-4)
conj_or(administering-4, administering-4')
amod(serotypes-8, different-5)
nn(serotypes-8, botulinum-6)
nn(serotypes-8, neurotoxin-7)
dobj(administering-4, serotypes-8)
det(time-12, the-10)
amod(time-12, same-11)
prep_at(administering-4, time-12)
mwe(than-16, less-15)
quantmod(4-17, than-16)
num(months-18, 4-17)
prep_within(administering-4', months-18)
det(other-21, each-20)
prep_of(months-18, other-21)
cop(unknown-23, is-22)
root(ROOT-0, unknown-23)

However/RB ,/, neuromuscular/NN paralysis/NN may/MD be/VB potentiated/VBN by/IN co-administration/NN or/CC overlapping/JJ administration/NN of/IN different/JJ botulinum/NN toxin/NN serotypes/NNS ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NN neuromuscular) (NN paralysis)) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (PP (IN by) (NP (NP (NN co-administration)) (CC or) (NP (NP (JJ overlapping) (NN administration)) (PP (IN of) (NP (JJ different) (NN botulinum) (NN toxin) (NNS serotypes)))))))))) (. .))))

advmod(potentiated-7, However-1)
nn(paralysis-4, neuromuscular-3)
nsubjpass(potentiated-7, paralysis-4)
aux(potentiated-7, may-5)
auxpass(potentiated-7, be-6)
root(ROOT-0, potentiated-7)
agent(potentiated-7, co-administration-9)
amod(administration-12, overlapping-11)
conj_or(co-administration-9, administration-12)
amod(serotypes-17, different-14)
nn(serotypes-17, botulinum-15)
nn(serotypes-17, toxin-16)
prep_of(administration-12, serotypes-17)

Although/IN specific/JJ drug/NN interaction/NN studies/NNS have/VBP not/RB been/VBN conducted/VBN with/IN ALPHAGAN/NN @/NN P/NN ,/, the/DT possibility/NN of/IN an/DT additive/JJ or/NN potentiating/NN effect/NN with/IN CNS/NN depressants/NNS (/-LRB- alcohol/NN ,/, barbiturates/NNS ,/, opiates/NNS ,/, sedatives/NNS ,/, or/CC anesthetics/NNS )/-RRB- should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (JJ specific) (NN drug) (NN interaction) (NNS studies)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN conducted) (PP (IN with) (NP (NN ALPHAGAN) (NN @) (NN P)))))))) (, ,) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (DT an) (JJ additive) (NN or) (NN potentiating) (NN effect)) (PP (IN with) (NP (NP (NN CNS) (NNS depressants)) (PRN (-LRB- -LRB-) (NP (NN alcohol)) (, ,) (NP (NP (NNS barbiturates)) (, ,) (NP (NNS opiates)) (, ,) (NP (NNS sedatives)) (, ,) (CC or) (NP (NNS anesthetics))) (-RRB- -RRB-))))))) (VP (MD should) (VP (VB be) (VP (VBN considered))))) (. .))))

mark(conducted-9, Although-1)
amod(studies-5, specific-2)
nn(studies-5, drug-3)
nn(studies-5, interaction-4)
nsubjpass(conducted-9, studies-5)
aux(conducted-9, have-6)
neg(conducted-9, not-7)
auxpass(conducted-9, been-8)
advcl(considered-40, conducted-9)
nn(P-13, ALPHAGAN-11)
nn(P-13, @-12)
prep_with(conducted-9, P-13)
det(possibility-16, the-15)
nsubjpass(considered-40, possibility-16)
det(effect-22, an-18)
amod(effect-22, additive-19)
nn(effect-22, or-20)
nn(effect-22, potentiating-21)
prep_of(possibility-16, effect-22)
nn(depressants-25, CNS-24)
prep_with(effect-22, depressants-25)
dep(depressants-25, alcohol-27)
dep(alcohol-27, barbiturates-29)
conj_or(barbiturates-29, opiates-31)
conj_or(barbiturates-29, sedatives-33)
conj_or(barbiturates-29, anesthetics-36)
aux(considered-40, should-38)
auxpass(considered-40, be-39)
root(ROOT-0, considered-40)

Alpha-/NN agonists/NNS ,/, as/IN a/DT class/NN ,/, may/MD reduce/VB pulse/NN and/CC blood/NN pressure/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Alpha-) (NNS agonists)) (, ,) (PP (IN as) (NP (DT a) (NN class))) (, ,)) (VP (MD may) (VP (VB reduce) (NP (NP (NN pulse)) (CC and) (NP (NN blood) (NN pressure)))))) (. .))))

nn(agonists-2, Alpha--1)
nsubj(reduce-9, agonists-2)
det(class-6, a-5)
prep_as(agonists-2, class-6)
aux(reduce-9, may-8)
root(ROOT-0, reduce-9)
dobj(reduce-9, pulse-10)
nn(pressure-13, blood-12)
conj_and(pulse-10, pressure-13)

Caution/NN in/IN using/VBG concomitant/JJ drugs/NNS such/JJ as/IN beta-blockers/NNS (/-LRB- ophthalmic/JJ and/CC systemic/JJ )/-RRB- ,/, anti-hypertensives/NNS and/or/CC cardiac/JJ glycosides/NNS is/VBZ advised/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Caution)) (PP (IN in) (S (VP (VBG using) (NP (NP (JJ concomitant) (NNS drugs)) (PP (JJ such) (IN as) (NP (NP (NP (NNS beta-blockers)) (PRN (-LRB- -LRB-) (ADJP (ADJP (JJ ophthalmic)) (CC and) (ADJP (JJ systemic))) (-RRB- -RRB-))) (, ,) (NP (NNS anti-hypertensives)) (CC and/or) (NP (JJ cardiac) (NNS glycosides))))))))) (VP (VBZ is) (VP (VBN advised)))) (. .))))

nsubjpass(advised-20, Caution-1)
prepc_in(Caution-1, using-3)
amod(drugs-5, concomitant-4)
dobj(using-3, drugs-5)
prep_such_as(drugs-5, beta-blockers-8)
dep(beta-blockers-8, ophthalmic-10)
conj_and(ophthalmic-10, systemic-12)
conj_and/or(beta-blockers-8, anti-hypertensives-15)
amod(glycosides-18, cardiac-17)
conj_and/or(beta-blockers-8, glycosides-18)
auxpass(advised-20, is-19)
root(ROOT-0, advised-20)

Tricyclic/JJ antidepressants/NNS have/VBP been/VBN reported/VBN to/TO blunt/VB the/DT hypotensive/JJ effect/NN of/IN systemic/JJ clonidine/NN .It/NN is/VBZ not/RB known/VBN whether/IN the/DT concurrent/JJ use/NN of/IN these/DT agents/NNS with/IN ALPHAGAN/NN @/NN P/NN in/IN humans/NNS can/MD lead/VB to/TO resulting/VBG interference/NN with/IN the/DT IOP/NN lowering/JJ effect/NN ./.

(ROOT (S1 (S (S (NP (JJ Tricyclic) (NNS antidepressants)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB blunt) (NP (NP (DT the) (JJ hypotensive) (NN effect)) (PP (IN of) (NP (NP (JJ systemic) (NN clonidine) (NN .It)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (IN whether) (S (NP (NP (DT the) (JJ concurrent) (NN use)) (PP (IN of) (NP (DT these) (NNS agents))) (PP (IN with) (NP (NP (NN ALPHAGAN) (NN @) (NN P)) (PP (IN in) (NP (NNS humans)))))) (VP (MD can) (VP (VB lead) (PP (TO to) (NP (NP (VBG resulting) (NN interference)) (PP (IN with) (NP (DT the) (NN IOP) (JJ lowering) (NN effect))))))))))))))))))))) (. .))))

amod(antidepressants-2, Tricyclic-1)
nsubjpass(reported-5, antidepressants-2)
xsubj(blunt-7, antidepressants-2)
aux(reported-5, have-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
aux(blunt-7, to-6)
xcomp(reported-5, blunt-7)
det(effect-10, the-8)
amod(effect-10, hypotensive-9)
dobj(blunt-7, effect-10)
amod(.It-14, systemic-12)
nn(.It-14, clonidine-13)
prep_of(effect-10, .It-14)
auxpass(known-17, is-15)
neg(known-17, not-16)
dep(.It-14, known-17)
complm(lead-32, whether-18)
det(use-21, the-19)
amod(use-21, concurrent-20)
nsubj(lead-32, use-21)
det(agents-24, these-23)
prep_of(use-21, agents-24)
nn(P-28, ALPHAGAN-26)
nn(P-28, @-27)
prep_with(use-21, P-28)
prep_in(P-28, humans-30)
aux(lead-32, can-31)
ccomp(known-17, lead-32)
amod(interference-35, resulting-34)
prep_to(lead-32, interference-35)
det(effect-40, the-37)
nn(effect-40, IOP-38)
amod(effect-40, lowering-39)
prep_with(interference-35, effect-40)

Caution/NN ,/, however/RB ,/, is/VBZ advised/VBN in/IN patients/NNS taking/VBG tricyclic/JJ antidepressants/NNS which/WDT can/MD affect/VB the/DT metabolism/NN and/CC uptake/NN of/IN circulating/VBG amines/NNS ./.

(ROOT (S1 (S (S (NP (NN Caution)) (, ,) (ADVP (RB however)) (, ,) (VP (VBZ is) (VP (VBN advised) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (JJ tricyclic) (NNS antidepressants)) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB affect) (NP (NP (DT the) (NP (NN metabolism)) (CC and) (NP (NN uptake))) (PP (IN of) (NP (VBG circulating) (NNS amines))))))))))))))) (. .))))

nsubjpass(advised-6, Caution-1)
advmod(advised-6, however-3)
auxpass(advised-6, is-5)
root(ROOT-0, advised-6)
prep_in(advised-6, patients-8)
partmod(patients-8, taking-9)
amod(antidepressants-11, tricyclic-10)
dobj(taking-9, antidepressants-11)
nsubj(affect-14, antidepressants-11)
aux(affect-14, can-13)
rcmod(antidepressants-11, affect-14)
dep(metabolism-16, the-15)
dobj(affect-14, metabolism-16)
conj_and(metabolism-16, uptake-18)
amod(amines-21, circulating-20)
prep_of(metabolism-16, amines-21)

AZOPT/NN (/-LRB- brinzolamide/NN ophthalmic/JJ suspension/NN )/-RRB- 1/CD %/NN contains/VBZ a/DT carbonic/JJ anhydrase/NN inhibitor/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN AZOPT)) (PRN (-LRB- -LRB-) (NP (NN brinzolamide) (JJ ophthalmic) (NN suspension)) (-RRB- -RRB-))) (ADJP (CD 1) (NN %))) (VP (VBZ contains) (NP (NP (DT a) (JJ carbonic) (NN anhydrase)) (NN inhibitor)))) (. .))))

nsubj(contains-9, AZOPT-1)
nn(suspension-5, brinzolamide-3)
amod(suspension-5, ophthalmic-4)
appos(AZOPT-1, suspension-5)
number(%-8, 1-7)
amod(AZOPT-1, %-8)
root(ROOT-0, contains-9)
det(anhydrase-12, a-10)
amod(anhydrase-12, carbonic-11)
nn(inhibitor-13, anhydrase-12)
dobj(contains-9, inhibitor-13)

Acid-base/NN and/CC electrolyte/NN alterations/NNS were/VBD not/RB reported/VBN in/IN the/DT clinical/JJ trials/NNS with/IN brinzolamide/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Acid-base)) (CC and) (NP (NN electrolyte))) (NNS alterations)) (VP (VBD were) (RB not) (VP (VBN reported) (PP (IN in) (NP (NP (DT the) (JJ clinical) (NNS trials)) (PP (IN with) (NP (NN brinzolamide)))))))) (. .))))

nn(alterations-4, Acid-base-1)
conj_and(Acid-base-1, electrolyte-3)
nsubjpass(reported-7, alterations-4)
auxpass(reported-7, were-5)
neg(reported-7, not-6)
root(ROOT-0, reported-7)
det(trials-11, the-9)
amod(trials-11, clinical-10)
prep_in(reported-7, trials-11)
prep_with(trials-11, brinzolamide-13)

However/RB ,/, in/IN patients/NNS treated/VBN with/IN oral/JJ carbonic/JJ anhydrase/NN inhibitors/NNS ,/, rare/JJ instances/NNS of/IN drug/NN interactions/NNS have/VBP occurred/VBN with/IN high-dose/JJ salicylate/NN therapy/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (JJ oral) (JJ carbonic) (NN anhydrase)) (NNS inhibitors)))))) (, ,) (NP (NP (JJ rare) (NNS instances)) (PP (IN of) (NP (NN drug) (NNS interactions)))) (VP (VBP have) (VP (VBN occurred) (PP (IN with) (NP (JJ high-dose) (NN salicylate) (NN therapy)))))) (. .))))

advmod(occurred-18, However-1)
prep_in(occurred-18, patients-4)
partmod(patients-4, treated-5)
amod(anhydrase-9, oral-7)
amod(anhydrase-9, carbonic-8)
nn(inhibitors-10, anhydrase-9)
prep_with(treated-5, inhibitors-10)
amod(instances-13, rare-12)
nsubj(occurred-18, instances-13)
nn(interactions-16, drug-15)
prep_of(instances-13, interactions-16)
aux(occurred-18, have-17)
root(ROOT-0, occurred-18)
amod(therapy-22, high-dose-20)
nn(therapy-22, salicylate-21)
prep_with(occurred-18, therapy-22)

Therefore/RB ,/, the/DT potential/NN for/IN such/JJ drug/NN interaction/NN should/MD be/VB considered/VBN in/IN patients/NNS receiving/VBG AZOPT/NN (/-LRB- brinzolamide/NN ophthalmic/JJ suspension/NN )/-RRB- 1/CD %./NN

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (JJ such) (NN drug) (NN interaction)))) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN AZOPT)) (PRN (-LRB- -LRB-) (NP (NN brinzolamide) (JJ ophthalmic) (NN suspension)) (-RRB- -RRB-)))))))))) (NP (CD 1) (NN %.)))))

advmod(considered-11, Therefore-1)
det(potential-4, the-3)
nsubjpass(considered-11, potential-4)
amod(interaction-8, such-6)
nn(interaction-8, drug-7)
prep_for(potential-4, interaction-8)
aux(considered-11, should-9)
auxpass(considered-11, be-10)
root(ROOT-0, considered-11)
prep_in(considered-11, patients-13)
partmod(patients-13, receiving-14)
dobj(receiving-14, AZOPT-15)
nn(suspension-19, brinzolamide-17)
amod(suspension-19, ophthalmic-18)
appos(AZOPT-15, suspension-19)
num(%.-22, 1-21)
dep(considered-11, %.-22)

The/DT risk/NN of/IN using/VBG bromocriptine/NN mesylate/NN in/IN combination/NN with/IN other/JJ drugs/NNS has/VBZ not/RB been/VBN systematically/RB evaluated/VBN ,/, but/CC alcohol/NN may/MD potentiate/VB the/DT side/JJ effects/NNS of/IN bromocriptine/NN mesylate/NN ./.

(ROOT (S1 (S (S (S (NP (NP (DT The) (NN risk)) (PP (IN of) (NP (VBG using) (NN bromocriptine) (NN mesylate))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ other) (NNS drugs)))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB systematically)) (VP (VBN evaluated))))) (, ,) (CC but) (S (NP (NN alcohol)) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (JJ side) (NNS effects)) (PP (IN of) (NP (NN bromocriptine) (NN mesylate)))))))) (. .))))

det(risk-2, The-1)
nsubjpass(evaluated-16, risk-2)
amod(mesylate-6, using-4)
nn(mesylate-6, bromocriptine-5)
prep_of(risk-2, mesylate-6)
prep_in(risk-2, combination-8)
amod(drugs-11, other-10)
prep_with(combination-8, drugs-11)
aux(evaluated-16, has-12)
neg(evaluated-16, not-13)
auxpass(evaluated-16, been-14)
advmod(evaluated-16, systematically-15)
root(ROOT-0, evaluated-16)
nsubj(potentiate-21, alcohol-19)
aux(potentiate-21, may-20)
conj_but(evaluated-16, potentiate-21)
det(effects-24, the-22)
amod(effects-24, side-23)
dobj(potentiate-21, effects-24)
nn(mesylate-27, bromocriptine-26)
prep_of(effects-24, mesylate-27)

Bromocriptine/NN mesylate/NN may/MD interact/VB with/IN dopamine/NN antagonists/NNS ,/, butyrophenones/NNS ,/, and/CC certain/JJ other/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (NN Bromocriptine) (NN mesylate)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NP (NN dopamine) (NNS antagonists)) (, ,) (NP (NNS butyrophenones)) (, ,) (CC and) (NP (JJ certain) (JJ other) (NNS agents))))))) (. .))))

nn(mesylate-2, Bromocriptine-1)
nsubj(interact-4, mesylate-2)
aux(interact-4, may-3)
root(ROOT-0, interact-4)
nn(antagonists-7, dopamine-6)
prep_with(interact-4, antagonists-7)
conj_and(antagonists-7, butyrophenones-9)
amod(agents-14, certain-12)
amod(agents-14, other-13)
conj_and(antagonists-7, agents-14)

Compounds/NNS in/IN these/DT categories/NNS result/VBP in/IN a/DT decreased/VBN efficacy/NN of/IN bromocriptine/NN mesylate/NN :/: phenothiazines/NNS ,/, haloperidol/NN ,/, metoclopramide/NN ,/, pimozide/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Compounds)) (PP (IN in) (NP (DT these) (NNS categories)))) (VP (VBP result) (PP (IN in) (NP (NP (NP (DT a) (VBN decreased) (NN efficacy)) (PP (IN of) (NP (NN bromocriptine) (NN mesylate)))) (: :) (NP (NNS phenothiazines)) (, ,) (NP (NN haloperidol)) (, ,) (NP (NN metoclopramide)) (, ,) (NP (NN pimozide)))))) (. .))))

nsubj(result-5, Compounds-1)
det(categories-4, these-3)
prep_in(Compounds-1, categories-4)
root(ROOT-0, result-5)
det(efficacy-9, a-7)
amod(efficacy-9, decreased-8)
prep_in(result-5, efficacy-9)
nn(mesylate-12, bromocriptine-11)
prep_of(efficacy-9, mesylate-12)
dep(efficacy-9, phenothiazines-14)
appos(efficacy-9, haloperidol-16)
appos(efficacy-9, metoclopramide-18)
appos(efficacy-9, pimozide-20)

Concomitant/JJ use/NN of/IN bromocriptine/NN mesylate/NN with/IN other/JJ ergot/NN alkaloids/NNS is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NN bromocriptine) (NN mesylate))) (PP (IN with) (NP (JJ other) (NN ergot) (NNS alkaloids)))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

amod(use-2, Concomitant-1)
nsubjpass(recommended-12, use-2)
nn(mesylate-5, bromocriptine-4)
prep_of(use-2, mesylate-5)
amod(alkaloids-9, other-7)
nn(alkaloids-9, ergot-8)
prep_with(use-2, alkaloids-9)
auxpass(recommended-12, is-10)
neg(recommended-12, not-11)
root(ROOT-0, recommended-12)

Dexbrompheniramine/NN can/MD interact/VB with/IN alcohol/NN or/CC other/JJ CNS/NN depressants/NNS (/-LRB- may/MD potentiate/VB the/DT CNS/NN depressant/NN effects/NNS of/IN either/CC these/DT medications/NNS or/CC antihistamines/NNS )/-RRB- ,/, anticholinergics/NN or/CC other/JJ medications/NNS with/IN anticholinergic/JJ activity/NN (/-LRB- anticholinergic/JJ effects/NNS may/MD be/VB potentiated/VBN when/WRB these/DT medications/NNS are/VBP used/VBN concurrently/RB with/IN antihistamines/NNS )/-RRB- ,/, and/CC monoamine/NN oxidase/NN (/-LRB- MAO/NN )/-RRB- inhibitors/NNS (/-LRB- concurrent/JJ use/NN with/IN antihistamines/NNS may/MD prolong/VB and/CC intensify/VB the/DT anticholinergic/JJ and/CC CNS/NN depressant/NN effects/NNS of/IN antihistamines/NNS )/-RRB- ./.

(ROOT (S1 (S (NP (NN Dexbrompheniramine)) (VP (MD can) (VP (VB interact) (PP (IN with) (NP (NP (NP (NP (NN alcohol)) (CC or) (NP (JJ other) (NN CNS) (NNS depressants))) (PRN (-LRB- -LRB-) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (NN CNS) (NN depressant) (NNS effects)) (PP (IN of) (NP (CC either) (DT these) (NP (NNS medications)) (CC or) (NP (NNS antihistamines))))))) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NN anticholinergics)) (CC or) (NP (NP (JJ other) (NNS medications)) (PP (IN with) (NP (JJ anticholinergic) (NN activity))))) (PRN (-LRB- -LRB-) (NP (NP (JJ anticholinergic) (NNS effects)) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (SBAR (WHADVP (WRB when)) (S (NP (DT these) (NNS medications)) (VP (VBP are) (VP (VBN used) (ADVP (RB concurrently)) (PP (IN with) (NP (NNS antihistamines))))))))))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NP (NP (NN monoamine) (NN oxidase)) (PRN (-LRB- -LRB-) (NP (NN MAO)) (-RRB- -RRB-))) (NNS inhibitors)) (PRN (-LRB- -LRB-) (S (NP (NP (JJ concurrent) (NN use)) (PP (IN with) (NP (NNS antihistamines)))) (VP (MD may) (VP (VP (VB prolong)) (CC and) (VP (VB intensify) (NP (NP (DT the) (JJ anticholinergic) (CC and) (NN CNS) (NN depressant) (NNS effects)) (PP (IN of) (NP (NNS antihistamines)))))))) (-RRB- -RRB-))))))) (. .))))

nsubj(interact-3, Dexbrompheniramine-1)
aux(interact-3, can-2)
root(ROOT-0, interact-3)
prep_with(interact-3, alcohol-5)
amod(depressants-9, other-7)
nn(depressants-9, CNS-8)
conj_or(alcohol-5, depressants-9)
aux(potentiate-12, may-11)
dep(alcohol-5, potentiate-12)
det(effects-16, the-13)
nn(effects-16, CNS-14)
nn(effects-16, depressant-15)
dobj(potentiate-12, effects-16)
preconj(medications-20, either-18)
dep(medications-20, these-19)
prep_of(effects-16, medications-20)
conj_or(medications-20, antihistamines-22)
conj_or(alcohol-5, anticholinergics-25)
amod(medications-28, other-27)
conj_or(anticholinergics-25, medications-28)
amod(activity-31, anticholinergic-30)
prep_with(medications-28, activity-31)
amod(effects-34, anticholinergic-33)
dep(anticholinergics-25, effects-34)
aux(potentiated-37, may-35)
auxpass(potentiated-37, be-36)
dep(effects-34, potentiated-37)
advmod(used-42, when-38)
det(medications-40, these-39)
nsubjpass(used-42, medications-40)
auxpass(used-42, are-41)
advcl(potentiated-37, used-42)
advmod(used-42, concurrently-43)
prep_with(used-42, antihistamines-45)
nn(oxidase-50, monoamine-49)
nn(inhibitors-54, oxidase-50)
abbrev(oxidase-50, MAO-52)
conj_and(alcohol-5, inhibitors-54)
amod(use-57, concurrent-56)
nsubj(prolong-61, use-57)
prep_with(use-57, antihistamines-59)
aux(prolong-61, may-60)
dep(inhibitors-54, prolong-61)
conj_and(prolong-61, intensify-63)
dep(anticholinergic-65, the-64)
dobj(intensify-63, anticholinergic-65)
nn(effects-69, CNS-67)
nn(effects-69, depressant-68)
conj_and(anticholinergic-65, effects-69)
prep_of(anticholinergic-65, antihistamines-71)

This/DT drug/NN may/MD interact/VB with/IN alcohol/NN or/CC other/JJ CNS/NN depressants/NNS (/-LRB- may/MD potentiate/VB the/DT CNS/NN depressant/NN effects/NNS of/IN either/CC these/DT medications/NNS or/CC antihistamines/NNS )/-RRB- ,/, anticholinergics/NN or/CC other/JJ medications/NNS with/IN anticholinergic/JJ activity/NN (/-LRB- anticholinergic/JJ effects/NNS may/MD be/VB potentiated/VBN when/WRB these/DT medications/NNS are/VBP used/VBN concurrently/RB with/IN antihistamines/NNS )/-RRB- ,/, and/CC monoamine/NN oxidase/NN (/-LRB- MAO/NN )/-RRB- inhibitors/NNS (/-LRB- concurrent/JJ use/NN with/IN antihistamines/NNS may/MD prolong/VB and/CC intensify/VB the/DT anticholinergic/JJ and/CC CNS/NN depressant/NN effects/NNS of/IN antihistamines/NNS )/-RRB- ./.

(ROOT (S1 (S (S (NP (DT This) (NN drug)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NP (NN alcohol)) (CC or) (NP (NP (JJ other) (NN CNS) (NNS depressants)) (-LRB- -LRB-) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (NN CNS) (NN depressant) (NNS effects)) (PP (IN of) (NP (CC either) (DT these) (NP (NNS medications)) (CC or) (NP (NNS antihistamines))))))) (-RRB- -RRB-)) (, ,) (NP (NP (NP (NN anticholinergics)) (CC or) (NP (NP (JJ other) (NNS medications)) (PP (IN with) (NP (JJ anticholinergic) (NN activity))))) (PRN (-LRB- -LRB-) (NP (NP (JJ anticholinergic) (NNS effects)) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (SBAR (WHADVP (WRB when)) (S (NP (DT these) (NNS medications)) (VP (VBP are) (VP (VBN used) (ADVP (RB concurrently)) (PP (IN with) (NP (NNS antihistamines))))))))))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NP (NP (NN monoamine) (NN oxidase)) (PRN (-LRB- -LRB-) (NP (NN MAO)) (-RRB- -RRB-))) (NNS inhibitors)) (PRN (-LRB- -LRB-) (S (NP (NP (JJ concurrent) (NN use)) (PP (IN with) (NP (NNS antihistamines)))) (VP (MD may) (VP (VP (VB prolong)) (CC and) (VP (VB intensify) (NP (NP (DT the) (JJ anticholinergic) (CC and) (NN CNS) (NN depressant) (NNS effects)) (PP (IN of) (NP (NNS antihistamines)))))))) (-RRB- -RRB-)))))))) (. .))))

det(drug-2, This-1)
nsubj(interact-4, drug-2)
aux(interact-4, may-3)
root(ROOT-0, interact-4)
prep_with(interact-4, alcohol-6)
amod(depressants-10, other-8)
nn(depressants-10, CNS-9)
conj_or(alcohol-6, depressants-10)
aux(potentiate-13, may-12)
dep(depressants-10, potentiate-13)
det(effects-17, the-14)
nn(effects-17, CNS-15)
nn(effects-17, depressant-16)
dobj(potentiate-13, effects-17)
preconj(medications-21, either-19)
dep(medications-21, these-20)
prep_of(effects-17, medications-21)
conj_or(medications-21, antihistamines-23)
conj_or(alcohol-6, anticholinergics-26)
amod(medications-29, other-28)
conj_or(anticholinergics-26, medications-29)
amod(activity-32, anticholinergic-31)
prep_with(medications-29, activity-32)
amod(effects-35, anticholinergic-34)
dep(anticholinergics-26, effects-35)
aux(potentiated-38, may-36)
auxpass(potentiated-38, be-37)
dep(effects-35, potentiated-38)
advmod(used-43, when-39)
det(medications-41, these-40)
nsubjpass(used-43, medications-41)
auxpass(used-43, are-42)
advcl(potentiated-38, used-43)
advmod(used-43, concurrently-44)
prep_with(used-43, antihistamines-46)
nn(oxidase-51, monoamine-50)
nn(inhibitors-55, oxidase-51)
abbrev(oxidase-51, MAO-53)
conj_and(alcohol-6, inhibitors-55)
amod(use-58, concurrent-57)
nsubj(prolong-62, use-58)
prep_with(use-58, antihistamines-60)
aux(prolong-62, may-61)
dep(inhibitors-55, prolong-62)
conj_and(prolong-62, intensify-64)
dep(anticholinergic-66, the-65)
dobj(intensify-64, anticholinergic-66)
nn(effects-70, CNS-68)
nn(effects-70, depressant-69)
conj_and(anticholinergic-66, effects-70)
prep_of(anticholinergic-66, antihistamines-72)

-/CC Drugs/NNS with/IN ototoxic/JJ potential/NN :/: Especially/RB in/IN the/DT presence/NN of/IN impaired/JJ renal/JJ function/NN ,/, the/DT use/NN of/IN parenterally/RB administered/VBN bumetanide/NN in/IN patients/NNS to/TO whom/WP aminoglycoside/NN antibiotics/NNS are/VBP also/RB being/VBG given/VBN should/MD be/VB avoided/VBN ,/, except/IN in/IN life-threatening/JJ conditions/NNS ./.

(ROOT (S1 (S (NP (NP (CC -) (NP (NNS Drugs)) (PP (IN with) (NP (JJ ototoxic) (NN potential)))) (: :) (S (PP (ADVP (RB Especially)) (IN in) (DT the) (NN presence) (IN of) (NP (JJ impaired) (JJ renal) (NN function))) (, ,) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (ADJP (RB parenterally) (VBN administered)) (NN bumetanide))) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHPP (TO to) (WHNP (WP whom))) (S (NP (NN aminoglycoside) (NNS antibiotics)) (VP (VBP are) (ADVP (RB also)) (VP (VBG being) (VP (VBN given))))))))) (VP (MD should) (VP (VB be) (VP (VBN avoided) (, ,) (PP (IN except) (PP (IN in) (NP (JJ life-threatening) (NNS conditions)))))))) (. .)))))

root(ROOT-0, Drugs-2)
amod(potential-5, ototoxic-4)
prep_with(Drugs-2, potential-5)
advmod(avoided-34, Especially-7)
dep(avoided-34, in-8)
dep(avoided-34, the-9)
dep(avoided-34, presence-10)
amod(function-14, impaired-12)
amod(function-14, renal-13)
prep_of(avoided-34, function-14)
det(use-17, the-16)
nsubjpass(avoided-34, use-17)
advmod(administered-20, parenterally-19)
amod(bumetanide-21, administered-20)
prep_of(use-17, bumetanide-21)
prep_in(use-17, patients-23)
rel(given-31, whom-25)
nn(antibiotics-27, aminoglycoside-26)
nsubjpass(given-31, antibiotics-27)
aux(given-31, are-28)
advmod(given-31, also-29)
auxpass(given-31, being-30)
rcmod(patients-23, given-31)
aux(avoided-34, should-32)
auxpass(avoided-34, be-33)
dep(Drugs-2, avoided-34)
prep(avoided-34, except-36)
pcomp(except-36, in-37)
amod(conditions-39, life-threatening-38)
prep_in(except-36, conditions-39)

-/CC Drugs/NNS with/IN nephrotoxic/JJ potential/NN :/: There/EX has/VBZ been/VBN no/RB experience/VBP on/IN the/DT concurrent/JJ use/NN of/IN bumetanide/NN with/IN drugs/NNS known/VBN to/TO have/VB a/DT nephrotoxic/JJ potential/NN ./.

(ROOT (S1 (S (NP (NP (CC -) (NP (NNS Drugs)) (PP (IN with) (NP (JJ nephrotoxic) (NN potential)))) (: :) (S (NP (EX There)) (VP (VBZ has) (VP (VBN been) (NP (RB no) (VBP experience)) (PP (IN on) (NP (NP (DT the) (JJ concurrent) (NN use)) (PP (IN of) (NP (NN bumetanide))) (PP (IN with) (NP (NP (NNS drugs)) (VP (VBN known) (S (VP (TO to) (VP (VB have) (NP (DT a) (JJ nephrotoxic) (NN potential))))))))))))) (. .)))))

root(ROOT-0, Drugs-2)
amod(potential-5, nephrotoxic-4)
prep_with(Drugs-2, potential-5)
expl(no-10, There-7)
aux(no-10, has-8)
cop(no-10, been-9)
dep(Drugs-2, no-10)
dep(no-10, experience-11)
det(use-15, the-13)
amod(use-15, concurrent-14)
prep_on(no-10, use-15)
prep_of(use-15, bumetanide-17)
prep_with(use-15, drugs-19)
xsubj(have-22, drugs-19)
partmod(drugs-19, known-20)
aux(have-22, to-21)
xcomp(known-20, have-22)
det(potential-25, a-23)
amod(potential-25, nephrotoxic-24)
dobj(have-22, potential-25)

Therefore/RB ,/, the/DT simultaneous/JJ administration/NN of/IN these/DT drugs/NNS should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT the) (JJ simultaneous) (NN administration)) (PP (IN of) (NP (DT these) (NNS drugs)))) (VP (MD should) (VP (VB be) (VP (VBN avoided))))) (. .))))

advmod(avoided-11, Therefore-1)
det(administration-5, the-3)
amod(administration-5, simultaneous-4)
nsubjpass(avoided-11, administration-5)
det(drugs-8, these-7)
prep_of(administration-5, drugs-8)
aux(avoided-11, should-9)
auxpass(avoided-11, be-10)
root(ROOT-0, avoided-11)

-/CC Lithium/NN :/: Lithium/NN should/MD generally/RB not/RB be/VB given/VBN with/IN diuretics/NNS (/-LRB- such/JJ as/IN bumetanide/NN )/-RRB- because/IN they/PRP reduce/VBP its/PRP$ renal/JJ clearance/NN and/CC add/VBP a/DT high/JJ risk/NN of/IN lithium/NN toxicity/NN ./.

(ROOT (S1 (S (NP (NP (CC -) (NN Lithium)) (: :) (S (NP (NN Lithium)) (VP (MD should) (ADVP (RB generally)) (RB not) (VP (VB be) (VP (VBN given) (PP (IN with) (NP (NP (NNS diuretics)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NN bumetanide)))) (-RRB- -RRB-)))) (SBAR (IN because) (S (NP (PRP they)) (VP (VP (VBP reduce) (NP (PRP$ its) (JJ renal) (NN clearance))) (CC and) (VP (VBP add) (NP (NP (DT a) (JJ high) (NN risk)) (PP (IN of) (NP (NN lithium) (NN toxicity)))))))))))) (. .)))))

root(ROOT-0, Lithium-2)
nsubjpass(given-9, Lithium-4)
aux(given-9, should-5)
advmod(given-9, generally-6)
neg(given-9, not-7)
auxpass(given-9, be-8)
dep(Lithium-2, given-9)
prep_with(given-9, diuretics-11)
prep_such_as(diuretics-11, bumetanide-15)
mark(reduce-19, because-17)
nsubj(reduce-19, they-18)
advcl(given-9, reduce-19)
poss(clearance-22, its-20)
amod(clearance-22, renal-21)
dobj(reduce-19, clearance-22)
conj_and(reduce-19, add-24)
det(risk-27, a-25)
amod(risk-27, high-26)
dobj(add-24, risk-27)
nn(toxicity-30, lithium-29)
prep_of(risk-27, toxicity-30)

-/CC Probenecid/NN :/: Pretreatment/NN with/IN probenecid/NN reduces/VBZ both/CC the/DT natriuresis/NN and/CC hyperreninemia/NN produced/VBN by/IN bumetanide/NN ./.

(ROOT (S1 (S (NP (NP (CC -) (NN Probenecid)) (: :) (S (NP (NP (NN Pretreatment)) (PP (IN with) (NP (NN probenecid)))) (VP (VBZ reduces) (NP (NP (CC both) (DT the) (NP (NN natriuresis)) (CC and) (NP (NN hyperreninemia))) (VP (VBN produced) (PP (IN by) (NP (NN bumetanide))))))) (. .)))))

root(ROOT-0, Probenecid-2)
nsubj(reduces-7, Pretreatment-4)
prep_with(Pretreatment-4, probenecid-6)
dep(Probenecid-2, reduces-7)
preconj(natriuresis-10, both-8)
dep(natriuresis-10, the-9)
dobj(reduces-7, natriuresis-10)
conj_and(natriuresis-10, hyperreninemia-12)
partmod(natriuresis-10, produced-13)
agent(produced-13, bumetanide-15)

This/DT antagonistic/JJ effect/NN of/IN probenecid/NN on/IN bu-metanide/JJ natriuresis/NN is/VBZ not/RB due/JJ to/TO a/DT direct/JJ action/NN on/IN sodium/NN excretion/NN but/CC is/VBZ probably/RB secondary/JJ to/TO its/PRP$ inhibitory/JJ effect/NN on/IN renal/JJ tubular/JJ secretion/NN of/IN bumetanide/NN ./.

(ROOT (S1 (S (S (NP (NP (DT This) (JJ antagonistic) (NN effect)) (PP (IN of) (NP (NN probenecid))) (PP (IN on) (NP (JJ bu-metanide) (NN natriuresis)))) (VP (VP (VBZ is) (RB not) (ADJP (JJ due) (PP (TO to) (NP (NP (DT a) (JJ direct) (NN action)) (PP (IN on) (NP (NN sodium) (NN excretion))))))) (CC but) (VP (VBZ is) (ADVP (RB probably)) (ADJP (JJ secondary) (PP (TO to) (NP (NP (PRP$ its) (JJ inhibitory) (NN effect)) (PP (IN on) (NP (NP (JJ renal) (JJ tubular) (NN secretion)) (PP (IN of) (NP (NN bumetanide))))))))))) (. .))))

det(effect-3, This-1)
amod(effect-3, antagonistic-2)
nsubj(due-11, effect-3)
prep_of(effect-3, probenecid-5)
amod(natriuresis-8, bu-metanide-7)
prep_on(effect-3, natriuresis-8)
cop(due-11, is-9)
neg(due-11, not-10)
root(ROOT-0, due-11)
det(action-15, a-13)
amod(action-15, direct-14)
prep_to(due-11, action-15)
nn(excretion-18, sodium-17)
prep_on(action-15, excretion-18)
cop(secondary-22, is-20)
advmod(secondary-22, probably-21)
conj_but(due-11, secondary-22)
poss(effect-26, its-24)
amod(effect-26, inhibitory-25)
prep_to(secondary-22, effect-26)
amod(secretion-30, renal-28)
amod(secretion-30, tubular-29)
prep_on(effect-26, secretion-30)
prep_of(secretion-30, bumetanide-32)

Thus/RB ,/, probenecid/NN should/MD not/RB be/VB administered/VBN concurrently/RB with/IN bumetanide/NN ./.

(ROOT (S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NN probenecid)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (ADVP (RB concurrently)) (PP (IN with) (NP (NN bumetanide))))))) (. .))))

advmod(administered-7, Thus-1)
nsubjpass(administered-7, probenecid-3)
aux(administered-7, should-4)
neg(administered-7, not-5)
auxpass(administered-7, be-6)
root(ROOT-0, administered-7)
advmod(administered-7, concurrently-8)
prep_with(administered-7, bumetanide-10)

-/CC Indomethacin/NN :/: Indomethacin/NN blunts/VBZ the/DT increases/NNS in/IN urine/NN volume/NN and/CC sodium/NN excretion/NN seen/VBN during/IN bumetanide/NN treatment/NN and/CC inhibits/VBZ the/DT bumetanide/NN -induced/JJ increase/NN in/IN plasma/NN renin/NN activity/NN ./.

(ROOT (S1 (S (NP (NP (CC -) (NN Indomethacin)) (: :) (S (NP (NN Indomethacin)) (VP (VP (VBZ blunts) (NP (NP (DT the) (NNS increases)) (PP (IN in) (NP (NP (NP (NN urine) (NN volume)) (CC and) (NP (NN sodium) (NN excretion))) (VP (VBN seen) (PP (IN during) (NP (NN bumetanide) (NN treatment)))))))) (CC and) (VP (VBZ inhibits) (NP (NP (DT the) (ADJP (NN bumetanide) (JJ -induced)) (NN increase)) (PP (IN in) (NP (NP (NN plasma) (NN renin)) (NN activity))))))) (. .)))))

root(ROOT-0, Indomethacin-2)
nsubj(blunts-5, Indomethacin-4)
dep(Indomethacin-2, blunts-5)
det(increases-7, the-6)
dobj(blunts-5, increases-7)
nn(volume-10, urine-9)
prep_in(increases-7, volume-10)
nn(excretion-13, sodium-12)
conj_and(volume-10, excretion-13)
partmod(volume-10, seen-14)
nn(treatment-17, bumetanide-16)
prep_during(seen-14, treatment-17)
conj_and(blunts-5, inhibits-19)
det(increase-23, the-20)
dep(-induced-22, bumetanide-21)
amod(increase-23, -induced-22)
dobj(inhibits-19, increase-23)
nn(renin-26, plasma-25)
nn(activity-27, renin-26)
prep_in(increase-23, activity-27)

Concurrent/JJ therapy/NN with/IN bumetanide/NN is/VBZ thus/RB not/RB recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN therapy)) (PP (IN with) (NP (NN bumetanide)))) (VP (VBZ is) (ADVP (RB thus)) (RB not) (VP (VBN recommended)))) (. .))))

amod(therapy-2, Concurrent-1)
nsubjpass(recommended-8, therapy-2)
prep_with(therapy-2, bumetanide-4)
auxpass(recommended-8, is-5)
advmod(recommended-8, thus-6)
neg(recommended-8, not-7)
root(ROOT-0, recommended-8)

-/CC Antihypertensives/NNS :/: Bumetanide/NN may/MD potentiate/VB the/DT effect/NN of/IN various/JJ antihypertensive/JJ drugs/NNS ,/, necessitating/VBG a/DT reduction/NN in/IN the/DT dosage/NN of/IN these/DT drugs/NNS ./.

(ROOT (S1 (S (NP (NP (CC -) (NNS Antihypertensives)) (: :) (S (NP (NN Bumetanide)) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ various) (JJ antihypertensive) (NNS drugs)))) (, ,) (S (VP (VBG necessitating) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN dosage)) (PP (IN of) (NP (DT these) (NNS drugs))))))))))) (. .)))))

root(ROOT-0, Antihypertensives-2)
nsubj(potentiate-6, Bumetanide-4)
aux(potentiate-6, may-5)
dep(Antihypertensives-2, potentiate-6)
det(effect-8, the-7)
dobj(potentiate-6, effect-8)
amod(drugs-12, various-10)
amod(drugs-12, antihypertensive-11)
prep_of(effect-8, drugs-12)
partmod(potentiate-6, necessitating-14)
xcomp(potentiate-6, necessitating-14)
det(reduction-16, a-15)
dobj(necessitating-14, reduction-16)
det(dosage-19, the-18)
prep_in(reduction-16, dosage-19)
det(drugs-22, these-21)
prep_of(dosage-19, drugs-22)

-/CC Digoxin/NN :/: Interaction/NN studies/NNS in/IN humans/NNS have/VBP shown/VBN no/DT effect/NN on/IN digoxin/NN blood/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NP (NN Digoxin) (: :)) (NN Interaction) (NNS studies)) (PP (IN in) (NP (NNS humans)))) (VP (VBP have) (VP (VBN shown) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NN digoxin) (NN blood) (NNS levels))))))) (. .))))

nn(studies-5, Digoxin-2)
nn(studies-5, Interaction-4)
nsubj(shown-9, studies-5)
prep_in(studies-5, humans-7)
aux(shown-9, have-8)
root(ROOT-0, shown-9)
det(effect-11, no-10)
dobj(shown-9, effect-11)
nn(levels-15, digoxin-13)
nn(levels-15, blood-14)
prep_on(effect-11, levels-15)

-/CC Anticoagulants/NNS :/: Interaction/NN studies/NNS in/IN humans/NNS have/VBP shown/VBN bumetanide/NN to/TO have/VB no/DT effect/NN on/IN warfarin/NN metabolism/NN or/CC on/IN plasma/NN prothrombin/NN activity/NN ./.

(ROOT (S1 (S (NP (NP (CC -) (NNS Anticoagulants)) (: :) (S (NP (NP (NN Interaction) (NNS studies)) (PP (IN in) (NP (NNS humans)))) (VP (VBP have) (VP (VBN shown) (NP (NN bumetanide)) (S (VP (TO to) (VP (VB have) (NP (DT no) (NN effect)) (PP (PP (IN on) (NP (NN warfarin) (NN metabolism))) (CC or) (PP (IN on) (NP (NN plasma) (NN prothrombin) (NN activity)))))))))) (. .)))))

root(ROOT-0, Anticoagulants-2)
nn(studies-5, Interaction-4)
nsubj(shown-9, studies-5)
prep_in(studies-5, humans-7)
aux(shown-9, have-8)
dep(Anticoagulants-2, shown-9)
dobj(shown-9, bumetanide-10)
aux(have-12, to-11)
xcomp(shown-9, have-12)
det(effect-14, no-13)
dobj(have-12, effect-14)
nn(metabolism-17, warfarin-16)
prep_on(have-12, metabolism-17)
nn(activity-22, plasma-20)
nn(activity-22, prothrombin-21)
conj_or(metabolism-17, activity-22)

Buprenorphine/NN is/VBZ metabolized/VBN to/TO norbuprenorphine/NN by/IN cytochrome/NN CYP/NN 3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Buprenorphine)) (VP (VBZ is) (VP (VBN metabolized) (PP (TO to) (NP (NN norbuprenorphine))) (PP (IN by) (NP (NN cytochrome) (NN CYP) (NN 3A4)))))) (. .))))

nsubjpass(metabolized-3, Buprenorphine-1)
auxpass(metabolized-3, is-2)
root(ROOT-0, metabolized-3)
prep_to(metabolized-3, norbuprenorphine-5)
nn(3A4-9, cytochrome-7)
nn(3A4-9, CYP-8)
agent(metabolized-3, 3A4-9)

Because/IN CYP/NN 3A4/NN inhibitors/NNS may/MD increase/VB plasma/NN concentrations/NNS of/IN buprenorphine/NN ,/, patients/NNS already/RB on/IN CYP/NN 3A4/NN inhibitors/NNS such/JJ as/IN azole/JJ antifungals/NNS (/-LRB- e.g./FW

(ROOT (S1 (S (SBAR (IN Because) (S (NP (NN CYP) (NN 3A4) (NNS inhibitors)) (VP (MD may) (VP (VB increase) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN buprenorphine)))))))) (, ,) (NP (NNS patients)) (ADVP (RB already)) (PP (IN on) (NP (NP (NN CYP) (NN 3A4) (NNS inhibitors)) (PP (JJ such) (IN as) (NP (NP (JJ azole) (NNS antifungals)) (PRN (-LRB- -LRB-) (PP (FW e.g.))))))))))

mark(increase-6, Because-1)
nn(inhibitors-4, CYP-2)
nn(inhibitors-4, 3A4-3)
nsubj(increase-6, inhibitors-4)
aux(increase-6, may-5)
root(ROOT-0, increase-6)
nn(concentrations-8, plasma-7)
dobj(increase-6, concentrations-8)
prep_of(concentrations-8, buprenorphine-10)
dep(increase-6, patients-12)
advmod(increase-6, already-13)
dep(increase-6, on-14)
nn(inhibitors-17, CYP-15)
nn(inhibitors-17, 3A4-16)
pobj(on-14, inhibitors-17)
amod(antifungals-21, azole-20)
prep_such_as(inhibitors-17, antifungals-21)
dep(antifungals-21, e.g.-23)

ketoconazole/NN )/-RRB- ,/, macrolide/NN antibiotics/NNS (/-LRB- e.g./FW erythromycin/NN )/-RRB- ,/, and/CC HIV/NN protease/NN inhibitors/NNS (/-LRB- e.g./FW ritonavir/NN ,/, indi-navir/NN and/CC saquinavir/NN )/-RRB- should/MD have/VB their/PRP$ dose/NN of/IN SUBUTEX/NN or/CC SUBOXONE/NN adjusted/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN ketoconazole) (-RRB- -RRB-)) (, ,) (NP (NP (NN macrolide) (NNS antibiotics)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (NP (NN erythromycin))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN HIV) (NN protease) (NNS inhibitors)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (NP (NP (NN ritonavir)) (, ,) (NP (NN indi-navir)) (CC and) (NP (NN saquinavir)))) (-RRB- -RRB-)))) (VP (MD should) (VP (VB have) (NP (NP (PRP$ their) (NN dose)) (PP (IN of) (NP (NP (NP (NN SUBUTEX)) (CC or) (NP (NN SUBOXONE))) (VP (VBN adjusted)))))))) (. .))))

nsubj(have-24, ketoconazole-1)
nn(antibiotics-5, macrolide-4)
conj_and(ketoconazole-1, antibiotics-5)
dep(antibiotics-5, e.g.-7)
pobj(e.g.-7, erythromycin-8)
nn(inhibitors-14, HIV-12)
nn(inhibitors-14, protease-13)
conj_and(ketoconazole-1, inhibitors-14)
dep(inhibitors-14, e.g.-16)
pobj(e.g.-16, ritonavir-17)
conj_and(ritonavir-17, indi-navir-19)
conj_and(ritonavir-17, saquinavir-21)
aux(have-24, should-23)
root(ROOT-0, have-24)
poss(dose-26, their-25)
dobj(have-24, dose-26)
prep_of(dose-26, SUBUTEX-28)
conj_or(SUBUTEX-28, SUBOXONE-30)
partmod(SUBUTEX-28, adjusted-31)

Based/VBN on/IN anecdotal/JJ reports/NNS ,/, there/EX may/MD be/VB an/DT interaction/NN between/IN buprenorphine/NN and/CC benzodiazepines/NN ./.

(ROOT (S1 (S (S (PP (VBN Based) (PP (IN on) (NP (JJ anecdotal) (NNS reports)))) (, ,) (NP (EX there)) (VP (MD may) (VP (VB be) (NP (NP (DT an) (NN interaction)) (PP (IN between) (NP (NP (NN buprenorphine)) (CC and) (NP (NN benzodiazepines)))))))) (. .))))

prepc_based_on(interaction-10, on-2)
amod(reports-4, anecdotal-3)
pobj(interaction-10, reports-4)
expl(interaction-10, there-6)
aux(interaction-10, may-7)
cop(interaction-10, be-8)
det(interaction-10, an-9)
root(ROOT-0, interaction-10)
prep_between(interaction-10, buprenorphine-12)
conj_and(buprenorphine-12, benzodiazepines-14)

There/EX have/VBP been/VBN a/DT number/NN of/IN reports/NNS in/IN the/DT post-marketing/JJ experience/VBP of/IN coma/NN and/CC death/NN associated/VBN with/IN the/DT concomitant/JJ intravenous/JJ misuse/NN of/IN buprenorphine/NN and/CC benzodiazepines/NN by/IN addicts/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (NNS reports)) (PP (IN in) (NP (NP (DT the) (JJ post-marketing) (VBP experience)) (PP (IN of) (NP (NP (NP (NN coma)) (CC and) (NP (NN death))) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (JJ concomitant) (JJ intravenous) (NN misuse)) (PP (IN of) (NP (NP (NP (NN buprenorphine)) (CC and) (NP (NN benzodiazepines))) (PP (IN by) (NP (NNS addicts)))))))))))))))))) (. .))))

expl(number-5, There-1)
aux(number-5, have-2)
cop(number-5, been-3)
det(number-5, a-4)
root(ROOT-0, number-5)
prep_of(number-5, reports-7)
det(post-marketing-10, the-9)
prep_in(reports-7, post-marketing-10)
dep(post-marketing-10, experience-11)
prep_of(post-marketing-10, coma-13)
conj_and(coma-13, death-15)
partmod(coma-13, associated-16)
det(misuse-21, the-18)
amod(misuse-21, concomitant-19)
amod(misuse-21, intravenous-20)
prep_with(associated-16, misuse-21)
prep_of(misuse-21, buprenorphine-23)
conj_and(buprenorphine-23, benzodiazepines-25)
prep_by(buprenorphine-23, addicts-27)

In/IN many/JJ of/IN these/DT cases/NNS ,/, buprenorphine/NN was/VBD misused/JJ by/IN self-injection/NN of/IN crushed/JJ SUBUTEX/NN tablets/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (JJ many)) (PP (IN of) (NP (DT these) (NNS cases))))) (, ,) (NP (NN buprenorphine)) (VP (VBD was) (ADJP (JJ misused) (PP (IN by) (NP (NP (NN self-injection)) (PP (IN of) (NP (JJ crushed) (NN SUBUTEX) (NNS tablets)))))))) (. .))))

prep_in(misused-9, many-2)
det(cases-5, these-4)
prep_of(many-2, cases-5)
nsubj(misused-9, buprenorphine-7)
cop(misused-9, was-8)
root(ROOT-0, misused-9)
prep_by(misused-9, self-injection-11)
amod(tablets-15, crushed-13)
nn(tablets-15, SUBUTEX-14)
prep_of(self-injection-11, tablets-15)

SUBUTEX/NN and/CC SUBOXONE/NN should/MD be/VB prescribed/VBN with/IN caution/NN to/TO patients/NNS on/IN benzodiazepines/NNS or/CC other/JJ drugs/NNS that/WDT act/VBP on/IN the/DT central/JJ nervous/JJ system/NN ,/, regardless/RB of/IN whether/IN these/DT drugs/NNS are/VBP taken/VBN on/IN the/DT advice/NN of/IN a/DT physician/NN or/CC are/VBP taken/VBN as/IN drugs/NNS of/IN abuse/NN ./.

(ROOT (S1 (S (NP (NP (NN SUBUTEX)) (CC and) (NP (NN SUBOXONE))) (VP (MD should) (VP (VB be) (VP (VBN prescribed) (PP (IN with) (NP (NN caution))) (PP (TO to) (NP (NP (NNS patients)) (PP (IN on) (NP (NP (NP (NNS benzodiazepines)) (CC or) (NP (JJ other) (NNS drugs))) (SBAR (WHNP (WDT that)) (S (VP (VBP act) (PP (IN on) (NP (DT the) (JJ central) (JJ nervous) (NN system))) (, ,) (ADVP (RB regardless) (PP (IN of) (SBAR (IN whether) (S (NP (DT these) (NNS drugs)) (VP (VP (VBP are) (VP (VBN taken) (PP (IN on) (NP (NP (DT the) (NN advice)) (PP (IN of) (NP (DT a) (NN physician))))))) (CC or) (VP (VBP are) (VP (VBN taken) (PP (IN as) (NP (NP (NNS drugs)) (PP (IN of) (NP (NN abuse)))))))))))))))))))))) (. .))))

nsubjpass(prescribed-6, SUBUTEX-1)
conj_and(SUBUTEX-1, SUBOXONE-3)
aux(prescribed-6, should-4)
auxpass(prescribed-6, be-5)
root(ROOT-0, prescribed-6)
prep_with(prescribed-6, caution-8)
prep_to(prescribed-6, patients-10)
prep_on(patients-10, benzodiazepines-12)
nsubj(act-17, benzodiazepines-12)
amod(drugs-15, other-14)
conj_or(benzodiazepines-12, drugs-15)
rcmod(benzodiazepines-12, act-17)
det(system-22, the-19)
amod(system-22, central-20)
amod(system-22, nervous-21)
prep_on(act-17, system-22)
complm(taken-30, whether-26)
det(drugs-28, these-27)
nsubjpass(taken-30, drugs-28)
auxpass(taken-30, are-29)
prepc_regardless_of(act-17, taken-30)
det(advice-33, the-32)
prep_on(taken-30, advice-33)
det(physician-36, a-35)
prep_of(advice-33, physician-36)
auxpass(taken-39, are-38)
conj_or(taken-30, taken-39)
prep_as(taken-39, drugs-41)
prep_of(drugs-41, abuse-43)

Patients/NNS should/MD be/VB warned/VBN of/IN the/DT potential/JJ danger/NN of/IN the/DT intravenous/JJ self-administration/NN of/IN benzodiazepines/NN while/IN under/IN treatment/NN with/IN SUBOXONE/NN or/CC SUBUTEX/NN ./.

(ROOT (S1 (S (S (NP (NNS Patients)) (VP (MD should) (VP (VB be) (VP (VBN warned) (PP (IN of) (NP (NP (DT the) (JJ potential) (NN danger)) (PP (IN of) (NP (NP (DT the) (JJ intravenous) (NN self-administration)) (PP (IN of) (NP (NN benzodiazepines))))))) (PP (IN while) (PP (IN under) (NP (NP (NN treatment)) (PP (IN with) (NP (NP (NN SUBOXONE)) (CC or) (NP (NN SUBUTEX))))))))))) (. .))))

nsubjpass(warned-4, Patients-1)
aux(warned-4, should-2)
auxpass(warned-4, be-3)
root(ROOT-0, warned-4)
det(danger-8, the-6)
amod(danger-8, potential-7)
prep_of(warned-4, danger-8)
det(self-administration-12, the-10)
amod(self-administration-12, intravenous-11)
prep_of(danger-8, self-administration-12)
prep_of(self-administration-12, benzodiazepines-14)
prep(warned-4, while-15)
pcomp(while-15, under-16)
prep_under(while-15, treatment-17)
prep_with(treatment-17, SUBOXONE-19)
conj_or(SUBOXONE-19, SUBUTEX-21)

Few/JJ systemic/JJ data/NNS have/VBP been/VBN collected/VBN on/IN the/DT metabolism/NN of/IN WELLBUTRIN/NN following/VBG concomitant/JJ administration/NN with/IN other/JJ drugs/NNS or/CC ,/, alternatively/RB ,/, the/DT effect/NN of/IN concomitant/JJ administration/NN of/IN WELLBUTRIN/NN on/IN the/DT metabolism/NN of/IN other/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (JJ Few) (JJ systemic) (NNS data)) (VP (VBP have) (VP (VBN been) (VP (VBN collected) (PP (IN on) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN WELLBUTRIN))))) (PP (VBG following) (NP (NP (JJ concomitant) (NN administration)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (CC or) (, ,) (ADVP (RB alternatively)) (, ,) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN WELLBUTRIN))))) (PP (IN on) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (JJ other) (NNS drugs)))))))))))))) (. .))))

amod(data-3, Few-1)
amod(data-3, systemic-2)
nsubjpass(collected-6, data-3)
aux(collected-6, have-4)
auxpass(collected-6, been-5)
root(ROOT-0, collected-6)
det(metabolism-9, the-8)
prep_on(collected-6, metabolism-9)
prep_of(metabolism-9, WELLBUTRIN-11)
amod(administration-14, concomitant-13)
prep_following(collected-6, administration-14)
amod(drugs-17, other-16)
prep_with(administration-14, drugs-17)
advmod(drugs-17, alternatively-20)
conj_or(drugs-17, alternatively-20)
det(effect-23, the-22)
conj_or(drugs-17, effect-23)
amod(administration-26, concomitant-25)
prep_of(effect-23, administration-26)
prep_of(administration-26, WELLBUTRIN-28)
det(metabolism-31, the-30)
prep_on(effect-23, metabolism-31)
amod(drugs-34, other-33)
prep_of(metabolism-31, drugs-34)

Because/IN bupropion/NN is/VBZ extensively/RB metabolized/VBN ,/, the/DT coadministration/NN of/IN other/JJ drugs/NNS may/MD affect/VB its/PRP$ clinical/JJ activity/NN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NN bupropion)) (VP (VBZ is) (ADVP (RB extensively)) (VP (VBN metabolized))))) (, ,) (NP (NP (DT the) (NN coadministration)) (PP (IN of) (NP (JJ other) (NNS drugs)))) (VP (MD may) (VP (VB affect) (NP (PRP$ its) (JJ clinical) (NN activity))))) (. .))))

mark(metabolized-5, Because-1)
nsubjpass(metabolized-5, bupropion-2)
auxpass(metabolized-5, is-3)
advmod(metabolized-5, extensively-4)
advcl(affect-13, metabolized-5)
det(coadministration-8, the-7)
nsubj(affect-13, coadministration-8)
amod(drugs-11, other-10)
prep_of(coadministration-8, drugs-11)
aux(affect-13, may-12)
root(ROOT-0, affect-13)
poss(activity-16, its-14)
amod(activity-16, clinical-15)
dobj(affect-13, activity-16)

In/FW vitro/FW studies/NNS indicate/VBP that/IN bupropion/NN is/VBZ primarily/RB metabolized/VBN to/TO hydroxybupropion/NN by/IN the/DT CYP2B6/NN isoenzyme/NN ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN bupropion)) (VP (VBZ is) (ADVP (RB primarily)) (VP (VBN metabolized) (PP (TO to) (NP (NN hydroxybupropion))) (PP (IN by) (NP (DT the) (NN CYP2B6) (NN isoenzyme))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(indicate-4, studies-3)
root(ROOT-0, indicate-4)
complm(metabolized-9, that-5)
nsubjpass(metabolized-9, bupropion-6)
auxpass(metabolized-9, is-7)
advmod(metabolized-9, primarily-8)
ccomp(indicate-4, metabolized-9)
prep_to(metabolized-9, hydroxybupropion-11)
det(isoenzyme-15, the-13)
nn(isoenzyme-15, CYP2B6-14)
agent(metabolized-9, isoenzyme-15)

Therefore/RB ,/, the/DT potential/NN exists/VBZ for/IN a/DT drug/NN interaction/NN between/IN WELLBUTRIN/NN and/CC drugs/NNS that/WDT affect/VBP the/DT CYP2B6/NN isoenzyme/NN (/-LRB- e.g./FW ,/, orphenadrine/NN and/CC cyclophosphamide/NN )/-RRB- ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (DT the) (NN potential)) (VP (VBZ exists) (PP (IN for) (NP (NP (DT a) (NN drug) (NN interaction)) (PP (IN between) (NP (NP (NN WELLBUTRIN)) (CC and) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP affect) (NP (NP (DT the) (NN CYP2B6) (NN isoenzyme)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN orphenadrine)) (CC and) (NP (NN cyclophosphamide)))) (-RRB- -RRB-))))))))))))) (. .))))

advmod(exists-5, Therefore-1)
det(potential-4, the-3)
nsubj(exists-5, potential-4)
root(ROOT-0, exists-5)
det(interaction-9, a-7)
nn(interaction-9, drug-8)
prep_for(exists-5, interaction-9)
prep_between(interaction-9, WELLBUTRIN-11)
conj_and(WELLBUTRIN-11, drugs-13)
nsubj(affect-15, drugs-13)
rcmod(drugs-13, affect-15)
det(isoenzyme-18, the-16)
nn(isoenzyme-18, CYP2B6-17)
dobj(affect-15, isoenzyme-18)
dep(isoenzyme-18, e.g.-20)
pobj(e.g.-20, orphenadrine-22)
conj_and(orphenadrine-22, cyclophosphamide-24)

The/DT threohydrobupropion/NN metabolite/NN of/IN bupropion/NN does/VBZ not/RB appear/VB to/TO be/VB produced/VBN by/IN the/DT cytochrome/NN P450/NN isoenzymes/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN threohydrobupropion) (NN metabolite)) (PP (IN of) (NP (NN bupropion)))) (VP (VBZ does) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB be) (VP (VBN produced) (PP (IN by) (NP (DT the) (NN cytochrome) (NN P450) (NNS isoenzymes)))))))))) (. .))))

det(metabolite-3, The-1)
nn(metabolite-3, threohydrobupropion-2)
nsubj(appear-8, metabolite-3)
xsubj(produced-11, metabolite-3)
prep_of(metabolite-3, bupropion-5)
aux(appear-8, does-6)
neg(appear-8, not-7)
root(ROOT-0, appear-8)
aux(produced-11, to-9)
auxpass(produced-11, be-10)
xcomp(appear-8, produced-11)
det(isoenzymes-16, the-13)
nn(isoenzymes-16, cytochrome-14)
nn(isoenzymes-16, P450-15)
agent(produced-11, isoenzymes-16)

The/DT effects/NNS of/IN concomitant/JJ administration/NN of/IN cimetidine/NN on/IN the/DT pharmacokinetics/NNS of/IN bupropion/NN and/CC its/PRP$ active/JJ metabolites/NNS were/VBD studied/VBN in/IN 24/CD healthy/JJ young/JJ male/JJ volunteers/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN cimetidine))))) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN bupropion)) (CC and) (NP (PRP$ its) (JJ active) (NNS metabolites))))))) (VP (VBD were) (VP (VBN studied) (PP (IN in) (NP (CD 24) (JJ healthy) (JJ young) (JJ male) (NNS volunteers)))))) (. .))))

det(effects-2, The-1)
nsubjpass(studied-18, effects-2)
amod(administration-5, concomitant-4)
prep_of(effects-2, administration-5)
prep_of(administration-5, cimetidine-7)
det(pharmacokinetics-10, the-9)
prep_on(effects-2, pharmacokinetics-10)
prep_of(pharmacokinetics-10, bupropion-12)
poss(metabolites-16, its-14)
amod(metabolites-16, active-15)
conj_and(bupropion-12, metabolites-16)
auxpass(studied-18, were-17)
root(ROOT-0, studied-18)
num(volunteers-24, 24-20)
amod(volunteers-24, healthy-21)
amod(volunteers-24, young-22)
amod(volunteers-24, male-23)
prep_in(studied-18, volunteers-24)

Following/VBG oral/JJ administration/NN of/IN two/CD 150-mg/NN sustained-release/NN tablets/NNS with/IN and/CC without/IN 800/CD mg/NN of/IN cimetidine/NN ,/, the/DT pharmacokinetics/NNS of/IN bupropion/NN and/CC hydroxybupropion/NN were/VBD unaffected/JJ ./.

(ROOT (S1 (S (S (PP (VBG Following) (NP (NP (JJ oral) (NN administration)) (PP (IN of) (NP (NP (CD two) (NN 150-mg) (NN sustained-release) (NNS tablets)) (PP (PP (IN with)) (CC and) (PP (IN without) (NP (NP (CD 800) (NN mg)) (PP (IN of) (NP (NN cimetidine)))))))))) (, ,) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN bupropion)) (CC and) (NP (NN hydroxybupropion))))) (VP (VBD were) (ADJP (JJ unaffected)))) (. .))))

amod(administration-3, oral-2)
prep_following(unaffected-24, administration-3)
num(tablets-8, two-5)
nn(tablets-8, 150-mg-6)
nn(tablets-8, sustained-release-7)
prep_of(administration-3, tablets-8)
prep(tablets-8, with-9)
conj_and(with-9, without-11)
num(mg-13, 800-12)
pobj(without-11, mg-13)
prep_of(mg-13, cimetidine-15)
det(pharmacokinetics-18, the-17)
nsubj(unaffected-24, pharmacokinetics-18)
prep_of(pharmacokinetics-18, bupropion-20)
conj_and(bupropion-20, hydroxybupropion-22)
cop(unaffected-24, were-23)
root(ROOT-0, unaffected-24)

While/IN not/RB systematically/RB studied/VBN ,/, certain/JJ drugs/NNS may/MD induce/VB the/DT metabolism/NN of/IN bupropion/NN (/-LRB- e.g./FW ,/, carbamazepine/NN ,/, phenobarbital/NN ,/, phenytoin/NN )/-RRB- ./.

(ROOT (S1 (S (S (SBAR (IN While) (VP (RB not) (ADVP (RB systematically)) (VBN studied))) (, ,) (NP (JJ certain) (NNS drugs)) (VP (MD may) (VP (VB induce) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NP (NN bupropion)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN carbamazepine)) (, ,) (NP (NN phenobarbital)) (, ,) (NP (NN phenytoin))) (-RRB- -RRB-)))))))) (. .))))

dep(studied-4, While-1)
neg(studied-4, not-2)
advmod(studied-4, systematically-3)
advcl(induce-9, studied-4)
amod(drugs-7, certain-6)
nsubj(induce-9, drugs-7)
aux(induce-9, may-8)
root(ROOT-0, induce-9)
det(metabolism-11, the-10)
dobj(induce-9, metabolism-11)
prep_of(metabolism-11, bupropion-13)
dep(carbamazepine-17, e.g.-15)
dep(bupropion-13, carbamazepine-17)
appos(carbamazepine-17, phenobarbital-19)
appos(carbamazepine-17, phenytoin-21)

Animal/NN data/NNS indicated/VBD that/IN bupropion/NN may/MD be/VB an/DT inducer/NN of/IN drug/NN -metabolizing/NN enzymes/NNS in/IN humans/NNS ./.

(ROOT (S1 (S (S (NP (NN Animal) (NNS data)) (VP (VBD indicated) (SBAR (IN that) (S (NP (NN bupropion)) (VP (MD may) (VP (VB be) (NP (NP (DT an) (NN inducer)) (PP (IN of) (NP (NP (NN drug) (NN -metabolizing) (NNS enzymes)) (PP (IN in) (NP (NNS humans)))))))))))) (. .))))

nn(data-2, Animal-1)
nsubj(indicated-3, data-2)
root(ROOT-0, indicated-3)
complm(inducer-9, that-4)
nsubj(inducer-9, bupropion-5)
aux(inducer-9, may-6)
cop(inducer-9, be-7)
det(inducer-9, an-8)
ccomp(indicated-3, inducer-9)
nn(enzymes-13, drug-11)
nn(enzymes-13, -metabolizing-12)
prep_of(inducer-9, enzymes-13)
prep_in(enzymes-13, humans-15)

In/IN one/CD study/NN ,/, following/VBG chronic/JJ administration/NN of/IN bupropion/NN ,/, 100/CD mg/NN 3/CD times/NNS daily/JJ to/TO 8/CD healthy/JJ male/JJ volunteers/NNS for/IN 14/CD days/NNS ,/, there/EX was/VBD no/DT evidence/NN of/IN induction/NN of/IN its/PRP$ own/JJ metabolism/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (CD one) (NN study))) (, ,) (PP (VBG following) (NP (NP (JJ chronic) (NN administration)) (PP (IN of) (NP (NP (NN bupropion)) (, ,) (NP (NP (CD 100) (NN mg)) (ADJP (CD 3) (NNS times) (JJ daily) (PP (TO to) (NP (CD 8) (JJ healthy) (JJ male) (NNS volunteers))) (PP (IN for) (NP (CD 14) (NNS days))))))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (NN induction)) (PP (IN of) (NP (PRP$ its) (JJ own) (NN metabolism)))))))) (. .))))

num(study-3, one-2)
prep_in(was-26, study-3)
amod(administration-7, chronic-6)
prep_following(was-26, administration-7)
prep_of(administration-7, bupropion-9)
num(mg-12, 100-11)
appos(bupropion-9, mg-12)
number(daily-15, 3-13)
dep(daily-15, times-14)
amod(mg-12, daily-15)
num(volunteers-20, 8-17)
amod(volunteers-20, healthy-18)
amod(volunteers-20, male-19)
prep_to(daily-15, volunteers-20)
num(days-23, 14-22)
prep_for(daily-15, days-23)
expl(was-26, there-25)
root(ROOT-0, was-26)
det(evidence-28, no-27)
nsubj(was-26, evidence-28)
prep_of(evidence-28, induction-30)
poss(metabolism-34, its-32)
amod(metabolism-34, own-33)
prep_of(induction-30, metabolism-34)

Nevertheless/RB ,/, there/EX may/MD be/VB the/DT potential/NN for/IN clinically/RB important/JJ alterations/NNS of/IN blood/NN levels/NNS of/IN coadministered/JJ drugs/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Nevertheless)) (, ,) (NP (EX there)) (VP (MD may) (VP (VB be) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (ADJP (RB clinically) (JJ important)) (NNS alterations)) (PP (IN of) (NP (NP (NN blood) (NNS levels)) (PP (IN of) (NP (JJ coadministered) (NNS drugs))))))))))) (. .))))

advmod(potential-7, Nevertheless-1)
expl(potential-7, there-3)
aux(potential-7, may-4)
cop(potential-7, be-5)
det(potential-7, the-6)
root(ROOT-0, potential-7)
advmod(important-10, clinically-9)
amod(alterations-11, important-10)
prep_for(potential-7, alterations-11)
nn(levels-14, blood-13)
prep_of(alterations-11, levels-14)
amod(drugs-17, coadministered-16)
prep_of(levels-14, drugs-17)

Drugs/NNS Metabolized/VBN by/IN Cytochrome/NN P450IID6/NN (/-LRB- CYP2D6/NN )/-RRB- :/: Many/JJ drugs/NNS ,/, including/VBG most/JJS antidepressants/NNS (/-LRB- SSRIs/NN ,/, many/JJ tricyclics/NNS )/-RRB- ,/, beta-blockers/NNS ,/, antiarrhythmics/NNS ,/, and/CC antipsychotics/NNS are/VBP metabolized/VBN by/IN the/DT CYP2D6/NN isoenzyme/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (VP (VBN Metabolized) (PP (IN by) (NP (NP (NN Cytochrome) (NN P450IID6) (-LRB- -LRB-) (NN CYP2D6) (-RRB- -RRB-) (: :) (JJ Many) (NNS drugs)) (, ,) (PP (VBG including) (NP (NP (NP (JJS most) (NNS antidepressants)) (PRN (-LRB- -LRB-) (NP (NP (NN SSRIs)) (, ,) (NP (JJ many) (NNS tricyclics))) (-RRB- -RRB-))) (, ,) (NP (NNS beta-blockers)) (, ,) (NP (NNS antiarrhythmics)) (, ,) (CC and) (NP (NNS antipsychotics)))))))) (VP (VBP are) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (NN CYP2D6) (NN isoenzyme)))))) (. .))))

nsubjpass(metabolized-30, Drugs-1)
partmod(Drugs-1, Metabolized-2)
nn(drugs-11, Cytochrome-4)
nn(drugs-11, P450IID6-5)
nn(drugs-11, CYP2D6-7)
amod(drugs-11, Many-10)
agent(Metabolized-2, drugs-11)
amod(antidepressants-15, most-14)
prep_including(drugs-11, antidepressants-15)
dep(antidepressants-15, SSRIs-17)
amod(tricyclics-20, many-19)
appos(SSRIs-17, tricyclics-20)
conj_and(antidepressants-15, beta-blockers-23)
conj_and(antidepressants-15, antiarrhythmics-25)
conj_and(antidepressants-15, antipsychotics-28)
auxpass(metabolized-30, are-29)
root(ROOT-0, metabolized-30)
det(isoenzyme-34, the-32)
nn(isoenzyme-34, CYP2D6-33)
agent(metabolized-30, isoenzyme-34)

Although/IN bupropion/NN is/VBZ not/RB metabolized/VBN by/IN this/DT isoenzyme/NN ,/, bupropion/NN and/CC hydroxybupropion/NN are/VBP inhibitors/NNS of/IN the/DT CYP2D6/NN isoenzyme/NN in/FW vitro/FW ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NN bupropion)) (VP (VBZ is) (RB not) (VP (VBN metabolized) (PP (IN by) (NP (DT this) (NN isoenzyme))))))) (, ,) (NP (NP (NN bupropion)) (CC and) (NP (NN hydroxybupropion))) (VP (VBP are) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (DT the) (NN CYP2D6) (NN isoenzyme)))) (ADVP (FW in) (FW vitro)))) (. .))))

mark(metabolized-5, Although-1)
nsubjpass(metabolized-5, bupropion-2)
auxpass(metabolized-5, is-3)
neg(metabolized-5, not-4)
advcl(inhibitors-14, metabolized-5)
det(isoenzyme-8, this-7)
agent(metabolized-5, isoenzyme-8)
nsubj(inhibitors-14, bupropion-10)
conj_and(bupropion-10, hydroxybupropion-12)
cop(inhibitors-14, are-13)
root(ROOT-0, inhibitors-14)
det(isoenzyme-18, the-16)
nn(isoenzyme-18, CYP2D6-17)
prep_of(inhibitors-14, isoenzyme-18)
nn(vitro-20, in-19)
advmod(inhibitors-14, vitro-20)

In/IN a/DT study/NN of/IN 15/CD male/JJ subjects/NNS (/-LRB- ages/NNS 19/CD to/TO 35/CD years/NNS )/-RRB- who/WP were/VBD extensive/JJ metabolizers/NNS of/IN the/DT CYP2D6/NN isoenzyme/NN ,/, daily/JJ doses/NNS of/IN bupropion/NN given/VBN as/IN 150/CD mg/NN twice/RB daily/RB followed/VBN by/IN a/DT single/JJ dose/NN of/IN 50/CD mg/NN desipramine/NN increased/VBD the/DT Cmax/NN ,/, AUC/NN ,/, and/CC t1/NN /2/CD of/IN desipramine/NN by/IN an/DT average/NN of/IN approximately/RB 2-/CD ,/, 5-/CD and/CC 2-fold/RB ,/, respectively/RB ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (DT a) (NN study)) (PP (IN of) (NP (NP (NP (CD 15) (JJ male) (NNS subjects)) (PRN (-LRB- -LRB-) (NP (NNS ages) (NP (CD 19) (TO to) (CD 35) (NNS years))) (-RRB- -RRB-))) (SBAR (WHNP (WP who)) (S (VP (VBD were) (NP (NP (JJ extensive) (NNS metabolizers)) (PP (IN of) (NP (DT the) (NN CYP2D6) (NN isoenzyme))))))))))) (, ,) (NP (NP (JJ daily) (NNS doses)) (PP (IN of) (NP (NP (NN bupropion)) (VP (VBN given) (PP (IN as) (NP (NP (CD 150) (NN mg)) (VP (ADVP (RB twice) (RB daily)) (VBN followed) (PP (IN by) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (ADJP (CD 50) (NN mg)) (NN desipramine)))))))))))) (VP (VP (VBD increased) (NP (NP (NP (DT the) (NN Cmax)) (, ,) (NP (NN AUC)) (, ,) (CC and) (NP (NN t1) (CD /2))) (PP (IN of) (NP (NN desipramine)))) (PP (IN by) (NP (NP (DT an) (NN average)) (PP (IN of) (NP (RB approximately) (CD 2-))))) (, ,) (NP (CD 5-))) (CC and) (ADVP (RB 2-fold)) (, ,) (ADVP (RB respectively))) (. .))))

det(study-3, a-2)
prep_in(increased-43, study-3)
num(subjects-7, 15-5)
amod(subjects-7, male-6)
prep_of(study-3, subjects-7)
nsubj(metabolizers-18, subjects-7)
appos(subjects-7, ages-9)
num(years-13, 19-10)
dep(years-13, to-11)
num(years-13, 35-12)
dep(ages-9, years-13)
cop(metabolizers-18, were-16)
amod(metabolizers-18, extensive-17)
rcmod(subjects-7, metabolizers-18)
det(isoenzyme-22, the-20)
nn(isoenzyme-22, CYP2D6-21)
prep_of(metabolizers-18, isoenzyme-22)
amod(doses-25, daily-24)
nsubj(increased-43, doses-25)
prep_of(doses-25, bupropion-27)
partmod(bupropion-27, given-28)
num(mg-31, 150-30)
prep_as(given-28, mg-31)
advmod(daily-33, twice-32)
advmod(followed-34, daily-33)
partmod(mg-31, followed-34)
det(dose-38, a-36)
amod(dose-38, single-37)
agent(followed-34, dose-38)
number(mg-41, 50-40)
amod(desipramine-42, mg-41)
prep_of(dose-38, desipramine-42)
root(ROOT-0, increased-43)
det(Cmax-45, the-44)
dobj(increased-43, Cmax-45)
conj_and(Cmax-45, AUC-47)
conj_and(Cmax-45, t1-50)
num(t1-50, /2-51)
prep_of(Cmax-45, desipramine-53)
det(average-56, an-55)
prep_by(increased-43, average-56)
advmod(2--59, approximately-58)
prep_of(average-56, 2--59)
dobj(increased-43, 5--61)
advmod(increased-43, 2-fold-63)
conj_and(increased-43, 2-fold-63)
advmod(increased-43, respectively-65)
conj_and(increased-43, respectively-65)

The/DT effect/NN was/VBD present/JJ for/IN at/IN least/JJS 7/CD days/NNS after/IN the/DT last/JJ dose/NN of/IN bupropion/NN ./.

(ROOT (S1 (S (S (NP (DT The) (NN effect)) (VP (VBD was) (ADJP (JJ present)) (PP (IN for) (NP (QP (IN at) (JJS least) (CD 7)) (NNS days))) (PP (IN after) (NP (NP (DT the) (JJ last) (NN dose)) (PP (IN of) (NP (NN bupropion))))))) (. .))))

det(effect-2, The-1)
nsubj(present-4, effect-2)
cop(present-4, was-3)
root(ROOT-0, present-4)
quantmod(7-8, at-6)
mwe(at-6, least-7)
pobj(at-6, least-7)
num(days-9, 7-8)
prep_for(present-4, days-9)
det(dose-13, the-11)
amod(dose-13, last-12)
prep_after(present-4, dose-13)
prep_of(dose-13, bupropion-15)

Concomitant/JJ use/NN of/IN bupropion/NN with/IN other/JJ drugs/NNS metabolized/VBN by/IN CYP2D6/NN has/VBZ not/RB been/VBN formally/RB studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NN bupropion))) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP2D6))))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB formally)) (VP (VBN studied))))) (. .))))

amod(use-2, Concomitant-1)
nsubjpass(studied-15, use-2)
prep_of(use-2, bupropion-4)
amod(drugs-7, other-6)
prep_with(use-2, drugs-7)
partmod(drugs-7, metabolized-8)
agent(metabolized-8, CYP2D6-10)
aux(studied-15, has-11)
neg(studied-15, not-12)
auxpass(studied-15, been-13)
advmod(studied-15, formally-14)
root(ROOT-0, studied-15)

Therefore/RB ,/, co-administration/NN of/IN bupropion/NN with/IN drugs/NNS that/WDT are/VBP metabolized/VBN by/IN CYP2D6/NN isoenzyme/NN including/VBG certain/JJ antidepressants/NNS (/-LRB- e.g./FW ,/, nortriptyline/NN ,/, imipramine/NN ,/, desipramine/NN ,/, paroxetine/NN ,/, fluoxetine/NN ,/, sertraline/NN )/-RRB- ,/, antipsychotics/NNS (/-LRB- e.g./FW ,/, haloperidol/NN ,/, risperidone/NN ,/, thioridazine/NN )/-RRB- ,/, beta-blockers/NNS (/-LRB- e.g./FW ,/, metoprolol/NN )/-RRB- ,/, and/CC Type/NN 1C/NN antiarrhythmics/NNS (/-LRB- e.g./FW ,/, propafenone/NN ,/, flecainide/NN )/-RRB- ,/, should/MD be/VB approached/VBN with/IN caution/NN and/CC should/MD be/VB initiated/VBN at/IN the/DT lower/JJR end/NN of/IN the/DT dose/NN range/NN of/IN the/DT concomitant/JJ medication/NN ./.

(ROOT (S1 (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN co-administration)) (PP (IN of) (NP (NN bupropion))) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN metabolized) (PP (IN by) (NP (NP (NN CYP2D6) (NN isoenzyme)) (PP (VBG including) (NP (NP (NP (JJ certain) (NNS antidepressants)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN nortriptyline)) (, ,) (NP (NN imipramine)) (, ,) (NP (NN desipramine)) (, ,) (NP (NN paroxetine)) (, ,) (NP (NN fluoxetine)) (, ,) (NP (NN sertraline)))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS antipsychotics)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN haloperidol)) (, ,) (NP (NN risperidone)) (, ,) (NP (NN thioridazine)))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS beta-blockers)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN metoprolol))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN Type) (NN 1C) (NNS antiarrhythmics)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN propafenone))) (, ,) (NP (NN flecainide)) (-RRB- -RRB-))) (, ,)))))))))))) (VP (VP (MD should) (VP (VB be) (VP (VBN approached) (PP (IN with) (NP (NN caution)))))) (CC and) (VP (MD should) (VP (VB be) (VP (VBN initiated) (PP (IN at) (NP (NP (DT the) (JJR lower) (NN end)) (PP (IN of) (NP (NP (DT the) (NN dose) (NN range)) (PP (IN of) (NP (DT the) (JJ concomitant) (NN medication))))))))))) (. .))))

advmod(approached-65, Therefore-1)
nsubjpass(approached-65, co-administration-3)
prep_of(co-administration-3, bupropion-5)
prep_with(co-administration-3, drugs-7)
nsubjpass(metabolized-10, drugs-7)
auxpass(metabolized-10, are-9)
rcmod(drugs-7, metabolized-10)
nn(isoenzyme-13, CYP2D6-12)
agent(metabolized-10, isoenzyme-13)
amod(antidepressants-16, certain-15)
prep_including(isoenzyme-13, antidepressants-16)
dep(antidepressants-16, e.g.-18)
pobj(e.g.-18, nortriptyline-20)
appos(nortriptyline-20, imipramine-22)
appos(nortriptyline-20, desipramine-24)
appos(nortriptyline-20, paroxetine-26)
appos(nortriptyline-20, fluoxetine-28)
appos(nortriptyline-20, sertraline-30)
conj_and(antidepressants-16, antipsychotics-33)
dep(antipsychotics-33, e.g.-35)
pobj(e.g.-35, haloperidol-37)
appos(haloperidol-37, risperidone-39)
appos(haloperidol-37, thioridazine-41)
conj_and(antidepressants-16, beta-blockers-44)
dep(beta-blockers-44, e.g.-46)
pobj(e.g.-46, metoprolol-48)
nn(antiarrhythmics-54, Type-52)
nn(antiarrhythmics-54, 1C-53)
conj_and(antidepressants-16, antiarrhythmics-54)
dep(flecainide-60, e.g.-56)
pobj(e.g.-56, propafenone-58)
appos(antiarrhythmics-54, flecainide-60)
aux(approached-65, should-63)
auxpass(approached-65, be-64)
root(ROOT-0, approached-65)
prep_with(approached-65, caution-67)
aux(initiated-71, should-69)
auxpass(initiated-71, be-70)
conj_and(approached-65, initiated-71)
det(end-75, the-73)
amod(end-75, lower-74)
prep_at(initiated-71, end-75)
det(range-79, the-77)
nn(range-79, dose-78)
prep_of(end-75, range-79)
det(medication-83, the-81)
amod(medication-83, concomitant-82)
prep_of(range-79, medication-83)

If/IN bupropion/NN is/VBZ added/VBN to/TO the/DT treatment/NN regimen/NN of/IN a/DT patient/NN already/RB receiving/VBG a/DT drug/NN metabolized/VBN by/IN CYP2D6/NN ,/, the/DT need/NN to/TO decrease/VB the/DT dose/NN of/IN the/DT original/JJ medication/NN should/MD be/VB considered/VBN ,/, particularly/RB for/IN those/DT concomitant/JJ medications/NNS with/IN a/DT narrow/JJ therapeutic/JJ index/NN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN bupropion)) (VP (VBZ is) (VP (VBN added) (PP (TO to) (NP (NP (DT the) (NN treatment) (NN regimen)) (PP (IN of) (NP (NP (DT a) (NN patient)) (VP (ADVP (RB already)) (VBG receiving) (NP (NP (DT a) (NN drug)) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP2D6)))))))))))))) (, ,) (NP (DT the) (NN need) (S (VP (TO to) (VP (VB decrease) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (DT the) (JJ original) (NN medication)))))))) (VP (MD should) (VP (VB be) (VP (VBN considered) (, ,) (ADVP (RB particularly)) (PP (IN for) (NP (NP (DT those) (JJ concomitant) (NNS medications)) (PP (IN with) (NP (DT a) (JJ narrow) (JJ therapeutic) (NN index))))))))) (. .))))

mark(added-4, If-1)
nsubjpass(added-4, bupropion-2)
auxpass(added-4, is-3)
advcl(considered-32, added-4)
det(regimen-8, the-6)
nn(regimen-8, treatment-7)
prep_to(added-4, regimen-8)
det(patient-11, a-10)
prep_of(regimen-8, patient-11)
advmod(receiving-13, already-12)
partmod(patient-11, receiving-13)
det(drug-15, a-14)
dobj(receiving-13, drug-15)
partmod(drug-15, metabolized-16)
agent(metabolized-16, CYP2D6-18)
det(need-21, the-20)
nsubjpass(considered-32, need-21)
aux(decrease-23, to-22)
infmod(need-21, decrease-23)
det(dose-25, the-24)
dobj(decrease-23, dose-25)
det(medication-29, the-27)
amod(medication-29, original-28)
prep_of(dose-25, medication-29)
aux(considered-32, should-30)
auxpass(considered-32, be-31)
root(ROOT-0, considered-32)
advmod(considered-32, particularly-34)
det(medications-38, those-36)
amod(medications-38, concomitant-37)
prep_for(considered-32, medications-38)
det(index-43, a-40)
amod(index-43, narrow-41)
amod(index-43, therapeutic-42)
prep_with(medications-38, index-43)

MAO/NN Inhibitors/NNS :/: Studies/NNS in/IN animals/NNS demonstrate/VBP that/IN the/DT acute/JJ toxicity/NN of/IN bupropion/NN is/VBZ enhanced/VBN by/IN the/DT MAO/NN inhibitor/NN phenelzine/NN ./.

(ROOT (S1 (S (S (NP (NN MAO) (NNS Inhibitors)) (: :) (NP (NP (NNS Studies)) (PP (IN in) (NP (NNS animals)))) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (DT the) (JJ acute) (NN toxicity)) (PP (IN of) (NP (NN bupropion)))) (VP (VBZ is) (VP (VBN enhanced) (PP (IN by) (NP (DT the) (NN MAO) (NN inhibitor) (NN phenelzine))))))))) (. .))))

nn(Inhibitors-2, MAO-1)
nsubj(demonstrate-7, Inhibitors-2)
nsubj(demonstrate-7, Studies-4)
prep_in(Studies-4, animals-6)
root(ROOT-0, demonstrate-7)
complm(enhanced-15, that-8)
det(toxicity-11, the-9)
amod(toxicity-11, acute-10)
nsubjpass(enhanced-15, toxicity-11)
prep_of(toxicity-11, bupropion-13)
auxpass(enhanced-15, is-14)
ccomp(demonstrate-7, enhanced-15)
det(phenelzine-20, the-17)
nn(phenelzine-20, MAO-18)
nn(phenelzine-20, inhibitor-19)
agent(enhanced-15, phenelzine-20)

Levodopa/NN and/CC Amantadine/NN :/: Limited/JJ clinical/JJ data/NNS suggest/VBP a/DT higher/JJR incidence/NN of/IN adverse/JJ experiences/NNS in/IN patients/NNS receiving/VBG bupropion/NN concurrently/RB with/IN either/CC levodopa/NN or/CC amantadine/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN Levodopa)) (CC and) (NP (NN Amantadine))) (: :) (S (NP (JJ Limited) (JJ clinical) (NNS data)) (VP (VBP suggest) (NP (NP (DT a) (JJR higher) (NN incidence)) (PP (IN of) (NP (NP (JJ adverse) (NNS experiences)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN bupropion))))) (PP (ADVP (RB concurrently)) (IN with) (NP (CC either) (NP (NN levodopa)) (CC or) (NP (NN amantadine))))))))) (. .)))))

root(ROOT-0, Levodopa-1)
conj_and(Levodopa-1, Amantadine-3)
amod(data-7, Limited-5)
amod(data-7, clinical-6)
nsubj(suggest-8, data-7)
dep(Levodopa-1, suggest-8)
det(incidence-11, a-9)
amod(incidence-11, higher-10)
dobj(suggest-8, incidence-11)
amod(experiences-14, adverse-13)
prep_of(incidence-11, experiences-14)
prep_in(experiences-14, patients-16)
partmod(patients-16, receiving-17)
dobj(receiving-17, bupropion-18)
advmod(experiences-14, concurrently-19)
preconj(levodopa-22, either-21)
prep_with(experiences-14, levodopa-22)
conj_or(levodopa-22, amantadine-24)

Administration/NN of/IN WELLBUTRIN/JJ Tablets/NNS to/TO patients/NNS receiving/VBG either/CC levodopa/NN or/CC amantadine/NN concurrently/RB should/MD be/VB undertaken/VBN with/IN caution/NN ,/, using/VBG small/JJ initial/JJ doses/NNS and/CC small/JJ gradual/JJ dose/NN increases/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Administration)) (PP (IN of) (NP (JJ WELLBUTRIN) (NNS Tablets))) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (CC either) (NP (NN levodopa)) (CC or) (NP (NN amantadine))))))) (ADVP (RB concurrently)) (VP (MD should) (VP (VB be) (VP (VBN undertaken) (PP (IN with) (NP (NN caution))) (, ,) (S (VP (VBG using) (NP (NP (JJ small) (JJ initial) (NNS doses)) (CC and) (NP (JJ small) (JJ gradual) (NN dose) (NNS increases))))))))) (. .))))

nsubjpass(undertaken-15, Administration-1)
amod(Tablets-4, WELLBUTRIN-3)
prep_of(Administration-1, Tablets-4)
prep_to(Administration-1, patients-6)
partmod(patients-6, receiving-7)
preconj(levodopa-9, either-8)
dobj(receiving-7, levodopa-9)
conj_or(levodopa-9, amantadine-11)
advmod(undertaken-15, concurrently-12)
aux(undertaken-15, should-13)
auxpass(undertaken-15, be-14)
root(ROOT-0, undertaken-15)
prep_with(undertaken-15, caution-17)
xcomp(undertaken-15, using-19)
amod(doses-22, small-20)
amod(doses-22, initial-21)
dobj(using-19, doses-22)
amod(increases-27, small-24)
amod(increases-27, gradual-25)
nn(increases-27, dose-26)
conj_and(doses-22, increases-27)

Drugs/NNS that/IN Lower/JJR Seizure/NN Threshold/NN :/: Concurrent/JJ administration/NN of/IN WELLBUTRIN/NN and/CC agents/NNS (/-LRB- e.g./FW ,/, antipsychotics/NNS ,/, other/JJ antidepressants/NNS ,/, theophylline/NN ,/, systemic/JJ steroids/NNS ,/, etc./NN )/-RRB- that/WDT lower/JJR seizure/NN threshold/NN should/MD be/VB undertaken/VBN only/RB with/IN extreme/JJ caution/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Drugs)) (PP (IN that) (NP (JJR Lower) (NN Seizure) (NN Threshold)))) (: :) (NP (NP (NP (JJ Concurrent) (NN administration)) (PP (IN of) (NP (NN WELLBUTRIN)))) (CC and) (NP (NP (NP (NNS agents)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NNS antipsychotics)) (, ,) (NP (JJ other) (NNS antidepressants)) (, ,) (NP (NN theophylline)) (, ,) (NP (JJ systemic) (NNS steroids)) (, ,) (NP (NN etc.))) (-RRB- -RRB-))) (SBAR (WHNP (WDT that)) (S (NP (JJR lower) (NN seizure) (NN threshold)) (VP (MD should) (VP (VB be) (VP (VBN undertaken) (ADVP (RB only)) (PP (IN with) (NP (JJ extreme) (NN caution)))))))))) (. .)))))

root(ROOT-0, Drugs-1)
amod(Threshold-5, Lower-3)
nn(Threshold-5, Seizure-4)
prep_that(Drugs-1, Threshold-5)
amod(administration-8, Concurrent-7)
dep(Drugs-1, administration-8)
prep_of(administration-8, WELLBUTRIN-10)
conj_and(administration-8, agents-12)
dobj(undertaken-34, agents-12)
dep(antipsychotics-16, e.g.-14)
dep(agents-12, antipsychotics-16)
amod(antidepressants-19, other-18)
appos(antipsychotics-16, antidepressants-19)
appos(antipsychotics-16, theophylline-21)
amod(steroids-24, systemic-23)
appos(antipsychotics-16, steroids-24)
appos(antipsychotics-16, etc.-26)
rel(undertaken-34, that-28)
amod(threshold-31, lower-29)
nn(threshold-31, seizure-30)
nsubjpass(undertaken-34, threshold-31)
aux(undertaken-34, should-32)
auxpass(undertaken-34, be-33)
rcmod(agents-12, undertaken-34)
advmod(undertaken-34, only-35)
amod(caution-38, extreme-37)
prep_with(undertaken-34, caution-38)

Nicotine/NN Transdermal/JJ System/NN :/: ./.

(ROOT (S1 (S (S (NP (NN Nicotine)) (VP (JJ Transdermal) (NN System)) (: :)) (. .))))

nsubj(System-3, Nicotine-1)
dep(System-3, Transdermal-2)
root(ROOT-0, System-3)

Alcohol/NN :/: In/IN post-marketing/JJ experience/VBP ,/, there/EX have/VBP been/VBN rare/JJ reports/NNS of/IN adverse/JJ neuropsychiatric/JJ events/NNS or/CC reduced/VBN alcohol/NN tolerance/NN in/IN patients/NNS who/WP were/VBD drinking/NN alcohol/NN during/IN treatment/NN with/IN WELLBUTRIN/NN ./.

(ROOT (S1 (S (NP (NP (NN Alcohol)) (: :) (S (PP (IN In) (NP (JJ post-marketing) (VBP experience))) (, ,) (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (JJ rare) (NNS reports)) (PP (IN of) (NP (NP (JJ adverse) (JJ neuropsychiatric) (NNS events)) (CC or) (NP (VBN reduced) (NN alcohol) (NN tolerance)))) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (NP (NN drinking) (NN alcohol)) (PP (IN during) (NP (NP (NN treatment)) (PP (IN with) (NP (NN WELLBUTRIN)))))))))))))) (. .)))))

root(ROOT-0, Alcohol-1)
prep_in(reports-11, post-marketing-4)
dep(post-marketing-4, experience-5)
expl(reports-11, there-7)
aux(reports-11, have-8)
cop(reports-11, been-9)
amod(reports-11, rare-10)
dep(Alcohol-1, reports-11)
amod(events-15, adverse-13)
amod(events-15, neuropsychiatric-14)
prep_of(reports-11, events-15)
amod(tolerance-19, reduced-17)
nn(tolerance-19, alcohol-18)
conj_or(events-15, tolerance-19)
prep_in(reports-11, patients-21)
nsubj(alcohol-25, patients-21)
cop(alcohol-25, were-23)
nn(alcohol-25, drinking-24)
rcmod(patients-21, alcohol-25)
prep_during(alcohol-25, treatment-27)
prep_with(treatment-27, WELLBUTRIN-29)

The/DT consumption/NN of/IN alcohol/NN during/IN treatment/NN with/IN WELLBUTRIN/NN should/MD be/VB minimized/VBN or/CC avoided/VBN (/-LRB- also/RB see/VB a/DT href=/JJ bupropz_od.htm/NN #/NN CI/CD CONTRAINDICATIONS/NNS )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN consumption)) (PP (IN of) (NP (NN alcohol))) (PP (IN during) (NP (NP (NN treatment)) (PP (IN with) (NP (NN WELLBUTRIN)))))) (VP (MD should) (VP (VB be) (VP (VP (VBN minimized)) (CC or) (VP (VBN avoided)) (PRN (-LRB- -LRB-) (S (VP (ADVP (RB also)) (VB see) (NP (NP (DT a) (JJ href=) (NN bupropz_od.htm) (NN #) (CD CI)) (NNS CONTRAINDICATIONS)))) (-RRB- -RRB-)))))) (. .))))

det(consumption-2, The-1)
nsubjpass(minimized-11, consumption-2)
prep_of(consumption-2, alcohol-4)
prep_during(consumption-2, treatment-6)
prep_with(treatment-6, WELLBUTRIN-8)
aux(minimized-11, should-9)
auxpass(minimized-11, be-10)
root(ROOT-0, minimized-11)
conj_or(minimized-11, avoided-13)
advmod(see-16, also-15)
parataxis(minimized-11, see-16)
parataxis(avoided-13, see-16)
det(#-20, a-17)
amod(#-20, href=-18)
nn(#-20, bupropz_od.htm-19)
nn(CONTRAINDICATIONS-22, #-20)
num(#-20, CI-21)
dobj(see-16, CONTRAINDICATIONS-22)

It/PRP is/VBZ recommended/VBN that/IN buspirone/NN hydrochloride/NN not/RB be/VB used/VBN concomitantly/RB with/IN MAO/NN inhibitors/NNS Because/IN the/DT effects/NNS of/IN concomitant/JJ administration/NN of/IN buspirone/NN HCl/NN with/IN most/JJS other/JJ psychotropic/JJ drugs/NNS have/VBP not/RB been/VBN studied/VBN ,/, the/DT concomitant/JJ use/NN of/IN buspirone/NN HCl/NN with/IN other/JJ CNS-active/JJ drugs/NNS should/MD be/VB approached/VBN with/IN caution/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NN buspirone) (NN hydrochloride)) (VP (RB not) (VP (VB be) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN MAO) (NNS inhibitors))) (SBAR (IN Because) (S (S (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN buspirone) (NN HCl)) (PP (IN with) (NP (JJS most) (JJ other) (JJ psychotropic) (NNS drugs)))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN studied))))) (, ,) (S (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN buspirone) (NN HCl)) (PP (IN with) (NP (JJ other) (JJ CNS-active) (NNS drugs)))))) (VP (MD should) (VP (VB be) (VP (VBN approached) (PP (IN with) (NP (NN caution))))))))))))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(used-9, that-4)
nn(hydrochloride-6, buspirone-5)
nsubjpass(used-9, hydrochloride-6)
neg(used-9, not-7)
auxpass(used-9, be-8)
ccomp(recommended-3, used-9)
advmod(used-9, concomitantly-10)
nn(inhibitors-13, MAO-12)
prep_with(used-9, inhibitors-13)
mark(studied-31, Because-14)
det(effects-16, the-15)
nsubjpass(studied-31, effects-16)
amod(administration-19, concomitant-18)
prep_of(effects-16, administration-19)
nn(HCl-22, buspirone-21)
prep_of(administration-19, HCl-22)
amod(drugs-27, most-24)
amod(drugs-27, other-25)
amod(drugs-27, psychotropic-26)
prep_with(HCl-22, drugs-27)
aux(studied-31, have-28)
neg(studied-31, not-29)
auxpass(studied-31, been-30)
advcl(used-9, studied-31)
det(use-35, the-33)
amod(use-35, concomitant-34)
nsubjpass(approached-45, use-35)
nn(HCl-38, buspirone-37)
prep_of(use-35, HCl-38)
amod(drugs-42, other-40)
amod(drugs-42, CNS-active-41)
prep_with(HCl-38, drugs-42)
aux(approached-45, should-43)
auxpass(approached-45, be-44)
dep(studied-31, approached-45)
prep_with(approached-45, caution-47)

There/EX is/VBZ one/CD report/NN suggesting/VBG that/IN the/DT concomitant/JJ use/NN of/IN trazodone/NN hydrochloride/NN (/-LRB- Desyrel/NN )/-RRB- and/CC buspirone/NN HCl/NN may/MD have/VB caused/VBD 3-/CD to/TO 6-fold/RB elevations/NNS on/IN SGPT/NN (/-LRB- ALT/NN )/-RRB- in/IN a/DT few/JJ patients/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ is) (NP (NP (CD one) (NN report)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NP (NN trazodone) (NN hydrochloride)) (PRN (-LRB- -LRB-) (NP (NN Desyrel)) (-RRB- -RRB-))) (CC and) (NP (NN buspirone) (NN HCl))))) (VP (MD may) (VP (VB have) (VP (VBD caused) (NP (NP (NP (CD 3-) (TO to) (RB 6-fold)) (NNS elevations)) (PP (IN on) (NP (NP (NN SGPT)) (PRN (-LRB- -LRB-) (NP (NN ALT)) (-RRB- -RRB-))))) (PP (IN in) (NP (DT a) (JJ few) (NNS patients)))))))))))) (. .))))

expl(is-2, There-1)
root(ROOT-0, is-2)
num(report-4, one-3)
nsubj(is-2, report-4)
partmod(report-4, suggesting-5)
complm(caused-21, that-6)
det(use-9, the-7)
amod(use-9, concomitant-8)
nsubj(caused-21, use-9)
nn(hydrochloride-12, trazodone-11)
prep_of(use-9, hydrochloride-12)
appos(hydrochloride-12, Desyrel-14)
nn(HCl-18, buspirone-17)
conj_and(hydrochloride-12, HCl-18)
aux(caused-21, may-19)
aux(caused-21, have-20)
ccomp(suggesting-5, caused-21)
nn(elevations-25, 3--22)
dep(3--22, to-23)
advmod(3--22, 6-fold-24)
dobj(caused-21, elevations-25)
prep_on(elevations-25, SGPT-27)
abbrev(SGPT-27, ALT-29)
det(patients-34, a-32)
amod(patients-34, few-33)
prep_in(caused-21, patients-34)

In/IN a/DT similar/JJ study/NN ,/, attempting/VBG to/TO replicate/VB this/DT finding/NN ,/, no/DT interactive/JJ effect/NN on/IN hepatic/JJ transaminases/NNS was/VBD identified/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT a) (JJ similar) (NN study))) (, ,) (S (VP (VBG attempting) (S (VP (TO to) (VP (VB replicate) (NP (DT this) (NN finding))))))) (, ,) (NP (NP (DT no) (JJ interactive) (NN effect)) (PP (IN on) (NP (JJ hepatic) (NNS transaminases)))) (VP (VBD was) (VP (VBN identified)))) (. .))))

det(study-4, a-2)
amod(study-4, similar-3)
prep_in(identified-19, study-4)
partmod(identified-19, attempting-6)
aux(replicate-8, to-7)
xcomp(attempting-6, replicate-8)
det(finding-10, this-9)
dobj(replicate-8, finding-10)
det(effect-14, no-12)
amod(effect-14, interactive-13)
nsubjpass(identified-19, effect-14)
amod(transaminases-17, hepatic-16)
prep_on(effect-14, transaminases-17)
auxpass(identified-19, was-18)
root(ROOT-0, identified-19)

In/IN a/DT study/NN in/IN normal/JJ volunteers/NNS ,/, concomitant/JJ administration/NN of/IN buspirone/NN HCl/NN and/CC haloperidol/NN resulted/VBD in/IN increased/VBN serum/NN haloperidol/NN concentrations/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT a) (NN study)) (PP (IN in) (NP (JJ normal) (NNS volunteers))))) (, ,) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN buspirone) (NP (NN HCl)) (CC and) (NP (NN haloperidol))))) (VP (VBD resulted) (PP (IN in) (NP (VBN increased) (NN serum) (NN haloperidol) (NNS concentrations))))) (. .))))

det(study-3, a-2)
prep_in(resulted-15, study-3)
amod(volunteers-6, normal-5)
prep_in(study-3, volunteers-6)
amod(administration-9, concomitant-8)
nsubj(resulted-15, administration-9)
prep_of(administration-9, buspirone-11)
dep(buspirone-11, HCl-12)
conj_and(buspirone-11, haloperidol-14)
root(ROOT-0, resulted-15)
amod(concentrations-20, increased-17)
nn(concentrations-20, serum-18)
nn(concentrations-20, haloperidol-19)
prep_in(resulted-15, concentrations-20)

In/FW vitro/FW ,/, buspirone/NN does/VBZ not/RB displace/VB tightly/RB bound/VBN drugs/NNS like/IN phenytoin/NN ,/, propranolol/NN ,/, and/CC warfarin/NN from/IN serum/NN proteins/NNS ./.

(ROOT (S1 (S (S (ADVP (FW In) (FW vitro)) (, ,) (NP (NN buspirone)) (VP (VBZ does) (RB not) (VP (VB displace) (NP (NP (ADJP (RB tightly) (VBN bound)) (NNS drugs)) (PP (IN like) (NP (NP (NP (NN phenytoin)) (, ,) (NP (NN propranolol)) (, ,) (CC and) (NP (NN warfarin))) (PP (IN from) (NP (NN serum) (NNS proteins))))))))) (. .))))

nn(vitro-2, In-1)
advmod(displace-7, vitro-2)
nsubj(displace-7, buspirone-4)
aux(displace-7, does-5)
neg(displace-7, not-6)
root(ROOT-0, displace-7)
advmod(bound-9, tightly-8)
amod(drugs-10, bound-9)
dobj(displace-7, drugs-10)
prep_like(drugs-10, phenytoin-12)
conj_and(phenytoin-12, propranolol-14)
conj_and(phenytoin-12, warfarin-17)
nn(proteins-20, serum-19)
prep_from(phenytoin-12, proteins-20)

However/RB ,/, there/EX has/VBZ been/VBN one/CD report/NN of/IN prolonged/JJ prothrombin/NN time/NN when/WRB buspirone/NN was/VBD added/VBN to/TO the/DT regimen/NN of/IN a/DT patient/NN treated/VBN with/IN warfarin/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBZ has) (VP (VBN been) (NP (NP (CD one) (NN report)) (PP (IN of) (NP (JJ prolonged) (NN prothrombin) (NN time)))) (SBAR (WHADVP (WRB when)) (S (NP (NN buspirone)) (VP (VBD was) (VP (VBN added) (PP (TO to) (NP (NP (DT the) (NN regimen)) (PP (IN of) (NP (NP (DT a) (NN patient)) (VP (VBN treated) (PP (IN with) (NP (NN warfarin))))))))))))))) (. .))))

advmod(report-7, However-1)
expl(report-7, there-3)
aux(report-7, has-4)
cop(report-7, been-5)
num(report-7, one-6)
root(ROOT-0, report-7)
amod(time-11, prolonged-9)
nn(time-11, prothrombin-10)
prep_of(report-7, time-11)
advmod(added-15, when-12)
nsubjpass(added-15, buspirone-13)
auxpass(added-15, was-14)
advcl(report-7, added-15)
det(regimen-18, the-17)
prep_to(added-15, regimen-18)
det(patient-21, a-20)
prep_of(regimen-18, patient-21)
partmod(patient-21, treated-22)
prep_with(treated-22, warfarin-24)

The/DT patient/NN was/VBD also/RB chronically/RB receiving/VBG phenytoin/NN ,/, phenobarbital/NN ,/, digoxin/NN ,/, and/CC levothyroxine/NN sodium/NN ./.

(ROOT (S1 (S (S (NP (DT The) (NN patient)) (VP (VBD was) (ADVP (RB also)) (ADVP (RB chronically)) (VP (VBG receiving) (NP (NP (NN phenytoin)) (, ,) (NP (NN phenobarbital)) (, ,) (NP (NN digoxin)) (, ,) (CC and) (NP (NN levothyroxine)) (NP (NN sodium)))))) (. .))))

det(patient-2, The-1)
nsubj(receiving-6, patient-2)
aux(receiving-6, was-3)
advmod(receiving-6, also-4)
advmod(receiving-6, chronically-5)
root(ROOT-0, receiving-6)
dobj(receiving-6, phenytoin-7)
conj_and(phenytoin-7, phenobarbital-9)
conj_and(phenytoin-7, digoxin-11)
conj_and(phenytoin-7, levothyroxine-14)
dobj(receiving-6, sodium-15)
dep(phenytoin-7, sodium-15)

In/FW vitro/FW ,/, buspirone/NN may/MD displace/VB less/RBR firmly/RB bound/VBN drugs/NNS like/IN digoxin/NN ./.

(ROOT (S1 (S (S (ADVP (FW In) (FW vitro)) (, ,) (NP (NN buspirone)) (VP (MD may) (VP (VB displace) (NP (ADVP (RBR less) (RB firmly)) (VBN bound) (NNS drugs)) (PP (IN like) (NP (NN digoxin)))))) (. .))))

nn(vitro-2, In-1)
advmod(displace-6, vitro-2)
nsubj(displace-6, buspirone-4)
aux(displace-6, may-5)
root(ROOT-0, displace-6)
advmod(firmly-8, less-7)
advmod(drugs-10, firmly-8)
amod(drugs-10, bound-9)
dobj(displace-6, drugs-10)
prep_like(displace-6, digoxin-12)

Itraconazole/NN decreases/VBZ busulfan/NN clearance/NN by/IN up/RB to/TO 25/CD %/NN ,/, and/CC may/MD produce/VB AUCs/NNS 1500/CD @/NN M/NN @/NN min/NN in/IN some/DT patients/NNS ./.

(ROOT (S1 (S (S (NP (NN Itraconazole)) (VP (VP (VBZ decreases) (NP (NN busulfan) (NN clearance)) (PP (IN by) (NP (QP (RB up) (TO to) (CD 25)) (NN %)))) (, ,) (CC and) (VP (MD may) (VP (VB produce) (NP (NP (NNS AUCs) (NP (CD 1500) (NN @) (NN M) (NN @) (NN min))) (PP (IN in) (NP (DT some) (NNS patients)))))))) (. .))))

nsubj(decreases-2, Itraconazole-1)
root(ROOT-0, decreases-2)
nn(clearance-4, busulfan-3)
dobj(decreases-2, clearance-4)
quantmod(25-8, up-6)
dep(25-8, to-7)
num(%-9, 25-8)
prep_by(decreases-2, %-9)
aux(produce-13, may-12)
conj_and(decreases-2, produce-13)
dobj(produce-13, AUCs-14)
num(min-19, 1500-15)
nn(min-19, @-16)
nn(min-19, M-17)
nn(min-19, @-18)
dep(AUCs-14, min-19)
det(patients-22, some-21)
prep_in(AUCs-14, patients-22)

Fluconazole/NN ,/, and/CC the/DT 5-HT3/NN antiemetics/NNS odansetron/NN (/-LRB- Zofran/NN )/-RRB- and/CC granisetron/NN (/-LRB- Kytril/NN )/-RRB- have/VBP all/RB been/VBN used/VBN with/IN BUSULFEX/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (NN Fluconazole)) (, ,) (CC and) (NP (DT the) (NN 5-HT3) (NNS antiemetics) (NN odansetron))) (PRN (-LRB- -LRB-) (NP (NN Zofran)) (-RRB- -RRB-))) (CC and) (NP (NP (NN granisetron)) (PRN (-LRB- -LRB-) (NP (NN Kytril)) (-RRB- -RRB-)))) (VP (VBP have) (ADVP (RB all)) (VP (VBN been) (VP (VBN used) (PP (IN with) (NP (NN BUSULFEX))))))) (. .))))

nsubjpass(used-19, Fluconazole-1)
det(odansetron-7, the-4)
nn(odansetron-7, 5-HT3-5)
nn(odansetron-7, antiemetics-6)
conj_and(Fluconazole-1, odansetron-7)
appos(Fluconazole-1, Zofran-9)
conj_and(Fluconazole-1, granisetron-12)
appos(granisetron-12, Kytril-14)
aux(used-19, have-16)
advmod(used-19, all-17)
auxpass(used-19, been-18)
root(ROOT-0, used-19)
prep_with(used-19, BUSULFEX-21)

Phenytoin/NN increases/VBZ the/DT clearance/NN of/IN busulfan/NN by/IN 15/CD %/NN or/CC more/JJR ,/, possibly/RB due/JJ to/TO the/DT induction/NN of/IN glutathione-S-transferase/NN ./.

(ROOT (S1 (S (S (NP (NN Phenytoin)) (VP (VBZ increases) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN busulfan)))) (PP (IN by) (NP (NP (CD 15) (NN %)) (CC or) (NP (JJR more)))) (, ,) (PP (ADVP (RB possibly)) (JJ due) (TO to) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NN glutathione-S-transferase))))))) (. .))))

nsubj(increases-2, Phenytoin-1)
root(ROOT-0, increases-2)
det(clearance-4, the-3)
dobj(increases-2, clearance-4)
prep_of(clearance-4, busulfan-6)
num(%-9, 15-8)
prep_by(increases-2, %-9)
conj_or(%-9, more-11)
advmod(increases-2, possibly-13)
det(induction-17, the-16)
prep_due_to(increases-2, induction-17)
prep_of(induction-17, glutathione-S-transferase-19)

Since/IN the/DT pharmacokinetics/NNS of/IN BUSULFEX/NN were/VBD studied/VBN in/IN patients/NNS treated/VBN with/IN phenytoin/NN ,/, the/DT clearance/NN of/IN BUSULFEX/NN at/IN the/DT recommended/VBN dose/NN may/MD be/VB lower/JJR and/CC exposure/NN (/-LRB- AUC/NN )/-RRB- higher/JJR in/IN patients/NNS not/RB treated/VBN with/IN phenytoin/NN ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN BUSULFEX)))) (VP (VBD were) (VP (VBN studied) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NN phenytoin)))))))))) (, ,) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN BUSULFEX))) (PP (IN at) (NP (DT the) (VBN recommended) (NN dose)))) (VP (MD may) (VP (VB be) (ADJP (ADJP (JJR lower)) (CC and) (ADJP (ADJP (NP (NP (NN exposure)) (PRN (-LRB- -LRB-) (NP (NN AUC)) (-RRB- -RRB-))) (JJR higher)) (PP (IN in) (NP (NP (NNS patients)) (VP (RB not) (VBN treated) (PP (IN with) (NP (NN phenytoin))))))))))) (. .))))

mark(studied-7, Since-1)
det(pharmacokinetics-3, the-2)
nsubjpass(studied-7, pharmacokinetics-3)
prep_of(pharmacokinetics-3, BUSULFEX-5)
auxpass(studied-7, were-6)
advcl(lower-24, studied-7)
prep_in(studied-7, patients-9)
partmod(patients-9, treated-10)
prep_with(treated-10, phenytoin-12)
det(clearance-15, the-14)
nsubj(lower-24, clearance-15)
prep_of(clearance-15, BUSULFEX-17)
det(dose-21, the-19)
amod(dose-21, recommended-20)
prep_at(clearance-15, dose-21)
aux(lower-24, may-22)
cop(lower-24, be-23)
root(ROOT-0, lower-24)
npadvmod(higher-30, exposure-26)
abbrev(exposure-26, AUC-28)
conj_and(lower-24, higher-30)
prep_in(higher-30, patients-32)
neg(treated-34, not-33)
partmod(patients-32, treated-34)
prep_with(treated-34, phenytoin-36)

Because/IN busulfan/NN is/VBZ eliminated/VBN from/IN the/DT body/NN via/IN conjugation/NN with/IN glutathione/NN ,/, use/NN of/IN acetaminophen/NN prior/JJ to/TO (/-LRB- 72/CD hours/NNS )/-RRB- or/CC concurrent/JJ with/IN BUSULFEX/NN may/MD result/VB in/IN reduced/VBN busulfan/NN clearance/NN based/VBN upon/IN the/DT known/JJ property/NN of/IN acetaminophen/NN to/TO decrease/VB glutathione/NN levels/NNS in/IN the/DT blood/NN and/CC tissues/NNS ./.

(ROOT (S1 (S (SBAR (IN Because) (S (NP (NN busulfan)) (VP (VBZ is) (VP (VBN eliminated) (PP (IN from) (NP (DT the) (NN body))) (PP (IN via) (NP (NP (NN conjugation)) (PP (IN with) (NP (NN glutathione))))))))) (, ,) (NP (NP (NN use)) (PP (IN of) (NP (NN acetaminophen))) (ADJP (ADJP (ADJP (JJ prior) (PP (TO to))) (PRN (-LRB- -LRB-) (NP (CD 72) (NNS hours)) (-RRB- -RRB-))) (CC or) (ADJP (JJ concurrent) (PP (IN with) (NP (NN BUSULFEX)))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (VBN reduced) (NN busulfan) (NN clearance)) (VP (VBN based) (PP (IN upon) (NP (NP (DT the) (JJ known) (NN property)) (PP (IN of) (NP (NN acetaminophen))) (S (VP (TO to) (VP (VB decrease) (NP (NP (NN glutathione) (NNS levels)) (PP (IN in) (NP (DT the) (NP (NN blood)) (CC and) (NP (NNS tissues))))))))))))))) (. .))))

mark(eliminated-4, Because-1)
nsubjpass(eliminated-4, busulfan-2)
auxpass(eliminated-4, is-3)
advcl(result-27, eliminated-4)
det(body-7, the-6)
prep_from(eliminated-4, body-7)
prep_via(eliminated-4, conjugation-9)
prep_with(conjugation-9, glutathione-11)
nsubj(result-27, use-13)
prep_of(use-13, acetaminophen-15)
amod(use-13, prior-16)
prep(prior-16, to-17)
num(hours-20, 72-19)
dep(prior-16, hours-20)
conj_or(prior-16, concurrent-23)
prep_with(concurrent-23, BUSULFEX-25)
aux(result-27, may-26)
root(ROOT-0, result-27)
amod(clearance-31, reduced-29)
nn(clearance-31, busulfan-30)
prep_in(result-27, clearance-31)
partmod(clearance-31, based-32)
det(property-36, the-34)
amod(property-36, known-35)
prep_upon(based-32, property-36)
prep_of(property-36, acetaminophen-38)
aux(decrease-40, to-39)
infmod(property-36, decrease-40)
nn(levels-42, glutathione-41)
dobj(decrease-40, levels-42)
dep(blood-45, the-44)
prep_in(levels-42, blood-45)
conj_and(blood-45, tissues-47)

Interactions/NNS may/MD occur/VB with/IN the/DT following/NN :/: adrenocorticoids/NNS (/-LRB- cortisone/NN -like/JJ medicine/NN )/-RRB- ,/, anticoagulants/NNS (/-LRB- blood/NN thinner/NN s/NNS )/-RRB- ,/, carbamazepine/NN ,/, corticotropin/NN (/-LRB- barbiturates/NNS may/MD decrease/VB the/DT effects/NNS of/IN these/DT medicines/NNS )/-RRB- ,/, central/JJ nervous/JJ system/NN (/-LRB- CNS/NN )/-RRB- depressants/NNS (/-LRB- using/VBG these/DT medicines/NNS with/IN barbiturates/NNS may/MD result/VB in/IN increased/VBN CNS/NN depressant/NN effects/NNS )/-RRB- ,/, divalproex/NN sodium/NN ,/, valproic/JJ acid/NN (/-LRB- using/VBG these/DT medicines/NNS with/IN barbiturates/NNS may/MD change/VB the/DT amount/NN of/IN either/DT medicine/NN that/WDT you/RB need/VBP to/TO take/VB )/-RRB- ,/, and/CC oral/JJ contraceptives/NNS containing/VBG estrogens/NNS (/-LRB- barbiturates/NNS may/MD decrease/VB the/DT effectiveness/NN of/IN these/DT oral/JJ contraceptives/NNS ,/, and/CC you/RB may/MD need/VBP to/TO change/NN to/TO a/DT different/JJ type/NN of/IN birth/NN control/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NNS Interactions)) (VP (MD may) (VP (VB occur) (PP (IN with) (NP (DT the) (NN following)))))) (: :) (S (NP (NP (NP (NP (NP (NNS adrenocorticoids)) (PRN (-LRB- -LRB-) (NP (NN cortisone) (JJ -like) (NN medicine)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS anticoagulants)) (PRN (-LRB- -LRB-) (NP (NN blood) (NN thinner) (NNS s)) (-RRB- -RRB-))) (, ,) (NP (NN carbamazepine)) (, ,) (NP (NN corticotropin)) (-LRB- -LRB-) (NP (NNS barbiturates)) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (DT these) (NNS medicines)))))) (-RRB- -RRB-)) (, ,) (NP (NP (NP (NP (JJ central) (JJ nervous) (NN system)) (PRN (-LRB- -LRB-) (NP (NN CNS)) (-RRB- -RRB-))) (NNS depressants)) (PRN (-LRB- -LRB-) (VP (VBG using) (NP (DT these) (NNS medicines)) (PP (IN with) (NP (NP (NNS barbiturates)) (VP (MD may) (VP (VB result) (PP (IN in) (NP (VBN increased) (NN CNS) (NN depressant) (NNS effects)))))))) (-RRB- -RRB-))) (, ,) (NP (NN divalproex) (NN sodium)) (, ,) (NP (NP (JJ valproic) (NN acid)) (PRN (-LRB- -LRB-) (VP (VBG using) (NP (NP (DT these) (NNS medicines)) (PP (IN with) (NP (NP (NNS barbiturates)) (VP (MD may) (VP (VB change) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NP (DT either) (NN medicine)) (SBAR (WHNP (WDT that)) (S (ADVP (RB you)) (VP (VBP need) (S (VP (TO to) (VP (VB take)))))))))))))))) (-RRB- -RRB-))) (, ,) (CC and) (NP (JJ oral) (NNS contraceptives))) (VP (VBG containing) (NP (NNS estrogens)))) (-LRB- -LRB-) (NP (NNS barbiturates)) (VP (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (DT these) (JJ oral) (NNS contraceptives)))))) (, ,) (CC and) (ADVP (RB you)) (VP (MD may) (VP (VBP need) (PP (TO to) (NP (NN change))) (PP (TO to) (NP (NP (DT a) (JJ different) (NN type)) (PP (IN of) (NP (NN birth) (NN control)))))))) (-RRB- -RRB-)) (. .))))

nsubj(occur-3, Interactions-1)
aux(occur-3, may-2)
root(ROOT-0, occur-3)
det(following-6, the-5)
prep_with(occur-3, following-6)
nsubj(decrease-91, adrenocorticoids-8)
nn(medicine-12, cortisone-10)
amod(medicine-12, -like-11)
appos(adrenocorticoids-8, medicine-12)
appos(adrenocorticoids-8, anticoagulants-15)
nn(s-19, blood-17)
nn(s-19, thinner-18)
appos(anticoagulants-15, s-19)
appos(adrenocorticoids-8, carbamazepine-22)
appos(adrenocorticoids-8, corticotropin-24)
dep(adrenocorticoids-8, barbiturates-26)
aux(decrease-28, may-27)
dep(adrenocorticoids-8, decrease-28)
det(effects-30, the-29)
dobj(decrease-28, effects-30)
det(medicines-33, these-32)
prep_of(effects-30, medicines-33)
amod(system-38, central-36)
amod(system-38, nervous-37)
nn(depressants-42, system-38)
abbrev(system-38, CNS-40)
conj_and(adrenocorticoids-8, depressants-42)
dep(depressants-42, using-44)
det(medicines-46, these-45)
dobj(using-44, medicines-46)
prep_with(using-44, barbiturates-48)
aux(result-50, may-49)
dep(barbiturates-48, result-50)
amod(effects-55, increased-52)
nn(effects-55, CNS-53)
nn(effects-55, depressant-54)
prep_in(result-50, effects-55)
nn(sodium-59, divalproex-58)
conj_and(adrenocorticoids-8, sodium-59)
amod(acid-62, valproic-61)
conj_and(adrenocorticoids-8, acid-62)
dep(acid-62, using-64)
det(medicines-66, these-65)
dobj(using-64, medicines-66)
prep_with(medicines-66, barbiturates-68)
aux(change-70, may-69)
dep(barbiturates-68, change-70)
det(amount-72, the-71)
dobj(change-70, amount-72)
det(medicine-75, either-74)
prep_of(amount-72, medicine-75)
nsubj(need-78, medicine-75)
advmod(need-78, you-77)
rcmod(medicine-75, need-78)
aux(take-80, to-79)
xcomp(need-78, take-80)
amod(contraceptives-85, oral-84)
conj_and(adrenocorticoids-8, contraceptives-85)
partmod(adrenocorticoids-8, containing-86)
dobj(containing-86, estrogens-87)
nsubj(decrease-91, barbiturates-89)
aux(decrease-91, may-90)
parataxis(occur-3, decrease-91)
det(effectiveness-93, the-92)
dobj(decrease-91, effectiveness-93)
det(contraceptives-97, these-95)
amod(contraceptives-97, oral-96)
prep_of(effectiveness-93, contraceptives-97)
advmod(decrease-91, you-100)
conj_and(decrease-91, you-100)
aux(need-102, may-101)
conj_and(decrease-91, need-102)
prep_to(need-102, change-104)
det(type-108, a-106)
amod(type-108, different-107)
prep_to(need-102, type-108)
nn(control-111, birth-110)
prep_of(type-108, control-111)

Potential/JJ drug/NN interactions/NNS between/IN Mentax/NN @/NN (/-LRB- butenafine/NN HCl/NN cream/NN )/-RRB- Cream/NN ,/, 1/CD %/NN ,/, and/CC other/JJ drugs/NNS have/VBP not/RB been/VBN systematically/RB evaluated/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Potential) (NN drug) (NNS interactions)) (PP (IN between) (NP (NP (NP (NP (NN Mentax) (NN @)) (PRN (-LRB- -LRB-) (NP (NN butenafine) (NN HCl) (NN cream)) (-RRB- -RRB-))) (NN Cream)) (, ,) (NP (CD 1) (NN %)) (, ,) (CC and) (NP (JJ other) (NNS drugs))))) (VP (VBP have) (RB not) (VP (VBN been) (ADVP (RB systematically)) (VP (VBN evaluated))))) (. .))))

amod(interactions-3, Potential-1)
nn(interactions-3, drug-2)
nsubjpass(evaluated-24, interactions-3)
nn(@-6, Mentax-5)
nn(Cream-12, @-6)
nn(cream-10, butenafine-8)
nn(cream-10, HCl-9)
abbrev(@-6, cream-10)
prep_between(interactions-3, Cream-12)
num(%-15, 1-14)
conj_and(Cream-12, %-15)
amod(drugs-19, other-18)
conj_and(Cream-12, drugs-19)
aux(evaluated-24, have-20)
neg(evaluated-24, not-21)
auxpass(evaluated-24, been-22)
advmod(evaluated-24, systematically-23)
root(ROOT-0, evaluated-24)

Concurrent/JJ use/NN of/IN butorphanol/NN with/IN central/JJ nervous/JJ system/NN depressants/NNS (/-LRB- e.g./FW ,/, alcohol/NN ,/, barbiturates/NNS ,/, tranquilizers/NNS ,/, and/CC antihistamines/NNS )/-RRB- may/MD result/VB in/IN increased/VBN central/JJ nervous/JJ system/NN depressant/NN effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN use)) (PP (IN of) (NP (NN butorphanol))) (PP (IN with) (NP (NP (NP (JJ central) (JJ nervous) (NN system)) (NNS depressants)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN alcohol))) (, ,) (NP (NP (NNS barbiturates)) (, ,) (NP (NNS tranquilizers)) (, ,) (CC and) (NP (NNS antihistamines))) (-RRB- -RRB-))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (VBN increased) (ADJP (JJ central) (JJ nervous) (NN system)) (NN depressant) (NNS effects)))))) (. .))))

amod(use-2, Concurrent-1)
nsubj(result-23, use-2)
prep_of(use-2, butorphanol-4)
amod(system-8, central-6)
amod(system-8, nervous-7)
nn(depressants-9, system-8)
prep_with(use-2, depressants-9)
dep(barbiturates-15, e.g.-11)
pobj(e.g.-11, alcohol-13)
dep(depressants-9, barbiturates-15)
conj_and(barbiturates-15, tranquilizers-17)
conj_and(barbiturates-15, antihistamines-20)
aux(result-23, may-22)
root(ROOT-0, result-23)
amod(effects-30, increased-25)
amod(system-28, central-26)
amod(system-28, nervous-27)
amod(effects-30, system-28)
nn(effects-30, depressant-29)
prep_in(result-23, effects-30)

When/WRB used/VBN concurrently/RB with/IN such/JJ drugs/NNS ,/, the/DT dose/NN of/IN butorphanol/NN should/MD be/VB the/DT smallest/JJ effective/JJ dose/NN and/CC the/DT frequency/NN of/IN dosing/NN reduced/VBD as/RB much/RB as/RB possible/JJ when/WRB administered/VBN concomitantly/RB with/IN drugs/NNS that/WDT potentiate/VB the/DT action/NN of/IN opioids/NNS ./.

(ROOT (S1 (S (SBAR (WHADVP (WRB When)) (S (VP (VBN used) (ADVP (RB concurrently)) (PP (IN with) (NP (JJ such) (NNS drugs)))))) (, ,) (S (S (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN butorphanol)))) (VP (MD should) (VP (VB be) (NP (DT the) (JJ smallest) (JJ effective) (NN dose))))) (CC and) (S (NP (NP (DT the) (NN frequency)) (PP (IN of) (NP (NN dosing)))) (VP (VBD reduced) (ADJP (ADVP (RB as) (RB much)) (RB as) (JJ possible)) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VB potentiate) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NNS opioids))))))))))))))) (. .))))

advmod(used-2, When-1)
advcl(dose-17, used-2)
advmod(used-2, concurrently-3)
amod(drugs-6, such-5)
prep_with(used-2, drugs-6)
det(dose-9, the-8)
nsubj(dose-17, dose-9)
prep_of(dose-9, butorphanol-11)
aux(dose-17, should-12)
cop(dose-17, be-13)
det(dose-17, the-14)
amod(dose-17, smallest-15)
amod(dose-17, effective-16)
root(ROOT-0, dose-17)
det(frequency-20, the-19)
nsubj(reduced-23, frequency-20)
prep_of(frequency-20, dosing-22)
conj_and(dose-17, reduced-23)
advmod(much-25, as-24)
advmod(possible-27, much-25)
advmod(possible-27, as-26)
acomp(reduced-23, possible-27)
advmod(administered-29, when-28)
advcl(reduced-23, administered-29)
advmod(administered-29, concomitantly-30)
prep_with(administered-29, drugs-32)
nsubj(potentiate-34, drugs-32)
rcmod(drugs-32, potentiate-34)
det(action-36, the-35)
dobj(potentiate-34, action-36)
prep_of(action-36, opioids-38)

In/IN healthy/JJ volunteers/NNS ,/, the/DT pharmacokinetics/NNS of/IN a/DT 1-mg/JJ dose/NN of/IN butorphanol/NN administered/VBN as/IN STADOL/NN NS/CD were/VBD not/RB affected/VBN by/IN the/DT coadministration/NN of/IN a/DT single/JJ 6-mg/JJ subcutaneous/NN dose/NN of/IN sumatriptan/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ healthy) (NNS volunteers))) (, ,) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (DT a) (JJ 1-mg) (NN dose)) (PP (IN of) (NP (NN butorphanol))) (VP (VBN administered) (PP (IN as) (NP (NN STADOL) (CD NS))))))) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (DT the) (NN coadministration)) (PP (IN of) (NP (NP (DT a) (JJ single) (JJ 6-mg) (NN subcutaneous) (NN dose)) (PP (IN of) (NP (NN sumatriptan)))))))))) (. .))))

amod(volunteers-3, healthy-2)
prep_in(affected-19, volunteers-3)
det(pharmacokinetics-6, the-5)
nsubjpass(affected-19, pharmacokinetics-6)
det(dose-10, a-8)
amod(dose-10, 1-mg-9)
prep_of(pharmacokinetics-6, dose-10)
prep_of(dose-10, butorphanol-12)
partmod(dose-10, administered-13)
prep_as(administered-13, STADOL-15)
num(STADOL-15, NS-16)
auxpass(affected-19, were-17)
neg(affected-19, not-18)
root(ROOT-0, affected-19)
det(coadministration-22, the-21)
agent(affected-19, coadministration-22)
det(dose-28, a-24)
amod(dose-28, single-25)
amod(dose-28, 6-mg-26)
nn(dose-28, subcutaneous-27)
prep_of(coadministration-22, dose-28)
prep_of(dose-28, sumatriptan-30)

However/RB ,/, in/IN another/DT study/NN in/IN healthy/JJ volunteers/NNS ,/, the/DT pharmacokinetics/NNS of/IN butorphanol/NN were/VBD significantly/RB altered/VBN (/-LRB- 29/CD %/NN decrease/NN in/IN AUC/NN and/CC 38/CD %/NN decrease/NN in/IN Cmax/NN )/-RRB- when/WRB a/DT 1-mg/JJ dose/NN of/IN STADOL/NN NS/NNS was/VBD administered/VBN 1/CD minute/NN after/IN a/DT 20-mg/JJ dose/NN of/IN sumatriptan/JJ nasal/JJ spray/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (NP (DT another) (NN study)) (PP (IN in) (NP (JJ healthy) (NNS volunteers))))) (, ,) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN butorphanol)))) (VP (VBD were) (ADVP (RB significantly)) (VP (VBN altered) (PRN (-LRB- -LRB-) (NP (NP (NP (ADJP (CD 29) (NN %)) (NN decrease)) (PP (IN in) (NP (NN AUC)))) (CC and) (NP (NP (ADJP (CD 38) (NN %)) (NN decrease)) (PP (IN in) (NP (NN Cmax))))) (-RRB- -RRB-)) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT a) (JJ 1-mg) (NN dose)) (PP (IN of) (NP (NN STADOL) (NNS NS)))) (VP (VBD was) (VP (VBN administered) (PP (NP (CD 1) (NN minute)) (IN after) (NP (NP (DT a) (JJ 20-mg) (NN dose)) (PP (IN of) (NP (JJ sumatriptan) (JJ nasal) (NN spray)))))))))))) (. .))))

advmod(altered-16, However-1)
det(study-5, another-4)
prep_in(altered-16, study-5)
amod(volunteers-8, healthy-7)
prep_in(study-5, volunteers-8)
det(pharmacokinetics-11, the-10)
nsubjpass(altered-16, pharmacokinetics-11)
prep_of(pharmacokinetics-11, butorphanol-13)
auxpass(altered-16, were-14)
advmod(altered-16, significantly-15)
root(ROOT-0, altered-16)
number(%-19, 29-18)
amod(decrease-20, %-19)
dep(altered-16, decrease-20)
prep_in(decrease-20, AUC-22)
number(%-25, 38-24)
amod(decrease-26, %-25)
conj_and(decrease-20, decrease-26)
prep_in(decrease-26, Cmax-28)
advmod(administered-38, when-30)
det(dose-33, a-31)
amod(dose-33, 1-mg-32)
nsubjpass(administered-38, dose-33)
nn(NS-36, STADOL-35)
prep_of(dose-33, NS-36)
auxpass(administered-38, was-37)
advcl(altered-16, administered-38)
num(minute-40, 1-39)
npadvmod(administered-38, minute-40)
det(dose-44, a-42)
amod(dose-44, 20-mg-43)
prep_after(administered-38, dose-44)
amod(spray-48, sumatriptan-46)
amod(spray-48, nasal-47)
prep_of(dose-44, spray-48)

(/-LRB- The/DT two/CD drugs/NNS were/VBD administered/VBN in/IN opposite/JJ nostrils./NNS )/-RRB- ./.

(ROOT (S1 (S (S (-LRB- -LRB-) (NP (DT The) (CD two) (NNS drugs)) (VP (VBD were) (VP (VBN administered) (PP (IN in) (NP (JJ opposite) (NNS nostrils.))))) (-RRB- -RRB-)) (. .))))

det(drugs-4, The-2)
num(drugs-4, two-3)
nsubjpass(administered-6, drugs-4)
auxpass(administered-6, were-5)
root(ROOT-0, administered-6)
amod(nostrils.-9, opposite-8)
prep_in(administered-6, nostrils.-9)

When/WRB the/DT STADOL/NN NS/NN was/VBD administered/VBN 30/CD minutes/NNS after/IN the/DT sumatriptan/NN nasal/JJ spray/NN ,/, the/DT AUC/NN of/IN butorphanol/NN increased/VBD 11/CD %/NN and/CC Cmax/NN decreased/VBD 18/CD %./NN

(ROOT (S1 (S (SBAR (WHADVP (WRB When)) (S (NP (DT the) (NN STADOL) (NN NS)) (VP (VBD was) (VP (VBN administered) (PP (NP (CD 30) (NNS minutes)) (IN after) (NP (DT the) (NN sumatriptan) (JJ nasal) (NN spray))))))) (, ,) (S (S (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NN butorphanol)))) (VP (VBD increased) (NP (CD 11) (NN %)))) (CC and) (S (NP (NN Cmax)) (VP (VBD decreased) (NP (CD 18) (NN %.))))))))

advmod(administered-6, When-1)
det(NS-4, the-2)
nn(NS-4, STADOL-3)
nsubjpass(administered-6, NS-4)
auxpass(administered-6, was-5)
advcl(increased-19, administered-6)
num(minutes-8, 30-7)
npadvmod(administered-6, minutes-8)
det(spray-13, the-10)
nn(spray-13, sumatriptan-11)
amod(spray-13, nasal-12)
prep_after(administered-6, spray-13)
det(AUC-16, the-15)
nsubj(increased-19, AUC-16)
prep_of(AUC-16, butorphanol-18)
root(ROOT-0, increased-19)
num(%-21, 11-20)
dobj(increased-19, %-21)
nsubj(decreased-24, Cmax-23)
conj_and(increased-19, decreased-24)
num(%.-26, 18-25)
dobj(decreased-24, %.-26)

In/IN neither/DT case/NN were/VBD the/DT pharmacokinetics/NNS of/IN sumatriptan/NN affected/VBN by/IN coadministration/NN with/IN STADOL/NN NS/CD ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT neither) (NN case))) (VP (VBD were) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN sumatriptan)) (VP (VBN affected) (PP (IN by) (NP (NP (NN coadministration)) (PP (IN with) (NP (NN STADOL) (CD NS))))))))))) (. .))))

det(case-3, neither-2)
prep_in(pharmacokinetics-6, case-3)
cop(pharmacokinetics-6, were-4)
det(pharmacokinetics-6, the-5)
root(ROOT-0, pharmacokinetics-6)
prep_of(pharmacokinetics-6, sumatriptan-8)
partmod(sumatriptan-8, affected-9)
agent(affected-9, coadministration-11)
prep_with(coadministration-11, STADOL-13)
num(STADOL-13, NS-14)

These/DT results/NNS suggest/VBP that/IN the/DT analgesic/JJ effect/NN of/IN STADOL/NN NS/NNS may/MD be/VB diminished/VBN when/WRB it/PRP is/VBZ administered/VBN shortly/RB after/IN sumatriptan/JJ nasal/JJ spray/NN ,/, but/CC by/IN 30/CD minutes/NNS any/DT such/JJ reduction/NN in/IN effect/NN should/MD be/VB minimal/JJ ./.

(ROOT (S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (S (NP (NP (DT the) (JJ analgesic) (NN effect)) (PP (IN of) (NP (NN STADOL) (NNS NS)))) (VP (MD may) (VP (VB be) (VP (VBN diminished) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB shortly)) (PP (IN after) (NP (JJ sumatriptan) (JJ nasal) (NN spray))))))))))) (, ,) (CC but) (S (PP (IN by) (NP (CD 30) (NNS minutes))) (NP (NP (DT any) (JJ such) (NN reduction)) (PP (IN in) (NP (NN effect)))) (VP (MD should) (VP (VB be) (ADJP (JJ minimal))))))))) (. .))))

det(results-2, These-1)
nsubj(suggest-3, results-2)
root(ROOT-0, suggest-3)
complm(diminished-13, that-4)
det(effect-7, the-5)
amod(effect-7, analgesic-6)
nsubjpass(diminished-13, effect-7)
nn(NS-10, STADOL-9)
prep_of(effect-7, NS-10)
aux(diminished-13, may-11)
auxpass(diminished-13, be-12)
ccomp(suggest-3, diminished-13)
advmod(administered-17, when-14)
nsubjpass(administered-17, it-15)
auxpass(administered-17, is-16)
advcl(diminished-13, administered-17)
advmod(administered-17, shortly-18)
amod(spray-22, sumatriptan-20)
amod(spray-22, nasal-21)
prep_after(administered-17, spray-22)
num(minutes-27, 30-26)
prep_by(minimal-35, minutes-27)
det(reduction-30, any-28)
amod(reduction-30, such-29)
nsubj(minimal-35, reduction-30)
prep_in(reduction-30, effect-32)
aux(minimal-35, should-33)
cop(minimal-35, be-34)
conj_but(diminished-13, minimal-35)

The/DT safety/NN of/IN using/VBG STADOL/NN NS/CD and/CC IMITREX/NN @/NN (/-LRB- sumatriptan/NN )/-RRB- Nasal/JJ Spray/NN during/IN the/DT same/JJ episode/NN of/IN migraine/NN has/VBZ not/RB been/VBN established/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN safety)) (PP (IN of) (S (VP (VBG using) (NP (NP (NN STADOL) (CD NS)) (CC and) (NP (NN IMITREX) (NN @) (-LRB- -LRB-) (NN sumatriptan) (-RRB- -RRB-) (JJ Nasal) (NN Spray))) (PP (IN during) (NP (NP (DT the) (JJ same) (NN episode)) (PP (IN of) (NP (NN migraine))))))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN established))))) (. .))))

det(safety-2, The-1)
nsubjpass(established-24, safety-2)
prepc_of(safety-2, using-4)
dobj(using-4, STADOL-5)
num(STADOL-5, NS-6)
nn(Spray-14, IMITREX-8)
nn(Spray-14, @-9)
nn(Spray-14, sumatriptan-11)
amod(Spray-14, Nasal-13)
conj_and(STADOL-5, Spray-14)
det(episode-18, the-16)
amod(episode-18, same-17)
prep_during(using-4, episode-18)
prep_of(episode-18, migraine-20)
aux(established-24, has-21)
neg(established-24, not-22)
auxpass(established-24, been-23)
root(ROOT-0, established-24)

The/DT pharmacokinetics/NNS of/IN a/DT 1-mg/JJ dose/NN of/IN butorphanol/NN administered/VBN as/IN STADOL/NN NS/NNS were/VBD not/RB affected/VBN by/IN the/DT coadministration/NN of/IN cimetidine/NN (/-LRB- 300/CD mg/NN QID/JJ )./CD

(ROOT (S1 (S (NP (NP (DT The) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (DT a) (JJ 1-mg) (NN dose)) (PP (IN of) (NP (NN butorphanol))) (VP (VBN administered) (PP (IN as) (NP (NN STADOL) (NNS NS))))))) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (DT the) (NN coadministration)) (PP (IN of) (NP (NN cimetidine))))) (PRN (-LRB- -LRB-) (NP (CD 300) (NN mg) (JJ QID) (CD -RRB-.))))))))

det(pharmacokinetics-2, The-1)
nsubjpass(affected-15, pharmacokinetics-2)
det(dose-6, a-4)
amod(dose-6, 1-mg-5)
prep_of(pharmacokinetics-2, dose-6)
prep_of(dose-6, butorphanol-8)
partmod(dose-6, administered-9)
nn(NS-12, STADOL-11)
prep_as(administered-9, NS-12)
auxpass(affected-15, were-13)
neg(affected-15, not-14)
root(ROOT-0, affected-15)
det(coadministration-18, the-17)
agent(affected-15, coadministration-18)
prep_of(coadministration-18, cimetidine-20)
num(mg-23, 300-22)
dep(affected-15, mg-23)
amod(mg-23, QID-24)
num(mg-23, -RRB-.-25)

Conversely/RB ,/, the/DT administration/NN of/IN STADOL/JJ NS/NNS (/-LRB- 1/CD mg/NN butorphanol/JJ QID/JJ )/-RRB- did/VBD not/RB alter/VB the/DT pharmacokinetics/NNS of/IN a/DT 300-mg/JJ dose/NN of/IN cimetidine/NN ./.

(ROOT (S1 (S (S (ADVP (RB Conversely)) (, ,) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (JJ STADOL) (NNS NS)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN mg) (JJ butorphanol) (JJ QID)) (-RRB- -RRB-))))) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (DT a) (JJ 300-mg) (NN dose)) (PP (IN of) (NP (NN cimetidine))))))))) (. .))))

advmod(alter-16, Conversely-1)
det(administration-4, the-3)
nsubj(alter-16, administration-4)
amod(NS-7, STADOL-6)
prep_of(administration-4, NS-7)
num(mg-10, 1-9)
appos(NS-7, mg-10)
amod(mg-10, butorphanol-11)
amod(mg-10, QID-12)
aux(alter-16, did-14)
neg(alter-16, not-15)
root(ROOT-0, alter-16)
det(pharmacokinetics-18, the-17)
dobj(alter-16, pharmacokinetics-18)
det(dose-22, a-20)
amod(dose-22, 300-mg-21)
prep_of(pharmacokinetics-18, dose-22)
prep_of(dose-22, cimetidine-24)

It/PRP is/VBZ not/RB known/VBN if/IN the/DT effects/NNS of/IN butorphanol/NN are/VBP altered/VBN by/IN concomitant/JJ medications/NNS that/WDT affect/VBP hepatic/JJ metabolism/NN of/IN drugs/NNS (/-LRB- erythromycin/NN ,/, etc./NN )/-RRB- ,/, but/CC physicians/NNS should/MD be/VB alert/JJ to/TO the/DT possibility/NN that/IN a/DT smaller/JJR initial/JJ dose/NN and/CC longer/JJR intervals/NNS between/IN doses/NNS may/MD be/VB needed/VBN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (IN if) (S (S (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN butorphanol)))) (VP (VBP are) (VP (VBN altered) (PP (IN by) (NP (NP (JJ concomitant) (NNS medications)) (SBAR (WHNP (WDT that)) (S (VP (VBP affect) (NP (NP (JJ hepatic) (NN metabolism)) (PP (IN of) (NP (NP (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NP (NN erythromycin)) (, ,) (NP (NN etc.))) (-RRB- -RRB-))))))))))))) (, ,) (CC but) (S (NP (NNS physicians)) (VP (MD should) (VP (VB be) (ADJP (JJ alert) (PP (TO to) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NP (DT a) (JJR smaller) (JJ initial) (NN dose)) (CC and) (NP (NP (JJR longer) (NNS intervals)) (PP (IN between) (NP (NNS doses))))) (VP (MD may) (VP (VB be) (VP (VBN needed))))))))))))))))) (. .))))

nsubjpass(known-4, It-1)
auxpass(known-4, is-2)
neg(known-4, not-3)
root(ROOT-0, known-4)
mark(altered-11, if-5)
det(effects-7, the-6)
nsubjpass(altered-11, effects-7)
prep_of(effects-7, butorphanol-9)
auxpass(altered-11, are-10)
advcl(known-4, altered-11)
amod(medications-14, concomitant-13)
agent(altered-11, medications-14)
nsubj(affect-16, medications-14)
rcmod(medications-14, affect-16)
amod(metabolism-18, hepatic-17)
dobj(affect-16, metabolism-18)
prep_of(metabolism-18, drugs-20)
dep(drugs-20, erythromycin-22)
appos(erythromycin-22, etc.-24)
nsubj(alert-31, physicians-28)
aux(alert-31, should-29)
cop(alert-31, be-30)
conj_but(altered-11, alert-31)
det(possibility-34, the-33)
prep_to(alert-31, possibility-34)
complm(needed-47, that-35)
det(dose-39, a-36)
amod(dose-39, smaller-37)
amod(dose-39, initial-38)
nsubjpass(needed-47, dose-39)
amod(intervals-42, longer-41)
conj_and(dose-39, intervals-42)
prep_between(intervals-42, doses-44)
aux(needed-47, may-45)
auxpass(needed-47, be-46)
ccomp(possibility-34, needed-47)

The/DT fraction/NN of/IN STADOL/NN NS/NN absorbed/NN is/VBZ unaffected/VBN by/IN the/DT concomitant/JJ administration/NN of/IN a/DT nasal/JJ vasoconstrictor/NN (/-LRB- oxymetazoline/NN )/-RRB- ,/, but/CC the/DT rate/NN of/IN absorption/NN is/VBZ decreased/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (DT The) (NN fraction)) (PP (IN of) (NP (NN STADOL) (NN NS) (NN absorbed)))) (VP (VBZ is) (VP (VBN unaffected) (PP (IN by) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (DT a) (JJ nasal) (NN vasoconstrictor)) (PRN (-LRB- -LRB-) (NP (NN oxymetazoline)) (-RRB- -RRB-))))))))) (, ,) (CC but) (S (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NN absorption)))) (VP (VBZ is) (VP (VBN decreased))))) (. .))))

det(fraction-2, The-1)
nsubjpass(unaffected-8, fraction-2)
nn(absorbed-6, STADOL-4)
nn(absorbed-6, NS-5)
prep_of(fraction-2, absorbed-6)
auxpass(unaffected-8, is-7)
root(ROOT-0, unaffected-8)
det(administration-12, the-10)
amod(administration-12, concomitant-11)
agent(unaffected-8, administration-12)
det(vasoconstrictor-16, a-14)
amod(vasoconstrictor-16, nasal-15)
prep_of(administration-12, vasoconstrictor-16)
appos(vasoconstrictor-16, oxymetazoline-18)
det(rate-23, the-22)
nsubjpass(decreased-27, rate-23)
prep_of(rate-23, absorption-25)
auxpass(decreased-27, is-26)
conj_but(unaffected-8, decreased-27)

Therefore/RB ,/, a/DT slower/JJR onset/NN can/MD be/VB anticipated/VBN if/IN STADOL/NN NS/NN is/VBZ administered/VBN concomitantly/RB with/IN ,/, or/CC immediately/RB following/VBG ,/, a/DT nasal/JJ vasoconstrictor/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (DT a) (JJR slower) (NN onset)) (VP (MD can) (VP (VB be) (VP (VBN anticipated) (SBAR (IN if) (S (NP (NN STADOL) (NN NS)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (PP (IN with)) (, ,) (CC or) (ADVP (RB immediately)) (VP (VBG following) (, ,) (NP (DT a) (JJ nasal) (NN vasoconstrictor)))))))))))) (. .))))

advmod(anticipated-8, Therefore-1)
det(onset-5, a-3)
amod(onset-5, slower-4)
nsubjpass(anticipated-8, onset-5)
aux(anticipated-8, can-6)
auxpass(anticipated-8, be-7)
root(ROOT-0, anticipated-8)
mark(administered-13, if-9)
nn(NS-11, STADOL-10)
nsubjpass(administered-13, NS-11)
auxpass(administered-13, is-12)
advcl(anticipated-8, administered-13)
advmod(administered-13, concomitantly-14)
prep(administered-13, with-15)
advmod(with-15, immediately-18)
conj_or(with-15, immediately-18)
conj_or(with-15, following-19)
det(vasoconstrictor-23, a-21)
amod(vasoconstrictor-23, nasal-22)
dobj(following-19, vasoconstrictor-23)

No/DT information/NN is/VBZ available/JJ about/IN the/DT use/NN of/IN butorphanol/NN concurrently/RB with/IN MAO/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (DT No) (NN information)) (VP (VBZ is) (ADJP (JJ available) (PP (IN about) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN butorphanol))) (PP (ADVP (RB concurrently)) (IN with) (NP (NN MAO) (NNS inhibitors)))))))) (. .))))

det(information-2, No-1)
nsubj(available-4, information-2)
cop(available-4, is-3)
root(ROOT-0, available-4)
det(use-7, the-6)
prep_about(available-4, use-7)
prep_of(use-7, butorphanol-9)
advmod(use-7, concurrently-10)
nn(inhibitors-13, MAO-12)
prep_with(use-7, inhibitors-13)

Cytochrome/NN P450/NN 1A2/NN (/-LRB- CYP1A2/NN )/-RRB- is/VBZ known/VBN to/TO be/VB the/DT major/JJ enzyme/NN involved/VBN in/IN the/DT metabolism/NN of/IN caffeine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Cytochrome) (NN P450) (NN 1A2)) (PRN (-LRB- -LRB-) (NP (NN CYP1A2)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (JJ major) (NN enzyme)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN caffeine))))))))))))) (. .))))

nn(1A2-3, Cytochrome-1)
nn(1A2-3, P450-2)
nsubjpass(known-8, 1A2-3)
xsubj(enzyme-13, 1A2-3)
abbrev(1A2-3, CYP1A2-5)
auxpass(known-8, is-7)
root(ROOT-0, known-8)
aux(enzyme-13, to-9)
cop(enzyme-13, be-10)
det(enzyme-13, the-11)
amod(enzyme-13, major-12)
xcomp(known-8, enzyme-13)
partmod(enzyme-13, involved-14)
det(metabolism-17, the-16)
prep_in(involved-14, metabolism-17)
prep_of(metabolism-17, caffeine-19)

Therefore/RB ,/, caffeine/NN has/VBZ the/DT potential/NN to/TO interact/VB with/IN drugs/NNS that/WDT are/VBP substrates/NNS for/IN CYP1A2/NN ,/, inhibit/VB CYP1A2/NN ,/, or/CC induce/VB CYP1A2/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NN caffeine)) (VP (VBZ has) (NP (DT the) (NN potential) (S (VP (TO to) (VP (VP (VB interact) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NNS substrates)) (PP (IN for) (NP (NN CYP1A2)))))))))) (, ,) (VP (VB inhibit) (NP (NN CYP1A2))) (, ,) (CC or) (VP (VB induce) (NP (NN CYP1A2))))))))) (. .))))

advmod(has-4, Therefore-1)
nsubj(has-4, caffeine-3)
root(ROOT-0, has-4)
det(potential-6, the-5)
dobj(has-4, potential-6)
aux(interact-8, to-7)
infmod(potential-6, interact-8)
prep_with(interact-8, drugs-10)
nsubj(substrates-13, drugs-10)
cop(substrates-13, are-12)
rcmod(drugs-10, substrates-13)
prep_for(substrates-13, CYP1A2-15)
conj_or(interact-8, inhibit-17)
dobj(inhibit-17, CYP1A2-18)
conj_or(interact-8, induce-21)
dobj(induce-21, CYP1A2-22)

Few/JJ data/NNS exist/VBP on/IN drug/NN interactions/NNS with/IN caffeine/NN in/IN preterm/NN neonates/NNS ./.

(ROOT (S1 (S (S (NP (JJ Few) (NNS data)) (VP (VBP exist) (PP (IN on) (NP (NP (NN drug) (NNS interactions)) (PP (IN with) (NP (NP (NN caffeine)) (PP (IN in) (NP (NN preterm) (NNS neonates))))))))) (. .))))

amod(data-2, Few-1)
nsubj(exist-3, data-2)
root(ROOT-0, exist-3)
nn(interactions-6, drug-5)
prep_on(exist-3, interactions-6)
prep_with(interactions-6, caffeine-8)
nn(neonates-11, preterm-10)
prep_in(caffeine-8, neonates-11)

Based/VBN on/IN adult/JJ data/NNS ,/, lower/JJR doses/NNS of/IN caffeine/NN may/MD be/VB needed/VBN following/VBG coadministration/NN of/IN drugs/NNS which/WDT are/VBP reported/VBN to/TO decrease/VB caffeine/NN elimination/NN (/-LRB- e.g./FW ,/, cimetidine/NN and/CC ketoconazole/NN )/-RRB- and/CC higher/JJR caffeine/NN doses/NNS may/MD be/VB needed/VBN following/VBG coadministration/NN of/IN drugs/NNS that/WDT increase/VBP caffeine/NN elimination/NN (/-LRB- e.g./FW ,/, phenobarbital/NN and/CC phenytoin/NN )/-RRB- ./.

(ROOT (S1 (S (PP (VBN Based) (PP (IN on) (NP (JJ adult) (NNS data)))) (, ,) (S (S (NP (NP (JJR lower) (NNS doses)) (PP (IN of) (NP (NN caffeine)))) (VP (MD may) (VP (VB be) (VP (VBN needed) (PP (VBG following) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (VP (VBN reported) (S (VP (TO to) (VP (VB decrease) (NP (NN caffeine) (NN elimination)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN cimetidine)) (CC and) (NP (NN ketoconazole))) (-RRB- -RRB-))))))))))))))))) (CC and) (S (NP (JJR higher) (NN caffeine) (NNS doses)) (VP (MD may) (VP (VB be) (VP (VBN needed) (PP (VBG following) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP increase) (NP (NP (NN caffeine) (NN elimination)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN phenobarbital)) (CC and) (NP (NN phenytoin)))) (-RRB- -RRB-))))))))))))))) (. .))))

prepc_based_on(needed-12, on-2)
amod(data-4, adult-3)
pobj(needed-12, data-4)
amod(doses-7, lower-6)
nsubjpass(needed-12, doses-7)
prep_of(doses-7, caffeine-9)
aux(needed-12, may-10)
auxpass(needed-12, be-11)
root(ROOT-0, needed-12)
prep_following(needed-12, coadministration-14)
prep_of(coadministration-14, drugs-16)
nsubjpass(reported-19, drugs-16)
auxpass(reported-19, are-18)
rcmod(drugs-16, reported-19)
aux(decrease-21, to-20)
xcomp(reported-19, decrease-21)
nn(elimination-23, caffeine-22)
dobj(decrease-21, elimination-23)
dep(cimetidine-27, e.g.-25)
dep(decrease-21, cimetidine-27)
conj_and(cimetidine-27, ketoconazole-29)
amod(doses-34, higher-32)
nn(doses-34, caffeine-33)
nsubjpass(needed-37, doses-34)
aux(needed-37, may-35)
auxpass(needed-37, be-36)
conj_and(needed-12, needed-37)
prep_following(needed-37, coadministration-39)
prep_of(coadministration-39, drugs-41)
nsubj(increase-43, drugs-41)
rcmod(drugs-41, increase-43)
nn(elimination-45, caffeine-44)
dobj(increase-43, elimination-45)
dep(elimination-45, e.g.-47)
pobj(e.g.-47, phenobarbital-49)
conj_and(phenobarbital-49, phenytoin-51)

Caffeine/NN administered/VBN concurrently/RB with/IN ketoprofen/NN reduced/VBD the/DT urine/NN volume/NN in/IN 4/CD healthy/JJ volunteers/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Caffeine)) (VP (VBN administered) (ADVP (RB concurrently)) (PP (IN with) (NP (NN ketoprofen))))) (VP (VBD reduced) (NP (DT the) (NN urine) (NN volume)) (PP (IN in) (NP (CD 4) (JJ healthy) (NNS volunteers))))) (. .))))

nsubj(reduced-6, Caffeine-1)
partmod(Caffeine-1, administered-2)
advmod(administered-2, concurrently-3)
prep_with(administered-2, ketoprofen-5)
root(ROOT-0, reduced-6)
det(volume-9, the-7)
nn(volume-9, urine-8)
dobj(reduced-6, volume-9)
num(volunteers-13, 4-11)
amod(volunteers-13, healthy-12)
prep_in(reduced-6, volunteers-13)

Interconversion/NN between/IN caffeine/NN and/CC theophylline/NN has/VBZ been/VBN reported/VBN in/IN preterm/NN neonates/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Interconversion)) (PP (IN between) (NP (NP (NN caffeine)) (CC and) (NP (NN theophylline))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NN preterm) (NNS neonates))))))) (. .))))

nsubjpass(reported-8, Interconversion-1)
prep_between(Interconversion-1, caffeine-3)
conj_and(caffeine-3, theophylline-5)
aux(reported-8, has-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
nn(neonates-11, preterm-10)
prep_in(reported-8, neonates-11)

The/DT concurrent/JJ use/NN of/IN these/DT drugs/NNS is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concurrent) (NN use)) (PP (IN of) (NP (DT these) (NNS drugs)))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

det(use-3, The-1)
amod(use-3, concurrent-2)
nsubjpass(recommended-9, use-3)
det(drugs-6, these-5)
prep_of(use-3, drugs-6)
auxpass(recommended-9, is-7)
neg(recommended-9, not-8)
root(ROOT-0, recommended-9)

Interactions/NNS for/IN vitamin/NN D/NN analogues/NNS (/-LRB- Vitamin/NN D2/NN ,/, Vitamin/NN D3/NN ,/, Calcitriol/NN ,/, and/CC Calcidiol/NN )/-RRB- :/: Cholestyramine/NN :/: Cholestyramine/NN has/VBZ been/VBN reported/VBN to/TO reduce/VB intestinal/JJ absorption/NN of/IN fat/JJ soluble/JJ vitamins/NNS ;/: ./.

(ROOT (S1 (S (NP (NP (NP (NNS Interactions)) (PP (IN for) (NP (NP (NN vitamin) (NN D) (NNS analogues)) (PRN (-LRB- -LRB-) (NP (NP (NN Vitamin) (NN D2)) (, ,) (NP (NN Vitamin) (NN D3)) (, ,) (NP (NN Calcitriol)) (, ,) (CC and) (NP (NN Calcidiol))) (-RRB- -RRB-))))) (: :) (NP (NP (NN Cholestyramine)) (: :) (S (NP (NN Cholestyramine)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB reduce) (NP (NP (JJ intestinal) (NN absorption)) (PP (IN of) (NP (JJ fat) (JJ soluble) (NNS vitamins))))))))))) (: ;)) (. .)))))

root(ROOT-0, Interactions-1)
nn(analogues-5, vitamin-3)
nn(analogues-5, D-4)
prep_for(Interactions-1, analogues-5)
nn(D2-8, Vitamin-7)
dep(analogues-5, D2-8)
nn(D3-11, Vitamin-10)
conj_and(D2-8, D3-11)
conj_and(D2-8, Calcitriol-13)
conj_and(D2-8, Calcidiol-16)
dep(Interactions-1, Cholestyramine-19)
nsubjpass(reported-24, Cholestyramine-21)
xsubj(reduce-26, Cholestyramine-21)
aux(reported-24, has-22)
auxpass(reported-24, been-23)
dep(Cholestyramine-19, reported-24)
aux(reduce-26, to-25)
xcomp(reported-24, reduce-26)
amod(absorption-28, intestinal-27)
dobj(reduce-26, absorption-28)
amod(vitamins-32, fat-30)
amod(vitamins-32, soluble-31)
prep_of(absorption-28, vitamins-32)

as/IN such/JJ it/PRP may/MD impair/VB intestinal/JJ absorption/NN of/IN any/DT of/IN vitamin/NN D/NN ./.

(ROOT (S1 (S (S (PP (IN as) (NP (JJ such))) (NP (PRP it)) (VP (MD may) (VP (VB impair) (NP (NP (JJ intestinal) (NN absorption)) (PP (IN of) (NP (NP (DT any)) (PP (IN of) (NP (NN vitamin) (NN D))))))))) (. .))))

prep_such_as(impair-5, such-2)
nsubj(impair-5, it-3)
aux(impair-5, may-4)
root(ROOT-0, impair-5)
amod(absorption-7, intestinal-6)
dobj(impair-5, absorption-7)
prep_of(absorption-7, any-9)
nn(D-12, vitamin-11)
prep_of(any-9, D-12)

Phenytoin/NN //: Phenobarbital/NN :/: The/DT coadministration/NN of/IN phenytoin/NN or/CC phenobarbital/NN will/MD not/RB affect/VB plasma/NN concentrations/NNS of/IN vitamin/NN D/NN ,/, but/CC may/MD reduce/VB endogenous/JJ plasma/NN levels/NNS of/IN calcitriol/NN /ergocalcitriol/NN by/IN accelerating/VBG metabolism/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Phenytoin)) (: /) (NP (NN Phenobarbital)) (: :) (NP (NP (DT The) (NN coadministration)) (PP (IN of) (NP (NP (NN phenytoin)) (CC or) (NP (NN phenobarbital)))))) (VP (MD will) (RB not) (VP (VB affect) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN vitamin) (NN D))))) (, ,) (CC but) (VP (MD may) (VP (VB reduce) (NP (NP (JJ endogenous) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN calcitriol) (NN /ergocalcitriol)))) (PP (IN by) (S (VP (VBG accelerating) (NP (NN metabolism))))))))) (. .))))

nsubj(affect-13, Phenytoin-1)
punct(Phenytoin-1, /-2)
dep(Phenytoin-1, Phenobarbital-3)
det(coadministration-6, The-5)
dep(Phenytoin-1, coadministration-6)
prep_of(coadministration-6, phenytoin-8)
conj_or(phenytoin-8, phenobarbital-10)
aux(affect-13, will-11)
neg(affect-13, not-12)
root(ROOT-0, affect-13)
nn(concentrations-15, plasma-14)
dobj(affect-13, concentrations-15)
nn(D-18, vitamin-17)
prep_of(concentrations-15, D-18)
aux(reduce-22, may-21)
conj_but(affect-13, reduce-22)
amod(levels-25, endogenous-23)
nn(levels-25, plasma-24)
dobj(reduce-22, levels-25)
nn(/ergocalcitriol-28, calcitriol-27)
prep_of(levels-25, /ergocalcitriol-28)
prepc_by(reduce-22, accelerating-30)
dobj(accelerating-30, metabolism-31)

Since/IN blood/NN level/NN of/IN calcitriol/NN /ergocalcitriol/NN will/MD be/VB reduced/VBN ,/, higher/JJR doses/NNS of/IN Rocaltrol/NN may/MD be/VB necessary/JJ if/IN these/DT drugs/NNS are/VBP administered/VBN simultaneously/RB ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NP (NN blood) (NN level)) (PP (IN of) (NP (NN calcitriol) (NN /ergocalcitriol)))) (VP (MD will) (VP (VB be) (VP (VBN reduced)))))) (, ,) (NP (NP (JJR higher) (NNS doses)) (PP (IN of) (NP (NN Rocaltrol)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary)) (SBAR (IN if) (S (NP (DT these) (NNS drugs)) (VP (VBP are) (VP (VBN administered) (ADVP (RB simultaneously))))))))) (. .))))

mark(reduced-9, Since-1)
nn(level-3, blood-2)
nsubjpass(reduced-9, level-3)
nn(/ergocalcitriol-6, calcitriol-5)
prep_of(level-3, /ergocalcitriol-6)
aux(reduced-9, will-7)
auxpass(reduced-9, be-8)
advcl(necessary-17, reduced-9)
amod(doses-12, higher-11)
nsubj(necessary-17, doses-12)
prep_of(doses-12, Rocaltrol-14)
aux(necessary-17, may-15)
cop(necessary-17, be-16)
root(ROOT-0, necessary-17)
mark(administered-22, if-18)
det(drugs-20, these-19)
nsubjpass(administered-22, drugs-20)
auxpass(administered-22, are-21)
advcl(necessary-17, administered-22)
advmod(administered-22, simultaneously-23)

Thiazides/NNS :/: Thiazides/NNS are/VBP known/VBN to/TO induce/VB hypercalcemia/NN by/IN the/DT reduction/NN of/IN calcium/NN excretion/NN in/IN urine/NN ./.

(ROOT (S1 (S (NP (NP (NNS Thiazides)) (: :) (S (NP (NNS Thiazides)) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB induce) (NP (NN hypercalcemia)) (PP (IN by) (NP (NP (DT the) (NN reduction)) (PP (IN of) (NP (NN calcium) (NN excretion))) (PP (IN in) (NP (NN urine))))))))))) (. .)))))

root(ROOT-0, Thiazides-1)
nsubjpass(known-5, Thiazides-3)
xsubj(induce-7, Thiazides-3)
auxpass(known-5, are-4)
dep(Thiazides-1, known-5)
aux(induce-7, to-6)
xcomp(known-5, induce-7)
dobj(induce-7, hypercalcemia-8)
det(reduction-11, the-10)
prep_by(induce-7, reduction-11)
nn(excretion-14, calcium-13)
prep_of(reduction-11, excretion-14)
prep_in(reduction-11, urine-16)

Some/DT reports/NNS have/VBP shown/VBN that/IN the/DT concomitant/JJ administration/NN of/IN thiazides/NNS with/IN vitamin/NN D/NN causes/VBZ hypercalcemia/NN ./.

(ROOT (S1 (S (S (NP (DT Some) (NNS reports)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NNS thiazides))) (PP (IN with) (NP (NN vitamin) (NN D)))) (VP (VBZ causes) (NP (NN hypercalcemia)))))))) (. .))))

det(reports-2, Some-1)
nsubj(shown-4, reports-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
complm(causes-14, that-5)
det(administration-8, the-6)
amod(administration-8, concomitant-7)
nsubj(causes-14, administration-8)
prep_of(administration-8, thiazides-10)
nn(D-13, vitamin-12)
prep_with(administration-8, D-13)
ccomp(shown-4, causes-14)
dobj(causes-14, hypercalcemia-15)

Digitalis/NN :/: Vitamin/NN D/NN dosage/NN must/MD be/VB determined/VBN with/IN care/NN in/IN patients/NNS undergoing/VBG treatment/NN with/IN digitalis/NN ,/, as/IN hypercalcemia/NN in/IN such/JJ patients/NNS may/MD precipitate/VB cardiac/JJ arrhythmias/NNS ./.

(ROOT (S1 (S (NP (NP (NN Digitalis)) (: :) (S (NP (NN Vitamin) (NN D) (NN dosage)) (VP (MD must) (VP (VB be) (VP (VBN determined) (PP (IN with) (NP (NP (NN care)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG undergoing) (NP (NP (NN treatment)) (PP (IN with) (NP (NN digitalis))))))))) (, ,) (SBAR (IN as) (S (NP (NP (NN hypercalcemia)) (PP (IN in) (NP (JJ such) (NNS patients)))) (VP (MD may) (VP (VB precipitate) (NP (JJ cardiac) (NNS arrhythmias)))))))))) (. .)))))

root(ROOT-0, Digitalis-1)
nn(dosage-5, Vitamin-3)
nn(dosage-5, D-4)
nsubjpass(determined-8, dosage-5)
aux(determined-8, must-6)
auxpass(determined-8, be-7)
dep(Digitalis-1, determined-8)
prep_with(determined-8, care-10)
prep_in(care-10, patients-12)
partmod(patients-12, undergoing-13)
dobj(undergoing-13, treatment-14)
prep_with(treatment-14, digitalis-16)
mark(precipitate-24, as-18)
nsubj(precipitate-24, hypercalcemia-19)
amod(patients-22, such-21)
prep_in(hypercalcemia-19, patients-22)
aux(precipitate-24, may-23)
advcl(determined-8, precipitate-24)
amod(arrhythmias-26, cardiac-25)
dobj(precipitate-24, arrhythmias-26)

Ketoconazole/NN :/: Ketoconazole/NN may/MD inhibit/VBP both/CC synthetic/JJ and/CC catabolic/JJ enzymes/NNS of/IN vitamin/NN D/NN ./.

(ROOT (S1 (S (NP (NP (NN Ketoconazole)) (: :) (S (NP (NN Ketoconazole)) (VP (MD may) (VP (VBP inhibit) (NP (NP (ADJP (CC both) (ADJP (JJ synthetic)) (CC and) (ADJP (JJ catabolic))) (NNS enzymes)) (PP (IN of) (NP (NN vitamin) (NN D))))))) (. .)))))

root(ROOT-0, Ketoconazole-1)
nsubj(inhibit-5, Ketoconazole-3)
aux(inhibit-5, may-4)
dep(Ketoconazole-1, inhibit-5)
preconj(synthetic-7, both-6)
amod(enzymes-10, synthetic-7)
conj_and(synthetic-7, catabolic-9)
dobj(inhibit-5, enzymes-10)
nn(D-13, vitamin-12)
prep_of(enzymes-10, D-13)

Reductions/NNS in/IN serum/NN endogenous/JJ vitamin/NN D/NN concentrations/NNS have/VBP been/VBN observed/VBN following/VBG the/DT administration/NN of/IN 300/CD mg/day/NN to/TO 1200/CD mg/day/NN ketoconazole/NN for/IN a/DT week/NN to/TO healthy/JJ men/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Reductions)) (PP (IN in) (NP (NN serum) (NP (JJ endogenous) (NN vitamin) (NN D)) (NNS concentrations)))) (VP (VBP have) (VP (VBN been) (VP (VBN observed) (PP (VBG following) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (CD 300) (NN mg/day))) (PP (TO to) (NP (NP (ADJP (CD 1200) (NN mg/day)) (NN ketoconazole)) (PP (IN for) (NP (NP (DT a) (NN week)) (PP (TO to) (NP (JJ healthy) (NNS men))))))))))))) (. .))))

nsubjpass(observed-10, Reductions-1)
nn(concentrations-7, serum-3)
amod(D-6, endogenous-4)
nn(D-6, vitamin-5)
nn(concentrations-7, D-6)
prep_in(Reductions-1, concentrations-7)
aux(observed-10, have-8)
auxpass(observed-10, been-9)
root(ROOT-0, observed-10)
det(administration-13, the-12)
prep_following(observed-10, administration-13)
num(mg/day-16, 300-15)
prep_of(administration-13, mg/day-16)
number(mg/day-19, 1200-18)
amod(ketoconazole-20, mg/day-19)
prep_to(administration-13, ketoconazole-20)
det(week-23, a-22)
prep_for(ketoconazole-20, week-23)
amod(men-26, healthy-25)
prep_to(week-23, men-26)

However/RB ,/, in/FW vivo/FW drug/NN interaction/NN studies/NNS of/IN ketoconazole/NN with/IN vitamin/NN D/NN have/VBP not/RB been/VBN investigated/VBN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (ADJP (FW in) (FW vivo)) (NN drug) (NN interaction) (NNS studies)) (PP (IN of) (NP (NN ketoconazole))) (PP (IN with) (NP (NN vitamin) (NN D)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN investigated))))) (. .))))

advmod(investigated-16, However-1)
nn(vivo-4, in-3)
amod(studies-7, vivo-4)
nn(studies-7, drug-5)
nn(studies-7, interaction-6)
nsubjpass(investigated-16, studies-7)
prep_of(studies-7, ketoconazole-9)
nn(D-12, vitamin-11)
prep_with(studies-7, D-12)
aux(investigated-16, have-13)
neg(investigated-16, not-14)
auxpass(investigated-16, been-15)
root(ROOT-0, investigated-16)

Corticosteroids/NNS :/: A/DT relationship/NN of/IN functional/JJ antagonism/NN exists/VBZ between/IN vitamin/NN D/NN analogues/NNS ,/, which/WDT promote/VBP calcium/NN absorption/NN ,/, and/CC corticosteroids/NNS ,/, which/WDT inhibit/VBP calcium/NN absorption/NN ./.

(ROOT (S1 (S (NP (NP (NNS Corticosteroids)) (: :) (S (NP (NP (DT A) (NN relationship)) (PP (IN of) (NP (JJ functional) (NN antagonism)))) (VP (VBZ exists) (PP (IN between) (NP (NP (NP (NP (NN vitamin) (NN D) (NNS analogues)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP promote) (NP (NN calcium) (NN absorption))))) (, ,)) (CC and) (NP (NNS corticosteroids))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP inhibit) (NP (NN calcium) (NN absorption))))))))) (. .)))))

root(ROOT-0, Corticosteroids-1)
det(relationship-4, A-3)
nsubj(exists-8, relationship-4)
amod(antagonism-7, functional-6)
prep_of(relationship-4, antagonism-7)
dep(Corticosteroids-1, exists-8)
nn(analogues-12, vitamin-10)
nn(analogues-12, D-11)
prep_between(exists-8, analogues-12)
nsubj(promote-15, analogues-12)
nsubj(inhibit-23, analogues-12)
rcmod(analogues-12, promote-15)
nn(absorption-17, calcium-16)
dobj(promote-15, absorption-17)
conj_and(analogues-12, corticosteroids-20)
rcmod(analogues-12, inhibit-23)
nn(absorption-25, calcium-24)
dobj(inhibit-23, absorption-25)

Phosphate-Binding/JJ Agents/NNS :/: Since/IN vitamin/NN D/NN also/RB has/VBZ an/DT effect/NN on/IN phosphate/NN transport/NN in/IN the/DT intestine/NN ,/, kidneys/NN and/CC bones/NN ,/, the/DT dosage/NN of/IN phosphate-binding/JJ agents/NNS must/MD be/VB adjusted/VBN in/IN accordance/NN with/IN the/DT serum/NN phosphate/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (JJ Phosphate-Binding) (NNS Agents)) (: :) (S (SBAR (IN Since) (S (NP (NN vitamin) (NN D)) (ADVP (RB also)) (VP (VBZ has) (NP (NP (DT an) (NN effect)) (PP (IN on) (NP (NN phosphate) (NN transport)))) (PP (IN in) (NP (DT the) (NP (NP (NN intestine)) (, ,) (NP (NN kidneys)) (CC and) (NP (NN bones)))))))) (, ,) (NP (NP (DT the) (NN dosage)) (PP (IN of) (NP (JJ phosphate-binding) (NNS agents)))) (VP (MD must) (VP (VB be) (VP (VBN adjusted) (PP (IN in) (NP (NP (NN accordance)) (PP (IN with) (NP (DT the) (NN serum) (NN phosphate) (NN concentration))))))))) (. .)))))

amod(Agents-2, Phosphate-Binding-1)
root(ROOT-0, Agents-2)
mark(has-8, Since-4)
nn(D-6, vitamin-5)
nsubj(has-8, D-6)
advmod(has-8, also-7)
advcl(adjusted-29, has-8)
det(effect-10, an-9)
dobj(has-8, effect-10)
nn(transport-13, phosphate-12)
prep_on(effect-10, transport-13)
det(intestine-16, the-15)
prep_in(has-8, intestine-16)
conj_and(intestine-16, kidneys-18)
conj_and(intestine-16, bones-20)
det(dosage-23, the-22)
nsubjpass(adjusted-29, dosage-23)
amod(agents-26, phosphate-binding-25)
prep_of(dosage-23, agents-26)
aux(adjusted-29, must-27)
auxpass(adjusted-29, be-28)
dep(Agents-2, adjusted-29)
det(concentration-36, the-33)
nn(concentration-36, serum-34)
nn(concentration-36, phosphate-35)
prep_in_accordance_with(adjusted-29, concentration-36)

Vitamin/NN D/NN :/: The/DT coadministration/NN of/IN any/DT of/IN the/DT vitamin/NN D/NN analogues/NNS should/MD be/VB avoided/VBN as/IN this/DT could/MD create/VB possible/JJ additive/JJ effects/NNS and/CC hypercalcemia/NN ./.

(ROOT (S1 (S (NP (NP (NN Vitamin) (NN D)) (: :) (S (NP (NP (DT The) (NN coadministration)) (PP (IN of) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (NN vitamin) (NN D) (NNS analogues)))))) (VP (MD should) (VP (VB be) (VP (VBN avoided) (SBAR (IN as) (S (NP (DT this)) (VP (MD could) (VP (VB create) (NP (NP (JJ possible) (JJ additive) (NNS effects)) (CC and) (NP (NN hypercalcemia))))))))))) (. .)))))

nn(D-2, Vitamin-1)
root(ROOT-0, D-2)
det(coadministration-5, The-4)
nsubjpass(avoided-15, coadministration-5)
prep_of(coadministration-5, any-7)
det(analogues-12, the-9)
nn(analogues-12, vitamin-10)
nn(analogues-12, D-11)
prep_of(any-7, analogues-12)
aux(avoided-15, should-13)
auxpass(avoided-15, be-14)
dep(D-2, avoided-15)
mark(create-19, as-16)
nsubj(create-19, this-17)
aux(create-19, could-18)
advcl(avoided-15, create-19)
amod(effects-22, possible-20)
amod(effects-22, additive-21)
dobj(create-19, effects-22)
conj_and(effects-22, hypercalcemia-24)

Calcium/NN Supplements/NNS :/: Uncontrolled/JJ intake/NN of/IN additional/JJ calcium-containing/JJ preparations/NNS should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (NP (NN Calcium) (NNS Supplements)) (: :) (NP (NP (JJ Uncontrolled) (NN intake)) (PP (IN of) (NP (JJ additional) (JJ calcium-containing) (NNS preparations)))) (VP (MD should) (VP (VB be) (VP (VBN avoided))))) (. .))))

nn(Supplements-2, Calcium-1)
nsubjpass(avoided-12, Supplements-2)
amod(intake-5, Uncontrolled-4)
nsubjpass(avoided-12, intake-5)
amod(preparations-9, additional-7)
amod(preparations-9, calcium-containing-8)
prep_of(intake-5, preparations-9)
aux(avoided-12, should-10)
auxpass(avoided-12, be-11)
root(ROOT-0, avoided-12)

Magnesium/NN :/: Magnesium-containing/JJ preparations/NNS (/-LRB- eg/FW ,/, antacids/NNS )/-RRB- may/MD cause/VB hypermagnesemia/NN and/CC should/MD therefore/RB not/RB be/VB taken/VBN during/IN therapy/NN with/IN vitamin/NN D/NN by/IN patients/NNS on/IN chronic/JJ renal/JJ dialysis/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Magnesium)) (: :) (NP (NP (JJ Magnesium-containing) (NNS preparations)) (PRN (-LRB- -LRB-) (PP (FW eg)) (, ,) (NP (NNS antacids)) (-RRB- -RRB-)))) (VP (VP (MD may) (VP (VB cause) (NP (NN hypermagnesemia)))) (CC and) (VP (MD should) (ADVP (RB therefore)) (RB not) (VP (VB be) (VP (VBN taken) (PP (IN during) (NP (NP (NN therapy)) (PP (IN with) (NP (NN vitamin) (NN D))))) (PP (IN by) (NP (NP (NNS patients)) (PP (IN on) (NP (JJ chronic) (JJ renal) (NN dialysis)))))))))) (. .))))

nsubj(cause-11, Magnesium-1)
amod(preparations-4, Magnesium-containing-3)
dep(Magnesium-1, preparations-4)
dep(antacids-8, eg-6)
appos(preparations-4, antacids-8)
aux(cause-11, may-10)
root(ROOT-0, cause-11)
dobj(cause-11, hypermagnesemia-12)
aux(taken-18, should-14)
advmod(taken-18, therefore-15)
neg(taken-18, not-16)
auxpass(taken-18, be-17)
conj_and(cause-11, taken-18)
prep_during(taken-18, therapy-20)
nn(D-23, vitamin-22)
prep_with(therapy-20, D-23)
agent(taken-18, patients-25)
amod(dialysis-29, chronic-27)
amod(dialysis-29, renal-28)
prep_on(patients-25, dialysis-29)

Interactions/NNS for/IN vitamin/NN D/NN analogues/NNS (/-LRB- Vitamin/NN D2/NN ,/, Vitamin/NN D3/NN ,/, Calcitriol/NN ,/, and/CC Calcidiol/NN )/-RRB- :/: Cholestyramine/NN :/: Cholestyramine/NN has/VBZ been/VBN reported/VBN to/TO reduce/VB intestinal/JJ absorption/NN of/IN fat/JJ soluble/JJ vitamins/NNS ;/: ./.

(ROOT (S1 (S (NP (NP (NP (NNS Interactions)) (PP (IN for) (NP (NP (NN vitamin) (NN D) (NNS analogues)) (PRN (-LRB- -LRB-) (NP (NP (NN Vitamin) (NN D2)) (, ,) (NP (NN Vitamin) (NN D3)) (, ,) (NP (NN Calcitriol)) (, ,) (CC and) (NP (NN Calcidiol))) (-RRB- -RRB-))))) (: :) (NP (NP (NN Cholestyramine)) (: :) (S (NP (NN Cholestyramine)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB reduce) (NP (NP (JJ intestinal) (NN absorption)) (PP (IN of) (NP (JJ fat) (JJ soluble) (NNS vitamins))))))))))) (: ;)) (. .)))))

root(ROOT-0, Interactions-1)
nn(analogues-5, vitamin-3)
nn(analogues-5, D-4)
prep_for(Interactions-1, analogues-5)
nn(D2-8, Vitamin-7)
dep(analogues-5, D2-8)
nn(D3-11, Vitamin-10)
conj_and(D2-8, D3-11)
conj_and(D2-8, Calcitriol-13)
conj_and(D2-8, Calcidiol-16)
dep(Interactions-1, Cholestyramine-19)
nsubjpass(reported-24, Cholestyramine-21)
xsubj(reduce-26, Cholestyramine-21)
aux(reported-24, has-22)
auxpass(reported-24, been-23)
dep(Cholestyramine-19, reported-24)
aux(reduce-26, to-25)
xcomp(reported-24, reduce-26)
amod(absorption-28, intestinal-27)
dobj(reduce-26, absorption-28)
amod(vitamins-32, fat-30)
amod(vitamins-32, soluble-31)
prep_of(absorption-28, vitamins-32)

as/IN such/JJ it/PRP may/MD impair/VB intestinal/JJ absorption/NN of/IN any/DT of/IN vitamin/NN D/NN ./.

(ROOT (S1 (S (S (PP (IN as) (NP (JJ such))) (NP (PRP it)) (VP (MD may) (VP (VB impair) (NP (NP (JJ intestinal) (NN absorption)) (PP (IN of) (NP (NP (DT any)) (PP (IN of) (NP (NN vitamin) (NN D))))))))) (. .))))

prep_such_as(impair-5, such-2)
nsubj(impair-5, it-3)
aux(impair-5, may-4)
root(ROOT-0, impair-5)
amod(absorption-7, intestinal-6)
dobj(impair-5, absorption-7)
prep_of(absorption-7, any-9)
nn(D-12, vitamin-11)
prep_of(any-9, D-12)

Phenytoin/NN //: Phenobarbital/NN :/: The/DT coadministration/NN of/IN phenytoin/NN or/CC phenobarbital/NN will/MD not/RB affect/VB plasma/NN concentrations/NNS of/IN vitamin/NN D/NN ,/, but/CC may/MD reduce/VB endogenous/JJ plasma/NN levels/NNS of/IN calcitriol/NN /ergocalcitriol/NN by/IN accelerating/VBG metabolism/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Phenytoin)) (: /) (NP (NN Phenobarbital)) (: :) (NP (NP (DT The) (NN coadministration)) (PP (IN of) (NP (NP (NN phenytoin)) (CC or) (NP (NN phenobarbital)))))) (VP (MD will) (RB not) (VP (VB affect) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN vitamin) (NN D))))) (, ,) (CC but) (VP (MD may) (VP (VB reduce) (NP (NP (JJ endogenous) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN calcitriol) (NN /ergocalcitriol)))) (PP (IN by) (S (VP (VBG accelerating) (NP (NN metabolism))))))))) (. .))))

nsubj(affect-13, Phenytoin-1)
punct(Phenytoin-1, /-2)
dep(Phenytoin-1, Phenobarbital-3)
det(coadministration-6, The-5)
dep(Phenytoin-1, coadministration-6)
prep_of(coadministration-6, phenytoin-8)
conj_or(phenytoin-8, phenobarbital-10)
aux(affect-13, will-11)
neg(affect-13, not-12)
root(ROOT-0, affect-13)
nn(concentrations-15, plasma-14)
dobj(affect-13, concentrations-15)
nn(D-18, vitamin-17)
prep_of(concentrations-15, D-18)
aux(reduce-22, may-21)
conj_but(affect-13, reduce-22)
amod(levels-25, endogenous-23)
nn(levels-25, plasma-24)
dobj(reduce-22, levels-25)
nn(/ergocalcitriol-28, calcitriol-27)
prep_of(levels-25, /ergocalcitriol-28)
prepc_by(reduce-22, accelerating-30)
dobj(accelerating-30, metabolism-31)

Since/IN blood/NN level/NN of/IN calcitriol/NN /ergocalcitriol/NN will/MD be/VB reduced/VBN ,/, higher/JJR doses/NNS of/IN Rocaltrol/NN may/MD be/VB necessary/JJ if/IN these/DT drugs/NNS are/VBP administered/VBN simultaneously/RB ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NP (NN blood) (NN level)) (PP (IN of) (NP (NN calcitriol) (NN /ergocalcitriol)))) (VP (MD will) (VP (VB be) (VP (VBN reduced)))))) (, ,) (NP (NP (JJR higher) (NNS doses)) (PP (IN of) (NP (NN Rocaltrol)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary)) (SBAR (IN if) (S (NP (DT these) (NNS drugs)) (VP (VBP are) (VP (VBN administered) (ADVP (RB simultaneously))))))))) (. .))))

mark(reduced-9, Since-1)
nn(level-3, blood-2)
nsubjpass(reduced-9, level-3)
nn(/ergocalcitriol-6, calcitriol-5)
prep_of(level-3, /ergocalcitriol-6)
aux(reduced-9, will-7)
auxpass(reduced-9, be-8)
advcl(necessary-17, reduced-9)
amod(doses-12, higher-11)
nsubj(necessary-17, doses-12)
prep_of(doses-12, Rocaltrol-14)
aux(necessary-17, may-15)
cop(necessary-17, be-16)
root(ROOT-0, necessary-17)
mark(administered-22, if-18)
det(drugs-20, these-19)
nsubjpass(administered-22, drugs-20)
auxpass(administered-22, are-21)
advcl(necessary-17, administered-22)
advmod(administered-22, simultaneously-23)

Thiazides/NNS :/: Thiazides/NNS are/VBP known/VBN to/TO induce/VB hypercalcemia/NN by/IN the/DT reduction/NN of/IN calcium/NN excretion/NN in/IN urine/NN ./.

(ROOT (S1 (S (NP (NP (NNS Thiazides)) (: :) (S (NP (NNS Thiazides)) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB induce) (NP (NN hypercalcemia)) (PP (IN by) (NP (NP (DT the) (NN reduction)) (PP (IN of) (NP (NN calcium) (NN excretion))) (PP (IN in) (NP (NN urine))))))))))) (. .)))))

root(ROOT-0, Thiazides-1)
nsubjpass(known-5, Thiazides-3)
xsubj(induce-7, Thiazides-3)
auxpass(known-5, are-4)
dep(Thiazides-1, known-5)
aux(induce-7, to-6)
xcomp(known-5, induce-7)
dobj(induce-7, hypercalcemia-8)
det(reduction-11, the-10)
prep_by(induce-7, reduction-11)
nn(excretion-14, calcium-13)
prep_of(reduction-11, excretion-14)
prep_in(reduction-11, urine-16)

Some/DT reports/NNS have/VBP shown/VBN that/IN the/DT concomitant/JJ administration/NN of/IN thiazides/NNS with/IN vitamin/NN D/NN causes/VBZ hypercalcemia/NN ./.

(ROOT (S1 (S (S (NP (DT Some) (NNS reports)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NNS thiazides))) (PP (IN with) (NP (NN vitamin) (NN D)))) (VP (VBZ causes) (NP (NN hypercalcemia)))))))) (. .))))

det(reports-2, Some-1)
nsubj(shown-4, reports-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
complm(causes-14, that-5)
det(administration-8, the-6)
amod(administration-8, concomitant-7)
nsubj(causes-14, administration-8)
prep_of(administration-8, thiazides-10)
nn(D-13, vitamin-12)
prep_with(administration-8, D-13)
ccomp(shown-4, causes-14)
dobj(causes-14, hypercalcemia-15)

Digitalis/NN :/: Vitamin/NN D/NN dosage/NN must/MD be/VB determined/VBN with/IN care/NN in/IN patients/NNS undergoing/VBG treatment/NN with/IN digitalis/NN ,/, as/IN hypercalcemia/NN in/IN such/JJ patients/NNS may/MD precipitate/VB cardiac/JJ arrhythmias/NNS ./.

(ROOT (S1 (S (NP (NP (NN Digitalis)) (: :) (S (NP (NN Vitamin) (NN D) (NN dosage)) (VP (MD must) (VP (VB be) (VP (VBN determined) (PP (IN with) (NP (NP (NN care)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG undergoing) (NP (NP (NN treatment)) (PP (IN with) (NP (NN digitalis))))))))) (, ,) (SBAR (IN as) (S (NP (NP (NN hypercalcemia)) (PP (IN in) (NP (JJ such) (NNS patients)))) (VP (MD may) (VP (VB precipitate) (NP (JJ cardiac) (NNS arrhythmias)))))))))) (. .)))))

root(ROOT-0, Digitalis-1)
nn(dosage-5, Vitamin-3)
nn(dosage-5, D-4)
nsubjpass(determined-8, dosage-5)
aux(determined-8, must-6)
auxpass(determined-8, be-7)
dep(Digitalis-1, determined-8)
prep_with(determined-8, care-10)
prep_in(care-10, patients-12)
partmod(patients-12, undergoing-13)
dobj(undergoing-13, treatment-14)
prep_with(treatment-14, digitalis-16)
mark(precipitate-24, as-18)
nsubj(precipitate-24, hypercalcemia-19)
amod(patients-22, such-21)
prep_in(hypercalcemia-19, patients-22)
aux(precipitate-24, may-23)
advcl(determined-8, precipitate-24)
amod(arrhythmias-26, cardiac-25)
dobj(precipitate-24, arrhythmias-26)

Ketoconazole/NN :/: Ketoconazole/NN may/MD inhibit/VBP both/CC synthetic/JJ and/CC catabolic/JJ enzymes/NNS of/IN vitamin/NN D/NN ./.

(ROOT (S1 (S (NP (NP (NN Ketoconazole)) (: :) (S (NP (NN Ketoconazole)) (VP (MD may) (VP (VBP inhibit) (NP (NP (ADJP (CC both) (ADJP (JJ synthetic)) (CC and) (ADJP (JJ catabolic))) (NNS enzymes)) (PP (IN of) (NP (NN vitamin) (NN D))))))) (. .)))))

root(ROOT-0, Ketoconazole-1)
nsubj(inhibit-5, Ketoconazole-3)
aux(inhibit-5, may-4)
dep(Ketoconazole-1, inhibit-5)
preconj(synthetic-7, both-6)
amod(enzymes-10, synthetic-7)
conj_and(synthetic-7, catabolic-9)
dobj(inhibit-5, enzymes-10)
nn(D-13, vitamin-12)
prep_of(enzymes-10, D-13)

Reductions/NNS in/IN serum/NN endogenous/JJ vitamin/NN D/NN concentrations/NNS have/VBP been/VBN observed/VBN following/VBG the/DT administration/NN of/IN 300/CD mg/day/NN to/TO 1200/CD mg/day/NN ketoconazole/NN for/IN a/DT week/NN to/TO healthy/JJ men/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Reductions)) (PP (IN in) (NP (NN serum) (NP (JJ endogenous) (NN vitamin) (NN D)) (NNS concentrations)))) (VP (VBP have) (VP (VBN been) (VP (VBN observed) (PP (VBG following) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (CD 300) (NN mg/day))) (PP (TO to) (NP (NP (ADJP (CD 1200) (NN mg/day)) (NN ketoconazole)) (PP (IN for) (NP (NP (DT a) (NN week)) (PP (TO to) (NP (JJ healthy) (NNS men))))))))))))) (. .))))

nsubjpass(observed-10, Reductions-1)
nn(concentrations-7, serum-3)
amod(D-6, endogenous-4)
nn(D-6, vitamin-5)
nn(concentrations-7, D-6)
prep_in(Reductions-1, concentrations-7)
aux(observed-10, have-8)
auxpass(observed-10, been-9)
root(ROOT-0, observed-10)
det(administration-13, the-12)
prep_following(observed-10, administration-13)
num(mg/day-16, 300-15)
prep_of(administration-13, mg/day-16)
number(mg/day-19, 1200-18)
amod(ketoconazole-20, mg/day-19)
prep_to(administration-13, ketoconazole-20)
det(week-23, a-22)
prep_for(ketoconazole-20, week-23)
amod(men-26, healthy-25)
prep_to(week-23, men-26)

However/RB ,/, in/FW vivo/FW drug/NN interaction/NN studies/NNS of/IN ketoconazole/NN with/IN vitamin/NN D/NN have/VBP not/RB been/VBN investigated/VBN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (ADJP (FW in) (FW vivo)) (NN drug) (NN interaction) (NNS studies)) (PP (IN of) (NP (NN ketoconazole))) (PP (IN with) (NP (NN vitamin) (NN D)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN investigated))))) (. .))))

advmod(investigated-16, However-1)
nn(vivo-4, in-3)
amod(studies-7, vivo-4)
nn(studies-7, drug-5)
nn(studies-7, interaction-6)
nsubjpass(investigated-16, studies-7)
prep_of(studies-7, ketoconazole-9)
nn(D-12, vitamin-11)
prep_with(studies-7, D-12)
aux(investigated-16, have-13)
neg(investigated-16, not-14)
auxpass(investigated-16, been-15)
root(ROOT-0, investigated-16)

Corticosteroids/NNS :/: A/DT relationship/NN of/IN functional/JJ antagonism/NN exists/VBZ between/IN vitamin/NN D/NN analogues/NNS ,/, which/WDT promote/VBP calcium/NN absorption/NN ,/, and/CC corticosteroids/NNS ,/, which/WDT inhibit/VBP calcium/NN absorption/NN ./.

(ROOT (S1 (S (NP (NP (NNS Corticosteroids)) (: :) (S (NP (NP (DT A) (NN relationship)) (PP (IN of) (NP (JJ functional) (NN antagonism)))) (VP (VBZ exists) (PP (IN between) (NP (NP (NP (NP (NN vitamin) (NN D) (NNS analogues)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP promote) (NP (NN calcium) (NN absorption))))) (, ,)) (CC and) (NP (NNS corticosteroids))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP inhibit) (NP (NN calcium) (NN absorption))))))))) (. .)))))

root(ROOT-0, Corticosteroids-1)
det(relationship-4, A-3)
nsubj(exists-8, relationship-4)
amod(antagonism-7, functional-6)
prep_of(relationship-4, antagonism-7)
dep(Corticosteroids-1, exists-8)
nn(analogues-12, vitamin-10)
nn(analogues-12, D-11)
prep_between(exists-8, analogues-12)
nsubj(promote-15, analogues-12)
nsubj(inhibit-23, analogues-12)
rcmod(analogues-12, promote-15)
nn(absorption-17, calcium-16)
dobj(promote-15, absorption-17)
conj_and(analogues-12, corticosteroids-20)
rcmod(analogues-12, inhibit-23)
nn(absorption-25, calcium-24)
dobj(inhibit-23, absorption-25)

Phosphate-Binding/JJ Agents/NNS :/: Since/IN vitamin/NN D/NN also/RB has/VBZ an/DT effect/NN on/IN phosphate/NN transport/NN in/IN the/DT intestine/NN ,/, kidneys/NN and/CC bones/NN ,/, the/DT dosage/NN of/IN phosphate-binding/JJ agents/NNS must/MD be/VB adjusted/VBN in/IN accordance/NN with/IN the/DT serum/NN phosphate/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (JJ Phosphate-Binding) (NNS Agents)) (: :) (S (SBAR (IN Since) (S (NP (NN vitamin) (NN D)) (ADVP (RB also)) (VP (VBZ has) (NP (NP (DT an) (NN effect)) (PP (IN on) (NP (NN phosphate) (NN transport)))) (PP (IN in) (NP (DT the) (NP (NP (NN intestine)) (, ,) (NP (NN kidneys)) (CC and) (NP (NN bones)))))))) (, ,) (NP (NP (DT the) (NN dosage)) (PP (IN of) (NP (JJ phosphate-binding) (NNS agents)))) (VP (MD must) (VP (VB be) (VP (VBN adjusted) (PP (IN in) (NP (NP (NN accordance)) (PP (IN with) (NP (DT the) (NN serum) (NN phosphate) (NN concentration))))))))) (. .)))))

amod(Agents-2, Phosphate-Binding-1)
root(ROOT-0, Agents-2)
mark(has-8, Since-4)
nn(D-6, vitamin-5)
nsubj(has-8, D-6)
advmod(has-8, also-7)
advcl(adjusted-29, has-8)
det(effect-10, an-9)
dobj(has-8, effect-10)
nn(transport-13, phosphate-12)
prep_on(effect-10, transport-13)
det(intestine-16, the-15)
prep_in(has-8, intestine-16)
conj_and(intestine-16, kidneys-18)
conj_and(intestine-16, bones-20)
det(dosage-23, the-22)
nsubjpass(adjusted-29, dosage-23)
amod(agents-26, phosphate-binding-25)
prep_of(dosage-23, agents-26)
aux(adjusted-29, must-27)
auxpass(adjusted-29, be-28)
dep(Agents-2, adjusted-29)
det(concentration-36, the-33)
nn(concentration-36, serum-34)
nn(concentration-36, phosphate-35)
prep_in_accordance_with(adjusted-29, concentration-36)

Vitamin/NN D/NN :/: The/DT coadministration/NN of/IN any/DT of/IN the/DT vitamin/NN D/NN analogues/NNS should/MD be/VB avoided/VBN as/IN this/DT could/MD create/VB possible/JJ additive/JJ effects/NNS and/CC hypercalcemia/NN ./.

(ROOT (S1 (S (NP (NP (NN Vitamin) (NN D)) (: :) (S (NP (NP (DT The) (NN coadministration)) (PP (IN of) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (NN vitamin) (NN D) (NNS analogues)))))) (VP (MD should) (VP (VB be) (VP (VBN avoided) (SBAR (IN as) (S (NP (DT this)) (VP (MD could) (VP (VB create) (NP (NP (JJ possible) (JJ additive) (NNS effects)) (CC and) (NP (NN hypercalcemia))))))))))) (. .)))))

nn(D-2, Vitamin-1)
root(ROOT-0, D-2)
det(coadministration-5, The-4)
nsubjpass(avoided-15, coadministration-5)
prep_of(coadministration-5, any-7)
det(analogues-12, the-9)
nn(analogues-12, vitamin-10)
nn(analogues-12, D-11)
prep_of(any-7, analogues-12)
aux(avoided-15, should-13)
auxpass(avoided-15, be-14)
dep(D-2, avoided-15)
mark(create-19, as-16)
nsubj(create-19, this-17)
aux(create-19, could-18)
advcl(avoided-15, create-19)
amod(effects-22, possible-20)
amod(effects-22, additive-21)
dobj(create-19, effects-22)
conj_and(effects-22, hypercalcemia-24)

Calcium/NN Supplements/NNS :/: Uncontrolled/JJ intake/NN of/IN additional/JJ calcium-containing/JJ preparations/NNS should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (NP (NN Calcium) (NNS Supplements)) (: :) (NP (NP (JJ Uncontrolled) (NN intake)) (PP (IN of) (NP (JJ additional) (JJ calcium-containing) (NNS preparations)))) (VP (MD should) (VP (VB be) (VP (VBN avoided))))) (. .))))

nn(Supplements-2, Calcium-1)
nsubjpass(avoided-12, Supplements-2)
amod(intake-5, Uncontrolled-4)
nsubjpass(avoided-12, intake-5)
amod(preparations-9, additional-7)
amod(preparations-9, calcium-containing-8)
prep_of(intake-5, preparations-9)
aux(avoided-12, should-10)
auxpass(avoided-12, be-11)
root(ROOT-0, avoided-12)

Magnesium/NN :/: Magnesium-containing/JJ preparations/NNS (/-LRB- eg/FW ,/, antacids/NNS )/-RRB- may/MD cause/VB hypermagnesemia/NN and/CC should/MD therefore/RB not/RB be/VB taken/VBN during/IN therapy/NN with/IN vitamin/NN D/NN by/IN patients/NNS on/IN chronic/JJ renal/JJ dialysis/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Magnesium)) (: :) (NP (NP (JJ Magnesium-containing) (NNS preparations)) (PRN (-LRB- -LRB-) (PP (FW eg)) (, ,) (NP (NNS antacids)) (-RRB- -RRB-)))) (VP (VP (MD may) (VP (VB cause) (NP (NN hypermagnesemia)))) (CC and) (VP (MD should) (ADVP (RB therefore)) (RB not) (VP (VB be) (VP (VBN taken) (PP (IN during) (NP (NP (NN therapy)) (PP (IN with) (NP (NN vitamin) (NN D))))) (PP (IN by) (NP (NP (NNS patients)) (PP (IN on) (NP (JJ chronic) (JJ renal) (NN dialysis)))))))))) (. .))))

nsubj(cause-11, Magnesium-1)
amod(preparations-4, Magnesium-containing-3)
dep(Magnesium-1, preparations-4)
dep(antacids-8, eg-6)
appos(preparations-4, antacids-8)
aux(cause-11, may-10)
root(ROOT-0, cause-11)
dobj(cause-11, hypermagnesemia-12)
aux(taken-18, should-14)
advmod(taken-18, therefore-15)
neg(taken-18, not-16)
auxpass(taken-18, be-17)
conj_and(cause-11, taken-18)
prep_during(taken-18, therapy-20)
nn(D-23, vitamin-22)
prep_with(therapy-20, D-23)
agent(taken-18, patients-25)
amod(dialysis-29, chronic-27)
amod(dialysis-29, renal-28)
prep_on(patients-25, dialysis-29)

Concomitant/JJ use/NN with/IN other/JJ calcium/NN -containing/JJ medicines/NNS (/-LRB- including/VBG antacids/NNS )/-RRB- may/MD cause/VB too/RB much/JJ calcium/NN in/IN the/DT blood/NN or/CC urine/NN ,/, which/WDT may/MD increase/VB the/DT chance/NN of/IN side/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN with) (NP (NP (JJ other) (NN calcium) (JJ -containing) (NNS medicines)) (PRN (-LRB- -LRB-) (NP (VBG including) (NNS antacids)) (-RRB- -RRB-))))) (VP (MD may) (VP (VB cause) (NP (ADJP (RB too) (JJ much)) (NN calcium)) (PP (IN in) (NP (NP (DT the) (NP (NN blood)) (CC or) (NP (NN urine))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN chance)) (PP (IN of) (NP (JJ side) (NNS effects))))))))))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(cause-13, use-2)
amod(medicines-7, other-4)
nn(medicines-7, calcium-5)
amod(medicines-7, -containing-6)
prep_with(use-2, medicines-7)
amod(antacids-10, including-9)
appos(medicines-7, antacids-10)
aux(cause-13, may-12)
root(ROOT-0, cause-13)
advmod(much-15, too-14)
amod(calcium-16, much-15)
dobj(cause-13, calcium-16)
dep(blood-19, the-18)
prep_in(cause-13, blood-19)
nsubj(increase-25, blood-19)
conj_or(blood-19, urine-21)
aux(increase-25, may-24)
rcmod(blood-19, increase-25)
det(chance-27, the-26)
dobj(increase-25, chance-27)
amod(effects-30, side-29)
prep_of(chance-27, effects-30)

Using/VBG calcium/NN acetate/NN with/IN digitalis/NN glycosides/NNS (/-LRB- heart/NN medicine/NN )/-RRB- may/MD cause/VB hypercalcemia/NN (/-LRB- too/RB much/JJ calcium/NN in/IN the/DT blood/NN )/-RRB- ,/, which/WDT could/MD increase/VB the/DT chance/NN of/IN developing/VBG an/DT irregular/JJ heartbeat/NN ./.

(ROOT (S1 (S (S (S (VP (VBG Using) (NP (NP (NN calcium) (NN acetate)) (PP (IN with) (NP (NP (NN digitalis) (NNS glycosides)) (PRN (-LRB- -LRB-) (NP (NN heart) (NN medicine)) (-RRB- -RRB-))))))) (VP (MD may) (VP (VB cause) (NP (NP (NP (NN hypercalcemia)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (RB too) (JJ much)) (NN calcium)) (PP (IN in) (NP (DT the) (NN blood)))) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD could) (VP (VB increase) (NP (NP (DT the) (NN chance)) (PP (IN of) (S (VP (VBG developing) (NP (DT an) (JJ irregular) (NN heartbeat)))))))))))))) (. .))))

csubj(cause-12, Using-1)
nn(acetate-3, calcium-2)
dobj(Using-1, acetate-3)
nn(glycosides-6, digitalis-5)
prep_with(acetate-3, glycosides-6)
nn(medicine-9, heart-8)
appos(glycosides-6, medicine-9)
aux(cause-12, may-11)
root(ROOT-0, cause-12)
dobj(cause-12, hypercalcemia-13)
nsubj(increase-25, hypercalcemia-13)
advmod(much-16, too-15)
amod(calcium-17, much-16)
dep(hypercalcemia-13, calcium-17)
det(blood-20, the-19)
prep_in(calcium-17, blood-20)
aux(increase-25, could-24)
rcmod(hypercalcemia-13, increase-25)
det(chance-27, the-26)
dobj(increase-25, chance-27)
prepc_of(chance-27, developing-29)
det(heartbeat-32, an-30)
amod(heartbeat-32, irregular-31)
dobj(developing-29, heartbeat-32)

May/MD interact/VB with/IN cefamandole/NN naftate/NN ,/, cephalothin/NN sodium/NN ,/, magnesium/NN sulfate/NN ,/, prednisolone/NN sodium/NN succi/NN @/NN nate/NN ,/, and/CC prochlorperazine/NN edisylate/NN ./.

(ROOT (S1 (S (S (VP (MD May) (VP (VB interact) (PP (IN with) (NP (NP (NN cefamandole) (NN naftate)) (, ,) (NP (NN cephalothin) (NN sodium)) (, ,) (NP (NN magnesium) (NN sulfate)) (, ,) (NP (NN prednisolone) (NN sodium) (NN succi) (NN @) (NN nate)) (, ,) (CC and) (NP (NN prochlorperazine) (NN edisylate))))))) (. .))))

aux(interact-2, May-1)
root(ROOT-0, interact-2)
nn(naftate-5, cefamandole-4)
prep_with(interact-2, naftate-5)
nn(sodium-8, cephalothin-7)
conj_and(naftate-5, sodium-8)
nn(sulfate-11, magnesium-10)
conj_and(naftate-5, sulfate-11)
nn(nate-17, prednisolone-13)
nn(nate-17, sodium-14)
nn(nate-17, succi-15)
nn(nate-17, @-16)
conj_and(naftate-5, nate-17)
nn(edisylate-21, prochlorperazine-20)
conj_and(naftate-5, edisylate-21)

Antacid/JJ :/: The/DT effect/NN of/IN an/DT aluminum/NN hydroxide/NN -/: and/CC magnesium/NN hydroxide-containing/JJ antacid/JJ (/-LRB- Maalox/NN )/-RRB- */NN on/IN the/DT pharmacokinetics/NNS of/IN capecitabine/NN was/VBD investigated/VBN in/IN 12/CD cancer/NN patients/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Antacid) (: :) (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (DT an) (NN aluminum) (NN hydroxide)))) (: -) (CC and) (NP (NN magnesium))) (NP (JJ hydroxide-containing) (JJ antacid) (-LRB- -LRB-) (NN Maalox) (-RRB- -RRB-) (NN *))) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN capecitabine)))))) (VP (VBD was) (VP (VBN investigated) (PP (IN in) (NP (CD 12) (NN cancer) (NNS patients)))))) (. .))))

amod(effect-4, Antacid-1)
det(effect-4, The-3)
nsubjpass(investigated-24, effect-4)
det(hydroxide-8, an-6)
nn(hydroxide-8, aluminum-7)
prep_of(effect-4, hydroxide-8)
conj_and(effect-4, magnesium-11)
amod(*-17, hydroxide-containing-12)
amod(*-17, antacid-13)
nn(*-17, Maalox-15)
dep(effect-4, *-17)
det(pharmacokinetics-20, the-19)
prep_on(effect-4, pharmacokinetics-20)
prep_of(pharmacokinetics-20, capecitabine-22)
auxpass(investigated-24, was-23)
root(ROOT-0, investigated-24)
num(patients-28, 12-26)
nn(patients-28, cancer-27)
prep_in(investigated-24, patients-28)

There/EX was/VBD a/DT small/JJ increase/NN in/IN plasma/NN concentrations/NNS of/IN capecitabine/NN and/CC one/CD metabolite/NN (/-LRB- 5-DFCR/NN )/-RRB- ;/: ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBD was) (NP (NP (NP (DT a) (JJ small) (NN increase)) (PP (IN in) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN capecitabine)))))) (CC and) (NP (NP (CD one) (NN metabolite)) (PRN (-LRB- -LRB-) (NP (NN 5-DFCR)) (-RRB- -RRB-))))) (: ;)) (. .))))

expl(was-2, There-1)
root(ROOT-0, was-2)
det(increase-5, a-3)
amod(increase-5, small-4)
nsubj(was-2, increase-5)
nn(concentrations-8, plasma-7)
prep_in(increase-5, concentrations-8)
prep_of(concentrations-8, capecitabine-10)
num(metabolite-13, one-12)
conj_and(increase-5, metabolite-13)
appos(metabolite-13, 5-DFCR-15)

there/EX was/VBD no/DT effect/NN on/IN the/DT 3/CD major/JJ metabolites/NNS (/-LRB- 5-DFUR/NN ,/, 5-FU/NN and/CC FBAL/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (CD 3) (JJ major) (NNS metabolites)) (PRN (-LRB- -LRB-) (NP (NP (NN 5-DFUR)) (, ,) (NP (NN 5-FU)) (CC and) (NP (NN FBAL))) (-RRB- -RRB-))))))) (. .))))

expl(was-2, there-1)
root(ROOT-0, was-2)
det(effect-4, no-3)
nsubj(was-2, effect-4)
det(metabolites-9, the-6)
num(metabolites-9, 3-7)
amod(metabolites-9, major-8)
prep_on(effect-4, metabolites-9)
dep(metabolites-9, 5-DFUR-11)
conj_and(5-DFUR-11, 5-FU-13)
conj_and(5-DFUR-11, FBAL-15)

Coumarin/JJ Anticoagulant/JJ s/NN Altered/JJ coagulation/NN parameters/NNS and/or/CC bleeding/JJ have/VBP been/VBN reported/VBN in/IN patients/NNS taking/VBG capecitabine/NN concomitantly/RB with/IN coumarin-derivative/JJ anticoagulants/NNS such/JJ as/IN warfarin/NN and/CC phenprocoumon/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Coumarin) (JJ Anticoagulant) (NN s) (JJ Altered) (NN coagulation) (NNS parameters)) (CC and/or) (NP (ADJP (JJ bleeding)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (NN capecitabine)) (PP (ADVP (RB concomitantly)) (IN with) (NP (NP (JJ coumarin-derivative) (NNS anticoagulants)) (PP (JJ such) (IN as) (NP (NP (NN warfarin)) (CC and) (NP (NN phenprocoumon)))))))))))))) (. .))))

amod(parameters-6, Coumarin-1)
amod(parameters-6, Anticoagulant-2)
nn(parameters-6, s-3)
amod(parameters-6, Altered-4)
nn(parameters-6, coagulation-5)
nsubjpass(reported-11, parameters-6)
conj_and/or(parameters-6, bleeding-8)
aux(reported-11, have-9)
auxpass(reported-11, been-10)
root(ROOT-0, reported-11)
prep_in(reported-11, patients-13)
partmod(patients-13, taking-14)
dobj(taking-14, capecitabine-15)
advmod(capecitabine-15, concomitantly-16)
amod(anticoagulants-19, coumarin-derivative-18)
prep_with(capecitabine-15, anticoagulants-19)
prep_such_as(anticoagulants-19, warfarin-22)
conj_and(warfarin-22, phenprocoumon-24)

Patients/NNS taking/VBG coumarin-derivative/JJ anticoagulants/NNS concomitantly/RB with/IN capecitabine/NN should/MD be/VB monitored/VBN regularly/RB for/IN alterations/NNS in/IN their/PRP$ coagulation/NN parameters/NNS (/-LRB- PT/NN or/CC INR/NN )./NN

(ROOT (S1 (S (NP (NP (NP (NNS Patients)) (VP (VBG taking) (NP (JJ coumarin-derivative) (NNS anticoagulants)))) (PP (ADVP (RB concomitantly)) (IN with) (NP (NN capecitabine)))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB regularly)) (PP (IN for) (NP (NP (NNS alterations)) (PP (IN in) (NP (PRP$ their) (NN coagulation) (NNS parameters)))))))) (PRN (-LRB- -LRB-) (NP (NP (NN PT)) (CC or) (NP (NN INR) (NN -RRB-.)))))))

nsubjpass(monitored-10, Patients-1)
partmod(Patients-1, taking-2)
amod(anticoagulants-4, coumarin-derivative-3)
dobj(taking-2, anticoagulants-4)
advmod(Patients-1, concomitantly-5)
prep_with(Patients-1, capecitabine-7)
aux(monitored-10, should-8)
auxpass(monitored-10, be-9)
root(ROOT-0, monitored-10)
advmod(monitored-10, regularly-11)
prep_for(monitored-10, alterations-13)
poss(parameters-17, their-15)
nn(parameters-17, coagulation-16)
prep_in(alterations-13, parameters-17)
dep(monitored-10, PT-19)
nn(-RRB-.-22, INR-21)
conj_or(PT-19, -RRB-.-22)

Leucovorin/NN :/: The/DT concentration/NN of/IN 5-/CD fluorouracil/NN is/VBZ increased/VBN and/CC its/PRP$ toxicity/NN may/MD be/VB enhanced/VBN by/IN leucovorin/NN ./.

(ROOT (S1 (S (NP (NP (NN Leucovorin)) (: :) (S (S (NP (NP (DT The) (NN concentration)) (PP (IN of) (NP (CD 5-) (NN fluorouracil)))) (VP (VBZ is) (VP (VBN increased)))) (CC and) (S (NP (PRP$ its) (NN toxicity)) (VP (MD may) (VP (VB be) (VP (VBN enhanced) (PP (IN by) (NP (NN leucovorin)))))))) (. .)))))

root(ROOT-0, Leucovorin-1)
det(concentration-4, The-3)
nsubjpass(increased-9, concentration-4)
num(fluorouracil-7, 5--6)
prep_of(concentration-4, fluorouracil-7)
auxpass(increased-9, is-8)
dep(Leucovorin-1, increased-9)
poss(toxicity-12, its-11)
nsubjpass(enhanced-15, toxicity-12)
aux(enhanced-15, may-13)
auxpass(enhanced-15, be-14)
conj_and(increased-9, enhanced-15)
agent(enhanced-15, leucovorin-17)

Deaths/NNS from/IN severe/JJ enterocolitis/NN ,/, diarrhea/NN ,/, and/CC dehydration/NN have/VBP been/VBN reported/VBN in/IN elderly/JJ patients/NNS receiving/VBG weekly/RB leucovorin/NN and/CC fluorouracil/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Deaths)) (PP (IN from) (NP (NP (JJ severe) (NN enterocolitis)) (, ,) (NP (NN diarrhea)) (, ,) (CC and) (NP (NN dehydration))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (JJ elderly) (NNS patients)) (VP (VBG receiving) (ADVP (RB weekly)) (NP (NP (NN leucovorin)) (CC and) (NP (NN fluorouracil)))))))))) (. .))))

nsubjpass(reported-12, Deaths-1)
amod(enterocolitis-4, severe-3)
prep_from(Deaths-1, enterocolitis-4)
conj_and(enterocolitis-4, diarrhea-6)
conj_and(enterocolitis-4, dehydration-9)
aux(reported-12, have-10)
auxpass(reported-12, been-11)
root(ROOT-0, reported-12)
amod(patients-15, elderly-14)
prep_in(reported-12, patients-15)
partmod(patients-15, receiving-16)
advmod(receiving-16, weekly-17)
dobj(receiving-16, leucovorin-18)
conj_and(leucovorin-18, fluorouracil-20)

Hypotension/NN @/NN Patients/NNS on/IN Diuretic/JJ Therapy/NN :/: Patients/NNS on/IN diuretics/NN and/CC especially/RB those/DT in/IN whom/WP diuretic/JJ therapy/NN was/VBD recently/RB instituted/VBN ,/, as/RB well/RB as/IN those/DT on/IN severe/JJ dietary/JJ salt/NN restriction/NN or/CC dialysis/NN ,/, may/MD occasionally/RB experience/VBP a/DT precipitous/JJ reduction/NN of/IN blood/NN pressure/NN usually/RB within/IN the/DT first/JJ hour/NN after/IN receiving/VBG the/DT initial/JJ dose/NN of/IN captopril/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Hypotension) (NN @) (NNS Patients)) (PP (IN on) (NP (JJ Diuretic) (NN Therapy)))) (: :) (NP (NP (NP (NNS Patients)) (PP (IN on) (NP (NN diuretics)))) (CC and) (ADVP (RB especially)) (NP (NP (DT those)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (JJ diuretic) (NN therapy)) (VP (VBD was) (ADVP (RB recently)) (VP (VBN instituted))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT those)) (PP (IN on) (NP (NP (JJ severe) (JJ dietary) (NN salt) (NN restriction)) (CC or) (NP (NN dialysis))))) (, ,)) (VP (MD may) (ADVP (RB occasionally)) (VP (VBP experience) (NP (NP (DT a) (JJ precipitous) (NN reduction)) (PP (IN of) (NP (NN blood) (NN pressure)))) (ADVP (RB usually)) (PP (IN within) (NP (NP (DT the) (JJ first) (NN hour)) (PP (IN after) (S (VP (VBG receiving) (NP (NP (DT the) (JJ initial) (NN dose)) (PP (IN of) (NP (NN captopril)))))))))))) (. .))))

nn(Patients-3, Hypotension-1)
nn(Patients-3, @-2)
nsubj(experience-36, Patients-3)
amod(Therapy-6, Diuretic-5)
prep_on(Patients-3, Therapy-6)
conj_and(Patients-3, Patients-8)
prep_on(Patients-8, diuretics-10)
advmod(Patients-8, especially-12)
conj_and(Patients-8, especially-12)
conj_and(Patients-8, those-13)
rel(instituted-20, whom-15)
amod(therapy-17, diuretic-16)
nsubjpass(instituted-20, therapy-17)
auxpass(instituted-20, was-18)
advmod(instituted-20, recently-19)
rcmod(those-13, instituted-20)
conj_and(Patients-3, those-25)
amod(restriction-30, severe-27)
amod(restriction-30, dietary-28)
nn(restriction-30, salt-29)
prep_on(those-25, restriction-30)
conj_or(restriction-30, dialysis-32)
aux(experience-36, may-34)
advmod(experience-36, occasionally-35)
root(ROOT-0, experience-36)
det(reduction-39, a-37)
amod(reduction-39, precipitous-38)
dobj(experience-36, reduction-39)
nn(pressure-42, blood-41)
prep_of(reduction-39, pressure-42)
advmod(experience-36, usually-43)
det(hour-47, the-45)
amod(hour-47, first-46)
prep_within(experience-36, hour-47)
prepc_after(hour-47, receiving-49)
det(dose-52, the-50)
amod(dose-52, initial-51)
dobj(receiving-49, dose-52)
prep_of(dose-52, captopril-54)

The/DT possibility/NN of/IN hypotensive/JJ effects/NNS with/IN captopril/NN can/MD be/VB minimized/VBN by/IN either/CC discontinuing/VBG the/DT diuretic/NN or/CC increasing/VBG the/DT salt/NN intake/NN approximately/RB one/CD week/NN prior/JJ to/TO initiation/NN of/IN treatment/NN with/IN captopril/NN (/-LRB- captopril/NN tablets/NNS ,/, USP/NN )/-RRB- or/CC initiating/VBG therapy/NN with/IN small/JJ doses/NNS (/-LRB- 6.25/CD or/CC 12.5/CD mg/NN )./NN

(ROOT (S1 (S (NP (NP (DT The) (NN possibility)) (PP (IN of) (NP (NP (JJ hypotensive) (NNS effects)) (PP (IN with) (NP (NN captopril)))))) (VP (MD can) (VP (VB be) (VP (VBN minimized) (PP (IN by) (S (VP (VP (VP (CC either) (VP (VBG discontinuing) (NP (DT the) (NN diuretic))) (CC or) (VP (VBG increasing) (NP (NP (DT the) (NN salt) (NN intake)) (ADJP (NP (QP (RB approximately) (CD one)) (NN week)) (JJ prior) (PP (TO to) (NP (NP (NN initiation)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN with) (NP (NN captopril))))))))))) (PRN (-LRB- -LRB-) (NP (NN captopril) (NNS tablets)) (, ,) (NP (NN USP)) (-RRB- -RRB-))) (CC or) (VP (VBG initiating) (NP (NP (NN therapy)) (PP (IN with) (NP (NP (JJ small) (NNS doses)) (PRN (-LRB- -LRB-) (NP (QP (CD 6.25) (CC or) (CD 12.5)) (NN mg) (NN -RRB-.))))))))))))))))

det(possibility-2, The-1)
nsubjpass(minimized-10, possibility-2)
amod(effects-5, hypotensive-4)
prep_of(possibility-2, effects-5)
prep_with(effects-5, captopril-7)
aux(minimized-10, can-8)
auxpass(minimized-10, be-9)
root(ROOT-0, minimized-10)
preconj(discontinuing-13, either-12)
agent(minimized-10, discontinuing-13)
det(diuretic-15, the-14)
dobj(discontinuing-13, diuretic-15)
conj_or(discontinuing-13, increasing-17)
det(intake-20, the-18)
nn(intake-20, salt-19)
dobj(increasing-17, intake-20)
quantmod(one-22, approximately-21)
num(week-23, one-22)
tmod(initiation-26, week-23)
prep_prior_to(intake-20, initiation-26)
prep_of(initiation-26, treatment-28)
prep_with(treatment-28, captopril-30)
nn(tablets-33, captopril-32)
dep(discontinuing-13, tablets-33)
dep(tablets-33, USP-35)
conj_or(discontinuing-13, initiating-38)
dobj(initiating-38, therapy-39)
amod(doses-42, small-41)
prep_with(therapy-39, doses-42)
num(-RRB-.-48, 6.25-44)
conj_or(6.25-44, 12.5-46)
nn(-RRB-.-48, mg-47)
dep(doses-42, -RRB-.-48)

If/IN hypotension/NN occurs/VBZ ,/, the/DT patient/NN should/MD be/VB placed/VBN in/IN a/DT supine/JJ position/NN and/CC ,/, if/IN necessary/JJ ,/, receive/VBP an/DT intravenous/JJ infusion/NN of/IN normal/JJ saline/NN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN hypotension)) (VP (VBZ occurs)))) (, ,) (NP (DT the) (NN patient)) (VP (VP (MD should) (VP (VB be) (VP (VBN placed) (PP (IN in) (NP (DT a) (JJ supine) (NN position)))))) (CC and) (, ,) (SBAR (IN if) (ADJP (JJ necessary))) (, ,) (VP (VBP receive) (NP (NP (DT an) (JJ intravenous) (NN infusion)) (PP (IN of) (NP (JJ normal) (NN saline))))))) (. .))))

mark(occurs-3, If-1)
nsubj(occurs-3, hypotension-2)
advcl(placed-9, occurs-3)
det(patient-6, the-5)
nsubjpass(placed-9, patient-6)
aux(placed-9, should-7)
auxpass(placed-9, be-8)
root(ROOT-0, placed-9)
det(position-13, a-11)
amod(position-13, supine-12)
prep_in(placed-9, position-13)
advcl(placed-9, if-16)
dep(if-16, necessary-17)
conj_and(placed-9, receive-19)
det(infusion-22, an-20)
amod(infusion-22, intravenous-21)
dobj(receive-19, infusion-22)
amod(saline-25, normal-24)
prep_of(infusion-22, saline-25)

Agents/NNS Having/VBG Vasodilator/NN Activity/NN :/: Data/NNS on/IN the/DT effect/NN of/IN concomitant/JJ use/NN of/IN other/JJ vasodilators/NNS in/IN patients/NNS receiving/VBG captopril/NN for/IN heart/NN failure/NN are/VBP not/RB available/JJ ;/: ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Agents)) (VP (VBG Having) (NP (NN Vasodilator) (NN Activity)))) (: :) (NP (NP (NNS Data)) (PP (IN on) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (JJ other) (NNS vasodilators))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN captopril)) (PP (IN for) (NP (NN heart) (NN failure))))))))))))) (VP (VBP are) (RB not) (ADJP (JJ available))) (: ;)) (. .))))

nsubj(available-25, Agents-1)
partmod(Agents-1, Having-2)
nn(Activity-4, Vasodilator-3)
dobj(Having-2, Activity-4)
dep(Agents-1, Data-6)
det(effect-9, the-8)
prep_on(Data-6, effect-9)
amod(use-12, concomitant-11)
prep_of(effect-9, use-12)
amod(vasodilators-15, other-14)
prep_of(use-12, vasodilators-15)
prep_in(use-12, patients-17)
partmod(patients-17, receiving-18)
dobj(receiving-18, captopril-19)
nn(failure-22, heart-21)
prep_for(captopril-19, failure-22)
cop(available-25, are-23)
neg(available-25, not-24)
root(ROOT-0, available-25)

therefore/RB ,/, nitroglycerin/NN or/CC other/JJ nitrates/NNS (/-LRB- as/IN used/VBN for/IN management/NN of/IN angina/NN )/-RRB- or/CC other/JJ drugs/NNS having/VBG vasodilator/NN activity/NN should/MD ,/, if/IN possible/JJ ,/, be/VB discontinued/VBN before/IN starting/VBG captopril/NN ./.

(ROOT (S1 (S (ADVP (RB therefore)) (, ,) (NP (NP (NP (NP (NN nitroglycerin)) (CC or) (NP (JJ other) (NNS nitrates))) (PRN (-LRB- -LRB-) (SBAR (IN as) (S (VP (VBN used) (PP (IN for) (NP (NP (NN management)) (PP (IN of) (NP (NN angina)))))))) (-RRB- -RRB-))) (CC or) (NP (NP (JJ other) (NNS drugs)) (VP (VBG having) (NP (NN vasodilator) (NN activity))))) (VP (MD should) (, ,) (PP (IN if) (NP (JJ possible))) (, ,) (VP (VB be) (VP (VBN discontinued) (PP (IN before) (S (VP (VBG starting) (NP (NN captopril)))))))) (. .))))

advmod(discontinued-27, therefore-1)
nsubjpass(discontinued-27, nitroglycerin-3)
amod(nitrates-6, other-5)
conj_or(nitroglycerin-3, nitrates-6)
mark(used-9, as-8)
dep(nitroglycerin-3, used-9)
prep_for(used-9, management-11)
prep_of(management-11, angina-13)
amod(drugs-17, other-16)
conj_or(nitroglycerin-3, drugs-17)
partmod(drugs-17, having-18)
nn(activity-20, vasodilator-19)
dobj(having-18, activity-20)
aux(discontinued-27, should-21)
prep_if(discontinued-27, possible-24)
auxpass(discontinued-27, be-26)
root(ROOT-0, discontinued-27)
prepc_before(discontinued-27, starting-29)
dobj(starting-29, captopril-30)

If/IN resumed/VBN during/IN captopril/NN therapy/NN ,/, such/JJ agents/NNS should/MD be/VB administered/VBN cautiously/RB ,/, and/CC perhaps/RB at/IN lower/JJR dosage/NN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (VP (VBN resumed) (PP (IN during) (NP (NN captopril) (NN therapy)))))) (, ,) (NP (JJ such) (NNS agents)) (VP (MD should) (VP (VB be) (VP (VBN administered) (ADVP (ADVP (RB cautiously)) (, ,) (CC and) (ADVP (RB perhaps))) (PP (IN at) (NP (JJR lower) (NN dosage))))))) (. .))))

mark(resumed-2, If-1)
advcl(administered-11, resumed-2)
nn(therapy-5, captopril-4)
prep_during(resumed-2, therapy-5)
amod(agents-8, such-7)
nsubjpass(administered-11, agents-8)
aux(administered-11, should-9)
auxpass(administered-11, be-10)
root(ROOT-0, administered-11)
advmod(administered-11, cautiously-12)
conj_and(cautiously-12, perhaps-15)
amod(dosage-18, lower-17)
prep_at(administered-11, dosage-18)

Agents/NNS Causing/VBG Renin/NN Release/NN Captopril/NN @/NN s/NN effect/NN will/MD be/VB augmented/VBN by/IN antihypertensive/JJ agents/NNS that/WDT cause/VBP renin/NN release/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Agents)) (VP (VBG Causing) (NP (NP (NN Renin) (NN Release)) (NP (NN Captopril) (NN @) (NN s) (NN effect))))) (VP (MD will) (VP (VB be) (VP (VBN augmented) (PP (IN by) (NP (NP (JJ antihypertensive) (NNS agents)) (SBAR (WHNP (WDT that)) (S (VP (VBP cause) (NP (NN renin) (NN release))))))))))) (. .))))

nsubjpass(augmented-11, Agents-1)
partmod(Agents-1, Causing-2)
nn(Release-4, Renin-3)
dobj(Causing-2, Release-4)
iobj(Causing-2, Release-4)
nn(effect-8, Captopril-5)
nn(effect-8, @-6)
nn(effect-8, s-7)
dobj(Causing-2, effect-8)
dep(Release-4, effect-8)
aux(augmented-11, will-9)
auxpass(augmented-11, be-10)
root(ROOT-0, augmented-11)
amod(agents-14, antihypertensive-13)
agent(augmented-11, agents-14)
nsubj(cause-16, agents-14)
rcmod(agents-14, cause-16)
nn(release-18, renin-17)
dobj(cause-16, release-18)

For/IN example/NN ,/, diuretics/NN (/-LRB- e.g./FW ,/, thiazides/NNS )/-RRB- may/MD activate/VB the/DT renin-angiotensin-aldosterone/JJ system/NN ./.

(ROOT (S1 (S (S (PP (IN For) (NP (NN example))) (, ,) (NP (NP (NN diuretics)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NNS thiazides)) (-RRB- -RRB-))) (VP (MD may) (VP (VB activate) (NP (DT the) (JJ renin-angiotensin-aldosterone) (NN system))))) (. .))))

prep_for(activate-11, example-2)
nsubj(activate-11, diuretics-4)
dep(thiazides-8, e.g.-6)
appos(diuretics-4, thiazides-8)
aux(activate-11, may-10)
root(ROOT-0, activate-11)
det(system-14, the-12)
amod(system-14, renin-angiotensin-aldosterone-13)
dobj(activate-11, system-14)

Agents/NNS Affecting/VBG Sympathetic/JJ Activity/NN :/: The/DT sympathetic/JJ nervous/JJ system/NN may/MD be/VB especially/RB important/JJ in/IN supporting/VBG blood/NN pressure/NN in/IN patients/NNS receiving/VBG captopril/NN alone/RB or/CC with/IN diuretics/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Agents)) (VP (VBG Affecting) (NP (JJ Sympathetic) (NN Activity)))) (: :) (S (NP (DT The) (JJ sympathetic) (JJ nervous) (NN system)) (VP (MD may) (VP (VB be) (ADJP (RB especially) (JJ important) (PP (IN in) (S (VP (VBG supporting) (NP (NP (NN blood) (NN pressure)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN captopril))))) (UCP (ADVP (RB alone)) (CC or) (PP (IN with) (NP (NN diuretics)))))))))))) (. .)))))

root(ROOT-0, Agents-1)
partmod(Agents-1, Affecting-2)
amod(Activity-4, Sympathetic-3)
dobj(Affecting-2, Activity-4)
det(system-9, The-6)
amod(system-9, sympathetic-7)
amod(system-9, nervous-8)
nsubj(important-13, system-9)
aux(important-13, may-10)
cop(important-13, be-11)
advmod(important-13, especially-12)
dep(Agents-1, important-13)
prepc_in(important-13, supporting-15)
nn(pressure-17, blood-16)
dobj(supporting-15, pressure-17)
prep_in(pressure-17, patients-19)
partmod(patients-19, receiving-20)
dobj(receiving-20, captopril-21)
dep(pressure-17, alone-22)
conj_or(alone-22, with-24)
pobj(with-24, diuretics-25)

Therefore/RB ,/, agents/NNS affecting/VBG sympathetic/JJ activity/NN (/-LRB- e.g./FW ,/, ganglionic/JJ blocking/NN agents/NNS or/CC adrenergic/JJ neuron/NN blocking/NN agents/NNS )/-RRB- should/MD be/VB used/VBN with/IN caution/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NNS agents)) (VP (VBG affecting) (NP (NP (JJ sympathetic) (NN activity)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (JJ ganglionic) (NN blocking) (NNS agents)) (CC or) (NP (JJ adrenergic) (NN neuron) (NN blocking) (NNS agents)))) (-RRB- -RRB-))))) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN caution))))))) (. .))))

advmod(used-21, Therefore-1)
nsubjpass(used-21, agents-3)
partmod(agents-3, affecting-4)
amod(activity-6, sympathetic-5)
dobj(affecting-4, activity-6)
dep(activity-6, e.g.-8)
amod(agents-12, ganglionic-10)
nn(agents-12, blocking-11)
pobj(e.g.-8, agents-12)
amod(agents-17, adrenergic-14)
nn(agents-17, neuron-15)
nn(agents-17, blocking-16)
conj_or(agents-12, agents-17)
aux(used-21, should-19)
auxpass(used-21, be-20)
root(ROOT-0, used-21)
prep_with(used-21, caution-23)

Beta-/NN adrenergic/JJ blocking/NN drugs/NNS add/VBP some/DT further/JJ antihypertensive/JJ effect/NN to/TO captopril/NN ,/, but/CC the/DT overall/JJ response/NN is/VBZ less/JJR than/IN additive/JJ ./.

(ROOT (S1 (S (S (S (NP (NN Beta-) (JJ adrenergic) (NN blocking) (NNS drugs)) (VP (VBP add) (NP (DT some) (JJ further) (JJ antihypertensive) (NN effect)) (PP (TO to) (NP (NN captopril))))) (, ,) (CC but) (S (NP (DT the) (JJ overall) (NN response)) (VP (VBZ is) (ADJP (ADJP (JJR less)) (PP (IN than) (ADJP (JJ additive))))))) (. .))))

nn(drugs-4, Beta--1)
amod(drugs-4, adrenergic-2)
nn(drugs-4, blocking-3)
nsubj(add-5, drugs-4)
root(ROOT-0, add-5)
det(effect-9, some-6)
amod(effect-9, further-7)
amod(effect-9, antihypertensive-8)
dobj(add-5, effect-9)
prep_to(add-5, captopril-11)
det(response-16, the-14)
amod(response-16, overall-15)
nsubj(less-18, response-16)
cop(less-18, is-17)
conj_but(add-5, less-18)
prep_than(less-18, additive-20)

Agents/NNS Increasing/VBG Serum/NN Potassium/NN :/: Since/IN captopril/NN decreases/VBZ aldosterone/NN production/NN ,/, elevation/NN of/IN serum/NN potassium/NN may/MD occur/VB ./.

(ROOT (S1 (S (S (S (NP (NNS Agents)) (VP (VBG Increasing) (NP (NN Serum) (NN Potassium)))) (: :) (S (SBAR (IN Since) (S (NP (NN captopril)) (VP (VBZ decreases) (NP (NN aldosterone) (NN production))))) (, ,) (NP (NP (NN elevation)) (PP (IN of) (NP (NN serum) (NN potassium)))) (VP (MD may) (VP (VB occur))))) (. .))))

nsubj(Increasing-2, Agents-1)
root(ROOT-0, Increasing-2)
nn(Potassium-4, Serum-3)
dobj(Increasing-2, Potassium-4)
mark(decreases-8, Since-6)
nsubj(decreases-8, captopril-7)
advcl(occur-17, decreases-8)
nn(production-10, aldosterone-9)
dobj(decreases-8, production-10)
nsubj(occur-17, elevation-12)
nn(potassium-15, serum-14)
prep_of(elevation-12, potassium-15)
aux(occur-17, may-16)
parataxis(Increasing-2, occur-17)

Potassium-sparing/JJ diuretics/NNS such/JJ as/IN spironolactone/NN ,/, triamterene/NN ,/, or/CC amiloride/NN ,/, or/CC potassium/NN supplement/NN s/NNS should/MD be/VB given/VBN only/RB for/IN documented/JJ hypokalemia/NN ,/, and/CC then/RB with/IN caution/NN ,/, since/IN they/PRP may/MD lead/VB to/TO a/DT significant/JJ increase/NN of/IN serum/NN potassium/NN ./.

(ROOT (S1 (S (NP (NP (JJ Potassium-sparing) (NNS diuretics)) (PP (JJ such) (IN as) (NP (NP (NN spironolactone)) (, ,) (NP (NN triamterene)) (, ,) (CC or) (NP (NN amiloride)) (, ,) (CC or) (NP (NN potassium) (NN supplement) (NNS s))))) (VP (MD should) (VP (VB be) (VP (VBN given) (ADVP (RB only)) (PP (PP (IN for) (NP (JJ documented) (NN hypokalemia))) (, ,) (CC and) (ADVP (RB then)) (PP (IN with) (NP (NN caution)))) (, ,) (SBAR (IN since) (S (NP (PRP they)) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN of) (NP (NN serum) (NN potassium)))))))))))) (. .))))

amod(diuretics-2, Potassium-sparing-1)
nsubjpass(given-18, diuretics-2)
prep_such_as(diuretics-2, spironolactone-5)
conj_or(spironolactone-5, triamterene-7)
conj_or(spironolactone-5, amiloride-10)
nn(s-15, potassium-13)
nn(s-15, supplement-14)
conj_or(spironolactone-5, s-15)
aux(given-18, should-16)
auxpass(given-18, be-17)
root(ROOT-0, given-18)
conj_and(given-18, given-18')
advmod(given-18, only-19)
amod(hypokalemia-22, documented-21)
prep_for(given-18, hypokalemia-22)
advmod(given-18, then-25)
conj(given-18, then-25)
prep_with(given-18', caution-27)
mark(lead-32, since-29)
nsubj(lead-32, they-30)
aux(lead-32, may-31)
advcl(given-18, lead-32)
det(increase-36, a-34)
amod(increase-36, significant-35)
prep_to(lead-32, increase-36)
nn(potassium-39, serum-38)
prep_of(increase-36, potassium-39)

Salt/NN substitutes/VBZ containing/VBG potassium/NN should/MD also/RB be/VB used/VBN with/IN caution/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Salt) (VBZ substitutes)) (VP (VBG containing) (NP (NN potassium)))) (VP (MD should) (ADVP (RB also)) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN caution))))))) (. .))))

nsubjpass(used-8, Salt-1)
dep(Salt-1, substitutes-2)
partmod(Salt-1, containing-3)
dobj(containing-3, potassium-4)
aux(used-8, should-5)
advmod(used-8, also-6)
auxpass(used-8, be-7)
root(ROOT-0, used-8)
prep_with(used-8, caution-10)

Inhibitors/NNS Of/IN Endogenous/JJ Prostaglandin/NN Synthesis/NN :/: It/PRP has/VBZ been/VBN reported/VBN that/IN indomethacin/NN may/MD reduce/VB the/DT antihypertensive/JJ effect/NN of/IN captopril/NN ,/, especially/RB in/IN cases/NNS of/IN low/JJ renin/NN hypertension/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Inhibitors)) (PP (IN Of) (NP (JJ Endogenous) (NN Prostaglandin) (NN Synthesis)))) (: :) (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (SBAR (IN that) (S (NP (NN indomethacin)) (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (JJ antihypertensive) (NN effect)) (PP (IN of) (NP (NN captopril)))) (, ,) (PP (ADVP (RB especially)) (IN in) (NP (NP (NNS cases)) (PP (IN of) (NP (JJ low) (NN renin) (NN hypertension))))))))))))) (. .)))))

root(ROOT-0, Inhibitors-1)
amod(Synthesis-5, Endogenous-3)
nn(Synthesis-5, Prostaglandin-4)
prep_of(Inhibitors-1, Synthesis-5)
nsubjpass(reported-10, It-7)
aux(reported-10, has-8)
auxpass(reported-10, been-9)
dep(Inhibitors-1, reported-10)
complm(reduce-14, that-11)
nsubj(reduce-14, indomethacin-12)
aux(reduce-14, may-13)
ccomp(reported-10, reduce-14)
det(effect-17, the-15)
amod(effect-17, antihypertensive-16)
dobj(reduce-14, effect-17)
prep_of(effect-17, captopril-19)
advmod(reduce-14, especially-21)
prep_in(reduce-14, cases-23)
amod(hypertension-27, low-25)
nn(hypertension-27, renin-26)
prep_of(cases-23, hypertension-27)

Other/JJ nonsteroidal/JJ anti-inflammatory/JJ agents/NNS (/-LRB- e.g./FW ,/, aspirin/NN )/-RRB- may/MD also/RB have/VB this/DT effect/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Other) (JJ nonsteroidal) (JJ anti-inflammatory) (NNS agents)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN aspirin))) (-RRB- -RRB-))) (VP (MD may) (ADVP (RB also)) (VP (VB have) (NP (DT this) (NN effect))))) (. .))))

amod(agents-4, Other-1)
amod(agents-4, nonsteroidal-2)
amod(agents-4, anti-inflammatory-3)
nsubj(have-12, agents-4)
dep(agents-4, e.g.-6)
pobj(e.g.-6, aspirin-8)
aux(have-12, may-10)
advmod(have-12, also-11)
root(ROOT-0, have-12)
det(effect-14, this-13)
dobj(have-12, effect-14)

Lithium/NN Increased/VBN serum/NN lithium/NN levels/NNS and/CC symptoms/NNS of/IN lithium/NN toxicity/NN have/VBP been/VBN reported/VBN in/IN patients/NNS receiving/VBG concomitant/JJ lithium/NN and/CC ACE/NN inhibitor/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (ADJP (NP (NN Lithium)) (VBN Increased)) (NN serum) (NN lithium) (NNS levels)) (CC and) (NP (NNS symptoms))) (PP (IN of) (NP (NN lithium) (NN toxicity)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ concomitant) (NN lithium) (CC and) (NN ACE) (NN inhibitor) (NN therapy))))))))) (. .))))

dep(Increased-2, Lithium-1)
amod(levels-5, Increased-2)
nn(levels-5, serum-3)
nn(levels-5, lithium-4)
nsubjpass(reported-13, levels-5)
conj_and(levels-5, symptoms-7)
nn(toxicity-10, lithium-9)
prep_of(levels-5, toxicity-10)
aux(reported-13, have-11)
auxpass(reported-13, been-12)
root(ROOT-0, reported-13)
prep_in(reported-13, patients-15)
partmod(patients-15, receiving-16)
amod(lithium-18, concomitant-17)
dobj(receiving-16, lithium-18)
nn(therapy-22, ACE-20)
nn(therapy-22, inhibitor-21)
conj_and(lithium-18, therapy-22)

These/DT drugs/NNS should/MD be/VB coad-ministered/VBN with/IN caution/NN and/CC frequent/JJ monitoring/NN of/IN serum/NN lithium/NN levels/NNS is/VBZ recommended/VBN ./.

(ROOT (S1 (S (S (S (NP (DT These) (NNS drugs)) (VP (MD should) (VP (VB be) (VP (VBN coad-ministered) (PP (IN with) (NP (NN caution))))))) (CC and) (S (NP (NP (JJ frequent) (NN monitoring)) (PP (IN of) (NP (NN serum) (NN lithium) (NNS levels)))) (VP (VBZ is) (VP (VBN recommended))))) (. .))))

det(drugs-2, These-1)
nsubjpass(coad-ministered-5, drugs-2)
aux(coad-ministered-5, should-3)
auxpass(coad-ministered-5, be-4)
root(ROOT-0, coad-ministered-5)
prep_with(coad-ministered-5, caution-7)
amod(monitoring-10, frequent-9)
nsubjpass(recommended-16, monitoring-10)
nn(levels-14, serum-12)
nn(levels-14, lithium-13)
prep_of(monitoring-10, levels-14)
auxpass(recommended-16, is-15)
conj_and(coad-ministered-5, recommended-16)

If/IN a/DT diuretic/NN is/VBZ also/RB used/VBN ,/, it/PRP may/MD increase/VB the/DT risk/NN of/IN lithium/NN toxicity/NN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (DT a) (NN diuretic)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN used))))) (, ,) (NP (PRP it)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN lithium) (NN toxicity))))))) (. .))))

mark(used-6, If-1)
det(diuretic-3, a-2)
nsubjpass(used-6, diuretic-3)
auxpass(used-6, is-4)
advmod(used-6, also-5)
advcl(increase-10, used-6)
nsubj(increase-10, it-8)
aux(increase-10, may-9)
root(ROOT-0, increase-10)
det(risk-12, the-11)
dobj(increase-10, risk-12)
nn(toxicity-15, lithium-14)
prep_of(risk-12, toxicity-15)

Cardiac/JJ Glycosides/NNS :/: In/IN a/DT study/NN of/IN young/JJ healthy/JJ male/JJ subjects/NNS no/DT evidence/NN of/IN a/DT direct/JJ pharmacokinetic/JJ captopril/NN -digoxin/NN interaction/NN could/MD be/VB found/VBN ./.

(ROOT (S1 (S (NP (NP (JJ Cardiac) (NNS Glycosides)) (: :) (S (PP (IN In) (NP (NP (DT a) (NN study)) (PP (IN of) (NP (JJ young) (JJ healthy) (JJ male) (NNS subjects))))) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (DT a) (JJ direct) (JJ pharmacokinetic) (NN captopril) (NN -digoxin) (NN interaction)))) (VP (MD could) (VP (VB be) (VP (VBN found))))) (. .)))))

amod(Glycosides-2, Cardiac-1)
root(ROOT-0, Glycosides-2)
det(study-6, a-5)
prep_in(found-23, study-6)
amod(subjects-11, young-8)
amod(subjects-11, healthy-9)
amod(subjects-11, male-10)
prep_of(study-6, subjects-11)
det(evidence-13, no-12)
nsubjpass(found-23, evidence-13)
det(interaction-20, a-15)
amod(interaction-20, direct-16)
amod(interaction-20, pharmacokinetic-17)
nn(interaction-20, captopril-18)
nn(interaction-20, -digoxin-19)
prep_of(evidence-13, interaction-20)
aux(found-23, could-21)
auxpass(found-23, be-22)
dep(Glycosides-2, found-23)

Loop/NN Diuretics/NNS :/: Furosemide/NN administered/VBN concurrently/RB with/IN cap-topril/NN does/VBZ not/RB alter/VB the/DT pharmacokinetics/NNS of/IN captopril/NN in/IN renally/RB impaired/JJ hypertensive/NN patients/NNS ./.

(ROOT (S1 (S (NP (NP (NN Loop) (NNS Diuretics)) (: :) (S (NP (NP (NN Furosemide)) (VP (VBN administered) (ADVP (RB concurrently)) (PP (IN with) (NP (NN cap-topril))))) (VP (VBZ does) (RB not) (VP (VB alter) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN captopril))) (PP (IN in) (NP (ADJP (RB renally) (JJ impaired)) (NN hypertensive) (NNS patients))))))) (. .)))))

nn(Diuretics-2, Loop-1)
root(ROOT-0, Diuretics-2)
nsubj(alter-11, Furosemide-4)
partmod(Furosemide-4, administered-5)
advmod(administered-5, concurrently-6)
prep_with(administered-5, cap-topril-8)
aux(alter-11, does-9)
neg(alter-11, not-10)
dep(Diuretics-2, alter-11)
det(pharmacokinetics-13, the-12)
dobj(alter-11, pharmacokinetics-13)
prep_of(pharmacokinetics-13, captopril-15)
advmod(impaired-18, renally-17)
amod(patients-20, impaired-18)
nn(patients-20, hypertensive-19)
prep_in(pharmacokinetics-13, patients-20)

Allopurinol/NN :/: In/IN a/DT study/NN of/IN healthy/JJ male/JJ volunteers/NNS no/DT significant/JJ pharmacokinetic/JJ interaction/NN occurred/VBD when/WRB captopril/NN and/CC allop-urinol/NN were/VBD administered/VBN concomitantly/RB for/IN 6/CD days/NNS ./.

(ROOT (S1 (S (S (NP (NN Allopurinol)) (: :) (PP (IN In) (NP (NP (DT a) (NN study)) (PP (IN of) (NP (JJ healthy) (JJ male) (NNS volunteers))))) (NP (DT no) (JJ significant) (JJ pharmacokinetic) (NN interaction)) (VP (VBD occurred) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN captopril)) (CC and) (NP (NN allop-urinol))) (VP (VBD were) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN for) (NP (CD 6) (NNS days))))))))) (. .))))

nsubj(occurred-14, Allopurinol-1)
det(study-5, a-4)
prep_in(occurred-14, study-5)
amod(volunteers-9, healthy-7)
amod(volunteers-9, male-8)
prep_of(study-5, volunteers-9)
det(interaction-13, no-10)
amod(interaction-13, significant-11)
amod(interaction-13, pharmacokinetic-12)
nsubj(occurred-14, interaction-13)
root(ROOT-0, occurred-14)
advmod(administered-20, when-15)
nsubjpass(administered-20, captopril-16)
conj_and(captopril-16, allop-urinol-18)
auxpass(administered-20, were-19)
advcl(occurred-14, administered-20)
advmod(administered-20, concomitantly-21)
num(days-24, 6-23)
prep_for(administered-20, days-24)

Drug/NN /Laboratory/NN Test/NN Interaction/NN Captopril/NN may/MD cause/VB a/DT false-positive/JJ urine/NN test/NN for/IN acetone/NN ./.

(ROOT (S1 (S (S (NP (NN Drug) (NN /Laboratory) (NN Test) (NN Interaction) (NN Captopril)) (VP (MD may) (VP (VB cause) (NP (NP (DT a) (JJ false-positive) (NN urine) (NN test)) (PP (IN for) (NP (NN acetone))))))) (. .))))

nn(Captopril-5, Drug-1)
nn(Captopril-5, /Laboratory-2)
nn(Captopril-5, Test-3)
nn(Captopril-5, Interaction-4)
nsubj(cause-7, Captopril-5)
aux(cause-7, may-6)
root(ROOT-0, cause-7)
det(test-11, a-8)
amod(test-11, false-positive-9)
nn(test-11, urine-10)
dobj(cause-7, test-11)
prep_for(test-11, acetone-13)

Clinically/RB meaningful/JJ drug/NN interactions/NNS have/VBP occurred/VBN with/IN concomitant/JJ medications/NNS and/CC include/VBP ,/, but/CC are/VBP not/RB limited/JJ to/TO the/DT following/NN :/: Agents/NNS Highly/RB Bound/VBN to/TO Plasma/NN Protein/NN Carbamazepine/NN is/VBZ not/RB highly/RB bound/VBN to/TO plasma/NN proteins/NNS ;/: ./.

(ROOT (S1 (S (S (NP (ADJP (RB Clinically) (JJ meaningful)) (NN drug) (NNS interactions)) (VP (VP (VBP have) (VP (VBN occurred) (PP (IN with) (NP (NP (JJ concomitant) (NNS medications)) (CC and) (NP (VBP include)))))) (, ,) (CC but) (VP (VBP are) (RB not) (ADJP (JJ limited) (PP (TO to) (NP (NP (DT the) (NN following)) (: :) (NP (NP (NNS Agents)) (VP (ADVP (RB Highly)) (VBN Bound) (PP (TO to) (NP (NP (NN Plasma) (NN Protein) (NN Carbamazepine)) (VP (VBZ is) (RB not) (ADVP (RB highly)) (VP (VBN bound) (PP (TO to) (NP (NN plasma) (NNS proteins))))))))) (: ;))))))) (. .))))

advmod(meaningful-2, Clinically-1)
amod(interactions-4, meaningful-2)
nn(interactions-4, drug-3)
nsubj(occurred-6, interactions-4)
aux(occurred-6, have-5)
root(ROOT-0, occurred-6)
amod(medications-9, concomitant-8)
prep_with(occurred-6, medications-9)
conj_and(medications-9, include-11)
cop(limited-16, are-14)
neg(limited-16, not-15)
conj_but(occurred-6, limited-16)
det(following-19, the-18)
prep_to(limited-16, following-19)
dep(following-19, Agents-21)
advmod(Bound-23, Highly-22)
partmod(Agents-21, Bound-23)
nn(Carbamazepine-27, Plasma-25)
nn(Carbamazepine-27, Protein-26)
prep_to(Bound-23, Carbamazepine-27)
auxpass(bound-31, is-28)
neg(bound-31, not-29)
advmod(bound-31, highly-30)
dep(Carbamazepine-27, bound-31)
nn(proteins-34, plasma-33)
prep_to(bound-31, proteins-34)

therefore/RB ,/, administration/NN of/IN EQUETROTM/NN to/TO a/DT patient/NN taking/VBG another/DT drug/NN that/WDT is/VBZ highly/RB protein/NN bound/VBN should/MD not/RB cause/VB increased/VBN free/JJ concentrations/NNS of/IN the/DT other/JJ drug/NN ./.

(ROOT (S1 (S (S (ADVP (RB therefore)) (, ,) (NP (NP (NN administration)) (PP (IN of) (NP (NN EQUETROTM))) (PP (TO to) (NP (NP (DT a) (NN patient)) (VP (VBG taking) (NP (NP (DT another) (NN drug)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADVP (RB highly)) (VP (NN protein) (VBN bound)))))))))) (VP (MD should) (RB not) (VP (VB cause) (NP (NP (VBN increased) (JJ free) (NNS concentrations)) (PP (IN of) (NP (DT the) (JJ other) (NN drug))))))) (. .))))

advmod(cause-19, therefore-1)
nsubj(cause-19, administration-3)
prep_of(administration-3, EQUETROTM-5)
det(patient-8, a-7)
prep_to(administration-3, patient-8)
partmod(patient-8, taking-9)
det(drug-11, another-10)
dobj(taking-9, drug-11)
nsubjpass(bound-16, drug-11)
auxpass(bound-16, is-13)
advmod(bound-16, highly-14)
dep(bound-16, protein-15)
rcmod(drug-11, bound-16)
aux(cause-19, should-17)
neg(cause-19, not-18)
root(ROOT-0, cause-19)
amod(concentrations-22, increased-20)
amod(concentrations-22, free-21)
dobj(cause-19, concentrations-22)
det(drug-26, the-24)
amod(drug-26, other-25)
prep_of(concentrations-22, drug-26)

Agents/NNS that/WDT Inhibit/VBP Cytochrome/NN P450/NN Isoenzymes/NNS and/or/CC Epoxide/NN Hydrolase/NN Carbamazepine/NN is/VBZ metabolized/VBN mainly/RB by/IN cytochrome/NN P450/NN (/-LRB- CYP/NN )/-RRB- 3A4/NN to/TO the/DT active/JJ carbamazepine/NN 10/CD ,/, 11-epoxide/NN ,/, which/WDT is/VBZ further/RB metabolized/VBN to/TO the/DT trans-diol/NN by/IN epoxide/NN hydrolase/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (NNS Agents)) (SBAR (WHNP (WDT that)) (S (VP (VBP Inhibit) (NP (NN Cytochrome) (NN P450) (NNS Isoenzymes)))))) (CC and/or) (NP (NN Epoxide) (NN Hydrolase))) (NN Carbamazepine)) (VP (VBZ is) (VP (VBN metabolized) (ADVP (RB mainly)) (PP (IN by) (NP (NP (NP (NN cytochrome) (NN P450) (-LRB- -LRB-) (NN CYP) (-RRB- -RRB-) (NN 3A4)) (TO to) (NP (DT the) (JJ active) (NN carbamazepine) (CD 10))) (, ,) (NP (NN 11-epoxide)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB further)) (VP (VBN metabolized) (PP (TO to) (NP (NP (DT the) (NN trans-diol)) (PP (IN by) (NP (NN epoxide) (NN hydrolase)))))))))))))) (. .))))

nsubj(Inhibit-3, Agents-1)
nn(Carbamazepine-10, Agents-1)
rcmod(Agents-1, Inhibit-3)
nn(Isoenzymes-6, Cytochrome-4)
nn(Isoenzymes-6, P450-5)
dobj(Inhibit-3, Isoenzymes-6)
nn(Hydrolase-9, Epoxide-8)
conj_and/or(Agents-1, Hydrolase-9)
nsubjpass(metabolized-12, Carbamazepine-10)
auxpass(metabolized-12, is-11)
root(ROOT-0, metabolized-12)
advmod(metabolized-12, mainly-13)
nn(3A4-20, cytochrome-15)
nn(3A4-20, P450-16)
nn(3A4-20, CYP-18)
agent(metabolized-12, 3A4-20)
dep(3A4-20, to-21)
det(carbamazepine-24, the-22)
amod(carbamazepine-24, active-23)
dep(3A4-20, carbamazepine-24)
num(carbamazepine-24, 10-25)
appos(3A4-20, 11-epoxide-27)
nsubjpass(metabolized-32, 11-epoxide-27)
auxpass(metabolized-32, is-30)
advmod(metabolized-32, further-31)
rcmod(3A4-20, metabolized-32)
rcmod(11-epoxide-27, metabolized-32)
det(trans-diol-35, the-34)
prep_to(metabolized-32, trans-diol-35)
nn(hydrolase-38, epoxide-37)
prep_by(trans-diol-35, hydrolase-38)

Therefore/RB ,/, the/DT potential/NN exists/VBZ for/IN interaction/NN between/IN carbamazepine/NN and/CC any/DT agent/NN that/WDT inhibits/VBZ CYP3A4/NN and/or/CC epoxide/NN hydrolase/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (DT the) (NN potential)) (VP (VBZ exists) (PP (IN for) (NP (NP (NN interaction)) (PP (IN between) (NP (NP (NN carbamazepine)) (CC and) (NP (NP (DT any) (NN agent)) (SBAR (WHNP (WDT that)) (S (VP (VBZ inhibits) (NP (NN CYP3A4) (CC and/or) (NN epoxide) (NN hydrolase)))))))))))) (. .))))

advmod(exists-5, Therefore-1)
det(potential-4, the-3)
nsubj(exists-5, potential-4)
root(ROOT-0, exists-5)
prep_for(exists-5, interaction-7)
prep_between(interaction-7, carbamazepine-9)
det(agent-12, any-11)
conj_and(carbamazepine-9, agent-12)
nsubj(inhibits-14, agent-12)
rcmod(agent-12, inhibits-14)
nn(hydrolase-18, CYP3A4-15)
conj_and/or(CYP3A4-15, epoxide-17)
dobj(inhibits-14, hydrolase-18)

Agents/NNS that/WDT are/VBP CYP3A4/JJ inhibitors/NNS that/WDT have/VBP been/VBN found/VBN ,/, or/CC are/VBP expected/VBN ,/, to/TO increase/NN plasma/NN levels/NNS of/IN EQUETROTM/NN are/VBP the/DT following/VBG :/: Acetazolamide/NN ,/, azole/JJ antifungals/NNS ,/, cimetidine/NN ,/, clarithromycin/NN (/-LRB- 1/CD )/-RRB- ,/, dalfopristin/NN ,/, danazol/NN ,/, delavirdine/NN ,/, diltiazem/NN ,/, erythromycin/NN (/-LRB- 1/CD )/-RRB- ,/, fluoxetine/NN ,/, fluvoxamine/NN ,/, grapefruit/NN juice/NN ,/, isoniazid/NN ,/, itraconazole/NN ,/, ketoconazole/NN ,/, loratadine/NN ,/, nefazodone/NN ,/, niacinamide/NN ,/, nicotinamide/NN ,/, protease/NN inhibitors/NNS ,/, propoxyphene/NN ,/, quinine/NN ,/, quinupristin/NN ,/, troleandomycin/NN ,/, valproate/NN (/-LRB- 1/CD )/-RRB- ,/, verapamil/NN ,/, zileuton/NN ./.

(ROOT (S1 (S (NP (NP (NNS Agents)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (JJ CYP3A4) (NNS inhibitors)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (VP (VBN been) (VP (VBN found) (, ,) (CC or) (VP (VBP are) (VP (VBN expected) (, ,) (PP (TO to) (NP (NP (NN increase) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN EQUETROTM))) (S (VP (VBP are) (NP (DT the) (VBG following) (: :) (NP (NP (NN Acetazolamide)) (, ,) (NP (JJ azole) (NNS antifungals)) (, ,) (NP (NN cimetidine)) (, ,) (NP (NN clarithromycin) (-LRB- -LRB-) (CD 1) (-RRB- -RRB-)) (, ,) (NP (NN dalfopristin)) (, ,) (NP (NN danazol)) (, ,) (NP (NN delavirdine)) (, ,) (NP (NN diltiazem)) (, ,) (NP (NN erythromycin) (-LRB- -LRB-) (CD 1) (-RRB- -RRB-)) (, ,) (NP (NN fluoxetine)) (, ,) (NP (NN fluvoxamine)) (, ,) (NP (NN grapefruit) (NN juice)) (, ,) (NP (NN isoniazid)) (, ,) (NP (NN itraconazole)) (, ,) (NP (NN ketoconazole)) (, ,) (NP (NN loratadine)) (, ,) (NP (NN nefazodone)) (, ,) (NP (NN niacinamide)) (, ,) (NP (NN nicotinamide)) (, ,) (NP (NN protease) (NNS inhibitors)) (, ,) (NP (NN propoxyphene)) (, ,) (NP (NN quinine)) (, ,) (NP (NN quinupristin)) (, ,) (NP (NN troleandomycin)) (, ,) (NP (NN valproate) (-LRB- -LRB-) (CD 1) (-RRB- -RRB-)) (, ,) (NP (NN verapamil)) (, ,) (NP (NN zileuton))))))))))))))))))) (. .)))))

root(ROOT-0, Agents-1)
nsubj(inhibitors-5, Agents-1)
cop(inhibitors-5, are-3)
amod(inhibitors-5, CYP3A4-4)
rcmod(Agents-1, inhibitors-5)
nsubjpass(found-9, inhibitors-5)
aux(found-9, have-7)
auxpass(found-9, been-8)
rcmod(inhibitors-5, found-9)
auxpass(expected-13, are-12)
conj_or(found-9, expected-13)
nn(levels-18, increase-16)
nn(levels-18, plasma-17)
prep_to(expected-13, levels-18)
prep_of(levels-18, EQUETROTM-20)
cop(Acetazolamide-25, are-21)
det(Acetazolamide-25, the-22)
amod(Acetazolamide-25, following-23)
dep(levels-18, Acetazolamide-25)
amod(antifungals-28, azole-27)
appos(Acetazolamide-25, antifungals-28)
appos(Acetazolamide-25, cimetidine-30)
appos(Acetazolamide-25, clarithromycin-32)
num(clarithromycin-32, 1-34)
appos(Acetazolamide-25, dalfopristin-37)
appos(Acetazolamide-25, danazol-39)
appos(Acetazolamide-25, delavirdine-41)
appos(Acetazolamide-25, diltiazem-43)
appos(Acetazolamide-25, erythromycin-45)
num(erythromycin-45, 1-47)
appos(Acetazolamide-25, fluoxetine-50)
appos(Acetazolamide-25, fluvoxamine-52)
nn(juice-55, grapefruit-54)
appos(Acetazolamide-25, juice-55)
appos(Acetazolamide-25, isoniazid-57)
appos(Acetazolamide-25, itraconazole-59)
appos(Acetazolamide-25, ketoconazole-61)
appos(Acetazolamide-25, loratadine-63)
appos(Acetazolamide-25, nefazodone-65)
appos(Acetazolamide-25, niacinamide-67)
appos(Acetazolamide-25, nicotinamide-69)
nn(inhibitors-72, protease-71)
appos(Acetazolamide-25, inhibitors-72)
appos(Acetazolamide-25, propoxyphene-74)
appos(Acetazolamide-25, quinine-76)
appos(Acetazolamide-25, quinupristin-78)
appos(Acetazolamide-25, troleandomycin-80)
appos(Acetazolamide-25, valproate-82)
num(valproate-82, 1-84)
appos(Acetazolamide-25, verapamil-87)
appos(Acetazolamide-25, zileuton-89)

Thus/RB ,/, if/IN a/DT patient/NN has/VBZ been/VBN titrated/VBN to/TO a/DT stable/JJ dosage/NN of/IN EQUETROTM/NN ,/, and/CC then/RB begins/VBZ a/DT course/NN of/IN treatment/NN with/IN one/CD of/IN these/DT CYP3A4/JJ or/CC epoxide/NN hydrolase/NN inhibitors/NNS ,/, it/PRP is/VBZ reasonable/JJ to/TO expect/VB that/IN a/DT dose/NN reduction/NN for/IN EQUETROTM/NN may/MD be/VB necessary/JJ ./.

(ROOT (S1 (S (S (ADVP (RB Thus)) (, ,) (SBAR (IN if) (S (NP (DT a) (NN patient)) (VP (VP (VBZ has) (VP (VBN been) (VP (VBN titrated) (PP (TO to) (NP (NP (DT a) (JJ stable) (NN dosage)) (PP (IN of) (NP (NN EQUETROTM)))))))) (, ,) (CC and) (VP (ADVP (RB then)) (VBZ begins) (NP (NP (DT a) (NN course)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN with) (NP (NP (CD one)) (PP (IN of) (NP (DT these) (JJ CYP3A4) (CC or) (NN epoxide) (NN hydrolase) (NNS inhibitors)))))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ reasonable) (S (VP (TO to) (VP (VB expect) (SBAR (IN that) (S (NP (NP (DT a) (NN dose) (NN reduction)) (PP (IN for) (NP (NN EQUETROTM)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary)))))))))))) (. .))))

advmod(reasonable-35, Thus-1)
mark(titrated-8, if-3)
det(patient-5, a-4)
nsubjpass(titrated-8, patient-5)
aux(titrated-8, has-6)
auxpass(titrated-8, been-7)
advcl(reasonable-35, titrated-8)
det(dosage-12, a-10)
amod(dosage-12, stable-11)
prep_to(titrated-8, dosage-12)
prep_of(dosage-12, EQUETROTM-14)
advmod(begins-18, then-17)
conj_and(titrated-8, begins-18)
det(course-20, a-19)
dobj(begins-18, course-20)
prep_of(course-20, treatment-22)
prep_with(treatment-22, one-24)
dep(CYP3A4-27, these-26)
prep_of(one-24, CYP3A4-27)
nn(inhibitors-31, epoxide-29)
nn(inhibitors-31, hydrolase-30)
conj_or(CYP3A4-27, inhibitors-31)
nsubj(reasonable-35, it-33)
cop(reasonable-35, is-34)
root(ROOT-0, reasonable-35)
aux(expect-37, to-36)
xcomp(reasonable-35, expect-37)
complm(necessary-46, that-38)
det(reduction-41, a-39)
nn(reduction-41, dose-40)
nsubj(necessary-46, reduction-41)
prep_for(reduction-41, EQUETROTM-43)
aux(necessary-46, may-44)
cop(necessary-46, be-45)
ccomp(expect-37, necessary-46)

Agents/NNS that/WDT Induce/VBP Cytochrome/NN P450/NN Isoenzymes/NNS Carbamazepine/NN is/VBZ metabolized/VBN by/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Agents)) (SBAR (WHNP (WDT that)) (S (VP (VBP Induce) (NP (NN Cytochrome) (NN P450) (NNS Isoenzymes) (NP (NN Carbamazepine))))))) (VP (VBZ is) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP3A4)))))) (. .))))

nsubj(Induce-3, Agents-1)
nsubjpass(metabolized-9, Agents-1)
rcmod(Agents-1, Induce-3)
nn(Isoenzymes-6, Cytochrome-4)
nn(Isoenzymes-6, P450-5)
dobj(Induce-3, Isoenzymes-6)
dep(Isoenzymes-6, Carbamazepine-7)
auxpass(metabolized-9, is-8)
root(ROOT-0, metabolized-9)
agent(metabolized-9, CYP3A4-11)

Therefore/RB ,/, the/DT potential/NN exists/VBZ for/IN interaction/NN between/IN carbamazepine/NN and/CC any/DT agent/NN that/WDT induces/VBZ CYP3A4/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (DT the) (NN potential)) (VP (VBZ exists) (PP (IN for) (NP (NP (NN interaction)) (PP (IN between) (NP (NP (NN carbamazepine)) (CC and) (NP (NP (DT any) (NN agent)) (SBAR (WHNP (WDT that)) (S (VP (VBZ induces) (NP (NN CYP3A4)))))))))))) (. .))))

advmod(exists-5, Therefore-1)
det(potential-4, the-3)
nsubj(exists-5, potential-4)
root(ROOT-0, exists-5)
prep_for(exists-5, interaction-7)
prep_between(interaction-7, carbamazepine-9)
det(agent-12, any-11)
conj_and(carbamazepine-9, agent-12)
nsubj(induces-14, agent-12)
rcmod(agent-12, induces-14)
dobj(induces-14, CYP3A4-15)

Agents/NNS that/WDT are/VBP CYP/JJ inducers/NNS that/WDT have/VBP been/VBN found/VBN ,/, or/CC are/VBP expected/VBN ,/, to/TO decrease/VB plasma/NN levels/NNS of/IN EQUETROTM/NNP are/VBP the/DT following/NN :/: Cisplatin/NN ,/, doxorubicin/NN HCL/NN ,/, felbamate/NN ,/, rifampin/NN ,/, phenobarbital/NN ,/, Phenytoin/NN (/-LRB- 2/CD )/-RRB- ,/, primidone/NN ,/, methsuximide/NN ,/, and/CC theophylline/NN Thus/RB ,/, if/IN a/DT patient/NN has/VBZ been/VBN titrated/VBN to/TO a/DT stable/JJ dosage/NN on/IN EQUETROTM/NN ,/, and/CC then/RB begins/VBZ a/DT course/NN of/IN treatment/NN with/IN one/CD of/IN these/DT CYP3A4/JJ inducers/NNS ,/, it/PRP is/VBZ reasonable/JJ to/TO expect/VB that/IN a/DT dose/NN increase/NN for/IN EQUETROTM/NN may/MD be/VB necessary/JJ ./.

(ROOT (S1 (S (NP (NP (NP (NP (NNS Agents)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (JJ CYP) (NNS inducers)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBP have) (VP (VBN been) (VP (VBN found)))) (, ,) (CC or) (VP (VBP are) (VP (VBN expected) (, ,) (S (VP (TO to) (VP (VB decrease) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (NP (NNP EQUETROTM)) (VP (VBP are) (NP (DT the) (NN following))))))))))))))))))) (: :) (NP (NP (NN Cisplatin)) (, ,) (NP (NN doxorubicin) (NN HCL)) (, ,) (NP (NN felbamate)) (, ,) (NP (NN rifampin)) (, ,) (NP (NN phenobarbital)) (, ,) (NP (NN Phenytoin) (-LRB- -LRB-) (CD 2) (-RRB- -RRB-)) (, ,) (NP (NN primidone)) (, ,) (NP (NN methsuximide)) (, ,) (CC and) (NP (NN theophylline)))) (S (ADVP (RB Thus)) (, ,) (SBAR (IN if) (S (NP (DT a) (NN patient)) (VP (VBZ has) (VP (VBN been) (VP (VBN titrated) (PP (TO to) (NP (NP (DT a) (JJ stable) (NN dosage)) (PP (IN on) (NP (NN EQUETROTM)))))) (, ,) (CC and) (VP (ADVP (RB then)) (VBZ begins) (NP (NP (DT a) (NN course)) (PP (IN of) (NP (NN treatment)))) (PP (IN with) (NP (NP (CD one)) (PP (IN of) (NP (DT these) (JJ CYP3A4) (NNS inducers)))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ reasonable) (S (VP (TO to) (VP (VB expect) (SBAR (IN that) (S (NP (NP (DT a) (NN dose) (NN increase)) (PP (IN for) (NP (NN EQUETROTM)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary)))))))))))) (. .)))))

root(ROOT-0, Agents-1)
nsubj(inducers-5, Agents-1)
cop(inducers-5, are-3)
amod(inducers-5, CYP-4)
rcmod(Agents-1, inducers-5)
nsubjpass(found-9, inducers-5)
aux(found-9, have-7)
auxpass(found-9, been-8)
rcmod(inducers-5, found-9)
auxpass(expected-13, are-12)
conj_or(found-9, expected-13)
aux(decrease-16, to-15)
xcomp(expected-13, decrease-16)
nn(levels-18, plasma-17)
dobj(decrease-16, levels-18)
prep_of(levels-18, EQUETROTM-20)
cop(following-23, are-21)
det(following-23, the-22)
dep(EQUETROTM-20, following-23)
dep(Agents-1, Cisplatin-25)
nn(HCL-28, doxorubicin-27)
conj_and(Cisplatin-25, HCL-28)
conj_and(Cisplatin-25, felbamate-30)
conj_and(Cisplatin-25, rifampin-32)
conj_and(Cisplatin-25, phenobarbital-34)
conj_and(Cisplatin-25, Phenytoin-36)
num(Phenytoin-36, 2-38)
conj_and(Cisplatin-25, primidone-41)
conj_and(Cisplatin-25, methsuximide-43)
conj_and(Cisplatin-25, theophylline-46)
advmod(reasonable-78, Thus-47)
mark(titrated-54, if-49)
det(patient-51, a-50)
nsubjpass(titrated-54, patient-51)
aux(titrated-54, has-52)
auxpass(titrated-54, been-53)
advcl(reasonable-78, titrated-54)
det(dosage-58, a-56)
amod(dosage-58, stable-57)
prep_to(titrated-54, dosage-58)
prep_on(dosage-58, EQUETROTM-60)
advmod(begins-64, then-63)
conj_and(titrated-54, begins-64)
det(course-66, a-65)
dobj(begins-64, course-66)
prep_of(course-66, treatment-68)
prep_with(begins-64, one-70)
det(inducers-74, these-72)
amod(inducers-74, CYP3A4-73)
prep_of(one-70, inducers-74)
nsubj(reasonable-78, it-76)
cop(reasonable-78, is-77)
dep(Agents-1, reasonable-78)
aux(expect-80, to-79)
xcomp(reasonable-78, expect-80)
complm(necessary-89, that-81)
det(increase-84, a-82)
nn(increase-84, dose-83)
nsubj(necessary-89, increase-84)
prep_for(increase-84, EQUETROTM-86)
aux(necessary-89, may-87)
cop(necessary-89, be-88)
ccomp(expect-80, necessary-89)

Agents/NNS with/IN Decreased/VBN Levels/NNS in/IN the/DT Presence/NN of/IN Carbamazepine/NN due/JJ to/TO Induction/NN of/IN Cytochrome/NN P450/NN Enzymes/NNS Carbamazepine/NN is/VBZ known/VBN to/TO induce/VB CYP1A2/NN and/CC CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Agents)) (PP (IN with) (NP (NP (VBN Decreased) (NNS Levels)) (PP (IN in) (NP (NP (DT the) (NN Presence)) (PP (IN of) (NP (NP (NN Carbamazepine)) (ADJP (JJ due) (PP (TO to) (NP (NP (NN Induction)) (PP (IN of) (NP (NN Cytochrome) (NN P450) (NNS Enzymes)))))) (NN Carbamazepine)))))))) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB induce) (NP (NP (NN CYP1A2)) (CC and) (NP (NN CYP3A4))))))))) (. .))))

nsubjpass(known-19, Agents-1)
xsubj(induce-21, Agents-1)
amod(Levels-4, Decreased-3)
prep_with(Agents-1, Levels-4)
det(Presence-7, the-6)
prep_in(Levels-4, Presence-7)
nn(Carbamazepine-17, Carbamazepine-9)
prep_due_to(Carbamazepine-17, Induction-12)
nn(Enzymes-16, Cytochrome-14)
nn(Enzymes-16, P450-15)
prep_of(Induction-12, Enzymes-16)
prep_of(Presence-7, Carbamazepine-17)
auxpass(known-19, is-18)
root(ROOT-0, known-19)
aux(induce-21, to-20)
xcomp(known-19, induce-21)
dobj(induce-21, CYP1A2-22)
conj_and(CYP1A2-22, CYP3A4-24)

Therefore/RB ,/, the/DT potential/NN exists/VBZ for/IN interaction/NN between/IN carbamazepine/NN and/CC any/DT agent/NN metabolized/VBN by/IN one/CD (/-LRB- or/CC more/JJR )/-RRB- of/IN these/DT enzymes/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (DT the) (NN potential)) (VP (VBZ exists) (PP (IN for) (NP (NP (NN interaction)) (PP (IN between) (NP (NP (NN carbamazepine)) (CC and) (NP (NP (DT any) (NN agent)) (VP (VBN metabolized) (PP (IN by) (NP (NP (NP (CD one)) (-LRB- -LRB-) (CC or) (NP (JJR more)) (-RRB- -RRB-)) (PP (IN of) (NP (DT these) (NNS enzymes))))))))))))) (. .))))

advmod(exists-5, Therefore-1)
det(potential-4, the-3)
nsubj(exists-5, potential-4)
root(ROOT-0, exists-5)
prep_for(exists-5, interaction-7)
prep_between(interaction-7, carbamazepine-9)
det(agent-12, any-11)
conj_and(carbamazepine-9, agent-12)
partmod(agent-12, metabolized-13)
agent(metabolized-13, one-15)
conj_or(one-15, more-18)
det(enzymes-22, these-21)
prep_of(one-15, enzymes-22)

Agents/NNS that/WDT have/VBP been/VBN found/VBN ,/, or/CC are/VBP expected/VBN to/TO have/VB decreased/VBN plasma/NN levels/NNS in/IN the/DT presence/NN of/IN EQUETROTM/NN due/JJ to/TO induction/NN of/IN CYP/NN enzymes/NNS are/VBP the/DT following/JJ :/: Acetaminophen/NN ,/, alprazolam/NN ,/, amitriptyline/NN ,/, bupropion/NN ,/, buspirone/NN ,/, citalopram/NN ,/, clobazam/NN ,/, clonazepam/NN ,/, clozapine/NN ,/, cyclosporin/NN ,/, delavirdine/NN ,/, desipramine/NN ,/, diazepam/NN ,/, dicumarol/NN ,/, doxycycline/NN ,/, ethosuximide/NN ,/, felbamate/NN ,/, felodipine/NN ,/, glucocorticoids/NNS ,/, haloperidol/NN ,/, itraconazole/NN ,/, lamotrigine/NN ,/, levothyroxine/NN ,/, lorazepam/NN ,/, methadone/NN ,/, midazolam/NN ,/, mirtazapine/NN ,/, nortriptyline/NN ,/, olanzapine/NN ,/, oral/JJ contraceptives/NNS (/-LRB- 3/CD )/-RRB- ,/, oxcarbazepine/NN ,/, Phenytoin/NN (/-LRB- 4/CD )/-RRB- ,/, praziquantel/NN ,/, protease/NN inhibitors/NNS ,/, quetiapine/NN ,/, risperidone/NN ,/, theophylline/NN ,/, topiramate/NN ,/, tiagabine/NN ,/, tramadol/NN ,/, triazolam/NN ,/, valproate/NN ,/, warfarin/NN (/-LRB- 5/CD )/-RRB- ,/, ziprasidone/NN ,/, and/CC zonisamide/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Agents)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (VP (VBN been) (VP (VBN found) (S (VP (, ,) (CC or) (VP (VBP are) (VP (VBN expected) (S (VP (TO to) (VP (VB have) (NP (VBN decreased) (NP (NP (NN plasma) (NNS levels)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN EQUETROTM) (ADJP (JJ due) (PP (TO to) (NP (NP (NN induction)) (PP (IN of) (NP (NN CYP) (NNS enzymes))) (VP (VBP are) (NP (DT the) (JJ following) (: :) (NP (NP (NP (NP (NP (NP (NN Acetaminophen)) (, ,) (NP (NN alprazolam)) (, ,) (NP (NN amitriptyline)) (, ,) (NP (NN bupropion)) (, ,) (NP (NN buspirone)) (, ,) (NP (NN citalopram)) (, ,) (NP (NN clobazam)) (, ,) (NP (NN clonazepam)) (, ,) (NP (NN clozapine)) (, ,) (NP (NN cyclosporin)) (, ,) (NP (NN delavirdine)) (, ,) (NP (NN desipramine)) (, ,) (NP (NN diazepam)) (, ,) (NP (NN dicumarol)) (, ,) (NP (NN doxycycline)) (, ,) (NP (NN ethosuximide)) (, ,)) (NN felbamate)) (, ,) (NP (NN felodipine)) (, ,) (NP (NNS glucocorticoids)) (, ,) (NP (NN haloperidol)) (, ,) (NP (NN itraconazole)) (, ,) (NP (NN lamotrigine)) (, ,) (NP (NN levothyroxine)) (, ,) (NP (NN lorazepam)) (, ,) (NP (NN methadone)) (, ,) (NP (NN midazolam)) (, ,) (NP (NN mirtazapine)) (, ,) (NP (NN nortriptyline)) (, ,) (NP (NN olanzapine)) (, ,) (NP (JJ oral) (NNS contraceptives))) (-LRB- -LRB-) (CD 3) (-RRB- -RRB-)) (, ,) (NP (NN oxcarbazepine)) (, ,) (NP (NN Phenytoin) (-LRB- -LRB-) (CD 4) (-RRB- -RRB-)) (, ,) (NP (NN praziquantel)) (, ,) (NP (NN protease) (NNS inhibitors)) (, ,) (NP (NN quetiapine)) (, ,) (NP (NN risperidone)) (, ,) (NP (NN theophylline)) (, ,) (NP (NN topiramate)) (, ,) (NP (NN tiagabine)) (, ,) (NP (NN tramadol)) (, ,) (NP (NN triazolam)) (, ,) (NP (NN valproate)) (, ,) (NP (NN warfarin) (-LRB- -LRB-) (CD 5) (-RRB- -RRB-)) (, ,) (NP (NN ziprasidone)) (, ,) (CC and) (NP (NN zonisamide)))))))))))))))))))))))))))) (. .))))

root(ROOT-0, Agents-1)
nsubjpass(found-5, Agents-1)
aux(found-5, have-3)
auxpass(found-5, been-4)
rcmod(Agents-1, found-5)
cc(expected-9, or-7)
auxpass(expected-9, are-8)
ccomp(found-5, expected-9)
aux(have-11, to-10)
xcomp(expected-9, have-11)
amod(levels-14, decreased-12)
nn(levels-14, plasma-13)
dobj(have-11, levels-14)
det(presence-17, the-16)
prep_in(levels-14, presence-17)
prep_of(presence-17, EQUETROTM-19)
prep_due_to(EQUETROTM-19, induction-22)
nn(enzymes-25, CYP-24)
prep_of(induction-22, enzymes-25)
cop(felbamate-62, are-26)
det(felbamate-62, the-27)
amod(felbamate-62, following-28)
nn(felbamate-62, Acetaminophen-30)
appos(Acetaminophen-30, alprazolam-32)
appos(Acetaminophen-30, amitriptyline-34)
appos(Acetaminophen-30, bupropion-36)
appos(Acetaminophen-30, buspirone-38)
appos(Acetaminophen-30, citalopram-40)
appos(Acetaminophen-30, clobazam-42)
appos(Acetaminophen-30, clonazepam-44)
appos(Acetaminophen-30, clozapine-46)
appos(Acetaminophen-30, cyclosporin-48)
appos(Acetaminophen-30, delavirdine-50)
appos(Acetaminophen-30, desipramine-52)
appos(Acetaminophen-30, diazepam-54)
appos(Acetaminophen-30, dicumarol-56)
appos(Acetaminophen-30, doxycycline-58)
appos(Acetaminophen-30, ethosuximide-60)
dep(induction-22, felbamate-62)
appos(felbamate-62, felodipine-64)
appos(felbamate-62, glucocorticoids-66)
appos(felbamate-62, haloperidol-68)
appos(felbamate-62, itraconazole-70)
appos(felbamate-62, lamotrigine-72)
appos(felbamate-62, levothyroxine-74)
appos(felbamate-62, lorazepam-76)
appos(felbamate-62, methadone-78)
appos(felbamate-62, midazolam-80)
appos(felbamate-62, mirtazapine-82)
appos(felbamate-62, nortriptyline-84)
appos(felbamate-62, olanzapine-86)
amod(contraceptives-89, oral-88)
appos(felbamate-62, contraceptives-89)
num(felbamate-62, 3-91)
conj_and(felbamate-62, oxcarbazepine-94)
conj_and(felbamate-62, Phenytoin-96)
num(Phenytoin-96, 4-98)
conj_and(felbamate-62, praziquantel-101)
nn(inhibitors-104, protease-103)
conj_and(felbamate-62, inhibitors-104)
conj_and(felbamate-62, quetiapine-106)
conj_and(felbamate-62, risperidone-108)
conj_and(felbamate-62, theophylline-110)
conj_and(felbamate-62, topiramate-112)
conj_and(felbamate-62, tiagabine-114)
conj_and(felbamate-62, tramadol-116)
conj_and(felbamate-62, triazolam-118)
conj_and(felbamate-62, valproate-120)
conj_and(felbamate-62, warfarin-122)
num(warfarin-122, 5-124)
conj_and(felbamate-62, ziprasidone-127)
conj_and(felbamate-62, zonisamide-130)

Thus/RB ,/, if/IN a/DT patient/NN has/VBZ been/VBN titrated/VBN to/TO a/DT stable/JJ dosage/NN on/IN one/CD of/IN the/DT agents/NNS in/IN this/DT category/NN ,/, and/CC then/RB begins/VBZ a/DT course/NN of/IN treatment/NN with/IN EQUETROTM/NN ,/, it/PRP is/VBZ reasonable/JJ to/TO expect/VB that/IN a/DT dose/NN increase/NN for/IN the/DT concomitant/JJ agent/NN may/MD be/VB necessary/JJ ./.

(ROOT (S1 (S (ADVP (RB Thus)) (, ,) (SBAR (IN if) (S (NP (DT a) (NN patient)) (VP (VP (VBZ has) (VP (VBN been) (VP (VBN titrated) (PP (TO to) (NP (DT a) (JJ stable) (NN dosage))) (PP (IN on) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (NNS agents)) (PP (IN in) (NP (DT this) (NN category)))))))))) (, ,) (CC and) (VP (ADVP (RB then)) (VBZ begins) (NP (NP (DT a) (NN course)) (PP (IN of) (NP (NN treatment)))) (PP (IN with) (NP (NN EQUETROTM))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ reasonable) (S (VP (TO to) (VP (VB expect) (SBAR (IN that) (S (NP (NP (DT a) (NN dose) (NN increase)) (PP (IN for) (NP (DT the) (JJ concomitant) (NN agent)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary))))))))))) (. .))))

advmod(reasonable-34, Thus-1)
mark(titrated-8, if-3)
det(patient-5, a-4)
nsubjpass(titrated-8, patient-5)
aux(titrated-8, has-6)
auxpass(titrated-8, been-7)
advcl(reasonable-34, titrated-8)
det(dosage-12, a-10)
amod(dosage-12, stable-11)
prep_to(titrated-8, dosage-12)
prep_on(titrated-8, one-14)
det(agents-17, the-16)
prep_of(one-14, agents-17)
det(category-20, this-19)
prep_in(agents-17, category-20)
advmod(begins-24, then-23)
conj_and(titrated-8, begins-24)
det(course-26, a-25)
dobj(begins-24, course-26)
prep_of(course-26, treatment-28)
prep_with(begins-24, EQUETROTM-30)
nsubj(reasonable-34, it-32)
cop(reasonable-34, is-33)
root(ROOT-0, reasonable-34)
aux(expect-36, to-35)
xcomp(reasonable-34, expect-36)
complm(necessary-47, that-37)
det(increase-40, a-38)
nn(increase-40, dose-39)
nsubj(necessary-47, increase-40)
det(agent-44, the-42)
amod(agent-44, concomitant-43)
prep_for(increase-40, agent-44)
aux(necessary-47, may-45)
cop(necessary-47, be-46)
ccomp(expect-36, necessary-47)

Agents/NNS with/IN Increased/VBN Levels/NNS in/IN the/DT Presence/NN of/IN Carbamazepine/NN :/: EQUETROTM/NN increases/VBZ the/DT plasma/NN levels/NNS of/IN the/DT following/JJ agents/NNS :/: Clomipramine/NN HCl/NN ,/, Phenytoin/NN (/-LRB- 6/CD )/-RRB- ,/, and/CC primidone/NN Thus/RB ,/, if/IN a/DT patient/NN has/VBZ been/VBN titrated/VBN to/TO a/DT stable/JJ dosage/NN on/IN one/CD of/IN the/DT agents/NNS in/IN this/DT category/NN ,/, and/CC then/RB begins/VBZ a/DT course/NN of/IN the/DT treatment/NN with/IN EQUETROTM/NN ,/, it/PRP is/VBZ reasonable/JJ to/TO expect/VB that/IN a/DT dose/NN decrease/NN for/IN the/DT concomitant/JJ agent/NN may/MD be/VB necessary/JJ ./.

(ROOT (S1 (S (ADVP (NP (NP (NNS Agents)) (PP (IN with) (NP (NP (VBN Increased) (NNS Levels)) (PP (IN in) (NP (NP (DT the) (NN Presence)) (PP (IN of) (NP (NP (NN Carbamazepine)) (: :) (S (NP (NN EQUETROTM)) (VP (VBZ increases) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (DT the) (JJ following) (NNS agents)))))) (: :) (NP (NN Clomipramine) (NN HCl)) (, ,) (NP (NP (NN Phenytoin)) (PRN (-LRB- -LRB-) (NP (CD 6)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN primidone))))))))) (RB Thus)) (, ,) (SBAR (IN if) (S (NP (DT a) (NN patient)) (VP (VP (VBZ has) (VP (VBN been) (VP (VBN titrated) (PP (TO to) (NP (DT a) (JJ stable) (NN dosage))) (PP (IN on) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (NNS agents)) (PP (IN in) (NP (DT this) (NN category)))))))))) (, ,) (CC and) (VP (ADVP (RB then)) (VBZ begins) (NP (NP (DT a) (NN course)) (PP (IN of) (NP (NP (DT the) (NN treatment)) (PP (IN with) (NP (NN EQUETROTM)))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ reasonable) (S (VP (TO to) (VP (VB expect) (SBAR (IN that) (S (NP (NP (DT a) (NN dose) (NN decrease)) (PP (IN for) (NP (DT the) (JJ concomitant) (NN agent)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary))))))))))) (. .))))

npadvmod(Thus-31, Agents-1)
amod(Levels-4, Increased-3)
prep_with(Agents-1, Levels-4)
det(Presence-7, the-6)
prep_in(Levels-4, Presence-7)
prep_of(Presence-7, Carbamazepine-9)
nsubj(increases-12, EQUETROTM-11)
conj_and(Carbamazepine-9, increases-12)
det(levels-15, the-13)
nn(levels-15, plasma-14)
dobj(increases-12, levels-15)
det(agents-19, the-17)
amod(agents-19, following-18)
prep_of(levels-15, agents-19)
nn(HCl-22, Clomipramine-21)
conj_and(Carbamazepine-9, HCl-22)
conj_and(Carbamazepine-9, Phenytoin-24)
appos(Phenytoin-24, 6-26)
conj_and(Carbamazepine-9, primidone-30)
advmod(reasonable-65, Thus-31)
mark(titrated-38, if-33)
det(patient-35, a-34)
nsubjpass(titrated-38, patient-35)
aux(titrated-38, has-36)
auxpass(titrated-38, been-37)
advcl(reasonable-65, titrated-38)
det(dosage-42, a-40)
amod(dosage-42, stable-41)
prep_to(titrated-38, dosage-42)
prep_on(titrated-38, one-44)
det(agents-47, the-46)
prep_of(one-44, agents-47)
det(category-50, this-49)
prep_in(agents-47, category-50)
advmod(begins-54, then-53)
conj_and(titrated-38, begins-54)
det(course-56, a-55)
dobj(begins-54, course-56)
det(treatment-59, the-58)
prep_of(course-56, treatment-59)
prep_with(treatment-59, EQUETROTM-61)
nsubj(reasonable-65, it-63)
cop(reasonable-65, is-64)
root(ROOT-0, reasonable-65)
aux(expect-67, to-66)
xcomp(reasonable-65, expect-67)
complm(necessary-78, that-68)
det(decrease-71, a-69)
nn(decrease-71, dose-70)
nsubj(necessary-78, decrease-71)
det(agent-75, the-73)
amod(agent-75, concomitant-74)
prep_for(decrease-71, agent-75)
aux(necessary-78, may-76)
cop(necessary-78, be-77)
ccomp(expect-67, necessary-78)

Pharmacological/Pharmacodynamic/JJ Interactions/NNS with/IN Carbamazepine/NN Concomitant/JJ administration/NN of/IN carbamazepine/NN and/CC lithium/NN may/MD increase/VB the/DT risk/NN of/IN neurotoxic/JJ side/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Pharmacological/Pharmacodynamic) (NNS Interactions)) (PP (IN with) (NP (NP (NN Carbamazepine) (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN carbamazepine)) (CC and) (NP (NN lithium))))))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ neurotoxic) (JJ side) (NNS effects))))))) (. .))))

amod(Interactions-2, Pharmacological/Pharmacodynamic-1)
nsubj(increase-12, Interactions-2)
nn(administration-6, Carbamazepine-4)
amod(administration-6, Concomitant-5)
prep_with(Interactions-2, administration-6)
prep_of(administration-6, carbamazepine-8)
conj_and(carbamazepine-8, lithium-10)
aux(increase-12, may-11)
root(ROOT-0, increase-12)
det(risk-14, the-13)
dobj(increase-12, risk-14)
amod(effects-18, neurotoxic-16)
amod(effects-18, side-17)
prep_of(risk-14, effects-18)

Given/IN the/DT anticonvulsant/JJ properties/NNS of/IN carbamazepine/NN ,/, EQUETROTM/NN may/MD reduce/VB the/DT thyroid/NN function/NN as/IN has/VBZ been/VBN reported/VBN with/IN other/JJ anticonvulsants/NNS ./.

(ROOT (S1 (S (S (PP (IN Given) (NP (NP (DT the) (JJ anticonvulsant) (NNS properties)) (PP (IN of) (NP (NN carbamazepine))))) (, ,) (NP (NN EQUETROTM)) (VP (MD may) (VP (VB reduce) (NP (DT the) (NN thyroid) (NN function)) (SBAR (IN as) (S (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (JJ other) (NNS anticonvulsants))))))))))) (. .))))

det(properties-4, the-2)
amod(properties-4, anticonvulsant-3)
prep_given(reduce-10, properties-4)
prep_of(properties-4, carbamazepine-6)
nsubj(reduce-10, EQUETROTM-8)
aux(reduce-10, may-9)
root(ROOT-0, reduce-10)
det(function-13, the-11)
nn(function-13, thyroid-12)
dobj(reduce-10, function-13)
mark(reported-17, as-14)
aux(reported-17, has-15)
auxpass(reported-17, been-16)
advcl(reduce-10, reported-17)
amod(anticonvulsants-20, other-19)
prep_with(reported-17, anticonvulsants-20)

Additionally/RB ,/, anti-malarial/JJ drugs/NNS ,/, such/JJ as/IN chloroquine/NN and/CC mefloquine/NN ,/, may/MD antagonize/VB the/DT activity/NN of/IN carbamazepine/NN ./.

(ROOT (S1 (S (S (ADVP (RB Additionally)) (, ,) (NP (NP (JJ anti-malarial) (NNS drugs)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN chloroquine)) (CC and) (NP (NN mefloquine)))) (, ,)) (VP (MD may) (VP (VB antagonize) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NN carbamazepine))))))) (. .))))

advmod(antagonize-13, Additionally-1)
amod(drugs-4, anti-malarial-3)
nsubj(antagonize-13, drugs-4)
prep_such_as(drugs-4, chloroquine-8)
conj_and(chloroquine-8, mefloquine-10)
aux(antagonize-13, may-12)
root(ROOT-0, antagonize-13)
det(activity-15, the-14)
dobj(antagonize-13, activity-15)
prep_of(activity-15, carbamazepine-17)

Thus/RB if/IN a/DT patient/NN has/VBZ been/VBN titrated/VBN to/TO a/DT stable/JJ dosage/NN on/IN one/CD of/IN the/DT agents/NNS in/IN this/DT category/NN ,/, and/CC then/RB begins/VBZ a/DT course/NN of/IN treatment/NN with/IN EQUETROTM/NN ,/, it/PRP is/VBZ reasonable/JJ to/TO expect/VB that/IN a/DT dose/NN adjustment/NN may/MD be/VB necessary/JJ ./.

(ROOT (S1 (S (S (ADVP (RB Thus) (SBAR (IN if) (S (NP (DT a) (NN patient)) (VP (VP (VBZ has) (VP (VBN been) (VP (VBN titrated) (PP (TO to) (NP (NP (DT a) (JJ stable) (NN dosage)) (PP (IN on) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (NNS agents)) (PP (IN in) (NP (DT this) (NN category)))))))))))) (, ,) (CC and) (VP (ADVP (RB then)) (VBZ begins) (NP (NP (DT a) (NN course)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN with) (NP (NN EQUETROTM))))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ reasonable) (S (VP (TO to) (VP (VB expect) (SBAR (IN that) (S (NP (DT a) (NN dose) (NN adjustment)) (VP (MD may) (VP (VB be) (ADJP (JJ necessary)))))))))))) (. .))))

advmod(reasonable-33, Thus-1)
mark(titrated-7, if-2)
det(patient-4, a-3)
nsubjpass(titrated-7, patient-4)
aux(titrated-7, has-5)
auxpass(titrated-7, been-6)
dep(Thus-1, titrated-7)
det(dosage-11, a-9)
amod(dosage-11, stable-10)
prep_to(titrated-7, dosage-11)
prep_on(dosage-11, one-13)
det(agents-16, the-15)
prep_of(one-13, agents-16)
det(category-19, this-18)
prep_in(agents-16, category-19)
advmod(begins-23, then-22)
conj_and(titrated-7, begins-23)
det(course-25, a-24)
dobj(begins-23, course-25)
prep_of(course-25, treatment-27)
prep_with(treatment-27, EQUETROTM-29)
nsubj(reasonable-33, it-31)
cop(reasonable-33, is-32)
root(ROOT-0, reasonable-33)
aux(expect-35, to-34)
xcomp(reasonable-33, expect-35)
complm(necessary-42, that-36)
det(adjustment-39, a-37)
nn(adjustment-39, dose-38)
nsubj(necessary-42, adjustment-39)
aux(necessary-42, may-40)
cop(necessary-42, be-41)
ccomp(expect-35, necessary-42)

Because/IN of/IN its/PRP$ primary/JJ CNS/NN effect/NN ,/, caution/NN should/MD be/VB used/VBN when/WRB EQUETROTM/NN is/VBZ taken/VBN with/IN other/JJ centrally/RB acting/VBG drugs/NNS and/CC alcohol/NN ./.

(ROOT (S1 (S (S (PP (IN Because) (PP (IN of) (NP (PRP$ its) (JJ primary) (NN CNS) (NN effect)))) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN used))) (SBAR (WHADVP (WRB when)) (S (NP (NN EQUETROTM)) (VP (VBZ is) (VP (VBN taken) (PP (IN with) (NP (NP (JJ other) (ADJP (RB centrally) (VBG acting)) (NNS drugs)) (CC and) (NP (NN alcohol)))))))))) (. .))))

prepc_because_of(used-11, of-2)
poss(effect-6, its-3)
amod(effect-6, primary-4)
nn(effect-6, CNS-5)
pobj(used-11, effect-6)
nsubjpass(used-11, caution-8)
aux(used-11, should-9)
auxpass(used-11, be-10)
root(ROOT-0, used-11)
advmod(taken-15, when-12)
nsubjpass(taken-15, EQUETROTM-13)
auxpass(taken-15, is-14)
advcl(used-11, taken-15)
amod(drugs-20, other-17)
advmod(acting-19, centrally-18)
amod(drugs-20, acting-19)
prep_with(taken-15, drugs-20)
conj_and(drugs-20, alcohol-22)

Caution/NN should/MD be/VB exercised/VBN when/WRB the/DT following/JJ drugs/NNS are/VBP administered/VBN concomitantly/RB with/IN LODOSYN/NN (/-LRB- Carbidopa/NN )/-RRB- given/VBN with/IN levodopa/NN or/CC carbidopa-levodopa/NN combination/NN products/NNS ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (JJ following) (NNS drugs)) (VP (VBP are) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NP (NN LODOSYN)) (PRN (-LRB- -LRB-) (NP (NN Carbidopa)) (-RRB- -RRB-))) (VP (VBN given) (PP (IN with) (NP (NP (NN levodopa)) (CC or) (NP (NN carbidopa-levodopa) (NN combination) (NNS products))))))))))))))) (. .))))

nsubjpass(exercised-4, Caution-1)
aux(exercised-4, should-2)
auxpass(exercised-4, be-3)
root(ROOT-0, exercised-4)
advmod(administered-10, when-5)
det(drugs-8, the-6)
amod(drugs-8, following-7)
nsubjpass(administered-10, drugs-8)
auxpass(administered-10, are-9)
advcl(exercised-4, administered-10)
advmod(administered-10, concomitantly-11)
prep_with(administered-10, LODOSYN-13)
appos(LODOSYN-13, Carbidopa-15)
partmod(LODOSYN-13, given-17)
prep_with(given-17, levodopa-19)
nn(products-23, carbidopa-levodopa-21)
nn(products-23, combination-22)
conj_or(levodopa-19, products-23)

Symptomatic/JJ postural/JJ hypotension/NN has/VBZ occurred/VBN when/WRB LODOSYN/NN ,/, given/VBN with/IN levodopa/NN or/CC carbidopa-levodopa/NN combination/NN products/NNS ,/, was/VBD added/VBN to/TO the/DT treatment/NN of/IN a/DT patient/NN receiving/VBG antihypertensive/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (JJ Symptomatic) (JJ postural) (NN hypotension)) (VP (VBZ has) (VP (VBN occurred) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN LODOSYN)) (, ,) (VP (VBN given) (PP (IN with) (NP (NP (NN levodopa)) (CC or) (NP (NN carbidopa-levodopa) (NN combination) (NNS products))))) (, ,)) (VP (VBD was) (VP (VBN added) (PP (TO to) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (JJ antihypertensive) (NNS drugs)))))))))))))) (. .))))

amod(hypotension-3, Symptomatic-1)
amod(hypotension-3, postural-2)
nsubj(occurred-5, hypotension-3)
aux(occurred-5, has-4)
root(ROOT-0, occurred-5)
advmod(added-18, when-6)
nsubjpass(added-18, LODOSYN-7)
partmod(LODOSYN-7, given-9)
prep_with(given-9, levodopa-11)
nn(products-15, carbidopa-levodopa-13)
nn(products-15, combination-14)
conj_or(levodopa-11, products-15)
auxpass(added-18, was-17)
advcl(occurred-5, added-18)
det(treatment-21, the-20)
prep_to(added-18, treatment-21)
det(patient-24, a-23)
prep_of(treatment-21, patient-24)
partmod(patient-24, receiving-25)
amod(drugs-27, antihypertensive-26)
dobj(receiving-25, drugs-27)

Therefore/RB ,/, when/WRB therapy/NN with/IN LODOSYN/NN ,/, given/VBN with/IN or/CC without/IN levodopa/NN or/CC carbidopa-levodopa/NN combination/NN products/NNS ,/, is/VBZ started/VBN ,/, dosage/NN adjustment/NN of/IN the/DT antihypertensive/JJ drug/NN may/MD be/VB required/VBN ./.

(ROOT (S1 (S (ADVP (RB Therefore)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN therapy)) (PP (IN with) (NP (NP (NN LODOSYN)) (, ,) (VP (VBN given) (PP (IN with) (CC or) (PP (IN without) (NP (NP (NN levodopa)) (CC or) (NP (NN carbidopa-levodopa) (NN combination) (NNS products)))))) (, ,)))) (VP (VBZ is) (VP (VBN started))))) (, ,) (NP (NP (NN dosage) (NN adjustment)) (PP (IN of) (NP (DT the) (JJ antihypertensive) (NN drug)))) (VP (MD may) (VP (VB be) (VP (VBN required)))) (. .))))

advmod(required-29, Therefore-1)
advmod(started-19, when-3)
nsubjpass(started-19, therapy-4)
prep_with(therapy-4, LODOSYN-6)
partmod(LODOSYN-6, given-8)
prep(given-8, with-9)
conj_or(with-9, without-11)
pobj(without-11, levodopa-12)
nn(products-16, carbidopa-levodopa-14)
nn(products-16, combination-15)
conj_or(levodopa-12, products-16)
auxpass(started-19, is-18)
advcl(required-29, started-19)
nn(adjustment-22, dosage-21)
nsubjpass(required-29, adjustment-22)
det(drug-26, the-24)
amod(drug-26, antihypertensive-25)
prep_of(adjustment-22, drug-26)
aux(required-29, may-27)
auxpass(required-29, be-28)
root(ROOT-0, required-29)

For/IN patients/NNS receiving/VBG monoamine/NN oxidase/NN inhibitors/NNS ,/, see/VB CONTRAINDICATIONS/NNS ./.

(ROOT (S1 (S (S (PP (IN For) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN monoamine) (NN oxidase) (NNS inhibitors))))) (, ,) (VP (VB see) (NP (NNS CONTRAINDICATIONS)))) (. .))))

prep_for(see-8, patients-2)
partmod(patients-2, receiving-3)
nn(inhibitors-6, monoamine-4)
nn(inhibitors-6, oxidase-5)
dobj(receiving-3, inhibitors-6)
root(ROOT-0, see-8)
dobj(see-8, CONTRAINDICATIONS-9)

Concomitant/JJ therapy/NN with/IN selegiline/NN and/CC carbidopa-levodopa/NN may/MD be/VB associated/VBN with/IN severe/JJ orthostatic/JJ hypotension/NN not/RB attributable/JJ to/TO carbidopa-levodopa/NN alone/RB ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN therapy)) (PP (IN with) (NP (NP (NN selegiline)) (CC and) (NP (NN carbidopa-levodopa))))) (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (JJ severe) (JJ orthostatic) (NN hypotension)) (ADJP (RB not) (JJ attributable) (PP (TO to) (NP (NP (NN carbidopa-levodopa)) (ADVP (RB alone))))))))))) (. .))))

amod(therapy-2, Concomitant-1)
nsubjpass(associated-9, therapy-2)
prep_with(therapy-2, selegiline-4)
conj_and(selegiline-4, carbidopa-levodopa-6)
aux(associated-9, may-7)
auxpass(associated-9, be-8)
root(ROOT-0, associated-9)
amod(hypotension-13, severe-11)
amod(hypotension-13, orthostatic-12)
prep_with(associated-9, hypotension-13)
neg(attributable-15, not-14)
amod(hypotension-13, attributable-15)
prep_to(attributable-15, carbidopa-levodopa-17)
advmod(carbidopa-levodopa-17, alone-18)

There/EX have/VBP been/VBN rare/JJ reports/NNS of/IN adverse/JJ reactions/NNS ,/, including/VBG hypertension/NN and/CC dyskinesia/NN ,/, resulting/VBG from/IN the/DT concomitant/JJ use/NN of/IN tricyclic/JJ antidepressants/NNS and/CC carbidopa-levodopa/NN preparations/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (JJ rare) (NNS reports)) (PP (IN of) (NP (JJ adverse) (NNS reactions))) (, ,) (PP (VBG including) (NP (NP (NN hypertension)) (CC and) (NP (NN dyskinesia)))) (, ,) (VP (VBG resulting) (PP (IN from) (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (JJ tricyclic) (NNS antidepressants)) (CC and) (NP (NN carbidopa-levodopa) (NNS preparations))))))))))) (. .))))

expl(reports-5, There-1)
aux(reports-5, have-2)
cop(reports-5, been-3)
amod(reports-5, rare-4)
root(ROOT-0, reports-5)
amod(reactions-8, adverse-7)
prep_of(reports-5, reactions-8)
prep_including(reports-5, hypertension-11)
conj_and(hypertension-11, dyskinesia-13)
partmod(reports-5, resulting-15)
det(use-19, the-17)
amod(use-19, concomitant-18)
prep_from(resulting-15, use-19)
amod(antidepressants-22, tricyclic-21)
prep_of(use-19, antidepressants-22)
nn(preparations-25, carbidopa-levodopa-24)
conj_and(antidepressants-22, preparations-25)

Dopamine/NN D2/NN receptor/NN antagonists/NNS (/-LRB- e.g./FW ,/, phenothiazines/NNS ,/, butyrophenones/NNS ,/, risperidone/NN )/-RRB- and/CC isoniazid/NN may/MD reduce/VB the/DT therapeutic/JJ effects/NNS of/IN levodopa/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Dopamine) (NN D2) (NN receptor) (NNS antagonists)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NNS phenothiazines)) (, ,) (NP (NNS butyrophenones)) (, ,) (NP (NN risperidone))) (-RRB- -RRB-))) (CC and) (NP (NN isoniazid))) (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (JJ therapeutic) (NNS effects)) (PP (IN of) (NP (NN levodopa))))))) (. .))))

nn(antagonists-4, Dopamine-1)
nn(antagonists-4, D2-2)
nn(antagonists-4, receptor-3)
nsubj(reduce-17, antagonists-4)
dep(phenothiazines-8, e.g.-6)
dep(antagonists-4, phenothiazines-8)
appos(phenothiazines-8, butyrophenones-10)
appos(phenothiazines-8, risperidone-12)
conj_and(antagonists-4, isoniazid-15)
aux(reduce-17, may-16)
root(ROOT-0, reduce-17)
det(effects-20, the-18)
amod(effects-20, therapeutic-19)
dobj(reduce-17, effects-20)
prep_of(effects-20, levodopa-22)

In/IN addition/NN ,/, the/DT beneficial/JJ effects/NNS of/IN levodopa/NN in/IN Parkinsons/NN disease/NN have/VBP been/VBN reported/VBN to/TO be/VB reversed/VBN by/IN phenytoin/NN and/CC papaverine/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT the) (JJ beneficial) (NNS effects)) (PP (IN of) (NP (NN levodopa))) (PP (IN in) (NP (NN Parkinsons) (NN disease)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (VP (VBN reversed) (PP (IN by) (NP (NP (NN phenytoin)) (CC and) (NP (NN papaverine)))))))))))) (. .))))

prep_in(reported-14, addition-2)
det(effects-6, the-4)
amod(effects-6, beneficial-5)
nsubjpass(reported-14, effects-6)
xsubj(reversed-17, effects-6)
prep_of(effects-6, levodopa-8)
nn(disease-11, Parkinsons-10)
prep_in(effects-6, disease-11)
aux(reported-14, have-12)
auxpass(reported-14, been-13)
root(ROOT-0, reported-14)
aux(reversed-17, to-15)
auxpass(reversed-17, be-16)
xcomp(reported-14, reversed-17)
agent(reversed-17, phenytoin-19)
conj_and(phenytoin-19, papaverine-21)

Patients/NNS taking/VBG these/DT drugs/NNS with/IN LODOSYN/NN and/CC levodopa/NN or/CC carbidopa-levodopa/NN combination/NN products/NNS should/MD be/VB carefully/RB observed/VBN for/IN loss/NN of/IN therapeutic/JJ response/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG taking) (NP (DT these) (NNS drugs)) (PP (IN with) (NP (NP (NP (NN LODOSYN)) (CC and) (NP (NN levodopa))) (CC or) (NP (NN carbidopa-levodopa) (NN combination) (NNS products)))))) (VP (MD should) (VP (VB be) (ADVP (RB carefully)) (VP (VBN observed) (PP (IN for) (NP (NP (NN loss)) (PP (IN of) (NP (JJ therapeutic) (NN response))))))))) (. .))))

nsubjpass(observed-16, Patients-1)
partmod(Patients-1, taking-2)
det(drugs-4, these-3)
dobj(taking-2, drugs-4)
prep_with(taking-2, LODOSYN-6)
conj_and(LODOSYN-6, levodopa-8)
nn(products-12, carbidopa-levodopa-10)
nn(products-12, combination-11)
conj_or(LODOSYN-6, products-12)
aux(observed-16, should-13)
auxpass(observed-16, be-14)
advmod(observed-16, carefully-15)
root(ROOT-0, observed-16)
prep_for(observed-16, loss-18)
amod(response-21, therapeutic-20)
prep_of(loss-18, response-21)

Iron/NN salts/NNS may/MD reduce/VB the/DT bioavailability/NN of/IN carbidopa/NN and/CC levodopa/NN ./.

(ROOT (S1 (S (S (NP (NN Iron) (NNS salts)) (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (NP (NN carbidopa)) (CC and) (NP (NN levodopa)))))))) (. .))))

nn(salts-2, Iron-1)
nsubj(reduce-4, salts-2)
aux(reduce-4, may-3)
root(ROOT-0, reduce-4)
det(bioavailability-6, the-5)
dobj(reduce-4, bioavailability-6)
prep_of(bioavailability-6, carbidopa-8)
conj_and(carbidopa-8, levodopa-10)

Although/IN metoclopramide/NN may/MD increase/VB the/DT bioavailability/NN of/IN levodopa/NN by/IN increasing/VBG gastric/JJ emptying/NN ,/, metoclopramide/NN may/MD also/RB adversely/RB affect/VBP disease/NN control/NN by/IN its/PRP$ dopamine/NN receptor/NN antagonistic/JJ properties/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NN metoclopramide)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (NN levodopa)))) (PP (IN by) (S (VP (VBG increasing) (NP (JJ gastric) (NN emptying))))))))) (, ,) (NP (NN metoclopramide)) (VP (MD may) (ADVP (RB also)) (VP (ADVP (RB adversely)) (VP (VBP affect) (NP (NN disease) (NN control)) (PP (IN by) (NP (PRP$ its) (NN dopamine) (NN receptor)))) (NP (JJ antagonistic) (NNS properties))))) (. .))))

mark(increase-4, Although-1)
nsubj(increase-4, metoclopramide-2)
aux(increase-4, may-3)
advcl(affect-18, increase-4)
det(bioavailability-6, the-5)
dobj(increase-4, bioavailability-6)
prep_of(bioavailability-6, levodopa-8)
prepc_by(increase-4, increasing-10)
amod(emptying-12, gastric-11)
dobj(increasing-10, emptying-12)
nsubj(affect-18, metoclopramide-14)
aux(affect-18, may-15)
advmod(affect-18, also-16)
advmod(affect-18, adversely-17)
root(ROOT-0, affect-18)
nn(control-20, disease-19)
dobj(affect-18, control-20)
poss(receptor-24, its-22)
nn(receptor-24, dopamine-23)
prep_by(affect-18, receptor-24)
amod(properties-26, antagonistic-25)
dobj(affect-18, properties-26)

Antihistamines/NNS may/MD enhance/VB the/DT effects/NNS of/IN tricyclic/JJ antidepressants/NNS ,/, barbiturates/NNS ,/, alcohol/NN ,/, and/CC other/JJ CNS/NN depressants/NNS ./.

(ROOT (S1 (S (S (NP (NNS Antihistamines)) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ tricyclic) (NNS antidepressants)) (, ,) (NP (NNS barbiturates)) (, ,) (NP (NN alcohol)) (, ,) (CC and) (NP (JJ other) (NN CNS) (NNS depressants)))))))) (. .))))

nsubj(enhance-3, Antihistamines-1)
aux(enhance-3, may-2)
root(ROOT-0, enhance-3)
det(effects-5, the-4)
dobj(enhance-3, effects-5)
amod(antidepressants-8, tricyclic-7)
prep_of(effects-5, antidepressants-8)
conj_and(antidepressants-8, barbiturates-10)
conj_and(antidepressants-8, alcohol-12)
amod(depressants-17, other-15)
nn(depressants-17, CNS-16)
conj_and(antidepressants-8, depressants-17)

MAO/NN inhibitors/NNS prolong/VBP and/CC intensify/VBP the/DT anticholinergic/JJ effects/NNS of/IN antihistamines/NNS ./.

(ROOT (S1 (S (S (NP (NN MAO) (NNS inhibitors)) (VP (VP (VBP prolong)) (CC and) (VP (VBP intensify) (NP (NP (DT the) (JJ anticholinergic) (NNS effects)) (PP (IN of) (NP (NNS antihistamines))))))) (. .))))

nn(inhibitors-2, MAO-1)
nsubj(prolong-3, inhibitors-2)
root(ROOT-0, prolong-3)
conj_and(prolong-3, intensify-5)
det(effects-8, the-6)
amod(effects-8, anticholinergic-7)
dobj(intensify-5, effects-8)
prep_of(effects-8, antihistamines-10)

Sympathomimetic/JJ amines/NNS may/MD reduce/VB the/DT antihypertensive/JJ effects/NNS of/IN reserpine/NN ,/, veratrum/NN alkaloids/NNS ,/, methyldopa/NN and/CC mecamylamine/NN ./.

(ROOT (S1 (S (S (NP (JJ Sympathomimetic) (NNS amines)) (VP (MD may) (VP (VB reduce) (NP (NP (NP (DT the) (JJ antihypertensive) (NNS effects)) (PP (IN of) (NP (NN reserpine)))) (, ,) (NP (NN veratrum) (NNS alkaloids)) (, ,) (NP (NP (NN methyldopa)) (CC and) (NP (NN mecamylamine))))))) (. .))))

amod(amines-2, Sympathomimetic-1)
nsubj(reduce-4, amines-2)
aux(reduce-4, may-3)
root(ROOT-0, reduce-4)
det(effects-7, the-5)
amod(effects-7, antihypertensive-6)
dobj(reduce-4, effects-7)
prep_of(effects-7, reserpine-9)
nn(alkaloids-12, veratrum-11)
appos(effects-7, alkaloids-12)
appos(effects-7, methyldopa-14)
conj_and(methyldopa-14, mecamylamine-16)

Effects/NNS of/IN sympathomimetics/NNS are/VBP increased/VBN with/IN MAO/NN inhibitors/NNS and/CC beta/NN adrenergic/JJ blockers/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Effects)) (PP (IN of) (NP (NNS sympathomimetics)))) (VP (VBP are) (VP (VBN increased) (PP (IN with) (NP (NP (NN MAO) (NNS inhibitors)) (CC and) (NP (NN beta) (JJ adrenergic) (NNS blockers))))))) (. .))))

nsubjpass(increased-5, Effects-1)
prep_of(Effects-1, sympathomimetics-3)
auxpass(increased-5, are-4)
root(ROOT-0, increased-5)
nn(inhibitors-8, MAO-7)
prep_with(increased-5, inhibitors-8)
nn(blockers-12, beta-10)
amod(blockers-12, adrenergic-11)
conj_and(inhibitors-8, blockers-12)

HEMABATE/NN may/MD augment/VB the/DT activity/NN of/IN other/JJ oxytocic/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (NN HEMABATE)) (VP (MD may) (VP (VB augment) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (JJ other) (JJ oxytocic) (NNS agents))))))) (. .))))

nsubj(augment-3, HEMABATE-1)
aux(augment-3, may-2)
root(ROOT-0, augment-3)
det(activity-5, the-4)
dobj(augment-3, activity-5)
amod(agents-9, other-7)
amod(agents-9, oxytocic-8)
prep_of(activity-5, agents-9)

Concomitant/JJ use/NN with/IN other/JJ oxytocic/JJ agents/NNS is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN with) (NP (JJ other) (JJ oxytocic) (NNS agents)))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

amod(use-2, Concomitant-1)
nsubjpass(recommended-9, use-2)
amod(agents-6, other-4)
amod(agents-6, oxytocic-5)
prep_with(use-2, agents-6)
auxpass(recommended-9, is-7)
neg(recommended-9, not-8)
root(ROOT-0, recommended-9)

Ocupress/NN should/MD be/VB used/VBN with/IN caution/NN in/IN patients/NNS who/WP are/VBP receiving/VBG a/DT beta-adrenergic/JJ blocking/NN agent/NN orally/RB because/IN of/IN the/DT potential/NN for/IN additive/JJ effects/NNS on/IN systemic/JJ beta-blockade/NN ./.

(ROOT (S1 (S (S (NP (NN Ocupress)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN caution))) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG receiving) (NP (NP (DT a) (JJ beta-adrenergic) (NN blocking) (NN agent)) (ADVP (RB orally))) (PP (IN because) (IN of) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (JJ additive) (NNS effects)) (PP (IN on) (NP (JJ systemic) (NN beta-blockade))))))))))))))))) (. .))))

nsubjpass(used-4, Ocupress-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
prep_with(used-4, caution-6)
prep_in(used-4, patients-8)
nsubj(receiving-11, patients-8)
aux(receiving-11, are-10)
rcmod(patients-8, receiving-11)
det(agent-15, a-12)
amod(agent-15, beta-adrenergic-13)
nn(agent-15, blocking-14)
dobj(receiving-11, agent-15)
advmod(agent-15, orally-16)
det(potential-20, the-19)
prep_because_of(receiving-11, potential-20)
amod(effects-23, additive-22)
prep_for(potential-20, effects-23)
amod(beta-blockade-26, systemic-25)
prep_on(effects-23, beta-blockade-26)

Close/JJ observation/NN of/IN the/DT patient/NN is/VBZ recommended/VBN when/WRB a/DT beta-blocker/NN is/VBZ administered/VBN to/TO patients/NNS receiving/VBG catecholamine-depleting/JJ drugs/NNS such/JJ as/IN reserpine/NN ,/, because/IN of/IN possible/JJ additive/JJ effects/NNS and/CC the/DT production/NN of/IN hypotension/NN and/or/CC marked/JJ bradycardia/NN ,/, which/WDT may/MD produce/VB vertigo/NN ,/, syncope/NN ,/, or/CC postural/JJ hypotension/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Close) (NN observation)) (PP (IN of) (NP (DT the) (NN patient)))) (VP (VBZ is) (VP (VBN recommended) (SBAR (WHADVP (WRB when)) (S (NP (DT a) (NN beta-blocker)) (VP (VBZ is) (VP (VBN administered) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (JJ catecholamine-depleting) (NNS drugs)) (PP (JJ such) (IN as) (NP (NN reserpine))) (, ,) (PP (IN because) (PP (IN of) (NP (NP (JJ possible) (JJ additive) (NNS effects)) (CC and) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (NN hypotension)) (CC and/or) (NP (JJ marked) (NN bradycardia)))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB produce) (NP (NP (NN vertigo)) (, ,) (NP (NN syncope)) (, ,) (CC or) (NP (JJ postural) (NN hypotension)))))))))))))))))) (. .))))

amod(observation-2, Close-1)
nsubjpass(recommended-7, observation-2)
det(patient-5, the-4)
prep_of(observation-2, patient-5)
auxpass(recommended-7, is-6)
root(ROOT-0, recommended-7)
advmod(administered-12, when-8)
det(beta-blocker-10, a-9)
nsubjpass(administered-12, beta-blocker-10)
auxpass(administered-12, is-11)
advcl(recommended-7, administered-12)
prep_to(administered-12, patients-14)
partmod(patients-14, receiving-15)
amod(drugs-17, catecholamine-depleting-16)
dobj(receiving-15, drugs-17)
prep_such_as(drugs-17, reserpine-20)
prepc_because_of(drugs-17, of-23)
amod(effects-26, possible-24)
amod(effects-26, additive-25)
pobj(drugs-17, effects-26)
det(production-29, the-28)
conj_and(effects-26, production-29)
prep_of(production-29, hypotension-31)
amod(bradycardia-34, marked-33)
conj_and/or(hypotension-31, bradycardia-34)
nsubj(produce-38, which-36)
aux(produce-38, may-37)
rcmod(drugs-17, produce-38)
dobj(produce-38, vertigo-39)
conj_or(vertigo-39, syncope-41)
amod(hypotension-45, postural-44)
conj_or(vertigo-39, hypotension-45)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS Positive/JJ direct/JJ Coombs/NN @/NN tests/NNS have/VBP been/VBN reported/VBN during/IN treatment/NN with/IN the/DT cephalosporin/JJ antibiotics/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (PP (JJ Positive) (NP (JJ direct) (NN Coombs) (NN @) (NNS tests)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN during) (NP (NP (NN treatment)) (PP (IN with) (NP (DT the) (JJ cephalosporin) (NNS antibiotics))))))))) (. .))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
nsubjpass(reported-12, Interactions-4)
prep(Interactions-4, Positive-5)
amod(tests-9, direct-6)
nn(tests-9, Coombs-7)
nn(tests-9, @-8)
dep(Positive-5, tests-9)
aux(reported-12, have-10)
auxpass(reported-12, been-11)
root(ROOT-0, reported-12)
prep_during(reported-12, treatment-14)
det(antibiotics-18, the-16)
amod(antibiotics-18, cephalosporin-17)
prep_with(treatment-14, antibiotics-18)

In/IN hematologic/JJ studies/NNS or/CC in/IN transfusion/NN cross-matching/NN procedures/NNS when/WRB anti-globulin/NN tests/NNS are/VBP performed/VBN on/IN the/DT minor/JJ side/NN or/CC in/IN Coombs/NN @/NN testing/NN of/IN newborns/NNS whose/WP$ mothers/NNS have/VBP received/VBN cephalosporin/JJ antibiotics/NNS before/IN parturition/NN ,/, it/PRP should/MD be/VB recognized/VBN that/IN a/DT positive/JJ Coombs/NN @/NN test/NN may/MD be/VB due/JJ to/TO the/DT drug/NN ./.

(ROOT (S1 (S (PP (PP (IN In) (NP (JJ hematologic) (NNS studies))) (CC or) (PP (IN in) (NP (NP (NN transfusion) (NN cross-matching) (NNS procedures)) (SBAR (WHADVP (WRB when)) (S (NP (NN anti-globulin) (NNS tests)) (VP (VBP are) (VP (VBN performed) (PP (IN on) (NP (DT the) (JJ minor) (NN side))))))))) (CC or) (PP (IN in) (NP (NP (NN Coombs) (NN @) (NN testing)) (PP (IN of) (NP (NP (NNS newborns)) (SBAR (WHNP (WP$ whose) (NNS mothers)) (S (VP (VBP have) (VP (VBN received) (NP (NP (JJ cephalosporin) (NNS antibiotics)) (PP (IN before) (NP (NN parturition))))))))))))) (, ,) (NP (PRP it)) (VP (MD should) (VP (VB be) (VP (VBN recognized) (SBAR (IN that) (S (NP (DT a) (JJ positive) (NN Coombs) (NN @) (NN test)) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (DT the) (NN drug))))))))))) (. .))))

amod(studies-3, hematologic-2)
prep_in(recognized-37, studies-3)
cc(recognized-37, or-4)
nn(procedures-8, transfusion-6)
nn(procedures-8, cross-matching-7)
tmod(performed-13, procedures-8)
prep_in(recognized-37', procedures-8)
advmod(performed-13, when-9)
nn(tests-11, anti-globulin-10)
nsubjpass(performed-13, tests-11)
auxpass(performed-13, are-12)
dep(procedures-8, performed-13)
det(side-17, the-15)
amod(side-17, minor-16)
prep_on(performed-13, side-17)
nn(testing-22, Coombs-20)
nn(testing-22, @-21)
prep_in(recognized-37'', testing-22)
prep_of(testing-22, newborns-24)
poss(mothers-26, newborns-24)
nsubj(received-28, mothers-26)
aux(received-28, have-27)
rcmod(newborns-24, received-28)
amod(antibiotics-30, cephalosporin-29)
dobj(received-28, antibiotics-30)
prep_before(antibiotics-30, parturition-32)
nsubjpass(recognized-37, it-34)
aux(recognized-37, should-35)
auxpass(recognized-37, be-36)
root(ROOT-0, recognized-37)
conj_or(recognized-37, recognized-37')
conj_or(recognized-37, recognized-37'')
complm(due-46, that-38)
det(test-43, a-39)
amod(test-43, positive-40)
nn(test-43, Coombs-41)
nn(test-43, @-42)
nsubj(due-46, test-43)
aux(due-46, may-44)
cop(due-46, be-45)
ccomp(recognized-37, due-46)
det(drug-49, the-48)
prep_to(due-46, drug-49)

Antacids/NNS (/-LRB- aluminum-/JJ or/CC magnesium/NN -containing/JJ )/-RRB- Concomitant/JJ administration/NN of/IN 300-mg/NN cefdinir/NN capsules/NNS with/IN 30/CD mL/NN Maalox/NN @/NN TC/NN suspension/NN reduces/VBZ the/DT rate/NN (/-LRB- Cmax/NN )/-RRB- and/CC extent/NN (/-LRB- AUC/NN )/-RRB- of/IN absorption/NN by/IN approximately/RB 40/CD %./NN

(ROOT (S1 (S (NP (NP (NP (NNS Antacids)) (PRN (-LRB- -LRB-) (ADJP (ADJP (JJ aluminum-)) (CC or) (ADJP (NN magnesium) (JJ -containing))) (-RRB- -RRB-))) (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN 300-mg) (NN cefdinir) (NNS capsules)) (PP (IN with) (NP (ADJP (CD 30) (NN mL)) (NN Maalox) (NN @) (NN TC) (NN suspension)))))) (VP (VBZ reduces) (NP (NP (NP (NP (DT the) (NN rate)) (PRN (-LRB- -LRB-) (NP (NN Cmax)) (-RRB- -RRB-))) (CC and) (NP (NP (NN extent)) (PRN (-LRB- -LRB-) (NP (NN AUC)) (-RRB- -RRB-)))) (PP (IN of) (NP (NN absorption)))) (PP (IN by) (NP (QP (RB approximately) (CD 40)) (NN %.)))))))))

root(ROOT-0, Antacids-1)
dep(Antacids-1, aluminum--3)
dep(-containing-6, magnesium-5)
conj_or(aluminum--3, -containing-6)
amod(administration-9, Concomitant-8)
nsubj(reduces-21, administration-9)
nn(capsules-13, 300-mg-11)
nn(capsules-13, cefdinir-12)
prep_of(administration-9, capsules-13)
number(mL-16, 30-15)
amod(suspension-20, mL-16)
nn(suspension-20, Maalox-17)
nn(suspension-20, @-18)
nn(suspension-20, TC-19)
prep_with(capsules-13, suspension-20)
dep(Antacids-1, reduces-21)
det(rate-23, the-22)
dobj(reduces-21, rate-23)
appos(rate-23, Cmax-25)
conj_and(rate-23, extent-28)
abbrev(extent-28, AUC-30)
prep_of(rate-23, absorption-33)
quantmod(40-36, approximately-35)
num(%.-37, 40-36)
prep_by(reduces-21, %.-37)

There/EX are/VBP no/DT significant/JJ effects/NNS on/IN cefdinir/NN pharmacokinetics/NNS if/IN the/DT antacid/JJ is/VBZ administered/VBN 2/CD hours/NNS before/IN or/CC 2/CD hours/NNS after/IN cefdinir/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP are) (NP (NP (DT no) (JJ significant) (NNS effects)) (PP (IN on) (NP (NN cefdinir) (NNS pharmacokinetics)))) (SBAR (IN if) (S (NP (DT the) (JJ antacid)) (VP (VBZ is) (VP (VBN administered) (NP (NP (NP (CD 2) (NNS hours)) (PP (IN before))) (CC or) (NP (NP (CD 2) (NNS hours)) (PP (IN after) (NP (NN cefdinir))))))))))) (. .))))

expl(are-2, There-1)
root(ROOT-0, are-2)
det(effects-5, no-3)
amod(effects-5, significant-4)
nsubj(are-2, effects-5)
nn(pharmacokinetics-8, cefdinir-7)
prep_on(effects-5, pharmacokinetics-8)
mark(administered-13, if-9)
det(antacid-11, the-10)
nsubjpass(administered-13, antacid-11)
auxpass(administered-13, is-12)
advcl(are-2, administered-13)
num(hours-15, 2-14)
dobj(administered-13, hours-15)
prep(hours-15, before-16)
num(hours-19, 2-18)
conj_or(hours-15, hours-19)
prep_after(hours-19, cefdinir-21)

If/IN antacids/NNS are/VBP required/VBN during/IN OMNICEF/NN therapy/NN ,/, OMNICEF/NN should/MD be/VB taken/VBN at/IN least/JJS 2/CD hours/NNS before/IN or/CC after/IN the/DT antacid/JJ ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NNS antacids)) (VP (VBP are) (VP (VBN required) (PP (IN during) (NP (NN OMNICEF) (NN therapy))))))) (, ,) (NP (NN OMNICEF)) (VP (MD should) (VP (VB be) (VP (VBN taken) (PP (IN at) (NP (QP (JJS least) (CD 2)) (NNS hours))) (PP (PP (IN before)) (CC or) (PP (IN after) (NP (DT the) (JJ antacid)))))))) (. .))))

mark(required-4, If-1)
nsubjpass(required-4, antacids-2)
auxpass(required-4, are-3)
advcl(taken-12, required-4)
nn(therapy-7, OMNICEF-6)
prep_during(required-4, therapy-7)
nsubjpass(taken-12, OMNICEF-9)
aux(taken-12, should-10)
auxpass(taken-12, be-11)
root(ROOT-0, taken-12)
quantmod(2-15, least-14)
num(hours-16, 2-15)
prep_at(taken-12, hours-16)
prep(taken-12, before-17)
conj_or(before-17, after-19)
det(antacid-21, the-20)
pobj(after-19, antacid-21)

Probenecid/NN :/: As/IN with/IN other/JJ b/NN span/NN class=/NN c233/NN -lactam/NN antibiotics/NNS ,/, probenecid/NN inhibits/VBZ the/DT renal/JJ excretion/NN of/IN cefdinir/NN ,/, resulting/VBG in/IN an/DT approximate/JJ doubling/JJ in/IN A.C./NNP a/DT 54/CD %/NN increase/NN in/IN peak/NN cefdinir/NN plasma/NN levels/NNS ,/, and/CC a/DT 50/CD %/NN prolongation/NN in/IN the/DT apparent/JJ elimination/NN half-life/NN ./.

(ROOT (S1 (S (NP (NP (NN Probenecid)) (: :) (S (PP (IN As) (PP (IN with) (NP (JJ other) (NN b) (NN span) (NN class=) (NN c233) (NN -lactam) (NNS antibiotics)))) (, ,) (NP (NN probenecid)) (VP (VBZ inhibits) (NP (NP (DT the) (JJ renal) (NN excretion)) (PP (IN of) (NP (NN cefdinir)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT an) (JJ approximate) (JJ doubling)) (PP (IN in) (NP (NNP A.C.))))) (NP (NP (NP (DT a) (ADJP (CD 54) (NN %)) (NN increase)) (PP (IN in) (NP (NN peak) (NN cefdinir) (NN plasma) (NNS levels)))) (, ,) (CC and) (NP (NP (DT a) (ADJP (CD 50) (NN %)) (NN prolongation)) (PP (IN in) (NP (DT the) (JJ apparent) (NN elimination) (NN half-life))))))))) (. .)))))

root(ROOT-0, Probenecid-1)
prep(inhibits-14, As-3)
pcomp(As-3, with-4)
amod(antibiotics-11, other-5)
nn(antibiotics-11, b-6)
nn(antibiotics-11, span-7)
nn(antibiotics-11, class=-8)
nn(antibiotics-11, c233-9)
nn(antibiotics-11, -lactam-10)
prep_with(As-3, antibiotics-11)
nsubj(inhibits-14, probenecid-13)
dep(Probenecid-1, inhibits-14)
det(excretion-17, the-15)
amod(excretion-17, renal-16)
dobj(inhibits-14, excretion-17)
prep_of(excretion-17, cefdinir-19)
partmod(inhibits-14, resulting-21)
xcomp(inhibits-14, resulting-21)
det(doubling-25, an-23)
amod(doubling-25, approximate-24)
prep_in(resulting-21, doubling-25)
prep_in(doubling-25, A.C.-27)
det(increase-31, a-28)
number(%-30, 54-29)
amod(increase-31, %-30)
dobj(resulting-21, increase-31)
nn(levels-36, peak-33)
nn(levels-36, cefdinir-34)
nn(levels-36, plasma-35)
prep_in(increase-31, levels-36)
det(prolongation-42, a-39)
number(%-41, 50-40)
amod(prolongation-42, %-41)
conj_and(increase-31, prolongation-42)
det(half-life-47, the-44)
amod(half-life-47, apparent-45)
nn(half-life-47, elimination-46)
prep_in(prolongation-42, half-life-47)

Iron/NN Supplement/NN s/NNS and/CC Foods/NNS Fortified/VBN With/IN Iron/NN Concomitant/JJ administration/NN of/IN cefdinir/NN with/IN a/DT therapeutic/JJ iron/NN supplement/NN containing/VBG 60/CD mg/NN of/IN elemental/JJ iron/NN (/-LRB- as/IN FeSO4/NN )/-RRB- or/CC vitamins/NNS supplemented/VBN with/IN 10/CD mg/NN of/IN elemental/JJ iron/NN reduced/VBD extent/NN of/IN absorption/NN by/IN 80/CD %/NN and/CC 31/CD %/NN ,/, respectively/RB ./.

(ROOT (S1 (S (NP (NP (NP (NN Iron) (NN Supplement) (NNS s)) (CC and) (NP (NNS Foods))) (VP (VBN Fortified) (PP (IN With) (NP (NP (NN Iron) (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NN cefdinir))))) (PP (IN with) (NP (NP (DT a) (JJ therapeutic) (NN iron) (NN supplement)) (VP (VBG containing) (NP (NP (CD 60) (NN mg)) (PP (IN of) (NP (NP (NP (JJ elemental) (NN iron)) (PRN (-LRB- -LRB-) (PP (IN as) (NP (NN FeSO4))) (-RRB- -RRB-))) (CC or) (NP (NP (NNS vitamins)) (VP (VBN supplemented) (PP (IN with) (NP (NP (CD 10) (NN mg)) (PP (IN of) (NP (JJ elemental) (NN iron))))))))))))))) (VP (VBD reduced) (NP (NP (NN extent)) (PP (IN of) (NP (NN absorption)))) (PP (IN by) (NP (NP (CD 80) (NN %)) (CC and) (NP (CD 31) (NN %)) (, ,) (ADVP (RB respectively))))) (. .))))

nn(s-3, Iron-1)
nn(s-3, Supplement-2)
nsubj(reduced-37, s-3)
conj_and(s-3, Foods-5)
partmod(s-3, Fortified-6)
nn(administration-10, Iron-8)
amod(administration-10, Concomitant-9)
prep_with(Fortified-6, administration-10)
prep_of(administration-10, cefdinir-12)
det(supplement-17, a-14)
amod(supplement-17, therapeutic-15)
nn(supplement-17, iron-16)
prep_with(Fortified-6, supplement-17)
partmod(supplement-17, containing-18)
num(mg-20, 60-19)
dobj(containing-18, mg-20)
amod(iron-23, elemental-22)
prep_of(mg-20, iron-23)
dep(iron-23, as-25)
pobj(as-25, FeSO4-26)
conj_or(iron-23, vitamins-29)
partmod(vitamins-29, supplemented-30)
num(mg-33, 10-32)
prep_with(supplemented-30, mg-33)
amod(iron-36, elemental-35)
prep_of(mg-33, iron-36)
root(ROOT-0, reduced-37)
dobj(reduced-37, extent-38)
prep_of(extent-38, absorption-40)
num(%-43, 80-42)
prep_by(reduced-37, %-43)
num(%-46, 31-45)
conj_and(%-43, %-46)
advmod(%-43, respectively-48)
conj_and(%-43, respectively-48)

If/IN iron/NN supplement/NN s/NNS are/VBP required/VBN during/IN OMNICEF/NN therapy/NN ,/, OMNICEF/NN should/MD be/VB taken/VBN at/IN least/JJS 2/CD hours/NNS before/IN or/CC after/IN the/DT supplement/NN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NP (NN iron) (NN supplement)) (NNS s)) (VP (VBP are) (VP (VBN required) (PP (IN during) (NP (NN OMNICEF) (NN therapy))))))) (, ,) (NP (NN OMNICEF)) (VP (MD should) (VP (VB be) (VP (VBN taken) (PP (PP (NP (QP (IN at) (JJS least) (CD 2)) (NNS hours)) (IN before)) (CC or) (PP (IN after) (NP (DT the) (NN supplement)))))))) (. .))))

mark(required-6, If-1)
nn(supplement-3, iron-2)
nn(s-4, supplement-3)
nsubjpass(required-6, s-4)
auxpass(required-6, are-5)
advcl(taken-14, required-6)
nn(therapy-9, OMNICEF-8)
prep_during(required-6, therapy-9)
nsubjpass(taken-14, OMNICEF-11)
aux(taken-14, should-12)
auxpass(taken-14, be-13)
root(ROOT-0, taken-14)
quantmod(2-17, at-15)
mwe(at-15, least-16)
pobj(at-15, least-16)
num(hours-18, 2-17)
npadvmod(before-19, hours-18)
prep(taken-14, before-19)
conj_or(before-19, after-21)
det(supplement-23, the-22)
pobj(after-21, supplement-23)

The/DT effect/NN of/IN foods/NNS highly/RB fortified/VBN with/IN elemental/JJ iron/NN (/-LRB- primarily/RB iron/NN -fortified/JJ breakfast/NN cereals/NNS )/-RRB- on/IN cefdinir/NN absorption/NN has/VBZ not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NP (NNS foods)) (VP (ADVP (RB highly)) (VBN fortified) (PP (IN with) (NP (JJ elemental) (NN iron))) (PRN (-LRB- -LRB-) (NP (ADVP (RB primarily)) (NP (NN iron) (JJ -fortified) (NN breakfast) (NNS cereals))) (-RRB- -RRB-))))) (PP (IN on) (NP (NN cefdinir) (NN absorption)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

det(effect-2, The-1)
nsubjpass(studied-23, effect-2)
prep_of(effect-2, foods-4)
advmod(fortified-6, highly-5)
partmod(foods-4, fortified-6)
amod(iron-9, elemental-8)
prep_with(fortified-6, iron-9)
advmod(cereals-15, primarily-11)
nn(cereals-15, iron-12)
amod(cereals-15, -fortified-13)
nn(cereals-15, breakfast-14)
dep(fortified-6, cereals-15)
nn(absorption-19, cefdinir-18)
prep_on(effect-2, absorption-19)
aux(studied-23, has-20)
neg(studied-23, not-21)
auxpass(studied-23, been-22)
root(ROOT-0, studied-23)

Concomitantly/RB administered/VBN iron-fortified/JJ infant/NN formula/NN (/-LRB- 2.2/CD mg/NN elemental/NN iron/NN /6/NN oz/NN )/-RRB- has/VBZ no/DT significant/JJ effect/NN on/IN cefdinir/NN pharmacokinetics/NNS ./.

(ROOT (S1 (S (S (NP (NP (ADJP (RB Concomitantly) (VBN administered)) (JJ iron-fortified) (NN infant) (NN formula)) (PRN (-LRB- -LRB-) (NP (CD 2.2) (NN mg) (NN elemental) (NN iron) (NN /6) (NN oz)) (-RRB- -RRB-))) (VP (VBZ has) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NN cefdinir) (NNS pharmacokinetics))))) (. .))))

advmod(administered-2, Concomitantly-1)
amod(formula-5, administered-2)
amod(formula-5, iron-fortified-3)
nn(formula-5, infant-4)
nsubj(has-14, formula-5)
num(oz-12, 2.2-7)
nn(oz-12, mg-8)
nn(oz-12, elemental-9)
nn(oz-12, iron-10)
nn(oz-12, /6-11)
appos(formula-5, oz-12)
root(ROOT-0, has-14)
det(effect-17, no-15)
amod(effect-17, significant-16)
dobj(has-14, effect-17)
nn(pharmacokinetics-20, cefdinir-19)
prep_on(has-14, pharmacokinetics-20)

Therefore/RB ,/, OMNICEF/NN for/IN Oral/JJ Suspension/NN can/MD be/VB administered/VBN with/IN iron/NN -fortified/JJ infant/NN formula/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN OMNICEF)) (PP (IN for) (NP (JJ Oral) (NN Suspension)))) (VP (MD can) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (NN iron) (JJ -fortified) (NN infant) (NN formula))))))) (. .))))

advmod(administered-9, Therefore-1)
nsubjpass(administered-9, OMNICEF-3)
amod(Suspension-6, Oral-5)
prep_for(OMNICEF-3, Suspension-6)
aux(administered-9, can-7)
auxpass(administered-9, be-8)
root(ROOT-0, administered-9)
nn(formula-14, iron-11)
amod(formula-14, -fortified-12)
nn(formula-14, infant-13)
prep_with(administered-9, formula-14)

There/EX have/VBP been/VBN rare/JJ reports/NNS of/IN reddish/NN stools/NNS in/IN patients/NNS who/WP have/VBP received/VBN cefdinir/NN in/IN Japan/NNP ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (JJ rare) (NNS reports)) (PP (IN of) (NP (NN reddish) (NNS stools))) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN received) (NP (NN cefdinir)) (PP (IN in) (NP (NNP Japan))))))))))))) (. .))))

expl(reports-5, There-1)
aux(reports-5, have-2)
cop(reports-5, been-3)
amod(reports-5, rare-4)
root(ROOT-0, reports-5)
nn(stools-8, reddish-7)
prep_of(reports-5, stools-8)
prep_in(reports-5, patients-10)
nsubj(received-13, patients-10)
aux(received-13, have-12)
rcmod(patients-10, received-13)
dobj(received-13, cefdinir-14)
prep_in(received-13, Japan-16)

The/DT reddish/NN color/NN is/VBZ due/JJ to/TO the/DT formation/NN of/IN a/DT nonabsorbable/JJ complex/NN between/IN cefdinir/NN or/CC its/PRP$ breakdown/NN products/NNS and/CC iron/NN in/IN the/DT gastrointestinal/JJ tract/NN ./.

(ROOT (S1 (S (S (NP (DT The) (NN reddish) (NN color)) (VP (VBZ is) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NP (DT a) (JJ nonabsorbable) (NN complex)) (PP (IN between) (NP (NP (NP (NN cefdinir)) (CC or) (NP (PRP$ its) (NN breakdown) (NNS products))) (CC and) (NP (NP (NN iron)) (PP (IN in) (NP (DT the) (JJ gastrointestinal) (NN tract))))))))))))) (. .))))

det(color-3, The-1)
nn(color-3, reddish-2)
nsubj(due-5, color-3)
cop(due-5, is-4)
root(ROOT-0, due-5)
det(formation-8, the-7)
prep_to(due-5, formation-8)
det(complex-12, a-10)
amod(complex-12, nonabsorbable-11)
prep_of(formation-8, complex-12)
prep_between(complex-12, cefdinir-14)
poss(products-18, its-16)
nn(products-18, breakdown-17)
conj_or(cefdinir-14, products-18)
conj_and(cefdinir-14, iron-20)
det(tract-24, the-22)
amod(tract-24, gastrointestinal-23)
prep_in(iron-20, tract-24)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: A/DT false-positive/JJ reaction/NN for/IN ketones/NNS in/IN the/DT urine/NN may/MD occur/VB with/IN tests/NNS using/VBG nitroprusside/NN ,/, but/CC not/RB with/IN those/DT using/VBG nitroferricyanide/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (NP (DT A) (JJ false-positive) (NN reaction)) (PP (IN for) (NP (NNS ketones))) (PP (IN in) (NP (DT the) (NN urine)))) (VP (MD may) (VP (VB occur) (PP (PP (IN with) (NP (NP (NNS tests)) (VP (VBG using) (NP (NN nitroprusside))))) (, ,) (CC but) (PP (RB not) (IN with) (NP (NP (DT those)) (VP (VBG using) (NP (NN nitroferricyanide))))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
det(reaction-8, A-6)
amod(reaction-8, false-positive-7)
nsubj(occur-15, reaction-8)
prep_for(reaction-8, ketones-10)
det(urine-13, the-12)
prep_in(reaction-8, urine-13)
aux(occur-15, may-14)
dep(Interactions-4, occur-15)
prep_with(occur-15, tests-17)
partmod(tests-17, using-18)
dobj(using-18, nitroprusside-19)
neg(occur-15, not-22)
conj_but(tests-17, those-24)
partmod(those-24, using-25)
dobj(using-25, nitroferricyanide-26)

The/DT administration/NN of/IN cefdinir/NN may/MD result/VB in/IN a/DT false-positive/JJ reaction/NN for/IN glucose/NN in/IN urine/NN using/VBG Clinitest/NN @/NN ,/, Benedict/NN @/NN s/NN solution/NN ,/, or/CC Fehlings/NN solution/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NN cefdinir)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT a) (JJ false-positive) (NN reaction)) (PP (IN for) (NP (NN glucose))))) (PP (IN in) (NP (NP (NN urine)) (VP (VBG using) (NP (NP (NN Clinitest) (NN @)) (, ,) (NP (NN Benedict) (NN @) (NN s) (NN solution)) (, ,) (CC or) (NP (NN Fehlings) (NN solution))))))))) (. .))))

det(administration-2, The-1)
nsubj(result-6, administration-2)
prep_of(administration-2, cefdinir-4)
aux(result-6, may-5)
root(ROOT-0, result-6)
det(reaction-10, a-8)
amod(reaction-10, false-positive-9)
prep_in(result-6, reaction-10)
prep_for(reaction-10, glucose-12)
prep_in(result-6, urine-14)
partmod(urine-14, using-15)
nn(@-17, Clinitest-16)
dobj(using-15, @-17)
nn(solution-22, Benedict-19)
nn(solution-22, @-20)
nn(solution-22, s-21)
conj_or(@-17, solution-22)
nn(solution-26, Fehlings-25)
conj_or(@-17, solution-26)

It/PRP is/VBZ recommended/VBN that/IN glucose/NN tests/NNS based/VBN on/IN enzymatic/JJ glucose/NN oxidase/NN reactions/NNS (/-LRB- such/JJ as/IN Clinistix/NN @/NN or/CC Tes-Tape/NN @/NN )/-RRB- be/VB used/VBN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NP (NN glucose) (NNS tests)) (VP (VBN based) (PP (IN on) (NP (NP (JJ enzymatic) (NN glucose) (NN oxidase) (NNS reactions)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NP (NN Clinistix) (NN @)) (CC or) (NP (NN Tes-Tape) (NN @))))) (-RRB- -RRB-)))))) (VP (VB be) (VP (VBN used)))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(used-23, that-4)
nn(tests-6, glucose-5)
nsubjpass(used-23, tests-6)
partmod(tests-6, based-7)
amod(reactions-12, enzymatic-9)
nn(reactions-12, glucose-10)
nn(reactions-12, oxidase-11)
prep_on(based-7, reactions-12)
nn(@-17, Clinistix-16)
prep_such_as(reactions-12, @-17)
nn(@-20, Tes-Tape-19)
conj_or(@-17, @-20)
auxpass(used-23, be-22)
ccomp(recommended-3, used-23)

Cephalosporins/NNS are/VBP known/VBN to/TO occasionally/RB induce/VB a/DT positive/JJ direct/JJ Coombs/NN @/NN test/NN ./.

(ROOT (S1 (S (S (NP (NNS Cephalosporins)) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (ADVP (RB occasionally)) (VP (VB induce) (NP (DT a) (JJ positive) (JJ direct) (NN Coombs) (NN @) (NN test)))))))) (. .))))

nsubjpass(known-3, Cephalosporins-1)
xsubj(induce-6, Cephalosporins-1)
auxpass(known-3, are-2)
root(ROOT-0, known-3)
aux(induce-6, to-4)
advmod(induce-6, occasionally-5)
xcomp(known-3, induce-6)
det(test-12, a-7)
amod(test-12, positive-8)
amod(test-12, direct-9)
nn(test-12, Coombs-10)
nn(test-12, @-11)
dobj(induce-6, test-12)

Renal/JJ function/NN should/MD be/VB monitored/VBN carefully/RB if/IN high/JJ doses/NNS of/IN aminoglycosides/NNS are/VBP to/TO be/VB administered/VBN with/IN MAXIPIME/NN because/IN of/IN the/DT increased/VBN potential/NN of/IN nephrotoxicity/NN and/CC ototoxicity/NN of/IN aminoglycoside/NN antibiotics/NNS ./.

(ROOT (S1 (S (S (NP (JJ Renal) (NN function)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB carefully)) (SBAR (IN if) (S (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NNS aminoglycosides)))) (VP (VBP are) (S (VP (TO to) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (NN MAXIPIME))) (PP (IN because) (IN of) (NP (NP (DT the) (VBN increased) (NN potential)) (PP (IN of) (NP (NP (NP (NN nephrotoxicity)) (CC and) (NP (NN ototoxicity))) (PP (IN of) (NP (NN aminoglycoside) (NNS antibiotics)))))))))))))))))) (. .))))

amod(function-2, Renal-1)
nsubjpass(monitored-5, function-2)
aux(monitored-5, should-3)
auxpass(monitored-5, be-4)
root(ROOT-0, monitored-5)
advmod(monitored-5, carefully-6)
mark(are-12, if-7)
amod(doses-9, high-8)
nsubj(are-12, doses-9)
prep_of(doses-9, aminoglycosides-11)
advcl(monitored-5, are-12)
aux(administered-15, to-13)
auxpass(administered-15, be-14)
xcomp(are-12, administered-15)
prep_with(administered-15, MAXIPIME-17)
det(potential-22, the-20)
amod(potential-22, increased-21)
prep_because_of(administered-15, potential-22)
prep_of(potential-22, nephrotoxicity-24)
conj_and(nephrotoxicity-24, ototoxicity-26)
nn(antibiotics-29, aminoglycoside-28)
prep_of(nephrotoxicity-24, antibiotics-29)

Nephrotoxicity/NN has/VBZ been/VBN reported/VBN following/VBG concomitant/JJ administration/NN of/IN other/JJ cephalosporins/NNS with/IN potent/JJ diuretics/NNS such/JJ as/IN furosemide/NN ./.

(ROOT (S1 (S (S (NP (NN Nephrotoxicity)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (VBG following) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (JJ other) (NNS cephalosporins))) (PP (IN with) (NP (NP (JJ potent) (NNS diuretics)) (PP (JJ such) (IN as) (NP (NN furosemide))))))))))) (. .))))

nsubjpass(reported-4, Nephrotoxicity-1)
aux(reported-4, has-2)
auxpass(reported-4, been-3)
root(ROOT-0, reported-4)
amod(administration-7, concomitant-6)
prep_following(reported-4, administration-7)
amod(cephalosporins-10, other-9)
prep_of(administration-7, cephalosporins-10)
amod(diuretics-13, potent-12)
prep_with(administration-7, diuretics-13)
prep_such_as(diuretics-13, furosemide-16)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: The/DT administration/NN of/IN cefepime/NN may/MD result/VB in/IN a/DT false-positive/JJ reaction/NN for/IN glucose/NN in/IN the/DT urine/NN when/WRB using/VBG Clinitest/NN @/NN tablets/NNS ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NN cefepime)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT a) (JJ false-positive) (NN reaction)) (PP (IN for) (NP (NN glucose))) (PP (IN in) (NP (DT the) (NN urine))))) (SBAR (WHADVP (WRB when)) (S (VP (VBG using) (NP (NN Clinitest) (NN @) (NNS tablets)))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
det(administration-7, The-6)
nsubj(result-11, administration-7)
prep_of(administration-7, cefepime-9)
aux(result-11, may-10)
dep(Interactions-4, result-11)
det(reaction-15, a-13)
amod(reaction-15, false-positive-14)
prep_in(result-11, reaction-15)
prep_for(reaction-15, glucose-17)
det(urine-20, the-19)
prep_in(reaction-15, urine-20)
advmod(using-22, when-21)
advcl(result-11, using-22)
nn(tablets-25, Clinitest-23)
nn(tablets-25, @-24)
dobj(using-22, tablets-25)

It/PRP is/VBZ recommended/VBN that/IN glucose/NN tests/NNS based/VBN on/IN enzymatic/JJ glucose/NN oxidase/NN reactions/NNS (/-LRB- such/JJ as/IN Clinistix/NN @/NN or/CC Tes-Tape/NN @/NN )/-RRB- be/VB used/VBN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NP (NN glucose) (NNS tests)) (VP (VBN based) (PP (IN on) (NP (NP (JJ enzymatic) (NN glucose) (NN oxidase) (NNS reactions)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NP (NN Clinistix) (NN @)) (CC or) (NP (NN Tes-Tape) (NN @))))) (-RRB- -RRB-)))))) (VP (VB be) (VP (VBN used)))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(used-23, that-4)
nn(tests-6, glucose-5)
nsubjpass(used-23, tests-6)
partmod(tests-6, based-7)
amod(reactions-12, enzymatic-9)
nn(reactions-12, glucose-10)
nn(reactions-12, oxidase-11)
prep_on(based-7, reactions-12)
nn(@-17, Clinistix-16)
prep_such_as(reactions-12, @-17)
nn(@-20, Tes-Tape-19)
conj_or(@-17, @-20)
auxpass(used-23, be-22)
ccomp(recommended-3, used-23)

Carbamazepine/NN :/: Elevated/JJ carbamazepine/NN levels/NNS have/VBP been/VBN reported/VBN in/IN postmarketing/NN experience/VBP when/WRB SUPRAX/NN is/VBZ administered/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NP (NN Carbamazepine)) (: :) (S (NP (JJ Elevated) (NN carbamazepine) (NNS levels)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NN postmarketing)))))))) (VP (VBP experience) (SBAR (WHADVP (WRB when)) (S (NP (NN SUPRAX)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concomitantly)))))))) (. .))))

nsubj(experience-11, Carbamazepine-1)
amod(levels-5, Elevated-3)
nn(levels-5, carbamazepine-4)
nsubjpass(reported-8, levels-5)
aux(reported-8, have-6)
auxpass(reported-8, been-7)
dep(Carbamazepine-1, reported-8)
prep_in(reported-8, postmarketing-10)
root(ROOT-0, experience-11)
advmod(administered-15, when-12)
nsubjpass(administered-15, SUPRAX-13)
auxpass(administered-15, is-14)
advcl(experience-11, administered-15)
advmod(administered-15, concomitantly-16)

Drug/NN monitoring/NN may/MD be/VB of/IN assistance/NN in/IN detecting/VBG alterations/NNS in/IN carbamazepine/NN plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NN Drug) (NN monitoring)) (VP (MD may) (VP (VB be) (PP (IN of) (NP (NN assistance))) (PP (IN in) (S (VP (VBG detecting) (NP (NP (NNS alterations)) (PP (IN in) (NP (NN carbamazepine) (NN plasma) (NNS concentrations)))))))))) (. .))))

nn(monitoring-2, Drug-1)
nsubj(be-4, monitoring-2)
aux(be-4, may-3)
root(ROOT-0, be-4)
prep_of(be-4, assistance-6)
prepc_in(be-4, detecting-8)
dobj(detecting-8, alterations-9)
nn(concentrations-13, carbamazepine-11)
nn(concentrations-13, plasma-12)
prep_in(alterations-9, concentrations-13)

Warfarin/NN and/CC Anticoagulants/NNS :/: Increased/VBN prothrombin/NN time/NN ,/, with/IN or/CC without/IN clinical/JJ bleeding/JJ ,/, has/VBZ been/VBN reported/VBN when/WRB cefixime/NN is/VBZ administered/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Warfarin)) (CC and) (NP (NNS Anticoagulants)) (: :) (NP (VBN Increased) (NN prothrombin) (NN time))) (, ,) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (JJ clinical) (JJ bleeding)))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (SBAR (WHADVP (WRB when)) (S (NP (NN cefixime)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concomitantly)))))))))) (. .))))

nsubjpass(reported-17, Warfarin-1)
conj_and(Warfarin-1, Anticoagulants-3)
amod(time-7, Increased-5)
nn(time-7, prothrombin-6)
conj_and(Warfarin-1, time-7)
prep(Warfarin-1, with-9)
conj_or(with-9, without-11)
amod(bleeding-13, clinical-12)
pobj(without-11, bleeding-13)
aux(reported-17, has-15)
auxpass(reported-17, been-16)
root(ROOT-0, reported-17)
advmod(administered-21, when-18)
nsubjpass(administered-21, cefixime-19)
auxpass(administered-21, is-20)
advcl(reported-17, administered-21)
advmod(administered-21, concomitantly-22)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: A/DT false-positive/JJ reaction/NN for/IN ketones/NNS in/IN the/DT urine/NN may/MD occur/VB with/IN tests/NNS using/VBG nitroprusside/NN but/CC not/RB with/IN those/DT using/VBG nitroferricyanide/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (NP (DT A) (JJ false-positive) (NN reaction)) (PP (IN for) (NP (NNS ketones))) (PP (IN in) (NP (DT the) (NN urine)))) (VP (MD may) (VP (VB occur) (PP (PP (IN with) (NP (NP (NNS tests)) (VP (VBG using) (NP (NN nitroprusside))))) (CC but) (PP (RB not) (IN with) (NP (NP (DT those)) (VP (VBG using) (NP (NN nitroferricyanide))))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
det(reaction-8, A-6)
amod(reaction-8, false-positive-7)
nsubj(occur-15, reaction-8)
prep_for(reaction-8, ketones-10)
det(urine-13, the-12)
prep_in(reaction-8, urine-13)
aux(occur-15, may-14)
dep(Interactions-4, occur-15)
prep_with(occur-15, tests-17)
partmod(tests-17, using-18)
dobj(using-18, nitroprusside-19)
neg(occur-15, not-21)
conj_but(tests-17, those-23)
partmod(those-23, using-24)
dobj(using-24, nitroferricyanide-25)

The/DT administration/NN of/IN SUPRAX/NN may/MD result/VB in/IN a/DT false-positive/JJ reaction/NN for/IN glucose/NN in/IN the/DT urine/NN using/VBG Clinitest/NN @/NN **/NN ,/, Benedict/NN @/NN s/NN solution/NN ,/, or/CC Fehling/JJ @/NN s/NN solution/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NN SUPRAX)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT a) (JJ false-positive) (NN reaction)) (PP (IN for) (NP (NP (NN glucose)) (PP (IN in) (NP (NP (DT the) (NN urine)) (VP (VBG using) (NP (NP (NN Clinitest) (NN @) (NN **)) (, ,) (NP (NN Benedict) (NN @) (NN s) (NN solution)) (, ,) (CC or) (NP (JJ Fehling) (NN @) (NN s) (NN solution))))))))))))) (. .))))

det(administration-2, The-1)
nsubj(result-6, administration-2)
prep_of(administration-2, SUPRAX-4)
aux(result-6, may-5)
root(ROOT-0, result-6)
det(reaction-10, a-8)
amod(reaction-10, false-positive-9)
prep_in(result-6, reaction-10)
prep_for(reaction-10, glucose-12)
det(urine-15, the-14)
prep_in(glucose-12, urine-15)
partmod(urine-15, using-16)
nn(**-19, Clinitest-17)
nn(**-19, @-18)
dobj(using-16, **-19)
nn(solution-24, Benedict-21)
nn(solution-24, @-22)
nn(solution-24, s-23)
conj_or(**-19, solution-24)
amod(solution-30, Fehling-27)
nn(solution-30, @-28)
nn(solution-30, s-29)
conj_or(**-19, solution-30)

It/PRP is/VBZ recommended/VBN that/IN glucose/NN tests/NNS based/VBN on/IN enzymatic/JJ glucose/NN oxidase/NN reactions/NNS (/-LRB- such/JJ as/IN Clinistix/NN @/NN */NN */NN or/CC Tes-Tape/NN @/NN **/NN )/-RRB- be/VB used/VBN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NP (NN glucose) (NNS tests)) (VP (VBN based) (PP (IN on) (NP (NP (JJ enzymatic) (NN glucose) (NN oxidase) (NNS reactions)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NP (NN Clinistix) (NN @) (NN *) (NN *)) (CC or) (NP (NN Tes-Tape) (NN @) (NN **))))) (-RRB- -RRB-)))))) (VP (VB be) (VP (VBN used)))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(used-26, that-4)
nn(tests-6, glucose-5)
nsubjpass(used-26, tests-6)
partmod(tests-6, based-7)
amod(reactions-12, enzymatic-9)
nn(reactions-12, glucose-10)
nn(reactions-12, oxidase-11)
prep_on(based-7, reactions-12)
nn(*-19, Clinistix-16)
nn(*-19, @-17)
nn(*-19, *-18)
prep_such_as(reactions-12, *-19)
nn(**-23, Tes-Tape-21)
nn(**-23, @-22)
conj_or(*-19, **-23)
auxpass(used-26, be-25)
ccomp(recommended-3, used-26)

A/DT false-positive/JJ direct/JJ Coombs/NN test/NN has/VBZ been/VBN reported/VBN during/IN treatment/NN with/IN other/JJ cephalosporin/JJ antibiotics/NNS ;/: ./.

(ROOT (S1 (S (S (NP (DT A) (JJ false-positive) (JJ direct) (NN Coombs) (NN test)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN during) (NP (NP (NN treatment)) (PP (IN with) (NP (JJ other) (JJ cephalosporin) (NNS antibiotics)))))))) (: ;)) (. .))))

det(test-5, A-1)
amod(test-5, false-positive-2)
amod(test-5, direct-3)
nn(test-5, Coombs-4)
nsubjpass(reported-8, test-5)
aux(reported-8, has-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
prep_during(reported-8, treatment-10)
amod(antibiotics-14, other-12)
amod(antibiotics-14, cephalosporin-13)
prep_with(treatment-10, antibiotics-14)

therefore/RB ,/, it/PRP should/MD be/VB recognized/VBN that/IN a/DT positive/JJ Coombs/NN test/NN may/MD be/VB due/JJ to/TO the/DT drug/NN ./.

(ROOT (S1 (S (S (ADVP (RB therefore)) (, ,) (NP (PRP it)) (VP (MD should) (VP (VB be) (VP (VBN recognized) (SBAR (IN that) (S (NP (DT a) (JJ positive) (NN Coombs) (NN test)) (VP (MD may) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (DT the) (NN drug)))))))))))) (. .))))

advmod(recognized-6, therefore-1)
nsubjpass(recognized-6, it-3)
aux(recognized-6, should-4)
auxpass(recognized-6, be-5)
root(ROOT-0, recognized-6)
complm(due-14, that-7)
det(test-11, a-8)
amod(test-11, positive-9)
nn(test-11, Coombs-10)
nsubj(due-14, test-11)
aux(due-14, may-12)
cop(due-14, be-13)
ccomp(recognized-6, due-14)
det(drug-17, the-16)
prep_to(due-14, drug-17)

Increased/VBN nephrotoxicity/NN has/VBZ been/VBN reported/VBN following/VBG concomitant/JJ administration/NN of/IN cephalosporins/NNS and/CC aminoglycoside/NN antibiotics/NNS ./.

(ROOT (S1 (S (S (NP (VBN Increased) (NN nephrotoxicity)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (VBG following) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NNS cephalosporins)) (CC and) (NP (NN aminoglycoside) (NNS antibiotics)))))))))) (. .))))

amod(nephrotoxicity-2, Increased-1)
nsubjpass(reported-5, nephrotoxicity-2)
aux(reported-5, has-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
amod(administration-8, concomitant-7)
prep_following(reported-5, administration-8)
prep_of(administration-8, cephalosporins-10)
nn(antibiotics-13, aminoglycoside-12)
conj_and(cephalosporins-10, antibiotics-13)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS Cephalosporins/NN ,/, including/VBG cefotaxime/NN sodium/NN ,/, are/VBP known/VBN to/TO occasionally/RB induce/VB a/DT positive/JJ direct/JJ Coombs/NN test/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions) (NP (NN Cephalosporins))) (, ,) (PP (VBG including) (NP (NN cefotaxime) (NN sodium))) (, ,)) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (ADVP (RB occasionally)) (VP (VB induce) (NP (DT a) (JJ positive) (JJ direct) (NN Coombs) (NN test)))))))) (. .))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
nsubjpass(known-12, Interactions-4)
xsubj(induce-15, Interactions-4)
dep(Interactions-4, Cephalosporins-5)
nn(sodium-9, cefotaxime-8)
prep_including(Interactions-4, sodium-9)
auxpass(known-12, are-11)
root(ROOT-0, known-12)
aux(induce-15, to-13)
advmod(induce-15, occasionally-14)
xcomp(known-12, induce-15)
det(test-20, a-16)
amod(test-20, positive-17)
amod(test-20, direct-18)
nn(test-20, Coombs-19)
dobj(induce-15, test-20)

Increases/NNS in/IN serum/NN creatinine/NN have/VBP occurred/VBN when/WRB CEFOTAN/NN was/VBD given/VBN alone/RB ./.

(ROOT (S1 (S (S (NP (NP (NNS Increases)) (PP (IN in) (NP (NN serum) (NN creatinine)))) (VP (VBP have) (VP (VBN occurred) (SBAR (WHADVP (WRB when)) (S (NP (NN CEFOTAN)) (VP (VBD was) (VP (VBN given) (ADVP (RB alone))))))))) (. .))))

nsubj(occurred-6, Increases-1)
nn(creatinine-4, serum-3)
prep_in(Increases-1, creatinine-4)
aux(occurred-6, have-5)
root(ROOT-0, occurred-6)
advmod(given-10, when-7)
nsubjpass(given-10, CEFOTAN-8)
auxpass(given-10, was-9)
advcl(occurred-6, given-10)
advmod(given-10, alone-11)

If/IN CEFOTAN/NN and/CC an/DT aminoglycoside/NN are/VBP used/VBN concomitantly/RB ,/, renal/JJ function/NN should/MD be/VB carefully/RB monitored/VBN ,/, because/IN nephrotoxicity/NN may/MD be/VB potentiated/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NP (NN CEFOTAN)) (CC and) (NP (DT an) (NN aminoglycoside))) (VP (VBP are) (VP (VBN used) (ADVP (RB concomitantly)))))) (, ,) (NP (JJ renal) (NN function)) (VP (MD should) (VP (VB be) (ADVP (RB carefully)) (VP (VBN monitored)) (, ,) (SBAR (IN because) (S (NP (NN nephrotoxicity)) (VP (MD may) (VP (VB be) (VP (VBN potentiated))))))))) (. .))))

mark(used-7, If-1)
nsubjpass(used-7, CEFOTAN-2)
det(aminoglycoside-5, an-4)
conj_and(CEFOTAN-2, aminoglycoside-5)
auxpass(used-7, are-6)
advcl(monitored-15, used-7)
advmod(used-7, concomitantly-8)
amod(function-11, renal-10)
nsubjpass(monitored-15, function-11)
aux(monitored-15, should-12)
auxpass(monitored-15, be-13)
advmod(monitored-15, carefully-14)
root(ROOT-0, monitored-15)
mark(potentiated-21, because-17)
nsubjpass(potentiated-21, nephrotoxicity-18)
aux(potentiated-21, may-19)
auxpass(potentiated-21, be-20)
advcl(monitored-15, potentiated-21)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: The/DT administration/NN of/IN CEFOTAN/NN may/MD result/VB in/IN a/DT false/JJ positive/JJ reaction/NN for/IN glucose/NN in/IN the/DT urine/NN using/VBG Clinitest/NN @@/NN ,/, Benedicts/NN solution/NN ,/, or/CC Fehlings/NN solution/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NN CEFOTAN)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT a) (ADJP (ADJP (JJ false)) (ADJP (JJ positive))) (NN reaction)) (PP (IN for) (NP (NN glucose))))) (PP (IN in) (NP (NP (DT the) (NN urine)) (VP (VBG using) (NP (NP (NN Clinitest) (NN @@)) (, ,) (NP (NN Benedicts) (NN solution)) (, ,) (CC or) (NP (NN Fehlings) (NN solution))))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
det(administration-7, The-6)
nsubj(result-11, administration-7)
prep_of(administration-7, CEFOTAN-9)
aux(result-11, may-10)
dep(Interactions-4, result-11)
det(reaction-16, a-13)
amod(reaction-16, false-14)
dep(false-14, positive-15)
prep_in(result-11, reaction-16)
prep_for(reaction-16, glucose-18)
det(urine-21, the-20)
prep_in(result-11, urine-21)
partmod(urine-21, using-22)
nn(@@-24, Clinitest-23)
dobj(using-22, @@-24)
nn(solution-27, Benedicts-26)
conj_or(@@-24, solution-27)
nn(solution-31, Fehlings-30)
conj_or(@@-24, solution-31)

It/PRP is/VBZ recommended/VBN that/IN glucose/NN tests/NNS based/VBN on/IN enzymatic/JJ glucose/NN oxidase/NN be/VB used/VBN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NP (NN glucose) (NNS tests)) (VP (VBN based) (PP (IN on) (NP (JJ enzymatic) (NN glucose) (NN oxidase))))) (VP (VB be) (VP (VBN used)))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(used-13, that-4)
nn(tests-6, glucose-5)
nsubjpass(used-13, tests-6)
partmod(tests-6, based-7)
amod(oxidase-11, enzymatic-9)
nn(oxidase-11, glucose-10)
prep_on(based-7, oxidase-11)
auxpass(used-13, be-12)
ccomp(recommended-3, used-13)

As/IN with/IN other/JJ cephalosporins/NNS ,/, high/JJ concentrations/NNS of/IN cefotetan/NN may/MD interfere/VB with/IN measurement/NN of/IN serum/NN and/CC urine/NN creatinine/NN levels/NNS by/IN Jaffe/NN @/NN reaction/NN and/CC produce/VB false/JJ increases/NNS in/IN the/DT levels/NNS of/IN creatinine/NN reported/VBD ./.

(ROOT (S1 (S (S (PP (IN As) (PP (IN with) (NP (JJ other) (NNS cephalosporins)))) (, ,) (NP (NP (JJ high) (NNS concentrations)) (PP (IN of) (NP (NN cefotetan)))) (VP (MD may) (VP (VP (VB interfere) (PP (IN with) (NP (NP (NN measurement)) (PP (IN of) (NP (NP (NN serum)) (CC and) (NP (NN urine)) (NP (NN creatinine) (NNS levels)))))) (PP (IN by) (NP (NN Jaffe) (NN @) (NN reaction)))) (CC and) (VP (VB produce) (NP (NP (JJ false) (NNS increases)) (PP (IN in) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NP (NN creatinine)) (VP (VBD reported))))))))))) (. .))))

prep(interfere-11, As-1)
pcomp(As-1, with-2)
amod(cephalosporins-4, other-3)
prep_with(As-1, cephalosporins-4)
amod(concentrations-7, high-6)
nsubj(interfere-11, concentrations-7)
prep_of(concentrations-7, cefotetan-9)
aux(interfere-11, may-10)
root(ROOT-0, interfere-11)
prep_with(interfere-11, measurement-13)
prep_of(measurement-13, serum-15)
conj_and(serum-15, urine-17)
nn(levels-19, creatinine-18)
dep(serum-15, levels-19)
nn(reaction-23, Jaffe-21)
nn(reaction-23, @-22)
prep_by(interfere-11, reaction-23)
conj_and(interfere-11, produce-25)
amod(increases-27, false-26)
dobj(produce-25, increases-27)
det(levels-30, the-29)
prep_in(increases-27, levels-30)
prep_of(levels-30, creatinine-32)
partmod(creatinine-32, reported-33)

Nephrotoxicity/NN has/VBZ been/VBN reported/VBN following/VBG concomitant/JJ administration/NN of/IN aminoglycoside/NN antibiotics/NNS and/CC cephalosporin/JJ antibiotics/NNS ./.

(ROOT (S1 (S (S (NP (NN Nephrotoxicity)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (VBG following) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN aminoglycoside) (NNS antibiotics)) (CC and) (NP (JJ cephalosporin) (NNS antibiotics)))))))))) (. .))))

nsubjpass(reported-4, Nephrotoxicity-1)
aux(reported-4, has-2)
auxpass(reported-4, been-3)
root(ROOT-0, reported-4)
amod(administration-7, concomitant-6)
prep_following(reported-4, administration-7)
nn(antibiotics-10, aminoglycoside-9)
prep_of(administration-7, antibiotics-10)
amod(antibiotics-13, cephalosporin-12)
conj_and(antibiotics-10, antibiotics-13)

Concomitant/JJ administration/NN of/IN probenecid/NN doubled/VBD the/DT AUC/NN for/IN cefprozil/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NN probenecid)))) (VP (VBD doubled) (NP (DT the) (NN AUC)) (PP (IN for) (NP (NN cefprozil))))) (. .))))

amod(administration-2, Concomitant-1)
nsubj(doubled-5, administration-2)
prep_of(administration-2, probenecid-4)
root(ROOT-0, doubled-5)
det(AUC-7, the-6)
dobj(doubled-5, AUC-7)
prep_for(doubled-5, cefprozil-9)

The/DT bioavailability/NN of/IN the/DT capsule/JJ formulation/NN of/IN cefprozil/NN was/VBD not/RB affected/VBN when/WRB administered/VBN 5/CD minutes/NNS following/VBG an/DT antacid/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN bioavailability)) (PP (IN of) (NP (NP (DT the) (JJ capsule) (NN formulation)) (PP (IN of) (NP (NN cefprozil)))))) (VP (VBD was) (RB not) (VP (VBN affected)) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (NP (CD 5) (NNS minutes)) (PP (VBG following) (NP (DT an) (JJ antacid)))))))) (. .))))

det(bioavailability-2, The-1)
nsubjpass(affected-11, bioavailability-2)
det(formulation-6, the-4)
amod(formulation-6, capsule-5)
prep_of(bioavailability-2, formulation-6)
prep_of(formulation-6, cefprozil-8)
auxpass(affected-11, was-9)
neg(affected-11, not-10)
root(ROOT-0, affected-11)
advmod(administered-13, when-12)
advcl(affected-11, administered-13)
num(minutes-15, 5-14)
dobj(administered-13, minutes-15)
det(antacid-18, an-17)
prep_following(administered-13, antacid-18)

Nephrotoxicity/NN has/VBZ been/VBN reported/VBN following/VBG concomitant/JJ administration/NN of/IN cephalosporins/NNS with/IN aminoglycoside/NN antibiotics/NNS or/CC potent/JJ diuretics/NNS such/JJ as/IN furosemide/NN ./.

(ROOT (S1 (S (S (NP (NN Nephrotoxicity)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (VBG following) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NNS cephalosporins))) (PP (IN with) (NP (NP (NN aminoglycoside) (NNS antibiotics)) (CC or) (NP (NP (JJ potent) (NNS diuretics)) (PP (JJ such) (IN as) (NP (NN furosemide)))))))))))) (. .))))

nsubjpass(reported-4, Nephrotoxicity-1)
aux(reported-4, has-2)
auxpass(reported-4, been-3)
root(ROOT-0, reported-4)
amod(administration-7, concomitant-6)
prep_following(reported-4, administration-7)
prep_of(administration-7, cephalosporins-9)
nn(antibiotics-12, aminoglycoside-11)
prep_with(administration-7, antibiotics-12)
amod(diuretics-15, potent-14)
conj_or(antibiotics-12, diuretics-15)
prep_such_as(diuretics-15, furosemide-18)

Renal/JJ function/NN should/MD be/VB carefully/RB monitored/VBN ,/, especially/RB if/IN higher/JJR dosages/NNS of/IN the/DT aminoglycosides/NNS are/VBP to/TO be/VB administered/VBN or/CC if/IN therapy/NN is/VBZ prolonged/JJ ,/, because/IN of/IN the/DT potential/JJ nephrotoxicity/NN and/CC ototoxicity/NN of/IN aminoglycosidic/JJ antibiotics/NNS ./.

(ROOT (S1 (S (S (NP (JJ Renal) (NN function)) (VP (MD should) (VP (VB be) (ADVP (RB carefully)) (VP (VBN monitored)) (, ,) (SBAR (SBAR (RB especially) (IN if) (S (NP (NP (JJR higher) (NNS dosages)) (PP (IN of) (NP (DT the) (NNS aminoglycosides)))) (VP (VBP are) (S (VP (TO to) (VP (VB be) (VP (VBN administered)))))))) (CC or) (SBAR (IN if) (S (NP (NN therapy)) (VP (VBZ is) (ADJP (JJ prolonged)) (, ,) (PP (IN because) (IN of) (NP (NP (DT the) (NP (JJ potential) (NN nephrotoxicity)) (CC and) (NP (NN ototoxicity))) (PP (IN of) (NP (JJ aminoglycosidic) (NNS antibiotics)))))))))))) (. .))))

amod(function-2, Renal-1)
nsubjpass(monitored-6, function-2)
aux(monitored-6, should-3)
auxpass(monitored-6, be-4)
advmod(monitored-6, carefully-5)
root(ROOT-0, monitored-6)
advmod(are-15, especially-8)
dep(are-15, if-9)
amod(dosages-11, higher-10)
nsubj(are-15, dosages-11)
det(aminoglycosides-14, the-13)
prep_of(dosages-11, aminoglycosides-14)
dep(monitored-6, are-15)
aux(administered-18, to-16)
auxpass(administered-18, be-17)
xcomp(are-15, administered-18)
mark(prolonged-23, if-20)
nsubj(prolonged-23, therapy-21)
cop(prolonged-23, is-22)
conj_or(are-15, prolonged-23)
dep(nephrotoxicity-29, the-27)
amod(nephrotoxicity-29, potential-28)
prep_because_of(prolonged-23, nephrotoxicity-29)
conj_and(nephrotoxicity-29, ototoxicity-31)
amod(antibiotics-34, aminoglycosidic-33)
prep_of(nephrotoxicity-29, antibiotics-34)

Nephrotoxicity/NN and/CC ototoxicity/NN were/VBD not/RB noted/VBN when/WRB ceftazidime/NN was/VBD given/VBN alone/RB in/IN clinical/JJ trials/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Nephrotoxicity)) (CC and) (NP (NN ototoxicity))) (VP (VBD were) (RB not) (VP (VBN noted)) (SBAR (WHADVP (WRB when)) (S (NP (NN ceftazidime)) (VP (VBD was) (VP (VBN given) (ADVP (RB alone)) (PP (IN in) (NP (JJ clinical) (NNS trials))))))))) (. .))))

nsubjpass(noted-6, Nephrotoxicity-1)
conj_and(Nephrotoxicity-1, ototoxicity-3)
auxpass(noted-6, were-4)
neg(noted-6, not-5)
root(ROOT-0, noted-6)
advmod(given-10, when-7)
nsubjpass(given-10, ceftazidime-8)
auxpass(given-10, was-9)
advcl(noted-6, given-10)
advmod(given-10, alone-11)
amod(trials-14, clinical-13)
prep_in(given-10, trials-14)

Chloramphenicol/NN has/VBZ been/VBN shown/VBN to/TO be/VB antagonistic/JJ to/TO beta-lactam/JJ antibiotic/JJ s/NNS ,/, including/VBG ceftazidime/NN ,/, based/VBN on/IN in/FW vitro/FW studies/NNS and/CC time/NN kill/VB curves/NNS with/IN enteric/JJ gram-negative/JJ bacilli/NNS ./.

(ROOT (S1 (S (S (NP (NN Chloramphenicol)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB be) (ADJP (JJ antagonistic) (PP (TO to) (NP (NP (JJ beta-lactam) (JJ antibiotic) (NNS s)) (, ,) (PP (VBG including) (NP (NN ceftazidime))) (, ,) (VP (VBN based) (PP (IN on) (NP (NP (NP (ADJP (FW in) (FW vitro)) (NNS studies)) (CC and) (NP (NN time) (VB kill) (NNS curves))) (PP (IN with) (NP (JJ enteric) (JJ gram-negative) (NNS bacilli)))))))))))))))) (. .))))

nsubjpass(shown-4, Chloramphenicol-1)
xsubj(antagonistic-7, Chloramphenicol-1)
aux(shown-4, has-2)
auxpass(shown-4, been-3)
root(ROOT-0, shown-4)
aux(antagonistic-7, to-5)
cop(antagonistic-7, be-6)
xcomp(shown-4, antagonistic-7)
amod(s-11, beta-lactam-9)
amod(s-11, antibiotic-10)
prep_to(antagonistic-7, s-11)
prep_including(s-11, ceftazidime-14)
partmod(s-11, based-16)
nn(vitro-19, in-18)
amod(studies-20, vitro-19)
prep_on(based-16, studies-20)
nn(curves-24, time-22)
dep(curves-24, kill-23)
conj_and(studies-20, curves-24)
amod(bacilli-28, enteric-26)
amod(bacilli-28, gram-negative-27)
prep_with(studies-20, bacilli-28)

Due/IN to/TO the/DT possibility/NN of/IN antagonism/NN in/FW vivo/FW ,/, particularly/RB when/WRB bactericidal/JJ activity/NN is/VBZ desired/VBN ,/, this/DT drug/NN combination/NN should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (PP (IN Due) (PP (TO to) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (NN antagonism)) (ADVP (FW in) (FW vivo))))))) (, ,) (SBAR (WHADVP (RB particularly) (WRB when)) (S (NP (JJ bactericidal) (NN activity)) (VP (VBZ is) (VP (VBN desired))))) (, ,) (NP (DT this) (NN drug) (NN combination)) (VP (MD should) (VP (VB be) (VP (VBN avoided))))) (. .))))

prepc_due_to(avoided-22, to-2)
det(possibility-4, the-3)
pobj(avoided-22, possibility-4)
prep_of(possibility-4, antagonism-6)
nn(vivo-8, in-7)
advmod(antagonism-6, vivo-8)
advmod(when-11, particularly-10)
advmod(desired-15, when-11)
amod(activity-13, bactericidal-12)
nsubjpass(desired-15, activity-13)
auxpass(desired-15, is-14)
advcl(avoided-22, desired-15)
det(combination-19, this-17)
nn(combination-19, drug-18)
nsubjpass(avoided-22, combination-19)
aux(avoided-22, should-20)
auxpass(avoided-22, be-21)
root(ROOT-0, avoided-22)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: The/DT administration/NN of/IN ceftazidime/NN may/MD result/VB in/IN a/DT false-positive/JJ reaction/NN for/IN glucose/NN in/IN the/DT urine/NN when/WRB using/VBG CLINITEST/NN @/NN tablets/NNS ,/, Benedicts/NN solution/NN ,/, or/CC Fehlings/NN solution/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NN ceftazidime)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT a) (JJ false-positive) (NN reaction)) (PP (IN for) (NP (NN glucose))) (PP (IN in) (NP (DT the) (NN urine))))) (SBAR (WHADVP (WRB when)) (S (VP (VBG using) (NP (NP (NN CLINITEST) (NN @) (NNS tablets)) (, ,) (NP (NP (NN Benedicts) (NN solution)) (, ,) (CC or) (NP (NN Fehlings) (NN solution)))))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
det(administration-7, The-6)
nsubj(result-11, administration-7)
prep_of(administration-7, ceftazidime-9)
aux(result-11, may-10)
dep(Interactions-4, result-11)
det(reaction-15, a-13)
amod(reaction-15, false-positive-14)
prep_in(result-11, reaction-15)
prep_for(reaction-15, glucose-17)
det(urine-20, the-19)
prep_in(reaction-15, urine-20)
advmod(using-22, when-21)
advcl(result-11, using-22)
nn(tablets-25, CLINITEST-23)
nn(tablets-25, @-24)
dobj(using-22, tablets-25)
nn(solution-28, Benedicts-27)
appos(tablets-25, solution-28)
nn(solution-32, Fehlings-31)
conj_or(solution-28, solution-32)

It/PRP is/VBZ recommended/VBN that/IN glucose/NN tests/NNS based/VBN on/IN enzymatic/JJ glucose/NN oxidase/NN reactions/NNS (/-LRB- such/JJ as/IN CLINISTIX/JJ @/NN or/CC TES-TAPE/JJ @/NN )/-RRB- be/VB used/VBN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NP (NN glucose) (NNS tests)) (VP (VBN based) (PP (IN on) (NP (NP (JJ enzymatic) (NN glucose) (NN oxidase) (NNS reactions)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NP (JJ CLINISTIX) (NN @)) (CC or) (NP (JJ TES-TAPE) (NN @))))) (-RRB- -RRB-)))))) (VP (VB be) (VP (VBN used)))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(used-23, that-4)
nn(tests-6, glucose-5)
nsubjpass(used-23, tests-6)
partmod(tests-6, based-7)
amod(reactions-12, enzymatic-9)
nn(reactions-12, glucose-10)
nn(reactions-12, oxidase-11)
prep_on(based-7, reactions-12)
amod(@-17, CLINISTIX-16)
prep_such_as(reactions-12, @-17)
amod(@-20, TES-TAPE-19)
conj_or(@-17, @-20)
auxpass(used-23, be-22)
ccomp(recommended-3, used-23)

Theophylline/NN :/: Twelve/CD healthy/JJ male/JJ volunteers/NNS were/VBD administered/VBN one/CD 200-mg/NN ceftibuten/NN capsule/NN twice/RB daily/RB for/IN 6/CD days/NNS ./.

(ROOT (S1 (S (NP (NP (NN Theophylline)) (: :) (S (NP (CD Twelve) (JJ healthy) (JJ male) (NNS volunteers)) (VP (VBD were) (VP (VBN administered) (NP (CD one) (NN 200-mg) (NN ceftibuten) (NN capsule)) (ADVP (RB twice) (RB daily)) (PP (IN for) (NP (CD 6) (NNS days)))))) (. .)))))

root(ROOT-0, Theophylline-1)
num(volunteers-6, Twelve-3)
amod(volunteers-6, healthy-4)
amod(volunteers-6, male-5)
nsubjpass(administered-8, volunteers-6)
auxpass(administered-8, were-7)
dep(Theophylline-1, administered-8)
num(capsule-12, one-9)
nn(capsule-12, 200-mg-10)
nn(capsule-12, ceftibuten-11)
dobj(administered-8, capsule-12)
advmod(daily-14, twice-13)
advmod(administered-8, daily-14)
num(days-17, 6-16)
prep_for(administered-8, days-17)

With/IN the/DT morning/NN dose/NN of/IN ceftibuten/NN on/IN day/NN 6/CD ,/, each/DT volunteer/NN received/VBD a/DT single/JJ intravenous/JJ infusion/NN of/IN theophylline/NN (/-LRB- 4/CD mg/kg/NN )./CD

(ROOT (S1 (S (PP (IN With) (NP (NP (DT the) (NN morning) (NN dose)) (PP (IN of) (NP (NN ceftibuten))) (PP (IN on) (NP (NN day) (CD 6))))) (, ,) (NP (DT each) (NN volunteer)) (VP (VBD received) (NP (NP (NP (DT a) (JJ single) (JJ intravenous) (NN infusion)) (PP (IN of) (NP (NN theophylline)))) (-LRB- -LRB-) (NP (CD 4) (NN mg/kg) (CD -RRB-.)))))))

det(dose-4, the-2)
nn(dose-4, morning-3)
prep_with(received-13, dose-4)
prep_of(dose-4, ceftibuten-6)
prep_on(dose-4, day-8)
num(day-8, 6-9)
det(volunteer-12, each-11)
nsubj(received-13, volunteer-12)
root(ROOT-0, received-13)
det(infusion-17, a-14)
amod(infusion-17, single-15)
amod(infusion-17, intravenous-16)
dobj(received-13, infusion-17)
iobj(received-13, infusion-17)
prep_of(infusion-17, theophylline-19)
num(mg/kg-22, 4-21)
dep(infusion-17, mg/kg-22)
num(mg/kg-22, -RRB-.-23)

The/DT pharmacokinetics/NNS of/IN theophylline/NN were/VBD not/RB altered/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS pharmacokinetics)) (PP (IN of) (NP (NN theophylline)))) (VP (VBD were) (RB not) (VP (VBN altered)))) (. .))))

det(pharmacokinetics-2, The-1)
nsubjpass(altered-7, pharmacokinetics-2)
prep_of(pharmacokinetics-2, theophylline-4)
auxpass(altered-7, were-5)
neg(altered-7, not-6)
root(ROOT-0, altered-7)

The/DT effect/NN of/IN ceftibuten/NN on/IN the/DT pharmacokinetics/NNS of/IN theophylline/NN administered/VBN orally/RB has/VBZ not/RB been/VBN investigated/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN ceftibuten))) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN theophylline)) (VP (VBN administered) (ADVP (RB orally)))))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN investigated))))) (. .))))

det(effect-2, The-1)
nsubjpass(investigated-15, effect-2)
prep_of(effect-2, ceftibuten-4)
det(pharmacokinetics-7, the-6)
prep_on(effect-2, pharmacokinetics-7)
prep_of(pharmacokinetics-7, theophylline-9)
partmod(theophylline-9, administered-10)
advmod(administered-10, orally-11)
aux(investigated-15, has-12)
neg(investigated-15, not-13)
auxpass(investigated-15, been-14)
root(ROOT-0, investigated-15)

Antacids/NNS or/CC H/NN 2/CD -receptor/NN antagonists/NNS :/: The/DT effect/NN of/IN increased/VBN gastric/JJ pH/NN on/IN the/DT bioavailability/NN of/IN ceftibuten/NN was/VBD evaluated/VBN in/IN 18/CD healthy/JJ adult/JJ volunteers/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NNS Antacids)) (CC or) (NP (NN H) (CD 2) (NN -receptor) (NNS antagonists))) (: :) (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (VBN increased) (JJ gastric) (NN pH))) (PP (IN on) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (NN ceftibuten)))))) (VP (VBD was) (VP (VBN evaluated) (PP (IN in) (NP (CD 18) (JJ healthy) (JJ adult) (NNS volunteers)))))) (. .)))))

root(ROOT-0, Antacids-1)
nn(antagonists-6, H-3)
num(antagonists-6, 2-4)
nn(antagonists-6, -receptor-5)
conj_or(Antacids-1, antagonists-6)
det(effect-9, The-8)
nsubjpass(evaluated-20, effect-9)
amod(pH-13, increased-11)
amod(pH-13, gastric-12)
prep_of(effect-9, pH-13)
det(bioavailability-16, the-15)
prep_on(effect-9, bioavailability-16)
prep_of(bioavailability-16, ceftibuten-18)
auxpass(evaluated-20, was-19)
dep(Antacids-1, evaluated-20)
num(volunteers-25, 18-22)
amod(volunteers-25, healthy-23)
amod(volunteers-25, adult-24)
prep_in(evaluated-20, volunteers-25)

A/DT single/JJ dose/NN of/IN liquid/JJ antacid/JJ did/VBD not/RB affect/VB the/DT C/NN max/NN or/CC AUC/NN of/IN ceftibuten/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (DT A) (JJ single) (NN dose)) (PP (IN of) (NP (JJ liquid) (JJ antacid)))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NN C) (NN max)) (CC or) (NP (NP (NN AUC)) (PP (IN of) (NP (NN ceftibuten))) (: ;)))))) (. .))))

det(dose-3, A-1)
amod(dose-3, single-2)
nsubj(affect-9, dose-3)
amod(antacid-6, liquid-5)
prep_of(dose-3, antacid-6)
aux(affect-9, did-7)
neg(affect-9, not-8)
root(ROOT-0, affect-9)
det(max-12, the-10)
nn(max-12, C-11)
dobj(affect-9, max-12)
conj_or(max-12, AUC-14)
prep_of(AUC-14, ceftibuten-16)

however/RB ,/, 150/CD mg/NN of/IN ranitidine/NN q12h/IN for/IN 3/CD days/NNS increased/VBD the/DT ceftibuten/NN C/NN max/NN by/IN 23/CD %/NN and/CC ceftibuten/NN AUC/NN by/IN 16/CD %./NN

(ROOT (S1 (S (ADVP (RB however)) (, ,) (NP (NP (CD 150) (NN mg)) (PP (IN of) (NP (NN ranitidine))) (PP (IN q12h) (PP (IN for) (NP (CD 3) (NNS days))))) (VP (VBD increased) (NP (DT the) (NN ceftibuten) (NN C) (NN max)) (PP (IN by) (NP (NP (CD 23) (NN %)) (CC and) (NP (NN ceftibuten) (NN AUC)))) (PP (IN by) (NP (CD 16) (NN %.)))))))

advmod(increased-11, however-1)
num(mg-4, 150-3)
nsubj(increased-11, mg-4)
prep_of(mg-4, ranitidine-6)
prep(mg-4, q12h-7)
pcomp(q12h-7, for-8)
num(days-10, 3-9)
prep_for(q12h-7, days-10)
root(ROOT-0, increased-11)
det(max-15, the-12)
nn(max-15, ceftibuten-13)
nn(max-15, C-14)
dobj(increased-11, max-15)
num(%-18, 23-17)
prep_by(increased-11, %-18)
nn(AUC-21, ceftibuten-20)
conj_and(%-18, AUC-21)
num(%.-24, 16-23)
prep_by(increased-11, %.-24)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: There/EX have/VBP been/VBN no/DT chemical/JJ or/CC laboratory/JJ test/NN interactions/NNS with/IN ceftibuten/NN noted/VBN to/TO date/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (DT no) (ADJP (ADJP (JJ chemical)) (CC or) (ADJP (JJ laboratory))) (NN test) (NNS interactions)) (PP (IN with) (NP (NP (NN ceftibuten)) (VP (VBN noted) (PP (TO to) (NP (NN date)))))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
expl(interactions-14, There-6)
aux(interactions-14, have-7)
cop(interactions-14, been-8)
det(interactions-14, no-9)
amod(interactions-14, chemical-10)
conj_or(chemical-10, laboratory-12)
nn(interactions-14, test-13)
dep(Interactions-4, interactions-14)
prep_with(interactions-14, ceftibuten-16)
partmod(ceftibuten-16, noted-17)
prep_to(noted-17, date-19)

False-positive/JJ direct/JJ Coombs/NN tests/NNS have/VBP been/VBN reported/VBN during/IN treatment/NN with/IN other/JJ cephalosporins/NNS ./.

(ROOT (S1 (S (S (NP (JJ False-positive) (JJ direct) (NN Coombs) (NNS tests)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN during) (NP (NP (NN treatment)) (PP (IN with) (NP (JJ other) (NNS cephalosporins))))))))) (. .))))

amod(tests-4, False-positive-1)
amod(tests-4, direct-2)
nn(tests-4, Coombs-3)
nsubjpass(reported-7, tests-4)
aux(reported-7, have-5)
auxpass(reported-7, been-6)
root(ROOT-0, reported-7)
prep_during(reported-7, treatment-9)
amod(cephalosporins-12, other-11)
prep_with(treatment-9, cephalosporins-12)

Therefore/RB ,/, it/PRP should/MD be/VB recognized/VBN that/IN a/DT positive/JJ Coombs/NN test/NN could/MD be/VB due/JJ to/TO the/DT drug/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (PRP it)) (VP (MD should) (VP (VB be) (VP (VBN recognized) (SBAR (IN that) (S (NP (DT a) (JJ positive) (NN Coombs) (NN test)) (VP (MD could) (VP (VB be) (ADJP (JJ due) (PP (TO to) (NP (DT the) (NN drug)))))))))))) (. .))))

advmod(recognized-6, Therefore-1)
nsubjpass(recognized-6, it-3)
aux(recognized-6, should-4)
auxpass(recognized-6, be-5)
root(ROOT-0, recognized-6)
complm(due-14, that-7)
det(test-11, a-8)
amod(test-11, positive-9)
nn(test-11, Coombs-10)
nsubj(due-14, test-11)
aux(due-14, could-12)
cop(due-14, be-13)
ccomp(recognized-6, due-14)
det(drug-17, the-16)
prep_to(due-14, drug-17)

The/DT results/NNS of/IN assays/NNS using/VBG red/JJ cells/NNS from/IN healthy/JJ subjects/NNS to/TO determine/VB whether/IN ceftibuten/NN would/MD cause/VB direct/JJ Coombs/NN reactions/NNS in/FW vitro/FW showed/VBD no/DT positive/JJ reaction/NN at/IN ceftibuten/NN concentrations/NNS as/RB high/JJ as/IN 40/CD @/NN g/mL./NN

(ROOT (S1 (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (NP (NNS assays)) (VP (VBG using) (NP (NP (JJ red) (NNS cells)) (PP (IN from) (NP (JJ healthy) (NNS subjects)))) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (NN ceftibuten)) (VP (MD would) (VP (VB cause) (NP (JJ direct) (NN Coombs) (NNS reactions)) (ADVP (FW in) (FW vitro))))))))))))) (VP (VBD showed) (NP (DT no) (JJ positive) (NN reaction)) (PP (IN at) (NP (NP (NN ceftibuten) (NNS concentrations)) (ADJP (RB as) (JJ high) (PP (IN as) (NP (CD 40) (NN @) (NN g/mL.))))))))))

det(results-2, The-1)
nsubj(showed-22, results-2)
prep_of(results-2, assays-4)
partmod(assays-4, using-5)
amod(cells-7, red-6)
dobj(using-5, cells-7)
amod(subjects-10, healthy-9)
prep_from(cells-7, subjects-10)
aux(determine-12, to-11)
xcomp(using-5, determine-12)
complm(cause-16, whether-13)
nsubj(cause-16, ceftibuten-14)
aux(cause-16, would-15)
ccomp(determine-12, cause-16)
amod(reactions-19, direct-17)
nn(reactions-19, Coombs-18)
dobj(cause-16, reactions-19)
nn(vitro-21, in-20)
advmod(cause-16, vitro-21)
root(ROOT-0, showed-22)
det(reaction-25, no-23)
amod(reaction-25, positive-24)
dobj(showed-22, reaction-25)
nn(concentrations-28, ceftibuten-27)
prep_at(showed-22, concentrations-28)
advmod(high-30, as-29)
amod(concentrations-28, high-30)
num(g/mL.-34, 40-32)
nn(g/mL.-34, @-33)
prep_as(high-30, g/mL.-34)

Although/IN the/DT occurrence/NN has/VBZ not/RB been/VBN reported/VBN with/IN Cefizox/NN ,/, nephrotoxicity/NN has/VBZ been/VBN reported/VBN following/VBG concomitant/JJ administration/NN of/IN other/JJ cephalosporins/NNS and/CC aminoglycosides/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (DT the) (NN occurrence)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NN Cefizox)))))))) (, ,) (NP (NN nephrotoxicity)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (VBG following) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (JJ other) (NNS cephalosporins)) (CC and) (NP (NNS aminoglycosides)))))))))) (. .))))

mark(reported-7, Although-1)
det(occurrence-3, the-2)
nsubjpass(reported-7, occurrence-3)
aux(reported-7, has-4)
neg(reported-7, not-5)
auxpass(reported-7, been-6)
advcl(reported-14, reported-7)
prep_with(reported-7, Cefizox-9)
nsubjpass(reported-14, nephrotoxicity-11)
aux(reported-14, has-12)
auxpass(reported-14, been-13)
root(ROOT-0, reported-14)
amod(administration-17, concomitant-16)
prep_following(reported-14, administration-17)
amod(cephalosporins-20, other-19)
prep_of(administration-17, cephalosporins-20)
conj_and(cephalosporins-20, aminoglycosides-22)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: A/DT false-positive/JJ reaction/NN for/IN glucose/NN in/IN the/DT urine/NN may/MD occur/VB with/IN copper/NN reduction/NN tests/NNS (/-LRB- Benedict/NN @/NN s/NN or/CC Fehling/NN @/NN s/NN solution/NN or/CC with/IN Clinitest/NN @/NN tablets/NNS )/-RRB- but/CC not/RB with/IN enzyme-based/JJ tests/NNS for/IN glycosuria/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (NP (DT A) (JJ false-positive) (NN reaction)) (PP (IN for) (NP (NN glucose))) (PP (IN in) (NP (DT the) (NN urine)))) (VP (MD may) (VP (VB occur) (PP (PP (IN with) (NP (NP (NN copper) (NN reduction) (NNS tests)) (PRN (-LRB- -LRB-) (NP (NN Benedict) (NN @) (NN s) (CC or) (NN Fehling) (NN @) (NN s) (NN solution)) (CC or) (PP (IN with) (NP (NN Clinitest) (NN @) (NNS tablets))) (-RRB- -RRB-)))) (CC but) (PP (RB not) (IN with) (NP (NP (JJ enzyme-based) (NNS tests)) (PP (IN for) (NP (NN glycosuria))))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
det(reaction-8, A-6)
amod(reaction-8, false-positive-7)
nsubj(occur-15, reaction-8)
prep_for(reaction-8, glucose-10)
det(urine-13, the-12)
prep_in(reaction-8, urine-13)
aux(occur-15, may-14)
dep(Interactions-4, occur-15)
nn(tests-19, copper-17)
nn(tests-19, reduction-18)
prep_with(occur-15, tests-19)
nn(s-23, Benedict-21)
nn(s-23, @-22)
dep(tests-19, s-23)
nn(solution-28, Fehling-25)
nn(solution-28, @-26)
nn(solution-28, s-27)
conj_or(s-23, solution-28)
dep(s-23, or-29)
dep(s-23, with-30)
nn(tablets-33, Clinitest-31)
nn(tablets-33, @-32)
pobj(with-30, tablets-33)
neg(occur-15, not-36)
amod(tests-39, enzyme-based-38)
conj_but(tests-19, tests-39)
prep_for(tests-39, glycosuria-41)

As/IN a/DT false-negative/JJ result/NN may/MD occur/VB in/IN the/DT ferricyanide/NN test/NN ,/, it/PRP is/VBZ recommended/VBN that/IN either/CC the/DT glucose/NN oxidase/NN or/CC hexokinase/NN method/NN be/VB used/VBN to/TO determine/VB blood/NN plasma/NN glucose/NN levels/NNS in/IN patients/NNS receiving/VBG cefuroxime/NN ./.

(ROOT (S1 (S (S (SBAR (IN As) (S (NP (DT a) (JJ false-negative) (NN result)) (VP (MD may) (VP (VB occur) (PP (IN in) (NP (DT the) (NN ferricyanide) (NN test))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (CC either) (DT the) (NP (NN glucose) (NN oxidase)) (CC or) (NP (NN hexokinase) (NN method))) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB determine) (NP (NP (NN blood) (NN plasma) (NN glucose) (NNS levels)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN cefuroxime)))))))))))))))) (. .))))

mark(occur-6, As-1)
det(result-4, a-2)
amod(result-4, false-negative-3)
nsubj(occur-6, result-4)
aux(occur-6, may-5)
advcl(recommended-14, occur-6)
det(test-10, the-8)
nn(test-10, ferricyanide-9)
prep_in(occur-6, test-10)
nsubjpass(recommended-14, it-12)
auxpass(recommended-14, is-13)
root(ROOT-0, recommended-14)
complm(used-24, that-15)
preconj(oxidase-19, either-16)
dep(oxidase-19, the-17)
nn(oxidase-19, glucose-18)
nsubjpass(used-24, oxidase-19)
nn(method-22, hexokinase-21)
conj_or(oxidase-19, method-22)
auxpass(used-24, be-23)
ccomp(recommended-14, used-24)
aux(determine-26, to-25)
xcomp(used-24, determine-26)
nn(levels-30, blood-27)
nn(levels-30, plasma-28)
nn(levels-30, glucose-29)
dobj(determine-26, levels-30)
prep_in(levels-30, patients-32)
partmod(patients-32, receiving-33)
dobj(receiving-33, cefuroxime-34)

Cefuroxime/NN does/VBZ not/RB interfere/VB with/IN the/DT assay/NN of/IN serum/NN and/CC urine/NN creatinine/NN by/IN the/DT alkaline/NN picrate/NN method/NN ./.

(ROOT (S1 (S (S (NP (NN Cefuroxime)) (VP (VBZ does) (RB not) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN assay)) (PP (IN of) (NP (NP (NN serum)) (CC and) (NP (NN urine)) (NP (NN creatinine)))))) (PP (IN by) (NP (DT the) (NN alkaline) (NN picrate) (NN method)))))) (. .))))

nsubj(interfere-4, Cefuroxime-1)
aux(interfere-4, does-2)
neg(interfere-4, not-3)
root(ROOT-0, interfere-4)
det(assay-7, the-6)
prep_with(interfere-4, assay-7)
prep_of(assay-7, serum-9)
conj_and(serum-9, urine-11)
dep(serum-9, creatinine-12)
det(method-17, the-14)
nn(method-17, alkaline-15)
nn(method-17, picrate-16)
prep_by(interfere-4, method-17)

General/JJ :/: Significant/JJ interactions/NNS may/MD occur/VB when/WRB celecoxib/NN is/VBZ administered/VBN together/RB with/IN drugs/NNS that/WDT inhibit/VBP P450/NN 2C9/NN ./.

(ROOT (S1 (S (S (NP (ADJP (ADJP (JJ General)) (: :) (ADJP (JJ Significant))) (NNS interactions)) (VP (MD may) (VP (VB occur) (SBAR (WHADVP (WRB when)) (S (NP (NN celecoxib)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB together)) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (NN P450) (NN 2C9)))))))))))))) (. .))))

amod(interactions-4, General-1)
dep(General-1, Significant-3)
nsubj(occur-6, interactions-4)
aux(occur-6, may-5)
root(ROOT-0, occur-6)
advmod(administered-10, when-7)
nsubjpass(administered-10, celecoxib-8)
auxpass(administered-10, is-9)
advcl(occur-6, administered-10)
prep_together_with(administered-10, drugs-13)
nsubj(inhibit-15, drugs-13)
rcmod(drugs-13, inhibit-15)
nn(2C9-17, P450-16)
dobj(inhibit-15, 2C9-17)

Celecoxib/NN metabolism/NN is/VBZ predominantly/RB mediated/VBN via/IN cytochrome/NN P450/NN 2C9/NN in/IN the/DT liver/NN ./.

(ROOT (S1 (S (S (NP (NN Celecoxib) (NN metabolism)) (VP (VBZ is) (ADVP (RB predominantly)) (VP (VBN mediated) (PP (IN via) (NP (NP (NN cytochrome) (NN P450) (NN 2C9)) (PP (IN in) (NP (DT the) (NN liver)))))))) (. .))))

nn(metabolism-2, Celecoxib-1)
nsubjpass(mediated-5, metabolism-2)
auxpass(mediated-5, is-3)
advmod(mediated-5, predominantly-4)
root(ROOT-0, mediated-5)
nn(2C9-9, cytochrome-7)
nn(2C9-9, P450-8)
prep_via(mediated-5, 2C9-9)
det(liver-12, the-11)
prep_in(2C9-9, liver-12)

Co-administration/NN of/IN celecoxib/NN with/IN drugs/NNS that/WDT are/VBP known/VBN to/TO inhibit/VB 2C9/NNS should/MD be/VB done/VBN with/IN caution/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NN celecoxib))) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB inhibit) (NP (NNS 2C9)))))))))))) (VP (MD should) (VP (VB be) (VP (VBN done) (PP (IN with) (NP (NN caution))))))) (. .))))

nsubjpass(done-14, Co-administration-1)
prep_of(Co-administration-1, celecoxib-3)
prep_with(Co-administration-1, drugs-5)
nsubjpass(known-8, drugs-5)
auxpass(known-8, are-7)
rcmod(drugs-5, known-8)
aux(inhibit-10, to-9)
xcomp(known-8, inhibit-10)
dobj(inhibit-10, 2C9-11)
aux(done-14, should-12)
auxpass(done-14, be-13)
root(ROOT-0, done-14)
prep_with(done-14, caution-16)

In/FW vitro/FW studies/NNS indicate/VBP that/IN celecoxib/NN is/VBZ not/RB an/DT inhibitor/NN of/IN cytochrome/NN P450/NN 2C9/NN ,/, 2C19/NN or/CC 3A4/NN ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN celecoxib)) (VP (VBZ is) (RB not) (NP (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN cytochrome) (NN P450) (NN 2C9)))) (, ,) (NP (NP (NN 2C19)) (CC or) (NP (NN 3A4))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(indicate-4, studies-3)
root(ROOT-0, indicate-4)
complm(inhibitor-10, that-5)
nsubj(inhibitor-10, celecoxib-6)
cop(inhibitor-10, is-7)
neg(inhibitor-10, not-8)
det(inhibitor-10, an-9)
ccomp(indicate-4, inhibitor-10)
nn(2C9-14, cytochrome-12)
nn(2C9-14, P450-13)
prep_of(inhibitor-10, 2C9-14)
appos(inhibitor-10, 2C19-16)
conj_or(2C19-16, 3A4-18)

In/FW vitro/FW studies/NNS also/RB indicate/VBP that/IN celecoxib/NN ,/, although/IN not/RB a/DT substrate/NN ,/, is/VBZ an/DT inhibitor/NN of/IN cytochrome/NN P450/NN 2D6/NN ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (ADVP (RB also)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN celecoxib)) (, ,) (CONJP (IN although) (RB not)) (NP (DT a) (NN substrate)) (, ,)) (VP (VBZ is) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN cytochrome) (NN P450) (NN 2D6))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(indicate-5, studies-3)
advmod(indicate-5, also-4)
root(ROOT-0, indicate-5)
complm(inhibitor-16, that-6)
nsubj(inhibitor-16, celecoxib-7)
det(substrate-12, a-11)
conj_negcc(celecoxib-7, substrate-12)
cop(inhibitor-16, is-14)
det(inhibitor-16, an-15)
ccomp(indicate-5, inhibitor-16)
nn(2D6-20, cytochrome-18)
nn(2D6-20, P450-19)
prep_of(inhibitor-16, 2D6-20)

Therefore/RB ,/, there/EX is/VBZ a/DT potential/NN for/IN an/DT in/FW vivo/FW drug/NN interaction/NN with/IN drugs/NNS that/WDT are/VBP metabolized/VBN by/IN P450/NN 2D6/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (NN potential)) (PP (IN for) (NP (NP (DT an) (ADJP (FW in) (FW vivo)) (NN drug) (NN interaction)) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN metabolized) (PP (IN by) (NP (NN P450) (NN 2D6)))))))))))))) (. .))))

advmod(is-4, Therefore-1)
expl(is-4, there-3)
root(ROOT-0, is-4)
det(potential-6, a-5)
nsubj(is-4, potential-6)
det(interaction-12, an-8)
nn(vivo-10, in-9)
amod(interaction-12, vivo-10)
nn(interaction-12, drug-11)
prep_for(potential-6, interaction-12)
prep_with(interaction-12, drugs-14)
nsubjpass(metabolized-17, drugs-14)
auxpass(metabolized-17, are-16)
rcmod(drugs-14, metabolized-17)
nn(2D6-20, P450-19)
agent(metabolized-17, 2D6-20)

Clinical/JJ studies/NNS with/IN celecoxib/NN have/VBP identified/VBN potentially/RB significant/JJ interactions/NNS with/IN fluconazole/NN and/CC lithium/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Clinical) (NNS studies)) (PP (IN with) (NP (NN celecoxib)))) (VP (VBP have) (VP (VBN identified) (NP (NP (ADJP (RB potentially) (JJ significant)) (NNS interactions)) (PP (IN with) (NP (NP (NN fluconazole)) (CC and) (NP (NN lithium)))))))) (. .))))

amod(studies-2, Clinical-1)
nsubj(identified-6, studies-2)
prep_with(studies-2, celecoxib-4)
aux(identified-6, have-5)
root(ROOT-0, identified-6)
advmod(significant-8, potentially-7)
amod(interactions-9, significant-8)
dobj(identified-6, interactions-9)
prep_with(interactions-9, fluconazole-11)
conj_and(fluconazole-11, lithium-13)

Experience/VBP with/IN nonsteroidal/JJ anti-inflammatory/JJ drugs/NNS (/-LRB- NSAIDs/NNS )/-RRB- suggests/VBZ the/DT potential/NN for/IN interactions/NNS with/IN furosemide/NN and/CC ACE/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (NP (VBP Experience)) (PP (IN with) (NP (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NNS NSAIDs)) (-RRB- -RRB-))))) (VP (VBZ suggests) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (NNS interactions)) (PP (IN with) (NP (NP (NN furosemide)) (CC and) (NP (NN ACE) (NNS inhibitors))))))))) (. .))))

nsubj(suggests-9, Experience-1)
amod(drugs-5, nonsteroidal-3)
amod(drugs-5, anti-inflammatory-4)
prep_with(Experience-1, drugs-5)
appos(drugs-5, NSAIDs-7)
root(ROOT-0, suggests-9)
det(potential-11, the-10)
dobj(suggests-9, potential-11)
prep_for(potential-11, interactions-13)
prep_with(interactions-13, furosemide-15)
nn(inhibitors-18, ACE-17)
conj_and(furosemide-15, inhibitors-18)

The/DT effects/NNS celecoxib/NN on/IN the/DT pharmacokinetics/NNS and/or/CC pharmacodynamics/NNS of/IN glyburide/NN ,/, ketoconazole/NN ,/, methotrexate/NN ,/, phenytoin/NN ,/, tolbutamide/NN ,/, and/CC warfarin/NN have/VBP been/VBN studied/VBN in/FW vivo/FW and/CC clinically/RB important/JJ interactions/NNS have/VBP not/RB been/VBN found/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (DT The) (NNS effects)) (PP (NP (NN celecoxib)) (IN on) (NP (NP (DT the) (NP (NNS pharmacokinetics)) (CC and/or) (NP (NNS pharmacodynamics))) (PP (IN of) (NP (NP (NN glyburide)) (, ,) (NP (NN ketoconazole)) (, ,) (NP (NN methotrexate)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN tolbutamide)) (, ,) (CC and) (NP (NN warfarin))))))) (VP (VBP have) (VP (VBN been) (VP (VBN studied) (ADVP (FW in) (FW vivo)))))) (CC and) (S (NP (ADJP (RB clinically) (JJ important)) (NNS interactions)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN found)))))) (. .))))

det(effects-2, The-1)
nsubjpass(studied-24, effects-2)
npadvmod(effects-2, celecoxib-3)
dep(pharmacokinetics-6, the-5)
prep_on(effects-2, pharmacokinetics-6)
conj_and/or(pharmacokinetics-6, pharmacodynamics-8)
prep_of(pharmacokinetics-6, glyburide-10)
conj_and(glyburide-10, ketoconazole-12)
conj_and(glyburide-10, methotrexate-14)
conj_and(glyburide-10, phenytoin-16)
conj_and(glyburide-10, tolbutamide-18)
conj_and(glyburide-10, warfarin-21)
aux(studied-24, have-22)
auxpass(studied-24, been-23)
root(ROOT-0, studied-24)
nn(vivo-26, in-25)
advmod(studied-24, vivo-26)
advmod(important-29, clinically-28)
amod(interactions-30, important-29)
nsubjpass(found-34, interactions-30)
aux(found-34, have-31)
neg(found-34, not-32)
auxpass(found-34, been-33)
conj_and(studied-24, found-34)

ACE/NN inhibitors/NNS :/: Reports/NNS suggest/VBP that/IN NSAIDs/NNS may/MD diminish/VB the/DT antihypertensive/JJ effect/NN of/IN Angiotensin/NN Converting/NN Enzyme/NN (/-LRB- ACE/NN )/-RRB- inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (NN ACE) (NNS inhibitors)) (: :) (NP (NNS Reports)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS NSAIDs)) (VP (MD may) (VP (VB diminish) (NP (NP (DT the) (JJ antihypertensive) (NN effect)) (PP (IN of) (NP (NP (NP (NN Angiotensin) (NN Converting) (NN Enzyme)) (PRN (-LRB- -LRB-) (NP (NN ACE)) (-RRB- -RRB-))) (NNS inhibitors)))))))))) (. .))))

nn(inhibitors-2, ACE-1)
nsubj(suggest-5, inhibitors-2)
nsubj(suggest-5, Reports-4)
root(ROOT-0, suggest-5)
complm(diminish-9, that-6)
nsubj(diminish-9, NSAIDs-7)
aux(diminish-9, may-8)
ccomp(suggest-5, diminish-9)
det(effect-12, the-10)
amod(effect-12, antihypertensive-11)
dobj(diminish-9, effect-12)
nn(Enzyme-16, Angiotensin-14)
nn(Enzyme-16, Converting-15)
nn(inhibitors-20, Enzyme-16)
abbrev(Enzyme-16, ACE-18)
prep_of(effect-12, inhibitors-20)

This/DT interaction/NN should/MD be/VB given/VBN consideration/NN in/IN patients/NNS taking/VBG CELEBREX/NN concomitantly/RB with/IN ACE-inhibitors/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN interaction)) (VP (MD should) (VP (VB be) (VP (VBN given) (NP (NP (NN consideration)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN CELEBREX)))))) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN ACE-inhibitors))))))) (. .))))

det(interaction-2, This-1)
nsubjpass(given-5, interaction-2)
aux(given-5, should-3)
auxpass(given-5, be-4)
root(ROOT-0, given-5)
dobj(given-5, consideration-6)
prep_in(consideration-6, patients-8)
partmod(patients-8, taking-9)
dobj(taking-9, CELEBREX-10)
advmod(given-5, concomitantly-11)
prep_with(given-5, ACE-inhibitors-13)

Furosemide/NN :/: Clinical/JJ studies/NNS ,/, as/RB well/RB as/IN post/JJ marketing/JJ observations/NNS ,/, have/VBP shown/VBN that/IN NSAIDs/NNS can/MD reduce/VB the/DT natriuretic/JJ effect/NN of/IN furosemide/NN and/CC thiazides/NNS in/IN some/DT patients/NNS ./.

(ROOT (S1 (S (NP (NP (NN Furosemide)) (: :) (S (NP (NP (JJ Clinical) (NNS studies)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (JJ post) (JJ marketing) (NNS observations)) (, ,)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NNS NSAIDs)) (VP (MD can) (VP (VB reduce) (NP (NP (DT the) (JJ natriuretic) (NN effect)) (PP (IN of) (NP (NP (NN furosemide)) (CC and) (NP (NNS thiazides)))) (PP (IN in) (NP (DT some) (NNS patients))))))))))) (. .)))))

root(ROOT-0, Furosemide-1)
amod(studies-4, Clinical-3)
nsubj(shown-14, studies-4)
amod(observations-11, post-9)
amod(observations-11, marketing-10)
conj_and(studies-4, observations-11)
aux(shown-14, have-13)
dep(Furosemide-1, shown-14)
complm(reduce-18, that-15)
nsubj(reduce-18, NSAIDs-16)
aux(reduce-18, can-17)
ccomp(shown-14, reduce-18)
det(effect-21, the-19)
amod(effect-21, natriuretic-20)
dobj(reduce-18, effect-21)
prep_of(effect-21, furosemide-23)
conj_and(furosemide-23, thiazides-25)
det(patients-28, some-27)
prep_in(effect-21, patients-28)

This/DT response/NN has/VBZ been/VBN attributed/VBN to/TO inhibition/NN of/IN renal/JJ prostaglandin/NN synthesis/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN response)) (VP (VBZ has) (VP (VBN been) (VP (VBN attributed) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ renal) (NN prostaglandin) (NN synthesis))))))))) (. .))))

det(response-2, This-1)
nsubjpass(attributed-5, response-2)
aux(attributed-5, has-3)
auxpass(attributed-5, been-4)
root(ROOT-0, attributed-5)
prep_to(attributed-5, inhibition-7)
amod(synthesis-11, renal-9)
nn(synthesis-11, prostaglandin-10)
prep_of(inhibition-7, synthesis-11)

Aspirin/NN :/: CELEBREX/NN can/MD be/VB used/VBN with/IN low/JJ dose/NN aspirin/NN ./.

(ROOT (S1 (S (S (NP (NN Aspirin) (: :) (NN CELEBREX)) (VP (MD can) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (JJ low) (NN dose) (NN aspirin))))))) (. .))))

nn(CELEBREX-3, Aspirin-1)
nsubjpass(used-6, CELEBREX-3)
aux(used-6, can-4)
auxpass(used-6, be-5)
root(ROOT-0, used-6)
amod(aspirin-10, low-8)
nn(aspirin-10, dose-9)
prep_with(used-6, aspirin-10)

However/RB ,/, concomitant/JJ administration/NN of/IN aspirin/NN with/IN CELEBREX/NN may/MD result/VB in/IN an/DT increased/VBN rate/NN of/IN GI/NN ulceration/NN or/CC other/JJ complications/NNS ,/, compared/VBN to/TO use/NN of/IN CELEBREX/NN alone/RB ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN aspirin))) (PP (IN with) (NP (NN CELEBREX)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT an) (VBN increased) (NN rate)) (PP (IN of) (NP (NP (NN GI) (NN ulceration)) (CC or) (NP (JJ other) (NNS complications)))))) (, ,) (S (VP (VBN compared) (PP (TO to) (NP (NP (NN use)) (PP (IN of) (NP (NP (NN CELEBREX)) (ADVP (RB alone))))))))))) (. .))))

advmod(result-10, However-1)
amod(administration-4, concomitant-3)
nsubj(result-10, administration-4)
prep_of(administration-4, aspirin-6)
prep_with(administration-4, CELEBREX-8)
aux(result-10, may-9)
root(ROOT-0, result-10)
det(rate-14, an-12)
amod(rate-14, increased-13)
prep_in(result-10, rate-14)
nn(ulceration-17, GI-16)
prep_of(rate-14, ulceration-17)
amod(complications-20, other-19)
conj_or(ulceration-17, complications-20)
prep_compared_to(result-10, use-24)
prep_of(use-24, CELEBREX-26)
advmod(CELEBREX-26, alone-27)

Because/IN of/IN its/PRP$ lack/NN of/IN platelet/NN effects/NNS ,/, CELEBREX/NN is/VBZ not/RB a/DT substitute/VB for/IN aspirin/NN for/IN cardiovascular/JJ prophylaxis/NNS ./.

(ROOT (S1 (S (S (PP (IN Because) (IN of) (NP (NP (PRP$ its) (NN lack)) (PP (IN of) (NP (NN platelet) (NNS effects))))) (, ,) (NP (NN CELEBREX)) (VP (VBZ is) (RB not) (VP (DT a) (VP (VB substitute) (PP (IN for) (NP (NN aspirin))) (PP (IN for) (NP (JJ cardiovascular) (NNS prophylaxis))))))) (. .))))

poss(lack-4, its-3)
prep_because_of(substitute-13, lack-4)
nn(effects-7, platelet-6)
prep_of(lack-4, effects-7)
nsubj(substitute-13, CELEBREX-9)
aux(substitute-13, is-10)
neg(substitute-13, not-11)
dep(substitute-13, a-12)
root(ROOT-0, substitute-13)
prep_for(substitute-13, aspirin-15)
amod(prophylaxis-18, cardiovascular-17)
prep_for(substitute-13, prophylaxis-18)

Fluconazole/NN :/: Concomitant/JJ administration/NN of/IN fluconazole/NN at/IN 200/CD mg/NN QD/NN resulted/VBD in/IN a/DT two-fold/JJ increase/NN in/IN celecoxib/NN plasma/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN Fluconazole)) (: :) (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NN fluconazole))) (PP (IN at) (NP (ADJP (CD 200) (NN mg)) (NN QD)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJ two-fold) (NN increase)) (PP (IN in) (NP (NN celecoxib) (NN plasma) (NN concentration))))))) (. .)))))

root(ROOT-0, Fluconazole-1)
amod(administration-4, Concomitant-3)
nsubj(resulted-11, administration-4)
prep_of(administration-4, fluconazole-6)
number(mg-9, 200-8)
amod(QD-10, mg-9)
prep_at(administration-4, QD-10)
dep(Fluconazole-1, resulted-11)
det(increase-15, a-13)
amod(increase-15, two-fold-14)
prep_in(resulted-11, increase-15)
nn(concentration-19, celecoxib-17)
nn(concentration-19, plasma-18)
prep_in(increase-15, concentration-19)

This/DT increase/NN is/VBZ due/JJ to/TO the/DT inhibition/NN of/IN celecoxib/NN metabolism/NN via/IN P450/NN 2C9/NN by/IN fluconazole/NN (/-LRB- see/VB CLINICAL/JJ PHARMACOLOGY/NN -/CC Pharmacokinetics/NNS :/: Metabolism/NN )./NN

(ROOT (S1 (S (NP (DT This) (NN increase)) (VP (VBZ is) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (NN inhibition)) (PP (IN of) (NP (NN celecoxib) (NN metabolism)))))) (PP (IN via) (NP (NN P450) (NN 2C9))) (PP (IN by) (NP (NN fluconazole))) (PRN (-LRB- -LRB-) (NP (VB see) (NP (NP (JJ CLINICAL) (NN PHARMACOLOGY)) (CC -) (NP (NNS Pharmacokinetics))) (: :) (NP (NN Metabolism) (NN -RRB-.))))))))

det(increase-2, This-1)
nsubj(due-4, increase-2)
cop(due-4, is-3)
root(ROOT-0, due-4)
det(inhibition-7, the-6)
prep_to(due-4, inhibition-7)
nn(metabolism-10, celecoxib-9)
prep_of(inhibition-7, metabolism-10)
nn(2C9-13, P450-12)
prep_via(due-4, 2C9-13)
prep_by(due-4, fluconazole-15)
dep(PHARMACOLOGY-19, see-17)
amod(PHARMACOLOGY-19, CLINICAL-18)
dep(due-4, PHARMACOLOGY-19)
conj(PHARMACOLOGY-19, Pharmacokinetics-21)
nn(-RRB-.-24, Metabolism-23)
dep(PHARMACOLOGY-19, -RRB-.-24)

CELEBREX/NN should/MD be/VB introduced/VBN at/IN the/DT lowest/JJS recommended/VBN dose/NN in/IN patients/NNS receiving/VBG fluconazole/NN ./.

(ROOT (S1 (S (S (NP (NN CELEBREX)) (VP (MD should) (VP (VB be) (VP (VBN introduced) (PP (IN at) (NP (NP (DT the) (JJS lowest) (VBN recommended) (NN dose)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN fluconazole))))))))))) (. .))))

nsubjpass(introduced-4, CELEBREX-1)
aux(introduced-4, should-2)
auxpass(introduced-4, be-3)
root(ROOT-0, introduced-4)
det(dose-9, the-6)
amod(dose-9, lowest-7)
amod(dose-9, recommended-8)
prep_at(introduced-4, dose-9)
prep_in(dose-9, patients-11)
partmod(patients-11, receiving-12)
dobj(receiving-12, fluconazole-13)

Lithium/NN :/: In/IN a/DT study/NN conducted/VBN in/IN healthy/JJ subjects/NNS ,/, mean/JJ steady-state/JJ lithium/NN plasma/NN levels/NNS increased/VBD approximately/RB 17/CD %/NN in/IN subjects/NNS receiving/VBG lithium/NN 450/CD mg/NN BID/JJ with/IN CELEBREX/NN 200/CD mg/NN BID/NN as/IN compared/VBN to/TO subjects/NNS receiving/VBG lithium/NN alone/RB ./.

(ROOT (S1 (S (NP (NP (NN Lithium)) (: :) (S (PP (IN In) (NP (NP (DT a) (NN study)) (VP (VBN conducted) (PP (IN in) (NP (JJ healthy) (NNS subjects)))))) (, ,) (NP (JJ mean) (JJ steady-state) (NN lithium) (NN plasma) (NNS levels)) (VP (VBD increased) (NP (QP (RB approximately) (CD 17)) (NN %)) (PP (IN in) (NP (NP (NNS subjects)) (VP (VBG receiving) (NP (NP (NN lithium) (CD 450) (NN mg)) (ADJP (JJ BID) (PP (IN with) (NP (NP (NN CELEBREX) (ADJP (CD 200) (NN mg)) (NN BID)) (SBAR (IN as) (S (VP (VBN compared) (PP (TO to) (NP (NP (NNS subjects)) (VP (VBG receiving) (NP (NP (NN lithium)) (ADVP (RB alone)))))))))))))))))) (. .)))))

root(ROOT-0, Lithium-1)
det(study-5, a-4)
prep_in(increased-16, study-5)
partmod(study-5, conducted-6)
amod(subjects-9, healthy-8)
prep_in(conducted-6, subjects-9)
amod(levels-15, mean-11)
amod(levels-15, steady-state-12)
nn(levels-15, lithium-13)
nn(levels-15, plasma-14)
nsubj(increased-16, levels-15)
dep(Lithium-1, increased-16)
quantmod(17-18, approximately-17)
num(%-19, 17-18)
dobj(increased-16, %-19)
prep_in(increased-16, subjects-21)
partmod(subjects-21, receiving-22)
nn(mg-25, lithium-23)
num(mg-25, 450-24)
dobj(receiving-22, mg-25)
amod(mg-25, BID-26)
nn(BID-31, CELEBREX-28)
number(mg-30, 200-29)
amod(BID-31, mg-30)
prep_with(BID-26, BID-31)
mark(BID-31, as-32)
prep_compared_to(BID-31, subjects-35)
partmod(subjects-35, receiving-36)
dobj(receiving-36, lithium-37)
advmod(lithium-37, alone-38)

Patients/NNS on/IN lithium/NN treatment/NN should/MD be/VB closely/RB monitored/VBN when/WRB CELEBREX/NN is/VBZ introduced/VBN or/CC withdrawn/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (PP (IN on) (NP (NN lithium) (NN treatment)))) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN monitored))) (SBAR (WHADVP (WRB when)) (S (NP (NN CELEBREX)) (VP (VBZ is) (VP (VP (VBN introduced)) (CC or) (VP (VBN withdrawn)))))))) (. .))))

nsubjpass(monitored-8, Patients-1)
nn(treatment-4, lithium-3)
prep_on(Patients-1, treatment-4)
aux(monitored-8, should-5)
auxpass(monitored-8, be-6)
advmod(monitored-8, closely-7)
root(ROOT-0, monitored-8)
advmod(introduced-12, when-9)
nsubjpass(introduced-12, CELEBREX-10)
auxpass(introduced-12, is-11)
advcl(monitored-8, introduced-12)
conj_or(introduced-12, withdrawn-14)

Methotrexate/NN :/: In/IN an/DT interaction/NN study/NN of/IN rheumatoid/JJ arthritis/NN patients/NNS taking/VBG methotrexate/NN ,/, CELEBREX/NN did/VBD not/RB have/VB a/DT significant/JJ effect/NN on/IN the/DT pharmacokinetics/NNS of/IN methotrexate/NN ./.

(ROOT (S1 (S (S (PP (NP (NP (NN Methotrexate) (: :)) (PP (IN In) (NP (NP (DT an) (NN interaction) (NN study)) (PP (IN of) (NP (NP (JJ rheumatoid) (NN arthritis)) (NNS patients)))))) (VBG taking) (NP (NN methotrexate))) (, ,) (NP (NN CELEBREX)) (VP (VBD did) (RB not) (VP (VB have) (NP (DT a) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN methotrexate)))))))) (. .))))

dep(have-17, Methotrexate-1)
det(study-6, an-4)
nn(study-6, interaction-5)
prep_in(Methotrexate-1, study-6)
amod(arthritis-9, rheumatoid-8)
nn(patients-10, arthritis-9)
prep_of(study-6, patients-10)
prep_taking(have-17, methotrexate-12)
nsubj(have-17, CELEBREX-14)
aux(have-17, did-15)
neg(have-17, not-16)
root(ROOT-0, have-17)
det(effect-20, a-18)
amod(effect-20, significant-19)
dobj(have-17, effect-20)
det(pharmacokinetics-23, the-22)
prep_on(have-17, pharmacokinetics-23)
prep_of(pharmacokinetics-23, methotrexate-25)

Warfarin/NN :/: The/DT effect/NN of/IN celecoxib/NN on/IN the/DT anti-coagulant/JJ effect/NN of/IN warfarin/NN was/VBD studied/VBN in/IN a/DT group/NN of/IN healthy/JJ subjects/NNS receiving/VBG daily/JJ doses/NNS of/IN 2-5/CD mg/NN of/IN warfarin/NN ./.

(ROOT (S1 (S (S (NP (NN Warfarin)) (: :) (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN celecoxib))) (PP (IN on) (NP (NP (DT the) (JJ anti-coagulant) (NN effect)) (PP (IN of) (NP (NN warfarin)))))) (VP (VBD was) (VP (VBN studied) (PP (IN in) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (NP (JJ healthy) (NNS subjects)) (VP (VBG receiving) (NP (NP (JJ daily) (NNS doses)) (PP (IN of) (NP (NP (CD 2-5) (NN mg)) (PP (IN of) (NP (NN warfarin)))))))))))))) (. .))))

nsubjpass(studied-14, Warfarin-1)
det(effect-4, The-3)
nsubjpass(studied-14, effect-4)
prep_of(effect-4, celecoxib-6)
det(effect-10, the-8)
amod(effect-10, anti-coagulant-9)
prep_on(effect-4, effect-10)
prep_of(effect-10, warfarin-12)
auxpass(studied-14, was-13)
root(ROOT-0, studied-14)
det(group-17, a-16)
prep_in(studied-14, group-17)
amod(subjects-20, healthy-19)
prep_of(group-17, subjects-20)
partmod(subjects-20, receiving-21)
amod(doses-23, daily-22)
dobj(receiving-21, doses-23)
num(mg-26, 2-5-25)
prep_of(doses-23, mg-26)
prep_of(mg-26, warfarin-28)

In/IN these/DT subjects/NNS ,/, celecoxib/NN did/VBD not/RB alter/VB the/DT anticoagulant/JJ effect/NN of/IN warfarin/NN as/IN determined/VBN by/IN prothrombin/NN time/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT these) (NNS subjects))) (, ,) (NP (NN celecoxib)) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (JJ anticoagulant) (NN effect)) (PP (IN of) (NP (NN warfarin)))) (SBAR (IN as) (S (VP (VBN determined) (PP (IN by) (NP (NN prothrombin) (NN time))))))))) (. .))))

det(subjects-3, these-2)
prep_in(alter-8, subjects-3)
nsubj(alter-8, celecoxib-5)
aux(alter-8, did-6)
neg(alter-8, not-7)
root(ROOT-0, alter-8)
det(effect-11, the-9)
amod(effect-11, anticoagulant-10)
dobj(alter-8, effect-11)
prep_of(effect-11, warfarin-13)
mark(determined-15, as-14)
advcl(alter-8, determined-15)
nn(time-18, prothrombin-17)
prep_by(determined-15, time-18)

However/RB ,/, caution/NN should/MD be/VB used/VBN when/WRB administering/VBG CELEBREX/NN with/IN warfarin/NN since/IN these/DT patients/NNS are/VBP at/IN increased/VBN risk/NN of/IN bleeding/JJ complications/NNS ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN used))) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (NN CELEBREX)) (PP (IN with) (NP (NN warfarin))) (SBAR (IN since) (S (NP (DT these) (NNS patients)) (VP (VBP are) (PP (IN at) (NP (NP (VBN increased) (NN risk)) (PP (IN of) (NP (JJ bleeding) (NNS complications))))))))))))) (. .))))

advmod(used-6, However-1)
nsubjpass(used-6, caution-3)
aux(used-6, should-4)
auxpass(used-6, be-5)
root(ROOT-0, used-6)
advmod(administering-8, when-7)
advcl(used-6, administering-8)
dobj(administering-8, CELEBREX-9)
prep_with(administering-8, warfarin-11)
mark(are-15, since-12)
det(patients-14, these-13)
nsubj(are-15, patients-14)
advcl(administering-8, are-15)
amod(risk-18, increased-17)
prep_at(are-15, risk-18)
amod(complications-21, bleeding-20)
prep_of(risk-18, complications-21)

Metformin/NN :/: In/IN healthy/JJ subjects/NNS given/VBN single/JJ 500/CD mg/NN doses/NNS of/IN cephalexin/NN and/CC metformin/NN ,/, plasma/NN metformin/NN mean/NN cmax/NN and/CC AUC/NN increased/VBD by/IN an/DT average/NN of/IN 34/CD %/NN and/CC 24/CD %/NN ,/, respectively/RB ,/, and/CC metformin/NN mean/JJ renal/JJ clearance/NN decreased/VBD by/IN 14/CD %./NN

(ROOT (S1 (S (NP (NP (NN Metformin)) (: :) (S (PP (IN In) (NP (NP (JJ healthy) (NNS subjects)) (VP (VBN given) (NP (NP (JJ single) (CD 500) (NN mg) (NNS doses)) (PP (IN of) (NP (NP (NN cephalexin)) (CC and) (NP (NN metformin)))))))) (, ,) (S (NP (NP (NN plasma) (NN metformin) (NN mean) (NN cmax)) (CC and) (NP (NN AUC))) (VP (VBD increased) (PP (IN by) (NP (NP (DT an) (NN average)) (PP (IN of) (NP (NP (CD 34) (NN %)) (CC and) (NP (CD 24) (NN %)) (, ,) (ADVP (RB respectively)))))))) (, ,) (CC and) (S (NP (NN metformin) (JJ mean) (JJ renal) (NN clearance)) (VP (VBD decreased) (PP (IN by) (NP (CD 14) (NN %.))))))))))

root(ROOT-0, Metformin-1)
amod(subjects-5, healthy-4)
prep_in(increased-22, subjects-5)
partmod(subjects-5, given-6)
amod(doses-10, single-7)
num(doses-10, 500-8)
nn(doses-10, mg-9)
dobj(given-6, doses-10)
prep_of(doses-10, cephalexin-12)
conj_and(cephalexin-12, metformin-14)
nn(cmax-19, plasma-16)
nn(cmax-19, metformin-17)
nn(cmax-19, mean-18)
nsubj(increased-22, cmax-19)
conj_and(cmax-19, AUC-21)
dep(Metformin-1, increased-22)
det(average-25, an-24)
prep_by(increased-22, average-25)
num(%-28, 34-27)
prep_of(average-25, %-28)
num(%-31, 24-30)
conj_and(%-28, %-31)
advmod(%-28, respectively-33)
conj_and(%-28, respectively-33)
nn(clearance-39, metformin-36)
amod(clearance-39, mean-37)
amod(clearance-39, renal-38)
nsubj(decreased-40, clearance-39)
conj_and(increased-22, decreased-40)
num(%.-43, 14-42)
prep_by(decreased-40, %.-43)

No/DT information/NN is/VBZ available/JJ about/IN the/DT interaction/NN of/IN cephalexin/NN and/CC metformin/NN following/VBG multiple/JJ doses/NNS of/IN either/DT drug/NN ./.

(ROOT (S1 (S (S (NP (DT No) (NN information)) (VP (VBZ is) (ADJP (JJ available) (PP (IN about) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (NP (NN cephalexin)) (CC and) (NP (NN metformin)))) (PP (VBG following) (NP (NP (JJ multiple) (NNS doses)) (PP (IN of) (NP (DT either) (NN drug)))))))))) (. .))))

det(information-2, No-1)
nsubj(available-4, information-2)
cop(available-4, is-3)
root(ROOT-0, available-4)
det(interaction-7, the-6)
prep_about(available-4, interaction-7)
prep_of(interaction-7, cephalexin-9)
conj_and(cephalexin-9, metformin-11)
amod(doses-14, multiple-13)
prep_following(interaction-7, doses-14)
det(drug-17, either-16)
prep_of(doses-14, drug-17)

Although/IN not/RB observed/VBN in/IN this/DT study/NN ,/, adverse/JJ effects/NNS could/MD potentially/RB arise/VB from/IN co-administration/NN of/IN cephalexin/NN and/CC metformin/NN by/IN inhibition/NN of/IN tubular/JJ secretion/NN via/IN organic/JJ cationic/JJ transporter/NN systems/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (VP (RB not) (VBN observed) (PP (IN in) (NP (DT this) (NN study)))))) (, ,) (NP (JJ adverse) (NNS effects)) (VP (MD could) (ADVP (RB potentially)) (VP (VB arise) (PP (IN from) (NP (NP (NN co-administration)) (PP (IN of) (NP (NP (NN cephalexin)) (CC and) (NP (NN metformin)))))) (PP (IN by) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (JJ tubular) (NN secretion)) (PP (IN via) (NP (JJ organic) (JJ cationic) (NN transporter) (NNS systems)))))))))) (. .))))

mark(observed-3, Although-1)
neg(observed-3, not-2)
advcl(arise-12, observed-3)
det(study-6, this-5)
prep_in(observed-3, study-6)
amod(effects-9, adverse-8)
nsubj(arise-12, effects-9)
aux(arise-12, could-10)
advmod(arise-12, potentially-11)
root(ROOT-0, arise-12)
prep_from(arise-12, co-administration-14)
prep_of(co-administration-14, cephalexin-16)
conj_and(cephalexin-16, metformin-18)
prep_by(arise-12, inhibition-20)
amod(secretion-23, tubular-22)
prep_of(inhibition-20, secretion-23)
amod(systems-28, organic-25)
amod(systems-28, cationic-26)
nn(systems-28, transporter-27)
prep_via(secretion-23, systems-28)

Accordingly/RB ,/, careful/JJ patient/NN monitoring/NN and/CC dose/NN adjustment/NN of/IN metformin/NN is/VBZ recommended/VBN in/IN patients/NNS concomitantly/RB taking/VBG cephalexin/NN and/CC metformin/NN ./.

(ROOT (S1 (S (S (ADVP (RB Accordingly)) (, ,) (NP (NP (NP (JJ careful) (NN patient) (NN monitoring)) (CC and) (NP (NN dose) (NN adjustment))) (PP (IN of) (NP (NN metformin)))) (VP (VBZ is) (VP (VBN recommended) (PP (IN in) (NP (NP (NNS patients)) (VP (ADVP (RB concomitantly)) (VBG taking) (NP (NP (NN cephalexin)) (CC and) (NP (NN metformin))))))))) (. .))))

advmod(recommended-12, Accordingly-1)
amod(monitoring-5, careful-3)
nn(monitoring-5, patient-4)
nsubjpass(recommended-12, monitoring-5)
nn(adjustment-8, dose-7)
conj_and(monitoring-5, adjustment-8)
prep_of(monitoring-5, metformin-10)
auxpass(recommended-12, is-11)
root(ROOT-0, recommended-12)
prep_in(recommended-12, patients-14)
advmod(taking-16, concomitantly-15)
partmod(patients-14, taking-16)
dobj(taking-16, cephalexin-17)
conj_and(cephalexin-17, metformin-19)

Probenecid/NN :/: As/IN with/IN other/JJ b-/NN lactams/NNS ,/, the/DT renal/JJ excretion/NN of/IN cephalexin/NN is/VBZ inhibited/VBN by/IN probenecid/NN ./.

(ROOT (S1 (S (S (NP (NN Probenecid)) (: :) (PP (IN As) (PP (IN with) (NP (JJ other) (NN b-) (NNS lactams)))) (, ,) (NP (NP (DT the) (JJ renal) (NN excretion)) (PP (IN of) (NP (NN cephalexin)))) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NN probenecid)))))) (. .))))

nsubjpass(inhibited-15, Probenecid-1)
prep(inhibited-15, As-3)
pcomp(As-3, with-4)
amod(lactams-7, other-5)
nn(lactams-7, b--6)
prep_with(As-3, lactams-7)
det(excretion-11, the-9)
amod(excretion-11, renal-10)
nsubjpass(inhibited-15, excretion-11)
prep_of(excretion-11, cephalexin-13)
auxpass(inhibited-15, is-14)
root(ROOT-0, inhibited-15)
agent(inhibited-15, probenecid-17)

Drug/NN //: Laboratory/NN Test/NN Interactions/NNS :/: As/IN a/DT result/NN of/IN administration/NN of/IN Keflex/NN ,/, a/DT false-positive/JJ reaction/NN for/IN glucose/NN in/IN the/DT urine/NN may/MD occur/VB ./.

(ROOT (S1 (S (NP (NP (NN Drug) (: /) (NN Laboratory) (NN Test) (NNS Interactions)) (: :) (S (PP (IN As) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (NN administration)) (PP (IN of) (NP (NN Keflex))))))) (, ,) (NP (NP (DT a) (JJ false-positive) (NN reaction)) (PP (IN for) (NP (NN glucose))) (PP (IN in) (NP (DT the) (NN urine)))) (VP (MD may) (VP (VB occur)))) (. .)))))

nn(Interactions-5, Drug-1)
punct(Interactions-5, /-2)
nn(Interactions-5, Laboratory-3)
nn(Interactions-5, Test-4)
root(ROOT-0, Interactions-5)
det(result-9, a-8)
prep_as(occur-24, result-9)
prep_of(result-9, administration-11)
prep_of(administration-11, Keflex-13)
det(reaction-17, a-15)
amod(reaction-17, false-positive-16)
nsubj(occur-24, reaction-17)
prep_for(reaction-17, glucose-19)
det(urine-22, the-21)
prep_in(reaction-17, urine-22)
aux(occur-24, may-23)
dep(Interactions-5, occur-24)

Pharmacokinetic/JJ interaction/NN studies/NNS with/IN cetirizine/NN in/IN adults/NNS were/VBD conducted/VBN with/IN pseudoephedrine/NN ,/, antipyrine/NN ,/, ketoconazole/NN ,/, erythromycin/NN and/CC azithromycin/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Pharmacokinetic) (NN interaction) (NNS studies)) (PP (IN with) (NP (NP (NN cetirizine)) (PP (IN in) (NP (NNS adults)))))) (VP (VBD were) (VP (VBN conducted) (PP (IN with) (NP (NP (NN pseudoephedrine)) (, ,) (NP (NN antipyrine)) (, ,) (NP (NN ketoconazole)) (, ,) (NP (NN erythromycin)) (CC and) (NP (NN azithromycin))))))) (. .))))

amod(studies-3, Pharmacokinetic-1)
nn(studies-3, interaction-2)
nsubjpass(conducted-9, studies-3)
prep_with(studies-3, cetirizine-5)
prep_in(cetirizine-5, adults-7)
auxpass(conducted-9, were-8)
root(ROOT-0, conducted-9)
prep_with(conducted-9, pseudoephedrine-11)
conj_and(pseudoephedrine-11, antipyrine-13)
conj_and(pseudoephedrine-11, ketoconazole-15)
conj_and(pseudoephedrine-11, erythromycin-17)
conj_and(pseudoephedrine-11, azithromycin-19)

In/IN a/DT multiple/JJ dose/NN study/NN of/IN theophylline/NN (/-LRB- 400/CD mg/NN once/RB daily/JJ for/IN 3/CD days/NNS )/-RRB- and/CC cetirizine/NN (/-LRB- 20/CD mg/NN once/RB daily/JJ for/IN 3/CD days/NNS )/-RRB- ,/, a/DT 16/CD %/NN decrease/NN in/IN the/DT clearance/NN of/IN cetirizine/NN was/VBD observed/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT a) (JJ multiple) (NN dose) (NN study)) (PP (IN of) (NP (NP (NP (NN theophylline)) (PRN (-LRB- -LRB-) (NP (NP (CD 400) (NN mg)) (ADJP (RB once) (JJ daily) (PP (IN for) (NP (CD 3) (NNS days))))) (-RRB- -RRB-))) (CC and) (NP (NP (NN cetirizine)) (PRN (-LRB- -LRB-) (NP (NP (CD 20) (NN mg)) (ADJP (RB once) (JJ daily) (PP (IN for) (NP (CD 3) (NNS days))))) (-RRB- -RRB-))))))) (, ,) (NP (NP (DT a) (ADJP (CD 16) (NN %)) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN cetirizine)))))) (VP (VBD was) (VP (VBN observed)))) (. .))))

det(study-5, a-2)
amod(study-5, multiple-3)
nn(study-5, dose-4)
prep_in(observed-39, study-5)
prep_of(study-5, theophylline-7)
num(mg-10, 400-9)
dep(theophylline-7, mg-10)
advmod(daily-12, once-11)
amod(mg-10, daily-12)
num(days-15, 3-14)
prep_for(daily-12, days-15)
conj_and(theophylline-7, cetirizine-18)
num(mg-21, 20-20)
dep(cetirizine-18, mg-21)
advmod(daily-23, once-22)
amod(mg-21, daily-23)
num(days-26, 3-25)
prep_for(daily-23, days-26)
det(decrease-32, a-29)
number(%-31, 16-30)
amod(decrease-32, %-31)
nsubjpass(observed-39, decrease-32)
det(clearance-35, the-34)
prep_in(decrease-32, clearance-35)
prep_of(clearance-35, cetirizine-37)
auxpass(observed-39, was-38)
root(ROOT-0, observed-39)

The/DT disposition/NN of/IN theophylline/NN was/VBD not/RB altered/VBN by/IN concomitant/JJ cetirizine/NN administration/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN disposition)) (PP (IN of) (NP (NN theophylline)))) (VP (VBD was) (RB not) (VP (VBN altered) (PP (IN by) (NP (JJ concomitant) (NN cetirizine) (NN administration)))))) (. .))))

det(disposition-2, The-1)
nsubjpass(altered-7, disposition-2)
prep_of(disposition-2, theophylline-4)
auxpass(altered-7, was-5)
neg(altered-7, not-6)
root(ROOT-0, altered-7)
amod(administration-11, concomitant-9)
nn(administration-11, cetirizine-10)
agent(altered-7, administration-11)

Drug-Drug/JJ Interactions/NNS :/: No/DT clinically/RB significant/JJ drug/NN interactions/NNS have/VBP been/VBN found/VBN with/IN theophylline/NN at/IN a/DT low/JJ dose/NN ,/, azithromycin/NN ,/, pseudoephedrine/NN ,/, ketoconazole/NN ,/, or/CC erythromycin/NN ./.

(ROOT (S1 (S (NP (NP (JJ Drug-Drug) (NNS Interactions)) (: :) (S (NP (DT No) (ADJP (RB clinically) (JJ significant)) (NN drug) (NNS interactions)) (VP (VBP have) (VP (VBN been) (VP (VBN found) (PP (IN with) (NP (NN theophylline))) (PP (IN at) (NP (NP (DT a) (JJ low) (NN dose)) (, ,) (NP (NN azithromycin)) (, ,) (NP (NN pseudoephedrine)) (, ,) (NP (NN ketoconazole)) (, ,) (CC or) (NP (NN erythromycin)))))))) (. .)))))

amod(Interactions-2, Drug-Drug-1)
root(ROOT-0, Interactions-2)
det(interactions-8, No-4)
advmod(significant-6, clinically-5)
amod(interactions-8, significant-6)
nn(interactions-8, drug-7)
nsubjpass(found-11, interactions-8)
aux(found-11, have-9)
auxpass(found-11, been-10)
dep(Interactions-2, found-11)
prep_with(found-11, theophylline-13)
det(dose-17, a-15)
amod(dose-17, low-16)
prep_at(found-11, dose-17)
conj_or(dose-17, azithromycin-19)
conj_or(dose-17, pseudoephedrine-21)
conj_or(dose-17, ketoconazole-23)
conj_or(dose-17, erythromycin-26)

There/EX was/VBD a/DT small/JJ decrease/NN in/IN the/DT clearance/NN of/IN cetirizine/NN caused/VBN by/IN a/DT 400-mg/JJ dose/NN of/IN theophylline/NN ;/: ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBD was) (NP (NP (DT a) (JJ small) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NP (NN cetirizine)) (VP (VBN caused) (PP (IN by) (NP (NP (DT a) (JJ 400-mg) (NN dose)) (PP (IN of) (NP (NN theophylline)))))))))))) (: ;)) (. .))))

expl(was-2, There-1)
root(ROOT-0, was-2)
det(decrease-5, a-3)
amod(decrease-5, small-4)
nsubj(was-2, decrease-5)
det(clearance-8, the-7)
prep_in(decrease-5, clearance-8)
prep_of(clearance-8, cetirizine-10)
partmod(cetirizine-10, caused-11)
det(dose-15, a-13)
amod(dose-15, 400-mg-14)
agent(caused-11, dose-15)
prep_of(dose-15, theophylline-17)

A/DT drug/NN interaction/NN study/NN was/VBD performed/VBN in/IN which/WDT ERBITUX/NN was/VBD administered/VBN in/IN combination/NN with/IN irinotecan/NN ./.

(ROOT (S1 (S (S (NP (DT A) (NN drug) (NN interaction) (NN study)) (VP (VBD was) (VP (VBN performed) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN ERBITUX)) (VP (VBD was) (VP (VBN administered) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN irinotecan)))))))))))) (. .))))

det(study-4, A-1)
nn(study-4, drug-2)
nn(study-4, interaction-3)
nsubjpass(performed-6, study-4)
auxpass(performed-6, was-5)
root(ROOT-0, performed-6)
dep(administered-11, in-7)
pobj(in-7, which-8)
nsubjpass(administered-11, ERBITUX-9)
auxpass(administered-11, was-10)
ccomp(performed-6, administered-11)
prep_in(administered-11, combination-13)
prep_with(combination-13, irinotecan-15)

There/EX was/VBD no/DT evidence/NN of/IN any/DT pharmacokinetic/JJ interactions/NNS between/IN ERBITUX/NN and/CC irinotecan/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (DT any) (JJ pharmacokinetic) (NNS interactions)) (PP (IN between) (NP (NP (NN ERBITUX)) (CC and) (NP (NN irinotecan))))))))) (. .))))

expl(was-2, There-1)
root(ROOT-0, was-2)
det(evidence-4, no-3)
nsubj(was-2, evidence-4)
det(interactions-8, any-6)
amod(interactions-8, pharmacokinetic-7)
prep_of(evidence-4, interactions-8)
prep_between(interactions-8, ERBITUX-10)
conj_and(ERBITUX-10, irinotecan-12)

Cevimeline/NN should/MD be/VB administered/VBN with/IN caution/NN to/TO patients/NNS taking/VBG beta/NN adrenergic/JJ antagonists/NNS ,/, because/IN of/IN the/DT possibility/NN of/IN conduction/NN disturbances/NNS ./.

(ROOT (S1 (S (S (NP (NN Cevimeline)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (NN caution))) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN beta) (JJ adrenergic) (NNS antagonists))))) (, ,) (PP (IN because) (IN of) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NN conduction) (NNS disturbances))))))))) (. .))))

nsubjpass(administered-4, Cevimeline-1)
aux(administered-4, should-2)
auxpass(administered-4, be-3)
root(ROOT-0, administered-4)
prep_with(administered-4, caution-6)
prep_to(administered-4, patients-8)
partmod(patients-8, taking-9)
nn(antagonists-12, beta-10)
amod(antagonists-12, adrenergic-11)
dobj(taking-9, antagonists-12)
det(possibility-17, the-16)
prep_because_of(administered-4, possibility-17)
nn(disturbances-20, conduction-19)
prep_of(possibility-17, disturbances-20)

Drugs/NNS with/IN parasympathomimetic/JJ effects/NNS administered/VBN concurrently/RB with/IN cevimeline/NN can/MD be/VB expected/VBN to/TO have/VB additive/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (PP (IN with) (NP (NP (JJ parasympathomimetic) (NNS effects)) (VP (VBN administered) (ADVP (RB concurrently)) (PP (IN with) (NP (NN cevimeline))))))) (VP (MD can) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB have) (NP (JJ additive) (NNS effects))))))))) (. .))))

nsubjpass(expected-11, Drugs-1)
amod(effects-4, parasympathomimetic-3)
prep_with(Drugs-1, effects-4)
partmod(effects-4, administered-5)
advmod(administered-5, concurrently-6)
prep_with(administered-5, cevimeline-8)
aux(expected-11, can-9)
auxpass(expected-11, be-10)
root(ROOT-0, expected-11)
aux(have-13, to-12)
xcomp(expected-11, have-13)
amod(effects-15, additive-14)
dobj(have-13, effects-15)

Cevimeline/NN might/MD interfere/VB with/IN desirable/JJ antimuscarinic/JJ effects/NNS of/IN drugs/NNS used/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NN Cevimeline)) (VP (MD might) (VP (VB interfere) (PP (IN with) (NP (NP (JJ desirable) (JJ antimuscarinic) (NNS effects)) (PP (IN of) (NP (NP (NNS drugs)) (VP (VBN used) (ADVP (RB concomitantly)))))))))) (. .))))

nsubj(interfere-3, Cevimeline-1)
aux(interfere-3, might-2)
root(ROOT-0, interfere-3)
amod(effects-7, desirable-5)
amod(effects-7, antimuscarinic-6)
prep_with(interfere-3, effects-7)
prep_of(effects-7, drugs-9)
partmod(drugs-9, used-10)
advmod(used-10, concomitantly-11)

Drugs/NNS which/WDT inhibit/VBP CYP2D6/NN and/CC CYP3A3/4/NN also/RB inhibit/VBP the/DT metabolism/NN of/IN cevimeline/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT which)) (S (VP (VBP inhibit) (NP (NP (NN CYP2D6)) (CC and) (NP (NN CYP3A3/4))))))) (ADVP (RB also)) (VP (VBP inhibit) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN cevimeline)))))) (. .))))

nsubj(inhibit-3, Drugs-1)
nsubj(inhibit-8, Drugs-1)
rcmod(Drugs-1, inhibit-3)
dobj(inhibit-3, CYP2D6-4)
conj_and(CYP2D6-4, CYP3A3/4-6)
advmod(inhibit-8, also-7)
root(ROOT-0, inhibit-8)
det(metabolism-10, the-9)
dobj(inhibit-8, metabolism-10)
prep_of(metabolism-10, cevimeline-12)

Cevimeline/NN should/MD be/VB used/VBN with/IN caution/NN in/IN individuals/NNS known/VBN or/CC suspected/VBN to/TO be/VB deficient/JJ in/IN CYP2D6/NN activity/NN ,/, based/VBN on/IN previous/JJ experience/VBP ,/, as/IN they/PRP may/MD be/VB at/IN a/DT higher/JJR risk/NN of/IN adverse/JJ events/NNS ./.

(ROOT (S1 (S (S (NP (NN Cevimeline)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NP (NN caution)) (PP (IN in) (NP (NP (NNS individuals)) (ADJP (ADJP (VBN known)) (CC or) (ADJP (VBN suspected))))) (S (VP (TO to) (VP (VB be) (ADJP (JJ deficient) (PP (IN in) (NP (NP (NN CYP2D6) (NN activity)) (, ,) (VP (VBN based) (PP (IN on) (NP (JJ previous) (VBP experience))))))) (, ,) (SBAR (IN as) (S (NP (PRP they)) (VP (MD may) (VP (VB be) (PP (IN at) (NP (NP (DT a) (JJR higher) (NN risk)) (PP (IN of) (NP (JJ adverse) (NNS events)))))))))))))))))) (. .))))

nsubjpass(used-4, Cevimeline-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
prep_with(used-4, caution-6)
prep_in(caution-6, individuals-8)
amod(individuals-8, known-9)
conj_or(known-9, suspected-11)
aux(deficient-14, to-12)
cop(deficient-14, be-13)
infmod(caution-6, deficient-14)
nn(activity-17, CYP2D6-16)
prep_in(deficient-14, activity-17)
partmod(activity-17, based-19)
prep_on(based-19, previous-21)
dep(previous-21, experience-22)
mark(be-27, as-24)
nsubj(be-27, they-25)
aux(be-27, may-26)
advcl(deficient-14, be-27)
det(risk-31, a-29)
amod(risk-31, higher-30)
prep_at(be-27, risk-31)
amod(events-34, adverse-33)
prep_of(risk-31, events-34)

In/IN an/DT in/FW vitro/FW study/NN ,/, cytochrome/NN P450/NN isozymes/NNS 1A2/NN ,/, 2A6/NN ,/, 2C9/NN ,/, 2C19/NN ,/, 2D6/NN ,/, 2E1/NN ,/, and/CC 3A4/NN were/VBD not/RB inhibited/VBN by/IN exposure/NN to/TO cevimeline/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT an) (ADJP (FW in) (FW vitro)) (NN study))) (, ,) (NP (NN cytochrome) (NN P450) (NNS isozymes) (NP (NP (NN 1A2)) (, ,) (NP (NN 2A6)) (, ,) (NP (NN 2C9)) (, ,) (NP (NN 2C19)) (, ,) (NP (NN 2D6)) (, ,) (NP (NN 2E1)) (, ,) (CC and) (NP (NN 3A4)))) (VP (VBD were) (RB not) (VP (VBN inhibited) (PP (IN by) (NP (NP (NN exposure)) (PP (TO to) (NP (NN cevimeline)))))))) (. .))))

det(study-5, an-2)
nn(vitro-4, in-3)
amod(study-5, vitro-4)
prep_in(inhibited-26, study-5)
nn(isozymes-9, cytochrome-7)
nn(isozymes-9, P450-8)
nsubjpass(inhibited-26, isozymes-9)
dep(isozymes-9, 1A2-10)
conj_and(1A2-10, 2A6-12)
conj_and(1A2-10, 2C9-14)
conj_and(1A2-10, 2C19-16)
conj_and(1A2-10, 2D6-18)
conj_and(1A2-10, 2E1-20)
conj_and(1A2-10, 3A4-23)
auxpass(inhibited-26, were-24)
neg(inhibited-26, not-25)
root(ROOT-0, inhibited-26)
agent(inhibited-26, exposure-28)
prep_to(exposure-28, cevimeline-30)

There/EX are/VBP no/DT known/JJ drug/NN /drug/NN interactions/NNS with/IN chlorambucil/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP are) (NP (NP (DT no) (JJ known) (NN drug) (NN /drug) (NNS interactions)) (PP (IN with) (NP (NN chlorambucil)))))) (. .))))

expl(are-2, There-1)
root(ROOT-0, are-2)
det(interactions-7, no-3)
amod(interactions-7, known-4)
nn(interactions-7, drug-5)
nn(interactions-7, /drug-6)
nsubj(are-2, interactions-7)
prep_with(interactions-7, chlorambucil-9)

Antacids/NNS and/CC kaolin/NN :/: Antacids/NNS and/CC kaolin/NN can/MD reduce/VB absorption/NN of/IN chloroquine/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Antacids)) (CC and) (NP (NN kaolin))) (: :) (NP (NP (NNS Antacids)) (CC and) (NP (NN kaolin)))) (VP (MD can) (VP (VB reduce) (NP (NP (NN absorption)) (PP (IN of) (NP (NN chloroquine)))))) (: ;)) (. .))))

nsubj(reduce-9, Antacids-1)
conj_and(Antacids-1, kaolin-3)
dep(Antacids-1, Antacids-5)
conj_and(Antacids-5, kaolin-7)
aux(reduce-9, can-8)
root(ROOT-0, reduce-9)
dobj(reduce-9, absorption-10)
prep_of(absorption-10, chloroquine-12)

an/DT interval/NN of/IN at/IN least/JJS 4/CD hours/NNS between/IN intake/NN of/IN these/DT agents/NNS and/CC chloroquine/NN should/MD be/VB observed/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT an) (NN interval)) (PP (IN of) (NP (QP (IN at) (JJS least) (CD 4)) (NNS hours))) (PP (IN between) (NP (NP (NP (NN intake)) (PP (IN of) (NP (DT these) (NNS agents)))) (CC and) (NP (NN chloroquine))))) (VP (MD should) (VP (VB be) (VP (VBN observed))))) (. .))))

det(interval-2, an-1)
nsubjpass(observed-17, interval-2)
quantmod(4-6, at-4)
mwe(at-4, least-5)
pobj(at-4, least-5)
num(hours-7, 4-6)
prep_of(interval-2, hours-7)
prep_between(interval-2, intake-9)
det(agents-12, these-11)
prep_of(intake-9, agents-12)
conj_and(intake-9, chloroquine-14)
aux(observed-17, should-15)
auxpass(observed-17, be-16)
root(ROOT-0, observed-17)

Cimetidine/NN :/: Cimetidine/NN can/MD inhibit/VB the/DT metabolism/NN of/IN chloroquine/NN ,/, increasing/VBG its/PRP$ plasma/NN level/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Cimetidine)) (: :) (NP (NN Cimetidine))) (VP (MD can) (VP (VB inhibit) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN chloroquine)))) (, ,) (S (VP (VBG increasing) (NP (PRP$ its) (NN plasma) (NN level))))))) (. .))))

nsubj(inhibit-5, Cimetidine-1)
dep(Cimetidine-1, Cimetidine-3)
aux(inhibit-5, can-4)
root(ROOT-0, inhibit-5)
det(metabolism-7, the-6)
dobj(inhibit-5, metabolism-7)
prep_of(metabolism-7, chloroquine-9)
partmod(inhibit-5, increasing-11)
xcomp(inhibit-5, increasing-11)
poss(level-14, its-12)
nn(level-14, plasma-13)
dobj(increasing-11, level-14)

Concomitant/JJ use/NN of/IN cimetidine/NN should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NN cimetidine)))) (VP (MD should) (VP (VB be) (VP (VBN avoided))))) (. .))))

amod(use-2, Concomitant-1)
nsubjpass(avoided-7, use-2)
prep_of(use-2, cimetidine-4)
aux(avoided-7, should-5)
auxpass(avoided-7, be-6)
root(ROOT-0, avoided-7)

Ampicillin/NN :/: In/IN a/DT study/NN of/IN healthy/JJ volunteers/NNS ,/, chloroquine/NN significantly/RB reduced/VBD the/DT bioavailability/NN of/IN ampicillin/NN ./.

(ROOT (S1 (S (S (NP (NN Ampicillin)) (: :) (PP (IN In) (NP (NP (DT a) (NN study)) (PP (IN of) (NP (JJ healthy) (NNS volunteers))))) (, ,) (NP (NN chloroquine)) (ADVP (RB significantly)) (VP (VBD reduced) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (NN ampicillin)))))) (. .))))

nsubj(reduced-12, Ampicillin-1)
det(study-5, a-4)
prep_in(reduced-12, study-5)
amod(volunteers-8, healthy-7)
prep_of(study-5, volunteers-8)
nsubj(reduced-12, chloroquine-10)
advmod(reduced-12, significantly-11)
root(ROOT-0, reduced-12)
det(bioavailability-14, the-13)
dobj(reduced-12, bioavailability-14)
prep_of(bioavailability-14, ampicillin-16)

An/DT interval/NN of/IN at/IN least/JJS two/CD hours/NNS between/IN intake/NN of/IN this/DT agent/NN and/CC chloroquine/NN should/MD be/VB observed/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT An) (NN interval)) (PP (IN of) (NP (QP (IN at) (JJS least) (CD two)) (NNS hours))) (PP (IN between) (NP (NP (NP (NN intake)) (PP (IN of) (NP (DT this) (NN agent)))) (CC and) (NP (NN chloroquine))))) (VP (MD should) (VP (VB be) (VP (VBN observed))))) (. .))))

det(interval-2, An-1)
nsubjpass(observed-17, interval-2)
quantmod(two-6, at-4)
mwe(at-4, least-5)
pobj(at-4, least-5)
num(hours-7, two-6)
prep_of(interval-2, hours-7)
prep_between(interval-2, intake-9)
det(agent-12, this-11)
prep_of(intake-9, agent-12)
conj_and(intake-9, chloroquine-14)
aux(observed-17, should-15)
auxpass(observed-17, be-16)
root(ROOT-0, observed-17)

Cyclosporin/NN :/: After/IN introduction/NN of/IN chloroquine/NN (/-LRB- oral/JJ form/NN )/-RRB- ,/, a/DT sudden/JJ increase/NN in/IN serum/NN cyclosporin/NN level/NN has/VBZ been/VBN reported/VBN ./.

(ROOT (S1 (S (NP (NP (NN Cyclosporin)) (: :) (S (PP (IN After) (NP (NP (NN introduction)) (PP (IN of) (NP (NP (NN chloroquine)) (PRN (-LRB- -LRB-) (NP (JJ oral) (NN form)) (-RRB- -RRB-)))))) (, ,) (NP (NP (DT a) (JJ sudden) (NN increase)) (PP (IN in) (NP (NN serum) (NN cyclosporin) (NN level)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported))))) (. .)))))

root(ROOT-0, Cyclosporin-1)
prep_after(reported-21, introduction-4)
prep_of(introduction-4, chloroquine-6)
amod(form-9, oral-8)
appos(chloroquine-6, form-9)
det(increase-14, a-12)
amod(increase-14, sudden-13)
nsubjpass(reported-21, increase-14)
nn(level-18, serum-16)
nn(level-18, cyclosporin-17)
prep_in(increase-14, level-18)
aux(reported-21, has-19)
auxpass(reported-21, been-20)
dep(Cyclosporin-1, reported-21)

Therefore/RB ,/, close/JJ monitoring/NN of/IN serum/NN cyclosporin/NN level/NN is/VBZ recommended/VBN and/CC ,/, if/IN necessary/JJ ,/, chloroquine/NN should/MD be/VB discontinued/VBN ./.

(ROOT (S1 (S (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (JJ close) (NN monitoring)) (PP (IN of) (NP (NN serum) (NN cyclosporin) (NN level)))) (VP (VBZ is) (VP (VBN recommended)))) (CC and) (S (, ,) (SBAR (IN if) (FRAG (JJ necessary))) (, ,) (NP (NN chloroquine)) (VP (MD should) (VP (VB be) (VP (VBN discontinued)))))) (. .))))

advmod(recommended-10, Therefore-1)
amod(monitoring-4, close-3)
nsubjpass(recommended-10, monitoring-4)
nn(level-8, serum-6)
nn(level-8, cyclosporin-7)
prep_of(monitoring-4, level-8)
auxpass(recommended-10, is-9)
root(ROOT-0, recommended-10)
mark(necessary-14, if-13)
advcl(discontinued-19, necessary-14)
nsubjpass(discontinued-19, chloroquine-16)
aux(discontinued-19, should-17)
auxpass(discontinued-19, be-18)
conj_and(recommended-10, discontinued-19)

Chlorotrianisene/NN may/MD interact/VB with/IN antidepressants/NNS ,/, aspirin/NN ,/, barbiturates/NNS ,/, bromocriptine/NN ,/, calcium/NN supplements/NNS ,/, corticosteroids/NNS ,/, corticotropin/NN ,/, cyclosporine/NN ,/, dantrolene/NN ,/, nicotine/NN ,/, somatropin/NN ,/, tamoxifen/NN ,/, and/CC warfarin/NN ./.

(ROOT (S1 (S (S (NP (NN Chlorotrianisene)) (VP (MD may) (VP (VB interact) (NP (IN with) (NP (NP (NNS antidepressants)) (, ,) (NP (NN aspirin)) (, ,) (NP (NNS barbiturates)) (, ,) (NP (NN bromocriptine)) (, ,) (NP (NN calcium) (NNS supplements)) (, ,) (NP (NNS corticosteroids)) (, ,) (NP (NP (NN corticotropin)) (, ,) (NP (NN cyclosporine)) (, ,) (NP (NN dantrolene)) (, ,) (NP (NN nicotine)) (, ,) (NP (NN somatropin)) (, ,) (NP (NN tamoxifen)) (, ,) (CC and) (NP (NN warfarin)))))))) (. .))))

nsubj(interact-3, Chlorotrianisene-1)
aux(interact-3, may-2)
root(ROOT-0, interact-3)
amod(antidepressants-5, with-4)
dobj(interact-3, antidepressants-5)
appos(antidepressants-5, aspirin-7)
appos(antidepressants-5, barbiturates-9)
appos(antidepressants-5, bromocriptine-11)
nn(supplements-14, calcium-13)
appos(antidepressants-5, supplements-14)
appos(antidepressants-5, corticosteroids-16)
appos(antidepressants-5, corticotropin-18)
conj_and(corticotropin-18, cyclosporine-20)
conj_and(corticotropin-18, dantrolene-22)
conj_and(corticotropin-18, nicotine-24)
conj_and(corticotropin-18, somatropin-26)
conj_and(corticotropin-18, tamoxifen-28)
conj_and(corticotropin-18, warfarin-31)

Substrate/NN of/IN CYP2D6/NNS (/-LRB- minor/JJ )/-RRB- ,/, 3A4/NN (/-LRB- major/JJ )/-RRB- ;/: ./.

(ROOT (S1 (S (NP (NP (NP (NN Substrate)) (PP (IN of) (NP (NP (NNS CYP2D6)) (PRN (-LRB- -LRB-) (NP (JJ minor)) (-RRB- -RRB-))))) (, ,) (NP (NN 3A4) (-LRB- -LRB-) (JJ major) (-RRB- -RRB-) (: ;)) (. .)))))

root(ROOT-0, Substrate-1)
prep_of(Substrate-1, CYP2D6-3)
dep(CYP2D6-3, minor-5)
appos(Substrate-1, 3A4-8)
amod(3A4-8, major-10)

Inhibits/VBZ CYP2D6/NN (/-LRB- weak)./NN

(ROOT (S1 (S (SINV (VBZ Inhibits) (NP (NP (NN CYP2D6)) (PRN (-LRB- -LRB-) (NP (NN weak-RRB-.))))))))

root(ROOT-0, Inhibits-1)
nsubj(Inhibits-1, CYP2D6-2)
dep(CYP2D6-2, weak-RRB-.-4)

Increased/VBN toxicity/NN (/-LRB- CNS/NN depression/NN )/-RRB- :/: CNS/NN depressants/NNS ,/, MAO/NN inhibitors/NNS ,/, tricyclic/JJ antidepressants/NNS ,/, phenothiazines/NNS ./.

(ROOT (S1 (S (NP (NP (NP (VBN Increased) (NN toxicity)) (PRN (-LRB- -LRB-) (NP (NN CNS) (NN depression)) (-RRB- -RRB-))) (: :) (NP (NP (NN CNS) (NNS depressants)) (, ,) (NP (NN MAO) (NNS inhibitors)) (, ,) (NP (JJ tricyclic) (NNS antidepressants)) (, ,) (NP (NNS phenothiazines))) (. .)))))

amod(toxicity-2, Increased-1)
root(ROOT-0, toxicity-2)
nn(depression-5, CNS-4)
abbrev(toxicity-2, depression-5)
nn(depressants-9, CNS-8)
dep(toxicity-2, depressants-9)
nn(inhibitors-12, MAO-11)
appos(depressants-9, inhibitors-12)
amod(antidepressants-15, tricyclic-14)
appos(depressants-9, antidepressants-15)
appos(depressants-9, phenothiazines-17)

CYP3A4/JJ inhibitors/NNS :/: May/MD increase/VB the/DT levels/effects/NNS of/IN chlorpheniramine/NN ./.

(ROOT (S1 (S (S (NP (JJ CYP3A4) (NNS inhibitors) (: :)) (VP (MD May) (VP (VB increase) (NP (NP (DT the) (NNS levels/effects)) (PP (IN of) (NP (NN chlorpheniramine))))))) (. .))))

amod(inhibitors-2, CYP3A4-1)
nsubj(increase-5, inhibitors-2)
aux(increase-5, May-4)
root(ROOT-0, increase-5)
det(levels/effects-7, the-6)
dobj(increase-5, levels/effects-7)
prep_of(levels/effects-7, chlorpheniramine-9)

Example/NN inhibitors/NNS include/VBP azole/JJ antifungals/NNS ,/, ciprofloxacin/NN ,/, clarithromycin/NN ,/, diclofenac/NN ,/, doxycycline/NN ,/, erythromycin/NN ,/, imatinib/NN ,/, isoniazid/NN ,/, nefazodone/NN ,/, nicardipine/NN ,/, propofol/NN ,/, protease/NN inhibitors/NNS ,/, quinidine/NN ,/, and/CC verapamil/NN ./.

(ROOT (S1 (S (S (NP (NN Example) (NNS inhibitors)) (VP (VBP include) (NP (NP (JJ azole) (NNS antifungals)) (, ,) (NP (NP (NN ciprofloxacin)) (, ,) (NP (NN clarithromycin)) (, ,) (NP (NN diclofenac)) (, ,) (NP (NN doxycycline)) (, ,) (NP (NN erythromycin)) (, ,) (NP (NN imatinib)) (, ,) (NP (NN isoniazid)) (, ,) (NP (NN nefazodone)) (, ,) (NP (NN nicardipine)) (, ,) (NP (NN propofol)) (, ,) (NP (NN protease) (NNS inhibitors)) (, ,) (NP (NN quinidine)) (, ,) (CC and) (NP (NN verapamil)))))) (. .))))

nn(inhibitors-2, Example-1)
nsubj(include-3, inhibitors-2)
root(ROOT-0, include-3)
amod(antifungals-5, azole-4)
dobj(include-3, antifungals-5)
appos(antifungals-5, ciprofloxacin-7)
conj_and(ciprofloxacin-7, clarithromycin-9)
conj_and(ciprofloxacin-7, diclofenac-11)
conj_and(ciprofloxacin-7, doxycycline-13)
conj_and(ciprofloxacin-7, erythromycin-15)
conj_and(ciprofloxacin-7, imatinib-17)
conj_and(ciprofloxacin-7, isoniazid-19)
conj_and(ciprofloxacin-7, nefazodone-21)
conj_and(ciprofloxacin-7, nicardipine-23)
conj_and(ciprofloxacin-7, propofol-25)
nn(inhibitors-28, protease-27)
conj_and(ciprofloxacin-7, inhibitors-28)
conj_and(ciprofloxacin-7, quinidine-30)
conj_and(ciprofloxacin-7, verapamil-33)

The/DT concurrent/JJ use/NN of/IN two/CD or/CC more/JJR drugs/NNS with/IN anticholinergic/JJ activity--such/NN as/IN an/DT antipsychotic/JJ drug/NN (/-LRB- eg/NN ,/, chlorpromazine/NN )/-RRB- ,/, an/DT antiparkinsonian/JJ drug/NN (/-LRB- eg/NN ,/, trihexyphenidyl/NN )/-RRB- ,/, and/or/CC a/DT tricyclic/JJ antidepressant/JJ (/-LRB- eg/NN ,/, amitriptyline/NN )/-RRB- --commonly/RB results/VBZ in/IN excessive/JJ anticholinergic/JJ effects/NNS ,/, including/VBG dry/JJ mouth/NN and/CC associated/VBN dental/JJ complications/NNS ,/, blurred/JJ vision/NN ,/, and/CC ,/, in/IN patients/NNS exposed/VBN to/TO high/JJ temperature/NN and/CC humidity/NN ,/, hyperpyrexia/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concurrent) (NN use)) (PP (IN of) (NP (NP (QP (CD two) (CC or) (JJR more)) (NNS drugs)) (PP (IN with) (NP (JJ anticholinergic) (NN activity--such))))) (PP (IN as) (NP (NP (NP (DT an) (JJ antipsychotic) (NN drug)) (PRN (-LRB- -LRB-) (NP (NN eg)) (, ,) (NP (NN chlorpromazine)) (-RRB- -RRB-))) (, ,) (NP (NP (DT an) (JJ antiparkinsonian) (NN drug)) (PRN (-LRB- -LRB-) (NP (NN eg)) (, ,) (NP (NN trihexyphenidyl)) (-RRB- -RRB-))) (, ,) (CC and/or) (NP (NP (DT a) (JJ tricyclic) (JJ antidepressant)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN amitriptyline))) (-RRB- -RRB-)))))) (ADVP (RB --commonly)) (VP (VBZ results) (PP (IN in) (NP (NP (JJ excessive) (JJ anticholinergic) (NNS effects)) (, ,) (PP (VBG including) (NP (NP (NP (JJ dry) (NN mouth)) (CC and) (NP (VBN associated) (JJ dental) (NNS complications))) (, ,) (NP (JJ blurred) (NN vision)) (, ,) (CC and) (, ,) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN exposed) (PP (TO to) (NP (NP (JJ high) (NN temperature)) (CC and) (NP (NN humidity))))))) (, ,) (NP (NN hyperpyrexia)))))))) (. .))))

det(use-3, The-1)
amod(use-3, concurrent-2)
nsubj(results-41, use-3)
num(drugs-8, two-5)
conj_or(two-5, more-7)
quantmod(two-5, more-7)
prep_of(use-3, drugs-8)
amod(activity--such-11, anticholinergic-10)
prep_with(drugs-8, activity--such-11)
det(drug-15, an-13)
amod(drug-15, antipsychotic-14)
prep_as(use-3, drug-15)
appos(drug-15, eg-17)
dep(eg-17, chlorpromazine-19)
det(drug-24, an-22)
amod(drug-24, antiparkinsonian-23)
conj_and/or(drug-15, drug-24)
appos(drug-24, eg-26)
dep(eg-26, trihexyphenidyl-28)
det(antidepressant-34, a-32)
amod(antidepressant-34, tricyclic-33)
conj_and/or(drug-15, antidepressant-34)
dep(antidepressant-34, eg-36)
appos(eg-36, amitriptyline-38)
advmod(results-41, --commonly-40)
root(ROOT-0, results-41)
amod(effects-45, excessive-43)
amod(effects-45, anticholinergic-44)
prep_in(results-41, effects-45)
amod(mouth-49, dry-48)
prep_including(effects-45, mouth-49)
amod(complications-53, associated-51)
amod(complications-53, dental-52)
conj_and(mouth-49, complications-53)
amod(vision-56, blurred-55)
conj_and(mouth-49, vision-56)
conj_and(mouth-49, in-60)
prep_in(mouth-49, patients-61)
partmod(patients-61, exposed-62)
amod(temperature-65, high-64)
prep_to(exposed-62, temperature-65)
conj_and(temperature-65, humidity-67)
conj_and(mouth-49, hyperpyrexia-69)

Interactions/NNS may/MD also/RB occur/VB with/IN the/DT following/NN :/: anti-depressants/NN //: anti-anxiety/JJ drugs/NNS ,/, drugs/NNS used/VBN to/TO treat/VB an/DT overactive/JJ thyroid/NN ,/, beta-blockers/NNS (/-LRB- e.g./FW ,/, propranolol/NN )/-RRB- ,/, sparfloxacin/NN ,/, grepafloxacin/NN ,/, guanethidine/NN ,/, guanadrel/NN ,/, metrizamide/NN ,/, cabergoline/NN ,/, lithium/NN ,/, narcotic/JJ pain/NN medication/NN (/-LRB- e.g./FW ,/, codeine/NN )/-RRB- ,/, drugs/NNS used/VBN to/TO aid/VB sleep/NN ,/, drowsiness-causing/JJ antihistamines/NNS (/-LRB- e.g./FW ,/, diphenhydramine/NN )/-RRB- ,/, any/DT other/JJ drugs/NNS that/WDT may/MD make/VB you/RB drowsy/JJ ./.

(ROOT (S1 (S (S (NP (NNS Interactions)) (VP (MD may) (ADVP (RB also)) (VP (VB occur) (PP (IN with) (NP (NP (DT the) (NN following)) (: :) (NP (NN anti-depressants)) (: /) (NP (NP (JJ anti-anxiety) (NNS drugs)) (, ,) (NP (NP (NNS drugs)) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (DT an) (JJ overactive) (NN thyroid))))))) (, ,) (NP (NP (NNS beta-blockers)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN propranolol))) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NP (NN sparfloxacin)) (, ,) (NP (NN grepafloxacin)) (, ,) (NP (NN guanethidine)) (, ,) (NP (NN guanadrel)) (, ,) (NP (NN metrizamide)) (, ,) (NP (NN cabergoline)) (, ,) (NP (NN lithium)) (, ,) (NP (NP (JJ narcotic) (NN pain) (NN medication)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN codeine)) (-RRB- -RRB-))) (, ,)) (NNS drugs)) (VP (VBN used) (S (VP (TO to) (VP (VB aid) (NP (NN sleep))))))) (, ,) (NP (NP (JJ drowsiness-causing) (NNS antihistamines)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN diphenhydramine))) (-RRB- -RRB-))) (, ,) (NP (NP (DT any) (JJ other) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB make) (ADJP (RB you) (JJ drowsy))))))))))))) (. .))))

nsubj(occur-4, Interactions-1)
aux(occur-4, may-2)
advmod(occur-4, also-3)
root(ROOT-0, occur-4)
det(following-7, the-6)
prep_with(occur-4, following-7)
dep(following-7, anti-depressants-9)
punct(following-7, /-10)
amod(drugs-12, anti-anxiety-11)
dep(following-7, drugs-12)
appos(drugs-12, drugs-14)
xsubj(treat-17, drugs-14)
partmod(drugs-14, used-15)
aux(treat-17, to-16)
xcomp(used-15, treat-17)
det(thyroid-20, an-18)
amod(thyroid-20, overactive-19)
dobj(treat-17, thyroid-20)
appos(drugs-12, beta-blockers-22)
dep(beta-blockers-22, e.g.-24)
pobj(e.g.-24, propranolol-26)
nn(drugs-52, sparfloxacin-29)
appos(sparfloxacin-29, grepafloxacin-31)
appos(sparfloxacin-29, guanethidine-33)
appos(sparfloxacin-29, guanadrel-35)
appos(sparfloxacin-29, metrizamide-37)
appos(sparfloxacin-29, cabergoline-39)
appos(sparfloxacin-29, lithium-41)
amod(medication-45, narcotic-43)
nn(medication-45, pain-44)
appos(sparfloxacin-29, medication-45)
dep(codeine-49, e.g.-47)
appos(medication-45, codeine-49)
appos(drugs-12, drugs-52)
xsubj(aid-55, drugs-52)
partmod(drugs-52, used-53)
aux(aid-55, to-54)
xcomp(used-53, aid-55)
dobj(aid-55, sleep-56)
amod(antihistamines-59, drowsiness-causing-58)
appos(drugs-12, antihistamines-59)
dep(antihistamines-59, e.g.-61)
pobj(e.g.-61, diphenhydramine-63)
det(drugs-68, any-66)
amod(drugs-68, other-67)
appos(drugs-12, drugs-68)
nsubj(make-71, drugs-68)
aux(make-71, may-70)
rcmod(drugs-68, make-71)
advmod(drowsy-73, you-72)
acomp(make-71, drowsy-73)

The/DT hypoglycemic/JJ action/NN of/IN sulfonylurea/NN may/MD be/VB potentiated/VBN by/IN certain/JJ drugs/NNS including/VBG nonsteroidal/JJ anti-inflammatory/JJ agents/NNS and/CC other/JJ drugs/NNS that/WDT are/VBP highly/RB protein/NN bound/VBN ,/, salicylates/NNS ,/, sulfonamides/NNS ,/, chloramphenicol/NN ,/, probenecid/NN ,/, coumarins/NN ,/, monoamine/NN oxidase/NN inhibitors/NNS ,/, and/CC beta/NN adrenergic/JJ blocking/NN agents/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ hypoglycemic) (NN action)) (PP (IN of) (NP (NN sulfonylurea)))) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (PP (IN by) (NP (NP (NP (JJ certain) (NNS drugs)) (PP (VBG including) (NP (NP (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS agents)) (CC and) (NP (JJ other) (NNS drugs))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB highly)) (VP (NN protein) (VBN bound)))))))) (, ,) (NP (NNS salicylates)) (, ,) (NP (NNS sulfonamides)) (, ,) (NP (NP (NN chloramphenicol)) (, ,) (NP (NN probenecid)) (, ,) (NP (NN coumarins))) (, ,) (NP (NP (NN monoamine) (NN oxidase)) (NNS inhibitors)) (, ,) (CC and) (NP (NN beta) (JJ adrenergic) (NN blocking) (NNS agents)))))))) (. .))))

det(action-3, The-1)
amod(action-3, hypoglycemic-2)
nsubjpass(potentiated-8, action-3)
prep_of(action-3, sulfonylurea-5)
aux(potentiated-8, may-6)
auxpass(potentiated-8, be-7)
root(ROOT-0, potentiated-8)
amod(drugs-11, certain-10)
agent(potentiated-8, drugs-11)
amod(agents-15, nonsteroidal-13)
amod(agents-15, anti-inflammatory-14)
prep_including(drugs-11, agents-15)
nsubjpass(bound-23, agents-15)
amod(drugs-18, other-17)
conj_and(agents-15, drugs-18)
auxpass(bound-23, are-20)
advmod(bound-23, highly-21)
dep(bound-23, protein-22)
rcmod(agents-15, bound-23)
conj_and(drugs-11, salicylates-25)
conj_and(drugs-11, sulfonamides-27)
conj_and(drugs-11, chloramphenicol-29)
appos(chloramphenicol-29, probenecid-31)
appos(chloramphenicol-29, coumarins-33)
nn(oxidase-36, monoamine-35)
nn(inhibitors-37, oxidase-36)
conj_and(drugs-11, inhibitors-37)
nn(agents-43, beta-40)
amod(agents-43, adrenergic-41)
nn(agents-43, blocking-42)
conj_and(drugs-11, agents-43)

When/WRB such/JJ drugs/NNS are/VBP administered/VBN to/TO a/DT patient/NN receiving/VBG DIABINESE/NN ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB for/IN hypoglycemia/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ such) (NNS drugs)) (VP (VBP are) (VP (VBN administered) (PP (TO to) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN DIABINESE))))))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (PP (IN for) (NP (NN hypoglycemia))))))) (. .))))

advmod(administered-5, When-1)
amod(drugs-3, such-2)
nsubjpass(administered-5, drugs-3)
auxpass(administered-5, are-4)
advcl(observed-16, administered-5)
det(patient-8, a-7)
prep_to(administered-5, patient-8)
partmod(patient-8, receiving-9)
dobj(receiving-9, DIABINESE-10)
det(patient-13, the-12)
nsubjpass(observed-16, patient-13)
aux(observed-16, should-14)
auxpass(observed-16, be-15)
root(ROOT-0, observed-16)
advmod(observed-16, closely-17)
prep_for(observed-16, hypoglycemia-19)

When/WRB such/JJ drugs/NNS are/VBP withdrawn/VBN from/IN a/DT patient/NN receiving/VBG DIABINESE/NN ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB for/IN loss/NN of/IN control/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ such) (NNS drugs)) (VP (VBP are) (VP (VBN withdrawn) (PP (IN from) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN DIABINESE))))))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (PP (IN for) (NP (NP (NN loss)) (PP (IN of) (NP (NN control))))))))) (. .))))

advmod(withdrawn-5, When-1)
amod(drugs-3, such-2)
nsubjpass(withdrawn-5, drugs-3)
auxpass(withdrawn-5, are-4)
advcl(observed-16, withdrawn-5)
det(patient-8, a-7)
prep_from(withdrawn-5, patient-8)
partmod(patient-8, receiving-9)
dobj(receiving-9, DIABINESE-10)
det(patient-13, the-12)
nsubjpass(observed-16, patient-13)
aux(observed-16, should-14)
auxpass(observed-16, be-15)
root(ROOT-0, observed-16)
advmod(observed-16, closely-17)
prep_for(observed-16, loss-19)
prep_of(loss-19, control-21)

Certain/JJ drugs/NNS tend/VBP to/TO produce/VB hyperglycemia/NN and/CC may/MD lead/VB to/TO loss/NN of/IN control/NN ./.

(ROOT (S1 (S (S (NP (JJ Certain) (NNS drugs)) (VP (VBP tend) (S (VP (VP (TO to) (VP (VB produce) (NP (NN hyperglycemia)))) (CC and) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (NN loss)) (PP (IN of) (NP (NN control))))))))))) (. .))))

amod(drugs-2, Certain-1)
nsubj(tend-3, drugs-2)
root(ROOT-0, tend-3)
aux(produce-5, to-4)
ccomp(tend-3, produce-5)
dobj(produce-5, hyperglycemia-6)
aux(lead-9, may-8)
conj_and(produce-5, lead-9)
prep_to(lead-9, loss-11)
prep_of(loss-11, control-13)

These/DT drugs/NNS include/VBP the/DT thiazides/NNS and/CC other/JJ diuretics/NNS ,/, corticosteroids/NNS ,/, phenothiazines/NNS ,/, thyroid/NN products/NNS ,/, estrogens/NNS ,/, oral/JJ contraceptives/NNS ,/, phenytoin/NN ,/, nicotinic/JJ acid/NN ,/, sympathomimetics/NNS ,/, calcium/NN channel/NN blocking/NN drugs/NNS ,/, and/CC isoniazid/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS drugs)) (VP (VBP include) (NP (NP (DT the) (NNS thiazides)) (CC and) (NP (NP (JJ other) (NNS diuretics)) (, ,) (NP (NNS corticosteroids)) (, ,) (NP (NNS phenothiazines)) (, ,) (NP (NN thyroid) (NNS products)) (, ,) (NP (NNS estrogens)) (, ,) (NP (JJ oral) (NNS contraceptives)) (, ,) (NP (NN phenytoin)) (, ,) (NP (JJ nicotinic) (NN acid)) (, ,) (NP (NNS sympathomimetics)) (, ,) (NP (NN calcium) (NN channel) (NN blocking) (NNS drugs)) (, ,) (CC and) (NP (NN isoniazid)))))) (. .))))

det(drugs-2, These-1)
nsubj(include-3, drugs-2)
root(ROOT-0, include-3)
det(thiazides-5, the-4)
dobj(include-3, thiazides-5)
amod(diuretics-8, other-7)
conj_and(thiazides-5, diuretics-8)
conj_and(diuretics-8, corticosteroids-10)
conj_and(diuretics-8, phenothiazines-12)
nn(products-15, thyroid-14)
conj_and(diuretics-8, products-15)
conj_and(diuretics-8, estrogens-17)
amod(contraceptives-20, oral-19)
conj_and(diuretics-8, contraceptives-20)
conj_and(diuretics-8, phenytoin-22)
amod(acid-25, nicotinic-24)
conj_and(diuretics-8, acid-25)
conj_and(diuretics-8, sympathomimetics-27)
nn(drugs-32, calcium-29)
nn(drugs-32, channel-30)
nn(drugs-32, blocking-31)
conj_and(diuretics-8, drugs-32)
conj_and(diuretics-8, isoniazid-35)

When/WRB such/JJ drugs/NNS are/VBP administered/VBN to/TO a/DT patient/NN receiving/VBG DIABINESE/NN ,/, the/DT patient/NN should/MD be/VB closely/RB observed/VBN for/IN loss/NN of/IN control/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ such) (NNS drugs)) (VP (VBP are) (VP (VBN administered) (PP (TO to) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN DIABINESE))))))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN observed) (PP (IN for) (NP (NP (NN loss)) (PP (IN of) (NP (NN control))))))))) (. .))))

advmod(administered-5, When-1)
amod(drugs-3, such-2)
nsubjpass(administered-5, drugs-3)
auxpass(administered-5, are-4)
advcl(observed-17, administered-5)
det(patient-8, a-7)
prep_to(administered-5, patient-8)
partmod(patient-8, receiving-9)
dobj(receiving-9, DIABINESE-10)
det(patient-13, the-12)
nsubjpass(observed-17, patient-13)
aux(observed-17, should-14)
auxpass(observed-17, be-15)
advmod(observed-17, closely-16)
root(ROOT-0, observed-17)
prep_for(observed-17, loss-19)
prep_of(loss-19, control-21)

When/WRB such/JJ drugs/NNS are/VBP withdrawn/VBN from/IN a/DT patient/NN receiving/VBG DIABINESE/NN ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB for/IN hypoglycemia/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ such) (NNS drugs)) (VP (VBP are) (VP (VBN withdrawn) (PP (IN from) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN DIABINESE))))))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (PP (IN for) (NP (NN hypoglycemia))))))) (. .))))

advmod(withdrawn-5, When-1)
amod(drugs-3, such-2)
nsubjpass(withdrawn-5, drugs-3)
auxpass(withdrawn-5, are-4)
advcl(observed-16, withdrawn-5)
det(patient-8, a-7)
prep_from(withdrawn-5, patient-8)
partmod(patient-8, receiving-9)
dobj(receiving-9, DIABINESE-10)
det(patient-13, the-12)
nsubjpass(observed-16, patient-13)
aux(observed-16, should-14)
auxpass(observed-16, be-15)
root(ROOT-0, observed-16)
advmod(observed-16, closely-17)
prep_for(observed-16, hypoglycemia-19)

Since/IN animal/NN studies/NNS suggest/VBP that/IN the/DT action/NN of/IN barbiturates/NNS may/MD be/VB prolonged/JJ by/IN therapy/NN with/IN chlorpropamide/NN ,/, barbiturates/NNS should/MD be/VB employed/VBN with/IN caution/NN ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NN animal) (NNS studies)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NNS barbiturates)))) (VP (MD may) (VP (VB be) (ADJP (JJ prolonged) (PP (IN by) (NP (NP (NN therapy)) (PP (IN with) (NP (NN chlorpropamide))))))))))))) (, ,) (NP (NNS barbiturates)) (VP (MD should) (VP (VB be) (VP (VBN employed) (PP (IN with) (NP (NN caution))))))) (. .))))

mark(suggest-4, Since-1)
nn(studies-3, animal-2)
nsubj(suggest-4, studies-3)
advcl(employed-21, suggest-4)
complm(prolonged-12, that-5)
det(action-7, the-6)
nsubj(prolonged-12, action-7)
prep_of(action-7, barbiturates-9)
aux(prolonged-12, may-10)
cop(prolonged-12, be-11)
ccomp(suggest-4, prolonged-12)
prep_by(prolonged-12, therapy-14)
prep_with(therapy-14, chlorpropamide-16)
nsubjpass(employed-21, barbiturates-18)
aux(employed-21, should-19)
auxpass(employed-21, be-20)
root(ROOT-0, employed-21)
prep_with(employed-21, caution-23)

In/IN some/DT patients/NNS ,/, a/DT disulfiram/NN -like/JJ reaction/NN may/MD be/VB produced/VBN by/IN the/DT ingestion/NN of/IN alcohol/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT some) (NNS patients))) (, ,) (NP (DT a) (ADJP (NN disulfiram) (JJ -like)) (NN reaction)) (VP (MD may) (VP (VB be) (VP (VBN produced) (PP (IN by) (NP (NP (DT the) (NN ingestion)) (PP (IN of) (NP (NN alcohol))))))))) (. .))))

det(patients-3, some-2)
prep_in(produced-11, patients-3)
det(reaction-8, a-5)
dep(-like-7, disulfiram-6)
amod(reaction-8, -like-7)
nsubjpass(produced-11, reaction-8)
aux(produced-11, may-9)
auxpass(produced-11, be-10)
root(ROOT-0, produced-11)
det(ingestion-14, the-13)
agent(produced-11, ingestion-14)
prep_of(ingestion-14, alcohol-16)

A/DT potential/JJ interaction/NN between/IN oral/JJ miconazole/NN and/CC oral/JJ hypoglycemic/JJ agents/NNS leading/VBG to/TO severe/JJ hypoglycemia/NN has/VBZ been/VBN reported/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT A) (JJ potential) (NN interaction)) (PP (IN between) (NP (NP (NP (JJ oral) (NN miconazole)) (CC and) (NP (JJ oral) (JJ hypoglycemic) (NNS agents))) (VP (VBG leading) (PP (TO to) (NP (JJ severe) (NN hypoglycemia))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported))))) (. .))))

det(interaction-3, A-1)
amod(interaction-3, potential-2)
nsubjpass(reported-17, interaction-3)
amod(miconazole-6, oral-5)
prep_between(interaction-3, miconazole-6)
amod(agents-10, oral-8)
amod(agents-10, hypoglycemic-9)
conj_and(miconazole-6, agents-10)
partmod(miconazole-6, leading-11)
amod(hypoglycemia-14, severe-13)
prep_to(leading-11, hypoglycemia-14)
aux(reported-17, has-15)
auxpass(reported-17, been-16)
root(ROOT-0, reported-17)

Whether/IN this/DT interaction/NN also/RB occurs/VBZ with/IN the/DT intravenous/JJ ,/, topical/JJ ,/, or/CC vaginal/JJ preparations/NNS of/IN miconazole/NN is/VBZ not/RB known/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Whether) (S (NP (DT this) (NN interaction)) (ADVP (RB also)) (VP (VBZ occurs) (PP (IN with) (NP (NP (DT the) (ADJP (ADJP (JJ intravenous)) (, ,) (ADJP (JJ topical)) (, ,) (CC or) (ADJP (JJ vaginal))) (NNS preparations)) (PP (IN of) (NP (NN miconazole)))))))) (VP (VBZ is) (RB not) (VP (VBN known)))) (. .))))

complm(occurs-5, Whether-1)
det(interaction-3, this-2)
nsubj(occurs-5, interaction-3)
advmod(occurs-5, also-4)
csubjpass(known-19, occurs-5)
det(preparations-14, the-7)
amod(preparations-14, intravenous-8)
conj_or(intravenous-8, topical-10)
conj_or(intravenous-8, vaginal-13)
prep_with(occurs-5, preparations-14)
prep_of(preparations-14, miconazole-16)
auxpass(known-19, is-17)
neg(known-19, not-18)
root(ROOT-0, known-19)

Chlorprothixene/NN may/MD increase/VB the/DT plasma-level/NN of/IN concomitantly/RB given/VBN lithium/NN ./.

(ROOT (S1 (S (S (NP (NN Chlorprothixene)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN plasma-level)) (PP (IN of) (NP (ADJP (RB concomitantly) (VBN given)) (NN lithium))))))) (. .))))

nsubj(increase-3, Chlorprothixene-1)
aux(increase-3, may-2)
root(ROOT-0, increase-3)
det(plasma-level-5, the-4)
dobj(increase-3, plasma-level-5)
advmod(given-8, concomitantly-7)
amod(lithium-9, given-8)
prep_of(plasma-level-5, lithium-9)

If/IN chlorprothixene/NN is/VBZ given/VBN concomitantly/RB with/IN opioids/NNS ,/, the/DT opioid/NN dose/NN should/MD be/VB reduced/VBN (/-LRB- by/IN approx./RB 50/CD %/NN )/-RRB- ,/, because/IN chlorprothixene/NN amplifies/VBZ the/DT therapeutic/JJ actions/NNS and/CC side-effects/NNS of/IN opioids/NNS massively/RB ./.

(ROOT (S1 (S (SBAR (IN If) (S (NP (NN chlorprothixene)) (VP (VBZ is) (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (NNS opioids))))))) (, ,) (NP (DT the) (NN opioid) (NN dose)) (VP (MD should) (VP (VB be) (VP (VBN reduced)) (PRN (-LRB- -LRB-) (PP (IN by) (NP (QP (RB approx.) (CD 50)) (NN %))) (-RRB- -RRB-)) (, ,) (SBAR (IN because) (S (NP (NN chlorprothixene)) (VP (VBZ amplifies) (NP (NP (DT the) (JJ therapeutic) (NP (NNS actions)) (CC and) (NP (NNS side-effects))) (PP (IN of) (NP (NNS opioids)))) (ADVP (RB massively))))))) (. .))))

mark(given-4, If-1)
nsubjpass(given-4, chlorprothixene-2)
auxpass(given-4, is-3)
advcl(reduced-14, given-4)
advmod(given-4, concomitantly-5)
prep_with(given-4, opioids-7)
det(dose-11, the-9)
nn(dose-11, opioid-10)
nsubjpass(reduced-14, dose-11)
aux(reduced-14, should-12)
auxpass(reduced-14, be-13)
root(ROOT-0, reduced-14)
dep(reduced-14, by-16)
quantmod(50-18, approx.-17)
num(%-19, 50-18)
pobj(by-16, %-19)
mark(amplifies-24, because-22)
nsubj(amplifies-24, chlorprothixene-23)
advcl(reduced-14, amplifies-24)
dep(actions-27, the-25)
amod(actions-27, therapeutic-26)
dobj(amplifies-24, actions-27)
conj_and(actions-27, side-effects-29)
prep_of(actions-27, opioids-31)
advmod(amplifies-24, massively-32)

Avoid/VB the/DT concomitant/JJ use/NN of/IN chlorprothixene/NN and/CC tramadol/NN (/-LRB- Ultram/NNP )/-RRB- ./.

(ROOT (S1 (S (S (VP (VB Avoid) (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN chlorprothixene)) (CC and) (NP (NN tramadol))))) (PRN (-LRB- -LRB-) (NP (NNP Ultram)) (-RRB- -RRB-)))) (. .))))

root(ROOT-0, Avoid-1)
det(use-4, the-2)
amod(use-4, concomitant-3)
dobj(Avoid-1, use-4)
prep_of(use-4, chlorprothixene-6)
conj_and(chlorprothixene-6, tramadol-8)
dep(Avoid-1, Ultram-10)

Consider/VB additive/JJ sedative/JJ effects/NNS and/CC confusional/JJ states/NNS to/TO emerge/VB ,/, if/IN chlorprothixene/NN is/VBZ given/VBN with/IN benzodiazepines/NN or/CC barbituates/NN ./.

(ROOT (S1 (S (S (VP (VB Consider) (S (NP (NP (JJ additive) (JJ sedative) (NNS effects)) (CC and) (NP (JJ confusional) (NNS states))) (VP (TO to) (VP (VB emerge)))) (, ,) (SBAR (IN if) (S (NP (NN chlorprothixene)) (VP (VBZ is) (VP (VBN given) (PP (IN with) (NP (NP (NN benzodiazepines)) (CC or) (NP (NN barbituates)))))))))) (. .))))

root(ROOT-0, Consider-1)
amod(effects-4, additive-2)
amod(effects-4, sedative-3)
nsubj(emerge-9, effects-4)
amod(states-7, confusional-6)
conj_and(effects-4, states-7)
aux(emerge-9, to-8)
xcomp(Consider-1, emerge-9)
mark(given-14, if-11)
nsubjpass(given-14, chlorprothixene-12)
auxpass(given-14, is-13)
advcl(Consider-1, given-14)
prep_with(given-14, benzodiazepines-16)
conj_or(benzodiazepines-16, barbituates-18)

Choose/VBP particular/JJ low/JJ doses/NNS of/IN these/DT drugs/NNS ./.

(ROOT (S1 (S (S (VP (VBP Choose) (NP (NP (JJ particular) (JJ low) (NNS doses)) (PP (IN of) (NP (DT these) (NNS drugs)))))) (. .))))

root(ROOT-0, Choose-1)
amod(doses-4, particular-2)
amod(doses-4, low-3)
dobj(Choose-1, doses-4)
det(drugs-7, these-6)
prep_of(doses-4, drugs-7)

Exert/VBP particular/JJ caution/NN in/IN combining/VBG chlorprothixene/NN with/IN other/JJ anticholinergic/JJ drugs/NNS (/-LRB- tricyclic/JJ antidepressants/NNS and/CC antiparkinsonian/JJ agents/NNS )/-RRB- :/: Particularly/RB the/DT elderly/JJ may/MD develop/VB delirium/NN ,/, high/JJ fever/NN ,/, severe/JJ obstipation/NN ,/, even/JJ ileus/NN and/CC glaucoma/NN ./.

(ROOT (S1 (S (S (VP (VBP Exert) (NP (JJ particular) (NN caution)) (PP (IN in) (S (VP (VBG combining) (NP (NN chlorprothixene)) (PP (IN with) (NP (NP (JJ other) (JJ anticholinergic) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NP (JJ tricyclic) (NNS antidepressants)) (CC and) (NP (JJ antiparkinsonian) (NNS agents))) (-RRB- -RRB-))))))))) (: :) (S (NP (RB Particularly) (DT the) (JJ elderly)) (VP (MD may) (VP (VB develop) (NP (NP (NN delirium)) (, ,) (NP (JJ high) (NN fever)) (, ,) (NP (JJ severe) (NN obstipation)) (, ,) (NP (JJ even) (NN ileus)) (CC and) (NP (NN glaucoma)))))) (. .))))

root(ROOT-0, Exert-1)
amod(caution-3, particular-2)
dobj(Exert-1, caution-3)
prepc_in(Exert-1, combining-5)
dobj(combining-5, chlorprothixene-6)
amod(drugs-10, other-8)
amod(drugs-10, anticholinergic-9)
prep_with(combining-5, drugs-10)
amod(antidepressants-13, tricyclic-12)
dep(drugs-10, antidepressants-13)
amod(agents-16, antiparkinsonian-15)
conj_and(antidepressants-13, agents-16)
advmod(elderly-21, Particularly-19)
det(elderly-21, the-20)
nsubj(develop-23, elderly-21)
aux(develop-23, may-22)
parataxis(Exert-1, develop-23)
dobj(develop-23, delirium-24)
amod(fever-27, high-26)
conj_and(delirium-24, fever-27)
amod(obstipation-30, severe-29)
conj_and(delirium-24, obstipation-30)
amod(ileus-33, even-32)
conj_and(delirium-24, ileus-33)
conj_and(delirium-24, glaucoma-35)

Chlorthalidone/NN may/MD add/VBP to/TO or/CC potentiate/VB the/DT action/NN of/IN other/JJ antihypertensive/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NN Chlorthalidone)) (VP (MD may) (VP (VP (VBP add) (PP (TO to))) (CC or) (VP (VB potentiate) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (JJ other) (JJ antihypertensive) (NNS drugs)))))))) (. .))))

nsubj(add-3, Chlorthalidone-1)
aux(add-3, may-2)
root(ROOT-0, add-3)
prep(add-3, to-4)
conj_or(add-3, potentiate-6)
det(action-8, the-7)
dobj(potentiate-6, action-8)
amod(drugs-12, other-10)
amod(drugs-12, antihypertensive-11)
prep_of(action-8, drugs-12)

Potentiation/NN occurs/VBZ with/IN ganglionic/JJ peripheral/JJ adrenergic/JJ blocking/NN drugs/NNS ./.

(ROOT (S1 (S (S (NP (NN Potentiation)) (VP (VBZ occurs) (PP (IN with) (NP (JJ ganglionic) (JJ peripheral) (JJ adrenergic) (NN blocking) (NNS drugs))))) (. .))))

nsubj(occurs-2, Potentiation-1)
root(ROOT-0, occurs-2)
amod(drugs-8, ganglionic-4)
amod(drugs-8, peripheral-5)
amod(drugs-8, adrenergic-6)
nn(drugs-8, blocking-7)
prep_with(occurs-2, drugs-8)

Medication/NN such/JJ as/IN digitalis/NN may/MD also/RB influence/VB serum/NN electrolytes/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Medication)) (PP (JJ such) (IN as) (NP (NN digitalis)))) (VP (MD may) (ADVP (RB also)) (VP (VB influence) (NP (NN serum) (NNS electrolytes))))) (. .))))

nsubj(influence-7, Medication-1)
prep_such_as(Medication-1, digitalis-4)
aux(influence-7, may-5)
advmod(influence-7, also-6)
root(ROOT-0, influence-7)
nn(electrolytes-9, serum-8)
dobj(influence-7, electrolytes-9)

Insulin/NN requirements/NNS in/IN diabetic/JJ patients/NNS may/MD be/VB increased/VBN ,/, decreased/VBN ,/, or/CC unchanged/JJ ./.

(ROOT (S1 (S (S (NP (NP (NN Insulin) (NNS requirements)) (PP (IN in) (NP (JJ diabetic) (NNS patients)))) (VP (MD may) (VP (VB be) (ADJP (ADJP (VBN increased)) (, ,) (ADJP (VBN decreased)) (, ,) (CC or) (ADJP (JJ unchanged)))))) (. .))))

nn(requirements-2, Insulin-1)
nsubjpass(increased-8, requirements-2)
amod(patients-5, diabetic-4)
prep_in(requirements-2, patients-5)
aux(increased-8, may-6)
auxpass(increased-8, be-7)
cop(increased-8, be-7)
root(ROOT-0, increased-8)
conj_or(increased-8, decreased-10)
conj_or(increased-8, unchanged-13)

Higher/JJR dosage/NN of/IN oral/JJ hypoglycemic/JJ agents/NNS may/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJR Higher) (NN dosage)) (PP (IN of) (NP (JJ oral) (JJ hypoglycemic) (NNS agents)))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (. .))))

amod(dosage-2, Higher-1)
nsubjpass(required-9, dosage-2)
amod(agents-6, oral-4)
amod(agents-6, hypoglycemic-5)
prep_of(dosage-2, agents-6)
aux(required-9, may-7)
auxpass(required-9, be-8)
root(ROOT-0, required-9)

Latent/JJ diabetes/NN mellitus/NN may/MD become/VB manifest/VBP during/IN chlorthalidone/NN administration/NN ./.

(ROOT (S1 (S (S (NP (JJ Latent) (NN diabetes) (NN mellitus)) (VP (MD may) (VP (VB become) (VP (VBP manifest) (PP (IN during) (NP (NN chlorthalidone) (NN administration))))))) (. .))))

amod(mellitus-3, Latent-1)
nn(mellitus-3, diabetes-2)
nsubj(manifest-6, mellitus-3)
aux(manifest-6, may-4)
aux(manifest-6, become-5)
root(ROOT-0, manifest-6)
nn(administration-9, chlorthalidone-8)
prep_during(manifest-6, administration-9)

Chlorthalidone/NN and/CC related/JJ drugs/NNS may/MD increase/VB the/DT responsiveness/NN to/TO tubocurarine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Chlorthalidone)) (CC and) (NP (JJ related) (NNS drugs))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN responsiveness)) (PP (TO to) (NP (NN tubocurarine))))))) (. .))))

nsubj(increase-6, Chlorthalidone-1)
amod(drugs-4, related-3)
conj_and(Chlorthalidone-1, drugs-4)
aux(increase-6, may-5)
root(ROOT-0, increase-6)
det(responsiveness-8, the-7)
dobj(increase-6, responsiveness-8)
prep_to(responsiveness-8, tubocurarine-10)

Chlorthalidone/NN and/CC related/JJ drugs/NNS may/MD decrease/VB arterial/JJ responsiveness/NN to/TO norepinephrine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Chlorthalidone)) (CC and) (NP (JJ related) (NNS drugs))) (VP (MD may) (VP (VB decrease) (NP (NP (JJ arterial) (NN responsiveness)) (PP (TO to) (NP (NN norepinephrine))))))) (. .))))

nsubj(decrease-6, Chlorthalidone-1)
amod(drugs-4, related-3)
conj_and(Chlorthalidone-1, drugs-4)
aux(decrease-6, may-5)
root(ROOT-0, decrease-6)
amod(responsiveness-8, arterial-7)
dobj(decrease-6, responsiveness-8)
prep_to(responsiveness-8, norepinephrine-10)

This/DT diminution/NN is/VBZ not/RB sufficient/JJ to/TO preclude/VB effectiveness/NN of/IN the/DT pressor/JJ agent/NN for/IN therapeutic/JJ use/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN diminution)) (VP (VBZ is) (RB not) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB preclude) (NP (NP (NN effectiveness)) (PP (IN of) (NP (NP (DT the) (JJ pressor) (NN agent)) (PP (IN for) (NP (JJ therapeutic) (NN use)))))))))))) (. .))))

det(diminution-2, This-1)
nsubj(sufficient-5, diminution-2)
cop(sufficient-5, is-3)
neg(sufficient-5, not-4)
root(ROOT-0, sufficient-5)
aux(preclude-7, to-6)
xcomp(sufficient-5, preclude-7)
dobj(preclude-7, effectiveness-8)
det(agent-12, the-10)
amod(agent-12, pressor-11)
prep_of(effectiveness-8, agent-12)
amod(use-15, therapeutic-14)
prep_for(agent-12, use-15)

The/DT concomitant/JJ use/NN of/IN alcohol/NN or/CC other/JJ central/JJ nervous/JJ system/NN depressants/NNS may/MD have/VB an/DT additive/JJ effect/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN alcohol)) (CC or) (NP (JJ other) (JJ central) (JJ nervous) (NN system)) (NP (NNS depressants))))) (VP (MD may) (VP (VB have) (NP (DT an) (JJ additive) (NN effect))))) (. .))))

det(use-3, The-1)
amod(use-3, concomitant-2)
nsubj(have-13, use-3)
prep_of(use-3, alcohol-5)
amod(system-10, other-7)
amod(system-10, central-8)
amod(system-10, nervous-9)
conj_or(alcohol-5, system-10)
dep(alcohol-5, depressants-11)
aux(have-13, may-12)
root(ROOT-0, have-13)
det(effect-16, an-14)
amod(effect-16, additive-15)
dobj(have-13, effect-16)

Cholestyramine/NN resin/NN may/MD delay/VB or/CC reduce/VB the/DT absorption/NN of/IN concomitant/JJ oral/JJ medication/NN such/JJ as/IN phenylbutazone/NN ,/, warfarin/NN ,/, thiazide/NN diuretics/NNS (/-LRB- acidic/JJ )/-RRB- or/CC propranolol/NN (/-LRB- basic/JJ )/-RRB- ,/, as/RB well/RB as/IN tetracycline/NN penicillin/NN G/NN ,/, phenobarbital/NN ,/, thyroid/NN and/CC thyroxine/NN preparation/NN s/NNS ,/, estrogens/NNS and/CC progestins/NNS ,/, and/CC digitalis/NN ./.

(ROOT (S1 (S (S (NP (NN Cholestyramine) (NN resin)) (VP (MD may) (VP (VB delay) (VP (CC or) (VP (VB reduce) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NP (JJ concomitant) (JJ oral) (NN medication)) (PP (JJ such) (PP (IN as) (NP (NP (NP (NP (NP (NP (NN phenylbutazone)) (, ,) (NP (NN warfarin)) (, ,) (NP (NP (NN thiazide) (NNS diuretics)) (PRN (-LRB- -LRB-) (ADJP (JJ acidic)) (-RRB- -RRB-))) (CC or) (NP (NN propranolol))) (PRN (-LRB- -LRB-) (ADJP (JJ basic)) (-RRB- -RRB-))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NN tetracycline) (NN penicillin) (NN G)) (, ,) (NP (NN phenobarbital)) (, ,) (NP (NN thyroid)) (CC and) (NP (NN thyroxine) (NN preparation) (NNS s))) (, ,) (NP (NP (NNS estrogens)) (CC and) (NP (NNS progestins))) (, ,)) (CC and) (NP (NN digitalis))))))))))))) (. .))))

nn(resin-2, Cholestyramine-1)
nsubj(delay-4, resin-2)
aux(delay-4, may-3)
root(ROOT-0, delay-4)
cc(reduce-6, or-5)
dep(delay-4, reduce-6)
det(absorption-8, the-7)
dobj(reduce-6, absorption-8)
amod(medication-12, concomitant-10)
amod(medication-12, oral-11)
prep_of(absorption-8, medication-12)
prep_such_as(medication-12, phenylbutazone-15)
conj_or(phenylbutazone-15, warfarin-17)
nn(diuretics-20, thiazide-19)
conj_or(phenylbutazone-15, diuretics-20)
dep(diuretics-20, acidic-22)
conj_or(phenylbutazone-15, propranolol-25)
dep(phenylbutazone-15, basic-27)
nn(G-35, tetracycline-33)
nn(G-35, penicillin-34)
conj_and(phenylbutazone-15, G-35)
conj_and(phenylbutazone-15, phenobarbital-37)
conj_and(phenylbutazone-15, thyroid-39)
nn(s-43, thyroxine-41)
nn(s-43, preparation-42)
conj_and(phenylbutazone-15, s-43)
appos(phenylbutazone-15, estrogens-45)
conj_and(estrogens-45, progestins-47)
conj_and(phenylbutazone-15, digitalis-50)

Interference/NN with/IN the/DT absorption/NN of/IN oral/JJ phosphate/NN supplements/NNS has/VBZ been/VBN observed/VBN with/IN another/DT positively-charged/JJ bile/NN acid/NN sequestrant/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Interference)) (PP (IN with) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (JJ oral) (NN phosphate) (NNS supplements)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN observed) (PP (IN with) (NP (DT another) (JJ positively-charged) (NN bile) (NN acid) (NN sequestrant))))))) (. .))))

nsubjpass(observed-11, Interference-1)
det(absorption-4, the-3)
prep_with(Interference-1, absorption-4)
amod(supplements-8, oral-6)
nn(supplements-8, phosphate-7)
prep_of(absorption-4, supplements-8)
aux(observed-11, has-9)
auxpass(observed-11, been-10)
root(ROOT-0, observed-11)
det(sequestrant-17, another-13)
amod(sequestrant-17, positively-charged-14)
nn(sequestrant-17, bile-15)
nn(sequestrant-17, acid-16)
prep_with(observed-11, sequestrant-17)

Cholestyramine/NN resin/NN may/MD interfere/VB with/IN the/DT pharmacokinetics/NNS of/IN drugs/NNS that/WDT undergo/VBP enterohepatic/JJ circulation/NN ,/, The/DT discontinuance/NN of/IN cholestyramine/NN resin/NN could/MD pose/VB a/DT hazard/NN to/TO health/NN if/IN a/DT potentially/RB toxic/JJ drug/NN such/JJ as/IN digitalis/NN has/VBZ been/VBN filtrated/VBN to/TO a/DT maintenance/NN level/NN while/IN the/DT patient/NN was/VBD taking/VBG cholestyramine/NN resin/NN ./.

(ROOT (S1 (S (S (NP (NN Cholestyramine) (NN resin)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP undergo) (NP (JJ enterohepatic) (NN circulation)) (, ,) (S (NP (NP (DT The) (NN discontinuance)) (PP (IN of) (NP (NN cholestyramine) (NN resin)))) (VP (MD could) (VP (VB pose) (NP (NP (DT a) (NN hazard)) (PP (TO to) (NP (NN health)))) (SBAR (IN if) (S (NP (NP (DT a) (ADJP (RB potentially) (JJ toxic)) (NN drug)) (PP (JJ such) (IN as) (NP (NN digitalis)))) (VP (VBZ has) (VP (VBN been) (VP (VBN filtrated) (PP (TO to) (NP (DT a) (NN maintenance) (NN level))) (SBAR (IN while) (S (NP (DT the) (NN patient)) (VP (VBD was) (VP (VBG taking) (NP (NN cholestyramine) (NN resin)))))))))))))))))))))))) (. .))))

nn(resin-2, Cholestyramine-1)
nsubj(interfere-4, resin-2)
aux(interfere-4, may-3)
root(ROOT-0, interfere-4)
det(pharmacokinetics-7, the-6)
prep_with(interfere-4, pharmacokinetics-7)
prep_of(pharmacokinetics-7, drugs-9)
nsubj(undergo-11, drugs-9)
rcmod(drugs-9, undergo-11)
amod(circulation-13, enterohepatic-12)
dobj(undergo-11, circulation-13)
det(discontinuance-16, The-15)
nsubj(pose-21, discontinuance-16)
nn(resin-19, cholestyramine-18)
prep_of(discontinuance-16, resin-19)
aux(pose-21, could-20)
dep(undergo-11, pose-21)
det(hazard-23, a-22)
dobj(pose-21, hazard-23)
prep_to(hazard-23, health-25)
mark(filtrated-36, if-26)
det(drug-30, a-27)
advmod(toxic-29, potentially-28)
amod(drug-30, toxic-29)
nsubjpass(filtrated-36, drug-30)
prep_such_as(drug-30, digitalis-33)
aux(filtrated-36, has-34)
auxpass(filtrated-36, been-35)
advcl(pose-21, filtrated-36)
det(level-40, a-38)
nn(level-40, maintenance-39)
prep_to(filtrated-36, level-40)
mark(taking-45, while-41)
det(patient-43, the-42)
nsubj(taking-45, patient-43)
aux(taking-45, was-44)
advcl(filtrated-36, taking-45)
nn(resin-47, cholestyramine-46)
dobj(taking-45, resin-47)

Because/IN cholestyramine/NN binds/VBZ bile/JJ acids/NNS ,/, cholestyramine/NN resin/NN may/MD interfere/VB with/IN normal/JJ fat/JJ digestion/NN and/CC absorption/NN and/CC thus/RB may/MD prevent/VB absorption/NN of/IN fat/JJ soluble/JJ vitamins/NNS such/JJ as/IN A/NN ,/, D/NN ,/, E/NN ,/, and/CC K/NN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NN cholestyramine)) (VP (VBZ binds) (NP (JJ bile) (NNS acids))))) (, ,) (NP (NN cholestyramine) (NN resin)) (VP (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (JJ normal) (JJ fat) (NN digestion)) (CC and) (NP (NN absorption)))))) (CC and) (ADVP (RB thus)) (VP (MD may) (VP (VB prevent) (NP (NP (NN absorption)) (PP (IN of) (NP (NP (JJ fat) (JJ soluble) (NNS vitamins)) (PP (JJ such) (IN as) (NP (NP (NN A)) (, ,) (NP (NN D)) (, ,) (NP (NN E)) (, ,) (CC and) (NP (NN K))))))))))) (. .))))

mark(binds-3, Because-1)
nsubj(binds-3, cholestyramine-2)
advcl(interfere-10, binds-3)
amod(acids-5, bile-4)
dobj(binds-3, acids-5)
nn(resin-8, cholestyramine-7)
nsubj(interfere-10, resin-8)
aux(interfere-10, may-9)
root(ROOT-0, interfere-10)
amod(digestion-14, normal-12)
amod(digestion-14, fat-13)
prep_with(interfere-10, digestion-14)
conj_and(digestion-14, absorption-16)
advmod(interfere-10, thus-18)
conj_and(interfere-10, thus-18)
aux(prevent-20, may-19)
conj_and(interfere-10, prevent-20)
dobj(prevent-20, absorption-21)
amod(vitamins-25, fat-23)
amod(vitamins-25, soluble-24)
prep_of(absorption-21, vitamins-25)
prep_such_as(vitamins-25, A-28)
conj_and(A-28, D-30)
conj_and(A-28, E-32)
conj_and(A-28, K-35)

When/WRB cholestyramine/NN resin/NN is/VBZ given/VBN for/IN long/JJ periods/NNS of/IN time/NN ,/, concomitant/JJ supplementation/NN with/IN water/NN -miscible/JJ (/-LRB- or/CC parenteral/JJ )/-RRB- forms/NNS of/IN fat-soluble/JJ vitamins/NNS should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN cholestyramine) (NN resin)) (VP (VBZ is) (VP (VBN given) (PP (IN for) (NP (NP (JJ long) (NNS periods)) (PP (IN of) (NP (NN time))))))))) (, ,) (NP (NP (JJ concomitant) (NN supplementation)) (PP (IN with) (NP (NP (NN water) (ADJP (ADJP (JJ -miscible)) (-LRB- -LRB-) (CC or) (ADJP (JJ parenteral)) (-RRB- -RRB-)) (NNS forms)) (PP (IN of) (NP (JJ fat-soluble) (NNS vitamins)))))) (VP (MD should) (VP (VB be) (VP (VBN considered))))) (. .))))

advmod(given-5, When-1)
nn(resin-3, cholestyramine-2)
nsubjpass(given-5, resin-3)
auxpass(given-5, is-4)
advcl(considered-27, given-5)
amod(periods-8, long-7)
prep_for(given-5, periods-8)
prep_of(periods-8, time-10)
amod(supplementation-13, concomitant-12)
nsubjpass(considered-27, supplementation-13)
nn(forms-21, water-15)
amod(forms-21, -miscible-16)
conj_or(-miscible-16, parenteral-19)
prep_with(supplementation-13, forms-21)
amod(vitamins-24, fat-soluble-23)
prep_of(forms-21, vitamins-24)
aux(considered-27, should-25)
auxpass(considered-27, be-26)
root(ROOT-0, considered-27)

SINCE/IN CHOLESTYRAMINE/NN RESIN/NN MAY/MD BIND/VB OTHER/JJ DRUGS/NNS GIVEN/VBN CONCURRENTLY/RB ,/, IT/PRP IS/VBZ RECOMMENDED/VBN THAT/IN PATIENTS/NNS TAKE/VBP OTHER/JJ DRUGS/NNS AT/IN LEAST/JJS 1/CD HOUR/NN BEFORE/IN OR/CC 4/CD TO/TO 6/CD HOURS/NNS AFTER/IN CHOLESTYRAMINE/NN RESIN/NN (/-LRB- OR/CC AT/IN AS/IN GREAT/JJ AN/DT INTERVAL/NN AS/RB POSSIBLE/JJ )/-RRB- TO/TO AVOID/VB IMPEDING/VBG THEIR/PRP$ ABSORPTION/NN ./.

(ROOT (S1 (S (SBAR (IN SINCE) (S (NP (NN CHOLESTYRAMINE) (NN RESIN)) (VP (MD MAY) (VP (VB BIND) (NP (NP (JJ OTHER) (NNS DRUGS)) (VP (VBN GIVEN) (ADVP (RB CONCURRENTLY)))))))) (, ,) (NP (PRP IT)) (VP (VBZ IS) (VP (VBN RECOMMENDED) (SBAR (IN THAT) (S (NP (NNS PATIENTS)) (VP (VBP TAKE) (NP (NP (NP (JJ OTHER) (NNS DRUGS)) (PP (NP (QP (IN AT) (JJS LEAST) (CD 1)) (NN HOUR)) (IN BEFORE))) (CC OR) (NP (NP (QP (CD 4) (TO TO) (CD 6)) (NNS HOURS)) (PP (IN AFTER) (NP (NP (NN CHOLESTYRAMINE) (NN RESIN)) (PRN (-LRB- -LRB-) (CC OR) (ADVP (IN AT) (PP (IN AS) (NP (JJ GREAT)))) (NP (NP (DT AN) (NN INTERVAL)) (ADJP (RB AS) (JJ POSSIBLE))) (-RRB- -RRB-)))))) (S (VP (TO TO) (VP (VB AVOID) (S (VP (VBG IMPEDING) (NP (PRP$ THEIR) (NN ABSORPTION)))))))))))) (. .))))

mark(BIND-5, SINCE-1)
nn(RESIN-3, CHOLESTYRAMINE-2)
nsubj(BIND-5, RESIN-3)
aux(BIND-5, MAY-4)
advcl(RECOMMENDED-13, BIND-5)
amod(DRUGS-7, OTHER-6)
dobj(BIND-5, DRUGS-7)
partmod(DRUGS-7, GIVEN-8)
advmod(GIVEN-8, CONCURRENTLY-9)
nsubjpass(RECOMMENDED-13, IT-11)
auxpass(RECOMMENDED-13, IS-12)
root(ROOT-0, RECOMMENDED-13)
dep(TAKE-16, THAT-14)
nsubj(TAKE-16, PATIENTS-15)
ccomp(RECOMMENDED-13, TAKE-16)
amod(DRUGS-18, OTHER-17)
dobj(TAKE-16, DRUGS-18)
quantmod(1-21, AT-19)
mwe(AT-19, LEAST-20)
pobj(AT-19, LEAST-20)
num(HOUR-22, 1-21)
npadvmod(BEFORE-23, HOUR-22)
prep(DRUGS-18, BEFORE-23)
number(6-27, 4-25)
dep(6-27, TO-26)
num(HOURS-28, 6-27)
conj_or(DRUGS-18, HOURS-28)
nn(RESIN-31, CHOLESTYRAMINE-30)
prep_after(HOURS-28, RESIN-31)
dep(INTERVAL-38, OR-33)
dep(INTERVAL-38, AT-34)
prep_as(AT-34, GREAT-36)
det(INTERVAL-38, AN-37)
dep(RESIN-31, INTERVAL-38)
advmod(POSSIBLE-40, AS-39)
amod(INTERVAL-38, POSSIBLE-40)
aux(AVOID-43, TO-42)
xcomp(TAKE-16, AVOID-43)
xcomp(AVOID-43, IMPEDING-44)
poss(ABSORPTION-46, THEIR-45)
dobj(IMPEDING-44, ABSORPTION-46)

Based/VBN on/IN in/FW vitro/FW studies/NNS in/IN human/JJ liver/NN microsomes/NNS ,/, des/NN -ciclesonide/NN appears/VBZ to/TO have/VB no/DT inhibitory/JJ or/NN induction/NN potential/NN on/IN the/DT metabolism/NN of/IN other/JJ drugs/NNS metabolized/VBN by/IN CYP/VBG 450/CD enzymes/NNS ./.

(ROOT (S1 (S (PP (VBN Based) (PP (IN on) (NP (NP (ADJP (FW in) (FW vitro)) (NNS studies)) (PP (IN in) (NP (JJ human) (NN liver) (NNS microsomes)))))) (, ,) (NP (NN des) (NN -ciclesonide)) (VP (VBZ appears) (S (VP (TO to) (VP (VB have) (NP (DT no) (JJ inhibitory) (NN or) (NN induction) (NN potential)) (PP (IN on) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NP (JJ other) (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (S (VP (VBG CYP) (NP (CD 450) (NNS enzymes)))))))))))))) (. .))))

prepc_based_on(appears-13, on-2)
nn(vitro-4, in-3)
amod(studies-5, vitro-4)
pobj(appears-13, studies-5)
amod(microsomes-9, human-7)
nn(microsomes-9, liver-8)
prep_in(studies-5, microsomes-9)
nn(-ciclesonide-12, des-11)
nsubj(appears-13, -ciclesonide-12)
xsubj(have-15, -ciclesonide-12)
root(ROOT-0, appears-13)
aux(have-15, to-14)
xcomp(appears-13, have-15)
det(potential-20, no-16)
amod(potential-20, inhibitory-17)
nn(potential-20, or-18)
nn(potential-20, induction-19)
dobj(have-15, potential-20)
det(metabolism-23, the-22)
prep_on(have-15, metabolism-23)
amod(drugs-26, other-25)
prep_of(metabolism-23, drugs-26)
partmod(drugs-26, metabolized-27)
agent(metabolized-27, CYP-29)
num(enzymes-31, 450-30)
dobj(CYP-29, enzymes-31)

The/DT inhibitory/JJ potential/NN of/IN ciclesonide/NN on/IN CYP450/NN isoenzymes/NNS has/VBZ not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ inhibitory) (NN potential)) (PP (IN of) (NP (NN ciclesonide))) (PP (IN on) (NP (NN CYP450) (NNS isoenzymes)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

det(potential-3, The-1)
amod(potential-3, inhibitory-2)
nsubjpass(studied-12, potential-3)
prep_of(potential-3, ciclesonide-5)
nn(isoenzymes-8, CYP450-7)
prep_on(potential-3, isoenzymes-8)
aux(studied-12, has-9)
neg(studied-12, not-10)
auxpass(studied-12, been-11)
root(ROOT-0, studied-12)

In/FW vitro/FW studies/NNS demonstrated/VBD that/IN the/DT plasma/NN protein/NN binding/NN of/IN des/NN -ciclesonide/NN was/VBD not/RB affected/VBN by/IN warfarin/NN or/CC salicylic/JJ acid/NN ,/, indicating/VBG no/DT potential/NN for/IN protein/NN binding-based/JJ drug/NN interactions/NNS ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (DT the) (NN plasma) (NN protein) (NN binding)) (PP (IN of) (NP (NN des) (NN -ciclesonide)))) (VP (VBD was) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (NN warfarin)) (CC or) (NP (JJ salicylic) (NN acid)))) (, ,) (S (VP (VBG indicating) (NP (NP (DT no) (NN potential)) (PP (IN for) (NP (NN protein) (JJ binding-based) (NN drug) (NNS interactions)))))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(demonstrated-4, studies-3)
root(ROOT-0, demonstrated-4)
complm(affected-15, that-5)
det(binding-9, the-6)
nn(binding-9, plasma-7)
nn(binding-9, protein-8)
nsubjpass(affected-15, binding-9)
nn(-ciclesonide-12, des-11)
prep_of(binding-9, -ciclesonide-12)
auxpass(affected-15, was-13)
neg(affected-15, not-14)
ccomp(demonstrated-4, affected-15)
agent(affected-15, warfarin-17)
amod(acid-20, salicylic-19)
conj_or(warfarin-17, acid-20)
xcomp(affected-15, indicating-22)
det(potential-24, no-23)
dobj(indicating-22, potential-24)
nn(interactions-29, protein-26)
amod(interactions-29, binding-based-27)
nn(interactions-29, drug-28)
prep_for(potential-24, interactions-29)

In/IN a/DT drug/NN interaction/NN study/NN ,/, co-administration/NN of/IN orally/RB inhaled/VBN ciclesonide/NN and/CC oral/JJ erythromycin/NN ,/, an/DT inhibitor/NN of/IN cytochrome/NN P450/NN 3A4/NN ,/, had/VBD no/DT effect/NN on/IN the/DT pharmacokinetics/NNS of/IN either/CC des/NN -ciclesonide/NN or/CC erythromycin/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (DT a) (NN drug) (NN interaction) (NN study))) (, ,) (NP (NP (NN co-administration)) (PP (IN of) (NP (NP (ADJP (RB orally) (VBN inhaled)) (NP (NP (NN ciclesonide)) (CC and) (NP (JJ oral) (NN erythromycin)))) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN cytochrome) (NN P450) (NN 3A4)))) (, ,)))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (CC either) (NP (NN des) (NN -ciclesonide)) (CC or) (NP (NN erythromycin))))))) (. .))))

det(study-5, a-2)
nn(study-5, drug-3)
nn(study-5, interaction-4)
prep_in(had-23, study-5)
nsubj(had-23, co-administration-7)
advmod(inhaled-10, orally-9)
amod(ciclesonide-11, inhaled-10)
prep_of(co-administration-7, ciclesonide-11)
amod(erythromycin-14, oral-13)
conj_and(ciclesonide-11, erythromycin-14)
det(inhibitor-17, an-16)
appos(ciclesonide-11, inhibitor-17)
nn(3A4-21, cytochrome-19)
nn(3A4-21, P450-20)
prep_of(inhibitor-17, 3A4-21)
root(ROOT-0, had-23)
det(effect-25, no-24)
dobj(had-23, effect-25)
det(pharmacokinetics-28, the-27)
prep_on(had-23, pharmacokinetics-28)
preconj(-ciclesonide-32, either-30)
nn(-ciclesonide-32, des-31)
prep_of(pharmacokinetics-28, -ciclesonide-32)
conj_or(-ciclesonide-32, erythromycin-34)

In/IN another/DT drug/NN interaction/NN study/NN ,/, co-administration/NN of/IN orally/RB inhaled/VBN ciclesonide/NN and/CC oral/JJ ketoconazole/NN ,/, a/DT potent/JJ inhibitor/NN of/IN cytochrome/NN P450/NN 3A4/NN ,/, increased/VBD the/DT exposure/NN (/-LRB- AUC/NN )/-RRB- of/IN des/NN -ciclesonide/NN by/IN approximately/RB 3.6-fold/NN at/IN steady/JJ state/NN ,/, while/IN levels/NNS of/IN ciclesonide/NN remained/VBD unchanged/JJ ./.

(ROOT (S1 (S (PP (IN In) (NP (DT another) (NN drug) (NN interaction) (NN study))) (, ,) (NP (NP (NN co-administration)) (PP (IN of) (NP (NP (NP (ADJP (RB orally) (VBN inhaled)) (NN ciclesonide)) (CC and) (NP (JJ oral) (NN ketoconazole))) (, ,) (NP (NP (DT a) (JJ potent) (NN inhibitor)) (PP (IN of) (NP (NN cytochrome) (NN P450) (NN 3A4)))) (, ,)))) (VP (VBD increased) (NP (NP (NP (DT the) (NN exposure)) (PRN (-LRB- -LRB-) (NP (NN AUC)) (-RRB- -RRB-))) (PP (IN of) (NP (NN des) (NN -ciclesonide)))) (PP (IN by) (NP (NP (RB approximately) (NN 3.6-fold)) (PP (IN at) (NP (JJ steady) (NN state))))) (, ,) (SBAR (IN while) (S (NP (NP (NNS levels)) (PP (IN of) (NP (NN ciclesonide)))) (VP (VBD remained) (ADJP (JJ unchanged)))))) (. .))))

det(study-5, another-2)
nn(study-5, drug-3)
nn(study-5, interaction-4)
prep_in(increased-24, study-5)
nsubj(increased-24, co-administration-7)
advmod(inhaled-10, orally-9)
amod(ciclesonide-11, inhaled-10)
prep_of(co-administration-7, ciclesonide-11)
amod(ketoconazole-14, oral-13)
conj_and(ciclesonide-11, ketoconazole-14)
det(inhibitor-18, a-16)
amod(inhibitor-18, potent-17)
appos(ciclesonide-11, inhibitor-18)
nn(3A4-22, cytochrome-20)
nn(3A4-22, P450-21)
prep_of(inhibitor-18, 3A4-22)
root(ROOT-0, increased-24)
det(exposure-26, the-25)
dobj(increased-24, exposure-26)
abbrev(exposure-26, AUC-28)
nn(-ciclesonide-32, des-31)
prep_of(exposure-26, -ciclesonide-32)
advmod(3.6-fold-35, approximately-34)
prep_by(increased-24, 3.6-fold-35)
amod(state-38, steady-37)
prep_at(3.6-fold-35, state-38)
mark(unchanged-45, while-40)
nsubj(unchanged-45, levels-41)
prep_of(levels-41, ciclesonide-43)
cop(unchanged-45, remained-44)
advcl(increased-24, unchanged-45)

Therefore/RB ,/, ketoconazole/NN should/MD be/VB administered/VBN with/IN caution/NN with/IN intranasal/JJ ciclesonide/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NN ketoconazole)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (NN caution))) (PP (IN with) (NP (JJ intranasal) (NN ciclesonide))))))) (. .))))

advmod(administered-6, Therefore-1)
nsubjpass(administered-6, ketoconazole-3)
aux(administered-6, should-4)
auxpass(administered-6, be-5)
root(ROOT-0, administered-6)
prep_with(administered-6, caution-8)
amod(ciclesonide-11, intranasal-10)
prep_with(administered-6, ciclesonide-11)

Probenecid/NN :/: Probenecid/NN is/VBZ known/VBN to/TO interact/VB with/IN the/DT metabolism/NN or/CC renal/JJ tubular/JJ excretion/NN of/IN many/JJ drugs/NNS (/-LRB- e.g./FW ,/, acetaminophen/NN ,/, acyclovir/NN ,/, angiotensin-converting/JJ enzyme/NN inhibitors/NNS ,/, aminosalicylic/JJ acid/NN ,/, barbiturates/NNS ,/, benzodiazepines/NN ,/, bumetanide/NN ,/, clofibrate/NN ,/, methotrexate/NN ,/, famotidine/NN ,/, furosemide/NN ,/, nonsteroidal/JJ anti-inflammatory/JJ agents/NNS ,/, theophylline/NN ,/, and/CC zidovudine/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NN Probenecid)) (: :) (S (NP (NN Probenecid)) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NP (NP (DT the) (NN metabolism)) (CC or) (NP (JJ renal) (JJ tubular) (NN excretion))) (PP (IN of) (NP (NP (JJ many) (NNS drugs)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN acetaminophen)) (, ,) (NP (NN acyclovir)) (, ,) (NP (JJ angiotensin-converting) (NN enzyme) (NNS inhibitors)) (, ,) (NP (JJ aminosalicylic) (NN acid)) (, ,) (NP (NNS barbiturates)) (, ,) (NP (NN benzodiazepines)) (, ,) (NP (NN bumetanide)) (, ,) (NP (NN clofibrate)) (, ,) (NP (NN methotrexate)) (, ,) (NP (NN famotidine)) (, ,) (NP (NN furosemide)) (, ,) (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS agents)) (, ,) (NP (NN theophylline)) (, ,) (CC and) (NP (NN zidovudine)))) (-RRB- -RRB-)))))))))))) (. .)))))

root(ROOT-0, Probenecid-1)
nsubjpass(known-5, Probenecid-3)
xsubj(interact-7, Probenecid-3)
auxpass(known-5, is-4)
dep(Probenecid-1, known-5)
aux(interact-7, to-6)
xcomp(known-5, interact-7)
det(metabolism-10, the-9)
prep_with(interact-7, metabolism-10)
amod(excretion-14, renal-12)
amod(excretion-14, tubular-13)
conj_or(metabolism-10, excretion-14)
amod(drugs-17, many-16)
prep_of(metabolism-10, drugs-17)
dep(drugs-17, e.g.-19)
pobj(e.g.-19, acetaminophen-21)
conj_and(acetaminophen-21, acyclovir-23)
amod(inhibitors-27, angiotensin-converting-25)
nn(inhibitors-27, enzyme-26)
conj_and(acetaminophen-21, inhibitors-27)
amod(acid-30, aminosalicylic-29)
conj_and(acetaminophen-21, acid-30)
conj_and(acetaminophen-21, barbiturates-32)
conj_and(acetaminophen-21, benzodiazepines-34)
conj_and(acetaminophen-21, bumetanide-36)
conj_and(acetaminophen-21, clofibrate-38)
conj_and(acetaminophen-21, methotrexate-40)
conj_and(acetaminophen-21, famotidine-42)
conj_and(acetaminophen-21, furosemide-44)
amod(agents-48, nonsteroidal-46)
amod(agents-48, anti-inflammatory-47)
conj_and(acetaminophen-21, agents-48)
conj_and(acetaminophen-21, theophylline-50)
conj_and(acetaminophen-21, zidovudine-53)

Concomitant/JJ medications/NNS should/MD be/VB carefully/RB assessed/VBN ./.

(ROOT (S1 (S (S (NP (JJ Concomitant) (NNS medications)) (VP (MD should) (VP (VB be) (ADVP (RB carefully)) (VP (VBN assessed))))) (. .))))

amod(medications-2, Concomitant-1)
nsubjpass(assessed-6, medications-2)
aux(assessed-6, should-3)
auxpass(assessed-6, be-4)
advmod(assessed-6, carefully-5)
root(ROOT-0, assessed-6)

Zidovudine/NN should/MD either/RB be/VB temporarily/RB discontinued/VBN or/CC decreased/VBD by/IN 50/CD %/NN when/WRB coadministered/VBN with/IN probenecid/NN on/IN the/DT day/NN of/IN VISTIDE/NN infusion/NN ./.

(ROOT (S1 (S (S (NP (NN Zidovudine)) (VP (VP (MD should) (ADVP (RB either)) (VP (VB be) (ADVP (RB temporarily)) (VP (VBN discontinued)))) (CC or) (VP (VBD decreased) (PP (IN by) (NP (CD 50) (NN %))) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NP (NN probenecid)) (PP (IN on) (NP (NP (DT the) (NN day)) (PP (IN of) (NP (NN VISTIDE) (NN infusion))))))))))))) (. .))))

nsubjpass(discontinued-6, Zidovudine-1)
aux(discontinued-6, should-2)
advmod(discontinued-6, either-3)
auxpass(discontinued-6, be-4)
advmod(discontinued-6, temporarily-5)
root(ROOT-0, discontinued-6)
conj_or(discontinued-6, decreased-8)
num(%-11, 50-10)
prep_by(decreased-8, %-11)
advmod(coadministered-13, when-12)
advcl(decreased-8, coadministered-13)
prep_with(coadministered-13, probenecid-15)
det(day-18, the-17)
prep_on(probenecid-15, day-18)
nn(infusion-21, VISTIDE-20)
prep_of(day-18, infusion-21)

Nephrotoxic/JJ agents/NNS :/: Concomitant/JJ administration/NN of/IN VISTIDE/NN and/CC agents/NNS with/IN nephrotoxic/JJ potential/JJ [e.g./NN ,/, intravenous/JJ aminoglycosides/NNS (/-LRB- e.g./FW ,/, tobramycin/NN ,/, gentamicin/NN ,/, and/CC amikacin/NN )/-RRB- ,/, amphotericin/NN B/NN ,/, foscarnet/NN ,/, intravenous/JJ pentamidin/NN e/NN ,/, vancomycin/NN ,/, and/CC non-steroidal/JJ anti-inflammatory/JJ agents/NNS ]/-RRB- is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (NP (NP (JJ Nephrotoxic) (NNS agents)) (: :) (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN VISTIDE)) (CC and) (NP (NNS agents)))) (PP (IN with) (NP (NP (JJ nephrotoxic) (JJ potential) (NN -LSB-e.g.)) (, ,) (NP (NP (JJ intravenous) (NNS aminoglycosides)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN tobramycin)) (, ,) (NP (NN gentamicin)) (, ,) (CC and) (NP (NN amikacin)))) (-RRB- -RRB-))) (, ,) (NP (NN amphotericin) (NN B)) (, ,) (NP (NN foscarnet)) (, ,) (NP (JJ intravenous) (NN pentamidin) (NN e)) (, ,) (NP (NN vancomycin)) (, ,) (CC and) (NP (JJ non-steroidal) (JJ anti-inflammatory) (NNS agents)) (-RRB- -RSB-)))) (VP (VBZ is) (VP (VBN contraindicated)))) (. .)))))

amod(agents-2, Nephrotoxic-1)
root(ROOT-0, agents-2)
amod(administration-5, Concomitant-4)
nsubjpass(contraindicated-45, administration-5)
prep_of(administration-5, VISTIDE-7)
conj_and(VISTIDE-7, agents-9)
amod(-LSB-e.g.-13, nephrotoxic-11)
amod(-LSB-e.g.-13, potential-12)
prep_with(administration-5, -LSB-e.g.-13)
amod(aminoglycosides-16, intravenous-15)
conj_and(-LSB-e.g.-13, aminoglycosides-16)
dep(aminoglycosides-16, e.g.-18)
pobj(e.g.-18, tobramycin-20)
conj_and(tobramycin-20, gentamicin-22)
conj_and(tobramycin-20, amikacin-25)
nn(B-29, amphotericin-28)
conj_and(-LSB-e.g.-13, B-29)
conj_and(-LSB-e.g.-13, foscarnet-31)
amod(e-35, intravenous-33)
nn(e-35, pentamidin-34)
conj_and(-LSB-e.g.-13, e-35)
conj_and(-LSB-e.g.-13, vancomycin-37)
amod(agents-42, non-steroidal-40)
amod(agents-42, anti-inflammatory-41)
conj_and(-LSB-e.g.-13, agents-42)
punct(-LSB-e.g.-13, -RSB--43)
auxpass(contraindicated-45, is-44)
dep(agents-2, contraindicated-45)

Such/JJ agents/NNS must/MD be/VB discontinued/VBN at/IN least/JJS seven/CD days/NNS prior/JJ to/TO starting/VBG therapy/NN with/IN VISTIDE/NN ./.

(ROOT (S1 (S (S (NP (JJ Such) (NNS agents)) (VP (MD must) (VP (VB be) (VP (VBN discontinued) (NP (NP (QP (IN at) (JJS least) (CD seven)) (NNS days)) (ADJP (JJ prior) (PP (TO to) (S (VP (VBG starting) (NP (NN therapy)) (PP (IN with) (NP (NN VISTIDE)))))))))))) (. .))))

amod(agents-2, Such-1)
nsubjpass(discontinued-5, agents-2)
aux(discontinued-5, must-3)
auxpass(discontinued-5, be-4)
root(ROOT-0, discontinued-5)
quantmod(seven-8, at-6)
mwe(at-6, least-7)
pobj(at-6, least-7)
num(days-9, seven-8)
dobj(discontinued-5, days-9)
prepc_prior_to(days-9, starting-12)
dobj(starting-12, therapy-13)
prep_with(starting-12, VISTIDE-15)

Since/IN PLETAL/NN is/VBZ extensively/RB metabolized/VBN by/IN cytochrome/NN P-450/NN isoenzymes/NNS ,/, caution/NN should/MD be/VB exercised/VBN when/WRB PLETAL/NN is/VBZ coadministered/VBN with/IN inhibitors/NNS of/IN C.P.A./NNP such/JJ as/IN ketoconazole/NN and/CC erythromycin/NN or/CC inhibitors/NNS of/IN CYP2C19/NN such/JJ as/IN omeprazole/NN ./.

(ROOT (S1 (S (SBAR (IN Since) (S (NP (NN PLETAL)) (VP (VBZ is) (ADVP (RB extensively)) (VP (VBN metabolized) (PP (IN by) (NP (NP (NN cytochrome) (NN P-450)) (NNS isoenzymes))))))) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (NP (NN PLETAL)) (VP (VBZ is) (VP (VBN coadministered) (PP (IN with) (NP (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NNP C.P.A.))) (PP (JJ such) (IN as) (NP (NP (NN ketoconazole)) (CC and) (NP (NN erythromycin))))) (CC or) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NN CYP2C19))) (PP (JJ such) (IN as) (NP (NN omeprazole))))))))))))) (. .))))

mark(metabolized-5, Since-1)
nsubjpass(metabolized-5, PLETAL-2)
auxpass(metabolized-5, is-3)
advmod(metabolized-5, extensively-4)
advcl(exercised-14, metabolized-5)
nn(P-450-8, cytochrome-7)
nn(isoenzymes-9, P-450-8)
agent(metabolized-5, isoenzymes-9)
nsubjpass(exercised-14, caution-11)
aux(exercised-14, should-12)
auxpass(exercised-14, be-13)
root(ROOT-0, exercised-14)
advmod(coadministered-18, when-15)
nsubjpass(coadministered-18, PLETAL-16)
auxpass(coadministered-18, is-17)
advcl(exercised-14, coadministered-18)
prep_with(coadministered-18, inhibitors-20)
prep_of(inhibitors-20, C.P.A.-22)
prep_such_as(inhibitors-20, ketoconazole-25)
conj_and(ketoconazole-25, erythromycin-27)
conj_or(inhibitors-20, inhibitors-29)
prep_of(inhibitors-29, CYP2C19-31)
prep_such_as(inhibitors-29, omeprazole-34)

Pharmacokinetic/JJ studies/NNS have/VBP demonstrated/VBN that/IN omeprazole/NN and/CC erythromycin/NN significantly/RB increased/VBD the/DT systemic/JJ exposure/NN of/IN cilostazol/NN and/or/CC its/PRP$ major/JJ metabolites/NNS ./.

(ROOT (S1 (S (S (NP (JJ Pharmacokinetic) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (NN omeprazole)) (CC and) (NP (NN erythromycin))) (ADVP (RB significantly)) (VP (VBD increased) (NP (NP (NP (DT the) (JJ systemic) (NN exposure)) (PP (IN of) (NP (NN cilostazol)))) (CC and/or) (NP (PRP$ its) (JJ major) (NNS metabolites))))))))) (. .))))

amod(studies-2, Pharmacokinetic-1)
nsubj(demonstrated-4, studies-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
complm(increased-10, that-5)
nsubj(increased-10, omeprazole-6)
conj_and(omeprazole-6, erythromycin-8)
advmod(increased-10, significantly-9)
ccomp(demonstrated-4, increased-10)
det(exposure-13, the-11)
amod(exposure-13, systemic-12)
dobj(increased-10, exposure-13)
prep_of(exposure-13, cilostazol-15)
poss(metabolites-19, its-17)
amod(metabolites-19, major-18)
conj_and/or(exposure-13, metabolites-19)

Population/NN pharmacokinetic/JJ studies/NNS showed/VBD higher/JJR concentrations/NNS of/IN cilostazol/NN among/IN patients/NNS concurrently/RB treated/VBN with/IN diltiazem/NN ,/, an/DT inhibitor/NN of/IN C.P.A./NN ./.

(ROOT (S1 (S (S (NP (NN Population) (JJ pharmacokinetic) (NNS studies)) (VP (VBD showed) (NP (NP (JJR higher) (NNS concentrations)) (PP (IN of) (NP (NN cilostazol)))) (PP (IN among) (NP (NP (NNS patients)) (VP (ADVP (RB concurrently)) (VBN treated) (PP (IN with) (NP (NP (NN diltiazem)) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN C.P.A.))))))))))) (. .))))

nn(studies-3, Population-1)
amod(studies-3, pharmacokinetic-2)
nsubj(showed-4, studies-3)
root(ROOT-0, showed-4)
amod(concentrations-6, higher-5)
dobj(showed-4, concentrations-6)
prep_of(concentrations-6, cilostazol-8)
prep_among(showed-4, patients-10)
advmod(treated-12, concurrently-11)
partmod(patients-10, treated-12)
prep_with(treated-12, diltiazem-14)
det(inhibitor-17, an-16)
appos(diltiazem-14, inhibitor-17)
prep_of(inhibitor-17, C.P.A.-19)

Pletal/NN does/VBZ not/RB ,/, however/RB ,/, appear/VBP to/TO cause/VB increased/VBN blood/NN levels/NNS of/IN drugs/NNS metabolized/VBN by/IN CYP3A4/NN ,/, as/IN it/PRP had/VBD no/DT effect/NN on/IN lovastatin/NN ,/, a/DT drug/NN with/IN metabolism/NN very/RB sensitive/JJ to/TO C.P.A./NN inhibition/NN ./.

(ROOT (S1 (S (S (NP (NN Pletal)) (VP (VBZ does) (RB not))) (, ,) (ADVP (RB however)) (, ,) (VP (VBP appear) (S (VP (TO to) (VP (VB cause) (NP (NP (VBN increased) (NN blood) (NNS levels)) (PP (IN of) (NP (NP (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP3A4)))))))))) (, ,) (SBAR (IN as) (S (NP (PRP it)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN lovastatin)) (, ,) (NP (NP (DT a) (NN drug)) (PP (IN with) (NP (NP (NN metabolism)) (ADJP (RB very) (JJ sensitive) (PP (TO to) (NP (NN C.P.A.) (NN inhibition))))))))))))) (. .))))

nsubj(does-2, Pletal-1)
ccomp(appear-7, does-2)
neg(does-2, not-3)
advmod(appear-7, however-5)
root(ROOT-0, appear-7)
aux(cause-9, to-8)
xcomp(appear-7, cause-9)
amod(levels-12, increased-10)
nn(levels-12, blood-11)
dobj(cause-9, levels-12)
prep_of(levels-12, drugs-14)
partmod(drugs-14, metabolized-15)
agent(metabolized-15, CYP3A4-17)
mark(had-21, as-19)
nsubj(had-21, it-20)
advcl(appear-7, had-21)
det(effect-23, no-22)
dobj(had-21, effect-23)
prep_on(had-21, lovastatin-25)
det(drug-28, a-27)
appos(lovastatin-25, drug-28)
prep_with(drug-28, metabolism-30)
advmod(sensitive-32, very-31)
amod(metabolism-30, sensitive-32)
nn(inhibition-35, C.P.A.-34)
prep_to(sensitive-32, inhibition-35)

Tagamet/NN ,/, apparently/RB through/IN an/DT effect/NN on/IN certain/JJ microsomal/JJ enzyme/NN systems/NNS ,/, has/VBZ been/VBN reported/VBN to/TO reduce/VB the/DT hepatic/JJ metabolism/NN of/IN warfarin-type/JJ anticoagulants/NNS ,/, phenytoin/NN ,/, propranolol/NN ,/, nifedipine/NN ,/, chlordiazepoxide/NN ,/, diazepam/NN ,/, certain/JJ tricyclic/JJ antidepressants/NNS ,/, lidocaine/NN ,/, theophylline/NN and/CC metronidazole/NN ,/, thereby/RB delaying/VBG elimination/NN and/CC increasing/VBG blood/NN levels/NNS of/IN these/DT drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Tagamet)) (, ,) (ADVP (RB apparently)) (PP (IN through) (NP (NP (DT an) (NN effect)) (PP (IN on) (NP (JJ certain) (JJ microsomal) (NN enzyme) (NNS systems))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB reduce) (NP (NP (DT the) (JJ hepatic) (NN metabolism)) (PP (IN of) (NP (NP (JJ warfarin-type) (NNS anticoagulants)) (, ,) (NP (NP (NN phenytoin)) (, ,) (NP (NN propranolol)) (, ,) (NP (NN nifedipine)) (, ,) (NP (NN chlordiazepoxide)) (, ,) (NP (NN diazepam)) (, ,) (NP (JJ certain) (JJ tricyclic) (NNS antidepressants)) (, ,) (NP (NN lidocaine)) (, ,) (NP (NN theophylline)) (CC and) (NP (NN metronidazole))))))))))) (, ,) (S (ADVP (RB thereby)) (VP (VP (VBG delaying) (NP (NN elimination))) (CC and) (VP (VBG increasing) (NP (NP (NN blood) (NNS levels)) (PP (IN of) (NP (DT these) (NNS drugs))))))))) (. .))))

nsubjpass(reported-15, Tagamet-1)
xsubj(reduce-17, Tagamet-1)
advmod(Tagamet-1, apparently-3)
det(effect-6, an-5)
prep_through(Tagamet-1, effect-6)
amod(systems-11, certain-8)
amod(systems-11, microsomal-9)
nn(systems-11, enzyme-10)
prep_on(effect-6, systems-11)
aux(reported-15, has-13)
auxpass(reported-15, been-14)
root(ROOT-0, reported-15)
aux(reduce-17, to-16)
xcomp(reported-15, reduce-17)
det(metabolism-20, the-18)
amod(metabolism-20, hepatic-19)
dobj(reduce-17, metabolism-20)
amod(anticoagulants-23, warfarin-type-22)
prep_of(metabolism-20, anticoagulants-23)
appos(anticoagulants-23, phenytoin-25)
conj_and(phenytoin-25, propranolol-27)
conj_and(phenytoin-25, nifedipine-29)
conj_and(phenytoin-25, chlordiazepoxide-31)
conj_and(phenytoin-25, diazepam-33)
amod(antidepressants-37, certain-35)
amod(antidepressants-37, tricyclic-36)
conj_and(phenytoin-25, antidepressants-37)
conj_and(phenytoin-25, lidocaine-39)
conj_and(phenytoin-25, theophylline-41)
conj_and(phenytoin-25, metronidazole-43)
advmod(delaying-46, thereby-45)
ccomp(reported-15, delaying-46)
dobj(delaying-46, elimination-47)
conj_and(delaying-46, increasing-49)
nn(levels-51, blood-50)
dobj(increasing-49, levels-51)
det(drugs-54, these-53)
prep_of(levels-51, drugs-54)

Clinically/RB significant/JJ effects/NNS have/VBP been/VBN reported/VBN with/IN the/DT warfarin/JJ anticoagulants/NNS ;/: ./.

(ROOT (S1 (S (S (NP (ADJP (RB Clinically) (JJ significant)) (NNS effects)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (DT the) (JJ warfarin) (NNS anticoagulants)))))) (: ;)) (. .))))

advmod(significant-2, Clinically-1)
amod(effects-3, significant-2)
nsubjpass(reported-6, effects-3)
aux(reported-6, have-4)
auxpass(reported-6, been-5)
root(ROOT-0, reported-6)
det(anticoagulants-10, the-8)
amod(anticoagulants-10, warfarin-9)
prep_with(reported-6, anticoagulants-10)

therefore/RB ,/, close/JJ monitoring/NN of/IN prothrombin/NN time/NN is/VBZ recommended/VBN ,/, and/CC adjustment/NN of/IN the/DT anticoagulant/JJ dose/NN may/MD be/VB necessary/JJ when/WRB Tagamet/NN is/VBZ administered/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (S (ADVP (RB therefore)) (, ,) (NP (NP (JJ close) (NN monitoring)) (PP (IN of) (NP (NN prothrombin) (NN time)))) (VP (VBZ is) (VP (VBN recommended)))) (, ,) (CC and) (S (NP (NP (NN adjustment)) (PP (IN of) (NP (DT the) (JJ anticoagulant) (NN dose)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary) (SBAR (WHADVP (WRB when)) (S (NP (NN Tagamet)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concomitantly))))))))))) (. .))))

advmod(recommended-9, therefore-1)
amod(monitoring-4, close-3)
nsubjpass(recommended-9, monitoring-4)
nn(time-7, prothrombin-6)
prep_of(monitoring-4, time-7)
auxpass(recommended-9, is-8)
root(ROOT-0, recommended-9)
nsubj(necessary-19, adjustment-12)
det(dose-16, the-14)
amod(dose-16, anticoagulant-15)
prep_of(adjustment-12, dose-16)
aux(necessary-19, may-17)
cop(necessary-19, be-18)
conj_and(recommended-9, necessary-19)
advmod(administered-23, when-20)
nsubjpass(administered-23, Tagamet-21)
auxpass(administered-23, is-22)
dep(necessary-19, administered-23)
advmod(administered-23, concomitantly-24)

Interaction/NN with/IN phenytoin/NN ,/, lidocaine/NN and/CC theophylline/NN has/VBZ also/RB been/VBN reported/VBN to/TO produce/VB adverse/JJ clinical/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Interaction)) (PP (IN with) (NP (NP (NN phenytoin)) (, ,) (NP (NN lidocaine)) (CC and) (NP (NN theophylline))))) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB produce) (NP (JJ adverse) (JJ clinical) (NNS effects))))))))) (. .))))

nsubjpass(reported-11, Interaction-1)
xsubj(produce-13, Interaction-1)
prep_with(Interaction-1, phenytoin-3)
conj_and(phenytoin-3, lidocaine-5)
conj_and(phenytoin-3, theophylline-7)
aux(reported-11, has-8)
advmod(reported-11, also-9)
auxpass(reported-11, been-10)
root(ROOT-0, reported-11)
aux(produce-13, to-12)
xcomp(reported-11, produce-13)
amod(effects-16, adverse-14)
amod(effects-16, clinical-15)
dobj(produce-13, effects-16)

However/RB ,/, a/DT crossover/NN study/NN in/IN healthy/JJ subjects/NNS receiving/VBG either/CC Tagamet/NN 300/CD mg/NN q.i.d./CD or/CC 800/CD mg/NN h.s./VBG concomitantly/RB with/IN a/DT 300/CD mg/NN b.i.d./NN dosage/NN of/IN theophylline/NN (/-LRB- Theo-Dur/NN @/NN ,/, Key/JJ Pharmaceuticals/NNP ,/, Inc./NNP )/-RRB- demonstrated/VBD less/RBR alteration/NN in/IN steady-state/JJ theophylline/NN peak/NN serum/NN levels/NNS with/IN the/DT 800/CD mg/NN h.s./NN regimen/NN ,/, particularly/RB in/IN subjects/NNS aged/JJ 54/CD years/NNS and/CC older/JJR ./.

(ROOT (S1 (S (ADVP (RB However)) (, ,) (NP (NP (DT a) (NN crossover) (NN study)) (PP (IN in) (NP (NP (JJ healthy) (NNS subjects)) (VP (VBG receiving) (NP (CC either) (NP (NN Tagamet) (CD 300) (NN mg) (CD q.i.d.)) (CC or) (NP (NP (CD 800) (NN mg)) (VP (VBG h.s.) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NP (DT a) (ADJP (CD 300) (NN mg)) (NN b.i.d.)) (NN dosage)) (PP (IN of) (NP (NP (NN theophylline)) (PRN (-LRB- -LRB-) (NP (NP (NN Theo-Dur) (NN @)) (, ,) (NP (JJ Key) (NP (NNP Pharmaceuticals) (, ,) (NNP Inc.)))) (-RRB- -RRB-))))))))))))) (VP (VBD demonstrated) (NP (RBR less) (NN alteration)) (PP (IN in) (NP (NP (JJ steady-state) (NN theophylline) (NN peak) (NN serum) (NNS levels)) (PP (IN with) (NP (DT the) (ADJP (CD 800) (NN mg)) (NN h.s.) (NN regimen))))) (, ,) (PP (ADVP (RB particularly)) (IN in) (NP (NP (NNS subjects)) (ADJP (JJ aged) (NP (NP (CD 54) (NNS years)) (CC and) (NP (JJR older))))))) (. .))))

advmod(demonstrated-37, However-1)
det(study-5, a-3)
nn(study-5, crossover-4)
nsubj(demonstrated-37, study-5)
amod(subjects-8, healthy-7)
prep_in(study-5, subjects-8)
partmod(subjects-8, receiving-9)
preconj(mg-13, either-10)
nn(mg-13, Tagamet-11)
num(mg-13, 300-12)
dobj(receiving-9, mg-13)
num(mg-13, q.i.d.-14)
num(mg-17, 800-16)
conj_or(mg-13, mg-17)
partmod(mg-17, h.s.-18)
advmod(h.s.-18, concomitantly-19)
det(b.i.d.-24, a-21)
number(mg-23, 300-22)
amod(b.i.d.-24, mg-23)
nn(dosage-25, b.i.d.-24)
prep_with(h.s.-18, dosage-25)
prep_of(dosage-25, theophylline-27)
nn(@-30, Theo-Dur-29)
dep(theophylline-27, @-30)
amod(Inc.-35, Key-32)
nn(Inc.-35, Pharmaceuticals-33)
appos(@-30, Inc.-35)
root(ROOT-0, demonstrated-37)
advmod(alteration-39, less-38)
dobj(demonstrated-37, alteration-39)
amod(levels-45, steady-state-41)
nn(levels-45, theophylline-42)
nn(levels-45, peak-43)
nn(levels-45, serum-44)
prep_in(demonstrated-37, levels-45)
det(regimen-51, the-47)
number(mg-49, 800-48)
amod(regimen-51, mg-49)
nn(regimen-51, h.s.-50)
prep_with(levels-45, regimen-51)
advmod(demonstrated-37, particularly-53)
prep_in(demonstrated-37, subjects-55)
amod(subjects-55, aged-56)
num(years-58, 54-57)
dep(aged-56, years-58)
conj_and(years-58, older-60)

(/-LRB- Note/NN :/: All/DT patients/NNS receiving/VBG theophylline/NN should/MD be/VB monitored/VBN appropriately/RB ,/, regardless/RB of/IN concomitant/JJ drug/NN therapy./NN )/-RRB- ./.

(ROOT (S1 (S (S (PRN (-LRB- -LRB-) (NP (NP (NN Note)) (: :) (S (NP (NP (DT All) (NNS patients)) (VP (VBG receiving) (NP (NN theophylline)))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB appropriately)) (, ,) (ADVP (RB regardless) (PP (IN of) (NP (JJ concomitant) (NN drug) (NN therapy.))))))))) (-RRB- -RRB-))) (. .))))

root(ROOT-0, Note-2)
det(patients-5, All-4)
nsubjpass(monitored-10, patients-5)
partmod(patients-5, receiving-6)
dobj(receiving-6, theophylline-7)
aux(monitored-10, should-8)
auxpass(monitored-10, be-9)
dep(Note-2, monitored-10)
advmod(monitored-10, appropriately-11)
amod(therapy.-17, concomitant-15)
nn(therapy.-17, drug-16)
prep_regardless_of(monitored-10, therapy.-17)

Dosage/NN of/IN the/DT drugs/NNS mentioned/VBN above/RB and/CC other/JJ similarly/RB metabolized/VBN drugs/NNS ,/, particularly/RB those/DT of/IN low/JJ therapeutic/JJ ratio/NN or/CC in/IN patients/NNS with/IN renal/JJ and/or/CC hepatic/JJ impairment/NN ,/, may/MD require/VB adjustment/NN when/WRB starting/VBG or/CC stopping/VBG concomitantly/RB administered/VBN Tagamet/NN to/TO maintain/VB optimum/JJ therapeutic/JJ blood/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Dosage)) (PP (IN of) (NP (NP (NP (DT the) (NNS drugs)) (VP (VBN mentioned) (ADVP (RB above)))) (CC and) (NP (NP (JJ other) (ADJP (RB similarly) (VBN metabolized)) (NNS drugs)) (, ,) (NP (NP (RB particularly) (DT those)) (PP (PP (IN of) (NP (JJ low) (JJ therapeutic) (NN ratio))) (CC or) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (ADJP (JJ renal)) (CC and/or) (ADJP (JJ hepatic))) (NN impairment))))))) (, ,))))) (VP (MD may) (VP (VB require) (NP (NP (NN adjustment)) (SBAR (WHADVP (WRB when)) (S (VP (VP (VBG starting)) (CC or) (VP (VBG stopping) (NP (NP (ADJP (RB concomitantly) (VBN administered)) (NN Tagamet)) (S (VP (TO to) (VP (VB maintain) (NP (JJ optimum) (JJ therapeutic) (NN blood) (NNS levels)))))))))))))) (. .))))

nsubj(require-29, Dosage-1)
det(drugs-4, the-3)
prep_of(Dosage-1, drugs-4)
partmod(drugs-4, mentioned-5)
advmod(mentioned-5, above-6)
amod(drugs-11, other-8)
advmod(metabolized-10, similarly-9)
amod(drugs-11, metabolized-10)
conj_and(drugs-4, drugs-11)
advmod(those-14, particularly-13)
appos(drugs-11, those-14)
conj_or(those-14, those-14')
amod(ratio-18, low-16)
amod(ratio-18, therapeutic-17)
prep_of(those-14, ratio-18)
prep_in(those-14', patients-21)
amod(impairment-26, renal-23)
conj_and/or(renal-23, hepatic-25)
prep_with(patients-21, impairment-26)
aux(require-29, may-28)
root(ROOT-0, require-29)
dobj(require-29, adjustment-30)
advmod(starting-32, when-31)
dep(adjustment-30, starting-32)
conj_or(starting-32, stopping-34)
advmod(administered-36, concomitantly-35)
amod(Tagamet-37, administered-36)
dobj(stopping-34, Tagamet-37)
aux(maintain-39, to-38)
infmod(Tagamet-37, maintain-39)
amod(levels-43, optimum-40)
amod(levels-43, therapeutic-41)
nn(levels-43, blood-42)
dobj(maintain-39, levels-43)

Alteration/NN of/IN pH/NN may/MD affect/VB absorption/NN of/IN certain/JJ drugs/NNS (/-LRB- e.g./FW ,/, ketoconazole/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (NN Alteration)) (PP (IN of) (NP (NN pH)))) (VP (MD may) (VP (VB affect) (NP (NP (NN absorption)) (PP (IN of) (NP (NP (JJ certain) (NNS drugs)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN ketoconazole))) (-RRB- -RRB-)))))))) (. .))))

nsubj(affect-5, Alteration-1)
prep_of(Alteration-1, pH-3)
aux(affect-5, may-4)
root(ROOT-0, affect-5)
dobj(affect-5, absorption-6)
amod(drugs-9, certain-8)
prep_of(absorption-6, drugs-9)
dep(drugs-9, e.g.-11)
pobj(e.g.-11, ketoconazole-13)

If/IN these/DT products/NNS are/VBP needed/VBN ,/, they/PRP should/MD be/VB given/VBN at/IN least/JJS 2/CD hours/NNS before/IN cimetidine/NN administration/NN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (DT these) (NNS products)) (VP (VBP are) (VP (VBN needed))))) (, ,) (NP (PRP they)) (VP (MD should) (VP (VB be) (VP (VBN given) (NP (QP (IN at) (JJS least) (CD 2)) (NNS hours)) (PP (IN before) (NP (NN cimetidine) (NN administration))))))) (. .))))

mark(needed-5, If-1)
det(products-3, these-2)
nsubjpass(needed-5, products-3)
auxpass(needed-5, are-4)
advcl(given-10, needed-5)
nsubjpass(given-10, they-7)
aux(given-10, should-8)
auxpass(given-10, be-9)
root(ROOT-0, given-10)
quantmod(2-13, at-11)
mwe(at-11, least-12)
pobj(at-11, least-12)
num(hours-14, 2-13)
dobj(given-10, hours-14)
nn(administration-17, cimetidine-16)
prep_before(given-10, administration-17)

Additional/JJ clinical/JJ experience/VBP may/MD reveal/VBP other/JJ drugs/NNS affected/VBN by/IN the/DT concomitant/JJ administration/NN of/IN Tagamet/NN ./.

(ROOT (S1 (S (S (NP (JJ Additional) (JJ clinical) (VBP experience)) (VP (MD may) (VP (VBP reveal) (NP (NP (JJ other) (NNS drugs)) (VP (VBN affected) (PP (IN by) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN Tagamet)))))))))) (. .))))

amod(clinical-2, Additional-1)
nsubj(reveal-5, clinical-2)
dep(clinical-2, experience-3)
aux(reveal-5, may-4)
root(ROOT-0, reveal-5)
amod(drugs-7, other-6)
dobj(reveal-5, drugs-7)
partmod(drugs-7, affected-8)
det(administration-12, the-10)
amod(administration-12, concomitant-11)
agent(affected-8, administration-12)
prep_of(administration-12, Tagamet-14)

and/or/CC Drug/NN /Laboratory/NN Test/NN Interactions/NNS See/VB CLINICAL/JJ PHARMACOLOGY/NN ,/, Pharmacokinetics/NNS and/CC Drug/NN Interactions/NNS ./.

(ROOT (S1 (S (S (NP (CC and/or) (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (VP (VB See) (NP (NP (JJ CLINICAL) (NN PHARMACOLOGY)) (, ,) (NP (NNS Pharmacokinetics)) (CC and) (NP (NN Drug) (NNS Interactions))))) (. .))))

cc(Interactions-5, and/or-1)
nn(Interactions-5, Drug-2)
nn(Interactions-5, /Laboratory-3)
nn(Interactions-5, Test-4)
nsubj(See-6, Interactions-5)
root(ROOT-0, See-6)
amod(PHARMACOLOGY-8, CLINICAL-7)
dobj(See-6, PHARMACOLOGY-8)
conj_and(PHARMACOLOGY-8, Pharmacokinetics-10)
nn(Interactions-13, Drug-12)
conj_and(PHARMACOLOGY-8, Interactions-13)

Effect/NN of/IN Sensipar/NN on/IN other/JJ drugs/NNS :/: Drugs/NNS metabolized/VBN by/IN cytochrome/NN P450/NN 2D6/NN (/-LRB- CYP2D6/NN )/-RRB- :/: Sensipar/NN @/NN is/VBZ a/DT strong/JJ in/FW vitro/FW inhibitor/NN of/IN CYP2D6/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Effect)) (PP (IN of) (NP (NN Sensipar))) (PP (IN on) (NP (NP (JJ other) (NNS drugs)) (: :) (NP (NP (NNS Drugs)) (VP (VBN metabolized) (PP (IN by) (NP (NP (NN cytochrome) (NN P450) (NN 2D6)) (PRN (-LRB- -LRB-) (NP (NN CYP2D6)) (-RRB- -RRB-)))))) (: :) (NP (NN Sensipar) (NN @))))) (VP (VBZ is) (NP (NP (DT a) (ADJP (ADJP (JJ strong)) (ADJP (FW in) (FW vitro))) (NN inhibitor)) (PP (IN of) (NP (NN CYP2D6)))))) (. .))))

nsubj(inhibitor-25, Effect-1)
prep_of(Effect-1, Sensipar-3)
amod(drugs-6, other-5)
prep_on(Effect-1, drugs-6)
dep(drugs-6, Drugs-8)
partmod(Drugs-8, metabolized-9)
nn(2D6-13, cytochrome-11)
nn(2D6-13, P450-12)
agent(metabolized-9, 2D6-13)
abbrev(2D6-13, CYP2D6-15)
nn(@-19, Sensipar-18)
dep(drugs-6, @-19)
cop(inhibitor-25, is-20)
det(inhibitor-25, a-21)
amod(inhibitor-25, strong-22)
nn(vitro-24, in-23)
dep(strong-22, vitro-24)
root(ROOT-0, inhibitor-25)
prep_of(inhibitor-25, CYP2D6-27)

Therefore/RB ,/, dose/NN adjustments/NNS of/IN concomitant/JJ medications/NNS that/WDT are/VBP predominantly/RB metabolized/VBN by/IN CYP2D6/NN and/CC have/VBP a/DT narrow/JJ therapeutic/JJ index/NN (/-LRB- e.g./FW ,/, flecainide/NN ,/, vinblastine/NN ,/, thioridazine/NN and/CC most/JJ tricyclic/JJ antidepressants/NNS )/-RRB- may/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN dose) (NNS adjustments)) (PP (IN of) (NP (NP (JJ concomitant) (NNS medications)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBP are) (ADVP (RB predominantly)) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP2D6))))) (CC and) (VP (VBP have) (NP (NP (DT a) (JJ narrow) (JJ therapeutic) (NN index)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN flecainide)) (, ,) (NP (NN vinblastine)) (, ,) (NP (NN thioridazine)) (CC and) (NP (JJ most) (JJ tricyclic) (NNS antidepressants)))) (-RRB- -RRB-)))))))))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (. .))))

advmod(required-35, Therefore-1)
nn(adjustments-4, dose-3)
nsubjpass(required-35, adjustments-4)
amod(medications-7, concomitant-6)
prep_of(adjustments-4, medications-7)
nsubjpass(metabolized-11, medications-7)
auxpass(metabolized-11, are-9)
advmod(metabolized-11, predominantly-10)
rcmod(medications-7, metabolized-11)
agent(metabolized-11, CYP2D6-13)
conj_and(metabolized-11, have-15)
det(index-19, a-16)
amod(index-19, narrow-17)
amod(index-19, therapeutic-18)
dobj(have-15, index-19)
dep(index-19, e.g.-21)
pobj(e.g.-21, flecainide-23)
conj_and(flecainide-23, vinblastine-25)
conj_and(flecainide-23, thioridazine-27)
amod(antidepressants-31, most-29)
amod(antidepressants-31, tricyclic-30)
conj_and(flecainide-23, antidepressants-31)
aux(required-35, may-33)
auxpass(required-35, be-34)
root(ROOT-0, required-35)

Amitriptyline/NN :/: Concurrent/JJ administration/NN of/IN 25/CD mg/NN or/CC 100/CD mg/NN cinacalcet/NN with/IN 50/CD mg/NN amitriptyline/NN increased/VBD amitriptyline/NN exposure/NN and/CC nortriptyline/NN (/-LRB- active/JJ metabolite/NN )/-RRB- exposure/NN by/IN approximately/RB 20/CD %/NN in/IN CYP2D6/NN extensive/JJ metabolizers/NNS ./.

(ROOT (S1 (S (NP (NP (NN Amitriptyline)) (: :) (S (NP (NP (JJ Concurrent) (NN administration)) (PP (IN of) (NP (ADJP (ADJP (CD 25) (NN mg)) (CC or) (ADJP (CD 100) (NN mg))) (NN cinacalcet))) (PP (IN with) (NP (ADJP (CD 50) (NN mg)) (NN amitriptyline)))) (VP (VBD increased) (NP (NP (NN amitriptyline) (NN exposure)) (CC and) (NP (NP (NN nortriptyline)) (PRN (-LRB- -LRB-) (NP (JJ active) (NN metabolite)) (-RRB- -RRB-))) (NP (NN exposure))) (PP (IN by) (NP (QP (RB approximately) (CD 20)) (NN %))) (PP (IN in) (NP (NN CYP2D6) (JJ extensive) (NNS metabolizers))))) (. .)))))

root(ROOT-0, Amitriptyline-1)
amod(administration-4, Concurrent-3)
nsubj(increased-16, administration-4)
number(mg-7, 25-6)
amod(cinacalcet-11, mg-7)
number(mg-10, 100-9)
conj_or(mg-7, mg-10)
prep_of(administration-4, cinacalcet-11)
number(mg-14, 50-13)
amod(amitriptyline-15, mg-14)
prep_with(administration-4, amitriptyline-15)
dep(Amitriptyline-1, increased-16)
nn(exposure-18, amitriptyline-17)
dobj(increased-16, exposure-18)
conj_and(exposure-18, nortriptyline-20)
amod(metabolite-23, active-22)
appos(nortriptyline-20, metabolite-23)
dobj(increased-16, exposure-25)
dep(exposure-18, exposure-25)
quantmod(20-28, approximately-27)
num(%-29, 20-28)
prep_by(increased-16, %-29)
nn(metabolizers-33, CYP2D6-31)
amod(metabolizers-33, extensive-32)
prep_in(increased-16, metabolizers-33)

Effect/NN of/IN other/JJ drugs/NNS on/IN Sensipar/NN :/: Sensipar/NN @/NN is/VBZ metabolized/VBN by/IN multiple/JJ cytochrome/NN P450/NN enzymes/NNS ,/, primarily/RB CYP3A4/NN ,/, CYP2D6/NN ,/, and/CC CYP1A2/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Effect)) (PP (IN of) (NP (JJ other) (NNS drugs))) (PP (IN on) (NP (NN Sensipar) (: :) (NN Sensipar) (NN @)))) (VP (VBZ is) (VP (VBN metabolized) (PP (IN by) (NP (NP (JJ multiple) (NN cytochrome) (NN P450) (NNS enzymes)) (, ,) (ADVP (RB primarily)) (NP (NP (NN CYP3A4)) (, ,) (NP (NN CYP2D6)) (, ,) (CC and) (NP (NN CYP1A2)))))))) (. .))))

nsubjpass(metabolized-11, Effect-1)
amod(drugs-4, other-3)
prep_of(Effect-1, drugs-4)
nn(@-9, Sensipar-6)
nn(@-9, Sensipar-8)
prep_on(Effect-1, @-9)
auxpass(metabolized-11, is-10)
root(ROOT-0, metabolized-11)
amod(enzymes-16, multiple-13)
nn(enzymes-16, cytochrome-14)
nn(enzymes-16, P450-15)
agent(metabolized-11, enzymes-16)
advmod(enzymes-16, primarily-18)
dep(enzymes-16, CYP3A4-19)
conj_and(CYP3A4-19, CYP2D6-21)
conj_and(CYP3A4-19, CYP1A2-24)

Ketoconazole/NN :/: Sensipar/NN is/VBZ metabolized/VBN in/IN part/NN by/IN CYP3A4/NN ./.

(ROOT (S1 (S (NP (NP (NN Ketoconazole)) (: :) (S (NP (NN Sensipar)) (VP (VBZ is) (VP (VBN metabolized) (PP (IN in) (NP (NN part))) (PP (IN by) (NP (NN CYP3A4)))))) (. .)))))

root(ROOT-0, Ketoconazole-1)
nsubjpass(metabolized-5, Sensipar-3)
auxpass(metabolized-5, is-4)
dep(Ketoconazole-1, metabolized-5)
prep_in(metabolized-5, part-7)
agent(metabolized-5, CYP3A4-9)

Co-administration/NN of/IN ketoconazole/NN ,/, a/DT strong/JJ inhibitor/NN of/IN CYP3A4/NN ,/, increased/VBD cinacalcet/NN exposure/NN following/VBG a/DT single/JJ 90/CD mg/NN dose/NN of/IN Sensipar/NN by/IN 2.3/CD fold/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NP (NN ketoconazole)) (, ,) (NP (NP (DT a) (JJ strong) (NN inhibitor)) (PP (IN of) (NP (NN CYP3A4)))) (, ,)))) (VP (VBD increased) (PP (NP (NN cinacalcet) (NN exposure)) (VBG following) (NP (NP (DT a) (JJ single) (ADJP (CD 90) (NN mg)) (NN dose)) (PP (IN of) (NP (NP (NN Sensipar)) (PP (IN by) (NP (CD 2.3) (NN fold))))))))) (. .))))

nsubj(increased-11, Co-administration-1)
prep_of(Co-administration-1, ketoconazole-3)
det(inhibitor-7, a-5)
amod(inhibitor-7, strong-6)
appos(ketoconazole-3, inhibitor-7)
prep_of(inhibitor-7, CYP3A4-9)
root(ROOT-0, increased-11)
nn(exposure-13, cinacalcet-12)
dep(increased-11, exposure-13)
det(dose-19, a-15)
amod(dose-19, single-16)
number(mg-18, 90-17)
amod(dose-19, mg-18)
prep_following(increased-11, dose-19)
prep_of(dose-19, Sensipar-21)
num(fold-24, 2.3-23)
prep_by(Sensipar-21, fold-24)

Dose/NN adjustment/NN of/IN Sensipar/NN may/MD be/VB required/VBN and/CC PTH/NN and/CC serum/NN calcium/NN concentrations/NNS should/MD be/VB closely/RB monitored/VBN if/IN a/DT patient/NN initiates/VBZ or/CC discontinues/VBZ therapy/NN with/IN a/DT strong/JJ CYP3A4/NN inhibitor/NN (/-LRB- e.g./FW ,/, ketoconazole/NN ,/, erythromycin/NN ,/, itraconazole/NN ;/: ./.

(ROOT (S1 (S (S (S (NP (NP (NN Dose) (NN adjustment)) (PP (IN of) (NP (NN Sensipar)))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (CC and) (S (NP (NN PTH) (CC and) (NN serum) (NN calcium) (NNS concentrations)) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN monitored) (SBAR (IN if) (S (NP (DT a) (NN patient)) (VP (VP (VBZ initiates)) (CC or) (VP (VBZ discontinues) (NP (NP (NN therapy)) (PP (IN with) (NP (NP (DT a) (JJ strong) (NN CYP3A4) (NN inhibitor)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN ketoconazole)) (, ,) (NP (NN erythromycin)) (, ,) (NP (NN itraconazole)) (: ;))))))))))))))) (. .))))

nn(adjustment-2, Dose-1)
nsubjpass(required-7, adjustment-2)
prep_of(adjustment-2, Sensipar-4)
aux(required-7, may-5)
auxpass(required-7, be-6)
root(ROOT-0, required-7)
nn(concentrations-13, PTH-9)
conj_and(PTH-9, serum-11)
nn(concentrations-13, calcium-12)
nsubjpass(monitored-17, concentrations-13)
aux(monitored-17, should-14)
auxpass(monitored-17, be-15)
advmod(monitored-17, closely-16)
conj_and(required-7, monitored-17)
mark(initiates-21, if-18)
det(patient-20, a-19)
nsubj(initiates-21, patient-20)
advcl(monitored-17, initiates-21)
conj_or(initiates-21, discontinues-23)
dobj(discontinues-23, therapy-24)
det(inhibitor-29, a-26)
amod(inhibitor-29, strong-27)
nn(inhibitor-29, CYP3A4-28)
prep_with(therapy-24, inhibitor-29)
dep(ketoconazole-33, e.g.-31)
dep(inhibitor-29, ketoconazole-33)
appos(ketoconazole-33, erythromycin-35)
appos(ketoconazole-33, itraconazole-37)

Some/DT quinolones/NNS ,/, including/VBG ciprofloxacin/NN ,/, have/VBP also/RB been/VBN shown/VBN to/TO interfere/VB with/IN the/DT metabolism/NN of/IN caffeine/NN ./.

(ROOT (S1 (S (S (NP (NP (DT Some) (NNS quinolones)) (, ,) (PP (VBG including) (NP (NN ciprofloxacin))) (, ,)) (VP (VBP have) (ADVP (RB also)) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN caffeine)))))))))))) (. .))))

det(quinolones-2, Some-1)
nsubjpass(shown-10, quinolones-2)
xsubj(interfere-12, quinolones-2)
prep_including(quinolones-2, ciprofloxacin-5)
aux(shown-10, have-7)
advmod(shown-10, also-8)
auxpass(shown-10, been-9)
root(ROOT-0, shown-10)
aux(interfere-12, to-11)
xcomp(shown-10, interfere-12)
det(metabolism-15, the-14)
prep_with(interfere-12, metabolism-15)
prep_of(metabolism-15, caffeine-17)

This/DT may/MD lead/VB to/TO reduced/VBN clearance/NN of/IN caffeine/NN and/CC a/DT prolongation/NN of/IN its/PRP$ serum/NN half-life/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (NP (VBN reduced) (NN clearance)) (PP (IN of) (NP (NN caffeine)))) (CC and) (NP (NP (DT a) (NN prolongation)) (PP (IN of) (NP (PRP$ its) (NN serum) (NN half-life))))))))) (. .))))

nsubj(lead-3, This-1)
aux(lead-3, may-2)
root(ROOT-0, lead-3)
amod(clearance-6, reduced-5)
prep_to(lead-3, clearance-6)
prep_of(clearance-6, caffeine-8)
det(prolongation-11, a-10)
conj_and(clearance-6, prolongation-11)
poss(half-life-15, its-13)
nn(half-life-15, serum-14)
prep_of(prolongation-11, half-life-15)

Some/DT quinolones/NNS ,/, including/VBG ciprofloxacin/NN ,/, have/VBP been/VBN associated/VBN with/IN transient/JJ elevations/NNS in/IN serum/NN creatinine/NN in/IN patients/NNS receiving/VBG cyclosporine/NN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NP (DT Some) (NNS quinolones)) (, ,) (PP (VBG including) (NP (NN ciprofloxacin))) (, ,)) (VP (VBP have) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (JJ transient) (NNS elevations)) (PP (IN in) (NP (NP (NN serum) (NN creatinine)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN cyclosporine))))))))) (ADVP (RB concomitantly)))))) (. .))))

det(quinolones-2, Some-1)
nsubjpass(associated-9, quinolones-2)
prep_including(quinolones-2, ciprofloxacin-5)
aux(associated-9, have-7)
auxpass(associated-9, been-8)
root(ROOT-0, associated-9)
amod(elevations-12, transient-11)
prep_with(associated-9, elevations-12)
nn(creatinine-15, serum-14)
prep_in(elevations-12, creatinine-15)
prep_in(creatinine-15, patients-17)
partmod(patients-17, receiving-18)
dobj(receiving-18, cyclosporine-19)
advmod(associated-9, concomitantly-20)

Glyburide/NN :/: The/DT concomitant/JJ administration/NN of/IN ciprofloxacin/NN with/IN the/DT sulfonylurea/NN glyburide/NN has/VBZ ,/, on/IN rare/JJ occasions/NNS ,/, resulted/VBD in/IN severe/JJ hypoglycemia/NN ./.

(ROOT (S1 (S (NP (NP (NN Glyburide)) (: :) (S (NP (NP (DT The) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN ciprofloxacin))) (PP (IN with) (NP (DT the) (NN sulfonylurea) (NN glyburide)))) (VP (VBZ has) (, ,) (PP (IN on) (NP (JJ rare) (NNS occasions))) (, ,) (VP (VBD resulted) (PP (IN in) (NP (JJ severe) (NN hypoglycemia)))))) (. .)))))

root(ROOT-0, Glyburide-1)
det(administration-5, The-3)
amod(administration-5, concomitant-4)
nsubj(resulted-18, administration-5)
prep_of(administration-5, ciprofloxacin-7)
det(glyburide-11, the-9)
nn(glyburide-11, sulfonylurea-10)
prep_with(administration-5, glyburide-11)
aux(resulted-18, has-12)
amod(occasions-16, rare-15)
prep_on(resulted-18, occasions-16)
dep(Glyburide-1, resulted-18)
amod(hypoglycemia-21, severe-20)
prep_in(resulted-18, hypoglycemia-21)

Histamine/NN H2-receptor/NN antagonists/NNS Histamine/NN H2-receptor/NN antagonists/NNS appear/VBP to/TO have/VB no/DT significant/JJ effect/NN on/IN the/DT bioavailability/NN of/IN ciprofloxacin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Histamine) (NN H2-receptor) (NNS antagonists)) (NP (NN Histamine) (NN H2-receptor) (NNS antagonists))) (VP (VBP appear) (S (VP (TO to) (VP (VB have) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (NN ciprofloxacin)))))))))) (. .))))

nn(antagonists-3, Histamine-1)
nn(antagonists-3, H2-receptor-2)
nsubj(appear-7, antagonists-3)
xsubj(have-9, antagonists-3)
nn(antagonists-6, Histamine-4)
nn(antagonists-6, H2-receptor-5)
dep(antagonists-3, antagonists-6)
root(ROOT-0, appear-7)
aux(have-9, to-8)
xcomp(appear-7, have-9)
det(effect-12, no-10)
amod(effect-12, significant-11)
dobj(have-9, effect-12)
det(bioavailability-15, the-14)
prep_on(have-9, bioavailability-15)
prep_of(bioavailability-15, ciprofloxacin-17)

Methotrexate/NN Renal/JJ tubular/JJ transport/NN of/IN methotrexate/NN may/MD be/VB inhibited/VBN by/IN concomitant/JJ administration/NN of/IN ciprofloxacin/NN ,/, potentially/RB leading/VBG to/TO increased/VBN plasma/NN levels/NNS of/IN methotrexate/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Methotrexate) (JJ Renal) (JJ tubular) (NN transport)) (PP (IN of) (NP (NN methotrexate)))) (VP (MD may) (VP (VB be) (VP (VBN inhibited) (PP (IN by) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN ciprofloxacin))))) (, ,) (S (ADVP (RB potentially)) (VP (VBG leading) (PP (TO to) (NP (NP (VBN increased) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN methotrexate))))))))))) (. .))))

nn(transport-4, Methotrexate-1)
amod(transport-4, Renal-2)
amod(transport-4, tubular-3)
nsubjpass(inhibited-9, transport-4)
prep_of(transport-4, methotrexate-6)
aux(inhibited-9, may-7)
auxpass(inhibited-9, be-8)
root(ROOT-0, inhibited-9)
amod(administration-12, concomitant-11)
agent(inhibited-9, administration-12)
prep_of(administration-12, ciprofloxacin-14)
advmod(leading-17, potentially-16)
xcomp(inhibited-9, leading-17)
amod(levels-21, increased-19)
nn(levels-21, plasma-20)
prep_to(leading-17, levels-21)
prep_of(levels-21, methotrexate-23)

This/DT might/MD increase/VB the/DT risk/NN of/IN methotrexate/NN toxic/JJ reactions/NNS ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (MD might) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN methotrexate) (JJ toxic) (NNS reactions))))))) (. .))))

nsubj(increase-3, This-1)
aux(increase-3, might-2)
root(ROOT-0, increase-3)
det(risk-5, the-4)
dobj(increase-3, risk-5)
nn(reactions-9, methotrexate-7)
amod(reactions-9, toxic-8)
prep_of(risk-5, reactions-9)

Therefore/RB ,/, patients/NNS under/IN methotrexate/NN therapy/NN should/MD be/VB carefully/RB monitored/VBN when/WRB concomitant/JJ ciprofloxacin/NN therapy/NN is/VBZ indicated/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NNS patients)) (PP (IN under) (NP (NN methotrexate) (NN therapy)))) (VP (MD should) (VP (VB be) (ADVP (RB carefully)) (VP (VBN monitored))) (SBAR (WHADVP (WRB when)) (S (NP (JJ concomitant) (NN ciprofloxacin) (NN therapy)) (VP (VBZ is) (VP (VBN indicated))))))) (. .))))

advmod(monitored-10, Therefore-1)
nsubjpass(monitored-10, patients-3)
nn(therapy-6, methotrexate-5)
prep_under(patients-3, therapy-6)
aux(monitored-10, should-7)
auxpass(monitored-10, be-8)
advmod(monitored-10, carefully-9)
root(ROOT-0, monitored-10)
advmod(indicated-16, when-11)
amod(therapy-14, concomitant-12)
nn(therapy-14, ciprofloxacin-13)
nsubjpass(indicated-16, therapy-14)
auxpass(indicated-16, is-15)
advcl(monitored-10, indicated-16)

Multivalent/JJ Cation/NN -Containing/JJ Products/NNS Concurrent/JJ administration/NN of/IN a/DT quinolone/NN ,/, including/VBG ciprofloxacin/NN ,/, with/IN multivalent/JJ cation/NN -containing/JJ products/NNS such/JJ as/IN magnesium/NN or/CC aluminum/NN antacids/NNS ,/, sucralfate/NN ,/, VIDEX/NN chewable//NN buffer/NN ed/NN tablets/NNS or/CC pediatric/JJ powder/NN ,/, or/CC products/NNS containing/VBG calcium/NN ,/, iron/NN ,/, or/CC zinc/NN may/MD substantially/RB decrease/VB the/DT absorption/NN of/IN ciprofloxacin/NN ,/, resulting/VBG in/IN serum/NN and/CC urine/NN levels/NNS considerably/RB lower/JJR than/IN desired/JJ ./.

(ROOT (S1 (S (NP (NP (NP (JJ Multivalent) (NN Cation) (JJ -Containing) (NNS Products)) (NP (NP (NP (JJ Concurrent) (NN administration)) (PP (IN of) (NP (NP (DT a) (NN quinolone)) (, ,) (PP (VBG including) (NP (NN ciprofloxacin))) (, ,) (PP (IN with) (NP (NP (JJ multivalent) (NN cation) (JJ -containing) (NNS products)) (PP (JJ such) (IN as) (NP (NP (NP (NN magnesium)) (CC or) (NP (NN aluminum))) (NNS antacids)))))))) (, ,) (NP (NN sucralfate)) (, ,) (NP (NN VIDEX) (NN chewable/) (NN buffer) (NN ed) (NNS tablets)) (CC or) (NP (JJ pediatric) (NN powder)))) (, ,) (CC or) (NP (NP (NNS products)) (VP (VBG containing) (NP (NP (NN calcium)) (, ,) (NP (NN iron)) (, ,) (CC or) (NP (NN zinc)))))) (VP (MD may) (ADVP (RB substantially)) (VP (VB decrease) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NN ciprofloxacin)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NP (NP (NN serum)) (CC and) (NP (NN urine))) (NNS levels)) (ADJP (ADJP (RB considerably) (JJR lower)) (PP (IN than) (NP (JJ desired)))))))))) (. .))))

amod(Products-4, Multivalent-1)
nn(Products-4, Cation-2)
amod(Products-4, -Containing-3)
nsubj(decrease-48, Products-4)
amod(administration-6, Concurrent-5)
dep(Products-4, administration-6)
det(quinolone-9, a-8)
prep_of(administration-6, quinolone-9)
prep_including(quinolone-9, ciprofloxacin-12)
amod(products-18, multivalent-15)
nn(products-18, cation-16)
amod(products-18, -containing-17)
prep_with(quinolone-9, products-18)
nn(antacids-24, magnesium-21)
conj_or(magnesium-21, aluminum-23)
prep_such_as(products-18, antacids-24)
conj_or(administration-6, sucralfate-26)
nn(tablets-32, VIDEX-28)
nn(tablets-32, chewable/-29)
nn(tablets-32, buffer-30)
nn(tablets-32, ed-31)
conj_or(administration-6, tablets-32)
amod(powder-35, pediatric-34)
conj_or(administration-6, powder-35)
conj_or(Products-4, products-38)
partmod(products-38, containing-39)
dobj(containing-39, calcium-40)
conj_or(calcium-40, iron-42)
conj_or(calcium-40, zinc-45)
aux(decrease-48, may-46)
advmod(decrease-48, substantially-47)
root(ROOT-0, decrease-48)
det(absorption-50, the-49)
dobj(decrease-48, absorption-50)
prep_of(absorption-50, ciprofloxacin-52)
partmod(decrease-48, resulting-54)
xcomp(decrease-48, resulting-54)
nn(levels-59, serum-56)
conj_and(serum-56, urine-58)
prep_in(resulting-54, levels-59)
advmod(lower-61, considerably-60)
amod(levels-59, lower-61)
prep_than(lower-61, desired-63)

This/DT time/NN window/NN is/VBZ different/JJ than/IN for/IN other/JJ oral/JJ formulations/NNS of/IN ciprofloxacin/NN ,/, which/WDT are/VBP usually/RB administered/VBN 2/CD hours/NNS before/IN or/CC 6/CD hours/NNS after/IN antacids/NNS ./.

(ROOT (S1 (S (S (NP (DT This) (NN time) (NN window)) (VP (VBZ is) (ADJP (JJ different) (PP (IN than) (PP (IN for) (NP (NP (JJ other) (JJ oral) (NNS formulations)) (PP (IN of) (NP (NN ciprofloxacin))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADVP (RB usually)) (VP (VBN administered) (NP (NP (NP (CD 2) (NNS hours)) (PP (IN before))) (CC or) (NP (NP (CD 6) (NNS hours)) (PP (IN after) (NP (NNS antacids))))))))))))))) (. .))))

det(window-3, This-1)
nn(window-3, time-2)
nsubj(different-5, window-3)
cop(different-5, is-4)
root(ROOT-0, different-5)
prep(different-5, than-6)
pcomp(than-6, for-7)
amod(formulations-10, other-8)
amod(formulations-10, oral-9)
prep_for(than-6, formulations-10)
nsubjpass(administered-17, formulations-10)
prep_of(formulations-10, ciprofloxacin-12)
auxpass(administered-17, are-15)
advmod(administered-17, usually-16)
rcmod(formulations-10, administered-17)
num(hours-19, 2-18)
dobj(administered-17, hours-19)
prep(hours-19, before-20)
num(hours-23, 6-22)
conj_or(hours-19, hours-23)
prep_after(hours-23, antacids-25)

Non-steroidal/JJ anti-inflammatory/JJ drugs/NNS (/-LRB- but/CC not/RB aspirin/NN )/-RRB- :/: These/DT drugs/NNS in/IN combination/NN with/IN very/RB high/JJ doses/NNS of/IN quinolones/NNS have/VBP been/VBN shown/VBN to/TO provoke/VB convulsions/NN in/IN pre-clinical/JJ studies/NNS ./.

(ROOT (S1 (S (NP (NP (NP (JJ Non-steroidal) (JJ anti-inflammatory) (NNS drugs)) (PRN (-LRB- -LRB-) (CONJP (CC but) (RB not)) (NP (NN aspirin)) (-RRB- -RRB-))) (: :) (S (NP (NP (DT These) (NNS drugs)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (ADJP (RB very) (JJ high)) (NNS doses)) (PP (IN of) (NP (NNS quinolones)))))))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB provoke) (NP (NN convulsions)) (PP (IN in) (NP (JJ pre-clinical) (NNS studies)))))))))) (. .)))))

amod(drugs-3, Non-steroidal-1)
amod(drugs-3, anti-inflammatory-2)
root(ROOT-0, drugs-3)
cc(not-6, but-5)
dep(aspirin-7, not-6)
appos(drugs-3, aspirin-7)
det(drugs-11, These-10)
nsubjpass(shown-22, drugs-11)
xsubj(provoke-24, drugs-11)
prep_in(drugs-11, combination-13)
advmod(high-16, very-15)
amod(doses-17, high-16)
prep_with(combination-13, doses-17)
prep_of(doses-17, quinolones-19)
aux(shown-22, have-20)
auxpass(shown-22, been-21)
dep(drugs-3, shown-22)
aux(provoke-24, to-23)
xcomp(shown-22, provoke-24)
dobj(provoke-24, convulsions-25)
amod(studies-28, pre-clinical-27)
prep_in(provoke-24, studies-28)

Omeprazole/NN :/: The/DT rate/NN and/CC extent/NN of/IN absorption/NN of/IN ciprofloxacin/NN was/VBD bioequivalent/JJ when/WRB Proquin/NN XR/NN was/VBD given/VBN alone/RB or/CC when/WRB Proquin/NN XR/NN was/VBD given/VBN 2/CD hours/NNS after/IN omeprazole/NN at/IN the/DT dose/NN that/WDT maximally/RB suppresses/VBZ gastric/JJ acid/NN secretion/NN ./.

(ROOT (S1 (S (NP (NP (NN Omeprazole)) (: :) (S (NP (NP (DT The) (NP (NN rate)) (CC and) (NP (NN extent))) (PP (IN of) (NP (NP (NN absorption)) (PP (IN of) (NP (NN ciprofloxacin)))))) (VP (VBD was) (ADJP (JJ bioequivalent)) (SBAR (SBAR (WHADVP (WRB when)) (S (NP (NN Proquin) (NN XR)) (VP (VBD was) (VP (VBN given) (ADVP (RB alone)))))) (CC or) (SBAR (WHADVP (WRB when)) (S (NP (NN Proquin) (NN XR)) (VP (VBD was) (VP (VBN given) (PP (NP (CD 2) (NNS hours)) (IN after) (NP (NN omeprazole))) (PP (IN at) (NP (NP (DT the) (NN dose)) (SBAR (WHNP (WDT that)) (S (ADVP (RB maximally)) (VP (VBZ suppresses) (NP (JJ gastric) (NN acid) (NN secretion)))))))))))))) (. .)))))

root(ROOT-0, Omeprazole-1)
dep(rate-4, The-3)
nsubj(bioequivalent-12, rate-4)
conj_and(rate-4, extent-6)
prep_of(rate-4, absorption-8)
prep_of(absorption-8, ciprofloxacin-10)
cop(bioequivalent-12, was-11)
dep(Omeprazole-1, bioequivalent-12)
advmod(given-17, when-13)
nn(XR-15, Proquin-14)
nsubjpass(given-17, XR-15)
auxpass(given-17, was-16)
dep(bioequivalent-12, given-17)
advmod(given-17, alone-18)
advmod(given-24, when-20)
nn(XR-22, Proquin-21)
nsubjpass(given-24, XR-22)
auxpass(given-24, was-23)
conj_or(given-17, given-24)
num(hours-26, 2-25)
npadvmod(given-24, hours-26)
prep_after(given-24, omeprazole-28)
det(dose-31, the-30)
prep_at(given-24, dose-31)
nsubj(suppresses-34, dose-31)
advmod(suppresses-34, maximally-33)
rcmod(dose-31, suppresses-34)
amod(secretion-37, gastric-35)
nn(secretion-37, acid-36)
dobj(suppresses-34, secretion-37)

Omeprazole/NN should/MD be/VB taken/VBN as/IN directed/VBN and/CC Proquin/NN XR/NN should/MD be/VB taken/VBN with/IN a/DT main/JJ meal/NN of/IN the/DT day/NN ,/, preferably/RB the/DT evening/NN meal/NN ../NN

(ROOT (S1 (S (S (NP (NN Omeprazole)) (VP (MD should) (VP (VB be) (VP (VBN taken) (SBAR (IN as) (S (VP (VBN directed)))))))) (CC and) (S (NP (NN Proquin) (NN XR)) (VP (MD should) (VP (VB be) (VP (VBN taken) (PP (IN with) (NP (NP (NP (DT a) (JJ main) (NN meal)) (PP (IN of) (NP (DT the) (NN day)))) (, ,) (NP (RB preferably) (DT the) (NN evening) (NN meal) (NN ..)))))))))))

nsubjpass(taken-4, Omeprazole-1)
aux(taken-4, should-2)
auxpass(taken-4, be-3)
root(ROOT-0, taken-4)
mark(directed-6, as-5)
advcl(taken-4, directed-6)
nn(XR-9, Proquin-8)
nsubjpass(taken-12, XR-9)
aux(taken-12, should-10)
auxpass(taken-12, be-11)
conj_and(taken-4, taken-12)
det(meal-16, a-14)
amod(meal-16, main-15)
prep_with(taken-12, meal-16)
det(day-19, the-18)
prep_of(meal-16, day-19)
advmod(..-25, preferably-21)
det(..-25, the-22)
nn(..-25, evening-23)
nn(..-25, meal-24)
appos(meal-16, ..-25)

Phenytoin/NN Altered/JJ serum/NN levels/NNS of/IN phenytoin/NN (/-LRB- increased/VBN and/CC decreased/VBN )/-RRB- have/VBP been/VBN reported/VBN in/IN patients/NNS receiving/VBG concomitant/JJ ciprofloxacin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Phenytoin) (JJ Altered) (NN serum) (NNS levels)) (PP (IN of) (NP (NP (NN phenytoin)) (PRN (-LRB- -LRB-) (VP (VP (VBN increased)) (CC and) (VP (VBN decreased))) (-RRB- -RRB-))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ concomitant) (NN ciprofloxacin))))))))) (. .))))

nn(levels-4, Phenytoin-1)
amod(levels-4, Altered-2)
nn(levels-4, serum-3)
nsubjpass(reported-14, levels-4)
prep_of(levels-4, phenytoin-6)
dep(phenytoin-6, increased-8)
conj_and(increased-8, decreased-10)
aux(reported-14, have-12)
auxpass(reported-14, been-13)
root(ROOT-0, reported-14)
prep_in(reported-14, patients-16)
partmod(patients-16, receiving-17)
amod(ciprofloxacin-19, concomitant-18)
dobj(receiving-17, ciprofloxacin-19)

Probenecid/NN Probenecid/NN interferes/VBZ with/IN renal/JJ tubular/JJ secretion/NN of/IN ciprofloxacin/NN and/CC produces/VBZ an/DT increase/NN in/IN the/DT level/NN of/IN ciprofloxacin/NN in/IN serum/NN ./.

(ROOT (S1 (S (S (NP (NN Probenecid) (NN Probenecid)) (VP (VP (VBZ interferes) (PP (IN with) (NP (NP (JJ renal) (JJ tubular) (NN secretion)) (PP (IN of) (NP (NN ciprofloxacin)))))) (CC and) (VP (VBZ produces) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN ciprofloxacin))) (PP (IN in) (NP (NN serum))))))))) (. .))))

nn(Probenecid-2, Probenecid-1)
nsubj(interferes-3, Probenecid-2)
root(ROOT-0, interferes-3)
amod(secretion-7, renal-5)
amod(secretion-7, tubular-6)
prep_with(interferes-3, secretion-7)
prep_of(secretion-7, ciprofloxacin-9)
conj_and(interferes-3, produces-11)
det(increase-13, an-12)
dobj(produces-11, increase-13)
det(level-16, the-15)
prep_in(increase-13, level-16)
prep_of(level-16, ciprofloxacin-18)
prep_in(level-16, serum-20)

Theophylline/NN :/: As/IN with/IN some/DT other/JJ quinolones/NNS ,/, concurrent/JJ administration/NN of/IN ciprofloxacin/NN with/IN theophylline/NN may/MD lead/VB to/TO elevated/JJ serum/NN concentrations/NNS of/IN theophylline/NN and/CC prolongation/NN of/IN its/PRP$ elimination/NN half-life/NN ./.

(ROOT (S1 (S (NP (NP (NN Theophylline)) (: :) (S (PP (IN As) (PP (IN with) (NP (DT some) (JJ other) (NNS quinolones)))) (, ,) (NP (NP (JJ concurrent) (NN administration)) (PP (IN of) (NP (NN ciprofloxacin))) (PP (IN with) (NP (NN theophylline)))) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (JJ elevated) (NN serum) (NNS concentrations)) (PP (IN of) (NP (NP (NP (NN theophylline)) (CC and) (NP (NN prolongation))) (PP (IN of) (NP (PRP$ its) (NN elimination) (NN half-life)))))))))) (. .)))))

root(ROOT-0, Theophylline-1)
prep(lead-16, As-3)
pcomp(As-3, with-4)
det(quinolones-7, some-5)
amod(quinolones-7, other-6)
prep_with(As-3, quinolones-7)
amod(administration-10, concurrent-9)
nsubj(lead-16, administration-10)
prep_of(administration-10, ciprofloxacin-12)
prep_with(administration-10, theophylline-14)
aux(lead-16, may-15)
dep(Theophylline-1, lead-16)
amod(concentrations-20, elevated-18)
nn(concentrations-20, serum-19)
prep_to(lead-16, concentrations-20)
prep_of(concentrations-20, theophylline-22)
conj_and(theophylline-22, prolongation-24)
poss(half-life-28, its-26)
nn(half-life-28, elimination-27)
prep_of(theophylline-22, half-life-28)

If/IN concomitant/JJ use/NN cannot/MD be/VB avoided/VBN ,/, serum/NN levels/NNS of/IN theophylline/NN should/MD be/VB monitored/VBN and/CC dosage/NN adjustments/NNS made/VBD as/IN appropriate/JJ ./.

(ROOT (S1 (S (S (S (SBAR (IN If) (S (NP (JJ concomitant) (NN use)) (VP (MD cannot) (VP (VB be) (VP (VBN avoided)))))) (, ,) (NP (NP (NN serum) (NNS levels)) (PP (IN of) (NP (NN theophylline)))) (VP (MD should) (VP (VB be) (VP (VBN monitored))))) (CC and) (S (NP (NN dosage) (NNS adjustments)) (VP (VBD made) (PP (IN as) (NP (JJ appropriate)))))) (. .))))

mark(cannot-4, If-1)
amod(use-3, concomitant-2)
nsubj(cannot-4, use-3)
advcl(monitored-14, cannot-4)
auxpass(avoided-6, be-5)
dep(cannot-4, avoided-6)
nn(levels-9, serum-8)
nsubjpass(monitored-14, levels-9)
prep_of(levels-9, theophylline-11)
aux(monitored-14, should-12)
auxpass(monitored-14, be-13)
root(ROOT-0, monitored-14)
nn(adjustments-17, dosage-16)
nsubj(made-18, adjustments-17)
conj_and(monitored-14, made-18)
prep_as(made-18, appropriate-20)

Warfarin/NN Quinolones/NNS have/VBP been/VBN reported/VBN to/TO enhance/VB the/DT effects/NNS of/IN the/DT oral/JJ anticoagulant/NN warfarin/NN or/CC its/PRP$ derivatives/NNS ./.

(ROOT (S1 (S (S (NP (NN Warfarin) (NNS Quinolones)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB enhance) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (DT the) (JJ oral) (NN anticoagulant) (NN warfarin)) (CC or) (NP (PRP$ its) (NNS derivatives)))))))))))) (. .))))

nn(Quinolones-2, Warfarin-1)
nsubjpass(reported-5, Quinolones-2)
xsubj(enhance-7, Quinolones-2)
aux(reported-5, have-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
aux(enhance-7, to-6)
xcomp(reported-5, enhance-7)
det(effects-9, the-8)
dobj(enhance-7, effects-9)
det(warfarin-14, the-11)
amod(warfarin-14, oral-12)
nn(warfarin-14, anticoagulant-13)
prep_of(effects-9, warfarin-14)
poss(derivatives-17, its-16)
conj_or(warfarin-14, derivatives-17)

Cisapride/NN is/VBZ metabolized/VBN mainly/RB via/IN the/DT cytochrome/NN P450/NN 3A4/NN enzyme/NN ./.

(ROOT (S1 (S (S (NP (NN Cisapride)) (VP (VBZ is) (VP (VBN metabolized) (ADVP (RB mainly)) (PP (IN via) (NP (DT the) (NP (NN cytochrome) (NN P450) (NN 3A4)) (NP (NN enzyme))))))) (. .))))

nsubjpass(metabolized-3, Cisapride-1)
auxpass(metabolized-3, is-2)
root(ROOT-0, metabolized-3)
advmod(metabolized-3, mainly-4)
det(3A4-9, the-6)
nn(3A4-9, cytochrome-7)
nn(3A4-9, P450-8)
prep_via(metabolized-3, 3A4-9)
dep(3A4-9, enzyme-10)

In/IN some/DT cases/NNS where/WRB serious/JJ ventricular/JJ arrhythmias/NNS ,/, QT/NN prolongation/NN ,/, and/CC torsades/NNS de/FW pointes/FW have/VBP occurred/VBN when/WRB cisapride/NN was/VBD taken/VBN in/IN conjunction/NN with/IN one/CD of/IN the/DT cytochrome/NN P450/NN 3A4/NN inhibitors/NNS ,/, elevated/JJ blood/NN cisapride/NN levels/NNS were/VBD noted/VBN at/IN the/DT time/NN of/IN the/DT QT/NN prolongation/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT some) (NNS cases)) (SBAR (WHADVP (WRB where)) (S (NP (NP (JJ serious) (JJ ventricular) (NNS arrhythmias)) (, ,) (NP (NN QT) (NN prolongation)) (, ,) (CC and) (NP (NP (NNS torsades)) (ADJP (FW de) (FW pointes)))) (VP (VBP have) (VP (VBN occurred) (SBAR (WHADVP (WRB when)) (S (NP (NN cisapride)) (VP (VBD was) (VP (VBN taken) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (NN cytochrome) (NN P450) (NN 3A4)) (NNS inhibitors))))))))))))))))) (, ,) (NP (JJ elevated) (NN blood) (NN cisapride) (NNS levels)) (VP (VBD were) (VP (VBN noted) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (DT the) (NN QT) (NN prolongation)))))))) (. .))))

det(cases-3, some-2)
prep_in(noted-38, cases-3)
advmod(occurred-17, where-4)
amod(arrhythmias-7, serious-5)
amod(arrhythmias-7, ventricular-6)
nsubj(occurred-17, arrhythmias-7)
nn(prolongation-10, QT-9)
conj_and(arrhythmias-7, prolongation-10)
conj_and(arrhythmias-7, torsades-13)
nn(pointes-15, de-14)
amod(torsades-13, pointes-15)
aux(occurred-17, have-16)
rcmod(cases-3, occurred-17)
advmod(taken-21, when-18)
nsubjpass(taken-21, cisapride-19)
auxpass(taken-21, was-20)
advcl(occurred-17, taken-21)
prep_in(taken-21, conjunction-23)
prep_with(conjunction-23, one-25)
det(3A4-30, the-27)
nn(3A4-30, cytochrome-28)
nn(3A4-30, P450-29)
nn(inhibitors-31, 3A4-30)
prep_of(one-25, inhibitors-31)
amod(levels-36, elevated-33)
nn(levels-36, blood-34)
nn(levels-36, cisapride-35)
nsubjpass(noted-38, levels-36)
auxpass(noted-38, were-37)
root(ROOT-0, noted-38)
det(time-41, the-40)
prep_at(noted-38, time-41)
det(prolongation-45, the-43)
nn(prolongation-45, QT-44)
prep_of(time-41, prolongation-45)

Antibiotics/NNS :/: In/FW vitro/FW and/or/CC in/FW vivo/FW data/NNS show/VBP that/IN clarithromycin/NN ,/, erythromycin/NN ,/, and/CC troleandomycin/NN markedly/RB inhibit/VBP the/DT metabolism/NN of/IN cisapride/NN ,/, which/WDT can/MD result/VB in/IN an/DT increase/NN in/IN plasma/NN cisapride/NN levels/NNS and/CC prolongation/NN of/IN the/DT QT/JJ interval/NN on/IN the/DT ECG/NN ./.

(ROOT (S1 (S (NP (NP (NNS Antibiotics)) (: :) (S (NP (ADJP (ADJP (FW In) (FW vitro)) (CC and/or) (ADJP (FW in) (FW vivo))) (NNS data)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN clarithromycin)) (, ,) (NP (NN erythromycin)) (, ,) (CC and) (NP (NN troleandomycin))) (ADVP (RB markedly)) (VP (VBP inhibit) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN cisapride))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB result) (PP (IN in) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN plasma) (NN cisapride) (NNS levels)))) (CC and) (NP (NP (NN prolongation)) (PP (IN of) (NP (NP (DT the) (JJ QT) (NN interval)) (PP (IN on) (NP (DT the) (NN ECG)))))))))))))))))) (. .)))))

root(ROOT-0, Antibiotics-1)
nn(vitro-4, In-3)
amod(data-8, vitro-4)
nn(vivo-7, in-6)
conj_and/or(vitro-4, vivo-7)
nsubj(show-9, data-8)
dep(Antibiotics-1, show-9)
complm(inhibit-18, that-10)
nsubj(inhibit-18, clarithromycin-11)
conj_and(clarithromycin-11, erythromycin-13)
conj_and(clarithromycin-11, troleandomycin-16)
advmod(inhibit-18, markedly-17)
ccomp(show-9, inhibit-18)
det(metabolism-20, the-19)
dobj(inhibit-18, metabolism-20)
nsubj(result-26, metabolism-20)
prep_of(metabolism-20, cisapride-22)
aux(result-26, can-25)
rcmod(metabolism-20, result-26)
det(increase-29, an-28)
prep_in(result-26, increase-29)
nn(levels-33, plasma-31)
nn(levels-33, cisapride-32)
prep_in(increase-29, levels-33)
conj_and(increase-29, prolongation-35)
det(interval-39, the-37)
amod(interval-39, QT-38)
prep_of(prolongation-35, interval-39)
det(ECG-42, the-41)
prep_on(interval-39, ECG-42)

Anticholinergics/NN :/: Concurrent/JJ administration/NN of/IN certain/JJ anticholinergic/JJ compounds/NNS ,/, such/JJ as/IN belladonna/NN alkaloids/NNS and/CC dicyclomine/NN ,/, would/MD be/VB expected/VBN to/TO compromise/VB the/DT beneficial/JJ effects/NNS of/IN cisapride/NN ./.

(ROOT (S1 (S (NP (NP (NN Anticholinergics)) (: :) (S (NP (NP (JJ Concurrent) (NN administration)) (PP (IN of) (NP (NP (JJ certain) (JJ anticholinergic) (NNS compounds)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN belladonna) (NNS alkaloids)) (CC and) (NP (NN dicyclomine)))) (, ,)))) (VP (MD would) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB compromise) (NP (NP (DT the) (JJ beneficial) (NNS effects)) (PP (IN of) (NP (NN cisapride))))))))))) (. .)))))

root(ROOT-0, Anticholinergics-1)
amod(administration-4, Concurrent-3)
nsubjpass(expected-19, administration-4)
amod(compounds-8, certain-6)
amod(compounds-8, anticholinergic-7)
prep_of(administration-4, compounds-8)
nn(alkaloids-13, belladonna-12)
prep_such_as(compounds-8, alkaloids-13)
conj_and(alkaloids-13, dicyclomine-15)
aux(expected-19, would-17)
auxpass(expected-19, be-18)
dep(Anticholinergics-1, expected-19)
aux(compromise-21, to-20)
xcomp(expected-19, compromise-21)
det(effects-24, the-22)
amod(effects-24, beneficial-23)
dobj(compromise-21, effects-24)
prep_of(effects-24, cisapride-26)

Anticoagulants/NNS (/-LRB- Oral/JJ )/-RRB- :/: In/IN patients/NNS receiving/VBG oral/JJ anticoagulants/NNS ,/, the/DT coagulation/NN times/NNS were/VBD increased/VBN in/IN some/DT cases/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NNS Anticoagulants)) (PRN (-LRB- -LRB-) (NP (JJ Oral)) (-RRB- -RRB-))) (: :) (S (PP (IN In) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ oral) (NNS anticoagulants))))) (, ,) (NP (DT the) (NN coagulation) (NNS times)) (VP (VBD were) (VP (VBN increased) (PP (IN in) (NP (DT some) (NNS cases)))))) (. .)))))

root(ROOT-0, Anticoagulants-1)
dep(Anticoagulants-1, Oral-3)
prep_in(increased-16, patients-7)
partmod(patients-7, receiving-8)
amod(anticoagulants-10, oral-9)
dobj(receiving-8, anticoagulants-10)
det(times-14, the-12)
nn(times-14, coagulation-13)
nsubjpass(increased-16, times-14)
auxpass(increased-16, were-15)
dep(Anticoagulants-1, increased-16)
det(cases-19, some-18)
prep_in(increased-16, cases-19)

It/PRP is/VBZ advisable/JJ to/TO check/VB coagulation/NN time/NN within/IN the/DT first/JJ few/JJ days/NNS after/IN the/DT start/NN and/CC discontinuation/NN of/IN cisapride/NN therapy/NN ,/, with/IN an/DT appropriate/JJ adjustment/NN of/IN the/DT anticoagulant/JJ dose/NN ,/, if/IN necessary/JJ ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ advisable) (S (VP (TO to) (VP (VB check) (NP (NN coagulation) (NN time)) (PP (IN within) (NP (NP (DT the) (JJ first) (JJ few) (NNS days)) (PP (IN after) (NP (NP (DT the) (NP (NN start)) (CC and) (NP (NN discontinuation))) (PP (IN of) (NP (NN cisapride) (NN therapy))))))) (, ,) (PP (IN with) (NP (NP (DT an) (JJ appropriate) (NN adjustment)) (PP (IN of) (NP (DT the) (JJ anticoagulant) (NN dose))))))))) (, ,) (SBAR (IN if) (FRAG (JJ necessary))))) (. .))))

nsubj(advisable-3, It-1)
cop(advisable-3, is-2)
root(ROOT-0, advisable-3)
aux(check-5, to-4)
xcomp(advisable-3, check-5)
nn(time-7, coagulation-6)
dobj(check-5, time-7)
det(days-12, the-9)
amod(days-12, first-10)
amod(days-12, few-11)
prep_within(check-5, days-12)
dep(start-15, the-14)
prep_after(days-12, start-15)
conj_and(start-15, discontinuation-17)
nn(therapy-20, cisapride-19)
prep_of(start-15, therapy-20)
det(adjustment-25, an-23)
amod(adjustment-25, appropriate-24)
prep_with(check-5, adjustment-25)
det(dose-29, the-27)
amod(dose-29, anticoagulant-28)
prep_of(adjustment-25, dose-29)
mark(necessary-32, if-31)
advcl(advisable-3, necessary-32)

Antidepressants/NNS :/: In/FW vitro/FW data/NNS indicate/VBP that/IN nefazodone/NN inhibits/VBZ the/DT metabolism/NN of/IN cisapride/NN ,/, which/WDT can/MD result/VB in/IN an/DT increase/NN in/IN plasma/NN cisapride/NN levels/NNS and/CC prolongation/NN of/IN the/DT QT/JJ interval/NN on/IN the/DT ECG/NN ./.

(ROOT (S1 (S (NP (NP (NNS Antidepressants)) (: :) (S (NP (ADJP (FW In) (FW vitro)) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN nefazodone)) (VP (VBZ inhibits) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN cisapride))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB result) (PP (IN in) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN plasma) (NN cisapride) (NNS levels)))) (CC and) (NP (NP (NN prolongation)) (PP (IN of) (NP (NP (DT the) (JJ QT) (NN interval)) (PP (IN on) (NP (DT the) (NN ECG)))))))))))))))))) (. .)))))

root(ROOT-0, Antidepressants-1)
nn(vitro-4, In-3)
amod(data-5, vitro-4)
nsubj(indicate-6, data-5)
dep(Antidepressants-1, indicate-6)
complm(inhibits-9, that-7)
nsubj(inhibits-9, nefazodone-8)
ccomp(indicate-6, inhibits-9)
det(metabolism-11, the-10)
dobj(inhibits-9, metabolism-11)
nsubj(result-17, metabolism-11)
prep_of(metabolism-11, cisapride-13)
aux(result-17, can-16)
rcmod(metabolism-11, result-17)
det(increase-20, an-19)
prep_in(result-17, increase-20)
nn(levels-24, plasma-22)
nn(levels-24, cisapride-23)
prep_in(increase-20, levels-24)
conj_and(increase-20, prolongation-26)
det(interval-30, the-28)
amod(interval-30, QT-29)
prep_of(prolongation-26, interval-30)
det(ECG-33, the-32)
prep_on(interval-30, ECG-33)

Antifungals/NNS :/: In/FW vitro/FW and/or/CC in/FW vivo/FW data/NNS indicate/VBP that/IN fluconazole/NN ,/, itraconazole/NN ,/, and/CC oral/JJ ketoconazole/NN markedly/RB inhibit/VBP the/DT metabolism/NN of/IN cisapride/NN ,/, which/WDT can/MD result/VB in/IN an/DT increase/NN in/IN plasma/NN cisapride/NN levels/NNS and/CC prolongation/NN of/IN the/DT QT/JJ interval/NN on/IN the/DT ECG/NN ./.

(ROOT (S1 (S (NP (NP (NNS Antifungals)) (: :) (S (NP (ADJP (ADJP (FW In) (FW vitro)) (CC and/or) (ADJP (FW in) (FW vivo))) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN fluconazole)) (, ,) (NP (NN itraconazole)) (, ,) (CC and) (NP (JJ oral) (NN ketoconazole))) (ADVP (RB markedly)) (VP (VBP inhibit) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN cisapride))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB result) (PP (IN in) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN plasma) (NN cisapride) (NNS levels)))) (CC and) (NP (NP (NN prolongation)) (PP (IN of) (NP (NP (DT the) (JJ QT) (NN interval)) (PP (IN on) (NP (DT the) (NN ECG)))))))))))))))))) (. .)))))

root(ROOT-0, Antifungals-1)
nn(vitro-4, In-3)
amod(data-8, vitro-4)
nn(vivo-7, in-6)
conj_and/or(vitro-4, vivo-7)
nsubj(indicate-9, data-8)
dep(Antifungals-1, indicate-9)
complm(inhibit-19, that-10)
nsubj(inhibit-19, fluconazole-11)
conj_and(fluconazole-11, itraconazole-13)
amod(ketoconazole-17, oral-16)
conj_and(fluconazole-11, ketoconazole-17)
advmod(inhibit-19, markedly-18)
ccomp(indicate-9, inhibit-19)
det(metabolism-21, the-20)
dobj(inhibit-19, metabolism-21)
nsubj(result-27, metabolism-21)
prep_of(metabolism-21, cisapride-23)
aux(result-27, can-26)
rcmod(metabolism-21, result-27)
det(increase-30, an-29)
prep_in(result-27, increase-30)
nn(levels-34, plasma-32)
nn(levels-34, cisapride-33)
prep_in(increase-30, levels-34)
conj_and(increase-30, prolongation-36)
det(interval-40, the-38)
amod(interval-40, QT-39)
prep_of(prolongation-36, interval-40)
det(ECG-43, the-42)
prep_on(interval-40, ECG-43)

Human/JJ pharmacokinetic/JJ data/NNS indicate/VBP that/IN oral/JJ ketoconazole/NN markedly/RB inhibits/VBZ the/DT metabolism/NN of/IN cisapride/NN ,/, resulting/VBG in/IN a/DT mean/NN eight-fold/JJ increase/NN in/IN AUC/NN of/IN cisapride/NN ./.

(ROOT (S1 (S (S (NP (JJ Human) (JJ pharmacokinetic) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (JJ oral) (NN ketoconazole)) (ADVP (RB markedly)) (VP (VBZ inhibits) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN cisapride)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (ADJP (NN mean) (JJ eight-fold)) (NN increase)) (PP (IN in) (NP (NP (NN AUC)) (PP (IN of) (NP (NN cisapride)))))))))))))) (. .))))

amod(data-3, Human-1)
amod(data-3, pharmacokinetic-2)
nsubj(indicate-4, data-3)
root(ROOT-0, indicate-4)
complm(inhibits-9, that-5)
amod(ketoconazole-7, oral-6)
nsubj(inhibits-9, ketoconazole-7)
advmod(inhibits-9, markedly-8)
ccomp(indicate-4, inhibits-9)
det(metabolism-11, the-10)
dobj(inhibits-9, metabolism-11)
prep_of(metabolism-11, cisapride-13)
partmod(inhibits-9, resulting-15)
xcomp(inhibits-9, resulting-15)
det(increase-20, a-17)
dep(eight-fold-19, mean-18)
amod(increase-20, eight-fold-19)
prep_in(resulting-15, increase-20)
prep_in(increase-20, AUC-22)
prep_of(AUC-22, cisapride-24)

A/DT study/NN in/IN 14/CD normal/JJ male/JJ and/CC female/JJ volunteers/NNS suggests/VBZ that/IN coadministration/NN of/IN cisapride/NN and/CC ketoconazole/NN can/MD result/VB in/IN prolongation/NN of/IN the/DT QT/JJ interval/NN on/IN the/DT ECG/NN ./.

(ROOT (S1 (S (S (NP (NP (DT A) (NN study)) (PP (IN in) (NP (CD 14) (JJ normal) (ADJP (ADJP (JJ male)) (CC and) (ADJP (JJ female))) (NNS volunteers)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NN cisapride)) (CC and) (NP (NN ketoconazole))))) (VP (MD can) (VP (VB result) (PP (IN in) (NP (NP (NN prolongation)) (PP (IN of) (NP (NP (DT the) (JJ QT) (NN interval)) (PP (IN on) (NP (DT the) (NN ECG))))))))))))) (. .))))

det(study-2, A-1)
nsubj(suggests-10, study-2)
num(volunteers-9, 14-4)
amod(volunteers-9, normal-5)
amod(volunteers-9, male-6)
conj_and(male-6, female-8)
prep_in(study-2, volunteers-9)
root(ROOT-0, suggests-10)
complm(result-18, that-11)
nsubj(result-18, coadministration-12)
prep_of(coadministration-12, cisapride-14)
conj_and(cisapride-14, ketoconazole-16)
aux(result-18, can-17)
ccomp(suggests-10, result-18)
prep_in(result-18, prolongation-20)
det(interval-24, the-22)
amod(interval-24, QT-23)
prep_of(prolongation-20, interval-24)
det(ECG-27, the-26)
prep_on(interval-24, ECG-27)

H2/NN Receptor/NN Antagonists/NNS :/: Cimetidine/NN coadministration/NN leads/VBZ to/TO an/DT increased/VBN peak/JJ plasma/NN concentration/NN and/CC AUC/NN of/IN cisapride/NN ,/, there/EX is/VBZ no/DT effect/NN on/IN cisapride/NN absorption/NN when/WRB it/PRP is/VBZ coadministered/VBN with/IN ranitidine/NN ./.

(ROOT (S1 (S (NP (NP (NN H2) (NN Receptor) (NNS Antagonists)) (: :) (S (S (NP (NN Cimetidine) (NN coadministration)) (VP (VBZ leads) (PP (TO to) (NP (NP (DT an) (VBN increased) (JJ peak) (NN plasma) (NN concentration)) (CC and) (NP (NP (NN AUC)) (PP (IN of) (NP (NN cisapride)))))))) (, ,) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NN cisapride) (NN absorption)))) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN coadministered) (PP (IN with) (NP (NN ranitidine)))))))))) (. .)))))

nn(Antagonists-3, H2-1)
nn(Antagonists-3, Receptor-2)
root(ROOT-0, Antagonists-3)
nn(coadministration-6, Cimetidine-5)
nsubj(leads-7, coadministration-6)
dep(Antagonists-3, leads-7)
det(concentration-13, an-9)
amod(concentration-13, increased-10)
amod(concentration-13, peak-11)
nn(concentration-13, plasma-12)
prep_to(leads-7, concentration-13)
conj_and(concentration-13, AUC-15)
prep_of(AUC-15, cisapride-17)
expl(is-20, there-19)
dep(leads-7, is-20)
det(effect-22, no-21)
nsubj(is-20, effect-22)
nn(absorption-25, cisapride-24)
prep_on(effect-22, absorption-25)
advmod(coadministered-29, when-26)
nsubjpass(coadministered-29, it-27)
auxpass(coadministered-29, is-28)
advcl(is-20, coadministered-29)
prep_with(coadministered-29, ranitidine-31)

The/DT gastrointestinal/JJ absorption/NN of/IN cimetidine/NN and/CC ranitidine/NN is/VBZ accelerated/VBN when/WRB they/PRP are/VBP coadministered/VBN with/IN cisapride/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ gastrointestinal) (NN absorption)) (PP (IN of) (NP (NP (NN cimetidine)) (CC and) (NP (NN ranitidine))))) (VP (VBZ is) (VP (VBN accelerated) (SBAR (WHADVP (WRB when)) (S (NP (PRP they)) (VP (VBP are) (VP (VBN coadministered) (PP (IN with) (NP (NN cisapride)))))))))) (. .))))

det(absorption-3, The-1)
amod(absorption-3, gastrointestinal-2)
nsubjpass(accelerated-9, absorption-3)
prep_of(absorption-3, cimetidine-5)
conj_and(cimetidine-5, ranitidine-7)
auxpass(accelerated-9, is-8)
root(ROOT-0, accelerated-9)
advmod(coadministered-13, when-10)
nsubjpass(coadministered-13, they-11)
auxpass(coadministered-13, are-12)
advcl(accelerated-9, coadministered-13)
prep_with(coadministered-13, cisapride-15)

Protease/NN Inhibitors/NNS :/: In/FW vitro/FW data/NNS indicate/VBP that/IN indinavir/NN and/CC ritonavir/NN markedly/RB inhibit/VBP the/DT metabolism/NN of/IN cisapride/NN which/WDT can/MD result/VB in/IN an/DT increase/NN in/IN plasma/NN cisapride/NN levels/NNS and/CC prolongation/NN of/IN the/DT QT/JJ interval/NN on/IN the/DT ECG/NN ./.

(ROOT (S1 (S (NP (NP (NN Protease) (NNS Inhibitors)) (: :) (S (NP (ADJP (FW In) (FW vitro)) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN indinavir)) (CC and) (NP (NN ritonavir))) (ADVP (RB markedly)) (VP (VBP inhibit) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN cisapride))) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB result) (PP (IN in) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN plasma) (NN cisapride) (NNS levels)))) (CC and) (NP (NP (NN prolongation)) (PP (IN of) (NP (NP (DT the) (JJ QT) (NN interval)) (PP (IN on) (NP (DT the) (NN ECG)))))))))))))))))) (. .)))))

nn(Inhibitors-2, Protease-1)
root(ROOT-0, Inhibitors-2)
nn(vitro-5, In-4)
amod(data-6, vitro-5)
nsubj(indicate-7, data-6)
dep(Inhibitors-2, indicate-7)
complm(inhibit-13, that-8)
nsubj(inhibit-13, indinavir-9)
conj_and(indinavir-9, ritonavir-11)
advmod(inhibit-13, markedly-12)
ccomp(indicate-7, inhibit-13)
det(metabolism-15, the-14)
dobj(inhibit-13, metabolism-15)
nsubj(result-20, metabolism-15)
prep_of(metabolism-15, cisapride-17)
aux(result-20, can-19)
rcmod(metabolism-15, result-20)
det(increase-23, an-22)
prep_in(result-20, increase-23)
nn(levels-27, plasma-25)
nn(levels-27, cisapride-26)
prep_in(increase-23, levels-27)
conj_and(increase-23, prolongation-29)
det(interval-33, the-31)
amod(interval-33, QT-32)
prep_of(prolongation-29, interval-33)
det(ECG-36, the-35)
prep_on(interval-33, ECG-36)

Other/JJ :/: Coadministration/NN of/IN grapefruit/NN juice/NN with/IN cisapride/NN increases/VBZ the/DT bioavailability/NN of/IN cisapride/NN and/CC concomitant/JJ use/NN should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (ADJP (ADJP (JJ Other)) (: :)) (NN Coadministration)) (PP (IN of) (NP (NN grapefruit) (NN juice))) (PP (IN with) (NP (NN cisapride)))) (VP (VBZ increases) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (NN cisapride)))))) (CC and) (S (NP (JJ concomitant) (NN use)) (VP (MD should) (VP (VB be) (VP (VBN avoided)))))) (. .))))

amod(Coadministration-3, Other-1)
nsubj(increases-9, Coadministration-3)
nn(juice-6, grapefruit-5)
prep_of(Coadministration-3, juice-6)
prep_with(Coadministration-3, cisapride-8)
root(ROOT-0, increases-9)
det(bioavailability-11, the-10)
dobj(increases-9, bioavailability-11)
prep_of(bioavailability-11, cisapride-13)
amod(use-16, concomitant-15)
nsubjpass(avoided-19, use-16)
aux(avoided-19, should-17)
auxpass(avoided-19, be-18)
conj_and(increases-9, avoided-19)

Cisapride/NN should/MD not/RB be/VB used/VBN concomitantly/RB with/IN other/JJ drugs/NNS known/VBN to/TO prolong/VBP the/DT QT/JJ interval/NN :/: certain/JJ antiarrhythmics/NNS ,/, including/VBG those/DT of/IN Class/NN IA/NNS (/-LRB- such/JJ as/IN quinidine/NN and/CC procainamide/NN )/-RRB- and/CC Class/NN III/CD (/-LRB- such/JJ as/IN sotalol/NN )/-RRB- ;/: ./.

(ROOT (S1 (S (NP (NN Cisapride)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NP (JJ other) (NNS drugs)) (VP (VBN known) (S (VP (TO to) (VP (VBP prolong) (NP (DT the) (JJ QT) (NN interval))))))) (: :) (NP (NP (NP (NP (JJ certain) (NNS antiarrhythmics)) (, ,) (PP (VBG including) (NP (NP (DT those)) (PP (IN of) (NP (NP (NN Class) (NNS IA)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NP (NN quinidine)) (CC and) (NP (NN procainamide))))) (-RRB- -RRB-))))))) (CC and) (NP (NN Class) (CD III))) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NN sotalol)))) (-RRB- -RRB-))) (: ;)))))) (. .))))

nsubjpass(used-5, Cisapride-1)
aux(used-5, should-2)
neg(used-5, not-3)
auxpass(used-5, be-4)
root(ROOT-0, used-5)
advmod(used-5, concomitantly-6)
amod(drugs-9, other-8)
prep_with(used-5, drugs-9)
partmod(drugs-9, known-10)
aux(prolong-12, to-11)
xcomp(known-10, prolong-12)
det(interval-15, the-13)
amod(interval-15, QT-14)
dobj(prolong-12, interval-15)
amod(antiarrhythmics-18, certain-17)
dep(drugs-9, antiarrhythmics-18)
prep_including(antiarrhythmics-18, those-21)
nn(IA-24, Class-23)
prep_of(those-21, IA-24)
dep(IA-24, such-26)
prep_as(such-26, quinidine-28)
conj_and(quinidine-28, procainamide-30)
conj_and(antiarrhythmics-18, Class-33)
num(Class-33, III-34)
prep_such_as(antiarrhythmics-18, sotalol-38)

tricyclic/JJ antidepressants/NNS (/-LRB- such/JJ as/IN amitriptyline/NN )/-RRB- ;/: ./.

(ROOT (S1 (S (S (NP (NP (JJ tricyclic) (NNS antidepressants)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NN amitriptyline)))) (-RRB- -RRB-))) (: ;)) (. .))))

amod(antidepressants-2, tricyclic-1)
root(ROOT-0, antidepressants-2)
prep_such_as(antidepressants-2, amitriptyline-6)

certain/JJ tetracyclic/JJ antidepressant/JJ s/NNS (/-LRB- such/JJ as/IN maprotilin/NN e/NN )/-RRB- ;/: ./.

(ROOT (S1 (S (NP (NP (NP (JJ certain) (JJ tetracyclic) (JJ antidepressant) (NNS s)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NN maprotilin) (NN e)))) (-RRB- -RRB-)) (: ;)) (. .)))))

amod(s-4, certain-1)
amod(s-4, tetracyclic-2)
amod(s-4, antidepressant-3)
root(ROOT-0, s-4)
nn(e-9, maprotilin-8)
prep_such_as(s-4, e-9)

certain/JJ antipsychotic/JJ medications/NNS (/-LRB- such/JJ as/IN sertindole/NN )/-RRB- ;/: ./.

(ROOT (S1 (S (S (NP (NP (JJ certain) (JJ antipsychotic) (NNS medications)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NN sertindole)))) (-RRB- -RRB-))) (: ;)) (. .))))

amod(medications-3, certain-1)
amod(medications-3, antipsychotic-2)
root(ROOT-0, medications-3)
prep_such_as(medications-3, sertindole-7)

astemizole/NN ,/, bepridil/NN ,/, sparfloxacin/NN ,/, and/CC terodiline/NN ./.

(ROOT (S1 (S (S (NP (NP (NN astemizole)) (, ,) (NP (NN bepridil)) (, ,) (NP (NN sparfloxacin)) (, ,) (CC and) (NP (NN terodiline)))) (. .))))

root(ROOT-0, astemizole-1)
conj_and(astemizole-1, bepridil-3)
conj_and(astemizole-1, sparfloxacin-5)
conj_and(astemizole-1, terodiline-8)

The/DT preceding/JJ lists/NNS of/IN drugs/NNS are/VBP not/RB comprehensive/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ preceding) (NNS lists)) (PP (IN of) (NP (NNS drugs)))) (VP (VBP are) (RB not) (ADJP (JJ comprehensive)))) (. .))))

det(lists-3, The-1)
amod(lists-3, preceding-2)
nsubj(comprehensive-8, lists-3)
prep_of(lists-3, drugs-5)
cop(comprehensive-8, are-6)
neg(comprehensive-8, not-7)
root(ROOT-0, comprehensive-8)

The/DT acceleration/NN of/IN gastric/JJ emptying/NN by/IN cisapride/NN could/MD affect/VB the/DT rate/NN of/IN absorption/NN of/IN other/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN acceleration)) (PP (IN of) (NP (JJ gastric) (NN emptying))) (PP (IN by) (NP (NN cisapride)))) (VP (MD could) (VP (VB affect) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NP (NN absorption)) (PP (IN of) (NP (JJ other) (NNS drugs))))))))) (. .))))

det(acceleration-2, The-1)
nsubj(affect-9, acceleration-2)
amod(emptying-5, gastric-4)
prep_of(acceleration-2, emptying-5)
prep_by(acceleration-2, cisapride-7)
aux(affect-9, could-8)
root(ROOT-0, affect-9)
det(rate-11, the-10)
dobj(affect-9, rate-11)
prep_of(rate-11, absorption-13)
amod(drugs-16, other-15)
prep_of(absorption-13, drugs-16)

Patients/NNS receiving/VBG narrow/JJ therapeutic/JJ ratio/NN drugs/NNS or/CC other/JJ drugs/NNS that/WDT require/VBP careful/JJ titration/NN should/MD be/VB followed/VBN closely/RB ;/: ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (NP (NP (JJ narrow) (JJ therapeutic) (NN ratio) (NNS drugs)) (CC or) (NP (JJ other) (NNS drugs))) (SBAR (WHNP (WDT that)) (S (VP (VBP require) (NP (JJ careful) (NN titration)))))))) (VP (MD should) (VP (VB be) (VP (VBN followed) (ADVP (RB closely))))) (: ;)) (. .))))

nsubjpass(followed-16, Patients-1)
partmod(Patients-1, receiving-2)
amod(drugs-6, narrow-3)
amod(drugs-6, therapeutic-4)
nn(drugs-6, ratio-5)
dobj(receiving-2, drugs-6)
nsubj(require-11, drugs-6)
amod(drugs-9, other-8)
conj_or(drugs-6, drugs-9)
rcmod(drugs-6, require-11)
amod(titration-13, careful-12)
dobj(require-11, titration-13)
aux(followed-16, should-14)
auxpass(followed-16, be-15)
root(ROOT-0, followed-16)
advmod(followed-16, closely-17)

NIMBEX/NN has/VBZ been/VBN used/VBN safely/RB following/VBG varying/VBG degrees/NNS of/IN recovery/NN from/IN succinylcholine/NN -induced/JJ neuromuscular/JJ block/NN ./.

(ROOT (S1 (S (S (NP (NN NIMBEX)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (ADVP (RB safely)) (PP (VBG following) (NP (NP (VBG varying) (NNS degrees)) (PP (IN of) (NP (NP (NN recovery)) (PP (IN from) (NP (NN succinylcholine) (JJ -induced) (JJ neuromuscular) (NN block))))))))))) (. .))))

nsubjpass(used-4, NIMBEX-1)
aux(used-4, has-2)
auxpass(used-4, been-3)
root(ROOT-0, used-4)
advmod(used-4, safely-5)
amod(degrees-8, varying-7)
prep_following(used-4, degrees-8)
prep_of(degrees-8, recovery-10)
nn(block-15, succinylcholine-12)
amod(block-15, -induced-13)
amod(block-15, neuromuscular-14)
prep_from(recovery-10, block-15)

Administration/NN of/IN 0.1-mg/kg/JJ (/-LRB- 2/CD x/NN ED95/NN )/-RRB- NIMBEX/NN at/IN 10/CD %/NN or/CC 95/CD %/NN recovery/NN following/VBG an/DT intubating/JJ dose/NN of/IN succinylcholine/NN (/-LRB- 1/CD mg/kg/NN )/-RRB- produced/VBD @/NN 95/CD %/NN neuromuscular/NN block/NN ./.

(ROOT (S1 (S (NP (NP (NN Administration)) (PP (IN of) (NP (NP (NP (ADJP (ADJP (JJ 0.1-mg/kg)) (PRN (-LRB- -LRB-) (NP (CD 2) (NN x) (NN ED95)) (-RRB- -RRB-))) (NN NIMBEX)) (PP (IN at) (NP (CD 10) (NN %)))) (CC or) (NP (NP (ADJP (CD 95) (NN %)) (NN recovery)) (PP (VBG following) (NP (NP (NP (DT an) (JJ intubating) (NN dose)) (PP (IN of) (NP (NN succinylcholine)))) (PRN (-LRB- -LRB-) (NP (CD 1) (NN mg/kg)) (-RRB- -RRB-)))))))) (VP (VBD produced) (NP (NN @) (ADJP (CD 95) (NN %)) (NN neuromuscular) (NN block))) (. .))))

nsubj(produced-27, Administration-1)
amod(NIMBEX-9, 0.1-mg/kg-3)
num(ED95-7, 2-5)
nn(ED95-7, x-6)
dep(0.1-mg/kg-3, ED95-7)
prep_of(Administration-1, NIMBEX-9)
num(%-12, 10-11)
prep_at(NIMBEX-9, %-12)
number(%-15, 95-14)
amod(recovery-16, %-15)
conj_or(NIMBEX-9, recovery-16)
det(dose-20, an-18)
amod(dose-20, intubating-19)
prep_following(recovery-16, dose-20)
prep_of(dose-20, succinylcholine-22)
num(mg/kg-25, 1-24)
appos(dose-20, mg/kg-25)
root(ROOT-0, produced-27)
nn(block-32, @-28)
number(%-30, 95-29)
amod(block-32, %-30)
nn(block-32, neuromuscular-31)
dobj(produced-27, block-32)

The/DT time/NN to/TO onset/NN of/IN maximum/NN block/NN following/VBG NIMBEX/NN is/VBZ approximately/RB 2/CD minutes/NNS faster/JJR with/IN prior/JJ administration/NN of/IN succinylcholine/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN time)) (PP (TO to) (NP (NP (NN onset)) (PP (IN of) (NP (NP (NN maximum) (NN block)) (PP (VBG following) (NP (NN NIMBEX)))))))) (VP (VBZ is) (ADJP (NP (QP (RB approximately) (CD 2)) (NNS minutes)) (JJR faster) (PP (IN with) (NP (NP (JJ prior) (NN administration)) (PP (IN of) (NP (NN succinylcholine)))))))) (. .))))

det(time-2, The-1)
nsubj(faster-14, time-2)
prep_to(time-2, onset-4)
nn(block-7, maximum-6)
prep_of(onset-4, block-7)
prep_following(block-7, NIMBEX-9)
cop(faster-14, is-10)
quantmod(2-12, approximately-11)
num(minutes-13, 2-12)
npadvmod(faster-14, minutes-13)
root(ROOT-0, faster-14)
amod(administration-17, prior-16)
prep_with(faster-14, administration-17)
prep_of(administration-17, succinylcholine-19)

Prior/JJ administration/NN of/IN succinylcholine/NN had/VBD no/DT effect/NN on/IN the/DT duration/NN of/IN neuromuscular/JJ block/NN following/VBG initial/JJ or/CC maintenance/NN bolus/NN doses/NNS of/IN NIMBEX/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Prior) (NN administration)) (PP (IN of) (NP (NN succinylcholine)))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NP (JJ neuromuscular) (NN block)) (PP (VBG following) (NP (NP (JJ initial) (CC or) (NN maintenance) (NN bolus) (NNS doses)) (PP (IN of) (NP (NN NIMBEX))))))))))) (. .))))

amod(administration-2, Prior-1)
nsubj(had-5, administration-2)
prep_of(administration-2, succinylcholine-4)
root(ROOT-0, had-5)
det(effect-7, no-6)
dobj(had-5, effect-7)
det(duration-10, the-9)
prep_on(had-5, duration-10)
amod(block-13, neuromuscular-12)
prep_of(duration-10, block-13)
amod(doses-19, initial-15)
conj_or(initial-15, maintenance-17)
nn(doses-19, bolus-18)
prep_following(block-13, doses-19)
prep_of(doses-19, NIMBEX-21)

Infusion/NN requirements/NNS of/IN NIMBEX/NN in/IN patients/NNS administered/VBN succinylcholine/NN prior/RB to/TO infusions/NNS of/IN NIMBEX/NN were/VBD comparable/JJ to/TO or/CC slightly/RB greater/JJR than/IN when/WRB succinylcholine/NN was/VBD not/RB administered/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Infusion) (NNS requirements)) (PP (IN of) (NP (NN NIMBEX))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN administered) (ADVP (NP (NN succinylcholine)) (RB prior)) (PP (TO to) (NP (NP (NNS infusions)) (PP (IN of) (NP (NN NIMBEX))))))))) (VP (VBD were) (ADJP (ADJP (JJ comparable) (PP (TO to))) (CC or) (ADJP (ADJP (RB slightly) (JJR greater)) (PP (IN than) (SBAR (WHADVP (WRB when)) (S (NP (NN succinylcholine)) (VP (VBD was) (RB not) (VP (VBN administered)))))))))) (. .))))

nn(requirements-2, Infusion-1)
nsubj(comparable-15, requirements-2)
prep_of(requirements-2, NIMBEX-4)
prep_in(requirements-2, patients-6)
partmod(patients-6, administered-7)
npadvmod(administered-7, succinylcholine-8)
prep_prior_to(administered-7, infusions-11)
prep_of(infusions-11, NIMBEX-13)
cop(comparable-15, were-14)
root(ROOT-0, comparable-15)
prep(comparable-15, to-16)
advmod(greater-19, slightly-18)
conj_or(comparable-15, greater-19)
advmod(administered-25, when-21)
nsubjpass(administered-25, succinylcholine-22)
auxpass(administered-25, was-23)
neg(administered-25, not-24)
prepc_than(greater-19, administered-25)

The/DT use/NN of/IN NIMBEX/NN before/IN succinylcholine/NN to/TO attenuate/VB some/DT of/IN the/DT side/JJ effects/NNS of/IN succinylcholine/NN has/VBZ not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NN NIMBEX))) (PP (IN before) (NP (NP (NN succinylcholine)) (VP (TO to) (VP (VB attenuate) (NP (NP (DT some)) (PP (IN of) (NP (NP (DT the) (JJ side) (NNS effects)) (PP (IN of) (NP (NN succinylcholine))))))))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

det(use-2, The-1)
nsubjpass(studied-19, use-2)
prep_of(use-2, NIMBEX-4)
prep_before(use-2, succinylcholine-6)
aux(attenuate-8, to-7)
dep(succinylcholine-6, attenuate-8)
dobj(attenuate-8, some-9)
det(effects-13, the-11)
amod(effects-13, side-12)
prep_of(some-9, effects-13)
prep_of(effects-13, succinylcholine-15)
aux(studied-19, has-16)
neg(studied-19, not-17)
auxpass(studied-19, been-18)
root(ROOT-0, studied-19)

Although/IN not/RB studied/VBN systematically/RB in/IN clinical/JJ trials/NNS ,/, no/DT drug/NN interactions/NNS were/VBD observed/VBN when/WRB vecuronium/NN ,/, pancuronium/NN ,/, or/CC atracurium/NN were/VBD administered/VBN following/VBG varying/VBG degrees/NNS of/IN recovery/NN from/IN single/JJ doses/NNS or/CC infusions/NNS of/IN NIMBEX/NN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (VP (RB not) (VBN studied) (ADVP (RB systematically)) (PP (IN in) (NP (JJ clinical) (NNS trials)))))) (, ,) (NP (DT no) (NN drug) (NNS interactions)) (VP (VBD were) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN vecuronium)) (, ,) (NP (NN pancuronium)) (, ,) (CC or) (NP (NN atracurium))) (VP (VBD were) (VP (VBN administered) (PP (VBG following) (NP (NP (VBG varying) (NNS degrees)) (PP (IN of) (NP (NP (NN recovery)) (PP (IN from) (NP (NP (NP (JJ single) (NNS doses)) (CC or) (NP (NNS infusions))) (PP (IN of) (NP (NN NIMBEX)))))))))))))))) (. .))))

mark(studied-3, Although-1)
neg(studied-3, not-2)
advcl(observed-13, studied-3)
advmod(studied-3, systematically-4)
amod(trials-7, clinical-6)
prep_in(studied-3, trials-7)
det(interactions-11, no-9)
nn(interactions-11, drug-10)
nsubjpass(observed-13, interactions-11)
auxpass(observed-13, were-12)
root(ROOT-0, observed-13)
advmod(administered-22, when-14)
nsubjpass(administered-22, vecuronium-15)
conj_or(vecuronium-15, pancuronium-17)
conj_or(vecuronium-15, atracurium-20)
auxpass(administered-22, were-21)
advcl(observed-13, administered-22)
amod(degrees-25, varying-24)
prep_following(administered-22, degrees-25)
prep_of(degrees-25, recovery-27)
amod(doses-30, single-29)
prep_from(recovery-27, doses-30)
conj_or(doses-30, infusions-32)
prep_of(doses-30, NIMBEX-34)

Isoflurane/NN or/CC enflurane/NN administered/VBN with/IN nitrous/JJ oxide/NN //: oxygen/NN to/TO achieve/VB 1.25/CD MAC/NN [Minimum/NN Alveolar/NN Concentration/NN ]/-RRB- may/MD prolong/VB the/DT clinically/RB effective/JJ duration/NN of/IN action/NN of/IN initial/JJ and/CC maintenance/NN doses/NNS of/IN NIMBEX/NN and/CC decrease/VB the/DT required/JJ infusion/NN rate/NN of/IN NIMBEX/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Isoflurane)) (CC or) (NP (NN enflurane))) (VP (VBN administered) (PP (IN with) (NP (NP (JJ nitrous) (NN oxide)) (PRN (: /) (S (NP (NN oxygen)) (VP (TO to) (VP (VB achieve) (NP (ADJP (CD 1.25) (NN MAC)) (NN -LSB-Minimum) (NN Alveolar) (NN Concentration))))) (-RRB- -RSB-)))))) (VP (MD may) (VP (VP (VB prolong) (NP (NP (DT the) (ADJP (RB clinically) (JJ effective)) (NN duration)) (PP (IN of) (NP (NP (NN action)) (PP (IN of) (NP (NP (JJ initial) (CC and) (NN maintenance) (NNS doses)) (PP (IN of) (NP (NN NIMBEX))))))))) (CC and) (VP (VB decrease) (NP (NP (DT the) (JJ required) (NN infusion) (NN rate)) (PP (IN of) (NP (NN NIMBEX)))))))) (. .))))

nsubj(prolong-19, Isoflurane-1)
conj_or(Isoflurane-1, enflurane-3)
partmod(Isoflurane-1, administered-4)
amod(oxide-7, nitrous-6)
prep_with(administered-4, oxide-7)
punct(achieve-11, /-8)
nsubj(achieve-11, oxygen-9)
aux(achieve-11, to-10)
dep(oxide-7, achieve-11)
number(MAC-13, 1.25-12)
amod(Concentration-16, MAC-13)
nn(Concentration-16, -LSB-Minimum-14)
nn(Concentration-16, Alveolar-15)
dobj(achieve-11, Concentration-16)
punct(achieve-11, -RSB--17)
aux(prolong-19, may-18)
root(ROOT-0, prolong-19)
det(duration-23, the-20)
advmod(effective-22, clinically-21)
amod(duration-23, effective-22)
dobj(prolong-19, duration-23)
prep_of(duration-23, action-25)
amod(doses-30, initial-27)
conj_and(initial-27, maintenance-29)
prep_of(action-25, doses-30)
prep_of(doses-30, NIMBEX-32)
conj_and(prolong-19, decrease-34)
det(rate-38, the-35)
amod(rate-38, required-36)
nn(rate-38, infusion-37)
dobj(decrease-34, rate-38)
prep_of(rate-38, NIMBEX-40)

Fifteen/CD to/TO 30/CD minutes/NNS of/IN exposure/NN to/TO 1.25/CD MAC/NN isoflurane/NN or/CC enflurane/NN had/VBD minimal/JJ effects/NNS on/IN the/DT duration/NN of/IN action/NN of/IN initial/JJ doses/NNS of/IN NIMBEX/NN and/CC therefore/RB ,/, no/DT adjustment/NN to/TO the/DT initial/JJ dose/NN should/MD be/VB necessary/JJ when/WRB NIMBEX/NN is/VBZ administered/VBN shortly/RB after/IN initiation/NN of/IN volatile/JJ agents/NNS ./.

(ROOT (S1 (S (S (S (NP (NP (CD Fifteen) (TO to) (CD 30) (NNS minutes)) (PP (IN of) (NP (NP (NP (NN exposure)) (PP (TO to) (NP (CD 1.25) (NN MAC) (NN isoflurane)))) (CC or) (NP (NN enflurane))))) (VP (VBD had) (NP (JJ minimal) (NNS effects)) (PP (IN on) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NP (NN action)) (PP (IN of) (NP (NP (JJ initial) (NNS doses)) (PP (IN of) (NP (NN NIMBEX))))))))))) (CC and) (S (ADVP (RB therefore)) (, ,) (NP (NP (DT no) (NN adjustment)) (PP (TO to) (NP (DT the) (JJ initial) (NN dose)))) (VP (MD should) (VP (VB be) (ADJP (JJ necessary) (SBAR (WHADVP (WRB when)) (S (NP (NN NIMBEX)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB shortly)) (PP (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (JJ volatile) (NNS agents)))))))))))))) (. .))))

num(minutes-4, Fifteen-1)
dep(minutes-4, to-2)
num(minutes-4, 30-3)
nsubj(had-13, minutes-4)
prep_of(minutes-4, exposure-6)
num(isoflurane-10, 1.25-8)
nn(isoflurane-10, MAC-9)
prep_to(exposure-6, isoflurane-10)
conj_or(exposure-6, enflurane-12)
root(ROOT-0, had-13)
amod(effects-15, minimal-14)
dobj(had-13, effects-15)
det(duration-18, the-17)
prep_on(had-13, duration-18)
prep_of(duration-18, action-20)
amod(doses-23, initial-22)
prep_of(action-20, doses-23)
prep_of(doses-23, NIMBEX-25)
advmod(necessary-37, therefore-27)
det(adjustment-30, no-29)
nsubj(necessary-37, adjustment-30)
det(dose-34, the-32)
amod(dose-34, initial-33)
prep_to(adjustment-30, dose-34)
aux(necessary-37, should-35)
cop(necessary-37, be-36)
conj_and(had-13, necessary-37)
advmod(administered-41, when-38)
nsubjpass(administered-41, NIMBEX-39)
auxpass(administered-41, is-40)
dep(necessary-37, administered-41)
advmod(administered-41, shortly-42)
prep_after(administered-41, initiation-44)
amod(agents-47, volatile-46)
prep_of(initiation-44, agents-47)

In/IN long/JJ surgical/JJ procedures/NNS during/IN enflurane/NN or/CC isoflurane/NN anesthesia/NN ,/, less/RBR frequent/JJ maintenance/NN dosing/NN ,/, lower/JJR maintenance/NN doses/NNS ,/, or/CC reduced/VBN infusion/NN rates/NNS of/IN NIMBEX/NN may/MD be/VB necessary/JJ ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (JJ long) (JJ surgical) (NNS procedures)) (PP (IN during) (NP (NP (NN enflurane)) (CC or) (NP (NN isoflurane) (NN anesthesia)))))) (, ,) (NP (NP (NP (ADJP (RBR less) (JJ frequent)) (NN maintenance) (NN dosing)) (, ,) (NP (JJR lower) (NN maintenance) (NNS doses)) (, ,) (CC or) (NP (VBN reduced) (NN infusion) (NNS rates))) (PP (IN of) (NP (NN NIMBEX)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary))))) (. .))))

amod(procedures-4, long-2)
amod(procedures-4, surgical-3)
prep_in(necessary-28, procedures-4)
prep_during(procedures-4, enflurane-6)
nn(anesthesia-9, isoflurane-8)
conj_or(enflurane-6, anesthesia-9)
advmod(frequent-12, less-11)
amod(dosing-14, frequent-12)
nn(dosing-14, maintenance-13)
nsubj(necessary-28, dosing-14)
amod(doses-18, lower-16)
nn(doses-18, maintenance-17)
conj_or(dosing-14, doses-18)
amod(rates-23, reduced-21)
nn(rates-23, infusion-22)
conj_or(dosing-14, rates-23)
prep_of(dosing-14, NIMBEX-25)
aux(necessary-28, may-26)
cop(necessary-28, be-27)
root(ROOT-0, necessary-28)

In/IN clinical/JJ studies/NNS propofol/NN had/VBD no/DT effect/NN on/IN the/DT duration/NN of/IN action/NN or/CC dosing/NN requirements/NNS for/IN NIMBEX/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ clinical) (NNS studies))) (NP (NN propofol)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NN action)))) (CC or) (NP (NP (NN dosing) (NNS requirements)) (PP (IN for) (NP (NN NIMBEX)))))))) (. .))))

amod(studies-3, clinical-2)
prep_in(had-5, studies-3)
nsubj(had-5, propofol-4)
root(ROOT-0, had-5)
det(effect-7, no-6)
dobj(had-5, effect-7)
det(duration-10, the-9)
prep_on(had-5, duration-10)
prep_of(duration-10, action-12)
nn(requirements-15, dosing-14)
conj_or(duration-10, requirements-15)
prep_for(requirements-15, NIMBEX-17)

Other/JJ drugs/NNS which/WDT may/MD enhance/VB the/DT neuromuscular/JJ blocking/NN action/NN of/IN nondepolarizing/NN agent/NN s/NNS such/JJ as/IN NIMBEX/NN include/VBP certain/JJ antibiotics/NNS (/-LRB- e./FW g./FW ,/, aminoglycosides/NNS ,/, tetracyclines/NNS ,/, bacitracin/NN ,/, polymyxins/NNS ,/, lincomycin/NN ,/, clindamycin/NN ,/, colistin/NN ,/, and/CC sodium/NN colistemethate/NN )/-RRB- ,/, magnesium/NN salt/NN s/NNS ,/, lithium/NN ,/, local/JJ anesthetics/NNS ,/, procainamide/NN ,/, and/CC quinidine/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Other) (NNS drugs)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (JJ neuromuscular) (NN blocking) (NN action)) (PP (IN of) (NP (NP (NN nondepolarizing) (NN agent) (NNS s)) (PP (JJ such) (IN as) (NP (NN NIMBEX))))))))))) (VP (VBP include) (NP (NP (NP (JJ certain) (NNS antibiotics)) (PRN (-LRB- -LRB-) (FRAG (NP (FW e.) (FW g.)) (, ,) (NP (NNS aminoglycosides)) (, ,) (NP (NNS tetracyclines)) (, ,) (NP (NN bacitracin)) (, ,) (NP (NP (NNS polymyxins)) (, ,) (NP (NN lincomycin)) (, ,) (NP (NN clindamycin)) (, ,) (NP (NN colistin)) (, ,) (CC and) (NP (NN sodium) (NN colistemethate)))) (-RRB- -RRB-))) (, ,) (NP (NN magnesium) (NN salt) (NNS s)) (, ,) (NP (NN lithium)) (, ,) (NP (JJ local) (NNS anesthetics)) (, ,) (NP (NN procainamide)) (, ,) (CC and) (NP (NN quinidine))))) (. .))))

amod(drugs-2, Other-1)
nsubj(enhance-5, drugs-2)
nsubj(include-17, drugs-2)
aux(enhance-5, may-4)
rcmod(drugs-2, enhance-5)
det(action-9, the-6)
amod(action-9, neuromuscular-7)
nn(action-9, blocking-8)
dobj(enhance-5, action-9)
nn(s-13, nondepolarizing-11)
nn(s-13, agent-12)
prep_of(action-9, s-13)
prep_such_as(s-13, NIMBEX-16)
root(ROOT-0, include-17)
amod(antibiotics-19, certain-18)
dobj(include-17, antibiotics-19)
nn(g.-22, e.-21)
dep(antibiotics-19, g.-22)
dep(g.-22, aminoglycosides-24)
dep(g.-22, tetracyclines-26)
dep(g.-22, bacitracin-28)
dep(g.-22, polymyxins-30)
conj_and(polymyxins-30, lincomycin-32)
conj_and(polymyxins-30, clindamycin-34)
conj_and(polymyxins-30, colistin-36)
nn(colistemethate-40, sodium-39)
conj_and(polymyxins-30, colistemethate-40)
nn(s-45, magnesium-43)
nn(s-45, salt-44)
conj_and(antibiotics-19, s-45)
conj_and(antibiotics-19, lithium-47)
amod(anesthetics-50, local-49)
conj_and(antibiotics-19, anesthetics-50)
conj_and(antibiotics-19, procainamide-52)
conj_and(antibiotics-19, quinidine-55)

Resistance/NN to/TO the/DT neuromuscular/JJ blocking/VBG action/NN of/IN nondepolarizing/NN neuromuscular/NN blocking/NN agents/NNS has/VBZ been/VBN demonstrated/VBN in/IN patients/NNS chronically/RB administered/VBN phenytoin/NN or/CC carbamazepine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Resistance)) (PP (TO to) (NP (NP (DT the) (JJ neuromuscular) (VBG blocking) (NN action)) (PP (IN of) (NP (NN nondepolarizing) (NN neuromuscular) (NN blocking) (NNS agents)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated) (PP (IN in) (NP (NP (NNS patients)) (NP (NP (ADJP (RB chronically) (VBN administered)) (NN phenytoin)) (CC or) (NP (NN carbamazepine))))))))) (. .))))

nsubjpass(demonstrated-14, Resistance-1)
det(action-6, the-3)
amod(action-6, neuromuscular-4)
amod(action-6, blocking-5)
prep_to(Resistance-1, action-6)
nn(agents-11, nondepolarizing-8)
nn(agents-11, neuromuscular-9)
nn(agents-11, blocking-10)
prep_of(action-6, agents-11)
aux(demonstrated-14, has-12)
auxpass(demonstrated-14, been-13)
root(ROOT-0, demonstrated-14)
prep_in(demonstrated-14, patients-16)
advmod(administered-18, chronically-17)
amod(phenytoin-19, administered-18)
dep(patients-16, phenytoin-19)
conj_or(phenytoin-19, carbamazepine-21)

While/IN the/DT effects/NNS of/IN chronic/JJ phenytoin/NN or/CC carbamazepine/NN therapy/NN on/IN the/DT action/NN of/IN NIMBEX/NN are/VBP unknown/JJ ,/, slightly/RB shorter/JJR durations/NNS of/IN neuromuscular/JJ block/NN may/MD be/VB anticipated/VBN and/CC infusion/NN rate/NN requirements/NNS may/MD be/VB higher/JJR ./.

(ROOT (S1 (S (S (SBAR (IN While) (S (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ chronic) (NN phenytoin)) (CC or) (NP (NN carbamazepine) (NN therapy)))) (PP (IN on) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NN NIMBEX)))))) (VP (VBP are) (ADJP (JJ unknown))))) (, ,) (S (NP (NP (ADJP (RB slightly) (JJR shorter)) (NNS durations)) (PP (IN of) (NP (JJ neuromuscular) (NN block)))) (VP (MD may) (VP (VB be) (VP (VBN anticipated))))) (CC and) (S (NP (NN infusion) (NN rate) (NNS requirements)) (VP (MD may) (VP (VB be) (ADJP (JJR higher)))))) (. .))))

mark(unknown-16, While-1)
det(effects-3, the-2)
nsubj(unknown-16, effects-3)
amod(phenytoin-6, chronic-5)
prep_of(effects-3, phenytoin-6)
nn(therapy-9, carbamazepine-8)
conj_or(phenytoin-6, therapy-9)
det(action-12, the-11)
prep_on(effects-3, action-12)
prep_of(action-12, NIMBEX-14)
cop(unknown-16, are-15)
advcl(anticipated-26, unknown-16)
advmod(shorter-19, slightly-18)
amod(durations-20, shorter-19)
nsubjpass(anticipated-26, durations-20)
amod(block-23, neuromuscular-22)
prep_of(durations-20, block-23)
aux(anticipated-26, may-24)
auxpass(anticipated-26, be-25)
root(ROOT-0, anticipated-26)
nn(requirements-30, infusion-28)
nn(requirements-30, rate-29)
nsubj(higher-33, requirements-30)
aux(higher-33, may-31)
cop(higher-33, be-32)
conj_and(anticipated-26, higher-33)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS None/NN known/VBN ./.

(ROOT (S1 (S (S (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (VP (NN None) (VBN known))) (. .))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
nsubj(known-6, Interactions-4)
dep(known-6, None-5)
root(ROOT-0, known-6)

There/EX are/VBP no/DT known/JJ drug/NN interactions/NNS with/IN LEUSTATIN/NN Injection/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP are) (NP (NP (DT no) (JJ known) (NN drug) (NNS interactions)) (PP (IN with) (NP (NN LEUSTATIN) (NN Injection)))))) (. .))))

expl(are-2, There-1)
root(ROOT-0, are-2)
det(interactions-6, no-3)
amod(interactions-6, known-4)
nn(interactions-6, drug-5)
nsubj(are-2, interactions-6)
nn(Injection-9, LEUSTATIN-8)
prep_with(interactions-6, Injection-9)

Caution/NN should/MD be/VB exercised/VBN if/IN LEUSTATIN/NN Injection/NN is/VBZ administered/VBN before/IN ,/, after/IN ,/, or/CC in/IN conjunction/NN with/IN other/JJ drugs/NNS known/VBN to/TO cause/VB immunosuppression/NN or/CC myelosuppression/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (IN if) (S (NP (NN LEUSTATIN) (NN Injection)) (VP (VBZ is) (VP (VBN administered) (PP (PP (IN before)) (, ,) (PP (IN after)) (, ,) (CC or) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (VP (VBN known) (S (VP (TO to) (VP (VB cause) (NP (NP (NN immunosuppression)) (CC or) (NP (NN myelosuppression)))))))))))))))))))) (. .))))

nsubjpass(exercised-4, Caution-1)
aux(exercised-4, should-2)
auxpass(exercised-4, be-3)
root(ROOT-0, exercised-4)
mark(administered-9, if-5)
nn(Injection-7, LEUSTATIN-6)
nsubjpass(administered-9, Injection-7)
auxpass(administered-9, is-8)
advcl(exercised-4, administered-9)
prep(administered-9, before-10)
conj_or(before-10, after-12)
conj_or(before-10, in-15)
pobj(in-15, conjunction-16)
amod(drugs-19, other-18)
prep_with(conjunction-16, drugs-19)
partmod(drugs-19, known-20)
aux(cause-22, to-21)
xcomp(known-20, cause-22)
dobj(cause-22, immunosuppression-23)
conj_or(immunosuppression-23, myelosuppression-25)

The/DT concurrent/JJ administration/NN of/IN allopurinol/NN and/CC ampicillin/NN increases/VBZ substantially/RB the/DT incidence/NN of/IN rashes/NNS in/IN patients/NNS receiving/VBG both/DT drugs/NNS as/IN compared/VBN to/TO patients/NNS receiving/VBG ampicillin/NN alone/RB ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concurrent) (NN administration)) (PP (IN of) (NP (NP (NN allopurinol)) (CC and) (NP (NN ampicillin))))) (VP (VBZ increases) (ADVP (RB substantially)) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NNS rashes))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (DT both) (NNS drugs)))))) (SBAR (IN as) (S (VP (VBN compared) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN ampicillin))))) (ADVP (RB alone))))))) (. .))))

det(administration-3, The-1)
amod(administration-3, concurrent-2)
nsubj(increases-8, administration-3)
prep_of(administration-3, allopurinol-5)
conj_and(allopurinol-5, ampicillin-7)
root(ROOT-0, increases-8)
advmod(increases-8, substantially-9)
det(incidence-11, the-10)
dobj(increases-8, incidence-11)
prep_of(incidence-11, rashes-13)
prep_in(incidence-11, patients-15)
partmod(patients-15, receiving-16)
det(drugs-18, both-17)
dobj(receiving-16, drugs-18)
mark(compared-20, as-19)
advcl(increases-8, compared-20)
prep_to(compared-20, patients-22)
partmod(patients-22, receiving-23)
dobj(receiving-23, ampicillin-24)
advmod(compared-20, alone-25)

It/PRP is/VBZ not/RB known/VBN whether/IN this/DT potentiation/NN of/IN ampicillin/NN rashes/NNS is/VBZ due/JJ to/TO allopurinol/NN or/CC the/DT hyperuricemia/NN present/JJ in/IN these/DT patients/NNS ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (IN whether) (S (NP (NP (DT this) (NN potentiation)) (PP (IN of) (NP (NN ampicillin) (NNS rashes)))) (VP (VBZ is) (ADJP (JJ due) (PP (TO to) (NP (NP (NP (NN allopurinol)) (CC or) (NP (DT the) (NN hyperuricemia))) (ADJP (JJ present) (PP (IN in) (NP (DT these) (NNS patients))))))))))))) (. .))))

nsubjpass(known-4, It-1)
auxpass(known-4, is-2)
neg(known-4, not-3)
root(ROOT-0, known-4)
complm(due-12, whether-5)
det(potentiation-7, this-6)
nsubj(due-12, potentiation-7)
nn(rashes-10, ampicillin-9)
prep_of(potentiation-7, rashes-10)
cop(due-12, is-11)
ccomp(known-4, due-12)
prep_to(due-12, allopurinol-14)
det(hyperuricemia-17, the-16)
conj_or(allopurinol-14, hyperuricemia-17)
amod(allopurinol-14, present-18)
det(patients-21, these-20)
prep_in(present-18, patients-21)

In/IN controlled/JJ clinical/JJ trials/NNS of/IN AUGMENTIN/NN XR/NN ,/, 22/CD patients/NNS received/VBD concomitant/JJ allopurinol/NN and/CC AUGMENTIN/NN XR/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (JJ controlled) (JJ clinical) (NNS trials)) (PP (IN of) (NP (NN AUGMENTIN) (NN XR))))) (, ,) (NP (CD 22) (NNS patients)) (VP (VBD received) (NP (JJ concomitant) (NP (NP (NN allopurinol)) (CC and) (NP (NN AUGMENTIN))) (NN XR)))) (. .))))

amod(trials-4, controlled-2)
amod(trials-4, clinical-3)
prep_in(received-11, trials-4)
nn(XR-7, AUGMENTIN-6)
prep_of(trials-4, XR-7)
num(patients-10, 22-9)
nsubj(received-11, patients-10)
root(ROOT-0, received-11)
amod(XR-16, concomitant-12)
nn(XR-16, allopurinol-13)
conj_and(allopurinol-13, AUGMENTIN-15)
dobj(received-11, XR-16)

However/RB ,/, this/DT sample/NN size/NN is/VBZ too/RB small/JJ to/TO allow/VB for/IN any/DT conclusions/NNS to/TO be/VB drawn/VBN regarding/VBG the/DT risk/NN of/IN rashes/NNS with/IN concomitant/JJ AUGMENTIN/NN XR/NN and/CC allopurinol/NN use/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (DT this) (NN sample) (NN size)) (VP (VBZ is) (ADJP (RB too) (JJ small) (S (VP (TO to) (VP (VB allow) (PP (IN for) (NP (DT any) (NNS conclusions))) (S (VP (TO to) (VP (VB be) (VP (VBN drawn) (PP (VBG regarding) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (NNS rashes)) (PP (IN with) (NP (NP (JJ concomitant) (NN AUGMENTIN) (NN XR)) (CC and) (NP (NN allopurinol) (NN use)))))))))))))))))) (. .))))

advmod(small-8, However-1)
det(size-5, this-3)
nn(size-5, sample-4)
nsubj(small-8, size-5)
cop(small-8, is-6)
advmod(small-8, too-7)
root(ROOT-0, small-8)
aux(allow-10, to-9)
xcomp(small-8, allow-10)
det(conclusions-13, any-12)
prep_for(allow-10, conclusions-13)
aux(drawn-16, to-14)
auxpass(drawn-16, be-15)
xcomp(allow-10, drawn-16)
det(risk-19, the-18)
prep_regarding(drawn-16, risk-19)
prep_of(risk-19, rashes-21)
amod(XR-25, concomitant-23)
nn(XR-25, AUGMENTIN-24)
prep_with(rashes-21, XR-25)
nn(use-28, allopurinol-27)
conj_and(XR-25, use-28)

In/IN common/JJ with/IN other/JJ broad-spectrum/NN antibiotics/NNS ,/, AUGMENTIN/NN XR/NN may/MD reduce/VB the/DT efficacy/NN of/IN oral/JJ contraceptives/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (JJ common)) (PP (IN with) (NP (JJ other) (NN broad-spectrum) (NNS antibiotics))))) (, ,) (NP (NN AUGMENTIN) (NN XR)) (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (JJ oral) (NNS contraceptives))))))) (. .))))

prep_in(reduce-11, common-2)
amod(antibiotics-6, other-4)
nn(antibiotics-6, broad-spectrum-5)
prep_with(common-2, antibiotics-6)
nn(XR-9, AUGMENTIN-8)
nsubj(reduce-11, XR-9)
aux(reduce-11, may-10)
root(ROOT-0, reduce-11)
det(efficacy-13, the-12)
dobj(reduce-11, efficacy-13)
amod(contraceptives-16, oral-15)
prep_of(efficacy-13, contraceptives-16)

Additive/JJ CNS/NN depression/NN may/MD occur/VB when/WRB antihistamines/NNS are/VBP administered/VBN concomitantly/RB with/IN other/JJ CNS/NN depressants/NNS including/VBG barbiturates/NNS ,/, tranquilizers/NNS ,/, and/CC alcohol/NN ./.

(ROOT (S1 (S (S (NP (JJ Additive) (NN CNS) (NN depression)) (VP (MD may) (VP (VB occur) (SBAR (WHADVP (WRB when)) (S (NP (NNS antihistamines)) (VP (VBP are) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (JJ other) (NN CNS) (NNS depressants)) (PP (VBG including) (NP (NP (NNS barbiturates)) (, ,) (NP (NNS tranquilizers)) (, ,) (CC and) (NP (NN alcohol))))))))))))) (. .))))

amod(depression-3, Additive-1)
nn(depression-3, CNS-2)
nsubj(occur-5, depression-3)
aux(occur-5, may-4)
root(ROOT-0, occur-5)
advmod(administered-9, when-6)
nsubjpass(administered-9, antihistamines-7)
auxpass(administered-9, are-8)
advcl(occur-5, administered-9)
advmod(administered-9, concomitantly-10)
amod(depressants-14, other-12)
nn(depressants-14, CNS-13)
prep_with(administered-9, depressants-14)
prep_including(depressants-14, barbiturates-16)
conj_and(barbiturates-16, tranquilizers-18)
conj_and(barbiturates-16, alcohol-21)

Patients/NNS receiving/VBG antihistamines/NNS should/MD be/VB advised/VBN against/IN the/DT concurrent/JJ use/NN of/IN other/JJ CNS/NN depressant/NN drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (NNS antihistamines)))) (VP (MD should) (VP (VB be) (VP (VBN advised) (PP (IN against) (NP (NP (DT the) (JJ concurrent) (NN use)) (PP (IN of) (NP (JJ other) (NN CNS) (NN depressant) (NNS drugs))))))))) (. .))))

nsubjpass(advised-6, Patients-1)
partmod(Patients-1, receiving-2)
dobj(receiving-2, antihistamines-3)
aux(advised-6, should-4)
auxpass(advised-6, be-5)
root(ROOT-0, advised-6)
det(use-10, the-8)
amod(use-10, concurrent-9)
prep_against(advised-6, use-10)
amod(drugs-15, other-12)
nn(drugs-15, CNS-13)
nn(drugs-15, depressant-14)
prep_of(use-10, drugs-15)

Monoamine/NN oxidase/NN (/-LRB- MAO/NN )/-RRB- inhibitors/NNS prolong/VBP and/CC intensify/VBP the/DT anticholinergic/JJ effects/NNS of/IN antihistamines/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Monoamine) (NN oxidase)) (PRN (-LRB- -LRB-) (NP (NN MAO)) (-RRB- -RRB-))) (NNS inhibitors)) (VP (VP (VBP prolong)) (CC and) (VP (VBP intensify) (NP (NP (DT the) (JJ anticholinergic) (NNS effects)) (PP (IN of) (NP (NNS antihistamines))))))) (. .))))

nn(oxidase-2, Monoamine-1)
nn(inhibitors-6, oxidase-2)
abbrev(oxidase-2, MAO-4)
nsubj(prolong-7, inhibitors-6)
root(ROOT-0, prolong-7)
conj_and(prolong-7, intensify-9)
det(effects-12, the-10)
amod(effects-12, anticholinergic-11)
dobj(intensify-9, effects-12)
prep_of(effects-12, antihistamines-14)

Caution/NN should/MD be/VB exercised/VBN when/WRB anticoagulants/NNS are/VBP given/VBN in/IN conjunction/NN with/IN Atromid-S/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (NP (NNS anticoagulants)) (VP (VBP are) (VP (VBN given) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (NN Atromid-S))))))))))))) (. .))))

nsubjpass(exercised-4, Caution-1)
aux(exercised-4, should-2)
auxpass(exercised-4, be-3)
root(ROOT-0, exercised-4)
advmod(given-8, when-5)
nsubjpass(given-8, anticoagulants-6)
auxpass(given-8, are-7)
advcl(exercised-4, given-8)
prep_in(given-8, conjunction-10)
prep_with(conjunction-10, Atromid-S-12)

Usually/RB ,/, the/DT dosage/NN of/IN the/DT anticoagulant/NN should/MD be/VB reduced/VBN by/IN one-half/NN (/-LRB- depending/VBG on/IN the/DT individual/JJ case/NN )/-RRB- to/TO maintain/VB the/DT prothrombin/NN time/NN at/IN the/DT desired/JJ level/NN to/TO prevent/VB bleeding/JJ complications/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Usually)) (, ,) (NP (NP (DT the) (NN dosage)) (PP (IN of) (NP (DT the) (NN anticoagulant)))) (VP (MD should) (VP (VB be) (VP (VBN reduced) (PP (IN by) (NP (NN one-half)))) (PRN (-LRB- -LRB-) (PP (VBG depending) (PP (IN on) (NP (DT the) (JJ individual) (NN case)))) (-RRB- -RRB-))) (S (VP (TO to) (VP (VB maintain) (NP (DT the) (NN prothrombin) (NN time)) (PP (IN at) (NP (DT the) (JJ desired) (NN level) (S (VP (TO to) (VP (VB prevent) (NP (JJ bleeding) (NNS complications)))))))))))) (. .))))

advmod(reduced-10, Usually-1)
det(dosage-4, the-3)
nsubjpass(reduced-10, dosage-4)
xsubj(maintain-21, dosage-4)
det(anticoagulant-7, the-6)
prep_of(dosage-4, anticoagulant-7)
aux(reduced-10, should-8)
auxpass(reduced-10, be-9)
root(ROOT-0, reduced-10)
agent(reduced-10, one-half-12)
prepc_depending_on(reduced-10, on-15)
det(case-18, the-16)
amod(case-18, individual-17)
pobj(reduced-10, case-18)
aux(maintain-21, to-20)
xcomp(reduced-10, maintain-21)
det(time-24, the-22)
nn(time-24, prothrombin-23)
dobj(maintain-21, time-24)
det(level-28, the-26)
amod(level-28, desired-27)
prep_at(maintain-21, level-28)
aux(prevent-30, to-29)
infmod(level-28, prevent-30)
amod(complications-32, bleeding-31)
dobj(prevent-30, complications-32)

Frequent/JJ prothrombin/NN determinations/NNS are/VBP advisable/JJ until/IN it/PRP has/VBZ been/VBN determined/VBN definitely/RB that/IN the/DT prothrombin/NN level/NN has/VBZ been/VBN stabilized/VBN ./.

(ROOT (S1 (S (S (NP (JJ Frequent) (NN prothrombin) (NNS determinations)) (VP (VBP are) (ADJP (JJ advisable) (SBAR (IN until) (S (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN determined) (ADVP (RB definitely)) (SBAR (IN that) (S (NP (DT the) (NN prothrombin) (NN level)) (VP (VBZ has) (VP (VBN been) (VP (VBN stabilized)))))))))))))) (. .))))

amod(determinations-3, Frequent-1)
nn(determinations-3, prothrombin-2)
nsubj(advisable-5, determinations-3)
cop(advisable-5, are-4)
root(ROOT-0, advisable-5)
mark(determined-10, until-6)
nsubjpass(determined-10, it-7)
aux(determined-10, has-8)
auxpass(determined-10, been-9)
ccomp(advisable-5, determined-10)
advmod(determined-10, definitely-11)
complm(stabilized-18, that-12)
det(level-15, the-13)
nn(level-15, prothrombin-14)
nsubjpass(stabilized-18, level-15)
aux(stabilized-18, has-16)
auxpass(stabilized-18, been-17)
ccomp(determined-10, stabilized-18)

Atromid-S/NN may/MD displace/VB acidic/JJ drugs/NNS such/JJ as/IN phenytoin/NN or/CC tolbutamide/NN from/IN their/PRP$ binding/VBG sites/NNS ./.

(ROOT (S1 (S (S (NP (NN Atromid-S)) (VP (MD may) (VP (VB displace) (NP (NP (JJ acidic) (NNS drugs)) (PP (JJ such) (IN as) (NP (NP (NN phenytoin)) (CC or) (NP (NN tolbutamide))))) (PP (IN from) (NP (PRP$ their) (VBG binding) (NNS sites)))))) (. .))))

nsubj(displace-3, Atromid-S-1)
aux(displace-3, may-2)
root(ROOT-0, displace-3)
amod(drugs-5, acidic-4)
dobj(displace-3, drugs-5)
prep_such_as(drugs-5, phenytoin-8)
conj_or(phenytoin-8, tolbutamide-10)
poss(sites-14, their-12)
amod(sites-14, binding-13)
prep_from(displace-3, sites-14)

Caution/NN should/MD be/VB exercised/VBN when/WRB treating/VBG patients/NNS with/IN either/DT of/IN these/DT drugs/NNS or/CC other/JJ highly/RB protein-bound/JJ drugs/NNS and/CC Atromid-S/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (VP (VBG treating) (NP (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT either)) (PP (IN of) (NP (NP (DT these) (NNS drugs)) (CC or) (NP (JJ other) (ADJP (RB highly) (JJ protein-bound)) (NNS drugs))))))) (CC and) (NP (NN Atromid-S)))))))))) (. .))))

nsubjpass(exercised-4, Caution-1)
aux(exercised-4, should-2)
auxpass(exercised-4, be-3)
root(ROOT-0, exercised-4)
advmod(treating-6, when-5)
advcl(exercised-4, treating-6)
dobj(treating-6, patients-7)
prep_with(patients-7, either-9)
det(drugs-12, these-11)
prep_of(either-9, drugs-12)
amod(drugs-17, other-14)
advmod(protein-bound-16, highly-15)
amod(drugs-17, protein-bound-16)
conj_or(drugs-12, drugs-17)
conj_and(patients-7, Atromid-S-19)

The/DT hypoglycemic/JJ effect/NN of/IN tolbutamide/NN has/VBZ been/VBN reported/VBN to/TO increase/VB when/WRB Atromid-S/NN is/VBZ given/VBN concurrently/RB ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ hypoglycemic) (NN effect)) (PP (IN of) (NP (NN tolbutamide)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB increase) (SBAR (WHADVP (WRB when)) (S (NP (NN Atromid-S)) (VP (VBZ is) (VP (VBN given) (ADVP (RB concurrently))))))))))))) (. .))))

det(effect-3, The-1)
amod(effect-3, hypoglycemic-2)
nsubjpass(reported-8, effect-3)
xsubj(increase-10, effect-3)
prep_of(effect-3, tolbutamide-5)
aux(reported-8, has-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
aux(increase-10, to-9)
xcomp(reported-8, increase-10)
advmod(given-14, when-11)
nsubjpass(given-14, Atromid-S-12)
auxpass(given-14, is-13)
advcl(increase-10, given-14)
advmod(given-14, concurrently-15)

Fulminant/JJ rhabdomyolysis/NN has/VBZ been/VBN seen/VBN as/RB early/RB as/IN three/CD weeks/NNS after/IN initiation/NN of/IN combined/JJ therapy/NN with/IN another/DT fibrate/NN and/CC lovastatin/NN but/CC may/MD be/VB seen/VBN after/IN several/JJ months/NNS ./.

(ROOT (S1 (S (S (NP (JJ Fulminant) (NN rhabdomyolysis)) (VP (VP (VBZ has) (VP (VBN been) (VP (VBN seen) (ADVP (RB as) (RB early)) (PP (IN as) (NP (NP (CD three) (NNS weeks)) (PP (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (NP (JJ combined) (NN therapy)) (PP (IN with) (NP (DT another) (NP (NN fibrate)) (CC and) (NP (NN lovastatin))))))))))))) (CC but) (VP (MD may) (VP (VB be) (VP (VBN seen) (PP (IN after) (NP (JJ several) (NNS months)))))))) (. .))))

amod(rhabdomyolysis-2, Fulminant-1)
nsubjpass(seen-5, rhabdomyolysis-2)
aux(seen-5, has-3)
auxpass(seen-5, been-4)
root(ROOT-0, seen-5)
advmod(early-7, as-6)
advmod(seen-5, early-7)
num(weeks-10, three-9)
prep_as(seen-5, weeks-10)
prep_after(weeks-10, initiation-12)
amod(therapy-15, combined-14)
prep_of(initiation-12, therapy-15)
dep(fibrate-18, another-17)
prep_with(therapy-15, fibrate-18)
conj_and(fibrate-18, lovastatin-20)
aux(seen-24, may-22)
auxpass(seen-24, be-23)
conj_but(seen-5, seen-24)
amod(months-27, several-26)
prep_after(seen-24, months-27)

For/IN these/DT reasons/NNS ,/, it/PRP is/VBZ felt/VBN that/IN ,/, in/IN most/JJS subjects/NNS who/WP have/VBP had/VBD an/DT unsatisfactory/JJ lipid/NN response/NN to/TO either/DT drug/NN alone/RB ,/, the/DT possible/JJ benefits/NNS of/IN combined/JJ therapy/NN with/IN lovastatin/NN and/CC a/DT fibrate/NN do/VBP not/RB outweigh/VB the/DT risks/NNS of/IN severe/JJ myopathy/NN ,/, rhabdomyolysis/NN ,/, and/CC acute/JJ renal/JJ failure/NN ./.

(ROOT (S1 (S (S (PP (IN For) (NP (DT these) (NNS reasons))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN felt) (SBAR (IN that) (S (, ,) (PP (IN in) (NP (NP (JJS most) (NNS subjects)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (S (VP (VBD had) (NP (NP (DT an) (JJ unsatisfactory) (NN lipid) (NN response)) (PP (TO to) (NP (NP (DT either) (NN drug)) (ADVP (RB alone)))))))))))) (, ,) (NP (NP (DT the) (JJ possible) (NNS benefits)) (PP (IN of) (NP (NP (JJ combined) (NN therapy)) (PP (IN with) (NP (NP (NN lovastatin)) (CC and) (NP (DT a) (NN fibrate))))))) (VP (VBP do) (RB not) (VP (VB outweigh) (NP (NP (DT the) (NNS risks)) (PP (IN of) (NP (NP (JJ severe) (NN myopathy)) (, ,) (NP (NN rhabdomyolysis)) (, ,) (CC and) (NP (JJ acute) (JJ renal) (NN failure)))))))))))) (. .))))

det(reasons-3, these-2)
prep_for(felt-7, reasons-3)
nsubjpass(felt-7, it-5)
auxpass(felt-7, is-6)
root(ROOT-0, felt-7)
complm(outweigh-38, that-8)
amod(subjects-12, most-11)
nsubj(have-14, subjects-12)
prep_in(outweigh-38, subjects-12)
rcmod(subjects-12, have-14)
ccomp(have-14, had-15)
det(response-19, an-16)
amod(response-19, unsatisfactory-17)
nn(response-19, lipid-18)
dobj(had-15, response-19)
det(drug-22, either-21)
prep_to(response-19, drug-22)
advmod(drug-22, alone-23)
det(benefits-27, the-25)
amod(benefits-27, possible-26)
nsubj(outweigh-38, benefits-27)
amod(therapy-30, combined-29)
prep_of(benefits-27, therapy-30)
prep_with(therapy-30, lovastatin-32)
det(fibrate-35, a-34)
conj_and(lovastatin-32, fibrate-35)
aux(outweigh-38, do-36)
neg(outweigh-38, not-37)
ccomp(felt-7, outweigh-38)
det(risks-40, the-39)
dobj(outweigh-38, risks-40)
amod(myopathy-43, severe-42)
prep_of(risks-40, myopathy-43)
conj_and(myopathy-43, rhabdomyolysis-45)
amod(failure-50, acute-48)
amod(failure-50, renal-49)
conj_and(myopathy-43, failure-50)

While/IN it/PRP is/VBZ not/RB known/VBN whether/IN this/DT interaction/NN occurs/VBZ with/IN fibrates/NNS other/JJ than/IN gemfibrozil/NN ,/, myopathy/NN and/CC rhabdomyolysis/NN have/VBP occasionally/RB been/VBN associated/VBN with/IN the/DT use/NN of/IN fibrates/NNS alone/RB ,/, including/VBG clofibrate/NN ./.

(ROOT (S1 (S (S (SBAR (IN While) (S (NP (PRP it)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (IN whether) (S (NP (DT this) (NN interaction)) (VP (VBZ occurs) (PP (IN with) (NP (NP (NNS fibrates)) (ADJP (JJ other) (PP (IN than) (NP (NN gemfibrozil))))))))))))) (, ,) (NP (NP (NN myopathy)) (CC and) (NP (NN rhabdomyolysis))) (VP (VBP have) (ADVP (RB occasionally)) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NNS fibrates)) (ADVP (RB alone)) (, ,) (PP (VBG including) (NP (NN clofibrate))))))))))) (. .))))

mark(known-5, While-1)
nsubjpass(known-5, it-2)
auxpass(known-5, is-3)
neg(known-5, not-4)
advcl(associated-22, known-5)
complm(occurs-9, whether-6)
det(interaction-8, this-7)
nsubj(occurs-9, interaction-8)
ccomp(known-5, occurs-9)
prep_with(occurs-9, fibrates-11)
amod(fibrates-11, other-12)
prep_than(other-12, gemfibrozil-14)
nsubjpass(associated-22, myopathy-16)
conj_and(myopathy-16, rhabdomyolysis-18)
aux(associated-22, have-19)
advmod(associated-22, occasionally-20)
auxpass(associated-22, been-21)
root(ROOT-0, associated-22)
det(use-25, the-24)
prep_with(associated-22, use-25)
prep_of(use-25, fibrates-27)
advmod(fibrates-27, alone-28)
prep_including(fibrates-27, clofibrate-31)

Therefore/RB ,/, the/DT combined/JJ use/NN of/IN lovastatin/NN with/IN fibrates/NNS should/MD generally/RB be/VB avoided/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT the) (JJ combined) (NN use)) (PP (IN of) (NP (NN lovastatin))) (PP (IN with) (NP (NNS fibrates)))) (VP (MD should) (ADVP (RB generally)) (VP (VB be) (VP (VBN avoided))))) (. .))))

advmod(avoided-13, Therefore-1)
det(use-5, the-3)
amod(use-5, combined-4)
nsubjpass(avoided-13, use-5)
prep_of(use-5, lovastatin-7)
prep_with(use-5, fibrates-9)
aux(avoided-13, should-10)
advmod(avoided-13, generally-11)
auxpass(avoided-13, be-12)
root(ROOT-0, avoided-13)

Drug/NN interactions/NNS with/IN clomiphene/NN citrate/NN tablets/NNS USP/NN have/VBP not/RB been/VBN documented/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NNS interactions)) (PP (IN with) (NP (NP (NN clomiphene) (NN citrate)) (NNS tablets) (NN USP)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN documented))))) (. .))))

nn(interactions-2, Drug-1)
nsubjpass(documented-11, interactions-2)
nn(citrate-5, clomiphene-4)
nn(USP-7, citrate-5)
nn(USP-7, tablets-6)
prep_with(interactions-2, USP-7)
aux(documented-11, have-8)
neg(documented-11, not-9)
auxpass(documented-11, been-10)
root(ROOT-0, documented-11)

The/DT risks/NNS of/IN using/VBG Anafranil/NN in/IN combination/NN with/IN other/JJ drugs/NNS have/VBP not/RB been/VBN systematically/RB evaluated/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS risks)) (PP (IN of) (S (VP (VBG using) (NP (NN Anafranil)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ other) (NNS drugs))))))))) (VP (VBP have) (RB not) (VP (VBN been) (ADVP (RB systematically)) (VP (VBN evaluated))))) (. .))))

det(risks-2, The-1)
nsubjpass(evaluated-15, risks-2)
prepc_of(risks-2, using-4)
dobj(using-4, Anafranil-5)
prep_in(using-4, combination-7)
amod(drugs-10, other-9)
prep_with(combination-7, drugs-10)
aux(evaluated-15, have-11)
neg(evaluated-15, not-12)
auxpass(evaluated-15, been-13)
advmod(evaluated-15, systematically-14)
root(ROOT-0, evaluated-15)

Given/IN the/DT primary/JJ CNS/NN effects/NNS of/IN Anafranil/NN ,/, caution/NN is/VBZ advised/VBN in/IN using/VBG it/PRP concomitantly/RB with/IN other/JJ CNS-active/JJ drugs/NNS ./.

(ROOT (S1 (S (S (PP (IN Given) (NP (NP (DT the) (JJ primary) (NN CNS) (NNS effects)) (PP (IN of) (NP (NN Anafranil))))) (, ,) (NP (NN caution)) (VP (VBZ is) (VP (VBN advised) (PP (IN in) (S (VP (VBG using) (NP (NP (PRP it)) (ADVP (RB concomitantly)) (PP (IN with) (NP (JJ other) (JJ CNS-active) (NNS drugs)))))))))) (. .))))

det(effects-5, the-2)
amod(effects-5, primary-3)
nn(effects-5, CNS-4)
prep_given(advised-11, effects-5)
prep_of(effects-5, Anafranil-7)
nsubjpass(advised-11, caution-9)
auxpass(advised-11, is-10)
root(ROOT-0, advised-11)
prepc_in(advised-11, using-13)
dobj(using-13, it-14)
advmod(it-14, concomitantly-15)
amod(drugs-19, other-17)
amod(drugs-19, CNS-active-18)
prep_with(it-14, drugs-19)

Anafranil/NN should/MD not/RB be/VB used/VBN with/IN MAO/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (NN Anafranil)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN MAO) (NNS inhibitors))))))) (. .))))

nsubjpass(used-5, Anafranil-1)
aux(used-5, should-2)
neg(used-5, not-3)
auxpass(used-5, be-4)
root(ROOT-0, used-5)
nn(inhibitors-8, MAO-7)
prep_with(used-5, inhibitors-8)

Close/JJ supervision/NN and/CC careful/JJ adjustment/NN of/IN dosage/NN are/VBP required/VBN when/WRB Anafranil/NN is/VBZ administered/VBN with/IN anticholinergic/JJ or/CC sympathomimetic/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Close) (NN supervision)) (CC and) (NP (JJ careful) (NN adjustment))) (PP (IN of) (NP (NN dosage)))) (VP (VBP are) (VP (VBN required) (SBAR (WHADVP (WRB when)) (S (NP (NN Anafranil)) (VP (VBZ is) (VP (VBN administered) (PP (IN with) (NP (ADJP (ADJP (JJ anticholinergic)) (CC or) (ADJP (JJ sympathomimetic))) (NNS drugs)))))))))) (. .))))

amod(supervision-2, Close-1)
nsubjpass(required-9, supervision-2)
amod(adjustment-5, careful-4)
conj_and(supervision-2, adjustment-5)
prep_of(supervision-2, dosage-7)
auxpass(required-9, are-8)
root(ROOT-0, required-9)
advmod(administered-13, when-10)
nsubjpass(administered-13, Anafranil-11)
auxpass(administered-13, is-12)
advcl(required-9, administered-13)
amod(drugs-18, anticholinergic-15)
conj_or(anticholinergic-15, sympathomimetic-17)
prep_with(administered-13, drugs-18)

Several/JJ tricyclic/JJ antidepressants/NNS have/VBP been/VBN reported/VBN to/TO block/VB the/DT pharmacologic/JJ effects/NNS of/IN guanethidine/NN ,/, clonidine/NN ,/, or/CC similar/JJ agents/NNS ,/, and/CC such/PDT an/DT effect/NN may/MD be/VB anticipated/VBN with/IN CMI/NN because/IN of/IN its/PRP$ structural/JJ similarity/NN to/TO other/JJ tricyclic/JJ antidepressants/NNS ./.

(ROOT (S1 (S (S (S (NP (JJ Several) (JJ tricyclic) (NNS antidepressants)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB block) (NP (NP (DT the) (JJ pharmacologic) (NNS effects)) (PP (IN of) (NP (NP (NN guanethidine)) (, ,) (NP (NN clonidine)) (, ,) (CC or) (NP (JJ similar) (NNS agents)))))))))))) (, ,) (CC and) (S (NP (PDT such) (DT an) (NN effect)) (VP (MD may) (VP (VB be) (VP (VBN anticipated) (PP (IN with) (NP (NN CMI))) (PP (IN because) (IN of) (NP (NP (PRP$ its) (JJ structural) (NN similarity)) (PP (TO to) (NP (JJ other) (JJ tricyclic) (NNS antidepressants)))))))))) (. .))))

amod(antidepressants-3, Several-1)
amod(antidepressants-3, tricyclic-2)
nsubjpass(reported-6, antidepressants-3)
xsubj(block-8, antidepressants-3)
aux(reported-6, have-4)
auxpass(reported-6, been-5)
root(ROOT-0, reported-6)
aux(block-8, to-7)
xcomp(reported-6, block-8)
det(effects-11, the-9)
amod(effects-11, pharmacologic-10)
dobj(block-8, effects-11)
prep_of(effects-11, guanethidine-13)
conj_or(guanethidine-13, clonidine-15)
amod(agents-19, similar-18)
conj_or(guanethidine-13, agents-19)
predet(effect-24, such-22)
det(effect-24, an-23)
nsubjpass(anticipated-27, effect-24)
aux(anticipated-27, may-25)
auxpass(anticipated-27, be-26)
conj_and(reported-6, anticipated-27)
prep_with(anticipated-27, CMI-29)
poss(similarity-34, its-32)
amod(similarity-34, structural-33)
prep_because_of(anticipated-27, similarity-34)
amod(antidepressants-38, other-36)
amod(antidepressants-38, tricyclic-37)
prep_to(similarity-34, antidepressants-38)

The/DT plasma/NN concentration/NN of/IN CMI/NN has/VBZ been/VBN reported/VBN to/TO be/VB increased/VBN by/IN the/DT concomitant/JJ administration/NN of/IN haloperidol/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN plasma) (NN concentration)) (PP (IN of) (NP (NN CMI)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (VP (VBN increased) (PP (IN by) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN haloperidol)))))))))))) (: ;)) (. .))))

det(concentration-3, The-1)
nn(concentration-3, plasma-2)
nsubjpass(reported-8, concentration-3)
xsubj(increased-11, concentration-3)
prep_of(concentration-3, CMI-5)
aux(reported-8, has-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
aux(increased-11, to-9)
auxpass(increased-11, be-10)
xcomp(reported-8, increased-11)
det(administration-15, the-13)
amod(administration-15, concomitant-14)
agent(increased-11, administration-15)
prep_of(administration-15, haloperidol-17)

plasma/NN levels/NNS of/IN several/JJ closely/RB related/JJ tricyclic/JJ antidepressants/NNS have/VBP been/VBN reported/VBN to/TO be/VB increased/VBN by/IN the/DT concomitant/JJ administration/NN of/IN methylphenidate/NN or/CC hepatic/JJ enzyme/NN inhibitors/NNS (/-LRB- e.g./FW ,/, cimetidine/NN ,/, fluoxetine/NN )/-RRB- and/CC decreased/VBN by/IN the/DT concomitant/JJ administration/NN of/IN hepatic/JJ enzyme/NN inducers/NNS (/-LRB- e.g./FW ,/, barbiturates/NNS ,/, phenytoin/NN )/-RRB- ,/, and/CC such/PDT an/DT effect/NN may/MD be/VB anticipated/VBN with/IN CMI/NN as/RB well/RB ./.

(ROOT (S1 (S (S (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (JJ several) (ADJP (RB closely) (JJ related)) (JJ tricyclic) (NNS antidepressants)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (VP (VP (VBN increased) (PP (IN by) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN methylphenidate)) (CC or) (NP (NP (JJ hepatic) (NN enzyme) (NNS inhibitors)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN cimetidine)) (, ,) (NP (NN fluoxetine))) (-RRB- -RRB-)))))))) (CC and) (VP (VBN decreased) (PP (IN by) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (JJ hepatic) (NN enzyme) (NNS inducers)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NNS barbiturates)) (, ,) (NP (NN phenytoin))) (-RRB- -RRB-))))))))))))))) (, ,) (CC and) (S (NP (PDT such) (DT an) (NN effect)) (VP (MD may) (VP (VB be) (VP (VBN anticipated) (PP (IN with) (NP (NN CMI))) (ADVP (RB as) (RB well)))))) (. .))))

nn(levels-2, plasma-1)
nsubjpass(reported-11, levels-2)
xsubj(increased-14, levels-2)
amod(antidepressants-8, several-4)
advmod(related-6, closely-5)
amod(antidepressants-8, related-6)
amod(antidepressants-8, tricyclic-7)
prep_of(levels-2, antidepressants-8)
aux(reported-11, have-9)
auxpass(reported-11, been-10)
root(ROOT-0, reported-11)
aux(increased-14, to-12)
auxpass(increased-14, be-13)
xcomp(reported-11, increased-14)
det(administration-18, the-16)
amod(administration-18, concomitant-17)
agent(increased-14, administration-18)
prep_of(administration-18, methylphenidate-20)
amod(inhibitors-24, hepatic-22)
nn(inhibitors-24, enzyme-23)
conj_or(methylphenidate-20, inhibitors-24)
dep(cimetidine-28, e.g.-26)
dep(inhibitors-24, cimetidine-28)
appos(cimetidine-28, fluoxetine-30)
conj_and(increased-14, decreased-33)
det(administration-37, the-35)
amod(administration-37, concomitant-36)
prep_by(decreased-33, administration-37)
amod(inducers-41, hepatic-39)
nn(inducers-41, enzyme-40)
prep_of(administration-37, inducers-41)
dep(barbiturates-45, e.g.-43)
dep(inducers-41, barbiturates-45)
appos(barbiturates-45, phenytoin-47)
predet(effect-53, such-51)
det(effect-53, an-52)
nsubjpass(anticipated-56, effect-53)
aux(anticipated-56, may-54)
auxpass(anticipated-56, be-55)
conj_and(reported-11, anticipated-56)
prep_with(anticipated-56, CMI-58)
advmod(well-60, as-59)
mwe(well-60, as-59)
advmod(anticipated-56, well-60)

Administration/NN of/IN CMI/NN has/VBZ been/VBN reported/VBN to/TO increase/VB the/DT plasma/NN levels/NNS of/IN phenobarbital/NN ,/, if/IN given/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN CMI)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN phenobarbital))))))))) (, ,) (SBAR (IN if) (S (VP (VBN given) (ADVP (RB concomitantly))))))) (. .))))

nsubjpass(reported-6, Administration-1)
xsubj(increase-8, Administration-1)
prep_of(Administration-1, CMI-3)
aux(reported-6, has-4)
auxpass(reported-6, been-5)
root(ROOT-0, reported-6)
aux(increase-8, to-7)
xcomp(reported-6, increase-8)
det(levels-11, the-9)
nn(levels-11, plasma-10)
dobj(increase-8, levels-11)
prep_of(levels-11, phenobarbital-13)
mark(given-16, if-15)
advcl(reported-6, given-16)
advmod(given-16, concomitantly-17)

Drugs/NNS Metabolized/VBN by/IN P450/NN 2D6/NN :/: The/DT biochemical/JJ activity/NN of/IN the/DT drug/NN metabolizing/NN isozyme/NN cytochrome/NN P450/NN 2D6/NN (/-LRB- debrisoquin/NN hydroxylase/NN )/-RRB- is/VBZ reduced/VBN in/IN a/DT subset/NN of/IN the/DT aucasian/JJ population/NN (/-LRB- about/RB 7/CD %/NN -10/CD %/NN of/IN Caucasians/NNP are/VBP so-called/JJ poor/JJ metabolizers/NNS )/-RRB- ;/: ./.

(ROOT (S1 (S (NP (NP (NP (NNS Drugs)) (VP (VBN Metabolized) (PP (IN by) (NP (NN P450) (NN 2D6))))) (: :) (S (NP (NP (DT The) (JJ biochemical) (NN activity)) (PP (IN of) (NP (NP (DT the) (NN drug) (NN metabolizing) (NN isozyme) (NN cytochrome) (NN P450) (NN 2D6)) (PRN (-LRB- -LRB-) (NP (NN debrisoquin) (NN hydroxylase)) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN reduced) (PP (IN in) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (NP (DT the) (JJ aucasian) (NN population)) (PRN (-LRB- -LRB-) (NP (NP (QP (RB about) (CD 7)) (NN %) (CD -10) (NN %)) (PP (IN of) (NP (NP (NNP Caucasians)) (VP (VBP are) (NP (JJ so-called) (JJ poor) (NNS metabolizers)))))) (-RRB- -RRB-)) (: ;)))))))) (. .)))))

root(ROOT-0, Drugs-1)
partmod(Drugs-1, Metabolized-2)
nn(2D6-5, P450-4)
agent(Metabolized-2, 2D6-5)
det(activity-9, The-7)
amod(activity-9, biochemical-8)
nsubjpass(reduced-23, activity-9)
det(2D6-17, the-11)
nn(2D6-17, drug-12)
nn(2D6-17, metabolizing-13)
nn(2D6-17, isozyme-14)
nn(2D6-17, cytochrome-15)
nn(2D6-17, P450-16)
prep_of(activity-9, 2D6-17)
nn(hydroxylase-20, debrisoquin-19)
appos(2D6-17, hydroxylase-20)
auxpass(reduced-23, is-22)
dep(Drugs-1, reduced-23)
det(subset-26, a-25)
prep_in(reduced-23, subset-26)
det(population-30, the-28)
amod(population-30, aucasian-29)
prep_of(subset-26, population-30)
quantmod(7-33, about-32)
num(%-36, 7-33)
nn(%-36, %-34)
num(%-36, -10-35)
dep(population-30, %-36)
prep_of(%-36, Caucasians-38)
cop(metabolizers-42, are-39)
amod(metabolizers-42, so-called-40)
amod(metabolizers-42, poor-41)
dep(Caucasians-38, metabolizers-42)

reliable/JJ estimates/NNS of/IN the/DT prevalence/NN of/IN reduced/VBN P450/NN 2D6/NN isozyme/NN activity/NN among/IN Asian/JJ ,/, African/JJ and/CC other/JJ populations/NNS are/VBP not/RB yet/RB available/JJ ./.

(ROOT (S1 (S (S (NP (NP (JJ reliable) (NNS estimates)) (PP (IN of) (NP (NP (DT the) (NN prevalence)) (PP (IN of) (NP (VBN reduced) (NN P450) (NN 2D6) (NN isozyme) (NN activity))) (PP (IN among) (NP (ADJP (ADJP (JJ Asian)) (, ,) (ADJP (JJ African)) (CC and) (ADJP (JJ other))) (NNS populations)))))) (VP (VBP are) (RB not) (ADVP (RB yet)) (ADJP (JJ available)))) (. .))))

amod(estimates-2, reliable-1)
nsubj(available-22, estimates-2)
det(prevalence-5, the-4)
prep_of(estimates-2, prevalence-5)
amod(activity-11, reduced-7)
nn(activity-11, P450-8)
nn(activity-11, 2D6-9)
nn(activity-11, isozyme-10)
prep_of(prevalence-5, activity-11)
amod(populations-18, Asian-13)
conj_and(Asian-13, African-15)
conj_and(Asian-13, other-17)
prep_among(prevalence-5, populations-18)
cop(available-22, are-19)
neg(available-22, not-20)
advmod(available-22, yet-21)
root(ROOT-0, available-22)

Poor/JJ metabolizers/NNS have/VBP higher/JJR than/IN expected/VBN lasma/NN concentrations/NNS of/IN tricyclic/JJ antidepressants/NNS (/-LRB- TCAs/NNS )/-RRB- when/WRB given/VBN usual/JJ doses/NNS ./.

(ROOT (S1 (S (S (NP (JJ Poor) (NNS metabolizers)) (VP (VBP have) (NP (NP (JJR higher) (IN than) (VBN expected) (NN lasma) (NNS concentrations)) (PP (IN of) (NP (NP (JJ tricyclic) (NNS antidepressants)) (PRN (-LRB- -LRB-) (NP (NNS TCAs)) (-RRB- -RRB-))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (NP (JJ usual) (NNS doses))))))) (. .))))

amod(metabolizers-2, Poor-1)
nsubj(have-3, metabolizers-2)
root(ROOT-0, have-3)
amod(concentrations-8, higher-4)
amod(concentrations-8, than-5)
amod(concentrations-8, expected-6)
nn(concentrations-8, lasma-7)
dobj(have-3, concentrations-8)
amod(antidepressants-11, tricyclic-10)
prep_of(concentrations-8, antidepressants-11)
appos(antidepressants-11, TCAs-13)
advmod(given-16, when-15)
advcl(have-3, given-16)
amod(doses-18, usual-17)
dobj(given-16, doses-18)

Depending/VBG on/IN the/DT fraction/NN of/IN drug/NN metabolized/VBN by/IN P450/NN 2D6/NN ,/, the/DT increase/NN in/IN plasma/NN concentration/NN may/MD be/VB small/JJ ,/, or/CC quite/RB large/JJ (/-LRB- 8/CD fold/JJ increase/NN in/IN plasma/NN AUC/NN of/IN the/DT TCA/NN )./NN

(ROOT (S1 (S (PP (VBG Depending) (PP (IN on) (NP (NP (DT the) (NN fraction)) (PP (IN of) (NP (NP (NN drug)) (VP (VBN metabolized) (PP (IN by) (NP (NN P450) (NN 2D6))))))))) (, ,) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NN plasma) (NN concentration)))) (VP (MD may) (VP (VB be) (ADJP (ADJP (JJ small)) (, ,) (CC or) (RB quite) (ADJP (JJ large))))) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 8) (JJ fold)) (NN increase)) (PP (IN in) (NP (NP (NN plasma) (NN AUC)) (PP (IN of) (NP (DT the) (NN TCA) (NN -RRB-.))))))))))

prepc_depending_on(small-19, on-2)
det(fraction-4, the-3)
pobj(small-19, fraction-4)
prep_of(fraction-4, drug-6)
partmod(drug-6, metabolized-7)
nn(2D6-10, P450-9)
agent(metabolized-7, 2D6-10)
det(increase-13, the-12)
nsubj(small-19, increase-13)
nn(concentration-16, plasma-15)
prep_in(increase-13, concentration-16)
aux(small-19, may-17)
cop(small-19, be-18)
root(ROOT-0, small-19)
advmod(small-19, quite-22)
conj_or(small-19, quite-22)
dep(small-19, large-23)
number(fold-26, 8-25)
amod(increase-27, fold-26)
dep(small-19, increase-27)
nn(AUC-30, plasma-29)
prep_in(increase-27, AUC-30)
det(-RRB-.-34, the-32)
nn(-RRB-.-34, TCA-33)
prep_of(AUC-30, -RRB-.-34)

In/IN addition/NN ,/, certain/JJ drugs/NNS inhibit/VB the/DT activity/NN of/IN this/DT isozyme/NN and/CC make/VB normal/JJ metabolizers/NNS resemble/VBP poor/JJ metabolizers/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (JJ certain) (NNS drugs)) (VP (VP (VB inhibit) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT this) (NN isozyme))))) (CC and) (VP (VB make) (NP (JJ normal) (NNS metabolizers)))) (VP (VBP resemble) (NP (JJ poor) (NNS metabolizers)))) (. .))))

prep_in(inhibit-6, addition-2)
amod(drugs-5, certain-4)
nsubj(inhibit-6, drugs-5)
root(ROOT-0, inhibit-6)
det(activity-8, the-7)
dobj(inhibit-6, activity-8)
det(isozyme-11, this-10)
prep_of(activity-8, isozyme-11)
conj_and(inhibit-6, make-13)
amod(metabolizers-15, normal-14)
dobj(make-13, metabolizers-15)
cop(metabolizers-18, resemble-16)
amod(metabolizers-18, poor-17)
dep(inhibit-6, metabolizers-18)

An/DT individual/JJ who/WP is/VBZ stable/JJ on/IN a/DT given/JJ dose/NN of/IN TCAmay/NN become/VBP abruptly/RB toxic/JJ when/WRB given/VBN one/CD of/IN these/DT inhibiting/JJ drugs/NNS as/IN concomitant/JJ therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (DT An) (JJ individual)) (SBAR (WHNP (WP who)) (S (VP (VBZ is) (ADJP (JJ stable) (PP (IN on) (NP (NP (DT a) (JJ given) (NN dose)) (PP (IN of) (NP (NN TCAmay)))))))))) (VP (VBP become) (ADJP (RB abruptly) (JJ toxic)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT these) (JJ inhibiting) (NNS drugs)) (PP (IN as) (NP (JJ concomitant) (NN therapy))))))))))) (. .))))

det(individual-2, An-1)
nsubj(stable-5, individual-2)
nsubj(toxic-14, individual-2)
cop(stable-5, is-4)
rcmod(individual-2, stable-5)
det(dose-9, a-7)
amod(dose-9, given-8)
prep_on(stable-5, dose-9)
prep_of(dose-9, TCAmay-11)
cop(toxic-14, become-12)
advmod(toxic-14, abruptly-13)
root(ROOT-0, toxic-14)
advmod(given-16, when-15)
advcl(toxic-14, given-16)
dobj(given-16, one-17)
det(drugs-21, these-19)
amod(drugs-21, inhibiting-20)
prep_of(one-17, drugs-21)
amod(therapy-24, concomitant-23)
prep_as(drugs-21, therapy-24)

The/DT drugs/NNS that/WDT inhibit/VBP cytochrome/NN P450/NN 2D6/NN include/VBP some/DT that/WDT are/VBP not/RB metabolized/VBN by/IN the/DT enzyme/NN (/-LRB- quinidine/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (NN cytochrome) (NN P450) (NN 2D6)))))) (VP (VBP include) (NP (NP (DT some)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (RB not) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (NN enzyme) (-LRB- -LRB-) (NN quinidine) (: ;)))))))))) (. .))))

det(drugs-2, The-1)
nsubj(inhibit-4, drugs-2)
nsubj(include-8, drugs-2)
rcmod(drugs-2, inhibit-4)
nn(2D6-7, cytochrome-5)
nn(2D6-7, P450-6)
dobj(inhibit-4, 2D6-7)
root(ROOT-0, include-8)
dobj(include-8, some-9)
nsubjpass(metabolized-13, some-9)
auxpass(metabolized-13, are-11)
neg(metabolized-13, not-12)
rcmod(some-9, metabolized-13)
det(quinidine-18, the-15)
nn(quinidine-18, enzyme-16)
agent(metabolized-13, quinidine-18)

cimetidine/NN )/-RRB- and/CC many/JJ that/WDT are/VBP substrates/NNS for/IN P450/NN 2D6/NN (/-LRB- many/JJ other/JJ antidepressants/NNS ,/, phenothiazines/NNS ,/, and/CC the/DT Type/NN 1C/NN antiarrhythmics/NNS propafenone/NN and/CC flecainide/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NP (NN cimetidine) (-RRB- -RRB-)) (CC and) (NP (NP (JJ many)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NNS substrates)) (PP (IN for) (NP (NN P450) (NN 2D6)))) (PRN (-LRB- -LRB-) (NP (NP (JJ many) (JJ other) (NNS antidepressants)) (, ,) (NP (NNS phenothiazines)) (, ,) (CC and) (NP (NP (DT the) (NN Type) (NN 1C) (NNS antiarrhythmics)) (NP (NP (NN propafenone)) (CC and) (NP (NN flecainide))))) (-RRB- -RRB-))))))) (. .)))))

root(ROOT-0, cimetidine-1)
conj_and(cimetidine-1, many-4)
nsubj(substrates-7, many-4)
cop(substrates-7, are-6)
rcmod(many-4, substrates-7)
nn(2D6-10, P450-9)
prep_for(substrates-7, 2D6-10)
amod(antidepressants-14, many-12)
amod(antidepressants-14, other-13)
dep(substrates-7, antidepressants-14)
conj_and(antidepressants-14, phenothiazines-16)
det(antiarrhythmics-22, the-19)
nn(antiarrhythmics-22, Type-20)
nn(antiarrhythmics-22, 1C-21)
conj_and(antidepressants-14, antiarrhythmics-22)
dep(antiarrhythmics-22, propafenone-23)
conj_and(propafenone-23, flecainide-25)

While/IN all/PDT the/DT selective/JJ serotonin/NN reuptake/NN inhibitors/NNS (/-LRB- SSRIs/NN )/-RRB- ,/, e.g./FW ,/, fluoxetine/NN ,/, sertraline/NN ,/, paroxetine/NN ,/, and/CC fluvoxamine/NN ,/, inhibit/VBP P450/NN 2D6/NN ,/, they/PRP may/MD vary/VB in/IN the/DT extent/NN of/IN inhibition/NN ./.

(ROOT (S1 (S (S (SBAR (IN While) (S (NP (NP (NP (PDT all) (DT the) (JJ selective) (NN serotonin) (NN reuptake) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NN SSRIs)) (-RRB- -RRB-))) (, ,) (PP (FW e.g.) (, ,) (NP (NN fluoxetine))) (, ,) (NP (NP (NN sertraline)) (, ,) (NP (NN paroxetine)) (, ,) (CC and) (NP (NN fluvoxamine))) (, ,)) (VP (VBP inhibit) (NP (NN P450) (NN 2D6))))) (, ,) (NP (PRP they)) (VP (MD may) (VP (VB vary) (PP (IN in) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NN inhibition)))))))) (. .))))

mark(inhibit-23, While-1)
predet(inhibitors-7, all-2)
det(inhibitors-7, the-3)
amod(inhibitors-7, selective-4)
nn(inhibitors-7, serotonin-5)
nn(inhibitors-7, reuptake-6)
nsubj(inhibit-23, inhibitors-7)
abbrev(inhibitors-7, SSRIs-9)
prep(inhibitors-7, e.g.-12)
pobj(e.g.-12, fluoxetine-14)
appos(inhibitors-7, sertraline-16)
conj_and(sertraline-16, paroxetine-18)
conj_and(sertraline-16, fluvoxamine-21)
advcl(vary-29, inhibit-23)
nn(2D6-25, P450-24)
dobj(inhibit-23, 2D6-25)
nsubj(vary-29, they-27)
aux(vary-29, may-28)
root(ROOT-0, vary-29)
det(extent-32, the-31)
prep_in(vary-29, extent-32)
prep_of(extent-32, inhibition-34)

Fluvoxamine/NN has/VBZ also/RB been/VBN shown/VBN to/TO inhibit/VB P450/NN 1A2/NN ,/, an/DT isoform/NN also/RB involved/VBN in/IN TCAmetabolism/NN ./.

(ROOT (S1 (S (S (NP (NN Fluvoxamine)) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB inhibit) (NP (NP (NN P450) (NN 1A2)) (, ,) (NP (NP (DT an) (NN isoform)) (VP (ADVP (RB also)) (VBN involved) (PP (IN in) (NP (NN TCAmetabolism))))))))))))) (. .))))

nsubjpass(shown-5, Fluvoxamine-1)
xsubj(inhibit-7, Fluvoxamine-1)
aux(shown-5, has-2)
advmod(shown-5, also-3)
auxpass(shown-5, been-4)
root(ROOT-0, shown-5)
aux(inhibit-7, to-6)
xcomp(shown-5, inhibit-7)
nn(1A2-9, P450-8)
dobj(inhibit-7, 1A2-9)
det(isoform-12, an-11)
appos(1A2-9, isoform-12)
advmod(involved-14, also-13)
partmod(isoform-12, involved-14)
prep_in(involved-14, TCAmetabolism-16)

Of/IN particular/JJ importance/NN ,/, sufficient/JJ time/NN must/MD elapse/VB before/IN initiating/VBG TCAtreatment/NN in/IN a/DT patient/NN being/VBG withdrawn/NN from/IN fluoxetine/NN ,/, given/IN the/DT long/JJ half-life/NN of/IN the/DT parent/JJ and/CC active/JJ metabolite/NN (/-LRB- at/IN least/JJS 5/CD weeks/NNS may/MD be/VB necessary/JJ )./NN

(ROOT (S1 (S (PP (IN Of) (NP (JJ particular) (NN importance))) (, ,) (S (NP (JJ sufficient) (NN time)) (VP (MD must) (VP (VB elapse) (PP (IN before) (S (VP (VBG initiating) (NP (NN TCAtreatment))))) (PP (IN in) (NP (NP (DT a) (NN patient)) (VP (VBG being) (NP (NP (NN withdrawn)) (PP (IN from) (NP (NN fluoxetine))))))) (, ,) (SBAR (IN given) (S (NP (NP (DT the) (JJ long) (NN half-life)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ parent)) (CC and) (ADJP (JJ active))) (NN metabolite) (-LRB- -LRB-) (QP (IN at) (JJS least) (CD 5)) (NNS weeks)))) (VP (MD may) (VP (VB be) (NP (JJ necessary) (NN -RRB-.))))))))))))

amod(importance-3, particular-2)
prep_of(elapse-8, importance-3)
amod(time-6, sufficient-5)
nsubj(elapse-8, time-6)
aux(elapse-8, must-7)
root(ROOT-0, elapse-8)
prepc_before(elapse-8, initiating-10)
dobj(initiating-10, TCAtreatment-11)
det(patient-14, a-13)
prep_in(elapse-8, patient-14)
cop(withdrawn-16, being-15)
partmod(patient-14, withdrawn-16)
prep_from(withdrawn-16, fluoxetine-18)
mark(-RRB-.-38, given-20)
det(half-life-23, the-21)
amod(half-life-23, long-22)
nsubj(-RRB-.-38, half-life-23)
det(weeks-34, the-25)
amod(weeks-34, parent-26)
conj_and(parent-26, active-28)
nn(weeks-34, metabolite-29)
quantmod(5-33, at-31)
mwe(at-31, least-32)
pobj(at-31, least-32)
num(weeks-34, 5-33)
prep_of(half-life-23, weeks-34)
aux(-RRB-.-38, may-35)
cop(-RRB-.-38, be-36)
amod(-RRB-.-38, necessary-37)
advcl(elapse-8, -RRB-.-38)

Concomitant/JJ use/NN of/IN agents/NNS in/IN the/DT tricyclic/JJ antidepressant/JJ class/NN (/-LRB- which/WDT includes/VBZ Anafranil/NN )/-RRB- with/IN drugs/NNS that/WDT can/MD inhibit/VB cytochrome/NN P450/NN 2D6/NN may/MD require/VB lower/JJR doses/NNS than/IN usually/RB prescribed/VBN for/IN either/CC the/DT tricyclic/JJ antidepressant/JJ agent/NN or/CC the/DT other/JJ drug/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (NNS agents)) (PP (IN in) (NP (NP (DT the) (JJ tricyclic) (JJ antidepressant) (NN class)) (-LRB- -LRB-) (SBAR (WHNP (WDT which)) (S (VP (VBZ includes) (NP (NN Anafranil))))) (-RRB- -RRB-))))) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB inhibit) (NP (NN cytochrome) (NN P450) (NN 2D6))))))))) (VP (MD may) (VP (VB require) (NP (NP (JJR lower) (NNS doses)) (VP (ADVP (IN than) (RB usually)) (VBN prescribed) (PP (IN for) (NP (CC either) (NP (DT the) (JJ tricyclic) (JJ antidepressant) (NN agent)) (CC or) (NP (DT the) (JJ other) (NN drug))))))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(require-24, use-2)
prep_of(use-2, agents-4)
det(class-9, the-6)
amod(class-9, tricyclic-7)
amod(class-9, antidepressant-8)
prep_in(agents-4, class-9)
nsubj(includes-12, which-11)
rcmod(class-9, includes-12)
dobj(includes-12, Anafranil-13)
prep_with(use-2, drugs-16)
nsubj(inhibit-19, drugs-16)
aux(inhibit-19, can-18)
rcmod(drugs-16, inhibit-19)
nn(2D6-22, cytochrome-20)
nn(2D6-22, P450-21)
dobj(inhibit-19, 2D6-22)
aux(require-24, may-23)
root(ROOT-0, require-24)
amod(doses-26, lower-25)
dobj(require-24, doses-26)
advmod(prescribed-29, than-27)
advmod(than-27, usually-28)
partmod(doses-26, prescribed-29)
preconj(agent-35, either-31)
det(agent-35, the-32)
amod(agent-35, tricyclic-33)
amod(agent-35, antidepressant-34)
prep_for(prescribed-29, agent-35)
det(drug-39, the-37)
amod(drug-39, other-38)
conj_or(agent-35, drug-39)

Furthermore/RB ,/, whenever/RB one/CD of/IN these/DT drugs/NNS is/VBZ withdrawn/VBN from/IN co-therapy/NN ,/, an/DT increased/VBN dose/NN of/IN tricyclic/JJ antidepressant/JJ agent/NN may/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Furthermore)) (, ,) (S (ADVP (RB whenever)) (NP (NP (CD one)) (PP (IN of) (NP (DT these) (NNS drugs)))) (VP (VBZ is) (VP (VBN withdrawn) (PP (IN from) (NP (NN co-therapy)))))) (, ,) (NP (NP (DT an) (VBN increased) (NN dose)) (PP (IN of) (NP (JJ tricyclic) (JJ antidepressant) (NN agent)))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (. .))))

advmod(required-22, Furthermore-1)
advmod(withdrawn-9, whenever-3)
nsubjpass(withdrawn-9, one-4)
det(drugs-7, these-6)
prep_of(one-4, drugs-7)
auxpass(withdrawn-9, is-8)
ccomp(required-22, withdrawn-9)
prep_from(withdrawn-9, co-therapy-11)
det(dose-15, an-13)
amod(dose-15, increased-14)
nsubjpass(required-22, dose-15)
amod(agent-19, tricyclic-17)
amod(agent-19, antidepressant-18)
prep_of(dose-15, agent-19)
aux(required-22, may-20)
auxpass(required-22, be-21)
root(ROOT-0, required-22)

It/PRP is/VBZ desirable/JJ to/TO monitor/VB TCAplasma/NN levels/NNS whenever/RB an/DT agent/NN of/IN the/DT tricyclic/JJ antidepressant/JJ class/NN including/VBG Anafranil/NN is/VBZ going/JJ to/TO be/VB co-administered/VBN with/IN another/DT drug/NN known/VBN to/TO be/VB an/DT inhibitor/NN of/IN P450/NN 2D6/NN (/-LRB- and/or/CC P450/NN 1A2/NN )./CD

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ desirable)) (S (VP (TO to) (VP (VB monitor) (NP (NN TCAplasma) (NNS levels))))))) (S (ADVP (RB whenever)) (NP (NP (DT an) (NN agent)) (PP (IN of) (NP (NP (DT the) (JJ tricyclic) (JJ antidepressant) (NN class)) (PP (VBG including) (NP (NN Anafranil)))))) (VP (VBZ is) (ADJP (JJ going) (S (VP (TO to) (VP (VB be) (VP (VBN co-administered) (PP (IN with) (NP (NP (NP (DT another) (NN drug)) (VP (VBN known) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN P450) (NN 2D6)))))))) (-LRB- -LRB-)) (CC and/or) (NP (NN P450) (NN 1A2) (CD -RRB-.))))))))))))))

nsubj(desirable-3, It-1)
xsubj(monitor-5, It-1)
cop(desirable-3, is-2)
root(ROOT-0, desirable-3)
aux(monitor-5, to-4)
xcomp(desirable-3, monitor-5)
nn(levels-7, TCAplasma-6)
dobj(monitor-5, levels-7)
advmod(going-19, whenever-8)
det(agent-10, an-9)
nsubj(going-19, agent-10)
det(class-15, the-12)
amod(class-15, tricyclic-13)
amod(class-15, antidepressant-14)
prep_of(agent-10, class-15)
prep_including(class-15, Anafranil-17)
cop(going-19, is-18)
dep(desirable-3, going-19)
aux(co-administered-22, to-20)
auxpass(co-administered-22, be-21)
xcomp(going-19, co-administered-22)
det(drug-25, another-24)
prep_with(co-administered-22, drug-25)
partmod(drug-25, known-26)
aux(inhibitor-30, to-27)
cop(inhibitor-30, be-28)
det(inhibitor-30, an-29)
xcomp(known-26, inhibitor-30)
nn(2D6-33, P450-32)
prep_of(inhibitor-30, 2D6-33)
nn(1A2-37, P450-36)
conj_and/or(drug-25, 1A2-37)
num(1A2-37, -RRB-.-38)

Because/IN Anafranil/NN is/VBZ highly/RB bound/VBN to/TO serum/NN protein/NN ,/, the/DT administration/NN of/IN Anafranil/NN to/TO patients/NNS taking/VBG other/JJ drugs/NNS that/WDT are/VBP highly/RB bound/VBN to/TO protein/NN (/-LRB- e.g./FW ,/, warfarin/NN ,/, digoxin/NN )/-RRB- may/MD cause/VB an/DT increase/NN in/IN plasma/NN concentrations/NNS of/IN these/DT drugs/NNS ,/, potentially/RB resulting/VBG in/IN adverse/JJ effects/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NN Anafranil)) (VP (VBZ is) (ADVP (RB highly)) (VP (VBN bound) (PP (TO to) (NP (NN serum) (NN protein))))))) (, ,) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NN Anafranil))) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB highly)) (VP (VBN bound) (PP (TO to) (NP (NP (NN protein)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN warfarin))) (, ,) (NP (NN digoxin)) (-RRB- -RRB-))))))))))))) (VP (MD may) (VP (VB cause) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (DT these) (NNS drugs)))))) (, ,) (S (ADVP (RB potentially)) (VP (VBG resulting) (PP (IN in) (NP (JJ adverse) (NNS effects)))))))) (. .))))

mark(bound-5, Because-1)
nsubjpass(bound-5, Anafranil-2)
auxpass(bound-5, is-3)
advmod(bound-5, highly-4)
advcl(cause-33, bound-5)
nn(protein-8, serum-7)
prep_to(bound-5, protein-8)
det(administration-11, the-10)
nsubj(cause-33, administration-11)
prep_of(administration-11, Anafranil-13)
prep_to(administration-11, patients-15)
partmod(patients-15, taking-16)
amod(drugs-18, other-17)
dobj(taking-16, drugs-18)
nsubjpass(bound-22, drugs-18)
auxpass(bound-22, are-20)
advmod(bound-22, highly-21)
rcmod(drugs-18, bound-22)
prep_to(bound-22, protein-24)
dep(digoxin-30, e.g.-26)
pobj(e.g.-26, warfarin-28)
appos(protein-24, digoxin-30)
aux(cause-33, may-32)
root(ROOT-0, cause-33)
det(increase-35, an-34)
dobj(cause-33, increase-35)
nn(concentrations-38, plasma-37)
prep_in(increase-35, concentrations-38)
det(drugs-41, these-40)
prep_of(concentrations-38, drugs-41)
advmod(resulting-44, potentially-43)
partmod(cause-33, resulting-44)
xcomp(cause-33, resulting-44)
amod(effects-47, adverse-46)
prep_in(resulting-44, effects-47)

Conversely/RB ,/, adverse/JJ effects/NNS may/MD result/VB from/IN displacement/NN of/IN protein-bound/JJ Anafranil/NN by/IN other/JJ highly/RB bound/VBN drugs/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Conversely)) (, ,) (NP (JJ adverse) (NNS effects)) (VP (MD may) (VP (VB result) (PP (IN from) (NP (NP (NN displacement)) (PP (IN of) (NP (JJ protein-bound) (NN Anafranil))) (PP (IN by) (NP (JJ other) (ADJP (RB highly) (VBN bound)) (NNS drugs)))))))) (. .))))

advmod(result-6, Conversely-1)
amod(effects-4, adverse-3)
nsubj(result-6, effects-4)
aux(result-6, may-5)
root(ROOT-0, result-6)
prep_from(result-6, displacement-8)
amod(Anafranil-11, protein-bound-10)
prep_of(displacement-8, Anafranil-11)
amod(drugs-16, other-13)
advmod(bound-15, highly-14)
amod(drugs-16, bound-15)
prep_by(displacement-8, drugs-16)

Effect/NN of/IN Clonazepam/NN on/IN the/DT Pharmacokinetics/NNS of/IN Other/JJ Drugs/NNS :/: Clonazepam/NN does/VBZ not/RB appear/VB to/TO alter/VB the/DT pharmacokinetics/NNS of/IN phenytoin/NN ,/, carbamazepine/NN ,/, or/CC phenobarbital/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Effect)) (PP (IN of) (NP (NN Clonazepam))) (PP (IN on) (NP (NP (DT the) (NNS Pharmacokinetics)) (PP (IN of) (NP (JJ Other) (NNS Drugs)))))) (: :) (NP (NN Clonazepam)) (VP (VBZ does) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB alter) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN phenytoin)) (, ,) (NP (NN carbamazepine)) (, ,) (CC or) (NP (NN phenobarbital))))))))))) (. .))))

nsubj(appear-14, Effect-1)
xsubj(alter-16, Effect-1)
prep_of(Effect-1, Clonazepam-3)
det(Pharmacokinetics-6, the-5)
prep_on(Effect-1, Pharmacokinetics-6)
amod(Drugs-9, Other-8)
prep_of(Pharmacokinetics-6, Drugs-9)
nsubj(appear-14, Clonazepam-11)
xsubj(alter-16, Clonazepam-11)
aux(appear-14, does-12)
neg(appear-14, not-13)
root(ROOT-0, appear-14)
aux(alter-16, to-15)
xcomp(appear-14, alter-16)
det(pharmacokinetics-18, the-17)
dobj(alter-16, pharmacokinetics-18)
prep_of(pharmacokinetics-18, phenytoin-20)
conj_or(phenytoin-20, carbamazepine-22)
conj_or(phenytoin-20, phenobarbital-25)

The/DT effect/NN of/IN clonazepam/NN on/IN the/DT metabolism/NN of/IN other/JJ drugs/NNS has/VBZ not/RB been/VBN investigated/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN clonazepam))) (PP (IN on) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (JJ other) (NNS drugs)))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN investigated))))) (. .))))

det(effect-2, The-1)
nsubjpass(investigated-14, effect-2)
prep_of(effect-2, clonazepam-4)
det(metabolism-7, the-6)
prep_on(effect-2, metabolism-7)
amod(drugs-10, other-9)
prep_of(metabolism-7, drugs-10)
aux(investigated-14, has-11)
neg(investigated-14, not-12)
auxpass(investigated-14, been-13)
root(ROOT-0, investigated-14)

Effect/NN of/IN Other/JJ Drugs/NNS on/IN the/DT Pharmacokinetics/NNS of/IN Clonazepam/NN :/: Literature/NN reports/NNS suggest/VBP that/IN ranitidine/NN ,/, an/DT agent/NN that/WDT decreases/VBZ stomach/NN acidity/NN ,/, does/VBZ not/RB greatly/RB alter/VB clonazepam/NN pharmacokinetics/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Effect)) (PP (IN of) (NP (JJ Other) (NNS Drugs))) (PP (IN on) (NP (NP (DT the) (NNS Pharmacokinetics)) (PP (IN of) (NP (NN Clonazepam) (: :) (NN Literature) (NNS reports)))))) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN ranitidine)) (, ,) (NP (NP (DT an) (NN agent)) (SBAR (WHNP (WDT that)) (S (VP (VBZ decreases) (NP (NN stomach) (NN acidity)))))) (, ,)) (VP (VBZ does) (RB not) (ADVP (RB greatly)) (VP (VB alter) (NP (NN clonazepam) (NNS pharmacokinetics)))))))) (. .))))

nsubj(suggest-13, Effect-1)
amod(Drugs-4, Other-3)
prep_of(Effect-1, Drugs-4)
det(Pharmacokinetics-7, the-6)
prep_on(Effect-1, Pharmacokinetics-7)
nn(reports-12, Clonazepam-9)
nn(reports-12, Literature-11)
prep_of(Pharmacokinetics-7, reports-12)
root(ROOT-0, suggest-13)
complm(alter-27, that-14)
nsubj(alter-27, ranitidine-15)
det(agent-18, an-17)
appos(ranitidine-15, agent-18)
nsubj(decreases-20, agent-18)
rcmod(agent-18, decreases-20)
nn(acidity-22, stomach-21)
dobj(decreases-20, acidity-22)
aux(alter-27, does-24)
neg(alter-27, not-25)
advmod(alter-27, greatly-26)
ccomp(suggest-13, alter-27)
nn(pharmacokinetics-29, clonazepam-28)
dobj(alter-27, pharmacokinetics-29)

In/IN a/DT study/NN in/IN which/WDT the/DT 2/CD mg/NN clonazepam/NN orally/RB disintegrating/VBG tablet/NN was/VBD administered/VBN with/IN and/CC without/IN propantheline/NN (/-LRB- an/DT anticholinergic/JJ agent/NN with/IN multiple/JJ effects/NNS on/IN the/DT GI/JJ tract/NN )/-RRB- to/TO healthy/JJ volunteers/NNS ,/, the/DT AUC/NN of/IN clonazepam/NN was/VBD 10/CD %/NN lower/JJR and/CC the/DT Cmax/NN of/IN clonazepam/NN was/VBD 20/CD %/NN lower/JJR when/WRB the/DT orally/RB disintegrating/JJ tablet/NN was/VBD given/VBN with/IN propantheline/NN compared/VBN to/TO when/WRB it/PRP was/VBD given/VBN alone/RB ./.

(ROOT (S1 (S (S (S (PP (IN In) (NP (NP (DT a) (NN study)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (DT the) (ADJP (CD 2) (NN mg)) (NN clonazepam)) (VP (ADVP (RB orally)) (VBG disintegrating) (NP (NN tablet)))) (VP (VBD was) (VP (VBN administered) (PP (IN with) (CC and) (PP (IN without) (NP (NP (NN propantheline)) (PRN (-LRB- -LRB-) (NP (NP (DT an) (JJ anticholinergic) (NN agent)) (PP (IN with) (NP (NP (JJ multiple) (NNS effects)) (PP (IN on) (NP (DT the) (JJ GI) (NN tract)))))) (-RRB- -RRB-))))) (PP (TO to) (NP (JJ healthy) (NNS volunteers))))))))) (, ,) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NN clonazepam)))) (VP (VBD was) (ADJP (NP (CD 10) (NN %)) (JJR lower)))) (CC and) (S (NP (NP (DT the) (NN Cmax)) (PP (IN of) (NP (NN clonazepam)))) (VP (VBD was) (ADJP (NP (CD 20) (NN %)) (JJR lower)) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (ADJP (RB orally) (JJ disintegrating)) (NN tablet)) (VP (VBD was) (VP (VBN given) (PP (IN with) (NP (NN propantheline))) (PP (VBN compared) (PP (TO to) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBD was) (VP (VBN given) (ADVP (RB alone))))))))))))))) (. .))))

det(study-3, a-2)
prep_in(lower-42, study-3)
rel(administered-14, which-5)
det(clonazepam-9, the-6)
number(mg-8, 2-7)
amod(clonazepam-9, mg-8)
nsubjpass(administered-14, clonazepam-9)
advmod(disintegrating-11, orally-10)
partmod(clonazepam-9, disintegrating-11)
dobj(disintegrating-11, tablet-12)
auxpass(administered-14, was-13)
rcmod(study-3, administered-14)
prep(administered-14, with-15)
conj_and(with-15, without-17)
pobj(without-17, propantheline-18)
det(agent-22, an-20)
amod(agent-22, anticholinergic-21)
dep(propantheline-18, agent-22)
amod(effects-25, multiple-24)
prep_with(agent-22, effects-25)
det(tract-29, the-27)
amod(tract-29, GI-28)
prep_on(effects-25, tract-29)
amod(volunteers-33, healthy-32)
prep_to(administered-14, volunteers-33)
det(AUC-36, the-35)
nsubj(lower-42, AUC-36)
prep_of(AUC-36, clonazepam-38)
cop(lower-42, was-39)
num(%-41, 10-40)
npadvmod(lower-42, %-41)
root(ROOT-0, lower-42)
det(Cmax-45, the-44)
nsubj(lower-51, Cmax-45)
prep_of(Cmax-45, clonazepam-47)
cop(lower-51, was-48)
num(%-50, 20-49)
npadvmod(lower-51, %-50)
conj_and(lower-42, lower-51)
advmod(given-58, when-52)
det(tablet-56, the-53)
advmod(disintegrating-55, orally-54)
amod(tablet-56, disintegrating-55)
nsubjpass(given-58, tablet-56)
auxpass(given-58, was-57)
advcl(lower-51, given-58)
prep_with(given-58, propantheline-60)
prepc_compared_to(given-58, to-62)
advmod(given-66, when-63)
nsubjpass(given-66, it-64)
auxpass(given-66, was-65)
pcomp(given-58, given-66)
advmod(given-66, alone-67)

Fluoxetine/NN does/VBZ not/RB affect/VB the/DT pharmacokinetics/NNS of/IN clonazepam/NN ./.

(ROOT (S1 (S (S (NP (NN Fluoxetine)) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN clonazepam))))))) (. .))))

nsubj(affect-4, Fluoxetine-1)
aux(affect-4, does-2)
neg(affect-4, not-3)
root(ROOT-0, affect-4)
det(pharmacokinetics-6, the-5)
dobj(affect-4, pharmacokinetics-6)
prep_of(pharmacokinetics-6, clonazepam-8)

Cytochrome/NN P-450/NN inducers/NNS ,/, such/JJ as/IN phenytoin/NN ,/, carbamazepine/NN and/CC phenobarbital/NN ,/, induce/VBP clonazepam/NN metabolism/NN ,/, causing/VBG an/DT approximately/RB 30/CD %/NN decrease/NN in/IN plasma/NN clonazepam/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Cytochrome) (NN P-450)) (NNS inducers)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN phenytoin)) (, ,) (NP (NN carbamazepine)) (CC and) (NP (NN phenobarbital)))) (, ,)) (VP (VBP induce) (NP (NN clonazepam) (NN metabolism)) (, ,) (S (VP (VBG causing) (NP (NP (DT an) (ADJP (QP (RB approximately) (CD 30)) (NN %)) (NN decrease)) (PP (IN in) (NP (NN plasma) (NN clonazepam) (NNS levels)))))))) (. .))))

nn(P-450-2, Cytochrome-1)
nn(inducers-3, P-450-2)
nsubj(induce-13, inducers-3)
prep_such_as(inducers-3, phenytoin-7)
conj_and(phenytoin-7, carbamazepine-9)
conj_and(phenytoin-7, phenobarbital-11)
root(ROOT-0, induce-13)
nn(metabolism-15, clonazepam-14)
dobj(induce-13, metabolism-15)
partmod(induce-13, causing-17)
xcomp(induce-13, causing-17)
det(decrease-22, an-18)
quantmod(30-20, approximately-19)
dep(%-21, 30-20)
dep(decrease-22, %-21)
dobj(causing-17, decrease-22)
nn(levels-26, plasma-24)
nn(levels-26, clonazepam-25)
prep_in(decrease-22, levels-26)

Although/IN clinical/JJ studies/NNS have/VBP not/RB been/VBN performed/VBN ,/, based/VBN on/IN the/DT involvement/NN of/IN the/DT cytochrome/NN P-450/NN 3A/NN family/NN in/IN clonazepam/NN metabolism/NN ,/, inhibitors/NNS of/IN this/DT enzyme/NN system/NN ,/, notably/RB oral/JJ antifungal/JJ agents/NNS ,/, should/MD be/VB used/VBN cautiously/RB in/IN patients/NNS receiving/VBG clonazepam/NN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (JJ clinical) (NNS studies)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN performed)))))) (, ,) (PP (VBN based) (PP (IN on) (NP (NP (DT the) (NN involvement)) (PP (IN of) (NP (DT the) (NP (NN cytochrome) (NN P-450)) (NN 3A) (NN family))) (PP (IN in) (NP (NN clonazepam) (NN metabolism)))))) (, ,) (NP (NP (NP (NNS inhibitors)) (PP (IN of) (NP (DT this) (NN enzyme) (NN system)))) (, ,) (NP (ADVP (RB notably)) (NP (JJ oral) (JJ antifungal) (NNS agents))) (, ,)) (VP (MD should) (VP (VB be) (VP (VBN used) (ADVP (RB cautiously)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN clonazepam))))))))) (. .))))

mark(performed-7, Although-1)
amod(studies-3, clinical-2)
nsubjpass(performed-7, studies-3)
aux(performed-7, have-4)
neg(performed-7, not-5)
auxpass(performed-7, been-6)
advcl(used-36, performed-7)
prepc_based_on(used-36, on-10)
det(involvement-12, the-11)
pobj(used-36, involvement-12)
det(family-18, the-14)
nn(P-450-16, cytochrome-15)
nn(family-18, P-450-16)
nn(family-18, 3A-17)
prep_of(involvement-12, family-18)
nn(metabolism-21, clonazepam-20)
prep_in(involvement-12, metabolism-21)
nsubjpass(used-36, inhibitors-23)
det(system-27, this-25)
nn(system-27, enzyme-26)
prep_of(inhibitors-23, system-27)
advmod(agents-32, notably-29)
amod(agents-32, oral-30)
amod(agents-32, antifungal-31)
appos(inhibitors-23, agents-32)
aux(used-36, should-34)
auxpass(used-36, be-35)
root(ROOT-0, used-36)
advmod(used-36, cautiously-37)
prep_in(used-36, patients-39)
partmod(patients-39, receiving-40)
dobj(receiving-40, clonazepam-41)

Pharmacodynamic/JJ Interactions/NNS :/: The/DT CNS-depressant/JJ action/NN of/IN the/DT benzodiazepine/JJ class/NN of/IN drugs/NNS may/MD be/VB potentiated/VBN by/IN alcohol/NN ,/, narcotics/NNS ,/, barbiturates/NNS ,/, nonbarbiturate/NN hypnotics/NNS ,/, antianxiety/NN agents/NNS ,/, the/DT phenothiazines/NNS ,/, thioxanthene/JJ and/CC butyrophenone/JJ classes/NNS of/IN antipsychotic/JJ agents/NNS ,/, monoamine/NN oxidase/NN inhibitors/NNS and/CC the/DT tricyclic/JJ antidepressants/NNS ,/, and/CC by/IN other/JJ anticonvulsant/JJ drugs/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Pharmacodynamic) (NNS Interactions)) (: :) (S (NP (NP (DT The) (JJ CNS-depressant) (NN action)) (PP (IN of) (NP (NP (DT the) (JJ benzodiazepine) (NN class)) (PP (IN of) (NP (NNS drugs)))))) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (PP (PP (IN by) (NP (NP (NN alcohol)) (, ,) (NP (NP (NNS narcotics)) (, ,) (NP (NNS barbiturates)) (, ,) (NP (NN nonbarbiturate) (NNS hypnotics)) (, ,) (NP (NN antianxiety) (NNS agents)) (, ,) (NP (DT the) (NNS phenothiazines)) (, ,) (NP (NP (ADJP (ADJP (JJ thioxanthene)) (CC and) (ADJP (JJ butyrophenone))) (NNS classes)) (PP (IN of) (NP (JJ antipsychotic) (NNS agents)))) (, ,) (NP (NN monoamine) (NN oxidase) (NNS inhibitors)) (CC and) (NP (DT the) (JJ tricyclic) (NNS antidepressants))))) (, ,) (CC and) (PP (IN by) (NP (JJ other) (JJ anticonvulsant) (NNS drugs)))))))) (. .)))))

amod(Interactions-2, Pharmacodynamic-1)
root(ROOT-0, Interactions-2)
det(action-6, The-4)
amod(action-6, CNS-depressant-5)
nsubjpass(potentiated-15, action-6)
det(class-10, the-8)
amod(class-10, benzodiazepine-9)
prep_of(action-6, class-10)
prep_of(class-10, drugs-12)
aux(potentiated-15, may-13)
auxpass(potentiated-15, be-14)
dep(Interactions-2, potentiated-15)
agent(potentiated-15, alcohol-17)
appos(alcohol-17, narcotics-19)
conj_and(narcotics-19, barbiturates-21)
nn(hypnotics-24, nonbarbiturate-23)
conj_and(narcotics-19, hypnotics-24)
nn(agents-27, antianxiety-26)
conj_and(narcotics-19, agents-27)
det(phenothiazines-30, the-29)
conj_and(narcotics-19, phenothiazines-30)
amod(classes-35, thioxanthene-32)
conj_and(thioxanthene-32, butyrophenone-34)
conj_and(narcotics-19, classes-35)
amod(agents-38, antipsychotic-37)
prep_of(classes-35, agents-38)
nn(inhibitors-42, monoamine-40)
nn(inhibitors-42, oxidase-41)
conj_and(narcotics-19, inhibitors-42)
det(antidepressants-46, the-44)
amod(antidepressants-46, tricyclic-45)
conj_and(narcotics-19, antidepressants-46)
amod(drugs-52, other-50)
amod(drugs-52, anticonvulsant-51)
conj_and(alcohol-17, drugs-52)

Aspirin/NN ,/, warfarin/NN ,/, heparin/NN ,/, NSAIDs/NN ./.

(ROOT (S1 (S (S (NP (NN Aspirin)) (, ,) (NP (NP (NN warfarin)) (, ,) (NP (NN heparin)) (, ,) (NP (NN NSAIDs)))) (. .))))

dep(warfarin-3, Aspirin-1)
root(ROOT-0, warfarin-3)
appos(warfarin-3, heparin-5)
appos(warfarin-3, NSAIDs-7)

If/IN TRANXENE/NN is/VBZ to/TO be/VB combined/VBN with/IN other/JJ drugs/NNS acting/VBG on/IN the/DT central/JJ nervous/JJ system/NN ,/, careful/JJ consideration/NN should/MD be/VB given/VBN to/TO the/DT pharmacology/NN of/IN the/DT agents/NNS to/TO be/VB employed/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN TRANXENE)) (VP (VBZ is) (S (VP (TO to) (VP (VB be) (VP (VBN combined) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (VP (VBG acting) (PP (IN on) (NP (DT the) (JJ central) (JJ nervous) (NN system))))))))))))) (, ,) (NP (JJ careful) (NN consideration)) (VP (MD should) (VP (VB be) (VP (VBN given) (PP (TO to) (NP (NP (DT the) (NN pharmacology)) (PP (IN of) (NP (DT the) (NNS agents))) (S (VP (TO to) (VP (VB be) (VP (VBN employed))))))))))) (. .))))

mark(is-3, If-1)
nsubj(is-3, TRANXENE-2)
xsubj(combined-6, TRANXENE-2)
advcl(given-21, is-3)
aux(combined-6, to-4)
auxpass(combined-6, be-5)
xcomp(is-3, combined-6)
amod(drugs-9, other-8)
prep_with(combined-6, drugs-9)
partmod(drugs-9, acting-10)
det(system-15, the-12)
amod(system-15, central-13)
amod(system-15, nervous-14)
prep_on(acting-10, system-15)
amod(consideration-18, careful-17)
nsubjpass(given-21, consideration-18)
aux(given-21, should-19)
auxpass(given-21, be-20)
root(ROOT-0, given-21)
det(pharmacology-24, the-23)
prep_to(given-21, pharmacology-24)
det(agents-27, the-26)
prep_of(pharmacology-24, agents-27)
aux(employed-30, to-28)
auxpass(employed-30, be-29)
infmod(pharmacology-24, employed-30)

Animal/JJ experience/VBP indicates/VBZ that/IN clorazepate/NN dipotassium/NN prolongs/VBZ the/DT sleeping/JJ time/NN after/IN hexobarbital/NN or/CC after/IN ethyl/NN alcohol/NN ,/, increases/VBZ the/DT inhibitory/JJ effects/NNS of/IN chlorpromazine/NN ,/, but/CC does/VBZ not/RB exhibit/VB monoamine/NN oxidase/NN inhibition/NN ./.

(ROOT (S1 (S (S (NP (JJ Animal) (VBP experience)) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NN clorazepate) (NN dipotassium)) (VP (VP (VBZ prolongs) (NP (NP (DT the) (JJ sleeping) (NN time)) (PP (PP (IN after) (NP (NN hexobarbital))) (CC or) (PP (IN after) (NP (NN ethyl) (NN alcohol)))))) (, ,) (VP (VBZ increases) (NP (NP (DT the) (JJ inhibitory) (NNS effects)) (PP (IN of) (NP (NN chlorpromazine))))) (, ,) (CC but) (VP (VBZ does) (RB not) (VP (VB exhibit) (NP (NP (NN monoamine) (NN oxidase)) (NN inhibition))))))))) (. .))))

nsubj(indicates-3, Animal-1)
dep(Animal-1, experience-2)
root(ROOT-0, indicates-3)
complm(prolongs-7, that-4)
nn(dipotassium-6, clorazepate-5)
nsubj(prolongs-7, dipotassium-6)
ccomp(indicates-3, prolongs-7)
det(time-10, the-8)
amod(time-10, sleeping-9)
dobj(prolongs-7, time-10)
prep_after(time-10, hexobarbital-12)
nn(alcohol-16, ethyl-15)
conj_or(hexobarbital-12, alcohol-16)
conj_but(prolongs-7, increases-18)
det(effects-21, the-19)
amod(effects-21, inhibitory-20)
dobj(increases-18, effects-21)
prep_of(effects-21, chlorpromazine-23)
aux(exhibit-28, does-26)
neg(exhibit-28, not-27)
conj_but(prolongs-7, exhibit-28)
nn(oxidase-30, monoamine-29)
nn(inhibition-31, oxidase-30)
dobj(exhibit-28, inhibition-31)

Clinical/JJ studies/NNS have/VBP shown/VBN increased/VBN sedation/NN with/IN concurrent/JJ hypnotic/JJ medications/NNS ./.

(ROOT (S1 (S (S (NP (JJ Clinical) (NNS studies)) (VP (VBP have) (VP (VBN shown) (NP (NP (VBN increased) (NN sedation)) (PP (IN with) (NP (JJ concurrent) (JJ hypnotic) (NNS medications))))))) (. .))))

amod(studies-2, Clinical-1)
nsubj(shown-4, studies-2)
aux(shown-4, have-3)
root(ROOT-0, shown-4)
amod(sedation-6, increased-5)
dobj(shown-4, sedation-6)
amod(medications-10, concurrent-8)
amod(medications-10, hypnotic-9)
prep_with(sedation-6, medications-10)

The/DT actions/NNS of/IN the/DT benzodiazepines/NNS may/MD be/VB potentiated/VBN by/IN barbiturates/NNS ,/, narcotics/NNS ,/, phenothiazines/NNS ,/, monoamine/NN oxidase/NN inhibitors/NNS or/CC other/JJ antidepressants/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS actions)) (PP (IN of) (NP (DT the) (NNS benzodiazepines)))) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (PP (IN by) (NP (NP (NNS barbiturates)) (, ,) (NP (NNS narcotics)) (, ,) (NP (NNS phenothiazines)) (, ,) (NP (NN monoamine) (NN oxidase) (NNS inhibitors)) (CC or) (NP (JJ other) (NNS antidepressants)))))))) (. .))))

det(actions-2, The-1)
nsubjpass(potentiated-8, actions-2)
det(benzodiazepines-5, the-4)
prep_of(actions-2, benzodiazepines-5)
aux(potentiated-8, may-6)
auxpass(potentiated-8, be-7)
root(ROOT-0, potentiated-8)
agent(potentiated-8, barbiturates-10)
conj_or(barbiturates-10, narcotics-12)
conj_or(barbiturates-10, phenothiazines-14)
nn(inhibitors-18, monoamine-16)
nn(inhibitors-18, oxidase-17)
conj_or(barbiturates-10, inhibitors-18)
amod(antidepressants-21, other-20)
conj_or(barbiturates-10, antidepressants-21)

If/IN TRANXENE/NN tablets/NNS are/VBP used/VBN to/TO treat/VB anxiety/NN associated/VBN with/IN somatic/JJ disease/NN states/NNS ,/, careful/JJ attention/NN must/MD be/VB paid/JJ to/TO possible/JJ drug/NN interaction/NN with/IN concomitant/JJ medication/NN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN TRANXENE) (NNS tablets)) (VP (VBP are) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (NP (NN anxiety)) (VP (VBN associated) (PP (IN with) (NP (JJ somatic) (NN disease) (NNS states)))))))))))) (, ,) (NP (JJ careful) (NN attention)) (VP (MD must) (VP (VB be) (ADJP (JJ paid) (PP (TO to) (NP (NP (JJ possible) (NN drug) (NN interaction)) (PP (IN with) (NP (JJ concomitant) (NN medication))))))))) (. .))))

mark(used-5, If-1)
nn(tablets-3, TRANXENE-2)
nsubjpass(used-5, tablets-3)
xsubj(treat-7, tablets-3)
auxpass(used-5, are-4)
advcl(paid-19, used-5)
aux(treat-7, to-6)
xcomp(used-5, treat-7)
dobj(treat-7, anxiety-8)
partmod(anxiety-8, associated-9)
amod(states-13, somatic-11)
nn(states-13, disease-12)
prep_with(associated-9, states-13)
amod(attention-16, careful-15)
nsubj(paid-19, attention-16)
aux(paid-19, must-17)
cop(paid-19, be-18)
root(ROOT-0, paid-19)
amod(interaction-23, possible-21)
nn(interaction-23, drug-22)
prep_to(paid-19, interaction-23)
amod(medication-26, concomitant-25)
prep_with(interaction-23, medication-26)

In/IN bioavailability/JJ studies/NNS with/IN normal/JJ subjects/NNS ,/, the/DT concurrent/JJ administration/NN of/IN antacids/NNS at/IN therapeutic/JJ levels/NNS did/VBD not/RB significantly/RB influence/VB the/DT bioavailability/NN of/IN TRANXENE/JJ tablets/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (JJ bioavailability) (NNS studies)) (PP (IN with) (NP (JJ normal) (NNS subjects))))) (, ,) (NP (NP (DT the) (JJ concurrent) (NN administration)) (PP (IN of) (NP (NNS antacids))) (PP (IN at) (NP (JJ therapeutic) (NNS levels)))) (VP (VBD did) (RB not) (ADVP (RB significantly)) (VP (VB influence) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (JJ TRANXENE) (NNS tablets))))))) (. .))))

amod(studies-3, bioavailability-2)
prep_in(influence-19, studies-3)
amod(subjects-6, normal-5)
prep_with(studies-3, subjects-6)
det(administration-10, the-8)
amod(administration-10, concurrent-9)
nsubj(influence-19, administration-10)
prep_of(administration-10, antacids-12)
amod(levels-15, therapeutic-14)
prep_at(administration-10, levels-15)
aux(influence-19, did-16)
neg(influence-19, not-17)
advmod(influence-19, significantly-18)
root(ROOT-0, influence-19)
det(bioavailability-21, the-20)
dobj(influence-19, bioavailability-21)
amod(tablets-24, TRANXENE-23)
prep_of(bioavailability-21, tablets-24)

The/DT risks/NNS of/IN using/VBG Clozapine/NN in/IN combination/NN with/IN other/JJ drugs/NNS have/VBP not/RB been/VBN systematically/RB evaluated/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS risks)) (PP (IN of) (S (VP (VBG using) (NP (NN Clozapine)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ other) (NNS drugs))))))))) (VP (VBP have) (RB not) (VP (VBN been) (ADVP (RB systematically)) (VP (VBN evaluated))))) (. .))))

det(risks-2, The-1)
nsubjpass(evaluated-15, risks-2)
prepc_of(risks-2, using-4)
dobj(using-4, Clozapine-5)
prep_in(using-4, combination-7)
amod(drugs-10, other-9)
prep_with(combination-7, drugs-10)
aux(evaluated-15, have-11)
neg(evaluated-15, not-12)
auxpass(evaluated-15, been-13)
advmod(evaluated-15, systematically-14)
root(ROOT-0, evaluated-15)

Pharmacodynamic-related/JJ Interactions/NNS :/: The/DT mechanism/NN of/IN Clozapine/NN induced/JJ agranulocytosis/NN is/VBZ unknown/JJ ;/: ./.

(ROOT (S1 (S (NP (NP (JJ Pharmacodynamic-related) (NNS Interactions)) (: :) (S (NP (NP (DT The) (NN mechanism)) (PP (IN of) (NP (NN Clozapine) (JJ induced) (NN agranulocytosis)))) (VP (VBZ is) (ADJP (JJ unknown))) (: ;)) (. .)))))

amod(Interactions-2, Pharmacodynamic-related-1)
root(ROOT-0, Interactions-2)
det(mechanism-5, The-4)
nsubj(unknown-11, mechanism-5)
nn(agranulocytosis-9, Clozapine-7)
amod(agranulocytosis-9, induced-8)
prep_of(mechanism-5, agranulocytosis-9)
cop(unknown-11, is-10)
dep(Interactions-2, unknown-11)

Therefore/RB ,/, Clozapine/NN should/MD not/RB be/VB used/VBN with/IN other/JJ agents/NNS having/VBG a/DT well-known/JJ potential/NN to/TO suppress/VB bone/NN marrow/NN function/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NN Clozapine)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NP (JJ other) (NNS agents)) (VP (VBG having) (NP (NP (DT a) (JJ well-known) (NN potential)) (S (VP (TO to) (VP (VB suppress) (NP (NP (NN bone) (NN marrow)) (NN function))))))))))))) (. .))))

advmod(used-7, Therefore-1)
nsubjpass(used-7, Clozapine-3)
aux(used-7, should-4)
neg(used-7, not-5)
auxpass(used-7, be-6)
root(ROOT-0, used-7)
amod(agents-10, other-9)
prep_with(used-7, agents-10)
partmod(agents-10, having-11)
det(potential-14, a-12)
amod(potential-14, well-known-13)
dobj(having-11, potential-14)
aux(suppress-16, to-15)
infmod(potential-14, suppress-16)
nn(marrow-18, bone-17)
nn(function-19, marrow-18)
dobj(suppress-16, function-19)

Given/IN the/DT primary/JJ CNS/NN effects/NNS of/IN Clozapine/NN ,/, caution/NN is/VBZ advised/VBN in/IN using/VBG it/PRP concomitantly/RB with/IN other/JJ CNS-active/JJ drugs/NNS or/CC alcohol/NN ./.

(ROOT (S1 (S (S (PP (IN Given) (NP (NP (DT the) (JJ primary) (NN CNS) (NNS effects)) (PP (IN of) (NP (NN Clozapine))))) (, ,) (NP (NN caution)) (VP (VBZ is) (VP (VBN advised) (PP (IN in) (S (VP (VBG using) (NP (NP (PRP it)) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (JJ other) (JJ CNS-active) (NNS drugs)) (CC or) (NP (NN alcohol))))))))))) (. .))))

det(effects-5, the-2)
amod(effects-5, primary-3)
nn(effects-5, CNS-4)
prep_given(advised-11, effects-5)
prep_of(effects-5, Clozapine-7)
nsubjpass(advised-11, caution-9)
auxpass(advised-11, is-10)
root(ROOT-0, advised-11)
prepc_in(advised-11, using-13)
dobj(using-13, it-14)
advmod(it-14, concomitantly-15)
amod(drugs-19, other-17)
amod(drugs-19, CNS-active-18)
prep_with(it-14, drugs-19)
conj_or(drugs-19, alcohol-21)

Orthostatic/JJ hypotension/NN in/IN patients/NNS taking/VBG clozapine/NN can/MD ,/, in/IN rare/JJ cases/NNS (/-LRB- approximately/RB 1/CD case/NN per/IN 3,000/CD patients/NNS )/-RRB- ,/, be/VB accompanied/VBN by/IN profound/JJ collapse/NN and/CC respiratory/JJ and/or/CC cardiac/JJ arrest/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Orthostatic) (NN hypotension)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN clozapine)))))) (VP (MD can) (, ,) (PP (IN in) (NP (NP (JJ rare) (NNS cases)) (PRN (-LRB- -LRB-) (NP (QP (RB approximately) (CD 1)) (NN case)) (PP (IN per) (NP (CD 3,000) (NNS patients))) (-RRB- -RRB-)))) (, ,) (VP (VB be) (VP (VBN accompanied) (PP (IN by) (NP (NP (JJ profound) (NN collapse)) (CC and) (NP (ADJP (ADJP (JJ respiratory)) (CC and/or) (ADJP (JJ cardiac))) (NN arrest)))))))) (. .))))

amod(hypotension-2, Orthostatic-1)
nsubjpass(accompanied-22, hypotension-2)
prep_in(hypotension-2, patients-4)
partmod(patients-4, taking-5)
dobj(taking-5, clozapine-6)
aux(accompanied-22, can-7)
amod(cases-11, rare-10)
prep_in(accompanied-22, cases-11)
quantmod(1-14, approximately-13)
num(case-15, 1-14)
dep(cases-11, case-15)
dep(case-15, per-16)
num(patients-18, 3,000-17)
pobj(per-16, patients-18)
auxpass(accompanied-22, be-21)
root(ROOT-0, accompanied-22)
amod(collapse-25, profound-24)
agent(accompanied-22, collapse-25)
amod(arrest-30, respiratory-27)
conj_and/or(respiratory-27, cardiac-29)
conj_and(collapse-25, arrest-30)

Some/DT of/IN the/DT cases/NNS of/IN collapse/respiratory/JJ arrest/cardiac/NN arrest/NN during/IN initial/JJ treatment/NN occurred/VBD in/IN patients/NNS who/WP were/VBD being/VBG administered/VBN benzodiazepines/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (DT Some)) (PP (IN of) (NP (NP (DT the) (NNS cases)) (PP (IN of) (NP (NP (JJ collapse/respiratory) (NN arrest/cardiac) (NN arrest)) (PP (IN during) (NP (JJ initial) (NN treatment)))))))) (VP (VBD occurred) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBG being) (VP (VBN administered) (NP (NN benzodiazepines)))))))))) (: ;)) (. .))))

nsubj(occurred-12, Some-1)
det(cases-4, the-3)
prep_of(Some-1, cases-4)
amod(arrest-8, collapse/respiratory-6)
nn(arrest-8, arrest/cardiac-7)
prep_of(cases-4, arrest-8)
amod(treatment-11, initial-10)
prep_during(arrest-8, treatment-11)
root(ROOT-0, occurred-12)
prep_in(occurred-12, patients-14)
nsubjpass(administered-18, patients-14)
aux(administered-18, were-16)
auxpass(administered-18, being-17)
rcmod(patients-14, administered-18)
dobj(administered-18, benzodiazepines-19)

similar/JJ events/NNS have/VBP been/VBN reported/VBN in/IN patients/NNS taking/VBG other/JJ psychotropic/JJ drugs/NNS or/CC even/RB Clozapine/NN by/IN itself/PRP ./.

(ROOT (S1 (S (S (NP (JJ similar) (NNS events)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (VP (VBG taking) (NP (JJ other) (JJ psychotropic) (NNS drugs))) (CC or) (VP (ADVP (RB even)) (NP (NN Clozapine)) (PP (IN by) (NP (PRP itself))))))))))) (. .))))

amod(events-2, similar-1)
nsubjpass(reported-5, events-2)
aux(reported-5, have-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
prep_in(reported-5, patients-7)
dep(patients-7, taking-8)
amod(drugs-11, other-9)
amod(drugs-11, psychotropic-10)
dobj(taking-8, drugs-11)
advmod(Clozapine-14, even-13)
conj_or(taking-8, Clozapine-14)
prep_by(Clozapine-14, itself-16)

Although/IN it/PRP has/VBZ not/RB been/VBN established/VBN that/IN there/EX is/VBZ an/DT interaction/NN between/IN Clozapine/NN and/CC benzodiazepines/NN or/CC other/JJ psychotropics/NNS ,/, caution/NN is/VBZ advised/VBN when/WRB clozapine/NN is/VBZ initiated/VBN in/IN patients/NNS taking/VBG a/DT benzodiazepine/NN or/CC any/DT other/JJ psychotropic/JJ drug/NN ./.

(ROOT (S1 (S (SBAR (IN Although) (S (NP (PRP it)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN established) (SBAR (IN that) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT an) (NN interaction)) (PP (IN between) (NP (NP (NP (NN Clozapine)) (CC and) (NP (NN benzodiazepines))) (CC or) (NP (JJ other) (NNS psychotropics))))))))))))) (, ,) (NP (NN caution)) (VP (VBZ is) (VP (VBN advised) (SBAR (WHADVP (WRB when)) (S (NP (NN clozapine)) (VP (VBZ is) (VP (VBN initiated) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (DT a) (NN benzodiazepine)) (CC or) (NP (DT any) (JJ other) (JJ psychotropic) (NN drug)))))))))))) (. .))))

mark(established-6, Although-1)
nsubjpass(established-6, it-2)
aux(established-6, has-3)
neg(established-6, not-4)
auxpass(established-6, been-5)
advcl(advised-22, established-6)
complm(is-9, that-7)
expl(is-9, there-8)
ccomp(established-6, is-9)
det(interaction-11, an-10)
nsubj(is-9, interaction-11)
prep_between(interaction-11, Clozapine-13)
conj_and(Clozapine-13, benzodiazepines-15)
amod(psychotropics-18, other-17)
conj_or(Clozapine-13, psychotropics-18)
nsubjpass(advised-22, caution-20)
auxpass(advised-22, is-21)
root(ROOT-0, advised-22)
advmod(initiated-26, when-23)
nsubjpass(initiated-26, clozapine-24)
auxpass(initiated-26, is-25)
advcl(advised-22, initiated-26)
prep_in(initiated-26, patients-28)
partmod(patients-28, taking-29)
det(benzodiazepine-31, a-30)
dobj(taking-29, benzodiazepine-31)
det(drug-36, any-33)
amod(drug-36, other-34)
amod(drug-36, psychotropic-35)
conj_or(benzodiazepine-31, drug-36)

Clozapine/NN may/MD potentiate/VB the/DT hypotensive/JJ effects/NNS of/IN antihypertensive/JJ drugs/NNS and/CC the/DT anticholinergic/JJ effects/NNS of/IN atropine/JJ -type/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NN Clozapine)) (VP (MD may) (VP (VB potentiate) (NP (NP (NP (DT the) (JJ hypotensive) (NNS effects)) (PP (IN of) (NP (JJ antihypertensive) (NNS drugs)))) (CC and) (NP (NP (DT the) (JJ anticholinergic) (NNS effects)) (PP (IN of) (NP (JJ atropine) (JJ -type) (NNS drugs)))))))) (. .))))

nsubj(potentiate-3, Clozapine-1)
aux(potentiate-3, may-2)
root(ROOT-0, potentiate-3)
det(effects-6, the-4)
amod(effects-6, hypotensive-5)
dobj(potentiate-3, effects-6)
amod(drugs-9, antihypertensive-8)
prep_of(effects-6, drugs-9)
det(effects-13, the-11)
amod(effects-13, anticholinergic-12)
conj_and(effects-6, effects-13)
amod(drugs-17, atropine-15)
amod(drugs-17, -type-16)
prep_of(effects-13, drugs-17)

The/DT administration/NN of/IN epinephrine/NN should/MD be/VB avoided/VBN in/IN the/DT treatment/NN of/IN drug/NN induced/JJ hypotension/NN because/IN of/IN a/DT possible/JJ reverse/NN epinephrine/NN effect/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NN epinephrine)))) (VP (MD should) (VP (VB be) (VP (VBN avoided) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN drug) (JJ induced) (NN hypotension))))) (PP (IN because) (IN of) (NP (DT a) (JJ possible) (NN reverse) (NN epinephrine) (NN effect))))))) (. .))))

det(administration-2, The-1)
nsubjpass(avoided-7, administration-2)
prep_of(administration-2, epinephrine-4)
aux(avoided-7, should-5)
auxpass(avoided-7, be-6)
root(ROOT-0, avoided-7)
det(treatment-10, the-9)
prep_in(avoided-7, treatment-10)
nn(hypotension-14, drug-12)
amod(hypotension-14, induced-13)
prep_of(treatment-10, hypotension-14)
det(effect-21, a-17)
amod(effect-21, possible-18)
nn(effect-21, reverse-19)
nn(effect-21, epinephrine-20)
prep_because_of(avoided-7, effect-21)

Pharmacokinetic-related/JJ Interactions/NNS :/: Clozapine/NN is/VBZ a/DT substrate/NN for/IN many/JJ CYP/NN 450/CD isozymes/NNS ,/, in/IN particular/JJ 1A2/NN ,/, 2D6/NN ,/, and/CC 3A4/NN ./.

(ROOT (S1 (S (NP (NP (JJ Pharmacokinetic-related) (NNS Interactions)) (: :) (S (NP (NN Clozapine)) (VP (VBZ is) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (JJ many) (NN CYP) (CD 450) (NNS isozymes)))) (, ,) (PP (IN in) (NP (NP (JJ particular) (NN 1A2)) (, ,) (NP (NN 2D6)) (, ,) (CC and) (NP (NN 3A4)))))) (. .)))))

amod(Interactions-2, Pharmacokinetic-related-1)
root(ROOT-0, Interactions-2)
nsubj(substrate-7, Clozapine-4)
cop(substrate-7, is-5)
det(substrate-7, a-6)
dep(Interactions-2, substrate-7)
amod(isozymes-12, many-9)
nn(isozymes-12, CYP-10)
num(isozymes-12, 450-11)
prep_for(substrate-7, isozymes-12)
amod(1A2-16, particular-15)
prep_in(substrate-7, 1A2-16)
conj_and(1A2-16, 2D6-18)
conj_and(1A2-16, 3A4-21)

The/DT risk/NN of/IN metabolic/JJ interactions/NNS caused/VBN by/IN an/DT effect/NN on/IN an/DT individual/JJ isoform/NN is/VBZ therefore/RB minimized/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN risk)) (PP (IN of) (NP (JJ metabolic) (NNS interactions))) (VP (VBN caused) (PP (IN by) (NP (NP (DT an) (NN effect)) (PP (IN on) (NP (DT an) (JJ individual) (NN isoform))))))) (VP (VBZ is) (ADVP (RB therefore)) (VP (VBN minimized)))) (. .))))

det(risk-2, The-1)
nsubjpass(minimized-16, risk-2)
amod(interactions-5, metabolic-4)
prep_of(risk-2, interactions-5)
partmod(risk-2, caused-6)
det(effect-9, an-8)
agent(caused-6, effect-9)
det(isoform-13, an-11)
amod(isoform-13, individual-12)
prep_on(effect-9, isoform-13)
auxpass(minimized-16, is-14)
advmod(minimized-16, therefore-15)
root(ROOT-0, minimized-16)

Nevertheless/RB ,/, caution/NN should/MD be/VB used/VBN in/IN patients/NNS receiving/VBG concomitant/JJ treatment/NN with/IN other/JJ drugs/NNS that/WDT are/VBP either/CC inhibitors/NNS or/CC inducers/NNS of/IN these/DT enzymes/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Nevertheless)) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (JJ concomitant) (NN treatment)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (CC either) (NP (NNS inhibitors)) (CC or) (NP (NNS inducers))) (PP (IN of) (NP (DT these) (NNS enzymes))))))))))))))))) (. .))))

advmod(used-6, Nevertheless-1)
nsubjpass(used-6, caution-3)
aux(used-6, should-4)
auxpass(used-6, be-5)
root(ROOT-0, used-6)
prep_in(used-6, patients-8)
partmod(patients-8, receiving-9)
amod(treatment-11, concomitant-10)
dobj(receiving-9, treatment-11)
amod(drugs-14, other-13)
prep_with(treatment-11, drugs-14)
nsubj(inhibitors-18, drugs-14)
cop(inhibitors-18, are-16)
preconj(inhibitors-18, either-17)
rcmod(drugs-14, inhibitors-18)
conj_or(inhibitors-18, inducers-20)
det(enzymes-23, these-22)
prep_of(inhibitors-18, enzymes-23)

Concomitant/JJ administration/NN of/IN drugs/NNS known/VBN to/TO induce/VB cytochrome/NN P450/NN enzymes/NNS may/MD decrease/VB the/DT plasma/NN levels/NNS of/IN clozapine/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NNS drugs)) (VP (VBN known) (S (VP (TO to) (VP (VB induce) (NP (NN cytochrome) (NN P450) (NNS enzymes))))))))) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN clozapine))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubj(decrease-12, administration-2)
prep_of(administration-2, drugs-4)
xsubj(induce-7, drugs-4)
partmod(drugs-4, known-5)
aux(induce-7, to-6)
xcomp(known-5, induce-7)
nn(enzymes-10, cytochrome-8)
nn(enzymes-10, P450-9)
dobj(induce-7, enzymes-10)
aux(decrease-12, may-11)
root(ROOT-0, decrease-12)
det(levels-15, the-13)
nn(levels-15, plasma-14)
dobj(decrease-12, levels-15)
prep_of(levels-15, clozapine-17)

Phenytoin/NN ,/, nicotine/NN ,/, and/CC rifampin/NN may/MD decrease/VB Clozapine/NN plasma/NN levels/NNS ,/, resulting/VBG in/IN a/DT decrease/NN in/IN effectiveness/NN of/IN a/DT previously/RB effective/JJ Clozapine/NN dose/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Phenytoin)) (, ,) (NP (NN nicotine)) (, ,) (CC and) (NP (NN rifampin))) (VP (MD may) (VP (VB decrease) (NP (NN Clozapine) (NN plasma) (NNS levels)) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (NN effectiveness)) (PP (IN of) (NP (DT a) (ADJP (RB previously) (JJ effective)) (NN Clozapine) (NN dose)))))))))))) (. .))))

nsubj(decrease-8, Phenytoin-1)
conj_and(Phenytoin-1, nicotine-3)
conj_and(Phenytoin-1, rifampin-6)
aux(decrease-8, may-7)
root(ROOT-0, decrease-8)
nn(levels-11, Clozapine-9)
nn(levels-11, plasma-10)
dobj(decrease-8, levels-11)
partmod(decrease-8, resulting-13)
xcomp(decrease-8, resulting-13)
det(decrease-16, a-15)
prep_in(resulting-13, decrease-16)
prep_in(decrease-16, effectiveness-18)
det(dose-24, a-20)
advmod(effective-22, previously-21)
amod(dose-24, effective-22)
nn(dose-24, Clozapine-23)
prep_of(effectiveness-18, dose-24)

Concomitant/JJ administration/NN of/IN drugs/NNS known/VBN to/TO inhibit/VB the/DT activity/NN of/IN cytochrome/NN P450/NN isozymes/NNS may/MD increase/VB the/DT plasma/NN levels/NNS of/IN clozapine/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NNS drugs)) (VP (VBN known) (S (VP (TO to) (VP (VB inhibit) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NN cytochrome) (NN P450) (NNS isozymes))))))))))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN clozapine))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubj(increase-15, administration-2)
prep_of(administration-2, drugs-4)
xsubj(inhibit-7, drugs-4)
partmod(drugs-4, known-5)
aux(inhibit-7, to-6)
xcomp(known-5, inhibit-7)
det(activity-9, the-8)
dobj(inhibit-7, activity-9)
nn(isozymes-13, cytochrome-11)
nn(isozymes-13, P450-12)
prep_of(activity-9, isozymes-13)
aux(increase-15, may-14)
root(ROOT-0, increase-15)
det(levels-18, the-16)
nn(levels-18, plasma-17)
dobj(increase-15, levels-18)
prep_of(levels-18, clozapine-20)

Cimetidine/NN ,/, caffeine/NN ,/, and/CC erythromycin/NN may/MD increase/VB plasma/NN levels/NNS of/IN Clozapine/NN ,/, potentially/RB resulting/VBG in/IN adverse/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Cimetidine)) (, ,) (NP (NN caffeine)) (, ,) (CC and) (NP (NN erythromycin))) (VP (MD may) (VP (VB increase) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (NN Clozapine)))) (, ,) (S (ADVP (RB potentially)) (VP (VBG resulting) (PP (IN in) (NP (JJ adverse) (NNS effects)))))))) (. .))))

nsubj(increase-8, Cimetidine-1)
conj_and(Cimetidine-1, caffeine-3)
conj_and(Cimetidine-1, erythromycin-6)
aux(increase-8, may-7)
root(ROOT-0, increase-8)
nn(levels-10, plasma-9)
dobj(increase-8, levels-10)
prep_of(levels-10, Clozapine-12)
advmod(resulting-15, potentially-14)
partmod(increase-8, resulting-15)
xcomp(increase-8, resulting-15)
amod(effects-18, adverse-17)
prep_in(resulting-15, effects-18)

Although/IN concomitant/JJ use/NN of/IN Clozapine/NN and/CC carbamazepine/NN is/VBZ not/RB recommended/VBN ,/, it/PRP should/MD be/VB noted/VBN that/IN discontinuation/NN of/IN concomitant/JJ carbamazepine/NN administration/NN may/MD result/VB in/IN an/DT increase/NN in/IN Clozapine/NN plasma/NN levels/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN Clozapine)) (CC and) (NP (NN carbamazepine))))) (VP (VBZ is) (RB not) (VP (VBN recommended))))) (, ,) (NP (PRP it)) (VP (MD should) (VP (VB be) (VP (VBN noted) (SBAR (IN that) (S (NP (NP (NN discontinuation)) (PP (IN of) (NP (JJ concomitant) (NN carbamazepine) (NN administration)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN Clozapine) (NN plasma) (NNS levels))))))))))))) (. .))))

mark(recommended-10, Although-1)
amod(use-3, concomitant-2)
nsubjpass(recommended-10, use-3)
prep_of(use-3, Clozapine-5)
conj_and(Clozapine-5, carbamazepine-7)
auxpass(recommended-10, is-8)
neg(recommended-10, not-9)
advcl(noted-15, recommended-10)
nsubjpass(noted-15, it-12)
aux(noted-15, should-13)
auxpass(noted-15, be-14)
root(ROOT-0, noted-15)
complm(result-23, that-16)
nsubj(result-23, discontinuation-17)
amod(administration-21, concomitant-19)
nn(administration-21, carbamazepine-20)
prep_of(discontinuation-17, administration-21)
aux(result-23, may-22)
ccomp(noted-15, result-23)
det(increase-26, an-25)
prep_in(result-23, increase-26)
nn(levels-30, Clozapine-28)
nn(levels-30, plasma-29)
prep_in(increase-26, levels-30)

In/IN a/DT study/NN of/IN schizophrenic/JJ patients/NNS who/WP received/VBD clozapine/NN under/IN steady/JJ state/NN conditions/NNS ,/, fluvoxamine/NN or/CC paroxetine/NN was/VBD added/VBN in/IN 16/CD and/CC 14/CD patients/NNS ,/, respectively/RB ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT a) (NN study)) (PP (IN of) (NP (NP (JJ schizophrenic) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NN clozapine)) (PP (IN under) (NP (JJ steady) (NN state) (NNS conditions)))))))))) (, ,) (NP (NP (NN fluvoxamine)) (CC or) (NP (NN paroxetine))) (VP (VBD was) (VP (VBN added) (PP (IN in) (NP (QP (CD 16) (CC and) (CD 14)) (NNS patients))) (, ,) (ADVP (RB respectively))))) (. .))))

det(study-3, a-2)
prep_in(added-19, study-3)
amod(patients-6, schizophrenic-5)
prep_of(study-3, patients-6)
nsubj(received-8, patients-6)
rcmod(patients-6, received-8)
dobj(received-8, clozapine-9)
amod(conditions-13, steady-11)
nn(conditions-13, state-12)
prep_under(received-8, conditions-13)
nsubjpass(added-19, fluvoxamine-15)
conj_or(fluvoxamine-15, paroxetine-17)
auxpass(added-19, was-18)
root(ROOT-0, added-19)
num(patients-24, 16-21)
conj_and(16-21, 14-23)
prep_in(added-19, patients-24)
advmod(added-19, respectively-26)

After/IN 14/CD days/NNS of/IN co-administration/NN ,/, mean/JJ trough/NN concentrations/NNS of/IN clozapine/NN and/CC its/PRP$ metabolites/NNS ,/, N-desmethylclozapine/NN and/CC clozapine/NN N-oxide/NN ,/, were/VBD elevated/VBN with/IN fluvoxamine/NN by/IN about/RB three-fold/RB compared/VBN to/TO baseline/NN concentrations/NNS ./.

(ROOT (S1 (S (S (PP (IN After) (NP (NP (CD 14) (NNS days)) (PP (IN of) (NP (NN co-administration))))) (, ,) (NP (NP (NP (JJ mean) (NN trough) (NNS concentrations)) (PP (IN of) (NP (NN clozapine)))) (CC and) (NP (NP (PRP$ its) (NNS metabolites)) (, ,) (NP (NP (NN N-desmethylclozapine)) (CC and) (NP (NN clozapine) (NN N-oxide))) (, ,))) (VP (VBD were) (VP (VBN elevated) (PP (IN with) (NP (NP (NN fluvoxamine)) (PP (IN by) (NP (NP (RB about) (RB three-fold)) (VP (VBN compared) (PP (TO to) (NP (NN baseline) (NNS concentrations))))))))))) (. .))))

num(days-3, 14-2)
prep_after(elevated-22, days-3)
prep_of(days-3, co-administration-5)
amod(concentrations-9, mean-7)
nn(concentrations-9, trough-8)
nsubjpass(elevated-22, concentrations-9)
prep_of(concentrations-9, clozapine-11)
poss(metabolites-14, its-13)
conj_and(concentrations-9, metabolites-14)
appos(metabolites-14, N-desmethylclozapine-16)
nn(N-oxide-19, clozapine-18)
conj_and(N-desmethylclozapine-16, N-oxide-19)
auxpass(elevated-22, were-21)
root(ROOT-0, elevated-22)
prep_with(elevated-22, fluvoxamine-24)
prep(fluvoxamine-24, by-25)
advmod(three-fold-27, about-26)
pobj(by-25, three-fold-27)
partmod(three-fold-27, compared-28)
nn(concentrations-31, baseline-30)
prep_to(compared-28, concentrations-31)

Paroxetine/NN produced/VBD only/RB minor/JJ changes/NNS in/IN the/DT levels/NNS of/IN clozapine/NN and/CC its/PRP$ metabolites/NNS ./.

(ROOT (S1 (S (S (NP (NN Paroxetine)) (VP (VBD produced) (NP (ADJP (RB only) (JJ minor)) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NP (NN clozapine)) (CC and) (NP (PRP$ its) (NNS metabolites)))))))) (. .))))

nsubj(produced-2, Paroxetine-1)
root(ROOT-0, produced-2)
advmod(minor-4, only-3)
amod(changes-5, minor-4)
dobj(produced-2, changes-5)
det(levels-8, the-7)
prep_in(produced-2, levels-8)
prep_of(levels-8, clozapine-10)
poss(metabolites-13, its-12)
conj_and(clozapine-10, metabolites-13)

However/RB ,/, other/JJ published/VBN reports/NNS describe/VBP modest/JJ elevations/NNS (/-LRB- less/JJR than/IN two-fold/JJ )/-RRB- of/IN clozapine/NN and/CC metabolite/NN concentrations/NNS when/WRB clozapine/NN was/VBD taken/VBN with/IN paroxetine/NN ,/, fluoxetine/NN ,/, and/CC sertraline/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (JJ other) (VBN published) (NNS reports)) (VP (VBP describe) (NP (NP (NP (NP (JJ modest) (NNS elevations)) (PRN (-LRB- -LRB-) (ADJP (JJR less) (IN than) (JJ two-fold)) (-RRB- -RRB-))) (PP (IN of) (NP (NN clozapine)))) (CC and) (NP (NN metabolite) (NNS concentrations))) (SBAR (WHADVP (WRB when)) (S (NP (NN clozapine)) (VP (VBD was) (VP (VBN taken) (PP (IN with) (NP (NP (NN paroxetine)) (, ,) (NP (NN fluoxetine)) (, ,) (CC and) (NP (NN sertraline)))))))))) (. .))))

advmod(describe-6, However-1)
amod(reports-5, other-3)
amod(reports-5, published-4)
nsubj(describe-6, reports-5)
root(ROOT-0, describe-6)
amod(elevations-8, modest-7)
dobj(describe-6, elevations-8)
dep(two-fold-12, less-10)
dep(two-fold-12, than-11)
dep(elevations-8, two-fold-12)
prep_of(elevations-8, clozapine-15)
nn(concentrations-18, metabolite-17)
conj_and(elevations-8, concentrations-18)
advmod(taken-22, when-19)
nsubjpass(taken-22, clozapine-20)
auxpass(taken-22, was-21)
advcl(describe-6, taken-22)
prep_with(taken-22, paroxetine-24)
conj_and(paroxetine-24, fluoxetine-26)
conj_and(paroxetine-24, sertraline-29)

Therefore/RB ,/, such/JJ combined/JJ treatment/NN should/MD be/VB approached/VBN with/IN caution/NN and/CC patients/NNS should/MD be/VB monitored/VBN closely/RB when/WRB Clozapine/NN is/VBZ combined/VBN with/IN these/DT drugs/NNS ,/, particularly/RB with/IN fluvoxamine/NN ./.

(ROOT (S1 (S (S (S (ADVP (RB Therefore)) (, ,) (NP (JJ such) (JJ combined) (NN treatment)) (VP (MD should) (VP (VB be) (VP (VBN approached) (PP (IN with) (NP (NN caution))))))) (CC and) (S (NP (NNS patients)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB closely)) (SBAR (WHADVP (WRB when)) (S (NP (NN Clozapine)) (VP (VBZ is) (VP (VBN combined) (PP (IN with) (NP (DT these) (NNS drugs))) (, ,) (PP (ADVP (RB particularly)) (IN with) (NP (NN fluvoxamine)))))))))))) (. .))))

advmod(approached-8, Therefore-1)
amod(treatment-5, such-3)
amod(treatment-5, combined-4)
nsubjpass(approached-8, treatment-5)
aux(approached-8, should-6)
auxpass(approached-8, be-7)
root(ROOT-0, approached-8)
prep_with(approached-8, caution-10)
nsubjpass(monitored-15, patients-12)
aux(monitored-15, should-13)
auxpass(monitored-15, be-14)
conj_and(approached-8, monitored-15)
advmod(monitored-15, closely-16)
advmod(combined-20, when-17)
nsubjpass(combined-20, Clozapine-18)
auxpass(combined-20, is-19)
advcl(monitored-15, combined-20)
det(drugs-23, these-22)
prep_with(combined-20, drugs-23)
advmod(combined-20, particularly-25)
prep_with(combined-20, fluvoxamine-27)

A/DT subset/NN (/-LRB- 3/CD %/NN -10/CD %/NN )/-RRB- of/IN the/DT population/NN has/VBZ reduced/VBN activity/NN of/IN certain/JJ drug/NN metabolizing/NN enzymes/NNS such/JJ as/IN the/DT cytochrome/NN P450/NN isozyme/NN P450/NN 2D6/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (DT A) (NN subset)) (PRN (-LRB- -LRB-) (NP (CD 3) (NN %) (CD -10) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN population)))) (VP (VBZ has) (NP (NP (VBN reduced) (NN activity)) (PP (IN of) (NP (NP (JJ certain) (NN drug) (NN metabolizing) (NNS enzymes)) (PP (JJ such) (IN as) (NP (DT the) (NN cytochrome) (NN P450) (NN isozyme) (NN P450) (NN 2D6)))))))) (. .))))

det(subset-2, A-1)
nsubj(has-12, subset-2)
num(%-7, 3-4)
nn(%-7, %-5)
num(%-7, -10-6)
appos(subset-2, %-7)
det(population-11, the-10)
prep_of(subset-2, population-11)
root(ROOT-0, has-12)
amod(activity-14, reduced-13)
dobj(has-12, activity-14)
amod(enzymes-19, certain-16)
nn(enzymes-19, drug-17)
nn(enzymes-19, metabolizing-18)
prep_of(activity-14, enzymes-19)
det(2D6-27, the-22)
nn(2D6-27, cytochrome-23)
nn(2D6-27, P450-24)
nn(2D6-27, isozyme-25)
nn(2D6-27, P450-26)
prep_such_as(enzymes-19, 2D6-27)

Such/JJ individuals/NNS are/VBP referred/VBN to/TO as/IN poor/JJ metabolizers/NNS of/IN drugs/NNS such/JJ as/IN debrisoquin/NN ,/, dextromethorphan/NN ,/, the/DT tricyclic/JJ antidepressants/NNS ,/, and/CC clozapine/NN ./.

(ROOT (S1 (S (S (NP (JJ Such) (NNS individuals)) (VP (VBP are) (VP (VBN referred) (PP (TO to)) (PP (IN as) (NP (NP (JJ poor) (NNS metabolizers)) (PP (IN of) (NP (NP (NNS drugs)) (PP (JJ such) (IN as) (NP (NP (NN debrisoquin)) (, ,) (NP (NN dextromethorphan)) (, ,) (NP (DT the) (JJ tricyclic) (NNS antidepressants)) (, ,) (CC and) (NP (NN clozapine))))))))))) (. .))))

amod(individuals-2, Such-1)
nsubjpass(referred-4, individuals-2)
auxpass(referred-4, are-3)
root(ROOT-0, referred-4)
prep(referred-4, to-5)
amod(metabolizers-8, poor-7)
prep_as(referred-4, metabolizers-8)
prep_of(metabolizers-8, drugs-10)
prep_such_as(drugs-10, debrisoquin-13)
conj_and(debrisoquin-13, dextromethorphan-15)
det(antidepressants-19, the-17)
amod(antidepressants-19, tricyclic-18)
conj_and(debrisoquin-13, antidepressants-19)
conj_and(debrisoquin-13, clozapine-22)

These/DT individuals/NNS may/MD develop/VBP higher/JJR than/IN expected/VBN plasma/NN concentrations/NNS of/IN clozapine/NN when/WRB given/VBN usual/JJ doses/NNS ./.

(ROOT (S1 (S (S (NP (DT These) (NNS individuals)) (VP (MD may) (VP (VBP develop) (NP (NP (JJR higher) (IN than) (VBN expected) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN clozapine)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (NP (JJ usual) (NNS doses)))))))) (. .))))

det(individuals-2, These-1)
nsubj(develop-4, individuals-2)
aux(develop-4, may-3)
root(ROOT-0, develop-4)
amod(concentrations-9, higher-5)
amod(concentrations-9, than-6)
amod(concentrations-9, expected-7)
nn(concentrations-9, plasma-8)
dobj(develop-4, concentrations-9)
prep_of(concentrations-9, clozapine-11)
advmod(given-13, when-12)
advcl(develop-4, given-13)
amod(doses-15, usual-14)
dobj(given-13, doses-15)

In/IN addition/NN ,/, certain/JJ drugs/NNS that/WDT are/VBP metabolized/VBN by/IN this/DT isozyme/NN ,/, including/VBG many/JJ antidepressants/NNS (/-LRB- clozapine/NN ,/, selective/JJ serotonin/NN reuptake/NN inhibitors/NNS ,/, and/CC others/NNS )/-RRB- ,/, may/MD inhibit/VB the/DT activity/NN of/IN this/DT isozyme/NN ,/, and/CC thus/RB may/MD make/VB normal/JJ metabolizers/NNS resemble/VBP poor/JJ metabolizers/NNS with/IN regard/NN to/TO concomitant/JJ therapy/NN with/IN other/JJ drugs/NNS metabolized/VBN by/IN this/DT enzyme/NN system/NN ,/, leading/VBG to/TO drug/NN interaction/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NP (JJ certain) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN metabolized) (PP (IN by) (NP (DT this) (NN isozyme)))))))) (, ,) (PP (VBG including) (NP (NP (JJ many) (NNS antidepressants)) (PRN (-LRB- -LRB-) (NP (NP (NN clozapine)) (, ,) (NP (JJ selective) (NN serotonin) (NN reuptake) (NNS inhibitors)) (, ,) (CC and) (NP (NNS others))) (-RRB- -RRB-)))) (, ,)) (VP (VP (MD may) (VP (VB inhibit) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT this) (NN isozyme)))))) (, ,) (CC and) (ADVP (RB thus)) (VP (MD may) (VP (VB make) (S (NP (JJ normal) (NNS metabolizers)) (VP (VBP resemble) (NP (JJ poor) (NNS metabolizers)) (PP (IN with) (NP (NP (NN regard)) (PP (TO to) (NP (NP (JJ concomitant) (NN therapy)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (DT this) (NN enzyme) (NN system)))))))))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NN drug) (NN interaction)))))))))) (. .))))

prep_in(inhibit-29, addition-2)
amod(drugs-5, certain-4)
nsubjpass(metabolized-8, drugs-5)
nsubj(inhibit-29, drugs-5)
auxpass(metabolized-8, are-7)
rcmod(drugs-5, metabolized-8)
det(isozyme-11, this-10)
agent(metabolized-8, isozyme-11)
amod(antidepressants-15, many-14)
prep_including(drugs-5, antidepressants-15)
dep(antidepressants-15, clozapine-17)
amod(inhibitors-22, selective-19)
nn(inhibitors-22, serotonin-20)
nn(inhibitors-22, reuptake-21)
conj_and(clozapine-17, inhibitors-22)
conj_and(clozapine-17, others-25)
aux(inhibit-29, may-28)
root(ROOT-0, inhibit-29)
det(activity-31, the-30)
dobj(inhibit-29, activity-31)
det(isozyme-34, this-33)
prep_of(activity-31, isozyme-34)
advmod(inhibit-29, thus-37)
conj_and(inhibit-29, thus-37)
aux(make-39, may-38)
conj_and(inhibit-29, make-39)
amod(metabolizers-41, normal-40)
nsubj(metabolizers-44, metabolizers-41)
cop(metabolizers-44, resemble-42)
amod(metabolizers-44, poor-43)
ccomp(make-39, metabolizers-44)
amod(therapy-49, concomitant-48)
prep_with_regard_to(metabolizers-44, therapy-49)
amod(drugs-52, other-51)
prep_with(therapy-49, drugs-52)
partmod(drugs-52, metabolized-53)
det(system-57, this-55)
nn(system-57, enzyme-56)
agent(metabolized-53, system-57)
partmod(metabolizers-44, leading-59)
xcomp(metabolizers-44, leading-59)
nn(interaction-62, drug-61)
prep_to(leading-59, interaction-62)

Concomitant/JJ use/NN of/IN clozapine/NN with/IN other/JJ drugs/NNS metabolized/VBN by/IN cytochrome/NN P450/NN 2D6/NN may/MD require/VBP lower/JJR doses/NNS than/IN usually/RB prescribed/VBN for/IN either/CC clozapine/NN or/CC the/DT other/JJ drug/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NN clozapine))) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (NN cytochrome) (NN P450) (NN 2D6))))))) (VP (MD may) (VP (VBP require) (NP (NP (JJR lower) (NNS doses)) (VP (ADVP (IN than) (RB usually)) (VBN prescribed) (PP (IN for) (NP (CC either) (NP (NN clozapine)) (CC or) (NP (DT the) (JJ other) (NN drug))))))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(require-14, use-2)
prep_of(use-2, clozapine-4)
amod(drugs-7, other-6)
prep_with(use-2, drugs-7)
partmod(drugs-7, metabolized-8)
nn(2D6-12, cytochrome-10)
nn(2D6-12, P450-11)
agent(metabolized-8, 2D6-12)
aux(require-14, may-13)
root(ROOT-0, require-14)
amod(doses-16, lower-15)
dobj(require-14, doses-16)
advmod(prescribed-19, than-17)
advmod(than-17, usually-18)
partmod(doses-16, prescribed-19)
preconj(clozapine-22, either-21)
prep_for(prescribed-19, clozapine-22)
det(drug-26, the-24)
amod(drug-26, other-25)
conj_or(clozapine-22, drug-26)

Therefore/RB ,/, co-administration/NN of/IN clozapine/NN with/IN other/JJ drugs/NNS that/WDT are/VBP metabolized/VBN by/IN this/DT isozyme/NN ,/, including/VBG antidepressants/NNS ,/, phenothiazines/NNS ,/, carbamazepine/NN ,/, and/CC Type/NN 1C/NN antiarrhythmics/NNS (/-LRB- e.g./FW ,/, propafenone/NN ,/, flecainide/NN and/CC encainide/NN )/-RRB- ,/, or/CC that/WDT inhibit/VBP this/DT enzyme/NN (/-LRB- e.g./FW ,/, quinidine/NN )/-RRB- ,/, should/MD be/VB approached/VBN with/IN caution/NN ./.

(ROOT (S1 (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN co-administration)) (PP (IN of) (NP (NN clozapine))) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (SBAR (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN metabolized) (PP (IN by) (NP (DT this) (NN isozyme))) (, ,) (PP (VBG including) (NP (NP (NNS antidepressants)) (, ,) (NP (NNS phenothiazines)) (, ,) (NP (NN carbamazepine)) (, ,) (CC and) (NP (NP (NN Type) (NN 1C) (NNS antiarrhythmics)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN propafenone)) (, ,) (NP (NN flecainide)) (CC and) (NP (NN encainide)))) (-RRB- -RRB-))))))))) (, ,) (CC or) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (DT this) (NN enzyme))))) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN quinidine))) (-RRB- -RRB-)))))) (, ,) (VP (MD should) (VP (VB be) (VP (VBN approached) (PP (IN with) (NP (NN caution)))))) (. .))))

advmod(approached-50, Therefore-1)
nsubjpass(approached-50, co-administration-3)
prep_of(co-administration-3, clozapine-5)
amod(drugs-8, other-7)
prep_with(co-administration-3, drugs-8)
nsubjpass(metabolized-11, drugs-8)
nsubj(inhibit-39, drugs-8)
auxpass(metabolized-11, are-10)
rcmod(drugs-8, metabolized-11)
det(isozyme-14, this-13)
agent(metabolized-11, isozyme-14)
prep_including(metabolized-11, antidepressants-17)
conj_and(antidepressants-17, phenothiazines-19)
conj_and(antidepressants-17, carbamazepine-21)
nn(antiarrhythmics-26, Type-24)
nn(antiarrhythmics-26, 1C-25)
conj_and(antidepressants-17, antiarrhythmics-26)
dep(antiarrhythmics-26, e.g.-28)
pobj(e.g.-28, propafenone-30)
conj_and(propafenone-30, flecainide-32)
conj_and(propafenone-30, encainide-34)
conj_or(metabolized-11, inhibit-39)
det(enzyme-41, this-40)
dobj(inhibit-39, enzyme-41)
dep(metabolized-11, e.g.-43)
pobj(e.g.-43, quinidine-45)
aux(approached-50, should-48)
auxpass(approached-50, be-49)
root(ROOT-0, approached-50)
prep_with(approached-50, caution-52)

The/DT risk/NN of/IN a/DT potential/JJ interaction/NN between/IN NovoSeven/NN and/CC coagulation/NN factor/NN concentrates/NNS has/VBZ not/RB been/VBN adequately/RB evaluated/VBN in/IN preclinical/JJ or/CC clinical/JJ studies/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN risk)) (PP (IN of) (NP (NP (DT a) (JJ potential) (NN interaction)) (PP (IN between) (NP (NP (NN NovoSeven)) (CC and) (NP (NN coagulation) (NN factor) (NNS concentrates))))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB adequately)) (VP (VBN evaluated) (PP (IN in) (NP (ADJP (ADJP (JJ preclinical)) (CC or) (ADJP (JJ clinical))) (NNS studies))))))) (. .))))

det(risk-2, The-1)
nsubjpass(evaluated-17, risk-2)
det(interaction-6, a-4)
amod(interaction-6, potential-5)
prep_of(risk-2, interaction-6)
prep_between(interaction-6, NovoSeven-8)
nn(concentrates-12, coagulation-10)
nn(concentrates-12, factor-11)
conj_and(NovoSeven-8, concentrates-12)
aux(evaluated-17, has-13)
neg(evaluated-17, not-14)
auxpass(evaluated-17, been-15)
advmod(evaluated-17, adequately-16)
root(ROOT-0, evaluated-17)
amod(studies-22, preclinical-19)
conj_or(preclinical-19, clinical-21)
prep_in(evaluated-17, studies-22)

Simultaneous/JJ use/NN of/IN activated/VBN prothrombin/NN complex/NN concentrate/NN s/NN or/CC prothrombin/NN complex/NN concentrates/NNS should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Simultaneous) (NN use)) (PP (IN of) (NP (VBN activated) (NP (NN prothrombin) (NP (NN complex) (NN concentrate) (NN s)) (CC or) (NP (NN prothrombin))) (NN complex) (NNS concentrates)))) (VP (MD should) (VP (VB be) (VP (VBN avoided))))) (. .))))

amod(use-2, Simultaneous-1)
nsubjpass(avoided-15, use-2)
amod(concentrates-12, activated-4)
nn(concentrates-12, prothrombin-5)
nn(s-8, complex-6)
nn(s-8, concentrate-7)
dep(prothrombin-5, s-8)
conj_or(prothrombin-5, prothrombin-10)
nn(concentrates-12, complex-11)
prep_of(use-2, concentrates-12)
aux(avoided-15, should-13)
auxpass(avoided-15, be-14)
root(ROOT-0, avoided-15)

Although/IN the/DT specific/JJ drug/NN interaction/NN was/VBD not/RB studied/VBN in/IN a/DT clinical/JJ trial/NN ,/, there/EX have/VBP been/VBN more/JJR than/IN 50/CD episodes/NNS of/IN concomitant/JJ use/NN of/IN antifibrinolytic/JJ therapies/NNS (/-LRB- i.e./FW ,/, tranexamic/JJ acid/NN ,/, aminocaproic/JJ acid/NN )/-RRB- and/CC NovoSeven/NN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (DT the) (JJ specific) (NN drug) (NN interaction)) (VP (VBD was) (RB not) (VP (VBN studied) (PP (IN in) (NP (DT a) (JJ clinical) (NN trial))))))) (, ,) (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (QP (JJR more) (IN than) (CD 50)) (NNS episodes)) (PP (IN of) (NP (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (JJ antifibrinolytic) (NNS therapies)) (PRN (-LRB- -LRB-) (PP (FW i.e.)) (, ,) (NP (NP (JJ tranexamic) (NN acid)) (, ,) (NP (JJ aminocaproic) (NN acid))) (-RRB- -RRB-))))) (CC and) (NP (NN NovoSeven)))))))) (. .))))

mark(studied-8, Although-1)
det(interaction-5, the-2)
amod(interaction-5, specific-3)
nn(interaction-5, drug-4)
nsubjpass(studied-8, interaction-5)
auxpass(studied-8, was-6)
neg(studied-8, not-7)
advcl(episodes-20, studied-8)
det(trial-12, a-10)
amod(trial-12, clinical-11)
prep_in(studied-8, trial-12)
expl(episodes-20, there-14)
aux(episodes-20, have-15)
cop(episodes-20, been-16)
mwe(than-18, more-17)
quantmod(50-19, than-18)
num(episodes-20, 50-19)
root(ROOT-0, episodes-20)
amod(use-23, concomitant-22)
prep_of(episodes-20, use-23)
amod(therapies-26, antifibrinolytic-25)
prep_of(use-23, therapies-26)
dep(acid-31, i.e.-28)
amod(acid-31, tranexamic-30)
dep(therapies-26, acid-31)
amod(acid-34, aminocaproic-33)
appos(acid-31, acid-34)
conj_and(use-23, NovoSeven-37)

NovoSeven/NN should/MD not/RB be/VB mixed/VBN with/IN infusion/NN solutions/NNS until/IN clinical/JJ data/NNS are/VBP available/JJ to/TO direct/VB this/DT use/NN ./.

(ROOT (S1 (S (S (NP (NN NovoSeven)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN mixed) (PP (IN with) (NP (NN infusion) (NNS solutions))) (SBAR (IN until) (S (NP (JJ clinical) (NNS data)) (VP (VBP are) (ADJP (JJ available) (S (VP (TO to) (VP (VB direct) (NP (DT this) (NN use))))))))))))) (. .))))

nsubjpass(mixed-5, NovoSeven-1)
aux(mixed-5, should-2)
neg(mixed-5, not-3)
auxpass(mixed-5, be-4)
root(ROOT-0, mixed-5)
nn(solutions-8, infusion-7)
prep_with(mixed-5, solutions-8)
mark(available-13, until-9)
amod(data-11, clinical-10)
nsubj(available-13, data-11)
cop(available-13, are-12)
advcl(mixed-5, available-13)
aux(direct-15, to-14)
xcomp(available-13, direct-15)
det(use-17, this-16)
dobj(direct-15, use-17)

Codeine/NN in/IN combination/NN with/IN other/JJ narcotic/JJ analgesic/JJ s/NNS ,/, general/JJ anesthetics/NNS ,/, phenothiazines/NNS ,/, tranquilizers/NNS ,/, sedative-hypnotics/NNS ,/, or/CC other/JJ CNS/NN depressants/NNS (/-LRB- including/VBG alcohol/NN )/-RRB- has/VBZ additive/JJ depressant/NN effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Codeine)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (JJ other) (JJ narcotic) (JJ analgesic) (NNS s)) (, ,) (NP (JJ general) (NNS anesthetics)) (, ,) (NP (NNS phenothiazines)) (, ,) (NP (NNS tranquilizers)) (, ,) (NP (NNS sedative-hypnotics)) (, ,) (CC or) (NP (NP (JJ other) (NN CNS) (NNS depressants)) (PRN (-LRB- -LRB-) (PP (VBG including) (NP (NN alcohol))) (-RRB- -RRB-)))))))) (VP (VBZ has) (NP (JJ additive) (NN depressant) (NNS effects)))) (. .))))

nsubj(has-27, Codeine-1)
prep_in(Codeine-1, combination-3)
amod(s-8, other-5)
amod(s-8, narcotic-6)
amod(s-8, analgesic-7)
prep_with(combination-3, s-8)
amod(anesthetics-11, general-10)
conj_or(s-8, anesthetics-11)
conj_or(s-8, phenothiazines-13)
conj_or(s-8, tranquilizers-15)
conj_or(s-8, sedative-hypnotics-17)
amod(depressants-22, other-20)
nn(depressants-22, CNS-21)
conj_or(s-8, depressants-22)
dep(depressants-22, including-24)
pobj(including-24, alcohol-25)
root(ROOT-0, has-27)
amod(effects-30, additive-28)
nn(effects-30, depressant-29)
dobj(has-27, effects-30)

WelChol/NN @/NN has/VBZ been/VBN studied/VBN in/IN several/JJ human/JJ drug/NN interaction/NN studies/NNS in/IN which/WDT it/PRP was/VBD administered/VBN with/IN a/DT meal/NN and/CC the/DT test/NN drug/NN ./.

(ROOT (S1 (S (S (NP (NN WelChol) (NN @)) (VP (VBZ has) (VP (VBN been) (VP (VBN studied) (PP (IN in) (NP (NP (JJ several) (JJ human) (NN drug) (NN interaction) (NNS studies)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (PRP it)) (VP (VBD was) (VP (VBN administered) (PP (IN with) (NP (NP (DT a) (NN meal)) (CC and) (NP (DT the) (NN test) (NN drug)))))))))))))) (. .))))

nn(@-2, WelChol-1)
nsubjpass(studied-5, @-2)
aux(studied-5, has-3)
auxpass(studied-5, been-4)
root(ROOT-0, studied-5)
amod(studies-11, several-7)
amod(studies-11, human-8)
nn(studies-11, drug-9)
nn(studies-11, interaction-10)
prep_in(studied-5, studies-11)
rel(administered-16, which-13)
nsubjpass(administered-16, it-14)
auxpass(administered-16, was-15)
rcmod(studies-11, administered-16)
det(meal-19, a-18)
prep_with(administered-16, meal-19)
det(drug-23, the-21)
nn(drug-23, test-22)
conj_and(meal-19, drug-23)

WelChol/NN @/NN was/VBD found/VBN to/TO have/VB no/DT significant/JJ effect/NN on/IN the/DT bioavailability/NN of/IN digoxin/NN ,/, lovastatin/NN ,/, metoprolol/NN ,/, quinidine/NN ,/, valproic/JJ acid/NN ,/, and/CC warfarin/NN ./.

(ROOT (S1 (S (S (NP (NN WelChol) (NN @)) (VP (VBD was) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (NP (NN digoxin)) (, ,) (NP (NN lovastatin)) (, ,) (NP (NN metoprolol)) (, ,) (NP (NN quinidine)) (, ,) (NP (JJ valproic) (NN acid)) (, ,) (CC and) (NP (NN warfarin)))))))))))) (. .))))

nn(@-2, WelChol-1)
nsubjpass(found-4, @-2)
xsubj(have-6, @-2)
auxpass(found-4, was-3)
root(ROOT-0, found-4)
aux(have-6, to-5)
xcomp(found-4, have-6)
det(effect-9, no-7)
amod(effect-9, significant-8)
dobj(have-6, effect-9)
det(bioavailability-12, the-11)
prep_on(have-6, bioavailability-12)
prep_of(bioavailability-12, digoxin-14)
conj_and(digoxin-14, lovastatin-16)
conj_and(digoxin-14, metoprolol-18)
conj_and(digoxin-14, quinidine-20)
amod(acid-23, valproic-22)
conj_and(digoxin-14, acid-23)
conj_and(digoxin-14, warfarin-26)

WelChol/NN @/NN decreased/VBD the/DT Cmax/NN and/CC AUC/NN of/IN sustained-release/NN verapamil/NN (/-LRB- Calan/NN SR/JJ @/NN )/-RRB- by/IN approximately/RB 31/CD %/NN and/CC 11/CD %/NN ,/, respectively/RB ./.

(ROOT (S1 (S (S (NP (NN WelChol) (NN @)) (VP (VBD decreased) (NP (NP (DT the) (NP (NN Cmax)) (CC and) (NP (NN AUC))) (PP (IN of) (NP (NP (NN sustained-release) (NN verapamil)) (PRN (-LRB- -LRB-) (NP (NN Calan) (JJ SR) (NN @)) (-RRB- -RRB-))))) (PP (IN by) (NP (NP (QP (RB approximately) (CD 31)) (NN %)) (CC and) (NP (CD 11) (NN %)) (, ,) (ADVP (RB respectively)))))) (. .))))

nn(@-2, WelChol-1)
nsubj(decreased-3, @-2)
root(ROOT-0, decreased-3)
dep(Cmax-5, the-4)
dobj(decreased-3, Cmax-5)
conj_and(Cmax-5, AUC-7)
nn(verapamil-10, sustained-release-9)
prep_of(Cmax-5, verapamil-10)
nn(@-14, Calan-12)
amod(@-14, SR-13)
appos(verapamil-10, @-14)
quantmod(31-18, approximately-17)
num(%-19, 31-18)
prep_by(decreased-3, %-19)
num(%-22, 11-21)
conj_and(%-19, %-22)
advmod(%-19, respectively-24)
conj_and(%-19, respectively-24)

Since/IN there/EX is/VBZ a/DT high/JJ degree/NN of/IN variability/NN in/IN the/DT bioavailability/NN of/IN verapamil/NN ,/, the/DT clinical/JJ significance/NN of/IN this/DT finding/NN is/VBZ unclear/JJ ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (JJ high) (NN degree)) (PP (IN of) (NP (NN variability))) (PP (IN in) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (NN verapamil))))))))) (, ,) (NP (NP (DT the) (JJ clinical) (NN significance)) (PP (IN of) (NP (DT this) (NN finding)))) (VP (VBZ is) (ADJP (JJ unclear)))) (. .))))

mark(is-3, Since-1)
expl(is-3, there-2)
advcl(is-21, is-3)
det(degree-6, a-4)
amod(degree-6, high-5)
nsubj(is-3, degree-6)
prep_of(degree-6, variability-8)
det(bioavailability-11, the-10)
prep_in(degree-6, bioavailability-11)
prep_of(bioavailability-11, verapamil-13)
det(significance-17, the-15)
amod(significance-17, clinical-16)
nsubj(is-21, significance-17)
det(finding-20, this-19)
prep_of(significance-17, finding-20)
root(ROOT-0, is-21)
acomp(is-21, unclear-22)

In/IN clinical/JJ studies/NNS ,/, coadministration/NN of/IN WelChol/NN @/NN with/IN atorvastatin/NN ,/, lovastatin/NN ,/, or/CC simvastatin/NN did/VBD not/RB interfere/VB with/IN the/DT lipid-lowering/JJ activity/NN of/IN the/DT HMG-CoA/NN reductase/NN inhibitor/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ clinical) (NNS studies))) (, ,) (NP (NP (NN coadministration)) (PP (IN of) (NP (NN WelChol) (NN @))) (PP (IN with) (NP (NP (NN atorvastatin)) (, ,) (NP (NN lovastatin)) (, ,) (CC or) (NP (NN simvastatin))))) (VP (VBD did) (RB not) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (JJ lipid-lowering) (NN activity)) (PP (IN of) (NP (DT the) (NN HMG-CoA) (NN reductase) (NN inhibitor)))))))) (. .))))

amod(studies-3, clinical-2)
prep_in(interfere-18, studies-3)
nsubj(interfere-18, coadministration-5)
nn(@-8, WelChol-7)
prep_of(coadministration-5, @-8)
prep_with(coadministration-5, atorvastatin-10)
conj_or(atorvastatin-10, lovastatin-12)
conj_or(atorvastatin-10, simvastatin-15)
aux(interfere-18, did-16)
neg(interfere-18, not-17)
root(ROOT-0, interfere-18)
det(activity-22, the-20)
amod(activity-22, lipid-lowering-21)
prep_with(interfere-18, activity-22)
det(inhibitor-27, the-24)
nn(inhibitor-27, HMG-CoA-25)
nn(inhibitor-27, reductase-26)
prep_of(activity-22, inhibitor-27)

Other/JJ drugs/NNS have/VBP not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (JJ Other) (NNS drugs)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

amod(drugs-2, Other-1)
nsubjpass(studied-6, drugs-2)
aux(studied-6, have-3)
neg(studied-6, not-4)
auxpass(studied-6, been-5)
root(ROOT-0, studied-6)

When/WRB administering/VBG other/JJ drugs/NNS for/IN which/WDT alterations/NNS in/IN blood/NN levels/NNS could/MD have/VB a/DT clinically/RB significant/JJ effect/NN on/IN safety/NN or/CC efficacy/NN ,/, physicians/NNS should/MD consider/VB monitoring/NN drug/NN levels/NNS or/CC effects/NNS ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBG administering) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (NP (NNS alterations)) (PP (IN in) (NP (NN blood) (NNS levels)))) (VP (MD could) (VP (VB have) (NP (DT a) (ADJP (RB clinically) (JJ significant)) (NN effect)) (PP (IN on) (NP (NP (NN safety)) (CC or) (NP (NN efficacy)))))))))))) (, ,) (NP (NNS physicians)) (VP (MD should) (VP (VB consider) (NP (NP (NN monitoring) (NN drug) (NNS levels)) (CC or) (NP (NNS effects)))))) (. .))))

advmod(administering-2, When-1)
advcl(consider-24, administering-2)
amod(drugs-4, other-3)
dobj(administering-2, drugs-4)
rel(have-12, which-6)
nsubj(have-12, alterations-7)
nn(levels-10, blood-9)
prep_in(alterations-7, levels-10)
aux(have-12, could-11)
rcmod(drugs-4, have-12)
det(effect-16, a-13)
advmod(significant-15, clinically-14)
amod(effect-16, significant-15)
dobj(have-12, effect-16)
prep_on(have-12, safety-18)
conj_or(safety-18, efficacy-20)
nsubj(consider-24, physicians-22)
aux(consider-24, should-23)
root(ROOT-0, consider-24)
nn(levels-27, monitoring-25)
nn(levels-27, drug-26)
dobj(consider-24, levels-27)
conj_or(levels-27, effects-29)

Since/IN colestipol/NN hydrochloride/NN is/VBZ an/DT anion/NN exchange/NN resin/NN ,/, it/PRP may/MD have/VB a/DT strong/JJ affinity/NN for/IN anions/NNS other/JJ than/IN the/DT bile/JJ acids/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NN colestipol) (NN hydrochloride)) (VP (VBZ is) (NP (NP (DT an) (NN anion) (NN exchange)) (NN resin))))) (, ,) (NP (PRP it)) (VP (MD may) (VP (VB have) (NP (NP (DT a) (JJ strong) (NN affinity)) (PP (IN for) (NP (NP (NNS anions)) (CONJP (JJ other) (IN than)) (NP (DT the) (JJ bile) (NNS acids)))))))) (. .))))

mark(resin-8, Since-1)
nn(hydrochloride-3, colestipol-2)
nsubj(resin-8, hydrochloride-3)
cop(resin-8, is-4)
det(exchange-7, an-5)
nn(exchange-7, anion-6)
nn(resin-8, exchange-7)
advcl(have-12, resin-8)
nsubj(have-12, it-10)
aux(have-12, may-11)
root(ROOT-0, have-12)
det(affinity-15, a-13)
amod(affinity-15, strong-14)
dobj(have-12, affinity-15)
prep_for(affinity-15, anions-17)
det(acids-22, the-20)
amod(acids-22, bile-21)
conj_other(anions-17, acids-22)

In/FW vitro/FW studies/NNS have/VBP indicated/VBN that/IN colestipol/NN hydrochloride/NN binds/VBZ a/DT number/NN of/IN drugs/NNS ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBP have) (VP (VBN indicated) (SBAR (IN that) (S (NP (NN colestipol) (NN hydrochloride)) (VP (VBZ binds) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NNS drugs)))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(indicated-5, studies-3)
aux(indicated-5, have-4)
root(ROOT-0, indicated-5)
complm(binds-9, that-6)
nn(hydrochloride-8, colestipol-7)
nsubj(binds-9, hydrochloride-8)
ccomp(indicated-5, binds-9)
det(number-11, a-10)
dobj(binds-9, number-11)
prep_of(number-11, drugs-13)

The/DT interval/NN between/IN the/DT administration/NN of/IN COLESTID/JJ Tablets/NNS and/CC any/DT other/JJ medication/NN should/MD be/VB as/RB long/JJ as/IN possible/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN interval)) (PP (IN between) (NP (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (JJ COLESTID) (NNS Tablets)))) (CC and) (NP (DT any) (JJ other) (NN medication))))) (VP (MD should) (VP (VB be) (ADJP (RB as) (JJ long) (PP (IN as) (NP (JJ possible))))))) (. .))))

det(interval-2, The-1)
nsubj(long-16, interval-2)
det(administration-5, the-4)
prep_between(interval-2, administration-5)
amod(Tablets-8, COLESTID-7)
prep_of(administration-5, Tablets-8)
det(medication-12, any-10)
amod(medication-12, other-11)
conj_and(administration-5, medication-12)
aux(long-16, should-13)
cop(long-16, be-14)
advmod(long-16, as-15)
root(ROOT-0, long-16)
prep_as(long-16, possible-18)

Patients/NNS should/MD take/VB other/JJ drugs/NNS at/IN least/JJS one/CD hour/NN before/IN or/CC four/CD hours/NNS after/IN COLESTID/JJ Tablets/NNS to/TO avoid/VB impeding/VBG their/PRP$ absorption/NN ./.

(ROOT (S1 (S (S (NP (NNS Patients)) (VP (MD should) (VP (VB take) (NP (JJ other) (NNS drugs)) (PP (NP (QP (IN at) (JJS least) (CD one)) (NN hour)) (IN before) (NP (NP (CC or) (CD four) (NNS hours)) (PP (IN after) (NP (JJ COLESTID) (NNS Tablets)))))) (S (VP (TO to) (VP (VB avoid) (S (VP (VBG impeding) (NP (PRP$ their) (NN absorption))))))))) (. .))))

nsubj(take-3, Patients-1)
xsubj(avoid-18, Patients-1)
aux(take-3, should-2)
root(ROOT-0, take-3)
amod(drugs-5, other-4)
dobj(take-3, drugs-5)
quantmod(one-8, at-6)
mwe(at-6, least-7)
pobj(at-6, least-7)
num(hour-9, one-8)
npadvmod(take-3, hour-9)
cc(hours-13, or-11)
dep(hours-13, four-12)
prep_before(take-3, hours-13)
amod(Tablets-16, COLESTID-15)
prep_after(hours-13, Tablets-16)
aux(avoid-18, to-17)
xcomp(take-3, avoid-18)
xcomp(avoid-18, impeding-19)
poss(absorption-21, their-20)
dobj(impeding-19, absorption-21)

Repeated/JJ doses/NNS of/IN colestipol/NN hydrochloride/NN given/VBN prior/JJ to/TO a/DT single/JJ dose/NN of/IN propranolol/NN in/IN human/JJ trials/NNS have/VBP been/VBN reported/VBN to/TO decrease/VB propranolol/NN absorption/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Repeated) (NNS doses)) (PP (IN of) (NP (NP (NN colestipol) (NN hydrochloride)) (VP (VBN given) (PP (JJ prior) (TO to) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NP (NN propranolol)) (PP (IN in) (NP (JJ human) (NNS trials))))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB decrease) (NP (NN propranolol) (NN absorption))))))))) (. .))))

amod(doses-2, Repeated-1)
nsubjpass(reported-19, doses-2)
xsubj(decrease-21, doses-2)
nn(hydrochloride-5, colestipol-4)
prep_of(doses-2, hydrochloride-5)
partmod(hydrochloride-5, given-6)
det(dose-11, a-9)
amod(dose-11, single-10)
prep_prior_to(given-6, dose-11)
prep_of(dose-11, propranolol-13)
amod(trials-16, human-15)
prep_in(propranolol-13, trials-16)
aux(reported-19, have-17)
auxpass(reported-19, been-18)
root(ROOT-0, reported-19)
aux(decrease-21, to-20)
xcomp(reported-19, decrease-21)
nn(absorption-23, propranolol-22)
dobj(decrease-21, absorption-23)

However/RB ,/, in/IN a/DT follow-up/JJ study/NN in/IN normal/JJ subjects/NNS ,/, single-dose/JJ administration/NN of/IN colestipol/NN hydrochloride/NN and/CC propranolol/NN and/CC twice-a-day/JJ administration/NN for/IN 5/CD days/NNS of/IN both/DT agents/NNS did/VBD not/RB affect/VB the/DT extent/NN of/IN propranolol/NN absorption/NN ,/, but/CC had/VBD a/DT small/JJ yet/CC statistically/RB significant/JJ effect/NN on/IN its/PRP$ rate/NN of/IN absorption/NN ;/: ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (NP (DT a) (JJ follow-up) (NN study)) (PP (IN in) (NP (JJ normal) (NNS subjects))))) (, ,) (NP (NP (NP (JJ single-dose) (NN administration)) (PP (IN of) (NP (NP (NN colestipol) (NN hydrochloride)) (CC and) (NP (NN propranolol))))) (CC and) (NP (NP (JJ twice-a-day) (NN administration)) (PP (IN for) (NP (NP (CD 5) (NNS days)) (PP (IN of) (NP (DT both) (NNS agents))))))) (VP (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NN propranolol) (NN absorption)))))) (, ,) (CC but) (VP (VBD had) (NP (DT a) (ADJP (ADJP (JJ small)) (CC yet) (ADJP (RB statistically) (JJ significant))) (NN effect)) (PP (IN on) (NP (NP (PRP$ its) (NN rate)) (PP (IN of) (NP (NN absorption))))))) (: ;)) (. .))))

advmod(affect-29, However-1)
det(study-6, a-4)
amod(study-6, follow-up-5)
prep_in(affect-29, study-6)
amod(subjects-9, normal-8)
prep_in(study-6, subjects-9)
amod(administration-12, single-dose-11)
nsubj(affect-29, administration-12)
nn(hydrochloride-15, colestipol-14)
prep_of(administration-12, hydrochloride-15)
conj_and(hydrochloride-15, propranolol-17)
amod(administration-20, twice-a-day-19)
conj_and(administration-12, administration-20)
num(days-23, 5-22)
prep_for(administration-20, days-23)
det(agents-26, both-25)
prep_of(days-23, agents-26)
aux(affect-29, did-27)
neg(affect-29, not-28)
root(ROOT-0, affect-29)
det(extent-31, the-30)
dobj(affect-29, extent-31)
nn(absorption-34, propranolol-33)
prep_of(extent-31, absorption-34)
conj_but(affect-29, had-37)
det(effect-43, a-38)
amod(effect-43, small-39)
advmod(significant-42, statistically-41)
conj_yet(small-39, significant-42)
dobj(had-37, effect-43)
poss(rate-46, its-45)
prep_on(had-37, rate-46)
prep_of(rate-46, absorption-48)

Effects/NNS on/IN the/DT absorption/NN of/IN other/JJ beta-blockers/NNS have/VBP not/RB been/VBN determined/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Effects)) (PP (IN on) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (JJ other) (NNS beta-blockers)))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN determined))))) (. .))))

nsubjpass(determined-11, Effects-1)
det(absorption-4, the-3)
prep_on(Effects-1, absorption-4)
amod(beta-blockers-7, other-6)
prep_of(absorption-4, beta-blockers-7)
aux(determined-11, have-8)
neg(determined-11, not-9)
auxpass(determined-11, been-10)
root(ROOT-0, determined-11)

Therefore/RB ,/, patients/NNS on/IN propranolol/NN should/MD be/VB observed/VBN when/WRB COLESTID/NN Tablets/NNS are/VBP either/CC added/VBN or/CC deleted/VBN from/IN a/DT therapeutic/JJ regimen/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NNS patients)) (PP (IN on) (NP (NN propranolol)))) (VP (MD should) (VP (VB be) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (NN COLESTID) (NNS Tablets)) (VP (VBP are) (VP (CC either) (VP (VBN added)) (CC or) (VP (VBN deleted) (PP (IN from) (NP (DT a) (JJ therapeutic) (NNS regimen)))))))))))) (. .))))

advmod(observed-8, Therefore-1)
nsubjpass(observed-8, patients-3)
prep_on(patients-3, propranolol-5)
aux(observed-8, should-6)
auxpass(observed-8, be-7)
root(ROOT-0, observed-8)
advmod(added-14, when-9)
nn(Tablets-11, COLESTID-10)
nsubjpass(added-14, Tablets-11)
auxpass(added-14, are-12)
preconj(added-14, either-13)
advcl(observed-8, added-14)
conj_or(added-14, deleted-16)
det(regimen-20, a-18)
amod(regimen-20, therapeutic-19)
prep_from(deleted-16, regimen-20)

Studies/NNS in/IN humans/NNS show/VBP that/IN the/DT absorption/NN of/IN chlorothiazide/NN as/IN reflected/VBN in/IN urinary/JJ excretion/NN is/VBZ markedly/RB decreased/VBN even/RB when/WRB administered/VBN one/CD hour/NN before/IN colestipol/NN hydrochloride/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Studies)) (PP (IN in) (NP (NNS humans)))) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NN chlorothiazide))) (SBAR (IN as) (S (VP (VBN reflected) (PP (IN in) (NP (JJ urinary) (NN excretion))))))) (VP (VBZ is) (ADVP (RB markedly)) (VP (VBN decreased) (SBAR (WHADVP (RB even) (WRB when)) (S (VP (VBN administered) (PP (NP (CD one) (NN hour)) (IN before) (NP (NN colestipol) (NN hydrochloride)))))))))))) (. .))))

nsubj(show-4, Studies-1)
prep_in(Studies-1, humans-3)
root(ROOT-0, show-4)
complm(decreased-17, that-5)
det(absorption-7, the-6)
nsubjpass(decreased-17, absorption-7)
prep_of(absorption-7, chlorothiazide-9)
mark(reflected-11, as-10)
dep(absorption-7, reflected-11)
amod(excretion-14, urinary-13)
prep_in(reflected-11, excretion-14)
auxpass(decreased-17, is-15)
advmod(decreased-17, markedly-16)
ccomp(show-4, decreased-17)
advmod(when-19, even-18)
advmod(administered-20, when-19)
advcl(decreased-17, administered-20)
num(hour-22, one-21)
npadvmod(administered-20, hour-22)
nn(hydrochloride-25, colestipol-24)
prep_before(administered-20, hydrochloride-25)

The/DT absorption/NN of/IN tetracycline/NN ,/, furosemide/NN ,/, penicillin/NN G/NN ,/, hydrochlorothiazide/NN ,/, and/CC gemfibrozil/NN was/VBD significantly/RB decreased/VBN when/WRB given/VBN simultaneously/RB with/IN colestipol/NN hydrochloride/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN absorption)) (PP (IN of) (NP (NP (NN tetracycline)) (, ,) (NP (NN furosemide)) (, ,) (NP (NN penicillin) (NN G)) (, ,) (NP (NN hydrochlorothiazide)) (, ,) (CC and) (NP (NN gemfibrozil))))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN decreased)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (ADVP (RB simultaneously)) (PP (IN with) (NP (NN colestipol) (NN hydrochloride))))))) (: ;)) (. .))))

det(absorption-2, The-1)
nsubjpass(decreased-17, absorption-2)
prep_of(absorption-2, tetracycline-4)
conj_and(tetracycline-4, furosemide-6)
nn(G-9, penicillin-8)
conj_and(tetracycline-4, G-9)
conj_and(tetracycline-4, hydrochlorothiazide-11)
conj_and(tetracycline-4, gemfibrozil-14)
auxpass(decreased-17, was-15)
advmod(decreased-17, significantly-16)
root(ROOT-0, decreased-17)
advmod(given-19, when-18)
advcl(decreased-17, given-19)
advmod(given-19, simultaneously-20)
nn(hydrochloride-23, colestipol-22)
prep_with(given-19, hydrochloride-23)

these/DT drugs/NNS were/VBD not/RB tested/VBN to/TO determine/VB the/DT effect/NN of/IN administration/NN one/CD hour/NN before/IN colestipol/NN hydrochloride/NN ./.

(ROOT (S1 (S (S (NP (DT these) (NNS drugs)) (VP (VBD were) (RB not) (VP (VBN tested) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN administration))) (PP (NP (CD one) (NN hour)) (IN before) (NP (NN colestipol) (NN hydrochloride)))))))))) (. .))))

det(drugs-2, these-1)
nsubjpass(tested-5, drugs-2)
xsubj(determine-7, drugs-2)
auxpass(tested-5, were-3)
neg(tested-5, not-4)
root(ROOT-0, tested-5)
aux(determine-7, to-6)
xcomp(tested-5, determine-7)
det(effect-9, the-8)
dobj(determine-7, effect-9)
prep_of(effect-9, administration-11)
num(hour-13, one-12)
npadvmod(effect-9, hour-13)
nn(hydrochloride-16, colestipol-15)
prep_before(effect-9, hydrochloride-16)

No/DT depressant/JJ effect/NN on/IN blood/NN levels/NNS in/IN humans/NNS was/VBD noted/VBN when/WRB colestipol/NN hydrochloride/NN was/VBD administered/VBN with/IN any/DT of/IN the/DT following/JJ drugs/NNS :/: aspirin/NN ,/, clindamycin/NN ,/, clofibrate/NN ,/, methyldopa/NN ,/, nicotinic/JJ acid/NN (/-LRB- niacin/NN )/-RRB- ,/, tolbutamide/NN ,/, phenytoin/NN or/CC warfarin/NN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (JJ depressant) (NN effect)) (PP (IN on) (NP (NP (NN blood) (NNS levels)) (PP (IN in) (NP (NNS humans)))))) (VP (VBD was) (VP (VBN noted)) (SBAR (WHADVP (WRB when)) (S (NP (NN colestipol) (NN hydrochloride)) (VP (VBD was) (VP (VBN administered) (PP (IN with) (NP (NP (DT any)) (PP (IN of) (NP (NP (DT the) (JJ following) (NNS drugs)) (: :) (NP (NP (NN aspirin)) (, ,) (NP (NN clindamycin)) (, ,) (NP (NN clofibrate)) (, ,) (NP (NN methyldopa)) (, ,) (NP (NP (JJ nicotinic) (NN acid)) (PRN (-LRB- -LRB-) (NP (NN niacin)) (-RRB- -RRB-))) (, ,) (NP (NN tolbutamide)) (, ,) (NP (NN phenytoin)) (CC or) (NP (NN warfarin))))))))))))) (. .))))

det(effect-3, No-1)
amod(effect-3, depressant-2)
nsubjpass(noted-10, effect-3)
nn(levels-6, blood-5)
prep_on(effect-3, levels-6)
prep_in(levels-6, humans-8)
auxpass(noted-10, was-9)
root(ROOT-0, noted-10)
advmod(administered-15, when-11)
nn(hydrochloride-13, colestipol-12)
nsubjpass(administered-15, hydrochloride-13)
auxpass(administered-15, was-14)
advcl(noted-10, administered-15)
prep_with(administered-15, any-17)
det(drugs-21, the-19)
amod(drugs-21, following-20)
prep_of(any-17, drugs-21)
dep(drugs-21, aspirin-23)
conj_or(aspirin-23, clindamycin-25)
conj_or(aspirin-23, clofibrate-27)
conj_or(aspirin-23, methyldopa-29)
amod(acid-32, nicotinic-31)
conj_or(aspirin-23, acid-32)
appos(acid-32, niacin-34)
conj_or(aspirin-23, tolbutamide-37)
conj_or(aspirin-23, phenytoin-39)
conj_or(aspirin-23, warfarin-41)

Particular/JJ caution/NN should/MD be/VB observed/VBN with/IN digitalis/NN preparation/NN s/NNS since/IN there/EX are/VBP conflicting/VBG results/NNS for/IN the/DT effect/NN of/IN colestipol/NN hydrochloride/NN on/IN the/DT availability/NN of/IN digoxin/NN and/CC digitoxin/NN ./.

(ROOT (S1 (S (S (NP (JJ Particular) (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN observed) (PP (IN with) (NP (NN digitalis) (NN preparation) (NNS s))))) (SBAR (IN since) (S (NP (EX there)) (VP (VBP are) (NP (VBG conflicting) (NNS results)) (PP (IN for) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN colestipol) (NN hydrochloride))) (PP (IN on) (NP (NP (DT the) (NN availability)) (PP (IN of) (NP (NP (NN digoxin)) (CC and) (NP (NN digitoxin))))))))))))) (. .))))

amod(caution-2, Particular-1)
nsubjpass(observed-5, caution-2)
aux(observed-5, should-3)
auxpass(observed-5, be-4)
root(ROOT-0, observed-5)
nn(s-9, digitalis-7)
nn(s-9, preparation-8)
prep_with(observed-5, s-9)
mark(are-12, since-10)
expl(are-12, there-11)
advcl(observed-5, are-12)
amod(results-14, conflicting-13)
nsubj(are-12, results-14)
det(effect-17, the-16)
prep_for(are-12, effect-17)
nn(hydrochloride-20, colestipol-19)
prep_of(effect-17, hydrochloride-20)
det(availability-23, the-22)
prep_on(effect-17, availability-23)
prep_of(availability-23, digoxin-25)
conj_and(digoxin-25, digitoxin-27)

The/DT potential/NN for/IN binding/NN of/IN these/DT drugs/NNS if/IN given/VBN concomitantly/RB is/VBZ present/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN potential)) (PP (IN for) (NP (NP (NN binding)) (PP (IN of) (NP (DT these) (NNS drugs)))))) (SBAR (IN if) (S (VP (VBN given) (ADVP (RB concomitantly))))) (VP (VBZ is) (ADJP (JJ present)))) (. .))))

det(potential-2, The-1)
nsubj(present-12, potential-2)
prep_for(potential-2, binding-4)
det(drugs-7, these-6)
prep_of(binding-4, drugs-7)
mark(given-9, if-8)
dep(present-12, given-9)
advmod(given-9, concomitantly-10)
cop(present-12, is-11)
root(ROOT-0, present-12)

Discontinuing/JJ colestipol/NN hydrochloride/NN could/MD pose/VB a/DT hazard/NN to/TO health/NN if/IN a/DT potentially/RB toxic/JJ drug/NN that/WDT is/VBZ significantly/RB bound/VBN to/TO the/DT resin/NN has/VBZ been/VBN titrated/VBN to/TO a/DT maintenance/NN level/NN while/IN the/DT patient/NN was/VBD taking/VBG colestipol/NN hydrochloride/NN ./.

(ROOT (S1 (S (S (NP (JJ Discontinuing) (NN colestipol) (NN hydrochloride)) (VP (MD could) (VP (VB pose) (NP (NP (DT a) (NN hazard)) (PP (TO to) (NP (NN health)))) (SBAR (IN if) (S (NP (NP (DT a) (ADJP (RB potentially) (JJ toxic)) (NN drug)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADVP (RB significantly)) (VP (VBN bound) (PP (TO to) (NP (DT the) (NN resin)))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN titrated) (PP (TO to) (NP (DT a) (NN maintenance) (NN level))) (SBAR (IN while) (S (NP (DT the) (NN patient)) (VP (VBD was) (VP (VBG taking) (NP (NN colestipol) (NN hydrochloride)))))))))))))) (. .))))

amod(hydrochloride-3, Discontinuing-1)
nn(hydrochloride-3, colestipol-2)
nsubj(pose-5, hydrochloride-3)
aux(pose-5, could-4)
root(ROOT-0, pose-5)
det(hazard-7, a-6)
dobj(pose-5, hazard-7)
prep_to(hazard-7, health-9)
mark(titrated-24, if-10)
det(drug-14, a-11)
advmod(toxic-13, potentially-12)
amod(drug-14, toxic-13)
nsubjpass(bound-18, drug-14)
nsubjpass(titrated-24, drug-14)
auxpass(bound-18, is-16)
advmod(bound-18, significantly-17)
rcmod(drug-14, bound-18)
det(resin-21, the-20)
prep_to(bound-18, resin-21)
aux(titrated-24, has-22)
auxpass(titrated-24, been-23)
advcl(pose-5, titrated-24)
det(level-28, a-26)
nn(level-28, maintenance-27)
prep_to(titrated-24, level-28)
mark(taking-33, while-29)
det(patient-31, the-30)
nsubj(taking-33, patient-31)
aux(taking-33, was-32)
advcl(titrated-24, taking-33)
nn(hydrochloride-35, colestipol-34)
dobj(taking-33, hydrochloride-35)

Bile/JJ acid/NN binding/NN resins/NNS may/MD also/RB interfere/VB with/IN the/DT absorption/NN of/IN oral/JJ phosphate/NN supplements/NNS and/CC hydrocortisone/NN ./.

(ROOT (S1 (S (S (NP (JJ Bile) (NN acid) (NN binding) (NNS resins)) (VP (MD may) (ADVP (RB also)) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NP (JJ oral) (NN phosphate) (NNS supplements)) (CC and) (NP (NN hydrocortisone))))))))) (. .))))

amod(resins-4, Bile-1)
nn(resins-4, acid-2)
nn(resins-4, binding-3)
nsubj(interfere-7, resins-4)
aux(interfere-7, may-5)
advmod(interfere-7, also-6)
root(ROOT-0, interfere-7)
det(absorption-10, the-9)
prep_with(interfere-7, absorption-10)
amod(supplements-14, oral-12)
nn(supplements-14, phosphate-13)
prep_of(absorption-10, supplements-14)
conj_and(supplements-14, hydrocortisone-16)

Certain/JJ other/JJ antibiotics/NNS (/-LRB- aminoglycosides/NN and/CC polymyxin/NN )/-RRB- have/VBP also/RB been/VBN reported/VBN to/TO interfere/VB with/IN the/DT nerve/NN transmission/NN at/IN the/DT neuromuscular/JJ junction/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Certain) (JJ other) (NNS antibiotics)) (PRN (-LRB- -LRB-) (NP (NP (NN aminoglycosides)) (CC and) (NP (NN polymyxin))) (-RRB- -RRB-))) (VP (VBP have) (ADVP (RB also)) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (DT the) (NN nerve) (NN transmission))) (PP (IN at) (NP (DT the) (JJ neuromuscular) (NN junction)))))))))) (. .))))

amod(antibiotics-3, Certain-1)
amod(antibiotics-3, other-2)
nsubjpass(reported-12, antibiotics-3)
xsubj(interfere-14, antibiotics-3)
dep(antibiotics-3, aminoglycosides-5)
conj_and(aminoglycosides-5, polymyxin-7)
aux(reported-12, have-9)
advmod(reported-12, also-10)
auxpass(reported-12, been-11)
root(ROOT-0, reported-12)
aux(interfere-14, to-13)
xcomp(reported-12, interfere-14)
det(transmission-18, the-16)
nn(transmission-18, nerve-17)
prep_with(interfere-14, transmission-18)
det(junction-22, the-20)
amod(junction-22, neuromuscular-21)
prep_at(interfere-14, junction-22)

Based/VBN on/IN this/DT reported/VBN activity/NN ,/, they/PRP should/MD not/RB be/VB given/VBN concomitantly/RB with/IN Coly-Mycin/NN M/NN Parenteral/JJ except/IN with/IN the/DT greatest/JJS caution/NN ./.

(ROOT (S1 (S (S (PP (VBN Based) (PP (IN on) (NP (DT this) (VBN reported) (NN activity)))) (, ,) (NP (PRP they)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN given) (ADVP (RB concomitantly)) (PP (PP (IN with) (NP (NN Coly-Mycin) (NN M))) (CONJP (JJ Parenteral) (IN except)) (PP (IN with) (NP (DT the) (JJS greatest) (NN caution)))))))) (. .))))

prepc_based_on(given-11, on-2)
det(activity-5, this-3)
amod(activity-5, reported-4)
pobj(given-11, activity-5)
nsubjpass(given-11, they-7)
aux(given-11, should-8)
neg(given-11, not-9)
auxpass(given-11, be-10)
root(ROOT-0, given-11)
advmod(given-11, concomitantly-12)
nn(M-15, Coly-Mycin-14)
prep_with(given-11, M-15)
det(caution-21, the-19)
amod(caution-21, greatest-20)
conj_parenteral(M-15, caution-21)

Curariform/JJ muscle/NN relaxants/NNS (/-LRB- eg/NN ,/, tubocurarine/NN )/-RRB- and/CC other/JJ drugs/NNS ,/, including/VBG ether/NN ,/, succinylcholine/NN ,/, gallamine/NN ,/, decamethonium/NN and/CC sodium/NN citrate/NN ,/, potentiate/VB the/DT neuromuscular/JJ blocking/NN effect/NN and/CC should/MD be/VB used/VBN with/IN extreme/JJ caution/NN in/IN patients/NNS being/VBG treated/VBN with/IN Coly-Mycin/NN M/NN Parenteral/JJ ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Curariform) (NN muscle) (NNS relaxants)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN tubocurarine))) (-RRB- -RRB-))) (CC and) (NP (NP (JJ other) (NNS drugs)) (, ,) (PP (VBG including) (NP (NP (NN ether)) (, ,) (NP (NN succinylcholine)) (, ,) (NP (NN gallamine)) (, ,) (NP (NN decamethonium)) (CC and) (NP (NN sodium) (NN citrate)))) (, ,))) (VP (VP (VB potentiate) (NP (DT the) (JJ neuromuscular) (NN blocking) (NN effect))) (CC and) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NP (JJ extreme) (NN caution)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NP (NN Coly-Mycin)) (ADJP (NN M) (JJ Parenteral))))))))))))))) (. .))))

amod(relaxants-3, Curariform-1)
nn(relaxants-3, muscle-2)
nsubj(potentiate-25, relaxants-3)
dep(relaxants-3, eg-5)
appos(eg-5, tubocurarine-7)
amod(drugs-11, other-10)
conj_and(relaxants-3, drugs-11)
prep_including(drugs-11, ether-14)
conj_and(ether-14, succinylcholine-16)
conj_and(ether-14, gallamine-18)
conj_and(ether-14, decamethonium-20)
nn(citrate-23, sodium-22)
conj_and(ether-14, citrate-23)
root(ROOT-0, potentiate-25)
det(effect-29, the-26)
amod(effect-29, neuromuscular-27)
nn(effect-29, blocking-28)
dobj(potentiate-25, effect-29)
aux(used-33, should-31)
auxpass(used-33, be-32)
conj_and(potentiate-25, used-33)
amod(caution-36, extreme-35)
prep_with(used-33, caution-36)
prep_in(caution-36, patients-38)
auxpass(treated-40, being-39)
partmod(patients-38, treated-40)
prep_with(treated-40, Coly-Mycin-42)
dep(Parenteral-44, M-43)
amod(Coly-Mycin-42, Parenteral-44)

Sodium/NN cephalothin/NN may/MD enhance/VB the/DT nephrotoxicity/NN of/IN Coly-Mycin/NN M/NN Parenteral/JJ ./.

(ROOT (S1 (S (S (NP (NN Sodium) (NN cephalothin)) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NN nephrotoxicity)) (PP (IN of) (NP (NN Coly-Mycin) (NN M) (JJ Parenteral))))))) (. .))))

nn(cephalothin-2, Sodium-1)
nsubj(enhance-4, cephalothin-2)
aux(enhance-4, may-3)
root(ROOT-0, enhance-4)
det(nephrotoxicity-6, the-5)
dobj(enhance-4, nephrotoxicity-6)
nn(M-9, Coly-Mycin-8)
prep_of(nephrotoxicity-6, M-9)
amod(M-9, Parenteral-10)

The/DT concomitant/JJ use/NN of/IN sodium/NN cephalothin/NN and/CC Coly-Mycin/NN M/NN Parenteral/JJ should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN sodium) (NN cephalothin)) (CC and) (NP (NN Coly-Mycin) (NN M) (JJ Parenteral))))) (VP (MD should) (VP (VB be) (VP (VBN avoided))))) (. .))))

det(use-3, The-1)
amod(use-3, concomitant-2)
nsubjpass(avoided-13, use-3)
nn(cephalothin-6, sodium-5)
prep_of(use-3, cephalothin-6)
nn(M-9, Coly-Mycin-8)
conj_and(cephalothin-6, M-9)
amod(M-9, Parenteral-10)
aux(avoided-13, should-11)
auxpass(avoided-13, be-12)
root(ROOT-0, avoided-13)

Digoxin/NN Coadministration/NN of/IN digoxin/NN ,/, a/DT P-/NN glycoprotein/NN substrate/NN ,/, with/IN oral/JJ conivaptan/NN resulted/VBD in/IN a/DT reduction/NN in/IN clearance/NN and/CC an/DT increase/NN in/IN digoxin/NN Cmax/NN and/CC AUC/NN values/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Digoxin) (NN Coadministration)) (PP (IN of) (NP (NP (NN digoxin)) (, ,) (NP (DT a) (NN P-) (NN glycoprotein) (NN substrate)) (, ,))) (PP (IN with) (NP (JJ oral) (NN conivaptan)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NN clearance)))) (CC and) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NP (NN digoxin) (NN Cmax)) (CC and) (NP (NN AUC))) (NNS values)))))))) (. .))))

nn(Coadministration-2, Digoxin-1)
nsubj(resulted-14, Coadministration-2)
prep_of(Coadministration-2, digoxin-4)
det(substrate-9, a-6)
nn(substrate-9, P--7)
nn(substrate-9, glycoprotein-8)
appos(digoxin-4, substrate-9)
amod(conivaptan-13, oral-12)
prep_with(Coadministration-2, conivaptan-13)
root(ROOT-0, resulted-14)
det(reduction-17, a-16)
prep_in(resulted-14, reduction-17)
prep_in(reduction-17, clearance-19)
det(increase-22, an-21)
conj_and(reduction-17, increase-22)
nn(Cmax-25, digoxin-24)
nn(values-28, Cmax-25)
conj_and(Cmax-25, AUC-27)
prep_in(increase-22, values-28)

Therefore/RB ,/, if/IN digoxin/NN is/VBZ administered/VBN with/IN VAPRISOL/NN ,/, the/DT clinician/NN should/MD be/VB alert/JJ to/TO the/DT possibility/NN of/IN increases/NNS in/IN digoxin/NN levels/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (SBAR (IN if) (S (NP (NN digoxin)) (VP (VBZ is) (VP (VBN administered) (PP (IN with) (NP (NN VAPRISOL))))))) (, ,) (NP (DT the) (NN clinician)) (VP (MD should) (VP (VB be) (ADJP (JJ alert) (PP (TO to) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (NNS increases)) (PP (IN in) (NP (NN digoxin) (NNS levels))))))))))) (. .))))

advmod(alert-14, Therefore-1)
mark(administered-6, if-3)
nsubjpass(administered-6, digoxin-4)
auxpass(administered-6, is-5)
advcl(alert-14, administered-6)
prep_with(administered-6, VAPRISOL-8)
det(clinician-11, the-10)
nsubj(alert-14, clinician-11)
aux(alert-14, should-12)
cop(alert-14, be-13)
root(ROOT-0, alert-14)
det(possibility-17, the-16)
prep_to(alert-14, possibility-17)
prep_of(possibility-17, increases-19)
nn(levels-22, digoxin-21)
prep_in(increases-19, levels-22)

DRUG/NN /LABORATORY/VBP TEST/NN INTERACTIONS/NNS 1/CD ./.

(ROOT (S1 (S (S (NP (NN DRUG)) (VP (VBP /LABORATORY) (NP (NN TEST) (NNS INTERACTIONS) (CD 1)))) (. .))))

nsubj(/LABORATORY-2, DRUG-1)
root(ROOT-0, /LABORATORY-2)
nn(INTERACTIONS-4, TEST-3)
dobj(/LABORATORY-2, INTERACTIONS-4)
num(INTERACTIONS-4, 1-5)

increased/VBN factors/NNS II/CD ,/, VII/NN antigen/NN ,/, VIII/NN antigen/NN ,/, VIII/NN coagulant/NN activity/NN ,/, IX/NN ,/, X/NN ,/, XII/NN ,/, VII-X/NN complex/NN ,/, II-VII-X/NN complex/NN ,/, and/CC beta-thromboglobulin/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NP (VBN increased) (NNS factors) (NP (CD II))) (, ,) (NP (NP (NN VII) (NN antigen)) (, ,) (NP (NN VIII) (NN antigen)) (, ,) (NP (NN VIII) (NN coagulant) (NN activity)) (, ,) (NP (NN IX)) (, ,) (NP (NN X)) (, ,) (NP (NN XII)) (, ,) (NP (NN VII-X) (NN complex)) (, ,) (NP (NN II-VII-X) (NN complex)) (, ,) (CC and) (NP (NN beta-thromboglobulin))) (: ;)) (. .)))))

amod(factors-2, increased-1)
root(ROOT-0, factors-2)
dep(factors-2, II-3)
nn(antigen-6, VII-5)
appos(factors-2, antigen-6)
nn(antigen-9, VIII-8)
conj_and(antigen-6, antigen-9)
nn(activity-13, VIII-11)
nn(activity-13, coagulant-12)
conj_and(antigen-6, activity-13)
conj_and(antigen-6, IX-15)
conj_and(antigen-6, X-17)
conj_and(antigen-6, XII-19)
nn(complex-22, VII-X-21)
conj_and(antigen-6, complex-22)
nn(complex-25, II-VII-X-24)
conj_and(antigen-6, complex-25)
conj_and(antigen-6, beta-thromboglobulin-28)

decreased/VBN levels/NNS of/IN anti-factor/NN Xa/NN and/CC antithrombin/NN III/CD ,/, decreased/VBD antithrombin/NN III/CD activity/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (VBN decreased) (NNS levels)) (PP (IN of) (NP (NP (NN anti-factor) (NN Xa)) (CC and) (NP (NN antithrombin) (CD III)))) (, ,)) (VP (VBD decreased) (NP (NN antithrombin) (CD III) (NN activity))) (: ;)) (. .))))

amod(levels-2, decreased-1)
nsubj(decreased-10, levels-2)
nn(Xa-5, anti-factor-4)
prep_of(levels-2, Xa-5)
conj_and(Xa-5, antithrombin-7)
num(antithrombin-7, III-8)
root(ROOT-0, decreased-10)
nn(activity-13, antithrombin-11)
num(activity-13, III-12)
dobj(decreased-10, activity-13)

increased/VBN levels/NNS of/IN fibrinogen/NN and/CC fibrinogen/NN activity/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NP (VBN increased) (NNS levels)) (PP (IN of) (NP (NP (NN fibrinogen)) (CC and) (NP (NN fibrinogen)) (NP (NN activity)))) (: ;)) (. .)))))

amod(levels-2, increased-1)
root(ROOT-0, levels-2)
prep_of(levels-2, fibrinogen-4)
conj_and(fibrinogen-4, fibrinogen-6)
dep(fibrinogen-4, activity-7)

Increased/VBN thyroid-binding/JJ globulin/NN (/-LRB- TBG/NN )/-RRB- levels/NNS leading/VBG to/TO increased/VBN circulating/JJ total/JJ thyroid/NN hormone/NN levels/NNS as/IN measured/VBN by/IN protein-bound/JJ iodine/NN (/-LRB- PBI/NN )/-RRB- ,/, T4/NN levels/NNS (/-LRB- by/IN column/NN or/CC by/IN radioimmunoassay/NN )/-RRB- or/CC T3/NN levels/NNS by/IN radioimmunoassay/NN ./.

(ROOT (S1 (S (NP (VBN Increased) (NP (NP (JJ thyroid-binding) (NN globulin)) (PRN (-LRB- -LRB-) (NP (NN TBG)) (-RRB- -RRB-))) (NNS levels)) (VP (VBG leading) (PP (TO to) (NP (VBN increased) (JJ circulating) (JJ total) (NN thyroid) (NN hormone) (NNS levels))) (SBAR (IN as) (S (VP (VBN measured) (PP (IN by) (NP (NP (NP (JJ protein-bound) (NN iodine)) (PRN (-LRB- -LRB-) (NP (NN PBI)) (-RRB- -RRB-))) (, ,) (NP (NP (NN T4) (NNS levels)) (PRN (-LRB- -LRB-) (PP (PP (IN by) (NP (NN column))) (CC or) (PP (IN by) (NP (NN radioimmunoassay)))) (-RRB- -RRB-))) (CC or) (NP (NN T3) (NNS levels)))) (PP (IN by) (NP (NN radioimmunoassay))))))) (. .))))

amod(levels-7, Increased-1)
amod(globulin-3, thyroid-binding-2)
nn(levels-7, globulin-3)
abbrev(globulin-3, TBG-5)
nsubj(leading-8, levels-7)
root(ROOT-0, leading-8)
amod(levels-15, increased-10)
amod(levels-15, circulating-11)
amod(levels-15, total-12)
nn(levels-15, thyroid-13)
nn(levels-15, hormone-14)
prep_to(leading-8, levels-15)
mark(measured-17, as-16)
advcl(leading-8, measured-17)
amod(iodine-20, protein-bound-19)
prep_by(measured-17, iodine-20)
abbrev(iodine-20, PBI-22)
nn(levels-26, T4-25)
conj_or(iodine-20, levels-26)
dep(levels-26, by-28)
pobj(by-28, column-29)
conj_or(by-28, by-31)
pobj(by-31, radioimmunoassay-32)
nn(levels-36, T3-35)
conj_or(iodine-20, levels-36)
prep_by(measured-17, radioimmunoassay-38)

Patients/NNS on/IN thyroid/NN replacement/NN therapy/NN may/MD require/VBP higher/JJR doses/NNS of/IN thyroid/NN hormone/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (PP (IN on) (NP (NN thyroid) (NN replacement) (NN therapy)))) (VP (MD may) (VP (VBP require) (NP (NP (JJR higher) (NNS doses)) (PP (IN of) (NP (NN thyroid) (NN hormone))))))) (. .))))

nsubj(require-7, Patients-1)
nn(therapy-5, thyroid-3)
nn(therapy-5, replacement-4)
prep_on(Patients-1, therapy-5)
aux(require-7, may-6)
root(ROOT-0, require-7)
amod(doses-9, higher-8)
dobj(require-7, doses-9)
nn(hormone-12, thyroid-11)
prep_of(doses-9, hormone-12)

Other/JJ binding/NN proteins/NNS may/MD be/VB elevated/VBN in/IN serum/NN ,/, (/-LRB- i.e./FW ,/, corticosteroid/NN binding/NN globulin/NN (/-LRB- CBG/NN )/-RRB- ,/, sex/NN hormone/NN binding/NN globulin/NN (/-LRB- SHBG/NN )/-RRB- )/-RRB- leading/VBG to/TO increased/VBN total/JJ circulating/JJ corticosteroids/NNS and/CC sex/NN steroids/NNS ,/, respectively/RB ./.

(ROOT (S1 (S (S (NP (JJ Other) (NN binding) (NNS proteins)) (VP (MD may) (VP (VB be) (VP (VBN elevated) (PP (IN in) (NP (NN serum))))) (, ,) (S (PRN (-LRB- -LRB-) (PP (FW i.e.)) (, ,) (NP (NP (NP (NN corticosteroid) (NN binding) (NN globulin)) (PRN (-LRB- -LRB-) (NP (NN CBG)) (-RRB- -RRB-))) (, ,) (NP (NP (NN sex) (NN hormone) (NN binding) (NN globulin)) (PRN (-LRB- -LRB-) (NP (NN SHBG)) (-RRB- -RRB-)))) (-RRB- -RRB-)) (VP (VBG leading) (PP (TO to) (NP (NP (VBN increased) (JJ total) (JJ circulating) (NNS corticosteroids)) (CC and) (NP (NN sex) (NNS steroids)))) (, ,) (ADVP (RB respectively)))))) (. .))))

amod(proteins-3, Other-1)
nn(proteins-3, binding-2)
nsubjpass(elevated-6, proteins-3)
aux(elevated-6, may-4)
auxpass(elevated-6, be-5)
root(ROOT-0, elevated-6)
prep_in(elevated-6, serum-8)
dep(globulin-15, i.e.-11)
nn(globulin-15, corticosteroid-13)
nn(globulin-15, binding-14)
dep(leading-28, globulin-15)
abbrev(globulin-15, CBG-17)
nn(globulin-23, sex-20)
nn(globulin-23, hormone-21)
nn(globulin-23, binding-22)
appos(globulin-15, globulin-23)
abbrev(globulin-23, SHBG-25)
xcomp(elevated-6, leading-28)
amod(corticosteroids-33, increased-30)
amod(corticosteroids-33, total-31)
amod(corticosteroids-33, circulating-32)
prep_to(leading-28, corticosteroids-33)
nn(steroids-36, sex-35)
conj_and(corticosteroids-33, steroids-36)
advmod(leading-28, respectively-38)

Other/JJ plasma/NN proteins/NNS may/MD be/VB increased/VBN (/-LRB- angiotensinogen/NN /renin/NN substrate/NN ,/, alpha-1-antitrypsin/JJ ,/, ceruloplasmin/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (JJ Other) (NN plasma) (NNS proteins)) (VP (MD may) (VP (VB be) (VP (VBN increased) (PRN (-LRB- -LRB-) (NP (NP (NN angiotensinogen) (NN /renin) (NN substrate)) (, ,) (NP (ADJP (JJ alpha-1-antitrypsin))) (, ,) (NP (NN ceruloplasmin))) (-RRB- -RRB-)))))) (. .))))

amod(proteins-3, Other-1)
nn(proteins-3, plasma-2)
nsubjpass(increased-6, proteins-3)
aux(increased-6, may-4)
auxpass(increased-6, be-5)
root(ROOT-0, increased-6)
nn(substrate-10, angiotensinogen-8)
nn(substrate-10, /renin-9)
dep(increased-6, substrate-10)
appos(substrate-10, alpha-1-antitrypsin-12)
appos(substrate-10, ceruloplasmin-14)

Increased/VBN plasma/NN HDL/NN and/CC HDL2/NN cholesterol/NN subfraction/NN concentrations/NNS ,/, reduced/VBD LDL/NN cholesterol/NN concentration/NN ,/, increased/VBD triglyceride/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (VBN Increased) (NN plasma) (NN HDL) (CC and) (NN HDL2) (NN cholesterol) (NN subfraction) (NNS concentrations)) (, ,) (VP (VP (VBD reduced) (NP (NN LDL) (NN cholesterol) (NN concentration))) (, ,) (VP (VBD increased) (NP (NN triglyceride) (NNS levels))))) (. .))))

amod(HDL-3, Increased-1)
nn(HDL-3, plasma-2)
nsubj(reduced-10, HDL-3)
nn(concentrations-8, HDL2-5)
nn(concentrations-8, cholesterol-6)
nn(concentrations-8, subfraction-7)
conj_and(HDL-3, concentrations-8)
root(ROOT-0, reduced-10)
nn(concentration-13, LDL-11)
nn(concentration-13, cholesterol-12)
dobj(reduced-10, concentration-13)
dep(reduced-10, increased-15)
nn(levels-17, triglyceride-16)
dobj(increased-15, levels-17)

Corticotropin/NN may/MD accentuate/VB the/DT electrolyte/NN loss/NN associated/VBN with/IN diuretic/JJ therapy/NN ./.

(ROOT (S1 (S (S (NP (NN Corticotropin)) (VP (MD may) (VP (VB accentuate) (NP (NP (DT the) (NN electrolyte) (NN loss)) (VP (VBN associated) (PP (IN with) (NP (JJ diuretic) (NN therapy)))))))) (. .))))

nsubj(accentuate-3, Corticotropin-1)
aux(accentuate-3, may-2)
root(ROOT-0, accentuate-3)
det(loss-6, the-4)
nn(loss-6, electrolyte-5)
dobj(accentuate-3, loss-6)
partmod(loss-6, associated-7)
amod(therapy-10, diuretic-9)
prep_with(associated-7, therapy-10)

Persons/NNS taking/VBG most/JJS antibiotics/NNS ,/, methotrexate/NN and/CC pyrimethamine/NN invalidate/VBP folic/JJ acid/NN and/CC vitamin/NN B12/NN diagnostic/JJ blood/NN assays/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Persons)) (VP (VBG taking) (NP (NP (JJS most) (NNS antibiotics)) (, ,) (NP (NP (NN methotrexate)) (CC and) (NP (NN pyrimethamine)))))) (VP (VBP invalidate) (NP (NP (JJ folic) (NN acid)) (CC and) (NP (NN vitamin) (NN B12)) (NP (JJ diagnostic) (NN blood) (NNS assays))))) (. .))))

nsubj(invalidate-9, Persons-1)
partmod(Persons-1, taking-2)
amod(antibiotics-4, most-3)
dobj(taking-2, antibiotics-4)
appos(antibiotics-4, methotrexate-6)
conj_and(methotrexate-6, pyrimethamine-8)
root(ROOT-0, invalidate-9)
amod(acid-11, folic-10)
dobj(invalidate-9, acid-11)
nn(B12-14, vitamin-13)
conj_and(acid-11, B12-14)
amod(assays-17, diagnostic-15)
nn(assays-17, blood-16)
dobj(invalidate-9, assays-17)
dep(acid-11, assays-17)

Colchicine/NN para-aminosalicylic/JJ acid/NN and/CC heavy/JJ alcohol/NN intake/NN for/IN longer/JJR than/IN 2/CD weeks/NNS may/MD produce/VB malabsorption/NN of/IN vitamin/NN B12/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Colchicine) (JJ para-aminosalicylic) (NN acid)) (CC and) (NP (JJ heavy) (NN alcohol) (NN intake))) (PP (IN for) (NP (QP (JJR longer) (IN than) (CD 2)) (NNS weeks)))) (VP (MD may) (VP (VB produce) (NP (NP (NN malabsorption)) (PP (IN of) (NP (NN vitamin) (NN B12))))))) (. .))))

nn(acid-3, Colchicine-1)
amod(acid-3, para-aminosalicylic-2)
nsubj(produce-14, acid-3)
amod(intake-7, heavy-5)
nn(intake-7, alcohol-6)
conj_and(acid-3, intake-7)
mwe(than-10, longer-9)
quantmod(2-11, than-10)
num(weeks-12, 2-11)
prep_for(acid-3, weeks-12)
aux(produce-14, may-13)
root(ROOT-0, produce-14)
dobj(produce-14, malabsorption-15)
nn(B12-18, vitamin-17)
prep_of(malabsorption-15, B12-18)

Persons/NNS taking/VBG most/JJS antibiotics/NNS ,/, methotrexate/NN and/CC pyrimethamine/NN invalidate/VBP folic/JJ acid/NN and/CC vitamin/NN B12/NN diagnostic/JJ blood/NN assays/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Persons)) (VP (VBG taking) (NP (NP (JJS most) (NNS antibiotics)) (, ,) (NP (NP (NN methotrexate)) (CC and) (NP (NN pyrimethamine)))))) (VP (VBP invalidate) (NP (NP (JJ folic) (NN acid)) (CC and) (NP (NN vitamin) (NN B12)) (NP (JJ diagnostic) (NN blood) (NNS assays))))) (. .))))

nsubj(invalidate-9, Persons-1)
partmod(Persons-1, taking-2)
amod(antibiotics-4, most-3)
dobj(taking-2, antibiotics-4)
appos(antibiotics-4, methotrexate-6)
conj_and(methotrexate-6, pyrimethamine-8)
root(ROOT-0, invalidate-9)
amod(acid-11, folic-10)
dobj(invalidate-9, acid-11)
nn(B12-14, vitamin-13)
conj_and(acid-11, B12-14)
amod(assays-17, diagnostic-15)
nn(assays-17, blood-16)
dobj(invalidate-9, assays-17)
dep(acid-11, assays-17)

Colchicine/NN para-aminosalicylic/JJ acid/NN and/CC heavy/JJ alcohol/NN intake/NN for/IN longer/JJR than/IN 2/CD weeks/NNS may/MD produce/VB malabsorption/NN of/IN vitamin/NN B12/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Colchicine) (JJ para-aminosalicylic) (NN acid)) (CC and) (NP (JJ heavy) (NN alcohol) (NN intake))) (PP (IN for) (NP (QP (JJR longer) (IN than) (CD 2)) (NNS weeks)))) (VP (MD may) (VP (VB produce) (NP (NP (NN malabsorption)) (PP (IN of) (NP (NN vitamin) (NN B12))))))) (. .))))

nn(acid-3, Colchicine-1)
amod(acid-3, para-aminosalicylic-2)
nsubj(produce-14, acid-3)
amod(intake-7, heavy-5)
nn(intake-7, alcohol-6)
conj_and(acid-3, intake-7)
mwe(than-10, longer-9)
quantmod(2-11, than-10)
num(weeks-12, 2-11)
prep_for(acid-3, weeks-12)
aux(produce-14, may-13)
root(ROOT-0, produce-14)
dobj(produce-14, malabsorption-15)
nn(B12-18, vitamin-17)
prep_of(malabsorption-15, B12-18)

FLEXERIL/NN may/MD have/VBP life-threatening/JJ interactions/NNS with/IN MAO/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (NN FLEXERIL)) (VP (MD may) (VP (VBP have) (NP (NP (JJ life-threatening) (NNS interactions)) (PP (IN with) (NP (NN MAO) (NNS inhibitors))))))) (. .))))

nsubj(have-3, FLEXERIL-1)
aux(have-3, may-2)
root(ROOT-0, have-3)
amod(interactions-5, life-threatening-4)
dobj(have-3, interactions-5)
nn(inhibitors-8, MAO-7)
prep_with(interactions-5, inhibitors-8)

FLEXERIL/NN may/MD enhance/VB the/DT effects/NNS of/IN alcohol/NN ,/, barbiturates/NNS ,/, and/CC other/JJ CNS/NN depressants/NNS ./.

(ROOT (S1 (S (S (NP (NN FLEXERIL)) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NN alcohol)) (, ,) (NP (NNS barbiturates)) (, ,) (CC and) (NP (JJ other) (NN CNS) (NNS depressants)))))))) (. .))))

nsubj(enhance-3, FLEXERIL-1)
aux(enhance-3, may-2)
root(ROOT-0, enhance-3)
det(effects-5, the-4)
dobj(enhance-3, effects-5)
prep_of(effects-5, alcohol-7)
conj_and(alcohol-7, barbiturates-9)
amod(depressants-14, other-12)
nn(depressants-14, CNS-13)
conj_and(alcohol-7, depressants-14)

Tricyclic/JJ antidepressants/NNS may/MD block/VB the/DT antihypertensive/JJ action/NN of/IN guanethidine/NN and/CC similarly/RB acting/NN compounds/NNS ./.

(ROOT (S1 (S (S (NP (JJ Tricyclic) (NNS antidepressants)) (VP (MD may) (VP (VP (VB block) (NP (NP (DT the) (JJ antihypertensive) (NN action)) (PP (IN of) (NP (NN guanethidine))))) (CC and) (VP (ADVP (RB similarly)) (NP (NN acting) (NNS compounds)))))) (. .))))

amod(antidepressants-2, Tricyclic-1)
nsubj(block-4, antidepressants-2)
aux(block-4, may-3)
root(ROOT-0, block-4)
det(action-7, the-5)
amod(action-7, antihypertensive-6)
dobj(block-4, action-7)
prep_of(action-7, guanethidine-9)
advmod(compounds-13, similarly-11)
nn(compounds-13, acting-12)
conj_and(block-4, compounds-13)

Tricyclic/JJ antidepressants/NNS may/MD enhance/VB the/DT seizure/JJ risk/NN in/IN patients/NNS taking/VBG tramadol/NN ./.

(ROOT (S1 (S (S (NP (JJ Tricyclic) (NNS antidepressants)) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (JJ seizure) (NN risk)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN tramadol))))))))) (. .))))

amod(antidepressants-2, Tricyclic-1)
nsubj(enhance-4, antidepressants-2)
aux(enhance-4, may-3)
root(ROOT-0, enhance-4)
det(risk-7, the-5)
amod(risk-7, seizure-6)
dobj(enhance-4, risk-7)
prep_in(risk-7, patients-9)
partmod(patients-9, taking-10)
dobj(taking-10, tramadol-11)

Cyclopentolate/NN may/MD interfere/VB with/IN the/DT anti-glaucoma/NN action/NN of/IN carbachol/NN or/CC pilocarpine/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN Cyclopentolate)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN anti-glaucoma) (NN action)) (PP (IN of) (NP (NP (NN carbachol)) (CC or) (NP (NN pilocarpine)))))))) (: ;)) (. .))))

nsubj(interfere-3, Cyclopentolate-1)
aux(interfere-3, may-2)
root(ROOT-0, interfere-3)
det(action-7, the-5)
nn(action-7, anti-glaucoma-6)
prep_with(interfere-3, action-7)
prep_of(action-7, carbachol-9)
conj_or(carbachol-9, pilocarpine-11)

also/RB ,/, concurrent/JJ use/NN of/IN this/DT medication/NN may/MD antagonise/VB the/DT anti-glaucoma/NN and/CC miotic/JJ actions/NNS of/IN ophthalmic/JJ cholinesterase/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (ADVP (RB also)) (, ,) (NP (NP (JJ concurrent) (NN use)) (PP (IN of) (NP (DT this) (NN medication)))) (VP (MD may) (VP (VB antagonise) (NP (NP (DT the) (NP (NN anti-glaucoma)) (CC and) (NP (JJ miotic) (NNS actions))) (PP (IN of) (NP (JJ ophthalmic) (NN cholinesterase) (NNS inhibitors))))))) (. .))))

advmod(antagonise-9, also-1)
amod(use-4, concurrent-3)
nsubj(antagonise-9, use-4)
det(medication-7, this-6)
prep_of(use-4, medication-7)
aux(antagonise-9, may-8)
root(ROOT-0, antagonise-9)
dep(anti-glaucoma-11, the-10)
dobj(antagonise-9, anti-glaucoma-11)
amod(actions-14, miotic-13)
conj_and(anti-glaucoma-11, actions-14)
amod(inhibitors-18, ophthalmic-16)
nn(inhibitors-18, cholinesterase-17)
prep_of(anti-glaucoma-11, inhibitors-18)

The/DT rate/NN of/IN metabolism/NN and/CC the/DT leukopenic/JJ activity/NN of/IN cyclophosphamide/NN reportedly/RB are/VBP increased/VBN by/IN chronic/JJ administration/NN of/IN high/JJ doses/NNS of/IN phenobarbital/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (DT The) (NN rate)) (PP (IN of) (NP (NN metabolism)))) (CC and) (NP (NP (DT the) (JJ leukopenic) (NN activity)) (PP (IN of) (NP (NN cyclophosphamide))))) (ADVP (RB reportedly)) (VP (VBP are) (VP (VBN increased) (PP (IN by) (NP (NP (JJ chronic) (NN administration)) (PP (IN of) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NN phenobarbital)))))))))) (. .))))

det(rate-2, The-1)
nsubjpass(increased-13, rate-2)
prep_of(rate-2, metabolism-4)
det(activity-8, the-6)
amod(activity-8, leukopenic-7)
conj_and(rate-2, activity-8)
prep_of(activity-8, cyclophosphamide-10)
advmod(increased-13, reportedly-11)
auxpass(increased-13, are-12)
root(ROOT-0, increased-13)
amod(administration-16, chronic-15)
agent(increased-13, administration-16)
amod(doses-19, high-18)
prep_of(administration-16, doses-19)
prep_of(doses-19, phenobarbital-21)

The/DT physician/NN should/MD be/VB alert/JJ for/IN possible/JJ combined/JJ drug/NN actions/NNS ,/, desirable/JJ or/CC undesirable/JJ ,/, involving/VBG cyclophosphamide/NN even/RB though/IN cyclophosphamide/NN has/VBZ been/VBN used/VBN successfully/RB concurrently/RB with/IN other/JJ drugs/NNS ,/, including/VBG other/JJ cytotoxic/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (DT The) (NN physician)) (VP (MD should) (VP (VB be) (ADJP (JJ alert) (PP (IN for) (NP (NP (JJ possible) (JJ combined) (NN drug) (NNS actions)) (, ,) (ADJP (ADJP (JJ desirable)) (CC or) (ADJP (JJ undesirable))) (, ,) (PP (VBG involving) (NP (NN cyclophosphamide)))))) (SBAR (RB even) (IN though) (S (NP (NN cyclophosphamide)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (ADVP (RB successfully)) (PP (ADVP (RB concurrently)) (IN with) (NP (NP (JJ other) (NNS drugs)) (, ,) (PP (VBG including) (NP (JJ other) (JJ cytotoxic) (NNS drugs))))))))))))) (. .))))

det(physician-2, The-1)
nsubj(alert-5, physician-2)
aux(alert-5, should-3)
cop(alert-5, be-4)
root(ROOT-0, alert-5)
amod(actions-10, possible-7)
amod(actions-10, combined-8)
nn(actions-10, drug-9)
prep_for(alert-5, actions-10)
amod(actions-10, desirable-12)
conj_or(desirable-12, undesirable-14)
prep_involving(actions-10, cyclophosphamide-17)
advmod(used-23, even-18)
dep(used-23, though-19)
nsubjpass(used-23, cyclophosphamide-20)
aux(used-23, has-21)
auxpass(used-23, been-22)
ccomp(alert-5, used-23)
advmod(used-23, successfully-24)
advmod(used-23, concurrently-25)
amod(drugs-28, other-27)
prep_with(used-23, drugs-28)
amod(drugs-33, other-31)
amod(drugs-33, cytotoxic-32)
prep_including(drugs-28, drugs-33)

Cyclophosphamide/NN treatment/NN ,/, which/WDT causes/VBZ a/DT marked/JJ and/CC persistent/JJ inhibition/NN of/IN cholinesterase/NN activity/NN ,/, potentiates/VBZ the/DT effect/NN of/IN succinylcholine/NN chloride/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Cyclophosphamide) (NN treatment)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ causes) (NP (NP (DT a) (ADJP (ADJP (JJ marked)) (CC and) (ADJP (JJ persistent))) (NN inhibition)) (PP (IN of) (NP (NN cholinesterase) (NN activity))))))) (, ,)) (VP (VBZ potentiates) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN succinylcholine) (NN chloride)))))) (. .))))

nn(treatment-2, Cyclophosphamide-1)
nsubj(causes-5, treatment-2)
nsubj(potentiates-15, treatment-2)
rcmod(treatment-2, causes-5)
det(inhibition-10, a-6)
amod(inhibition-10, marked-7)
conj_and(marked-7, persistent-9)
dobj(causes-5, inhibition-10)
nn(activity-13, cholinesterase-12)
prep_of(inhibition-10, activity-13)
root(ROOT-0, potentiates-15)
det(effect-17, the-16)
dobj(potentiates-15, effect-17)
nn(chloride-20, succinylcholine-19)
prep_of(effect-17, chloride-20)

If/IN a/DT patient/NN has/VBZ been/VBN treated/VBN with/IN cyclophosphamide/NN within/IN 10/CD days/NNS of/IN general/JJ anesthesia/NN ,/, the/DT anesthesiologist/NN should/MD be/VB alerted/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (DT a) (NN patient)) (VP (VBZ has) (VP (VBN been) (VP (VBN treated) (PP (IN with) (NP (NN cyclophosphamide))) (PP (IN within) (NP (NP (CD 10) (NNS days)) (PP (IN of) (NP (JJ general) (NN anesthesia)))))))))) (, ,) (NP (DT the) (NN anesthesiologist)) (VP (MD should) (VP (VB be) (VP (VBN alerted))))) (. .))))

mark(treated-6, If-1)
det(patient-3, a-2)
nsubjpass(treated-6, patient-3)
aux(treated-6, has-4)
auxpass(treated-6, been-5)
advcl(alerted-20, treated-6)
prep_with(treated-6, cyclophosphamide-8)
num(days-11, 10-10)
prep_within(treated-6, days-11)
amod(anesthesia-14, general-13)
prep_of(days-11, anesthesia-14)
det(anesthesiologist-17, the-16)
nsubjpass(alerted-20, anesthesiologist-17)
aux(alerted-20, should-18)
auxpass(alerted-20, be-19)
root(ROOT-0, alerted-20)

MAO/NN inhibitors/NNS prolong/VBP and/CC intensify/VBP the/DT anticholinergic/JJ effects/NNS of/IN antihistamines/NNS ./.

(ROOT (S1 (S (S (NP (NN MAO) (NNS inhibitors)) (VP (VP (VBP prolong)) (CC and) (VP (VBP intensify) (NP (NP (DT the) (JJ anticholinergic) (NNS effects)) (PP (IN of) (NP (NNS antihistamines))))))) (. .))))

nn(inhibitors-2, MAO-1)
nsubj(prolong-3, inhibitors-2)
root(ROOT-0, prolong-3)
conj_and(prolong-3, intensify-5)
det(effects-8, the-6)
amod(effects-8, anticholinergic-7)
dobj(intensify-5, effects-8)
prep_of(effects-8, antihistamines-10)

Antihistamines/NNS may/MD have/VB additive/JJ effects/NNS with/IN alcohol/NN and/CC other/JJ CNS/NN depressants/NNS ,/, e.g./FW ,/, hypnotics/NNS ,/, sedatives/NNS ,/, tranquilizers/NNS ,/, antianxiety/NN agents/NNS ./.

(ROOT (S1 (S (S (NP (NNS Antihistamines)) (VP (MD may) (VP (VB have) (NP (JJ additive) (NNS effects)) (PP (IN with) (NP (NP (NN alcohol)) (CC and) (NP (NP (JJ other) (NN CNS) (NNS depressants)) (, ,) (ADVP (FW e.g.)) (, ,) (NP (NNS hypnotics)) (, ,) (NP (NNS sedatives)) (, ,) (NP (NNS tranquilizers)) (, ,) (NP (NN antianxiety) (NNS agents)))))))) (. .))))

nsubj(have-3, Antihistamines-1)
aux(have-3, may-2)
root(ROOT-0, have-3)
amod(effects-5, additive-4)
dobj(have-3, effects-5)
prep_with(have-3, alcohol-7)
amod(depressants-11, other-9)
nn(depressants-11, CNS-10)
conj_and(alcohol-7, depressants-11)
advmod(depressants-11, e.g.-13)
appos(depressants-11, hypnotics-15)
appos(depressants-11, sedatives-17)
appos(depressants-11, tranquilizers-19)
nn(agents-22, antianxiety-21)
appos(depressants-11, agents-22)

Reversible/JJ decreases/NNS in/IN steady-state/JJ plasma/NN digoxin/NN concentrations/NNS and/CC renal/JJ glycoside/NN excretion/NN were/VBD observed/VBN in/IN patients/NNS receiving/VBG beta-acetyl/NN digoxin/NN and/CC chemotherapy/NN regimens/NNS containing/VBG cyclophosphamide/NN ,/, vincristine/NN ,/, and/CC prednisone/NN with/IN or/CC without/IN cytarabine/NN or/CC procarbazine/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Reversible) (NNS decreases)) (PP (IN in) (NP (NP (JJ steady-state) (NN plasma) (NN digoxin) (NNS concentrations)) (CC and) (NP (JJ renal) (NN glycoside) (NN excretion))))) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN beta-acetyl) (NN digoxin) (CC and) (NN chemotherapy) (NNS regimens)) (VP (VBG containing) (NP (NP (NP (NN cyclophosphamide)) (, ,) (NP (NN vincristine)) (, ,) (CC and) (NP (NN prednisone))) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NP (NN cytarabine)) (CC or) (NP (NN procarbazine)))))))))))))) (. .))))

amod(decreases-2, Reversible-1)
nsubjpass(observed-13, decreases-2)
amod(concentrations-7, steady-state-4)
nn(concentrations-7, plasma-5)
nn(concentrations-7, digoxin-6)
prep_in(decreases-2, concentrations-7)
amod(excretion-11, renal-9)
nn(excretion-11, glycoside-10)
conj_and(concentrations-7, excretion-11)
auxpass(observed-13, were-12)
root(ROOT-0, observed-13)
prep_in(observed-13, patients-15)
partmod(patients-15, receiving-16)
nn(digoxin-18, beta-acetyl-17)
dobj(receiving-16, digoxin-18)
nn(regimens-21, chemotherapy-20)
conj_and(digoxin-18, regimens-21)
partmod(digoxin-18, containing-22)
dobj(containing-22, cyclophosphamide-23)
conj_and(cyclophosphamide-23, vincristine-25)
conj_and(cyclophosphamide-23, prednisone-28)
prep(cyclophosphamide-23, with-29)
conj_or(with-29, without-31)
pobj(without-31, cytarabine-32)
conj_or(cytarabine-32, procarbazine-34)

Steady/JJ state/NN plasma/NN digitoxin/NN concentrations/NNS did/VBD not/RB appear/VB to/TO change/VB ./.

(ROOT (S1 (S (S (NP (JJ Steady) (NN state) (NN plasma) (NN digitoxin) (NNS concentrations)) (VP (VBD did) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB change))))))) (. .))))

amod(concentrations-5, Steady-1)
nn(concentrations-5, state-2)
nn(concentrations-5, plasma-3)
nn(concentrations-5, digitoxin-4)
nsubj(appear-8, concentrations-5)
xsubj(change-10, concentrations-5)
aux(appear-8, did-6)
neg(appear-8, not-7)
root(ROOT-0, appear-8)
aux(change-10, to-9)
xcomp(appear-8, change-10)

The/DT utilization/NN of/IN digitoxin/NN for/IN such/JJ patients/NNS may/MD be/VB considered/VBN as/IN an/DT alternative/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN utilization)) (PP (IN of) (NP (NN digitoxin))) (PP (IN for) (NP (JJ such) (NNS patients)))) (VP (MD may) (VP (VB be) (VP (VBN considered) (PP (IN as) (NP (DT an) (NN alternative))))))) (. .))))

det(utilization-2, The-1)
nsubjpass(considered-10, utilization-2)
prep_of(utilization-2, digitoxin-4)
amod(patients-7, such-6)
prep_for(utilization-2, patients-7)
aux(considered-10, may-8)
auxpass(considered-10, be-9)
root(ROOT-0, considered-10)
det(alternative-13, an-12)
prep_as(considered-10, alternative-13)

Also/RB flucytosine/NN ./.

(ROOT (S1 (S (S (VP (ADVP (RB Also)) (NP (NN flucytosine)))) (. .))))

advmod(flucytosine-2, Also-1)
root(ROOT-0, flucytosine-2)

Drug/NN /LaboratoryTest/NN Interactions/NNS Dactinomycin/NN may/MD interfere/VB with/IN bioassay/NN procedures/NNS for/IN the/DT determination/NN of/IN antibacterial/JJ drug/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NN Drug) (NN /LaboratoryTest) (NNS Interactions) (NP (NN Dactinomycin))) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NN bioassay) (NNS procedures))) (PP (IN for) (NP (NP (DT the) (NN determination)) (PP (IN of) (NP (JJ antibacterial) (NN drug) (NNS levels)))))))) (. .))))

nn(Interactions-3, Drug-1)
nn(Interactions-3, /LaboratoryTest-2)
nsubj(interfere-6, Interactions-3)
dep(Interactions-3, Dactinomycin-4)
aux(interfere-6, may-5)
root(ROOT-0, interfere-6)
nn(procedures-9, bioassay-8)
prep_with(interfere-6, procedures-9)
det(determination-12, the-11)
prep_for(interfere-6, determination-12)
amod(levels-16, antibacterial-14)
nn(levels-16, drug-15)
prep_of(determination-12, levels-16)

Dantrium/NN is/VBZ metabolized/VBN by/IN the/DT liver/NN ,/, and/CC it/PRP is/VBZ theoretically/RB possible/JJ that/IN its/PRP$ metabolism/NN may/MD be/VB enhanced/VBN by/IN drugs/NNS known/VBN to/TO induce/VB hepatic/JJ microsomal/JJ enzymes/NNS ./.

(ROOT (S1 (S (S (S (NP (NN Dantrium)) (VP (VBZ is) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (NN liver)))))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBZ is) (ADJP (RB theoretically) (JJ possible)) (SBAR (IN that) (S (NP (PRP$ its) (NN metabolism)) (VP (MD may) (VP (VB be) (VP (VBN enhanced) (PP (IN by) (NP (NP (NNS drugs)) (VP (VBN known) (S (VP (TO to) (VP (VB induce) (NP (JJ hepatic) (JJ microsomal) (NNS enzymes)))))))))))))))) (. .))))

nsubjpass(metabolized-3, Dantrium-1)
auxpass(metabolized-3, is-2)
root(ROOT-0, metabolized-3)
det(liver-6, the-5)
agent(metabolized-3, liver-6)
nsubj(possible-12, it-9)
cop(possible-12, is-10)
advmod(possible-12, theoretically-11)
conj_and(metabolized-3, possible-12)
complm(enhanced-18, that-13)
poss(metabolism-15, its-14)
nsubjpass(enhanced-18, metabolism-15)
aux(enhanced-18, may-16)
auxpass(enhanced-18, be-17)
ccomp(possible-12, enhanced-18)
agent(enhanced-18, drugs-20)
partmod(drugs-20, known-21)
aux(induce-23, to-22)
xcomp(known-21, induce-23)
amod(enzymes-26, hepatic-24)
amod(enzymes-26, microsomal-25)
dobj(induce-23, enzymes-26)

However/RB ,/, neither/CC phenobarbital/NN nor/CC diazepam/NN appears/VBZ to/TO affect/VB Dantrium/NN metabolism/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (CC neither) (NP (NN phenobarbital)) (CC nor) (NP (NN diazepam))) (VP (VBZ appears) (S (VP (TO to) (VP (VB affect) (NP (NN Dantrium) (NN metabolism))))))) (. .))))

advmod(appears-7, However-1)
preconj(phenobarbital-4, neither-3)
nsubj(appears-7, phenobarbital-4)
xsubj(affect-9, phenobarbital-4)
conj_nor(phenobarbital-4, diazepam-6)
root(ROOT-0, appears-7)
aux(affect-9, to-8)
xcomp(appears-7, affect-9)
nn(metabolism-11, Dantrium-10)
dobj(affect-9, metabolism-11)

Binding/NN to/TO plasma/NN protein/NN is/VBZ not/RB significantly/RB altered/VBN by/IN diazepam/NN ,/, diphenylhydantoin/NN ,/, or/CC phenylbutazone/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Binding)) (PP (TO to) (NP (NN plasma) (NN protein)))) (VP (VBZ is) (RB not) (ADVP (RB significantly)) (VP (VBN altered) (PP (IN by) (NP (NP (NN diazepam)) (, ,) (NP (NN diphenylhydantoin)) (, ,) (CC or) (NP (NN phenylbutazone))))))) (. .))))

nsubjpass(altered-8, Binding-1)
nn(protein-4, plasma-3)
prep_to(Binding-1, protein-4)
auxpass(altered-8, is-5)
neg(altered-8, not-6)
advmod(altered-8, significantly-7)
root(ROOT-0, altered-8)
agent(altered-8, diazepam-10)
conj_or(diazepam-10, diphenylhydantoin-12)
conj_or(diazepam-10, phenylbutazone-15)

Binding/NN to/TO plasma/NN proteins/NNS is/VBZ reduced/VBN by/IN warfarin/NN and/CC clotibrate/NN and/CC increased/VBN by/IN tolbutamide/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Binding)) (PP (TO to) (NP (NN plasma) (NNS proteins)))) (VP (VBZ is) (VP (VP (VBN reduced) (PP (IN by) (NP (NP (NN warfarin)) (CC and) (NP (NN clotibrate))))) (CC and) (VP (VBN increased) (PP (IN by) (NP (NN tolbutamide))))))) (. .))))

nsubjpass(reduced-6, Binding-1)
nn(proteins-4, plasma-3)
prep_to(Binding-1, proteins-4)
auxpass(reduced-6, is-5)
root(ROOT-0, reduced-6)
agent(reduced-6, warfarin-8)
conj_and(warfarin-8, clotibrate-10)
conj_and(reduced-6, increased-12)
prep_by(increased-12, tolbutamide-14)

Cardiovascular/JJ collapse/NN in/IN patients/NNS treated/VBN simultaneously/RB with/IN varapamil/NN and/CC dantrolene/NN sodium/NN is/VBZ rare/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Cardiovascular) (NN collapse)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN treated) (ADVP (RB simultaneously)) (PP (IN with) (NP (NP (NN varapamil)) (CC and) (NP (NN dantrolene)) (NP (NN sodium)))))))) (VP (VBZ is) (NP (NN rare)))) (. .))))

amod(collapse-2, Cardiovascular-1)
nsubj(rare-13, collapse-2)
prep_in(collapse-2, patients-4)
partmod(patients-4, treated-5)
advmod(treated-5, simultaneously-6)
prep_with(treated-5, varapamil-8)
conj_and(varapamil-8, dantrolene-10)
dep(varapamil-8, sodium-11)
cop(rare-13, is-12)
root(ROOT-0, rare-13)

The/DT combination/NN of/IN therapeutic/JJ doses/NNS of/IN intravenous/JJ dantrolene/NN sodium/NN and/CC verapamil/NN in/IN halothane/NN //: span/NN class=/NN c35/NN a-chloralose/NN anesthetized/JJ swine/NN has/VBZ resulted/VBD in/IN ventricular/JJ fibrillation/NN and/CC cardiovascular/JJ collapse/NN in/IN association/NN with/IN marked/JJ hyperkalemia/NN ./.

(ROOT (S1 (S (NP (NP (DT The) (NN combination)) (PP (IN of) (NP (NP (JJ therapeutic) (NNS doses)) (PP (IN of) (NP (NP (NP (JJ intravenous) (NN dantrolene) (NN sodium)) (CC and) (NP (NN verapamil))) (PP (IN in) (NP (NN halothane) (: /) (NN span) (NN class=) (NN c35) (NN a-chloralose) (JJ anesthetized) (NN swine)))))))) (VP (VBZ has) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ ventricular) (NN fibrillation)) (CC and) (NP (JJ cardiovascular) (NN collapse)))) (PP (IN in) (NP (NP (NN association)) (PP (IN with) (NP (JJ marked) (NN hyperkalemia))))))) (. .))))

det(combination-2, The-1)
nsubj(resulted-22, combination-2)
amod(doses-5, therapeutic-4)
prep_of(combination-2, doses-5)
amod(sodium-9, intravenous-7)
nn(sodium-9, dantrolene-8)
prep_of(doses-5, sodium-9)
conj_and(sodium-9, verapamil-11)
nn(swine-20, halothane-13)
punct(swine-20, /-14)
nn(swine-20, span-15)
nn(swine-20, class=-16)
nn(swine-20, c35-17)
nn(swine-20, a-chloralose-18)
amod(swine-20, anesthetized-19)
prep_in(sodium-9, swine-20)
aux(resulted-22, has-21)
root(ROOT-0, resulted-22)
amod(fibrillation-25, ventricular-24)
prep_in(resulted-22, fibrillation-25)
amod(collapse-28, cardiovascular-27)
conj_and(fibrillation-25, collapse-28)
prep_in(resulted-22, association-30)
amod(hyperkalemia-33, marked-32)
prep_with(association-30, hyperkalemia-33)

It/PRP is/VBZ recommended/VBN that/IN the/DT combination/NN of/IN intravenous/JJ dantrolene/NN sodium/NN and/CC calcium/NN channel/NN blockers/NNS ,/, such/JJ as/IN verapamil/NN ,/, not/RB be/VB used/VBN together/RB during/IN the/DT management/NN of/IN malignant/JJ hyperthermia/NN crisis/NN until/IN the/DT relevance/NN of/IN these/DT findings/NNS to/TO humans/NNS is/VBZ established/VBN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NP (JJ intravenous) (NN dantrolene) (NN sodium) (CC and) (NN calcium) (NN channel) (NNS blockers)) (, ,) (PP (JJ such) (IN as) (NP (NN verapamil))) (, ,)))) (ADVP (RB not)) (VP (VB be) (VP (VBN used) (ADVP (RB together)) (PP (IN during) (NP (NP (DT the) (NN management)) (PP (IN of) (NP (NP (JJ malignant) (NN hyperthermia)) (NN crisis))))) (SBAR (IN until) (S (NP (NP (DT the) (NN relevance)) (PP (IN of) (NP (DT these) (NNS findings))) (PP (TO to) (NP (NNS humans)))) (VP (VBZ is) (VP (VBN established)))))))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(used-22, that-4)
det(combination-6, the-5)
nsubjpass(used-22, combination-6)
amod(sodium-10, intravenous-8)
nn(sodium-10, dantrolene-9)
prep_of(combination-6, sodium-10)
nn(blockers-14, calcium-12)
nn(blockers-14, channel-13)
conj_and(sodium-10, blockers-14)
prep_such_as(sodium-10, verapamil-18)
neg(used-22, not-20)
auxpass(used-22, be-21)
ccomp(recommended-3, used-22)
advmod(used-22, together-23)
det(management-26, the-25)
prep_during(used-22, management-26)
amod(hyperthermia-29, malignant-28)
nn(crisis-30, hyperthermia-29)
prep_of(management-26, crisis-30)
mark(established-40, until-31)
det(relevance-33, the-32)
nsubjpass(established-40, relevance-33)
det(findings-36, these-35)
prep_of(relevance-33, findings-36)
prep_to(relevance-33, humans-38)
auxpass(established-40, is-39)
advcl(used-22, established-40)

Administration/NN of/IN dantrolene/NN may/MD potentiate/VB vecuronium/NN -induced/JJ neuromuscular/NN block/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN dantrolene)))) (VP (MD may) (VP (VB potentiate) (NP (NN vecuronium) (JJ -induced) (NN neuromuscular) (NN block))))) (. .))))

nsubj(potentiate-5, Administration-1)
prep_of(Administration-1, dantrolene-3)
aux(potentiate-5, may-4)
root(ROOT-0, potentiate-5)
nn(block-9, vecuronium-6)
amod(block-9, -induced-7)
nn(block-9, neuromuscular-8)
dobj(potentiate-5, block-9)

A/DT drug-drug/JJ interaction/NN study/NN evaluated/VBD the/DT effect/NN of/IN the/DT use/NN of/IN ACZONE/NN Gel/NN ,/, 5/CD %/NN ,/, in/IN combination/NN with/IN double/JJ strength/NN (/-LRB- 160/CD mg/800/CD mg/NN )/-RRB- trimethoprim/NN //: sulfamethoxazole/NN (/-LRB- TMP/NN /SMX/NN )./CD

(ROOT (S1 (S (NP (DT A) (JJ drug-drug) (NN interaction) (NN study)) (VP (VBD evaluated) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NN ACZONE) (NN Gel)) (, ,) (NP (CD 5) (NN %)) (, ,)))))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NP (NP (JJ double) (NN strength)) (PRN (-LRB- -LRB-) (NP (CD 160) (CD mg/800) (NN mg)) (-RRB- -RRB-))) (NN trimethoprim) (: /) (NP (NN sulfamethoxazole))) (-LRB- -LRB-) (NP (NN TMP) (NN /SMX) (CD -RRB-.))))))))))

det(study-4, A-1)
amod(study-4, drug-drug-2)
nn(study-4, interaction-3)
nsubj(evaluated-5, study-4)
root(ROOT-0, evaluated-5)
det(effect-7, the-6)
dobj(evaluated-5, effect-7)
det(use-10, the-9)
prep_of(effect-7, use-10)
nn(Gel-13, ACZONE-12)
prep_of(use-10, Gel-13)
num(%-16, 5-15)
appos(Gel-13, %-16)
prep_in(evaluated-5, combination-19)
amod(strength-22, double-21)
nn(trimethoprim-28, strength-22)
num(mg-26, 160-24)
num(mg-26, mg/800-25)
appos(strength-22, mg-26)
prep_with(combination-19, trimethoprim-28)
punct(trimethoprim-28, /-29)
dep(trimethoprim-28, sulfamethoxazole-30)
nn(/SMX-33, TMP-32)
dep(trimethoprim-28, /SMX-33)
num(/SMX-33, -RRB-.-34)

During/IN co-administration/NN ,/, systemic/JJ levels/NNS of/IN TMP/NN and/CC SMX/NN were/VBD essentially/RB unchanged/JJ ./.

(ROOT (S1 (S (S (PP (IN During) (NP (NN co-administration))) (, ,) (NP (NP (JJ systemic) (NNS levels)) (PP (IN of) (NP (NP (NN TMP)) (CC and) (NP (NN SMX))))) (VP (VBD were) (ADJP (RB essentially) (JJ unchanged)))) (. .))))

prep_during(unchanged-12, co-administration-2)
amod(levels-5, systemic-4)
nsubj(unchanged-12, levels-5)
prep_of(levels-5, TMP-7)
conj_and(TMP-7, SMX-9)
cop(unchanged-12, were-10)
advmod(unchanged-12, essentially-11)
root(ROOT-0, unchanged-12)

However/RB ,/, levels/NNS of/IN dapsone/NN and/CC its/PRP$ metabolites/NNS increased/VBD in/IN the/DT presence/NN of/IN TMP/NN /SMX/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NNS levels)) (PP (IN of) (NP (NP (NN dapsone)) (CC and) (NP (PRP$ its) (NNS metabolites))))) (VP (VBD increased) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN TMP) (NN /SMX))))))) (. .))))

advmod(increased-9, However-1)
nsubj(increased-9, levels-3)
prep_of(levels-3, dapsone-5)
poss(metabolites-8, its-7)
conj_and(dapsone-5, metabolites-8)
root(ROOT-0, increased-9)
det(presence-12, the-11)
prep_in(increased-9, presence-12)
nn(/SMX-15, TMP-14)
prep_of(presence-12, /SMX-15)

Systemic/JJ exposure/NN (/-LRB- AUC0-12/CD )/-RRB- of/IN dapsone/NN and/CC N-acetyl-/NN dapsone/NN (/-LRB- NAD/NN )/-RRB- were/VBD increased/VBN by/IN about/RB 40/CD %/NN and/CC 20/CD %/NN respectively/RB in/IN presence/NN of/IN TMP/NN /SMX/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Systemic) (NN exposure)) (PRN (-LRB- -LRB-) (NP (CD AUC0-12)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN dapsone)) (CC and) (NP (NP (NN N-acetyl-) (NN dapsone)) (PRN (-LRB- -LRB-) (NP (NN NAD)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN increased) (PP (IN by) (NP (NP (QP (RB about) (CD 40)) (NN %)) (CC and) (NP (NP (CD 20) (NN %)) (ADVP (RB respectively))))) (PP (IN in) (NP (NP (NN presence)) (PP (IN of) (NP (NN TMP) (NN /SMX)))))))) (. .))))

amod(exposure-2, Systemic-1)
nsubjpass(increased-15, exposure-2)
appos(exposure-2, AUC0-12-4)
prep_of(exposure-2, dapsone-7)
nn(dapsone-10, N-acetyl--9)
conj_and(dapsone-7, dapsone-10)
abbrev(dapsone-10, NAD-12)
auxpass(increased-15, were-14)
root(ROOT-0, increased-15)
quantmod(40-18, about-17)
num(%-19, 40-18)
agent(increased-15, %-19)
num(%-22, 20-21)
conj_and(%-19, %-22)
advmod(%-22, respectively-23)
prep_in(increased-15, presence-25)
nn(/SMX-28, TMP-27)
prep_of(presence-25, /SMX-28)

Notably/RB ,/, systemic/JJ exposure/NN (/-LRB- AUC0-12/CD )/-RRB- of/IN dapsone/NN hydroxylamine/NN (/-LRB- DHA/NN )/-RRB- was/VBD more/RBR than/IN doubled/VBN in/IN the/DT presence/NN of/IN TMP/NN /SMX/NN ./.

(ROOT (S1 (S (S (ADVP (RB Notably)) (, ,) (NP (NP (NP (JJ systemic) (NN exposure)) (PRN (-LRB- -LRB-) (NP (CD AUC0-12)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN dapsone) (NN hydroxylamine)) (PRN (-LRB- -LRB-) (NP (NN DHA)) (-RRB- -RRB-))))) (VP (VBD was) (ADVP (RBR more) (IN than)) (VP (VBN doubled) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN TMP) (NN /SMX)))))))) (. .))))

advmod(doubled-17, Notably-1)
amod(exposure-4, systemic-3)
nsubjpass(doubled-17, exposure-4)
appos(exposure-4, AUC0-12-6)
nn(hydroxylamine-10, dapsone-9)
prep_of(exposure-4, hydroxylamine-10)
abbrev(hydroxylamine-10, DHA-12)
auxpass(doubled-17, was-14)
advmod(than-16, more-15)
advmod(doubled-17, than-16)
root(ROOT-0, doubled-17)
det(presence-20, the-19)
prep_in(doubled-17, presence-20)
nn(/SMX-23, TMP-22)
prep_of(presence-20, /SMX-23)

Exposure/NN from/IN the/DT proposed/JJ topical/JJ dose/NN is/VBZ about/IN 1/CD %/NN of/IN that/DT from/IN the/DT 100/CD mg/NN oral/JJ dose/NN ,/, even/RB when/WRB co-administered/VBN with/IN TMP/NN /SMX/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Exposure)) (PP (IN from) (NP (DT the) (JJ proposed) (JJ topical) (NN dose)))) (VP (VBZ is) (PP (IN about) (NP (NP (CD 1) (NN %)) (PP (IN of) (NP (NP (DT that)) (PP (IN from) (NP (DT the) (ADJP (CD 100) (NN mg)) (JJ oral) (NN dose))))))) (, ,) (SBAR (WHADVP (RB even) (WRB when)) (S (VP (VBN co-administered) (PP (IN with) (NP (NN TMP) (NN /SMX)))))))) (. .))))

nsubj(is-7, Exposure-1)
det(dose-6, the-3)
amod(dose-6, proposed-4)
amod(dose-6, topical-5)
prep_from(Exposure-1, dose-6)
root(ROOT-0, is-7)
num(%-10, 1-9)
prep_about(is-7, %-10)
prep_of(%-10, that-12)
det(dose-18, the-14)
number(mg-16, 100-15)
amod(dose-18, mg-16)
amod(dose-18, oral-17)
prep_from(that-12, dose-18)
advmod(when-21, even-20)
advmod(co-administered-22, when-21)
advcl(is-7, co-administered-22)
nn(/SMX-25, TMP-24)
prep_with(co-administered-22, /SMX-25)

Certain/JJ concomitant/JJ medications/NNS (/-LRB- such/JJ as/IN rifampin/NN ,/, anticonvulsants/NNS ,/, St./NN

(ROOT (S1 (S (NP (NP (NP (JJ Certain) (JJ concomitant) (NNS medications)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NN rifampin)))))) (, ,) (NP (NNS anticonvulsants)) (, ,) (NP (NN St.))))))

amod(medications-3, Certain-1)
amod(medications-3, concomitant-2)
root(ROOT-0, medications-3)
prep_such_as(medications-3, rifampin-7)
appos(medications-3, anticonvulsants-9)
appos(medications-3, St.-11)

John/NN @/NN s/NN wort/NN )/-RRB- may/MD increase/VB the/DT formation/NN of/IN dapsone/NN hydroxylamine/NN ,/, a/DT metabolite/NN of/IN dapsone/NN associated/VBN with/IN hemolysis/NN ./.

(ROOT (S1 (S (S (NP (NN John) (NN @) (NN s) (NN wort) (-RRB- -RRB-)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (NP (NN dapsone) (NN hydroxylamine)) (, ,) (NP (NP (DT a) (NN metabolite)) (PP (IN of) (NP (NP (NN dapsone)) (VP (VBN associated) (PP (IN with) (NP (NN hemolysis))))))))))))) (. .))))

nn(wort-4, John-1)
nn(wort-4, @-2)
nn(wort-4, s-3)
nsubj(increase-7, wort-4)
aux(increase-7, may-6)
root(ROOT-0, increase-7)
det(formation-9, the-8)
dobj(increase-7, formation-9)
nn(hydroxylamine-12, dapsone-11)
prep_of(formation-9, hydroxylamine-12)
det(metabolite-15, a-14)
appos(hydroxylamine-12, metabolite-15)
prep_of(metabolite-15, dapsone-17)
partmod(dapsone-17, associated-18)
prep_with(associated-18, hemolysis-20)

With/IN oral/JJ dapsone/NN treatment/NN ,/, folic/JJ acid/NN antagonists/NNS such/JJ as/IN pyrimethamine/NN have/VBP been/VBN noted/VBN to/TO possibly/RB increase/VB the/DT likelihood/NN of/IN hematologic/JJ reactions/NNS ./.

(ROOT (S1 (S (S (PP (IN With) (NP (JJ oral) (NN dapsone) (NN treatment))) (, ,) (NP (NP (JJ folic) (NN acid) (NNS antagonists)) (PP (JJ such) (IN as) (NP (NN pyrimethamine)))) (VP (VBP have) (VP (VBN been) (VP (VBN noted) (S (VP (TO to) (ADVP (RB possibly)) (VP (VB increase) (NP (NP (DT the) (NN likelihood)) (PP (IN of) (NP (JJ hematologic) (NNS reactions))))))))))) (. .))))

amod(treatment-4, oral-2)
nn(treatment-4, dapsone-3)
prep_with(noted-14, treatment-4)
amod(antagonists-8, folic-6)
nn(antagonists-8, acid-7)
nsubjpass(noted-14, antagonists-8)
xsubj(increase-17, antagonists-8)
prep_such_as(antagonists-8, pyrimethamine-11)
aux(noted-14, have-12)
auxpass(noted-14, been-13)
root(ROOT-0, noted-14)
aux(increase-17, to-15)
advmod(increase-17, possibly-16)
xcomp(noted-14, increase-17)
det(likelihood-19, the-18)
dobj(increase-17, likelihood-19)
amod(reactions-22, hematologic-21)
prep_of(likelihood-19, reactions-22)

The/DT daily/JJ dose/NN of/IN ENABLEX/NN should/MD not/RB exceed/VB 7.5/CD mg/NN when/WRB coadministered/VBN with/IN potent/JJ CYP3A4/JJ inhibitors/NNS (/-LRB- e.g./FW ,/, ketoconazole/NN ,/, itraconazole/NN ,/, ritonavir/NN ,/, nelfinavir/NN ,/, clarithromycin/NN and/CC nefazadone/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ daily) (NN dose)) (PP (IN of) (NP (NN ENABLEX)))) (VP (MD should) (RB not) (VP (VB exceed) (NP (CD 7.5) (NN mg)) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NP (JJ potent) (JJ CYP3A4) (NNS inhibitors)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN ketoconazole)) (, ,) (NP (NN itraconazole)) (, ,) (NP (NN ritonavir)) (, ,) (NP (NN nelfinavir)) (, ,) (NP (NN clarithromycin)) (CC and) (NP (NN nefazadone)))) (-RRB- -RRB-)))))))))) (. .))))

det(dose-3, The-1)
amod(dose-3, daily-2)
nsubj(exceed-8, dose-3)
prep_of(dose-3, ENABLEX-5)
aux(exceed-8, should-6)
neg(exceed-8, not-7)
root(ROOT-0, exceed-8)
num(mg-10, 7.5-9)
dobj(exceed-8, mg-10)
advmod(coadministered-12, when-11)
advcl(exceed-8, coadministered-12)
amod(inhibitors-16, potent-14)
amod(inhibitors-16, CYP3A4-15)
prep_with(coadministered-12, inhibitors-16)
dep(inhibitors-16, e.g.-18)
pobj(e.g.-18, ketoconazole-20)
conj_and(ketoconazole-20, itraconazole-22)
conj_and(ketoconazole-20, ritonavir-24)
conj_and(ketoconazole-20, nelfinavir-26)
conj_and(ketoconazole-20, clarithromycin-28)
conj_and(ketoconazole-20, nefazadone-30)

Caution/NN should/MD be/VB taken/VBN when/WRB ENABLEX/NN is/VBZ used/VBN concomitantly/RB with/IN medications/NNS that/WDT are/VBP predominantly/RB metabolized/VBN by/IN CYP2D6/NN and/CC which/WDT have/VBP a/DT narrow/JJ therapeutic/JJ window/NN ,/, such/JJ as/IN flecainide/NN ,/, thioridazine/NN and/CC tricyclic/JJ antidepressants/NNS (/-LRB- see/VB CLINICAL/JJ PHARMACOLOGY/NN )./CD

(ROOT (S1 (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN taken) (SBAR (WHADVP (WRB when)) (S (NP (NN ENABLEX)) (VP (VBZ is) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NNS medications)) (SBAR (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB predominantly)) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP2D6))))))) (CC and) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (NP (DT a) (JJ narrow) (JJ therapeutic) (NN window)))))) (, ,) (PP (JJ such) (IN as) (NP (NP (NN flecainide)) (, ,) (NP (NN thioridazine)) (CC and) (NP (NP (JJ tricyclic) (NNS antidepressants)) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (JJ CLINICAL) (NN PHARMACOLOGY) (CD -RRB-.))))))))))))))))))))

nsubjpass(taken-4, Caution-1)
aux(taken-4, should-2)
auxpass(taken-4, be-3)
root(ROOT-0, taken-4)
advmod(used-8, when-5)
nsubjpass(used-8, ENABLEX-6)
auxpass(used-8, is-7)
advcl(taken-4, used-8)
advmod(used-8, concomitantly-9)
prep_with(used-8, medications-11)
nsubjpass(metabolized-15, medications-11)
nsubj(have-20, medications-11)
auxpass(metabolized-15, are-13)
advmod(metabolized-15, predominantly-14)
rcmod(medications-11, metabolized-15)
agent(metabolized-15, CYP2D6-17)
conj_and(metabolized-15, have-20)
det(window-24, a-21)
amod(window-24, narrow-22)
amod(window-24, therapeutic-23)
dobj(have-20, window-24)
prep_such_as(medications-11, flecainide-28)
conj_and(flecainide-28, thioridazine-30)
amod(antidepressants-33, tricyclic-32)
conj_and(flecainide-28, antidepressants-33)
dep(antidepressants-33, see-35)
amod(PHARMACOLOGY-37, CLINICAL-36)
dobj(see-35, PHARMACOLOGY-37)
num(PHARMACOLOGY-37, -RRB-.-38)

The/DT concomitant/JJ use/NN of/IN ENABLEX/NN with/IN other/JJ anticholinergic/JJ agents/NNS may/MD increase/VB the/DT frequency/NN and/or/CC severity/NN of/IN dry/JJ mouth/NN ,/, constipation/NN ,/, blurred/JJ vision/NN and/CC other/JJ anticholinergic/JJ pharmacological/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (NN ENABLEX))) (PP (IN with) (NP (JJ other) (JJ anticholinergic) (NNS agents)))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NP (NN frequency)) (CC and/or) (NP (NN severity))) (PP (IN of) (NP (NP (JJ dry) (NN mouth)) (, ,) (NP (NN constipation)) (, ,) (NP (JJ blurred) (NN vision)) (CC and) (NP (JJ other) (JJ anticholinergic) (JJ pharmacological) (NNS effects)))))))) (. .))))

det(use-3, The-1)
amod(use-3, concomitant-2)
nsubj(increase-11, use-3)
prep_of(use-3, ENABLEX-5)
amod(agents-9, other-7)
amod(agents-9, anticholinergic-8)
prep_with(use-3, agents-9)
aux(increase-11, may-10)
root(ROOT-0, increase-11)
dep(frequency-13, the-12)
dobj(increase-11, frequency-13)
conj_and/or(frequency-13, severity-15)
amod(mouth-18, dry-17)
prep_of(frequency-13, mouth-18)
conj_and(mouth-18, constipation-20)
amod(vision-23, blurred-22)
conj_and(mouth-18, vision-23)
amod(effects-28, other-25)
amod(effects-28, anticholinergic-26)
amod(effects-28, pharmacological-27)
conj_and(mouth-18, effects-28)

Anticholinergic/JJ agents/NNS may/MD potentially/RB alter/VB the/DT absorption/NN of/IN some/DT concomitantly/RB administered/VBN drugs/NNS due/JJ to/TO effects/NNS on/IN gastrointestinal/JJ motility/NN ./.

(ROOT (S1 (S (S (NP (JJ Anticholinergic) (NNS agents)) (VP (MD may) (ADVP (RB potentially)) (VP (VB alter) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NP (DT some) (ADJP (RB concomitantly) (VBN administered)) (NNS drugs)) (ADJP (JJ due) (PP (TO to) (NP (NP (NNS effects)) (PP (IN on) (NP (JJ gastrointestinal) (NN motility)))))))))))) (. .))))

amod(agents-2, Anticholinergic-1)
nsubj(alter-5, agents-2)
aux(alter-5, may-3)
advmod(alter-5, potentially-4)
root(ROOT-0, alter-5)
det(absorption-7, the-6)
dobj(alter-5, absorption-7)
det(drugs-12, some-9)
advmod(administered-11, concomitantly-10)
amod(drugs-12, administered-11)
prep_of(absorption-7, drugs-12)
prep_due_to(drugs-12, effects-15)
amod(motility-18, gastrointestinal-17)
prep_on(effects-15, motility-18)

Drug/NN Laboratory/NN Test/NN Interactions/NNS Interactions/NNS between/IN darifenacin/NN and/CC laboratory/NN tests/NNS have/VBP not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN Laboratory) (NN Test) (NNS Interactions) (NNS Interactions)) (PP (IN between) (NP (NP (NN darifenacin)) (CC and) (NP (NN laboratory) (NNS tests))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

nn(Interactions-5, Drug-1)
nn(Interactions-5, Laboratory-2)
nn(Interactions-5, Test-3)
nn(Interactions-5, Interactions-4)
nsubjpass(studied-14, Interactions-5)
prep_between(Interactions-5, darifenacin-7)
nn(tests-10, laboratory-9)
conj_and(darifenacin-7, tests-10)
aux(studied-14, have-11)
neg(studied-14, not-12)
auxpass(studied-14, been-13)
root(ROOT-0, studied-14)

Drugs/NNS that/WDT may/MD increase/VB dasatinib/NN plasma/NN concentrations/NNS CYP3A4/JJ Inhibitors/NNS :/: Dasatinib/NN is/VBZ a/DT CYP3A4/NN substrate/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB increase) (NP (NN dasatinib) (NN plasma) (NNS concentrations) (NP (JJ CYP3A4) (NNS Inhibitors)))))))) (: :) (S (NP (NN Dasatinib)) (VP (VBZ is) (NP (DT a) (NN CYP3A4) (NN substrate)))) (. .)))))

root(ROOT-0, Drugs-1)
nsubj(increase-4, Drugs-1)
aux(increase-4, may-3)
rcmod(Drugs-1, increase-4)
nn(concentrations-7, dasatinib-5)
nn(concentrations-7, plasma-6)
dobj(increase-4, concentrations-7)
amod(Inhibitors-9, CYP3A4-8)
dep(concentrations-7, Inhibitors-9)
nsubj(substrate-15, Dasatinib-11)
cop(substrate-15, is-12)
det(substrate-15, a-13)
nn(substrate-15, CYP3A4-14)
dep(Drugs-1, substrate-15)

Concomitant/JJ use/NN of/IN SPRYCEL/NN and/CC drugs/NNS that/WDT inhibit/VBP CYP3A4/NN (/-LRB- eg/NN ,/, ketoconazole/NN ,/, itraconazole/NN ,/, erythromycin/NN ,/, clarithromycin/NN ,/, ritonavir/NN ,/, atazanavir/NN ,/, indinavir/NN ,/, nefazodone/NN ,/, nelfinavir/NN ,/, saquinavir/NN ,/, telithromycin/NN )/-RRB- may/MD increase/VB exposure/NN to/TO dasatinib/NN and/CC should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (NN SPRYCEL)) (CC and) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (NP (NN CYP3A4)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN ketoconazole) (, ,) (NN itraconazole) (, ,) (NN erythromycin) (, ,) (NN clarithromycin) (, ,) (NN ritonavir) (, ,) (NN atazanavir) (, ,) (NN indinavir) (, ,) (NN nefazodone) (, ,) (NN nelfinavir) (, ,) (NN saquinavir) (, ,) (NN telithromycin))) (-RRB- -RRB-)))))))))) (VP (VP (MD may) (VP (VB increase) (NP (NP (NN exposure)) (PP (TO to) (NP (NN dasatinib)))))) (CC and) (VP (MD should) (VP (VB be) (VP (VBN avoided)))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(increase-36, use-2)
prep_of(use-2, SPRYCEL-4)
conj_and(SPRYCEL-4, drugs-6)
nsubj(inhibit-8, drugs-6)
rcmod(drugs-6, inhibit-8)
dobj(inhibit-8, CYP3A4-9)
dep(CYP3A4-9, eg-11)
nn(telithromycin-33, ketoconazole-13)
dep(telithromycin-33, itraconazole-15)
dep(telithromycin-33, erythromycin-17)
dep(telithromycin-33, clarithromycin-19)
dep(telithromycin-33, ritonavir-21)
dep(telithromycin-33, atazanavir-23)
dep(telithromycin-33, indinavir-25)
dep(telithromycin-33, nefazodone-27)
dep(telithromycin-33, nelfinavir-29)
dep(telithromycin-33, saquinavir-31)
appos(eg-11, telithromycin-33)
aux(increase-36, may-35)
root(ROOT-0, increase-36)
dobj(increase-36, exposure-37)
prep_to(exposure-37, dasatinib-39)
aux(avoided-43, should-41)
auxpass(avoided-43, be-42)
conj_and(increase-36, avoided-43)

In/IN patients/NNS receiving/VBG treatment/NN with/IN SPRYCEL/NN ,/, close/JJ monitoring/NN for/IN toxicity/NN and/CC a/DT SPRYCEL/JJ dose/NN reduction/NN should/MD be/VB considered/VBN if/IN systemic/JJ administration/NN of/IN a/DT potent/JJ CYP3A4/NN inhibitor/NN cannot/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN treatment)) (PP (IN with) (NP (NN SPRYCEL))))))) (, ,) (NP (NP (JJ close) (NN monitoring)) (PP (IN for) (NP (NP (NN toxicity)) (CC and) (NP (DT a) (JJ SPRYCEL) (NN dose) (NN reduction))))) (VP (MD should) (VP (VB be) (VP (VBN considered) (SBAR (IN if) (S (NP (NP (JJ systemic) (NN administration)) (PP (IN of) (NP (DT a) (JJ potent) (NN CYP3A4) (NN inhibitor)))) (VP (MD cannot) (VP (VB be) (VP (VBN avoided)))))))))) (. .))))

prep_in(considered-19, patients-2)
partmod(patients-2, receiving-3)
dobj(receiving-3, treatment-4)
prep_with(treatment-4, SPRYCEL-6)
amod(monitoring-9, close-8)
nsubjpass(considered-19, monitoring-9)
prep_for(monitoring-9, toxicity-11)
det(reduction-16, a-13)
amod(reduction-16, SPRYCEL-14)
nn(reduction-16, dose-15)
conj_and(toxicity-11, reduction-16)
aux(considered-19, should-17)
auxpass(considered-19, be-18)
root(ROOT-0, considered-19)
mark(cannot-28, if-20)
amod(administration-22, systemic-21)
nsubj(cannot-28, administration-22)
det(inhibitor-27, a-24)
amod(inhibitor-27, potent-25)
nn(inhibitor-27, CYP3A4-26)
prep_of(administration-22, inhibitor-27)
advcl(considered-19, cannot-28)
auxpass(avoided-30, be-29)
dep(cannot-28, avoided-30)

Drugs/NNS that/WDT may/MD decrease/VB dasatinib/NN plasma/NN concentrations/NNS CYP3A4/JJ Inducers/NNS :/: Drugs/NNS that/WDT induce/VBP CYP3A4/NN activity/NN may/MD decrease/VB dasatinib/NN plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB decrease) (NP (NN dasatinib) (NN plasma) (NNS concentrations))))))) (NP (JJ CYP3A4) (NNS Inducers)) (: :) (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP induce) (NP (NN CYP3A4) (NN activity))))))) (VP (MD may) (VP (VB decrease) (NP (NN dasatinib) (NN plasma) (NNS concentrations))))) (. .))))

nsubj(decrease-4, Drugs-1)
nsubj(decrease-17, Drugs-1)
aux(decrease-4, may-3)
rcmod(Drugs-1, decrease-4)
nn(concentrations-7, dasatinib-5)
nn(concentrations-7, plasma-6)
dobj(decrease-4, concentrations-7)
amod(Inducers-9, CYP3A4-8)
dep(Drugs-1, Inducers-9)
dep(Drugs-1, Drugs-11)
nsubj(induce-13, Drugs-11)
rcmod(Drugs-11, induce-13)
nn(activity-15, CYP3A4-14)
dobj(induce-13, activity-15)
aux(decrease-17, may-16)
root(ROOT-0, decrease-17)
nn(concentrations-20, dasatinib-18)
nn(concentrations-20, plasma-19)
dobj(decrease-17, concentrations-20)

In/IN patients/NNS in/IN whom/WP CYP3A4/JJ inducers/NNS (/-LRB- eg/NN ,/, dexamethasone/NN ,/, phenytoin/NN ,/, carbamazepine/NN ,/, rifampicin/NN ,/, phenobarbital/NN )/-RRB- are/VBP indicated/VBN ,/, alternative/JJ agents/NNS with/IN less/RBR enzyme/NN induction/NN potential/NN should/MD be/VB used/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NNS patients)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (NP (JJ CYP3A4) (NNS inducers)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN dexamethasone)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN carbamazepine)) (, ,) (NP (NN rifampicin)) (, ,) (NP (NN phenobarbital))) (-RRB- -RRB-))) (VP (VBP are) (VP (VBN indicated))))))) (, ,) (NP (NP (JJ alternative) (NNS agents)) (PP (IN with) (NP (RBR less) (NN enzyme) (NN induction) (NN potential)))) (VP (MD should) (VP (VB be) (VP (VBN used))))) (. .))))

prep_in(used-32, patients-2)
rel(indicated-21, whom-4)
amod(inducers-6, CYP3A4-5)
nsubjpass(indicated-21, inducers-6)
dep(inducers-6, eg-8)
appos(eg-8, dexamethasone-10)
appos(eg-8, phenytoin-12)
appos(eg-8, carbamazepine-14)
appos(eg-8, rifampicin-16)
appos(eg-8, phenobarbital-18)
auxpass(indicated-21, are-20)
rcmod(patients-2, indicated-21)
amod(agents-24, alternative-23)
nsubjpass(used-32, agents-24)
advmod(potential-29, less-26)
nn(potential-29, enzyme-27)
nn(potential-29, induction-28)
prep_with(agents-24, potential-29)
aux(used-32, should-30)
auxpass(used-32, be-31)
root(ROOT-0, used-32)

If/IN SPRYCEL/NN must/MD be/VB administered/VBN with/IN a/DT CYP3A4/NN inducer/NN ,/, a/DT dose/NN increase/NN in/IN SPRYCEL/NN should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN SPRYCEL)) (VP (MD must) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (DT a) (NN CYP3A4) (NN inducer)))))))) (, ,) (NP (NP (DT a) (NN dose) (NN increase)) (PP (IN in) (NP (NN SPRYCEL)))) (VP (MD should) (VP (VB be) (VP (VBN considered))))) (. .))))

mark(administered-5, If-1)
nsubjpass(administered-5, SPRYCEL-2)
aux(administered-5, must-3)
auxpass(administered-5, be-4)
advcl(considered-18, administered-5)
det(inducer-9, a-7)
nn(inducer-9, CYP3A4-8)
prep_with(administered-5, inducer-9)
det(increase-13, a-11)
nn(increase-13, dose-12)
nsubjpass(considered-18, increase-13)
prep_in(increase-13, SPRYCEL-15)
aux(considered-18, should-16)
auxpass(considered-18, be-17)
root(ROOT-0, considered-18)

St./NN Johns/NNP wort/NN (/-LRB- Hypericum/NN perforatum/NN )/-RRB- may/MD decrease/VB SPRYCEL/NN plasma/NN concentrations/NNS unpredictably/RB ./.

(ROOT (S1 (S (S (NP (NP (NN St.) (NNP Johns) (NN wort)) (PRN (-LRB- -LRB-) (NP (NN Hypericum) (NN perforatum)) (-RRB- -RRB-))) (VP (MD may) (VP (VB decrease) (NP (NN SPRYCEL) (NN plasma) (NNS concentrations)) (ADVP (RB unpredictably))))) (. .))))

nn(wort-3, St.-1)
nn(wort-3, Johns-2)
nsubj(decrease-9, wort-3)
nn(perforatum-6, Hypericum-5)
appos(wort-3, perforatum-6)
aux(decrease-9, may-8)
root(ROOT-0, decrease-9)
nn(concentrations-12, SPRYCEL-10)
nn(concentrations-12, plasma-11)
dobj(decrease-9, concentrations-12)
advmod(decrease-9, unpredictably-13)

Patients/NNS receiving/VBG SPRYCEL/NN should/MD not/RB take/VB St./NN Johns/NNP wort/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (NN SPRYCEL)))) (VP (MD should) (RB not) (VP (VB take) (NP (NN St.) (NNP Johns) (NN wort))))) (. .))))

nsubj(take-6, Patients-1)
partmod(Patients-1, receiving-2)
dobj(receiving-2, SPRYCEL-3)
aux(take-6, should-4)
neg(take-6, not-5)
root(ROOT-0, take-6)
nn(wort-9, St.-7)
nn(wort-9, Johns-8)
dobj(take-6, wort-9)

Antacids/NNS :/: Nonclinical/JJ data/NNS demonstrate/VBP that/IN the/DT solubility/NN of/IN dasatinib/NN is/VBZ pH/NN dependent/JJ ./.

(ROOT (S1 (S (NP (NP (NNS Antacids)) (: :) (S (NP (JJ Nonclinical) (NNS data)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (DT the) (NN solubility)) (PP (IN of) (NP (NN dasatinib)))) (VP (VBZ is) (ADJP (NN pH) (JJ dependent))))))) (. .)))))

root(ROOT-0, Antacids-1)
amod(data-4, Nonclinical-3)
nsubj(demonstrate-5, data-4)
dep(Antacids-1, demonstrate-5)
complm(dependent-13, that-6)
det(solubility-8, the-7)
nsubj(dependent-13, solubility-8)
prep_of(solubility-8, dasatinib-10)
cop(dependent-13, is-11)
dep(dependent-13, pH-12)
ccomp(demonstrate-5, dependent-13)

Simultaneous/JJ administration/NN of/IN SPRYCEL/NN with/IN antacids/NNS should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Simultaneous) (NN administration)) (PP (IN of) (NP (NN SPRYCEL))) (PP (IN with) (NP (NNS antacids)))) (VP (MD should) (VP (VB be) (VP (VBN avoided))))) (. .))))

amod(administration-2, Simultaneous-1)
nsubjpass(avoided-9, administration-2)
prep_of(administration-2, SPRYCEL-4)
prep_with(administration-2, antacids-6)
aux(avoided-9, should-7)
auxpass(avoided-9, be-8)
root(ROOT-0, avoided-9)

If/IN antacid/JJ therapy/NN is/VBZ needed/VBN ,/, the/DT antacid/JJ dose/NN should/MD be/VB administered/VBN at/IN least/JJS 2/CD hours/NNS prior/RB to/TO or/CC 2/CD hours/NNS after/IN the/DT dose/NN of/IN SPRYCEL/NN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (JJ antacid) (NN therapy)) (VP (VBZ is) (VP (VBN needed))))) (, ,) (NP (DT the) (JJ antacid) (NN dose)) (VP (MD should) (VP (VB be) (VP (VBN administered) (ADVP (NP (QP (IN at) (JJS least) (CD 2)) (NNS hours)) (RB prior) (PP (TO to) (NP (CC or) (CD 2) (NNS hours)))) (PP (IN after) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN SPRYCEL))))))))) (. .))))

mark(needed-5, If-1)
amod(therapy-3, antacid-2)
nsubjpass(needed-5, therapy-3)
auxpass(needed-5, is-4)
advcl(administered-12, needed-5)
det(dose-9, the-7)
amod(dose-9, antacid-8)
nsubjpass(administered-12, dose-9)
aux(administered-12, should-10)
auxpass(administered-12, be-11)
root(ROOT-0, administered-12)
quantmod(2-15, at-13)
mwe(at-13, least-14)
pobj(at-13, least-14)
num(hours-16, 2-15)
npadvmod(administered-12, hours-16)
cc(hours-21, or-19)
dep(hours-21, 2-20)
prep_prior_to(administered-12, hours-21)
det(dose-24, the-23)
prep_after(administered-12, dose-24)
prep_of(dose-24, SPRYCEL-26)

H2/JJ Blockers/NN //: Proton/NN Pump/NN Inhibitors/NNS :/: Long-term/JJ suppression/NN of/IN gastric/JJ acid/NN secretion/NN by/IN H2/NN blockers/NNS or/CC proton/NN pump/NN inhibitors/NNS (/-LRB- eg/NN ,/, famotidine/NN and/CC omeprazole/NN )/-RRB- is/VBZ likely/JJ to/TO reduce/VB dasatinib/NN exposure/NN ./.

(ROOT (S1 (S (NP (NP (JJ H2) (NN Blockers) (: /) (NN Proton) (NN Pump) (NNS Inhibitors)) (: :) (S (NP (NP (JJ Long-term) (NN suppression)) (PP (IN of) (NP (JJ gastric) (NN acid) (NN secretion))) (PP (IN by) (NP (NP (NN H2) (NNS blockers)) (CC or) (NP (NP (NN proton) (NN pump) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN famotidine)) (CC and) (NP (NN omeprazole))) (-RRB- -RRB-)))))) (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VB reduce) (NP (NN dasatinib) (NN exposure)))))))) (. .)))))

amod(Inhibitors-6, H2-1)
nn(Inhibitors-6, Blockers-2)
punct(Inhibitors-6, /-3)
nn(Inhibitors-6, Proton-4)
nn(Inhibitors-6, Pump-5)
root(ROOT-0, Inhibitors-6)
amod(suppression-9, Long-term-8)
nsubj(likely-29, suppression-9)
amod(secretion-13, gastric-11)
nn(secretion-13, acid-12)
prep_of(suppression-9, secretion-13)
nn(blockers-16, H2-15)
prep_by(suppression-9, blockers-16)
nn(inhibitors-20, proton-18)
nn(inhibitors-20, pump-19)
conj_or(blockers-16, inhibitors-20)
dep(inhibitors-20, eg-22)
conj_and(eg-22, famotidine-24)
conj_and(eg-22, omeprazole-26)
cop(likely-29, is-28)
dep(Inhibitors-6, likely-29)
aux(reduce-31, to-30)
xcomp(likely-29, reduce-31)
nn(exposure-33, dasatinib-32)
dobj(reduce-31, exposure-33)

The/DT concomitant/JJ use/NN of/IN H2/NN blockers/NNS or/CC proton/NN pump/NN inhibitors/NNS with/IN SPRYCEL/NN is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN H2) (NNS blockers)) (CC or) (NP (NN proton) (NN pump) (NNS inhibitors)))) (PP (IN with) (NP (NN SPRYCEL)))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

det(use-3, The-1)
amod(use-3, concomitant-2)
nsubjpass(recommended-15, use-3)
nn(blockers-6, H2-5)
prep_of(use-3, blockers-6)
nn(inhibitors-10, proton-8)
nn(inhibitors-10, pump-9)
conj_or(blockers-6, inhibitors-10)
prep_with(use-3, SPRYCEL-12)
auxpass(recommended-15, is-13)
neg(recommended-15, not-14)
root(ROOT-0, recommended-15)

The/DT use/NN of/IN antacids/NNS should/MD be/VB considered/VBN in/IN place/NN of/IN H2/NN blockers/NNS or/CC proton/NN pump/NN inhibitors/NNS in/IN patients/NNS receiving/VBG SPRYCEL/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NNS antacids)))) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN in) (NP (NP (NN place)) (PP (IN of) (NP (NP (NN H2) (NNS blockers)) (CC or) (NP (NN proton) (NN pump) (NNS inhibitors)))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN SPRYCEL) (NN therapy))))))))))) (. .))))

det(use-2, The-1)
nsubjpass(considered-7, use-2)
prep_of(use-2, antacids-4)
aux(considered-7, should-5)
auxpass(considered-7, be-6)
root(ROOT-0, considered-7)
nn(blockers-12, H2-11)
prep_in_place_of(considered-7, blockers-12)
nn(inhibitors-16, proton-14)
nn(inhibitors-16, pump-15)
conj_or(blockers-12, inhibitors-16)
prep_in(considered-7, patients-18)
partmod(patients-18, receiving-19)
nn(therapy-21, SPRYCEL-20)
dobj(receiving-19, therapy-21)

Drugs/NNS that/WDT may/MD have/VB their/PRP$ plasma/NN concentration/NN altered/VBN by/IN dasatinib/NN CYP3A4/NN Substrates/NNS :/: Dasatinib/NN is/VBZ a/DT time-dependent/JJ inhibitor/NN of/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB have) (NP (PRP$ their) (NN plasma) (NN concentration))))))) (VP (VBN altered) (PP (IN by) (NP (NN dasatinib) (NN CYP3A4) (NNS Substrates))))) (: :) (S (NP (NN Dasatinib)) (VP (VBZ is) (NP (NP (DT a) (JJ time-dependent) (NN inhibitor)) (PP (IN of) (NP (NN CYP3A4))))))) (. .))))

nsubj(have-4, Drugs-1)
nsubj(altered-8, Drugs-1)
aux(have-4, may-3)
rcmod(Drugs-1, have-4)
poss(concentration-7, their-5)
nn(concentration-7, plasma-6)
dobj(have-4, concentration-7)
root(ROOT-0, altered-8)
nn(Substrates-12, dasatinib-10)
nn(Substrates-12, CYP3A4-11)
prep_by(altered-8, Substrates-12)
nsubj(inhibitor-18, Dasatinib-14)
cop(inhibitor-18, is-15)
det(inhibitor-18, a-16)
amod(inhibitor-18, time-dependent-17)
parataxis(altered-8, inhibitor-18)
prep_of(inhibitor-18, CYP3A4-20)

Therefore/RB ,/, CYP3A4/JJ substrates/NNS known/VBN to/TO have/VB a/DT narrow/JJ therapeutic/JJ index/NN such/JJ as/IN alfentanil/NN ,/, astemizole/NN ,/, terfenadine/NN ,/, cisapride/NN ,/, cyclosporine/NN ,/, fentanyl/NN ,/, pimozide/NN ,/, quinidine/NN ,/, sirolimus/NN ,/, tacrolimus/NN ,/, or/CC ergot/NN alkaloids/NNS (/-LRB- ergotamine/NN ,/, dihydroergotamine/NN )/-RRB- should/MD be/VB administered/VBN with/IN caution/NN in/IN patients/NNS receiving/VBG SPRYCEL/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (JJ CYP3A4) (NNS substrates)) (VP (VBN known) (S (VP (TO to) (VP (VB have) (NP (NP (DT a) (JJ narrow) (JJ therapeutic) (NN index)) (PP (JJ such) (PP (IN as) (NP (NP (NN alfentanil)) (, ,) (NP (NN astemizole) (, ,) (NN terfenadine) (, ,) (NN cisapride) (, ,) (NN cyclosporine) (, ,) (NN fentanyl) (, ,) (NN pimozide) (, ,) (NN quinidine) (, ,) (NN sirolimus) (, ,) (NN tacrolimus)) (, ,) (CC or) (NP (NP (NN ergot) (NNS alkaloids)) (PRN (-LRB- -LRB-) (NP (NN ergotamine)) (, ,) (NP (NN dihydroergotamine)) (-RRB- -RRB-)))))))))))) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (NP (NN caution)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN SPRYCEL))))))))))) (. .))))

advmod(administered-44, Therefore-1)
amod(substrates-4, CYP3A4-3)
xsubj(have-7, substrates-4)
nsubjpass(administered-44, substrates-4)
partmod(substrates-4, known-5)
aux(have-7, to-6)
xcomp(known-5, have-7)
det(index-11, a-8)
amod(index-11, narrow-9)
amod(index-11, therapeutic-10)
dobj(have-7, index-11)
prep_such_as(index-11, alfentanil-14)
nn(tacrolimus-32, astemizole-16)
dep(tacrolimus-32, terfenadine-18)
dep(tacrolimus-32, cisapride-20)
dep(tacrolimus-32, cyclosporine-22)
dep(tacrolimus-32, fentanyl-24)
dep(tacrolimus-32, pimozide-26)
dep(tacrolimus-32, quinidine-28)
dep(tacrolimus-32, sirolimus-30)
conj_or(alfentanil-14, tacrolimus-32)
nn(alkaloids-36, ergot-35)
conj_or(alfentanil-14, alkaloids-36)
appos(alkaloids-36, ergotamine-38)
dep(ergotamine-38, dihydroergotamine-40)
aux(administered-44, should-42)
auxpass(administered-44, be-43)
root(ROOT-0, administered-44)
prep_with(administered-44, caution-46)
prep_in(caution-46, patients-48)
partmod(patients-48, receiving-49)
dobj(receiving-49, SPRYCEL-50)

Hepatic/JJ Impairment/NN :/: There/EX are/VBP currently/RB no/DT clinical/JJ studies/NNS with/IN SPRYCEL/NN in/IN patients/NNS with/IN impaired/JJ liver/NN function/NN (/-LRB- clinical/JJ studies/NNS have/VBP excluded/VBN patients/NNS with/IN ALT/NN and/or/CC AST/NN 2.5/CD times/NNS the/DT upper/JJ limit/NN of/IN the/DT normal/JJ range/NN and/or/CC total/JJ bilirubin/NN 2/CD times/NNS the/DT upper/JJ limit/NN of/IN the/DT normal/JJ range/NN )./NN

(ROOT (S1 (S (NP (NP (JJ Hepatic) (NN Impairment)) (: :) (S (NP (EX There)) (VP (VBP are) (ADVP (RB currently)) (NP (NP (DT no) (JJ clinical) (NNS studies)) (PP (IN with) (NP (NN SPRYCEL))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ impaired) (NN liver) (NN function)))))) (-LRB- -LRB-) (S (NP (JJ clinical) (NNS studies)) (VP (VBP have) (VP (VBN excluded) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN ALT)) (CC and/or) (NP (NN AST)) (NP (NP (CD 2.5) (NNS times)) (NP (NP (NP (DT the) (JJ upper) (NN limit)) (PP (IN of) (NP (DT the) (JJ normal) (NN range)))) (CC and/or) (NP (NP (JJ total) (NN bilirubin)) (VP (CD 2) (NNS times) (NP (NP (DT the) (JJ upper) (NN limit)) (PP (IN of) (NP (DT the) (JJ normal) (NN range) (NN -RRB-.))))))))))))))))))))

amod(Impairment-2, Hepatic-1)
root(ROOT-0, Impairment-2)
expl(are-5, There-4)
dep(Impairment-2, are-5)
advmod(are-5, currently-6)
det(studies-9, no-7)
amod(studies-9, clinical-8)
nsubj(are-5, studies-9)
prep_with(studies-9, SPRYCEL-11)
prep_in(studies-9, patients-13)
amod(function-17, impaired-15)
nn(function-17, liver-16)
prep_with(patients-13, function-17)
amod(studies-20, clinical-19)
nsubj(excluded-22, studies-20)
aux(excluded-22, have-21)
dep(are-5, excluded-22)
dobj(excluded-22, patients-23)
prep_with(patients-23, ALT-25)
conj_and/or(ALT-25, AST-27)
num(times-29, 2.5-28)
dep(ALT-25, times-29)
det(limit-32, the-30)
amod(limit-32, upper-31)
dep(times-29, limit-32)
det(range-36, the-34)
amod(range-36, normal-35)
prep_of(limit-32, range-36)
amod(bilirubin-39, total-38)
conj_and/or(limit-32, bilirubin-39)
dep(times-41, 2-40)
dep(bilirubin-39, times-41)
det(limit-44, the-42)
amod(limit-44, upper-43)
dobj(times-41, limit-44)
det(-RRB-.-49, the-46)
amod(-RRB-.-49, normal-47)
nn(-RRB-.-49, range-48)
prep_of(limit-44, -RRB-.-49)

Renal/JJ Impairment/NN :/: There/EX are/VBP currently/RB no/DT clinical/JJ studies/NNS with/IN SPRYCEL/NN in/IN patients/NNS with/IN impaired/JJ renal/JJ function/NN (/-LRB- clinical/JJ studies/NNS have/VBP excluded/VBN patients/NNS with/IN serum/NN creatinine/NN concentration/NN 1.5/CD times/NNS the/DT upper/JJ limit/NN of/IN the/DT normal/JJ range/NN )./RB

(ROOT (S1 (S (NP (NP (JJ Renal) (NN Impairment)) (: :) (S (NP (EX There)) (VP (VBP are) (ADVP (RB currently)) (NP (NP (DT no) (JJ clinical) (NNS studies)) (PP (IN with) (NP (NN SPRYCEL))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ impaired) (JJ renal) (NN function))))))))) (-LRB- -LRB-) (NP (JJ clinical) (NNS studies)) (VP (VBP have) (VP (VBN excluded) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN serum) (NN creatinine) (NN concentration) (CD 1.5)) (VP (NNS times) (NP (NP (DT the) (JJ upper) (NN limit)) (PP (IN of) (NP (DT the) (JJ normal) (NN range)))) (ADVP (RB -RRB-.)))))))))))

amod(Impairment-2, Renal-1)
nsubj(excluded-22, Impairment-2)
expl(are-5, There-4)
dep(Impairment-2, are-5)
advmod(are-5, currently-6)
det(studies-9, no-7)
amod(studies-9, clinical-8)
nsubj(are-5, studies-9)
prep_with(studies-9, SPRYCEL-11)
prep_in(studies-9, patients-13)
amod(function-17, impaired-15)
amod(function-17, renal-16)
prep_with(patients-13, function-17)
amod(studies-20, clinical-19)
nsubj(excluded-22, studies-20)
aux(excluded-22, have-21)
root(ROOT-0, excluded-22)
dobj(excluded-22, patients-23)
nn(concentration-27, serum-25)
nn(concentration-27, creatinine-26)
prep_with(patients-23, concentration-27)
num(concentration-27, 1.5-28)
dep(concentration-27, times-29)
det(limit-32, the-30)
amod(limit-32, upper-31)
dobj(times-29, limit-32)
det(range-36, the-34)
amod(range-36, normal-35)
prep_of(limit-32, range-36)
advmod(times-29, -RRB-.-37)

Dasatinib/NN and/CC its/PRP$ metabolites/NNS are/VBP minimally/RB excreted/VBN via/IN the/DT kidney/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Dasatinib)) (CC and) (NP (PRP$ its) (NNS metabolites))) (VP (VBP are) (ADVP (RB minimally)) (VP (VBN excreted) (PP (IN via) (NP (DT the) (NN kidney)))))) (. .))))

nsubjpass(excreted-7, Dasatinib-1)
poss(metabolites-4, its-3)
conj_and(Dasatinib-1, metabolites-4)
auxpass(excreted-7, are-5)
advmod(excreted-7, minimally-6)
root(ROOT-0, excreted-7)
det(kidney-10, the-9)
prep_via(excreted-7, kidney-10)

Since/IN the/DT renal/JJ excretion/NN of/IN unchanged/JJ dasatinib/NN and/CC its/PRP$ metabolites/NNS is/VBZ 4/CD %/NN ,/, a/DT decrease/NN in/IN total/JJ body/NN clearance/NN is/VBZ not/RB expected/VBN in/IN patients/NNS with/IN renal/JJ insufficiency/NN ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NP (DT the) (JJ renal) (NN excretion)) (PP (IN of) (NP (NP (JJ unchanged) (NN dasatinib)) (CC and) (NP (PRP$ its) (NNS metabolites))))) (VP (VBZ is) (NP (CD 4) (NN %))))) (, ,) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (JJ total) (NN body) (NN clearance)))) (VP (VBZ is) (RB not) (VP (VBN expected) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ renal) (NN insufficiency)))))))) (. .))))

mark(%-13, Since-1)
det(excretion-4, the-2)
amod(excretion-4, renal-3)
nsubj(%-13, excretion-4)
amod(dasatinib-7, unchanged-6)
prep_of(excretion-4, dasatinib-7)
poss(metabolites-10, its-9)
conj_and(dasatinib-7, metabolites-10)
cop(%-13, is-11)
num(%-13, 4-12)
advcl(expected-23, %-13)
det(decrease-16, a-15)
nsubjpass(expected-23, decrease-16)
amod(clearance-20, total-18)
nn(clearance-20, body-19)
prep_in(decrease-16, clearance-20)
auxpass(expected-23, is-21)
neg(expected-23, not-22)
root(ROOT-0, expected-23)
prep_in(expected-23, patients-25)
amod(insufficiency-28, renal-27)
prep_with(patients-25, insufficiency-28)

Potentially/RB fatal/JJ drug/NN interactions/NNS may/MD occur/VB when/WRB coadministered/VBN with/IN digoxin/NN ,/, as/IN this/DT may/MD enhance/VB cardiovascular/JJ depression/NN and/CC bradyarrhythmias/NNS may/MD occur/VB ./.

(ROOT (S1 (S (S (NP (ADJP (RB Potentially) (JJ fatal)) (NN drug) (NNS interactions)) (VP (MD may) (VP (VB occur) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NN digoxin))) (, ,) (SBAR (IN as) (S (S (NP (DT this)) (VP (MD may) (VP (VB enhance) (NP (JJ cardiovascular) (NN depression))))) (CC and) (S (NP (NNS bradyarrhythmias)) (VP (MD may) (VP (VB occur)))))))))))) (. .))))

advmod(fatal-2, Potentially-1)
amod(interactions-4, fatal-2)
nn(interactions-4, drug-3)
nsubj(occur-6, interactions-4)
aux(occur-6, may-5)
root(ROOT-0, occur-6)
advmod(coadministered-8, when-7)
advcl(occur-6, coadministered-8)
prep_with(coadministered-8, digoxin-10)
mark(enhance-15, as-12)
nsubj(enhance-15, this-13)
aux(enhance-15, may-14)
advcl(coadministered-8, enhance-15)
amod(depression-17, cardiovascular-16)
dobj(enhance-15, depression-17)
nsubj(occur-21, bradyarrhythmias-19)
aux(occur-21, may-20)
conj_and(enhance-15, occur-21)

Anticholinesterases/NNS (/-LRB- neostgmine/NN ,/, physostigmine/NN )/-RRB- ,/, lignocaine/NN ,/, quinine/NN ,/, procainamide/NN can/MD enhance/VB toxicity/NN and/CC cause/VB cardio/NN respiratory/JJ depression/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Anticholinesterases)) (PRN (-LRB- -LRB-) (NP (NP (NN neostgmine)) (, ,) (NP (NN physostigmine))) (-RRB- -RRB-))) (, ,) (NP (NP (NN lignocaine)) (, ,) (NP (NN quinine)) (, ,) (NP (NN procainamide)))) (VP (MD can) (VP (VP (VB enhance) (NP (NN toxicity))) (CC and) (VP (VB cause) (NP (NN cardio) (JJ respiratory) (NN depression)))))) (. .))))

nsubj(enhance-14, Anticholinesterases-1)
dep(Anticholinesterases-1, neostgmine-3)
appos(neostgmine-3, physostigmine-5)
appos(Anticholinesterases-1, lignocaine-8)
appos(lignocaine-8, quinine-10)
appos(lignocaine-8, procainamide-12)
aux(enhance-14, can-13)
root(ROOT-0, enhance-14)
dobj(enhance-14, toxicity-15)
conj_and(enhance-14, cause-17)
nn(depression-20, cardio-18)
amod(depression-20, respiratory-19)
dobj(cause-17, depression-20)

In/IN addition/NN ,/, neuromuscular/JJ blocking/NN action/NN is/VBZ enhanced/VBN by/IN general/JJ anesthetics/NNS ,/, local/JJ anesthetics/NNS like/IN lidocaine/NN ,/, procaine/NN ,/, beta-blockers/NN ,/, metaclopramide/NN ,/, lithium/NN carbonate/NN ,/, and/CC terbutaline/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (JJ neuromuscular) (NN blocking) (NN action)) (VP (VBZ is) (VP (VBN enhanced) (PP (IN by) (NP (NP (JJ general) (NNS anesthetics)) (, ,) (NP (NP (JJ local) (NNS anesthetics)) (PP (IN like) (NP (NP (NN lidocaine)) (, ,) (NP (NN procaine)) (, ,) (NP (NN beta-blockers)) (, ,) (NP (NN metaclopramide)) (, ,) (NP (NN lithium) (NN carbonate)) (, ,) (CC and) (NP (NN terbutaline))))))))) (. .))))

prep_in(enhanced-8, addition-2)
amod(action-6, neuromuscular-4)
nn(action-6, blocking-5)
nsubjpass(enhanced-8, action-6)
auxpass(enhanced-8, is-7)
root(ROOT-0, enhanced-8)
amod(anesthetics-11, general-10)
agent(enhanced-8, anesthetics-11)
amod(anesthetics-14, local-13)
appos(anesthetics-11, anesthetics-14)
prep_like(anesthetics-14, lidocaine-16)
conj_and(lidocaine-16, procaine-18)
conj_and(lidocaine-16, beta-blockers-20)
conj_and(lidocaine-16, metaclopramide-22)
nn(carbonate-25, lithium-24)
conj_and(lidocaine-16, carbonate-25)
conj_and(lidocaine-16, terbutaline-28)

The/DT concomitant/JJ administration/NN of/IN Exjade/JJ and/CC aluminum-containing/JJ antacid/JJ preparations/NNS has/VBZ not/RB been/VBN formally/RB studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN administration)) (PP (IN of) (NP (ADJP (ADJP (JJ Exjade)) (CC and) (ADJP (JJ aluminum-containing))) (JJ antacid) (NNS preparations)))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB formally)) (VP (VBN studied))))) (. .))))

det(administration-3, The-1)
amod(administration-3, concomitant-2)
nsubjpass(studied-14, administration-3)
amod(preparations-9, Exjade-5)
conj_and(Exjade-5, aluminum-containing-7)
amod(preparations-9, antacid-8)
prep_of(administration-3, preparations-9)
aux(studied-14, has-10)
neg(studied-14, not-11)
auxpass(studied-14, been-12)
advmod(studied-14, formally-13)
root(ROOT-0, studied-14)

Although/IN deferasirox/NN has/VBZ a/DT lower/JJR affinity/NN for/IN aluminum/NN than/IN for/IN iron/NN ,/, Exjade/NN should/MD not/RB be/VB taken/VBN with/IN aluminum-containing/JJ antacid/JJ preparations/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NN deferasirox)) (VP (VBZ has) (NP (NP (DT a) (JJR lower) (NN affinity)) (PP (IN for) (NP (NN aluminum)))) (PP (IN than) (PP (IN for) (NP (NN iron))))))) (, ,) (NP (NN Exjade)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN taken) (PP (IN with) (NP (JJ aluminum-containing) (JJ antacid) (NNS preparations))))))) (. .))))

mark(has-3, Although-1)
nsubj(has-3, deferasirox-2)
advcl(taken-17, has-3)
det(affinity-6, a-4)
amod(affinity-6, lower-5)
dobj(has-3, affinity-6)
prep_for(affinity-6, aluminum-8)
prep(has-3, than-9)
pcomp(than-9, for-10)
prep_for(than-9, iron-11)
nsubjpass(taken-17, Exjade-13)
aux(taken-17, should-14)
neg(taken-17, not-15)
auxpass(taken-17, be-16)
root(ROOT-0, taken-17)
amod(preparations-21, aluminum-containing-19)
amod(preparations-21, antacid-20)
prep_with(taken-17, preparations-21)

In/IN healthy/JJ volunteers/NNS ,/, Exjade/NN had/VBD no/DT effect/NN on/IN the/DT pharmacokinetics/NNS of/IN digoxin/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ healthy) (NNS volunteers))) (, ,) (NP (NN Exjade)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN digoxin))))))) (. .))))

amod(volunteers-3, healthy-2)
prep_in(had-6, volunteers-3)
nsubj(had-6, Exjade-5)
root(ROOT-0, had-6)
det(effect-8, no-7)
dobj(had-6, effect-8)
det(pharmacokinetics-11, the-10)
prep_on(had-6, pharmacokinetics-11)
prep_of(pharmacokinetics-11, digoxin-13)

The/DT effect/NN of/IN digoxin/NN on/IN Exjade/NN pharmacokinetics/NNS has/VBZ not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN digoxin))) (PP (IN on) (NP (NN Exjade) (NNS pharmacokinetics)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

det(effect-2, The-1)
nsubjpass(studied-11, effect-2)
prep_of(effect-2, digoxin-4)
nn(pharmacokinetics-7, Exjade-6)
prep_on(effect-2, pharmacokinetics-7)
aux(studied-11, has-8)
neg(studied-11, not-9)
auxpass(studied-11, been-10)
root(ROOT-0, studied-11)

The/DT concomitant/JJ administration/NN of/IN Exjade/NN and/CC vitamin/NN C/NN has/VBZ not/RB been/VBN formally/RB studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN Exjade)) (CC and) (NP (NN vitamin) (NN C))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB formally)) (VP (VBN studied))))) (. .))))

det(administration-3, The-1)
amod(administration-3, concomitant-2)
nsubjpass(studied-13, administration-3)
prep_of(administration-3, Exjade-5)
nn(C-8, vitamin-7)
conj_and(Exjade-5, C-8)
aux(studied-13, has-9)
neg(studied-13, not-10)
auxpass(studied-13, been-11)
advmod(studied-13, formally-12)
root(ROOT-0, studied-13)

Doses/NNS of/IN vitamin/NN C/NN up/RB to/TO 200/CD mg/NN were/VBD allowed/VBN in/IN clinical/JJ studies/NNS without/IN negative/JJ consequences/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Doses)) (PP (IN of) (NP (NN vitamin) (NN C)))) (NP (QP (RB up) (TO to) (CD 200)) (NN mg))) (VP (VBD were) (VP (VBN allowed) (PP (IN in) (NP (NP (JJ clinical) (NNS studies)) (PP (IN without) (NP (JJ negative) (NNS consequences)))))))) (. .))))

nsubjpass(allowed-10, Doses-1)
nn(C-4, vitamin-3)
prep_of(Doses-1, C-4)
quantmod(200-7, up-5)
dep(200-7, to-6)
num(mg-8, 200-7)
dep(Doses-1, mg-8)
auxpass(allowed-10, were-9)
root(ROOT-0, allowed-10)
amod(studies-13, clinical-12)
prep_in(allowed-10, studies-13)
amod(consequences-16, negative-15)
prep_without(studies-13, consequences-16)

The/DT interaction/NN of/IN Exjade/NN with/IN hydroxyurea/NN has/VBZ not/RB been/VBN formally/RB studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN interaction)) (PP (IN of) (NP (NN Exjade))) (PP (IN with) (NP (NN hydroxyurea)))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB formally)) (VP (VBN studied))))) (. .))))

det(interaction-2, The-1)
nsubjpass(studied-11, interaction-2)
prep_of(interaction-2, Exjade-4)
prep_with(interaction-2, hydroxyurea-6)
aux(studied-11, has-7)
neg(studied-11, not-8)
auxpass(studied-11, been-9)
advmod(studied-11, formally-10)
root(ROOT-0, studied-11)

No/DT inhibition/NN of/IN deferasirox/NN metabolism/NN by/IN hydroxyurea/NN is/VBZ expected/VBN based/VBN on/IN the/DT results/NNS of/IN an/DT in/FW vitro/FW study/NN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (NN inhibition)) (PP (IN of) (NP (NN deferasirox) (NN metabolism))) (PP (IN by) (NP (NN hydroxyurea)))) (VP (VBZ is) (VP (VBN expected) (PP (VBN based) (PP (IN on) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (DT an) (ADJP (FW in) (FW vitro)) (NN study))))))))) (. .))))

det(inhibition-2, No-1)
nsubjpass(expected-9, inhibition-2)
nn(metabolism-5, deferasirox-4)
prep_of(inhibition-2, metabolism-5)
prep_by(inhibition-2, hydroxyurea-7)
auxpass(expected-9, is-8)
root(ROOT-0, expected-9)
prepc_based_on(expected-9, on-11)
det(results-13, the-12)
pobj(expected-9, results-13)
det(study-18, an-15)
nn(vitro-17, in-16)
amod(study-18, vitro-17)
prep_of(results-13, study-18)

Exjade/NN should/MD not/RB be/VB combined/VBN with/IN other/JJ iron/NN chelator/NN therapies/NNS ,/, as/IN safety/NN of/IN such/JJ combinations/NNS has/VBZ not/RB been/VBN established/VBN ./.

(ROOT (S1 (S (S (NP (NN Exjade)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN combined) (PP (IN with) (NP (JJ other) (NN iron) (NN chelator) (NNS therapies))) (, ,) (SBAR (IN as) (S (NP (NP (NN safety)) (PP (IN of) (NP (JJ such) (NNS combinations)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN established)))))))))) (. .))))

nsubjpass(combined-5, Exjade-1)
aux(combined-5, should-2)
neg(combined-5, not-3)
auxpass(combined-5, be-4)
root(ROOT-0, combined-5)
amod(therapies-10, other-7)
nn(therapies-10, iron-8)
nn(therapies-10, chelator-9)
prep_with(combined-5, therapies-10)
mark(established-20, as-12)
nsubjpass(established-20, safety-13)
amod(combinations-16, such-15)
prep_of(safety-13, combinations-16)
aux(established-20, has-17)
neg(established-20, not-18)
auxpass(established-20, been-19)
advcl(combined-5, established-20)

Drug/NN /Food/NN Interactions/NNS :/: The/DT bioavailability/NN (/-LRB- AUC/NN )/-RRB- of/IN deferasirox/NN was/VBD variably/RB increased/VBN when/WRB taken/VBN with/IN a/DT meal/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Food) (NNS Interactions)) (: :) (S (NP (NP (NP (DT The) (NN bioavailability)) (PRN (-LRB- -LRB-) (NP (NN AUC)) (-RRB- -RRB-))) (PP (IN of) (NP (NN deferasirox)))) (VP (VBD was) (ADVP (RB variably)) (VP (VBN increased)) (SBAR (WHADVP (WRB when)) (S (VP (VBN taken) (PP (IN with) (NP (DT a) (NN meal)))))))) (. .)))))

nn(Interactions-3, Drug-1)
nn(Interactions-3, /Food-2)
root(ROOT-0, Interactions-3)
det(bioavailability-6, The-5)
nsubjpass(increased-14, bioavailability-6)
abbrev(bioavailability-6, AUC-8)
prep_of(bioavailability-6, deferasirox-11)
auxpass(increased-14, was-12)
advmod(increased-14, variably-13)
dep(Interactions-3, increased-14)
advmod(taken-16, when-15)
advcl(increased-14, taken-16)
det(meal-19, a-18)
prep_with(taken-16, meal-19)

Deferasirox/NN should/MD be/VB taken/VBN on/IN an/DT empty/JJ stomach/NN 30/CD minutes/NNS before/IN eating/NN ./.

(ROOT (S1 (S (S (NP (NN Deferasirox)) (VP (MD should) (VP (VB be) (VP (VBN taken) (PP (IN on) (NP (DT an) (JJ empty) (NN stomach))) (PP (NP (CD 30) (NNS minutes)) (IN before) (NP (NN eating))))))) (. .))))

nsubjpass(taken-4, Deferasirox-1)
aux(taken-4, should-2)
auxpass(taken-4, be-3)
root(ROOT-0, taken-4)
det(stomach-8, an-6)
amod(stomach-8, empty-7)
prep_on(taken-4, stomach-8)
num(minutes-10, 30-9)
npadvmod(taken-4, minutes-10)
prep_before(taken-4, eating-12)

Exjade/NN tablets/NNS for/IN oral/JJ suspension/NN can/MD be/VB dispersed/VBN in/IN water/NN ,/, orange/NN juice/NN ,/, or/CC apple/NN juice/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Exjade) (NNS tablets)) (PP (IN for) (NP (JJ oral) (NN suspension)))) (VP (MD can) (VP (VB be) (VP (VBN dispersed) (PP (IN in) (NP (NP (NN water)) (, ,) (NP (NN orange) (NN juice)) (, ,) (CC or) (NP (NN apple) (NN juice)))))))) (. .))))

nn(tablets-2, Exjade-1)
nsubjpass(dispersed-8, tablets-2)
amod(suspension-5, oral-4)
prep_for(tablets-2, suspension-5)
aux(dispersed-8, can-6)
auxpass(dispersed-8, be-7)
root(ROOT-0, dispersed-8)
prep_in(dispersed-8, water-10)
nn(juice-13, orange-12)
conj_or(water-10, juice-13)
nn(juice-17, apple-16)
conj_or(water-10, juice-17)

Antiacid/NN ,/, clarithromycin/NN ,/, Didanosine/NN ,/, Fluconazole/NN ,/, Fluoxetine/NN ,/, Indanavir/NNP ,/, Ketoconazole/NN ,/, Phenytoin/NN ,/, Phenobarbitol/NN ,/, carbamazepine/NN ,/, Rifabutin/NN ,/, Rifampin/NN ,/, Ritanovir/NNP ,/, Saquinavir/NN ./.

(ROOT (S1 (S (NP (NP (NN Antiacid)) (, ,) (NP (NN clarithromycin)) (, ,) (NP (NN Didanosine)) (, ,) (NP (NN Fluconazole)) (, ,) (NP (NN Fluoxetine)) (, ,) (NP (NNP Indanavir) (, ,) (NN Ketoconazole) (, ,) (NN Phenytoin) (, ,) (NN Phenobarbitol) (, ,) (NN carbamazepine) (, ,) (NN Rifabutin) (, ,) (NN Rifampin) (, ,) (NNP Ritanovir)) (, ,) (NP (NN Saquinavir)) (. .)))))

root(ROOT-0, Antiacid-1)
appos(Antiacid-1, clarithromycin-3)
appos(Antiacid-1, Didanosine-5)
appos(Antiacid-1, Fluconazole-7)
appos(Antiacid-1, Fluoxetine-9)
nn(Ritanovir-25, Indanavir-11)
dep(Ritanovir-25, Ketoconazole-13)
dep(Ritanovir-25, Phenytoin-15)
dep(Ritanovir-25, Phenobarbitol-17)
dep(Ritanovir-25, carbamazepine-19)
dep(Ritanovir-25, Rifabutin-21)
dep(Ritanovir-25, Rifampin-23)
appos(Antiacid-1, Ritanovir-25)
appos(Antiacid-1, Saquinavir-27)

Possible/JJ drug/NN interactions/NNS of/IN HUMORSOL/NN with/IN succinylcholine/NN or/CC with/IN other/JJ anticholinesterase/NN agents/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Possible) (NN drug) (NNS interactions)) (PP (IN of) (NP (NN HUMORSOL))) (PP (PP (IN with) (NP (NN succinylcholine))) (CC or) (PP (IN with) (NP (JJ other) (NN anticholinesterase) (NNS agents)))))) (. .))))

amod(interactions-3, Possible-1)
nn(interactions-3, drug-2)
root(ROOT-0, interactions-3)
prep_of(interactions-3, HUMORSOL-5)
prep_with(interactions-3, succinylcholine-7)
amod(agents-12, other-10)
nn(agents-12, anticholinesterase-11)
conj_or(succinylcholine-7, agents-12)

However/RB ,/, in/IN a/DT single/JJ in/FW vivo/FW rodent/JJ study/NN denileukin/NN diftitox/NN had/VBD no/DT effect/NN on/IN P450/NN levels/NNS ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (PP (IN in) (NP (DT a) (JJ single) (ADJP (FW in) (FW vivo)) (JJ rodent) (NN study))) (NP (NN denileukin) (NN diftitox)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NN P450) (NNS levels))))) (. .))))

advmod(had-12, However-1)
det(study-9, a-4)
amod(study-9, single-5)
nn(vivo-7, in-6)
amod(study-9, vivo-7)
amod(study-9, rodent-8)
prep_in(had-12, study-9)
nn(diftitox-11, denileukin-10)
nsubj(had-12, diftitox-11)
root(ROOT-0, had-12)
det(effect-14, no-13)
dobj(had-12, effect-14)
nn(levels-17, P450-16)
prep_on(had-12, levels-17)

Taking/VBG a/DT rauwolfia/NN alkaloid/NN while/IN you/RB are/VBP taking/VBG or/CC within/IN 2/CD weeks/NNS of/IN taking/VBG MAO/NN inhibitors/NNS may/MD increase/VB the/DT risk/NN of/IN central/JJ nervous/JJ system/NN depression/NN or/CC may/MD cause/VB a/DT severe/JJ high/JJ blood/NN pressure/NN reaction/NN ./.

(ROOT (S1 (S (S (VP (VBG Taking) (NP (NP (DT a) (NN rauwolfia) (NN alkaloid)) (SBAR (IN while) (S (ADVP (RB you)) (VP (VBP are) (VP (VBG taking) (PP (CC or) (IN within) (NP (NP (CD 2) (NNS weeks)) (PP (IN of) (NP (VBG taking) (NN MAO) (NNS inhibitors)))))))))))) (VP (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (JJ central) (JJ nervous) (NN system)) (NN depression)))))) (CC or) (VP (MD may) (VP (VB cause) (NP (NP (DT a) (JJ severe) (JJ high) (NN blood) (NN pressure)) (NN reaction))))) (. .))))

csubj(increase-18, Taking-1)
det(alkaloid-4, a-2)
nn(alkaloid-4, rauwolfia-3)
dobj(Taking-1, alkaloid-4)
mark(taking-8, while-5)
advmod(taking-8, you-6)
aux(taking-8, are-7)
dep(alkaloid-4, taking-8)
cc(taking-8, or-9)
num(weeks-12, 2-11)
prep_within(taking-8, weeks-12)
amod(inhibitors-16, taking-14)
nn(inhibitors-16, MAO-15)
prep_of(weeks-12, inhibitors-16)
aux(increase-18, may-17)
root(ROOT-0, increase-18)
det(risk-20, the-19)
dobj(increase-18, risk-20)
amod(system-24, central-22)
amod(system-24, nervous-23)
nn(depression-25, system-24)
prep_of(risk-20, depression-25)
aux(cause-28, may-27)
conj_or(increase-18, cause-28)
det(pressure-33, a-29)
amod(pressure-33, severe-30)
amod(pressure-33, high-31)
nn(pressure-33, blood-32)
nn(reaction-34, pressure-33)
dobj(cause-28, reaction-34)

No/DT clinically/RB significant/JJ adverse/JJ interactions/NNS with/IN commonly/RB used/VBN preanesthetic/JJ drugs/NNS ,/, or/CC drugs/NNS used/VBN during/IN anesthesia/NN (/-LRB- muscle/NN relaxants/NNS ,/, intravenous/JJ agents/NNS ,/, and/CC local/JJ anesthetic/JJ agents/NNS )/-RRB- were/VBD reported/VBN in/IN clinical/JJ trials/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT No) (ADJP (RB clinically) (JJ significant)) (JJ adverse) (NNS interactions)) (PP (IN with) (NP (NP (ADJP (RB commonly) (VBN used)) (JJ preanesthetic) (NNS drugs)) (, ,) (CC or) (NP (NP (NP (NNS drugs)) (VP (VBN used) (PP (IN during) (NP (NN anesthesia))))) (PRN (-LRB- -LRB-) (NP (NP (NN muscle) (NNS relaxants)) (, ,) (NP (JJ intravenous) (NNS agents)) (, ,) (CC and) (NP (JJ local) (JJ anesthetic) (NNS agents))) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN reported) (PP (IN in) (NP (JJ clinical) (NNS trials)))))) (. .))))

det(interactions-5, No-1)
advmod(significant-3, clinically-2)
amod(interactions-5, significant-3)
amod(interactions-5, adverse-4)
nsubjpass(reported-30, interactions-5)
advmod(used-8, commonly-7)
amod(drugs-10, used-8)
amod(drugs-10, preanesthetic-9)
prep_with(interactions-5, drugs-10)
conj_or(drugs-10, drugs-13)
partmod(drugs-13, used-14)
prep_during(used-14, anesthesia-16)
nn(relaxants-19, muscle-18)
dep(drugs-13, relaxants-19)
amod(agents-22, intravenous-21)
conj_and(relaxants-19, agents-22)
amod(agents-27, local-25)
amod(agents-27, anesthetic-26)
conj_and(relaxants-19, agents-27)
auxpass(reported-30, were-29)
root(ROOT-0, reported-30)
amod(trials-33, clinical-32)
prep_in(reported-30, trials-33)

The/DT effect/NN of/IN desflurane/NN on/IN the/DT disposition/NN of/IN other/JJ drugs/NNS has/VBZ not/RB been/VBN determined/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN desflurane))) (PP (IN on) (NP (NP (DT the) (NN disposition)) (PP (IN of) (NP (JJ other) (NNS drugs)))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN determined))))) (. .))))

det(effect-2, The-1)
nsubjpass(determined-14, effect-2)
prep_of(effect-2, desflurane-4)
det(disposition-7, the-6)
prep_on(effect-2, disposition-7)
amod(drugs-10, other-9)
prep_of(disposition-7, drugs-10)
aux(determined-14, has-11)
neg(determined-14, not-12)
auxpass(determined-14, been-13)
root(ROOT-0, determined-14)

Like/IN isoflurane/NN ,/, desflurane/NN does/VBZ not/RB predispose/VB to/TO premature/JJ ventricular/JJ arrhythmias/NNS in/IN the/DT presence/NN of/IN exogenously/RB infused/VBN epinephrine/NN in/IN swine/NN ./.

(ROOT (S1 (S (S (PP (IN Like) (NP (NN isoflurane))) (, ,) (NP (NN desflurane)) (VP (VBZ does) (RB not) (VP (VB predispose) (PP (TO to) (NP (JJ premature) (JJ ventricular) (NNS arrhythmias))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (ADJP (RB exogenously) (VBN infused)) (NN epinephrine))) (PP (IN in) (NP (NN swine)))))))) (. .))))

prep_like(predispose-7, isoflurane-2)
nsubj(predispose-7, desflurane-4)
aux(predispose-7, does-5)
neg(predispose-7, not-6)
root(ROOT-0, predispose-7)
amod(arrhythmias-11, premature-9)
amod(arrhythmias-11, ventricular-10)
prep_to(predispose-7, arrhythmias-11)
det(presence-14, the-13)
prep_in(predispose-7, presence-14)
advmod(infused-17, exogenously-16)
amod(epinephrine-18, infused-17)
prep_of(presence-14, epinephrine-18)
prep_in(presence-14, swine-20)

In/IN two/CD controlled/JJ crossover/NN clinical/JJ pharmacology/NN studies/NNS in/IN healthy/JJ male/JJ (/-LRB- n=12/NN in/IN each/DT study/NN )/-RRB- a/DT nd/JJ female/NN (/-LRB- n=12/NN in/IN each/DT study/NN )/-RRB- volunteers/NNS ,/, desloratadine/NN 7/CD .5/NN mg/NN (/-LRB- 1.5/CD times/NNS the/DT daily/JJ dose/NN )/-RRB- once/RB daily/RB was/VBD coadministered/VBN with/IN erythromycin/NN 500/CD mg/NN every/DT 8/CD hours/NNS or/CC ketoconazole/NN 200/CD mg/NN every/DT 12/CD hours/NNS for/IN 10/CD days/NNS ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (CD two) (JJ controlled) (NN crossover) (JJ clinical) (NN pharmacology) (NNS studies)) (PP (IN in) (NP (ADJP (ADJP (JJ healthy)) (ADJP (JJ male) (PRN (-LRB- -LRB-) (NP (NP (NN n=12)) (PP (IN in) (NP (DT each) (NN study)))) (-RRB- -RRB-)))) (NP (NP (DT a) (JJ nd) (NN female)) (PRN (-LRB- -LRB-) (NP (NN n=12)) (PP (IN in) (NP (DT each) (NN study))) (-RRB- -RRB-))) (NNS volunteers))))) (, ,) (NP (NP (NP (NN desloratadine) (CD 7) (NN .5) (NN mg)) (PRN (-LRB- -LRB-) (NP (NP (CD 1.5) (NNS times)) (NP (DT the) (JJ daily) (NN dose))) (-RRB- -RRB-))) (ADVP (RB once) (RB daily))) (VP (VBD was) (VP (VBN coadministered) (PP (IN with) (NP (NP (NP (NN erythromycin) (CD 500) (NN mg)) (NP (DT every) (CD 8) (NNS hours))) (CC or) (NP (NP (NP (NN ketoconazole) (CD 200) (NN mg)) (NP (DT every) (CD 12) (NNS hours))) (PP (IN for) (NP (CD 10) (NNS days)))))))) (. .))))

num(studies-7, two-2)
amod(studies-7, controlled-3)
nn(studies-7, crossover-4)
amod(studies-7, clinical-5)
nn(studies-7, pharmacology-6)
prep_in(coadministered-42, studies-7)
amod(volunteers-26, healthy-9)
dep(healthy-9, male-10)
dep(male-10, n=12-12)
det(study-15, each-14)
prep_in(n=12-12, study-15)
det(female-19, a-17)
amod(female-19, nd-18)
nn(volunteers-26, female-19)
dep(female-19, n=12-21)
dep(n=12-21, in-22)
det(study-24, each-23)
pobj(in-22, study-24)
prep_in(studies-7, volunteers-26)
nn(mg-31, desloratadine-28)
num(mg-31, 7-29)
nn(mg-31, .5-30)
nsubjpass(coadministered-42, mg-31)
num(times-34, 1.5-33)
dep(mg-31, times-34)
det(dose-37, the-35)
amod(dose-37, daily-36)
dep(times-34, dose-37)
advmod(daily-40, once-39)
advmod(mg-31, daily-40)
auxpass(coadministered-42, was-41)
root(ROOT-0, coadministered-42)
nn(mg-46, erythromycin-44)
num(mg-46, 500-45)
prep_with(coadministered-42, mg-46)
det(hours-49, every-47)
num(hours-49, 8-48)
dep(mg-46, hours-49)
nn(mg-53, ketoconazole-51)
num(mg-53, 200-52)
conj_or(mg-46, mg-53)
det(hours-56, every-54)
num(hours-56, 12-55)
dep(mg-53, hours-56)
num(days-59, 10-58)
prep_for(mg-53, days-59)

In/IN three/CD separate/JJ controlled/JJ ,/, parallel/JJ group/NN clinical/JJ pharmacology/NN studies/NNS ,/, desloratadine/NN at/IN the/DT clinical/JJ dose/NN of/IN 5/CD mg/NN has/VBZ been/VBN coadministered/VBN with/IN azithromycin/NN 500/CD mg/NN followed/VBN by/IN 250/CD mg/NN once/IN daily/JJ for/IN 4/CD days/NNS (/-LRB- n=18/NN )/-RRB- or/CC with/IN fluoxetine/NN 20/CD mg/NN once/RB daily/JJ for/IN 7/CD days/NNS after/IN a/DT 23/CD day/NN pretreatment/NN period/NN with/IN fluoxetine/NN (/-LRB- n=18/CD )/-RRB- or/CC with/IN cimetidine/NN 600/CD mg/NN every/DT 12/CD hours/NNS for/IN 14/CD days/NNS (/-LRB- n=18/CD )/-RRB- under/IN steady/JJ state/NN conditions/NNS to/TO normal/JJ healthy/JJ male/JJ and/CC female/JJ volunteers/NNS ./.

(ROOT (S1 (S (PP (IN In) (NP (CD three) (JJ separate) (JJ controlled) (, ,) (JJ parallel) (NN group) (JJ clinical) (NN pharmacology) (NNS studies))) (, ,) (NP (NP (NN desloratadine)) (PP (IN at) (NP (NP (DT the) (JJ clinical) (NN dose)) (PP (IN of) (NP (CD 5) (NN mg)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN coadministered) (PP (PP (IN with) (NP (NP (NN azithromycin) (CD 500) (NN mg)) (VP (VBN followed) (PP (IN by) (NP (NP (CD 250) (NN mg)) (PP (IN once) (NP (ADJP (JJ daily) (PP (IN for) (NP (NP (CD 4) (NNS days)) (PRN (-LRB- -LRB-) (NP (NN n=18)) (-RRB- -RRB-)))))))))))) (CC or) (PP (IN with) (NP (NP (NN fluoxetine) (CD 20) (NN mg)) (ADJP (RB once) (JJ daily) (PP (IN for) (NP (NP (CD 7) (NNS days)) (PP (PP (IN after) (NP (NP (DT a) (ADJP (CD 23) (NN day)) (NN pretreatment) (NN period)) (PP (IN with) (NP (NN fluoxetine) (-LRB- -LRB-) (CD n=18) (-RRB- -RRB-))))) (CC or) (PP (IN with) (NP (NP (NP (NN cimetidine) (CD 600) (NN mg)) (NP (DT every) (CD 12) (NNS hours))) (PP (IN for) (NP (NP (CD 14) (NNS days)) (PRN (-LRB- -LRB-) (NP (CD n=18)) (-RRB- -RRB-)))))) (PP (IN under) (NP (NP (JJ steady) (NN state) (NNS conditions)) (PP (TO to) (NP (JJ normal) (JJ healthy) (ADJP (ADJP (JJ male)) (CC and) (ADJP (JJ female))) (NNS volunteers))))))))))))))) (. .))))

num(studies-10, three-2)
amod(studies-10, separate-3)
amod(studies-10, controlled-4)
amod(studies-10, parallel-6)
nn(studies-10, group-7)
amod(studies-10, clinical-8)
nn(studies-10, pharmacology-9)
prep_in(coadministered-22, studies-10)
nsubjpass(coadministered-22, desloratadine-12)
det(dose-16, the-14)
amod(dose-16, clinical-15)
prep_at(desloratadine-12, dose-16)
num(mg-19, 5-18)
prep_of(dose-16, mg-19)
aux(coadministered-22, has-20)
auxpass(coadministered-22, been-21)
root(ROOT-0, coadministered-22)
nn(mg-26, azithromycin-24)
num(mg-26, 500-25)
prep_with(coadministered-22, mg-26)
partmod(mg-26, followed-27)
num(mg-30, 250-29)
agent(followed-27, mg-30)
prep_once(mg-30, daily-32)
num(days-35, 4-34)
prep_for(daily-32, days-35)
appos(days-35, n=18-37)
nn(mg-43, fluoxetine-41)
num(mg-43, 20-42)
conj_or(mg-26, mg-43)
advmod(daily-45, once-44)
amod(mg-43, daily-45)
num(days-48, 7-47)
prep_for(daily-45, days-48)
conj_or(days-48, days-48')
det(period-54, a-50)
number(day-52, 23-51)
amod(period-54, day-52)
nn(period-54, pretreatment-53)
prep_after(days-48, period-54)
prep_with(period-54, fluoxetine-56)
num(fluoxetine-56, n=18-58)
nn(mg-64, cimetidine-62)
num(mg-64, 600-63)
prep_with(days-48', mg-64)
det(hours-67, every-65)
num(hours-67, 12-66)
dep(mg-64, hours-67)
num(days-70, 14-69)
prep_for(mg-64, days-70)
appos(days-70, n=18-72)
amod(conditions-77, steady-75)
nn(conditions-77, state-76)
prep_under(days-48, conditions-77)
amod(volunteers-84, normal-79)
amod(volunteers-84, healthy-80)
amod(volunteers-84, male-81)
conj_and(male-81, female-83)
prep_to(conditions-77, volunteers-84)

Although/IN increased/VBN plasma/NN concentrations/NNS (/-LRB- C/NN max/NN and/CC AUC/NN 0-24/CD hrs/NNS )/-RRB- of/IN desloratadine/NN and/CC 3-hydroxydesloratadine/NN were/VBD observed/VBN ,/, there/EX were/VBD no/DT clinically/RB relevant/JJ changes/NNS in/IN the/DT safety/NN profile/NN of/IN desloratadine/NN ,/, as/IN assessed/VBN by/IN electrocardiographic/JJ parameters/NNS (/-LRB- including/VBG the/DT corrected/JJ QT/JJ interval/NN )/-RRB- ,/, clinical/JJ laboratory/NN tests/NNS ,/, vital/JJ signs/NNS ,/, and/CC adverse/JJ events/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NP (NP (VBN increased) (NN plasma) (NNS concentrations)) (PRN (-LRB- -LRB-) (NP (NN C) (NN max) (CC and) (NN AUC) (CD 0-24) (NNS hrs)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN desloratadine)) (CC and) (NP (NN 3-hydroxydesloratadine))))) (VP (VBD were) (VP (VBN observed))))) (, ,) (NP (EX there)) (VP (VBD were) (NP (DT no) (ADJP (RB clinically) (JJ relevant)) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN safety) (NN profile)) (PP (IN of) (NP (NN desloratadine))))) (, ,) (SBAR (IN as) (S (VP (VBN assessed) (PP (IN by) (NP (NP (NP (JJ electrocardiographic) (NNS parameters)) (PRN (-LRB- -LRB-) (VP (VBG including) (NP (DT the) (JJ corrected) (JJ QT) (NN interval))) (-RRB- -RRB-))) (, ,) (NP (JJ clinical) (NN laboratory) (NNS tests)) (, ,) (NP (JJ vital) (NNS signs)) (, ,) (CC and) (NP (JJ adverse) (NNS events))))))))) (. .))))

mark(observed-18, Although-1)
amod(concentrations-4, increased-2)
nn(concentrations-4, plasma-3)
nsubjpass(observed-18, concentrations-4)
nn(max-7, C-6)
dep(concentrations-4, max-7)
nn(hrs-11, AUC-9)
num(hrs-11, 0-24-10)
conj_and(max-7, hrs-11)
prep_of(concentrations-4, desloratadine-14)
conj_and(desloratadine-14, 3-hydroxydesloratadine-16)
auxpass(observed-18, were-17)
advcl(were-21, observed-18)
expl(were-21, there-20)
root(ROOT-0, were-21)
det(changes-25, no-22)
advmod(relevant-24, clinically-23)
amod(changes-25, relevant-24)
nsubj(were-21, changes-25)
det(profile-29, the-27)
nn(profile-29, safety-28)
prep_in(were-21, profile-29)
prep_of(profile-29, desloratadine-31)
mark(assessed-34, as-33)
advcl(were-21, assessed-34)
amod(parameters-37, electrocardiographic-36)
prep_by(assessed-34, parameters-37)
dep(parameters-37, including-39)
det(interval-43, the-40)
amod(interval-43, corrected-41)
amod(interval-43, QT-42)
dobj(including-39, interval-43)
amod(tests-48, clinical-46)
nn(tests-48, laboratory-47)
conj_and(parameters-37, tests-48)
amod(signs-51, vital-50)
conj_and(parameters-37, signs-51)
amod(events-55, adverse-54)
conj_and(parameters-37, events-55)

Table/NN 1/CD Changes/VBZ in/IN Desloratadine/NN and/CC 3-Hydroxydesloratadine/NN Pharmacokinetics/NNS in/IN Healthy/JJ Male/JJ and/CC Female/JJ Volunteers/NNS ./.

(ROOT (S1 (S (S (NP (NN Table) (CD 1)) (VP (VBZ Changes) (PP (IN in) (NP (NP (NP (NN Desloratadine)) (CC and) (NP (NN 3-Hydroxydesloratadine) (NNS Pharmacokinetics))) (PP (IN in) (NP (JJ Healthy) (ADJP (ADJP (JJ Male)) (CC and) (ADJP (JJ Female))) (NNS Volunteers))))))) (. .))))

nsubj(Changes-3, Table-1)
num(Table-1, 1-2)
root(ROOT-0, Changes-3)
prep_in(Changes-3, Desloratadine-5)
nn(Pharmacokinetics-8, 3-Hydroxydesloratadine-7)
conj_and(Desloratadine-5, Pharmacokinetics-8)
amod(Volunteers-14, Healthy-10)
amod(Volunteers-14, Male-11)
conj_and(Male-11, Female-13)
prep_in(Desloratadine-5, Volunteers-14)

Desloratadine/NN 3-Hydroxydesloratadine/NN ./.

(ROOT (S1 (S (NP (NP (NN Desloratadine) (NN 3-Hydroxydesloratadine)) (. .)))))

nn(3-Hydroxydesloratadine-2, Desloratadine-1)
root(ROOT-0, 3-Hydroxydesloratadine-2)

Erythromycin/NN ./.

(ROOT (S1 (S (NP (NP (NN Erythromycin)) (. .)))))

root(ROOT-0, Erythromycin-1)

Ketoconazole/NN ./.

(ROOT (S1 (S (NP (NP (NN Ketoconazole)) (. .)))))

root(ROOT-0, Ketoconazole-1)

Azithromycin/NN ./.

(ROOT (S1 (S (NP (NP (NN Azithromycin)) (. .)))))

root(ROOT-0, Azithromycin-1)

(/-LRB- 500/CD mg/NN day/NN 1/CD ,/, 250/CD mg/NN QD/NN @/NN 4/CD days/NNS )/-RRB- ./.

(ROOT (S1 (S (S (PRN (-LRB- -LRB-) (NP (CD 500) (NN mg) (NN day) (CD 1)) (, ,) (NP (ADJP (CD 250) (NN mg)) (NN QD) (NN @) (CD 4) (NNS days)) (-RRB- -RRB-))) (. .))))

num(day-4, 500-2)
nn(day-4, mg-3)
root(ROOT-0, day-4)
num(day-4, 1-5)
number(mg-8, 250-7)
amod(days-12, mg-8)
nn(days-12, QD-9)
nn(days-12, @-10)
num(days-12, 4-11)
dep(day-4, days-12)

Fluoxetine/NN ./.

(ROOT (S1 (S (NP (NP (NN Fluoxetine)) (. .)))))

root(ROOT-0, Fluoxetine-1)

Cimetidine/NN ./.

(ROOT (S1 (S (NP (NP (NN Cimetidine)) (. .)))))

root(ROOT-0, Cimetidine-1)

Although/IN the/DT pressor/JJ activity/NN of/IN Desmopressin/NN is/VBZ very/RB low/JJ compared/VBN to/TO its/PRP$ antidiuretic/JJ activity/NN ,/, large/JJ doses/NNS of/IN Desmopressin/NN Tablets/NNS should/MD be/VB used/VBN with/IN other/JJ pressor/JJ agents/NNS only/RB with/IN careful/JJ patient/NN monitoring/NN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NP (DT the) (JJ pressor) (NN activity)) (PP (IN of) (NP (NN Desmopressin)))) (VP (VBZ is) (ADJP (RB very) (JJ low) (PP (VBN compared) (PP (TO to) (NP (PRP$ its) (JJ antidiuretic) (NN activity)))))))) (, ,) (NP (NP (JJ large) (NNS doses)) (PP (IN of) (NP (NN Desmopressin) (NNS Tablets)))) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NP (JJ other) (JJ pressor) (NNS agents)) (PP (ADVP (RB only)) (IN with) (NP (JJ careful) (NN patient) (NN monitoring))))))))) (. .))))

mark(low-9, Although-1)
det(activity-4, the-2)
amod(activity-4, pressor-3)
nsubj(low-9, activity-4)
prep_of(activity-4, Desmopressin-6)
cop(low-9, is-7)
advmod(low-9, very-8)
advcl(used-23, low-9)
prepc_compared_to(low-9, to-11)
poss(activity-14, its-12)
amod(activity-14, antidiuretic-13)
pobj(low-9, activity-14)
amod(doses-17, large-16)
nsubjpass(used-23, doses-17)
nn(Tablets-20, Desmopressin-19)
prep_of(doses-17, Tablets-20)
aux(used-23, should-21)
auxpass(used-23, be-22)
root(ROOT-0, used-23)
amod(agents-27, other-25)
amod(agents-27, pressor-26)
prep_with(used-23, agents-27)
advmod(agents-27, only-28)
amod(monitoring-32, careful-30)
nn(monitoring-32, patient-31)
prep_with(agents-27, monitoring-32)

Reduced/VBN efficacy/NN and/CC increased/VBN incidence/NN of/IN breakthrough/JJ bleeding/JJ and/CC menstrual/JJ irregularities/NNS have/VBP been/VBN associated/VBN with/IN concomitant/JJ use/NN of/IN rifampin/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (VBN Reduced) (NN efficacy)) (CC and) (NP (VBN increased) (NN incidence))) (PP (IN of) (NP (JJ breakthrough) (JJ bleeding)))) (CC and) (NP (JJ menstrual) (NNS irregularities))) (VP (VBP have) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NN rifampin))))))))) (. .))))

amod(efficacy-2, Reduced-1)
nsubjpass(associated-14, efficacy-2)
amod(incidence-5, increased-4)
conj_and(efficacy-2, incidence-5)
amod(bleeding-8, breakthrough-7)
prep_of(efficacy-2, bleeding-8)
amod(irregularities-11, menstrual-10)
conj_and(efficacy-2, irregularities-11)
aux(associated-14, have-12)
auxpass(associated-14, been-13)
root(ROOT-0, associated-14)
amod(use-17, concomitant-16)
prep_with(associated-14, use-17)
prep_of(use-17, rifampin-19)

A/DT similar/JJ association/NN ,/, though/RB less/RBR marked/JJ ,/, has/VBZ been/VBN suggested/VBN with/IN barbiturates/NNS ,/, phenyl/NN -butazone/NN ,/, phenytoin/NN sodium/NN ,/, carbamazepine/NN and/CC possibly/RB with/IN griseofulvin/NN ,/, ampicillin/NN ,/, and/CC tetracyclines/NN (/-LRB- 72/CD )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (DT A) (JJ similar) (NN association)) (, ,) (ADJP (RB though) (RBR less) (JJ marked)) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (PP (PP (IN with) (NP (NP (NNS barbiturates)) (, ,) (NP (NN phenyl) (NN -butazone)) (, ,) (NP (NN phenytoin) (NN sodium)) (, ,) (NP (NN carbamazepine)))) (CC and) (ADVP (RB possibly)) (PP (IN with) (NP (NP (NN griseofulvin)) (, ,) (NP (NN ampicillin)) (, ,) (CC and) (NP (NN tetracyclines) (-LRB- -LRB-) (CD 72) (-RRB- -RRB-))))))))) (. .))))

det(association-3, A-1)
amod(association-3, similar-2)
nsubjpass(suggested-11, association-3)
advmod(marked-7, though-5)
advmod(marked-7, less-6)
amod(association-3, marked-7)
aux(suggested-11, has-9)
auxpass(suggested-11, been-10)
root(ROOT-0, suggested-11)
prep_with(suggested-11, barbiturates-13)
nn(-butazone-16, phenyl-15)
appos(barbiturates-13, -butazone-16)
nn(sodium-19, phenytoin-18)
appos(barbiturates-13, sodium-19)
appos(barbiturates-13, carbamazepine-21)
advmod(suggested-11, possibly-23)
conj(suggested-11, possibly-23)
conj_and(barbiturates-13, griseofulvin-25)
conj_and(griseofulvin-25, ampicillin-27)
conj_and(griseofulvin-25, tetracyclines-30)
num(tetracyclines-30, 72-32)

Aminoglutethimide/NN :/: Aminoglutethimide/NN may/MD diminish/VB adrenal/JJ suppression/NN by/IN corticosteroids/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Aminoglutethimide)) (: :) (NP (NN Aminoglutethimide))) (VP (MD may) (VP (VB diminish) (NP (NP (JJ adrenal) (NN suppression)) (PP (IN by) (NP (NNS corticosteroids))))))) (. .))))

nsubj(diminish-5, Aminoglutethimide-1)
dep(Aminoglutethimide-1, Aminoglutethimide-3)
aux(diminish-5, may-4)
root(ROOT-0, diminish-5)
amod(suppression-7, adrenal-6)
dobj(diminish-5, suppression-7)
prep_by(suppression-7, corticosteroids-9)

Amphotericin/NN B/NN injection/NN and/CC potassium/NN -depleting/JJ agents/NNS :/: When/WRB corticosteroids/NNS are/VBP administered/VBN concomitantly/RB with/IN potassium/NN -depleting/NN agents/NNS (/-LRB- e.g./FW ,/, amphotericin/NN B/NN ,/, diuretics/NNS )/-RRB- ,/, patients/NNS should/MD be/VB observed/VBN closely/RB for/IN development/NN of/IN hypokalemia/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN Amphotericin) (NN B)) (NN injection) (CC and) (NN potassium) (JJ -depleting) (NNS agents)) (: :) (S (SBAR (WHADVP (WRB When)) (S (NP (NNS corticosteroids)) (VP (VBP are) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NN potassium) (NN -depleting) (NNS agents)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN amphotericin) (NN B))) (, ,) (NP (NNS diuretics)) (-RRB- -RRB-)))))))) (, ,) (NP (NNS patients)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (PP (IN for) (NP (NP (NN development)) (PP (IN of) (NP (NN hypokalemia))))))))) (. .)))))

nn(B-2, Amphotericin-1)
nn(injection-3, B-2)
root(ROOT-0, injection-3)
nn(agents-7, potassium-5)
amod(agents-7, -depleting-6)
conj_and(injection-3, agents-7)
advmod(administered-12, When-9)
nsubjpass(administered-12, corticosteroids-10)
auxpass(administered-12, are-11)
advcl(observed-30, administered-12)
advmod(administered-12, concomitantly-13)
nn(agents-17, potassium-15)
nn(agents-17, -depleting-16)
prep_with(administered-12, agents-17)
dep(diuretics-24, e.g.-19)
nn(B-22, amphotericin-21)
pobj(e.g.-19, B-22)
appos(agents-17, diuretics-24)
nsubjpass(observed-30, patients-27)
aux(observed-30, should-28)
auxpass(observed-30, be-29)
dep(injection-3, observed-30)
advmod(observed-30, closely-31)
prep_for(observed-30, development-33)
prep_of(development-33, hypokalemia-35)

In/IN addition/NN ,/, there/EX have/VBP been/VBN cases/NNS reported/VBN in/IN which/WDT concomitant/JJ use/NN of/IN amphotericin/NN B/NN and/CC hydrocortisone/NN was/VBD followed/VBN by/IN cardiac/JJ enlargement/NN and/CC congestive/JJ heart/NN failure/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (NNS cases)) (VP (VBN reported)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN amphotericin) (NN B)) (CC and) (NP (NN hydrocortisone))))) (VP (VBD was) (VP (VBN followed) (PP (IN by) (NP (NP (JJ cardiac) (NN enlargement)) (CC and) (NP (JJ congestive) (NN heart) (NN failure)))))))))))) (. .))))

prep_in(cases-7, addition-2)
expl(cases-7, there-4)
aux(cases-7, have-5)
cop(cases-7, been-6)
root(ROOT-0, cases-7)
partmod(cases-7, reported-8)
rel(followed-19, which-10)
amod(use-12, concomitant-11)
nsubjpass(followed-19, use-12)
nn(B-15, amphotericin-14)
prep_of(use-12, B-15)
conj_and(B-15, hydrocortisone-17)
auxpass(followed-19, was-18)
rcmod(cases-7, followed-19)
amod(enlargement-22, cardiac-21)
agent(followed-19, enlargement-22)
amod(failure-26, congestive-24)
nn(failure-26, heart-25)
conj_and(enlargement-22, failure-26)

Antibiotics/NNS :/: Macrolide/NN antibiotics/NNS have/VBP been/VBN reported/VBN to/TO cause/VB a/DT significant/JJ decrease/NN in/IN corticosteroid/NN clearance/NN ./.

(ROOT (S1 (S (NP (NP (NNS Antibiotics)) (: :) (S (NP (NN Macrolide) (NNS antibiotics)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB cause) (NP (NP (DT a) (JJ significant) (NN decrease)) (PP (IN in) (NP (NN corticosteroid) (NN clearance))))))))))) (. .)))))

root(ROOT-0, Antibiotics-1)
nn(antibiotics-4, Macrolide-3)
nsubjpass(reported-7, antibiotics-4)
xsubj(cause-9, antibiotics-4)
aux(reported-7, have-5)
auxpass(reported-7, been-6)
dep(Antibiotics-1, reported-7)
aux(cause-9, to-8)
xcomp(reported-7, cause-9)
det(decrease-12, a-10)
amod(decrease-12, significant-11)
dobj(cause-9, decrease-12)
nn(clearance-15, corticosteroid-14)
prep_in(decrease-12, clearance-15)

Anticholinesterases/NNS :/: Concomitant/JJ use/NN of/IN anticholinesterase/NN agents/NNS and/CC corticosteroids/NNS may/MD produce/VB severe/JJ weakness/NN in/IN patients/NNS with/IN myasthenia/JJ gravis/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Anticholinesterases)) (: :) (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (NN anticholinesterase) (NNS agents)) (CC and) (NP (NNS corticosteroids))))) (VP (MD may) (VP (VB produce) (NP (NP (JJ severe) (NN weakness)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ myasthenia) (NNS gravis))))))))) (. .)))))

root(ROOT-0, Anticholinesterases-1)
amod(use-4, Concomitant-3)
nsubj(produce-11, use-4)
nn(agents-7, anticholinesterase-6)
prep_of(use-4, agents-7)
conj_and(agents-7, corticosteroids-9)
aux(produce-11, may-10)
dep(Anticholinesterases-1, produce-11)
amod(weakness-13, severe-12)
dobj(produce-11, weakness-13)
prep_in(weakness-13, patients-15)
amod(gravis-18, myasthenia-17)
prep_with(patients-15, gravis-18)

If/IN possible/JJ ,/, anticholinesterase/NN agents/NNS should/MD be/VB withdrawn/VBN at/IN least/JJS 24/CD hours/NNS before/IN initiating/VBG corticosteroid/NN therapy/NN ./.

(ROOT (S1 (S (S (SBAR (IN If) (FRAG (JJ possible))) (, ,) (NP (NN anticholinesterase) (NNS agents)) (VP (MD should) (VP (VB be) (VP (VBN withdrawn) (PP (IN at) (NP (QP (JJS least) (CD 24)) (NNS hours))) (PP (IN before) (S (VP (VBG initiating) (NP (NN corticosteroid) (NN therapy))))))))) (. .))))

mark(possible-2, If-1)
advcl(withdrawn-8, possible-2)
nn(agents-5, anticholinesterase-4)
nsubjpass(withdrawn-8, agents-5)
aux(withdrawn-8, should-6)
auxpass(withdrawn-8, be-7)
root(ROOT-0, withdrawn-8)
quantmod(24-11, least-10)
num(hours-12, 24-11)
prep_at(withdrawn-8, hours-12)
prepc_before(withdrawn-8, initiating-14)
nn(therapy-16, corticosteroid-15)
dobj(initiating-14, therapy-16)

Anticoagulants/NNS ,/, oral/JJ :/: Co-administration/NN of/IN corticosteroids/NNS and/CC warfarin/NN usually/RB results/VBZ in/IN inhibition/NN of/IN response/NN to/TO warfarin/NN ,/, although/IN there/EX have/VBP been/VBN some/DT conflicting/VBG reports/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NNS Anticoagulants)) (, ,) (NP (JJ oral))) (: :) (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NP (NNS corticosteroids)) (CC and) (NP (NN warfarin))))) (ADVP (RB usually)) (VP (VBZ results) (PP (IN in) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (NN response)) (PP (TO to) (NP (NN warfarin))))))) (, ,) (SBAR (IN although) (S (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (DT some) (VBG conflicting) (NNS reports)))))))) (. .)))))

root(ROOT-0, Anticoagulants-1)
appos(Anticoagulants-1, oral-3)
nsubj(results-11, Co-administration-5)
prep_of(Co-administration-5, corticosteroids-7)
conj_and(corticosteroids-7, warfarin-9)
advmod(results-11, usually-10)
dep(Anticoagulants-1, results-11)
prep_in(results-11, inhibition-13)
prep_of(inhibition-13, response-15)
prep_to(response-15, warfarin-17)
mark(reports-25, although-19)
expl(reports-25, there-20)
aux(reports-25, have-21)
cop(reports-25, been-22)
det(reports-25, some-23)
amod(reports-25, conflicting-24)
advcl(results-11, reports-25)

Antidiabetics/NNS :/: Because/IN corticosteroids/NNS may/MD increase/VB blood/NN glucose/NN concentrations/NNS ,/, dosage/JJ adjustments/NNS of/IN antidiabetic/JJ agents/NNS may/MD be/VB required/VBN ./.

(ROOT (S1 (S (NP (NP (NNS Antidiabetics)) (: :) (S (SBAR (IN Because) (S (NP (NNS corticosteroids)) (VP (MD may) (VP (VB increase) (NP (NN blood) (NN glucose) (NNS concentrations)))))) (, ,) (NP (NP (JJ dosage) (NNS adjustments)) (PP (IN of) (NP (JJ antidiabetic) (NNS agents)))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (. .)))))

root(ROOT-0, Antidiabetics-1)
mark(increase-6, Because-3)
nsubj(increase-6, corticosteroids-4)
aux(increase-6, may-5)
advcl(required-18, increase-6)
nn(concentrations-9, blood-7)
nn(concentrations-9, glucose-8)
dobj(increase-6, concentrations-9)
amod(adjustments-12, dosage-11)
nsubjpass(required-18, adjustments-12)
amod(agents-15, antidiabetic-14)
prep_of(adjustments-12, agents-15)
aux(required-18, may-16)
auxpass(required-18, be-17)
dep(Antidiabetics-1, required-18)

Antitubercular/JJ drugs/NNS :/: Serum/NN concentrations/NNS of/IN isoniazid/NN may/MD be/VB decreased/VBN ./.

(ROOT (S1 (S (NP (NP (JJ Antitubercular) (NNS drugs)) (: :) (S (NP (NP (NN Serum) (NNS concentrations)) (PP (IN of) (NP (NN isoniazid)))) (VP (MD may) (VP (VB be) (VP (VBN decreased))))) (. .)))))

amod(drugs-2, Antitubercular-1)
root(ROOT-0, drugs-2)
nn(concentrations-5, Serum-4)
nsubjpass(decreased-10, concentrations-5)
prep_of(concentrations-5, isoniazid-7)
aux(decreased-10, may-8)
auxpass(decreased-10, be-9)
dep(drugs-2, decreased-10)

Cholestyramine/NN :/: Cholestyramine/NN may/MD increase/VB the/DT clearance/NN of/IN corticosteroids/NNS ./.

(ROOT (S1 (S (S (NP (NN Cholestyramine) (: :) (NN Cholestyramine)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NNS corticosteroids))))))) (. .))))

nn(Cholestyramine-3, Cholestyramine-1)
nsubj(increase-5, Cholestyramine-3)
aux(increase-5, may-4)
root(ROOT-0, increase-5)
det(clearance-7, the-6)
dobj(increase-5, clearance-7)
prep_of(clearance-7, corticosteroids-9)

Cyclosporine/NN :/: Increased/VBN activity/NN of/IN both/CC cyclosporine/NN and/CC corticosteroids/NNS may/MD occur/VB when/WRB the/DT two/CD are/VBP used/VBN concurrently/RB ./.

(ROOT (S1 (S (NP (NP (NN Cyclosporine)) (: :) (S (NP (NP (VBN Increased) (NN activity)) (PP (IN of) (NP (CC both) (NP (NN cyclosporine)) (CC and) (NP (NNS corticosteroids))))) (VP (MD may) (VP (VB occur) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (CD two)) (VP (VBP are) (VP (VBN used) (ADVP (RB concurrently))))))))) (. .)))))

root(ROOT-0, Cyclosporine-1)
amod(activity-4, Increased-3)
nsubj(occur-11, activity-4)
preconj(cyclosporine-7, both-6)
prep_of(activity-4, cyclosporine-7)
conj_and(cyclosporine-7, corticosteroids-9)
aux(occur-11, may-10)
dep(Cyclosporine-1, occur-11)
advmod(used-16, when-12)
det(two-14, the-13)
nsubjpass(used-16, two-14)
auxpass(used-16, are-15)
advcl(occur-11, used-16)
advmod(used-16, concurrently-17)

Dexamethasone/NN suppression/NN test/NN (/-LRB- DST/NN )/-RRB- :/: False-negative/JJ results/NNS in/IN the/DT dexamethasone/NN suppression/NN test/NN (/-LRB- DST/NN )/-RRB- in/IN patients/NNS being/VBG treated/VBN with/IN indomethacin/NN have/VBP been/VBN reported/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (NN Dexamethasone) (NN suppression) (NN test)) (PRN (-LRB- -LRB-) (NP (NN DST)) (-RRB- -RRB-))) (: :) (JJ False-negative) (NNS results)) (PP (IN in) (NP (NP (NP (DT the) (NN dexamethasone) (NN suppression) (NN test)) (PRN (-LRB- -LRB-) (NP (NN DST)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NN indomethacin)))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported))))) (. .))))

nn(test-3, Dexamethasone-1)
nn(test-3, suppression-2)
nn(results-9, test-3)
abbrev(test-3, DST-5)
amod(results-9, False-negative-8)
nsubjpass(reported-26, results-9)
det(test-14, the-11)
nn(test-14, dexamethasone-12)
nn(test-14, suppression-13)
prep_in(results-9, test-14)
abbrev(test-14, DST-16)
prep_in(test-14, patients-19)
auxpass(treated-21, being-20)
partmod(patients-19, treated-21)
prep_with(treated-21, indomethacin-23)
aux(reported-26, have-24)
auxpass(reported-26, been-25)
root(ROOT-0, reported-26)

Digitalis/NN glycosides/NNS :/: Patients/NNS on/IN digitalis/NN glycosides/NNS may/MD be/VB at/IN increased/VBN risk/NN of/IN arrhythmias/NN due/IN to/TO hypokalemia/NN ./.

(ROOT (S1 (S (NP (NP (NN Digitalis) (NNS glycosides)) (: :) (S (NP (NP (NNS Patients)) (PP (IN on) (NP (NN digitalis) (NNS glycosides)))) (VP (MD may) (VP (VB be) (PP (IN at) (NP (NP (VBN increased) (NN risk)) (PP (IN of) (NP (NN arrhythmias))) (PP (IN due) (TO to) (NP (NN hypokalemia)))))))) (. .)))))

nn(glycosides-2, Digitalis-1)
root(ROOT-0, glycosides-2)
nsubj(be-9, Patients-4)
nn(glycosides-7, digitalis-6)
prep_on(Patients-4, glycosides-7)
aux(be-9, may-8)
dep(glycosides-2, be-9)
amod(risk-12, increased-11)
prep_at(be-9, risk-12)
prep_of(risk-12, arrhythmias-14)
prep_due_to(risk-12, hypokalemia-17)

Ephedrine/NN :/: Ephedrine/NN may/MD enhance/VB the/DT metabolic/JJ clearance/NN of/IN corticosteroids/NNS ,/, resulting/VBG in/IN decreased/VBN blood/NN levels/NNS and/CC lessened/JJ physiologic/JJ activity/NN ,/, thus/RB requiring/VBG an/DT increase/NN in/IN corticosteroid/NN dosage/NN ./.

(ROOT (S1 (S (NP (NP (NN Ephedrine)) (: :) (S (NP (NN Ephedrine)) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (JJ metabolic) (NN clearance)) (PP (IN of) (NP (NNS corticosteroids)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (VBN decreased) (NN blood) (NNS levels)) (CC and) (NP (JJ lessened) (JJ physiologic) (NN activity)))))) (, ,) (S (ADVP (RB thus)) (VP (VBG requiring) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN corticosteroid) (NN dosage))))))))) (. .)))))

root(ROOT-0, Ephedrine-1)
nsubj(enhance-5, Ephedrine-3)
aux(enhance-5, may-4)
dep(Ephedrine-1, enhance-5)
det(clearance-8, the-6)
amod(clearance-8, metabolic-7)
dobj(enhance-5, clearance-8)
prep_of(clearance-8, corticosteroids-10)
partmod(enhance-5, resulting-12)
xcomp(enhance-5, resulting-12)
amod(levels-16, decreased-14)
nn(levels-16, blood-15)
prep_in(resulting-12, levels-16)
amod(activity-20, lessened-18)
amod(activity-20, physiologic-19)
conj_and(levels-16, activity-20)
advmod(requiring-23, thus-22)
xcomp(enhance-5, requiring-23)
det(increase-25, an-24)
dobj(requiring-23, increase-25)
nn(dosage-28, corticosteroid-27)
prep_in(increase-25, dosage-28)

Estrogens/NNS ,/, including/VBG oral/JJ contraceptives/NNS :/: Estrogens/NNS may/MD decrease/VB the/DT hepatic/JJ metabolism/NN of/IN certain/JJ corticosteroids/NNS ,/, thereby/RB increasing/VBG their/PRP$ effect/NN ./.

(ROOT (S1 (S (S (S (NP (NNS Estrogens)) (, ,) (VP (VBG including) (NP (JJ oral) (NNS contraceptives)))) (: :) (S (NP (NNS Estrogens)) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (JJ hepatic) (NN metabolism)) (PP (IN of) (NP (JJ certain) (NNS corticosteroids)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG increasing) (NP (PRP$ their) (NN effect)))))))) (. .))))

nsubj(including-3, Estrogens-1)
root(ROOT-0, including-3)
amod(contraceptives-5, oral-4)
dobj(including-3, contraceptives-5)
nsubj(decrease-9, Estrogens-7)
aux(decrease-9, may-8)
parataxis(including-3, decrease-9)
det(metabolism-12, the-10)
amod(metabolism-12, hepatic-11)
dobj(decrease-9, metabolism-12)
amod(corticosteroids-15, certain-14)
prep_of(metabolism-12, corticosteroids-15)
advmod(increasing-18, thereby-17)
partmod(decrease-9, increasing-18)
xcomp(decrease-9, increasing-18)
poss(effect-20, their-19)
dobj(increasing-18, effect-20)

Hepatic/JJ Enzyme/NN Inducers/NNS ,/, Inhibitors/NNS and/CC Substrates/NNS :/: Drugs/NNS which/WDT induce/VBP cytochrome/NN P450/NN 3A4/NN (/-LRB- CYP/CD 3A4/NN )/-RRB- enzyme/NN activity/NN (/-LRB- e.g./FW ,/, barbiturates/NNS ,/, phenytoin/NN ,/, carbamazepine/NN ,/, rifampin/NN )/-RRB- may/MD enhance/VB the/DT metabolism/NN of/IN corticosteroids/NNS and/CC require/VB that/IN the/DT dosage/NN of/IN the/DT corticosteroid/NN be/VB increased/VBN ./.

(ROOT (S1 (S (NP (NP (NP (JJ Hepatic) (NN Enzyme) (NNS Inducers)) (, ,) (NP (NNS Inhibitors)) (CC and) (NP (NNS Substrates))) (: :) (S (NP (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT which)) (S (VP (VBP induce) (NP (NP (NP (NN cytochrome) (NN P450) (NN 3A4)) (PRN (-LRB- -LRB-) (NP (CD CYP) (NN 3A4)) (-RRB- -RRB-))) (NN enzyme) (NN activity)))))) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NNS barbiturates)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN carbamazepine)) (, ,) (NP (NN rifampin))) (-RRB- -RRB-))) (VP (MD may) (VP (VP (VB enhance) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NNS corticosteroids))))) (CC and) (VP (VB require) (SBAR (IN that) (S (NP (NP (DT the) (NN dosage)) (PP (IN of) (NP (DT the) (NN corticosteroid)))) (VP (VB be) (VP (VBN increased))))))))) (. .)))))

amod(Inducers-3, Hepatic-1)
nn(Inducers-3, Enzyme-2)
root(ROOT-0, Inducers-3)
conj_and(Inducers-3, Inhibitors-5)
conj_and(Inducers-3, Substrates-7)
nsubj(induce-11, Drugs-9)
nsubj(enhance-33, Drugs-9)
rcmod(Drugs-9, induce-11)
nn(3A4-14, cytochrome-12)
nn(3A4-14, P450-13)
nn(activity-20, 3A4-14)
num(3A4-17, CYP-16)
appos(3A4-14, 3A4-17)
nn(activity-20, enzyme-19)
dobj(induce-11, activity-20)
dep(barbiturates-24, e.g.-22)
dep(Drugs-9, barbiturates-24)
appos(barbiturates-24, phenytoin-26)
appos(barbiturates-24, carbamazepine-28)
appos(barbiturates-24, rifampin-30)
aux(enhance-33, may-32)
dep(Inducers-3, enhance-33)
det(metabolism-35, the-34)
dobj(enhance-33, metabolism-35)
prep_of(metabolism-35, corticosteroids-37)
conj_and(enhance-33, require-39)
complm(increased-47, that-40)
det(dosage-42, the-41)
nsubjpass(increased-47, dosage-42)
det(corticosteroid-45, the-44)
prep_of(dosage-42, corticosteroid-45)
auxpass(increased-47, be-46)
ccomp(require-39, increased-47)

Drugs/NNS which/WDT inhibit/VBP CYP/NN 3A4/NN (/-LRB- e.g./FW ,/, ketoconazole/NN ,/, macrolide/NN antibiotics/NNS such/JJ as/IN erythromycin/NN )/-RRB- have/VBP the/DT potential/NN to/TO result/VB in/IN increased/VBN plasma/NN concentrations/NNS of/IN corticosteroids/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT which)) (S (VP (VBP inhibit) (NP (NN CYP) (NN 3A4)))))) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN ketoconazole))) (, ,) (NP (NP (NN macrolide) (NNS antibiotics)) (PP (JJ such) (IN as) (NP (NN erythromycin)))) (-RRB- -RRB-))) (VP (VBP have) (NP (DT the) (NN potential) (S (VP (TO to) (VP (VB result) (PP (IN in) (NP (NP (VBN increased) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NNS corticosteroids))))))))))) (. .))))

nsubj(inhibit-3, Drugs-1)
nsubj(have-17, Drugs-1)
rcmod(Drugs-1, inhibit-3)
nn(3A4-5, CYP-4)
dobj(inhibit-3, 3A4-5)
dep(antibiotics-12, e.g.-7)
pobj(e.g.-7, ketoconazole-9)
nn(antibiotics-12, macrolide-11)
dep(Drugs-1, antibiotics-12)
prep_such_as(antibiotics-12, erythromycin-15)
root(ROOT-0, have-17)
det(potential-19, the-18)
dobj(have-17, potential-19)
aux(result-21, to-20)
infmod(potential-19, result-21)
amod(concentrations-25, increased-23)
nn(concentrations-25, plasma-24)
prep_in(result-21, concentrations-25)
prep_of(concentrations-25, corticosteroids-27)

Dexamethasone/NN is/VBZ a/DT moderate/JJ inducer/NN of/IN CYP/NN 3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Dexamethasone)) (VP (VBZ is) (NP (NP (DT a) (JJ moderate) (NN inducer)) (PP (IN of) (NP (NN CYP) (NN 3A4)))))) (. .))))

nsubj(inducer-5, Dexamethasone-1)
cop(inducer-5, is-2)
det(inducer-5, a-3)
amod(inducer-5, moderate-4)
root(ROOT-0, inducer-5)
nn(3A4-8, CYP-7)
prep_of(inducer-5, 3A4-8)

Co-administration/NN with/IN other/JJ drugs/NNS that/WDT are/VBP metabolized/VBN by/IN CYP/NN 3A4/NN (/-LRB- e.g./FW ,/, indinavir/NN ,/, erythromycin/NN )/-RRB- may/MD increase/VB their/PRP$ clearance/NN ,/, resulting/VBG in/IN decreased/VBN plasma/NN concentration/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN metabolized) (PP (IN by) (NP (NP (NN CYP) (NN 3A4)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN indinavir)) (, ,) (NP (NN erythromycin))) (-RRB- -RRB-))))))))))) (VP (MD may) (VP (VB increase) (NP (PRP$ their) (NN clearance)) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (VBN decreased) (NN plasma) (NN concentration)))))))) (. .))))

nsubj(increase-19, Co-administration-1)
amod(drugs-4, other-3)
prep_with(Co-administration-1, drugs-4)
nsubjpass(metabolized-7, drugs-4)
auxpass(metabolized-7, are-6)
rcmod(drugs-4, metabolized-7)
nn(3A4-10, CYP-9)
agent(metabolized-7, 3A4-10)
dep(indinavir-14, e.g.-12)
dep(3A4-10, indinavir-14)
appos(indinavir-14, erythromycin-16)
aux(increase-19, may-18)
root(ROOT-0, increase-19)
poss(clearance-21, their-20)
dobj(increase-19, clearance-21)
partmod(increase-19, resulting-23)
xcomp(increase-19, resulting-23)
amod(concentration-27, decreased-25)
nn(concentration-27, plasma-26)
prep_in(resulting-23, concentration-27)

Ketoconazole/NN :/: Ketoconazole/NN has/VBZ been/VBN reported/VBN to/TO decrease/VB the/DT metabolism/NN of/IN certain/JJ corticosteroids/NNS by/IN up/RB to/TO 60/CD %/NN ,/, leading/VBG to/TO increased/VBN risk/NN of/IN corticosteroid/NN side/NN effects/NNS ./.

(ROOT (S1 (S (NP (NP (NN Ketoconazole)) (: :) (S (NP (NN Ketoconazole)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB decrease) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (JJ certain) (NNS corticosteroids))) (PP (IN by) (NP (QP (RB up) (TO to) (CD 60)) (NN %))))))))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NP (VBN increased) (NN risk)) (PP (IN of) (NP (NN corticosteroid) (NN side) (NNS effects))))))))) (. .)))))

root(ROOT-0, Ketoconazole-1)
nsubjpass(reported-6, Ketoconazole-3)
xsubj(decrease-8, Ketoconazole-3)
aux(reported-6, has-4)
auxpass(reported-6, been-5)
dep(Ketoconazole-1, reported-6)
aux(decrease-8, to-7)
xcomp(reported-6, decrease-8)
det(metabolism-10, the-9)
dobj(decrease-8, metabolism-10)
amod(corticosteroids-13, certain-12)
prep_of(metabolism-10, corticosteroids-13)
quantmod(60-17, up-15)
dep(60-17, to-16)
num(%-18, 60-17)
prep_by(metabolism-10, %-18)
xcomp(reported-6, leading-20)
amod(risk-23, increased-22)
prep_to(leading-20, risk-23)
nn(effects-27, corticosteroid-25)
nn(effects-27, side-26)
prep_of(risk-23, effects-27)

In/IN addition/NN ,/, ketoconazole/NN alone/RB can/MD inhibit/VB adrenal/JJ corticosteroid/NN synthesis/NN and/CC may/MD cause/VBP adrenal/JJ insufficiency/NN during/IN corticosteroid/NN withdrawal/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN ketoconazole)) (ADVP (RB alone))) (VP (VP (MD can) (VP (VB inhibit) (NP (JJ adrenal) (NN corticosteroid) (NN synthesis)))) (CC and) (VP (MD may) (VP (VBP cause) (NP (JJ adrenal) (NN insufficiency)) (PP (IN during) (NP (NN corticosteroid) (NN withdrawal))))))) (. .))))

prep_in(inhibit-7, addition-2)
nsubj(inhibit-7, ketoconazole-4)
advmod(ketoconazole-4, alone-5)
aux(inhibit-7, can-6)
root(ROOT-0, inhibit-7)
amod(synthesis-10, adrenal-8)
nn(synthesis-10, corticosteroid-9)
dobj(inhibit-7, synthesis-10)
aux(cause-13, may-12)
conj_and(inhibit-7, cause-13)
amod(insufficiency-15, adrenal-14)
dobj(cause-13, insufficiency-15)
nn(withdrawal-18, corticosteroid-17)
prep_during(cause-13, withdrawal-18)

Nonsteroidal/JJ anti-inflammatory/JJ agents/NNS (/-LRB- NSAIDS/NNS )/-RRB- :/: Concomitant/JJ use/NN of/IN aspirin/NN (/-LRB- or/CC other/JJ nonsteroidal/JJ antiinflammatory/JJ agents/NNS )/-RRB- and/CC corticosteroids/NNS increases/VBZ the/DT risk/NN of/IN gastrointestinal/JJ side/JJ effects/NNS ./.

(ROOT (S1 (S (NP (NP (NP (JJ Nonsteroidal) (JJ anti-inflammatory) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NNS NSAIDS)) (-RRB- -RRB-))) (: :) (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (NP (NN aspirin)) (PRN (-LRB- -LRB-) (CC or) (NP (JJ other) (JJ nonsteroidal) (JJ antiinflammatory) (NNS agents)) (-RRB- -RRB-))) (CC and) (NP (NNS corticosteroids))))) (VP (VBZ increases) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ gastrointestinal) (JJ side) (NNS effects)))))) (. .)))))

amod(agents-3, Nonsteroidal-1)
amod(agents-3, anti-inflammatory-2)
root(ROOT-0, agents-3)
appos(agents-3, NSAIDS-5)
amod(use-9, Concomitant-8)
nsubj(increases-21, use-9)
prep_of(use-9, aspirin-11)
dep(agents-17, or-13)
amod(agents-17, other-14)
amod(agents-17, nonsteroidal-15)
amod(agents-17, antiinflammatory-16)
appos(aspirin-11, agents-17)
conj_and(aspirin-11, corticosteroids-20)
dep(agents-3, increases-21)
det(risk-23, the-22)
dobj(increases-21, risk-23)
amod(effects-27, gastrointestinal-25)
amod(effects-27, side-26)
prep_of(risk-23, effects-27)

Aspirin/NN should/MD be/VB used/VBN cautiously/RB in/IN conjunction/NN with/IN corticosteroids/NNS in/IN hypoprothrombinemia/NN ./.

(ROOT (S1 (S (S (NP (NN Aspirin)) (VP (MD should) (VP (VB be) (VP (VBN used) (ADVP (RB cautiously)) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (NP (NNS corticosteroids)) (PP (IN in) (NP (NN hypoprothrombinemia))))))))))) (. .))))

nsubjpass(used-4, Aspirin-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
advmod(used-4, cautiously-5)
prep_in(used-4, conjunction-7)
prep_with(conjunction-7, corticosteroids-9)
prep_in(corticosteroids-9, hypoprothrombinemia-11)

The/DT clearance/NN of/IN salicylates/NNS may/MD be/VB increased/VBN with/IN concurrent/JJ use/NN of/IN corticosteroids/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN clearance)) (PP (IN of) (NP (NNS salicylates)))) (VP (MD may) (VP (VB be) (VP (VBN increased) (PP (IN with) (NP (NP (JJ concurrent) (NN use)) (PP (IN of) (NP (NNS corticosteroids))))))))) (. .))))

det(clearance-2, The-1)
nsubjpass(increased-7, clearance-2)
prep_of(clearance-2, salicylates-4)
aux(increased-7, may-5)
auxpass(increased-7, be-6)
root(ROOT-0, increased-7)
amod(use-10, concurrent-9)
prep_with(increased-7, use-10)
prep_of(use-10, corticosteroids-12)

Phenytoin/NN :/: In/IN post-marketing/JJ experience/VBP ,/, there/EX have/VBP been/VBN reports/NNS of/IN both/CC increases/NNS and/CC decreases/NNS in/IN phenytoin/NN levels/NNS with/IN dexamethasone/NN co-administration/NN ,/, leading/VBG to/TO alterations/NNS in/IN seizure/NN control/NN ./.

(ROOT (S1 (S (NP (NP (NN Phenytoin)) (: :) (S (PP (IN In) (NP (JJ post-marketing) (VBP experience))) (, ,) (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (NNS reports)) (PP (IN of) (NP (NP (CC both) (NP (NNS increases)) (CC and) (NP (NNS decreases))) (PP (IN in) (NP (NP (NN phenytoin) (NNS levels)) (PP (IN with) (NP (NN dexamethasone) (NN co-administration))))))))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NP (NNS alterations)) (PP (IN in) (NP (NN seizure) (NN control))))))))) (. .)))))

root(ROOT-0, Phenytoin-1)
prep_in(reports-10, post-marketing-4)
dep(post-marketing-4, experience-5)
expl(reports-10, there-7)
aux(reports-10, have-8)
cop(reports-10, been-9)
dep(Phenytoin-1, reports-10)
preconj(increases-13, both-12)
prep_of(reports-10, increases-13)
conj_and(increases-13, decreases-15)
nn(levels-18, phenytoin-17)
prep_in(increases-13, levels-18)
nn(co-administration-21, dexamethasone-20)
prep_with(levels-18, co-administration-21)
xcomp(reports-10, leading-23)
prep_to(leading-23, alterations-25)
nn(control-28, seizure-27)
prep_in(alterations-25, control-28)

Skin/NN tests/NNS :/: Corticosteroids/NNS may/MD suppress/VB reactions/NNS to/TO skin/NN tests/NNS ./.

(ROOT (S1 (S (NP (NP (NN Skin) (NNS tests)) (: :) (S (NP (NNS Corticosteroids)) (VP (MD may) (VP (VB suppress) (NP (NP (NNS reactions)) (PP (TO to) (NP (NN skin) (NNS tests))))))) (. .)))))

nn(tests-2, Skin-1)
root(ROOT-0, tests-2)
nsubj(suppress-6, Corticosteroids-4)
aux(suppress-6, may-5)
dep(tests-2, suppress-6)
dobj(suppress-6, reactions-7)
nn(tests-10, skin-9)
prep_to(reactions-7, tests-10)

Thalidomide/NN :/: Co-administration/NN with/IN thalidomide/NN should/MD be/VB employed/VBN cautiously/RB ,/, as/IN toxic/JJ epidermal/JJ necrolysis/NNS has/VBZ been/VBN reported/VBN with/IN concomitant/JJ use/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Thalidomide)) (: :) (S (NP (NP (NN Co-administration)) (PP (IN with) (NP (NN thalidomide)))) (VP (MD should) (VP (VB be) (VP (VBN employed) (ADVP (RB cautiously)) (, ,) (PP (IN as) (NP (JJ toxic) (JJ epidermal) (NNS necrolysis)))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (JJ concomitant) (NN use))))))) (. .))))

nsubjpass(reported-17, Thalidomide-1)
nsubjpass(employed-8, Co-administration-3)
prep_with(Co-administration-3, thalidomide-5)
aux(employed-8, should-6)
auxpass(employed-8, be-7)
dep(Thalidomide-1, employed-8)
advmod(employed-8, cautiously-9)
amod(necrolysis-14, toxic-12)
amod(necrolysis-14, epidermal-13)
prep_as(employed-8, necrolysis-14)
aux(reported-17, has-15)
auxpass(reported-17, been-16)
root(ROOT-0, reported-17)
amod(use-20, concomitant-19)
prep_with(reported-17, use-20)

Vaccines/NNS :/: Patients/NNS on/IN corticosteroid/NN therapy/NN may/MD exhibit/VBP a/DT diminished/VBN response/NN to/TO toxoids/NNS and/CC live/JJ or/CC inactivated/VBN vaccines/NNS due/JJ to/TO inhibition/NN of/IN antibody/NN response/NN ./.

(ROOT (S1 (S (NP (NP (NNS Vaccines)) (: :) (S (NP (NP (NNS Patients)) (PP (IN on) (NP (NN corticosteroid) (NN therapy)))) (VP (MD may) (VP (VBP exhibit) (NP (NP (DT a) (VBN diminished) (NN response)) (PP (TO to) (NP (NP (NNS toxoids)) (CC and) (NP (ADJP (ADJP (JJ live)) (CC or) (ADJP (VBN inactivated))) (NNS vaccines)))) (PP (JJ due) (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN antibody) (NN response))))))))) (. .)))))

root(ROOT-0, Vaccines-1)
nsubj(exhibit-8, Patients-3)
nn(therapy-6, corticosteroid-5)
prep_on(Patients-3, therapy-6)
aux(exhibit-8, may-7)
dep(Vaccines-1, exhibit-8)
det(response-11, a-9)
amod(response-11, diminished-10)
dobj(exhibit-8, response-11)
prep_to(response-11, toxoids-13)
amod(vaccines-18, live-15)
conj_or(live-15, inactivated-17)
conj_and(toxoids-13, vaccines-18)
prep_due_to(response-11, inhibition-21)
nn(response-24, antibody-23)
prep_of(inhibition-21, response-24)

Corticosteroids/NNS may/MD also/RB potentiate/VB the/DT replication/NN of/IN some/DT organisms/NNS contained/VBN in/IN live/JJ attenuated/VBN vaccines/NNS ./.

(ROOT (S1 (S (S (NP (NNS Corticosteroids)) (VP (MD may) (ADVP (RB also)) (VP (VB potentiate) (NP (NP (DT the) (NN replication)) (PP (IN of) (NP (NP (DT some) (NNS organisms)) (VP (VBN contained) (PP (IN in) (NP (JJ live) (VBN attenuated) (NNS vaccines)))))))))) (. .))))

nsubj(potentiate-4, Corticosteroids-1)
aux(potentiate-4, may-2)
advmod(potentiate-4, also-3)
root(ROOT-0, potentiate-4)
det(replication-6, the-5)
dobj(potentiate-4, replication-6)
det(organisms-9, some-8)
prep_of(replication-6, organisms-9)
partmod(organisms-9, contained-10)
amod(vaccines-14, live-12)
amod(vaccines-14, attenuated-13)
prep_in(contained-10, vaccines-14)

Routine/JJ administration/NN of/IN vaccines/NNS or/CC toxoids/NNS should/MD be/VB deferred/VBN until/IN corticosteroid/NN therapy/NN is/VBZ discontinued/VBN if/IN possible/JJ ./.

(ROOT (S1 (S (S (NP (NP (JJ Routine) (NN administration)) (PP (IN of) (NP (NP (NNS vaccines)) (CC or) (NP (NNS toxoids))))) (VP (MD should) (VP (VB be) (VP (VBN deferred) (SBAR (IN until) (S (NP (NN corticosteroid) (NN therapy)) (VP (VBZ is) (VP (VBN discontinued) (PP (IN if) (NP (JJ possible))))))))))) (. .))))

amod(administration-2, Routine-1)
nsubjpass(deferred-9, administration-2)
prep_of(administration-2, vaccines-4)
conj_or(vaccines-4, toxoids-6)
aux(deferred-9, should-7)
auxpass(deferred-9, be-8)
root(ROOT-0, deferred-9)
mark(discontinued-14, until-10)
nn(therapy-12, corticosteroid-11)
nsubjpass(discontinued-14, therapy-12)
auxpass(discontinued-14, is-13)
advcl(deferred-9, discontinued-14)
prep_if(discontinued-14, possible-16)

Dexbrompheniramine/NN can/MD interact/VB with/IN alcohol/NN or/CC other/JJ CNS/NN depressants/NNS (/-LRB- may/MD potentiate/VB the/DT CNS/NN depressant/NN effects/NNS of/IN either/CC these/DT medications/NNS or/CC antihistamines/NNS )/-RRB- ,/, anticholinergics/NN or/CC other/JJ medications/NNS with/IN anticholinergic/JJ activity/NN (/-LRB- anticholinergic/JJ effects/NNS may/MD be/VB potentiated/VBN when/WRB these/DT medications/NNS are/VBP used/VBN concurrently/RB with/IN antihistamines/NNS )/-RRB- ,/, and/CC monoamine/NN oxidase/NN (/-LRB- MAO/NN )/-RRB- inhibitors/NNS (/-LRB- concurrent/JJ use/NN with/IN antihistamines/NNS may/MD prolong/VB and/CC intensify/VB the/DT anticholinergic/JJ and/CC CNS/NN depressant/NN effects/NNS of/IN antihistamines/NNS )/-RRB- ./.

(ROOT (S1 (S (NP (NN Dexbrompheniramine)) (VP (MD can) (VP (VB interact) (PP (IN with) (NP (NP (NP (NP (NN alcohol)) (CC or) (NP (JJ other) (NN CNS) (NNS depressants))) (PRN (-LRB- -LRB-) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (NN CNS) (NN depressant) (NNS effects)) (PP (IN of) (NP (CC either) (DT these) (NP (NNS medications)) (CC or) (NP (NNS antihistamines))))))) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NN anticholinergics)) (CC or) (NP (NP (JJ other) (NNS medications)) (PP (IN with) (NP (JJ anticholinergic) (NN activity))))) (PRN (-LRB- -LRB-) (NP (NP (JJ anticholinergic) (NNS effects)) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (SBAR (WHADVP (WRB when)) (S (NP (DT these) (NNS medications)) (VP (VBP are) (VP (VBN used) (ADVP (RB concurrently)) (PP (IN with) (NP (NNS antihistamines))))))))))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NP (NP (NN monoamine) (NN oxidase)) (PRN (-LRB- -LRB-) (NP (NN MAO)) (-RRB- -RRB-))) (NNS inhibitors)) (PRN (-LRB- -LRB-) (S (NP (NP (JJ concurrent) (NN use)) (PP (IN with) (NP (NNS antihistamines)))) (VP (MD may) (VP (VP (VB prolong)) (CC and) (VP (VB intensify) (NP (NP (DT the) (JJ anticholinergic) (CC and) (NN CNS) (NN depressant) (NNS effects)) (PP (IN of) (NP (NNS antihistamines)))))))) (-RRB- -RRB-))))))) (. .))))

nsubj(interact-3, Dexbrompheniramine-1)
aux(interact-3, can-2)
root(ROOT-0, interact-3)
prep_with(interact-3, alcohol-5)
amod(depressants-9, other-7)
nn(depressants-9, CNS-8)
conj_or(alcohol-5, depressants-9)
aux(potentiate-12, may-11)
dep(alcohol-5, potentiate-12)
det(effects-16, the-13)
nn(effects-16, CNS-14)
nn(effects-16, depressant-15)
dobj(potentiate-12, effects-16)
preconj(medications-20, either-18)
dep(medications-20, these-19)
prep_of(effects-16, medications-20)
conj_or(medications-20, antihistamines-22)
conj_or(alcohol-5, anticholinergics-25)
amod(medications-28, other-27)
conj_or(anticholinergics-25, medications-28)
amod(activity-31, anticholinergic-30)
prep_with(medications-28, activity-31)
amod(effects-34, anticholinergic-33)
dep(anticholinergics-25, effects-34)
aux(potentiated-37, may-35)
auxpass(potentiated-37, be-36)
dep(effects-34, potentiated-37)
advmod(used-42, when-38)
det(medications-40, these-39)
nsubjpass(used-42, medications-40)
auxpass(used-42, are-41)
advcl(potentiated-37, used-42)
advmod(used-42, concurrently-43)
prep_with(used-42, antihistamines-45)
nn(oxidase-50, monoamine-49)
nn(inhibitors-54, oxidase-50)
abbrev(oxidase-50, MAO-52)
conj_and(alcohol-5, inhibitors-54)
amod(use-57, concurrent-56)
nsubj(prolong-61, use-57)
prep_with(use-57, antihistamines-59)
aux(prolong-61, may-60)
dep(inhibitors-54, prolong-61)
conj_and(prolong-61, intensify-63)
dep(anticholinergic-65, the-64)
dobj(intensify-63, anticholinergic-65)
nn(effects-69, CNS-67)
nn(effects-69, depressant-68)
conj_and(anticholinergic-65, effects-69)
prep_of(anticholinergic-65, antihistamines-71)

In/IN patients/NNS receiving/VBG nonselective/JJ monoamine/NN oxidase/NN inhibitors/NNS (/-LRB- MAOIs/NN )/-RRB- (/-LRB- e.g./FW ,/, selegiline/NN hydrochloride/NN )/-RRB- in/IN combination/NN with/IN serotoninergic/JJ agents/NNS (/-LRB- e.g./FW ,/, fluoxetine/NN ,/, fluvoxamine/NN ,/, paroxetine/NN ,/, sertraline/NN ,/, venlafaxine/NN )/-RRB- ,/, there/EX have/VBP been/VBN reports/NNS of/IN serious/JJ ,/, sometimes/RB fatal/JJ ,/, reactions/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NP (JJ nonselective) (NN monoamine) (NN oxidase) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NN MAOIs)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN selegiline) (NN hydrochloride))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (JJ serotoninergic) (NNS agents)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN fluoxetine)) (, ,) (NP (NN fluvoxamine)) (, ,) (NP (NP (NN paroxetine)) (, ,) (NP (NN sertraline)) (, ,) (NP (NN venlafaxine)))) (-RRB- -RRB-))))))))) (, ,) (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (NNS reports)) (PP (IN of) (NP (ADJP (ADJP (JJ serious)) (, ,) (RB sometimes) (ADJP (JJ fatal)) (, ,)) (NNS reactions))))))) (. .))))

prep_in(reports-39, patients-2)
partmod(patients-2, receiving-3)
amod(inhibitors-7, nonselective-4)
nn(inhibitors-7, monoamine-5)
nn(inhibitors-7, oxidase-6)
dobj(receiving-3, inhibitors-7)
abbrev(inhibitors-7, MAOIs-9)
dep(inhibitors-7, e.g.-12)
nn(hydrochloride-15, selegiline-14)
pobj(e.g.-12, hydrochloride-15)
prep_in(receiving-3, combination-18)
amod(agents-21, serotoninergic-20)
prep_with(combination-18, agents-21)
dep(fluoxetine-25, e.g.-23)
dep(agents-21, fluoxetine-25)
appos(fluoxetine-25, fluvoxamine-27)
appos(fluoxetine-25, paroxetine-29)
appos(paroxetine-29, sertraline-31)
appos(paroxetine-29, venlafaxine-33)
expl(reports-39, there-36)
aux(reports-39, have-37)
cop(reports-39, been-38)
root(ROOT-0, reports-39)
amod(reactions-46, serious-41)
advmod(serious-41, sometimes-43)
dep(serious-41, fatal-44)
prep_of(reports-39, reactions-46)

Because/IN dexfenfluramine/NN is/VBZ a/DT serotonin/NN releaser/NN and/CC reuptake/NN inhibitor/NN ,/, dexfenfluramine/NN should/MD not/RB be/VB used/VBN concomitantly/RB with/IN a/DT MAO/NN inhibitor/NN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NN dexfenfluramine)) (VP (VBZ is) (NP (DT a) (NN serotonin) (NN releaser) (CC and) (NN reuptake) (NN inhibitor))))) (, ,) (NP (NN dexfenfluramine)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (DT a) (NN MAO) (NN inhibitor))))))) (. .))))

mark(releaser-6, Because-1)
nsubj(releaser-6, dexfenfluramine-2)
cop(releaser-6, is-3)
det(releaser-6, a-4)
nn(releaser-6, serotonin-5)
advcl(used-15, releaser-6)
nn(inhibitor-9, reuptake-8)
conj_and(releaser-6, inhibitor-9)
nsubjpass(used-15, dexfenfluramine-11)
aux(used-15, should-12)
neg(used-15, not-13)
auxpass(used-15, be-14)
root(ROOT-0, used-15)
advmod(used-15, concomitantly-16)
det(inhibitor-20, a-18)
nn(inhibitor-20, MAO-19)
prep_with(used-15, inhibitor-20)

At/IN least/JJS 14/CD days/NNS should/MD elapse/VB between/IN discontinuation/NN of/IN a/DT MAO/NN inhibitor/NN and/CC initiation/NN of/IN treatment/NN with/IN dexfenfluramine/NN ./.

(ROOT (S1 (S (S (NP (QP (IN At) (JJS least) (CD 14)) (NNS days)) (VP (MD should) (VP (VB elapse) (PP (IN between) (NP (NP (NP (NN discontinuation)) (PP (IN of) (NP (DT a) (NN MAO) (NN inhibitor)))) (CC and) (NP (NP (NN initiation)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN with) (NP (NN dexfenfluramine))))))))))) (. .))))

quantmod(14-3, At-1)
mwe(At-1, least-2)
pobj(At-1, least-2)
num(days-4, 14-3)
nsubj(elapse-6, days-4)
aux(elapse-6, should-5)
root(ROOT-0, elapse-6)
prep_between(elapse-6, discontinuation-8)
det(inhibitor-12, a-10)
nn(inhibitor-12, MAO-11)
prep_of(discontinuation-8, inhibitor-12)
conj_and(discontinuation-8, initiation-14)
prep_of(initiation-14, treatment-16)
prep_with(treatment-16, dexfenfluramine-18)

At/IN least/JJS 3/CD weeks/NNS should/MD elapse/VB between/IN discontinuation/NN of/IN dexfenfluramine/NN and/CC initiation/NN of/IN treatment/NN with/IN a/DT MAO/NN inhibitor/NN ./.

(ROOT (S1 (S (S (NP (QP (IN At) (JJS least) (CD 3)) (NNS weeks)) (VP (MD should) (VP (VB elapse) (PP (IN between) (NP (NP (NP (NN discontinuation)) (PP (IN of) (NP (NN dexfenfluramine)))) (CC and) (NP (NP (NN initiation)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN with) (NP (DT a) (NN MAO) (NN inhibitor))))))))))) (. .))))

quantmod(3-3, At-1)
mwe(At-1, least-2)
pobj(At-1, least-2)
num(weeks-4, 3-3)
nsubj(elapse-6, weeks-4)
aux(elapse-6, should-5)
root(ROOT-0, elapse-6)
prep_between(elapse-6, discontinuation-8)
prep_of(discontinuation-8, dexfenfluramine-10)
conj_and(discontinuation-8, initiation-12)
prep_of(initiation-12, treatment-14)
det(inhibitor-18, a-16)
nn(inhibitor-18, MAO-17)
prep_with(treatment-14, inhibitor-18)

A/DT rare/JJ ,/, but/CC serious/JJ ,/, constellation/NN of/IN symptoms/NNS ,/, termed/VBN serotonin/NN syndrome/NN ,/, has/VBZ been/VBN reported/VBN with/IN the/DT concomitant/JJ use/NN of/IN selective/JJ serotonin/NN reuptake/NN inhibitors/NNS (/-LRB- SSRIs/NN )/-RRB- and/CC agents/NNS for/IN migraine/NN therapy/NN ,/, such/JJ as/IN Imitrex/NN (/-LRB- sumatriptan/NN succinate/NN )/-RRB- and/CC dihydroergotamine/NN ./.

(ROOT (S1 (S (S (NP (NP (DT A) (ADJP (ADJP (JJ rare)) (, ,) (CC but) (ADJP (JJ serious)) (, ,)) (NN constellation)) (PP (IN of) (NP (NNS symptoms))) (, ,) (VP (VBN termed) (NP (NN serotonin) (NN syndrome))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (JJ selective) (NN serotonin) (NN reuptake) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NN SSRIs)) (-RRB- -RRB-))))) (CC and) (NP (NP (NNS agents)) (PP (IN for) (NP (NN migraine) (NN therapy))) (, ,) (PP (JJ such) (IN as) (NP (NP (NP (NN Imitrex)) (PRN (-LRB- -LRB-) (NP (NN sumatriptan) (NN succinate)) (-RRB- -RRB-))) (CC and) (NP (NN dihydroergotamine))))))))))) (. .))))

det(constellation-7, A-1)
amod(constellation-7, rare-2)
conj_but(rare-2, serious-5)
nsubjpass(reported-17, constellation-7)
prep_of(constellation-7, symptoms-9)
partmod(constellation-7, termed-11)
nn(syndrome-13, serotonin-12)
dobj(termed-11, syndrome-13)
aux(reported-17, has-15)
auxpass(reported-17, been-16)
root(ROOT-0, reported-17)
det(use-21, the-19)
amod(use-21, concomitant-20)
prep_with(reported-17, use-21)
amod(inhibitors-26, selective-23)
nn(inhibitors-26, serotonin-24)
nn(inhibitors-26, reuptake-25)
prep_of(use-21, inhibitors-26)
abbrev(inhibitors-26, SSRIs-28)
conj_and(use-21, agents-31)
nn(therapy-34, migraine-33)
prep_for(agents-31, therapy-34)
prep_such_as(agents-31, Imitrex-38)
nn(succinate-41, sumatriptan-40)
appos(Imitrex-38, succinate-41)
conj_and(Imitrex-38, dihydroergotamine-44)

Dexfenfluramine/NN should/MD not/RB be/VB administered/VBN with/IN other/JJ serotoninergic/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (NN Dexfenfluramine)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (JJ other) (JJ serotoninergic) (NNS agents))))))) (. .))))

nsubjpass(administered-5, Dexfenfluramine-1)
aux(administered-5, should-2)
neg(administered-5, not-3)
auxpass(administered-5, be-4)
root(ROOT-0, administered-5)
amod(agents-9, other-7)
amod(agents-9, serotoninergic-8)
prep_with(administered-5, agents-9)

The/DT appropriate/JJ interval/NN between/IN administration/NN of/IN these/DT agents/NNS and/CC dexfenfluramine/NN has/VBZ not/RB been/VBN established/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ appropriate) (NN interval)) (PP (IN between) (NP (NP (NP (NN administration)) (PP (IN of) (NP (DT these) (NNS agents)))) (CC and) (NP (NN dexfenfluramine))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN established))))) (. .))))

det(interval-3, The-1)
amod(interval-3, appropriate-2)
nsubjpass(established-14, interval-3)
prep_between(interval-3, administration-5)
det(agents-8, these-7)
prep_of(administration-5, agents-8)
conj_and(administration-5, dexfenfluramine-10)
aux(established-14, has-11)
neg(established-14, not-12)
auxpass(established-14, been-13)
root(ROOT-0, established-14)

The/DT use/NN of/IN dexfenfluramine/NN with/IN other/JJ CNS-active/JJ drugs/NNS has/VBZ not/RB been/VBN systematically/RB evaluated/VBN ;/: ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NN dexfenfluramine))) (PP (IN with) (NP (JJ other) (JJ CNS-active) (NNS drugs)))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB systematically)) (VP (VBN evaluated)))) (: ;)) (. .))))

det(use-2, The-1)
nsubjpass(evaluated-13, use-2)
prep_of(use-2, dexfenfluramine-4)
amod(drugs-8, other-6)
amod(drugs-8, CNS-active-7)
prep_with(use-2, drugs-8)
aux(evaluated-13, has-9)
neg(evaluated-13, not-10)
auxpass(evaluated-13, been-11)
advmod(evaluated-13, systematically-12)
root(ROOT-0, evaluated-13)

consequently/RB ,/, caution/NN is/VBZ advised/VBN if/IN dexfenfluramine/NN and/CC such/JJ drugs/NNS are/VBP prescribed/VBN concurrently/RB ./.

(ROOT (S1 (S (S (ADVP (RB consequently)) (, ,) (NP (NN caution)) (VP (VBZ is) (VP (VBN advised) (SBAR (IN if) (S (NP (NP (NN dexfenfluramine)) (CC and) (NP (JJ such) (NNS drugs))) (VP (VBP are) (VP (VBN prescribed) (ADVP (RB concurrently))))))))) (. .))))

advmod(advised-5, consequently-1)
nsubjpass(advised-5, caution-3)
auxpass(advised-5, is-4)
root(ROOT-0, advised-5)
mark(prescribed-12, if-6)
nsubjpass(prescribed-12, dexfenfluramine-7)
amod(drugs-10, such-9)
conj_and(dexfenfluramine-7, drugs-10)
auxpass(prescribed-12, are-11)
advcl(advised-5, prescribed-12)
advmod(prescribed-12, concurrently-13)

ZINECARD/NN does/VBZ not/RB influence/VB the/DT pharmacokinetics/NNS of/IN doxorubicin/NN ./.

(ROOT (S1 (S (S (NP (NN ZINECARD)) (VP (VBZ does) (RB not) (VP (VB influence) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN doxorubicin))))))) (. .))))

nsubj(influence-4, ZINECARD-1)
aux(influence-4, does-2)
neg(influence-4, not-3)
root(ROOT-0, influence-4)
det(pharmacokinetics-6, the-5)
dobj(influence-4, pharmacokinetics-6)
prep_of(pharmacokinetics-6, doxorubicin-8)

Carcinogenesis/NN ,/, Mutagenesis/NN ,/, Impairment/NN of/IN Fertility/NN :/: No/DT long-term/JJ carcinogenicity/NN studies/NNS have/VBP been/VBN carried/VBN out/RP with/IN dexrazoxane/NN in/IN animals/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NN Carcinogenesis)) (, ,) (NP (NN Mutagenesis)) (, ,) (NP (NP (NN Impairment)) (PP (IN of) (NP (NN Fertility))))) (: :) (S (NP (DT No) (JJ long-term) (NN carcinogenicity) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN carried) (PRT (RP out)) (PP (IN with) (NP (NP (NN dexrazoxane)) (PP (IN in) (NP (NNS animals))))))))) (. .)))))

root(ROOT-0, Carcinogenesis-1)
appos(Carcinogenesis-1, Mutagenesis-3)
appos(Carcinogenesis-1, Impairment-5)
prep_of(Impairment-5, Fertility-7)
det(studies-12, No-9)
amod(studies-12, long-term-10)
nn(studies-12, carcinogenicity-11)
nsubjpass(carried-15, studies-12)
aux(carried-15, have-13)
auxpass(carried-15, been-14)
dep(Carcinogenesis-1, carried-15)
prt(carried-15, out-16)
prep_with(carried-15, dexrazoxane-18)
prep_in(dexrazoxane-18, animals-20)

Dexrazoxane/NN was/VBD not/RB mutagenic/JJ in/IN the/DT Ame/NN s/NN test/NN but/CC was/VBD found/VBN to/TO be/VB clastogenic/JJ to/TO human/JJ lymphocytes/NNS in/FW vitro/FW and/CC to/TO mouse/NN bone/NN marrow/NN erythrocytes/NNS in/FW vivo/FW (/-LRB- micronucleus/NN test/NN )./CD

(ROOT (S1 (S (NP (NN Dexrazoxane)) (VP (VP (VBD was) (RB not) (ADJP (JJ mutagenic) (PP (IN in) (NP (DT the) (NN Ame) (NN s) (NN test))))) (CC but) (VP (VBD was) (VP (VBN found) (S (VP (VP (TO to) (VP (VB be) (ADJP (JJ clastogenic) (PP (TO to) (NP (JJ human) (NNS lymphocytes))) (ADVP (FW in) (FW vitro))))) (CC and) (VP (TO to) (NP (NP (NN mouse) (NN bone) (NN marrow)) (NNS erythrocytes)) (ADVP (FW in) (FW vivo)) (-LRB- -LRB-) (NP (NN micronucleus) (NN test) (CD -RRB-.)))))))))))

nsubj(mutagenic-4, Dexrazoxane-1)
cop(mutagenic-4, was-2)
neg(mutagenic-4, not-3)
root(ROOT-0, mutagenic-4)
det(test-9, the-6)
nn(test-9, Ame-7)
nn(test-9, s-8)
prep_in(mutagenic-4, test-9)
auxpass(found-12, was-11)
conj_but(mutagenic-4, found-12)
aux(clastogenic-15, to-13)
cop(clastogenic-15, be-14)
ccomp(found-12, clastogenic-15)
amod(lymphocytes-18, human-17)
prep_to(clastogenic-15, lymphocytes-18)
nn(vitro-20, in-19)
advmod(clastogenic-15, vitro-20)
conj_and(clastogenic-15, to-22)
nn(marrow-25, mouse-23)
nn(marrow-25, bone-24)
nn(erythrocytes-26, marrow-25)
dobj(to-22, erythrocytes-26)
nn(vivo-28, in-27)
advmod(to-22, vivo-28)
nn(test-31, micronucleus-30)
dobj(to-22, test-31)
num(test-31, -RRB-.-32)

The/DT possible/JJ adverse/JJ effects/NNS of/IN ZINECARD/NN on/IN the/DT fertility/NN of/IN humans/NNS and/CC experimental/JJ animals/NNS ,/, male/JJ or/CC female/JJ ,/, have/VBP not/RB been/VBN adequately/RB studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ possible) (JJ adverse) (NNS effects)) (PP (IN of) (NP (NN ZINECARD))) (PP (IN on) (NP (NP (DT the) (NN fertility)) (PP (IN of) (NP (NP (NP (NNS humans)) (CC and) (NP (JJ experimental) (NNS animals))) (, ,) (ADJP (ADJP (JJ male)) (CC or) (ADJP (JJ female))) (, ,)))))) (VP (VBP have) (RB not) (VP (VBN been) (ADVP (RB adequately)) (VP (VBN studied))))) (. .))))

det(effects-4, The-1)
amod(effects-4, possible-2)
amod(effects-4, adverse-3)
nsubjpass(studied-24, effects-4)
prep_of(effects-4, ZINECARD-6)
det(fertility-9, the-8)
prep_on(effects-4, fertility-9)
prep_of(fertility-9, humans-11)
amod(animals-14, experimental-13)
conj_and(humans-11, animals-14)
amod(humans-11, male-16)
conj_or(male-16, female-18)
aux(studied-24, have-20)
neg(studied-24, not-21)
auxpass(studied-24, been-22)
advmod(studied-24, adequately-23)
root(ROOT-0, studied-24)

Testicular/JJ atrophy/NN was/VBD seen/VBN with/IN dexrazoxane/NN administration/NN at/IN doses/NNS as/RB low/JJ as/IN 30/CD mg/kg/NN weekly/RB for/IN 6/CD weeks/NNS in/IN rats/NNS (/-LRB- 1/3/CD the/DT human/JJ dose/NN on/IN a/DT mg/m/NN 2/CD basis/NN )/-RRB- and/CC as/RB low/JJ as/IN 20/CD mg/kg/NN weekly/RB for/IN 13/CD weeks/NNS in/IN dogs/NNS (/-LRB- approximately/RB equal/JJ to/TO the/DT human/JJ dose/NN on/IN a/DT mg/m/NN 2/CD basis/NN )./CD

(ROOT (S1 (S (NP (JJ Testicular) (NN atrophy)) (VP (VBD was) (VP (VBN seen) (PP (IN with) (NP (NN dexrazoxane) (NN administration))) (PP (IN at) (NP (NP (NNS doses)) (ADJP (RB as) (JJ low) (PP (IN as) (NP (NP (NP (NP (CD 30) (NN mg/kg) (RB weekly)) (PP (IN for) (NP (NP (CD 6) (NNS weeks)) (PP (IN in) (NP (NNS rats)))))) (PRN (-LRB- -LRB-) (NP (NP (CD 1/3) (NP (DT the) (JJ human) (NN dose))) (PP (IN on) (NP (DT a) (NN mg/m) (CD 2) (NN basis)))) (-RRB- -RRB-))) (CC and) (NP (NP (QP (RB as) (JJ low) (IN as) (CD 20)) (NN mg/kg)) (ADVP (RB weekly)) (PP (IN for) (NP (NP (CD 13) (NNS weeks)) (PP (IN in) (NP (NNS dogs)))))) (-LRB- -LRB-) (ADJP (RB approximately) (JJ equal) (PP (TO to) (NP (NP (DT the) (JJ human) (NN dose)) (PP (IN on) (NP (DT a) (NN mg/m) (CD 2) (NN basis) (CD -RRB-.))))))))))))))))

amod(atrophy-2, Testicular-1)
nsubjpass(seen-4, atrophy-2)
auxpass(seen-4, was-3)
root(ROOT-0, seen-4)
nn(administration-7, dexrazoxane-6)
prep_with(seen-4, administration-7)
prep_at(seen-4, doses-9)
advmod(low-11, as-10)
amod(doses-9, low-11)
num(mg/kg-14, 30-13)
prep_as(low-11, mg/kg-14)
advmod(mg/kg-14, weekly-15)
num(weeks-18, 6-17)
prep_for(mg/kg-14, weeks-18)
prep_in(weeks-18, rats-20)
num(dose-25, 1/3-22)
det(dose-25, the-23)
amod(dose-25, human-24)
dep(mg/kg-14, dose-25)
det(basis-30, a-27)
nn(basis-30, mg/m-28)
num(basis-30, 2-29)
prep_on(dose-25, basis-30)
quantmod(20-36, as-33)
quantmod(20-36, low-34)
quantmod(20-36, as-35)
num(mg/kg-37, 20-36)
conj_and(mg/kg-14, mg/kg-37)
advmod(mg/kg-37, weekly-38)
num(weeks-41, 13-40)
prep_for(mg/kg-37, weeks-41)
prep_in(weeks-41, dogs-43)
advmod(equal-46, approximately-45)
amod(mg/kg-14, equal-46)
conj_and(mg/kg-14, equal-46)
det(dose-50, the-48)
amod(dose-50, human-49)
prep_to(equal-46, dose-50)
det(basis-55, a-52)
nn(basis-55, mg/m-53)
num(basis-55, 2-54)
prep_on(dose-50, basis-55)
num(basis-55, -RRB-.-56)

Acidifying/JJ agents/NNS :/: Gastrointestinal/JJ acidifying/JJ agents/NNS (/-LRB- guanethidine/NN ,/, reserpine/NN ,/, glutamic/JJ acid/NN HCl/NN ,/, ascorbic/JJ acid/NN ,/, fruit/NN juices/NNS ,/, etc./NN )/-RRB- lower/JJR absorption/NN of/IN amphetamines/NN ./.

(ROOT (S1 (S (NP (NP (JJ Acidifying) (NNS agents)) (: :) (NP (NP (NP (NP (JJ Gastrointestinal) (JJ acidifying) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NP (NN guanethidine)) (, ,) (NP (NN reserpine)) (, ,) (NP (JJ glutamic) (NN acid) (NN HCl)) (, ,) (NP (JJ ascorbic) (NN acid)) (, ,) (NP (NN fruit) (NNS juices)) (, ,) (NP (NN etc.))) (-RRB- -RRB-))) (JJR lower) (NN absorption)) (PP (IN of) (NP (NN amphetamines)))) (. .)))))

amod(agents-2, Acidifying-1)
root(ROOT-0, agents-2)
amod(agents-6, Gastrointestinal-4)
amod(agents-6, acidifying-5)
nn(absorption-25, agents-6)
dep(agents-6, guanethidine-8)
appos(guanethidine-8, reserpine-10)
amod(HCl-14, glutamic-12)
nn(HCl-14, acid-13)
appos(guanethidine-8, HCl-14)
amod(acid-17, ascorbic-16)
appos(guanethidine-8, acid-17)
nn(juices-20, fruit-19)
appos(guanethidine-8, juices-20)
appos(guanethidine-8, etc.-22)
amod(absorption-25, lower-24)
dep(agents-2, absorption-25)
prep_of(absorption-25, amphetamines-27)

Urinary/JJ acidifying/JJ agents/NNS (/-LRB- ammonium/NN chloride/NN ,/, sodium/NN acid/NN phosphate/NN ,/, etc./NN )/-RRB- increase/VBP the/DT concentration/NN of/IN the/DT ionized/VBN species/NNS of/IN the/DT amphetamine/NN molecule/NN ,/, thereby/RB increasing/VBG urinary/JJ excretion/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Urinary) (JJ acidifying) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NP (NN ammonium) (NN chloride)) (, ,) (NP (NN sodium) (NN acid) (NN phosphate)) (, ,) (NP (NN etc.))) (-RRB- -RRB-))) (VP (VBP increase) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NP (DT the) (VBN ionized) (NNS species)) (PP (IN of) (NP (DT the) (NN amphetamine) (NN molecule)))))) (, ,) (S (ADVP (RB thereby)) (VP (VBG increasing) (NP (JJ urinary) (NN excretion)))))) (. .))))

amod(agents-3, Urinary-1)
amod(agents-3, acidifying-2)
nsubj(increase-14, agents-3)
nn(chloride-6, ammonium-5)
dep(agents-3, chloride-6)
nn(phosphate-10, sodium-8)
nn(phosphate-10, acid-9)
appos(chloride-6, phosphate-10)
appos(chloride-6, etc.-12)
root(ROOT-0, increase-14)
det(concentration-16, the-15)
dobj(increase-14, concentration-16)
det(species-20, the-18)
amod(species-20, ionized-19)
prep_of(concentration-16, species-20)
det(molecule-24, the-22)
nn(molecule-24, amphetamine-23)
prep_of(species-20, molecule-24)
advmod(increasing-27, thereby-26)
partmod(increase-14, increasing-27)
xcomp(increase-14, increasing-27)
amod(excretion-29, urinary-28)
dobj(increasing-27, excretion-29)

Both/CC groups/NNS of/IN agents/NNS lower/JJR blood/NN levels/NNS and/CC efficacy/NN of/IN amphetamines/NN ./.

(ROOT (S1 (S (S (NP (NP (CC Both) (NNS groups)) (PP (IN of) (NP (NNS agents)))) (VP (JJR lower) (NP (NP (NN blood) (NNS levels)) (CC and) (NP (NP (NN efficacy)) (PP (IN of) (NP (NN amphetamines))))))) (. .))))

dep(groups-2, Both-1)
nsubj(levels-7, groups-2)
prep_of(groups-2, agents-4)
dep(levels-7, lower-5)
nn(levels-7, blood-6)
root(ROOT-0, levels-7)
conj_and(levels-7, efficacy-9)
prep_of(efficacy-9, amphetamines-11)

Adrenergic/JJ blockers/NN :/: Adrenergic/JJ blockers/NNS are/VBP inhibited/VBN by/IN amphetamines/NN ./.

(ROOT (S1 (S (S (NP (JJ Adrenergic) (NN blockers) (: :) (JJ Adrenergic) (NNS blockers)) (VP (VBP are) (VP (VBN inhibited) (PP (IN by) (NP (NN amphetamines)))))) (. .))))

amod(blockers-5, Adrenergic-1)
nn(blockers-5, blockers-2)
amod(blockers-5, Adrenergic-4)
nsubjpass(inhibited-7, blockers-5)
auxpass(inhibited-7, are-6)
root(ROOT-0, inhibited-7)
agent(inhibited-7, amphetamines-9)

Alkalinizing/NN agents/NNS :/: Gastrointestinal/JJ alkalinizing/NN agents/NNS (/-LRB- sodium/NN bicarbonate/NN ,/, etc./NN )/-RRB- increase/VBP absorption/NN of/IN amphetamines/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Alkalinizing) (NNS agents)) (: :) (NP (NP (JJ Gastrointestinal) (NN alkalinizing) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NP (NN sodium) (NN bicarbonate)) (, ,) (NP (NN etc.))) (-RRB- -RRB-)))) (VP (VBP increase) (NP (NP (NN absorption)) (PP (IN of) (NP (NN amphetamines)))))) (. .))))

nn(agents-2, Alkalinizing-1)
nsubj(increase-13, agents-2)
amod(agents-6, Gastrointestinal-4)
nn(agents-6, alkalinizing-5)
dep(agents-2, agents-6)
nn(bicarbonate-9, sodium-8)
dep(agents-6, bicarbonate-9)
appos(bicarbonate-9, etc.-11)
root(ROOT-0, increase-13)
dobj(increase-13, absorption-14)
prep_of(absorption-14, amphetamines-16)

Urinary/JJ alkalinizing/NN agents/NNS (/-LRB- acetazolamide/NN ,/, some/DT thiazides/NNS )/-RRB- increase/VBP the/DT concentration/NN of/IN the/DT non-ionized/JJ species/NNS of/IN the/DT amphetamine/NN molecule/NN ,/, thereby/RB decreasing/VBG urinary/JJ excretion/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Urinary) (NN alkalinizing) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NP (NN acetazolamide)) (, ,) (NP (DT some) (NNS thiazides))) (-RRB- -RRB-))) (VP (VBP increase) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NP (DT the) (JJ non-ionized) (NNS species)) (PP (IN of) (NP (DT the) (NN amphetamine) (NN molecule)))))) (, ,) (S (ADVP (RB thereby)) (VP (VBG decreasing) (NP (JJ urinary) (NN excretion)))))) (. .))))

amod(agents-3, Urinary-1)
nn(agents-3, alkalinizing-2)
nsubj(increase-10, agents-3)
dep(agents-3, acetazolamide-5)
det(thiazides-8, some-7)
appos(acetazolamide-5, thiazides-8)
root(ROOT-0, increase-10)
det(concentration-12, the-11)
dobj(increase-10, concentration-12)
det(species-16, the-14)
amod(species-16, non-ionized-15)
prep_of(concentration-12, species-16)
det(molecule-20, the-18)
nn(molecule-20, amphetamine-19)
prep_of(species-16, molecule-20)
advmod(decreasing-23, thereby-22)
partmod(increase-10, decreasing-23)
xcomp(increase-10, decreasing-23)
amod(excretion-25, urinary-24)
dobj(decreasing-23, excretion-25)

Both/DT groups/NNS of/IN agents/NNS increase/VBP blood/NN levels/NNS and/CC therefore/RB potentiate/VB the/DT actions/NNS of/IN amphetamines/NN ./.

(ROOT (S1 (S (S (NP (NP (DT Both) (NNS groups)) (PP (IN of) (NP (NNS agents)))) (VP (VP (VBP increase) (NP (NN blood) (NNS levels))) (CC and) (ADVP (RB therefore)) (VP (VB potentiate) (NP (NP (DT the) (NNS actions)) (PP (IN of) (NP (NN amphetamines))))))) (. .))))

det(groups-2, Both-1)
nsubj(increase-5, groups-2)
prep_of(groups-2, agents-4)
root(ROOT-0, increase-5)
nn(levels-7, blood-6)
dobj(increase-5, levels-7)
advmod(increase-5, therefore-9)
conj_and(increase-5, therefore-9)
conj_and(increase-5, potentiate-10)
det(actions-12, the-11)
dobj(potentiate-10, actions-12)
prep_of(actions-12, amphetamines-14)

Antidepressants/NNS ,/, tricyclic/JJ :/: Amphetamines/NN may/MD enhance/VB the/DT activity/NN of/IN tricyclic/JJ or/CC sympathomimetic/JJ agents/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NP (NNS Antidepressants)) (, ,) (NP (ADJP (JJ tricyclic))) (: :) (NP (NN Amphetamines))) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (ADJP (ADJP (JJ tricyclic)) (CC or) (ADJP (JJ sympathomimetic))) (NNS agents)))))) (: ;)) (. .))))

nsubj(enhance-7, Antidepressants-1)
appos(Antidepressants-1, tricyclic-3)
dep(Antidepressants-1, Amphetamines-5)
aux(enhance-7, may-6)
root(ROOT-0, enhance-7)
det(activity-9, the-8)
dobj(enhance-7, activity-9)
amod(agents-14, tricyclic-11)
conj_or(tricyclic-11, sympathomimetic-13)
prep_of(activity-9, agents-14)

d-amphetamine/NN with/IN desipramine/NN or/CC protriptyline/NN and/CC possibly/RB other/JJ tricyclics/NNS cause/VBP striking/JJ and/CC sustained/JJ increases/NNS in/IN the/DT concentration/NN of/IN d-amphetamine/NN in/IN the/DT brain/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NP (NN d-amphetamine)) (PP (IN with) (NP (NP (NN desipramine)) (CC or) (NP (NN protriptyline))))) (CC and) (ADVP (RB possibly)) (NP (JJ other) (NNS tricyclics))) (VP (VBP cause) (NP (NP (ADJP (ADJP (JJ striking)) (CC and) (ADJP (JJ sustained))) (NNS increases)) (PP (IN in) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NN d-amphetamine))) (PP (IN in) (NP (DT the) (NN brain))))))) (: ;)) (. .))))

nsubj(cause-10, d-amphetamine-1)
prep_with(d-amphetamine-1, desipramine-3)
conj_or(desipramine-3, protriptyline-5)
advmod(d-amphetamine-1, possibly-7)
conj_and(d-amphetamine-1, possibly-7)
amod(tricyclics-9, other-8)
conj_and(d-amphetamine-1, tricyclics-9)
root(ROOT-0, cause-10)
amod(increases-14, striking-11)
conj_and(striking-11, sustained-13)
dobj(cause-10, increases-14)
det(concentration-17, the-16)
prep_in(increases-14, concentration-17)
prep_of(concentration-17, d-amphetamine-19)
det(brain-22, the-21)
prep_in(concentration-17, brain-22)

MAO/NN inhibitors/NNS :/: MAOI/NN antidepressants/NNS ,/, as/RB well/RB as/IN a/DT metabolite/NN of/IN furazolidone/NN ,/, slow/JJ amphetamine/NN metabolism/NN ./.

(ROOT (S1 (S (NP (NP (NN MAO) (NNS inhibitors)) (: :) (NP (NP (NN MAOI) (NNS antidepressants)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NP (DT a) (NN metabolite)) (PP (IN of) (NP (NN furazolidone)))) (, ,) (NP (JJ slow) (NN amphetamine) (NN metabolism)))) (. .)))))

nn(inhibitors-2, MAO-1)
root(ROOT-0, inhibitors-2)
nn(antidepressants-5, MAOI-4)
dep(inhibitors-2, antidepressants-5)
det(metabolite-11, a-10)
conj_and(antidepressants-5, metabolite-11)
prep_of(metabolite-11, furazolidone-13)
amod(metabolism-17, slow-15)
nn(metabolism-17, amphetamine-16)
appos(metabolite-11, metabolism-17)

This/DT slowing/NN potentiates/VBZ amphetamines/NN ,/, increasing/VBG their/PRP$ effect/NN on/IN the/DT release/NN of/IN norepinephrine/NN and/CC other/JJ monoamines/NNS from/IN adrenergic/JJ nerve/NN endings/NNS ;/: ./.

(ROOT (S1 (S (S (NP (DT This) (NN slowing)) (VP (VBZ potentiates) (NP (NN amphetamines)) (, ,) (S (VP (VBG increasing) (NP (NP (PRP$ their) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (NP (NN norepinephrine)) (CC and) (NP (JJ other) (NNS monoamines)))) (PP (IN from) (NP (JJ adrenergic) (NN nerve) (NNS endings))))))))) (: ;)) (. .))))

det(slowing-2, This-1)
nsubj(potentiates-3, slowing-2)
root(ROOT-0, potentiates-3)
dobj(potentiates-3, amphetamines-4)
partmod(potentiates-3, increasing-6)
xcomp(potentiates-3, increasing-6)
poss(effect-8, their-7)
dobj(increasing-6, effect-8)
det(release-11, the-10)
prep_on(effect-8, release-11)
prep_of(release-11, norepinephrine-13)
amod(monoamines-16, other-15)
conj_and(norepinephrine-13, monoamines-16)
amod(endings-20, adrenergic-18)
nn(endings-20, nerve-19)
prep_from(release-11, endings-20)

Antihistamines/NNS :/: Amphetamines/NN may/MD counteract/VB the/DT sedative/JJ effect/NN of/IN antihistamines/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Antihistamines)) (: :) (S (NP (NN Amphetamines)) (VP (MD may) (VP (VB counteract) (NP (NP (DT the) (JJ sedative) (NN effect)) (PP (IN of) (NP (NNS antihistamines))))))) (. .)))))

root(ROOT-0, Antihistamines-1)
nsubj(counteract-5, Amphetamines-3)
aux(counteract-5, may-4)
dep(Antihistamines-1, counteract-5)
det(effect-8, the-6)
amod(effect-8, sedative-7)
dobj(counteract-5, effect-8)
prep_of(effect-8, antihistamines-10)

Antihypertensives/NNS :/: Amphetamines/NN may/MD antagonize/VB the/DT hypotensive/JJ effects/NNS of/IN antihypertensives/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Antihypertensives)) (: :) (S (NP (NN Amphetamines)) (VP (MD may) (VP (VB antagonize) (NP (NP (DT the) (JJ hypotensive) (NNS effects)) (PP (IN of) (NP (NNS antihypertensives))))))) (. .)))))

root(ROOT-0, Antihypertensives-1)
nsubj(antagonize-5, Amphetamines-3)
aux(antagonize-5, may-4)
dep(Antihypertensives-1, antagonize-5)
det(effects-8, the-6)
amod(effects-8, hypotensive-7)
dobj(antagonize-5, effects-8)
prep_of(effects-8, antihypertensives-10)

Chlorpromazine/NN :/: Chlorpromazine/NN blocks/VBZ dopamine/NN and/CC norepinephrine/NN reuptake/NN ,/, thus/RB inhibiting/VBG the/DT central/JJ stimulant/JJ effects/NNS of/IN amphetamines/NN ,/, and/CC can/MD be/VB used/VBN to/TO treat/VB amphetamine/NN poisoning/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Chlorpromazine)) (: :) (NP (NN Chlorpromazine))) (VP (VP (VBZ blocks) (NP (NP (NN dopamine)) (CC and) (NP (NN norepinephrine)) (NP (NN reuptake))) (, ,) (S (ADVP (RB thus)) (VP (VBG inhibiting) (NP (NP (DT the) (JJ central) (JJ stimulant) (NNS effects)) (PP (IN of) (NP (NN amphetamines))))))) (, ,) (CC and) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (NN amphetamine) (NN poisoning)))))))))) (. .))))

nsubj(blocks-4, Chlorpromazine-1)
dep(Chlorpromazine-1, Chlorpromazine-3)
root(ROOT-0, blocks-4)
dobj(blocks-4, dopamine-5)
conj_and(dopamine-5, norepinephrine-7)
dobj(blocks-4, reuptake-8)
dep(dopamine-5, reuptake-8)
advmod(inhibiting-11, thus-10)
partmod(blocks-4, inhibiting-11)
xcomp(blocks-4, inhibiting-11)
det(effects-15, the-12)
amod(effects-15, central-13)
amod(effects-15, stimulant-14)
dobj(inhibiting-11, effects-15)
prep_of(effects-15, amphetamines-17)
aux(used-22, can-20)
auxpass(used-22, be-21)
conj_and(blocks-4, used-22)
aux(treat-24, to-23)
xcomp(used-22, treat-24)
nn(poisoning-26, amphetamine-25)
dobj(treat-24, poisoning-26)

Ethosuximide/NN :/: Amphetamines/NN may/MD delay/VB intestinal/JJ absorption/NN of/IN ethosuximide/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Ethosuximide)) (: :) (NP (NN Amphetamines))) (VP (MD may) (VP (VB delay) (NP (NP (JJ intestinal) (NN absorption)) (PP (IN of) (NP (NN ethosuximide))))))) (. .))))

nsubj(delay-5, Ethosuximide-1)
dep(Ethosuximide-1, Amphetamines-3)
aux(delay-5, may-4)
root(ROOT-0, delay-5)
amod(absorption-7, intestinal-6)
dobj(delay-5, absorption-7)
prep_of(absorption-7, ethosuximide-9)

Haloperidol/NN :/: Haloperidol/NN blocks/VBZ dopamine/NN and/CC norepinephrine/NN reuptake/NN ,/, thus/RB inhibiting/VBG the/DT central/JJ stimulant/JJ effects/NNS of/IN amphetamines/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Haloperidol)) (: :) (NP (NN Haloperidol))) (VP (VBZ blocks) (NP (NP (NN dopamine)) (CC and) (NP (NN norepinephrine)) (NP (NN reuptake))) (, ,) (S (ADVP (RB thus)) (VP (VBG inhibiting) (NP (NP (DT the) (JJ central) (JJ stimulant) (NNS effects)) (PP (IN of) (NP (NN amphetamines)))))))) (. .))))

nsubj(blocks-4, Haloperidol-1)
dep(Haloperidol-1, Haloperidol-3)
root(ROOT-0, blocks-4)
dobj(blocks-4, dopamine-5)
conj_and(dopamine-5, norepinephrine-7)
dobj(blocks-4, reuptake-8)
dep(dopamine-5, reuptake-8)
advmod(inhibiting-11, thus-10)
partmod(blocks-4, inhibiting-11)
xcomp(blocks-4, inhibiting-11)
det(effects-15, the-12)
amod(effects-15, central-13)
amod(effects-15, stimulant-14)
dobj(inhibiting-11, effects-15)
prep_of(effects-15, amphetamines-17)

Lithium/NN carbonate/NN :/: The/DT stimulatory/JJ effects/NNS of/IN amphetamines/NN may/MD be/VB inhibited/VBN by/IN lithium/NN carbonate/NN ./.

(ROOT (S1 (S (NP (NP (NN Lithium) (NN carbonate)) (: :) (S (NP (NP (DT The) (JJ stimulatory) (NNS effects)) (PP (IN of) (NP (NN amphetamines)))) (VP (MD may) (VP (VB be) (VP (VBN inhibited) (PP (IN by) (NP (NN lithium) (NN carbonate))))))) (. .)))))

nn(carbonate-2, Lithium-1)
root(ROOT-0, carbonate-2)
det(effects-6, The-4)
amod(effects-6, stimulatory-5)
nsubjpass(inhibited-11, effects-6)
prep_of(effects-6, amphetamines-8)
aux(inhibited-11, may-9)
auxpass(inhibited-11, be-10)
dep(carbonate-2, inhibited-11)
nn(carbonate-14, lithium-13)
agent(inhibited-11, carbonate-14)

Meperidine/NN :/: Amphetamines/NN potentiate/VB the/DT analgesic/JJ effect/NN of/IN meperidine/NN ./.

(ROOT (S1 (S (S (NP (NN Meperidine) (: :) (NN Amphetamines)) (VP (VB potentiate) (NP (NP (DT the) (JJ analgesic) (NN effect)) (PP (IN of) (NP (NN meperidine)))))) (. .))))

nn(Amphetamines-3, Meperidine-1)
nsubj(potentiate-4, Amphetamines-3)
root(ROOT-0, potentiate-4)
det(effect-7, the-5)
amod(effect-7, analgesic-6)
dobj(potentiate-4, effect-7)
prep_of(effect-7, meperidine-9)

Methenamine/NN therapy/NN :/: Urinary/JJ excretion/NN of/IN amphetamines/NN is/VBZ increased/VBN ,/, and/CC efficacy/NN is/VBZ reduced/VBN ,/, by/IN acidifying/VBG agents/NNS used/VBN in/IN methenamine/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NN Methenamine) (NN therapy)) (: :) (S (NP (NP (JJ Urinary) (NN excretion)) (PP (IN of) (NP (NN amphetamines)))) (VP (VBZ is) (VP (VBN increased)))) (, ,) (CC and) (S (NP (NN efficacy)) (VP (VBZ is) (VP (VBN reduced) (, ,) (PP (IN by) (S (VP (VBG acidifying) (NP (NP (NNS agents)) (VP (VBN used) (PP (IN in) (NP (NN methenamine) (NN therapy)))))))))))) (. .))))

nn(therapy-2, Methenamine-1)
dep(increased-9, therapy-2)
amod(excretion-5, Urinary-4)
nsubjpass(increased-9, excretion-5)
prep_of(excretion-5, amphetamines-7)
auxpass(increased-9, is-8)
root(ROOT-0, increased-9)
nsubjpass(reduced-14, efficacy-12)
auxpass(reduced-14, is-13)
conj_and(increased-9, reduced-14)
agent(reduced-14, acidifying-17)
dobj(acidifying-17, agents-18)
partmod(agents-18, used-19)
nn(therapy-22, methenamine-21)
prep_in(used-19, therapy-22)

Norepinephrine/NN :/: Amphetamines/NN enhance/VBP the/DT adrenergic/JJ effect/NN of/IN norepinephrine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Norepinephrine)) (: :) (NP (NN Amphetamines))) (VP (VBP enhance) (NP (NP (DT the) (JJ adrenergic) (NN effect)) (PP (IN of) (NP (NN norepinephrine)))))) (. .))))

nsubj(enhance-4, Norepinephrine-1)
dep(Norepinephrine-1, Amphetamines-3)
root(ROOT-0, enhance-4)
det(effect-7, the-5)
amod(effect-7, adrenergic-6)
dobj(enhance-4, effect-7)
prep_of(effect-7, norepinephrine-9)

Phenobarbital/NN :/: Amphetamines/NN may/MD delay/VB intestinal/JJ absorption/NN of/IN phenobarbital/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NN Phenobarbital)) (: :) (NP (NN Amphetamines))) (VP (MD may) (VP (VB delay) (NP (NP (JJ intestinal) (NN absorption)) (PP (IN of) (NP (NN phenobarbital)))))) (: ;)) (. .))))

nsubj(delay-5, Phenobarbital-1)
dep(Phenobarbital-1, Amphetamines-3)
aux(delay-5, may-4)
root(ROOT-0, delay-5)
amod(absorption-7, intestinal-6)
dobj(delay-5, absorption-7)
prep_of(absorption-7, phenobarbital-9)

co-administration/NN of/IN phenobarbital/NN may/MD produce/VB a/DT synergistic/JJ anticonvulsant/JJ action/NN ./.

(ROOT (S1 (S (S (NP (NP (NN co-administration)) (PP (IN of) (NP (NN phenobarbital)))) (VP (MD may) (VP (VB produce) (NP (DT a) (JJ synergistic) (JJ anticonvulsant) (NN action))))) (. .))))

nsubj(produce-5, co-administration-1)
prep_of(co-administration-1, phenobarbital-3)
aux(produce-5, may-4)
root(ROOT-0, produce-5)
det(action-9, a-6)
amod(action-9, synergistic-7)
amod(action-9, anticonvulsant-8)
dobj(produce-5, action-9)

Phenytoin/NN :/: Amphetamines/NN may/MD delay/VB intestinal/JJ absorption/NN of/IN phenytoin/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN Phenytoin)) (: :) (S (NP (NN Amphetamines)) (VP (MD may) (VP (VB delay) (NP (NP (JJ intestinal) (NN absorption)) (PP (IN of) (NP (NN phenytoin)))))) (: ;)) (. .)))))

root(ROOT-0, Phenytoin-1)
nsubj(delay-5, Amphetamines-3)
aux(delay-5, may-4)
dep(Phenytoin-1, delay-5)
amod(absorption-7, intestinal-6)
dobj(delay-5, absorption-7)
prep_of(absorption-7, phenytoin-9)

co-administration/NN of/IN phenytoin/NN may/MD produce/VB a/DT synergistic/JJ anticonvulsant/JJ action/NN ./.

(ROOT (S1 (S (S (NP (NP (NN co-administration)) (PP (IN of) (NP (NN phenytoin)))) (VP (MD may) (VP (VB produce) (NP (DT a) (JJ synergistic) (JJ anticonvulsant) (NN action))))) (. .))))

nsubj(produce-5, co-administration-1)
prep_of(co-administration-1, phenytoin-3)
aux(produce-5, may-4)
root(ROOT-0, produce-5)
det(action-9, a-6)
amod(action-9, synergistic-7)
amod(action-9, anticonvulsant-8)
dobj(produce-5, action-9)

Propoxyphene/NN :/: In/IN cases/NNS of/IN propoxyphene/NN overdosage/NN ,/, amphetamine/NN CNS/NN stimulation/NN is/VBZ potentiated/VBN and/CC fatal/JJ convulsions/NNS can/MD occur/VB ./.

(ROOT (S1 (S (NP (NP (NN Propoxyphene)) (: :) (S (PP (IN In) (NP (NP (NNS cases)) (PP (IN of) (NP (NN propoxyphene) (NN overdosage))))) (, ,) (S (NP (NN amphetamine) (NN CNS) (NN stimulation)) (VP (VBZ is) (VP (VBN potentiated)))) (CC and) (S (NP (JJ fatal) (NNS convulsions)) (VP (MD can) (VP (VB occur))))) (. .)))))

root(ROOT-0, Propoxyphene-1)
prep_in(potentiated-13, cases-4)
nn(overdosage-7, propoxyphene-6)
prep_of(cases-4, overdosage-7)
nn(stimulation-11, amphetamine-9)
nn(stimulation-11, CNS-10)
nsubjpass(potentiated-13, stimulation-11)
auxpass(potentiated-13, is-12)
dep(Propoxyphene-1, potentiated-13)
amod(convulsions-16, fatal-15)
nsubj(occur-18, convulsions-16)
aux(occur-18, can-17)
conj_and(potentiated-13, occur-18)

Veratrum/NN alkaloids/NNS :/: Amphetamines/NN inhibit/VBP the/DT hypotensive/JJ effect/NN of/IN veratrum/NN alkaloids/NNS ./.

(ROOT (S1 (S (S (NP (NN Veratrum) (NNS alkaloids)) (: :) (NP (NN Amphetamines)) (VP (VBP inhibit) (NP (NP (DT the) (JJ hypotensive) (NN effect)) (PP (IN of) (NP (NN veratrum) (NNS alkaloids)))))) (. .))))

nn(alkaloids-2, Veratrum-1)
nsubj(inhibit-5, alkaloids-2)
nsubj(inhibit-5, Amphetamines-4)
root(ROOT-0, inhibit-5)
det(effect-8, the-6)
amod(effect-8, hypotensive-7)
dobj(inhibit-5, effect-8)
nn(alkaloids-11, veratrum-10)
prep_of(effect-8, alkaloids-11)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: Amphetamines/NN can/MD cause/VB a/DT significant/JJ elevation/NN in/IN plasma/NN corticosteroid/NN levels/NNS ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (NN Amphetamines)) (VP (MD can) (VP (VB cause) (NP (NP (DT a) (JJ significant) (NN elevation)) (PP (IN in) (NP (NN plasma) (NN corticosteroid) (NNS levels))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
nsubj(cause-8, Amphetamines-6)
aux(cause-8, can-7)
dep(Interactions-4, cause-8)
det(elevation-11, a-9)
amod(elevation-11, significant-10)
dobj(cause-8, elevation-11)
nn(levels-15, plasma-13)
nn(levels-15, corticosteroid-14)
prep_in(elevation-11, levels-15)

Amphetamines/NN may/MD interfere/VB with/IN urinary/JJ steroid/NN determinations/NNS ./.

(ROOT (S1 (S (S (NP (NN Amphetamines)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (JJ urinary) (NN steroid) (NNS determinations)))))) (. .))))

nsubj(interfere-3, Amphetamines-1)
aux(interfere-3, may-2)
root(ROOT-0, interfere-3)
amod(determinations-7, urinary-5)
nn(determinations-7, steroid-6)
prep_with(interfere-3, determinations-7)

Additive/JJ depressant/JJ effect/NN when/WRB used/VBN with/IN general/JJ anesthetics/NNS ,/, sedatives/NNS ,/, antianxiety/NN drugs/NNS ,/, hypnotics/NN ,/, alcohol/NN ,/, and/CC other/JJ opiate/NN analgesics/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Additive) (JJ depressant) (NN effect)) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (PP (IN with) (NP (NP (JJ general) (NNS anesthetics)) (, ,) (NP (NNS sedatives)) (, ,) (NP (NN antianxiety) (NNS drugs)) (, ,) (NP (NN hypnotics)) (, ,) (NP (NN alcohol)) (, ,) (CC and) (NP (JJ other) (NN opiate) (NNS analgesics))))))) (. .)))))

amod(effect-3, Additive-1)
amod(effect-3, depressant-2)
root(ROOT-0, effect-3)
advmod(used-5, when-4)
dep(effect-3, used-5)
amod(anesthetics-8, general-7)
prep_with(used-5, anesthetics-8)
conj_and(anesthetics-8, sedatives-10)
nn(drugs-13, antianxiety-12)
conj_and(anesthetics-8, drugs-13)
conj_and(anesthetics-8, hypnotics-15)
conj_and(anesthetics-8, alcohol-17)
amod(analgesics-22, other-20)
nn(analgesics-22, opiate-21)
conj_and(anesthetics-8, analgesics-22)

May/MD interact/VB with/IN thyroid/NN medication/NN (/-LRB- e.g./FW ,/, levothyroxine/NN )/-RRB- ,/, iodine-containing/VBG products/NNS ,/, antacids/NNS ,/, H2-antagonists/NN (/-LRB- e.g./FW ,/, famotidine/NN ,/, ranitidine/NN )/-RRB- ,/, and/CC proton/NN pump/NN inhibitors/NNS (/-LRB- e.g./FW ,/, lansoprazole/NN ,/, omeprazole/NN )/-RRB- ./.

(ROOT (S1 (S (S (VP (MD May) (VP (VB interact) (PP (IN with) (NP (NP (NN thyroid) (NN medication)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN levothyroxine))) (-RRB- -RRB-)))) (, ,) (S (VP (VBG iodine-containing) (NP (NP (NNS products)) (, ,) (NP (NNS antacids)) (, ,) (NP (NP (NN H2-antagonists)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN famotidine)) (, ,) (NP (NN ranitidine))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN proton) (NN pump) (NNS inhibitors)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN lansoprazole)) (, ,) (NP (NN omeprazole)))) (-RRB- -RRB-))))))))) (. .))))

aux(interact-2, May-1)
root(ROOT-0, interact-2)
nn(medication-5, thyroid-4)
prep_with(interact-2, medication-5)
dep(medication-5, e.g.-7)
pobj(e.g.-7, levothyroxine-9)
xcomp(interact-2, iodine-containing-12)
dobj(iodine-containing-12, products-13)
conj_and(products-13, antacids-15)
conj_and(products-13, H2-antagonists-17)
dep(famotidine-21, e.g.-19)
dep(H2-antagonists-17, famotidine-21)
appos(famotidine-21, ranitidine-23)
nn(inhibitors-29, proton-27)
nn(inhibitors-29, pump-28)
conj_and(products-13, inhibitors-29)
dep(inhibitors-29, e.g.-31)
pobj(e.g.-31, lansoprazole-33)
appos(lansoprazole-33, omeprazole-35)

Caution/NN is/VBZ advised/VBN in/IN patients/NNS receiving/VBG concomitant/JJ high-dose/JJ aspirin/NN and/CC carbonic/JJ anhydrase/NN inhibitors/NNS ,/, as/IN anorexia/NN ,/, tachypnea/NN ,/, lethargy/NN and/CC coma/NN have/VBP been/VBN rarely/RB reported/VBN due/JJ to/TO a/DT possible/JJ drug/NN interaction/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (VBZ is) (VP (VBN advised) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ concomitant) (NP (NP (JJ high-dose) (NN aspirin)) (CC and) (NP (JJ carbonic) (NN anhydrase))) (NNS inhibitors))))) (, ,) (SBAR (IN as) (S (NP (NP (NN anorexia)) (, ,) (NP (NN tachypnea)) (, ,) (NP (NN lethargy)) (CC and) (NP (NN coma))) (VP (VBP have) (VP (VBN been) (ADVP (RB rarely)) (VP (VBN reported) (PP (JJ due) (TO to) (NP (DT a) (JJ possible) (NN drug) (NN interaction))))))))))) (. .))))

nsubjpass(advised-3, Caution-1)
auxpass(advised-3, is-2)
root(ROOT-0, advised-3)
prep_in(advised-3, patients-5)
partmod(patients-5, receiving-6)
amod(inhibitors-13, concomitant-7)
amod(aspirin-9, high-dose-8)
nn(inhibitors-13, aspirin-9)
amod(anhydrase-12, carbonic-11)
conj_and(aspirin-9, anhydrase-12)
dobj(receiving-6, inhibitors-13)
mark(reported-26, as-15)
nsubjpass(reported-26, anorexia-16)
conj_and(anorexia-16, tachypnea-18)
conj_and(anorexia-16, lethargy-20)
conj_and(anorexia-16, coma-22)
aux(reported-26, have-23)
auxpass(reported-26, been-24)
advmod(reported-26, rarely-25)
advcl(advised-3, reported-26)
det(interaction-32, a-29)
amod(interaction-32, possible-30)
nn(interaction-32, drug-31)
prep_due_to(reported-26, interaction-32)

Aspirin/NN :/: Concomitant/JJ administration/NN of/IN diclofenac/NN and/CC aspirin/NN is/VBZ not/RB recommended/VBN because/IN diclofenac/NN is/VBZ displaced/VBN from/IN its/PRP$ binding/NN sites/NNS during/IN the/DT concomitant/JJ administration/NN of/IN aspirin/NN ,/, resulting/VBG in/IN lower/JJR plasma/NN concentrations/NNS ,/, peak/NN plasma/NN levels/NNS ,/, and/CC AUC/NN values/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Aspirin)) (: :) (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NN diclofenac)))) (CC and) (NP (NN aspirin))) (VP (VBZ is) (RB not) (VP (VBN recommended) (SBAR (IN because) (S (NP (NN diclofenac)) (VP (VBZ is) (VP (VBN displaced) (PP (IN from) (NP (PRP$ its) (NN binding) (NNS sites))) (PP (IN during) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN aspirin)))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (JJR lower) (NN plasma) (NNS concentrations)) (, ,) (NP (NN peak) (NN plasma) (NNS levels)) (, ,) (CC and) (NP (NN AUC) (NNS values)))))))))))) (. .))))

nsubjpass(recommended-11, Aspirin-1)
amod(administration-4, Concomitant-3)
conj_and(Aspirin-1, administration-4)
prep_of(administration-4, diclofenac-6)
conj_and(Aspirin-1, aspirin-8)
auxpass(recommended-11, is-9)
neg(recommended-11, not-10)
root(ROOT-0, recommended-11)
mark(displaced-15, because-12)
nsubjpass(displaced-15, diclofenac-13)
auxpass(displaced-15, is-14)
advcl(recommended-11, displaced-15)
poss(sites-19, its-17)
nn(sites-19, binding-18)
prep_from(displaced-15, sites-19)
det(administration-23, the-21)
amod(administration-23, concomitant-22)
prep_during(displaced-15, administration-23)
prep_of(administration-23, aspirin-25)
xcomp(displaced-15, resulting-27)
amod(concentrations-31, lower-29)
nn(concentrations-31, plasma-30)
prep_in(resulting-27, concentrations-31)
nn(levels-35, peak-33)
nn(levels-35, plasma-34)
conj_and(concentrations-31, levels-35)
nn(values-39, AUC-38)
conj_and(concentrations-31, values-39)

Anticoagulants/NNS :/: While/IN studies/NNS have/VBP not/RB shown/VBN diclofenac/NN to/TO interact/VB with/IN anticoagulants/NNS of/IN the/DT warfarin/JJ type/NN ,/, caution/NN should/MD be/VB exercised/VBN ,/, nonetheless/RB ,/, since/IN interactions/NNS have/VBP been/VBN seen/VBN with/IN other/JJ NSAIDs/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Anticoagulants)) (: :) (S (SBAR (IN While) (S (NP (NNS studies)) (VP (VBP have) (RB not) (VP (VBN shown) (NP (NN diclofenac)) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NP (NNS anticoagulants)) (PP (IN of) (NP (DT the) (JJ warfarin) (NN type)))))))))))) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (, ,) (ADVP (RB nonetheless)) (, ,) (SBAR (IN since) (S (NP (NNS interactions)) (VP (VBP have) (VP (VBN been) (VP (VBN seen) (PP (IN with) (NP (JJ other) (NNS NSAIDs)))))))))))) (. .)))))

root(ROOT-0, Anticoagulants-1)
mark(shown-7, While-3)
nsubj(shown-7, studies-4)
aux(shown-7, have-5)
neg(shown-7, not-6)
advcl(exercised-21, shown-7)
dobj(shown-7, diclofenac-8)
aux(interact-10, to-9)
xcomp(shown-7, interact-10)
prep_with(interact-10, anticoagulants-12)
det(type-16, the-14)
amod(type-16, warfarin-15)
prep_of(anticoagulants-12, type-16)
nsubjpass(exercised-21, caution-18)
aux(exercised-21, should-19)
auxpass(exercised-21, be-20)
dep(Anticoagulants-1, exercised-21)
advmod(exercised-21, nonetheless-23)
mark(seen-29, since-25)
nsubjpass(seen-29, interactions-26)
aux(seen-29, have-27)
auxpass(seen-29, been-28)
advcl(exercised-21, seen-29)
amod(NSAIDs-32, other-31)
prep_with(seen-29, NSAIDs-32)

Because/IN prostaglandins/NNS play/VBP an/DT important/JJ role/NN in/IN hemostasis/NN ,/, and/CC NSAIDs/NNS affect/VBP platelet/NN function/NN as/IN well/NN ,/, concurrent/JJ therapy/NN with/IN all/DT NSAIDs/NNS ,/, including/VBG diclofenac/NN ,/, and/CC warfarin/NN requires/VBZ close/JJ monitoring/NN of/IN patients/NNS to/TO be/VB certain/JJ that/IN no/DT change/NN in/IN their/PRP$ anticoagulant/JJ dosage/NN is/VBZ required/VBN ./.

(ROOT (S1 (S (SBAR (IN Because) (S (S (NP (NNS prostaglandins)) (VP (VBP play) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (NP (NN hemostasis))))) (, ,) (CC and) (S (NP (NNS NSAIDs)) (VP (VBP affect) (NP (NN platelet) (NN function)) (PP (IN as) (NP (NN well))))))) (, ,) (NP (NP (JJ concurrent) (NN therapy)) (PP (IN with) (NP (NP (NP (DT all) (NNS NSAIDs)) (, ,) (PP (VBG including) (NP (NN diclofenac))) (, ,)) (CC and) (NP (NN warfarin))))) (VP (VBZ requires) (NP (NP (JJ close) (NN monitoring)) (PP (IN of) (NP (NNS patients)))) (S (VP (TO to) (VP (VB be) (ADJP (JJ certain) (SBAR (IN that) (S (NP (NP (DT no) (NN change)) (PP (IN in) (NP (PRP$ their) (JJ anticoagulant) (NN dosage)))) (VP (VBZ is) (VP (VBN required)))))))))) (. .))))

mark(play-3, Because-1)
nsubj(play-3, prostaglandins-2)
advcl(requires-29, play-3)
det(role-6, an-4)
amod(role-6, important-5)
dobj(play-3, role-6)
prep_in(play-3, hemostasis-8)
nsubj(affect-12, NSAIDs-11)
conj_and(play-3, affect-12)
nn(function-14, platelet-13)
dobj(affect-12, function-14)
prep_as(affect-12, well-16)
amod(therapy-19, concurrent-18)
nsubj(requires-29, therapy-19)
det(NSAIDs-22, all-21)
prep_with(therapy-19, NSAIDs-22)
prep_including(NSAIDs-22, diclofenac-25)
conj_and(NSAIDs-22, warfarin-28)
root(ROOT-0, requires-29)
amod(monitoring-31, close-30)
dobj(requires-29, monitoring-31)
prep_of(monitoring-31, patients-33)
aux(certain-36, to-34)
cop(certain-36, be-35)
xcomp(requires-29, certain-36)
complm(required-45, that-37)
det(change-39, no-38)
nsubjpass(required-45, change-39)
poss(dosage-43, their-41)
amod(dosage-43, anticoagulant-42)
prep_in(change-39, dosage-43)
auxpass(required-45, is-44)
ccomp(certain-36, required-45)

Digoxin/NN ,/, Methotrexate/NN ,/, Cyclosporine/NN :/: Diclofenac/NN ,/, like/IN other/JJ NSAIDs/NNS ,/, may/MD affect/VB renal/JJ prostaglandins/NNS and/CC increase/VB the/DT toxicity/NN of/IN certain/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Digoxin)) (, ,) (NP (NN Methotrexate)) (, ,) (NP (NN Cyclosporine)) (: :) (NP (NN Diclofenac))) (, ,) (PP (IN like) (NP (JJ other) (NNS NSAIDs))) (, ,) (VP (MD may) (VP (VP (VB affect) (NP (JJ renal) (NNS prostaglandins))) (CC and) (VP (VB increase) (NP (NP (DT the) (NN toxicity)) (PP (IN of) (NP (JJ certain) (NNS drugs)))))))) (. .))))

nsubj(affect-14, Digoxin-1)
appos(Digoxin-1, Methotrexate-3)
appos(Digoxin-1, Cyclosporine-5)
dep(Digoxin-1, Diclofenac-7)
amod(NSAIDs-11, other-10)
prep_like(affect-14, NSAIDs-11)
aux(affect-14, may-13)
root(ROOT-0, affect-14)
amod(prostaglandins-16, renal-15)
dobj(affect-14, prostaglandins-16)
conj_and(affect-14, increase-18)
det(toxicity-20, the-19)
dobj(increase-18, toxicity-20)
amod(drugs-23, certain-22)
prep_of(toxicity-20, drugs-23)

Ingestion/NN of/IN diclofenac/NN may/MD increase/VB serum/NN concentrations/NNS of/IN digoxin/NN and/CC methotrexate/NN and/CC increase/VB cyclosporine/NN @/NN s/NN nephrotoxicity/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Ingestion)) (PP (IN of) (NP (NN diclofenac)))) (VP (MD may) (VP (VP (VB increase) (NP (NP (NN serum) (NNS concentrations)) (PP (IN of) (NP (NP (NN digoxin)) (CC and) (NP (NN methotrexate)))))) (CC and) (VP (VB increase) (NP (NN cyclosporine) (NN @) (NN s) (NN nephrotoxicity)))))) (. .))))

nsubj(increase-5, Ingestion-1)
prep_of(Ingestion-1, diclofenac-3)
aux(increase-5, may-4)
root(ROOT-0, increase-5)
nn(concentrations-7, serum-6)
dobj(increase-5, concentrations-7)
prep_of(concentrations-7, digoxin-9)
conj_and(digoxin-9, methotrexate-11)
conj_and(increase-5, increase-13)
nn(nephrotoxicity-17, cyclosporine-14)
nn(nephrotoxicity-17, @-15)
nn(nephrotoxicity-17, s-16)
dobj(increase-13, nephrotoxicity-17)

Patients/NNS who/WP begin/VBP taking/VBG diclofenac/NN or/CC who/WP increase/VBP their/PRP$ diclofenac/NN dose/NN or/CC any/DT other/JJ NSAID/NN while/IN taking/VBG digoxin/NN ,/, methotrexate/NN ,/, or/CC cyclosporine/NN may/MD develop/VBP toxicity/NN characteristics/NNS for/IN these/DT drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (SBAR (SBAR (WHNP (WP who)) (S (VP (VBP begin) (VP (VBG taking) (NP (NN diclofenac)))))) (CC or) (SBAR (WHNP (WP who)) (S (VP (VBP increase) (NP (NP (PRP$ their) (NN diclofenac) (NN dose)) (CC or) (NP (DT any) (JJ other) (NN NSAID))) (SBAR (IN while) (S (VP (VBG taking) (NP (NP (NN digoxin)) (, ,) (NP (NN methotrexate)) (, ,) (CC or) (NP (NN cyclosporine))))))))))) (VP (MD may) (VP (VBP develop) (NP (NP (NN toxicity) (NNS characteristics)) (PP (IN for) (NP (DT these) (NNS drugs))))))) (. .))))

nsubj(begin-3, Patients-1)
nsubj(increase-8, Patients-1)
nsubj(taking-17, Patients-1)
nsubj(develop-25, Patients-1)
rcmod(Patients-1, begin-3)
dep(begin-3, taking-4)
dobj(taking-4, diclofenac-5)
conj_or(begin-3, increase-8)
poss(dose-11, their-9)
nn(dose-11, diclofenac-10)
dobj(increase-8, dose-11)
det(NSAID-15, any-13)
amod(NSAID-15, other-14)
conj_or(dose-11, NSAID-15)
mark(taking-17, while-16)
advcl(increase-8, taking-17)
dobj(taking-17, digoxin-18)
conj_or(digoxin-18, methotrexate-20)
conj_or(digoxin-18, cyclosporine-23)
aux(develop-25, may-24)
root(ROOT-0, develop-25)
nn(characteristics-27, toxicity-26)
dobj(develop-25, characteristics-27)
det(drugs-30, these-29)
prep_for(characteristics-27, drugs-30)

In/IN the/DT case/NN of/IN digoxin/NN ,/, serum/NN levels/NNS should/MD be/VB monitored/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN digoxin))))) (, ,) (NP (NN serum) (NNS levels)) (VP (MD should) (VP (VB be) (VP (VBN monitored))))) (. .))))

det(case-3, the-2)
prep_in(monitored-11, case-3)
prep_of(case-3, digoxin-5)
nn(levels-8, serum-7)
nsubjpass(monitored-11, levels-8)
aux(monitored-11, should-9)
auxpass(monitored-11, be-10)
root(ROOT-0, monitored-11)

Lithium/NN :/: Diclofenac/NN decreases/VBZ lithium/NN renal/JJ clearance/NN and/CC increases/VBZ lithium/NN plasma/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NN Lithium)) (: :) (NP (NN Diclofenac)) (VP (VP (VBZ decreases) (NP (NN lithium) (JJ renal) (NN clearance))) (CC and) (VP (VBZ increases) (NP (NN lithium) (NN plasma) (NNS levels))))) (. .))))

nsubj(decreases-4, Lithium-1)
nsubj(decreases-4, Diclofenac-3)
root(ROOT-0, decreases-4)
nn(clearance-7, lithium-5)
amod(clearance-7, renal-6)
dobj(decreases-4, clearance-7)
conj_and(decreases-4, increases-9)
nn(levels-12, lithium-10)
nn(levels-12, plasma-11)
dobj(increases-9, levels-12)

In/IN patients/NNS taking/VBG diclofenac/NN and/CC lithium/NN concomitantly/RB ,/, lithium/NN toxicity/NN may/MD develop/VB ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (NP (NN diclofenac)) (CC and) (NP (NN lithium))) (ADVP (RB concomitantly)))))) (, ,) (NP (NN lithium) (NN toxicity)) (VP (MD may) (VP (VB develop)))) (. .))))

prep_in(develop-12, patients-2)
partmod(patients-2, taking-3)
dobj(taking-3, diclofenac-4)
conj_and(diclofenac-4, lithium-6)
advmod(diclofenac-4, concomitantly-7)
nn(toxicity-10, lithium-9)
nsubj(develop-12, toxicity-10)
aux(develop-12, may-11)
root(ROOT-0, develop-12)

Oral/JJ Hypoglycemics/NN :/: Diclofenac/NN does/VBZ not/RB alter/VB glucose/NN metabolism/NN in/IN normal/JJ subjects/NNS nor/CC does/VBZ it/PRP alter/VBP the/DT effects/NNS of/IN oral/JJ hypoglycemic/JJ agents/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Oral) (NN Hypoglycemics)) (: :) (S (NP (NN Diclofenac)) (VP (VP (VBZ does) (RB not) (VP (VB alter) (NP (NP (NN glucose) (NN metabolism)) (PP (IN in) (NP (JJ normal) (NNS subjects)))))) (CC nor) (VP (VBZ does) (NP (NP (PRP it)) (VP (VBP alter) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ oral) (JJ hypoglycemic) (NNS agents))))))))) (. .)))))

amod(Hypoglycemics-2, Oral-1)
root(ROOT-0, Hypoglycemics-2)
nsubj(alter-7, Diclofenac-4)
aux(alter-7, does-5)
neg(alter-7, not-6)
dep(Hypoglycemics-2, alter-7)
nn(metabolism-9, glucose-8)
dobj(alter-7, metabolism-9)
amod(subjects-12, normal-11)
prep_in(metabolism-9, subjects-12)
conj_nor(alter-7, does-14)
dobj(does-14, it-15)
dep(it-15, alter-16)
det(effects-18, the-17)
dobj(alter-16, effects-18)
amod(agents-22, oral-20)
amod(agents-22, hypoglycemic-21)
prep_of(effects-18, agents-22)

There/EX are/VBP rare/JJ reports/NNS ,/, however/RB ,/, from/IN marketing/JJ experiences/NNS ,/, of/IN changes/NNS in/IN effects/NNS of/IN insulin/NN or/CC oral/JJ hypoglycemic/JJ agents/NNS in/IN the/DT presence/NN of/IN diclofenac/NN that/WDT necessitated/VBD changes/NNS in/IN the/DT doses/NNS of/IN such/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP are) (NP (NP (JJ rare) (NNS reports)) (, ,) (ADVP (RB however)) (, ,) (PP (IN from) (NP (JJ marketing) (NNS experiences))) (, ,) (PP (IN of) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NNS effects)) (PP (IN of) (NP (NP (NN insulin)) (CC or) (NP (JJ oral) (JJ hypoglycemic) (NNS agents)))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NN diclofenac)) (SBAR (WHNP (WDT that)) (S (VP (VBD necessitated) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (DT the) (NNS doses)) (PP (IN of) (NP (JJ such) (NNS agents)))))))))))))))))))) (. .))))

expl(are-2, There-1)
root(ROOT-0, are-2)
amod(reports-4, rare-3)
nsubj(are-2, reports-4)
advmod(reports-4, however-6)
amod(experiences-10, marketing-9)
prep_from(reports-4, experiences-10)
prep_of(reports-4, changes-13)
prep_in(changes-13, effects-15)
prep_of(effects-15, insulin-17)
amod(agents-21, oral-19)
amod(agents-21, hypoglycemic-20)
conj_or(insulin-17, agents-21)
det(presence-24, the-23)
prep_in(effects-15, presence-24)
prep_of(presence-24, diclofenac-26)
nsubj(necessitated-28, diclofenac-26)
rcmod(diclofenac-26, necessitated-28)
dobj(necessitated-28, changes-29)
det(doses-32, the-31)
prep_in(changes-29, doses-32)
amod(agents-35, such-34)
prep_of(doses-32, agents-35)

A/DT direct/JJ causal/JJ relationship/NN has/VBZ not/RB been/VBN established/VBN ,/, but/CC physicians/NNS should/MD consider/VB the/DT possibility/NN that/IN diclofenac/NN may/MD alter/VB a/DT diabetic/JJ patient/NN @/NN s/NN response/NN to/TO insulin/NN or/CC oral/JJ hypoglycemic/JJ agents/NNS ./.

(ROOT (S1 (S (S (S (NP (DT A) (JJ direct) (JJ causal) (NN relationship)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN established))))) (, ,) (CC but) (S (NP (NNS physicians)) (VP (MD should) (VP (VB consider) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NN diclofenac)) (VP (MD may) (VP (VB alter) (NP (NP (DT a) (JJ diabetic) (NN patient) (NN @) (NN s) (NN response)) (PP (TO to) (NP (NP (NN insulin)) (CC or) (NP (JJ oral) (JJ hypoglycemic) (NNS agents)))))))))))))) (. .))))

det(relationship-4, A-1)
amod(relationship-4, direct-2)
amod(relationship-4, causal-3)
nsubjpass(established-8, relationship-4)
aux(established-8, has-5)
neg(established-8, not-6)
auxpass(established-8, been-7)
root(ROOT-0, established-8)
nsubj(consider-13, physicians-11)
aux(consider-13, should-12)
conj_but(established-8, consider-13)
det(possibility-15, the-14)
dobj(consider-13, possibility-15)
complm(alter-19, that-16)
nsubj(alter-19, diclofenac-17)
aux(alter-19, may-18)
ccomp(possibility-15, alter-19)
det(response-25, a-20)
amod(response-25, diabetic-21)
nn(response-25, patient-22)
nn(response-25, @-23)
nn(response-25, s-24)
dobj(alter-19, response-25)
prep_to(response-25, insulin-27)
amod(agents-31, oral-29)
amod(agents-31, hypoglycemic-30)
conj_or(insulin-27, agents-31)

Diuretics/NN :/: Diclofenac/NN and/CC other/JJ NSAIDs/NNS can/MD inhibit/VB the/DT activity/NN of/IN diuretics/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Diuretics)) (: :) (NP (NN Diclofenac)) (CC and) (NP (JJ other) (NNS NSAIDs))) (VP (MD can) (VP (VB inhibit) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NNS diuretics))))))) (. .))))

nsubj(inhibit-8, Diuretics-1)
conj_and(Diuretics-1, Diclofenac-3)
amod(NSAIDs-6, other-5)
conj_and(Diuretics-1, NSAIDs-6)
aux(inhibit-8, can-7)
root(ROOT-0, inhibit-8)
det(activity-10, the-9)
dobj(inhibit-8, activity-10)
prep_of(activity-10, diuretics-12)

Concomitant/JJ treatment/NN with/IN potassium-sparing/JJ diuretics/NNS may/MD be/VB associated/VBN with/IN increased/VBN serum/NN potassium/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN treatment)) (PP (IN with) (NP (JJ potassium-sparing) (NNS diuretics)))) (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (VBN increased) (NN serum) (NN potassium) (NNS levels))))))) (. .))))

amod(treatment-2, Concomitant-1)
nsubjpass(associated-8, treatment-2)
amod(diuretics-5, potassium-sparing-4)
prep_with(treatment-2, diuretics-5)
aux(associated-8, may-6)
auxpass(associated-8, be-7)
root(ROOT-0, associated-8)
amod(levels-13, increased-10)
nn(levels-13, serum-11)
nn(levels-13, potassium-12)
prep_with(associated-8, levels-13)

Other/JJ Drugs/NNS :/: In/IN small/JJ groups/NNS of/IN patients/NNS (/-LRB- 7-10/interaction/JJ study/NN )/-RRB- ,/, the/DT concomitant/JJ administration/NN of/IN azathioprine/NN ,/, gold/NN ,/, chloroquine/NN ,/, D-penicillamine/NN ,/, prednisolone/NN ,/, doxycycline/NN ,/, or/CC digitoxin/NN did/VBD not/RB significantly/RB affect/VB the/DT peak/NN levels/NNS and/CC AUC/NN values/NNS of/IN diclofenac/NN ./.

(ROOT (S1 (S (NP (NP (JJ Other) (NNS Drugs)) (: :) (S (PP (IN In) (NP (NP (JJ small) (NNS groups)) (PP (IN of) (NP (NP (NNS patients)) (PRN (-LRB- -LRB-) (NP (JJ 7-10/interaction) (NN study)) (-RRB- -RRB-)))))) (, ,) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN azathioprine)) (, ,) (NP (NN gold)) (, ,) (NP (NN chloroquine)) (, ,) (NP (NN D-penicillamine)) (, ,) (NP (NN prednisolone)) (, ,) (NP (NN doxycycline)) (, ,) (CC or) (NP (NN digitoxin))))) (VP (VBD did) (RB not) (ADVP (RB significantly)) (VP (VB affect) (NP (NP (DT the) (NN peak) (NNS levels)) (CC and) (NP (NP (NN AUC) (NNS values)) (PP (IN of) (NP (NN diclofenac)))))))) (. .)))))

amod(Drugs-2, Other-1)
root(ROOT-0, Drugs-2)
amod(groups-6, small-5)
prep_in(affect-35, groups-6)
prep_of(groups-6, patients-8)
amod(study-11, 7-10/interaction-10)
appos(patients-8, study-11)
det(administration-16, the-14)
amod(administration-16, concomitant-15)
nsubj(affect-35, administration-16)
prep_of(administration-16, azathioprine-18)
conj_or(azathioprine-18, gold-20)
conj_or(azathioprine-18, chloroquine-22)
conj_or(azathioprine-18, D-penicillamine-24)
conj_or(azathioprine-18, prednisolone-26)
conj_or(azathioprine-18, doxycycline-28)
conj_or(azathioprine-18, digitoxin-31)
aux(affect-35, did-32)
neg(affect-35, not-33)
advmod(affect-35, significantly-34)
dep(Drugs-2, affect-35)
det(levels-38, the-36)
nn(levels-38, peak-37)
dobj(affect-35, levels-38)
nn(values-41, AUC-40)
conj_and(levels-38, values-41)
prep_of(values-41, diclofenac-43)

Phenobarbital/JJ toxicity/NN has/VBZ been/VBN reported/VBN to/TO have/VB occurred/VBN in/IN a/DT patient/NN on/IN chronic/JJ phenobarbital/NN treatment/NN following/VBG the/DT initiation/NN of/IN diclofenac/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (JJ Phenobarbital) (NN toxicity)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB have) (VP (VBN occurred) (PP (IN in) (NP (NP (DT a) (NN patient)) (PP (IN on) (NP (NP (JJ chronic) (NN phenobarbital) (NN treatment)) (PP (VBG following) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (NN diclofenac) (NN therapy))))))))))))))))) (. .))))

amod(toxicity-2, Phenobarbital-1)
nsubjpass(reported-5, toxicity-2)
xsubj(occurred-8, toxicity-2)
aux(reported-5, has-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
aux(occurred-8, to-6)
aux(occurred-8, have-7)
xcomp(reported-5, occurred-8)
det(patient-11, a-10)
prep_in(occurred-8, patient-11)
amod(treatment-15, chronic-13)
nn(treatment-15, phenobarbital-14)
prep_on(patient-11, treatment-15)
det(initiation-18, the-17)
prep_following(treatment-15, initiation-18)
nn(therapy-21, diclofenac-20)
prep_of(initiation-18, therapy-21)

Protein/NN Binding/NN :/: In/FW vitro/FW ,/, diclofenac/NN interferes/VBZ minimally/RB or/CC not/RB at/IN all/NN with/IN the/DT protein/NN binding/NN of/IN salicylic/JJ acid/NN (/-LRB- 20/CD %/NN decrease/NN in/IN binding/NN )/-RRB- ,/, tolbutamide/NN ,/, prednisolone/NN (/-LRB- 10/CD %/NN decrease/NN in/IN binding/NN )/-RRB- ,/, or/CC warfarin/NN ./.

(ROOT (S1 (S (NP (NP (NN Protein) (NN Binding)) (: :) (S (ADVP (FW In) (FW vitro)) (, ,) (NP (NN diclofenac)) (VP (VBZ interferes) (ADVP (ADVP (RB minimally)) (CC or) (ADVP (RB not))) (PP (IN at) (NP (NN all))) (PP (IN with) (NP (NP (DT the) (NN protein) (NN binding)) (PP (IN of) (NP (NP (NP (JJ salicylic) (NN acid)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 20) (NN %)) (NN decrease)) (PP (IN in) (NP (NN binding)))) (-RRB- -RRB-))) (, ,) (NP (NN tolbutamide)) (, ,) (NP (NP (NN prednisolone)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 10) (NN %)) (NN decrease)) (PP (IN in) (NP (NN binding)))) (-RRB- -RRB-))) (, ,) (CC or) (NP (NN warfarin)))))))) (. .)))))

nn(Binding-2, Protein-1)
root(ROOT-0, Binding-2)
nn(vitro-5, In-4)
advmod(interferes-8, vitro-5)
nsubj(interferes-8, diclofenac-7)
dep(Binding-2, interferes-8)
advmod(interferes-8, minimally-9)
conj_or(minimally-9, not-11)
prep_at(interferes-8, all-13)
det(binding-17, the-15)
nn(binding-17, protein-16)
prep_with(interferes-8, binding-17)
amod(acid-20, salicylic-19)
prep_of(binding-17, acid-20)
number(%-23, 20-22)
amod(decrease-24, %-23)
dep(acid-20, decrease-24)
prep_in(decrease-24, binding-26)
conj_or(acid-20, tolbutamide-29)
conj_or(acid-20, prednisolone-31)
number(%-34, 10-33)
amod(decrease-35, %-34)
dep(prednisolone-31, decrease-35)
prep_in(decrease-35, binding-37)
conj_or(acid-20, warfarin-41)

Benzylpenicillin/NN ,/, ampicillin/NN ,/, oxacillin/NN ,/, chlortetracycline/NN ,/, doxycycline/NN ,/, cephalothin/NN ,/, erythromycin/NN ,/, and/CC sulfamethoxazole/NN have/VBP no/DT influence/NN in/FW vitro/FW on/IN the/DT protein/NN binding/NN of/IN diclofenac/NN in/IN human/JJ serum/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Benzylpenicillin)) (, ,) (NP (NN ampicillin)) (, ,) (NP (NN oxacillin)) (, ,) (NP (NN chlortetracycline)) (, ,) (NP (NN doxycycline)) (, ,) (NP (NN cephalothin)) (, ,) (NP (NN erythromycin)) (, ,) (CC and) (NP (NN sulfamethoxazole))) (VP (VBP have) (NP (DT no) (NN influence)) (ADVP (FW in) (FW vitro)) (PP (IN on) (NP (NP (DT the) (NN protein) (NN binding)) (PP (IN of) (NP (NN diclofenac))) (PP (IN in) (NP (JJ human) (NN serum))))))) (. .))))

nsubj(have-17, Benzylpenicillin-1)
conj_and(Benzylpenicillin-1, ampicillin-3)
conj_and(Benzylpenicillin-1, oxacillin-5)
conj_and(Benzylpenicillin-1, chlortetracycline-7)
conj_and(Benzylpenicillin-1, doxycycline-9)
conj_and(Benzylpenicillin-1, cephalothin-11)
conj_and(Benzylpenicillin-1, erythromycin-13)
conj_and(Benzylpenicillin-1, sulfamethoxazole-16)
root(ROOT-0, have-17)
det(influence-19, no-18)
dobj(have-17, influence-19)
nn(vitro-21, in-20)
advmod(have-17, vitro-21)
det(binding-25, the-23)
nn(binding-25, protein-24)
prep_on(have-17, binding-25)
prep_of(binding-25, diclofenac-27)
amod(serum-30, human-29)
prep_in(binding-25, serum-30)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS Effect/NN on/IN Blood/NN Coagulation/NN :/: Diclofenac/NN increases/VBZ platelet/NN aggregation/NN time/NN but/CC does/VBZ not/RB affect/VB bleeding/JJ time/NN ,/, plasma/NN thrombin/NN clotting/NN time/NN ,/, plasma/NN fibrinogen/NN ,/, or/CC factors/NNS V/NN and/CC VII/NN to/TO XII/NN ./.

(ROOT (S1 (S (S (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (VP (NN Effect) (PP (IN on) (NP (NN Blood) (NN Coagulation))))) (: :) (S (NP (NN Diclofenac)) (VP (VP (VBZ increases) (NP (NN platelet) (NN aggregation) (NN time))) (CC but) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NP (JJ bleeding) (NN time)) (, ,) (NP (NN plasma) (NN thrombin) (NN clotting) (NN time)) (, ,) (NP (NN plasma) (NN fibrinogen)) (, ,) (CC or) (NP (NP (NNS factors)) (NP (NP (NN V)) (CC and) (NP (NN VII) (TO to) (NN XII))))))))) (. .))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
nsubj(Effect-5, Interactions-4)
root(ROOT-0, Effect-5)
nn(Coagulation-8, Blood-7)
prep_on(Effect-5, Coagulation-8)
nsubj(increases-11, Diclofenac-10)
parataxis(Effect-5, increases-11)
nn(time-14, platelet-12)
nn(time-14, aggregation-13)
dobj(increases-11, time-14)
aux(affect-18, does-16)
neg(affect-18, not-17)
conj_but(increases-11, affect-18)
amod(time-20, bleeding-19)
dobj(affect-18, time-20)
nn(time-25, plasma-22)
nn(time-25, thrombin-23)
nn(time-25, clotting-24)
conj_or(time-20, time-25)
nn(fibrinogen-28, plasma-27)
conj_or(time-20, fibrinogen-28)
conj_or(time-20, factors-31)
dep(factors-31, V-32)
nn(XII-36, VII-34)
dep(XII-36, to-35)
conj_and(V-32, XII-36)

Statistically/RB significant/JJ changes/NNS in/IN prothrombin/JJ and/CC partial/JJ thromboplastin/NN times/NNS have/VBP been/VBN reported/VBN in/IN normal/JJ volunteers/NNS ./.

(ROOT (S1 (S (S (NP (NP (ADJP (RB Statistically) (JJ significant)) (NNS changes)) (PP (IN in) (NP (ADJP (ADJP (JJ prothrombin)) (CC and) (ADJP (JJ partial))) (NN thromboplastin) (NNS times)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (JJ normal) (NNS volunteers))))))) (. .))))

advmod(significant-2, Statistically-1)
amod(changes-3, significant-2)
nsubjpass(reported-12, changes-3)
amod(times-9, prothrombin-5)
conj_and(prothrombin-5, partial-7)
nn(times-9, thromboplastin-8)
prep_in(changes-3, times-9)
aux(reported-12, have-10)
auxpass(reported-12, been-11)
root(ROOT-0, reported-12)
amod(volunteers-15, normal-14)
prep_in(reported-12, volunteers-15)

Diclofenac/NN is/VBZ a/DT prostaglandin/NN synthetase/NN inhibitor/NN ,/, however/RB ,/, and/CC all/DT drugs/NNS that/WDT inhibit/VBP prostaglandin/NN synthesis/NN interfere/VBP with/IN platelet/NN function/NN to/TO some/DT degree/NN ;/: ./.

(ROOT (S1 (S (S (S (NP (NN Diclofenac)) (VP (VBZ is) (NP (NP (DT a) (NN prostaglandin) (NN synthetase) (NN inhibitor)) (, ,) (ADVP (RB however))))) (, ,) (CC and) (S (NP (NP (DT all) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (NN prostaglandin) (NN synthesis)))))) (VP (VBP interfere) (PP (IN with) (NP (NP (NN platelet) (NN function)) (PP (TO to) (NP (DT some) (NN degree))) (: ;)))))) (. .))))

nsubj(inhibitor-6, Diclofenac-1)
cop(inhibitor-6, is-2)
det(inhibitor-6, a-3)
nn(inhibitor-6, prostaglandin-4)
nn(inhibitor-6, synthetase-5)
root(ROOT-0, inhibitor-6)
advmod(inhibitor-6, however-8)
det(drugs-12, all-11)
nsubj(inhibit-14, drugs-12)
nsubj(interfere-17, drugs-12)
rcmod(drugs-12, inhibit-14)
nn(synthesis-16, prostaglandin-15)
dobj(inhibit-14, synthesis-16)
conj_and(inhibitor-6, interfere-17)
nn(function-20, platelet-19)
prep_with(interfere-17, function-20)
det(degree-23, some-22)
prep_to(function-20, degree-23)

Tetracycline/NN ,/, a/DT bacteriostat/NN ic/NN antibiotic/JJ ,/, may/MD antagonize/VB the/DT bactercidal/JJ effect/NN of/IN penicillin/NN and/CC concurrent/JJ use/NN of/IN these/DT drugs/NNS should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (NN Tetracycline)) (, ,) (NP (DT a) (NN bacteriostat) (NN ic) (JJ antibiotic)) (, ,)) (VP (MD may) (VP (VB antagonize) (NP (NP (DT the) (JJ bactercidal) (NN effect)) (PP (IN of) (NP (NN penicillin))))))) (CC and) (S (NP (NP (JJ concurrent) (NN use)) (PP (IN of) (NP (DT these) (NNS drugs)))) (VP (MD should) (VP (VB be) (VP (VBN avoided)))))) (. .))))

nsubj(antagonize-9, Tetracycline-1)
det(ic-5, a-3)
nn(ic-5, bacteriostat-4)
appos(Tetracycline-1, ic-5)
amod(ic-5, antibiotic-6)
aux(antagonize-9, may-8)
root(ROOT-0, antagonize-9)
det(effect-12, the-10)
amod(effect-12, bactercidal-11)
dobj(antagonize-9, effect-12)
prep_of(effect-12, penicillin-14)
amod(use-17, concurrent-16)
nsubjpass(avoided-23, use-17)
det(drugs-20, these-19)
prep_of(use-17, drugs-20)
aux(avoided-23, should-21)
auxpass(avoided-23, be-22)
conj_and(antagonize-9, avoided-23)

The/DT following/VBG agents/NNS may/MD increase/VB certain/JJ actions/NNS or/CC side/JJ effects/NNS of/IN anticholinergic/JJ drugs/NNS ./. amantadine/NN antiarrhythmic/JJ agents/NNS of/IN class/NN (/-LRB- e.g./FW quinidine/NN )/-RRB- ,/, antihistamines/NNS antipsychotic/JJ agents/NNS (/-LRB- e.g./FW phenothiazines/NNS )/-RRB- ,/, benzodiazepines/NNS ./.

(ROOT (S1 (S (S (NP (DT The) (VBG following) (NNS agents)) (VP (MD may) (VP (VB increase) (NP (NP (NP (JJ certain) (NNS actions)) (CC or) (NP (JJ side) (NNS effects))) (PP (IN of) (NP (JJ anticholinergic) (NNS drugs)))))) (. .)) (NP (NP (NP (NN amantadine) (JJ antiarrhythmic) (NNS agents)) (PP (IN of) (NP (NN class))) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (NP (NN quinidine)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS antihistamines)) (NP (NP (JJ antipsychotic) (NNS agents)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (NP (NNS phenothiazines)) (-RRB- -RRB-)))) (, ,) (NP (NNS benzodiazepines))) (. .))))

det(agents-3, The-1)
amod(agents-3, following-2)
nsubj(increase-5, agents-3)
aux(increase-5, may-4)
root(ROOT-0, increase-5)
amod(actions-7, certain-6)
dobj(increase-5, actions-7)
amod(effects-10, side-9)
conj_or(actions-7, effects-10)
amod(drugs-13, anticholinergic-12)
prep_of(actions-7, drugs-13)
nn(agents-17, amantadine-15)
amod(agents-17, antiarrhythmic-16)
dep(increase-5, agents-17)
prep_of(agents-17, class-19)
dep(quinidine-22, e.g.-21)
appos(agents-17, quinidine-22)
appos(agents-17, antihistamines-25)
amod(agents-27, antipsychotic-26)
dep(antihistamines-25, agents-27)
dep(phenothiazines-30, e.g.-29)
appos(agents-27, phenothiazines-30)
appos(agents-17, benzodiazepines-33)

MAO/NN inhibitors/NNS ,/, narcotic/JJ analgesics/NNS (/-LRB- e.g./FW ,/, meperidine/NN )/-RRB- ,/, nitrates/NNS and/CC nitrites/NNS ,/, sympathomimetic/JJ agents/NNS ,/, tricyclic/JJ antidepressants/NNS ,/, and/CC other/JJ drugs/NNS having/VBG anticholinergic/JJ activity/NN ./.

(ROOT (S1 (S (NP (NP (NN MAO) (NNS inhibitors)) (, ,) (NP (NP (JJ narcotic) (NNS analgesics)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN meperidine))) (-RRB- -RRB-))) (, ,) (NP (NP (NNS nitrates)) (CC and) (NP (NNS nitrites))) (, ,) (NP (JJ sympathomimetic) (NNS agents)) (, ,) (NP (JJ tricyclic) (NNS antidepressants)) (, ,) (CC and) (NP (JJ other) (NNS drugs))) (VP (VBG having) (NP (JJ anticholinergic) (NN activity))) (. .))))

nn(inhibitors-2, MAO-1)
nsubj(having-25, inhibitors-2)
amod(analgesics-5, narcotic-4)
conj_and(inhibitors-2, analgesics-5)
dep(analgesics-5, e.g.-7)
pobj(e.g.-7, meperidine-9)
conj_and(inhibitors-2, nitrates-12)
conj_and(nitrates-12, nitrites-14)
amod(agents-17, sympathomimetic-16)
conj_and(inhibitors-2, agents-17)
amod(antidepressants-20, tricyclic-19)
conj_and(inhibitors-2, antidepressants-20)
amod(drugs-24, other-23)
conj_and(inhibitors-2, drugs-24)
root(ROOT-0, having-25)
amod(activity-27, anticholinergic-26)
dobj(having-25, activity-27)

Anticholinergics/NN antagonize/VBP the/DT effects/NNS of/IN antiglaucoma/NN agents/NNS ./.

(ROOT (S1 (S (S (NP (NN Anticholinergics)) (VP (VBP antagonize) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN antiglaucoma) (NNS agents)))))) (. .))))

nsubj(antagonize-2, Anticholinergics-1)
root(ROOT-0, antagonize-2)
det(effects-4, the-3)
dobj(antagonize-2, effects-4)
nn(agents-7, antiglaucoma-6)
prep_of(effects-4, agents-7)

Anticholinergic/JJ drugs/NNS in/IN the/DT presence/NN of/IN increased/VBN intraocular/JJ pressure/NN may/MD be/VB hazardous/JJ when/WRB taken/VBN concurrently/RB with/IN agents/NNS such/JJ as/IN corti/NN costeroids/NN ../NN

(ROOT (S1 (S (NP (NP (JJ Anticholinergic) (NNS drugs)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (VBN increased) (JJ intraocular) (NN pressure)))))) (VP (MD may) (VP (VB be) (ADJP (JJ hazardous))) (SBAR (WHADVP (WRB when)) (S (VP (VBN taken) (ADVP (RB concurrently)) (PP (IN with) (NP (NP (NNS agents)) (PP (JJ such) (IN as) (NP (NN corti) (NN costeroids) (NN ..))))))))))))

amod(drugs-2, Anticholinergic-1)
nsubj(hazardous-12, drugs-2)
det(presence-5, the-4)
prep_in(drugs-2, presence-5)
amod(pressure-9, increased-7)
amod(pressure-9, intraocular-8)
prep_of(presence-5, pressure-9)
aux(hazardous-12, may-10)
cop(hazardous-12, be-11)
root(ROOT-0, hazardous-12)
advmod(taken-14, when-13)
advcl(hazardous-12, taken-14)
advmod(taken-14, concurrently-15)
prep_with(taken-14, agents-17)
nn(..-22, corti-20)
nn(..-22, costeroids-21)
prep_such_as(agents-17, ..-22)

Anticholinergic/JJ agents/NNS may/MD affect/VB gastrointestinal/JJ absorption/NN of/IN various/JJ drugs/NNS ,/, such/JJ as/IN slowly/RB dissolving/VBG dosage/NN forms/NNS of/IN digoxin/NN ;/: ./.

(ROOT (S1 (S (S (NP (JJ Anticholinergic) (NNS agents)) (VP (MD may) (VP (VB affect) (NP (NP (JJ gastrointestinal) (NN absorption)) (PP (IN of) (NP (NP (JJ various) (NNS drugs)) (, ,) (PP (JJ such) (IN as) (NP (NP (ADJP (RB slowly) (VBG dissolving)) (NN dosage) (NNS forms)) (PP (IN of) (NP (NN digoxin))))) (: ;))))))) (. .))))

amod(agents-2, Anticholinergic-1)
nsubj(affect-4, agents-2)
aux(affect-4, may-3)
root(ROOT-0, affect-4)
amod(absorption-6, gastrointestinal-5)
dobj(affect-4, absorption-6)
amod(drugs-9, various-8)
prep_of(absorption-6, drugs-9)
advmod(dissolving-14, slowly-13)
amod(forms-16, dissolving-14)
nn(forms-16, dosage-15)
prep_such_as(drugs-9, forms-16)
prep_of(forms-16, digoxin-18)

increased/VBN serum/NN digoxin/NN concentrations/NNS may/MD result/VB ./.

(ROOT (S1 (S (S (NP (VBN increased) (NN serum) (NN digoxin) (NNS concentrations)) (VP (MD may) (VP (VB result)))) (. .))))

amod(concentrations-4, increased-1)
nn(concentrations-4, serum-2)
nn(concentrations-4, digoxin-3)
nsubj(result-6, concentrations-4)
aux(result-6, may-5)
root(ROOT-0, result-6)

Anticholinergic/JJ drugs/NNS may/MD antagonize/VB the/DT effects/NNS of/IN the/DT drugs/NNS that/WDT alter/VBP gastrointestinal/JJ motility/NN ,/, such/JJ as/IN metoclopramide/NN ./.

(ROOT (S1 (S (S (NP (JJ Anticholinergic) (NNS drugs)) (VP (MD may) (VP (VB antagonize) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (DT the) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP alter) (NP (JJ gastrointestinal) (NN motility))))) (, ,) (PP (JJ such) (IN as) (NP (NN metoclopramide))))))))) (. .))))

amod(drugs-2, Anticholinergic-1)
nsubj(antagonize-4, drugs-2)
aux(antagonize-4, may-3)
root(ROOT-0, antagonize-4)
det(effects-6, the-5)
dobj(antagonize-4, effects-6)
det(drugs-9, the-8)
prep_of(effects-6, drugs-9)
nsubj(alter-11, drugs-9)
rcmod(drugs-9, alter-11)
amod(motility-13, gastrointestinal-12)
dobj(alter-11, motility-13)
prep_such_as(drugs-9, metoclopramide-17)

Because/IN antacids/NNS may/MD interfere/VB with/IN the/DT absorption/NN of/IN anticholinergic/JJ agents/NNS ,/, simultaneous/JJ use/NN of/IN these/DT drugs/NNS should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NNS antacids)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (JJ anticholinergic) (NNS agents))))))))) (, ,) (NP (NP (JJ simultaneous) (NN use)) (PP (IN of) (NP (DT these) (NNS drugs)))) (VP (MD should) (VP (VB be) (VP (VBN avoided))))) (. .))))

mark(interfere-4, Because-1)
nsubj(interfere-4, antacids-2)
aux(interfere-4, may-3)
advcl(avoided-19, interfere-4)
det(absorption-7, the-6)
prep_with(interfere-4, absorption-7)
amod(agents-10, anticholinergic-9)
prep_of(absorption-7, agents-10)
amod(use-13, simultaneous-12)
nsubjpass(avoided-19, use-13)
det(drugs-16, these-15)
prep_of(use-13, drugs-16)
aux(avoided-19, should-17)
auxpass(avoided-19, be-18)
root(ROOT-0, avoided-19)

The/DT inhibiting/NN effects/NNS of/IN anticholinergic/JJ drugs/NNS on/IN gastric/JJ hydrochloric/JJ acid/NN secretion/NN are/VBP antagonized/VBN by/IN agents/NNS used/VBN to/TO treat/VB achlorhydria/NN and/CC those/DT used/VBN to/TO test/VB gastric/JJ secretion/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN inhibiting) (NNS effects)) (PP (IN of) (NP (JJ anticholinergic) (NNS drugs))) (PP (IN on) (NP (JJ gastric) (JJ hydrochloric) (NN acid) (NN secretion)))) (VP (VBP are) (VP (VBN antagonized) (PP (IN by) (NP (NP (NP (NNS agents)) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (NN achlorhydria))))))) (CC and) (NP (NP (DT those)) (VP (VBN used) (S (VP (TO to) (VP (VB test) (NP (JJ gastric) (NN secretion)))))))))))) (. .))))

det(effects-3, The-1)
nn(effects-3, inhibiting-2)
nsubjpass(antagonized-13, effects-3)
amod(drugs-6, anticholinergic-5)
prep_of(effects-3, drugs-6)
amod(secretion-11, gastric-8)
amod(secretion-11, hydrochloric-9)
nn(secretion-11, acid-10)
prep_on(effects-3, secretion-11)
auxpass(antagonized-13, are-12)
root(ROOT-0, antagonized-13)
agent(antagonized-13, agents-15)
xsubj(treat-18, agents-15)
partmod(agents-15, used-16)
aux(treat-18, to-17)
xcomp(used-16, treat-18)
dobj(treat-18, achlorhydria-19)
conj_and(agents-15, those-21)
xsubj(test-24, those-21)
partmod(those-21, used-22)
aux(test-24, to-23)
xcomp(used-22, test-24)
amod(secretion-26, gastric-25)
dobj(test-24, secretion-26)

Coadministration/NN of/IN VIDEX/NN with/IN drugs/NNS that/WDT are/VBP known/VBN to/TO cause/VB pancreatitis/NN may/MD increase/VB the/DT risk/NN of/IN this/DT toxicity/NN (/-LRB- see/VB WARNINGS/NNS )/-RRB- and/CC should/MD be/VB done/VBN with/IN extreme/JJ caution/NN ,/, only/RB if/IN other/JJ alternatives/NNS are/VBP not/RB available/JJ ,/, and/CC only/RB if/IN clearly/RB indicated/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN VIDEX))) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB cause) (NP (NN pancreatitis)))))))))))) (VP (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (DT this) (NN toxicity)))) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NNS WARNINGS)))) (-RRB- -RRB-)))) (CC and) (VP (MD should) (VP (VB be) (VP (VBN done) (PP (IN with) (NP (JJ extreme) (NN caution))) (, ,) (SBAR (SBAR (RB only) (IN if) (S (NP (JJ other) (NNS alternatives)) (VP (VBP are) (RB not) (ADJP (JJ available))))) (, ,) (CC and) (SBAR (RB only) (IN if) (S (ADVP (RB clearly)) (VP (VBN indicated)))))))))) (. .))))

nsubj(increase-13, Coadministration-1)
prep_of(Coadministration-1, VIDEX-3)
prep_with(Coadministration-1, drugs-5)
nsubjpass(known-8, drugs-5)
auxpass(known-8, are-7)
rcmod(drugs-5, known-8)
aux(cause-10, to-9)
xcomp(known-8, cause-10)
dobj(cause-10, pancreatitis-11)
aux(increase-13, may-12)
root(ROOT-0, increase-13)
det(risk-15, the-14)
dobj(increase-13, risk-15)
det(toxicity-18, this-17)
prep_of(risk-15, toxicity-18)
parataxis(increase-13, see-20)
dobj(see-20, WARNINGS-21)
aux(done-26, should-24)
auxpass(done-26, be-25)
conj_and(increase-13, done-26)
amod(caution-29, extreme-28)
prep_with(done-26, caution-29)
advmod(available-37, only-31)
dep(available-37, if-32)
amod(alternatives-34, other-33)
nsubj(available-37, alternatives-34)
cop(available-37, are-35)
neg(available-37, not-36)
dep(done-26, available-37)
advmod(indicated-43, only-40)
dep(indicated-43, if-41)
advmod(indicated-43, clearly-42)
conj_and(available-37, indicated-43)

Neuropathy/NN has/VBZ occurred/VBN more/RBR frequently/RB in/IN patients/NNS with/IN a/DT history/NN of/IN neuropathy/NN or/CC neurotoxic/JJ drug/NN therapy/NN ,/, including/VBG stavudine/NN ,/, and/CC these/DT patients/NNS may/MD be/VB at/IN increased/VBN risk/NN of/IN neuropathy/NN during/IN VIDEX/NN therapy/NN (/-LRB- see/VB ADVERSE/JJ REACTIONS/NNS )./RB

(ROOT (S1 (S (S (NP (NN Neuropathy)) (VP (VBZ has) (VP (VBN occurred) (ADVP (RBR more) (RB frequently)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NN neuropathy)))) (CC or) (NP (JJ neurotoxic) (NN drug) (NN therapy)))) (, ,) (PP (VBG including) (NP (NN stavudine)))))))) (, ,) (CC and) (S (NP (DT these) (NNS patients)) (VP (MD may) (VP (VP (VB be) (PP (IN at) (NP (NP (VBN increased) (NN risk)) (PP (IN of) (NP (NN neuropathy))))) (PP (IN during) (NP (NN VIDEX) (NN therapy)))) (-LRB- -LRB-) (S (VP (VB see) (NP (JJ ADVERSE) (NNS REACTIONS)) (ADVP (RB -RRB-.))))))))))

nsubj(occurred-3, Neuropathy-1)
aux(occurred-3, has-2)
root(ROOT-0, occurred-3)
advmod(frequently-5, more-4)
advmod(occurred-3, frequently-5)
prep_in(occurred-3, patients-7)
det(history-10, a-9)
prep_with(patients-7, history-10)
prep_of(history-10, neuropathy-12)
amod(therapy-16, neurotoxic-14)
nn(therapy-16, drug-15)
conj_or(history-10, therapy-16)
prep_including(patients-7, stavudine-19)
det(patients-23, these-22)
nsubj(be-25, patients-23)
aux(be-25, may-24)
conj_and(occurred-3, be-25)
amod(risk-28, increased-27)
prep_at(be-25, risk-28)
prep_of(risk-28, neuropathy-30)
nn(therapy-33, VIDEX-32)
prep_during(be-25, therapy-33)
ccomp(be-25, see-35)
amod(REACTIONS-37, ADVERSE-36)
dobj(see-35, REACTIONS-37)
advmod(see-35, -RRB-.-38)

Allopurinol/NN :/: The/DT AUC/NN of/IN didanosine/NN was/VBD increased/VBN about/RB 4-fold/RB when/WRB allopurinol/NN at/IN 300/CD mg/day/NN was/VBD coadministered/VBN with/IN a/DT single/JJ 200-mg/JJ dose/NN of/IN VIDEX/NN to/TO two/CD patients/NNS with/IN renal/JJ impairment/NN (/-LRB- CLcr=15/CD and/CC 18/CD mL/min/NN )./CD

(ROOT (S1 (S (NP (NP (NN Allopurinol)) (: :) (S (NP (NP (DT The) (NN AUC)) (PP (IN of) (NP (NN didanosine)))) (VP (VBD was) (VP (VBN increased) (ADVP (RB about) (RB 4-fold)) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN allopurinol)) (PP (IN at) (NP (CD 300) (NN mg/day)))) (VP (VBD was) (VP (VBN coadministered) (PP (IN with) (NP (NP (DT a) (JJ single) (JJ 200-mg) (NN dose)) (PP (IN of) (NP (NN VIDEX))) (PP (TO to) (NP (NP (NP (CD two) (NNS patients)) (PP (IN with) (NP (JJ renal) (NN impairment)))) (-LRB- -LRB-) (NP (QP (CD CLcr=15) (CC and) (CD 18)) (NN mL/min) (CD -RRB-.)))))))))))))))))

root(ROOT-0, Allopurinol-1)
det(AUC-4, The-3)
nsubjpass(increased-8, AUC-4)
prep_of(AUC-4, didanosine-6)
auxpass(increased-8, was-7)
dep(Allopurinol-1, increased-8)
advmod(4-fold-10, about-9)
advmod(increased-8, 4-fold-10)
advmod(coadministered-17, when-11)
nsubjpass(coadministered-17, allopurinol-12)
num(mg/day-15, 300-14)
prep_at(allopurinol-12, mg/day-15)
auxpass(coadministered-17, was-16)
advcl(increased-8, coadministered-17)
det(dose-22, a-19)
amod(dose-22, single-20)
amod(dose-22, 200-mg-21)
prep_with(coadministered-17, dose-22)
prep_of(dose-22, VIDEX-24)
num(patients-27, two-26)
prep_to(dose-22, patients-27)
amod(impairment-30, renal-29)
prep_with(patients-27, impairment-30)
num(mL/min-35, CLcr=15-32)
conj_and(CLcr=15-32, 18-34)
dep(patients-27, mL/min-35)
num(mL/min-35, -RRB-.-36)

The/DT effects/NNS of/IN allopurinol/NN on/IN didanosine/NN pharmacokinetics/NNS in/IN subjects/NNS with/IN normal/JJ renal/JJ function/NN are/VBP not/RB known/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NN allopurinol))) (PP (IN on) (NP (NP (NN didanosine) (NNS pharmacokinetics)) (PP (IN in) (NP (NP (NNS subjects)) (PP (IN with) (NP (JJ normal) (JJ renal) (NN function)))))))) (VP (VBP are) (RB not) (VP (VBN known)))) (. .))))

det(effects-2, The-1)
nsubjpass(known-16, effects-2)
prep_of(effects-2, allopurinol-4)
nn(pharmacokinetics-7, didanosine-6)
prep_on(effects-2, pharmacokinetics-7)
prep_in(pharmacokinetics-7, subjects-9)
amod(function-13, normal-11)
amod(function-13, renal-12)
prep_with(subjects-9, function-13)
auxpass(known-16, are-14)
neg(known-16, not-15)
root(ROOT-0, known-16)

Antacids/NNS :/: Concomitant/JJ administration/NN of/IN antacids/NNS containing/VBG magnesium/NN or/CC aluminum/NN with/IN VIDEX/NN Chewable//NN Dispersible/JJ Buffered/JJ Tablets/NNS or/CC Pediatric/JJ Powder/NN for/IN Oral/JJ Solution/NN may/MD potentiate/VB adverse/JJ events/NNS associated/VBN with/IN the/DT antacid/JJ components/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Antacids)) (: :) (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NNS antacids)) (VP (VBG containing) (NP (NP (NP (NN magnesium)) (CC or) (NP (NN aluminum))) (PP (IN with) (NP (NN VIDEX) (NN Chewable/) (NP (JJ Dispersible) (JJ Buffered) (NNS Tablets)) (CC or) (NP (JJ Pediatric) (NN Powder)))) (PP (IN for) (NP (JJ Oral) (NN Solution)))))))) (VP (MD may) (VP (VB potentiate) (NP (NP (JJ adverse) (NNS events)) (VP (VBN associated) (PP (IN with) (NP (DT the) (JJ antacid) (NNS components)))))))) (. .)))))

root(ROOT-0, Antacids-1)
amod(administration-4, Concomitant-3)
nsubj(potentiate-24, administration-4)
prep_of(administration-4, antacids-6)
partmod(antacids-6, containing-7)
dobj(containing-7, magnesium-8)
conj_or(magnesium-8, aluminum-10)
nn(Chewable/-13, VIDEX-12)
prep_with(magnesium-8, Chewable/-13)
amod(Tablets-16, Dispersible-14)
amod(Tablets-16, Buffered-15)
dep(Chewable/-13, Tablets-16)
amod(Powder-19, Pediatric-18)
conj_or(Chewable/-13, Powder-19)
amod(Solution-22, Oral-21)
prep_for(magnesium-8, Solution-22)
aux(potentiate-24, may-23)
dep(Antacids-1, potentiate-24)
amod(events-26, adverse-25)
dobj(potentiate-24, events-26)
partmod(events-26, associated-27)
det(components-31, the-29)
amod(components-31, antacid-30)
prep_with(associated-27, components-31)

Drugs/NNS Whose/WP$ Absorption/NN Can/MD Be/VB Affected/VBN by/IN the/DT Level/NN of/IN Acidity/NN in/IN the/DT Stomach/NN :/: Drugs/NNS such/JJ as/IN ketoconazole/NN and/CC itraconazole/NN should/MD be/VB administered/VBN at/IN least/JJS 2/CD hours/NNS prior/RB to/TO dosing/NN with/IN VIDEX/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Drugs)) (SBAR (WHNP (WP$ Whose) (NN Absorption)) (S (VP (MD Can) (VP (VB Be) (VP (VBN Affected) (PP (IN by) (NP (NP (DT the) (NN Level)) (PP (IN of) (NP (NP (NN Acidity)) (PP (IN in) (NP (DT the) (NN Stomach))))))))))))) (: :) (NP (NP (NNS Drugs)) (PP (JJ such) (IN as) (NP (NP (NN ketoconazole)) (CC and) (NP (NN itraconazole)))))) (VP (MD should) (VP (VB be) (VP (VBN administered) (ADVP (NP (QP (IN at) (JJS least) (CD 2)) (NNS hours)) (RB prior) (PP (TO to) (NP (NN dosing)))) (PP (IN with) (NP (NN VIDEX))))))) (. .))))

poss(Absorption-3, Drugs-1)
nsubjpass(administered-24, Drugs-1)
nsubjpass(Affected-6, Absorption-3)
aux(Affected-6, Can-4)
auxpass(Affected-6, Be-5)
rcmod(Drugs-1, Affected-6)
det(Level-9, the-8)
agent(Affected-6, Level-9)
prep_of(Level-9, Acidity-11)
det(Stomach-14, the-13)
prep_in(Acidity-11, Stomach-14)
dep(Drugs-1, Drugs-16)
prep_such_as(Drugs-16, ketoconazole-19)
conj_and(ketoconazole-19, itraconazole-21)
aux(administered-24, should-22)
auxpass(administered-24, be-23)
root(ROOT-0, administered-24)
quantmod(2-27, at-25)
mwe(at-25, least-26)
pobj(at-25, least-26)
num(hours-28, 2-27)
npadvmod(administered-24, hours-28)
prep_prior_to(administered-24, dosing-31)
prep_with(administered-24, VIDEX-33)

Ganciclovir/NN :/: Administration/NN of/IN VIDEX/NN 2/CD hours/NNS prior/RB to/TO or/CC concurrent/JJ with/IN oral/JJ ganciclovir/NN was/VBD associated/VBN with/IN a/DT 111/NN (/-LRB- 114/CD )/-RRB- %/NN increase/NN in/IN the/DT steady-state/JJ AUC/NN of/IN didanosine/NN (/-LRB- n/NN =/JJ 12/CD )./NN

(ROOT (S1 (S (NP (NP (NN Ganciclovir)) (: :) (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN VIDEX) (CD 2) (NNS hours))) (ADVP (ADVP (RB prior)) (TO to) (CC or) (ADVP (JJ concurrent) (PP (IN with) (NP (JJ oral) (NN ganciclovir)))))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (NN 111) (-LRB- -LRB-) (CD 114) (-RRB- -RRB-) (NN %) (NN increase)) (PP (IN in) (NP (NP (DT the) (JJ steady-state) (NN AUC)) (PP (IN of) (NP (NN didanosine))))))) (PRN (-LRB- -LRB-) (NP (NP (NN n)) (ADJP (JJ =) (NP (CD 12) (NN -RRB-.))))))))))))

root(ROOT-0, Ganciclovir-1)
nsubjpass(associated-16, Administration-3)
nn(hours-7, VIDEX-5)
num(hours-7, 2-6)
prep_of(Administration-3, hours-7)
advmod(Administration-3, prior-8)
dep(prior-8, to-9)
conj_or(prior-8, concurrent-11)
amod(ganciclovir-14, oral-13)
prep_with(concurrent-11, ganciclovir-14)
auxpass(associated-16, was-15)
dep(Ganciclovir-1, associated-16)
det(increase-24, a-18)
nn(increase-24, 111-19)
num(increase-24, 114-21)
nn(increase-24, %-23)
prep_with(associated-16, increase-24)
det(AUC-28, the-26)
amod(AUC-28, steady-state-27)
prep_in(increase-24, AUC-28)
prep_of(AUC-28, didanosine-30)
dep(associated-16, n-32)
amod(n-32, =-33)
num(-RRB-.-35, 12-34)
dep(=-33, -RRB-.-35)

A/DT 21/CD (/-LRB- 17/CD )/-RRB- %/NN decrease/NN in/IN the/DT steady-state/JJ AUC/NN of/IN ganciclovir/NN was/VBD observed/VBN when/WRB VIDEX/NN was/VBD administered/VBN 2/CD hours/NNS prior/RB to/TO ganciclovir/NN ,/, but/CC not/RB when/WRB the/DT two/CD drugs/NNS were/VBD administered/VBN simultaneously/RB (/-LRB- n/NN =/JJ 12/CD )./NN

(ROOT (S1 (S (S (NP (NP (DT A) (ADJP (CD 21) (-LRB- -LRB-) (CD 17) (-RRB- -RRB-) (NN %)) (NN decrease)) (PP (IN in) (NP (NP (DT the) (JJ steady-state) (NN AUC)) (PP (IN of) (NP (NN ganciclovir)))))) (VP (VBD was) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (NN VIDEX)) (VP (VBD was) (VP (VBN administered) (ADVP (NP (CD 2) (NNS hours)) (RB prior) (PP (TO to) (NP (NN ganciclovir))))))))) (, ,) (SBAR (CONJP (CC but) (RB not)) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (CD two) (NNS drugs)) (VP (VBD were) (VP (VBN administered) (ADVP (RB simultaneously))))))))) (PRN (-LRB- -LRB-) (NP (NP (NN n)) (ADJP (JJ =) (NP (CD 12) (NN -RRB-.))))))))

det(decrease-7, A-1)
number(%-6, 21-2)
number(%-6, 17-4)
amod(decrease-7, %-6)
nsubjpass(observed-15, decrease-7)
det(AUC-11, the-9)
amod(AUC-11, steady-state-10)
prep_in(decrease-7, AUC-11)
prep_of(AUC-11, ganciclovir-13)
auxpass(observed-15, was-14)
root(ROOT-0, observed-15)
advmod(administered-19, when-16)
nsubjpass(administered-19, VIDEX-17)
auxpass(administered-19, was-18)
advcl(observed-15, administered-19)
num(hours-21, 2-20)
npadvmod(administered-19, hours-21)
prep_prior_to(administered-19, ganciclovir-24)
cc(administered-33, not-27)
advmod(administered-33, when-28)
det(drugs-31, the-29)
num(drugs-31, two-30)
nsubjpass(administered-33, drugs-31)
auxpass(administered-33, were-32)
dep(observed-15, administered-33)
advmod(administered-33, simultaneously-34)
dep(observed-15, n-36)
amod(n-36, =-37)
num(-RRB-.-39, 12-38)
dep(=-37, -RRB-.-39)

Quinolone/JJ Antibiotic/JJ s/NNS :/: VIDEX/NN should/MD be/VB administered/VBN at/IN least/JJS 2/CD hours/NNS after/IN or/CC 6/CD hours/NNS before/IN dosing/NN with/IN ciprofloxacin/NN because/IN plasma/NN concentrations/NNS of/IN ciprofloxacin/NN are/VBP decreased/VBN when/WRB administered/VBN with/IN antacids/NNS containing/VBG magnesium/NN ,/, calcium/NN ,/, or/CC aluminum/NN ./.

(ROOT (S1 (S (NP (NP (JJ Quinolone) (JJ Antibiotic) (NNS s)) (: :) (S (NP (NN VIDEX)) (VP (MD should) (VP (VB be) (VP (VBN administered) (NP (NP (NP (QP (IN at) (JJS least) (CD 2)) (NNS hours)) (PP (IN after))) (CC or) (NP (NP (CD 6) (NNS hours)) (PP (IN before) (NP (NP (NN dosing)) (PP (IN with) (NP (NN ciprofloxacin))))))) (SBAR (IN because) (S (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN ciprofloxacin)))) (VP (VBP are) (VP (VBN decreased) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN with) (NP (NP (NNS antacids)) (VP (VBG containing) (NP (NP (NN magnesium)) (, ,) (NP (NN calcium)) (, ,) (CC or) (NP (NN aluminum))))))))))))))))) (. .)))))

amod(s-3, Quinolone-1)
amod(s-3, Antibiotic-2)
root(ROOT-0, s-3)
nsubjpass(administered-8, VIDEX-5)
aux(administered-8, should-6)
auxpass(administered-8, be-7)
dep(s-3, administered-8)
quantmod(2-11, at-9)
mwe(at-9, least-10)
pobj(at-9, least-10)
num(hours-12, 2-11)
dobj(administered-8, hours-12)
prep(hours-12, after-13)
num(hours-16, 6-15)
conj_or(hours-12, hours-16)
prep_before(hours-16, dosing-18)
prep_with(dosing-18, ciprofloxacin-20)
mark(decreased-27, because-21)
nn(concentrations-23, plasma-22)
nsubjpass(decreased-27, concentrations-23)
prep_of(concentrations-23, ciprofloxacin-25)
auxpass(decreased-27, are-26)
advcl(administered-8, decreased-27)
advmod(administered-29, when-28)
advcl(decreased-27, administered-29)
prep_with(administered-29, antacids-31)
partmod(antacids-31, containing-32)
dobj(containing-32, magnesium-33)
conj_or(magnesium-33, calcium-35)
conj_or(magnesium-33, aluminum-38)

In/IN eight/CD HIV-infected/JJ patients/NNS ,/, the/DT steady-state/JJ AUC/NN of/IN ciprofloxacin/NN was/VBD decreased/VBN an/DT average/JJ of/IN 26/CD %/NN (/-LRB- 95/CD %/NN CI/NN =/JJ 14/CD %/NN ,/, 37/CD %/NN )/-RRB- when/WRB ciprofloxacin/NN was/VBD administered/VBN 2/CD hours/NNS prior/RB to/TO a/DT marketed/VBN chewable//NN dispersible/NN tablet/NN formulation/NN of/IN VIDEX/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (CD eight) (JJ HIV-infected) (NNS patients))) (, ,) (NP (NP (DT the) (JJ steady-state) (NN AUC)) (PP (IN of) (NP (NN ciprofloxacin)))) (VP (VBD was) (VP (VBN decreased) (NP (NP (DT an) (JJ average) (IN of) (CD 26) (NN %)) (PRN (-LRB- -LRB-) (NP (CD 95) (NN %) (NN CI) (JJ =) (CD 14) (NN %) (, ,) (CD 37) (NN %)) (-RRB- -RRB-)))) (SBAR (WHADVP (WRB when)) (S (NP (NN ciprofloxacin)) (VP (VBD was) (VP (VBN administered) (ADVP (NP (CD 2) (NNS hours)) (RB prior)) (PP (TO to) (NP (NP (DT a) (VBN marketed) (NN chewable/) (NN dispersible) (NN tablet) (NN formulation)) (PP (IN of) (NP (NN VIDEX))))))))))) (. .))))

num(patients-4, eight-2)
amod(patients-4, HIV-infected-3)
prep_in(decreased-12, patients-4)
det(AUC-8, the-6)
amod(AUC-8, steady-state-7)
nsubjpass(decreased-12, AUC-8)
prep_of(AUC-8, ciprofloxacin-10)
auxpass(decreased-12, was-11)
root(ROOT-0, decreased-12)
det(%-17, an-13)
amod(%-17, average-14)
amod(%-17, of-15)
num(%-17, 26-16)
dobj(decreased-12, %-17)
num(%-27, 95-19)
nn(%-27, %-20)
nn(%-27, CI-21)
amod(%-27, =-22)
num(%-27, 14-23)
nn(%-27, %-24)
num(%-27, 37-26)
appos(%-17, %-27)
advmod(administered-32, when-29)
nsubjpass(administered-32, ciprofloxacin-30)
auxpass(administered-32, was-31)
advcl(decreased-12, administered-32)
num(hours-34, 2-33)
npadvmod(administered-32, hours-34)
det(formulation-42, a-37)
amod(formulation-42, marketed-38)
nn(formulation-42, chewable/-39)
nn(formulation-42, dispersible-40)
nn(formulation-42, tablet-41)
prep_prior_to(administered-32, formulation-42)
prep_of(formulation-42, VIDEX-44)

The/DT AUC/NN of/IN ciprofloxacin/NN was/VBD decreased/VBN an/DT average/NN of/IN 15-fold/JJ in/IN 12/CD healthy/JJ subjects/NNS given/IN ciprofloxacin/NN and/CC didanosine/NN -placebo/NN tablets/NNS concurrently/RB ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN AUC)) (PP (IN of) (NP (NN ciprofloxacin)))) (VP (VBD was) (VP (VBN decreased) (NP (NP (DT an) (NN average)) (PP (IN of) (NP (JJ 15-fold))) (PP (IN in) (NP (CD 12) (JJ healthy) (NNS subjects))) (PP (IN given) (NP (NP (NN ciprofloxacin)) (CC and) (NP (NN didanosine)) (NP (NN -placebo) (NNS tablets))))) (ADVP (RB concurrently))))) (. .))))

det(AUC-2, The-1)
nsubjpass(decreased-6, AUC-2)
prep_of(AUC-2, ciprofloxacin-4)
auxpass(decreased-6, was-5)
root(ROOT-0, decreased-6)
det(average-8, an-7)
dobj(decreased-6, average-8)
prep_of(average-8, 15-fold-10)
num(subjects-14, 12-12)
amod(subjects-14, healthy-13)
prep_in(average-8, subjects-14)
prep_given(average-8, ciprofloxacin-16)
conj_and(ciprofloxacin-16, didanosine-18)
nn(tablets-20, -placebo-19)
dep(ciprofloxacin-16, tablets-20)
advmod(decreased-6, concurrently-21)

In/IN a/DT single/JJ subject/NN given/VBN one/CD dose/NN of/IN ciprofloxacin/NN 2/CD hours/NNS after/IN a/DT dose/NN of/IN didanosine/NN -placebo/NN tablets/NNS ,/, a/DT greater/JJR than/IN 50/CD %/NN reduction/NN in/IN the/DT AUC/NN of/IN ciprofloxacin/NN was/VBD observed/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT a) (JJ single) (NN subject)) (VP (VBN given) (NP (NP (CD one) (NN dose)) (PP (IN of) (NP (NP (NN ciprofloxacin) (CD 2) (NNS hours)) (PP (IN after) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (NN didanosine) (NN -placebo) (NNS tablets))))))))))) (, ,) (NP (NP (DT a) (ADJP (QP (JJR greater) (IN than) (CD 50)) (NN %)) (NN reduction)) (PP (IN in) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NN ciprofloxacin)))))) (VP (VBD was) (VP (VBN observed)))) (. .))))

det(subject-4, a-2)
amod(subject-4, single-3)
prep_in(observed-32, subject-4)
partmod(subject-4, given-5)
num(dose-7, one-6)
dobj(given-5, dose-7)
nn(hours-11, ciprofloxacin-9)
num(hours-11, 2-10)
prep_of(dose-7, hours-11)
det(dose-14, a-13)
prep_after(hours-11, dose-14)
nn(tablets-18, didanosine-16)
nn(tablets-18, -placebo-17)
prep_of(dose-14, tablets-18)
det(reduction-25, a-20)
mwe(than-22, greater-21)
quantmod(50-23, than-22)
dep(%-24, 50-23)
dep(reduction-25, %-24)
nsubjpass(observed-32, reduction-25)
det(AUC-28, the-27)
prep_in(reduction-25, AUC-28)
prep_of(AUC-28, ciprofloxacin-30)
auxpass(observed-32, was-31)
root(ROOT-0, observed-32)

Plasma/NN concentrations/NNS of/IN quinolone/JJ antibiotic/JJ s/NNS are/VBP decreased/VBN when/WRB administered/VBN with/IN antacids/NNS containing/VBG magnesium/NN ,/, calcium/NN ,/, or/CC aluminum/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Plasma) (NNS concentrations)) (PP (IN of) (NP (JJ quinolone) (JJ antibiotic) (NNS s)))) (VP (VBP are) (VP (VBN decreased) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN with) (NP (NP (NNS antacids)) (VP (VBG containing) (NP (NP (NN magnesium)) (, ,) (NP (NN calcium)) (, ,) (CC or) (NP (NN aluminum)))))))))))) (. .))))

nn(concentrations-2, Plasma-1)
nsubjpass(decreased-8, concentrations-2)
amod(s-6, quinolone-4)
amod(s-6, antibiotic-5)
prep_of(concentrations-2, s-6)
auxpass(decreased-8, are-7)
root(ROOT-0, decreased-8)
advmod(administered-10, when-9)
advcl(decreased-8, administered-10)
prep_with(administered-10, antacids-12)
partmod(antacids-12, containing-13)
dobj(containing-13, magnesium-14)
conj_or(magnesium-14, calcium-16)
conj_or(magnesium-14, aluminum-19)

The/DT optimal/JJ dosing/NN interval/NN for/IN coadministration/NN with/IN VIDEX/NN should/MD be/VB determined/VBN by/IN consulting/VBG the/DT appropriate/JJ quinolone/NN package/NN insert/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ optimal) (NN dosing) (NN interval)) (PP (IN for) (NP (NP (NN coadministration)) (PP (IN with) (NP (NN VIDEX)))))) (VP (MD should) (VP (VB be) (VP (VBN determined) (PP (IN by) (S (VP (VBG consulting) (NP (DT the) (JJ appropriate) (NN quinolone) (NN package) (NN insert))))))))) (. .))))

det(interval-4, The-1)
amod(interval-4, optimal-2)
nn(interval-4, dosing-3)
nsubjpass(determined-11, interval-4)
prep_for(interval-4, coadministration-6)
prep_with(coadministration-6, VIDEX-8)
aux(determined-11, should-9)
auxpass(determined-11, be-10)
root(ROOT-0, determined-11)
agent(determined-11, consulting-13)
det(insert-18, the-14)
amod(insert-18, appropriate-15)
nn(insert-18, quinolone-16)
nn(insert-18, package-17)
dobj(consulting-13, insert-18)

Interactions/NNS with/IN Other/JJ Antiretroviral/JJ Drugs/NNS :/: Significant/JJ decreases/NNS in/IN the/DT AUC/NN of/IN delavirdine/NN (/-LRB- 20/CD %/NN )/-RRB- and/CC indinavir/NN (/-LRB- 84/CD %/NN )/-RRB- occurred/VBD following/VBG simultaneous/JJ administration/NN of/IN these/DT agents/NNS with/IN VIDEX/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Interactions)) (PP (IN with) (NP (JJ Other) (JJ Antiretroviral) (NNS Drugs)))) (: :) (S (NP (NP (JJ Significant) (NNS decreases)) (PP (IN in) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NP (NP (NN delavirdine)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN %)) (-RRB- -RRB-))) (CC and) (NP (NP (NN indinavir)) (PRN (-LRB- -LRB-) (NP (CD 84) (NN %)) (-RRB- -RRB-)))))))) (VP (VBD occurred) (PP (VBG following) (NP (NP (JJ simultaneous) (NN administration)) (PP (IN of) (NP (DT these) (NNS agents))) (PP (IN with) (NP (NN VIDEX))))))) (. .)))))

root(ROOT-0, Interactions-1)
amod(Drugs-5, Other-3)
amod(Drugs-5, Antiretroviral-4)
prep_with(Interactions-1, Drugs-5)
amod(decreases-8, Significant-7)
nsubj(occurred-24, decreases-8)
det(AUC-11, the-10)
prep_in(decreases-8, AUC-11)
prep_of(AUC-11, delavirdine-13)
num(%-16, 20-15)
appos(delavirdine-13, %-16)
conj_and(delavirdine-13, indinavir-19)
num(%-22, 84-21)
appos(indinavir-19, %-22)
dep(Interactions-1, occurred-24)
amod(administration-27, simultaneous-26)
prep_following(occurred-24, administration-27)
det(agents-30, these-29)
prep_of(administration-27, agents-30)
prep_with(administration-27, VIDEX-32)

To/TO avoid/VB this/DT interaction/NN ,/, delavirdine/NN or/CC indinavir/NN should/MD be/VB given/IN 1/CD hour/NN prior/JJ to/TO dosing/NN with/IN VIDEX/NN ./.

(ROOT (S1 (S (S (S (VP (TO To) (VP (VB avoid) (NP (DT this) (NN interaction))))) (, ,) (NP (NP (NN delavirdine)) (CC or) (NP (NN indinavir))) (VP (MD should) (VP (VB be) (PP (IN given) (NP (NP (CD 1) (NN hour)) (ADJP (JJ prior) (PP (TO to) (NP (NP (NN dosing)) (PP (IN with) (NP (NN VIDEX))))))))))) (. .))))

aux(avoid-2, To-1)
purpcl(be-10, avoid-2)
det(interaction-4, this-3)
dobj(avoid-2, interaction-4)
nsubj(be-10, delavirdine-6)
conj_or(delavirdine-6, indinavir-8)
aux(be-10, should-9)
root(ROOT-0, be-10)
num(hour-13, 1-12)
prep_given(be-10, hour-13)
prep_prior_to(hour-13, dosing-16)
prep_with(dosing-16, VIDEX-18)

The/DT pharmacokinetics/NNS of/IN nelfinavir/NN are/VBP not/RB altered/VBN to/TO a/DT clinically/RB significant/JJ degree/NN when/WRB it/PRP is/VBZ administered/VBN with/IN a/DT light/JJ meal/NN 1/CD hour/NN after/IN VIDEX/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS pharmacokinetics)) (PP (IN of) (NP (NN nelfinavir)))) (VP (VBP are) (RB not) (VP (VBN altered) (PP (TO to) (NP (NP (DT a) (ADJP (RB clinically) (JJ significant)) (NN degree)) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN administered) (PP (IN with) (NP (DT a) (JJ light) (NN meal))) (PP (NP (CD 1) (NN hour)) (IN after) (NP (NN VIDEX)))))))))))) (. .))))

det(pharmacokinetics-2, The-1)
nsubjpass(altered-7, pharmacokinetics-2)
prep_of(pharmacokinetics-2, nelfinavir-4)
auxpass(altered-7, are-5)
neg(altered-7, not-6)
root(ROOT-0, altered-7)
det(degree-12, a-9)
advmod(significant-11, clinically-10)
amod(degree-12, significant-11)
prep_to(altered-7, degree-12)
tmod(administered-16, degree-12)
advmod(administered-16, when-13)
nsubjpass(administered-16, it-14)
auxpass(administered-16, is-15)
dep(degree-12, administered-16)
det(meal-20, a-18)
amod(meal-20, light-19)
prep_with(administered-16, meal-20)
num(hour-22, 1-21)
npadvmod(administered-16, hour-22)
prep_after(administered-16, VIDEX-24)

Drug/NN //: Laboratory/NN Test/NN Interactions/NNS Certain/JJ endocrine/JJ and/CC liver/NN function/NN tests/NNS may/MD be/VB affected/VBN by/IN estrogen/NN -containing/JJ oral/JJ contraceptives/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Drug) (: /) (NN Laboratory) (NN Test) (NNS Interactions)) (ADJP (JJ Certain) (JJ endocrine))) (CC and) (NP (NN liver) (NN function) (NNS tests))) (VP (MD may) (VP (VB be) (VP (VBN affected) (PP (IN by) (NP (ADJP (NN estrogen) (JJ -containing)) (JJ oral) (NNS contraceptives))))))) (. .))))

nn(Interactions-5, Drug-1)
punct(Interactions-5, /-2)
nn(Interactions-5, Laboratory-3)
nn(Interactions-5, Test-4)
nsubjpass(affected-14, Interactions-5)
amod(endocrine-7, Certain-6)
amod(Interactions-5, endocrine-7)
nn(tests-11, liver-9)
nn(tests-11, function-10)
conj_and(Interactions-5, tests-11)
aux(affected-14, may-12)
auxpass(affected-14, be-13)
root(ROOT-0, affected-14)
dep(-containing-17, estrogen-16)
amod(contraceptives-19, -containing-17)
amod(contraceptives-19, oral-18)
agent(affected-14, contraceptives-19)

The/DT following/JJ similar/JJ changes/NNS may/MD be/VB expected/VBN with/IN larger/JJR doses/NNS of/IN estrogen/NN :/: -/CC Increased/VBN sulfobromophthalein/NN retention/NN ./.

(ROOT (S1 (S (S (NP (DT The) (JJ following) (JJ similar) (NNS changes)) (VP (MD may) (VP (VB be) (VP (VBN expected) (PP (IN with) (NP (NP (JJR larger) (NNS doses)) (PP (IN of) (NP (NP (NP (NN estrogen)) (: :)) (CC -) (NP (VBN Increased) (NN sulfobromophthalein) (NN retention)))))))))) (. .))))

det(changes-4, The-1)
amod(changes-4, following-2)
amod(changes-4, similar-3)
nsubjpass(expected-7, changes-4)
aux(expected-7, may-5)
auxpass(expected-7, be-6)
root(ROOT-0, expected-7)
amod(doses-10, larger-9)
prep_with(expected-7, doses-10)
prep_of(doses-10, estrogen-12)
amod(retention-17, Increased-15)
nn(retention-17, sulfobromophthalein-16)
conj(estrogen-12, retention-17)

-/CC Increased/VBN prothrombin/NN and/CC factors/NNS VII/NN ,/, VIII/NN ,/, IX/NN ,/, and/CC X/NN ;/: ./.

(ROOT (S1 (S (S (NP (CC -) (NP (VBN Increased) (NN prothrombin)) (CC and) (NP (NP (NP (NNS factors) (NN VII)) (, ,) (NP (NN VIII)) (, ,) (NP (NN IX)) (, ,) (CC and) (NP (NN X))) (: ;)))) (. .))))

amod(prothrombin-3, Increased-2)
root(ROOT-0, prothrombin-3)
nn(VII-6, factors-5)
conj_and(prothrombin-3, VII-6)
conj_and(VII-6, VIII-8)
conj_and(VII-6, IX-10)
conj_and(VII-6, X-13)

decreased/VBN antithrombin/NN 3/CD ;/: ./.

(ROOT (S1 (S (S (VP (VBN decreased) (NP (NN antithrombin) (CD 3))) (: ;)) (. .))))

root(ROOT-0, decreased-1)
dobj(decreased-1, antithrombin-2)
num(antithrombin-2, 3-3)

increased/VBN norepinephrine/NN -induced/JJ platelet/NN aggregability/NN ./.

(ROOT (S1 (S (S (VP (VBN increased) (NP (ADJP (NN norepinephrine) (JJ -induced)) (NN platelet) (NN aggregability)))) (. .))))

root(ROOT-0, increased-1)
dep(-induced-3, norepinephrine-2)
amod(aggregability-5, -induced-3)
nn(aggregability-5, platelet-4)
dobj(increased-1, aggregability-5)

-/CC Increased/VBN thyroid-binding/JJ globulin/NN (/-LRB- TBG/NN )/-RRB- leading/VBG to/TO in-creased/JJ circulating/VBG total/JJ thyroid/NN hormone/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (CC -) (VBN Increased) (JJ thyroid-binding) (NN globulin)) (PRN (-LRB- -LRB-) (NP (NN TBG)) (-RRB- -RRB-))) (VP (VBG leading) (PP (TO to) (NP (JJ in-creased) (VBG circulating) (JJ total) (NN thyroid) (NN hormone)))) (: ;)) (. .))))

dep(globulin-4, Increased-2)
amod(globulin-4, thyroid-binding-3)
nsubj(leading-8, globulin-4)
abbrev(globulin-4, TBG-6)
root(ROOT-0, leading-8)
amod(hormone-14, in-creased-10)
amod(hormone-14, circulating-11)
amod(hormone-14, total-12)
nn(hormone-14, thyroid-13)
prep_to(leading-8, hormone-14)

as/IN measured/VBN by/IN PBI/NN ,/, T4/NN by/IN column/NN ,/, or/CC T4/NN by/IN radioimmunoassay/NN ./.

(ROOT (S1 (S (S (IN as) (VP (VBN measured) (PP (IN by) (NP (NP (NN PBI)) (, ,) (NP (NN T4)))) (PP (IN by) (NP (NP (NN column)) (, ,) (CC or) (NP (NN T4)))) (PP (IN by) (NP (NN radioimmunoassay))))) (. .))))

dep(measured-2, as-1)
root(ROOT-0, measured-2)
prep_by(measured-2, PBI-4)
appos(PBI-4, T4-6)
prep_by(measured-2, column-8)
conj_or(column-8, T4-11)
prep_by(measured-2, radioimmunoassay-13)

-/CC Increased/VBN serum/NN triglyceride/NN and/CC phospholipid/NN concentration/NN ./.

(ROOT (S1 (S (S (NP (CC -) (NP (VBN Increased) (NN serum) (NN triglyceride)) (CC and) (NP (NN phospholipid) (NN concentration)))) (. .))))

amod(triglyceride-4, Increased-2)
nn(triglyceride-4, serum-3)
root(ROOT-0, triglyceride-4)
nn(concentration-7, phospholipid-6)
conj_and(triglyceride-4, concentration-7)

Antidiabetic/JJ drug/NN requirements/NNS (/-LRB- i.e./FW ,/, insulin/NN )/-RRB- may/MD be/VB altered/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Antidiabetic) (NN drug) (NNS requirements)) (PRN (-LRB- -LRB-) (PP (FW i.e.)) (, ,) (NP (NN insulin)) (-RRB- -RRB-))) (VP (MD may) (VP (VB be) (VP (VBN altered))))) (. .))))

amod(requirements-3, Antidiabetic-1)
nn(requirements-3, drug-2)
nsubjpass(altered-11, requirements-3)
dep(insulin-7, i.e.-5)
appos(requirements-3, insulin-7)
aux(altered-11, may-9)
auxpass(altered-11, be-10)
root(ROOT-0, altered-11)

Concurrent/JJ use/NN with/IN general/JJ anesthetics/NNS may/MD result/VB in/IN arrhythmias/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN use)) (PP (IN with) (NP (JJ general) (NNS anesthetics)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NN arrhythmias)))))) (. .))))

amod(use-2, Concurrent-1)
nsubj(result-7, use-2)
amod(anesthetics-5, general-4)
prep_with(use-2, anesthetics-5)
aux(result-7, may-6)
root(ROOT-0, result-7)
prep_in(result-7, arrhythmias-9)

The/DT pressor/JJ effects/NNS of/IN diethylpropion/NN and/CC those/DT of/IN other/JJ drugs/NNS may/MD be/VB additive/JJ when/WRB the/DT drugs/NNS are/VBP used/VBN concomitantly/RB ;/: ./.

(ROOT (S1 (S (S (NP (NP (NP (DT The) (JJ pressor) (NNS effects)) (PP (IN of) (NP (NN diethylpropion)))) (CC and) (NP (NP (DT those)) (PP (IN of) (NP (JJ other) (NNS drugs))))) (VP (MD may) (VP (VB be) (ADJP (JJ additive))) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NNS drugs)) (VP (VBP are) (VP (VBN used) (ADVP (RB concomitantly))))))) (: ;)) (. .))))

det(effects-3, The-1)
amod(effects-3, pressor-2)
nsubj(additive-13, effects-3)
prep_of(effects-3, diethylpropion-5)
conj_and(effects-3, those-7)
amod(drugs-10, other-9)
prep_of(those-7, drugs-10)
aux(additive-13, may-11)
cop(additive-13, be-12)
root(ROOT-0, additive-13)
advmod(used-18, when-14)
det(drugs-16, the-15)
nsubjpass(used-18, drugs-16)
auxpass(used-18, are-17)
advcl(additive-13, used-18)
advmod(used-18, concomitantly-19)

conversely/RB ,/, diethylpropion/NN may/MD interfere/VB with/IN antihypertensive/JJ drugs/NNS (/-LRB- i.e./FW ,/, guanethidine/NN ,/, a-/NN methyldopa/NNS )/-RRB- ./.

(ROOT (S1 (S (S (ADVP (RB conversely)) (, ,) (NP (NN diethylpropion)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (JJ antihypertensive) (NNS drugs)) (PRN (-LRB- -LRB-) (PP (FW i.e.) (, ,) (NP (NN guanethidine))) (, ,) (NP (NN a-) (NNS methyldopa)) (-RRB- -RRB-))))))) (. .))))

advmod(interfere-5, conversely-1)
nsubj(interfere-5, diethylpropion-3)
aux(interfere-5, may-4)
root(ROOT-0, interfere-5)
amod(drugs-8, antihypertensive-7)
prep_with(interfere-5, drugs-8)
dep(methyldopa-15, i.e.-10)
pobj(i.e.-10, guanethidine-12)
nn(methyldopa-15, a--14)
appos(drugs-8, methyldopa-15)

Concurrent/JJ use/NN of/IN phenothiazines/NNS may/MD antagonize/VB the/DT anorectic/JJ effect/NN of/IN diethylpropion/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN use)) (PP (IN of) (NP (NNS phenothiazines)))) (VP (MD may) (VP (VB antagonize) (NP (NP (DT the) (JJ anorectic) (NN effect)) (PP (IN of) (NP (NN diethylpropion))))))) (. .))))

amod(use-2, Concurrent-1)
nsubj(antagonize-6, use-2)
prep_of(use-2, phenothiazines-4)
aux(antagonize-6, may-5)
root(ROOT-0, antagonize-6)
det(effect-9, the-7)
amod(effect-9, anorectic-8)
dobj(antagonize-6, effect-9)
prep_of(effect-9, diethylpropion-11)

Oral/JJ Anticoagulants/NNS :/: In/IN some/DT normal/JJ volunteers/NNS ,/, the/DT concomitant/JJ administration/NN of/IN diflunisal/NN and/CC warfarin/NN ,/, acenocoumarol/NN ,/, or/CC phenprocoumon/NN resulted/VBD in/IN prolongation/NN of/IN prothrombin/NN time/NN ./.

(ROOT (S1 (S (NP (NP (JJ Oral) (NNS Anticoagulants)) (: :) (S (PP (IN In) (NP (DT some) (JJ normal) (NNS volunteers))) (, ,) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN diflunisal)) (CC and) (NP (NN warfarin)) (, ,) (NP (NN acenocoumarol)) (, ,) (CC or) (NP (NN phenprocoumon))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NN prolongation)) (PP (IN of) (NP (NN prothrombin) (NN time))))))) (. .)))))

amod(Anticoagulants-2, Oral-1)
root(ROOT-0, Anticoagulants-2)
det(volunteers-7, some-5)
amod(volunteers-7, normal-6)
prep_in(resulted-21, volunteers-7)
det(administration-11, the-9)
amod(administration-11, concomitant-10)
nsubj(resulted-21, administration-11)
prep_of(administration-11, diflunisal-13)
conj_and(diflunisal-13, warfarin-15)
conj_and(diflunisal-13, acenocoumarol-17)
conj_or(diflunisal-13, phenprocoumon-20)
dep(Anticoagulants-2, resulted-21)
prep_in(resulted-21, prolongation-23)
nn(time-26, prothrombin-25)
prep_of(prolongation-23, time-26)

This/DT may/MD occur/VB because/IN diflunisal/NN competitively/RB displaces/VBZ coumarins/NN from/IN protein/NN binding/NN sites/NNS ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (MD may) (VP (VB occur) (SBAR (IN because) (S (NP (NN diflunisal)) (ADVP (RB competitively)) (VP (VBZ displaces) (NP (NN coumarins)) (PP (IN from) (NP (NN protein) (NN binding) (NNS sites))))))))) (. .))))

nsubj(occur-3, This-1)
aux(occur-3, may-2)
root(ROOT-0, occur-3)
mark(displaces-7, because-4)
nsubj(displaces-7, diflunisal-5)
advmod(displaces-7, competitively-6)
advcl(occur-3, displaces-7)
dobj(displaces-7, coumarins-8)
nn(sites-12, protein-10)
nn(sites-12, binding-11)
prep_from(displaces-7, sites-12)

Accordingly/RB ,/, when/WRB diflunisal/NN is/VBZ administered/VBN with/IN oral/JJ anticoagulants/NNS ,/, the/DT prothrombin/NN time/NN should/MD be/VB closely/RB monitored/VBN during/IN and/CC for/IN several/JJ days/NNS after/IN concomitant/JJ drug/NN administration/NN ./.

(ROOT (S1 (S (S (ADVP (RB Accordingly)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NN diflunisal)) (VP (VBZ is) (VP (VBN administered) (PP (IN with) (NP (JJ oral) (NNS anticoagulants))))))) (, ,) (NP (DT the) (NN prothrombin) (NN time)) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN monitored) (PP (PP (IN during)) (CC and) (PP (IN for) (NP (NP (JJ several) (NNS days)) (PP (IN after) (NP (JJ concomitant) (NN drug) (NN administration)))))))))) (. .))))

advmod(monitored-17, Accordingly-1)
advmod(administered-6, when-3)
nsubjpass(administered-6, diflunisal-4)
auxpass(administered-6, is-5)
advcl(monitored-17, administered-6)
amod(anticoagulants-9, oral-8)
prep_with(administered-6, anticoagulants-9)
det(time-13, the-11)
nn(time-13, prothrombin-12)
nsubjpass(monitored-17, time-13)
aux(monitored-17, should-14)
auxpass(monitored-17, be-15)
advmod(monitored-17, closely-16)
root(ROOT-0, monitored-17)
prep(monitored-17, during-18)
conj_and(during-18, for-20)
amod(days-22, several-21)
pobj(for-20, days-22)
amod(administration-26, concomitant-24)
nn(administration-26, drug-25)
prep_after(days-22, administration-26)

Adjustment/NN of/IN dosage/NN of/IN oral/JJ anticoagulants/NNS may/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Adjustment)) (PP (IN of) (NP (NP (NN dosage)) (PP (IN of) (NP (JJ oral) (NNS anticoagulants)))))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (. .))))

nsubjpass(required-9, Adjustment-1)
prep_of(Adjustment-1, dosage-3)
amod(anticoagulants-6, oral-5)
prep_of(dosage-3, anticoagulants-6)
aux(required-9, may-7)
auxpass(required-9, be-8)
root(ROOT-0, required-9)

Tolbutamide/NN :/: In/IN diabetic/JJ patients/NNS receiving/VBG diflunisal/NN and/CC tolbutamide/NN ,/, no/DT significant/JJ effects/NNS were/VBD seen/VBN on/IN tolbutamide/NN plasma/NN levels/NNS or/CC fasting/JJ blood/NN glucose/NN ./.

(ROOT (S1 (S (NP (NP (NN Tolbutamide)) (: :) (S (PP (IN In) (NP (NP (JJ diabetic) (NNS patients)) (VP (VBG receiving) (NP (NP (NN diflunisal)) (CC and) (NP (NN tolbutamide)))))) (, ,) (NP (DT no) (JJ significant) (NNS effects)) (VP (VBD were) (VP (VBN seen) (PP (IN on) (NP (NP (NN tolbutamide) (NN plasma) (NNS levels)) (CC or) (NP (JJ fasting) (NN blood) (NN glucose))))))) (. .)))))

root(ROOT-0, Tolbutamide-1)
amod(patients-5, diabetic-4)
prep_in(seen-15, patients-5)
partmod(patients-5, receiving-6)
dobj(receiving-6, diflunisal-7)
conj_and(diflunisal-7, tolbutamide-9)
det(effects-13, no-11)
amod(effects-13, significant-12)
nsubjpass(seen-15, effects-13)
auxpass(seen-15, were-14)
dep(Tolbutamide-1, seen-15)
nn(levels-19, tolbutamide-17)
nn(levels-19, plasma-18)
prep_on(seen-15, levels-19)
amod(glucose-23, fasting-21)
nn(glucose-23, blood-22)
conj_or(levels-19, glucose-23)

Hydrochlorothiazide/NN :/: In/IN normal/JJ volunteers/NNS ,/, concomitant/JJ administration/NN of/IN diflunisal/NN and/CC hydrochlorothiazide/NN resulted/VBD in/IN significantly/RB increased/VBN plasma/NN levels/NNS of/IN hydrochlorothiazide/NN ./.

(ROOT (S1 (S (S (NP (NN Hydrochlorothiazide)) (: :) (PP (IN In) (NP (JJ normal) (NNS volunteers))) (, ,) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN diflunisal)) (CC and) (NP (NN hydrochlorothiazide))))) (VP (VBD resulted) (PP (IN in) (NP (NP (ADJP (RB significantly) (VBN increased)) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN hydrochlorothiazide))))))) (. .))))

nsubj(resulted-13, Hydrochlorothiazide-1)
amod(volunteers-5, normal-4)
prep_in(resulted-13, volunteers-5)
amod(administration-8, concomitant-7)
nsubj(resulted-13, administration-8)
prep_of(administration-8, diflunisal-10)
conj_and(diflunisal-10, hydrochlorothiazide-12)
root(ROOT-0, resulted-13)
advmod(increased-16, significantly-15)
amod(levels-18, increased-16)
nn(levels-18, plasma-17)
prep_in(resulted-13, levels-18)
prep_of(levels-18, hydrochlorothiazide-20)

Diflunisal/NN decreased/VBD the/DT hyperuricemic/JJ effect/NN of/IN hydrochlorothiazide/NN ./.

(ROOT (S1 (S (S (NP (NN Diflunisal)) (VP (VBD decreased) (NP (NP (DT the) (JJ hyperuricemic) (NN effect)) (PP (IN of) (NP (NN hydrochlorothiazide)))))) (. .))))

nsubj(decreased-2, Diflunisal-1)
root(ROOT-0, decreased-2)
det(effect-5, the-3)
amod(effect-5, hyperuricemic-4)
dobj(decreased-2, effect-5)
prep_of(effect-5, hydrochlorothiazide-7)

Furosemide/NN :/: In/IN normal/JJ volunteers/NNS ,/, the/DT concomitant/JJ administration/NN of/IN diflunisal/NN and/CC furosemide/NN had/VBD no/DT effect/NN on/IN the/DT diuretic/JJ activity/NN of/IN furosemide/NN ./.

(ROOT (S1 (S (S (NP (NN Furosemide)) (: :) (PP (IN In) (NP (JJ normal) (NNS volunteers))) (, ,) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN diflunisal)) (CC and) (NP (NN furosemide))))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (JJ diuretic) (NN activity)) (PP (IN of) (NP (NN furosemide))))))) (. .))))

nsubj(had-14, Furosemide-1)
amod(volunteers-5, normal-4)
prep_in(had-14, volunteers-5)
det(administration-9, the-7)
amod(administration-9, concomitant-8)
nsubj(had-14, administration-9)
prep_of(administration-9, diflunisal-11)
conj_and(diflunisal-11, furosemide-13)
root(ROOT-0, had-14)
det(effect-16, no-15)
dobj(had-14, effect-16)
det(activity-20, the-18)
amod(activity-20, diuretic-19)
prep_on(had-14, activity-20)
prep_of(activity-20, furosemide-22)

Diflunisal/NN decreased/VBD the/DT hyperuricemic/JJ effect/NN of/IN furosemide/NN ./.

(ROOT (S1 (S (S (NP (NN Diflunisal)) (VP (VBD decreased) (NP (NP (DT the) (JJ hyperuricemic) (NN effect)) (PP (IN of) (NP (NN furosemide)))))) (. .))))

nsubj(decreased-2, Diflunisal-1)
root(ROOT-0, decreased-2)
det(effect-5, the-3)
amod(effect-5, hyperuricemic-4)
dobj(decreased-2, effect-5)
prep_of(effect-5, furosemide-7)

Antacids/NNS :/: Concomitant/JJ administration/NN of/IN antacids/NNS may/MD reduce/VB plasma/NN levels/NNS of/IN diflunisal/NN ./.

(ROOT (S1 (S (NP (NP (NNS Antacids)) (: :) (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NNS antacids)))) (VP (MD may) (VP (VB reduce) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (NN diflunisal))))))) (. .)))))

root(ROOT-0, Antacids-1)
amod(administration-4, Concomitant-3)
nsubj(reduce-8, administration-4)
prep_of(administration-4, antacids-6)
aux(reduce-8, may-7)
dep(Antacids-1, reduce-8)
nn(levels-10, plasma-9)
dobj(reduce-8, levels-10)
prep_of(levels-10, diflunisal-12)

This/DT effect/NN is/VBZ small/JJ with/IN occasional/JJ doses/NNS of/IN antacids/NNS ,/, but/CC may/MD be/VB clinically/RB significant/JJ when/WRB antacids/NNS are/VBP used/VBN on/IN a/DT continuous/JJ schedule/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN effect)) (VP (VP (VBZ is) (ADJP (JJ small) (PP (IN with) (NP (NP (JJ occasional) (NNS doses)) (PP (IN of) (NP (NNS antacids))))))) (, ,) (CC but) (VP (MD may) (VP (VB be) (ADJP (RB clinically) (JJ significant) (SBAR (WHADVP (WRB when)) (S (NP (NNS antacids)) (VP (VBP are) (VP (VBN used) (PP (IN on) (NP (DT a) (JJ continuous) (NN schedule)))))))))))) (. .))))

det(effect-2, This-1)
nsubj(small-4, effect-2)
cop(small-4, is-3)
root(ROOT-0, small-4)
amod(doses-7, occasional-6)
prep_with(small-4, doses-7)
prep_of(doses-7, antacids-9)
aux(significant-15, may-12)
cop(significant-15, be-13)
advmod(significant-15, clinically-14)
conj_but(small-4, significant-15)
advmod(used-19, when-16)
nsubjpass(used-19, antacids-17)
auxpass(used-19, are-18)
dep(significant-15, used-19)
det(schedule-23, a-21)
amod(schedule-23, continuous-22)
prep_on(used-19, schedule-23)

Acetaminophen/NN :/: In/IN normal/JJ volunteers/NNS ,/, concomitant/JJ administration/NN of/IN diflunisal/NN and/CC acetaminophen/NN resulted/VBD in/IN an/DT approximate/JJ 50/CD %/NN increase/NN in/IN plasma/NN levels/NNS of/IN acetaminophen/NN ./.

(ROOT (S1 (S (S (NP (NN Acetaminophen)) (: :) (PP (IN In) (NP (JJ normal) (NNS volunteers))) (, ,) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN diflunisal)) (CC and) (NP (NN acetaminophen))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT an) (JJ approximate) (ADJP (CD 50) (NN %)) (NN increase)) (PP (IN in) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (NN acetaminophen))))))))) (. .))))

nsubj(resulted-13, Acetaminophen-1)
amod(volunteers-5, normal-4)
prep_in(resulted-13, volunteers-5)
amod(administration-8, concomitant-7)
nsubj(resulted-13, administration-8)
prep_of(administration-8, diflunisal-10)
conj_and(diflunisal-10, acetaminophen-12)
root(ROOT-0, resulted-13)
det(increase-19, an-15)
amod(increase-19, approximate-16)
number(%-18, 50-17)
amod(increase-19, %-18)
prep_in(resulted-13, increase-19)
nn(levels-22, plasma-21)
prep_in(increase-19, levels-22)
prep_of(levels-22, acetaminophen-24)

Acetaminophen/NN had/VBD no/DT effect/NN on/IN plasma/NN levels/NNS of/IN diflunisal/NN ./.

(ROOT (S1 (S (S (NP (NN Acetaminophen)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (NN diflunisal))))))) (. .))))

nsubj(had-2, Acetaminophen-1)
root(ROOT-0, had-2)
det(effect-4, no-3)
dobj(had-2, effect-4)
nn(levels-7, plasma-6)
prep_on(had-2, levels-7)
prep_of(levels-7, diflunisal-9)

Since/IN acetaminophen/NN in/IN high/JJ doses/NNS has/VBZ been/VBN associated/VBN with/IN hepatotoxicity/NN ,/, concomitant/JJ administration/NN of/IN diflunisal/NN and/CC acetaminophen/NN should/MD be/VB used/VBN cautiously/RB ,/, with/IN careful/JJ monitoring/NN of/IN patients/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NP (NN acetaminophen)) (PP (IN in) (NP (JJ high) (NNS doses)))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NN hepatotoxicity)))))))) (, ,) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN diflunisal)) (CC and) (NP (NN acetaminophen))))) (VP (MD should) (VP (VB be) (VP (VBN used) (ADVP (RB cautiously)) (, ,) (PP (IN with) (NP (NP (JJ careful) (NN monitoring)) (PP (IN of) (NP (NNS patients))))))))) (. .))))

mark(associated-8, Since-1)
nsubjpass(associated-8, acetaminophen-2)
amod(doses-5, high-4)
prep_in(acetaminophen-2, doses-5)
aux(associated-8, has-6)
auxpass(associated-8, been-7)
advcl(used-20, associated-8)
prep_with(associated-8, hepatotoxicity-10)
amod(administration-13, concomitant-12)
nsubjpass(used-20, administration-13)
prep_of(administration-13, diflunisal-15)
conj_and(diflunisal-15, acetaminophen-17)
aux(used-20, should-18)
auxpass(used-20, be-19)
root(ROOT-0, used-20)
advmod(used-20, cautiously-21)
amod(monitoring-25, careful-24)
prep_with(used-20, monitoring-25)
prep_of(monitoring-25, patients-27)

Concomitant/JJ administration/NN of/IN diflunisal/NN and/CC acetaminophen/NN in/IN dogs/NNS ,/, but/CC not/RB in/IN rats/NNS ,/, at/IN approximately/RB 2/CD times/NNS the/DT recommended/VBN maximum/JJ human/JJ therapeutic/JJ dose/NN of/IN each/DT (/-LRB- 40/CD to/TO 52/CD mg/kg/day/NN of/IN diflunisal/NN //: acetaminophen/NN )/-RRB- resulted/VBD in/IN greater/JJR gastrointestinal/JJ toxicity/NN than/IN when/WRB either/DT drug/NN was/VBD administered/VBN alone/RB ./.

(ROOT (S1 (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN diflunisal)) (CC and) (NP (NN acetaminophen)))) (PP (PP (IN in) (NP (NNS dogs))) (, ,) (CC but) (RB not) (PP (IN in) (NP (NNS rats))) (, ,)) (PP (IN at) (NP (QP (RB approximately) (CD 2) (NNS times)) (NP (NP (DT the) (VBN recommended) (JJ maximum) (JJ human) (JJ therapeutic) (NN dose)) (PP (IN of) (NP (DT each)))) (PRN (-LRB- -LRB-) (NP (NP (NP (QP (CD 40) (TO to) (CD 52)) (NN mg/kg/day)) (PP (IN of) (NP (NN diflunisal)))) (: /) (NP (NN acetaminophen))) (-RRB- -RRB-))))) (VP (VBD resulted) (PP (IN in) (NP (JJR greater) (JJ gastrointestinal) (NN toxicity))) (PP (IN than) (SBAR (WHADVP (WRB when)) (S (NP (DT either) (NN drug)) (VP (VBD was) (VP (VBN administered) (ADVP (RB alone)))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubj(resulted-37, administration-2)
prep_of(administration-2, diflunisal-4)
conj_and(diflunisal-4, acetaminophen-6)
prep(administration-2, in-7)
pobj(in-7, dogs-8)
conj_but(in-7, not-11)
neg(in-7, not-11)
dep(in-7, in-12)
pobj(in-12, rats-13)
quantmod(times-18, approximately-16)
number(times-18, 2-17)
num(dose-24, times-18)
det(dose-24, the-19)
amod(dose-24, recommended-20)
amod(dose-24, maximum-21)
amod(dose-24, human-22)
amod(dose-24, therapeutic-23)
prep_at(administration-2, dose-24)
prep_of(dose-24, each-26)
number(52-30, 40-28)
dep(52-30, to-29)
num(mg/kg/day-31, 52-30)
dep(dose-24, mg/kg/day-31)
prep_of(mg/kg/day-31, diflunisal-33)
punct(mg/kg/day-31, /-34)
dep(mg/kg/day-31, acetaminophen-35)
root(ROOT-0, resulted-37)
amod(toxicity-41, greater-39)
amod(toxicity-41, gastrointestinal-40)
prep_in(resulted-37, toxicity-41)
advmod(administered-47, when-43)
det(drug-45, either-44)
nsubjpass(administered-47, drug-45)
auxpass(administered-47, was-46)
prepc_than(resulted-37, administered-47)
advmod(administered-47, alone-48)

Methotrexate/NN :/: Caution/NN should/MD be/VB used/VBN if/IN diflunisal/NN is/VBZ administered/VBN concomitantly/RB with/IN methotrexate/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Methotrexate)) (: :) (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN if) (NP (NN diflunisal)))))))) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN methotrexate)))))) (. .))))

nsubjpass(administered-10, Methotrexate-1)
nsubjpass(used-6, Caution-3)
aux(used-6, should-4)
auxpass(used-6, be-5)
dep(Methotrexate-1, used-6)
prep_if(used-6, diflunisal-8)
auxpass(administered-10, is-9)
root(ROOT-0, administered-10)
advmod(administered-10, concomitantly-11)
prep_with(administered-10, methotrexate-13)

Nonsteroidal/JJ anti-inflammatory/JJ drugs/NNS have/VBP been/VBN reported/VBN to/TO decrease/VB the/DT tubular/JJ secretion/NN of/IN methotrexate/NN and/CC to/TO potentiate/VB its/PRP$ toxicity/NN ./.

(ROOT (S1 (S (S (NP (JJ Nonsteroidal) (JJ anti-inflammatory) (NNS drugs)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (VP (TO to) (VP (VB decrease) (NP (NP (DT the) (JJ tubular) (NN secretion)) (PP (IN of) (NP (NN methotrexate)))))) (CC and) (VP (TO to) (VP (VB potentiate) (NP (PRP$ its) (NN toxicity)))))))))) (. .))))

amod(drugs-3, Nonsteroidal-1)
amod(drugs-3, anti-inflammatory-2)
nsubjpass(reported-6, drugs-3)
aux(reported-6, have-4)
auxpass(reported-6, been-5)
root(ROOT-0, reported-6)
aux(decrease-8, to-7)
ccomp(reported-6, decrease-8)
det(secretion-11, the-9)
amod(secretion-11, tubular-10)
dobj(decrease-8, secretion-11)
prep_of(secretion-11, methotrexate-13)
aux(potentiate-16, to-15)
conj_and(decrease-8, potentiate-16)
poss(toxicity-18, its-17)
dobj(potentiate-16, toxicity-18)

Cyclosporine/NN :/: Administration/NN of/IN nonsteroial/JJ anti-inflammatory/JJ drugs/NNS concomitantly/RB with/IN cyclosporine/NN has/VBZ been/VBN associated/VBN with/IN an/DT increase/NN in/IN cyclosporine-induced/JJ toxicity/NN ,/, possibly/RB due/JJ to/TO decreased/VBN synthesis/NN of/IN renal/JJ prostacyclin/NN ./.

(ROOT (S1 (S (NP (NP (NN Cyclosporine)) (: :) (S (NP (NP (NN Administration)) (PP (IN of) (NP (JJ nonsteroial) (JJ anti-inflammatory) (NNS drugs))) (PP (ADVP (RB concomitantly)) (IN with) (NP (NN cyclosporine)))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (JJ cyclosporine-induced) (NN toxicity))))) (, ,) (PP (ADVP (RB possibly)) (JJ due) (TO to) (NP (NP (VBN decreased) (NN synthesis)) (PP (IN of) (NP (JJ renal) (NN prostacyclin))))))))) (. .)))))

root(ROOT-0, Cyclosporine-1)
nsubjpass(associated-13, Administration-3)
amod(drugs-7, nonsteroial-5)
amod(drugs-7, anti-inflammatory-6)
prep_of(Administration-3, drugs-7)
advmod(Administration-3, concomitantly-8)
prep_with(Administration-3, cyclosporine-10)
aux(associated-13, has-11)
auxpass(associated-13, been-12)
dep(Cyclosporine-1, associated-13)
det(increase-16, an-15)
prep_with(associated-13, increase-16)
amod(toxicity-19, cyclosporine-induced-18)
prep_in(increase-16, toxicity-19)
advmod(associated-13, possibly-21)
amod(synthesis-25, decreased-24)
prep_due_to(associated-13, synthesis-25)
amod(prostacyclin-28, renal-27)
prep_of(synthesis-25, prostacyclin-28)

NSAIDs/NN should/MD be/VB used/VBN with/IN caution/NN in/IN patients/NNS taking/VBG cyclosporine/NN ,/, and/CC renal/JJ function/NN should/MD be/VB carefully/RB monitored/VBN ./.

(ROOT (S1 (S (S (S (NP (NN NSAIDs)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN caution))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN cyclosporine))))))))) (, ,) (CC and) (S (NP (JJ renal) (NN function)) (VP (MD should) (VP (VB be) (ADVP (RB carefully)) (VP (VBN monitored)))))) (. .))))

nsubjpass(used-4, NSAIDs-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
prep_with(used-4, caution-6)
prep_in(used-4, patients-8)
partmod(patients-8, taking-9)
dobj(taking-9, cyclosporine-10)
amod(function-14, renal-13)
nsubjpass(monitored-18, function-14)
aux(monitored-18, should-15)
auxpass(monitored-18, be-16)
advmod(monitored-18, carefully-17)
conj_and(used-4, monitored-18)

Nonsteroidal/JJ Anti-Inflammatory/JJ Drugs/NNS :/: The/DT administration/NN of/IN diflunisal/NN to/TO normal/JJ volunteers/NNS receiving/VBG indomethacin/NN decreased/VBD the/DT renal/JJ clearance/NN and/CC significantly/RB increased/VBD the/DT plasma/NN levels/NNS of/IN indomethacin/NN ./.

(ROOT (S1 (S (NP (NP (JJ Nonsteroidal) (JJ Anti-Inflammatory) (NNS Drugs)) (: :) (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NN diflunisal))) (PP (TO to) (NP (NP (JJ normal) (NNS volunteers)) (VP (VBG receiving) (NP (NN indomethacin)))))) (VP (VP (VBD decreased) (NP (DT the) (JJ renal) (NN clearance))) (CC and) (VP (ADVP (RB significantly)) (VBD increased) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN indomethacin))))))) (. .)))))

amod(Drugs-3, Nonsteroidal-1)
amod(Drugs-3, Anti-Inflammatory-2)
root(ROOT-0, Drugs-3)
det(administration-6, The-5)
nsubj(decreased-14, administration-6)
prep_of(administration-6, diflunisal-8)
amod(volunteers-11, normal-10)
prep_to(administration-6, volunteers-11)
partmod(volunteers-11, receiving-12)
dobj(receiving-12, indomethacin-13)
dep(Drugs-3, decreased-14)
det(clearance-17, the-15)
amod(clearance-17, renal-16)
dobj(decreased-14, clearance-17)
advmod(increased-20, significantly-19)
conj_and(decreased-14, increased-20)
det(levels-23, the-21)
nn(levels-23, plasma-22)
dobj(increased-20, levels-23)
prep_of(levels-23, indomethacin-25)

In/IN some/DT patients/NNS the/DT combined/JJ use/NN of/IN indomethacin/NN and/CC diflunisal/NN has/VBZ been/VBN associated/VBN with/IN fatal/JJ gastrointestinal/JJ hemorrhage/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT some) (NNS patients))) (NP (NP (DT the) (JJ combined) (NN use)) (PP (IN of) (NP (NP (NN indomethacin)) (CC and) (NP (NN diflunisal))))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (JJ fatal) (JJ gastrointestinal) (NN hemorrhage))))))) (. .))))

det(patients-3, some-2)
prep_in(associated-13, patients-3)
det(use-6, the-4)
amod(use-6, combined-5)
nsubjpass(associated-13, use-6)
prep_of(use-6, indomethacin-8)
conj_and(indomethacin-8, diflunisal-10)
aux(associated-13, has-11)
auxpass(associated-13, been-12)
root(ROOT-0, associated-13)
amod(hemorrhage-17, fatal-15)
amod(hemorrhage-17, gastrointestinal-16)
prep_with(associated-13, hemorrhage-17)

Therefore/RB ,/, indomethacin/NN and/CC diflunisal/NN should/MD not/RB be/VB used/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN indomethacin)) (CC and) (NP (NN diflunisal))) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (ADVP (RB concomitantly)))))) (. .))))

advmod(used-9, Therefore-1)
nsubjpass(used-9, indomethacin-3)
conj_and(indomethacin-3, diflunisal-5)
aux(used-9, should-6)
neg(used-9, not-7)
auxpass(used-9, be-8)
root(ROOT-0, used-9)
advmod(used-9, concomitantly-10)

The/DT concomitant/JJ use/NN of/IN diflunisal/NN tablets/NNS and/CC other/JJ NSAIDs/NNS is/VBZ not/RB recommended/VBN due/JJ to/TO the/DT increased/VBN possibility/NN of/IN gastrointestinal/JJ toxicity/NN ,/, with/IN little/JJ or/CC no/DT increase/VBP in/IN efficacy/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN diflunisal) (NNS tablets)) (CC and) (NP (JJ other) (NNS NSAIDs))))) (VP (VBZ is) (RB not) (VP (VBN recommended) (PP (JJ due) (TO to) (NP (NP (DT the) (VBN increased) (NN possibility)) (PP (IN of) (NP (JJ gastrointestinal) (NN toxicity))))) (, ,) (SBAR (IN with) (S (NP (NP (ADJP (JJ little))) (CC or) (NP (DT no))) (VP (VBP increase) (PP (IN in) (NP (NN efficacy))))))))) (. .))))

det(use-3, The-1)
amod(use-3, concomitant-2)
nsubjpass(recommended-12, use-3)
nn(tablets-6, diflunisal-5)
prep_of(use-3, tablets-6)
amod(NSAIDs-9, other-8)
conj_and(tablets-6, NSAIDs-9)
auxpass(recommended-12, is-10)
neg(recommended-12, not-11)
root(ROOT-0, recommended-12)
det(possibility-17, the-15)
amod(possibility-17, increased-16)
prep_due_to(recommended-12, possibility-17)
amod(toxicity-20, gastrointestinal-19)
prep_of(possibility-17, toxicity-20)
mark(increase-26, with-22)
nsubj(increase-26, little-23)
conj_or(little-23, no-25)
advcl(recommended-12, increase-26)
prep_in(increase-26, efficacy-28)

Aspirin/NN :/: In/IN normal/JJ volunteers/NNS ,/, a/DT small/JJ decrease/NN in/IN diflunisal/NN levels/NNS was/VBD observed/VBN when/WRB multiple/JJ doses/NNS of/IN diflunisal/NN and/CC aspirin/NN were/VBD administered/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NN Aspirin)) (: :) (PP (IN In) (NP (JJ normal) (NNS volunteers))) (, ,) (NP (NP (DT a) (JJ small) (NN decrease)) (PP (IN in) (NP (NN diflunisal) (NNS levels)))) (VP (VBD was) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (NP (JJ multiple) (NNS doses)) (PP (IN of) (NP (NP (NN diflunisal)) (CC and) (NP (NN aspirin))))) (VP (VBD were) (VP (VBN administered) (ADVP (RB concomitantly))))))))) (. .))))

nsubjpass(observed-14, Aspirin-1)
amod(volunteers-5, normal-4)
prep_in(observed-14, volunteers-5)
det(decrease-9, a-7)
amod(decrease-9, small-8)
nsubjpass(observed-14, decrease-9)
nn(levels-12, diflunisal-11)
prep_in(decrease-9, levels-12)
auxpass(observed-14, was-13)
root(ROOT-0, observed-14)
advmod(administered-23, when-15)
amod(doses-17, multiple-16)
nsubjpass(administered-23, doses-17)
prep_of(doses-17, diflunisal-19)
conj_and(diflunisal-19, aspirin-21)
auxpass(administered-23, were-22)
advcl(observed-14, administered-23)
advmod(administered-23, concomitantly-24)

Sulindac/NN :/: The/DT concomitant/JJ administration/NN of/IN diflunisal/NN and/CC sulindac/NN in/IN normal/JJ volunteers/NNS resulted/VBD in/IN lowering/NN of/IN the/DT plasma/NN levels/NNS of/IN the/DT active/JJ sulindac/NN sulfide/NN metabolite/NN by/IN approximately/RB one-third/CD ./.

(ROOT (S1 (S (NP (NP (NN Sulindac)) (: :) (S (NP (NP (DT The) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN diflunisal)) (CC and) (NP (NN sulindac)))) (PP (IN in) (NP (JJ normal) (NNS volunteers)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NN lowering)) (PP (IN of) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (DT the) (JJ active) (NN sulindac) (NN sulfide) (NN metabolite))))) (PP (IN by) (NP (RB approximately) (CD one-third))))))) (. .)))))

root(ROOT-0, Sulindac-1)
det(administration-5, The-3)
amod(administration-5, concomitant-4)
nsubj(resulted-13, administration-5)
prep_of(administration-5, diflunisal-7)
conj_and(diflunisal-7, sulindac-9)
amod(volunteers-12, normal-11)
prep_in(administration-5, volunteers-12)
dep(Sulindac-1, resulted-13)
prep_in(resulted-13, lowering-15)
det(levels-19, the-17)
nn(levels-19, plasma-18)
prep_of(lowering-15, levels-19)
det(metabolite-25, the-21)
amod(metabolite-25, active-22)
nn(metabolite-25, sulindac-23)
nn(metabolite-25, sulfide-24)
prep_of(levels-19, metabolite-25)
advmod(one-third-28, approximately-27)
prep_by(lowering-15, one-third-28)

Naproxen/NN :/: The/DT concomitant/JJ administration/NN of/IN diflunisal/NN and/CC naproxen/NN in/IN normal/JJ volunteers/NNS had/VBD no/DT effect/NN on/IN the/DT plasma/NN levels/NNS of/IN naproxen/NN ,/, but/CC significantly/RB decreased/VBD the/DT urinary/JJ excretion/NN of/IN naproxen/NN and/CC its/PRP$ glucuronide/JJ metabolite/NN ./.

(ROOT (S1 (S (NP (NP (NN Naproxen)) (: :) (S (NP (NP (DT The) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN diflunisal)) (CC and) (NP (NN naproxen)))) (PP (IN in) (NP (JJ normal) (NNS volunteers)))) (VP (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN naproxen)))))) (, ,) (CC but) (VP (ADVP (RB significantly)) (VBD decreased) (NP (NP (DT the) (JJ urinary) (NN excretion)) (PP (IN of) (NP (NP (NN naproxen)) (CC and) (NP (PRP$ its) (JJ glucuronide) (NN metabolite)))))))) (. .)))))

root(ROOT-0, Naproxen-1)
det(administration-5, The-3)
amod(administration-5, concomitant-4)
nsubj(had-13, administration-5)
prep_of(administration-5, diflunisal-7)
conj_and(diflunisal-7, naproxen-9)
amod(volunteers-12, normal-11)
prep_in(administration-5, volunteers-12)
dep(Naproxen-1, had-13)
det(effect-15, no-14)
dobj(had-13, effect-15)
det(levels-19, the-17)
nn(levels-19, plasma-18)
prep_on(had-13, levels-19)
prep_of(levels-19, naproxen-21)
advmod(decreased-25, significantly-24)
conj_but(had-13, decreased-25)
det(excretion-28, the-26)
amod(excretion-28, urinary-27)
dobj(decreased-25, excretion-28)
prep_of(excretion-28, naproxen-30)
poss(metabolite-34, its-32)
amod(metabolite-34, glucuronide-33)
conj_and(naproxen-30, metabolite-34)

Naproxen/NN had/VBD no/DT effect/NN on/IN plasma/NN levels/NNS of/IN diflunisal/NN ./.

(ROOT (S1 (S (S (NP (NN Naproxen)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (NN diflunisal))))))) (. .))))

nsubj(had-2, Naproxen-1)
root(ROOT-0, had-2)
det(effect-4, no-3)
dobj(had-2, effect-4)
nn(levels-7, plasma-6)
prep_on(had-2, levels-7)
prep_of(levels-7, diflunisal-9)

Drug/NN laboratory/NN Test/NN Interactions/NNS Serum/NN Salicylate/NN Assays/NNS :/: Caution/NN should/MD be/VB used/VBN in/IN interpreting/VBG the/DT results/NNS of/IN serum/NN salicylate/NN assays/NNS when/WRB diflunisal/NN is/VBZ present/JJ ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN laboratory) (NN Test) (NNS Interactions) (NN Serum) (NN Salicylate) (NNS Assays)) (: :) (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN in) (S (VP (VBG interpreting) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (NN serum) (NN salicylate) (NNS assays))))))) (SBAR (WHADVP (WRB when)) (S (NP (NN diflunisal)) (VP (VBZ is) (ADJP (JJ present))))))))) (. .)))))

nn(Assays-7, Drug-1)
nn(Assays-7, laboratory-2)
nn(Assays-7, Test-3)
nn(Assays-7, Interactions-4)
nn(Assays-7, Serum-5)
nn(Assays-7, Salicylate-6)
root(ROOT-0, Assays-7)
nsubjpass(used-12, Caution-9)
aux(used-12, should-10)
auxpass(used-12, be-11)
dep(Assays-7, used-12)
prepc_in(used-12, interpreting-14)
det(results-16, the-15)
dobj(interpreting-14, results-16)
nn(assays-20, serum-18)
nn(assays-20, salicylate-19)
prep_of(results-16, assays-20)
advmod(present-24, when-21)
nsubj(present-24, diflunisal-22)
cop(present-24, is-23)
advcl(used-12, present-24)

Potassium-depleting/NN diuretics/NNS are/VBP a/DT major/JJ contributing/VBG factor/NN to/TO digitalis/NN toxicity/NN ./.

(ROOT (S1 (S (S (NP (NN Potassium-depleting) (NNS diuretics)) (VP (VBP are) (NP (NP (DT a) (JJ major) (VBG contributing) (NN factor)) (PP (TO to) (NP (NN digitalis) (NN toxicity)))))) (. .))))

nn(diuretics-2, Potassium-depleting-1)
nsubj(factor-7, diuretics-2)
cop(factor-7, are-3)
det(factor-7, a-4)
amod(factor-7, major-5)
amod(factor-7, contributing-6)
root(ROOT-0, factor-7)
nn(toxicity-10, digitalis-9)
prep_to(factor-7, toxicity-10)

Calcium/NN ,/, particularly/RB if/IN administered/VBN rapidly/RB by/IN the/DT intravenous/JJ route/NN ,/, may/MD produce/VB serious/JJ arrhythmias/NNS in/IN digitalized/JJ patients/NNS ./.

(ROOT (S1 (S (S (NP (NN Calcium)) (, ,) (SBAR (RB particularly) (IN if) (S (VP (VBN administered) (ADVP (RB rapidly)) (PP (IN by) (NP (DT the) (JJ intravenous) (NN route)))))) (, ,) (VP (MD may) (VP (VB produce) (NP (NP (JJ serious) (NNS arrhythmias)) (PP (IN in) (NP (JJ digitalized) (NNS patients))))))) (. .))))

nsubj(produce-13, Calcium-1)
advmod(administered-5, particularly-3)
dep(administered-5, if-4)
dep(produce-13, administered-5)
advmod(administered-5, rapidly-6)
det(route-10, the-8)
amod(route-10, intravenous-9)
prep_by(administered-5, route-10)
aux(produce-13, may-12)
root(ROOT-0, produce-13)
amod(arrhythmias-15, serious-14)
dobj(produce-13, arrhythmias-15)
amod(patients-18, digitalized-17)
prep_in(arrhythmias-15, patients-18)

Quinidine/NN ,/, verapamil/NN ,/, amiodarone/NN ,/, propafenone/NN ,/, indomethacin/NN ,/, itraconazole/NN ,/, alprazolam/NN ,/, and/CC spironolactone/NN raise/VBP the/DT serum/NN digoxin/NN concentration/NN due/JJ to/TO a/DT reduction/NN in/IN clearance/NN and/or/CC in/IN volume/NN of/IN distribution/NN of/IN the/DT drug/NN ,/, with/IN the/DT implication/NN that/IN digitalis/NN intoxication/NN may/MD result/VB ./.

(ROOT (S1 (S (S (NP (NP (NN Quinidine)) (, ,) (NP (NN verapamil)) (, ,) (NP (NP (NN amiodarone)) (, ,) (NP (NN propafenone)) (, ,) (NP (NN indomethacin))) (, ,) (NP (NN itraconazole)) (, ,) (NP (NN alprazolam)) (, ,) (CC and) (NP (NN spironolactone))) (VP (VBP raise) (NP (NP (DT the) (NN serum) (NN digoxin) (NN concentration)) (ADJP (JJ due) (PP (TO to) (NP (NP (DT a) (NN reduction)) (PP (PP (IN in) (NP (NN clearance))) (CC and/or) (PP (IN in) (NP (NP (NN volume)) (PP (IN of) (NP (NP (NN distribution)) (PP (IN of) (NP (DT the) (NN drug))) (, ,) (SBAR (IN with) (S (NP (NP (DT the) (NN implication)) (PP (IN that) (NP (NN digitalis) (NN intoxication)))) (VP (MD may) (VP (VB result)))))))))))))))) (. .))))

nsubj(raise-17, Quinidine-1)
conj_and(Quinidine-1, verapamil-3)
conj_and(Quinidine-1, amiodarone-5)
appos(amiodarone-5, propafenone-7)
appos(amiodarone-5, indomethacin-9)
conj_and(Quinidine-1, itraconazole-11)
conj_and(Quinidine-1, alprazolam-13)
conj_and(Quinidine-1, spironolactone-16)
root(ROOT-0, raise-17)
det(concentration-21, the-18)
nn(concentration-21, serum-19)
nn(concentration-21, digoxin-20)
dobj(raise-17, concentration-21)
det(reduction-25, a-24)
prep_due_to(concentration-21, reduction-25)
prep_in(reduction-25, clearance-27)
conj_and/or(clearance-27, volume-30)
prep_of(volume-30, distribution-32)
dobj(result-44, distribution-32)
det(drug-35, the-34)
prep_of(distribution-32, drug-35)
mark(result-44, with-37)
det(implication-39, the-38)
nsubj(result-44, implication-39)
nn(intoxication-42, digitalis-41)
prep_that(implication-39, intoxication-42)
aux(result-44, may-43)
dep(distribution-32, result-44)

Erythromycin/NN and/CC clarithromycin/NN (/-LRB- and/CC possibly/RB other/JJ macrolide/NN antibiotics/NNS )/-RRB- and/CC tetracycline/NN may/MD increase/VB digoxin/NN absorption/NN in/IN patients/NNS who/WP inactivate/VBP digoxin/NN by/IN bacterial/JJ metabolism/NN in/IN the/DT lower/JJR intestine/NN ,/, so/IN that/IN digitalis/NN intoxication/NN may/MD result/VB ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (NN Erythromycin)) (CC and) (NP (NN clarithromycin))) (PRN (-LRB- -LRB-) (CC and) (ADVP (RB possibly)) (NP (JJ other) (NN macrolide) (NNS antibiotics)) (-RRB- -RRB-))) (CC and) (NP (NN tetracycline))) (VP (MD may) (VP (VB increase) (NP (NN digoxin) (NN absorption)) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP inactivate) (NP (NN digoxin)) (PP (IN by) (NP (JJ bacterial) (NN metabolism))) (PP (IN in) (NP (DT the) (JJR lower) (NN intestine))) (, ,) (SBAR (IN so) (IN that) (S (NP (NN digitalis) (NN intoxication)) (VP (MD may) (VP (VB result))))))))))))) (. .))))

nsubj(increase-14, Erythromycin-1)
conj_and(Erythromycin-1, clarithromycin-3)
dep(antibiotics-9, and-5)
dep(antibiotics-9, possibly-6)
amod(antibiotics-9, other-7)
nn(antibiotics-9, macrolide-8)
appos(Erythromycin-1, antibiotics-9)
conj_and(Erythromycin-1, tetracycline-12)
aux(increase-14, may-13)
root(ROOT-0, increase-14)
nn(absorption-16, digoxin-15)
dobj(increase-14, absorption-16)
prep_in(increase-14, patients-18)
nsubj(inactivate-20, patients-18)
rcmod(patients-18, inactivate-20)
dobj(inactivate-20, digoxin-21)
amod(metabolism-24, bacterial-23)
prep_by(inactivate-20, metabolism-24)
det(intestine-28, the-26)
amod(intestine-28, lower-27)
prep_in(inactivate-20, intestine-28)
mark(result-35, so-30)
dep(result-35, that-31)
nn(intoxication-33, digitalis-32)
nsubj(result-35, intoxication-33)
aux(result-35, may-34)
advcl(inactivate-20, result-35)

The/DT risk/NN of/IN this/DT interaction/NN may/MD be/VB reduced/VBN if/IN digoxin/NN is/VBZ given/VBN as/IN capsules/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN risk)) (PP (IN of) (NP (DT this) (NN interaction)))) (VP (MD may) (VP (VB be) (VP (VBN reduced) (SBAR (IN if) (S (NP (NN digoxin)) (VP (VBZ is) (VP (VBN given) (PP (IN as) (NP (NNS capsules))))))))))) (. .))))

det(risk-2, The-1)
nsubjpass(reduced-8, risk-2)
det(interaction-5, this-4)
prep_of(risk-2, interaction-5)
aux(reduced-8, may-6)
auxpass(reduced-8, be-7)
root(ROOT-0, reduced-8)
mark(given-12, if-9)
nsubjpass(given-12, digoxin-10)
auxpass(given-12, is-11)
advcl(reduced-8, given-12)
prep_as(given-12, capsules-14)

Propantheline/NN and/CC diphenoxylate/NN ,/, by/IN decreasing/VBG gut/NN motility/NN ,/, may/MD increase/VB digoxin/NN absorption/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Propantheline)) (CC and) (NP (NN diphenoxylate))) (, ,) (PP (IN by) (S (VP (VBG decreasing) (NP (NN gut) (NN motility))))) (, ,) (VP (MD may) (VP (VB increase) (NP (NN digoxin) (NN absorption))))) (. .))))

nsubj(increase-11, Propantheline-1)
conj_and(Propantheline-1, diphenoxylate-3)
prepc_by(increase-11, decreasing-6)
nn(motility-8, gut-7)
dobj(decreasing-6, motility-8)
aux(increase-11, may-10)
root(ROOT-0, increase-11)
nn(absorption-13, digoxin-12)
dobj(increase-11, absorption-13)

Antacids/NNS ,/, kaolin-pectin/NN ,/, sulfasalazine/NN ,/, neomycin/NN ,/, cholestyramine/NN ,/, certain/JJ anticancer/NN drugs/NNS ,/, and/CC metoclopramide/NN may/MD interfere/VB with/IN intestinal/JJ digoxin/NN absorption/NN ,/, resulting/VBG in/IN unexpectedly/RB low/JJ serum/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Antacids)) (, ,) (NP (NP (NN kaolin-pectin)) (, ,) (NP (NN sulfasalazine)) (, ,) (NP (NN neomycin)) (, ,) (NP (NN cholestyramine)) (, ,) (NP (JJ certain) (NN anticancer) (NNS drugs)) (, ,) (CC and) (NP (NN metoclopramide)))) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (JJ intestinal) (NN digoxin) (NN absorption))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (ADJP (RB unexpectedly) (JJ low)) (NN serum) (NNS concentrations)))))))) (. .))))

nsubj(interfere-18, Antacids-1)
appos(Antacids-1, kaolin-pectin-3)
conj_and(kaolin-pectin-3, sulfasalazine-5)
conj_and(kaolin-pectin-3, neomycin-7)
conj_and(kaolin-pectin-3, cholestyramine-9)
amod(drugs-13, certain-11)
nn(drugs-13, anticancer-12)
conj_and(kaolin-pectin-3, drugs-13)
conj_and(kaolin-pectin-3, metoclopramide-16)
aux(interfere-18, may-17)
root(ROOT-0, interfere-18)
amod(absorption-22, intestinal-20)
nn(absorption-22, digoxin-21)
prep_with(interfere-18, absorption-22)
xcomp(interfere-18, resulting-24)
advmod(low-27, unexpectedly-26)
amod(concentrations-29, low-27)
nn(concentrations-29, serum-28)
prep_in(resulting-24, concentrations-29)

Rifampin/NN may/MD decrease/VB serum/NN digoxin/NN concentration/NN ,/, especially/RB in/IN patients/NNS with/IN renal/JJ dysfunction/NN ,/, by/IN increasing/VBG the/DT non-renal/JJ clearance/NN of/IN digoxin/NN ./.

(ROOT (S1 (S (S (NP (NN Rifampin)) (VP (MD may) (VP (VB decrease) (NP (NN serum) (NN digoxin) (NN concentration)) (, ,) (PP (ADVP (RB especially)) (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ renal) (NN dysfunction))))) (, ,) (PP (IN by) (S (VP (VBG increasing) (NP (NP (DT the) (JJ non-renal) (NN clearance)) (PP (IN of) (NP (NN digoxin)))))))))) (. .))))

nsubj(decrease-3, Rifampin-1)
aux(decrease-3, may-2)
root(ROOT-0, decrease-3)
nn(concentration-6, serum-4)
nn(concentration-6, digoxin-5)
dobj(decrease-3, concentration-6)
advmod(decrease-3, especially-8)
prep_in(decrease-3, patients-10)
amod(dysfunction-13, renal-12)
prep_with(patients-10, dysfunction-13)
prepc_by(decrease-3, increasing-16)
det(clearance-19, the-17)
amod(clearance-19, non-renal-18)
dobj(increasing-16, clearance-19)
prep_of(clearance-19, digoxin-21)

There/EX have/VBP been/VBN inconsistent/JJ reports/NNS regarding/VBG the/DT effects/NNS of/IN other/JJ drugs/NNS (/-LRB- e.g./FW ,/, quinine/NN ,/, penicillamine/NN )/-RRB- on/IN serum/NN digoxin/NN concentration/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (JJ inconsistent) (NNS reports)) (VP (VBG regarding) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ other) (NNS drugs)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN quinine)) (, ,) (NP (NN penicillamine)))) (-RRB- -RRB-)))) (PP (IN on) (NP (NN serum) (NN digoxin) (NN concentration))))))))) (. .))))

expl(reports-5, There-1)
aux(reports-5, have-2)
cop(reports-5, been-3)
amod(reports-5, inconsistent-4)
root(ROOT-0, reports-5)
partmod(reports-5, regarding-6)
det(effects-8, the-7)
dobj(regarding-6, effects-8)
amod(drugs-11, other-10)
prep_of(effects-8, drugs-11)
dep(drugs-11, e.g.-13)
pobj(e.g.-13, quinine-15)
appos(quinine-15, penicillamine-17)
nn(concentration-22, serum-20)
nn(concentration-22, digoxin-21)
prep_on(effects-8, concentration-22)

Thyroid/NN administration/NN to/TO a/DT digitalized/JJ ,/, hypothyroid/JJ patient/NN may/MD increase/VB the/DT dose/NN requirement/NN of/IN digoxin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Thyroid) (NN administration)) (PP (TO to) (NP (DT a) (ADJP (ADJP (JJ digitalized)) (, ,) (ADJP (JJ hypothyroid))) (NN patient)))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN dose) (NN requirement)) (PP (IN of) (NP (NN digoxin))))))) (. .))))

nn(administration-2, Thyroid-1)
nsubj(increase-10, administration-2)
det(patient-8, a-4)
amod(patient-8, digitalized-5)
dep(digitalized-5, hypothyroid-7)
prep_to(administration-2, patient-8)
aux(increase-10, may-9)
root(ROOT-0, increase-10)
det(requirement-13, the-11)
nn(requirement-13, dose-12)
dobj(increase-10, requirement-13)
prep_of(requirement-13, digoxin-15)

Concomitant/JJ use/NN of/IN digoxin/NN and/CC sympathomimetics/NN increases/VBZ the/DT risk/NN of/IN cardiac/JJ arrhythmias/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (NN digoxin)) (CC and) (NP (NN sympathomimetics))))) (VP (VBZ increases) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ cardiac) (NNS arrhythmias)))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(increases-7, use-2)
prep_of(use-2, digoxin-4)
conj_and(digoxin-4, sympathomimetics-6)
root(ROOT-0, increases-7)
det(risk-9, the-8)
dobj(increases-7, risk-9)
amod(arrhythmias-12, cardiac-11)
prep_of(risk-9, arrhythmias-12)

Succinylcholine/NN may/MD cause/VB a/DT sudden/JJ extrusion/NN of/IN potassium/NN from/IN muscle/NN cells/NNS ,/, and/CC may/MD thereby/RB cause/VB arrhythmias/NNS in/IN digitalized/JJ patients/NNS ./.

(ROOT (S1 (S (S (NP (NN Succinylcholine)) (VP (VP (MD may) (VP (VB cause) (NP (NP (DT a) (JJ sudden) (NN extrusion)) (PP (IN of) (NP (NN potassium))) (PP (IN from) (NP (NN muscle) (NNS cells)))))) (, ,) (CC and) (VP (MD may) (ADVP (RB thereby)) (VP (VB cause) (NP (NP (NNS arrhythmias)) (PP (IN in) (NP (JJ digitalized) (NNS patients)))))))) (. .))))

nsubj(cause-3, Succinylcholine-1)
aux(cause-3, may-2)
root(ROOT-0, cause-3)
det(extrusion-6, a-4)
amod(extrusion-6, sudden-5)
dobj(cause-3, extrusion-6)
prep_of(extrusion-6, potassium-8)
nn(cells-11, muscle-10)
prep_from(extrusion-6, cells-11)
aux(cause-16, may-14)
advmod(cause-16, thereby-15)
conj_and(cause-3, cause-16)
dobj(cause-16, arrhythmias-17)
amod(patients-20, digitalized-19)
prep_in(arrhythmias-17, patients-20)

Although/IN beta-adrenergic/JJ blockers/NNS or/CC calcium/NN channel/NN blockers/NNS and/CC digoxin/NN may/MD be/VB useful/JJ in/IN combination/NN to/TO control/VB atrial/NN fibrillation/NN ,/, their/PRP$ additive/JJ effects/NNS on/IN AV/NN node/NN conduction/NN can/MD result/VB in/IN advanced/JJ or/CC complete/JJ heart/NN block/NN ./.

(ROOT (S1 (S (SBAR (IN Although) (S (NP (NP (NP (JJ beta-adrenergic) (NNS blockers)) (CC or) (NP (NN calcium) (NN channel) (NNS blockers))) (CC and) (NP (NN digoxin))) (VP (MD may) (VP (VB be) (ADJP (JJ useful) (PP (IN in) (NP (NN combination))))) (S (VP (TO to) (VP (VB control) (NP (NN atrial) (NN fibrillation)))))))) (, ,) (NP (NP (PRP$ their) (JJ additive) (NNS effects)) (PP (IN on) (NP (NN AV) (NN node) (NN conduction)))) (VP (MD can) (VP (VB result) (PP (IN in) (NP (ADJP (ADJP (JJ advanced)) (CC or) (ADJP (JJ complete))) (NN heart) (NN block))))) (. .))))

mark(useful-12, Although-1)
amod(blockers-3, beta-adrenergic-2)
nsubj(useful-12, blockers-3)
xsubj(control-16, blockers-3)
nn(blockers-7, calcium-5)
nn(blockers-7, channel-6)
conj_or(blockers-3, blockers-7)
conj_and(blockers-3, digoxin-9)
aux(useful-12, may-10)
cop(useful-12, be-11)
advcl(result-28, useful-12)
prep_in(useful-12, combination-14)
aux(control-16, to-15)
xcomp(useful-12, control-16)
nn(fibrillation-18, atrial-17)
dobj(control-16, fibrillation-18)
poss(effects-22, their-20)
amod(effects-22, additive-21)
nsubj(result-28, effects-22)
nn(conduction-26, AV-24)
nn(conduction-26, node-25)
prep_on(effects-22, conduction-26)
aux(result-28, can-27)
root(ROOT-0, result-28)
amod(block-34, advanced-30)
conj_or(advanced-30, complete-32)
nn(block-34, heart-33)
prep_in(result-28, block-34)

Due/IN to/TO the/DT considerable/JJ variability/NN of/IN these/DT interactions/NNS ,/, the/DT dosage/NN of/IN digoxin/NN should/MD be/VB individualized/VBN when/WRB patients/NNS receive/VBP these/DT medications/NNS concurrently/RB ./.

(ROOT (S1 (S (S (PP (IN Due) (PP (TO to) (NP (NP (DT the) (JJ considerable) (NN variability)) (PP (IN of) (NP (DT these) (NNS interactions)))))) (, ,) (NP (NP (DT the) (NN dosage)) (PP (IN of) (NP (NN digoxin)))) (VP (MD should) (VP (VB be) (VP (VBN individualized))) (SBAR (WHADVP (WRB when)) (S (NP (NNS patients)) (VP (VBP receive) (NP (DT these) (NNS medications)) (ADVP (RB concurrently))))))) (. .))))

prepc_due_to(individualized-16, to-2)
det(variability-5, the-3)
amod(variability-5, considerable-4)
pobj(individualized-16, variability-5)
det(interactions-8, these-7)
prep_of(variability-5, interactions-8)
det(dosage-11, the-10)
nsubjpass(individualized-16, dosage-11)
prep_of(dosage-11, digoxin-13)
aux(individualized-16, should-14)
auxpass(individualized-16, be-15)
root(ROOT-0, individualized-16)
advmod(receive-19, when-17)
nsubj(receive-19, patients-18)
advcl(individualized-16, receive-19)
det(medications-21, these-20)
dobj(receive-19, medications-21)
advmod(receive-19, concurrently-22)

Furthermore/RB ,/, caution/NN should/MD be/VB exercised/VBN when/WRB combining/VBG digoxin/NN with/IN any/DT drug/NN that/WDT may/MD cause/VB a/DT significant/JJ deterioration/NN in/IN renal/JJ function/NN ,/, since/IN a/DT decline/NN in/IN glomerular/JJ filtration/NN or/CC tubular/JJ secretion/NN may/MD impair/VB the/DT excretion/NN of/IN digoxin/NN ./.

(ROOT (S1 (S (S (ADVP (RB Furthermore)) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (VP (VBG combining) (NP (NN digoxin)) (PP (IN with) (NP (NP (DT any) (NN drug)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB cause) (NP (NP (DT a) (JJ significant) (NN deterioration)) (PP (IN in) (NP (JJ renal) (NN function))))) (, ,) (SBAR (IN since) (S (NP (NP (DT a) (NN decline)) (PP (IN in) (NP (NP (JJ glomerular) (NN filtration)) (CC or) (NP (JJ tubular) (NN secretion))))) (VP (MD may) (VP (VB impair) (NP (NP (DT the) (NN excretion)) (PP (IN of) (NP (NN digoxin)))))))))))))))))))) (. .))))

advmod(exercised-6, Furthermore-1)
nsubjpass(exercised-6, caution-3)
aux(exercised-6, should-4)
auxpass(exercised-6, be-5)
root(ROOT-0, exercised-6)
advmod(combining-8, when-7)
advcl(exercised-6, combining-8)
dobj(combining-8, digoxin-9)
det(drug-12, any-11)
prep_with(combining-8, drug-12)
nsubj(cause-15, drug-12)
aux(cause-15, may-14)
rcmod(drug-12, cause-15)
det(deterioration-18, a-16)
amod(deterioration-18, significant-17)
dobj(cause-15, deterioration-18)
amod(function-21, renal-20)
prep_in(deterioration-18, function-21)
mark(impair-33, since-23)
det(decline-25, a-24)
nsubj(impair-33, decline-25)
amod(filtration-28, glomerular-27)
prep_in(decline-25, filtration-28)
amod(secretion-31, tubular-30)
conj_or(filtration-28, secretion-31)
aux(impair-33, may-32)
advcl(cause-15, impair-33)
det(excretion-35, the-34)
dobj(impair-33, excretion-35)
prep_of(excretion-35, digoxin-37)

Vasoconstrictors/NNS :/: D.H.E./NN 45/CD @/NN (/-LRB- dihydroergotamine/NN mesylate/NN )/-RRB- Injection/NN ,/, USP/NN should/MD not/RB be/VB used/VBN with/IN peripheral/JJ vasoconstrictors/NNS because/IN the/DT combination/NN may/MD cause/VB synergistic/JJ elevation/NN of/IN blood/NN pressure/NN ./.

(ROOT (S1 (S (NP (NP (NNS Vasoconstrictors)) (: :) (S (NP (NP (NN D.H.E.) (CD 45) (NN @) (-LRB- -LRB-) (NN dihydroergotamine) (NN mesylate) (-RRB- -RRB-) (NN Injection)) (, ,) (NP (NN USP))) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (JJ peripheral) (NNS vasoconstrictors))) (SBAR (IN because) (S (NP (DT the) (NN combination)) (VP (MD may) (VP (VB cause) (NP (NP (JJ synergistic) (NN elevation)) (PP (IN of) (NP (NN blood) (NN pressure)))))))))))) (. .)))))

root(ROOT-0, Vasoconstrictors-1)
nn(Injection-10, D.H.E.-3)
num(Injection-10, 45-4)
nn(Injection-10, @-5)
nn(Injection-10, dihydroergotamine-7)
nn(Injection-10, mesylate-8)
nsubjpass(used-16, Injection-10)
appos(Injection-10, USP-12)
aux(used-16, should-13)
neg(used-16, not-14)
auxpass(used-16, be-15)
dep(Vasoconstrictors-1, used-16)
amod(vasoconstrictors-19, peripheral-18)
prep_with(used-16, vasoconstrictors-19)
mark(cause-24, because-20)
det(combination-22, the-21)
nsubj(cause-24, combination-22)
aux(cause-24, may-23)
advcl(used-16, cause-24)
amod(elevation-26, synergistic-25)
dobj(cause-24, elevation-26)
nn(pressure-29, blood-28)
prep_of(elevation-26, pressure-29)

Sumatriptan/NN :/: Sumatriptan/NN has/VBZ been/VBN reported/VBN to/TO cause/VB coronary/JJ artery/NN vasospasm/NN ,/, and/CC its/PRP$ effect/NN could/MD be/VB additive/JJ with/IN D.H.E./NN 45/CD @/NN (/-LRB- dihydroergotamine/NN mesylate/NN )/-RRB- Injection/NN ,/, USP/NN ./.

(ROOT (S1 (S (NP (NP (NN Sumatriptan)) (: :) (S (S (NP (NN Sumatriptan)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB cause) (NP (JJ coronary) (NN artery) (NN vasospasm))))))))) (, ,) (CC and) (S (NP (PRP$ its) (NN effect)) (VP (MD could) (VP (VB be) (ADJP (JJ additive) (PP (IN with) (NP (NP (NN D.H.E.) (CD 45) (NN @) (-LRB- -LRB-) (NN dihydroergotamine) (NN mesylate) (-RRB- -RRB-) (NN Injection)) (, ,) (NP (NN USP))))))))) (. .)))))

root(ROOT-0, Sumatriptan-1)
nsubjpass(reported-6, Sumatriptan-3)
xsubj(cause-8, Sumatriptan-3)
aux(reported-6, has-4)
auxpass(reported-6, been-5)
dep(Sumatriptan-1, reported-6)
aux(cause-8, to-7)
xcomp(reported-6, cause-8)
amod(vasospasm-11, coronary-9)
nn(vasospasm-11, artery-10)
dobj(cause-8, vasospasm-11)
poss(effect-15, its-14)
nsubj(additive-18, effect-15)
aux(additive-18, could-16)
cop(additive-18, be-17)
conj_and(reported-6, additive-18)
nn(Injection-27, D.H.E.-20)
num(Injection-27, 45-21)
nn(Injection-27, @-22)
nn(Injection-27, dihydroergotamine-24)
nn(Injection-27, mesylate-25)
prep_with(additive-18, Injection-27)
appos(Injection-27, USP-29)

Sumatriptan/NNP and/CC D.H.E./NNP 45/CD @/NN (/-LRB- dihydroergotamine/NN mesylate/NN )/-RRB- Injection/NN ,/, USP/NN should/MD not/RB be/VB taken/VBN within/IN 24/CD hours/NNS of/IN each/DT other/JJ ../NN

(ROOT (S1 (S (NP (NP (NP (NNP Sumatriptan)) (CC and) (NP (NNP D.H.E.)) (NP (CD 45) (NN @) (-LRB- -LRB-) (NN dihydroergotamine) (NN mesylate) (-RRB- -RRB-) (NN Injection))) (, ,) (S (NP (NN USP)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN taken) (PP (IN within) (NP (NP (CD 24) (NNS hours)) (PP (IN of) (NP (DT each) (JJ other) (NN ..)))))))))))))

root(ROOT-0, Sumatriptan-1)
conj_and(Sumatriptan-1, D.H.E.-3)
num(Injection-10, 45-4)
nn(Injection-10, @-5)
nn(Injection-10, dihydroergotamine-7)
nn(Injection-10, mesylate-8)
dep(Sumatriptan-1, Injection-10)
nsubjpass(taken-16, USP-12)
aux(taken-16, should-13)
neg(taken-16, not-14)
auxpass(taken-16, be-15)
dep(Sumatriptan-1, taken-16)
num(hours-19, 24-18)
prep_within(taken-16, hours-19)
det(..-23, each-21)
amod(..-23, other-22)
prep_of(hours-19, ..-23)

Beta/NN Blockers/NNS :/: Although/IN the/DT results/NNS of/IN a/DT clinical/JJ study/NN did/VBD not/RB indicate/VB a/DT safe/JJ problem/NN associated/VBN with/IN the/DT administration/NN of/IN D.H.E./NN 45/CD @/NN (/-LRB- dihydroergotamine/NN mesylate/NN )/-RRB- Injection/NN ,/, USP/NN to/TO subjects/NNS already/RB receiving/VBG propranolol/NN ,/, there/EX have/VBP been/VBN reports/NNS that/IN propranolol/NN may/MD potentiate/VB the/DT vasoconstrictive/JJ action/NN of/IN ergotamine/NN by/IN blocking/VBG the/DT vasodilating/JJ property/NN of/IN epinephrine/NN ./.

(ROOT (S1 (S (NP (NP (NN Beta) (NNS Blockers)) (: :) (S (SBAR (IN Although) (S (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (DT a) (JJ clinical) (NN study)))) (VP (VBD did) (RB not) (VP (VB indicate) (NP (NP (NP (DT a) (JJ safe) (NN problem)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NN D.H.E.) (CD 45) (NN @) (-LRB- -LRB-) (NN dihydroergotamine) (NN mesylate) (-RRB- -RRB-) (NN Injection))))))) (, ,) (NP (NP (NN USP)) (PP (TO to) (NP (NP (NNS subjects)) (VP (ADVP (RB already)) (VBG receiving) (NP (NN propranolol))))))))))) (, ,) (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (NNS reports)) (SBAR (IN that) (S (NP (NN propranolol)) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (JJ vasoconstrictive) (NN action)) (PP (IN of) (NP (NN ergotamine)))) (PP (IN by) (S (VP (VBG blocking) (NP (NP (DT the) (JJ vasodilating) (NN property)) (PP (IN of) (NP (NN epinephrine))))))))))))))) (. .)))))

nn(Blockers-2, Beta-1)
root(ROOT-0, Blockers-2)
mark(indicate-13, Although-4)
det(results-6, the-5)
nsubj(indicate-13, results-6)
det(study-10, a-8)
amod(study-10, clinical-9)
prep_of(results-6, study-10)
aux(indicate-13, did-11)
neg(indicate-13, not-12)
advcl(reports-41, indicate-13)
det(problem-16, a-14)
amod(problem-16, safe-15)
dobj(indicate-13, problem-16)
partmod(problem-16, associated-17)
det(administration-20, the-19)
prep_with(associated-17, administration-20)
nn(Injection-29, D.H.E.-22)
num(Injection-29, 45-23)
nn(Injection-29, @-24)
nn(Injection-29, dihydroergotamine-26)
nn(Injection-29, mesylate-27)
prep_of(administration-20, Injection-29)
appos(problem-16, USP-31)
prep_to(USP-31, subjects-33)
advmod(receiving-35, already-34)
partmod(subjects-33, receiving-35)
dobj(receiving-35, propranolol-36)
expl(reports-41, there-38)
aux(reports-41, have-39)
cop(reports-41, been-40)
dep(Blockers-2, reports-41)
complm(potentiate-45, that-42)
nsubj(potentiate-45, propranolol-43)
aux(potentiate-45, may-44)
dep(reports-41, potentiate-45)
det(action-48, the-46)
amod(action-48, vasoconstrictive-47)
dobj(potentiate-45, action-48)
prep_of(action-48, ergotamine-50)
prepc_by(potentiate-45, blocking-52)
det(property-55, the-53)
amod(property-55, vasodilating-54)
dobj(blocking-52, property-55)
prep_of(property-55, epinephrine-57)

Nicotine/NN :/: Nicotine/NN may/MD provoke/VB vasoconstriction/NN in/IN some/DT patients/NNS ,/, predisposing/VBG to/TO a/DT greater/JJR ischemic/JJ response/NN to/TO ergot/NN therapy/NN ./.

(ROOT (S1 (S (NP (NP (NN Nicotine)) (: :) (S (NP (NN Nicotine)) (VP (MD may) (VP (VB provoke) (NP (NN vasoconstriction)) (PP (IN in) (NP (DT some) (NNS patients))) (, ,) (PP (VBG predisposing) (PP (TO to) (NP (NP (DT a) (JJR greater) (JJ ischemic) (NN response)) (PP (TO to) (NP (NN ergot) (NN therapy))))))))) (. .)))))

root(ROOT-0, Nicotine-1)
nsubj(provoke-5, Nicotine-3)
aux(provoke-5, may-4)
dep(Nicotine-1, provoke-5)
dobj(provoke-5, vasoconstriction-6)
det(patients-9, some-8)
prep_in(provoke-5, patients-9)
prep(provoke-5, predisposing-11)
pcomp(predisposing-11, to-12)
det(response-16, a-13)
amod(response-16, greater-14)
amod(response-16, ischemic-15)
prep_to(predisposing-11, response-16)
nn(therapy-19, ergot-18)
prep_to(response-16, therapy-19)

Macrolide/NN Antibiotics/NNS (/-LRB- e./FW g./FW erythromycin/NN and/CC troleandomycin/NN )/-RRB- :/: Agents/NNS of/IN the/DT ergot/NN alkaloid/NN class/NN ,/, of/IN which/WDT D.H.E./NN 45/CD @/NN (/-LRB- dihydroergotamine/NN mesylate/NN )/-RRB- Injection/NN ,/, USP/NN is/VBZ a/DT member/NN ,/, have/VBP been/VBN shown/VBN to/TO interact/VB with/IN antibiotics/NNS of/IN the/DT macrolide/NN class/NN ,/, resulting/VBG in/IN increased/VBN plasma/NN levels/NNS of/IN unchanged/JJ alkaloids/NNS and/CC peripheral/JJ vasoconstriction/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Macrolide) (NNS Antibiotics)) (PRN (-LRB- -LRB-) (NP (NP (FW e.) (FW g.)) (NP (NP (NN erythromycin)) (CC and) (NP (NN troleandomycin)))) (-RRB- -RRB-))) (: :) (NP (NP (NNS Agents)) (PP (IN of) (NP (DT the) (NN ergot) (NN alkaloid) (NN class)))) (, ,) (SBAR (WHPP (IN of) (WHNP (WDT which))) (S (NP (NP (NN D.H.E.) (CD 45) (NN @) (-LRB- -LRB-) (NN dihydroergotamine) (NN mesylate) (-RRB- -RRB-) (NN Injection)) (, ,) (NP (NN USP))) (VP (VBZ is) (NP (DT a) (NN member))))) (, ,)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NP (NNS antibiotics)) (PP (IN of) (NP (DT the) (NN macrolide) (NN class))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NP (VBN increased) (NN plasma) (NNS levels)) (PP (IN of) (NP (JJ unchanged) (NNS alkaloids)))) (CC and) (NP (JJ peripheral) (NN vasoconstriction))))))))))))) (. .))))

nn(Antibiotics-2, Macrolide-1)
nsubjpass(shown-36, Antibiotics-2)
xsubj(interact-38, Antibiotics-2)
nn(g.-5, e.-4)
dep(Antibiotics-2, g.-5)
dep(g.-5, erythromycin-6)
conj_and(erythromycin-6, troleandomycin-8)
dep(Antibiotics-2, Agents-11)
det(class-16, the-13)
nn(class-16, ergot-14)
nn(class-16, alkaloid-15)
prep_of(Agents-11, class-16)
rel(member-32, which-19)
nn(Injection-27, D.H.E.-20)
num(Injection-27, 45-21)
nn(Injection-27, @-22)
nn(Injection-27, dihydroergotamine-24)
nn(Injection-27, mesylate-25)
nsubj(member-32, Injection-27)
appos(Injection-27, USP-29)
cop(member-32, is-30)
det(member-32, a-31)
rcmod(Antibiotics-2, member-32)
rcmod(Agents-11, member-32)
aux(shown-36, have-34)
auxpass(shown-36, been-35)
root(ROOT-0, shown-36)
aux(interact-38, to-37)
xcomp(shown-36, interact-38)
prep_with(interact-38, antibiotics-40)
det(class-44, the-42)
nn(class-44, macrolide-43)
prep_of(antibiotics-40, class-44)
xcomp(interact-38, resulting-46)
amod(levels-50, increased-48)
nn(levels-50, plasma-49)
prep_in(resulting-46, levels-50)
amod(alkaloids-53, unchanged-52)
prep_of(levels-50, alkaloids-53)
amod(vasoconstriction-56, peripheral-55)
conj_and(levels-50, vasoconstriction-56)

Vasospastic/JJ reactions/NNS have/VBP been/VBN reported/VBN with/IN therapeutic/JJ doses/NNS of/IN ergotamine/JJ -containing/JJ drugs/NNS when/WRB co-administered/VBN with/IN these/DT antibiotics/NNS ./.

(ROOT (S1 (S (S (NP (JJ Vasospastic) (NNS reactions)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NP (JJ therapeutic) (NNS doses)) (PP (IN of) (NP (JJ ergotamine) (JJ -containing) (NNS drugs))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN co-administered) (PP (IN with) (NP (DT these) (NNS antibiotics)))))))))) (. .))))

amod(reactions-2, Vasospastic-1)
nsubjpass(reported-5, reactions-2)
aux(reported-5, have-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
amod(doses-8, therapeutic-7)
prep_with(reported-5, doses-8)
amod(drugs-12, ergotamine-10)
amod(drugs-12, -containing-11)
prep_of(doses-8, drugs-12)
advmod(co-administered-14, when-13)
advcl(reported-5, co-administered-14)
det(antibiotics-17, these-16)
prep_with(co-administered-14, antibiotics-17)

SSRIs/NNS :/: Weakness/NN hyperreflexia/NN ,/, and/CC incoordination/NN have/VBP been/VBN reported/VBN rarely/RB when/WRB 5-HT1/NN agonists/NNS have/VBP been/VBN co-administered/VBN with/IN SSRIs/NN (/-LRB- e./NNP g/NN ./.

(ROOT (S1 (S (NP (NP (NNS SSRIs)) (: :) (S (NP (NP (NN Weakness)) (NP (NN hyperreflexia)) (, ,) (CC and) (NP (NN incoordination))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (ADVP (RB rarely)) (SBAR (WHADVP (WRB when)) (S (NP (NN 5-HT1) (NNS agonists)) (VP (VBP have) (VP (VBN been) (VP (VBN co-administered) (PP (IN with) (NP (NN SSRIs))) (PRN (-LRB- -LRB-) (NP (NP (NNP e.)) (NP (NN g))))))))))))) (. .)))))

root(ROOT-0, SSRIs-1)
nsubjpass(reported-10, Weakness-3)
dep(Weakness-3, hyperreflexia-4)
conj_and(Weakness-3, incoordination-7)
aux(reported-10, have-8)
auxpass(reported-10, been-9)
dep(SSRIs-1, reported-10)
advmod(reported-10, rarely-11)
advmod(co-administered-17, when-12)
nn(agonists-14, 5-HT1-13)
nsubjpass(co-administered-17, agonists-14)
aux(co-administered-17, have-15)
auxpass(co-administered-17, been-16)
advcl(reported-10, co-administered-17)
prep_with(co-administered-17, SSRIs-19)
dep(co-administered-17, e.-21)
dep(e.-21, g-22)

fluoxetine/NN ,/, fluvoxamine/NN ,/, paroxetine/NN ,/, sertraline/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (NN fluoxetine)) (, ,) (NP (NN fluvoxamine)) (, ,) (NP (NN paroxetine)) (, ,) (NP (NN sertraline))) (-RRB- -RRB-)) (. .))))

root(ROOT-0, fluoxetine-1)
appos(fluoxetine-1, fluvoxamine-3)
appos(fluoxetine-1, paroxetine-5)
appos(fluoxetine-1, sertraline-7)

There/EX have/VBP been/VBN no/DT reported/VBN cases/NNS from/IN spontaneous/JJ reports/NNS of/IN drug/NN interaction/NN between/IN SSRIs/NN and/CC D.H.E./NN 45/CD @/NN (/-LRB- dihydroergotamine/NN mesylate/NN )/-RRB- Injection/NN ,/, USP/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (DT no) (VBN reported) (NNS cases)) (PP (IN from) (NP (NP (JJ spontaneous) (NNS reports)) (PP (IN of) (NP (NP (NN drug) (NN interaction)) (PP (IN between) (NP (NP (NN SSRIs)) (CC and) (NP (NP (NN D.H.E.) (CD 45) (NN @) (-LRB- -LRB-) (NN dihydroergotamine) (NN mesylate) (-RRB- -RRB-) (NN Injection)) (, ,) (NP (NN USP)))))))))))) (. .))))

expl(cases-6, There-1)
aux(cases-6, have-2)
dep(cases-6, been-3)
det(cases-6, no-4)
amod(cases-6, reported-5)
root(ROOT-0, cases-6)
amod(reports-9, spontaneous-8)
prep_from(cases-6, reports-9)
nn(interaction-12, drug-11)
prep_of(reports-9, interaction-12)
prep_between(interaction-12, SSRIs-14)
nn(Injection-23, D.H.E.-16)
num(Injection-23, 45-17)
nn(Injection-23, @-18)
nn(Injection-23, dihydroergotamine-20)
nn(Injection-23, mesylate-21)
conj_and(SSRIs-14, Injection-23)
appos(Injection-23, USP-25)

Oral/JJ Contraceptives/NNS :/: The/DT effect/NN of/IN oral/JJ contraceptives/NNS on/IN the/DT pharmacokinetics/NNS of/IN D.H.E./NN 45/CD @/NN (/-LRB- dihydroergotamine/NN mesylate/NN )/-RRB- Injection/NN ,/, USP/NN has/VBZ not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (NP (NP (JJ Oral) (NNS Contraceptives)) (: :) (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (JJ oral) (NNS contraceptives))) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN D.H.E.) (CD 45) (NN @) (-LRB- -LRB-) (NN dihydroergotamine) (NN mesylate) (-RRB- -RRB-) (NN Injection)) (, ,) (NP (NN USP))))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .)))))

amod(Contraceptives-2, Oral-1)
root(ROOT-0, Contraceptives-2)
det(effect-5, The-4)
nsubjpass(studied-26, effect-5)
amod(contraceptives-8, oral-7)
prep_of(effect-5, contraceptives-8)
det(pharmacokinetics-11, the-10)
prep_on(effect-5, pharmacokinetics-11)
nn(Injection-20, D.H.E.-13)
num(Injection-20, 45-14)
nn(Injection-20, @-15)
nn(Injection-20, dihydroergotamine-17)
nn(Injection-20, mesylate-18)
prep_of(pharmacokinetics-11, Injection-20)
appos(Injection-20, USP-22)
aux(studied-26, has-23)
neg(studied-26, not-24)
auxpass(studied-26, been-25)
dep(Contraceptives-2, studied-26)

Due/JJ to/TO the/DT potential/NN for/IN additive/JJ effects/NNS ,/, caution/NN and/CC careful/JJ titration/NN are/VBP warranted/VBN in/IN patients/NNS receiving/VBG diltiazem/NN hydrochloride/NN concomitantly/RB with/IN other/JJ agents/NNS known/VBN to/TO affect/VB cardiac/JJ contractility/NN and/or/CC conduction/NN ./.

(ROOT (S1 (S (S (PP (JJ Due) (TO to) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (JJ additive) (NNS effects))))) (, ,) (NP (NP (NN caution)) (CC and) (NP (JJ careful) (NN titration))) (VP (VBP are) (VP (VBN warranted) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN diltiazem) (NN hydrochloride)) (PP (ADVP (RB concomitantly)) (IN with) (NP (NP (JJ other) (NNS agents)) (VP (VBN known) (S (VP (TO to) (VP (VB affect) (NP (NP (JJ cardiac) (NN contractility)) (CC and/or) (NP (NN conduction)))))))))))))))) (. .))))

det(potential-4, the-3)
prep_due_to(warranted-14, potential-4)
amod(effects-7, additive-6)
prep_for(potential-4, effects-7)
nsubjpass(warranted-14, caution-9)
amod(titration-12, careful-11)
conj_and(caution-9, titration-12)
auxpass(warranted-14, are-13)
root(ROOT-0, warranted-14)
prep_in(warranted-14, patients-16)
partmod(patients-16, receiving-17)
nn(hydrochloride-19, diltiazem-18)
dobj(receiving-17, hydrochloride-19)
advmod(hydrochloride-19, concomitantly-20)
amod(agents-23, other-22)
prep_with(hydrochloride-19, agents-23)
xsubj(affect-26, agents-23)
partmod(agents-23, known-24)
aux(affect-26, to-25)
xcomp(known-24, affect-26)
amod(contractility-28, cardiac-27)
dobj(affect-26, contractility-28)
conj_and/or(contractility-28, conduction-30)

Pharmacologic/JJ studies/NNS indicate/VBP that/IN there/EX may/MD be/VB additive/JJ effects/NNS in/IN prolonging/VBG AV/NN conduction/NN when/WRB using/VBG beta-blockers/NN or/CC digitalis/NN concomitantly/RB with/IN Tiazac/NN ./.

(ROOT (S1 (S (S (NP (JJ Pharmacologic) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (EX there)) (VP (MD may) (VP (VB be) (NP (JJ additive) (NNS effects)) (PP (IN in) (S (VP (VBG prolonging) (NP (NN AV) (NN conduction))))) (SBAR (WHADVP (WRB when)) (S (VP (VBG using) (NP (NP (NN beta-blockers)) (CC or) (NP (NN digitalis))) (PP (RB concomitantly) (IN with) (NP (NN Tiazac)))))))))))) (. .))))

amod(studies-2, Pharmacologic-1)
nsubj(indicate-3, studies-2)
root(ROOT-0, indicate-3)
complm(effects-9, that-4)
expl(effects-9, there-5)
aux(effects-9, may-6)
cop(effects-9, be-7)
amod(effects-9, additive-8)
ccomp(indicate-3, effects-9)
prepc_in(effects-9, prolonging-11)
nn(conduction-13, AV-12)
dobj(prolonging-11, conduction-13)
advmod(using-15, when-14)
advcl(effects-9, using-15)
dobj(using-15, beta-blockers-16)
conj_or(beta-blockers-16, digitalis-18)
advmod(using-15, concomitantly-19)
prep_with(using-15, Tiazac-21)

As/IN with/IN all/DT drugs/NNS ,/, care/NN should/MD be/VB exercised/VBN when/WRB treating/VBG patients/NNS with/IN multiple/JJ medications/NNS ./.

(ROOT (S1 (S (S (PP (IN As) (PP (IN with) (NP (DT all) (NNS drugs)))) (, ,) (NP (NN care)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (VP (VBG treating) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ multiple) (NNS medications))))))))))) (. .))))

prep(exercised-9, As-1)
pcomp(As-1, with-2)
det(drugs-4, all-3)
prep_with(As-1, drugs-4)
nsubjpass(exercised-9, care-6)
aux(exercised-9, should-7)
auxpass(exercised-9, be-8)
root(ROOT-0, exercised-9)
advmod(treating-11, when-10)
advcl(exercised-9, treating-11)
dobj(treating-11, patients-12)
amod(medications-15, multiple-14)
prep_with(patients-12, medications-15)

Diltiazem/NN is/VBZ both/CC a/DT substrate/NN and/CC an/DT inhibitor/NN of/IN the/DT cytochrome/NN P-450/NN 3A4/NN enzyme/NN system/NN ./.

(ROOT (S1 (S (S (NP (NN Diltiazem)) (VP (VBZ is) (NP (NP (CC both) (NP (DT a) (NN substrate)) (CC and) (NP (DT an) (NN inhibitor))) (PP (IN of) (NP (DT the) (NP (NN cytochrome) (NN P-450)) (NN 3A4) (NN enzyme) (NN system)))))) (. .))))

nsubj(substrate-5, Diltiazem-1)
cop(substrate-5, is-2)
preconj(substrate-5, both-3)
det(substrate-5, a-4)
root(ROOT-0, substrate-5)
det(inhibitor-8, an-7)
conj_and(substrate-5, inhibitor-8)
det(system-15, the-10)
nn(P-450-12, cytochrome-11)
nn(system-15, P-450-12)
nn(system-15, 3A4-13)
nn(system-15, enzyme-14)
prep_of(substrate-5, system-15)

Other/JJ drugs/NNS that/WDT are/VBP specific/JJ substrates/NNS ,/, inhibitors/NNS ,/, or/CC inducers/NNS of/IN the/DT enzyme/NN system/NN may/MD have/VB a/DT significant/JJ impact/NN on/IN the/DT efficacy/NN and/CC side/JJ effect/NN profile/NN of/IN diltiazem/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Other) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NP (JJ specific) (NNS substrates)) (, ,) (NP (NNS inhibitors)) (, ,) (CC or) (NP (NNS inducers))) (PP (IN of) (NP (DT the) (NN enzyme) (NN system)))))))) (VP (MD may) (VP (VB have) (NP (DT a) (JJ significant) (NN impact)) (PP (IN on) (NP (NP (DT the) (NP (NN efficacy)) (CC and) (NP (JJ side) (NN effect) (NN profile))) (PP (IN of) (NP (NN diltiazem)))))))) (. .))))

amod(drugs-2, Other-1)
nsubj(substrates-6, drugs-2)
nsubj(have-17, drugs-2)
cop(substrates-6, are-4)
amod(substrates-6, specific-5)
rcmod(drugs-2, substrates-6)
conj_or(substrates-6, inhibitors-8)
conj_or(substrates-6, inducers-11)
det(system-15, the-13)
nn(system-15, enzyme-14)
prep_of(substrates-6, system-15)
aux(have-17, may-16)
root(ROOT-0, have-17)
det(impact-20, a-18)
amod(impact-20, significant-19)
dobj(have-17, impact-20)
dep(efficacy-23, the-22)
prep_on(have-17, efficacy-23)
amod(profile-27, side-25)
nn(profile-27, effect-26)
conj_and(efficacy-23, profile-27)
prep_of(efficacy-23, diltiazem-29)

Patients/NNS taking/VBG other/JJ drugs/NNS that/WDT are/VBP substrates/NNS of/IN CYP450/NN 3A4/NN ,/, especially/RB patients/NNS with/IN renal/JJ and/or/CC hepatic/JJ impairment/NN ,/, may/MD require/VBP dosage/NN adjustment/NN when/WRB starting/VBG or/CC stopping/VBG concomitantly/RB administered/VBN diltiazem/NN in/IN order/NN to/TO maintain/VB optimum/JJ therapeutic/JJ blood/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Patients)) (VP (VBG taking) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NNS substrates)) (PP (IN of) (NP (NN CYP450) (NN 3A4)))))))))) (, ,) (ADVP (RB especially)) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (ADJP (JJ renal)) (CC and/or) (ADJP (JJ hepatic))) (NN impairment)))) (, ,)) (VP (MD may) (VP (VBP require) (NP (NN dosage) (NN adjustment)) (SBAR (WHADVP (WRB when)) (S (VP (VP (VBG starting)) (CC or) (VP (VBG stopping) (NP (ADJP (RB concomitantly) (VBN administered)) (NN diltiazem) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB maintain) (NP (JJ optimum) (JJ therapeutic) (NN blood) (NNS levels)))))))))))))) (. .))))

nsubj(require-21, Patients-1)
partmod(Patients-1, taking-2)
amod(drugs-4, other-3)
dobj(taking-2, drugs-4)
nsubj(substrates-7, drugs-4)
cop(substrates-7, are-6)
rcmod(drugs-4, substrates-7)
nn(3A4-10, CYP450-9)
prep_of(substrates-7, 3A4-10)
advmod(Patients-1, especially-12)
dep(Patients-1, patients-13)
amod(impairment-18, renal-15)
conj_and/or(renal-15, hepatic-17)
prep_with(patients-13, impairment-18)
aux(require-21, may-20)
root(ROOT-0, require-21)
nn(adjustment-23, dosage-22)
dobj(require-21, adjustment-23)
advmod(starting-25, when-24)
advcl(require-21, starting-25)
conj_or(starting-25, stopping-27)
advmod(administered-29, concomitantly-28)
amod(diltiazem-30, administered-29)
dobj(stopping-27, diltiazem-30)
mark(maintain-34, in-31)
dep(maintain-34, order-32)
aux(maintain-34, to-33)
ccomp(diltiazem-30, maintain-34)
infmod(diltiazem-30, maintain-34)
amod(levels-38, optimum-35)
amod(levels-38, therapeutic-36)
nn(levels-38, blood-37)
dobj(maintain-34, levels-38)

Beta/NN Blockers/NN ./.

(ROOT (S1 (S (NP (NP (NN Beta) (NN Blockers)) (. .)))))

nn(Blockers-2, Beta-1)
root(ROOT-0, Blockers-2)

Controlled/JJ and/CC uncontrolled/JJ domestic/JJ studies/NNS suggest/VBP that/IN concomitant/JJ use/NN of/IN diltiazem/NN hydrochloride/NN and/CC beta-blockers/NNS is/VBZ usually/RB well/RB tolerated/VBN ,/, but/CC available/JJ data/NNS are/VBP not/RB sufficient/JJ to/TO predict/VB the/DT effects/NNS of/IN concomitant/JJ treatment/NN in/IN patients/NNS with/IN left/JJ ventricular/JJ dysfunction/NN or/CC cardiac/JJ conduction/JJ abnormalities/NNS ./.

(ROOT (S1 (S (NP (JJ Controlled) (CC and) (JJ uncontrolled) (JJ domestic) (NNS studies)) (VP (VBP suggest) (SBAR (IN that) (S (S (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN diltiazem) (NN hydrochloride)) (CC and) (NP (NNS beta-blockers))))) (VP (VBZ is) (ADVP (RB usually)) (VP (ADVP (RB well)) (VBN tolerated)))) (, ,) (CC but) (S (NP (JJ available) (NNS data)) (VP (VBP are) (RB not) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB predict) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ concomitant) (NN treatment))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (JJ left) (JJ ventricular) (NN dysfunction)) (CC or) (NP (JJ cardiac) (JJ conduction) (NNS abnormalities)))))))))))))))) (. .))))

amod(studies-5, Controlled-1)
conj_and(Controlled-1, uncontrolled-3)
amod(studies-5, domestic-4)
nsubj(suggest-6, studies-5)
root(ROOT-0, suggest-6)
complm(tolerated-18, that-7)
amod(use-9, concomitant-8)
nsubjpass(tolerated-18, use-9)
nn(hydrochloride-12, diltiazem-11)
prep_of(use-9, hydrochloride-12)
conj_and(hydrochloride-12, beta-blockers-14)
auxpass(tolerated-18, is-15)
advmod(tolerated-18, usually-16)
advmod(tolerated-18, well-17)
ccomp(suggest-6, tolerated-18)
amod(data-22, available-21)
nsubj(sufficient-25, data-22)
cop(sufficient-25, are-23)
neg(sufficient-25, not-24)
conj_but(tolerated-18, sufficient-25)
aux(predict-27, to-26)
xcomp(sufficient-25, predict-27)
det(effects-29, the-28)
dobj(predict-27, effects-29)
amod(treatment-32, concomitant-31)
prep_of(effects-29, treatment-32)
prep_in(effects-29, patients-34)
amod(dysfunction-38, left-36)
amod(dysfunction-38, ventricular-37)
prep_with(patients-34, dysfunction-38)
amod(abnormalities-42, cardiac-40)
amod(abnormalities-42, conduction-41)
conj_or(dysfunction-38, abnormalities-42)

Administration/NN of/IN diltiazem/NN hydrochloride/NN concomitantly/RB with/IN propranolol/NN in/IN five/CD normal/JJ volunteers/NNS resulted/VBD in/IN increased/VBN propranolol/NN levels/NNS in/IN all/DT subjects/NNS and/CC bioavailability/NN of/IN propranolol/NN was/VBD increased/VBN approximately/RB 50/CD %./NN

(ROOT (S1 (S (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN diltiazem) (NN hydrochloride))) (PP (ADVP (RB concomitantly)) (IN with) (NP (NN propranolol))) (PP (IN in) (NP (CD five) (JJ normal) (NNS volunteers)))) (VP (VBD resulted) (PP (IN in) (NP (NP (VBN increased) (NN propranolol) (NNS levels)) (PP (IN in) (NP (DT all) (NNS subjects))))))) (CC and) (S (NP (NP (NN bioavailability)) (PP (IN of) (NP (NN propranolol)))) (VP (VBD was) (VP (VBN increased) (NP (QP (RB approximately) (CD 50)) (NN %.))))))))

nsubj(resulted-12, Administration-1)
nn(hydrochloride-4, diltiazem-3)
prep_of(Administration-1, hydrochloride-4)
advmod(Administration-1, concomitantly-5)
prep_with(Administration-1, propranolol-7)
num(volunteers-11, five-9)
amod(volunteers-11, normal-10)
prep_in(Administration-1, volunteers-11)
root(ROOT-0, resulted-12)
amod(levels-16, increased-14)
nn(levels-16, propranolol-15)
prep_in(resulted-12, levels-16)
det(subjects-19, all-18)
prep_in(levels-16, subjects-19)
nsubjpass(increased-25, bioavailability-21)
prep_of(bioavailability-21, propranolol-23)
auxpass(increased-25, was-24)
conj_and(resulted-12, increased-25)
quantmod(50-27, approximately-26)
num(%.-28, 50-27)
dobj(increased-25, %.-28)

In/FW vitro/FW ,/, propranolol/NN appears/VBZ to/TO be/VB displaced/VBN from/IN its/PRP$ binding/NN sites/NNS by/IN diltiazem/NN ./.

(ROOT (S1 (S (S (ADVP (FW In) (FW vitro)) (, ,) (NP (NN propranolol)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (VP (VBN displaced) (PP (IN from) (NP (PRP$ its) (NN binding) (NNS sites))) (PP (IN by) (NP (NN diltiazem))))))))) (. .))))

nn(vitro-2, In-1)
advmod(appears-5, vitro-2)
nsubj(appears-5, propranolol-4)
xsubj(displaced-8, propranolol-4)
root(ROOT-0, appears-5)
aux(displaced-8, to-6)
auxpass(displaced-8, be-7)
xcomp(appears-5, displaced-8)
poss(sites-12, its-10)
nn(sites-12, binding-11)
prep_from(displaced-8, sites-12)
agent(displaced-8, diltiazem-14)

If/IN combination/NN therapy/NN is/VBZ initiated/VBN or/CC withdrawn/VBN in/IN conjunction/NN with/IN propranolol/NN ,/, an/DT adjustment/NN in/IN the/DT propranolol/NN dose/NN may/MD be/VB warranted/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN combination) (NN therapy)) (VP (VBZ is) (VP (VP (VBN initiated)) (CC or) (VP (VBN withdrawn) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (NN propranolol)))))))))) (, ,) (NP (NP (DT an) (NN adjustment)) (PP (IN in) (NP (DT the) (NN propranolol) (NN dose)))) (VP (MD may) (VP (VB be) (VP (VBN warranted))))) (. .))))

mark(initiated-5, If-1)
nn(therapy-3, combination-2)
nsubjpass(initiated-5, therapy-3)
auxpass(initiated-5, is-4)
advcl(warranted-21, initiated-5)
conj_or(initiated-5, withdrawn-7)
prep_in(withdrawn-7, conjunction-9)
prep_with(conjunction-9, propranolol-11)
det(adjustment-14, an-13)
nsubjpass(warranted-21, adjustment-14)
det(dose-18, the-16)
nn(dose-18, propranolol-17)
prep_in(adjustment-14, dose-18)
aux(warranted-21, may-19)
auxpass(warranted-21, be-20)
root(ROOT-0, warranted-21)

Cimetidine/NN ./.

(ROOT (S1 (S (NP (NP (NN Cimetidine)) (. .)))))

root(ROOT-0, Cimetidine-1)

A/DT study/NN in/IN six/CD healthy/JJ volunteers/NNS has/VBZ shown/VBN a/DT significant/JJ increase/NN in/IN peak/NN diltiazem/NN plasma/NN levels/NNS (/-LRB- 58/CD %/NN )/-RRB- and/CC AUC/NN (/-LRB- 53/CD %/NN )/-RRB- after/IN a/DT 1-week/JJ course/NN of/IN cimetidine/NN 1200/CD mg/day/NN and/CC a/DT single/JJ dose/NN of/IN diltiazem/NN 60mg/NN ./.

(ROOT (S1 (S (S (NP (NP (DT A) (NN study)) (PP (IN in) (NP (CD six) (JJ healthy) (NNS volunteers)))) (VP (VBZ has) (VP (VBN shown) (NP (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (NP (NN peak) (NN diltiazem) (NN plasma) (NNS levels)) (PRN (-LRB- -LRB-) (NP (CD 58) (NN %)) (-RRB- -RRB-))))) (CC and) (NP (NP (NN AUC)) (PRN (-LRB- -LRB-) (NP (CD 53) (NN %)) (-RRB- -RRB-)))) (PP (IN after) (NP (NP (DT a) (JJ 1-week) (NN course)) (PP (IN of) (NP (NP (NN cimetidine) (CD 1200) (NN mg/day)) (CC and) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NN diltiazem) (NN 60mg))))))))))) (. .))))

det(study-2, A-1)
nsubj(shown-8, study-2)
num(volunteers-6, six-4)
amod(volunteers-6, healthy-5)
prep_in(study-2, volunteers-6)
aux(shown-8, has-7)
root(ROOT-0, shown-8)
det(increase-11, a-9)
amod(increase-11, significant-10)
dobj(shown-8, increase-11)
nn(levels-16, peak-13)
nn(levels-16, diltiazem-14)
nn(levels-16, plasma-15)
prep_in(increase-11, levels-16)
num(%-19, 58-18)
appos(levels-16, %-19)
conj_and(increase-11, AUC-22)
num(%-25, 53-24)
appos(AUC-22, %-25)
det(course-30, a-28)
amod(course-30, 1-week-29)
prep_after(shown-8, course-30)
nn(mg/day-34, cimetidine-32)
num(mg/day-34, 1200-33)
prep_of(course-30, mg/day-34)
det(dose-38, a-36)
amod(dose-38, single-37)
conj_and(mg/day-34, dose-38)
nn(60mg-41, diltiazem-40)
prep_of(dose-38, 60mg-41)

Ranitidine/NN produced/VBD smaller/JJR ,/, nonsignificant/JJ increases/NNS ./.

(ROOT (S1 (S (S (NP (NN Ranitidine)) (VP (VBD produced) (NP (ADJP (ADJP (JJR smaller)) (, ,) (ADJP (JJ nonsignificant))) (NNS increases)))) (. .))))

nsubj(produced-2, Ranitidine-1)
root(ROOT-0, produced-2)
amod(increases-6, smaller-3)
dep(smaller-3, nonsignificant-5)
dobj(produced-2, increases-6)

The/DT effect/NN may/MD be/VB mediated/VBN by/IN cimetidine/NN s/NN known/JJ inhibition/NN of/IN hepatic/JJ cytochrome/NN P-450/NN ,/, the/DT enzyme/NN system/NN responsible/JJ for/IN the/DT first-pass/NN metabolism/NN of/IN diltiazem/NN ./.

(ROOT (S1 (S (S (NP (DT The) (NN effect)) (VP (MD may) (VP (VB be) (VP (VBN mediated) (PP (IN by) (NP (NP (NN cimetidine) (NN s) (JJ known) (NN inhibition)) (PP (IN of) (NP (NP (JJ hepatic) (NN cytochrome) (NN P-450)) (, ,) (NP (NP (DT the) (NN enzyme) (NN system)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN first-pass) (NN metabolism)) (PP (IN of) (NP (NN diltiazem))))))))))))))) (. .))))

det(effect-2, The-1)
nsubjpass(mediated-5, effect-2)
aux(mediated-5, may-3)
auxpass(mediated-5, be-4)
root(ROOT-0, mediated-5)
nn(inhibition-10, cimetidine-7)
nn(inhibition-10, s-8)
amod(inhibition-10, known-9)
agent(mediated-5, inhibition-10)
amod(P-450-14, hepatic-12)
nn(P-450-14, cytochrome-13)
prep_of(inhibition-10, P-450-14)
det(system-18, the-16)
nn(system-18, enzyme-17)
appos(P-450-14, system-18)
amod(system-18, responsible-19)
det(metabolism-23, the-21)
nn(metabolism-23, first-pass-22)
prep_for(responsible-19, metabolism-23)
prep_of(metabolism-23, diltiazem-25)

Patients/NNS currently/RB receiving/VBG diltiazem/NN therapy/NN should/MD be/VB carefully/RB monitored/VBN for/IN a/DT change/NN in/IN pharmacological/JJ effect/NN when/WRB initiating/VBG and/CC discontinuing/VBG therapy/NN with/IN cimetidine/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (ADVP (RB currently)) (VBG receiving) (NP (NN diltiazem) (NN therapy)))) (VP (MD should) (VP (VB be) (ADVP (RB carefully)) (VP (VBN monitored) (PP (IN for) (NP (NP (DT a) (NN change)) (PP (IN in) (NP (NP (JJ pharmacological) (NN effect)) (SBAR (WHADVP (WRB when)) (S (VP (VP (VBG initiating)) (CC and) (VP (VBG discontinuing) (NP (NN therapy)) (PP (IN with) (NP (NN cimetidine))))))))))))))) (. .))))

nsubjpass(monitored-9, Patients-1)
advmod(receiving-3, currently-2)
partmod(Patients-1, receiving-3)
nn(therapy-5, diltiazem-4)
dobj(receiving-3, therapy-5)
aux(monitored-9, should-6)
auxpass(monitored-9, be-7)
advmod(monitored-9, carefully-8)
root(ROOT-0, monitored-9)
det(change-12, a-11)
prep_for(monitored-9, change-12)
amod(effect-15, pharmacological-14)
prep_in(change-12, effect-15)
advmod(initiating-17, when-16)
dep(effect-15, initiating-17)
conj_and(initiating-17, discontinuing-19)
dobj(discontinuing-19, therapy-20)
prep_with(discontinuing-19, cimetidine-22)

An/DT adjustment/NN in/IN the/DT diltiazem/NN dose/NN may/MD be/VB warranted/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT An) (NN adjustment)) (PP (IN in) (NP (DT the) (NN diltiazem) (NN dose)))) (VP (MD may) (VP (VB be) (VP (VBN warranted))))) (. .))))

det(adjustment-2, An-1)
nsubjpass(warranted-9, adjustment-2)
det(dose-6, the-4)
nn(dose-6, diltiazem-5)
prep_in(adjustment-2, dose-6)
aux(warranted-9, may-7)
auxpass(warranted-9, be-8)
root(ROOT-0, warranted-9)

Digitalis/NN ./.

(ROOT (S1 (S (NP (NP (NN Digitalis)) (. .)))))

root(ROOT-0, Digitalis-1)

Administration/NN of/IN diltiazem/NN hydrochloride/NN with/IN digoxin/NN in/IN 24/CD healthy/JJ male/JJ subjects/NNS increased/VBD plasma/NN digoxin/NN concentrations/NNS approximately/RB 20/CD %./NN

(ROOT (S1 (S (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN diltiazem) (NN hydrochloride))) (PP (IN with) (NP (NN digoxin))) (PP (IN in) (NP (CD 24) (JJ healthy) (JJ male) (NNS subjects)))) (VP (VBD increased) (NP (NN plasma) (NN digoxin) (NNS concentrations)))) (NP (QP (RB approximately) (CD 20)) (NN %.)))))

nsubj(increased-12, Administration-1)
nn(hydrochloride-4, diltiazem-3)
prep_of(Administration-1, hydrochloride-4)
prep_with(Administration-1, digoxin-6)
num(subjects-11, 24-8)
amod(subjects-11, healthy-9)
amod(subjects-11, male-10)
prep_in(Administration-1, subjects-11)
root(ROOT-0, increased-12)
nn(concentrations-15, plasma-13)
nn(concentrations-15, digoxin-14)
dobj(increased-12, concentrations-15)
quantmod(20-17, approximately-16)
num(%.-18, 20-17)
dep(increased-12, %.-18)

Since/IN there/EX have/VBP been/VBN conflicting/VBG results/NNS regarding/VBG the/DT effect/NN of/IN digoxin/NN levels/NNS ,/, it/PRP is/VBZ recommended/VBN that/IN digoxin/NN levels/NNS be/VB monitored/VBN when/WRB initiating/VBG ,/, adjusting/VBG ,/, and/CC discontinuing/VBG diltiazem/NN hydrochloride/NN therapy/NN to/TO avoid/VB possible/JJ over-/NN or/CC under-digitalization/NN ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (VBG conflicting) (NNS results)) (PP (VBG regarding) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN digoxin) (NNS levels))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NN digoxin) (NNS levels)) (VP (VB be) (VP (VBN monitored) (SBAR (WHADVP (WRB when)) (S (VP (VP (VBG initiating)) (, ,) (VP (VBG adjusting)) (, ,) (CC and) (VP (VBG discontinuing) (NP (NP (NN diltiazem) (NN hydrochloride) (NN therapy)) (S (VP (TO to) (VP (VB avoid) (NP (NP (JJ possible) (NN over-)) (CC or) (NP (NN under-digitalization)))))))))))))))))) (. .))))

mark(results-6, Since-1)
expl(results-6, there-2)
aux(results-6, have-3)
cop(results-6, been-4)
amod(results-6, conflicting-5)
advcl(recommended-16, results-6)
det(effect-9, the-8)
prep_regarding(results-6, effect-9)
nn(levels-12, digoxin-11)
prep_of(effect-9, levels-12)
nsubjpass(recommended-16, it-14)
auxpass(recommended-16, is-15)
root(ROOT-0, recommended-16)
complm(monitored-21, that-17)
nn(levels-19, digoxin-18)
nsubjpass(monitored-21, levels-19)
auxpass(monitored-21, be-20)
ccomp(recommended-16, monitored-21)
advmod(initiating-23, when-22)
advcl(monitored-21, initiating-23)
conj_and(initiating-23, adjusting-25)
conj_and(initiating-23, discontinuing-28)
nn(therapy-31, diltiazem-29)
nn(therapy-31, hydrochloride-30)
dobj(discontinuing-28, therapy-31)
aux(avoid-33, to-32)
infmod(therapy-31, avoid-33)
amod(over--35, possible-34)
dobj(avoid-33, over--35)
conj_or(over--35, under-digitalization-37)

Anesthetics/NN ./.

(ROOT (S1 (S (NP (NP (NN Anesthetics)) (. .)))))

root(ROOT-0, Anesthetics-1)

The/DT depression/NN of/IN cardiac/JJ contractility/NN ,/, conductivity/NN ,/, and/CC automaticity/NN as/RB well/RB as/IN the/DT vascular/JJ dilation/NN associated/VBN with/IN anesthetics/NNS may/MD be/VB potentiated/VBN by/IN calcium/NN channel/NN blockers/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (DT The) (NN depression)) (PP (IN of) (NP (NP (JJ cardiac) (NN contractility)) (, ,) (NP (NN conductivity)) (, ,) (CC and) (NP (NN automaticity))))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (JJ vascular) (NN dilation)) (VP (VBN associated) (PP (IN with) (NP (NNS anesthetics)))))) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (PP (IN by) (NP (NN calcium) (NN channel) (NNS blockers))))))) (. .))))

det(depression-2, The-1)
nsubjpass(potentiated-22, depression-2)
amod(contractility-5, cardiac-4)
prep_of(depression-2, contractility-5)
conj_and(contractility-5, conductivity-7)
conj_and(contractility-5, automaticity-10)
det(dilation-16, the-14)
amod(dilation-16, vascular-15)
conj_and(depression-2, dilation-16)
partmod(dilation-16, associated-17)
prep_with(associated-17, anesthetics-19)
aux(potentiated-22, may-20)
auxpass(potentiated-22, be-21)
root(ROOT-0, potentiated-22)
nn(blockers-26, calcium-24)
nn(blockers-26, channel-25)
agent(potentiated-22, blockers-26)

When/WRB used/VBN concomitantly/RB ,/, anesthetics/NNS and/CC calcium/NN channel/NN blockers/NNS should/MD be/VB titrated/VBN carefully/RB ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN used) (ADVP (RB concomitantly))))) (, ,) (NP (NP (NNS anesthetics)) (CC and) (NP (NN calcium) (NN channel) (NNS blockers))) (VP (MD should) (VP (VB be) (VP (VBN titrated) (ADVP (RB carefully)))))) (. .))))

advmod(used-2, When-1)
advcl(titrated-12, used-2)
advmod(used-2, concomitantly-3)
nsubjpass(titrated-12, anesthetics-5)
nn(blockers-9, calcium-7)
nn(blockers-9, channel-8)
conj_and(anesthetics-5, blockers-9)
aux(titrated-12, should-10)
auxpass(titrated-12, be-11)
root(ROOT-0, titrated-12)
advmod(titrated-12, carefully-13)

Cyclosporine/NN ./.

(ROOT (S1 (S (NP (NP (NN Cyclosporine)) (. .)))))

root(ROOT-0, Cyclosporine-1)

A/DT pharmacokinetic/JJ interaction/NN between/IN diltiazem/NN and/CC cyclosporine/NN has/VBZ been/VBN observed/VBN during/IN studies/NNS involving/VBG renal/JJ and/CC cardiac/JJ transplant/NN patients/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT A) (JJ pharmacokinetic) (NN interaction)) (PP (IN between) (NP (NP (NN diltiazem)) (CC and) (NP (NN cyclosporine))))) (VP (VBZ has) (VP (VBN been) (VP (VBN observed) (PP (IN during) (NP (NP (NNS studies)) (VP (VBG involving) (NP (ADJP (ADJP (JJ renal)) (CC and) (ADJP (JJ cardiac))) (NN transplant) (NNS patients))))))))) (. .))))

det(interaction-3, A-1)
amod(interaction-3, pharmacokinetic-2)
nsubjpass(observed-10, interaction-3)
prep_between(interaction-3, diltiazem-5)
conj_and(diltiazem-5, cyclosporine-7)
aux(observed-10, has-8)
auxpass(observed-10, been-9)
root(ROOT-0, observed-10)
prep_during(observed-10, studies-12)
partmod(studies-12, involving-13)
amod(patients-18, renal-14)
conj_and(renal-14, cardiac-16)
nn(patients-18, transplant-17)
dobj(involving-13, patients-18)

In/IN renal/JJ and/CC cardiac/JJ transplant/NN recipients/NNS ,/, a/DT reduction/NN of/IN cyclosporine/NN dose/NN ranging/VBG from/IN 15/CD %/NN to/TO 48/CD %/NN was/VBD necessary/JJ to/TO maintain/VB cyclosporine/NN trough/NN concentrations/NNS similar/JJ to/TO those/DT seen/VBN prior/JJ to/TO the/DT addition/NN of/IN diltiazem/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (ADJP (ADJP (JJ renal)) (CC and) (ADJP (JJ cardiac))) (NN transplant) (NNS recipients))) (, ,) (NP (NP (DT a) (NN reduction)) (PP (IN of) (NP (NP (NN cyclosporine) (NN dose)) (VP (VBG ranging) (PP (IN from) (NP (CD 15) (NN %))) (PP (TO to) (NP (CD 48) (NN %))))))) (VP (VBD was) (ADJP (JJ necessary) (S (VP (TO to) (VP (VB maintain) (NP (NP (NN cyclosporine) (NN trough) (NNS concentrations)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT those)) (VP (VBN seen) (PP (JJ prior) (TO to) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN diltiazem)))))))))))))))) (. .))))

amod(recipients-6, renal-2)
conj_and(renal-2, cardiac-4)
nn(recipients-6, transplant-5)
prep_in(necessary-21, recipients-6)
det(reduction-9, a-8)
nsubj(necessary-21, reduction-9)
nn(dose-12, cyclosporine-11)
prep_of(reduction-9, dose-12)
partmod(dose-12, ranging-13)
num(%-16, 15-15)
prep_from(ranging-13, %-16)
num(%-19, 48-18)
prep_to(ranging-13, %-19)
cop(necessary-21, was-20)
root(ROOT-0, necessary-21)
aux(maintain-23, to-22)
xcomp(necessary-21, maintain-23)
nn(concentrations-26, cyclosporine-24)
nn(concentrations-26, trough-25)
dobj(maintain-23, concentrations-26)
amod(concentrations-26, similar-27)
prep_to(similar-27, those-29)
partmod(those-29, seen-30)
det(addition-34, the-33)
prep_prior_to(seen-30, addition-34)
prep_of(addition-34, diltiazem-36)

If/IN these/DT agents/NNS are/VBP to/TO be/VB administered/VBN concurrently/RB ,/, cyclosporine/NN concentrations/NNS should/MD be/VB monitored/VBN ,/, especially/RB when/WRB diltiazem/NN therapy/NN is/VBZ initiated/VBN ,/, adjusted/VBN ,/, or/CC discontinued/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (DT these) (NNS agents)) (VP (VBP are) (S (VP (TO to) (VP (VB be) (VP (VBN administered) (ADVP (RB concurrently))))))))) (, ,) (NP (NN cyclosporine) (NNS concentrations)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (, ,) (SBAR (WHADVP (RB especially) (WRB when)) (S (NP (NN diltiazem) (NN therapy)) (VP (VBZ is) (VP (VP (VBN initiated)) (, ,) (VP (VBN adjusted)) (, ,) (CC or) (VP (VBN discontinued)))))))))) (. .))))

mark(are-4, If-1)
det(agents-3, these-2)
nsubj(are-4, agents-3)
xsubj(administered-7, agents-3)
advcl(monitored-14, are-4)
aux(administered-7, to-5)
auxpass(administered-7, be-6)
xcomp(are-4, administered-7)
advmod(administered-7, concurrently-8)
nn(concentrations-11, cyclosporine-10)
nsubjpass(monitored-14, concentrations-11)
aux(monitored-14, should-12)
auxpass(monitored-14, be-13)
root(ROOT-0, monitored-14)
advmod(when-17, especially-16)
advmod(initiated-21, when-17)
nn(therapy-19, diltiazem-18)
nsubjpass(initiated-21, therapy-19)
auxpass(initiated-21, is-20)
advcl(monitored-14, initiated-21)
conj_or(initiated-21, adjusted-23)
conj_or(initiated-21, discontinued-26)

The/DT effect/NN of/IN cyclosporine/NN on/IN diltiazem/NN plasma/NN concentrations/NNS has/VBZ not/RB been/VBN evaluated/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN cyclosporine))) (PP (IN on) (NP (NN diltiazem) (NN plasma) (NNS concentrations)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN evaluated))))) (. .))))

det(effect-2, The-1)
nsubjpass(evaluated-12, effect-2)
prep_of(effect-2, cyclosporine-4)
nn(concentrations-8, diltiazem-6)
nn(concentrations-8, plasma-7)
prep_on(effect-2, concentrations-8)
aux(evaluated-12, has-9)
neg(evaluated-12, not-10)
auxpass(evaluated-12, been-11)
root(ROOT-0, evaluated-12)

Carbamazepine/NN ./.

(ROOT (S1 (S (NP (NP (NN Carbamazepine)) (. .)))))

root(ROOT-0, Carbamazepine-1)

Concomitant/JJ administration/NN of/IN diltiazem/NN with/IN carbamazepine/NN has/VBZ been/VBN reported/VBN to/TO result/VB in/IN elevated/JJ serum/NN levels/NNS of/IN carbamazepine/NN (/-LRB- 40/CD %/NN to/TO 72/CD %/NN increase/NN )/-RRB- ,/, resulting/VBG in/IN toxicity/NN in/IN some/DT cases/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NN diltiazem))) (PP (IN with) (NP (NN carbamazepine)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB result) (PP (IN in) (NP (NP (JJ elevated) (NN serum) (NNS levels)) (PP (IN of) (NP (NP (NN carbamazepine)) (PRN (-LRB- -LRB-) (NP (QP (CD 40) (NN %) (TO to) (CD 72)) (NN %) (NN increase)) (-RRB- -RRB-))))))))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NN toxicity))) (PP (IN in) (NP (DT some) (NNS cases))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubjpass(reported-9, administration-2)
xsubj(result-11, administration-2)
prep_of(administration-2, diltiazem-4)
prep_with(administration-2, carbamazepine-6)
aux(reported-9, has-7)
auxpass(reported-9, been-8)
root(ROOT-0, reported-9)
aux(result-11, to-10)
xcomp(reported-9, result-11)
amod(levels-15, elevated-13)
nn(levels-15, serum-14)
prep_in(result-11, levels-15)
prep_of(levels-15, carbamazepine-17)
number(%-20, 40-19)
num(increase-24, %-20)
dep(%-20, to-21)
number(%-20, 72-22)
nn(increase-24, %-23)
appos(carbamazepine-17, increase-24)
xcomp(reported-9, resulting-27)
prep_in(resulting-27, toxicity-29)
det(cases-32, some-31)
prep_in(resulting-27, cases-32)

Patients/NNS receiving/VBG these/DT drugs/NNS concurrently/RB should/MD be/VB monitored/VBN for/IN a/DT potential/JJ drug/NN interaction/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (DT these) (NNS drugs)))) (ADVP (RB concurrently)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (PP (IN for) (NP (DT a) (JJ potential) (NN drug) (NN interaction))))))) (. .))))

nsubjpass(monitored-8, Patients-1)
partmod(Patients-1, receiving-2)
det(drugs-4, these-3)
dobj(receiving-2, drugs-4)
advmod(monitored-8, concurrently-5)
aux(monitored-8, should-6)
auxpass(monitored-8, be-7)
root(ROOT-0, monitored-8)
det(interaction-13, a-10)
amod(interaction-13, potential-11)
nn(interaction-13, drug-12)
prep_for(monitored-8, interaction-13)

Benzodiazepines/NN ./.

(ROOT (S1 (S (NP (NP (NN Benzodiazepines)) (. .)))))

root(ROOT-0, Benzodiazepines-1)

Studies/NNS showed/VBD that/IN diltiazem/NN increased/VBD the/DT AUC/NN of/IN midazolam/NN and/CC triazolam/NN by/IN 3-4/JJ fold/NN and/CC the/DT Cmax/NN by/IN 2-fold/RB ,/, compared/VBN to/TO placebo/NN ./.

(ROOT (S1 (S (S (NP (NNS Studies)) (VP (VBD showed) (SBAR (IN that) (S (NP (NN diltiazem)) (VP (VBD increased) (NP (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NP (NN midazolam)) (CC and) (NP (NN triazolam)))) (PP (IN by) (NP (JJ 3-4) (NN fold)))) (CC and) (NP (DT the) (NN Cmax))) (PP (IN by) (NP (RB 2-fold))) (, ,) (S (VP (VBN compared) (PP (TO to) (NP (NN placebo)))))))))) (. .))))

nsubj(showed-2, Studies-1)
root(ROOT-0, showed-2)
complm(increased-5, that-3)
nsubj(increased-5, diltiazem-4)
ccomp(showed-2, increased-5)
det(AUC-7, the-6)
dobj(increased-5, AUC-7)
prep_of(AUC-7, midazolam-9)
conj_and(midazolam-9, triazolam-11)
amod(fold-14, 3-4-13)
prep_by(AUC-7, fold-14)
det(Cmax-17, the-16)
conj_and(AUC-7, Cmax-17)
prep(increased-5, by-18)
pobj(by-18, 2-fold-19)
partmod(increased-5, compared-21)
prep_to(compared-21, placebo-23)

The/DT elimination/NN half/NN life/NN of/IN midazolam/NN and/CC triazolam/NN also/RB increased/VBD (/-LRB- 1.5-2.5/CD fold/NN )/-RRB- during/IN coadministration/NN with/IN diltiazem/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN elimination) (NN half) (NN life)) (PP (IN of) (NP (NP (NN midazolam)) (CC and) (NP (NN triazolam))))) (ADVP (RB also)) (VP (VBD increased) (PRN (-LRB- -LRB-) (NP (CD 1.5-2.5) (NN fold)) (-RRB- -RRB-)) (PP (IN during) (NP (NP (NN coadministration)) (PP (IN with) (NP (NN diltiazem))))))) (. .))))

det(life-4, The-1)
nn(life-4, elimination-2)
nn(life-4, half-3)
nsubj(increased-10, life-4)
prep_of(life-4, midazolam-6)
conj_and(midazolam-6, triazolam-8)
advmod(increased-10, also-9)
root(ROOT-0, increased-10)
num(fold-13, 1.5-2.5-12)
dep(increased-10, fold-13)
prep_during(increased-10, coadministration-16)
prep_with(coadministration-16, diltiazem-18)

These/DT pharmacokinetic/JJ effects/NNS seen/VBN during/IN diltiazem/NN coadministration/NN can/MD result/VB in/IN increased/VBN clinical/JJ effects/NNS (/-LRB- e.g./FW ,/, prolonged/JJ sodation/NN )/-RRB- of/IN both/CC midazolam/NN and/CC triazolam/NN ./.

(ROOT (S1 (S (S (NP (NP (DT These) (JJ pharmacokinetic) (NNS effects)) (VP (VBN seen) (PP (IN during) (NP (NN diltiazem) (NN coadministration))))) (VP (MD can) (VP (VB result) (PP (IN in) (NP (NP (NP (VBN increased) (JJ clinical) (NNS effects)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (JJ prolonged) (NN sodation))) (-RRB- -RRB-))) (PP (IN of) (NP (CC both) (NP (NN midazolam)) (CC and) (NP (NN triazolam))))))))) (. .))))

det(effects-3, These-1)
amod(effects-3, pharmacokinetic-2)
nsubj(result-9, effects-3)
partmod(effects-3, seen-4)
nn(coadministration-7, diltiazem-6)
prep_during(seen-4, coadministration-7)
aux(result-9, can-8)
root(ROOT-0, result-9)
amod(effects-13, increased-11)
amod(effects-13, clinical-12)
prep_in(result-9, effects-13)
dep(effects-13, e.g.-15)
amod(sodation-18, prolonged-17)
pobj(e.g.-15, sodation-18)
preconj(midazolam-22, both-21)
prep_of(effects-13, midazolam-22)
conj_and(midazolam-22, triazolam-24)

Lovastatin/NN ./.

(ROOT (S1 (S (NP (NP (NN Lovastatin)) (. .)))))

root(ROOT-0, Lovastatin-1)

In/IN a/DT ten-subject/JJ study/NN ,/, coadministration/NN of/IN diltiazem/NN (/-LRB- 120/CD mg/NN bid/NN )/-RRB- with/IN lovastatin/NN resulted/VBD in/IN a/DT 3-4/JJ times/NNS increase/NN in/IN mean/JJ lovastatin/NN AUC/NN and/CC Cmax/NN vs./CC lovastatin/NN alone/RB ;/: ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT a) (JJ ten-subject) (NN study))) (, ,) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NN diltiazem)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 120) (NN mg)) (NN bid)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN lovastatin)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJ 3-4) (NNS times) (NN increase)) (PP (IN in) (NP (NP (JJ mean) (NN lovastatin) (NN AUC)) (CC and) (NP (NP (NP (NN Cmax)) (CC vs.) (NP (NN lovastatin))) (ADVP (RB alone)))))))) (: ;)) (. .))))

det(study-4, a-2)
amod(study-4, ten-subject-3)
prep_in(resulted-16, study-4)
nsubj(resulted-16, coadministration-6)
prep_of(coadministration-6, diltiazem-8)
number(mg-11, 120-10)
amod(bid-12, mg-11)
appos(diltiazem-8, bid-12)
prep_with(coadministration-6, lovastatin-15)
root(ROOT-0, resulted-16)
det(increase-21, a-18)
amod(increase-21, 3-4-19)
nn(increase-21, times-20)
prep_in(resulted-16, increase-21)
amod(AUC-25, mean-23)
nn(AUC-25, lovastatin-24)
prep_in(increase-21, AUC-25)
conj_and(AUC-25, Cmax-27)
conj_vs.(Cmax-27, lovastatin-29)
advmod(Cmax-27, alone-30)

no/DT change/NN in/IN pravastatin/NN AUC/NN and/CC Cmax/NN was/VBD observed/VBN during/IN diltiazem/NN coadministration/NN ./.

(ROOT (S1 (S (S (NP (NP (DT no) (NN change)) (PP (IN in) (NP (NP (NN pravastatin) (NN AUC)) (CC and) (NP (NN Cmax))))) (VP (VBD was) (VP (VBN observed) (PP (IN during) (NP (NN diltiazem) (NN coadministration)))))) (. .))))

det(change-2, no-1)
nsubjpass(observed-9, change-2)
nn(AUC-5, pravastatin-4)
prep_in(change-2, AUC-5)
conj_and(AUC-5, Cmax-7)
auxpass(observed-9, was-8)
root(ROOT-0, observed-9)
nn(coadministration-12, diltiazem-11)
prep_during(observed-9, coadministration-12)

Diltiazem/NN plasma/NN levels/NNS were/VBD not/RB significantly/RB affected/VBN by/IN lovastatin/NN or/CC pravastatin/NN ./.

(ROOT (S1 (S (S (NP (NN Diltiazem) (NN plasma) (NNS levels)) (VP (VBD were) (RB not) (ADVP (RB significantly)) (VP (VBN affected) (PP (IN by) (NP (NP (NN lovastatin)) (CC or) (NP (NN pravastatin))))))) (. .))))

nn(levels-3, Diltiazem-1)
nn(levels-3, plasma-2)
nsubjpass(affected-7, levels-3)
auxpass(affected-7, were-4)
neg(affected-7, not-5)
advmod(affected-7, significantly-6)
root(ROOT-0, affected-7)
agent(affected-7, lovastatin-9)
conj_or(lovastatin-9, pravastatin-11)

Rifampin/NN ./.

(ROOT (S1 (S (NP (NP (NN Rifampin)) (. .)))))

root(ROOT-0, Rifampin-1)

Coadministration/NN of/IN rifampin/NN with/IN diltiazem/NN lowered/VBD the/DT diltiazem/NN plasma/NN concentrations/NNS to/TO undetectable/JJ levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN rifampin))) (PP (IN with) (NP (NN diltiazem)))) (VP (VBD lowered) (NP (DT the) (NN diltiazem) (NN plasma) (NNS concentrations)) (PP (TO to) (NP (JJ undetectable) (NNS levels))))) (. .))))

nsubj(lowered-6, Coadministration-1)
prep_of(Coadministration-1, rifampin-3)
prep_with(Coadministration-1, diltiazem-5)
root(ROOT-0, lowered-6)
det(concentrations-10, the-7)
nn(concentrations-10, diltiazem-8)
nn(concentrations-10, plasma-9)
dobj(lowered-6, concentrations-10)
amod(levels-13, undetectable-12)
prep_to(lowered-6, levels-13)

Coadministration/NN of/IN diltiazem/NN with/IN rifampin/NN or/CC any/DT known/JJ CYP3A4/NN inducer/NN should/MD be/VB avoided/VBN when/WRB possible/JJ ,/, and/CC alternative/JJ therapy/NN considered/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN diltiazem))) (PP (IN with) (NP (NP (NN rifampin)) (CC or) (NP (DT any) (JJ known) (NN CYP3A4) (NN inducer))))) (VP (MD should) (VP (VB be) (VP (VBN avoided) (SBAR (WHADVP (WRB when)) (FRAG (JJ possible))))))) (, ,) (CC and) (S (NP (JJ alternative) (NN therapy)) (VP (VBN considered)))) (. .))))

nsubjpass(avoided-13, Coadministration-1)
prep_of(Coadministration-1, diltiazem-3)
prep_with(Coadministration-1, rifampin-5)
det(inducer-10, any-7)
amod(inducer-10, known-8)
nn(inducer-10, CYP3A4-9)
conj_or(rifampin-5, inducer-10)
aux(avoided-13, should-11)
auxpass(avoided-13, be-12)
root(ROOT-0, avoided-13)
advmod(possible-15, when-14)
advcl(avoided-13, possible-15)
amod(therapy-19, alternative-18)
nsubj(considered-20, therapy-19)
conj_and(avoided-13, considered-20)

Dimenhydrinate/NN may/MD decrease/VB emetic/JJ response/NN to/TO apomorphine/NN ./.

(ROOT (S1 (S (S (NP (NN Dimenhydrinate)) (VP (MD may) (VP (VB decrease) (NP (NP (JJ emetic) (NN response)) (PP (TO to) (NP (NN apomorphine))))))) (. .))))

nsubj(decrease-3, Dimenhydrinate-1)
aux(decrease-3, may-2)
root(ROOT-0, decrease-3)
amod(response-5, emetic-4)
dobj(decrease-3, response-5)
prep_to(response-5, apomorphine-7)

Oxytocin/NN or/CC other/JJ oxytocics/NNS (/-LRB- concurrent/JJ use/NN with/IN dinoprost/NN may/MD result/VB in/IN uterine/NN hypertonus/NN ,/, possibly/RB causing/VBG uterine/NN rupture/NN or/CC cervical/JJ laceration/NN ,/, especially/RB in/IN the/DT absence/NN of/IN adequate/JJ cervical/JJ dilatation/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NN Oxytocin)) (CC or) (NP (JJ other) (NNS oxytocics))) (-LRB- -LRB-) (NP (NP (JJ concurrent) (NN use)) (PP (IN with) (NP (NN dinoprost)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NN uterine) (NN hypertonus))) (, ,) (S (ADVP (RB possibly)) (VP (VBG causing) (NP (NP (NN uterine) (NN rupture)) (CC or) (NP (JJ cervical) (NN laceration))) (, ,) (PP (ADVP (RB especially)) (IN in) (DT the) (NN absence) (IN of) (NP (JJ adequate) (JJ cervical) (NN dilatation))))))) (: ;)) (. .))))

nsubj(result-11, Oxytocin-1)
amod(oxytocics-4, other-3)
conj_or(Oxytocin-1, oxytocics-4)
amod(use-7, concurrent-6)
nsubj(result-11, use-7)
prep_with(use-7, dinoprost-9)
aux(result-11, may-10)
root(ROOT-0, result-11)
nn(hypertonus-14, uterine-13)
prep_in(result-11, hypertonus-14)
advmod(causing-17, possibly-16)
xcomp(result-11, causing-17)
nn(rupture-19, uterine-18)
dobj(causing-17, rupture-19)
amod(laceration-22, cervical-21)
conj_or(rupture-19, laceration-22)
advmod(causing-17, especially-24)
dep(causing-17, in-25)
dep(causing-17, the-26)
dep(causing-17, absence-27)
amod(dilatation-31, adequate-29)
amod(dilatation-31, cervical-30)
prep_of(causing-17, dilatation-31)

PROSTIN/NN E2/NN may/MD augment/VB the/DT activity/NN of/IN other/JJ oxytocic/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NN PROSTIN) (NN E2)) (VP (MD may) (VP (VB augment) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (JJ other) (JJ oxytocic) (NNS drugs))))))) (. .))))

nn(E2-2, PROSTIN-1)
nsubj(augment-4, E2-2)
aux(augment-4, may-3)
root(ROOT-0, augment-4)
det(activity-6, the-5)
dobj(augment-4, activity-6)
amod(drugs-10, other-8)
amod(drugs-10, oxytocic-9)
prep_of(activity-6, drugs-10)

Concomitant/JJ use/NN with/IN other/JJ oxytocic/JJ agents/NNS is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN with) (NP (JJ other) (JJ oxytocic) (NNS agents)))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

amod(use-2, Concomitant-1)
nsubjpass(recommended-9, use-2)
amod(agents-6, other-4)
amod(agents-6, oxytocic-5)
prep_with(use-2, agents-6)
auxpass(recommended-9, is-7)
neg(recommended-9, not-8)
root(ROOT-0, recommended-9)

This/DT drug/NN may/MD interact/VB with/IN alcohol/NN or/CC other/JJ CNS/NN depressants/NNS (/-LRB- may/MD potentiate/VB the/DT CNS/NN depressant/NN effects/NNS of/IN either/CC these/DT medications/NNS or/CC antihistamines/NNS )/-RRB- ,/, anticholinergics/NN or/CC other/JJ medications/NNS with/IN anticholinergic/JJ activity/NN (/-LRB- anticholinergic/JJ effects/NNS may/MD be/VB potentiated/VBN when/WRB these/DT medications/NNS are/VBP used/VBN concurrently/RB with/IN antihistamines/NNS )/-RRB- ,/, and/CC monoamine/NN oxidase/NN (/-LRB- MAO/NN )/-RRB- inhibitors/NNS (/-LRB- concurrent/JJ use/NN with/IN antihistamines/NNS may/MD prolong/VB and/CC intensify/VB the/DT anticholinergic/JJ and/CC CNS/NN depressant/NN effects/NNS of/IN antihistamines/NNS )/-RRB- ./.

(ROOT (S1 (S (S (NP (DT This) (NN drug)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NP (NN alcohol)) (CC or) (NP (NP (JJ other) (NN CNS) (NNS depressants)) (-LRB- -LRB-) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (NN CNS) (NN depressant) (NNS effects)) (PP (IN of) (NP (CC either) (DT these) (NP (NNS medications)) (CC or) (NP (NNS antihistamines))))))) (-RRB- -RRB-)) (, ,) (NP (NP (NP (NN anticholinergics)) (CC or) (NP (NP (JJ other) (NNS medications)) (PP (IN with) (NP (JJ anticholinergic) (NN activity))))) (PRN (-LRB- -LRB-) (NP (NP (JJ anticholinergic) (NNS effects)) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (SBAR (WHADVP (WRB when)) (S (NP (DT these) (NNS medications)) (VP (VBP are) (VP (VBN used) (ADVP (RB concurrently)) (PP (IN with) (NP (NNS antihistamines))))))))))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NP (NP (NN monoamine) (NN oxidase)) (PRN (-LRB- -LRB-) (NP (NN MAO)) (-RRB- -RRB-))) (NNS inhibitors)) (PRN (-LRB- -LRB-) (S (NP (NP (JJ concurrent) (NN use)) (PP (IN with) (NP (NNS antihistamines)))) (VP (MD may) (VP (VP (VB prolong)) (CC and) (VP (VB intensify) (NP (NP (DT the) (JJ anticholinergic) (CC and) (NN CNS) (NN depressant) (NNS effects)) (PP (IN of) (NP (NNS antihistamines)))))))) (-RRB- -RRB-)))))))) (. .))))

det(drug-2, This-1)
nsubj(interact-4, drug-2)
aux(interact-4, may-3)
root(ROOT-0, interact-4)
prep_with(interact-4, alcohol-6)
amod(depressants-10, other-8)
nn(depressants-10, CNS-9)
conj_or(alcohol-6, depressants-10)
aux(potentiate-13, may-12)
dep(depressants-10, potentiate-13)
det(effects-17, the-14)
nn(effects-17, CNS-15)
nn(effects-17, depressant-16)
dobj(potentiate-13, effects-17)
preconj(medications-21, either-19)
dep(medications-21, these-20)
prep_of(effects-17, medications-21)
conj_or(medications-21, antihistamines-23)
conj_or(alcohol-6, anticholinergics-26)
amod(medications-29, other-28)
conj_or(anticholinergics-26, medications-29)
amod(activity-32, anticholinergic-31)
prep_with(medications-29, activity-32)
amod(effects-35, anticholinergic-34)
dep(anticholinergics-26, effects-35)
aux(potentiated-38, may-36)
auxpass(potentiated-38, be-37)
dep(effects-35, potentiated-38)
advmod(used-43, when-39)
det(medications-41, these-40)
nsubjpass(used-43, medications-41)
auxpass(used-43, are-42)
advcl(potentiated-38, used-43)
advmod(used-43, concurrently-44)
prep_with(used-43, antihistamines-46)
nn(oxidase-51, monoamine-50)
nn(inhibitors-55, oxidase-51)
abbrev(oxidase-51, MAO-53)
conj_and(alcohol-6, inhibitors-55)
amod(use-58, concurrent-57)
nsubj(prolong-62, use-58)
prep_with(use-58, antihistamines-60)
aux(prolong-62, may-61)
dep(inhibitors-55, prolong-62)
conj_and(prolong-62, intensify-64)
dep(anticholinergic-66, the-65)
dobj(intensify-64, anticholinergic-66)
nn(effects-70, CNS-68)
nn(effects-70, depressant-69)
conj_and(anticholinergic-66, effects-70)
prep_of(anticholinergic-66, antihistamines-72)

No/DT pharmacokinetic/JJ drug-drug/JJ interaction/NN studies/NNS were/VBD conducted/VBN with/IN PERSANTINE/JJ @/NN (/-LRB- dipyridamole/NN USP/NN )/-RRB- Tablets/NNS ./.

(ROOT (S1 (S (S (NP (DT No) (JJ pharmacokinetic) (JJ drug-drug) (NN interaction) (NNS studies)) (VP (VBD were) (VP (VBN conducted) (PP (IN with) (NP (JJ PERSANTINE) (NN @) (-LRB- -LRB-) (NN dipyridamole) (NN USP) (-RRB- -RRB-) (NNS Tablets)))))) (. .))))

det(studies-5, No-1)
amod(studies-5, pharmacokinetic-2)
amod(studies-5, drug-drug-3)
nn(studies-5, interaction-4)
nsubjpass(conducted-7, studies-5)
auxpass(conducted-7, were-6)
root(ROOT-0, conducted-7)
amod(Tablets-15, PERSANTINE-9)
nn(Tablets-15, @-10)
nn(Tablets-15, dipyridamole-12)
nn(Tablets-15, USP-13)
prep_with(conducted-7, Tablets-15)

Adenosine/NN :/: Dipyridamole/NN has/VBZ been/VBN reported/VBN to/TO increase/VB the/DT plasma/NN levels/NNS and/CC cardiovascular/VB effects/NNS of/IN adenosine/NN ./.

(ROOT (S1 (S (NP (NP (NN Adenosine)) (: :) (S (NP (NN Dipyridamole)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VP (VB increase) (NP (DT the) (NN plasma) (NNS levels))) (CC and) (VP (VB cardiovascular) (NP (NP (NNS effects)) (PP (IN of) (NP (NN adenosine)))))))))))) (. .)))))

root(ROOT-0, Adenosine-1)
nsubjpass(reported-6, Dipyridamole-3)
xsubj(increase-8, Dipyridamole-3)
aux(reported-6, has-4)
auxpass(reported-6, been-5)
dep(Adenosine-1, reported-6)
aux(increase-8, to-7)
xcomp(reported-6, increase-8)
det(levels-11, the-9)
nn(levels-11, plasma-10)
dobj(increase-8, levels-11)
conj_and(increase-8, cardiovascular-13)
dobj(cardiovascular-13, effects-14)
prep_of(effects-14, adenosine-16)

Adjustment/NN of/IN adenosine/NN dosage/NN may/MD be/VB necessary/JJ ./.

(ROOT (S1 (S (S (NP (NP (NN Adjustment)) (PP (IN of) (NP (NN adenosine) (NN dosage)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary))))) (. .))))

nsubj(necessary-7, Adjustment-1)
nn(dosage-4, adenosine-3)
prep_of(Adjustment-1, dosage-4)
aux(necessary-7, may-5)
cop(necessary-7, be-6)
root(ROOT-0, necessary-7)

Cholinesterase/JJ Inhibitors/NNS :/: Dipyridamole/NN may/MD counteract/VB the/DT anticholinesterase/NN effect/NN of/IN cholinesterase/NN inhibitors/NNS ,/, thereby/RB potentially/RB aggravating/VBG myasthenia/NN gravis/NN ./.

(ROOT (S1 (S (NP (NP (JJ Cholinesterase) (NNS Inhibitors)) (: :) (S (NP (NN Dipyridamole)) (VP (MD may) (VP (VB counteract) (NP (NP (DT the) (NN anticholinesterase) (NN effect)) (PP (IN of) (NP (NN cholinesterase) (NNS inhibitors)))) (, ,) (ADVP (RB thereby)) (S (ADVP (RB potentially)) (VP (VBG aggravating) (NP (NN myasthenia) (NN gravis))))))) (. .)))))

amod(Inhibitors-2, Cholinesterase-1)
root(ROOT-0, Inhibitors-2)
nsubj(counteract-6, Dipyridamole-4)
aux(counteract-6, may-5)
dep(Inhibitors-2, counteract-6)
det(effect-9, the-7)
nn(effect-9, anticholinesterase-8)
dobj(counteract-6, effect-9)
nn(inhibitors-12, cholinesterase-11)
prep_of(effect-9, inhibitors-12)
advmod(counteract-6, thereby-14)
advmod(aggravating-16, potentially-15)
xcomp(counteract-6, aggravating-16)
nn(gravis-18, myasthenia-17)
dobj(aggravating-16, gravis-18)

Terfenadine/NN :/: In/IN a/DT prospective/JJ study/NN involving/VBG six-healthy-male/JJ volunteers/NNS ,/, dirithromycin/NN did/VBD not/RB affect/VB the/DT metabolism/NN of/IN terfenadine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Terfenadine) (: :)) (PP (IN In) (NP (NP (NP (DT a) (JJ prospective) (NN study)) (VP (VBG involving) (NP (JJ six-healthy-male) (NNS volunteers)))) (, ,) (NP (NN dirithromycin))))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN terfenadine))))))) (. .))))

nsubj(affect-14, Terfenadine-1)
det(study-6, a-4)
amod(study-6, prospective-5)
prep_in(Terfenadine-1, study-6)
partmod(study-6, involving-7)
amod(volunteers-9, six-healthy-male-8)
dobj(involving-7, volunteers-9)
appos(study-6, dirithromycin-11)
aux(affect-14, did-12)
neg(affect-14, not-13)
root(ROOT-0, affect-14)
det(metabolism-16, the-15)
dobj(affect-14, metabolism-16)
prep_of(metabolism-16, terfenadine-18)

These/DT six/CD volunteers/NNS received/VBD terfenadine/NN alone/RB (/-LRB- 60/CD mg/NN twice/RB daily/RB )/-RRB- for/IN 8/CD days/NNS ,/, followed/VBN by/IN terfenadine/NN in/IN combination/NN with/IN dirithromycin/NN (/-LRB- 500/CD mg/NN once/RB daily/JJ )/-RRB- for/IN 10/CD days/NNS ./.

(ROOT (S1 (S (S (NP (DT These) (CD six) (NNS volunteers)) (VP (VBD received) (NP (NP (NP (NN terfenadine)) (ADVP (RB alone))) (PRN (-LRB- -LRB-) (NP (NP (CD 60) (NN mg)) (ADVP (RB twice) (RB daily))) (-RRB- -RRB-))) (PP (IN for) (NP (CD 8) (NNS days))) (, ,) (S (VP (VBN followed) (PP (IN by) (NP (NP (NN terfenadine)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NN dirithromycin)) (PRN (-LRB- -LRB-) (NP (NP (CD 500) (NN mg)) (ADJP (RB once) (JJ daily))) (-RRB- -RRB-)))))) (PP (IN for) (NP (CD 10) (NNS days))))))))) (. .))))

det(volunteers-3, These-1)
num(volunteers-3, six-2)
nsubj(received-4, volunteers-3)
root(ROOT-0, received-4)
dobj(received-4, terfenadine-5)
advmod(terfenadine-5, alone-6)
num(mg-9, 60-8)
dep(terfenadine-5, mg-9)
advmod(daily-11, twice-10)
advmod(mg-9, daily-11)
num(days-15, 8-14)
prep_for(received-4, days-15)
partmod(received-4, followed-17)
agent(followed-17, terfenadine-19)
prep_in(terfenadine-19, combination-21)
prep_with(combination-21, dirithromycin-23)
num(mg-26, 500-25)
dep(dirithromycin-23, mg-26)
advmod(daily-28, once-27)
amod(mg-26, daily-28)
num(days-32, 10-31)
prep_for(terfenadine-19, days-32)

(/-LRB- Both/DT drugs/NNS were/VBD thus/RB dosed/VBN to/TO steady/JJ state./NN )/-RRB- ./.

(ROOT (S1 (S (S (-LRB- -LRB-) (NP (DT Both) (NNS drugs)) (VP (VBD were) (ADVP (RB thus)) (VP (VBN dosed) (PP (TO to) (NP (JJ steady) (NN state.))))) (-RRB- -RRB-)) (. .))))

det(drugs-3, Both-2)
nsubjpass(dosed-6, drugs-3)
auxpass(dosed-6, were-4)
advmod(dosed-6, thus-5)
root(ROOT-0, dosed-6)
amod(state.-9, steady-8)
prep_to(dosed-6, state.-9)

The/DT pharmacokinetics/NNS of/IN terfenadine/NN and/CC its/PRP$ acid/NN metabolite/NN and/CC the/DT electrocardiographic/JJ QT/JJ c/NN interval/NN were/VBD measured/VBN during/IN both/DT periods/NNS :/: with/IN terfenadine/NN alone/RB ,/, and/CC with/IN terfenadine/NN plus/CC dirithromycin/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (DT The) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN terfenadine)) (CC and) (NP (PRP$ its) (NN acid) (NN metabolite))))) (CC and) (NP (DT the) (JJ electrocardiographic) (JJ QT) (NN c) (NN interval))) (VP (VBD were) (VP (VBN measured) (PP (IN during) (NP (NP (DT both) (NNS periods)) (: :) (PP (PP (IN with) (NP (NP (NN terfenadine)) (ADVP (RB alone)))) (, ,) (CC and) (PP (IN with) (NP (NP (NN terfenadine)) (CC plus) (NP (NN dirithromycin)))))))))) (. .))))

det(pharmacokinetics-2, The-1)
nsubjpass(measured-16, pharmacokinetics-2)
prep_of(pharmacokinetics-2, terfenadine-4)
poss(metabolite-8, its-6)
nn(metabolite-8, acid-7)
conj_and(terfenadine-4, metabolite-8)
det(interval-14, the-10)
amod(interval-14, electrocardiographic-11)
amod(interval-14, QT-12)
nn(interval-14, c-13)
conj_and(pharmacokinetics-2, interval-14)
auxpass(measured-16, were-15)
root(ROOT-0, measured-16)
det(periods-19, both-18)
prep_during(measured-16, periods-19)
prep_with(periods-19, terfenadine-22)
advmod(terfenadine-22, alone-23)
conj_and(terfenadine-22, terfenadine-27)
conj_plus(terfenadine-27, dirithromycin-29)

In/IN five/CD men/NNS ,/, terfenadine/NN levels/NNS were/VBD undetectable/JJ (/-LRB- 5/CD ng/mL/NN )/-RRB- throughout/IN the/DT study/NN ;/: ./.

(ROOT (S1 (S (S (PP (IN In) (NP (CD five) (NNS men))) (, ,) (NP (NN terfenadine) (NNS levels)) (VP (VBD were) (ADJP (JJ undetectable)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN ng/mL)) (-RRB- -RRB-)) (PP (IN throughout) (NP (DT the) (NN study)))) (: ;)) (. .))))

num(men-3, five-2)
prep_in(undetectable-8, men-3)
nn(levels-6, terfenadine-5)
nsubj(undetectable-8, levels-6)
cop(undetectable-8, were-7)
root(ROOT-0, undetectable-8)
num(ng/mL-11, 5-10)
dep(undetectable-8, ng/mL-11)
det(study-15, the-14)
prep_throughout(undetectable-8, study-15)

in/IN one/CD man/NN ,/, the/DT C/NN max/NN of/IN terfenadine/NN was/VBD 8.1/CD ng/mL/NN with/IN terfenadine/NN alone/RB and/CC 7.2/CD ng/mL/NN with/IN terfenadine/NN plus/CC dirithromycin/NN ./.

(ROOT (S1 (S (S (PP (IN in) (NP (CD one) (NN man))) (, ,) (NP (NP (DT the) (NN C) (NN max)) (PP (IN of) (NP (NN terfenadine)))) (VP (VBD was) (NP (NP (NP (CD 8.1) (NN ng/mL)) (PP (IN with) (NP (NP (NN terfenadine)) (ADVP (RB alone))))) (CC and) (NP (NP (CD 7.2) (NN ng/mL)) (PP (IN with) (NP (NP (NN terfenadine)) (CC plus) (NP (NN dirithromycin)))))))) (. .))))

num(man-3, one-2)
prep_in(ng/mL-12, man-3)
det(max-7, the-5)
nn(max-7, C-6)
nsubj(ng/mL-12, max-7)
prep_of(max-7, terfenadine-9)
cop(ng/mL-12, was-10)
num(ng/mL-12, 8.1-11)
root(ROOT-0, ng/mL-12)
prep_with(ng/mL-12, terfenadine-14)
advmod(terfenadine-14, alone-15)
num(ng/mL-18, 7.2-17)
conj_and(ng/mL-12, ng/mL-18)
prep_with(ng/mL-18, terfenadine-20)
conj_plus(terfenadine-20, dirithromycin-22)

The/DT mean/JJ C/NN max/NN ,/, T/NN max/NN ,/, and/CC AUC/NN of/IN the/DT acid/NN metabolite/NN of/IN terfenadine/NN were/VBD not/RB significantly/RB changed/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ mean) (NN C) (NN max)) (, ,) (NP (NN T) (NN max)) (, ,) (CC and) (NP (NP (NN AUC)) (PP (IN of) (NP (NP (DT the) (NN acid) (NN metabolite)) (PP (IN of) (NP (NN terfenadine))))))) (VP (VBD were) (RB not) (ADVP (RB significantly)) (VP (VBN changed)))) (. .))))

det(max-4, The-1)
amod(max-4, mean-2)
nn(max-4, C-3)
nsubjpass(changed-20, max-4)
nn(max-7, T-6)
conj_and(max-4, max-7)
conj_and(max-4, AUC-10)
det(metabolite-14, the-12)
nn(metabolite-14, acid-13)
prep_of(AUC-10, metabolite-14)
prep_of(metabolite-14, terfenadine-16)
auxpass(changed-20, were-17)
neg(changed-20, not-18)
advmod(changed-20, significantly-19)
root(ROOT-0, changed-20)

The/DT mean/JJ QT/NN c/NN interval/NN (/-LRB- msec/NNS )/-RRB- was/VBD 369/CD with/IN terfenadine/NN alone/RB and/CC 367/CD with/IN terfenadine/NN plus/CC dirithromycin/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ mean) (NN QT) (NN c) (NN interval)) (PRN (-LRB- -LRB-) (NP (NNS msec)) (-RRB- -RRB-))) (VP (VBD was) (NP (NP (NP (CD 369)) (PP (IN with) (NP (NP (NN terfenadine)) (ADVP (RB alone))))) (CC and) (NP (NP (CD 367)) (PP (IN with) (NP (NP (NN terfenadine)) (CC plus) (NP (NN dirithromycin)))))))) (. .))))

det(interval-5, The-1)
amod(interval-5, mean-2)
nn(interval-5, QT-3)
nn(interval-5, c-4)
nsubj(369-10, interval-5)
appos(interval-5, msec-7)
cop(369-10, was-9)
root(ROOT-0, 369-10)
prep_with(369-10, terfenadine-12)
advmod(terfenadine-12, alone-13)
conj_and(369-10, 367-15)
prep_with(367-15, terfenadine-17)
conj_plus(terfenadine-17, dirithromycin-19)

Also/RB ,/, in/FW vitro/FW experiments/NNS demonstrated/VBD a/DT lack/NN of/IN interaction/NN between/IN dirithromycin/NN and/CC terfenadine/NN ./.

(ROOT (S1 (S (S (ADVP (RB Also)) (, ,) (NP (ADJP (FW in) (FW vitro)) (NNS experiments)) (VP (VBD demonstrated) (NP (NP (DT a) (NN lack)) (PP (IN of) (NP (NP (NN interaction)) (PP (IN between) (NP (NP (NN dirithromycin)) (CC and) (NP (NN terfenadine))))))))) (. .))))

advmod(demonstrated-6, Also-1)
nn(vitro-4, in-3)
amod(experiments-5, vitro-4)
nsubj(demonstrated-6, experiments-5)
root(ROOT-0, demonstrated-6)
det(lack-8, a-7)
dobj(demonstrated-6, lack-8)
prep_of(lack-8, interaction-10)
prep_between(interaction-10, dirithromycin-12)
conj_and(dirithromycin-12, terfenadine-14)

Thus/RB ,/, the/DT interaction/NN observed/VBN between/IN erythromycin/NN and/CC terfenadine/NN is/VBZ not/RB expected/VBN for/IN dirithromycin/NN ./.

(ROOT (S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (DT the) (NN interaction)) (VP (VBN observed) (PP (IN between) (NP (NP (NN erythromycin)) (CC and) (NP (NN terfenadine)))))) (VP (VBZ is) (RB not) (VP (VBN expected) (PP (IN for) (NP (NN dirithromycin)))))) (. .))))

advmod(expected-12, Thus-1)
det(interaction-4, the-3)
nsubjpass(expected-12, interaction-4)
partmod(interaction-4, observed-5)
prep_between(observed-5, erythromycin-7)
conj_and(erythromycin-7, terfenadine-9)
auxpass(expected-12, is-10)
neg(expected-12, not-11)
root(ROOT-0, expected-12)
prep_for(expected-12, dirithromycin-14)

Serious/JJ cardiac/JJ dysrhythmias/NNS ,/, some/DT resulting/VBG in/IN death/NN ,/, have/VBP occurred/VBN in/IN patients/NNS receiving/VBG terfenadine/NN concomitantly/RB with/IN other/JJ macrolide/NN antibiotics/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Serious) (JJ cardiac) (NNS dysrhythmias)) (, ,) (NP (NP (DT some)) (VP (VBG resulting) (PP (IN in) (NP (NN death))))) (, ,)) (VP (VBP have) (VP (VBN occurred) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN terfenadine))))) (ADVP (RB concomitantly)) (PP (IN with) (NP (JJ other) (NN macrolide) (NNS antibiotics)))))) (. .))))

amod(dysrhythmias-3, Serious-1)
amod(dysrhythmias-3, cardiac-2)
nsubj(occurred-11, dysrhythmias-3)
appos(dysrhythmias-3, some-5)
partmod(some-5, resulting-6)
prep_in(resulting-6, death-8)
aux(occurred-11, have-10)
root(ROOT-0, occurred-11)
prep_in(occurred-11, patients-13)
partmod(patients-13, receiving-14)
dobj(receiving-14, terfenadine-15)
advmod(occurred-11, concomitantly-16)
amod(antibiotics-20, other-18)
nn(antibiotics-20, macrolide-19)
prep_with(occurred-11, antibiotics-20)

In/IN addition/NN ,/, most/JJS macrolides/NNS are/VBP contraindicated/VBN in/IN patients/NNS receiving/VBG terfenadine/NN therapy/NN who/WP have/VBP pre-existing/JJ cardiac/JJ abnormalities/NNS (/-LRB- arrhythmia/NN ,/, bradycardia/NN ,/, QT/NN c/NN interval/NN prolongation/NN ,/, ischemic/JJ heart/NN disease/NN ,/, congestive/JJ heart/NN failure/NN ,/, etc./NN )/-RRB- or/CC electrolyte/NN disturbances/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (JJS most) (NNS macrolides)) (VP (VBP are) (VP (VBN contraindicated) (PP (IN in) (NP (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN terfenadine) (NN therapy)))) (SBAR (WHNP (WP who)) (S (VP (VBP have) (NP (NP (NP (JJ pre-existing) (JJ cardiac) (NNS abnormalities)) (PRN (-LRB- -LRB-) (NP (NP (NN arrhythmia)) (, ,) (NP (NN bradycardia)) (, ,) (NP (NN QT) (NN c) (NN interval) (NN prolongation)) (, ,) (NP (JJ ischemic) (NN heart) (NN disease)) (, ,) (NP (JJ congestive) (NN heart) (NN failure)) (, ,) (NP (NN etc.))) (-RRB- -RRB-))) (CC or) (NP (NN electrolyte) (NNS disturbances))))))))))) (. .))))

prep_in(contraindicated-7, addition-2)
amod(macrolides-5, most-4)
nsubjpass(contraindicated-7, macrolides-5)
auxpass(contraindicated-7, are-6)
root(ROOT-0, contraindicated-7)
prep_in(contraindicated-7, patients-9)
nsubj(have-14, patients-9)
partmod(patients-9, receiving-10)
nn(therapy-12, terfenadine-11)
dobj(receiving-10, therapy-12)
rcmod(patients-9, have-14)
amod(abnormalities-17, pre-existing-15)
amod(abnormalities-17, cardiac-16)
dobj(have-14, abnormalities-17)
dep(abnormalities-17, arrhythmia-19)
appos(arrhythmia-19, bradycardia-21)
nn(prolongation-26, QT-23)
nn(prolongation-26, c-24)
nn(prolongation-26, interval-25)
appos(arrhythmia-19, prolongation-26)
amod(disease-30, ischemic-28)
nn(disease-30, heart-29)
appos(arrhythmia-19, disease-30)
amod(failure-34, congestive-32)
nn(failure-34, heart-33)
appos(arrhythmia-19, failure-34)
appos(arrhythmia-19, etc.-36)
nn(disturbances-40, electrolyte-39)
conj_or(abnormalities-17, disturbances-40)

Theophylline/NN Following/VBG co-administration/NN of/IN two/CD 250-mg/NN dirithromycin/NN tablets/NNS administered/VBN once/RB daily/RB with/IN 200-mg/NN theophylline/NN tablets/NNS administered/VBN twice/RB daily/RB for/IN 10/CD days/NNS to/TO 14/CD healthy/JJ subjects/NNS ,/, the/DT steady-state/JJ plasma/NN concentration/NN of/IN theophylline/NN was/VBD not/RB significantly/RB altered/VBN ./.

(ROOT (S1 (S (S (NP (NN Theophylline)) (VP (VBG Following) (NP (NP (NN co-administration)) (PP (IN of) (NP (NP (CD two) (NN 250-mg) (NN dirithromycin) (NNS tablets)) (VP (VBN administered) (ADVP (RB once) (RB daily)) (PP (IN with) (NP (NP (NN 200-mg) (NN theophylline) (NNS tablets)) (VP (VBN administered) (ADVP (RB twice) (RB daily)) (PP (IN for) (NP (CD 10) (NNS days))) (PP (TO to) (NP (CD 14) (JJ healthy) (NNS subjects)))))))))))) (, ,) (S (NP (NP (DT the) (JJ steady-state) (NN plasma) (NN concentration)) (PP (IN of) (NP (NN theophylline)))) (VP (VBD was) (RB not) (ADVP (RB significantly)) (VP (VBN altered)))) (. .))))

nsubj(Following-2, Theophylline-1)
root(ROOT-0, Following-2)
dobj(Following-2, co-administration-3)
num(tablets-8, two-5)
nn(tablets-8, 250-mg-6)
nn(tablets-8, dirithromycin-7)
prep_of(co-administration-3, tablets-8)
partmod(tablets-8, administered-9)
advmod(daily-11, once-10)
advmod(administered-9, daily-11)
nn(tablets-15, 200-mg-13)
nn(tablets-15, theophylline-14)
prep_with(administered-9, tablets-15)
partmod(tablets-15, administered-16)
advmod(daily-18, twice-17)
advmod(administered-16, daily-18)
num(days-21, 10-20)
prep_for(administered-16, days-21)
num(subjects-25, 14-23)
amod(subjects-25, healthy-24)
prep_to(administered-16, subjects-25)
det(concentration-30, the-27)
amod(concentration-30, steady-state-28)
nn(concentration-30, plasma-29)
nsubjpass(altered-36, concentration-30)
prep_of(concentration-30, theophylline-32)
auxpass(altered-36, was-33)
neg(altered-36, not-34)
advmod(altered-36, significantly-35)
ccomp(Following-2, altered-36)

In/IN general/JJ ,/, most/JJS patients/NNS treated/VBN with/IN dirithromycin/NN who/WP are/VBP receiving/VBG concomitant/JJ theophylline/NN therapy/NN may/MD not/RB require/VB empiric/JJ adjustment/NN of/IN theophylline/NN dosage/NN or/CC monitoring/NN of/IN theophylline/NN plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (PP (IN In) (NP (JJ general))) (, ,) (NP (NP (NP (JJS most) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NN dirithromycin))))) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG receiving) (NP (JJ concomitant) (NN theophylline) (NN therapy))))))) (VP (MD may) (RB not) (VP (VB require) (NP (NP (NP (JJ empiric) (NN adjustment)) (PP (IN of) (NP (NN theophylline) (NN dosage)))) (CC or) (NP (NP (NN monitoring)) (PP (IN of) (NP (NN theophylline) (NN plasma) (NNS concentrations))))))) (. .))))

prep_in(require-17, general-2)
amod(patients-5, most-4)
nsubj(receiving-11, patients-5)
nsubj(require-17, patients-5)
partmod(patients-5, treated-6)
prep_with(treated-6, dirithromycin-8)
aux(receiving-11, are-10)
rcmod(patients-5, receiving-11)
amod(therapy-14, concomitant-12)
nn(therapy-14, theophylline-13)
dobj(receiving-11, therapy-14)
aux(require-17, may-15)
neg(require-17, not-16)
root(ROOT-0, require-17)
amod(adjustment-19, empiric-18)
dobj(require-17, adjustment-19)
nn(dosage-22, theophylline-21)
prep_of(adjustment-19, dosage-22)
conj_or(adjustment-19, monitoring-24)
nn(concentrations-28, theophylline-26)
nn(concentrations-28, plasma-27)
prep_of(monitoring-24, concentrations-28)

However/RB ,/, theophylline/NN plasma/NN concentrations/NNS should/MD be/VB monitored/VBN ,/, with/IN dosage/NN adjustment/NN as/IN appropriate/JJ ,/, in/IN patients/NNS whose/WP$ pulmonary/JJ disease/NN requires/VBZ maintaining/VBG a/DT given/JJ theophylline/NN plasma/NN concentration/NN for/IN optimal/JJ pulmonary/JJ function/NN or/CC in/IN patients/NNS with/IN theophylline/NN concentrations/NNS at/IN the/DT higher/JJR end/NN of/IN the/DT therapeutic/JJ range/NN ./.

(ROOT (S1 (S (ADVP (RB However)) (, ,) (NP (NN theophylline) (NN plasma) (NNS concentrations)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (, ,) (PP (IN with) (NP (NP (NN dosage) (NN adjustment)) (PP (IN as) (NP (JJ appropriate))))) (, ,) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP$ whose) (JJ pulmonary) (NN disease)) (S (VP (VBZ requires) (S (VP (VBG maintaining) (NP (DT a) (JJ given) (NN theophylline) (NN plasma) (NN concentration)) (PP (PP (IN for) (NP (JJ optimal) (JJ pulmonary) (NN function))) (CC or) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN theophylline) (NNS concentrations)) (PP (IN at) (NP (NP (DT the) (JJR higher) (NN end)) (PP (IN of) (NP (DT the) (JJ therapeutic) (NN range)))))))))))))))))))) (. .))))

advmod(monitored-8, However-1)
nn(concentrations-5, theophylline-3)
nn(concentrations-5, plasma-4)
nsubjpass(monitored-8, concentrations-5)
aux(monitored-8, should-6)
auxpass(monitored-8, be-7)
root(ROOT-0, monitored-8)
nn(adjustment-12, dosage-11)
prep_with(monitored-8, adjustment-12)
prep_as(adjustment-12, appropriate-14)
prep_in(monitored-8, patients-17)
poss(disease-20, patients-17)
amod(disease-20, pulmonary-19)
nsubj(requires-21, disease-20)
rcmod(patients-17, requires-21)
xcomp(requires-21, maintaining-22)
conj_or(maintaining-22, maintaining-22')
det(concentration-27, a-23)
amod(concentration-27, given-24)
nn(concentration-27, theophylline-25)
nn(concentration-27, plasma-26)
dobj(maintaining-22, concentration-27)
amod(function-31, optimal-29)
amod(function-31, pulmonary-30)
prep_for(maintaining-22, function-31)
prep_in(maintaining-22', patients-34)
nn(concentrations-37, theophylline-36)
prep_with(patients-34, concentrations-37)
det(end-41, the-39)
amod(end-41, higher-40)
prep_at(concentrations-37, end-41)
det(range-45, the-43)
amod(range-45, therapeutic-44)
prep_of(end-41, range-45)

Antacids/NNS or/CC H/NN 2/CD receptor/NN antagonists/NNS When/WRB dirithromycin/NN is/VBZ administered/VBN immediately/RB following/VBG antacids/NNS or/CC H/NN 2/CD -receptor/NN antagonists/NNS ,/, the/DT absorption/NN of/IN dirithromycin/NN is/VBZ slightly/RB enhanced/VBN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Antacids)) (CC or) (NP (NN H) (CD 2) (NN receptor) (NNS antagonists))) (SBAR (WHADVP (WRB When)) (S (NP (NN dirithromycin)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB immediately)) (PP (VBG following) (NP (NP (NNS antacids)) (CC or) (NP (NN H) (CD 2) (NN -receptor) (NNS antagonists))))))))) (, ,) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NN dirithromycin)))) (VP (VBZ is) (ADVP (RB slightly)) (VP (VBN enhanced))) (. .))))

nsubjpass(enhanced-26, Antacids-1)
nn(antagonists-6, H-3)
num(antagonists-6, 2-4)
nn(antagonists-6, receptor-5)
conj_or(Antacids-1, antagonists-6)
advmod(administered-10, When-7)
nsubjpass(administered-10, dirithromycin-8)
auxpass(administered-10, is-9)
dep(Antacids-1, administered-10)
advmod(administered-10, immediately-11)
prep_following(administered-10, antacids-13)
nn(antagonists-18, H-15)
num(antagonists-18, 2-16)
nn(antagonists-18, -receptor-17)
conj_or(antacids-13, antagonists-18)
det(absorption-21, the-20)
nsubjpass(enhanced-26, absorption-21)
prep_of(absorption-21, dirithromycin-23)
auxpass(enhanced-26, is-24)
advmod(enhanced-26, slightly-25)
root(ROOT-0, enhanced-26)

The/DT following/JJ drug/NN interactions/NNS have/VBP been/VBN reported/VBN with/IN erythromycin/NN product/NN s/NN ./.

(ROOT (S1 (S (S (NP (DT The) (JJ following) (NN drug) (NNS interactions)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NN erythromycin) (NN product) (NN s))))))) (. .))))

det(interactions-4, The-1)
amod(interactions-4, following-2)
nn(interactions-4, drug-3)
nsubjpass(reported-7, interactions-4)
aux(reported-7, have-5)
auxpass(reported-7, been-6)
root(ROOT-0, reported-7)
nn(s-11, erythromycin-9)
nn(s-11, product-10)
prep_with(reported-7, s-11)

It/PRP is/VBZ presently/RB not/RB known/VBN whether/IN these/DT same/JJ drug/NN interactions/NNS occur/VBP with/IN dirithromycin/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADVP (RB presently)) (RB not) (VP (VBN known) (SBAR (IN whether) (S (NP (DT these) (JJ same) (NN drug) (NNS interactions)) (VP (VBP occur) (PP (IN with) (NP (NN dirithromycin))))))))) (. .))))

nsubjpass(known-5, It-1)
auxpass(known-5, is-2)
advmod(known-5, presently-3)
neg(known-5, not-4)
root(ROOT-0, known-5)
complm(occur-11, whether-6)
det(interactions-10, these-7)
amod(interactions-10, same-8)
nn(interactions-10, drug-9)
nsubj(occur-11, interactions-10)
ccomp(known-5, occur-11)
prep_with(occur-11, dirithromycin-13)

Until/IN further/JJ data/NNS are/VBP available/JJ regarding/VBG the/DT potential/JJ interaction/NN of/IN dirithromycin/NN with/IN these/DT compounds/NNS ,/, caution/NN should/MD be/VB used/VBN during/IN coadministration/NN ./.

(ROOT (S1 (S (S (SBAR (IN Until) (S (NP (JJ further) (NNS data)) (VP (VBP are) (ADJP (JJ available) (PP (VBG regarding) (NP (NP (DT the) (JJ potential) (NN interaction)) (PP (IN of) (NP (NN dirithromycin))) (PP (IN with) (NP (DT these) (NNS compounds))))))))) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN during) (NP (NN coadministration))))))) (. .))))

mark(available-5, Until-1)
amod(data-3, further-2)
nsubj(available-5, data-3)
cop(available-5, are-4)
advcl(used-19, available-5)
det(interaction-9, the-7)
amod(interaction-9, potential-8)
prep_regarding(available-5, interaction-9)
prep_of(interaction-9, dirithromycin-11)
det(compounds-14, these-13)
prep_with(interaction-9, compounds-14)
nsubjpass(used-19, caution-16)
aux(used-19, should-17)
auxpass(used-19, be-18)
root(ROOT-0, used-19)
prep_during(used-19, coadministration-21)

Triazolam/NN Erythromycin/NN has/VBZ been/VBN reported/VBN to/TO decrease/VB the/DT clearance/NN of/IN triazolam/NN and/CC ,/, thus/RB ,/, may/MD increase/VB the/DT pharmacologic/JJ effect/NN of/IN triazolam/NN ./.

(ROOT (S1 (S (S (NP (NN Triazolam) (NN Erythromycin)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (VP (TO to) (VP (VB decrease) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN triazolam)))))) (CC and) (, ,) (ADVP (RB thus)) (, ,) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (JJ pharmacologic) (NN effect)) (PP (IN of) (NP (NN triazolam)))))))))))) (. .))))

nn(Erythromycin-2, Triazolam-1)
nsubjpass(reported-5, Erythromycin-2)
aux(reported-5, has-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
aux(decrease-7, to-6)
ccomp(reported-5, decrease-7)
det(clearance-9, the-8)
dobj(decrease-7, clearance-9)
prep_of(clearance-9, triazolam-11)
advmod(decrease-7, thus-14)
conj_and(decrease-7, thus-14)
aux(increase-17, may-16)
conj_and(decrease-7, increase-17)
det(effect-20, the-18)
amod(effect-20, pharmacologic-19)
dobj(increase-17, effect-20)
prep_of(effect-20, triazolam-22)

Digoxin/NN Concomitant/JJ administration/NN of/IN erythromycin/NN and/CC digoxin/NN has/VBZ been/VBN reported/VBN to/TO result/VB in/IN elevated/JJ digoxin/NN serum/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Digoxin) (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN erythromycin)) (CC and) (NP (NN digoxin))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB result) (PP (IN in) (NP (JJ elevated) (NN digoxin) (NN serum) (NNS levels)))))))))) (. .))))

nn(administration-3, Digoxin-1)
amod(administration-3, Concomitant-2)
nsubjpass(reported-10, administration-3)
xsubj(result-12, administration-3)
prep_of(administration-3, erythromycin-5)
conj_and(erythromycin-5, digoxin-7)
aux(reported-10, has-8)
auxpass(reported-10, been-9)
root(ROOT-0, reported-10)
aux(result-12, to-11)
xcomp(reported-10, result-12)
amod(levels-17, elevated-14)
nn(levels-17, digoxin-15)
nn(levels-17, serum-16)
prep_in(result-12, levels-17)

Anticoagulants/NNS :/: There/EX have/VBP been/VBN reports/NNS of/IN increased/VBN anticoagulant/JJ effects/NNS when/WRB erythromycin/NN and/CC oral/JJ anticoagulants/NNS were/VBD used/VBN concomitantly/RB ./.

(ROOT (S1 (S (NP (NP (NNS Anticoagulants)) (: :) (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (NNS reports)) (PP (IN of) (NP (VBN increased) (JJ anticoagulant) (NNS effects)))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN erythromycin)) (CC and) (NP (JJ oral) (NNS anticoagulants))) (VP (VBD were) (VP (VBN used) (ADVP (RB concomitantly))))))))) (. .)))))

root(ROOT-0, Anticoagulants-1)
expl(reports-6, There-3)
aux(reports-6, have-4)
cop(reports-6, been-5)
dep(Anticoagulants-1, reports-6)
amod(effects-10, increased-8)
amod(effects-10, anticoagulant-9)
prep_of(reports-6, effects-10)
advmod(used-17, when-11)
nsubjpass(used-17, erythromycin-12)
amod(anticoagulants-15, oral-14)
conj_and(erythromycin-12, anticoagulants-15)
auxpass(used-17, were-16)
advcl(reports-6, used-17)
advmod(used-17, concomitantly-18)

Increased/VBN anticoagulation/NN effects/NNS due/JJ to/TO a/DT drug/NN interaction/NN with/IN erythromycin/NN may/MD be/VB more/RBR pronounced/JJ in/IN the/DT elderly/JJ ./.

(ROOT (S1 (S (S (NP (NP (VBN Increased) (NN anticoagulation) (NNS effects)) (ADJP (JJ due) (PP (TO to) (NP (NP (DT a) (NN drug) (NN interaction)) (PP (IN with) (NP (NN erythromycin))))))) (VP (MD may) (VP (VB be) (ADJP (RBR more) (JJ pronounced)) (PP (IN in) (NP (DT the) (JJ elderly)))))) (. .))))

amod(effects-3, Increased-1)
nn(effects-3, anticoagulation-2)
nsubj(pronounced-14, effects-3)
det(interaction-8, a-6)
nn(interaction-8, drug-7)
prep_due_to(effects-3, interaction-8)
prep_with(interaction-8, erythromycin-10)
aux(pronounced-14, may-11)
cop(pronounced-14, be-12)
advmod(pronounced-14, more-13)
root(ROOT-0, pronounced-14)
det(elderly-17, the-16)
prep_in(pronounced-14, elderly-17)

Ergotamine/JJ Concurrent/JJ use/NN of/IN erythromycin/NN and/CC ergotamine/NN or/CC dihydroergotamine/NN has/VBZ been/VBN associated/VBN in/IN some/DT patients/NNS with/IN acute/JJ ergot/NN toxicity/NN characterized/VBN by/IN severe/JJ peripheral/JJ vasospasm/NN and/CC dysesthesia/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Ergotamine) (JJ Concurrent) (NN use)) (PP (IN of) (NP (NP (NN erythromycin)) (CC and) (NP (NP (NN ergotamine)) (CC or) (NP (NN dihydroergotamine)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN in) (NP (NP (DT some) (NNS patients)) (PP (IN with) (NP (NP (JJ acute) (NN ergot) (NN toxicity)) (VP (VBN characterized) (PP (IN by) (NP (NP (JJ severe) (JJ peripheral) (NN vasospasm)) (CC and) (NP (NN dysesthesia))))))))))))) (. .))))

amod(use-3, Ergotamine-1)
amod(use-3, Concurrent-2)
nsubjpass(associated-12, use-3)
prep_of(use-3, erythromycin-5)
conj_and(erythromycin-5, ergotamine-7)
conj_or(ergotamine-7, dihydroergotamine-9)
aux(associated-12, has-10)
auxpass(associated-12, been-11)
root(ROOT-0, associated-12)
det(patients-15, some-14)
prep_in(associated-12, patients-15)
amod(toxicity-19, acute-17)
nn(toxicity-19, ergot-18)
prep_with(patients-15, toxicity-19)
partmod(toxicity-19, characterized-20)
amod(vasospasm-24, severe-22)
amod(vasospasm-24, peripheral-23)
agent(characterized-20, vasospasm-24)
conj_and(vasospasm-24, dysesthesia-26)

Other/JJ drugs/NNS Drug/NN interactions/NNS have/VBP been/VBN reported/VBN with/IN concomitant/JJ administration/NN of/IN erythromycin/NN and/CC other/JJ medications/NNS ,/, including/VBG cyclosporine/NN ,/, hexobarbital/NN ,/, carbamazepine/NN ,/, alfentanil/NN ,/, disopyramide/NN ,/, phenytoin/NN ,/, bromocriptine/NN ,/, valproate/NN ,/, astemizole/NN ,/, and/CC lovastatin/NN ./.

(ROOT (S1 (S (S (NP (JJ Other) (NNS drugs) (NN Drug) (NNS interactions)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN erythromycin)) (CC and) (NP (NP (JJ other) (NNS medications)) (, ,) (PP (VBG including) (NP (NP (NN cyclosporine)) (, ,) (NP (NN hexobarbital)) (, ,) (NP (NN carbamazepine)) (, ,) (NP (NN alfentanil)) (, ,) (NP (NN disopyramide)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN bromocriptine)) (, ,) (NP (NN valproate)) (, ,) (NP (NN astemizole)) (, ,) (CC and) (NP (NN lovastatin))))))))))))) (. .))))

amod(interactions-4, Other-1)
nn(interactions-4, drugs-2)
nn(interactions-4, Drug-3)
nsubjpass(reported-7, interactions-4)
aux(reported-7, have-5)
auxpass(reported-7, been-6)
root(ROOT-0, reported-7)
amod(administration-10, concomitant-9)
prep_with(reported-7, administration-10)
prep_of(administration-10, erythromycin-12)
amod(medications-15, other-14)
conj_and(erythromycin-12, medications-15)
prep_including(medications-15, cyclosporine-18)
conj_and(cyclosporine-18, hexobarbital-20)
conj_and(cyclosporine-18, carbamazepine-22)
conj_and(cyclosporine-18, alfentanil-24)
conj_and(cyclosporine-18, disopyramide-26)
conj_and(cyclosporine-18, phenytoin-28)
conj_and(cyclosporine-18, bromocriptine-30)
conj_and(cyclosporine-18, valproate-32)
conj_and(cyclosporine-18, astemizole-34)
conj_and(cyclosporine-18, lovastatin-37)

If/IN phenytoin/NN or/CC other/JJ hepatic/JJ enzyme/NN inducers/NNS are/VBP taken/VBN concurrently/RB with/IN Norpace/NN or/CC Norpace/NN CR/NN ,/, lower/JJR plasma/NN levels/NNS of/IN disopyramide/NN may/MD occur/VB ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NP (NN phenytoin)) (CC or) (NP (JJ other) (JJ hepatic) (NN enzyme) (NNS inducers))) (VP (VBP are) (VP (VBN taken) (ADVP (RB concurrently)) (PP (IN with) (NP (NP (NN Norpace)) (CC or) (NP (NN Norpace) (NN CR)))))))) (, ,) (NP (NP (JJR lower) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN disopyramide)))) (VP (MD may) (VP (VB occur)))) (. .))))

mark(taken-9, If-1)
nsubjpass(taken-9, phenytoin-2)
amod(inducers-7, other-4)
amod(inducers-7, hepatic-5)
nn(inducers-7, enzyme-6)
conj_or(phenytoin-2, inducers-7)
auxpass(taken-9, are-8)
advcl(occur-23, taken-9)
advmod(taken-9, concurrently-10)
prep_with(taken-9, Norpace-12)
nn(CR-15, Norpace-14)
conj_or(Norpace-12, CR-15)
amod(levels-19, lower-17)
nn(levels-19, plasma-18)
nsubj(occur-23, levels-19)
prep_of(levels-19, disopyramide-21)
aux(occur-23, may-22)
root(ROOT-0, occur-23)

Monitoring/NN of/IN disopyramide/NN plasma/NN levels/NNS is/VBZ recommended/VBN in/IN such/JJ concurrent/JJ use/NN to/TO avoid/VB ineffective/JJ therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Monitoring)) (PP (IN of) (NP (NN disopyramide) (NN plasma) (NNS levels)))) (VP (VBZ is) (VP (VBN recommended) (PP (IN in) (NP (JJ such) (JJ concurrent) (NN use))) (S (VP (TO to) (VP (VB avoid) (NP (JJ ineffective) (NN therapy)))))))) (. .))))

nsubjpass(recommended-7, Monitoring-1)
xsubj(avoid-13, Monitoring-1)
nn(levels-5, disopyramide-3)
nn(levels-5, plasma-4)
prep_of(Monitoring-1, levels-5)
auxpass(recommended-7, is-6)
root(ROOT-0, recommended-7)
amod(use-11, such-9)
amod(use-11, concurrent-10)
prep_in(recommended-7, use-11)
aux(avoid-13, to-12)
xcomp(recommended-7, avoid-13)
amod(therapy-15, ineffective-14)
dobj(avoid-13, therapy-15)

Other/JJ antiarrhythmic/JJ drugs/NNS (/-LRB- eg/NN ,/, quinidine/NN ,/, procainamide/NN ,/, lidocaine/NN ,/, propranolol/NN )/-RRB- have/VBP occasionally/RB been/VBN used/VBN concurrently/RB with/IN Norpace/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Other) (JJ antiarrhythmic) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN quinidine)) (, ,) (NP (NN procainamide)) (, ,) (NP (NN lidocaine)) (, ,) (NP (NN propranolol))) (-RRB- -RRB-))) (VP (VBP have) (ADVP (RB occasionally)) (VP (VBN been) (VP (VBN used) (ADVP (RB concurrently)) (PP (IN with) (NP (NN Norpace))))))) (. .))))

amod(drugs-3, Other-1)
amod(drugs-3, antiarrhythmic-2)
nsubjpass(used-18, drugs-3)
dep(drugs-3, eg-5)
appos(eg-5, quinidine-7)
appos(eg-5, procainamide-9)
appos(eg-5, lidocaine-11)
appos(eg-5, propranolol-13)
aux(used-18, have-15)
advmod(used-18, occasionally-16)
auxpass(used-18, been-17)
root(ROOT-0, used-18)
advmod(used-18, concurrently-19)
prep_with(used-18, Norpace-21)

In/IN healthy/JJ subjects/NNS ,/, no/DT significant/JJ drug-drug/JJ interaction/NN was/VBD observed/VBN when/WRB Norpace/NN was/VBD coadministered/VBN with/IN either/CC propranolol/NN or/CC diazepam/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ healthy) (NNS subjects))) (, ,) (NP (DT no) (JJ significant) (JJ drug-drug) (NN interaction)) (VP (VBD was) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (NN Norpace)) (VP (VBD was) (VP (VBN coadministered) (PP (IN with) (NP (CC either) (NP (NN propranolol)) (CC or) (NP (NN diazepam))))))))))) (. .))))

amod(subjects-3, healthy-2)
prep_in(observed-10, subjects-3)
det(interaction-8, no-5)
amod(interaction-8, significant-6)
amod(interaction-8, drug-drug-7)
nsubjpass(observed-10, interaction-8)
auxpass(observed-10, was-9)
root(ROOT-0, observed-10)
advmod(coadministered-14, when-11)
nsubjpass(coadministered-14, Norpace-12)
auxpass(coadministered-14, was-13)
advcl(observed-10, coadministered-14)
preconj(propranolol-17, either-16)
prep_with(coadministered-14, propranolol-17)
conj_or(propranolol-17, diazepam-19)

Concomitant/JJ administration/NN of/IN Norpace/NN and/CC quinidine/NN resulted/VBD in/IN slight/JJ increases/NNS in/IN plasma/NN disopyramide/NN levels/NNS and/CC slight/JJ decreases/NNS in/IN plasma/NN quinidine/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN Norpace)) (CC and) (NP (NN quinidine))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (JJ slight) (NNS increases)) (PP (IN in) (NP (NN plasma) (NN disopyramide) (NNS levels)))) (CC and) (NP (NP (JJ slight) (NNS decreases)) (PP (IN in) (NP (NN plasma) (NN quinidine) (NNS levels)))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubj(resulted-7, administration-2)
prep_of(administration-2, Norpace-4)
conj_and(Norpace-4, quinidine-6)
root(ROOT-0, resulted-7)
amod(increases-10, slight-9)
prep_in(resulted-7, increases-10)
nn(levels-14, plasma-12)
nn(levels-14, disopyramide-13)
prep_in(increases-10, levels-14)
amod(decreases-17, slight-16)
conj_and(increases-10, decreases-17)
nn(levels-21, plasma-19)
nn(levels-21, quinidine-20)
prep_in(decreases-17, levels-21)

Norpace/NN does/VBZ not/RB increase/VB serum/NN digoxin/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NN Norpace)) (VP (VBZ does) (RB not) (VP (VB increase) (NP (NN serum) (NN digoxin) (NNS levels))))) (. .))))

nsubj(increase-4, Norpace-1)
aux(increase-4, does-2)
neg(increase-4, not-3)
root(ROOT-0, increase-4)
nn(levels-7, serum-5)
nn(levels-7, digoxin-6)
dobj(increase-4, levels-7)

Patients/NNS taking/VBG disopyramide/NN phosphate/NN and/CC erythromycin/NN concomitantly/RB may/MD develop/VB increased/VBN serum/NN concentrations/NNS of/IN disopyramide/NN resulting/VBG in/IN excessive/JJ widening/NN of/IN the/DT QRS/NN complex/NN and/or/CC prolongation/NN of/IN the/DT Q-T/JJ interval/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG taking) (NP (NP (NN disopyramide) (NP (NN phosphate)) (CC and) (NP (NN erythromycin))) (ADVP (RB concomitantly))))) (VP (MD may) (VP (VB develop) (NP (NP (VBN increased) (NN serum) (NNS concentrations)) (PP (IN of) (NP (NP (NN disopyramide)) (VP (VBG resulting) (PP (IN in) (NP (NP (NP (JJ excessive) (NN widening)) (PP (IN of) (NP (DT the) (NN QRS) (NN complex)))) (CC and/or) (NP (NP (NN prolongation)) (PP (IN of) (NP (DT the) (JJ Q-T) (NN interval))))))))))))) (. .))))

nsubj(develop-9, Patients-1)
partmod(Patients-1, taking-2)
dobj(taking-2, disopyramide-3)
dep(disopyramide-3, phosphate-4)
conj_and(disopyramide-3, erythromycin-6)
advmod(disopyramide-3, concomitantly-7)
aux(develop-9, may-8)
root(ROOT-0, develop-9)
amod(concentrations-12, increased-10)
nn(concentrations-12, serum-11)
dobj(develop-9, concentrations-12)
prep_of(concentrations-12, disopyramide-14)
partmod(disopyramide-14, resulting-15)
amod(widening-18, excessive-17)
prep_in(resulting-15, widening-18)
det(complex-22, the-20)
nn(complex-22, QRS-21)
prep_of(widening-18, complex-22)
conj_and/or(widening-18, prolongation-24)
det(interval-28, the-26)
amod(interval-28, Q-T-27)
prep_of(prolongation-24, interval-28)

Patients/NNS taking/VBG disopyramide/NN phosphate/NN and/CC hepatic/JJ enzyme/NN inhibitors/NNS concomitantly/RB should/MD be/VB closely/RB monitored/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Patients)) (VP (VBG taking) (NP (NN disopyramide) (NN phosphate)))) (CC and) (NP (NP (JJ hepatic) (NN enzyme) (NNS inhibitors)) (ADVP (RB concomitantly)))) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN monitored))))) (. .))))

nsubjpass(monitored-13, Patients-1)
partmod(Patients-1, taking-2)
nn(phosphate-4, disopyramide-3)
dobj(taking-2, phosphate-4)
amod(inhibitors-8, hepatic-6)
nn(inhibitors-8, enzyme-7)
conj_and(Patients-1, inhibitors-8)
advmod(inhibitors-8, concomitantly-9)
aux(monitored-13, should-10)
auxpass(monitored-13, be-11)
advmod(monitored-13, closely-12)
root(ROOT-0, monitored-13)

Until/IN data/NNS on/IN possible/JJ interactions/NNS between/IN verapamil/NN and/CC disopyramide/NN phosphate/NN are/VBP obtained/VBN ,/, disopyramide/NN should/MD not/RB be/VB administered/VBN within/IN 48/CD hours/NNS before/IN or/CC 24/CD hours/NNS after/IN verapamil/NN administration/NN ./.

(ROOT (S1 (S (S (SBAR (IN Until) (S (NP (NP (NNS data)) (PP (IN on) (NP (NP (JJ possible) (NNS interactions)) (PP (IN between) (NP (NP (NN verapamil)) (CC and) (NP (NN disopyramide)) (NP (NN phosphate))))))) (VP (VBP are) (VP (VBN obtained))))) (, ,) (NP (NN disopyramide)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (PP (IN within) (NP (NP (NP (CD 48) (NNS hours)) (PP (IN before))) (CC or) (NP (NP (CD 24) (NNS hours)) (PP (IN after) (NP (NN verapamil) (NN administration)))))))))) (. .))))

mark(obtained-12, Until-1)
nsubjpass(obtained-12, data-2)
amod(interactions-5, possible-4)
prep_on(data-2, interactions-5)
prep_between(interactions-5, verapamil-7)
conj_and(verapamil-7, disopyramide-9)
dep(verapamil-7, phosphate-10)
auxpass(obtained-12, are-11)
advcl(administered-18, obtained-12)
nsubjpass(administered-18, disopyramide-14)
aux(administered-18, should-15)
neg(administered-18, not-16)
auxpass(administered-18, be-17)
root(ROOT-0, administered-18)
num(hours-21, 48-20)
prep_within(administered-18, hours-21)
prep(hours-21, before-22)
num(hours-25, 24-24)
conj_or(hours-21, hours-25)
nn(administration-28, verapamil-27)
prep_after(hours-25, administration-28)

Animal/NN studies/NNS indicate/VBP that/IN dobutamine/NN may/MD be/VB ineffective/JJ if/IN the/DT patient/NN has/VBZ recently/RB received/VBN a/DT span/NN class=/IN c65/CD b-blocking/JJ drug/NN ./.

(ROOT (S1 (S (S (NP (NN Animal) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN dobutamine)) (VP (MD may) (VP (VB be) (ADJP (JJ ineffective)) (SBAR (IN if) (S (NP (DT the) (NN patient)) (VP (VBZ has) (ADVP (RB recently)) (VP (VBN received) (NP (NP (DT a) (NN span)) (PP (IN class=) (NP (CD c65) (JJ b-blocking) (NN drug)))))))))))))) (. .))))

nn(studies-2, Animal-1)
nsubj(indicate-3, studies-2)
root(ROOT-0, indicate-3)
complm(ineffective-8, that-4)
nsubj(ineffective-8, dobutamine-5)
aux(ineffective-8, may-6)
cop(ineffective-8, be-7)
ccomp(indicate-3, ineffective-8)
mark(received-14, if-9)
det(patient-11, the-10)
nsubj(received-14, patient-11)
aux(received-14, has-12)
advmod(received-14, recently-13)
advcl(ineffective-8, received-14)
det(span-16, a-15)
dobj(received-14, span-16)
num(drug-20, c65-18)
amod(drug-20, b-blocking-19)
prep_class=(span-16, drug-20)

Preliminary/JJ studies/NNS indicate/VBP that/IN the/DT concomitant/JJ use/NN of/IN dobutamine/NN and/CC nitroprusside/NN results/VBZ in/IN a/DT higher/JJR cardiac/JJ output/NN and/CC ,/, usually/RB ,/, a/DT lower/JJR pulmonary/JJ wedge/NN pressure/NN than/IN when/WRB either/DT drug/NN is/VBZ used/VBN alone/RB ./.

(ROOT (S1 (S (S (NP (JJ Preliminary) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN dobutamine)) (CC and) (NP (NN nitroprusside))))) (VP (VBZ results) (PP (IN in) (NP (NP (DT a) (JJR higher) (JJ cardiac) (NN output)) (CC and) (, ,) (ADVP (RB usually)) (, ,) (NP (NP (DT a) (JJR lower) (JJ pulmonary) (NN wedge) (NN pressure)) (PP (IN than) (SBAR (WHADVP (WRB when)) (S (NP (DT either) (NN drug)) (VP (VBZ is) (VP (VBN used) (ADVP (RB alone))))))))))))))) (. .))))

amod(studies-2, Preliminary-1)
nsubj(indicate-3, studies-2)
root(ROOT-0, indicate-3)
complm(results-12, that-4)
det(use-7, the-5)
amod(use-7, concomitant-6)
nsubj(results-12, use-7)
prep_of(use-7, dobutamine-9)
conj_and(dobutamine-9, nitroprusside-11)
ccomp(indicate-3, results-12)
det(output-17, a-14)
amod(output-17, higher-15)
amod(output-17, cardiac-16)
prep_in(results-12, output-17)
advmod(output-17, usually-20)
conj_and(output-17, usually-20)
det(pressure-26, a-22)
amod(pressure-26, lower-23)
amod(pressure-26, pulmonary-24)
nn(pressure-26, wedge-25)
conj_and(output-17, pressure-26)
advmod(used-32, when-28)
det(drug-30, either-29)
nsubjpass(used-32, drug-30)
auxpass(used-32, is-31)
prepc_than(pressure-26, used-32)
advmod(used-32, alone-33)

There/EX was/VBD no/DT evidence/NN of/IN drug/NN interactions/NNS in/IN clinical/JJ studies/NNS in/IN which/WDT dobutamine/NN was/VBD administered/VBN concurrently/RB with/IN other/JJ drugs/NNS ,/, including/VBG digitalis/NN preparation/NN s/NN ,/, furosemide/NN ,/, spironolactone/NN ,/, lidocaine/NN ,/, glyceryl/NN trinitrate/NN ,/, isosorbide/NN dinitrate/NN ,/, morphine/NN ,/, atropine/NN ,/, heparin/NN ,/, protamine/NN ,/, potassium/NN chloride/NN ,/, folic/JJ acid/NN ,/, and/CC acetaminophen/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (NN drug) (NNS interactions)) (PP (IN in) (NP (NP (JJ clinical) (NNS studies)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN dobutamine)) (VP (VBD was) (VP (VBN administered) (ADVP (RB concurrently)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (, ,) (PP (VBG including) (NP (NP (NN digitalis) (NN preparation) (NN s)) (, ,) (NP (NN furosemide)) (, ,) (NP (NN spironolactone)) (, ,) (NP (NN lidocaine)) (, ,) (NP (NN glyceryl) (NN trinitrate)) (, ,) (NP (NN isosorbide) (NN dinitrate)) (, ,) (NP (NN morphine)) (, ,) (NP (NN atropine)) (, ,) (NP (NN heparin)) (, ,) (NP (NN protamine)) (, ,) (NP (NN potassium) (NN chloride)) (, ,) (NP (JJ folic) (NN acid)) (, ,) (CC and) (NP (NN acetaminophen))))))))))))))))) (. .))))

expl(was-2, There-1)
root(ROOT-0, was-2)
det(evidence-4, no-3)
nsubj(was-2, evidence-4)
nn(interactions-7, drug-6)
prep_of(evidence-4, interactions-7)
amod(studies-10, clinical-9)
prep_in(interactions-7, studies-10)
rel(administered-15, which-12)
nsubjpass(administered-15, dobutamine-13)
auxpass(administered-15, was-14)
rcmod(studies-10, administered-15)
advmod(administered-15, concurrently-16)
amod(drugs-19, other-18)
prep_with(administered-15, drugs-19)
nn(s-24, digitalis-22)
nn(s-24, preparation-23)
prep_including(drugs-19, s-24)
conj_and(s-24, furosemide-26)
conj_and(s-24, spironolactone-28)
conj_and(s-24, lidocaine-30)
nn(trinitrate-33, glyceryl-32)
conj_and(s-24, trinitrate-33)
nn(dinitrate-36, isosorbide-35)
conj_and(s-24, dinitrate-36)
conj_and(s-24, morphine-38)
conj_and(s-24, atropine-40)
conj_and(s-24, heparin-42)
conj_and(s-24, protamine-44)
nn(chloride-47, potassium-46)
conj_and(s-24, chloride-47)
amod(acid-50, folic-49)
conj_and(s-24, acid-50)
conj_and(s-24, acetaminophen-53)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS None/NN known/VBN ./.

(ROOT (S1 (S (S (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (VP (NN None) (VBN known))) (. .))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
nsubj(known-6, Interactions-4)
dep(known-6, None-5)
root(ROOT-0, known-6)

Drug-Drug/JJ Interactions/NNS Cimetidine/NN :/: Concomitant/JJ use/NN of/IN cimetidine/NN is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (S (S (NP (JJ Drug-Drug) (NNS Interactions)) (NP (NN Cimetidine))) (: :) (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NN cimetidine)))) (VP (VBZ is) (VP (VBN contraindicated))))) (. .))))

amod(Interactions-2, Drug-Drug-1)
dep(Cimetidine-3, Interactions-2)
root(ROOT-0, Cimetidine-3)
amod(use-6, Concomitant-5)
nsubjpass(contraindicated-10, use-6)
prep_of(use-6, cimetidine-8)
auxpass(contraindicated-10, is-9)
parataxis(Cimetidine-3, contraindicated-10)

Cimetidine/NN at/IN 400/CD mg/NN BID/JJ (/-LRB- the/DT usual/JJ prescription/NN dose/NN )/-RRB- co-administered/VBN with/IN TIKOSYN/NN (/-LRB- 500/CD mcg/NN BID/JJ )/-RRB- for/IN 7/CD days/NNS has/VBZ been/VBN shown/VBN to/TO increase/VB dofetilide/NN plasma/NN levels/NNS by/IN 58/CD %./NN

(ROOT (S1 (S (NP (NP (NN Cimetidine)) (PP (IN at) (NP (NP (NP (CD 400) (NN mg) (JJ BID)) (PRN (-LRB- -LRB-) (NP (DT the) (JJ usual) (NN prescription) (NN dose)) (-RRB- -RRB-))) (VP (VBN co-administered) (PP (IN with) (NP (NP (NN TIKOSYN)) (PRN (-LRB- -LRB-) (NP (CD 500) (NN mcg) (JJ BID)) (-RRB- -RRB-))))))) (PP (IN for) (NP (CD 7) (NNS days)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB increase) (NP (NN dofetilide) (NN plasma) (NNS levels)) (PP (IN by) (NP (CD 58) (NN %.))))))))))))

nsubjpass(shown-25, Cimetidine-1)
xsubj(increase-27, Cimetidine-1)
num(mg-4, 400-3)
prep_at(Cimetidine-1, mg-4)
amod(mg-4, BID-5)
det(dose-10, the-7)
amod(dose-10, usual-8)
nn(dose-10, prescription-9)
appos(mg-4, dose-10)
partmod(mg-4, co-administered-12)
prep_with(co-administered-12, TIKOSYN-14)
num(mcg-17, 500-16)
appos(TIKOSYN-14, mcg-17)
amod(mcg-17, BID-18)
num(days-22, 7-21)
prep_for(Cimetidine-1, days-22)
aux(shown-25, has-23)
auxpass(shown-25, been-24)
root(ROOT-0, shown-25)
aux(increase-27, to-26)
xcomp(shown-25, increase-27)
nn(levels-30, dofetilide-28)
nn(levels-30, plasma-29)
dobj(increase-27, levels-30)
num(%.-33, 58-32)
prep_by(increase-27, %.-33)

Cimetidine/NN at/IN doses/NNS of/IN 100/CD mg/NN BID/NN (/-LRB- OTC/NN dose/NN )/-RRB- resulted/VBD in/IN a/DT 13/CD %/NN increase/NN in/IN dofetilide/NN plasma/NN levels/NNS (/-LRB- 500/CD mcg/NN single/JJ dose/NN )./CD

(ROOT (S1 (S (NP (NP (NN Cimetidine)) (PP (IN at) (NP (NP (NNS doses)) (PP (IN of) (NP (NP (ADJP (CD 100) (NN mg)) (NN BID)) (PRN (-LRB- -LRB-) (NP (NN OTC) (NN dose)) (-RRB- -RRB-))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (ADJP (CD 13) (NN %)) (NN increase)) (PP (IN in) (NP (NN dofetilide) (NN plasma) (NNS levels)))))) (PRN (-LRB- -LRB-) (NP (CD 500) (NN mcg) (JJ single) (NN dose) (CD -RRB-.))))))

nsubj(resulted-12, Cimetidine-1)
prep_at(Cimetidine-1, doses-3)
number(mg-6, 100-5)
amod(BID-7, mg-6)
prep_of(doses-3, BID-7)
nn(dose-10, OTC-9)
abbrev(BID-7, dose-10)
root(ROOT-0, resulted-12)
det(increase-17, a-14)
number(%-16, 13-15)
amod(increase-17, %-16)
prep_in(resulted-12, increase-17)
nn(levels-21, dofetilide-19)
nn(levels-21, plasma-20)
prep_in(increase-17, levels-21)
num(dose-26, 500-23)
nn(dose-26, mcg-24)
amod(dose-26, single-25)
dep(resulted-12, dose-26)
num(dose-26, -RRB-.-27)

No/DT studies/NNS have/VBP been/VBN conducted/VBN at/IN intermediate/JJ doses/NNS of/IN cimetidine/NN ./.

(ROOT (S1 (S (S (NP (DT No) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN conducted) (PP (IN at) (NP (NP (JJ intermediate) (NNS doses)) (PP (IN of) (NP (NN cimetidine))))))))) (. .))))

det(studies-2, No-1)
nsubjpass(conducted-5, studies-2)
aux(conducted-5, have-3)
auxpass(conducted-5, been-4)
root(ROOT-0, conducted-5)
amod(doses-8, intermediate-7)
prep_at(conducted-5, doses-8)
prep_of(doses-8, cimetidine-10)

If/IN a/DT patient/NN requires/VBZ TIKOSYN/NN and/CC anti-ulcer/NN therapy/NN ,/, it/PRP is/VBZ suggested/VBN that/IN omeprazole/NN ,/, ranitidine/NN ,/, or/CC antacids/NNS (/-LRB- aluminum/NN and/CC magnesium/NN hydroxide/NN s/NN )/-RRB- be/VB used/VBN as/IN alternatives/NNS to/TO cimetidine/NN ,/, as/IN these/DT agents/NNS have/VBP no/DT effect/NN on/IN the/DT pharmacokinetic/JJ profile/NN of/IN TIKOSYN/NN ./.

(ROOT (S1 (S (SBAR (IN If) (S (NP (DT a) (NN patient)) (VP (VBZ requires) (NP (NP (NN TIKOSYN)) (CC and) (NP (NN anti-ulcer) (NN therapy)))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN suggested) (SBAR (IN that) (S (NP (NP (NN omeprazole)) (, ,) (NP (NN ranitidine)) (, ,) (CC or) (NP (NP (NNS antacids)) (PRN (-LRB- -LRB-) (NP (NP (NN aluminum)) (CC and) (NP (NN magnesium) (NN hydroxide) (NN s))) (-RRB- -RRB-)))) (VP (VB be) (VP (VBN used) (PP (IN as) (NP (NP (NNS alternatives)) (PP (TO to) (NP (NN cimetidine))))) (, ,) (SBAR (IN as) (S (NP (DT these) (NNS agents)) (VP (VBP have) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (JJ pharmacokinetic) (NN profile)) (PP (IN of) (NP (NN TIKOSYN)))))))))))))) (. .))))

mark(requires-4, If-1)
det(patient-3, a-2)
nsubj(requires-4, patient-3)
advcl(suggested-12, requires-4)
dobj(requires-4, TIKOSYN-5)
nn(therapy-8, anti-ulcer-7)
conj_and(TIKOSYN-5, therapy-8)
nsubjpass(suggested-12, it-10)
auxpass(suggested-12, is-11)
root(ROOT-0, suggested-12)
complm(used-28, that-13)
nsubjpass(used-28, omeprazole-14)
conj_or(omeprazole-14, ranitidine-16)
conj_or(omeprazole-14, antacids-19)
dep(antacids-19, aluminum-21)
nn(s-25, magnesium-23)
nn(s-25, hydroxide-24)
conj_and(aluminum-21, s-25)
auxpass(used-28, be-27)
ccomp(suggested-12, used-28)
prep_as(used-28, alternatives-30)
prep_to(alternatives-30, cimetidine-32)
mark(have-37, as-34)
det(agents-36, these-35)
nsubj(have-37, agents-36)
advcl(used-28, have-37)
det(effect-39, no-38)
dobj(have-37, effect-39)
det(profile-43, the-41)
amod(profile-43, pharmacokinetic-42)
prep_on(have-37, profile-43)
prep_of(profile-43, TIKOSYN-45)

Verapamil/NN :/: Concomitant/JJ use/NN of/IN verapamil/NN is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (NP (NP (NN Verapamil)) (: :) (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NN verapamil)))) (VP (VBZ is) (VP (VBN contraindicated)))) (. .)))))

root(ROOT-0, Verapamil-1)
amod(use-4, Concomitant-3)
nsubjpass(contraindicated-8, use-4)
prep_of(use-4, verapamil-6)
auxpass(contraindicated-8, is-7)
dep(Verapamil-1, contraindicated-8)

Co-administration/NN of/IN TIKOSYN/NN with/IN verapamil/NN resulted/VBD in/IN increases/NNS in/IN dofetilide/NN peak/NN plasma/NN levels/NNS of/IN 42/CD %/NN ,/, although/IN overall/JJ exposure/NN to/TO dofetilide/NN was/VBD not/RB significantly/RB increased/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NN TIKOSYN))) (PP (IN with) (NP (NN verapamil)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (NN dofetilide) (NN peak) (NN plasma) (NNS levels)) (PP (IN of) (NP (CD 42) (NN %))))))) (, ,) (SBAR (IN although) (S (NP (NP (JJ overall) (NN exposure)) (PP (TO to) (NP (NN dofetilide)))) (VP (VBD was) (RB not) (ADVP (RB significantly)) (VP (VBN increased))))))) (. .))))

nsubj(resulted-6, Co-administration-1)
prep_of(Co-administration-1, TIKOSYN-3)
prep_with(Co-administration-1, verapamil-5)
root(ROOT-0, resulted-6)
prep_in(resulted-6, increases-8)
nn(levels-13, dofetilide-10)
nn(levels-13, peak-11)
nn(levels-13, plasma-12)
prep_in(increases-8, levels-13)
num(%-16, 42-15)
prep_of(levels-13, %-16)
mark(increased-26, although-18)
amod(exposure-20, overall-19)
nsubjpass(increased-26, exposure-20)
prep_to(exposure-20, dofetilide-22)
auxpass(increased-26, was-23)
neg(increased-26, not-24)
advmod(increased-26, significantly-25)
advcl(resulted-6, increased-26)

In/IN an/DT analysis/NN of/IN the/DT supraventricular/JJ arrhythmia/NNS and/CC DIAMOND/JJ patient/NN populations/NNS ,/, the/DT concomitant/JJ administration/NN of/IN verapamil/NN with/IN dofetilide/NN was/VBD associated/VBN with/IN a/DT higher/JJR occurrence/NN of/IN torsade/NN de/NN pointes/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT an) (NN analysis)) (PP (IN of) (NP (NP (DT the) (JJ supraventricular) (NNS arrhythmia)) (CC and) (NP (JJ DIAMOND) (NN patient) (NNS populations)))))) (, ,) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN verapamil))) (PP (IN with) (NP (NN dofetilide)))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJR higher) (NN occurrence)) (PP (IN of) (NP (NN torsade) (NN de) (NNS pointes)))))))) (. .))))

det(analysis-3, an-2)
prep_in(associated-21, analysis-3)
det(arrhythmia-7, the-5)
amod(arrhythmia-7, supraventricular-6)
prep_of(analysis-3, arrhythmia-7)
amod(populations-11, DIAMOND-9)
nn(populations-11, patient-10)
conj_and(arrhythmia-7, populations-11)
det(administration-15, the-13)
amod(administration-15, concomitant-14)
nsubjpass(associated-21, administration-15)
prep_of(administration-15, verapamil-17)
prep_with(administration-15, dofetilide-19)
auxpass(associated-21, was-20)
root(ROOT-0, associated-21)
det(occurrence-25, a-23)
amod(occurrence-25, higher-24)
prep_with(associated-21, occurrence-25)
nn(pointes-29, torsade-27)
nn(pointes-29, de-28)
prep_of(occurrence-25, pointes-29)

Ketoconazole/NN :/: Concomitant/JJ use/NN of/IN ketoconazole/NN is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (NP (NP (NN Ketoconazole)) (: :) (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NN ketoconazole)))) (VP (VBZ is) (VP (VBN contraindicated)))) (. .)))))

root(ROOT-0, Ketoconazole-1)
amod(use-4, Concomitant-3)
nsubjpass(contraindicated-8, use-4)
prep_of(use-4, ketoconazole-6)
auxpass(contraindicated-8, is-7)
dep(Ketoconazole-1, contraindicated-8)

Ketoconazole/NN at/IN 400/CD mg/NN daily/RB (/-LRB- the/DT maximum/JJ approved/JJ prescription/NN dose/NN )/-RRB- co-administered/VBN with/IN TIKOSYN/NN (/-LRB- 500/CD mcg/NN BID/JJ )/-RRB- for/IN 7/CD days/NNS has/VBZ been/VBN shown/VBN to/TO increase/VB dofetilide/NN Cmax/NN by/IN 53/CD %/NN in/IN males/NNS and/CC 97/CD %/NN in/IN females/NNS ,/, and/CC AUC/NN by/IN 41/CD %/NN in/IN males/NNS and/CC 69/CD %/NN in/IN females/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Ketoconazole)) (PP (IN at) (NP (NP (NP (CD 400) (NN mg) (RB daily)) (PRN (-LRB- -LRB-) (NP (DT the) (JJ maximum) (JJ approved) (NN prescription) (NN dose)) (-RRB- -RRB-))) (VP (VBN co-administered) (PP (IN with) (NP (NP (NN TIKOSYN)) (PRN (-LRB- -LRB-) (NP (CD 500) (NN mcg) (JJ BID)) (-RRB- -RRB-)))) (PP (IN for) (NP (CD 7) (NNS days))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB increase) (NP (NP (NP (NN dofetilide) (NN Cmax)) (PP (IN by) (NP (NP (NP (CD 53) (NN %)) (PP (IN in) (NP (NNS males)))) (CC and) (NP (NP (CD 97) (NN %)) (PP (IN in) (NP (NNS females))))))) (, ,) (CC and) (NP (NN AUC))) (PP (IN by) (NP (NP (NP (CD 41) (NN %)) (PP (IN in) (NP (NNS males)))) (CC and) (NP (NP (CD 69) (NN %)) (PP (IN in) (NP (NNS females))))))))))))) (. .))))

nsubjpass(shown-26, Ketoconazole-1)
xsubj(increase-28, Ketoconazole-1)
num(mg-4, 400-3)
prep_at(Ketoconazole-1, mg-4)
advmod(mg-4, daily-5)
det(dose-11, the-7)
amod(dose-11, maximum-8)
amod(dose-11, approved-9)
nn(dose-11, prescription-10)
appos(mg-4, dose-11)
partmod(mg-4, co-administered-13)
prep_with(co-administered-13, TIKOSYN-15)
num(mcg-18, 500-17)
appos(TIKOSYN-15, mcg-18)
amod(mcg-18, BID-19)
num(days-23, 7-22)
prep_for(co-administered-13, days-23)
aux(shown-26, has-24)
auxpass(shown-26, been-25)
root(ROOT-0, shown-26)
aux(increase-28, to-27)
xcomp(shown-26, increase-28)
nn(Cmax-30, dofetilide-29)
dobj(increase-28, Cmax-30)
num(%-33, 53-32)
prep_by(Cmax-30, %-33)
prep_in(%-33, males-35)
num(%-38, 97-37)
conj_and(%-33, %-38)
prep_in(%-38, females-40)
conj_and(Cmax-30, AUC-43)
num(%-46, 41-45)
prep_by(increase-28, %-46)
prep_in(%-46, males-48)
num(%-51, 69-50)
conj_and(%-46, %-51)
prep_in(%-51, females-53)

Trimethoprim/NN Alone/RB or/CC in/IN Combination/NN with/IN Sulfamethoxazole/NN :/: Concomitant/JJ use/NN of/IN trimethoprim/NN alone/RB or/CC in/IN combination/NN with/IN sulfamethoxazole/NN is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (NP (NP (NP (NN Trimethoprim)) (UCP (ADVP (RB Alone)) (CC or) (PP (IN in) (NP (NP (NN Combination)) (PP (IN with) (NP (NN Sulfamethoxazole))))))) (: :) (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NN trimethoprim))) (UCP (ADVP (RB alone)) (CC or) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN sulfamethoxazole))))))) (VP (VBZ is) (VP (VBN contraindicated)))) (. .)))))

root(ROOT-0, Trimethoprim-1)
dep(Trimethoprim-1, Alone-2)
conj_or(Alone-2, in-4)
pobj(in-4, Combination-5)
prep_with(Combination-5, Sulfamethoxazole-7)
amod(use-10, Concomitant-9)
nsubjpass(contraindicated-20, use-10)
prep_of(use-10, trimethoprim-12)
dep(use-10, alone-13)
conj_or(alone-13, in-15)
pobj(in-15, combination-16)
prep_with(combination-16, sulfamethoxazole-18)
auxpass(contraindicated-20, is-19)
dep(Trimethoprim-1, contraindicated-20)

Trimethoprim/NN 160/CD mg/NN in/IN combination/NN with/IN 800/CD mg/NN sulfamethoxazole/NN co-administered/NN BID/NN with/IN TIKOSYN/NN (/-LRB- 500/CD mcg/NN BID/JJ )/-RRB- for/IN 4/CD days/NNS has/VBZ been/VBN shown/VBN to/TO increase/VB dofetilide/NN AUC/NN by/IN 103/CD %/NN and/CC Cmax/NN by/IN 93/CD %./NN

(ROOT (S1 (S (NP (NP (NN Trimethoprim) (CD 160) (NN mg)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (ADJP (CD 800) (NN mg)) (NN sulfamethoxazole) (NN co-administered) (NN BID))) (PP (IN with) (NP (NP (NN TIKOSYN)) (PRN (-LRB- -LRB-) (NP (CD 500) (NN mcg) (JJ BID)) (-RRB- -RRB-)))))) (PP (IN for) (NP (CD 4) (NNS days)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB increase) (NP (NP (NP (NN dofetilide) (NN AUC)) (PP (IN by) (NP (CD 103) (NN %)))) (CC and) (NP (NN Cmax))) (PP (IN by) (NP (CD 93) (NN %.))))))))))))

nn(mg-3, Trimethoprim-1)
num(mg-3, 160-2)
nsubjpass(shown-24, mg-3)
xsubj(increase-26, mg-3)
prep_in(mg-3, combination-5)
number(mg-8, 800-7)
amod(BID-11, mg-8)
nn(BID-11, sulfamethoxazole-9)
nn(BID-11, co-administered-10)
prep_with(combination-5, BID-11)
prep_with(combination-5, TIKOSYN-13)
num(mcg-16, 500-15)
appos(TIKOSYN-13, mcg-16)
amod(mcg-16, BID-17)
num(days-21, 4-20)
prep_for(mg-3, days-21)
aux(shown-24, has-22)
auxpass(shown-24, been-23)
root(ROOT-0, shown-24)
aux(increase-26, to-25)
xcomp(shown-24, increase-26)
nn(AUC-28, dofetilide-27)
dobj(increase-26, AUC-28)
num(%-31, 103-30)
prep_by(AUC-28, %-31)
conj_and(AUC-28, Cmax-33)
num(%.-36, 93-35)
prep_by(increase-26, %.-36)

Hydrochlorothiazide/NN (/-LRB- HCTZ/NN )/-RRB- Alone/RB or/CC in/IN Combination/NN with/IN Triamterene/NN :/: Concomitant/JJ use/NN of/IN HCTZ/NN alone/RB or/CC in/IN combination/NN with/IN triamterene/NN is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Hydrochlorothiazide)) (PRN (-LRB- -LRB-) (NP (NN HCTZ)) (-RRB- -RRB-))) (UCP (ADVP (RB Alone)) (CC or) (PP (IN in) (NP (NP (NN Combination)) (PP (IN with) (NP (NN Triamterene))))))) (: :) (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NN HCTZ))) (UCP (ADVP (RB alone)) (CC or) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN triamterene))))))) (VP (VBZ is) (VP (VBN contraindicated)))) (. .))))

nsubjpass(contraindicated-23, Hydrochlorothiazide-1)
abbrev(Hydrochlorothiazide-1, HCTZ-3)
dep(Hydrochlorothiazide-1, Alone-5)
conj_or(Alone-5, in-7)
pobj(in-7, Combination-8)
prep_with(Combination-8, Triamterene-10)
amod(use-13, Concomitant-12)
nsubjpass(contraindicated-23, use-13)
prep_of(use-13, HCTZ-15)
dep(use-13, alone-16)
conj_or(alone-16, in-18)
pobj(in-18, combination-19)
prep_with(combination-19, triamterene-21)
auxpass(contraindicated-23, is-22)
root(ROOT-0, contraindicated-23)

HCTZ/NN 50/CD mg/NN QD/NN or/CC HCTZ/NN /triamterene/NN 50/100/NN mg/NN QD/NN was/VBD co-administered/VBN with/IN TIKOSYN/NN (/-LRB- 500/CD mcg/NN BID/JJ )/-RRB- for/IN 5/CD days/NNS (/-LRB- following/VBG 2/CD days/NNS of/IN diuretic/JJ use/NN at/IN half/NN dose/NN )./NN

(ROOT (S1 (S (NP (NN HCTZ) (NP (ADJP (CD 50) (NN mg)) (NN QD)) (CC or) (NP (NN HCTZ)) (NP (NN /triamterene) (NN 50/100) (NN mg) (NN QD))) (VP (VBD was) (VP (VBN co-administered) (PP (IN with) (NP (NP (NN TIKOSYN)) (PRN (-LRB- -LRB-) (NP (CD 500) (NN mcg) (JJ BID)) (-RRB- -RRB-)))) (PP (IN for) (NP (NP (CD 5) (NNS days)) (-LRB- -LRB-) (PP (VBG following) (NP (NP (CD 2) (NNS days)) (PP (IN of) (NP (NP (JJ diuretic) (NN use)) (PP (IN at) (NP (NN half) (NN dose) (NN -RRB-.))))))))))))))

nsubjpass(co-administered-12, HCTZ-1)
number(mg-3, 50-2)
amod(QD-4, mg-3)
dep(HCTZ-1, QD-4)
conj_or(HCTZ-1, HCTZ-6)
nn(QD-10, /triamterene-7)
nn(QD-10, 50/100-8)
nn(QD-10, mg-9)
dep(HCTZ-1, QD-10)
auxpass(co-administered-12, was-11)
root(ROOT-0, co-administered-12)
prep_with(co-administered-12, TIKOSYN-14)
num(mcg-17, 500-16)
appos(TIKOSYN-14, mcg-17)
amod(mcg-17, BID-18)
num(days-22, 5-21)
prep_for(co-administered-12, days-22)
num(days-26, 2-25)
prep_following(days-22, days-26)
amod(use-29, diuretic-28)
prep_of(days-26, use-29)
nn(-RRB-.-33, half-31)
nn(-RRB-.-33, dose-32)
prep_at(use-29, -RRB-.-33)

In/IN patients/NNS receiving/VBG HCTZ/NN alone/RB ,/, dofetilide/NN AUC/NN increased/VBN by/IN 27/CD %/NN and/CC Cmax/NN by/IN 21/CD %./NN

(ROOT (S1 (S (PP (IN In) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN HCTZ)) (ADVP (RB alone)))))) (, ,) (NP (NP (NN dofetilide) (NN AUC)) (VP (VBN increased) (PP (IN by) (NP (NP (CD 27) (NN %)) (CC and) (NP (NN Cmax)))) (PP (IN by) (NP (CD 21) (NN %.))))))))

dep(AUC-8, In-1)
pobj(In-1, patients-2)
partmod(patients-2, receiving-3)
dobj(receiving-3, HCTZ-4)
advmod(HCTZ-4, alone-5)
nn(AUC-8, dofetilide-7)
root(ROOT-0, AUC-8)
partmod(AUC-8, increased-9)
num(%-12, 27-11)
agent(increased-9, %-12)
conj_and(%-12, Cmax-14)
num(%.-17, 21-16)
agent(increased-9, %.-17)

In/IN patients/NNS receiving/VBG HCTZ/NN in/IN combination/NN with/IN triamterene/NN ,/, dofetilide/NN AUC/NN increased/VBD by/IN 30/CD %/NN and/CC Cmax/NN by/IN 16/CD %./NN

(ROOT (S1 (S (PP (IN In) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN HCTZ)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN triamterene)))))))) (, ,) (NP (NN dofetilide) (NN AUC)) (VP (VBD increased) (PP (IN by) (NP (NP (CD 30) (NN %)) (CC and) (NP (NN Cmax)))) (PP (IN by) (NP (CD 16) (NN %.)))))))

prep_in(increased-12, patients-2)
partmod(patients-2, receiving-3)
dobj(receiving-3, HCTZ-4)
prep_in(receiving-3, combination-6)
prep_with(combination-6, triamterene-8)
nn(AUC-11, dofetilide-10)
nsubj(increased-12, AUC-11)
root(ROOT-0, increased-12)
num(%-15, 30-14)
prep_by(increased-12, %-15)
conj_and(%-15, Cmax-17)
num(%.-20, 16-19)
prep_by(increased-12, %.-20)

The/DT pharmacodynamic/JJ effects/NNS can/MD be/VB explained/VBN by/IN a/DT combination/NN of/IN the/DT increase/NN in/IN dofetilide/NN exposure/NN and/CC the/DT reductions/NNS in/IN serum/NN potassium/NN ./.

(ROOT (S1 (S (S (NP (DT The) (JJ pharmacodynamic) (NNS effects)) (VP (MD can) (VP (VB be) (VP (VBN explained) (PP (IN by) (NP (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NN dofetilide) (NN exposure)))))) (CC and) (NP (NP (DT the) (NNS reductions)) (PP (IN in) (NP (NN serum) (NN potassium)))))))))) (. .))))

det(effects-3, The-1)
amod(effects-3, pharmacodynamic-2)
nsubjpass(explained-6, effects-3)
aux(explained-6, can-4)
auxpass(explained-6, be-5)
root(ROOT-0, explained-6)
det(combination-9, a-8)
agent(explained-6, combination-9)
det(increase-12, the-11)
prep_of(combination-9, increase-12)
nn(exposure-15, dofetilide-14)
prep_in(increase-12, exposure-15)
det(reductions-18, the-17)
conj_and(combination-9, reductions-18)
nn(potassium-21, serum-20)
prep_in(reductions-18, potassium-21)

In/IN the/DT DIAMOND/JJ trials/NNS ,/, 1252/CD patients/NNS were/VBD treated/VBN with/IN TIKOSYN/NN and/CC diuretics/NN concomitantly/RB of/IN whom/WP 493/CD died/VBD compared/VBN to/TO 508/CD deaths/NNS among/IN the/DT 1248/CD patients/NNS receiving/VBG placebo/NN and/CC diuretics/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (DT the) (JJ DIAMOND) (NNS trials))) (, ,) (NP (CD 1252) (NNS patients)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NN TIKOSYN)) (CC and) (NP (NN diuretics)))) (ADVP (ADVP (RB concomitantly)) (SBAR (WHPP (IN of) (WHNP (WP whom))) (S (NP (CD 493)) (VP (VBD died) (PP (VBN compared) (PP (TO to) (NP (NP (CD 508) (NNS deaths)) (PP (IN among) (NP (NP (DT the) (CD 1248) (NNS patients)) (VP (VBG receiving) (NP (NP (NN placebo)) (CC and) (NP (NN diuretics))))))))))))))) (. .))))

det(trials-4, the-2)
amod(trials-4, DIAMOND-3)
prep_in(treated-9, trials-4)
num(patients-7, 1252-6)
nsubjpass(treated-9, patients-7)
auxpass(treated-9, were-8)
root(ROOT-0, treated-9)
prep_with(treated-9, TIKOSYN-11)
conj_and(TIKOSYN-11, diuretics-13)
advmod(treated-9, concomitantly-14)
dep(died-18, of-15)
pobj(of-15, whom-16)
nsubj(died-18, 493-17)
dep(concomitantly-14, died-18)
prepc_compared_to(died-18, to-20)
num(deaths-22, 508-21)
pobj(died-18, deaths-22)
det(patients-26, the-24)
num(patients-26, 1248-25)
prep_among(deaths-22, patients-26)
partmod(patients-26, receiving-27)
dobj(receiving-27, placebo-28)
conj_and(placebo-28, diuretics-30)

Of/IN the/DT 229/CD patients/NNS who/WP had/VBD potassium/NN depleting/VBG diuretics/NNS added/VBN to/TO their/PRP$ concomitant/JJ medications/NNS in/IN the/DT DIAMOND/JJ trials/NNS ,/, the/DT patients/NNS on/IN TIKOSYN/NN had/VBD a/DT non-significantly/RB reduced/VBN relative/JJ risk/NN for/IN death/NN of/IN 0.68/CD (/-LRB- 95/CD %/NN CI/NN 0.376/CD ,/, 1.230/CD )./NN

(ROOT (S1 (S (PP (IN Of) (NP (NP (DT the) (CD 229) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (NP (NP (NN potassium) (VBG depleting) (NNS diuretics)) (VP (VBN added) (PP (TO to) (NP (NP (PRP$ their) (JJ concomitant) (NNS medications)) (PP (IN in) (NP (DT the) (JJ DIAMOND) (NNS trials)))))))))))) (, ,) (NP (NP (DT the) (NNS patients)) (PP (IN on) (NP (NN TIKOSYN)))) (VP (VBD had) (NP (NP (DT a) (ADJP (RB non-significantly) (VBN reduced)) (JJ relative) (NN risk)) (PP (IN for) (NP (NP (NN death)) (PP (IN of) (NP (CD 0.68))))) (PRN (-LRB- -LRB-) (NP (CD 95) (NN %) (NN CI) (CD 0.376)) (, ,) (NP (CD 1.230) (NN -RRB-.))))))))

det(patients-4, the-2)
num(patients-4, 229-3)
nsubj(had-6, patients-4)
prep_of(had-24, patients-4)
rcmod(patients-4, had-6)
nn(diuretics-9, potassium-7)
amod(diuretics-9, depleting-8)
dobj(had-6, diuretics-9)
partmod(diuretics-9, added-10)
poss(medications-14, their-12)
amod(medications-14, concomitant-13)
prep_to(added-10, medications-14)
det(trials-18, the-16)
amod(trials-18, DIAMOND-17)
prep_in(medications-14, trials-18)
det(patients-21, the-20)
nsubj(had-24, patients-21)
prep_on(patients-21, TIKOSYN-23)
root(ROOT-0, had-24)
det(risk-29, a-25)
advmod(reduced-27, non-significantly-26)
amod(risk-29, reduced-27)
amod(risk-29, relative-28)
dobj(had-24, risk-29)
prep_for(risk-29, death-31)
prep_of(death-31, 0.68-33)
num(CI-37, 95-35)
nn(CI-37, %-36)
dep(risk-29, CI-37)
num(CI-37, 0.376-38)
num(-RRB-.-41, 1.230-40)
dep(CI-37, -RRB-.-41)

Potential/JJ Drug/NN Interactions/NNS Dofetilide/NN is/VBZ eliminated/VBN in/IN the/DT kidney/NN by/IN cation/JJ ic/NN secretion/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Potential) (NN Drug) (NNS Interactions)) (NN Dofetilide)) (VP (VBZ is) (VP (VBN eliminated) (PP (IN in) (NP (DT the) (NN kidney))) (PP (IN by) (NP (JJ cation) (NN ic) (NN secretion)))))) (. .))))

amod(Interactions-3, Potential-1)
nn(Interactions-3, Drug-2)
nn(Dofetilide-4, Interactions-3)
nsubjpass(eliminated-6, Dofetilide-4)
auxpass(eliminated-6, is-5)
root(ROOT-0, eliminated-6)
det(kidney-9, the-8)
prep_in(eliminated-6, kidney-9)
amod(secretion-13, cation-11)
nn(secretion-13, ic-12)
agent(eliminated-6, secretion-13)

Inhibitors/NNS of/IN renal/JJ cation/NN ic/NN secretion/NN are/VBP contraindicated/VBN with/IN TIKOSYN/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Inhibitors)) (PP (IN of) (NP (JJ renal) (NN cation) (NN ic) (NN secretion)))) (VP (VBP are) (VP (VBN contraindicated) (PP (IN with) (NP (NN TIKOSYN)))))) (. .))))

nsubjpass(contraindicated-8, Inhibitors-1)
amod(secretion-6, renal-3)
nn(secretion-6, cation-4)
nn(secretion-6, ic-5)
prep_of(Inhibitors-1, secretion-6)
auxpass(contraindicated-8, are-7)
root(ROOT-0, contraindicated-8)
prep_with(contraindicated-8, TIKOSYN-10)

In/IN addition/NN ,/, drugs/NNS that/WDT are/VBP actively/RB secreted/VBN via/IN this/DT route/NN (/-LRB- e.g./FW ,/, triamterene/NN ,/, metformin/NN and/CC amiloride/NN )/-RRB- should/MD be/VB co-administered/VBN with/IN care/NN as/IN they/PRP might/MD increase/VB dofetilide/NN levels/NNS ./.

(ROOT (S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB actively)) (VP (VBN secreted) (PP (IN via) (NP (NP (DT this) (NN route)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN triamterene)) (, ,) (NP (NN metformin)) (CC and) (NP (NN amiloride)))) (-RRB- -RRB-))))))))) (VP (MD should) (VP (VB be) (VP (VBN co-administered) (PP (IN with) (NP (NN care))) (SBAR (IN as) (S (NP (PRP they)) (VP (MD might) (VP (VB increase) (NP (NN dofetilide) (NNS levels))))))))) (. .))))

prep_in(co-administered-23, addition-2)
nsubjpass(secreted-8, drugs-4)
nsubjpass(co-administered-23, drugs-4)
auxpass(secreted-8, are-6)
advmod(secreted-8, actively-7)
rcmod(drugs-4, secreted-8)
det(route-11, this-10)
prep_via(secreted-8, route-11)
dep(route-11, e.g.-13)
pobj(e.g.-13, triamterene-15)
conj_and(triamterene-15, metformin-17)
conj_and(triamterene-15, amiloride-19)
aux(co-administered-23, should-21)
auxpass(co-administered-23, be-22)
root(ROOT-0, co-administered-23)
prep_with(co-administered-23, care-25)
mark(increase-29, as-26)
nsubj(increase-29, they-27)
aux(increase-29, might-28)
advcl(co-administered-23, increase-29)
nn(levels-31, dofetilide-30)
dobj(increase-29, levels-31)

Dofetilide/NN is/VBZ metabolized/VBN to/TO a/DT small/JJ extent/NN by/IN the/DT CYP3A4/NN isoenzyme/NN of/IN the/DT cytochrome/NN P450/NN system/NN ./.

(ROOT (S1 (S (S (NP (NN Dofetilide)) (VP (VBZ is) (VP (VBN metabolized) (PP (TO to) (NP (DT a) (JJ small) (NN extent))) (PP (IN by) (NP (NP (DT the) (NN CYP3A4) (NN isoenzyme)) (PP (IN of) (NP (DT the) (NN cytochrome) (NN P450) (NN system)))))))) (. .))))

nsubjpass(metabolized-3, Dofetilide-1)
auxpass(metabolized-3, is-2)
root(ROOT-0, metabolized-3)
det(extent-7, a-5)
amod(extent-7, small-6)
prep_to(metabolized-3, extent-7)
det(isoenzyme-11, the-9)
nn(isoenzyme-11, CYP3A4-10)
agent(metabolized-3, isoenzyme-11)
det(system-16, the-13)
nn(system-16, cytochrome-14)
nn(system-16, P450-15)
prep_of(isoenzyme-11, system-16)

Inhibitors/NNS of/IN the/DT CYP3A4/NN isoenzyme/NN could/MD increase/VB systemic/JJ dofetilide/NN exposure/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Inhibitors)) (PP (IN of) (NP (DT the) (NN CYP3A4) (NN isoenzyme)))) (VP (MD could) (VP (VB increase) (NP (JJ systemic) (NN dofetilide) (NN exposure))))) (. .))))

nsubj(increase-7, Inhibitors-1)
det(isoenzyme-5, the-3)
nn(isoenzyme-5, CYP3A4-4)
prep_of(Inhibitors-1, isoenzyme-5)
aux(increase-7, could-6)
root(ROOT-0, increase-7)
amod(exposure-10, systemic-8)
nn(exposure-10, dofetilide-9)
dobj(increase-7, exposure-10)

Inhibitors/NNS of/IN this/DT isoenzyme/NN (/-LRB- e.g./FW ,/, macrolide/NN antibiotics/NNS ,/, azole/JJ antifungal/JJ agents/NNS ,/, protease/NN inhibitors/NNS ,/, serotonin/NN reuptake/NN inhibitors/NNS ,/, amiodarone/NN ,/, cannabinoids/NNS ,/, diltiazem/NN ,/, grapefruit/NN juice/NN ,/, nefazadone/NN ,/, norfloxacin/NN ,/, quinine/NN ,/, zafirlukast/NN )/-RRB- should/MD be/VB cautiously/RB coadministered/VBN with/IN TIKOSYN/NN as/IN they/PRP can/MD potentially/RB increase/VB dofetilide/NN levels/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Inhibitors)) (PP (IN of) (NP (NP (DT this) (NN isoenzyme)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN macrolide) (NNS antibiotics)) (, ,) (NP (JJ azole) (JJ antifungal) (NNS agents)) (, ,) (NP (NN protease) (NNS inhibitors)) (, ,) (NP (NN serotonin) (NN reuptake) (NNS inhibitors)) (, ,) (NP (NN amiodarone)) (, ,) (NP (NNS cannabinoids)) (, ,) (NP (NN diltiazem)) (, ,) (NP (NN grapefruit) (NN juice)) (, ,) (NP (NP (NN nefazadone)) (, ,) (NP (NN norfloxacin)) (, ,) (NP (NN quinine)) (, ,) (NP (NN zafirlukast)))) (-RRB- -RRB-))))) (VP (MD should) (VP (VB be) (ADVP (RB cautiously)) (VP (VBN coadministered) (PP (IN with) (NP (NN TIKOSYN))) (SBAR (IN as) (S (NP (PRP they)) (VP (MD can) (ADVP (RB potentially)) (VP (VB increase) (NP (NN dofetilide) (NNS levels))))))))) (. .))))

nsubjpass(coadministered-42, Inhibitors-1)
det(isoenzyme-4, this-3)
prep_of(Inhibitors-1, isoenzyme-4)
dep(antibiotics-9, e.g.-6)
nn(antibiotics-9, macrolide-8)
dep(isoenzyme-4, antibiotics-9)
amod(agents-13, azole-11)
amod(agents-13, antifungal-12)
appos(antibiotics-9, agents-13)
nn(inhibitors-16, protease-15)
appos(antibiotics-9, inhibitors-16)
nn(inhibitors-20, serotonin-18)
nn(inhibitors-20, reuptake-19)
appos(antibiotics-9, inhibitors-20)
appos(antibiotics-9, amiodarone-22)
appos(antibiotics-9, cannabinoids-24)
appos(antibiotics-9, diltiazem-26)
nn(juice-29, grapefruit-28)
appos(antibiotics-9, juice-29)
appos(antibiotics-9, nefazadone-31)
appos(nefazadone-31, norfloxacin-33)
appos(nefazadone-31, quinine-35)
appos(nefazadone-31, zafirlukast-37)
aux(coadministered-42, should-39)
auxpass(coadministered-42, be-40)
advmod(coadministered-42, cautiously-41)
root(ROOT-0, coadministered-42)
prep_with(coadministered-42, TIKOSYN-44)
mark(increase-49, as-45)
nsubj(increase-49, they-46)
aux(increase-49, can-47)
advmod(increase-49, potentially-48)
advcl(coadministered-42, increase-49)
nn(levels-51, dofetilide-50)
dobj(increase-49, levels-51)

Dofetilide/NN is/VBZ not/RB an/DT inhibitor/NN of/IN CYP3A4/NN nor/CC of/IN other/JJ cytochrome/NN P450/NN isoenzymes/NNS (/-LRB- e.g./FW ,/, CYP2C9/NN ,/, CYP2D6/NNS )/-RRB- and/CC is/VBZ not/RB expected/VBN to/TO increase/VB levels/NNS of/IN drugs/NNS metabolized/VBN by/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Dofetilide)) (VP (VP (VBZ is) (RB not) (NP (NP (DT an) (NN inhibitor)) (PP (PP (IN of) (NP (NN CYP3A4))) (CC nor) (PP (IN of) (NP (NP (JJ other) (NN cytochrome) (NN P450) (NNS isoenzymes)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN CYP2C9))) (, ,) (NP (NNS CYP2D6)) (-RRB- -RRB-))))))) (CC and) (VP (VBZ is) (RB not) (VP (VBN expected) (S (VP (TO to) (VP (VB increase) (NP (NP (NNS levels)) (PP (IN of) (NP (NP (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP3A4)))))))))))))) (. .))))

nsubj(inhibitor-5, Dofetilide-1)
xsubj(increase-26, Dofetilide-1)
cop(inhibitor-5, is-2)
neg(inhibitor-5, not-3)
det(inhibitor-5, an-4)
root(ROOT-0, inhibitor-5)
prep_of(inhibitor-5, CYP3A4-7)
amod(isoenzymes-13, other-10)
nn(isoenzymes-13, cytochrome-11)
nn(isoenzymes-13, P450-12)
conj_nor(CYP3A4-7, isoenzymes-13)
dep(CYP2D6-19, e.g.-15)
pobj(e.g.-15, CYP2C9-17)
appos(isoenzymes-13, CYP2D6-19)
auxpass(expected-24, is-22)
neg(expected-24, not-23)
conj_and(inhibitor-5, expected-24)
aux(increase-26, to-25)
xcomp(expected-24, increase-26)
dobj(increase-26, levels-27)
prep_of(levels-27, drugs-29)
partmod(drugs-29, metabolized-30)
agent(metabolized-30, CYP3A4-32)

Other/JJ Drug/NN Interaction/NN Information/NN Digoxin/NN :/: Studies/NNS in/IN healthy/JJ volunteers/NNS have/VBP shown/VBN that/IN TIKOSYN/NN does/VBZ not/RB affect/VB the/DT pharmacokinetics/NNS of/IN digoxin/NN ./.

(ROOT (S1 (S (NP (NP (JJ Other) (NN Drug) (NN Interaction) (NN Information) (NN Digoxin)) (: :) (S (NP (NP (NNS Studies)) (PP (IN in) (NP (JJ healthy) (NNS volunteers)))) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NN TIKOSYN)) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN digoxin))))))))))) (. .)))))

amod(Digoxin-5, Other-1)
nn(Digoxin-5, Drug-2)
nn(Digoxin-5, Interaction-3)
nn(Digoxin-5, Information-4)
root(ROOT-0, Digoxin-5)
nsubj(shown-12, Studies-7)
amod(volunteers-10, healthy-9)
prep_in(Studies-7, volunteers-10)
aux(shown-12, have-11)
dep(Digoxin-5, shown-12)
complm(affect-17, that-13)
nsubj(affect-17, TIKOSYN-14)
aux(affect-17, does-15)
neg(affect-17, not-16)
ccomp(shown-12, affect-17)
det(pharmacokinetics-19, the-18)
dobj(affect-17, pharmacokinetics-19)
prep_of(pharmacokinetics-19, digoxin-21)

In/IN patients/NNS ,/, the/DT concomitant/JJ administration/NN of/IN digoxin/NN with/IN dofetilide/NN was/VBD associated/VBN with/IN a/DT higher/JJR occurrence/NN of/IN torsade/NN de/NN pointes/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NNS patients))) (, ,) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN digoxin))) (PP (IN with) (NP (NN dofetilide)))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJR higher) (NN occurrence)) (PP (IN of) (NP (NN torsade) (NN de) (NNS pointes)))))))) (. .))))

prep_in(associated-12, patients-2)
det(administration-6, the-4)
amod(administration-6, concomitant-5)
nsubjpass(associated-12, administration-6)
prep_of(administration-6, digoxin-8)
prep_with(administration-6, dofetilide-10)
auxpass(associated-12, was-11)
root(ROOT-0, associated-12)
det(occurrence-16, a-14)
amod(occurrence-16, higher-15)
prep_with(associated-12, occurrence-16)
nn(pointes-20, torsade-18)
nn(pointes-20, de-19)
prep_of(occurrence-16, pointes-20)

It/PRP is/VBZ not/RB clear/JJ whether/IN this/DT represents/VBZ an/DT interaction/NN with/IN TIKOSYN/NN or/CC the/DT presence/NN of/IN more/RBR severe/JJ structural/JJ heart/NN disease/NN in/IN patients/NNS on/IN digoxin/NN ;/: ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (RB not) (ADJP (JJ clear)) (SBAR (IN whether) (S (NP (DT this)) (VP (VBZ represents) (NP (NP (NP (DT an) (NN interaction)) (PP (IN with) (NP (NN TIKOSYN)))) (CC or) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (ADJP (ADJP (RBR more) (JJ severe)) (ADJP (JJ structural))) (NN heart) (NN disease))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN on) (NP (NN digoxin))))))))))) (: ;)) (. .))))

nsubj(clear-4, It-1)
cop(clear-4, is-2)
neg(clear-4, not-3)
root(ROOT-0, clear-4)
complm(represents-7, whether-5)
nsubj(represents-7, this-6)
ccomp(clear-4, represents-7)
det(interaction-9, an-8)
dobj(represents-7, interaction-9)
prep_with(interaction-9, TIKOSYN-11)
det(presence-14, the-13)
conj_or(interaction-9, presence-14)
advmod(severe-17, more-16)
amod(disease-20, severe-17)
dep(severe-17, structural-18)
nn(disease-20, heart-19)
prep_of(presence-14, disease-20)
prep_in(presence-14, patients-22)
prep_on(patients-22, digoxin-24)

No/DT increase/NN in/IN mortality/NN was/VBD observed/VBN in/IN patients/NNS taking/VBG digoxin/NN as/IN concomitant/JJ medication/NN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (NN increase)) (PP (IN in) (NP (NN mortality)))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN digoxin)) (PP (IN as) (NP (JJ concomitant) (NN medication))))))))) (. .))))

det(increase-2, No-1)
nsubjpass(observed-6, increase-2)
prep_in(increase-2, mortality-4)
auxpass(observed-6, was-5)
root(ROOT-0, observed-6)
prep_in(observed-6, patients-8)
partmod(patients-8, taking-9)
dobj(taking-9, digoxin-10)
amod(medication-13, concomitant-12)
prep_as(taking-9, medication-13)

Other/JJ Drugs/NNS :/: In/FW healthy/JJ volunteers/NNS ,/, amlodipine/NN ,/, phenytoin/NN ,/, glyburide/NN ,/, ranitidine/NN ,/, omeprazole/NN ,/, hormone/NN replacement/NN therapy/NN (/-LRB- a/DT combination/NN of/IN conjugated/VBN estrogens/NNS and/CC medroxyprogesterone/NN )/-RRB- ,/, antacid/JJ (/-LRB- aluminum/NN and/CC magnesium/NN hydroxide/NN s/NN )/-RRB- and/CC theophylline/NN did/VBD not/RB affect/VB the/DT pharmacokinetics/NNS of/IN TIKOSYN/NN ./.

(ROOT (S1 (S (NP (NP (JJ Other) (NNS Drugs)) (: :) (S (NP (FW In) (NP (NP (JJ healthy) (NNS volunteers)) (, ,) (NP (NP (NN amlodipine)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN glyburide)) (, ,) (NP (NN ranitidine)) (, ,) (NP (NN omeprazole)) (, ,) (NP (NP (NN hormone) (NN replacement) (NN therapy)) (PRN (-LRB- -LRB-) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP (NP (VBN conjugated) (NNS estrogens)) (CC and) (NP (NN medroxyprogesterone))))) (-RRB- -RRB-))) (, ,) (NP (JJ antacid) (PRN (-LRB- -LRB-) (NP (NP (NN aluminum)) (CC and) (NP (NN magnesium) (NN hydroxide) (NN s))) (-RRB- -RRB-))) (CC and) (NP (NN theophylline))))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN TIKOSYN))))))) (. .)))))

amod(Drugs-2, Other-1)
root(ROOT-0, Drugs-2)
dep(volunteers-6, In-4)
amod(volunteers-6, healthy-5)
nsubj(affect-43, volunteers-6)
appos(volunteers-6, amlodipine-8)
conj_and(amlodipine-8, phenytoin-10)
conj_and(amlodipine-8, glyburide-12)
conj_and(amlodipine-8, ranitidine-14)
conj_and(amlodipine-8, omeprazole-16)
nn(therapy-20, hormone-18)
nn(therapy-20, replacement-19)
conj_and(amlodipine-8, therapy-20)
det(combination-23, a-22)
dep(therapy-20, combination-23)
amod(estrogens-26, conjugated-25)
prep_of(combination-23, estrogens-26)
conj_and(estrogens-26, medroxyprogesterone-28)
amod(aluminum-33, antacid-31)
conj_and(amlodipine-8, aluminum-33)
nn(s-37, magnesium-35)
nn(s-37, hydroxide-36)
conj_and(aluminum-33, s-37)
conj_and(amlodipine-8, theophylline-40)
aux(affect-43, did-41)
neg(affect-43, not-42)
dep(Drugs-2, affect-43)
det(pharmacokinetics-45, the-44)
dobj(affect-43, pharmacokinetics-45)
prep_of(pharmacokinetics-45, TIKOSYN-47)

In/IN addition/NN ,/, studies/NNS in/IN healthy/JJ volunteers/NNS have/VBP shown/VBN that/IN TIKOSYN/NN does/VBZ not/RB affect/VB the/DT pharmacokinetics/NNS or/CC pharmacodynamics/NNS of/IN warfarin/NN ,/, or/CC the/DT pharmacokinetics/NNS of/IN propranolol/NN (/-LRB- 40/CD mg/NN twice/RB daily/RB )/-RRB- ,/, phenytoin/NN ,/, theophylline/NN ,/, or/CC oral/JJ contraceptives/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NNS studies)) (PP (IN in) (NP (JJ healthy) (NNS volunteers)))) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NN TIKOSYN)) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NP (DT the) (NP (NNS pharmacokinetics)) (CC or) (NP (NNS pharmacodynamics))) (PP (IN of) (NP (NP (NN warfarin)) (, ,) (CC or) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN propranolol)) (PRN (-LRB- -LRB-) (NP (NP (CD 40) (NN mg)) (ADVP (RB twice) (RB daily))) (-RRB- -RRB-))))) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN theophylline)) (, ,) (CC or) (NP (JJ oral) (NNS contraceptives)))))))))))) (. .))))

prep_in(shown-9, addition-2)
nsubj(shown-9, studies-4)
amod(volunteers-7, healthy-6)
prep_in(studies-4, volunteers-7)
aux(shown-9, have-8)
root(ROOT-0, shown-9)
complm(affect-14, that-10)
nsubj(affect-14, TIKOSYN-11)
aux(affect-14, does-12)
neg(affect-14, not-13)
ccomp(shown-9, affect-14)
dep(pharmacokinetics-16, the-15)
dobj(affect-14, pharmacokinetics-16)
conj_or(pharmacokinetics-16, pharmacodynamics-18)
prep_of(pharmacokinetics-16, warfarin-20)
det(pharmacokinetics-24, the-23)
conj_or(warfarin-20, pharmacokinetics-24)
prep_of(pharmacokinetics-24, propranolol-26)
num(mg-29, 40-28)
dep(propranolol-26, mg-29)
advmod(daily-31, twice-30)
advmod(mg-29, daily-31)
conj_or(warfarin-20, phenytoin-34)
conj_or(warfarin-20, theophylline-36)
amod(contraceptives-40, oral-39)
conj_or(warfarin-20, contraceptives-40)

Population/NN pharmacokinetic/JJ analyses/NNS were/VBD conducted/VBN on/IN plasma/NN concentration/NN data/NNS from/IN 1445/CD patients/NNS in/IN clinical/JJ trials/NNS to/TO examine/VB the/DT effects/NNS of/IN concomitant/JJ medications/NNS on/IN clearance/NN or/CC volume/NN of/IN distribution/NN of/IN dofetilide/NN ./.

(ROOT (S1 (S (S (NP (NN Population) (JJ pharmacokinetic) (NNS analyses)) (VP (VBD were) (VP (VBN conducted) (PP (IN on) (NP (NP (NN plasma) (NN concentration) (NNS data)) (PP (IN from) (NP (NP (CD 1445) (NNS patients)) (PP (IN in) (NP (JJ clinical) (NNS trials))))))) (S (VP (TO to) (VP (VB examine) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ concomitant) (NNS medications))) (PP (IN on) (NP (NP (NP (NN clearance)) (CC or) (NP (NN volume))) (PP (IN of) (NP (NP (NN distribution)) (PP (IN of) (NP (NN dofetilide)))))))))))))) (. .))))

nn(analyses-3, Population-1)
amod(analyses-3, pharmacokinetic-2)
nsubjpass(conducted-5, analyses-3)
xsubj(examine-17, analyses-3)
auxpass(conducted-5, were-4)
root(ROOT-0, conducted-5)
nn(data-9, plasma-7)
nn(data-9, concentration-8)
prep_on(conducted-5, data-9)
num(patients-12, 1445-11)
prep_from(data-9, patients-12)
amod(trials-15, clinical-14)
prep_in(patients-12, trials-15)
aux(examine-17, to-16)
xcomp(conducted-5, examine-17)
det(effects-19, the-18)
dobj(examine-17, effects-19)
amod(medications-22, concomitant-21)
prep_of(effects-19, medications-22)
prep_on(effects-19, clearance-24)
conj_or(clearance-24, volume-26)
prep_of(clearance-24, distribution-28)
prep_of(distribution-28, dofetilide-30)

Concomitant/JJ medications/NNS were/VBD grouped/VBN as/IN ACE/NN inhibitors/NNS ,/, oral/JJ anticoagulants/NNS ,/, calcium/NN channel/NN blockers/NNS ,/, beta/NN blockers/NNS ,/, cardiac/JJ glycosides/NNS ,/, inducers/NNS of/IN CYP3A4/NN ,/, substrates/NNS and/CC inhibitors/NNS of/IN CYP3A4/NN ,/, substrates/NNS and/CC inhibitors/NNS of/IN P-/NN glycoprotein/NN ,/, nitrates/NNS ,/, sulphonylureas/NN ,/, loop/NN diuretics/NNS ,/, potassium/NN sparing/NN diuretics/NNS ,/, thiazide/NN diuretics/NNS ,/, substrates/NNS and/CC inhibitors/NNS of/IN tubular/JJ organic/JJ cation/NN transport/NN ,/, and/CC QTc-prolonging/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (JJ Concomitant) (NNS medications)) (VP (VBD were) (VP (VBN grouped) (PP (IN as) (FRAG (NP (NN ACE) (NNS inhibitors)) (, ,) (NP (NP (JJ oral) (NNS anticoagulants)) (, ,) (NP (NN calcium) (NN channel) (NNS blockers)) (, ,) (NP (NN beta) (NNS blockers)) (, ,) (NP (JJ cardiac) (NNS glycosides)) (, ,) (NP (NP (NNS inducers)) (PP (IN of) (NP (NN CYP3A4)))) (, ,) (NP (NP (NP (NNS substrates)) (CC and) (NP (NNS inhibitors))) (PP (IN of) (NP (NN CYP3A4)))) (, ,) (NP (NP (NP (NNS substrates)) (CC and) (NP (NNS inhibitors))) (PP (IN of) (NP (NN P-) (NN glycoprotein)))) (, ,) (NP (NNS nitrates)) (, ,) (NP (NN sulphonylureas)) (, ,) (NP (NN loop) (NNS diuretics)) (, ,) (NP (NN potassium) (NN sparing) (NNS diuretics)) (, ,) (NP (NN thiazide) (NNS diuretics)) (, ,) (NP (NP (NP (NNS substrates)) (CC and) (NP (NNS inhibitors))) (PP (IN of) (NP (JJ tubular) (JJ organic) (NN cation) (NN transport)))) (, ,) (CC and) (NP (JJ QTc-prolonging) (NNS drugs)))))))) (. .))))

amod(medications-2, Concomitant-1)
nsubjpass(grouped-4, medications-2)
auxpass(grouped-4, were-3)
root(ROOT-0, grouped-4)
prep(grouped-4, as-5)
nn(inhibitors-7, ACE-6)
dep(as-5, inhibitors-7)
amod(anticoagulants-10, oral-9)
dep(inhibitors-7, anticoagulants-10)
nn(blockers-14, calcium-12)
nn(blockers-14, channel-13)
conj_and(anticoagulants-10, blockers-14)
nn(blockers-17, beta-16)
conj_and(anticoagulants-10, blockers-17)
amod(glycosides-20, cardiac-19)
conj_and(anticoagulants-10, glycosides-20)
conj_and(anticoagulants-10, inducers-22)
prep_of(inducers-22, CYP3A4-24)
conj_and(anticoagulants-10, substrates-26)
conj_and(substrates-26, inhibitors-28)
prep_of(substrates-26, CYP3A4-30)
conj_and(anticoagulants-10, substrates-32)
conj_and(substrates-32, inhibitors-34)
nn(glycoprotein-37, P--36)
prep_of(substrates-32, glycoprotein-37)
conj_and(anticoagulants-10, nitrates-39)
conj_and(anticoagulants-10, sulphonylureas-41)
nn(diuretics-44, loop-43)
conj_and(anticoagulants-10, diuretics-44)
nn(diuretics-48, potassium-46)
nn(diuretics-48, sparing-47)
conj_and(anticoagulants-10, diuretics-48)
nn(diuretics-51, thiazide-50)
conj_and(anticoagulants-10, diuretics-51)
conj_and(anticoagulants-10, substrates-53)
conj_and(substrates-53, inhibitors-55)
amod(transport-60, tubular-57)
amod(transport-60, organic-58)
nn(transport-60, cation-59)
prep_of(substrates-53, transport-60)
amod(drugs-64, QTc-prolonging-63)
conj_and(anticoagulants-10, drugs-64)

Differences/NNS in/IN clearance/NN between/IN patients/NNS on/IN these/DT medications/NNS (/-LRB- at/IN any/DT occasion/NN in/IN the/DT study/NN )/-RRB- and/CC those/DT off/RP medications/NNS varied/VBD between/IN -16/CD %/NN and/CC +3/CD %./NN

(ROOT (S1 (S (NP (NP (NNS Differences)) (PP (IN in) (NP (NN clearance))) (PP (IN between) (NP (NP (NP (NNS patients)) (PP (IN on) (NP (DT these) (NNS medications))) (PRN (-LRB- -LRB-) (PP (IN at) (NP (NP (DT any) (NN occasion)) (PP (IN in) (NP (DT the) (NN study))))) (-RRB- -RRB-))) (CC and) (NP (NP (DT those)) (PP (RP off) (NP (NNS medications))))))) (VP (VBD varied) (PP (IN between) (NP (NP (CD -16) (NN %)) (CC and) (NP (CD +3) (NN %.))))))))

nsubj(varied-21, Differences-1)
prep_in(Differences-1, clearance-3)
prep_between(Differences-1, patients-5)
det(medications-8, these-7)
prep_on(patients-5, medications-8)
dep(patients-5, at-10)
det(occasion-12, any-11)
pobj(at-10, occasion-12)
det(study-15, the-14)
prep_in(occasion-12, study-15)
conj_and(patients-5, those-18)
prep(those-18, off-19)
dep(off-19, medications-20)
root(ROOT-0, varied-21)
num(%-24, -16-23)
prep_between(varied-21, %-24)
num(%.-27, +3-26)
conj_and(%-24, %.-27)

The/DT mean/JJ clearances/NNS of/IN dofetilide/NN were/VBD 16/CD %/NN and/CC 15/CD %/NN lower/RBR in/IN patients/NNS on/IN thiazide/NN diuretics/NNS and/CC inhibitors/NNS of/IN tubular/JJ organic/JJ cation/NN transport/NN ,/, respectively/RB ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ mean) (NNS clearances)) (PP (IN of) (NP (NN dofetilide)))) (VP (VBD were) (NP (NP (CD 16) (NN %)) (CC and) (NP (NP (CD 15) (NN %) (RBR lower)) (PP (IN in) (NP (NP (NP (NNS patients)) (PP (IN on) (NP (NN thiazide) (NNS diuretics)))) (CC and) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (JJ tubular) (JJ organic) (NN cation) (NN transport))))))) (, ,) (ADVP (RB respectively))))) (. .))))

det(clearances-3, The-1)
amod(clearances-3, mean-2)
nsubj(%-8, clearances-3)
prep_of(clearances-3, dofetilide-5)
cop(%-8, were-6)
num(%-8, 16-7)
root(ROOT-0, %-8)
num(%-11, 15-10)
conj_and(%-8, %-11)
advmod(%-11, lower-12)
prep_in(%-11, patients-14)
nn(diuretics-17, thiazide-16)
prep_on(patients-14, diuretics-17)
conj_and(patients-14, inhibitors-19)
amod(transport-24, tubular-21)
amod(transport-24, organic-22)
nn(transport-24, cation-23)
prep_of(inhibitors-19, transport-24)
advmod(%-8, respectively-26)
conj_and(%-8, respectively-26)

The/DT potential/NN for/IN clinically/RB significant/JJ drug-drug/JJ interactions/NNS posed/VBN by/IN dolasetron/NN and/CC hydrodolasetron/NN appears/VBZ to/TO be/VB low/JJ for/IN drugs/NNS commonly/RB used/VBN in/IN chemotherapy/NN or/CC surgery/NN ,/, because/IN hydrodolasetron/NN is/VBZ eliminated/VBN by/IN multiple/JJ routes/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN potential)) (PP (IN for) (NP (NP (ADJP (RB clinically) (JJ significant)) (JJ drug-drug) (NNS interactions)) (VP (VBN posed) (PP (IN by) (NP (NP (NN dolasetron)) (CC and) (NP (NN hydrodolasetron)))))))) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (JJ low) (PP (IN for) (NP (NP (NNS drugs)) (VP (ADVP (RB commonly)) (VBN used) (PP (IN in) (NP (NP (NN chemotherapy)) (CC or) (NP (NN surgery))))))))))) (, ,) (SBAR (IN because) (S (NP (NN hydrodolasetron)) (VP (VBZ is) (VP (VBN eliminated) (PP (IN by) (NP (JJ multiple) (NNS routes))))))))) (. .))))

det(potential-2, The-1)
nsubj(appears-13, potential-2)
xsubj(low-16, potential-2)
advmod(significant-5, clinically-4)
amod(interactions-7, significant-5)
amod(interactions-7, drug-drug-6)
prep_for(potential-2, interactions-7)
partmod(interactions-7, posed-8)
agent(posed-8, dolasetron-10)
conj_and(dolasetron-10, hydrodolasetron-12)
root(ROOT-0, appears-13)
aux(low-16, to-14)
cop(low-16, be-15)
xcomp(appears-13, low-16)
prep_for(low-16, drugs-18)
advmod(used-20, commonly-19)
partmod(drugs-18, used-20)
prep_in(used-20, chemotherapy-22)
conj_or(chemotherapy-22, surgery-24)
mark(eliminated-29, because-26)
nsubjpass(eliminated-29, hydrodolasetron-27)
auxpass(eliminated-29, is-28)
advcl(appears-13, eliminated-29)
amod(routes-32, multiple-31)
agent(eliminated-29, routes-32)

Blood/NN levels/NNS of/IN hydro/NN dolasetron/NN increased/VBD 24/CD %/NN when/WRB dolasetron/NN was/VBD coadministered/VBN with/IN cimetidine/NN (/-LRB- nonselective/JJ inhibitor/NN of/IN cytochrome/NN P-450/NN )/-RRB- for/IN 7/CD days/NNS ,/, and/CC decreased/VBD 28/CD %/NN with/IN coadministration/NN of/IN rifampin/NN (/-LRB- potent/JJ inducer/NN of/IN cytochrome/NN P-450/NN )/-RRB- for/IN 7/CD days/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Blood) (NNS levels)) (PP (IN of) (NP (NN hydro) (NN dolasetron)))) (VP (VP (VBD increased) (NP (CD 24) (NN %)) (SBAR (WHADVP (WRB when)) (S (NP (NN dolasetron)) (VP (VBD was) (VP (VBN coadministered) (PP (IN with) (NP (NP (NN cimetidine)) (PRN (-LRB- -LRB-) (NP (NP (JJ nonselective) (NN inhibitor)) (PP (IN of) (NP (NN cytochrome) (NN P-450)))) (-RRB- -RRB-)))) (PP (IN for) (NP (CD 7) (NNS days)))))))) (, ,) (CC and) (VP (VBD decreased) (NP (CD 28) (NN %)) (PP (IN with) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NP (NN rifampin)) (PRN (-LRB- -LRB-) (NP (NP (JJ potent) (NN inducer)) (PP (IN of) (NP (NN cytochrome) (NN P-450)))) (-RRB- -RRB-))) (PP (IN for) (NP (CD 7) (NNS days)))))))))) (. .))))

nn(levels-2, Blood-1)
nsubj(increased-6, levels-2)
nn(dolasetron-5, hydro-4)
prep_of(levels-2, dolasetron-5)
root(ROOT-0, increased-6)
num(%-8, 24-7)
dobj(increased-6, %-8)
advmod(coadministered-12, when-9)
nsubjpass(coadministered-12, dolasetron-10)
auxpass(coadministered-12, was-11)
advcl(increased-6, coadministered-12)
prep_with(coadministered-12, cimetidine-14)
amod(inhibitor-17, nonselective-16)
dep(cimetidine-14, inhibitor-17)
nn(P-450-20, cytochrome-19)
prep_of(inhibitor-17, P-450-20)
num(days-24, 7-23)
prep_for(coadministered-12, days-24)
conj_and(increased-6, decreased-27)
num(%-29, 28-28)
dobj(decreased-27, %-29)
prep_with(decreased-27, coadministration-31)
prep_of(coadministration-31, rifampin-33)
amod(inducer-36, potent-35)
dep(rifampin-33, inducer-36)
nn(P-450-39, cytochrome-38)
prep_of(inducer-36, P-450-39)
num(days-43, 7-42)
prep_for(rifampin-33, days-43)

Dolasetron/NN has/VBZ been/VBN safely/RB coadministered/VBN with/IN drugs/NNS used/VBN in/IN chemotherapy/NN and/CC surgery/NN ./.

(ROOT (S1 (S (S (NP (NN Dolasetron)) (VP (VBZ has) (VP (VBN been) (ADVP (RB safely)) (VP (VBN coadministered) (PP (IN with) (NP (NP (NNS drugs)) (VP (VBN used) (PP (IN in) (NP (NP (NN chemotherapy)) (CC and) (NP (NN surgery))))))))))) (. .))))

nsubjpass(coadministered-5, Dolasetron-1)
aux(coadministered-5, has-2)
auxpass(coadministered-5, been-3)
advmod(coadministered-5, safely-4)
root(ROOT-0, coadministered-5)
prep_with(coadministered-5, drugs-7)
partmod(drugs-7, used-8)
prep_in(used-8, chemotherapy-10)
conj_and(chemotherapy-10, surgery-12)

As/IN with/IN other/JJ agents/NNS which/WDT prolong/VBP ECG/NN intervals/NNS ,/, caution/NN should/MD be/VB exercised/VBN in/IN patients/NNS taking/VBG drugs/NNS which/WDT prolong/VBP ECG/NN intervals/NNS ,/, particularly/RB QTc/NN ./.

(ROOT (S1 (S (S (PP (IN As) (PP (IN with) (NP (NP (JJ other) (NNS agents)) (SBAR (WHNP (WDT which)) (S (VP (VBP prolong) (NP (NN ECG) (NNS intervals)))))))) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT which)) (S (VP (VBP prolong) (NP (NP (NN ECG) (NNS intervals)) (, ,) (ADVP (RB particularly)) (NP (NN QTc)))))))))))))) (. .))))

prep(exercised-13, As-1)
pcomp(As-1, with-2)
amod(agents-4, other-3)
prep_with(As-1, agents-4)
nsubj(prolong-6, agents-4)
rcmod(agents-4, prolong-6)
nn(intervals-8, ECG-7)
dobj(prolong-6, intervals-8)
nsubjpass(exercised-13, caution-10)
aux(exercised-13, should-11)
auxpass(exercised-13, be-12)
root(ROOT-0, exercised-13)
prep_in(exercised-13, patients-15)
partmod(patients-15, taking-16)
dobj(taking-16, drugs-17)
nsubj(prolong-19, drugs-17)
rcmod(drugs-17, prolong-19)
nn(intervals-21, ECG-20)
dobj(prolong-19, intervals-21)
advmod(intervals-21, particularly-23)
dep(intervals-21, QTc-24)

In/IN patients/NNS taking/VBG furosemide/NN ,/, nifedipine/NN ,/, diltiazem/NN ,/, ACE/NN inhibitors/NNS ,/, verapamil/NN ,/, glyburide/NN ,/, propranolol/NN ,/, and/CC various/JJ chemotherapy/NN agents/NNS ,/, no/DT effect/NN was/VBD shown/VBN on/IN the/DT clearance/NN of/IN hydrodolasetron/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN furosemide)))) (, ,) (NP (NP (NN nifedipine)) (, ,) (NP (NN diltiazem)) (, ,) (NP (NN ACE) (NNS inhibitors)) (, ,) (NP (NN verapamil)) (, ,) (NP (NN glyburide)) (, ,) (NP (NN propranolol)) (, ,) (CC and) (NP (JJ various) (NN chemotherapy) (NNS agents))))) (, ,) (NP (DT no) (NN effect)) (VP (VBD was) (VP (VBN shown) (PP (IN on) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN hydrodolasetron)))))))) (. .))))

prep_in(shown-27, patients-2)
partmod(patients-2, taking-3)
dobj(taking-3, furosemide-4)
appos(patients-2, nifedipine-6)
conj_and(nifedipine-6, diltiazem-8)
nn(inhibitors-11, ACE-10)
conj_and(nifedipine-6, inhibitors-11)
conj_and(nifedipine-6, verapamil-13)
conj_and(nifedipine-6, glyburide-15)
conj_and(nifedipine-6, propranolol-17)
amod(agents-22, various-20)
nn(agents-22, chemotherapy-21)
conj_and(nifedipine-6, agents-22)
det(effect-25, no-24)
nsubjpass(shown-27, effect-25)
auxpass(shown-27, was-26)
root(ROOT-0, shown-27)
det(clearance-30, the-29)
prep_on(shown-27, clearance-30)
prep_of(clearance-30, hydrodolasetron-32)

Clearance/NN of/IN hydrodolasetron/NN decreased/VBD by/IN about/RB 27/CD %/NN when/WRB dolasetron/NN mesylate/NN was/VBD administered/VBN intravenously/RB concomitantly/RB with/IN atenolol/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Clearance)) (PP (IN of) (NP (NN hydrodolasetron)))) (VP (VBD decreased) (PP (IN by) (NP (QP (RB about) (CD 27)) (NN %))) (SBAR (WHADVP (WRB when)) (S (NP (NN dolasetron) (NN mesylate)) (VP (VBD was) (VP (VBN administered) (ADVP (RB intravenously)) (PP (ADVP (RB concomitantly)) (IN with) (NP (NN atenolol))))))))) (. .))))

nsubj(decreased-4, Clearance-1)
prep_of(Clearance-1, hydrodolasetron-3)
root(ROOT-0, decreased-4)
quantmod(27-7, about-6)
num(%-8, 27-7)
prep_by(decreased-4, %-8)
advmod(administered-13, when-9)
nn(mesylate-11, dolasetron-10)
nsubjpass(administered-13, mesylate-11)
auxpass(administered-13, was-12)
advcl(decreased-4, administered-13)
advmod(administered-13, intravenously-14)
advmod(administered-13, concomitantly-15)
prep_with(administered-13, atenolol-17)

Dolasetron/NN does/VBZ not/RB influence/VB anesthesia/NN recovery/NN time/NN in/IN patients/NNS ./.

(ROOT (S1 (S (S (NP (NN Dolasetron)) (VP (VBZ does) (RB not) (VP (VB influence) (NP (NP (NN anesthesia) (NN recovery) (NN time)) (PP (IN in) (NP (NNS patients))))))) (. .))))

nsubj(influence-4, Dolasetron-1)
aux(influence-4, does-2)
neg(influence-4, not-3)
root(ROOT-0, influence-4)
nn(time-7, anesthesia-5)
nn(time-7, recovery-6)
dobj(influence-4, time-7)
prep_in(time-7, patients-9)

Dolasetron/NN mesylate/NN did/VBD not/RB inhibit/VB the/DT antitumor/JJ activity/NN of/IN four/CD chemotherapeutic/JJ agent/NN s/NNS (/-LRB- cisplatin/NN ,/, 5-fluorouracil/NN ,/, doxorubicin/NN ,/, cyclophosphamide/NN )/-RRB- in/IN four/CD murine/JJ models/NNS ./.

(ROOT (S1 (S (S (NP (NN Dolasetron) (NN mesylate)) (VP (VBD did) (RB not) (VP (VB inhibit) (NP (NP (DT the) (JJ antitumor) (NN activity)) (PP (IN of) (NP (NP (CD four) (JJ chemotherapeutic) (NN agent) (NNS s)) (PRN (-LRB- -LRB-) (NP (NP (NN cisplatin)) (, ,) (NP (NN 5-fluorouracil)) (, ,) (NP (NN doxorubicin)) (, ,) (NP (NN cyclophosphamide))) (-RRB- -RRB-)))) (PP (IN in) (NP (CD four) (JJ murine) (NNS models))))))) (. .))))

nn(mesylate-2, Dolasetron-1)
nsubj(inhibit-5, mesylate-2)
aux(inhibit-5, did-3)
neg(inhibit-5, not-4)
root(ROOT-0, inhibit-5)
det(activity-8, the-6)
amod(activity-8, antitumor-7)
dobj(inhibit-5, activity-8)
num(s-13, four-10)
amod(s-13, chemotherapeutic-11)
nn(s-13, agent-12)
prep_of(activity-8, s-13)
dep(s-13, cisplatin-15)
appos(cisplatin-15, 5-fluorouracil-17)
appos(cisplatin-15, doxorubicin-19)
appos(cisplatin-15, cyclophosphamide-21)
num(models-26, four-24)
amod(models-26, murine-25)
prep_in(activity-8, models-26)

Drugs/NNS that/WDT inhibit/VBP or/CC Induce/VBP CYP/NN 2D6/NN and/CC CYP/NN 3A4/NN may/MD affect/VB the/DT concentration/NN on/IN Aricept/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBP inhibit)) (CC or) (VP (VBP Induce) (NP (NP (NN CYP) (NN 2D6)) (CC and) (NP (NN CYP) (NN 3A4)))))))) (VP (MD may) (VP (VB affect) (NP (NP (DT the) (NN concentration)) (PP (IN on) (NP (NN Aricept))))))) (. .))))

nsubj(inhibit-3, Drugs-1)
nsubj(affect-12, Drugs-1)
rcmod(Drugs-1, inhibit-3)
conj_or(inhibit-3, Induce-5)
nn(2D6-7, CYP-6)
dobj(Induce-5, 2D6-7)
nn(3A4-10, CYP-9)
conj_and(2D6-7, 3A4-10)
aux(affect-12, may-11)
root(ROOT-0, affect-12)
det(concentration-14, the-13)
dobj(affect-12, concentration-14)
prep_on(concentration-14, Aricept-16)

Because/IN dopamine/NN is/VBZ metabolized/VBN by/IN monoamine/NN oxidase/NN (/-LRB- MAO/NN )/-RRB- ,/, inhibition/NN of/IN this/DT enzyme/NN prolongs/VBZ and/CC potentiates/VBZ the/DT effect/NN of/IN dopamine/NN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NN dopamine)) (VP (VBZ is) (VP (VBN metabolized) (PP (IN by) (NP (NP (NN monoamine) (NN oxidase)) (PRN (-LRB- -LRB-) (NP (NN MAO)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (NN inhibition)) (PP (IN of) (NP (DT this) (NN enzyme)))) (VP (VP (VBZ prolongs)) (CC and) (VP (VBZ potentiates) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN dopamine))))))) (. .))))

mark(metabolized-4, Because-1)
nsubjpass(metabolized-4, dopamine-2)
auxpass(metabolized-4, is-3)
advcl(prolongs-16, metabolized-4)
nn(oxidase-7, monoamine-6)
agent(metabolized-4, oxidase-7)
abbrev(oxidase-7, MAO-9)
nsubj(prolongs-16, inhibition-12)
det(enzyme-15, this-14)
prep_of(inhibition-12, enzyme-15)
root(ROOT-0, prolongs-16)
conj_and(prolongs-16, potentiates-18)
det(effect-20, the-19)
dobj(potentiates-18, effect-20)
prep_of(effect-20, dopamine-22)

Patients/NNS who/WP have/VBP been/VBN treated/VBN with/IN MAO/NN inhibitors/NNS within/IN two/CD to/TO three/CD weeks/NNS prior/JJ to/TO the/DT administration/NN of/IN dopamine/NN HCl/NN should/MD receive/VBP initial/JJ doses/NNS of/IN dopamine/NN HCl/NN no/RB greater/JJR than/IN one-tenth/CD (/-LRB- 1/10/CD )/-RRB- of/IN the/DT usual/JJ dose/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN been) (VP (VBN treated) (PP (IN with) (NP (NN MAO) (NNS inhibitors))) (PP (IN within) (NP (NP (QP (CD two) (TO to) (CD three)) (NNS weeks)) (ADJP (JJ prior) (PP (TO to) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NN dopamine) (NN HCl)))))))))))))) (VP (MD should) (VP (VBP receive) (NP (NP (JJ initial) (NNS doses)) (PP (IN of) (NP (NN dopamine) (NN HCl))) (ADJP (RB no) (JJR greater) (PP (IN than) (NP (NP (NP (CD one-tenth)) (PRN (-LRB- -LRB-) (NP (CD 1/10)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (JJ usual) (NN dose)))))))))) (. .))))

nsubjpass(treated-5, Patients-1)
nsubj(receive-22, Patients-1)
aux(treated-5, have-3)
auxpass(treated-5, been-4)
rcmod(Patients-1, treated-5)
nn(inhibitors-8, MAO-7)
prep_with(treated-5, inhibitors-8)
number(three-12, two-10)
dep(three-12, to-11)
num(weeks-13, three-12)
prep_within(treated-5, weeks-13)
det(administration-17, the-16)
prep_prior_to(weeks-13, administration-17)
nn(HCl-20, dopamine-19)
prep_of(administration-17, HCl-20)
aux(receive-22, should-21)
root(ROOT-0, receive-22)
amod(doses-24, initial-23)
dobj(receive-22, doses-24)
nn(HCl-27, dopamine-26)
prep_of(doses-24, HCl-27)
advmod(greater-29, no-28)
amod(doses-24, greater-29)
prep_than(greater-29, one-tenth-31)
appos(one-tenth-31, 1/10-33)
det(dose-38, the-36)
amod(dose-38, usual-37)
prep_of(one-tenth-31, dose-38)

Concurrent/JJ administration/NN of/IN low-dose/JJ dopamine/NN HCl/NN and/CC diuretic/JJ agents/NNS may/MD produce/VB an/DT additive/JJ or/NN potentiating/NN effect/NN on/IN urine/NN flow/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN administration)) (PP (IN of) (NP (NP (JJ low-dose) (NN dopamine) (NN HCl)) (CC and) (NP (JJ diuretic) (NNS agents))))) (VP (MD may) (VP (VB produce) (NP (NP (DT an) (JJ additive) (NN or) (NN potentiating) (NN effect)) (PP (IN on) (NP (NN urine) (NN flow))))))) (. .))))

amod(administration-2, Concurrent-1)
nsubj(produce-11, administration-2)
amod(HCl-6, low-dose-4)
nn(HCl-6, dopamine-5)
prep_of(administration-2, HCl-6)
amod(agents-9, diuretic-8)
conj_and(HCl-6, agents-9)
aux(produce-11, may-10)
root(ROOT-0, produce-11)
det(effect-16, an-12)
amod(effect-16, additive-13)
nn(effect-16, or-14)
nn(effect-16, potentiating-15)
dobj(produce-11, effect-16)
nn(flow-19, urine-18)
prep_on(effect-16, flow-19)

Tricyclic/JJ antidepressants/NNS may/MD potentiate/VB the/DT cardiovascular/JJ effects/NNS of/IN adreneric/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (JJ Tricyclic) (NNS antidepressants)) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (JJ cardiovascular) (NNS effects)) (PP (IN of) (NP (JJ adreneric) (NNS agents))))))) (. .))))

amod(antidepressants-2, Tricyclic-1)
nsubj(potentiate-4, antidepressants-2)
aux(potentiate-4, may-3)
root(ROOT-0, potentiate-4)
det(effects-7, the-5)
amod(effects-7, cardiovascular-6)
dobj(potentiate-4, effects-7)
amod(agents-10, adreneric-9)
prep_of(effects-7, agents-10)

Cardiac/JJ effects/NNS of/IN dopamine/NN are/VBP antagonized/VBN by/IN beta-adrenergic/JJ blocking/NN agents/NNS ,/, such/JJ as/IN propranolol/NN and/CC metoprolol/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Cardiac) (NNS effects)) (PP (IN of) (NP (NN dopamine)))) (VP (VBP are) (VP (VBN antagonized) (PP (IN by) (NP (NP (JJ beta-adrenergic) (NN blocking) (NNS agents)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN propranolol)) (CC and) (NP (NN metoprolol))))))))) (. .))))

amod(effects-2, Cardiac-1)
nsubjpass(antagonized-6, effects-2)
prep_of(effects-2, dopamine-4)
auxpass(antagonized-6, are-5)
root(ROOT-0, antagonized-6)
amod(agents-10, beta-adrenergic-8)
nn(agents-10, blocking-9)
agent(antagonized-6, agents-10)
prep_such_as(agents-10, propranolol-14)
conj_and(propranolol-14, metoprolol-16)

The/DT peripheral/JJ vasoconstriction/NN caused/VBN by/IN high/JJ doses/NNS of/IN dopamine/NN HCl/NN is/VBZ antagonized/VBN by/IN alpha-adrenergic/JJ blocking/VBG agents/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ peripheral) (NN vasoconstriction)) (VP (VBN caused) (PP (IN by) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NN dopamine) (NN HCl))))))) (VP (VBZ is) (VP (VBN antagonized) (PP (IN by) (NP (JJ alpha-adrenergic) (VBG blocking) (NNS agents)))))) (. .))))

det(vasoconstriction-3, The-1)
amod(vasoconstriction-3, peripheral-2)
nsubjpass(antagonized-12, vasoconstriction-3)
partmod(vasoconstriction-3, caused-4)
amod(doses-7, high-6)
agent(caused-4, doses-7)
nn(HCl-10, dopamine-9)
prep_of(doses-7, HCl-10)
auxpass(antagonized-12, is-11)
root(ROOT-0, antagonized-12)
amod(agents-16, alpha-adrenergic-14)
amod(agents-16, blocking-15)
agent(antagonized-12, agents-16)

Dopamine/NN -induced/JJ renal/JJ and/CC mesenteric/JJ vasodilation/NN is/VBZ not/RB antagonized/VBN by/IN either/DT alpha-or/NN beta-adrenergic/JJ blocking/NN agents/NNS ./.

(ROOT (S1 (S (S (NP (ADJP (NN Dopamine) (JJ -induced)) (ADJP (ADJP (JJ renal)) (CC and) (ADJP (JJ mesenteric))) (NN vasodilation)) (VP (VBZ is) (RB not) (VP (VBN antagonized) (PP (IN by) (NP (DT either) (NN alpha-or) (JJ beta-adrenergic) (NN blocking) (NNS agents)))))) (. .))))

dep(-induced-2, Dopamine-1)
amod(vasodilation-6, -induced-2)
amod(vasodilation-6, renal-3)
conj_and(renal-3, mesenteric-5)
nsubjpass(antagonized-9, vasodilation-6)
auxpass(antagonized-9, is-7)
neg(antagonized-9, not-8)
root(ROOT-0, antagonized-9)
det(agents-15, either-11)
nn(agents-15, alpha-or-12)
amod(agents-15, beta-adrenergic-13)
nn(agents-15, blocking-14)
agent(antagonized-9, agents-15)

Butyrophenones/NNS (/-LRB- such/JJ as/IN haloperidol/NN )/-RRB- and/CC phenothiazines/NNS can/MD suppress/VB the/DT dopaminergic/JJ renal/JJ and/CC mesenteric/JJ vasodilation/NN induced/VBN with/IN low/JJ dose/NN dopamine/NN infusion/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Butyrophenones)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NN haloperidol)))) (-RRB- -RRB-))) (CC and) (NP (NNS phenothiazines))) (VP (MD can) (VP (VB suppress) (NP (NP (DT the) (JJ dopaminergic) (ADJP (ADJP (JJ renal)) (CC and) (ADJP (JJ mesenteric))) (NN vasodilation)) (VP (VBN induced) (PP (IN with) (NP (JJ low) (NN dose) (NN dopamine) (NN infusion)))))))) (. .))))

nsubj(suppress-10, Butyrophenones-1)
prep_such_as(Butyrophenones-1, haloperidol-5)
conj_and(Butyrophenones-1, phenothiazines-8)
aux(suppress-10, can-9)
root(ROOT-0, suppress-10)
det(vasodilation-16, the-11)
amod(vasodilation-16, dopaminergic-12)
amod(vasodilation-16, renal-13)
conj_and(renal-13, mesenteric-15)
dobj(suppress-10, vasodilation-16)
partmod(vasodilation-16, induced-17)
amod(infusion-22, low-19)
nn(infusion-22, dose-20)
nn(infusion-22, dopamine-21)
prep_with(induced-17, infusion-22)

Cyclopropane/NN or/CC halogenated/JJ hydrocarbon/NN anesthetics/NNS increase/VBP cardiac/JJ autonomic/JJ irritability/NN and/CC may/MD sensitize/VB the/DT myocardium/NN to/TO the/DT action/NN of/IN certain/JJ intravenously/RB administered/VBN catecholamines/NNS ,/, such/JJ as/IN dopamine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Cyclopropane)) (CC or) (NP (JJ halogenated) (NN hydrocarbon) (NNS anesthetics))) (VP (VP (VBP increase) (NP (JJ cardiac) (JJ autonomic) (NN irritability))) (CC and) (VP (MD may) (VP (VB sensitize) (NP (DT the) (NN myocardium)) (PP (TO to) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NP (JJ certain) (ADJP (RB intravenously) (VBN administered)) (NNS catecholamines)) (, ,) (PP (JJ such) (IN as) (NP (NN dopamine))))))))))) (. .))))

nsubj(increase-6, Cyclopropane-1)
amod(anesthetics-5, halogenated-3)
nn(anesthetics-5, hydrocarbon-4)
conj_or(Cyclopropane-1, anesthetics-5)
root(ROOT-0, increase-6)
amod(irritability-9, cardiac-7)
amod(irritability-9, autonomic-8)
dobj(increase-6, irritability-9)
aux(sensitize-12, may-11)
conj_and(increase-6, sensitize-12)
det(myocardium-14, the-13)
dobj(sensitize-12, myocardium-14)
det(action-17, the-16)
prep_to(sensitize-12, action-17)
amod(catecholamines-22, certain-19)
advmod(administered-21, intravenously-20)
amod(catecholamines-22, administered-21)
prep_of(action-17, catecholamines-22)
prep_such_as(catecholamines-22, dopamine-26)

This/DT interaction/NN appears/VBZ to/TO be/VB related/JJ both/CC to/TO pressor/NN activity/NN and/CC to/TO beta-adrenergic/JJ stimulating/JJ properties/NNS of/IN these/DT catecholamines/NNS and/CC may/MD produce/VB ventricular/JJ arrhythmias/NNS and/CC hypertension/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN interaction)) (VP (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (ADJP (JJ related) (PP (CC both) (PP (TO to) (NP (NN pressor) (NN activity))) (CC and) (PP (TO to) (NP (NP (JJ beta-adrenergic) (JJ stimulating) (NNS properties)) (PP (IN of) (NP (DT these) (NNS catecholamines))))))))))) (CC and) (VP (MD may) (VP (VB produce) (NP (NP (JJ ventricular) (NNS arrhythmias)) (CC and) (NP (NN hypertension))))))) (. .))))

det(interaction-2, This-1)
nsubj(appears-3, interaction-2)
xsubj(related-6, interaction-2)
root(ROOT-0, appears-3)
aux(related-6, to-4)
cop(related-6, be-5)
xcomp(appears-3, related-6)
preconj(related-6, both-7)
nn(activity-10, pressor-9)
prep_to(related-6, activity-10)
amod(properties-15, beta-adrenergic-13)
amod(properties-15, stimulating-14)
conj_and(activity-10, properties-15)
det(catecholamines-18, these-17)
prep_of(properties-15, catecholamines-18)
aux(produce-21, may-20)
conj_and(appears-3, produce-21)
amod(arrhythmias-23, ventricular-22)
dobj(produce-21, arrhythmias-23)
conj_and(arrhythmias-23, hypertension-25)

Therefore/RB ,/, EXTREME/JJ CAUTION/NN should/MD be/VB exercised/VBN when/WRB administering/VBG dopamine/NN HCl/NN to/TO patients/NNS receiving/VBG cyclopropane/NN or/CC halogenated/JJ hydrocarbon/NN anesthetics/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (JJ EXTREME) (NN CAUTION)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (NN dopamine) (NN HCl)) (PP (TO to) (NP (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN cyclopropane)))) (CC or) (NP (JJ halogenated) (NN hydrocarbon) (NNS anesthetics))))))))))) (. .))))

advmod(exercised-7, Therefore-1)
amod(CAUTION-4, EXTREME-3)
nsubjpass(exercised-7, CAUTION-4)
aux(exercised-7, should-5)
auxpass(exercised-7, be-6)
root(ROOT-0, exercised-7)
advmod(administering-9, when-8)
advcl(exercised-7, administering-9)
nn(HCl-11, dopamine-10)
dobj(administering-9, HCl-11)
prep_to(administering-9, patients-13)
partmod(patients-13, receiving-14)
dobj(receiving-14, cyclopropane-15)
amod(anesthetics-19, halogenated-17)
nn(anesthetics-19, hydrocarbon-18)
conj_or(patients-13, anesthetics-19)

It/PRP has/VBZ been/VBN reported/VBN that/IN results/NNS of/IN studies/NNS in/IN animals/NNS indicate/VBP that/IN dopamine/NN -induced/JJ ventricular/JJ arrhythmias/NNS during/IN anesthesia/NN can/MD be/VB reversed/VBN by/IN propranolol/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (SBAR (IN that) (S (NP (NP (NNS results)) (PP (IN of) (NP (NP (NNS studies)) (PP (IN in) (NP (NNS animals)))))) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN dopamine) (JJ -induced) (JJ ventricular) (NNS arrhythmias)) (PP (IN during) (NP (NN anesthesia)))) (VP (MD can) (VP (VB be) (VP (VBN reversed) (PP (IN by) (NP (NN propranolol))))))))))))))) (. .))))

nsubjpass(reported-4, It-1)
aux(reported-4, has-2)
auxpass(reported-4, been-3)
root(ROOT-0, reported-4)
complm(indicate-11, that-5)
nsubj(indicate-11, results-6)
prep_of(results-6, studies-8)
prep_in(studies-8, animals-10)
ccomp(reported-4, indicate-11)
complm(reversed-21, that-12)
nn(arrhythmias-16, dopamine-13)
amod(arrhythmias-16, -induced-14)
amod(arrhythmias-16, ventricular-15)
nsubjpass(reversed-21, arrhythmias-16)
prep_during(arrhythmias-16, anesthesia-18)
aux(reversed-21, can-19)
auxpass(reversed-21, be-20)
ccomp(indicate-11, reversed-21)
agent(reversed-21, propranolol-23)

The/DT concomitant/JJ use/NN of/IN vasopressor/NN s/NNS ,/, vasoconstricting/VBG agents/NNS (/-LRB- such/JJ as/IN ergonovine/NN )/-RRB- and/CC some/DT oxytocic/JJ drugs/NNS may/MD result/VB in/IN severe/JJ hypertension/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN vasopressor) (NNS s)) (, ,) (NP (NP (NP (VBG vasoconstricting) (NNS agents)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NN ergonovine)))) (-RRB- -RRB-))) (CC and) (NP (DT some) (JJ oxytocic) (NNS drugs)))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (JJ severe) (NN hypertension)))))) (. .))))

det(use-3, The-1)
amod(use-3, concomitant-2)
nsubj(result-20, use-3)
nn(s-6, vasopressor-5)
prep_of(use-3, s-6)
amod(agents-9, vasoconstricting-8)
appos(s-6, agents-9)
prep_such_as(agents-9, ergonovine-13)
det(drugs-18, some-16)
amod(drugs-18, oxytocic-17)
conj_and(agents-9, drugs-18)
aux(result-20, may-19)
root(ROOT-0, result-20)
amod(hypertension-23, severe-22)
prep_in(result-20, hypertension-23)

Administration/NN of/IN phenytoin/NN to/TO patients/NNS receiving/VBG dopamine/NN HCl/NN has/VBZ been/VBN reported/VBN to/TO lead/VB to/TO hypotension/NN and/CC bradycardia/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN phenytoin))) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN dopamine) (NN HCl)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB lead) (PP (TO to) (NP (NP (NN hypotension)) (CC and) (NP (NN bradycardia))))))))))) (. .))))

nsubjpass(reported-11, Administration-1)
xsubj(lead-13, Administration-1)
prep_of(Administration-1, phenytoin-3)
prep_to(Administration-1, patients-5)
partmod(patients-5, receiving-6)
nn(HCl-8, dopamine-7)
dobj(receiving-6, HCl-8)
aux(reported-11, has-9)
auxpass(reported-11, been-10)
root(ROOT-0, reported-11)
aux(lead-13, to-12)
xcomp(reported-11, lead-13)
prep_to(lead-13, hypotension-15)
conj_and(hypotension-15, bradycardia-17)

It/PRP is/VBZ suggested/VBN that/IN in/IN patients/NNS receiving/VBG dopamine/NN HCl/NN ,/, alternatives/NNS to/TO phenytoin/NN should/MD be/VB used/VBN if/IN anticonvulsant/JJ therapy/NN is/VBZ needed/VBN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN suggested) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN dopamine) (NN HCl))))) (, ,) (NP (NP (NNS alternatives)) (PP (TO to) (NP (NN phenytoin)))) (VP (MD should) (VP (VB be) (VP (VBN used) (SBAR (IN if) (S (NP (JJ anticonvulsant) (NN therapy)) (VP (VBZ is) (VP (VBN needed))))))))))))) (. .))))

nsubjpass(suggested-3, It-1)
auxpass(suggested-3, is-2)
root(ROOT-0, suggested-3)
complm(used-16, that-4)
prep_in(used-16, patients-6)
partmod(patients-6, receiving-7)
nn(HCl-9, dopamine-8)
dobj(receiving-7, HCl-9)
nsubjpass(used-16, alternatives-11)
prep_to(alternatives-11, phenytoin-13)
aux(used-16, should-14)
auxpass(used-16, be-15)
ccomp(suggested-3, used-16)
mark(needed-21, if-17)
amod(therapy-19, anticonvulsant-18)
nsubjpass(needed-21, therapy-19)
auxpass(needed-21, is-20)
advcl(used-16, needed-21)

Although/IN acid-base/NN and/CC electrolyte/NN disturbances/NNS were/VBD not/RB reported/VBN in/IN the/DT clinical/JJ trials/NNS with/IN dorzolamide/NN ,/, these/DT disturbances/NNS have/VBP been/VBN reported/VBN with/IN oral/JJ carbonic/JJ anhydrase/NN inhibitors/NNS and/CC have/VB ,/, in/IN some/DT instances/NNS ,/, resulted/VBD in/IN drug/NN interactions/NNS (/-LRB- e.g./FW ,/, toxicity/NN associated/VBN with/IN high-dose/JJ salicylate/NN therapy/NN )./CD

(ROOT (S1 (S (SBAR (IN Although) (S (NP (NP (NP (NN acid-base)) (CC and) (NP (NN electrolyte))) (NNS disturbances)) (VP (VBD were) (RB not) (VP (VBN reported) (PP (IN in) (NP (NP (DT the) (JJ clinical) (NNS trials)) (PP (IN with) (NP (NN dorzolamide))))))))) (, ,) (S (NP (DT these) (NNS disturbances)) (VP (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NP (JJ oral) (JJ carbonic) (NN anhydrase)) (NNS inhibitors)))))) (CC and) (VP (VB have) (, ,) (PP (IN in) (NP (DT some) (NNS instances))) (, ,) (S (VP (VBD resulted) (PP (IN in) (NP (NN drug) (NNS interactions))))) (PRN (-LRB- -LRB-) (NP (NP (FW e.g.)) (, ,) (NP (NP (NN toxicity)) (VP (VBN associated) (PP (IN with) (NP (JJ high-dose) (NN salicylate) (NN therapy) (CD -RRB-.)))))))))))))

mark(reported-8, Although-1)
nn(disturbances-5, acid-base-2)
conj_and(acid-base-2, electrolyte-4)
nsubjpass(reported-8, disturbances-5)
auxpass(reported-8, were-6)
neg(reported-8, not-7)
advcl(reported-20, reported-8)
det(trials-12, the-10)
amod(trials-12, clinical-11)
prep_in(reported-8, trials-12)
prep_with(trials-12, dorzolamide-14)
det(disturbances-17, these-16)
nsubjpass(reported-20, disturbances-17)
aux(reported-20, have-18)
auxpass(reported-20, been-19)
root(ROOT-0, reported-20)
amod(anhydrase-24, oral-22)
amod(anhydrase-24, carbonic-23)
nn(inhibitors-25, anhydrase-24)
prep_with(reported-20, inhibitors-25)
conj_and(reported-20, have-27)
det(instances-31, some-30)
prep_in(have-27, instances-31)
ccomp(have-27, resulted-33)
nn(interactions-36, drug-35)
prep_in(resulted-33, interactions-36)
dep(have-27, e.g.-38)
appos(e.g.-38, toxicity-40)
partmod(toxicity-40, associated-41)
amod(therapy-45, high-dose-43)
nn(therapy-45, salicylate-44)
prep_with(associated-41, therapy-45)
num(therapy-45, -RRB-.-46)

Therefore/RB ,/, the/DT potential/NN for/IN such/JJ drug/NN interactions/NNS should/MD be/VB considered/VBN in/IN patients/NNS receiving/VBG dorzolamide/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (JJ such) (NN drug) (NNS interactions)))) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN dorzolamide))))))))) (. .))))

advmod(considered-11, Therefore-1)
det(potential-4, the-3)
nsubjpass(considered-11, potential-4)
amod(interactions-8, such-6)
nn(interactions-8, drug-7)
prep_for(potential-4, interactions-8)
aux(considered-11, should-9)
auxpass(considered-11, be-10)
root(ROOT-0, considered-11)
prep_in(considered-11, patients-13)
partmod(patients-13, receiving-14)
dobj(receiving-14, dorzolamide-15)

Most/JJS (/-LRB- 98/CD %/NN )/-RRB- of/IN plasma/NN doxazosin/NN is/VBZ protein/NN bound/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJS Most)) (PRN (-LRB- -LRB-) (NP (CD 98) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (NN plasma) (NN doxazosin)))) (VP (VBZ is) (VP (NN protein) (VBN bound)))) (. .))))

nsubjpass(bound-11, Most-1)
num(%-4, 98-3)
appos(Most-1, %-4)
nn(doxazosin-8, plasma-7)
prep_of(Most-1, doxazosin-8)
auxpass(bound-11, is-9)
dep(bound-11, protein-10)
root(ROOT-0, bound-11)

In/FW vitro/FW data/NNS in/IN human/JJ plasma/NN indicate/VBP that/IN doxazosin/NN mesylate/NN has/VBZ no/DT effect/NN on/IN protein/NN binding/NN of/IN digoxin/NN ,/, warfarin/NN ,/, phenytoin/NN or/CC indomethacin/NN ./.

(ROOT (S1 (S (S (NP (NP (ADJP (FW In) (FW vitro)) (NNS data)) (PP (IN in) (NP (JJ human) (NN plasma)))) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN doxazosin) (NN mesylate)) (VP (VBZ has) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN protein) (NN binding)) (PP (IN of) (NP (NP (NN digoxin)) (, ,) (NP (NN warfarin)) (, ,) (NP (NN phenytoin)) (CC or) (NP (NN indomethacin))))))))))) (. .))))

nn(vitro-2, In-1)
amod(data-3, vitro-2)
nsubj(indicate-7, data-3)
amod(plasma-6, human-5)
prep_in(data-3, plasma-6)
root(ROOT-0, indicate-7)
complm(has-11, that-8)
nn(mesylate-10, doxazosin-9)
nsubj(has-11, mesylate-10)
ccomp(indicate-7, has-11)
det(effect-13, no-12)
dobj(has-11, effect-13)
nn(binding-16, protein-15)
prep_on(has-11, binding-16)
prep_of(binding-16, digoxin-18)
conj_or(digoxin-18, warfarin-20)
conj_or(digoxin-18, phenytoin-22)
conj_or(digoxin-18, indomethacin-24)

There/EX is/VBZ no/DT information/NN on/IN the/DT effect/NN of/IN other/JJ highly/RB plasma/NN protein/NN bound/VBN drugs/NNS on/IN doxazosin/NN binding/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT no) (NN information)) (PP (IN on) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ other) (ADJP (RB highly) (NP (NN plasma) (NN protein)) (VBN bound)) (NNS drugs))) (PP (IN on) (NP (NN doxazosin) (NN binding)))))))) (. .))))

expl(is-2, There-1)
root(ROOT-0, is-2)
det(information-4, no-3)
nsubj(is-2, information-4)
det(effect-7, the-6)
prep_on(information-4, effect-7)
amod(drugs-14, other-9)
advmod(bound-13, highly-10)
nn(protein-12, plasma-11)
dep(bound-13, protein-12)
amod(drugs-14, bound-13)
prep_of(effect-7, drugs-14)
nn(binding-17, doxazosin-16)
prep_on(effect-7, binding-17)

Doxazosin/NN mesylate/NN has/VBZ been/VBN administered/VBN without/IN any/DT evidence/NN of/IN an/DT adverse/JJ drug/NN interaction/NN to/TO patients/NNS receiving/VBG thiazide/NN diuretics/NNS ,/, beta-blocking/JJ agent/NN s/NNS ,/, and/CC nonsteroidal/JJ anti-inflammatory/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NN Doxazosin) (NN mesylate)) (VP (VBZ has) (VP (VBN been) (VP (VBN administered) (PP (IN without) (NP (NP (DT any) (NN evidence)) (PP (IN of) (NP (NP (DT an) (JJ adverse) (NN drug) (NN interaction)) (PP (TO to) (NP (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN thiazide) (NNS diuretics)))) (, ,) (NP (JJ beta-blocking) (NN agent) (NNS s)) (, ,) (CC and) (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs)))))))))))) (. .))))

nn(mesylate-2, Doxazosin-1)
nsubjpass(administered-5, mesylate-2)
aux(administered-5, has-3)
auxpass(administered-5, been-4)
root(ROOT-0, administered-5)
det(evidence-8, any-7)
prep_without(administered-5, evidence-8)
det(interaction-13, an-10)
amod(interaction-13, adverse-11)
nn(interaction-13, drug-12)
prep_of(evidence-8, interaction-13)
prep_to(interaction-13, patients-15)
partmod(patients-15, receiving-16)
nn(diuretics-18, thiazide-17)
dobj(receiving-16, diuretics-18)
amod(s-22, beta-blocking-20)
nn(s-22, agent-21)
conj_and(patients-15, s-22)
amod(drugs-27, nonsteroidal-25)
amod(drugs-27, anti-inflammatory-26)
conj_and(patients-15, drugs-27)

In/IN a/DT placebo-controlled/JJ trial/NN in/IN normal/JJ volunteers/NNS ,/, the/DT administration/NN of/IN a/DT single/JJ 1/CD mg/NN dose/NN of/IN doxazosin/NN on/IN day/NN 1/CD of/IN a/DT four-day/JJ regimen/NN of/IN oral/JJ cimetidine/NN (/-LRB- 400/CD mg/NN twice/RB daily/RB )/-RRB- resulted/VBD in/IN a/DT 10/CD %/NN increase/NN in/IN mean/JJ AUC/NN of/IN doxazosin/NN (/-LRB- p=0.006/NN )/-RRB- ,/, and/CC a/DT slight/JJ but/CC not/RB statistically/RB significant/JJ increase/NN in/IN mean/NN Cmax/NN and/CC mean/NN half-life/NN of/IN doxazosin/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (DT a) (JJ placebo-controlled) (NN trial)) (PP (IN in) (NP (JJ normal) (NNS volunteers))))) (, ,) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (DT a) (JJ single) (ADJP (CD 1) (NN mg)) (NN dose)) (PP (IN of) (NP (NP (NN doxazosin)) (PP (IN on) (NP (NP (NN day) (CD 1)) (PP (IN of) (NP (NP (DT a) (JJ four-day) (NN regimen)) (PP (IN of) (NP (NP (JJ oral) (NN cimetidine)) (PRN (-LRB- -LRB-) (NP (NP (CD 400) (NN mg)) (ADVP (RB twice) (RB daily))) (-RRB- -RRB-))))))))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (ADJP (CD 10) (NN %)) (NN increase)) (PP (IN in) (NP (NP (JJ mean) (NN AUC)) (PP (IN of) (NP (NP (NN doxazosin)) (PRN (-LRB- -LRB-) (NP (NN p=0.006)) (-RRB- -RRB-))))))) (, ,) (CC and) (NP (NP (DT a) (ADJP (ADJP (JJ slight)) (CC but) (ADJP (RB not) (RB statistically) (JJ significant))) (NN increase)) (PP (IN in) (NP (NP (NP (NN mean) (NN Cmax)) (CC and) (NP (NN mean) (NN half-life))) (PP (IN of) (NP (NN doxazosin))))))))) (. .))))

det(trial-4, a-2)
amod(trial-4, placebo-controlled-3)
prep_in(resulted-35, trial-4)
amod(volunteers-7, normal-6)
prep_in(trial-4, volunteers-7)
det(administration-10, the-9)
nsubj(resulted-35, administration-10)
det(dose-16, a-12)
amod(dose-16, single-13)
number(mg-15, 1-14)
amod(dose-16, mg-15)
prep_of(administration-10, dose-16)
prep_of(dose-16, doxazosin-18)
prep_on(doxazosin-18, day-20)
num(day-20, 1-21)
det(regimen-25, a-23)
amod(regimen-25, four-day-24)
prep_of(day-20, regimen-25)
amod(cimetidine-28, oral-27)
prep_of(regimen-25, cimetidine-28)
num(mg-31, 400-30)
dep(cimetidine-28, mg-31)
advmod(daily-33, twice-32)
advmod(mg-31, daily-33)
root(ROOT-0, resulted-35)
det(increase-40, a-37)
number(%-39, 10-38)
amod(increase-40, %-39)
prep_in(resulted-35, increase-40)
amod(AUC-43, mean-42)
prep_in(increase-40, AUC-43)
prep_of(AUC-43, doxazosin-45)
appos(doxazosin-45, p=0.006-47)
det(increase-57, a-51)
amod(increase-57, slight-52)
neg(significant-56, not-54)
advmod(significant-56, statistically-55)
conj_but(slight-52, significant-56)
conj_and(increase-40, increase-57)
nn(Cmax-60, mean-59)
prep_in(increase-57, Cmax-60)
nn(half-life-63, mean-62)
conj_and(Cmax-60, half-life-63)
prep_of(Cmax-60, doxazosin-65)

The/DT clinical/JJ significance/NN of/IN this/DT increase/NN in/IN doxazosin/NN AUC/NN is/VBZ unknown/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ clinical) (NN significance)) (PP (IN of) (NP (DT this) (NN increase))) (PP (IN in) (NP (NN doxazosin) (NN AUC)))) (VP (VBZ is) (ADJP (JJ unknown)))) (. .))))

det(significance-3, The-1)
amod(significance-3, clinical-2)
nsubj(unknown-11, significance-3)
det(increase-6, this-5)
prep_of(significance-3, increase-6)
nn(AUC-9, doxazosin-8)
prep_in(significance-3, AUC-9)
cop(unknown-11, is-10)
root(ROOT-0, unknown-11)

In/IN clinical/JJ trials/NNS ,/, doxazosin/NN mesylate/NN tablets/NNS have/VBP been/VBN administered/VBN to/TO patients/NNS on/IN a/DT variety/NN of/IN concomitant/JJ medications/NNS ;/: ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ clinical) (NNS trials))) (, ,) (NP (NN doxazosin) (NN mesylate) (NNS tablets)) (VP (VBP have) (VP (VBN been) (VP (VBN administered) (PP (TO to) (NP (NNS patients))) (PP (IN on) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ concomitant) (NNS medications)))))))) (: ;)) (. .))))

amod(trials-3, clinical-2)
prep_in(administered-10, trials-3)
nn(tablets-7, doxazosin-5)
nn(tablets-7, mesylate-6)
nsubjpass(administered-10, tablets-7)
aux(administered-10, have-8)
auxpass(administered-10, been-9)
root(ROOT-0, administered-10)
prep_to(administered-10, patients-12)
det(variety-15, a-14)
prep_on(administered-10, variety-15)
amod(medications-18, concomitant-17)
prep_of(variety-15, medications-18)

Doxazosin/NN mesylate/NN tablets/NNS have/VBP been/VBN used/VBN with/IN the/DT following/JJ drugs/NNS or/CC drug/NN classes/NNS :/: 1/CD ./.

(ROOT (S1 (S (S (NP (NN Doxazosin) (NN mesylate) (NNS tablets)) (VP (VBP have) (VP (VBN been) (VP (VBN used) (PP (IN with) (NP (NP (NP (DT the) (JJ following) (NNS drugs)) (CC or) (NP (NN drug) (NNS classes))) (: :) (NP (CD 1)))))))) (. .))))

nn(tablets-3, Doxazosin-1)
nn(tablets-3, mesylate-2)
nsubjpass(used-6, tablets-3)
aux(used-6, have-4)
auxpass(used-6, been-5)
root(ROOT-0, used-6)
det(drugs-10, the-8)
amod(drugs-10, following-9)
prep_with(used-6, drugs-10)
nn(classes-13, drug-12)
conj_or(drugs-10, classes-13)
dep(drugs-10, 1-15)

Analgesic/JJ /anti-inflammatory/NN (/-LRB- e.g./FW ,/, acetaminophen/NN ,/, aspirin/NN ,/, codeine/NN and/CC codeine/NN combinations/NNS ,/, ibuprofen/NN ,/, indomethacin/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NP (JJ Analgesic) (NN /anti-inflammatory)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN acetaminophen))) (, ,) (NP (NP (NN aspirin)) (, ,) (NP (NN codeine)) (CC and) (NP (NN codeine) (NNS combinations)) (, ,) (NP (NN ibuprofen)) (, ,) (NP (NN indomethacin))) (-RRB- -RRB-))) (. .)))))

amod(/anti-inflammatory-2, Analgesic-1)
root(ROOT-0, /anti-inflammatory-2)
dep(aspirin-8, e.g.-4)
pobj(e.g.-4, acetaminophen-6)
dep(/anti-inflammatory-2, aspirin-8)
conj_and(aspirin-8, codeine-10)
nn(combinations-13, codeine-12)
conj_and(aspirin-8, combinations-13)
conj_and(aspirin-8, ibuprofen-15)
conj_and(aspirin-8, indomethacin-17)

Antibiotics/NNS (/-LRB- e.g./FW ,/, erythromycin/NN ,/, trimethoprim/NN and/CC sulfamethoxazole/NN ,/, amoxicillin/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (NNS Antibiotics)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN erythromycin)) (, ,) (NP (NN trimethoprim)) (CC and) (NP (NN sulfamethoxazole)) (, ,) (NP (NN amoxicillin)))) (-RRB- -RRB-)))) (. .))))

root(ROOT-0, Antibiotics-1)
dep(Antibiotics-1, e.g.-3)
pobj(e.g.-3, erythromycin-5)
conj_and(erythromycin-5, trimethoprim-7)
conj_and(erythromycin-5, sulfamethoxazole-9)
conj_and(erythromycin-5, amoxicillin-11)

Antihistamines/NNS (/-LRB- e.g./FW ,/, chlorpheniramine/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (NNS Antihistamines)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN chlorpheniramine))) (-RRB- -RRB-)))) (. .))))

root(ROOT-0, Antihistamines-1)
dep(Antihistamines-1, e.g.-3)
pobj(e.g.-3, chlorpheniramine-5)

Cardiovascular/JJ agents/NNS (/-LRB- e.g./FW ,/, atenolol/NN ,/, hydrochlorothiazide/NN ,/, propranolol/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (JJ Cardiovascular) (NNS agents)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN atenolol)) (, ,) (NP (NN hydrochlorothiazide)) (, ,) (NP (NN propranolol))) (-RRB- -RRB-)))) (. .))))

amod(agents-2, Cardiovascular-1)
root(ROOT-0, agents-2)
dep(atenolol-6, e.g.-4)
dep(agents-2, atenolol-6)
appos(atenolol-6, hydrochlorothiazide-8)
appos(atenolol-6, propranolol-10)

Corticosteroids/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Corticosteroids)) (. .)))))

root(ROOT-0, Corticosteroids-1)

Gastrointestinal/JJ agents/NNS (/-LRB- e.g./FW ,/, antacids/NNS )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (JJ Gastrointestinal) (NNS agents)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NNS antacids)) (-RRB- -RRB-)))) (. .))))

amod(agents-2, Gastrointestinal-1)
root(ROOT-0, agents-2)
dep(antacids-6, e.g.-4)
appos(agents-2, antacids-6)

Hypoglycemics/NN and/CC endocrine/JJ drugs/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NN Hypoglycemics)) (CC and) (NP (JJ endocrine) (NNS drugs))) (. .)))))

root(ROOT-0, Hypoglycemics-1)
amod(drugs-4, endocrine-3)
conj_and(Hypoglycemics-1, drugs-4)

Sedatives/NNS and/CC tranquilizers/NNS (/-LRB- e.g./FW ,/, diazepam/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Sedatives)) (CC and) (NP (NNS tranquilizers))) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN diazepam))) (-RRB- -RRB-)))) (. .))))

root(ROOT-0, Sedatives-1)
conj_and(Sedatives-1, tranquilizers-3)
dep(Sedatives-1, e.g.-5)
pobj(e.g.-5, diazepam-7)

Cold/NN and/CC flu/NN remedies/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NP (NN Cold)) (CC and) (NP (NN flu))) (NNS remedies)) (. .)))))

nn(remedies-4, Cold-1)
conj_and(Cold-1, flu-3)
root(ROOT-0, remedies-4)

Drugs/NNS Metabolized/VBN by/IN P450/NN 2D6/NN :/: The/DT biochemical/JJ activity/NN of/IN the/DT drug/NN metabolizing/NN isozyme/NN cytochrome/NN P450/NN 2D6/NN (/-LRB- debrisoquin/NN hydroxylase/NN )/-RRB- is/VBZ reduced/VBN in/IN a/DT subset/NN of/IN the/DT Caucasian/NN population/NN (/-LRB- about/RB 7-10/CD %/NN of/IN Caucasians/NNP are/VBP so-called/JJ poor/JJ metabolizers/NNS )/-RRB- ;/: ./.

(ROOT (S1 (S (NP (NP (NP (NNS Drugs)) (VP (VBN Metabolized) (PP (IN by) (NP (NN P450) (NN 2D6))))) (: :) (S (NP (NP (DT The) (JJ biochemical) (NN activity)) (PP (IN of) (NP (NP (DT the) (NN drug) (NN metabolizing) (NN isozyme) (NN cytochrome) (NN P450) (NN 2D6)) (PRN (-LRB- -LRB-) (NP (NN debrisoquin) (NN hydroxylase)) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN reduced) (PP (IN in) (NP (NP (DT a) (NN subset)) (PP (IN of) (NP (DT the) (NN Caucasian) (NN population))))) (PRN (-LRB- -LRB-) (NP (NP (QP (RB about) (CD 7-10)) (NN %)) (PP (IN of) (NP (NP (NNP Caucasians)) (VP (VBP are) (NP (JJ so-called) (JJ poor) (NNS metabolizers)))))) (-RRB- -RRB-)))) (: ;)) (. .)))))

root(ROOT-0, Drugs-1)
partmod(Drugs-1, Metabolized-2)
nn(2D6-5, P450-4)
agent(Metabolized-2, 2D6-5)
det(activity-9, The-7)
amod(activity-9, biochemical-8)
nsubjpass(reduced-23, activity-9)
det(2D6-17, the-11)
nn(2D6-17, drug-12)
nn(2D6-17, metabolizing-13)
nn(2D6-17, isozyme-14)
nn(2D6-17, cytochrome-15)
nn(2D6-17, P450-16)
prep_of(activity-9, 2D6-17)
nn(hydroxylase-20, debrisoquin-19)
appos(2D6-17, hydroxylase-20)
auxpass(reduced-23, is-22)
dep(Drugs-1, reduced-23)
det(subset-26, a-25)
prep_in(reduced-23, subset-26)
det(population-30, the-28)
nn(population-30, Caucasian-29)
prep_of(subset-26, population-30)
quantmod(7-10-33, about-32)
num(%-34, 7-10-33)
dep(reduced-23, %-34)
prep_of(%-34, Caucasians-36)
cop(metabolizers-40, are-37)
amod(metabolizers-40, so-called-38)
amod(metabolizers-40, poor-39)
dep(Caucasians-36, metabolizers-40)

reliable/JJ estimates/NNS of/IN the/DT prevalence/NN of/IN reduced/VBN P450/NN 2D6/NN isozyme/NN activity/NN among/IN Asian/JJ ,/, African/JJ and/CC other/JJ populations/NNS are/VBP not/RB yet/RB available/JJ ./.

(ROOT (S1 (S (S (NP (NP (JJ reliable) (NNS estimates)) (PP (IN of) (NP (NP (DT the) (NN prevalence)) (PP (IN of) (NP (VBN reduced) (NN P450) (NN 2D6) (NN isozyme) (NN activity))) (PP (IN among) (NP (ADJP (ADJP (JJ Asian)) (, ,) (ADJP (JJ African)) (CC and) (ADJP (JJ other))) (NNS populations)))))) (VP (VBP are) (RB not) (ADVP (RB yet)) (ADJP (JJ available)))) (. .))))

amod(estimates-2, reliable-1)
nsubj(available-22, estimates-2)
det(prevalence-5, the-4)
prep_of(estimates-2, prevalence-5)
amod(activity-11, reduced-7)
nn(activity-11, P450-8)
nn(activity-11, 2D6-9)
nn(activity-11, isozyme-10)
prep_of(prevalence-5, activity-11)
amod(populations-18, Asian-13)
conj_and(Asian-13, African-15)
conj_and(Asian-13, other-17)
prep_among(prevalence-5, populations-18)
cop(available-22, are-19)
neg(available-22, not-20)
advmod(available-22, yet-21)
root(ROOT-0, available-22)

Poor/JJ metabolizers/NNS have/VBP higher/JJR than/IN expected/VBN plasma/NN concentrations/NNS of/IN tricyclic/JJ antidepressants/NNS (/-LRB- TCAs/NNS )/-RRB- when/WRB given/VBN usual/JJ doses/NNS ./.

(ROOT (S1 (S (S (NP (JJ Poor) (NNS metabolizers)) (VP (VBP have) (NP (NP (JJR higher) (IN than) (VBN expected) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (JJ tricyclic) (NNS antidepressants)) (PRN (-LRB- -LRB-) (NP (NNS TCAs)) (-RRB- -RRB-))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (NP (JJ usual) (NNS doses))))))) (. .))))

amod(metabolizers-2, Poor-1)
nsubj(have-3, metabolizers-2)
root(ROOT-0, have-3)
amod(concentrations-8, higher-4)
amod(concentrations-8, than-5)
amod(concentrations-8, expected-6)
nn(concentrations-8, plasma-7)
dobj(have-3, concentrations-8)
amod(antidepressants-11, tricyclic-10)
prep_of(concentrations-8, antidepressants-11)
appos(antidepressants-11, TCAs-13)
advmod(given-16, when-15)
advcl(have-3, given-16)
amod(doses-18, usual-17)
dobj(given-16, doses-18)

Depending/VBG on/IN the/DT fraction/NN of/IN drug/NN metabolized/VBN by/IN P450/NN 2D6/NN ,/, the/DT increase/NN in/IN plasma/NN concentration/NN may/MD be/VB small/JJ ,/, or/CC quite/RB large/JJ (/-LRB- 8-fold/JJ increase/NN in/IN plasma/NN AUC/NN of/IN the/DT TCA/NN )./NN

(ROOT (S1 (S (PP (VBG Depending) (PP (IN on) (NP (NP (DT the) (NN fraction)) (PP (IN of) (NP (NP (NN drug)) (VP (VBN metabolized) (PP (IN by) (NP (NN P450) (NN 2D6))))))))) (, ,) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NN plasma) (NN concentration)))) (VP (MD may) (VP (VB be) (ADJP (ADJP (JJ small)) (, ,) (CC or) (RB quite) (ADJP (JJ large))))) (PRN (-LRB- -LRB-) (NP (NP (JJ 8-fold) (NN increase)) (PP (IN in) (NP (NP (NN plasma) (NN AUC)) (PP (IN of) (NP (DT the) (NN TCA) (NN -RRB-.))))))))))

prepc_depending_on(small-19, on-2)
det(fraction-4, the-3)
pobj(small-19, fraction-4)
prep_of(fraction-4, drug-6)
partmod(drug-6, metabolized-7)
nn(2D6-10, P450-9)
agent(metabolized-7, 2D6-10)
det(increase-13, the-12)
nsubj(small-19, increase-13)
nn(concentration-16, plasma-15)
prep_in(increase-13, concentration-16)
aux(small-19, may-17)
cop(small-19, be-18)
root(ROOT-0, small-19)
advmod(small-19, quite-22)
conj_or(small-19, quite-22)
dep(small-19, large-23)
amod(increase-26, 8-fold-25)
dep(small-19, increase-26)
nn(AUC-29, plasma-28)
prep_in(increase-26, AUC-29)
det(-RRB-.-33, the-31)
nn(-RRB-.-33, TCA-32)
prep_of(AUC-29, -RRB-.-33)

In/IN addition/NN ,/, certain/JJ drugs/NNS inhibit/VB the/DT activity/NN of/IN this/DT isozyme/NN and/CC make/VB normal/JJ metabolizers/NNS resemble/VBP poor/JJ metabolizers/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (JJ certain) (NNS drugs)) (VP (VP (VB inhibit) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT this) (NN isozyme))))) (CC and) (VP (VB make) (NP (JJ normal) (NNS metabolizers)))) (VP (VBP resemble) (NP (JJ poor) (NNS metabolizers)))) (. .))))

prep_in(inhibit-6, addition-2)
amod(drugs-5, certain-4)
nsubj(inhibit-6, drugs-5)
root(ROOT-0, inhibit-6)
det(activity-8, the-7)
dobj(inhibit-6, activity-8)
det(isozyme-11, this-10)
prep_of(activity-8, isozyme-11)
conj_and(inhibit-6, make-13)
amod(metabolizers-15, normal-14)
dobj(make-13, metabolizers-15)
cop(metabolizers-18, resemble-16)
amod(metabolizers-18, poor-17)
dep(inhibit-6, metabolizers-18)

An/DT individual/JJ who/WP is/VBZ stable/JJ on/IN a/DT given/JJ dose/NN of/IN TCA/NN may/MD become/VB abruptly/RB toxic/JJ when/WRB given/VBN one/CD of/IN these/DT inhibiting/JJ drugs/NNS as/IN concomitant/JJ therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (DT An) (JJ individual)) (SBAR (WHNP (WP who)) (S (VP (VBZ is) (ADJP (JJ stable) (PP (IN on) (NP (NP (DT a) (JJ given) (NN dose)) (PP (IN of) (NP (NN TCA)))))))))) (VP (MD may) (VP (VB become) (ADJP (RB abruptly) (JJ toxic)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT these) (JJ inhibiting) (NNS drugs)) (PP (IN as) (NP (JJ concomitant) (NN therapy)))))))))))) (. .))))

det(individual-2, An-1)
nsubj(stable-5, individual-2)
nsubj(toxic-15, individual-2)
cop(stable-5, is-4)
rcmod(individual-2, stable-5)
det(dose-9, a-7)
amod(dose-9, given-8)
prep_on(stable-5, dose-9)
prep_of(dose-9, TCA-11)
aux(toxic-15, may-12)
cop(toxic-15, become-13)
advmod(toxic-15, abruptly-14)
root(ROOT-0, toxic-15)
advmod(given-17, when-16)
advcl(toxic-15, given-17)
dobj(given-17, one-18)
det(drugs-22, these-20)
amod(drugs-22, inhibiting-21)
prep_of(one-18, drugs-22)
amod(therapy-25, concomitant-24)
prep_as(drugs-22, therapy-25)

The/DT drugs/NNS that/WDT inhibit/VBP cytochrome/NN P450/NN 2D6/NN include/VBP some/DT that/WDT are/VBP not/RB metabolized/VBN by/IN the/DT enzyme/NN (/-LRB- quinidine/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (NN cytochrome) (NN P450) (NN 2D6)))))) (VP (VBP include) (NP (NP (DT some)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (RB not) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (NN enzyme) (-LRB- -LRB-) (NN quinidine) (: ;)))))))))) (. .))))

det(drugs-2, The-1)
nsubj(inhibit-4, drugs-2)
nsubj(include-8, drugs-2)
rcmod(drugs-2, inhibit-4)
nn(2D6-7, cytochrome-5)
nn(2D6-7, P450-6)
dobj(inhibit-4, 2D6-7)
root(ROOT-0, include-8)
dobj(include-8, some-9)
nsubjpass(metabolized-13, some-9)
auxpass(metabolized-13, are-11)
neg(metabolized-13, not-12)
rcmod(some-9, metabolized-13)
det(quinidine-18, the-15)
nn(quinidine-18, enzyme-16)
agent(metabolized-13, quinidine-18)

cimetidine/NN )/-RRB- and/CC many/JJ that/WDT are/VBP substrates/NNS for/IN P450/NN 2D6/NN (/-LRB- many/JJ other/JJ antidepressants/NNS ,/, phenothiazines/NNS ,/, and/CC the/DT Type/NN 1C/NN antiarrhythmics/NNS propafenone/NN and/CC flecainide/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NP (NN cimetidine) (-RRB- -RRB-)) (CC and) (NP (NP (JJ many)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NNS substrates)) (PP (IN for) (NP (NN P450) (NN 2D6)))) (PRN (-LRB- -LRB-) (NP (NP (JJ many) (JJ other) (NNS antidepressants)) (, ,) (NP (NNS phenothiazines)) (, ,) (CC and) (NP (NP (DT the) (NN Type) (NN 1C) (NNS antiarrhythmics)) (NP (NP (NN propafenone)) (CC and) (NP (NN flecainide))))) (-RRB- -RRB-))))))) (. .)))))

root(ROOT-0, cimetidine-1)
conj_and(cimetidine-1, many-4)
nsubj(substrates-7, many-4)
cop(substrates-7, are-6)
rcmod(many-4, substrates-7)
nn(2D6-10, P450-9)
prep_for(substrates-7, 2D6-10)
amod(antidepressants-14, many-12)
amod(antidepressants-14, other-13)
dep(substrates-7, antidepressants-14)
conj_and(antidepressants-14, phenothiazines-16)
det(antiarrhythmics-22, the-19)
nn(antiarrhythmics-22, Type-20)
nn(antiarrhythmics-22, 1C-21)
conj_and(antidepressants-14, antiarrhythmics-22)
dep(antiarrhythmics-22, propafenone-23)
conj_and(propafenone-23, flecainide-25)

While/IN all/PDT the/DT selective/JJ serotonin/NN reuptake/NN inhibitors/NNS (/-LRB- SSRIs/NN )/-RRB- ,/, e.g./FW ,/, citalopram/NN ,/, escitalopram/NN ,/, fluoxetine/NN ,/, sertraline/NN ,/, and/CC paroxetine/NN ,/, inhibit/VBP P450/NN 2D6/NN ,/, they/PRP may/MD vary/VB in/IN the/DT extent/NN of/IN inhibition/NN ./.

(ROOT (S1 (S (S (SBAR (IN While) (S (NP (NP (NP (PDT all) (DT the) (JJ selective) (NN serotonin) (NN reuptake) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NN SSRIs)) (-RRB- -RRB-))) (, ,) (PP (FW e.g.) (, ,) (NP (NP (NN citalopram)) (, ,) (NP (NN escitalopram)) (, ,) (NP (NN fluoxetine)) (, ,) (NP (NN sertraline)) (, ,) (CC and) (NP (NN paroxetine)))) (, ,)) (VP (VBP inhibit) (NP (NN P450) (NN 2D6))))) (, ,) (NP (PRP they)) (VP (MD may) (VP (VB vary) (PP (IN in) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NN inhibition)))))))) (. .))))

mark(inhibit-25, While-1)
predet(inhibitors-7, all-2)
det(inhibitors-7, the-3)
amod(inhibitors-7, selective-4)
nn(inhibitors-7, serotonin-5)
nn(inhibitors-7, reuptake-6)
nsubj(inhibit-25, inhibitors-7)
abbrev(inhibitors-7, SSRIs-9)
prep(inhibitors-7, e.g.-12)
pobj(e.g.-12, citalopram-14)
conj_and(citalopram-14, escitalopram-16)
conj_and(citalopram-14, fluoxetine-18)
conj_and(citalopram-14, sertraline-20)
conj_and(citalopram-14, paroxetine-23)
advcl(vary-31, inhibit-25)
nn(2D6-27, P450-26)
dobj(inhibit-25, 2D6-27)
nsubj(vary-31, they-29)
aux(vary-31, may-30)
root(ROOT-0, vary-31)
det(extent-34, the-33)
prep_in(vary-31, extent-34)
prep_of(extent-34, inhibition-36)

Of/IN particular/JJ importance/NN ,/, sufficient/JJ time/NN must/MD elapse/VB before/IN initiating/VBG TCA/NN treatment/NN in/IN a/DT patient/NN being/VBG withdrawn/NN from/IN fluoxetine/NN ,/, given/IN the/DT long/JJ half-life/NN of/IN the/DT parent/JJ and/CC active/JJ metabolite/NN (/-LRB- at/IN least/JJS 5/CD weeks/NNS may/MD be/VB necessary/JJ )./NN

(ROOT (S1 (S (PP (IN Of) (NP (JJ particular) (NN importance))) (, ,) (S (NP (JJ sufficient) (NN time)) (VP (MD must) (VP (VB elapse) (PP (IN before) (S (VP (VBG initiating) (NP (NN TCA) (NN treatment))))) (PP (IN in) (NP (NP (DT a) (NN patient)) (VP (VBG being) (NP (NP (NN withdrawn)) (PP (IN from) (NP (NN fluoxetine))))))) (, ,) (SBAR (IN given) (S (NP (NP (DT the) (JJ long) (NN half-life)) (PP (IN of) (NP (DT the) (ADJP (ADJP (JJ parent)) (CC and) (ADJP (JJ active))) (NN metabolite) (-LRB- -LRB-) (QP (IN at) (JJS least) (CD 5)) (NNS weeks)))) (VP (MD may) (VP (VB be) (NP (JJ necessary) (NN -RRB-.))))))))))))

amod(importance-3, particular-2)
prep_of(elapse-8, importance-3)
amod(time-6, sufficient-5)
nsubj(elapse-8, time-6)
aux(elapse-8, must-7)
root(ROOT-0, elapse-8)
prepc_before(elapse-8, initiating-10)
nn(treatment-12, TCA-11)
dobj(initiating-10, treatment-12)
det(patient-15, a-14)
prep_in(elapse-8, patient-15)
cop(withdrawn-17, being-16)
partmod(patient-15, withdrawn-17)
prep_from(withdrawn-17, fluoxetine-19)
mark(-RRB-.-39, given-21)
det(half-life-24, the-22)
amod(half-life-24, long-23)
nsubj(-RRB-.-39, half-life-24)
det(weeks-35, the-26)
amod(weeks-35, parent-27)
conj_and(parent-27, active-29)
nn(weeks-35, metabolite-30)
quantmod(5-34, at-32)
mwe(at-32, least-33)
pobj(at-32, least-33)
num(weeks-35, 5-34)
prep_of(half-life-24, weeks-35)
aux(-RRB-.-39, may-36)
cop(-RRB-.-39, be-37)
amod(-RRB-.-39, necessary-38)
advcl(elapse-8, -RRB-.-39)

Concomitant/JJ use/NN of/IN tricyclic/JJ antidepressants/NNS with/IN drugs/NNS that/WDT can/MD inhibit/VB cytochrome/NN P450/NN 2D6/NN may/MD require/VB lower/JJR doses/NNS than/IN usually/RB prescribed/VBN for/IN either/CC the/DT tricyclic/JJ antidepressant/JJ or/CC the/DT other/JJ drug/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (JJ tricyclic) (NNS antidepressants)) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB inhibit) (NP (NN cytochrome) (NN P450) (NN 2D6))))))))))) (VP (MD may) (VP (VB require) (NP (NP (JJR lower) (NNS doses)) (VP (ADVP (IN than) (RB usually)) (VBN prescribed) (PP (IN for) (NP (CC either) (NP (DT the) (JJ tricyclic) (JJ antidepressant)) (CC or) (NP (DT the) (JJ other) (NN drug))))))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(require-15, use-2)
amod(antidepressants-5, tricyclic-4)
prep_of(use-2, antidepressants-5)
prep_with(antidepressants-5, drugs-7)
nsubj(inhibit-10, drugs-7)
aux(inhibit-10, can-9)
rcmod(drugs-7, inhibit-10)
nn(2D6-13, cytochrome-11)
nn(2D6-13, P450-12)
dobj(inhibit-10, 2D6-13)
aux(require-15, may-14)
root(ROOT-0, require-15)
amod(doses-17, lower-16)
dobj(require-15, doses-17)
advmod(prescribed-20, than-18)
advmod(than-18, usually-19)
partmod(doses-17, prescribed-20)
preconj(antidepressant-25, either-22)
det(antidepressant-25, the-23)
amod(antidepressant-25, tricyclic-24)
prep_for(prescribed-20, antidepressant-25)
det(drug-29, the-27)
amod(drug-29, other-28)
conj_or(antidepressant-25, drug-29)

Furthermore/RB ,/, whenever/RB one/CD of/IN these/DT other/JJ drugs/NNS is/VBZ withdrawn/VBN from/IN co-therapy/NN ,/, an/DT increased/VBN dose/NN of/IN tricyclic/JJ antidepressant/JJ may/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Furthermore)) (, ,) (S (ADVP (RB whenever)) (NP (NP (CD one)) (PP (IN of) (NP (DT these) (JJ other) (NNS drugs)))) (VP (VBZ is) (VP (VBN withdrawn) (PP (IN from) (NP (NN co-therapy)))))) (, ,) (NP (NP (DT an) (VBN increased) (NN dose)) (PP (IN of) (NP (JJ tricyclic) (JJ antidepressant)))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (. .))))

advmod(required-22, Furthermore-1)
advmod(withdrawn-10, whenever-3)
nsubjpass(withdrawn-10, one-4)
det(drugs-8, these-6)
amod(drugs-8, other-7)
prep_of(one-4, drugs-8)
auxpass(withdrawn-10, is-9)
ccomp(required-22, withdrawn-10)
prep_from(withdrawn-10, co-therapy-12)
det(dose-16, an-14)
amod(dose-16, increased-15)
nsubjpass(required-22, dose-16)
amod(antidepressant-19, tricyclic-18)
prep_of(dose-16, antidepressant-19)
aux(required-22, may-20)
auxpass(required-22, be-21)
root(ROOT-0, required-22)

It/PRP is/VBZ desirable/JJ to/TO monitor/VB TCA/NN plasma/NN levels/NNS whenever/RB a/DT TCA/NN is/VBZ going/JJ to/TO be/VB co-administered/VBN with/IN another/DT drug/NN known/VBN to/TO be/VB an/DT inhibitor/NN of/IN P450/NN 2D6/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ desirable)) (S (VP (TO to) (VP (VB monitor) (NP (NN TCA) (NN plasma) (NNS levels)) (S (ADVP (RB whenever)) (NP (DT a) (NN TCA)) (VP (VBZ is) (ADJP (JJ going) (S (VP (TO to) (VP (VB be) (VP (VBN co-administered) (PP (IN with) (NP (NP (DT another) (NN drug)) (VP (VBN known) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN P450) (NN 2D6)))))))))))))))))))))) (. .))))

nsubj(desirable-3, It-1)
xsubj(monitor-5, It-1)
cop(desirable-3, is-2)
root(ROOT-0, desirable-3)
aux(monitor-5, to-4)
xcomp(desirable-3, monitor-5)
nn(levels-8, TCA-6)
nn(levels-8, plasma-7)
dobj(monitor-5, levels-8)
advmod(going-13, whenever-9)
det(TCA-11, a-10)
nsubj(going-13, TCA-11)
cop(going-13, is-12)
dep(monitor-5, going-13)
aux(co-administered-16, to-14)
auxpass(co-administered-16, be-15)
xcomp(going-13, co-administered-16)
det(drug-19, another-18)
prep_with(co-administered-16, drug-19)
partmod(drug-19, known-20)
aux(inhibitor-24, to-21)
cop(inhibitor-24, be-22)
det(inhibitor-24, an-23)
xcomp(known-20, inhibitor-24)
nn(2D6-27, P450-26)
prep_of(inhibitor-24, 2D6-27)

Doxepin/NN is/VBZ primarily/RB metabolized/VBN by/IN CYP2D6/NN (/-LRB- with/IN CYP1A2/NN and/CC CYP3A4/NN as/IN minor/JJ pathways/NNS )./CD

(ROOT (S1 (S (NP (NN Doxepin)) (VP (VBZ is) (ADVP (RB primarily)) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP2D6))) (-LRB- -LRB-) (PP (IN with) (NP (NP (NN CYP1A2)) (CC and) (NP (NN CYP3A4)))) (PP (IN as) (NP (JJ minor) (NNS pathways))) (NP (CD -RRB-.)))))))

nsubjpass(metabolized-4, Doxepin-1)
auxpass(metabolized-4, is-2)
advmod(metabolized-4, primarily-3)
root(ROOT-0, metabolized-4)
agent(metabolized-4, CYP2D6-6)
prep_with(metabolized-4, CYP1A2-9)
conj_and(CYP1A2-9, CYP3A4-11)
amod(pathways-14, minor-13)
prep_as(metabolized-4, pathways-14)
dobj(metabolized-4, -RRB-.-15)

Inhibitors/NNS or/CC substrates/NNS of/IN CYP2D6/NNS (/-LRB- i.e./FW ,/, quinidine/NN ,/, selective/JJ serotonin/NN reuptake/NN inhibitors/NNS [SSRIs/NN ]/-RRB- )/-RRB- may/MD increase/VB the/DT plasma/NN concentration/NN of/IN doxepin/NN when/WRB administered/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Inhibitors)) (CC or) (NP (NNS substrates))) (PP (IN of) (NP (NP (NNS CYP2D6)) (PRN (-LRB- -LRB-) (PP (FW i.e.) (, ,) (NP (NN quinidine))) (, ,) (NP (NP (JJ selective) (NN serotonin) (NN reuptake) (NNS inhibitors)) (PRN (NN -LSB-SSRIs) (-RRB- -RSB-))) (-RRB- -RRB-))))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN plasma) (NN concentration)) (PP (IN of) (NP (NN doxepin)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (ADVP (RB concomitantly)))))))) (. .))))

nsubj(increase-19, Inhibitors-1)
conj_or(Inhibitors-1, substrates-3)
prep_of(Inhibitors-1, CYP2D6-5)
dep(inhibitors-14, i.e.-7)
pobj(i.e.-7, quinidine-9)
amod(inhibitors-14, selective-11)
nn(inhibitors-14, serotonin-12)
nn(inhibitors-14, reuptake-13)
dep(CYP2D6-5, inhibitors-14)
dep(inhibitors-14, -LSB-SSRIs-15)
punct(-LSB-SSRIs-15, -RSB--16)
aux(increase-19, may-18)
root(ROOT-0, increase-19)
det(concentration-22, the-20)
nn(concentration-22, plasma-21)
dobj(increase-19, concentration-22)
prep_of(concentration-22, doxepin-24)
advmod(administered-26, when-25)
advcl(increase-19, administered-26)
advmod(administered-26, concomitantly-27)

The/DT extent/NN of/IN interaction/NN depends/VBZ on/IN the/DT variability/NN of/IN effect/NN on/IN CYP2D6/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN extent)) (PP (IN of) (NP (NN interaction)))) (VP (VBZ depends) (PP (IN on) (NP (NP (DT the) (NN variability)) (PP (IN of) (NP (NN effect))) (PP (IN on) (NP (NN CYP2D6))))))) (. .))))

det(extent-2, The-1)
nsubj(depends-5, extent-2)
prep_of(extent-2, interaction-4)
root(ROOT-0, depends-5)
det(variability-8, the-7)
prep_on(depends-5, variability-8)
prep_of(variability-8, effect-10)
prep_on(variability-8, CYP2D6-12)

The/DT clinical/JJ significance/NN of/IN this/DT interaction/NN with/IN doxepin/NN has/VBZ not/RB been/VBN systematically/RB evaluated/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ clinical) (NN significance)) (PP (IN of) (NP (NP (DT this) (NN interaction)) (PP (IN with) (NP (NN doxepin)))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB systematically)) (VP (VBN evaluated))))) (. .))))

det(significance-3, The-1)
amod(significance-3, clinical-2)
nsubjpass(evaluated-13, significance-3)
det(interaction-6, this-5)
prep_of(significance-3, interaction-6)
prep_with(interaction-6, doxepin-8)
aux(evaluated-13, has-9)
neg(evaluated-13, not-10)
auxpass(evaluated-13, been-11)
advmod(evaluated-13, systematically-12)
root(ROOT-0, evaluated-13)

MAO/NN Inhibitors/NNS :/: Serious/JJ side/JJ effects/NNS and/CC even/JJ death/NN have/VBP been/VBN reported/VBN following/VBG the/DT concomitant/JJ use/NN of/IN certain/JJ drugs/NNS with/IN MAO/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (NN MAO) (NNS Inhibitors)) (: :) (NP (NP (JJ Serious) (JJ side) (NNS effects)) (CC and) (NP (JJ even) (NN death))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (VBG following) (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (JJ certain) (NNS drugs))) (PP (IN with) (NP (NN MAO) (NNS inhibitors))))))))) (. .))))

nn(Inhibitors-2, MAO-1)
nsubjpass(reported-12, Inhibitors-2)
amod(effects-6, Serious-4)
amod(effects-6, side-5)
nsubjpass(reported-12, effects-6)
amod(death-9, even-8)
conj_and(effects-6, death-9)
aux(reported-12, have-10)
auxpass(reported-12, been-11)
root(ROOT-0, reported-12)
det(use-16, the-14)
amod(use-16, concomitant-15)
prep_following(reported-12, use-16)
amod(drugs-19, certain-18)
prep_of(use-16, drugs-19)
nn(inhibitors-22, MAO-21)
prep_with(use-16, inhibitors-22)

Therefore/RB ,/, MAO/NN inhibitors/NNS should/MD be/VB discontinued/VBN at/IN least/JJS two/CD weeks/NNS prior/JJ to/TO the/DT cautious/JJ initiation/NN of/IN therapy/NN with/IN SINEQUAN/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NN MAO) (NNS inhibitors)) (VP (MD should) (VP (VB be) (VP (VBN discontinued) (NP (NP (QP (IN at) (JJS least) (CD two)) (NNS weeks)) (ADJP (JJ prior) (PP (TO to) (NP (NP (DT the) (JJ cautious) (NN initiation)) (PP (IN of) (NP (NP (NN therapy)) (PP (IN with) (NP (NN SINEQUAN))))))))))))) (. .))))

advmod(discontinued-7, Therefore-1)
nn(inhibitors-4, MAO-3)
nsubjpass(discontinued-7, inhibitors-4)
aux(discontinued-7, should-5)
auxpass(discontinued-7, be-6)
root(ROOT-0, discontinued-7)
quantmod(two-10, at-8)
mwe(at-8, least-9)
pobj(at-8, least-9)
num(weeks-11, two-10)
dobj(discontinued-7, weeks-11)
det(initiation-16, the-14)
amod(initiation-16, cautious-15)
prep_prior_to(weeks-11, initiation-16)
prep_of(initiation-16, therapy-18)
prep_with(therapy-18, SINEQUAN-20)

The/DT exact/JJ length/NN of/IN time/NN may/MD vary/VB and/CC is/VBZ dependent/JJ upon/IN the/DT particular/JJ MAO/NN inhibitor/NN being/VBG used/VBN ,/, the/DT length/NN of/IN time/NN it/PRP has/VBZ been/VBN administered/VBN ,/, and/CC the/DT dosage/NN involved/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ exact) (NN length)) (PP (IN of) (NP (NN time)))) (VP (VP (MD may) (VP (VB vary))) (CC and) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN upon) (NP (NP (NP (DT the) (JJ particular) (NN MAO) (NN inhibitor)) (VP (VBG being) (VP (VBN used)))) (, ,) (NP (NP (DT the) (NN length)) (PP (IN of) (NP (NN time))) (S (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN administered)))))) (, ,) (CC and) (NP (NP (DT the) (NN dosage)) (VP (VBN involved))))))))) (. .))))

det(length-3, The-1)
amod(length-3, exact-2)
nsubj(vary-7, length-3)
prep_of(length-3, time-5)
aux(vary-7, may-6)
root(ROOT-0, vary-7)
cop(dependent-10, is-9)
conj_and(vary-7, dependent-10)
det(inhibitor-15, the-12)
amod(inhibitor-15, particular-13)
nn(inhibitor-15, MAO-14)
prep_upon(dependent-10, inhibitor-15)
auxpass(used-17, being-16)
partmod(inhibitor-15, used-17)
det(length-20, the-19)
conj_and(inhibitor-15, length-20)
prep_of(length-20, time-22)
nsubjpass(administered-26, it-23)
aux(administered-26, has-24)
auxpass(administered-26, been-25)
dep(length-20, administered-26)
det(dosage-30, the-29)
conj_and(inhibitor-15, dosage-30)
partmod(dosage-30, involved-31)

Cimetidine/NN :/: Cimetidine/NN has/VBZ been/VBN reported/VBN to/TO produce/VB clinically/RB significant/JJ fluctuations/NNS in/IN steady-state/JJ serum/NN concentrations/NNS of/IN various/JJ tricyclic/JJ antidepressants/NNS ./.

(ROOT (S1 (S (S (NP (NN Cimetidine) (: :) (NN Cimetidine)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB produce) (NP (NP (ADJP (RB clinically) (JJ significant)) (NNS fluctuations)) (PP (IN in) (NP (NP (JJ steady-state) (NN serum) (NNS concentrations)) (PP (IN of) (NP (JJ various) (JJ tricyclic) (NNS antidepressants))))))))))))) (. .))))

nn(Cimetidine-3, Cimetidine-1)
nsubjpass(reported-6, Cimetidine-3)
xsubj(produce-8, Cimetidine-3)
aux(reported-6, has-4)
auxpass(reported-6, been-5)
root(ROOT-0, reported-6)
aux(produce-8, to-7)
xcomp(reported-6, produce-8)
advmod(significant-10, clinically-9)
amod(fluctuations-11, significant-10)
dobj(produce-8, fluctuations-11)
amod(concentrations-15, steady-state-13)
nn(concentrations-15, serum-14)
prep_in(fluctuations-11, concentrations-15)
amod(antidepressants-19, various-17)
amod(antidepressants-19, tricyclic-18)
prep_of(concentrations-15, antidepressants-19)

Serious/JJ anticholinergic/JJ symptoms/NNS (/-LRB- i.e./FW ,/, severe/JJ dry/JJ mouth/NN ,/, urinary/JJ retention/NN and/CC blurred/JJ vision/NN )/-RRB- have/VBP been/VBN associated/VBN with/IN elevations/NNS in/IN the/DT serum/NN levels/NNS of/IN tricyclic/JJ antidepressant/JJ when/WRB cimetidine/NN therapy/NN is/VBZ initiated/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Serious) (JJ anticholinergic) (NNS symptoms)) (PRN (-LRB- -LRB-) (PP (FW i.e.) (, ,) (NP (NP (JJ severe) (JJ dry) (NN mouth)) (, ,) (NP (JJ urinary) (NN retention)) (CC and) (NP (JJ blurred) (NN vision)))) (-RRB- -RRB-))) (VP (VBP have) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (NNS elevations)) (PP (IN in) (NP (NP (DT the) (NN serum) (NNS levels)) (PP (IN of) (NP (JJ tricyclic) (JJ antidepressant))))))) (SBAR (WHADVP (WRB when)) (S (NP (NN cimetidine) (NN therapy)) (VP (VBZ is) (VP (VBN initiated))))))))) (. .))))

amod(symptoms-3, Serious-1)
amod(symptoms-3, anticholinergic-2)
nsubjpass(associated-19, symptoms-3)
dep(symptoms-3, i.e.-5)
amod(mouth-9, severe-7)
amod(mouth-9, dry-8)
pobj(i.e.-5, mouth-9)
amod(retention-12, urinary-11)
conj_and(mouth-9, retention-12)
amod(vision-15, blurred-14)
conj_and(mouth-9, vision-15)
aux(associated-19, have-17)
auxpass(associated-19, been-18)
root(ROOT-0, associated-19)
prep_with(associated-19, elevations-21)
det(levels-25, the-23)
nn(levels-25, serum-24)
prep_in(elevations-21, levels-25)
amod(antidepressant-28, tricyclic-27)
prep_of(levels-25, antidepressant-28)
advmod(initiated-33, when-29)
nn(therapy-31, cimetidine-30)
nsubjpass(initiated-33, therapy-31)
auxpass(initiated-33, is-32)
advcl(associated-19, initiated-33)

Additionally/RB ,/, higher/JJR than/IN expected/VBN tricyclic/JJ antidepressant/JJ levels/NNS have/VBP been/VBN observed/VBN when/WRB they/PRP are/VBP begun/VBN in/IN patients/NNS already/RB taking/VBG cimetidine/NN ./.

(ROOT (S1 (S (S (ADVP (RB Additionally)) (, ,) (NP (JJR higher) (IN than) (VBN expected) (JJ tricyclic) (JJ antidepressant) (NNS levels)) (VP (VBP have) (VP (VBN been) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (PRP they)) (VP (VBP are) (VP (VBN begun) (PP (IN in) (NP (NP (NNS patients)) (VP (ADVP (RB already)) (VBG taking) (NP (NN cimetidine))))))))))))) (. .))))

advmod(observed-11, Additionally-1)
amod(levels-8, higher-3)
amod(levels-8, than-4)
amod(levels-8, expected-5)
amod(levels-8, tricyclic-6)
amod(levels-8, antidepressant-7)
nsubjpass(observed-11, levels-8)
aux(observed-11, have-9)
auxpass(observed-11, been-10)
root(ROOT-0, observed-11)
advmod(begun-15, when-12)
nsubjpass(begun-15, they-13)
auxpass(begun-15, are-14)
advcl(observed-11, begun-15)
prep_in(begun-15, patients-17)
advmod(taking-19, already-18)
partmod(patients-17, taking-19)
dobj(taking-19, cimetidine-20)

In/IN patients/NNS who/WP have/VBP been/VBN reported/VBN to/TO be/VB well/RB controlled/VBN on/IN tricyclic/JJ antidepressants/NNS receiving/VBG concurrent/JJ cimetidine/NN therapy/NN ,/, discontinuation/NN of/IN cimetidine/NN has/VBZ been/VBN reported/VBN to/TO decrease/VB established/JJ steady-state/JJ serum/NN tricyclic/JJ antidepressant/JJ levels/NNS and/CC compromise/VB their/PRP$ therapeutic/JJ effects/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (ADVP (RB well)) (VP (VBN controlled) (PP (IN on) (NP (NP (JJ tricyclic) (NNS antidepressants)) (VP (VBG receiving) (NP (JJ concurrent) (NN cimetidine) (NN therapy)))))))))))))))) (, ,) (NP (NP (NN discontinuation)) (PP (IN of) (NP (NN cimetidine)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VP (VB decrease) (NP (JJ established) (JJ steady-state) (NN serum) (JJ tricyclic) (JJ antidepressant) (NNS levels))) (CC and) (VP (VB compromise) (NP (PRP$ their) (JJ therapeutic) (NNS effects)))))))))) (. .))))

nsubjpass(reported-6, patients-2)
prep_in(reported-24, patients-2)
aux(reported-6, have-4)
auxpass(reported-6, been-5)
rcmod(patients-2, reported-6)
aux(controlled-10, to-7)
auxpass(controlled-10, be-8)
advmod(controlled-10, well-9)
xcomp(reported-6, controlled-10)
amod(antidepressants-13, tricyclic-12)
prep_on(controlled-10, antidepressants-13)
partmod(antidepressants-13, receiving-14)
amod(therapy-17, concurrent-15)
nn(therapy-17, cimetidine-16)
dobj(receiving-14, therapy-17)
nsubjpass(reported-24, discontinuation-19)
xsubj(decrease-26, discontinuation-19)
prep_of(discontinuation-19, cimetidine-21)
aux(reported-24, has-22)
auxpass(reported-24, been-23)
root(ROOT-0, reported-24)
aux(decrease-26, to-25)
xcomp(reported-24, decrease-26)
amod(levels-32, established-27)
amod(levels-32, steady-state-28)
nn(levels-32, serum-29)
amod(levels-32, tricyclic-30)
amod(levels-32, antidepressant-31)
dobj(decrease-26, levels-32)
conj_and(decrease-26, compromise-34)
poss(effects-37, their-35)
amod(effects-37, therapeutic-36)
dobj(compromise-34, effects-37)

Alcohol/NN :/: It/PRP should/MD be/VB borne/VBN in/IN mind/NN that/IN alcohol/NN ingestion/NN may/MD increase/VB the/DT danger/NN inherent/JJ in/IN any/DT intentional/JJ or/CC unintentional/JJ SINEQUAN/NN overdosage/NN ./.

(ROOT (S1 (S (NP (NP (NN Alcohol)) (: :) (S (NP (PRP It)) (VP (MD should) (VP (VB be) (VP (VBN borne) (PP (IN in) (NP (NN mind))) (SBAR (IN that) (S (NP (NN alcohol) (NN ingestion)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN danger)) (ADJP (JJ inherent) (PP (IN in) (NP (DT any) (ADJP (ADJP (JJ intentional)) (CC or) (ADJP (JJ unintentional))) (NN SINEQUAN) (NN overdosage))))))))))))) (. .)))))

root(ROOT-0, Alcohol-1)
nsubjpass(borne-6, It-3)
aux(borne-6, should-4)
auxpass(borne-6, be-5)
dep(Alcohol-1, borne-6)
prep_in(borne-6, mind-8)
complm(increase-13, that-9)
nn(ingestion-11, alcohol-10)
nsubj(increase-13, ingestion-11)
aux(increase-13, may-12)
ccomp(borne-6, increase-13)
det(danger-15, the-14)
dobj(increase-13, danger-15)
amod(danger-15, inherent-16)
det(overdosage-23, any-18)
amod(overdosage-23, intentional-19)
conj_or(intentional-19, unintentional-21)
nn(overdosage-23, SINEQUAN-22)
prep_in(inherent-16, overdosage-23)

This/DT is/VBZ especially/RB important/JJ in/IN patients/NNS who/WP may/MD use/VB alcohol/NN excessively/RB ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (VBZ is) (ADJP (RB especially) (JJ important) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (MD may) (VP (VB use) (NP (NN alcohol)) (ADVP (RB excessively))))))))))) (. .))))

nsubj(important-4, This-1)
cop(important-4, is-2)
advmod(important-4, especially-3)
root(ROOT-0, important-4)
prep_in(important-4, patients-6)
nsubj(use-9, patients-6)
aux(use-9, may-8)
rcmod(patients-6, use-9)
dobj(use-9, alcohol-10)
advmod(use-9, excessively-11)

Tolazamide/NN :/: A/DT case/NN of/IN severe/JJ hypoglycemia/NN has/VBZ been/VBN reported/VBN in/IN a/DT type/NN II/CD diabetic/JJ patient/NN maintained/VBN on/IN tolazamide/NN (/-LRB- 1/CD gm/day/NN )/-RRB- 11/CD days/NNS after/IN the/DT addition/NN of/IN doxepin/NN (/-LRB- 75/CD mg/day/NN )./NN

(ROOT (S1 (S (NP (NP (NN Tolazamide)) (: :) (S (NP (NP (DT A) (NN case)) (PP (IN of) (NP (JJ severe) (NN hypoglycemia)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (DT a) (NN type) (CD II) (JJ diabetic) (NN patient)) (VP (VBN maintained) (PP (IN on) (NP (NP (NN tolazamide)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN gm/day)) (-RRB- -RRB-)))) (PP (NP (CD 11) (NNS days)) (IN after) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN doxepin))))) (-LRB- -LRB-) (NP (ADJP (CD 75) (NN mg/day)) (NN -RRB-.)))))))))))))

root(ROOT-0, Tolazamide-1)
det(case-4, A-3)
nsubjpass(reported-10, case-4)
amod(hypoglycemia-7, severe-6)
prep_of(case-4, hypoglycemia-7)
aux(reported-10, has-8)
auxpass(reported-10, been-9)
dep(Tolazamide-1, reported-10)
det(patient-16, a-12)
nn(patient-16, type-13)
num(patient-16, II-14)
amod(patient-16, diabetic-15)
prep_in(reported-10, patient-16)
partmod(patient-16, maintained-17)
prep_on(maintained-17, tolazamide-19)
num(gm/day-22, 1-21)
appos(tolazamide-19, gm/day-22)
num(days-25, 11-24)
npadvmod(maintained-17, days-25)
det(addition-28, the-27)
prep_after(maintained-17, addition-28)
prep_of(addition-28, doxepin-30)
number(mg/day-33, 75-32)
amod(-RRB-.-34, mg/day-33)
dobj(maintained-17, -RRB-.-34)

Until/IN specific/JJ compatibility/NN data/NNS are/VBP available/JJ ,/, it/PRP is/VBZ not/RB recommended/VBN that/IN DOXIL/NN @/NN be/VB mixed/VBN with/IN other/JJ drugs/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Until) (S (NP (JJ specific) (NN compatibility) (NNS data)) (VP (VBP are) (ADJP (JJ available))))) (, ,) (NP (PRP it)) (VP (VBZ is) (RB not) (VP (VBN recommended) (SBAR (IN that) (S (NP (NN DOXIL) (NN @)) (VP (VB be) (VP (VBN mixed) (PP (IN with) (NP (JJ other) (NNS drugs)))))))))) (. .))))

mark(available-6, Until-1)
amod(data-4, specific-2)
nn(data-4, compatibility-3)
nsubj(available-6, data-4)
cop(available-6, are-5)
advcl(recommended-11, available-6)
nsubjpass(recommended-11, it-8)
auxpass(recommended-11, is-9)
neg(recommended-11, not-10)
root(ROOT-0, recommended-11)
complm(mixed-16, that-12)
nn(@-14, DOXIL-13)
nsubjpass(mixed-16, @-14)
auxpass(mixed-16, be-15)
ccomp(recommended-11, mixed-16)
amod(drugs-19, other-18)
prep_with(mixed-16, drugs-19)

DOXIL/NN @/NN may/MD interact/VB with/IN drugs/NNS known/VBN to/TO interact/VB with/IN the/DT conventional/JJ formulation/NN of/IN doxorubicin/NN HCl/NN ./.

(ROOT (S1 (S (S (NP (NN DOXIL) (NN @)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NP (NNS drugs)) (VP (VBN known) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NP (DT the) (JJ conventional) (NN formulation)) (PP (IN of) (NP (NN doxorubicin) (NN HCl)))))))))))))) (. .))))

nn(@-2, DOXIL-1)
nsubj(interact-4, @-2)
aux(interact-4, may-3)
root(ROOT-0, interact-4)
prep_with(interact-4, drugs-6)
xsubj(interact-9, drugs-6)
partmod(drugs-6, known-7)
aux(interact-9, to-8)
xcomp(known-7, interact-9)
det(formulation-13, the-11)
amod(formulation-13, conventional-12)
prep_with(interact-9, formulation-13)
nn(HCl-16, doxorubicin-15)
prep_of(formulation-13, HCl-16)

Because/IN tetracyclines/NNS have/VBP been/VBN shown/VBN to/TO depress/VB plasma/NN prothrombin/NN activity/NN ,/, patients/NNS who/WP are/VBP on/IN anticoagulant/NN therapy/NN may/MD require/VB downward/JJ adjustment/NN of/IN their/PRP$ anticoagulant/JJ dosage/NN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NNS tetracyclines)) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB depress) (NP (NN plasma) (NN prothrombin) (NN activity)))))))))) (, ,) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (PP (IN on) (NP (NN anticoagulant) (NN therapy))))))) (VP (MD may) (VP (VB require) (NP (NP (JJ downward) (NN adjustment)) (PP (IN of) (NP (PRP$ their) (JJ anticoagulant) (NN dosage))))))) (. .))))

mark(shown-5, Because-1)
nsubjpass(shown-5, tetracyclines-2)
xsubj(depress-7, tetracyclines-2)
aux(shown-5, have-3)
auxpass(shown-5, been-4)
advcl(require-19, shown-5)
aux(depress-7, to-6)
xcomp(shown-5, depress-7)
nn(activity-10, plasma-8)
nn(activity-10, prothrombin-9)
dobj(depress-7, activity-10)
nsubj(are-14, patients-12)
nsubj(require-19, patients-12)
rcmod(patients-12, are-14)
nn(therapy-17, anticoagulant-16)
prep_on(are-14, therapy-17)
aux(require-19, may-18)
root(ROOT-0, require-19)
amod(adjustment-21, downward-20)
dobj(require-19, adjustment-21)
poss(dosage-25, their-23)
amod(dosage-25, anticoagulant-24)
prep_of(adjustment-21, dosage-25)

Since/IN bacteriostat/NN ic/NN drugs/NNS may/MD interfere/VB with/IN the/DT bactericidal/JJ action/NN of/IN penicillin/NN ,/, it/PRP is/VBZ advisable/JJ to/TO avoid/VB giving/NN tetracyclines/NNS in/IN conjunction/NN with/IN penicillin/NN ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NN bacteriostat) (NN ic) (NNS drugs)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (JJ bactericidal) (NN action)) (PP (IN of) (NP (NN penicillin))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ advisable) (S (VP (TO to) (VP (VB avoid) (NP (NN giving) (NNS tetracyclines)) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (NN penicillin))))))))))) (. .))))

mark(interfere-6, Since-1)
nn(drugs-4, bacteriostat-2)
nn(drugs-4, ic-3)
nsubj(interfere-6, drugs-4)
aux(interfere-6, may-5)
advcl(advisable-16, interfere-6)
det(action-10, the-8)
amod(action-10, bactericidal-9)
prep_with(interfere-6, action-10)
prep_of(action-10, penicillin-12)
nsubj(advisable-16, it-14)
cop(advisable-16, is-15)
root(ROOT-0, advisable-16)
aux(avoid-18, to-17)
xcomp(advisable-16, avoid-18)
nn(tetracyclines-20, giving-19)
dobj(avoid-18, tetracyclines-20)
prep_in(avoid-18, conjunction-22)
prep_with(conjunction-22, penicillin-24)

Absorption/NN of/IN tetracyclines/NNS is/VBZ impaired/VBN by/IN antacids/NNS containing/VBG aluminum/NN ,/, calcium/NN ,/, or/CC magnesium/NN ,/, and/CC iron-containing/JJ preparations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Absorption)) (PP (IN of) (NP (NNS tetracyclines)))) (VP (VBZ is) (VP (VBN impaired) (PP (IN by) (NP (NP (NP (NNS antacids)) (VP (VBG containing) (NP (NP (NN aluminum)) (, ,) (NP (NN calcium)) (, ,) (CC or) (NP (NN magnesium))))) (, ,) (CC and) (NP (JJ iron-containing) (NNS preparations))))))) (. .))))

nsubjpass(impaired-5, Absorption-1)
prep_of(Absorption-1, tetracyclines-3)
auxpass(impaired-5, is-4)
root(ROOT-0, impaired-5)
agent(impaired-5, antacids-7)
partmod(antacids-7, containing-8)
dobj(containing-8, aluminum-9)
conj_or(aluminum-9, calcium-11)
conj_or(aluminum-9, magnesium-14)
amod(preparations-18, iron-containing-17)
conj_and(antacids-7, preparations-18)

Absorption/NN of/IN tetracycline/NN is/VBZ impaired/VBN by/IN bismuth/NN subsalicylate/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Absorption)) (PP (IN of) (NP (NN tetracycline)))) (VP (VBZ is) (VP (VBN impaired) (PP (IN by) (NP (NN bismuth) (NN subsalicylate)))))) (. .))))

nsubjpass(impaired-5, Absorption-1)
prep_of(Absorption-1, tetracycline-3)
auxpass(impaired-5, is-4)
root(ROOT-0, impaired-5)
nn(subsalicylate-8, bismuth-7)
agent(impaired-5, subsalicylate-8)

Barbiturates/NNS ,/, carbamazepine/NN ,/, and/CC phenytoin/NN decrease/VBP the/DT half-life/NN of/IN doxycycline/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Barbiturates)) (, ,) (NP (NP (NN carbamazepine)) (, ,) (CC and) (NP (NN phenytoin)))) (VP (VBP decrease) (NP (NP (DT the) (NN half-life)) (PP (IN of) (NP (NN doxycycline)))))) (. .))))

nsubj(decrease-7, Barbiturates-1)
appos(Barbiturates-1, carbamazepine-3)
conj_and(carbamazepine-3, phenytoin-6)
root(ROOT-0, decrease-7)
det(half-life-9, the-8)
dobj(decrease-7, half-life-9)
prep_of(half-life-9, doxycycline-11)

The/DT concurrent/JJ use/NN of/IN tetracycline/NN and/CC Penthrane/NN (/-LRB- methoxyflurane/NN )/-RRB- has/VBZ been/VBN reported/VBN to/TO result/VB in/IN fatal/JJ renal/JJ toxicity/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concurrent) (NN use)) (PP (IN of) (NP (NP (NN tetracycline)) (CC and) (NP (NP (NN Penthrane)) (PRN (-LRB- -LRB-) (NP (NN methoxyflurane)) (-RRB- -RRB-)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB result) (PP (IN in) (NP (JJ fatal) (JJ renal) (NN toxicity)))))))))) (. .))))

det(use-3, The-1)
amod(use-3, concurrent-2)
nsubjpass(reported-13, use-3)
xsubj(result-15, use-3)
prep_of(use-3, tetracycline-5)
conj_and(tetracycline-5, Penthrane-7)
appos(Penthrane-7, methoxyflurane-9)
aux(reported-13, has-11)
auxpass(reported-13, been-12)
root(ROOT-0, reported-13)
aux(result-15, to-14)
xcomp(reported-13, result-15)
amod(toxicity-19, fatal-17)
amod(toxicity-19, renal-18)
prep_in(result-15, toxicity-19)

Concurrent/JJ use/NN of/IN tetracycline/NN may/MD render/VB oral/JJ contraceptives/NNS less/CC effect/VB ive/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN use)) (PP (IN of) (NP (NN tetracycline)))) (VP (MD may) (VP (VP (VB render) (NP (JJ oral) (NNS contraceptives))) (CC less) (VP (VB effect) (NP (NN ive)))))) (. .))))

amod(use-2, Concurrent-1)
nsubj(render-6, use-2)
prep_of(use-2, tetracycline-4)
aux(render-6, may-5)
root(ROOT-0, render-6)
amod(contraceptives-8, oral-7)
dobj(render-6, contraceptives-8)
conj_less(render-6, effect-10)
dobj(effect-10, ive-11)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS False/JJ elevations/NNS of/IN urinary/JJ catecholamine/NN levels/NNS may/MD occur/VB due/JJ to/TO interference/NN with/IN the/DT fluorescence/NN test/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions) (JJ False) (NNS elevations)) (PP (IN of) (NP (JJ urinary) (NN catecholamine) (NNS levels)))) (VP (MD may) (VP (VB occur) (ADJP (JJ due) (PP (TO to) (NP (NP (NN interference)) (PP (IN with) (NP (DT the) (NN fluorescence) (NN test))))))))) (. .))))

nn(elevations-6, Drug-1)
nn(elevations-6, /Laboratory-2)
nn(elevations-6, Test-3)
nn(elevations-6, Interactions-4)
amod(elevations-6, False-5)
nsubj(occur-12, elevations-6)
amod(levels-10, urinary-8)
nn(levels-10, catecholamine-9)
prep_of(elevations-6, levels-10)
aux(occur-12, may-11)
root(ROOT-0, occur-12)
acomp(occur-12, due-13)
prep_to(due-13, interference-15)
det(test-19, the-17)
nn(test-19, fluorescence-18)
prep_with(interference-15, test-19)

Potential/JJ drug/NN interactions/NNS for/IN doxylamine/NN include/VBP ,/, increased/VBN seda/NN @/NN tion/NN if/IN doxylamine/NN is/VBZ combined/VBN with/IN other/JJ CNS/NN depressant/NN drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Potential) (NN drug) (NNS interactions)) (PP (IN for) (NP (NN doxylamine)))) (VP (VBP include) (, ,) (NP (NP (VBN increased) (NN seda) (NN @) (NN tion)) (SBAR (IN if) (S (NP (NN doxylamine)) (VP (VBZ is) (VP (VBN combined) (PP (IN with) (NP (JJ other) (NN CNS) (NN depressant) (NNS drugs)))))))))) (. .))))

amod(interactions-3, Potential-1)
nn(interactions-3, drug-2)
nsubj(include-6, interactions-3)
prep_for(interactions-3, doxylamine-5)
root(ROOT-0, include-6)
amod(tion-11, increased-8)
nn(tion-11, seda-9)
nn(tion-11, @-10)
dobj(include-6, tion-11)
mark(combined-15, if-12)
nsubjpass(combined-15, doxylamine-13)
auxpass(combined-15, is-14)
dep(tion-11, combined-15)
amod(drugs-20, other-17)
nn(drugs-20, CNS-18)
nn(drugs-20, depressant-19)
prep_with(combined-15, drugs-20)

Antihistamines/NNS may/MD partially/RB counteract/VB the/DT anticoagulation/NN effects/NNS of/IN heparin/NN or/CC warfarin/NN ./.

(ROOT (S1 (S (S (NP (NNS Antihistamines)) (VP (MD may) (ADVP (RB partially)) (VP (VB counteract) (NP (NP (DT the) (NN anticoagulation) (NNS effects)) (PP (IN of) (NP (NP (NN heparin)) (CC or) (NP (NN warfarin)))))))) (. .))))

nsubj(counteract-4, Antihistamines-1)
aux(counteract-4, may-2)
advmod(counteract-4, partially-3)
root(ROOT-0, counteract-4)
det(effects-7, the-5)
nn(effects-7, anticoagulation-6)
dobj(counteract-4, effects-7)
prep_of(effects-7, heparin-9)
conj_or(heparin-9, warfarin-11)

Doxylamine/NN may/MD enhance/VB the/DT effects/NNS of/IN epinephrine/NN ./.

(ROOT (S1 (S (S (NP (NN Doxylamine)) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN epinephrine))))))) (. .))))

nsubj(enhance-3, Doxylamine-1)
aux(enhance-3, may-2)
root(ROOT-0, enhance-3)
det(effects-5, the-4)
dobj(enhance-3, effects-5)
prep_of(effects-5, epinephrine-7)

Androgens/NNS may/MD increase/VB sensitivity/NN to/TO oral/JJ anticoagulahts/NNS ./.

(ROOT (S1 (S (S (NP (NNS Androgens)) (VP (MD may) (VP (VB increase) (NP (NP (NN sensitivity)) (PP (TO to) (NP (JJ oral) (NNS anticoagulahts))))))) (. .))))

nsubj(increase-3, Androgens-1)
aux(increase-3, may-2)
root(ROOT-0, increase-3)
dobj(increase-3, sensitivity-4)
amod(anticoagulahts-7, oral-6)
prep_to(sensitivity-4, anticoagulahts-7)

Dosage/NN of/IN the/DT anticoagulant/NN may/MD require/VB reduction/NN in/IN order/NN to/TO maintain/VB satisfactory/JJ therapeutic/JJ hypoprothrombinemia/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Dosage)) (PP (IN of) (NP (DT the) (NN anticoagulant)))) (VP (MD may) (VP (VB require) (NP (NN reduction))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB maintain) (NP (JJ satisfactory) (JJ therapeutic) (NN hypoprothrombinemia)))))))) (. .))))

nsubj(require-6, Dosage-1)
det(anticoagulant-4, the-3)
prep_of(Dosage-1, anticoagulant-4)
aux(require-6, may-5)
root(ROOT-0, require-6)
dobj(require-6, reduction-7)
mark(maintain-11, in-8)
dep(maintain-11, order-9)
aux(maintain-11, to-10)
purpcl(require-6, maintain-11)
amod(hypoprothrombinemia-14, satisfactory-12)
amod(hypoprothrombinemia-14, therapeutic-13)
dobj(maintain-11, hypoprothrombinemia-14)

Concurrent/JJ administration/NN of/IN oxyphenbutazone/NN and/CC androgens/NNS may/MD result/VB in/IN elevated/JJ serum/NN levels/NNS of/IN oxyphenbutazone/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN administration)) (PP (IN of) (NP (NP (NN oxyphenbutazone)) (CC and) (NP (NNS androgens))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (JJ elevated) (NN serum) (NNS levels)) (PP (IN of) (NP (NN oxyphenbutazone)))))))) (. .))))

amod(administration-2, Concurrent-1)
nsubj(result-8, administration-2)
prep_of(administration-2, oxyphenbutazone-4)
conj_and(oxyphenbutazone-4, androgens-6)
aux(result-8, may-7)
root(ROOT-0, result-8)
amod(levels-12, elevated-10)
nn(levels-12, serum-11)
prep_in(result-8, levels-12)
prep_of(levels-12, oxyphenbutazone-14)

In/IN diabetic/JJ patients/NNS ,/, the/DT metabolic/JJ effects/NNS of/IN androgens/NNS may/MD decrease/VB blood/NN glucose/NN and/CC therefore/RB ,/, insulin/NN requirements/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ diabetic) (NNS patients))) (, ,) (NP (NP (DT the) (JJ metabolic) (NNS effects)) (PP (IN of) (NP (NNS androgens)))) (VP (MD may) (VP (VP (VB decrease) (NP (NN blood) (NN glucose))) (CC and) (ADVP (RB therefore)) (, ,) (NP (NN insulin) (NNS requirements))))) (. .))))

amod(patients-3, diabetic-2)
prep_in(decrease-11, patients-3)
det(effects-7, the-5)
amod(effects-7, metabolic-6)
nsubj(decrease-11, effects-7)
prep_of(effects-7, androgens-9)
aux(decrease-11, may-10)
root(ROOT-0, decrease-11)
nn(glucose-13, blood-12)
dobj(decrease-11, glucose-13)
advmod(decrease-11, therefore-15)
conj_and(decrease-11, therefore-15)
nn(requirements-18, insulin-17)
conj_and(decrease-11, requirements-18)
dobj(decrease-11, requirements-18)

Other/JJ CNS/NN depressant/NN drugs/NNS (/-LRB- e.g./FW barbiturates/NNS ,/, tranquilizers/NNS ,/, opioids/NNS and/CC general/JJ anesthetics/NNS )/-RRB- have/VBP additive/JJ or/CC potentiating/NN effects/NNS with/IN INAPSINE/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Other) (NN CNS) (NN depressant) (NNS drugs)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (NP (NP (NNS barbiturates)) (, ,) (NP (NNS tranquilizers)) (, ,) (NP (NNS opioids)) (CC and) (NP (JJ general) (NNS anesthetics))) (-RRB- -RRB-))) (VP (VBP have) (NP (JJ additive) (CC or) (NN potentiating) (NNS effects)) (PP (IN with) (NP (NN INAPSINE))))) (. .))))

amod(drugs-4, Other-1)
nn(drugs-4, CNS-2)
nn(drugs-4, depressant-3)
nsubj(have-16, drugs-4)
dep(barbiturates-7, e.g.-6)
dep(drugs-4, barbiturates-7)
conj_and(barbiturates-7, tranquilizers-9)
conj_and(barbiturates-7, opioids-11)
amod(anesthetics-14, general-13)
conj_and(barbiturates-7, anesthetics-14)
root(ROOT-0, have-16)
amod(effects-20, additive-17)
conj_or(additive-17, potentiating-19)
dobj(have-16, effects-20)
prep_with(have-16, INAPSINE-22)

When/WRB patients/NNS have/VBP received/VBN such/JJ drugs/NNS ,/, the/DT dose/NN of/IN INAPSINE/NN required/VBN will/MD be/VB less/JJR than/IN usual/JJ ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NNS patients)) (VP (VBP have) (VP (VBN received) (NP (JJ such) (NNS drugs)))))) (, ,) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NP (NN INAPSINE)) (VP (VBN required))))) (VP (MD will) (VP (VB be) (ADJP (ADJP (JJR less)) (PP (IN than) (NP (JJ usual))))))) (. .))))

advmod(received-4, When-1)
nsubj(received-4, patients-2)
aux(received-4, have-3)
advcl(less-15, received-4)
amod(drugs-6, such-5)
dobj(received-4, drugs-6)
det(dose-9, the-8)
nsubj(less-15, dose-9)
prep_of(dose-9, INAPSINE-11)
partmod(INAPSINE-11, required-12)
aux(less-15, will-13)
cop(less-15, be-14)
root(ROOT-0, less-15)
prep_than(less-15, usual-17)

Following/VBG the/DT administration/NN of/IN INAPSINE/NN ,/, the/DT dose/NN of/IN other/JJ CNS/NN depressant/NN drugs/NNS should/MD be/VB reduced/VBN ./.

(ROOT (S1 (S (S (PP (VBG Following) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NN INAPSINE))))) (, ,) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (JJ other) (NN CNS) (NN depressant) (NNS drugs)))) (VP (MD should) (VP (VB be) (VP (VBN reduced))))) (. .))))

det(administration-3, the-2)
prep_following(reduced-16, administration-3)
prep_of(administration-3, INAPSINE-5)
det(dose-8, the-7)
nsubjpass(reduced-16, dose-8)
amod(drugs-13, other-10)
nn(drugs-13, CNS-11)
nn(drugs-13, depressant-12)
prep_of(dose-8, drugs-13)
aux(reduced-16, should-14)
auxpass(reduced-16, be-15)
root(ROOT-0, reduced-16)

Potential/NN for/IN Other/JJ Drugs/NNS to/TO Affect/VB Duloxetine/NN :/: Both/CC CYP1A2/NN and/CC CYP2D6/NN are/VBP responsible/JJ for/IN duloxetine/NN metabolism/NN ./.

(ROOT (S1 (S (S (S (NP (NP (NN Potential)) (PP (IN for) (NP (JJ Other) (NNS Drugs)))) (VP (TO to) (VP (VB Affect) (NP (NN Duloxetine))))) (: :) (S (NP (CC Both) (NP (NN CYP1A2)) (CC and) (NP (NN CYP2D6))) (VP (VBP are) (ADJP (JJ responsible) (PP (IN for) (NP (NN duloxetine) (NN metabolism))))))) (. .))))

nsubj(Affect-6, Potential-1)
amod(Drugs-4, Other-3)
prep_for(Potential-1, Drugs-4)
aux(Affect-6, to-5)
root(ROOT-0, Affect-6)
dobj(Affect-6, Duloxetine-7)
preconj(CYP1A2-10, Both-9)
nsubj(responsible-14, CYP1A2-10)
conj_and(CYP1A2-10, CYP2D6-12)
cop(responsible-14, are-13)
parataxis(Affect-6, responsible-14)
nn(metabolism-17, duloxetine-16)
prep_for(responsible-14, metabolism-17)

Inhibitors/NNS of/IN CYP1A2/NN :/: Concomitant/JJ use/NN of/IN duloxetine/NN with/IN fluvoxamine/NN ,/, an/DT inhibitor/NN of/IN CYP1A2/NN ,/, results/VBZ in/IN approximately/RB a/DT 6-fold/RB increase/NN in/IN AUC/NN and/CC about/RB a/DT 2.5-fold/JJ increase/NN in/IN Cmax/NN of/IN duloxetine/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Inhibitors)) (PP (IN of) (NP (NN CYP1A2)))) (: :) (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NN duloxetine))) (PP (IN with) (NP (NP (NN fluvoxamine)) (, ,) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN CYP1A2)))) (, ,)))) (VP (VBZ results) (PP (IN in) (NP (NP (NP (RB approximately) (DT a) (ADJP (RB 6-fold)) (NN increase)) (PP (IN in) (NP (NN AUC)))) (CC and) (NP (NP (RB about) (DT a) (JJ 2.5-fold) (NN increase)) (PP (IN in) (NP (NP (NN Cmax)) (PP (IN of) (NP (NN duloxetine)))))))))) (. .)))))

root(ROOT-0, Inhibitors-1)
prep_of(Inhibitors-1, CYP1A2-3)
amod(use-6, Concomitant-5)
nsubj(results-17, use-6)
prep_of(use-6, duloxetine-8)
prep_with(use-6, fluvoxamine-10)
det(inhibitor-13, an-12)
appos(fluvoxamine-10, inhibitor-13)
prep_of(inhibitor-13, CYP1A2-15)
dep(Inhibitors-1, results-17)
advmod(increase-22, approximately-19)
det(increase-22, a-20)
amod(increase-22, 6-fold-21)
prep_in(results-17, increase-22)
prep_in(increase-22, AUC-24)
advmod(increase-29, about-26)
det(increase-29, a-27)
amod(increase-29, 2.5-fold-28)
conj_and(increase-22, increase-29)
prep_in(increase-29, Cmax-31)
prep_of(Cmax-31, duloxetine-33)

Some/DT quinolone/NN antibiotic/JJ s/NNS would/MD be/VB expected/VBN to/TO have/VB similar/JJ effects/NNS and/CC these/DT combinations/NNS should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (S (NP (DT Some) (NN quinolone) (JJ antibiotic) (NNS s)) (VP (MD would) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB have) (NP (JJ similar) (NNS effects))))))))) (CC and) (S (NP (DT these) (NNS combinations)) (VP (MD should) (VP (VB be) (VP (VBN avoided)))))) (. .))))

det(s-4, Some-1)
nn(s-4, quinolone-2)
amod(s-4, antibiotic-3)
nsubjpass(expected-7, s-4)
aux(expected-7, would-5)
auxpass(expected-7, be-6)
root(ROOT-0, expected-7)
aux(have-9, to-8)
xcomp(expected-7, have-9)
amod(effects-11, similar-10)
dobj(have-9, effects-11)
det(combinations-14, these-13)
nsubjpass(avoided-17, combinations-14)
aux(avoided-17, should-15)
auxpass(avoided-17, be-16)
conj_and(expected-7, avoided-17)

Inhibitors/NNS of/IN CYP2D6/NN :/: Because/IN CYP2D6/NN is/VBZ involved/VBN in/IN duloxetine/NN metabolism/NN ,/, concomitant/JJ use/NN of/IN duloxetine/NN with/IN potent/JJ inhibitors/NNS of/IN CYP2D6/NN may/MD result/VB in/IN higher/JJR concentrations/NNS of/IN duloxetine/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Inhibitors)) (PP (IN of) (NP (NN CYP2D6)))) (: :) (S (SBAR (IN Because) (S (NP (NN CYP2D6)) (VP (VBZ is) (VP (VBN involved) (PP (IN in) (NP (NN duloxetine) (NN metabolism))))))) (, ,) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NN duloxetine))) (PP (IN with) (NP (NP (JJ potent) (NNS inhibitors)) (PP (IN of) (NP (NN CYP2D6)))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (JJR higher) (NNS concentrations)) (PP (IN of) (NP (NN duloxetine)))))))) (. .)))))

root(ROOT-0, Inhibitors-1)
prep_of(Inhibitors-1, CYP2D6-3)
mark(involved-8, Because-5)
nsubjpass(involved-8, CYP2D6-6)
auxpass(involved-8, is-7)
advcl(result-23, involved-8)
nn(metabolism-11, duloxetine-10)
prep_in(involved-8, metabolism-11)
amod(use-14, concomitant-13)
nsubj(result-23, use-14)
prep_of(use-14, duloxetine-16)
amod(inhibitors-19, potent-18)
prep_with(use-14, inhibitors-19)
prep_of(inhibitors-19, CYP2D6-21)
aux(result-23, may-22)
dep(Inhibitors-1, result-23)
amod(concentrations-26, higher-25)
prep_in(result-23, concentrations-26)
prep_of(concentrations-26, duloxetine-28)

Paroxetine/NN (/-LRB- 20/CD mg/NN QD/NN )/-RRB- increased/VBD the/DT concentration/NN of/IN duloxetine/NN (/-LRB- 40/CD mg/NN QD/NN )/-RRB- by/IN about/RB 60/CD %/NN ,/, and/CC greater/JJR degrees/NNS of/IN inhibition/NN are/VBP expected/VBN with/IN higher/JJR doses/NNS of/IN paroxetine/NN ./.

(ROOT (S1 (S (S (S (NP (NP (NN Paroxetine)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 20) (NN mg)) (NN QD)) (-RRB- -RRB-))) (VP (VBD increased) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NP (NN duloxetine)) (PRN (-LRB- -LRB-) (NP (CD 40) (NN mg) (NN QD)) (-RRB- -RRB-))))) (PP (IN by) (NP (QP (RB about) (CD 60)) (NN %))))) (, ,) (CC and) (S (NP (NP (JJR greater) (NNS degrees)) (PP (IN of) (NP (NN inhibition)))) (VP (VBP are) (VP (VBN expected) (PP (IN with) (NP (NP (JJR higher) (NNS doses)) (PP (IN of) (NP (NN paroxetine))))))))) (. .))))

nsubj(increased-7, Paroxetine-1)
number(mg-4, 20-3)
amod(QD-5, mg-4)
appos(Paroxetine-1, QD-5)
root(ROOT-0, increased-7)
det(concentration-9, the-8)
dobj(increased-7, concentration-9)
prep_of(concentration-9, duloxetine-11)
num(QD-15, 40-13)
nn(QD-15, mg-14)
appos(duloxetine-11, QD-15)
quantmod(60-19, about-18)
num(%-20, 60-19)
prep_by(increased-7, %-20)
amod(degrees-24, greater-23)
nsubjpass(expected-28, degrees-24)
prep_of(degrees-24, inhibition-26)
auxpass(expected-28, are-27)
conj_and(increased-7, expected-28)
amod(doses-31, higher-30)
prep_with(expected-28, doses-31)
prep_of(doses-31, paroxetine-33)

Similar/JJ effects/NNS would/MD be/VB expected/VBN with/IN other/JJ potent/JJ CYP2D6/NN inhibitors/NNS (/-LRB- e.g./FW ,/, fluoxetine/NN ,/, quinidine/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (JJ Similar) (NNS effects)) (VP (MD would) (VP (VB be) (VP (VBN expected) (PP (IN with) (NP (NP (JJ other) (JJ potent) (NN CYP2D6) (NNS inhibitors)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN fluoxetine)) (, ,) (NP (NN quinidine))) (-RRB- -RRB-)))))))) (. .))))

amod(effects-2, Similar-1)
nsubjpass(expected-5, effects-2)
aux(expected-5, would-3)
auxpass(expected-5, be-4)
root(ROOT-0, expected-5)
amod(inhibitors-10, other-7)
amod(inhibitors-10, potent-8)
nn(inhibitors-10, CYP2D6-9)
prep_with(expected-5, inhibitors-10)
dep(fluoxetine-14, e.g.-12)
dep(inhibitors-10, fluoxetine-14)
appos(fluoxetine-14, quinidine-16)

Potential/NN for/IN Duloxetine/NN to/TO Affect/VB Other/JJ Drugs/NNS :/: Drugs/NNS Metabolized/VBN by/IN CYP1A2/NN :/: In/FW vitro/FW drug/NN interaction/NN studies/NNS demonstrate/VBP that/IN duloxetine/NN does/VBZ not/RB induce/VB CYP1A2/NN activity/NN ,/, and/CC it/PRP is/VBZ unlikely/JJ to/TO have/VB a/DT clinically/RB significant/JJ effect/NN on/IN the/DT metabolism/NN of/IN CYP1A2/NN substrates/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Potential)) (PP (IN for) (NP (NN Duloxetine))) (S (VP (TO to) (VP (VB Affect) (NP (JJ Other) (NNS Drugs)))))) (: :) (S (NP (NNS Drugs)) (VP (VBN Metabolized) (PP (IN by) (NP (NN CYP1A2))))) (: :) (S (NP (ADJP (FW In) (FW vitro)) (NN drug) (NN interaction) (NNS studies)) (VP (VBP demonstrate) (SBAR (IN that) (S (S (NP (NN duloxetine)) (VP (VBZ does) (RB not) (VP (VB induce) (NP (NN CYP1A2) (NN activity))))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB have) (NP (NP (DT a) (ADJP (RB clinically) (JJ significant)) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN CYP1A2) (NNS substrates))))))))))))))))) (. .))))

dep(Metabolized-10, Potential-1)
prep_for(Potential-1, Duloxetine-3)
aux(Affect-5, to-4)
infmod(Potential-1, Affect-5)
amod(Drugs-7, Other-6)
dobj(Affect-5, Drugs-7)
nsubj(Metabolized-10, Drugs-9)
root(ROOT-0, Metabolized-10)
prep_by(Metabolized-10, CYP1A2-12)
nn(vitro-15, In-14)
amod(studies-18, vitro-15)
nn(studies-18, drug-16)
nn(studies-18, interaction-17)
nsubj(demonstrate-19, studies-18)
parataxis(Metabolized-10, demonstrate-19)
complm(induce-24, that-20)
nsubj(induce-24, duloxetine-21)
aux(induce-24, does-22)
neg(induce-24, not-23)
ccomp(demonstrate-19, induce-24)
nn(activity-26, CYP1A2-25)
dobj(induce-24, activity-26)
nsubj(unlikely-31, it-29)
cop(unlikely-31, is-30)
conj_and(induce-24, unlikely-31)
aux(have-33, to-32)
xcomp(unlikely-31, have-33)
det(effect-37, a-34)
advmod(significant-36, clinically-35)
amod(effect-37, significant-36)
dobj(have-33, effect-37)
det(metabolism-40, the-39)
prep_on(effect-37, metabolism-40)
nn(substrates-43, CYP1A2-42)
prep_of(metabolism-40, substrates-43)

Drugs/NNS Metabolized/VBN by/IN CYP2D6/NN :/: Duloxetine/NN is/VBZ a/DT moderate/JJ inhibitor/NN of/IN CYP2D6/NN ./.

(ROOT (S1 (S (S (S (NP (NNS Drugs)) (VP (VBN Metabolized) (PP (IN by) (NP (NN CYP2D6))))) (: :) (S (NP (NN Duloxetine)) (VP (VBZ is) (NP (NP (DT a) (JJ moderate) (NN inhibitor)) (PP (IN of) (NP (NN CYP2D6))))))) (. .))))

nsubj(Metabolized-2, Drugs-1)
root(ROOT-0, Metabolized-2)
prep_by(Metabolized-2, CYP2D6-4)
nsubj(inhibitor-10, Duloxetine-6)
cop(inhibitor-10, is-7)
det(inhibitor-10, a-8)
amod(inhibitor-10, moderate-9)
parataxis(Metabolized-2, inhibitor-10)
prep_of(inhibitor-10, CYP2D6-12)

When/WRB duloxetine/NN was/VBD administered/VBN (/-LRB- at/IN a/DT dose/NN of/IN 60/CD mg/NN BID/NN )/-RRB- in/IN conjunction/NN with/IN a/DT single/JJ 50-mg/JJ dose/NN of/IN desipramine/NN ,/, a/DT CYP2D6/NN substrate/NN ,/, the/DT AUC/NN of/IN desipramine/NN increased/VBD 3-fold/RB ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN duloxetine)) (VP (VBD was) (VP (VBN administered) (PRN (-LRB- -LRB-) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (ADJP (CD 60) (NN mg)) (NN BID))))) (-RRB- -RRB-)) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (NP (DT a) (JJ single) (JJ 50-mg) (NN dose)) (PP (IN of) (NP (NP (NN desipramine)) (, ,) (NP (DT a) (NN CYP2D6) (NN substrate)))))))))))) (, ,) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NN desipramine)))) (VP (VBD increased) (ADVP (RB 3-fold)))) (. .))))

advmod(administered-4, When-1)
nsubjpass(administered-4, duloxetine-2)
auxpass(administered-4, was-3)
advcl(increased-32, administered-4)
dep(administered-4, at-6)
det(dose-8, a-7)
pobj(at-6, dose-8)
number(mg-11, 60-10)
amod(BID-12, mg-11)
prep_of(dose-8, BID-12)
prep_in(administered-4, conjunction-15)
det(dose-20, a-17)
amod(dose-20, single-18)
amod(dose-20, 50-mg-19)
prep_with(conjunction-15, dose-20)
prep_of(dose-20, desipramine-22)
det(substrate-26, a-24)
nn(substrate-26, CYP2D6-25)
appos(desipramine-22, substrate-26)
det(AUC-29, the-28)
nsubj(increased-32, AUC-29)
prep_of(AUC-29, desipramine-31)
root(ROOT-0, increased-32)
advmod(increased-32, 3-fold-33)

Therefore/RB ,/, co-administration/NN of/IN Duloxetine/NN with/IN other/JJ drugs/NNS that/WDT are/VBP extensively/RB metabolized/VBN by/IN this/DT isozyme/NN and/CC which/WDT have/VBP a/DT narrow/JJ therapeutic/JJ index/NN ,/, including/VBG certain/JJ antidepressants/NNS (/-LRB- tricyclic/JJ antidepressants/NNS [TCAs/NNS ]/-RRB- ,/, such/JJ as/IN nortriptyline/NN ,/, amitriptyline/NN ,/, and/CC imipramine/NN )/-RRB- ,/, phenothiazines/NNS and/CC Type/NN 1C/NN antiarrhythmics/NNS (/-LRB- e.g./FW ,/, propafenone/NN ,/, flecainide/NN )/-RRB- ,/, should/MD be/VB approached/VBN with/IN caution/NN ./.

(ROOT (S1 (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN co-administration)) (PP (IN of) (NP (NN Duloxetine))) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (SBAR (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (ADVP (RB extensively)) (VBN metabolized) (PP (IN by) (NP (DT this) (NN isozyme))))))) (CC and) (SBAR (WHNP (WDT which)) (S (VP (VBP have) (NP (DT a) (JJ narrow) (JJ therapeutic) (NN index)))))) (, ,) (PP (VBG including) (NP (NP (NP (NP (JJ certain) (NNS antidepressants)) (PRN (-LRB- -LRB-) (NP (NP (JJ tricyclic) (NNS antidepressants)) (NNS -LSB-TCAs)) (-RRB- -RSB-))) (PRN (, ,) (ADJP (JJ such) (PP (IN as) (NP (NP (NN nortriptyline)) (, ,) (NP (NN amitriptyline)) (, ,) (CC and) (NP (NN imipramine))))) (-RRB- -RRB-))) (, ,) (NP (NNS phenothiazines)) (CC and) (NP (NP (NN Type) (NN 1C) (NNS antiarrhythmics)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN propafenone))) (, ,) (NP (NN flecainide)) (-RRB- -RRB-))))) (, ,)))) (VP (MD should) (VP (VB be) (VP (VBN approached) (PP (IN with) (NP (NN caution)))))) (. .))))

advmod(approached-58, Therefore-1)
nsubjpass(approached-58, co-administration-3)
prep_of(co-administration-3, Duloxetine-5)
amod(drugs-8, other-7)
prep_with(co-administration-3, drugs-8)
nsubjpass(metabolized-12, drugs-8)
nsubj(have-18, drugs-8)
auxpass(metabolized-12, are-10)
advmod(metabolized-12, extensively-11)
rcmod(drugs-8, metabolized-12)
det(isozyme-15, this-14)
agent(metabolized-12, isozyme-15)
conj_and(metabolized-12, have-18)
det(index-22, a-19)
amod(index-22, narrow-20)
amod(index-22, therapeutic-21)
dobj(have-18, index-22)
amod(antidepressants-26, certain-25)
prep_including(drugs-8, antidepressants-26)
amod(antidepressants-29, tricyclic-28)
nn(-LSB-TCAs-30, antidepressants-29)
appos(antidepressants-26, -LSB-TCAs-30)
punct(-LSB-TCAs-30, -RSB--31)
prep_such_as(antidepressants-26, nortriptyline-35)
conj_and(nortriptyline-35, amitriptyline-37)
conj_and(nortriptyline-35, imipramine-40)
conj_and(antidepressants-26, phenothiazines-43)
nn(antiarrhythmics-47, Type-45)
nn(antiarrhythmics-47, 1C-46)
conj_and(antidepressants-26, antiarrhythmics-47)
dep(flecainide-53, e.g.-49)
pobj(e.g.-49, propafenone-51)
appos(antiarrhythmics-47, flecainide-53)
aux(approached-58, should-56)
auxpass(approached-58, be-57)
root(ROOT-0, approached-58)
prep_with(approached-58, caution-60)

Plasma/NN TCA/NN concentrations/NNS may/MD need/VBP to/TO be/VB monitored/VBN and/CC the/DT dose/NN of/IN the/DT TCA/NN may/MD need/VBP to/TO be/VB reduced/VBN if/IN a/DT TCA/NN is/VBZ co-administered/VBN with/IN Duloxetine/NN ./.

(ROOT (S1 (S (S (S (NP (NN Plasma) (NN TCA) (NNS concentrations)) (VP (MD may) (VP (VBP need) (S (VP (TO to) (VP (VB be) (VP (VBN monitored)))))))) (CC and) (S (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (DT the) (NN TCA)))) (VP (MD may) (VP (VBP need) (S (VP (TO to) (VP (VB be) (VP (VBN reduced) (SBAR (IN if) (S (NP (DT a) (NN TCA)) (VP (VBZ is) (VP (VBN co-administered) (PP (IN with) (NP (NN Duloxetine))))))))))))))) (. .))))

nn(concentrations-3, Plasma-1)
nn(concentrations-3, TCA-2)
nsubj(need-5, concentrations-3)
xsubj(monitored-8, concentrations-3)
aux(need-5, may-4)
root(ROOT-0, need-5)
aux(monitored-8, to-6)
auxpass(monitored-8, be-7)
xcomp(need-5, monitored-8)
det(dose-11, the-10)
nsubj(need-16, dose-11)
xsubj(reduced-19, dose-11)
det(TCA-14, the-13)
prep_of(dose-11, TCA-14)
aux(need-16, may-15)
conj_and(need-5, need-16)
aux(reduced-19, to-17)
auxpass(reduced-19, be-18)
xcomp(need-16, reduced-19)
mark(co-administered-24, if-20)
det(TCA-22, a-21)
nsubjpass(co-administered-24, TCA-22)
auxpass(co-administered-24, is-23)
advcl(reduced-19, co-administered-24)
prep_with(co-administered-24, Duloxetine-26)

Because/IN of/IN the/DT risk/NN of/IN serious/JJ ventricular/JJ arrhythmias/NNS and/CC sudden/NN death/NN potentially/RB associated/VBN with/IN elevated/JJ plasma/NN levels/NNS of/IN thioridazine/NN ,/, Duloxetine/NN and/CC thioridazine/NN should/MD not/RB be/VB co-administered/VBN ./.

(ROOT (S1 (S (S (PP (IN Because) (PP (IN of) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (JJ serious) (JJ ventricular) (NNS arrhythmias)) (CC and) (NP (NN sudden) (NN death)))) (VP (ADVP (RB potentially)) (VBN associated) (PP (IN with) (NP (NP (JJ elevated) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN thioridazine))))))))) (, ,) (NP (NP (NN Duloxetine)) (CC and) (NP (NN thioridazine))) (VP (MD should) (RB not) (VP (VB be) (VP (VBN co-administered))))) (. .))))

prepc_because_of(co-administered-27, of-2)
det(risk-4, the-3)
pobj(co-administered-27, risk-4)
amod(arrhythmias-8, serious-6)
amod(arrhythmias-8, ventricular-7)
prep_of(risk-4, arrhythmias-8)
nn(death-11, sudden-10)
conj_and(arrhythmias-8, death-11)
advmod(associated-13, potentially-12)
partmod(risk-4, associated-13)
amod(levels-17, elevated-15)
nn(levels-17, plasma-16)
prep_with(associated-13, levels-17)
prep_of(levels-17, thioridazine-19)
nsubjpass(co-administered-27, Duloxetine-21)
conj_and(Duloxetine-21, thioridazine-23)
aux(co-administered-27, should-24)
neg(co-administered-27, not-25)
auxpass(co-administered-27, be-26)
root(ROOT-0, co-administered-27)

Drugs/NNS Metabolized/VBN by/IN CYP3A/NN :/: Results/NNS of/IN in/FW vitro/FW studies/NNS demonstrate/VBP that/IN duloxetine/NN does/VBZ not/RB inhibit/VB or/CC induce/VB CYP3A/NN activity/NN ./.

(ROOT (S1 (S (S (S (NP (NNS Drugs)) (VP (VBN Metabolized) (PP (IN by) (NP (NN CYP3A))))) (: :) (S (NP (NP (NNS Results)) (PP (IN of) (NP (ADJP (FW in) (FW vitro)) (NNS studies)))) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN duloxetine)) (VP (VBZ does) (RB not) (VP (VP (VB inhibit)) (CC or) (VP (VB induce) (NP (NN CYP3A) (NN activity)))))))))) (. .))))

nsubj(Metabolized-2, Drugs-1)
root(ROOT-0, Metabolized-2)
prep_by(Metabolized-2, CYP3A-4)
nsubj(demonstrate-11, Results-6)
nn(vitro-9, in-8)
amod(studies-10, vitro-9)
prep_of(Results-6, studies-10)
parataxis(Metabolized-2, demonstrate-11)
complm(inhibit-16, that-12)
nsubj(inhibit-16, duloxetine-13)
aux(inhibit-16, does-14)
neg(inhibit-16, not-15)
ccomp(demonstrate-11, inhibit-16)
conj_or(inhibit-16, induce-18)
nn(activity-20, CYP3A-19)
dobj(induce-18, activity-20)

Duloxetine/NN May/MD Have/VB a/DT Clinically/RB Important/JJ Interaction/NN with/IN the/DT Following/JJ Other/JJ Drugs/NNS :/: Alcohol/NN :/: When/WRB Duloxetine/NN and/CC ethanol/NN were/VBD administered/VBN several/JJ hours/NNS apart/RB so/RB that/IN peak/NN concentrations/NNS of/IN each/DT would/MD coincide/VB ,/, Duloxetine/NN did/VBD not/RB increase/VB the/DT impairment/NN of/IN mental/JJ and/CC motor/NN skills/NNS caused/VBN by/IN alcohol/NN ./.

(ROOT (S1 (S (S (NP (NN Duloxetine)) (VP (MD May) (VP (VB Have) (NP (NP (DT a) (ADJP (RB Clinically) (JJ Important)) (NN Interaction)) (PP (IN with) (NP (NP (DT the) (JJ Following) (JJ Other) (NNS Drugs)) (: :) (NP (NP (NN Alcohol)) (: :) (S (SBAR (WHADVP (WRB When)) (S (NP (NP (NN Duloxetine)) (CC and) (NP (NN ethanol))) (VP (VBD were) (VP (VBN administered) (NP (JJ several) (NNS hours)) (ADVP (RB apart)) (ADVP (RB so)) (SBAR (IN that) (S (NP (NP (NN peak) (NNS concentrations)) (PP (IN of) (NP (DT each)))) (VP (MD would) (VP (VB coincide))))))))) (, ,) (NP (NN Duloxetine)) (VP (VBD did) (RB not) (VP (VB increase) (NP (NP (DT the) (NN impairment)) (PP (IN of) (NP (NP (JJ mental) (CC and) (NN motor) (NNS skills)) (VP (VBN caused) (PP (IN by) (NP (NN alcohol))))))))))))))))) (. .))))

nsubj(Have-3, Duloxetine-1)
aux(Have-3, May-2)
root(ROOT-0, Have-3)
det(Interaction-7, a-4)
advmod(Important-6, Clinically-5)
amod(Interaction-7, Important-6)
dobj(Have-3, Interaction-7)
det(Drugs-12, the-9)
amod(Drugs-12, Following-10)
amod(Drugs-12, Other-11)
prep_with(Interaction-7, Drugs-12)
dep(Drugs-12, Alcohol-14)
advmod(administered-21, When-16)
nsubjpass(administered-21, Duloxetine-17)
conj_and(Duloxetine-17, ethanol-19)
auxpass(administered-21, were-20)
advcl(increase-37, administered-21)
amod(hours-23, several-22)
dobj(administered-21, hours-23)
advmod(administered-21, apart-24)
advmod(administered-21, so-25)
complm(coincide-32, that-26)
nn(concentrations-28, peak-27)
nsubj(coincide-32, concentrations-28)
prep_of(concentrations-28, each-30)
aux(coincide-32, would-31)
ccomp(administered-21, coincide-32)
nsubj(increase-37, Duloxetine-34)
aux(increase-37, did-35)
neg(increase-37, not-36)
dep(Alcohol-14, increase-37)
det(impairment-39, the-38)
dobj(increase-37, impairment-39)
amod(skills-44, mental-41)
conj_and(mental-41, motor-43)
prep_of(impairment-39, skills-44)
partmod(skills-44, caused-45)
agent(caused-45, alcohol-47)

In/IN the/DT Duloxetine/NN clinical/JJ trials/NNS database/NN ,/, three/CD Duloxetine/NN -treated/JJ patients/NNS had/VBD liver/NN injury/NN as/IN manifested/VBN by/IN ALT/NN and/CC total/JJ bilirubin/NN elevations/NNS ,/, with/IN evidence/NN of/IN obstruction/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT the) (NP (NN Duloxetine) (JJ clinical) (NNS trials)) (NN database))) (, ,) (NP (CD three) (NN Duloxetine) (JJ -treated) (NNS patients)) (VP (VBD had) (NP (NN liver) (NN injury)) (SBAR (IN as) (S (VP (VBN manifested) (PP (IN by) (NP (NP (NP (NN ALT)) (CC and) (NP (JJ total) (NN bilirubin))) (NNS elevations))) (, ,) (PP (IN with) (NP (NP (NN evidence)) (PP (IN of) (NP (NN obstruction)))))))))) (. .))))

det(database-6, the-2)
nn(trials-5, Duloxetine-3)
amod(trials-5, clinical-4)
nn(database-6, trials-5)
prep_in(had-12, database-6)
num(patients-11, three-8)
nn(patients-11, Duloxetine-9)
amod(patients-11, -treated-10)
nsubj(had-12, patients-11)
root(ROOT-0, had-12)
nn(injury-14, liver-13)
dobj(had-12, injury-14)
mark(manifested-16, as-15)
advcl(had-12, manifested-16)
nn(elevations-22, ALT-18)
amod(bilirubin-21, total-20)
conj_and(ALT-18, bilirubin-21)
prep_by(manifested-16, elevations-22)
prep_with(manifested-16, evidence-25)
prep_of(evidence-25, obstruction-27)

Substantial/JJ intercurrent/NN ethanol/NN use/NN was/VBD present/JJ in/IN each/DT of/IN these/DT cases/NNS ,/, and/CC this/DT may/MD have/VB contributed/VBN to/TO the/DT abnormalities/NNS seen/VBN ./.

(ROOT (S1 (S (S (S (NP (JJ Substantial) (NN intercurrent) (NN ethanol) (NN use)) (VP (VBD was) (ADJP (JJ present) (PP (IN in) (NP (NP (DT each)) (PP (IN of) (NP (DT these) (NNS cases)))))))) (, ,) (CC and) (S (NP (DT this)) (VP (MD may) (VP (VB have) (VP (VBN contributed) (PP (TO to) (NP (NP (DT the) (NNS abnormalities)) (VP (VBN seen))))))))) (. .))))

amod(use-4, Substantial-1)
nn(use-4, intercurrent-2)
nn(use-4, ethanol-3)
nsubj(present-6, use-4)
cop(present-6, was-5)
root(ROOT-0, present-6)
prep_in(present-6, each-8)
det(cases-11, these-10)
prep_of(each-8, cases-11)
nsubj(contributed-17, this-14)
aux(contributed-17, may-15)
aux(contributed-17, have-16)
conj_and(present-6, contributed-17)
det(abnormalities-20, the-19)
prep_to(contributed-17, abnormalities-20)
partmod(abnormalities-20, seen-21)

CNS/NN Acting/NN Drugs/NNS :/: Given/IN the/DT primary/JJ CNS/NN effects/NNS of/IN Duloxetine/NN ,/, it/PRP should/MD be/VB used/VBN with/IN caution/NN when/WRB it/PRP is/VBZ taken/VBN in/IN combination/NN with/IN or/NN substituted/VBN for/IN other/JJ centrally/RB acting/VBG drugs/NNS ,/, including/VBG those/DT with/IN a/DT similar/JJ mechanism/NN of/IN action/NN ./.

(ROOT (S1 (S (NP (NP (NN CNS) (NN Acting) (NNS Drugs)) (: :) (S (PP (IN Given) (NP (NP (DT the) (JJ primary) (NN CNS) (NNS effects)) (PP (IN of) (NP (NN Duloxetine))))) (, ,) (NP (PRP it)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN caution))) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN taken) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NN or)) (VP (VBN substituted) (PP (IN for) (NP (NP (JJ other) (ADJP (RB centrally) (VBG acting)) (NNS drugs)) (, ,) (PP (VBG including) (NP (NP (DT those)) (PP (IN with) (NP (NP (DT a) (JJ similar) (NN mechanism)) (PP (IN of) (NP (NN action)))))))))))))))))))))) (. .)))))

nn(Drugs-3, CNS-1)
nn(Drugs-3, Acting-2)
root(ROOT-0, Drugs-3)
det(effects-9, the-6)
amod(effects-9, primary-7)
nn(effects-9, CNS-8)
prep_given(used-16, effects-9)
prep_of(effects-9, Duloxetine-11)
nsubjpass(used-16, it-13)
aux(used-16, should-14)
auxpass(used-16, be-15)
dep(Drugs-3, used-16)
prep_with(used-16, caution-18)
advmod(taken-22, when-19)
nsubjpass(taken-22, it-20)
auxpass(taken-22, is-21)
advcl(used-16, taken-22)
prep_in(taken-22, combination-24)
prep_with(combination-24, or-26)
partmod(or-26, substituted-27)
amod(drugs-32, other-29)
advmod(acting-31, centrally-30)
amod(drugs-32, acting-31)
prep_for(substituted-27, drugs-32)
prep_including(drugs-32, those-35)
det(mechanism-39, a-37)
amod(mechanism-39, similar-38)
prep_with(those-35, mechanism-39)
prep_of(mechanism-39, action-41)

Potential/NN for/IN Interaction/NN with/IN Drugs/NNS that/WDT Affect/VBP Gastric/JJ Acidity/NN :/: Duloxetine/NN has/VBZ an/DT enteric/JJ coating/NN that/WDT resists/VBZ dissolution/NN until/IN reaching/VBG a/DT segment/NN of/IN the/DT gastrointestinal/JJ tract/NN where/WRB the/DT pH/NN exceeds/VBZ 5.5/CD ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Potential)) (PP (IN for) (NP (NP (NN Interaction)) (PP (IN with) (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP Affect) (NP (JJ Gastric) (NN Acidity)))))))))) (: :) (NP (NN Duloxetine))) (VP (VBZ has) (NP (NP (DT an) (JJ enteric) (NN coating)) (SBAR (WHNP (WDT that)) (S (VP (VBZ resists) (NP (NN dissolution)) (PP (IN until) (S (VP (VBG reaching) (NP (NP (DT a) (NN segment)) (PP (IN of) (NP (NP (DT the) (JJ gastrointestinal) (NN tract)) (SBAR (WHADVP (WRB where)) (S (NP (DT the) (NN pH)) (VP (VBZ exceeds) (NP (CD 5.5))))))))))))))))) (. .))))

nsubj(has-12, Potential-1)
prep_for(Potential-1, Interaction-3)
prep_with(Interaction-3, Drugs-5)
nsubj(Affect-7, Drugs-5)
rcmod(Drugs-5, Affect-7)
amod(Acidity-9, Gastric-8)
dobj(Affect-7, Acidity-9)
dep(Potential-1, Duloxetine-11)
root(ROOT-0, has-12)
det(coating-15, an-13)
amod(coating-15, enteric-14)
dobj(has-12, coating-15)
nsubj(resists-17, coating-15)
rcmod(coating-15, resists-17)
dobj(resists-17, dissolution-18)
prepc_until(resists-17, reaching-20)
det(segment-22, a-21)
dobj(reaching-20, segment-22)
det(tract-26, the-24)
amod(tract-26, gastrointestinal-25)
prep_of(segment-22, tract-26)
advmod(exceeds-30, where-27)
det(pH-29, the-28)
nsubj(exceeds-30, pH-29)
rcmod(tract-26, exceeds-30)
dobj(exceeds-30, 5.5-31)

In/IN extremely/RB acidic/JJ conditions/NNS ,/, Duloxetine/NN ,/, unprotected/VBN by/IN the/DT enteric/JJ coating/NN ,/, may/MD undergo/VB hydrolysis/NN to/TO form/VB naphthol/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (ADJP (RB extremely) (JJ acidic)) (NNS conditions))) (, ,) (NP (NP (NN Duloxetine)) (, ,) (VP (VBN unprotected) (PP (IN by) (NP (DT the) (JJ enteric) (NN coating)))) (, ,)) (VP (MD may) (VP (VB undergo) (NP (NN hydrolysis)) (S (VP (TO to) (VP (VB form) (NP (NN naphthol)))))))) (. .))))

advmod(acidic-3, extremely-2)
amod(conditions-4, acidic-3)
prep_in(undergo-15, conditions-4)
nsubj(undergo-15, Duloxetine-6)
partmod(Duloxetine-6, unprotected-8)
det(coating-12, the-10)
amod(coating-12, enteric-11)
agent(unprotected-8, coating-12)
aux(undergo-15, may-14)
root(ROOT-0, undergo-15)
dobj(undergo-15, hydrolysis-16)
aux(form-18, to-17)
xcomp(undergo-15, form-18)
dobj(form-18, naphthol-19)

Caution/NN is/VBZ advised/VBN in/IN using/VBG Duloxetine/NN in/IN patients/NNS with/IN conditions/NNS that/WDT may/MD slow/JJ gastric/JJ emptying/NN (/-LRB- e.g./FW ,/, some/DT diabetics/NNS )./CD

(ROOT (S1 (S (NP (NN Caution)) (VP (VBZ is) (VP (VBN advised) (PP (IN in) (S (VP (VBG using) (NP (NP (NN Duloxetine)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS conditions)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (JJ slow) (NP (JJ gastric) (NN emptying)))))))))))))) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (DT some) (NNS diabetics)) (CD -RRB-.))))))))

nsubjpass(advised-3, Caution-1)
auxpass(advised-3, is-2)
root(ROOT-0, advised-3)
prepc_in(advised-3, using-5)
dobj(using-5, Duloxetine-6)
prep_in(Duloxetine-6, patients-8)
prep_with(patients-8, conditions-10)
nsubj(slow-13, conditions-10)
aux(slow-13, may-12)
rcmod(conditions-10, slow-13)
amod(emptying-15, gastric-14)
dobj(slow-13, emptying-15)
dep(diabetics-20, e.g.-17)
det(diabetics-20, some-19)
dep(advised-3, diabetics-20)
num(diabetics-20, -RRB-.-21)

Drugs/NNS that/WDT raise/VBP the/DT gastrointestinal/JJ pH/NN may/MD lead/VB to/TO an/DT earlier/JJR release/NN of/IN duloxetine/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP raise) (NP (DT the) (JJ gastrointestinal) (NN pH)))))) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (DT an) (JJR earlier) (NN release)) (PP (IN of) (NP (NN duloxetine)))))))) (. .))))

nsubj(raise-3, Drugs-1)
nsubj(lead-8, Drugs-1)
rcmod(Drugs-1, raise-3)
det(pH-6, the-4)
amod(pH-6, gastrointestinal-5)
dobj(raise-3, pH-6)
aux(lead-8, may-7)
root(ROOT-0, lead-8)
det(release-12, an-10)
amod(release-12, earlier-11)
prep_to(lead-8, release-12)
prep_of(release-12, duloxetine-14)

However/RB ,/, co-administration/NN of/IN Duloxetine/NN with/IN aluminum-/JJ and/CC magnesium-containing/JJ antacids/NNS (/-LRB- 51/CD mEq/NN )/-RRB- or/CC Duloxetine/NN with/IN famotidine/NN ,/, had/VBD no/DT significant/JJ effect/NN on/IN the/DT rate/NN or/CC extent/NN of/IN duloxetine/NN absorption/NN after/IN administration/NN of/IN a/DT 40-mg/JJ oral/JJ dose/NN ./.

(ROOT (S1 (S (ADVP (RB However)) (, ,) (NP (NP (NN co-administration)) (PP (IN of) (NP (NN Duloxetine))) (PP (IN with) (NP (NP (NP (ADJP (ADJP (JJ aluminum-)) (CC and) (ADJP (JJ magnesium-containing))) (NNS antacids)) (PRN (-LRB- -LRB-) (NP (CD 51) (NN mEq)) (-RRB- -RRB-))) (CC or) (NP (NN Duloxetine)))) (PP (IN with) (NP (NN famotidine)))) (, ,) (VP (VBD had) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (DT the) (NP (NN rate)) (CC or) (NP (NN extent))) (PP (IN of) (NP (NN duloxetine) (NN absorption))) (PP (IN after) (NP (NP (NN administration)) (PP (IN of) (NP (DT a) (JJ 40-mg) (JJ oral) (NN dose)))))))) (. .))))

advmod(had-20, However-1)
nsubj(had-20, co-administration-3)
prep_of(co-administration-3, Duloxetine-5)
amod(antacids-10, aluminum--7)
conj_and(aluminum--7, magnesium-containing-9)
prep_with(co-administration-3, antacids-10)
num(mEq-13, 51-12)
appos(antacids-10, mEq-13)
conj_or(antacids-10, Duloxetine-16)
prep_with(co-administration-3, famotidine-18)
root(ROOT-0, had-20)
det(effect-23, no-21)
amod(effect-23, significant-22)
dobj(had-20, effect-23)
dep(rate-26, the-25)
prep_on(had-20, rate-26)
conj_or(rate-26, extent-28)
nn(absorption-31, duloxetine-30)
prep_of(rate-26, absorption-31)
prep_after(rate-26, administration-33)
det(dose-38, a-35)
amod(dose-38, 40-mg-36)
amod(dose-38, oral-37)
prep_of(administration-33, dose-38)

It/PRP is/VBZ unknown/JJ whether/IN the/DT concomitant/JJ administration/NN of/IN proton/NN pump/NN inhibitors/NNS affects/VBZ duloxetine/NN absorption/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ unknown)) (SBAR (IN whether) (S (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN proton) (NN pump) (NNS inhibitors)))) (VP (VBZ affects) (NP (NN duloxetine) (NN absorption))))))) (. .))))

nsubj(unknown-3, It-1)
cop(unknown-3, is-2)
root(ROOT-0, unknown-3)
complm(affects-12, whether-4)
det(administration-7, the-5)
amod(administration-7, concomitant-6)
nsubj(affects-12, administration-7)
nn(inhibitors-11, proton-9)
nn(inhibitors-11, pump-10)
prep_of(administration-7, inhibitors-11)
ccomp(unknown-3, affects-12)
nn(absorption-14, duloxetine-13)
dobj(affects-12, absorption-14)

Synergism/NN between/IN xanthine/NN bronchodilators/NNS (/-LRB- e.g./FW ,/, theophylline/NN )/-RRB- ,/, ephedrine/NN ,/, and/CC other/JJ sympathomimetic/JJ bronchodilators/NNS has/VBZ been/VBN reported/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Synergism)) (PP (IN between) (NP (NP (NP (NN xanthine) (NNS bronchodilators)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN theophylline))) (-RRB- -RRB-))) (, ,) (NP (NN ephedrine)) (, ,) (CC and) (NP (JJ other) (JJ sympathomimetic) (NNS bronchodilators))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported))))) (. .))))

nsubjpass(reported-19, Synergism-1)
nn(bronchodilators-4, xanthine-3)
prep_between(Synergism-1, bronchodilators-4)
dep(bronchodilators-4, e.g.-6)
pobj(e.g.-6, theophylline-8)
conj_and(bronchodilators-4, ephedrine-11)
amod(bronchodilators-16, other-14)
amod(bronchodilators-16, sympathomimetic-15)
conj_and(bronchodilators-4, bronchodilators-16)
aux(reported-19, has-17)
auxpass(reported-19, been-18)
root(ROOT-0, reported-19)

Concurrent/JJ administration/NN of/IN dyphylline/NN and/CC probenecid/NN ,/, which/WDT compete/VBP s/NNS for/IN tubular/JJ secretion/NN ,/, has/VBZ been/VBN shown/VBN to/TO increase/VB the/DT plasma/NN half-life/NN of/IN dyphylline/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN administration)) (PP (IN of) (NP (NP (NN dyphylline)) (CC and) (NP (NN probenecid)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP compete) (NP (NP (NNS s)) (PP (IN for) (NP (JJ tubular) (NN secretion))))))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN plasma) (NN half-life)) (PP (IN of) (NP (NN dyphylline))))))))))) (. .))))

amod(administration-2, Concurrent-1)
nsubj(compete-9, administration-2)
nsubjpass(shown-17, administration-2)
xsubj(increase-19, administration-2)
prep_of(administration-2, dyphylline-4)
conj_and(dyphylline-4, probenecid-6)
rcmod(administration-2, compete-9)
dobj(compete-9, s-10)
amod(secretion-13, tubular-12)
prep_for(s-10, secretion-13)
aux(shown-17, has-15)
auxpass(shown-17, been-16)
root(ROOT-0, shown-17)
aux(increase-19, to-18)
xcomp(shown-17, increase-19)
det(half-life-22, the-20)
nn(half-life-22, plasma-21)
dobj(increase-19, half-life-22)
prep_of(half-life-22, dyphylline-24)

Phospholine/NN Iodide/NN potentiates/VBZ other/JJ cholinesterase/NN inhibitors/NNS such/JJ as/IN succinylcholine/NN or/CC organophosphate/NN and/CC carbamate/NN insecticide/NN s/NNS ./.

(ROOT (S1 (S (S (NP (NN Phospholine) (NN Iodide)) (VP (VBZ potentiates) (NP (NP (JJ other) (NN cholinesterase) (NNS inhibitors)) (PP (JJ such) (IN as) (NP (NP (NN succinylcholine)) (CC or) (NP (NP (NP (NN organophosphate)) (CC and) (NP (NN carbamate))) (NN insecticide) (NNS s))))))) (. .))))

nn(Iodide-2, Phospholine-1)
nsubj(potentiates-3, Iodide-2)
root(ROOT-0, potentiates-3)
amod(inhibitors-6, other-4)
nn(inhibitors-6, cholinesterase-5)
dobj(potentiates-3, inhibitors-6)
prep_such_as(inhibitors-6, succinylcholine-9)
nn(s-15, organophosphate-11)
conj_and(organophosphate-11, carbamate-13)
nn(s-15, insecticide-14)
conj_or(succinylcholine-9, s-15)

Patients/NNS undergoing/VBG systemic/JJ anticholinesterase/NN treatment/NN should/MD be/VB warned/VBN of/IN the/DT possible/JJ additive/JJ effects/NNS of/IN Phospholine/NN Iodide/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG undergoing) (NP (JJ systemic) (NN anticholinesterase) (NN treatment)))) (VP (MD should) (VP (VB be) (VP (VBN warned) (PP (IN of) (NP (NP (DT the) (JJ possible) (JJ additive) (NNS effects)) (PP (IN of) (NP (NN Phospholine) (NN Iodide))))))))) (. .))))

nsubjpass(warned-8, Patients-1)
partmod(Patients-1, undergoing-2)
amod(treatment-5, systemic-3)
nn(treatment-5, anticholinesterase-4)
dobj(undergoing-2, treatment-5)
aux(warned-8, should-6)
auxpass(warned-8, be-7)
root(ROOT-0, warned-8)
det(effects-13, the-10)
amod(effects-13, possible-11)
amod(effects-13, additive-12)
prep_of(warned-8, effects-13)
nn(Iodide-16, Phospholine-15)
prep_of(effects-13, Iodide-16)

Care/NN should/MD be/VB given/VBN when/WRB administering/VBG this/DT drug/NN to/TO patients/NNS with/IN symptoms/NNS of/IN myasthenic/JJ weakness/NN who/WP are/VBP also/RB on/IN anticholinesterase/NN drugs/NNS ./.

(ROOT (S1 (S (S (NP (NN Care)) (VP (MD should) (VP (VB be) (VP (VBN given) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (DT this) (NN drug)) (PP (TO to) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NNS symptoms)) (PP (IN of) (NP (JJ myasthenic) (NN weakness))))) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADVP (RB also)) (PP (IN on) (NP (NN anticholinesterase) (NNS drugs))))))))))))))) (. .))))

nsubjpass(given-4, Care-1)
aux(given-4, should-2)
auxpass(given-4, be-3)
root(ROOT-0, given-4)
advmod(administering-6, when-5)
advcl(given-4, administering-6)
det(drug-8, this-7)
dobj(administering-6, drug-8)
prep_to(administering-6, patients-10)
nsubj(are-17, patients-10)
prep_with(patients-10, symptoms-12)
amod(weakness-15, myasthenic-14)
prep_of(symptoms-12, weakness-15)
rcmod(patients-10, are-17)
advmod(are-17, also-18)
nn(drugs-21, anticholinesterase-20)
prep_on(are-17, drugs-21)

Since/IN symptoms/NNS of/IN anticholinesterase/NN overdose/NN (/-LRB- cholinergic/JJ crisis/NN )/-RRB- may/MD mimic/VB underdosage/NN (/-LRB- myasthenic/JJ weakness/NN )/-RRB- ,/, their/PRP$ condition/NN may/MD be/VB worsened/VBN by/IN the/DT use/NN of/IN this/DT drug/NN ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NP (NNS symptoms)) (PP (IN of) (NP (NP (NN anticholinesterase) (NN overdose)) (PRN (-LRB- -LRB-) (NP (JJ cholinergic) (NN crisis)) (-RRB- -RRB-))))) (VP (MD may) (VP (VB mimic) (NP (NP (NN underdosage)) (PRN (-LRB- -LRB-) (NP (JJ myasthenic) (NN weakness)) (-RRB- -RRB-))))))) (, ,) (NP (PRP$ their) (NN condition)) (VP (MD may) (VP (VB be) (VP (VBN worsened) (PP (IN by) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (DT this) (NN drug))))))))) (. .))))

mark(mimic-11, Since-1)
nsubj(mimic-11, symptoms-2)
nn(overdose-5, anticholinesterase-4)
prep_of(symptoms-2, overdose-5)
amod(crisis-8, cholinergic-7)
appos(overdose-5, crisis-8)
aux(mimic-11, may-10)
advcl(worsened-22, mimic-11)
dobj(mimic-11, underdosage-12)
amod(weakness-15, myasthenic-14)
appos(underdosage-12, weakness-15)
poss(condition-19, their-18)
nsubjpass(worsened-22, condition-19)
aux(worsened-22, may-20)
auxpass(worsened-22, be-21)
root(ROOT-0, worsened-22)
det(use-25, the-24)
agent(worsened-22, use-25)
det(drug-28, this-27)
prep_of(use-25, drug-28)

No/DT formal/JJ drug/NN interaction/NN studies/NNS have/VBP been/VBN performed/VBN with/IN RAPTIVA/NN ./.

(ROOT (S1 (S (S (NP (DT No) (JJ formal) (NN drug) (NN interaction) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN performed) (PP (IN with) (NP (NN RAPTIVA))))))) (. .))))

det(studies-5, No-1)
amod(studies-5, formal-2)
nn(studies-5, drug-3)
nn(studies-5, interaction-4)
nsubjpass(performed-8, studies-5)
aux(performed-8, have-6)
auxpass(performed-8, been-7)
root(ROOT-0, performed-8)
prep_with(performed-8, RAPTIVA-10)

RAPTIVA/NN should/MD not/RB be/VB used/VBN with/IN other/JJ immunosuppressive/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NN RAPTIVA)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (JJ other) (JJ immunosuppressive) (NNS drugs))))))) (. .))))

nsubjpass(used-5, RAPTIVA-1)
aux(used-5, should-2)
neg(used-5, not-3)
auxpass(used-5, be-4)
root(ROOT-0, used-5)
amod(drugs-9, other-7)
amod(drugs-9, immunosuppressive-8)
prep_with(used-5, drugs-9)

Acellular/JJ ,/, live/JJ and/CC live-attenuated/JJ vaccines/NNS should/MD not/RB be/VB administered/VBN during/IN RAPTIVA/NN treatment/NN ./.

(ROOT (S1 (S (S (NP (ADJP (ADJP (JJ Acellular)) (, ,) (ADJP (JJ live)) (CC and) (ADJP (JJ live-attenuated))) (NNS vaccines)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (PP (IN during) (NP (NN RAPTIVA) (NN treatment))))))) (. .))))

amod(vaccines-6, Acellular-1)
conj_and(Acellular-1, live-3)
conj_and(Acellular-1, live-attenuated-5)
nsubjpass(administered-10, vaccines-6)
aux(administered-10, should-7)
neg(administered-10, not-8)
auxpass(administered-10, be-9)
root(ROOT-0, administered-10)
nn(treatment-13, RAPTIVA-12)
prep_during(administered-10, treatment-13)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS Increases/NNS in/IN lymphocyte/NN counts/NNS related/JJ to/TO the/DT pharmacologic/JJ mechanism/NN of/IN action/NN are/VBP frequently/RB observed/VBN during/IN RAPTIVA/NN treatment/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions) (NNS Increases)) (PP (IN in) (NP (NP (NN lymphocyte) (NNS counts)) (ADJP (JJ related) (PP (TO to) (NP (NP (DT the) (JJ pharmacologic) (NN mechanism)) (PP (IN of) (NP (NN action))))))))) (VP (VBP are) (ADVP (RB frequently)) (VP (VBN observed) (PP (IN during) (NP (NN RAPTIVA) (NN treatment)))))) (. .))))

nn(Increases-5, Drug-1)
nn(Increases-5, /Laboratory-2)
nn(Increases-5, Test-3)
nn(Increases-5, Interactions-4)
nsubjpass(observed-18, Increases-5)
nn(counts-8, lymphocyte-7)
prep_in(Increases-5, counts-8)
amod(counts-8, related-9)
det(mechanism-13, the-11)
amod(mechanism-13, pharmacologic-12)
prep_to(related-9, mechanism-13)
prep_of(mechanism-13, action-15)
auxpass(observed-18, are-16)
advmod(observed-18, frequently-17)
root(ROOT-0, observed-18)
nn(treatment-21, RAPTIVA-20)
prep_during(observed-18, treatment-21)

The/DT potential/NN for/IN drug/NN interactions/NNS with/IN EMTRIVA/NN has/VBZ been/VBN studied/VBN in/IN combination/NN with/IN indinavir/NN ,/, stavudine/NN ,/, famciclovir/NN ,/, and/CC tenofovir/JJ disoproxil/NN fumarate/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN potential)) (PP (IN for) (NP (NP (NN drug) (NNS interactions)) (PP (IN with) (NP (NN EMTRIVA)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN studied) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NN indinavir)) (, ,) (NP (NN stavudine)) (, ,) (NP (NN famciclovir)) (, ,) (CC and) (NP (JJ tenofovir) (NN disoproxil) (NN fumarate)))))))))) (. .))))

det(potential-2, The-1)
nsubjpass(studied-10, potential-2)
nn(interactions-5, drug-4)
prep_for(potential-2, interactions-5)
prep_with(interactions-5, EMTRIVA-7)
aux(studied-10, has-8)
auxpass(studied-10, been-9)
root(ROOT-0, studied-10)
prep_in(studied-10, combination-12)
prep_with(combination-12, indinavir-14)
conj_and(indinavir-14, stavudine-16)
conj_and(indinavir-14, famciclovir-18)
amod(fumarate-23, tenofovir-21)
nn(fumarate-23, disoproxil-22)
conj_and(indinavir-14, fumarate-23)

There/EX were/VBD no/DT clinically/RB significant/JJ drug/NN interactions/NNS for/IN any/DT of/IN these/DT drugs/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBD were) (NP (NP (DT no) (ADJP (RB clinically) (JJ significant)) (NN drug) (NNS interactions)) (PP (IN for) (NP (NP (DT any)) (PP (IN of) (NP (DT these) (NNS drugs)))))))) (. .))))

expl(were-2, There-1)
root(ROOT-0, were-2)
det(interactions-7, no-3)
advmod(significant-5, clinically-4)
amod(interactions-7, significant-5)
nn(interactions-7, drug-6)
nsubj(were-2, interactions-7)
prep_for(interactions-7, any-9)
det(drugs-12, these-11)
prep_of(any-9, drugs-12)

Hypotension/NN :/: Patients/NNS on/IN Diuretic/JJ Therapy/NN :/: Patients/NNS on/IN diuretics/NN and/CC especially/RB those/DT in/IN whom/WP diuretic/JJ therapy/NN was/VBD recently/RB instituted/VBN ,/, may/MD occasionally/RB experience/VBP an/DT excessive/JJ reduction/NN of/IN blood/NN pressure/NN after/IN initiation/NN of/IN therapy/NN with/IN enalapril/NN or/CC enalaprilat/NN ./.

(ROOT (S1 (S (NP (NP (NN Hypotension)) (: :) (S (NP (NP (NP (NP (NNS Patients)) (PP (IN on) (NP (JJ Diuretic) (NN Therapy)))) (: :) (NP (NP (NNS Patients)) (PP (IN on) (NP (NN diuretics))))) (CC and) (ADVP (RB especially)) (NP (NP (DT those)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (JJ diuretic) (NN therapy)) (VP (VBD was) (ADVP (RB recently)) (VP (VBN instituted)))))) (, ,)) (VP (MD may) (ADVP (RB occasionally)) (VP (VBP experience) (NP (NP (DT an) (JJ excessive) (NN reduction)) (PP (IN of) (NP (NN blood) (NN pressure))) (PP (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (NP (NN therapy)) (PP (IN with) (NP (NP (NN enalapril)) (CC or) (NP (NN enalaprilat)))))))))))) (. .)))))

root(ROOT-0, Hypotension-1)
nsubj(experience-24, Patients-3)
amod(Therapy-6, Diuretic-5)
prep_on(Patients-3, Therapy-6)
dep(Patients-3, Patients-8)
prep_on(Patients-8, diuretics-10)
advmod(Patients-3, especially-12)
conj_and(Patients-3, especially-12)
conj_and(Patients-3, those-13)
rel(instituted-20, whom-15)
amod(therapy-17, diuretic-16)
nsubjpass(instituted-20, therapy-17)
auxpass(instituted-20, was-18)
advmod(instituted-20, recently-19)
rcmod(those-13, instituted-20)
aux(experience-24, may-22)
advmod(experience-24, occasionally-23)
dep(Hypotension-1, experience-24)
det(reduction-27, an-25)
amod(reduction-27, excessive-26)
dobj(experience-24, reduction-27)
nn(pressure-30, blood-29)
prep_of(reduction-27, pressure-30)
prep_after(reduction-27, initiation-32)
prep_of(initiation-32, therapy-34)
prep_with(therapy-34, enalapril-36)
conj_or(enalapril-36, enalaprilat-38)

The/DT possibility/NN of/IN hypotensive/JJ effects/NNS with/IN enalapril/NN or/CC enalaprilat/NN can/MD be/VB minimized/VBN by/IN either/CC discontinuing/VBG the/DT diuretic/JJ or/CC increasing/VBG the/DT salt/NN intake/NN prior/RB to/TO initiation/NN of/IN treatment/NN with/IN enalapril/NN or/CC enalaprilat/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN possibility)) (PP (IN of) (NP (NP (JJ hypotensive) (NNS effects)) (PP (IN with) (NP (NP (NN enalapril)) (CC or) (NP (NN enalaprilat))))))) (VP (MD can) (VP (VB be) (VP (VBN minimized) (PP (IN by) (S (VP (CC either) (VP (VBG discontinuing) (NP (DT the) (JJ diuretic))) (CC or) (VP (VBG increasing) (NP (NP (DT the) (NN salt) (NN intake)) (ADVP (ADVP (RB prior)) (PP (TO to) (NP (NP (NN initiation)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN with) (NP (NP (NN enalapril)) (CC or) (NP (NN enalaprilat)))))))))))))))))) (. .))))

det(possibility-2, The-1)
nsubjpass(minimized-12, possibility-2)
amod(effects-5, hypotensive-4)
prep_of(possibility-2, effects-5)
prep_with(effects-5, enalapril-7)
conj_or(enalapril-7, enalaprilat-9)
aux(minimized-12, can-10)
auxpass(minimized-12, be-11)
root(ROOT-0, minimized-12)
preconj(discontinuing-15, either-14)
agent(minimized-12, discontinuing-15)
det(diuretic-17, the-16)
dobj(discontinuing-15, diuretic-17)
conj_or(discontinuing-15, increasing-19)
det(intake-22, the-20)
nn(intake-22, salt-21)
dobj(increasing-19, intake-22)
prep_prior_to(intake-22, initiation-25)
prep_of(initiation-25, treatment-27)
prep_with(treatment-27, enalapril-29)
conj_or(enalapril-29, enalaprilat-31)

If/IN it/PRP is/VBZ necessary/JJ to/TO continue/VB the/DT diuretic/JJ ,/, provide/VBP close/JJ medical/JJ supervision/NN after/IN the/DT initial/JJ dose/NN for/IN at/IN least/JJS two/CD hours/NNS and/CC until/IN blood/NN pressure/NN has/VBZ stabilized/VBN for/IN at/IN least/JJS an/DT additional/JJ hour/NN ../NN

(ROOT (S1 (S (SBAR (IN If) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ necessary) (S (VP (TO to) (VP (VB continue) (NP (DT the) (JJ diuretic))))))))) (, ,) (VP (VBP provide) (NP (NP (JJ close) (JJ medical) (NN supervision)) (PP (IN after) (NP (DT the) (JJ initial) (NN dose))) (PP (PP (IN for) (NP (QP (IN at) (JJS least) (CD two)) (NNS hours))) (CC and) (PP (IN until) (NP (NN blood) (NN pressure))))) (VP (VBZ has) (VP (VBN stabilized) (PP (IN for) (NP (NP (ADVP (IN at) (JJS least)) (DT an) (JJ additional) (NN hour)) (NN ..)))))))))

mark(necessary-4, If-1)
nsubj(necessary-4, it-2)
cop(necessary-4, is-3)
advcl(provide-10, necessary-4)
aux(continue-6, to-5)
xcomp(necessary-4, continue-6)
det(diuretic-8, the-7)
dobj(continue-6, diuretic-8)
root(ROOT-0, provide-10)
amod(supervision-13, close-11)
amod(supervision-13, medical-12)
dobj(provide-10, supervision-13)
conj_and(supervision-13, supervision-13')
det(dose-17, the-15)
amod(dose-17, initial-16)
prep_after(supervision-13, dose-17)
quantmod(two-21, at-19)
mwe(at-19, least-20)
pobj(at-19, least-20)
num(hours-22, two-21)
prep_for(supervision-13, hours-22)
nn(pressure-26, blood-25)
prep_until(supervision-13', pressure-26)
aux(stabilized-28, has-27)
dep(provide-10, stabilized-28)
advmod(hour-34, at-30)
pobj(at-30, least-31)
det(hour-34, an-32)
amod(hour-34, additional-33)
nn(..-35, hour-34)
prep_for(stabilized-28, ..-35)

Agents/NNS Causing/VBG Renin/NN Release/NN :/: The/DT antihypertensive/JJ effect/NN of/IN enalapril/NN and/CC enalapril/NN IV/CD is/VBZ augmented/VBN by/IN antihypertensive/JJ agents/NNS that/WDT cause/VBP renin/NN release/NN (/-LRB- e.g./FW ,/, diuretics/NNS )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NP (NNS Agents)) (VP (VBG Causing) (NP (NN Renin) (NN Release)))) (: :) (S (NP (NP (DT The) (JJ antihypertensive) (NN effect)) (PP (IN of) (NP (NP (NN enalapril)) (CC and) (NP (NN enalapril) (CD IV))))) (VP (VBZ is) (VP (VBN augmented) (PP (IN by) (NP (NP (JJ antihypertensive) (NNS agents)) (SBAR (WHNP (WDT that)) (S (VP (VBP cause) (NP (NP (NN renin) (NN release)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NNS diuretics)) (-RRB- -RRB-))))))))))) (. .)))))

root(ROOT-0, Agents-1)
partmod(Agents-1, Causing-2)
nn(Release-4, Renin-3)
dobj(Causing-2, Release-4)
det(effect-8, The-6)
amod(effect-8, antihypertensive-7)
nsubjpass(augmented-15, effect-8)
prep_of(effect-8, enalapril-10)
conj_and(enalapril-10, enalapril-12)
num(enalapril-12, IV-13)
auxpass(augmented-15, is-14)
dep(Agents-1, augmented-15)
amod(agents-18, antihypertensive-17)
agent(augmented-15, agents-18)
nsubj(cause-20, agents-18)
rcmod(agents-18, cause-20)
nn(release-22, renin-21)
dobj(cause-20, release-22)
dep(diuretics-26, e.g.-24)
appos(release-22, diuretics-26)

Non-steroidal/JJ Anti-inflammatory/JJ Agents/NNS :/: In/IN some/DT patients/NNS with/IN compromised/VBN renal/JJ function/NN who/WP are/VBP being/VBG treated/VBN with/IN nonsteroidal/JJ anti-inflammatory/JJ drugs/NNS ,/, the/DT co-administration/NN of/IN enalapril/NN may/MD result/VB in/IN a/DT further/JJ deterioration/NN of/IN renal/JJ function/NN ./.

(ROOT (S1 (S (NP (NP (JJ Non-steroidal) (JJ Anti-inflammatory) (NNS Agents)) (: :) (S (PP (IN In) (NP (NP (DT some) (NNS patients)) (PP (IN with) (NP (VBN compromised) (JJ renal) (NN function))) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs)))))))))) (, ,) (NP (NP (DT the) (NN co-administration)) (PP (IN of) (NP (NN enalapril)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT a) (JJ further) (NN deterioration)) (PP (IN of) (NP (JJ renal) (NN function)))))))) (. .)))))

amod(Agents-3, Non-steroidal-1)
amod(Agents-3, Anti-inflammatory-2)
root(ROOT-0, Agents-3)
det(patients-7, some-6)
nsubjpass(treated-15, patients-7)
prep_in(result-26, patients-7)
amod(function-11, compromised-9)
amod(function-11, renal-10)
prep_with(patients-7, function-11)
aux(treated-15, are-13)
auxpass(treated-15, being-14)
rcmod(patients-7, treated-15)
amod(drugs-19, nonsteroidal-17)
amod(drugs-19, anti-inflammatory-18)
prep_with(treated-15, drugs-19)
det(co-administration-22, the-21)
nsubj(result-26, co-administration-22)
prep_of(co-administration-22, enalapril-24)
aux(result-26, may-25)
dep(Agents-3, result-26)
det(deterioration-30, a-28)
amod(deterioration-30, further-29)
prep_in(result-26, deterioration-30)
amod(function-33, renal-32)
prep_of(deterioration-30, function-33)

In/IN a/DT clinical/JJ pharmacology/NN study/NN ,/, indomethacin/NN or/CC sulindac/NN was/VBD administered/VBN to/TO hypertensive/JJ patients/NNS receiving/VBG VASOTEC/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT a) (JJ clinical) (NN pharmacology) (NN study))) (, ,) (NP (NP (NN indomethacin)) (CC or) (NP (NN sulindac))) (VP (VBD was) (VP (VBN administered) (PP (TO to) (NP (NP (JJ hypertensive) (NNS patients)) (VP (VBG receiving) (NP (NN VASOTEC)))))))) (. .))))

det(study-5, a-2)
amod(study-5, clinical-3)
nn(study-5, pharmacology-4)
prep_in(administered-11, study-5)
nsubjpass(administered-11, indomethacin-7)
conj_or(indomethacin-7, sulindac-9)
auxpass(administered-11, was-10)
root(ROOT-0, administered-11)
amod(patients-14, hypertensive-13)
prep_to(administered-11, patients-14)
partmod(patients-14, receiving-15)
dobj(receiving-15, VASOTEC-16)

In/IN this/DT study/NN there/EX was/VBD no/DT evidence/NN of/IN a/DT blunting/NN of/IN the/DT antihypertensive/JJ action/NN of/IN VASOTEC/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (DT a) (NN blunting)) (PP (IN of) (NP (NP (DT the) (JJ antihypertensive) (NN action)) (PP (IN of) (NP (NN VASOTEC)))))))))) (. .))))

det(study-3, this-2)
prep_in(was-5, study-3)
expl(was-5, there-4)
root(ROOT-0, was-5)
det(evidence-7, no-6)
nsubj(was-5, evidence-7)
det(blunting-10, a-9)
prep_of(evidence-7, blunting-10)
det(action-14, the-12)
amod(action-14, antihypertensive-13)
prep_of(blunting-10, action-14)
prep_of(action-14, VASOTEC-16)

However/RB ,/, reports/NNS suggest/VBP that/IN NSAIDs/NNS may/MD diminish/VB the/DT antihypertensive/JJ effect/NN of/IN ACE/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NNS reports)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS NSAIDs)) (VP (MD may) (VP (VB diminish) (NP (NP (DT the) (JJ antihypertensive) (NN effect)) (PP (IN of) (NP (NN ACE) (NNS inhibitors)))))))))) (. .))))

advmod(suggest-4, However-1)
nsubj(suggest-4, reports-3)
root(ROOT-0, suggest-4)
complm(diminish-8, that-5)
nsubj(diminish-8, NSAIDs-6)
aux(diminish-8, may-7)
ccomp(suggest-4, diminish-8)
det(effect-11, the-9)
amod(effect-11, antihypertensive-10)
dobj(diminish-8, effect-11)
nn(inhibitors-14, ACE-13)
prep_of(effect-11, inhibitors-14)

This/DT interaction/NN should/MD be/VB given/VBN consideration/NN in/IN patients/NNS taking/VBG NSAIDs/NN concomitantly/RB with/IN ACE/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (DT This) (NN interaction)) (VP (MD should) (VP (VB be) (VP (VBN given) (NP (NP (NN consideration)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN NSAIDs)))))) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN ACE) (NNS inhibitors))))))) (. .))))

det(interaction-2, This-1)
nsubjpass(given-5, interaction-2)
aux(given-5, should-3)
auxpass(given-5, be-4)
root(ROOT-0, given-5)
dobj(given-5, consideration-6)
prep_in(consideration-6, patients-8)
partmod(patients-8, taking-9)
dobj(taking-9, NSAIDs-10)
advmod(given-5, concomitantly-11)
nn(inhibitors-14, ACE-13)
prep_with(given-5, inhibitors-14)

Other/JJ Cardiovascular/JJ Agents/NNS :/: Enalapril/NN and/CC enalapril/NN IV/CD have/VBP been/VBN used/VBN concomitantly/RB with/IN beta/NN adrenergic-blocking/JJ agents/NNS ,/, methyldopa/NN ,/, nitrates/NNS ,/, calcium/NN -blocking/JJ agents/NNS ,/, hydralazine/NN ,/, prazosin/NN and/CC digoxin/NN without/IN evidence/NN of/IN clinically/RB significant/JJ adverse/JJ interactions/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Other) (JJ Cardiovascular) (NNS Agents)) (: :) (NP (NP (NN Enalapril)) (CC and) (NP (NN enalapril) (CD IV)))) (VP (VBP have) (VP (VBN been) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NN beta) (JJ adrenergic-blocking) (NNS agents)) (, ,) (NP (NP (NN methyldopa)) (, ,) (NP (NNS nitrates)) (, ,) (NP (NN calcium) (JJ -blocking) (NNS agents)) (, ,) (NP (NN hydralazine)) (, ,) (NP (NN prazosin)) (CC and) (NP (NN digoxin))))) (PP (IN without) (NP (NP (NN evidence)) (PP (IN of) (NP (ADJP (RB clinically) (JJ significant)) (JJ adverse) (NNS interactions))))))))) (. .))))

amod(Agents-3, Other-1)
amod(Agents-3, Cardiovascular-2)
nsubjpass(used-11, Agents-3)
dep(Agents-3, Enalapril-5)
conj_and(Enalapril-5, enalapril-7)
num(enalapril-7, IV-8)
aux(used-11, have-9)
auxpass(used-11, been-10)
root(ROOT-0, used-11)
advmod(used-11, concomitantly-12)
nn(agents-16, beta-14)
amod(agents-16, adrenergic-blocking-15)
prep_with(used-11, agents-16)
appos(agents-16, methyldopa-18)
conj_and(methyldopa-18, nitrates-20)
nn(agents-24, calcium-22)
amod(agents-24, -blocking-23)
conj_and(methyldopa-18, agents-24)
conj_and(methyldopa-18, hydralazine-26)
conj_and(methyldopa-18, prazosin-28)
conj_and(methyldopa-18, digoxin-30)
prep_without(used-11, evidence-32)
advmod(significant-35, clinically-34)
amod(interactions-37, significant-35)
amod(interactions-37, adverse-36)
prep_of(evidence-32, interactions-37)

Enalapril/NN IV/CD has/VBZ been/VBN used/VBN concomitantly/RB with/IN digitalis/NN without/IN evidence/NN of/IN clinically/RB significant/JJ adverse/JJ reactions/NNS ./.

(ROOT (S1 (S (S (NP (NN Enalapril) (CD IV)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN digitalis))) (PP (IN without) (NP (NP (NN evidence)) (PP (IN of) (NP (ADJP (RB clinically) (JJ significant)) (JJ adverse) (NNS reactions))))))))) (. .))))

nsubjpass(used-5, Enalapril-1)
num(Enalapril-1, IV-2)
aux(used-5, has-3)
auxpass(used-5, been-4)
root(ROOT-0, used-5)
advmod(used-5, concomitantly-6)
prep_with(used-5, digitalis-8)
prep_without(used-5, evidence-10)
advmod(significant-13, clinically-12)
amod(reactions-15, significant-13)
amod(reactions-15, adverse-14)
prep_of(evidence-10, reactions-15)

Agents/NNS Increasing/VBG Serum/NN Potassium/NN :/: Enalapril/NN and/CC enalapril/NN IV/CD attenuate/VBP potassium/NN loss/NN caused/VBN by/IN thiazide-type/JJ diuretics/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Agents)) (PP (VBG Increasing) (NP (NN Serum) (NN Potassium)))) (: :) (NP (NP (NN Enalapril)) (CC and) (NP (NN enalapril) (CD IV)))) (VP (VBP attenuate) (NP (NP (NN potassium) (NN loss)) (VP (VBN caused) (PP (IN by) (NP (JJ thiazide-type) (NNS diuretics))))))) (. .))))

nsubj(attenuate-10, Agents-1)
nn(Potassium-4, Serum-3)
prep_increasing(Agents-1, Potassium-4)
dep(Agents-1, Enalapril-6)
conj_and(Enalapril-6, enalapril-8)
num(enalapril-8, IV-9)
root(ROOT-0, attenuate-10)
nn(loss-12, potassium-11)
dobj(attenuate-10, loss-12)
partmod(loss-12, caused-13)
amod(diuretics-16, thiazide-type-15)
agent(caused-13, diuretics-16)

Potassium-sparing/JJ diuretics/NNS (/-LRB- e.g./FW ,/, spironolactone/NN ,/, triamterene/NN ,/, or/CC amiloride/NN )/-RRB- ,/, potassium/NN supplement/NN s/NNS ,/, or/CC potassium-containing/JJ salt/NN substitutes/VBZ may/MD lead/VB to/TO significant/JJ increases/NNS in/IN serum/NN potassium/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Potassium-sparing) (NNS diuretics)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN spironolactone)) (, ,) (NP (NN triamterene)) (, ,) (CC or) (NP (NN amiloride)))) (-RRB- -RRB-))) (, ,) (NP (NN potassium) (NN supplement) (NNS s)) (, ,) (CC or) (NP (JJ potassium-containing) (NN salt) (VBZ substitutes))) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (JJ significant) (NNS increases)) (PP (IN in) (NP (NN serum) (NN potassium)))))))) (. .))))

amod(diuretics-2, Potassium-sparing-1)
nsubj(lead-23, diuretics-2)
dep(diuretics-2, e.g.-4)
pobj(e.g.-4, spironolactone-6)
conj_or(spironolactone-6, triamterene-8)
conj_or(spironolactone-6, amiloride-11)
nn(s-16, potassium-14)
nn(s-16, supplement-15)
conj_or(diuretics-2, s-16)
amod(salt-20, potassium-containing-19)
conj_or(diuretics-2, salt-20)
dep(salt-20, substitutes-21)
aux(lead-23, may-22)
root(ROOT-0, lead-23)
amod(increases-26, significant-25)
prep_to(lead-23, increases-26)
nn(potassium-29, serum-28)
prep_in(increases-26, potassium-29)

Potassium/NN sparing/NN agents/NNS should/MD generally/RB not/RB be/VB used/VBN in/IN patients/NNS with/IN heart/NN failure/NN receiving/VBG enalapril/NN ./.

(ROOT (S1 (S (S (NP (NN Potassium) (NN sparing) (NNS agents)) (VP (MD should) (ADVP (RB generally)) (RB not) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN heart) (NN failure))) (VP (VBG receiving) (NP (NN enalapril))))))))) (. .))))

nn(agents-3, Potassium-1)
nn(agents-3, sparing-2)
nsubjpass(used-8, agents-3)
aux(used-8, should-4)
advmod(used-8, generally-5)
neg(used-8, not-6)
auxpass(used-8, be-7)
root(ROOT-0, used-8)
prep_in(used-8, patients-10)
nn(failure-13, heart-12)
prep_with(patients-10, failure-13)
partmod(patients-10, receiving-14)
dobj(receiving-14, enalapril-15)

Lithium/NN :/: Lithium/NN toxicity/NN has/VBZ been/VBN reported/VBN in/IN patients/NNS receiving/VBG lithium/NN concomitantly/RB with/IN drugs/NNS which/WDT cause/VBP elimination/NN of/IN sodium/NN ,/, including/VBG ACE/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Lithium)) (: :) (NP (NN Lithium) (NN toxicity))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN lithium)) (PP (ADVP (RB concomitantly)) (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT which)) (S (VP (VBP cause) (NP (NP (NN elimination)) (PP (IN of) (NP (NN sodium))))))) (, ,) (PP (VBG including) (NP (NN ACE) (NNS inhibitors))))))))))))) (. .))))

nsubjpass(reported-7, Lithium-1)
nn(toxicity-4, Lithium-3)
dep(Lithium-1, toxicity-4)
aux(reported-7, has-5)
auxpass(reported-7, been-6)
root(ROOT-0, reported-7)
prep_in(reported-7, patients-9)
partmod(patients-9, receiving-10)
dobj(receiving-10, lithium-11)
advmod(lithium-11, concomitantly-12)
prep_with(lithium-11, drugs-14)
nsubj(cause-16, drugs-14)
rcmod(drugs-14, cause-16)
dobj(cause-16, elimination-17)
prep_of(elimination-17, sodium-19)
nn(inhibitors-23, ACE-22)
prep_including(drugs-14, inhibitors-23)

A/DT few/JJ cases/NNS of/IN lithium/NN toxicity/NN have/VBP been/VBN reported/VBN in/IN patients/NNS receiving/VBG concomitant/JJ enalapril/NN //: enalapril/NN IV/CD and/CC lithium/NN and/CC were/VBD reversible/JJ upon/IN discontinuation/NN of/IN both/DT drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT A) (JJ few) (NNS cases)) (PP (IN of) (NP (NN lithium) (NN toxicity)))) (VP (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ concomitant) (NN enalapril)))) (: /) (NP (NP (NN enalapril) (CD IV)) (CC and) (NP (NN lithium)))))))) (CC and) (VP (VBD were) (ADJP (JJ reversible) (PP (IN upon) (NP (NP (NN discontinuation)) (PP (IN of) (NP (DT both) (NNS drugs))))))))) (. .))))

det(cases-3, A-1)
amod(cases-3, few-2)
nsubjpass(reported-9, cases-3)
nn(toxicity-6, lithium-5)
prep_of(cases-3, toxicity-6)
aux(reported-9, have-7)
auxpass(reported-9, been-8)
root(ROOT-0, reported-9)
prep_in(reported-9, patients-11)
partmod(patients-11, receiving-12)
amod(enalapril-14, concomitant-13)
dobj(receiving-12, enalapril-14)
punct(patients-11, /-15)
dep(patients-11, enalapril-16)
num(enalapril-16, IV-17)
conj_and(enalapril-16, lithium-19)
cop(reversible-22, were-21)
conj_and(reported-9, reversible-22)
prep_upon(reversible-22, discontinuation-24)
det(drugs-27, both-26)
prep_of(discontinuation-24, drugs-27)

It/PRP is/VBZ recommended/VBN that/IN serum/NN lithium/NN levels/NNS be/VB monitored/VBN frequently/RB if/IN enalapril/NN is/VBZ administered/VBN concomitantly/RB with/IN lithium/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NN serum) (NN lithium) (NNS levels)) (VP (VB be) (VP (VBN monitored) (ADVP (RB frequently)) (SBAR (IN if) (S (NP (NN enalapril)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN lithium)))))))))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(monitored-9, that-4)
nn(levels-7, serum-5)
nn(levels-7, lithium-6)
nsubjpass(monitored-9, levels-7)
auxpass(monitored-9, be-8)
ccomp(recommended-3, monitored-9)
advmod(monitored-9, frequently-10)
mark(administered-14, if-11)
nsubjpass(administered-14, enalapril-12)
auxpass(administered-14, is-13)
advcl(monitored-9, administered-14)
advmod(administered-14, concomitantly-15)
prep_with(administered-14, lithium-17)

The/DT action/NN of/IN nondepolarizing/JJ relaxants/NNS is/VBZ augmented/VBN by/IN Enflurane/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN action)) (PP (IN of) (NP (JJ nondepolarizing) (NNS relaxants)))) (VP (VBZ is) (VP (VBN augmented) (PP (IN by) (NP (NN Enflurane)))))) (. .))))

det(action-2, The-1)
nsubjpass(augmented-7, action-2)
amod(relaxants-5, nondepolarizing-4)
prep_of(action-2, relaxants-5)
auxpass(augmented-7, is-6)
root(ROOT-0, augmented-7)
agent(augmented-7, Enflurane-9)

Less/JJR than/IN the/DT usual/JJ amounts/NNS of/IN these/DT medicines/NNS should/MD be/VB used/VBN ./.

(ROOT (S1 (S (S (NP (ADJP (JJR Less) (PP (IN than) (NP (NP (DT the) (JJ usual) (NNS amounts)) (PP (IN of) (NP (DT these) (NNS medicines))))))) (VP (MD should) (VP (VB be) (VP (VBN used))))) (. .))))

nsubjpass(used-11, Less-1)
det(amounts-5, the-3)
amod(amounts-5, usual-4)
prep_than(Less-1, amounts-5)
det(medicines-8, these-7)
prep_of(amounts-5, medicines-8)
aux(used-11, should-9)
auxpass(used-11, be-10)
root(ROOT-0, used-11)

If/IN the/DT usual/JJ amounts/NNS of/IN nondepolarizing/JJ relaxants/NNS are/VBP given/VBN ,/, the/DT time/NN for/IN recovery/NN from/IN neuromuscular/JJ blockade/NN will/MD be/VB longer/JJR in/IN the/DT presence/NN of/IN Enflurane/NN than/IN when/WRB halothane/NN or/CC nitrous/NN oxide/NN with/IN a/DT balanced/JJ technique/NN are/VBP used/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NP (DT the) (JJ usual) (NNS amounts)) (PP (IN of) (NP (JJ nondepolarizing) (NNS relaxants)))) (VP (VBP are) (VP (VBN given))))) (, ,) (NP (NP (DT the) (NN time)) (PP (IN for) (NP (NP (NN recovery)) (PP (IN from) (NP (JJ neuromuscular) (NN blockade)))))) (VP (MD will) (VP (VB be) (ADJP (ADJP (JJR longer)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN Enflurane))))) (PP (IN than) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN halothane)) (CC or) (NP (NP (NN nitrous) (NN oxide)) (PP (IN with) (NP (DT a) (JJ balanced) (NN technique))))) (VP (VBP are) (VP (VBN used)))))))))) (. .))))

mark(given-9, If-1)
det(amounts-4, the-2)
amod(amounts-4, usual-3)
nsubjpass(given-9, amounts-4)
amod(relaxants-7, nondepolarizing-6)
prep_of(amounts-4, relaxants-7)
auxpass(given-9, are-8)
advcl(longer-20, given-9)
det(time-12, the-11)
nsubj(longer-20, time-12)
prep_for(time-12, recovery-14)
amod(blockade-17, neuromuscular-16)
prep_from(recovery-14, blockade-17)
aux(longer-20, will-18)
cop(longer-20, be-19)
root(ROOT-0, longer-20)
det(presence-23, the-22)
prep_in(longer-20, presence-23)
prep_of(presence-23, Enflurane-25)
advmod(used-37, when-27)
nsubjpass(used-37, halothane-28)
nn(oxide-31, nitrous-30)
conj_or(halothane-28, oxide-31)
det(technique-35, a-33)
amod(technique-35, balanced-34)
prep_with(oxide-31, technique-35)
auxpass(used-37, are-36)
prepc_than(longer-20, used-37)

CYP450/CD Metabolized/JJ Drugs/NNS Results/NNS from/IN in/FW vitro/FW and/CC in/FW vivo/FW studies/NNS suggest/VBP that/IN enfuvirtide/NN is/VBZ unlikely/JJ to/TO have/VB significant/JJ drug/NN interactions/NNS with/IN concomitantly/RB administered/VBN drugs/NNS metabolized/VBN by/IN CYP450/NN enzymes/NNS ./.

(ROOT (S1 (S (S (NP (NP (CD CYP450) (JJ Metabolized) (NNS Drugs) (NNS Results)) (PP (IN from) (NP (ADJP (ADJP (FW in) (FW vitro)) (CC and) (ADJP (FW in) (FW vivo))) (NNS studies)))) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN enfuvirtide)) (VP (VBZ is) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB have) (NP (NP (JJ significant) (NN drug) (NNS interactions)) (PP (IN with) (NP (NP (ADJP (RB concomitantly) (VBN administered)) (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP450) (NNS enzymes)))))))))))))))) (. .))))

num(Results-4, CYP450-1)
amod(Results-4, Metabolized-2)
nn(Results-4, Drugs-3)
nsubj(suggest-12, Results-4)
nn(vitro-7, in-6)
amod(studies-11, vitro-7)
nn(vivo-10, in-9)
conj_and(vitro-7, vivo-10)
prep_from(Results-4, studies-11)
root(ROOT-0, suggest-12)
complm(unlikely-16, that-13)
nsubj(unlikely-16, enfuvirtide-14)
cop(unlikely-16, is-15)
ccomp(suggest-12, unlikely-16)
aux(have-18, to-17)
xcomp(unlikely-16, have-18)
amod(interactions-21, significant-19)
nn(interactions-21, drug-20)
dobj(have-18, interactions-21)
advmod(administered-24, concomitantly-23)
amod(drugs-25, administered-24)
prep_with(interactions-21, drugs-25)
partmod(drugs-25, metabolized-26)
nn(enzymes-29, CYP450-28)
agent(metabolized-26, enzymes-29)

Antiretroviral/JJ Agents/NNS :/: No/DT drug/NN interactions/NNS with/IN other/JJ antiretroviral/JJ medications/NNS have/VBP been/VBN identified/VBN that/WDT would/MD warrant/VBP alteration/NN of/IN either/CC the/DT enfuvirtide/NN dose/NN or/CC the/DT dose/NN of/IN the/DT other/JJ antiretroviral/JJ medication/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Antiretroviral) (NNS Agents)) (: :) (NP (NP (DT No) (NN drug) (NNS interactions)) (PP (IN with) (NP (JJ other) (JJ antiretroviral) (NNS medications))))) (VP (VBP have) (VP (VBN been) (VP (VBN identified) (SBAR (WHNP (WDT that)) (S (VP (MD would) (VP (VBP warrant) (NP (NP (NN alteration)) (PP (IN of) (NP (CC either) (NP (DT the) (NN enfuvirtide) (NN dose)) (CC or) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (DT the) (JJ other) (JJ antiretroviral) (NN medication))))))))))))))) (. .))))

amod(Agents-2, Antiretroviral-1)
nsubjpass(identified-13, Agents-2)
det(interactions-6, No-4)
nn(interactions-6, drug-5)
dep(Agents-2, interactions-6)
amod(medications-10, other-8)
amod(medications-10, antiretroviral-9)
prep_with(interactions-6, medications-10)
aux(identified-13, have-11)
auxpass(identified-13, been-12)
root(ROOT-0, identified-13)
nsubj(warrant-16, that-14)
aux(warrant-16, would-15)
ccomp(identified-13, warrant-16)
dobj(warrant-16, alteration-17)
preconj(dose-22, either-19)
det(dose-22, the-20)
nn(dose-22, enfuvirtide-21)
prep_of(alteration-17, dose-22)
det(dose-25, the-24)
conj_or(dose-22, dose-25)
det(medication-30, the-27)
amod(medication-30, other-28)
amod(medication-30, antiretroviral-29)
prep_of(dose-25, medication-30)

Bismuth/NN :/: Bismuth/NN subsalicylate/NN ,/, given/VBN concomitantly/RB with/IN enoxacin/NN or/CC 60/CD minutes/NNS following/VBG enoxacin/NN administration/NN ,/, decreased/VBN enoxacin/NN bioavailability/NN by/IN approximately/RB 25/CD %./NN

(ROOT (S1 (S (NP (NP (NN Bismuth) (: :) (NN Bismuth) (NN subsalicylate)) (, ,) (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NN enoxacin)) (CC or) (NP (CD 60) (NNS minutes)))) (PP (VBG following) (NP (NN enoxacin) (NN administration)))) (, ,)) (VP (VBN decreased) (NP (NN enoxacin) (NN bioavailability)) (PP (IN by) (NP (QP (RB approximately) (CD 25)) (NN %.)))))))

nn(subsalicylate-4, Bismuth-1)
nn(subsalicylate-4, Bismuth-3)
nsubj(decreased-17, subsalicylate-4)
partmod(subsalicylate-4, given-6)
advmod(given-6, concomitantly-7)
prep_with(given-6, enoxacin-9)
num(minutes-12, 60-11)
conj_or(enoxacin-9, minutes-12)
nn(administration-15, enoxacin-14)
prep_following(given-6, administration-15)
root(ROOT-0, decreased-17)
nn(bioavailability-19, enoxacin-18)
dobj(decreased-17, bioavailability-19)
quantmod(25-22, approximately-21)
num(%.-23, 25-22)
prep_by(decreased-17, %.-23)

Thus/RB ,/, concomitant/JJ administration/NN of/IN enoxacin/NN and/CC bismuth/NN subsalicylate/NN should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN enoxacin)) (CC and) (NP (NN bismuth)) (NP (NN subsalicylate))))) (VP (MD should) (VP (VB be) (VP (VBN avoided))))) (. .))))

advmod(avoided-12, Thus-1)
amod(administration-4, concomitant-3)
nsubjpass(avoided-12, administration-4)
prep_of(administration-4, enoxacin-6)
conj_and(enoxacin-6, bismuth-8)
dep(enoxacin-6, subsalicylate-9)
aux(avoided-12, should-10)
auxpass(avoided-12, be-11)
root(ROOT-0, avoided-12)

Caffeine/NN :/: Enoxacin/NN is/VBZ a/DT potent/JJ inhibitor/NN of/IN the/DT cytochrome/NN P-450/NN isozymes/NNS responsible/JJ for/IN the/DT metabolism/NN of/IN methylxanthines/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Caffeine)) (: :) (NP (NN Enoxacin))) (VP (VBZ is) (NP (NP (DT a) (JJ potent) (NN inhibitor)) (PP (IN of) (NP (NP (DT the) (NP (NN cytochrome) (NN P-450)) (NNS isozymes)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NNS methylxanthines))))))))))) (. .))))

nsubj(inhibitor-7, Caffeine-1)
dep(Caffeine-1, Enoxacin-3)
cop(inhibitor-7, is-4)
det(inhibitor-7, a-5)
amod(inhibitor-7, potent-6)
root(ROOT-0, inhibitor-7)
det(isozymes-12, the-9)
nn(P-450-11, cytochrome-10)
nn(isozymes-12, P-450-11)
prep_of(inhibitor-7, isozymes-12)
amod(isozymes-12, responsible-13)
det(metabolism-16, the-15)
prep_for(responsible-13, metabolism-16)
prep_of(metabolism-16, methylxanthines-18)

In/IN a/DT multiple-dose/JJ study/NN ,/, enoxacin/NN caused/VBD a/DT dose-related/JJ increase/NN in/IN the/DT mean/JJ elimination/NN half-life/NN of/IN caffeine/NN ,/, thereby/RB decreasing/VBG the/DT clearance/NN of/IN caffeine/NN by/IN up/RB to/TO 80/CD %/NN and/CC leading/VBG to/TO a/DT five-fold/JJ increase/NN in/IN the/DT AUC/NN and/CC the/DT half-life/NN of/IN caffeine/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT a) (JJ multiple-dose) (NN study))) (, ,) (NP (NN enoxacin)) (VP (VBD caused) (NP (NP (DT a) (JJ dose-related) (NN increase)) (PP (IN in) (NP (NP (DT the) (JJ mean) (NN elimination) (NN half-life)) (PP (IN of) (NP (NN caffeine)))))) (, ,) (S (ADVP (RB thereby)) (VP (VP (VBG decreasing) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN caffeine))) (PP (IN by) (NP (QP (RB up) (TO to) (CD 80)) (NN %))))) (CC and) (VP (VBG leading) (PP (TO to) (NP (NP (NP (DT a) (JJ five-fold) (NN increase)) (PP (IN in) (NP (DT the) (NN AUC)))) (CC and) (NP (NP (DT the) (NN half-life)) (PP (IN of) (NP (NN caffeine))))))))))) (. .))))

det(study-4, a-2)
amod(study-4, multiple-dose-3)
prep_in(caused-7, study-4)
nsubj(caused-7, enoxacin-6)
root(ROOT-0, caused-7)
det(increase-10, a-8)
amod(increase-10, dose-related-9)
dobj(caused-7, increase-10)
det(half-life-15, the-12)
amod(half-life-15, mean-13)
nn(half-life-15, elimination-14)
prep_in(increase-10, half-life-15)
prep_of(half-life-15, caffeine-17)
advmod(decreasing-20, thereby-19)
dep(caused-7, decreasing-20)
det(clearance-22, the-21)
dobj(decreasing-20, clearance-22)
prep_of(clearance-22, caffeine-24)
quantmod(80-28, up-26)
dep(80-28, to-27)
num(%-29, 80-28)
prep_by(clearance-22, %-29)
conj_and(decreasing-20, leading-31)
det(increase-35, a-33)
amod(increase-35, five-fold-34)
prep_to(leading-31, increase-35)
det(AUC-38, the-37)
prep_in(increase-35, AUC-38)
det(half-life-41, the-40)
conj_and(increase-35, half-life-41)
prep_of(half-life-41, caffeine-43)

Trough/NN plasma/NN enoxacin/NN levels/NNS were/VBD also/RB 20/CD %/NN higher/JJR when/WRB caffeine/NN and/CC enoxacin/NN were/VBD administered/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NN Trough) (NN plasma) (NN enoxacin) (NNS levels)) (VP (VBD were) (ADVP (RB also)) (ADJP (NP (CD 20) (NN %)) (JJR higher)) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN caffeine)) (CC and) (NP (NN enoxacin))) (VP (VBD were) (VP (VBN administered) (ADVP (RB concomitantly)))))))) (. .))))

nn(levels-4, Trough-1)
nn(levels-4, plasma-2)
nn(levels-4, enoxacin-3)
nsubj(higher-9, levels-4)
cop(higher-9, were-5)
advmod(higher-9, also-6)
num(%-8, 20-7)
npadvmod(higher-9, %-8)
root(ROOT-0, higher-9)
advmod(administered-15, when-10)
nsubjpass(administered-15, caffeine-11)
conj_and(caffeine-11, enoxacin-13)
auxpass(administered-15, were-14)
advcl(higher-9, administered-15)
advmod(administered-15, concomitantly-16)

Caffeine/NN -related/JJ adverse/JJ effects/NNS have/VBP occurred/VBN in/IN patients/NNS consuming/VBG caffeine/NN while/IN on/IN therapy/NN with/IN enoxacin/NN ./.

(ROOT (S1 (S (S (NP (ADJP (NN Caffeine) (JJ -related)) (JJ adverse) (NNS effects)) (VP (VBP have) (VP (VBN occurred) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG consuming) (NP (NN caffeine)) (PP (IN while) (PP (IN on) (NP (NP (NN therapy)) (PP (IN with) (NP (NN enoxacin)))))))))))) (. .))))

dep(-related-2, Caffeine-1)
amod(effects-4, -related-2)
amod(effects-4, adverse-3)
nsubj(occurred-6, effects-4)
aux(occurred-6, have-5)
root(ROOT-0, occurred-6)
prep_in(occurred-6, patients-8)
partmod(patients-8, consuming-9)
dobj(consuming-9, caffeine-10)
prep(consuming-9, while-11)
pcomp(while-11, on-12)
prep_on(while-11, therapy-13)
prep_with(therapy-13, enoxacin-15)

Cyclosporine/NN :/: Elevated/JJ serum/NN levels/NNS of/IN cyclosporine/NN have/VBP been/VBN reported/VBN with/IN concomitant/JJ use/NN of/IN cyclosporine/NN with/IN other/JJ members/NNS of/IN the/DT quinolone/NN class/NN ./.

(ROOT (S1 (S (NP (NP (NN Cyclosporine)) (: :) (S (NP (NP (JJ Elevated) (NN serum) (NNS levels)) (PP (IN of) (NP (NN cyclosporine)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NN cyclosporine))) (PP (IN with) (NP (NP (JJ other) (NNS members)) (PP (IN of) (NP (DT the) (NN quinolone) (NN class))))))))))) (. .)))))

root(ROOT-0, Cyclosporine-1)
amod(levels-5, Elevated-3)
nn(levels-5, serum-4)
nsubjpass(reported-10, levels-5)
prep_of(levels-5, cyclosporine-7)
aux(reported-10, have-8)
auxpass(reported-10, been-9)
dep(Cyclosporine-1, reported-10)
amod(use-13, concomitant-12)
prep_with(reported-10, use-13)
prep_of(use-13, cyclosporine-15)
amod(members-18, other-17)
prep_with(use-13, members-18)
det(class-22, the-20)
nn(class-22, quinolone-21)
prep_of(members-18, class-22)

Digoxin/NN :/: Enoxacin/NN may/MD raise/VBP serum/NN digoxin/NN levels/NNS in/IN some/DT individuals/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Digoxin)) (: :) (NP (NN Enoxacin))) (VP (MD may) (VP (VBP raise) (NP (NN serum) (NN digoxin) (NNS levels)) (PP (IN in) (NP (DT some) (NNS individuals)))))) (. .))))

nsubj(raise-5, Digoxin-1)
dep(Digoxin-1, Enoxacin-3)
aux(raise-5, may-4)
root(ROOT-0, raise-5)
nn(levels-8, serum-6)
nn(levels-8, digoxin-7)
dobj(raise-5, levels-8)
det(individuals-11, some-10)
prep_in(raise-5, individuals-11)

If/IN signs/NNS and/CC symptoms/NNS suggestive/JJ of/IN digoxin/NN toxicity/NN occur/VBP when/WRB enoxacin/NN and/CC digoxin/NN are/VBP given/VBN concomitantly/RB ,/, physicians/NNS are/VBP advised/VBN to/TO obtain/VB serum/NN digoxin/NN levels/NNS and/CC adjust/VB digoxin/NN doses/NNS appropriately/RB ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NP (NNS signs)) (CC and) (NP (NP (NNS symptoms)) (ADJP (JJ suggestive) (PP (IN of) (NP (NN digoxin) (NN toxicity)))))) (VP (VBP occur) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN enoxacin)) (CC and) (NP (NN digoxin))) (VP (VBP are) (VP (VBN given) (ADVP (RB concomitantly))))))))) (, ,) (NP (NNS physicians)) (VP (VBP are) (VP (VBN advised) (S (VP (TO to) (VP (VP (VB obtain) (NP (NN serum) (NN digoxin) (NNS levels))) (CC and) (VP (VB adjust) (NP (NN digoxin) (NNS doses)) (ADVP (RB appropriately))))))))) (. .))))

mark(occur-9, If-1)
nsubj(occur-9, signs-2)
conj_and(signs-2, symptoms-4)
amod(symptoms-4, suggestive-5)
nn(toxicity-8, digoxin-7)
prep_of(suggestive-5, toxicity-8)
advcl(advised-20, occur-9)
advmod(given-15, when-10)
nsubjpass(given-15, enoxacin-11)
conj_and(enoxacin-11, digoxin-13)
auxpass(given-15, are-14)
advcl(occur-9, given-15)
advmod(given-15, concomitantly-16)
nsubjpass(advised-20, physicians-18)
xsubj(obtain-22, physicians-18)
auxpass(advised-20, are-19)
root(ROOT-0, advised-20)
aux(obtain-22, to-21)
xcomp(advised-20, obtain-22)
nn(levels-25, serum-23)
nn(levels-25, digoxin-24)
dobj(obtain-22, levels-25)
conj_and(obtain-22, adjust-27)
nn(doses-29, digoxin-28)
dobj(adjust-27, doses-29)
advmod(adjust-27, appropriately-30)

Non-steroidal/JJ anti-inflammatory/JJ agents/NNS :/: Seizures/NNS have/VBP been/VBN reported/VBN in/IN patients/NNS taking/VBG enoxacin/NN concomitantly/RB with/IN the/DT nonsteroidal/JJ anti-inflammatory/JJ drug/NN fenbufen/CD ./.

(ROOT (S1 (S (NP (NP (JJ Non-steroidal) (JJ anti-inflammatory) (NNS agents)) (: :) (S (NP (NNS Seizures)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (NN enoxacin)) (PP (ADVP (RB concomitantly)) (IN with) (NP (DT the) (JJ nonsteroidal) (JJ anti-inflammatory) (NN drug) (CD fenbufen))))))))))) (. .)))))

amod(agents-3, Non-steroidal-1)
amod(agents-3, anti-inflammatory-2)
root(ROOT-0, agents-3)
nsubjpass(reported-8, Seizures-5)
aux(reported-8, have-6)
auxpass(reported-8, been-7)
dep(agents-3, reported-8)
prep_in(reported-8, patients-10)
partmod(patients-10, taking-11)
dobj(taking-11, enoxacin-12)
advmod(enoxacin-12, concomitantly-13)
det(drug-18, the-15)
amod(drug-18, nonsteroidal-16)
amod(drug-18, anti-inflammatory-17)
prep_with(enoxacin-12, drug-18)
num(drug-18, fenbufen-19)

Animal/NN studies/NNS also/RB suggest/VBP an/DT increased/VBN potential/NN for/IN seizures/NNS when/WRB these/DT two/CD drugs/NNS are/VBP given/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NN Animal) (NNS studies)) (ADVP (RB also)) (VP (VBP suggest) (NP (NP (DT an) (VBN increased) (NN potential)) (PP (IN for) (NP (NNS seizures)))) (SBAR (WHADVP (WRB when)) (S (NP (DT these) (CD two) (NNS drugs)) (VP (VBP are) (VP (VBN given) (ADVP (RB concomitantly)))))))) (. .))))

nn(studies-2, Animal-1)
nsubj(suggest-4, studies-2)
advmod(suggest-4, also-3)
root(ROOT-0, suggest-4)
det(potential-7, an-5)
amod(potential-7, increased-6)
dobj(suggest-4, potential-7)
prep_for(potential-7, seizures-9)
advmod(given-15, when-10)
det(drugs-13, these-11)
num(drugs-13, two-12)
nsubjpass(given-15, drugs-13)
auxpass(given-15, are-14)
advcl(suggest-4, given-15)
advmod(given-15, concomitantly-16)

Fenbufen/NN is/VBZ not/RB approved/JJ in/IN the/DT United/JJ States/NNS at/IN this/DT time/NN ./.

(ROOT (S1 (S (S (NP (NN Fenbufen)) (VP (VBZ is) (RB not) (ADJP (JJ approved)) (PP (IN in) (NP (DT the) (JJ United) (NNS States))) (PP (IN at) (NP (DT this) (NN time))))) (. .))))

nsubj(approved-4, Fenbufen-1)
cop(approved-4, is-2)
neg(approved-4, not-3)
root(ROOT-0, approved-4)
det(States-8, the-6)
amod(States-8, United-7)
prep_in(approved-4, States-8)
det(time-11, this-10)
prep_at(approved-4, time-11)

Sucralfate/NN and/CC antacids/NNS :/: Quinolones/NNS form/VBP chelates/NNS with/IN metal/JJ cations/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NN Sucralfate)) (CC and) (NP (NNS antacids))) (: :) (S (NP (NNS Quinolones)) (VP (VBP form) (NP (NP (NNS chelates)) (PP (IN with) (NP (JJ metal) (NNS cations)))))) (. .)))))

root(ROOT-0, Sucralfate-1)
conj_and(Sucralfate-1, antacids-3)
nsubj(form-6, Quinolones-5)
dep(Sucralfate-1, form-6)
dobj(form-6, chelates-7)
amod(cations-10, metal-9)
prep_with(chelates-7, cations-10)

Therefore/RB ,/, administration/NN of/IN quinolones/NNS with/IN antacids/NNS containing/VBG calcium/NN ,/, magnesium/NN ,/, or/CC aluminum/NN ;/: ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN administration)) (PP (IN of) (NP (NNS quinolones))) (PP (IN with) (NP (NNS antacids)))) (VP (VBG containing) (NP (NP (NN calcium)) (, ,) (NP (NN magnesium)) (, ,) (CC or) (NP (NN aluminum)))) (: ;)) (. .))))

advmod(containing-8, Therefore-1)
nsubj(containing-8, administration-3)
prep_of(administration-3, quinolones-5)
prep_with(administration-3, antacids-7)
root(ROOT-0, containing-8)
dobj(containing-8, calcium-9)
conj_or(calcium-9, magnesium-11)
conj_or(calcium-9, aluminum-14)

with/IN sucralfate/NN ;/: ./.

(ROOT (S1 (S (PP (IN with) (NP (NN sucralfate) (: ;))) (. .))))

root(ROOT-0, with-1)
pobj(with-1, sucralfate-2)

with/IN divalent/JJ or/CC trivalent/JJ cations/NNS such/JJ as/IN iron/NN ;/: ./.

(ROOT (S1 (S (PP (IN with) (NP (NP (ADJP (ADJP (JJ divalent)) (CC or) (ADJP (JJ trivalent))) (NNS cations)) (PP (JJ such) (IN as) (NP (NN iron) (: ;))))) (. .))))

root(ROOT-0, with-1)
amod(cations-5, divalent-2)
conj_or(divalent-2, trivalent-4)
pobj(with-1, cations-5)
prep_such_as(cations-5, iron-8)

or/NN with/IN multivitamins/NNS containing/VBG zinc/NN may/MD substantially/RB interfere/VB with/IN drug/NN absorption/NN and/CC result/VB in/IN insufficient/JJ plasma/NN and/CC tissue/NN quinolone/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN or)) (PP (IN with) (NP (NP (NNS multivitamins)) (VP (VBG containing) (NP (NN zinc)))))) (VP (MD may) (ADVP (RB substantially)) (VP (VP (VB interfere) (PP (IN with) (NP (NN drug) (NN absorption)))) (CC and) (VP (VB result) (PP (IN in) (NP (NP (JJ insufficient) (NN plasma)) (CC and) (NP (NN tissue) (NN quinolone) (NNS concentrations)))))))) (. .))))

nsubj(interfere-8, or-1)
prep_with(or-1, multivitamins-3)
partmod(multivitamins-3, containing-4)
dobj(containing-4, zinc-5)
aux(interfere-8, may-6)
advmod(interfere-8, substantially-7)
root(ROOT-0, interfere-8)
nn(absorption-11, drug-10)
prep_with(interfere-8, absorption-11)
conj_and(interfere-8, result-13)
amod(plasma-16, insufficient-15)
prep_in(result-13, plasma-16)
nn(concentrations-20, tissue-18)
nn(concentrations-20, quinolone-19)
conj_and(plasma-16, concentrations-20)

Antacids/NNS containing/VBG aluminum/NN hydroxide/NN and/CC magnesium/NN hydroxide/NN reduce/VBP the/DT oral/JJ absorption/NN of/IN enoxacin/NN by/IN 75/CD %./NN

(ROOT (S1 (S (NP (NP (NNS Antacids)) (VP (VBG containing) (NP (NP (NN aluminum) (NN hydroxide)) (CC and) (NP (NN magnesium) (NN hydroxide))))) (VP (VBP reduce) (NP (NP (DT the) (JJ oral) (NN absorption)) (PP (IN of) (NP (NN enoxacin))) (PP (IN by) (NP (CD 75) (NN %.))))))))

nsubj(reduce-8, Antacids-1)
partmod(Antacids-1, containing-2)
nn(hydroxide-4, aluminum-3)
dobj(containing-2, hydroxide-4)
nn(hydroxide-7, magnesium-6)
conj_and(hydroxide-4, hydroxide-7)
root(ROOT-0, reduce-8)
det(absorption-11, the-9)
amod(absorption-11, oral-10)
dobj(reduce-8, absorption-11)
prep_of(absorption-11, enoxacin-13)
num(%.-16, 75-15)
prep_by(absorption-11, %.-16)

The/DT oral/JJ bioavailability/NN of/IN enoxacin/NN is/VBZ reduced/VBN by/IN 60/CD %/NN with/IN coadministration/NN of/IN ranitidine/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ oral) (NN bioavailability)) (PP (IN of) (NP (NN enoxacin)))) (VP (VBZ is) (VP (VBN reduced) (PP (IN by) (NP (CD 60) (NN %))) (PP (IN with) (NP (NP (NN coadministration)) (PP (IN of) (NP (NN ranitidine)))))))) (. .))))

det(bioavailability-3, The-1)
amod(bioavailability-3, oral-2)
nsubjpass(reduced-7, bioavailability-3)
prep_of(bioavailability-3, enoxacin-5)
auxpass(reduced-7, is-6)
root(ROOT-0, reduced-7)
num(%-10, 60-9)
agent(reduced-7, %-10)
prep_with(reduced-7, coadministration-12)
prep_of(coadministration-12, ranitidine-14)

These/DT agents/NNS should/MD not/RB be/VB taken/VBN for/IN 8/CD hours/NNS before/IN or/CC for/IN 2/CD hours/NNS after/IN enoxacin/NN administration/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS agents)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN taken) (PP (IN for) (NP (CD 8) (NNS hours))) (PP (PP (IN before)) (CC or) (PP (IN for) (NP (CD 2) (NNS hours))) (PP (IN after) (NP (NN enoxacin) (NN administration)))))))) (. .))))

det(agents-2, These-1)
nsubjpass(taken-6, agents-2)
aux(taken-6, should-3)
neg(taken-6, not-4)
auxpass(taken-6, be-5)
root(ROOT-0, taken-6)
num(hours-9, 8-8)
prep_for(taken-6, hours-9)
prep(taken-6, before-10)
conj_or(before-10, for-12)
num(hours-14, 2-13)
pobj(for-12, hours-14)
dep(before-10, after-15)
nn(administration-17, enoxacin-16)
pobj(after-15, administration-17)

Theophylline/NN :/: Enoxacin/NN is/VBZ a/DT potent/JJ inhibitor/NN of/IN the/DT cytochrome/NN P-450/NN isozymes/NNS responsible/JJ for/IN the/DT metabolism/NN of/IN methylxanthines/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Theophylline)) (: :) (NP (NN Enoxacin))) (VP (VBZ is) (NP (NP (DT a) (JJ potent) (NN inhibitor)) (PP (IN of) (NP (NP (DT the) (NP (NN cytochrome) (NN P-450)) (NNS isozymes)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NNS methylxanthines))))))))))) (. .))))

nsubj(inhibitor-7, Theophylline-1)
dep(Theophylline-1, Enoxacin-3)
cop(inhibitor-7, is-4)
det(inhibitor-7, a-5)
amod(inhibitor-7, potent-6)
root(ROOT-0, inhibitor-7)
det(isozymes-12, the-9)
nn(P-450-11, cytochrome-10)
nn(isozymes-12, P-450-11)
prep_of(inhibitor-7, isozymes-12)
amod(isozymes-12, responsible-13)
det(metabolism-16, the-15)
prep_for(responsible-13, metabolism-16)
prep_of(metabolism-16, methylxanthines-18)

Enoxacin/NN interferes/VBZ with/IN the/DT metabolism/NN of/IN theophylline/NN resulting/VBG in/IN a/DT 42/CD %/NN to/TO 74/CD %/NN dose-related/JJ decrease/NN in/IN theophylline/NN clearance/NN and/CC a/DT subsequent/JJ 260/CD %/NN to/TO 350/CD %/NN increase/NN in/IN serum/NN theophylline/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NN Enoxacin)) (VP (VBZ interferes) (PP (IN with) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NP (NN theophylline)) (VP (VBG resulting) (PP (IN in) (NP (NP (NP (DT a) (ADJP (NP (CD 42) (NN %) (TO to) (CD 74) (NN %)) (JJ dose-related)) (NN decrease)) (PP (IN in) (NP (NN theophylline) (NN clearance)))) (CC and) (NP (NP (DT a) (JJ subsequent) (CD 260) (NN %) (TO to) (CD 350) (NN %) (NN increase)) (PP (IN in) (NP (NN serum) (NN theophylline) (NNS levels))))))))))))) (. .))))

nsubj(interferes-2, Enoxacin-1)
root(ROOT-0, interferes-2)
det(metabolism-5, the-4)
prep_with(interferes-2, metabolism-5)
prep_of(metabolism-5, theophylline-7)
partmod(theophylline-7, resulting-8)
det(decrease-17, a-10)
num(%-15, 42-11)
nn(%-15, %-12)
dep(%-15, to-13)
num(%-15, 74-14)
npadvmod(dose-related-16, %-15)
amod(decrease-17, dose-related-16)
prep_in(resulting-8, decrease-17)
nn(clearance-20, theophylline-19)
prep_in(decrease-17, clearance-20)
det(increase-29, a-22)
amod(increase-29, subsequent-23)
num(increase-29, 260-24)
nn(increase-29, %-25)
dep(increase-29, to-26)
num(increase-29, 350-27)
nn(increase-29, %-28)
conj_and(decrease-17, increase-29)
nn(levels-33, serum-31)
nn(levels-33, theophylline-32)
prep_in(increase-29, levels-33)

Theophylline/NN -related/JJ adverse/JJ effects/NNS have/VBP occurred/VBN in/IN patients/NNS when/WRB theophylline/NN and/CC enoxacin/NN were/VBD coadministered/VBN ./.

(ROOT (S1 (S (S (NP (ADJP (NN Theophylline) (JJ -related)) (JJ adverse) (NNS effects)) (VP (VBP have) (VP (VBN occurred) (PP (IN in) (NP (NNS patients))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN theophylline)) (CC and) (NP (NN enoxacin))) (VP (VBD were) (VP (VBN coadministered)))))))) (. .))))

dep(-related-2, Theophylline-1)
amod(effects-4, -related-2)
amod(effects-4, adverse-3)
nsubj(occurred-6, effects-4)
aux(occurred-6, have-5)
root(ROOT-0, occurred-6)
prep_in(occurred-6, patients-8)
advmod(coadministered-14, when-9)
nsubjpass(coadministered-14, theophylline-10)
conj_and(theophylline-10, enoxacin-12)
auxpass(coadministered-14, were-13)
advcl(occurred-6, coadministered-14)

Warfarin/NN :/: Quinolones/NNS ,/, including/VBG enoxacin/NN ,/, decrease/VBP the/DT clearance/NN of/IN R-/NN warfarin/NN ,/, the/DT less/RBR active/JJ isomer/NN of/IN racemic/JJ warfarin/NN ./.

(ROOT (S1 (S (NP (NP (NN Warfarin)) (: :) (S (NP (NP (NNS Quinolones)) (, ,) (PP (VBG including) (NP (NN enoxacin))) (, ,)) (VP (VBP decrease) (NP (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN R-) (NN warfarin)))) (, ,) (NP (NP (DT the) (ADJP (RBR less) (JJ active)) (NN isomer)) (PP (IN of) (NP (JJ racemic) (NN warfarin))))))) (. .)))))

root(ROOT-0, Warfarin-1)
nsubj(decrease-8, Quinolones-3)
prep_including(Quinolones-3, enoxacin-6)
dep(Warfarin-1, decrease-8)
det(clearance-10, the-9)
dobj(decrease-8, clearance-10)
nn(warfarin-13, R--12)
prep_of(clearance-10, warfarin-13)
det(isomer-18, the-15)
advmod(active-17, less-16)
amod(isomer-18, active-17)
appos(clearance-10, isomer-18)
amod(warfarin-21, racemic-20)
prep_of(isomer-18, warfarin-21)

Enoxacin/NN does/VBZ not/RB affect/VB the/DT clearance/NN of/IN the/DT active/JJ S-isomer/NN ,/, and/CC changes/NNS in/IN clotting/NN time/NN have/VBP not/RB been/VBN observed/VBN when/WRB enoxacin/NN and/CC warfarin/NN were/VBD coadministered/VBN ./.

(ROOT (S1 (S (S (S (NP (NN Enoxacin)) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (DT the) (JJ active) (NN S-isomer))))))) (, ,) (CC and) (S (NP (NP (NNS changes)) (PP (IN in) (NP (NN clotting) (NN time)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN enoxacin)) (CC and) (NP (NN warfarin))) (VP (VBD were) (VP (VBN coadministered)))))))))) (. .))))

nsubj(affect-4, Enoxacin-1)
aux(affect-4, does-2)
neg(affect-4, not-3)
root(ROOT-0, affect-4)
det(clearance-6, the-5)
dobj(affect-4, clearance-6)
det(S-isomer-10, the-8)
amod(S-isomer-10, active-9)
prep_of(clearance-6, S-isomer-10)
nsubjpass(observed-20, changes-13)
nn(time-16, clotting-15)
prep_in(changes-13, time-16)
aux(observed-20, have-17)
neg(observed-20, not-18)
auxpass(observed-20, been-19)
conj_and(affect-4, observed-20)
advmod(coadministered-26, when-21)
nsubjpass(coadministered-26, enoxacin-22)
conj_and(enoxacin-22, warfarin-24)
auxpass(coadministered-26, were-25)
advcl(observed-20, coadministered-26)

Nevertheless/RB ,/, the/DT prothrombin/NN time/NN or/CC other/JJ suitable/JJ coagulation/NN test/NN should/MD be/VB monitored/VBN when/WRB warfarin/NN or/CC its/PRP$ derivatives/NNS and/CC enoxacin/NN are/VBP given/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (ADVP (RB Nevertheless)) (, ,) (NP (NP (DT the) (NN prothrombin) (NN time)) (CC or) (NP (JJ other) (JJ suitable) (NN coagulation) (NN test))) (VP (MD should) (VP (VB be) (VP (VBN monitored))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NP (NN warfarin)) (CC or) (NP (PRP$ its) (NNS derivatives))) (CC and) (NP (NN enoxacin))) (VP (VBP are) (VP (VBN given) (ADVP (RB concomitantly)))))))) (. .))))

advmod(monitored-13, Nevertheless-1)
det(time-5, the-3)
nn(time-5, prothrombin-4)
nsubjpass(monitored-13, time-5)
amod(test-10, other-7)
amod(test-10, suitable-8)
nn(test-10, coagulation-9)
conj_or(time-5, test-10)
aux(monitored-13, should-11)
auxpass(monitored-13, be-12)
root(ROOT-0, monitored-13)
advmod(given-22, when-14)
nsubjpass(given-22, warfarin-15)
poss(derivatives-18, its-17)
conj_or(warfarin-15, derivatives-18)
conj_and(warfarin-15, enoxacin-20)
auxpass(given-22, are-21)
advcl(monitored-13, given-22)
advmod(given-22, concomitantly-23)

Unless/IN really/RB needed/VBN ,/, agents/NNS which/WDT may/MD enhance/VB the/DT risk/NN of/IN hemorrhage/NN should/MD be/VB discontinued/VBN prior/JJ to/TO initiation/NN of/IN Lovenox/NN Injection/NN therapy/NN ./.

(ROOT (S1 (S (SBAR (IN Unless) (S (ADVP (RB really)) (VP (VBN needed)))) (, ,) (NP (NP (NNS agents)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN hemorrhage))))))))) (VP (MD should) (VP (VB be) (VP (VBN discontinued) (PP (JJ prior) (TO to) (NP (NP (NN initiation)) (PP (IN of) (NP (NN Lovenox) (NN Injection) (NN therapy)))))))) (. .))))

mark(needed-3, Unless-1)
advmod(needed-3, really-2)
advcl(discontinued-15, needed-3)
nsubj(enhance-8, agents-5)
nsubjpass(discontinued-15, agents-5)
aux(enhance-8, may-7)
rcmod(agents-5, enhance-8)
det(risk-10, the-9)
dobj(enhance-8, risk-10)
prep_of(risk-10, hemorrhage-12)
aux(discontinued-15, should-13)
auxpass(discontinued-15, be-14)
root(ROOT-0, discontinued-15)
prep_prior_to(discontinued-15, initiation-18)
nn(therapy-22, Lovenox-20)
nn(therapy-22, Injection-21)
prep_of(initiation-18, therapy-22)

These/DT agents/NNS include/VBP medications/NNS such/JJ as/IN :/: anticoagulants/NNS ,/, platelet/NN inhibitors/NNS including/VBG acetylsalicylic/JJ acid/NN ,/, sali-/NN cylate/NN s/NNS ,/, NSAIDs/NN (/-LRB- including/VBG ketorolac/NN tromethamine/NN )/-RRB- ,/, dipyridamole/NN ,/, or/CC sulfinpyrazone/NN ./.

(ROOT (S1 (S (NP (DT These) (NNS agents)) (VP (VBP include) (NP (NP (NNS medications)) (PP (JJ such) (IN as) (FRAG (: :) (NP (NP (NNS anticoagulants)) (, ,) (NP (NP (NN platelet) (NNS inhibitors)) (PP (VBG including) (NP (NP (JJ acetylsalicylic) (NN acid)) (, ,) (NP (NN sali-) (NN cylate) (NNS s)) (, ,) (NP (NP (NN NSAIDs)) (PRN (-LRB- -LRB-) (NP (VBG including) (NN ketorolac) (NN tromethamine)) (-RRB- -RRB-))) (, ,) (NP (NN dipyridamole)) (, ,) (CC or) (NP (NN sulfinpyrazone)))))))))) (. .))))

det(agents-2, These-1)
nsubj(include-3, agents-2)
root(ROOT-0, include-3)
dobj(include-3, medications-4)
mwe(as-6, such-5)
prep(medications-4, as-6)
dep(as-6, anticoagulants-8)
nn(inhibitors-11, platelet-10)
appos(anticoagulants-8, inhibitors-11)
amod(acid-14, acetylsalicylic-13)
prep_including(inhibitors-11, acid-14)
nn(s-18, sali--16)
nn(s-18, cylate-17)
conj_or(acid-14, s-18)
conj_or(acid-14, NSAIDs-20)
amod(tromethamine-24, including-22)
nn(tromethamine-24, ketorolac-23)
appos(NSAIDs-20, tromethamine-24)
conj_or(acid-14, dipyridamole-27)
conj_or(acid-14, sulfinpyrazone-30)

In/FW vitro/FW studies/NNS of/IN human/JJ CYP/JJ enzymes/NNS showed/VBD that/IN entacapone/NN inhibited/VBD the/DT CYP/NN enzyme/NN s/NNS 1A2/NN ,/, 2A6/NN ,/, 2C9/NN ,/, 2C19/NN ,/, 2D6/NN ,/, 2E1/NN and/CC 3A/NN only/RB at/IN very/RB high/JJ concentrations/NNS (/-LRB- IC50/NN from/IN 200/CD to/TO over/IN 1000/CD uM/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (PP (IN of) (NP (JJ human) (JJ CYP) (NNS enzymes)))) (VP (VBD showed) (SBAR (IN that) (S (NP (NN entacapone)) (VP (VBD inhibited) (NP (NP (DT the) (NN CYP) (NN enzyme) (NNS s)) (NP (NP (NN 1A2)) (, ,) (NP (NN 2A6)) (, ,) (NP (NN 2C9)) (, ,) (NP (NN 2C19)) (, ,) (NP (NN 2D6)) (, ,) (NP (NN 2E1)) (CC and) (NP (NN 3A)))) (ADVP (RB only)) (PP (IN at) (NP (NP (ADJP (RB very) (JJ high)) (NNS concentrations)) (PRN (-LRB- -LRB-) (NP (NP (NN IC50)) (PP (IN from) (NP (QP (CD 200) (TO to) (IN over) (CD 1000)) (NN uM))))))))))) (: ;)) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(showed-8, studies-3)
amod(enzymes-7, human-5)
amod(enzymes-7, CYP-6)
prep_of(studies-3, enzymes-7)
root(ROOT-0, showed-8)
complm(inhibited-11, that-9)
nsubj(inhibited-11, entacapone-10)
ccomp(showed-8, inhibited-11)
det(s-15, the-12)
nn(s-15, CYP-13)
nn(s-15, enzyme-14)
dobj(inhibited-11, s-15)
iobj(inhibited-11, s-15)
dobj(inhibited-11, 1A2-16)
dep(s-15, 1A2-16)
conj_and(1A2-16, 2A6-18)
conj_and(1A2-16, 2C9-20)
conj_and(1A2-16, 2C19-22)
conj_and(1A2-16, 2D6-24)
conj_and(1A2-16, 2E1-26)
conj_and(1A2-16, 3A-28)
advmod(inhibited-11, only-29)
advmod(high-32, very-31)
amod(concentrations-33, high-32)
prep_at(inhibited-11, concentrations-33)
dep(concentrations-33, IC50-35)
number(1000-40, 200-37)
dep(1000-40, to-38)
quantmod(1000-40, over-39)
num(uM-41, 1000-40)
prep_from(IC50-35, uM-41)

Protein/NN Binding/NN :/: Entacapone/NN is/VBZ highly/RB protein/NN bound/VBN (/-LRB- 98%)./CD

(ROOT (S1 (S (NP (NP (NN Protein) (NN Binding)) (: :) (S (NP (NN Entacapone)) (VP (VBZ is) (ADVP (RB highly)) (VP (NN protein) (VBN bound)))) (-LRB- -LRB-) (CD 98%-RRB-.)))))

nn(Binding-2, Protein-1)
root(ROOT-0, Binding-2)
nsubjpass(bound-8, Entacapone-4)
auxpass(bound-8, is-5)
advmod(bound-8, highly-6)
dep(bound-8, protein-7)
dep(Binding-2, bound-8)
num(Binding-2, 98%-RRB-.-10)

In/FW vitro/FW studies/NNS have/VBP shown/VBN no/DT binding/VBG displacement/NN between/IN entacapone/NN and/CC other/JJ highly/RB bound/VBN drugs/NNS ,/, such/JJ as/IN warfarin/NN ,/, salicylic/JJ acid/NN ,/, phenylbutazone/NN ,/, and/CC diazepam/NN ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBP have) (VP (VBN shown) (NP (NP (DT no) (VBG binding) (NN displacement)) (PP (IN between) (NP (NP (NN entacapone)) (CC and) (NP (NP (JJ other) (ADJP (RB highly) (VBN bound)) (NNS drugs)) (, ,) (PP (JJ such) (IN as) (NP (NN warfarin))) (, ,) (NP (NP (JJ salicylic) (NN acid)) (, ,) (NP (NN phenylbutazone)) (, ,) (CC and) (NP (NN diazepam)))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(shown-5, studies-3)
aux(shown-5, have-4)
root(ROOT-0, shown-5)
det(displacement-8, no-6)
amod(displacement-8, binding-7)
dobj(shown-5, displacement-8)
prep_between(displacement-8, entacapone-10)
amod(drugs-15, other-12)
advmod(bound-14, highly-13)
amod(drugs-15, bound-14)
conj_and(entacapone-10, drugs-15)
prep_such_as(drugs-15, warfarin-19)
amod(acid-22, salicylic-21)
appos(drugs-15, acid-22)
conj_and(acid-22, phenylbutazone-24)
conj_and(acid-22, diazepam-27)

Drugs/NNS Metabolized/VBN by/IN Catechol-O-methyltransferase/NN (/-LRB- COMT/NN )/-RRB- :/: Hormone/NN levels/NNS :/: Levodopa/NN is/VBZ known/VBN to/TO depress/VB prolactin/NN secretion/NN and/CC increase/VB growth/NN hormone/NN levels/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NNS Drugs)) (VP (VBN Metabolized) (PP (IN by) (NP (NN Catechol-O-methyltransferase) (-LRB- -LRB-) (NN COMT) (-RRB- -RRB-) (: :) (NN Hormone) (NNS levels))))) (: :) (S (NP (NN Levodopa)) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VP (VB depress) (NP (NN prolactin) (NN secretion))) (CC and) (VP (VB increase) (NP (NN growth) (NN hormone) (NNS levels))))))))) (. .)))))

root(ROOT-0, Drugs-1)
partmod(Drugs-1, Metabolized-2)
nn(levels-10, Catechol-O-methyltransferase-4)
nn(levels-10, COMT-6)
nn(levels-10, Hormone-9)
agent(Metabolized-2, levels-10)
nsubjpass(known-14, Levodopa-12)
xsubj(depress-16, Levodopa-12)
auxpass(known-14, is-13)
dep(Drugs-1, known-14)
aux(depress-16, to-15)
xcomp(known-14, depress-16)
nn(secretion-18, prolactin-17)
dobj(depress-16, secretion-18)
conj_and(depress-16, increase-20)
nn(levels-23, growth-21)
nn(levels-23, hormone-22)
dobj(increase-20, levels-23)

Treatment/NN with/IN entacapone/NN coadministered/VBN with/IN levodopa/NN //: dopa/NN decarboxylase/NN inhibitor/NN does/VBZ not/RB change/VB these/DT effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Treatment)) (PP (IN with) (NP (NP (NP (NN entacapone)) (VP (VBN coadministered) (PP (IN with) (NP (NN levodopa))))) (: /) (NP (NP (NN dopa) (NN decarboxylase)) (NN inhibitor))))) (VP (VBZ does) (RB not) (VP (VB change) (NP (DT these) (NNS effects))))) (. .))))

nsubj(change-13, Treatment-1)
prep_with(Treatment-1, entacapone-3)
partmod(entacapone-3, coadministered-4)
prep_with(coadministered-4, levodopa-6)
punct(entacapone-3, /-7)
nn(decarboxylase-9, dopa-8)
nn(inhibitor-10, decarboxylase-9)
dep(entacapone-3, inhibitor-10)
aux(change-13, does-11)
neg(change-13, not-12)
root(ROOT-0, change-13)
det(effects-15, these-14)
dobj(change-13, effects-15)

No/DT interaction/NN was/VBD noted/VBN with/IN the/DT MAO-B/NN inhibitor/NN selegiline/NN in/IN two/CD multiple-dose/NN interaction/NN studies/NNS when/WRB entacapone/NN was/VBD coadministered/VBN with/IN a/DT levodopa/NN //: dopa/NN decarboxylase/NN inhibitor/NN (/-LRB- n=29)./NN

(ROOT (S1 (S (NP (DT No) (NN interaction)) (VP (VBD was) (VP (VBN noted) (PP (IN with) (NP (DT the) (NN MAO-B) (NN inhibitor) (NN selegiline))) (PP (IN in) (NP (CD two) (NN multiple-dose) (NN interaction) (NNS studies)))) (SBAR (WHADVP (WRB when)) (S (NP (NN entacapone)) (VP (VBD was) (VP (VBN coadministered) (PP (IN with) (NP (NP (DT a) (NN levodopa) (: /) (NP (NN dopa) (NN decarboxylase)) (NN inhibitor)) (PRN (-LRB- -LRB-) (NP (NN n=29-RRB-.)))))))))))))

det(interaction-2, No-1)
nsubjpass(noted-4, interaction-2)
auxpass(noted-4, was-3)
root(ROOT-0, noted-4)
det(selegiline-9, the-6)
nn(selegiline-9, MAO-B-7)
nn(selegiline-9, inhibitor-8)
prep_with(noted-4, selegiline-9)
num(studies-14, two-11)
nn(studies-14, multiple-dose-12)
nn(studies-14, interaction-13)
prep_in(noted-4, studies-14)
advmod(coadministered-18, when-15)
nsubjpass(coadministered-18, entacapone-16)
auxpass(coadministered-18, was-17)
advcl(noted-4, coadministered-18)
det(inhibitor-25, a-20)
nn(inhibitor-25, levodopa-21)
punct(inhibitor-25, /-22)
nn(decarboxylase-24, dopa-23)
nn(inhibitor-25, decarboxylase-24)
prep_with(coadministered-18, inhibitor-25)
dep(inhibitor-25, n=29-RRB-.-27)

More/JJR than/IN 600/CD Parkinsons/NN disease/NN patients/NNS in/IN clinical/JJ trials/NNS have/VBP used/VBN selegiline/NN in/IN combination/NN with/IN entacapone/NN and/CC levodopa/NN //: dopa/NN decarboxylase/NN inhibitor/NN ./.

(ROOT (S1 (S (S (NP (NP (QP (JJR More) (IN than) (CD 600)) (NN Parkinsons) (NN disease) (NNS patients)) (PP (IN in) (NP (JJ clinical) (NNS trials)))) (VP (VBP have) (VP (VBN used) (NP (NN selegiline)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NP (NN entacapone)) (CC and) (NP (NN levodopa))) (: /) (NP (NP (NN dopa) (NN decarboxylase)) (NN inhibitor))))))))) (. .))))

mwe(than-2, More-1)
quantmod(600-3, than-2)
num(patients-6, 600-3)
nn(patients-6, Parkinsons-4)
nn(patients-6, disease-5)
nsubj(used-11, patients-6)
amod(trials-9, clinical-8)
prep_in(patients-6, trials-9)
aux(used-11, have-10)
root(ROOT-0, used-11)
dobj(used-11, selegiline-12)
prep_in(used-11, combination-14)
prep_with(combination-14, entacapone-16)
conj_and(entacapone-16, levodopa-18)
punct(entacapone-16, /-19)
nn(decarboxylase-21, dopa-20)
nn(inhibitor-22, decarboxylase-21)
dep(entacapone-16, inhibitor-22)

As/IN most/JJ entacapone/NN excretion/NN is/VBZ via/IN the/DT bile/NN ,/, caution/NN should/MD be/VB exercised/VBN when/WRB drugs/NNS known/VBN to/TO interfere/VB with/IN biliary/JJ excretion/NN ,/, glucuronidation/NN ,/, and/CC intestinal/JJ beta-glucuronidase/NN are/VBP given/VBN concurrently/RB with/IN entacapone/NN ./.

(ROOT (S1 (S (S (SBAR (IN As) (S (NP (JJ most) (NN entacapone) (NN excretion)) (VP (VBZ is) (PP (IN via) (NP (DT the) (NN bile)))))) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (NP (NP (NNS drugs)) (VP (VBN known) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (NP (JJ biliary) (NN excretion)) (, ,) (NP (NN glucuronidation)) (, ,) (CC and) (NP (JJ intestinal) (NN beta-glucuronidase))))))))) (VP (VBP are) (VP (VBN given) (ADVP (RB concurrently)) (PP (IN with) (NP (NN entacapone))))))))))) (. .))))

mark(is-5, As-1)
amod(excretion-4, most-2)
nn(excretion-4, entacapone-3)
nsubj(is-5, excretion-4)
advcl(exercised-13, is-5)
det(bile-8, the-7)
prep_via(is-5, bile-8)
nsubjpass(exercised-13, caution-10)
aux(exercised-13, should-11)
auxpass(exercised-13, be-12)
root(ROOT-0, exercised-13)
advmod(given-29, when-14)
nsubjpass(given-29, drugs-15)
partmod(drugs-15, known-16)
aux(interfere-18, to-17)
xcomp(known-16, interfere-18)
amod(excretion-21, biliary-20)
prep_with(interfere-18, excretion-21)
conj_and(excretion-21, glucuronidation-23)
amod(beta-glucuronidase-27, intestinal-26)
conj_and(excretion-21, beta-glucuronidase-27)
auxpass(given-29, are-28)
advcl(exercised-13, given-29)
advmod(given-29, concurrently-30)
prep_with(given-29, entacapone-32)

These/DT include/VBP probenecid/NN ,/, cholestyramine/NN ,/, and/CC some/DT antibiotics/NNS (/-LRB- e.g./FW erythromycin/NN ,/, rifamipicin/NN ,/, ampicillin/NN and/CC chloramphenicol/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (DT These)) (VP (VBP include) (NP (NP (NN probenecid)) (, ,) (NP (NN cholestyramine)) (, ,) (CC and) (NP (NP (DT some) (NNS antibiotics)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (NP (NP (NN erythromycin)) (, ,) (NP (NN rifamipicin)) (, ,) (NP (NN ampicillin)) (CC and) (NP (NN chloramphenicol)))) (-RRB- -RRB-)))))) (. .))))

nsubj(include-2, These-1)
root(ROOT-0, include-2)
dobj(include-2, probenecid-3)
conj_and(probenecid-3, cholestyramine-5)
det(antibiotics-9, some-8)
conj_and(probenecid-3, antibiotics-9)
dep(antibiotics-9, e.g.-11)
pobj(e.g.-11, erythromycin-12)
conj_and(erythromycin-12, rifamipicin-14)
conj_and(erythromycin-12, ampicillin-16)
conj_and(erythromycin-12, chloramphenicol-18)

No/DT interaction/NN with/IN the/DT tricyclic/JJ antidepressant/JJ imipramine/NN was/VBD shown/VBN in/IN a/DT single-dose/JJ study/NN with/IN entacapone/NN without/IN coadministered/JJ levodopa/NN //: dopa-decarboxylase/NN inhibitor/NN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (NN interaction)) (PP (IN with) (NP (DT the) (JJ tricyclic) (JJ antidepressant) (NN imipramine)))) (VP (VBD was) (VP (VBN shown) (PP (IN in) (NP (NP (DT a) (JJ single-dose) (NN study)) (PP (IN with) (NP (NP (NN entacapone)) (PP (IN without) (NP (JJ coadministered) (NN levodopa) (: /) (NN dopa-decarboxylase) (NN inhibitor)))))))))) (. .))))

det(interaction-2, No-1)
nsubjpass(shown-9, interaction-2)
det(imipramine-7, the-4)
amod(imipramine-7, tricyclic-5)
amod(imipramine-7, antidepressant-6)
prep_with(interaction-2, imipramine-7)
auxpass(shown-9, was-8)
root(ROOT-0, shown-9)
det(study-13, a-11)
amod(study-13, single-dose-12)
prep_in(shown-9, study-13)
prep_with(study-13, entacapone-15)
amod(inhibitor-21, coadministered-17)
nn(inhibitor-21, levodopa-18)
punct(inhibitor-21, /-19)
nn(inhibitor-21, dopa-decarboxylase-20)
prep_without(entacapone-15, inhibitor-21)

Since/IN entecavir/NN is/VBZ primarily/RB eliminated/VBN by/IN the/DT kidneys/NNS ,/, coadministration/NN of/IN BARACLUDE/NN with/IN drugs/NNS that/WDT reduce/VBP renal/JJ function/NN or/CC compete/VBP for/IN active/JJ tubular/JJ secretion/NN may/MD increase/VB serum/NN concentrations/NNS of/IN either/CC entecavir/NN or/CC the/DT coadministered/JJ drug/NN ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NN entecavir)) (VP (VBZ is) (ADVP (RB primarily)) (VP (VBN eliminated) (PP (IN by) (NP (DT the) (NNS kidneys))))))) (, ,) (NP (NP (NN coadministration)) (PP (IN of) (NP (NN BARACLUDE))) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBP reduce) (NP (JJ renal) (NN function))) (CC or) (VP (VBP compete) (PP (IN for) (NP (JJ active) (JJ tubular) (NN secretion)))))))))) (VP (MD may) (VP (VB increase) (NP (NP (NN serum) (NNS concentrations)) (PP (IN of) (NP (CC either) (NP (NN entecavir)) (CC or) (NP (DT the) (JJ coadministered) (NN drug)))))))) (. .))))

mark(eliminated-5, Since-1)
nsubjpass(eliminated-5, entecavir-2)
auxpass(eliminated-5, is-3)
advmod(eliminated-5, primarily-4)
advcl(increase-26, eliminated-5)
det(kidneys-8, the-7)
agent(eliminated-5, kidneys-8)
nsubj(increase-26, coadministration-10)
prep_of(coadministration-10, BARACLUDE-12)
prep_with(coadministration-10, drugs-14)
nsubj(reduce-16, drugs-14)
rcmod(drugs-14, reduce-16)
amod(function-18, renal-17)
dobj(reduce-16, function-18)
conj_or(reduce-16, compete-20)
amod(secretion-24, active-22)
amod(secretion-24, tubular-23)
prep_for(compete-20, secretion-24)
aux(increase-26, may-25)
root(ROOT-0, increase-26)
nn(concentrations-28, serum-27)
dobj(increase-26, concentrations-28)
preconj(entecavir-31, either-30)
prep_of(concentrations-28, entecavir-31)
det(drug-35, the-33)
amod(drug-35, coadministered-34)
conj_or(entecavir-31, drug-35)

Coadministration/NN of/IN entecavir/NN with/IN lamivudine/NN ,/, adefovir/NN dipivoxil/NN ,/, or/CC tenofovir/JJ disoproxil/NN fumarate/NN did/VBD not/RB result/VB in/IN significant/JJ drug/NN interactions/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN entecavir))) (PP (IN with) (NP (NP (NN lamivudine)) (, ,) (NP (NN adefovir) (NN dipivoxil)) (, ,) (CC or) (NP (JJ tenofovir) (NN disoproxil) (NN fumarate))))) (VP (VBD did) (RB not) (VP (VB result) (PP (IN in) (NP (JJ significant) (NN drug) (NNS interactions)))))) (. .))))

nsubj(result-16, Coadministration-1)
prep_of(Coadministration-1, entecavir-3)
prep_with(Coadministration-1, lamivudine-5)
nn(dipivoxil-8, adefovir-7)
conj_or(lamivudine-5, dipivoxil-8)
amod(fumarate-13, tenofovir-11)
nn(fumarate-13, disoproxil-12)
conj_or(lamivudine-5, fumarate-13)
aux(result-16, did-14)
neg(result-16, not-15)
root(ROOT-0, result-16)
amod(interactions-20, significant-18)
nn(interactions-20, drug-19)
prep_in(result-16, interactions-20)

The/DT effects/NNS of/IN coadministration/NN of/IN BARACLUDE/NN with/IN other/JJ drugs/NNS that/WDT are/VBP renally/RB eliminated/VBN or/CC are/VBP known/VBN to/TO affect/VB renal/JJ function/NN have/VBP not/RB been/VBN evaluated/VBN ,/, and/CC patients/NNS should/MD be/VB monitored/VBN closely/RB for/IN adverse/JJ events/NNS when/WRB BARACLUDE/NN is/VBZ coadministered/VBN with/IN such/JJ drugs/NNS ./.

(ROOT (S1 (S (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NN coadministration)) (PP (IN of) (NP (NN BARACLUDE))) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VP (VBP are) (ADVP (RB renally)) (VP (VBN eliminated))) (CC or) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB affect) (NP (JJ renal) (NN function))))))))))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN evaluated))))) (, ,) (CC and) (S (NP (NNS patients)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB closely)) (PP (IN for) (NP (JJ adverse) (NNS events))) (SBAR (WHADVP (WRB when)) (S (NP (NN BARACLUDE)) (VP (VBZ is) (VP (VBN coadministered) (PP (IN with) (NP (JJ such) (NNS drugs)))))))))))) (. .))))

det(effects-2, The-1)
nsubjpass(evaluated-24, effects-2)
prep_of(effects-2, coadministration-4)
prep_of(coadministration-4, BARACLUDE-6)
amod(drugs-9, other-8)
prep_with(coadministration-4, drugs-9)
nsubjpass(eliminated-13, drugs-9)
auxpass(eliminated-13, are-11)
advmod(eliminated-13, renally-12)
rcmod(drugs-9, eliminated-13)
auxpass(known-16, are-15)
conj_or(eliminated-13, known-16)
aux(affect-18, to-17)
xcomp(known-16, affect-18)
amod(function-20, renal-19)
dobj(affect-18, function-20)
aux(evaluated-24, have-21)
neg(evaluated-24, not-22)
auxpass(evaluated-24, been-23)
root(ROOT-0, evaluated-24)
nsubjpass(monitored-30, patients-27)
aux(monitored-30, should-28)
auxpass(monitored-30, be-29)
conj_and(evaluated-24, monitored-30)
advmod(monitored-30, closely-31)
amod(events-34, adverse-33)
prep_for(monitored-30, events-34)
advmod(coadministered-38, when-35)
nsubjpass(coadministered-38, BARACLUDE-36)
auxpass(coadministered-38, is-37)
advcl(monitored-30, coadministered-38)
amod(drugs-41, such-40)
prep_with(coadministered-38, drugs-41)

Epinephrine/NN should/MD be/VB used/VBN cautiously/RB in/IN patients/NNS with/IN hyperthyroidism/NN ,/, hypertension/NN and/CC cardiac/JJ arrhythmias/NNS ./.

(ROOT (S1 (S (S (NP (NN Epinephrine)) (VP (MD should) (VP (VB be) (VP (VBN used) (ADVP (RB cautiously)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN hyperthyroidism)) (, ,) (NP (NN hypertension)) (CC and) (NP (JJ cardiac) (NNS arrhythmias)))))))))) (. .))))

nsubjpass(used-4, Epinephrine-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
advmod(used-4, cautiously-5)
prep_in(used-4, patients-7)
prep_with(patients-7, hyperthyroidism-9)
conj_and(hyperthyroidism-9, hypertension-11)
amod(arrhythmias-14, cardiac-13)
conj_and(hyperthyroidism-9, arrhythmias-14)

All/DT vasopressor/JJ s/NNS should/MD be/VB used/VBN cautiously/RB in/IN patients/NNS taking/VBG monoamine/NN oxidase/NN (/-LRB- MAO/NN )/-RRB- inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (DT All) (JJ vasopressor) (NNS s)) (VP (MD should) (VP (VB be) (VP (VBN used) (ADVP (RB cautiously)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (NP (NN monoamine) (NN oxidase)) (PRN (-LRB- -LRB-) (NP (NN MAO)) (-RRB- -RRB-))) (NNS inhibitors))))))))) (. .))))

det(s-3, All-1)
amod(s-3, vasopressor-2)
nsubjpass(used-6, s-3)
aux(used-6, should-4)
auxpass(used-6, be-5)
root(ROOT-0, used-6)
advmod(used-6, cautiously-7)
prep_in(used-6, patients-9)
partmod(patients-9, taking-10)
nn(oxidase-12, monoamine-11)
nn(inhibitors-16, oxidase-12)
abbrev(oxidase-12, MAO-14)
dobj(taking-10, inhibitors-16)

Epinephrine/NN should/MD not/RB be/VB administered/VBN concomitantly/RB with/IN other/JJ sympathomimetic/JJ drugs/NNS (/-LRB- such/JJ as/IN isoproterenol/NN )/-RRB- because/IN of/IN possible/JJ additive/JJ effects/NNS and/CC increased/VBN toxicity/NN ./.

(ROOT (S1 (S (S (NP (NN Epinephrine)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (JJ other) (JJ sympathomimetic) (NNS drugs)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NN isoproterenol)))) (-RRB- -RRB-)))) (PP (IN because) (IN of) (NP (NP (JJ possible) (JJ additive) (NNS effects)) (CC and) (NP (VBN increased) (NN toxicity)))))))) (. .))))

nsubjpass(administered-5, Epinephrine-1)
aux(administered-5, should-2)
neg(administered-5, not-3)
auxpass(administered-5, be-4)
root(ROOT-0, administered-5)
advmod(administered-5, concomitantly-6)
amod(drugs-10, other-8)
amod(drugs-10, sympathomimetic-9)
prep_with(administered-5, drugs-10)
prep_such_as(drugs-10, isoproterenol-14)
amod(effects-20, possible-18)
amod(effects-20, additive-19)
prep_because_of(administered-5, effects-20)
amod(toxicity-23, increased-22)
conj_and(effects-20, toxicity-23)

They/PRP may/MD be/VB administered/VBN alternately/RB when/WRB the/DT preceding/JJ effect/NN of/IN other/JJ such/JJ drug/NN has/VBZ subsided/VBN ./.

(ROOT (S1 (S (S (NP (PRP They)) (VP (MD may) (VP (VB be) (VP (VBN administered) (ADVP (RB alternately)) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT the) (JJ preceding) (NN effect)) (PP (IN of) (NP (JJ other) (JJ such) (NN drug)))) (VP (VBZ has) (VP (VBN subsided))))))))) (. .))))

nsubjpass(administered-4, They-1)
aux(administered-4, may-2)
auxpass(administered-4, be-3)
root(ROOT-0, administered-4)
advmod(administered-4, alternately-5)
advmod(subsided-15, when-6)
det(effect-9, the-7)
amod(effect-9, preceding-8)
nsubj(subsided-15, effect-9)
amod(drug-13, other-11)
amod(drug-13, such-12)
prep_of(effect-9, drug-13)
aux(subsided-15, has-14)
advcl(administered-4, subsided-15)

Administration/NN of/IN epinephrine/NN to/TO patients/NNS receiving/VBG cyclopropane/NN or/CC halogenated/JJ hydrocarbon/NN general/JJ anesthetics/NNS such/JJ as/IN halothane/NN which/WDT sensitize/VB the/DT myocardium/NN ,/, may/MD induce/VB cardiac/JJ arrhythmia/NN ../NN

(ROOT (S1 (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN epinephrine))) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN cyclopropane)) (CC or) (NP (NP (JJ halogenated) (NN hydrocarbon) (JJ general) (NNS anesthetics)) (PP (JJ such) (IN as) (NP (NP (NN halothane)) (SBAR (WHNP (WDT which)) (S (VP (VB sensitize) (NP (DT the) (NN myocardium))))))) (, ,))))))) (VP (MD may) (VP (VB induce) (NP (JJ cardiac) (NN arrhythmia) (NN ..)))))))

nsubj(induce-22, Administration-1)
prep_of(Administration-1, epinephrine-3)
prep_to(Administration-1, patients-5)
partmod(patients-5, receiving-6)
dobj(receiving-6, cyclopropane-7)
amod(anesthetics-12, halogenated-9)
nn(anesthetics-12, hydrocarbon-10)
amod(anesthetics-12, general-11)
conj_or(cyclopropane-7, anesthetics-12)
prep_such_as(anesthetics-12, halothane-15)
nsubj(sensitize-17, halothane-15)
rcmod(halothane-15, sensitize-17)
det(myocardium-19, the-18)
dobj(sensitize-17, myocardium-19)
aux(induce-22, may-21)
root(ROOT-0, induce-22)
amod(..-25, cardiac-23)
nn(..-25, arrhythmia-24)
dobj(induce-22, ..-25)

When/WRB encountered/VBN ,/, such/JJ arrhythmias/NNS may/MD respond/VB to/TO administration/NN of/IN a/DT beta-adrenergic/JJ blocking/NN drug/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN encountered)))) (, ,) (NP (JJ such) (NNS arrhythmias)) (VP (MD may) (VP (VB respond) (PP (TO to) (NP (NP (NN administration)) (PP (IN of) (NP (DT a) (JJ beta-adrenergic) (NN blocking) (NN drug)))))))) (. .))))

advmod(encountered-2, When-1)
advcl(respond-7, encountered-2)
amod(arrhythmias-5, such-4)
nsubj(respond-7, arrhythmias-5)
aux(respond-7, may-6)
root(ROOT-0, respond-7)
prep_to(respond-7, administration-9)
det(drug-14, a-11)
amod(drug-14, beta-adrenergic-12)
nn(drug-14, blocking-13)
prep_of(administration-9, drug-14)

Epinephrine/NN also/RB should/MD be/VB used/VBN cautiously/RB with/IN other/JJ drugs/NNS (/-LRB- e.g./FW ,/, digitalis/NN ,/, glycosides/NNS )/-RRB- that/WDT sensitize/VB the/DT myocardium/NN to/TO the/DT actions/NNS of/IN sympathomimetic/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NN Epinephrine)) (VP (ADVP (RB also)) (MD should) (VP (VB be) (VP (VBN used) (ADVP (RB cautiously)) (PP (IN with) (NP (NP (NP (JJ other) (NNS drugs)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN digitalis))) (, ,) (NP (NNS glycosides)) (-RRB- -RRB-))) (SBAR (WHNP (WDT that)) (S (VP (VB sensitize) (NP (DT the) (NN myocardium)) (PP (TO to) (NP (NP (DT the) (NNS actions)) (PP (IN of) (NP (JJ sympathomimetic) (NNS drugs)))))))))))))) (. .))))

nsubjpass(used-5, Epinephrine-1)
advmod(used-5, also-2)
aux(used-5, should-3)
auxpass(used-5, be-4)
root(ROOT-0, used-5)
advmod(used-5, cautiously-6)
amod(drugs-9, other-8)
prep_with(used-5, drugs-9)
nsubj(sensitize-18, drugs-9)
dep(glycosides-15, e.g.-11)
pobj(e.g.-11, digitalis-13)
appos(drugs-9, glycosides-15)
rcmod(drugs-9, sensitize-18)
det(myocardium-20, the-19)
dobj(sensitize-18, myocardium-20)
det(actions-23, the-22)
prep_to(sensitize-18, actions-23)
amod(drugs-26, sympathomimetic-25)
prep_of(actions-23, drugs-26)

Diuretic/JJ agents/NNS may/MD decrease/VB vascular/JJ response/NN to/TO pressor/JJ drugs/NNS such/JJ as/IN epinephrine/NN ./.

(ROOT (S1 (S (S (NP (JJ Diuretic) (NNS agents)) (VP (MD may) (VP (VB decrease) (NP (NP (JJ vascular) (NN response)) (PP (TO to) (NP (NP (JJ pressor) (NNS drugs)) (PP (JJ such) (IN as) (NP (NN epinephrine))))))))) (. .))))

amod(agents-2, Diuretic-1)
nsubj(decrease-4, agents-2)
aux(decrease-4, may-3)
root(ROOT-0, decrease-4)
amod(response-6, vascular-5)
dobj(decrease-4, response-6)
amod(drugs-9, pressor-8)
prep_to(response-6, drugs-9)
prep_such_as(drugs-9, epinephrine-12)

Epinephrine/NN may/MD antagonize/VB the/DT neuron/NN blockade/NN produced/VBN by/IN guanethidine/NN resulting/VBG in/IN decreased/VBN antihypertensive/JJ effect/NN and/CC requiring/VBG increased/VBN dosage/NN of/IN the/DT latter/JJ ./.

(ROOT (S1 (S (S (NP (NN Epinephrine)) (VP (MD may) (VP (VB antagonize) (NP (NP (DT the) (NN neuron) (NN blockade)) (VP (VBN produced) (PP (IN by) (NP (NP (NN guanethidine)) (VP (VP (VBG resulting) (PP (IN in) (NP (VBN decreased) (JJ antihypertensive) (NN effect)))) (CC and) (VP (VBG requiring) (NP (NP (VBN increased) (NN dosage)) (PP (IN of) (NP (DT the) (JJ latter))))))))))))) (. .))))

nsubj(antagonize-3, Epinephrine-1)
aux(antagonize-3, may-2)
root(ROOT-0, antagonize-3)
det(blockade-6, the-4)
nn(blockade-6, neuron-5)
dobj(antagonize-3, blockade-6)
partmod(blockade-6, produced-7)
agent(produced-7, guanethidine-9)
dep(guanethidine-9, resulting-10)
amod(effect-14, decreased-12)
amod(effect-14, antihypertensive-13)
prep_in(resulting-10, effect-14)
conj_and(resulting-10, requiring-16)
amod(dosage-18, increased-17)
dobj(requiring-16, dosage-18)
det(latter-21, the-20)
prep_of(dosage-18, latter-21)

ELLENCE/NN when/WRB used/VBN in/IN combination/NN with/IN other/JJ cytotoxic/JJ drugs/NNS may/MD show/VB on-treatment/JJ additive/JJ toxicity/NN ,/, especially/RB hematologic/JJ and/CC gastrointestinal/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN ELLENCE)) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ other) (JJ cytotoxic) (NNS drugs))))))))) (VP (MD may) (VP (VB show) (NP (NP (JJ on-treatment) (JJ additive) (NN toxicity)) (, ,) (NP (ADVP (RB especially)) (NP (ADJP (ADJP (JJ hematologic)) (CC and) (ADJP (JJ gastrointestinal))) (NNS effects))))))) (. .))))

nsubj(show-11, ELLENCE-1)
advmod(used-3, when-2)
dep(ELLENCE-1, used-3)
prep_in(used-3, combination-5)
amod(drugs-9, other-7)
amod(drugs-9, cytotoxic-8)
prep_with(combination-5, drugs-9)
aux(show-11, may-10)
root(ROOT-0, show-11)
amod(toxicity-14, on-treatment-12)
amod(toxicity-14, additive-13)
dobj(show-11, toxicity-14)
advmod(effects-20, especially-16)
amod(effects-20, hematologic-17)
conj_and(hematologic-17, gastrointestinal-19)
appos(toxicity-14, effects-20)

Concomitant/JJ use/NN of/IN ELLENCE/NN with/IN other/JJ cardioactive/JJ compounds/NNS that/WDT could/MD cause/VB heart/NN failure/NN (/-LRB- e.g./FW ,/, calcium/NN channel/NN blockers/NNS )/-RRB- ,/, requires/VBZ close/JJ monitoring/NN of/IN cardiac/JJ function/NN throughout/IN treatment/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (NN ELLENCE)) (PP (IN with) (NP (NP (JJ other) (JJ cardioactive) (NNS compounds)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VB cause) (NP (NP (NN heart) (NN failure)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN calcium) (NN channel) (NNS blockers))) (-RRB- -RRB-))))))))))) (, ,)) (VP (VBZ requires) (NP (NP (JJ close) (NN monitoring)) (PP (IN of) (NP (JJ cardiac) (NN function)))) (PP (IN throughout) (NP (NN treatment))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(requires-22, use-2)
prep_of(use-2, ELLENCE-4)
amod(compounds-8, other-6)
amod(compounds-8, cardioactive-7)
prep_with(ELLENCE-4, compounds-8)
nsubj(cause-11, compounds-8)
aux(cause-11, could-10)
rcmod(compounds-8, cause-11)
nn(failure-13, heart-12)
dobj(cause-11, failure-13)
dep(failure-13, e.g.-15)
nn(blockers-19, calcium-17)
nn(blockers-19, channel-18)
pobj(e.g.-15, blockers-19)
root(ROOT-0, requires-22)
amod(monitoring-24, close-23)
dobj(requires-22, monitoring-24)
amod(function-27, cardiac-26)
prep_of(monitoring-24, function-27)
prep_throughout(requires-22, treatment-29)

There/EX are/VBP few/JJ data/NNS regarding/VBG the/DT coadministration/NN of/IN radiation/NN therapy/NN and/CC epirubicin/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP are) (NP (NP (JJ few) (NNS data)) (PP (VBG regarding) (NP (NP (DT the) (NN coadministration)) (PP (IN of) (NP (NP (NN radiation) (NN therapy)) (CC and) (NP (NN epirubicin))))))))) (. .))))

expl(are-2, There-1)
root(ROOT-0, are-2)
amod(data-4, few-3)
nsubj(are-2, data-4)
det(coadministration-7, the-6)
prep_regarding(data-4, coadministration-7)
nn(therapy-10, radiation-9)
prep_of(coadministration-7, therapy-10)
conj_and(therapy-10, epirubicin-12)

In/IN adjuvant/JJ trials/NNS of/IN epirubicin/NN -containing/JJ CEF-120/CD or/CC FEC-100/CD chemotherapies/NNS ,/, breast/NN irradiation/NN was/VBD delayed/VBN until/IN after/IN chemotherapy/NN was/VBD completed/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (JJ adjuvant) (NNS trials)) (PP (IN of) (NP (NP (NN epirubicin)) (ADJP (JJ -containing) (NP (QP (CD CEF-120) (CC or) (CD FEC-100)) (NNS chemotherapies))))))) (, ,) (NP (NN breast) (NN irradiation)) (VP (VBD was) (VP (VBN delayed) (SBAR (IN until) (S (PP (IN after) (NP (NN chemotherapy))) (VP (VBD was) (VP (VBN completed)))))))) (. .))))

amod(trials-3, adjuvant-2)
prep_in(delayed-15, trials-3)
prep_of(trials-3, epirubicin-5)
amod(epirubicin-5, -containing-6)
num(chemotherapies-10, CEF-120-7)
conj_or(CEF-120-7, FEC-100-9)
dep(-containing-6, chemotherapies-10)
nn(irradiation-13, breast-12)
nsubjpass(delayed-15, irradiation-13)
auxpass(delayed-15, was-14)
root(ROOT-0, delayed-15)
mark(completed-20, until-16)
prep_after(completed-20, chemotherapy-18)
auxpass(completed-20, was-19)
advcl(delayed-15, completed-20)

A/DT small/JJ number/NN of/IN patients/NNS received/VBD epirubicin/NN -based/JJ chemotherapy/NN concomitantly/RB with/IN radiation/NN therapy/NN but/CC had/VBD chemotherapy/NN interrupted/VBN in/IN order/NN to/TO avoid/VB potential/JJ overlapping/VBG toxicities/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT A) (JJ small) (NN number)) (PP (IN of) (NP (NNS patients)))) (VP (VP (VBD received) (NP (NN epirubicin) (JJ -based) (NN chemotherapy)) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN radiation) (NN therapy)))) (CC but) (VP (VBD had) (NP (NP (NN chemotherapy)) (VP (VBN interrupted) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB avoid) (NP (JJ potential) (VBG overlapping) (NNS toxicities))))))))))) (. .))))

det(number-3, A-1)
amod(number-3, small-2)
nsubj(received-6, number-3)
prep_of(number-3, patients-5)
root(ROOT-0, received-6)
nn(chemotherapy-9, epirubicin-7)
amod(chemotherapy-9, -based-8)
dobj(received-6, chemotherapy-9)
advmod(received-6, concomitantly-10)
nn(therapy-13, radiation-12)
prep_with(received-6, therapy-13)
conj_but(received-6, had-15)
dobj(had-15, chemotherapy-16)
partmod(chemotherapy-16, interrupted-17)
mark(avoid-21, in-18)
dep(avoid-21, order-19)
aux(avoid-21, to-20)
purpcl(interrupted-17, avoid-21)
amod(toxicities-24, potential-22)
amod(toxicities-24, overlapping-23)
dobj(avoid-21, toxicities-24)

It/PRP is/VBZ likely/JJ that/IN use/NN of/IN epirubicin/NN with/IN radiotherapy/NN may/MD sensitize/VB tissues/NNS to/TO the/DT cytotoxic/JJ actions/NNS of/IN irradiation/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ likely) (SBAR (IN that) (S (NP (NP (NN use)) (PP (IN of) (NP (NN epirubicin))) (PP (IN with) (NP (NN radiotherapy)))) (VP (MD may) (VP (VB sensitize) (NP (NNS tissues)) (PP (TO to) (NP (NP (DT the) (JJ cytotoxic) (NNS actions)) (PP (IN of) (NP (NN irradiation)))))))))))) (. .))))

nsubj(likely-3, It-1)
cop(likely-3, is-2)
root(ROOT-0, likely-3)
complm(sensitize-11, that-4)
nsubj(sensitize-11, use-5)
prep_of(use-5, epirubicin-7)
prep_with(use-5, radiotherapy-9)
aux(sensitize-11, may-10)
ccomp(likely-3, sensitize-11)
dobj(sensitize-11, tissues-12)
det(actions-16, the-14)
amod(actions-16, cytotoxic-15)
prep_to(sensitize-11, actions-16)
prep_of(actions-16, irradiation-18)

Administration/NN of/IN ELLENCE/NN after/IN previous/JJ radiation/NN therapy/NN may/MD induce/VB an/DT inflammatory/JJ recall/NN reaction/NN at/IN the/DT site/NN of/IN the/DT irradiation/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN ELLENCE))) (PP (IN after) (NP (JJ previous) (NN radiation) (NN therapy)))) (VP (MD may) (VP (VB induce) (NP (DT an) (JJ inflammatory) (NN recall) (NN reaction)) (PP (IN at) (NP (NP (DT the) (NN site)) (PP (IN of) (NP (DT the) (NN irradiation)))))))) (. .))))

nsubj(induce-9, Administration-1)
prep_of(Administration-1, ELLENCE-3)
amod(therapy-7, previous-5)
nn(therapy-7, radiation-6)
prep_after(Administration-1, therapy-7)
aux(induce-9, may-8)
root(ROOT-0, induce-9)
det(reaction-13, an-10)
amod(reaction-13, inflammatory-11)
nn(reaction-13, recall-12)
dobj(induce-9, reaction-13)
det(site-16, the-15)
prep_at(induce-9, site-16)
det(irradiation-19, the-18)
prep_of(site-16, irradiation-19)

Epirubicin/NN is/VBZ extensively/RB metabolized/VBN by/IN the/DT liver/NN ./.

(ROOT (S1 (S (S (NP (NN Epirubicin)) (VP (VBZ is) (ADVP (RB extensively)) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (NN liver)))))) (. .))))

nsubjpass(metabolized-4, Epirubicin-1)
auxpass(metabolized-4, is-2)
advmod(metabolized-4, extensively-3)
root(ROOT-0, metabolized-4)
det(liver-7, the-6)
agent(metabolized-4, liver-7)

Changes/NNS in/IN hepatic/JJ function/NN induced/VBN by/IN concomitant/JJ therapies/NNS may/MD affect/VBP epirubicin/NN metabolism/NN ,/, pharmacokinetics/NNS ,/, therapeutic/JJ efficacy/NN ,/, and/or/CC toxicity/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Changes)) (PP (IN in) (NP (NP (JJ hepatic) (NN function)) (VP (VBN induced) (PP (IN by) (NP (JJ concomitant) (NNS therapies))))))) (VP (MD may) (VP (VBP affect) (NP (NP (NN epirubicin) (NN metabolism)) (, ,) (NP (NNS pharmacokinetics)) (, ,) (NP (JJ therapeutic) (NN efficacy)) (, ,) (CC and/or) (NP (NN toxicity)))))) (. .))))

nsubj(affect-10, Changes-1)
amod(function-4, hepatic-3)
prep_in(Changes-1, function-4)
partmod(function-4, induced-5)
amod(therapies-8, concomitant-7)
agent(induced-5, therapies-8)
aux(affect-10, may-9)
root(ROOT-0, affect-10)
nn(metabolism-12, epirubicin-11)
dobj(affect-10, metabolism-12)
conj_and/or(metabolism-12, pharmacokinetics-14)
amod(efficacy-17, therapeutic-16)
conj_and/or(metabolism-12, efficacy-17)
conj_and/or(metabolism-12, toxicity-20)

Cimetidine/NN increased/VBD the/DT AUC/NN of/IN epirubicin/NN by/IN 50/CD %./NN

(ROOT (S1 (S (NP (NN Cimetidine)) (VP (VBD increased) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NN epirubicin))) (PP (IN by) (NP (CD 50) (NN %.))))))))

nsubj(increased-2, Cimetidine-1)
root(ROOT-0, increased-2)
det(AUC-4, the-3)
dobj(increased-2, AUC-4)
prep_of(AUC-4, epirubicin-6)
num(%.-9, 50-8)
prep_by(AUC-4, %.-9)

Cimetidine/NN treatment/NN should/MD be/VB stopped/VBN during/IN treatment/NN with/IN ELLENCE/NN ./.

(ROOT (S1 (S (S (NP (NN Cimetidine) (NN treatment)) (VP (MD should) (VP (VB be) (VP (VBN stopped) (PP (IN during) (NP (NP (NN treatment)) (PP (IN with) (NP (NN ELLENCE))))))))) (. .))))

nn(treatment-2, Cimetidine-1)
nsubjpass(stopped-5, treatment-2)
aux(stopped-5, should-3)
auxpass(stopped-5, be-4)
root(ROOT-0, stopped-5)
prep_during(stopped-5, treatment-7)
prep_with(treatment-7, ELLENCE-9)

Drug-Laboratory/JJ Test/NN Interactions/NNS :/: There/EX are/VBP no/DT known/JJ interactions/NNS between/IN ELLENCE/NN and/CC laboratory/NN tests/NNS ./.

(ROOT (S1 (S (S (NP (JJ Drug-Laboratory) (NN Test) (NNS Interactions)) (: :) (NP (EX There)) (VP (VBP are) (NP (NP (DT no) (JJ known) (NNS interactions)) (PP (IN between) (NP (NP (NN ELLENCE)) (CC and) (NP (NN laboratory) (NNS tests))))))) (. .))))

amod(Interactions-3, Drug-Laboratory-1)
nn(Interactions-3, Test-2)
nsubj(are-6, Interactions-3)
expl(are-6, There-5)
root(ROOT-0, are-6)
det(interactions-9, no-7)
amod(interactions-9, known-8)
nsubj(are-6, interactions-9)
prep_between(interactions-9, ELLENCE-11)
nn(tests-14, laboratory-13)
conj_and(ELLENCE-11, tests-14)

No/DT evidence/NN of/IN interaction/NN of/IN PROCRIT/NN with/IN other/JJ drugs/NNS was/VBD observed/VBN in/IN the/DT course/NN of/IN clinical/JJ trials./NNS ?/.

(ROOT (S1 (S (S (NP (NP (DT No) (NN evidence)) (PP (IN of) (NP (NP (NN interaction)) (PP (IN of) (NP (NN PROCRIT))) (PP (IN with) (NP (JJ other) (NNS drugs)))))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (JJ clinical) (NNS trials.)))))))) (. ?))))

det(evidence-2, No-1)
nsubjpass(observed-11, evidence-2)
prep_of(evidence-2, interaction-4)
prep_of(interaction-4, PROCRIT-6)
amod(drugs-9, other-8)
prep_with(interaction-4, drugs-9)
auxpass(observed-11, was-10)
root(ROOT-0, observed-11)
det(course-14, the-13)
prep_in(observed-11, course-14)
amod(trials.-17, clinical-16)
prep_of(course-14, trials.-17)

Additional/JJ reductions/NNS in/IN blood/NN pressure/NN may/MD occur/VB when/WRB FLOLAN/NN is/VBZ administered/VBN with/IN diuretics/NN ,/, antihypertensive/JJ agents/NNS ,/, or/CC other/JJ vasodilators/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Additional) (NNS reductions)) (PP (IN in) (NP (NN blood) (NN pressure)))) (VP (MD may) (VP (VB occur) (SBAR (WHADVP (WRB when)) (S (NP (NN FLOLAN)) (VP (VBZ is) (VP (VBN administered) (PP (IN with) (NP (NP (NN diuretics)) (, ,) (NP (JJ antihypertensive) (NNS agents)) (, ,) (CC or) (NP (JJ other) (NNS vasodilators))))))))))) (. .))))

amod(reductions-2, Additional-1)
nsubj(occur-7, reductions-2)
nn(pressure-5, blood-4)
prep_in(reductions-2, pressure-5)
aux(occur-7, may-6)
root(ROOT-0, occur-7)
advmod(administered-11, when-8)
nsubjpass(administered-11, FLOLAN-9)
auxpass(administered-11, is-10)
advcl(occur-7, administered-11)
prep_with(administered-11, diuretics-13)
amod(agents-16, antihypertensive-15)
conj_or(diuretics-13, agents-16)
amod(vasodilators-20, other-19)
conj_or(diuretics-13, vasodilators-20)

When/WRB other/JJ antiplatelet/JJ agents/NNS or/CC anticoagulants/NNS are/VBP used/VBN concomitantly/RB ,/, there/EX is/VBZ the/DT potential/NN for/IN FLOLAN/NN to/TO increase/VB the/DT risk/NN of/IN bleeding/JJ ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NP (JJ other) (JJ antiplatelet) (NNS agents)) (CC or) (NP (NNS anticoagulants))) (VP (VBP are) (VP (VBN used) (ADVP (RB concomitantly)))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NN FLOLAN))) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ bleeding)))))))))) (. .))))

advmod(used-8, When-1)
amod(agents-4, other-2)
amod(agents-4, antiplatelet-3)
nsubjpass(used-8, agents-4)
conj_or(agents-4, anticoagulants-6)
auxpass(used-8, are-7)
advcl(is-12, used-8)
advmod(used-8, concomitantly-9)
expl(is-12, there-11)
root(ROOT-0, is-12)
det(potential-14, the-13)
nsubj(is-12, potential-14)
prep_for(potential-14, FLOLAN-16)
aux(increase-18, to-17)
infmod(potential-14, increase-18)
det(risk-20, the-19)
dobj(increase-18, risk-20)
prep_of(risk-20, bleeding-22)

However/RB ,/, patients/NNS receiving/VBG infusions/NN of/IN FLOLAN/NN in/IN clinical/JJ trials/NNS were/VBD maintained/VBN on/IN anticoagulants/NNS without/IN evidence/NN of/IN increased/VBN bleeding/JJ ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN infusions)) (PP (IN of) (NP (NN FLOLAN))) (PP (IN in) (NP (JJ clinical) (NNS trials)))))) (VP (VBD were) (VP (VBN maintained) (PP (IN on) (NP (NP (NNS anticoagulants)) (PP (IN without) (NP (NP (NN evidence)) (PP (IN of) (NP (VBN increased) (JJ bleeding)))))))))) (. .))))

advmod(maintained-12, However-1)
nsubjpass(maintained-12, patients-3)
partmod(patients-3, receiving-4)
dobj(receiving-4, infusions-5)
prep_of(infusions-5, FLOLAN-7)
amod(trials-10, clinical-9)
prep_in(infusions-5, trials-10)
auxpass(maintained-12, were-11)
root(ROOT-0, maintained-12)
prep_on(maintained-12, anticoagulants-14)
prep_without(anticoagulants-14, evidence-16)
amod(bleeding-19, increased-18)
prep_of(evidence-16, bleeding-19)

In/IN clinical/JJ trials/NNS ,/, FLOLAN/NNP was/VBD used/VBN with/IN digoxin/NN ,/, diuretics/NN ,/, anticoagulants/NNS ,/, oral/JJ vasodilators/NNS ,/, and/CC supplemental/JJ oxygen/NN .In/NN a/DT pharmacokinetic/JJ substudy/NN in/IN patients/NNS with/IN congestive/JJ heart/NN failure/NN receiving/VBG furosemide/NN or/CC digoxin/NN in/IN whom/WP therapy/NN with/IN FLOLAN/NN was/VBD initiated/VBN ,/, apparent/JJ oral/JJ clearance/NN values/NNS for/IN furosemide/NN (/-LRB- n/NN =/JJ 23/CD )/-RRB- and/CC digoxin/NN (/-LRB- n/NN =/JJ 30/CD )/-RRB- were/VBD decreased/VBN by/IN 13/CD %/NN and/CC 15/CD %/NN ,/, respectively/RB ,/, on/IN the/DT second/JJ day/NN of/IN therapy/NN and/CC had/VBD returned/VBD to/TO baseline/NN values/NNS by/IN day/NN 87/CD ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ clinical) (NNS trials))) (, ,) (NP (NNP FLOLAN)) (VP (VBD was) (VP (VBN used) (PP (IN with) (NP (NP (NN digoxin)) (, ,) (NP (NN diuretics)) (, ,) (NP (NNS anticoagulants)) (, ,) (NP (JJ oral) (NNS vasodilators)) (, ,) (CC and) (NP (JJ supplemental) (NN oxygen) (NN .In))))))) (S (NP (NP (DT a) (JJ pharmacokinetic) (NN substudy)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ congestive) (NN heart) (NN failure))) (VP (VBG receiving) (NP (NP (NP (NP (NN furosemide)) (CC or) (NP (NN digoxin))) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (NP (NN therapy)) (PP (IN with) (NP (NN FLOLAN)))) (VP (VBD was) (VP (VBN initiated)))))) (, ,) (NP (NP (JJ apparent) (JJ oral) (NN clearance) (NNS values)) (PP (IN for) (NP (NP (NP (NP (NN furosemide)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 23)) (-RRB- -RRB-))) (CC and) (NP (NN digoxin))) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 30)) (-RRB- -RRB-)))))))))) (VP (VP (VBD were) (VP (VBN decreased) (PP (IN by) (NP (NP (CD 13) (NN %)) (CC and) (NP (CD 15) (NN %)))) (, ,) (ADVP (RB respectively)) (, ,) (PP (IN on) (NP (NP (DT the) (JJ second) (NN day)) (PP (IN of) (NP (NN therapy))))))) (CC and) (VP (VBD had) (VP (VBD returned) (PP (TO to) (NP (NN baseline) (NNS values))) (PP (IN by) (NP (NN day) (CD 87))))))) (. .))))

amod(trials-3, clinical-2)
prep_in(used-7, trials-3)
nsubjpass(used-7, FLOLAN-5)
auxpass(used-7, was-6)
root(ROOT-0, used-7)
prep_with(used-7, digoxin-9)
conj_and(digoxin-9, diuretics-11)
conj_and(digoxin-9, anticoagulants-13)
amod(vasodilators-16, oral-15)
conj_and(digoxin-9, vasodilators-16)
amod(.In-21, supplemental-19)
nn(.In-21, oxygen-20)
conj_and(digoxin-9, .In-21)
det(substudy-24, a-22)
amod(substudy-24, pharmacokinetic-23)
nsubjpass(decreased-62, substudy-24)
prep_in(substudy-24, patients-26)
amod(failure-30, congestive-28)
nn(failure-30, heart-29)
prep_with(patients-26, failure-30)
partmod(patients-26, receiving-31)
dobj(receiving-31, furosemide-32)
conj_or(furosemide-32, digoxin-34)
rel(initiated-41, whom-36)
nsubjpass(initiated-41, therapy-37)
prep_with(therapy-37, FLOLAN-39)
auxpass(initiated-41, was-40)
rcmod(furosemide-32, initiated-41)
amod(values-46, apparent-43)
amod(values-46, oral-44)
nn(values-46, clearance-45)
appos(furosemide-32, values-46)
prep_for(values-46, furosemide-48)
appos(furosemide-48, n-50)
amod(n-50, =-51)
num(n-50, 23-52)
conj_and(furosemide-48, digoxin-55)
appos(furosemide-48, n-57)
amod(n-57, =-58)
num(n-57, 30-59)
auxpass(decreased-62, were-61)
ccomp(used-7, decreased-62)
num(%-65, 13-64)
agent(decreased-62, %-65)
num(%-68, 15-67)
conj_and(%-65, %-68)
advmod(decreased-62, respectively-70)
det(day-75, the-73)
amod(day-75, second-74)
prep_on(decreased-62, day-75)
prep_of(day-75, therapy-77)
aux(returned-80, had-79)
conj_and(decreased-62, returned-80)
nn(values-83, baseline-82)
prep_to(returned-80, values-83)
prep_by(returned-80, day-85)
num(day-85, 87-86)

The/DT change/NN in/IN furosemide/NN clearance/NN value/NN is/VBZ not/RB likely/JJ to/TO be/VB clinically/RB significant/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN change)) (PP (IN in) (NP (NN furosemide) (NN clearance) (NN value)))) (VP (VBZ is) (RB not) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (ADJP (RB clinically) (JJ significant)))))))) (. .))))

det(change-2, The-1)
nsubj(likely-9, change-2)
nn(value-6, furosemide-4)
nn(value-6, clearance-5)
prep_in(change-2, value-6)
cop(likely-9, is-7)
neg(likely-9, not-8)
root(ROOT-0, likely-9)
aux(significant-13, to-10)
cop(significant-13, be-11)
advmod(significant-13, clinically-12)
xcomp(likely-9, significant-13)

However/RB ,/, patients/NNS on/IN digoxin/NN may/MD show/VB elevations/NNS of/IN digoxin/NN concentrations/NNS after/IN initiation/NN of/IN therapy/NN with/IN FLOLAN/NN ,/, which/WDT may/MD be/VB clinically/RB significant/JJ in/IN patients/NNS prone/JJ to/TO digoxin/NN toxicity/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NNS patients)) (PP (IN on) (NP (NN digoxin)))) (VP (MD may) (VP (VB show) (NP (NP (NNS elevations)) (PP (IN of) (NP (NN digoxin) (NNS concentrations)))) (PP (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (NP (NN therapy)) (PP (IN with) (NP (NP (NN FLOLAN)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB be) (ADJP (RB clinically) (JJ significant) (PP (IN in) (NP (NP (NNS patients)) (ADJP (JJ prone) (PP (TO to) (NP (NN digoxin) (NN toxicity)))))))))))))))))))) (. .))))

advmod(show-7, However-1)
nsubj(show-7, patients-3)
prep_on(patients-3, digoxin-5)
aux(show-7, may-6)
root(ROOT-0, show-7)
dobj(show-7, elevations-8)
nn(concentrations-11, digoxin-10)
prep_of(elevations-8, concentrations-11)
prep_after(show-7, initiation-13)
prep_of(initiation-13, therapy-15)
prep_with(therapy-15, FLOLAN-17)
nsubj(significant-23, FLOLAN-17)
aux(significant-23, may-20)
cop(significant-23, be-21)
advmod(significant-23, clinically-22)
rcmod(FLOLAN-17, significant-23)
prep_in(significant-23, patients-25)
amod(patients-25, prone-26)
nn(toxicity-29, digoxin-28)
prep_to(prone-26, toxicity-29)

Eprosartan/NN has/VBZ been/VBN shown/VBN to/TO have/VB no/DT effect/NN on/IN the/DT pharmacokinetics/NNS of/IN digoxin/NN and/CC the/DT pharmacodynamics/NNS of/IN warfarin/NN and/CC glyburide/NN ./.

(ROOT (S1 (S (S (NP (NN Eprosartan)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB have) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN digoxin)))) (CC and) (NP (NP (DT the) (NNS pharmacodynamics)) (PP (IN of) (NP (NP (NN warfarin)) (CC and) (NP (NN glyburide)))))))))))))) (. .))))

nsubjpass(shown-4, Eprosartan-1)
xsubj(have-6, Eprosartan-1)
aux(shown-4, has-2)
auxpass(shown-4, been-3)
root(ROOT-0, shown-4)
aux(have-6, to-5)
xcomp(shown-4, have-6)
det(effect-8, no-7)
dobj(have-6, effect-8)
det(pharmacokinetics-11, the-10)
prep_on(have-6, pharmacokinetics-11)
prep_of(pharmacokinetics-11, digoxin-13)
det(pharmacodynamics-16, the-15)
conj_and(pharmacokinetics-11, pharmacodynamics-16)
prep_of(pharmacodynamics-16, warfarin-18)
conj_and(warfarin-18, glyburide-20)

Because/IN eprosartan/NN is/VBZ not/RB metabolized/VBN by/IN the/DT cytochrome/NN P450/NN system/NN ,/, inhibitors/NNS of/IN CYP450/CD enzyme/NN would/MD not/RB be/VB expected/VBN to/TO affect/VB its/PRP$ metabolism/NN ,/, and/CC ketoconazole/NN and/CC fluconazole/NN ,/, potent/JJ inhibitors/NNS of/IN CYP3A/NN and/CC 2C9/NN ,/, respectively/RB ,/, have/VBP been/VBN shown/VBN to/TO have/VB no/DT effect/NN on/IN eprosartan/JJ pharmacokinetics/NNS ./.

(ROOT (S1 (S (SBAR (IN Because) (S (NP (NN eprosartan)) (VP (VBZ is) (RB not) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (NN cytochrome) (NN P450) (NN system))))))) (, ,) (S (S (NP (NP (NNS inhibitors)) (PP (IN of) (NP (CD CYP450) (NN enzyme)))) (VP (MD would) (RB not) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB affect) (NP (PRP$ its) (NN metabolism))))))))) (, ,) (CC and) (S (NP (NP (NN ketoconazole)) (CC and) (NP (NP (NN fluconazole)) (, ,) (NP (NP (JJ potent) (NNS inhibitors)) (PP (IN of) (NP (NP (NN CYP3A)) (CC and) (NP (NN 2C9)) (, ,) (ADVP (RB respectively))))) (, ,))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB have) (NP (DT no) (NN effect)) (PP (IN on) (NP (JJ eprosartan) (NNS pharmacokinetics))))))))))) (. .))))

mark(metabolized-5, Because-1)
nsubjpass(metabolized-5, eprosartan-2)
auxpass(metabolized-5, is-3)
neg(metabolized-5, not-4)
advcl(expected-19, metabolized-5)
det(system-10, the-7)
nn(system-10, cytochrome-8)
nn(system-10, P450-9)
agent(metabolized-5, system-10)
nsubjpass(expected-19, inhibitors-12)
num(enzyme-15, CYP450-14)
prep_of(inhibitors-12, enzyme-15)
aux(expected-19, would-16)
neg(expected-19, not-17)
auxpass(expected-19, be-18)
root(ROOT-0, expected-19)
aux(affect-21, to-20)
xcomp(expected-19, affect-21)
poss(metabolism-23, its-22)
dobj(affect-21, metabolism-23)
nsubjpass(shown-41, ketoconazole-26)
xsubj(have-43, ketoconazole-26)
conj_and(ketoconazole-26, fluconazole-28)
amod(inhibitors-31, potent-30)
appos(fluconazole-28, inhibitors-31)
prep_of(inhibitors-31, CYP3A-33)
conj_and(CYP3A-33, 2C9-35)
advmod(CYP3A-33, respectively-37)
conj_and(CYP3A-33, respectively-37)
aux(shown-41, have-39)
auxpass(shown-41, been-40)
conj_and(expected-19, shown-41)
aux(have-43, to-42)
xcomp(shown-41, have-43)
det(effect-45, no-44)
dobj(have-43, effect-45)
amod(pharmacokinetics-48, eprosartan-47)
prep_on(have-43, pharmacokinetics-48)

Ranitidine/NN also/RB has/VBZ no/DT effect/NN on/IN eprosartan/JJ pharmacokinetics/NNS ./.

(ROOT (S1 (S (S (NP (NN Ranitidine)) (ADVP (RB also)) (VP (VBZ has) (NP (DT no) (NN effect)) (PP (IN on) (NP (JJ eprosartan) (NNS pharmacokinetics))))) (. .))))

nsubj(has-3, Ranitidine-1)
advmod(has-3, also-2)
root(ROOT-0, has-3)
det(effect-5, no-4)
dobj(has-3, effect-5)
amod(pharmacokinetics-8, eprosartan-7)
prep_on(has-3, pharmacokinetics-8)

Eprosartan/NN (/-LRB- up/RB to/TO 400/CD mg/NN b.i.d./NN or/CC 800/CD mg/NN q.d./NN )/-RRB- doses/NNS have/VBP been/VBN safely/RB used/VBN concomitantly/RB with/IN a/DT thiazide/NN diuretic/JJ (/-LRB- hydrochlorothiazide/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Eprosartan)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (QP (RB up) (TO to) (CD 400)) (NN mg)) (NN b.i.d.)) (CC or) (NP (ADJP (CD 800) (NN mg)) (NN q.d.))) (-RRB- -RRB-))) (NNS doses)) (VP (VBP have) (VP (VBN been) (ADVP (RB safely)) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (DT a) (NN thiazide) (JJ diuretic) (-LRB- -LRB-) (NN hydrochlorothiazide) (-RRB- -RRB-))))))) (. .))))

nn(doses-13, Eprosartan-1)
quantmod(400-5, up-3)
dep(400-5, to-4)
dep(mg-6, 400-5)
dep(b.i.d.-7, mg-6)
dep(Eprosartan-1, b.i.d.-7)
number(mg-10, 800-9)
amod(q.d.-11, mg-10)
conj_or(b.i.d.-7, q.d.-11)
nsubjpass(used-17, doses-13)
aux(used-17, have-14)
auxpass(used-17, been-15)
advmod(used-17, safely-16)
root(ROOT-0, used-17)
advmod(used-17, concomitantly-18)
det(hydrochlorothiazide-24, a-20)
nn(hydrochlorothiazide-24, thiazide-21)
amod(hydrochlorothiazide-24, diuretic-22)
prep_with(used-17, hydrochlorothiazide-24)

Eprosartan/JJ doses/NNS of/IN up/RB to/TO 300/CD mg/NN b.i.d./NN have/VBP been/VBN safely/RB used/VBN concomitantly/RB with/IN sustained-release/NN calcium/NN channel/NN blockers/NNS (/-LRB- sustained-release/NN nifedipine/NN )/-RRB- with/IN no/DT clinically/RB significant/JJ adverse/JJ interactions/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Eprosartan) (NNS doses)) (PP (IN of) (NP (ADJP (QP (RB up) (TO to) (CD 300)) (NN mg)) (NN b.i.d.)))) (VP (VBP have) (VP (VBN been) (ADVP (RB safely)) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NN sustained-release) (NN calcium) (NN channel) (NNS blockers)) (PRN (-LRB- -LRB-) (NP (NN sustained-release) (NN nifedipine)) (-RRB- -RRB-)))) (PP (IN with) (NP (DT no) (ADJP (RB clinically) (JJ significant)) (JJ adverse) (NNS interactions))))))) (. .))))

amod(doses-2, Eprosartan-1)
nsubjpass(used-12, doses-2)
quantmod(300-6, up-4)
dep(300-6, to-5)
dep(mg-7, 300-6)
dep(b.i.d.-8, mg-7)
prep_of(doses-2, b.i.d.-8)
aux(used-12, have-9)
auxpass(used-12, been-10)
advmod(used-12, safely-11)
root(ROOT-0, used-12)
advmod(used-12, concomitantly-13)
nn(blockers-18, sustained-release-15)
nn(blockers-18, calcium-16)
nn(blockers-18, channel-17)
prep_with(used-12, blockers-18)
nn(nifedipine-21, sustained-release-20)
appos(blockers-18, nifedipine-21)
det(interactions-28, no-24)
advmod(significant-26, clinically-25)
amod(interactions-28, significant-26)
amod(interactions-28, adverse-27)
prep_with(used-12, interactions-28)

Enoxaparin/NN dosed/VBN as/IN a/DT 1.0/CD mg/kg/NN subcutaneous/NN injection/NN q12h/IN for/IN four/CD doses/NNS did/VBD not/RB alter/VB the/DT pharmacokinetics/NNS of/IN eptifibatide/NN or/CC the/DT level/NN of/IN platelet/NN aggregation/NN in/IN healthy/JJ adults/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Enoxaparin)) (VP (VBN dosed) (PP (IN as) (NP (NP (DT a) (ADJP (CD 1.0) (NN mg/kg)) (NN subcutaneous) (NN injection)) (PP (IN q12h) (PP (IN for) (NP (CD four) (NNS doses)))))))) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN eptifibatide)) (CC or) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN platelet) (NN aggregation)))))) (PP (IN in) (NP (JJ healthy) (NNS adults))))))) (. .))))

nsubj(alter-15, Enoxaparin-1)
partmod(Enoxaparin-1, dosed-2)
det(injection-8, a-4)
number(mg/kg-6, 1.0-5)
amod(injection-8, mg/kg-6)
nn(injection-8, subcutaneous-7)
prep_as(dosed-2, injection-8)
prep(injection-8, q12h-9)
pcomp(q12h-9, for-10)
num(doses-12, four-11)
prep_for(q12h-9, doses-12)
aux(alter-15, did-13)
neg(alter-15, not-14)
root(ROOT-0, alter-15)
det(pharmacokinetics-17, the-16)
dobj(alter-15, pharmacokinetics-17)
prep_of(pharmacokinetics-17, eptifibatide-19)
det(level-22, the-21)
conj_or(eptifibatide-19, level-22)
nn(aggregation-25, platelet-24)
prep_of(level-22, aggregation-25)
amod(adults-28, healthy-27)
prep_in(pharmacokinetics-17, adults-28)

Mineral/JJ oil/NN interferes/VBZ with/IN the/DT absorption/NN of/IN fat-soluble/JJ vitamins/NNS ,/, including/VBG vitamin/NN D/NN preparations/NNS ./.

(ROOT (S1 (S (S (NP (JJ Mineral) (NN oil)) (VP (VBZ interferes) (PP (IN with) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NP (JJ fat-soluble) (NNS vitamins)) (, ,) (PP (VBG including) (NP (NN vitamin) (NN D) (NNS preparations))))))))) (. .))))

amod(oil-2, Mineral-1)
nsubj(interferes-3, oil-2)
root(ROOT-0, interferes-3)
det(absorption-6, the-5)
prep_with(interferes-3, absorption-6)
amod(vitamins-9, fat-soluble-8)
prep_of(absorption-6, vitamins-9)
nn(preparations-14, vitamin-12)
nn(preparations-14, D-13)
prep_including(vitamins-9, preparations-14)

Administration/NN of/IN thiazide/NN diuretics/NNS to/TO hypoparathyroid/JJ patients/NNS who/WP are/VBP concurrently/RB being/VBG treated/VBN with/IN ergocalciferol/NN may/MD cause/VB hypercalcemia/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN thiazide) (NNS diuretics))) (PP (TO to) (NP (NP (JJ hypoparathyroid) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADVP (RB concurrently)) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NN ergocalciferol))))))))))) (VP (MD may) (VP (VB cause) (NP (NN hypercalcemia))))) (. .))))

nsubj(cause-16, Administration-1)
nn(diuretics-4, thiazide-3)
prep_of(Administration-1, diuretics-4)
amod(patients-7, hypoparathyroid-6)
prep_to(Administration-1, patients-7)
nsubjpass(treated-12, patients-7)
aux(treated-12, are-9)
advmod(treated-12, concurrently-10)
auxpass(treated-12, being-11)
rcmod(patients-7, treated-12)
prep_with(treated-12, ergocalciferol-14)
aux(cause-16, may-15)
root(ROOT-0, cause-16)
dobj(cause-16, hypercalcemia-17)

The/DT effects/NNS of/IN ERGOMAR/NN may/MD be/VB potentiated/VBN by/IN triacetyloleandomycin/NN which/WDT inhibits/VBZ the/DT metabolism/NN of/IN ergotamine/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NN ERGOMAR)))) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (PP (IN by) (NP (NP (NN triacetyloleandomycin)) (SBAR (WHNP (WDT which)) (S (VP (VBZ inhibits) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN ergotamine))))))))))))) (. .))))

det(effects-2, The-1)
nsubjpass(potentiated-7, effects-2)
prep_of(effects-2, ERGOMAR-4)
aux(potentiated-7, may-5)
auxpass(potentiated-7, be-6)
root(ROOT-0, potentiated-7)
agent(potentiated-7, triacetyloleandomycin-9)
nsubj(inhibits-11, triacetyloleandomycin-9)
rcmod(triacetyloleandomycin-9, inhibits-11)
det(metabolism-13, the-12)
dobj(inhibits-11, metabolism-13)
prep_of(metabolism-13, ergotamine-15)

The/DT pressor/NN effects/NNS of/IN ERGOMAR/JJ and/CC other/JJ vasoconstrictor/JJ drugs/NNS can/MD combine/VB to/TO cause/VB dangerous/JJ hypertension/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN pressor) (NNS effects)) (PP (IN of) (NP (ADJP (ADJP (JJ ERGOMAR)) (CC and) (ADJP (JJ other))) (JJ vasoconstrictor) (NNS drugs)))) (VP (MD can) (VP (VB combine) (S (VP (TO to) (VP (VB cause) (NP (JJ dangerous) (NN hypertension)))))))) (. .))))

det(effects-3, The-1)
nn(effects-3, pressor-2)
nsubj(combine-11, effects-3)
xsubj(cause-13, effects-3)
amod(drugs-9, ERGOMAR-5)
conj_and(ERGOMAR-5, other-7)
amod(drugs-9, vasoconstrictor-8)
prep_of(effects-3, drugs-9)
aux(combine-11, can-10)
root(ROOT-0, combine-11)
aux(cause-13, to-12)
xcomp(combine-11, cause-13)
amod(hypertension-15, dangerous-14)
dobj(cause-13, hypertension-15)

Erythromycin/NN use/NN in/IN patients/NNS who/WP are/VBP receiving/VBG high/JJ doses/NNS of/IN theophylline/NN may/MD be/VB associated/VBN with/IN an/DT increase/NN in/IN serum/NN theophylline/NN levels/NNS and/CC potential/JJ theophylline/NN toxicity/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Erythromycin) (NN use)) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG receiving) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NN theophylline))))))))))) (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN serum) (NN theophylline) (NNS levels)) (CC and) (NP (JJ potential) (NN theophylline) (NN toxicity)))))))))) (. .))))

nn(use-2, Erythromycin-1)
nsubjpass(associated-14, use-2)
prep_in(use-2, patients-4)
nsubj(receiving-7, patients-4)
aux(receiving-7, are-6)
rcmod(patients-4, receiving-7)
amod(doses-9, high-8)
dobj(receiving-7, doses-9)
prep_of(doses-9, theophylline-11)
aux(associated-14, may-12)
auxpass(associated-14, be-13)
root(ROOT-0, associated-14)
det(increase-17, an-16)
prep_with(associated-14, increase-17)
nn(levels-21, serum-19)
nn(levels-21, theophylline-20)
prep_in(increase-17, levels-21)
amod(toxicity-25, potential-23)
nn(toxicity-25, theophylline-24)
conj_and(levels-21, toxicity-25)

In/IN case/NN of/IN theophylline/NN toxicity/NN and/or/CC elevated/JJ serum/NN theophylline/NN levels/NNS ,/, the/DT dose/NN of/IN theophylline/NN should/MD be/VB reduced/VBN while/IN the/DT patient/NN is/VBZ receiving/VBG concomitant/JJ erythromycin/NN therapy/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NN case)) (PP (IN of) (NP (NP (NN theophylline) (NN toxicity)) (CC and/or) (NP (JJ elevated) (NN serum) (NN theophylline) (NNS levels)))))) (, ,) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN theophylline)))) (VP (MD should) (VP (VB be) (VP (VBN reduced) (SBAR (IN while) (S (NP (DT the) (NN patient)) (VP (VBZ is) (VP (VBG receiving) (NP (JJ concomitant) (NN erythromycin) (NN therapy)))))))))) (. .))))

nn(toxicity-5, theophylline-4)
prep_in_case_of(reduced-18, toxicity-5)
amod(levels-10, elevated-7)
nn(levels-10, serum-8)
nn(levels-10, theophylline-9)
conj_and/or(toxicity-5, levels-10)
det(dose-13, the-12)
nsubjpass(reduced-18, dose-13)
prep_of(dose-13, theophylline-15)
aux(reduced-18, should-16)
auxpass(reduced-18, be-17)
root(ROOT-0, reduced-18)
mark(receiving-23, while-19)
det(patient-21, the-20)
nsubj(receiving-23, patient-21)
aux(receiving-23, is-22)
advcl(reduced-18, receiving-23)
amod(therapy-26, concomitant-24)
nn(therapy-26, erythromycin-25)
dobj(receiving-23, therapy-26)

Concomitant/JJ administration/NN of/IN erythromycin/NN and/CC digoxin/NN has/VBZ been/VBN reported/VBN to/TO result/VB in/IN elevated/JJ digoxin/NN serum/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN erythromycin)) (CC and) (NP (NN digoxin))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB result) (PP (IN in) (NP (JJ elevated) (NN digoxin) (NN serum) (NNS levels)))))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubjpass(reported-9, administration-2)
xsubj(result-11, administration-2)
prep_of(administration-2, erythromycin-4)
conj_and(erythromycin-4, digoxin-6)
aux(reported-9, has-7)
auxpass(reported-9, been-8)
root(ROOT-0, reported-9)
aux(result-11, to-10)
xcomp(reported-9, result-11)
amod(levels-16, elevated-13)
nn(levels-16, digoxin-14)
nn(levels-16, serum-15)
prep_in(result-11, levels-16)

There/EX have/VBP been/VBN reports/NNS of/IN increased/VBN anticoagulant/JJ effects/NNS when/WRB erythromycin/NN and/CC oral/JJ anticoagulants/NNS were/VBD used/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (NNS reports)) (PP (IN of) (NP (VBN increased) (JJ anticoagulant) (NNS effects)))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN erythromycin)) (CC and) (NP (JJ oral) (NNS anticoagulants))) (VP (VBD were) (VP (VBN used) (ADVP (RB concomitantly))))))))) (. .))))

expl(reports-4, There-1)
aux(reports-4, have-2)
cop(reports-4, been-3)
root(ROOT-0, reports-4)
amod(effects-8, increased-6)
amod(effects-8, anticoagulant-7)
prep_of(reports-4, effects-8)
advmod(used-15, when-9)
nsubjpass(used-15, erythromycin-10)
amod(anticoagulants-13, oral-12)
conj_and(erythromycin-10, anticoagulants-13)
auxpass(used-15, were-14)
advcl(reports-4, used-15)
advmod(used-15, concomitantly-16)

Increased/VBN anticoagulation/NN effects/NNS due/JJ to/TO interactions/NNS of/IN erythromycin/NN with/IN various/JJ oral/JJ anticoagulents/NNS may/MD be/VB more/RBR pronounced/JJ in/IN the/DT elderly/JJ ./.

(ROOT (S1 (S (S (NP (NP (VBN Increased) (NN anticoagulation) (NNS effects)) (ADJP (JJ due) (PP (TO to) (NP (NP (NNS interactions)) (PP (IN of) (NP (NN erythromycin))) (PP (IN with) (NP (JJ various) (JJ oral) (NNS anticoagulents))))))) (VP (MD may) (VP (VB be) (ADJP (RBR more) (JJ pronounced)) (PP (IN in) (NP (DT the) (JJ elderly)))))) (. .))))

amod(effects-3, Increased-1)
nn(effects-3, anticoagulation-2)
nsubj(pronounced-16, effects-3)
prep_due_to(effects-3, interactions-6)
prep_of(interactions-6, erythromycin-8)
amod(anticoagulents-12, various-10)
amod(anticoagulents-12, oral-11)
prep_with(interactions-6, anticoagulents-12)
aux(pronounced-16, may-13)
cop(pronounced-16, be-14)
advmod(pronounced-16, more-15)
root(ROOT-0, pronounced-16)
det(elderly-19, the-18)
prep_in(pronounced-16, elderly-19)

Concurrent/JJ use/NN of/IN erythromycin/NN and/CC ergotamine/NN or/CC dihydroergotamine/NN has/VBZ been/VBN associated/VBN in/IN some/DT patients/NNS with/IN acute/JJ ergot/NN toxicity/NN characterized/VBN by/IN severe/JJ peripheral/JJ vasospasm/NN and/CC dysesthesia/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN use)) (PP (IN of) (NP (NP (NN erythromycin)) (CC and) (NP (NP (NN ergotamine)) (CC or) (NP (NN dihydroergotamine)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN in) (NP (NP (DT some) (NNS patients)) (PP (IN with) (NP (NP (JJ acute) (NN ergot) (NN toxicity)) (VP (VBN characterized) (PP (IN by) (NP (NP (JJ severe) (JJ peripheral) (NN vasospasm)) (CC and) (NP (NN dysesthesia))))))))))))) (. .))))

amod(use-2, Concurrent-1)
nsubjpass(associated-11, use-2)
prep_of(use-2, erythromycin-4)
conj_and(erythromycin-4, ergotamine-6)
conj_or(ergotamine-6, dihydroergotamine-8)
aux(associated-11, has-9)
auxpass(associated-11, been-10)
root(ROOT-0, associated-11)
det(patients-14, some-13)
prep_in(associated-11, patients-14)
amod(toxicity-18, acute-16)
nn(toxicity-18, ergot-17)
prep_with(patients-14, toxicity-18)
partmod(toxicity-18, characterized-19)
amod(vasospasm-23, severe-21)
amod(vasospasm-23, peripheral-22)
agent(characterized-19, vasospasm-23)
conj_and(vasospasm-23, dysesthesia-25)

Erythromycin/NN has/VBZ been/VBN reported/VBN to/TO decrease/VB the/DT clearance/NN of/IN triazolam/NN and/CC midazolam/NN and/CC thus/RB may/MD increase/VB the/DT pharmacologic/JJ effect/NN of/IN these/DT benzodiazepines/NNS ./.

(ROOT (S1 (S (S (S (NP (NN Erythromycin)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB decrease) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NP (NN triazolam)) (CC and) (NP (NN midazolam)))))))))))) (CC and) (S (ADVP (RB thus)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (JJ pharmacologic) (NN effect)) (PP (IN of) (NP (DT these) (NNS benzodiazepines)))))))) (. .))))

nsubjpass(reported-4, Erythromycin-1)
xsubj(decrease-6, Erythromycin-1)
aux(reported-4, has-2)
auxpass(reported-4, been-3)
root(ROOT-0, reported-4)
aux(decrease-6, to-5)
xcomp(reported-4, decrease-6)
det(clearance-8, the-7)
dobj(decrease-6, clearance-8)
prep_of(clearance-8, triazolam-10)
conj_and(triazolam-10, midazolam-12)
advmod(increase-16, thus-14)
aux(increase-16, may-15)
conj_and(reported-4, increase-16)
det(effect-19, the-17)
amod(effect-19, pharmacologic-18)
dobj(increase-16, effect-19)
det(benzodiazepines-22, these-21)
prep_of(effect-19, benzodiazepines-22)

The/DT use/NN of/IN erythromycin/NN in/IN patients/NNS concurrently/RB taking/VBG drugs/NNS metabolized/VBN by/IN the/DT cytochrome/NN P450/NN system/NN may/MD be/VB associated/VBN with/IN elevations/NNS in/IN serum/NN levels/NNS of/IN these/DT other/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NN erythromycin))) (PP (IN in) (NP (NP (NNS patients)) (VP (ADVP (RB concurrently)) (VBG taking) (NP (NP (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (NN cytochrome) (NN P450) (NN system))))))))) (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (NNS elevations)) (PP (IN in) (NP (NP (NN serum) (NNS levels)) (PP (IN of) (NP (DT these) (JJ other) (NNS drugs))))))))))) (. .))))

det(use-2, The-1)
nsubjpass(associated-18, use-2)
prep_of(use-2, erythromycin-4)
prep_in(use-2, patients-6)
advmod(taking-8, concurrently-7)
partmod(patients-6, taking-8)
dobj(taking-8, drugs-9)
partmod(drugs-9, metabolized-10)
det(system-15, the-12)
nn(system-15, cytochrome-13)
nn(system-15, P450-14)
agent(metabolized-10, system-15)
aux(associated-18, may-16)
auxpass(associated-18, be-17)
root(ROOT-0, associated-18)
prep_with(associated-18, elevations-20)
nn(levels-23, serum-22)
prep_in(elevations-20, levels-23)
det(drugs-27, these-25)
amod(drugs-27, other-26)
prep_of(levels-23, drugs-27)

There/EX have/VBP been/VBN reports/NNS of/IN interactions/NNS of/IN erythromycin/NN with/IN carbamazepine/NN ,/, cyclosporine/NN ,/, tacrolimus/NN ,/, hexobarbital/NN ,/, phenytoin/NN ,/, alfentanil/NN ,/, cisapride/NN ,/, disopyramide/NN ,/, lovastatin/NN ,/, bromocriptine/NN ,/, valproate/NN ,/, terfenadine/NN ,/, and/CC astemizole/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (NNS reports)) (PP (IN of) (NP (NP (NNS interactions)) (PP (IN of) (NP (NN erythromycin))) (PP (IN with) (NP (NP (NN carbamazepine)) (, ,) (NP (NN cyclosporine)) (, ,) (NP (NN tacrolimus)) (, ,) (NP (NN hexobarbital)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN alfentanil)) (, ,) (NP (NN cisapride)) (, ,) (NP (NN disopyramide)) (, ,) (NP (NN lovastatin)) (, ,) (NP (NN bromocriptine)) (, ,) (NP (NN valproate)) (, ,) (NP (NN terfenadine)) (, ,) (CC and) (NP (NN astemizole)))))))))) (. .))))

expl(reports-4, There-1)
aux(reports-4, have-2)
cop(reports-4, been-3)
root(ROOT-0, reports-4)
prep_of(reports-4, interactions-6)
prep_of(interactions-6, erythromycin-8)
prep_with(interactions-6, carbamazepine-10)
conj_and(carbamazepine-10, cyclosporine-12)
conj_and(carbamazepine-10, tacrolimus-14)
conj_and(carbamazepine-10, hexobarbital-16)
conj_and(carbamazepine-10, phenytoin-18)
conj_and(carbamazepine-10, alfentanil-20)
conj_and(carbamazepine-10, cisapride-22)
conj_and(carbamazepine-10, disopyramide-24)
conj_and(carbamazepine-10, lovastatin-26)
conj_and(carbamazepine-10, bromocriptine-28)
conj_and(carbamazepine-10, valproate-30)
conj_and(carbamazepine-10, terfenadine-32)
conj_and(carbamazepine-10, astemizole-35)

Serum/NN concentrations/NNS of/IN drugs/NNS metabolized/VBN by/IN the/DT cytochrome/NN P450/NN system/NN should/MD be/VB monitored/VBN closely/RB in/IN patients/NNS concurrently/RB receiving/VBG erythromycin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Serum) (NNS concentrations)) (PP (IN of) (NP (NP (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (NN cytochrome) (NN P450) (NN system))))))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB closely)) (PP (IN in) (NP (NP (NNS patients)) (VP (ADVP (RB concurrently)) (VBG receiving) (NP (NN erythromycin))))))))) (. .))))

nn(concentrations-2, Serum-1)
nsubjpass(monitored-13, concentrations-2)
prep_of(concentrations-2, drugs-4)
partmod(drugs-4, metabolized-5)
det(system-10, the-7)
nn(system-10, cytochrome-8)
nn(system-10, P450-9)
agent(metabolized-5, system-10)
aux(monitored-13, should-11)
auxpass(monitored-13, be-12)
root(ROOT-0, monitored-13)
advmod(monitored-13, closely-14)
prep_in(monitored-13, patients-16)
advmod(receiving-18, concurrently-17)
partmod(patients-16, receiving-18)
dobj(receiving-18, erythromycin-19)

Erythromycin/NN has/VBZ been/VBN reported/VBN to/TO significantly/RB alter/VB the/DT metabolism/NN of/IN nonsedating/JJ antihistamines/NNS terfenadine/NN and/CC astemizole/NN when/WRB taken/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NN Erythromycin)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (ADVP (RB significantly)) (VP (VB alter) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (JJ nonsedating) (NNS antihistamines) (NP (NP (NN terfenadine)) (CC and) (NP (NN astemizole)))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN taken) (ADVP (RB concomitantly)))))))))))) (. .))))

nsubjpass(reported-4, Erythromycin-1)
xsubj(alter-7, Erythromycin-1)
aux(reported-4, has-2)
auxpass(reported-4, been-3)
root(ROOT-0, reported-4)
aux(alter-7, to-5)
advmod(alter-7, significantly-6)
xcomp(reported-4, alter-7)
det(metabolism-9, the-8)
dobj(alter-7, metabolism-9)
amod(antihistamines-12, nonsedating-11)
prep_of(metabolism-9, antihistamines-12)
dep(antihistamines-12, terfenadine-13)
conj_and(terfenadine-13, astemizole-15)
advmod(taken-17, when-16)
advcl(alter-7, taken-17)
advmod(taken-17, concomitantly-18)

In/IN addition/NN ,/, deaths/NNS have/VBP been/VBN reported/VBN rarely/RB with/IN concomitant/JJ administration/NN of/IN terfenadine/NN and/CC erythromycin/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NNS deaths)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (ADVP (RB rarely)) (PP (IN with) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN terfenadine)) (CC and) (NP (NN erythromycin)))))))))) (. .))))

prep_in(reported-7, addition-2)
nsubjpass(reported-7, deaths-4)
aux(reported-7, have-5)
auxpass(reported-7, been-6)
root(ROOT-0, reported-7)
advmod(reported-7, rarely-8)
amod(administration-11, concomitant-10)
prep_with(reported-7, administration-11)
prep_of(administration-11, terfenadine-13)
conj_and(terfenadine-13, erythromycin-15)

There/EX have/VBP been/VBN postmarketing/JJ reports/NNS of/IN drug/NN interactions/NNS when/WRB erythromycin/NN is/VBZ coadministered/VBN with/IN cisapride/NN ,/, resulting/VBG in/IN QT/NN prolongation/NN ,/, cardiac/JJ arrythmias/NN ,/, ventricular/JJ tachycardia/NN ,/, ventricular/JJ fibrulation/NN ,/, and/CC torsades/NNS de/FW pointes/FW ,/, most/RBS like/IN due/JJ to/TO inhibition/NN of/IN hepatic/JJ metabolism/NN of/IN cisapride/NN by/IN erythromycin/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (JJ postmarketing) (NNS reports)) (PP (IN of) (NP (NP (NN drug) (NNS interactions)) (SBAR (WHADVP (WRB when)) (S (NP (NN erythromycin)) (VP (VBZ is) (VP (VBN coadministered) (PP (IN with) (NP (NN cisapride)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NN QT) (NN prolongation)) (, ,) (NP (JJ cardiac) (NN arrythmias)) (, ,) (NP (JJ ventricular) (NN tachycardia)) (, ,) (NP (JJ ventricular) (NN fibrulation)) (, ,) (CC and) (NP (NP (NNS torsades)) (ADJP (FW de) (FW pointes))))) (, ,) (ADVP (RBS most)) (PP (IN like) (ADJP (JJ due) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (JJ hepatic) (NN metabolism)) (PP (IN of) (NP (NN cisapride))))) (PP (IN by) (NP (NN erythromycin)))))))))))))))))) (. .))))

expl(reports-5, There-1)
aux(reports-5, have-2)
cop(reports-5, been-3)
amod(reports-5, postmarketing-4)
root(ROOT-0, reports-5)
nn(interactions-8, drug-7)
prep_of(reports-5, interactions-8)
tmod(coadministered-12, interactions-8)
advmod(coadministered-12, when-9)
nsubjpass(coadministered-12, erythromycin-10)
auxpass(coadministered-12, is-11)
dep(interactions-8, coadministered-12)
prep_with(coadministered-12, cisapride-14)
xcomp(coadministered-12, resulting-16)
nn(prolongation-19, QT-18)
prep_in(resulting-16, prolongation-19)
amod(arrythmias-22, cardiac-21)
conj_and(prolongation-19, arrythmias-22)
amod(tachycardia-25, ventricular-24)
conj_and(prolongation-19, tachycardia-25)
amod(fibrulation-28, ventricular-27)
conj_and(prolongation-19, fibrulation-28)
conj_and(prolongation-19, torsades-31)
nn(pointes-33, de-32)
amod(torsades-31, pointes-33)
advmod(resulting-16, most-35)
prep_like(resulting-16, due-37)
prep_to(due-37, inhibition-39)
amod(metabolism-42, hepatic-41)
prep_of(inhibition-39, metabolism-42)
prep_of(metabolism-42, cisapride-44)
prep_by(inhibition-39, erythromycin-46)

Patients/NNS receiving/VBG concomitant/JJ lovastatin/NN and/CC erythromycin/NN should/MD be/VB carefully/RB monitored/VBN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (JJ concomitant) (NP (NP (NN lovastatin)) (CC and) (NP (NN erythromycin)))))) (VP (MD should) (VP (VB be) (ADVP (RB carefully)) (VP (VBN monitored)))) (: ;)) (. .))))

nsubjpass(monitored-10, Patients-1)
partmod(Patients-1, receiving-2)
amod(lovastatin-4, concomitant-3)
dobj(receiving-2, lovastatin-4)
conj_and(lovastatin-4, erythromycin-6)
aux(monitored-10, should-7)
auxpass(monitored-10, be-8)
advmod(monitored-10, carefully-9)
root(ROOT-0, monitored-10)

CNS/NN Drug/NN s/NNS -/: Given/IN the/DT primary/JJ CNS/NN effects/NNS of/IN escitalopram/NN ,/, caution/NN should/MD be/VB used/VBN when/WRB it/PRP is/VBZ taken/VBN in/IN combination/NN with/IN other/JJ centrally/RB acting/VBG drugs/NNS ./.

(ROOT (S1 (S (NP (NP (NN CNS) (NN Drug) (NNS s)) (: -) (S (PP (IN Given) (NP (NP (DT the) (JJ primary) (NN CNS) (NNS effects)) (PP (IN of) (NP (NN escitalopram))))) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN used) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN taken) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ other) (ADJP (RB centrally) (VBG acting)) (NNS drugs))))))))))))) (. .)))))

nn(s-3, CNS-1)
nn(s-3, Drug-2)
root(ROOT-0, s-3)
det(effects-9, the-6)
amod(effects-9, primary-7)
nn(effects-9, CNS-8)
prep_given(used-16, effects-9)
prep_of(effects-9, escitalopram-11)
nsubjpass(used-16, caution-13)
aux(used-16, should-14)
auxpass(used-16, be-15)
dep(s-3, used-16)
advmod(taken-20, when-17)
nsubjpass(taken-20, it-18)
auxpass(taken-20, is-19)
advcl(used-16, taken-20)
prep_in(taken-20, combination-22)
amod(drugs-27, other-24)
advmod(acting-26, centrally-25)
amod(drugs-27, acting-26)
prep_with(combination-22, drugs-27)

Alcohol/NN -/: Although/IN LEXAPRO/NN did/VBD not/RB potentiate/VB the/DT cognitive/NN and/CC motor/NN effects/NNS of/IN alcohol/NN in/IN a/DT clinical/JJ trial/NN ,/, as/IN with/IN other/JJ psychotropic/JJ medications/NNS ,/, the/DT use/NN of/IN alcohol/NN by/IN patients/NNS taking/VBG LEXAPRO/NN is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (NP (NP (NN Alcohol)) (: -) (S (SBAR (IN Although) (S (NP (NN LEXAPRO)) (VP (VBD did) (RB not) (VP (VB potentiate) (NP (NP (DT the) (NN cognitive) (CC and) (NN motor) (NNS effects)) (PP (IN of) (NP (NN alcohol))) (PP (IN in) (NP (DT a) (JJ clinical) (NN trial)))))))) (, ,) (PP (IN as) (PP (IN with) (NP (JJ other) (JJ psychotropic) (NNS medications)))) (, ,) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN alcohol))) (PP (IN by) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN LEXAPRO)))))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .)))))

root(ROOT-0, Alcohol-1)
mark(potentiate-7, Although-3)
nsubj(potentiate-7, LEXAPRO-4)
aux(potentiate-7, did-5)
neg(potentiate-7, not-6)
advcl(recommended-36, potentiate-7)
det(effects-12, the-8)
nn(effects-12, cognitive-9)
conj_and(cognitive-9, motor-11)
dobj(potentiate-7, effects-12)
prep_of(effects-12, alcohol-14)
det(trial-18, a-16)
amod(trial-18, clinical-17)
prep_in(effects-12, trial-18)
prep(recommended-36, as-20)
pcomp(as-20, with-21)
amod(medications-24, other-22)
amod(medications-24, psychotropic-23)
prep_with(as-20, medications-24)
det(use-27, the-26)
nsubjpass(recommended-36, use-27)
prep_of(use-27, alcohol-29)
prep_by(use-27, patients-31)
partmod(patients-31, taking-32)
dobj(taking-32, LEXAPRO-33)
auxpass(recommended-36, is-34)
neg(recommended-36, not-35)
dep(Alcohol-1, recommended-36)

Monoamine/NN Oxidase/NN Inhibitors/NNS (/-LRB- MAOIs/NN )/-RRB- -/: See/VB Contraindications/NNS and/CC a/DT href=/JJ lexapro/NN _wcp.htm/NN #/NN W/NN Warnings/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NP (NN Monoamine) (NN Oxidase)) (NNS Inhibitors)) (PRN (-LRB- -LRB-) (NP (NN MAOIs)) (-RRB- -RRB-))) (: -) (S (VP (VB See) (NP (NP (NNS Contraindications)) (CC and) (NP (DT a) (JJ href=) (NN lexapro) (NN _wcp.htm) (NN #) (NN W) (NNS Warnings))))) (. .)))))

nn(Oxidase-2, Monoamine-1)
nn(Inhibitors-3, Oxidase-2)
root(ROOT-0, Inhibitors-3)
abbrev(Inhibitors-3, MAOIs-5)
dep(Inhibitors-3, See-8)
dobj(See-8, Contraindications-9)
det(Warnings-17, a-11)
amod(Warnings-17, href=-12)
nn(Warnings-17, lexapro-13)
nn(Warnings-17, _wcp.htm-14)
nn(Warnings-17, #-15)
nn(Warnings-17, W-16)
conj_and(Contraindications-9, Warnings-17)

Drugs/NNS That/DT Interfere/VBP With/IN Hemostasis/NN (/-LRB- NSAIDs/NN ,/, Aspirin/NN ,/, Warfarin/NN ,/, etc./NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (NP (DT That))) (VP (VBP Interfere) (PP (IN With) (NP (NP (NN Hemostasis)) (PRN (-LRB- -LRB-) (NP (NP (NN NSAIDs)) (, ,) (NP (NN Aspirin)) (, ,) (NP (NN Warfarin)) (, ,) (NP (NN etc.))) (-RRB- -RRB-)))))) (. .))))

nsubj(Interfere-3, Drugs-1)
dep(Drugs-1, That-2)
root(ROOT-0, Interfere-3)
prep_with(Interfere-3, Hemostasis-5)
dep(Hemostasis-5, NSAIDs-7)
appos(NSAIDs-7, Aspirin-9)
appos(NSAIDs-7, Warfarin-11)
appos(NSAIDs-7, etc.-13)

Epidemiological/JJ studies/NNS of/IN the/DT case-control/JJ and/CC cohort/NN design/NN that/WDT have/VBP demonstrated/VBN an/DT association/NN between/IN use/NN of/IN psychotropic/JJ drugs/NNS that/WDT interfere/VBP with/IN serotonin/NN reuptake/NN and/CC the/DT occurrence/NN of/IN upper/JJ gastrointestinal/JJ bleeding/JJ have/VBP also/RB shown/VBN that/IN concurrent/JJ use/NN of/IN an/DT NSAID/NN or/CC aspirin/NN potentiated/VBD the/DT risk/NN of/IN bleeding/JJ ./.

(ROOT (S1 (S (S (NP (NP (JJ Epidemiological) (NNS studies)) (PP (IN of) (NP (NP (DT the) (JJ case-control)) (CC and) (NP (NN cohort)) (NP (NN design)))) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT an) (NN association)) (PP (IN between) (NP (NP (NP (NN use)) (PP (IN of) (NP (NP (JJ psychotropic) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP interfere) (PP (IN with) (NP (NN serotonin) (NN reuptake))))))))) (CC and) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (JJ upper) (JJ gastrointestinal) (JJ bleeding)))))))))))) (VP (VBP have) (ADVP (RB also)) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (JJ concurrent) (NN use)) (PP (IN of) (NP (DT an) (NP (NN NSAID)) (CC or) (NP (NN aspirin))))) (VP (VBD potentiated) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ bleeding)))))))))) (. .))))

amod(studies-2, Epidemiological-1)
nsubj(demonstrated-11, studies-2)
nsubj(shown-33, studies-2)
det(case-control-5, the-4)
prep_of(studies-2, case-control-5)
conj_and(case-control-5, cohort-7)
dep(case-control-5, design-8)
aux(demonstrated-11, have-10)
rcmod(studies-2, demonstrated-11)
det(association-13, an-12)
dobj(demonstrated-11, association-13)
prep_between(association-13, use-15)
amod(drugs-18, psychotropic-17)
prep_of(use-15, drugs-18)
nsubj(interfere-20, drugs-18)
rcmod(drugs-18, interfere-20)
nn(reuptake-23, serotonin-22)
prep_with(interfere-20, reuptake-23)
det(occurrence-26, the-25)
conj_and(use-15, occurrence-26)
amod(bleeding-30, upper-28)
amod(bleeding-30, gastrointestinal-29)
prep_of(occurrence-26, bleeding-30)
aux(shown-33, have-31)
advmod(shown-33, also-32)
root(ROOT-0, shown-33)
complm(potentiated-42, that-34)
amod(use-36, concurrent-35)
nsubj(potentiated-42, use-36)
dep(NSAID-39, an-38)
prep_of(use-36, NSAID-39)
conj_or(NSAID-39, aspirin-41)
ccomp(shown-33, potentiated-42)
det(risk-44, the-43)
dobj(potentiated-42, risk-44)
prep_of(risk-44, bleeding-46)

Thus/RB ,/, patients/NNS should/MD be/VB cautioned/VBN about/IN the/DT use/NN of/IN such/JJ drugs/NNS concurrently/RB with/IN LEXAPRO/NN ./.

(ROOT (S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NNS patients)) (VP (MD should) (VP (VB be) (VP (VBN cautioned) (PP (IN about) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (JJ such) (NNS drugs)) (PP (ADVP (RB concurrently)) (IN with) (NP (NN LEXAPRO))))))))))) (. .))))

advmod(cautioned-6, Thus-1)
nsubjpass(cautioned-6, patients-3)
aux(cautioned-6, should-4)
auxpass(cautioned-6, be-5)
root(ROOT-0, cautioned-6)
det(use-9, the-8)
prep_about(cautioned-6, use-9)
amod(drugs-12, such-11)
prep_of(use-9, drugs-12)
advmod(drugs-12, concurrently-13)
prep_with(drugs-12, LEXAPRO-15)

Cimetidine/NN -/: In/IN subjects/NNS who/WP had/VBD received/VBN 21/CD days/NNS of/IN 40/CD mg/day/NN racemic/JJ citalopram/NN ,/, combined/JJ administration/NN of/IN 400/CD mg/day/NN cimetidine/NN for/IN 8/CD days/NNS resulted/VBD in/IN an/DT increase/NN in/IN citalopram/NN AUC/NN and/CC Cmax/NN of/IN 43/CD %/NN and/CC 39/CD %/NN ,/, respectively/RB ./.

(ROOT (S1 (S (NP (NP (NN Cimetidine)) (: -) (S (PP (IN In) (NP (NP (NNS subjects)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN received) (NP (NP (CD 21) (NNS days)) (PP (IN of) (NP (ADJP (CD 40) (NN mg/day)) (JJ racemic) (NN citalopram)))))))))) (, ,) (NP (NP (JJ combined) (NN administration)) (PP (IN of) (NP (ADJP (CD 400) (NN mg/day)) (NN cimetidine))) (PP (IN for) (NP (CD 8) (NNS days)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN citalopram) (NP (NP (NN AUC)) (CC and) (NP (NN Cmax)))) (PP (IN of) (NP (NP (CD 43) (NN %)) (CC and) (NP (CD 39) (NN %)) (, ,) (ADVP (RB respectively)))))))))) (. .)))))

root(ROOT-0, Cimetidine-1)
nsubj(received-7, subjects-4)
prep_in(resulted-25, subjects-4)
aux(received-7, had-6)
rcmod(subjects-4, received-7)
num(days-9, 21-8)
dobj(received-7, days-9)
number(mg/day-12, 40-11)
amod(citalopram-14, mg/day-12)
amod(citalopram-14, racemic-13)
prep_of(days-9, citalopram-14)
amod(administration-17, combined-16)
nsubj(resulted-25, administration-17)
number(mg/day-20, 400-19)
amod(cimetidine-21, mg/day-20)
prep_of(administration-17, cimetidine-21)
num(days-24, 8-23)
prep_for(administration-17, days-24)
dep(Cimetidine-1, resulted-25)
det(increase-28, an-27)
prep_in(resulted-25, increase-28)
prep_in(increase-28, citalopram-30)
dep(citalopram-30, AUC-31)
conj_and(AUC-31, Cmax-33)
num(%-36, 43-35)
prep_of(citalopram-30, %-36)
num(%-39, 39-38)
conj_and(%-36, %-39)
advmod(%-36, respectively-41)
conj_and(%-36, respectively-41)

Digoxin/NN -/: In/IN subjects/NNS who/WP had/VBD received/VBN 21/CD days/NNS of/IN 40/CD mg/day/NN racemic/JJ citalopram/NN ,/, combined/JJ administration/NN of/IN citalopram/NN and/CC digoxin/NN (/-LRB- single/JJ dose/NN of/IN 1/CD mg/NN )/-RRB- did/VBD not/RB significantly/RB affect/VB the/DT pharmacokinetics/NNS of/IN either/CC citalopram/NN or/CC digoxin/NN ./.

(ROOT (S1 (S (NP (NP (NN Digoxin)) (: -) (S (PP (IN In) (NP (NP (NNS subjects)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBN received) (NP (NP (CD 21) (NNS days)) (PP (IN of) (NP (ADJP (CD 40) (NN mg/day)) (JJ racemic) (NN citalopram)))))))))) (, ,) (NP (NP (JJ combined) (NN administration)) (PP (IN of) (NP (NP (NP (NN citalopram)) (CC and) (NP (NN digoxin))) (PRN (-LRB- -LRB-) (NP (NP (JJ single) (NN dose)) (PP (IN of) (NP (CD 1) (NN mg)))) (-RRB- -RRB-))))) (VP (VBD did) (RB not) (ADVP (RB significantly)) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (CC either) (NP (NN citalopram)) (CC or) (NP (NN digoxin)))))))) (. .)))))

root(ROOT-0, Digoxin-1)
nsubj(received-7, subjects-4)
prep_in(affect-32, subjects-4)
aux(received-7, had-6)
rcmod(subjects-4, received-7)
num(days-9, 21-8)
dobj(received-7, days-9)
number(mg/day-12, 40-11)
amod(citalopram-14, mg/day-12)
amod(citalopram-14, racemic-13)
prep_of(days-9, citalopram-14)
amod(administration-17, combined-16)
nsubj(affect-32, administration-17)
prep_of(administration-17, citalopram-19)
conj_and(citalopram-19, digoxin-21)
amod(dose-24, single-23)
dep(citalopram-19, dose-24)
num(mg-27, 1-26)
prep_of(dose-24, mg-27)
aux(affect-32, did-29)
neg(affect-32, not-30)
advmod(affect-32, significantly-31)
dep(Digoxin-1, affect-32)
det(pharmacokinetics-34, the-33)
dobj(affect-32, pharmacokinetics-34)
preconj(citalopram-37, either-36)
prep_of(pharmacokinetics-34, citalopram-37)
conj_or(citalopram-37, digoxin-39)

Lithium/NN -/CC Coadministration/NN of/IN racemic/JJ citalopram/NN (/-LRB- 40/CD mg/day/NN for/IN 10/CD days/NNS )/-RRB- and/CC lithium/NN (/-LRB- 30/CD mmol/day/NN for/IN 5/CD days/NNS )/-RRB- had/VBD no/DT significant/JJ effect/NN on/IN the/DT pharmacokinetics/NNS of/IN citalopram/NN or/CC lithium/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Lithium)) (CC -) (NP (NN Coadministration))) (PP (IN of) (NP (NP (NP (JJ racemic) (NN citalopram)) (PRN (-LRB- -LRB-) (NP (NP (CD 40) (NN mg/day)) (PP (IN for) (NP (CD 10) (NNS days)))) (-RRB- -RRB-))) (CC and) (NP (NP (NN lithium)) (PRN (-LRB- -LRB-) (NP (CD 30) (NN mmol/day)) (PP (IN for) (NP (CD 5) (NNS days))) (-RRB- -RRB-)))))) (VP (VBD had) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN citalopram)) (CC or) (NP (NN lithium)))))))) (. .))))

nsubj(had-23, Lithium-1)
conj(Lithium-1, Coadministration-3)
amod(citalopram-6, racemic-5)
prep_of(Lithium-1, citalopram-6)
num(mg/day-9, 40-8)
dep(citalopram-6, mg/day-9)
num(days-12, 10-11)
prep_for(mg/day-9, days-12)
conj_and(citalopram-6, lithium-15)
num(mmol/day-18, 30-17)
dep(lithium-15, mmol/day-18)
dep(mmol/day-18, for-19)
num(days-21, 5-20)
pobj(for-19, days-21)
root(ROOT-0, had-23)
det(effect-26, no-24)
amod(effect-26, significant-25)
dobj(had-23, effect-26)
det(pharmacokinetics-29, the-28)
prep_on(had-23, pharmacokinetics-29)
prep_of(pharmacokinetics-29, citalopram-31)
conj_or(citalopram-31, lithium-33)

Because/IN lithium/NN may/MD enhance/VB the/DT serotonergic/JJ effects/NNS of/IN escitalopram/NN ,/, caution/NN should/MD be/VB exercised/VBN when/WRB LEXAPRO/NN and/CC lithium/NN are/VBP coadministered/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NN lithium)) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (JJ serotonergic) (NNS effects)) (PP (IN of) (NP (NN escitalopram)))))))) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN LEXAPRO)) (CC and) (NP (NN lithium))) (VP (VBP are) (VP (VBN coadministered))))))))) (. .))))

mark(enhance-4, Because-1)
nsubj(enhance-4, lithium-2)
aux(enhance-4, may-3)
advcl(exercised-14, enhance-4)
det(effects-7, the-5)
amod(effects-7, serotonergic-6)
dobj(enhance-4, effects-7)
prep_of(effects-7, escitalopram-9)
nsubjpass(exercised-14, caution-11)
aux(exercised-14, should-12)
auxpass(exercised-14, be-13)
root(ROOT-0, exercised-14)
advmod(coadministered-20, when-15)
nsubjpass(coadministered-20, LEXAPRO-16)
conj_and(LEXAPRO-16, lithium-18)
auxpass(coadministered-20, are-19)
advcl(exercised-14, coadministered-20)

Pimozide/NN and/CC Celexa/NN -/: In/IN a/DT controlled/JJ study/NN ,/, a/DT single/JJ dose/NN of/IN pimozide/NN 2/CD mg/NN co-administered/VBN with/IN racemic/JJ citalopram/NN 40/CD mg/NN given/VBN once/IN daily/JJ for/IN 11/CD days/NNS was/VBD associated/VBN with/IN a/DT mean/JJ increase/NN in/IN QTc/NN values/NNS of/IN approximately/RB 10/CD msec/NNS compared/VBN to/TO pimozide/NN given/VBN alone/RB ./.

(ROOT (S1 (S (NP (NP (NP (NN Pimozide)) (CC and) (NP (NN Celexa))) (: -) (S (PP (IN In) (NP (DT a) (JJ controlled) (NN study))) (, ,) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NP (NN pimozide) (CD 2) (NN mg)) (VP (VBN co-administered) (PP (IN with) (NP (NP (JJ racemic) (NN citalopram) (CD 40) (NN mg)) (VP (VBN given) (PP (IN once) (NP (JJ daily))) (PP (IN for) (NP (CD 11) (NNS days)))))))))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJ mean) (NN increase)) (PP (IN in) (NP (NP (NN QTc) (NNS values)) (PP (IN of) (NP (QP (RB approximately) (CD 10)) (NNS msec))))) (VP (VBN compared) (PP (TO to) (NP (NP (NN pimozide)) (VP (VBN given) (ADVP (RB alone))))))))))) (. .)))))

root(ROOT-0, Pimozide-1)
conj_and(Pimozide-1, Celexa-3)
det(study-8, a-6)
amod(study-8, controlled-7)
prep_in(associated-30, study-8)
det(dose-12, a-10)
amod(dose-12, single-11)
nsubjpass(associated-30, dose-12)
nn(mg-16, pimozide-14)
num(mg-16, 2-15)
prep_of(dose-12, mg-16)
partmod(mg-16, co-administered-17)
amod(mg-22, racemic-19)
nn(mg-22, citalopram-20)
num(mg-22, 40-21)
prep_with(co-administered-17, mg-22)
partmod(mg-22, given-23)
prep_once(given-23, daily-25)
num(days-28, 11-27)
prep_for(given-23, days-28)
auxpass(associated-30, was-29)
dep(Pimozide-1, associated-30)
det(increase-34, a-32)
amod(increase-34, mean-33)
prep_with(associated-30, increase-34)
nn(values-37, QTc-36)
prep_in(increase-34, values-37)
quantmod(10-40, approximately-39)
num(msec-41, 10-40)
prep_of(values-37, msec-41)
partmod(increase-34, compared-42)
prep_to(compared-42, pimozide-44)
partmod(pimozide-44, given-45)
advmod(given-45, alone-46)

Racemic/JJ citalopram/NN did/VBD not/RB alter/VB the/DT mean/JJ AUC/NN or/CC Cmax/NN of/IN pimozide/NN ./.

(ROOT (S1 (S (S (NP (JJ Racemic) (NN citalopram)) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (NP (DT the) (JJ mean) (NN AUC)) (CC or) (NP (NN Cmax))) (PP (IN of) (NP (NN pimozide))))))) (. .))))

amod(citalopram-2, Racemic-1)
nsubj(alter-5, citalopram-2)
aux(alter-5, did-3)
neg(alter-5, not-4)
root(ROOT-0, alter-5)
det(AUC-8, the-6)
amod(AUC-8, mean-7)
dobj(alter-5, AUC-8)
conj_or(AUC-8, Cmax-10)
prep_of(AUC-8, pimozide-12)

Sumatriptan/NN -/: There/EX have/VBP been/VBN rare/JJ postmarketing/JJ reports/NNS describing/VBG patients/NNS with/IN weakness/NN ,/, hyperreflexia/NN ,/, and/CC incoordination/NN following/VBG the/DT use/NN of/IN a/DT selective/JJ serotonin/NN reuptake/NN inhibitor/NN (/-LRB- SSRI/NN )/-RRB- and/CC sumatriptan/NN ./.

(ROOT (S1 (S (NP (NP (NN Sumatriptan)) (: -) (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (JJ rare) (JJ postmarketing) (NNS reports)) (VP (VBG describing) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (NN weakness)) (, ,) (NP (NN hyperreflexia)) (, ,) (CC and) (NP (NN incoordination))))))) (PP (VBG following) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NP (DT a) (JJ selective) (NN serotonin) (NN reuptake) (NN inhibitor)) (PRN (-LRB- -LRB-) (NP (NN SSRI)) (-RRB- -RRB-))) (CC and) (NP (NN sumatriptan))))))))) (. .)))))

root(ROOT-0, Sumatriptan-1)
expl(reports-8, There-3)
aux(reports-8, have-4)
cop(reports-8, been-5)
amod(reports-8, rare-6)
amod(reports-8, postmarketing-7)
dep(Sumatriptan-1, reports-8)
partmod(reports-8, describing-9)
dobj(describing-9, patients-10)
prep_with(patients-10, weakness-12)
conj_and(weakness-12, hyperreflexia-14)
conj_and(weakness-12, incoordination-17)
det(use-20, the-19)
prep_following(reports-8, use-20)
det(inhibitor-26, a-22)
amod(inhibitor-26, selective-23)
nn(inhibitor-26, serotonin-24)
nn(inhibitor-26, reuptake-25)
prep_of(use-20, inhibitor-26)
abbrev(inhibitor-26, SSRI-28)
conj_and(inhibitor-26, sumatriptan-31)

If/IN concomitant/JJ treatment/NN with/IN sumatriptan/NN and/CC an/DT SSRI/NN (/-LRB- e.g./FW ,/, fluoxetine/NN ,/, fluvoxamine/NN ,/, paroxetine/NN ,/, sertraline/NN ,/, citalopram/NN ,/, escitalopram/NN )/-RRB- is/VBZ clinically/RB warranted/VBN ,/, appropriate/JJ observation/NN of/IN the/DT patient/NN is/VBZ advised/VBN ./.

(ROOT (S1 (S (SBAR (IN If) (S (NP (NP (JJ concomitant) (NN treatment)) (PP (IN with) (NP (NP (NN sumatriptan)) (CC and) (NP (NP (DT an) (NN SSRI)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN fluoxetine)) (, ,) (NP (NN fluvoxamine)) (, ,) (NP (NN paroxetine)) (, ,) (NP (NN sertraline)) (, ,) (NP (NN citalopram)) (, ,) (NP (NN escitalopram))) (-RRB- -RRB-)))))) (VP (VBZ is) (ADVP (RB clinically)) (VP (VBN warranted))))) (, ,) (NP (NP (JJ appropriate) (NN observation)) (PP (IN of) (NP (DT the) (NN patient)))) (VP (VBZ is) (VP (VBN advised))) (. .))))

mark(warranted-26, If-1)
amod(treatment-3, concomitant-2)
nsubjpass(warranted-26, treatment-3)
prep_with(treatment-3, sumatriptan-5)
det(SSRI-8, an-7)
conj_and(sumatriptan-5, SSRI-8)
dep(fluoxetine-12, e.g.-10)
dep(SSRI-8, fluoxetine-12)
appos(fluoxetine-12, fluvoxamine-14)
appos(fluoxetine-12, paroxetine-16)
appos(fluoxetine-12, sertraline-18)
appos(fluoxetine-12, citalopram-20)
appos(fluoxetine-12, escitalopram-22)
auxpass(warranted-26, is-24)
advmod(warranted-26, clinically-25)
advcl(advised-34, warranted-26)
amod(observation-29, appropriate-28)
nsubjpass(advised-34, observation-29)
det(patient-32, the-31)
prep_of(observation-29, patient-32)
auxpass(advised-34, is-33)
root(ROOT-0, advised-34)

Theophylline/NN -/CC Combined/JJ administration/NN of/IN racemic/JJ citalopram/NN (/-LRB- 40/CD mg/day/NN for/IN 21/CD days/NNS )/-RRB- and/CC the/DT CYP1A2/NN substrate/NN theophylline/NN (/-LRB- single/JJ dose/NN of/IN 300/CD mg/NN )/-RRB- did/VBD not/RB affect/VB the/DT pharmacokinetics/NNS of/IN theophylline/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Theophylline)) (CC -) (NP (JJ Combined) (NN administration))) (PP (IN of) (NP (NP (NP (JJ racemic) (NN citalopram)) (PRN (-LRB- -LRB-) (NP (NP (CD 40) (NN mg/day)) (PP (IN for) (NP (CD 21) (NNS days)))) (-RRB- -RRB-))) (CC and) (NP (NP (DT the) (NN CYP1A2) (NN substrate) (NN theophylline)) (PRN (-LRB- -LRB-) (NP (NP (JJ single) (NN dose)) (PP (IN of) (NP (CD 300) (NN mg)))) (-RRB- -RRB-)))))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN theophylline))))))) (. .))))

nsubj(affect-29, Theophylline-1)
amod(administration-4, Combined-3)
conj(Theophylline-1, administration-4)
amod(citalopram-7, racemic-6)
prep_of(Theophylline-1, citalopram-7)
num(mg/day-10, 40-9)
dep(citalopram-7, mg/day-10)
num(days-13, 21-12)
prep_for(mg/day-10, days-13)
det(theophylline-19, the-16)
nn(theophylline-19, CYP1A2-17)
nn(theophylline-19, substrate-18)
conj_and(citalopram-7, theophylline-19)
amod(dose-22, single-21)
dep(theophylline-19, dose-22)
num(mg-25, 300-24)
prep_of(dose-22, mg-25)
aux(affect-29, did-27)
neg(affect-29, not-28)
root(ROOT-0, affect-29)
det(pharmacokinetics-31, the-30)
dobj(affect-29, pharmacokinetics-31)
prep_of(pharmacokinetics-31, theophylline-33)

The/DT effect/NN of/IN theophylline/NN on/IN the/DT pharmacokinetics/NNS of/IN citalopram/NN was/VBD not/RB evaluated/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN theophylline))) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN citalopram)))))) (VP (VBD was) (RB not) (VP (VBN evaluated)))) (. .))))

det(effect-2, The-1)
nsubjpass(evaluated-12, effect-2)
prep_of(effect-2, theophylline-4)
det(pharmacokinetics-7, the-6)
prep_on(effect-2, pharmacokinetics-7)
prep_of(pharmacokinetics-7, citalopram-9)
auxpass(evaluated-12, was-10)
neg(evaluated-12, not-11)
root(ROOT-0, evaluated-12)

Warfarin/NN -/CC Administration/NN of/IN 40/CD mg/day/NN racemic/JJ citalopram/NN for/IN 21/CD days/NNS did/VBD not/RB affect/VB the/DT pharmacokinetics/NNS of/IN warfarin/NN ,/, a/DT CYP3A4/NN substrate/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Warfarin)) (CC -) (NP (NN Administration))) (PP (IN of) (NP (ADJP (CD 40) (NN mg/day)) (JJ racemic) (NN citalopram))) (PP (IN for) (NP (CD 21) (NNS days)))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN warfarin)) (, ,) (NP (DT a) (NN CYP3A4) (NN substrate)))))))) (. .))))

nsubj(affect-14, Warfarin-1)
conj(Warfarin-1, Administration-3)
number(mg/day-6, 40-5)
amod(citalopram-8, mg/day-6)
amod(citalopram-8, racemic-7)
prep_of(Warfarin-1, citalopram-8)
num(days-11, 21-10)
prep_for(Warfarin-1, days-11)
aux(affect-14, did-12)
neg(affect-14, not-13)
root(ROOT-0, affect-14)
det(pharmacokinetics-16, the-15)
dobj(affect-14, pharmacokinetics-16)
prep_of(pharmacokinetics-16, warfarin-18)
det(substrate-22, a-20)
nn(substrate-22, CYP3A4-21)
appos(warfarin-18, substrate-22)

Carbamazepine/NN -/: Combined/JJ administration/NN of/IN racemic/JJ citalopram/NN (/-LRB- 40/CD mg/day/NN for/IN 14/CD days/NNS )/-RRB- and/CC carbamazepine/NN (/-LRB- titrated/JJ to/TO 400/CD mg/day/NN for/IN 35/CD days/NNS )/-RRB- did/VBD not/RB significantly/RB affect/VB the/DT pharmacokinetics/NNS of/IN carbamazepine/NN ,/, a/DT CYP3A4/NN substrate/NN ./.

(ROOT (S1 (S (NP (NP (NN Carbamazepine)) (: -) (S (NP (NP (JJ Combined) (NN administration)) (PP (IN of) (NP (NP (NP (JJ racemic) (NN citalopram)) (PRN (-LRB- -LRB-) (NP (NP (CD 40) (NN mg/day)) (PP (IN for) (NP (CD 14) (NNS days)))) (-RRB- -RRB-))) (CC and) (NP (NP (NN carbamazepine)) (PRN (-LRB- -LRB-) (NP (NP (JJ titrated) (TO to) (CD 400) (NN mg/day)) (PP (IN for) (NP (CD 35) (NNS days)))) (-RRB- -RRB-)))))) (VP (VBD did) (RB not) (ADVP (RB significantly)) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN carbamazepine)) (, ,) (NP (DT a) (NN CYP3A4) (NN substrate)))))))) (. .)))))

root(ROOT-0, Carbamazepine-1)
amod(administration-4, Combined-3)
nsubj(affect-29, administration-4)
amod(citalopram-7, racemic-6)
prep_of(administration-4, citalopram-7)
num(mg/day-10, 40-9)
dep(citalopram-7, mg/day-10)
num(days-13, 14-12)
prep_for(mg/day-10, days-13)
conj_and(citalopram-7, carbamazepine-16)
amod(mg/day-21, titrated-18)
dep(mg/day-21, to-19)
num(mg/day-21, 400-20)
dep(carbamazepine-16, mg/day-21)
num(days-24, 35-23)
prep_for(mg/day-21, days-24)
aux(affect-29, did-26)
neg(affect-29, not-27)
advmod(affect-29, significantly-28)
dep(Carbamazepine-1, affect-29)
det(pharmacokinetics-31, the-30)
dobj(affect-29, pharmacokinetics-31)
prep_of(pharmacokinetics-31, carbamazepine-33)
det(substrate-37, a-35)
nn(substrate-37, CYP3A4-36)
appos(carbamazepine-33, substrate-37)

Although/IN trough/NN citalopram/NN plasma/NN levels/NNS were/VBD unaffected/JJ ,/, given/IN the/DT enzyme-inducing/JJ properties/NNS of/IN carbamazepine/NN ,/, the/DT possibility/NN that/IN carbamazepine/NN might/MD increase/VB the/DT clearance/NN of/IN escitalopram/NN should/MD be/VB considered/VBN if/IN the/DT two/CD drugs/NNS are/VBP coadministered/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NN trough) (NN citalopram) (NN plasma) (NNS levels)) (VP (VBD were) (ADJP (JJ unaffected)) (, ,) (PP (IN given) (NP (NP (DT the) (JJ enzyme-inducing) (NNS properties)) (PP (IN of) (NP (NN carbamazepine)))))))) (, ,) (NP (DT the) (NN possibility) (SBAR (IN that) (S (NP (NN carbamazepine)) (VP (MD might) (VP (VB increase) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN escitalopram))))))))) (VP (MD should) (VP (VB be) (VP (VBN considered) (SBAR (IN if) (S (NP (DT the) (CD two) (NNS drugs)) (VP (VBP are) (VP (VBN coadministered))))))))) (. .))))

mark(unaffected-7, Although-1)
nn(levels-5, trough-2)
nn(levels-5, citalopram-3)
nn(levels-5, plasma-4)
nsubj(unaffected-7, levels-5)
cop(unaffected-7, were-6)
advcl(considered-28, unaffected-7)
det(properties-12, the-10)
amod(properties-12, enzyme-inducing-11)
prep_given(unaffected-7, properties-12)
prep_of(properties-12, carbamazepine-14)
det(possibility-17, the-16)
nsubjpass(considered-28, possibility-17)
complm(increase-21, that-18)
nsubj(increase-21, carbamazepine-19)
aux(increase-21, might-20)
ccomp(possibility-17, increase-21)
det(clearance-23, the-22)
dobj(increase-21, clearance-23)
prep_of(clearance-23, escitalopram-25)
aux(considered-28, should-26)
auxpass(considered-28, be-27)
root(ROOT-0, considered-28)
mark(coadministered-34, if-29)
det(drugs-32, the-30)
num(drugs-32, two-31)
nsubjpass(coadministered-34, drugs-32)
auxpass(coadministered-34, are-33)
advcl(considered-28, coadministered-34)

Triazolam/NN -/: Combined/JJ administration/NN of/IN racemic/JJ citalopram/NN (/-LRB- titrated/VBN to/TO 40/CD mg/day/NN for/IN 28/CD days/NNS )/-RRB- and/CC the/DT CYP3A4/NN substrate/NN triazolam/NN (/-LRB- single/JJ dose/NN of/IN 0.25/CD mg/NN )/-RRB- did/VBD not/RB significantly/RB affect/VB the/DT pharmacokinetics/NNS of/IN either/CC citalopram/NN or/CC triazolam/NN ./.

(ROOT (S1 (S (NP (NP (NN Triazolam)) (: -) (S (NP (NP (JJ Combined) (NN administration)) (PP (IN of) (NP (NP (NP (JJ racemic) (NN citalopram)) (PRN (-LRB- -LRB-) (VP (VBN titrated) (PP (TO to) (NP (NP (CD 40) (NN mg/day)) (PP (IN for) (NP (CD 28) (NNS days)))))) (-RRB- -RRB-))) (CC and) (NP (NP (DT the) (NN CYP3A4) (NN substrate) (NN triazolam)) (PRN (-LRB- -LRB-) (NP (NP (JJ single) (NN dose)) (PP (IN of) (NP (CD 0.25) (NN mg)))) (-RRB- -RRB-)))))) (VP (VBD did) (RB not) (ADVP (RB significantly)) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (CC either) (NP (NN citalopram)) (CC or) (NP (NN triazolam)))))))) (. .)))))

root(ROOT-0, Triazolam-1)
amod(administration-4, Combined-3)
nsubj(affect-32, administration-4)
amod(citalopram-7, racemic-6)
prep_of(administration-4, citalopram-7)
dep(citalopram-7, titrated-9)
num(mg/day-12, 40-11)
prep_to(titrated-9, mg/day-12)
num(days-15, 28-14)
prep_for(mg/day-12, days-15)
det(triazolam-21, the-18)
nn(triazolam-21, CYP3A4-19)
nn(triazolam-21, substrate-20)
conj_and(citalopram-7, triazolam-21)
amod(dose-24, single-23)
dep(triazolam-21, dose-24)
num(mg-27, 0.25-26)
prep_of(dose-24, mg-27)
aux(affect-32, did-29)
neg(affect-32, not-30)
advmod(affect-32, significantly-31)
dep(Triazolam-1, affect-32)
det(pharmacokinetics-34, the-33)
dobj(affect-32, pharmacokinetics-34)
preconj(citalopram-37, either-36)
prep_of(pharmacokinetics-34, citalopram-37)
conj_or(citalopram-37, triazolam-39)

Ketoconazole/NN -/CC Combined/JJ administration/NN of/IN racemic/JJ citalopram/NN (/-LRB- 40/CD mg/NN )/-RRB- and/CC ketoconazole/NN (/-LRB- 200/CD mg/NN )/-RRB- decreased/VBD the/DT Cmax/NN and/CC AUC/NN of/IN ketoconazole/NN by/IN 21/CD %/NN and/CC 10/CD %/NN ,/, respectively/RB ,/, and/CC did/VBD not/RB significantly/RB affect/VB the/DT pharmacokinetics/NNS of/IN citalopram/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Ketoconazole)) (CC -) (NP (NP (JJ Combined) (NN administration)) (PP (IN of) (NP (NP (NP (JJ racemic) (NN citalopram)) (PRN (-LRB- -LRB-) (NP (CD 40) (NN mg)) (-RRB- -RRB-))) (CC and) (NP (NP (NN ketoconazole)) (PRN (-LRB- -LRB-) (NP (CD 200) (NN mg)) (-RRB- -RRB-))))))) (VP (VP (VBD decreased) (NP (NP (DT the) (NP (NN Cmax)) (CC and) (NP (NN AUC))) (PP (IN of) (NP (NN ketoconazole)))) (PP (IN by) (NP (NP (CD 21) (NN %)) (CC and) (NP (CD 10) (NN %)) (, ,) (ADVP (RB respectively))))) (, ,) (CC and) (VP (VBD did) (RB not) (ADVP (RB significantly)) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN citalopram)))))))) (. .))))

nsubj(decreased-18, Ketoconazole-1)
amod(administration-4, Combined-3)
conj(Ketoconazole-1, administration-4)
amod(citalopram-7, racemic-6)
prep_of(administration-4, citalopram-7)
num(mg-10, 40-9)
appos(citalopram-7, mg-10)
conj_and(citalopram-7, ketoconazole-13)
num(mg-16, 200-15)
appos(ketoconazole-13, mg-16)
root(ROOT-0, decreased-18)
dep(Cmax-20, the-19)
dobj(decreased-18, Cmax-20)
conj_and(Cmax-20, AUC-22)
prep_of(Cmax-20, ketoconazole-24)
num(%-27, 21-26)
prep_by(decreased-18, %-27)
num(%-30, 10-29)
conj_and(%-27, %-30)
advmod(%-27, respectively-32)
conj_and(%-27, respectively-32)
aux(affect-38, did-35)
neg(affect-38, not-36)
advmod(affect-38, significantly-37)
conj_and(decreased-18, affect-38)
det(pharmacokinetics-40, the-39)
dobj(affect-38, pharmacokinetics-40)
prep_of(pharmacokinetics-40, citalopram-42)

Ritonavir/NN -/CC Combined/JJ administration/NN of/IN a/DT single/JJ dose/NN of/IN ritonavir/NN (/-LRB- 600/CD mg/NN )/-RRB- ,/, both/CC a/DT CYP3A4/NN substrate/NN and/CC a/DT potent/JJ inhibitor/NN of/IN CYP3A4/NN ,/, and/CC escitalopram/NN (/-LRB- 20/CD mg/NN )/-RRB- did/VBD not/RB affect/VB the/DT pharmacokinetics/NNS of/IN either/CC ritonavir/NN or/CC escitalopram/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (NN Ritonavir)) (CC -) (NP (NP (JJ Combined) (NN administration)) (PP (IN of) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NN ritonavir))))))) (PRN (-LRB- -LRB-) (NP (CD 600) (NN mg)) (-RRB- -RRB-))) (, ,) (NP (CC both) (NP (DT a) (NN CYP3A4) (NN substrate)) (CC and) (NP (NP (DT a) (JJ potent) (NN inhibitor)) (PP (IN of) (NP (NN CYP3A4))))) (, ,) (CC and) (NP (NP (NN escitalopram)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN mg)) (-RRB- -RRB-)))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (CC either) (NP (NN ritonavir)) (CC or) (NP (NN escitalopram)))))))) (. .))))

nsubj(affect-35, Ritonavir-1)
amod(administration-4, Combined-3)
conj_and(Ritonavir-1, administration-4)
det(dose-8, a-6)
amod(dose-8, single-7)
prep_of(administration-4, dose-8)
prep_of(dose-8, ritonavir-10)
num(mg-13, 600-12)
appos(Ritonavir-1, mg-13)
preconj(substrate-19, both-16)
det(substrate-19, a-17)
nn(substrate-19, CYP3A4-18)
conj_and(Ritonavir-1, substrate-19)
det(inhibitor-23, a-21)
amod(inhibitor-23, potent-22)
conj_and(substrate-19, inhibitor-23)
prep_of(inhibitor-23, CYP3A4-25)
conj_and(Ritonavir-1, escitalopram-28)
num(mg-31, 20-30)
appos(escitalopram-28, mg-31)
aux(affect-35, did-33)
neg(affect-35, not-34)
root(ROOT-0, affect-35)
det(pharmacokinetics-37, the-36)
dobj(affect-35, pharmacokinetics-37)
preconj(ritonavir-40, either-39)
prep_of(pharmacokinetics-37, ritonavir-40)
conj_or(ritonavir-40, escitalopram-42)

CYP3A4/NN and/CC -2C19/NN Inhibitors/NNS -/CC In/FW vitro/FW studies/NNS indicated/VBD that/IN CYP3A4/NN and/CC -2C19/NN are/VBP the/DT primary/JJ enzymes/NNS involved/VBN in/IN the/DT metabolism/NN of/IN escitalopram/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (NN CYP3A4)) (CC and) (NP (NN -2C19))) (NNS Inhibitors)) (CC -) (NP (ADJP (FW In) (FW vitro)) (NNS studies))) (VP (VBD indicated) (SBAR (IN that) (S (NP (NP (NN CYP3A4)) (CC and) (NP (NN -2C19))) (VP (VBP are) (NP (NP (DT the) (JJ primary) (NNS enzymes)) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN escitalopram)))))))))))) (. .))))

nn(Inhibitors-4, CYP3A4-1)
conj_and(CYP3A4-1, -2C19-3)
nsubj(indicated-9, Inhibitors-4)
nn(vitro-7, In-6)
amod(studies-8, vitro-7)
conj(Inhibitors-4, studies-8)
root(ROOT-0, indicated-9)
complm(enzymes-17, that-10)
nsubj(enzymes-17, CYP3A4-11)
conj_and(CYP3A4-11, -2C19-13)
cop(enzymes-17, are-14)
det(enzymes-17, the-15)
amod(enzymes-17, primary-16)
ccomp(indicated-9, enzymes-17)
partmod(enzymes-17, involved-18)
det(metabolism-21, the-20)
prep_in(involved-18, metabolism-21)
prep_of(metabolism-21, escitalopram-23)

However/RB ,/, coadministration/NN of/IN escitalopram/NN (/-LRB- 20/CD mg/NN )/-RRB- and/CC ritonavir/NN (/-LRB- 600/CD mg/NN )/-RRB- ,/, a/DT potent/JJ inhibitor/NN of/IN CYP3A4/NN ,/, did/VBD not/RB significantly/RB affect/VB the/DT pharmacokinetics/NNS of/IN escitalopram/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NP (NP (NN escitalopram)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN mg)) (-RRB- -RRB-))) (CC and) (NP (NP (NN ritonavir)) (PRN (-LRB- -LRB-) (NP (CD 600) (NN mg)) (-RRB- -RRB-)))) (, ,) (NP (NP (DT a) (JJ potent) (NN inhibitor)) (PP (IN of) (NP (NN CYP3A4)))) (, ,)))) (VP (VBD did) (RB not) (ADVP (RB significantly)) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN escitalopram))))))) (. .))))

advmod(affect-26, However-1)
nsubj(affect-26, coadministration-3)
prep_of(coadministration-3, escitalopram-5)
num(mg-8, 20-7)
appos(escitalopram-5, mg-8)
conj_and(escitalopram-5, ritonavir-11)
num(mg-14, 600-13)
appos(ritonavir-11, mg-14)
det(inhibitor-19, a-17)
amod(inhibitor-19, potent-18)
appos(escitalopram-5, inhibitor-19)
prep_of(inhibitor-19, CYP3A4-21)
aux(affect-26, did-23)
neg(affect-26, not-24)
advmod(affect-26, significantly-25)
root(ROOT-0, affect-26)
det(pharmacokinetics-28, the-27)
dobj(affect-26, pharmacokinetics-28)
prep_of(pharmacokinetics-28, escitalopram-30)

Because/IN escitalopram/NN is/VBZ metabolized/VBN by/IN multiple/JJ enzyme/NN systems/NNS ,/, inhibition/NN of/IN a/DT single/JJ enzyme/NN may/MD not/RB appreciably/RB decrease/VB escitalopram/NN clearance/NN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NN escitalopram)) (VP (VBZ is) (VP (VBN metabolized) (PP (IN by) (NP (JJ multiple) (NN enzyme) (NNS systems))))))) (, ,) (NP (NP (NN inhibition)) (PP (IN of) (NP (DT a) (JJ single) (NN enzyme)))) (VP (MD may) (RB not) (ADVP (RB appreciably)) (VP (VB decrease) (NP (NN escitalopram) (NN clearance))))) (. .))))

mark(metabolized-4, Because-1)
nsubjpass(metabolized-4, escitalopram-2)
auxpass(metabolized-4, is-3)
advcl(decrease-18, metabolized-4)
amod(systems-8, multiple-6)
nn(systems-8, enzyme-7)
agent(metabolized-4, systems-8)
nsubj(decrease-18, inhibition-10)
det(enzyme-14, a-12)
amod(enzyme-14, single-13)
prep_of(inhibition-10, enzyme-14)
aux(decrease-18, may-15)
neg(decrease-18, not-16)
advmod(decrease-18, appreciably-17)
root(ROOT-0, decrease-18)
nn(clearance-20, escitalopram-19)
dobj(decrease-18, clearance-20)

Drugs/NNS Metabolized/VBN by/IN Cytochrome/NN P4502D6/NN -/CC In/FW vitro/FW studies/NNS did/VBD not/RB reveal/VB an/DT inhibitory/JJ effect/NN of/IN escitalopram/NN on/IN CYP2D6/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (VP (VBN Metabolized) (PP (IN by) (NP (NP (NN Cytochrome) (NN P4502D6)) (CC -) (NP (ADJP (FW In) (FW vitro)) (NNS studies)))))) (VP (VBD did) (RB not) (VP (VB reveal) (NP (NP (DT an) (JJ inhibitory) (NN effect)) (PP (IN of) (NP (NN escitalopram))) (PP (IN on) (NP (NN CYP2D6))))))) (. .))))

nsubj(reveal-12, Drugs-1)
partmod(Drugs-1, Metabolized-2)
nn(P4502D6-5, Cytochrome-4)
agent(Metabolized-2, P4502D6-5)
nn(vitro-8, In-7)
amod(studies-9, vitro-8)
conj(P4502D6-5, studies-9)
aux(reveal-12, did-10)
neg(reveal-12, not-11)
root(ROOT-0, reveal-12)
det(effect-15, an-13)
amod(effect-15, inhibitory-14)
dobj(reveal-12, effect-15)
prep_of(effect-15, escitalopram-17)
prep_on(effect-15, CYP2D6-19)

In/IN addition/NN ,/, steady/JJ state/NN levels/NNS of/IN racemic/JJ citalopram/NN were/VBD not/RB significantly/RB different/JJ in/IN poor/JJ metabolizers/NNS and/CC extensive/JJ CYP2D6/NN metabolizers/NNS after/IN multiple-dose/JJ administration/NN of/IN citalopram/NN ,/, suggesting/VBG that/IN coadministration/NN ,/, with/IN escitalopram/NN ,/, of/IN a/DT drug/NN that/WDT inhibits/VBZ CYP2D6/NN ,/, is/VBZ unlikely/JJ to/TO have/VB clinically/RB significant/JJ effects/NNS on/IN escitalopram/NN metabolism/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (JJ steady) (NN state) (NNS levels)) (PP (IN of) (NP (JJ racemic) (NN citalopram)))) (VP (VBD were) (RB not) (ADJP (RB significantly) (JJ different) (PP (IN in) (NP (NP (JJ poor) (NNS metabolizers)) (CC and) (NP (JJ extensive) (NN CYP2D6) (NNS metabolizers))))) (PP (IN after) (NP (NP (JJ multiple-dose) (NN administration)) (PP (IN of) (NP (NN citalopram))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (NN coadministration)) (, ,) (PP (IN with) (NP (NN escitalopram))) (, ,) (PP (IN of) (NP (NP (DT a) (NN drug)) (SBAR (WHNP (WDT that)) (S (VP (VBZ inhibits) (NP (NN CYP2D6))))))) (, ,)) (VP (VBZ is) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB have) (NP (ADJP (RB clinically) (JJ significant)) (NNS effects)) (PP (IN on) (NP (NN escitalopram) (NN metabolism)))))))))))))) (. .))))

prep_in(different-13, addition-2)
amod(levels-6, steady-4)
nn(levels-6, state-5)
nsubj(different-13, levels-6)
amod(citalopram-9, racemic-8)
prep_of(levels-6, citalopram-9)
cop(different-13, were-10)
neg(different-13, not-11)
advmod(different-13, significantly-12)
root(ROOT-0, different-13)
amod(metabolizers-16, poor-15)
prep_in(different-13, metabolizers-16)
amod(metabolizers-20, extensive-18)
nn(metabolizers-20, CYP2D6-19)
conj_and(metabolizers-16, metabolizers-20)
amod(administration-23, multiple-dose-22)
prep_after(different-13, administration-23)
prep_of(administration-23, citalopram-25)
xcomp(different-13, suggesting-27)
complm(unlikely-42, that-28)
nsubj(unlikely-42, coadministration-29)
prep_with(coadministration-29, escitalopram-32)
det(drug-36, a-35)
prep_of(coadministration-29, drug-36)
nsubj(inhibits-38, drug-36)
rcmod(drug-36, inhibits-38)
dobj(inhibits-38, CYP2D6-39)
cop(unlikely-42, is-41)
ccomp(suggesting-27, unlikely-42)
aux(have-44, to-43)
xcomp(unlikely-42, have-44)
advmod(significant-46, clinically-45)
amod(effects-47, significant-46)
dobj(have-44, effects-47)
nn(metabolism-50, escitalopram-49)
prep_on(have-44, metabolism-50)

However/RB ,/, there/EX are/VBP limited/JJ in/IN vivo/FW data/NNS suggesting/VBG a/DT modest/JJ CYP2D6/NN inhibitory/JJ effect/NN for/IN escitalopram/NN ,/, i.e./FW ,/, coadministration/NN of/IN escitalopram/NN (/-LRB- 20/CD mg/day/NN for/IN 21/CD days/NNS )/-RRB- with/IN the/DT tricyclic/JJ antidepressant/JJ desipramine/NN (/-LRB- single/JJ dose/NN of/IN 50/CD mg/NN )/-RRB- ,/, a/DT substrate/NN for/IN CYP2D6/NN ,/, resulted/VBD in/IN a/DT 40/CD %/NN increase/NN in/IN Cmax/NN and/CC a/DT 100/CD %/NN increase/NN in/IN AUC/NN of/IN desipramine/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (EX there)) (VP (VBP are) (ADJP (JJ limited) (PP (IN in) (NP (NP (FW vivo) (NNS data)) (VP (VBG suggesting) (NP (DT a) (JJ modest) (NN CYP2D6) (JJ inhibitory) (NN effect) (SBAR (IN for) (S (NP (NN escitalopram)) (, ,) (PP (FW i.e.)) (, ,) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NN escitalopram)) (PRN (-LRB- -LRB-) (NP (NP (CD 20) (NN mg/day)) (PP (IN for) (NP (CD 21) (NNS days)))) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (NP (DT the) (JJ tricyclic) (JJ antidepressant) (NN desipramine)) (PRN (-LRB- -LRB-) (NP (NP (JJ single) (NN dose)) (PP (IN of) (NP (CD 50) (NN mg)))) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN CYP2D6)))) (, ,)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (ADJP (CD 40) (NN %)) (NN increase)) (PP (IN in) (NP (NN Cmax)))) (CC and) (NP (NP (DT a) (ADJP (CD 100) (NN %)) (NN increase)) (PP (IN in) (NP (NP (NN AUC)) (PP (IN of) (NP (NN desipramine)))))))))))))))))) (. .))))

advmod(are-4, However-1)
expl(are-4, there-3)
root(ROOT-0, are-4)
acomp(are-4, limited-5)
nn(data-8, vivo-7)
prep_in(limited-5, data-8)
partmod(data-8, suggesting-9)
det(effect-14, a-10)
amod(effect-14, modest-11)
nn(effect-14, CYP2D6-12)
amod(effect-14, inhibitory-13)
dobj(suggesting-9, effect-14)
mark(resulted-48, for-15)
nsubj(resulted-48, escitalopram-16)
prep(resulted-48, i.e.-18)
nsubj(resulted-48, coadministration-20)
prep_of(coadministration-20, escitalopram-22)
num(mg/day-25, 20-24)
dep(escitalopram-22, mg/day-25)
num(days-28, 21-27)
prep_for(mg/day-25, days-28)
det(desipramine-34, the-31)
amod(desipramine-34, tricyclic-32)
amod(desipramine-34, antidepressant-33)
prep_with(coadministration-20, desipramine-34)
amod(dose-37, single-36)
dep(desipramine-34, dose-37)
num(mg-40, 50-39)
prep_of(dose-37, mg-40)
det(substrate-44, a-43)
appos(desipramine-34, substrate-44)
prep_for(substrate-44, CYP2D6-46)
ccomp(effect-14, resulted-48)
det(increase-53, a-50)
number(%-52, 40-51)
amod(increase-53, %-52)
prep_in(resulted-48, increase-53)
prep_in(increase-53, Cmax-55)
det(increase-60, a-57)
number(%-59, 100-58)
amod(increase-60, %-59)
conj_and(increase-53, increase-60)
prep_in(increase-60, AUC-62)
prep_of(AUC-62, desipramine-64)

Nevertheless/RB ,/, caution/NN is/VBZ indicated/VBN in/IN the/DT coadministration/NN of/IN escitalopram/NN and/CC drugs/NNS metabolized/VBN by/IN CYP2D6/NN ./.

(ROOT (S1 (S (S (ADVP (RB Nevertheless)) (, ,) (NP (NN caution)) (VP (VBZ is) (VP (VBN indicated) (PP (IN in) (NP (NP (DT the) (NN coadministration)) (PP (IN of) (NP (NP (NP (NN escitalopram)) (CC and) (NP (NNS drugs))) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP2D6))))))))))) (. .))))

advmod(indicated-5, Nevertheless-1)
nsubjpass(indicated-5, caution-3)
auxpass(indicated-5, is-4)
root(ROOT-0, indicated-5)
det(coadministration-8, the-7)
prep_in(indicated-5, coadministration-8)
prep_of(coadministration-8, escitalopram-10)
conj_and(escitalopram-10, drugs-12)
partmod(escitalopram-10, metabolized-13)
agent(metabolized-13, CYP2D6-15)

Metoprolol/NN -/: Administration/NN of/IN 20/CD mg/day/NN LEXAPRO/NN for/IN 21/CD days/NNS in/IN healthy/JJ volunteers/NNS resulted/VBD in/IN a/DT 50/CD %/NN increase/NN in/IN Cmax/NN and/CC 82/CD %/NN increase/NN in/IN AUC/NN of/IN the/DT beta-adrenergic/JJ blocker/NN metoprolol/NN (/-LRB- given/VBN in/IN a/DT single/JJ dose/NN of/IN 100/CD mg/NN )./NN

(ROOT (S1 (S (NP (NP (NN Metoprolol)) (: -) (S (NP (NP (NN Administration)) (PP (IN of) (NP (ADJP (CD 20) (NN mg/day)) (NN LEXAPRO))) (PP (IN for) (NP (CD 21) (NNS days))) (PP (IN in) (NP (JJ healthy) (NNS volunteers)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (ADJP (CD 50) (NN %)) (NN increase)) (PP (IN in) (NP (NN Cmax)))) (CC and) (NP (NP (ADJP (CD 82) (NN %)) (NN increase)) (PP (IN in) (NP (NP (NN AUC)) (PP (IN of) (NP (DT the) (JJ beta-adrenergic) (NN blocker) (NN metoprolol))) (-LRB- -LRB-) (VP (VBN given) (PP (IN in) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (ADJP (CD 100) (NN mg)) (NN -RRB-.)))))))))))))))))

root(ROOT-0, Metoprolol-1)
nsubj(resulted-14, Administration-3)
number(mg/day-6, 20-5)
amod(LEXAPRO-7, mg/day-6)
prep_of(Administration-3, LEXAPRO-7)
num(days-10, 21-9)
prep_for(Administration-3, days-10)
amod(volunteers-13, healthy-12)
prep_in(Administration-3, volunteers-13)
dep(Metoprolol-1, resulted-14)
det(increase-19, a-16)
number(%-18, 50-17)
amod(increase-19, %-18)
prep_in(resulted-14, increase-19)
prep_in(increase-19, Cmax-21)
number(%-24, 82-23)
amod(increase-25, %-24)
conj_and(increase-19, increase-25)
prep_in(increase-25, AUC-27)
det(metoprolol-32, the-29)
amod(metoprolol-32, beta-adrenergic-30)
nn(metoprolol-32, blocker-31)
prep_of(AUC-27, metoprolol-32)
partmod(AUC-27, given-34)
det(dose-38, a-36)
amod(dose-38, single-37)
prep_in(given-34, dose-38)
number(mg-41, 100-40)
amod(-RRB-.-42, mg-41)
prep_of(dose-38, -RRB-.-42)

Increased/VBN metoprolol/NN plasma/NN levels/NNS have/VBP been/VBN associated/VBN with/IN decreased/VBN cardioselectivity/NN ./.

(ROOT (S1 (S (S (NP (VBN Increased) (NN metoprolol) (NN plasma) (NNS levels)) (VP (VBP have) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (VBN decreased) (NN cardioselectivity))))))) (. .))))

amod(levels-4, Increased-1)
nn(levels-4, metoprolol-2)
nn(levels-4, plasma-3)
nsubjpass(associated-7, levels-4)
aux(associated-7, have-5)
auxpass(associated-7, been-6)
root(ROOT-0, associated-7)
amod(cardioselectivity-10, decreased-9)
prep_with(associated-7, cardioselectivity-10)

Coadministration/NN of/IN LEXAPRO/NN and/CC metoprolol/NN had/VBD no/DT clinically/RB significant/JJ effects/NNS on/IN blood/NN pressure/NN or/CC heart/NN rate/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NN LEXAPRO)) (CC and) (NP (NN metoprolol))))) (VP (VBD had) (NP (DT no) (ADJP (RB clinically) (JJ significant)) (NNS effects)) (PP (IN on) (NP (NP (NN blood) (NN pressure)) (CC or) (NP (NN heart) (NN rate)))))) (. .))))

nsubj(had-6, Coadministration-1)
prep_of(Coadministration-1, LEXAPRO-3)
conj_and(LEXAPRO-3, metoprolol-5)
root(ROOT-0, had-6)
det(effects-10, no-7)
advmod(significant-9, clinically-8)
amod(effects-10, significant-9)
dobj(had-6, effects-10)
nn(pressure-13, blood-12)
prep_on(had-6, pressure-13)
nn(rate-16, heart-15)
conj_or(pressure-13, rate-16)

Electroconvulsive/JJ Therapy/NN (/-LRB- ECT/NN )/-RRB- -/: There/EX are/VBP no/DT clinical/JJ studies/NNS of/IN the/DT combined/JJ use/NN of/IN ECT/NN and/CC escitalopram/NN ./.

(ROOT (S1 (S (NP (NP (NP (JJ Electroconvulsive) (NN Therapy)) (PRN (-LRB- -LRB-) (NP (NN ECT)) (-RRB- -RRB-))) (: -) (S (NP (EX There)) (VP (VBP are) (NP (NP (DT no) (JJ clinical) (NNS studies)) (PP (IN of) (NP (NP (DT the) (JJ combined) (NN use)) (PP (IN of) (NP (NP (NN ECT)) (CC and) (NP (NN escitalopram))))))))) (. .)))))

amod(Therapy-2, Electroconvulsive-1)
root(ROOT-0, Therapy-2)
abbrev(Therapy-2, ECT-4)
expl(are-8, There-7)
dep(Therapy-2, are-8)
det(studies-11, no-9)
amod(studies-11, clinical-10)
nsubj(are-8, studies-11)
det(use-15, the-13)
amod(use-15, combined-14)
prep_of(studies-11, use-15)
prep_of(use-15, ECT-17)
conj_and(ECT-17, escitalopram-19)

Concomitant/JJ Administration/NN with/IN Racemic/JJ Citalopram/NN Citalopram/NN -/: Since/IN escitalopram/NN is/VBZ the/DT active/JJ isomer/NN of/IN racemic/JJ citalopram/NN (/-LRB- Celexa/NN )/-RRB- ,/, the/DT two/CD agents/NNS should/MD not/RB be/VB coadministered/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN Administration)) (PP (IN with) (NP (JJ Racemic) (NN Citalopram) (NN Citalopram)))) (: -) (S (SBAR (IN Since) (S (NP (NN escitalopram)) (VP (VBZ is) (NP (NP (DT the) (JJ active) (NN isomer)) (PP (IN of) (NP (NP (JJ racemic) (NN citalopram)) (PRN (-LRB- -LRB-) (NP (NN Celexa)) (-RRB- -RRB-)))))))) (, ,) (NP (DT the) (CD two) (NNS agents)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN coadministered)))))) (. .))))

amod(Administration-2, Concomitant-1)
dep(coadministered-27, Administration-2)
amod(Citalopram-6, Racemic-4)
nn(Citalopram-6, Citalopram-5)
prep_with(Administration-2, Citalopram-6)
mark(isomer-13, Since-8)
nsubj(isomer-13, escitalopram-9)
cop(isomer-13, is-10)
det(isomer-13, the-11)
amod(isomer-13, active-12)
advcl(coadministered-27, isomer-13)
amod(citalopram-16, racemic-15)
prep_of(isomer-13, citalopram-16)
appos(citalopram-16, Celexa-18)
det(agents-23, the-21)
num(agents-23, two-22)
nsubjpass(coadministered-27, agents-23)
aux(coadministered-27, should-24)
neg(coadministered-27, not-25)
auxpass(coadministered-27, be-26)
root(ROOT-0, coadministered-27)

Catecholamine-depleting/JJ drugs/NNS ,/, e.g./FW ,/, reserpine/NN ,/, may/MD have/VB an/DT additive/JJ effect/NN when/WRB given/VBN with/IN beta/NN blocking/NN agents/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Catecholamine-depleting) (NNS drugs)) (, ,) (PP (FW e.g.) (, ,) (NP (NN reserpine))) (, ,)) (VP (MD may) (VP (VB have) (NP (DT an) (JJ additive) (NN effect)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN with) (NP (NN beta) (NN blocking) (NNS agents))))))))) (. .))))

amod(drugs-2, Catecholamine-depleting-1)
nsubj(have-9, drugs-2)
prep(drugs-2, e.g.-4)
pobj(e.g.-4, reserpine-6)
aux(have-9, may-8)
root(ROOT-0, have-9)
det(effect-12, an-10)
amod(effect-12, additive-11)
dobj(have-9, effect-12)
advmod(given-14, when-13)
advcl(have-9, given-14)
nn(agents-18, beta-16)
nn(agents-18, blocking-17)
prep_with(given-14, agents-18)

Patients/NNS treated/VBN concurrently/RB with/IN BREVIBLOC/NN (/-LRB- esmolol/NN HCl/NN )/-RRB- and/CC a/DT catecholamine/NN depletor/NN should/MD therefore/RB be/VB closely/RB observed/VBN for/IN evidence/NN of/IN hypotension/NN or/CC marked/JJ bradycardia/NN ,/, which/WDT may/MD result/VB in/IN vertigo/NN ,/, syncope/NN ,/, or/CC postural/JJ hypotension/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBN treated) (ADVP (RB concurrently)) (PP (IN with) (NP (NP (NP (NN BREVIBLOC)) (PRN (-LRB- -LRB-) (NP (NN esmolol) (NN HCl)) (-RRB- -RRB-))) (CC and) (NP (DT a) (NN catecholamine) (NN depletor)))))) (VP (MD should) (ADVP (RB therefore)) (VP (VB be) (ADVP (RB closely)) (VP (VBN observed) (PP (IN for) (NP (NP (NN evidence)) (PP (IN of) (NP (NP (NP (NN hypotension)) (CC or) (NP (JJ marked) (NN bradycardia))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (NN vertigo)) (, ,) (NP (NN syncope)) (, ,) (CC or) (NP (JJ postural) (NN hypotension)))))))))))))))) (. .))))

nsubjpass(observed-18, Patients-1)
partmod(Patients-1, treated-2)
advmod(treated-2, concurrently-3)
prep_with(treated-2, BREVIBLOC-5)
nn(HCl-8, esmolol-7)
abbrev(BREVIBLOC-5, HCl-8)
det(depletor-13, a-11)
nn(depletor-13, catecholamine-12)
conj_and(BREVIBLOC-5, depletor-13)
aux(observed-18, should-14)
advmod(observed-18, therefore-15)
auxpass(observed-18, be-16)
advmod(observed-18, closely-17)
root(ROOT-0, observed-18)
prep_for(observed-18, evidence-20)
prep_of(evidence-20, hypotension-22)
nsubj(result-29, hypotension-22)
amod(bradycardia-25, marked-24)
conj_or(hypotension-22, bradycardia-25)
aux(result-29, may-28)
rcmod(hypotension-22, result-29)
prep_in(result-29, vertigo-31)
conj_or(vertigo-31, syncope-33)
amod(hypotension-37, postural-36)
conj_or(vertigo-31, hypotension-37)

A/DT study/NN of/IN interaction/NN between/IN BREVIBLOC/NN and/CC warfarin/NN showed/VBD that/IN concomitant/JJ administration/NN of/IN BREVIBLOC/NN and/CC warfarin/NN does/VBZ not/RB alter/VB warfarin/NN plasma/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT A) (NN study)) (PP (IN of) (NP (NP (NN interaction)) (PP (IN between) (NP (NP (NN BREVIBLOC)) (CC and) (NP (NN warfarin))))))) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN BREVIBLOC)) (CC and) (NP (NN warfarin))))) (VP (VBZ does) (RB not) (VP (VB alter) (NP (NN warfarin) (NN plasma) (NNS levels)))))))) (. .))))

det(study-2, A-1)
nsubj(showed-9, study-2)
prep_of(study-2, interaction-4)
prep_between(interaction-4, BREVIBLOC-6)
conj_and(BREVIBLOC-6, warfarin-8)
root(ROOT-0, showed-9)
complm(alter-19, that-10)
amod(administration-12, concomitant-11)
nsubj(alter-19, administration-12)
prep_of(administration-12, BREVIBLOC-14)
conj_and(BREVIBLOC-14, warfarin-16)
aux(alter-19, does-17)
neg(alter-19, not-18)
ccomp(showed-9, alter-19)
nn(levels-22, warfarin-20)
nn(levels-22, plasma-21)
dobj(alter-19, levels-22)

BREVIBLOC/NN concentrations/NNS were/VBD equivocally/RB higher/JJR when/WRB given/VBN with/IN warfarin/NN ,/, but/CC this/DT is/VBZ not/RB likely/JJ to/TO be/VB clinically/RB important/JJ ./.

(ROOT (S1 (S (S (S (NP (NN BREVIBLOC) (NNS concentrations)) (VP (VBD were) (ADJP (RB equivocally) (JJR higher)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN with) (NP (NN warfarin)))))))) (, ,) (CC but) (S (NP (DT this)) (VP (VBZ is) (RB not) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (ADJP (RB clinically) (JJ important))))))))) (. .))))

nn(concentrations-2, BREVIBLOC-1)
nsubj(higher-5, concentrations-2)
cop(higher-5, were-3)
advmod(higher-5, equivocally-4)
root(ROOT-0, higher-5)
advmod(given-7, when-6)
advcl(higher-5, given-7)
prep_with(given-7, warfarin-9)
nsubj(likely-15, this-12)
cop(likely-15, is-13)
neg(likely-15, not-14)
conj_but(higher-5, likely-15)
aux(important-19, to-16)
cop(important-19, be-17)
advmod(important-19, clinically-18)
xcomp(likely-15, important-19)

When/WRB digoxin/NN and/CC BREVIBLOC/NN were/VBD concomitantly/RB administered/VBN intravenously/RB to/TO normal/JJ volunteers/NNS ,/, there/EX was/VBD a/DT 10-20/CD %/NN increase/NN in/IN digoxin/NN blood/NN levels/NNS at/IN some/DT time/NN points/NNS ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NP (NN digoxin)) (CC and) (NP (NN BREVIBLOC))) (VP (VBD were) (ADVP (RB concomitantly)) (VP (VBN administered) (ADVP (RB intravenously)) (PP (TO to) (NP (JJ normal) (NNS volunteers))))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT a) (ADJP (CD 10-20) (NN %)) (NN increase)) (PP (IN in) (NP (NN digoxin) (NN blood) (NNS levels)))) (PP (IN at) (NP (DT some) (NN time) (NNS points))))) (. .))))

advmod(administered-7, When-1)
nsubjpass(administered-7, digoxin-2)
conj_and(digoxin-2, BREVIBLOC-4)
auxpass(administered-7, were-5)
advmod(administered-7, concomitantly-6)
advcl(was-14, administered-7)
advmod(administered-7, intravenously-8)
amod(volunteers-11, normal-10)
prep_to(administered-7, volunteers-11)
expl(was-14, there-13)
root(ROOT-0, was-14)
det(increase-18, a-15)
number(%-17, 10-20-16)
amod(increase-18, %-17)
nsubj(was-14, increase-18)
nn(levels-22, digoxin-20)
nn(levels-22, blood-21)
prep_in(increase-18, levels-22)
det(points-26, some-24)
nn(points-26, time-25)
prep_at(was-14, points-26)

Digoxin/NN did/VBD not/RB affect/VB BREVIBLOC/NN pharmacokinetics/NNS ./.

(ROOT (S1 (S (S (NP (NN Digoxin)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NN BREVIBLOC) (NNS pharmacokinetics))))) (. .))))

nsubj(affect-4, Digoxin-1)
aux(affect-4, did-2)
neg(affect-4, not-3)
root(ROOT-0, affect-4)
nn(pharmacokinetics-6, BREVIBLOC-5)
dobj(affect-4, pharmacokinetics-6)

When/WRB intravenous/JJ morphine/NN and/CC BREVIBLOC/NN were/VBD concomitantly/RB administered/VBN in/IN normal/JJ subjects/NNS ,/, no/DT effect/NN on/IN morphine/NN blood/NN levels/NNS was/VBD seen/VBN ,/, but/CC BREVIBLOC/NN steady-state/JJ blood/NN levels/NNS were/VBD increased/VBN by/IN 46/CD %/NN in/IN the/DT presence/NN of/IN morphine/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NP (JJ intravenous) (NN morphine)) (CC and) (NP (NN BREVIBLOC))) (VP (VBD were) (ADVP (RB concomitantly)) (VP (VBN administered) (PP (IN in) (NP (JJ normal) (NNS subjects))))))) (, ,) (S (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NN morphine) (NN blood) (NNS levels)))) (VP (VBD was) (VP (VBN seen)))) (, ,) (CC but) (S (NP (NN BREVIBLOC) (JJ steady-state) (NN blood) (NNS levels)) (VP (VBD were) (VP (VBN increased) (PP (IN by) (NP (CD 46) (NN %))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN morphine))))))))) (. .))))

advmod(administered-8, When-1)
amod(morphine-3, intravenous-2)
nsubjpass(administered-8, morphine-3)
conj_and(morphine-3, BREVIBLOC-5)
auxpass(administered-8, were-6)
advmod(administered-8, concomitantly-7)
advcl(seen-20, administered-8)
amod(subjects-11, normal-10)
prep_in(administered-8, subjects-11)
det(effect-14, no-13)
nsubjpass(seen-20, effect-14)
nn(levels-18, morphine-16)
nn(levels-18, blood-17)
prep_on(effect-14, levels-18)
auxpass(seen-20, was-19)
root(ROOT-0, seen-20)
nn(levels-26, BREVIBLOC-23)
amod(levels-26, steady-state-24)
nn(levels-26, blood-25)
nsubjpass(increased-28, levels-26)
auxpass(increased-28, were-27)
conj_but(seen-20, increased-28)
num(%-31, 46-30)
agent(increased-28, %-31)
det(presence-34, the-33)
prep_in(increased-28, presence-34)
prep_of(presence-34, morphine-36)

The/DT effect/NN of/IN BREVIBLOC/NN on/IN the/DT duration/NN of/IN succinylcholine/NN -induced/JJ neuromuscular/JJ blockade/NN was/VBD studied/VBN in/IN patients/NNS undergoing/VBG surgery/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN BREVIBLOC))) (PP (IN on) (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (NN succinylcholine) (JJ -induced) (JJ neuromuscular) (NN blockade)))))) (VP (VBD was) (VP (VBN studied) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG undergoing) (NP (NN surgery)))))))) (. .))))

det(effect-2, The-1)
nsubjpass(studied-14, effect-2)
prep_of(effect-2, BREVIBLOC-4)
det(duration-7, the-6)
prep_on(effect-2, duration-7)
nn(blockade-12, succinylcholine-9)
amod(blockade-12, -induced-10)
amod(blockade-12, neuromuscular-11)
prep_of(duration-7, blockade-12)
auxpass(studied-14, was-13)
root(ROOT-0, studied-14)
prep_in(studied-14, patients-16)
partmod(patients-16, undergoing-17)
dobj(undergoing-17, surgery-18)

The/DT onset/NN of/IN neuromuscular/JJ blockade/NN by/IN succinylcholine/NN was/VBD unaffected/VBN by/IN BREVIBLOC/NN ,/, but/CC the/DT duration/NN of/IN neuromuscular/JJ blockade/NN was/VBD prolonged/VBD from/IN 5/CD minutes/NNS to/TO 8/CD minutes/NNS ./.

(ROOT (S1 (S (S (S (NP (NP (DT The) (NN onset)) (PP (IN of) (NP (NP (JJ neuromuscular) (NN blockade)) (PP (IN by) (NP (NN succinylcholine)))))) (VP (VBD was) (VP (VBN unaffected) (PP (IN by) (NP (NN BREVIBLOC)))))) (, ,) (CC but) (S (NP (NP (DT the) (NN duration)) (PP (IN of) (NP (JJ neuromuscular) (NN blockade)))) (VP (VBD was) (VP (VBD prolonged) (PP (IN from) (NP (NP (CD 5) (NNS minutes)) (PP (TO to) (NP (CD 8) (NNS minutes))))))))) (. .))))

det(onset-2, The-1)
nsubjpass(unaffected-9, onset-2)
amod(blockade-5, neuromuscular-4)
prep_of(onset-2, blockade-5)
prep_by(blockade-5, succinylcholine-7)
auxpass(unaffected-9, was-8)
root(ROOT-0, unaffected-9)
agent(unaffected-9, BREVIBLOC-11)
det(duration-15, the-14)
nsubjpass(prolonged-20, duration-15)
amod(blockade-18, neuromuscular-17)
prep_of(duration-15, blockade-18)
auxpass(prolonged-20, was-19)
conj_but(unaffected-9, prolonged-20)
num(minutes-23, 5-22)
prep_from(prolonged-20, minutes-23)
num(minutes-26, 8-25)
prep_to(minutes-23, minutes-26)

Although/IN the/DT interactions/NNS observed/VBN in/IN these/DT studies/NNS do/VBP not/RB appear/VB to/TO be/VB of/IN major/JJ clinical/JJ importance/NN ,/, BREVIBLOC/NN should/MD be/VB titrated/VBN with/IN caution/NN in/IN patients/NNS being/VBG treated/VBN concurrently/RB with/IN digoxin/NN ,/, morphine/NN ,/, succinylcholine/NN or/CC warfarin/NN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NP (DT the) (NNS interactions)) (VP (VBN observed) (PP (IN in) (NP (DT these) (NNS studies))))) (VP (VBP do) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB be) (PP (IN of) (NP (JJ major) (JJ clinical) (NN importance)))))))))) (, ,) (NP (NN BREVIBLOC)) (VP (MD should) (VP (VB be) (VP (VBN titrated) (PP (IN with) (NP (NP (NN caution)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG being) (VP (VBN treated) (ADVP (RB concurrently)) (PP (IN with) (NP (NP (NN digoxin)) (, ,) (NP (NN morphine)) (, ,) (NP (NN succinylcholine)) (CC or) (NP (NN warfarin)))))))))))))) (. .))))

mark(appear-10, Although-1)
det(interactions-3, the-2)
nsubj(appear-10, interactions-3)
xsubj(be-12, interactions-3)
partmod(interactions-3, observed-4)
det(studies-7, these-6)
prep_in(observed-4, studies-7)
aux(appear-10, do-8)
neg(appear-10, not-9)
advcl(titrated-21, appear-10)
aux(be-12, to-11)
xcomp(appear-10, be-12)
amod(importance-16, major-14)
amod(importance-16, clinical-15)
prep_of(be-12, importance-16)
nsubjpass(titrated-21, BREVIBLOC-18)
aux(titrated-21, should-19)
auxpass(titrated-21, be-20)
root(ROOT-0, titrated-21)
prep_with(titrated-21, caution-23)
prep_in(caution-23, patients-25)
auxpass(treated-27, being-26)
partmod(patients-25, treated-27)
advmod(treated-27, concurrently-28)
prep_with(treated-27, digoxin-30)
conj_or(digoxin-30, morphine-32)
conj_or(digoxin-30, succinylcholine-34)
conj_or(digoxin-30, warfarin-36)

While/IN taking/VBG beta/NN blockers/NNS ,/, patients/NNS with/IN a/DT history/NN of/IN severe/JJ anaphylactic/JJ reaction/NN to/TO a/DT variety/NN of/IN allergens/NNS may/MD be/VB more/RBR reactive/JJ to/TO repeated/JJ challenge/NN ,/, either/CC accidental/JJ ,/, diagnostic/JJ ,/, or/CC therapeutic/JJ ./.

(ROOT (S1 (S (S (SBAR (IN While) (S (VP (VBG taking) (NP (NN beta) (NNS blockers))))) (, ,) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (JJ severe) (JJ anaphylactic) (NN reaction)) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS allergens)))))))))) (VP (MD may) (VP (VB be) (ADJP (RBR more) (JJ reactive) (PP (TO to) (NP (NP (JJ repeated) (NN challenge)) (, ,) (UCP (CC either) (ADJP (JJ accidental)) (, ,) (ADJP (JJ diagnostic)) (, ,) (CC or) (ADJP (JJ therapeutic))))))))) (. .))))

mark(taking-2, While-1)
advcl(reactive-22, taking-2)
nn(blockers-4, beta-3)
dobj(taking-2, blockers-4)
nsubj(reactive-22, patients-6)
det(history-9, a-8)
prep_with(patients-6, history-9)
amod(reaction-13, severe-11)
amod(reaction-13, anaphylactic-12)
prep_of(history-9, reaction-13)
det(variety-16, a-15)
prep_to(reaction-13, variety-16)
prep_of(variety-16, allergens-18)
aux(reactive-22, may-19)
cop(reactive-22, be-20)
advmod(reactive-22, more-21)
root(ROOT-0, reactive-22)
amod(challenge-25, repeated-24)
prep_to(reactive-22, challenge-25)
dep(challenge-25, either-27)
dep(either-27, accidental-28)
conj_or(either-27, diagnostic-30)
conj_or(either-27, therapeutic-33)

Such/JJ patients/NNS may/MD be/VB unresponsive/JJ to/TO the/DT usual/JJ doses/NNS of/IN epinephrine/NN used/VBN to/TO treat/VB allergic/JJ reaction/NN ./.

(ROOT (S1 (S (S (NP (JJ Such) (NNS patients)) (VP (MD may) (VP (VB be) (ADJP (JJ unresponsive) (PP (TO to) (NP (NP (DT the) (JJ usual) (NNS doses)) (PP (IN of) (NP (NN epinephrine))) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (JJ allergic) (NN reaction)))))))))))) (. .))))

amod(patients-2, Such-1)
nsubj(unresponsive-5, patients-2)
aux(unresponsive-5, may-3)
cop(unresponsive-5, be-4)
root(ROOT-0, unresponsive-5)
det(doses-9, the-7)
amod(doses-9, usual-8)
prep_to(unresponsive-5, doses-9)
prep_of(doses-9, epinephrine-11)
partmod(doses-9, used-12)
aux(treat-14, to-13)
xcomp(used-12, treat-14)
amod(reaction-16, allergic-15)
dobj(treat-14, reaction-16)

Caution/NN should/MD be/VB exercised/VBN when/WRB considering/VBG the/DT use/NN of/IN BREVIBLOC/NN and/CC verapamil/NN in/IN patients/NNS with/IN depressed/JJ myocardial/JJ function/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (VP (VBG considering) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NN BREVIBLOC)) (CC and) (NP (NN verapamil)))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ depressed) (JJ myocardial) (NN function))))))))))))) (. .))))

nsubjpass(exercised-4, Caution-1)
aux(exercised-4, should-2)
auxpass(exercised-4, be-3)
root(ROOT-0, exercised-4)
advmod(considering-6, when-5)
advcl(exercised-4, considering-6)
det(use-8, the-7)
dobj(considering-6, use-8)
prep_of(use-8, BREVIBLOC-10)
conj_and(BREVIBLOC-10, verapamil-12)
prep_in(use-8, patients-14)
amod(function-18, depressed-16)
amod(function-18, myocardial-17)
prep_with(patients-14, function-18)

Fatal/JJ cardiac/JJ arrests/VBZ have/VBP occurred/VBN in/IN patients/NNS receiving/VBG both/DT drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Fatal) (JJ cardiac)) (VBZ arrests)) (VP (VBP have) (VP (VBN occurred) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (DT both) (NNS drugs)))))))) (. .))))

amod(cardiac-2, Fatal-1)
nsubj(occurred-5, cardiac-2)
dep(cardiac-2, arrests-3)
aux(occurred-5, have-4)
root(ROOT-0, occurred-5)
prep_in(occurred-5, patients-7)
partmod(patients-7, receiving-8)
det(drugs-10, both-9)
dobj(receiving-8, drugs-10)

Additionally/RB ,/, BREVIBLOC/NN should/MD not/RB be/VB used/VBN to/TO control/VB supraventricular/JJ tachycardia/NN in/IN the/DT presence/NN of/IN agents/NNS which/WDT are/VBP vasoconstrictive/JJ and/CC inotropic/JJ such/JJ as/IN dopamine/NN ,/, epinephrine/NN ,/, and/CC norepinephrine/NN because/IN of/IN the/DT danger/NN of/IN blocking/VBG cardiac/JJ contractility/NN when/WRB systemic/JJ vascular/JJ resistance/NN is/VBZ high/JJ ./.

(ROOT (S1 (S (ADVP (RB Additionally)) (, ,) (NP (NN BREVIBLOC)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB control) (NP (JJ supraventricular) (NN tachycardia)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NNS agents)) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADJP (ADJP (JJ vasoconstrictive)) (CC and) (ADJP (JJ inotropic))) (PP (JJ such) (IN as) (NP (NP (NN dopamine)) (, ,) (NP (NN epinephrine)) (, ,) (CC and) (NP (NN norepinephrine)))) (PP (IN because) (IN of) (NP (NP (DT the) (NN danger)) (PP (IN of) (S (VP (VBG blocking) (NP (JJ cardiac) (NN contractility)))))))))))))) (SBAR (WHADVP (WRB when)) (S (NP (JJ systemic) (JJ vascular) (NN resistance)) (VP (VBZ is) (ADJP (JJ high))))))))))) (. .))))

advmod(used-7, Additionally-1)
nsubjpass(used-7, BREVIBLOC-3)
aux(used-7, should-4)
neg(used-7, not-5)
auxpass(used-7, be-6)
root(ROOT-0, used-7)
aux(control-9, to-8)
xcomp(used-7, control-9)
amod(tachycardia-11, supraventricular-10)
dobj(control-9, tachycardia-11)
det(presence-14, the-13)
prep_in(control-9, presence-14)
prep_of(presence-14, agents-16)
nsubj(vasoconstrictive-19, agents-16)
cop(vasoconstrictive-19, are-18)
rcmod(agents-16, vasoconstrictive-19)
conj_and(vasoconstrictive-19, inotropic-21)
prep_such_as(vasoconstrictive-19, dopamine-24)
conj_and(dopamine-24, epinephrine-26)
conj_and(dopamine-24, norepinephrine-29)
det(danger-33, the-32)
prep_because_of(vasoconstrictive-19, danger-33)
prepc_of(danger-33, blocking-35)
amod(contractility-37, cardiac-36)
dobj(blocking-35, contractility-37)
advmod(high-43, when-38)
amod(resistance-41, systemic-39)
amod(resistance-41, vascular-40)
nsubj(high-43, resistance-41)
cop(high-43, is-42)
advcl(control-9, high-43)

Esomeprazole/NN is/VBZ extensively/RB metabolized/VBN in/IN the/DT liver/NN by/IN CYP2C19/NN and/CC CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Esomeprazole)) (VP (VBZ is) (ADVP (RB extensively)) (VP (VBN metabolized) (PP (IN in) (NP (DT the) (NN liver))) (PP (IN by) (NP (NP (NN CYP2C19)) (CC and) (NP (NN CYP3A4))))))) (. .))))

nsubjpass(metabolized-4, Esomeprazole-1)
auxpass(metabolized-4, is-2)
advmod(metabolized-4, extensively-3)
root(ROOT-0, metabolized-4)
det(liver-7, the-6)
prep_in(metabolized-4, liver-7)
agent(metabolized-4, CYP2C19-9)
conj_and(CYP2C19-9, CYP3A4-11)

In/FW vitro/FW and/CC in/FW vivo/FW studies/NNS have/VBP shown/VBN that/IN esomeprazole/NN is/VBZ not/RB likely/JJ to/TO inhibit/VB CYPs/NNS 1A2/NN ,/, 2A6/NN ,/, 2C9/NN ,/, 2D6/NN ,/, 2E1/NN and/CC 3A4/NN ./.

(ROOT (S1 (S (S (NP (ADJP (ADJP (FW In) (FW vitro)) (CC and) (ADJP (FW in) (FW vivo))) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NN esomeprazole)) (VP (VBZ is) (RB not) (ADJP (JJ likely) (S (VP (TO to) (VP (VB inhibit) (NP (NNS CYPs) (NP (NP (NN 1A2)) (, ,) (NP (NN 2A6)) (, ,) (NP (NN 2C9)) (, ,) (NP (NN 2D6)) (, ,) (NP (NN 2E1)) (CC and) (NP (NN 3A4)))))))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-6, vitro-2)
nn(vivo-5, in-4)
conj_and(vitro-2, vivo-5)
nsubj(shown-8, studies-6)
aux(shown-8, have-7)
root(ROOT-0, shown-8)
complm(likely-13, that-9)
nsubj(likely-13, esomeprazole-10)
cop(likely-13, is-11)
neg(likely-13, not-12)
ccomp(shown-8, likely-13)
aux(inhibit-15, to-14)
xcomp(likely-13, inhibit-15)
dobj(inhibit-15, CYPs-16)
dep(CYPs-16, 1A2-17)
conj_and(1A2-17, 2A6-19)
conj_and(1A2-17, 2C9-21)
conj_and(1A2-17, 2D6-23)
conj_and(1A2-17, 2E1-25)
conj_and(1A2-17, 3A4-27)

No/DT clinically/RB relevant/JJ interactions/NNS with/IN drugs/NNS metabolized/VBN by/IN these/DT CYP/JJ enzymes/NNS would/MD be/VB expected/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (ADJP (RB clinically) (JJ relevant)) (NNS interactions)) (PP (IN with) (NP (NP (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (DT these) (JJ CYP) (NNS enzymes))))))) (VP (MD would) (VP (VB be) (VP (VBN expected))))) (. .))))

det(interactions-4, No-1)
advmod(relevant-3, clinically-2)
amod(interactions-4, relevant-3)
nsubjpass(expected-14, interactions-4)
prep_with(interactions-4, drugs-6)
partmod(drugs-6, metabolized-7)
det(enzymes-11, these-9)
amod(enzymes-11, CYP-10)
agent(metabolized-7, enzymes-11)
aux(expected-14, would-12)
auxpass(expected-14, be-13)
root(ROOT-0, expected-14)

Drug/NN interaction/NN studies/NNS have/VBP shown/VBN that/IN esomeprazole/NN does/VBZ not/RB have/VB any/DT clinically/RB significant/JJ interactions/NNS with/IN phenytoin/NN ,/, warfarin/NN ,/, quinidine/NN ,/, clarithromycin/NN or/CC amoxicillin/NN ./.

(ROOT (S1 (S (S (NP (NN Drug) (NN interaction) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NN esomeprazole)) (VP (VBZ does) (RB not) (VP (VB have) (NP (NP (DT any) (ADJP (RB clinically) (JJ significant)) (NNS interactions)) (PP (IN with) (NP (NP (NN phenytoin)) (, ,) (NP (NN warfarin)) (, ,) (NP (NN quinidine)) (, ,) (NP (NN clarithromycin)) (CC or) (NP (NN amoxicillin)))))))))))) (. .))))

nn(studies-3, Drug-1)
nn(studies-3, interaction-2)
nsubj(shown-5, studies-3)
aux(shown-5, have-4)
root(ROOT-0, shown-5)
complm(have-10, that-6)
nsubj(have-10, esomeprazole-7)
aux(have-10, does-8)
neg(have-10, not-9)
ccomp(shown-5, have-10)
det(interactions-14, any-11)
advmod(significant-13, clinically-12)
amod(interactions-14, significant-13)
dobj(have-10, interactions-14)
prep_with(interactions-14, phenytoin-16)
conj_or(phenytoin-16, warfarin-18)
conj_or(phenytoin-16, quinidine-20)
conj_or(phenytoin-16, clarithromycin-22)
conj_or(phenytoin-16, amoxicillin-24)

Post-marketing/JJ reports/NNS of/IN changes/NNS in/IN prothrombin/NN measures/NNS have/VBP been/VBN received/VBN among/IN patients/NNS on/IN concomitant/JJ warfarin/NN and/CC esomeprazole/JJ therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Post-marketing) (NNS reports)) (PP (IN of) (NP (NP (NNS changes)) (PP (IN in) (NP (NN prothrombin) (NNS measures)))))) (VP (VBP have) (VP (VBN been) (VP (VBN received) (PP (IN among) (NP (NP (NNS patients)) (PP (IN on) (NP (NP (JJ concomitant) (NN warfarin)) (CC and) (NP (JJ esomeprazole) (NN therapy)))))))))) (. .))))

amod(reports-2, Post-marketing-1)
nsubjpass(received-10, reports-2)
prep_of(reports-2, changes-4)
nn(measures-7, prothrombin-6)
prep_in(changes-4, measures-7)
aux(received-10, have-8)
auxpass(received-10, been-9)
root(ROOT-0, received-10)
prep_among(received-10, patients-12)
amod(warfarin-15, concomitant-14)
prep_on(patients-12, warfarin-15)
amod(therapy-18, esomeprazole-17)
conj_and(warfarin-15, therapy-18)

Patients/NNS treated/VBN with/IN proton/NN pump/NN inhibitors/NNS and/CC warfarin/NN concomitantly/RB may/MD need/VBP to/TO be/VB monitored/VBN for/IN increases/NNS in/IN INR/NN and/CC prothrombin/NN time/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBN treated) (PP (IN with) (NP (NP (NN proton) (NN pump) (NNS inhibitors)) (CC and) (NP (NN warfarin)))) (ADVP (RB concomitantly)))) (VP (MD may) (VP (VBP need) (S (VP (TO to) (VP (VB be) (VP (VBN monitored) (PP (IN for) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (NN INR)) (CC and) (NP (NN prothrombin) (NN time))))))))))))) (. .))))

nsubj(need-11, Patients-1)
xsubj(monitored-14, Patients-1)
partmod(Patients-1, treated-2)
nn(inhibitors-6, proton-4)
nn(inhibitors-6, pump-5)
prep_with(treated-2, inhibitors-6)
conj_and(inhibitors-6, warfarin-8)
advmod(treated-2, concomitantly-9)
aux(need-11, may-10)
root(ROOT-0, need-11)
aux(monitored-14, to-12)
auxpass(monitored-14, be-13)
xcomp(need-11, monitored-14)
prep_for(monitored-14, increases-16)
prep_in(increases-16, INR-18)
nn(time-21, prothrombin-20)
conj_and(INR-18, time-21)

Esomeprazole/NN may/MD potentially/RB interfere/VB with/IN CYP2C19/NN ,/, the/DT major/JJ esomeprazole/NN metabolizing/NN enzyme/NN ./.

(ROOT (S1 (S (S (NP (NN Esomeprazole)) (VP (MD may) (ADVP (RB potentially)) (VP (VB interfere) (PP (IN with) (NP (NP (NN CYP2C19)) (, ,) (NP (DT the) (JJ major) (NN esomeprazole) (NN metabolizing) (NN enzyme))))))) (. .))))

nsubj(interfere-4, Esomeprazole-1)
aux(interfere-4, may-2)
advmod(interfere-4, potentially-3)
root(ROOT-0, interfere-4)
prep_with(interfere-4, CYP2C19-6)
det(enzyme-12, the-8)
amod(enzyme-12, major-9)
nn(enzyme-12, esomeprazole-10)
nn(enzyme-12, metabolizing-11)
appos(CYP2C19-6, enzyme-12)

Coadministration/NN of/IN esomeprazole/NN 30/CD mg/NN and/CC diazepam/NN ,/, a/DT CYP2C19/NN substrate/NN ,/, resulted/VBD in/IN a/DT 45/CD %/NN decrease/NN in/IN clearance/NN of/IN diazepam/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NN esomeprazole) (CD 30) (NN mg)) (CC and) (NP (NP (NN diazepam)) (, ,) (NP (DT a) (NN CYP2C19) (NN substrate)) (, ,))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (ADJP (CD 45) (NN %)) (NN decrease)) (PP (IN in) (NP (NP (NN clearance)) (PP (IN of) (NP (NN diazepam))))))))) (. .))))

nsubj(resulted-13, Coadministration-1)
nn(mg-5, esomeprazole-3)
num(mg-5, 30-4)
prep_of(Coadministration-1, mg-5)
conj_and(mg-5, diazepam-7)
det(substrate-11, a-9)
nn(substrate-11, CYP2C19-10)
appos(diazepam-7, substrate-11)
root(ROOT-0, resulted-13)
det(decrease-18, a-15)
number(%-17, 45-16)
amod(decrease-18, %-17)
prep_in(resulted-13, decrease-18)
prep_in(decrease-18, clearance-20)
prep_of(clearance-20, diazepam-22)

Increased/VBN plasma/NN levels/NNS of/IN diazepam/NN were/VBD observed/VBN 12/CD hours/NNS after/IN dosing/NN and/CC onwards/NN ./.

(ROOT (S1 (S (S (NP (NP (VBN Increased) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN diazepam)))) (VP (VBD were) (VP (VBN observed) (PP (NP (CD 12) (NNS hours)) (IN after) (NP (NP (NN dosing)) (CC and) (NP (NN onwards))))))) (. .))))

amod(levels-3, Increased-1)
nn(levels-3, plasma-2)
nsubjpass(observed-7, levels-3)
prep_of(levels-3, diazepam-5)
auxpass(observed-7, were-6)
root(ROOT-0, observed-7)
num(hours-9, 12-8)
npadvmod(observed-7, hours-9)
prep_after(observed-7, dosing-11)
conj_and(dosing-11, onwards-13)

However/RB ,/, at/IN that/DT time/NN ,/, the/DT plasma/NN levels/NNS of/IN diazepam/NN were/VBD below/IN the/DT therapeutic/JJ interval/NN ,/, and/CC thus/RB this/DT interaction/NN is/VBZ unlikely/JJ to/TO be/VB of/IN clinical/JJ relevance/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (PP (IN at) (NP (DT that) (NN time))) (, ,) (S (S (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN diazepam)))) (VP (VBD were) (PP (IN below) (NP (DT the) (JJ therapeutic) (NN interval))))) (, ,) (CC and) (S (ADVP (RB thus)) (NP (DT this) (NN interaction)) (VP (VBZ is) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB be) (PP (IN of) (NP (JJ clinical) (NN relevance))))))))))) (. .))))

advmod(were-12, However-1)
det(time-5, that-4)
prep_at(were-12, time-5)
det(levels-9, the-7)
nn(levels-9, plasma-8)
nsubj(were-12, levels-9)
prep_of(levels-9, diazepam-11)
root(ROOT-0, were-12)
det(interval-16, the-14)
amod(interval-16, therapeutic-15)
prep_below(were-12, interval-16)
advmod(unlikely-23, thus-19)
det(interaction-21, this-20)
nsubj(unlikely-23, interaction-21)
cop(unlikely-23, is-22)
conj_and(were-12, unlikely-23)
aux(be-25, to-24)
xcomp(unlikely-23, be-25)
amod(relevance-28, clinical-27)
prep_of(be-25, relevance-28)

Esomeprazole/NN inhibits/VBZ gastric/JJ acid/NN secretion/NN ./.

(ROOT (S1 (S (S (NP (NN Esomeprazole)) (VP (VBZ inhibits) (NP (JJ gastric) (NN acid) (NN secretion)))) (. .))))

nsubj(inhibits-2, Esomeprazole-1)
root(ROOT-0, inhibits-2)
amod(secretion-5, gastric-3)
nn(secretion-5, acid-4)
dobj(inhibits-2, secretion-5)

Therefore/RB ,/, esomeprazole/NN may/MD interfere/VB with/IN the/DT absorption/NN of/IN drugs/NNS where/WRB gastric/JJ pH/NN is/VBZ an/DT important/JJ determinant/NN of/IN bioavailability/NN (/-LRB- eg/NN ,/, ketoconazole/NN ,/, iron/NN salts/NNS and/CC digoxin/NN )/-RRB- ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NN esomeprazole)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NP (NNS drugs)) (SBAR (WHADVP (WRB where)) (S (NP (JJ gastric) (NN pH)) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN determinant)) (PP (IN of) (NP (NP (NN bioavailability)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN ketoconazole)) (, ,) (NP (NN iron) (NNS salts)) (CC and) (NP (NN digoxin))) (-RRB- -RRB-))))))))))))))) (. .))))

advmod(interfere-5, Therefore-1)
nsubj(interfere-5, esomeprazole-3)
aux(interfere-5, may-4)
root(ROOT-0, interfere-5)
det(absorption-8, the-7)
prep_with(interfere-5, absorption-8)
prep_of(absorption-8, drugs-10)
advmod(determinant-17, where-11)
amod(pH-13, gastric-12)
nsubj(determinant-17, pH-13)
cop(determinant-17, is-14)
det(determinant-17, an-15)
amod(determinant-17, important-16)
rcmod(drugs-10, determinant-17)
prep_of(determinant-17, bioavailability-19)
dep(bioavailability-19, eg-21)
conj_and(eg-21, ketoconazole-23)
nn(salts-26, iron-25)
conj_and(eg-21, salts-26)
conj_and(eg-21, digoxin-28)

Coadministration/NN of/IN oral/JJ contraceptives/NNS ,/, diazepam/NN ,/, phenytoin/NN ,/, or/CC quinidine/NN did/VBD not/RB seem/VB to/TO change/VB the/DT pharmacokinetic/JJ profile/NN of/IN esomeprazole/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (JJ oral) (NNS contraceptives)) (, ,) (NP (NP (NN diazepam)) (, ,) (NP (NN phenytoin)) (, ,) (CC or) (NP (NN quinidine)))))) (VP (VBD did) (RB not) (VP (VB seem) (S (VP (TO to) (VP (VB change) (NP (NP (DT the) (JJ pharmacokinetic) (NN profile)) (PP (IN of) (NP (NN esomeprazole)))))))))) (. .))))

nsubj(seem-14, Coadministration-1)
xsubj(change-16, Coadministration-1)
amod(contraceptives-4, oral-3)
prep_of(Coadministration-1, contraceptives-4)
appos(contraceptives-4, diazepam-6)
conj_or(diazepam-6, phenytoin-8)
conj_or(diazepam-6, quinidine-11)
aux(seem-14, did-12)
neg(seem-14, not-13)
root(ROOT-0, seem-14)
aux(change-16, to-15)
xcomp(seem-14, change-16)
det(profile-19, the-17)
amod(profile-19, pharmacokinetic-18)
dobj(change-16, profile-19)
prep_of(profile-19, esomeprazole-21)

Combination/NN Therapy/NN with/IN Clarithromycin/NN Co-administration/NN of/IN esomeprazole/NN ,/, clarithromycin/NN ,/, and/CC amoxicillin/NN has/VBZ resulted/VBD in/IN increases/NNS in/IN the/DT plasma/NN levels/NNS of/IN esomeprazole/NN and/CC 14-hydroxyclarithromycin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Combination) (NN Therapy)) (PP (IN with) (NP (NP (NN Clarithromycin) (NN Co-administration)) (PP (IN of) (NP (NP (NN esomeprazole)) (, ,) (NP (NN clarithromycin)) (, ,) (CC and) (NP (NN amoxicillin))))))) (VP (VBZ has) (VP (VBD resulted) (PP (IN in) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (NP (NN esomeprazole)) (CC and) (NP (NN 14-hydroxyclarithromycin))))))))))) (. .))))

nn(Therapy-2, Combination-1)
nsubj(resulted-14, Therapy-2)
nn(Co-administration-5, Clarithromycin-4)
prep_with(Therapy-2, Co-administration-5)
prep_of(Co-administration-5, esomeprazole-7)
conj_and(esomeprazole-7, clarithromycin-9)
conj_and(esomeprazole-7, amoxicillin-12)
aux(resulted-14, has-13)
root(ROOT-0, resulted-14)
prep_in(resulted-14, increases-16)
det(levels-20, the-18)
nn(levels-20, plasma-19)
prep_in(increases-16, levels-20)
prep_of(levels-20, esomeprazole-22)
conj_and(esomeprazole-22, 14-hydroxyclarithromycin-24)

Concomitant/JJ administration/NN of/IN clarithromycin/NN with/IN pimozide/NN is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NN clarithromycin))) (PP (IN with) (NP (NN pimozide)))) (VP (VBZ is) (VP (VBN contraindicated)))) (. .))))

amod(administration-2, Concomitant-1)
nsubjpass(contraindicated-8, administration-2)
prep_of(administration-2, clarithromycin-4)
prep_with(administration-2, pimozide-6)
auxpass(contraindicated-8, is-7)
root(ROOT-0, contraindicated-8)

If/IN ProSom/NN is/VBZ given/VBN concomitantly/RB with/IN other/JJ drugs/NNS acting/VBG on/IN the/DT central/JJ nervous/JJ system/NN ,/, careful/JJ consideration/NN should/MD be/VB given/VBN to/TO the/DT pharmacology/NN of/IN all/DT agents/NNS ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN ProSom)) (VP (VBZ is) (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (VP (VBG acting) (PP (IN on) (NP (DT the) (JJ central) (JJ nervous) (NN system)))))))))) (, ,) (NP (JJ careful) (NN consideration)) (VP (MD should) (VP (VB be) (VP (VBN given) (PP (TO to) (NP (NP (DT the) (NN pharmacology)) (PP (IN of) (NP (DT all) (NNS agents))))))))) (. .))))

mark(given-4, If-1)
nsubjpass(given-4, ProSom-2)
auxpass(given-4, is-3)
advcl(given-20, given-4)
advmod(given-4, concomitantly-5)
amod(drugs-8, other-7)
prep_with(given-4, drugs-8)
partmod(drugs-8, acting-9)
det(system-14, the-11)
amod(system-14, central-12)
amod(system-14, nervous-13)
prep_on(acting-9, system-14)
amod(consideration-17, careful-16)
nsubjpass(given-20, consideration-17)
aux(given-20, should-18)
auxpass(given-20, be-19)
root(ROOT-0, given-20)
det(pharmacology-23, the-22)
prep_to(given-20, pharmacology-23)
det(agents-26, all-25)
prep_of(pharmacology-23, agents-26)

The/DT action/NN of/IN the/DT benzodiazepines/NNS may/MD be/VB potentiated/VBN by/IN anticonvulsants/NNS ,/, antihistamines/NNS ,/, alcohol/NN ,/, barbiturates/NNS ,/, monoamine/NN oxidase/NN inhibitors/NNS ,/, narcotics/NNS ,/, phenothiazines/NNS ,/, psychotropic/JJ medications/NNS ,/, or/CC other/JJ drugs/NNS that/WDT produce/VBP CNS/NN depression/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN action)) (PP (IN of) (NP (DT the) (NNS benzodiazepines)))) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (PP (IN by) (NP (NP (NP (NNS anticonvulsants)) (, ,) (NP (NNS antihistamines)) (, ,) (NP (NN alcohol)) (, ,) (NP (NNS barbiturates)) (, ,) (NP (NN monoamine) (NN oxidase) (NNS inhibitors)) (, ,) (NP (NNS narcotics)) (, ,) (NP (NNS phenothiazines)) (, ,) (NP (JJ psychotropic) (NNS medications)) (, ,) (CC or) (NP (JJ other) (NNS drugs))) (SBAR (WHNP (WDT that)) (S (VP (VBP produce) (NP (NN CNS) (NN depression))))))))))) (. .))))

det(action-2, The-1)
nsubjpass(potentiated-8, action-2)
det(benzodiazepines-5, the-4)
prep_of(action-2, benzodiazepines-5)
aux(potentiated-8, may-6)
auxpass(potentiated-8, be-7)
root(ROOT-0, potentiated-8)
agent(potentiated-8, anticonvulsants-10)
nsubj(produce-33, anticonvulsants-10)
conj_or(anticonvulsants-10, antihistamines-12)
conj_or(anticonvulsants-10, alcohol-14)
conj_or(anticonvulsants-10, barbiturates-16)
nn(inhibitors-20, monoamine-18)
nn(inhibitors-20, oxidase-19)
conj_or(anticonvulsants-10, inhibitors-20)
conj_or(anticonvulsants-10, narcotics-22)
conj_or(anticonvulsants-10, phenothiazines-24)
amod(medications-27, psychotropic-26)
conj_or(anticonvulsants-10, medications-27)
amod(drugs-31, other-30)
conj_or(anticonvulsants-10, drugs-31)
rcmod(anticonvulsants-10, produce-33)
nn(depression-35, CNS-34)
dobj(produce-33, depression-35)

Smokers/NNS have/VBP an/DT increased/VBN clearance/NN of/IN benzodiazepines/NN as/IN compared/VBN to/TO nonsmokers/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NNS Smokers)) (VP (VBP have) (NP (NP (DT an) (VBN increased) (NN clearance)) (PP (IN of) (NP (NN benzodiazepines)))) (SBAR (IN as) (S (VP (VBN compared) (PP (TO to) (NP (NNS nonsmokers))))))) (: ;)) (. .))))

nsubj(have-2, Smokers-1)
root(ROOT-0, have-2)
det(clearance-5, an-3)
amod(clearance-5, increased-4)
dobj(have-2, clearance-5)
prep_of(clearance-5, benzodiazepines-7)
mark(compared-9, as-8)
advcl(have-2, compared-9)
prep_to(compared-9, nonsmokers-11)

this/DT was/VBD seen/VBN in/IN studies/NNS with/IN estazolam/NN ./.

(ROOT (S1 (S (S (NP (DT this)) (VP (VBD was) (VP (VBN seen) (PP (IN in) (NP (NP (NNS studies)) (PP (IN with) (NP (NN estazolam)))))))) (. .))))

nsubjpass(seen-3, this-1)
auxpass(seen-3, was-2)
root(ROOT-0, seen-3)
prep_in(seen-3, studies-5)
prep_with(studies-5, estazolam-7)

While/IN no/DT in/FW vivo/FW drug-drug/JJ interaction/NN studies/NNS were/VBD conducted/VBN between/IN estazolam/NN and/CC inducers/NNS of/IN CYP3A/NN ,/, compounds/NNS that/WDT are/VBP potent/JJ CYP3A/NN inducers/NNS (/-LRB- such/JJ as/IN carbamazepine/NN ,/, phenytoin/NN ,/, rifampin/NN ,/, and/CC barbiturates/NNS )/-RRB- would/MD be/VB expected/VBN to/TO decrease/VB estazolam/NN concentrations/NNS ./.

(ROOT (S1 (S (S (SBAR (IN While) (S (NP (DT no) (ADJP (FW in) (FW vivo)) (JJ drug-drug) (NN interaction) (NNS studies)) (VP (VBD were) (VP (VBN conducted) (PP (IN between) (NP (NP (NN estazolam)) (CC and) (NP (NP (NNS inducers)) (PP (IN of) (NP (NN CYP3A)))))))))) (, ,) (NP (NP (NNS compounds)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (JJ potent) (NN CYP3A) (NNS inducers)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NP (NN carbamazepine)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN rifampin)) (, ,) (CC and) (NP (NNS barbiturates))))) (-RRB- -RRB-))))))) (VP (MD would) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB decrease) (NP (NN estazolam) (NNS concentrations))))))))) (. .))))

mark(conducted-9, While-1)
det(studies-7, no-2)
nn(vivo-4, in-3)
amod(studies-7, vivo-4)
amod(studies-7, drug-drug-5)
nn(studies-7, interaction-6)
nsubjpass(conducted-9, studies-7)
auxpass(conducted-9, were-8)
advcl(expected-37, conducted-9)
prep_between(conducted-9, estazolam-11)
conj_and(estazolam-11, inducers-13)
prep_of(inducers-13, CYP3A-15)
nsubj(inducers-22, compounds-17)
nsubjpass(expected-37, compounds-17)
cop(inducers-22, are-19)
amod(inducers-22, potent-20)
nn(inducers-22, CYP3A-21)
rcmod(compounds-17, inducers-22)
prep_such_as(inducers-22, carbamazepine-26)
conj_and(carbamazepine-26, phenytoin-28)
conj_and(carbamazepine-26, rifampin-30)
conj_and(carbamazepine-26, barbiturates-33)
aux(expected-37, would-35)
auxpass(expected-37, be-36)
root(ROOT-0, expected-37)
aux(decrease-39, to-38)
xcomp(expected-37, decrease-39)
nn(concentrations-41, estazolam-40)
dobj(decrease-39, concentrations-41)

Estazolam/NN Interaction/NN with/IN Drugs/NNS that/WDT Inhibit/VBP Metabolism/NN via/IN Cytochrome/NN P450/NN 3A/NN (/-LRB- CYP3A/NN )/-RRB- :/: The/DT metabolism/NN of/IN estazolam/NN to/TO the/DT major/JJ circulating/JJ metabolite/NN 4-hydroxy-/JJ estazolam/NN and/CC the/DT metabolism/NN of/IN other/JJ triazolobenzodiazepines/NNS is/VBZ catalyzed/VBN by/IN CYP3A/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Estazolam) (NN Interaction)) (PP (IN with) (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP Inhibit) (NP (NP (NP (NN Metabolism)) (PP (IN via) (NP (NN Cytochrome) (NN P450) (NP (NP (NN 3A)) (PRN (-LRB- -LRB-) (NP (NN CYP3A)) (-RRB- -RRB-)))))) (: :) (NP (NP (DT The) (NN metabolism)) (PP (IN of) (NP (NP (NN estazolam)) (PP (TO to) (NP (NP (DT the) (JJ major) (JJ circulating) (NN metabolite)) (JJ 4-hydroxy-) (NN estazolam)))))) (CC and) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (JJ other) (NNS triazolobenzodiazepines))))))))))) (VP (VBZ is) (VP (VBN catalyzed) (PP (IN by) (NP (NN CYP3A)))))) (. .))))

nn(Interaction-2, Estazolam-1)
nsubjpass(catalyzed-34, Interaction-2)
prep_with(Interaction-2, Drugs-4)
nsubj(Inhibit-6, Drugs-4)
rcmod(Drugs-4, Inhibit-6)
dobj(Inhibit-6, Metabolism-7)
nn(P450-10, Cytochrome-9)
prep_via(Metabolism-7, P450-10)
dep(P450-10, 3A-11)
abbrev(3A-11, CYP3A-13)
det(metabolism-17, The-16)
conj_and(Metabolism-7, metabolism-17)
prep_of(metabolism-17, estazolam-19)
det(metabolite-24, the-21)
amod(metabolite-24, major-22)
amod(metabolite-24, circulating-23)
nn(estazolam-26, metabolite-24)
amod(estazolam-26, 4-hydroxy--25)
prep_to(estazolam-19, estazolam-26)
det(metabolism-29, the-28)
conj_and(Metabolism-7, metabolism-29)
amod(triazolobenzodiazepines-32, other-31)
prep_of(metabolism-29, triazolobenzodiazepines-32)
auxpass(catalyzed-34, is-33)
root(ROOT-0, catalyzed-34)
agent(catalyzed-34, CYP3A-36)

Consequently/RB ,/, estazolam/NN should/MD be/VB avoided/VBN in/IN patients/NNS receiving/VBG ketoconazole/NN and/CC itraconazole/NN ,/, which/WDT are/VBP very/RB potent/JJ inhibitors/NNS of/IN CYP3A/NN ./.

(ROOT (S1 (S (S (ADVP (RB Consequently)) (, ,) (NP (NN estazolam)) (VP (MD should) (VP (VB be) (VP (VBN avoided) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NP (NN ketoconazole)) (CC and) (NP (NN itraconazole))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (NP (NP (ADJP (RB very) (JJ potent)) (NNS inhibitors)) (PP (IN of) (NP (NN CYP3A))))))))))))))) (. .))))

advmod(avoided-6, Consequently-1)
nsubjpass(avoided-6, estazolam-3)
aux(avoided-6, should-4)
auxpass(avoided-6, be-5)
root(ROOT-0, avoided-6)
prep_in(avoided-6, patients-8)
partmod(patients-8, receiving-9)
dobj(receiving-9, ketoconazole-10)
nsubj(inhibitors-18, ketoconazole-10)
conj_and(ketoconazole-10, itraconazole-12)
cop(inhibitors-18, are-15)
advmod(potent-17, very-16)
amod(inhibitors-18, potent-17)
rcmod(ketoconazole-10, inhibitors-18)
prep_of(inhibitors-18, CYP3A-20)

With/IN drugs/NNS inhibiting/VBG CYP3A/NN to/TO a/DT lesser/JJR ,/, but/CC still/RB significant/JJ degree/NN ,/, estazolam/NN should/MD be/VB used/VBN only/RB with/IN caution/NN and/CC consideration/NN of/IN appropriate/JJ dosage/NN reduction/NN ./.

(ROOT (S1 (S (PP (IN With) (NP (NP (NNS drugs)) (VP (VBG inhibiting) (NP (NN CYP3A)) (PP (TO to) (NP (DT a) (ADJP (ADJP (JJR lesser)) (, ,) (CC but) (ADJP (ADVP (RB still)) (JJ significant))) (NN degree)))))) (, ,) (NP (NN estazolam)) (VP (MD should) (VP (VB be) (VP (VBN used) (ADVP (RB only)) (PP (IN with) (NP (NP (NN caution)) (CC and) (NP (NP (NN consideration)) (PP (IN of) (NP (JJ appropriate) (NN dosage) (NN reduction))))))))) (. .))))

prep_with(used-17, drugs-2)
partmod(drugs-2, inhibiting-3)
dobj(inhibiting-3, CYP3A-4)
det(degree-12, a-6)
amod(degree-12, lesser-7)
advmod(significant-11, still-10)
conj_but(lesser-7, significant-11)
prep_to(inhibiting-3, degree-12)
nsubjpass(used-17, estazolam-14)
aux(used-17, should-15)
auxpass(used-17, be-16)
root(ROOT-0, used-17)
advmod(used-17, only-18)
prep_with(used-17, caution-20)
conj_and(caution-20, consideration-22)
amod(reduction-26, appropriate-24)
nn(reduction-26, dosage-25)
prep_of(consideration-22, reduction-26)

The/DT following/NN are/VBP examples/NNS of/IN drugs/NNS known/VBN to/TO inhibit/VB the/DT metabolism/NN of/IN other/JJ related/JJ benzodiazepines/NNS ,/, presumably/RB through/IN inhibition/NN of/IN CYP3A/NN :/: nefazodone/NN ,/, fluvoxamine/NN ,/, cimetidine/NN ,/, diltiazem/NN ,/, isoniazide/NN ,/, and/CC some/DT macrolide/NN antibiotics/NNS ./.

(ROOT (S1 (S (S (NP (DT The) (NN following)) (VP (VBP are) (NP (NP (NP (NNS examples)) (PP (IN of) (NP (NP (NNS drugs)) (VP (VBN known) (S (VP (TO to) (VP (VB inhibit) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (JJ other) (JJ related) (NNS benzodiazepines)))) (, ,) (PP (ADVP (RB presumably)) (IN through) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN CYP3A)))))))))))) (: :) (NP (NP (NN nefazodone)) (, ,) (NP (NN fluvoxamine)) (, ,) (NP (NN cimetidine)) (, ,) (NP (NN diltiazem)) (, ,) (NP (NN isoniazide)) (, ,) (CC and) (NP (DT some) (NN macrolide) (NNS antibiotics)))))) (. .))))

det(following-2, The-1)
nsubj(examples-4, following-2)
cop(examples-4, are-3)
root(ROOT-0, examples-4)
prep_of(examples-4, drugs-6)
xsubj(inhibit-9, drugs-6)
partmod(drugs-6, known-7)
aux(inhibit-9, to-8)
xcomp(known-7, inhibit-9)
det(metabolism-11, the-10)
dobj(inhibit-9, metabolism-11)
amod(benzodiazepines-15, other-13)
amod(benzodiazepines-15, related-14)
prep_of(metabolism-11, benzodiazepines-15)
advmod(inhibit-9, presumably-17)
prep_through(inhibit-9, inhibition-19)
prep_of(inhibition-19, CYP3A-21)
dep(examples-4, nefazodone-23)
conj_and(nefazodone-23, fluvoxamine-25)
conj_and(nefazodone-23, cimetidine-27)
conj_and(nefazodone-23, diltiazem-29)
conj_and(nefazodone-23, isoniazide-31)
det(antibiotics-36, some-34)
nn(antibiotics-36, macrolide-35)
conj_and(nefazodone-23, antibiotics-36)

Drug/NN Interaction/NN with/IN Fluoxetine/NN :/: A/DT multiple-dose/JJ study/NN was/VBD conducted/VBN to/TO assess/VB the/DT effect/NN of/IN fluoxetine/NN 20/CD mg/NN BID/NN on/IN the/DT pharmacokinetics/NNS of/IN estazolam/NN 2/CD mg/NN QHS/NNS after/IN seven/CD days/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NN Drug) (NN Interaction)) (PP (IN with) (NP (NN Fluoxetine)))) (: :) (S (NP (DT A) (JJ multiple-dose) (NN study)) (VP (VBD was) (VP (VBN conducted) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN fluoxetine) (ADJP (CD 20) (NN mg)) (NN BID))) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN estazolam) (CD 2) (NN mg) (NNS QHS)))))) (PP (IN after) (NP (CD seven) (NNS days))))))))) (. .)))))

nn(Interaction-2, Drug-1)
root(ROOT-0, Interaction-2)
prep_with(Interaction-2, Fluoxetine-4)
det(study-8, A-6)
amod(study-8, multiple-dose-7)
nsubjpass(conducted-10, study-8)
xsubj(assess-12, study-8)
auxpass(conducted-10, was-9)
dep(Interaction-2, conducted-10)
aux(assess-12, to-11)
xcomp(conducted-10, assess-12)
det(effect-14, the-13)
dobj(assess-12, effect-14)
nn(BID-19, fluoxetine-16)
number(mg-18, 20-17)
amod(BID-19, mg-18)
prep_of(effect-14, BID-19)
det(pharmacokinetics-22, the-21)
prep_on(effect-14, pharmacokinetics-22)
nn(QHS-27, estazolam-24)
num(QHS-27, 2-25)
nn(QHS-27, mg-26)
prep_of(pharmacokinetics-22, QHS-27)
num(days-30, seven-29)
prep_after(assess-12, days-30)

The/DT pharmacokinetics/NNS of/IN estazolam/NN (/-LRB- Cmax/NN and/CC AUC/NN )/-RRB- were/VBD not/RB affected/VBN during/IN multiple-dose/NN fluoxetine/NN ,/, suggesting/VBG no/DT clinically/RB significant/JJ pharmacokinetic/JJ interaction/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN estazolam)) (PRN (-LRB- -LRB-) (NP (NP (NN Cmax)) (CC and) (NP (NN AUC))) (-RRB- -RRB-))))) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN during) (NP (NN multiple-dose) (NN fluoxetine))) (, ,) (S (VP (VBG suggesting) (NP (DT no) (ADJP (RB clinically) (JJ significant)) (JJ pharmacokinetic) (NN interaction))))))) (. .))))

det(pharmacokinetics-2, The-1)
nsubjpass(affected-12, pharmacokinetics-2)
prep_of(pharmacokinetics-2, estazolam-4)
dep(estazolam-4, Cmax-6)
conj_and(Cmax-6, AUC-8)
auxpass(affected-12, were-10)
neg(affected-12, not-11)
root(ROOT-0, affected-12)
nn(fluoxetine-15, multiple-dose-14)
prep_during(affected-12, fluoxetine-15)
xcomp(affected-12, suggesting-17)
det(interaction-22, no-18)
advmod(significant-20, clinically-19)
amod(interaction-22, significant-20)
amod(interaction-22, pharmacokinetic-21)
dobj(suggesting-17, interaction-22)

Estazolam/NN Interaction/NN with/IN Other/JJ Drugs/NNS that/WDT are/VBP Metabolized/VBN by/IN Cytochrome/NN P450/NN (/-LRB- CYP/NN )/-RRB- :/: At/IN clinically/RB relevant/JJ concentrations/NNS ,/, in/FW vitro/FW studies/NNS indicate/VBP that/IN estazolam/NN (/-LRB- 0.6/CD @/NN M/NN )/-RRB- was/VBD not/RB inhibitory/JJ towards/IN the/DT major/JJ cytochrome/NN P450/NN isoforms/NNS CYP1A2/NN ,/, CYP2A6/NN ,/, CYP2C9/NN ,/, CYP2C19/NN ,/, CYP2D6/NN ,/, CYP2E1/NN ,/, and/CC CYP3A/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN Estazolam) (NN Interaction)) (PP (IN with) (NP (NP (JJ Other) (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN Metabolized) (PP (IN by) (NP (NP (NN Cytochrome) (NN P450)) (PRN (-LRB- -LRB-) (NP (NN CYP)) (-RRB- -RRB-))))))))))) (: :) (S (PP (IN At) (NP (ADJP (RB clinically) (JJ relevant)) (NNS concentrations))) (, ,) (NP (ADJP (FW in) (FW vitro)) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN estazolam)) (PRN (-LRB- -LRB-) (NP (CD 0.6) (NN @) (NN M)) (-RRB- -RRB-))) (VP (VBD was) (RB not) (ADJP (JJ inhibitory) (PP (IN towards) (NP (NP (DT the) (JJ major) (NN cytochrome) (NN P450) (NNS isoforms) (NN CYP1A2)) (, ,) (NP (NN CYP2A6)) (, ,) (NP (NN CYP2C9)) (, ,) (NP (NN CYP2C19)) (, ,) (NP (NN CYP2D6)) (, ,) (NP (NN CYP2E1)) (, ,) (CC and) (NP (NN CYP3A)))))))))) (. .)))))

nn(Interaction-2, Estazolam-1)
root(ROOT-0, Interaction-2)
amod(Drugs-5, Other-4)
prep_with(Interaction-2, Drugs-5)
nsubjpass(Metabolized-8, Drugs-5)
auxpass(Metabolized-8, are-7)
rcmod(Drugs-5, Metabolized-8)
nn(P450-11, Cytochrome-10)
agent(Metabolized-8, P450-11)
abbrev(P450-11, CYP-13)
advmod(relevant-18, clinically-17)
amod(concentrations-19, relevant-18)
prep_at(indicate-24, concentrations-19)
nn(vitro-22, in-21)
amod(studies-23, vitro-22)
nsubj(indicate-24, studies-23)
dep(Interaction-2, indicate-24)
complm(inhibitory-34, that-25)
nsubj(inhibitory-34, estazolam-26)
num(M-30, 0.6-28)
nn(M-30, @-29)
appos(estazolam-26, M-30)
cop(inhibitory-34, was-32)
neg(inhibitory-34, not-33)
ccomp(indicate-24, inhibitory-34)
det(CYP1A2-41, the-36)
amod(CYP1A2-41, major-37)
nn(CYP1A2-41, cytochrome-38)
nn(CYP1A2-41, P450-39)
nn(CYP1A2-41, isoforms-40)
prep_towards(inhibitory-34, CYP1A2-41)
conj_and(CYP1A2-41, CYP2A6-43)
conj_and(CYP1A2-41, CYP2C9-45)
conj_and(CYP1A2-41, CYP2C19-47)
conj_and(CYP1A2-41, CYP2D6-49)
conj_and(CYP1A2-41, CYP2E1-51)
conj_and(CYP1A2-41, CYP3A-54)

Therefore/RB ,/, based/VBN on/IN these/DT in/FW vitro/FW data/NNS ,/, estazolam/NN is/VBZ very/RB unlikely/JJ to/TO inhibit/VB the/DT biotransformation/NN of/IN other/JJ drugs/NNS metabolized/VBN by/IN these/DT CYP/JJ isoforms/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (PP (VBN based) (PP (IN on) (NP (DT these) (ADJP (FW in) (FW vitro)) (NNS data)))) (, ,) (NP (NN estazolam)) (VP (VBZ is) (ADJP (RB very) (JJ unlikely) (S (VP (TO to) (VP (VB inhibit) (NP (NP (DT the) (NN biotransformation)) (PP (IN of) (NP (NP (JJ other) (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (DT these) (JJ CYP) (NNS isoforms))))))))))))) (. .))))

advmod(unlikely-13, Therefore-1)
prepc_based_on(unlikely-13, on-4)
det(data-8, these-5)
nn(vitro-7, in-6)
amod(data-8, vitro-7)
pobj(unlikely-13, data-8)
nsubj(unlikely-13, estazolam-10)
cop(unlikely-13, is-11)
advmod(unlikely-13, very-12)
root(ROOT-0, unlikely-13)
aux(inhibit-15, to-14)
xcomp(unlikely-13, inhibit-15)
det(biotransformation-17, the-16)
dobj(inhibit-15, biotransformation-17)
amod(drugs-20, other-19)
prep_of(biotransformation-17, drugs-20)
partmod(drugs-20, metabolized-21)
det(isoforms-25, these-23)
amod(isoforms-25, CYP-24)
agent(metabolized-21, isoforms-25)

Milk/NN ,/, milk/NN products/NNS ,/, and/CC calcium/NN -rich/NN foods/NNS or/CC drugs/NNS may/MD impair/VB the/DT absorption/NN of/IN EMCYT/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Milk)) (, ,) (NP (NN milk) (NNS products)) (, ,) (CC and) (NP (NP (NN calcium) (NN -rich) (NNS foods)) (CC or) (NP (NNS drugs)))) (VP (MD may) (VP (VB impair) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NN EMCYT))))))) (. .))))

nsubj(impair-13, Milk-1)
nn(products-4, milk-3)
conj_and(Milk-1, products-4)
nn(foods-9, calcium-7)
nn(foods-9, -rich-8)
conj_and(Milk-1, foods-9)
conj_or(foods-9, drugs-11)
aux(impair-13, may-12)
root(ROOT-0, impair-13)
det(absorption-15, the-14)
dobj(impair-13, absorption-15)
prep_of(absorption-15, EMCYT-17)

CNS-Active/JJ Drugs/NNS Ethanol/NN :/: An/DT additive/JJ effect/NN on/IN psychomotor/NN performance/NN was/VBD seen/VBN with/IN coadministration/NN of/IN eszopiclone/NN and/CC ethanol/NN 0.70/CD g/kg/NNS for/IN up/RB to/TO 4/CD hours/NNS after/IN ethanol/NN administration/NN ./.

(ROOT (S1 (S (NP (NP (JJ CNS-Active) (NNS Drugs) (NN Ethanol)) (: :) (S (NP (NP (DT An) (JJ additive) (NN effect)) (PP (IN on) (NP (NN psychomotor) (NN performance)))) (VP (VBD was) (VP (VBN seen) (PP (IN with) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NP (NP (NN eszopiclone)) (CC and) (NP (NN ethanol))) (CD 0.70) (NNS g/kg)) (PP (IN for) (NP (NP (QP (RB up) (TO to) (CD 4)) (NNS hours)) (PP (IN after) (NP (NN ethanol) (NN administration)))))))))))) (. .)))))

amod(Ethanol-3, CNS-Active-1)
nn(Ethanol-3, Drugs-2)
root(ROOT-0, Ethanol-3)
det(effect-7, An-5)
amod(effect-7, additive-6)
nsubjpass(seen-12, effect-7)
nn(performance-10, psychomotor-9)
prep_on(effect-7, performance-10)
auxpass(seen-12, was-11)
dep(Ethanol-3, seen-12)
prep_with(seen-12, coadministration-14)
nn(g/kg-20, eszopiclone-16)
conj_and(eszopiclone-16, ethanol-18)
num(g/kg-20, 0.70-19)
prep_of(coadministration-14, g/kg-20)
quantmod(4-24, up-22)
dep(4-24, to-23)
num(hours-25, 4-24)
prep_for(g/kg-20, hours-25)
nn(administration-28, ethanol-27)
prep_after(hours-25, administration-28)

Paroxetine/NN Coadministration/NN of/IN single/JJ doses/NNS of/IN eszopiclone/NN 3/CD mg/NN and/CC paroxetine/NN 20/CD mg/NN daily/JJ for/IN 7/CD days/NNS produced/VBD no/DT pharmacokinetic/JJ or/CC pharmacodynamic/JJ interaction/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Paroxetine) (NN Coadministration)) (PP (IN of) (NP (NP (JJ single) (NNS doses)) (PP (IN of) (NP (NP (NN eszopiclone) (CD 3) (NN mg)) (CC and) (NP (NP (NN paroxetine) (CD 20) (NN mg)) (ADJP (JJ daily) (PP (IN for) (NP (CD 7) (NNS days)))))))))) (VP (VBD produced) (NP (DT no) (ADJP (ADJP (JJ pharmacokinetic)) (CC or) (ADJP (JJ pharmacodynamic))) (NN interaction)))) (. .))))

nn(Coadministration-2, Paroxetine-1)
nsubj(produced-18, Coadministration-2)
amod(doses-5, single-4)
prep_of(Coadministration-2, doses-5)
nn(mg-9, eszopiclone-7)
num(mg-9, 3-8)
prep_of(doses-5, mg-9)
nn(mg-13, paroxetine-11)
num(mg-13, 20-12)
conj_and(mg-9, mg-13)
amod(mg-13, daily-14)
num(days-17, 7-16)
prep_for(daily-14, days-17)
root(ROOT-0, produced-18)
det(interaction-23, no-19)
amod(interaction-23, pharmacokinetic-20)
conj_or(pharmacokinetic-20, pharmacodynamic-22)
dobj(produced-18, interaction-23)

Lorazepam/NN Coadministration/NN of/IN single/JJ doses/NNS of/IN eszopiclone/NN 3/CD mg/NN and/CC lorazepam/NN 2/CD mg/NN did/VBD not/RB have/VB clinically/RB relevant/JJ effects/NNS on/IN the/DT pharmacodynamics/NNS or/CC pharmacokinetics/NNS of/IN either/DT drug/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Lorazepam) (NN Coadministration)) (PP (IN of) (NP (NP (JJ single) (NNS doses)) (PP (IN of) (NP (NP (NN eszopiclone) (CD 3) (NN mg)) (CC and) (NP (NN lorazepam) (CD 2) (NN mg))))))) (VP (VBD did) (RB not) (VP (VB have) (NP (ADJP (RB clinically) (JJ relevant)) (NNS effects)) (PP (IN on) (NP (NP (DT the) (NP (NNS pharmacodynamics)) (CC or) (NP (NNS pharmacokinetics))) (PP (IN of) (NP (DT either) (NN drug)))))))) (. .))))

nn(Coadministration-2, Lorazepam-1)
nsubj(have-16, Coadministration-2)
amod(doses-5, single-4)
prep_of(Coadministration-2, doses-5)
nn(mg-9, eszopiclone-7)
num(mg-9, 3-8)
prep_of(doses-5, mg-9)
nn(mg-13, lorazepam-11)
num(mg-13, 2-12)
conj_and(mg-9, mg-13)
aux(have-16, did-14)
neg(have-16, not-15)
root(ROOT-0, have-16)
advmod(relevant-18, clinically-17)
amod(effects-19, relevant-18)
dobj(have-16, effects-19)
dep(pharmacodynamics-22, the-21)
prep_on(have-16, pharmacodynamics-22)
conj_or(pharmacodynamics-22, pharmacokinetics-24)
det(drug-27, either-26)
prep_of(pharmacodynamics-22, drug-27)

Olanzapine/NN Coadministration/NN of/IN eszopiclone/NN 3/CD mg/NN and/CC olanzapine/NN 10/CD mg/NN produced/VBD a/DT decrease/NN in/IN DSST/NN scores/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Olanzapine) (NN Coadministration)) (PP (IN of) (NP (NP (NN eszopiclone) (CD 3) (NN mg)) (CC and) (NP (NN olanzapine) (CD 10) (NN mg))))) (VP (VBD produced) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NN DSST) (NNS scores)))))) (. .))))

nn(Coadministration-2, Olanzapine-1)
nsubj(produced-11, Coadministration-2)
nn(mg-6, eszopiclone-4)
num(mg-6, 3-5)
prep_of(Coadministration-2, mg-6)
nn(mg-10, olanzapine-8)
num(mg-10, 10-9)
conj_and(mg-6, mg-10)
root(ROOT-0, produced-11)
det(decrease-13, a-12)
dobj(produced-11, decrease-13)
nn(scores-16, DSST-15)
prep_in(decrease-13, scores-16)

there/EX was/VBD no/DT alteration/NN in/IN the/DT pharmacokinetics/NNS of/IN either/DT drug/NN ./.

(ROOT (S1 (S (S (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN alteration)) (PP (IN in) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (DT either) (NN drug)))))))) (. .))))

expl(was-2, there-1)
root(ROOT-0, was-2)
det(alteration-4, no-3)
nsubj(was-2, alteration-4)
det(pharmacokinetics-7, the-6)
prep_in(alteration-4, pharmacokinetics-7)
det(drug-10, either-9)
prep_of(pharmacokinetics-7, drug-10)

Drugs/NNS That/WDT Inhibit/VBP CYP3A4/NN (/-LRB- Ketoconazole/NN )/-RRB- CYP3A4/NN is/VBZ a/DT major/JJ metabolic/JJ pathway/NN for/IN elimination/NN of/IN eszopiclone/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT That)) (S (VP (VBP Inhibit) (NP (NN CYP3A4) (-LRB- -LRB-) (NN Ketoconazole) (-RRB- -RRB-) (NN CYP3A4)))))) (VP (VBZ is) (NP (NP (DT a) (JJ major) (JJ metabolic) (NN pathway)) (PP (IN for) (NP (NP (NN elimination)) (PP (IN of) (NP (NN eszopiclone)))))))) (. .))))

nsubj(Inhibit-3, Drugs-1)
nsubj(pathway-13, Drugs-1)
rcmod(Drugs-1, Inhibit-3)
nn(CYP3A4-8, CYP3A4-4)
nn(CYP3A4-8, Ketoconazole-6)
dobj(Inhibit-3, CYP3A4-8)
cop(pathway-13, is-9)
det(pathway-13, a-10)
amod(pathway-13, major-11)
amod(pathway-13, metabolic-12)
root(ROOT-0, pathway-13)
prep_for(pathway-13, elimination-15)
prep_of(elimination-15, eszopiclone-17)

The/DT AUC/NN of/IN eszopiclone/NN was/VBD increased/VBN 2.2-fold/RB by/IN coadministration/NN of/IN ketoconazole/NN ,/, a/DT potent/JJ inhibitor/NN of/IN CYP3A4/NN ,/, 400/CD mg/NN daily/JJ for/IN 5/CD days/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN AUC)) (PP (IN of) (NP (NN eszopiclone)))) (VP (VBD was) (VP (VBN increased) (ADVP (RB 2.2-fold)) (PP (IN by) (NP (NP (NP (NN coadministration)) (PP (IN of) (NP (NN ketoconazole)))) (, ,) (NP (NP (NP (DT a) (JJ potent) (NN inhibitor)) (PP (IN of) (NP (NN CYP3A4)))) (, ,) (NP (NP (CD 400) (NN mg)) (ADJP (JJ daily) (PP (IN for) (NP (CD 5) (NNS days))))))))))) (. .))))

det(AUC-2, The-1)
nsubjpass(increased-6, AUC-2)
prep_of(AUC-2, eszopiclone-4)
auxpass(increased-6, was-5)
root(ROOT-0, increased-6)
advmod(increased-6, 2.2-fold-7)
agent(increased-6, coadministration-9)
prep_of(coadministration-9, ketoconazole-11)
det(inhibitor-15, a-13)
amod(inhibitor-15, potent-14)
appos(coadministration-9, inhibitor-15)
prep_of(inhibitor-15, CYP3A4-17)
num(mg-20, 400-19)
appos(inhibitor-15, mg-20)
amod(mg-20, daily-21)
num(days-24, 5-23)
prep_for(daily-21, days-24)

Cmax/NN and/CC t1/NN /2/CD were/VBD increased/VBN 1.4-fold/RB and/CC 1.3-fold/RB ,/, respectively/RB ./.

(ROOT (S1 (S (S (NP (NP (NN Cmax)) (CC and) (NP (NN t1) (CD /2))) (VP (VBD were) (VP (VBN increased) (ADVP (ADVP (RB 1.4-fold)) (CC and) (ADVP (RB 1.3-fold))) (, ,) (ADVP (RB respectively))))) (. .))))

nsubjpass(increased-6, Cmax-1)
conj_and(Cmax-1, t1-3)
num(t1-3, /2-4)
auxpass(increased-6, were-5)
root(ROOT-0, increased-6)
advmod(increased-6, 1.4-fold-7)
conj_and(1.4-fold-7, 1.3-fold-9)
advmod(increased-6, respectively-11)

Other/JJ strong/JJ inhibitors/NNS of/IN CYP3A4/NN (/-LRB- e.g./FW ,/, itraconazole/NN ,/, clarithromycin/NN ,/, nefazodone/NN ,/, troleandomycin/NN ,/, ritonavir/NN ,/, nelfinavir/NN )/-RRB- would/MD be/VB expected/VBN to/TO behave/VBP similarly/RB ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Other) (JJ strong) (NNS inhibitors)) (PP (IN of) (NP (NN CYP3A4)))) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN itraconazole)) (, ,) (NP (NN clarithromycin)) (, ,) (NP (NN nefazodone)) (, ,) (NP (NN troleandomycin)) (, ,) (NP (NN ritonavir)) (, ,) (NP (NN nelfinavir)))) (-RRB- -RRB-))) (VP (MD would) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VBP behave) (ADVP (RB similarly))))))))) (. .))))

amod(inhibitors-3, Other-1)
amod(inhibitors-3, strong-2)
nsubjpass(expected-23, inhibitors-3)
prep_of(inhibitors-3, CYP3A4-5)
dep(inhibitors-3, e.g.-7)
pobj(e.g.-7, itraconazole-9)
appos(itraconazole-9, clarithromycin-11)
appos(itraconazole-9, nefazodone-13)
appos(itraconazole-9, troleandomycin-15)
appos(itraconazole-9, ritonavir-17)
appos(itraconazole-9, nelfinavir-19)
aux(expected-23, would-21)
auxpass(expected-23, be-22)
root(ROOT-0, expected-23)
aux(behave-25, to-24)
xcomp(expected-23, behave-25)
advmod(behave-25, similarly-26)

Drugs/NNS That/WDT Induce/VBP CYP3A4/NN (/-LRB- Rifampicin/NN )/-RRB- Racemic/JJ zopiclone/NN exposure/NN was/VBD decreased/VBN 80/CD %/NN by/IN concomitant/JJ useof/NN rifampicin/NN ,/, a/DT potent/JJ inducer/NN of/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT That)) (S (VP (VBP Induce) (NP (ADJP (NN CYP3A4) (-LRB- -LRB-) (NN Rifampicin) (-RRB- -RRB-) (JJ Racemic)) (NN zopiclone) (NN exposure)))))) (VP (VBD was) (VP (VBN decreased) (NP (CD 80) (NN %)) (PP (IN by) (NP (NP (JJ concomitant) (NN useof) (NN rifampicin)) (, ,) (NP (NP (DT a) (JJ potent) (NN inducer)) (PP (IN of) (NP (NN CYP3A4))))))))) (. .))))

nsubj(Induce-3, Drugs-1)
nsubjpass(decreased-12, Drugs-1)
rcmod(Drugs-1, Induce-3)
dep(Racemic-8, CYP3A4-4)
dep(Racemic-8, Rifampicin-6)
amod(exposure-10, Racemic-8)
nn(exposure-10, zopiclone-9)
dobj(Induce-3, exposure-10)
auxpass(decreased-12, was-11)
root(ROOT-0, decreased-12)
num(%-14, 80-13)
dobj(decreased-12, %-14)
amod(rifampicin-18, concomitant-16)
nn(rifampicin-18, useof-17)
agent(decreased-12, rifampicin-18)
det(inducer-22, a-20)
amod(inducer-22, potent-21)
appos(rifampicin-18, inducer-22)
prep_of(inducer-22, CYP3A4-24)

A/DT similar/JJ effect/NN would/MD be/VB expected/VBN with/IN eszopiclone/NN ./.

(ROOT (S1 (S (S (NP (DT A) (JJ similar) (NN effect)) (VP (MD would) (VP (VB be) (VP (VBN expected) (PP (IN with) (NP (NN eszopiclone))))))) (. .))))

det(effect-3, A-1)
amod(effect-3, similar-2)
nsubjpass(expected-6, effect-3)
aux(expected-6, would-4)
auxpass(expected-6, be-5)
root(ROOT-0, expected-6)
prep_with(expected-6, eszopiclone-8)

Drugs/NNS Highly/RB Bound/VBN To/TO Plasma/NN Protein/NN Eszopiclone/NN is/VBZ not/RB highly/RB bound/VBN to/TO plasma/NN proteins/NNS (/-LRB- 52-59/CD %/NN bound/VBD )/-RRB- ;/: ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (VP (ADVP (RB Highly)) (VBN Bound) (PP (TO To) (NP (NN Plasma) (NN Protein) (NN Eszopiclone))))) (VP (VBZ is) (RB not) (ADVP (RB highly)) (VP (VBN bound) (PP (TO to) (NP (NN plasma) (NNS proteins))) (PRN (-LRB- -LRB-) (NP (NP (CD 52-59) (NN %)) (VP (VBD bound))) (-RRB- -RRB-)))) (: ;)) (. .))))

nsubjpass(bound-11, Drugs-1)
advmod(Bound-3, Highly-2)
partmod(Drugs-1, Bound-3)
nn(Eszopiclone-7, Plasma-5)
nn(Eszopiclone-7, Protein-6)
prep_to(Bound-3, Eszopiclone-7)
auxpass(bound-11, is-8)
neg(bound-11, not-9)
advmod(bound-11, highly-10)
root(ROOT-0, bound-11)
nn(proteins-14, plasma-13)
prep_to(bound-11, proteins-14)
num(%-17, 52-59-16)
dep(bound-11, %-17)
partmod(%-17, bound-18)

therefore/RB ,/, the/DT disposition/NN of/IN eszopiclone/NN is/VBZ not/RB expected/VBN to/TO be/VB sensitive/JJ to/TO alterations/NNS in/IN protein/NN binding/NN ./.

(ROOT (S1 (S (S (ADVP (RB therefore)) (, ,) (NP (NP (DT the) (NN disposition)) (PP (IN of) (NP (NN eszopiclone)))) (VP (VBZ is) (RB not) (VP (VBN expected) (S (VP (TO to) (VP (VB be) (ADJP (JJ sensitive) (PP (TO to) (NP (NP (NNS alterations)) (PP (IN in) (NP (NN protein) (NN binding)))))))))))) (. .))))

advmod(expected-9, therefore-1)
det(disposition-4, the-3)
nsubjpass(expected-9, disposition-4)
xsubj(sensitive-12, disposition-4)
prep_of(disposition-4, eszopiclone-6)
auxpass(expected-9, is-7)
neg(expected-9, not-8)
root(ROOT-0, expected-9)
aux(sensitive-12, to-10)
cop(sensitive-12, be-11)
xcomp(expected-9, sensitive-12)
prep_to(sensitive-12, alterations-14)
nn(binding-17, protein-16)
prep_in(alterations-14, binding-17)

Administration/NN of/IN eszopiclone/NN 3/CD mg/NN to/TO a/DT patient/NN taking/VBG another/DT drug/NN that/WDT is/VBZ highly/RB protein/NN -bound/JJ would/MD not/RB be/VB expected/VBN to/TO cause/VB an/DT alteration/NN in/IN the/DT free/JJ concentration/NN of/IN either/DT drug/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN eszopiclone) (CD 3) (NN mg))) (PP (TO to) (NP (NP (DT a) (NN patient)) (VP (VBG taking) (NP (NP (DT another) (NN drug)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADJP (RB highly) (NN protein) (JJ -bound)))))))))) (VP (MD would) (RB not) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB cause) (NP (NP (DT an) (NN alteration)) (PP (IN in) (NP (NP (DT the) (JJ free) (NN concentration)) (PP (IN of) (NP (DT either) (NN drug))))))))))))) (. .))))

nsubjpass(expected-20, Administration-1)
nn(mg-5, eszopiclone-3)
num(mg-5, 3-4)
prep_of(Administration-1, mg-5)
det(patient-8, a-7)
prep_to(Administration-1, patient-8)
partmod(patient-8, taking-9)
det(drug-11, another-10)
dobj(taking-9, drug-11)
nsubj(-bound-16, drug-11)
cop(-bound-16, is-13)
advmod(-bound-16, highly-14)
dep(-bound-16, protein-15)
rcmod(drug-11, -bound-16)
aux(expected-20, would-17)
neg(expected-20, not-18)
auxpass(expected-20, be-19)
root(ROOT-0, expected-20)
aux(cause-22, to-21)
xcomp(expected-20, cause-22)
det(alteration-24, an-23)
dobj(cause-22, alteration-24)
det(concentration-28, the-26)
amod(concentration-28, free-27)
prep_in(alteration-24, concentration-28)
det(drug-31, either-30)
prep_of(concentration-28, drug-31)

Drugs/NNS With/IN A/DT Narrow/JJ Therapeutic/JJ Index/NN Digoxin/NN :/: A/DT single/JJ dose/NN of/IN eszopiclone/NN 3/CD mg/NN did/VBD not/RB affect/VB the/DT pharmacokinetics/NNS of/IN digoxin/NN measured/VBN at/IN steady/JJ state/NN following/VBG dosing/NN of/IN 0.5/CD mg/NN twice/RB daily/JJ for/IN one/CD day/NN and/CC 0.25/CD mg/NN daily/JJ for/IN the/DT next/JJ 6/CD days/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (PP (IN With) (NP (NP (DT A) (JJ Narrow) (JJ Therapeutic) (NN Index) (NN Digoxin)) (: :) (NP (NP (DT A) (JJ single) (NN dose)) (PP (IN of) (NP (NN eszopiclone) (CD 3) (NN mg))))))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN digoxin)) (VP (VBN measured) (PP (IN at) (NP (JJ steady) (NN state))) (PP (VBG following) (NP (NP (NN dosing)) (PP (IN of) (NP (NP (NP (CD 0.5) (NN mg)) (ADJP (RB twice) (JJ daily) (PP (IN for) (NP (CD one) (NN day))))) (CC and) (NP (NP (CD 0.25) (NN mg)) (ADJP (JJ daily) (PP (IN for) (NP (DT the) (JJ next) (CD 6) (NNS days)))))))))))))))) (. .))))

nsubj(affect-18, Drugs-1)
det(Digoxin-7, A-3)
amod(Digoxin-7, Narrow-4)
amod(Digoxin-7, Therapeutic-5)
nn(Digoxin-7, Index-6)
prep_with(Drugs-1, Digoxin-7)
det(dose-11, A-9)
amod(dose-11, single-10)
dep(Digoxin-7, dose-11)
nn(mg-15, eszopiclone-13)
num(mg-15, 3-14)
prep_of(dose-11, mg-15)
aux(affect-18, did-16)
neg(affect-18, not-17)
root(ROOT-0, affect-18)
det(pharmacokinetics-20, the-19)
dobj(affect-18, pharmacokinetics-20)
prep_of(pharmacokinetics-20, digoxin-22)
partmod(digoxin-22, measured-23)
amod(state-26, steady-25)
prep_at(measured-23, state-26)
prep_following(measured-23, dosing-28)
num(mg-31, 0.5-30)
prep_of(dosing-28, mg-31)
advmod(daily-33, twice-32)
amod(mg-31, daily-33)
num(day-36, one-35)
prep_for(daily-33, day-36)
num(mg-39, 0.25-38)
conj_and(mg-31, mg-39)
amod(mg-39, daily-40)
det(days-45, the-42)
amod(days-45, next-43)
num(days-45, 6-44)
prep_for(daily-40, days-45)

Warfarin/NN Eszopiclone/NN 3/CD mg/NN administered/VBN daily/RB for/IN 5/CD days/NNS did/VBD not/RB affect/VB the/DT pharmacokinetics/NNS of/IN (/-LRB- R/NN )/-RRB- -/: or/CC (/-LRB- S/NN )/-RRB- -/: warfarin/NN ,/, nor/CC were/VBD there/RB any/DT changes/NNS in/IN the/DT pharmacodynamic/JJ profile/NN (/-LRB- prothrombin/NN time/NN )/-RRB- following/VBG a/DT single/JJ 25/CD mg/NN oral/JJ dose/NN of/IN warfarin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Warfarin) (NN Eszopiclone) (CD 3) (NN mg)) (VP (VBN administered) (ADVP (RB daily)) (PP (IN for) (NP (CD 5) (NNS days))))) (VP (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (-LRB- -LRB-) (NN R) (-RRB- -RRB-) (: -)) (CC or) (NP (-LRB- -LRB-) (NN S) (-RRB- -RRB-) (: -)) (NP (NN warfarin))))))) (, ,) (CC nor) (VP (VBD were) (ADVP (RB there)) (NP (NP (DT any) (NNS changes)) (PP (IN in) (NP (NP (DT the) (JJ pharmacodynamic) (NN profile)) (PRN (-LRB- -LRB-) (NP (NN prothrombin) (NN time)) (-RRB- -RRB-)))) (PP (VBG following) (NP (NP (DT a) (JJ single) (CD 25) (NN mg) (JJ oral) (NN dose)) (PP (IN of) (NP (NN warfarin))))))))) (. .))))

nn(mg-4, Warfarin-1)
nn(mg-4, Eszopiclone-2)
num(mg-4, 3-3)
nsubj(affect-12, mg-4)
partmod(mg-4, administered-5)
advmod(administered-5, daily-6)
num(days-9, 5-8)
prep_for(administered-5, days-9)
aux(affect-12, did-10)
neg(affect-12, not-11)
root(ROOT-0, affect-12)
det(pharmacokinetics-14, the-13)
dobj(affect-12, pharmacokinetics-14)
prep_of(pharmacokinetics-14, R-17)
conj_or(R-17, S-22)
dep(R-17, warfarin-25)
cop(changes-31, were-28)
advmod(changes-31, there-29)
det(changes-31, any-30)
conj_nor(affect-12, changes-31)
det(profile-35, the-33)
amod(profile-35, pharmacodynamic-34)
prep_in(changes-31, profile-35)
nn(time-38, prothrombin-37)
appos(profile-35, time-38)
det(dose-46, a-41)
amod(dose-46, single-42)
num(dose-46, 25-43)
nn(dose-46, mg-44)
amod(dose-46, oral-45)
prep_following(changes-31, dose-46)
prep_of(dose-46, warfarin-48)

Lithium/NN generally/RB should/MD not/RB be/VB given/VBN with/IN diuretics/NN because/IN they/PRP reduce/VBP its/PRP$ renal/JJ clearance/NN and/CC add/VBP a/DT high/JJ risk/NN of/IN lithium/NN toxicity/NN ./.

(ROOT (S1 (S (S (NP (NN Lithium)) (ADVP (RB generally)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN given) (PP (IN with) (NP (NN diuretics))) (SBAR (IN because) (S (NP (PRP they)) (VP (VP (VBP reduce) (NP (PRP$ its) (JJ renal) (NN clearance))) (CC and) (VP (VBP add) (NP (NP (DT a) (JJ high) (NN risk)) (PP (IN of) (NP (NN lithium) (NN toxicity)))))))))))) (. .))))

nsubjpass(given-6, Lithium-1)
advmod(given-6, generally-2)
aux(given-6, should-3)
neg(given-6, not-4)
auxpass(given-6, be-5)
root(ROOT-0, given-6)
prep_with(given-6, diuretics-8)
mark(reduce-11, because-9)
nsubj(reduce-11, they-10)
advcl(given-6, reduce-11)
poss(clearance-14, its-12)
amod(clearance-14, renal-13)
dobj(reduce-11, clearance-14)
conj_and(reduce-11, add-16)
det(risk-19, a-17)
amod(risk-19, high-18)
dobj(add-16, risk-19)
nn(toxicity-22, lithium-21)
prep_of(risk-19, toxicity-22)

Read/VBN circulars/VBZ for/IN lithium/NN preparation/NN s/NNS before/IN use/NN of/IN such/JJ concomitant/JJ therapy/NN ./.

(ROOT (S1 (S (S (NP (VBN Read)) (VP (VBZ circulars) (PP (IN for) (NP (NP (NN lithium) (NN preparation) (NNS s)) (PP (IN before) (NP (NP (NN use)) (PP (IN of) (NP (JJ such) (JJ concomitant) (NN therapy))))))))) (. .))))

nsubj(circulars-2, Read-1)
root(ROOT-0, circulars-2)
nn(s-6, lithium-4)
nn(s-6, preparation-5)
prep_for(circulars-2, s-6)
prep_before(s-6, use-8)
amod(therapy-12, such-10)
amod(therapy-12, concomitant-11)
prep_of(use-8, therapy-12)

EDECRIN/NN may/MD increase/VB the/DT ototoxic/JJ potential/NN of/IN other/JJ drugs/NNS such/JJ as/IN aminoglycoside/NN and/CC some/DT cephalosporin/JJ antibiotics/NNS ./.

(ROOT (S1 (S (S (NP (NN EDECRIN)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (JJ ototoxic) (NN potential)) (PP (IN of) (NP (NP (JJ other) (NNS drugs)) (PP (JJ such) (IN as) (NP (NP (NN aminoglycoside)) (CC and) (NP (DT some) (JJ cephalosporin) (NNS antibiotics)))))))))) (. .))))

nsubj(increase-3, EDECRIN-1)
aux(increase-3, may-2)
root(ROOT-0, increase-3)
det(potential-6, the-4)
amod(potential-6, ototoxic-5)
dobj(increase-3, potential-6)
amod(drugs-9, other-8)
prep_of(potential-6, drugs-9)
prep_such_as(drugs-9, aminoglycoside-12)
det(antibiotics-16, some-14)
amod(antibiotics-16, cephalosporin-15)
conj_and(aminoglycoside-12, antibiotics-16)

A/DT number/NN of/IN drugs/NNS ,/, including/VBG ethacrynic/JJ acid/NN ,/, have/VBP been/VBN shown/VBN to/TO displace/VB warfarin/NN from/IN plasma/NN protein/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (DT A) (NN number)) (PP (IN of) (NP (NP (NNS drugs)) (, ,) (PP (VBG including) (NP (JJ ethacrynic) (NN acid))) (, ,)))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB displace) (NP (NN warfarin)) (PP (IN from) (NP (NN plasma) (NN protein))))))))) (: ;)) (. .))))

det(number-2, A-1)
nsubjpass(shown-12, number-2)
xsubj(displace-14, number-2)
prep_of(number-2, drugs-4)
amod(acid-8, ethacrynic-7)
prep_including(drugs-4, acid-8)
aux(shown-12, have-10)
auxpass(shown-12, been-11)
root(ROOT-0, shown-12)
aux(displace-14, to-13)
xcomp(shown-12, displace-14)
dobj(displace-14, warfarin-15)
nn(protein-18, plasma-17)
prep_from(displace-14, protein-18)

a/DT reduction/NN in/IN the/DT usual/JJ anticoagulant/NN dosage/NN may/MD be/VB required/VBN in/IN patients/NNS receiving/VBG both/DT drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (DT the) (JJ usual) (NN anticoagulant) (NN dosage)))) (VP (MD may) (VP (VB be) (VP (VBN required) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (DT both) (NNS drugs))))))))) (. .))))

det(reduction-2, a-1)
nsubjpass(required-10, reduction-2)
det(dosage-7, the-4)
amod(dosage-7, usual-5)
nn(dosage-7, anticoagulant-6)
prep_in(reduction-2, dosage-7)
aux(required-10, may-8)
auxpass(required-10, be-9)
root(ROOT-0, required-10)
prep_in(required-10, patients-12)
partmod(patients-12, receiving-13)
det(drugs-15, both-14)
dobj(receiving-13, drugs-15)

In/IN some/DT patients/NNS ,/, the/DT administration/NN of/IN a/DT non-/JJ steroidal/JJ antiinflammatory/JJ agent/NN can/MD reduce/VB the/DT diuretic/JJ ,/, natriuretic/JJ ,/, and/CC antihypertensive/JJ effects/NNS of/IN loop/NN ,/, potassium/NN -/CC sparing/NN and/CC thiazide/NN diuretics/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT some) (NNS patients))) (, ,) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (DT a) (JJ non-) (JJ steroidal) (JJ antiinflammatory) (NN agent)))) (VP (MD can) (VP (VB reduce) (NP (NP (DT the) (ADJP (ADJP (JJ diuretic)) (, ,) (ADJP (JJ natriuretic)) (, ,) (CC and) (ADJP (JJ antihypertensive))) (NNS effects)) (PP (IN of) (NP (NP (NP (NN loop)) (, ,) (NP (NN potassium)) (CC -) (NP (NN sparing))) (CC and) (NP (NN thiazide) (NNS diuretics)))))))) (. .))))

det(patients-3, some-2)
prep_in(reduce-14, patients-3)
det(administration-6, the-5)
nsubj(reduce-14, administration-6)
det(agent-12, a-8)
amod(agent-12, non--9)
amod(agent-12, steroidal-10)
amod(agent-12, antiinflammatory-11)
prep_of(administration-6, agent-12)
aux(reduce-14, can-13)
root(ROOT-0, reduce-14)
det(effects-22, the-15)
amod(effects-22, diuretic-16)
conj_and(diuretic-16, natriuretic-18)
conj_and(diuretic-16, antihypertensive-21)
dobj(reduce-14, effects-22)
prep_of(effects-22, loop-24)
conj_and(loop-24, potassium-26)
conj_and(loop-24, sparing-28)
nn(diuretics-31, thiazide-30)
conj_and(loop-24, diuretics-31)

Therefore/RB ,/, when/WRB EDECRIN/JJ and/CC non-/JJ steroidal/JJ anti-/NN inflammatory/JJ agents/NNS are/VBP used/VBN concomitantly/RB ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB to/TO determine/VB if/IN the/DT desired/JJ effect/NN of/IN the/DT diuretic/NN is/VBZ obtained/VBN ./.

(ROOT (S1 (S (ADVP (RB Therefore)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (ADJP (ADJP (JJ EDECRIN)) (CC and) (ADJP (JJ non-))) (JJ steroidal) (NN anti-) (JJ inflammatory) (NNS agents)) (VP (VBP are) (VP (VBN used) (ADVP (RB concomitantly)))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (NP (DT the) (JJ desired) (NN effect)) (PP (IN of) (NP (DT the) (NN diuretic)))) (VP (VBZ is) (VP (VBN obtained))))))))))) (. .))))

advmod(observed-19, Therefore-1)
advmod(used-12, when-3)
amod(agents-10, EDECRIN-4)
conj_and(EDECRIN-4, non--6)
amod(agents-10, steroidal-7)
nn(agents-10, anti--8)
amod(agents-10, inflammatory-9)
nsubjpass(used-12, agents-10)
auxpass(used-12, are-11)
advcl(observed-19, used-12)
advmod(used-12, concomitantly-13)
det(patient-16, the-15)
nsubjpass(observed-19, patient-16)
aux(observed-19, should-17)
auxpass(observed-19, be-18)
root(ROOT-0, observed-19)
advmod(observed-19, closely-20)
aux(determine-22, to-21)
xcomp(observed-19, determine-22)
mark(obtained-31, if-23)
det(effect-26, the-24)
amod(effect-26, desired-25)
nsubjpass(obtained-31, effect-26)
det(diuretic-29, the-28)
prep_of(effect-26, diuretic-29)
auxpass(obtained-31, is-30)
advcl(determine-22, obtained-31)

The/DT results/NNS of/IN a/DT study/NN of/IN coadministration/NN of/IN ethambutol/NN (/-LRB- 50/CD mg/kg/NN )/-RRB- with/IN an/DT aluminum/NN hydroxide/NN containing/VBG antacid/JJ to/TO 13/CD patients/NNS with/IN tuberculosis/NN showed/VBD a/DT reduction/NN of/IN mean/JJ serum/NN concentrations/NNS and/CC urinary/JJ excretion/NN of/IN ethambutol/NN of/IN approximately/RB 20/CD %/NN and/CC 13/CD %/NN ,/, respectively/RB ,/, suggesting/VBG that/IN the/DT oral/JJ absorption/NN of/IN ethambutol/NN may/MD be/VB reduced/VBN by/IN these/DT antacid/JJ products/NNS ./.

(ROOT (S1 (S (NP (NP (DT The) (NNS results)) (PP (IN of) (NP (NP (DT a) (NN study)) (PP (IN of) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NN ethambutol)) (PRN (-LRB- -LRB-) (NP (CD 50) (NN mg/kg)) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (DT an) (NN aluminum) (NN hydroxide)) (VP (VBG containing) (PP (JJ antacid) (TO to) (NP (NP (CD 13) (NNS patients)) (PP (IN with) (NP (NN tuberculosis))))))))))))) (VP (VBD showed) (NP (NP (DT a) (NN reduction)) (PP (IN of) (NP (NP (JJ mean) (NN serum) (NNS concentrations)) (CC and) (NP (NP (JJ urinary) (NN excretion)) (PP (IN of) (NP (NP (NN ethambutol)) (PP (IN of) (NP (NP (QP (RB approximately) (CD 20)) (NN %)) (CC and) (NP (CD 13) (NN %)) (, ,) (ADVP (RB respectively)))))))))) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (NP (DT the) (JJ oral) (NN absorption)) (PP (IN of) (NP (NN ethambutol)))) (VP (MD may) (VP (VB be) (VP (VBN reduced) (PP (IN by) (NP (DT these) (JJ antacid) (NNS products))))))))))) (. .))))

det(results-2, The-1)
nsubj(showed-25, results-2)
det(study-5, a-4)
prep_of(results-2, study-5)
prep_of(study-5, coadministration-7)
prep_of(coadministration-7, ethambutol-9)
num(mg/kg-12, 50-11)
appos(ethambutol-9, mg/kg-12)
det(hydroxide-17, an-15)
nn(hydroxide-17, aluminum-16)
prep_with(coadministration-7, hydroxide-17)
partmod(hydroxide-17, containing-18)
dep(containing-18, antacid-19)
num(patients-22, 13-21)
prep_to(containing-18, patients-22)
prep_with(patients-22, tuberculosis-24)
root(ROOT-0, showed-25)
det(reduction-27, a-26)
dobj(showed-25, reduction-27)
amod(concentrations-31, mean-29)
nn(concentrations-31, serum-30)
prep_of(reduction-27, concentrations-31)
amod(excretion-34, urinary-33)
conj_and(concentrations-31, excretion-34)
prep_of(excretion-34, ethambutol-36)
quantmod(20-39, approximately-38)
num(%-40, 20-39)
prep_of(ethambutol-36, %-40)
num(%-43, 13-42)
conj_and(%-40, %-43)
advmod(%-40, respectively-45)
conj_and(%-40, respectively-45)
partmod(showed-25, suggesting-47)
xcomp(showed-25, suggesting-47)
complm(reduced-56, that-48)
det(absorption-51, the-49)
amod(absorption-51, oral-50)
nsubjpass(reduced-56, absorption-51)
prep_of(absorption-51, ethambutol-53)
aux(reduced-56, may-54)
auxpass(reduced-56, be-55)
ccomp(suggesting-47, reduced-56)
det(products-60, these-58)
amod(products-60, antacid-59)
agent(reduced-56, products-60)

It/PRP is/VBZ recommended/VBN to/TO avoid/VB concurrent/JJ administration/NN of/IN ethambutol/NN with/IN aluminum/NN hydroxide/NN containing/VBG antacids/NNS for/IN at/IN least/JJS 4/CD hours/NNS following/VBG ethambutol/NN administration/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (S (VP (TO to) (VP (VB avoid) (NP (NP (JJ concurrent) (NN administration)) (PP (IN of) (NP (NN ethambutol))) (PP (IN with) (NP (NP (NN aluminum) (NN hydroxide)) (VP (VBG containing) (NP (NP (NNS antacids)) (PP (IN for) (NP (NP (QP (IN at) (JJS least) (CD 4)) (NNS hours)) (PP (VBG following) (NP (NN ethambutol) (NN administration)))))))))))))))) (. .))))

nsubjpass(recommended-3, It-1)
xsubj(avoid-5, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
aux(avoid-5, to-4)
xcomp(recommended-3, avoid-5)
amod(administration-7, concurrent-6)
dobj(avoid-5, administration-7)
prep_of(administration-7, ethambutol-9)
nn(hydroxide-12, aluminum-11)
prep_with(administration-7, hydroxide-12)
partmod(hydroxide-12, containing-13)
dobj(containing-13, antacids-14)
quantmod(4-18, at-16)
mwe(at-16, least-17)
pobj(at-16, least-17)
num(hours-19, 4-18)
prep_for(antacids-14, hours-19)
nn(administration-22, ethambutol-21)
prep_following(hours-19, administration-22)

May/MD interact/VB with/IN addictive/JJ medications/NNS ,/, especially/RB central/JJ nervous/JJ system/NN (/-LRB- CNS/NN )/-RRB- depressants/NNS with/IN habituating/JJ potential/NN (/-LRB- prolonged/JJ concurrent/JJ use/NN may/MD increase/VB the/DT risk/NN of/IN habituation/NN )/-RRB- ,/, alcohol/NN or/CC CNS/NN depression/NN @/NN producing/NN medications/NNS (/-LRB- concurrent/JJ use/NN may/MD increase/VB the/DT CNS/NN depressant/NN effects/NNS of/IN either/CC these/DT medications/NNS or/CC ethinamate/NN )/-RRB- ./.

(ROOT (S1 (S (S (VP (MD May) (VP (VB interact) (PP (IN with) (NP (NP (JJ addictive) (NNS medications)) (, ,) (NP (NP (ADVP (RB especially)) (NP (NP (JJ central) (JJ nervous) (NN system)) (PRN (-LRB- -LRB-) (NP (NN CNS)) (-RRB- -RRB-))) (NNS depressants)) (PP (IN with) (NP (NP (NP (JJ habituating) (NN potential)) (PRN (-LRB- -LRB-) (S (NP (JJ prolonged) (JJ concurrent) (NN use)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN habituation))))))) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NN alcohol)) (CC or) (NP (NN CNS) (NN depression)) (NP (NN @) (NN producing) (NNS medications))) (PRN (-LRB- -LRB-) (S (NP (JJ concurrent) (NN use)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN CNS) (NN depressant) (NNS effects)) (PP (IN of) (NP (CC either) (DT these) (NP (NNS medications)) (CC or) (NP (NN ethinamate)))))))) (-RRB- -RRB-))))))))))) (. .))))

aux(interact-2, May-1)
root(ROOT-0, interact-2)
amod(medications-5, addictive-4)
prep_with(interact-2, medications-5)
advmod(depressants-14, especially-7)
amod(system-10, central-8)
amod(system-10, nervous-9)
nn(depressants-14, system-10)
abbrev(system-10, CNS-12)
appos(medications-5, depressants-14)
amod(potential-17, habituating-16)
prep_with(depressants-14, potential-17)
amod(use-21, prolonged-19)
amod(use-21, concurrent-20)
nsubj(increase-23, use-21)
aux(increase-23, may-22)
dep(potential-17, increase-23)
det(risk-25, the-24)
dobj(increase-23, risk-25)
prep_of(risk-25, habituation-27)
appos(potential-17, alcohol-30)
nn(depression-33, CNS-32)
conj_or(alcohol-30, depression-33)
nn(medications-36, @-34)
nn(medications-36, producing-35)
dep(alcohol-30, medications-36)
amod(use-39, concurrent-38)
nsubj(increase-41, use-39)
aux(increase-41, may-40)
dep(alcohol-30, increase-41)
det(effects-45, the-42)
nn(effects-45, CNS-43)
nn(effects-45, depressant-44)
dobj(increase-41, effects-45)
preconj(medications-49, either-47)
dep(medications-49, these-48)
prep_of(effects-45, medications-49)
conj_or(medications-49, ethinamate-51)

Trecator/NN has/VBZ been/VBN found/VBN to/TO temporarily/RB raise/VBP serum/NN concentrations/NNS of/IN isoniazid/NN ./.

(ROOT (S1 (S (S (NP (NN Trecator)) (VP (VBZ has) (VP (VBN been) (VP (VBN found) (S (VP (TO to) (ADVP (RB temporarily)) (VP (VBP raise) (NP (NP (NN serum) (NNS concentrations)) (PP (IN of) (NP (NN isoniazid))))))))))) (. .))))

nsubjpass(found-4, Trecator-1)
xsubj(raise-7, Trecator-1)
aux(found-4, has-2)
auxpass(found-4, been-3)
root(ROOT-0, found-4)
aux(raise-7, to-5)
advmod(raise-7, temporarily-6)
xcomp(found-4, raise-7)
nn(concentrations-9, serum-8)
dobj(raise-7, concentrations-9)
prep_of(concentrations-9, isoniazid-11)

Trecator/NN may/MD potentiate/VB the/DT adverse/JJ effects/NNS of/IN other/JJ antituberculous/JJ drugs/NNS administered/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NN Trecator)) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (JJ adverse) (NNS effects)) (PP (IN of) (NP (NP (JJ other) (JJ antituberculous) (NNS drugs)) (VP (VBN administered) (ADVP (RB concomitantly))))))))) (. .))))

nsubj(potentiate-3, Trecator-1)
aux(potentiate-3, may-2)
root(ROOT-0, potentiate-3)
det(effects-6, the-4)
amod(effects-6, adverse-5)
dobj(potentiate-3, effects-6)
amod(drugs-10, other-8)
amod(drugs-10, antituberculous-9)
prep_of(effects-6, drugs-10)
partmod(drugs-10, administered-11)
advmod(administered-11, concomitantly-12)

In/IN particular/JJ ,/, convulsions/NNS have/VBP been/VBN reported/VBN when/WRB ethionamide/NN is/VBZ administered/VBN with/IN cycloserine/NN and/CC special/JJ care/NN should/MD be/VB taken/VBN when/WRB the/DT treatment/NN regimen/NN includes/VBZ both/DT of/IN these/DT drugs/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ particular))) (, ,) (NP (NNS convulsions)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (SBAR (WHADVP (WRB when)) (S (S (NP (NN ethionamide)) (VP (VBZ is) (VP (VBN administered) (PP (IN with) (NP (NN cycloserine)))))) (CC and) (S (NP (JJ special) (NN care)) (VP (MD should) (VP (VB be) (VP (VBN taken) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN treatment) (NN regimen)) (VP (VBZ includes) (NP (NP (DT both)) (PP (IN of) (NP (DT these) (NNS drugs))))))))))))))))) (. .))))

prep_in(reported-7, particular-2)
nsubjpass(reported-7, convulsions-4)
aux(reported-7, have-5)
auxpass(reported-7, been-6)
root(ROOT-0, reported-7)
advmod(administered-11, when-8)
nsubjpass(administered-11, ethionamide-9)
auxpass(administered-11, is-10)
advcl(reported-7, administered-11)
prep_with(administered-11, cycloserine-13)
amod(care-16, special-15)
nsubjpass(taken-19, care-16)
aux(taken-19, should-17)
auxpass(taken-19, be-18)
conj_and(administered-11, taken-19)
advmod(includes-24, when-20)
det(regimen-23, the-21)
nn(regimen-23, treatment-22)
nsubj(includes-24, regimen-23)
advcl(taken-19, includes-24)
dobj(includes-24, both-25)
det(drugs-28, these-27)
prep_of(both-25, drugs-28)

Excessive/JJ ethanol/NN ingestion/NN should/MD be/VB avoided/VBN because/IN a/DT psychotic/JJ reaction/NN has/VBZ been/VBN reported/VBN ./.

(ROOT (S1 (S (S (NP (JJ Excessive) (NN ethanol) (NN ingestion)) (VP (MD should) (VP (VB be) (VP (VBN avoided) (SBAR (IN because) (S (NP (DT a) (JJ psychotic) (NN reaction)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported)))))))))) (. .))))

amod(ingestion-3, Excessive-1)
nn(ingestion-3, ethanol-2)
nsubjpass(avoided-6, ingestion-3)
aux(avoided-6, should-4)
auxpass(avoided-6, be-5)
root(ROOT-0, avoided-6)
mark(reported-13, because-7)
det(reaction-10, a-8)
amod(reaction-10, psychotic-9)
nsubjpass(reported-13, reaction-10)
aux(reported-13, has-11)
auxpass(reported-13, been-12)
advcl(avoided-6, reported-13)

Ethopropazine/NN may/MD interact/VB with/IN alcohol/NN or/CC other/JJ CNS/NN depressants/NNS ,/, causing/VBG increased/VBN sedative/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NN Ethopropazine)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NP (NN alcohol)) (CC or) (NP (JJ other) (NN CNS) (NNS depressants)))) (, ,) (S (VP (VBG causing) (NP (VBN increased) (JJ sedative) (NNS effects))))))) (. .))))

nsubj(interact-3, Ethopropazine-1)
aux(interact-3, may-2)
root(ROOT-0, interact-3)
prep_with(interact-3, alcohol-5)
amod(depressants-9, other-7)
nn(depressants-9, CNS-8)
conj_or(alcohol-5, depressants-9)
xcomp(interact-3, causing-11)
amod(effects-14, increased-12)
amod(effects-14, sedative-13)
dobj(causing-11, effects-14)

It/PRP may/MD also/RB interact/VB with/IN amantadine/NN or/CC other/JJ anticholinergic/JJ drugs/NNS or/CC MAOIs/NN ,/, which/WDT may/MD intensify/VB the/DT anticholinergic/JJ action/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (MD may) (ADVP (RB also)) (VP (VB interact) (PP (IN with) (NP (NP (NP (NN amantadine)) (CC or) (NP (NP (JJ other) (JJ anticholinergic) (NNS drugs)) (CC or) (NP (NN MAOIs)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB intensify) (NP (DT the) (JJ anticholinergic) (NN action))))))))))) (. .))))

nsubj(interact-4, It-1)
aux(interact-4, may-2)
advmod(interact-4, also-3)
root(ROOT-0, interact-4)
prep_with(interact-4, amantadine-6)
nsubj(intensify-16, amantadine-6)
amod(drugs-10, other-8)
amod(drugs-10, anticholinergic-9)
conj_or(amantadine-6, drugs-10)
conj_or(drugs-10, MAOIs-12)
aux(intensify-16, may-15)
rcmod(amantadine-6, intensify-16)
det(action-19, the-17)
amod(action-19, anticholinergic-18)
dobj(intensify-16, action-19)

Ethopropazine/NN can/MD interact/VB with/IN chlorpromazine/NN ,/, increasing/VBG the/DT metabolism/NN of/IN chlorpromazine/NN ./.

(ROOT (S1 (S (S (NP (NN Ethopropazine)) (VP (MD can) (VP (VB interact) (PP (IN with) (NP (NN chlorpromazine))) (, ,) (S (VP (VBG increasing) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN chlorpromazine))))))))) (. .))))

nsubj(interact-3, Ethopropazine-1)
aux(interact-3, can-2)
root(ROOT-0, interact-3)
prep_with(interact-3, chlorpromazine-5)
xcomp(interact-3, increasing-7)
det(metabolism-9, the-8)
dobj(increasing-7, metabolism-9)
prep_of(metabolism-9, chlorpromazine-11)

Since/IN Zarontin/NN (/-LRB- ethosuximide/NN )/-RRB- may/MD interact/VB with/IN concurrently/RB administered/VBN antiepileptic/JJ drugs/NNS ,/, periodic/JJ serum/NN level/NN determinations/NNS of/IN these/DT drugs/NNS may/MD be/VB necessary/JJ (/-LRB- eg/NN ,/, ethosuximide/NN may/MD elevate/VBP phenytoin/NN serum/NN levels/NNS and/CC valproic/JJ acid/NN has/VBZ been/VBN reported/VBN to/TO both/CC increase/NN and/CC decrease/NN ethosuximide/NN levels/NNS )./RB

(ROOT (S1 (S (SBAR (IN Since) (S (NP (NP (NN Zarontin)) (PRN (-LRB- -LRB-) (NP (NN ethosuximide)) (-RRB- -RRB-))) (VP (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NP (ADJP (RB concurrently) (VBN administered)) (JJ antiepileptic) (NNS drugs)) (, ,) (S (NP (NP (JJ periodic) (NN serum) (NN level) (NNS determinations)) (PP (IN of) (NP (DT these) (NNS drugs)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary))))))))) (-LRB- -LRB-) (NP (NN eg))))) (, ,) (S (S (NP (NN ethosuximide)) (VP (MD may) (VP (VBP elevate) (NP (NN phenytoin) (NN serum) (NNS levels))))) (CC and) (S (NP (JJ valproic) (NN acid)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (TO to) (NP (CC both) (NP (NN increase)) (CC and) (NP (NN decrease)) (NP (NN ethosuximide) (NNS levels)))) (ADVP (RB -RRB-.))))))))))

mark(interact-7, Since-1)
nsubj(interact-7, Zarontin-2)
appos(Zarontin-2, ethosuximide-4)
aux(interact-7, may-6)
advcl(elevate-29, interact-7)
advmod(administered-10, concurrently-9)
amod(drugs-12, administered-10)
amod(drugs-12, antiepileptic-11)
prep_with(interact-7, drugs-12)
amod(determinations-17, periodic-14)
nn(determinations-17, serum-15)
nn(determinations-17, level-16)
nsubj(necessary-23, determinations-17)
det(drugs-20, these-19)
prep_of(determinations-17, drugs-20)
aux(necessary-23, may-21)
cop(necessary-23, be-22)
dep(drugs-12, necessary-23)
dobj(interact-7, eg-25)
nsubj(elevate-29, ethosuximide-27)
aux(elevate-29, may-28)
root(ROOT-0, elevate-29)
nn(levels-32, phenytoin-30)
nn(levels-32, serum-31)
dobj(elevate-29, levels-32)
amod(acid-35, valproic-34)
nsubjpass(reported-38, acid-35)
aux(reported-38, has-36)
auxpass(reported-38, been-37)
conj_and(elevate-29, reported-38)
preconj(increase-41, both-40)
prep_to(reported-38, increase-41)
conj_and(increase-41, decrease-43)
nn(levels-45, ethosuximide-44)
dep(increase-41, levels-45)
advmod(reported-38, -RRB-.-46)

PEGANONE/NN used/VBN in/IN combination/NN with/IN other/JJ drugs/NNS known/VBN to/TO adversely/RB affect/VB the/DT hematopoietic/JJ system/NN should/MD be/VB avoided/VBN if/IN possible/JJ ./.

(ROOT (S1 (S (S (NP (NP (NN PEGANONE)) (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (VP (VBN known) (S (VP (TO to) (ADVP (RB adversely)) (VP (VB affect) (NP (DT the) (JJ hematopoietic) (NN system)))))))))))) (VP (MD should) (VP (VB be) (VP (VBN avoided) (SBAR (IN if) (FRAG (JJ possible))))))) (. .))))

nsubjpass(avoided-17, PEGANONE-1)
partmod(PEGANONE-1, used-2)
prep_in(used-2, combination-4)
amod(drugs-7, other-6)
prep_with(combination-4, drugs-7)
xsubj(affect-11, drugs-7)
partmod(drugs-7, known-8)
aux(affect-11, to-9)
advmod(affect-11, adversely-10)
xcomp(known-8, affect-11)
det(system-14, the-12)
amod(system-14, hematopoietic-13)
dobj(affect-11, system-14)
aux(avoided-17, should-15)
auxpass(avoided-17, be-16)
root(ROOT-0, avoided-17)
mark(possible-19, if-18)
advcl(avoided-17, possible-19)

Considerable/JJ caution/NN should/MD be/VB exercised/VBN if/IN PEGANONE/NN is/VBZ administered/VBN concurrently/RB with/IN Phenurone/NN (/-LRB- phenacemide/NN )/-RRB- since/IN paranoid/JJ symptoms/NNS have/VBP been/VBN reported/VBN during/IN therapy/NN with/IN this/DT combination/NN ./.

(ROOT (S1 (S (S (NP (JJ Considerable) (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (IN if) (S (NP (NN PEGANONE)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concurrently)) (PP (IN with) (NP (NP (NN Phenurone)) (PRN (-LRB- -LRB-) (NP (NN phenacemide)) (-RRB- -RRB-)))) (SBAR (IN since) (S (NP (JJ paranoid) (NNS symptoms)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN during) (NP (NP (NN therapy)) (PP (IN with) (NP (DT this) (NN combination)))))))))))))))))) (. .))))

amod(caution-2, Considerable-1)
nsubjpass(exercised-5, caution-2)
aux(exercised-5, should-3)
auxpass(exercised-5, be-4)
root(ROOT-0, exercised-5)
mark(administered-9, if-6)
nsubjpass(administered-9, PEGANONE-7)
auxpass(administered-9, is-8)
advcl(exercised-5, administered-9)
advmod(administered-9, concurrently-10)
prep_with(administered-9, Phenurone-12)
appos(Phenurone-12, phenacemide-14)
mark(reported-21, since-16)
amod(symptoms-18, paranoid-17)
nsubjpass(reported-21, symptoms-18)
aux(reported-21, have-19)
auxpass(reported-21, been-20)
advcl(administered-9, reported-21)
prep_during(reported-21, therapy-23)
det(combination-26, this-25)
prep_with(therapy-23, combination-26)

A/DT two-way/JJ interaction/NN between/IN the/DT hydantoin/NN antiepileptic/JJ ,/, phenytoin/NN ,/, and/CC the/DT coumarin/NN anticoagulant/NN s/NNS has/VBZ been/VBN suggested/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT A) (JJ two-way) (NN interaction)) (PP (IN between) (NP (NP (DT the) (NN hydantoin) (JJ antiepileptic)) (, ,) (NP (NN phenytoin)) (, ,) (CC and) (NP (DT the) (NN coumarin) (NN anticoagulant) (NNS s))))) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested))))) (. .))))

det(interaction-3, A-1)
amod(interaction-3, two-way-2)
nsubjpass(suggested-18, interaction-3)
det(hydantoin-6, the-5)
prep_between(interaction-3, hydantoin-6)
amod(hydantoin-6, antiepileptic-7)
conj_and(hydantoin-6, phenytoin-9)
det(s-15, the-12)
nn(s-15, coumarin-13)
nn(s-15, anticoagulant-14)
conj_and(hydantoin-6, s-15)
aux(suggested-18, has-16)
auxpass(suggested-18, been-17)
root(ROOT-0, suggested-18)

Presumably/RB ,/, phenytoin/NN acts/VBZ as/IN a/DT stimulator/NN of/IN coumarin/NN metabolism/NN and/CC has/VBZ been/VBN reported/VBN to/TO cause/VB decreased/VBN serum/NN levels/NNS of/IN the/DT coumarin/NN anticoagulant/NN s/NNS and/CC increased/VBN prothrombin/NN -proconvertin/NN concentrations/NNS ./.

(ROOT (S1 (S (ADVP (RB Presumably)) (, ,) (NP (NN phenytoin)) (VP (VP (VBZ acts) (PP (IN as) (NP (NP (DT a) (NN stimulator)) (PP (IN of) (NP (NN coumarin) (NN metabolism)))))) (CC and) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB cause) (NP (NP (VBN decreased) (NN serum) (NNS levels)) (PP (IN of) (NP (NP (DT the) (NN coumarin) (NN anticoagulant) (NNS s)) (CC and) (NP (VBN increased) (NN prothrombin) (NN -proconvertin) (NNS concentrations)))))))))))) (. .))))

advmod(acts-4, Presumably-1)
nsubj(acts-4, phenytoin-3)
xsubj(cause-16, phenytoin-3)
root(ROOT-0, acts-4)
det(stimulator-7, a-6)
prep_as(acts-4, stimulator-7)
nn(metabolism-10, coumarin-9)
prep_of(stimulator-7, metabolism-10)
aux(reported-14, has-12)
auxpass(reported-14, been-13)
conj_and(acts-4, reported-14)
aux(cause-16, to-15)
xcomp(reported-14, cause-16)
amod(levels-19, decreased-17)
nn(levels-19, serum-18)
dobj(cause-16, levels-19)
det(s-24, the-21)
nn(s-24, coumarin-22)
nn(s-24, anticoagulant-23)
prep_of(levels-19, s-24)
amod(concentrations-29, increased-26)
nn(concentrations-29, prothrombin-27)
nn(concentrations-29, -proconvertin-28)
conj_and(s-24, concentrations-29)

Conversely/RB ,/, the/DT coumarin/NN anticoagulant/NN s/NNS have/VBP been/VBN reported/VBN to/TO increase/VB the/DT serum/NN levels/NNS and/CC prolong/VB the/DT serum/NN half-life/NN of/IN phenytoin/NN by/IN inhibiting/VBG its/PRP$ metabolism/NN ./.

(ROOT (S1 (S (S (ADVP (RB Conversely)) (, ,) (NP (DT the) (NN coumarin) (NN anticoagulant) (NNS s)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VP (VB increase) (NP (DT the) (NN serum) (NNS levels))) (CC and) (VP (VB prolong) (NP (NP (DT the) (NN serum) (NN half-life)) (PP (IN of) (NP (NN phenytoin)))) (PP (IN by) (S (VP (VBG inhibiting) (NP (PRP$ its) (NN metabolism))))))))))))) (. .))))

advmod(reported-9, Conversely-1)
det(s-6, the-3)
nn(s-6, coumarin-4)
nn(s-6, anticoagulant-5)
nsubjpass(reported-9, s-6)
xsubj(increase-11, s-6)
aux(reported-9, have-7)
auxpass(reported-9, been-8)
root(ROOT-0, reported-9)
aux(increase-11, to-10)
xcomp(reported-9, increase-11)
det(levels-14, the-12)
nn(levels-14, serum-13)
dobj(increase-11, levels-14)
conj_and(increase-11, prolong-16)
det(half-life-19, the-17)
nn(half-life-19, serum-18)
dobj(prolong-16, half-life-19)
prep_of(half-life-19, phenytoin-21)
prepc_by(prolong-16, inhibiting-23)
poss(metabolism-25, its-24)
dobj(inhibiting-23, metabolism-25)

Although/IN there/EX is/VBZ no/DT documentation/NN of/IN such/JJ ,/, a/DT similar/JJ interaction/NN between/IN ethotoin/NN and/CC the/DT coumarin/NN anticoagulant/NN s/NNS may/MD occur/VB ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT no) (NN documentation)) (PP (IN of) (NP (JJ such))))))) (, ,) (NP (NP (DT a) (JJ similar) (NN interaction)) (PP (IN between) (NP (NP (NP (NN ethotoin)) (CC and) (NP (DT the) (NN coumarin) (NN anticoagulant))) (NNS s)))) (VP (MD may) (VP (VB occur)))) (. .))))

mark(is-3, Although-1)
expl(is-3, there-2)
advcl(occur-20, is-3)
det(documentation-5, no-4)
nsubj(is-3, documentation-5)
prep_of(documentation-5, such-7)
det(interaction-11, a-9)
amod(interaction-11, similar-10)
nsubj(occur-20, interaction-11)
nn(s-18, ethotoin-13)
det(anticoagulant-17, the-15)
nn(anticoagulant-17, coumarin-16)
conj_and(ethotoin-13, anticoagulant-17)
prep_between(interaction-11, s-18)
aux(occur-20, may-19)
root(ROOT-0, occur-20)

Caution/NN is/VBZ therefore/RB advised/VBN when/WRB administering/VBG PEGANONE/NN to/TO patients/NNS receiving/VBG coumarin/NN anticoagulant/NN s/NNS ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (VBZ is) (ADVP (RB therefore)) (VP (VBN advised) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (NN PEGANONE)) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN coumarin) (NN anticoagulant) (NNS s))))))))))) (. .))))

nsubjpass(advised-4, Caution-1)
auxpass(advised-4, is-2)
advmod(advised-4, therefore-3)
root(ROOT-0, advised-4)
advmod(administering-6, when-5)
advcl(advised-4, administering-6)
dobj(administering-6, PEGANONE-7)
prep_to(administering-6, patients-9)
partmod(patients-9, receiving-10)
nn(s-13, coumarin-11)
nn(s-13, anticoagulant-12)
dobj(receiving-10, s-13)

Ethoxzolamide/NN may/MD increase/VBP the/DT action/NN of/IN tricyclics/NNS ,/, amphetamines/NN ,/, procainamide/NN ,/, and/CC quinidine/NN ./.

(ROOT (S1 (S (S (NP (NN Ethoxzolamide)) (VP (MD may) (VP (VBP increase) (NP (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NNS tricyclics)))) (, ,) (NP (NN amphetamines)) (, ,) (NP (NN procainamide)) (, ,) (CC and) (NP (NN quinidine)))))) (. .))))

nsubj(increase-3, Ethoxzolamide-1)
aux(increase-3, may-2)
root(ROOT-0, increase-3)
det(action-5, the-4)
dobj(increase-3, action-5)
prep_of(action-5, tricyclics-7)
conj_and(action-5, amphetamines-9)
conj_and(action-5, procainamide-11)
conj_and(action-5, quinidine-14)

It/PRP may/MD increase/VB excretion/NN of/IN barbiturates/NNS ,/, lithium/NN ,/, and/CC ASA/NN and/CC may/MD also/RB increase/VB the/DT toxicity/NN of/IN salicylates/NNS ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VP (MD may) (VP (VB increase) (NP (NP (NP (NN excretion)) (PP (IN of) (NP (NNS barbiturates)))) (, ,) (NP (NN lithium)) (, ,) (CC and) (NP (NN ASA))))) (CC and) (VP (MD may) (ADVP (RB also)) (VP (VB increase) (NP (NP (DT the) (NN toxicity)) (PP (IN of) (NP (NNS salicylates)))))))) (. .))))

nsubj(increase-3, It-1)
aux(increase-3, may-2)
root(ROOT-0, increase-3)
dobj(increase-3, excretion-4)
prep_of(excretion-4, barbiturates-6)
conj_and(excretion-4, lithium-8)
conj_and(excretion-4, ASA-11)
aux(increase-15, may-13)
advmod(increase-15, also-14)
conj_and(increase-3, increase-15)
det(toxicity-17, the-16)
dobj(increase-15, toxicity-17)
prep_of(toxicity-17, salicylates-19)

Coadministration/NN of/IN ethoxzolamide/NN with/IN other/JJ diuretics/NNS ,/, amphotericin/NN B/NN ,/, and/CC corticosteroids/NNS may/MD cause/VB hypokalemia/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN ethoxzolamide))) (PP (IN with) (NP (NP (JJ other) (NNS diuretics)) (, ,) (NP (NN amphotericin) (NN B)) (, ,) (CC and) (NP (NNS corticosteroids))))) (VP (MD may) (VP (VB cause) (NP (NN hypokalemia))))) (. .))))

nsubj(cause-14, Coadministration-1)
prep_of(Coadministration-1, ethoxzolamide-3)
amod(diuretics-6, other-5)
prep_with(Coadministration-1, diuretics-6)
nn(B-9, amphotericin-8)
conj_and(diuretics-6, B-9)
conj_and(diuretics-6, corticosteroids-12)
aux(cause-14, may-13)
root(ROOT-0, cause-14)
dobj(cause-14, hypokalemia-15)

There/EX have/VBP been/VBN isolated/VBN reports/NNS of/IN patients/NNS experiencing/VBG increases/NNS in/IN their/PRP$ prothrombin/NN times/NNS when/WRB etidronate/NN was/VBD added/VBN to/TO warfarin/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (VBN isolated) (NNS reports)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBG experiencing) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (PRP$ their) (NN prothrombin) (NNS times)) (SBAR (WHADVP (WRB when)) (S (NP (NN etidronate)) (VP (VBD was) (VP (VBN added) (PP (TO to) (NP (NN warfarin) (NN therapy))))))))))))))))) (. .))))

expl(reports-5, There-1)
aux(reports-5, have-2)
cop(reports-5, been-3)
amod(reports-5, isolated-4)
root(ROOT-0, reports-5)
prep_of(reports-5, patients-7)
partmod(patients-7, experiencing-8)
dobj(experiencing-8, increases-9)
poss(times-13, their-11)
nn(times-13, prothrombin-12)
prep_in(increases-9, times-13)
tmod(added-17, times-13)
advmod(added-17, when-14)
nsubjpass(added-17, etidronate-15)
auxpass(added-17, was-16)
dep(times-13, added-17)
nn(therapy-20, warfarin-19)
prep_to(added-17, therapy-20)

Although/IN the/DT relevance/NN of/IN these/DT reports/NNS and/CC any/DT mechanism/NN of/IN coagulation/NN alterations/NNS is/VBZ unclear/JJ ,/, patients/NNS on/IN warfarin/NN should/MD have/VB their/PRP$ prothrombin/NN time/NN monitored/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NP (NP (DT the) (NN relevance)) (PP (IN of) (NP (DT these) (NNS reports)))) (CC and) (NP (NP (DT any) (NN mechanism)) (PP (IN of) (NP (NN coagulation) (NNS alterations))))) (VP (VBZ is) (ADJP (JJ unclear))))) (, ,) (NP (NP (NNS patients)) (PP (IN on) (NP (NN warfarin)))) (VP (MD should) (VP (VB have) (NP (NP (PRP$ their) (NN prothrombin) (NN time)) (VP (VBN monitored)))))) (. .))))

mark(unclear-14, Although-1)
det(relevance-3, the-2)
nsubj(unclear-14, relevance-3)
det(reports-6, these-5)
prep_of(relevance-3, reports-6)
det(mechanism-9, any-8)
conj_and(relevance-3, mechanism-9)
nn(alterations-12, coagulation-11)
prep_of(mechanism-9, alterations-12)
cop(unclear-14, is-13)
advcl(have-20, unclear-14)
nsubj(have-20, patients-16)
prep_on(patients-16, warfarin-18)
aux(have-20, should-19)
root(ROOT-0, have-20)
poss(time-23, their-21)
nn(time-23, prothrombin-22)
dobj(have-20, time-23)
partmod(time-23, monitored-24)

ACE-inhibitors/NN Reports/NNS suggest/VBP that/IN NSAIDs/NNS may/MD diminish/VB the/DT antihypertensive/JJ effect/NN of/IN ACE-inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (NN ACE-inhibitors) (NNS Reports)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS NSAIDs)) (VP (MD may) (VP (VB diminish) (NP (NP (DT the) (JJ antihypertensive) (NN effect)) (PP (IN of) (NP (NNS ACE-inhibitors)))))))))) (. .))))

nn(Reports-2, ACE-inhibitors-1)
nsubj(suggest-3, Reports-2)
root(ROOT-0, suggest-3)
complm(diminish-7, that-4)
nsubj(diminish-7, NSAIDs-5)
aux(diminish-7, may-6)
ccomp(suggest-3, diminish-7)
det(effect-10, the-8)
amod(effect-10, antihypertensive-9)
dobj(diminish-7, effect-10)
prep_of(effect-10, ACE-inhibitors-12)

This/DT interaction/NN should/MD be/VB given/VBN consideration/NN in/IN patients/NNS taking/VBG NSAIDs/NN concomitantly/RB with/IN ACE-inhibitors/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN interaction)) (VP (MD should) (VP (VB be) (VP (VBN given) (NP (NP (NN consideration)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN NSAIDs)))))) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN ACE-inhibitors))))))) (. .))))

det(interaction-2, This-1)
nsubjpass(given-5, interaction-2)
aux(given-5, should-3)
auxpass(given-5, be-4)
root(ROOT-0, given-5)
dobj(given-5, consideration-6)
prep_in(consideration-6, patients-8)
partmod(patients-8, taking-9)
dobj(taking-9, NSAIDs-10)
advmod(given-5, concomitantly-11)
prep_with(given-5, ACE-inhibitors-13)

Antacids/NNS :/: The/DT concomitant/JJ administration/NN of/IN antacids/NNS has/VBZ no/DT apparent/JJ effect/NN on/IN the/DT extent/NN of/IN absorption/NN of/IN Lodine/NN ./.

(ROOT (S1 (S (NP (NP (NNS Antacids)) (: :) (S (NP (NP (DT The) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NNS antacids)))) (VP (VBZ has) (NP (DT no) (JJ apparent) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NP (NN absorption)) (PP (IN of) (NP (NN Lodine))))))))) (. .)))))

root(ROOT-0, Antacids-1)
det(administration-5, The-3)
amod(administration-5, concomitant-4)
nsubj(has-8, administration-5)
prep_of(administration-5, antacids-7)
dep(Antacids-1, has-8)
det(effect-11, no-9)
amod(effect-11, apparent-10)
dobj(has-8, effect-11)
det(extent-14, the-13)
prep_on(has-8, extent-14)
prep_of(extent-14, absorption-16)
prep_of(absorption-16, Lodine-18)

However/RB ,/, antacids/NNS can/MD decrease/VB the/DT peak/JJ concentration/NN reached/VBN by/IN 15/CD %/NN to/TO 20/CD %/NN but/CC have/VB no/DT detectable/JJ effect/NN on/IN the/DT time-to-peak/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NNS antacids)) (VP (MD can) (VP (VP (VB decrease) (NP (NP (DT the) (JJ peak) (NN concentration)) (VP (VBN reached) (PP (IN by) (NP (QP (CD 15) (NN %) (TO to) (CD 20)) (NN %)))))) (CC but) (VP (VB have) (NP (DT no) (JJ detectable) (NN effect)) (PP (IN on) (NP (DT the) (NN time-to-peak))))))) (. .))))

advmod(decrease-5, However-1)
nsubj(decrease-5, antacids-3)
aux(decrease-5, can-4)
root(ROOT-0, decrease-5)
det(concentration-8, the-6)
amod(concentration-8, peak-7)
dobj(decrease-5, concentration-8)
partmod(concentration-8, reached-9)
number(%-12, 15-11)
num(%-15, %-12)
dep(%-12, to-13)
number(%-12, 20-14)
agent(reached-9, %-15)
conj_but(decrease-5, have-17)
det(effect-20, no-18)
amod(effect-20, detectable-19)
dobj(have-17, effect-20)
det(time-to-peak-23, the-22)
prep_on(have-17, time-to-peak-23)

Aspirin/NN When/WRB Lodine/NN is/VBZ administered/VBN with/IN aspirin/NN ,/, its/PRP$ protein/NN binding/NN is/VBZ reduced/VBN ,/, although/IN the/DT clearance/NN of/IN free/JJ etodolac/NN is/VBZ not/RB altered/VBN ./.

(ROOT (S1 (S (S (NP (NN Aspirin)) (SBAR (WHADVP (WRB When)) (S (NP (NN Lodine)) (VP (VBZ is) (VP (VBN administered) (PP (IN with) (NP (NN aspirin))))))) (, ,) (NP (PRP$ its) (NN protein) (NN binding)) (VP (VBZ is) (VP (VBN reduced)) (, ,) (SBAR (IN although) (S (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (JJ free) (NN etodolac)))) (VP (VBZ is) (RB not) (VP (VBN altered))))))) (. .))))

nsubjpass(reduced-13, Aspirin-1)
advmod(administered-5, When-2)
nsubjpass(administered-5, Lodine-3)
auxpass(administered-5, is-4)
advcl(reduced-13, administered-5)
prep_with(administered-5, aspirin-7)
poss(binding-11, its-9)
nn(binding-11, protein-10)
nsubjpass(reduced-13, binding-11)
auxpass(reduced-13, is-12)
root(ROOT-0, reduced-13)
mark(altered-23, although-15)
det(clearance-17, the-16)
nsubjpass(altered-23, clearance-17)
amod(etodolac-20, free-19)
prep_of(clearance-17, etodolac-20)
auxpass(altered-23, is-21)
neg(altered-23, not-22)
advcl(reduced-13, altered-23)

however/RB ,/, as/IN with/IN other/JJ NSAIDs/NNS ,/, concomitant/JJ administration/NN of/IN Lodine/NN and/CC aspirin/NN is/VBZ not/RB generally/RB recommended/VBN because/IN of/IN the/DT potential/NN of/IN increased/VBN adverse/JJ effects/NNS ./.

(ROOT (S1 (S (S (ADVP (RB however)) (, ,) (PP (IN as) (PP (IN with) (NP (JJ other) (NNS NSAIDs)))) (, ,) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN Lodine)) (CC and) (NP (NN aspirin))))) (VP (VBZ is) (RB not) (ADVP (RB generally)) (VP (VBN recommended) (PP (IN because) (IN of) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (VBN increased) (JJ adverse) (NNS effects)))))))) (. .))))

advmod(recommended-17, however-1)
prep(recommended-17, as-3)
pcomp(as-3, with-4)
amod(NSAIDs-6, other-5)
prep_with(as-3, NSAIDs-6)
amod(administration-9, concomitant-8)
nsubjpass(recommended-17, administration-9)
prep_of(administration-9, Lodine-11)
conj_and(Lodine-11, aspirin-13)
auxpass(recommended-17, is-14)
neg(recommended-17, not-15)
advmod(recommended-17, generally-16)
root(ROOT-0, recommended-17)
det(potential-21, the-20)
prep_because_of(recommended-17, potential-21)
amod(effects-25, increased-23)
amod(effects-25, adverse-24)
prep_of(potential-21, effects-25)

Cyclosporine/NN ,/, Digoxin/NN ,/, Methotrexate/NN Lodine/NN ,/, like/IN other/JJ NSAIDs/NNS ,/, through/IN effects/NNS on/IN renal/JJ prostaglandins/NNS ,/, may/MD cause/VB changes/NNS in/IN the/DT elimination/NN of/IN these/DT drugs/NNS leading/VBG to/TO elevated/JJ serum/NN levels/NNS of/IN cyclosporine/NN ,/, digoxin/NN ,/, methotrexate/NN ,/, and/CC increased/VBN toxicity/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Cyclosporine)) (, ,) (NP (NN Digoxin)) (, ,) (NP (NN Methotrexate) (NN Lodine)) (, ,)) (PP (IN like) (NP (JJ other) (NNS NSAIDs)))) (, ,) (PP (IN through) (NP (NP (NNS effects)) (PP (IN on) (NP (JJ renal) (NNS prostaglandins))))) (, ,) (VP (MD may) (VP (VB cause) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN elimination)) (PP (IN of) (NP (DT these) (NNS drugs))))))) (S (VP (VBG leading) (PP (TO to) (NP (NP (JJ elevated) (NN serum) (NNS levels)) (PP (IN of) (NP (NP (NN cyclosporine)) (, ,) (NP (NN digoxin)) (, ,) (NP (NN methotrexate)) (, ,) (CC and) (NP (VBN increased) (NN toxicity)))))))))) (. .))))

nsubj(cause-19, Cyclosporine-1)
appos(Cyclosporine-1, Digoxin-3)
nn(Lodine-6, Methotrexate-5)
appos(Cyclosporine-1, Lodine-6)
amod(NSAIDs-10, other-9)
prep_like(Cyclosporine-1, NSAIDs-10)
prep_through(cause-19, effects-13)
amod(prostaglandins-16, renal-15)
prep_on(effects-13, prostaglandins-16)
aux(cause-19, may-18)
root(ROOT-0, cause-19)
dobj(cause-19, changes-20)
det(elimination-23, the-22)
prep_in(changes-20, elimination-23)
det(drugs-26, these-25)
prep_of(elimination-23, drugs-26)
xcomp(cause-19, leading-27)
amod(levels-31, elevated-29)
nn(levels-31, serum-30)
prep_to(leading-27, levels-31)
prep_of(levels-31, cyclosporine-33)
conj_and(cyclosporine-33, digoxin-35)
conj_and(cyclosporine-33, methotrexate-37)
amod(toxicity-41, increased-40)
conj_and(cyclosporine-33, toxicity-41)

Nephrotoxicity/NN associated/VBN with/IN cyclosporine/NN may/MD also/RB be/VB enhanced/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Nephrotoxicity)) (VP (VBN associated) (PP (IN with) (NP (NN cyclosporine))))) (VP (MD may) (ADVP (RB also)) (VP (VB be) (VP (VBN enhanced))))) (. .))))

nsubjpass(enhanced-8, Nephrotoxicity-1)
partmod(Nephrotoxicity-1, associated-2)
prep_with(associated-2, cyclosporine-4)
aux(enhanced-8, may-5)
advmod(enhanced-8, also-6)
auxpass(enhanced-8, be-7)
root(ROOT-0, enhanced-8)

Patients/NNS receiving/VBG these/DT drugs/NNS who/WP are/VBP given/VBN Lodine/NN ,/, or/CC any/DT other/JJ NSAID/NN ,/, and/CC particularly/RB those/DT patients/NNS with/IN altered/JJ renal/JJ function/NN ,/, should/MD be/VB observed/VBN for/IN the/DT development/NN of/IN the/DT specific/JJ toxicities/NNS of/IN these/DT drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (DT these) (NNS drugs)))) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBN given) (NP (NP (NN Lodine)) (, ,) (CC or) (NP (DT any) (JJ other) (NN NSAID)))))))) (, ,) (CONJP (CC and) (RB particularly)) (NP (NP (DT those) (NNS patients)) (PP (IN with) (NP (JJ altered) (JJ renal) (NN function)))) (, ,)) (VP (MD should) (VP (VB be) (VP (VBN observed) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (DT the) (JJ specific) (NNS toxicities)) (PP (IN of) (NP (DT these) (NNS drugs))))))))))) (. .))))

nsubjpass(given-7, Patients-1)
nsubjpass(observed-26, Patients-1)
partmod(Patients-1, receiving-2)
det(drugs-4, these-3)
dobj(receiving-2, drugs-4)
auxpass(given-7, are-6)
rcmod(Patients-1, given-7)
dobj(given-7, Lodine-8)
det(NSAID-13, any-11)
amod(NSAID-13, other-12)
conj_or(Lodine-8, NSAID-13)
det(patients-18, those-17)
conj_particularly(Patients-1, patients-18)
amod(function-22, altered-20)
amod(function-22, renal-21)
prep_with(patients-18, function-22)
aux(observed-26, should-24)
auxpass(observed-26, be-25)
root(ROOT-0, observed-26)
det(development-29, the-28)
prep_for(observed-26, development-29)
det(toxicities-33, the-31)
amod(toxicities-33, specific-32)
prep_of(development-29, toxicities-33)
det(drugs-36, these-35)
prep_of(toxicities-33, drugs-36)

Diuretics/NN Etodolac/NN has/VBZ no/DT apparent/JJ pharmacokinetic/JJ interaction/NN when/WRB administered/VBN with/IN furosemide/NN or/CC hydrochlorothiazide/NN ./.

(ROOT (S1 (S (S (NP (NN Diuretics) (NN Etodolac)) (VP (VBZ has) (NP (DT no) (JJ apparent) (JJ pharmacokinetic) (NN interaction)) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN with) (NP (NP (NN furosemide)) (CC or) (NP (NN hydrochlorothiazide))))))))) (. .))))

nn(Etodolac-2, Diuretics-1)
nsubj(has-3, Etodolac-2)
root(ROOT-0, has-3)
det(interaction-7, no-4)
amod(interaction-7, apparent-5)
amod(interaction-7, pharmacokinetic-6)
dobj(has-3, interaction-7)
advmod(administered-9, when-8)
advcl(has-3, administered-9)
prep_with(administered-9, furosemide-11)
conj_or(furosemide-11, hydrochlorothiazide-13)

Nevertheless/RB ,/, clinical/JJ studies/NNS ,/, as/RB well/RB as/IN postmarketing/VBG observations/NNS have/VBP shown/VBN that/IN Lodine/NN can/MD reduce/VB the/DT natriuretic/JJ effect/NN of/IN furosemide/NN and/CC thiazides/NNS in/IN some/DT patients/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Nevertheless)) (, ,) (NP (NP (JJ clinical) (NNS studies)) (, ,) (CONJP (RB as) (RB well) (IN as)) (VP (VBG postmarketing) (NP (NNS observations)))) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NN Lodine)) (VP (MD can) (VP (VB reduce) (NP (NP (DT the) (JJ natriuretic) (NN effect)) (PP (IN of) (NP (NP (NN furosemide)) (CC and) (NP (NNS thiazides)))) (PP (IN in) (NP (DT some) (NNS patients))))))))))) (. .))))

advmod(shown-12, Nevertheless-1)
amod(studies-4, clinical-3)
nsubj(shown-12, studies-4)
conj_and(studies-4, postmarketing-9)
partmod(studies-4, postmarketing-9)
dobj(postmarketing-9, observations-10)
aux(shown-12, have-11)
root(ROOT-0, shown-12)
complm(reduce-16, that-13)
nsubj(reduce-16, Lodine-14)
aux(reduce-16, can-15)
ccomp(shown-12, reduce-16)
det(effect-19, the-17)
amod(effect-19, natriuretic-18)
dobj(reduce-16, effect-19)
prep_of(effect-19, furosemide-21)
conj_and(furosemide-21, thiazides-23)
det(patients-26, some-25)
prep_in(effect-19, patients-26)

This/DT response/NN has/VBZ been/VBN attributed/VBN to/TO inhibition/NN of/IN renal/JJ prostaglandin/NN synthesis/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN response)) (VP (VBZ has) (VP (VBN been) (VP (VBN attributed) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ renal) (NN prostaglandin) (NN synthesis))))))))) (. .))))

det(response-2, This-1)
nsubjpass(attributed-5, response-2)
aux(attributed-5, has-3)
auxpass(attributed-5, been-4)
root(ROOT-0, attributed-5)
prep_to(attributed-5, inhibition-7)
amod(synthesis-11, renal-9)
nn(synthesis-11, prostaglandin-10)
prep_of(inhibition-7, synthesis-11)

During/IN concomitant/JJ therapy/NN with/IN NSAIDs/NN ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB for/IN signs/NNS of/IN renal/JJ failure/NN ,/, as/RB well/RB as/IN to/TO assure/VB diuretic/JJ efficacy/NN ./.

(ROOT (S1 (S (S (PP (IN During) (NP (NP (JJ concomitant) (NN therapy)) (PP (IN with) (NP (NN NSAIDs))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (PP (IN for) (NP (NP (NNS signs)) (PP (IN of) (NP (JJ renal) (NN failure))))) (, ,) (S (CONJP (RB as) (RB well) (IN as)) (VP (TO to) (VP (VB assure) (NP (JJ diuretic) (NN efficacy))))))))) (. .))))

amod(therapy-3, concomitant-2)
prep_during(observed-11, therapy-3)
prep_with(therapy-3, NSAIDs-5)
det(patient-8, the-7)
nsubjpass(observed-11, patient-8)
aux(observed-11, should-9)
auxpass(observed-11, be-10)
root(ROOT-0, observed-11)
advmod(observed-11, closely-12)
prep_for(observed-11, signs-14)
amod(failure-17, renal-16)
prep_of(signs-14, failure-17)
cc(assure-23, well-20)
aux(assure-23, to-22)
xcomp(observed-11, assure-23)
amod(efficacy-25, diuretic-24)
dobj(assure-23, efficacy-25)

Glyburide/NN Etodolac/NN has/VBZ no/DT apparent/JJ pharmacokinetic/JJ interaction/NN when/WRB administered/VBN with/IN glyburide/NN ./.

(ROOT (S1 (S (S (NP (NN Glyburide) (NN Etodolac)) (VP (VBZ has) (NP (DT no) (JJ apparent) (JJ pharmacokinetic) (NN interaction)) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN with) (NP (NN glyburide)))))))) (. .))))

nn(Etodolac-2, Glyburide-1)
nsubj(has-3, Etodolac-2)
root(ROOT-0, has-3)
det(interaction-7, no-4)
amod(interaction-7, apparent-5)
amod(interaction-7, pharmacokinetic-6)
dobj(has-3, interaction-7)
advmod(administered-9, when-8)
advcl(has-3, administered-9)
prep_with(administered-9, glyburide-11)

Lithium/NN NSAIDs/NNS have/VBP produced/VBN an/DT elevation/NN of/IN plasma/NN lithium/NN levels/NNS and/CC a/DT reduction/NN in/IN renal/JJ lithium/NN clearance/NN ./.

(ROOT (S1 (S (S (NP (NN Lithium) (NNS NSAIDs)) (VP (VBP have) (VP (VBN produced) (NP (NP (NP (DT an) (NN elevation)) (PP (IN of) (NP (NN plasma) (NN lithium) (NNS levels)))) (CC and) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (JJ renal) (NN lithium) (NN clearance)))))))) (. .))))

nn(NSAIDs-2, Lithium-1)
nsubj(produced-4, NSAIDs-2)
aux(produced-4, have-3)
root(ROOT-0, produced-4)
det(elevation-6, an-5)
dobj(produced-4, elevation-6)
nn(levels-10, plasma-8)
nn(levels-10, lithium-9)
prep_of(elevation-6, levels-10)
det(reduction-13, a-12)
conj_and(elevation-6, reduction-13)
amod(clearance-17, renal-15)
nn(clearance-17, lithium-16)
prep_in(reduction-13, clearance-17)

The/DT mean/JJ minimum/JJ lithium/NN concentration/NN increased/VBD 15/CD %/NN and/CC the/DT renal/JJ clearance/NN was/VBD decreased/VBN by/IN approximately/RB 20/CD %./NN

(ROOT (S1 (S (S (NP (DT The) (JJ mean) (JJ minimum) (NN lithium) (NN concentration)) (VP (VBD increased) (NP (CD 15) (NN %)))) (CC and) (S (NP (DT the) (JJ renal) (NN clearance)) (VP (VBD was) (VP (VBN decreased) (PP (IN by) (NP (QP (RB approximately) (CD 20)) (NN %.)))))))))

det(concentration-5, The-1)
amod(concentration-5, mean-2)
amod(concentration-5, minimum-3)
nn(concentration-5, lithium-4)
nsubj(increased-6, concentration-5)
root(ROOT-0, increased-6)
num(%-8, 15-7)
dobj(increased-6, %-8)
det(clearance-12, the-10)
amod(clearance-12, renal-11)
nsubjpass(decreased-14, clearance-12)
auxpass(decreased-14, was-13)
conj_and(increased-6, decreased-14)
quantmod(20-17, approximately-16)
num(%.-18, 20-17)
agent(decreased-14, %.-18)

These/DT effects/NNS have/VBP been/VBN attributed/VBN to/TO inhibition/NN of/IN renal/JJ prostaglandin/NN synthesis/NN by/IN the/DT NSAID/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS effects)) (VP (VBP have) (VP (VBN been) (VP (VBN attributed) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ renal) (NN prostaglandin) (NN synthesis))) (PP (IN by) (NP (DT the) (NN NSAID))))))))) (. .))))

det(effects-2, These-1)
nsubjpass(attributed-5, effects-2)
aux(attributed-5, have-3)
auxpass(attributed-5, been-4)
root(ROOT-0, attributed-5)
prep_to(attributed-5, inhibition-7)
amod(synthesis-11, renal-9)
nn(synthesis-11, prostaglandin-10)
prep_of(inhibition-7, synthesis-11)
det(NSAID-14, the-13)
prep_by(inhibition-7, NSAID-14)

Thus/RB ,/, when/WRB NSAIDs/NN and/CC lithium/NN are/VBP administered/VBN concurrently/RB ,/, subjects/NNS should/MD be/VB observed/VBN carefully/RB for/IN signs/NNS of/IN lithium/NN toxicity/NN ./.

(ROOT (S1 (S (S (ADVP (RB Thus)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN NSAIDs)) (CC and) (NP (NN lithium))) (VP (VBP are) (VP (VBN administered) (ADVP (RB concurrently)))))) (, ,) (NP (NNS subjects)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB carefully)) (PP (IN for) (NP (NP (NNS signs)) (PP (IN of) (NP (NN lithium) (NN toxicity))))))))) (. .))))

advmod(observed-14, Thus-1)
advmod(administered-8, when-3)
nsubjpass(administered-8, NSAIDs-4)
conj_and(NSAIDs-4, lithium-6)
auxpass(administered-8, are-7)
advcl(observed-14, administered-8)
advmod(administered-8, concurrently-9)
nsubjpass(observed-14, subjects-11)
aux(observed-14, should-12)
auxpass(observed-14, be-13)
root(ROOT-0, observed-14)
advmod(observed-14, carefully-15)
prep_for(observed-14, signs-17)
nn(toxicity-20, lithium-19)
prep_of(signs-17, toxicity-20)

Phenylbutazone/NN Phenylbutazone/NN causes/VBZ increase/NN (/-LRB- by/IN about/RB 80/CD %/NN )/-RRB- in/IN the/DT free/JJ fraction/NN of/IN etodolac/NN ./.

(ROOT (S1 (S (S (NP (NN Phenylbutazone) (NN Phenylbutazone)) (VP (VBZ causes) (NP (NP (NN increase)) (PRN (-LRB- -LRB-) (PP (IN by) (NP (QP (RB about) (CD 80)) (NN %))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (JJ free) (NN fraction)) (PP (IN of) (NP (NN etodolac))))))) (. .))))

nn(Phenylbutazone-2, Phenylbutazone-1)
nsubj(causes-3, Phenylbutazone-2)
root(ROOT-0, causes-3)
dobj(causes-3, increase-4)
dep(increase-4, by-6)
quantmod(80-8, about-7)
num(%-9, 80-8)
pobj(by-6, %-9)
det(fraction-14, the-12)
amod(fraction-14, free-13)
prep_in(causes-3, fraction-14)
prep_of(fraction-14, etodolac-16)

Although/IN in/FW vivo/FW studies/NNS have/VBP not/RB been/VBN done/VBN to/TO see/VB if/IN etodolac/NN clearance/NN is/VBZ changed/VBN by/IN coadministration/NN of/IN phenylbutazone/NN ,/, it/PRP is/VBZ not/RB recommended/VBN that/IN they/PRP be/VB coadministered/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (ADJP (FW in) (FW vivo)) (NNS studies)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN done) (S (VP (TO to) (VP (VB see) (SBAR (IN if) (S (NP (NN etodolac) (NN clearance)) (VP (VBZ is) (VP (VBN changed) (PP (IN by) (NP (NP (NN coadministration)) (PP (IN of) (NP (NN phenylbutazone))))))))))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (RB not) (VP (VBN recommended) (SBAR (IN that) (S (NP (PRP they)) (VP (VB be) (VP (VBN coadministered)))))))) (. .))))

mark(done-8, Although-1)
nn(vivo-3, in-2)
amod(studies-4, vivo-3)
nsubjpass(done-8, studies-4)
xsubj(see-10, studies-4)
aux(done-8, have-5)
neg(done-8, not-6)
auxpass(done-8, been-7)
advcl(recommended-24, done-8)
aux(see-10, to-9)
xcomp(done-8, see-10)
mark(changed-15, if-11)
nn(clearance-13, etodolac-12)
nsubjpass(changed-15, clearance-13)
auxpass(changed-15, is-14)
advcl(see-10, changed-15)
agent(changed-15, coadministration-17)
prep_of(coadministration-17, phenylbutazone-19)
nsubjpass(recommended-24, it-21)
auxpass(recommended-24, is-22)
neg(recommended-24, not-23)
root(ROOT-0, recommended-24)
complm(coadministered-28, that-25)
nsubjpass(coadministered-28, they-26)
auxpass(coadministered-28, be-27)
ccomp(recommended-24, coadministered-28)

Phenytoin/NN Etodolac/NN has/VBZ no/DT apparent/JJ pharmacokinetic/JJ interaction/NN when/WRB administered/VBN with/IN phenytoin/NN ./.

(ROOT (S1 (S (S (NP (NN Phenytoin) (NN Etodolac)) (VP (VBZ has) (NP (DT no) (JJ apparent) (JJ pharmacokinetic) (NN interaction)) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN with) (NP (NN phenytoin)))))))) (. .))))

nn(Etodolac-2, Phenytoin-1)
nsubj(has-3, Etodolac-2)
root(ROOT-0, has-3)
det(interaction-7, no-4)
amod(interaction-7, apparent-5)
amod(interaction-7, pharmacokinetic-6)
dobj(has-3, interaction-7)
advmod(administered-9, when-8)
advcl(has-3, administered-9)
prep_with(administered-9, phenytoin-11)

Warfarin/NN :/: The/DT effects/NNS of/IN warfarin/NN and/CC NSAIDs/NN on/IN GI/JJ bleeding/JJ are/VBP synergistic/JJ ,/, such/JJ that/IN users/NNS of/IN both/DT drugs/NNS together/RB have/VBP a/DT risk/NN of/IN serious/JJ GI/JJ bleeding/JJ higher/JJR than/IN that/DT of/IN users/NNS of/IN either/DT drug/NN alone/RB ./.

(ROOT (S1 (S (NP (NP (NN Warfarin)) (: :) (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NN warfarin)) (CC and) (NP (NN NSAIDs)))) (PP (IN on) (NP (JJ GI) (JJ bleeding)))) (VP (VBP are) (ADJP (JJ synergistic)) (, ,) (SBAR (JJ such) (IN that) (S (NP (NP (NNS users)) (PP (IN of) (NP (DT both) (NNS drugs)))) (ADVP (RB together)) (VP (VBP have) (NP (NP (DT a) (NN risk)) (PP (IN of) (NP (JJ serious) (JJ GI) (JJ bleeding))) (ADJP (ADJP (JJR higher)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NP (NNS users)) (PP (IN of) (NP (NP (DT either) (NN drug)) (ADVP (RB alone))))))))))))))) (. .)))))

root(ROOT-0, Warfarin-1)
det(effects-4, The-3)
nsubj(synergistic-13, effects-4)
prep_of(effects-4, warfarin-6)
conj_and(warfarin-6, NSAIDs-8)
amod(bleeding-11, GI-10)
prep_on(effects-4, bleeding-11)
cop(synergistic-13, are-12)
dep(Warfarin-1, synergistic-13)
dep(have-22, such-15)
dep(have-22, that-16)
nsubj(have-22, users-17)
det(drugs-20, both-19)
prep_of(users-17, drugs-20)
advmod(have-22, together-21)
ccomp(synergistic-13, have-22)
det(risk-24, a-23)
dobj(have-22, risk-24)
amod(bleeding-28, serious-26)
amod(bleeding-28, GI-27)
prep_of(risk-24, bleeding-28)
amod(risk-24, higher-29)
prep_than(higher-29, that-31)
prep_of(that-31, users-33)
det(drug-36, either-35)
prep_of(users-33, drug-36)
advmod(drug-36, alone-37)

Short-term/JJ pharmacokinetic/JJ studies/NNS have/VBP demonstrated/VBN that/IN concomitant/JJ administration/NN of/IN warfarin/NN and/CC Lodine/NN @/NN (/-LRB- etodolac/NN capsules/NNS and/CC tablets/NNS )/-RRB- results/VBZ in/IN reduced/VBN protein/NN binding/NN of/IN warfarin/NN ,/, but/CC there/EX was/VBD no/DT change/NN in/IN the/DT clearance/NN of/IN free/JJ warfarin/NN ./.

(ROOT (S1 (S (S (NP (JJ Short-term) (JJ pharmacokinetic) (NNS studies)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (S (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN warfarin)) (CC and) (NP (NP (NN Lodine) (NN @)) (PRN (-LRB- -LRB-) (NP (NP (NN etodolac) (NNS capsules)) (CC and) (NP (NNS tablets))) (-RRB- -RRB-)))))) (VP (VBZ results) (PP (IN in) (NP (NP (VBN reduced) (NN protein) (NN binding)) (PP (IN of) (NP (NN warfarin))))))) (, ,) (CC but) (S (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN change)) (PP (IN in) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (JJ free) (NN warfarin))))))))))))) (. .))))

amod(studies-3, Short-term-1)
amod(studies-3, pharmacokinetic-2)
nsubj(demonstrated-5, studies-3)
aux(demonstrated-5, have-4)
root(ROOT-0, demonstrated-5)
complm(results-20, that-6)
amod(administration-8, concomitant-7)
nsubj(results-20, administration-8)
prep_of(administration-8, warfarin-10)
nn(@-13, Lodine-12)
conj_and(warfarin-10, @-13)
nn(capsules-16, etodolac-15)
dep(@-13, capsules-16)
conj_and(capsules-16, tablets-18)
ccomp(demonstrated-5, results-20)
amod(binding-24, reduced-22)
nn(binding-24, protein-23)
prep_in(results-20, binding-24)
prep_of(binding-24, warfarin-26)
expl(was-30, there-29)
conj_but(results-20, was-30)
det(change-32, no-31)
nsubj(was-30, change-32)
det(clearance-35, the-34)
prep_in(change-32, clearance-35)
amod(warfarin-38, free-37)
prep_of(clearance-35, warfarin-38)

There/EX was/VBD no/DT significant/JJ difference/NN in/IN the/DT pharmacodynamic/JJ effect/NN of/IN warfarin/NN administered/VBN alone/RB and/CC warfarin/NN administered/VBN with/IN Lodine/NN as/IN measured/VBN by/IN prothrombin/NN time/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBD was) (NP (DT no) (JJ significant) (NN difference)) (PP (IN in) (NP (NP (DT the) (JJ pharmacodynamic) (NN effect)) (PP (IN of) (NP (NP (NP (NP (NN warfarin)) (VP (VBN administered) (ADVP (RB alone)))) (CC and) (NP (NN warfarin))) (VP (VBN administered) (PP (IN with) (NP (NN Lodine)))))))) (SBAR (IN as) (S (VP (VBN measured) (PP (IN by) (NP (NN prothrombin) (NN time)))))))) (. .))))

expl(was-2, There-1)
root(ROOT-0, was-2)
det(difference-5, no-3)
amod(difference-5, significant-4)
nsubj(was-2, difference-5)
det(effect-9, the-7)
amod(effect-9, pharmacodynamic-8)
prep_in(was-2, effect-9)
prep_of(effect-9, warfarin-11)
partmod(warfarin-11, administered-12)
advmod(administered-12, alone-13)
conj_and(warfarin-11, warfarin-15)
partmod(warfarin-11, administered-16)
prep_with(administered-16, Lodine-18)
mark(measured-20, as-19)
advcl(was-2, measured-20)
nn(time-23, prothrombin-22)
prep_by(measured-20, time-23)

Thus/RB ,/, concomitant/JJ therapy/NN with/IN warfarin/NN and/CC Lodine/NN should/MD not/RB require/VBP dosage/JJ adjustment/NN of/IN either/DT drug/NN ./.

(ROOT (S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (JJ concomitant) (NN therapy)) (PP (IN with) (NP (NP (NN warfarin)) (CC and) (NP (NN Lodine))))) (VP (MD should) (RB not) (VP (VBP require) (NP (NP (JJ dosage) (NN adjustment)) (PP (IN of) (NP (DT either) (NN drug))))))) (. .))))

advmod(require-11, Thus-1)
amod(therapy-4, concomitant-3)
nsubj(require-11, therapy-4)
prep_with(therapy-4, warfarin-6)
conj_and(warfarin-6, Lodine-8)
aux(require-11, should-9)
neg(require-11, not-10)
root(ROOT-0, require-11)
amod(adjustment-13, dosage-12)
dobj(require-11, adjustment-13)
det(drug-16, either-15)
prep_of(adjustment-13, drug-16)

However/RB ,/, caution/NN should/MD be/VB exercised/VBN because/IN there/EX have/VBP been/VBN a/DT few/JJ spontaneous/JJ reports/NNS of/IN prolonged/JJ prothrombin/NN times/NNS ,/, with/IN or/CC without/IN bleeding/JJ ,/, in/IN etodolac/NN -treated/JJ patients/NNS receiving/VBG concomitant/JJ warfarin/NN therapy/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (IN because) (S (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (DT a) (JJ few) (JJ spontaneous) (NNS reports)) (PP (IN of) (NP (JJ prolonged) (NN prothrombin) (NNS times)))) (, ,) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (JJ bleeding)))) (, ,) (PP (IN in) (NP (NP (NN etodolac) (JJ -treated) (NNS patients)) (VP (VBG receiving) (NP (JJ concomitant) (NN warfarin) (NN therapy))))))))))))) (. .))))

advmod(exercised-6, However-1)
nsubjpass(exercised-6, caution-3)
aux(exercised-6, should-4)
auxpass(exercised-6, be-5)
root(ROOT-0, exercised-6)
mark(reports-14, because-7)
expl(reports-14, there-8)
aux(reports-14, have-9)
cop(reports-14, been-10)
det(reports-14, a-11)
amod(reports-14, few-12)
amod(reports-14, spontaneous-13)
advcl(exercised-6, reports-14)
amod(times-18, prolonged-16)
nn(times-18, prothrombin-17)
prep_of(reports-14, times-18)
prep(reports-14, with-20)
conj_or(with-20, without-22)
pobj(without-22, bleeding-23)
nn(patients-28, etodolac-26)
amod(patients-28, -treated-27)
prep_in(reports-14, patients-28)
partmod(patients-28, receiving-29)
amod(therapy-32, concomitant-30)
nn(therapy-32, warfarin-31)
dobj(receiving-29, therapy-32)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: The/DT urine/NN of/IN patients/NNS who/WP take/VBP Lodine/NN can/MD give/VBP a/DT false-positive/JJ reaction/NN for/IN urinary/JJ bilirubin/NN (/-LRB- urobilin/NN )/-RRB- due/JJ to/TO the/DT presence/NN of/IN phenolic/JJ metabolite/NN s/NNS of/IN etodolac/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (NP (DT The) (NN urine)) (PP (IN of) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP take) (NP (NN Lodine)))))))) (VP (MD can) (VP (VBP give) (NP (NP (DT a) (JJ false-positive) (NN reaction)) (PP (IN for) (NP (NP (JJ urinary) (NN bilirubin)) (PRN (-LRB- -LRB-) (NP (NN urobilin)) (-RRB- -RRB-))))) (PP (JJ due) (TO to) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ phenolic) (NN metabolite) (NNS s)) (PP (IN of) (NP (NN etodolac)))))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
det(urine-7, The-6)
nsubj(give-14, urine-7)
prep_of(urine-7, patients-9)
nsubj(take-11, patients-9)
rcmod(patients-9, take-11)
dobj(take-11, Lodine-12)
aux(give-14, can-13)
dep(Interactions-4, give-14)
det(reaction-17, a-15)
amod(reaction-17, false-positive-16)
dobj(give-14, reaction-17)
amod(bilirubin-20, urinary-19)
prep_for(reaction-17, bilirubin-20)
appos(bilirubin-20, urobilin-22)
det(presence-27, the-26)
prep_due_to(give-14, presence-27)
amod(s-31, phenolic-29)
nn(s-31, metabolite-30)
prep_of(presence-27, s-31)
prep_of(s-31, etodolac-33)

Diagnostic/JJ dip-stick/JJ methodology/NN ,/, used/VBN to/TO detect/VB ketone/NN bodies/NNS in/IN urine/NN ,/, has/VBZ resulted/VBD in/IN false-positive/JJ findings/NNS in/IN some/DT patients/NNS treated/VBN with/IN Lodine/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Diagnostic) (JJ dip-stick) (NN methodology)) (, ,) (VP (VBN used) (S (VP (TO to) (VP (VB detect) (NP (NN ketone) (NNS bodies)) (PP (IN in) (NP (NN urine))))))) (, ,)) (VP (VBZ has) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ false-positive) (NNS findings)) (PP (IN in) (NP (NP (DT some) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NN Lodine))))))))))) (. .))))

amod(methodology-3, Diagnostic-1)
amod(methodology-3, dip-stick-2)
xsubj(detect-7, methodology-3)
nsubj(resulted-14, methodology-3)
partmod(methodology-3, used-5)
aux(detect-7, to-6)
xcomp(used-5, detect-7)
nn(bodies-9, ketone-8)
dobj(detect-7, bodies-9)
prep_in(detect-7, urine-11)
aux(resulted-14, has-13)
root(ROOT-0, resulted-14)
amod(findings-17, false-positive-16)
prep_in(resulted-14, findings-17)
det(patients-20, some-19)
prep_in(findings-17, patients-20)
partmod(patients-20, treated-21)
prep_with(treated-21, Lodine-23)

Lodine/NN treatment/NN is/VBZ associated/VBN with/IN a/DT small/JJ decrease/NN in/IN serum/NN uric/JJ acid/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NN Lodine) (NN treatment)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (JJ small) (NN decrease)) (PP (IN in) (NP (NN serum) (JJ uric) (NN acid) (NNS levels)))))))) (. .))))

nn(treatment-2, Lodine-1)
nsubjpass(associated-4, treatment-2)
auxpass(associated-4, is-3)
root(ROOT-0, associated-4)
det(decrease-8, a-6)
amod(decrease-8, small-7)
prep_with(associated-4, decrease-8)
nn(levels-13, serum-10)
amod(levels-13, uric-11)
nn(levels-13, acid-12)
prep_in(decrease-8, levels-13)

In/IN clinical/JJ trials/NNS ,/, mean/JJ decreases/NNS of/IN 1/CD to/TO 2/CD mg/dL/NN were/VBD observed/VBN in/IN arthritic/JJ patients/NNS receiving/VBG etodolac/NN (/-LRB- 600/CD mg/NN to/TO 1000/CD mg/day/NN )/-RRB- after/IN 4/CD weeks/NNS of/IN therapy/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ clinical) (NNS trials))) (, ,) (NP (NP (JJ mean) (NNS decreases)) (PP (IN of) (NP (QP (CD 1) (TO to) (CD 2)) (NN mg/dL)))) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (JJ arthritic) (NNS patients)) (VP (VBG receiving) (NP (NP (NN etodolac)) (PRN (-LRB- -LRB-) (NP (CD 600) (NN mg) (TO to) (CD 1000) (NN mg/day)) (-RRB- -RRB-))) (PP (IN after) (NP (NP (CD 4) (NNS weeks)) (PP (IN of) (NP (NN therapy))))))))))) (. .))))

amod(trials-3, clinical-2)
prep_in(observed-13, trials-3)
amod(decreases-6, mean-5)
nsubjpass(observed-13, decreases-6)
number(2-10, 1-8)
dep(2-10, to-9)
num(mg/dL-11, 2-10)
prep_of(decreases-6, mg/dL-11)
auxpass(observed-13, were-12)
root(ROOT-0, observed-13)
amod(patients-16, arthritic-15)
prep_in(observed-13, patients-16)
partmod(patients-16, receiving-17)
dobj(receiving-17, etodolac-18)
num(mg/day-24, 600-20)
nn(mg/day-24, mg-21)
dep(mg/day-24, to-22)
num(mg/day-24, 1000-23)
appos(etodolac-18, mg/day-24)
num(weeks-28, 4-27)
prep_after(receiving-17, weeks-28)
prep_of(weeks-28, therapy-30)

The/DT following/JJ drug/NN interactions/NNS have/VBP been/VBN reported/VBN with/IN etomidate/NN ./.

(ROOT (S1 (S (S (NP (DT The) (JJ following) (NN drug) (NNS interactions)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NN etomidate))))))) (. .))))

det(interactions-4, The-1)
amod(interactions-4, following-2)
nn(interactions-4, drug-3)
nsubjpass(reported-7, interactions-4)
aux(reported-7, have-5)
auxpass(reported-7, been-6)
root(ROOT-0, reported-7)
prep_with(reported-7, etomidate-9)

@@@/NN Opioid/NN analgesics/NNS @@@/VBD Decreased/VBN antinociceptive/JJ action/NN ./.

(ROOT (S1 (S (S (NP (NN @@@) (NN Opioid) (NNS analgesics)) (VP (VBD @@@) (NP (VBN Decreased) (JJ antinociceptive) (NN action)))) (. .))))

nn(analgesics-3, @@@-1)
nn(analgesics-3, Opioid-2)
nsubj(@@@-4, analgesics-3)
root(ROOT-0, @@@-4)
amod(action-7, Decreased-5)
amod(action-7, antinociceptive-6)
dobj(@@@-4, action-7)

Etonogestrel/NN may/MD interact/VB with/IN the/DT following/VBG medications/NNS :/: acetaminophen/NN (/-LRB- Tylenol/NNP )/-RRB- ,/, antibiotics/NNS such/JJ as/IN ampicillin/NN and/CC tetracycline/NN ,/, anticonvulsants/NNS (/-LRB- Dilantin/NN ,/, Phenobarbital/NN ,/, Tegretol/NNP ,/, Trileptal/NNP ,/, Topamax/NNP ,/, Felbatol/NNP )/-RRB- ,/, antifungals/NNS (/-LRB- Gris-PEG/NN ,/, Nizoral/NNP ,/, Sporanox/NNP )/-RRB- ,/, atorvastatin/NN (/-LRB- Lipitor/NN )/-RRB- ,/, clofibrate/NN (/-LRB- Atromid-S/NN )/-RRB- ,/, cyclosporine/NN (/-LRB- Neoral/NN ,/, Sandimmune/NN )/-RRB- ,/, HIV/NN drugs/NNS classified/VBN as/IN protease/NN inhibitors/NNS (/-LRB- Agenerase/NNP ,/, Crixivan/NNP ,/, Fortovase/NNP ,/, Invirase/NNP ,/, Kaletra/NNP ,/, Norvir/NNP ,/, Viracept/NN )/-RRB- ,/, morphine/NN (/-LRB- Astramorph/NN ,/, Kadian/NNP ,/, MS/NN Contin/NN )/-RRB- ,/, phenylbutazone/NN ,/, prednisolone/NN (/-LRB- Prelone/NN )/-RRB- ,/, rifadin/NN (/-LRB- rifampin/NN )/-RRB- ,/, St./NN Johns/NNP wort/NNP ,/, temazepam/NN ,/, theophylline/NN (/-LRB- Theo-Dur/NN )/-RRB- ,/, and/CC vitamin/NN C/NN ./.

(ROOT (S1 (S (NP (NN Etonogestrel)) (VP (MD may) (VP (VB interact) (SBAR (IN with) (FRAG (NP (NP (DT the) (VBG following) (NNS medications)) (PRN (: :) (NP (NP (NP (NN acetaminophen)) (PRN (-LRB- -LRB-) (NP (NNP Tylenol)) (-RRB- -RRB-) (, ,) (NP (NP (NP (NNS antibiotics)) (PP (JJ such) (IN as) (NP (NP (NN ampicillin)) (CC and) (NP (NN tetracycline))))) (, ,) (NP (NP (NP (NP (NNS anticonvulsants)) (PRN (-LRB- -LRB-) (NP (NN Dilantin)) (, ,) (NP (NN Phenobarbital)) (, ,) (NP (NNP Tegretol) (, ,) (NNP Trileptal) (, ,) (NNP Topamax) (, ,) (NNP Felbatol)) (-RRB- -RRB-))) (, ,) (NP (NNS antifungals)) (PRN (-LRB- -LRB-) (NP (NN Gris-PEG)) (, ,) (NP (NNP Nizoral) (, ,) (NNP Sporanox)) (-RRB- -RRB-)) (, ,) (NP (NP (NN atorvastatin)) (PRN (-LRB- -LRB-) (NP (NN Lipitor)) (-RRB- -RRB-))) (, ,) (NP (NP (NN clofibrate)) (PRN (-LRB- -LRB-) (NP (NN Atromid-S)) (-RRB- -RRB-))) (, ,) (NP (NN cyclosporine))) (-LRB- -LRB-) (NP (NN Neoral))) (, ,) (NP (NN Sandimmune))) (-RRB- -RRB-))) (, ,) (NP (NP (NN HIV) (NNS drugs)) (VP (VBN classified) (PP (IN as) (NP (NP (NN protease) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NP (NNP Agenerase) (, ,) (NNP Crixivan)) (, ,) (NP (NNP Fortovase) (, ,) (NNP Invirase)) (, ,) (NP (NNP Kaletra) (, ,) (NNP Norvir)) (, ,) (NP (NN Viracept))) (-RRB- -RRB-)))))) (, ,) (NP (NN morphine) (-LRB- -LRB-) (NN Astramorph) (, ,) (NNP Kadian)) (, ,) (NP (NN MS) (NN Contin))) (-RRB- -RRB-))) (, ,) (NP (NP (NN phenylbutazone)) (, ,) (NP (NP (NN prednisolone)) (PRN (-LRB- -LRB-) (NP (NN Prelone)) (-RRB- -RRB-))) (, ,) (NP (NP (NN rifadin)) (PRN (-LRB- -LRB-) (NP (NN rifampin)) (-RRB- -RRB-))) (, ,) (NP (NN St.) (NNP Johns) (NNP wort)) (, ,) (NP (NN temazepam)) (, ,) (NP (NP (NN theophylline)) (PRN (-LRB- -LRB-) (NP (NN Theo-Dur)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN vitamin) (NN C))))))) (. .))))

nsubj(interact-3, Etonogestrel-1)
aux(interact-3, may-2)
root(ROOT-0, interact-3)
mark(medications-7, with-4)
det(medications-7, the-5)
amod(medications-7, following-6)
advcl(interact-3, medications-7)
dep(medications-7, acetaminophen-9)
appos(acetaminophen-9, Tylenol-11)
dep(Tylenol-11, antibiotics-14)
prep_such_as(antibiotics-14, ampicillin-17)
conj_and(ampicillin-17, tetracycline-19)
appos(antibiotics-14, anticonvulsants-21)
appos(anticonvulsants-21, Dilantin-23)
dep(Dilantin-23, Phenobarbital-25)
nn(Felbatol-33, Tegretol-27)
appos(Felbatol-33, Trileptal-29)
appos(Felbatol-33, Topamax-31)
dep(Dilantin-23, Felbatol-33)
appos(anticonvulsants-21, antifungals-36)
appos(anticonvulsants-21, Gris-PEG-38)
nn(Sporanox-42, Nizoral-40)
dep(Gris-PEG-38, Sporanox-42)
appos(anticonvulsants-21, atorvastatin-45)
appos(atorvastatin-45, Lipitor-47)
appos(anticonvulsants-21, clofibrate-50)
appos(clofibrate-50, Atromid-S-52)
appos(anticonvulsants-21, cyclosporine-55)
dep(anticonvulsants-21, Neoral-57)
appos(antibiotics-14, Sandimmune-59)
nn(drugs-63, HIV-62)
appos(acetaminophen-9, drugs-63)
partmod(drugs-63, classified-64)
nn(inhibitors-67, protease-66)
prep_as(classified-64, inhibitors-67)
nn(Crixivan-71, Agenerase-69)
dep(inhibitors-67, Crixivan-71)
nn(Invirase-75, Fortovase-73)
appos(Crixivan-71, Invirase-75)
nn(Norvir-79, Kaletra-77)
appos(Crixivan-71, Norvir-79)
appos(Crixivan-71, Viracept-81)
nn(Kadian-88, morphine-84)
nn(Kadian-88, Astramorph-86)
appos(acetaminophen-9, Kadian-88)
nn(Contin-91, MS-90)
appos(acetaminophen-9, Contin-91)
dep(medications-7, phenylbutazone-94)
conj_and(phenylbutazone-94, prednisolone-96)
appos(prednisolone-96, Prelone-98)
conj_and(phenylbutazone-94, rifadin-101)
appos(rifadin-101, rifampin-103)
nn(wort-108, St.-106)
nn(wort-108, Johns-107)
conj_and(phenylbutazone-94, wort-108)
conj_and(phenylbutazone-94, temazepam-110)
conj_and(phenylbutazone-94, theophylline-112)
appos(theophylline-112, Theo-Dur-114)
nn(C-119, vitamin-118)
conj_and(phenylbutazone-94, C-119)

Caution/NN should/MD be/VB exercised/VBN when/WRB administering/VBG ETOPOPHOS/NN with/IN drugs/NNS that/WDT are/VBP known/VBN to/TO inhibit/VB phosphatase/NN activities/NNS (/-LRB- e.g./FW ,/, levamisole/NN hydrochloride/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (NN ETOPOPHOS)) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB inhibit) (NP (NP (NN phosphatase) (NNS activities)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN levamisole) (NN hydrochloride))) (-RRB- -RRB-))))))))))))))))))) (. .))))

nsubjpass(exercised-4, Caution-1)
aux(exercised-4, should-2)
auxpass(exercised-4, be-3)
root(ROOT-0, exercised-4)
advmod(administering-6, when-5)
advcl(exercised-4, administering-6)
dobj(administering-6, ETOPOPHOS-7)
prep_with(administering-6, drugs-9)
nsubjpass(known-12, drugs-9)
auxpass(known-12, are-11)
rcmod(drugs-9, known-12)
aux(inhibit-14, to-13)
xcomp(known-12, inhibit-14)
nn(activities-16, phosphatase-15)
dobj(inhibit-14, activities-16)
dep(activities-16, e.g.-18)
nn(hydrochloride-21, levamisole-20)
pobj(e.g.-18, hydrochloride-21)

High-dose/JJ cyclosporin/NN A/NN resulting/VBG in/IN concentrations/NNS above/IN 2000/CD ng/mL/NN administered/VBN with/IN oral/JJ etoposide/NN has/VBZ led/VBN to/TO an/DT 80/CD %/NN increase/NN in/IN etoposide/NN exposure/NN with/IN a/DT 38/CD %/NN decrease/NN in/IN total/JJ body/NN clearance/NN of/IN etoposide/NN compared/VBN to/TO etoposide/NN alone/RB ./.

(ROOT (S1 (S (S (NP (NP (JJ High-dose) (NN cyclosporin) (NN A)) (VP (VBG resulting) (PP (IN in) (NP (NP (NNS concentrations)) (PP (IN above) (NP (NP (CD 2000) (NN ng/mL)) (VP (VBN administered) (PP (IN with) (NP (JJ oral) (NN etoposide)))))))))) (VP (VBZ has) (VP (VBN led) (PP (TO to) (NP (NP (DT an) (ADJP (CD 80) (NN %)) (NN increase)) (PP (IN in) (NP (NP (NN etoposide) (NN exposure)) (PP (IN with) (NP (NP (DT a) (ADJP (CD 38) (NN %)) (NN decrease)) (PP (IN in) (NP (NP (JJ total) (NN body) (NN clearance)) (PP (IN of) (NP (NN etoposide))))))) (PP (VBN compared) (PP (TO to) (NP (NP (NN etoposide)) (ADVP (RB alone)))))))))))) (. .))))

amod(A-3, High-dose-1)
nn(A-3, cyclosporin-2)
nsubj(led-15, A-3)
partmod(A-3, resulting-4)
prep_in(resulting-4, concentrations-6)
num(ng/mL-9, 2000-8)
prep_above(concentrations-6, ng/mL-9)
partmod(ng/mL-9, administered-10)
amod(etoposide-13, oral-12)
prep_with(administered-10, etoposide-13)
aux(led-15, has-14)
root(ROOT-0, led-15)
det(increase-20, an-17)
number(%-19, 80-18)
amod(increase-20, %-19)
prep_to(led-15, increase-20)
nn(exposure-23, etoposide-22)
prep_in(increase-20, exposure-23)
det(decrease-28, a-25)
number(%-27, 38-26)
amod(decrease-28, %-27)
prep_with(exposure-23, decrease-28)
amod(clearance-32, total-30)
nn(clearance-32, body-31)
prep_in(decrease-28, clearance-32)
prep_of(clearance-32, etoposide-34)
prepc_compared_to(exposure-23, to-36)
pobj(exposure-23, etoposide-37)
advmod(etoposide-37, alone-38)

Exemestane/NN is/VBZ extensively/RB metabolized/VBN by/IN CYP/NN 3A4/NN ,/, but/CC coadministration/NN of/IN ketoconazole/NN ,/, a/DT potent/JJ inhibitor/NN of/IN CYP/NN 3A4/NN ,/, has/VBZ no/DT significant/JJ effect/NN on/IN exemestane/NN pharmacokinetics/NNS ./.

(ROOT (S1 (S (S (S (NP (NN Exemestane)) (VP (VBZ is) (ADVP (RB extensively)) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP) (NN 3A4)))))) (, ,) (CC but) (S (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NN ketoconazole)) (, ,) (NP (NP (DT a) (JJ potent) (NN inhibitor)) (PP (IN of) (NP (NN CYP) (NN 3A4)))) (, ,)))) (VP (VBZ has) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NN exemestane) (NNS pharmacokinetics)))))) (. .))))

nsubjpass(metabolized-4, Exemestane-1)
auxpass(metabolized-4, is-2)
advmod(metabolized-4, extensively-3)
root(ROOT-0, metabolized-4)
nn(3A4-7, CYP-6)
agent(metabolized-4, 3A4-7)
nsubj(has-21, coadministration-10)
prep_of(coadministration-10, ketoconazole-12)
det(inhibitor-16, a-14)
amod(inhibitor-16, potent-15)
appos(ketoconazole-12, inhibitor-16)
nn(3A4-19, CYP-18)
prep_of(inhibitor-16, 3A4-19)
conj_but(metabolized-4, has-21)
det(effect-24, no-22)
amod(effect-24, significant-23)
dobj(has-21, effect-24)
nn(pharmacokinetics-27, exemestane-26)
prep_on(has-21, pharmacokinetics-27)

Significant/JJ pharmacokinetic/JJ interactions/NNS mediated/VBN by/IN inhibition/NN of/IN CYP/NN isoenzymes/NNS therefore/RB appear/VBP unlikely/JJ ./.

(ROOT (S1 (S (S (NP (NP (JJ Significant) (JJ pharmacokinetic) (NNS interactions)) (VP (VBN mediated) (PP (IN by) (NP (NP (NN inhibition)) (PP (IN of) (NP (NN CYP) (NNS isoenzymes))))))) (ADVP (RB therefore)) (VP (VBP appear) (ADJP (JJ unlikely)))) (. .))))

amod(interactions-3, Significant-1)
amod(interactions-3, pharmacokinetic-2)
nsubj(unlikely-12, interactions-3)
partmod(interactions-3, mediated-4)
agent(mediated-4, inhibition-6)
nn(isoenzymes-9, CYP-8)
prep_of(inhibition-6, isoenzymes-9)
advmod(unlikely-12, therefore-10)
cop(unlikely-12, appear-11)
root(ROOT-0, unlikely-12)

Co-/NN medications/NNS that/WDT induce/VBP CYP/NN 3A4/NN (/-LRB- e.g./FW ,/, rifampicin/NN ,/, phenytoin/NN ,/, carbamazepine/NN ,/, phenobarbital/NN ,/, or/CC St./NN John/NN @/NN s/NN wort/NN )/-RRB- may/MD significantly/RB decrease/VB exposure/NN to/TO exemestane/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-) (NNS medications)) (SBAR (WHNP (WDT that)) (S (VP (VBP induce) (NP (NP (NN CYP) (NN 3A4)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN rifampicin)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN carbamazepine)) (, ,) (NP (NN phenobarbital)) (, ,) (CC or) (NP (NN St.) (NN John) (NN @) (NN s) (NN wort)))) (-RRB- -RRB-))))))) (VP (MD may) (ADVP (RB significantly)) (VP (VB decrease) (NP (NP (NN exposure)) (PP (TO to) (NP (NN exemestane))))))) (. .))))

nn(medications-2, Co--1)
nsubj(induce-4, medications-2)
nsubj(decrease-27, medications-2)
rcmod(medications-2, induce-4)
nn(3A4-6, CYP-5)
dobj(induce-4, 3A4-6)
dep(3A4-6, e.g.-8)
pobj(e.g.-8, rifampicin-10)
conj_or(rifampicin-10, phenytoin-12)
conj_or(rifampicin-10, carbamazepine-14)
conj_or(rifampicin-10, phenobarbital-16)
nn(wort-23, St.-19)
nn(wort-23, John-20)
nn(wort-23, @-21)
nn(wort-23, s-22)
conj_or(rifampicin-10, wort-23)
aux(decrease-27, may-25)
advmod(decrease-27, significantly-26)
root(ROOT-0, decrease-27)
dobj(decrease-27, exposure-28)
prep_to(exposure-28, exemestane-30)

Dose/NN modification/NN is/VBZ recommended/VBN for/IN patients/NNS who/WP are/VBP also/RB receiving/VBG a/DT potent/JJ CYP/NN 3A4/NN inducer/NN ./.

(ROOT (S1 (S (S (NP (NN Dose) (NN modification)) (VP (VBZ is) (VP (VBN recommended) (PP (IN for) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADVP (RB also)) (VP (VBG receiving) (NP (DT a) (JJ potent) (NN CYP) (NN 3A4) (NN inducer))))))))))) (. .))))

nn(modification-2, Dose-1)
nsubjpass(recommended-4, modification-2)
auxpass(recommended-4, is-3)
root(ROOT-0, recommended-4)
prep_for(recommended-4, patients-6)
nsubj(receiving-10, patients-6)
aux(receiving-10, are-8)
advmod(receiving-10, also-9)
rcmod(patients-6, receiving-10)
det(inducer-15, a-11)
amod(inducer-15, potent-12)
nn(inducer-15, CYP-13)
nn(inducer-15, 3A4-14)
dobj(receiving-10, inducer-15)

Drug/NN /Laboratory/NN Tests/NNS Interactions/NNS :/: No/DT clinically/RB relevant/JJ changes/NNS in/IN the/DT results/NNS of/IN clinical/JJ laboratory/NN tests/NNS have/VBP been/VBN observed/VBN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NNS Tests) (NNS Interactions)) (: :) (S (NP (NP (DT No) (ADJP (RB clinically) (JJ relevant)) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (JJ clinical) (NN laboratory) (NNS tests)))))) (VP (VBP have) (VP (VBN been) (VP (VBN observed))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Tests-3)
root(ROOT-0, Interactions-4)
det(changes-9, No-6)
advmod(relevant-8, clinically-7)
amod(changes-9, relevant-8)
nsubjpass(observed-19, changes-9)
det(results-12, the-11)
prep_in(changes-9, results-12)
amod(tests-16, clinical-14)
nn(tests-16, laboratory-15)
prep_of(results-12, tests-16)
aux(observed-19, have-17)
auxpass(observed-19, been-18)
dep(Interactions-4, observed-19)

Concurrent/JJ use/NN with/IN probenecid/NN or/CC other/JJ drugs/NNS significantly/RB eliminated/VBN by/IN active/JJ renal/JJ tubular/JJ secretion/NN may/MD result/VB in/IN increased/VBN plasma/NN concentrations/NNS of/IN penciclovir/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN use)) (PP (IN with) (NP (NP (NP (NN probenecid)) (CC or) (NP (JJ other) (NNS drugs))) (VP (ADVP (RB significantly)) (VBN eliminated) (PP (IN by) (NP (JJ active) (JJ renal) (JJ tubular) (NN secretion))))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (VBN increased) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN penciclovir)))))))) (. .))))

amod(use-2, Concurrent-1)
nsubj(result-16, use-2)
prep_with(use-2, probenecid-4)
amod(drugs-7, other-6)
conj_or(probenecid-4, drugs-7)
advmod(eliminated-9, significantly-8)
partmod(probenecid-4, eliminated-9)
amod(secretion-14, active-11)
amod(secretion-14, renal-12)
amod(secretion-14, tubular-13)
agent(eliminated-9, secretion-14)
aux(result-16, may-15)
root(ROOT-0, result-16)
amod(concentrations-20, increased-18)
nn(concentrations-20, plasma-19)
prep_in(result-16, concentrations-20)
prep_of(concentrations-20, penciclovir-22)

The/DT conversion/NN of/IN 6-deoxy/JJ penciclovir/NN to/TO penciclovir/NN is/VBZ catalyzed/VBN by/IN aldehyde/NN oxidase/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN conversion)) (PP (IN of) (NP (JJ 6-deoxy) (NN penciclovir))) (PP (TO to) (NP (NN penciclovir)))) (VP (VBZ is) (VP (VBN catalyzed) (PP (IN by) (NP (NN aldehyde) (NN oxidase)))))) (. .))))

det(conversion-2, The-1)
nsubjpass(catalyzed-9, conversion-2)
amod(penciclovir-5, 6-deoxy-4)
prep_of(conversion-2, penciclovir-5)
prep_to(conversion-2, penciclovir-7)
auxpass(catalyzed-9, is-8)
root(ROOT-0, catalyzed-9)
nn(oxidase-12, aldehyde-11)
agent(catalyzed-9, oxidase-12)

Interactions/NNS with/IN other/JJ drugs/NNS metabolized/VBN by/IN this/DT enzyme/NN could/MD potentially/RB occur/VB ./.

(ROOT (S1 (S (S (NP (NP (NNS Interactions)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (DT this) (NN enzyme))))))) (VP (MD could) (ADVP (RB potentially)) (VP (VB occur)))) (. .))))

nsubj(occur-11, Interactions-1)
amod(drugs-4, other-3)
prep_with(Interactions-1, drugs-4)
partmod(drugs-4, metabolized-5)
det(enzyme-8, this-7)
agent(metabolized-5, enzyme-8)
aux(occur-11, could-9)
advmod(occur-11, potentially-10)
root(ROOT-0, occur-11)

Studies/NNS with/IN famotidine/NN in/IN man/NN ,/, in/IN animal/NN models/NNS ,/, and/CC in/IN vitro/FW have/VBP shown/VBN no/DT significant/JJ interference/NN with/IN the/DT disposition/NN of/IN compounds/NNS metabolized/VBN by/IN the/DT hepatic/JJ microsomal/JJ enzymes/NNS ,/, e.g./FW ,/, cytochrome/NN P450/NN system/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Studies)) (PP (IN with) (NP (NN famotidine))) (PP (PP (IN in) (NP (NN man))) (, ,) (PP (IN in) (NP (NN animal) (NNS models))) (, ,) (CC and) (PP (IN in) (NP (FW vitro))))) (VP (VBP have) (VP (VBN shown) (NP (NP (DT no) (JJ significant) (NN interference)) (PP (IN with) (NP (NP (DT the) (NN disposition)) (PP (IN of) (NP (NP (NNS compounds)) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (JJ hepatic) (JJ microsomal) (NNS enzymes)))) (, ,) (PP (FW e.g.) (, ,) (NP (NP (NN cytochrome) (NN P450)) (NN system))))))))))) (. .))))

nsubj(shown-15, Studies-1)
prep_with(Studies-1, famotidine-3)
prep_in(Studies-1, man-5)
nn(models-9, animal-8)
conj_and(man-5, models-9)
conj_and(man-5, vitro-13)
aux(shown-15, have-14)
root(ROOT-0, shown-15)
det(interference-18, no-16)
amod(interference-18, significant-17)
dobj(shown-15, interference-18)
det(disposition-21, the-20)
prep_with(interference-18, disposition-21)
prep_of(disposition-21, compounds-23)
partmod(compounds-23, metabolized-24)
det(enzymes-29, the-26)
amod(enzymes-29, hepatic-27)
amod(enzymes-29, microsomal-28)
agent(metabolized-24, enzymes-29)
prep(compounds-23, e.g.-31)
nn(P450-34, cytochrome-33)
nn(system-35, P450-34)
pobj(e.g.-31, system-35)

Compounds/NNS tested/VBN in/IN man/NN include/VBP warfarin/NN ,/, theophylline/NN ,/, phenytoin/NN ,/, diazepam/NN ,/, aminopyrine/NN and/CC antipyrine/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Compounds)) (VP (VBN tested) (PP (IN in) (NP (NN man))))) (VP (VBP include) (NP (NP (NN warfarin)) (, ,) (NP (NN theophylline)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN diazepam)) (, ,) (NP (NN aminopyrine)) (CC and) (NP (NN antipyrine))))) (. .))))

nsubj(include-5, Compounds-1)
partmod(Compounds-1, tested-2)
prep_in(tested-2, man-4)
root(ROOT-0, include-5)
dobj(include-5, warfarin-6)
conj_and(warfarin-6, theophylline-8)
conj_and(warfarin-6, phenytoin-10)
conj_and(warfarin-6, diazepam-12)
conj_and(warfarin-6, aminopyrine-14)
conj_and(warfarin-6, antipyrine-16)

Use/NN in/IN Conjunction/NN with/IN Other/JJ Antiepileptic/JJ Drugs/NNS :/: The/DT addition/NN of/IN Felbatol/NN @/NN to/TO antiepileptic/JJ drugs/NNS (/-LRB- AEDs/NNS )/-RRB- affects/VBZ the/DT steady-state/JJ plasma/NN concentrations/NNS of/IN AEDs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Use)) (PP (IN in) (NP (NP (NN Conjunction)) (PP (IN with) (NP (JJ Other) (JJ Antiepileptic) (NNS Drugs)))))) (: :) (NP (NP (DT The) (NN addition)) (PP (IN of) (NP (NN Felbatol) (NN @))) (PP (TO to) (NP (NP (JJ antiepileptic) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NNS AEDs)) (-RRB- -RRB-))))) (VP (VBZ affects) (NP (NP (DT the) (JJ steady-state) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NNS AEDs)))))) (. .))))

nsubj(affects-20, Use-1)
prep_in(Use-1, Conjunction-3)
amod(Drugs-7, Other-5)
amod(Drugs-7, Antiepileptic-6)
prep_with(Conjunction-3, Drugs-7)
det(addition-10, The-9)
nsubj(affects-20, addition-10)
nn(@-13, Felbatol-12)
prep_of(addition-10, @-13)
amod(drugs-16, antiepileptic-15)
prep_to(addition-10, drugs-16)
appos(drugs-16, AEDs-18)
root(ROOT-0, affects-20)
det(concentrations-24, the-21)
amod(concentrations-24, steady-state-22)
nn(concentrations-24, plasma-23)
dobj(affects-20, concentrations-24)
prep_of(concentrations-24, AEDs-26)

Phenytoin/NN @/NN ?/.

(ROOT (S1 (S (NP (NP (NN Phenytoin) (NN @)) (. ?)))))

nn(@-2, Phenytoin-1)
root(ROOT-0, @-2)

Valproate/NN @/NN @/NN */NN */NN ./.

(ROOT (S1 (S (S (NP (NN Valproate) (NN @) (NN @) (NN *) (NN *))) (. .))))

nn(*-5, Valproate-1)
nn(*-5, @-2)
nn(*-5, @-3)
nn(*-5, *-4)
root(ROOT-0, *-5)

Carbamazepine/NN (/-LRB- CBZ/NN )/-RRB- @/NN ?/.

(ROOT (S1 (S (S (NP (NP (NN Carbamazepine)) (PRN (-LRB- -LRB-) (NP (NN CBZ)) (-RRB- -RRB-))) (NP (NN @))) (. ?))))

dep(@-5, Carbamazepine-1)
abbrev(Carbamazepine-1, CBZ-3)
root(ROOT-0, @-5)

Phenobarbital/NN @/NN ?/.

(ROOT (S1 (S (NP (NP (NN Phenobarbital) (NN @)) (. ?)))))

nn(@-2, Phenobarbital-1)
root(ROOT-0, @-2)

*/NN Not/RB administered/VBN ,/, but/CC an/DT active/JJ metabolite/NN of/IN carbamazepine/NN ./.

(ROOT (S1 (S (S (S (NP (NN *)) (VP (RB Not) (VBN administered))) (, ,) (CC but) (S (NP (NP (DT an) (JJ active) (NN metabolite)) (PP (IN of) (NP (NN carbamazepine)))))) (. .))))

nsubj(administered-3, *-1)
neg(administered-3, Not-2)
root(ROOT-0, administered-3)
det(metabolite-8, an-6)
amod(metabolite-8, active-7)
conj_but(administered-3, metabolite-8)
prep_of(metabolite-8, carbamazepine-10)

Specific/JJ Effects/NNS of/IN Felbatol/NN @/NN on/IN Other/JJ Antiepileptic/JJ Drugs/NNS Phenytoin/NN :/: Felbatol/NN @/NN causes/VBZ an/DT increase/NN in/IN steady-state/JJ phenytoin/NN plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Specific) (NNS Effects)) (PP (IN of) (NP (NN Felbatol) (NN @))) (PP (IN on) (NP (JJ Other) (JJ Antiepileptic) (NNS Drugs)))) (NP (NP (NN Phenytoin)) (: :) (S (NP (NN Felbatol) (NN @)) (VP (VBZ causes) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (JJ steady-state) (NN phenytoin) (NN plasma) (NNS concentrations)))))) (. .)))))

amod(Effects-2, Specific-1)
dep(Phenytoin-10, Effects-2)
nn(@-5, Felbatol-4)
prep_of(Effects-2, @-5)
amod(Drugs-9, Other-7)
amod(Drugs-9, Antiepileptic-8)
prep_on(Effects-2, Drugs-9)
root(ROOT-0, Phenytoin-10)
nn(@-13, Felbatol-12)
nsubj(causes-14, @-13)
dep(Phenytoin-10, causes-14)
det(increase-16, an-15)
dobj(causes-14, increase-16)
amod(concentrations-21, steady-state-18)
nn(concentrations-21, phenytoin-19)
nn(concentrations-21, plasma-20)
prep_in(increase-16, concentrations-21)

In/IN 10/CD otherwise/JJ healthy/JJ subjects/NNS with/IN epilepsy/NN ingesting/VBG phenytoin/NN ,/, the/DT steadystate/JJ trough/NN (/-LRB- Cmin/NN )/-RRB- phenytoin/NN plasma/NN concentration/NN was/VBD 17/CD @/NN 5/CD micrograms/mL/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (CD 10) (JJ otherwise) (JJ healthy) (NNS subjects)) (PP (IN with) (NP (NP (NN epilepsy)) (VP (VBG ingesting) (NP (NN phenytoin))))))) (, ,) (NP (DT the) (JJ steadystate) (NN trough) (-LRB- -LRB-) (NN Cmin) (-RRB- -RRB-) (NN phenytoin) (NN plasma) (NN concentration)) (VP (VBD was) (NP (CD 17) (NN @) (CD 5) (NN micrograms/mL)))) (. .))))

num(subjects-5, 10-2)
amod(subjects-5, otherwise-3)
amod(subjects-5, healthy-4)
prep_in(micrograms/mL-24, subjects-5)
prep_with(subjects-5, epilepsy-7)
partmod(epilepsy-7, ingesting-8)
dobj(ingesting-8, phenytoin-9)
det(concentration-19, the-11)
amod(concentration-19, steadystate-12)
nn(concentration-19, trough-13)
nn(concentration-19, Cmin-15)
nn(concentration-19, phenytoin-17)
nn(concentration-19, plasma-18)
nsubj(micrograms/mL-24, concentration-19)
cop(micrograms/mL-24, was-20)
num(micrograms/mL-24, 17-21)
nn(micrograms/mL-24, @-22)
num(micrograms/mL-24, 5-23)
root(ROOT-0, micrograms/mL-24)

The/DT steady-state/JJ Cmin/NN increased/VBD to/TO 21/CD @/NN 5/CD micrograms/mL/NNS when/WRB 1200/CD mg/day/NN of/IN felbamate/NN was/VBD coadministered/VBN ./.

(ROOT (S1 (S (S (NP (DT The) (JJ steady-state) (NN Cmin)) (VP (VBD increased) (PP (TO to) (NP (CD 21) (NN @) (CD 5) (NNS micrograms/mL))) (SBAR (WHADVP (WRB when)) (S (NP (NP (CD 1200) (NN mg/day)) (PP (IN of) (NP (NN felbamate)))) (VP (VBD was) (VP (VBN coadministered))))))) (. .))))

det(Cmin-3, The-1)
amod(Cmin-3, steady-state-2)
nsubj(increased-4, Cmin-3)
root(ROOT-0, increased-4)
num(micrograms/mL-9, 21-6)
nn(micrograms/mL-9, @-7)
num(micrograms/mL-9, 5-8)
prep_to(increased-4, micrograms/mL-9)
advmod(coadministered-16, when-10)
num(mg/day-12, 1200-11)
nsubjpass(coadministered-16, mg/day-12)
prep_of(mg/day-12, felbamate-14)
auxpass(coadministered-16, was-15)
advcl(increased-4, coadministered-16)

Increasing/VBG the/DT felbamate/JJ dose/NN to/TO 1800/CD mg/day/NN in/IN six/CD of/IN these/DT subjects/NNS increased/VBD the/DT steady-state/JJ phenytoin/NN Cmin/NN to/TO 25/CD @/NN 7/CD micrograms/mL/NNS ./.

(ROOT (S1 (S (S (VP (VBG Increasing) (NP (NP (DT the) (JJ felbamate) (NN dose)) (PP (TO to) (NP (CD 1800) (NN mg/day)))) (PP (IN in) (NP (NP (CD six)) (PP (IN of) (NP (DT these) (NNS subjects))))))) (VP (VBD increased) (NP (NP (DT the) (JJ steady-state) (NN phenytoin) (NN Cmin)) (PP (TO to) (NP (CD 25) (NN @) (CD 7) (NNS micrograms/mL))))) (. .))))

csubj(increased-13, Increasing-1)
det(dose-4, the-2)
amod(dose-4, felbamate-3)
dobj(Increasing-1, dose-4)
num(mg/day-7, 1800-6)
prep_to(dose-4, mg/day-7)
prep_in(Increasing-1, six-9)
det(subjects-12, these-11)
prep_of(six-9, subjects-12)
root(ROOT-0, increased-13)
det(Cmin-17, the-14)
amod(Cmin-17, steady-state-15)
nn(Cmin-17, phenytoin-16)
dobj(increased-13, Cmin-17)
num(micrograms/mL-22, 25-19)
nn(micrograms/mL-22, @-20)
num(micrograms/mL-22, 7-21)
prep_to(Cmin-17, micrograms/mL-22)

Carbamazepine/NN :/: Felbatol/NN @/NN causes/VBZ a/DT decrease/NN in/IN the/DT steady-state/JJ carbamazepine/NN plasma/NN concentrations/NNS and/CC an/DT increase/NN in/IN the/DT steady-state/JJ carbamazepine/NN epoxide/NN plasma/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN Carbamazepine)) (: :) (S (NP (NN Felbatol) (NN @)) (VP (VBZ causes) (NP (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (DT the) (JJ steady-state) (NN carbamazepine) (NN plasma) (NNS concentrations)))) (CC and) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (DT the) (JJ steady-state) (NN carbamazepine) (NN epoxide) (NN plasma) (NN concentration))))))) (. .)))))

root(ROOT-0, Carbamazepine-1)
nn(@-4, Felbatol-3)
nsubj(causes-5, @-4)
dep(Carbamazepine-1, causes-5)
det(decrease-7, a-6)
dobj(causes-5, decrease-7)
det(concentrations-13, the-9)
amod(concentrations-13, steady-state-10)
nn(concentrations-13, carbamazepine-11)
nn(concentrations-13, plasma-12)
prep_in(decrease-7, concentrations-13)
det(increase-16, an-15)
conj_and(decrease-7, increase-16)
det(concentration-23, the-18)
amod(concentration-23, steady-state-19)
nn(concentration-23, carbamazepine-20)
nn(concentration-23, epoxide-21)
nn(concentration-23, plasma-22)
prep_in(increase-16, concentration-23)

In/IN nine/CD otherwise/JJ healthy/JJ subjects/NNS with/IN epilepsy/NN ingesting/VBG carbamazepine/NN ,/, the/DT steady-state/JJ trough/NN (/-LRB- Cmin/NN )/-RRB- carbamazepine/NN concentration/NN was/VBD 8/CD @/NN 2/CD micrograms/mL/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (CD nine) (JJ otherwise) (JJ healthy) (NNS subjects)) (PP (IN with) (NP (NP (NN epilepsy)) (VP (VBG ingesting) (NP (NN carbamazepine))))))) (, ,) (NP (DT the) (JJ steady-state) (NN trough) (-LRB- -LRB-) (NN Cmin) (-RRB- -RRB-) (NN carbamazepine) (NN concentration)) (VP (VBD was) (NP (CD 8) (NN @) (CD 2) (NN micrograms/mL)))) (. .))))

num(subjects-5, nine-2)
amod(subjects-5, otherwise-3)
amod(subjects-5, healthy-4)
prep_in(micrograms/mL-23, subjects-5)
prep_with(subjects-5, epilepsy-7)
partmod(epilepsy-7, ingesting-8)
dobj(ingesting-8, carbamazepine-9)
det(concentration-18, the-11)
amod(concentration-18, steady-state-12)
nn(concentration-18, trough-13)
nn(concentration-18, Cmin-15)
nn(concentration-18, carbamazepine-17)
nsubj(micrograms/mL-23, concentration-18)
cop(micrograms/mL-23, was-19)
num(micrograms/mL-23, 8-20)
nn(micrograms/mL-23, @-21)
num(micrograms/mL-23, 2-22)
root(ROOT-0, micrograms/mL-23)

The/DT carbamazepine/NN steady-state/NN Cmin/NN decreased/VBD 31/CD %/NN to/TO 5/CD @/NN 1/CD micrograms/mL/NNS when/WRB felbamate/NN (/-LRB- 3000/CD mg/day/NN ,/, divided/VBN into/IN three/CD doses/NNS )/-RRB- was/VBD coadministered/VBN ./.

(ROOT (S1 (S (S (NP (DT The) (NN carbamazepine) (NN steady-state) (NN Cmin)) (VP (VBD decreased) (NP (CD 31) (NN %)) (PP (TO to) (NP (CD 5) (NN @) (CD 1) (NNS micrograms/mL))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN felbamate)) (PRN (-LRB- -LRB-) (NP (NP (CD 3000) (NN mg/day)) (, ,) (VP (VBN divided) (PP (IN into) (NP (CD three) (NNS doses))))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN coadministered))))))) (. .))))

det(Cmin-4, The-1)
nn(Cmin-4, carbamazepine-2)
nn(Cmin-4, steady-state-3)
nsubj(decreased-5, Cmin-4)
root(ROOT-0, decreased-5)
num(%-7, 31-6)
dobj(decreased-5, %-7)
num(micrograms/mL-12, 5-9)
nn(micrograms/mL-12, @-10)
num(micrograms/mL-12, 1-11)
prep_to(decreased-5, micrograms/mL-12)
advmod(coadministered-25, when-13)
nsubjpass(coadministered-25, felbamate-14)
num(mg/day-17, 3000-16)
dep(felbamate-14, mg/day-17)
partmod(mg/day-17, divided-19)
num(doses-22, three-21)
prep_into(divided-19, doses-22)
auxpass(coadministered-25, was-24)
advcl(decreased-5, coadministered-25)

Carbamazepine/NN epoxide/NN steady-state/JJ Cmin/NN concentrations/NNS increased/VBD 57/CD %/NN from/IN 1.0/CD @/NN 0.3/CD to/TO 1.6/CD @/NN 0.4/CD micrograms/mL/NNS with/IN the/DT addition/NN of/IN felbamate/NN ./.

(ROOT (S1 (S (S (NP (NN Carbamazepine) (NN epoxide) (JJ steady-state) (NN Cmin) (NNS concentrations)) (VP (VBD increased) (NP (CD 57) (NN %)) (PP (IN from) (NP (CD 1.0) (NN @) (QP (CD 0.3) (TO to) (CD 1.6) (NN @) (CD 0.4)) (NNS micrograms/mL))) (PP (IN with) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN felbamate))))))) (. .))))

nn(concentrations-5, Carbamazepine-1)
nn(concentrations-5, epoxide-2)
amod(concentrations-5, steady-state-3)
nn(concentrations-5, Cmin-4)
nsubj(increased-6, concentrations-5)
root(ROOT-0, increased-6)
num(%-8, 57-7)
dobj(increased-6, %-8)
num(micrograms/mL-17, 1.0-10)
nn(micrograms/mL-17, @-11)
number(@-15, 0.3-12)
dep(@-15, to-13)
number(@-15, 1.6-14)
num(micrograms/mL-17, @-15)
number(@-15, 0.4-16)
prep_from(increased-6, micrograms/mL-17)
det(addition-20, the-19)
prep_with(increased-6, addition-20)
prep_of(addition-20, felbamate-22)

In/IN clinical/JJ trials/NNS ,/, similar/JJ changes/NNS in/IN carbamazepine/NN and/CC carbamazepine/NN epoxide/NN were/VBD seen/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ clinical) (NNS trials))) (, ,) (NP (NP (JJ similar) (NNS changes)) (PP (IN in) (NP (NP (NN carbamazepine)) (CC and) (NP (NN carbamazepine)) (NP (NN epoxide))))) (VP (VBD were) (VP (VBN seen)))) (. .))))

amod(trials-3, clinical-2)
prep_in(seen-13, trials-3)
amod(changes-6, similar-5)
nsubjpass(seen-13, changes-6)
prep_in(changes-6, carbamazepine-8)
conj_and(carbamazepine-8, carbamazepine-10)
dep(carbamazepine-8, epoxide-11)
auxpass(seen-13, were-12)
root(ROOT-0, seen-13)

Valproate/NN :/: Felbatol/NN @/NN causes/VBZ an/DT increase/NN in/IN steady-state/JJ valproate/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Valproate)) (: :) (NP (NN Felbatol) (NN @))) (VP (VBZ causes) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (JJ steady-state) (NN valproate) (NNS concentrations)))))) (. .))))

nsubj(causes-5, Valproate-1)
nn(@-4, Felbatol-3)
dep(Valproate-1, @-4)
root(ROOT-0, causes-5)
det(increase-7, an-6)
dobj(causes-5, increase-7)
amod(concentrations-11, steady-state-9)
nn(concentrations-11, valproate-10)
prep_in(increase-7, concentrations-11)

In/IN four/CD subjects/NNS with/IN epilepsy/NN ingesting/VBG valproate/NN ,/, the/DT steady-state/JJ trough/NN (/-LRB- Cmin/NN )/-RRB- valproate/NN plasma/NN concentration/NN was/VBD 63/CD @/NN 16/CD micrograms/mL/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (CD four) (NNS subjects)) (PP (IN with) (NP (NP (NN epilepsy)) (VP (VBG ingesting) (NP (NN valproate))))))) (, ,) (NP (DT the) (JJ steady-state) (NN trough) (-LRB- -LRB-) (NN Cmin) (-RRB- -RRB-) (NN valproate) (NN plasma) (NN concentration)) (VP (VBD was) (NP (CD 63) (NN @) (CD 16) (NN micrograms/mL)))) (. .))))

num(subjects-3, four-2)
prep_in(micrograms/mL-22, subjects-3)
prep_with(subjects-3, epilepsy-5)
partmod(epilepsy-5, ingesting-6)
dobj(ingesting-6, valproate-7)
det(concentration-17, the-9)
amod(concentration-17, steady-state-10)
nn(concentration-17, trough-11)
nn(concentration-17, Cmin-13)
nn(concentration-17, valproate-15)
nn(concentration-17, plasma-16)
nsubj(micrograms/mL-22, concentration-17)
cop(micrograms/mL-22, was-18)
num(micrograms/mL-22, 63-19)
nn(micrograms/mL-22, @-20)
num(micrograms/mL-22, 16-21)
root(ROOT-0, micrograms/mL-22)

The/DT steady-state/JJ Cmin/NN increased/VBD to/TO 78/CD @/NN 14/CD micrograms/mL/NNS when/WRB 1200/CD mg/day/NN of/IN felbamate/NN was/VBD coadministered/VBN ./.

(ROOT (S1 (S (S (NP (DT The) (JJ steady-state) (NN Cmin)) (VP (VBD increased) (PP (TO to) (NP (CD 78) (NN @) (CD 14) (NNS micrograms/mL))) (SBAR (WHADVP (WRB when)) (S (NP (NP (CD 1200) (NN mg/day)) (PP (IN of) (NP (NN felbamate)))) (VP (VBD was) (VP (VBN coadministered))))))) (. .))))

det(Cmin-3, The-1)
amod(Cmin-3, steady-state-2)
nsubj(increased-4, Cmin-3)
root(ROOT-0, increased-4)
num(micrograms/mL-9, 78-6)
nn(micrograms/mL-9, @-7)
num(micrograms/mL-9, 14-8)
prep_to(increased-4, micrograms/mL-9)
advmod(coadministered-16, when-10)
num(mg/day-12, 1200-11)
nsubjpass(coadministered-16, mg/day-12)
prep_of(mg/day-12, felbamate-14)
auxpass(coadministered-16, was-15)
advcl(increased-4, coadministered-16)

Increasing/VBG the/DT felbamate/JJ dose/NN to/TO 2400/CD mg/day/NN increased/VBD the/DT steadystate/JJ valproate/NN Cmin/NN to/TO 96/CD @/NN 25/CD micrograms/mL/NNS ./.

(ROOT (S1 (S (S (VP (VBG Increasing) (NP (NP (DT the) (JJ felbamate) (NN dose)) (PP (TO to) (NP (CD 2400) (NN mg/day)))))) (VP (VBD increased) (NP (NP (DT the) (JJ steadystate) (NN valproate) (NN Cmin)) (PP (TO to) (NP (CD 96) (NN @) (CD 25) (NNS micrograms/mL))))) (. .))))

csubj(increased-8, Increasing-1)
det(dose-4, the-2)
amod(dose-4, felbamate-3)
dobj(Increasing-1, dose-4)
num(mg/day-7, 2400-6)
prep_to(dose-4, mg/day-7)
root(ROOT-0, increased-8)
det(Cmin-12, the-9)
amod(Cmin-12, steadystate-10)
nn(Cmin-12, valproate-11)
dobj(increased-8, Cmin-12)
num(micrograms/mL-17, 96-14)
nn(micrograms/mL-17, @-15)
num(micrograms/mL-17, 25-16)
prep_to(Cmin-12, micrograms/mL-17)

The/DT ratios/NNS of/IN the/DT AUCs/NNS of/IN unbound/JJ valproate/NN to/TO the/DT AUCs/NNS of/IN the/DT total/JJ valproate/NN were/VBD 11.1/CD %/NN ,/, 13.0/CD %/NN ,/, and/CC 11.5/CD %/NN ,/, with/IN coadministration/NN of/IN 0/CD ,/, 1200/CD ,/, and/CC 2400/CD mg/day/NN of/IN Felbatol/NN @/NN ,/, respectively/RB ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS ratios)) (PP (IN of) (NP (NP (DT the) (NNS AUCs)) (PP (IN of) (NP (NP (JJ unbound) (NN valproate)) (PP (TO to) (NP (NP (DT the) (NNS AUCs)) (PP (IN of) (NP (DT the) (JJ total) (NN valproate)))))))))) (VP (VBD were) (NP (NP (CD 11.1) (NN %)) (, ,) (NP (CD 13.0) (NN %)) (, ,) (CC and) (NP (CD 11.5) (NN %))) (, ,) (PP (IN with) (NP (NP (NN coadministration)) (PP (IN of) (NP (QP (CD 0) (, ,) (CD 1200) (, ,) (CC and) (CD 2400)) (NN mg/day))) (PP (IN of) (NP (NN Felbatol) (NN @))))) (, ,) (ADVP (RB respectively)))) (. .))))

det(ratios-2, The-1)
nsubj(%-18, ratios-2)
det(AUCs-5, the-4)
prep_of(ratios-2, AUCs-5)
amod(valproate-8, unbound-7)
prep_of(AUCs-5, valproate-8)
det(AUCs-11, the-10)
prep_to(valproate-8, AUCs-11)
det(valproate-15, the-13)
amod(valproate-15, total-14)
prep_of(AUCs-11, valproate-15)
cop(%-18, were-16)
num(%-18, 11.1-17)
root(ROOT-0, %-18)
num(%-21, 13.0-20)
conj_and(%-18, %-21)
num(%-25, 11.5-24)
conj_and(%-18, %-25)
prep_with(%-18, coadministration-28)
num(mg/day-36, 0-30)
number(0-30, 1200-32)
conj_and(0-30, 2400-35)
prep_of(coadministration-28, mg/day-36)
nn(@-39, Felbatol-38)
prep_of(coadministration-28, @-39)
advmod(%-18, respectively-41)

This/DT indicates/VBZ that/IN the/DT protein/NN binding/NN of/IN valproate/NN did/VBD not/RB change/VB appreciably/RB with/IN increasing/VBG doses/NNS of/IN Felbatol/NN @/NN Phenobarbital/NN :/: Coadministration/NN of/IN felbamate/NN with/IN phenobarbital/NN causes/VBZ an/DT increase/NN in/IN phenobarbital/NN plasma/NN concentrations/NNS ,/, In/IN 12/CD otherwise/RB healthy/JJ male/JJ volunteers/NNS ingesting/VBG phenobarbital/NN ,/, the/DT steady-state/JJ trough/NN (/-LRB- Cmin/NN )/-RRB- phenobarbital/NN concentration/NN was/VBD 14.2/CD micrograms/mL/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NP (DT the) (NN protein) (NN binding)) (PP (IN of) (NP (NN valproate)))) (VP (VBD did) (RB not) (VP (VB change) (ADVP (RB appreciably)) (PP (IN with) (NP (NP (VBG increasing) (NNS doses)) (PP (IN of) (NP (NN Felbatol) (NN @) (NN Phenobarbital))))))))))) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN felbamate))) (PP (IN with) (NP (NN phenobarbital)))) (VP (VBZ causes) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN phenobarbital) (NN plasma) (NNS concentrations)))) (, ,) (PP (IN In) (NP (NP (CD 12) (ADJP (RB otherwise) (JJ healthy)) (JJ male) (NNS volunteers)) (VP (VBG ingesting) (NP (NP (NN phenobarbital)) (, ,) (NP (NP (DT the) (JJ steady-state) (NN trough) (-LRB- -LRB-) (NN Cmin) (-RRB- -RRB-) (NN phenobarbital) (NN concentration)) (VP (VBD was) (NP (CD 14.2) (NN micrograms/mL)))))))))) (. .))))

nsubj(indicates-2, This-1)
root(ROOT-0, indicates-2)
complm(change-11, that-3)
det(binding-6, the-4)
nn(binding-6, protein-5)
nsubj(change-11, binding-6)
prep_of(binding-6, valproate-8)
aux(change-11, did-9)
neg(change-11, not-10)
ccomp(indicates-2, change-11)
advmod(change-11, appreciably-12)
amod(doses-15, increasing-14)
prep_with(change-11, doses-15)
nn(Phenobarbital-19, Felbatol-17)
nn(Phenobarbital-19, @-18)
prep_of(doses-15, Phenobarbital-19)
nsubj(causes-26, Coadministration-21)
prep_of(Coadministration-21, felbamate-23)
prep_with(Coadministration-21, phenobarbital-25)
parataxis(indicates-2, causes-26)
det(increase-28, an-27)
dobj(causes-26, increase-28)
nn(concentrations-32, phenobarbital-30)
nn(concentrations-32, plasma-31)
prep_in(increase-28, concentrations-32)
num(volunteers-39, 12-35)
advmod(healthy-37, otherwise-36)
amod(volunteers-39, healthy-37)
amod(volunteers-39, male-38)
prep_in(causes-26, volunteers-39)
partmod(volunteers-39, ingesting-40)
dobj(ingesting-40, phenobarbital-41)
det(concentration-50, the-43)
amod(concentration-50, steady-state-44)
nn(concentration-50, trough-45)
nn(concentration-50, Cmin-47)
nn(concentration-50, phenobarbital-49)
appos(phenobarbital-41, concentration-50)
cop(micrograms/mL-53, was-51)
num(micrograms/mL-53, 14.2-52)
partmod(concentration-50, micrograms/mL-53)

The/DT steady-state/JJ Cmin/NN concentration/NN increased/VBD to/TO 17.8/CD micrograms/mL/NNS when/WRB 2400/CD mg/day/NN of/IN felbamate/NN was/VBD coadministered/VBN for/IN one/CD week/NN ./.

(ROOT (S1 (S (S (NP (DT The) (JJ steady-state) (NN Cmin) (NN concentration)) (VP (VBD increased) (PP (TO to) (NP (CD 17.8) (NNS micrograms/mL))) (SBAR (WHADVP (WRB when)) (S (NP (NP (CD 2400) (NN mg/day)) (PP (IN of) (NP (NN felbamate)))) (VP (VBD was) (VP (VBN coadministered) (PP (IN for) (NP (CD one) (NN week))))))))) (. .))))

det(concentration-4, The-1)
amod(concentration-4, steady-state-2)
nn(concentration-4, Cmin-3)
nsubj(increased-5, concentration-4)
root(ROOT-0, increased-5)
num(micrograms/mL-8, 17.8-7)
prep_to(increased-5, micrograms/mL-8)
advmod(coadministered-15, when-9)
num(mg/day-11, 2400-10)
nsubjpass(coadministered-15, mg/day-11)
prep_of(mg/day-11, felbamate-13)
auxpass(coadministered-15, was-14)
advcl(increased-5, coadministered-15)
num(week-18, one-17)
prep_for(coadministered-15, week-18)

Effects/NNS of/IN Other/JJ Antiepileptic/JJ Drugs/NNS on/IN Felbatol/NN @/NN Phenytoin/NN :/: Phenytoin/NN causes/VBZ an/DT approximate/JJ doubling/JJ of/IN the/DT clearance/NN of/IN Felbatol/NN @/NN (/-LRB- felbamate/NN )/-RRB- at/IN steady/JJ state/NN and/CC ,/, therefore/RB ,/, the/DT addition/NN of/IN phenytoin/NN causes/VBZ an/DT approximate/JJ 45/CD %/NN decrease/NN in/IN the/DT steady-state/JJ trough/NN concentrations/NNS of/IN Felbatol/NN @/NN as/IN compared/VBN to/TO the/DT same/JJ dose/NN of/IN Felbatol/NN @/NN given/VBN as/IN monotherapy/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Effects)) (PP (IN of) (NP (JJ Other) (JJ Antiepileptic) (NNS Drugs))) (PP (IN on) (NP (NN Felbatol) (NN @) (NN Phenytoin)))) (: :) (S (S (NP (NN Phenytoin)) (VP (VBZ causes) (NP (NP (DT an) (JJ approximate) (JJ doubling)) (PP (IN of) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NP (NN Felbatol) (NN @)) (PRN (-LRB- -LRB-) (NP (NN felbamate)) (-RRB- -RRB-))))))) (PP (IN at) (NP (JJ steady) (NN state))))) (CC and) (, ,) (S (ADVP (RB therefore)) (, ,) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN phenytoin)))) (VP (VBZ causes) (NP (NP (DT an) (JJ approximate) (ADJP (CD 45) (NN %)) (NN decrease)) (PP (IN in) (NP (NP (DT the) (JJ steady-state) (NN trough) (NNS concentrations)) (PP (IN of) (NP (NN Felbatol) (NN @)))))) (SBAR (IN as) (S (VP (VBN compared) (PP (TO to) (NP (NP (DT the) (JJ same) (NN dose)) (PP (IN of) (NP (NN Felbatol) (NN @))) (VP (VBN given) (PP (IN as) (NP (NN monotherapy)))))))))))) (. .)))))

root(ROOT-0, Effects-1)
amod(Drugs-5, Other-3)
amod(Drugs-5, Antiepileptic-4)
prep_of(Effects-1, Drugs-5)
nn(Phenytoin-9, Felbatol-7)
nn(Phenytoin-9, @-8)
prep_on(Effects-1, Phenytoin-9)
nsubj(causes-12, Phenytoin-11)
dep(Effects-1, causes-12)
det(doubling-15, an-13)
amod(doubling-15, approximate-14)
dobj(causes-12, doubling-15)
det(clearance-18, the-17)
prep_of(doubling-15, clearance-18)
nn(@-21, Felbatol-20)
prep_of(clearance-18, @-21)
appos(@-21, felbamate-23)
amod(state-27, steady-26)
prep_at(causes-12, state-27)
advmod(causes-36, therefore-30)
det(addition-33, the-32)
nsubj(causes-36, addition-33)
prep_of(addition-33, phenytoin-35)
conj_and(causes-12, causes-36)
det(decrease-41, an-37)
amod(decrease-41, approximate-38)
number(%-40, 45-39)
amod(decrease-41, %-40)
dobj(causes-36, decrease-41)
det(concentrations-46, the-43)
amod(concentrations-46, steady-state-44)
nn(concentrations-46, trough-45)
prep_in(decrease-41, concentrations-46)
nn(@-49, Felbatol-48)
prep_of(concentrations-46, @-49)
mark(compared-51, as-50)
advcl(causes-36, compared-51)
det(dose-55, the-53)
amod(dose-55, same-54)
prep_to(compared-51, dose-55)
nn(@-58, Felbatol-57)
prep_of(dose-55, @-58)
partmod(dose-55, given-59)
prep_as(given-59, monotherapy-61)

Carbamazepine/NN :/: Carbamazepine/NN causes/VBZ an/DT approximate/JJ 50/CD %/NN increase/NN in/IN the/DT clearance/NN of/IN Felbatol/NN @/NN at/IN steady/JJ state/NN and/CC ,/, therefore/RB ,/, the/DT addition/NN of/IN carbamazepine/NN results/VBZ in/IN an/DT approximate/JJ 40/CD %/NN decrease/NN in/IN the/DT steady-state/JJ trough/NN concentrations/NNS of/IN Felbatol/NN @/NN as/IN compared/VBN to/TO the/DT same/JJ dose/NN of/IN Felbatol/NN @/NN given/VBN as/IN monotherapy/NN ./.

(ROOT (S1 (S (NP (NP (NN Carbamazepine)) (: :) (S (S (NP (NN Carbamazepine)) (VP (VBZ causes) (NP (NP (DT an) (JJ approximate) (ADJP (CD 50) (NN %)) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN Felbatol) (NN @))) (PP (IN at) (NP (JJ steady) (NN state)))))))) (CC and) (, ,) (S (ADVP (RB therefore)) (, ,) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN carbamazepine)))) (VP (VBZ results) (PP (IN in) (NP (NP (DT an) (JJ approximate) (ADJP (CD 40) (NN %)) (NN decrease)) (PP (IN in) (NP (NP (DT the) (JJ steady-state) (NN trough) (NNS concentrations)) (PP (IN of) (NP (NN Felbatol) (NN @))))))) (SBAR (IN as) (S (VP (VBN compared) (PP (TO to) (NP (NP (DT the) (JJ same) (NN dose)) (PP (IN of) (NP (NN Felbatol) (NN @))) (VP (VBN given) (PP (IN as) (NP (NN monotherapy)))))))))))) (. .)))))

root(ROOT-0, Carbamazepine-1)
nsubj(causes-4, Carbamazepine-3)
dep(Carbamazepine-1, causes-4)
det(increase-9, an-5)
amod(increase-9, approximate-6)
number(%-8, 50-7)
amod(increase-9, %-8)
dobj(causes-4, increase-9)
det(clearance-12, the-11)
prep_in(increase-9, clearance-12)
nn(@-15, Felbatol-14)
prep_of(clearance-12, @-15)
amod(state-18, steady-17)
prep_at(clearance-12, state-18)
advmod(results-27, therefore-21)
det(addition-24, the-23)
nsubj(results-27, addition-24)
prep_of(addition-24, carbamazepine-26)
conj_and(causes-4, results-27)
det(decrease-33, an-29)
amod(decrease-33, approximate-30)
number(%-32, 40-31)
amod(decrease-33, %-32)
prep_in(results-27, decrease-33)
det(concentrations-38, the-35)
amod(concentrations-38, steady-state-36)
nn(concentrations-38, trough-37)
prep_in(decrease-33, concentrations-38)
nn(@-41, Felbatol-40)
prep_of(concentrations-38, @-41)
mark(compared-43, as-42)
advcl(results-27, compared-43)
det(dose-47, the-45)
amod(dose-47, same-46)
prep_to(compared-43, dose-47)
nn(@-50, Felbatol-49)
prep_of(dose-47, @-50)
partmod(dose-47, given-51)
prep_as(given-51, monotherapy-53)

Valproate/NN :/: Available/JJ data/NNS suggest/VBP that/IN there/EX is/VBZ no/DT significant/JJ effect/NN of/IN valproate/NN on/IN the/DT clearance/NN of/IN Felbatol/NN @/NN at/IN steady/JJ state/NN ,/, Therefore/RB ,/, the/DT addition/NN of/IN valproate/NN is/VBZ not/RB expected/VBN to/TO cause/VB a/DT clinically/RB important/JJ effect/NN on/IN Felbatol/NNP @/NN (/-LRB- felbamate/NN )/-RRB- plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (NP (NP (NN Valproate)) (: :) (S (NP (JJ Available) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT no) (JJ significant) (NN effect)) (PP (IN of) (NP (NN valproate))) (PP (IN on) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN Felbatol) (NN @))) (PP (IN at) (NP (JJ steady) (NN state)))))))) (, ,) (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN valproate)))) (VP (VBZ is) (RB not) (VP (VBN expected) (S (VP (TO to) (VP (VB cause) (NP (NP (DT a) (ADJP (RB clinically) (JJ important)) (NN effect)) (PP (IN on) (NP (NNP Felbatol) (NN @) (-LRB- -LRB-) (NN felbamate) (-RRB- -RRB-) (NN plasma) (NNS concentrations)))))))))))))) (. .)))))

root(ROOT-0, Valproate-1)
amod(data-4, Available-3)
nsubj(suggest-5, data-4)
dep(Valproate-1, suggest-5)
complm(is-8, that-6)
expl(is-8, there-7)
ccomp(suggest-5, is-8)
det(effect-11, no-9)
amod(effect-11, significant-10)
nsubj(is-8, effect-11)
prep_of(effect-11, valproate-13)
det(clearance-16, the-15)
prep_on(effect-11, clearance-16)
nn(@-19, Felbatol-18)
prep_of(clearance-16, @-19)
amod(state-22, steady-21)
prep_at(clearance-16, state-22)
advmod(expected-32, Therefore-24)
det(addition-27, the-26)
nsubjpass(expected-32, addition-27)
xsubj(cause-34, addition-27)
prep_of(addition-27, valproate-29)
auxpass(expected-32, is-30)
neg(expected-32, not-31)
dep(is-8, expected-32)
aux(cause-34, to-33)
xcomp(expected-32, cause-34)
det(effect-38, a-35)
advmod(important-37, clinically-36)
amod(effect-38, important-37)
dobj(cause-34, effect-38)
nn(concentrations-46, Felbatol-40)
nn(concentrations-46, @-41)
nn(concentrations-46, felbamate-43)
nn(concentrations-46, plasma-45)
prep_on(effect-38, concentrations-46)

Phenobarbital/NN :/: It/PRP appears/VBZ that/IN phenobarbital/NN may/MD reduce/VB plasma/NN felbamate/NN concentrations/NNS ./.

(ROOT (S1 (S (NP (NP (NN Phenobarbital)) (: :) (S (NP (PRP It)) (VP (VBZ appears) (SBAR (IN that) (S (NP (NN phenobarbital)) (VP (MD may) (VP (VB reduce) (NP (NN plasma) (NN felbamate) (NNS concentrations)))))))) (. .)))))

root(ROOT-0, Phenobarbital-1)
nsubj(appears-4, It-3)
dep(Phenobarbital-1, appears-4)
complm(reduce-8, that-5)
nsubj(reduce-8, phenobarbital-6)
aux(reduce-8, may-7)
ccomp(appears-4, reduce-8)
nn(concentrations-11, plasma-9)
nn(concentrations-11, felbamate-10)
dobj(reduce-8, concentrations-11)

Steady-state/JJ plasma/NN felbamate/NN concentrations/NNS were/VBD found/VBN to/TO be/VB 29/CD %/NN lower/JJR than/IN the/DT mean/JJ concentrations/NNS of/IN a/DT group/NN of/IN newly/RB diagnosed/VBN subjects/NNS with/IN epilepsy/NN also/RB receiving/VBG 2400/CD mg/NN of/IN felbamate/NN a/NN day/NN ./.

(ROOT (S1 (S (S (NP (JJ Steady-state) (NN plasma) (NN felbamate) (NNS concentrations)) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (NP (CD 29) (NN %)) (JJR lower) (PP (IN than) (NP (NP (DT the) (JJ mean) (NNS concentrations)) (PP (IN of) (NP (NP (DT a) (NN group)) (PP (IN of) (NP (NP (NP (ADJP (RB newly) (VBN diagnosed)) (NNS subjects)) (PP (IN with) (NP (NN epilepsy)))) (VP (ADVP (RB also)) (VBG receiving) (NP (NP (CD 2400) (NN mg)) (PP (IN of) (NP (NN felbamate) (NN a) (NN day)))))))))))))))))) (. .))))

amod(concentrations-4, Steady-state-1)
nn(concentrations-4, plasma-2)
nn(concentrations-4, felbamate-3)
nsubjpass(found-6, concentrations-4)
xsubj(lower-11, concentrations-4)
auxpass(found-6, were-5)
root(ROOT-0, found-6)
aux(lower-11, to-7)
cop(lower-11, be-8)
num(%-10, 29-9)
npadvmod(lower-11, %-10)
xcomp(found-6, lower-11)
det(concentrations-15, the-13)
amod(concentrations-15, mean-14)
prep_than(lower-11, concentrations-15)
det(group-18, a-17)
prep_of(concentrations-15, group-18)
advmod(diagnosed-21, newly-20)
amod(subjects-22, diagnosed-21)
prep_of(group-18, subjects-22)
prep_with(subjects-22, epilepsy-24)
advmod(receiving-26, also-25)
partmod(subjects-22, receiving-26)
num(mg-28, 2400-27)
dobj(receiving-26, mg-28)
nn(day-32, felbamate-30)
nn(day-32, a-31)
prep_of(mg-28, day-32)

Effects/NNS of/IN Antacids/NNS on/IN Felbatol/NN @/NN :/: The/DT rate/NN and/CC extent/NN of/IN absorption/NN of/IN a/DT 2400/CD mg/NN dose/NN of/IN Felbatol/NN @/NN as/IN monotherapy/NN given/VBN as/IN tablets/NNS was/VBD not/RB affected/VBN when/WRB coadministered/VBN with/IN antacids/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NNS Effects)) (PP (IN of) (NP (NNS Antacids))) (PP (IN on) (NP (NN Felbatol) (NN @)))) (: :) (S (NP (NP (DT The) (NP (NN rate)) (CC and) (NP (NN extent))) (PP (IN of) (NP (NP (NN absorption)) (PP (IN of) (NP (NP (NP (DT a) (ADJP (CD 2400) (NN mg)) (NN dose)) (PP (IN of) (NP (NP (NN Felbatol) (NN @)) (PP (IN as) (NP (NN monotherapy)))))) (VP (VBN given) (PP (IN as) (NP (NNS tablets))))))))) (VP (VBD was) (RB not) (VP (VBN affected)) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NNS antacids)))))))) (. .)))))

root(ROOT-0, Effects-1)
prep_of(Effects-1, Antacids-3)
nn(@-6, Felbatol-5)
prep_on(Effects-1, @-6)
dep(rate-9, The-8)
nsubjpass(affected-29, rate-9)
conj_and(rate-9, extent-11)
prep_of(rate-9, absorption-13)
det(dose-18, a-15)
number(mg-17, 2400-16)
amod(dose-18, mg-17)
prep_of(absorption-13, dose-18)
nn(@-21, Felbatol-20)
prep_of(dose-18, @-21)
prep_as(@-21, monotherapy-23)
partmod(dose-18, given-24)
prep_as(given-24, tablets-26)
auxpass(affected-29, was-27)
neg(affected-29, not-28)
dep(Effects-1, affected-29)
advmod(coadministered-31, when-30)
advcl(affected-29, coadministered-31)
prep_with(coadministered-31, antacids-33)

Effects/NNS of/IN Erythromycin/NN on/IN Felbatol/NN @/NN :/: The/DT coadministration/NN of/IN erythromycin/NN (/-LRB- 1000/CD mg/day/NN )/-RRB- for/IN 10/CD days/NNS did/VBD not/RB alter/VB the/DT pharmacokinetic/JJ parameters/NNS of/IN Cmax/NN ,/, Cmin/NN ,/, AUC/NN ,/, CI/kg/NN or/CC tmax/NN at/IN felbamate/JJ daily/JJ doses/NNS of/IN 3000/CD or/CC 3600/CD mg/day/NN in/IN 10/CD otherwise/JJ healthy/JJ subjects/NNS with/IN epilepsy/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Effects)) (PP (IN of) (NP (NN Erythromycin))) (PP (IN on) (NP (NN Felbatol) (NN @)))) (: :) (S (NP (NP (DT The) (NN coadministration)) (PP (IN of) (NP (NP (NP (NN erythromycin)) (PRN (-LRB- -LRB-) (NP (CD 1000) (NN mg/day)) (-RRB- -RRB-))) (PP (IN for) (NP (CD 10) (NNS days)))))) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (JJ pharmacokinetic) (NNS parameters)) (PP (IN of) (NP (NP (NN Cmax)) (, ,) (NP (NN Cmin)) (, ,) (NP (NN AUC)) (, ,) (NP (NN CI/kg)) (CC or) (NP (NN tmax)))) (PP (IN at) (NP (NP (JJ felbamate) (JJ daily) (NNS doses)) (PP (IN of) (NP (CD 3000) (CC or) (CD 3600) (NN mg/day)))))) (PP (IN in) (NP (NP (CD 10) (JJ otherwise) (JJ healthy) (NNS subjects)) (PP (IN with) (NP (NN epilepsy)))))))) (. .)))))

root(ROOT-0, Effects-1)
prep_of(Effects-1, Erythromycin-3)
nn(@-6, Felbatol-5)
prep_on(Effects-1, @-6)
det(coadministration-9, The-8)
nsubj(alter-21, coadministration-9)
prep_of(coadministration-9, erythromycin-11)
num(mg/day-14, 1000-13)
appos(erythromycin-11, mg/day-14)
num(days-18, 10-17)
prep_for(erythromycin-11, days-18)
aux(alter-21, did-19)
neg(alter-21, not-20)
dep(Effects-1, alter-21)
det(parameters-24, the-22)
amod(parameters-24, pharmacokinetic-23)
dobj(alter-21, parameters-24)
prep_of(parameters-24, Cmax-26)
conj_or(Cmax-26, Cmin-28)
conj_or(Cmax-26, AUC-30)
conj_or(Cmax-26, CI/kg-32)
conj_or(Cmax-26, tmax-34)
amod(doses-38, felbamate-36)
amod(doses-38, daily-37)
prep_at(parameters-24, doses-38)
nn(mg/day-43, 3000-40)
conj_or(3000-40, 3600-42)
prep_of(doses-38, mg/day-43)
num(subjects-48, 10-45)
amod(subjects-48, otherwise-46)
amod(subjects-48, healthy-47)
prep_in(alter-21, subjects-48)
prep_with(subjects-48, epilepsy-50)

Effects/NNS of/IN Felbatol/NN @/NN on/IN Low-Dose/JJ Combination/NN Oral/JJ Contraceptives/NNS :/: A/DT group/NN of/IN 24/CD nonsmoking/JJ ,/, healthy/JJ white/JJ female/JJ volunteers/NNS established/VBN on/IN an/DT oral/JJ contraceptive/JJ regimen/NN containing/VBG 30/CD mg/NN ethinyl/NN estradiol/NN and/CC 75/CD mg/NN gestodene/NN for/IN at/IN least/JJS 3/CD months/NNS received/VBD 2400/CD mg/day/NN of/IN felbamate/NN from/IN midcycle/NN (/-LRB- day/NN 15/CD )/-RRB- to/TO midcycle/NN (/-LRB- day/NN 14/CD )/-RRB- of/IN two/CD consecutive/JJ oral/JJ contraceptive/NN cycles/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NNS Effects)) (PP (IN of) (NP (NN Felbatol) (NN @))) (PP (IN on) (NP (JJ Low-Dose) (NN Combination) (JJ Oral) (NNS Contraceptives)))) (: :) (S (NP (NP (DT A) (NN group)) (PP (IN of) (NP (CD 24) (JJ nonsmoking) (, ,) (JJ healthy) (JJ white) (JJ female) (NNS volunteers))) (VP (VBN established) (PP (IN on) (NP (NP (DT an) (JJ oral) (JJ contraceptive) (NN regimen)) (VP (VBG containing) (NP (NP (ADJP (CD 30) (NN mg)) (NN ethinyl) (NN estradiol)) (CC and) (NP (ADJP (CD 75) (NN mg)) (NN gestodene))) (PP (IN for) (NP (QP (IN at) (JJS least) (CD 3)) (NNS months)))))))) (VP (VBD received) (NP (NP (CD 2400) (NN mg/day)) (PP (IN of) (NP (NN felbamate)))) (PP (PP (IN from) (NP (NP (NN midcycle)) (PRN (-LRB- -LRB-) (NP (NN day) (CD 15)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (NP (NN midcycle)) (PRN (-LRB- -LRB-) (NP (NN day) (CD 14)) (-RRB- -RRB-))) (PP (IN of) (NP (CD two) (JJ consecutive) (JJ oral) (NN contraceptive) (NNS cycles)))))))) (. .)))))

root(ROOT-0, Effects-1)
nn(@-4, Felbatol-3)
prep_of(Effects-1, @-4)
amod(Contraceptives-9, Low-Dose-6)
nn(Contraceptives-9, Combination-7)
amod(Contraceptives-9, Oral-8)
prep_on(Effects-1, Contraceptives-9)
det(group-12, A-11)
nsubj(received-41, group-12)
num(volunteers-20, 24-14)
amod(volunteers-20, nonsmoking-15)
amod(volunteers-20, healthy-17)
amod(volunteers-20, white-18)
amod(volunteers-20, female-19)
prep_of(group-12, volunteers-20)
partmod(group-12, established-21)
det(regimen-26, an-23)
amod(regimen-26, oral-24)
amod(regimen-26, contraceptive-25)
prep_on(established-21, regimen-26)
partmod(regimen-26, containing-27)
number(mg-29, 30-28)
amod(estradiol-31, mg-29)
nn(estradiol-31, ethinyl-30)
dobj(containing-27, estradiol-31)
number(mg-34, 75-33)
amod(gestodene-35, mg-34)
conj_and(estradiol-31, gestodene-35)
quantmod(3-39, at-37)
mwe(at-37, least-38)
pobj(at-37, least-38)
num(months-40, 3-39)
prep_for(containing-27, months-40)
dep(Effects-1, received-41)
num(mg/day-43, 2400-42)
dobj(received-41, mg/day-43)
prep_of(mg/day-43, felbamate-45)
prep_from(received-41, midcycle-47)
appos(midcycle-47, day-49)
num(day-49, 15-50)
prep_to(received-41, midcycle-53)
appos(midcycle-53, day-55)
num(day-55, 14-56)
num(cycles-63, two-59)
amod(cycles-63, consecutive-60)
amod(cycles-63, oral-61)
nn(cycles-63, contraceptive-62)
prep_of(midcycle-53, cycles-63)

Felbamate/NN treatment/NN resulted/VBD in/IN a/DT 42/CD %/NN decrease/NN in/IN the/DT gestodene/NN AUC/NN 0-24/CD ,/, but/CC no/DT clinically/RB relevant/JJ effect/NN was/VBD observed/VBN on/IN the/DT pharmacokinetic/JJ parameters/NNS of/IN ethinyl/NN estradiol/NN ./.

(ROOT (S1 (S (S (S (NP (NN Felbamate) (NN treatment)) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (ADJP (CD 42) (NN %)) (NN decrease)) (PP (IN in) (NP (DT the) (NN gestodene) (NN AUC) (CD 0-24))))))) (, ,) (CC but) (S (NP (DT no) (ADJP (RB clinically) (JJ relevant)) (NN effect)) (VP (VBD was) (VP (VBN observed) (PP (IN on) (NP (NP (DT the) (JJ pharmacokinetic) (NNS parameters)) (PP (IN of) (NP (NN ethinyl) (NN estradiol))))))))) (. .))))

nn(treatment-2, Felbamate-1)
nsubj(resulted-3, treatment-2)
root(ROOT-0, resulted-3)
det(decrease-8, a-5)
number(%-7, 42-6)
amod(decrease-8, %-7)
prep_in(resulted-3, decrease-8)
det(AUC-12, the-10)
nn(AUC-12, gestodene-11)
prep_in(decrease-8, AUC-12)
num(AUC-12, 0-24-13)
det(effect-19, no-16)
advmod(relevant-18, clinically-17)
amod(effect-19, relevant-18)
nsubjpass(observed-21, effect-19)
auxpass(observed-21, was-20)
conj_but(resulted-3, observed-21)
det(parameters-25, the-23)
amod(parameters-25, pharmacokinetic-24)
prep_on(observed-21, parameters-25)
nn(estradiol-28, ethinyl-27)
prep_of(parameters-25, estradiol-28)

No/DT volunteer/NN showed/VBD hormonal/JJ evidence/NN of/IN ovulation/NN ,/, but/CC one/CD volunteer/NN reported/VBD intermenstrual/JJ bleeding/JJ during/IN felbamate/NN treatment/NN ./.

(ROOT (S1 (S (S (S (NP (DT No) (NN volunteer)) (VP (VBD showed) (NP (NP (JJ hormonal) (NN evidence)) (PP (IN of) (NP (NN ovulation)))))) (, ,) (CC but) (S (NP (CD one) (NN volunteer)) (VP (VBD reported) (ADJP (JJ intermenstrual) (JJ bleeding)) (PP (IN during) (NP (NN felbamate) (NN treatment)))))) (. .))))

det(volunteer-2, No-1)
nsubj(showed-3, volunteer-2)
root(ROOT-0, showed-3)
amod(evidence-5, hormonal-4)
dobj(showed-3, evidence-5)
prep_of(evidence-5, ovulation-7)
num(volunteer-11, one-10)
nsubj(reported-12, volunteer-11)
conj_but(showed-3, reported-12)
amod(bleeding-14, intermenstrual-13)
acomp(reported-12, bleeding-14)
nn(treatment-17, felbamate-16)
prep_during(reported-12, treatment-17)

Drug/NN Interactions/NNS with/IN Beta-Blockers/NN :/: Concomitant/JJ use/NN of/IN fenoldopam/NN with/IN beta-blockers/NNS should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (NP (NP (NP (NN Drug) (NNS Interactions)) (PP (IN with) (NP (NN Beta-Blockers)))) (: :) (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NN fenoldopam))) (PP (IN with) (NP (NNS beta-blockers)))) (VP (MD should) (VP (VB be) (VP (VBN avoided))))) (. .)))))

nn(Interactions-2, Drug-1)
root(ROOT-0, Interactions-2)
prep_with(Interactions-2, Beta-Blockers-4)
amod(use-7, Concomitant-6)
nsubjpass(avoided-14, use-7)
prep_of(use-7, fenoldopam-9)
prep_with(use-7, beta-blockers-11)
aux(avoided-14, should-12)
auxpass(avoided-14, be-13)
dep(Interactions-2, avoided-14)

If/IN the/DT drugs/NNS are/VBP used/VBN together/RB ,/, caution/NN should/MD be/VB exercised/VBN because/IN unexpected/JJ hypotension/NN could/MD result/VB from/IN beta-blocker/NN inhibition/NN of/IN the/DT sympathetic/JJ reflex/NN response/NN to/TO fenoldopam/NN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (DT the) (NNS drugs)) (VP (VBP are) (VP (VBN used) (ADVP (RB together)))))) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (IN because) (S (NP (JJ unexpected) (NN hypotension)) (VP (MD could) (VP (VB result) (PP (IN from) (NP (NP (NN beta-blocker) (NN inhibition)) (PP (IN of) (NP (NP (DT the) (JJ sympathetic) (NN reflex) (NN response)) (PP (TO to) (NP (NN fenoldopam))))))))))))))) (. .))))

mark(used-5, If-1)
det(drugs-3, the-2)
nsubjpass(used-5, drugs-3)
auxpass(used-5, are-4)
advcl(exercised-11, used-5)
advmod(used-5, together-6)
nsubjpass(exercised-11, caution-8)
aux(exercised-11, should-9)
auxpass(exercised-11, be-10)
root(ROOT-0, exercised-11)
mark(result-16, because-12)
amod(hypotension-14, unexpected-13)
nsubj(result-16, hypotension-14)
aux(result-16, could-15)
advcl(exercised-11, result-16)
nn(inhibition-19, beta-blocker-18)
prep_from(result-16, inhibition-19)
det(response-24, the-21)
amod(response-24, sympathetic-22)
nn(response-24, reflex-23)
prep_of(inhibition-19, response-24)
prep_to(response-24, fenoldopam-26)

Drug/NN Interactions/NNS ,/, General/JJ :/: Although/IN there/EX have/VBP been/VBN no/DT formal/JJ interaction/NN studies/NNS ,/, intravenous/JJ fenoldopam/NN has/VBZ been/VBN administered/VBN safely/RB with/IN drugs/NNS such/JJ as/IN digitalis/NN and/CC sublingual/JJ nitroglycerin/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN Drug) (NNS Interactions)) (, ,) (NP (JJ General))) (: :) (S (SBAR (IN Although) (S (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (DT no) (JJ formal) (NN interaction) (NNS studies)))))) (, ,) (NP (JJ intravenous) (NN fenoldopam)) (VP (VBZ has) (VP (VBN been) (VP (VBN administered) (ADVP (RB safely)) (PP (IN with) (NP (NP (NNS drugs)) (PP (JJ such) (IN as) (NP (NP (NN digitalis)) (CC and) (NP (JJ sublingual) (NN nitroglycerin)))))))))) (. .)))))

nn(Interactions-2, Drug-1)
root(ROOT-0, Interactions-2)
appos(Interactions-2, General-4)
mark(studies-13, Although-6)
expl(studies-13, there-7)
aux(studies-13, have-8)
cop(studies-13, been-9)
det(studies-13, no-10)
amod(studies-13, formal-11)
nn(studies-13, interaction-12)
advcl(administered-19, studies-13)
amod(fenoldopam-16, intravenous-15)
nsubjpass(administered-19, fenoldopam-16)
aux(administered-19, has-17)
auxpass(administered-19, been-18)
dep(Interactions-2, administered-19)
advmod(administered-19, safely-20)
prep_with(administered-19, drugs-22)
prep_such_as(drugs-22, digitalis-25)
amod(nitroglycerin-28, sublingual-27)
conj_and(digitalis-25, nitroglycerin-28)

There/EX is/VBZ limited/VBN experience/VBP with/IN concomitant/JJ antihypertensive/JJ agents/NNS such/JJ as/IN alpha-blockers/NNS ,/, calcium/NN channel-blockers/NNS ,/, ACE/NN inhibitors/NNS ,/, and/CC diuretics/NNS (/-LRB- both/CC thiazide/NN -like/JJ and/CC loop/NN )./NNS

(ROOT (S1 (S (NP (EX There)) (VP (VBZ is) (VP (VBN limited) (PP (VBP experience) (PP (IN with) (NP (NP (JJ concomitant) (JJ antihypertensive) (NNS agents)) (PP (JJ such) (IN as) (NP (NP (NNS alpha-blockers)) (, ,) (NP (NN calcium) (NNS channel-blockers)) (, ,) (NP (NN ACE) (NNS inhibitors)) (, ,) (CC and) (NP (NNS diuretics)) (-LRB- -LRB-) (CC both) (NP (NN thiazide) (JJ -like)) (CC and) (NP (NN loop) (NNS -RRB-.))))))))))))

expl(limited-3, There-1)
auxpass(limited-3, is-2)
root(ROOT-0, limited-3)
dep(limited-3, experience-4)
amod(agents-8, concomitant-6)
amod(agents-8, antihypertensive-7)
prep_with(limited-3, agents-8)
prep_such_as(agents-8, alpha-blockers-11)
nn(channel-blockers-14, calcium-13)
conj_and(alpha-blockers-11, channel-blockers-14)
nn(inhibitors-17, ACE-16)
conj_and(alpha-blockers-11, inhibitors-17)
conj_and(alpha-blockers-11, diuretics-20)
preconj(alpha-blockers-11, both-22)
conj_and(alpha-blockers-11, thiazide-23)
amod(thiazide-23, -like-24)
nn(-RRB-.-27, loop-26)
conj_and(alpha-blockers-11, -RRB-.-27)

The/DT coadministration/NN of/IN aspirin/NN decreases/VBZ the/DT biologic/JJ half-life/NN of/IN fenoprofen/NN because/IN of/IN an/DT increase/NN in/IN metabolic/JJ clearance/NN that/WDT results/VBZ in/IN a/DT greater/JJR amount/NN of/IN hydroxylated/JJ fenoprofen/NN in/IN the/DT urine/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN coadministration)) (PP (IN of) (NP (NN aspirin)))) (VP (VBZ decreases) (NP (NP (DT the) (JJ biologic) (NN half-life)) (PP (IN of) (NP (NN fenoprofen)))) (PP (IN because) (IN of) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (JJ metabolic) (NN clearance)) (SBAR (WHNP (WDT that)) (S (VP (VBZ results) (PP (IN in) (NP (NP (DT a) (JJR greater) (NN amount)) (PP (IN of) (NP (JJ hydroxylated) (NN fenoprofen))) (PP (IN in) (NP (DT the) (NN urine)))))))))))))) (. .))))

det(coadministration-2, The-1)
nsubj(decreases-5, coadministration-2)
prep_of(coadministration-2, aspirin-4)
root(ROOT-0, decreases-5)
det(half-life-8, the-6)
amod(half-life-8, biologic-7)
dobj(decreases-5, half-life-8)
prep_of(half-life-8, fenoprofen-10)
det(increase-14, an-13)
prep_because_of(decreases-5, increase-14)
amod(clearance-17, metabolic-16)
prep_in(increase-14, clearance-17)
nsubj(results-19, clearance-17)
rcmod(clearance-17, results-19)
det(amount-23, a-21)
amod(amount-23, greater-22)
prep_in(results-19, amount-23)
amod(fenoprofen-26, hydroxylated-25)
prep_of(amount-23, fenoprofen-26)
det(urine-29, the-28)
prep_in(amount-23, urine-29)

Although/IN the/DT mechanism/NN of/IN interaction/NN between/IN fenoprofen/NN and/CC aspirin/NN is/VBZ not/RB totally/RB known/VBN ,/, enzyme/NN induction/NN and/CC displacement/NN of/IN fenoprofen/NN from/IN plasma/NN albumin/NN binding/NN sites/NNS are/VBP possibilities/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NP (NN interaction)) (PP (IN between) (NP (NP (NN fenoprofen)) (CC and) (NP (NN aspirin))))))) (VP (VBZ is) (RB not) (ADVP (RB totally)) (VP (VBN known))))) (, ,) (NP (NP (NN enzyme) (NN induction)) (CC and) (NP (NP (NN displacement)) (PP (IN of) (NP (NN fenoprofen))) (PP (IN from) (NP (NN plasma) (NN albumin)))) (NP (NN binding) (NNS sites))) (VP (VBP are) (NP (NNS possibilities)))) (. .))))

mark(known-13, Although-1)
det(mechanism-3, the-2)
nsubjpass(known-13, mechanism-3)
prep_of(mechanism-3, interaction-5)
prep_between(interaction-5, fenoprofen-7)
conj_and(fenoprofen-7, aspirin-9)
auxpass(known-13, is-10)
neg(known-13, not-11)
advmod(known-13, totally-12)
advcl(possibilities-27, known-13)
nn(induction-16, enzyme-15)
nsubj(possibilities-27, induction-16)
conj_and(induction-16, displacement-18)
prep_of(displacement-18, fenoprofen-20)
nn(albumin-23, plasma-22)
prep_from(displacement-18, albumin-23)
nn(sites-25, binding-24)
dep(induction-16, sites-25)
cop(possibilities-27, are-26)
root(ROOT-0, possibilities-27)

Because/IN Nalfon/NN has/VBZ not/RB been/VBN shown/VBN to/TO produce/VB any/DT additional/JJ effect/NN beyond/IN that/DT obtained/VBN with/IN aspirin/NN alone/RB and/CC because/IN aspirin/NN increases/VBZ the/DT rate/NN of/IN excretion/NN of/IN Nalfon/NN ,/, the/DT concomitant/JJ use/NN of/IN Nalfon/NN and/CC salicylates/NNS is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (SBAR (SBAR (IN Because) (S (NP (NN Nalfon)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB produce) (NP (DT any) (JJ additional) (NN effect)) (PP (IN beyond) (NP (NP (DT that)) (VP (VBN obtained) (PP (IN with) (NP (NP (NN aspirin)) (ADVP (RB alone))))))))))))))) (CC and) (SBAR (IN because) (S (NP (NN aspirin)) (VP (VBZ increases) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NP (NN excretion)) (PP (IN of) (NP (NN Nalfon)))))))))) (, ,) (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN Nalfon)) (CC and) (NP (NNS salicylates))))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

mark(shown-6, Because-1)
nsubjpass(shown-6, Nalfon-2)
xsubj(produce-8, Nalfon-2)
aux(shown-6, has-3)
neg(shown-6, not-4)
auxpass(shown-6, been-5)
dep(recommended-38, shown-6)
aux(produce-8, to-7)
xcomp(shown-6, produce-8)
det(effect-11, any-9)
amod(effect-11, additional-10)
dobj(produce-8, effect-11)
prep_beyond(produce-8, that-13)
partmod(that-13, obtained-14)
prep_with(obtained-14, aspirin-16)
advmod(aspirin-16, alone-17)
mark(increases-21, because-19)
nsubj(increases-21, aspirin-20)
conj_and(shown-6, increases-21)
det(rate-23, the-22)
dobj(increases-21, rate-23)
prep_of(rate-23, excretion-25)
prep_of(excretion-25, Nalfon-27)
det(use-31, the-29)
amod(use-31, concomitant-30)
nsubjpass(recommended-38, use-31)
prep_of(use-31, Nalfon-33)
conj_and(Nalfon-33, salicylates-35)
auxpass(recommended-38, is-36)
neg(recommended-38, not-37)
root(ROOT-0, recommended-38)

Chronic/JJ administration/NN of/IN phenobarbital/NN ,/, a/DT known/JJ enzyme/NN inducer/NN ,/, may/MD be/VB associated/VBN with/IN a/DT decrease/NN in/IN the/DT plasma/NN half-life/NN of/IN fenoprofen/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Chronic) (NN administration)) (PP (IN of) (NP (NP (NN phenobarbital)) (, ,) (NP (DT a) (JJ known) (NN enzyme) (NN inducer)) (, ,)))) (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN plasma) (NN half-life)) (PP (IN of) (NP (NN fenoprofen))))))))))) (. .))))

amod(administration-2, Chronic-1)
nsubjpass(associated-13, administration-2)
prep_of(administration-2, phenobarbital-4)
det(inducer-9, a-6)
amod(inducer-9, known-7)
nn(inducer-9, enzyme-8)
appos(phenobarbital-4, inducer-9)
aux(associated-13, may-11)
auxpass(associated-13, be-12)
root(ROOT-0, associated-13)
det(decrease-16, a-15)
prep_with(associated-13, decrease-16)
det(half-life-20, the-18)
nn(half-life-20, plasma-19)
prep_in(decrease-16, half-life-20)
prep_of(half-life-20, fenoprofen-22)

When/WRB phenobarbital/NN is/VBZ added/VBN to/TO or/CC withdrawn/VBN from/IN treatment/NN ,/, dosage/NN adjustment/NN of/IN Nalfon/NN may/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN phenobarbital)) (VP (VBZ is) (VP (VP (VBN added) (PP (TO to))) (CC or) (VP (VBN withdrawn) (PP (IN from) (NP (NN treatment)))))))) (, ,) (NP (NP (NN dosage) (NN adjustment)) (PP (IN of) (NP (NN Nalfon)))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (. .))))

advmod(added-4, When-1)
nsubjpass(added-4, phenobarbital-2)
auxpass(added-4, is-3)
advcl(required-17, added-4)
prep(added-4, to-5)
conj_or(added-4, withdrawn-7)
prep_from(withdrawn-7, treatment-9)
nn(adjustment-12, dosage-11)
nsubjpass(required-17, adjustment-12)
prep_of(adjustment-12, Nalfon-14)
aux(required-17, may-15)
auxpass(required-17, be-16)
root(ROOT-0, required-17)

In/FW vitro/FW studies/NNS have/VBP shown/VBN that/IN fenoprofen/NN ,/, because/IN of/IN its/PRP$ affinity/NN for/IN albumin/NN ,/, may/MD displace/VB from/IN their/PRP$ binding/NN sites/NNS other/JJ drugs/NNS that/WDT are/VBP also/RB albumin/NN bound/VBN ,/, and/CC this/DT may/MD lead/VB to/TO drug/NN interaction/NN ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (S (NP (NN fenoprofen)) (, ,) (PP (IN because) (PP (IN of) (NP (NP (PRP$ its) (NN affinity)) (PP (IN for) (NP (NN albumin)))))) (, ,) (VP (MD may) (VP (VB displace) (PP (IN from) (NP (PRP$ their) (NN binding) (NNS sites))) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB also)) (VP (NN albumin) (VBN bound))))))))) (, ,) (CC and) (S (NP (DT this)) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NN drug) (NN interaction))))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(shown-5, studies-3)
aux(shown-5, have-4)
root(ROOT-0, shown-5)
complm(displace-17, that-6)
nsubj(displace-17, fenoprofen-7)
prepc_because_of(displace-17, of-10)
poss(affinity-12, its-11)
pobj(displace-17, affinity-12)
prep_for(affinity-12, albumin-14)
aux(displace-17, may-16)
ccomp(shown-5, displace-17)
poss(sites-21, their-19)
nn(sites-21, binding-20)
prep_from(displace-17, sites-21)
amod(drugs-23, other-22)
dobj(displace-17, drugs-23)
nsubjpass(bound-28, drugs-23)
auxpass(bound-28, are-25)
advmod(bound-28, also-26)
dep(bound-28, albumin-27)
rcmod(drugs-23, bound-28)
nsubj(lead-33, this-31)
aux(lead-33, may-32)
conj_and(displace-17, lead-33)
nn(interaction-36, drug-35)
prep_to(lead-33, interaction-36)

Theoretically/RB ,/, fenoprofen/NN could/MD likewise/RB be/VB displaced/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Theoretically)) (, ,) (NP (NN fenoprofen)) (VP (MD could) (ADVP (RB likewise)) (VP (VB be) (VP (VBN displaced))))) (. .))))

advmod(displaced-7, Theoretically-1)
nsubjpass(displaced-7, fenoprofen-3)
aux(displaced-7, could-4)
advmod(displaced-7, likewise-5)
auxpass(displaced-7, be-6)
root(ROOT-0, displaced-7)

Patients/NNS receiving/VBG hydantoins/NNS ,/, sulfonamides/NNS ,/, or/CC sulfonylureas/NNS should/MD be/VB observed/VBN for/IN increased/VBN activity/NN of/IN these/DT drugs/NNS and/CC ,/, therefore/RB ,/, signs/NNS of/IN toxicity/NN from/IN these/DT drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (NP (NNS hydantoins)) (, ,) (NP (NNS sulfonamides)) (, ,) (CC or) (NP (NNS sulfonylureas))))) (VP (VP (MD should) (VP (VB be) (VP (VBN observed) (PP (IN for) (NP (NP (VBN increased) (NN activity)) (PP (IN of) (NP (DT these) (NNS drugs)))))))) (CC and) (, ,) (ADVP (RB therefore)) (, ,) (NP (NP (NNS signs)) (PP (IN of) (NP (NN toxicity))) (PP (IN from) (NP (DT these) (NNS drugs)))))) (. .))))

nsubjpass(observed-11, Patients-1)
partmod(Patients-1, receiving-2)
dobj(receiving-2, hydantoins-3)
conj_or(hydantoins-3, sulfonamides-5)
conj_or(hydantoins-3, sulfonylureas-8)
aux(observed-11, should-9)
auxpass(observed-11, be-10)
root(ROOT-0, observed-11)
amod(activity-14, increased-13)
prep_for(observed-11, activity-14)
det(drugs-17, these-16)
prep_of(activity-14, drugs-17)
advmod(observed-11, therefore-20)
conj_and(observed-11, therefore-20)
conj_and(observed-11, signs-22)
dobj(observed-11, signs-22)
prep_of(signs-22, toxicity-24)
det(drugs-27, these-26)
prep_from(signs-22, drugs-27)

In/IN patients/NNS receiving/VBG coumarin-type/NN anticoagulants/NNS ,/, the/DT addition/NN of/IN Nalfon/NN to/TO therapy/NN could/MD prolong/VB the/DT prothrombin/NN time/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN coumarin-type) (NNS anticoagulants))))) (, ,) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN Nalfon))) (PP (TO to) (NP (NN therapy)))) (VP (MD could) (VP (VB prolong) (NP (DT the) (NN prothrombin) (NN time))))) (. .))))

prep_in(prolong-14, patients-2)
partmod(patients-2, receiving-3)
nn(anticoagulants-5, coumarin-type-4)
dobj(receiving-3, anticoagulants-5)
det(addition-8, the-7)
nsubj(prolong-14, addition-8)
prep_of(addition-8, Nalfon-10)
prep_to(addition-8, therapy-12)
aux(prolong-14, could-13)
root(ROOT-0, prolong-14)
det(time-17, the-15)
nn(time-17, prothrombin-16)
dobj(prolong-14, time-17)

Patients/NNS receiving/VBG both/DT drugs/NNS should/MD be/VB under/IN careful/JJ observation/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (DT both) (NNS drugs)))) (VP (MD should) (VP (VB be) (PP (IN under) (NP (JJ careful) (NN observation)))))) (. .))))

nsubj(be-6, Patients-1)
partmod(Patients-1, receiving-2)
det(drugs-4, both-3)
dobj(receiving-2, drugs-4)
aux(be-6, should-5)
root(ROOT-0, be-6)
amod(observation-9, careful-8)
prep_under(be-6, observation-9)

Patients/NNS treated/VBN with/IN Nalfon/NN may/MD be/VB resistant/JJ to/TO the/DT effects/NNS of/IN loop/NN diuretics/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBN treated) (PP (IN with) (NP (NN Nalfon))))) (VP (MD may) (VP (VB be) (ADJP (JJ resistant) (PP (TO to) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN loop) (NNS diuretics))))))))) (. .))))

nsubj(resistant-7, Patients-1)
partmod(Patients-1, treated-2)
prep_with(treated-2, Nalfon-4)
aux(resistant-7, may-5)
cop(resistant-7, be-6)
root(ROOT-0, resistant-7)
det(effects-10, the-9)
prep_to(resistant-7, effects-10)
nn(diuretics-13, loop-12)
prep_of(effects-10, diuretics-13)

In/IN patients/NNS receiving/VBG Nalfon/NN and/CC a/DT steroid/NN concomitantly/RB ,/, any/DT reduction/NN in/IN steroid/NN dosage/NN should/MD be/VB gradual/JJ in/IN order/NN to/TO avoid/VB the/DT possible/JJ complications/NNS of/IN sudden/CD steroid/NN withdrawal/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN Nalfon)))) (CC and) (NP (NP (DT a) (NN steroid)) (ADVP (RB concomitantly))))) (, ,) (NP (NP (DT any) (NN reduction)) (PP (IN in) (NP (NN steroid) (NN dosage)))) (VP (MD should) (VP (VB be) (ADJP (JJ gradual))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB avoid) (NP (NP (DT the) (JJ possible) (NNS complications)) (PP (IN of) (NP (CD sudden) (NN steroid) (NN withdrawal)))))))))) (. .))))

prep_in(gradual-17, patients-2)
partmod(patients-2, receiving-3)
dobj(receiving-3, Nalfon-4)
det(steroid-7, a-6)
conj_and(patients-2, steroid-7)
advmod(steroid-7, concomitantly-8)
det(reduction-11, any-10)
nsubj(gradual-17, reduction-11)
nn(dosage-14, steroid-13)
prep_in(reduction-11, dosage-14)
aux(gradual-17, should-15)
cop(gradual-17, be-16)
root(ROOT-0, gradual-17)
mark(avoid-21, in-18)
dep(avoid-21, order-19)
aux(avoid-21, to-20)
purpcl(gradual-17, avoid-21)
det(complications-24, the-22)
amod(complications-24, possible-23)
dobj(avoid-21, complications-24)
num(withdrawal-28, sudden-26)
nn(withdrawal-28, steroid-27)
prep_of(complications-24, withdrawal-28)

Agents/NNS Affecting/VBG Cytochrome/NN P450/NN 3A4/NN Isoenzyme/NN System/NN Fentanyl/NN is/VBZ metabolized/VBN mainly/RB via/IN the/DT human/JJ cytochrome/NN P450/NN 3A4/NN isoenzyme/NN system/NN (/-LRB- CYP3A4/NN )/-RRB- ,/, therefore/RB potential/JJ interactions/NNS may/MD occur/VB when/WRB DURAGESIC/JJ @/NN is/VBZ given/VBN concurrently/RB with/IN agents/NNS that/WDT affect/VBP CYP3A4/NN activity/NN ./.

(ROOT (S1 (S (NP (NP (NNS Agents)) (VP (VBG Affecting) (NP (NP (NP (NN Cytochrome) (NN P450) (NN 3A4)) (S (NP (NN Isoenzyme) (NN System) (NN Fentanyl)) (VP (VBZ is) (VP (VBN metabolized) (ADVP (RB mainly)) (PP (IN via) (NP (DT the) (NP (JJ human) (NN cytochrome) (NN P450) (NN 3A4)) (NN isoenzyme) (NN system))))))) (PRN (-LRB- -LRB-) (NP (NN CYP3A4)) (-RRB- -RRB-))))) (, ,) (ADVP (RB therefore)) (NP (JJ potential) (NNS interactions)) (VP (MD may) (VP (VB occur) (SBAR (WHADVP (WRB when)) (S (NP (JJ DURAGESIC) (NN @)) (VP (VBZ is) (VP (VBN given) (ADVP (RB concurrently)) (PP (IN with) (NP (NP (NNS agents)) (SBAR (WHNP (WDT that)) (S (VP (VBP affect) (NP (NN CYP3A4) (NN activity))))))))))))) (. .))))

nsubj(occur-28, Agents-1)
partmod(Agents-1, Affecting-2)
nn(3A4-5, Cytochrome-3)
nn(3A4-5, P450-4)
dobj(Affecting-2, 3A4-5)
nn(Fentanyl-8, Isoenzyme-6)
nn(Fentanyl-8, System-7)
nsubjpass(metabolized-10, Fentanyl-8)
auxpass(metabolized-10, is-9)
dep(3A4-5, metabolized-10)
advmod(metabolized-10, mainly-11)
det(system-19, the-13)
amod(3A4-17, human-14)
nn(3A4-17, cytochrome-15)
nn(3A4-17, P450-16)
nn(system-19, 3A4-17)
nn(system-19, isoenzyme-18)
prep_via(metabolized-10, system-19)
abbrev(3A4-5, CYP3A4-21)
advmod(occur-28, therefore-24)
amod(interactions-26, potential-25)
nsubj(occur-28, interactions-26)
aux(occur-28, may-27)
root(ROOT-0, occur-28)
advmod(given-33, when-29)
amod(@-31, DURAGESIC-30)
nsubjpass(given-33, @-31)
auxpass(given-33, is-32)
advcl(occur-28, given-33)
advmod(given-33, concurrently-34)
prep_with(given-33, agents-36)
nsubj(affect-38, agents-36)
rcmod(agents-36, affect-38)
nn(activity-40, CYP3A4-39)
dobj(affect-38, activity-40)

The/DT concomitant/JJ use/NN of/IN transdermal/JJ fentanyl/NN with/IN ritonavir/NN or/CC other/JJ potent/JJ 3A4/NN inhibitors/NNS such/JJ as/IN ketoconazole/NN ,/, itraconazole/NN ,/, troleandomycin/NN ,/, clarithromycin/NN ,/, nelfinavir/NN ,/, and/CC nefazadone/NN may/MD result/VB in/IN an/DT increase/NN in/IN fentanyl/NN plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (JJ transdermal) (NN fentanyl))) (PP (IN with) (NP (NP (NN ritonavir)) (CC or) (NP (NP (JJ other) (JJ potent) (NN 3A4) (NNS inhibitors)) (PP (JJ such) (IN as) (NP (NP (NN ketoconazole)) (, ,) (NP (NN itraconazole)) (, ,) (NP (NN troleandomycin)) (, ,) (NP (NN clarithromycin)) (, ,) (NP (NN nelfinavir)) (, ,) (CC and) (NP (NN nefazadone)))))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN fentanyl) (NN plasma) (NNS concentrations)))))))) (. .))))

det(use-3, The-1)
amod(use-3, concomitant-2)
nsubj(result-29, use-3)
amod(fentanyl-6, transdermal-5)
prep_of(use-3, fentanyl-6)
prep_with(use-3, ritonavir-8)
amod(inhibitors-13, other-10)
amod(inhibitors-13, potent-11)
nn(inhibitors-13, 3A4-12)
conj_or(ritonavir-8, inhibitors-13)
prep_such_as(inhibitors-13, ketoconazole-16)
conj_and(ketoconazole-16, itraconazole-18)
conj_and(ketoconazole-16, troleandomycin-20)
conj_and(ketoconazole-16, clarithromycin-22)
conj_and(ketoconazole-16, nelfinavir-24)
conj_and(ketoconazole-16, nefazadone-27)
aux(result-29, may-28)
root(ROOT-0, result-29)
det(increase-32, an-31)
prep_in(result-29, increase-32)
nn(concentrations-36, fentanyl-34)
nn(concentrations-36, plasma-35)
prep_in(increase-32, concentrations-36)

The/DT concomitant/JJ use/NN of/IN other/JJ CYP3A4/JJ inhibitors/NNS such/JJ as/IN diltiazem/NN and/CC erythromycin/NN with/IN transdermal/JJ fentanyl/NN may/MD also/RB result/VB in/IN an/DT increase/NN in/IN fentanyl/NN plasma/NN concentrations/NNS ,/, which/WDT could/MD increase/VB or/CC prolong/VB adverse/JJ drug/NN effects/NNS and/CC may/MD cause/VB serious/JJ respiratory/JJ depression/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (JJ other) (JJ CYP3A4) (NNS inhibitors)) (PP (JJ such) (IN as) (NP (NP (NN diltiazem)) (CC and) (NP (NN erythromycin)))))) (PP (IN with) (NP (JJ transdermal) (NN fentanyl)))) (VP (MD may) (ADVP (RB also)) (VP (VB result) (PP (IN in) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN fentanyl) (NN plasma) (NNS concentrations))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (MD could) (VP (VP (VB increase)) (CC or) (VP (VB prolong) (NP (JJ adverse) (NN drug) (NNS effects))))) (CC and) (VP (MD may) (VP (VB cause) (NP (JJ serious) (JJ respiratory) (NN depression)))))))))))) (. .))))

det(use-3, The-1)
amod(use-3, concomitant-2)
nsubj(result-18, use-3)
amod(inhibitors-7, other-5)
amod(inhibitors-7, CYP3A4-6)
prep_of(use-3, inhibitors-7)
prep_such_as(inhibitors-7, diltiazem-10)
conj_and(diltiazem-10, erythromycin-12)
amod(fentanyl-15, transdermal-14)
prep_with(use-3, fentanyl-15)
aux(result-18, may-16)
advmod(result-18, also-17)
root(ROOT-0, result-18)
det(increase-21, an-20)
prep_in(result-18, increase-21)
nsubj(increase-29, increase-21)
nn(concentrations-25, fentanyl-23)
nn(concentrations-25, plasma-24)
prep_in(increase-21, concentrations-25)
aux(increase-29, could-28)
rcmod(increase-21, increase-29)
conj_or(increase-29, prolong-31)
amod(effects-34, adverse-32)
nn(effects-34, drug-33)
dobj(prolong-31, effects-34)
aux(cause-37, may-36)
conj_and(increase-29, cause-37)
amod(depression-40, serious-38)
amod(depression-40, respiratory-39)
dobj(cause-37, depression-40)

Central/JJ Nervous/JJ System/NN Depressants/NNS :/: The/DT concomitant/JJ use/NN of/IN DURAGESIC/JJ @/NN (/-LRB- fentanyl/NN transdermal/JJ system/NN )/-RRB- with/IN other/JJ central/JJ nervous/JJ system/NN depressants/NNS ,/, including/VBG but/CC not/RB limited/JJ to/TO other/JJ opioids/NNS ,/, sedatives/NNS ,/, hypnotics/NNS ,/, tranquilizers/NNS (/-LRB- e.g./FW ,/, benzodiazepines/NNS )/-RRB- ,/, general/JJ anesthetics/NNS ,/, phenothiazines/NNS ,/, skeletal/JJ muscle/NN relaxants/NNS ,/, and/CC alcohol/NN ,/, may/MD cause/VB respiratory/JJ depression/NN ,/, hypotension/NN ,/, and/CC profound/JJ sedation/NN ,/, or/CC potentially/RB result/VB in/IN coma/NN or/CC death/NN ./.

(ROOT (S1 (S (NP (NP (NP (JJ Central) (JJ Nervous) (NN System)) (NNS Depressants)) (: :) (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NP (JJ DURAGESIC) (NN @)) (PRN (-LRB- -LRB-) (NP (NN fentanyl) (JJ transdermal) (NN system)) (-RRB- -RRB-))) (PP (IN with) (NP (NP (JJ other) (JJ central) (JJ nervous) (NN system) (NNS depressants)) (, ,) (S (VP (VBG including) (UCP (CC but) (ADJP (RB not) (JJ limited) (PP (TO to) (NP (JJ other) (NNS opioids)))) (, ,) (NP (NP (NNS sedatives)) (, ,) (NP (NNS hypnotics)) (, ,) (NP (NP (NNS tranquilizers)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NNS benzodiazepines)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (JJ general) (NNS anesthetics)) (, ,) (NP (NNS phenothiazines)) (, ,) (NP (JJ skeletal) (NN muscle) (NNS relaxants)) (, ,) (CC and) (NP (NN alcohol))) (, ,) (VP (MD may) (VP (VB cause) (NP (JJ respiratory) (NN depression))))) (, ,) (NP (NN hypotension)) (, ,) (CC and) (NP (JJ profound) (NN sedation)))) (, ,) (CC or) (ADVP (RB potentially)) (VP (VB result) (PP (IN in) (NP (NP (NN coma)) (CC or) (NP (NN death)))))))))))) (. .)))))

amod(System-3, Central-1)
amod(System-3, Nervous-2)
nn(Depressants-4, System-3)
root(ROOT-0, Depressants-4)
det(use-8, The-6)
amod(use-8, concomitant-7)
dep(Depressants-4, use-8)
amod(@-11, DURAGESIC-10)
prep_of(use-8, @-11)
nn(system-15, fentanyl-13)
amod(system-15, transdermal-14)
appos(@-11, system-15)
amod(depressants-22, other-18)
amod(depressants-22, central-19)
amod(depressants-22, nervous-20)
nn(depressants-22, system-21)
prep_with(@-11, depressants-22)
dep(depressants-22, including-24)
dep(including-24, but-25)
neg(limited-27, not-26)
dep(but-25, limited-27)
amod(opioids-30, other-29)
prep_to(limited-27, opioids-30)
dep(but-25, sedatives-32)
conj_and(sedatives-32, hypnotics-34)
conj_and(sedatives-32, tranquilizers-36)
dep(benzodiazepines-40, e.g.-38)
appos(tranquilizers-36, benzodiazepines-40)
amod(anesthetics-44, general-43)
conj_and(sedatives-32, anesthetics-44)
conj_and(anesthetics-44, phenothiazines-46)
amod(relaxants-50, skeletal-48)
nn(relaxants-50, muscle-49)
conj_and(anesthetics-44, relaxants-50)
conj_and(anesthetics-44, alcohol-53)
aux(cause-56, may-55)
dep(anesthetics-44, cause-56)
amod(depression-58, respiratory-57)
dobj(cause-56, depression-58)
conj_and(sedatives-32, hypotension-60)
amod(sedation-64, profound-63)
conj_and(sedatives-32, sedation-64)
advmod(including-24, potentially-67)
conj_or(including-24, potentially-67)
conj_or(including-24, result-68)
prep_in(result-68, coma-70)
conj_or(coma-70, death-72)

MAO/NN Inhibitors/NNS DURAGESIC/JJ @/NN is/VBZ not/RB recommended/VBN for/IN use/NN in/IN patients/NNS who/WP have/VBP received/VBN MAOI/NN within/IN 14/CD days/NNS because/IN severe/JJ and/CC unpredictable/JJ potentiation/NN by/IN MAO/NN inhibitors/NNS has/VBZ been/VBN reported/VBN with/IN opioid/JJ analgesics/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN MAO) (NNS Inhibitors)) (JJ DURAGESIC) (NN @)) (VP (VBZ is) (RB not) (VP (VBN recommended) (PP (IN for) (NP (NP (NN use)) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN received) (NP (NP (NN MAOI)) (PP (IN within) (NP (CD 14) (NNS days)))) (SBAR (IN because) (S (NP (NP (ADJP (ADJP (JJ severe)) (CC and) (ADJP (JJ unpredictable))) (NN potentiation)) (PP (IN by) (NP (NN MAO) (NNS inhibitors)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (JJ opioid) (NNS analgesics))))))))))))))))))) (. .))))

nn(Inhibitors-2, MAO-1)
nn(@-4, Inhibitors-2)
amod(@-4, DURAGESIC-3)
nsubjpass(recommended-7, @-4)
auxpass(recommended-7, is-5)
neg(recommended-7, not-6)
root(ROOT-0, recommended-7)
prep_for(recommended-7, use-9)
prep_in(use-9, patients-11)
nsubj(received-14, patients-11)
aux(received-14, have-13)
rcmod(patients-11, received-14)
dobj(received-14, MAOI-15)
num(days-18, 14-17)
prep_within(MAOI-15, days-18)
mark(reported-29, because-19)
amod(potentiation-23, severe-20)
conj_and(severe-20, unpredictable-22)
nsubjpass(reported-29, potentiation-23)
nn(inhibitors-26, MAO-25)
prep_by(potentiation-23, inhibitors-26)
aux(reported-29, has-27)
auxpass(reported-29, been-28)
advcl(received-14, reported-29)
amod(analgesics-32, opioid-31)
prep_with(reported-29, analgesics-32)

Drug/NN interactions/NNS between/IN NEUPOGEN/JJ @/NN and/CC other/JJ drugs/NNS have/VBP not/RB been/VBN fully/RB evaluated/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NNS interactions)) (PP (IN between) (NP (NP (JJ NEUPOGEN) (NN @)) (CC and) (NP (JJ other) (NNS drugs))))) (VP (VBP have) (RB not) (VP (VBN been) (ADVP (RB fully)) (VP (VBN evaluated))))) (. .))))

nn(interactions-2, Drug-1)
nsubjpass(evaluated-13, interactions-2)
amod(@-5, NEUPOGEN-4)
prep_between(interactions-2, @-5)
amod(drugs-8, other-7)
conj_and(@-5, drugs-8)
aux(evaluated-13, have-9)
neg(evaluated-13, not-10)
auxpass(evaluated-13, been-11)
advmod(evaluated-13, fully-12)
root(ROOT-0, evaluated-13)

Drugs/NNS which/WDT may/MD potentiate/VB the/DT release/NN of/IN neutrophils/NNS ,/, such/JJ as/IN lithium/NN ,/, should/MD be/VB used/VBN with/IN caution/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (NNS neutrophils)))))))) (, ,) (PP (JJ such) (IN as) (NP (NN lithium))) (, ,)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN caution))))))) (. .))))

nsubj(potentiate-4, Drugs-1)
nsubjpass(used-16, Drugs-1)
aux(potentiate-4, may-3)
rcmod(Drugs-1, potentiate-4)
det(release-6, the-5)
dobj(potentiate-4, release-6)
prep_of(release-6, neutrophils-8)
prep_such_as(Drugs-1, lithium-12)
aux(used-16, should-14)
auxpass(used-16, be-15)
root(ROOT-0, used-16)
prep_with(used-16, caution-18)

Finasteride/NN does/VBZ not/RB appear/VB to/TO affect/VB the/DT cytochrome/NN P450/NN -linked/JJ drug-metabolizing/JJ enzyme/NN system/NN ./.

(ROOT (S1 (S (S (NP (NN Finasteride)) (VP (VBZ does) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB affect) (NP (DT the) (NN cytochrome) (NN P450) (JJ -linked) (JJ drug-metabolizing) (NN enzyme) (NN system)))))))) (. .))))

nsubj(appear-4, Finasteride-1)
xsubj(affect-6, Finasteride-1)
aux(appear-4, does-2)
neg(appear-4, not-3)
root(ROOT-0, appear-4)
aux(affect-6, to-5)
xcomp(appear-4, affect-6)
det(system-13, the-7)
nn(system-13, cytochrome-8)
nn(system-13, P450-9)
amod(system-13, -linked-10)
amod(system-13, drug-metabolizing-11)
nn(system-13, enzyme-12)
dobj(affect-6, system-13)

Compounds/NNS that/WDT have/VBP been/VBN tested/VBN in/IN man/NN include/VBP antipyrine/NN ,/, digoxin/NN ,/, propranolol/NN ,/, theophylline/NN ,/, and/CC warfarin/NN and/CC no/DT clinically/RB meaningful/JJ interactions/NNS were/VBD found/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (NNS Compounds)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (VP (VBN been) (VP (VBN tested) (PP (IN in) (NP (NN man))))))))) (VP (VBP include) (NP (NP (NN antipyrine)) (, ,) (NP (NN digoxin)) (, ,) (NP (NN propranolol)) (, ,) (NP (NN theophylline)) (, ,) (CC and) (NP (NN warfarin))))) (CC and) (S (NP (DT no) (ADJP (RB clinically) (JJ meaningful)) (NNS interactions)) (VP (VBD were) (VP (VBN found))))) (. .))))

nsubjpass(tested-5, Compounds-1)
nsubj(include-8, Compounds-1)
aux(tested-5, have-3)
auxpass(tested-5, been-4)
rcmod(Compounds-1, tested-5)
prep_in(tested-5, man-7)
root(ROOT-0, include-8)
dobj(include-8, antipyrine-9)
conj_and(antipyrine-9, digoxin-11)
conj_and(antipyrine-9, propranolol-13)
conj_and(antipyrine-9, theophylline-15)
conj_and(antipyrine-9, warfarin-18)
det(interactions-23, no-20)
advmod(meaningful-22, clinically-21)
amod(interactions-23, meaningful-22)
nsubjpass(found-25, interactions-23)
auxpass(found-25, were-24)
conj_and(include-8, found-25)

Other/JJ concomitant/JJ therapy/NN Although/IN specific/JJ interaction/NN studies/NNS were/VBD not/RB performed/VBN ,/, finasteride/NN doses/NNS of/IN 1/CD mg/NN or/CC more/JJR were/VBD concomitantly/RB used/VBN in/IN clinical/JJ studies/NNS with/IN acetaminophen/NN ,/, acetylsalicylic/JJ acid/NN ,/, a-blockers/NNS ,/, analgesics/NNS ,/, angiotensin-converting/JJ enzyme/NN (/-LRB- ACE/NN )/-RRB- inhibitors/NNS ,/, anticonvulsants/NNS ,/, benzodiazepines/NN ,/, beta/NN blockers/NNS ,/, calcium-channel/NN blockers/NNS ,/, cardiac/JJ nitrates/NNS ,/, diuretics/NN ,/, H2/NNP antagonists/NNS ,/, HMG-CoA/NN reductase/NN inhibitors/NNS ,/, prostaglandin/NN synthetase/NN inhibitors/NNS (/-LRB- also/RB referred/VBN to/TO as/JJ NSAIDs/NNS )/-RRB- ,/, and/CC quinolone/NN anti-infectives/NNS without/IN evidence/NN of/IN clinically/RB significant/JJ adverse/JJ interactions/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Other) (JJ concomitant) (NN therapy)) (PP (IN Although) (NP (JJ specific) (NN interaction) (NNS studies)))) (VP (VBD were) (RB not) (VP (VBN performed)))) (, ,) (S (NP (NP (NN finasteride) (NNS doses)) (PP (IN of) (NP (NP (CD 1) (NN mg)) (CC or) (NP (JJR more))))) (VP (VBD were) (ADVP (RB concomitantly)) (VP (VBN used) (PP (IN in) (NP (NP (JJ clinical) (NNS studies)) (PP (IN with) (NP (NP (UCP (NP (NN acetaminophen)) (, ,) (NP (JJ acetylsalicylic) (NN acid)) (, ,) (NP (NNS a-blockers)) (, ,) (NP (NNS analgesics)) (, ,) (NP (NP (JJ angiotensin-converting) (NN enzyme) (-LRB- -LRB-) (NN ACE) (-RRB- -RRB-) (NNS inhibitors)) (, ,) (NP (NNS anticonvulsants)) (, ,) (NP (NN benzodiazepines)) (, ,) (NP (NN beta) (NNS blockers)) (, ,) (NP (NN calcium-channel) (NNS blockers)) (, ,) (NP (JJ cardiac) (NNS nitrates)) (, ,) (NP (NN diuretics)) (, ,) (NP (NNP H2)))) (NNS antagonists)) (, ,) (NP (NN HMG-CoA) (NN reductase) (NNS inhibitors)) (, ,) (NP (NP (NN prostaglandin) (NN synthetase) (NNS inhibitors)) (PRN (-LRB- -LRB-) (ADVP (RB also)) (VP (VBN referred) (PP (TO to) (NP (JJ as) (NNS NSAIDs)))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN quinolone) (NNS anti-infectives)) (PP (IN without) (NP (NP (NN evidence)) (PP (IN of) (NP (ADJP (RB clinically) (JJ significant)) (JJ adverse) (NNS interactions))))))))))))) (. .))))

amod(therapy-3, Other-1)
amod(therapy-3, concomitant-2)
nsubjpass(performed-10, therapy-3)
amod(studies-7, specific-5)
nn(studies-7, interaction-6)
prep_although(therapy-3, studies-7)
auxpass(performed-10, were-8)
neg(performed-10, not-9)
root(ROOT-0, performed-10)
nn(doses-13, finasteride-12)
nsubjpass(used-21, doses-13)
num(mg-16, 1-15)
prep_of(doses-13, mg-16)
conj_or(mg-16, more-18)
auxpass(used-21, were-19)
advmod(used-21, concomitantly-20)
ccomp(performed-10, used-21)
amod(studies-24, clinical-23)
prep_in(used-21, studies-24)
nn(antagonists-58, acetaminophen-26)
amod(acid-29, acetylsalicylic-28)
appos(acetaminophen-26, acid-29)
appos(acetaminophen-26, a-blockers-31)
appos(acetaminophen-26, analgesics-33)
amod(inhibitors-40, angiotensin-converting-35)
nn(inhibitors-40, enzyme-36)
nn(inhibitors-40, ACE-38)
appos(acetaminophen-26, inhibitors-40)
appos(inhibitors-40, anticonvulsants-42)
appos(inhibitors-40, benzodiazepines-44)
nn(blockers-47, beta-46)
appos(inhibitors-40, blockers-47)
nn(blockers-50, calcium-channel-49)
appos(inhibitors-40, blockers-50)
amod(nitrates-53, cardiac-52)
appos(inhibitors-40, nitrates-53)
appos(inhibitors-40, diuretics-55)
appos(inhibitors-40, H2-57)
prep_with(studies-24, antagonists-58)
nn(inhibitors-62, HMG-CoA-60)
nn(inhibitors-62, reductase-61)
conj_and(antagonists-58, inhibitors-62)
nn(inhibitors-66, prostaglandin-64)
nn(inhibitors-66, synthetase-65)
conj_and(antagonists-58, inhibitors-66)
dep(referred-69, also-68)
dep(inhibitors-66, referred-69)
amod(NSAIDs-72, as-71)
prep_to(referred-69, NSAIDs-72)
nn(anti-infectives-77, quinolone-76)
conj_and(antagonists-58, anti-infectives-77)
prep_without(anti-infectives-77, evidence-79)
advmod(significant-82, clinically-81)
amod(interactions-84, significant-82)
amod(interactions-84, adverse-83)
prep_of(evidence-79, interactions-84)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS Finasteride/NN had/VBD no/DT effect/NN on/IN circulating/JJ levels/NNS of/IN cortisol/NN ,/, thyroid-stimulating/JJ hormone/NN ,/, or/CC thyroxine/NN ,/, nor/CC did/VBD it/PRP affect/VB the/DT plasma/NN lipid/NN profile/NN (/-LRB- e.g./FW ,/, total/JJ cholesterol/NN ,/, low-density/JJ lipoproteins/NNS ,/, high-density/JJ lipoproteins/NNS and/CC triglycerides/NNS )/-RRB- or/CC bone/NN mineral/JJ density/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (NN Finasteride)) (VP (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (JJ circulating) (NNS levels)) (PP (IN of) (NP (NP (NN cortisol)) (, ,) (NP (JJ thyroid-stimulating) (NN hormone)) (, ,) (CC or) (NP (NN thyroxine))))))) (, ,) (CC nor) (VP (VBD did) (NP (PRP it)) (VP (VB affect) (NP (NP (NP (DT the) (NN plasma) (NN lipid) (NN profile)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (JJ total) (NN cholesterol)) (, ,) (NP (JJ low-density) (NNS lipoproteins)) (, ,) (NP (JJ high-density) (NNS lipoproteins)) (CC and) (NP (NNS triglycerides)))) (-RRB- -RRB-))) (CC or) (NP (NN bone) (JJ mineral) (NN density))))))) (. .))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
nn(Finasteride-5, Interactions-4)
nsubj(had-6, Finasteride-5)
root(ROOT-0, had-6)
det(effect-8, no-7)
dobj(had-6, effect-8)
amod(levels-11, circulating-10)
prep_on(had-6, levels-11)
prep_of(levels-11, cortisol-13)
amod(hormone-16, thyroid-stimulating-15)
conj_or(cortisol-13, hormone-16)
conj_or(cortisol-13, thyroxine-19)
aux(affect-24, did-22)
dobj(affect-24, it-23)
conj_nor(had-6, affect-24)
det(profile-28, the-25)
nn(profile-28, plasma-26)
nn(profile-28, lipid-27)
dobj(affect-24, profile-28)
dep(profile-28, e.g.-30)
amod(cholesterol-33, total-32)
pobj(e.g.-30, cholesterol-33)
amod(lipoproteins-36, low-density-35)
conj_and(cholesterol-33, lipoproteins-36)
amod(lipoproteins-39, high-density-38)
conj_and(cholesterol-33, lipoproteins-39)
conj_and(cholesterol-33, triglycerides-41)
nn(density-46, bone-44)
amod(density-46, mineral-45)
conj_or(profile-28, density-46)

In/IN studies/NNS with/IN finasteride/NN ,/, no/DT clinically/RB meaningful/JJ changes/NNS in/IN luteinizing/JJ hormone/NN (/-LRB- LH/NN )/-RRB- ,/, follicle-stimulating/JJ hormone/NN (/-LRB- FSH/NN )/-RRB- or/CC prolactin/NN were/VBD detected/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NNS studies)) (PP (IN with) (NP (NN finasteride))))) (, ,) (NP (NP (DT no) (ADJP (RB clinically) (JJ meaningful)) (NNS changes)) (PP (IN in) (NP (NP (NP (JJ luteinizing) (NN hormone)) (PRN (-LRB- -LRB-) (NP (NN LH)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ follicle-stimulating) (NN hormone)) (PRN (-LRB- -LRB-) (NP (NN FSH)) (-RRB- -RRB-))) (CC or) (NP (NN prolactin))))) (VP (VBD were) (VP (VBN detected)))) (. .))))

prep_in(detected-25, studies-2)
prep_with(studies-2, finasteride-4)
det(changes-9, no-6)
advmod(meaningful-8, clinically-7)
amod(changes-9, meaningful-8)
nsubjpass(detected-25, changes-9)
amod(hormone-12, luteinizing-11)
prep_in(changes-9, hormone-12)
abbrev(hormone-12, LH-14)
amod(hormone-18, follicle-stimulating-17)
conj_or(hormone-12, hormone-18)
abbrev(hormone-18, FSH-20)
conj_or(hormone-12, prolactin-23)
auxpass(detected-25, were-24)
root(ROOT-0, detected-25)

In/IN healthy/JJ volunteers/NNS ,/, treatment/NN with/IN finasteride/NN did/VBD not/RB alter/VB the/DT response/NN of/IN LH/NN and/CC FSH/NN to/TO gonadotropin-releasing/JJ hormone/NN indicating/VBG that/IN the/DT hypothalamic-pituitary-testicular/JJ axis/NN was/VBD not/RB affected/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ healthy) (NNS volunteers))) (, ,) (NP (NP (NN treatment)) (PP (IN with) (NP (NN finasteride)))) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (NN response)) (PP (IN of) (NP (NP (NN LH)) (CC and) (NP (NN FSH)))) (PP (TO to) (NP (JJ gonadotropin-releasing) (NN hormone))))) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (DT the) (JJ hypothalamic-pituitary-testicular) (NN axis)) (VP (VBD was) (RB not) (VP (VBN affected))))))))) (. .))))

amod(volunteers-3, healthy-2)
prep_in(alter-10, volunteers-3)
nsubj(alter-10, treatment-5)
prep_with(treatment-5, finasteride-7)
aux(alter-10, did-8)
neg(alter-10, not-9)
root(ROOT-0, alter-10)
det(response-12, the-11)
dobj(alter-10, response-12)
prep_of(response-12, LH-14)
conj_and(LH-14, FSH-16)
amod(hormone-19, gonadotropin-releasing-18)
prep_to(response-12, hormone-19)
xcomp(alter-10, indicating-20)
complm(affected-27, that-21)
det(axis-24, the-22)
amod(axis-24, hypothalamic-pituitary-testicular-23)
nsubjpass(affected-27, axis-24)
auxpass(affected-27, was-25)
neg(affected-27, not-26)
ccomp(indicating-20, affected-27)

In/IN clinical/JJ studies/NNS with/IN PROPECIA/NN (/-LRB- finasteride/NN ,/, 1/CD mg/NN )/-RRB- in/IN men/NNS 18-41/CD years/NNS of/IN age/NN ,/, the/DT mean/NN value/NN of/IN serum/NN prostate-specific/JJ antigen/NN (/-LRB- PSA/NN )/-RRB- decreased/VBD from/IN 0.7/CD ng/mL/NN at/IN baseline/NN to/TO 0.5/CD ng/mL/NN at/IN Month/NN 12/CD ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (JJ clinical) (NNS studies)) (PP (IN with) (NP (NP (NP (NN PROPECIA)) (PRN (-LRB- -LRB-) (NP (NP (NN finasteride)) (, ,) (NP (CD 1) (NN mg))) (-RRB- -RRB-))) (PP (IN in) (NP (NP (NNS men) (CD 18-41) (NNS years)) (PP (IN of) (NP (NN age))))))))) (, ,) (NP (NP (DT the) (NN mean) (NN value)) (PP (IN of) (NP (NP (NN serum) (JJ prostate-specific) (NN antigen)) (PRN (-LRB- -LRB-) (NP (NN PSA)) (-RRB- -RRB-))))) (VP (VBD decreased) (PP (IN from) (NP (CD 0.7) (NN ng/mL))) (PP (IN at) (NP (NN baseline))) (PP (TO to) (NP (NP (CD 0.5) (NN ng/mL)) (PP (IN at) (NP (NN Month) (CD 12)))))) (. .))))

amod(studies-3, clinical-2)
prep_in(decreased-29, studies-3)
prep_with(studies-3, PROPECIA-5)
dep(PROPECIA-5, finasteride-7)
num(mg-10, 1-9)
appos(finasteride-7, mg-10)
nn(years-15, men-13)
num(years-15, 18-41-14)
prep_in(PROPECIA-5, years-15)
prep_of(years-15, age-17)
det(value-21, the-19)
nn(value-21, mean-20)
nsubj(decreased-29, value-21)
nn(antigen-25, serum-23)
amod(antigen-25, prostate-specific-24)
prep_of(value-21, antigen-25)
abbrev(antigen-25, PSA-27)
root(ROOT-0, decreased-29)
num(ng/mL-32, 0.7-31)
prep_from(decreased-29, ng/mL-32)
prep_at(decreased-29, baseline-34)
num(ng/mL-37, 0.5-36)
prep_to(decreased-29, ng/mL-37)
prep_at(ng/mL-37, Month-39)
num(Month-39, 12-40)

Further/RB ,/, in/IN clinical/JJ studies/NNS with/IN PROSCAR/NN (/-LRB- finasteride/NN ,/, 5/CD mg/NN )/-RRB- when/WRB used/VBN in/IN older/JJR men/NNS who/WP have/VBP benign/JJ prostatic/JJ hyperplasia/NN (/-LRB- BPH/NN )/-RRB- ,/, PSA/NN levels/NNS are/VBP decreased/VBN by/IN approximately/RB 50/CD %./NN

(ROOT (S1 (S (ADVP (RB Further)) (, ,) (PP (IN in) (NP (NP (JJ clinical) (NNS studies)) (PP (IN with) (NP (NP (NN PROSCAR)) (PRN (-LRB- -LRB-) (NP (NP (NN finasteride)) (, ,) (NP (CD 5) (NN mg))) (-RRB- -RRB-)))))) (S (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (PP (IN in) (NP (NP (JJR older) (NNS men)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (NP (NP (JJ benign) (JJ prostatic) (NN hyperplasia)) (PRN (-LRB- -LRB-) (NP (NN BPH)) (-RRB- -RRB-))))))))))) (, ,) (S (NP (NN PSA) (NNS levels)) (VP (VBP are) (VP (VBN decreased) (PP (IN by) (NP (QP (RB approximately) (CD 50)) (NN %.))))))))))

advmod(decreased-31, Further-1)
amod(studies-5, clinical-4)
prep_in(decreased-31, studies-5)
prep_with(studies-5, PROSCAR-7)
dep(PROSCAR-7, finasteride-9)
num(mg-12, 5-11)
appos(finasteride-9, mg-12)
advmod(used-15, when-14)
advcl(decreased-31, used-15)
amod(men-18, older-17)
prep_in(used-15, men-18)
nsubj(have-20, men-18)
rcmod(men-18, have-20)
amod(hyperplasia-23, benign-21)
amod(hyperplasia-23, prostatic-22)
dobj(have-20, hyperplasia-23)
abbrev(hyperplasia-23, BPH-25)
nn(levels-29, PSA-28)
nsubjpass(decreased-31, levels-29)
auxpass(decreased-31, are-30)
root(ROOT-0, decreased-31)
quantmod(50-34, approximately-33)
num(%.-35, 50-34)
agent(decreased-31, %.-35)

These/DT findings/NNS should/MD be/VB taken/VBN into/IN account/NN for/IN proper/JJ interpretation/NN of/IN serum/NN PSA/NN when/WRB evaluating/VBG men/NNS treated/VBN with/IN finasteride/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS findings)) (VP (MD should) (VP (VB be) (VP (VBN taken) (PP (IN into) (NP (NN account))) (PP (IN for) (NP (NP (JJ proper) (NN interpretation)) (PP (IN of) (NP (NN serum) (NN PSA))))) (SBAR (WHADVP (WRB when)) (S (VP (VBG evaluating) (NP (NP (NNS men)) (VP (VBN treated) (PP (IN with) (NP (NN finasteride)))))))))))) (. .))))

det(findings-2, These-1)
nsubjpass(taken-5, findings-2)
aux(taken-5, should-3)
auxpass(taken-5, be-4)
root(ROOT-0, taken-5)
prep_into(taken-5, account-7)
amod(interpretation-10, proper-9)
prep_for(taken-5, interpretation-10)
nn(PSA-13, serum-12)
prep_of(interpretation-10, PSA-13)
advmod(evaluating-15, when-14)
advcl(taken-5, evaluating-15)
dobj(evaluating-15, men-16)
partmod(men-16, treated-17)
prep_with(treated-17, finasteride-19)

TAMBOCOR/NN has/VBZ been/VBN administered/VBN to/TO patients/NNS receiving/VBG digitalis/NN preparation/NN s/NN or/CC beta-adrenergic/JJ blocking/NN agents/NNS without/IN adverse/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NN TAMBOCOR)) (VP (VBZ has) (VP (VBN been) (VP (VBN administered) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN digitalis) (NN preparation) (NN s) (CC or) (JJ beta-adrenergic) (NN blocking) (NNS agents)) (PP (IN without) (NP (JJ adverse) (NNS effects)))))))))) (. .))))

nsubjpass(administered-4, TAMBOCOR-1)
aux(administered-4, has-2)
auxpass(administered-4, been-3)
root(ROOT-0, administered-4)
prep_to(administered-4, patients-6)
partmod(patients-6, receiving-7)
nn(s-10, digitalis-8)
nn(s-10, preparation-9)
dobj(receiving-7, s-10)
amod(agents-14, beta-adrenergic-12)
nn(agents-14, blocking-13)
conj_or(s-10, agents-14)
amod(effects-17, adverse-16)
prep_without(receiving-7, effects-17)

During/IN administration/NN of/IN multiple/JJ oral/JJ doses/NNS of/IN TAMBOCOR/NN to/TO healthy/JJ subjects/NNS stabilized/VBN on/IN a/DT maintenance/NN dose/NN of/IN digoxin/NN ,/, a/DT 13/CD %/NN -19/CD %/NN increase/NN in/IN plasma/NN digoxin/NN levels/NNS occurred/VBD at/IN six/CD hours/NNS postdose/NN ./.

(ROOT (S1 (S (S (PP (IN During) (NP (NP (NN administration)) (PP (IN of) (NP (NP (JJ multiple) (JJ oral) (NNS doses)) (PP (IN of) (NP (NN TAMBOCOR))))) (PP (TO to) (NP (NP (JJ healthy) (NNS subjects)) (VP (VBN stabilized) (PP (IN on) (NP (NP (DT a) (NN maintenance) (NN dose)) (PP (IN of) (NP (NN digoxin)))))))))) (, ,) (NP (NP (DT a) (ADJP (QP (CD 13) (NN %) (CD -19)) (NN %)) (NN increase)) (PP (IN in) (NP (NN plasma) (NN digoxin) (NNS levels)))) (VP (VBD occurred) (PP (IN at) (NP (CD six) (NNS hours))) (NP (NN postdose)))) (. .))))

prep_during(occurred-30, administration-2)
amod(doses-6, multiple-4)
amod(doses-6, oral-5)
prep_of(administration-2, doses-6)
prep_of(doses-6, TAMBOCOR-8)
amod(subjects-11, healthy-10)
prep_to(administration-2, subjects-11)
partmod(subjects-11, stabilized-12)
det(dose-16, a-14)
nn(dose-16, maintenance-15)
prep_on(stabilized-12, dose-16)
prep_of(dose-16, digoxin-18)
det(increase-25, a-20)
number(%-22, 13-21)
dep(%-24, %-22)
number(%-22, -19-23)
dep(increase-25, %-24)
nsubj(occurred-30, increase-25)
nn(levels-29, plasma-27)
nn(levels-29, digoxin-28)
prep_in(increase-25, levels-29)
root(ROOT-0, occurred-30)
num(hours-33, six-32)
prep_at(occurred-30, hours-33)
dobj(occurred-30, postdose-34)

In/IN a/DT study/NN involving/VBG healthy/JJ subjects/NNS receiving/VBG TAMBOCOR/NN and/CC propranolol/NN concurrently/RB ,/, plasma/NN flecainide/NN levels/NNS were/VBD increased/VBN about/IN 20/CD %/NN and/CC propranolol/NN levels/NNS were/VBD increased/VBN about/IN 30/CD %/NN compared/VBN to/TO control/NN values/NNS ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (DT a) (NN study)) (VP (VBG involving) (NP (NP (JJ healthy) (NNS subjects)) (VP (VBG receiving) (NP (NP (NN TAMBOCOR)) (CC and) (NP (NN propranolol)))))))) (S (ADVP (RB concurrently)) (, ,) (S (NP (NN plasma) (NN flecainide) (NNS levels)) (VP (VBD were) (VP (VBN increased) (PP (IN about) (NP (CD 20) (NN %)))))) (CC and) (S (NP (NN propranolol) (NNS levels)) (VP (VBD were) (VP (VBN increased) (PP (IN about) (NP (CD 30) (NN %))) (S (VP (VBN compared) (PP (TO to) (NP (NN control) (NNS values))))))))) (. .))))

det(study-3, a-2)
prep_in(increased-17, study-3)
partmod(study-3, involving-4)
amod(subjects-6, healthy-5)
dobj(involving-4, subjects-6)
partmod(subjects-6, receiving-7)
dobj(receiving-7, TAMBOCOR-8)
conj_and(TAMBOCOR-8, propranolol-10)
advmod(increased-17, concurrently-11)
nn(levels-15, plasma-13)
nn(levels-15, flecainide-14)
nsubjpass(increased-17, levels-15)
auxpass(increased-17, were-16)
root(ROOT-0, increased-17)
num(%-20, 20-19)
prep_about(increased-17, %-20)
nn(levels-23, propranolol-22)
nsubjpass(increased-25, levels-23)
auxpass(increased-25, were-24)
conj_and(increased-17, increased-25)
num(%-28, 30-27)
prep_about(increased-25, %-28)
nn(values-32, control-31)
prep_compared_to(increased-25, values-32)

In/IN this/DT formal/JJ interaction/NN study/NN ,/, TAMBOCOR/NN and/CC propranolol/NN were/VBD each/DT found/VBN to/TO have/VB negative/JJ inotropic/JJ effects/NNS ;/: ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT this) (JJ formal) (NN interaction) (NN study))) (, ,) (NP (NP (NN TAMBOCOR)) (CC and) (NP (NN propranolol))) (VP (VBD were) (DT each) (VP (VBN found) (S (VP (TO to) (VP (VB have) (NP (JJ negative) (JJ inotropic) (NNS effects))))))) (: ;)) (. .))))

det(study-5, this-2)
amod(study-5, formal-3)
nn(study-5, interaction-4)
prep_in(found-12, study-5)
nsubjpass(found-12, TAMBOCOR-7)
xsubj(have-14, TAMBOCOR-7)
conj_and(TAMBOCOR-7, propranolol-9)
auxpass(found-12, were-10)
dep(found-12, each-11)
root(ROOT-0, found-12)
aux(have-14, to-13)
xcomp(found-12, have-14)
amod(effects-17, negative-15)
amod(effects-17, inotropic-16)
dobj(have-14, effects-17)

when/WRB the/DT drugs/NNS were/VBD administered/VBN together/RB ,/, the/DT effects/NNS were/VBD additive/JJ ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NNS drugs)) (VP (VBD were) (VP (VBN administered) (ADVP (RB together)))))) (, ,) (NP (DT the) (NNS effects)) (VP (VBD were) (ADJP (JJ additive)))) (. .))))

advmod(administered-5, when-1)
det(drugs-3, the-2)
nsubjpass(administered-5, drugs-3)
auxpass(administered-5, were-4)
advcl(additive-11, administered-5)
advmod(administered-5, together-6)
det(effects-9, the-8)
nsubj(additive-11, effects-9)
cop(additive-11, were-10)
root(ROOT-0, additive-11)

The/DT effects/NNS of/IN concomitant/JJ administration/NN of/IN TAMBOCOR/NN and/CC propranolol/NN on/IN the/DT PR/NN interval/NNS were/VBD less/JJR than/IN additive/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN TAMBOCOR)) (CC and) (NP (NN propranolol)))))) (PP (IN on) (NP (DT the) (NN PR) (NNS interval)))) (VP (VBD were) (ADJP (ADJP (JJR less)) (PP (IN than) (ADJP (JJ additive)))))) (. .))))

det(effects-2, The-1)
nsubj(less-15, effects-2)
amod(administration-5, concomitant-4)
prep_of(effects-2, administration-5)
prep_of(administration-5, TAMBOCOR-7)
conj_and(TAMBOCOR-7, propranolol-9)
det(interval-13, the-11)
nn(interval-13, PR-12)
prep_on(effects-2, interval-13)
cop(less-15, were-14)
root(ROOT-0, less-15)
prep_than(less-15, additive-17)

In/IN TAMBOCOR/JJ clinical/JJ trials/NNS ,/, patients/NNS who/WP were/VBD receiving/VBG beta/NN blockers/NNS concurrently/RB did/VBD not/RB experience/VBP an/DT increased/VBN incidence/NN of/IN side/JJ effects/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ TAMBOCOR) (JJ clinical) (NNS trials))) (, ,) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBG receiving) (NP (NN beta) (NNS blockers))))))) (ADVP (RB concurrently)) (VP (VBD did) (RB not) (VP (VBP experience) (NP (NP (DT an) (VBN increased) (NN incidence)) (PP (IN of) (NP (JJ side) (NNS effects))))))) (. .))))

amod(trials-4, TAMBOCOR-2)
amod(trials-4, clinical-3)
prep_in(experience-15, trials-4)
nsubj(receiving-9, patients-6)
nsubj(experience-15, patients-6)
aux(receiving-9, were-8)
rcmod(patients-6, receiving-9)
nn(blockers-11, beta-10)
dobj(receiving-9, blockers-11)
advmod(experience-15, concurrently-12)
aux(experience-15, did-13)
neg(experience-15, not-14)
root(ROOT-0, experience-15)
det(incidence-18, an-16)
amod(incidence-18, increased-17)
dobj(experience-15, incidence-18)
amod(effects-21, side-20)
prep_of(incidence-18, effects-21)

Nevertheless/RB ,/, the/DT possibility/NN of/IN additive/JJ negative/JJ inotropic/JJ effects/NNS of/IN beta/NN blockers/NNS and/CC flecainide/NN should/MD be/VB recognized/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Nevertheless)) (, ,) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (JJ additive) (JJ negative) (JJ inotropic) (NNS effects)) (PP (IN of) (NP (NP (NN beta) (NNS blockers)) (CC and) (NP (NN flecainide))))))) (VP (MD should) (VP (VB be) (VP (VBN recognized))))) (. .))))

advmod(recognized-17, Nevertheless-1)
det(possibility-4, the-3)
nsubjpass(recognized-17, possibility-4)
amod(effects-9, additive-6)
amod(effects-9, negative-7)
amod(effects-9, inotropic-8)
prep_of(possibility-4, effects-9)
nn(blockers-12, beta-11)
prep_of(effects-9, blockers-12)
conj_and(blockers-12, flecainide-14)
aux(recognized-17, should-15)
auxpass(recognized-17, be-16)
root(ROOT-0, recognized-17)

Flecainide/NN is/VBZ not/RB extensively/RB bound/VBN to/TO plasma/NN proteins/NNS ./.

(ROOT (S1 (S (S (NP (NN Flecainide)) (VP (VBZ is) (RB not) (ADVP (RB extensively)) (VP (VBN bound) (PP (TO to) (NP (NN plasma) (NNS proteins)))))) (. .))))

nsubjpass(bound-5, Flecainide-1)
auxpass(bound-5, is-2)
neg(bound-5, not-3)
advmod(bound-5, extensively-4)
root(ROOT-0, bound-5)
nn(proteins-8, plasma-7)
prep_to(bound-5, proteins-8)

In/FW vitro/FW studies/NNS with/IN several/JJ drugs/NNS which/WDT may/MD be/VB administered/VBN concomitantly/RB showed/VBD that/IN the/DT extent/NN of/IN flecainide/NN binding/NN to/TO human/JJ plasma/NN proteins/NNS is/VBZ either/CC unchanged/JJ or/CC only/RB slightly/RB less/JJR ./.

(ROOT (S1 (S (S (NP (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (PP (IN with) (NP (NP (JJ several) (NNS drugs)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB be) (VP (VBN administered) (ADVP (RB concomitantly)))))))))) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NP (NN flecainide) (NN binding)) (PP (TO to) (NP (JJ human) (NN plasma) (NNS proteins)))))) (VP (VBZ is) (ADJP (CC either) (ADJP (JJ unchanged)) (CC or) (ADJP (ADVP (RB only) (RB slightly)) (JJR less)))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(showed-12, studies-3)
amod(drugs-6, several-5)
prep_with(studies-3, drugs-6)
nsubjpass(administered-10, drugs-6)
aux(administered-10, may-8)
auxpass(administered-10, be-9)
rcmod(drugs-6, administered-10)
advmod(administered-10, concomitantly-11)
root(ROOT-0, showed-12)
complm(unchanged-25, that-13)
det(extent-15, the-14)
nsubj(unchanged-25, extent-15)
nn(binding-18, flecainide-17)
prep_of(extent-15, binding-18)
amod(proteins-22, human-20)
nn(proteins-22, plasma-21)
prep_to(binding-18, proteins-22)
cop(unchanged-25, is-23)
preconj(unchanged-25, either-24)
ccomp(showed-12, unchanged-25)
advmod(slightly-28, only-27)
advmod(less-29, slightly-28)
conj_or(unchanged-25, less-29)

Consequently/RB ,/, interactions/NNS with/IN other/JJ drugs/NNS which/WDT are/VBP highly/RB protein/NN bound/VBN (/-LRB- e.g./FW ,/, anticoagulants/NNS )/-RRB- would/MD not/RB be/VB expected/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Consequently)) (, ,) (NP (NP (NNS interactions)) (PP (IN with) (NP (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADVP (RB highly)) (VP (NN protein) (VBN bound)))))) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NNS anticoagulants)) (-RRB- -RRB-))))) (VP (MD would) (RB not) (VP (VB be) (VP (VBN expected))))) (. .))))

advmod(expected-20, Consequently-1)
nsubjpass(expected-20, interactions-3)
amod(drugs-6, other-5)
prep_with(interactions-3, drugs-6)
nsubjpass(bound-11, drugs-6)
auxpass(bound-11, are-8)
advmod(bound-11, highly-9)
dep(bound-11, protein-10)
rcmod(drugs-6, bound-11)
dep(anticoagulants-15, e.g.-13)
appos(drugs-6, anticoagulants-15)
aux(expected-20, would-17)
neg(expected-20, not-18)
auxpass(expected-20, be-19)
root(ROOT-0, expected-20)

TAMBOCOR/NN has/VBZ been/VBN used/VBN in/IN a/DT large/JJ number/NN of/IN patients/NNS receiving/VBG diuretics/NN without/IN apparent/JJ interaction/NN ./.

(ROOT (S1 (S (S (NP (NN TAMBOCOR)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (PP (IN in) (NP (NP (DT a) (JJ large) (NN number)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN diuretics)) (PP (IN without) (NP (JJ apparent) (NN interaction)))))))))))) (. .))))

nsubjpass(used-4, TAMBOCOR-1)
aux(used-4, has-2)
auxpass(used-4, been-3)
root(ROOT-0, used-4)
det(number-8, a-6)
amod(number-8, large-7)
prep_in(used-4, number-8)
prep_of(number-8, patients-10)
partmod(patients-10, receiving-11)
dobj(receiving-11, diuretics-12)
amod(interaction-15, apparent-14)
prep_without(receiving-11, interaction-15)

Limited/JJ data/NNS in/IN patients/NNS receiving/VBG known/JJ enzyme/NN inducers/NNS (/-LRB- phenytoin/NN ,/, phenobarbital/NN ,/, carbamazepine/NN )/-RRB- indicate/VBP only/RB a/DT 30/CD %/NN increase/NN in/IN the/DT rate/NN of/IN flecainide/NN elimination/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Limited) (NNS data)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (JJ known) (NN enzyme) (NNS inducers)) (PRN (-LRB- -LRB-) (NP (NP (NN phenytoin)) (, ,) (NP (NN phenobarbital)) (, ,) (NP (NN carbamazepine))) (-RRB- -RRB-))))))) (VP (VBP indicate) (NP (NP (RB only) (DT a) (CD 30) (NN %) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NN flecainide) (NN elimination)))))))) (. .))))

amod(data-2, Limited-1)
nsubj(indicate-16, data-2)
prep_in(data-2, patients-4)
partmod(patients-4, receiving-5)
amod(inducers-8, known-6)
nn(inducers-8, enzyme-7)
dobj(receiving-5, inducers-8)
dep(inducers-8, phenytoin-10)
appos(phenytoin-10, phenobarbital-12)
appos(phenytoin-10, carbamazepine-14)
root(ROOT-0, indicate-16)
advmod(increase-21, only-17)
det(increase-21, a-18)
num(increase-21, 30-19)
nn(increase-21, %-20)
dobj(indicate-16, increase-21)
det(rate-24, the-23)
prep_in(increase-21, rate-24)
nn(elimination-27, flecainide-26)
prep_of(rate-24, elimination-27)

In/IN healthy/JJ subjects/NNS receiving/VBG cimetidine/NN (/-LRB- 1/CD gm/NN daily/RB )/-RRB- for/IN one/CD week/NN ,/, plasma/NN flecainide/NN levels/NNS increased/VBD by/IN about/RB 30/CD %/NN and/CC half-life/NN increased/VBD by/IN about/RB 10/CD %./NN

(ROOT (S1 (S (PP (IN In) (NP (NP (JJ healthy) (NNS subjects)) (VP (VBG receiving) (NP (NP (NN cimetidine)) (PRN (-LRB- -LRB-) (NP (NP (CD 1) (NN gm)) (ADVP (RB daily))) (-RRB- -RRB-))) (PP (IN for) (NP (CD one) (NN week)))))) (, ,) (S (S (NP (NN plasma) (NN flecainide) (NNS levels)) (VP (VBD increased) (PP (IN by) (NP (QP (RB about) (CD 30)) (NN %))))) (CC and) (S (NP (NN half-life)) (VP (VBD increased) (PP (IN by) (NP (QP (RB about) (CD 10)) (NN %.)))))))))

amod(subjects-3, healthy-2)
prep_in(increased-18, subjects-3)
partmod(subjects-3, receiving-4)
dobj(receiving-4, cimetidine-5)
num(gm-8, 1-7)
dep(cimetidine-5, gm-8)
advmod(gm-8, daily-9)
num(week-13, one-12)
prep_for(receiving-4, week-13)
nn(levels-17, plasma-15)
nn(levels-17, flecainide-16)
nsubj(increased-18, levels-17)
root(ROOT-0, increased-18)
quantmod(30-21, about-20)
num(%-22, 30-21)
prep_by(increased-18, %-22)
nsubj(increased-25, half-life-24)
conj_and(increased-18, increased-25)
quantmod(10-28, about-27)
num(%.-29, 10-28)
prep_by(increased-25, %.-29)

When/WRB amiodarone/NN is/VBZ added/VBN to/TO flecainide/NN therapy/NN ,/, plasma/NN flecainide/NN levels/NNS may/MD increase/VB two-fold/RB or/CC more/RBR in/IN some/DT patients/NNS ,/, if/IN flecainide/NN dosage/NN is/VBZ not/RB reduced/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN amiodarone)) (VP (VBZ is) (VP (VBN added) (PP (TO to) (NP (NN flecainide) (NN therapy))))))) (, ,) (NP (NN plasma) (NN flecainide) (NNS levels)) (VP (MD may) (VP (VB increase) (ADVP (ADVP (RB two-fold)) (CC or) (RBR more)) (PP (IN in) (NP (DT some) (NNS patients))) (, ,) (SBAR (IN if) (S (NP (NN flecainide) (NN dosage)) (VP (VBZ is) (RB not) (VP (VBN reduced)))))))) (. .))))

advmod(added-4, When-1)
nsubjpass(added-4, amiodarone-2)
auxpass(added-4, is-3)
advcl(increase-13, added-4)
nn(therapy-7, flecainide-6)
prep_to(added-4, therapy-7)
nn(levels-11, plasma-9)
nn(levels-11, flecainide-10)
nsubj(increase-13, levels-11)
aux(increase-13, may-12)
root(ROOT-0, increase-13)
advmod(increase-13, two-fold-14)
conj_or(two-fold-14, more-16)
det(patients-19, some-18)
prep_in(increase-13, patients-19)
mark(reduced-26, if-21)
nn(dosage-23, flecainide-22)
nsubjpass(reduced-26, dosage-23)
auxpass(reduced-26, is-24)
neg(reduced-26, not-25)
advcl(increase-13, reduced-26)

Drugs/NNS that/WDT inhibit/VBP cytochrome/NN P450IID6/NN ,/, such/JJ as/IN quinidine/NN ,/, might/MD increase/VB the/DT plasma/NN concentrations/NNS of/IN flecainide/NN in/IN patients/NNS that/WDT are/VBP on/IN chronic/JJ flecainide/NN therapy/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (NN cytochrome) (NN P450IID6))))) (, ,) (PP (JJ such) (IN as) (NP (NN quinidine))) (, ,)) (VP (MD might) (VP (VB increase) (NP (NP (DT the) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN flecainide))) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (PP (IN on) (NP (JJ chronic) (NN flecainide) (NN therapy))))))))))) (: ;)) (. .))))

nsubj(inhibit-3, Drugs-1)
nsubj(increase-12, Drugs-1)
rcmod(Drugs-1, inhibit-3)
nn(P450IID6-5, cytochrome-4)
dobj(inhibit-3, P450IID6-5)
prep_such_as(Drugs-1, quinidine-9)
aux(increase-12, might-11)
root(ROOT-0, increase-12)
det(concentrations-15, the-13)
nn(concentrations-15, plasma-14)
dobj(increase-12, concentrations-15)
prep_of(concentrations-15, flecainide-17)
prep_in(concentrations-15, patients-19)
nsubj(are-21, patients-19)
rcmod(patients-19, are-21)
amod(therapy-25, chronic-23)
nn(therapy-25, flecainide-24)
prep_on(are-21, therapy-25)

There/EX has/VBZ been/VBN little/JJ experience/VBP with/IN the/DT coadministration/NN of/IN TAMBOCOR/NN and/CC either/CC disopyramide/NN or/CC verapamil/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ has) (VP (VBN been) (NP (JJ little) (VBP experience)) (PP (IN with) (NP (NP (DT the) (NN coadministration)) (PP (IN of) (NP (NP (NN TAMBOCOR)) (CC and) (NP (CC either) (NP (NN disopyramide)) (CC or) (NP (NN verapamil)))))))))) (. .))))

expl(little-4, There-1)
aux(little-4, has-2)
cop(little-4, been-3)
root(ROOT-0, little-4)
dep(little-4, experience-5)
det(coadministration-8, the-7)
prep_with(little-4, coadministration-8)
prep_of(coadministration-8, TAMBOCOR-10)
preconj(disopyramide-13, either-12)
conj_and(TAMBOCOR-10, disopyramide-13)
conj_or(disopyramide-13, verapamil-15)

Because/IN both/DT of/IN these/DT drugs/NNS have/VBP negative/JJ inotropic/JJ properties/NNS and/CC the/DT effects/NNS of/IN coadministration/NN with/IN TAMBOCOR/NN are/VBP unknown/JJ ,/, neither/CC disopyramide/NN nor/CC verapamil/NN should/MD be/VB administered/VBN concurrently/RB with/IN TAMBOCOR/NN unless/IN ,/, in/IN the/DT judgment/NN of/IN the/DT physician/NN ,/, the/DT benefits/NNS of/IN this/DT combination/NN outweigh/VBP the/DT risks/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (S (NP (NP (DT both)) (PP (IN of) (NP (DT these) (NNS drugs)))) (VP (VBP have) (NP (JJ negative) (JJ inotropic) (NNS properties)))) (CC and) (S (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NN coadministration)) (PP (IN with) (NP (NN TAMBOCOR)))))) (VP (VBP are) (ADJP (JJ unknown)))))) (, ,) (NP (CC neither) (NP (NN disopyramide)) (CC nor) (NP (NN verapamil))) (VP (MD should) (VP (VB be) (VP (VBN administered) (ADVP (RB concurrently)) (PP (IN with) (NP (NN TAMBOCOR))) (SBAR (IN unless) (S (, ,) (PP (IN in) (NP (NP (DT the) (NN judgment)) (PP (IN of) (NP (DT the) (NN physician))))) (, ,) (NP (NP (DT the) (NNS benefits)) (PP (IN of) (NP (DT this) (NN combination)))) (VP (VBP outweigh) (NP (DT the) (NNS risks))))))))) (. .))))

mark(have-6, Because-1)
nsubj(have-6, both-2)
det(drugs-5, these-4)
prep_of(both-2, drugs-5)
advcl(administered-26, have-6)
amod(properties-9, negative-7)
amod(properties-9, inotropic-8)
dobj(have-6, properties-9)
det(effects-12, the-11)
nsubj(unknown-18, effects-12)
prep_of(effects-12, coadministration-14)
prep_with(coadministration-14, TAMBOCOR-16)
cop(unknown-18, are-17)
conj_and(have-6, unknown-18)
preconj(disopyramide-21, neither-20)
nsubjpass(administered-26, disopyramide-21)
conj_nor(disopyramide-21, verapamil-23)
aux(administered-26, should-24)
auxpass(administered-26, be-25)
root(ROOT-0, administered-26)
advmod(administered-26, concurrently-27)
prep_with(administered-26, TAMBOCOR-29)
mark(outweigh-44, unless-30)
det(judgment-34, the-33)
prep_in(outweigh-44, judgment-34)
det(physician-37, the-36)
prep_of(judgment-34, physician-37)
det(benefits-40, the-39)
nsubj(outweigh-44, benefits-40)
det(combination-43, this-42)
prep_of(benefits-40, combination-43)
advcl(administered-26, outweigh-44)
det(risks-46, the-45)
dobj(outweigh-44, risks-46)

There/EX has/VBZ been/VBN too/RB little/JJ experience/VBP with/IN the/DT coadministration/NN of/IN TAMBOCOR/NN with/IN nifedipine/NN or/CC diltiazem/NN to/TO recommend/VB concomitant/JJ use/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ has) (VP (VBN been) (ADJP (RB too) (JJ little) (S (VP (VBP experience) (PP (IN with) (NP (NP (DT the) (NN coadministration)) (PP (IN of) (NP (NN TAMBOCOR))) (PP (IN with) (NP (NP (NN nifedipine)) (CC or) (NP (NN diltiazem)))))) (S (VP (TO to) (VP (VB recommend) (NP (JJ concomitant) (NN use))))))))))) (. .))))

expl(little-5, There-1)
aux(little-5, has-2)
cop(little-5, been-3)
advmod(little-5, too-4)
root(ROOT-0, little-5)
dep(little-5, experience-6)
det(coadministration-9, the-8)
prep_with(experience-6, coadministration-9)
prep_of(coadministration-9, TAMBOCOR-11)
prep_with(coadministration-9, nifedipine-13)
conj_or(nifedipine-13, diltiazem-15)
aux(recommend-17, to-16)
xcomp(experience-6, recommend-17)
amod(use-19, concomitant-18)
dobj(recommend-17, use-19)

Combination/NN Therapy/NN :/: Any/DT form/NN of/IN therapy/NN which/WDT adds/VBZ to/TO the/DT stress/NN of/IN the/DT patient/NN ,/, interferes/VBZ with/IN nutrition/NN or/CC depresses/VBZ bone/NN marrow/NN function/NN will/MD increase/VB the/DT toxicity/NN of/IN Floxuridine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Combination) (NN Therapy)) (: :) (NP (NP (DT Any) (NN form)) (PP (IN of) (NP (NN therapy))) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ adds) (PP (TO to) (NP (NP (DT the) (NN stress)) (PP (IN of) (NP (DT the) (NN patient)))))) (, ,) (VP (VBZ interferes) (PP (IN with) (NP (NN nutrition)))) (CC or) (VP (VBZ depresses) (NP (NP (NN bone) (NN marrow)) (NN function)))))))) (VP (MD will) (VP (VB increase) (NP (NP (DT the) (NN toxicity)) (PP (IN of) (NP (NN Floxuridine))))))) (. .))))

nn(Therapy-2, Combination-1)
nsubj(increase-26, Therapy-2)
det(form-5, Any-4)
dep(Therapy-2, form-5)
nsubj(adds-9, form-5)
prep_of(form-5, therapy-7)
rcmod(form-5, adds-9)
det(stress-12, the-11)
prep_to(adds-9, stress-12)
det(patient-15, the-14)
prep_of(stress-12, patient-15)
conj_or(adds-9, interferes-17)
prep_with(interferes-17, nutrition-19)
conj_or(adds-9, depresses-21)
nn(marrow-23, bone-22)
nn(function-24, marrow-23)
dobj(depresses-21, function-24)
aux(increase-26, will-25)
root(ROOT-0, increase-26)
det(toxicity-28, the-27)
dobj(increase-26, toxicity-28)
prep_of(toxicity-28, Floxuridine-30)

Cytosine/NN arabinoside/NN ,/, a/DT cytostatic/JJ agent/NN ,/, has/VBZ been/VBN reported/VBN to/TO inactivate/VB the/DT antifungal/JJ activity/NN of/IN flucytosine/NN by/IN competitive/JJ inhibition/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Cytosine) (NN arabinoside)) (, ,) (NP (DT a) (JJ cytostatic) (NN agent)) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB inactivate) (NP (NP (DT the) (JJ antifungal) (NN activity)) (PP (IN of) (NP (NN flucytosine))) (PP (IN by) (NP (JJ competitive) (NN inhibition))))))))))) (. .))))

nn(arabinoside-2, Cytosine-1)
nsubjpass(reported-10, arabinoside-2)
xsubj(inactivate-12, arabinoside-2)
det(agent-6, a-4)
amod(agent-6, cytostatic-5)
appos(arabinoside-2, agent-6)
aux(reported-10, has-8)
auxpass(reported-10, been-9)
root(ROOT-0, reported-10)
aux(inactivate-12, to-11)
xcomp(reported-10, inactivate-12)
det(activity-15, the-13)
amod(activity-15, antifungal-14)
dobj(inactivate-12, activity-15)
prep_of(activity-15, flucytosine-17)
amod(inhibition-20, competitive-19)
prep_by(activity-15, inhibition-20)

Drugs/NNS which/WDT impair/VBP glomerular/JJ filtration/NN may/MD prolong/VB the/DT biological/JJ half-life/NN of/IN flucytosine/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT which)) (S (VP (VBP impair) (NP (JJ glomerular) (NN filtration)))))) (VP (MD may) (VP (VB prolong) (NP (NP (DT the) (JJ biological) (NN half-life)) (PP (IN of) (NP (NN flucytosine))))))) (. .))))

nsubj(impair-3, Drugs-1)
nsubj(prolong-7, Drugs-1)
rcmod(Drugs-1, impair-3)
amod(filtration-5, glomerular-4)
dobj(impair-3, filtration-5)
aux(prolong-7, may-6)
root(ROOT-0, prolong-7)
det(half-life-10, the-8)
amod(half-life-10, biological-9)
dobj(prolong-7, half-life-10)
prep_of(half-life-10, flucytosine-12)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: Measurement/NN of/IN serum/NN creatinine/NN levels/NNS should/MD be/VB determined/VBN by/IN the/DT Jaffe/NN reaction/NN ,/, since/IN Ancobon/NN does/VBZ not/RB interfere/VB with/IN the/DT determination/NN of/IN creatinine/NN values/NNS by/IN this/DT method/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (NP (NN Measurement)) (PP (IN of) (NP (NN serum) (NN creatinine) (NNS levels)))) (VP (MD should) (VP (VB be) (VP (VBN determined) (PP (IN by) (NP (DT the) (NN Jaffe) (NN reaction))))) (, ,) (SBAR (IN since) (S (NP (NN Ancobon)) (VP (VBZ does) (RB not) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN determination)) (PP (IN of) (NP (NN creatinine) (NNS values))) (PP (IN by) (NP (DT this) (NN method))))))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
nsubjpass(determined-13, Measurement-6)
nn(levels-10, serum-8)
nn(levels-10, creatinine-9)
prep_of(Measurement-6, levels-10)
aux(determined-13, should-11)
auxpass(determined-13, be-12)
dep(Interactions-4, determined-13)
det(reaction-17, the-15)
nn(reaction-17, Jaffe-16)
agent(determined-13, reaction-17)
mark(interfere-23, since-19)
nsubj(interfere-23, Ancobon-20)
aux(interfere-23, does-21)
neg(interfere-23, not-22)
advcl(determined-13, interfere-23)
det(determination-26, the-25)
prep_with(interfere-23, determination-26)
nn(values-29, creatinine-28)
prep_of(determination-26, values-29)
det(method-32, this-31)
prep_by(determination-26, method-32)

Most/JJ automated/JJ equipment/NN for/IN measurement/NN of/IN creatinine/NN makes/VBZ use/NN of/IN the/DT Jaffe/NN reaction/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Most) (JJ automated) (NN equipment)) (PP (IN for) (NP (NP (NN measurement)) (PP (IN of) (NP (NN creatinine)))))) (VP (VBZ makes) (NP (NP (NN use)) (PP (IN of) (NP (DT the) (NN Jaffe) (NN reaction)))))) (. .))))

amod(equipment-3, Most-1)
amod(equipment-3, automated-2)
nsubj(makes-8, equipment-3)
prep_for(equipment-3, measurement-5)
prep_of(measurement-5, creatinine-7)
root(ROOT-0, makes-8)
dobj(makes-8, use-9)
det(reaction-13, the-11)
nn(reaction-13, Jaffe-12)
prep_of(use-9, reaction-13)

The/DT use/NN of/IN FLUDARA/NN FOR/IN INJECTION/NN in/IN combination/NN with/IN pentostatin/NN is/VBZ not/RB recommended/VBN due/JJ to/TO the/DT risk/NN of/IN severe/JJ pulmonary/JJ toxicity/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NN FLUDARA))) (PP (IN FOR) (NP (NN INJECTION))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN pentostatin)))))) (VP (VBZ is) (RB not) (VP (VBN recommended) (PP (JJ due) (TO to) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ severe) (JJ pulmonary) (NN toxicity)))))))) (. .))))

det(use-2, The-1)
nsubjpass(recommended-13, use-2)
prep_of(use-2, FLUDARA-4)
prep_for(use-2, INJECTION-6)
prep_in(use-2, combination-8)
prep_with(combination-8, pentostatin-10)
auxpass(recommended-13, is-11)
neg(recommended-13, not-12)
root(ROOT-0, recommended-13)
det(risk-17, the-16)
prep_due_to(recommended-13, risk-17)
amod(toxicity-21, severe-19)
amod(toxicity-21, pulmonary-20)
prep_of(risk-17, toxicity-21)

When/WRB administered/VBN concurrently/RB ,/, the/DT following/JJ drugs/NNS may/MD interact/VB with/IN adrenal/JJ corticosteroids/NNS ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN administered) (ADVP (RB concurrently))))) (, ,) (NP (DT the) (JJ following) (NNS drugs)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (JJ adrenal) (NNS corticosteroids)))))) (. .))))

advmod(administered-2, When-1)
advcl(interact-9, administered-2)
advmod(administered-2, concurrently-3)
det(drugs-7, the-5)
amod(drugs-7, following-6)
nsubj(interact-9, drugs-7)
aux(interact-9, may-8)
root(ROOT-0, interact-9)
amod(corticosteroids-12, adrenal-11)
prep_with(interact-9, corticosteroids-12)

Amphotericin/NN B/NN or/CC potassium-depleting/JJ diuretics/NNS (/-LRB- benzothiadiazines/NNS and/CC related/JJ drugs/NNS ,/, ethacrynic/JJ acid/NN and/CC furosemide/NN )/-RRB- @/NN enhanced/VBD hypokalemia/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Amphotericin) (NN B)) (CC or) (NP (NP (JJ potassium-depleting) (NNS diuretics)) (PRN (-LRB- -LRB-) (NP (NP (NP (NNS benzothiadiazines)) (CC and) (NP (JJ related) (NNS drugs))) (, ,) (NP (NP (JJ ethacrynic) (NN acid)) (CC and) (NP (NN furosemide)))) (-RRB- -RRB-)))) (NN @)) (VP (VBD enhanced) (NP (NN hypokalemia)))) (. .))))

nn(B-2, Amphotericin-1)
nn(@-17, B-2)
amod(diuretics-5, potassium-depleting-4)
conj_or(B-2, diuretics-5)
dep(diuretics-5, benzothiadiazines-7)
amod(drugs-10, related-9)
conj_and(benzothiadiazines-7, drugs-10)
amod(acid-13, ethacrynic-12)
appos(benzothiadiazines-7, acid-13)
conj_and(acid-13, furosemide-15)
nsubj(enhanced-18, @-17)
root(ROOT-0, enhanced-18)
dobj(enhanced-18, hypokalemia-19)

use/NN potassium/NN supplements/VBZ if/IN necessary/JJ ./.

(ROOT (S1 (S (S (NP (NN use) (NN potassium)) (VP (VBZ supplements) (SBAR (IN if) (FRAG (JJ necessary))))) (. .))))

nn(potassium-2, use-1)
nsubj(supplements-3, potassium-2)
root(ROOT-0, supplements-3)
mark(necessary-5, if-4)
advcl(supplements-3, necessary-5)

Digitalis/NN glycosides/NNS @/NN enhanced/VBN possibility/NN of/IN arrhythmias/NNS or/CC digitalis/NN toxicity/NN associated/VBN with/IN hypokalemia/NN ./.

(ROOT (S1 (S (S (NP (NN Digitalis)) (VP (NNS glycosides) (NP (NP (NN @) (VBN enhanced) (NN possibility)) (PP (IN of) (NP (NP (NP (NNS arrhythmias)) (CC or) (NP (NN digitalis) (NN toxicity))) (VP (VBN associated) (PP (IN with) (NP (NN hypokalemia))))))))) (. .))))

nsubj(glycosides-2, Digitalis-1)
root(ROOT-0, glycosides-2)
nn(possibility-5, @-3)
amod(possibility-5, enhanced-4)
dobj(glycosides-2, possibility-5)
prep_of(possibility-5, arrhythmias-7)
nn(toxicity-10, digitalis-9)
conj_or(arrhythmias-7, toxicity-10)
partmod(arrhythmias-7, associated-11)
prep_with(associated-11, hypokalemia-13)

use/NN potassium/NN supplements/VBZ if/IN necessary/JJ ./.

(ROOT (S1 (S (S (NP (NN use) (NN potassium)) (VP (VBZ supplements) (SBAR (IN if) (FRAG (JJ necessary))))) (. .))))

nn(potassium-2, use-1)
nsubj(supplements-3, potassium-2)
root(ROOT-0, supplements-3)
mark(necessary-5, if-4)
advcl(supplements-3, necessary-5)

Monitor/VB prothrombin/NN levels/NNS and/CC adjust/VB anticoagulant/NN dosage/NN accordingly/RB ./.

(ROOT (S1 (S (S (VP (VP (VB Monitor) (NP (NN prothrombin) (NNS levels))) (CC and) (VP (VB adjust) (NP (NN anticoagulant) (NN dosage)) (ADVP (RB accordingly))))) (. .))))

root(ROOT-0, Monitor-1)
nn(levels-3, prothrombin-2)
dobj(Monitor-1, levels-3)
conj_and(Monitor-1, adjust-5)
nn(dosage-7, anticoagulant-6)
dobj(adjust-5, dosage-7)
advmod(adjust-5, accordingly-8)

Antidiabetic/JJ drugs/NNS (/-LRB- oral/JJ agents/NNS and/CC insulin/NN )/-RRB- @/NN diminished/VBD antidiabetic/JJ effect/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Antidiabetic) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NP (JJ oral) (NNS agents)) (CC and) (NP (NN insulin))) (-RRB- -RRB-))) (NN @)) (VP (VBD diminished) (NP (JJ antidiabetic) (NN effect)))) (. .))))

amod(drugs-2, Antidiabetic-1)
nn(@-9, drugs-2)
amod(agents-5, oral-4)
dep(drugs-2, agents-5)
conj_and(agents-5, insulin-7)
nsubj(diminished-10, @-9)
root(ROOT-0, diminished-10)
amod(effect-12, antidiabetic-11)
dobj(diminished-10, effect-12)

adjust/NN dosage/NN of/IN antidiabetic/JJ drug/NN upward/VBN if/IN necessary/JJ ./.

(ROOT (S1 (S (S (NP (NP (NN adjust) (NN dosage)) (PP (IN of) (NP (JJ antidiabetic) (NN drug)))) (VP (VBN upward) (SBAR (IN if) (ADJP (JJ necessary))))) (. .))))

nn(dosage-2, adjust-1)
nsubj(upward-6, dosage-2)
amod(drug-5, antidiabetic-4)
prep_of(dosage-2, drug-5)
root(ROOT-0, upward-6)
advcl(upward-6, if-7)
dep(if-7, necessary-8)

decreased/VBD pharmacologic/JJ effect/NN of/IN aspirin/NN ./.

(ROOT (S1 (S (S (VP (VBD decreased) (NP (NP (JJ pharmacologic) (NN effect)) (PP (IN of) (NP (NN aspirin)))))) (. .))))

root(ROOT-0, decreased-1)
amod(effect-3, pharmacologic-2)
dobj(decreased-1, effect-3)
prep_of(effect-3, aspirin-5)

Rarely/RB salicylate/NN toxicity/NN may/MD occur/VB in/IN patients/NNS who/WP discontinue/VBP steroids/NNS after/IN concurrent/JJ high-dose/JJ aspirin/NN therapy/NN ./.

(ROOT (S1 (S (S (ADVP (RB Rarely)) (NP (NN salicylate) (NN toxicity)) (VP (MD may) (VP (VB occur) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP discontinue) (NP (NNS steroids)) (PP (IN after) (NP (JJ concurrent) (JJ high-dose) (NN aspirin) (NN therapy))))))))))) (. .))))

advmod(occur-5, Rarely-1)
nn(toxicity-3, salicylate-2)
nsubj(occur-5, toxicity-3)
aux(occur-5, may-4)
root(ROOT-0, occur-5)
prep_in(occur-5, patients-7)
nsubj(discontinue-9, patients-7)
rcmod(patients-7, discontinue-9)
dobj(discontinue-9, steroids-10)
amod(therapy-15, concurrent-12)
amod(therapy-15, high-dose-13)
nn(therapy-15, aspirin-14)
prep_after(discontinue-9, therapy-15)

Monitor/NN salicylate/NN levels/NNS or/CC the/DT therapeutic/JJ effect/NN for/IN which/WDT aspirin/NN is/VBZ given/VBN ;/: ./.

(ROOT (S1 (S (NP (NP (NP (NN Monitor) (NN salicylate) (NNS levels)) (CC or) (NP (NP (DT the) (JJ therapeutic) (NN effect)) (SBAR (WHPP (IN for) (WHNP (WDT which))) (S (NP (NN aspirin)) (VP (VBZ is) (VP (VBN given)))))) (: ;)) (. .)))))

nn(levels-3, Monitor-1)
nn(levels-3, salicylate-2)
root(ROOT-0, levels-3)
det(effect-7, the-5)
amod(effect-7, therapeutic-6)
conj_or(levels-3, effect-7)
rel(given-12, which-9)
nsubjpass(given-12, aspirin-10)
auxpass(given-12, is-11)
rcmod(effect-7, given-12)

adjust/VB salicylate/NN dosage/NN accordingly/RB if/IN effect/NN is/VBZ altered/VBN ./.

(ROOT (S1 (S (S (VP (VB adjust) (NP (NN salicylate) (NN dosage)) (ADVP (RB accordingly)) (SBAR (IN if) (S (NP (NN effect)) (VP (VBZ is) (VP (VBN altered))))))) (. .))))

root(ROOT-0, adjust-1)
nn(dosage-3, salicylate-2)
dobj(adjust-1, dosage-3)
advmod(adjust-1, accordingly-4)
mark(altered-8, if-5)
nsubjpass(altered-8, effect-6)
auxpass(altered-8, is-7)
advcl(adjust-1, altered-8)

Barbiturates/NNS ,/, phenytoin/NN ,/, or/CC rifampin/NN @/NN increased/VBD metabolic/JJ clearance/NN of/IN fludrocortisone/NN acetate/NN because/IN of/IN the/DT induction/NN of/IN hepatic/JJ enzymes/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Barbiturates)) (, ,) (NP (NN phenytoin)) (, ,) (CC or) (NP (NN rifampin) (NN @))) (VP (VBD increased) (NP (NP (JJ metabolic) (NN clearance)) (PP (IN of) (NP (NN fludrocortisone) (NN acetate)))) (PP (IN because) (IN of) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (JJ hepatic) (NNS enzymes))))))) (. .))))

nsubj(increased-8, Barbiturates-1)
conj_or(Barbiturates-1, phenytoin-3)
nn(@-7, rifampin-6)
conj_or(Barbiturates-1, @-7)
root(ROOT-0, increased-8)
amod(clearance-10, metabolic-9)
dobj(increased-8, clearance-10)
nn(acetate-13, fludrocortisone-12)
prep_of(clearance-10, acetate-13)
det(induction-17, the-16)
prep_because_of(increased-8, induction-17)
amod(enzymes-20, hepatic-19)
prep_of(induction-17, enzymes-20)

Anabolic/JJ steroids/NNS (/-LRB- particularly/RB C-17/NN alkylated/JJ androgens/NNS such/JJ as/IN oxymetholone/NN ,/, methandrostenolone/NN ,/, norethandrolone/NN ,/, and/CC similar/JJ compounds/NNS )/-RRB- @/NN enhanced/VBD tendency/NN toward/IN edema/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Anabolic) (NNS steroids)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (RB particularly) (NN C-17) (JJ alkylated)) (NNS androgens)) (PP (JJ such) (IN as) (NP (NP (NN oxymetholone)) (, ,) (NP (NN methandrostenolone)) (, ,) (NP (NN norethandrolone)) (, ,) (CC and) (NP (JJ similar) (NNS compounds))))) (-RRB- -RRB-))) (NN @)) (VP (VBD enhanced) (NP (NP (NN tendency)) (PP (IN toward) (NP (NN edema)))))) (. .))))

amod(steroids-2, Anabolic-1)
nn(@-20, steroids-2)
advmod(alkylated-6, particularly-4)
dep(alkylated-6, C-17-5)
amod(androgens-7, alkylated-6)
dep(steroids-2, androgens-7)
prep_such_as(androgens-7, oxymetholone-10)
conj_and(oxymetholone-10, methandrostenolone-12)
conj_and(oxymetholone-10, norethandrolone-14)
amod(compounds-18, similar-17)
conj_and(oxymetholone-10, compounds-18)
nsubj(enhanced-21, @-20)
root(ROOT-0, enhanced-21)
dobj(enhanced-21, tendency-22)
prep_toward(tendency-22, edema-24)

Use/VBP caution/NN when/WRB giving/VBG these/DT drugs/NNS together/RB ,/, especially/RB in/IN patients/NNS with/IN hepatic/JJ or/CC cardiac/JJ disease/NN ./.

(ROOT (S1 (S (S (VP (VBP Use) (NP (NN caution)) (SBAR (WHADVP (WRB when)) (S (VP (VBG giving) (NP (DT these) (NNS drugs)) (ADVP (RB together)) (, ,) (PP (ADVP (RB especially)) (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (ADJP (JJ hepatic)) (CC or) (ADJP (JJ cardiac))) (NN disease)))))))))) (. .))))

root(ROOT-0, Use-1)
dobj(Use-1, caution-2)
advmod(giving-4, when-3)
advcl(Use-1, giving-4)
det(drugs-6, these-5)
dobj(giving-4, drugs-6)
advmod(giving-4, together-7)
advmod(giving-4, especially-9)
prep_in(giving-4, patients-11)
amod(disease-16, hepatic-13)
conj_or(hepatic-13, cardiac-15)
prep_with(patients-11, disease-16)

Estrogen/NN @/NN increased/VBD levels/NNS of/IN corticosteroid-binding/JJ globulin/NN ,/, thereby/RB increasing/VBG the/DT bound/VBN (/-LRB- inactive/JJ )/-RRB- fraction/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN Estrogen) (NN @)) (VP (VBD increased) (NP (NP (NNS levels)) (PP (IN of) (NP (JJ corticosteroid-binding) (NN globulin)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG increasing) (NP (DT the) (VBN bound) (-LRB- -LRB-) (JJ inactive) (-RRB- -RRB-) (NN fraction))))) (: ;)) (. .))))

nn(@-2, Estrogen-1)
nsubj(increased-3, @-2)
root(ROOT-0, increased-3)
dobj(increased-3, levels-4)
amod(globulin-7, corticosteroid-binding-6)
prep_of(levels-4, globulin-7)
advmod(increasing-10, thereby-9)
partmod(increased-3, increasing-10)
xcomp(increased-3, increasing-10)
det(fraction-16, the-11)
amod(fraction-16, bound-12)
amod(fraction-16, inactive-14)
dobj(increasing-10, fraction-16)

this/DT effect/NN is/VBZ at/IN least/JJS balanced/JJ by/IN decreased/VBN metabolism/NN of/IN corticosteroids/NNS ./.

(ROOT (S1 (S (S (NP (DT this) (NN effect)) (VP (VBZ is) (ADVP (IN at) (JJS least)) (ADJP (JJ balanced) (PP (IN by) (NP (NP (VBN decreased) (NN metabolism)) (PP (IN of) (NP (NNS corticosteroids)))))))) (. .))))

det(effect-2, this-1)
nsubj(balanced-6, effect-2)
cop(balanced-6, is-3)
advmod(balanced-6, at-4)
pobj(at-4, least-5)
root(ROOT-0, balanced-6)
amod(metabolism-9, decreased-8)
prep_by(balanced-6, metabolism-9)
prep_of(metabolism-9, corticosteroids-11)

When/WRB estrogen/NN therapy/NN is/VBZ initiated/VBN ,/, a/DT reduction/NN in/IN corticosteroid/NN dosage/NN may/MD be/VB required/VBN ,/, and/CC increased/VBN amounts/NNS may/MD be/VB required/VBN when/WRB estrogen/NN is/VBZ terminated/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN estrogen) (NN therapy)) (VP (VBZ is) (VP (VBN initiated))))) (, ,) (S (S (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NN corticosteroid) (NN dosage)))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (, ,) (CC and) (S (NP (VBN increased) (NNS amounts)) (VP (MD may) (VP (VB be) (VP (VBN required) (SBAR (WHADVP (WRB when)) (S (NP (NN estrogen)) (VP (VBZ is) (VP (VBN terminated))))))))))) (. .))))

advmod(initiated-5, When-1)
nn(therapy-3, estrogen-2)
nsubjpass(initiated-5, therapy-3)
auxpass(initiated-5, is-4)
advcl(required-14, initiated-5)
det(reduction-8, a-7)
nsubjpass(required-14, reduction-8)
nn(dosage-11, corticosteroid-10)
prep_in(reduction-8, dosage-11)
aux(required-14, may-12)
auxpass(required-14, be-13)
root(ROOT-0, required-14)
amod(amounts-18, increased-17)
nsubjpass(required-21, amounts-18)
aux(required-21, may-19)
auxpass(required-21, be-20)
conj_and(required-14, required-21)
advmod(terminated-25, when-22)
nsubjpass(terminated-25, estrogen-23)
auxpass(terminated-25, is-24)
advcl(required-21, terminated-25)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS Corticosteroids/NNS may/MD affect/VB the/DT nitrobluetetrazolium/NN test/NN for/IN bacterial/JJ infection/NN and/CC produce/VB false-negative/JJ results/NNS ./.

(ROOT (S1 (S (S (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions) (NNS Corticosteroids)) (VP (MD may) (VP (VP (VB affect) (NP (NP (DT the) (NN nitrobluetetrazolium) (NN test)) (PP (IN for) (NP (JJ bacterial) (NN infection))))) (CC and) (VP (VB produce) (NP (JJ false-negative) (NNS results)))))) (. .))))

nn(Corticosteroids-5, Drug-1)
nn(Corticosteroids-5, /Laboratory-2)
nn(Corticosteroids-5, Test-3)
nn(Corticosteroids-5, Interactions-4)
nsubj(affect-7, Corticosteroids-5)
aux(affect-7, may-6)
root(ROOT-0, affect-7)
det(test-10, the-8)
nn(test-10, nitrobluetetrazolium-9)
dobj(affect-7, test-10)
amod(infection-13, bacterial-12)
prep_for(test-10, infection-13)
conj_and(affect-7, produce-15)
amod(results-17, false-negative-16)
dobj(produce-15, results-17)

Interaction/NN with/IN central/JJ nervous/JJ system/NN depressants/NNS other/JJ than/IN benzodiazepines/NNS has/VBZ not/RB been/VBN specifically/RB studied/VBN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NN Interaction)) (PP (IN with) (NP (NP (NP (JJ central) (JJ nervous) (NN system)) (NNS depressants)) (CONJP (JJ other) (IN than)) (NP (NNS benzodiazepines))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB specifically)) (VP (VBN studied)))) (: ;)) (. .))))

nsubjpass(studied-14, Interaction-1)
amod(system-5, central-3)
amod(system-5, nervous-4)
nn(depressants-6, system-5)
prep_with(Interaction-1, depressants-6)
conj_other(depressants-6, benzodiazepines-9)
aux(studied-14, has-10)
neg(studied-14, not-11)
auxpass(studied-14, been-12)
advmod(studied-14, specifically-13)
root(ROOT-0, studied-14)

however/RB ,/, no/DT deleterious/JJ interactions/NNS were/VBD seen/VBN when/WRB ROMAZICON/NN was/VBD administered/VBN after/IN narcotics/NNS ,/, inhalational/JJ anesthetics/NNS ,/, muscle/NN relaxants/NNS and/CC muscle/NN relaxant/NN antagonists/NNS administered/VBN in/IN conjunction/NN with/IN sedation/NN or/CC anesthesia/NN ./.

(ROOT (S1 (S (S (ADVP (RB however)) (, ,) (NP (DT no) (JJ deleterious) (NNS interactions)) (VP (VBD were) (VP (VBN seen) (SBAR (WHADVP (WRB when)) (S (NP (NN ROMAZICON)) (VP (VBD was) (VP (VBN administered) (PP (IN after) (NP (NP (NP (NNS narcotics)) (, ,) (NP (JJ inhalational) (NNS anesthetics)) (, ,) (NP (NN muscle) (NNS relaxants)) (CC and) (NP (NN muscle) (NN relaxant) (NNS antagonists))) (VP (VBN administered) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (NP (NN sedation)) (CC or) (NP (NN anesthesia)))))))))))))))) (. .))))

advmod(seen-7, however-1)
det(interactions-5, no-3)
amod(interactions-5, deleterious-4)
nsubjpass(seen-7, interactions-5)
auxpass(seen-7, were-6)
root(ROOT-0, seen-7)
advmod(administered-11, when-8)
nsubjpass(administered-11, ROMAZICON-9)
auxpass(administered-11, was-10)
advcl(seen-7, administered-11)
prep_after(administered-11, narcotics-13)
amod(anesthetics-16, inhalational-15)
conj_and(narcotics-13, anesthetics-16)
nn(relaxants-19, muscle-18)
conj_and(narcotics-13, relaxants-19)
nn(antagonists-23, muscle-21)
nn(antagonists-23, relaxant-22)
conj_and(narcotics-13, antagonists-23)
partmod(narcotics-13, administered-24)
prep_in(administered-24, conjunction-26)
prep_with(conjunction-26, sedation-28)
conj_or(sedation-28, anesthesia-30)

Particular/JJ caution/NN is/VBZ necessary/JJ when/WRB using/VBG ROMAZICON/NN in/IN cases/NNS of/IN mixed/JJ drug/NN overdosage/NN since/IN the/DT toxic/JJ effects/NNS (/-LRB- such/JJ as/IN convulsions/NN and/CC cardiac/JJ dysrhythmias/NNS )/-RRB- of/IN other/JJ drugs/NNS taken/VBN in/IN overdose/NN (/-LRB- especially/RB cyclic/JJ antidepressants/NNS )/-RRB- may/MD emerge/VB with/IN the/DT reversal/NN of/IN the/DT benzodiazepine/NN effect/NN by/IN flumazenil/NN ./.

(ROOT (S1 (S (NP (JJ Particular) (NN caution)) (VP (VBZ is) (ADJP (JJ necessary)) (SBAR (WHADVP (WRB when)) (S (VP (VBG using) (NP (NN ROMAZICON)) (PP (IN in) (NP (NP (NNS cases)) (PP (IN of) (NP (JJ mixed) (NN drug) (NN overdosage))))) (SBAR (IN since) (S (NP (NP (NP (DT the) (JJ toxic) (NNS effects)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NP (NN convulsions)) (CC and) (NP (JJ cardiac) (NNS dysrhythmias))))) (-RRB- -RRB-))) (PP (IN of) (NP (NP (JJ other) (NNS drugs)) (VP (VBN taken) (PP (IN in) (NP (NN overdose))) (PRN (-LRB- -LRB-) (NP (ADVP (RB especially)) (NP (JJ cyclic) (NNS antidepressants))) (-RRB- -RRB-)))))) (VP (MD may) (VP (VB emerge) (PP (IN with) (NP (NP (DT the) (NN reversal)) (PP (IN of) (NP (DT the) (NN benzodiazepine) (NN effect))) (PP (IN by) (NP (NN flumazenil))))))))))))) (. .))))

amod(caution-2, Particular-1)
nsubj(necessary-4, caution-2)
cop(necessary-4, is-3)
root(ROOT-0, necessary-4)
advmod(using-6, when-5)
advcl(necessary-4, using-6)
dobj(using-6, ROMAZICON-7)
prep_in(using-6, cases-9)
amod(overdosage-13, mixed-11)
nn(overdosage-13, drug-12)
prep_of(cases-9, overdosage-13)
mark(emerge-38, since-14)
det(effects-17, the-15)
amod(effects-17, toxic-16)
nsubj(emerge-38, effects-17)
prep_such_as(effects-17, convulsions-21)
amod(dysrhythmias-24, cardiac-23)
conj_and(convulsions-21, dysrhythmias-24)
amod(drugs-28, other-27)
prep_of(effects-17, drugs-28)
partmod(drugs-28, taken-29)
prep_in(taken-29, overdose-31)
advmod(antidepressants-35, especially-33)
amod(antidepressants-35, cyclic-34)
dep(taken-29, antidepressants-35)
aux(emerge-38, may-37)
advcl(using-6, emerge-38)
det(reversal-41, the-40)
prep_with(emerge-38, reversal-41)
det(effect-45, the-43)
nn(effect-45, benzodiazepine-44)
prep_of(reversal-41, effect-45)
prep_by(reversal-41, flumazenil-47)

The/DT use/NN of/IN ROMAZICON/NN is/VBZ not/RB recommended/VBN in/IN epileptic/JJ patients/NNS who/WP have/VBP been/VBN receiving/VBG benzodiazepine/NN treatment/NN for/IN a/DT prolonged/JJ period/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NN ROMAZICON)))) (VP (VBZ is) (RB not) (VP (VBN recommended) (PP (IN in) (NP (NP (JJ epileptic) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN been) (VP (VBG receiving) (NP (NN benzodiazepine) (NN treatment)) (PP (IN for) (NP (DT a) (JJ prolonged) (NN period))))))))))))) (. .))))

det(use-2, The-1)
nsubjpass(recommended-7, use-2)
prep_of(use-2, ROMAZICON-4)
auxpass(recommended-7, is-5)
neg(recommended-7, not-6)
root(ROOT-0, recommended-7)
amod(patients-10, epileptic-9)
prep_in(recommended-7, patients-10)
nsubj(receiving-14, patients-10)
aux(receiving-14, have-12)
aux(receiving-14, been-13)
rcmod(patients-10, receiving-14)
nn(treatment-16, benzodiazepine-15)
dobj(receiving-14, treatment-16)
det(period-20, a-18)
amod(period-20, prolonged-19)
prep_for(receiving-14, period-20)

Although/IN ROMAZICON/NN exerts/VBZ a/DT slight/JJ intrinsic/JJ anticonvulsant/JJ effect/NN ,/, its/PRP$ abrupt/JJ suppression/NN of/IN the/DT protective/JJ effect/NN of/IN a/DT benzodiazepine/JJ agonist/NN can/MD give/VBP rise/NN to/TO convulsions/NNS in/IN epileptic/JJ patients/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NN ROMAZICON)) (VP (VBZ exerts) (NP (DT a) (JJ slight) (JJ intrinsic) (JJ anticonvulsant) (NN effect))))) (, ,) (NP (NP (PRP$ its) (JJ abrupt) (NN suppression)) (PP (IN of) (NP (NP (DT the) (JJ protective) (NN effect)) (PP (IN of) (NP (DT a) (JJ benzodiazepine) (NN agonist)))))) (VP (MD can) (VP (VBP give) (NP (NN rise)) (PP (TO to) (NP (NP (NNS convulsions)) (PP (IN in) (NP (JJ epileptic) (NNS patients)))))))) (. .))))

mark(exerts-3, Although-1)
nsubj(exerts-3, ROMAZICON-2)
advcl(give-22, exerts-3)
det(effect-8, a-4)
amod(effect-8, slight-5)
amod(effect-8, intrinsic-6)
amod(effect-8, anticonvulsant-7)
dobj(exerts-3, effect-8)
poss(suppression-12, its-10)
amod(suppression-12, abrupt-11)
nsubj(give-22, suppression-12)
det(effect-16, the-14)
amod(effect-16, protective-15)
prep_of(suppression-12, effect-16)
det(agonist-20, a-18)
amod(agonist-20, benzodiazepine-19)
prep_of(effect-16, agonist-20)
aux(give-22, can-21)
root(ROOT-0, give-22)
dobj(give-22, rise-23)
prep_to(give-22, convulsions-25)
amod(patients-28, epileptic-27)
prep_in(convulsions-25, patients-28)

ROMAZICON/NN blocks/VBZ the/DT central/JJ effects/NNS of/IN benzodiazepines/NNS by/IN competitive/JJ interaction/NN at/IN the/DT receptor/NN level/NN ./.

(ROOT (S1 (S (S (NP (NN ROMAZICON)) (VP (VBZ blocks) (NP (NP (DT the) (JJ central) (NNS effects)) (PP (IN of) (NP (NNS benzodiazepines)))) (PP (IN by) (NP (NP (JJ competitive) (NN interaction)) (PP (IN at) (NP (DT the) (NN receptor) (NN level))))))) (. .))))

nsubj(blocks-2, ROMAZICON-1)
root(ROOT-0, blocks-2)
det(effects-5, the-3)
amod(effects-5, central-4)
dobj(blocks-2, effects-5)
prep_of(effects-5, benzodiazepines-7)
amod(interaction-10, competitive-9)
prep_by(blocks-2, interaction-10)
det(level-14, the-12)
nn(level-14, receptor-13)
prep_at(interaction-10, level-14)

The/DT effects/NNS of/IN nonbenzodiazepine/NN agonists/NNS at/IN benzodiazepine/NN receptors/NNS ,/, such/JJ as/IN zopiclone/NN ,/, triazolopyridazines/NN and/CC others/NNS ,/, are/VBP also/RB blocked/VBN by/IN ROMAZICON/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NN nonbenzodiazepine) (NNS agonists))) (PP (IN at) (NP (NP (NN benzodiazepine) (NNS receptors)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN zopiclone)) (, ,) (NP (NN triazolopyridazines)) (CC and) (NP (NNS others)))) (, ,)))) (VP (VBP are) (ADVP (RB also)) (VP (VBN blocked) (PP (IN by) (NP (NN ROMAZICON)))))) (. .))))

det(effects-2, The-1)
nsubjpass(blocked-20, effects-2)
nn(agonists-5, nonbenzodiazepine-4)
prep_of(effects-2, agonists-5)
nn(receptors-8, benzodiazepine-7)
prep_at(effects-2, receptors-8)
prep_such_as(receptors-8, zopiclone-12)
conj_and(zopiclone-12, triazolopyridazines-14)
conj_and(zopiclone-12, others-16)
auxpass(blocked-20, are-18)
advmod(blocked-20, also-19)
root(ROOT-0, blocked-20)
agent(blocked-20, ROMAZICON-22)

The/DT pharmacokinetics/NNS of/IN benzodiazepines/NNS are/VBP unaltered/JJ in/IN the/DT presence/NN of/IN flumazenil/NN and/CC vice/RB versa/RB ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS pharmacokinetics)) (PP (IN of) (NP (NNS benzodiazepines)))) (VP (VBP are) (UCP (ADJP (JJ unaltered) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN flumazenil)))))) (CC and) (ADVP (RB vice) (RB versa))))) (. .))))

det(pharmacokinetics-2, The-1)
nsubj(unaltered-6, pharmacokinetics-2)
prep_of(pharmacokinetics-2, benzodiazepines-4)
cop(unaltered-6, are-5)
root(ROOT-0, unaltered-6)
det(presence-9, the-8)
prep_in(unaltered-6, presence-9)
prep_of(presence-9, flumazenil-11)
advmod(versa-14, vice-13)
advmod(unaltered-6, versa-14)
conj_and(unaltered-6, versa-14)

There/EX is/VBZ no/DT pharmacokinetic/JJ interaction/NN between/IN ethanol/NN and/CC flumazenil/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT no) (JJ pharmacokinetic) (NN interaction)) (PP (IN between) (NP (NP (NN ethanol)) (CC and) (NP (NN flumazenil))))))) (. .))))

expl(is-2, There-1)
root(ROOT-0, is-2)
det(interaction-5, no-3)
amod(interaction-5, pharmacokinetic-4)
nsubj(is-2, interaction-5)
prep_between(interaction-5, ethanol-7)
conj_and(ethanol-7, flumazenil-9)

Use/NN in/IN Ambulatory/JJ Patients/NNS :/: The/DT effects/NNS of/IN ROMAZICON/NN may/MD wear/JJ off/RP before/IN a/DT long-acting/JJ benzodiazepine/NN is/VBZ completely/RB cleared/VBN from/IN the/DT body/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Use)) (PP (IN in) (NP (JJ Ambulatory) (NNS Patients)))) (: :) (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NN ROMAZICON))))) (VP (MD may) (VP (JJ wear) (RP off) (SBAR (IN before) (S (NP (DT a) (JJ long-acting) (NN benzodiazepine)) (VP (VBZ is) (ADVP (RB completely)) (VP (VBN cleared) (PP (IN from) (NP (DT the) (NN body)))))))))) (. .))))

nsubj(wear-11, Use-1)
amod(Patients-4, Ambulatory-3)
prep_in(Use-1, Patients-4)
det(effects-7, The-6)
dep(Use-1, effects-7)
prep_of(effects-7, ROMAZICON-9)
aux(wear-11, may-10)
root(ROOT-0, wear-11)
dep(wear-11, off-12)
mark(cleared-19, before-13)
det(benzodiazepine-16, a-14)
amod(benzodiazepine-16, long-acting-15)
nsubjpass(cleared-19, benzodiazepine-16)
auxpass(cleared-19, is-17)
advmod(cleared-19, completely-18)
advcl(wear-11, cleared-19)
det(body-22, the-21)
prep_from(cleared-19, body-22)

In/IN general/JJ ,/, if/IN a/DT patient/NN shows/VBZ no/DT signs/NNS of/IN sedation/NN within/IN 2/CD hours/NNS after/IN a/DT 1-mg/JJ dose/NN of/IN flumazenil/NN ,/, serious/JJ resedation/NN at/IN a/DT later/JJ time/NN is/VBZ unlikely/JJ ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ general))) (, ,) (SBAR (IN if) (S (NP (DT a) (NN patient)) (VP (VBZ shows) (NP (NP (DT no) (NNS signs)) (PP (IN of) (NP (NN sedation)))) (PP (IN within) (NP (NP (CD 2) (NNS hours)) (PP (IN after) (NP (NP (DT a) (JJ 1-mg) (NN dose)) (PP (IN of) (NP (NN flumazenil)))))))))) (, ,) (NP (NP (JJ serious) (NN resedation)) (PP (IN at) (NP (DT a) (JJ later) (NN time)))) (VP (VBZ is) (ADJP (JJ unlikely)))) (. .))))

prep_in(unlikely-29, general-2)
mark(shows-7, if-4)
det(patient-6, a-5)
nsubj(shows-7, patient-6)
advcl(unlikely-29, shows-7)
det(signs-9, no-8)
dobj(shows-7, signs-9)
prep_of(signs-9, sedation-11)
num(hours-14, 2-13)
prep_within(shows-7, hours-14)
det(dose-18, a-16)
amod(dose-18, 1-mg-17)
prep_after(hours-14, dose-18)
prep_of(dose-18, flumazenil-20)
amod(resedation-23, serious-22)
nsubj(unlikely-29, resedation-23)
det(time-27, a-25)
amod(time-27, later-26)
prep_at(resedation-23, time-27)
cop(unlikely-29, is-28)
root(ROOT-0, unlikely-29)

An/DT adequate/JJ period/NN of/IN observation/NN must/MD be/VB provided/VBN for/IN any/DT patient/NN in/IN whom/WP either/CC long-acting/JJ benzodiazepines/NNS (/-LRB- such/JJ as/IN diazepam/NN )/-RRB- or/CC large/JJ doses/NNS of/IN short-acting/JJ benzodiazepines/NNS (/-LRB- such/JJ as/IN 10/CD mg/NN of/IN midazolam/NN )/-RRB- have/VBP been/VBN used/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT An) (JJ adequate) (NN period)) (PP (IN of) (NP (NN observation)))) (VP (MD must) (VP (VB be) (VP (VBN provided) (PP (IN for) (NP (NP (DT any) (NN patient)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (CC either) (NP (NP (JJ long-acting) (NNS benzodiazepines)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NN diazepam)))) (-RRB- -RRB-))) (CC or) (NP (NP (NP (JJ large) (NNS doses)) (PP (IN of) (NP (JJ short-acting) (NNS benzodiazepines)))) (PRN (-LRB- -LRB-) (CONJP (JJ such) (IN as)) (NP (NP (CD 10) (NN mg)) (PP (IN of) (NP (NN midazolam)))) (-RRB- -RRB-)))) (VP (VBP have) (VP (VBN been) (VP (VBN used)))))))))))) (. .))))

det(period-3, An-1)
amod(period-3, adequate-2)
nsubjpass(provided-8, period-3)
prep_of(period-3, observation-5)
aux(provided-8, must-6)
auxpass(provided-8, be-7)
root(ROOT-0, provided-8)
det(patient-11, any-10)
prep_for(provided-8, patient-11)
rel(used-38, whom-13)
preconj(benzodiazepines-16, either-14)
amod(benzodiazepines-16, long-acting-15)
nsubjpass(used-38, benzodiazepines-16)
dep(benzodiazepines-16, such-18)
prep_as(such-18, diazepam-20)
amod(doses-24, large-23)
conj_or(benzodiazepines-16, doses-24)
amod(benzodiazepines-27, short-acting-26)
prep_of(doses-24, benzodiazepines-27)
dep(mg-32, such-29)
dep(such-29, as-30)
num(mg-32, 10-31)
dep(doses-24, mg-32)
prep_of(mg-32, midazolam-34)
aux(used-38, have-36)
auxpass(used-38, been-37)
rcmod(patient-11, used-38)

Because/IN of/IN the/DT increased/VBN risk/NN of/IN adverse/JJ reactions/NNS in/IN patients/NNS who/WP have/VBP been/VBN taking/VBG benzodiazepines/NNS on/IN a/DT regular/JJ basis/NN ,/, it/PRP is/VBZ particularly/RB important/JJ that/IN physicians/NNS query/VB patients/NNS or/CC their/PRP$ guardians/NNS carefully/RB about/IN benzodiazepine/NN ,/, alcohol/NN and/CC sedative/JJ use/NN as/IN part/NN of/IN the/DT history/NN prior/RB to/TO any/DT procedure/NN in/IN which/WDT the/DT use/NN of/IN ROMAZICON/NN is/VBZ planned/VBN ./.

(ROOT (S1 (S (PP (IN Because) (PP (IN of) (NP (NP (DT the) (VBN increased) (NN risk)) (PP (IN of) (NP (NP (JJ adverse) (NNS reactions)) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN been) (S (VP (VBG taking) (NP (NNS benzodiazepines)) (PP (IN on) (NP (DT a) (JJ regular) (NN basis)))))))))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (RB particularly) (JJ important)) (SBAR (IN that) (S (NP (NNS physicians)) (VP (VB query) (NP (NP (NNS patients)) (CC or) (NP (PRP$ their) (NNS guardians))) (ADVP (RB carefully)) (PP (IN about) (NP (NP (NN benzodiazepine)) (, ,) (NP (NN alcohol)) (CC and) (NP (JJ sedative) (NN use)))) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (NP (DT the) (NN history)) (ADVP (ADVP (RB prior)) (PP (TO to) (NP (NP (DT any) (NN procedure)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN ROMAZICON)))) (VP (VBZ is) (VP (VBN planned)))))))))))))))) (. .))))

prepc_because_of(important-24, of-2)
det(risk-5, the-3)
amod(risk-5, increased-4)
pobj(important-24, risk-5)
amod(reactions-8, adverse-7)
prep_of(risk-5, reactions-8)
prep_in(reactions-8, patients-10)
nsubj(been-13, patients-10)
aux(been-13, have-12)
rcmod(patients-10, been-13)
xcomp(been-13, taking-14)
dobj(taking-14, benzodiazepines-15)
det(basis-19, a-17)
amod(basis-19, regular-18)
prep_on(taking-14, basis-19)
nsubj(important-24, it-21)
cop(important-24, is-22)
advmod(important-24, particularly-23)
root(ROOT-0, important-24)
complm(query-27, that-25)
nsubj(query-27, physicians-26)
ccomp(important-24, query-27)
dobj(query-27, patients-28)
poss(guardians-31, their-30)
conj_or(patients-28, guardians-31)
advmod(query-27, carefully-32)
prep_about(query-27, benzodiazepine-34)
conj_and(benzodiazepine-34, alcohol-36)
amod(use-39, sedative-38)
conj_and(benzodiazepine-34, use-39)
prep_as(query-27, part-41)
det(history-44, the-43)
prep_of(part-41, history-44)
det(procedure-48, any-47)
prep_prior_to(history-44, procedure-48)
rel(planned-56, which-50)
det(use-52, the-51)
nsubjpass(planned-56, use-52)
prep_of(use-52, ROMAZICON-54)
auxpass(planned-56, is-55)
rcmod(procedure-48, planned-56)

Do/VBP not/RB take/VB this/DT medicine/NN with/IN thioridizine/NN ,/, or/CC within/IN 5/CD weeks/NNS of/IN taking/VBG fluoxetine/NN ./.

(ROOT (S1 (S (S (VP (VBP Do) (RB not) (VP (VB take) (NP (DT this) (NN medicine)) (PP (PP (IN with) (NP (NN thioridizine))) (, ,) (CC or) (PP (IN within) (NP (NP (CD 5) (NNS weeks)) (PP (IN of) (NP (VBG taking) (NN fluoxetine))))))))) (. .))))

aux(take-3, Do-1)
neg(take-3, not-2)
root(ROOT-0, take-3)
conj_or(take-3, take-3')
det(medicine-5, this-4)
dobj(take-3, medicine-5)
prep_with(take-3, thioridizine-7)
num(weeks-12, 5-11)
prep_within(take-3', weeks-12)
amod(fluoxetine-15, taking-14)
prep_of(weeks-12, fluoxetine-15)

Talk/NN to/TO your/NN doctor/NN if/IN you/NN are/VBP taking/VBG certain/JJ antibiotics/NNS such/JJ as/IN erythromycin/NN ,/, clarithromycin/NN or/CC azithromycin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Talk)) (PP (TO to) (NP (NN your) (NN doctor))) (PP (IN if) (NP (NN you)))) (VP (VBP are) (VP (VBG taking) (NP (NP (JJ certain) (NNS antibiotics)) (PP (JJ such) (IN as) (NP (NP (NN erythromycin)) (, ,) (NP (NN clarithromycin)) (CC or) (NP (NN azithromycin)))))))) (. .))))

nsubj(taking-8, Talk-1)
nn(doctor-4, your-3)
prep_to(Talk-1, doctor-4)
prep_if(Talk-1, you-6)
aux(taking-8, are-7)
root(ROOT-0, taking-8)
amod(antibiotics-10, certain-9)
dobj(taking-8, antibiotics-10)
prep_such_as(antibiotics-10, erythromycin-13)
conj_or(erythromycin-13, clarithromycin-15)
conj_or(erythromycin-13, azithromycin-17)

This/DT medicine/NN should/MD not/RB be/VB taken/VBN with/IN MAO/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (DT This) (NN medicine)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN taken) (PP (IN with) (NP (NN MAO) (NNS inhibitors))))))) (. .))))

det(medicine-2, This-1)
nsubjpass(taken-6, medicine-2)
aux(taken-6, should-3)
neg(taken-6, not-4)
auxpass(taken-6, be-5)
root(ROOT-0, taken-6)
nn(inhibitors-9, MAO-8)
prep_with(taken-6, inhibitors-9)

Caution/NN should/MD be/VB exercised/VBN when/WRB taking/VBG this/DT medicine/NN certain/JJ antibiotics/NNS ,/, such/JJ as/IN erythromycin/NN ,/, clarithromycin/NN ,/, or/CC azithromycin/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (VP (VBG taking) (NP (NP (DT this) (NN medicine) (JJ certain) (NNS antibiotics)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN erythromycin)) (, ,) (NP (NN clarithromycin)) (, ,) (CC or) (NP (NN azithromycin)))))))))))) (. .))))

nsubjpass(exercised-4, Caution-1)
aux(exercised-4, should-2)
auxpass(exercised-4, be-3)
root(ROOT-0, exercised-4)
advmod(taking-6, when-5)
advcl(exercised-4, taking-6)
det(antibiotics-10, this-7)
nn(antibiotics-10, medicine-8)
amod(antibiotics-10, certain-9)
dobj(taking-6, antibiotics-10)
prep_such_as(antibiotics-10, erythromycin-14)
conj_or(erythromycin-14, clarithromycin-16)
conj_or(erythromycin-14, azithromycin-19)

This/DT medicine/NN should/MD not/RB be/VB taken/VBN with/IN MAO/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (DT This) (NN medicine)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN taken) (PP (IN with) (NP (NN MAO) (NNS inhibitors))))))) (. .))))

det(medicine-2, This-1)
nsubjpass(taken-6, medicine-2)
aux(taken-6, should-3)
neg(taken-6, not-4)
auxpass(taken-6, be-5)
root(ROOT-0, taken-6)
nn(inhibitors-9, MAO-8)
prep_with(taken-6, inhibitors-9)

If/IN you/VBN think/VBP you/VBZ are/VBP taking/VBG an/DT MAO/NN inhibitor/NN talk/NN to/TO your/NN doctor/NN or/CC pharmacist/NN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (VP (VBN you)))) (VP (VBP think) (S (VP (VBZ you) (S (VP (VBP are) (VP (VBG taking) (NP (DT an) (NN MAO) (NN inhibitor) (NN talk)) (PP (TO to) (NP (NP (NN your) (NN doctor)) (CC or) (NP (NN pharmacist))))))))))) (. .))))

mark(you-2, If-1)
csubj(think-3, you-2)
root(ROOT-0, think-3)
ccomp(think-3, you-4)
aux(taking-6, are-5)
ccomp(you-4, taking-6)
det(talk-10, an-7)
nn(talk-10, MAO-8)
nn(talk-10, inhibitor-9)
dobj(taking-6, talk-10)
nn(doctor-13, your-12)
prep_to(taking-6, doctor-13)
conj_or(doctor-13, pharmacist-15)

Do/VBP not/RB take/VB this/DT medicine/NN with/IN St./NN Johns/NNP Wort/NNP because/IN of/IN the/DT additive/JJ effects/NNS of/IN sertonin/NN ./.

(ROOT (S1 (S (S (VP (VBP Do) (RB not) (VP (VB take) (NP (NP (DT this) (NN medicine)) (PP (IN with) (NP (NN St.) (NNP Johns) (NNP Wort)))) (PP (IN because) (IN of) (NP (NP (DT the) (JJ additive) (NNS effects)) (PP (IN of) (NP (NN sertonin)))))))) (. .))))

aux(take-3, Do-1)
neg(take-3, not-2)
root(ROOT-0, take-3)
det(medicine-5, this-4)
dobj(take-3, medicine-5)
nn(Wort-9, St.-7)
nn(Wort-9, Johns-8)
prep_with(medicine-5, Wort-9)
det(effects-14, the-12)
amod(effects-14, additive-13)
prep_because_of(take-3, effects-14)
prep_of(effects-14, sertonin-16)

This/DT medication/NN should/MD not/RB be/VB taken/VBN with/IN MAO/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (DT This) (NN medication)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN taken) (PP (IN with) (NP (NN MAO) (NNS inhibitors))))))) (. .))))

det(medication-2, This-1)
nsubjpass(taken-6, medication-2)
aux(taken-6, should-3)
neg(taken-6, not-4)
auxpass(taken-6, be-5)
root(ROOT-0, taken-6)
nn(inhibitors-9, MAO-8)
prep_with(taken-6, inhibitors-9)

Your/NN doctor/NN or/CC pharmacist/NN can/MD give/VB you/RB more/JJR information/NN on/IN MAO/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Your) (NN doctor)) (CC or) (NP (NN pharmacist))) (VP (MD can) (VP (VB give) (NP (NP (ADJP (RB you) (JJR more)) (NN information)) (PP (IN on) (NP (NN MAO) (NNS inhibitors))))))) (. .))))

nn(doctor-2, Your-1)
nsubj(give-6, doctor-2)
conj_or(doctor-2, pharmacist-4)
aux(give-6, can-5)
root(ROOT-0, give-6)
advmod(more-8, you-7)
amod(information-9, more-8)
dobj(give-6, information-9)
nn(inhibitors-12, MAO-11)
prep_on(information-9, inhibitors-12)

Wait/VBP 5/CD weeks/NNS after/IN stopping/VBG escitalopram/NN before/IN starting/VBG a/DT non-selective/JJ MAO/NN inhibitor/NN ./.

(ROOT (S1 (S (S (VP (VBP Wait) (NP (NP (CD 5) (NNS weeks)) (PP (IN after) (S (VP (VBG stopping) (NP (NN escitalopram)) (PP (IN before) (S (VP (VBG starting) (NP (DT a) (JJ non-selective) (NN MAO) (NN inhibitor))))))))))) (. .))))

root(ROOT-0, Wait-1)
num(weeks-3, 5-2)
dobj(Wait-1, weeks-3)
prepc_after(weeks-3, stopping-5)
dobj(stopping-5, escitalopram-6)
prepc_before(stopping-5, starting-8)
det(inhibitor-12, a-9)
amod(inhibitor-12, non-selective-10)
nn(inhibitor-12, MAO-11)
dobj(starting-8, inhibitor-12)

Wait/VBP 2/CD weeks/NNS after/IN stopping/VBG an/DT MAO/NN inhibitor/NN before/IN starting/VBG escitalopram/NN ./.

(ROOT (S1 (S (S (VP (VBP Wait) (NP (CD 2) (NNS weeks)) (PP (IN after) (S (VP (VBG stopping) (NP (DT an) (NN MAO) (NN inhibitor)) (PP (IN before) (S (VP (VBG starting) (NP (NN escitalopram)))))))))) (. .))))

root(ROOT-0, Wait-1)
num(weeks-3, 2-2)
tmod(Wait-1, weeks-3)
prepc_after(Wait-1, stopping-5)
det(inhibitor-8, an-6)
nn(inhibitor-8, MAO-7)
dobj(stopping-5, inhibitor-8)
prepc_before(stopping-5, starting-10)
dobj(starting-10, escitalopram-11)

If/IN you/VBN are/VBP taking/VBG medications/NNS for/IN migraines/NNS such/JJ as/IN Imitrex/NN ,/, talk/NN to/TO your/NN doctor/NN before/IN starting/VBG this/DT medicine/NN ./.

(ROOT (S1 (S (SBAR (IN If) (S (VP (VBN you)))) (VP (VBP are) (VP (VBG taking) (NP (NP (NNS medications)) (PP (IN for) (NP (NP (NNS migraines)) (PP (JJ such) (IN as) (NP (NP (NP (NN Imitrex)) (, ,) (NP (NN talk))) (PP (TO to) (NP (NN your) (NN doctor)))))))) (PP (IN before) (S (VP (VBG starting) (NP (DT this) (NN medicine))))))) (. .))))

mark(you-2, If-1)
csubj(taking-4, you-2)
aux(taking-4, are-3)
root(ROOT-0, taking-4)
dobj(taking-4, medications-5)
prep_for(medications-5, migraines-7)
prep_such_as(migraines-7, Imitrex-10)
appos(Imitrex-10, talk-12)
nn(doctor-15, your-14)
prep_to(Imitrex-10, doctor-15)
prepc_before(taking-4, starting-17)
det(medicine-19, this-18)
dobj(starting-17, medicine-19)

If/IN you/VBN are/VBP taking/VBG a/DT tricyclic/JJ antidepressant/JJ ,/, talk/NN to/TO your/NN doctor/NN before/IN taking/VBG this/DT medicine/NN ./.

(ROOT (S1 (S (SBAR (IN If) (S (VP (VBN you)))) (VP (VBP are) (VP (VBG taking) (NP (NP (DT a) (JJ tricyclic) (JJ antidepressant) (, ,) (NN talk)) (PP (TO to) (NP (NN your) (NN doctor)))) (PP (IN before) (S (VP (VBG taking) (NP (DT this) (NN medicine))))))) (. .))))

mark(you-2, If-1)
csubj(taking-4, you-2)
aux(taking-4, are-3)
root(ROOT-0, taking-4)
det(talk-9, a-5)
amod(talk-9, tricyclic-6)
amod(talk-9, antidepressant-7)
dobj(taking-4, talk-9)
nn(doctor-12, your-11)
prep_to(talk-9, doctor-12)
prepc_before(taking-4, taking-14)
det(medicine-16, this-15)
dobj(taking-14, medicine-16)

St./NN John/NNP @@/NNP s/NNP Wort/NNP should/MD be/VB avoided/VBN while/IN taking/VBG this/DT medicine/NN due/JJ to/TO the/DT additive/JJ effects/NNS of/IN serotonin/NN ./.

(ROOT (S1 (S (S (NP (NN St.) (NNP John) (NNP @@) (NNP s) (NNP Wort)) (VP (MD should) (VP (VB be) (VP (VBN avoided) (SBAR (IN while) (S (VP (VBG taking) (NP (NP (DT this) (NN medicine)) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (JJ additive) (NNS effects)) (PP (IN of) (NP (NN serotonin)))))))))))))) (. .))))

nn(Wort-5, St.-1)
nn(Wort-5, John-2)
nn(Wort-5, @@-3)
nn(Wort-5, s-4)
nsubjpass(avoided-8, Wort-5)
aux(avoided-8, should-6)
auxpass(avoided-8, be-7)
root(ROOT-0, avoided-8)
mark(taking-10, while-9)
advcl(avoided-8, taking-10)
det(medicine-12, this-11)
dobj(taking-10, medicine-12)
det(effects-17, the-15)
amod(effects-17, additive-16)
prep_due_to(medicine-12, effects-17)
prep_of(effects-17, serotonin-19)

Tell/NN your/NN doctor/NN if/IN you/NN are/VBP taking/VBG any/DT of/IN the/DT following/JJ drugs/NNS :/: blood/NN thinner/NN s/NN (/-LRB- Coumadin/NN )/-RRB- other/JJ antidepressants/NNS metoprolol/NN antihistamines/NNS carbamazepine/NN (/-LRB- Tegretol/NN )/-RRB- cimetidine/NN (/-LRB- Tagamet/NN )/-RRB- estrogens/NNS fluoxetine/NN (/-LRB- Prozac/NN )/-RRB- intraconazole/NN (/-LRB- Sporanox/NN )/-RRB- ketoconazole/NN (/-LRB- Nizoral/NN )/-RRB- levodopa/NN lithium/NN muscle/NN relaxants/NNS birth/NN control/NN pills/NNS sleeping/VBG pills/NNS thyroid/NN medications/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Tell) (NN your) (NN doctor)) (PP (IN if) (NP (NN you)))) (VP (VBP are) (VP (VBG taking) (NP (NP (DT any)) (PP (IN of) (NP (DT the) (JJ following) (NNS drugs))))))) (: :) (S (NP (NP (NN blood) (NN thinner) (NN s) (-LRB- -LRB-) (NN Coumadin) (-RRB- -RRB-) (JJ other) (NNS antidepressants)) (NN metoprolol) (NNS antihistamines) (NP (NP (NN carbamazepine) (-LRB- -LRB-) (NN Tegretol) (-RRB- -RRB-) (NN cimetidine) (-LRB- -LRB-) (NN Tagamet) (-RRB- -RRB-) (NNS estrogens) (NP (NP (NN fluoxetine)) (PRN (-LRB- -LRB-) (NP (NN Prozac)) (-RRB- -RRB-)))) (NN intraconazole) (-LRB- -LRB-) (NN Sporanox) (-RRB- -RRB-) (NN ketoconazole) (-LRB- -LRB-) (NN Nizoral) (-RRB- -RRB-) (NN levodopa) (NN lithium) (NN muscle) (NNS relaxants) (NP (NN birth) (NN control) (NNS pills)))) (VP (VBG sleeping) (NP (NNS pills) (NP (NN thyroid) (NNS medications))))) (. .))))

nn(doctor-3, Tell-1)
nn(doctor-3, your-2)
nsubj(taking-7, doctor-3)
prep_if(doctor-3, you-5)
aux(taking-7, are-6)
root(ROOT-0, taking-7)
dobj(taking-7, any-8)
det(drugs-12, the-10)
amod(drugs-12, following-11)
prep_of(any-8, drugs-12)
nn(antidepressants-21, blood-14)
nn(antidepressants-21, thinner-15)
nn(antidepressants-21, s-16)
nn(antidepressants-21, Coumadin-18)
amod(antidepressants-21, other-20)
nn(antihistamines-23, antidepressants-21)
nn(antihistamines-23, metoprolol-22)
nsubj(sleeping-52, antihistamines-23)
nn(estrogens-32, carbamazepine-24)
nn(estrogens-32, Tegretol-26)
nn(estrogens-32, cimetidine-28)
nn(estrogens-32, Tagamet-30)
nn(relaxants-48, estrogens-32)
dep(estrogens-32, fluoxetine-33)
appos(fluoxetine-33, Prozac-35)
nn(relaxants-48, intraconazole-37)
nn(relaxants-48, Sporanox-39)
nn(relaxants-48, ketoconazole-41)
nn(relaxants-48, Nizoral-43)
nn(relaxants-48, levodopa-45)
nn(relaxants-48, lithium-46)
nn(relaxants-48, muscle-47)
dep(antihistamines-23, relaxants-48)
nn(pills-51, birth-49)
nn(pills-51, control-50)
dep(relaxants-48, pills-51)
parataxis(taking-7, sleeping-52)
dobj(sleeping-52, pills-53)
nn(medications-55, thyroid-54)
dep(pills-53, medications-55)

Drug/NN Interactions/NNS :/: Flupenthixol/NN may/MD interact/VB with/IN some/DT drugs/NNS ,/, like/IN :/: -/CC Monoamine/NN oxidase/NN inhibitors/NNS (/-LRB- MAOI/NNP )/-RRB- :/: MAOI/NNP could/MD theoretically/RB affect/VB flupenthixol/NN pharmacodynamics/NNS -/CC Arecoline/NN -/CC Eproxindine/NN -/CC Ethanol/NN :/: Flupenthixol/NN and/CC Ethanol/NN cause/VBP additive/JJ CNS/NN depression/NN -/CC Tricyclic/JJ antidepressants/NNS :/: Flupenthixol/NN increases/VBZ the/DT effect/NN of/IN Tricyclic/JJ antidepressants/NNS ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NNS Interactions)) (: :) (S (S (NP (NN Flupenthixol)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (DT some) (NNS drugs))) (, ,) (PP (IN like) (: :) (NP (NP (CC -) (NN Monoamine) (NN oxidase) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NNP MAOI)) (-RRB- -RRB-))))))) (: :) (S (NP (NNP MAOI)) (VP (MD could) (ADVP (RB theoretically)) (VP (VB affect) (NP (NP (NN flupenthixol) (NNS pharmacodynamics)) (CC -) (NP (NP (NN Arecoline)) (CC -) (NP (NP (NN Eproxindine)) (CC -) (NP (NN Ethanol)))))))) (: :) (S (NP (NP (NN Flupenthixol)) (CC and) (NP (NN Ethanol))) (VP (VBP cause) (NP (NP (JJ additive) (NN CNS) (NN depression)) (CC -) (NP (JJ Tricyclic) (NNS antidepressants))))) (: :) (S (NP (NN Flupenthixol)) (VP (VBZ increases) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ Tricyclic) (NNS antidepressants))))))) (. .)))))

nn(Interactions-2, Drug-1)
root(ROOT-0, Interactions-2)
nsubj(interact-6, Flupenthixol-4)
aux(interact-6, may-5)
dep(Interactions-2, interact-6)
det(drugs-9, some-8)
prep_with(interact-6, drugs-9)
nn(inhibitors-16, Monoamine-14)
nn(inhibitors-16, oxidase-15)
prep_like(interact-6, inhibitors-16)
abbrev(inhibitors-16, MAOI-18)
nsubj(affect-24, MAOI-21)
aux(affect-24, could-22)
advmod(affect-24, theoretically-23)
parataxis(interact-6, affect-24)
nn(pharmacodynamics-26, flupenthixol-25)
dobj(affect-24, pharmacodynamics-26)
conj(pharmacodynamics-26, Arecoline-28)
conj(Arecoline-28, Eproxindine-30)
conj(Eproxindine-30, Ethanol-32)
nsubj(cause-37, Flupenthixol-34)
conj_and(Flupenthixol-34, Ethanol-36)
parataxis(interact-6, cause-37)
amod(depression-40, additive-38)
nn(depression-40, CNS-39)
dobj(cause-37, depression-40)
amod(antidepressants-43, Tricyclic-42)
conj(depression-40, antidepressants-43)
nsubj(increases-46, Flupenthixol-45)
parataxis(interact-6, increases-46)
det(effect-48, the-47)
dobj(increases-46, effect-48)
amod(antidepressants-51, Tricyclic-50)
prep_of(effect-48, antidepressants-51)

Increases/NNS in/IN prothrombin/NN time/NN have/VBP been/VBN noted/VBN in/IN patients/NNS receiving/VBG long-/NN term/NN warfarin/NN therapy/NN after/IN flutamide/NN was/VBD initiated/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Increases)) (PP (IN in) (NP (NN prothrombin) (NN time)))) (VP (VBP have) (VP (VBN been) (VP (VBN noted) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN long-) (NN term) (NN warfarin) (NN therapy)) (PP (IN after) (S (NP (NN flutamide)) (VP (VBD was) (VP (VBN initiated)))))))))))) (. .))))

nsubjpass(noted-7, Increases-1)
nn(time-4, prothrombin-3)
prep_in(Increases-1, time-4)
aux(noted-7, have-5)
auxpass(noted-7, been-6)
root(ROOT-0, noted-7)
prep_in(noted-7, patients-9)
partmod(patients-9, receiving-10)
nn(therapy-14, long--11)
nn(therapy-14, term-12)
nn(therapy-14, warfarin-13)
dobj(receiving-10, therapy-14)
nsubjpass(initiated-18, flutamide-16)
auxpass(initiated-18, was-17)
prepc_after(receiving-10, initiated-18)

Therefore/RB ,/, close/JJ monitoring/NN of/IN prothrombin/NN time/NN is/VBZ recommended/VBN and/CC adjustment/NN of/IN the/DT anticoagulant/JJ dose/NN may/MD be/VB necessary/JJ when/WRB EULEXIN/NN Capsules/NNS are/VBP administered/VBN concomitantly/RB with/IN warfarin/NN ./.

(ROOT (S1 (S (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (JJ close) (NN monitoring)) (PP (IN of) (NP (NN prothrombin) (NN time)))) (VP (VBZ is) (VP (VBN recommended)))) (CC and) (S (NP (NP (NN adjustment)) (PP (IN of) (NP (DT the) (JJ anticoagulant) (NN dose)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary) (SBAR (WHADVP (WRB when)) (S (NP (NN EULEXIN) (NNS Capsules)) (VP (VBP are) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN warfarin)))))))))))) (. .))))

advmod(recommended-9, Therefore-1)
amod(monitoring-4, close-3)
nsubjpass(recommended-9, monitoring-4)
nn(time-7, prothrombin-6)
prep_of(monitoring-4, time-7)
auxpass(recommended-9, is-8)
root(ROOT-0, recommended-9)
nsubj(necessary-18, adjustment-11)
det(dose-15, the-13)
amod(dose-15, anticoagulant-14)
prep_of(adjustment-11, dose-15)
aux(necessary-18, may-16)
cop(necessary-18, be-17)
conj_and(recommended-9, necessary-18)
advmod(administered-23, when-19)
nn(Capsules-21, EULEXIN-20)
nsubjpass(administered-23, Capsules-21)
auxpass(administered-23, are-22)
dep(necessary-18, administered-23)
advmod(administered-23, concomitantly-24)
prep_with(administered-23, warfarin-26)

Potential/JJ for/IN Interaction/NN with/IN Monoamine/NN Oxidase/NN Inhibitors/NNS ./.

(ROOT (S1 (S (S (ADJP (JJ Potential) (PP (IN for) (NP (NP (NN Interaction)) (PP (IN with) (NP (NN Monoamine) (NN Oxidase) (NNS Inhibitors))))))) (. .))))

root(ROOT-0, Potential-1)
prep_for(Potential-1, Interaction-3)
nn(Inhibitors-7, Monoamine-5)
nn(Inhibitors-7, Oxidase-6)
prep_with(Interaction-3, Inhibitors-7)

In/IN patients/NNS receiving/VBG another/DT serotonin/NN reuptake/NN inhibitor/NN drug/NN in/IN combination/NN with/IN monoamine/NN oxidase/NN inhibitors/NNS (/-LRB- MAOI/NN )/-RRB- ,/, there/EX have/VBP been/VBN reports/NNS of/IN serious/JJ ,/, sometimes/RB fatal/JJ ,/, reactions/NNS including/VBG hyperthermia/NN ,/, rigidity/NN ,/, myoclonus/NN ,/, autonomic/JJ instability/NN with/IN possible/JJ rapid/JJ fluctuations/NNS of/IN vital/JJ signs/NNS ,/, and/CC mental/JJ status/NN changes/NNS that/WDT include/VBP extreme/JJ agitation/NN progressing/VBG to/TO delirium/NN and/CC coma/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (DT another) (NN serotonin) (NN reuptake) (NN inhibitor)) (NP (NN drug))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NP (NN monoamine) (NN oxidase)) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NN MAOI)) (-RRB- -RRB-))))))))) (, ,) (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (NNS reports)) (PP (IN of) (NP (JJ serious) (, ,) (ADJP (RB sometimes) (JJ fatal)) (, ,) (NNS reactions))) (PP (VBG including) (NP (NP (NN hyperthermia)) (, ,) (NP (NN rigidity)) (, ,) (NP (NN myoclonus)) (, ,) (NP (NP (JJ autonomic) (NN instability)) (PP (IN with) (NP (NP (JJ possible) (JJ rapid) (NNS fluctuations)) (PP (IN of) (NP (JJ vital) (NNS signs)))))) (, ,) (CC and) (NP (NP (JJ mental) (NN status) (NNS changes)) (SBAR (WHNP (WDT that)) (S (VP (VBP include) (NP (NP (JJ extreme) (NN agitation)) (VP (VBG progressing) (PP (TO to) (NP (NP (NN delirium)) (CC and) (NP (NN coma))))))))))))))) (. .))))

prep_in(reports-22, patients-2)
partmod(patients-2, receiving-3)
det(inhibitor-7, another-4)
nn(inhibitor-7, serotonin-5)
nn(inhibitor-7, reuptake-6)
dobj(receiving-3, inhibitor-7)
iobj(receiving-3, inhibitor-7)
dobj(receiving-3, drug-8)
dep(inhibitor-7, drug-8)
prep_in(receiving-3, combination-10)
nn(oxidase-13, monoamine-12)
nn(inhibitors-14, oxidase-13)
prep_with(combination-10, inhibitors-14)
abbrev(inhibitors-14, MAOI-16)
expl(reports-22, there-19)
aux(reports-22, have-20)
cop(reports-22, been-21)
root(ROOT-0, reports-22)
amod(reactions-29, serious-24)
advmod(fatal-27, sometimes-26)
amod(reactions-29, fatal-27)
prep_of(reports-22, reactions-29)
prep_including(reports-22, hyperthermia-31)
conj_and(hyperthermia-31, rigidity-33)
conj_and(hyperthermia-31, myoclonus-35)
amod(instability-38, autonomic-37)
conj_and(hyperthermia-31, instability-38)
amod(fluctuations-42, possible-40)
amod(fluctuations-42, rapid-41)
prep_with(instability-38, fluctuations-42)
amod(signs-45, vital-44)
prep_of(fluctuations-42, signs-45)
amod(changes-50, mental-48)
nn(changes-50, status-49)
conj_and(hyperthermia-31, changes-50)
nsubj(include-52, changes-50)
rcmod(changes-50, include-52)
amod(agitation-54, extreme-53)
dobj(include-52, agitation-54)
partmod(agitation-54, progressing-55)
prep_to(progressing-55, delirium-57)
conj_and(delirium-57, coma-59)

These/DT reactions/NNS have/VBP also/RB been/VBN reported/VBN in/IN patients/NNS who/WP have/VBP discontinued/VBN that/DT drug/NN and/CC have/VBP been/VBN started/VBN on/IN a/DT MAOI/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS reactions)) (VP (VBP have) (ADVP (RB also)) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VP (VBP have) (VP (VBN discontinued) (NP (DT that) (NN drug)))) (CC and) (VP (VBP have) (VP (VBN been) (VP (VBN started) (PP (IN on) (NP (DT a) (NN MAOI))))))))))))))) (. .))))

det(reactions-2, These-1)
nsubjpass(reported-6, reactions-2)
aux(reported-6, have-3)
advmod(reported-6, also-4)
auxpass(reported-6, been-5)
root(ROOT-0, reported-6)
prep_in(reported-6, patients-8)
nsubj(discontinued-11, patients-8)
aux(discontinued-11, have-10)
rcmod(patients-8, discontinued-11)
det(drug-13, that-12)
dobj(discontinued-11, drug-13)
aux(started-17, have-15)
auxpass(started-17, been-16)
conj_and(discontinued-11, started-17)
det(MAOI-20, a-19)
prep_on(started-17, MAOI-20)

Therefore/RB ,/, it/PRP is/VBZ recommended/VBN that/IN Fluvoxamine/NN Tablets/NNS not/RB be/VB used/VBN in/IN combination/NN with/IN MAOIs/NN ,/, or/CC within/IN 14/CD days/NNS of/IN discontinuing/NN treatment/NN with/IN a/DT MAOI/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NN Fluvoxamine)) (VP (NNS Tablets) (RB not) (VP (VB be) (VP (VBN used) (PP (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN MAOIs))))) (, ,) (CC or) (PP (IN within) (NP (NP (CD 14) (NNS days)) (PP (IN of) (NP (NP (NN discontinuing) (NN treatment)) (PP (IN with) (NP (DT a) (NN MAOI)))))))))))))))) (. .))))

advmod(recommended-5, Therefore-1)
nsubjpass(recommended-5, it-3)
auxpass(recommended-5, is-4)
root(ROOT-0, recommended-5)
complm(used-11, that-6)
nsubjpass(used-11, Fluvoxamine-7)
dep(used-11, Tablets-8)
neg(used-11, not-9)
auxpass(used-11, be-10)
ccomp(recommended-5, used-11)
conj_or(used-11, used-11')
prep_in(used-11, combination-13)
prep_with(combination-13, MAOIs-15)
num(days-20, 14-19)
prep_within(used-11', days-20)
nn(treatment-23, discontinuing-22)
prep_of(days-20, treatment-23)
det(MAOI-26, a-25)
prep_with(treatment-23, MAOI-26)

After/IN stopping/VBG Fluvoxamine/NN Tablets/NNS ,/, at/IN least/JJS 2/CD weeks/NNS should/MD be/VB allowed/VBN before/IN starting/VBG a/DT MAOI/NN ./.

(ROOT (S1 (S (S (PP (IN After) (S (VP (VBG stopping) (NP (NN Fluvoxamine) (NNS Tablets))))) (, ,) (NP (QP (IN at) (JJS least) (CD 2)) (NNS weeks)) (VP (MD should) (VP (VB be) (VP (VBN allowed) (PP (IN before) (S (VP (VBG starting) (NP (DT a) (NN MAOI))))))))) (. .))))

prepc_after(allowed-12, stopping-2)
nn(Tablets-4, Fluvoxamine-3)
dobj(stopping-2, Tablets-4)
quantmod(2-8, at-6)
mwe(at-6, least-7)
pobj(at-6, least-7)
num(weeks-9, 2-8)
nsubjpass(allowed-12, weeks-9)
aux(allowed-12, should-10)
auxpass(allowed-12, be-11)
root(ROOT-0, allowed-12)
prepc_before(allowed-12, starting-14)
det(MAOI-16, a-15)
dobj(starting-14, MAOI-16)

Potential/JJ Terfenadine/NN ,/, Astemizole/NN ,/, and/CC Cisapride/NN Interactions/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Potential) (NN Terfenadine)) (, ,) (NP (NN Astemizole)) (, ,) (CC and) (NP (NN Cisapride) (NNS Interactions)))) (. .))))

amod(Terfenadine-2, Potential-1)
root(ROOT-0, Terfenadine-2)
conj_and(Terfenadine-2, Astemizole-4)
nn(Interactions-8, Cisapride-7)
conj_and(Terfenadine-2, Interactions-8)

Terfenadine/NN ,/, astemizole/NN and/CC cisapride/NN are/VBP all/RB metabolized/VBN by/IN the/DT cytochrome/NN P450IIIA4/NN isozyme/NN ,/, and/CC it/PRP has/VBZ been/VBN demonstrated/VBN that/IN ketoconazole/NN ,/, a/DT potent/JJ inhibitor/NN of/IN IIIA4/NN ,/, blocks/VBZ the/DT metabolism/NN of/IN these/DT drugs/NNS ,/, resulting/VBG in/IN increased/VBN plasma/NN concentrations/NNS of/IN parent/JJ drug/NN ./.

(ROOT (S1 (S (S (S (NP (NP (NN Terfenadine)) (, ,) (NP (NN astemizole)) (CC and) (NP (NN cisapride))) (VP (VBP are) (ADVP (RB all)) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (NN cytochrome) (NN P450IIIA4) (NN isozyme)))))) (, ,) (CC and) (S (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (NN ketoconazole)) (, ,) (NP (NP (DT a) (JJ potent) (NN inhibitor)) (PP (IN of) (NP (NN IIIA4)))) (, ,)) (VP (VBZ blocks) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (DT these) (NNS drugs)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (VBN increased) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (JJ parent) (NN drug))))))))))))))) (. .))))

nsubjpass(metabolized-8, Terfenadine-1)
conj_and(Terfenadine-1, astemizole-3)
conj_and(Terfenadine-1, cisapride-5)
auxpass(metabolized-8, are-6)
advmod(metabolized-8, all-7)
root(ROOT-0, metabolized-8)
det(isozyme-13, the-10)
nn(isozyme-13, cytochrome-11)
nn(isozyme-13, P450IIIA4-12)
agent(metabolized-8, isozyme-13)
nsubjpass(demonstrated-19, it-16)
aux(demonstrated-19, has-17)
auxpass(demonstrated-19, been-18)
conj_and(metabolized-8, demonstrated-19)
complm(blocks-29, that-20)
nsubj(blocks-29, ketoconazole-21)
det(inhibitor-25, a-23)
amod(inhibitor-25, potent-24)
appos(ketoconazole-21, inhibitor-25)
prep_of(inhibitor-25, IIIA4-27)
ccomp(demonstrated-19, blocks-29)
det(metabolism-31, the-30)
dobj(blocks-29, metabolism-31)
det(drugs-34, these-33)
prep_of(metabolism-31, drugs-34)
partmod(blocks-29, resulting-36)
xcomp(blocks-29, resulting-36)
amod(concentrations-40, increased-38)
nn(concentrations-40, plasma-39)
prep_in(resulting-36, concentrations-40)
amod(drug-43, parent-42)
prep_of(concentrations-40, drug-43)

Increased/VBN plasma/NN concentrations/NNS of/IN terfenadine/NN ,/, astemizole/NN ,/, and/CC cisapride/NN cause/VBP QT/NN prolongation/NN and/CC have/VBP been/VBN associated/VBN with/IN torsades/NNS de/FW pointes-type/JJ ventricular/JJ tachycardia/NN ,/, sometimes/RB fatal/JJ ./.

(ROOT (S1 (S (S (NP (NP (VBN Increased) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (NN terfenadine)) (, ,) (NP (NN astemizole)) (, ,) (CC and) (NP (NN cisapride))))) (VP (VP (VBP cause) (NP (NN QT) (NN prolongation))) (CC and) (VP (VBP have) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (NNS torsades)) (PP (FW de) (NP (JJ pointes-type) (JJ ventricular) (NN tachycardia))))) (, ,) (ADVP (RB sometimes)) (ADJP (JJ fatal))))))) (. .))))

amod(concentrations-3, Increased-1)
nn(concentrations-3, plasma-2)
nsubj(cause-11, concentrations-3)
prep_of(concentrations-3, terfenadine-5)
conj_and(terfenadine-5, astemizole-7)
conj_and(terfenadine-5, cisapride-10)
root(ROOT-0, cause-11)
nn(prolongation-13, QT-12)
dobj(cause-11, prolongation-13)
aux(associated-17, have-15)
auxpass(associated-17, been-16)
conj_and(cause-11, associated-17)
prep_with(associated-17, torsades-19)
prep(torsades-19, de-20)
amod(tachycardia-23, pointes-type-21)
amod(tachycardia-23, ventricular-22)
pobj(de-20, tachycardia-23)
advmod(associated-17, sometimes-25)
acomp(associated-17, fatal-26)

As/IN noted/VBN below/IN ,/, a/DT sub-/NN for/IN fluvoxamine/NN in/IN combination/NN with/IN alprazolam/NN ,/, a/DT drug/NN that/WDT is/VBZ known/VBN to/TO be/VB metabolized/VBN by/IN the/DT IIIA4/NN isozyme/NN ./.

(ROOT (S1 (S (SBAR (IN As) (S (VP (VBN noted) (ADVP (IN below))))) (, ,) (NP (NP (NP (DT a) (NN sub-)) (PP (IN for) (NP (NN fluvoxamine))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN alprazolam)))))) (, ,) (NP (NP (DT a) (NN drug)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB be) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (NN IIIA4) (NN isozyme))))))))))))) (. .))))

mark(noted-2, As-1)
root(ROOT-0, noted-2)
advmod(noted-2, below-3)
det(sub--6, a-5)
dep(noted-2, sub--6)
prep_for(sub--6, fluvoxamine-8)
prep_in(sub--6, combination-10)
prep_with(combination-10, alprazolam-12)
det(drug-15, a-14)
appos(sub--6, drug-15)
nsubjpass(known-18, drug-15)
auxpass(known-18, is-17)
rcmod(drug-15, known-18)
aux(metabolized-21, to-19)
auxpass(metabolized-21, be-20)
xcomp(known-18, metabolized-21)
det(isozyme-25, the-23)
nn(isozyme-25, IIIA4-24)
agent(metabolized-21, isozyme-25)

Although/IN it/PRP has/VBZ not/RB been/VBN definitively/RB demonstrated/VBN that/IN fluvoxamine/NN is/VBZ a/DT potent/JJ IIIA4/NN inhibitor/NN ,/, it/PRP is/VBZ likely/JJ to/TO be/VB ,/, given/IN the/DT substantial/JJ interaction/NN of/IN fluvoxamine/NN with/IN alprazolam/NN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (PRP it)) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB definitively)) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NN fluvoxamine)) (VP (VBZ is) (NP (DT a) (JJ potent) (NN IIIA4) (NN inhibitor)))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (, ,) (PP (IN given) (NP (NP (DT the) (JJ substantial) (NN interaction)) (PP (IN of) (NP (NN fluvoxamine))) (PP (IN with) (NP (NN alprazolam))))))))))) (. .))))

mark(demonstrated-7, Although-1)
nsubjpass(demonstrated-7, it-2)
aux(demonstrated-7, has-3)
neg(demonstrated-7, not-4)
auxpass(demonstrated-7, been-5)
advmod(demonstrated-7, definitively-6)
advcl(likely-18, demonstrated-7)
complm(inhibitor-14, that-8)
nsubj(inhibitor-14, fluvoxamine-9)
cop(inhibitor-14, is-10)
det(inhibitor-14, a-11)
amod(inhibitor-14, potent-12)
nn(inhibitor-14, IIIA4-13)
ccomp(demonstrated-7, inhibitor-14)
nsubj(likely-18, it-16)
cop(likely-18, is-17)
root(ROOT-0, likely-18)
aux(be-20, to-19)
xcomp(likely-18, be-20)
det(interaction-25, the-23)
amod(interaction-25, substantial-24)
prep_given(be-20, interaction-25)
prep_of(interaction-25, fluvoxamine-27)
prep_with(interaction-25, alprazolam-29)

Consequently/RB ,/, it/PRP is/VBZ recommended/VBN that/IN fluvoxamine/NN not/RB be/VB used/VBN in/IN combination/NN with/IN either/CC terbinafine/NN ,/, astemizole/NN ,/, or/CC cisapride/NN ./.

(ROOT (S1 (S (S (ADVP (RB Consequently)) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NN fluvoxamine)) (VP (RB not) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (CC either) (NP (NN terbinafine)) (, ,) (NP (NN astemizole)) (, ,) (CC or) (NP (NN cisapride)))))))))))))) (. .))))

advmod(recommended-5, Consequently-1)
nsubjpass(recommended-5, it-3)
auxpass(recommended-5, is-4)
root(ROOT-0, recommended-5)
complm(used-10, that-6)
nsubjpass(used-10, fluvoxamine-7)
neg(used-10, not-8)
auxpass(used-10, be-9)
ccomp(recommended-5, used-10)
prep_in(used-10, combination-12)
preconj(terbinafine-15, either-14)
prep_with(combination-12, terbinafine-15)
conj_or(terbinafine-15, astemizole-17)
conj_or(terbinafine-15, cisapride-20)

Other/JJ Potentially/RB Important/JJ Drug/NN Interactions/NNS :/: Benzodiazepines/NN :/: Benzodiazepines/NNS metabolized/VBN by/IN hepatic/JJ oxidation/NN (/-LRB- e.g./FW ,/, alprazolam/NN ,/, midazolam/NN ,/, triazolam/NN elc./NN )/-RRB- should/MD be/VB used/VBN with/IN caution/NN because/IN the/DT clearance/NN of/IN these/DT drugs/NNS is/VBZ likely/JJ to/TO be/VB reduced/VBN by/IN fluvoxamine/NN ./.

(ROOT (S1 (S (S (NP (JJ Other) (ADJP (RB Potentially) (JJ Important)) (NN Drug) (NNS Interactions)) (: :) (NP (NN Benzodiazepines))) (: :) (S (NP (NP (NNS Benzodiazepines)) (VP (VBN metabolized) (PP (IN by) (NP (NP (JJ hepatic) (NN oxidation)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN alprazolam)) (, ,) (NP (NN midazolam)) (, ,) (NP (NN triazolam) (NN elc.))) (-RRB- -RRB-)))))) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN caution))) (SBAR (IN because) (S (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (DT these) (NNS drugs)))) (VP (VBZ is) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (VP (VBN reduced) (PP (IN by) (NP (NN fluvoxamine))))))))))))))) (. .))))

amod(Interactions-5, Other-1)
advmod(Important-3, Potentially-2)
amod(Interactions-5, Important-3)
nn(Interactions-5, Drug-4)
dep(Benzodiazepines-7, Interactions-5)
root(ROOT-0, Benzodiazepines-7)
nsubjpass(used-26, Benzodiazepines-9)
partmod(Benzodiazepines-9, metabolized-10)
amod(oxidation-13, hepatic-12)
agent(metabolized-10, oxidation-13)
dep(alprazolam-17, e.g.-15)
dep(oxidation-13, alprazolam-17)
appos(alprazolam-17, midazolam-19)
nn(elc.-22, triazolam-21)
appos(alprazolam-17, elc.-22)
aux(used-26, should-24)
auxpass(used-26, be-25)
parataxis(Benzodiazepines-7, used-26)
prep_with(used-26, caution-28)
mark(likely-36, because-29)
det(clearance-31, the-30)
nsubj(likely-36, clearance-31)
det(drugs-34, these-33)
prep_of(clearance-31, drugs-34)
cop(likely-36, is-35)
advcl(used-26, likely-36)
aux(reduced-39, to-37)
auxpass(reduced-39, be-38)
xcomp(likely-36, reduced-39)
agent(reduced-39, fluvoxamine-41)

The/DT clearance/NN of/IN benzodiazepines/NNS metabolized/VBN by/IN glucuronidation/NN (/-LRB- e./FW g./FW ,/, lorazepam/NN ,/, oxazepam/NN ,/, temazepam/NN )/-RRB- is/VBZ unlikely/JJ to/TO be/VB affected/VBN by/IN fluvoxamine/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN clearance)) (PP (IN of) (NP (NP (NNS benzodiazepines)) (VP (VBN metabolized) (PP (IN by) (NP (NP (NN glucuronidation)) (PRN (-LRB- -LRB-) (NP (FW e.) (FW g.) (, ,) (NP (NN lorazepam)) (, ,) (NP (NN oxazepam)) (, ,) (NP (NN temazepam))) (-RRB- -RRB-)))))))) (VP (VBZ is) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB be) (VP (VBN affected) (PP (IN by) (NP (NN fluvoxamine)))))))))) (. .))))

det(clearance-2, The-1)
nsubj(unlikely-19, clearance-2)
prep_of(clearance-2, benzodiazepines-4)
partmod(benzodiazepines-4, metabolized-5)
agent(metabolized-5, glucuronidation-7)
nn(lorazepam-12, e.-9)
dep(lorazepam-12, g.-10)
dep(glucuronidation-7, lorazepam-12)
appos(lorazepam-12, oxazepam-14)
appos(lorazepam-12, temazepam-16)
cop(unlikely-19, is-18)
root(ROOT-0, unlikely-19)
aux(affected-22, to-20)
auxpass(affected-22, be-21)
xcomp(unlikely-19, affected-22)
agent(affected-22, fluvoxamine-24)

Alprazolam/NNP :/: When/WRB fluvoxamine/NN maleate/NN (/-LRB- 100/CD mg/NN qd/NN )/-RRB- and/CC alprazolam/NN (/-LRB- 1/CD mg/NN q.d./NN were/VBD co-administered/VBN to/TO steady/JJ state/NN ,/, plasma/NN concentration/NN and/CC other/JJ pharmacokinetics/NNS parameters/NNS (/-LRB- AUC/NN ,/, Cmax/NN ,/, T1/NN /2/CD ,/, )/-RRB- of/IN alprazolam/NN were/VBD approximately/RB twice/RB those/DT observed/VBN when/WRB alprazolam/NN was/VBD administered/VBN alone/RB ;/: ./.

(ROOT (S1 (S (NP (NP (NP (NNP Alprazolam)) (PRN (: :) (SBAR (WHADVP (WRB When)) (S (NP (NP (NP (NP (NN fluvoxamine) (NN maleate)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 100) (NN mg)) (NN qd)) (-RRB- -RRB-))) (CC and) (NP (NP (NN alprazolam)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 1) (NN mg)) (NN q.d.)) (VP (VBD were) (VBN co-administered) (PP (TO to) (NP (NP (JJ steady) (NN state)) (, ,) (NP (NN plasma) (NN concentration)) (CC and) (NP (NP (JJ other) (NNS pharmacokinetics) (NNS parameters)) (-LRB- -LRB-) (NP (NP (NN AUC)) (, ,) (NP (NN Cmax)) (, ,) (NP (NN T1) (CD /2)) (, ,))))))) (-RRB- -RRB-)))) (PP (IN of) (NP (NN alprazolam)))) (VP (VBD were) (ADVP (RB approximately) (RB twice)) (NP (NP (DT those)) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (NN alprazolam)) (VP (VBD was) (VP (VBN administered) (ADVP (RB alone))))))))))) (: ;))) (. .)))))

root(ROOT-0, Alprazolam-1)
advmod(those-43, When-3)
nn(maleate-5, fluvoxamine-4)
nsubj(those-43, maleate-5)
number(mg-8, 100-7)
amod(qd-9, mg-8)
appos(maleate-5, qd-9)
conj_and(maleate-5, alprazolam-12)
number(mg-15, 1-14)
amod(q.d.-16, mg-15)
dep(alprazolam-12, q.d.-16)
partmod(q.d.-16, were-17)
dep(were-17, co-administered-18)
amod(state-21, steady-20)
prep_to(were-17, state-21)
nn(concentration-24, plasma-23)
conj_and(state-21, concentration-24)
amod(parameters-28, other-26)
nn(parameters-28, pharmacokinetics-27)
conj_and(state-21, parameters-28)
dep(parameters-28, AUC-30)
appos(AUC-30, Cmax-32)
appos(AUC-30, T1-34)
num(T1-34, /2-35)
prep_of(maleate-5, alprazolam-39)
cop(those-43, were-40)
advmod(twice-42, approximately-41)
advmod(those-43, twice-42)
dep(Alprazolam-1, those-43)
partmod(those-43, observed-44)
advmod(administered-48, when-45)
nsubjpass(administered-48, alprazolam-46)
auxpass(administered-48, was-47)
advcl(observed-44, administered-48)
advmod(administered-48, alone-49)

The/DT elevated/JJ plasma/NN alprazolam/NN concentrations/NNS resulted/VBD in/IN decreased/VBN psychomotor/NN performance/NN and/CC memory/NN ./.

(ROOT (S1 (S (S (NP (DT The) (JJ elevated) (NN plasma) (NN alprazolam) (NNS concentrations)) (VP (VBD resulted) (PP (IN in) (NP (NP (VBN decreased) (NN psychomotor) (NN performance)) (CC and) (NP (NN memory)))))) (. .))))

det(concentrations-5, The-1)
amod(concentrations-5, elevated-2)
nn(concentrations-5, plasma-3)
nn(concentrations-5, alprazolam-4)
nsubj(resulted-6, concentrations-5)
root(ROOT-0, resulted-6)
amod(performance-10, decreased-8)
nn(performance-10, psychomotor-9)
prep_in(resulted-6, performance-10)
conj_and(performance-10, memory-12)

This/DT interaction/NN ,/, which/WDT has/VBZ not/RB been/VBN investigated/VBN using/VBG higher/JJR doses/NNS of/IN fluvoxamine/NN ,/, may/MD be/VB more/RBR pronounced/JJ if/IN a/DT 300/CD mg/NN daily/JJ dose/NN is/VBZ co-administered/VBN ,/, particularly/RB since/IN fluvoxamine/NN exhibits/VBZ non-linear/JJ pharmacokinetics/NNS over/IN the/DT dosage/NN range/NN 100-300/CD mg./CC If/IN alprazolam/NN is/VBZ co-administered/VBN with/IN Fluvoxamine/NN Tablets/NNS ,/, the/DT initial/JJ alprazolam/NN dosage/NN should/MD be/VB at/IN least/JJS halved/VBN and/CC titration/NN to/TO the/DT lowest/JJS effective/JJ dose/NN is/VBZ recommended/VBN ./.

(ROOT (S1 (S (NP (NP (DT This) (NN interaction)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN investigated) (S (VP (VBG using) (NP (NP (JJR higher) (NNS doses)) (PP (IN of) (NP (NN fluvoxamine))))))))))) (, ,)) (VP (MD may) (VP (VB be) (ADJP (RBR more) (JJ pronounced)) (SBAR (IN if) (S (S (NP (DT a) (ADJP (CD 300) (NN mg)) (JJ daily) (NN dose)) (VP (VBZ is) (VP (VBN co-administered)) (, ,) (SBAR (SBAR (RB particularly) (IN since) (S (NP (NN fluvoxamine)) (VP (VBZ exhibits) (NP (JJ non-linear) (NNS pharmacokinetics)) (PP (IN over) (NP (DT the) (NN dosage) (NN range) (CD 100-300)))))) (CC mg.) (SBAR (IN If) (S (NP (NN alprazolam)) (VP (VBZ is) (VP (VBN co-administered) (PP (IN with) (NP (NN Fluvoxamine) (NNS Tablets)))))))))) (, ,) (S (NP (DT the) (JJ initial) (NN alprazolam) (NN dosage)) (VP (MD should) (VP (VB be) (ADVP (IN at) (JJS least)) (VP (VBN halved))))) (CC and) (S (NP (NP (NN titration)) (PP (TO to) (NP (DT the) (ADJP (JJS lowest) (JJ effective)) (NN dose)))) (VP (VBZ is) (VP (VBN recommended)))))))) (. .))))

det(interaction-2, This-1)
nsubjpass(investigated-8, interaction-2)
nsubj(pronounced-18, interaction-2)
aux(investigated-8, has-5)
neg(investigated-8, not-6)
auxpass(investigated-8, been-7)
rcmod(interaction-2, investigated-8)
xcomp(investigated-8, using-9)
amod(doses-11, higher-10)
dobj(using-9, doses-11)
prep_of(doses-11, fluvoxamine-13)
aux(pronounced-18, may-15)
cop(pronounced-18, be-16)
advmod(pronounced-18, more-17)
root(ROOT-0, pronounced-18)
mark(co-administered-26, if-19)
det(dose-24, a-20)
number(mg-22, 300-21)
amod(dose-24, mg-22)
amod(dose-24, daily-23)
nsubjpass(co-administered-26, dose-24)
auxpass(co-administered-26, is-25)
advcl(pronounced-18, co-administered-26)
advmod(exhibits-31, particularly-28)
dep(exhibits-31, since-29)
nsubj(exhibits-31, fluvoxamine-30)
dep(co-administered-26, exhibits-31)
amod(pharmacokinetics-33, non-linear-32)
dobj(exhibits-31, pharmacokinetics-33)
det(range-37, the-35)
nn(range-37, dosage-36)
prep_over(exhibits-31, range-37)
num(range-37, 100-300-38)
mark(co-administered-43, If-40)
nsubjpass(co-administered-43, alprazolam-41)
auxpass(co-administered-43, is-42)
conj_mg.(exhibits-31, co-administered-43)
nn(Tablets-46, Fluvoxamine-45)
prep_with(co-administered-43, Tablets-46)
det(dosage-51, the-48)
amod(dosage-51, initial-49)
nn(dosage-51, alprazolam-50)
nsubjpass(halved-56, dosage-51)
aux(halved-56, should-52)
auxpass(halved-56, be-53)
advmod(halved-56, at-54)
pobj(at-54, least-55)
conj_and(co-administered-26, halved-56)
nsubjpass(recommended-65, titration-58)
det(dose-63, the-60)
dep(effective-62, lowest-61)
amod(dose-63, effective-62)
prep_to(titration-58, dose-63)
auxpass(recommended-65, is-64)
conj_and(co-administered-26, recommended-65)

No/DT dosage/JJ adjustment/NN is/VBZ required/VBN for/IN Fluvoxamine/NN Tablets/NNS ./.

(ROOT (S1 (S (S (NP (DT No) (JJ dosage) (NN adjustment)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NN Fluvoxamine) (NNS Tablets)))))) (. .))))

det(adjustment-3, No-1)
amod(adjustment-3, dosage-2)
nsubjpass(required-5, adjustment-3)
auxpass(required-5, is-4)
root(ROOT-0, required-5)
nn(Tablets-8, Fluvoxamine-7)
prep_for(required-5, Tablets-8)

Diazepam/NN :/: The/DT co-administration/NN of/IN Fluvoxamine/NN Tablets/NNS and/CC diazepam/NNS is/VBZ generally/RB not/RB advisable/JJ ./.

(ROOT (S1 (S (NP (NP (NN Diazepam)) (: :) (S (NP (NP (DT The) (NN co-administration)) (PP (IN of) (NP (NP (NN Fluvoxamine) (NNS Tablets)) (CC and) (NP (NNS diazepam))))) (VP (VBZ is) (ADVP (RB generally)) (RB not) (ADJP (JJ advisable)))) (. .)))))

root(ROOT-0, Diazepam-1)
det(co-administration-4, The-3)
nsubj(advisable-13, co-administration-4)
nn(Tablets-7, Fluvoxamine-6)
prep_of(co-administration-4, Tablets-7)
conj_and(Tablets-7, diazepam-9)
cop(advisable-13, is-10)
advmod(advisable-13, generally-11)
neg(advisable-13, not-12)
dep(Diazepam-1, advisable-13)

Because/IN fluvoxamine/NN reduces/VBZ the/DT clearance/NN of/IN both/CC diazepam/NN and/CC its/PRP$ active/JJ metabolite/NN ,/, N-/NN desmethyldiazepam/NN ,/, there/EX is/VBZ a/DT strong/JJ likelihood/NN of/IN substantial/JJ accumulation/NN of/IN both/DT species/NNS during/IN chronic/JJ co-administration/NN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NN fluvoxamine)) (VP (VBZ reduces) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (CC both) (NP (NN diazepam)) (CC and) (NP (NP (PRP$ its) (JJ active) (NN metabolite)) (, ,) (NP (NN N-) (NN desmethyldiazepam))))))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (JJ strong) (NN likelihood)) (PP (IN of) (NP (NP (JJ substantial) (NN accumulation)) (PP (IN of) (NP (DT both) (NNS species))) (PP (IN during) (NP (JJ chronic) (NN co-administration)))))))) (. .))))

mark(reduces-3, Because-1)
nsubj(reduces-3, fluvoxamine-2)
advcl(is-18, reduces-3)
det(clearance-5, the-4)
dobj(reduces-3, clearance-5)
preconj(diazepam-8, both-7)
prep_of(clearance-5, diazepam-8)
poss(metabolite-12, its-10)
amod(metabolite-12, active-11)
conj_and(diazepam-8, metabolite-12)
nn(desmethyldiazepam-15, N--14)
appos(metabolite-12, desmethyldiazepam-15)
expl(is-18, there-17)
root(ROOT-0, is-18)
det(likelihood-21, a-19)
amod(likelihood-21, strong-20)
nsubj(is-18, likelihood-21)
amod(accumulation-24, substantial-23)
prep_of(likelihood-21, accumulation-24)
det(species-27, both-26)
prep_of(accumulation-24, species-27)
amod(co-administration-30, chronic-29)
prep_during(accumulation-24, co-administration-30)

Evidence/NN supporting/VBG the/DT conclusion/NN that/IN it/PRP is/VBZ inadvisable/JJ to/TO co-administer/NN fluvoxamine/NN and/CC diazepam/NN is/VBZ derived/VBN from/IN a/DT study/NN in/IN which/WDT healthy/JJ volunteers/NNS taking/VBG 150/CD mg/day/NN of/IN fluvoxamine/NN were/VBD administered/VBN a/DT single/JJ oral/JJ dose/NN of/IN 10/CD mg/NN of/IN diazepam/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Evidence)) (VP (VBG supporting) (NP (DT the) (NN conclusion) (SBAR (IN that) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ inadvisable) (PP (TO to) (NP (NN co-administer) (NP (NN fluvoxamine)) (CC and) (NP (NN diazepam))))))))))) (VP (VBZ is) (VP (VBN derived) (PP (IN from) (NP (NP (DT a) (NN study)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NP (JJ healthy) (NNS volunteers)) (VP (VBG taking) (NP (NP (CD 150) (NN mg/day)) (PP (IN of) (NP (NN fluvoxamine)))))) (VP (VBD were) (VP (VBN administered) (NP (NP (DT a) (JJ single) (JJ oral) (NN dose)) (PP (IN of) (NP (NP (CD 10) (NN mg)) (PP (IN of) (NP (NN diazepam))))))))))))))) (. .))))

nsubjpass(derived-15, Evidence-1)
partmod(Evidence-1, supporting-2)
det(conclusion-4, the-3)
dobj(supporting-2, conclusion-4)
complm(inadvisable-8, that-5)
nsubj(inadvisable-8, it-6)
cop(inadvisable-8, is-7)
ccomp(conclusion-4, inadvisable-8)
prep_to(inadvisable-8, co-administer-10)
dep(co-administer-10, fluvoxamine-11)
conj_and(co-administer-10, diazepam-13)
auxpass(derived-15, is-14)
root(ROOT-0, derived-15)
det(study-18, a-17)
prep_from(derived-15, study-18)
rel(administered-29, which-20)
amod(volunteers-22, healthy-21)
nsubjpass(administered-29, volunteers-22)
partmod(volunteers-22, taking-23)
num(mg/day-25, 150-24)
dobj(taking-23, mg/day-25)
prep_of(mg/day-25, fluvoxamine-27)
auxpass(administered-29, were-28)
rcmod(study-18, administered-29)
det(dose-33, a-30)
amod(dose-33, single-31)
amod(dose-33, oral-32)
dobj(administered-29, dose-33)
num(mg-36, 10-35)
prep_of(dose-33, mg-36)
prep_of(mg-36, diazepam-38)

In/IN these/DT subjects/NNS (/-LRB- R=/NN B/NN )/-RRB- ,/, the/DT clearance/NN of/IN diazepam/NN was/VBD reduced/VBN by/IN 65/CD %/NN and/CC that/DT of/IN N-/NN desmethyldiazepam/NN to/TO a/DT level/NN that/WDT was/VBD too/RB low/JJ to/TO measure/VB over/IN the/DT course/NN of/IN the/DT 2/CD week/NN long/JJ study/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT these) (NNS subjects)) (PRN (-LRB- -LRB-) (NP (NN R=) (NN B)) (-RRB- -RRB-)))) (, ,) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN diazepam)))) (VP (VBD was) (VP (VBN reduced) (PP (IN by) (NP (NP (CD 65) (NN %)) (CC and) (NP (NP (DT that)) (PP (IN of) (NP (NN N-) (NN desmethyldiazepam)))))) (PP (TO to) (NP (NP (DT a) (NN level)) (SBAR (WHNP (WDT that)) (S (VP (VBD was) (ADJP (RB too) (JJ low) (S (VP (TO to) (VP (VB measure) (PP (IN over) (NP (NP (DT the) (NN course)) (PP (IN of) (NP (DT the) (ADJP (CD 2) (NN week)) (JJ long) (NN study))))))))))))))))) (. .))))

det(subjects-3, these-2)
prep_in(reduced-14, subjects-3)
nn(B-6, R=-5)
appos(subjects-3, B-6)
det(clearance-10, the-9)
nsubjpass(reduced-14, clearance-10)
prep_of(clearance-10, diazepam-12)
auxpass(reduced-14, was-13)
root(ROOT-0, reduced-14)
num(%-17, 65-16)
agent(reduced-14, %-17)
conj_and(%-17, that-19)
nn(desmethyldiazepam-22, N--21)
prep_of(that-19, desmethyldiazepam-22)
det(level-25, a-24)
prep_to(reduced-14, level-25)
nsubj(low-29, level-25)
cop(low-29, was-27)
advmod(low-29, too-28)
rcmod(level-25, low-29)
aux(measure-31, to-30)
xcomp(low-29, measure-31)
det(course-34, the-33)
prep_over(measure-31, course-34)
det(study-40, the-36)
number(week-38, 2-37)
amod(study-40, week-38)
amod(study-40, long-39)
prep_of(course-34, study-40)

It/PRP is/VBZ likely/JJ that/IN experience/VBP significantly/RB underestimates/VBZ the/DT degree/NN of/IN accumulation/NN that/WDT might/MD occur/VB with/IN repealed/JJ diazepam/NN administration/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ likely) (SBAR (IN that) (S (VP (VBP experience) (S (ADVP (RB significantly)) (VP (VBZ underestimates) (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NP (NN accumulation)) (SBAR (WHNP (WDT that)) (S (VP (MD might) (VP (VB occur) (PP (IN with) (NP (JJ repealed) (NN diazepam) (NN administration)))))))))))))))))) (. .))))

nsubj(likely-3, It-1)
cop(likely-3, is-2)
root(ROOT-0, likely-3)
complm(experience-5, that-4)
ccomp(likely-3, experience-5)
advmod(underestimates-7, significantly-6)
ccomp(experience-5, underestimates-7)
det(degree-9, the-8)
dobj(underestimates-7, degree-9)
prep_of(degree-9, accumulation-11)
nsubj(occur-14, accumulation-11)
aux(occur-14, might-13)
rcmod(accumulation-11, occur-14)
amod(administration-18, repealed-16)
nn(administration-18, diazepam-17)
prep_with(occur-14, administration-18)

Moreover/RB ,/, as/IN noted/VBN with/IN alprazolam/NN ,/, the/DT effect/NN of/IN fluvoxamine/NN may/MD even/RB be/VB more/RBR pronounced/JJ when/WRB it/PRP is/VBZ administered/VBN at/IN higher/JJR doses/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Moreover)) (, ,) (SBAR (IN as) (S (VP (VBN noted) (PP (IN with) (NP (NN alprazolam)))))) (, ,) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN fluvoxamine)))) (VP (MD may) (ADVP (RB even)) (VP (VB be) (ADJP (RBR more) (JJ pronounced)) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN administered) (PP (IN at) (NP (JJR higher) (NNS doses)))))))))) (. .))))

advmod(pronounced-16, Moreover-1)
mark(noted-4, as-3)
advcl(pronounced-16, noted-4)
prep_with(noted-4, alprazolam-6)
det(effect-9, the-8)
nsubj(pronounced-16, effect-9)
prep_of(effect-9, fluvoxamine-11)
aux(pronounced-16, may-12)
advmod(pronounced-16, even-13)
cop(pronounced-16, be-14)
advmod(pronounced-16, more-15)
root(ROOT-0, pronounced-16)
advmod(administered-20, when-17)
nsubjpass(administered-20, it-18)
auxpass(administered-20, is-19)
advcl(pronounced-16, administered-20)
amod(doses-23, higher-22)
prep_at(administered-20, doses-23)

Accordingly/RB ,/, diazepam/NN and/CC fluvoxamine/NN should/MD not/RB ordinarily/RB be/VB co-administered/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Accordingly)) (, ,) (NP (NP (NN diazepam)) (CC and) (NP (NN fluvoxamine))) (VP (MD should) (RB not) (ADVP (RB ordinarily)) (VP (VB be) (VP (VBN co-administered))))) (. .))))

advmod(co-administered-10, Accordingly-1)
nsubjpass(co-administered-10, diazepam-3)
conj_and(diazepam-3, fluvoxamine-5)
aux(co-administered-10, should-6)
neg(co-administered-10, not-7)
advmod(co-administered-10, ordinarily-8)
auxpass(co-administered-10, be-9)
root(ROOT-0, co-administered-10)

Theophylline/NN :/: The/DT effect/NN of/IN steady-state/JJ fluvoxamine/NN l50/NN mg/NN bid/NN on/IN the/DT pharmacokinetics/NNS of/IN a/DT single/JJ dose/NN of/IN Theophylline/NN (/-LRB- 375/CD mg/NN )/-RRB- as/IN 442/CD mg/NN aminophylline/NN was/VBD evaluated/VBN in/IN 12/CD healthy/JJ non-smoking/JJ ,/, male/JJ volunteers/NNS ./.

(ROOT (S1 (S (NP (NP (NN Theophylline)) (: :) (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (JJ steady-state) (NN fluvoxamine) (NN l50) (NN mg) (NN bid))) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NN Theophylline)))) (PRN (-LRB- -LRB-) (NP (CD 375) (NN mg)) (-RRB- -RRB-)))) (PP (IN as) (NP (ADJP (CD 442) (NN mg)) (NN aminophylline)))))) (VP (VBD was) (VP (VBN evaluated) (PP (IN in) (NP (CD 12) (ADJP (ADJP (ADJP (JJ healthy)) (ADJP (JJ non-smoking))) (, ,) (ADJP (JJ male))) (NNS volunteers)))))) (. .)))))

root(ROOT-0, Theophylline-1)
det(effect-4, The-3)
nsubjpass(evaluated-29, effect-4)
amod(bid-10, steady-state-6)
nn(bid-10, fluvoxamine-7)
nn(bid-10, l50-8)
nn(bid-10, mg-9)
prep_of(effect-4, bid-10)
det(pharmacokinetics-13, the-12)
prep_on(effect-4, pharmacokinetics-13)
det(dose-17, a-15)
amod(dose-17, single-16)
prep_of(pharmacokinetics-13, dose-17)
prep_of(dose-17, Theophylline-19)
num(mg-22, 375-21)
appos(dose-17, mg-22)
number(mg-26, 442-25)
amod(aminophylline-27, mg-26)
prep_as(pharmacokinetics-13, aminophylline-27)
auxpass(evaluated-29, was-28)
dep(Theophylline-1, evaluated-29)
num(volunteers-36, 12-31)
amod(volunteers-36, healthy-32)
dep(healthy-32, non-smoking-33)
dep(healthy-32, male-35)
prep_in(evaluated-29, volunteers-36)

The/DT clearance/NN of/IN theophylline/NN was/VBD decreased/VBN approximately/RB 3-fold/RB ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN clearance)) (PP (IN of) (NP (NN theophylline)))) (VP (VBD was) (VP (VBN decreased) (ADVP (RB approximately) (RB 3-fold))))) (. .))))

det(clearance-2, The-1)
nsubjpass(decreased-6, clearance-2)
prep_of(clearance-2, theophylline-4)
auxpass(decreased-6, was-5)
root(ROOT-0, decreased-6)
advmod(3-fold-8, approximately-7)
advmod(decreased-6, 3-fold-8)

Therefore/RB ,/, if/IN theophylline/NN is/VBZ co-administered/VBN with/IN fluvoxamine/NN maleate/NN ,/, its/PRP$ dose/NN should/MD be/VB reduced/VBN to/TO one/CD third/JJ of/IN the/DT usual/JJ daily/JJ maintenance/NN dose/NN and/CC plasma/NN concentrations/NNS of/IN theophylline/NN should/MD to/TO monitored/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (SBAR (IN if) (S (NP (NN theophylline)) (VP (VBZ is) (VP (VBN co-administered) (PP (IN with) (NP (NN fluvoxamine) (NN maleate))))))) (, ,) (NP (PRP$ its) (NN dose)) (VP (MD should) (VP (VB be) (VP (VBN reduced) (PP (TO to) (NP (NP (CD one) (JJ third)) (PP (IN of) (NP (DT the) (JJ usual) (JJ daily) (NN maintenance) (NN dose))))))))) (CC and) (S (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN theophylline)))) (VP (MD should) (VP (TO to) (VP (VBN monitored))))) (. .))))

advmod(reduced-15, Therefore-1)
mark(co-administered-6, if-3)
nsubjpass(co-administered-6, theophylline-4)
auxpass(co-administered-6, is-5)
advcl(reduced-15, co-administered-6)
nn(maleate-9, fluvoxamine-8)
prep_with(co-administered-6, maleate-9)
poss(dose-12, its-11)
nsubjpass(reduced-15, dose-12)
aux(reduced-15, should-13)
auxpass(reduced-15, be-14)
root(ROOT-0, reduced-15)
prep_to(reduced-15, one-17)
amod(one-17, third-18)
det(dose-24, the-20)
amod(dose-24, usual-21)
amod(dose-24, daily-22)
nn(dose-24, maintenance-23)
prep_of(one-17, dose-24)
nn(concentrations-27, plasma-26)
nsubj(monitored-32, concentrations-27)
prep_of(concentrations-27, theophylline-29)
aux(monitored-32, should-30)
aux(monitored-32, to-31)
conj_and(reduced-15, monitored-32)

No/DT dosage/JJ adjustment/NN is/VBZ required/VBN for/IN Fluvoxamine/NN Tablets/NNS ./.

(ROOT (S1 (S (S (NP (DT No) (JJ dosage) (NN adjustment)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NN Fluvoxamine) (NNS Tablets)))))) (. .))))

det(adjustment-3, No-1)
amod(adjustment-3, dosage-2)
nsubjpass(required-5, adjustment-3)
auxpass(required-5, is-4)
root(ROOT-0, required-5)
nn(Tablets-8, Fluvoxamine-7)
prep_for(required-5, Tablets-8)

Warfarin/NN :/: When/WRB fluvoxamine/NN maleate/NN (/-LRB- 50/CD mg/NN tid/NN )/-RRB- was/VBD administered/VBN concomitantly/RB with/IN warfarin/NN for/IN two/CD weeks/NNS ,/, warfarin/NN plasma/NN concentrations/NNS increased/VBD by/IN 98/CD %/NN and/CC prothrombin/NN times/NNS were/VBD prolonged/JJ ./.

(ROOT (S1 (S (NP (NP (NN Warfarin)) (: :) (S (SBAR (WHADVP (WRB When)) (S (NP (NP (NN fluvoxamine) (NN maleate)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 50) (NN mg)) (NN tid)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN warfarin))) (PP (IN for) (NP (CD two) (NNS weeks))))))) (, ,) (S (S (NP (NN warfarin) (NN plasma) (NNS concentrations)) (VP (VBD increased) (PP (IN by) (NP (CD 98) (NN %))))) (CC and) (S (NP (NN prothrombin) (NNS times)) (VP (VBD were) (ADJP (JJ prolonged)))))) (. .)))))

root(ROOT-0, Warfarin-1)
advmod(administered-12, When-3)
nn(maleate-5, fluvoxamine-4)
nsubjpass(administered-12, maleate-5)
number(mg-8, 50-7)
amod(tid-9, mg-8)
appos(maleate-5, tid-9)
auxpass(administered-12, was-11)
advcl(increased-23, administered-12)
advmod(administered-12, concomitantly-13)
prep_with(administered-12, warfarin-15)
num(weeks-18, two-17)
prep_for(administered-12, weeks-18)
nn(concentrations-22, warfarin-20)
nn(concentrations-22, plasma-21)
nsubj(increased-23, concentrations-22)
dep(Warfarin-1, increased-23)
num(%-26, 98-25)
prep_by(increased-23, %-26)
nn(times-29, prothrombin-28)
nsubj(prolonged-31, times-29)
cop(prolonged-31, were-30)
conj_and(increased-23, prolonged-31)

Thus/RB patients/NNS receiving/VBG oral/JJ anticoagulants/NNS and/CC Fluvoxamine/NN Tablets/NNS should/MD have/VBP their/PRP$ prothrombin/NN time/NN monitored/VBN and/CC their/PRP$ anticoagulant/JJ dose/NN adjusted/VBN accordingly/RB ./.

(ROOT (S1 (S (ADVP (RB Thus)) (NP (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ oral) (NNS anticoagulants)))) (CC and) (NP (NN Fluvoxamine) (NNS Tablets))) (VP (MD should) (VP (VBP have) (NP (NP (NP (PRP$ their) (NN prothrombin) (NN time)) (VP (VBN monitored))) (CC and) (NP (NP (PRP$ their) (JJ anticoagulant) (NN dose)) (VP (VBN adjusted) (ADVP (RB accordingly))))))) (. .))))

advmod(have-10, Thus-1)
nsubj(have-10, patients-2)
partmod(patients-2, receiving-3)
amod(anticoagulants-5, oral-4)
dobj(receiving-3, anticoagulants-5)
nn(Tablets-8, Fluvoxamine-7)
conj_and(patients-2, Tablets-8)
aux(have-10, should-9)
root(ROOT-0, have-10)
poss(time-13, their-11)
nn(time-13, prothrombin-12)
dobj(have-10, time-13)
partmod(time-13, monitored-14)
poss(dose-18, their-16)
amod(dose-18, anticoagulant-17)
conj_and(time-13, dose-18)
partmod(dose-18, adjusted-19)
advmod(adjusted-19, accordingly-20)

No/DT dosage/JJ adjustment/NN is/VBZ required/VBN for/IN Fluvoxamine/NN Tablets/NNS ./.

(ROOT (S1 (S (S (NP (DT No) (JJ dosage) (NN adjustment)) (VP (VBZ is) (VP (VBN required) (PP (IN for) (NP (NN Fluvoxamine) (NNS Tablets)))))) (. .))))

det(adjustment-3, No-1)
amod(adjustment-3, dosage-2)
nsubjpass(required-5, adjustment-3)
auxpass(required-5, is-4)
root(ROOT-0, required-5)
nn(Tablets-8, Fluvoxamine-7)
prep_for(required-5, Tablets-8)

Medications/NNS that/WDT interfere/VBP with/IN your/NN bodys/NN ability/NN to/TO use/VB folate/NN may/MD also/RB increase/VBP the/DT need/NN for/IN this/DT vitamin/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Medications)) (SBAR (WHNP (WDT that)) (S (VP (VBP interfere) (PP (IN with) (NP (NP (NN your) (NN bodys) (NN ability)) (S (VP (TO to) (VP (VB use) (NP (NN folate))))))))))) (VP (MD may) (ADVP (RB also)) (VP (VBP increase) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (DT this) (NN vitamin))))))) (. .))))

nsubj(interfere-3, Medications-1)
nsubj(increase-13, Medications-1)
rcmod(Medications-1, interfere-3)
nn(ability-7, your-5)
nn(ability-7, bodys-6)
prep_with(interfere-3, ability-7)
aux(use-9, to-8)
infmod(ability-7, use-9)
dobj(use-9, folate-10)
aux(increase-13, may-11)
advmod(increase-13, also-12)
root(ROOT-0, increase-13)
det(need-15, the-14)
dobj(increase-13, need-15)
det(vitamin-18, this-17)
prep_for(need-15, vitamin-18)

Medications/NNS can/MD interfere/VB with/IN folate/NN utilization/NN ,/, including/VBG :/: anticonvulsant/JJ medications/NNS (/-LRB- such/JJ as/IN phenytoin/NN ,/, and/CC primidone/NN )/-RRB- metformin/NN (/-LRB- sometimes/RB prescribed/VBN to/TO control/VB blood/NN sugar/NN in/IN type/NN 2/CD diabetes/NNS )/-RRB- sulfasalazine/NN (/-LRB- used/VBN to/TO control/VB inflammation/NN associated/VBN with/IN Crohns/JJ disease/NN and/CC ulcerative/JJ colitis/NN )/-RRB- triamterene/NN (/-LRB- a/DT diuretic/JJ )/-RRB- Methotrexate/NN There/EX has/VBZ been/VBN concern/VBN about/IN the/DT interaction/NN between/IN vitamin/NN B12/NN and/CC folic/JJ acid/NN ./.

(ROOT (S1 (S (S (NP (NNS Medications)) (VP (MD can) (VP (VB interfere) (PP (IN with) (NP (NN folate) (NN utilization))) (, ,) (S (VP (VBG including)))))) (: :) (S (NP (NP (NP (NP (NP (NP (JJ anticonvulsant) (NNS medications)) (PRN (-LRB- -LRB-) (ADJP (JJ such) (PP (IN as) (NP (NP (NN phenytoin)) (, ,) (CC and) (NP (NN primidone))))) (-RRB- -RRB-))) (NN metformin)) (PRN (-LRB- -LRB-) (ADVP (RB sometimes)) (VP (VBN prescribed) (S (VP (TO to) (VP (VB control) (NP (NP (NN blood) (NN sugar)) (PP (IN in) (NP (NN type) (CD 2) (NNS diabetes)))))))) (-RRB- -RRB-))) (NN sulfasalazine)) (-LRB- -LRB-) (VP (VBN used) (S (VP (TO to) (VP (VB control) (NP (NP (NN inflammation)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ Crohns) (NN disease)) (CC and) (NP (JJ ulcerative) (NN colitis)))))))))) (-RRB- -RRB-) (NP (NP (NN triamterene)) (PRN (-LRB- -LRB-) (NP (DT a) (JJ diuretic)) (-RRB- -RRB-))) (NP (NN Methotrexate) (EX There))) (VP (VBZ has) (VP (VBN been) (VP (VBN concern) (PP (IN about) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN vitamin) (NN B12)) (CC and) (NP (JJ folic) (NN acid)))))))))) (. .))))

nsubj(interfere-3, Medications-1)
aux(interfere-3, can-2)
root(ROOT-0, interfere-3)
nn(utilization-6, folate-5)
prep_with(interfere-3, utilization-6)
xcomp(interfere-3, including-8)
amod(medications-11, anticonvulsant-10)
nn(metformin-20, medications-11)
prep_such_as(medications-11, phenytoin-15)
conj_and(phenytoin-15, primidone-18)
nn(sulfasalazine-33, metformin-20)
dep(prescribed-23, sometimes-22)
dep(metformin-20, prescribed-23)
aux(control-25, to-24)
xcomp(prescribed-23, control-25)
nn(sugar-27, blood-26)
dobj(control-25, sugar-27)
nn(diabetes-31, type-29)
num(diabetes-31, 2-30)
prep_in(sugar-27, diabetes-31)
xsubj(control-37, sulfasalazine-33)
nsubjpass(concern-56, sulfasalazine-33)
partmod(sulfasalazine-33, used-35)
aux(control-37, to-36)
xcomp(used-35, control-37)
dobj(control-37, inflammation-38)
partmod(inflammation-38, associated-39)
amod(disease-42, Crohns-41)
prep_with(associated-39, disease-42)
amod(colitis-45, ulcerative-44)
conj_and(disease-42, colitis-45)
dep(sulfasalazine-33, triamterene-47)
det(diuretic-50, a-49)
dep(triamterene-47, diuretic-50)
dep(sulfasalazine-33, Methotrexate-52)
dep(Methotrexate-52, There-53)
aux(concern-56, has-54)
auxpass(concern-56, been-55)
parataxis(interfere-3, concern-56)
det(interaction-59, the-58)
prep_about(concern-56, interaction-59)
nn(B12-62, vitamin-61)
prep_between(interaction-59, B12-62)
amod(acid-65, folic-64)
conj_and(B12-62, acid-65)

Folic/JJ acid/NN supplements/NNS can/MD correct/VB the/DT anemia/NN associated/VBN with/IN vitamin/NN B12/NN deficiency/NN ./.

(ROOT (S1 (S (S (NP (JJ Folic) (NN acid) (NNS supplements)) (VP (MD can) (VP (VB correct) (NP (NP (DT the) (NN anemia)) (VP (VBN associated) (PP (IN with) (NP (NN vitamin) (NN B12) (NN deficiency)))))))) (. .))))

amod(supplements-3, Folic-1)
nn(supplements-3, acid-2)
nsubj(correct-5, supplements-3)
aux(correct-5, can-4)
root(ROOT-0, correct-5)
det(anemia-7, the-6)
dobj(correct-5, anemia-7)
partmod(anemia-7, associated-8)
nn(deficiency-12, vitamin-10)
nn(deficiency-12, B12-11)
prep_with(associated-8, deficiency-12)

Unfortunately/RB ,/, folic/JJ acid/NN will/MD not/RB correct/VB changes/NNS in/IN the/DT nervous/JJ system/NN that/WDT result/VBP from/IN vitamin/NN B12/NN deficiency/NN ./.

(ROOT (S1 (S (S (ADVP (RB Unfortunately)) (, ,) (NP (JJ folic) (NN acid)) (VP (MD will) (RB not) (VP (VB correct) (NP (NP (NNS changes)) (PP (IN in) (NP (DT the) (JJ nervous) (NN system))) (SBAR (WHNP (WDT that)) (S (VP (VBP result) (PP (IN from) (NP (NN vitamin) (NN B12) (NN deficiency)))))))))) (. .))))

advmod(correct-7, Unfortunately-1)
amod(acid-4, folic-3)
nsubj(correct-7, acid-4)
aux(correct-7, will-5)
neg(correct-7, not-6)
root(ROOT-0, correct-7)
dobj(correct-7, changes-8)
nsubj(result-14, changes-8)
det(system-12, the-10)
amod(system-12, nervous-11)
prep_in(changes-8, system-12)
rcmod(changes-8, result-14)
nn(deficiency-18, vitamin-16)
nn(deficiency-18, B12-17)
prep_from(result-14, deficiency-18)

Therefore/RB ,/, intake/NN of/IN supplemental/JJ folic/JJ acid/NN should/MD not/RB exceed/VB 1000/CD micrograms/NNS (/-LRB- @/NN g/NN ,/, sometimes/RB mcg/NN )/-RRB- per/IN day/NN to/TO prevent/VB folic/JJ acid/NN from/IN masking/JJ symptoms/NNS of/IN vitamin/NN B12/NN deficiency/NN ./.

(ROOT (S1 (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN intake)) (PP (IN of) (NP (JJ supplemental) (JJ folic) (NN acid)))) (VP (MD should) (RB not) (VP (VB exceed) (NP (NP (NP (CD 1000) (NNS micrograms)) (PRN (-LRB- -LRB-) (NP (NP (NN @) (NN g)) (, ,) (ADVP (RB sometimes)) (NP (NN mcg))) (-RRB- -RRB-))) (PP (IN per) (NP (NN day)))) (S (VP (TO to) (VP (VB prevent) (NP (NP (JJ folic) (NN acid)) (PP (IN from) (NP (NP (JJ masking) (NNS symptoms)) (PP (IN of) (NP (NN vitamin) (NN B12) (NN deficiency))))))))))) (. .))))

advmod(exceed-10, Therefore-1)
nsubj(exceed-10, intake-3)
amod(acid-7, supplemental-5)
amod(acid-7, folic-6)
prep_of(intake-3, acid-7)
aux(exceed-10, should-8)
neg(exceed-10, not-9)
root(ROOT-0, exceed-10)
num(micrograms-12, 1000-11)
dobj(exceed-10, micrograms-12)
nn(g-15, @-14)
dep(micrograms-12, g-15)
advmod(g-15, sometimes-17)
dep(g-15, mcg-18)
prep_per(micrograms-12, day-21)
aux(prevent-23, to-22)
xcomp(exceed-10, prevent-23)
amod(acid-25, folic-24)
dobj(prevent-23, acid-25)
amod(symptoms-28, masking-27)
prep_from(acid-25, symptoms-28)
nn(deficiency-32, vitamin-30)
nn(deficiency-32, B12-31)
prep_of(symptoms-28, deficiency-32)

It/PRP is/VBZ important/JJ for/IN older/JJR adults/NNS to/TO be/VB aware/NN of/IN the/DT relationship/NN between/IN folic/JJ acid/NN and/CC vitamin/NN B12/NN because/IN they/PRP are/VBP at/IN greater/JJR risk/NN of/IN having/VBG a/DT vitamin/NN B12/NN deficiency/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ important) (PP (IN for) (S (NP (JJR older) (NNS adults)) (VP (TO to) (VP (VB be) (NP (NP (NN aware)) (PP (IN of) (NP (NP (DT the) (NN relationship)) (PP (IN between) (NP (NP (JJ folic) (NN acid)) (CC and) (NP (NN vitamin) (NN B12))))))) (SBAR (IN because) (S (NP (PRP they)) (VP (VBP are) (PP (IN at) (NP (NP (JJR greater) (NN risk)) (PP (IN of) (S (VP (VBG having) (NP (DT a) (NN vitamin) (NN B12) (NN deficiency))))))))))))))))) (. .))))

nsubj(important-3, It-1)
cop(important-3, is-2)
root(ROOT-0, important-3)
amod(adults-6, older-5)
nsubj(aware-9, adults-6)
aux(aware-9, to-7)
cop(aware-9, be-8)
prepc_for(important-3, aware-9)
det(relationship-12, the-11)
prep_of(aware-9, relationship-12)
amod(acid-15, folic-14)
prep_between(relationship-12, acid-15)
nn(B12-18, vitamin-17)
conj_and(acid-15, B12-18)
mark(are-21, because-19)
nsubj(are-21, they-20)
advcl(aware-9, are-21)
amod(risk-24, greater-23)
prep_at(are-21, risk-24)
prepc_of(risk-24, having-26)
det(deficiency-30, a-27)
nn(deficiency-30, vitamin-28)
nn(deficiency-30, B12-29)
dobj(having-26, deficiency-30)

If/IN you/RB are/VBP 50/CD years/NNS of/IN age/NN or/CC older/JJR ,/, ask/VB your/NN physician/NN to/TO check/VB your/JJ B12/NN status/NN before/IN you/VBN take/VB a/DT supplement/NN that/WDT contains/VBZ folic/JJ acid/NN ./.

(ROOT (S1 (S (SBAR (IN If) (S (ADVP (RB you)) (VP (VBP are) (ADJP (NP (NP (CD 50) (NNS years)) (PP (IN of) (NP (NN age)))) (CC or) (ADJP (JJR older)))))) (, ,) (VP (VB ask) (S (NP (NN your) (NN physician)) (VP (TO to) (VP (VB check) (NP (JJ your) (NN B12) (NN status))) (SBAR (IN before) (S (VP (VBN you) (VP (VB take) (NP (NP (DT a) (NN supplement)) (SBAR (WHNP (WDT that)) (S (VP (VBZ contains) (NP (JJ folic) (NN acid))))))))))))) (. .))))

mark(years-5, If-1)
advmod(years-5, you-2)
cop(years-5, are-3)
num(years-5, 50-4)
advcl(ask-11, years-5)
prep_of(years-5, age-7)
conj_or(years-5, older-9)
root(ROOT-0, ask-11)
nn(physician-13, your-12)
nsubj(check-15, physician-13)
aux(check-15, to-14)
xcomp(ask-11, check-15)
amod(status-18, your-16)
nn(status-18, B12-17)
dobj(check-15, status-18)
mark(you-20, before-19)
advcl(check-15, you-20)
xcomp(you-20, take-21)
det(supplement-23, a-22)
dobj(take-21, supplement-23)
nsubj(contains-25, supplement-23)
rcmod(supplement-23, contains-25)
amod(acid-27, folic-26)
dobj(contains-25, acid-27)

No/DT drug/NN /drug/NN interaction/NN studies/NNS have/VBP been/VBN performed/VBN ./.

(ROOT (S1 (S (S (NP (DT No) (NN drug) (NN /drug) (NN interaction) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN performed))))) (. .))))

det(studies-5, No-1)
nn(studies-5, drug-2)
nn(studies-5, /drug-3)
nn(studies-5, interaction-4)
nsubjpass(performed-8, studies-5)
aux(performed-8, have-6)
auxpass(performed-8, been-7)
root(ROOT-0, performed-8)

Oral/JJ doses/NNS of/IN Antizol/NN (/-LRB- 10-20/CD mg/kg/NN )/-RRB- ,/, via/IN alcohol/NN dehydrogenase/NN inhibition/NN ,/, significantly/RB reduced/VBD the/DT rate/NN of/IN elimination/NN of/IN ethanol/NN (/-LRB- by/IN approximately/RB 40/CD %/NN )/-RRB- given/VBN to/TO healthy/JJ volunteers/NNS in/IN moderate/JJ doses/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Oral) (NNS doses)) (PP (IN of) (NP (NP (NN Antizol)) (PRN (-LRB- -LRB-) (NP (CD 10-20) (NN mg/kg)) (-RRB- -RRB-)))) (, ,) (PP (IN via) (NP (NP (NN alcohol) (NN dehydrogenase)) (NN inhibition))) (, ,)) (ADVP (RB significantly)) (VP (VBD reduced) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NP (NN elimination)) (PP (IN of) (NP (NN ethanol))))) (PRN (-LRB- -LRB-) (PP (IN by) (NP (QP (RB approximately) (CD 40)) (NN %))) (-RRB- -RRB-)) (VP (VBN given) (PP (TO to) (NP (NP (JJ healthy) (NNS volunteers)) (PP (IN in) (NP (JJ moderate) (NNS doses))))))))) (. .))))

amod(doses-2, Oral-1)
nsubj(reduced-16, doses-2)
prep_of(doses-2, Antizol-4)
num(mg/kg-7, 10-20-6)
appos(Antizol-4, mg/kg-7)
nn(dehydrogenase-12, alcohol-11)
nn(inhibition-13, dehydrogenase-12)
prep_via(doses-2, inhibition-13)
advmod(reduced-16, significantly-15)
root(ROOT-0, reduced-16)
det(rate-18, the-17)
dobj(reduced-16, rate-18)
prep_of(rate-18, elimination-20)
prep_of(elimination-20, ethanol-22)
dep(rate-18, by-24)
quantmod(40-26, approximately-25)
num(%-27, 40-26)
pobj(by-24, %-27)
partmod(rate-18, given-29)
amod(volunteers-32, healthy-31)
prep_to(given-29, volunteers-32)
amod(doses-35, moderate-34)
prep_in(volunteers-32, doses-35)

Similarly/RB ,/, ethanol/NN decreased/VBD the/DT rate/NN of/IN elimination/NN of/IN Antizol/NN (/-LRB- by/IN approximately/RB 50/CD %/NN )/-RRB- by/IN the/DT same/JJ mechanism/NN ./.

(ROOT (S1 (S (S (ADVP (RB Similarly)) (, ,) (NP (NN ethanol)) (VP (VBD decreased) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (NP (NN elimination)) (PP (IN of) (NP (NP (NN Antizol)) (PRN (-LRB- -LRB-) (PP (IN by) (NP (QP (RB approximately) (CD 50)) (NN %))) (-RRB- -RRB-))))))) (PP (IN by) (NP (DT the) (JJ same) (NN mechanism))))) (. .))))

advmod(decreased-4, Similarly-1)
nsubj(decreased-4, ethanol-3)
root(ROOT-0, decreased-4)
det(rate-6, the-5)
dobj(decreased-4, rate-6)
prep_of(rate-6, elimination-8)
prep_of(elimination-8, Antizol-10)
dep(Antizol-10, by-12)
quantmod(50-14, approximately-13)
num(%-15, 50-14)
pobj(by-12, %-15)
det(mechanism-20, the-18)
amod(mechanism-20, same-19)
prep_by(decreased-4, mechanism-20)

Reciprocal/JJ interactions/NNS may/MD occur/VB with/IN concomitant/JJ use/NN of/IN Antizol/NN and/CC drugs/NNS that/WDT increase/VBP or/CC inhibit/VBP the/DT cytochrome/NN P450/NN system/NN (/-LRB- e.g./FW ,/, phenytoin/NN ,/, carbamazepine/NN ,/, cimetidine/NN ,/, ketoconazole/NN )/-RRB- ,/, though/IN this/DT has/VBZ not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (JJ Reciprocal) (NNS interactions)) (VP (MD may) (VP (VB occur) (PP (IN with) (NP (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NN Antizol)))) (CC and) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VP (VP (VBP increase)) (CC or) (VP (VBP inhibit) (NP (DT the) (NP (NN cytochrome) (NN P450)) (NN system)))) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (NN phenytoin)) (, ,) (NP (NN carbamazepine)) (, ,) (NP (NN cimetidine)) (, ,) (NP (NN ketoconazole))) (-RRB- -RRB-)) (, ,) (SBAR (IN though) (S (NP (DT this)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))))))))))))) (. .))))

amod(interactions-2, Reciprocal-1)
nsubj(occur-4, interactions-2)
aux(occur-4, may-3)
root(ROOT-0, occur-4)
amod(use-7, concomitant-6)
prep_with(occur-4, use-7)
prep_of(use-7, Antizol-9)
conj_and(use-7, drugs-11)
nsubj(increase-13, drugs-11)
rcmod(drugs-11, increase-13)
conj_or(increase-13, inhibit-15)
det(system-19, the-16)
nn(P450-18, cytochrome-17)
nn(system-19, P450-18)
dobj(inhibit-15, system-19)
dep(phenytoin-23, e.g.-21)
dep(increase-13, phenytoin-23)
appos(phenytoin-23, carbamazepine-25)
appos(phenytoin-23, cimetidine-27)
appos(phenytoin-23, ketoconazole-29)
mark(studied-37, though-32)
nsubjpass(studied-37, this-33)
aux(studied-37, has-34)
neg(studied-37, not-35)
auxpass(studied-37, been-36)
advcl(increase-13, studied-37)

In/IN clinical/JJ studies/NNS performed/VBN with/IN Fondaparinux/NN ,/, the/DT concomitant/JJ use/NN of/IN oral/JJ anticoagulants/NNS (/-LRB- warfarin/NN )/-RRB- ,/, platelet/NN inhibitors/NNS (/-LRB- acetylsalicylic/JJ acid/NN )/-RRB- ,/, NSAIDs/NNS (/-LRB- piroxicam/NN )/-RRB- ,/, and/CC digoxin/NN did/VBD not/RB significantly/RB affect/VB the/DT pharmacokinetics/pharmacodynamics/NNS of/IN fondaparinux/NN sodium/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (JJ clinical) (NNS studies)) (VP (VBN performed) (PP (IN with) (NP (NN Fondaparinux)))))) (, ,) (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NP (JJ oral) (NNS anticoagulants)) (PRN (-LRB- -LRB-) (NP (NN warfarin)) (-RRB- -RRB-))) (, ,) (NP (NP (NN platelet) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (JJ acetylsalicylic) (NN acid)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS NSAIDs)) (PRN (-LRB- -LRB-) (NP (NN piroxicam)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN digoxin))))) (VP (VBD did) (RB not) (ADVP (RB significantly)) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics/pharmacodynamics)) (PP (IN of) (NP (NN fondaparinux) (NN sodium))))))) (. .))))

amod(studies-3, clinical-2)
prep_in(affect-35, studies-3)
partmod(studies-3, performed-4)
prep_with(performed-4, Fondaparinux-6)
det(use-10, the-8)
amod(use-10, concomitant-9)
nsubj(affect-35, use-10)
amod(anticoagulants-13, oral-12)
prep_of(use-10, anticoagulants-13)
appos(anticoagulants-13, warfarin-15)
nn(inhibitors-19, platelet-18)
conj_and(anticoagulants-13, inhibitors-19)
amod(acid-22, acetylsalicylic-21)
appos(inhibitors-19, acid-22)
conj_and(anticoagulants-13, NSAIDs-25)
appos(NSAIDs-25, piroxicam-27)
conj_and(anticoagulants-13, digoxin-31)
aux(affect-35, did-32)
neg(affect-35, not-33)
advmod(affect-35, significantly-34)
root(ROOT-0, affect-35)
det(pharmacokinetics/pharmacodynamics-37, the-36)
dobj(affect-35, pharmacokinetics/pharmacodynamics-37)
nn(sodium-40, fondaparinux-39)
prep_of(pharmacokinetics/pharmacodynamics-37, sodium-40)

In/IN addition/NN ,/, Fondaparinux/NN neither/RB influenced/VBD the/DT pharmacodynamics/NNS of/IN warfarin/NN ,/, acetylsalicylic/JJ acid/NN ,/, piroxicam/NN ,/, and/CC digoxin/NN ,/, nor/CC the/DT pharmacokinetics/NNS of/IN digoxin/NN at/IN steady/JJ state/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NN Fondaparinux)) (ADVP (RB neither)) (VP (VBD influenced) (NP (NP (NP (DT the) (NNS pharmacodynamics)) (PP (IN of) (NP (NP (NN warfarin)) (, ,) (NP (JJ acetylsalicylic) (NN acid)) (, ,) (NP (NN piroxicam)) (, ,) (CC and) (NP (NN digoxin))))) (, ,) (CC nor) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN digoxin))))) (PP (IN at) (NP (JJ steady) (NN state))))) (. .))))

prep_in(influenced-6, addition-2)
nsubj(influenced-6, Fondaparinux-4)
advmod(influenced-6, neither-5)
root(ROOT-0, influenced-6)
det(pharmacodynamics-8, the-7)
dobj(influenced-6, pharmacodynamics-8)
prep_of(pharmacodynamics-8, warfarin-10)
amod(acid-13, acetylsalicylic-12)
conj_and(warfarin-10, acid-13)
conj_and(warfarin-10, piroxicam-15)
conj_and(warfarin-10, digoxin-18)
det(pharmacokinetics-22, the-21)
conj_nor(pharmacodynamics-8, pharmacokinetics-22)
prep_of(pharmacokinetics-22, digoxin-24)
amod(state-27, steady-26)
prep_at(influenced-6, state-27)

Agents/NNS that/WDT may/MD enhance/VB the/DT risk/NN of/IN hemorrhage/NN should/MD be/VB discontinued/VBN prior/JJ to/TO initiation/NN of/IN Fondaparinux/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Agents)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN hemorrhage))))))))) (VP (MD should) (VP (VB be) (VP (VBN discontinued) (PP (JJ prior) (TO to) (NP (NP (NN initiation)) (PP (IN of) (NP (NN Fondaparinux) (NN therapy))))))))) (. .))))

nsubj(enhance-4, Agents-1)
nsubjpass(discontinued-11, Agents-1)
aux(enhance-4, may-3)
rcmod(Agents-1, enhance-4)
det(risk-6, the-5)
dobj(enhance-4, risk-6)
prep_of(risk-6, hemorrhage-8)
aux(discontinued-11, should-9)
auxpass(discontinued-11, be-10)
root(ROOT-0, discontinued-11)
prep_prior_to(discontinued-11, initiation-14)
nn(therapy-17, Fondaparinux-16)
prep_of(initiation-14, therapy-17)

In/IN an/DT in/FW vitro/FW study/NN in/IN human/JJ liver/NN microsomes/NNS ,/, inhibition/NN of/IN CYP2A6/NN hydroxylation/NN of/IN coumarin/NN by/IN fondaparinux/NN (/-LRB- 200/CD m/NN m/NN M/NN i.e./FW ,/, 350/CD mg/L/NN )/-RRB- was/VBD 17-28/CD %./NN

(ROOT (S1 (S (PP (IN In) (NP (NP (DT an) (ADJP (FW in) (FW vitro)) (NN study)) (PP (IN in) (NP (JJ human) (NN liver) (NNS microsomes))))) (, ,) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (NN CYP2A6) (NN hydroxylation)) (PP (IN of) (NP (NN coumarin))))) (PP (IN by) (NP (NP (NN fondaparinux)) (PRN (-LRB- -LRB-) (NP (CD 200) (NN m) (NN m) (NN M)) (PP (FW i.e.) (, ,) (NP (CD 350) (NN mg/L))) (-RRB- -RRB-))))) (VP (VBD was) (NP (CD 17-28) (NN %.))))))

det(study-5, an-2)
nn(vitro-4, in-3)
amod(study-5, vitro-4)
prep_in(%.-31, study-5)
amod(microsomes-9, human-7)
nn(microsomes-9, liver-8)
prep_in(study-5, microsomes-9)
nsubj(%.-31, inhibition-11)
nn(hydroxylation-14, CYP2A6-13)
prep_of(inhibition-11, hydroxylation-14)
prep_of(hydroxylation-14, coumarin-16)
prep_by(inhibition-11, fondaparinux-18)
num(M-23, 200-20)
nn(M-23, m-21)
nn(M-23, m-22)
dep(fondaparinux-18, M-23)
dep(M-23, i.e.-24)
num(mg/L-27, 350-26)
pobj(i.e.-24, mg/L-27)
cop(%.-31, was-29)
num(%.-31, 17-28-30)
root(ROOT-0, %.-31)

Inhibition/NN of/IN the/DT other/JJ isozymes/NNS evaluated/VBN (/-LRB- CYP/NN s/NN 2A1/NN ,/, 2C9/NN ,/, 2C19/NN ,/, 2D6/NN ,/, 3A4/NN ,/, and/CC 3E1/NN )/-RRB- was/VBD 0-16/CD %./NN

(ROOT (S1 (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (NP (DT the) (JJ other) (NNS isozymes)) (VP (VBN evaluated) (PRN (-LRB- -LRB-) (NP (NP (NN CYP) (NN s) (NN 2A1)) (, ,) (NP (NN 2C9)) (, ,) (NP (NN 2C19)) (, ,) (NP (NN 2D6)) (, ,) (NP (NN 3A4)) (, ,) (CC and) (NP (NN 3E1))) (-RRB- -RRB-)))))) (VP (VBD was) (NP (CD 0-16) (NN %.))))))

nsubj(%.-25, Inhibition-1)
det(isozymes-5, the-3)
amod(isozymes-5, other-4)
prep_of(Inhibition-1, isozymes-5)
partmod(isozymes-5, evaluated-6)
nn(2A1-10, CYP-8)
nn(2A1-10, s-9)
dep(evaluated-6, 2A1-10)
conj_and(2A1-10, 2C9-12)
conj_and(2A1-10, 2C19-14)
conj_and(2A1-10, 2D6-16)
conj_and(2A1-10, 3A4-18)
conj_and(2A1-10, 3E1-21)
cop(%.-25, was-23)
num(%.-25, 0-16-24)
root(ROOT-0, %.-25)

Since/IN fondaparinux/NN does/VBZ not/RB markedly/RB inhibit/VB CYP450s/NNS (/-LRB- CYP1A2/NN ,/, CYP2A6/NN ,/, CYP2C9/NN ,/, CYP2C19/NN ,/, CYP2D6/NN ,/, CYP2E1/NN ,/, or/CC CYP3A4/NN )/-RRB- in/FW vitro/FW ,/, fondaparinux/NN sodium/NN is/VBZ not/RB expected/VBN to/TO significantly/RB interact/VB with/IN other/JJ drugs/NNS in/FW vivo/FW by/IN inhibition/NN of/IN metabolism/NN mediated/VBN by/IN these/DT isozymes/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NN fondaparinux)) (VP (VBZ does) (RB not) (ADVP (RB markedly)) (VP (VB inhibit) (NP (NP (NNS CYP450s)) (PRN (-LRB- -LRB-) (NP (NP (NN CYP1A2)) (, ,) (NP (NN CYP2A6)) (, ,) (NP (NN CYP2C9)) (, ,) (NP (NN CYP2C19)) (, ,) (NP (NN CYP2D6)) (, ,) (NP (NN CYP2E1)) (, ,) (CC or) (NP (NN CYP3A4))) (-RRB- -RRB-))) (ADVP (FW in) (FW vitro)))))) (, ,) (NP (NN fondaparinux) (NN sodium)) (VP (VBZ is) (RB not) (VP (VBN expected) (S (VP (TO to) (ADVP (RB significantly)) (VP (VB interact) (PP (IN with) (NP (JJ other) (NNS drugs))) (ADVP (FW in) (FW vivo)) (PP (IN by) (NP (NP (NN inhibition)) (PP (IN of) (NP (NP (NN metabolism)) (VP (VBN mediated) (PP (IN by) (NP (DT these) (NNS isozymes)))))))))))))) (. .))))

mark(inhibit-6, Since-1)
nsubj(inhibit-6, fondaparinux-2)
aux(inhibit-6, does-3)
neg(inhibit-6, not-4)
advmod(inhibit-6, markedly-5)
advcl(expected-31, inhibit-6)
dobj(inhibit-6, CYP450s-7)
dep(CYP450s-7, CYP1A2-9)
conj_or(CYP1A2-9, CYP2A6-11)
conj_or(CYP1A2-9, CYP2C9-13)
conj_or(CYP1A2-9, CYP2C19-15)
conj_or(CYP1A2-9, CYP2D6-17)
conj_or(CYP1A2-9, CYP2E1-19)
conj_or(CYP1A2-9, CYP3A4-22)
nn(vitro-25, in-24)
advmod(inhibit-6, vitro-25)
nn(sodium-28, fondaparinux-27)
nsubjpass(expected-31, sodium-28)
xsubj(interact-34, sodium-28)
auxpass(expected-31, is-29)
neg(expected-31, not-30)
root(ROOT-0, expected-31)
aux(interact-34, to-32)
advmod(interact-34, significantly-33)
xcomp(expected-31, interact-34)
amod(drugs-37, other-36)
prep_with(interact-34, drugs-37)
nn(vivo-39, in-38)
advmod(interact-34, vivo-39)
prep_by(interact-34, inhibition-41)
prep_of(inhibition-41, metabolism-43)
partmod(metabolism-43, mediated-44)
det(isozymes-47, these-46)
agent(mediated-44, isozymes-47)

Since/IN fondaparinux/NN sodium/NN does/VBZ not/RB bind/VB significantly/RB to/TO plasma/NN proteins/NNS other/JJ than/IN ATIII/NN ,/, no/DT drug/NN interactions/NNS by/IN protein-binding/JJ displacement/NN are/VBP expected/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NN fondaparinux) (NN sodium)) (VP (VBZ does) (RB not) (VP (VB bind) (ADVP (RB significantly)) (PP (TO to) (NP (NP (NN plasma) (NNS proteins)) (ADJP (JJ other) (PP (IN than) (NP (NN ATIII)))))))))) (, ,) (NP (NP (DT no) (NN drug) (NNS interactions)) (PP (IN by) (NP (JJ protein-binding) (NN displacement)))) (VP (VBP are) (VP (VBN expected)))) (. .))))

mark(bind-6, Since-1)
nn(sodium-3, fondaparinux-2)
nsubj(bind-6, sodium-3)
aux(bind-6, does-4)
neg(bind-6, not-5)
advcl(expected-22, bind-6)
advmod(bind-6, significantly-7)
nn(proteins-10, plasma-9)
prep_to(bind-6, proteins-10)
amod(proteins-10, other-11)
prep_than(other-11, ATIII-13)
det(interactions-17, no-15)
nn(interactions-17, drug-16)
nsubjpass(expected-22, interactions-17)
amod(displacement-20, protein-binding-19)
prep_by(interactions-17, displacement-20)
auxpass(expected-22, are-21)
root(ROOT-0, expected-22)

Short-Acting/JJ @/NN 2-/CD agonists/NNS :/: Aerosol/NN bronchodilators/NNS of/IN the/DT short-acting/JJ adrenergic/JJ stimulant/NN type/NN may/MD be/VB used/VBN for/IN relief/NN of/IN breakthrough/NN symptoms/NNS while/IN using/VBG formoterol/NN ./.

(ROOT (S1 (S (NP (NP (JJ Short-Acting) (NN @) (CD 2-) (NNS agonists)) (: :) (S (NP (NP (NN Aerosol) (NNS bronchodilators)) (PP (IN of) (NP (DT the) (JJ short-acting) (JJ adrenergic) (NN stimulant) (NN type)))) (VP (MD may) (VP (VB be) (VP (VBN used) (PP (IN for) (NP (NP (NN relief)) (PP (IN of) (NP (NN breakthrough) (NNS symptoms))))) (SBAR (IN while) (S (VP (VBG using) (NP (NN formoterol))))))))) (. .)))))

amod(agonists-4, Short-Acting-1)
nn(agonists-4, @-2)
num(agonists-4, 2--3)
root(ROOT-0, agonists-4)
nn(bronchodilators-7, Aerosol-6)
nsubjpass(used-16, bronchodilators-7)
det(type-13, the-9)
amod(type-13, short-acting-10)
amod(type-13, adrenergic-11)
nn(type-13, stimulant-12)
prep_of(bronchodilators-7, type-13)
aux(used-16, may-14)
auxpass(used-16, be-15)
dep(agonists-4, used-16)
prep_for(used-16, relief-18)
nn(symptoms-21, breakthrough-20)
prep_of(relief-18, symptoms-21)
mark(using-23, while-22)
advcl(used-16, using-23)
dobj(using-23, formoterol-24)

Concomitant/JJ administration/NN of/IN other/JJ sympathomimetic/JJ agents/NNS may/MD potentiate/VB the/DT undesirable/JJ effects/NNS of/IN FORADIL/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (JJ other) (JJ sympathomimetic) (NNS agents)))) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (JJ undesirable) (NNS effects)) (PP (IN of) (NP (NN FORADIL))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubj(potentiate-8, administration-2)
amod(agents-6, other-4)
amod(agents-6, sympathomimetic-5)
prep_of(administration-2, agents-6)
aux(potentiate-8, may-7)
root(ROOT-0, potentiate-8)
det(effects-11, the-9)
amod(effects-11, undesirable-10)
dobj(potentiate-8, effects-11)
prep_of(effects-11, FORADIL-13)

Monoamine/NN Oxidase/NN Inhibitors/NNS and/CC Tricyclic/JJ Antidepressants/NNS :/: FORADIL/NN should/MD be/VB administered/VBN with/IN extreme/JJ caution/NN in/IN patients/NNS being/VBG treated/VBN with/IN monoamine/NN oxidase/NN inhibitors/NNS or/CC tricyclic/JJ antidepressants/NNS because/IN the/DT action/NN of/IN formoterol/NN on/IN the/DT cardiovascular/JJ system/NN may/MD be/VB potentiated/VBN by/IN these/DT agents/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NN Monoamine) (NN Oxidase) (NNS Inhibitors)) (CC and) (NP (JJ Tricyclic) (NNS Antidepressants))) (: :) (S (NP (NN FORADIL)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (NP (JJ extreme) (NN caution)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NP (NN monoamine) (NN oxidase) (NNS inhibitors)) (CC or) (NP (JJ tricyclic) (NNS antidepressants)))) (SBAR (IN because) (S (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NN formoterol))) (PP (IN on) (NP (DT the) (JJ cardiovascular) (NN system)))) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (PP (IN by) (NP (DT these) (NNS agents)))))))))))))))))) (. .)))))

nn(Inhibitors-3, Monoamine-1)
nn(Inhibitors-3, Oxidase-2)
root(ROOT-0, Inhibitors-3)
amod(Antidepressants-6, Tricyclic-5)
conj_and(Inhibitors-3, Antidepressants-6)
nsubjpass(administered-11, FORADIL-8)
aux(administered-11, should-9)
auxpass(administered-11, be-10)
dep(Inhibitors-3, administered-11)
amod(caution-14, extreme-13)
prep_with(administered-11, caution-14)
prep_in(caution-14, patients-16)
auxpass(treated-18, being-17)
partmod(patients-16, treated-18)
nn(inhibitors-22, monoamine-20)
nn(inhibitors-22, oxidase-21)
prep_with(treated-18, inhibitors-22)
amod(antidepressants-25, tricyclic-24)
conj_or(inhibitors-22, antidepressants-25)
mark(potentiated-37, because-26)
det(action-28, the-27)
nsubjpass(potentiated-37, action-28)
prep_of(action-28, formoterol-30)
det(system-34, the-32)
amod(system-34, cardiovascular-33)
prep_on(action-28, system-34)
aux(potentiated-37, may-35)
auxpass(potentiated-37, be-36)
advcl(treated-18, potentiated-37)
det(agents-40, these-39)
agent(potentiated-37, agents-40)

Corticosteroids/NNS ,/, Methylxanthines/NNS and/CC Diuretics/NNS :/: Concomitant/JJ treatment/NN with/IN xanthine/NN derivatives/NNS ,/, steroids/NNS ,/, or/CC diuretics/NNS may/MD potentiate/VB a/DT possible/JJ hypokalemic/JJ effect/NN of/IN @/NN 2-/CD agonists/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NNS Corticosteroids)) (, ,) (NP (NNS Methylxanthines)) (CC and) (NP (NNS Diuretics))) (: :) (S (NP (NP (JJ Concomitant) (NN treatment)) (PP (IN with) (NP (NP (NN xanthine) (NNS derivatives)) (, ,) (NP (NNS steroids)) (, ,) (CC or) (NP (NNS diuretics))))) (VP (MD may) (VP (VB potentiate) (NP (NP (DT a) (JJ possible) (JJ hypokalemic) (NN effect)) (PP (IN of) (NP (NN @) (CD 2-) (NNS agonists))))))) (. .)))))

root(ROOT-0, Corticosteroids-1)
conj_and(Corticosteroids-1, Methylxanthines-3)
conj_and(Corticosteroids-1, Diuretics-5)
amod(treatment-8, Concomitant-7)
nsubj(potentiate-18, treatment-8)
nn(derivatives-11, xanthine-10)
prep_with(treatment-8, derivatives-11)
conj_or(derivatives-11, steroids-13)
conj_or(derivatives-11, diuretics-16)
aux(potentiate-18, may-17)
dep(Corticosteroids-1, potentiate-18)
det(effect-22, a-19)
amod(effect-22, possible-20)
amod(effect-22, hypokalemic-21)
dobj(potentiate-18, effect-22)
nn(agonists-26, @-24)
num(agonists-26, 2--25)
prep_of(effect-22, agonists-26)

Hypokalemia/NN may/MD increase/VB susceptibility/NN to/TO cardiac/JJ arrhythmias/NNS in/IN patients/NNS treated/VBN with/IN digitalis/NN ./.

(ROOT (S1 (S (S (NP (NN Hypokalemia)) (VP (MD may) (VP (VB increase) (NP (NP (NN susceptibility)) (PP (TO to) (NP (JJ cardiac) (NNS arrhythmias)))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NN digitalis))))))))) (. .))))

nsubj(increase-3, Hypokalemia-1)
aux(increase-3, may-2)
root(ROOT-0, increase-3)
dobj(increase-3, susceptibility-4)
amod(arrhythmias-7, cardiac-6)
prep_to(susceptibility-4, arrhythmias-7)
prep_in(increase-3, patients-9)
partmod(patients-9, treated-10)
prep_with(treated-10, digitalis-12)

@/NN -/CC adrenergic/JJ Blockers/NN :/: @/NN -/CC adrenergic/JJ blockers/NNS may/MD weaken/VB or/CC antagonise/VB the/DT effect/NN of/IN FORADIL/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN @)) (CC -) (NP (JJ adrenergic) (NN Blockers))) (: :) (S (NP (NP (NN @)) (CC -) (NP (JJ adrenergic) (NNS blockers))) (VP (MD may) (VP (VP (VB weaken)) (CC or) (VP (VB antagonise) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN FORADIL)))))))) (. .)))))

root(ROOT-0, @-1)
amod(Blockers-4, adrenergic-3)
conj(@-1, Blockers-4)
nsubj(weaken-11, @-6)
amod(blockers-9, adrenergic-8)
conj(@-6, blockers-9)
aux(weaken-11, may-10)
dep(@-1, weaken-11)
conj_or(weaken-11, antagonise-13)
det(effect-15, the-14)
dobj(antagonise-13, effect-15)
prep_of(effect-15, FORADIL-17)

Therefore/RB FORADIL/NN should/MD not/RB be/VB given/VBN together/RB with/IN @/NN -/CC adrenergic/JJ blockers/NNS (/-LRB- including/VBG eye/NN drops/NN )/-RRB- unless/IN there/EX are/VBP compelling/JJ reasons/NNS for/IN their/PRP$ use/NN ./.

(ROOT (S1 (S (ADVP (RB Therefore)) (NP (NN FORADIL)) (VP (MD should) (ADVP (RB not)) (VP (VB be) (VP (VBN given) (ADVP (RB together)) (PP (IN with) (NP (NP (NN @)) (CC -) (NP (NP (JJ adrenergic) (NNS blockers)) (PRN (-LRB- -LRB-) (VP (VBG including) (NP (NN eye) (NN drops))) (-RRB- -RRB-))))) (SBAR (IN unless) (S (NP (EX there)) (VP (VBP are) (NP (NP (JJ compelling) (NNS reasons)) (PP (IN for) (NP (PRP$ their) (NN use)))))))))) (. .))))

advmod(given-6, Therefore-1)
nsubjpass(given-6, FORADIL-2)
aux(given-6, should-3)
neg(given-6, not-4)
auxpass(given-6, be-5)
root(ROOT-0, given-6)
prep_together_with(given-6, @-9)
amod(blockers-12, adrenergic-11)
conj(@-9, blockers-12)
dep(blockers-12, including-14)
nn(drops-16, eye-15)
dobj(including-14, drops-16)
mark(are-20, unless-18)
expl(are-20, there-19)
advcl(given-6, are-20)
amod(reasons-22, compelling-21)
nsubj(are-20, reasons-22)
poss(use-25, their-24)
prep_for(reasons-22, use-25)

Other/JJ Drugs/NNS :/: Drugs/NNS such/JJ as/IN quinidine/NN ,/, disopyramide/NN ,/, procainamide/NN ,/, phenothiazines/NNS ,/, antihistamines/NNS ,/, and/CC tricyclic/JJ antidepressants/NNS may/MD be/VB associated/VBN with/IN QT-interval/JJ prolongation/NN and/CC an/DT increased/VBN risk/NN of/IN ventricular/JJ arrhythmia/NN ./.

(ROOT (S1 (S (NP (NP (JJ Other) (NNS Drugs)) (: :) (S (NP (NP (NNS Drugs)) (PP (JJ such) (IN as) (NP (NP (NN quinidine)) (, ,) (NP (NN disopyramide)) (, ,) (NP (NN procainamide)) (, ,) (NP (NNS phenothiazines)) (, ,) (NP (NNS antihistamines)) (, ,) (CC and) (NP (JJ tricyclic) (NNS antidepressants))))) (VP (MD may) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (JJ QT-interval) (NN prolongation)) (CC and) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (JJ ventricular) (NN arrhythmia)))))))))) (. .)))))

amod(Drugs-2, Other-1)
root(ROOT-0, Drugs-2)
nsubjpass(associated-22, Drugs-4)
prep_such_as(Drugs-4, quinidine-7)
conj_and(quinidine-7, disopyramide-9)
conj_and(quinidine-7, procainamide-11)
conj_and(quinidine-7, phenothiazines-13)
conj_and(quinidine-7, antihistamines-15)
amod(antidepressants-19, tricyclic-18)
conj_and(quinidine-7, antidepressants-19)
aux(associated-22, may-20)
auxpass(associated-22, be-21)
dep(Drugs-2, associated-22)
amod(prolongation-25, QT-interval-24)
prep_with(associated-22, prolongation-25)
det(risk-29, an-27)
amod(risk-29, increased-28)
conj_and(prolongation-25, risk-29)
amod(arrhythmia-32, ventricular-31)
prep_of(risk-29, arrhythmia-32)

It/PRP is/VBZ important/JJ that/IN patients/NNS understand/VB how/WRB to/TO use/VB FORADIL/NN @/NN (/-LRB- formoterol/NN fumarate/NN )/-RRB- capsules/NNS with/IN the/DT supplied/VBN AerolizerTM/NN inhalation/NN device/NN and/CC how/WRB it/PRP should/MD be/VB used/VBN in/IN relation/NN to/TO other/JJ asthma/NN or/CC COPD/NN medications/NNS they/PRP are/VBP taking/VBG ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ important)) (SBAR (IN that) (S (NP (NNS patients)) (VP (VB understand) (SBAR (SBAR (WRB how) (S (VP (TO to) (VP (VB use) (NP (NP (NN FORADIL) (NN @) (-LRB- -LRB-) (NN formoterol) (NN fumarate) (-RRB- -RRB-) (NNS capsules)) (PP (IN with) (NP (DT the) (VBN supplied) (NN AerolizerTM) (NN inhalation) (NN device)))))))) (CC and) (SBAR (WHADVP (WRB how)) (S (NP (PRP it)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (NN relation)) (PP (TO to) (NP (JJ other) (NN asthma) (CC or) (NN COPD) (NNS medications))))) (S (NP (PRP they)) (VP (VBP are) (VP (VBG taking))))))))))))))) (. .))))

nsubj(important-3, It-1)
cop(important-3, is-2)
root(ROOT-0, important-3)
complm(understand-6, that-4)
nsubj(understand-6, patients-5)
ccomp(important-3, understand-6)
advmod(use-9, how-7)
aux(use-9, to-8)
dep(understand-6, use-9)
nn(capsules-16, FORADIL-10)
nn(capsules-16, @-11)
nn(capsules-16, formoterol-13)
nn(capsules-16, fumarate-14)
dobj(use-9, capsules-16)
det(device-22, the-18)
amod(device-22, supplied-19)
nn(device-22, AerolizerTM-20)
nn(device-22, inhalation-21)
prep_with(capsules-16, device-22)
advmod(used-28, how-24)
nsubjpass(used-28, it-25)
aux(used-28, should-26)
auxpass(used-28, be-27)
conj_and(use-9, used-28)
prep_in(used-28, relation-30)
amod(asthma-33, other-32)
prep_to(relation-30, asthma-33)
nn(medications-36, COPD-35)
conj_or(asthma-33, medications-36)
nsubj(taking-39, they-37)
aux(taking-39, are-38)
ccomp(used-28, taking-39)

FORADIL/NN is/VBZ not/RB meant/JJ to/TO relieve/VBP acute/JJ asthma/NN or/CC COPD/NN symptoms/NNS and/CC extra/JJ doses/NNS should/MD not/RB be/VB used/VBN for/IN that/DT purpose/NN ./.

(ROOT (S1 (S (S (S (NP (NN FORADIL)) (VP (VBZ is) (RB not) (ADJP (JJ meant)) (S (VP (TO to) (VP (VBP relieve) (NP (JJ acute) (NN asthma) (CC or) (NN COPD) (NNS symptoms))))))) (CC and) (S (NP (JJ extra) (NNS doses)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (PP (IN for) (NP (DT that) (NN purpose)))))))) (. .))))

nsubj(meant-4, FORADIL-1)
xsubj(relieve-6, FORADIL-1)
cop(meant-4, is-2)
neg(meant-4, not-3)
root(ROOT-0, meant-4)
aux(relieve-6, to-5)
xcomp(meant-4, relieve-6)
amod(asthma-8, acute-7)
dobj(relieve-6, asthma-8)
nn(symptoms-11, COPD-10)
conj_or(asthma-8, symptoms-11)
amod(doses-14, extra-13)
nsubjpass(used-18, doses-14)
aux(used-18, should-15)
neg(used-18, not-16)
auxpass(used-18, be-17)
conj_and(meant-4, used-18)
det(purpose-21, that-20)
prep_for(used-18, purpose-21)

Acute/JJ symptoms/NNS should/MD be/VB treated/VBN with/IN a/DT short-acting/JJ ,/, inhaled/JJ @/NN 2/CD -/: agonist/NN such/JJ as/IN salbutamol/NN (/-LRB- the/DT physician/NN should/MD provide/VBP the/DT patient/NN with/IN such/JJ medication/NN and/CC instruct/VBP the/DT patient/NN in/IN how/WRB it/PRP should/MD be/VB used/VBN )./NN

(ROOT (S1 (S (S (NP (JJ Acute) (NNS symptoms)) (VP (MD should) (VP (VB be) (VP (VBN treated) (PP (IN with) (NP (NP (DT a) (JJ short-acting) (, ,) (JJ inhaled) (NN @) (CD 2) (: -) (NN agonist)) (PP (JJ such) (IN as) (NP (NN salbutamol))))))))) (S (-LRB- -LRB-) (NP (DT the) (NN physician)) (VP (MD should) (VP (VP (VBP provide) (NP (NP (DT the) (NN patient)) (PP (IN with) (NP (JJ such) (NN medication))))) (CC and) (VP (VBP instruct) (NP (NP (DT the) (NN patient)) (PP (IN in) (SBAR (WHADVP (WRB how)) (S (NP (PRP it)) (VP (MD should) (VP (VB be) (VP (VBN used) (NP (NN -RRB-.))))))))))))))))

amod(symptoms-2, Acute-1)
nsubjpass(treated-5, symptoms-2)
aux(treated-5, should-3)
auxpass(treated-5, be-4)
root(ROOT-0, treated-5)
det(agonist-14, a-7)
amod(agonist-14, short-acting-8)
amod(agonist-14, inhaled-10)
nn(agonist-14, @-11)
num(agonist-14, 2-12)
prep_with(treated-5, agonist-14)
prep_such_as(agonist-14, salbutamol-17)
det(physician-20, the-19)
nsubj(provide-22, physician-20)
aux(provide-22, should-21)
dep(treated-5, provide-22)
det(patient-24, the-23)
dobj(provide-22, patient-24)
amod(medication-27, such-26)
prep_with(patient-24, medication-27)
conj_and(provide-22, instruct-29)
det(patient-31, the-30)
dobj(instruct-29, patient-31)
advmod(used-37, how-33)
nsubjpass(used-37, it-34)
aux(used-37, should-35)
auxpass(used-37, be-36)
prepc_in(patient-31, used-37)
dobj(used-37, -RRB-.-38)

The/DT physician/NN should/MD be/VB notified/VBN immediately/RB if/IN any/DT of/IN the/DT following/JJ situations/NNS occur/VBP ,/, which/WDT may/MD be/VB a/DT sign/NN of/IN seriously/RB worsening/JJ asthma/NN :/: @/NN Decreased/VBN effectiveness/NN of/IN short-acting/JJ ,/, inhaled/JJ @/NN 2-/CD agonists/NNS ;/: ./.

(ROOT (S1 (S (S (NP (DT The) (NN physician)) (VP (MD should) (VP (VB be) (VP (VBN notified) (ADVP (RB immediately)) (SBAR (IN if) (S (NP (NP (DT any)) (PP (IN of) (NP (DT the) (JJ following) (NNS situations)))) (VP (VBP occur) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB be) (NP (NP (DT a) (NN sign)) (PP (IN of) (NP (ADJP (RB seriously) (JJ worsening)) (NN asthma))))))))))))))) (: :) (NP (NP (NN @) (VBN Decreased) (NN effectiveness)) (PP (IN of) (NP (JJ short-acting) (, ,) (JJ inhaled) (NN @) (CD 2-) (NNS agonists))) (: ;)) (. .))))

det(physician-2, The-1)
nsubjpass(notified-5, physician-2)
aux(notified-5, should-3)
auxpass(notified-5, be-4)
root(ROOT-0, notified-5)
advmod(notified-5, immediately-6)
mark(occur-13, if-7)
nsubj(occur-13, any-8)
det(situations-12, the-10)
amod(situations-12, following-11)
prep_of(any-8, situations-12)
advcl(notified-5, occur-13)
nsubj(sign-19, which-15)
aux(sign-19, may-16)
cop(sign-19, be-17)
det(sign-19, a-18)
ccomp(occur-13, sign-19)
advmod(worsening-22, seriously-21)
amod(asthma-23, worsening-22)
prep_of(sign-19, asthma-23)
nn(effectiveness-27, @-25)
amod(effectiveness-27, Decreased-26)
dep(notified-5, effectiveness-27)
amod(agonists-34, short-acting-29)
amod(agonists-34, inhaled-31)
nn(agonists-34, @-32)
num(agonists-34, 2--33)
prep_of(effectiveness-27, agonists-34)

@/NN Need/NN for/IN more/JJR inhalations/NNS than/IN usual/JJ of/IN short-acting/JJ ,/, inhaled/JJ @/NN 2/CD -/CC agonists/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NN @) (NN Need)) (PP (IN for) (NP (NP (JJR more) (NNS inhalations)) (PP (IN than) (NP (NP (JJ usual)) (PP (IN of) (NP (JJ short-acting)))))))) (, ,) (NP (NP (JJ inhaled) (NN @) (CD 2)) (CC -) (NP (NNS agonists))) (. .)))))

nn(Need-2, @-1)
root(ROOT-0, Need-2)
amod(inhalations-5, more-4)
prep_for(Need-2, inhalations-5)
prep_than(inhalations-5, usual-7)
prep_of(usual-7, short-acting-9)
amod(@-12, inhaled-11)
appos(Need-2, @-12)
num(@-12, 2-13)
conj(@-12, agonists-15)

FORADIL/NN should/MD not/RB be/VB used/VBN as/IN a/DT substitute/VB for/IN oral/JJ or/CC inhaled/JJ corticosteroids/NNS ./.

(ROOT (S1 (S (S (NP (NN FORADIL)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (PP (IN as) (NP (NP (DT a)) (VP (VB substitute) (PP (IN for) (NP (JJ oral) (CC or) (JJ inhaled) (NNS corticosteroids)))))))))) (. .))))

nsubjpass(used-5, FORADIL-1)
aux(used-5, should-2)
neg(used-5, not-3)
auxpass(used-5, be-4)
root(ROOT-0, used-5)
prep_as(used-5, a-7)
dep(a-7, substitute-8)
amod(corticosteroids-13, oral-10)
conj_or(oral-10, inhaled-12)
prep_for(substitute-8, corticosteroids-13)

The/DT dosage/NN of/IN these/DT medications/NNS should/MD not/RB be/VB changed/VBN and/CC they/PRP should/MD not/RB be/VB stopped/VBN without/IN consulting/VBG the/DT physician/NN ,/, even/RB if/IN the/DT patient/NN feels/VBZ better/RB after/IN initiating/VBG treatment/NN with/IN FORADIL/NN ./.

(ROOT (S1 (S (S (S (NP (NP (DT The) (NN dosage)) (PP (IN of) (NP (DT these) (NNS medications)))) (VP (MD should) (RB not) (VP (VB be) (VP (VBN changed))))) (CC and) (S (NP (PRP they)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN stopped) (PP (IN without) (S (VP (VBG consulting) (NP (DT the) (NN physician))))) (, ,) (SBAR (RB even) (IN if) (S (NP (DT the) (NN patient)) (VP (VBZ feels) (ADVP (RB better)) (PP (IN after) (S (VP (VBG initiating) (NP (NP (NN treatment)) (PP (IN with) (NP (NN FORADIL))))))))))))))) (. .))))

det(dosage-2, The-1)
nsubjpass(changed-9, dosage-2)
det(medications-5, these-4)
prep_of(dosage-2, medications-5)
aux(changed-9, should-6)
neg(changed-9, not-7)
auxpass(changed-9, be-8)
root(ROOT-0, changed-9)
nsubjpass(stopped-15, they-11)
aux(stopped-15, should-12)
neg(stopped-15, not-13)
auxpass(stopped-15, be-14)
conj_and(changed-9, stopped-15)
prepc_without(stopped-15, consulting-17)
det(physician-19, the-18)
dobj(consulting-17, physician-19)
advmod(feels-25, even-21)
dep(feels-25, if-22)
det(patient-24, the-23)
nsubj(feels-25, patient-24)
ccomp(stopped-15, feels-25)
advmod(feels-25, better-26)
prepc_after(feels-25, initiating-28)
dobj(initiating-28, treatment-29)
prep_with(treatment-29, FORADIL-31)

In/IN patients/NNS receiving/VBG FORADIL/NN ,/, other/JJ inhaled/JJ medications/NNS should/MD be/VB used/VBN only/RB as/IN directed/VBN by/IN the/DT physician/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN FORADIL))))) (, ,) (NP (JJ other) (JJ inhaled) (NNS medications)) (VP (MD should) (VP (VB be) (VP (VBN used) (ADVP (RB only)) (SBAR (IN as) (S (VP (VBN directed) (PP (IN by) (NP (DT the) (NN physician)))))))))) (. .))))

prep_in(used-11, patients-2)
partmod(patients-2, receiving-3)
dobj(receiving-3, FORADIL-4)
amod(medications-8, other-6)
amod(medications-8, inhaled-7)
nsubjpass(used-11, medications-8)
aux(used-11, should-9)
auxpass(used-11, be-10)
root(ROOT-0, used-11)
advmod(used-11, only-12)
mark(directed-14, as-13)
advcl(used-11, directed-14)
det(physician-17, the-16)
prep_by(directed-14, physician-17)

Guardians/NNS of/IN children/NNS who/WP have/VBP been/VBN prescribed/VBN FORADIL/NN should/MD be/VB alerted/VBN to/TO the/DT general/JJ concern/NN regarding/VBG asthma/NN therapy/NN compliance/NN ,/, especially/RB neglect/NN of/IN anti-inflammatory/JJ therapy/NN and/CC overuse/NN of/IN short-acting/JJ @/NN 2-/CD agonists/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Guardians)) (PP (IN of) (NP (NP (NNS children)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN been) (VP (VBN prescribed) (NP (NN FORADIL)))))))))) (VP (MD should) (VP (VB be) (VP (VBN alerted) (PP (TO to) (NP (NP (DT the) (JJ general) (NN concern)) (VP (VBG regarding) (NP (NN asthma) (NN therapy) (NP (NN compliance)) (, ,) (NP (NP (RB especially) (NN neglect)) (PP (IN of) (NP (JJ anti-inflammatory) (NN therapy)))) (CC and) (NP (NP (NN overuse)) (PP (IN of) (NP (JJ short-acting) (NN @) (CD 2-) (NNS agonists))))))))))) (. .))))

nsubjpass(alerted-11, Guardians-1)
prep_of(Guardians-1, children-3)
nsubjpass(prescribed-7, children-3)
aux(prescribed-7, have-5)
auxpass(prescribed-7, been-6)
rcmod(children-3, prescribed-7)
dobj(prescribed-7, FORADIL-8)
aux(alerted-11, should-9)
auxpass(alerted-11, be-10)
root(ROOT-0, alerted-11)
det(concern-15, the-13)
amod(concern-15, general-14)
prep_to(alerted-11, concern-15)
partmod(concern-15, regarding-16)
nn(therapy-18, asthma-17)
dobj(regarding-16, therapy-18)
dep(therapy-18, compliance-19)
advmod(neglect-22, especially-21)
conj_and(therapy-18, neglect-22)
amod(therapy-25, anti-inflammatory-24)
prep_of(neglect-22, therapy-25)
conj_and(therapy-18, overuse-27)
amod(agonists-32, short-acting-29)
nn(agonists-32, @-30)
num(agonists-32, 2--31)
prep_of(overuse-27, agonists-32)

A/DT possible/JJ drug/NN interaction/NN of/IN FOSCAVIR/JJ and/CC intravenous/JJ pentamidin/NN e/NN has/VBZ been/VBN described/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT A) (JJ possible) (NN drug) (NN interaction)) (PP (IN of) (NP (ADJP (ADJP (JJ FOSCAVIR)) (CC and) (ADJP (JJ intravenous))) (NN pentamidin) (NN e)))) (VP (VBZ has) (VP (VBN been) (VP (VBN described))))) (. .))))

det(interaction-4, A-1)
amod(interaction-4, possible-2)
nn(interaction-4, drug-3)
nsubjpass(described-13, interaction-4)
amod(e-10, FOSCAVIR-6)
conj_and(FOSCAVIR-6, intravenous-8)
nn(e-10, pentamidin-9)
prep_of(interaction-4, e-10)
aux(described-13, has-11)
auxpass(described-13, been-12)
root(ROOT-0, described-13)

Concomitant/JJ treatment/NN of/IN four/CD patients/NNS in/IN the/DT United/JJ Kingdom/NN with/IN FOSCAVIR/JJ and/CC intravenous/JJ pentamidin/NN e/NN may/MD have/VB caused/VBN hypocalcemia/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN treatment)) (PP (IN of) (NP (NP (CD four) (NNS patients)) (PP (IN in) (NP (DT the) (JJ United) (NN Kingdom))))) (PP (IN with) (NP (ADJP (ADJP (JJ FOSCAVIR)) (CC and) (ADJP (JJ intravenous))) (NN pentamidin) (NN e)))) (VP (MD may) (VP (VB have) (VP (VBN caused) (NP (NN hypocalcemia))))) (: ;)) (. .))))

amod(treatment-2, Concomitant-1)
nsubj(caused-18, treatment-2)
num(patients-5, four-4)
prep_of(treatment-2, patients-5)
det(Kingdom-9, the-7)
amod(Kingdom-9, United-8)
prep_in(patients-5, Kingdom-9)
amod(e-15, FOSCAVIR-11)
conj_and(FOSCAVIR-11, intravenous-13)
nn(e-15, pentamidin-14)
prep_with(treatment-2, e-15)
aux(caused-18, may-16)
aux(caused-18, have-17)
root(ROOT-0, caused-18)
dobj(caused-18, hypocalcemia-19)

Toxicity/NN associated/VBN with/IN concomitant/JJ use/NN of/IN aerosolized/JJ pentamidin/NN e/NN has/VBZ not/RB been/VBN reported/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Toxicity)) (VP (VBN associated) (PP (IN with) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (JJ aerosolized) (NN pentamidin) (NN e))))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN reported))))) (. .))))

nsubjpass(reported-13, Toxicity-1)
partmod(Toxicity-1, associated-2)
amod(use-5, concomitant-4)
prep_with(associated-2, use-5)
amod(e-9, aerosolized-7)
nn(e-9, pentamidin-8)
prep_of(use-5, e-9)
aux(reported-13, has-10)
neg(reported-13, not-11)
auxpass(reported-13, been-12)
root(ROOT-0, reported-13)

Because/IN of/IN foscarnet/NN s/NN tendency/NN to/TO cause/VB renal/JJ impairment/NN ,/, the/DT use/NN of/IN FOSCAVIR/NN should/MD be/VB avoided/VBN in/IN combination/NN with/IN potentially/RB nephrotoxic/JJ drugs/NNS such/JJ as/IN aminoglycosides/NN ,/, amphotericin/NN B/NN and/CC intravenous/JJ pentamidin/NN e/NN unless/IN the/DT potential/JJ benefits/NNS outweigh/VBP the/DT risks/NNS to/TO the/DT patient/NN ./.

(ROOT (S1 (S (PP (IN Because) (PP (IN of) (NP (NP (NN foscarnet) (NN s) (NN tendency)) (S (VP (TO to) (VP (VB cause) (NP (JJ renal) (NN impairment)))))))) (, ,) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN FOSCAVIR)))) (VP (MD should) (VP (VB be) (VP (VBN avoided) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (RB potentially) (JJ nephrotoxic) (NNS drugs)) (PP (JJ such) (IN as) (NP (NP (NP (NN aminoglycosides)) (, ,) (NP (NN amphotericin) (NN B)) (CC and) (NP (JJ intravenous) (NN pentamidin) (NN e))) (SBAR (IN unless) (S (NP (DT the) (JJ potential) (NNS benefits)) (VP (VBP outweigh) (NP (NP (DT the) (NNS risks)) (PP (TO to) (NP (DT the) (NN patient)))))))))))))))) (. .))))

prepc_because_of(avoided-17, of-2)
nn(tendency-5, foscarnet-3)
nn(tendency-5, s-4)
pobj(avoided-17, tendency-5)
aux(cause-7, to-6)
infmod(tendency-5, cause-7)
amod(impairment-9, renal-8)
dobj(cause-7, impairment-9)
det(use-12, the-11)
nsubjpass(avoided-17, use-12)
prep_of(use-12, FOSCAVIR-14)
aux(avoided-17, should-15)
auxpass(avoided-17, be-16)
root(ROOT-0, avoided-17)
prep_in(avoided-17, combination-19)
advmod(drugs-23, potentially-21)
amod(drugs-23, nephrotoxic-22)
prep_with(combination-19, drugs-23)
prep_such_as(drugs-23, aminoglycosides-26)
nn(B-29, amphotericin-28)
conj_and(aminoglycosides-26, B-29)
amod(e-33, intravenous-31)
nn(e-33, pentamidin-32)
conj_and(aminoglycosides-26, e-33)
mark(outweigh-38, unless-34)
det(benefits-37, the-35)
amod(benefits-37, potential-36)
nsubj(outweigh-38, benefits-37)
dep(aminoglycosides-26, outweigh-38)
det(risks-40, the-39)
dobj(outweigh-38, risks-40)
det(patient-43, the-42)
prep_to(risks-40, patient-43)

Abnormal/JJ renal/JJ function/NN has/VBZ been/VBN observed/VBN in/IN clinical/JJ practice/NN during/IN the/DT use/NN of/IN FASCAVIR/NN and/CC ritonavir/NN ,/, or/CC FOSCAVIR/NN ,/, ritonavir/NN ,/, and/CC saquinavir/NN ./.

(ROOT (S1 (S (S (NP (JJ Abnormal) (JJ renal) (NN function)) (VP (VBZ has) (VP (VBN been) (VP (VBN observed) (PP (IN in) (NP (JJ clinical) (NN practice))) (PP (IN during) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NN FASCAVIR)) (CC and) (NP (NN ritonavir)) (, ,) (CC or) (NP (NN FOSCAVIR)) (, ,) (NP (NN ritonavir)) (, ,) (CC and) (NP (NN saquinavir)))))))))) (. .))))

amod(function-3, Abnormal-1)
amod(function-3, renal-2)
nsubjpass(observed-6, function-3)
aux(observed-6, has-4)
auxpass(observed-6, been-5)
root(ROOT-0, observed-6)
amod(practice-9, clinical-8)
prep_in(observed-6, practice-9)
det(use-12, the-11)
prep_during(observed-6, use-12)
prep_of(use-12, FASCAVIR-14)
conj_and(FASCAVIR-14, ritonavir-16)
conj_or(FASCAVIR-14, FOSCAVIR-19)
conj_or(FASCAVIR-14, ritonavir-21)
conj_and(FASCAVIR-14, saquinavir-24)

Since/IN FOSCAVIR/NN decreases/VBZ serum/NN concentrations/NNS of/IN ionized/VBN calcium/NN ,/, concurrent/JJ treatment/NN with/IN other/JJ drugs/NNS known/VBN to/TO influence/VB serum/NN calcium/NN concentrations/NNS should/MD be/VB used/VBN with/IN particular/JJ caution/NN ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NN FOSCAVIR)) (VP (VBZ decreases) (NP (NP (NN serum) (NNS concentrations)) (PP (IN of) (NP (VBN ionized) (NN calcium))))))) (, ,) (NP (NP (JJ concurrent) (NN treatment)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (VP (VBN known) (S (VP (TO to) (VP (VB influence) (NP (NN serum) (NN calcium) (NNS concentrations))))))))) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (JJ particular) (NN caution))))))) (. .))))

mark(decreases-3, Since-1)
nsubj(decreases-3, FOSCAVIR-2)
advcl(used-23, decreases-3)
nn(concentrations-5, serum-4)
dobj(decreases-3, concentrations-5)
amod(calcium-8, ionized-7)
prep_of(concentrations-5, calcium-8)
amod(treatment-11, concurrent-10)
nsubjpass(used-23, treatment-11)
amod(drugs-14, other-13)
prep_with(treatment-11, drugs-14)
xsubj(influence-17, drugs-14)
partmod(drugs-14, known-15)
aux(influence-17, to-16)
xcomp(known-15, influence-17)
nn(concentrations-20, serum-18)
nn(concentrations-20, calcium-19)
dobj(influence-17, concentrations-20)
aux(used-23, should-21)
auxpass(used-23, be-22)
root(ROOT-0, used-23)
amod(caution-26, particular-25)
prep_with(used-23, caution-26)

Ganciclovir/NN :/: The/DT pharmacokinetics/NNS of/IN foscarnet/NN and/CC ganciclovir/NN were/VBD not/RB altered/VBN in/IN 13/CD patients/NNS receiving/VBG either/CC concomitant/JJ therapy/NN or/CC daily/JJ alternating/VBG therapy/NN for/IN maintenance/NN of/IN CMV/NN disease/NN ./.

(ROOT (S1 (S (NP (NP (NN Ganciclovir)) (: :) (S (NP (NP (DT The) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN foscarnet)) (CC and) (NP (NN ganciclovir))))) (VP (VBD were) (RB not) (VP (VBN altered) (PP (IN in) (NP (NP (CD 13) (NNS patients)) (VP (VBG receiving) (NP (NP (CC either) (NP (JJ concomitant) (NN therapy)) (CC or) (NP (JJ daily) (VBG alternating) (NN therapy))) (PP (IN for) (NP (NP (NN maintenance)) (PP (IN of) (NP (NN CMV) (NN disease)))))))))))) (. .)))))

root(ROOT-0, Ganciclovir-1)
det(pharmacokinetics-4, The-3)
nsubjpass(altered-11, pharmacokinetics-4)
prep_of(pharmacokinetics-4, foscarnet-6)
conj_and(foscarnet-6, ganciclovir-8)
auxpass(altered-11, were-9)
neg(altered-11, not-10)
dep(Ganciclovir-1, altered-11)
num(patients-14, 13-13)
prep_in(altered-11, patients-14)
partmod(patients-14, receiving-15)
preconj(therapy-18, either-16)
amod(therapy-18, concomitant-17)
dobj(receiving-15, therapy-18)
amod(therapy-22, daily-20)
amod(therapy-22, alternating-21)
conj_or(therapy-18, therapy-22)
prep_for(therapy-18, maintenance-24)
nn(disease-27, CMV-26)
prep_of(maintenance-24, disease-27)

Metoclopramide/NN :/: When/WRB coadministered/VBN with/IN MONUROL/NN ,/, metoclopramide/NN ,/, a/DT drug/NN which/WDT increases/VBZ gastrointestinal/JJ motility/NN ,/, lowers/VBZ the/DT serum/NN concentration/NN and/CC urinary/JJ excretion/NN of/IN fosfomycin/NN ./.

(ROOT (S1 (S (NP (NP (NN Metoclopramide)) (: :) (S (SBAR (WHADVP (WRB When)) (S (VP (VBN coadministered) (PP (IN with) (NP (NN MONUROL)))))) (, ,) (NP (NP (NN metoclopramide)) (, ,) (NP (NP (DT a) (NN drug)) (SBAR (WHNP (WDT which)) (S (VP (VBZ increases) (NP (JJ gastrointestinal) (NN motility)))))) (, ,)) (VP (VBZ lowers) (NP (NP (DT the) (NP (NN serum) (NN concentration)) (CC and) (NP (JJ urinary) (NN excretion))) (PP (IN of) (NP (NN fosfomycin)))))) (. .)))))

root(ROOT-0, Metoclopramide-1)
advmod(coadministered-4, When-3)
advcl(lowers-17, coadministered-4)
prep_with(coadministered-4, MONUROL-6)
nsubj(lowers-17, metoclopramide-8)
det(drug-11, a-10)
appos(metoclopramide-8, drug-11)
nsubj(increases-13, drug-11)
rcmod(drug-11, increases-13)
amod(motility-15, gastrointestinal-14)
dobj(increases-13, motility-15)
dep(Metoclopramide-1, lowers-17)
dep(concentration-20, the-18)
nn(concentration-20, serum-19)
dobj(lowers-17, concentration-20)
amod(excretion-23, urinary-22)
conj_and(concentration-20, excretion-23)
prep_of(concentration-20, fosfomycin-25)

Other/JJ drugs/NNS that/WDT increase/VBP gastrointestinal/JJ motility/NN may/MD produce/VB similar/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Other) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP increase) (NP (JJ gastrointestinal) (NN motility)))))) (VP (MD may) (VP (VB produce) (NP (JJ similar) (NNS effects))))) (. .))))

amod(drugs-2, Other-1)
nsubj(increase-4, drugs-2)
nsubj(produce-8, drugs-2)
rcmod(drugs-2, increase-4)
amod(motility-6, gastrointestinal-5)
dobj(increase-4, motility-6)
aux(produce-8, may-7)
root(ROOT-0, produce-8)
amod(effects-10, similar-9)
dobj(produce-8, effects-10)

Cimetidine/NN :/: Cimetidine/NN does/VBZ not/RB affect/VB the/DT pharmacokinetics/NNS of/IN fosfomycin/NN when/WRB coadministered/VBN with/IN MONUROL/NN ./.

(ROOT (S1 (S (S (NP (NN Cimetidine) (: :) (NN Cimetidine)) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN fosfomycin)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NN MONUROL))))))))) (. .))))

nn(Cimetidine-3, Cimetidine-1)
nsubj(affect-6, Cimetidine-3)
aux(affect-6, does-4)
neg(affect-6, not-5)
root(ROOT-0, affect-6)
det(pharmacokinetics-8, the-7)
dobj(affect-6, pharmacokinetics-8)
prep_of(pharmacokinetics-8, fosfomycin-10)
advmod(coadministered-12, when-11)
advcl(affect-6, coadministered-12)
prep_with(coadministered-12, MONUROL-14)

Ergot-containing/JJ drugs/NNS have/VBP been/VBN reported/VBN to/TO cause/VB prolonged/JJ vasospastic/JJ reactions/NNS ./.

(ROOT (S1 (S (S (NP (JJ Ergot-containing) (NNS drugs)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB cause) (NP (JJ prolonged) (JJ vasospastic) (NNS reactions))))))))) (. .))))

amod(drugs-2, Ergot-containing-1)
nsubjpass(reported-5, drugs-2)
xsubj(cause-7, drugs-2)
aux(reported-5, have-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
aux(cause-7, to-6)
xcomp(reported-5, cause-7)
amod(reactions-10, prolonged-8)
amod(reactions-10, vasospastic-9)
dobj(cause-7, reactions-10)

Due/IN to/TO a/DT theoretical/JJ risk/NN of/IN a/DT pharmacodynamic/JJ interaction/NN ,/, use/NN of/IN ergotamine/NN -containing/JJ or/CC ergot-type/JJ medications/NNS (/-LRB- like/IN dihydroergotamine/NN or/CC methysergide/NN )/-RRB- and/CC FROVA/NN within/IN 24/CD hours/NNS of/IN each/DT other/JJ should/MD be/VB avoided/VBN (/-LRB- see/VB a/DT href=/JJ frova/NN _od.htm/NN #/NN CI/CD CONTRAINDICATIONS/NNS )./NN

(ROOT (S1 (S (PP (IN Due) (PP (TO to) (NP (NP (DT a) (JJ theoretical) (NN risk)) (PP (IN of) (NP (DT a) (JJ pharmacodynamic) (NN interaction)))))) (, ,) (NP (NP (NN use)) (PP (IN of) (NP (NP (NP (ADJP (ADJP (NN ergotamine) (JJ -containing)) (CC or) (ADJP (JJ ergot-type))) (NNS medications)) (PRN (-LRB- -LRB-) (PP (IN like) (NP (NP (NN dihydroergotamine)) (CC or) (NP (NN methysergide)))) (-RRB- -RRB-))) (CC and) (NP (NP (NN FROVA)) (PP (IN within) (NP (CD 24) (NNS hours))) (PP (IN of) (NP (DT each) (JJ other))))))) (VP (MD should) (VP (VB be) (VP (VBN avoided)))) (PRN (-LRB- -LRB-) (NP (VB see) (NP (DT a) (JJ href=) (NN frova) (NN _od.htm) (NN #) (CD CI) (NNS CONTRAINDICATIONS) (NN -RRB-.)))))))

prepc_due_to(avoided-34, to-2)
det(risk-5, a-3)
amod(risk-5, theoretical-4)
pobj(avoided-34, risk-5)
det(interaction-9, a-7)
amod(interaction-9, pharmacodynamic-8)
prep_of(risk-5, interaction-9)
nsubjpass(avoided-34, use-11)
dep(-containing-14, ergotamine-13)
amod(medications-17, -containing-14)
conj_or(-containing-14, ergot-type-16)
prep_of(use-11, medications-17)
dep(medications-17, like-19)
pobj(like-19, dihydroergotamine-20)
conj_or(dihydroergotamine-20, methysergide-22)
conj_and(medications-17, FROVA-25)
num(hours-28, 24-27)
prep_within(FROVA-25, hours-28)
det(other-31, each-30)
prep_of(FROVA-25, other-31)
aux(avoided-34, should-32)
auxpass(avoided-34, be-33)
root(ROOT-0, avoided-34)
dep(-RRB-.-44, see-36)
det(-RRB-.-44, a-37)
amod(-RRB-.-44, href=-38)
nn(-RRB-.-44, frova-39)
nn(-RRB-.-44, _od.htm-40)
nn(-RRB-.-44, #-41)
num(-RRB-.-44, CI-42)
nn(-RRB-.-44, CONTRAINDICATIONS-43)
dep(avoided-34, -RRB-.-44)

Concomitant/JJ use/NN of/IN other/JJ 5-HT1B/1D/JJ agonists/NNS within/IN 24/CD hours/NNS of/IN FROVA/NN treatment/NN is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (JJ other) (JJ 5-HT1B/1D) (NNS agonists))) (PP (IN within) (NP (NP (CD 24) (NNS hours)) (PP (IN of) (NP (NN FROVA) (NN treatment)))))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

amod(use-2, Concomitant-1)
nsubjpass(recommended-15, use-2)
amod(agonists-6, other-4)
amod(agonists-6, 5-HT1B/1D-5)
prep_of(use-2, agonists-6)
num(hours-9, 24-8)
prep_within(use-2, hours-9)
nn(treatment-12, FROVA-11)
prep_of(hours-9, treatment-12)
auxpass(recommended-15, is-13)
neg(recommended-15, not-14)
root(ROOT-0, recommended-15)

Selective/JJ serotonin/NN reuptake/NN inhibitors/NNS (/-LRB- SSRIs/NN )/-RRB- (/-LRB- e.g./FW ,/, fluoxetine/NN ,/, fluvoxamine/NN ,/, paroxetine/NN ,/, sertraline/NN )/-RRB- have/VBP been/VBN reported/VBN ,/, rarely/RB ,/, to/TO cause/VB weakness/NN ,/, hyperreflexia/NN ,/, and/CC incoordination/NN when/WRB coadministered/VBN with/IN 5-HT1/NN agonists/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Selective) (NN serotonin) (NN reuptake) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NN SSRIs)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN fluoxetine)) (, ,) (NP (NN fluvoxamine)) (, ,) (NP (NN paroxetine)) (, ,) (NP (NN sertraline)))) (-RRB- -RRB-))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (, ,) (ADVP (RB rarely)) (, ,) (S (VP (TO to) (VP (VB cause) (NP (NP (NN weakness)) (, ,) (NP (NN hyperreflexia)) (, ,) (CC and) (NP (NN incoordination))) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NN 5-HT1) (NNS agonists))))))))))))) (. .))))

amod(inhibitors-4, Selective-1)
nn(inhibitors-4, serotonin-2)
nn(inhibitors-4, reuptake-3)
nsubjpass(reported-21, inhibitors-4)
xsubj(cause-26, inhibitors-4)
abbrev(inhibitors-4, SSRIs-6)
dep(inhibitors-4, e.g.-9)
pobj(e.g.-9, fluoxetine-11)
appos(fluoxetine-11, fluvoxamine-13)
appos(fluoxetine-11, paroxetine-15)
appos(fluoxetine-11, sertraline-17)
aux(reported-21, have-19)
auxpass(reported-21, been-20)
root(ROOT-0, reported-21)
advmod(reported-21, rarely-23)
aux(cause-26, to-25)
xcomp(reported-21, cause-26)
dobj(cause-26, weakness-27)
conj_and(weakness-27, hyperreflexia-29)
conj_and(weakness-27, incoordination-32)
advmod(coadministered-34, when-33)
advcl(cause-26, coadministered-34)
nn(agonists-37, 5-HT1-36)
prep_with(coadministered-34, agonists-37)

If/IN concomitant/JJ treatment/NN with/IN frovatriptan/NN and/CC an/DT SSRI/NN is/VBZ clinically/RB warranted/VBN ,/, appropriate/JJ observation/NN of/IN the/DT patient/NN is/VBZ advised/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NP (JJ concomitant) (NN treatment)) (PP (IN with) (NP (NP (NN frovatriptan)) (CC and) (NP (DT an) (NN SSRI))))) (VP (VBZ is) (ADVP (RB clinically)) (VP (VBN warranted))))) (, ,) (NP (NP (JJ appropriate) (NN observation)) (PP (IN of) (NP (DT the) (NN patient)))) (VP (VBZ is) (VP (VBN advised)))) (. .))))

mark(warranted-11, If-1)
amod(treatment-3, concomitant-2)
nsubjpass(warranted-11, treatment-3)
prep_with(treatment-3, frovatriptan-5)
det(SSRI-8, an-7)
conj_and(frovatriptan-5, SSRI-8)
auxpass(warranted-11, is-9)
advmod(warranted-11, clinically-10)
advcl(advised-19, warranted-11)
amod(observation-14, appropriate-13)
nsubjpass(advised-19, observation-14)
det(patient-17, the-16)
prep_of(observation-14, patient-17)
auxpass(advised-19, is-18)
root(ROOT-0, advised-19)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS FROVA/NN is/VBZ not/RB known/VBN to/TO interfere/VB with/IN commonly/RB employed/VBN clinical/JJ laboratory/NN tests/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (NN FROVA)) (VP (VBZ is) (RB not) (VP (VBN known) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (ADJP (RB commonly) (VBN employed)) (JJ clinical) (NN laboratory) (NNS tests))))))))) (. .))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
nn(FROVA-5, Interactions-4)
nsubjpass(known-8, FROVA-5)
xsubj(interfere-10, FROVA-5)
auxpass(known-8, is-6)
neg(known-8, not-7)
root(ROOT-0, known-8)
aux(interfere-10, to-9)
xcomp(known-8, interfere-10)
advmod(employed-13, commonly-12)
amod(tests-16, employed-13)
amod(tests-16, clinical-14)
nn(tests-16, laboratory-15)
prep_with(interfere-10, tests-16)

Fulvestrant/NN is/VBZ metabolized/VBN by/IN CYP/NN 3A4/NN in/FW vitro/FW ./.

(ROOT (S1 (S (S (NP (NN Fulvestrant)) (VP (VBZ is) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP) (NN 3A4))) (ADVP (FW in) (FW vitro))))) (. .))))

nsubjpass(metabolized-3, Fulvestrant-1)
auxpass(metabolized-3, is-2)
root(ROOT-0, metabolized-3)
nn(3A4-6, CYP-5)
agent(metabolized-3, 3A4-6)
nn(vitro-8, in-7)
advmod(metabolized-3, vitro-8)

Clinical/JJ studies/NNS of/IN the/DT effect/NN of/IN strong/JJ CYP/NN 3A4/NN inhibitors/NNS on/IN the/DT pharmacokinetics/NNS of/IN fulvestrant/NN have/VBP not/RB been/VBN performed/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Clinical) (NNS studies)) (PP (IN of) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ strong) (NN CYP) (NN 3A4) (NNS inhibitors))) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN fulvestrant)))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN performed))))) (. .))))

amod(studies-2, Clinical-1)
nsubjpass(performed-19, studies-2)
det(effect-5, the-4)
prep_of(studies-2, effect-5)
amod(inhibitors-10, strong-7)
nn(inhibitors-10, CYP-8)
nn(inhibitors-10, 3A4-9)
prep_of(effect-5, inhibitors-10)
det(pharmacokinetics-13, the-12)
prep_on(effect-5, pharmacokinetics-13)
prep_of(pharmacokinetics-13, fulvestrant-15)
aux(performed-19, have-16)
neg(performed-19, not-17)
auxpass(performed-19, been-18)
root(ROOT-0, performed-19)

Induction/NN of/IN such/JJ tumors/NNS is/VBZ consistent/JJ with/IN the/DT pharmacology-related/JJ endocrine/JJ feedback/NN alterations/NNS in/IN gonadotropin/NN levels/NNS caused/VBN by/IN an/DT antiestrogen/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Induction)) (PP (IN of) (NP (JJ such) (NNS tumors)))) (VP (VBZ is) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (JJ pharmacology-related) (JJ endocrine) (NN feedback) (NNS alterations)) (PP (IN in) (NP (NN gonadotropin) (NNS levels))) (VP (VBN caused) (PP (IN by) (NP (DT an) (NN antiestrogen))))))))) (. .))))

nsubj(consistent-6, Induction-1)
amod(tumors-4, such-3)
prep_of(Induction-1, tumors-4)
cop(consistent-6, is-5)
root(ROOT-0, consistent-6)
det(alterations-12, the-8)
amod(alterations-12, pharmacology-related-9)
amod(alterations-12, endocrine-10)
nn(alterations-12, feedback-11)
prep_with(consistent-6, alterations-12)
nn(levels-15, gonadotropin-14)
prep_in(alterations-12, levels-15)
partmod(alterations-12, caused-16)
det(antiestrogen-19, an-18)
agent(caused-16, antiestrogen-19)

Fulvestrant/NN was/VBD not/RB mutagenic/JJ or/CC clastogenic/JJ in/IN multiple/JJ in/FW vitro/FW tests/NNS with/IN and/CC without/IN the/DT addition/NN of/IN a/DT mammalian/JJ liver/NN metabolic/JJ activation/NN factor/NN (/-LRB- bacterial/JJ mutation/NN assay/NN in/IN strains/NNS of/IN Salmonella/FW typhimurium/FW and/CC Escherichia/FW coli/FW ,/, in/FW vitro/FW cytogenetics/NNS study/NN in/IN human/JJ lymphocytes/NNS ,/, mammalian/JJ cell/NN mutation/NN assay/NN in/IN mouse/NN lymphoma/NN cells/NNS and/CC in/FW vivo/FW micronucleus/NN test/NN in/IN rat/NN ./.

(ROOT (S1 (S (S (NP (NN Fulvestrant)) (VP (VBD was) (RB not) (ADJP (ADJP (JJ mutagenic)) (CC or) (ADJP (JJ clastogenic))) (PP (IN in) (NP (JJ multiple) (ADJP (FW in) (FW vitro)) (NNS tests))) (PP (IN with) (CC and) (PP (IN without) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (DT a) (JJ mammalian) (NN liver) (JJ metabolic) (NN activation) (NN factor)))))) (-LRB- -LRB-) (NP (NP (NP (JJ bacterial) (NN mutation) (NN assay)) (PP (IN in) (NP (NP (NNS strains)) (PP (IN of) (NP (NP (FW Salmonella) (FW typhimurium)) (CC and) (NP (FW Escherichia) (FW coli))))))) (, ,) (NP (NP (ADJP (FW in) (FW vitro)) (NNS cytogenetics) (NN study)) (PP (IN in) (NP (JJ human) (NNS lymphocytes)))) (, ,) (NP (NP (JJ mammalian) (NN cell) (NN mutation) (NN assay)) (PP (IN in) (NP (NN mouse) (NN lymphoma) (NNS cells)))) (CC and) (NP (NP (ADJP (FW in) (FW vivo)) (NN micronucleus) (NN test)) (PP (IN in) (NP (NN rat))))))) (. .))))

nsubj(mutagenic-4, Fulvestrant-1)
cop(mutagenic-4, was-2)
neg(mutagenic-4, not-3)
root(ROOT-0, mutagenic-4)
conj_or(mutagenic-4, clastogenic-6)
amod(tests-11, multiple-8)
nn(vitro-10, in-9)
amod(tests-11, vitro-10)
prep_in(mutagenic-4, tests-11)
prep(mutagenic-4, with-12)
conj_and(with-12, without-14)
det(addition-16, the-15)
pobj(without-14, addition-16)
det(factor-23, a-18)
amod(factor-23, mammalian-19)
nn(factor-23, liver-20)
amod(factor-23, metabolic-21)
nn(factor-23, activation-22)
prep_of(addition-16, factor-23)
amod(assay-27, bacterial-25)
nn(assay-27, mutation-26)
attr(mutagenic-4, assay-27)
prep_in(assay-27, strains-29)
nn(typhimurium-32, Salmonella-31)
prep_of(strains-29, typhimurium-32)
nn(coli-35, Escherichia-34)
conj_and(typhimurium-32, coli-35)
nn(vitro-38, in-37)
amod(study-40, vitro-38)
nn(study-40, cytogenetics-39)
conj_and(assay-27, study-40)
amod(lymphocytes-43, human-42)
prep_in(study-40, lymphocytes-43)
amod(assay-48, mammalian-45)
nn(assay-48, cell-46)
nn(assay-48, mutation-47)
conj_and(assay-27, assay-48)
nn(cells-52, mouse-50)
nn(cells-52, lymphoma-51)
prep_in(assay-48, cells-52)
nn(vivo-55, in-54)
amod(test-57, vivo-55)
nn(test-57, micronucleus-56)
conj_and(assay-27, test-57)
prep_in(test-57, rat-59)

In/IN female/JJ rats/NNS ,/, fulvestrant/NN administered/VBN at/IN doses/NNS 0.01/CD mg/kg/day/NN (/-LRB- approximately/RB one-hundredth/CD of/IN the/DT human/JJ recommended/VBN dose/NN based/VBN on/IN body/NN surface/NN area/NN [/-LRB- BSA/NN ]/-RRB- ,/, for/IN 2/CD weeks/NNS prior/JJ to/TO and/CC for/IN 1/CD week/NN following/VBG mating/NN ,/, caused/VBD a/DT reduction/NN in/IN fertility/NN and/CC embryonic/JJ survival/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (JJ female) (NNS rats))) (, ,) (NP (NP (NN fulvestrant)) (VP (VBN administered) (PP (IN at) (NP (NP (NNS doses)) (NP (NP (CD 0.01) (NN mg/kg/day)) (-LRB- -LRB-) (NP (NP (RB approximately) (CD one-hundredth)) (PP (IN of) (NP (NP (DT the) (JJ human) (VBN recommended) (NN dose)) (PP (VBN based) (PP (IN on) (NP (NP (NN body) (NN surface) (NN area)) (PRN (-LRB- -LSB-) (NP (NN BSA)) (-RRB- -RSB-)))) (, ,) (PP (IN for) (NP (NP (CD 2) (NNS weeks)) (ADJP (JJ prior) (PP (TO to))))) (CC and) (PP (IN for) (NP (NP (CD 1) (NN week)) (PP (VBG following) (NP (NN mating))))))))) (, ,)))))) (VP (VBD caused) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NP (NN fertility)) (CC and) (NP (JJ embryonic) (NN survival)))))) (. .))))

amod(rats-3, female-2)
prep_in(caused-40, rats-3)
nsubj(caused-40, fulvestrant-5)
partmod(fulvestrant-5, administered-6)
prep_at(administered-6, doses-8)
num(mg/kg/day-10, 0.01-9)
dep(doses-8, mg/kg/day-10)
advmod(one-hundredth-13, approximately-12)
dep(mg/kg/day-10, one-hundredth-13)
det(dose-18, the-15)
amod(dose-18, human-16)
amod(dose-18, recommended-17)
prep_of(one-hundredth-13, dose-18)
prepc_based_on(dose-18, on-20)
nn(area-23, body-21)
nn(area-23, surface-22)
pobj(dose-18, area-23)
punct(BSA-25, -LSB--24)
abbrev(area-23, BSA-25)
punct(BSA-25, -RSB--26)
conj_and(dose-18, for-28)
num(weeks-30, 2-29)
pobj(for-28, weeks-30)
amod(weeks-30, prior-31)
prep(prior-31, to-32)
conj_and(dose-18, for-34)
num(week-36, 1-35)
pobj(for-34, week-36)
prep_following(week-36, mating-38)
root(ROOT-0, caused-40)
det(reduction-42, a-41)
dobj(caused-40, reduction-42)
prep_in(reduction-42, fertility-44)
amod(survival-47, embryonic-46)
conj_and(fertility-44, survival-47)

No/DT adverse/JJ effects/NNS on/IN female/NN fertility/NN and/CC embryonic/JJ survival/NN were/VBD evident/JJ in/IN female/JJ animals/NNS dosed/VBN at/IN 0.001/CD mg/kg/day/NN (/-LRB- approximately/RB one-thousandth/CD of/IN the/DT human/JJ dose/NN based/VBN on/IN BSA/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (DT No) (JJ adverse) (NNS effects)) (PP (IN on) (NP (NP (NN female) (NN fertility)) (CC and) (NP (JJ embryonic) (NN survival))))) (VP (VBD were) (ADJP (JJ evident) (PP (IN in) (NP (NP (JJ female) (NNS animals)) (VP (VBN dosed) (PP (IN at) (NP (NP (CD 0.001) (NN mg/kg/day)) (PRN (-LRB- -LRB-) (NP (NP (RB approximately) (CD one-thousandth)) (PP (IN of) (NP (NP (DT the) (JJ human) (NN dose)) (VP (VBN based) (PP (IN on) (NP (NN BSA))))))) (-RRB- -RRB-)))))))))) (. .))))

det(effects-3, No-1)
amod(effects-3, adverse-2)
nsubj(evident-11, effects-3)
nn(fertility-6, female-5)
prep_on(effects-3, fertility-6)
amod(survival-9, embryonic-8)
conj_and(fertility-6, survival-9)
cop(evident-11, were-10)
root(ROOT-0, evident-11)
amod(animals-14, female-13)
prep_in(evident-11, animals-14)
partmod(animals-14, dosed-15)
num(mg/kg/day-18, 0.001-17)
prep_at(dosed-15, mg/kg/day-18)
advmod(one-thousandth-21, approximately-20)
dep(mg/kg/day-18, one-thousandth-21)
det(dose-25, the-23)
amod(dose-25, human-24)
prep_of(one-thousandth-21, dose-25)
partmod(dose-25, based-26)
prep_on(based-26, BSA-28)

Restoration/NN of/IN female/NN fertility/NN to/TO values/NNS similar/JJ to/TO controls/NNS was/VBD evident/JJ following/VBG a/DT 29-day/JJ withdrawal/NN period/NN after/IN dosing/NN at/IN 2/CD mg/kg/day/NN (/-LRB- twice/RB the/DT human/JJ dose/NN based/VBN on/IN BSA/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (NN Restoration)) (PP (IN of) (NP (NN female) (NN fertility))) (PP (TO to) (NP (NP (NNS values)) (ADJP (JJ similar) (PP (TO to) (NP (NNS controls))))))) (VP (VBD was) (ADJP (JJ evident)) (PP (VBG following) (NP (DT a) (JJ 29-day) (NN withdrawal) (NN period))) (PP (IN after) (NP (NP (NN dosing)) (PP (IN at) (NP (CD 2) (NN mg/kg/day))))) (PRN (-LRB- -LRB-) (NP (NP (RB twice) (DT the) (JJ human) (NN dose)) (VP (VBN based) (PP (IN on) (NP (NN BSA))))) (-RRB- -RRB-)))) (. .))))

nsubj(evident-11, Restoration-1)
nn(fertility-4, female-3)
prep_of(Restoration-1, fertility-4)
prep_to(Restoration-1, values-6)
amod(values-6, similar-7)
prep_to(similar-7, controls-9)
cop(evident-11, was-10)
root(ROOT-0, evident-11)
det(period-16, a-13)
amod(period-16, 29-day-14)
nn(period-16, withdrawal-15)
prep_following(evident-11, period-16)
prep_after(evident-11, dosing-18)
num(mg/kg/day-21, 2-20)
prep_at(dosing-18, mg/kg/day-21)
advmod(dose-26, twice-23)
det(dose-26, the-24)
amod(dose-26, human-25)
dep(evident-11, dose-26)
partmod(dose-26, based-27)
prep_on(based-27, BSA-29)

The/DT effects/NNS of/IN fulvestrant/NN on/IN the/DT fertility/NN of/IN female/JJ rats/NNS appear/VBP to/TO be/VB consistent/JJ with/IN its/PRP$ anti-estrogenic/JJ activity/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NN fulvestrant))) (PP (IN on) (NP (NP (DT the) (NN fertility)) (PP (IN of) (NP (JJ female) (NNS rats)))))) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (ADJP (JJ consistent) (PP (IN with) (NP (PRP$ its) (JJ anti-estrogenic) (NN activity))))))))) (. .))))

det(effects-2, The-1)
nsubj(appear-11, effects-2)
xsubj(consistent-14, effects-2)
prep_of(effects-2, fulvestrant-4)
det(fertility-7, the-6)
prep_on(effects-2, fertility-7)
amod(rats-10, female-9)
prep_of(fertility-7, rats-10)
root(ROOT-0, appear-11)
aux(consistent-14, to-12)
cop(consistent-14, be-13)
xcomp(appear-11, consistent-14)
poss(activity-18, its-16)
amod(activity-18, anti-estrogenic-17)
prep_with(consistent-14, activity-18)

The/DT potential/JJ effects/NNS of/IN fulvestrant/NN on/IN the/DT fertility/NN of/IN male/JJ animals/NNS were/VBD not/RB studied/VBN but/CC in/IN a/DT 6-month/JJ toxicology/NN study/NN ,/, male/JJ rats/NNS treated/VBN with/IN intramuscular/JJ doses/NNS of/IN 15/CD mg/kg/30/NN days/NNS ,/, 10/CD mg/rat/30/NN days/NNS ,/, or/CC 10/CD mg/rat/15/NN days/NNS fulvestrant/NN showed/VBD a/DT loss/NN of/IN spermatozoa/NN from/IN the/DT seminiferous/JJ tubules/NNS ,/, seminiferous/JJ tubular/JJ atrophy/NN ,/, and/CC degenerative/JJ changes/NNS in/IN the/DT epididymides/NNS ./.

(ROOT (S1 (S (S (S (NP (NP (DT The) (JJ potential) (NNS effects)) (PP (IN of) (NP (NN fulvestrant))) (PP (IN on) (NP (NP (DT the) (NN fertility)) (PP (IN of) (NP (JJ male) (NNS animals)))))) (VP (VBD were) (RB not) (VP (VBN studied)))) (CC but) (S (PP (IN in) (NP (DT a) (JJ 6-month) (NN toxicology) (NN study))) (, ,) (NP (NP (JJ male) (NNS rats)) (VP (VBN treated) (PP (IN with) (NP (NP (JJ intramuscular) (NNS doses)) (PP (IN of) (NP (NP (NP (CD 15) (NN mg/kg/30) (NNS days)) (, ,) (NP (CD 10) (NN mg/rat/30) (NNS days)) (, ,) (CC or) (NP (CD 10) (NN mg/rat/15) (NNS days))) (NN fulvestrant))))))) (VP (VBD showed) (NP (NP (NP (DT a) (NN loss)) (PP (IN of) (NP (NP (NN spermatozoa)) (PP (IN from) (NP (DT the) (JJ seminiferous) (NNS tubules)))))) (, ,) (NP (JJ seminiferous) (JJ tubular) (NN atrophy)) (, ,) (CC and) (NP (NP (JJ degenerative) (NNS changes)) (PP (IN in) (NP (DT the) (NNS epididymides)))))))) (. .))))

det(effects-3, The-1)
amod(effects-3, potential-2)
nsubjpass(studied-14, effects-3)
prep_of(effects-3, fulvestrant-5)
det(fertility-8, the-7)
prep_on(effects-3, fertility-8)
amod(animals-11, male-10)
prep_of(fertility-8, animals-11)
auxpass(studied-14, were-12)
neg(studied-14, not-13)
root(ROOT-0, studied-14)
det(study-20, a-17)
amod(study-20, 6-month-18)
nn(study-20, toxicology-19)
prep_in(showed-42, study-20)
amod(rats-23, male-22)
nsubj(showed-42, rats-23)
partmod(rats-23, treated-24)
amod(doses-27, intramuscular-26)
prep_with(treated-24, doses-27)
num(days-31, 15-29)
nn(days-31, mg/kg/30-30)
nn(fulvestrant-41, days-31)
num(days-35, 10-33)
nn(days-35, mg/rat/30-34)
conj_or(days-31, days-35)
num(days-40, 10-38)
nn(days-40, mg/rat/15-39)
conj_or(days-31, days-40)
prep_of(doses-27, fulvestrant-41)
conj_but(studied-14, showed-42)
det(loss-44, a-43)
dobj(showed-42, loss-44)
prep_of(loss-44, spermatozoa-46)
det(tubules-50, the-48)
amod(tubules-50, seminiferous-49)
prep_from(spermatozoa-46, tubules-50)
amod(atrophy-54, seminiferous-52)
amod(atrophy-54, tubular-53)
conj_and(loss-44, atrophy-54)
amod(changes-58, degenerative-57)
conj_and(loss-44, changes-58)
det(epididymides-61, the-60)
prep_in(changes-58, epididymides-61)

These/DT fulvestrant/NN doses/NNS correspond/VBP to/TO approximately/RB 2-/CD ,/, 3-/CD ,/, and/CC 3-fold/RB the/DT systemic/JJ exposure/NN [AUC0-30/CD days/NNS ]/-RRB- achieved/VBN in/IN women/NNS ./.

(ROOT (S1 (S (S (NP (DT These) (NN fulvestrant) (NNS doses)) (VP (VBP correspond) (PP (TO to) (NP (RB approximately) (NP (CD 2-)) (, ,) (NP (CD 3-)) (, ,) (CC and) (NP (NP (ADVP (RB 3-fold)) (DT the) (JJ systemic) (NN exposure) (CD -LSB-AUC0-30) (NNS days) (-RRB- -RSB-)) (VP (VBN achieved) (PP (IN in) (NP (NNS women))))))))) (. .))))

det(doses-3, These-1)
nn(doses-3, fulvestrant-2)
nsubj(correspond-4, doses-3)
root(ROOT-0, correspond-4)
advmod(2--7, approximately-6)
prep_to(correspond-4, 2--7)
conj_and(2--7, 3--9)
advmod(days-17, 3-fold-12)
det(days-17, the-13)
amod(days-17, systemic-14)
nn(days-17, exposure-15)
num(days-17, -LSB-AUC0-30-16)
conj_and(2--7, days-17)
punct(days-17, -RSB--18)
partmod(days-17, achieved-19)
prep_in(achieved-19, women-21)

approximately/RB one-hundredth/JJ of/IN the/DT human/JJ recommended/VBN dose/NN based/VBN on/IN body/NN surface/NN area/NN [/-LRB- BSA/NN ]/-RRB- )/-RRB- ,/, fulvestrant/NN caused/VBD a/DT reversible/JJ reduction/NN in/IN female/NN fertility/NN ,/, as/RB well/RB as/IN effects/NNS on/IN embryo/fetal/JJ development/NN consistent/JJ with/IN its/PRP$ anti-estrogenic/JJ activity/NN ./.

(ROOT (S1 (S (S (S (ADJP (RB approximately) (JJ one-hundredth) (PP (IN of) (NP (NP (DT the) (JJ human) (VBN recommended) (NN dose)) (VP (VBN based) (PP (IN on) (NP (NP (NN body) (NN surface) (NN area)) (PRN (-LRB- -LSB-) (NP (NN BSA)) (-RRB- -RSB-) (-RRB- -RRB-))))))))) (, ,) (NP (NN fulvestrant)) (VP (VBD caused) (NP (NP (NP (DT a) (JJ reversible) (NN reduction)) (PP (IN in) (NP (NN female) (NN fertility)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NNS effects)) (PP (IN on) (NP (JJ embryo/fetal) (NN development))))) (S (ADJP (JJ consistent) (PP (IN with) (NP (PRP$ its) (JJ anti-estrogenic) (NN activity))))))) (. .))))

advmod(one-hundredth-2, approximately-1)
ccomp(caused-19, one-hundredth-2)
det(dose-7, the-4)
amod(dose-7, human-5)
amod(dose-7, recommended-6)
prep_of(one-hundredth-2, dose-7)
partmod(dose-7, based-8)
nn(area-12, body-10)
nn(area-12, surface-11)
prep_on(based-8, area-12)
punct(BSA-14, -LSB--13)
abbrev(area-12, BSA-14)
punct(BSA-14, -RSB--15)
nsubj(caused-19, fulvestrant-18)
root(ROOT-0, caused-19)
det(reduction-22, a-20)
amod(reduction-22, reversible-21)
dobj(caused-19, reduction-22)
nn(fertility-25, female-24)
prep_in(reduction-22, fertility-25)
conj_and(reduction-22, effects-30)
amod(development-33, embryo/fetal-32)
prep_on(effects-30, development-33)
dep(caused-19, consistent-34)
poss(activity-38, its-36)
amod(activity-38, anti-estrogenic-37)
prep_with(consistent-34, activity-38)

Fulvestrant/NN caused/VBD an/DT increased/VBN incidence/NN of/IN fetal/JJ abnormalities/NNS in/IN rats/NNS (/-LRB- tarsal/JJ flexure/NN of/IN the/DT hind/JJ paw/NN at/IN 2/CD mg/kg/day/NN IM/CD ;/: ./.

(ROOT (S1 (S (S (NP (NN Fulvestrant)) (VP (VBD caused) (NP (NP (DT an) (VBN increased) (NN incidence)) (PP (IN of) (NP (JJ fetal) (NNS abnormalities))) (PP (IN in) (NP (NNS rats)))) (-LRB- -LRB-) (NP (NP (JJ tarsal) (NN flexure)) (PP (IN of) (NP (DT the) (JJ hind) (NN paw)))) (PP (IN at) (NP (CD 2) (NN mg/kg/day) (CD IM)))) (: ;)) (. .))))

nsubj(caused-2, Fulvestrant-1)
root(ROOT-0, caused-2)
det(incidence-5, an-3)
amod(incidence-5, increased-4)
dobj(caused-2, incidence-5)
amod(abnormalities-8, fetal-7)
prep_of(incidence-5, abnormalities-8)
prep_in(incidence-5, rats-10)
amod(flexure-13, tarsal-12)
dobj(caused-2, flexure-13)
det(paw-17, the-15)
amod(paw-17, hind-16)
prep_of(flexure-13, paw-17)
num(mg/kg/day-20, 2-19)
prep_at(caused-2, mg/kg/day-20)
num(mg/kg/day-20, IM-21)

twice/RB the/DT human/JJ dose/NN on/IN BSA/NN )/-RRB- and/CC non-ossification/NN of/IN the/DT odontoid/JJ and/CC ventral/JJ tubercle/NN of/IN the/DT first/JJ cervical/JJ vertebra/NN at/IN doses/NNS 0.1/CD mg/kg/day/NN IM/NN (/-LRB- approximately/RB one-tenth/CD of/IN the/DT human/JJ dose/NN on/IN BSA/NN )/-RRB- when/WRB administered/VBN during/IN the/DT period/NN of/IN organogenesis/NN ./.

(ROOT (S1 (S (S (NP (RB twice) (DT the) (JJ human) (NN dose)) (VP (PP (IN on) (NP (NP (NN BSA) (-RRB- -RRB-)) (CC and) (NP (NP (NN non-ossification)) (PP (IN of) (NP (NP (DT the) (ADJP (ADJP (JJ odontoid)) (CC and) (ADJP (JJ ventral))) (NN tubercle)) (PP (IN of) (NP (DT the) (JJ first) (JJ cervical) (NN vertebra))))) (PP (IN at) (NP (NNS doses) (NP (NP (ADJP (CD 0.1) (NN mg/kg/day)) (NN IM)) (PRN (-LRB- -LRB-) (NP (QP (RB approximately) (CD one-tenth)) (PP (IN of) (NP (NP (DT the) (JJ human) (NN dose)) (PP (IN on) (NP (NN BSA)))))) (-RRB- -RRB-)))))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN during) (NP (NP (DT the) (NN period)) (PP (IN of) (NP (NN organogenesis)))))))))) (. .))))

advmod(dose-4, twice-1)
det(dose-4, the-2)
amod(dose-4, human-3)
nsubj(on-5, dose-4)
root(ROOT-0, on-5)
pobj(on-5, BSA-6)
conj_and(BSA-6, non-ossification-9)
det(tubercle-15, the-11)
amod(tubercle-15, odontoid-12)
conj_and(odontoid-12, ventral-14)
prep_of(non-ossification-9, tubercle-15)
det(vertebra-20, the-17)
amod(vertebra-20, first-18)
amod(vertebra-20, cervical-19)
prep_of(tubercle-15, vertebra-20)
prep_at(non-ossification-9, doses-22)
number(mg/kg/day-24, 0.1-23)
amod(IM-25, mg/kg/day-24)
dep(doses-22, IM-25)
quantmod(one-tenth-28, approximately-27)
dep(IM-25, one-tenth-28)
det(dose-32, the-30)
amod(dose-32, human-31)
prep_of(one-tenth-28, dose-32)
prep_on(dose-32, BSA-34)
advmod(administered-37, when-36)
advcl(on-5, administered-37)
det(period-40, the-39)
prep_during(administered-37, period-40)
prep_of(period-40, organogenesis-42)

Rabbits/NNS failed/VBD to/TO maintain/VB pregnancy/NN when/WRB dosed/VBN with/IN 1/CD mg/kg/day/NN fulvestrant/NN IM/NN (/-LRB- twice/RB the/DT human/JJ dose/NN on/IN BSA/NN )/-RRB- during/IN the/DT period/NN of/IN organogenesis/NN ./.

(ROOT (S1 (S (NP (NNS Rabbits)) (VP (VBD failed) (S (VP (TO to) (VP (VB maintain) (NP (NN pregnancy)) (SBAR (WHADVP (WRB when)) (S (VP (VBN dosed) (PP (IN with) (NP (NP (ADJP (CD 1) (NN mg/kg/day)) (NN fulvestrant) (NN IM)) (PRN (-LRB- -LRB-) (NP (NP (RB twice) (DT the) (JJ human) (NN dose)) (PP (IN on) (NP (NN BSA)))) (-RRB- -RRB-)))) (PP (IN during) (NP (NP (DT the) (NN period)) (PP (IN of) (NP (NN organogenesis)))))))))))) (. .))))

nsubj(failed-2, Rabbits-1)
xsubj(maintain-4, Rabbits-1)
root(ROOT-0, failed-2)
aux(maintain-4, to-3)
xcomp(failed-2, maintain-4)
dobj(maintain-4, pregnancy-5)
advmod(dosed-7, when-6)
advcl(maintain-4, dosed-7)
number(mg/kg/day-10, 1-9)
amod(IM-12, mg/kg/day-10)
nn(IM-12, fulvestrant-11)
prep_with(dosed-7, IM-12)
advmod(dose-17, twice-14)
det(dose-17, the-15)
amod(dose-17, human-16)
dep(IM-12, dose-17)
prep_on(dose-17, BSA-19)
det(period-23, the-22)
prep_during(dosed-7, period-23)
prep_of(period-23, organogenesis-25)

Further/RB ,/, in/IN rabbits/NNS dosed/VBN at/IN 0.25/CD mg/kg/day/NN (/-LRB- about/IN one-half/NN the/DT human/JJ dose/NN on/IN BSA/NN )/-RRB- ,/, increases/NNS in/IN placental/JJ weight/NN and/CC post-implantation/NN loss/NN were/VBD observed/VBN but/CC ,/, there/EX were/VBD no/DT observed/VBN effects/NNS on/IN fetal/JJ development/NN ./.

(ROOT (S1 (S (S (ADVP (RB Further)) (, ,) (PP (IN in) (NP (NP (NNS rabbits)) (VP (VBN dosed) (PP (IN at) (NP (NP (CD 0.25) (NN mg/kg/day)) (PRN (-LRB- -LRB-) (PP (IN about) (NP (NN one-half))) (NP (NP (DT the) (JJ human) (NN dose)) (PP (IN on) (NP (NN BSA)))) (-RRB- -RRB-))))))) (, ,) (S (NP (NP (NNS increases)) (PP (IN in) (NP (NP (JJ placental) (NN weight)) (CC and) (NP (NN post-implantation) (NN loss))))) (VP (VBD were) (VP (VBN observed)))) (CC but) (, ,) (S (NP (EX there)) (VP (VBD were) (NP (NP (DT no) (VBN observed) (NNS effects)) (PP (IN on) (NP (JJ fetal) (NN development))))))) (. .))))

advmod(observed-27, Further-1)
conj_but(observed-27, in-3)
prep_in(observed-27, rabbits-4)
partmod(rabbits-4, dosed-5)
num(mg/kg/day-8, 0.25-7)
prep_at(dosed-5, mg/kg/day-8)
dep(dose-14, about-10)
pobj(about-10, one-half-11)
det(dose-14, the-12)
amod(dose-14, human-13)
dep(mg/kg/day-8, dose-14)
prep_on(dose-14, BSA-16)
nsubjpass(observed-27, increases-19)
amod(weight-22, placental-21)
prep_in(increases-19, weight-22)
nn(loss-25, post-implantation-24)
conj_and(weight-22, loss-25)
auxpass(observed-27, were-26)
root(ROOT-0, observed-27)
expl(were-31, there-30)
conj_but(observed-27, were-31)
det(effects-34, no-32)
amod(effects-34, observed-33)
nsubj(were-31, effects-34)
amod(development-37, fetal-36)
prep_on(effects-34, development-37)

Fulvestrant/NN was/VBD associated/VBN with/IN an/DT increased/VBN incidence/NN of/IN fetal/JJ variations/NNS in/IN rabbits/NNS (/-LRB- backwards/NNS displacement/NN of/IN the/DT pelvic/JJ girdle/NN ,/, and/CC 27/CD pre-sacral/JJ vertebrae/NNS at/IN 0.25/CD mg/kg/day/NN IM/CD ;/: ./.

(ROOT (S1 (S (S (NP (NN Fulvestrant)) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (VBN increased) (NN incidence)) (PP (IN of) (NP (NP (JJ fetal) (NNS variations)) (PP (IN in) (NP (NP (NNS rabbits)) (PRN (-LRB- -LRB-) (NP (NNS backwards) (NP (NP (NN displacement)) (PP (IN of) (NP (DT the) (JJ pelvic) (NN girdle)))) (, ,) (CC and) (NP (NP (CD 27) (JJ pre-sacral) (NNS vertebrae)) (PP (IN at) (NP (CD 0.25) (NN mg/kg/day) (CD IM))))) (: ;))))))))))) (. .))))

nsubjpass(associated-3, Fulvestrant-1)
auxpass(associated-3, was-2)
root(ROOT-0, associated-3)
det(incidence-7, an-5)
amod(incidence-7, increased-6)
prep_with(associated-3, incidence-7)
amod(variations-10, fetal-9)
prep_of(incidence-7, variations-10)
prep_in(variations-10, rabbits-12)
dep(rabbits-12, backwards-14)
dep(backwards-14, displacement-15)
det(girdle-19, the-17)
amod(girdle-19, pelvic-18)
prep_of(displacement-15, girdle-19)
num(vertebrae-24, 27-22)
amod(vertebrae-24, pre-sacral-23)
conj_and(backwards-14, vertebrae-24)
num(mg/kg/day-27, 0.25-26)
prep_at(vertebrae-24, mg/kg/day-27)
num(mg/kg/day-27, IM-28)

one-half/NN the/DT human/JJ dose/NN on/IN BSA/NN )/-RRB- when/WRB administered/VBN during/IN the/DT period/NN of/IN organogenesis/NN ./.

(ROOT (S1 (S (S (NP (NN one-half) (NP (DT the) (JJ human) (NN dose))) (VP (PP (IN on) (NP (NN BSA) (-RRB- -RRB-))) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN during) (NP (NP (DT the) (NN period)) (PP (IN of) (NP (NN organogenesis)))))))))) (. .))))

nsubj(on-5, one-half-1)
det(dose-4, the-2)
amod(dose-4, human-3)
dep(one-half-1, dose-4)
root(ROOT-0, on-5)
pobj(on-5, BSA-6)
advmod(administered-9, when-8)
advcl(on-5, administered-9)
det(period-12, the-11)
prep_during(administered-9, period-12)
prep_of(period-12, organogenesis-14)

Because/IN pregnancy/NN could/MD not/RB be/VB maintained/VBN in/IN the/DT rabbit/NN following/VBG doses/NNS of/IN fulvestrant/NN of/IN 1/CD mg/kg/day/NN and/CC above/JJ ,/, this/DT study/NN was/VBD inadequate/JJ to/TO fully/RB define/VB the/DT possible/JJ adverse/JJ effects/NNS on/IN fetal/JJ development/NN at/IN clinically/RB relevant/JJ exposures/NNS ./.

(ROOT (S1 (S (SBAR (IN Because) (S (NP (NN pregnancy)) (VP (MD could) (RB not) (VP (VB be) (VP (VBN maintained) (PP (IN in) (NP (DT the) (NN rabbit))) (PP (VBG following) (NP (NP (NP (NNS doses)) (PP (IN of) (NP (NP (NN fulvestrant)) (PP (IN of) (NP (CD 1) (NN mg/kg/day)))))) (CC and) (NP (ADJP (JJ above)))))))))) (, ,) (NP (DT this) (NN study)) (VP (VBD was) (ADJP (JJ inadequate) (S (VP (TO to) (ADVP (RB fully)) (VP (VB define) (NP (NP (DT the) (JJ possible) (JJ adverse) (NNS effects)) (PP (IN on) (NP (JJ fetal) (NN development))) (PP (IN at) (NP (ADJP (RB clinically) (JJ relevant)) (NNS exposures))))))))) (. .))))

mark(maintained-6, Because-1)
nsubjpass(maintained-6, pregnancy-2)
aux(maintained-6, could-3)
neg(maintained-6, not-4)
auxpass(maintained-6, be-5)
advcl(inadequate-23, maintained-6)
det(rabbit-9, the-8)
prep_in(maintained-6, rabbit-9)
prep_following(maintained-6, doses-11)
prep_of(doses-11, fulvestrant-13)
num(mg/kg/day-16, 1-15)
prep_of(fulvestrant-13, mg/kg/day-16)
conj_and(doses-11, above-18)
det(study-21, this-20)
nsubj(inadequate-23, study-21)
cop(inadequate-23, was-22)
root(ROOT-0, inadequate-23)
aux(define-26, to-24)
advmod(define-26, fully-25)
xcomp(inadequate-23, define-26)
det(effects-30, the-27)
amod(effects-30, possible-28)
amod(effects-30, adverse-29)
dobj(define-26, effects-30)
amod(development-33, fetal-32)
prep_on(effects-30, development-33)
advmod(relevant-36, clinically-35)
amod(exposures-37, relevant-36)
prep_at(effects-30, exposures-37)

Nursing/JJ Mothers/NNS Fulvestrant/NN is/VBZ found/VBN in/IN rat/NN milk/NN at/IN levels/NNS significantly/RB higher/JJR (/-LRB- approximately/RB 12-fold/JJ )/-RRB- than/IN plasma/NN after/IN administration/NN of/IN 2/CD mg/kg/NN ./.

(ROOT (S1 (S (S (NP (JJ Nursing) (NNS Mothers) (NN Fulvestrant)) (VP (VBZ is) (VP (VBN found) (PP (IN in) (NP (NN rat) (NN milk))) (PP (IN at) (NP (NP (NNS levels)) (ADJP (RB significantly) (JJR higher) (PRN (-LRB- -LRB-) (ADJP (RB approximately) (JJ 12-fold)) (-RRB- -RRB-)) (PP (IN than) (NP (NP (NN plasma)) (PP (IN after) (NP (NP (NN administration)) (PP (IN of) (NP (CD 2) (NN mg/kg))))))))))))) (. .))))

amod(Fulvestrant-3, Nursing-1)
nn(Fulvestrant-3, Mothers-2)
nsubjpass(found-5, Fulvestrant-3)
auxpass(found-5, is-4)
root(ROOT-0, found-5)
nn(milk-8, rat-7)
prep_in(found-5, milk-8)
prep_at(found-5, levels-10)
advmod(higher-12, significantly-11)
amod(levels-10, higher-12)
advmod(12-fold-15, approximately-14)
dep(higher-12, 12-fold-15)
prep_than(higher-12, plasma-18)
prep_after(plasma-18, administration-20)
num(mg/kg-23, 2-22)
prep_of(administration-20, mg/kg-23)

Drug/NN exposure/NN in/IN rodent/JJ pups/NNS from/IN fulvestrant/NN -treated/JJ lactating/JJ dams/NNS was/VBD estimated/VBN as/IN 10/CD %/NN of/IN the/DT administered/VBN dose/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN exposure)) (PP (IN in) (NP (NP (JJ rodent) (NNS pups)) (PP (IN from) (NP (NN fulvestrant) (JJ -treated) (JJ lactating) (NNS dams)))))) (VP (VBD was) (VP (VBN estimated) (PP (IN as) (NP (NP (CD 10) (NN %)) (PP (IN of) (NP (DT the) (VBN administered) (NN dose)))))))) (. .))))

nn(exposure-2, Drug-1)
nsubjpass(estimated-12, exposure-2)
amod(pups-5, rodent-4)
prep_in(exposure-2, pups-5)
nn(dams-10, fulvestrant-7)
amod(dams-10, -treated-8)
amod(dams-10, lactating-9)
prep_from(pups-5, dams-10)
auxpass(estimated-12, was-11)
root(ROOT-0, estimated-12)
num(%-15, 10-14)
prep_as(estimated-12, %-15)
det(dose-19, the-17)
amod(dose-19, administered-18)
prep_of(%-15, dose-19)

It/PRP is/VBZ not/RB known/VBN if/IN fulvestrant/NN is/VBZ excreted/VBN in/IN human/JJ milk/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (IN if) (S (NP (NN fulvestrant)) (VP (VBZ is) (VP (VBN excreted) (PP (IN in) (NP (JJ human) (NN milk)))))))))) (. .))))

nsubjpass(known-4, It-1)
auxpass(known-4, is-2)
neg(known-4, not-3)
root(ROOT-0, known-4)
mark(excreted-8, if-5)
nsubjpass(excreted-8, fulvestrant-6)
auxpass(excreted-8, is-7)
advcl(known-4, excreted-8)
amod(milk-11, human-10)
prep_in(excreted-8, milk-11)

Because/IN many/JJ drugs/NNS are/VBP excreted/VBN in/IN human/JJ milk/NN ,/, and/CC because/IN of/IN the/DT potential/NN for/IN serious/JJ adverse/JJ reactions/NNS from/IN FASLODEX/NN in/IN nursing/JJ infants/NNS ,/, a/DT decision/NN should/MD be/VB made/VBN whether/IN to/TO discontinue/VBP nursing/NN or/CC to/TO discontinue/VBP the/DT drug/NN taking/VBG into/IN account/VBP the/DT importance/NN of/IN the/DT drug/NN to/TO the/DT mother/NN ./.

(ROOT (S1 (S (SBAR (IN Because) (S (NP (JJ many) (NNS drugs)) (VP (VP (VBP are) (VP (VBN excreted) (PP (IN in) (NP (JJ human) (NN milk))))) (, ,) (CC and) (PP (IN because) (IN of) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (JJ serious) (JJ adverse) (NNS reactions)) (PP (IN from) (NP (NP (NN FASLODEX)) (PP (IN in) (NP (JJ nursing) (NNS infants)))))))))))) (, ,) (NP (DT a) (NN decision)) (VP (MD should) (VP (VB be) (VP (VBN made) (SBAR (IN whether) (S (VP (VP (TO to) (VP (VBP discontinue) (NP (NN nursing)))) (CC or) (VP (TO to) (VP (VBP discontinue) (NP (NP (DT the) (NN drug)) (VP (VBG taking) (SBAR (IN into) (S (VP (VBP account) (NP (NP (DT the) (NN importance)) (PP (IN of) (NP (DT the) (NN drug))) (PP (TO to) (NP (DT the) (NN mother))))))))))))))))) (. .))))

mark(excreted-5, Because-1)
amod(drugs-3, many-2)
nsubjpass(excreted-5, drugs-3)
auxpass(excreted-5, are-4)
advcl(made-29, excreted-5)
amod(milk-8, human-7)
prep_in(excreted-5, milk-8)
conj_and(excreted-5, of-12)
det(potential-14, the-13)
prep_because_of(excreted-5, potential-14)
amod(reactions-18, serious-16)
amod(reactions-18, adverse-17)
prep_for(potential-14, reactions-18)
prep_from(reactions-18, FASLODEX-20)
amod(infants-23, nursing-22)
prep_in(FASLODEX-20, infants-23)
det(decision-26, a-25)
nsubjpass(made-29, decision-26)
aux(made-29, should-27)
auxpass(made-29, be-28)
root(ROOT-0, made-29)
complm(discontinue-32, whether-30)
aux(discontinue-32, to-31)
ccomp(made-29, discontinue-32)
dobj(discontinue-32, nursing-33)
aux(discontinue-36, to-35)
conj_or(discontinue-32, discontinue-36)
det(drug-38, the-37)
dobj(discontinue-36, drug-38)
partmod(drug-38, taking-39)
mark(account-41, into-40)
advcl(taking-39, account-41)
det(importance-43, the-42)
dobj(account-41, importance-43)
det(drug-46, the-45)
prep_of(importance-43, drug-46)
det(mother-49, the-48)
prep_to(importance-43, mother-49)

Pediatric/JJ Use/NN :/: The/DT safety/NN and/CC efficacy/NN of/IN FASLODEX/NN in/IN pediatric/JJ patients/NNS have/VBP not/RB been/VBN established/VBN ./.

(ROOT (S1 (S (NP (NP (JJ Pediatric) (NN Use)) (: :) (S (NP (NP (DT The) (NP (NN safety)) (CC and) (NP (NN efficacy))) (PP (IN of) (NP (NN FASLODEX))) (PP (IN in) (NP (JJ pediatric) (NNS patients)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN established))))) (. .)))))

amod(Use-2, Pediatric-1)
root(ROOT-0, Use-2)
dep(safety-5, The-4)
nsubjpass(established-16, safety-5)
conj_and(safety-5, efficacy-7)
prep_of(safety-5, FASLODEX-9)
amod(patients-12, pediatric-11)
prep_in(safety-5, patients-12)
aux(established-16, have-13)
neg(established-16, not-14)
auxpass(established-16, been-15)
dep(Use-2, established-16)

Geriatric/JJ Use/NN :/: When/WRB tumor/NN response/NN was/VBD considered/VBN by/IN age/NN ,/, objective/NN responses/NNS were/VBD seen/VBN in/IN 24/CD %/NN and/CC 22/CD %/NN of/IN patients/NNS under/IN 65/CD years/NNS of/IN age/NN and/CC in/IN 16/CD %/NN and/CC 11/CD %/NN of/IN patients/NNS 65/CD years/NNS of/IN age/NN and/CC older/JJR ,/, who/WP were/VBD treated/VBN with/IN FASLODEX/NN in/IN the/DT European/NNP and/CC North/NNP American/NNP trials/NNS ,/, respectively/RB ./.

(ROOT (S1 (S (NP (NP (JJ Geriatric) (NN Use)) (: :) (S (SBAR (WHADVP (WRB When)) (S (NP (NN tumor) (NN response)) (VP (VBD was) (VP (VBN considered) (PP (IN by) (NP (NN age))))))) (, ,) (NP (NN objective) (NNS responses)) (VP (VBD were) (VP (VBN seen) (PP (PP (IN in) (NP (NP (NP (CD 24) (NN %)) (CC and) (NP (CD 22) (NN %))) (PP (IN of) (NP (NP (NNS patients)) (PP (IN under) (NP (NP (CD 65) (NNS years)) (PP (IN of) (NP (NN age))))))))) (CC and) (PP (IN in) (NP (NP (CD 16) (NN %)) (CC and) (NP (NP (CD 11) (NN %)) (PP (IN of) (NP (NP (NNS patients) (CD 65) (NNS years)) (PP (IN of) (NP (NP (NN age)) (CC and) (NP (JJR older)))) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NN FASLODEX))) (PP (IN in) (NP (DT the) (NP (NNP European)) (CC and) (NP (NNP North) (NNP American)) (NP (NNS trials))))))))))) (, ,) (ADVP (RB respectively)))))))) (. .)))))

amod(Use-2, Geriatric-1)
root(ROOT-0, Use-2)
advmod(considered-8, When-4)
nn(response-6, tumor-5)
nsubjpass(considered-8, response-6)
auxpass(considered-8, was-7)
advcl(seen-15, considered-8)
agent(considered-8, age-10)
nn(responses-13, objective-12)
nsubjpass(seen-15, responses-13)
auxpass(seen-15, were-14)
dep(Use-2, seen-15)
num(%-18, 24-17)
prep_in(seen-15, %-18)
num(%-21, 22-20)
conj_and(%-18, %-21)
prep_of(%-18, patients-23)
num(years-26, 65-25)
prep_under(patients-23, years-26)
prep_of(years-26, age-28)
num(%-32, 16-31)
conj_and(%-18, %-32)
num(%-35, 11-34)
conj_and(%-32, %-35)
nn(years-39, patients-37)
num(years-39, 65-38)
prep_of(%-35, years-39)
nsubjpass(treated-47, years-39)
prep_of(years-39, age-41)
conj_and(age-41, older-43)
auxpass(treated-47, were-46)
rcmod(years-39, treated-47)
prep_with(treated-47, FASLODEX-49)
dep(European-52, the-51)
prep_in(treated-47, European-52)
nn(American-55, North-54)
conj_and(European-52, American-55)
dep(European-52, trials-56)
advmod(%-32, respectively-58)
conj_and(%-32, respectively-58)

Furosemide/NN may/MD increase/VB the/DT ototoxic/JJ potential/NN of/IN aminoglycoside/NN antibiotics/NNS ,/, especially/RB in/IN the/DT presence/NN of/IN impaired/JJ renal/JJ function/NN ./.

(ROOT (S1 (S (S (NP (NN Furosemide)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (JJ ototoxic) (NN potential)) (PP (IN of) (NP (NN aminoglycoside) (NNS antibiotics)))) (, ,) (PP (ADVP (RB especially)) (IN in) (DT the) (NN presence) (IN of) (NP (JJ impaired) (JJ renal) (NN function)))))) (. .))))

nsubj(increase-3, Furosemide-1)
aux(increase-3, may-2)
root(ROOT-0, increase-3)
det(potential-6, the-4)
amod(potential-6, ototoxic-5)
dobj(increase-3, potential-6)
nn(antibiotics-9, aminoglycoside-8)
prep_of(potential-6, antibiotics-9)
advmod(increase-3, especially-11)
dep(increase-3, in-12)
dep(increase-3, the-13)
dep(increase-3, presence-14)
amod(function-18, impaired-16)
amod(function-18, renal-17)
prep_of(increase-3, function-18)

Furosemide/NN should/MD not/RB be/VB used/VBN concomitantly/RB with/IN ethacrynic/JJ acid/NN because/IN of/IN the/DT possibility/NN of/IN ototoxicity/NN ./.

(ROOT (S1 (S (S (NP (NN Furosemide)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (JJ ethacrynic) (NN acid))) (PP (IN because) (IN of) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NN ototoxicity))))))))) (. .))))

nsubjpass(used-5, Furosemide-1)
aux(used-5, should-2)
neg(used-5, not-3)
auxpass(used-5, be-4)
root(ROOT-0, used-5)
advmod(used-5, concomitantly-6)
amod(acid-9, ethacrynic-8)
prep_with(used-5, acid-9)
det(possibility-13, the-12)
prep_because_of(used-5, possibility-13)
prep_of(possibility-13, ototoxicity-15)

Patients/NNS receiving/VBG high/JJ doses/NNS of/IN salicylates/NNS concomitantly/RB with/IN furosemide/NN ,/, as/IN in/IN rheumatic/JJ disease/NN ,/, may/MD experience/VBP salicylate/NN toxicity/NN at/IN lower/JJR doses/NNS because/IN of/IN competitive/JJ renal/JJ excretory/NN sites/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NNS salicylates)))))) (PP (ADVP (RB concomitantly)) (IN with) (NP (NN furosemide)))) (, ,) (PP (IN as) (PP (IN in) (NP (JJ rheumatic) (NN disease)))) (, ,) (VP (MD may) (VP (VBP experience) (NP (NN salicylate) (NN toxicity)) (PP (IN at) (NP (NP (JJR lower) (NNS doses)) (PP (IN because) (PP (IN of) (NP (JJ competitive) (JJ renal) (NN excretory) (NNS sites))))))))) (. .))))

nsubj(experience-17, Patients-1)
partmod(Patients-1, receiving-2)
amod(doses-4, high-3)
dobj(receiving-2, doses-4)
prep_of(doses-4, salicylates-6)
advmod(Patients-1, concomitantly-7)
prep_with(Patients-1, furosemide-9)
prep(experience-17, as-11)
pcomp(as-11, in-12)
amod(disease-14, rheumatic-13)
prep_in(as-11, disease-14)
aux(experience-17, may-16)
root(ROOT-0, experience-17)
nn(toxicity-19, salicylate-18)
dobj(experience-17, toxicity-19)
amod(doses-22, lower-21)
prep_at(experience-17, doses-22)
prepc_because_of(doses-22, of-24)
amod(sites-28, competitive-25)
amod(sites-28, renal-26)
nn(sites-28, excretory-27)
pobj(doses-22, sites-28)

Furosemide/NN has/VBZ a/DT tendency/NN to/TO antagonize/VB the/DT skeletal/JJ muscle/NN relaxing/NN effect/NN of/IN tubocurarine/NN and/CC may/MD potentiate/VB the/DT action/NN of/IN succinylcholine/NN ./.

(ROOT (S1 (S (S (NP (NN Furosemide)) (VP (VP (VBZ has) (NP (NP (DT a) (NN tendency)) (S (VP (TO to) (VP (VB antagonize) (NP (NP (DT the) (JJ skeletal) (NN muscle) (NN relaxing) (NN effect)) (PP (IN of) (NP (NN tubocurarine))))))))) (CC and) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (NN succinylcholine)))))))) (. .))))

nsubj(has-2, Furosemide-1)
root(ROOT-0, has-2)
det(tendency-4, a-3)
dobj(has-2, tendency-4)
aux(antagonize-6, to-5)
infmod(tendency-4, antagonize-6)
det(effect-11, the-7)
amod(effect-11, skeletal-8)
nn(effect-11, muscle-9)
nn(effect-11, relaxing-10)
dobj(antagonize-6, effect-11)
prep_of(effect-11, tubocurarine-13)
aux(potentiate-16, may-15)
conj_and(has-2, potentiate-16)
det(action-18, the-17)
dobj(potentiate-16, action-18)
prep_of(action-18, succinylcholine-20)

Lithium/NN generally/RB should/MD not/RB be/VB given/VBN with/IN diuretics/NN because/IN they/PRP reduce/VBP lithium/NN s/NN renal/JJ clearance/NN and/CC add/VBP a/DT high/JJ risk/NN of/IN lithium/NN toxicity/NN ./.

(ROOT (S1 (S (S (NP (NN Lithium)) (ADVP (RB generally)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN given) (PP (IN with) (NP (NN diuretics))) (SBAR (IN because) (S (NP (PRP they)) (VP (VP (VBP reduce) (NP (NN lithium) (NN s) (JJ renal) (NN clearance))) (CC and) (VP (VBP add) (NP (NP (DT a) (JJ high) (NN risk)) (PP (IN of) (NP (NN lithium) (NN toxicity)))))))))))) (. .))))

nsubjpass(given-6, Lithium-1)
advmod(given-6, generally-2)
aux(given-6, should-3)
neg(given-6, not-4)
auxpass(given-6, be-5)
root(ROOT-0, given-6)
prep_with(given-6, diuretics-8)
mark(reduce-11, because-9)
nsubj(reduce-11, they-10)
advcl(given-6, reduce-11)
nn(clearance-15, lithium-12)
nn(clearance-15, s-13)
amod(clearance-15, renal-14)
dobj(reduce-11, clearance-15)
conj_and(reduce-11, add-17)
det(risk-20, a-18)
amod(risk-20, high-19)
dobj(add-17, risk-20)
nn(toxicity-23, lithium-22)
prep_of(risk-20, toxicity-23)

Furosemide/NN may/MD add/VBP to/TO or/CC potentiate/VB the/DT therapeutic/JJ effect/NN of/IN other/JJ antihypertensive/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NN Furosemide)) (VP (MD may) (VP (VP (VBP add) (PP (TO to))) (CC or) (VP (VB potentiate) (NP (NP (DT the) (JJ therapeutic) (NN effect)) (PP (IN of) (NP (JJ other) (JJ antihypertensive) (NNS drugs)))))))) (. .))))

nsubj(add-3, Furosemide-1)
aux(add-3, may-2)
root(ROOT-0, add-3)
prep(add-3, to-4)
conj_or(add-3, potentiate-6)
det(effect-9, the-7)
amod(effect-9, therapeutic-8)
dobj(potentiate-6, effect-9)
amod(drugs-13, other-11)
amod(drugs-13, antihypertensive-12)
prep_of(effect-9, drugs-13)

Potentiation/NN occurs/VBZ with/IN ganglionic/JJ or/CC peripheral/JJ adrenergic/JJ blocking/NN drugs/NNS ./.

(ROOT (S1 (S (S (NP (NN Potentiation)) (VP (VBZ occurs) (PP (IN with) (NP (ADJP (ADJP (JJ ganglionic)) (CC or) (ADJP (JJ peripheral))) (JJ adrenergic) (NN blocking) (NNS drugs))))) (. .))))

nsubj(occurs-2, Potentiation-1)
root(ROOT-0, occurs-2)
amod(drugs-9, ganglionic-4)
conj_or(ganglionic-4, peripheral-6)
amod(drugs-9, adrenergic-7)
nn(drugs-9, blocking-8)
prep_with(occurs-2, drugs-9)

Furosemide/NN may/MD decrease/VB arterial/JJ responsiveness/NN to/TO norepinephrine/NN ./.

(ROOT (S1 (S (S (NP (NN Furosemide)) (VP (MD may) (VP (VB decrease) (NP (NP (JJ arterial) (NN responsiveness)) (PP (TO to) (NP (NN norepinephrine))))))) (. .))))

nsubj(decrease-3, Furosemide-1)
aux(decrease-3, may-2)
root(ROOT-0, decrease-3)
amod(responsiveness-5, arterial-4)
dobj(decrease-3, responsiveness-5)
prep_to(responsiveness-5, norepinephrine-7)

However/RB ,/, norepinephrine/NN may/MD still/RB be/VB used/VBN effectively/RB ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NN norepinephrine)) (VP (MD may) (ADVP (RB still)) (VP (VB be) (VP (VBN used) (ADVP (RB effectively)))))) (. .))))

advmod(used-7, However-1)
nsubjpass(used-7, norepinephrine-3)
aux(used-7, may-4)
advmod(used-7, still-5)
auxpass(used-7, be-6)
root(ROOT-0, used-7)
advmod(used-7, effectively-8)

Tablets/NNS Simultaneous/JJ administration/NN of/IN sucralfate/NN and/CC furosemide/NN tablets/NNS may/MD reduce/VB the/DT natriuretic/JJ and/CC antihypertensive/JJ effects/NNS of/IN furosemide/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Tablets) (JJ Simultaneous) (NN administration)) (PP (IN of) (NP (NP (NP (NN sucralfate)) (CC and) (NP (NN furosemide))) (NNS tablets)))) (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (ADJP (ADJP (JJ natriuretic)) (CC and) (ADJP (JJ antihypertensive))) (NNS effects)) (PP (IN of) (NP (NN furosemide))))))) (. .))))

nn(administration-3, Tablets-1)
amod(administration-3, Simultaneous-2)
nsubj(reduce-10, administration-3)
nn(tablets-8, sucralfate-5)
conj_and(sucralfate-5, furosemide-7)
prep_of(administration-3, tablets-8)
aux(reduce-10, may-9)
root(ROOT-0, reduce-10)
det(effects-15, the-11)
amod(effects-15, natriuretic-12)
conj_and(natriuretic-12, antihypertensive-14)
dobj(reduce-10, effects-15)
prep_of(effects-15, furosemide-17)

Patients/NNS receiving/VBG both/DT drugs/NNS should/MD be/VB observed/VBN closely/RB to/TO determine/VB if/IN the/DT desired/JJ diuretic/JJ and/or/CC antihypertensive/JJ effect/NN of/IN furosemide/NN is/VBZ achieved/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (DT both) (NNS drugs)))) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (NP (DT the) (JJ desired) (ADJP (ADJP (JJ diuretic)) (CC and/or) (ADJP (JJ antihypertensive))) (NN effect)) (PP (IN of) (NP (NN furosemide)))) (VP (VBZ is) (VP (VBN achieved)))))))))))) (. .))))

nsubjpass(observed-7, Patients-1)
partmod(Patients-1, receiving-2)
det(drugs-4, both-3)
dobj(receiving-2, drugs-4)
aux(observed-7, should-5)
auxpass(observed-7, be-6)
root(ROOT-0, observed-7)
advmod(observed-7, closely-8)
aux(determine-10, to-9)
xcomp(observed-7, determine-10)
mark(achieved-21, if-11)
det(effect-17, the-12)
amod(effect-17, desired-13)
amod(effect-17, diuretic-14)
conj_and/or(diuretic-14, antihypertensive-16)
nsubjpass(achieved-21, effect-17)
prep_of(effect-17, furosemide-19)
auxpass(achieved-21, is-20)
advcl(determine-10, achieved-21)

The/DT intake/NN of/IN furosemide/NN and/CC sucralfate/NN should/MD be/VB separated/VBN by/IN at/IN least/JJS two/CD hours/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN intake)) (PP (IN of) (NP (NP (NN furosemide)) (CC and) (NP (NN sucralfate))))) (VP (MD should) (VP (VB be) (VP (VBN separated) (PP (IN by) (NP (QP (IN at) (JJS least) (CD two)) (NNS hours))))))) (. .))))

det(intake-2, The-1)
nsubjpass(separated-9, intake-2)
prep_of(intake-2, furosemide-4)
conj_and(furosemide-4, sucralfate-6)
aux(separated-9, should-7)
auxpass(separated-9, be-8)
root(ROOT-0, separated-9)
quantmod(two-13, at-11)
mwe(at-11, least-12)
pobj(at-11, least-12)
num(hours-14, two-13)
agent(separated-9, hours-14)

Tablets/NNS ,/, Injection/NN ,/, and/CC Oral/JJ Solution/NN One/CD study/NN in/IN six/CD subjects/NNS demonstrated/VBD that/IN the/DT combination/NN of/IN furosemide/NN and/CC acetylsalicylic/JJ acid/NN temporarily/RB reduced/VBD creatinine/NN clearance/NN in/IN patients/NNS with/IN chronic/JJ renal/JJ insufficiency/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Tablets)) (, ,) (NP (NN Injection)) (, ,) (CC and) (NP (JJ Oral) (NN Solution) (CD One) (NN study))) (PP (IN in) (NP (CD six) (NNS subjects)))) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NP (NN furosemide)) (CC and) (NP (JJ acetylsalicylic) (NN acid))))) (ADVP (RB temporarily)) (VP (VBD reduced) (NP (NN creatinine) (NN clearance)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ chronic) (JJ renal) (NN insufficiency)))))))))) (. .))))

nsubj(demonstrated-13, Tablets-1)
conj_and(Tablets-1, Injection-3)
amod(study-9, Oral-6)
nn(study-9, Solution-7)
num(study-9, One-8)
conj_and(Tablets-1, study-9)
num(subjects-12, six-11)
prep_in(Tablets-1, subjects-12)
root(ROOT-0, demonstrated-13)
complm(reduced-23, that-14)
det(combination-16, the-15)
nsubj(reduced-23, combination-16)
prep_of(combination-16, furosemide-18)
amod(acid-21, acetylsalicylic-20)
conj_and(furosemide-18, acid-21)
advmod(reduced-23, temporarily-22)
ccomp(demonstrated-13, reduced-23)
nn(clearance-25, creatinine-24)
dobj(reduced-23, clearance-25)
prep_in(reduced-23, patients-27)
amod(insufficiency-31, chronic-29)
amod(insufficiency-31, renal-30)
prep_with(patients-27, insufficiency-31)

There/EX are/VBP case/NN reports/NNS of/IN patients/NNS who/WP developed/VBD increased/VBN BUN/NN ,/, serum/NN creatinine/NN and/CC serum/NN potassium/NN levels/NNS ,/, and/CC weight/NN gain/NN when/WRB furosemide/NN was/VBD used/VBN in/IN conjunction/NN with/IN NSAIDs/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP are) (NP (NP (NN case) (NNS reports)) (PP (IN of) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD developed) (NP (NP (VBN increased) (NP (NP (NN BUN)) (, ,) (NP (NN serum) (NN creatinine)) (CC and) (NP (NN serum) (NN potassium) (NNS levels)))) (, ,) (CC and) (NP (NN weight) (NN gain))) (SBAR (WHADVP (WRB when)) (S (NP (NN furosemide)) (VP (VBD was) (VP (VBN used) (PP (IN in) (NP (NP (NN conjunction)) (PP (IN with) (NP (NNS NSAIDs))))))))))))))))) (. .))))

expl(are-2, There-1)
root(ROOT-0, are-2)
nn(reports-4, case-3)
nsubj(are-2, reports-4)
prep_of(reports-4, patients-6)
nsubj(developed-8, patients-6)
rcmod(patients-6, developed-8)
amod(BUN-10, increased-9)
dobj(developed-8, BUN-10)
nn(creatinine-13, serum-12)
conj_and(BUN-10, creatinine-13)
nn(levels-17, serum-15)
nn(levels-17, potassium-16)
conj_and(BUN-10, levels-17)
nn(gain-21, weight-20)
conj_and(BUN-10, gain-21)
advmod(used-25, when-22)
nsubjpass(used-25, furosemide-23)
auxpass(used-25, was-24)
advcl(developed-8, used-25)
prep_in(used-25, conjunction-27)
prep_with(conjunction-27, NSAIDs-29)

Literature/NN reports/NNS indicate/VBP that/IN coadministration/NN of/IN indomethacin/NN may/MD reduce/VB the/DT natriuretic/JJ and/CC antihypertensive/JJ effects/NNS of/IN furosemide/NN in/IN some/DT patients/NNS by/IN inhibiting/VBG prostaglandin/NN synthesis/NN ./.

(ROOT (S1 (S (S (NP (NN Literature) (NNS reports)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (NN coadministration)) (PP (IN of) (NP (NN indomethacin)))) (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (ADJP (ADJP (JJ natriuretic)) (CC and) (ADJP (JJ antihypertensive))) (NNS effects)) (PP (IN of) (NP (NN furosemide))) (PP (IN in) (NP (DT some) (NNS patients)))) (PP (IN by) (S (VP (VBG inhibiting) (NP (NN prostaglandin) (NN synthesis))))))))))) (. .))))

nn(reports-2, Literature-1)
nsubj(indicate-3, reports-2)
root(ROOT-0, indicate-3)
complm(reduce-9, that-4)
nsubj(reduce-9, coadministration-5)
prep_of(coadministration-5, indomethacin-7)
aux(reduce-9, may-8)
ccomp(indicate-3, reduce-9)
det(effects-14, the-10)
amod(effects-14, natriuretic-11)
conj_and(natriuretic-11, antihypertensive-13)
dobj(reduce-9, effects-14)
prep_of(effects-14, furosemide-16)
det(patients-19, some-18)
prep_in(effects-14, patients-19)
prepc_by(reduce-9, inhibiting-21)
nn(synthesis-23, prostaglandin-22)
dobj(inhibiting-21, synthesis-23)

Indomethacin/NN may/MD also/RB affect/VB plasma/NN renin/NN levels/NNS ,/, aldosterone/NN excretion/NN ,/, and/CC renin/NN profile/NN evaluation/NN ./.

(ROOT (S1 (S (S (NP (NN Indomethacin)) (VP (MD may) (ADVP (RB also)) (VP (VB affect) (NP (NP (NN plasma) (NN renin) (NNS levels)) (, ,) (NP (NN aldosterone) (NN excretion)) (, ,) (CC and) (NP (NN renin) (NN profile) (NN evaluation)))))) (. .))))

nsubj(affect-4, Indomethacin-1)
aux(affect-4, may-2)
advmod(affect-4, also-3)
root(ROOT-0, affect-4)
nn(levels-7, plasma-5)
nn(levels-7, renin-6)
dobj(affect-4, levels-7)
nn(excretion-10, aldosterone-9)
conj_and(levels-7, excretion-10)
nn(evaluation-15, renin-13)
nn(evaluation-15, profile-14)
conj_and(levels-7, evaluation-15)

Patients/NNS receiving/VBG both/CC indomethacin/NN and/CC furosemide/NN should/MD be/VB observed/VBN closely/RB to/TO determine/VB if/IN the/DT desired/JJ diuretic/JJ and/or/CC antihypertensive/JJ effect/NN of/IN furosemide/NN is/VBZ achieved/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (CC both) (NP (NN indomethacin)) (CC and) (NP (NN furosemide))))) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (NP (DT the) (JJ desired) (ADJP (ADJP (JJ diuretic)) (CC and/or) (ADJP (JJ antihypertensive))) (NN effect)) (PP (IN of) (NP (NN furosemide)))) (VP (VBZ is) (VP (VBN achieved)))))))))))) (. .))))

nsubjpass(observed-9, Patients-1)
partmod(Patients-1, receiving-2)
preconj(indomethacin-4, both-3)
dobj(receiving-2, indomethacin-4)
conj_and(indomethacin-4, furosemide-6)
aux(observed-9, should-7)
auxpass(observed-9, be-8)
root(ROOT-0, observed-9)
advmod(observed-9, closely-10)
aux(determine-12, to-11)
xcomp(observed-9, determine-12)
mark(achieved-23, if-13)
det(effect-19, the-14)
amod(effect-19, desired-15)
amod(effect-19, diuretic-16)
conj_and/or(diuretic-16, antihypertensive-18)
nsubjpass(achieved-23, effect-19)
prep_of(effect-19, furosemide-21)
auxpass(achieved-23, is-22)
advcl(determine-12, achieved-23)

In/FW vitro/FW studies/NNS were/VBD conducted/VBN to/TO investigate/VB the/DT potential/NN of/IN gabapentin/NN to/TO inhibit/VB the/DT major/JJ cytochrome/NN P450/NN enzymes/NNS (/-LRB- CYP1A2/NN ,/, CYP2A6/NN ,/, CYP2C9/NN ,/, CYP2C19/NN ,/, CYP2D6/NN ,/, CYP2E1/NN ,/, and/CC CYP3A4/NN )/-RRB- that/WDT mediate/VBP drug/NN and/CC xenobiotic/JJ metabolism/NN using/VBG isoform/NN selective/JJ marker/NN substrates/NNS and/CC human/JJ liver/NN microsomal/JJ preparations/NNS ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBD were) (VP (VBN conducted) (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (NN gabapentin))) (S (VP (TO to) (VP (VB inhibit) (NP (NP (NP (DT the) (JJ major) (NN cytochrome) (NN P450) (NNS enzymes)) (PRN (-LRB- -LRB-) (NP (NP (NN CYP1A2)) (, ,) (NP (NN CYP2A6)) (, ,) (NP (NN CYP2C9)) (, ,) (NP (NN CYP2C19)) (, ,) (NP (NN CYP2D6)) (, ,) (NP (NN CYP2E1)) (, ,) (CC and) (NP (NN CYP3A4))) (-RRB- -RRB-))) (SBAR (WHNP (WDT that)) (S (VP (VBP mediate) (NP (NP (NP (NN drug)) (CC and) (NP (JJ xenobiotic) (NN metabolism))) (VP (VBG using) (NP (NP (NN isoform) (JJ selective) (NN marker) (NNS substrates)) (CC and) (NP (JJ human) (NN liver) (JJ microsomal) (NNS preparations))))))))))))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubjpass(conducted-5, studies-3)
xsubj(investigate-7, studies-3)
auxpass(conducted-5, were-4)
root(ROOT-0, conducted-5)
aux(investigate-7, to-6)
xcomp(conducted-5, investigate-7)
det(potential-9, the-8)
dobj(investigate-7, potential-9)
prep_of(potential-9, gabapentin-11)
aux(inhibit-13, to-12)
infmod(potential-9, inhibit-13)
det(enzymes-18, the-14)
amod(enzymes-18, major-15)
nn(enzymes-18, cytochrome-16)
nn(enzymes-18, P450-17)
dobj(inhibit-13, enzymes-18)
nsubj(mediate-36, enzymes-18)
dep(enzymes-18, CYP1A2-20)
conj_and(CYP1A2-20, CYP2A6-22)
conj_and(CYP1A2-20, CYP2C9-24)
conj_and(CYP1A2-20, CYP2C19-26)
conj_and(CYP1A2-20, CYP2D6-28)
conj_and(CYP1A2-20, CYP2E1-30)
conj_and(CYP1A2-20, CYP3A4-33)
rcmod(enzymes-18, mediate-36)
dobj(mediate-36, drug-37)
amod(metabolism-40, xenobiotic-39)
conj_and(drug-37, metabolism-40)
partmod(drug-37, using-41)
nn(substrates-45, isoform-42)
amod(substrates-45, selective-43)
nn(substrates-45, marker-44)
dobj(using-41, substrates-45)
amod(preparations-50, human-47)
nn(preparations-50, liver-48)
amod(preparations-50, microsomal-49)
conj_and(substrates-45, preparations-50)

1/CD mM/NN )/-RRB- was/VBD a/DT slight/JJ degree/NN of/IN inhibition/NN (/-LRB- 14/CD %/NN -30/CD %/NN )/-RRB- of/IN isoform/NN CYP2A6/NN observed/VBN ./.

(ROOT (S1 (S (S (NP (CD 1) (NN mM) (-RRB- -RRB-)) (VP (VBD was) (NP (NP (DT a) (JJ slight) (NN degree)) (PP (IN of) (NP (NP (NP (NN inhibition)) (PRN (-LRB- -LRB-) (NP (CD 14) (NN %) (CD -30) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN isoform) (NN CYP2A6)) (VP (VBN observed))))))))) (. .))))

num(mM-2, 1-1)
nsubj(degree-7, mM-2)
cop(degree-7, was-4)
det(degree-7, a-5)
amod(degree-7, slight-6)
root(ROOT-0, degree-7)
prep_of(degree-7, inhibition-9)
num(%-14, 14-11)
nn(%-14, %-12)
num(%-14, -30-13)
appos(inhibition-9, %-14)
nn(CYP2A6-18, isoform-17)
prep_of(inhibition-9, CYP2A6-18)
partmod(CYP2A6-18, observed-19)

No/DT inhibition/NN of/IN any/DT of/IN the/DT other/JJ isoforms/NNS tested/VBN was/VBD observed/VBN at/IN gabapentin/NN concentrations/NNS up/RB to/TO 171/CD mg/mL/NN (/-LRB- approximately/RB 15/CD times/NNS the/DT Cmax/NN at/IN 3600/CD mg/day/NN )./CD

(ROOT (S1 (S (S (NP (NP (DT No) (NN inhibition)) (PP (IN of) (NP (NP (DT any)) (PP (IN of) (NP (NP (DT the) (JJ other) (NNS isoforms)) (VP (VBN tested))))))) (VP (VBD was) (VP (VBN observed) (PP (IN at) (NP (NP (NN gabapentin) (NNS concentrations)) (ADJP (QP (RB up) (TO to) (CD 171)) (NN mg/mL)))) (PRN (-LRB- -LRB-) (NP (QP (RB approximately) (CD 15)) (NNS times)))))) (NP (NP (DT the) (NN Cmax)) (PP (IN at) (NP (CD 3600) (NN mg/day) (CD -RRB-.)))))))

det(inhibition-2, No-1)
nsubjpass(observed-11, inhibition-2)
prep_of(inhibition-2, any-4)
det(isoforms-8, the-6)
amod(isoforms-8, other-7)
prep_of(any-4, isoforms-8)
partmod(isoforms-8, tested-9)
auxpass(observed-11, was-10)
root(ROOT-0, observed-11)
nn(concentrations-14, gabapentin-13)
prep_at(observed-11, concentrations-14)
quantmod(171-17, up-15)
dep(171-17, to-16)
dep(mg/mL-18, 171-17)
dep(concentrations-14, mg/mL-18)
quantmod(15-21, approximately-20)
num(times-22, 15-21)
dep(observed-11, times-22)
det(Cmax-24, the-23)
dep(observed-11, Cmax-24)
num(mg/day-27, 3600-26)
prep_at(Cmax-24, mg/day-27)
num(mg/day-27, -RRB-.-28)

Gabapentin/NN is/VBZ not/RB appreciably/RB metabolized/VBN nor/CC does/VBZ it/PRP interfere/VB with/IN the/DT metabolism/NN of/IN commonly/RB coadministered/VBN antiepileptic/JJ drugs/NNS ./.

(ROOT (S1 (S (S (S (NP (NN Gabapentin)) (VP (VBZ is) (RB not) (ADVP (RB appreciably)) (VP (VBN metabolized)))) (CC nor) (SINV (VBZ does) (NP (PRP it)) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (ADJP (RB commonly) (VBN coadministered)) (JJ antiepileptic) (NNS drugs)))))))) (. .))))

nsubjpass(metabolized-5, Gabapentin-1)
auxpass(metabolized-5, is-2)
neg(metabolized-5, not-3)
advmod(metabolized-5, appreciably-4)
root(ROOT-0, metabolized-5)
aux(interfere-9, does-7)
nsubj(interfere-9, it-8)
conj_nor(metabolized-5, interfere-9)
det(metabolism-12, the-11)
prep_with(interfere-9, metabolism-12)
advmod(coadministered-15, commonly-14)
amod(drugs-17, coadministered-15)
amod(drugs-17, antiepileptic-16)
prep_of(metabolism-12, drugs-17)

Phenytoin/NN :/: In/IN a/DT single/JJ (/-LRB- 400/CD mg/NN )/-RRB- and/CC multiple/JJ dose/NN (/-LRB- 400/CD mg/NN TID/JJ )/-RRB- study/NN of/IN Neurontin/NN span/NN class=/NN c11/NN @/NN in/IN epileptic/JJ patients/NNS (/-LRB- N=8/NN )/-RRB- maintained/VBN on/IN phenytoin/NN monotherapy/NN for/IN at/IN least/JJS 2/CD months/NNS ,/, gabapentin/NN had/VBD no/DT effect/NN on/IN the/DT steady-state/JJ trough/NN plasma/NN concentrations/NNS of/IN phenytoin/NN and/CC phenytoin/NN had/VBD no/DT effect/NN on/IN gabapentin/NN pharmacokinetics/NNS ./.

(ROOT (S1 (S (NP (NP (NN Phenytoin)) (: :) (S (PP (IN In) (NP (NP (NP (NP (DT a) (ADJP (ADJP (JJ single) (PRN (-LRB- -LRB-) (NP (CD 400) (NN mg)) (-RRB- -RRB-))) (CC and) (ADJP (JJ multiple))) (NN dose)) (PRN (-LRB- -LRB-) (NP (CD 400) (NN mg) (JJ TID)) (-RRB- -RRB-))) (NN study)) (PP (IN of) (NP (NN Neurontin) (NN span) (NN class=) (NN c11) (NN @))) (PP (IN in) (NP (NP (NP (JJ epileptic) (NNS patients)) (PRN (-LRB- -LRB-) (NP (NN N=8)) (-RRB- -RRB-))) (VP (VBN maintained) (PP (IN on) (NP (NN phenytoin) (NN monotherapy))) (PP (IN for) (NP (QP (IN at) (JJS least) (CD 2)) (NNS months)))))))) (, ,) (S (NP (NN gabapentin)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (JJ steady-state) (NN trough) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN phenytoin))))))) (CC and) (S (NP (NN phenytoin)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NN gabapentin) (NNS pharmacokinetics)))))) (. .)))))

root(ROOT-0, Phenytoin-1)
det(dose-12, a-4)
amod(dose-12, single-5)
num(mg-8, 400-7)
dep(single-5, mg-8)
conj_and(single-5, multiple-11)
nn(study-18, dose-12)
num(mg-15, 400-14)
appos(dose-12, mg-15)
amod(mg-15, TID-16)
prep_in(had-42, study-18)
nn(@-24, Neurontin-20)
nn(@-24, span-21)
nn(@-24, class=-22)
nn(@-24, c11-23)
prep_of(study-18, @-24)
amod(patients-27, epileptic-26)
prep_in(study-18, patients-27)
appos(patients-27, N=8-29)
partmod(patients-27, maintained-31)
nn(monotherapy-34, phenytoin-33)
prep_on(maintained-31, monotherapy-34)
quantmod(2-38, at-36)
mwe(at-36, least-37)
pobj(at-36, least-37)
num(months-39, 2-38)
prep_for(maintained-31, months-39)
nsubj(had-42, gabapentin-41)
dep(Phenytoin-1, had-42)
det(effect-44, no-43)
dobj(had-42, effect-44)
det(concentrations-50, the-46)
amod(concentrations-50, steady-state-47)
nn(concentrations-50, trough-48)
nn(concentrations-50, plasma-49)
prep_on(had-42, concentrations-50)
prep_of(concentrations-50, phenytoin-52)
nsubj(had-55, phenytoin-54)
conj_and(had-42, had-55)
det(effect-57, no-56)
dobj(had-55, effect-57)
nn(pharmacokinetics-60, gabapentin-59)
prep_on(had-55, pharmacokinetics-60)

Carbamazepine/NN :/: Steady-state/NN trough/NN plasma/NN carbamazepine/NN and/CC carbamazepine/NN 10/CD ,/, 11/CD epoxide/NN concentrations/NNS were/VBD not/RB affected/VBN by/IN concomitant/JJ gabapentin/NN (/-LRB- 400/CD mg/NN TID/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN Carbamazepine)) (: :) (S (NP (NP (NP (NN Steady-state) (NN trough) (NN plasma) (NN carbamazepine)) (CC and) (NP (NN carbamazepine) (CD 10) (, ,) (CD 11))) (NN epoxide) (NNS concentrations)) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (JJ concomitant) (NN gabapentin)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 400) (NN mg)) (NN TID))))))) (: ;)) (. .)))))

root(ROOT-0, Carbamazepine-1)
nn(carbamazepine-6, Steady-state-3)
nn(carbamazepine-6, trough-4)
nn(carbamazepine-6, plasma-5)
nn(concentrations-13, carbamazepine-6)
conj_and(carbamazepine-6, carbamazepine-8)
num(carbamazepine-8, 10-9)
num(carbamazepine-8, 11-11)
nn(concentrations-13, epoxide-12)
nsubjpass(affected-16, concentrations-13)
auxpass(affected-16, were-14)
neg(affected-16, not-15)
dep(Carbamazepine-1, affected-16)
amod(gabapentin-19, concomitant-18)
agent(affected-16, gabapentin-19)
number(mg-22, 400-21)
amod(TID-23, mg-22)
dep(gabapentin-19, TID-23)

Likewise/RB ,/, gabapentin/NN pharmacokinetics/NNS were/VBD unaltered/JJ by/IN carbamazepine/NN administration/NN ./.

(ROOT (S1 (S (S (ADVP (RB Likewise)) (, ,) (NP (NN gabapentin) (NNS pharmacokinetics)) (VP (VBD were) (ADJP (JJ unaltered) (PP (IN by) (NP (NN carbamazepine) (NN administration)))))) (. .))))

advmod(unaltered-6, Likewise-1)
nn(pharmacokinetics-4, gabapentin-3)
nsubj(unaltered-6, pharmacokinetics-4)
cop(unaltered-6, were-5)
root(ROOT-0, unaltered-6)
nn(administration-9, carbamazepine-8)
prep_by(unaltered-6, administration-9)

Valproic/JJ Acid/NN :/: The/DT mean/JJ steady-state/JJ trough/NN serum/NN valproic/JJ acid/NN concentrations/NNS prior/RB to/TO and/CC during/IN concomitant/JJ gabapentin/NN administration/NN (/-LRB- 400/CD mg/NN TID/NN ;/: ./.

(ROOT (S1 (S (S (NP (JJ Valproic) (NN Acid)) (: :) (NP (NP (NP (DT The) (JJ mean) (JJ steady-state) (NN trough) (NN serum) (NP (JJ valproic) (NN acid)) (NNS concentrations)) (ADVP (ADVP (RB prior)) (PP (TO to) (CC and) (PP (IN during) (NP (JJ concomitant) (NN gabapentin) (NN administration)))))) (-LRB- -LRB-) (NP (ADJP (CD 400) (NN mg)) (NN TID) (: ;)))) (. .))))

amod(Acid-2, Valproic-1)
dep(concentrations-11, Acid-2)
det(concentrations-11, The-4)
amod(concentrations-11, mean-5)
amod(concentrations-11, steady-state-6)
nn(concentrations-11, trough-7)
nn(concentrations-11, serum-8)
amod(acid-10, valproic-9)
nn(concentrations-11, acid-10)
root(ROOT-0, concentrations-11)
advmod(concentrations-11, prior-12)
prep(prior-12, to-13)
conj_and(to-13, during-15)
amod(administration-18, concomitant-16)
nn(administration-18, gabapentin-17)
pobj(during-15, administration-18)
number(mg-21, 400-20)
amod(TID-22, mg-21)
dep(concentrations-11, TID-22)

N=17/NN )/-RRB- were/VBD not/RB different/JJ and/CC neither/DT were/VBD gabapentin/NN pharmacokinetic/JJ parameters/NNS affected/VBN by/IN valproic/JJ acid/NN ./.

(ROOT (S1 (S (S (S (NP (NN N=17) (-RRB- -RRB-)) (VP (VBD were) (RB not) (ADJP (JJ different)))) (CC and) (S (NP (DT neither)) (VP (VBD were) (NP (NP (NN gabapentin) (JJ pharmacokinetic) (NNS parameters)) (VP (VBN affected) (PP (IN by) (NP (JJ valproic) (NN acid)))))))) (. .))))

nsubj(different-5, N=17-1)
cop(different-5, were-3)
neg(different-5, not-4)
root(ROOT-0, different-5)
nsubj(parameters-11, neither-7)
cop(parameters-11, were-8)
nn(parameters-11, gabapentin-9)
amod(parameters-11, pharmacokinetic-10)
conj_and(different-5, parameters-11)
partmod(parameters-11, affected-12)
amod(acid-15, valproic-14)
agent(affected-12, acid-15)

Phenobarbital/NN :/: Estimates/NN of/IN steady-state/JJ pharmacokinetic/JJ parameters/NNS for/IN phenobarbital/NN or/CC gabapentin/NN (/-LRB- 300/CD mg/NN TID/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN Phenobarbital)) (: :) (NP (NP (NP (NN Estimates)) (PP (IN of) (NP (NP (JJ steady-state) (JJ pharmacokinetic) (NNS parameters)) (PP (IN for) (NP (NP (NN phenobarbital)) (CC or) (NP (NN gabapentin))))))) (-LRB- -LRB-) (NP (ADJP (CD 300) (NN mg)) (NN TID) (: ;))) (. .)))))

root(ROOT-0, Phenobarbital-1)
dep(Phenobarbital-1, Estimates-3)
amod(parameters-7, steady-state-5)
amod(parameters-7, pharmacokinetic-6)
prep_of(Estimates-3, parameters-7)
prep_for(parameters-7, phenobarbital-9)
conj_or(phenobarbital-9, gabapentin-11)
number(mg-14, 300-13)
amod(TID-15, mg-14)
dep(Estimates-3, TID-15)

N=12/CD )/-RRB- are/VBP identical/JJ whether/IN the/DT drugs/NNS are/VBP administered/VBN alone/RB or/CC together/RB ./.

(ROOT (S1 (S (S (NP (CD N=12) (-RRB- -RRB-)) (VP (VBP are) (ADJP (JJ identical) (SBAR (IN whether) (S (NP (DT the) (NNS drugs)) (VP (VBP are) (VP (VBN administered) (ADVP (ADVP (RB alone)) (CC or) (ADVP (RB together)))))))))) (. .))))

nsubj(identical-4, N=12-1)
cop(identical-4, are-3)
root(ROOT-0, identical-4)
complm(administered-9, whether-5)
det(drugs-7, the-6)
nsubjpass(administered-9, drugs-7)
auxpass(administered-9, are-8)
ccomp(identical-4, administered-9)
advmod(administered-9, alone-10)
conj_or(alone-10, together-12)

Naproxen/NN :/: Coadministration/NN (/-LRB- N=18/NN )/-RRB- of/IN naproxen/NN sodium/NN capsules/NNS (/-LRB- 250/CD mg/NN )/-RRB- with/IN Neurontin/NN span/NN class=/NN c11/NN @/NN (/-LRB- 125/CD mg/NN )/-RRB- appears/VBZ to/TO increase/VB the/DT amount/NN of/IN gabapentin/NN absorbed/VBN by/IN 12/CD %/NN to/TO 15/CD %./NN

(ROOT (S1 (S (NP (NP (NN Naproxen)) (: :) (S (NP (NP (NP (NN Coadministration)) (PRN (-LRB- -LRB-) (NP (NN N=18)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN naproxen) (NN sodium) (NNS capsules)) (PRN (-LRB- -LRB-) (NP (CD 250) (NN mg)) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (NN Neurontin) (NN span) (NN class=) (NN c11) (NN @)) (PRN (-LRB- -LRB-) (NP (CD 125) (NN mg)) (-RRB- -RRB-))))) (VP (VBZ appears) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN gabapentin))) (VP (VBN absorbed) (PP (IN by) (NP (QP (CD 12) (NN %) (TO to) (CD 15)) (NN %.))))))))))))))

root(ROOT-0, Naproxen-1)
nsubj(appears-25, Coadministration-3)
xsubj(increase-27, Coadministration-3)
appos(Coadministration-3, N=18-5)
nn(capsules-10, naproxen-8)
nn(capsules-10, sodium-9)
prep_of(Coadministration-3, capsules-10)
num(mg-13, 250-12)
appos(capsules-10, mg-13)
nn(@-20, Neurontin-16)
nn(@-20, span-17)
nn(@-20, class=-18)
nn(@-20, c11-19)
prep_with(Coadministration-3, @-20)
num(mg-23, 125-22)
appos(@-20, mg-23)
dep(Naproxen-1, appears-25)
aux(increase-27, to-26)
xcomp(appears-25, increase-27)
det(amount-29, the-28)
dobj(increase-27, amount-29)
prep_of(amount-29, gabapentin-31)
partmod(amount-29, absorbed-32)
number(%-35, 12-34)
num(%.-38, %-35)
dep(%-35, to-36)
number(%-35, 15-37)
agent(absorbed-32, %.-38)

Gabapentin/NN had/VBD no/DT effect/NN on/IN naproxen/JJ pharmacokinetic/JJ parameters/NNS ./.

(ROOT (S1 (S (S (NP (NN Gabapentin)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (JJ naproxen) (JJ pharmacokinetic) (NNS parameters))))) (. .))))

nsubj(had-2, Gabapentin-1)
root(ROOT-0, had-2)
det(effect-4, no-3)
dobj(had-2, effect-4)
amod(parameters-8, naproxen-6)
amod(parameters-8, pharmacokinetic-7)
prep_on(had-2, parameters-8)

These/DT doses/NNS are/VBP lower/JJR than/IN the/DT therapeutic/JJ doses/NNS for/IN both/DT drugs/NNS ./.

(ROOT (S1 (S (S (NP (DT These) (NNS doses)) (VP (VBP are) (ADJP (ADJP (JJR lower)) (PP (IN than) (NP (NP (DT the) (JJ therapeutic) (NNS doses)) (PP (IN for) (NP (DT both) (NNS drugs)))))))) (. .))))

det(doses-2, These-1)
nsubj(lower-4, doses-2)
cop(lower-4, are-3)
root(ROOT-0, lower-4)
det(doses-8, the-6)
amod(doses-8, therapeutic-7)
prep_than(lower-4, doses-8)
det(drugs-11, both-10)
prep_for(doses-8, drugs-11)

The/DT magnitude/NN of/IN interaction/NN within/IN the/DT recommended/VBN dose/NN ranges/NNS of/IN either/DT drug/NN is/VBZ not/RB known/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN magnitude)) (PP (IN of) (NP (NN interaction))) (PP (IN within) (NP (NP (DT the) (VBN recommended) (NN dose) (NNS ranges)) (PP (IN of) (NP (DT either) (NN drug)))))) (VP (VBZ is) (RB not) (VP (VBN known)))) (. .))))

det(magnitude-2, The-1)
nsubjpass(known-15, magnitude-2)
prep_of(magnitude-2, interaction-4)
det(ranges-9, the-6)
amod(ranges-9, recommended-7)
nn(ranges-9, dose-8)
prep_within(magnitude-2, ranges-9)
det(drug-12, either-11)
prep_of(ranges-9, drug-12)
auxpass(known-15, is-13)
neg(known-15, not-14)
root(ROOT-0, known-15)

Hydrocodone/NN :/: Coadministration/NN of/IN Neurontin/NN @/NN (/-LRB- 125/CD to/TO 500/CD mg/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN Hydrocodone)) (: :) (NP (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN Neurontin) (NN @)))) (-LRB- -LRB-) (NP (NP (QP (CD 125) (TO to) (CD 500)) (NN mg)) (: ;))) (. .)))))

root(ROOT-0, Hydrocodone-1)
dep(Hydrocodone-1, Coadministration-3)
nn(@-6, Neurontin-5)
prep_of(Coadministration-3, @-6)
number(500-10, 125-8)
dep(500-10, to-9)
num(mg-11, 500-10)
dep(Coadministration-3, mg-11)

N=48/NN )/-RRB- decreases/VBZ hydrocodone/NN (/-LRB- 10/CD mg/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN N=48) (-RRB- -RRB-)) (VP (VBZ decreases) (NP (NP (NN hydrocodone)) (-LRB- -LRB-) (NP (CD 10) (NN mg)))) (: ;)) (. .))))

nsubj(decreases-3, N=48-1)
root(ROOT-0, decreases-3)
dobj(decreases-3, hydrocodone-4)
iobj(decreases-3, hydrocodone-4)
num(mg-7, 10-6)
dep(hydrocodone-4, mg-7)

N=50/CD )/-RRB- Cmax/NN and/CC AUC/NN values/NNS in/IN a/DT dose-dependent/JJ manner/NN relative/JJ to/TO administration/NN of/IN hydrocodon/NN e/NN alone/RB ;/: ./.

(ROOT (S1 (S (S (LST (CD N=50) (-RRB- -RRB-)) (NP (NP (NN Cmax)) (CC and) (NP (NN AUC))) (VP (NNS values) (PP (IN in) (NP (NP (DT a) (JJ dose-dependent) (NN manner)) (ADJP (JJ relative) (PP (TO to) (NP (NP (NN administration)) (PP (IN of) (NP (NP (NN hydrocodon) (NN e)) (ADVP (RB alone)))))))))) (: ;)) (. .))))

dep(values-6, N=50-1)
nsubj(values-6, Cmax-3)
conj_and(Cmax-3, AUC-5)
root(ROOT-0, values-6)
det(manner-10, a-8)
amod(manner-10, dose-dependent-9)
prep_in(values-6, manner-10)
amod(manner-10, relative-11)
prep_to(relative-11, administration-13)
nn(e-16, hydrocodon-15)
prep_of(administration-13, e-16)
advmod(e-16, alone-17)

Hydrocodone/NN increases/VBZ gabapentin/NN AUC/NN values/NNS by/IN 14/CD %./NN

(ROOT (S1 (S (NP (NN Hydrocodone)) (VP (VBZ increases) (NP (NN gabapentin) (NN AUC) (NNS values)) (PP (IN by) (NP (CD 14) (NN %.)))))))

nsubj(increases-2, Hydrocodone-1)
root(ROOT-0, increases-2)
nn(values-5, gabapentin-3)
nn(values-5, AUC-4)
dobj(increases-2, values-5)
num(%.-8, 14-7)
prep_by(increases-2, %.-8)

Morphine/NN :/: A/DT literature/NN article/NN reported/VBD that/IN when/WRB a/DT 60-mg/JJ controlled-release/JJ morphine/NN capsule/NN was/VBD administered/VBN 2/CD hours/NNS prior/RB to/TO a/DT 600-mg/JJ Neurontin/NN @/NN capsule/NN (/-LRB- N=12/NN )/-RRB- ,/, mean/JJ gabapentin/NN AUC/NN increased/VBD by/IN 44/CD %/NN compared/VBN to/TO gabapentin/NN administered/VBN without/IN morphine/NN ./.

(ROOT (S1 (S (NP (NP (NN Morphine)) (: :) (S (NP (DT A) (NN literature) (NN article)) (VP (VBD reported) (SBAR (IN that) (S (SBAR (WHADVP (WRB when)) (S (NP (DT a) (JJ 60-mg) (JJ controlled-release) (NN morphine) (NN capsule)) (VP (VBD was) (VP (VBN administered) (ADVP (NP (CD 2) (NNS hours)) (RB prior)) (PP (TO to) (NP (NP (DT a) (JJ 600-mg) (NN Neurontin) (NN @) (NN capsule)) (PRN (-LRB- -LRB-) (NP (NN N=12)) (-RRB- -RRB-)))))))) (, ,) (NP (JJ mean) (NN gabapentin) (NN AUC)) (VP (VBD increased) (PP (IN by) (NP (CD 44) (NN %))) (PP (VBN compared) (PP (TO to) (NP (NP (NN gabapentin)) (VP (VBN administered) (PP (IN without) (NP (NN morphine)))))))))))) (. .)))))

root(ROOT-0, Morphine-1)
det(article-5, A-3)
nn(article-5, literature-4)
nsubj(reported-6, article-5)
dep(Morphine-1, reported-6)
complm(increased-32, that-7)
advmod(administered-15, when-8)
det(capsule-13, a-9)
amod(capsule-13, 60-mg-10)
amod(capsule-13, controlled-release-11)
nn(capsule-13, morphine-12)
nsubjpass(administered-15, capsule-13)
auxpass(administered-15, was-14)
advcl(increased-32, administered-15)
num(hours-17, 2-16)
npadvmod(administered-15, hours-17)
det(capsule-24, a-20)
amod(capsule-24, 600-mg-21)
nn(capsule-24, Neurontin-22)
nn(capsule-24, @-23)
prep_prior_to(administered-15, capsule-24)
appos(capsule-24, N=12-26)
amod(AUC-31, mean-29)
nn(AUC-31, gabapentin-30)
nsubj(increased-32, AUC-31)
ccomp(reported-6, increased-32)
num(%-35, 44-34)
prep_by(increased-32, %-35)
prepc_compared_to(increased-32, to-37)
pobj(increased-32, gabapentin-38)
partmod(gabapentin-38, administered-39)
prep_without(administered-39, morphine-41)

Morphine/NN pharmacokinetic/JJ parameter/NN values/NNS were/VBD not/RB affected/VBN by/IN administration/NN of/IN Neurontin/NN @/NN 2/CD hours/NNS after/IN morphine/NN ./.

(ROOT (S1 (S (S (NP (NN Morphine) (JJ pharmacokinetic) (NN parameter) (NNS values)) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (NN administration)) (PP (IN of) (NP (NN Neurontin) (NN @) (CD 2) (NNS hours))) (PP (IN after) (NP (NN morphine)))))))) (. .))))

nn(values-4, Morphine-1)
amod(values-4, pharmacokinetic-2)
nn(values-4, parameter-3)
nsubjpass(affected-7, values-4)
auxpass(affected-7, were-5)
neg(affected-7, not-6)
root(ROOT-0, affected-7)
agent(affected-7, administration-9)
nn(hours-14, Neurontin-11)
nn(hours-14, @-12)
num(hours-14, 2-13)
prep_of(administration-9, hours-14)
prep_after(administration-9, morphine-16)

Cimetidine/NN :/: In/IN the/DT presence/NN of/IN cimetidine/NN at/IN 300/CD mg/NN QID/JJ (/-LRB- N=12/NN )/-RRB- the/DT mean/JJ apparent/JJ oral/JJ clearance/NN of/IN gabapentin/NN fell/NN by/IN 14/CD %/NN and/CC creatinine/NN clearance/NN fell/VBP by/IN 10/CD %./NN

(ROOT (S1 (S (NP (NP (NN Cimetidine)) (: :) (S (PP (IN In) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN cimetidine))) (PP (IN at) (NP (NP (CD 300) (NN mg) (JJ QID)) (PRN (-LRB- -LRB-) (NP (NN N=12)) (-RRB- -RRB-)))))) (NP (NP (NP (DT the) (JJ mean) (JJ apparent) (JJ oral) (NN clearance)) (PP (IN of) (NP (NN gabapentin) (NN fell))) (PP (IN by) (NP (CD 14) (NN %)))) (CC and) (NP (NN creatinine) (NN clearance))) (VP (VBP fell) (PP (IN by) (NP (CD 10) (NN %.)))))))))

root(ROOT-0, Cimetidine-1)
det(presence-5, the-4)
prep_in(fell-29, presence-5)
prep_of(presence-5, cimetidine-7)
num(mg-10, 300-9)
prep_at(presence-5, mg-10)
amod(mg-10, QID-11)
appos(mg-10, N=12-13)
det(clearance-19, the-15)
amod(clearance-19, mean-16)
amod(clearance-19, apparent-17)
amod(clearance-19, oral-18)
nsubj(fell-29, clearance-19)
nn(fell-22, gabapentin-21)
prep_of(clearance-19, fell-22)
num(%-25, 14-24)
prep_by(clearance-19, %-25)
nn(clearance-28, creatinine-27)
conj_and(clearance-19, clearance-28)
dep(Cimetidine-1, fell-29)
num(%.-32, 10-31)
prep_by(fell-29, %.-32)

Thus/RB cimetidine/NN appeared/VBD to/TO alter/VB the/DT renal/JJ excretion/NN of/IN both/CC gabapentin/NN and/CC creatinine/NN ,/, an/DT endogenous/JJ marker/NN of/IN renal/JJ function/NN ./.

(ROOT (S1 (S (S (ADVP (RB Thus)) (NP (NN cimetidine)) (VP (VBD appeared) (S (VP (TO to) (VP (VB alter) (NP (NP (DT the) (JJ renal) (NN excretion)) (PP (IN of) (NP (NP (CC both) (NP (NN gabapentin)) (CC and) (NP (NN creatinine))) (, ,) (NP (NP (DT an) (JJ endogenous) (NN marker)) (PP (IN of) (NP (JJ renal) (NN function)))))))))))) (. .))))

advmod(appeared-3, Thus-1)
nsubj(appeared-3, cimetidine-2)
xsubj(alter-5, cimetidine-2)
root(ROOT-0, appeared-3)
aux(alter-5, to-4)
xcomp(appeared-3, alter-5)
det(excretion-8, the-6)
amod(excretion-8, renal-7)
dobj(alter-5, excretion-8)
preconj(gabapentin-11, both-10)
prep_of(excretion-8, gabapentin-11)
conj_and(gabapentin-11, creatinine-13)
det(marker-17, an-15)
amod(marker-17, endogenous-16)
appos(gabapentin-11, marker-17)
amod(function-20, renal-19)
prep_of(marker-17, function-20)

This/DT small/JJ decrease/NN in/IN excretion/NN of/IN gabapentin/NN by/IN cimetidine/NN is/VBZ not/RB expected/VBN to/TO be/VB of/IN clinical/JJ importance/NN ./.

(ROOT (S1 (S (S (NP (NP (DT This) (JJ small) (NN decrease)) (PP (IN in) (NP (NP (NN excretion)) (PP (IN of) (NP (NN gabapentin))) (PP (IN by) (NP (NN cimetidine)))))) (VP (VBZ is) (RB not) (VP (VBN expected) (S (VP (TO to) (VP (VB be) (PP (IN of) (NP (JJ clinical) (NN importance))))))))) (. .))))

det(decrease-3, This-1)
amod(decrease-3, small-2)
nsubjpass(expected-12, decrease-3)
xsubj(be-14, decrease-3)
prep_in(decrease-3, excretion-5)
prep_of(excretion-5, gabapentin-7)
prep_by(excretion-5, cimetidine-9)
auxpass(expected-12, is-10)
neg(expected-12, not-11)
root(ROOT-0, expected-12)
aux(be-14, to-13)
xcomp(expected-12, be-14)
amod(importance-17, clinical-16)
prep_of(be-14, importance-17)

The/DT effect/NN of/IN gabapentin/NN on/IN cimetidine/NN was/VBD not/RB evaluated/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN gabapentin))) (PP (IN on) (NP (NN cimetidine)))) (VP (VBD was) (RB not) (VP (VBN evaluated)))) (. .))))

det(effect-2, The-1)
nsubjpass(evaluated-9, effect-2)
prep_of(effect-2, gabapentin-4)
prep_on(effect-2, cimetidine-6)
auxpass(evaluated-9, was-7)
neg(evaluated-9, not-8)
root(ROOT-0, evaluated-9)

Oral/JJ Contraceptive/NN :/: Based/VBN on/IN AUC/NN and/CC half-life/NN ,/, multiple-dose/JJ pharmacokinetic/JJ profiles/NNS of/IN norethindrone/NN and/CC ethinyl/NN estradiol/NN following/VBG administration/NN of/IN tablets/NNS containing/VBG 2.5/CD mg/NN of/IN norethindrone/NN acetate/NN and/CC 50/CD mcg/NN of/IN ethinyl/NN estradiol/NN were/VBD similar/JJ with/IN and/CC without/IN coadministration/NN of/IN gabapentin/NN (/-LRB- 400/CD mg/NN TID/NN ;/: ./.

(ROOT (S1 (S (NP (NP (JJ Oral) (NN Contraceptive)) (: :) (S (PP (VBN Based) (PP (IN on) (NP (NP (NN AUC)) (CC and) (NP (NN half-life))))) (, ,) (NP (NP (JJ multiple-dose) (JJ pharmacokinetic) (NNS profiles)) (PP (IN of) (NP (NP (NP (NN norethindrone)) (CC and) (NP (NN ethinyl) (NN estradiol))) (PP (VBG following) (NP (NP (NN administration)) (PP (IN of) (NP (NP (NNS tablets)) (VP (VBG containing) (NP (NP (NP (CD 2.5) (NN mg)) (PP (IN of) (NP (NN norethindrone) (NN acetate)))) (CC and) (NP (NP (CD 50) (NN mcg)) (PP (IN of) (NP (NN ethinyl) (NN estradiol))))))))))))) (VP (VBD were) (ADJP (JJ similar)) (PP (PP (IN with)) (CC and) (PP (IN without) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NN gabapentin)) (-LRB- -LRB-) (NP (ADJP (CD 400) (NN mg)) (NN TID) (: ;))))))))) (. .)))))

amod(Contraceptive-2, Oral-1)
root(ROOT-0, Contraceptive-2)
prepc_based_on(similar-35, on-5)
pobj(similar-35, AUC-6)
conj_and(AUC-6, half-life-8)
amod(profiles-12, multiple-dose-10)
amod(profiles-12, pharmacokinetic-11)
nsubj(similar-35, profiles-12)
prep_of(profiles-12, norethindrone-14)
nn(estradiol-17, ethinyl-16)
conj_and(norethindrone-14, estradiol-17)
prep_following(norethindrone-14, administration-19)
prep_of(administration-19, tablets-21)
partmod(tablets-21, containing-22)
num(mg-24, 2.5-23)
dobj(containing-22, mg-24)
nn(acetate-27, norethindrone-26)
prep_of(mg-24, acetate-27)
num(mcg-30, 50-29)
conj_and(mg-24, mcg-30)
nn(estradiol-33, ethinyl-32)
prep_of(mcg-30, estradiol-33)
cop(similar-35, were-34)
dep(Contraceptive-2, similar-35)
prep(similar-35, with-36)
conj_and(with-36, without-38)
pobj(without-38, coadministration-39)
prep_of(coadministration-39, gabapentin-41)
number(mg-44, 400-43)
amod(TID-45, mg-44)
dep(gabapentin-41, TID-45)

The/DT Cmax/NN of/IN norethindrone/NN was/VBD 13/CD %/NN higher/JJR when/WRB it/PRP was/VBD coadministered/VBN with/IN gabapentin/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN Cmax)) (PP (IN of) (NP (NN norethindrone)))) (VP (VBD was) (ADJP (NP (CD 13) (NN %)) (JJR higher)) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBD was) (VP (VBN coadministered) (PP (IN with) (NP (NN gabapentin)))))))) (: ;)) (. .))))

det(Cmax-2, The-1)
nsubj(higher-8, Cmax-2)
prep_of(Cmax-2, norethindrone-4)
cop(higher-8, was-5)
num(%-7, 13-6)
npadvmod(higher-8, %-7)
root(ROOT-0, higher-8)
advmod(coadministered-12, when-9)
nsubjpass(coadministered-12, it-10)
auxpass(coadministered-12, was-11)
advcl(higher-8, coadministered-12)
prep_with(coadministered-12, gabapentin-14)

Antacid/JJ (/-LRB- Maalox/NN @/NN )/-RRB- :/: Maalox/NNP reduced/VBD the/DT bioavailability/NN of/IN gabapentin/NN (/-LRB- N=16/NN )/-RRB- by/IN about/RB 20/CD %./NN

(ROOT (S1 (S (NP (NP (NP (JJ Antacid)) (PRN (-LRB- -LRB-) (NP (NN Maalox) (NN @)) (-RRB- -RRB-))) (: :) (NP (NP (NNP Maalox)) (VP (VBD reduced) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (NP (NN gabapentin)) (PRN (-LRB- -LRB-) (NP (NN N=16)) (-RRB- -RRB-))))) (PP (IN by) (NP (QP (RB about) (CD 20)) (NN %.)))))))))

root(ROOT-0, Antacid-1)
nn(@-4, Maalox-3)
appos(Antacid-1, @-4)
dep(Antacid-1, Maalox-7)
partmod(Maalox-7, reduced-8)
det(bioavailability-10, the-9)
dobj(reduced-8, bioavailability-10)
prep_of(bioavailability-10, gabapentin-12)
appos(gabapentin-12, N=16-14)
quantmod(20-18, about-17)
num(%.-19, 20-18)
agent(reduced-8, %.-19)

This/DT decrease/NN in/IN bioavailability/NN was/VBD about/RB 5/CD %/NN when/WRB gabapentin/NN was/VBD administered/VBN 2/CD hours/NNS after/IN Maalox/NN ./.

(ROOT (S1 (S (S (NP (NP (DT This) (NN decrease)) (PP (IN in) (NP (NN bioavailability)))) (VP (VBD was) (NP (QP (RB about) (CD 5)) (NN %)) (SBAR (WHADVP (WRB when)) (S (NP (NN gabapentin)) (VP (VBD was) (VP (VBN administered) (PP (NP (CD 2) (NNS hours)) (IN after) (NP (NN Maalox))))))))) (. .))))

det(decrease-2, This-1)
nsubj(%-8, decrease-2)
prep_in(decrease-2, bioavailability-4)
cop(%-8, was-5)
quantmod(5-7, about-6)
num(%-8, 5-7)
root(ROOT-0, %-8)
advmod(administered-12, when-9)
nsubjpass(administered-12, gabapentin-10)
auxpass(administered-12, was-11)
advcl(%-8, administered-12)
num(hours-14, 2-13)
npadvmod(administered-12, hours-14)
prep_after(administered-12, Maalox-16)

It/PRP is/VBZ recommended/VBN that/IN gabapentin/NN be/VB taken/VBN at/IN least/JJS 2/CD hours/NNS following/VBG Maalox/NN administration/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NN gabapentin)) (VP (VB be) (VP (VBN taken) (PP (NP (QP (IN at) (JJS least) (CD 2)) (NNS hours)) (VBG following) (NP (NN Maalox) (NN administration)))))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(taken-7, that-4)
nsubjpass(taken-7, gabapentin-5)
auxpass(taken-7, be-6)
ccomp(recommended-3, taken-7)
quantmod(2-10, at-8)
mwe(at-8, least-9)
pobj(at-8, least-9)
num(hours-11, 2-10)
dep(taken-7, hours-11)
nn(administration-14, Maalox-13)
prep_following(taken-7, administration-14)

Effect/NN of/IN Probenecid/NN :/: Probenecid/NN is/VBZ a/DT blocker/NN of/IN renal/JJ tubular/JJ secretion/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Effect)) (PP (IN of) (NP (NP (NN Probenecid)) (: :) (NP (NN Probenecid))))) (VP (VBZ is) (NP (NP (DT a) (NN blocker)) (PP (IN of) (NP (JJ renal) (JJ tubular) (NN secretion)))))) (. .))))

nsubj(blocker-8, Effect-1)
prep_of(Effect-1, Probenecid-3)
dep(Probenecid-3, Probenecid-5)
cop(blocker-8, is-6)
det(blocker-8, a-7)
root(ROOT-0, blocker-8)
amod(secretion-12, renal-10)
amod(secretion-12, tubular-11)
prep_of(blocker-8, secretion-12)

Gabapentin/NN pharmacokinetic/JJ parameters/NNS without/IN and/CC with/IN probenecid/NN were/VBD comparable/JJ ./.

(ROOT (S1 (S (S (NP (NP (NN Gabapentin) (JJ pharmacokinetic) (NNS parameters)) (PP (PP (IN without)) (CC and) (PP (IN with) (NP (NN probenecid))))) (VP (VBD were) (ADJP (JJ comparable)))) (. .))))

nn(parameters-3, Gabapentin-1)
amod(parameters-3, pharmacokinetic-2)
nsubj(comparable-9, parameters-3)
prep(parameters-3, without-4)
conj_and(without-4, with-6)
pobj(with-6, probenecid-7)
cop(comparable-9, were-8)
root(ROOT-0, comparable-9)

This/DT indicates/VBZ that/IN gabapentin/NN does/VBZ not/RB undergo/VB renal/JJ tubular/JJ secretion/NN by/IN the/DT pathway/NN that/WDT is/VBZ blocked/VBN by/IN probenecid/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NN gabapentin)) (VP (VBZ does) (RB not) (VP (VB undergo) (NP (JJ renal) (JJ tubular) (NN secretion)) (PP (IN by) (NP (NP (DT the) (NN pathway)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN blocked) (PP (IN by) (NP (NN probenecid))))))))))))))) (. .))))

nsubj(indicates-2, This-1)
root(ROOT-0, indicates-2)
complm(undergo-7, that-3)
nsubj(undergo-7, gabapentin-4)
aux(undergo-7, does-5)
neg(undergo-7, not-6)
ccomp(indicates-2, undergo-7)
amod(secretion-10, renal-8)
amod(secretion-10, tubular-9)
dobj(undergo-7, secretion-10)
det(pathway-13, the-12)
prep_by(undergo-7, pathway-13)
nsubjpass(blocked-16, pathway-13)
auxpass(blocked-16, is-15)
rcmod(pathway-13, blocked-16)
agent(blocked-16, probenecid-18)

Drug/NN /Laboratory/NN Tests/NNS Interactions/NNS :/: Because/IN false/JJ positive/JJ readings/NNS were/VBD reported/VBN with/IN the/DT Ame/NN s/NN N-Multistix/JJ SG/NN span/NN class=/NN c11/NN @/NN dipstick/NN test/NN for/IN urinary/JJ protein/NN when/WRB gabapentin/NN was/VBD added/VBN to/TO other/JJ antiepileptic/JJ drugs/NNS ,/, the/DT more/RBR specific/JJ sulfosalicylic/JJ acid/NN precipitation/NN procedure/NN is/VBZ recommended/VBN to/TO determine/VB the/DT presence/NN of/IN urine/NN protein/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NNS Tests) (NNS Interactions)) (: :) (S (SBAR (IN Because) (S (NP (ADJP (ADJP (JJ false)) (ADJP (JJ positive))) (NNS readings)) (VP (VBD were) (VP (VBN reported) (PP (IN with) (NP (NP (DT the) (NN Ame) (NN s) (JJ N-Multistix) (NN SG) (NN span) (NN class=) (NN c11) (NN @) (NN dipstick) (NN test)) (PP (IN for) (NP (JJ urinary) (NN protein)))))) (SBAR (WHADVP (WRB when)) (S (NP (NN gabapentin)) (VP (VBD was) (VP (VBN added) (PP (TO to) (NP (JJ other) (JJ antiepileptic) (NNS drugs)))))))))) (, ,) (NP (DT the) (ADJP (RBR more) (JJ specific)) (JJ sulfosalicylic) (NN acid) (NN precipitation) (NN procedure)) (VP (VBZ is) (VP (VBN recommended) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN urine) (NN protein)))))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Tests-3)
root(ROOT-0, Interactions-4)
mark(reported-11, Because-6)
amod(readings-9, false-7)
dep(false-7, positive-8)
nsubjpass(reported-11, readings-9)
auxpass(reported-11, were-10)
advcl(recommended-44, reported-11)
det(test-23, the-13)
nn(test-23, Ame-14)
nn(test-23, s-15)
amod(test-23, N-Multistix-16)
nn(test-23, SG-17)
nn(test-23, span-18)
nn(test-23, class=-19)
nn(test-23, c11-20)
nn(test-23, @-21)
nn(test-23, dipstick-22)
prep_with(reported-11, test-23)
amod(protein-26, urinary-25)
prep_for(test-23, protein-26)
advmod(added-30, when-27)
nsubjpass(added-30, gabapentin-28)
auxpass(added-30, was-29)
advcl(reported-11, added-30)
amod(drugs-34, other-32)
amod(drugs-34, antiepileptic-33)
prep_to(added-30, drugs-34)
det(procedure-42, the-36)
advmod(specific-38, more-37)
amod(procedure-42, specific-38)
amod(procedure-42, sulfosalicylic-39)
nn(procedure-42, acid-40)
nn(procedure-42, precipitation-41)
nsubjpass(recommended-44, procedure-42)
xsubj(determine-46, procedure-42)
auxpass(recommended-44, is-43)
dep(Interactions-4, recommended-44)
aux(determine-46, to-45)
xcomp(recommended-44, determine-46)
det(presence-48, the-47)
dobj(determine-46, presence-48)
nn(protein-51, urine-50)
prep_of(presence-48, protein-51)

Administration/NN of/IN repeat/NN doses/NNS of/IN FACTIVE/NN had/VBD no/DT effect/NN on/IN the/DT repeat/NN dose/NN pharmacokinetics/NNS of/IN theophylline/NN ,/, digoxin/NN or/CC an/DT ethinylestradiol/NN /levonorgestrol/NN oral/JJ contraceptive/NN product/NN in/IN healthy/JJ subjects/NNS ./.

(ROOT (S1 (S (NP (NP (NN Administration)) (PP (IN of) (NP (NP (NN repeat) (NNS doses)) (PP (IN of) (NP (NN FACTIVE)))))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN repeat) (NN dose) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN theophylline)) (, ,) (NP (NN digoxin)) (CC or) (NP (NP (DT an) (NN ethinylestradiol) (NN /levonorgestrol) (JJ oral) (NN contraceptive)) (NN product)))) (PP (IN in) (NP (JJ healthy) (NNS subjects)))))) (. .))))

nsubj(had-7, Administration-1)
nn(doses-4, repeat-3)
prep_of(Administration-1, doses-4)
prep_of(doses-4, FACTIVE-6)
root(ROOT-0, had-7)
det(effect-9, no-8)
dobj(had-7, effect-9)
det(pharmacokinetics-14, the-11)
nn(pharmacokinetics-14, repeat-12)
nn(pharmacokinetics-14, dose-13)
prep_on(had-7, pharmacokinetics-14)
prep_of(pharmacokinetics-14, theophylline-16)
conj_or(theophylline-16, digoxin-18)
det(contraceptive-24, an-20)
nn(contraceptive-24, ethinylestradiol-21)
nn(contraceptive-24, /levonorgestrol-22)
amod(contraceptive-24, oral-23)
nn(product-25, contraceptive-24)
conj_or(theophylline-16, product-25)
amod(subjects-28, healthy-27)
prep_in(pharmacokinetics-14, subjects-28)

Concomitant/JJ administration/NN of/IN FACTIVE/NN and/CC calcium/NN carbonate/NN ,/, cimetidine/NN ,/, omeprazole/NN ,/, or/CC an/DT estrogen/NN //: progesterone/NN oral/JJ contraceptive/NN produced/VBD minor/JJ changes/NNS in/IN the/DT pharmacokinetics/NNS of/IN gemifloxacin/NN ,/, which/WDT were/VBD considered/VBN to/TO be/VB without/IN clinical/JJ significance/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN FACTIVE)) (CC and) (NP (NP (NN calcium) (NN carbonate)) (, ,) (NP (NP (NN cimetidine)) (, ,) (NP (NN omeprazole)) (, ,) (CC or) (NP (DT an) (NN estrogen) (: /) (NN progesterone) (JJ oral) (NN contraceptive))))))) (VP (VBD produced) (NP (NP (JJ minor) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN gemifloxacin))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (PP (IN without) (NP (JJ clinical) (NN significance))))))))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubj(produced-20, administration-2)
prep_of(administration-2, FACTIVE-4)
nn(carbonate-7, calcium-6)
conj_and(FACTIVE-4, carbonate-7)
appos(carbonate-7, cimetidine-9)
conj_or(cimetidine-9, omeprazole-11)
det(contraceptive-19, an-14)
nn(contraceptive-19, estrogen-15)
punct(contraceptive-19, /-16)
nn(contraceptive-19, progesterone-17)
amod(contraceptive-19, oral-18)
conj_or(cimetidine-9, contraceptive-19)
root(ROOT-0, produced-20)
amod(changes-22, minor-21)
dobj(produced-20, changes-22)
nsubjpass(considered-31, changes-22)
det(pharmacokinetics-25, the-24)
prep_in(changes-22, pharmacokinetics-25)
prep_of(pharmacokinetics-25, gemifloxacin-27)
auxpass(considered-31, were-30)
rcmod(changes-22, considered-31)
aux(be-33, to-32)
xcomp(considered-31, be-33)
amod(significance-36, clinical-35)
prep_without(be-33, significance-36)

Concomitant/JJ administration/NN of/IN FACTIVE/NN with/IN probenecid/NN resulted/VBD in/IN a/DT 45/CD %/NN increase/NN in/IN systemic/JJ exposure/NN to/TO gemifloxacin/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NN FACTIVE))) (PP (IN with) (NP (NN probenecid)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (ADJP (CD 45) (NN %)) (NN increase)) (PP (IN in) (NP (NP (JJ systemic) (NN exposure)) (PP (TO to) (NP (NN gemifloxacin))))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubj(resulted-7, administration-2)
prep_of(administration-2, FACTIVE-4)
prep_with(administration-2, probenecid-6)
root(ROOT-0, resulted-7)
det(increase-12, a-9)
number(%-11, 45-10)
amod(increase-12, %-11)
prep_in(resulted-7, increase-12)
amod(exposure-15, systemic-14)
prep_in(increase-12, exposure-15)
prep_to(exposure-15, gemifloxacin-17)

FACTIVE/NN had/VBD no/DT significant/JJ effect/NN on/IN the/DT anticoagulant/JJ effect/NN of/IN warfarin/NN in/IN healthy/JJ subjects/NNS on/IN stable/JJ warfarin/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NN FACTIVE)) (VP (VBD had) (NP (DT no) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (DT the) (JJ anticoagulant) (NN effect)) (PP (IN of) (NP (NP (NN warfarin)) (PP (IN in) (NP (JJ healthy) (NNS subjects))))) (PP (IN on) (NP (JJ stable) (NN warfarin) (NN therapy))))))) (. .))))

nsubj(had-2, FACTIVE-1)
root(ROOT-0, had-2)
det(effect-5, no-3)
amod(effect-5, significant-4)
dobj(had-2, effect-5)
det(effect-9, the-7)
amod(effect-9, anticoagulant-8)
prep_on(had-2, effect-9)
prep_of(effect-9, warfarin-11)
amod(subjects-14, healthy-13)
prep_in(warfarin-11, subjects-14)
amod(therapy-18, stable-16)
nn(therapy-18, warfarin-17)
prep_on(effect-9, therapy-18)

However/RB ,/, because/IN some/DT quinolones/NNS have/VBP been/VBN reported/VBN to/TO enhance/VB the/DT anticoagulant/JJ effects/NNS of/IN warfarin/NN or/CC its/PRP$ derivatives/NNS in/IN patients/NNS ,/, the/DT prothrombin/NN time/NN or/CC other/JJ suitable/JJ coagulation/NN test/NN should/MD be/VB closely/RB monitored/VBN if/IN a/DT quinolone/JJ antimicrobial/NN is/VBZ administered/VBN concomitantly/RB with/IN warfarin/NN or/CC its/PRP$ derivatives/NNS ./.

(ROOT (S1 (S (ADVP (RB However)) (, ,) (SBAR (IN because) (S (NP (DT some) (NNS quinolones)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB enhance) (NP (NP (DT the) (JJ anticoagulant) (NNS effects)) (PP (IN of) (NP (NP (NN warfarin)) (CC or) (NP (PRP$ its) (NNS derivatives)))) (PP (IN in) (NP (NNS patients)))))))))))) (, ,) (NP (NP (DT the) (NN prothrombin) (NN time)) (CC or) (NP (JJ other) (JJ suitable) (NN coagulation) (NN test))) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN monitored) (SBAR (IN if) (S (NP (DT a) (JJ quinolone) (NN antimicrobial)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NN warfarin)) (CC or) (NP (PRP$ its) (NNS derivatives))))))))))) (. .))))

advmod(monitored-33, However-1)
mark(reported-8, because-3)
det(quinolones-5, some-4)
nsubjpass(reported-8, quinolones-5)
xsubj(enhance-10, quinolones-5)
aux(reported-8, have-6)
auxpass(reported-8, been-7)
advcl(monitored-33, reported-8)
aux(enhance-10, to-9)
xcomp(reported-8, enhance-10)
det(effects-13, the-11)
amod(effects-13, anticoagulant-12)
dobj(enhance-10, effects-13)
prep_of(effects-13, warfarin-15)
poss(derivatives-18, its-17)
conj_or(warfarin-15, derivatives-18)
prep_in(effects-13, patients-20)
det(time-24, the-22)
nn(time-24, prothrombin-23)
nsubjpass(monitored-33, time-24)
amod(test-29, other-26)
amod(test-29, suitable-27)
nn(test-29, coagulation-28)
conj_or(time-24, test-29)
aux(monitored-33, should-30)
auxpass(monitored-33, be-31)
advmod(monitored-33, closely-32)
root(ROOT-0, monitored-33)
mark(administered-39, if-34)
det(antimicrobial-37, a-35)
amod(antimicrobial-37, quinolone-36)
nsubjpass(administered-39, antimicrobial-37)
auxpass(administered-39, is-38)
advcl(monitored-33, administered-39)
advmod(administered-39, concomitantly-40)
prep_with(administered-39, warfarin-42)
poss(derivatives-45, its-44)
conj_or(warfarin-42, derivatives-45)

Quinolones/NNS form/VBP chelates/NNS with/IN alkaline/NN earth/NN and/CC transition/NN metals/NNS ./.

(ROOT (S1 (S (S (NP (NNS Quinolones)) (VP (VBP form) (NP (NNS chelates)) (PP (IN with) (NP (NP (NN alkaline) (NN earth)) (CC and) (NP (NN transition) (NNS metals)))))) (. .))))

nsubj(form-2, Quinolones-1)
root(ROOT-0, form-2)
dobj(form-2, chelates-3)
nn(earth-6, alkaline-5)
prep_with(form-2, earth-6)
nn(metals-9, transition-8)
conj_and(earth-6, metals-9)

The/DT absorption/NN of/IN oral/JJ gemifloxacin/NN is/VBZ significantly/RB reduced/VBN by/IN the/DT concomitant/JJ administration/NN of/IN an/DT antacid/JJ containing/VBG aluminum/NN and/CC magnesium/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN absorption)) (PP (IN of) (NP (JJ oral) (NN gemifloxacin)))) (VP (VBZ is) (VP (ADVP (RB significantly)) (VBN reduced) (PP (IN by) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (DT an) (JJ antacid)) (VP (VBG containing) (NP (NP (NN aluminum)) (CC and) (NP (NN magnesium))))))))))) (. .))))

det(absorption-2, The-1)
nsubjpass(reduced-8, absorption-2)
amod(gemifloxacin-5, oral-4)
prep_of(absorption-2, gemifloxacin-5)
auxpass(reduced-8, is-6)
advmod(reduced-8, significantly-7)
root(ROOT-0, reduced-8)
det(administration-12, the-10)
amod(administration-12, concomitant-11)
agent(reduced-8, administration-12)
det(antacid-15, an-14)
prep_of(administration-12, antacid-15)
partmod(antacid-15, containing-16)
dobj(containing-16, aluminum-17)
conj_and(aluminum-17, magnesium-19)

Magnesium/NN -/: and/or/CC aluminum-containing/JJ antacids/NNS ,/, products/NNS containing/VBG ferrous/JJ sulfate/NN (/-LRB- iron/NN )/-RRB- ,/, multivitamin/NN preparations/NNS containing/VBG zinc/NN or/CC other/JJ metal/JJ cations/NNS ,/, or/CC Videx/NN (/-LRB- didanosine/NN )/-RRB- chewable//JJ buffer/NN ed/NN tablets/NNS or/CC the/DT pediatric/JJ powder/NN for/IN oral/JJ solution/NN should/MD not/RB be/VB taken/VBN within/IN 3/CD hours/NNS before/IN or/CC 2/CD hours/NNS after/IN FACTIVE/NN ./.

(ROOT (S1 (S (NP (NP (NN Magnesium)) (: -) (S (NP (CC and/or) (NP (NP (JJ aluminum-containing) (NNS antacids)) (, ,) (NP (NP (NNS products)) (VP (VBG containing) (NP (NP (JJ ferrous) (NN sulfate)) (PRN (-LRB- -LRB-) (NP (NN iron)) (-RRB- -RRB-))))) (, ,) (NP (NP (NN multivitamin) (NNS preparations)) (VP (VBG containing) (NP (NP (NN zinc)) (CC or) (NP (JJ other) (JJ metal) (NNS cations))))) (, ,) (CC or) (NP (ADJP (NN Videx) (-LRB- -LRB-) (NN didanosine) (-RRB- -RRB-) (JJ chewable/)) (NN buffer) (NN ed) (NNS tablets))) (CC or) (NP (NP (DT the) (JJ pediatric) (NN powder)) (PP (IN for) (NP (JJ oral) (NN solution))))) (VP (MD should) (RB not) (VP (VB be) (VP (VBN taken) (PP (IN within) (NP (NP (NP (CD 3) (NNS hours)) (PP (IN before))) (CC or) (NP (NP (CD 2) (NNS hours)) (PP (IN after) (NP (NN FACTIVE)))))))))) (. .)))))

root(ROOT-0, Magnesium-1)
amod(antacids-5, aluminum-containing-4)
nsubjpass(taken-43, antacids-5)
conj_and/or(antacids-5, products-7)
partmod(products-7, containing-8)
amod(sulfate-10, ferrous-9)
dobj(containing-8, sulfate-10)
appos(sulfate-10, iron-12)
nn(preparations-16, multivitamin-15)
conj_and/or(antacids-5, preparations-16)
partmod(preparations-16, containing-17)
dobj(containing-17, zinc-18)
amod(cations-22, other-20)
amod(cations-22, metal-21)
conj_or(zinc-18, cations-22)
dep(chewable/-29, Videx-25)
dep(chewable/-29, didanosine-27)
amod(tablets-32, chewable/-29)
nn(tablets-32, buffer-30)
nn(tablets-32, ed-31)
conj_or(antacids-5, tablets-32)
det(powder-36, the-34)
amod(powder-36, pediatric-35)
conj_or(antacids-5, powder-36)
amod(solution-39, oral-38)
prep_for(powder-36, solution-39)
aux(taken-43, should-40)
neg(taken-43, not-41)
auxpass(taken-43, be-42)
dep(Magnesium-1, taken-43)
num(hours-46, 3-45)
prep_within(taken-43, hours-46)
prep(hours-46, before-47)
num(hours-50, 2-49)
conj_or(hours-46, hours-50)
prep_after(hours-50, FACTIVE-52)

Sucralfate/NN should/MD not/RB be/VB taken/VBN within/IN 2/CD hours/NNS of/IN FACTIVE/NN ./.

(ROOT (S1 (S (S (NP (NN Sucralfate)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN taken) (PP (IN within) (NP (NP (CD 2) (NNS hours)) (PP (IN of) (NP (NN FACTIVE))))))))) (. .))))

nsubjpass(taken-5, Sucralfate-1)
aux(taken-5, should-2)
neg(taken-5, not-3)
auxpass(taken-5, be-4)
root(ROOT-0, taken-5)
num(hours-8, 2-7)
prep_within(taken-5, hours-8)
prep_of(hours-8, FACTIVE-10)

There/EX have/VBP been/VBN no/DT formal/JJ drug-interaction/NN studies/NNS performed/VBN with/IN Mylotarg/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (DT no) (JJ formal) (NN drug-interaction) (NNS studies)) (VP (VBN performed) (PP (IN with) (NP (NN Mylotarg)))))))) (. .))))

expl(studies-7, There-1)
aux(studies-7, have-2)
cop(studies-7, been-3)
det(studies-7, no-4)
amod(studies-7, formal-5)
nn(studies-7, drug-interaction-6)
root(ROOT-0, studies-7)
partmod(studies-7, performed-8)
prep_with(performed-8, Mylotarg-10)

The/DT potential/NN for/IN drug-drug/JJ interaction/NN with/IN drugs/NNS affected/VBN by/IN cytochrome/NN P450/NN enzymes/NNS may/MD not/RB be/VB ruled/VBN out/RP ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN potential)) (PP (IN for) (NP (NP (JJ drug-drug) (NN interaction)) (PP (IN with) (NP (NP (NNS drugs)) (VP (VBN affected) (PP (IN by) (NP (NN cytochrome) (NN P450) (NNS enzymes))))))))) (VP (MD may) (RB not) (VP (VB be) (VP (VBN ruled) (PRT (RP out)))))) (. .))))

det(potential-2, The-1)
nsubjpass(ruled-16, potential-2)
amod(interaction-5, drug-drug-4)
prep_for(potential-2, interaction-5)
prep_with(interaction-5, drugs-7)
partmod(drugs-7, affected-8)
nn(enzymes-12, cytochrome-10)
nn(enzymes-12, P450-11)
agent(affected-8, enzymes-12)
aux(ruled-16, may-13)
neg(ruled-16, not-14)
auxpass(ruled-16, be-15)
root(ROOT-0, ruled-16)
prt(ruled-16, out-17)

Mylotarg/NN is/VBZ not/RB known/VBN to/TO interfere/VB with/IN any/DT routine/NN diagnostic/JJ tests/NNS ./.

(ROOT (S1 (S (S (NP (NN Mylotarg)) (VP (VBZ is) (RB not) (VP (VBN known) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (DT any) (NN routine) (JJ diagnostic) (NNS tests))))))))) (. .))))

nsubjpass(known-4, Mylotarg-1)
xsubj(interfere-6, Mylotarg-1)
auxpass(known-4, is-2)
neg(known-4, not-3)
root(ROOT-0, known-4)
aux(interfere-6, to-5)
xcomp(known-4, interfere-6)
det(tests-11, any-8)
nn(tests-11, routine-9)
amod(tests-11, diagnostic-10)
prep_with(interfere-6, tests-11)

Interactions/NNS between/IN COPAXONE/NN @/NN and/CC other/JJ drugs/NNS have/VBP not/RB been/VBN fully/RB evaluated/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Interactions)) (PP (IN between) (NP (NP (NN COPAXONE) (NN @)) (CC and) (NP (JJ other) (NNS drugs))))) (VP (VBP have) (RB not) (VP (VBN been) (ADVP (RB fully)) (VP (VBN evaluated))))) (. .))))

nsubjpass(evaluated-12, Interactions-1)
nn(@-4, COPAXONE-3)
prep_between(Interactions-1, @-4)
amod(drugs-7, other-6)
conj_and(@-4, drugs-7)
aux(evaluated-12, have-8)
neg(evaluated-12, not-9)
auxpass(evaluated-12, been-10)
advmod(evaluated-12, fully-11)
root(ROOT-0, evaluated-12)

Results/NNS from/IN existing/JJ clinical/JJ trials/NNS suggest/VBP no/DT significant/JJ interactions/NNS between/IN COPAXONE/NN @/NN and/CC other/JJ therapies/NNS commonly/RB used/VBN in/IN MS/NN patients/NNS ,/, including/VBG the/DT concurrent/JJ use/NN of/IN corticosteroids/NNS for/IN up/RB to/TO 28/CD days/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Results)) (PP (IN from) (NP (JJ existing) (JJ clinical) (NNS trials)))) (VP (VBP suggest) (NP (NP (DT no) (JJ significant) (NNS interactions)) (PP (IN between) (NP (NP (NN COPAXONE) (NN @)) (CC and) (NP (NP (JJ other) (NNS therapies)) (VP (ADVP (RB commonly)) (VBN used) (PP (IN in) (NP (NN MS) (NNS patients))))))) (, ,) (PP (VBG including) (NP (NP (DT the) (JJ concurrent) (NN use)) (PP (IN of) (NP (NNS corticosteroids))) (PP (IN for) (NP (QP (RB up) (TO to) (CD 28)) (NNS days)))))))) (. .))))

nsubj(suggest-6, Results-1)
amod(trials-5, existing-3)
amod(trials-5, clinical-4)
prep_from(Results-1, trials-5)
root(ROOT-0, suggest-6)
det(interactions-9, no-7)
amod(interactions-9, significant-8)
dobj(suggest-6, interactions-9)
nn(@-12, COPAXONE-11)
prep_between(interactions-9, @-12)
amod(therapies-15, other-14)
conj_and(@-12, therapies-15)
advmod(used-17, commonly-16)
partmod(therapies-15, used-17)
nn(patients-20, MS-19)
prep_in(used-17, patients-20)
det(use-25, the-23)
amod(use-25, concurrent-24)
prep_including(interactions-9, use-25)
prep_of(use-25, corticosteroids-27)
quantmod(28-31, up-29)
dep(28-31, to-30)
num(days-32, 28-31)
prep_for(use-25, days-32)

COPAXONE/NN @/NN has/VBZ not/RB been/VBN formally/RB evaluated/VBN in/IN combination/NN with/IN Interferon/NN beta/NN ./.

(ROOT (S1 (S (S (NP (NN COPAXONE) (NN @)) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB formally)) (VP (VBN evaluated) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN Interferon) (NN beta))))))))) (. .))))

nn(@-2, COPAXONE-1)
nsubjpass(evaluated-7, @-2)
aux(evaluated-7, has-3)
neg(evaluated-7, not-4)
auxpass(evaluated-7, been-5)
advmod(evaluated-7, formally-6)
root(ROOT-0, evaluated-7)
prep_in(evaluated-7, combination-9)
nn(beta-12, Interferon-11)
prep_with(combination-9, beta-12)

However/RB ,/, 10/CD patients/NNS who/WP switched/VBD from/IN therapy/NN with/IN Interferon/NN beta/NN to/TO COPAXONE/NN @/NN did/VBD not/RB report/VBP any/DT serious/JJ and/CC unexpected/JJ adverse/JJ reactions/NNS thought/VBN to/TO be/VB related/JJ to/TO treatment/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (CD 10) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD switched) (PP (IN from) (NP (NN therapy))) (PP (IN with) (NP (NP (NN Interferon) (NN beta)) (PP (TO to) (NP (NN COPAXONE) (NN @))))))))) (VP (VBD did) (RB not) (VP (VBP report) (NP (NP (DT any) (ADJP (ADJP (JJ serious)) (CC and) (ADJP (JJ unexpected))) (JJ adverse) (NNS reactions)) (VP (VBN thought) (S (VP (TO to) (VP (VB be) (ADJP (JJ related) (PP (TO to) (NP (NN treatment)))))))))))) (. .))))

advmod(report-17, However-1)
num(patients-4, 10-3)
nsubj(switched-6, patients-4)
nsubj(report-17, patients-4)
rcmod(patients-4, switched-6)
prep_from(switched-6, therapy-8)
nn(beta-11, Interferon-10)
prep_with(switched-6, beta-11)
nn(@-14, COPAXONE-13)
prep_to(beta-11, @-14)
aux(report-17, did-15)
neg(report-17, not-16)
root(ROOT-0, report-17)
det(reactions-23, any-18)
amod(reactions-23, serious-19)
conj_and(serious-19, unexpected-21)
amod(reactions-23, adverse-22)
dobj(report-17, reactions-23)
xsubj(related-27, reactions-23)
partmod(reactions-23, thought-24)
aux(related-27, to-25)
cop(related-27, be-26)
xcomp(thought-24, related-27)
prep_to(related-27, treatment-29)

The/DT hypoglycemic/JJ action/NN of/IN sulfonylureas/NN may/MD be/VB potentiated/VBN by/IN certain/JJ drugs/NNS including/VBG nonsteroidal/JJ anti-inflammatory/JJ agents/NNS and/CC other/JJ drugs/NNS that/WDT are/VBP highly/RB protein/NN bound/VBN ,/, salicylates/NNS ,/, sulfonamides/NNS ,/, chloramphenicol/NN ,/, probenecid/NN ,/, coumarins/NN ,/, monoamine/NN oxidase/NN inhibitors/NNS ,/, and/CC beta/NN adrenergic/JJ blocking/NN agents/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ hypoglycemic) (NN action)) (PP (IN of) (NP (NN sulfonylureas)))) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (PP (IN by) (NP (NP (NP (JJ certain) (NNS drugs)) (PP (VBG including) (NP (NP (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS agents)) (CC and) (NP (JJ other) (NNS drugs))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB highly)) (VP (NN protein) (VBN bound)))))))) (, ,) (NP (NNS salicylates)) (, ,) (NP (NNS sulfonamides)) (, ,) (NP (NP (NN chloramphenicol)) (, ,) (NP (NN probenecid)) (, ,) (NP (NN coumarins))) (, ,) (NP (NP (NN monoamine) (NN oxidase)) (NNS inhibitors)) (, ,) (CC and) (NP (NN beta) (JJ adrenergic) (NN blocking) (NNS agents)))))))) (. .))))

det(action-3, The-1)
amod(action-3, hypoglycemic-2)
nsubjpass(potentiated-8, action-3)
prep_of(action-3, sulfonylureas-5)
aux(potentiated-8, may-6)
auxpass(potentiated-8, be-7)
root(ROOT-0, potentiated-8)
amod(drugs-11, certain-10)
agent(potentiated-8, drugs-11)
amod(agents-15, nonsteroidal-13)
amod(agents-15, anti-inflammatory-14)
prep_including(drugs-11, agents-15)
nsubjpass(bound-23, agents-15)
amod(drugs-18, other-17)
conj_and(agents-15, drugs-18)
auxpass(bound-23, are-20)
advmod(bound-23, highly-21)
dep(bound-23, protein-22)
rcmod(agents-15, bound-23)
conj_and(drugs-11, salicylates-25)
conj_and(drugs-11, sulfonamides-27)
conj_and(drugs-11, chloramphenicol-29)
appos(chloramphenicol-29, probenecid-31)
appos(chloramphenicol-29, coumarins-33)
nn(oxidase-36, monoamine-35)
nn(inhibitors-37, oxidase-36)
conj_and(drugs-11, inhibitors-37)
nn(agents-43, beta-40)
amod(agents-43, adrenergic-41)
nn(agents-43, blocking-42)
conj_and(drugs-11, agents-43)

When/WRB such/JJ drugs/NNS are/VBP administered/VBN to/TO a/DT patient/NN receiving/VBG MICRONASE/NN ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB for/IN hypoglycemia/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ such) (NNS drugs)) (VP (VBP are) (VP (VBN administered) (PP (TO to) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN MICRONASE))))))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (PP (IN for) (NP (NN hypoglycemia))))))) (. .))))

advmod(administered-5, When-1)
amod(drugs-3, such-2)
nsubjpass(administered-5, drugs-3)
auxpass(administered-5, are-4)
advcl(observed-16, administered-5)
det(patient-8, a-7)
prep_to(administered-5, patient-8)
partmod(patient-8, receiving-9)
dobj(receiving-9, MICRONASE-10)
det(patient-13, the-12)
nsubjpass(observed-16, patient-13)
aux(observed-16, should-14)
auxpass(observed-16, be-15)
root(ROOT-0, observed-16)
advmod(observed-16, closely-17)
prep_for(observed-16, hypoglycemia-19)

When/WRB such/JJ drugs/NNS are/VBP withdrawn/VBN from/IN a/DT patient/NN receiving/VBG MICRONASE/NN ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB for/IN loss/NN of/IN control/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ such) (NNS drugs)) (VP (VBP are) (VP (VBN withdrawn) (PP (IN from) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN MICRONASE))))))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (PP (IN for) (NP (NP (NN loss)) (PP (IN of) (NP (NN control))))))))) (. .))))

advmod(withdrawn-5, When-1)
amod(drugs-3, such-2)
nsubjpass(withdrawn-5, drugs-3)
auxpass(withdrawn-5, are-4)
advcl(observed-16, withdrawn-5)
det(patient-8, a-7)
prep_from(withdrawn-5, patient-8)
partmod(patient-8, receiving-9)
dobj(receiving-9, MICRONASE-10)
det(patient-13, the-12)
nsubjpass(observed-16, patient-13)
aux(observed-16, should-14)
auxpass(observed-16, be-15)
root(ROOT-0, observed-16)
advmod(observed-16, closely-17)
prep_for(observed-16, loss-19)
prep_of(loss-19, control-21)

Certain/JJ drugs/NNS tend/VBP to/TO produce/VB hyperglycemia/NN and/CC may/MD lead/VB to/TO loss/NN of/IN control/NN ./.

(ROOT (S1 (S (S (NP (JJ Certain) (NNS drugs)) (VP (VBP tend) (S (VP (VP (TO to) (VP (VB produce) (NP (NN hyperglycemia)))) (CC and) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (NN loss)) (PP (IN of) (NP (NN control))))))))))) (. .))))

amod(drugs-2, Certain-1)
nsubj(tend-3, drugs-2)
root(ROOT-0, tend-3)
aux(produce-5, to-4)
ccomp(tend-3, produce-5)
dobj(produce-5, hyperglycemia-6)
aux(lead-9, may-8)
conj_and(produce-5, lead-9)
prep_to(lead-9, loss-11)
prep_of(loss-11, control-13)

These/DT drugs/NNS include/VBP the/DT thiazides/NNS and/CC other/JJ diuretics/NNS ,/, corticosteroids/NNS ,/, phe/NN -nothiazines/NNS ,/, thyroid/NN products/NNS ,/, estrogens/NNS ,/, oral/JJ contraceptives/NNS ,/, phenytoin/NN ,/, nicotinic/JJ acid/NN ,/, sympathomimet-ics/NNS ,/, calcium/NN channel/NN blocking/NN drugs/NNS ,/, and/CC isoniazid/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS drugs)) (VP (VBP include) (NP (NP (DT the) (NNS thiazides)) (CC and) (NP (NP (JJ other) (NNS diuretics)) (, ,) (NP (NNS corticosteroids)) (, ,) (NP (NN phe) (NNS -nothiazines)) (, ,) (NP (NN thyroid) (NNS products)) (, ,) (NP (NNS estrogens)) (, ,) (NP (JJ oral) (NNS contraceptives)) (, ,) (NP (NN phenytoin)) (, ,) (NP (JJ nicotinic) (NN acid)) (, ,) (NP (NNS sympathomimet-ics)) (, ,) (NP (NN calcium) (NN channel) (NN blocking) (NNS drugs)) (, ,) (CC and) (NP (NN isoniazid)))))) (. .))))

det(drugs-2, These-1)
nsubj(include-3, drugs-2)
root(ROOT-0, include-3)
det(thiazides-5, the-4)
dobj(include-3, thiazides-5)
amod(diuretics-8, other-7)
conj_and(thiazides-5, diuretics-8)
conj_and(diuretics-8, corticosteroids-10)
nn(-nothiazines-13, phe-12)
conj_and(diuretics-8, -nothiazines-13)
nn(products-16, thyroid-15)
conj_and(diuretics-8, products-16)
conj_and(diuretics-8, estrogens-18)
amod(contraceptives-21, oral-20)
conj_and(diuretics-8, contraceptives-21)
conj_and(diuretics-8, phenytoin-23)
amod(acid-26, nicotinic-25)
conj_and(diuretics-8, acid-26)
conj_and(diuretics-8, sympathomimet-ics-28)
nn(drugs-33, calcium-30)
nn(drugs-33, channel-31)
nn(drugs-33, blocking-32)
conj_and(diuretics-8, drugs-33)
conj_and(diuretics-8, isoniazid-36)

When/WRB such/JJ drugs/NNS are/VBP administered/VBN to/TO a/DT patient/NN receiving/VBG MICRONASE/NN ,/, the/DT patient/NN should/MD be/VB closely/RB observed/VBN for/IN loss/NN of/IN control/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ such) (NNS drugs)) (VP (VBP are) (VP (VBN administered) (PP (TO to) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN MICRONASE))))))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN observed) (PP (IN for) (NP (NP (NN loss)) (PP (IN of) (NP (NN control))))))))) (. .))))

advmod(administered-5, When-1)
amod(drugs-3, such-2)
nsubjpass(administered-5, drugs-3)
auxpass(administered-5, are-4)
advcl(observed-17, administered-5)
det(patient-8, a-7)
prep_to(administered-5, patient-8)
partmod(patient-8, receiving-9)
dobj(receiving-9, MICRONASE-10)
det(patient-13, the-12)
nsubjpass(observed-17, patient-13)
aux(observed-17, should-14)
auxpass(observed-17, be-15)
advmod(observed-17, closely-16)
root(ROOT-0, observed-17)
prep_for(observed-17, loss-19)
prep_of(loss-19, control-21)

When/WRB such/JJ drugs/NNS are/VBP withdrawn/VBN from/IN a/DT patient/NN receiving/VBG MICRONASE/NN ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB for/IN hypoglycemia/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ such) (NNS drugs)) (VP (VBP are) (VP (VBN withdrawn) (PP (IN from) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN MICRONASE))))))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (PP (IN for) (NP (NN hypoglycemia))))))) (. .))))

advmod(withdrawn-5, When-1)
amod(drugs-3, such-2)
nsubjpass(withdrawn-5, drugs-3)
auxpass(withdrawn-5, are-4)
advcl(observed-16, withdrawn-5)
det(patient-8, a-7)
prep_from(withdrawn-5, patient-8)
partmod(patient-8, receiving-9)
dobj(receiving-9, MICRONASE-10)
det(patient-13, the-12)
nsubjpass(observed-16, patient-13)
aux(observed-16, should-14)
auxpass(observed-16, be-15)
root(ROOT-0, observed-16)
advmod(observed-16, closely-17)
prep_for(observed-16, hypoglycemia-19)

A/DT possible/JJ interaction/NN between/IN glyburide/NN and/CC ciprofloxacin/NN ,/, a/DT fluoroquinolone/JJ antibiotic/JJ ,/, has/VBZ been/VBN reported/VBN ,/, resulting/VBG in/IN a/DT potentiation/NN of/IN the/DT hypoglycemic/JJ action/NN of/IN glyburide/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (DT A) (JJ possible) (NN interaction)) (PP (IN between) (NP (NP (NN glyburide)) (CC and) (NP (NN ciprofloxacin))))) (, ,) (NP (DT a) (JJ fluoroquinolone) (JJ antibiotic)) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (NN potentiation)) (PP (IN of) (NP (NP (DT the) (JJ hypoglycemic) (NN action)) (PP (IN of) (NP (NN glyburide))))))))))) (. .))))

det(interaction-3, A-1)
amod(interaction-3, possible-2)
nsubjpass(reported-15, interaction-3)
prep_between(interaction-3, glyburide-5)
conj_and(glyburide-5, ciprofloxacin-7)
det(antibiotic-11, a-9)
amod(antibiotic-11, fluoroquinolone-10)
appos(interaction-3, antibiotic-11)
aux(reported-15, has-13)
auxpass(reported-15, been-14)
root(ROOT-0, reported-15)
xcomp(reported-15, resulting-17)
det(potentiation-20, a-19)
prep_in(resulting-17, potentiation-20)
det(action-24, the-22)
amod(action-24, hypoglycemic-23)
prep_of(potentiation-20, action-24)
prep_of(action-24, glyburide-26)

A/DT potential/JJ interaction/NN between/IN oral/JJ miconazole/NN and/CC oral/JJ hypoglycemic/JJ agents/NNS leading/VBG to/TO severe/JJ hypoglycemia/NN has/VBZ been/VBN reported/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT A) (JJ potential) (NN interaction)) (PP (IN between) (NP (NP (NP (JJ oral) (NN miconazole)) (CC and) (NP (JJ oral) (JJ hypoglycemic) (NNS agents))) (VP (VBG leading) (PP (TO to) (NP (JJ severe) (NN hypoglycemia))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported))))) (. .))))

det(interaction-3, A-1)
amod(interaction-3, potential-2)
nsubjpass(reported-17, interaction-3)
amod(miconazole-6, oral-5)
prep_between(interaction-3, miconazole-6)
amod(agents-10, oral-8)
amod(agents-10, hypoglycemic-9)
conj_and(miconazole-6, agents-10)
partmod(miconazole-6, leading-11)
amod(hypoglycemia-14, severe-13)
prep_to(leading-11, hypoglycemia-14)
aux(reported-17, has-15)
auxpass(reported-17, been-16)
root(ROOT-0, reported-17)

Whether/IN this/DT interaction/NN also/RB occurs/VBZ with/IN the/DT intravenous/JJ ,/, topical/JJ or/CC vaginal/JJ preparations/NNS of/IN miconazole/NN is/VBZ not/RB known/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Whether) (S (NP (DT this) (NN interaction)) (ADVP (RB also)) (VP (VBZ occurs) (PP (IN with) (NP (NP (DT the) (ADJP (ADJP (JJ intravenous)) (, ,) (ADJP (JJ topical)) (CC or) (ADJP (JJ vaginal))) (NNS preparations)) (PP (IN of) (NP (NN miconazole)))))))) (VP (VBZ is) (RB not) (VP (VBN known)))) (. .))))

complm(occurs-5, Whether-1)
det(interaction-3, this-2)
nsubj(occurs-5, interaction-3)
advmod(occurs-5, also-4)
csubjpass(known-18, occurs-5)
det(preparations-13, the-7)
amod(preparations-13, intravenous-8)
conj_or(intravenous-8, topical-10)
conj_or(intravenous-8, vaginal-12)
prep_with(occurs-5, preparations-13)
prep_of(preparations-13, miconazole-15)
auxpass(known-18, is-16)
neg(known-18, not-17)
root(ROOT-0, known-18)

Metformin/NN :/: In/IN a/DT single-dose/JJ interaction/NN study/NN in/IN NIDDM/NN subjects/NNS ,/, decreases/NNS in/IN glyburide/NN AUC/NN and/CC Cmax/NN were/VBD observed/VBN ,/, but/CC were/VBD highly/RB variable/JJ ./.

(ROOT (S1 (S (S (NP (NN Metformin)) (: :) (PP (IN In) (NP (NP (DT a) (JJ single-dose) (NN interaction) (NN study)) (PP (IN in) (NP (NN NIDDM) (NNS subjects))))) (, ,) (NP (NP (NNS decreases)) (PP (IN in) (NP (NP (NN glyburide) (NN AUC)) (CC and) (NP (NN Cmax))))) (VP (VP (VBD were) (VP (VBN observed))) (, ,) (CC but) (VP (VBD were) (ADJP (RB highly) (JJ variable))))) (. .))))

nsubjpass(observed-19, Metformin-1)
det(study-7, a-4)
amod(study-7, single-dose-5)
nn(study-7, interaction-6)
prep_in(observed-19, study-7)
nn(subjects-10, NIDDM-9)
prep_in(study-7, subjects-10)
nsubjpass(observed-19, decreases-12)
nn(AUC-15, glyburide-14)
prep_in(decreases-12, AUC-15)
conj_and(AUC-15, Cmax-17)
auxpass(observed-19, were-18)
root(ROOT-0, observed-19)
cop(variable-24, were-22)
advmod(variable-24, highly-23)
conj_but(observed-19, variable-24)

The/DT single-dose/JJ nature/NN of/IN this/DT study/NN and/CC the/DT lack/NN of/IN correlation/NN between/IN glyburide/NN blood/NN levels/NNS and/CC pharmaco-dynamic/JJ effects/NNS ,/, makes/VBZ the/DT clinical/JJ significance/NN of/IN this/DT interaction/NN uncertain/JJ ./.

(ROOT (S1 (S (S (NP (NP (NP (DT The) (JJ single-dose) (NN nature)) (PP (IN of) (NP (DT this) (NN study)))) (CC and) (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (NP (NN correlation)) (PP (IN between) (NP (NP (NN glyburide) (NN blood) (NNS levels)) (CC and) (NP (JJ pharmaco-dynamic) (NNS effects))))))) (, ,)) (VP (VBZ makes) (NP (NP (DT the) (JJ clinical) (NN significance)) (PP (IN of) (NP (DT this) (NN interaction) (JJ uncertain)))))) (. .))))

det(nature-3, The-1)
amod(nature-3, single-dose-2)
nsubj(makes-20, nature-3)
det(study-6, this-5)
prep_of(nature-3, study-6)
det(lack-9, the-8)
conj_and(nature-3, lack-9)
prep_of(lack-9, correlation-11)
nn(levels-15, glyburide-13)
nn(levels-15, blood-14)
prep_between(correlation-11, levels-15)
amod(effects-18, pharmaco-dynamic-17)
conj_and(levels-15, effects-18)
root(ROOT-0, makes-20)
det(significance-23, the-21)
amod(significance-23, clinical-22)
dobj(makes-20, significance-23)
det(interaction-26, this-25)
prep_of(significance-23, interaction-26)
amod(interaction-26, uncertain-27)

Coadministration/NN of/IN gly/NN -buride/NN and/CC metformin/NN did/VBD not/RB result/VB in/IN any/DT changes/NNS in/IN either/CC metformin/NN pharmacokinetics/NNS or/CC pharmaco-dynamics/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NN gly) (NN -buride)) (CC and) (NP (NN metformin))))) (VP (VBD did) (RB not) (VP (VB result) (PP (IN in) (NP (NP (DT any) (NNS changes)) (PP (IN in) (NP (CC either) (NP (NN metformin) (NNS pharmacokinetics)) (CC or) (NP (NNS pharmaco-dynamics))))))))) (. .))))

nsubj(result-9, Coadministration-1)
nn(-buride-4, gly-3)
prep_of(Coadministration-1, -buride-4)
conj_and(-buride-4, metformin-6)
aux(result-9, did-7)
neg(result-9, not-8)
root(ROOT-0, result-9)
det(changes-12, any-11)
prep_in(result-9, changes-12)
preconj(pharmacokinetics-16, either-14)
nn(pharmacokinetics-16, metformin-15)
prep_in(changes-12, pharmacokinetics-16)
conj_or(pharmacokinetics-16, pharmaco-dynamics-18)

Immediate/JJ and/CC Extended/JJ Release/NN Tablets/NNS :/: The/DT hypoglycemic/JJ action/NN of/IN sulfonylureas/NN may/MD be/VB potentiated/VBN by/IN certain/JJ drugs/NNS including/VBG nonsteroidal/JJ anti-inflammatory/JJ agents/NNS ,/, some/DT azoles/NNS and/CC other/JJ drugs/NNS that/WDT are/VBP highly/RB protein/NN bound/VBN ,/, salicylates/NNS ,/, sulfonamides/NNS ,/, chloramphenicol/NN ,/, probenecid/NN ,/, coumarins/NNS ,/, monoamine/NN oxidase/NN inhibitors/NNS ,/, and/CC beta/NN adrenergic/JJ blocking/NN agents/NNS ./.

(ROOT (S1 (S (NP (NP (ADJP (ADJP (JJ Immediate)) (CC and) (ADJP (JJ Extended))) (NN Release) (NNS Tablets)) (: :) (S (NP (NP (DT The) (JJ hypoglycemic) (NN action)) (PP (IN of) (NP (NN sulfonylureas)))) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (PP (IN by) (NP (NP (NP (JJ certain) (NNS drugs)) (PP (VBG including) (NP (NP (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS agents)) (, ,) (NP (DT some) (NNS azoles)) (CC and) (NP (JJ other) (NNS drugs))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB highly)) (VP (NN protein) (VBN bound)))))))) (, ,) (NP (NNS salicylates)) (, ,) (NP (NNS sulfonamides)) (, ,) (NP (NN chloramphenicol)) (, ,) (NP (NN probenecid)) (, ,) (NP (NNS coumarins)) (, ,) (NP (NN monoamine) (NN oxidase) (NNS inhibitors)) (, ,) (CC and) (NP (NN beta) (JJ adrenergic) (NN blocking) (NNS agents)))))))) (. .)))))

amod(Tablets-5, Immediate-1)
conj_and(Immediate-1, Extended-3)
nn(Tablets-5, Release-4)
root(ROOT-0, Tablets-5)
det(action-9, The-7)
amod(action-9, hypoglycemic-8)
nsubjpass(potentiated-14, action-9)
prep_of(action-9, sulfonylureas-11)
aux(potentiated-14, may-12)
auxpass(potentiated-14, be-13)
dep(Tablets-5, potentiated-14)
amod(drugs-17, certain-16)
agent(potentiated-14, drugs-17)
amod(agents-21, nonsteroidal-19)
amod(agents-21, anti-inflammatory-20)
prep_including(drugs-17, agents-21)
nsubjpass(bound-32, agents-21)
det(azoles-24, some-23)
conj_and(agents-21, azoles-24)
amod(drugs-27, other-26)
conj_and(agents-21, drugs-27)
auxpass(bound-32, are-29)
advmod(bound-32, highly-30)
dep(bound-32, protein-31)
rcmod(agents-21, bound-32)
conj_and(drugs-17, salicylates-34)
conj_and(drugs-17, sulfonamides-36)
conj_and(drugs-17, chloramphenicol-38)
conj_and(drugs-17, probenecid-40)
conj_and(drugs-17, coumarins-42)
nn(inhibitors-46, monoamine-44)
nn(inhibitors-46, oxidase-45)
conj_and(drugs-17, inhibitors-46)
nn(agents-52, beta-49)
amod(agents-52, adrenergic-50)
nn(agents-52, blocking-51)
conj_and(drugs-17, agents-52)

When/WRB such/JJ drugs/NNS are/VBP administered/VBN to/TO a/DT patient/NN receiving/VBG glipizide/NN ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB for/IN hypoglycemia/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ such) (NNS drugs)) (VP (VBP are) (VP (VBN administered) (PP (TO to) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN glipizide))))))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (PP (IN for) (NP (NN hypoglycemia))))))) (. .))))

advmod(administered-5, When-1)
amod(drugs-3, such-2)
nsubjpass(administered-5, drugs-3)
auxpass(administered-5, are-4)
advcl(observed-16, administered-5)
det(patient-8, a-7)
prep_to(administered-5, patient-8)
partmod(patient-8, receiving-9)
dobj(receiving-9, glipizide-10)
det(patient-13, the-12)
nsubjpass(observed-16, patient-13)
aux(observed-16, should-14)
auxpass(observed-16, be-15)
root(ROOT-0, observed-16)
advmod(observed-16, closely-17)
prep_for(observed-16, hypoglycemia-19)

When/WRB such/JJ drugs/NNS are/VBP withdrawn/VBN from/IN a/DT patient/NN receiving/VBG glipizide/NN ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB for/IN loss/NN of/IN control/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ such) (NNS drugs)) (VP (VBP are) (VP (VBN withdrawn) (PP (IN from) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN glipizide))))))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (PP (IN for) (NP (NP (NN loss)) (PP (IN of) (NP (NN control))))))))) (. .))))

advmod(withdrawn-5, When-1)
amod(drugs-3, such-2)
nsubjpass(withdrawn-5, drugs-3)
auxpass(withdrawn-5, are-4)
advcl(observed-16, withdrawn-5)
det(patient-8, a-7)
prep_from(withdrawn-5, patient-8)
partmod(patient-8, receiving-9)
dobj(receiving-9, glipizide-10)
det(patient-13, the-12)
nsubjpass(observed-16, patient-13)
aux(observed-16, should-14)
auxpass(observed-16, be-15)
root(ROOT-0, observed-16)
advmod(observed-16, closely-17)
prep_for(observed-16, loss-19)
prep_of(loss-19, control-21)

In/FW vitro/FW binding/NN studies/NNS with/IN human/JJ serum/NN proteins/NNS indicate/VBP that/IN glipizide/NN binds/VBZ differently/RB than/IN tolbutamide/NN and/CC does/VBZ not/RB interact/VB with/IN salicylate/NN or/CC dicumarol/NN ./.

(ROOT (S1 (S (S (NP (NP (ADJP (FW In) (FW vitro)) (NN binding) (NNS studies)) (PP (IN with) (NP (JJ human) (NN serum) (NNS proteins)))) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN glipizide)) (VP (VP (VBZ binds) (ADVP (RB differently)) (PP (IN than) (NP (NN tolbutamide)))) (CC and) (VP (VBZ does) (RB not) (VP (VB interact) (PP (IN with) (NP (NP (NN salicylate)) (CC or) (NP (NN dicumarol))))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-4, vitro-2)
nn(studies-4, binding-3)
nsubj(indicate-9, studies-4)
amod(proteins-8, human-6)
nn(proteins-8, serum-7)
prep_with(studies-4, proteins-8)
root(ROOT-0, indicate-9)
complm(binds-12, that-10)
nsubj(binds-12, glipizide-11)
ccomp(indicate-9, binds-12)
advmod(binds-12, differently-13)
prep_than(binds-12, tolbutamide-15)
aux(interact-19, does-17)
neg(interact-19, not-18)
conj_and(binds-12, interact-19)
prep_with(interact-19, salicylate-21)
conj_or(salicylate-21, dicumarol-23)

However/RB ,/, caution/NN must/MD be/VB exercised/VBN in/IN extrapolating/VBG these/DT findings/NNS to/TO the/DT clinical/JJ situation/NN and/CC in/IN the/DT use/NN of/IN glipizide/NN with/IN these/DT drugs/NNS ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NN caution)) (VP (MD must) (VP (VB be) (VP (VBN exercised) (PP (PP (IN in) (S (VP (VBG extrapolating) (NP (DT these) (NNS findings)) (PP (TO to) (NP (DT the) (JJ clinical) (NN situation)))))) (CC and) (PP (IN in) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN glipizide))) (PP (IN with) (NP (DT these) (NNS drugs)))))))))) (. .))))

advmod(exercised-6, However-1)
nsubjpass(exercised-6, caution-3)
aux(exercised-6, must-4)
auxpass(exercised-6, be-5)
root(ROOT-0, exercised-6)
prepc_in(exercised-6, extrapolating-8)
det(findings-10, these-9)
dobj(extrapolating-8, findings-10)
det(situation-14, the-12)
amod(situation-14, clinical-13)
prep_to(extrapolating-8, situation-14)
det(use-18, the-17)
conj_and(extrapolating-8, use-18)
prep_of(use-18, glipizide-20)
det(drugs-23, these-22)
prep_with(use-18, drugs-23)

Certain/JJ drugs/NNS tend/VBP to/TO produce/VB hyperglycemia/NN and/CC may/MD lead/VB to/TO loss/NN of/IN control/NN ./.

(ROOT (S1 (S (S (NP (JJ Certain) (NNS drugs)) (VP (VBP tend) (S (VP (VP (TO to) (VP (VB produce) (NP (NN hyperglycemia)))) (CC and) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (NN loss)) (PP (IN of) (NP (NN control))))))))))) (. .))))

amod(drugs-2, Certain-1)
nsubj(tend-3, drugs-2)
root(ROOT-0, tend-3)
aux(produce-5, to-4)
ccomp(tend-3, produce-5)
dobj(produce-5, hyperglycemia-6)
aux(lead-9, may-8)
conj_and(produce-5, lead-9)
prep_to(lead-9, loss-11)
prep_of(loss-11, control-13)

These/DT drugs/NNS include/VBP the/DT thiazides/NNS and/CC other/JJ diuretics/NNS ,/, corticosteroids/NNS ,/, phenothiazines/NNS ,/, thyroid/NN products/NNS ,/, estrogens/NNS ,/, oral/JJ contraceptives/NNS ,/, phenytoin/NN ,/, nicotinic/JJ acid/NN ,/, sympathomimetics/NNS ,/, calcium/NN channel/NN blocking/NN drugs/NNS ,/, and/CC isoniazid/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS drugs)) (VP (VBP include) (NP (NP (DT the) (NNS thiazides)) (CC and) (NP (NP (JJ other) (NNS diuretics)) (, ,) (NP (NNS corticosteroids)) (, ,) (NP (NNS phenothiazines)) (, ,) (NP (NN thyroid) (NNS products)) (, ,) (NP (NNS estrogens)) (, ,) (NP (JJ oral) (NNS contraceptives)) (, ,) (NP (NN phenytoin)) (, ,) (NP (JJ nicotinic) (NN acid)) (, ,) (NP (NNS sympathomimetics)) (, ,) (NP (NN calcium) (NN channel) (NN blocking) (NNS drugs)) (, ,) (CC and) (NP (NN isoniazid)))))) (. .))))

det(drugs-2, These-1)
nsubj(include-3, drugs-2)
root(ROOT-0, include-3)
det(thiazides-5, the-4)
dobj(include-3, thiazides-5)
amod(diuretics-8, other-7)
conj_and(thiazides-5, diuretics-8)
conj_and(diuretics-8, corticosteroids-10)
conj_and(diuretics-8, phenothiazines-12)
nn(products-15, thyroid-14)
conj_and(diuretics-8, products-15)
conj_and(diuretics-8, estrogens-17)
amod(contraceptives-20, oral-19)
conj_and(diuretics-8, contraceptives-20)
conj_and(diuretics-8, phenytoin-22)
amod(acid-25, nicotinic-24)
conj_and(diuretics-8, acid-25)
conj_and(diuretics-8, sympathomimetics-27)
nn(drugs-32, calcium-29)
nn(drugs-32, channel-30)
nn(drugs-32, blocking-31)
conj_and(diuretics-8, drugs-32)
conj_and(diuretics-8, isoniazid-35)

When/WRB such/JJ drugs/NNS are/VBP administered/VBN to/TO a/DT patient/NN receiving/VBG glipizide/NN ,/, the/DT patient/NN should/MD be/VB closely/RB observed/VBN for/IN loss/NN of/IN control/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ such) (NNS drugs)) (VP (VBP are) (VP (VBN administered) (PP (TO to) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN glipizide))))))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN observed) (PP (IN for) (NP (NP (NN loss)) (PP (IN of) (NP (NN control))))))))) (. .))))

advmod(administered-5, When-1)
amod(drugs-3, such-2)
nsubjpass(administered-5, drugs-3)
auxpass(administered-5, are-4)
advcl(observed-17, administered-5)
det(patient-8, a-7)
prep_to(administered-5, patient-8)
partmod(patient-8, receiving-9)
dobj(receiving-9, glipizide-10)
det(patient-13, the-12)
nsubjpass(observed-17, patient-13)
aux(observed-17, should-14)
auxpass(observed-17, be-15)
advmod(observed-17, closely-16)
root(ROOT-0, observed-17)
prep_for(observed-17, loss-19)
prep_of(loss-19, control-21)

When/WRB such/JJ drugs/NNS are/VBP withdrawn/VBN from/IN a/DT patient/NN receiving/VBG glipizide/NN ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB for/IN hypoglycemia/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (JJ such) (NNS drugs)) (VP (VBP are) (VP (VBN withdrawn) (PP (IN from) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN glipizide))))))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (PP (IN for) (NP (NN hypoglycemia))))))) (. .))))

advmod(withdrawn-5, When-1)
amod(drugs-3, such-2)
nsubjpass(withdrawn-5, drugs-3)
auxpass(withdrawn-5, are-4)
advcl(observed-16, withdrawn-5)
det(patient-8, a-7)
prep_from(withdrawn-5, patient-8)
partmod(patient-8, receiving-9)
dobj(receiving-9, glipizide-10)
det(patient-13, the-12)
nsubjpass(observed-16, patient-13)
aux(observed-16, should-14)
auxpass(observed-16, be-15)
root(ROOT-0, observed-16)
advmod(observed-16, closely-17)
prep_for(observed-16, hypoglycemia-19)

A/DT potential/JJ interaction/NN between/IN oral/JJ miconazole/NN and/CC oral/JJ hypoglycemic/JJ agents/NNS leading/VBG to/TO severe/JJ hypoglycemia/NN has/VBZ been/VBN reported/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT A) (JJ potential) (NN interaction)) (PP (IN between) (NP (NP (NP (JJ oral) (NN miconazole)) (CC and) (NP (JJ oral) (JJ hypoglycemic) (NNS agents))) (VP (VBG leading) (PP (TO to) (NP (JJ severe) (NN hypoglycemia))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported))))) (. .))))

det(interaction-3, A-1)
amod(interaction-3, potential-2)
nsubjpass(reported-17, interaction-3)
amod(miconazole-6, oral-5)
prep_between(interaction-3, miconazole-6)
amod(agents-10, oral-8)
amod(agents-10, hypoglycemic-9)
conj_and(miconazole-6, agents-10)
partmod(miconazole-6, leading-11)
amod(hypoglycemia-14, severe-13)
prep_to(leading-11, hypoglycemia-14)
aux(reported-17, has-15)
auxpass(reported-17, been-16)
root(ROOT-0, reported-17)

Whether/IN this/DT interaction/NN also/RB occurs/VBZ with/IN the/DT intravenous/JJ ,/, topical/JJ ,/, or/CC vaginal/JJ preparations/NNS of/IN miconazole/NN is/VBZ not/RB known/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Whether) (S (NP (DT this) (NN interaction)) (ADVP (RB also)) (VP (VBZ occurs) (PP (IN with) (NP (NP (DT the) (ADJP (ADJP (JJ intravenous)) (, ,) (ADJP (JJ topical)) (, ,) (CC or) (ADJP (JJ vaginal))) (NNS preparations)) (PP (IN of) (NP (NN miconazole)))))))) (VP (VBZ is) (RB not) (VP (VBN known)))) (. .))))

complm(occurs-5, Whether-1)
det(interaction-3, this-2)
nsubj(occurs-5, interaction-3)
advmod(occurs-5, also-4)
csubjpass(known-19, occurs-5)
det(preparations-14, the-7)
amod(preparations-14, intravenous-8)
conj_or(intravenous-8, topical-10)
conj_or(intravenous-8, vaginal-13)
prep_with(occurs-5, preparations-14)
prep_of(preparations-14, miconazole-16)
auxpass(known-19, is-17)
neg(known-19, not-18)
root(ROOT-0, known-19)

The/DT effect/NN of/IN concomitant/JJ administration/NN of/IN fluconazole/NN and/CC glipizide/NN has/VBZ been/VBN demonstrated/VBN in/IN a/DT placebo-controlled/JJ crossover/NN study/NN in/IN normal/JJ volunteers/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN fluconazole)) (CC and) (NP (NN glipizide))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated) (PP (IN in) (NP (NP (DT a) (JJ placebo-controlled) (NN crossover) (NN study)) (PP (IN in) (NP (JJ normal) (NNS volunteers))))))))) (. .))))

det(effect-2, The-1)
nsubjpass(demonstrated-12, effect-2)
amod(administration-5, concomitant-4)
prep_of(effect-2, administration-5)
prep_of(administration-5, fluconazole-7)
conj_and(fluconazole-7, glipizide-9)
aux(demonstrated-12, has-10)
auxpass(demonstrated-12, been-11)
root(ROOT-0, demonstrated-12)
det(study-17, a-14)
amod(study-17, placebo-controlled-15)
nn(study-17, crossover-16)
prep_in(demonstrated-12, study-17)
amod(volunteers-20, normal-19)
prep_in(study-17, volunteers-20)

All/DT subjects/NNS received/VBD glipizide/NN alone/RB and/CC following/VBG treatment/NN with/IN 100/CD mg/NN of/IN fluconazole/NN as/IN a/DT single/JJ daily/JJ oral/JJ dose/NN for/IN seven/CD days/NNS ./.

(ROOT (S1 (S (S (NP (DT All) (NNS subjects)) (VP (VBD received) (NP (NP (NP (NN glipizide)) (ADVP (RB alone))) (CC and) (NP (NP (VBG following) (NN treatment)) (PP (IN with) (NP (NP (CD 100) (NN mg)) (PP (IN of) (NP (NN fluconazole))))))) (PP (IN as) (NP (NP (DT a) (JJ single) (JJ daily) (JJ oral) (NN dose)) (PP (IN for) (NP (CD seven) (NNS days))))))) (. .))))

det(subjects-2, All-1)
nsubj(received-3, subjects-2)
root(ROOT-0, received-3)
dobj(received-3, glipizide-4)
advmod(glipizide-4, alone-5)
amod(treatment-8, following-7)
conj_and(glipizide-4, treatment-8)
num(mg-11, 100-10)
prep_with(treatment-8, mg-11)
prep_of(mg-11, fluconazole-13)
det(dose-19, a-15)
amod(dose-19, single-16)
amod(dose-19, daily-17)
amod(dose-19, oral-18)
prep_as(received-3, dose-19)
num(days-22, seven-21)
prep_for(dose-19, days-22)

The/DT mean/NN percentage/NN increase/NN in/IN the/DT glipizide/NN AUC/NN after/IN fluconazole/NN administration/NN was/VBD 56.9/CD %/NN (/-LRB- range/NN :/: 35/CD to/TO 81/CD )./NN

(ROOT (S1 (S (NP (NP (DT The) (NN mean) (NN percentage) (NN increase)) (PP (IN in) (NP (DT the) (NN glipizide) (NN AUC))) (PP (IN after) (NP (NN fluconazole) (NN administration)))) (VP (VBD was) (NP (CD 56.9) (NN %)) (PRN (-LRB- -LRB-) (NP (NP (NN range)) (: :) (NP (QP (CD 35) (TO to) (CD 81)) (NN -RRB-.))))))))

det(increase-4, The-1)
nn(increase-4, mean-2)
nn(increase-4, percentage-3)
nsubj(%-14, increase-4)
det(AUC-8, the-6)
nn(AUC-8, glipizide-7)
prep_in(increase-4, AUC-8)
nn(administration-11, fluconazole-10)
prep_after(increase-4, administration-11)
cop(%-14, was-12)
num(%-14, 56.9-13)
root(ROOT-0, %-14)
dep(%-14, range-16)
number(81-20, 35-18)
dep(81-20, to-19)
num(-RRB-.-21, 81-20)
dep(range-16, -RRB-.-21)

The/DT concurrent/JJ use/NN of/IN Robinul/JJ Injection/NN with/IN other/JJ anticholinergics/NN or/CC medications/NNS with/IN anticholinergic/JJ activity/NN ,/, such/JJ as/IN phenothiazines/NNS ,/, antiparkinson/JJ drugs/NNS ,/, or/CC tricyclic/JJ antidepressants/NNS ,/, may/MD intensify/VB the/DT antimuscarinic/JJ effects/NNS and/CC may/MD result/VB in/IN an/DT increase/NN in/IN anticholinergic/JJ side/JJ effects/NNS ./.

(ROOT (S1 (S (NP (NP (DT The) (JJ concurrent) (NN use)) (PP (IN of) (NP (NP (JJ Robinul) (NN Injection)) (PP (IN with) (NP (NP (JJ other) (NN anticholinergics)) (CC or) (NP (NP (NNS medications)) (PP (IN with) (NP (JJ anticholinergic) (NN activity))) (, ,) (PP (JJ such) (IN as) (NP (NP (NNS phenothiazines)) (, ,) (NP (JJ antiparkinson) (NNS drugs)) (, ,) (CC or) (NP (JJ tricyclic) (NNS antidepressants)))) (, ,))))))) (VP (VP (MD may) (VP (VB intensify) (NP (DT the) (JJ antimuscarinic) (NNS effects)))) (CC and) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (JJ anticholinergic) (JJ side) (NNS effects)))))))) (. .))))

det(use-3, The-1)
amod(use-3, concurrent-2)
nsubj(intensify-28, use-3)
amod(Injection-6, Robinul-5)
prep_of(use-3, Injection-6)
amod(anticholinergics-9, other-8)
prep_with(Injection-6, anticholinergics-9)
conj_or(anticholinergics-9, medications-11)
amod(activity-14, anticholinergic-13)
prep_with(medications-11, activity-14)
prep_such_as(medications-11, phenothiazines-18)
amod(drugs-21, antiparkinson-20)
conj_or(phenothiazines-18, drugs-21)
amod(antidepressants-25, tricyclic-24)
conj_or(phenothiazines-18, antidepressants-25)
aux(intensify-28, may-27)
root(ROOT-0, intensify-28)
det(effects-31, the-29)
amod(effects-31, antimuscarinic-30)
dobj(intensify-28, effects-31)
aux(result-34, may-33)
conj_and(intensify-28, result-34)
det(increase-37, an-36)
prep_in(result-34, increase-37)
amod(effects-41, anticholinergic-39)
amod(effects-41, side-40)
prep_in(increase-37, effects-41)

Concomitant/JJ administration/NN of/IN Robinul/NN Injection/NN and/CC potassium/NN chloride/NN in/IN a/DT wax/NN matrix/NN may/MD increase/VB the/DT severity/NN of/IN potassium/NN chloride/NN -induced/JJ gastrointestinal/JJ lesions/NNS as/IN a/DT result/NN of/IN a/DT slower/JJR gastrointestinal/JJ transit/NN time/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN Robinul) (NN Injection)) (CC and) (NP (NN potassium) (NN chloride)))) (PP (IN in) (NP (DT a) (NN wax) (NN matrix)))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (NP (NN potassium) (NN chloride)) (JJ -induced) (JJ gastrointestinal) (NNS lesions)))) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (DT a) (JJR slower) (JJ gastrointestinal) (NN transit) (NN time)))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubj(increase-14, administration-2)
nn(Injection-5, Robinul-4)
prep_of(administration-2, Injection-5)
nn(chloride-8, potassium-7)
conj_and(Injection-5, chloride-8)
det(matrix-12, a-10)
nn(matrix-12, wax-11)
prep_in(administration-2, matrix-12)
aux(increase-14, may-13)
root(ROOT-0, increase-14)
det(severity-16, the-15)
dobj(increase-14, severity-16)
nn(chloride-19, potassium-18)
nn(lesions-22, chloride-19)
amod(lesions-22, -induced-20)
amod(lesions-22, gastrointestinal-21)
prep_of(severity-16, lesions-22)
det(result-25, a-24)
prep_as(increase-14, result-25)
det(time-31, a-27)
amod(time-31, slower-28)
amod(time-31, gastrointestinal-29)
nn(time-31, transit-30)
prep_of(result-25, time-31)

The/DT Factrel/NN test/NN should/MD be/VB conducted/VBN in/IN the/DT absence/NN of/IN other/JJ drugs/NNS which/WDT directly/RB affect/VBP the/DT pituitary/JJ secretion/NN of/IN the/DT gonadotropins/NNS ./.

(ROOT (S1 (S (S (NP (DT The) (NN Factrel) (NN test)) (VP (MD should) (VP (VB be) (VP (VBN conducted) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT which)) (S (ADVP (RB directly)) (VP (VBP affect) (NP (NP (DT the) (JJ pituitary) (NN secretion)) (PP (IN of) (NP (DT the) (NNS gonadotropins))))))))))))))) (. .))))

det(test-3, The-1)
nn(test-3, Factrel-2)
nsubjpass(conducted-6, test-3)
aux(conducted-6, should-4)
auxpass(conducted-6, be-5)
root(ROOT-0, conducted-6)
det(absence-9, the-8)
prep_in(conducted-6, absence-9)
amod(drugs-12, other-11)
prep_of(absence-9, drugs-12)
nsubj(affect-15, drugs-12)
advmod(affect-15, directly-14)
rcmod(drugs-12, affect-15)
det(secretion-18, the-16)
amod(secretion-18, pituitary-17)
dobj(affect-15, secretion-18)
det(gonadotropins-21, the-20)
prep_of(secretion-18, gonadotropins-21)

These/DT would/MD include/VB a/DT variety/NN of/IN preparations/NNS which/WDT contain/VBP androgens/NNS ,/, estrogens/NNS ,/, progestins/NNS ,/, or/CC glucocorticoids/NNS ./.

(ROOT (S1 (S (S (NP (DT These)) (VP (MD would) (VP (VB include) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (NNS preparations)) (SBAR (WHNP (WDT which)) (S (VP (VBP contain) (NP (NP (NNS androgens)) (, ,) (NP (NNS estrogens)) (, ,) (NP (NNS progestins)) (, ,) (CC or) (NP (NNS glucocorticoids)))))))))))) (. .))))

nsubj(include-3, These-1)
aux(include-3, would-2)
root(ROOT-0, include-3)
det(variety-5, a-4)
dobj(include-3, variety-5)
prep_of(variety-5, preparations-7)
nsubj(contain-9, preparations-7)
rcmod(preparations-7, contain-9)
dobj(contain-9, androgens-10)
conj_or(androgens-10, estrogens-12)
conj_or(androgens-10, progestins-14)
conj_or(androgens-10, glucocorticoids-17)

The/DT gonadotropin/NN levels/NNS may/MD be/VB transiently/RB elevated/VBN by/IN spironolactone/NN ,/, minimally/RB elevated/VBN by/IN levodopa/NN ,/, and/CC suppressed/VBN by/IN oral/JJ contraceptives/NNS and/CC digoxin/NN ./.

(ROOT (S1 (S (S (NP (DT The) (NN gonadotropin) (NNS levels)) (VP (MD may) (VP (VB be) (VP (VP (ADVP (RB transiently)) (VBN elevated) (PP (IN by) (NP (NN spironolactone)))) (, ,) (VP (ADVP (RB minimally)) (VBN elevated) (PP (IN by) (NP (NN levodopa)))) (, ,) (CC and) (VP (VBN suppressed) (PP (IN by) (NP (NP (JJ oral) (NNS contraceptives)) (CC and) (NP (NN digoxin))))))))) (. .))))

det(levels-3, The-1)
nn(levels-3, gonadotropin-2)
nsubjpass(elevated-7, levels-3)
aux(elevated-7, may-4)
auxpass(elevated-7, be-5)
advmod(elevated-7, transiently-6)
root(ROOT-0, elevated-7)
agent(elevated-7, spironolactone-9)
advmod(elevated-12, minimally-11)
conj_and(elevated-7, elevated-12)
prep_by(elevated-12, levodopa-14)
conj_and(elevated-7, suppressed-17)
amod(contraceptives-20, oral-19)
prep_by(suppressed-17, contraceptives-20)
conj_and(contraceptives-20, digoxin-22)

The/DT response/NN to/TO Factrel/NN may/MD be/VB blunted/VBN by/IN phenothiazines/NNS and/CC dopamine/NN antagonists/NNS which/WDT cause/VBP a/DT rise/NN in/IN prolactin/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN response)) (PP (TO to) (NP (NN Factrel)))) (VP (MD may) (VP (VB be) (VP (VBN blunted) (PP (IN by) (NP (NP (NP (NNS phenothiazines)) (CC and) (NP (NN dopamine) (NNS antagonists))) (SBAR (WHNP (WDT which)) (S (VP (VBP cause) (NP (NP (DT a) (NN rise)) (PP (IN in) (NP (NN prolactin))))))))))))) (. .))))

det(response-2, The-1)
nsubjpass(blunted-7, response-2)
prep_to(response-2, Factrel-4)
aux(blunted-7, may-5)
auxpass(blunted-7, be-6)
root(ROOT-0, blunted-7)
agent(blunted-7, phenothiazines-9)
nsubj(cause-14, phenothiazines-9)
nn(antagonists-12, dopamine-11)
conj_and(phenothiazines-9, antagonists-12)
rcmod(phenothiazines-9, cause-14)
det(rise-16, a-15)
dobj(cause-14, rise-16)
prep_in(rise-16, prolactin-18)

No/DT confirmed/VBN interactions/NNS have/VBP been/VBN reported/VBN between/IN ZOLADEX/NN and/CC other/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (DT No) (VBN confirmed) (NNS interactions)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN between) (NP (NP (NN ZOLADEX)) (CC and) (NP (JJ other) (NNS drugs)))))))) (. .))))

det(interactions-3, No-1)
amod(interactions-3, confirmed-2)
nsubjpass(reported-6, interactions-3)
aux(reported-6, have-4)
auxpass(reported-6, been-5)
root(ROOT-0, reported-6)
prep_between(reported-6, ZOLADEX-8)
amod(drugs-11, other-10)
conj_and(ZOLADEX-8, drugs-11)

Antacids/NNS ,/, Sucralfate/NN ,/, Metal/JJ Cations/NNS ,/, Multivitamins/NN Quinolones/NN form/VBP chelates/NNS with/IN alkaline/NN earth/NN and/CC transition/NN metal/JJ cations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Antacids)) (, ,) (NP (NN Sucralfate)) (, ,) (NP (JJ Metal) (NNS Cations)) (, ,) (NP (NN Multivitamins) (NN Quinolones))) (VP (VBP form) (NP (NNS chelates)) (PP (IN with) (NP (NP (NN alkaline) (NN earth)) (CC and) (NP (NN transition) (JJ metal) (NNS cations)))))) (. .))))

nsubj(form-10, Antacids-1)
appos(Antacids-1, Sucralfate-3)
amod(Cations-6, Metal-5)
appos(Antacids-1, Cations-6)
nn(Quinolones-9, Multivitamins-8)
appos(Antacids-1, Quinolones-9)
root(ROOT-0, form-10)
dobj(form-10, chelates-11)
nn(earth-14, alkaline-13)
prep_with(form-10, earth-14)
nn(cations-18, transition-16)
amod(cations-18, metal-17)
conj_and(earth-14, cations-18)

Administration/NN of/IN quinolones/NNS with/IN antacids/NNS containing/VBG aluminum/NN ,/, magnesium/NN ,/, or/CC calcium/NN ,/, with/IN sucralfate/NN ,/, with/IN metal/JJ cations/NNS such/JJ as/IN iron/NN ,/, or/CC with/IN multivitamins/NNS containing/VBG iron/NN or/CC zinc/NN ,/, or/CC with/IN formulations/NNS containing/VBG divalent/JJ and/CC trivalent/JJ cations/NNS such/JJ as/IN VIDEX/NN (/-LRB- didanosine/NN )/-RRB- chewable//NN buffer/NN ed/NN tablets/NNS or/CC the/DT pediatric/JJ powder/NN for/IN oral/JJ solution/NN ,/, may/MD substantially/RB interfere/VB with/IN the/DT absorption/NN of/IN quinolones/NNS ,/, resulting/VBG in/IN systemic/JJ concentrations/NNS considerably/RB lower/JJR than/IN desired/JJ ./.

(ROOT (S1 (S (S (NP (NP (NN Administration)) (PP (IN of) (NP (NP (NP (NNS quinolones)) (PP (PP (IN with) (NP (NP (NNS antacids)) (VP (VBG containing) (NP (NP (NN aluminum)) (, ,) (NP (NN magnesium)) (, ,) (CC or) (NP (NN calcium)))))) (, ,) (PP (IN with) (NP (NN sucralfate))) (, ,) (PP (IN with) (NP (NP (JJ metal) (NNS cations)) (PP (JJ such) (IN as) (NP (NN iron))))) (, ,) (CC or) (PP (IN with) (NP (NP (NNS multivitamins)) (VP (VBG containing) (NP (NP (NN iron)) (CC or) (NP (NN zinc)))))) (, ,) (CC or) (PP (IN with) (NP (NP (NNS formulations)) (VP (VBG containing) (NP (NP (JJ divalent) (CC and) (JJ trivalent) (NNS cations)) (PP (JJ such) (IN as) (NP (NN VIDEX) (-LRB- -LRB-) (NN didanosine) (-RRB- -RRB-) (NN chewable/) (NN buffer) (NN ed) (NNS tablets))))))))) (CC or) (NP (NP (DT the) (JJ pediatric) (NN powder)) (PP (IN for) (NP (JJ oral) (NN solution)))) (, ,)))) (VP (MD may) (ADVP (RB substantially)) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NNS quinolones))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (JJ systemic) (NNS concentrations)) (ADJP (RB considerably) (JJR lower) (IN than) (JJ desired))))))))) (. .))))

nsubj(interfere-60, Administration-1)
prep_of(Administration-1, quinolones-3)
prep_with(quinolones-3, antacids-5)
partmod(antacids-5, containing-6)
dobj(containing-6, aluminum-7)
conj_or(aluminum-7, magnesium-9)
conj_or(aluminum-7, calcium-12)
conj_or(antacids-5, sucralfate-15)
amod(cations-19, metal-18)
conj_or(antacids-5, cations-19)
prep_such_as(cations-19, iron-22)
conj_or(antacids-5, multivitamins-26)
partmod(multivitamins-26, containing-27)
dobj(containing-27, iron-28)
conj_or(iron-28, zinc-30)
conj_or(antacids-5, formulations-34)
partmod(formulations-34, containing-35)
amod(cations-39, divalent-36)
conj_and(divalent-36, trivalent-38)
dobj(containing-35, cations-39)
nn(tablets-49, VIDEX-42)
nn(tablets-49, didanosine-44)
nn(tablets-49, chewable/-46)
nn(tablets-49, buffer-47)
nn(tablets-49, ed-48)
prep_such_as(cations-39, tablets-49)
det(powder-53, the-51)
amod(powder-53, pediatric-52)
conj_or(quinolones-3, powder-53)
amod(solution-56, oral-55)
prep_for(powder-53, solution-56)
aux(interfere-60, may-58)
advmod(interfere-60, substantially-59)
root(ROOT-0, interfere-60)
det(absorption-63, the-62)
prep_with(interfere-60, absorption-63)
prep_of(absorption-63, quinolones-65)
xcomp(interfere-60, resulting-67)
amod(concentrations-70, systemic-69)
prep_in(resulting-67, concentrations-70)
advmod(desired-74, considerably-71)
dep(desired-74, lower-72)
dep(desired-74, than-73)
amod(concentrations-70, desired-74)

These/DT agents/NNS should/MD not/RB be/VB taken/VBN within/IN 4/CD hours/NNS before/IN or/CC 4/CD hours/NNS after/IN grepafloxacin/NN administration/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS agents)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN taken) (PP (IN within) (NP (NP (NP (CD 4) (NNS hours)) (PP (IN before))) (CC or) (NP (NP (CD 4) (NNS hours)) (PP (IN after) (NP (NN grepafloxacin) (NN administration)))))))))) (. .))))

det(agents-2, These-1)
nsubjpass(taken-6, agents-2)
aux(taken-6, should-3)
neg(taken-6, not-4)
auxpass(taken-6, be-5)
root(ROOT-0, taken-6)
num(hours-9, 4-8)
prep_within(taken-6, hours-9)
prep(hours-9, before-10)
num(hours-13, 4-12)
conj_or(hours-9, hours-13)
nn(administration-16, grepafloxacin-15)
prep_after(hours-13, administration-16)

Caffeine/NN Theobromine/NN Grepafloxacin/NN ,/, like/IN other/JJ quinolones/NNS ,/, may/MD inhibit/VB the/DT metabolism/NN of/IN caffeine/NN and/CC theobromine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Caffeine) (NN Theobromine) (NN Grepafloxacin)) (, ,) (PP (IN like) (NP (JJ other) (NNS quinolones))) (, ,)) (VP (MD may) (VP (VB inhibit) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NP (NN caffeine)) (CC and) (NP (NN theobromine)))))))) (. .))))

nn(Grepafloxacin-3, Caffeine-1)
nn(Grepafloxacin-3, Theobromine-2)
nsubj(inhibit-10, Grepafloxacin-3)
amod(quinolones-7, other-6)
prep_like(Grepafloxacin-3, quinolones-7)
aux(inhibit-10, may-9)
root(ROOT-0, inhibit-10)
det(metabolism-12, the-11)
dobj(inhibit-10, metabolism-12)
prep_of(metabolism-12, caffeine-14)
conj_and(caffeine-14, theobromine-16)

These/DT stimulants/NNS are/VBP commonly/RB found/VBN in/IN coffee/NN and/CC tea/NN ,/, respectively/RB ./.

(ROOT (S1 (S (S (NP (DT These) (NNS stimulants)) (VP (VBP are) (ADVP (RB commonly)) (VP (VBN found) (PP (IN in) (NP (NP (NN coffee)) (CC and) (NP (NN tea)))) (, ,) (ADVP (RB respectively))))) (. .))))

det(stimulants-2, These-1)
nsubjpass(found-5, stimulants-2)
auxpass(found-5, are-3)
advmod(found-5, commonly-4)
root(ROOT-0, found-5)
prep_in(found-5, coffee-7)
conj_and(coffee-7, tea-9)
advmod(found-5, respectively-11)

In/IN some/DT patients/NNS ,/, this/DT may/MD lead/VB to/TO reduced/VBN clearance/NN ,/, prolongation/NN of/IN plasma/NN half-life/NN ,/, and/CC enhanced/VBN effects/NNS of/IN caffeine/NN and/CC theobromine/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT some) (NNS patients))) (, ,) (NP (DT this)) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (VBN reduced) (NN clearance)) (, ,) (NP (NP (NN prolongation)) (PP (IN of) (NP (NN plasma) (NN half-life)))) (, ,) (CC and) (NP (NP (VBN enhanced) (NNS effects)) (PP (IN of) (NP (NP (NN caffeine)) (CC and) (NP (NN theobromine)))))))))) (. .))))

det(patients-3, some-2)
prep_in(lead-7, patients-3)
nsubj(lead-7, this-5)
aux(lead-7, may-6)
root(ROOT-0, lead-7)
amod(clearance-10, reduced-9)
prep_to(lead-7, clearance-10)
conj_and(clearance-10, prolongation-12)
nn(half-life-15, plasma-14)
prep_of(prolongation-12, half-life-15)
amod(effects-19, enhanced-18)
conj_and(clearance-10, effects-19)
prep_of(effects-19, caffeine-21)
conj_and(caffeine-21, theobromine-23)

Theophylline/NN Grepafloxacin/NN is/VBZ a/DT competitive/JJ inhibitor/NN of/IN the/DT metabolism/NN of/IN theophylline/NN ./.

(ROOT (S1 (S (S (NP (NN Theophylline) (NN Grepafloxacin)) (VP (VBZ is) (NP (NP (DT a) (JJ competitive) (NN inhibitor)) (PP (IN of) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN theophylline)))))))) (. .))))

nn(Grepafloxacin-2, Theophylline-1)
nsubj(inhibitor-6, Grepafloxacin-2)
cop(inhibitor-6, is-3)
det(inhibitor-6, a-4)
amod(inhibitor-6, competitive-5)
root(ROOT-0, inhibitor-6)
det(metabolism-9, the-8)
prep_of(inhibitor-6, metabolism-9)
prep_of(metabolism-9, theophylline-11)

Serum/NN theophylline/NN concentrations/NNS increase/VBP when/WRB grepafloxacin/NN is/VBZ initiated/VBN in/IN a/DT patient/NN maintained/VBN on/IN theophylline/NN ./.

(ROOT (S1 (S (S (NP (NN Serum) (NN theophylline) (NNS concentrations)) (VP (VBP increase) (SBAR (WHADVP (WRB when)) (S (NP (NN grepafloxacin)) (VP (VBZ is) (VP (VBN initiated) (PP (IN in) (NP (NP (DT a) (NN patient)) (VP (VBN maintained) (PP (IN on) (NP (NN theophylline)))))))))))) (. .))))

nn(concentrations-3, Serum-1)
nn(concentrations-3, theophylline-2)
nsubj(increase-4, concentrations-3)
root(ROOT-0, increase-4)
advmod(initiated-8, when-5)
nsubjpass(initiated-8, grepafloxacin-6)
auxpass(initiated-8, is-7)
advcl(increase-4, initiated-8)
det(patient-11, a-10)
prep_in(initiated-8, patient-11)
partmod(patient-11, maintained-12)
prep_on(maintained-12, theophylline-14)

When/WRB initiating/VBG a/DT multi-day/JJ course/NN of/IN grepafloxacin/NN in/IN a/DT patient/NN maintained/VBN on/IN theophylline/NN ,/, the/DT theophylline/NN maintenance/NN dose/NN should/MD be/VB halved/VBN for/IN the/DT period/NN of/IN concurrent/JJ use/NN of/IN grepafloxacin/NN and/CC monitoring/NN of/IN serum/NN theophylline/NN concentrations/NNS should/MD be/VB initiated/VBN as/IN a/DT guide/NN to/TO further/JJ dosage/NN adjustments/NNS ./.

(ROOT (S1 (S (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBG initiating) (NP (NP (DT a) (JJ multi-day) (NN course)) (PP (IN of) (NP (NN grepafloxacin)))) (PP (IN in) (NP (NP (DT a) (NN patient)) (VP (VBN maintained) (PP (IN on) (NP (NN theophylline))))))))) (, ,) (NP (DT the) (NN theophylline) (NN maintenance) (NN dose)) (VP (MD should) (VP (VB be) (VP (VBN halved) (PP (IN for) (NP (NP (DT the) (NN period)) (PP (IN of) (NP (NP (JJ concurrent) (NN use)) (PP (IN of) (NP (NN grepafloxacin))))))))))) (CC and) (S (NP (NP (NN monitoring)) (PP (IN of) (NP (NN serum) (NN theophylline) (NNS concentrations)))) (VP (MD should) (VP (VB be) (VP (VBN initiated) (PP (IN as) (NP (NP (DT a) (NN guide)) (PP (TO to) (NP (JJ further) (NN dosage) (NNS adjustments)))))))))) (. .))))

advmod(initiating-2, When-1)
advcl(halved-21, initiating-2)
det(course-5, a-3)
amod(course-5, multi-day-4)
dobj(initiating-2, course-5)
prep_of(course-5, grepafloxacin-7)
det(patient-10, a-9)
prep_in(initiating-2, patient-10)
partmod(patient-10, maintained-11)
prep_on(maintained-11, theophylline-13)
det(dose-18, the-15)
nn(dose-18, theophylline-16)
nn(dose-18, maintenance-17)
nsubjpass(halved-21, dose-18)
aux(halved-21, should-19)
auxpass(halved-21, be-20)
root(ROOT-0, halved-21)
det(period-24, the-23)
prep_for(halved-21, period-24)
amod(use-27, concurrent-26)
prep_of(period-24, use-27)
prep_of(use-27, grepafloxacin-29)
nsubjpass(initiated-38, monitoring-31)
nn(concentrations-35, serum-33)
nn(concentrations-35, theophylline-34)
prep_of(monitoring-31, concentrations-35)
aux(initiated-38, should-36)
auxpass(initiated-38, be-37)
conj_and(halved-21, initiated-38)
det(guide-41, a-40)
prep_as(initiated-38, guide-41)
amod(adjustments-45, further-43)
nn(adjustments-45, dosage-44)
prep_to(guide-41, adjustments-45)

Warfarin/NN :/: In/IN subjects/NNS receiving/VBG warfarin/NN ,/, no/DT significant/JJ change/NN in/IN clotting/NN time/NN was/VBD observed/VBN when/WRB grepafloxacin/NN was/VBD coadministered/VBN ./.

(ROOT (S1 (S (S (NP (NN Warfarin)) (: :) (PP (IN In) (NP (NP (NNS subjects)) (VP (VBG receiving) (NP (NN warfarin))))) (, ,) (NP (NP (DT no) (JJ significant) (NN change)) (PP (IN in) (NP (NN clotting) (NN time)))) (VP (VBD was) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (NN grepafloxacin)) (VP (VBD was) (VP (VBN coadministered)))))))) (. .))))

nsubjpass(observed-15, Warfarin-1)
prep_in(observed-15, subjects-4)
partmod(subjects-4, receiving-5)
dobj(receiving-5, warfarin-6)
det(change-10, no-8)
amod(change-10, significant-9)
nsubjpass(observed-15, change-10)
nn(time-13, clotting-12)
prep_in(change-10, time-13)
auxpass(observed-15, was-14)
root(ROOT-0, observed-15)
advmod(coadministered-19, when-16)
nsubjpass(coadministered-19, grepafloxacin-17)
auxpass(coadministered-19, was-18)
advcl(observed-15, coadministered-19)

However/RB ,/, because/IN some/DT quinolones/NNS have/VBP been/VBN reported/VBN to/TO enhance/VB the/DT effects/NNS of/IN warfarin/NN or/CC its/PRP$ derivatives/NNS ,/, prothrombin/NN time/NN or/CC other/JJ suitable/JJ anticoagulation/NN test/NN should/MD be/VB monitored/VBN closely/RB if/IN a/DT quinolone/JJ antimicrobial/NN is/VBZ administered/VBN with/IN warfarin/NN or/CC its/PRP$ derivatives/NNS ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (SBAR (IN because) (S (NP (DT some) (NNS quinolones)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB enhance) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NN warfarin)) (CC or) (NP (PRP$ its) (NNS derivatives))))))))))))) (, ,) (NP (NP (NN prothrombin) (NN time)) (CC or) (NP (JJ other) (JJ suitable) (NN anticoagulation) (NN test))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB closely)) (SBAR (IN if) (S (NP (DT a) (JJ quinolone) (NN antimicrobial)) (VP (VBZ is) (VP (VBN administered) (PP (IN with) (NP (NP (NN warfarin)) (CC or) (NP (PRP$ its) (NNS derivatives)))))))))))) (. .))))

advmod(monitored-28, However-1)
mark(reported-8, because-3)
det(quinolones-5, some-4)
nsubjpass(reported-8, quinolones-5)
xsubj(enhance-10, quinolones-5)
aux(reported-8, have-6)
auxpass(reported-8, been-7)
advcl(monitored-28, reported-8)
aux(enhance-10, to-9)
xcomp(reported-8, enhance-10)
det(effects-12, the-11)
dobj(enhance-10, effects-12)
prep_of(effects-12, warfarin-14)
poss(derivatives-17, its-16)
conj_or(warfarin-14, derivatives-17)
nn(time-20, prothrombin-19)
nsubjpass(monitored-28, time-20)
amod(test-25, other-22)
amod(test-25, suitable-23)
nn(test-25, anticoagulation-24)
conj_or(time-20, test-25)
aux(monitored-28, should-26)
auxpass(monitored-28, be-27)
root(ROOT-0, monitored-28)
advmod(monitored-28, closely-29)
mark(administered-35, if-30)
det(antimicrobial-33, a-31)
amod(antimicrobial-33, quinolone-32)
nsubjpass(administered-35, antimicrobial-33)
auxpass(administered-35, is-34)
advcl(monitored-28, administered-35)
prep_with(administered-35, warfarin-37)
poss(derivatives-40, its-39)
conj_or(warfarin-37, derivatives-40)

Drugs/NNS Metabolized/VBN by/IN Cytochrome/NN P450/NN Enzymes/NNS :/: The/DT drug/NN interaction/NN study/NN evaluating/VBG the/DT effect/NN of/IN grepafloxacin/NN on/IN theophylline/NN indicates/VBZ that/IN grepafloxacin/NN inhibits/VBZ theophylline/NN metabolism/NN ,/, which/WDT is/VBZ mediated/VBN by/IN CYP1A2/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Drugs)) (VP (VBN Metabolized) (PP (IN by) (NP (NN Cytochrome) (NN P450) (NNS Enzymes))))) (: :) (S (NP (NP (DT The) (NN drug) (NN interaction) (NN study)) (VP (VBG evaluating) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN grepafloxacin))) (PP (IN on) (NP (NN theophylline)))))) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NN grepafloxacin)) (VP (VBZ inhibits) (NP (NP (NN theophylline) (NN metabolism)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NN CYP1A2))))))))))))) (. .)))))

root(ROOT-0, Drugs-1)
partmod(Drugs-1, Metabolized-2)
nn(Enzymes-6, Cytochrome-4)
nn(Enzymes-6, P450-5)
agent(Metabolized-2, Enzymes-6)
det(study-11, The-8)
nn(study-11, drug-9)
nn(study-11, interaction-10)
nsubj(indicates-19, study-11)
partmod(study-11, evaluating-12)
det(effect-14, the-13)
dobj(evaluating-12, effect-14)
prep_of(effect-14, grepafloxacin-16)
prep_on(effect-14, theophylline-18)
dep(Drugs-1, indicates-19)
complm(inhibits-22, that-20)
nsubj(inhibits-22, grepafloxacin-21)
ccomp(indicates-19, inhibits-22)
nn(metabolism-24, theophylline-23)
dobj(inhibits-22, metabolism-24)
nsubjpass(mediated-28, metabolism-24)
auxpass(mediated-28, is-27)
rcmod(metabolism-24, mediated-28)
agent(mediated-28, CYP1A2-30)

While/IN no/DT clinical/JJ studies/NNS have/VBP been/VBN conducted/VBN to/TO evaluate/VB the/DT effect/NN of/IN grepafloxacin/NN on/IN the/DT metabolism/NN of/IN C.P.A./NN ./.

(ROOT (S1 (S (S (NP (IN While) (DT no) (JJ clinical) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN conducted) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN grepafloxacin))) (PP (IN on) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN C.P.A.))))))))))))) (. .))))

amod(studies-4, While-1)
det(studies-4, no-2)
amod(studies-4, clinical-3)
nsubjpass(conducted-7, studies-4)
xsubj(evaluate-9, studies-4)
aux(conducted-7, have-5)
auxpass(conducted-7, been-6)
root(ROOT-0, conducted-7)
aux(evaluate-9, to-8)
xcomp(conducted-7, evaluate-9)
det(effect-11, the-10)
dobj(evaluate-9, effect-11)
prep_of(effect-11, grepafloxacin-13)
det(metabolism-16, the-15)
prep_on(effect-11, metabolism-16)
prep_of(metabolism-16, C.P.A.-18)

substrates/NNS ,/, in/FW vitro/FW data/NNS suggest/VBP similar/JJ effects/NNS of/IN grepafloxacin/NN in/IN CYP3A4/NN mediated/VBD metabolism/NN and/CC theophylline/NN metabolism/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS substrates)) (, ,) (S (NP (ADJP (FW in) (FW vitro)) (NNS data)) (VP (VBP suggest) (NP (NP (JJ similar) (NNS effects)) (PP (IN of) (NP (NN grepafloxacin))) (PP (IN in) (NP (NN CYP3A4))))))) (VP (VBD mediated) (NP (NP (NN metabolism)) (CC and) (NP (NN theophylline) (NN metabolism))))) (. .))))

nsubj(mediated-13, substrates-1)
nn(vitro-4, in-3)
amod(data-5, vitro-4)
nsubj(suggest-6, data-5)
dep(substrates-1, suggest-6)
amod(effects-8, similar-7)
dobj(suggest-6, effects-8)
prep_of(effects-8, grepafloxacin-10)
prep_in(effects-8, CYP3A4-12)
root(ROOT-0, mediated-13)
dobj(mediated-13, metabolism-14)
nn(metabolism-17, theophylline-16)
conj_and(metabolism-14, metabolism-17)

In/IN addition/NN ,/, other/JJ quinolones/NNS have/VBP been/VBN reported/VBN to/TO decrease/VB the/DT CYP3A4/NN -mediated/JJ metabolism/NN of/IN cyclosporine/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (JJ other) (NNS quinolones)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB decrease) (NP (NP (DT the) (ADJP (NN CYP3A4) (JJ -mediated)) (NN metabolism)) (PP (IN of) (NP (NN cyclosporine))))))))))) (. .))))

prep_in(reported-8, addition-2)
amod(quinolones-5, other-4)
nsubjpass(reported-8, quinolones-5)
xsubj(decrease-10, quinolones-5)
aux(reported-8, have-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
aux(decrease-10, to-9)
xcomp(reported-8, decrease-10)
det(metabolism-14, the-11)
dep(-mediated-13, CYP3A4-12)
amod(metabolism-14, -mediated-13)
dobj(decrease-10, metabolism-14)
prep_of(metabolism-14, cyclosporine-16)

Other/JJ drugs/NNS metabolized/VBN by/IN C.P.A./NN ./.

(ROOT (S1 (S (S (NP (JJ Other) (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (NN C.P.A.))))) (. .))))

amod(drugs-2, Other-1)
nsubj(metabolized-3, drugs-2)
root(ROOT-0, metabolized-3)
prep_by(metabolized-3, C.P.A.-5)

include/VBP terfenadine/NN ,/, astemizole/NN ,/, cisapride/NN ,/, midazolam/NN ,/, and/CC triazolam/NN ./.

(ROOT (S1 (S (S (VP (VBP include) (NP (NP (NN terfenadine)) (, ,) (NP (NN astemizole)) (, ,) (NP (NN cisapride)) (, ,) (NP (NN midazolam)) (, ,) (CC and) (NP (NN triazolam))))) (. .))))

root(ROOT-0, include-1)
dobj(include-1, terfenadine-2)
conj_and(terfenadine-2, astemizole-4)
conj_and(terfenadine-2, cisapride-6)
conj_and(terfenadine-2, midazolam-8)
conj_and(terfenadine-2, triazolam-11)

The/DT clinical/JJ relevance/NN of/IN the/DT potential/JJ effect/NN of/IN grepafloxacin/NN on/IN the/DT metabolism/NN of/IN C.P.A./NN substrates/NNS is/VBZ not/RB known/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ clinical) (NN relevance)) (PP (IN of) (NP (NP (DT the) (JJ potential) (NN effect)) (PP (IN of) (NP (NN grepafloxacin))) (PP (IN on) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN C.P.A.) (NNS substrates)))))))) (VP (VBZ is) (RB not) (VP (VBN known)))) (. .))))

det(relevance-3, The-1)
amod(relevance-3, clinical-2)
nsubjpass(known-18, relevance-3)
det(effect-7, the-5)
amod(effect-7, potential-6)
prep_of(relevance-3, effect-7)
prep_of(effect-7, grepafloxacin-9)
det(metabolism-12, the-11)
prep_on(effect-7, metabolism-12)
nn(substrates-15, C.P.A.-14)
prep_of(metabolism-12, substrates-15)
auxpass(known-18, is-16)
neg(known-18, not-17)
root(ROOT-0, known-18)

Patients/NNS receiving/VBG concurrent/JJ administration/NN of/IN substrates/NNS of/IN C.P.A./NNP were/VBD not/RB excluded/VBN from/IN clinical/JJ trials/NNS of/IN grepafloxacin/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (NP (JJ concurrent) (NN administration)) (PP (IN of) (NP (NP (NNS substrates)) (PP (IN of) (NP (NNP C.P.A.)))))))) (VP (VBD were) (RB not) (VP (VBN excluded) (PP (IN from) (NP (NP (JJ clinical) (NNS trials)) (PP (IN of) (NP (NN grepafloxacin)))))))) (. .))))

nsubjpass(excluded-11, Patients-1)
partmod(Patients-1, receiving-2)
amod(administration-4, concurrent-3)
dobj(receiving-2, administration-4)
prep_of(administration-4, substrates-6)
prep_of(substrates-6, C.P.A.-8)
auxpass(excluded-11, were-9)
neg(excluded-11, not-10)
root(ROOT-0, excluded-11)
amod(trials-14, clinical-13)
prep_from(excluded-11, trials-14)
prep_of(trials-14, grepafloxacin-16)

Nonsteroidal/JJ Anti-inflammatory/JJ Drugs/NNS (/-LRB- NSAIDs/NNS )/-RRB- :/: The/DT concomitant/JJ administration/NN of/IN a/DT nonsteroidal/JJ anti/JJ inflammatory/JJ drug/NN with/IN a/DT quinolone/NN may/MD increase/VBP the/DT risks/NNS of/IN CNS/NN stimulation/NN and/CC convulsions/NN ./.

(ROOT (S1 (S (NP (NP (NP (JJ Nonsteroidal) (JJ Anti-inflammatory) (NNS Drugs)) (PRN (-LRB- -LRB-) (NP (NNS NSAIDs)) (-RRB- -RRB-))) (: :) (S (NP (NP (DT The) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (DT a) (JJ nonsteroidal) (JJ anti) (JJ inflammatory) (NN drug)) (PP (IN with) (NP (DT a) (NN quinolone)))))) (VP (MD may) (VP (VBP increase) (NP (NP (DT the) (NNS risks)) (PP (IN of) (NP (NP (NN CNS)) (NP (NN stimulation)) (CC and) (NP (NN convulsions)))))))) (. .)))))

amod(Drugs-3, Nonsteroidal-1)
amod(Drugs-3, Anti-inflammatory-2)
root(ROOT-0, Drugs-3)
appos(Drugs-3, NSAIDs-5)
det(administration-10, The-8)
amod(administration-10, concomitant-9)
nsubj(increase-21, administration-10)
det(drug-16, a-12)
amod(drug-16, nonsteroidal-13)
amod(drug-16, anti-14)
amod(drug-16, inflammatory-15)
prep_of(administration-10, drug-16)
det(quinolone-19, a-18)
prep_with(drug-16, quinolone-19)
aux(increase-21, may-20)
dep(Drugs-3, increase-21)
det(risks-23, the-22)
dobj(increase-21, risks-23)
prep_of(risks-23, CNS-25)
dep(CNS-25, stimulation-26)
conj_and(CNS-25, convulsions-28)

Antidiabetic/JJ Agents/NNS Disturbances/NNS of/IN blood/NN glucose/NN ,/, including/VBG hyperglycemia/NN and/CC hypoglycemia/NN ,/, have/VBP been/VBN reported/VBN in/IN patients/NNS treated/VBN concomitantly/RB with/IN quinolones/NNS and/CC an/DT antidiabetic/JJ agent/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Antidiabetic) (NNS Agents) (NNS Disturbances)) (PP (IN of) (NP (NN blood) (NN glucose))) (, ,) (PP (VBG including) (NP (NP (NN hyperglycemia)) (CC and) (NP (NN hypoglycemia)))) (, ,)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN treated) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NNS quinolones)) (CC and) (NP (DT an) (JJ antidiabetic) (NN agent))))))))))) (. .))))

amod(Disturbances-3, Antidiabetic-1)
nn(Disturbances-3, Agents-2)
nsubjpass(reported-15, Disturbances-3)
nn(glucose-6, blood-5)
prep_of(Disturbances-3, glucose-6)
prep_including(Disturbances-3, hyperglycemia-9)
conj_and(hyperglycemia-9, hypoglycemia-11)
aux(reported-15, have-13)
auxpass(reported-15, been-14)
root(ROOT-0, reported-15)
prep_in(reported-15, patients-17)
partmod(patients-17, treated-18)
advmod(treated-18, concomitantly-19)
prep_with(treated-18, quinolones-21)
det(agent-25, an-23)
amod(agent-25, antidiabetic-24)
conj_and(quinolones-21, agent-25)

Patients/NNS on/IN warfarin/NN -type/NN anticoagulant/NN therapy/NN may/MD require/VB dosage/NN adjustment/NN of/IN the/DT anticoagulant/NN during/IN and/CC after/IN griseofulvin/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (PP (IN on) (NP (NN warfarin) (NN -type) (NN anticoagulant) (NN therapy)))) (VP (MD may) (VP (VB require) (NP (NP (NN dosage) (NN adjustment)) (PP (IN of) (NP (DT the) (NN anticoagulant)))) (PP (PP (IN during)) (CC and) (PP (IN after) (NP (NN griseofulvin) (NN therapy))))))) (. .))))

nsubj(require-8, Patients-1)
nn(therapy-6, warfarin-3)
nn(therapy-6, -type-4)
nn(therapy-6, anticoagulant-5)
prep_on(Patients-1, therapy-6)
aux(require-8, may-7)
root(ROOT-0, require-8)
nn(adjustment-10, dosage-9)
dobj(require-8, adjustment-10)
det(anticoagulant-13, the-12)
prep_of(adjustment-10, anticoagulant-13)
prep(require-8, during-14)
conj_and(during-14, after-16)
nn(therapy-18, griseofulvin-17)
pobj(after-16, therapy-18)

Concomitant/JJ use/NN of/IN barbiturates/NNS usually/RB depresses/VBZ griseofulvin/NN activity/NN and/CC may/MD necessitate/VBP raising/VBG the/DT dosage/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NNS barbiturates)))) (VP (VP (ADVP (RB usually)) (VBZ depresses) (NP (NN griseofulvin) (NN activity))) (CC and) (VP (MD may) (VP (VBP necessitate) (S (VP (VBG raising) (NP (DT the) (NN dosage)))))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(depresses-6, use-2)
prep_of(use-2, barbiturates-4)
advmod(depresses-6, usually-5)
root(ROOT-0, depresses-6)
nn(activity-8, griseofulvin-7)
dobj(depresses-6, activity-8)
aux(necessitate-11, may-10)
conj_and(depresses-6, necessitate-11)
xcomp(necessitate-11, raising-12)
det(dosage-14, the-13)
dobj(raising-12, dosage-14)

The/DT concomitant/JJ administration/NN of/IN griseofulvin/NN has/VBZ been/VBN reported/VBN to/TO reduce/VB the/DT efficacy/NN of/IN oral/JJ contraceptives/NNS and/CC to/TO increase/VB the/DT incidence/NN of/IN breakthrough/JJ bleeding/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN griseofulvin)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (VP (TO to) (VP (VB reduce) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (JJ oral) (NNS contraceptives)))))) (CC and) (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (JJ breakthrough) (JJ bleeding)))))))))))) (. .))))

det(administration-3, The-1)
amod(administration-3, concomitant-2)
nsubjpass(reported-8, administration-3)
prep_of(administration-3, griseofulvin-5)
aux(reported-8, has-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
aux(reduce-10, to-9)
ccomp(reported-8, reduce-10)
det(efficacy-12, the-11)
dobj(reduce-10, efficacy-12)
amod(contraceptives-15, oral-14)
prep_of(efficacy-12, contraceptives-15)
aux(increase-18, to-17)
conj_and(reduce-10, increase-18)
det(incidence-20, the-19)
dobj(increase-18, incidence-20)
amod(bleeding-23, breakthrough-22)
prep_of(incidence-20, bleeding-23)

The/DT potential/NN for/IN increased/VBN sedation/NN when/WRB guanfacine/NN is/VBZ given/VBN with/IN other/JJ CNS-depressant/JJ drug/NN should/MD be/VB appreciated/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN potential)) (PP (IN for) (NP (NP (VBN increased) (NN sedation)) (SBAR (WHADVP (WRB when)) (S (NP (NN guanfacine)) (VP (VBZ is) (VP (VBN given) (PP (IN with) (NP (JJ other) (JJ CNS-depressant) (NN drug)))))))))) (VP (MD should) (VP (VB be) (VP (VBN appreciated))))) (. .))))

det(potential-2, The-1)
nsubjpass(appreciated-16, potential-2)
amod(sedation-5, increased-4)
prep_for(potential-2, sedation-5)
tmod(given-9, sedation-5)
advmod(given-9, when-6)
nsubjpass(given-9, guanfacine-7)
auxpass(given-9, is-8)
dep(sedation-5, given-9)
amod(drug-13, other-11)
amod(drug-13, CNS-depressant-12)
prep_with(given-9, drug-13)
aux(appreciated-16, should-14)
auxpass(appreciated-16, be-15)
root(ROOT-0, appreciated-16)

The/DT administration/NN of/IN guanfacine/NN concomitantly/RB with/IN known/JJ microsomal/JJ enzyme/NN inducer/NN (/-LRB- phenobarbital/NN or/CC phenytoin/NN )/-RRB- to/TO two/CD patients/NNS with/IN renal/JJ impairment/NN reportedly/RB resulted/VBD in/IN significant/JJ reductions/NNS in/IN elimination/NN half-life/NN and/CC plasma/NN concentration/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NN guanfacine))) (PP (ADVP (RB concomitantly)) (IN with) (NP (NP (JJ known) (JJ microsomal) (NN enzyme) (NN inducer)) (PRN (-LRB- -LRB-) (NP (NP (NN phenobarbital)) (CC or) (NP (NN phenytoin))) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (CD two) (NNS patients)) (PP (IN with) (NP (JJ renal) (NN impairment)))))) (ADVP (RB reportedly)) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ significant) (NNS reductions)) (PP (IN in) (NP (NP (NN elimination) (NN half-life)) (CC and) (NP (NN plasma) (NN concentration)))))))) (. .))))

det(administration-2, The-1)
nsubj(resulted-23, administration-2)
prep_of(administration-2, guanfacine-4)
advmod(administration-2, concomitantly-5)
amod(inducer-10, known-7)
amod(inducer-10, microsomal-8)
nn(inducer-10, enzyme-9)
prep_with(administration-2, inducer-10)
dep(inducer-10, phenobarbital-12)
conj_or(phenobarbital-12, phenytoin-14)
num(patients-18, two-17)
prep_to(administration-2, patients-18)
amod(impairment-21, renal-20)
prep_with(patients-18, impairment-21)
advmod(resulted-23, reportedly-22)
root(ROOT-0, resulted-23)
amod(reductions-26, significant-25)
prep_in(resulted-23, reductions-26)
nn(half-life-29, elimination-28)
prep_in(reductions-26, half-life-29)
nn(concentration-32, plasma-31)
conj_and(half-life-29, concentration-32)

Further/RB ,/, if/IN guanfacine/NN is/VBZ to/TO be/VB discontinued/VBN in/IN such/JJ patients/NNS ,/, careful/JJ tapering/NN of/IN the/DT dosage/NN may/MD be/VB necessary/JJ in/IN order/NN to/TO avoid/VB rebound/JJ phenomena/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Further)) (, ,) (SBAR (IN if) (S (NP (NN guanfacine)) (VP (VBZ is) (S (VP (TO to) (VP (VB be) (VP (VBN discontinued) (PP (IN in) (NP (JJ such) (NNS patients)))))))))) (, ,) (NP (NP (JJ careful) (NN tapering)) (PP (IN of) (NP (DT the) (NN dosage)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary))) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB avoid) (NP (JJ rebound) (NNS phenomena)))))))) (. .))))

advmod(necessary-20, Further-1)
mark(is-5, if-3)
nsubj(is-5, guanfacine-4)
xsubj(discontinued-8, guanfacine-4)
advcl(necessary-20, is-5)
aux(discontinued-8, to-6)
auxpass(discontinued-8, be-7)
xcomp(is-5, discontinued-8)
amod(patients-11, such-10)
prep_in(discontinued-8, patients-11)
amod(tapering-14, careful-13)
nsubj(necessary-20, tapering-14)
det(dosage-17, the-16)
prep_of(tapering-14, dosage-17)
aux(necessary-20, may-18)
cop(necessary-20, be-19)
root(ROOT-0, necessary-20)
mark(avoid-24, in-21)
dep(avoid-24, order-22)
aux(avoid-24, to-23)
purpcl(necessary-20, avoid-24)
amod(phenomena-26, rebound-25)
dobj(avoid-24, phenomena-26)

TCAs/NNS decrease/VBP the/DT hypotensive/JJ effect/NN of/IN guanfacine/NN ./.

(ROOT (S1 (S (S (NP (NNS TCAs)) (VP (VBP decrease) (NP (NP (DT the) (JJ hypotensive) (NN effect)) (PP (IN of) (NP (NN guanfacine)))))) (. .))))

nsubj(decrease-2, TCAs-1)
root(ROOT-0, decrease-2)
det(effect-5, the-3)
amod(effect-5, hypotensive-4)
dobj(decrease-2, effect-5)
prep_of(effect-5, guanfacine-7)

Noncardioselective/JJ beta-blockers/NNS (/-LRB- nadolol/NN ,/, porpranolol/NN ,/, timolol/NN )/-RRB- may/MD exacerbate/VB rebound/JJ hypertension/NN when/WRB guanfacine/NN is/VBZ withdrawn/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Noncardioselective) (NNS beta-blockers)) (PRN (-LRB- -LRB-) (NP (NP (NN nadolol)) (, ,) (NP (NN porpranolol)) (, ,) (NP (NN timolol))) (-RRB- -RRB-))) (VP (MD may) (VP (VB exacerbate) (NP (JJ rebound) (NN hypertension)) (SBAR (WHADVP (WRB when)) (S (NP (NN guanfacine)) (VP (VBZ is) (VP (VBN withdrawn)))))))) (. .))))

amod(beta-blockers-2, Noncardioselective-1)
nsubj(exacerbate-11, beta-blockers-2)
dep(beta-blockers-2, nadolol-4)
appos(nadolol-4, porpranolol-6)
appos(nadolol-4, timolol-8)
aux(exacerbate-11, may-10)
root(ROOT-0, exacerbate-11)
amod(hypertension-13, rebound-12)
dobj(exacerbate-11, hypertension-13)
advmod(withdrawn-17, when-14)
nsubjpass(withdrawn-17, guanfacine-15)
auxpass(withdrawn-17, is-16)
advcl(exacerbate-11, withdrawn-17)

The/DT beta-blocker/NN should/MD be/VB withdrawn/VBN first/RB ./.

(ROOT (S1 (S (S (NP (DT The) (NN beta-blocker)) (VP (MD should) (VP (VB be) (VP (VBN withdrawn) (ADVP (RB first)))))) (. .))))

det(beta-blocker-2, The-1)
nsubjpass(withdrawn-5, beta-blocker-2)
aux(withdrawn-5, should-3)
auxpass(withdrawn-5, be-4)
root(ROOT-0, withdrawn-5)
advmod(withdrawn-5, first-6)

The/DT gradual/JJ withdrawal/NN of/IN guafacine/NN or/CC a/DT cardioselective/JJ beta-blocker/NN could/MD be/VB substituted/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ gradual) (NN withdrawal)) (PP (IN of) (NP (NP (NN guafacine)) (CC or) (NP (DT a) (JJ cardioselective) (NN beta-blocker))))) (VP (MD could) (VP (VB be) (VP (VBN substituted))))) (. .))))

det(withdrawal-3, The-1)
amod(withdrawal-3, gradual-2)
nsubjpass(substituted-12, withdrawal-3)
prep_of(withdrawal-3, guafacine-5)
det(beta-blocker-9, a-7)
amod(beta-blocker-9, cardioselective-8)
conj_or(guafacine-5, beta-blocker-9)
aux(substituted-12, could-10)
auxpass(substituted-12, be-11)
root(ROOT-0, substituted-12)

Anticoagulants/NNS Ten/CD patients/NNS who/WP were/VBD stabilized/VBN on/IN oral/JJ anticoagulants/NNS were/VBD given/VBN guanfacine/NN ,/, 1-2/CD mg/day/NN ,/, for/IN 4/CD weeks/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Anticoagulants) (CD Ten) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBN stabilized) (PP (IN on) (NP (JJ oral) (NNS anticoagulants)))))))) (VP (VBD were) (VP (VBN given) (NP (NP (NN guanfacine)) (, ,) (NP (QP (CD 1-2)) (NN mg/day)) (, ,)) (PP (IN for) (NP (CD 4) (NNS weeks)))))) (. .))))

nn(patients-3, Anticoagulants-1)
num(patients-3, Ten-2)
nsubjpass(stabilized-6, patients-3)
nsubjpass(given-11, patients-3)
auxpass(stabilized-6, were-5)
rcmod(patients-3, stabilized-6)
amod(anticoagulants-9, oral-8)
prep_on(stabilized-6, anticoagulants-9)
auxpass(given-11, were-10)
root(ROOT-0, given-11)
dobj(given-11, guanfacine-12)
num(mg/day-15, 1-2-14)
appos(guanfacine-12, mg/day-15)
num(weeks-19, 4-18)
prep_for(given-11, weeks-19)

In/IN several/JJ well-controlled/JJ studies/NNS ,/, guanfacine/NN was/VBD administered/VBN together/RB with/IN diuretics/NN with/IN no/DT drug/NN interactions/NNS reported/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ several) (JJ well-controlled) (NNS studies))) (, ,) (NP (NN guanfacine)) (VP (VBD was) (VP (VBN administered) (ADVP (RB together)) (PP (IN with) (NP (NN diuretics))) (PP (IN with) (NP (NP (DT no) (NN drug) (NNS interactions)) (VP (VBN reported))))))) (. .))))

amod(studies-4, several-2)
amod(studies-4, well-controlled-3)
prep_in(administered-8, studies-4)
nsubjpass(administered-8, guanfacine-6)
auxpass(administered-8, was-7)
root(ROOT-0, administered-8)
prep_together_with(administered-8, diuretics-11)
det(interactions-15, no-13)
nn(interactions-15, drug-14)
prep_with(administered-8, interactions-15)
partmod(interactions-15, reported-16)

In/IN the/DT long-term/JJ safety/NN studies/NNS ,/, guanfacine/NN was/VBD given/VBN concomitantly/RB with/IN many/JJ drugs/NNS without/IN evidence/NN of/IN any/DT interactions/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT the) (JJ long-term) (NN safety) (NNS studies))) (, ,) (NP (NN guanfacine)) (VP (VBD was) (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (JJ many) (NNS drugs))) (PP (IN without) (NP (NP (NN evidence)) (PP (IN of) (NP (DT any) (NNS interactions)))))))) (. .))))

det(studies-5, the-2)
amod(studies-5, long-term-3)
nn(studies-5, safety-4)
prep_in(given-9, studies-5)
nsubjpass(given-9, guanfacine-7)
auxpass(given-9, was-8)
root(ROOT-0, given-9)
advmod(given-9, concomitantly-10)
amod(drugs-13, many-12)
prep_with(given-9, drugs-13)
prep_without(given-9, evidence-15)
det(interactions-18, any-17)
prep_of(evidence-15, interactions-18)

The/DT principal/JJ drugs/NNS given/VBN (/-LRB- number/NN of/IN patients/NNS in/IN parentheses/NNS )/-RRB- were/VBD :/: cardiac/JJ glycosides/NNS (/-LRB- 115/CD )/-RRB- ,/, sedatives/NNS and/CC hypnotics/NNS (/-LRB- 103/CD )/-RRB- ,/, coronary/JJ vasodilator/NN s/NNS (/-LRB- 52/CD )/-RRB- ,/, oral/JJ hypoglycemics/NNS (/-LRB- 45/CD )/-RRB- ,/, cough/NN and/CC cold/JJ preparations/NNS (/-LRB- 45/CD )/-RRB- ,/, NSAIDs/NNS (/-LRB- 38/CD )/-RRB- ,/, antihyperlipidemics/NNS (/-LRB- 29/CD )/-RRB- ,/, antigout/NN drugs/NNS (/-LRB- 24/CD )/-RRB- ,/, oral/JJ contraceptives/NNS (/-LRB- 18/CD )/-RRB- ,/, bronchodilators/NNS (/-LRB- 13/CD )/-RRB- ,/, insulin/NN (/-LRB- 10/CD )/-RRB- ,/, and/CC beta/NN blockers/NNS (/-LRB- 10)./CD

(ROOT (S1 (S (S (NP (NP (DT The) (JJ principal) (NNS drugs)) (VP (VBN given) (PRN (-LRB- -LRB-) (NP (NP (NN number)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN in) (NP (NNS parentheses)))))) (-RRB- -RRB-)))) (VP (VBD were))) (: :) (NP (NP (NP (NP (NP (JJ cardiac) (NNS glycosides)) (PRN (-LRB- -LRB-) (NP (CD 115)) (-RRB- -RRB-))) (, ,) (NP (NP (NP (NNS sedatives)) (CC and) (NP (NNS hypnotics))) (PRN (-LRB- -LRB-) (NP (CD 103)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ coronary) (NN vasodilator) (NNS s)) (PRN (-LRB- -LRB-) (NP (CD 52)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ oral) (NNS hypoglycemics)) (PRN (-LRB- -LRB-) (NP (CD 45)) (-RRB- -RRB-))) (, ,) (NP (NN cough)) (CC and) (NP (JJ cold) (NNS preparations))) (PRN (-LRB- -LRB-) (NP (CD 45)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS NSAIDs)) (PRN (-LRB- -LRB-) (NP (CD 38)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS antihyperlipidemics)) (PRN (-LRB- -LRB-) (NP (CD 29)) (-RRB- -RRB-))) (, ,) (NP (NP (NN antigout) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (CD 24)) (-RRB- -RRB-))) (, ,) (NP (NP (JJ oral) (NNS contraceptives)) (PRN (-LRB- -LRB-) (NP (CD 18)) (-RRB- -RRB-))) (, ,) (NP (NP (NNS bronchodilators)) (PRN (-LRB- -LRB-) (NP (CD 13)) (-RRB- -RRB-))) (, ,) (NP (NP (NN insulin)) (PRN (-LRB- -LRB-) (NP (CD 10)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN beta) (NNS blockers)) (-LRB- -LRB-) (CD 10-RRB-.)))))

det(drugs-3, The-1)
amod(drugs-3, principal-2)
nsubj(were-12, drugs-3)
partmod(drugs-3, given-4)
dep(given-4, number-6)
prep_of(number-6, patients-8)
prep_in(patients-8, parentheses-10)
root(ROOT-0, were-12)
amod(glycosides-15, cardiac-14)
dep(were-12, glycosides-15)
appos(glycosides-15, 115-17)
conj_and(glycosides-15, sedatives-20)
conj_and(sedatives-20, hypnotics-22)
appos(sedatives-20, 103-24)
amod(s-29, coronary-27)
nn(s-29, vasodilator-28)
conj_and(glycosides-15, s-29)
appos(s-29, 52-31)
amod(hypoglycemics-35, oral-34)
conj_and(glycosides-15, hypoglycemics-35)
appos(hypoglycemics-35, 45-37)
conj_and(glycosides-15, cough-40)
amod(preparations-43, cold-42)
conj_and(glycosides-15, preparations-43)
appos(glycosides-15, 45-45)
conj_and(glycosides-15, NSAIDs-48)
appos(NSAIDs-48, 38-50)
conj_and(glycosides-15, antihyperlipidemics-53)
appos(antihyperlipidemics-53, 29-55)
nn(drugs-59, antigout-58)
conj_and(glycosides-15, drugs-59)
appos(drugs-59, 24-61)
amod(contraceptives-65, oral-64)
conj_and(glycosides-15, contraceptives-65)
appos(contraceptives-65, 18-67)
conj_and(glycosides-15, bronchodilators-70)
appos(bronchodilators-70, 13-72)
conj_and(glycosides-15, insulin-75)
appos(insulin-75, 10-77)
nn(blockers-82, beta-81)
conj_and(glycosides-15, blockers-82)
nn(glycosides-15, blockers-82)
num(glycosides-15, 10-RRB-.-84)

Laboratory/NN Test/NN :/: In/IN clinical/JJ trials/NNS ,/, no/DT clinically/RB relevant/JJ laboratory/NN test/NN abnormalities/NNS were/VBD identified/VBN as/IN causally/RB related/JJ to/TO drug/NN during/IN short-term/JJ treatment/NN with/IN guanfacine/NN ./.

(ROOT (S1 (S (S (NP (NN Laboratory) (NN Test)) (: :) (PP (IN In) (NP (JJ clinical) (NNS trials))) (, ,) (NP (DT no) (ADJP (RB clinically) (JJ relevant)) (NN laboratory) (NN test) (NNS abnormalities)) (VP (VBD were) (VP (VBN identified) (PP (IN as) (ADJP (RB causally) (JJ related) (PP (TO to) (NP (NN drug))))) (PP (IN during) (NP (NP (JJ short-term) (NN treatment)) (PP (IN with) (NP (NN guanfacine)))))))) (. .))))

nn(Test-2, Laboratory-1)
nsubjpass(identified-15, Test-2)
amod(trials-6, clinical-5)
prep_in(identified-15, trials-6)
det(abnormalities-13, no-8)
advmod(relevant-10, clinically-9)
amod(abnormalities-13, relevant-10)
nn(abnormalities-13, laboratory-11)
nn(abnormalities-13, test-12)
nsubjpass(identified-15, abnormalities-13)
auxpass(identified-15, were-14)
root(ROOT-0, identified-15)
advmod(related-18, causally-17)
prep_as(identified-15, related-18)
prep_to(related-18, drug-20)
amod(treatment-23, short-term-22)
prep_during(identified-15, treatment-23)
prep_with(treatment-23, guanfacine-25)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: No/DT laboratory/NN test/NN abnormalities/NNS related/JJ to/TO the/DT use/NN of/IN guanfacine/NN have/VBP been/VBN identified/VBN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (NP (DT No) (NN laboratory) (NN test) (NNS abnormalities)) (ADJP (JJ related) (PP (TO to) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN guanfacine))))))) (VP (VBP have) (VP (VBN been) (VP (VBN identified))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
det(abnormalities-9, No-6)
nn(abnormalities-9, laboratory-7)
nn(abnormalities-9, test-8)
nsubjpass(identified-18, abnormalities-9)
amod(abnormalities-9, related-10)
det(use-13, the-12)
prep_to(related-10, use-13)
prep_of(use-13, guanfacine-15)
aux(identified-18, have-16)
auxpass(identified-18, been-17)
dep(Interactions-4, identified-18)

An/DT encephalopathic/JJ syndrome/NN (/-LRB- characterized/VBN by/IN weakness/NN ,/, lethargy/NN ,/, fever/NN ,/, tremulousness/NN and/CC confusion/NN ,/, extrapyramidal/JJ symptoms/NNS ,/, leukocytosis/NN ,/, elevated/JJ serum/NN enzymes/NNS ,/, BUN/NN ,/, and/CC FBS/NN )/-RRB- followed/VBN by/IN irreversible/JJ brain/NN damage/NN has/VBZ occurred/VBN in/IN a/DT few/JJ patients/NNS treated/VBN with/IN lithium/NN plus/CC HALDOL/NN ./.

(ROOT (S1 (S (S (NP (NP (DT An) (JJ encephalopathic) (NN syndrome)) (-LRB- -LRB-) (VP (VBN characterized) (PP (IN by) (NP (NP (NN weakness)) (, ,) (NP (NN lethargy)) (, ,) (NP (NN fever)) (, ,) (NP (NN tremulousness)) (CC and) (NP (NN confusion)) (, ,) (NP (JJ extrapyramidal) (NNS symptoms)) (, ,) (NP (NN leukocytosis)) (, ,) (NP (JJ elevated) (NN serum) (NNS enzymes)) (, ,) (NP (NN BUN)) (, ,) (CC and) (NP (NN FBS))))) (-RRB- -RRB-) (VP (VBN followed) (PP (IN by) (NP (JJ irreversible) (NN brain) (NN damage))))) (VP (VBZ has) (VP (VBN occurred) (PP (IN in) (NP (NP (DT a) (JJ few) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (NN lithium)) (CC plus) (NP (NN HALDOL)))))))))) (. .))))

det(syndrome-3, An-1)
amod(syndrome-3, encephalopathic-2)
nsubj(occurred-37, syndrome-3)
partmod(syndrome-3, characterized-5)
agent(characterized-5, weakness-7)
conj_and(weakness-7, lethargy-9)
conj_and(weakness-7, fever-11)
conj_and(weakness-7, tremulousness-13)
conj_and(weakness-7, confusion-15)
amod(symptoms-18, extrapyramidal-17)
conj_and(weakness-7, symptoms-18)
conj_and(weakness-7, leukocytosis-20)
amod(enzymes-24, elevated-22)
nn(enzymes-24, serum-23)
conj_and(weakness-7, enzymes-24)
conj_and(weakness-7, BUN-26)
conj_and(weakness-7, FBS-29)
partmod(syndrome-3, followed-31)
amod(damage-35, irreversible-33)
nn(damage-35, brain-34)
agent(followed-31, damage-35)
aux(occurred-37, has-36)
root(ROOT-0, occurred-37)
det(patients-41, a-39)
amod(patients-41, few-40)
prep_in(occurred-37, patients-41)
partmod(patients-41, treated-42)
prep_with(treated-42, lithium-44)
conj_plus(lithium-44, HALDOL-46)

A/DT causal/JJ relationship/NN between/IN these/DT events/NNS and/CC the/DT concomitant/JJ administration/NN of/IN lithium/NN and/CC HALDOL/NN has/VBZ not/RB been/VBN established/VBN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NP (DT A) (JJ causal) (NN relationship)) (PP (IN between) (NP (DT these) (NNS events)))) (CC and) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN lithium)) (CC and) (NP (NN HALDOL)))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN established)))) (: ;)) (. .))))

det(relationship-3, A-1)
amod(relationship-3, causal-2)
nsubjpass(established-18, relationship-3)
det(events-6, these-5)
prep_between(relationship-3, events-6)
det(administration-10, the-8)
amod(administration-10, concomitant-9)
conj_and(relationship-3, administration-10)
prep_of(administration-10, lithium-12)
conj_and(lithium-12, HALDOL-14)
aux(established-18, has-15)
neg(established-18, not-16)
auxpass(established-18, been-17)
root(ROOT-0, established-18)

As/IN with/IN other/JJ antipsychotic/JJ agents/NNS ,/, it/PRP should/MD be/VB noted/VBN that/IN HALDOL/NN may/MD be/VB capable/JJ of/IN potentiating/NN CNS/NN depressants/NNS such/JJ as/IN anesthetics/NN ,/, opiates/NN ,/, and/CC alcohol/NN ./.

(ROOT (S1 (S (S (PP (IN As) (PP (IN with) (NP (JJ other) (JJ antipsychotic) (NNS agents)))) (, ,) (NP (PRP it)) (VP (MD should) (VP (VB be) (VP (VBN noted) (SBAR (IN that) (S (NP (NN HALDOL)) (VP (MD may) (VP (VB be) (ADJP (JJ capable) (PP (IN of) (NP (NP (NN potentiating) (NN CNS) (NNS depressants)) (PP (JJ such) (IN as) (NP (NP (NN anesthetics)) (, ,) (NP (NN opiates)) (, ,) (CC and) (NP (NN alcohol))))))))))))))) (. .))))

prep(noted-10, As-1)
pcomp(As-1, with-2)
amod(agents-5, other-3)
amod(agents-5, antipsychotic-4)
prep_with(As-1, agents-5)
nsubjpass(noted-10, it-7)
aux(noted-10, should-8)
auxpass(noted-10, be-9)
root(ROOT-0, noted-10)
complm(capable-15, that-11)
nsubj(capable-15, HALDOL-12)
aux(capable-15, may-13)
cop(capable-15, be-14)
ccomp(noted-10, capable-15)
nn(depressants-19, potentiating-17)
nn(depressants-19, CNS-18)
prep_of(capable-15, depressants-19)
prep_such_as(depressants-19, anesthetics-22)
conj_and(anesthetics-22, opiates-24)
conj_and(anesthetics-22, alcohol-27)

In/IN a/DT study/NN of/IN 12/CD schizophrenic/JJ patients/NNS coadministered/JJ oral/JJ haloperidol/NN and/CC rifampin/NN ,/, plasma/NN haloperidol/NN levels/NNS were/VBD decreased/VBN by/IN a/DT mean/NN of/IN 70/CD %/NN and/CC mean/NN scores/NNS on/IN the/DT Brief/JJ Psychiatric/JJ Rating/NN Scale/NN were/VBD increased/VBN from/IN baseline/NN ./.

(ROOT (S1 (S (S (S (PP (IN In) (NP (NP (DT a) (NN study)) (PP (IN of) (NP (NP (CD 12) (JJ schizophrenic) (NNS patients)) (NP (NP (JJ coadministered) (JJ oral) (NN haloperidol)) (CC and) (NP (NN rifampin))))))) (, ,) (NP (NN plasma) (NN haloperidol) (NNS levels)) (VP (VBD were) (VP (VBN decreased) (PP (IN by) (DT a) (NN mean) (IN of) (NP (CD 70) (NN %)))))) (CC and) (S (NP (NP (NN mean) (NNS scores)) (PP (IN on) (NP (DT the) (JJ Brief) (JJ Psychiatric) (NN Rating) (NN Scale)))) (VP (VBD were) (VP (VBN increased) (PP (IN from) (NP (NN baseline))))))) (. .))))

det(study-3, a-2)
prep_in(decreased-18, study-3)
num(patients-7, 12-5)
amod(patients-7, schizophrenic-6)
prep_of(study-3, patients-7)
amod(haloperidol-10, coadministered-8)
amod(haloperidol-10, oral-9)
dep(patients-7, haloperidol-10)
conj_and(haloperidol-10, rifampin-12)
nn(levels-16, plasma-14)
nn(levels-16, haloperidol-15)
nsubjpass(decreased-18, levels-16)
auxpass(decreased-18, were-17)
root(ROOT-0, decreased-18)
dep(decreased-18, by-19)
dep(decreased-18, a-20)
dep(decreased-18, mean-21)
num(%-24, 70-23)
prep_of(decreased-18, %-24)
nn(scores-27, mean-26)
nsubjpass(increased-35, scores-27)
det(Scale-33, the-29)
amod(Scale-33, Brief-30)
amod(Scale-33, Psychiatric-31)
nn(Scale-33, Rating-32)
prep_on(scores-27, Scale-33)
auxpass(increased-35, were-34)
conj_and(decreased-18, increased-35)
prep_from(increased-35, baseline-37)

In/IN 5/CD other/JJ schizophrenic/JJ patients/NNS treated/VBN with/IN oral/JJ haloperidol/NN and/CC rifampin/NN ,/, discontinuation/NN of/IN rifampin/NN produced/VBD a/DT mean/JJ 3.3-fold/RB increase/NN in/IN haloperidol/JJ concentrations/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (CD 5) (JJ other) (JJ schizophrenic) (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (JJ oral) (NN haloperidol)) (CC and) (NP (NN rifampin))))))) (, ,) (NP (NP (NN discontinuation)) (PP (IN of) (NP (NN rifampin)))) (VP (VBD produced) (NP (NP (DT a) (JJ mean) (RB 3.3-fold) (NN increase)) (PP (IN in) (NP (JJ haloperidol) (NNS concentrations)))))) (. .))))

num(patients-5, 5-2)
amod(patients-5, other-3)
amod(patients-5, schizophrenic-4)
prep_in(produced-16, patients-5)
partmod(patients-5, treated-6)
amod(haloperidol-9, oral-8)
prep_with(treated-6, haloperidol-9)
conj_and(haloperidol-9, rifampin-11)
nsubj(produced-16, discontinuation-13)
prep_of(discontinuation-13, rifampin-15)
root(ROOT-0, produced-16)
det(increase-20, a-17)
amod(increase-20, mean-18)
advmod(increase-20, 3.3-fold-19)
dobj(produced-16, increase-20)
amod(concentrations-23, haloperidol-22)
prep_in(increase-20, concentrations-23)

Thus/RB ,/, careful/JJ monitoring/NN of/IN clinical/JJ status/NN is/VBZ warranted/VBN when/WRB rifampin/NN is/VBZ administered/VBN or/CC discontinued/VBN in/IN haloperidol/JJ -treated/JJ patients/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NP (JJ careful) (NN monitoring)) (PP (IN of) (NP (JJ clinical) (NN status)))) (VP (VBZ is) (VP (VBN warranted) (SBAR (WHADVP (WRB when)) (S (NP (NN rifampin)) (VP (VBZ is) (VP (VP (VBN administered)) (CC or) (VP (VBN discontinued) (PP (IN in) (NP (JJ haloperidol) (JJ -treated) (NNS patients))))))))))) (. .))))

advmod(warranted-9, Thus-1)
amod(monitoring-4, careful-3)
nsubjpass(warranted-9, monitoring-4)
amod(status-7, clinical-6)
prep_of(monitoring-4, status-7)
auxpass(warranted-9, is-8)
root(ROOT-0, warranted-9)
advmod(administered-13, when-10)
nsubjpass(administered-13, rifampin-11)
auxpass(administered-13, is-12)
advcl(warranted-9, administered-13)
conj_or(administered-13, discontinued-15)
amod(patients-19, haloperidol-17)
amod(patients-19, -treated-18)
prep_in(discontinued-15, patients-19)

FLUOTHANE/NN augments/VBZ the/DT action/NN of/IN non-depolarising/JJ muscle/NN relaxant/NN s/NNS and/CC the/DT muscle/NN relaxant/JJ effects/NNS of/IN aminoglycosides/NNS ./.

(ROOT (S1 (S (S (NP (NN FLUOTHANE)) (VP (VBZ augments) (NP (NP (NP (DT the) (NN action)) (PP (IN of) (NP (JJ non-depolarising) (NN muscle) (NN relaxant) (NNS s)))) (CC and) (NP (NP (DT the) (NN muscle) (JJ relaxant) (NNS effects)) (PP (IN of) (NP (NNS aminoglycosides))))))) (. .))))

nsubj(augments-2, FLUOTHANE-1)
root(ROOT-0, augments-2)
det(action-4, the-3)
dobj(augments-2, action-4)
amod(s-9, non-depolarising-6)
nn(s-9, muscle-7)
nn(s-9, relaxant-8)
prep_of(action-4, s-9)
det(effects-14, the-11)
nn(effects-14, muscle-12)
amod(effects-14, relaxant-13)
conj_and(action-4, effects-14)
prep_of(effects-14, aminoglycosides-16)

FLUOTHANE/NN may/MD augment/VB the/DT hypotension/NN caused/VBN by/IN the/DT ganglionic-blocking/JJ effect/NN of/IN tubocurarine/NN ./.

(ROOT (S1 (S (S (NP (NN FLUOTHANE)) (VP (MD may) (VP (VB augment) (NP (NP (DT the) (NN hypotension)) (VP (VBN caused) (PP (IN by) (NP (NP (DT the) (JJ ganglionic-blocking) (NN effect)) (PP (IN of) (NP (NN tubocurarine)))))))))) (. .))))

nsubj(augment-3, FLUOTHANE-1)
aux(augment-3, may-2)
root(ROOT-0, augment-3)
det(hypotension-5, the-4)
dobj(augment-3, hypotension-5)
partmod(hypotension-5, caused-6)
det(effect-10, the-8)
amod(effect-10, ganglionic-blocking-9)
agent(caused-6, effect-10)
prep_of(effect-10, tubocurarine-12)

Caution/NN should/MD be/VB exercised/VBN during/IN the/DT administration/NN of/IN adrenaline/NN to/TO patients/NNS anaesthetised/JJ with/IN FLUOTHANE/NN as/IN arrhythmias/NNS may/MD be/VB precipitated/JJ ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (PP (IN during) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NN adrenaline))) (PP (TO to) (NP (NP (NNS patients)) (VP (JJ anaesthetised) (PP (IN with) (NP (NN FLUOTHANE))) (SBAR (IN as) (S (NP (NNS arrhythmias)) (VP (MD may) (VP (VB be) (ADJP (JJ precipitated))))))))))))))) (. .))))

nsubjpass(exercised-4, Caution-1)
aux(exercised-4, should-2)
auxpass(exercised-4, be-3)
root(ROOT-0, exercised-4)
det(administration-7, the-6)
prep_during(exercised-4, administration-7)
prep_of(administration-7, adrenaline-9)
prep_to(administration-7, patients-11)
dep(patients-11, anaesthetised-12)
prep_with(anaesthetised-12, FLUOTHANE-14)
mark(precipitated-19, as-15)
nsubj(precipitated-19, arrhythmias-16)
aux(precipitated-19, may-17)
cop(precipitated-19, be-18)
advcl(anaesthetised-12, precipitated-19)

For/IN this/DT reason/NN the/DT dose/NN of/IN adrenaline/NN should/MD be/VB restricted/VBN and/CC an/DT antiarrhythmic/JJ agent/NN administered/VBN as/IN appropriate/JJ ./.

(ROOT (S1 (S (S (S (PP (IN For) (NP (DT this) (NN reason))) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN adrenaline)))) (VP (MD should) (VP (VB be) (VP (VBN restricted))))) (CC and) (S (NP (NP (DT an) (JJ antiarrhythmic) (NN agent)) (VP (VBN administered) (PP (IN as) (NP (JJ appropriate))))))) (. .))))

det(reason-3, this-2)
prep_for(restricted-10, reason-3)
det(dose-5, the-4)
nsubjpass(restricted-10, dose-5)
prep_of(dose-5, adrenaline-7)
aux(restricted-10, should-8)
auxpass(restricted-10, be-9)
root(ROOT-0, restricted-10)
det(agent-14, an-12)
amod(agent-14, antiarrhythmic-13)
conj_and(restricted-10, agent-14)
partmod(agent-14, administered-15)
prep_as(administered-15, appropriate-17)

Caution/NN should/MD also/RB be/VB applied/VBN for/IN other/JJ sympathomimetics/NNS ,/, and/CC for/IN aminophylline/NN and/CC theophylline/NN and/CC tricyclic/JJ antidepressants/NNS ,/, which/WDT may/MD also/RB precipitate/VB arrhythmias/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (ADVP (RB also)) (VP (VB be) (VP (VBN applied) (PP (PP (IN for) (NP (JJ other) (NNS sympathomimetics))) (, ,) (CC and) (PP (IN for) (NP (NP (NP (NN aminophylline)) (CC and) (NP (NN theophylline))) (CC and) (NP (NP (JJ tricyclic) (NNS antidepressants)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (ADVP (RB also)) (VP (VB precipitate) (NP (NN arrhythmias)))))))))))))) (. .))))

nsubjpass(applied-5, Caution-1)
aux(applied-5, should-2)
advmod(applied-5, also-3)
auxpass(applied-5, be-4)
root(ROOT-0, applied-5)
amod(sympathomimetics-8, other-7)
prep_for(applied-5, sympathomimetics-8)
conj_and(sympathomimetics-8, aminophylline-12)
conj_and(aminophylline-12, theophylline-14)
amod(antidepressants-17, tricyclic-16)
conj_and(aminophylline-12, antidepressants-17)
nsubj(precipitate-22, antidepressants-17)
aux(precipitate-22, may-20)
advmod(precipitate-22, also-21)
rcmod(antidepressants-17, precipitate-22)
dobj(precipitate-22, arrhythmias-23)

Drug/NN Interactions/NNS :/: a./FW Drugs/NNS Enhancing/NN Heparin/NN Effect/NN :/: Oral/JJ anticoagulants/NNS :/: Heparin/NN sodium/NN may/MD prolong/VB the/DT one-stage/JJ prothrombin/NN time/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NNS Interactions)) (: :) (NP (FW a.) (NNS Drugs) (NN Enhancing) (NN Heparin) (NN Effect)) (: :) (NP (JJ Oral) (NNS anticoagulants)) (: :) (NP (NN Heparin) (NN sodium))) (VP (MD may) (VP (VB prolong) (NP (DT the) (JJ one-stage) (NN prothrombin) (NN time))))) (. .))))

nn(Interactions-2, Drug-1)
nsubj(prolong-16, Interactions-2)
nn(Effect-8, a.-4)
nn(Effect-8, Drugs-5)
nn(Effect-8, Enhancing-6)
nn(Effect-8, Heparin-7)
dep(Interactions-2, Effect-8)
amod(anticoagulants-11, Oral-10)
dep(Interactions-2, anticoagulants-11)
nn(sodium-14, Heparin-13)
dep(Interactions-2, sodium-14)
aux(prolong-16, may-15)
root(ROOT-0, prolong-16)
det(time-20, the-17)
amod(time-20, one-stage-18)
nn(time-20, prothrombin-19)
dobj(prolong-16, time-20)

Therefore/RB ,/, when/WRB heparin/NN sodium/NN is/VBZ given/VBN with/IN dicumarol/NN or/CC warfarin/NN sodium/NN ,/, a/DT period/NN of/IN at/IN least/JJS 5/CD hours/NNS after/IN the/DT last/JJ intravenous/JJ dose/NN or/CC 24/CD hours/NNS after/IN the/DT last/JJ subcutaneous/NN dose/NN should/MD elapse/VB before/IN blood/NN is/VBZ drawn/VBN if/IN a/DT valid/JJ prothrombin/NN time/NN is/VBZ to/TO be/VB obtained/VBN ./.

(ROOT (S1 (S (ADVP (RB Therefore)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NN heparin) (NN sodium)) (VP (VBZ is) (VP (VBN given) (PP (IN with) (NP (NP (NN dicumarol)) (CC or) (NP (NN warfarin)) (NP (NN sodium)))))))) (, ,) (NP (NP (DT a) (NN period)) (PP (IN of) (NP (NP (NP (QP (IN at) (JJS least) (CD 5)) (NNS hours)) (PP (IN after) (NP (DT the) (JJ last) (JJ intravenous) (NN dose)))) (CC or) (NP (NP (CD 24) (NNS hours)) (PP (IN after) (NP (DT the) (JJ last) (NN subcutaneous) (NN dose))))))) (VP (MD should) (VP (VB elapse) (SBAR (IN before) (S (NP (NN blood)) (VP (VBZ is) (VP (VBN drawn) (SBAR (IN if) (S (NP (DT a) (JJ valid) (NN prothrombin) (NN time)) (VP (VBZ is) (S (VP (TO to) (VP (VB be) (VP (VBN obtained)))))))))))))) (. .))))

advmod(elapse-35, Therefore-1)
advmod(given-7, when-3)
nn(sodium-5, heparin-4)
nsubjpass(given-7, sodium-5)
auxpass(given-7, is-6)
advcl(elapse-35, given-7)
prep_with(given-7, dicumarol-9)
conj_or(dicumarol-9, warfarin-11)
dep(dicumarol-9, sodium-12)
det(period-15, a-14)
nsubj(elapse-35, period-15)
quantmod(5-19, at-17)
mwe(at-17, least-18)
pobj(at-17, least-18)
num(hours-20, 5-19)
prep_of(period-15, hours-20)
det(dose-25, the-22)
amod(dose-25, last-23)
amod(dose-25, intravenous-24)
prep_after(hours-20, dose-25)
num(hours-28, 24-27)
conj_or(hours-20, hours-28)
det(dose-33, the-30)
amod(dose-33, last-31)
nn(dose-33, subcutaneous-32)
prep_after(hours-28, dose-33)
aux(elapse-35, should-34)
root(ROOT-0, elapse-35)
mark(drawn-39, before-36)
nsubjpass(drawn-39, blood-37)
auxpass(drawn-39, is-38)
advcl(elapse-35, drawn-39)
mark(is-45, if-40)
det(time-44, a-41)
amod(time-44, valid-42)
nn(time-44, prothrombin-43)
nsubj(is-45, time-44)
xsubj(obtained-48, time-44)
advcl(drawn-39, is-45)
aux(obtained-48, to-46)
auxpass(obtained-48, be-47)
xcomp(is-45, obtained-48)

Platelet/NN inhibitors/NNS :/: Drugs/NNS such/JJ as/IN acetylsalicylic/JJ acid/NN ,/, dextran/NN ,/, phenylbutazone/NN ,/, ibuprofen/NN ,/, indomethacin/NN ,/, dipyridamole/NN ,/, hydroxychloroquine/NN and/CC others/NNS that/WDT interfere/VBP with/IN platelet-aggregation/JJ reactions/NNS (/-LRB- the/DT main/JJ hemostatic/JJ defense/NN of/IN heparinized/JJ patients/NNS )/-RRB- may/MD induce/VB bleeding/JJ and/CC should/MD be/VB used/VBN with/IN caution/NN in/IN patients/NNS receiving/VBG heparin/NN sodium/NN ./.

(ROOT (S1 (S (NP (NP (NN Platelet) (NNS inhibitors)) (: :) (S (NP (NP (NNS Drugs)) (PP (JJ such) (IN as) (NP (NP (NP (JJ acetylsalicylic) (NN acid)) (, ,) (NP (NN dextran)) (, ,) (NP (NN phenylbutazone)) (, ,) (NP (NN ibuprofen)) (, ,) (NP (NN indomethacin)) (, ,) (NP (NN dipyridamole)) (, ,) (NP (NN hydroxychloroquine)) (CC and) (NP (NNS others))) (SBAR (WHNP (WDT that)) (S (VP (VBP interfere) (PP (IN with) (NP (NP (JJ platelet-aggregation) (NNS reactions)) (PRN (-LRB- -LRB-) (NP (NP (DT the) (JJ main) (JJ hemostatic) (NN defense)) (PP (IN of) (NP (JJ heparinized) (NNS patients)))) (-RRB- -RRB-)))))))))) (VP (VP (MD may) (VP (VB induce) (ADJP (JJ bleeding)))) (CC and) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NP (NN caution)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN heparin) (NN sodium)))))))))))) (. .)))))

nn(inhibitors-2, Platelet-1)
root(ROOT-0, inhibitors-2)
nsubj(induce-38, Drugs-4)
amod(acid-8, acetylsalicylic-7)
prep_such_as(Drugs-4, acid-8)
nsubj(interfere-24, acid-8)
conj_and(acid-8, dextran-10)
conj_and(acid-8, phenylbutazone-12)
conj_and(acid-8, ibuprofen-14)
conj_and(acid-8, indomethacin-16)
conj_and(acid-8, dipyridamole-18)
conj_and(acid-8, hydroxychloroquine-20)
conj_and(acid-8, others-22)
rcmod(acid-8, interfere-24)
amod(reactions-27, platelet-aggregation-26)
prep_with(interfere-24, reactions-27)
det(defense-32, the-29)
amod(defense-32, main-30)
amod(defense-32, hemostatic-31)
dep(reactions-27, defense-32)
amod(patients-35, heparinized-34)
prep_of(defense-32, patients-35)
aux(induce-38, may-37)
dep(inhibitors-2, induce-38)
acomp(induce-38, bleeding-39)
aux(used-43, should-41)
auxpass(used-43, be-42)
conj_and(induce-38, used-43)
prep_with(used-43, caution-45)
prep_in(caution-45, patients-47)
partmod(patients-47, receiving-48)
nn(sodium-50, heparin-49)
dobj(receiving-48, sodium-50)

The/DT anticoagulant/JJ effect/NN of/IN heparin/NN is/VBZ enhanced/VBN by/IN concurrent/JJ treatment/NN with/IN antithrombin/NN III/CD (/-LRB- human/NN )/-RRB- in/IN patients/NNS with/IN hereditary/JJ antithrombin/NN III/CD deficiency/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ anticoagulant) (NN effect)) (PP (IN of) (NP (NN heparin)))) (VP (VBZ is) (VP (VBN enhanced) (PP (IN by) (NP (NP (JJ concurrent) (NN treatment)) (PP (IN with) (NP (NP (NN antithrombin) (CD III)) (PRN (-LRB- -LRB-) (NP (NN human)) (-RRB- -RRB-)))))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ hereditary) (NN antithrombin) (CD III) (NN deficiency)))))))) (. .))))

det(effect-3, The-1)
amod(effect-3, anticoagulant-2)
nsubjpass(enhanced-7, effect-3)
prep_of(effect-3, heparin-5)
auxpass(enhanced-7, is-6)
root(ROOT-0, enhanced-7)
amod(treatment-10, concurrent-9)
agent(enhanced-7, treatment-10)
prep_with(treatment-10, antithrombin-12)
num(antithrombin-12, III-13)
appos(antithrombin-12, human-15)
prep_in(enhanced-7, patients-18)
amod(deficiency-23, hereditary-20)
nn(deficiency-23, antithrombin-21)
num(deficiency-23, III-22)
prep_with(patients-18, deficiency-23)

Thus/RB in/IN order/NN to/TO avoid/VB bleeding/JJ ,/, reduced/VBN dosage/NN of/IN heparin/NN is/VBZ recommended/VBN during/IN treatment/NN with/IN antithrombin/NN III/CD (/-LRB- human)./NN

(ROOT (S1 (S (ADVP (RB Thus)) (SBAR (IN in) (NN order) (S (VP (TO to) (VP (VB avoid) (ADJP (JJ bleeding)))))) (, ,) (NP (NP (VBN reduced) (NN dosage)) (PP (IN of) (NP (NN heparin)))) (VP (VBZ is) (VP (VBN recommended) (PP (IN during) (NP (NP (NN treatment)) (PP (IN with) (NP (NN antithrombin) (CD III))))) (PRN (-LRB- -LRB-) (NP (NN human-RRB-.))))))))

advmod(recommended-13, Thus-1)
mark(avoid-5, in-2)
dep(avoid-5, order-3)
aux(avoid-5, to-4)
dep(recommended-13, avoid-5)
acomp(avoid-5, bleeding-6)
amod(dosage-9, reduced-8)
nsubjpass(recommended-13, dosage-9)
prep_of(dosage-9, heparin-11)
auxpass(recommended-13, is-12)
root(ROOT-0, recommended-13)
prep_during(recommended-13, treatment-15)
prep_with(treatment-15, antithrombin-17)
num(antithrombin-17, III-18)
dep(recommended-13, human-RRB-.-20)

Drugs/NNS Decreasing/VBG Heparin/NN Effect/NN :/: Digitalis/NN ,/, tetracyclines/NN ,/, nicotine/NN ,/, or/CC antihistamines/NNS may/MD partially/RB counteract/VB the/DT anticoagulant/JJ action/NN of/IN heparin/NN sodium/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Drugs)) (PP (VBG Decreasing) (NP (NN Heparin) (NN Effect)))) (: :) (NP (NP (NN Digitalis)) (, ,) (NP (NN tetracyclines)) (, ,) (NP (NN nicotine)) (, ,) (CC or) (NP (NNS antihistamines)))) (VP (MD may) (ADVP (RB partially)) (VP (VB counteract) (NP (NP (DT the) (JJ anticoagulant) (NN action)) (PP (IN of) (NP (NN heparin) (NN sodium))))))) (. .))))

nsubj(counteract-16, Drugs-1)
nn(Effect-4, Heparin-3)
prep_decreasing(Drugs-1, Effect-4)
dep(Drugs-1, Digitalis-6)
conj_or(Digitalis-6, tetracyclines-8)
conj_or(Digitalis-6, nicotine-10)
conj_or(Digitalis-6, antihistamines-13)
aux(counteract-16, may-14)
advmod(counteract-16, partially-15)
root(ROOT-0, counteract-16)
det(action-19, the-17)
amod(action-19, anticoagulant-18)
dobj(counteract-16, action-19)
nn(sodium-22, heparin-21)
prep_of(action-19, sodium-22)

Heparin/NN Sodium/NN Injection/NN should/MD not/RB be/VB mixed/VBN with/IN doxorubicin/NN ,/, droperidol/NN ,/, ciprofloxacin/NN ,/, or/CC mitoxantrone/NN ,/, since/IN it/PRP has/VBZ been/VBN reported/VBN that/IN these/DT drugs/NNS are/VBP incompatible/JJ with/IN heparin/NN and/CC a/DT precipitate/NN may/MD form/VB ./.

(ROOT (S1 (S (S (NP (NN Heparin) (NN Sodium) (NN Injection)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN mixed) (PP (IN with) (NP (NP (NN doxorubicin)) (, ,) (NP (NN droperidol)) (, ,) (NP (NN ciprofloxacin)) (, ,) (CC or) (NP (NN mitoxantrone)))) (, ,) (SBAR (IN since) (S (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (SBAR (IN that) (S (S (NP (DT these) (NNS drugs)) (VP (VBP are) (ADJP (JJ incompatible) (PP (IN with) (NP (NN heparin)))))) (CC and) (S (NP (DT a) (NN precipitate)) (VP (MD may) (VP (VB form))))))))))))))) (. .))))

nn(Injection-3, Heparin-1)
nn(Injection-3, Sodium-2)
nsubjpass(mixed-7, Injection-3)
aux(mixed-7, should-4)
neg(mixed-7, not-5)
auxpass(mixed-7, be-6)
root(ROOT-0, mixed-7)
prep_with(mixed-7, doxorubicin-9)
conj_or(doxorubicin-9, droperidol-11)
conj_or(doxorubicin-9, ciprofloxacin-13)
conj_or(doxorubicin-9, mitoxantrone-16)
mark(reported-22, since-18)
nsubjpass(reported-22, it-19)
aux(reported-22, has-20)
auxpass(reported-22, been-21)
advcl(mixed-7, reported-22)
complm(incompatible-27, that-23)
det(drugs-25, these-24)
nsubj(incompatible-27, drugs-25)
cop(incompatible-27, are-26)
ccomp(reported-22, incompatible-27)
prep_with(incompatible-27, heparin-29)
det(precipitate-32, a-31)
nsubj(form-34, precipitate-32)
aux(form-34, may-33)
conj_and(incompatible-27, form-34)

Drug/NN //: Laboratory/NN Tests/NNS Interactions/NNS Hyperaminotransferasemia/FW :/: Significant/JJ elevations/NNS of/IN aminotransferase/NN (/-LRB- SGOT/NN [S-/JJ AST/NN ]/-RRB- and/CC SGPT/NN [S-ALT/NN ]/-RRB- )/-RRB- levels/NNS have/VBP occurred/VBN in/IN a/DT high/JJ percentage/NN of/IN patients/NNS (/-LRB- and/CC healthy/JJ subjects/NNS )/-RRB- who/WP have/VBP received/VBN heparin/NN sodium/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Drug)) (PRN (: /) (NP (NP (NN Laboratory) (NNS Tests)) (NP (NP (NNS Interactions)) (ADVP (FW Hyperaminotransferasemia))) (: :) (NP (NP (JJ Significant) (NNS elevations)) (PP (IN of) (NP (NP (NP (NN aminotransferase)) (PRN (-LRB- -LRB-) (NP (NN SGOT) (JJ -LSB-S-) (NN AST)) (-RRB- -RSB-))) (CC and) (NP (NN SGPT) (NN -LSB-S-ALT)))) (-RRB- -RSB-))) (-RRB- -RRB-))) (NNS levels)) (VP (VBP have) (VP (VBN occurred) (PP (IN in) (NP (NP (DT a) (JJ high) (NN percentage)) (PP (IN of) (NP (NP (NP (NNS patients)) (-LRB- -LRB-) (CC and) (NP (JJ healthy) (NNS subjects)) (-RRB- -RRB-)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN received) (NP (NN heparin) (NN sodium))))))))))))) (. .))))

nn(levels-22, Drug-1)
punct(Tests-4, /-2)
nn(Tests-4, Laboratory-3)
dep(Drug-1, Tests-4)
dep(Tests-4, Interactions-5)
advmod(Interactions-5, Hyperaminotransferasemia-6)
amod(elevations-9, Significant-8)
dep(Tests-4, elevations-9)
prep_of(elevations-9, aminotransferase-11)
nn(AST-15, SGOT-13)
amod(AST-15, -LSB-S--14)
abbrev(aminotransferase-11, AST-15)
punct(AST-15, -RSB--16)
nn(-LSB-S-ALT-19, SGPT-18)
conj_and(aminotransferase-11, -LSB-S-ALT-19)
punct(elevations-9, -RSB--20)
nsubj(occurred-24, levels-22)
aux(occurred-24, have-23)
root(ROOT-0, occurred-24)
det(percentage-28, a-26)
amod(percentage-28, high-27)
prep_in(occurred-24, percentage-28)
prep_of(percentage-28, patients-30)
nsubj(received-38, patients-30)
amod(subjects-34, healthy-33)
conj_and(patients-30, subjects-34)
aux(received-38, have-37)
rcmod(patients-30, received-38)
nn(sodium-40, heparin-39)
dobj(received-38, sodium-40)

Since/IN aminotransferase/NN determinations/NNS are/VBP important/JJ in/IN the/DT differential/JJ diagnosis/NN of/IN myocardial/JJ infarction/NN ,/, liver/NN disease/NN and/CC pulmonary/JJ emboli/NNS ,/, rises/VBZ that/WDT might/MD be/VB caused/VBN by/IN drugs/NNS (/-LRB- heparin/NN sodium/NN )/-RRB- should/MD be/VB interpreted/VBN with/IN caution/NN ./.

(ROOT (S1 (S (SBAR (IN Since) (S (NP (NN aminotransferase) (NNS determinations)) (VP (VBP are) (ADJP (JJ important) (PP (IN in) (NP (NP (DT the) (JJ differential) (NN diagnosis)) (PP (IN of) (NP (NP (JJ myocardial) (NN infarction)) (, ,) (NP (NN liver) (NN disease)) (CC and) (NP (JJ pulmonary) (NNS emboli)))))))))) (, ,) (NP (NP (VBZ rises)) (SBAR (WHNP (WDT that)) (S (VP (MD might) (VP (VB be) (VP (VBN caused) (PP (IN by) (NP (NP (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NN heparin) (NN sodium)) (-RRB- -RRB-)))))))))) (VP (MD should) (VP (VB be) (VP (VBN interpreted) (PP (IN with) (NP (NN caution)))))) (. .))))

mark(important-5, Since-1)
nn(determinations-3, aminotransferase-2)
nsubj(important-5, determinations-3)
cop(important-5, are-4)
advcl(interpreted-33, important-5)
det(diagnosis-9, the-7)
amod(diagnosis-9, differential-8)
prep_in(important-5, diagnosis-9)
amod(infarction-12, myocardial-11)
prep_of(diagnosis-9, infarction-12)
nn(disease-15, liver-14)
conj_and(infarction-12, disease-15)
amod(emboli-18, pulmonary-17)
conj_and(infarction-12, emboli-18)
nsubjpass(caused-24, rises-20)
nsubjpass(interpreted-33, rises-20)
aux(caused-24, might-22)
auxpass(caused-24, be-23)
rcmod(rises-20, caused-24)
agent(caused-24, drugs-26)
nn(sodium-29, heparin-28)
appos(drugs-26, sodium-29)
aux(interpreted-33, should-31)
auxpass(interpreted-33, be-32)
root(ROOT-0, interpreted-33)
prep_with(interpreted-33, caution-35)

Opioids/NNS are/VBP strong/JJ central/JJ nervous/JJ system/NN depressants/NNS ,/, but/CC regular/JJ users/NNS develop/VBP physiological/JJ tolerance/NN allowing/VBG gradually/RB increased/VBN dosages/NNS ./.

(ROOT (S1 (S (S (S (NP (NNS Opioids)) (VP (VBP are) (NP (JJ strong) (NP (JJ central) (JJ nervous) (NN system)) (NNS depressants)))) (, ,) (CC but) (S (NP (JJ regular) (NNS users)) (VP (VBP develop) (NP (NP (JJ physiological) (NN tolerance)) (VP (VBG allowing) (NP (ADVP (RB gradually)) (VBN increased) (NNS dosages))))))) (. .))))

nsubj(depressants-7, Opioids-1)
cop(depressants-7, are-2)
amod(depressants-7, strong-3)
amod(system-6, central-4)
amod(system-6, nervous-5)
nn(depressants-7, system-6)
root(ROOT-0, depressants-7)
amod(users-11, regular-10)
nsubj(develop-12, users-11)
conj_but(depressants-7, develop-12)
amod(tolerance-14, physiological-13)
dobj(develop-12, tolerance-14)
partmod(tolerance-14, allowing-15)
advmod(dosages-18, gradually-16)
amod(dosages-18, increased-17)
dobj(allowing-15, dosages-18)

In/IN combination/NN with/IN other/JJ central/JJ nervous/JJ system/NN depressants/NNS ,/, heroin/NN may/MD still/RB kill/VB even/RB experienced/VBN users/NNS ,/, particularly/RB if/IN their/PRP$ tolerance/NN to/TO the/DT drug/NN has/VBZ reduced/VBN or/CC the/DT strength/NN of/IN their/PRP$ usual/JJ dose/NN has/VBZ increased/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NN combination)) (PP (IN with) (NP (JJ other) (NP (JJ central) (JJ nervous) (NN system)) (NNS depressants))))) (, ,) (NP (NN heroin)) (VP (MD may) (ADVP (RB still)) (VP (VB kill) (NP (ADJP (RB even) (VBN experienced)) (NNS users)) (, ,) (SBAR (RB particularly) (IN if) (S (S (NP (NP (PRP$ their) (NN tolerance)) (PP (TO to) (NP (DT the) (NN drug)))) (VP (VBZ has) (VP (VBN reduced)))) (CC or) (S (NP (NP (DT the) (NN strength)) (PP (IN of) (NP (PRP$ their) (JJ usual) (NN dose)))) (VP (VBZ has) (VP (VBN increased))))))))) (. .))))

prep_in(kill-13, combination-2)
amod(depressants-8, other-4)
amod(system-7, central-5)
amod(system-7, nervous-6)
nn(depressants-8, system-7)
prep_with(combination-2, depressants-8)
nsubj(kill-13, heroin-10)
aux(kill-13, may-11)
advmod(kill-13, still-12)
root(ROOT-0, kill-13)
advmod(experienced-15, even-14)
amod(users-16, experienced-15)
dobj(kill-13, users-16)
advmod(reduced-26, particularly-18)
dep(reduced-26, if-19)
poss(tolerance-21, their-20)
nsubj(reduced-26, tolerance-21)
det(drug-24, the-23)
prep_to(tolerance-21, drug-24)
aux(reduced-26, has-25)
dep(kill-13, reduced-26)
det(strength-29, the-28)
nsubj(increased-35, strength-29)
poss(dose-33, their-31)
amod(dose-33, usual-32)
prep_of(strength-29, dose-33)
aux(increased-35, has-34)
conj_or(reduced-26, increased-35)

Toxicology/NN studies/NNS of/IN heroin/NN -related/JJ deaths/NNS reveal/VBP frequent/JJ involvement/NN of/IN other/JJ central/JJ nervous/JJ system/NN depressants/NNS ,/, including/VBG alcohol/NN ,/, benzodiazepines/NNS such/JJ as/IN diazepam/NN (/-LRB- Valium/NN )/-RRB- ,/, and/CC ,/, to/TO a/DT rising/JJ degree/NN ,/, methadone/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Toxicology) (NNS studies)) (PP (IN of) (NP (NN heroin) (JJ -related) (NNS deaths)))) (VP (VBP reveal) (NP (NP (JJ frequent) (NN involvement)) (PP (IN of) (NP (NP (JJ other) (NP (JJ central) (JJ nervous) (NN system)) (NNS depressants)) (, ,) (PP (VBG including) (NP (NP (NN alcohol)) (, ,) (NP (NP (NNS benzodiazepines)) (PP (JJ such) (IN as) (NP (NP (NN diazepam)) (PRN (-LRB- -LRB-) (NP (NN Valium)) (-RRB- -RRB-))))) (, ,) (CC and) (, ,) (PP (TO to) (NP (DT a) (JJ rising) (NN degree))) (, ,) (NP (NN methadone))))))))) (. .))))

nn(studies-2, Toxicology-1)
nsubj(reveal-7, studies-2)
nn(deaths-6, heroin-4)
amod(deaths-6, -related-5)
prep_of(studies-2, deaths-6)
root(ROOT-0, reveal-7)
amod(involvement-9, frequent-8)
dobj(reveal-7, involvement-9)
amod(depressants-15, other-11)
amod(system-14, central-12)
amod(system-14, nervous-13)
nn(depressants-15, system-14)
prep_of(involvement-9, depressants-15)
prep_including(depressants-15, alcohol-18)
conj_and(alcohol-18, benzodiazepines-20)
prep_such_as(benzodiazepines-20, diazepam-23)
appos(diazepam-23, Valium-25)
conj_and(alcohol-18, to-30)
det(degree-33, a-31)
amod(degree-33, rising-32)
prep_to(alcohol-18, degree-33)
conj_and(alcohol-18, methadone-35)

Ironically/RB ,/, benzodiazepines/NNS are/VBP often/RB used/VBN in/IN the/DT treatment/NN of/IN heroin/NN addiction/NN while/IN they/PRP cause/VBP much/RB more/RBR severe/JJ withdrawal/NN symptoms/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Ironically)) (, ,) (NP (NNS benzodiazepines)) (VP (VBP are) (ADVP (RB often)) (VP (VBN used) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN heroin) (NN addiction))))) (SBAR (IN while) (S (NP (PRP they)) (VP (VBP cause) (NP (ADJP (RB much) (RBR more) (JJ severe)) (NN withdrawal) (NNS symptoms)))))))) (. .))))

advmod(used-6, Ironically-1)
nsubjpass(used-6, benzodiazepines-3)
auxpass(used-6, are-4)
advmod(used-6, often-5)
root(ROOT-0, used-6)
det(treatment-9, the-8)
prep_in(used-6, treatment-9)
nn(addiction-12, heroin-11)
prep_of(treatment-9, addiction-12)
mark(cause-15, while-13)
nsubj(cause-15, they-14)
advcl(used-6, cause-15)
advmod(severe-18, much-16)
advmod(severe-18, more-17)
amod(symptoms-20, severe-18)
nn(symptoms-20, withdrawal-19)
dobj(cause-15, symptoms-20)

Cocaine/NN sometimes/RB proves/VBZ to/TO be/VB fatal/JJ when/WRB used/VBN in/IN combination/NN with/IN heroin/NN ./.

(ROOT (S1 (S (S (NP (NN Cocaine)) (ADVP (RB sometimes)) (VP (VBZ proves) (S (VP (TO to) (VP (VB be) (ADJP (JJ fatal))) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN heroin)))))))))))) (. .))))

nsubj(proves-3, Cocaine-1)
xsubj(fatal-6, Cocaine-1)
advmod(proves-3, sometimes-2)
root(ROOT-0, proves-3)
aux(fatal-6, to-4)
cop(fatal-6, be-5)
xcomp(proves-3, fatal-6)
advmod(used-8, when-7)
advcl(fatal-6, used-8)
prep_in(used-8, combination-10)
prep_with(combination-10, heroin-12)

Barbiturates/NNS may/MD decrease/VB the/DT effectiveness/NN of/IN oral/JJ contraceptives/NNS ,/, certain/JJ antibiotics/NNS ,/, quinidine/NN ,/, theophylline/NN ,/, corticosteroids/NNS ,/, anticoagulants/NNS ,/, and/CC beta/NN blockers/NNS ./.

(ROOT (S1 (S (S (NP (NNS Barbiturates)) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (NP (JJ oral) (NNS contraceptives)) (, ,) (NP (JJ certain) (NNS antibiotics)) (, ,) (NP (NN quinidine)) (, ,) (NP (NN theophylline)) (, ,) (NP (NNS corticosteroids)) (, ,) (NP (NNS anticoagulants)) (, ,) (CC and) (NP (NN beta) (NNS blockers)))))))) (. .))))

nsubj(decrease-3, Barbiturates-1)
aux(decrease-3, may-2)
root(ROOT-0, decrease-3)
det(effectiveness-5, the-4)
dobj(decrease-3, effectiveness-5)
amod(contraceptives-8, oral-7)
prep_of(effectiveness-5, contraceptives-8)
amod(antibiotics-11, certain-10)
conj_and(contraceptives-8, antibiotics-11)
conj_and(contraceptives-8, quinidine-13)
conj_and(contraceptives-8, theophylline-15)
conj_and(contraceptives-8, corticosteroids-17)
conj_and(contraceptives-8, anticoagulants-19)
nn(blockers-23, beta-22)
conj_and(contraceptives-8, blockers-23)

MAO/NN inhibitors/NNS should/MD be/VB used/VBN with/IN caution/NN in/IN patients/NNS receiving/VBG hydralazine/NN ./.

(ROOT (S1 (S (S (NP (NN MAO) (NNS inhibitors)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN caution))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN hydralazine))))))))) (. .))))

nn(inhibitors-2, MAO-1)
nsubjpass(used-5, inhibitors-2)
aux(used-5, should-3)
auxpass(used-5, be-4)
root(ROOT-0, used-5)
prep_with(used-5, caution-7)
prep_in(used-5, patients-9)
partmod(patients-9, receiving-10)
dobj(receiving-10, hydralazine-11)

When/WRB other/JJ potent/JJ parental/JJ antihypertensive/JJ drugs/NNS ,/, such/JJ as/IN diazoxide/NN ,/, are/VBP used/VBN in/IN combination/NN with/IN hydralazine/NN ,/, patients/NNS should/MD be/VB continuously/RB observed/VBN for/IN several/JJ hours/NNS for/IN any/DT excessive/JJ fall/VBP in/IN blood/NN pressure/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NP (JJ other) (JJ potent) (JJ parental) (JJ antihypertensive) (NNS drugs)) (, ,) (PP (JJ such) (IN as) (NP (NN diazoxide))) (, ,)) (VP (VBP are) (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN hydralazine))))))))) (, ,) (NP (NNS patients)) (VP (MD should) (VP (VB be) (ADVP (RB continuously)) (VP (VBN observed) (PP (IN for) (NP (NP (JJ several) (NNS hours)) (PP (IN for) (NP (NP (DT any) (JJ excessive)) (VP (VBP fall) (PP (IN in) (NP (NN blood) (NN pressure)))))))))))) (. .))))

advmod(used-13, When-1)
amod(drugs-6, other-2)
amod(drugs-6, potent-3)
amod(drugs-6, parental-4)
amod(drugs-6, antihypertensive-5)
nsubjpass(used-13, drugs-6)
prep_such_as(drugs-6, diazoxide-10)
auxpass(used-13, are-12)
advcl(observed-23, used-13)
prep_in(used-13, combination-15)
prep_with(combination-15, hydralazine-17)
nsubjpass(observed-23, patients-19)
aux(observed-23, should-20)
auxpass(observed-23, be-21)
advmod(observed-23, continuously-22)
root(ROOT-0, observed-23)
amod(hours-26, several-25)
prep_for(observed-23, hours-26)
det(excessive-29, any-28)
prep_for(hours-26, excessive-29)
dep(excessive-29, fall-30)
nn(pressure-33, blood-32)
prep_in(fall-30, pressure-33)

Profound/JJ hypotensive/JJ episodes/NNS may/MD occur/VB when/WRB diazoxide/NN infection/NN and/CC hydralazine/NN are/VBP used/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (JJ Profound) (JJ hypotensive) (NNS episodes)) (VP (MD may) (VP (VB occur) (SBAR (WHADVP (WRB when)) (S (NP (NN diazoxide) (NP (NP (NN infection)) (CC and) (NP (NN hydralazine)))) (VP (VBP are) (VP (VBN used) (ADVP (RB concomitantly))))))))) (. .))))

amod(episodes-3, Profound-1)
amod(episodes-3, hypotensive-2)
nsubj(occur-5, episodes-3)
aux(occur-5, may-4)
root(ROOT-0, occur-5)
advmod(used-12, when-6)
nsubjpass(used-12, diazoxide-7)
dep(diazoxide-7, infection-8)
conj_and(infection-8, hydralazine-10)
auxpass(used-12, are-11)
advcl(occur-5, used-12)
advmod(used-12, concomitantly-13)

Beta-blockers/NN (/-LRB- metoprolol/NN ,/, propranolol/NN )/-RRB- serum/NN concentrations/NNS and/CC pharmacologic/JJ effects/NNS may/MD be/VB increased/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (NN Beta-blockers)) (PRN (-LRB- -LRB-) (NP (NP (NN metoprolol)) (, ,) (NP (NN propranolol))) (-RRB- -RRB-))) (NN serum) (NNS concentrations)) (CC and) (NP (JJ pharmacologic) (NNS effects))) (VP (MD may) (VP (VB be) (VP (VBN increased))))) (. .))))

nn(concentrations-8, Beta-blockers-1)
dep(Beta-blockers-1, metoprolol-3)
appos(metoprolol-3, propranolol-5)
nn(concentrations-8, serum-7)
nsubjpass(increased-14, concentrations-8)
amod(effects-11, pharmacologic-10)
conj_and(concentrations-8, effects-11)
aux(increased-14, may-12)
auxpass(increased-14, be-13)
root(ROOT-0, increased-14)

Propranolol/NN increases/VBZ hydralazine/NN s/NN serum/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NN Propranolol)) (VP (VBZ increases) (NP (NN hydralazine) (NN s) (NN serum) (NNS concentrations)))) (. .))))

nsubj(increases-2, Propranolol-1)
root(ROOT-0, increases-2)
nn(concentrations-6, hydralazine-3)
nn(concentrations-6, s-4)
nn(concentrations-6, serum-5)
dobj(increases-2, concentrations-6)

Acebutolol/NN ,/, atenolol/NN ,/, and/CC nadolol/NN (/-LRB- low/JJ hepatic/JJ clearance/NN or/CC no/NN first-pass/NN metabolism/NN )/-RRB- are/VBP unlikely/JJ to/TO be/VB affected/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Acebutolol)) (, ,) (NP (NN atenolol)) (, ,) (CC and) (NP (NN nadolol))) (PRN (-LRB- -LRB-) (NP (NP (JJ low) (JJ hepatic) (NN clearance)) (CC or) (NP (NN no) (NN first-pass) (NN metabolism))) (-RRB- -RRB-))) (VP (VBP are) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB be) (VP (VBN affected)))))))) (. .))))

nsubj(unlikely-17, Acebutolol-1)
conj_and(Acebutolol-1, atenolol-3)
conj_and(Acebutolol-1, nadolol-6)
amod(clearance-10, low-8)
amod(clearance-10, hepatic-9)
dep(Acebutolol-1, clearance-10)
nn(metabolism-14, no-12)
nn(metabolism-14, first-pass-13)
conj_or(clearance-10, metabolism-14)
cop(unlikely-17, are-16)
root(ROOT-0, unlikely-17)
aux(affected-20, to-18)
auxpass(affected-20, be-19)
xcomp(unlikely-17, affected-20)

NSAIDs/NNS may/MD decrease/VB the/DT hemodynamic/JJ effects/NNS of/IN hydralazine/NN ;/: ./.

(ROOT (S1 (S (S (NP (NNS NSAIDs)) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (JJ hemodynamic) (NNS effects)) (PP (IN of) (NP (NN hydralazine)))))) (: ;)) (. .))))

nsubj(decrease-3, NSAIDs-1)
aux(decrease-3, may-2)
root(ROOT-0, decrease-3)
det(effects-6, the-4)
amod(effects-6, hemodynamic-5)
dobj(decrease-3, effects-6)
prep_of(effects-6, hydralazine-8)

When/WRB given/VBN concurrently/RB the/DT following/JJ drugs/NNS may/MD interact/VB with/IN thiazide/NN diuretics/NNS ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN given) (ADVP (RB concurrently))))) (NP (DT the) (JJ following) (NNS drugs)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NN thiazide) (NNS diuretics)))))) (. .))))

advmod(given-2, When-1)
advcl(interact-8, given-2)
advmod(given-2, concurrently-3)
det(drugs-6, the-4)
amod(drugs-6, following-5)
nsubj(interact-8, drugs-6)
aux(interact-8, may-7)
root(ROOT-0, interact-8)
nn(diuretics-11, thiazide-10)
prep_with(interact-8, diuretics-11)

Alcohol/NN ,/, barbiturates/NNS ,/, or/CC narcotics/NNS :/: potentiation/NN of/IN orthostatic/JJ hypotension/NN may/MD occur/VB ./.

(ROOT (S1 (S (S (S (NP (NP (NN Alcohol)) (, ,) (NP (NNS barbiturates)) (, ,) (CC or) (NP (NNS narcotics)))) (: :) (S (NP (NP (NN potentiation)) (PP (IN of) (NP (JJ orthostatic) (NN hypotension)))) (VP (MD may) (VP (VB occur))))) (. .))))

root(ROOT-0, Alcohol-1)
conj_or(Alcohol-1, barbiturates-3)
conj_or(Alcohol-1, narcotics-6)
nsubj(occur-13, potentiation-8)
amod(hypotension-11, orthostatic-10)
prep_of(potentiation-8, hypotension-11)
aux(occur-13, may-12)
parataxis(Alcohol-1, occur-13)

Antidiabetic/JJ drugs/NNS :/: (/-LRB- oral/JJ agents/NNS and/CC insulin/NN )/-RRB- -/CC dosage/NN adjustment/NN of/IN the/DT antidiabetic/JJ drug/NN may/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Antidiabetic) (NNS drugs) (: :)) (PRN (-LRB- -LRB-) (NP (NP (JJ oral) (NNS agents)) (CC and) (NP (NN insulin))) (-RRB- -RRB-))) (CC -) (NP (NP (NN dosage) (NN adjustment)) (PP (IN of) (NP (DT the) (JJ antidiabetic) (NN drug))))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (. .))))

amod(drugs-2, Antidiabetic-1)
nsubjpass(required-19, drugs-2)
amod(agents-6, oral-5)
dep(drugs-2, agents-6)
conj_and(agents-6, insulin-8)
nn(adjustment-12, dosage-11)
conj(drugs-2, adjustment-12)
det(drug-16, the-14)
amod(drug-16, antidiabetic-15)
prep_of(adjustment-12, drug-16)
aux(required-19, may-17)
auxpass(required-19, be-18)
root(ROOT-0, required-19)

Other/JJ antihypertensive/JJ drugs/NNS :/: additive/JJ effect/NN or/CC potentiation/NN ./.

(ROOT (S1 (S (NP (NP (JJ Other) (JJ antihypertensive) (NNS drugs)) (: :) (NP (NP (JJ additive) (NN effect)) (CC or) (NP (NN potentiation))) (. .)))))

amod(drugs-3, Other-1)
amod(drugs-3, antihypertensive-2)
root(ROOT-0, drugs-3)
amod(effect-6, additive-5)
dep(drugs-3, effect-6)
conj_or(effect-6, potentiation-8)

Cholestyramine/NN and/CC colestipol/NN resins/NNS :/: Absorption/NN of/IN hydrochlorothiazide/NN is/VBZ impaired/VBN in/IN the/DT presence/NN of/IN anionic/JJ exchange/NN resins/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NP (NN Cholestyramine)) (CC and) (NP (NN colestipol))) (NNS resins)) (: :) (S (NP (NP (NN Absorption)) (PP (IN of) (NP (NN hydrochlorothiazide)))) (VP (VBZ is) (VP (VBN impaired) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ anionic) (NN exchange) (NNS resins)))))))) (. .)))))

nn(resins-4, Cholestyramine-1)
conj_and(Cholestyramine-1, colestipol-3)
root(ROOT-0, resins-4)
nsubjpass(impaired-10, Absorption-6)
prep_of(Absorption-6, hydrochlorothiazide-8)
auxpass(impaired-10, is-9)
dep(resins-4, impaired-10)
det(presence-13, the-12)
prep_in(impaired-10, presence-13)
amod(resins-17, anionic-15)
nn(resins-17, exchange-16)
prep_of(presence-13, resins-17)

Single/JJ doses/NNS of/IN either/CC cholestyramine/NN or/CC colestipol/NN resins/NNS bind/VB the/DT hydrochlorothiazide/NN and/CC reduce/VB its/PRP$ absorption/NN from/IN the/DT gastrointestinal/JJ tract/NN by/IN up/RB to/TO 85/CD and/CC 43/CD percent/NN ,/, respectively/RB ./.

(ROOT (S1 (S (S (NP (NP (JJ Single) (NNS doses)) (PP (IN of) (NP (CC either) (NP (NN cholestyramine)) (CC or) (NP (NN colestipol) (NNS resins))))) (VP (VP (VB bind) (NP (DT the) (NN hydrochlorothiazide))) (CC and) (VP (VB reduce) (NP (NP (PRP$ its) (NN absorption)) (PP (IN from) (NP (DT the) (JJ gastrointestinal) (NN tract)))) (PP (IN by) (NP (NP (QP (RB up) (TO to) (CD 85) (CC and) (CD 43)) (NN percent)) (, ,) (ADVP (RB respectively))))))) (. .))))

amod(doses-2, Single-1)
nsubj(bind-9, doses-2)
preconj(cholestyramine-5, either-4)
prep_of(doses-2, cholestyramine-5)
nn(resins-8, colestipol-7)
conj_or(cholestyramine-5, resins-8)
root(ROOT-0, bind-9)
det(hydrochlorothiazide-11, the-10)
dobj(bind-9, hydrochlorothiazide-11)
conj_and(bind-9, reduce-13)
poss(absorption-15, its-14)
dobj(reduce-13, absorption-15)
det(tract-19, the-17)
amod(tract-19, gastrointestinal-18)
prep_from(absorption-15, tract-19)
quantmod(85-23, up-21)
dep(85-23, to-22)
num(percent-26, 85-23)
conj_and(85-23, 43-25)
prep_by(reduce-13, percent-26)
advmod(percent-26, respectively-28)

Corticosteroids/NNS ,/, ACTH/NN :/: intensified/JJ electrolyte/NN depletion/NN ,/, particularly/RB hypokalemia/NN ./.

(ROOT (S1 (S (NP (NP (NNS Corticosteroids)) (, ,) (NP (NN ACTH)) (: :) (NP (NP (JJ intensified) (NN electrolyte) (NN depletion)) (, ,) (ADVP (RB particularly)) (NP (NN hypokalemia))) (. .)))))

root(ROOT-0, Corticosteroids-1)
appos(Corticosteroids-1, ACTH-3)
amod(depletion-7, intensified-5)
nn(depletion-7, electrolyte-6)
dep(Corticosteroids-1, depletion-7)
advmod(depletion-7, particularly-9)
dep(depletion-7, hypokalemia-10)

Pressor/JJ amines/NNS (/-LRB- e.g./FW ,/, norepinephrine/NN )/-RRB- :/: possible/JJ decreased/VBD response/NN to/TO pressor/JJ amines/NNS but/CC not/RB sufficient/JJ to/TO preclude/VB their/PRP$ use/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Pressor) (NNS amines)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN norepinephrine))) (-RRB- -RRB-))) (: :) (ADJP (JJ possible))) (VP (VP (VBD decreased) (NP (NP (NN response)) (PP (TO to) (NP (JJ pressor) (NNS amines))))) (CC but) (RB not) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB preclude) (NP (PRP$ their) (NN use)))))))) (. .))))

amod(amines-2, Pressor-1)
nsubj(decreased-10, amines-2)
dep(amines-2, e.g.-4)
pobj(e.g.-4, norepinephrine-6)
amod(amines-2, possible-9)
root(ROOT-0, decreased-10)
dobj(decreased-10, response-11)
amod(amines-14, pressor-13)
prep_to(response-11, amines-14)
conj_but(decreased-10, not-16)
neg(decreased-10, not-16)
acomp(decreased-10, sufficient-17)
aux(preclude-19, to-18)
xcomp(sufficient-17, preclude-19)
poss(use-21, their-20)
dobj(preclude-19, use-21)

Skeletal/JJ muscle/NN relaxants/NNS ,/, nondepolarizing/NN (/-LRB- e.g./FW ,/, tubocurarine/NN )/-RRB- :/: possible/JJ increased/VBN responsiveness/NN to/TO the/DT muscle/NN relaxant/NN ./.

(ROOT (S1 (S (NP (NP (JJ Skeletal) (NN muscle) (NNS relaxants)) (, ,) (NP (NP (NN nondepolarizing)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN tubocurarine)) (-RRB- -RRB-))) (: :) (NP (NP (JJ possible) (VBN increased) (NN responsiveness)) (PP (TO to) (NP (DT the) (NN muscle) (NN relaxant)))) (. .)))))

amod(relaxants-3, Skeletal-1)
nn(relaxants-3, muscle-2)
root(ROOT-0, relaxants-3)
appos(relaxants-3, nondepolarizing-5)
dep(tubocurarine-9, e.g.-7)
appos(nondepolarizing-5, tubocurarine-9)
amod(responsiveness-14, possible-12)
amod(responsiveness-14, increased-13)
dep(relaxants-3, responsiveness-14)
det(relaxant-18, the-16)
nn(relaxant-18, muscle-17)
prep_to(responsiveness-14, relaxant-18)

Lithium/NN :/: generally/RB should/MD not/RB be/VB given/VBN with/IN diuretics/NN ./.

(ROOT (S1 (S (S (S (NP (NN Lithium))) (: :) (S (ADVP (RB generally)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN given) (PP (IN with) (NP (NN diuretics)))))))) (. .))))

root(ROOT-0, Lithium-1)
advmod(given-7, generally-3)
aux(given-7, should-4)
neg(given-7, not-5)
auxpass(given-7, be-6)
parataxis(Lithium-1, given-7)
prep_with(given-7, diuretics-9)

Diuretic/JJ agents/NNS reduce/VBP the/DT renal/JJ clearance/NN of/IN lithium/NN and/CC add/VBP a/DT high/JJ risk/NN of/IN lithium/NN toxicity/NN ./.

(ROOT (S1 (S (S (NP (JJ Diuretic) (NNS agents)) (VP (VP (VBP reduce) (NP (NP (DT the) (JJ renal) (NN clearance)) (PP (IN of) (NP (NN lithium))))) (CC and) (VP (VBP add) (NP (NP (DT a) (JJ high) (NN risk)) (PP (IN of) (NP (NN lithium) (NN toxicity))))))) (. .))))

amod(agents-2, Diuretic-1)
nsubj(reduce-3, agents-2)
root(ROOT-0, reduce-3)
det(clearance-6, the-4)
amod(clearance-6, renal-5)
dobj(reduce-3, clearance-6)
prep_of(clearance-6, lithium-8)
conj_and(reduce-3, add-10)
det(risk-13, a-11)
amod(risk-13, high-12)
dobj(add-10, risk-13)
nn(toxicity-16, lithium-15)
prep_of(risk-13, toxicity-16)

Refer/VBP to/TO the/DT package/JJ insert/NN for/IN lithium/NN preparation/NN s/NNS before/IN use/NN of/IN such/JJ preparations/NNS with/IN Hydrochlorothiazide/NN ./.

(ROOT (S1 (S (S (VP (VBP Refer) (PP (TO to) (NP (NP (DT the) (JJ package) (NN insert)) (PP (IN for) (NP (NP (NN lithium) (NN preparation) (NNS s)) (PP (IN before) (NP (NP (NN use)) (PP (IN of) (NP (NP (JJ such) (NNS preparations)) (PP (IN with) (NP (NN Hydrochlorothiazide))))))))))))) (. .))))

root(ROOT-0, Refer-1)
det(insert-5, the-3)
amod(insert-5, package-4)
prep_to(Refer-1, insert-5)
nn(s-9, lithium-7)
nn(s-9, preparation-8)
prep_for(insert-5, s-9)
prep_before(s-9, use-11)
amod(preparations-14, such-13)
prep_of(use-11, preparations-14)
prep_with(preparations-14, Hydrochlorothiazide-16)

Non-steroidal/JJ Anti-inflammatory/JJ Drugs/NNS :/: In/IN some/DT patients/NNS ,/, the/DT administration/NN of/IN a/DT non-steroidal/JJ anti-inflammatory/JJ agent/NN can/MD reduce/VB the/DT diuretic/JJ ,/, natriuretic/JJ ,/, and/CC antihypertensive/JJ effects/NNS of/IN loop/NN ,/, potassium/NN -sparing/NN and/CC thiazide/NN diuretics/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Non-steroidal) (JJ Anti-inflammatory) (NNS Drugs)) (: :) (S (PP (IN In) (NP (DT some) (NNS patients))) (, ,) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (DT a) (JJ non-steroidal) (JJ anti-inflammatory) (NN agent)))) (VP (MD can) (VP (VB reduce) (NP (NP (DT the) (ADJP (ADJP (JJ diuretic)) (, ,) (ADJP (JJ natriuretic)) (, ,) (CC and) (ADJP (JJ antihypertensive))) (NNS effects)) (PP (IN of) (NP (NP (NN loop)) (, ,) (NP (NN potassium) (NN -sparing)) (CC and) (NP (NN thiazide) (NNS diuretics)))))))) (. .)))))

amod(Drugs-3, Non-steroidal-1)
amod(Drugs-3, Anti-inflammatory-2)
root(ROOT-0, Drugs-3)
det(patients-7, some-6)
prep_in(reduce-17, patients-7)
det(administration-10, the-9)
nsubj(reduce-17, administration-10)
det(agent-15, a-12)
amod(agent-15, non-steroidal-13)
amod(agent-15, anti-inflammatory-14)
prep_of(administration-10, agent-15)
aux(reduce-17, can-16)
dep(Drugs-3, reduce-17)
det(effects-25, the-18)
amod(effects-25, diuretic-19)
conj_and(diuretic-19, natriuretic-21)
conj_and(diuretic-19, antihypertensive-24)
dobj(reduce-17, effects-25)
prep_of(effects-25, loop-27)
nn(-sparing-30, potassium-29)
conj_and(loop-27, -sparing-30)
nn(diuretics-33, thiazide-32)
conj_and(loop-27, diuretics-33)

Therefore/RB ,/, when/WRB Hydrochlorothiazide/NN and/CC non-steroidal/JJ anti-inflammatory/JJ agents/NNS are/VBP used/VBN concomitantly/RB ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB to/TO determine/VB if/IN the/DT desired/JJ effect/NN of/IN the/DT diuretic/NN is/VBZ obtained/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN Hydrochlorothiazide)) (CC and) (NP (JJ non-steroidal) (JJ anti-inflammatory) (NNS agents))) (VP (VBP are) (VP (VBN used) (ADVP (RB concomitantly)))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (NP (DT the) (JJ desired) (NN effect)) (PP (IN of) (NP (DT the) (NN diuretic)))) (VP (VBZ is) (VP (VBN obtained)))))))))))) (. .))))

advmod(observed-17, Therefore-1)
advmod(used-10, when-3)
nsubjpass(used-10, Hydrochlorothiazide-4)
amod(agents-8, non-steroidal-6)
amod(agents-8, anti-inflammatory-7)
conj_and(Hydrochlorothiazide-4, agents-8)
auxpass(used-10, are-9)
advcl(observed-17, used-10)
advmod(used-10, concomitantly-11)
det(patient-14, the-13)
nsubjpass(observed-17, patient-14)
aux(observed-17, should-15)
auxpass(observed-17, be-16)
root(ROOT-0, observed-17)
advmod(observed-17, closely-18)
aux(determine-20, to-19)
xcomp(observed-17, determine-20)
mark(obtained-29, if-21)
det(effect-24, the-22)
amod(effect-24, desired-23)
nsubjpass(obtained-29, effect-24)
det(diuretic-27, the-26)
prep_of(effect-24, diuretic-27)
auxpass(obtained-29, is-28)
advcl(determine-20, obtained-29)

Patients/NNS receiving/VBG other/JJ narcotic/JJ analgesic/JJ s/NNS ,/, antipsychotics/NNS ,/, antianxiety/NN agents/NNS ,/, or/CC other/JJ CNS/NN depressants/NNS (/-LRB- including/VBG alcohol/NN )/-RRB- concomitantly/RB with/IN hydrocodon/NN e/NN and/CC acetaminophen/NN tablets/NNS may/MD exhibit/VBP an/DT additive/JJ CNS/NN depression/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (NP (JJ other) (JJ narcotic) (JJ analgesic) (NNS s)) (, ,) (NP (NNS antipsychotics)) (, ,) (NP (NN antianxiety) (NNS agents)) (, ,) (CC or) (NP (NP (JJ other) (NN CNS) (NNS depressants)) (PRN (-LRB- -LRB-) (PP (VBG including) (NP (NN alcohol))) (-RRB- -RRB-)))))) (PP (ADVP (RB concomitantly)) (IN with) (NP (NP (NN hydrocodon) (NN e)) (CC and) (NP (NN acetaminophen) (NNS tablets))))) (VP (MD may) (VP (VBP exhibit) (NP (DT an) (JJ additive) (NN CNS) (NN depression)))) (. .))))

nsubj(exhibit-29, Patients-1)
partmod(Patients-1, receiving-2)
amod(s-6, other-3)
amod(s-6, narcotic-4)
amod(s-6, analgesic-5)
dobj(receiving-2, s-6)
conj_or(s-6, antipsychotics-8)
nn(agents-11, antianxiety-10)
conj_or(s-6, agents-11)
amod(depressants-16, other-14)
nn(depressants-16, CNS-15)
conj_or(s-6, depressants-16)
dep(depressants-16, including-18)
pobj(including-18, alcohol-19)
advmod(Patients-1, concomitantly-21)
nn(e-24, hydrocodon-23)
prep_with(Patients-1, e-24)
nn(tablets-27, acetaminophen-26)
conj_and(e-24, tablets-27)
aux(exhibit-29, may-28)
root(ROOT-0, exhibit-29)
det(depression-33, an-30)
amod(depression-33, additive-31)
nn(depression-33, CNS-32)
dobj(exhibit-29, depression-33)

The/DT use/NN of/IN MAO/NN inhibitors/NNS or/CC tricyclic/JJ antidepressants/NNS with/IN hydrocodone/NN preparation/NN s/NNS may/MD increase/VB the/DT effect/NN of/IN either/CC the/DT antidepressant/JJ or/CC hydrocodone/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NP (NN MAO) (NNS inhibitors)) (CC or) (NP (NP (JJ tricyclic) (NNS antidepressants)) (PP (IN with) (NP (NN hydrocodone) (NN preparation) (NNS s))))))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (CC either) (NP (DT the) (JJ antidepressant)) (CC or) (NP (NN hydrocodone)))))))) (. .))))

det(use-2, The-1)
nsubj(increase-14, use-2)
nn(inhibitors-5, MAO-4)
prep_of(use-2, inhibitors-5)
amod(antidepressants-8, tricyclic-7)
conj_or(inhibitors-5, antidepressants-8)
nn(s-12, hydrocodone-10)
nn(s-12, preparation-11)
prep_with(antidepressants-8, s-12)
aux(increase-14, may-13)
root(ROOT-0, increase-14)
det(effect-16, the-15)
dobj(increase-14, effect-16)
preconj(antidepressant-20, either-18)
det(antidepressant-20, the-19)
prep_of(effect-16, antidepressant-20)
conj_or(antidepressant-20, hydrocodone-22)

The/DT concurrent/JJ use/NN of/IN anticholinergics/NN with/IN hydrocodon/NN e/NN may/MD produce/VB paralytic/JJ ileus/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concurrent) (NN use)) (PP (IN of) (NP (NN anticholinergics))) (PP (IN with) (NP (NN hydrocodon) (NN e)))) (VP (MD may) (VP (VB produce) (NP (JJ paralytic) (NN ileus))))) (. .))))

det(use-3, The-1)
amod(use-3, concurrent-2)
nsubj(produce-10, use-3)
prep_of(use-3, anticholinergics-5)
nn(e-8, hydrocodon-7)
prep_with(use-3, e-8)
aux(produce-10, may-9)
root(ROOT-0, produce-10)
amod(ileus-12, paralytic-11)
dobj(produce-10, ileus-12)

Anticoagulants/NNS ,/, oral/JJ ./.

(ROOT (S1 (S (S (NP (NNS Anticoagulants)) (VP (, ,) (ADJP (JJ oral)))) (. .))))

nsubj(oral-3, Anticoagulants-1)
root(ROOT-0, oral-3)

(/-LRB- Effects/NNS may/MD be/VB decreased/VBN when/WRB used/VBN concurrently/RB with/IN thiazide/NN diuretics/NNS ;/: ./.

(ROOT (S1 (S (S (-LRB- -LRB-) (NP (NNS Effects)) (VP (MD may) (VP (VB be) (VP (VBN decreased) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (ADVP (RB concurrently)) (PP (IN with) (NP (NN thiazide) (NNS diuretics))))))))) (: ;)) (. .))))

nsubjpass(decreased-5, Effects-2)
aux(decreased-5, may-3)
auxpass(decreased-5, be-4)
root(ROOT-0, decreased-5)
advmod(used-7, when-6)
advcl(decreased-5, used-7)
advmod(used-7, concurrently-8)
nn(diuretics-11, thiazide-10)
prep_with(used-7, diuretics-11)

Antigout/NN medications/VBZ ./.

(ROOT (S1 (S (S (NP (NN Antigout)) (VP (VBZ medications))) (. .))))

nsubj(medications-2, Antigout-1)
root(ROOT-0, medications-2)

(/-LRB- Thiazide/NN diuretics/NNS may/MD raise/VB the/DT level/NN of/IN blood/NN uric/JJ acid/NN ;/: ./.

(ROOT (S1 (S (S (-LRB- -LRB-) (NP (NN Thiazide) (NNS diuretics)) (VP (MD may) (VP (VB raise) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN blood) (JJ uric) (NN acid)))))) (: ;)) (. .))))

nn(diuretics-3, Thiazide-2)
nsubj(raise-5, diuretics-3)
aux(raise-5, may-4)
root(ROOT-0, raise-5)
det(level-7, the-6)
dobj(raise-5, level-7)
nn(acid-11, blood-9)
amod(acid-11, uric-10)
prep_of(level-7, acid-11)

dosage/JJ adjustment/NN of/IN antigout/JJ medications/NNS may/MD be/VB necessary/JJ to/TO control/VB hyperuricemia/NN and/CC gout./NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (JJ dosage) (NN adjustment)) (PP (IN of) (NP (JJ antigout) (NNS medications)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary) (S (VP (TO to) (VP (VB control) (NP (NP (NN hyperuricemia)) (CC and) (NP (NN gout.))))) (-RRB- -RRB-)))))) (. .))))

amod(adjustment-2, dosage-1)
nsubj(necessary-8, adjustment-2)
amod(medications-5, antigout-4)
prep_of(adjustment-2, medications-5)
aux(necessary-8, may-6)
cop(necessary-8, be-7)
root(ROOT-0, necessary-8)
aux(control-10, to-9)
xcomp(necessary-8, control-10)
dobj(control-10, hyperuricemia-11)
conj_and(hyperuricemia-11, gout.-13)

Antihypertensive/JJ medications/NNS ,/, other/JJ ,/, especially/RB diazoxide/NN ,/, or/CC preanesthetic/JJ and/CC anesthetic/JJ agents/NNS used/VBN in/IN surgery/NN or/CC skeletal-muscle/JJ relaxants/NNS ,/, nondepolarizing/NN ,/, used/VBN in/IN surgery/NN ./.

(ROOT (S1 (S (NP (NP (NP (JJ Antihypertensive) (NNS medications)) (, ,) (NP (JJ other)) (, ,) (ADVP (RB especially)) (NP (NN diazoxide))) (, ,) (NP (NP (ADJP (CC or) (ADJP (JJ preanesthetic)) (CC and) (ADJP (JJ anesthetic))) (NNS agents)) (VP (VBN used) (PP (IN in) (NP (NP (NN surgery)) (CC or) (NP (JJ skeletal-muscle) (NNS relaxants)))))) (, ,) (NP (NN nondepolarizing)) (, ,)) (VP (VBN used) (PP (IN in) (NP (NN surgery)))) (. .))))

amod(medications-2, Antihypertensive-1)
nsubj(used-23, medications-2)
appos(medications-2, other-4)
advmod(medications-2, especially-6)
dep(medications-2, diazoxide-7)
amod(agents-13, preanesthetic-10)
conj_and(preanesthetic-10, anesthetic-12)
appos(medications-2, agents-13)
partmod(agents-13, used-14)
prep_in(used-14, surgery-16)
amod(relaxants-19, skeletal-muscle-18)
conj_or(surgery-16, relaxants-19)
appos(medications-2, nondepolarizing-21)
root(ROOT-0, used-23)
prep_in(used-23, surgery-25)

(/-LRB- Effects/NNS may/MD be/VB potentiated/VBN when/WRB used/VBN concurrently/RB with/IN thiazide/NN diuretics/NNS ;/: ./.

(ROOT (S1 (S (S (-LRB- -LRB-) (NP (NNS Effects)) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (ADVP (RB concurrently)) (PP (IN with) (NP (NN thiazide) (NNS diuretics))))))))) (: ;)) (. .))))

nsubjpass(potentiated-5, Effects-2)
aux(potentiated-5, may-3)
auxpass(potentiated-5, be-4)
root(ROOT-0, potentiated-5)
advmod(used-7, when-6)
advcl(potentiated-5, used-7)
advmod(used-7, concurrently-8)
nn(diuretics-11, thiazide-10)
prep_with(used-7, diuretics-11)

Amphotericin/NN B/NN or/CC Corticosteroids/NNS or/CC Corticotropin/NN (/-LRB- ACTH/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Amphotericin) (NN B)) (CC or) (NP (NNS Corticosteroids))) (CC or) (NP (NP (NN Corticotropin)) (PRN (-LRB- -LRB-) (NP (NN ACTH)) (-RRB- -RRB-))))) (. .))))

nn(B-2, Amphotericin-1)
root(ROOT-0, B-2)
conj_or(B-2, Corticosteroids-4)
conj_or(B-2, Corticotropin-6)
abbrev(Corticotropin-6, ACTH-8)

(/-LRB- Concurrent/JJ use/NN with/IN thiazide/NN diuretics/NNS may/MD intensify/VB electrolyte/NN imbalance/NN ,/, particularly/RB hypokalemia./NN )/-RRB- ./.

(ROOT (S1 (S (S (-LRB- -LRB-) (NP (NP (JJ Concurrent) (NN use)) (PP (IN with) (NP (NN thiazide) (NNS diuretics)))) (VP (MD may) (VP (VB intensify) (NP (NP (NN electrolyte) (NN imbalance)) (, ,) (NP (ADVP (RB particularly)) (NP (NN hypokalemia.)))))) (-RRB- -RRB-)) (. .))))

amod(use-3, Concurrent-2)
nsubj(intensify-8, use-3)
nn(diuretics-6, thiazide-5)
prep_with(use-3, diuretics-6)
aux(intensify-8, may-7)
root(ROOT-0, intensify-8)
nn(imbalance-10, electrolyte-9)
dobj(intensify-8, imbalance-10)
advmod(hypokalemia.-13, particularly-12)
appos(imbalance-10, hypokalemia.-13)

Cardiac/JJ glycosides/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Cardiac) (NNS glycosides)) (. .)))))

amod(glycosides-2, Cardiac-1)
root(ROOT-0, glycosides-2)

(/-LRB- Concurrent/JJ use/NN with/IN thiazide/NN diuretics/NNS may/MD enhance/VB the/DT possibility/NN of/IN digitalis/NN toxicity/NN associated/VBN with/IN hypokalemia./NN )/-RRB- ./.

(ROOT (S1 (S (S (-LRB- -LRB-) (NP (NP (JJ Concurrent) (NN use)) (PP (IN with) (NP (NN thiazide) (NNS diuretics)))) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (NN digitalis) (NN toxicity)) (VP (VBN associated) (PP (IN with) (NP (NN hypokalemia.))))))))) (-RRB- -RRB-)) (. .))))

amod(use-3, Concurrent-2)
nsubj(enhance-8, use-3)
nn(diuretics-6, thiazide-5)
prep_with(use-3, diuretics-6)
aux(enhance-8, may-7)
root(ROOT-0, enhance-8)
det(possibility-10, the-9)
dobj(enhance-8, possibility-10)
nn(toxicity-13, digitalis-12)
prep_of(possibility-10, toxicity-13)
partmod(toxicity-13, associated-14)
prep_with(associated-14, hypokalemia.-16)

Colestipol/NN ./.

(ROOT (S1 (S (NP (NP (NN Colestipol)) (. .)))))

root(ROOT-0, Colestipol-1)

(/-LRB- May/MD inhibit/VB gastrointestinal/JJ absorption/NN of/IN the/DT thiazide/NN diuretics/NNS ;/: ./.

(ROOT (S1 (S (S (-LRB- -LRB-) (VP (MD May) (VP (VB inhibit) (NP (NP (JJ gastrointestinal) (NN absorption)) (PP (IN of) (NP (DT the) (NN thiazide) (NNS diuretics)))))) (: ;)) (. .))))

aux(inhibit-3, May-2)
root(ROOT-0, inhibit-3)
amod(absorption-5, gastrointestinal-4)
dobj(inhibit-3, absorption-5)
det(diuretics-9, the-7)
nn(diuretics-9, thiazide-8)
prep_of(absorption-5, diuretics-9)

administration/NN 1/CD hour/NN before/IN or/CC 4/CD hours/NNS after/IN colestipol/NN is/VBZ recommended./NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (NN administration)) (PP (NP (CD 1) (NN hour)) (IN before) (NP (CC or) (CD 4) (NNS hours))) (PP (IN after) (NP (NN colestipol)))) (VP (VBZ is) (NP (NN recommended.) (-RRB- -RRB-)))) (. .))))

nsubj(recommended.-11, administration-1)
num(hour-3, 1-2)
npadvmod(administration-1, hour-3)
cc(hours-7, or-5)
dep(hours-7, 4-6)
prep_before(administration-1, hours-7)
prep_after(administration-1, colestipol-9)
cop(recommended.-11, is-10)
root(ROOT-0, recommended.-11)

Hypoglycemics/NN ./.

(ROOT (S1 (S (NP (NP (NN Hypoglycemics)) (. .)))))

root(ROOT-0, Hypoglycemics-1)

(/-LRB- Thiazide/NN diuretics/NNS may/MD raise/VB blood/NN glucose/NN levels/NNS ;/: ./.

(ROOT (S1 (S (S (-LRB- -LRB-) (NP (NN Thiazide) (NNS diuretics)) (VP (MD may) (VP (VB raise) (NP (NN blood) (NN glucose) (NNS levels)))) (: ;)) (. .))))

nn(diuretics-3, Thiazide-2)
nsubj(raise-5, diuretics-3)
aux(raise-5, may-4)
root(ROOT-0, raise-5)
nn(levels-8, blood-6)
nn(levels-8, glucose-7)
dobj(raise-5, levels-8)

for/IN adult-onset/JJ diabetics/NNS ,/, dosage/NN adjustment/NN of/IN hypoglycemic/JJ medications/NNS may/MD be/VB necessary/JJ during/IN and/CC after/IN thiazide/NN diuretic/JJ therapy/NN ;/: ./.

(ROOT (S1 (S (S (PP (IN for) (NP (JJ adult-onset) (NNS diabetics))) (, ,) (NP (NP (NN dosage) (NN adjustment)) (PP (IN of) (NP (JJ hypoglycemic) (NNS medications)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary) (PP (PP (IN during)) (CC and) (PP (IN after) (NP (NN thiazide) (JJ diuretic) (NN therapy))))))) (: ;)) (. .))))

amod(diabetics-3, adult-onset-2)
prep_for(necessary-12, diabetics-3)
nn(adjustment-6, dosage-5)
nsubj(necessary-12, adjustment-6)
amod(medications-9, hypoglycemic-8)
prep_of(adjustment-6, medications-9)
aux(necessary-12, may-10)
cop(necessary-12, be-11)
root(ROOT-0, necessary-12)
prep(necessary-12, during-13)
conj_and(during-13, after-15)
nn(therapy-18, thiazide-16)
amod(therapy-18, diuretic-17)
pobj(after-15, therapy-18)

insulin/NN requirements/NNS may/MD be/VB increased/VBN ,/, decreased/VBN ,/, or/CC unchanged./VBN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NN insulin) (NNS requirements)) (VP (MD may) (VP (VB be) (NP (NP (VBN increased)) (, ,) (NP (VBN decreased)) (, ,) (CC or) (NP (VBN unchanged.)) (-RRB- -RRB-))))) (. .))))

nn(requirements-2, insulin-1)
nsubj(increased-5, requirements-2)
aux(increased-5, may-3)
cop(increased-5, be-4)
root(ROOT-0, increased-5)
conj_or(increased-5, decreased-7)
conj_or(increased-5, unchanged.-10)

Lithium/NN salt/NN s/NN ./.

(ROOT (S1 (S (NP (NP (NN Lithium) (NN salt) (NN s)) (. .)))))

nn(s-3, Lithium-1)
nn(s-3, salt-2)
root(ROOT-0, s-3)

(/-LRB- Concurrent/JJ use/NN with/IN thiazide/NN diuretics/NNS is/VBZ not/RB recommended/VBN ,/, as/IN they/PRP may/MD provoke/VB lithium/NN toxicity/NN because/IN of/IN reduced/VBN renal/JJ clearance./NN )/-RRB- ./.

(ROOT (S1 (S (S (-LRB- -LRB-) (NP (NP (JJ Concurrent) (NN use)) (PP (IN with) (NP (NN thiazide) (NNS diuretics)))) (VP (VBZ is) (RB not) (VP (VBN recommended) (, ,) (SBAR (IN as) (S (NP (PRP they)) (VP (MD may) (VP (VB provoke) (NP (NN lithium) (NN toxicity)) (PP (IN because) (IN of) (NP (VBN reduced) (JJ renal) (NN clearance.))))))))) (-RRB- -RRB-)) (. .))))

amod(use-3, Concurrent-2)
nsubjpass(recommended-9, use-3)
nn(diuretics-6, thiazide-5)
prep_with(use-3, diuretics-6)
auxpass(recommended-9, is-7)
neg(recommended-9, not-8)
root(ROOT-0, recommended-9)
mark(provoke-14, as-11)
nsubj(provoke-14, they-12)
aux(provoke-14, may-13)
advcl(recommended-9, provoke-14)
nn(toxicity-16, lithium-15)
dobj(provoke-14, toxicity-16)
amod(clearance.-21, reduced-19)
amod(clearance.-21, renal-20)
prep_because_of(provoke-14, clearance.-21)

Methenamine/NN ./.

(ROOT (S1 (S (NP (NP (NN Methenamine)) (. .)))))

root(ROOT-0, Methenamine-1)

(/-LRB- Effectiveness/NN may/MD be/VB decreased/VBN when/WRB used/VBN concurrently/RB with/IN thiazide/NN diuretics/NNS because/IN of/IN alkalinization/NN of/IN the/DT urine./NNS )/-RRB- ./.

(ROOT (S1 (S (S (-LRB- -LRB-) (NP (NN Effectiveness)) (VP (MD may) (VP (VB be) (VP (VBN decreased) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (ADVP (RB concurrently)) (PP (IN with) (NP (NN thiazide) (NNS diuretics))) (PP (IN because) (IN of) (NP (NP (NN alkalinization)) (PP (IN of) (NP (DT the) (NNS urine.))))))))))) (-RRB- -RRB-)) (. .))))

nsubjpass(decreased-5, Effectiveness-2)
aux(decreased-5, may-3)
auxpass(decreased-5, be-4)
root(ROOT-0, decreased-5)
advmod(used-7, when-6)
advcl(decreased-5, used-7)
advmod(used-7, concurrently-8)
nn(diuretics-11, thiazide-10)
prep_with(used-7, diuretics-11)
prep_because_of(used-7, alkalinization-14)
det(urine.-17, the-16)
prep_of(alkalinization-14, urine.-17)

Nonsteroidal/JJ anti-inflammatory/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (JJ Nonsteroidal) (JJ anti-inflammatory) (NNS agents))) (. .))))

amod(agents-3, Nonsteroidal-1)
amod(agents-3, anti-inflammatory-2)
root(ROOT-0, agents-3)

(/-LRB- In/IN some/DT patients/NNS ,/, the/DT steroidal/JJ anti-inflammatory/JJ agent/NN can/MD reduce/VB the/DT diuretic/JJ ,/, natriuretic/JJ ,/, and/CC antihypertensive/JJ effects/NNS of/IN loop/NN ,/, potassium/NN sparing/NN ,/, and/CC thiazide/NN diuretics/NNS ./.

(ROOT (S1 (S (S (-LRB- -LRB-) (PP (IN In) (NP (DT some) (NNS patients))) (, ,) (NP (DT the) (JJ steroidal) (JJ anti-inflammatory) (NN agent)) (VP (MD can) (VP (VB reduce) (NP (NP (DT the) (ADJP (ADJP (JJ diuretic)) (, ,) (ADJP (JJ natriuretic)) (, ,) (CC and) (ADJP (JJ antihypertensive))) (NNS effects)) (PP (IN of) (NP (NP (NN loop)) (, ,) (NP (NN potassium) (NN sparing)) (, ,) (CC and) (NP (NN thiazide) (NNS diuretics)))))))) (. .))))

det(patients-4, some-3)
prep_in(reduce-11, patients-4)
det(agent-9, the-6)
amod(agent-9, steroidal-7)
amod(agent-9, anti-inflammatory-8)
nsubj(reduce-11, agent-9)
aux(reduce-11, can-10)
root(ROOT-0, reduce-11)
det(effects-19, the-12)
amod(effects-19, diuretic-13)
conj_and(diuretic-13, natriuretic-15)
conj_and(diuretic-13, antihypertensive-18)
dobj(reduce-11, effects-19)
prep_of(effects-19, loop-21)
nn(sparing-24, potassium-23)
conj_and(loop-21, sparing-24)
nn(diuretics-28, thiazide-27)
conj_and(loop-21, diuretics-28)

Therefore/RB ,/, when/WRB hydroflumethiazide/NN and/CC nonsteroidal/JJ anti-inflammatory/JJ agents/NNS are/VBP used/VBN concomitantly/RB ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB to/TO determine/VB if/IN the/DT desired/JJ effect/NN of/IN the/DT diuretic/NN is/VBZ obtained./NN )/-RRB- ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN hydroflumethiazide)) (CC and) (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS agents))) (VP (VBP are) (VP (VBN used) (ADVP (RB concomitantly)))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (S (VP (TO to) (VP (VB determine) (SBAR (IN if) (S (NP (NP (DT the) (JJ desired) (NN effect)) (PP (IN of) (NP (DT the) (NN diuretic)))) (VP (VBZ is) (NP (NN obtained.) (-RRB- -RRB-)))))))))))) (. .))))

advmod(observed-17, Therefore-1)
advmod(used-10, when-3)
nsubjpass(used-10, hydroflumethiazide-4)
amod(agents-8, nonsteroidal-6)
amod(agents-8, anti-inflammatory-7)
conj_and(hydroflumethiazide-4, agents-8)
auxpass(used-10, are-9)
advcl(observed-17, used-10)
advmod(used-10, concomitantly-11)
det(patient-14, the-13)
nsubjpass(observed-17, patient-14)
aux(observed-17, should-15)
auxpass(observed-17, be-16)
root(ROOT-0, observed-17)
advmod(observed-17, closely-18)
aux(determine-20, to-19)
xcomp(observed-17, determine-20)
mark(obtained.-29, if-21)
det(effect-24, the-22)
amod(effect-24, desired-23)
nsubj(obtained.-29, effect-24)
det(diuretic-27, the-26)
prep_of(effect-24, diuretic-27)
cop(obtained.-29, is-28)
advcl(determine-20, obtained.-29)

Norepinephrine/NN ./.

(ROOT (S1 (S (NP (NP (NN Norepinephrine)) (. .)))))

root(ROOT-0, Norepinephrine-1)

(/-LRB- Thiazides/NNS may/MD decrease/VB arterial/JJ responsiveness/NN to/TO norepinephrine/NN ./.

(ROOT (S1 (S (S (NP (-LRB- -LRB-) (NNS Thiazides)) (VP (MD may) (VP (VB decrease) (NP (NP (JJ arterial) (NN responsiveness)) (PP (TO to) (NP (NN norepinephrine))))))) (. .))))

nsubj(decrease-4, Thiazides-2)
aux(decrease-4, may-3)
root(ROOT-0, decrease-4)
amod(responsiveness-6, arterial-5)
dobj(decrease-4, responsiveness-6)
prep_to(responsiveness-6, norepinephrine-8)

This/DT diminution/NN is/VBZ not/RB sufficient/JJ to/TO preclude/VB effectiveness/NN of/IN the/DT pressor/JJ agent/NN for/IN therapeutic/JJ use./NNS )/-RRB- ./.

(ROOT (S1 (S (S (NP (DT This) (NN diminution)) (VP (VBZ is) (RB not) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VB preclude) (NP (NP (NN effectiveness)) (PP (IN of) (NP (NP (DT the) (JJ pressor) (NN agent)) (PP (IN for) (NP (JJ therapeutic) (NNS use.) (-RRB- -RRB-)))))))))))) (. .))))

det(diminution-2, This-1)
nsubj(sufficient-5, diminution-2)
cop(sufficient-5, is-3)
neg(sufficient-5, not-4)
root(ROOT-0, sufficient-5)
aux(preclude-7, to-6)
xcomp(sufficient-5, preclude-7)
dobj(preclude-7, effectiveness-8)
det(agent-12, the-10)
amod(agent-12, pressor-11)
prep_of(effectiveness-8, agent-12)
amod(use.-15, therapeutic-14)
prep_for(agent-12, use.-15)

Tubocurarine/NN ./.

(ROOT (S1 (S (NP (NP (NN Tubocurarine)) (. .)))))

root(ROOT-0, Tubocurarine-1)

(/-LRB- Thiazide/NN drugs/NNS may/MD increase/VB the/DT responsiveness/NN to/TO tubocurarine/NN ./. )/-RRB- ./.

(ROOT (S1 (S (S (-LRB- -LRB-) (NP (NN Thiazide) (NNS drugs)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN responsiveness)) (PP (TO to) (NP (NN tubocurarine)))))) (. .) (-RRB- -RRB-)) (. .))))

nn(drugs-3, Thiazide-2)
nsubj(increase-5, drugs-3)
aux(increase-5, may-4)
root(ROOT-0, increase-5)
det(responsiveness-7, the-6)
dobj(increase-5, responsiveness-7)
prep_to(responsiveness-7, tubocurarine-9)

DIAGNOSTIC/JJ INTERFERENCE/NN With/IN expected/VBN physiologic/JJ effects/NNS :/: Blood/NN and/CC urine/NN glucose/NN levels/NNS (/-LRB- usually/RB only/RB in/IN patients/NNS with/IN a/DT predisposition/NN for/IN glucose/NN intolerance/NN )/-RRB- and/CC Serum/NN bilirubin/NN levels/NNS (/-LRB- by/IN displacement/NN from/IN albumin/NN binding/NN )/-RRB- and/CC Serum/NN calcium/NN levels/NNS (/-LRB- thiazide/NN diuretics/NNS should/MD be/VB discontinued/VBN before/IN parathyroid/JJ -function/NN tests/NNS are/VBP carried/VBN out/RP )/-RRB- and/CC Serum/NN uric/JJ acid/NN levels/NNS (/-LRB- may/MD be/VB increased/VBN )/-RRB- Serum/NN magnesium/NN ,/, potassium/NN ,/, and/CC sodium/NN levels/NNS (/-LRB- may/MD be/VB decreased/VBN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ DIAGNOSTIC) (NN INTERFERENCE) (IN With) (VBN expected) (JJ physiologic) (NNS effects)) (PRN (: :) (S (NP (NP (NP (NP (NP (NP (NP (NN Blood)) (CC and) (NP (NN urine)) (NP (NN glucose) (NNS levels))) (PRN (-LRB- -LRB-) (ADVP (RB usually) (RB only)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (NN predisposition)) (PP (IN for) (NP (NN glucose) (NN intolerance))))))) (-RRB- -RRB-))) (CC and) (NP (NN Serum) (NN bilirubin))) (NNS levels)) (PRN (-LRB- -LRB-) (PP (IN by) (NP (NP (NN displacement)) (PP (IN from) (NP (NN albumin) (NN binding))))) (-RRB- -RRB-))) (CC and) (NP (NN Serum) (NN calcium) (NNS levels)) (-LRB- -LRB-) (NP (NN thiazide) (NNS diuretics)) (VP (MD should) (VP (VB be) (VP (VBN discontinued) (PP (IN before) (NP (JJ parathyroid) (NN -function) (NNS tests))))))) (VP (VBP are) (VP (VBN carried) (RP out)))) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN Serum) (JJ uric) (NN acid)) (NNS levels)) (-LRB- -LRB-) (VP (MD may) (VP (VB be) (VP (VBN increased)))) (-RRB- -RRB-))) (NP (NN Serum) (NP (NN magnesium)) (, ,) (NP (NN potassium)) (, ,) (CC and) (NP (NP (NN sodium) (NNS levels)) (-LRB- -LRB-) (VP (MD may) (VP (VB be) (VP (VBN decreased)))) (: ;)))) (. .))))

amod(effects-6, DIAGNOSTIC-1)
nn(effects-6, INTERFERENCE-2)
amod(effects-6, With-3)
amod(effects-6, expected-4)
amod(effects-6, physiologic-5)
dep(Serum-64, effects-6)
nn(levels-28, Blood-8)
conj_and(Blood-8, urine-10)
nn(levels-12, glucose-11)
dep(Blood-8, levels-12)
advmod(only-15, usually-14)
dep(in-16, only-15)
dep(Blood-8, in-16)
pobj(in-16, patients-17)
det(predisposition-20, a-19)
prep_with(patients-17, predisposition-20)
nn(intolerance-23, glucose-22)
prep_for(predisposition-20, intolerance-23)
nn(bilirubin-27, Serum-26)
conj_and(Blood-8, bilirubin-27)
nsubjpass(carried-51, levels-28)
dep(levels-28, by-30)
pobj(by-30, displacement-31)
nn(binding-34, albumin-33)
prep_from(displacement-31, binding-34)
nn(levels-39, Serum-37)
nn(levels-39, calcium-38)
conj_and(levels-28, levels-39)
nn(diuretics-42, thiazide-41)
conj_and(levels-28, diuretics-42)
aux(discontinued-45, should-43)
auxpass(discontinued-45, be-44)
dep(levels-28, discontinued-45)
amod(tests-49, parathyroid-47)
nn(tests-49, -function-48)
prep_before(discontinued-45, tests-49)
auxpass(carried-51, are-50)
dep(effects-6, carried-51)
dep(carried-51, out-52)
nn(acid-57, Serum-55)
amod(acid-57, uric-56)
nn(levels-58, acid-57)
conj_and(effects-6, levels-58)
aux(increased-62, may-60)
auxpass(increased-62, be-61)
dep(levels-58, increased-62)
root(ROOT-0, Serum-64)
dep(Serum-64, magnesium-65)
conj_and(Serum-64, potassium-67)
nn(levels-71, sodium-70)
conj_and(Serum-64, levels-71)
aux(decreased-75, may-73)
auxpass(decreased-75, be-74)
dep(levels-71, decreased-75)

serum/NN magnesium/NN levels/NNS may/MD increase/VB in/IN uremic/JJ patients/NNS )/-RRB- Serum/NN protein-bound/JJ iodine/NN (/-LRB- PBI/NN )/-RRB- levels/NNS (/-LRB- may/MD be/VB decreased/VBN )/-RRB- Thiazides/NNS should/MD be/VB discontinued/VBN before/IN carrying/VBG out/RP tests/NNS for/IN parathyroid/JJ function/NN ./.

(ROOT (S1 (S (S (S (NP (NN serum) (NN magnesium) (NNS levels)) (VP (MD may) (VP (VB increase) (PP (IN in) (NP (JJ uremic) (NNS patients))) (-RRB- -RRB-) (NP (NP (NN Serum) (JJ protein-bound) (NN iodine) (-LRB- -LRB-) (NN PBI) (-RRB- -RRB-) (NNS levels)) (PRN (-LRB- -LRB-) (VP (MD may) (VP (VB be) (VP (VBN decreased)))) (-RRB- -RRB-)))))) (S (NP (NNS Thiazides)) (VP (MD should) (VP (VB be) (VP (VBN discontinued) (PP (IN before) (S (VP (VBG carrying) (PRT (RP out)) (NP (NP (NNS tests)) (PP (IN for) (NP (JJ parathyroid) (NN function)))))))))))) (. .))))

nn(levels-3, serum-1)
nn(levels-3, magnesium-2)
nsubj(increase-5, levels-3)
aux(increase-5, may-4)
root(ROOT-0, increase-5)
amod(patients-8, uremic-7)
prep_in(increase-5, patients-8)
nn(levels-16, Serum-10)
amod(levels-16, protein-bound-11)
nn(levels-16, iodine-12)
nn(levels-16, PBI-14)
dobj(increase-5, levels-16)
aux(decreased-20, may-18)
auxpass(decreased-20, be-19)
dep(levels-16, decreased-20)
nsubjpass(discontinued-25, Thiazides-22)
aux(discontinued-25, should-23)
auxpass(discontinued-25, be-24)
dep(increase-5, discontinued-25)
prepc_before(discontinued-25, carrying-27)
prt(carrying-27, out-28)
dobj(carrying-27, tests-29)
amod(function-32, parathyroid-31)
prep_for(tests-29, function-32)

Patients/NNS receiving/VBG other/JJ narcotic/JJ analgesic/JJ s/NNS ,/, general/JJ anesthetics/NNS ,/, phenothiazines/NNS ,/, tranquilizers/NNS ,/, sedative-hypnotics/NNS ,/, tricyclic/JJ antidepressants/NNS or/CC other/JJ CNS/NN depressants/NNS (/-LRB- including/VBG alcohol/NN )/-RRB- concomitantly/RB with/IN DILAUDID/NN may/MD exhibit/VBP an/DT additive/JJ CNS/NN depression/NN ./.

(ROOT (S1 (S (NP (NP (NP (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (JJ other) (JJ narcotic) (JJ analgesic) (NNS s)))) (, ,) (NP (JJ general) (NNS anesthetics)) (, ,) (NP (NNS phenothiazines)) (, ,) (NP (NNS tranquilizers)) (, ,) (NP (NNS sedative-hypnotics)) (, ,) (NP (JJ tricyclic) (NNS antidepressants)) (CC or) (NP (JJ other) (NN CNS) (NNS depressants))) (PRN (-LRB- -LRB-) (PP (VBG including) (NP (NN alcohol))) (-RRB- -RRB-))) (PP (ADVP (RB concomitantly)) (IN with) (NP (NN DILAUDID)))) (VP (MD may) (VP (VBP exhibit) (NP (DT an) (JJ additive) (NN CNS) (NN depression)))) (. .))))

nsubj(exhibit-31, Patients-1)
partmod(Patients-1, receiving-2)
amod(s-6, other-3)
amod(s-6, narcotic-4)
amod(s-6, analgesic-5)
dobj(receiving-2, s-6)
amod(anesthetics-9, general-8)
conj_or(Patients-1, anesthetics-9)
conj_or(Patients-1, phenothiazines-11)
conj_or(Patients-1, tranquilizers-13)
conj_or(Patients-1, sedative-hypnotics-15)
amod(antidepressants-18, tricyclic-17)
conj_or(Patients-1, antidepressants-18)
amod(depressants-22, other-20)
nn(depressants-22, CNS-21)
conj_or(Patients-1, depressants-22)
dep(Patients-1, including-24)
pobj(including-24, alcohol-25)
advmod(Patients-1, concomitantly-27)
prep_with(Patients-1, DILAUDID-29)
aux(exhibit-31, may-30)
root(ROOT-0, exhibit-31)
det(depression-35, an-32)
amod(depression-35, additive-33)
nn(depression-35, CNS-34)
dobj(exhibit-31, depression-35)

Prospective/JJ studies/NNS on/IN the/DT potential/NN for/IN hydroxyurea/NN to/TO interact/VB with/IN other/JJ drugs/NNS have/VBP not/RB been/VBN performed/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Prospective) (NNS studies)) (PP (IN on) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NN hydroxyurea))) (VP (TO to) (VP (VB interact) (PP (IN with) (NP (JJ other) (NNS drugs)))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN performed))))) (. .))))

amod(studies-2, Prospective-1)
nsubjpass(performed-16, studies-2)
det(potential-5, the-4)
prep_on(studies-2, potential-5)
prep_for(potential-5, hydroxyurea-7)
aux(interact-9, to-8)
dep(potential-5, interact-9)
amod(drugs-12, other-11)
prep_with(interact-9, drugs-12)
aux(performed-16, have-13)
neg(performed-16, not-14)
auxpass(performed-16, been-15)
root(ROOT-0, performed-16)

Concurrent/JJ use/NN of/IN hydroxyurea/NN and/CC other/JJ myelosuppressive/JJ agents/NNS or/CC radiation/NN therapy/NN may/MD increase/VB the/DT likelihood/NN of/IN bone/NN marrow/NN depression/NN or/CC other/JJ adverse/JJ events/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN use)) (PP (IN of) (NP (NP (NN hydroxyurea)) (CC and) (NP (NP (JJ other) (JJ myelosuppressive) (NNS agents)) (CC or) (NP (NN radiation) (NN therapy)))))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN likelihood)) (PP (IN of) (NP (NP (NN bone) (NN marrow) (NN depression)) (CC or) (NP (JJ other) (JJ adverse) (NNS events)))))))) (. .))))

amod(use-2, Concurrent-1)
nsubj(increase-13, use-2)
prep_of(use-2, hydroxyurea-4)
amod(agents-8, other-6)
amod(agents-8, myelosuppressive-7)
conj_and(hydroxyurea-4, agents-8)
nn(therapy-11, radiation-10)
conj_or(agents-8, therapy-11)
aux(increase-13, may-12)
root(ROOT-0, increase-13)
det(likelihood-15, the-14)
dobj(increase-13, likelihood-15)
nn(depression-19, bone-17)
nn(depression-19, marrow-18)
prep_of(likelihood-15, depression-19)
amod(events-23, other-21)
amod(events-23, adverse-22)
conj_or(depression-19, events-23)

Since/IN hydroxyurea/NN may/MD raise/VB the/DT serum/NN uric/JJ acid/NN level/NN ,/, dosage/JJ adjustment/NN of/IN uricosuric/JJ medication/NN may/MD be/VB necessary/JJ ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NN hydroxyurea)) (VP (MD may) (VP (VB raise) (NP (NP (DT the) (NN serum) (JJ uric) (NN acid)) (NN level)))))) (, ,) (NP (NP (JJ dosage) (NN adjustment)) (PP (IN of) (NP (JJ uricosuric) (NN medication)))) (VP (MD may) (VP (VB be) (ADJP (JJ necessary))))) (. .))))

mark(raise-4, Since-1)
nsubj(raise-4, hydroxyurea-2)
aux(raise-4, may-3)
advcl(necessary-18, raise-4)
det(acid-8, the-5)
nn(acid-8, serum-6)
amod(acid-8, uric-7)
nn(level-9, acid-8)
dobj(raise-4, level-9)
amod(adjustment-12, dosage-11)
nsubj(necessary-18, adjustment-12)
amod(medication-15, uricosuric-14)
prep_of(adjustment-12, medication-15)
aux(necessary-18, may-16)
cop(necessary-18, be-17)
root(ROOT-0, necessary-18)

THE/DT POTENTIATING/NN ACTION/NN OF/IN HYDROXYZINE/NN MUST/MD BE/VB CONSIDERED/VBN WHEN/WRB THE/DT DRUG/NN IS/VBZ USED/VBN IN/IN CONJUNCTION/NN WITH/IN CENTRAL/JJ NERVOUS/JJ SYSTEM/NN DEPRESSANTS/NNS SUCH/JJ AS/IN NARCOTICS/NNS ,/, NON-NARCOTIC/JJ ANALGESICS/NNS AND/CC BARBITURATES/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT THE) (NN POTENTIATING) (NN ACTION)) (PP (IN OF) (NP (NN HYDROXYZINE)))) (VP (MD MUST) (VP (VB BE) (VP (VBN CONSIDERED) (SBAR (WHADVP (WRB WHEN)) (S (NP (DT THE) (NN DRUG)) (VP (VBZ IS) (VP (VBN USED) (PP (IN IN) (NP (NP (NN CONJUNCTION)) (PP (IN WITH) (NP (NP (NP (JJ CENTRAL) (JJ NERVOUS) (NN SYSTEM)) (NNS DEPRESSANTS)) (PP (JJ SUCH) (IN AS) (NP (NP (NNS NARCOTICS)) (, ,) (NP (JJ NON-NARCOTIC) (NNS ANALGESICS)) (CC AND) (NP (NNS BARBITURATES)))))))))))))))) (. .))))

det(ACTION-3, THE-1)
nn(ACTION-3, POTENTIATING-2)
nsubjpass(CONSIDERED-8, ACTION-3)
prep_of(ACTION-3, HYDROXYZINE-5)
aux(CONSIDERED-8, MUST-6)
auxpass(CONSIDERED-8, BE-7)
root(ROOT-0, CONSIDERED-8)
advmod(USED-13, WHEN-9)
det(DRUG-11, THE-10)
nsubjpass(USED-13, DRUG-11)
auxpass(USED-13, IS-12)
advcl(CONSIDERED-8, USED-13)
prep_in(USED-13, CONJUNCTION-15)
amod(SYSTEM-19, CENTRAL-17)
amod(SYSTEM-19, NERVOUS-18)
nn(DEPRESSANTS-20, SYSTEM-19)
prep_with(CONJUNCTION-15, DEPRESSANTS-20)
prep_such_as(DEPRESSANTS-20, NARCOTICS-23)
amod(ANALGESICS-26, NON-NARCOTIC-25)
conj_and(NARCOTICS-23, ANALGESICS-26)
conj_and(NARCOTICS-23, BARBITURATES-28)

Therefore/RB when/WRB central/JJ nervous/JJ system/NN depressants/NNS are/VBP administered/VBN concomitantly/RB with/IN hydroxyzine/NN their/PRP$ dosage/NN should/MD be/VB reduced/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (SBAR (WHADVP (WRB when)) (S (NP (NP (JJ central) (JJ nervous) (NN system)) (NNS depressants)) (VP (VBP are) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN hydroxyzine))))))) (NP (PRP$ their) (NN dosage)) (VP (MD should) (VP (VB be) (VP (VBN reduced))))) (. .))))

advmod(reduced-16, Therefore-1)
advmod(administered-8, when-2)
amod(system-5, central-3)
amod(system-5, nervous-4)
nn(depressants-6, system-5)
nsubjpass(administered-8, depressants-6)
auxpass(administered-8, are-7)
advcl(reduced-16, administered-8)
advmod(administered-8, concomitantly-9)
prep_with(administered-8, hydroxyzine-11)
poss(dosage-13, their-12)
nsubjpass(reduced-16, dosage-13)
aux(reduced-16, should-14)
auxpass(reduced-16, be-15)
root(ROOT-0, reduced-16)

Since/IN drowsiness/NN may/MD occur/VB with/IN use/NN of/IN this/DT drug/NN ,/, patients/NNS should/MD be/VB warned/VBN of/IN this/DT possibility/NN and/CC cautioned/VBN against/IN driving/VBG a/DT car/NN or/CC operating/VBG dangerous/NN machinery/NN while/IN taking/VBG Atarax/NN ./.

(ROOT (S1 (S (SBAR (IN Since) (S (NP (NN drowsiness)) (VP (MD may) (VP (VB occur) (PP (IN with) (NP (NP (NN use)) (PP (IN of) (NP (DT this) (NN drug))))))))) (, ,) (NP (NNS patients)) (VP (MD should) (VP (VB be) (VP (VP (VBN warned) (PP (IN of) (NP (DT this) (NN possibility)))) (CC and) (VP (VBN cautioned) (PP (IN against) (S (S (VP (VBG driving) (NP (DT a) (NN car)))) (CC or) (S (VP (VBG operating) (NP (NN dangerous) (NN machinery)) (PP (IN while) (S (VP (VBG taking) (NP (NN Atarax))))))))))))) (. .))))

mark(occur-4, Since-1)
nsubj(occur-4, drowsiness-2)
aux(occur-4, may-3)
advcl(warned-14, occur-4)
prep_with(occur-4, use-6)
det(drug-9, this-8)
prep_of(use-6, drug-9)
nsubjpass(warned-14, patients-11)
aux(warned-14, should-12)
auxpass(warned-14, be-13)
root(ROOT-0, warned-14)
det(possibility-17, this-16)
prep_of(warned-14, possibility-17)
conj_and(warned-14, cautioned-19)
prepc_against(cautioned-19, driving-21)
det(car-23, a-22)
dobj(driving-21, car-23)
conj_or(driving-21, operating-25)
nn(machinery-27, dangerous-26)
dobj(operating-25, machinery-27)
prepc_while(operating-25, taking-29)
dobj(taking-29, Atarax-30)

Patients/NNS should/MD be/VB advised/VBN against/IN the/DT simultaneous/JJ use/NN of/IN other/JJ CNS/NN depressant/NN drugs/NNS ,/, and/CC cautioned/VBN that/IN the/DT effect/NN of/IN alcohol/NN may/MD be/VB increased/VBN ./.

(ROOT (S1 (S (S (NP (NNS Patients)) (VP (VP (MD should) (VP (VB be) (VP (VBN advised) (PP (IN against) (NP (NP (DT the) (JJ simultaneous) (NN use)) (PP (IN of) (NP (JJ other) (NN CNS) (NN depressant) (NNS drugs)))))))) (, ,) (CC and) (VP (VBN cautioned) (SBAR (IN that) (S (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN alcohol)))) (VP (MD may) (VP (VB be) (VP (VBN increased))))))))) (. .))))

nsubjpass(advised-4, Patients-1)
aux(advised-4, should-2)
auxpass(advised-4, be-3)
root(ROOT-0, advised-4)
det(use-8, the-6)
amod(use-8, simultaneous-7)
prep_against(advised-4, use-8)
amod(drugs-13, other-10)
nn(drugs-13, CNS-11)
nn(drugs-13, depressant-12)
prep_of(use-8, drugs-13)
conj_and(advised-4, cautioned-16)
complm(increased-24, that-17)
det(effect-19, the-18)
nsubjpass(increased-24, effect-19)
prep_of(effect-19, alcohol-21)
aux(increased-24, may-22)
auxpass(increased-24, be-23)
ccomp(cautioned-16, increased-24)

Additive/JJ adverse/JJ effects/NNS resulting/VBG from/IN cholinergic/JJ blockade/NN may/MD occur/VB when/WRB LEVSIN/NN is/VBZ administered/VBN concomitantly/RB with/IN other/JJ antimuscarinic/JJ s/NNS ,/, amantadine/NN ,/, haloperidol/NN ,/, phenothiazines/NNS ,/, monoamine/NN oxidase/NN (/-LRB- MAO/NN )/-RRB- inhibitors/NNS ,/, tricyclic/JJ antidepressants/NNS or/CC some/DT antihistamines/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Additive) (JJ adverse) (NNS effects)) (VP (VBG resulting) (PP (IN from) (NP (JJ cholinergic) (NN blockade))))) (VP (MD may) (VP (VB occur) (SBAR (WHADVP (WRB when)) (S (NP (NN LEVSIN)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (JJ other) (JJ antimuscarinic) (NNS s)) (, ,) (NP (NN amantadine)) (, ,) (NP (NN haloperidol)) (, ,) (NP (NNS phenothiazines)) (, ,) (NP (NP (NP (NN monoamine) (NN oxidase)) (PRN (-LRB- -LRB-) (NP (NN MAO)) (-RRB- -RRB-))) (NNS inhibitors)) (, ,) (NP (JJ tricyclic) (NNS antidepressants)) (CC or) (NP (DT some) (NNS antihistamines))))))))))) (. .))))

amod(effects-3, Additive-1)
amod(effects-3, adverse-2)
nsubj(occur-9, effects-3)
partmod(effects-3, resulting-4)
amod(blockade-7, cholinergic-6)
prep_from(resulting-4, blockade-7)
aux(occur-9, may-8)
root(ROOT-0, occur-9)
advmod(administered-13, when-10)
nsubjpass(administered-13, LEVSIN-11)
auxpass(administered-13, is-12)
advcl(occur-9, administered-13)
advmod(administered-13, concomitantly-14)
amod(s-18, other-16)
amod(s-18, antimuscarinic-17)
prep_with(administered-13, s-18)
conj_or(s-18, amantadine-20)
conj_or(s-18, haloperidol-22)
conj_or(s-18, phenothiazines-24)
nn(oxidase-27, monoamine-26)
nn(inhibitors-31, oxidase-27)
abbrev(oxidase-27, MAO-29)
conj_or(s-18, inhibitors-31)
amod(antidepressants-34, tricyclic-33)
conj_or(s-18, antidepressants-34)
det(antihistamines-37, some-36)
conj_or(s-18, antihistamines-37)

Antacids/NNS may/MD interfere/VB with/IN the/DT absorption/NN of/IN LEVSIN/NN ./.

(ROOT (S1 (S (S (NP (NNS Antacids)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NN LEVSIN)))))))) (. .))))

nsubj(interfere-3, Antacids-1)
aux(interfere-3, may-2)
root(ROOT-0, interfere-3)
det(absorption-6, the-5)
prep_with(interfere-3, absorption-6)
prep_of(absorption-6, LEVSIN-8)

Administer/NN LEVSIN/VBP before/IN meals/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN Administer)) (VP (VBP LEVSIN) (PP (IN before) (NP (NN meals) (: ;))))) (. .))))

nsubj(LEVSIN-2, Administer-1)
root(ROOT-0, LEVSIN-2)
prep_before(LEVSIN-2, meals-4)

antacids/NNS after/IN meals/NN ./.

(ROOT (S1 (S (S (VP (NNS antacids) (PP (IN after) (NP (NN meals))))) (. .))))

root(ROOT-0, antacids-1)
prep_after(antacids-1, meals-3)

No/DT formal/JJ drug/NN interaction/NN studies/NNS have/VBP been/VBN performed/VBN with/IN ZEVALIN/NN ./.

(ROOT (S1 (S (S (NP (DT No) (JJ formal) (NN drug) (NN interaction) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN performed) (PP (IN with) (NP (NN ZEVALIN))))))) (. .))))

det(studies-5, No-1)
amod(studies-5, formal-2)
nn(studies-5, drug-3)
nn(studies-5, interaction-4)
nsubjpass(performed-8, studies-5)
aux(performed-8, have-6)
auxpass(performed-8, been-7)
root(ROOT-0, performed-8)
prep_with(performed-8, ZEVALIN-10)

Due/IN to/TO the/DT frequent/JJ occurrence/NN of/IN severe/JJ and/CC prolonged/JJ thrombocytopenia/NN ,/, the/DT potential/JJ benefits/NNS of/IN medications/NNS which/WDT interfere/VBP with/IN platelet/NN function/NN and/or/CC anticoagulation/NN should/MD be/VB weighed/VBN against/IN the/DT potential/JJ increased/VBN risks/NNS of/IN bleeding/JJ and/CC hemorrhage/JJ ./.

(ROOT (S1 (S (S (PP (IN Due) (PP (TO to) (NP (NP (DT the) (JJ frequent) (NN occurrence)) (PP (IN of) (NP (ADJP (ADJP (JJ severe)) (CC and) (ADJP (JJ prolonged))) (NN thrombocytopenia)))))) (, ,) (NP (NP (DT the) (JJ potential) (NNS benefits)) (PP (IN of) (NP (NP (NNS medications)) (SBAR (WHNP (WDT which)) (S (VP (VBP interfere) (PP (IN with) (NP (NP (NN platelet) (NN function)) (CC and/or) (NP (NN anticoagulation)))))))))) (VP (MD should) (VP (VB be) (VP (VBN weighed) (PP (IN against) (NP (NP (DT the) (JJ potential) (VBN increased) (NNS risks)) (PP (IN of) (NP (NP (ADJP (JJ bleeding))) (CC and) (NP (ADJP (JJ hemorrhage))))))))))) (. .))))

prepc_due_to(weighed-26, to-2)
det(occurrence-5, the-3)
amod(occurrence-5, frequent-4)
pobj(weighed-26, occurrence-5)
amod(thrombocytopenia-10, severe-7)
conj_and(severe-7, prolonged-9)
prep_of(occurrence-5, thrombocytopenia-10)
det(benefits-14, the-12)
amod(benefits-14, potential-13)
nsubjpass(weighed-26, benefits-14)
prep_of(benefits-14, medications-16)
nsubj(interfere-18, medications-16)
rcmod(medications-16, interfere-18)
nn(function-21, platelet-20)
prep_with(interfere-18, function-21)
conj_and/or(function-21, anticoagulation-23)
aux(weighed-26, should-24)
auxpass(weighed-26, be-25)
root(ROOT-0, weighed-26)
det(risks-31, the-28)
amod(risks-31, potential-29)
amod(risks-31, increased-30)
prep_against(weighed-26, risks-31)
prep_of(risks-31, bleeding-33)
conj_and(bleeding-33, hemorrhage-35)

Patients/NNS receiving/VBG medications/NNS that/WDT interfere/VBP with/IN platelet/NN function/NN or/CC coagulation/NN should/MD have/VB more/RBR frequent/JJ laboratory/NN monitoring/NN for/IN thrombocytopenia/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (NP (NNS medications)) (SBAR (WHNP (WDT that)) (S (VP (VBP interfere) (PP (IN with) (NP (NP (NN platelet) (NN function)) (CC or) (NP (NN coagulation)))))))))) (VP (MD should) (VP (VB have) (NP (ADJP (RBR more) (JJ frequent)) (NN laboratory) (NN monitoring)) (PP (IN for) (NP (NN thrombocytopenia)))))) (. .))))

nsubj(have-12, Patients-1)
partmod(Patients-1, receiving-2)
dobj(receiving-2, medications-3)
nsubj(interfere-5, medications-3)
rcmod(medications-3, interfere-5)
nn(function-8, platelet-7)
prep_with(interfere-5, function-8)
conj_or(function-8, coagulation-10)
aux(have-12, should-11)
root(ROOT-0, have-12)
advmod(frequent-14, more-13)
amod(monitoring-16, frequent-14)
nn(monitoring-16, laboratory-15)
dobj(have-12, monitoring-16)
prep_for(have-12, thrombocytopenia-18)

Patients/NNS in/IN clinical/JJ studies/NNS were/VBD prohibit/VB ed/NN from/IN receiving/VBG growth/NN factor/NN treatment/NN for/IN 2/CD weeks/NNS prior/JJ to/TO the/DT ZEVALIN/NN therapeutic/JJ regimen/NN as/RB well/RB as/IN for/IN 2/CD weeks/NNS following/VBG completion/NN of/IN the/DT regimen/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (PP (IN in) (NP (JJ clinical) (NNS studies)))) (VP (VBD were) (VP (VB prohibit) (NP (NN ed)) (PP (IN from) (S (VP (VBG receiving) (NP (NP (NP (NN growth) (NN factor)) (NN treatment)) (PP (PP (IN for) (NP (NP (CD 2) (NNS weeks)) (ADJP (JJ prior) (PP (TO to) (NP (DT the) (NN ZEVALIN) (JJ therapeutic) (NN regimen)))))) (CONJP (RB as) (RB well) (IN as)) (PP (IN for) (NP (NP (CD 2) (NNS weeks)) (PP (VBG following) (NP (NP (NN completion)) (PP (IN of) (NP (DT the) (NN regimen))))))))))))))) (. .))))

nsubj(prohibit-6, Patients-1)
amod(studies-4, clinical-3)
prep_in(Patients-1, studies-4)
aux(prohibit-6, were-5)
root(ROOT-0, prohibit-6)
dobj(prohibit-6, ed-7)
prepc_from(prohibit-6, receiving-9)
nn(factor-11, growth-10)
nn(treatment-12, factor-11)
dobj(receiving-9, treatment-12)
num(weeks-15, 2-14)
prep_for(treatment-12, weeks-15)
det(regimen-21, the-18)
nn(regimen-21, ZEVALIN-19)
amod(regimen-21, therapeutic-20)
prep_prior_to(weeks-15, regimen-21)
num(weeks-27, 2-26)
conj_and(weeks-15, weeks-27)
prep_following(weeks-27, completion-29)
det(regimen-32, the-31)
prep_of(completion-29, regimen-32)

Coumarin-Type/JJ Anticoagulants/NNS :/: Several/JJ short-term/JJ controlled/JJ studies/NNS failed/VBD to/TO wshow/VB that/IN ibuprofen/NN significantly/RB affected/VBD prothrombin/NN times/NNS or/CC a/DT variety/NN of/IN other/JJ clotting/NN factor/NN s/NNS when/WRB administered/VBN to/TO individuals/NNS on/IN coumarin-type/JJ anticoagulants/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Coumarin-Type) (NNS Anticoagulants)) (: :) (S (NP (JJ Several) (JJ short-term) (JJ controlled) (NNS studies)) (VP (VBD failed) (S (VP (TO to) (VP (VB wshow) (SBAR (IN that) (S (NP (NN ibuprofen)) (ADVP (RB significantly)) (VP (VBD affected) (NP (NP (NN prothrombin) (NNS times)) (CC or) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (JJ other) (NN clotting) (NN factor) (NNS s))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (TO to) (NP (NP (NNS individuals)) (PP (IN on) (NP (JJ coumarin-type) (NNS anticoagulants)))))))))))))))) (. .)))))

amod(Anticoagulants-2, Coumarin-Type-1)
root(ROOT-0, Anticoagulants-2)
amod(studies-7, Several-4)
amod(studies-7, short-term-5)
amod(studies-7, controlled-6)
nsubj(failed-8, studies-7)
xsubj(wshow-10, studies-7)
dep(Anticoagulants-2, failed-8)
aux(wshow-10, to-9)
xcomp(failed-8, wshow-10)
complm(affected-14, that-11)
nsubj(affected-14, ibuprofen-12)
advmod(affected-14, significantly-13)
ccomp(wshow-10, affected-14)
nn(times-16, prothrombin-15)
dobj(affected-14, times-16)
det(variety-19, a-18)
conj_or(times-16, variety-19)
amod(s-24, other-21)
nn(s-24, clotting-22)
nn(s-24, factor-23)
prep_of(variety-19, s-24)
advmod(administered-26, when-25)
advcl(affected-14, administered-26)
prep_to(administered-26, individuals-28)
amod(anticoagulants-31, coumarin-type-30)
prep_on(individuals-28, anticoagulants-31)

However/RB ,/, because/IN bleeding/JJ has/VBZ been/VBN reported/VBN when/WRB ibuprofen/NN and/CC other/JJ nonsteroidal/JJ anti-inflammatory/JJ agents/NNS have/VBP been/VBN administered/VBN to/TO patients/NNS on/IN coumarin-type/JJ anticoagulants/NNS ,/, the/DT physician/NN should/MD be/VB cautious/JJ when/WRB administering/VBG ibuprofen/NN to/TO patients/NNS on/IN anticoagulants/NNS ./.

(ROOT (S1 (S (ADVP (RB However)) (, ,) (SBAR (IN because) (S (NP (JJ bleeding)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN ibuprofen)) (CC and) (NP (JJ other) (JJ nonsteroidal) (JJ anti-inflammatory) (NNS agents))) (VP (VBP have) (VP (VBN been) (VP (VBN administered) (PP (TO to) (NP (NNS patients))) (PP (IN on) (NP (JJ coumarin-type) (NNS anticoagulants))))))))))))) (, ,) (NP (DT the) (NN physician)) (VP (MD should) (VP (VB be) (ADJP (JJ cautious))) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (NN ibuprofen)) (PP (TO to) (NP (NP (NNS patients)) (PP (IN on) (NP (NNS anticoagulants))))))))) (. .))))

advmod(cautious-28, However-1)
mark(reported-7, because-3)
nsubjpass(reported-7, bleeding-4)
aux(reported-7, has-5)
auxpass(reported-7, been-6)
advcl(cautious-28, reported-7)
advmod(administered-17, when-8)
nsubjpass(administered-17, ibuprofen-9)
amod(agents-14, other-11)
amod(agents-14, nonsteroidal-12)
amod(agents-14, anti-inflammatory-13)
conj_and(ibuprofen-9, agents-14)
aux(administered-17, have-15)
auxpass(administered-17, been-16)
advcl(reported-7, administered-17)
prep_to(administered-17, patients-19)
amod(anticoagulants-22, coumarin-type-21)
prep_on(administered-17, anticoagulants-22)
det(physician-25, the-24)
nsubj(cautious-28, physician-25)
aux(cautious-28, should-26)
cop(cautious-28, be-27)
root(ROOT-0, cautious-28)
advmod(administering-30, when-29)
advcl(cautious-28, administering-30)
dobj(administering-30, ibuprofen-31)
prep_to(administering-30, patients-33)
prep_on(patients-33, anticoagulants-35)

Aspirin/NN :/: Animal/NN studies/NNS wshow/VBP that/IN aspirin/NN given/VBN with/IN nonsteroidal/JJ anti-inflammatory/JJ agents/NNS ,/, including/VBG ibuprofen/NN ,/, yields/VBZ a/DT net/JJ decrease/NN in/IN anti-inflammatory/JJ activity/NN with/IN lowered/JJ blood/NN levels/NNS of/IN the/DT non-aspirin/JJ drug/NN ./.

(ROOT (S1 (S (NP (NP (NN Aspirin)) (: :) (S (NP (NN Animal) (NNS studies)) (VP (VBP wshow) (SBAR (IN that) (S (NP (NP (NN aspirin)) (VP (VBN given) (PP (IN with) (NP (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS agents)) (, ,) (PP (VBG including) (NP (NN ibuprofen))) (, ,))))) (VP (VBZ yields) (NP (NP (DT a) (JJ net) (NN decrease)) (PP (IN in) (NP (NP (JJ anti-inflammatory) (NN activity)) (PP (IN with) (NP (NP (JJ lowered) (NN blood) (NNS levels)) (PP (IN of) (NP (DT the) (JJ non-aspirin) (NN drug))))))))))))) (. .)))))

root(ROOT-0, Aspirin-1)
nn(studies-4, Animal-3)
nsubj(wshow-5, studies-4)
dep(Aspirin-1, wshow-5)
complm(yields-17, that-6)
nsubj(yields-17, aspirin-7)
partmod(aspirin-7, given-8)
amod(agents-12, nonsteroidal-10)
amod(agents-12, anti-inflammatory-11)
prep_with(given-8, agents-12)
prep_including(agents-12, ibuprofen-15)
ccomp(wshow-5, yields-17)
det(decrease-20, a-18)
amod(decrease-20, net-19)
dobj(yields-17, decrease-20)
amod(activity-23, anti-inflammatory-22)
prep_in(decrease-20, activity-23)
amod(levels-27, lowered-25)
nn(levels-27, blood-26)
prep_with(activity-23, levels-27)
det(drug-31, the-29)
amod(drug-31, non-aspirin-30)
prep_of(levels-27, drug-31)

Single/JJ dose/NN bioavailability/NN studies/NNS in/IN normal/JJ volunteers/NNS have/VBP failed/VBN to/TO wshow/VB an/DT effect/NN of/IN aspirin/NN on/IN ibuprofen/NN blood/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Single) (NN dose) (NN bioavailability) (NNS studies)) (PP (IN in) (NP (JJ normal) (NNS volunteers)))) (VP (VBP have) (VP (VBN failed) (S (VP (TO to) (VP (VB wshow) (NP (NP (DT an) (NN effect)) (PP (IN of) (NP (NN aspirin))) (PP (IN on) (NP (NN ibuprofen) (NN blood) (NNS levels)))))))))) (. .))))

amod(studies-4, Single-1)
nn(studies-4, dose-2)
nn(studies-4, bioavailability-3)
nsubj(failed-9, studies-4)
xsubj(wshow-11, studies-4)
amod(volunteers-7, normal-6)
prep_in(studies-4, volunteers-7)
aux(failed-9, have-8)
root(ROOT-0, failed-9)
aux(wshow-11, to-10)
xcomp(failed-9, wshow-11)
det(effect-13, an-12)
dobj(wshow-11, effect-13)
prep_of(effect-13, aspirin-15)
nn(levels-19, ibuprofen-17)
nn(levels-19, blood-18)
prep_on(effect-13, levels-19)

Methotrexate/NN :/: Ibuprofen/NN ,/, as/RB well/RB as/IN other/JJ nonsteroidal/JJ anti-inflammatory/JJ drugs/NNS ,/, probably/RB reduces/VBZ the/DT tubular/JJ secretion/NN of/IN methotrexate/NN based/VBN on/IN in/FW vitro/FW studies/NNS in/IN rabbit/NN kidney/NN slices/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Methotrexate)) (: :) (NP (NN Ibuprofen)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (JJ other) (JJ nonsteroidal) (JJ anti-inflammatory) (NNS drugs)) (, ,)) (ADVP (RB probably)) (VP (VBZ reduces) (NP (NP (DT the) (JJ tubular) (NN secretion)) (PP (IN of) (NP (NP (NN methotrexate)) (VP (VBN based) (PP (IN on) (NP (NP (ADJP (FW in) (FW vitro)) (NNS studies)) (PP (IN in) (NP (NN rabbit) (NN kidney) (NNS slices))))))))))) (. .))))

nsubj(reduces-14, Methotrexate-1)
conj_and(Methotrexate-1, Ibuprofen-3)
amod(drugs-11, other-8)
amod(drugs-11, nonsteroidal-9)
amod(drugs-11, anti-inflammatory-10)
conj_and(Methotrexate-1, drugs-11)
advmod(reduces-14, probably-13)
root(ROOT-0, reduces-14)
det(secretion-17, the-15)
amod(secretion-17, tubular-16)
dobj(reduces-14, secretion-17)
prep_of(secretion-17, methotrexate-19)
partmod(methotrexate-19, based-20)
nn(vitro-23, in-22)
amod(studies-24, vitro-23)
prep_on(based-20, studies-24)
nn(slices-28, rabbit-26)
nn(slices-28, kidney-27)
prep_in(studies-24, slices-28)

This/DT may/MD indicate/VB that/IN ibuprofen/NN could/MD enhance/VB the/DT toxicity/NN of/IN methotrexate/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (MD may) (VP (VB indicate) (SBAR (IN that) (S (NP (NN ibuprofen)) (VP (MD could) (VP (VB enhance) (NP (NP (DT the) (NN toxicity)) (PP (IN of) (NP (NN methotrexate))))))))))) (. .))))

nsubj(indicate-3, This-1)
aux(indicate-3, may-2)
root(ROOT-0, indicate-3)
complm(enhance-7, that-4)
nsubj(enhance-7, ibuprofen-5)
aux(enhance-7, could-6)
ccomp(indicate-3, enhance-7)
det(toxicity-9, the-8)
dobj(enhance-7, toxicity-9)
prep_of(toxicity-9, methotrexate-11)

Caution/NN should/MD be/VB used/VBN if/IN ibuprofen/NN is/VBZ administered/VBN concomitantly/RB with/IN methotrexate/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN used) (SBAR (IN if) (S (NP (NN ibuprofen)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN methotrexate))))))))))) (. .))))

nsubjpass(used-4, Caution-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
mark(administered-8, if-5)
nsubjpass(administered-8, ibuprofen-6)
auxpass(administered-8, is-7)
advcl(used-4, administered-8)
advmod(administered-8, concomitantly-9)
prep_with(administered-8, methotrexate-11)

H-2/NN Antagonists/NNS :/: In/IN studies/NNS with/IN human/JJ volunteers/NNS ,/, co-administration/NN of/IN cimetidine/NN or/CC ranitidine/NN with/IN ibuprofen/NN had/VBD no/DT substantive/JJ effect/NN on/IN ibuprofen/NN serum/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NN H-2) (NNS Antagonists)) (: :) (PP (IN In) (NP (NP (NNS studies)) (PP (IN with) (NP (JJ human) (NNS volunteers))))) (, ,) (NP (NP (NN co-administration)) (PP (IN of) (NP (NP (NN cimetidine)) (CC or) (NP (NN ranitidine)))) (PP (IN with) (NP (NN ibuprofen)))) (VP (VBD had) (NP (DT no) (JJ substantive) (NN effect)) (PP (IN on) (NP (NN ibuprofen) (NN serum) (NNS concentrations))))) (. .))))

nn(Antagonists-2, H-2-1)
nsubj(had-17, Antagonists-2)
prep_in(had-17, studies-5)
amod(volunteers-8, human-7)
prep_with(studies-5, volunteers-8)
nsubj(had-17, co-administration-10)
prep_of(co-administration-10, cimetidine-12)
conj_or(cimetidine-12, ranitidine-14)
prep_with(co-administration-10, ibuprofen-16)
root(ROOT-0, had-17)
det(effect-20, no-18)
amod(effect-20, substantive-19)
dobj(had-17, effect-20)
nn(concentrations-24, ibuprofen-22)
nn(concentrations-24, serum-23)
prep_on(had-17, concentrations-24)

Furosemide/NN :/: Clinical/JJ studies/NNS ,/, as/RB well/RB as/IN random/JJ observations/NNS ,/, have/VBP shown/VBN that/IN ibuprofen/NN can/MD reduce/VB the/DT natriuretic/JJ effect/NN of/IN furosemide/NN and/CC thiazides/NNS in/IN some/DT patients/NNS ./.

(ROOT (S1 (S (NP (NP (NN Furosemide)) (: :) (S (NP (NP (JJ Clinical) (NNS studies)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (JJ random) (NNS observations)) (, ,)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NN ibuprofen)) (VP (MD can) (VP (VB reduce) (NP (NP (DT the) (JJ natriuretic) (NN effect)) (PP (IN of) (NP (NP (NN furosemide)) (CC and) (NP (NNS thiazides)))) (PP (IN in) (NP (DT some) (NNS patients))))))))))) (. .)))))

root(ROOT-0, Furosemide-1)
amod(studies-4, Clinical-3)
nsubj(shown-13, studies-4)
amod(observations-10, random-9)
conj_and(studies-4, observations-10)
aux(shown-13, have-12)
dep(Furosemide-1, shown-13)
complm(reduce-17, that-14)
nsubj(reduce-17, ibuprofen-15)
aux(reduce-17, can-16)
ccomp(shown-13, reduce-17)
det(effect-20, the-18)
amod(effect-20, natriuretic-19)
dobj(reduce-17, effect-20)
prep_of(effect-20, furosemide-22)
conj_and(furosemide-22, thiazides-24)
det(patients-27, some-26)
prep_in(effect-20, patients-27)

This/DT response/NN has/VBZ been/VBN attributed/VBN to/TO inhibition/NN of/IN renal/JJ prostaglandin/NN synthesis/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN response)) (VP (VBZ has) (VP (VBN been) (VP (VBN attributed) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ renal) (NN prostaglandin) (NN synthesis))))))))) (. .))))

det(response-2, This-1)
nsubjpass(attributed-5, response-2)
aux(attributed-5, has-3)
auxpass(attributed-5, been-4)
root(ROOT-0, attributed-5)
prep_to(attributed-5, inhibition-7)
amod(synthesis-11, renal-9)
nn(synthesis-11, prostaglandin-10)
prep_of(inhibition-7, synthesis-11)

During/IN concomitant/JJ therapy/NN with/IN ibuprofen/NN ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB for/IN signs/NNS of/IN renal/JJ failure/NN ,/, as/RB well/RB as/IN to/TO assure/VB diuretic/JJ efficacy/NN ./.

(ROOT (S1 (S (S (PP (IN During) (NP (NP (JJ concomitant) (NN therapy)) (PP (IN with) (NP (NN ibuprofen))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (PP (IN for) (NP (NP (NNS signs)) (PP (IN of) (NP (JJ renal) (NN failure))))) (, ,) (S (CONJP (RB as) (RB well) (IN as)) (VP (TO to) (VP (VB assure) (NP (JJ diuretic) (NN efficacy))))))))) (. .))))

amod(therapy-3, concomitant-2)
prep_during(observed-11, therapy-3)
prep_with(therapy-3, ibuprofen-5)
det(patient-8, the-7)
nsubjpass(observed-11, patient-8)
aux(observed-11, should-9)
auxpass(observed-11, be-10)
root(ROOT-0, observed-11)
advmod(observed-11, closely-12)
prep_for(observed-11, signs-14)
amod(failure-17, renal-16)
prep_of(signs-14, failure-17)
cc(assure-23, well-20)
aux(assure-23, to-22)
xcomp(observed-11, assure-23)
amod(efficacy-25, diuretic-24)
dobj(assure-23, efficacy-25)

Lithium/NN :/: Ibuprofen/NN produced/VBD an/DT elevation/NN of/IN plasma/NN lithium/NN levels/NNS and/CC a/DT reduction/NN in/IN renal/JJ lithium/NN clearance/NN in/IN a/DT study/NN of/IN eleven/CD normal/JJ volunteers/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Lithium)) (: :) (NP (NN Ibuprofen))) (VP (VBD produced) (NP (NP (NP (DT an) (NN elevation)) (PP (IN of) (NP (NN plasma) (NN lithium) (NNS levels)))) (CC and) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (JJ renal) (NN lithium) (NN clearance))))) (PP (IN in) (NP (NP (DT a) (NN study)) (PP (IN of) (NP (CD eleven) (JJ normal) (NNS volunteers))))))) (. .))))

nsubj(produced-4, Lithium-1)
dep(Lithium-1, Ibuprofen-3)
root(ROOT-0, produced-4)
det(elevation-6, an-5)
dobj(produced-4, elevation-6)
nn(levels-10, plasma-8)
nn(levels-10, lithium-9)
prep_of(elevation-6, levels-10)
det(reduction-13, a-12)
conj_and(elevation-6, reduction-13)
amod(clearance-17, renal-15)
nn(clearance-17, lithium-16)
prep_in(reduction-13, clearance-17)
det(study-20, a-19)
prep_in(produced-4, study-20)
num(volunteers-24, eleven-22)
amod(volunteers-24, normal-23)
prep_of(study-20, volunteers-24)

The/DT mean/JJ minimum/JJ lithium/NN concentration/NN increased/VBD 15/CD %/NN and/CC the/DT renal/JJ clearance/NN of/IN lithium/NN was/VBD decreased/VBN by/IN 19/CD %/NN during/IN this/DT period/NN of/IN concomitant/JJ drug/NN administration/NN ./.

(ROOT (S1 (S (S (S (NP (DT The) (JJ mean) (JJ minimum) (NN lithium) (NN concentration)) (VP (VBD increased) (NP (CD 15) (NN %)))) (CC and) (S (NP (NP (DT the) (JJ renal) (NN clearance)) (PP (IN of) (NP (NN lithium)))) (VP (VBD was) (VP (VBN decreased) (PP (IN by) (NP (CD 19) (NN %))) (PP (IN during) (NP (NP (DT this) (NN period)) (PP (IN of) (NP (JJ concomitant) (NN drug) (NN administration))))))))) (. .))))

det(concentration-5, The-1)
amod(concentration-5, mean-2)
amod(concentration-5, minimum-3)
nn(concentration-5, lithium-4)
nsubj(increased-6, concentration-5)
root(ROOT-0, increased-6)
num(%-8, 15-7)
dobj(increased-6, %-8)
det(clearance-12, the-10)
amod(clearance-12, renal-11)
nsubjpass(decreased-16, clearance-12)
prep_of(clearance-12, lithium-14)
auxpass(decreased-16, was-15)
conj_and(increased-6, decreased-16)
num(%-19, 19-18)
agent(decreased-16, %-19)
det(period-22, this-21)
prep_during(decreased-16, period-22)
amod(administration-26, concomitant-24)
nn(administration-26, drug-25)
prep_of(period-22, administration-26)

This/DT effect/NN has/VBZ been/VBN attributed/VBN to/TO inhibition/NN of/IN renal/JJ prostaglandin/NN synthesis/NN by/IN ibuprofen/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN effect)) (VP (VBZ has) (VP (VBN been) (VP (VBN attributed) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ renal) (NN prostaglandin) (NN synthesis))) (PP (IN by) (NP (NN ibuprofen))))))))) (. .))))

det(effect-2, This-1)
nsubjpass(attributed-5, effect-2)
aux(attributed-5, has-3)
auxpass(attributed-5, been-4)
root(ROOT-0, attributed-5)
prep_to(attributed-5, inhibition-7)
amod(synthesis-11, renal-9)
nn(synthesis-11, prostaglandin-10)
prep_of(inhibition-7, synthesis-11)
prep_by(inhibition-7, ibuprofen-13)

Thus/RB ,/, when/WRB ibuprofen/NN and/CC lithium/NN are/VBP administered/VBN concurrently/RB ,/, subjects/NNS should/MD be/VB observed/VBN carefully/RB for/IN signs/NNS of/IN lithium/NN toxicity/NN ./.

(ROOT (S1 (S (S (ADVP (RB Thus)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN ibuprofen)) (CC and) (NP (NN lithium))) (VP (VBP are) (VP (VBN administered) (ADVP (RB concurrently)))))) (, ,) (NP (NNS subjects)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB carefully)) (PP (IN for) (NP (NP (NNS signs)) (PP (IN of) (NP (NN lithium) (NN toxicity))))))))) (. .))))

advmod(observed-14, Thus-1)
advmod(administered-8, when-3)
nsubjpass(administered-8, ibuprofen-4)
conj_and(ibuprofen-4, lithium-6)
auxpass(administered-8, are-7)
advcl(observed-14, administered-8)
advmod(administered-8, concurrently-9)
nsubjpass(observed-14, subjects-11)
aux(observed-14, should-12)
auxpass(observed-14, be-13)
root(ROOT-0, observed-14)
advmod(observed-14, carefully-15)
prep_for(observed-14, signs-17)
nn(toxicity-20, lithium-19)
prep_of(signs-17, toxicity-20)

(/-LRB- Read/VBN circulars/NNS for/IN lithium/NN preparation/NN before/IN use/NN of/IN such/JJ concurrent/JJ therapy/NN )./NNS

(ROOT (S1 (S (NP (-LRB- -LRB-) (NP (VBN Read) (NNS circulars)) (PP (IN for) (NP (NN lithium) (NN preparation))) (PP (IN before) (NP (NP (NN use)) (PP (IN of) (NP (JJ such) (JJ concurrent) (NN therapy) (NNS -RRB-.)))))))))

amod(circulars-3, Read-2)
root(ROOT-0, circulars-3)
nn(preparation-6, lithium-5)
prep_for(circulars-3, preparation-6)
prep_before(circulars-3, use-8)
amod(-RRB-.-13, such-10)
amod(-RRB-.-13, concurrent-11)
nn(-RRB-.-13, therapy-12)
prep_of(use-8, -RRB-.-13)

Digoxin/NN :/: Supraventricular/JJ arrhythmias/NNS may/MD mask/VB the/DT cardiotoxicity/NN associated/VBN with/IN excessive/JJ digoxin/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NN Digoxin) (: :) (JJ Supraventricular) (NNS arrhythmias)) (VP (MD may) (VP (VB mask) (NP (NP (DT the) (NN cardiotoxicity)) (VP (VBN associated) (PP (IN with) (NP (JJ excessive) (NN digoxin) (NNS levels)))))))) (. .))))

nn(arrhythmias-4, Digoxin-1)
amod(arrhythmias-4, Supraventricular-3)
nsubj(mask-6, arrhythmias-4)
aux(mask-6, may-5)
root(ROOT-0, mask-6)
det(cardiotoxicity-8, the-7)
dobj(mask-6, cardiotoxicity-8)
partmod(cardiotoxicity-8, associated-9)
amod(levels-13, excessive-11)
nn(levels-13, digoxin-12)
prep_with(associated-9, levels-13)

Coadministration/NN of/IN digoxin/NN did/VBD not/RB have/VB effects/NNS on/IN either/CC the/DT safety/NN or/CC efficacy/NN of/IN ibutilide/NN in/IN the/DT clinical/JJ trials/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN digoxin)))) (VP (VBD did) (RB not) (VP (VB have) (NP (NP (NNS effects)) (PP (IN on) (NP (NP (CC either) (DT the) (NP (NN safety)) (CC or) (NP (NN efficacy))) (PP (IN of) (NP (NN ibutilide)))))) (PP (IN in) (NP (DT the) (JJ clinical) (NNS trials)))))) (. .))))

nsubj(have-6, Coadministration-1)
prep_of(Coadministration-1, digoxin-3)
aux(have-6, did-4)
neg(have-6, not-5)
root(ROOT-0, have-6)
dobj(have-6, effects-7)
preconj(safety-11, either-9)
dep(safety-11, the-10)
prep_on(effects-7, safety-11)
conj_or(safety-11, efficacy-13)
prep_of(safety-11, ibutilide-15)
det(trials-19, the-17)
amod(trials-19, clinical-18)
prep_in(have-6, trials-19)

Calcium/NN channel/NN blocking/NN agents/NNS :/: Coadministration/NN of/IN calcium/NN channel/NN blockers/NNS did/VBD not/RB have/VB any/DT effect/NN on/IN either/CC the/DT safety/NN or/CC efficacy/NN of/IN ibutilide/NN in/IN the/DT clinical/JJ trials/NNS ./.

(ROOT (S1 (S (NP (NP (NN Calcium) (NN channel) (NN blocking) (NNS agents)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN calcium) (NN channel) (NNS blockers)))) (VP (VBD did) (RB not) (VP (VB have) (NP (DT any) (NN effect)) (PP (IN on) (NP (NP (CC either) (DT the) (NP (NN safety)) (CC or) (NP (NN efficacy))) (PP (IN of) (NP (NN ibutilide))) (PP (IN in) (NP (DT the) (JJ clinical) (NNS trials)))))))) (. .)))))

nn(agents-4, Calcium-1)
nn(agents-4, channel-2)
nn(agents-4, blocking-3)
root(ROOT-0, agents-4)
nsubj(have-13, Coadministration-6)
nn(blockers-10, calcium-8)
nn(blockers-10, channel-9)
prep_of(Coadministration-6, blockers-10)
aux(have-13, did-11)
neg(have-13, not-12)
dep(agents-4, have-13)
det(effect-15, any-14)
dobj(have-13, effect-15)
preconj(safety-19, either-17)
dep(safety-19, the-18)
prep_on(have-13, safety-19)
conj_or(safety-19, efficacy-21)
prep_of(safety-19, ibutilide-23)
det(trials-27, the-25)
amod(trials-27, clinical-26)
prep_in(safety-19, trials-27)

Beta-adrenergic/JJ blocking/NN agents/NNS :/: Coadministration/NN of/IN beta-adrenergic/JJ blocking/VBG agents/NNS did/VBD not/RB have/VB any/DT effect/NN on/IN either/CC the/DT safety/NN or/CC efficacy/NN of/IN ibutilide/NN in/IN the/DT clinical/JJ trials/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Beta-adrenergic) (NN blocking) (NNS agents)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (JJ beta-adrenergic) (VBG blocking) (NNS agents)))) (VP (VBD did) (RB not) (VP (VB have) (NP (DT any) (NN effect)) (PP (IN on) (NP (NP (CC either) (DT the) (NP (NN safety)) (CC or) (NP (NN efficacy))) (PP (IN of) (NP (NN ibutilide))) (PP (IN in) (NP (DT the) (JJ clinical) (NNS trials)))))))) (. .)))))

amod(agents-3, Beta-adrenergic-1)
nn(agents-3, blocking-2)
root(ROOT-0, agents-3)
nsubj(have-12, Coadministration-5)
amod(agents-9, beta-adrenergic-7)
amod(agents-9, blocking-8)
prep_of(Coadministration-5, agents-9)
aux(have-12, did-10)
neg(have-12, not-11)
dep(agents-3, have-12)
det(effect-14, any-13)
dobj(have-12, effect-14)
preconj(safety-18, either-16)
dep(safety-18, the-17)
prep_on(have-12, safety-18)
conj_or(safety-18, efficacy-20)
prep_of(safety-18, ibutilide-22)
det(trials-26, the-24)
amod(trials-26, clinical-25)
prep_in(safety-18, trials-26)

Interactions/NNS may/MD occur/VB between/IN EPA/NN supplements/NNS and/CC aspirin/NN and/CC other/JJ non-steroidal/JJ anti-inflammatory/JJ drugs/NNS and/CC herbs/NNS such/JJ as/IN garlic/NN (/-LRB- Allium/NNP sativum/FW )/-RRB- and/CC ginkgo/NN (/-LRB- Ginkgo/NNP biloba/NNP )/-RRB- ./.

(ROOT (S1 (S (S (NP (NNS Interactions)) (VP (MD may) (VP (VB occur) (PP (IN between) (NP (NP (NN EPA) (NNS supplements)) (CC and) (NP (NP (NN aspirin)) (CC and) (NP (NP (NP (JJ other) (JJ non-steroidal) (JJ anti-inflammatory) (NNS drugs)) (CC and) (NP (NNS herbs))) (PP (JJ such) (IN as) (NP (NP (NP (NN garlic)) (PRN (-LRB- -LRB-) (NP (NNP Allium) (FW sativum)) (-RRB- -RRB-))) (CC and) (NP (NP (NN ginkgo)) (PRN (-LRB- -LRB-) (NP (NNP Ginkgo) (NNP biloba)) (-RRB- -RRB-)))))))))))) (. .))))

nsubj(occur-3, Interactions-1)
aux(occur-3, may-2)
root(ROOT-0, occur-3)
nn(supplements-6, EPA-5)
prep_between(occur-3, supplements-6)
conj_and(supplements-6, aspirin-8)
amod(drugs-13, other-10)
amod(drugs-13, non-steroidal-11)
amod(drugs-13, anti-inflammatory-12)
conj_and(aspirin-8, drugs-13)
conj_and(drugs-13, herbs-15)
prep_such_as(drugs-13, garlic-18)
appos(garlic-18, Allium-20)
dep(Allium-20, sativum-21)
conj_and(garlic-18, ginkgo-24)
nn(biloba-27, Ginkgo-26)
appos(ginkgo-24, biloba-27)

Most/JJS who/WP take/VBP EPA/NN supplements/NNS and/CC the/DT above/JJ drugs/NNS or/CC herbs/NNS do/VBP not/RB suffer/VB from/IN these/DT problems/NNS and/CC if/IN they/PRP occur/VBP ,/, they/PRP are/VBP rare/JJ ./.

(ROOT (S1 (S (S (S (NP (NP (NP (JJS Most)) (SBAR (WHNP (WP who)) (S (VP (VBP take) (NP (NN EPA) (NNS supplements)))))) (CC and) (NP (NP (DT the) (JJ above) (NNS drugs)) (CC or) (NP (NNS herbs)))) (VP (VBP do) (RB not) (VP (VB suffer) (PP (IN from) (NP (DT these) (NNS problems)))))) (CC and) (S (SBAR (IN if) (S (NP (PRP they)) (VP (VBP occur)))) (, ,) (NP (PRP they)) (VP (VBP are) (ADJP (JJ rare))))) (. .))))

nsubj(take-3, Most-1)
nsubj(suffer-14, Most-1)
rcmod(Most-1, take-3)
nn(supplements-5, EPA-4)
dobj(take-3, supplements-5)
det(drugs-9, the-7)
amod(drugs-9, above-8)
conj_and(Most-1, drugs-9)
conj_or(drugs-9, herbs-11)
aux(suffer-14, do-12)
neg(suffer-14, not-13)
root(ROOT-0, suffer-14)
det(problems-17, these-16)
prep_from(suffer-14, problems-17)
mark(occur-21, if-19)
nsubj(occur-21, they-20)
advcl(rare-25, occur-21)
nsubj(rare-25, they-23)
cop(rare-25, are-24)
conj_and(suffer-14, rare-25)

If/IN they/PRP do/VBP occur/VB ,/, the/DT EPA/NN dose/NN should/MD be/VB lowered/JJ or/CC discontinued/JJ ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (PRP they)) (VP (VBP do) (VP (VB occur))))) (, ,) (NP (DT the) (NN EPA) (NN dose)) (VP (MD should) (VP (VB be) (ADJP (ADJP (JJ lowered)) (CC or) (ADJP (JJ discontinued)))))) (. .))))

mark(occur-4, If-1)
nsubj(occur-4, they-2)
aux(occur-4, do-3)
advcl(lowered-11, occur-4)
det(dose-8, the-6)
nn(dose-8, EPA-7)
nsubj(lowered-11, dose-8)
aux(lowered-11, should-9)
cop(lowered-11, be-10)
root(ROOT-0, lowered-11)
conj_or(lowered-11, discontinued-13)

Conflicting/VBG results/NNS have/VBP been/VBN reported/VBN regarding/VBG the/DT effects/NNS of/IN EPA/NN supplements/NNS on/IN glycemic/JJ control/NN in/IN non-diabetics/NNS with/IN glucose/NN intolerance/NN ,/, and/CC those/DT with/IN type/NN 2/CD diabetes/NNS ./.

(ROOT (S1 (S (S (NP (VBG Conflicting) (NNS results)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (VBG regarding) (NP (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN EPA) (NNS supplements))) (PP (IN on) (NP (NP (JJ glycemic) (NN control)) (PP (IN in) (NP (NP (NNS non-diabetics)) (PP (IN with) (NP (NN glucose) (NN intolerance)))))))) (, ,) (CC and) (NP (NP (DT those)) (PP (IN with) (NP (NN type) (CD 2) (NNS diabetes))))))))))) (. .))))

amod(results-2, Conflicting-1)
nsubjpass(reported-5, results-2)
aux(reported-5, have-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
xcomp(reported-5, regarding-6)
det(effects-8, the-7)
dobj(regarding-6, effects-8)
nn(supplements-11, EPA-10)
prep_of(effects-8, supplements-11)
amod(control-14, glycemic-13)
prep_on(effects-8, control-14)
prep_in(control-14, non-diabetics-16)
nn(intolerance-19, glucose-18)
prep_with(non-diabetics-16, intolerance-19)
conj_and(effects-8, those-22)
nn(diabetes-26, type-24)
num(diabetes-26, 2-25)
prep_with(those-22, diabetes-26)

Some/DT early/JJ studies/NNS indicated/VBD that/IN EPA/NN supplements/NNS might/MD have/VB detrimental/JJ effects/NNS in/IN those/DT groups/NNS ./.

(ROOT (S1 (S (S (NP (DT Some) (JJ early) (NNS studies)) (VP (VBD indicated) (SBAR (IN that) (S (NP (NN EPA) (NNS supplements)) (VP (MD might) (VP (VB have) (NP (JJ detrimental) (NNS effects)) (PP (IN in) (NP (DT those) (NNS groups))))))))) (. .))))

det(studies-3, Some-1)
amod(studies-3, early-2)
nsubj(indicated-4, studies-3)
root(ROOT-0, indicated-4)
complm(have-9, that-5)
nn(supplements-7, EPA-6)
nsubj(have-9, supplements-7)
aux(have-9, might-8)
ccomp(indicated-4, have-9)
amod(effects-11, detrimental-10)
dobj(have-9, effects-11)
det(groups-14, those-13)
prep_in(have-9, groups-14)

There/EX is/VBZ no/DT evidence/NN that/IN EPA/NN supplements/NNS have/VBP detrimental/JJ effects/NNS on/IN glucose/NN tolerance/NN ,/, insulin/NN secretion/NN or/CC insulin/NN resistance/NN in/IN non-diabetic/JJ subjects/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ is) (NP (DT no) (NN evidence) (SBAR (IN that) (S (NP (NN EPA) (NNS supplements)) (VP (VBP have) (NP (JJ detrimental) (NNS effects)) (PP (IN on) (NP (NP (NP (NN glucose) (NN tolerance)) (, ,) (NP (NN insulin) (NN secretion)) (CC or) (NP (NN insulin) (NN resistance))) (PP (IN in) (NP (JJ non-diabetic) (NNS subjects))))))))))) (. .))))

expl(is-2, There-1)
root(ROOT-0, is-2)
det(evidence-4, no-3)
nsubj(is-2, evidence-4)
complm(have-8, that-5)
nn(supplements-7, EPA-6)
nsubj(have-8, supplements-7)
ccomp(evidence-4, have-8)
amod(effects-10, detrimental-9)
dobj(have-8, effects-10)
nn(tolerance-13, glucose-12)
prep_on(have-8, tolerance-13)
nn(secretion-16, insulin-15)
conj_or(tolerance-13, secretion-16)
nn(resistance-19, insulin-18)
conj_or(tolerance-13, resistance-19)
amod(subjects-22, non-diabetic-21)
prep_in(tolerance-13, subjects-22)

Diabetics/NNS who/WP take/VBP EPA/NN supplements/NNS should/MD be/VB monitored/VBN by/IN their/PRP$ physicians/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Diabetics)) (SBAR (WHNP (WP who)) (S (VP (VBP take) (NP (NN EPA) (NNS supplements)))))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (PP (IN by) (NP (PRP$ their) (NNS physicians))))))) (. .))))

nsubj(take-3, Diabetics-1)
nsubjpass(monitored-8, Diabetics-1)
rcmod(Diabetics-1, take-3)
nn(supplements-5, EPA-4)
dobj(take-3, supplements-5)
aux(monitored-8, should-6)
auxpass(monitored-8, be-7)
root(ROOT-0, monitored-8)
poss(physicians-11, their-10)
agent(monitored-8, physicians-11)

Other/JJ medicines/NNS -/: Although/IN certain/JJ medicines/NNS should/MD not/RB be/VB used/VBN together/RB at/IN all/NN ,/, in/IN other/JJ cases/NNS two/CD different/JJ medicines/NNS may/MD be/VB used/VBN together/RB even/RB if/IN an/DT interaction/NN might/MD occur/VB ./.

(ROOT (S1 (S (NP (NP (JJ Other) (NNS medicines)) (: -) (S (SBAR (IN Although) (S (NP (JJ certain) (NNS medicines)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (ADVP (RB together)) (PP (IN at) (NP (NN all)))))))) (, ,) (PP (IN in) (NP (JJ other) (NNS cases))) (NP (CD two) (JJ different) (NNS medicines)) (VP (MD may) (VP (VB be) (VP (VBN used) (ADVP (RB together)) (SBAR (RB even) (IN if) (S (NP (DT an) (NN interaction)) (VP (MD might) (VP (VB occur))))))))) (. .)))))

amod(medicines-2, Other-1)
root(ROOT-0, medicines-2)
mark(used-10, Although-4)
amod(medicines-6, certain-5)
nsubjpass(used-10, medicines-6)
aux(used-10, should-7)
neg(used-10, not-8)
auxpass(used-10, be-9)
advcl(used-23, used-10)
advmod(used-10, together-11)
prep_at(used-10, all-13)
amod(cases-17, other-16)
prep_in(used-23, cases-17)
num(medicines-20, two-18)
amod(medicines-20, different-19)
nsubjpass(used-23, medicines-20)
aux(used-23, may-21)
auxpass(used-23, be-22)
dep(medicines-2, used-23)
advmod(used-23, together-24)
advmod(occur-30, even-25)
dep(occur-30, if-26)
det(interaction-28, an-27)
nsubj(occur-30, interaction-28)
aux(occur-30, might-29)
ccomp(used-23, occur-30)

When/WRB you/RB are/VBP using/VBG idoxuridine/NN ,/, it/PRP is/VBZ especially/RB important/JJ that/IN your/NN health/NN care/NN professional/NN know/VB if/IN you/NN are/VBP using/VBG the/DT following/NN :/: Eye/NN product/NN containing/VBG boric/JJ acid/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (ADVP (RB you)) (VP (VBP are) (VP (VBG using) (NP (NN idoxuridine)))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (RB especially) (JJ important)) (SBAR (IN that) (S (NP (NN your) (NN health) (NN care) (NN professional)) (VP (VB know) (SBAR (IN if) (S (NP (NN you)) (VP (VBP are) (VP (VBG using) (NP (DT the) (NN following))))))))))) (: :) (NP (NP (NN Eye) (NN product)) (VP (VBG containing) (NP (JJ boric) (NN acid)))) (. .))))

advmod(using-4, When-1)
advmod(using-4, you-2)
aux(using-4, are-3)
advcl(important-10, using-4)
dobj(using-4, idoxuridine-5)
nsubj(important-10, it-7)
cop(important-10, is-8)
advmod(important-10, especially-9)
root(ROOT-0, important-10)
complm(know-16, that-11)
nn(professional-15, your-12)
nn(professional-15, health-13)
nn(professional-15, care-14)
nsubj(know-16, professional-15)
ccomp(important-10, know-16)
mark(using-20, if-17)
nsubj(using-20, you-18)
aux(using-20, are-19)
advcl(know-16, using-20)
det(following-22, the-21)
dobj(using-20, following-22)
nn(product-25, Eye-24)
dep(important-10, product-25)
partmod(product-25, containing-26)
amod(acid-28, boric-27)
dobj(containing-26, acid-28)

Boric/JJ acid/NN may/MD interact/VB with/IN the/DT idoxuridine/NN preparation/NN causing/VBG a/DT gritty/NN substance/NN to/TO form/VB or/CC may/MD interact/VB with/IN the/DT preservative/NN in/IN the/DT idoxuridine/NN preparation/NN causing/VBG a/DT toxic/JJ effect/NN in/IN the/DT eye/NN ./.

(ROOT (S1 (S (S (NP (JJ Boric) (NN acid)) (VP (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NP (DT the) (NN idoxuridine) (NN preparation)) (VP (VBG causing) (NP (DT a) (NN gritty) (NN substance))))) (S (VP (TO to) (VP (VB form)))))) (CC or) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NP (DT the) (NN preservative)) (PP (IN in) (NP (NP (DT the) (NN idoxuridine) (NN preparation)) (VP (VBG causing) (NP (DT a) (JJ toxic) (NN effect)) (PP (IN in) (NP (DT the) (NN eye)))))))))))) (. .))))

amod(acid-2, Boric-1)
nsubj(interact-4, acid-2)
xsubj(form-14, acid-2)
aux(interact-4, may-3)
root(ROOT-0, interact-4)
det(preparation-8, the-6)
nn(preparation-8, idoxuridine-7)
prep_with(interact-4, preparation-8)
partmod(preparation-8, causing-9)
det(substance-12, a-10)
nn(substance-12, gritty-11)
dobj(causing-9, substance-12)
aux(form-14, to-13)
xcomp(interact-4, form-14)
aux(interact-17, may-16)
conj_or(interact-4, interact-17)
det(preservative-20, the-19)
prep_with(interact-17, preservative-20)
det(preparation-24, the-22)
nn(preparation-24, idoxuridine-23)
prep_in(preservative-20, preparation-24)
partmod(preparation-24, causing-25)
det(effect-28, a-26)
amod(effect-28, toxic-27)
dobj(causing-25, effect-28)
det(eye-31, the-30)
prep_in(causing-25, eye-31)

In/IN studies/NNS in/IN normal/JJ volunteers/NNS ,/, there/EX was/VBD no/DT pharmacodynamic/JJ interaction/NN between/IN intravenous/JJ iloprost/NN and/CC either/CC nifedipine/NN ,/, diltiazem/NN ,/, or/CC captopril/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NNS studies)) (PP (IN in) (NP (JJ normal) (NNS volunteers))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (JJ pharmacodynamic) (NN interaction)) (PP (IN between) (NP (NP (JJ intravenous) (NN iloprost)) (CC and) (NP (CC either) (NP (NN nifedipine)) (, ,) (NP (NN diltiazem)) (, ,) (CC or) (NP (NN captopril)))))))) (. .))))

prep_in(was-8, studies-2)
amod(volunteers-5, normal-4)
prep_in(studies-2, volunteers-5)
expl(was-8, there-7)
root(ROOT-0, was-8)
det(interaction-11, no-9)
amod(interaction-11, pharmacodynamic-10)
nsubj(was-8, interaction-11)
amod(iloprost-14, intravenous-13)
prep_between(interaction-11, iloprost-14)
preconj(nifedipine-17, either-16)
conj_and(iloprost-14, nifedipine-17)
conj_or(nifedipine-17, diltiazem-19)
conj_or(nifedipine-17, captopril-22)

However/RB ,/, iloprost/NN has/VBZ the/DT potential/NN to/TO increase/VB the/DT hypotensive/JJ effect/NN of/IN vasodilators/NNS and/CC antihypertensive/JJ agents/NNS ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NN iloprost)) (VP (VBZ has) (NP (DT the) (NN potential) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (JJ hypotensive) (NN effect)) (PP (IN of) (NP (NP (NNS vasodilators)) (CC and) (NP (JJ antihypertensive) (NNS agents))))))))))) (. .))))

advmod(has-4, However-1)
nsubj(has-4, iloprost-3)
root(ROOT-0, has-4)
det(potential-6, the-5)
dobj(has-4, potential-6)
aux(increase-8, to-7)
infmod(potential-6, increase-8)
det(effect-11, the-9)
amod(effect-11, hypotensive-10)
dobj(increase-8, effect-11)
prep_of(effect-11, vasodilators-13)
amod(agents-16, antihypertensive-15)
conj_and(vasodilators-13, agents-16)

Since/IN iloprost/NN inhibits/VBZ platelet/NN function/NN ,/, there/EX is/VBZ a/DT potential/NN for/IN increased/VBN risk/NN of/IN bleeding/JJ ,/, particularly/RB in/IN patients/NNS maintained/VBN on/IN anticoagulants/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NN iloprost)) (VP (VBZ inhibits) (NP (NN platelet) (NN function))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (NN potential)) (PP (IN for) (NP (NP (VBN increased) (NN risk)) (PP (IN of) (NP (JJ bleeding)))))) (, ,) (PP (ADVP (RB particularly)) (IN in) (NP (NP (NNS patients)) (VP (VBN maintained) (PP (IN on) (NP (NNS anticoagulants)))))))) (. .))))

mark(inhibits-3, Since-1)
nsubj(inhibits-3, iloprost-2)
advcl(is-8, inhibits-3)
nn(function-5, platelet-4)
dobj(inhibits-3, function-5)
expl(is-8, there-7)
root(ROOT-0, is-8)
det(potential-10, a-9)
nsubj(is-8, potential-10)
amod(risk-13, increased-12)
prep_for(potential-10, risk-13)
prep_of(risk-13, bleeding-15)
advmod(is-8, particularly-17)
prep_in(is-8, patients-19)
partmod(patients-19, maintained-20)
prep_on(maintained-20, anticoagulants-22)

During/IN clinical/JJ trials/NNS ,/, iloprost/NN was/VBD used/VBN concurrently/RB with/IN anticoagulants/NNS ,/, diuretics/NNS ,/, cardiac/JJ glycosides/NNS ,/, calcium/NN channel/NN blockers/NNS ,/, analgesics/NNS ,/, antipyretics/NNS ,/, nonsteroidal/JJ antiinflammatories/NNS ,/, corticosteroids/NNS ,/, and/CC other/JJ medications/NNS ./.

(ROOT (S1 (S (PP (IN During) (NP (JJ clinical) (NNS trials))) (, ,) (NP (NN iloprost)) (VP (VBD was) (VP (VBN used) (ADVP (RB concurrently)) (PP (IN with) (NP (NP (NNS anticoagulants)) (, ,) (NP (NNS diuretics)) (, ,) (NP (JJ cardiac) (NNS glycosides)) (, ,) (NP (NN calcium) (NN channel) (NNS blockers)) (, ,) (NP (NNS analgesics)) (, ,) (NP (NNS antipyretics)) (, ,) (NP (JJ nonsteroidal) (NNS antiinflammatories)) (, ,) (NP (NNS corticosteroids)) (, ,) (CC and) (NP (JJ other) (NNS medications)))))) (. .))))

amod(trials-3, clinical-2)
prep_during(used-7, trials-3)
nsubjpass(used-7, iloprost-5)
auxpass(used-7, was-6)
root(ROOT-0, used-7)
advmod(used-7, concurrently-8)
prep_with(used-7, anticoagulants-10)
conj_and(anticoagulants-10, diuretics-12)
amod(glycosides-15, cardiac-14)
conj_and(anticoagulants-10, glycosides-15)
nn(blockers-19, calcium-17)
nn(blockers-19, channel-18)
conj_and(anticoagulants-10, blockers-19)
conj_and(anticoagulants-10, analgesics-21)
conj_and(anticoagulants-10, antipyretics-23)
amod(antiinflammatories-26, nonsteroidal-25)
conj_and(anticoagulants-10, antiinflammatories-26)
conj_and(anticoagulants-10, corticosteroids-28)
amod(medications-32, other-31)
conj_and(anticoagulants-10, medications-32)

Intravenous/JJ infusion/NN of/IN iloprost/NN had/VBD no/DT effect/NN on/IN the/DT pharmacokinetics/NNS of/IN digoxin/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Intravenous) (NN infusion)) (PP (IN of) (NP (NN iloprost)))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN digoxin))))))) (. .))))

amod(infusion-2, Intravenous-1)
nsubj(had-5, infusion-2)
prep_of(infusion-2, iloprost-4)
root(ROOT-0, had-5)
det(effect-7, no-6)
dobj(had-5, effect-7)
det(pharmacokinetics-10, the-9)
prep_on(had-5, pharmacokinetics-10)
prep_of(pharmacokinetics-10, digoxin-12)

Acetylsalicylic/JJ acid/NN did/VBD not/RB alter/VB the/DT clearance/NN (/-LRB- pharmacokinetics/NNS )/-RRB- of/IN iloprost/NN ./.

(ROOT (S1 (S (S (NP (JJ Acetylsalicylic) (NN acid)) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (NN clearance) (-LRB- -LRB-) (NNS pharmacokinetics) (-RRB- -RRB-)) (PP (IN of) (NP (NN iloprost))))))) (. .))))

amod(acid-2, Acetylsalicylic-1)
nsubj(alter-5, acid-2)
aux(alter-5, did-3)
neg(alter-5, not-4)
root(ROOT-0, alter-5)
det(pharmacokinetics-9, the-6)
nn(pharmacokinetics-9, clearance-7)
dobj(alter-5, pharmacokinetics-9)
prep_of(pharmacokinetics-9, iloprost-12)

Although/IN clinical/JJ studies/NNS have/VBP not/RB been/VBN conducted/VBN ,/, in/FW vitro/FW studies/NNS of/IN iloprost/NN indicate/VBP that/IN no/DT relevant/JJ inhibition/NN of/IN cytochrome/NN P450/NN drug/NN metabolism/NN would/MD be/VB expected/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (JJ clinical) (NNS studies)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN conducted)))))) (, ,) (NP (NP (ADJP (FW in) (FW vitro)) (NNS studies)) (PP (IN of) (NP (NN iloprost)))) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (DT no) (JJ relevant) (NN inhibition)) (PP (IN of) (NP (NN cytochrome) (NN P450) (NN drug) (NN metabolism)))) (VP (MD would) (VP (VB be) (VP (VBN expected)))))))) (. .))))

mark(conducted-7, Although-1)
amod(studies-3, clinical-2)
nsubjpass(conducted-7, studies-3)
aux(conducted-7, have-4)
neg(conducted-7, not-5)
auxpass(conducted-7, been-6)
advcl(indicate-14, conducted-7)
nn(vitro-10, in-9)
amod(studies-11, vitro-10)
nsubj(indicate-14, studies-11)
prep_of(studies-11, iloprost-13)
root(ROOT-0, indicate-14)
complm(expected-26, that-15)
det(inhibition-18, no-16)
amod(inhibition-18, relevant-17)
nsubjpass(expected-26, inhibition-18)
nn(metabolism-23, cytochrome-20)
nn(metabolism-23, P450-21)
nn(metabolism-23, drug-22)
prep_of(inhibition-18, metabolism-23)
aux(expected-26, would-24)
auxpass(expected-26, be-25)
ccomp(indicate-14, expected-26)

Drugs/NNS that/WDT may/MD alter/VB imatinib/NN plasma/NN concentrations/NNS Drugs/NNS that/WDT may/MD increase/VB imatinib/NN plasma/NN concentrations/NNS :/: Caution/NN is/VBZ recommended/VBN when/WRB administering/VBG Gleevec/NNP with/IN inhibitors/NNS of/IN the/DT CYP3A4/NN family/NN (/-LRB- e.g./FW ,/, ketoconazole/NN ,/, itraconazole/NN ,/, erythromycin/NN ,/, clarithromycin/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB alter) (NP (NP (NN imatinib) (NN plasma) (NNS concentrations)) (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB increase) (NP (NN imatinib) (NN plasma) (NNS concentrations))))))))))))) (: :) (S (NP (NN Caution)) (VP (VBZ is) (VP (VBN recommended) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (NNP Gleevec)) (PP (IN with) (NP (NP (NP (NNS inhibitors)) (PP (IN of) (NP (DT the) (NN CYP3A4) (NN family)))) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN ketoconazole)) (, ,) (NP (NN itraconazole)) (, ,) (NP (NN erythromycin)) (, ,) (NP (NN clarithromycin)))) (-RRB- -RRB-)))))))))) (. .)))))

root(ROOT-0, Drugs-1)
nsubj(alter-4, Drugs-1)
aux(alter-4, may-3)
rcmod(Drugs-1, alter-4)
nn(concentrations-7, imatinib-5)
nn(concentrations-7, plasma-6)
dobj(alter-4, concentrations-7)
iobj(alter-4, concentrations-7)
dobj(alter-4, Drugs-8)
dep(concentrations-7, Drugs-8)
nsubj(increase-11, Drugs-8)
aux(increase-11, may-10)
rcmod(Drugs-8, increase-11)
nn(concentrations-14, imatinib-12)
nn(concentrations-14, plasma-13)
dobj(increase-11, concentrations-14)
nsubjpass(recommended-18, Caution-16)
auxpass(recommended-18, is-17)
dep(Drugs-1, recommended-18)
advmod(administering-20, when-19)
advcl(recommended-18, administering-20)
dobj(administering-20, Gleevec-21)
prep_with(administering-20, inhibitors-23)
det(family-27, the-25)
nn(family-27, CYP3A4-26)
prep_of(inhibitors-23, family-27)
dep(inhibitors-23, e.g.-29)
pobj(e.g.-29, ketoconazole-31)
appos(ketoconazole-31, itraconazole-33)
appos(ketoconazole-31, erythromycin-35)
appos(ketoconazole-31, clarithromycin-37)

Substances/NNS that/WDT inhibit/VBP the/DT cytochrome/NN P450/NN isoenzyme/NN (/-LRB- CYP3A4/NN )/-RRB- activity/NN may/MD decrease/VB metabolism/NN and/CC increase/VB imatinib/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Substances)) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (DT the) (NN cytochrome) (NN P450) (NN isoenzyme) (-LRB- -LRB-) (NN CYP3A4) (-RRB- -RRB-) (NN activity)))))) (VP (MD may) (VP (VP (VB decrease) (NP (NN metabolism))) (CC and) (VP (VB increase) (NP (NN imatinib) (NNS concentrations)))))) (. .))))

nsubj(inhibit-3, Substances-1)
nsubj(decrease-13, Substances-1)
rcmod(Substances-1, inhibit-3)
det(activity-11, the-4)
nn(activity-11, cytochrome-5)
nn(activity-11, P450-6)
nn(activity-11, isoenzyme-7)
nn(activity-11, CYP3A4-9)
dobj(inhibit-3, activity-11)
aux(decrease-13, may-12)
root(ROOT-0, decrease-13)
dobj(decrease-13, metabolism-14)
conj_and(decrease-13, increase-16)
nn(concentrations-18, imatinib-17)
dobj(increase-16, concentrations-18)

There/EX is/VBZ a/DT significant/JJ increase/NN in/IN exposure/NN to/TO imatinib/NN when/WRB Gleevec/NNP is/VBZ coadministered/VBN with/IN ketoconazole/NN (/-LRB- CYP3A4/NN inhibitor/NN )./NN

(ROOT (S1 (S (NP (EX There)) (VP (VBZ is) (NP (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (NP (NN exposure)) (PP (TO to) (NP (NN imatinib))))) (SBAR (WHADVP (WRB when)) (S (NP (NNP Gleevec)) (VP (VBZ is) (VP (VBN coadministered) (PP (IN with) (NP (NN ketoconazole)))))))) (-LRB- -LRB-) (NP (NN CYP3A4) (NN inhibitor) (NN -RRB-.)))))))

expl(is-2, There-1)
root(ROOT-0, is-2)
det(increase-5, a-3)
amod(increase-5, significant-4)
iobj(is-2, increase-5)
nsubj(is-2, increase-5)
tmod(coadministered-13, increase-5)
prep_in(increase-5, exposure-7)
prep_to(exposure-7, imatinib-9)
advmod(coadministered-13, when-10)
nsubjpass(coadministered-13, Gleevec-11)
auxpass(coadministered-13, is-12)
dep(increase-5, coadministered-13)
prep_with(coadministered-13, ketoconazole-15)
nn(-RRB-.-19, CYP3A4-17)
nn(-RRB-.-19, inhibitor-18)
dep(increase-5, -RRB-.-19)

Drugs/NNS that/WDT may/MD decrease/VB imatinib/NN plasma/NN concentrations/NNS :/: Substances/NNS that/WDT are/VBP inducers/NNS of/IN CYP3A4/NN activity/NN may/MD increase/VB metabolism/NN and/CC decrease/VB imatinib/NN plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB decrease) (NP (NN imatinib) (NN plasma) (NNS concentrations))))))) (: :) (NP (NP (NNS Substances)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NNS inducers)) (PP (IN of) (NP (NN CYP3A4) (NN activity))))))))) (VP (MD may) (VP (VP (VB increase) (NP (NN metabolism))) (CC and) (VP (VB decrease) (NP (NN imatinib) (NN plasma) (NNS concentrations)))))) (. .))))

nsubj(decrease-4, Drugs-1)
nsubj(increase-17, Drugs-1)
aux(decrease-4, may-3)
rcmod(Drugs-1, decrease-4)
nn(concentrations-7, imatinib-5)
nn(concentrations-7, plasma-6)
dobj(decrease-4, concentrations-7)
dep(Drugs-1, Substances-9)
nsubj(inducers-12, Substances-9)
cop(inducers-12, are-11)
rcmod(Substances-9, inducers-12)
nn(activity-15, CYP3A4-14)
prep_of(inducers-12, activity-15)
aux(increase-17, may-16)
root(ROOT-0, increase-17)
dobj(increase-17, metabolism-18)
conj_and(increase-17, decrease-20)
nn(concentrations-23, imatinib-21)
nn(concentrations-23, plasma-22)
dobj(decrease-20, concentrations-23)

Co-/NN medications/VBZ that/IN induce/VBP CYP3A4/NN (/-LRB- e.g./FW ,/, dexamethasone/NN ,/, phenytoin/NN ,/, carbamazepine/NN ,/, rifampin/NN ,/, phenobarbital/NN or/CC St./NN ./.

(ROOT (S1 (S (S (NP (NN Co-)) (VP (VBZ medications) (SBAR (IN that) (S (VP (VBP induce) (NP (NP (NN CYP3A4)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN dexamethasone)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN carbamazepine)) (, ,) (NP (NN rifampin)) (, ,) (NP (NN phenobarbital)) (CC or) (NP (NN St.))))))))))) (. .))))

nsubj(medications-2, Co--1)
root(ROOT-0, medications-2)
complm(induce-4, that-3)
ccomp(medications-2, induce-4)
dobj(induce-4, CYP3A4-5)
dep(CYP3A4-5, e.g.-7)
pobj(e.g.-7, dexamethasone-9)
conj_or(dexamethasone-9, phenytoin-11)
conj_or(dexamethasone-9, carbamazepine-13)
conj_or(dexamethasone-9, rifampin-15)
conj_or(dexamethasone-9, phenobarbital-17)
conj_or(dexamethasone-9, St.-19)

Johns/NNP Wort/NNP )/-RRB- may/MD significantly/RB reduce/VB exposure/NN to/TO Gleevec/NNP ./.

(ROOT (S1 (S (S (NP (NNP Johns) (NNP Wort) (-RRB- -RRB-)) (VP (MD may) (ADVP (RB significantly)) (VP (VB reduce) (NP (NP (NN exposure)) (PP (TO to) (NP (NNP Gleevec))))))) (. .))))

nn(Wort-2, Johns-1)
nsubj(reduce-6, Wort-2)
aux(reduce-6, may-4)
advmod(reduce-6, significantly-5)
root(ROOT-0, reduce-6)
dobj(reduce-6, exposure-7)
prep_to(exposure-7, Gleevec-9)

Pretreatment/NN of/IN healthy/JJ volunteers/NNS with/IN multiple/JJ doses/NNS of/IN rifampin/NN followed/VBN by/IN a/DT single/JJ dose/NN of/IN Gleevec/NNP ,/, increased/VBD Gleevec/NNP oral-dose/NN clearance/NN by/IN 3.8-fold/NN ,/, which/WDT significantly/RB (/-LRB- p/NN 0.05/CD )/-RRB- decreased/VBD mean/NN cmax/NN and/CC AUC/NN (0-8)./CD

(ROOT (S1 (S (S (NP (NP (NN Pretreatment)) (PP (IN of) (NP (JJ healthy) (NNS volunteers))) (PP (IN with) (NP (NP (JJ multiple) (NNS doses)) (PP (IN of) (NP (NN rifampin)))))) (VP (VBN followed) (PP (IN by) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NNP Gleevec))))))) (, ,) (VP (VBD increased) (NP (NNP Gleevec) (NN oral-dose) (NN clearance)) (PP (IN by) (NP (NN 3.8-fold))) (, ,) (SBAR (WHNP (WDT which)) (S (ADVP (ADVP (RB significantly)) (PRN (-LRB- -LRB-) (NP (NN p) (CD 0.05)) (-RRB- -RRB-))) (VP (VBD decreased) (NP (NP (NN mean) (NN cmax)) (CC and) (NP (NN AUC) (CD -LRB-0-8-RRB-.))))))))))

nsubj(increased-18, Pretreatment-1)
amod(volunteers-4, healthy-3)
prep_of(Pretreatment-1, volunteers-4)
amod(doses-7, multiple-6)
prep_with(Pretreatment-1, doses-7)
prep_of(doses-7, rifampin-9)
det(dose-14, a-12)
amod(dose-14, single-13)
prep_followed_by(increased-18, dose-14)
prep_of(dose-14, Gleevec-16)
root(ROOT-0, increased-18)
nn(clearance-21, Gleevec-19)
nn(clearance-21, oral-dose-20)
dobj(increased-18, clearance-21)
prep_by(increased-18, 3.8-fold-23)
nsubj(decreased-31, which-25)
advmod(decreased-31, significantly-26)
dep(significantly-26, p-28)
num(p-28, 0.05-29)
dep(increased-18, decreased-31)
nn(cmax-33, mean-32)
dobj(decreased-31, cmax-33)
conj_and(cmax-33, AUC-35)
num(AUC-35, -LRB-0-8-RRB-.-36)

In/IN patients/NNS where/WRB rifampin/NN or/CC other/JJ CYP3A4/NN inducers/NNS are/VBP indicated/VBN ,/, alternative/JJ therapeutic/JJ agents/NNS with/IN less/RBR enzyme/NN induction/NN potential/NN should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NNS patients)) (SBAR (WHADVP (WRB where)) (S (NP (NP (NN rifampin)) (CC or) (NP (JJ other) (NN CYP3A4) (NNS inducers))) (VP (VBP are) (VP (VBN indicated))))))) (, ,) (NP (NP (JJ alternative) (JJ therapeutic) (NNS agents)) (PP (IN with) (NP (RBR less) (NN enzyme) (NN induction) (NN potential)))) (VP (MD should) (VP (VB be) (VP (VBN considered))))) (. .))))

prep_in(considered-22, patients-2)
advmod(indicated-10, where-3)
nsubjpass(indicated-10, rifampin-4)
amod(inducers-8, other-6)
nn(inducers-8, CYP3A4-7)
conj_or(rifampin-4, inducers-8)
auxpass(indicated-10, are-9)
rcmod(patients-2, indicated-10)
amod(agents-14, alternative-12)
amod(agents-14, therapeutic-13)
nsubjpass(considered-22, agents-14)
advmod(potential-19, less-16)
nn(potential-19, enzyme-17)
nn(potential-19, induction-18)
prep_with(agents-14, potential-19)
aux(considered-22, should-20)
auxpass(considered-22, be-21)
root(ROOT-0, considered-22)

Drugs/NNS that/WDT may/MD have/VB their/PRP$ plasma/NN concentration/NN altered/JJ by/IN Gleevec/NNP Gleevec/NNP increases/VBZ the/DT mean/NN cmax/NN and/CC AUC/NN of/IN simvastatin/NN (/-LRB- CYP3A4/NN substrate/NN )/-RRB- 2-/CD and/CC 3.5-fold/JJ ,/, respectively/RB ,/, suggesting/VBG an/DT inhibition/NN of/IN the/DT CYP3A4/NN by/IN Gleevec/NNP ./.

(ROOT (S1 (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB have) (NP (PRP$ their) (NN plasma) (NN concentration) (JJ altered)) (PP (IN by) (NP (NNP Gleevec) (NNP Gleevec)))))))) (VP (VBZ increases) (NP (NP (DT the) (NN mean) (NN cmax)) (CC and) (NP (NP (NN AUC)) (PP (IN of) (NP (NP (NP (NN simvastatin)) (PRN (-LRB- -LRB-) (NP (NN CYP3A4) (NN substrate)) (-RRB- -RRB-))) (ADJP (CD 2-) (CC and) (JJ 3.5-fold))))) (, ,) (ADVP (RB respectively))) (, ,) (S (VP (VBG suggesting) (NP (NP (DT an) (NN inhibition)) (PP (IN of) (NP (DT the) (NN CYP3A4))) (PP (IN by) (NP (NNP Gleevec))))))) (. .))))

nsubj(have-4, Drugs-1)
nsubj(increases-12, Drugs-1)
aux(have-4, may-3)
rcmod(Drugs-1, have-4)
poss(concentration-7, their-5)
nn(concentration-7, plasma-6)
dobj(have-4, concentration-7)
amod(concentration-7, altered-8)
nn(Gleevec-11, Gleevec-10)
prep_by(have-4, Gleevec-11)
root(ROOT-0, increases-12)
det(cmax-15, the-13)
nn(cmax-15, mean-14)
dobj(increases-12, cmax-15)
conj_and(cmax-15, AUC-17)
prep_of(AUC-17, simvastatin-19)
nn(substrate-22, CYP3A4-21)
abbrev(simvastatin-19, substrate-22)
amod(simvastatin-19, 2--24)
conj_and(2--24, 3.5-fold-26)
advmod(cmax-15, respectively-28)
conj_and(cmax-15, respectively-28)
partmod(increases-12, suggesting-30)
xcomp(increases-12, suggesting-30)
det(inhibition-32, an-31)
dobj(suggesting-30, inhibition-32)
det(CYP3A4-35, the-34)
prep_of(inhibition-32, CYP3A4-35)
prep_by(inhibition-32, Gleevec-37)

Particular/JJ caution/NN is/VBZ recommended/VBN when/WRB administering/VBG Gleevec/NNP with/IN CYP3A4/JJ substrates/NNS that/WDT have/VBP a/DT narrow/JJ therapeutic/JJ window/NN (/-LRB- e.g./FW ,/, cyclosporine/NN or/CC pimozide/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (JJ Particular) (NN caution)) (VP (VBZ is) (VP (VBN recommended) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (NNP Gleevec)) (PP (IN with) (NP (NP (JJ CYP3A4) (NNS substrates)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (NP (NP (DT a) (JJ narrow) (JJ therapeutic) (NN window)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN cyclosporine)) (CC or) (NP (NN pimozide)))) (-RRB- -RRB-)))))))))))))) (. .))))

amod(caution-2, Particular-1)
nsubjpass(recommended-4, caution-2)
auxpass(recommended-4, is-3)
root(ROOT-0, recommended-4)
advmod(administering-6, when-5)
advcl(recommended-4, administering-6)
dobj(administering-6, Gleevec-7)
amod(substrates-10, CYP3A4-9)
prep_with(administering-6, substrates-10)
nsubj(have-12, substrates-10)
rcmod(substrates-10, have-12)
det(window-16, a-13)
amod(window-16, narrow-14)
amod(window-16, therapeutic-15)
dobj(have-12, window-16)
dep(window-16, e.g.-18)
pobj(e.g.-18, cyclosporine-20)
conj_or(cyclosporine-20, pimozide-22)

Gleevec/NNP will/MD increase/VB plasmaconcentration/NN of/IN other/JJ CYP3A4/JJ metabolized/JJ drugs/NNS (/-LRB- e.g./FW ,/, triazolo-/JJ benzodiazepines/NNS ,/, dihydropyridine/NN calcium/NN channel/NN blockers/NNS ,/, certain/JJ HMG-CoA/NN reductase/NN inhibitors/NNS ,/, etc/NN .)./CD

(ROOT (S1 (S (NP (NP (NNP Gleevec)) (VP (MD will) (VP (VB increase) (NP (NP (NN plasmaconcentration)) (PP (IN of) (NP (NP (NP (JJ other) (JJ CYP3A4) (JJ metabolized) (NNS drugs)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (JJ triazolo-) (NNS benzodiazepines)))) (, ,) (NP (NN dihydropyridine) (NN calcium) (NN channel) (NNS blockers)) (, ,) (NP (JJ certain) (NN HMG-CoA) (NN reductase) (NNS inhibitors)) (, ,) (NP (NN etc) (CD .-RRB-.)))))))))))

root(ROOT-0, Gleevec-1)
aux(increase-3, will-2)
dep(Gleevec-1, increase-3)
dobj(increase-3, plasmaconcentration-4)
amod(drugs-9, other-6)
amod(drugs-9, CYP3A4-7)
amod(drugs-9, metabolized-8)
prep_of(plasmaconcentration-4, drugs-9)
dep(benzodiazepines-14, e.g.-11)
amod(benzodiazepines-14, triazolo--13)
dep(drugs-9, benzodiazepines-14)
nn(blockers-19, dihydropyridine-16)
nn(blockers-19, calcium-17)
nn(blockers-19, channel-18)
appos(drugs-9, blockers-19)
amod(inhibitors-24, certain-21)
nn(inhibitors-24, HMG-CoA-22)
nn(inhibitors-24, reductase-23)
appos(drugs-9, inhibitors-24)
appos(drugs-9, etc-26)
num(etc-26, .-RRB-.-27)

Because/IN warfarin/NN is/VBZ metabolized/VBN by/IN CYP2C9/NN and/CC CYP3A4/NN ,/, patients/NNS who/WP require/VBP anticoagulation/NN should/MD receive/VBP low-molecular/JJ weight/NN or/CC standard/JJ heparin/NN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NN warfarin)) (VP (VBZ is) (VP (VBN metabolized) (PP (IN by) (NP (NP (NN CYP2C9)) (CC and) (NP (NN CYP3A4)))))))) (, ,) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP require) (NP (NN anticoagulation)))))) (VP (MD should) (VP (VBP receive) (NP (NP (JJ low-molecular) (NN weight)) (CC or) (NP (JJ standard) (NN heparin)))))) (. .))))

mark(metabolized-4, Because-1)
nsubjpass(metabolized-4, warfarin-2)
auxpass(metabolized-4, is-3)
advcl(receive-15, metabolized-4)
agent(metabolized-4, CYP2C9-6)
conj_and(CYP2C9-6, CYP3A4-8)
nsubj(require-12, patients-10)
nsubj(receive-15, patients-10)
rcmod(patients-10, require-12)
dobj(require-12, anticoagulation-13)
aux(receive-15, should-14)
root(ROOT-0, receive-15)
amod(weight-17, low-molecular-16)
dobj(receive-15, weight-17)
amod(heparin-20, standard-19)
conj_or(weight-17, heparin-20)

in/FW vitro/FW ,/, Gleevec/NNP inhibits/VBZ the/DT cytochrome/NN P450/NN isoenzyme/NN CYP2D6/NN activity/NN at/IN similar/JJ concentrations/NNS that/WDT affect/VBP CYP3A4/NN activity/NN ./.

(ROOT (S1 (S (S (ADVP (FW in) (FW vitro)) (, ,) (NP (NNP Gleevec)) (VP (VBZ inhibits) (NP (DT the) (NP (NN cytochrome) (NN P450)) (NN isoenzyme) (NN CYP2D6) (NN activity)) (PP (IN at) (NP (NP (JJ similar) (NNS concentrations)) (SBAR (WHNP (WDT that)) (S (VP (VBP affect) (NP (NN CYP3A4) (NN activity))))))))) (. .))))

nn(vitro-2, in-1)
advmod(inhibits-5, vitro-2)
nsubj(inhibits-5, Gleevec-4)
root(ROOT-0, inhibits-5)
det(activity-11, the-6)
nn(P450-8, cytochrome-7)
nn(activity-11, P450-8)
nn(activity-11, isoenzyme-9)
nn(activity-11, CYP2D6-10)
dobj(inhibits-5, activity-11)
amod(concentrations-14, similar-13)
prep_at(inhibits-5, concentrations-14)
nsubj(affect-16, concentrations-14)
rcmod(concentrations-14, affect-16)
nn(activity-18, CYP3A4-17)
dobj(affect-16, activity-18)

Systemic/JJ exposure/NN to/TO substrates/NNS of/IN CYP2D6/NN is/VBZ expected/VBN to/TO be/VB increased/VBN when/WRB coadministered/VBN with/IN Gleevec/NNP ./.

(ROOT (S1 (S (S (NP (NP (JJ Systemic) (NN exposure)) (PP (TO to) (NP (NP (NNS substrates)) (PP (IN of) (NP (NN CYP2D6)))))) (VP (VBZ is) (VP (VBN expected) (S (VP (TO to) (VP (VB be) (VP (VBN increased))) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NNP Gleevec))))))))))) (. .))))

amod(exposure-2, Systemic-1)
nsubjpass(expected-8, exposure-2)
xsubj(increased-11, exposure-2)
prep_to(exposure-2, substrates-4)
prep_of(substrates-4, CYP2D6-6)
auxpass(expected-8, is-7)
root(ROOT-0, expected-8)
aux(increased-11, to-9)
auxpass(increased-11, be-10)
xcomp(expected-8, increased-11)
advmod(coadministered-13, when-12)
advcl(increased-11, coadministered-13)
prep_with(coadministered-13, Gleevec-15)

in/FW vitro/FW ,/, Gleevec/NNP inhibits/VBZ acetaminophen/JJ O-glucuronidation/NN (/-LRB- Ki/NN value/NN of/IN 58.5/CD @/NN M/NN )/-RRB- at/IN therapeutic/JJ levels/NNS ./.

(ROOT (S1 (S (ADVP (FW in) (FW vitro)) (, ,) (NP (NNP Gleevec)) (VP (VBZ inhibits) (NP (NP (JJ acetaminophen) (NN O-glucuronidation)) (PRN (-LRB- -LRB-) (NP (NP (NN Ki) (NN value)) (PP (IN of) (NP (CD 58.5) (NN @) (NN M)))) (-RRB- -RRB-))) (PP (IN at) (NP (JJ therapeutic) (NNS levels)))) (. .))))

nn(vitro-2, in-1)
advmod(inhibits-5, vitro-2)
nsubj(inhibits-5, Gleevec-4)
root(ROOT-0, inhibits-5)
amod(O-glucuronidation-7, acetaminophen-6)
dobj(inhibits-5, O-glucuronidation-7)
nn(value-10, Ki-9)
dep(O-glucuronidation-7, value-10)
num(M-14, 58.5-12)
nn(M-14, @-13)
prep_of(value-10, M-14)
amod(levels-18, therapeutic-17)
prep_at(inhibits-5, levels-18)

Systemic/JJ exposure/NN to/TO acetaminophen/NN is/VBZ expected/VBN to/TO be/VB increased/VBN when/WRB coadministered/VBN with/IN Gleevec/NNP ./.

(ROOT (S1 (S (S (NP (NP (JJ Systemic) (NN exposure)) (PP (TO to) (NP (NN acetaminophen)))) (VP (VBZ is) (VP (VBN expected) (S (VP (TO to) (VP (VB be) (VP (VBN increased))) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NNP Gleevec))))))))))) (. .))))

amod(exposure-2, Systemic-1)
nsubjpass(expected-6, exposure-2)
xsubj(increased-9, exposure-2)
prep_to(exposure-2, acetaminophen-4)
auxpass(expected-6, is-5)
root(ROOT-0, expected-6)
aux(increased-9, to-7)
auxpass(increased-9, be-8)
xcomp(expected-6, increased-9)
advmod(coadministered-11, when-10)
advcl(increased-9, coadministered-11)
prep_with(coadministered-11, Gleevec-13)

Indinavir/NN is/VBZ an/DT inhibitor/NN of/IN the/DT cytochrome/NN P450/NN isoform/NN CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Indinavir)) (VP (VBZ is) (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (DT the) (NN cytochrome) (NN P450) (NN isoform) (NN CYP3A4)))))) (. .))))

nsubj(inhibitor-4, Indinavir-1)
cop(inhibitor-4, is-2)
det(inhibitor-4, an-3)
root(ROOT-0, inhibitor-4)
det(CYP3A4-10, the-6)
nn(CYP3A4-10, cytochrome-7)
nn(CYP3A4-10, P450-8)
nn(CYP3A4-10, isoform-9)
prep_of(inhibitor-4, CYP3A4-10)

Coadministration/NN of/IN CRIXIVAN/NN and/CC drugs/NNS primarily/RB metabolized/VBN by/IN CYP3A4/NN may/MD result/VB in/IN increased/VBN plasma/NN concentrations/NNS of/IN the/DT other/JJ drug/NN ,/, which/WDT could/MD increase/VB or/CC prolong/VB its/PRP$ therapeutic/JJ and/CC adverse/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NP (NN CRIXIVAN)) (CC and) (NP (NNS drugs))) (VP (ADVP (RB primarily)) (VBN metabolized) (PP (IN by) (NP (NN CYP3A4))))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (VBN increased) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (DT the) (JJ other) (NN drug)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD could) (VP (VP (VB increase)) (CC or) (VP (VB prolong) (NP (PRP$ its) (ADJP (ADJP (JJ therapeutic)) (CC and) (ADJP (JJ adverse))) (NNS effects)))))))))))))) (. .))))

nsubj(result-11, Coadministration-1)
prep_of(Coadministration-1, CRIXIVAN-3)
conj_and(CRIXIVAN-3, drugs-5)
advmod(metabolized-7, primarily-6)
partmod(CRIXIVAN-3, metabolized-7)
agent(metabolized-7, CYP3A4-9)
aux(result-11, may-10)
root(ROOT-0, result-11)
amod(concentrations-15, increased-13)
nn(concentrations-15, plasma-14)
prep_in(result-11, concentrations-15)
det(drug-19, the-17)
amod(drug-19, other-18)
prep_of(concentrations-15, drug-19)
nsubj(increase-23, drug-19)
aux(increase-23, could-22)
rcmod(drug-19, increase-23)
conj_or(increase-23, prolong-25)
poss(effects-30, its-26)
amod(effects-30, therapeutic-27)
conj_and(therapeutic-27, adverse-29)
dobj(prolong-25, effects-30)

Indinavir/NN is/VBZ metabolized/VBN by/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NN Indinavir)) (VP (VBZ is) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP3A4)))))) (. .))))

nsubjpass(metabolized-3, Indinavir-1)
auxpass(metabolized-3, is-2)
root(ROOT-0, metabolized-3)
agent(metabolized-3, CYP3A4-5)

Drugs/NNS that/WDT induce/VBP CYP3A4/NN activity/NN would/MD be/VB expected/VBN to/TO increase/VB the/DT clearance/NN of/IN indinavir/NN ,/, resulting/VBG in/IN lowered/JJ plasma/NN concentrations/NNS of/IN indinavir/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP induce) (NP (NN CYP3A4) (NN activity)))))) (VP (MD would) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN indinavir)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (JJ lowered) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN indinavir)))))))))))))) (. .))))

nsubj(induce-3, Drugs-1)
nsubjpass(expected-8, Drugs-1)
rcmod(Drugs-1, induce-3)
nn(activity-5, CYP3A4-4)
dobj(induce-3, activity-5)
aux(expected-8, would-6)
auxpass(expected-8, be-7)
root(ROOT-0, expected-8)
aux(increase-10, to-9)
xcomp(expected-8, increase-10)
det(clearance-12, the-11)
dobj(increase-10, clearance-12)
prep_of(clearance-12, indinavir-14)
partmod(increase-10, resulting-16)
xcomp(increase-10, resulting-16)
amod(concentrations-20, lowered-18)
nn(concentrations-20, plasma-19)
prep_in(resulting-16, concentrations-20)
prep_of(concentrations-20, indinavir-22)

Coadministration/NN of/IN CRIXIVAN/JJ and/CC other/JJ drugs/NNS that/WDT inhibit/VBP CYP3A4/NN may/MD decrease/VB the/DT clearance/NN of/IN indinavir/NN and/CC may/MD result/VB in/IN increased/VBN plasma/NN concentrations/NNS of/IN indinavir/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (ADJP (ADJP (JJ CRIXIVAN)) (CC and) (ADJP (JJ other))) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (NN CYP3A4)))))))) (VP (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN indinavir)))))) (CC and) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (VBN increased) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN indinavir))))))))) (. .))))

nsubj(decrease-11, Coadministration-1)
amod(drugs-6, CRIXIVAN-3)
conj_and(CRIXIVAN-3, other-5)
prep_of(Coadministration-1, drugs-6)
nsubj(inhibit-8, drugs-6)
rcmod(drugs-6, inhibit-8)
dobj(inhibit-8, CYP3A4-9)
aux(decrease-11, may-10)
root(ROOT-0, decrease-11)
det(clearance-13, the-12)
dobj(decrease-11, clearance-13)
prep_of(clearance-13, indinavir-15)
aux(result-18, may-17)
conj_and(decrease-11, result-18)
amod(concentrations-22, increased-20)
nn(concentrations-22, plasma-21)
prep_in(result-18, concentrations-22)
prep_of(concentrations-22, indinavir-24)

Drugs/NNS That/WDT Should/MD Not/RB Be/VB Coadministered/VBN with/IN CRIXIVAN/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT That)) (S (VP (MD Should) (RB Not) (VP (VB Be) (VP (VBN Coadministered) (PP (IN with) (NP (NN CRIXIVAN)))))))))) (. .))))

root(ROOT-0, Drugs-1)
nsubjpass(Coadministered-6, Drugs-1)
aux(Coadministered-6, Should-3)
neg(Coadministered-6, Not-4)
auxpass(Coadministered-6, Be-5)
rcmod(Drugs-1, Coadministered-6)
prep_with(Coadministered-6, CRIXIVAN-8)

Drug/NN Class/NN :/: Drug/NN Name/NN Clinical/JJ Comment/NN ./.

(ROOT (S1 (S (S (NP (NN Drug) (NN Class)) (: :) (NP (NN Drug) (NN Name) (JJ Clinical) (NN Comment))) (. .))))

nn(Class-2, Drug-1)
dep(Comment-7, Class-2)
nn(Comment-7, Drug-4)
nn(Comment-7, Name-5)
amod(Comment-7, Clinical-6)
root(ROOT-0, Comment-7)

Antiarrhythmics/NN :/: amiodarone/NN ./.

(ROOT (S1 (S (S (NP (NN Antiarrhythmics)) (: :) (NP (NN amiodarone))) (. .))))

dep(amiodarone-3, Antiarrhythmics-1)
root(ROOT-0, amiodarone-3)

Ergot/NN derivatives/NNS :/: dihydroergotamine/NN ,/, ergonovine/NN ,/, ergotamine/NN ,/, methylergonovine/NN ./.

(ROOT (S1 (S (S (NP (NN Ergot) (NNS derivatives)) (: :) (NP (NP (NN dihydroergotamine)) (, ,) (NP (NN ergonovine)) (, ,) (NP (NN ergotamine)) (, ,) (NP (NN methylergonovine)))) (. .))))

nn(derivatives-2, Ergot-1)
dep(dihydroergotamine-4, derivatives-2)
root(ROOT-0, dihydroergotamine-4)
appos(dihydroergotamine-4, ergonovine-6)
appos(dihydroergotamine-4, ergotamine-8)
appos(dihydroergotamine-4, methylergonovine-10)

CONTRAINDICATED/VBN due/JJ to/TO potential/NN for/IN serious/JJ and/or/CC life-threatening/JJ reactions/NNS such/JJ as/IN acute/JJ ergot/NN toxicity/NN characterized/VBN by/IN peripheral/JJ vasospasm/NN and/CC ischemia/NN of/IN the/DT extremities/NN and/CC other/JJ tissues/NNS ./.

(ROOT (S1 (S (S (VP (VBN CONTRAINDICATED) (PP (JJ due) (TO to) (NP (NP (NN potential)) (PP (IN for) (NP (NP (ADJP (ADJP (JJ serious)) (CC and/or) (ADJP (JJ life-threatening))) (NNS reactions)) (PP (JJ such) (IN as) (NP (NP (JJ acute) (NN ergot) (NN toxicity)) (VP (VBN characterized) (PP (IN by) (NP (NP (NP (JJ peripheral) (NN vasospasm)) (CC and) (NP (NN ischemia))) (PP (IN of) (NP (DT the) (NP (NN extremities)) (CC and) (NP (JJ other) (NNS tissues))))))))))))))) (. .))))

root(ROOT-0, CONTRAINDICATED-1)
prep_due_to(CONTRAINDICATED-1, potential-4)
amod(reactions-9, serious-6)
conj_and/or(serious-6, life-threatening-8)
prep_for(potential-4, reactions-9)
amod(toxicity-14, acute-12)
nn(toxicity-14, ergot-13)
prep_such_as(reactions-9, toxicity-14)
partmod(toxicity-14, characterized-15)
amod(vasospasm-18, peripheral-17)
agent(characterized-15, vasospasm-18)
conj_and(vasospasm-18, ischemia-20)
dep(extremities-23, the-22)
prep_of(vasospasm-18, extremities-23)
amod(tissues-26, other-25)
conj_and(extremities-23, tissues-26)

Sedative/JJ //: hypnotics/NNS :/: midazolam/NN ,/, triazolam/NN ./.

(ROOT (S1 (S (NP (NP (ADJP (ADJP (JJ Sedative)) (: /)) (NNS hypnotics)) (: :) (NP (NP (NN midazolam)) (, ,) (NP (NN triazolam))) (. .)))))

amod(hypnotics-3, Sedative-1)
punct(Sedative-1, /-2)
root(ROOT-0, hypnotics-3)
dep(hypnotics-3, midazolam-5)
appos(midazolam-5, triazolam-7)

GI/NN motility/NN agents/NNS :/: cisapride/NN ./.

(ROOT (S1 (S (S (NP (NN GI) (NN motility) (NNS agents)) (: :) (NP (NN cisapride))) (. .))))

nn(agents-3, GI-1)
nn(agents-3, motility-2)
dep(cisapride-5, agents-3)
root(ROOT-0, cisapride-5)

Neuroleptic/JJ :/: pimozide/NN ./.

(ROOT (S1 (S (S (NP (JJ Neuroleptic)) (: :) (NP (NN pimozide))) (. .))))

dep(pimozide-3, Neuroleptic-1)
root(ROOT-0, pimozide-3)

Herbal/JJ products/NNS :/: St./NN John/NN @/NN s/NN wort/NN (/-LRB- Hypericum/NN perforatum/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (JJ Herbal) (NNS products)) (: :) (NP (NP (NN St.) (NN John) (NN @) (NN s) (NN wort)) (PRN (-LRB- -LRB-) (NP (NN Hypericum) (NN perforatum)) (-RRB- -RRB-))) (. .)))))

amod(products-2, Herbal-1)
root(ROOT-0, products-2)
nn(wort-8, St.-4)
nn(wort-8, John-5)
nn(wort-8, @-6)
nn(wort-8, s-7)
dep(products-2, wort-8)
nn(perforatum-11, Hypericum-10)
appos(wort-8, perforatum-11)

May/MD lead/VB to/TO loss/NN of/IN virologic/JJ response/NN and/CC possible/JJ resistance/NN to/TO CRIXIVAN/NN or/CC to/TO the/DT class/NN of/IN protease/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (VP (MD May) (VP (VB lead) (PP (TO to) (NP (NP (NN loss)) (PP (IN of) (NP (NP (JJ virologic) (NN response)) (CC and) (NP (JJ possible) (NN resistance)))) (PP (PP (TO to) (NP (NN CRIXIVAN))) (CC or) (PP (TO to) (NP (NP (DT the) (NN class)) (PP (IN of) (NP (NN protease) (NNS inhibitors))))))))))) (. .))))

aux(lead-2, May-1)
root(ROOT-0, lead-2)
prep_to(lead-2, loss-4)
amod(response-7, virologic-6)
prep_of(loss-4, response-7)
amod(resistance-10, possible-9)
conj_and(response-7, resistance-10)
prep_to(loss-4, CRIXIVAN-12)
det(class-16, the-15)
conj_or(CRIXIVAN-12, class-16)
nn(inhibitors-19, protease-18)
prep_of(class-16, inhibitors-19)

Antimycobacterial/JJ :/: rifampin/NN ./.

(ROOT (S1 (S (S (NP (JJ Antimycobacterial)) (: :) (NP (NN rifampin))) (. .))))

dep(rifampin-3, Antimycobacterial-1)
root(ROOT-0, rifampin-3)

May/MD lead/VB to/TO loss/NN of/IN virologic/JJ response/NN and/CC possible/JJ resistance/NN to/TO CRIXIVAN/NN or/CC to/TO the/DT class/NN of/IN protease/NN inhibitors/NNS or/CC other/JJ coadministered/JJ antiretroviral/JJ agents/NNS ./.

(ROOT (S1 (S (S (VP (MD May) (VP (VB lead) (PP (TO to) (NP (NP (NN loss)) (PP (IN of) (NP (NP (JJ virologic) (NN response)) (CC and) (NP (JJ possible) (NN resistance)))) (PP (PP (TO to) (NP (NN CRIXIVAN))) (CC or) (PP (TO to) (NP (NP (DT the) (NN class)) (PP (IN of) (NP (NP (NN protease) (NNS inhibitors)) (CC or) (NP (JJ other) (JJ coadministered) (JJ antiretroviral) (NNS agents)))))))))))) (. .))))

aux(lead-2, May-1)
root(ROOT-0, lead-2)
prep_to(lead-2, loss-4)
amod(response-7, virologic-6)
prep_of(loss-4, response-7)
amod(resistance-10, possible-9)
conj_and(response-7, resistance-10)
prep_to(loss-4, CRIXIVAN-12)
det(class-16, the-15)
conj_or(CRIXIVAN-12, class-16)
nn(inhibitors-19, protease-18)
prep_of(class-16, inhibitors-19)
amod(agents-24, other-21)
amod(agents-24, coadministered-22)
amod(agents-24, antiretroviral-23)
conj_or(inhibitors-19, agents-24)

HMG-CoA/NN Reductase/NN inhibitors/NNS :/: lovastatin/NN ,/, simvastatin/NN ./.

(ROOT (S1 (S (S (NP (NN HMG-CoA) (NN Reductase) (NNS inhibitors)) (: :) (NP (NP (NN lovastatin)) (, ,) (NP (NN simvastatin)))) (. .))))

nn(inhibitors-3, HMG-CoA-1)
nn(inhibitors-3, Reductase-2)
dep(lovastatin-5, inhibitors-3)
root(ROOT-0, lovastatin-5)
appos(lovastatin-5, simvastatin-7)

Protease/NN inhibitor/NN :/: atazanavir/NN ./.

(ROOT (S1 (S (S (NP (NN Protease) (NN inhibitor)) (: :) (NP (NN atazanavir))) (. .))))

nn(inhibitor-2, Protease-1)
dep(atazanavir-4, inhibitor-2)
root(ROOT-0, atazanavir-4)

Both/CC CRIXIVAN/NN and/CC atazanavir/NN are/VBP associated/VBN with/IN indirect/JJ (/-LRB- unconjugated/JJ )/-RRB- hyperbilirubinemia/NN ./.

(ROOT (S1 (S (S (NP (CC Both) (NP (NN CRIXIVAN)) (CC and) (NP (NN atazanavir))) (VP (VBP are) (VP (VBN associated) (PP (IN with) (NP (JJ indirect) (-LRB- -LRB-) (JJ unconjugated) (-RRB- -RRB-) (NN hyperbilirubinemia)))))) (. .))))

preconj(CRIXIVAN-2, Both-1)
nsubjpass(associated-6, CRIXIVAN-2)
conj_and(CRIXIVAN-2, atazanavir-4)
auxpass(associated-6, are-5)
root(ROOT-0, associated-6)
amod(hyperbilirubinemia-12, indirect-8)
amod(hyperbilirubinemia-12, unconjugated-10)
prep_with(associated-6, hyperbilirubinemia-12)

Combinations/NNS of/IN these/DT drugs/NNS have/VBP not/RB been/VBN studied/VBN and/CC coadministration/NN of/IN CRIXIVAN/NN and/CC atazanavir/NN is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (NNS Combinations)) (PP (IN of) (NP (DT these) (NNS drugs)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN studied))))) (CC and) (S (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NN CRIXIVAN)) (CC and) (NP (NN atazanavir))))) (VP (VBZ is) (RB not) (VP (VBN recommended))))) (. .))))

nsubjpass(studied-8, Combinations-1)
det(drugs-4, these-3)
prep_of(Combinations-1, drugs-4)
aux(studied-8, have-5)
neg(studied-8, not-6)
auxpass(studied-8, been-7)
root(ROOT-0, studied-8)
nsubjpass(recommended-17, coadministration-10)
prep_of(coadministration-10, CRIXIVAN-12)
conj_and(CRIXIVAN-12, atazanavir-14)
auxpass(recommended-17, is-15)
neg(recommended-17, not-16)
conj_and(studied-8, recommended-17)

Drug/NN Name/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN Name)) (. .)))))

nn(Name-2, Drug-1)
root(ROOT-0, Name-2)

HIV/VBP Antiviral/JJ Agents/NNS ./.

(ROOT (S1 (S (S (VP (VBP HIV) (NP (JJ Antiviral) (NNS Agents)))) (. .))))

root(ROOT-0, HIV-1)
amod(Agents-3, Antiviral-2)
dobj(HIV-1, Agents-3)

Delavirdine/NN ./.

(ROOT (S1 (S (NP (NP (NN Delavirdine)) (. .)))))

root(ROOT-0, Delavirdine-1)

@/NN indinavir/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN indinavir) (NN concentration)) (. .)))))

nn(concentration-3, @-1)
nn(concentration-3, indinavir-2)
root(ROOT-0, concentration-3)

Dose/NN reduction/NN of/IN CRIXIVAN/NN to/TO 600/CD mg/NN every/DT 8/CD hours/NNS should/MD be/VB considered/VBN when/WRB taking/VBG delavirdine/NN 400/CD mg/NN three/CD times/NNS a/DT day/NN ./.

(ROOT (S1 (S (NP (NP (NN Dose) (NN reduction)) (PP (IN of) (NP (NN CRIXIVAN))) (PP (TO to) (NP (NP (CD 600) (NN mg)) (NP (DT every) (CD 8) (NNS hours))))) (VP (MD should) (VP (VB be) (VP (VBN considered) (SBAR (WHADVP (WRB when)) (S (VP (VBG taking) (NP (NP (NN delavirdine) (CD 400) (NN mg) (CD three) (NNS times)) (NP (DT a) (NN day))))))))) (. .))))

nn(reduction-2, Dose-1)
nsubjpass(considered-13, reduction-2)
prep_of(reduction-2, CRIXIVAN-4)
num(mg-7, 600-6)
prep_to(reduction-2, mg-7)
det(hours-10, every-8)
num(hours-10, 8-9)
dep(mg-7, hours-10)
aux(considered-13, should-11)
auxpass(considered-13, be-12)
root(ROOT-0, considered-13)
advmod(taking-15, when-14)
advcl(considered-13, taking-15)
nn(times-20, delavirdine-16)
num(times-20, 400-17)
nn(times-20, mg-18)
num(times-20, three-19)
dobj(taking-15, times-20)
det(day-22, a-21)
dep(times-20, day-22)

Didanosine/NN ./.

(ROOT (S1 (S (NP (NP (NN Didanosine)) (. .)))))

root(ROOT-0, Didanosine-1)

Indinavir/NN and/CC didanosine/NN formulations/NNS containing/VBG buffer/NN should/MD be/VB administered/VBN at/IN least/JJS one/CD hour/NN apart/RB on/IN an/DT empty/JJ stomach/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (NN Indinavir)) (CC and) (NP (NN didanosine))) (NNS formulations)) (VP (VBG containing) (NP (NN buffer)))) (VP (MD should) (VP (VB be) (VP (VBN administered) (ADVP (NP (QP (IN at) (JJS least) (CD one)) (NN hour)) (RB apart)) (PP (IN on) (NP (DT an) (JJ empty) (NN stomach))))))) (. .))))

nn(formulations-4, Indinavir-1)
conj_and(Indinavir-1, didanosine-3)
nsubjpass(administered-9, formulations-4)
partmod(formulations-4, containing-5)
dobj(containing-5, buffer-6)
aux(administered-9, should-7)
auxpass(administered-9, be-8)
root(ROOT-0, administered-9)
quantmod(one-12, at-10)
mwe(at-10, least-11)
pobj(at-10, least-11)
num(hour-13, one-12)
npadvmod(apart-14, hour-13)
advmod(administered-9, apart-14)
det(stomach-18, an-16)
amod(stomach-18, empty-17)
prep_on(administered-9, stomach-18)

Efavirenz/NN ./.

(ROOT (S1 (S (NP (NP (NN Efavirenz)) (. .)))))

root(ROOT-0, Efavirenz-1)

The/DT optimal/JJ dose/NN of/IN indinavir/NN ,/, when/WRB given/VBN in/IN combination/NN with/IN efavirenz/NN ,/, is/VBZ not/RB known/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ optimal) (NN dose)) (PP (IN of) (NP (NN indinavir))) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN efavirenz)))))))) (, ,)) (VP (VBZ is) (RB not) (VP (VBN known)))) (. .))))

det(dose-3, The-1)
amod(dose-3, optimal-2)
nsubjpass(known-16, dose-3)
prep_of(dose-3, indinavir-5)
advmod(given-8, when-7)
dep(dose-3, given-8)
prep_in(given-8, combination-10)
prep_with(combination-10, efavirenz-12)
auxpass(known-16, is-14)
neg(known-16, not-15)
root(ROOT-0, known-16)

Increasing/VBG the/DT indinavir/NN dose/NN to/TO 1000/CD mg/NN every/DT 8/CD hours/NNS does/VBZ not/RB compensate/VB for/IN the/DT increased/VBN indinavir/NN metabolism/NN due/JJ to/TO efavirenz/NN ./.

(ROOT (S1 (S (S (NP (VBG Increasing) (NP (NP (DT the) (NN indinavir) (NN dose) (TO to) (CD 1000) (NN mg)) (NP (DT every) (CD 8) (NNS hours)))) (VP (VBZ does) (RB not) (VP (VB compensate) (PP (IN for) (NP (NP (DT the) (VBN increased) (NN indinavir) (NN metabolism)) (ADJP (JJ due) (PP (TO to) (NP (NN efavirenz))))))))) (. .))))

amod(mg-7, Increasing-1)
det(mg-7, the-2)
nn(mg-7, indinavir-3)
nn(mg-7, dose-4)
dep(mg-7, to-5)
num(mg-7, 1000-6)
nsubj(compensate-13, mg-7)
det(hours-10, every-8)
num(hours-10, 8-9)
dep(mg-7, hours-10)
aux(compensate-13, does-11)
neg(compensate-13, not-12)
root(ROOT-0, compensate-13)
det(metabolism-18, the-15)
amod(metabolism-18, increased-16)
nn(metabolism-18, indinavir-17)
prep_for(compensate-13, metabolism-18)
prep_due_to(metabolism-18, efavirenz-21)

Nelfinavir/NN ./.

(ROOT (S1 (S (NP (NP (NN Nelfinavir)) (. .)))))

root(ROOT-0, Nelfinavir-1)

@/NN indinavir/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN indinavir) (NN concentration)) (. .)))))

nn(concentration-3, @-1)
nn(concentration-3, indinavir-2)
root(ROOT-0, concentration-3)

Nevirapine/NN ./.

(ROOT (S1 (S (NP (NP (NN Nevirapine)) (. .)))))

root(ROOT-0, Nevirapine-1)

@/NN indinavir/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN indinavir) (NN concentration)) (. .)))))

nn(concentration-3, @-1)
nn(concentration-3, indinavir-2)
root(ROOT-0, concentration-3)

Indinavir/NN concentrations/NNS may/MD be/VB decreased/VBN in/IN the/DT presence/NN of/IN nevirapine/NN ./.

(ROOT (S1 (S (S (NP (NN Indinavir) (NNS concentrations)) (VP (MD may) (VP (VB be) (VP (VBN decreased) (PP (IN in) (DT the) (NN presence) (IN of) (NP (NN nevirapine))))))) (. .))))

nn(concentrations-2, Indinavir-1)
nsubjpass(decreased-5, concentrations-2)
aux(decreased-5, may-3)
auxpass(decreased-5, be-4)
root(ROOT-0, decreased-5)
dep(decreased-5, in-6)
dep(decreased-5, the-7)
dep(decreased-5, presence-8)
prep_of(decreased-5, nevirapine-10)

Ritonavir/NN ./.

(ROOT (S1 (S (NP (NP (NN Ritonavir)) (. .)))))

root(ROOT-0, Ritonavir-1)

@/NN indinavir/NN concentration/NN @/NN ritonavir/NN concentration/NN ./.

(ROOT (S1 (S (S (NP (NN @) (NN indinavir) (NN concentration) (NN @) (NN ritonavir) (NN concentration))) (. .))))

nn(concentration-6, @-1)
nn(concentration-6, indinavir-2)
nn(concentration-6, concentration-3)
nn(concentration-6, @-4)
nn(concentration-6, ritonavir-5)
root(ROOT-0, concentration-6)

Preliminary/JJ clinical/JJ data/NNS suggest/VBP that/IN the/DT incidence/NN of/IN nephrolithiasis/NN is/VBZ higher/JJR in/IN patients/NNS receiving/VBG indinavir/NN in/IN combination/NN with/IN ritonavir/NN than/IN those/DT receiving/VBG CRIXIVAN/NN 800/CD mg/NN q8h/NN ./.

(ROOT (S1 (S (S (NP (JJ Preliminary) (JJ clinical) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (DT the) (NN incidence)) (PP (IN of) (NP (NN nephrolithiasis)))) (VP (VBZ is) (ADJP (ADJP (JJR higher)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN indinavir)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN ritonavir))))))))) (PP (IN than) (NP (NP (DT those)) (VP (VBG receiving) (NP (NP (NN CRIXIVAN) (CD 800) (NN mg)) (NN q8h))))))))))) (. .))))

amod(data-3, Preliminary-1)
amod(data-3, clinical-2)
nsubj(suggest-4, data-3)
root(ROOT-0, suggest-4)
complm(higher-11, that-5)
det(incidence-7, the-6)
nsubj(higher-11, incidence-7)
prep_of(incidence-7, nephrolithiasis-9)
cop(higher-11, is-10)
ccomp(suggest-4, higher-11)
prep_in(higher-11, patients-13)
partmod(patients-13, receiving-14)
dobj(receiving-14, indinavir-15)
prep_in(indinavir-15, combination-17)
prep_with(combination-17, ritonavir-19)
prep_than(higher-11, those-21)
partmod(those-21, receiving-22)
nn(mg-25, CRIXIVAN-23)
num(mg-25, 800-24)
nn(q8h-26, mg-25)
dobj(receiving-22, q8h-26)

Saquinavir/NN ./.

(ROOT (S1 (S (NP (NP (NN Saquinavir)) (. .)))))

root(ROOT-0, Saquinavir-1)

@/NN saquinavir/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN saquinavir) (NN concentration)) (. .)))))

nn(concentration-3, @-1)
nn(concentration-3, saquinavir-2)
root(ROOT-0, concentration-3)

Antiarrhythmics/NNS :/: bepridil/NN ,/, lidocaine/NN (/-LRB- systemic/JJ )/-RRB- and/CC quinidine/NN ./.

(ROOT (S1 (S (NP (NP (NNS Antiarrhythmics)) (: :) (NP (NP (NN bepridil)) (, ,) (NP (NP (NN lidocaine)) (PRN (-LRB- -LRB-) (NP (JJ systemic)) (-RRB- -RRB-))) (CC and) (NP (NN quinidine))) (. .)))))

root(ROOT-0, Antiarrhythmics-1)
dep(Antiarrhythmics-1, bepridil-3)
conj_and(bepridil-3, lidocaine-5)
dep(lidocaine-5, systemic-7)
conj_and(bepridil-3, quinidine-10)

@/NN antiarrhythmic/JJ agent/NN s/NN concentration/NN ./.

(ROOT (S1 (S (S (NP (NN @) (JJ antiarrhythmic) (NN agent) (NN s) (NN concentration))) (. .))))

nn(concentration-5, @-1)
amod(concentration-5, antiarrhythmic-2)
nn(concentration-5, agent-3)
nn(concentration-5, s-4)
root(ROOT-0, concentration-5)

Caution/NN is/VBZ warranted/VBN and/CC therapeutic/JJ concentration/NN monitoring/NN is/VBZ recommended/VBN for/IN antiarrhythmics/NN when/WRB coadministered/VBN with/IN CRIXIVAN/NN ./.

(ROOT (S1 (S (S (S (NP (NN Caution)) (VP (VBZ is) (VP (VBN warranted)))) (CC and) (S (NP (JJ therapeutic) (NN concentration) (NN monitoring)) (VP (VBZ is) (VP (VBN recommended) (PP (IN for) (NP (NN antiarrhythmics))) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NN CRIXIVAN)))))))))) (. .))))

nsubjpass(warranted-3, Caution-1)
auxpass(warranted-3, is-2)
root(ROOT-0, warranted-3)
amod(monitoring-7, therapeutic-5)
nn(monitoring-7, concentration-6)
nsubjpass(recommended-9, monitoring-7)
auxpass(recommended-9, is-8)
conj_and(warranted-3, recommended-9)
prep_for(recommended-9, antiarrhythmics-11)
advmod(coadministered-13, when-12)
advcl(recommended-9, coadministered-13)
prep_with(coadministered-13, CRIXIVAN-15)

Anticonvulsants/NNS :/: carbamazepine/NN ,/, phenobarbital/NN ,/, phenytoin/NN ./.

(ROOT (S1 (S (S (NP (NNS Anticonvulsants) (: :) (NP (NP (NN carbamazepine)) (, ,) (NP (NN phenobarbital)) (, ,) (NP (NN phenytoin))))) (. .))))

root(ROOT-0, Anticonvulsants-1)
dep(Anticonvulsants-1, carbamazepine-3)
appos(carbamazepine-3, phenobarbital-5)
appos(carbamazepine-3, phenytoin-7)

@/NN indinavir/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN indinavir) (NN concentration)) (. .)))))

nn(concentration-3, @-1)
nn(concentration-3, indinavir-2)
root(ROOT-0, concentration-3)

CRIXIVAN/NN may/MD not/RB be/VB effective/JJ due/JJ to/TO decreased/VBN indinavir/NN concentrations/NNS in/IN patients/NNS taking/VBG these/DT agents/NNS concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NN CRIXIVAN)) (VP (MD may) (RB not) (VP (VB be) (VP (JJ effective) (PP (JJ due) (TO to) (NP (NP (VBN decreased) (NN indinavir) (NNS concentrations)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (DT these) (NNS agents))))))) (ADVP (RB concomitantly)))))) (. .))))

nsubj(effective-5, CRIXIVAN-1)
aux(effective-5, may-2)
neg(effective-5, not-3)
aux(effective-5, be-4)
root(ROOT-0, effective-5)
amod(concentrations-10, decreased-8)
nn(concentrations-10, indinavir-9)
prep_due_to(effective-5, concentrations-10)
prep_in(concentrations-10, patients-12)
partmod(patients-12, taking-13)
det(agents-15, these-14)
dobj(taking-13, agents-15)
advmod(effective-5, concomitantly-16)

Calcium/NN Channel/NN Blockers/NNS ,/, Dihydropyridine/NN :/: e.g./FW ,/, felodipine/NN ,/, nifedipine/NN ,/, nicardipine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Calcium) (NN Channel) (NNS Blockers)) (PRN (, ,) (NP (NN Dihydropyridine)) (: :) (NP (FW e.g.) (, ,) (NP (NN felodipine))) (, ,) (NP (NP (NN nifedipine)) (, ,) (NP (NN nicardipine)))))) (. .))))

nn(Blockers-3, Calcium-1)
nn(Blockers-3, Channel-2)
root(ROOT-0, Blockers-3)
dep(Blockers-3, Dihydropyridine-5)
dep(felodipine-9, e.g.-7)
dep(Dihydropyridine-5, felodipine-9)
dep(Dihydropyridine-5, nifedipine-11)
appos(nifedipine-11, nicardipine-13)

@/NN dihydropyridine/NN calcium/NN channel/NN blockers/NNS concentration/NN ./.

(ROOT (S1 (S (S (NP (NN @) (NN dihydropyridine) (NN calcium) (NN channel) (NNS blockers)) (NP (NN concentration))) (. .))))

nn(blockers-5, @-1)
nn(blockers-5, dihydropyridine-2)
nn(blockers-5, calcium-3)
nn(blockers-5, channel-4)
dep(concentration-6, blockers-5)
root(ROOT-0, concentration-6)

Clarithromycin/NN ./.

(ROOT (S1 (S (NP (NP (NN Clarithromycin)) (. .)))))

root(ROOT-0, Clarithromycin-1)

@/NN clarithromycin/NN concentration/NN @/NN indinavir/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN clarithromycin) (NN concentration) (NN @) (NN indinavir) (NN concentration)) (. .)))))

nn(concentration-6, @-1)
nn(concentration-6, clarithromycin-2)
nn(concentration-6, concentration-3)
nn(concentration-6, @-4)
nn(concentration-6, indinavir-5)
root(ROOT-0, concentration-6)

HMG-CoA/NN Reductase/NN Inhibitor/NN :/: atorvastatin/NN ./.

(ROOT (S1 (S (S (NP (NN HMG-CoA) (NN Reductase) (NN Inhibitor)) (: :) (NP (NN atorvastatin))) (. .))))

nn(Inhibitor-3, HMG-CoA-1)
nn(Inhibitor-3, Reductase-2)
dep(atorvastatin-5, Inhibitor-3)
root(ROOT-0, atorvastatin-5)

@/NN atorvastatin/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN atorvastatin) (NN concentration)) (. .)))))

nn(concentration-3, @-1)
nn(concentration-3, atorvastatin-2)
root(ROOT-0, concentration-3)

Use/VB lowest/JJS possible/JJ dose/NN of/IN atorvastatin/NN with/IN careful/JJ monitoring/NN ,/, or/CC consider/VB HMG-CoA/NN reductase/NN inhibitors/NNS that/WDT are/VBP not/RB primarily/RB metabolized/VBN by/IN CYP3A4/NN ,/, such/JJ as/IN pravastatin/NN ,/, fluvastatin/NN ,/, or/CC rosuvastatin/NN in/IN combination/NN with/IN CRIXIVAN/NN ./.

(ROOT (S1 (S (S (VP (VP (VB Use) (NP (NP (JJS lowest) (JJ possible) (NN dose)) (PP (IN of) (NP (NP (NN atorvastatin)) (PP (IN with) (NP (JJ careful) (NN monitoring))))))) (, ,) (CC or) (VP (VB consider) (NP (NP (NN HMG-CoA) (NN reductase) (NNS inhibitors)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (RB not) (ADVP (RB primarily)) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP3A4))))))) (, ,) (PP (JJ such) (IN as) (NP (NP (NP (NN pravastatin)) (, ,) (NP (NN fluvastatin)) (, ,) (CC or) (NP (NN rosuvastatin))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN CRIXIVAN))))))))))) (. .))))

root(ROOT-0, Use-1)
amod(dose-4, lowest-2)
amod(dose-4, possible-3)
dobj(Use-1, dose-4)
prep_of(dose-4, atorvastatin-6)
amod(monitoring-9, careful-8)
prep_with(atorvastatin-6, monitoring-9)
conj_or(Use-1, consider-12)
nn(inhibitors-15, HMG-CoA-13)
nn(inhibitors-15, reductase-14)
dobj(consider-12, inhibitors-15)
nsubjpass(metabolized-20, inhibitors-15)
auxpass(metabolized-20, are-17)
neg(metabolized-20, not-18)
advmod(metabolized-20, primarily-19)
rcmod(inhibitors-15, metabolized-20)
agent(metabolized-20, CYP3A4-22)
prep_such_as(inhibitors-15, pravastatin-26)
conj_or(pravastatin-26, fluvastatin-28)
conj_or(pravastatin-26, rosuvastatin-31)
prep_in(pravastatin-26, combination-33)
prep_with(combination-33, CRIXIVAN-35)

Immunosuppressants/NNS :/: cyclosporine/NN ,/, tacrolimus/NN ,/, sirolimus/NN ./.

(ROOT (S1 (S (S (NP (NNS Immunosuppressants)) (: :) (NP (NP (NN cyclosporine)) (, ,) (NP (NN tacrolimus)) (, ,) (NP (NN sirolimus)))) (. .))))

dep(cyclosporine-3, Immunosuppressants-1)
root(ROOT-0, cyclosporine-3)
appos(cyclosporine-3, tacrolimus-5)
appos(cyclosporine-3, sirolimus-7)

@/NN immunosuppressant/NN agents/NNS concentration/NN ./.

(ROOT (S1 (S (S (NP (NN @) (NN immunosuppressant) (NNS agents)) (NP (NN concentration))) (. .))))

nn(agents-3, @-1)
nn(agents-3, immunosuppressant-2)
dep(concentration-4, agents-3)
root(ROOT-0, concentration-4)

Plasma/NN concentrations/NNS may/MD be/VB increased/VBN by/IN CRIXIVAN/NN ./.

(ROOT (S1 (S (S (NP (NN Plasma) (NNS concentrations)) (VP (MD may) (VP (VB be) (VP (VBN increased) (PP (IN by) (NP (NN CRIXIVAN))))))) (. .))))

nn(concentrations-2, Plasma-1)
nsubjpass(increased-5, concentrations-2)
aux(increased-5, may-3)
auxpass(increased-5, be-4)
root(ROOT-0, increased-5)
agent(increased-5, CRIXIVAN-7)

Itraconazole/NN ./.

(ROOT (S1 (S (NP (NP (NN Itraconazole)) (. .)))))

root(ROOT-0, Itraconazole-1)

@/NN indinavir/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN indinavir) (NN concentration)) (. .)))))

nn(concentration-3, @-1)
nn(concentration-3, indinavir-2)
root(ROOT-0, concentration-3)

Dose/NN reduction/NN of/IN CRIXIVAN/NN to/TO 600/CD mg/NN every/DT 8/CD hours/NNS is/VBZ recommended/VBN when/WRB administering/VBG itraconazole/NN concurrently/RB ./.

(ROOT (S1 (S (S (NP (NP (NN Dose) (NN reduction)) (PP (IN of) (NP (NN CRIXIVAN))) (PP (TO to) (NP (NP (CD 600) (NN mg)) (NP (DT every) (CD 8) (NNS hours))))) (VP (VBZ is) (VP (VBN recommended) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (NP (NN itraconazole)) (ADVP (RB concurrently))))))))) (. .))))

nn(reduction-2, Dose-1)
nsubjpass(recommended-12, reduction-2)
prep_of(reduction-2, CRIXIVAN-4)
num(mg-7, 600-6)
prep_to(reduction-2, mg-7)
det(hours-10, every-8)
num(hours-10, 8-9)
dep(mg-7, hours-10)
auxpass(recommended-12, is-11)
root(ROOT-0, recommended-12)
advmod(administering-14, when-13)
advcl(recommended-12, administering-14)
dobj(administering-14, itraconazole-15)
advmod(itraconazole-15, concurrently-16)

Ketoconazole/NN ./.

(ROOT (S1 (S (NP (NP (NN Ketoconazole)) (. .)))))

root(ROOT-0, Ketoconazole-1)

@/NN indinavir/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN indinavir) (NN concentration)) (. .)))))

nn(concentration-3, @-1)
nn(concentration-3, indinavir-2)
root(ROOT-0, concentration-3)

Dose/NN reduction/NN of/IN CRIXIVAN/NN to/TO 600/CD mg/NN every/DT 8/CD hours/NNS should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Dose) (NN reduction)) (PP (IN of) (NP (NN CRIXIVAN))) (PP (TO to) (NP (NP (CD 600) (NN mg)) (NP (DT every) (CD 8) (NNS hours))))) (VP (MD should) (VP (VB be) (VP (VBN considered))))) (. .))))

nn(reduction-2, Dose-1)
nsubjpass(considered-13, reduction-2)
prep_of(reduction-2, CRIXIVAN-4)
num(mg-7, 600-6)
prep_to(reduction-2, mg-7)
det(hours-10, every-8)
num(hours-10, 8-9)
dep(mg-7, hours-10)
aux(considered-13, should-11)
auxpass(considered-13, be-12)
root(ROOT-0, considered-13)

Rifabutin/NN ./.

(ROOT (S1 (S (NP (NP (NN Rifabutin)) (. .)))))

root(ROOT-0, Rifabutin-1)

@/NN indinavir/NN concentration/NN @/NN rifabutin/NN concentration/NN ./.

(ROOT (S1 (S (S (NP (NN @) (NN indinavir) (NN concentration) (NN @) (NN rifabutin)) (NP (NN concentration))) (. .))))

nn(rifabutin-5, @-1)
nn(rifabutin-5, indinavir-2)
nn(rifabutin-5, concentration-3)
nn(rifabutin-5, @-4)
dep(concentration-6, rifabutin-5)
root(ROOT-0, concentration-6)

Dose/NN reduction/NN of/IN rifabutin/NN to/TO half/NN the/DT standard/JJ dose/NN and/CC a/DT dose/NN increase/NN of/IN CRIXIVAN/NN to/TO 1000/CD mg/NN (/-LRB- three/CD 333-mg/NN capsules/NNS )/-RRB- every/DT 8/CD hours/NNS are/VBP recommended/VBN when/WRB rifabutin/NN and/CC CRIXIVAN/NN are/VBP coadministered/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Dose) (NN reduction)) (PP (IN of) (NP (NN rifabutin))) (PP (TO to) (NP (NN half) (NP (DT the) (JJ standard) (NN dose))))) (CC and) (NP (NP (DT a) (NN dose) (NN increase)) (PP (IN of) (NP (NP (NN CRIXIVAN) (TO to) (CD 1000) (NN mg)) (PRN (-LRB- -LRB-) (NP (CD three) (NN 333-mg) (NNS capsules)) (-RRB- -RRB-))))) (NP (DT every) (CD 8) (NNS hours))) (VP (VBP are) (VP (VBN recommended) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN rifabutin)) (CC and) (NP (NN CRIXIVAN))) (VP (VBP are) (VP (VBN coadministered)))))))) (. .))))

nn(reduction-2, Dose-1)
nsubjpass(recommended-28, reduction-2)
prep_of(reduction-2, rifabutin-4)
prep_to(reduction-2, half-6)
det(dose-9, the-7)
amod(dose-9, standard-8)
dep(half-6, dose-9)
det(increase-13, a-11)
nn(increase-13, dose-12)
conj_and(reduction-2, increase-13)
nn(mg-18, CRIXIVAN-15)
dep(mg-18, to-16)
num(mg-18, 1000-17)
prep_of(increase-13, mg-18)
num(capsules-22, three-20)
nn(capsules-22, 333-mg-21)
appos(mg-18, capsules-22)
det(hours-26, every-24)
num(hours-26, 8-25)
dep(reduction-2, hours-26)
auxpass(recommended-28, are-27)
root(ROOT-0, recommended-28)
advmod(coadministered-34, when-29)
nsubjpass(coadministered-34, rifabutin-30)
conj_and(rifabutin-30, CRIXIVAN-32)
auxpass(coadministered-34, are-33)
advcl(recommended-28, coadministered-34)

Sildenafil/NN ./.

(ROOT (S1 (S (NP (NP (NN Sildenafil)) (. .)))))

root(ROOT-0, Sildenafil-1)

@/NN sildenafil/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN sildenafil) (NN concentration)) (. .)))))

nn(concentration-3, @-1)
nn(concentration-3, sildenafil-2)
root(ROOT-0, concentration-3)

Sildenafil/NN dose/NN should/MD not/RB exceed/VB a/DT maximum/NN of/IN 25/CD mg/NN in/IN a/DT 48-/CD hour/NN period/NN in/IN patients/NNS receiving/VBG concomitant/JJ indinavir/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NN Sildenafil) (NN dose)) (VP (MD should) (RB not) (VP (VB exceed) (NP (NP (DT a) (NN maximum)) (PP (IN of) (NP (CD 25) (NN mg)))) (PP (IN in) (NP (NP (DT a) (ADJP (CD 48-) (NN hour)) (NN period)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ concomitant) (NN indinavir) (NN therapy)))))))))) (. .))))

nn(dose-2, Sildenafil-1)
nsubj(exceed-5, dose-2)
aux(exceed-5, should-3)
neg(exceed-5, not-4)
root(ROOT-0, exceed-5)
det(maximum-7, a-6)
dobj(exceed-5, maximum-7)
num(mg-10, 25-9)
prep_of(maximum-7, mg-10)
det(period-15, a-12)
number(hour-14, 48--13)
amod(period-15, hour-14)
prep_in(exceed-5, period-15)
prep_in(period-15, patients-17)
partmod(patients-17, receiving-18)
amod(therapy-21, concomitant-19)
nn(therapy-21, indinavir-20)
dobj(receiving-18, therapy-21)

Tadalafil/NN ./.

(ROOT (S1 (S (NP (NP (NN Tadalafil)) (. .)))))

root(ROOT-0, Tadalafil-1)

@/NN tadalafil/VBP concentration/NN ./.

(ROOT (S1 (S (S (NP (NN @)) (VP (VBP tadalafil) (NP (NN concentration)))) (. .))))

nsubj(tadalafil-2, @-1)
root(ROOT-0, tadalafil-2)
dobj(tadalafil-2, concentration-3)

Tadalafil/NN dose/NN should/MD not/RB exceed/VB a/DT maximum/NN of/IN 10/CD mg/NN in/IN a/DT 72-/NN hour/NN period/NN in/IN patients/NNS receiving/VBG concomitant/JJ indinavir/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NN Tadalafil) (NN dose)) (VP (MD should) (RB not) (VP (VB exceed) (NP (NP (DT a) (NN maximum)) (PP (IN of) (NP (CD 10) (NN mg)))) (PP (IN in) (NP (NP (DT a) (NN 72-) (NN hour) (NN period)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ concomitant) (NN indinavir) (NN therapy)))))))))) (. .))))

nn(dose-2, Tadalafil-1)
nsubj(exceed-5, dose-2)
aux(exceed-5, should-3)
neg(exceed-5, not-4)
root(ROOT-0, exceed-5)
det(maximum-7, a-6)
dobj(exceed-5, maximum-7)
num(mg-10, 10-9)
prep_of(maximum-7, mg-10)
det(period-15, a-12)
nn(period-15, 72--13)
nn(period-15, hour-14)
prep_in(exceed-5, period-15)
prep_in(period-15, patients-17)
partmod(patients-17, receiving-18)
amod(therapy-21, concomitant-19)
nn(therapy-21, indinavir-20)
dobj(receiving-18, therapy-21)

Vardenafil/NN ./.

(ROOT (S1 (S (NP (NP (NN Vardenafil)) (. .)))))

root(ROOT-0, Vardenafil-1)

@/NN vardenafil/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN vardenafil) (NN concentration)) (. .)))))

nn(concentration-3, @-1)
nn(concentration-3, vardenafil-2)
root(ROOT-0, concentration-3)

Vardenafil/NN dose/NN should/MD not/RB exceed/VB a/DT maximum/NN of/IN 2.5/CD mg/NN in/IN a/DT 24-hour/JJ period/NN in/IN patients/NNS receiving/VBG concomitant/JJ indinavir/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NN Vardenafil) (NN dose)) (VP (MD should) (RB not) (VP (VB exceed) (NP (NP (DT a) (NN maximum)) (PP (IN of) (NP (CD 2.5) (NN mg)))) (PP (IN in) (NP (NP (DT a) (JJ 24-hour) (NN period)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ concomitant) (NN indinavir) (NN therapy)))))))))) (. .))))

nn(dose-2, Vardenafil-1)
nsubj(exceed-5, dose-2)
aux(exceed-5, should-3)
neg(exceed-5, not-4)
root(ROOT-0, exceed-5)
det(maximum-7, a-6)
dobj(exceed-5, maximum-7)
num(mg-10, 2.5-9)
prep_of(maximum-7, mg-10)
det(period-14, a-12)
amod(period-14, 24-hour-13)
prep_in(exceed-5, period-14)
prep_in(period-14, patients-16)
partmod(patients-16, receiving-17)
amod(therapy-20, concomitant-18)
nn(therapy-20, indinavir-19)
dobj(receiving-17, therapy-20)

Concurrent/JJ administration/NN of/IN etanercept/NN (/-LRB- another/DT TNF/NN @/NN -blocking/JJ agent/NN )/-RRB- and/CC anakinra/NN (/-LRB- an/DT interleukin-1/NN antagonist/NN )/-RRB- has/VBZ been/VBN associated/VBN with/IN an/DT increased/VBN risk/NN of/IN serious/JJ infections/NNS ,/, and/CC increased/VBN risk/NN of/IN neutropenia/NN and/CC no/DT additional/JJ benefit/NN compared/VBN to/TO these/DT medicinal/JJ product/NN s/NNS alone/RB ./.

(ROOT (S1 (S (S (S (NP (NP (JJ Concurrent) (NN administration)) (PP (IN of) (NP (NP (NP (NN etanercept)) (PRN (-LRB- -LRB-) (NP (DT another) (NN TNF) (NN @) (JJ -blocking) (NN agent)) (-RRB- -RRB-))) (CC and) (NP (NP (NN anakinra)) (PRN (-LRB- -LRB-) (NP (DT an) (NN interleukin-1) (NN antagonist)) (-RRB- -RRB-)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (JJ serious) (NNS infections))))))))) (, ,) (CC and) (S (NP (NP (VBN increased) (NN risk)) (PP (IN of) (NP (NP (NN neutropenia)) (CC and) (NP (DT no) (JJ additional) (NN benefit))))) (VP (VBN compared) (PP (TO to) (NP (DT these) (JJ medicinal) (NN product) (NNS s))) (ADVP (RB alone))))) (. .))))

amod(administration-2, Concurrent-1)
nsubjpass(associated-21, administration-2)
prep_of(administration-2, etanercept-4)
det(agent-10, another-6)
nn(agent-10, TNF-7)
nn(agent-10, @-8)
amod(agent-10, -blocking-9)
abbrev(etanercept-4, agent-10)
conj_and(etanercept-4, anakinra-13)
det(antagonist-17, an-15)
nn(antagonist-17, interleukin-1-16)
appos(anakinra-13, antagonist-17)
aux(associated-21, has-19)
auxpass(associated-21, been-20)
root(ROOT-0, associated-21)
det(risk-25, an-23)
amod(risk-25, increased-24)
prep_with(associated-21, risk-25)
amod(infections-28, serious-27)
prep_of(risk-25, infections-28)
amod(risk-32, increased-31)
nsubj(compared-39, risk-32)
prep_of(risk-32, neutropenia-34)
det(benefit-38, no-36)
amod(benefit-38, additional-37)
conj_and(neutropenia-34, benefit-38)
conj_and(associated-21, compared-39)
det(s-44, these-41)
amod(s-44, medicinal-42)
nn(s-44, product-43)
prep_to(compared-39, s-44)
advmod(compared-39, alone-45)

Other/JJ TNFa/NN -blocking/NN agents/NNS (/-LRB- including/VBG REMICADE/NN )/-RRB- used/VBN in/IN combination/NN with/IN anakinra/NN may/MD also/RB result/VB in/IN similar/JJ toxicities/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Other) (NN TNFa) (NN -blocking) (NNS agents)) (PRN (-LRB- -LRB-) (VP (VBG including) (NP (NN REMICADE))) (-RRB- -RRB-))) (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN anakinra))))))) (VP (MD may) (ADVP (RB also)) (VP (VB result) (PP (IN in) (NP (JJ similar) (NNS toxicities)))))) (. .))))

amod(agents-4, Other-1)
nn(agents-4, TNFa-2)
nn(agents-4, -blocking-3)
nsubj(result-16, agents-4)
dep(agents-4, including-6)
dobj(including-6, REMICADE-7)
partmod(agents-4, used-9)
prep_in(used-9, combination-11)
prep_with(combination-11, anakinra-13)
aux(result-16, may-14)
advmod(result-16, also-15)
root(ROOT-0, result-16)
amod(toxicities-19, similar-18)
prep_in(result-16, toxicities-19)

Specific/JJ drug/NN interaction/NN studies/NNS ,/, including/VBG interactions/NNS with/IN MTX/NN ,/, have/VBP not/RB been/VBN conducted/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Specific) (NN drug) (NN interaction) (NNS studies)) (, ,) (PP (VBG including) (NP (NP (NNS interactions)) (PP (IN with) (NP (NN MTX))))) (, ,)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN conducted))))) (. .))))

amod(studies-4, Specific-1)
nn(studies-4, drug-2)
nn(studies-4, interaction-3)
nsubjpass(conducted-14, studies-4)
prep_including(studies-4, interactions-7)
prep_with(interactions-7, MTX-9)
aux(conducted-14, have-11)
neg(conducted-14, not-12)
auxpass(conducted-14, been-13)
root(ROOT-0, conducted-14)

The/DT majority/NN of/IN patients/NNS in/IN rheumatoid/JJ arthritis/NN or/CC Crohn/NN @/NN s/NN disease/NN clinical/JJ studies/NNS received/VBD one/CD or/CC more/JJR concomitant/JJ medications/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN majority)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN in) (NP (NP (JJ rheumatoid) (NN arthritis)) (CC or) (NP (NN Crohn) (NN @) (NN s) (NN disease)) (NP (JJ clinical) (NNS studies))))))) (VP (VBD received) (NP (QP (CD one) (CC or) (JJR more)) (JJ concomitant) (NNS medications)))) (. .))))

det(majority-2, The-1)
nsubj(received-15, majority-2)
prep_of(majority-2, patients-4)
amod(arthritis-7, rheumatoid-6)
prep_in(patients-4, arthritis-7)
nn(disease-12, Crohn-9)
nn(disease-12, @-10)
nn(disease-12, s-11)
conj_or(arthritis-7, disease-12)
amod(studies-14, clinical-13)
dep(arthritis-7, studies-14)
root(ROOT-0, received-15)
num(medications-20, one-16)
conj_or(one-16, more-18)
quantmod(one-16, more-18)
amod(medications-20, concomitant-19)
dobj(received-15, medications-20)

In/IN rheumatoid/JJ arthritis/NN ,/, concomitant/JJ medications/NNS besides/IN MTX/NN were/VBD nonsteroidal/JJ anti-inflammatory/JJ agents/NNS ,/, folic/JJ acid/NN ,/, corticosteroids/NNS and/or/CC narcotics/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ rheumatoid) (NN arthritis))) (, ,) (NP (NP (JJ concomitant) (NNS medications)) (PP (IN besides) (NP (NN MTX)))) (VP (VBD were) (NP (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS agents)) (, ,) (NP (JJ folic) (NN acid)) (, ,) (NP (NNS corticosteroids)) (CC and/or) (NP (NNS narcotics))))) (. .))))

amod(arthritis-3, rheumatoid-2)
prep_in(agents-12, arthritis-3)
amod(medications-6, concomitant-5)
nsubj(agents-12, medications-6)
prep_besides(medications-6, MTX-8)
cop(agents-12, were-9)
amod(agents-12, nonsteroidal-10)
amod(agents-12, anti-inflammatory-11)
root(ROOT-0, agents-12)
amod(acid-15, folic-14)
conj_and/or(agents-12, acid-15)
conj_and/or(agents-12, corticosteroids-17)
conj_and/or(agents-12, narcotics-19)

Concomitant/JJ Crohn/NN @/NN s/NN disease/NN medications/NNS were/VBD antibiotics/NNS ,/, antivirals/NNS ,/, corticosteroids/NNS ,/, 6-MP/AZA/NN and/CC aminosalicylate/NN s/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN Crohn) (NN @) (NN s) (NN disease)) (NNS medications)) (VP (VBD were) (NP (NP (NNS antibiotics)) (, ,) (NP (NNS antivirals)) (, ,) (NP (NNS corticosteroids)) (, ,) (NP (NN 6-MP/AZA)) (CC and) (NP (NN aminosalicylate) (NNS s))))) (. .))))

amod(disease-5, Concomitant-1)
nn(disease-5, Crohn-2)
nn(disease-5, @-3)
nn(disease-5, s-4)
nn(medications-6, disease-5)
nsubj(antibiotics-8, medications-6)
cop(antibiotics-8, were-7)
root(ROOT-0, antibiotics-8)
conj_and(antibiotics-8, antivirals-10)
conj_and(antibiotics-8, corticosteroids-12)
conj_and(antibiotics-8, 6-MP/AZA-14)
nn(s-17, aminosalicylate-16)
conj_and(antibiotics-8, s-17)

In/IN psoriatic/JJ arthritis/NN clinical/JJ trials/NNS ,/, concomitant/JJ medications/NNS included/VBD MTX/NN in/IN approximately/RB half/NN of/IN the/DT patients/NNS as/RB well/RB as/IN nonsteroidal/JJ anti-inflammatory/JJ agents/NNS ,/, folic/JJ acid/NN and/CC corticosteroids/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (JJ psoriatic) (NN arthritis)) (JJ clinical) (NNS trials))) (, ,) (NP (JJ concomitant) (NNS medications)) (VP (VBD included) (NP (NP (NP (NN MTX)) (PP (IN in) (NP (NP (RB approximately) (NN half)) (PP (IN of) (NP (DT the) (NNS patients)))))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (JJ nonsteroidal) (JJ anti-inflammatory) (NNS agents)) (, ,) (NP (JJ folic) (NN acid)) (CC and) (NP (NNS corticosteroids)))))) (. .))))

amod(arthritis-3, psoriatic-2)
nn(trials-5, arthritis-3)
amod(trials-5, clinical-4)
prep_in(included-9, trials-5)
amod(medications-8, concomitant-7)
nsubj(included-9, medications-8)
root(ROOT-0, included-9)
dobj(included-9, MTX-10)
advmod(half-13, approximately-12)
prep_in(MTX-10, half-13)
det(patients-16, the-15)
prep_of(half-13, patients-16)
amod(agents-22, nonsteroidal-20)
amod(agents-22, anti-inflammatory-21)
conj_and(MTX-10, agents-22)
amod(acid-25, folic-24)
conj_and(agents-22, acid-25)
conj_and(agents-22, corticosteroids-27)

Patients/NNS with/IN Crohn/NN @/NN s/NN disease/NN who/WP received/VBD immunosuppressants/NNS tended/VBD to/TO experience/VBP fewer/JJR infusion/NN reactions/NNS compared/VBN to/TO patients/NNS on/IN no/DT immunosuppressants/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (PP (IN with) (NP (NN Crohn) (NN @) (NN s) (NN disease))) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NNS immunosuppressants)))))) (VP (VBD tended) (S (VP (TO to) (VP (VBP experience) (NP (JJR fewer) (NN infusion) (NNS reactions)) (PP (VBN compared) (PP (TO to) (NP (NP (NNS patients)) (PP (IN on) (NP (DT no) (NNS immunosuppressants))))))))))) (. .))))

nsubj(received-8, Patients-1)
nsubj(tended-10, Patients-1)
xsubj(experience-12, Patients-1)
nn(disease-6, Crohn-3)
nn(disease-6, @-4)
nn(disease-6, s-5)
prep_with(Patients-1, disease-6)
rcmod(Patients-1, received-8)
dobj(received-8, immunosuppressants-9)
root(ROOT-0, tended-10)
aux(experience-12, to-11)
xcomp(tended-10, experience-12)
amod(reactions-15, fewer-13)
nn(reactions-15, infusion-14)
dobj(experience-12, reactions-15)
prepc_compared_to(experience-12, to-17)
pobj(experience-12, patients-18)
det(immunosuppressants-21, no-20)
prep_on(patients-18, immunosuppressants-21)

Serum/NN infliximab/NN concentrations/NNS appeared/VBD to/TO be/VB unaffected/VBN by/IN baseline/NN use/NN of/IN medications/NNS for/IN the/DT treatment/NN of/IN Crohn/NN @/NN s/NN disease/NN including/VBG corticosteroids/NNS ,/, antibiotics/NNS (/-LRB- metronidazole/NN or/CC ciprofloxacin/NN )/-RRB- and/CC aminosalicylate/NN s/NNS ./.

(ROOT (S1 (S (S (NP (NN Serum) (NN infliximab) (NNS concentrations)) (VP (VBD appeared) (S (VP (TO to) (VP (VB be) (VP (VBN unaffected) (PP (IN by) (NP (NP (NN baseline) (NN use)) (PP (IN of) (NP (NNS medications))) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN Crohn) (NN @) (NN s) (NN disease))) (PP (VBG including) (NP (NP (NNS corticosteroids)) (, ,) (NP (NP (NNS antibiotics)) (PRN (-LRB- -LRB-) (NP (NP (NN metronidazole)) (CC or) (NP (NN ciprofloxacin))) (-RRB- -RRB-))) (CC and) (NP (NN aminosalicylate) (NNS s)))))))))))))) (. .))))

nn(concentrations-3, Serum-1)
nn(concentrations-3, infliximab-2)
nsubj(appeared-4, concentrations-3)
xsubj(unaffected-7, concentrations-3)
root(ROOT-0, appeared-4)
aux(unaffected-7, to-5)
auxpass(unaffected-7, be-6)
xcomp(appeared-4, unaffected-7)
nn(use-10, baseline-9)
agent(unaffected-7, use-10)
prep_of(use-10, medications-12)
det(treatment-15, the-14)
prep_for(use-10, treatment-15)
nn(disease-20, Crohn-17)
nn(disease-20, @-18)
nn(disease-20, s-19)
prep_of(treatment-15, disease-20)
prep_including(treatment-15, corticosteroids-22)
conj_and(corticosteroids-22, antibiotics-24)
dep(antibiotics-24, metronidazole-26)
conj_or(metronidazole-26, ciprofloxacin-28)
nn(s-32, aminosalicylate-31)
conj_and(corticosteroids-22, s-32)

A/DT number/NN of/IN substances/NNS affect/VBP glucose/NN metabolism/NN and/CC may/MD require/VBP insulin/NN dose/NN adjustment/NN and/CC particularly/RB close/JJ monitoring/NN ./.

(ROOT (S1 (S (S (NP (NP (DT A) (NN number)) (PP (IN of) (NP (NNS substances)))) (VP (VP (VBP affect) (NP (NN glucose) (NN metabolism))) (CC and) (VP (MD may) (VP (VBP require) (NP (NP (NN insulin) (NN dose) (NN adjustment)) (CC and) (ADVP (RB particularly)) (NP (JJ close) (NN monitoring))))))) (. .))))

det(number-2, A-1)
nsubj(affect-5, number-2)
prep_of(number-2, substances-4)
root(ROOT-0, affect-5)
nn(metabolism-7, glucose-6)
dobj(affect-5, metabolism-7)
aux(require-10, may-9)
conj_and(affect-5, require-10)
nn(adjustment-13, insulin-11)
nn(adjustment-13, dose-12)
dobj(require-10, adjustment-13)
advmod(adjustment-13, particularly-15)
conj_and(adjustment-13, particularly-15)
amod(monitoring-17, close-16)
conj_and(adjustment-13, monitoring-17)

The/DT following/NN are/VBP examples/NNS of/IN substances/NNS that/WDT may/MD increase/VB the/DT blood-glucose-lowering/JJ effect/NN and/CC susceptibility/NN to/TO hypoglycemia/NN :/: oral/JJ antidiabetes/NNS products/NNS ,/, ACE/NN inhibitors/NNS ,/, disopyramide/NN ,/, fibrates/NNS ,/, fluoxetine/NN ,/, MAO/NN inhibitors/NNS ,/, propoxyphene/NN ,/, salicylates/NNS ,/, somatostatin/NN analog/NN (/-LRB- e.g./FW ,/, octreotide/NN )/-RRB- ,/, sulfonamide/NN antibiotics/NNS ./.

(ROOT (S1 (S (S (NP (DT The) (NN following)) (VP (VBP are) (NP (NP (NP (NNS examples)) (PP (IN of) (NP (NP (NNS substances)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB increase) (NP (NP (DT the) (JJ blood-glucose-lowering) (NN effect)) (CC and) (NP (NP (NN susceptibility)) (PP (TO to) (NP (NN hypoglycemia)))))))))))) (: :) (NP (NP (JJ oral) (NNS antidiabetes) (NNS products)) (, ,) (NP (NN ACE) (NNS inhibitors)) (, ,) (NP (NN disopyramide)) (, ,) (NP (NNS fibrates)) (, ,) (NP (NN fluoxetine)) (, ,) (NP (NN MAO) (NNS inhibitors)) (, ,) (NP (NN propoxyphene)) (, ,) (NP (NNS salicylates)) (, ,) (NP (NP (NN somatostatin) (NN analog)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN octreotide)) (-RRB- -RRB-))) (, ,) (NP (NN sulfonamide) (NNS antibiotics)))))) (. .))))

det(following-2, The-1)
nsubj(examples-4, following-2)
cop(examples-4, are-3)
root(ROOT-0, examples-4)
prep_of(examples-4, substances-6)
nsubj(increase-9, substances-6)
aux(increase-9, may-8)
rcmod(substances-6, increase-9)
det(effect-12, the-10)
amod(effect-12, blood-glucose-lowering-11)
dobj(increase-9, effect-12)
conj_and(effect-12, susceptibility-14)
prep_to(susceptibility-14, hypoglycemia-16)
amod(products-20, oral-18)
nn(products-20, antidiabetes-19)
dep(examples-4, products-20)
nn(inhibitors-23, ACE-22)
appos(products-20, inhibitors-23)
appos(products-20, disopyramide-25)
appos(products-20, fibrates-27)
appos(products-20, fluoxetine-29)
nn(inhibitors-32, MAO-31)
appos(products-20, inhibitors-32)
appos(products-20, propoxyphene-34)
appos(products-20, salicylates-36)
nn(analog-39, somatostatin-38)
appos(products-20, analog-39)
dep(octreotide-43, e.g.-41)
appos(analog-39, octreotide-43)
nn(antibiotics-47, sulfonamide-46)
appos(products-20, antibiotics-47)

The/DT following/JJ are/VBP examples/NNS of/IN substances/NNS that/WDT may/MD reduce/VB the/DT blood-glucose-lowering/JJ effect/NN of/IN insulin/NN :/: corticosteroids/NNS ,/, danazol/NN ,/, diuretics/NN ,/, sympathomimetic/JJ agents/NNS (/-LRB- e.g./FW ,/, epinephrine/NN ,/, albuterol/NN ,/, terbutaline/NN )/-RRB- ,/, isoniazid/NN ,/, phenothiazine/JJ derivatives/NNS ,/, somatropin/NN ,/, thyroid/NN hormones/NNS ,/, estrogens/NNS ,/, progestogens/NNS (/-LRB- e.g./FW ,/, in/IN oral/JJ contraceptives/NNS )/-RRB- ./.

(ROOT (S1 (S (S (NP (DT The) (JJ following)) (VP (VBP are) (NP (NP (NP (NNS examples)) (PP (IN of) (NP (NNS substances))) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB reduce) (NP (DT the) (JJ blood-glucose-lowering) (NN effect)) (PP (IN of) (NP (NN insulin)))))))) (: :) (NP (NP (NNS corticosteroids)) (, ,) (NP (NN danazol)) (, ,) (NP (NN diuretics)) (, ,) (NP (NP (JJ sympathomimetic) (NNS agents)) (PRN (-LRB- -LRB-) (NP (FW e.g.) (, ,) (NP (NN epinephrine)) (, ,) (NP (NN albuterol)) (, ,) (NP (NN terbutaline))) (-RRB- -RRB-))) (, ,) (NP (NN isoniazid)) (, ,) (NP (JJ phenothiazine) (NNS derivatives)) (, ,) (NP (NN somatropin)) (, ,) (NP (NN thyroid) (NNS hormones)) (, ,) (NP (NNS estrogens)) (, ,) (NP (NNS progestogens)))) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (PP (IN in) (NP (JJ oral) (NNS contraceptives))) (-RRB- -RRB-)))) (. .))))

det(following-2, The-1)
nsubj(examples-4, following-2)
cop(examples-4, are-3)
root(ROOT-0, examples-4)
nsubj(reduce-9, examples-4)
prep_of(examples-4, substances-6)
aux(reduce-9, may-8)
rcmod(examples-4, reduce-9)
det(effect-12, the-10)
amod(effect-12, blood-glucose-lowering-11)
dobj(reduce-9, effect-12)
prep_of(reduce-9, insulin-14)
dep(examples-4, corticosteroids-16)
appos(corticosteroids-16, danazol-18)
appos(corticosteroids-16, diuretics-20)
amod(agents-23, sympathomimetic-22)
appos(corticosteroids-16, agents-23)
dep(epinephrine-27, e.g.-25)
dep(agents-23, epinephrine-27)
appos(epinephrine-27, albuterol-29)
appos(epinephrine-27, terbutaline-31)
appos(corticosteroids-16, isoniazid-34)
amod(derivatives-37, phenothiazine-36)
appos(corticosteroids-16, derivatives-37)
appos(corticosteroids-16, somatropin-39)
nn(hormones-42, thyroid-41)
appos(corticosteroids-16, hormones-42)
appos(corticosteroids-16, estrogens-44)
appos(corticosteroids-16, progestogens-46)
dep(examples-4, e.g.-48)
dep(e.g.-48, in-50)
amod(contraceptives-52, oral-51)
pobj(in-50, contraceptives-52)

Beta-blockers/NN ,/, clonidine/NN ,/, lithium/NN salt/NN s/NN ,/, and/CC alcohol/NN may/MD either/CC potentiate/VB or/CC weaken/VB the/DT blood-glucose-lowering/JJ effect/NN of/IN insulin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Beta-blockers)) (, ,) (NP (NN clonidine)) (, ,) (NP (NN lithium) (NN salt) (NN s)) (, ,) (CC and) (NP (NN alcohol))) (VP (MD may) (VP (CC either) (VP (VB potentiate)) (CC or) (VP (VB weaken) (NP (NP (DT the) (JJ blood-glucose-lowering) (NN effect)) (PP (IN of) (NP (NN insulin)))))))) (. .))))

nsubj(potentiate-13, Beta-blockers-1)
conj_and(Beta-blockers-1, clonidine-3)
nn(s-7, lithium-5)
nn(s-7, salt-6)
conj_and(Beta-blockers-1, s-7)
conj_and(Beta-blockers-1, alcohol-10)
aux(potentiate-13, may-11)
preconj(potentiate-13, either-12)
root(ROOT-0, potentiate-13)
conj_or(potentiate-13, weaken-15)
det(effect-18, the-16)
amod(effect-18, blood-glucose-lowering-17)
dobj(weaken-15, effect-18)
prep_of(effect-18, insulin-20)

Pentamidine/NN may/MD cause/VB hypoglycemia/NN ,/, which/WDT may/MD sometimes/RB be/VB followed/VBN by/IN hyperglycemia/NN ./.

(ROOT (S1 (S (S (NP (NN Pentamidine)) (VP (MD may) (VP (VB cause) (NP (NP (NN hypoglycemia)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD may) (ADVP (RB sometimes)) (VP (VB be) (VP (VBN followed) (PP (IN by) (NP (NN hyperglycemia)))))))))))) (. .))))

nsubj(cause-3, Pentamidine-1)
aux(cause-3, may-2)
root(ROOT-0, cause-3)
dobj(cause-3, hypoglycemia-4)
nsubjpass(followed-10, hypoglycemia-4)
aux(followed-10, may-7)
advmod(followed-10, sometimes-8)
auxpass(followed-10, be-9)
rcmod(hypoglycemia-4, followed-10)
agent(followed-10, hyperglycemia-12)

In/IN addition/NN ,/, under/IN the/DT influence/NN of/IN sympatholytic/JJ medicinal/NN products/NNS such/JJ as/IN beta-blockers/NN ,/, clonidine/NN ,/, guanethidine/NN ,/, and/CC reserpine/NN ,/, the/DT signs/NNS of/IN hypoglycemia/NN may/MD be/VB reduced/VBN or/CC absent/JJ ./.

(ROOT (S1 (S (PP (IN In) (NP (NN addition))) (, ,) (PP (IN under) (NP (NP (DT the) (NN influence)) (PP (IN of) (NP (NP (JJ sympatholytic) (NN medicinal) (NNS products)) (PP (JJ such) (IN as) (NP (NP (NN beta-blockers)) (, ,) (NP (NN clonidine)) (, ,) (NP (NN guanethidine)) (, ,) (CC and) (NP (NN reserpine)))))))) (, ,) (NP (NP (DT the) (NNS signs)) (PP (IN of) (NP (NN hypoglycemia)))) (VP (MD may) (VP (VP (VB be) (VP (VBN reduced))) (CC or) (ADJP (JJ absent)))) (. .))))

prep_in(reduced-28, addition-2)
det(influence-6, the-5)
prep_under(reduced-28, influence-6)
amod(products-10, sympatholytic-8)
nn(products-10, medicinal-9)
prep_of(influence-6, products-10)
prep_such_as(products-10, beta-blockers-13)
conj_and(beta-blockers-13, clonidine-15)
conj_and(beta-blockers-13, guanethidine-17)
conj_and(beta-blockers-13, reserpine-20)
det(signs-23, the-22)
nsubjpass(reduced-28, signs-23)
prep_of(signs-23, hypoglycemia-25)
aux(reduced-28, may-26)
auxpass(reduced-28, be-27)
root(ROOT-0, reduced-28)
acomp(reduced-28, absent-30)
conj_or(reduced-28, absent-30)

Interactions/NNS between/IN Betaseron/NN and/CC other/JJ drugs/NNS have/VBP not/RB been/VBN fully/RB evaluated/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Interactions)) (PP (IN between) (NP (NP (NN Betaseron)) (CC and) (NP (JJ other) (NNS drugs))))) (VP (VBP have) (RB not) (VP (VBN been) (ADVP (RB fully)) (VP (VBN evaluated))))) (. .))))

nsubjpass(evaluated-11, Interactions-1)
prep_between(Interactions-1, Betaseron-3)
amod(drugs-6, other-5)
conj_and(Betaseron-3, drugs-6)
aux(evaluated-11, have-7)
neg(evaluated-11, not-8)
auxpass(evaluated-11, been-9)
advmod(evaluated-11, fully-10)
root(ROOT-0, evaluated-11)

Although/IN studies/NNS designed/VBN to/TO examine/VB drug/NN interactions/NNS have/VBP not/RB been/VBN done/VBN ,/, it/PRP was/VBD noted/VBN that/IN corticosteroid/NN or/CC ACTH/NN treatment/NN of/IN relapses/NNS for/IN periods/NNS of/IN up/RB to/TO 28/CD days/NNS has/VBZ been/VBN administered/VBN to/TO patients/NNS (/-LRB- N=180/NN )/-RRB- receiving/VBG Betaseron/NN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NP (NNS studies)) (VP (VBN designed) (S (VP (TO to) (VP (VB examine) (NP (NN drug) (NNS interactions))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN done)))))) (, ,) (NP (PRP it)) (VP (VBD was) (VP (VBN noted) (SBAR (IN that) (S (NP (NP (NN corticosteroid) (CC or) (NN ACTH) (NN treatment)) (PP (IN of) (NP (NNS relapses))) (PP (IN for) (NP (NP (NNS periods)) (PP (IN of) (NP (QP (RB up) (TO to) (CD 28)) (NNS days)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN administered) (PP (TO to) (NP (NP (NP (NNS patients)) (PRN (-LRB- -LRB-) (NP (NN N=180)) (-RRB- -RRB-))) (VP (VBG receiving) (NP (NN Betaseron))))))))))))) (. .))))

mark(done-11, Although-1)
xsubj(examine-5, studies-2)
nsubjpass(done-11, studies-2)
partmod(studies-2, designed-3)
aux(examine-5, to-4)
xcomp(designed-3, examine-5)
nn(interactions-7, drug-6)
dobj(examine-5, interactions-7)
aux(done-11, have-8)
neg(done-11, not-9)
auxpass(done-11, been-10)
advcl(noted-15, done-11)
nsubjpass(noted-15, it-13)
auxpass(noted-15, was-14)
root(ROOT-0, noted-15)
complm(administered-32, that-16)
nn(treatment-20, corticosteroid-17)
conj_or(corticosteroid-17, ACTH-19)
nsubjpass(administered-32, treatment-20)
prep_of(treatment-20, relapses-22)
prep_for(treatment-20, periods-24)
quantmod(28-28, up-26)
dep(28-28, to-27)
num(days-29, 28-28)
prep_of(periods-24, days-29)
aux(administered-32, has-30)
auxpass(administered-32, been-31)
ccomp(noted-15, administered-32)
prep_to(administered-32, patients-34)
appos(patients-34, N=180-36)
partmod(patients-34, receiving-38)
dobj(receiving-38, Betaseron-39)

Betaseron/NN administration/NN to/TO three/CD cancer/NN patients/NNS over/IN a/DT dose/NN range/NN of/IN 0.025/CD mg/NN to/TO 2.2/CD mg/NN led/VBD to/TO a/DT dose-dependent/JJ inhibition/NN of/IN antipyrine/NN elimination.14/NN The/DT effect/NN of/IN alternate-day/JJ administration/NN of/IN 0.25/CD mg/NN of/IN Betaseron/NN on/IN drug/NN metabolism/NN in/IN MS/NN patients/NNS is/VBZ unknown/JJ ./.

(ROOT (S1 (S (S (NP (NP (NN Betaseron) (NN administration)) (PP (TO to) (NP (NP (CD three) (NN cancer) (NNS patients)) (PP (IN over) (NP (NP (DT a) (NN dose) (NN range)) (PP (IN of) (NP (QP (CD 0.025) (NN mg) (TO to) (CD 2.2)) (NN mg)))))))) (VP (VBD led) (PP (TO to) (NP (NP (DT a) (JJ dose-dependent) (NN inhibition)) (PP (IN of) (NP (NP (NN antipyrine) (NN elimination.14)) (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NP (JJ alternate-day) (NN administration)) (PP (IN of) (NP (NP (CD 0.25) (NN mg)) (PP (IN of) (NP (NN Betaseron))))))) (PP (IN on) (NP (NP (NN drug) (NN metabolism)) (PP (IN in) (NP (NN MS) (NNS patients)))))) (VP (VBZ is) (ADJP (JJ unknown)))))))))) (. .))))

nn(administration-2, Betaseron-1)
nsubj(led-17, administration-2)
num(patients-6, three-4)
nn(patients-6, cancer-5)
prep_to(administration-2, patients-6)
det(range-10, a-8)
nn(range-10, dose-9)
prep_over(patients-6, range-10)
number(mg-13, 0.025-12)
num(mg-16, mg-13)
dep(mg-13, to-14)
number(mg-13, 2.2-15)
prep_of(range-10, mg-16)
root(ROOT-0, led-17)
det(inhibition-21, a-19)
amod(inhibition-21, dose-dependent-20)
prep_to(led-17, inhibition-21)
nn(elimination.14-24, antipyrine-23)
prep_of(inhibition-21, elimination.14-24)
det(effect-26, The-25)
nsubj(unknown-42, effect-26)
amod(administration-29, alternate-day-28)
prep_of(effect-26, administration-29)
num(mg-32, 0.25-31)
prep_of(administration-29, mg-32)
prep_of(mg-32, Betaseron-34)
nn(metabolism-37, drug-36)
prep_on(effect-26, metabolism-37)
nn(patients-40, MS-39)
prep_in(metabolism-37, patients-40)
cop(unknown-42, is-41)
dep(elimination.14-24, unknown-42)

ATROVENT/JJ Inhalation/NN Aerosol/NN has/VBZ been/VBN used/VBN concomitantly/RB with/IN other/JJ drugs/NNS ,/, including/VBG sympathomimetic/JJ bronchodilators/NNS ,/, methylxanthines/NNS ,/, and/CC steroids/NNS ,/, commonly/RB used/VBN in/IN the/DT treatment/NN of/IN chronic/JJ obstructive/JJ pulmonary/JJ disease/NN ./.

(ROOT (S1 (S (S (NP (JJ ATROVENT) (NN Inhalation) (NN Aerosol)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (, ,) (PP (VBG including) (NP (NP (JJ sympathomimetic) (NNS bronchodilators)) (, ,) (NP (NNS methylxanthines)) (, ,) (CC and) (NP (NNS steroids)))) (, ,) (VP (ADVP (RB commonly)) (VBN used) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ chronic) (JJ obstructive) (JJ pulmonary) (NN disease)))))))))))) (. .))))

amod(Aerosol-3, ATROVENT-1)
nn(Aerosol-3, Inhalation-2)
nsubjpass(used-6, Aerosol-3)
aux(used-6, has-4)
auxpass(used-6, been-5)
root(ROOT-0, used-6)
advmod(used-6, concomitantly-7)
amod(drugs-10, other-9)
prep_with(used-6, drugs-10)
amod(bronchodilators-14, sympathomimetic-13)
prep_including(drugs-10, bronchodilators-14)
conj_and(bronchodilators-14, methylxanthines-16)
conj_and(bronchodilators-14, steroids-19)
advmod(used-22, commonly-21)
partmod(drugs-10, used-22)
det(treatment-25, the-24)
prep_in(used-22, treatment-25)
amod(disease-30, chronic-27)
amod(disease-30, obstructive-28)
amod(disease-30, pulmonary-29)
prep_of(treatment-25, disease-30)

With/IN the/DT exception/NN of/IN albuterol/NN ,/, there/EX are/VBP no/DT formal/JJ studies/NNS fully/RB evaluating/VBG the/DT interaction/NN effects/NNS of/IN ATROVENT/JJ Inhalation/NN Aerosol/NN and/CC these/DT drugs/NNS with/IN respect/NN to/TO effectiveness/NN ./.

(ROOT (S1 (S (S (PP (IN With) (NP (NP (DT the) (NN exception)) (PP (IN of) (NP (NN albuterol))))) (, ,) (NP (EX there)) (VP (VBP are) (NP (NP (DT no) (JJ formal) (NNS studies)) (VP (ADVP (RB fully)) (VBG evaluating) (NP (NP (DT the) (NN interaction) (NNS effects)) (PP (IN of) (NP (NP (JJ ATROVENT) (NN Inhalation) (NN Aerosol)) (CC and) (NP (NP (DT these) (NNS drugs)) (PP (IN with) (NP (NP (NN respect)) (PP (TO to) (NP (NN effectiveness))))))))))))) (. .))))

det(exception-3, the-2)
prep_with(are-8, exception-3)
prep_of(exception-3, albuterol-5)
expl(are-8, there-7)
root(ROOT-0, are-8)
det(studies-11, no-9)
amod(studies-11, formal-10)
nsubj(are-8, studies-11)
advmod(evaluating-13, fully-12)
partmod(studies-11, evaluating-13)
det(effects-16, the-14)
nn(effects-16, interaction-15)
dobj(evaluating-13, effects-16)
amod(Aerosol-20, ATROVENT-18)
nn(Aerosol-20, Inhalation-19)
prep_of(effects-16, Aerosol-20)
det(drugs-23, these-22)
conj_and(Aerosol-20, drugs-23)
prep_with_respect_to(drugs-23, effectiveness-27)

Anticholinergic/JJ agents/NNS :/: Although/IN ipratropium/NN bromide/NN is/VBZ minimally/RB absorbed/VBN into/IN the/DT systemic/JJ circulation/NN ,/, there/EX is/VBZ some/DT potential/NN for/IN an/DT additive/JJ interaction/NN with/IN concomitantly/RB used/VBN anticholinergic/JJ medications/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Anticholinergic) (NNS agents)) (: :) (S (SBAR (IN Although) (S (NP (NN ipratropium) (NN bromide)) (VP (VBZ is) (ADVP (RB minimally)) (VP (VBN absorbed) (PP (IN into) (NP (DT the) (JJ systemic) (NN circulation))))))) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT some) (NN potential)) (PP (IN for) (NP (NP (DT an) (JJ additive) (NN interaction)) (PP (IN with) (NP (ADJP (RB concomitantly) (VBN used)) (JJ anticholinergic) (NNS medications)))))))) (. .)))))

amod(agents-2, Anticholinergic-1)
root(ROOT-0, agents-2)
mark(absorbed-9, Although-4)
nn(bromide-6, ipratropium-5)
nsubjpass(absorbed-9, bromide-6)
auxpass(absorbed-9, is-7)
advmod(absorbed-9, minimally-8)
advcl(is-16, absorbed-9)
det(circulation-13, the-11)
amod(circulation-13, systemic-12)
prep_into(absorbed-9, circulation-13)
expl(is-16, there-15)
dep(agents-2, is-16)
det(potential-18, some-17)
nsubj(is-16, potential-18)
det(interaction-22, an-20)
amod(interaction-22, additive-21)
prep_for(potential-18, interaction-22)
advmod(used-25, concomitantly-24)
amod(medications-27, used-25)
amod(medications-27, anticholinergic-26)
prep_with(interaction-22, medications-27)

Caution/NN is/VBZ therefore/RB advised/VBN in/IN the/DT coadministration/NN of/IN ATROVENT/JJ Inhalation/NN Aerosol/NN with/IN other/JJ anticholinergic-containing/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (VBZ is) (ADVP (RB therefore)) (VP (VBN advised) (PP (IN in) (NP (NP (DT the) (NN coadministration)) (PP (IN of) (NP (JJ ATROVENT) (NN Inhalation) (NN Aerosol))) (PP (IN with) (NP (JJ other) (JJ anticholinergic-containing) (NNS drugs)))))))) (. .))))

nsubjpass(advised-4, Caution-1)
auxpass(advised-4, is-2)
advmod(advised-4, therefore-3)
root(ROOT-0, advised-4)
det(coadministration-7, the-6)
prep_in(advised-4, coadministration-7)
amod(Aerosol-11, ATROVENT-9)
nn(Aerosol-11, Inhalation-10)
prep_of(coadministration-7, Aerosol-11)
amod(drugs-15, other-13)
amod(drugs-15, anticholinergic-containing-14)
prep_with(coadministration-7, drugs-15)

Isocarboxazid/NN should/MD be/VB administered/VBN with/IN caution/NN to/TO patients/NNS receiving/VBG Antabuse/NN (/-LRB- disulfiram/NN ,/, Wyeth-Ayerst/NN Laboratories/NNS )./CD

(ROOT (S1 (S (NP (NN Isocarboxazid)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (NN caution))) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN Antabuse)) (PRN (-LRB- -LRB-) (NP (NN disulfiram)) (, ,) (NP (NN Wyeth-Ayerst) (NNS Laboratories) (CD -RRB-.)))))))))))))

nsubjpass(administered-4, Isocarboxazid-1)
aux(administered-4, should-2)
auxpass(administered-4, be-3)
root(ROOT-0, administered-4)
prep_with(administered-4, caution-6)
prep_to(administered-4, patients-8)
partmod(patients-8, receiving-9)
dobj(receiving-9, Antabuse-10)
dep(Antabuse-10, disulfiram-12)
nn(Laboratories-15, Wyeth-Ayerst-14)
dep(disulfiram-12, Laboratories-15)
num(Laboratories-15, -RRB-.-16)

In/IN a/DT single/JJ study/NN ,/, rats/NNS given/VBN high/JJ intraperitoneal/JJ doses/NNS of/IN an/DT MAO/NN inhibitor/NN plus/NN disulfiram/NN experienced/VBN severe/JJ toxicity/NN ,/, including/VBG convulsions/NN and/CC death/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT a) (JJ single) (NN study))) (, ,) (NP (NP (NNS rats)) (VP (VBN given) (NP (NP (JJ high) (JJ intraperitoneal) (NNS doses)) (PP (IN of) (NP (DT an) (NN MAO) (NN inhibitor) (NN plus) (NN disulfiram)))))) (VP (VBN experienced) (NP (JJ severe) (NN toxicity)) (, ,) (PP (VBG including) (NP (NP (NN convulsions)) (CC and) (NP (NN death)))))) (. .))))

det(study-4, a-2)
amod(study-4, single-3)
prep_in(experienced-17, study-4)
nsubj(experienced-17, rats-6)
partmod(rats-6, given-7)
amod(doses-10, high-8)
amod(doses-10, intraperitoneal-9)
dobj(given-7, doses-10)
det(disulfiram-16, an-12)
nn(disulfiram-16, MAO-13)
nn(disulfiram-16, inhibitor-14)
nn(disulfiram-16, plus-15)
prep_of(doses-10, disulfiram-16)
root(ROOT-0, experienced-17)
amod(toxicity-19, severe-18)
dobj(experienced-17, toxicity-19)
prep_including(experienced-17, convulsions-22)
conj_and(convulsions-22, death-24)

Concomitant/JJ use/NN of/IN Isocarboxazid/NN and/CC other/JJ psychotropic/JJ agents/NNS is/VBZ generally/RB not/RB recommended/VBN because/IN of/IN possible/JJ potentiating/NN effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (NN Isocarboxazid)) (CC and) (NP (JJ other) (JJ psychotropic) (NNS agents))))) (VP (VBZ is) (ADVP (RB generally)) (RB not) (VP (VBN recommended) (PP (IN because) (IN of) (NP (JJ possible) (NN potentiating) (NNS effects)))))) (. .))))

amod(use-2, Concomitant-1)
nsubjpass(recommended-12, use-2)
prep_of(use-2, Isocarboxazid-4)
amod(agents-8, other-6)
amod(agents-8, psychotropic-7)
conj_and(Isocarboxazid-4, agents-8)
auxpass(recommended-12, is-9)
advmod(recommended-12, generally-10)
neg(recommended-12, not-11)
root(ROOT-0, recommended-12)
amod(effects-17, possible-15)
nn(effects-17, potentiating-16)
prep_because_of(recommended-12, effects-17)

This/DT is/VBZ especially/RB true/JJ in/IN patients/NNS who/WP may/MD subject/NN themselves/PRP to/TO an/DT overdosage/NN of/IN drugs/NNS ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (VBZ is) (ADJP (RB especially) (JJ true) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (MD may) (VP (NN subject) (NP (PRP themselves)) (PP (TO to) (NP (NP (DT an) (NN overdosage)) (PP (IN of) (NP (NNS drugs)))))))))))))) (. .))))

nsubj(true-4, This-1)
cop(true-4, is-2)
advmod(true-4, especially-3)
root(ROOT-0, true-4)
prep_in(true-4, patients-6)
nsubj(subject-9, patients-6)
aux(subject-9, may-8)
rcmod(patients-6, subject-9)
dobj(subject-9, themselves-10)
det(overdosage-13, an-12)
prep_to(subject-9, overdosage-13)
prep_of(overdosage-13, drugs-15)

The/DT monoamine/NN oxidase/NN inhibitor/NN y/NN effects/NNS of/IN Isocarboxazid/NN may/MD persist/VB for/IN a/DT substantial/JJ period/NN after/IN discontinuation/NN of/IN the/DT drug/NN ,/, and/CC this/DT should/MD be/VB borne/VBN in/IN mind/NN when/WRB another/DT drug/NN is/VBZ prescribed/VBN following/VBG Isocarboxazid/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NP (NN monoamine) (NN oxidase)) (NN inhibitor) (NN y) (NNS effects)) (PP (IN of) (NP (NN Isocarboxazid)))) (VP (MD may) (VP (VB persist) (PP (IN for) (NP (NP (DT a) (JJ substantial) (NN period)) (PP (IN after) (NP (NP (NN discontinuation)) (PP (IN of) (NP (DT the) (NN drug)))))))))) (, ,) (CC and) (S (NP (DT this)) (VP (MD should) (VP (VB be) (VP (VBN borne) (PP (IN in) (NP (NN mind))))) (SBAR (WHADVP (WRB when)) (S (NP (DT another) (NN drug)) (VP (VBZ is) (VP (VBN prescribed) (PP (VBG following) (NP (NN Isocarboxazid))))))))) (. .))))

det(effects-6, The-1)
nn(oxidase-3, monoamine-2)
nn(effects-6, oxidase-3)
nn(effects-6, inhibitor-4)
nn(effects-6, y-5)
nsubj(persist-10, effects-6)
prep_of(effects-6, Isocarboxazid-8)
aux(persist-10, may-9)
root(ROOT-0, persist-10)
det(period-14, a-12)
amod(period-14, substantial-13)
prep_for(persist-10, period-14)
prep_after(period-14, discontinuation-16)
det(drug-19, the-18)
prep_of(discontinuation-16, drug-19)
nsubjpass(borne-25, this-22)
aux(borne-25, should-23)
auxpass(borne-25, be-24)
conj_and(persist-10, borne-25)
prep_in(borne-25, mind-27)
advmod(prescribed-32, when-28)
det(drug-30, another-29)
nsubjpass(prescribed-32, drug-30)
auxpass(prescribed-32, is-31)
advcl(borne-25, prescribed-32)
prep_following(prescribed-32, Isocarboxazid-34)

To/TO avoid/VB potentiation/NN ,/, the/DT physician/NN wishing/VBG to/TO terminate/VB treatment/NN with/IN Isocarboxazid/NN and/CC begin/VBP therapy/NN with/IN another/DT agent/NN should/MD allow/VB for/IN an/DT interval/NN of/IN 10/CD days/NNS ./.

(ROOT (S1 (S (S (S (VP (TO To) (VP (VB avoid) (NP (NN potentiation))))) (, ,) (NP (DT the) (NN physician)) (VP (VBG wishing) (S (VP (TO to) (VP (VP (VB terminate) (NP (NP (NN treatment)) (PP (IN with) (NP (NN Isocarboxazid))))) (CC and) (VP (VBP begin) (S (NP (NP (NN therapy)) (PP (IN with) (NP (DT another) (NN agent)))) (VP (MD should) (VP (VB allow) (PP (IN for) (NP (NP (DT an) (NN interval)) (PP (IN of) (NP (CD 10) (NNS days)))))))))))))) (. .))))

aux(avoid-2, To-1)
purpcl(wishing-7, avoid-2)
dobj(avoid-2, potentiation-3)
det(physician-6, the-5)
nsubj(wishing-7, physician-6)
xsubj(terminate-9, physician-6)
root(ROOT-0, wishing-7)
aux(terminate-9, to-8)
xcomp(wishing-7, terminate-9)
dobj(terminate-9, treatment-10)
prep_with(treatment-10, Isocarboxazid-12)
conj_and(terminate-9, begin-14)
nsubj(allow-20, therapy-15)
det(agent-18, another-17)
prep_with(therapy-15, agent-18)
aux(allow-20, should-19)
ccomp(begin-14, allow-20)
det(interval-23, an-22)
prep_for(allow-20, interval-23)
num(days-26, 10-25)
prep_of(interval-23, days-26)

May/MD interact/VBP with/IN the/DT following/NN :/: beta-adrenergic/JJ blocking/NN agents/NNS (/-LRB- these/DT medicines/NNS may/MD make/VB your/NN condition/NN worse/JJ and/CC prevent/VB the/DT adrenergic/JJ bronchodilators/NNS from/IN working/NNP properly/RB )/-RRB- and/CC disopyramide/NN ,/, quinidine/NN ,/, phenothiazines/NNS ,/, and/CC procainamide/NN (/-LRB- these/DT medicines/NNS may/MD increase/VB the/DT risk/NN of/IN heart/NN problems/NNS )./CD

(ROOT (S1 (S (MD May) (VP (VBP interact) (PP (IN with) (NP (NP (DT the) (NN following)) (: :) (S (NP (NP (NP (JJ beta-adrenergic) (NN blocking) (NNS agents)) (PRN (-LRB- -LRB-) (S (NP (DT these) (NNS medicines)) (VP (VP (MD may) (VP (VB make) (ADJP (NN your) (NN condition) (JJ worse)))) (CC and) (VP (VB prevent) (NP (NP (DT the) (JJ adrenergic) (NNS bronchodilators)) (PP (IN from) (NP (NNP working)))) (ADVP (RB properly))))) (-RRB- -RRB-))) (CC and) (NP (NP (NN disopyramide)) (, ,) (NP (NN quinidine)) (, ,) (NP (NNS phenothiazines)) (, ,) (CC and) (NP (NN procainamide)))) (-LRB- -LRB-) (NP (DT these) (NNS medicines)) (VP (MD may) (VP (VB increase) (NP (DT the) (NN risk)) (PP (IN of) (NP (NN heart) (NNS problems) (CD -RRB-.))))))))))))

dep(interact-2, May-1)
root(ROOT-0, interact-2)
det(following-5, the-4)
prep_with(interact-2, following-5)
amod(agents-9, beta-adrenergic-7)
nn(agents-9, blocking-8)
nsubj(increase-40, agents-9)
det(medicines-12, these-11)
nsubj(make-14, medicines-12)
aux(make-14, may-13)
dep(agents-9, make-14)
dep(worse-17, your-15)
dep(worse-17, condition-16)
acomp(make-14, worse-17)
conj_and(make-14, prevent-19)
det(bronchodilators-22, the-20)
amod(bronchodilators-22, adrenergic-21)
dobj(prevent-19, bronchodilators-22)
prep_from(bronchodilators-22, working-24)
advmod(prevent-19, properly-25)
conj_and(agents-9, disopyramide-28)
conj_and(disopyramide-28, quinidine-30)
conj_and(disopyramide-28, phenothiazines-32)
conj_and(disopyramide-28, procainamide-35)
det(medicines-38, these-37)
nsubj(increase-40, medicines-38)
aux(increase-40, may-39)
dep(following-5, increase-40)
det(risk-42, the-41)
dobj(increase-40, risk-42)
nn(problems-45, heart-44)
prep_of(increase-40, problems-45)
num(problems-45, -RRB-.-46)

Food/NN :/: Isoniazid/NN should/MD not/RB be/VB administered/VBN with/IN food/NN ./.

(ROOT (S1 (S (S (NP (NN Food) (: :) (NN Isoniazid)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (NN food))))))) (. .))))

nn(Isoniazid-3, Food-1)
nsubjpass(administered-7, Isoniazid-3)
aux(administered-7, should-4)
neg(administered-7, not-5)
auxpass(administered-7, be-6)
root(ROOT-0, administered-7)
prep_with(administered-7, food-9)

Studies/NNS have/VBP shown/VBN that/IN the/DT bioavailability/NN of/IN isoniazid/NN is/VBZ reduced/VBN significantly/RB when/WRB administered/VBN with/IN food/NN ./.

(ROOT (S1 (S (S (NP (NNS Studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (NN isoniazid)))) (VP (VBZ is) (VP (VBN reduced) (ADVP (RB significantly)) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN with) (NP (NN food))))))))))))) (. .))))

nsubj(shown-3, Studies-1)
aux(shown-3, have-2)
root(ROOT-0, shown-3)
complm(reduced-10, that-4)
det(bioavailability-6, the-5)
nsubjpass(reduced-10, bioavailability-6)
prep_of(bioavailability-6, isoniazid-8)
auxpass(reduced-10, is-9)
ccomp(shown-3, reduced-10)
advmod(reduced-10, significantly-11)
advmod(administered-13, when-12)
advcl(reduced-10, administered-13)
prep_with(administered-13, food-15)

Acetaminophen/NN :/: A/DT report/NN of/IN severe/JJ acetaminophen/NN toxicity/NN was/VBD reported/VBN in/IN a/DT patient/NN receiving/VBG Isoniazid/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Acetaminophen)) (: :) (NP (NP (DT A) (NN report)) (PP (IN of) (NP (JJ severe) (NN acetaminophen) (NN toxicity))))) (VP (VBD was) (VP (VBN reported) (PP (IN in) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN Isoniazid)))))))) (. .))))

nsubjpass(reported-10, Acetaminophen-1)
det(report-4, A-3)
dep(Acetaminophen-1, report-4)
amod(toxicity-8, severe-6)
nn(toxicity-8, acetaminophen-7)
prep_of(report-4, toxicity-8)
auxpass(reported-10, was-9)
root(ROOT-0, reported-10)
det(patient-13, a-12)
prep_in(reported-10, patient-13)
partmod(patient-13, receiving-14)
dobj(receiving-14, Isoniazid-15)

It/PRP is/VBZ believed/VBN that/IN the/DT toxicity/NN may/MD have/VB resulted/VBD from/IN a/DT previously/RB unrecognized/JJ interaction/NN between/IN isoniazid/NN and/CC acetaminophen/NN and/CC a/DT molecular/JJ basis/NN for/IN this/DT interaction/NN has/VBZ been/VBN proposed/VBN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN believed) (SBAR (IN that) (S (S (NP (DT the) (NN toxicity)) (VP (MD may) (VP (VB have) (VP (VBD resulted) (PP (IN from) (NP (NP (DT a) (ADJP (RB previously) (JJ unrecognized)) (NN interaction)) (PP (IN between) (NP (NP (NN isoniazid)) (CC and) (NP (NN acetaminophen)))))))))) (CC and) (S (NP (NP (DT a) (JJ molecular) (NN basis)) (PP (IN for) (NP (DT this) (NN interaction)))) (VP (VBZ has) (VP (VBN been) (VP (VBN proposed)))))))))) (. .))))

nsubjpass(believed-3, It-1)
auxpass(believed-3, is-2)
root(ROOT-0, believed-3)
complm(resulted-9, that-4)
det(toxicity-6, the-5)
nsubj(resulted-9, toxicity-6)
aux(resulted-9, may-7)
aux(resulted-9, have-8)
ccomp(believed-3, resulted-9)
det(interaction-14, a-11)
advmod(unrecognized-13, previously-12)
amod(interaction-14, unrecognized-13)
prep_from(resulted-9, interaction-14)
prep_between(interaction-14, isoniazid-16)
conj_and(isoniazid-16, acetaminophen-18)
det(basis-22, a-20)
amod(basis-22, molecular-21)
nsubjpass(proposed-28, basis-22)
det(interaction-25, this-24)
prep_for(basis-22, interaction-25)
aux(proposed-28, has-26)
auxpass(proposed-28, been-27)
conj_and(resulted-9, proposed-28)

However/RB ,/, current/JJ evidence/NN suggests/VBZ that/IN isoniazid/NN does/VBZ induce/VB P-450IIE1/NN ,/, a/DT mixed-function/JJ oxidase/NN enzyme/NN that/WDT appears/VBZ to/TO generate/VB the/DT toxic/JJ metabolites/NNS ,/, in/IN the/DT liver/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (JJ current) (NN evidence)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN isoniazid)) (VP (VBZ does) (VP (VB induce) (NP (NP (NN P-450IIE1)) (, ,) (NP (NP (DT a) (JJ mixed-function) (NN oxidase) (NN enzyme)) (SBAR (WHNP (WDT that)) (S (VP (VBZ appears) (S (VP (TO to) (VP (VB generate) (NP (DT the) (JJ toxic) (NNS metabolites)))))))))) (, ,) (PP (IN in) (NP (DT the) (NN liver))))))))) (. .))))

advmod(suggests-5, However-1)
amod(evidence-4, current-3)
nsubj(suggests-5, evidence-4)
root(ROOT-0, suggests-5)
complm(induce-9, that-6)
nsubj(induce-9, isoniazid-7)
aux(induce-9, does-8)
ccomp(suggests-5, induce-9)
dobj(induce-9, P-450IIE1-10)
det(enzyme-15, a-12)
amod(enzyme-15, mixed-function-13)
nn(enzyme-15, oxidase-14)
appos(P-450IIE1-10, enzyme-15)
nsubj(appears-17, enzyme-15)
rcmod(enzyme-15, appears-17)
aux(generate-19, to-18)
xcomp(appears-17, generate-19)
det(metabolites-22, the-20)
amod(metabolites-22, toxic-21)
dobj(generate-19, metabolites-22)
det(liver-26, the-25)
prep_in(induce-9, liver-26)

Furthermore/RB it/PRP has/VBZ been/VBN proposed/VBN that/IN isoniazid/NN resulted/VBD In/IN induction/NN of/IN P-450IIE1/NN in/IN the/DT patients/NNS liver/NN which/WDT ,/, in/IN turn/NN ,/, resulted/VBD in/IN a/DT greater/JJR proportion/NN of/IN the/DT ingested/VBN acetaminophen/NN being/VBG converted/VBN to/TO the/DT toxic/JJ metabolites/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Furthermore)) (NP (PRP it)) (VP (VBZ has) (VP (VBN been) (VP (VBN proposed) (SBAR (IN that) (S (NP (NN isoniazid)) (VP (VBD resulted) (PP (IN In) (NP (NP (NN induction)) (PP (IN of) (NP (NN P-450IIE1))) (PP (IN in) (NP (NP (DT the) (NNS patients) (NN liver)) (SBAR (WHNP (WDT which)) (S (, ,) (PP (IN in) (NP (NN turn))) (, ,) (VP (VBD resulted) (PP (IN in) (S (NP (NP (DT a) (JJR greater) (NN proportion)) (PP (IN of) (NP (DT the) (VBN ingested) (NN acetaminophen)))) (VP (VBG being) (VP (VBN converted) (PP (TO to) (NP (DT the) (JJ toxic) (NNS metabolites))))))))))))))))))))) (. .))))

advmod(proposed-5, Furthermore-1)
nsubjpass(proposed-5, it-2)
aux(proposed-5, has-3)
auxpass(proposed-5, been-4)
root(ROOT-0, proposed-5)
complm(resulted-8, that-6)
nsubj(resulted-8, isoniazid-7)
ccomp(proposed-5, resulted-8)
prep_in(resulted-8, induction-10)
prep_of(induction-10, P-450IIE1-12)
det(liver-16, the-14)
nn(liver-16, patients-15)
prep_in(induction-10, liver-16)
nsubj(resulted-22, liver-16)
prep_in(resulted-22, turn-20)
rcmod(liver-16, resulted-22)
det(proportion-26, a-24)
amod(proportion-26, greater-25)
nsubjpass(converted-32, proportion-26)
det(acetaminophen-30, the-28)
amod(acetaminophen-30, ingested-29)
prep_of(proportion-26, acetaminophen-30)
auxpass(converted-32, being-31)
prepc_in(resulted-22, converted-32)
det(metabolites-36, the-34)
amod(metabolites-36, toxic-35)
prep_to(converted-32, metabolites-36)

Studies/NNS have/VBP demonstrated/VBN that/IN pretreatment/NN with/IN isoniazid/NN potentiates/VBZ a/DT cetaminophen/JJ hepatoxicity/NN in/IN rats/NNS ./.

(ROOT (S1 (S (S (NP (NNS Studies)) (VP (VBP have) (VP (VBN demonstrated) (SBAR (IN that) (S (NP (NP (NN pretreatment)) (PP (IN with) (NP (NN isoniazid)))) (VP (VBZ potentiates) (NP (NP (DT a) (JJ cetaminophen) (NN hepatoxicity)) (PP (IN in) (NP (NNS rats)))))))))) (. .))))

nsubj(demonstrated-3, Studies-1)
aux(demonstrated-3, have-2)
root(ROOT-0, demonstrated-3)
complm(potentiates-8, that-4)
nsubj(potentiates-8, pretreatment-5)
prep_with(pretreatment-5, isoniazid-7)
ccomp(demonstrated-3, potentiates-8)
det(hepatoxicity-11, a-9)
amod(hepatoxicity-11, cetaminophen-10)
dobj(potentiates-8, hepatoxicity-11)
prep_in(hepatoxicity-11, rats-13)

Carbamazepine/NN :/: Isoniazid/NN is/VBZ known/VBN to/TO slow/JJ the/DT metabolism/NN of/IN carbamazepine/NN and/CC increase/VB its/PRP$ serum/NN levels/NNS Carbamazepine/NN levels/NNS should/MD be/VB determined/VBN prior/RB to/TO concurrent/JJ administration/NN with/IN isoniazid/NN ,/, signs/NNS and/CC symptoms/NNS of/IN carbamazepine/NN toxicity/NN should/MD be/VB monitored/VBN closely/RB ,/, and/CC appropriate/JJ dosage/NN adjustment/NN of/IN the/DT anticonvulsant/JJ should/MD be/VB made/VBN ./.

(ROOT (S1 (S (NP (NP (NN Carbamazepine)) (: :) (S (NP (NN Isoniazid)) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VP (JJ slow) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN carbamazepine))))) (CC and) (VP (VB increase) (NP (PRP$ its) (NN serum) (NNS levels))))))) (S (S (NP (NN Carbamazepine) (NNS levels)) (VP (MD should) (VP (VB be) (VP (VBN determined) (ADVP (ADVP (RB prior)) (PP (TO to) (NP (JJ concurrent) (NN administration)))) (PP (IN with) (NP (NN isoniazid))))))) (, ,) (S (NP (NP (NP (NNS signs)) (CC and) (NP (NNS symptoms))) (PP (IN of) (NP (NN carbamazepine) (NN toxicity)))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB closely)))))) (, ,) (CC and) (S (NP (NP (JJ appropriate) (NN dosage) (NN adjustment)) (PP (IN of) (NP (DT the) (JJ anticonvulsant)))) (VP (MD should) (VP (VB be) (VP (VBN made)))))))) (. .)))))

root(ROOT-0, Carbamazepine-1)
nsubjpass(known-5, Isoniazid-3)
xsubj(slow-7, Isoniazid-3)
auxpass(known-5, is-4)
dep(Carbamazepine-1, known-5)
aux(slow-7, to-6)
xcomp(known-5, slow-7)
det(metabolism-9, the-8)
dobj(slow-7, metabolism-9)
prep_of(metabolism-9, carbamazepine-11)
conj_and(slow-7, increase-13)
poss(levels-16, its-14)
nn(levels-16, serum-15)
dobj(increase-13, levels-16)
nn(levels-18, Carbamazepine-17)
nsubjpass(determined-21, levels-18)
aux(determined-21, should-19)
auxpass(determined-21, be-20)
dep(known-5, determined-21)
amod(administration-25, concurrent-24)
prep_prior_to(determined-21, administration-25)
prep_with(determined-21, isoniazid-27)
nsubjpass(monitored-37, signs-29)
conj_and(signs-29, symptoms-31)
nn(toxicity-34, carbamazepine-33)
prep_of(signs-29, toxicity-34)
aux(monitored-37, should-35)
auxpass(monitored-37, be-36)
ccomp(determined-21, monitored-37)
conj_and(determined-21, monitored-37)
advmod(monitored-37, closely-38)
amod(adjustment-43, appropriate-41)
nn(adjustment-43, dosage-42)
nsubjpass(made-49, adjustment-43)
det(anticonvulsant-46, the-45)
prep_of(adjustment-43, anticonvulsant-46)
aux(made-49, should-47)
auxpass(made-49, be-48)
conj_and(determined-21, made-49)

Ketoconazole/NN :/: Potential/JJ interaction/NN of/IN Ketoconazole/NN and/CC Isoniazid/NN may/MD exist/VB ./.

(ROOT (S1 (S (NP (NP (NN Ketoconazole)) (: :) (S (NP (NP (JJ Potential) (NN interaction)) (PP (IN of) (NP (NP (NN Ketoconazole)) (CC and) (NP (NN Isoniazid))))) (VP (MD may) (VP (VB exist)))) (. .)))))

root(ROOT-0, Ketoconazole-1)
amod(interaction-4, Potential-3)
nsubj(exist-10, interaction-4)
prep_of(interaction-4, Ketoconazole-6)
conj_and(Ketoconazole-6, Isoniazid-8)
aux(exist-10, may-9)
dep(Ketoconazole-1, exist-10)

When/WRB Ketoconazole/NN is/VBZ given/VBN in/IN combination/NN with/IN isoniazid/NN and/CC rifampin/NN the/DT AUC/NN of/IN ketoconazole/NN is/VBZ decreased/VBN by/IN as/RB much/JJ as/IN 88/CD %/NN after/IN 5/CD months/NNS of/IN concurrent/JJ Isoniazid/NN and/CC Rifampin/NN therapy/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN Ketoconazole)) (VP (VBZ is) (VP (VBN given) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (NN isoniazid)) (CC and) (NP (NN rifampin)))))))))) (NP (NP (DT the) (NN AUC)) (PP (IN of) (NP (NN ketoconazole)))) (VP (VBZ is) (VP (VBN decreased) (PP (IN by) (NP (QP (RB as) (JJ much) (IN as) (CD 88)) (NN %))) (PP (IN after) (NP (NP (CD 5) (NNS months)) (PP (IN of) (NP (NP (JJ concurrent) (NN Isoniazid)) (CC and) (NP (NN Rifampin) (NN therapy))))))))) (. .))))

advmod(given-4, When-1)
nsubjpass(given-4, Ketoconazole-2)
auxpass(given-4, is-3)
advcl(decreased-16, given-4)
prep_in(given-4, combination-6)
prep_with(combination-6, isoniazid-8)
conj_and(isoniazid-8, rifampin-10)
det(AUC-12, the-11)
nsubjpass(decreased-16, AUC-12)
prep_of(AUC-12, ketoconazole-14)
auxpass(decreased-16, is-15)
root(ROOT-0, decreased-16)
quantmod(88-21, as-18)
quantmod(88-21, much-19)
quantmod(88-21, as-20)
num(%-22, 88-21)
agent(decreased-16, %-22)
num(months-25, 5-24)
prep_after(decreased-16, months-25)
amod(Isoniazid-28, concurrent-27)
prep_of(months-25, Isoniazid-28)
nn(therapy-31, Rifampin-30)
conj_and(Isoniazid-28, therapy-31)

Phenytoin/NN :/: Isoniazid/NN may/MD increase/VB serum/NN levels/NNS of/IN phenytoin/NN ./.

(ROOT (S1 (S (NP (NP (NN Phenytoin)) (: :) (S (NP (NN Isoniazid)) (VP (MD may) (VP (VB increase) (NP (NP (NN serum) (NNS levels)) (PP (IN of) (NP (NN phenytoin))))))) (. .)))))

root(ROOT-0, Phenytoin-1)
nsubj(increase-5, Isoniazid-3)
aux(increase-5, may-4)
dep(Phenytoin-1, increase-5)
nn(levels-7, serum-6)
dobj(increase-5, levels-7)
prep_of(levels-7, phenytoin-9)

To/TO avoid/VB phenytoin/NN intoxication/NN ,/, appropriate/JJ adjustment/NN of/IN the/DT anticonvulsant/JJ should/MD be/VB made/VBN ./.

(ROOT (S1 (S (S (S (VP (TO To) (VP (VB avoid) (NP (NN phenytoin) (NN intoxication))))) (, ,) (NP (NP (JJ appropriate) (NN adjustment)) (PP (IN of) (NP (DT the) (JJ anticonvulsant)))) (VP (MD should) (VP (VB be) (VP (VBN made))))) (. .))))

aux(avoid-2, To-1)
purpcl(made-13, avoid-2)
nn(intoxication-4, phenytoin-3)
dobj(avoid-2, intoxication-4)
amod(adjustment-7, appropriate-6)
nsubjpass(made-13, adjustment-7)
det(anticonvulsant-10, the-9)
prep_of(adjustment-7, anticonvulsant-10)
aux(made-13, should-11)
auxpass(made-13, be-12)
root(ROOT-0, made-13)

Therophylline/NN :/: A/DT recent/JJ study/NN has/VBZ shown/VBN that/IN concomitan/NN administration/NN of/IN isoniazid/NN and/CC theophylline/NN may/MD cause/VB elevated/JJ plasma/NN levels/NNS of/IN theophylline/NN ,/, and/CC in/IN some/DT instances/NNS a/DT slight/JJ decrease/NN in/IN the/DT elimination/NN of/IN isoniazid/NN ./.

(ROOT (S1 (S (NP (NP (NN Therophylline)) (: :) (S (NP (DT A) (JJ recent) (NN study)) (VP (VBZ has) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (NN concomitan) (NN administration)) (PP (IN of) (NP (NP (NN isoniazid)) (CC and) (NP (NN theophylline))))) (VP (MD may) (VP (VB cause) (NP (NP (JJ elevated) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN theophylline)))) (, ,) (PP (CC and) (PP (IN in) (NP (DT some) (NNS instances))) (NP (NP (DT a) (JJ slight) (NN decrease)) (PP (IN in) (NP (NP (DT the) (NN elimination)) (PP (IN of) (NP (NN isoniazid)))))))))))))) (. .)))))

root(ROOT-0, Therophylline-1)
det(study-5, A-3)
amod(study-5, recent-4)
nsubj(shown-7, study-5)
aux(shown-7, has-6)
dep(Therophylline-1, shown-7)
complm(cause-16, that-8)
nn(administration-10, concomitan-9)
nsubj(cause-16, administration-10)
prep_of(administration-10, isoniazid-12)
conj_and(isoniazid-12, theophylline-14)
aux(cause-16, may-15)
ccomp(shown-7, cause-16)
amod(levels-19, elevated-17)
nn(levels-19, plasma-18)
dobj(cause-16, levels-19)
prep_of(levels-19, theophylline-21)
cc(cause-16, and-23)
det(instances-26, some-25)
prep_in(cause-16, instances-26)
det(decrease-29, a-27)
amod(decrease-29, slight-28)
dep(cause-16, decrease-29)
det(elimination-32, the-31)
prep_in(decrease-29, elimination-32)
prep_of(elimination-32, isoniazid-34)

Since/IN the/DT therapeutic/JJ range/NN of/IN theophylline/NN is/VBZ narrow/JJ theophylline/NN serum/NN levels/NNS should/MD be/VB monitored/VBN closely/RB ,/, and/CC appropriate/JJ dosage/NN adjustments/NNS of/IN theophylline/NN should/MD be/VB made/VBN ./.

(ROOT (S1 (S (S (S (SBAR (IN Since) (S (NP (NP (DT the) (JJ therapeutic) (NN range)) (PP (IN of) (NP (NN theophylline)))) (VP (VBZ is) (ADJP (JJ narrow))))) (NP (NN theophylline) (NN serum) (NNS levels)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB closely)))))) (, ,) (CC and) (S (NP (NP (JJ appropriate) (NN dosage) (NNS adjustments)) (PP (IN of) (NP (NN theophylline)))) (VP (MD should) (VP (VB be) (VP (VBN made)))))) (. .))))

mark(narrow-8, Since-1)
det(range-4, the-2)
amod(range-4, therapeutic-3)
nsubj(narrow-8, range-4)
prep_of(range-4, theophylline-6)
cop(narrow-8, is-7)
advcl(monitored-14, narrow-8)
nn(levels-11, theophylline-9)
nn(levels-11, serum-10)
nsubjpass(monitored-14, levels-11)
aux(monitored-14, should-12)
auxpass(monitored-14, be-13)
root(ROOT-0, monitored-14)
advmod(monitored-14, closely-15)
amod(adjustments-20, appropriate-18)
nn(adjustments-20, dosage-19)
nsubjpass(made-25, adjustments-20)
prep_of(adjustments-20, theophylline-22)
aux(made-25, should-23)
auxpass(made-25, be-24)
conj_and(monitored-14, made-25)

Valproate/NN :/: A/DT recent/JJ case/NN study/NN has/VBZ shown/VBN a/DT possible/JJ increase/NN in/IN the/DT plasma/NN level/NN of/IN valproate/NN when/WRB co/RB administered/VBN with/IN isoniazid/NN ./.

(ROOT (S1 (S (NP (NP (NN Valproate)) (: :) (S (NP (DT A) (JJ recent) (NN case) (NN study)) (VP (VBZ has) (VP (VBN shown) (NP (NP (DT a) (JJ possible) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN plasma) (NN level)) (PP (IN of) (NP (NN valproate))))) (SBAR (WHADVP (WRB when)) (S (ADVP (RB co)) (VP (VBN administered) (PP (IN with) (NP (NN isoniazid)))))))))) (. .)))))

root(ROOT-0, Valproate-1)
det(study-6, A-3)
amod(study-6, recent-4)
nn(study-6, case-5)
nsubj(shown-8, study-6)
aux(shown-8, has-7)
dep(Valproate-1, shown-8)
det(increase-11, a-9)
amod(increase-11, possible-10)
dobj(shown-8, increase-11)
det(level-15, the-13)
nn(level-15, plasma-14)
prep_in(increase-11, level-15)
prep_of(level-15, valproate-17)
advmod(administered-20, when-18)
advmod(administered-20, co-19)
dep(increase-11, administered-20)
prep_with(administered-20, isoniazid-22)

Plasma/NN valproate/NN concentration/NN should/MD be/VB monitored/VBN when/WRB isoniazid/NN and/CC valproate/NN are/VBP co/RB administered/VBN ,/, and/CC appropriate/JJ dosage/NN adjustments/NNS of/IN valproate/NN should/MD be/VB made/VBN ./.

(ROOT (S1 (S (S (S (NP (NN Plasma) (NN valproate) (NN concentration)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN isoniazid)) (CC and) (NP (NN valproate))) (VP (VBP are) (ADVP (RB co)) (VP (VBN administered))))))))) (, ,) (CC and) (S (NP (NP (JJ appropriate) (NN dosage) (NNS adjustments)) (PP (IN of) (NP (NN valproate)))) (VP (MD should) (VP (VB be) (VP (VBN made)))))) (. .))))

nn(concentration-3, Plasma-1)
nn(concentration-3, valproate-2)
nsubjpass(monitored-6, concentration-3)
aux(monitored-6, should-4)
auxpass(monitored-6, be-5)
root(ROOT-0, monitored-6)
advmod(administered-13, when-7)
nsubjpass(administered-13, isoniazid-8)
conj_and(isoniazid-8, valproate-10)
auxpass(administered-13, are-11)
advmod(administered-13, co-12)
advcl(monitored-6, administered-13)
amod(adjustments-18, appropriate-16)
nn(adjustments-18, dosage-17)
nsubjpass(made-23, adjustments-18)
prep_of(adjustments-18, valproate-20)
aux(made-23, should-21)
auxpass(made-23, be-22)
conj_and(monitored-6, made-23)

Isoproterenol/NN hydrochloride/NN injection/NN and/CC epinephrine/NN should/MD not/RB be/VB administered/VBN simultaneously/RB because/IN both/DT drugs/NNS are/VBP direct/JJ cardiac/JJ stimulants/NNS and/CC their/PRP$ combined/JJ effects/NNS may/MD induce/VB serious/JJ arrhythmias/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Isoproterenol) (NN hydrochloride) (NN injection)) (CC and) (NP (NN epinephrine))) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (ADVP (RB simultaneously)) (SBAR (IN because) (S (S (NP (DT both) (NNS drugs)) (VP (VBP are) (NP (JJ direct) (JJ cardiac) (NNS stimulants)))) (CC and) (S (NP (PRP$ their) (JJ combined) (NNS effects)) (VP (MD may) (VP (VB induce) (NP (JJ serious) (NNS arrhythmias))))))))))) (. .))))

nn(injection-3, Isoproterenol-1)
nn(injection-3, hydrochloride-2)
nsubjpass(administered-9, injection-3)
conj_and(injection-3, epinephrine-5)
aux(administered-9, should-6)
neg(administered-9, not-7)
auxpass(administered-9, be-8)
root(ROOT-0, administered-9)
advmod(administered-9, simultaneously-10)
mark(stimulants-17, because-11)
det(drugs-13, both-12)
nsubj(stimulants-17, drugs-13)
cop(stimulants-17, are-14)
amod(stimulants-17, direct-15)
amod(stimulants-17, cardiac-16)
advcl(administered-9, stimulants-17)
poss(effects-21, their-19)
amod(effects-21, combined-20)
nsubj(induce-23, effects-21)
aux(induce-23, may-22)
conj_and(stimulants-17, induce-23)
amod(arrhythmias-25, serious-24)
dobj(induce-23, arrhythmias-25)

The/DT drugs/NNS may/MD ,/, however/RB ,/, be/VB administered/VBN alternately/RB provided/VBN a/DT proper/JJ interval/NN has/VBZ elapsed/VBN between/IN doses/NNS ./.

(ROOT (S1 (S (S (NP (DT The) (NNS drugs)) (VP (MD may) (, ,) (ADVP (RB however)) (, ,) (VP (VB be) (VP (VBN administered) (ADVP (RB alternately)) (VP (VBN provided) (S (NP (DT a) (JJ proper) (NN interval)) (VP (VBZ has) (VP (VBN elapsed) (PP (IN between) (NP (NNS doses))))))))))) (. .))))

det(drugs-2, The-1)
nsubjpass(administered-8, drugs-2)
aux(administered-8, may-3)
advmod(administered-8, however-5)
auxpass(administered-8, be-7)
root(ROOT-0, administered-8)
advmod(administered-8, alternately-9)
dep(administered-8, provided-10)
det(interval-13, a-11)
amod(interval-13, proper-12)
nsubj(elapsed-15, interval-13)
aux(elapsed-15, has-14)
ccomp(provided-10, elapsed-15)
prep_between(elapsed-15, doses-17)

ISUPREL/NN should/MD be/VB used/VBN with/IN caution/NN ,/, if/IN at/IN all/NN ,/, when/WRB potent/JJ inhalational/JJ anesthetics/NNS such/JJ as/IN halothane/NN are/VBP employed/VBN because/IN of/IN potential/NN to/TO sensitize/VB the/DT myocardium/NN to/TO effects/NNS of/IN sympathomimetic/JJ amines/NNS ./.

(ROOT (S1 (S (S (NP (NN ISUPREL)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN caution))) (, ,) (SBAR (IN if) (S (PP (IN at) (NP (NN all))) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (JJ potent) (JJ inhalational) (NNS anesthetics)) (PP (JJ such) (IN as) (NP (NN halothane)))) (VP (VBP are) (VP (VBN employed) (PP (IN because) (IN of) (NP (NN potential))) (S (VP (TO to) (VP (VB sensitize) (NP (DT the) (NN myocardium)) (PP (TO to) (NP (NP (NNS effects)) (PP (IN of) (NP (JJ sympathomimetic) (NNS amines)))))))))))))))))) (. .))))

nsubjpass(used-4, ISUPREL-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
prep_with(used-4, caution-6)
mark(employed-20, if-8)
dep(employed-20, at-9)
pobj(at-9, all-10)
advmod(employed-20, when-12)
amod(anesthetics-15, potent-13)
amod(anesthetics-15, inhalational-14)
nsubjpass(employed-20, anesthetics-15)
prep_such_as(anesthetics-15, halothane-18)
auxpass(employed-20, are-19)
advcl(used-4, employed-20)
prep_because_of(employed-20, potential-23)
aux(sensitize-25, to-24)
xcomp(employed-20, sensitize-25)
det(myocardium-27, the-26)
dobj(sensitize-25, myocardium-27)
prep_to(sensitize-25, effects-29)
amod(amines-32, sympathomimetic-31)
prep_of(effects-29, amines-32)

The/DT vasodilating/JJ effects/NNS of/IN isosorbide/NN mononitrate/NN may/MD be/VB additive/JJ with/IN those/DT of/IN other/JJ vasodilators/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ vasodilating) (NNS effects)) (PP (IN of) (NP (NN isosorbide) (NN mononitrate)))) (VP (MD may) (VP (VB be) (ADJP (JJ additive) (PP (IN with) (NP (NP (DT those)) (PP (IN of) (NP (JJ other) (NNS vasodilators))))))))) (. .))))

det(effects-3, The-1)
amod(effects-3, vasodilating-2)
nsubj(additive-9, effects-3)
nn(mononitrate-6, isosorbide-5)
prep_of(effects-3, mononitrate-6)
aux(additive-9, may-7)
cop(additive-9, be-8)
root(ROOT-0, additive-9)
prep_with(additive-9, those-11)
amod(vasodilators-14, other-13)
prep_of(those-11, vasodilators-14)

Alcohol/NN ,/, in/IN particular/JJ ,/, has/VBZ been/VBN found/VBN to/TO exhibit/VBP additive/JJ effects/NNS of/IN this/DT variety/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Alcohol)) (, ,) (PP (IN in) (NP (JJ particular))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN found) (S (VP (TO to) (VP (VBP exhibit) (NP (NP (JJ additive) (NNS effects)) (PP (IN of) (NP (DT this) (NN variety))))))))))) (. .))))

nsubjpass(found-8, Alcohol-1)
xsubj(exhibit-10, Alcohol-1)
prep_in(Alcohol-1, particular-4)
aux(found-8, has-6)
auxpass(found-8, been-7)
root(ROOT-0, found-8)
aux(exhibit-10, to-9)
xcomp(found-8, exhibit-10)
amod(effects-12, additive-11)
dobj(exhibit-10, effects-12)
det(variety-15, this-14)
prep_of(effects-12, variety-15)

Marked/JJ symptomatic/JJ orthostatic/JJ hypotension/NN has/VBZ been/VBN reported/VBN when/WRB calcium/NN channel/NN blockers/NNS and/CC organic/JJ nitrates/NNS were/VBD used/VBN in/IN combination/NN ./.

(ROOT (S1 (S (S (NP (JJ Marked) (JJ symptomatic) (JJ orthostatic) (NN hypotension)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN calcium) (NN channel) (NNS blockers)) (CC and) (NP (JJ organic) (NNS nitrates))) (VP (VBD were) (VP (VBN used) (PP (IN in) (NP (NN combination))))))))))) (. .))))

amod(hypotension-4, Marked-1)
amod(hypotension-4, symptomatic-2)
amod(hypotension-4, orthostatic-3)
nsubjpass(reported-7, hypotension-4)
aux(reported-7, has-5)
auxpass(reported-7, been-6)
root(ROOT-0, reported-7)
advmod(used-16, when-8)
nn(blockers-11, calcium-9)
nn(blockers-11, channel-10)
nsubjpass(used-16, blockers-11)
amod(nitrates-14, organic-13)
conj_and(blockers-11, nitrates-14)
auxpass(used-16, were-15)
advcl(reported-7, used-16)
prep_in(used-16, combination-18)

@/NN Vitamin/NN A/NN :/: Because/IN of/IN the/DT relationship/NN of/IN Accutane/NN to/TO vitamin/NN A/NN ,/, patients/NNS should/MD be/VB advised/VBN against/IN taking/VBG vitamin/NN supplements/NNS containing/VBG vitamin/NN A/NN to/TO avoid/VB additive/JJ toxic/JJ effects/NNS ./.

(ROOT (S1 (S (NP (NP (NN @) (NN Vitamin) (NN A)) (: :) (S (PP (IN Because) (PP (IN of) (NP (NP (DT the) (NN relationship)) (PP (IN of) (NP (NN Accutane))) (PP (TO to) (NP (NN vitamin) (NN A)))))) (, ,) (NP (NNS patients)) (VP (MD should) (VP (VB be) (VP (VBN advised) (PP (IN against) (S (VP (VBG taking) (NP (NP (NN vitamin) (NNS supplements)) (VP (VBG containing) (NP (NN vitamin) (NN A)))) (S (VP (TO to) (VP (VB avoid) (NP (JJ additive) (JJ toxic) (NNS effects)))))))))))) (. .)))))

nn(A-3, @-1)
nn(A-3, Vitamin-2)
root(ROOT-0, A-3)
prepc_because_of(advised-18, of-6)
det(relationship-8, the-7)
pobj(advised-18, relationship-8)
prep_of(relationship-8, Accutane-10)
nn(A-13, vitamin-12)
prep_to(relationship-8, A-13)
nsubjpass(advised-18, patients-15)
aux(advised-18, should-16)
auxpass(advised-18, be-17)
dep(A-3, advised-18)
prepc_against(advised-18, taking-20)
nn(supplements-22, vitamin-21)
dobj(taking-20, supplements-22)
partmod(supplements-22, containing-23)
nn(A-25, vitamin-24)
dobj(containing-23, A-25)
aux(avoid-27, to-26)
xcomp(taking-20, avoid-27)
amod(effects-30, additive-28)
amod(effects-30, toxic-29)
dobj(avoid-27, effects-30)

@/NN Tetracyclines/NNS :/: Concomitant/JJ treatment/NN with/IN Accutane/NN and/CC tetracyclines/NN should/MD be/VB avoided/VBN because/IN Accutane/NN use/NN has/VBZ been/VBN associated/VBN with/IN a/DT number/NN of/IN cases/NNS of/IN pseudotumor/JJ cerebri/NN (/-LRB- benign/JJ intracranial/JJ hypertension/NN )/-RRB- ,/, some/DT of/IN which/WDT involved/VBD concomitant/JJ use/NN of/IN tetracyclines/NNS ./.

(ROOT (S1 (S (NP (NP (NN @) (NNS Tetracyclines)) (: :) (S (NP (NP (JJ Concomitant) (NN treatment)) (PP (IN with) (NP (NP (NN Accutane)) (CC and) (NP (NN tetracyclines))))) (VP (MD should) (VP (VB be) (VP (VBN avoided) (SBAR (IN because) (S (NP (NN Accutane) (NN use)) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (NNS cases)) (PP (IN of) (NP (NP (JJ pseudotumor) (NN cerebri)) (PRN (-LRB- -LRB-) (NP (JJ benign) (JJ intracranial) (NN hypertension)) (-RRB- -RRB-)))))) (, ,) (SBAR (WHNP (NP (DT some)) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (VBD involved) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NNS tetracyclines)))))))))))))))))) (. .)))))

nn(Tetracyclines-2, @-1)
root(ROOT-0, Tetracyclines-2)
amod(treatment-5, Concomitant-4)
nsubjpass(avoided-12, treatment-5)
prep_with(treatment-5, Accutane-7)
conj_and(Accutane-7, tetracyclines-9)
aux(avoided-12, should-10)
auxpass(avoided-12, be-11)
dep(Tetracyclines-2, avoided-12)
mark(associated-18, because-13)
nn(use-15, Accutane-14)
nsubjpass(associated-18, use-15)
aux(associated-18, has-16)
auxpass(associated-18, been-17)
advcl(avoided-12, associated-18)
det(number-21, a-20)
prep_with(associated-18, number-21)
prep_of(some-33, number-21)
prep_of(number-21, cases-23)
amod(cerebri-26, pseudotumor-25)
prep_of(cases-23, cerebri-26)
amod(hypertension-30, benign-28)
amod(hypertension-30, intracranial-29)
appos(cerebri-26, hypertension-30)
nsubj(involved-36, some-33)
rcmod(number-21, involved-36)
amod(use-38, concomitant-37)
dobj(involved-36, use-38)
prep_of(use-38, tetracyclines-40)

@/NN Micro-dosed/JJ Progesterone/NN Preparation/NN s/NN :/: Micro-dosed/JJ progesterone/NN preparation/NN s/NNS (/-LRB- minipills/NNS that/WDT do/VBP not/RB contain/VB an/DT estrogen/NN )/-RRB- may/MD be/VB an/DT inadequate/JJ method/NN of/IN contraception/NN during/IN Accutane/NN therapy/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (JJ Micro-dosed) (NN Progesterone) (NN Preparation) (NN s)) (: :) (S (NP (NP (JJ Micro-dosed) (NN progesterone) (NN preparation) (NNS s)) (PRN (-LRB- -LRB-) (NP (NP (NNS minipills)) (SBAR (WHNP (WDT that)) (S (VP (VBP do) (RB not) (VP (VB contain) (NP (DT an) (NN estrogen))))))) (-RRB- -RRB-))) (VP (MD may) (VP (VB be) (NP (NP (DT an) (JJ inadequate) (NN method)) (PP (IN of) (NP (NN contraception)))) (PP (IN during) (NP (NN Accutane) (NN therapy)))))) (. .)))))

nn(s-5, @-1)
amod(s-5, Micro-dosed-2)
nn(s-5, Progesterone-3)
nn(s-5, Preparation-4)
root(ROOT-0, s-5)
amod(s-10, Micro-dosed-7)
nn(s-10, progesterone-8)
nn(s-10, preparation-9)
nsubj(method-24, s-10)
dep(s-10, minipills-12)
nsubj(contain-16, minipills-12)
aux(contain-16, do-14)
neg(contain-16, not-15)
rcmod(minipills-12, contain-16)
det(estrogen-18, an-17)
dobj(contain-16, estrogen-18)
aux(method-24, may-20)
cop(method-24, be-21)
det(method-24, an-22)
amod(method-24, inadequate-23)
dep(s-5, method-24)
prep_of(method-24, contraception-26)
nn(therapy-29, Accutane-28)
prep_during(method-24, therapy-29)

Although/IN other/JJ hormonal/JJ contraceptives/NNS are/VBP highly/RB effective/JJ ,/, there/EX have/VBP been/VBN reports/NNS of/IN pregnancy/NN from/IN women/NNS who/WP have/VBP used/VBN combined/JJ oral/JJ contraceptives/NNS ,/, as/RB well/RB as/IN topical/injectable/implantable/insertable/JJ hormonal/JJ birth/NN control/NN products/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (JJ other) (JJ hormonal) (NNS contraceptives)) (VP (VBP are) (ADJP (RB highly) (JJ effective))))) (, ,) (NP (EX there)) (VP (VBP have) (VP (VBN been) (NP (NP (NNS reports)) (PP (IN of) (NP (NN pregnancy))) (PP (IN from) (NP (NP (NNS women)) (SBAR (WHNP (WP who)) (S (VP (VBP have) (VP (VBN used) (NP (NP (JJ combined) (JJ oral) (NNS contraceptives)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (JJ topical/injectable/implantable/insertable) (JJ hormonal) (NN birth) (NN control) (NNS products))))))))))))) (. .))))

mark(effective-7, Although-1)
amod(contraceptives-4, other-2)
amod(contraceptives-4, hormonal-3)
nsubj(effective-7, contraceptives-4)
cop(effective-7, are-5)
advmod(effective-7, highly-6)
advcl(reports-12, effective-7)
expl(reports-12, there-9)
aux(reports-12, have-10)
cop(reports-12, been-11)
root(ROOT-0, reports-12)
prep_of(reports-12, pregnancy-14)
prep_from(reports-12, women-16)
nsubj(used-19, women-16)
aux(used-19, have-18)
rcmod(women-16, used-19)
amod(contraceptives-22, combined-20)
amod(contraceptives-22, oral-21)
dobj(used-19, contraceptives-22)
amod(products-31, topical/injectable/implantable/insertable-27)
amod(products-31, hormonal-28)
nn(products-31, birth-29)
nn(products-31, control-30)
conj_and(contraceptives-22, products-31)

It/PRP is/VBZ not/RB known/VBN if/IN hormonal/JJ contraceptives/NNS differ/VBP in/IN their/PRP$ effectiveness/NN when/WRB used/VBN with/IN Accutane/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (IN if) (S (NP (JJ hormonal) (NNS contraceptives)) (VP (VBP differ) (PP (IN in) (NP (PRP$ their) (NN effectiveness))) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (PP (IN with) (NP (NN Accutane)))))))))))) (. .))))

nsubjpass(known-4, It-1)
auxpass(known-4, is-2)
neg(known-4, not-3)
root(ROOT-0, known-4)
mark(differ-8, if-5)
amod(contraceptives-7, hormonal-6)
nsubj(differ-8, contraceptives-7)
advcl(known-4, differ-8)
poss(effectiveness-11, their-10)
prep_in(differ-8, effectiveness-11)
advmod(used-13, when-12)
advcl(differ-8, used-13)
prep_with(used-13, Accutane-15)

Therefore/RB ,/, it/PRP is/VBZ critically/RB important/JJ for/IN women/NNS of/IN childbearing/JJ potential/NN to/TO select/VB and/CC commit/VB to/TO use/VB 2/CD forms/NNS of/IN effective/JJ contraception/NN simultaneously/RB ,/, at/IN least/JJS 1/CD of/IN which/WDT must/MD be/VB a/DT primary/JJ form/NN ,/, unless/IN absolute/JJ abstinence/NN is/VBZ the/DT chosen/VBN method/NN ,/, or/CC the/DT patient/NN has/VBZ undergone/VBN a/DT hysterectomy/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (RB critically) (JJ important) (PP (IN for) (NP (NP (NNS women)) (PP (IN of) (NP (JJ childbearing) (NN potential)))))) (S (VP (TO to) (VP (VP (VB select)) (CC and) (VP (VB commit) (S (VP (TO to) (VP (VB use) (NP (NP (CD 2) (NNS forms)) (PP (IN of) (NP (NP (JJ effective) (NN contraception)) (ADVP (RB simultaneously)))) (, ,) (SBAR (WHNP (NP (ADVP (IN at) (JJS least)) (NP (CD 1))) (WHPP (IN of) (WHNP (WDT which)))) (S (VP (MD must) (VP (VB be) (NP (DT a) (JJ primary) (NN form)) (, ,) (SBAR (IN unless) (S (S (NP (JJ absolute) (NN abstinence)) (VP (VBZ is) (NP (DT the) (VBN chosen) (NN method)))) (, ,) (CC or) (S (NP (DT the) (NN patient)) (VP (VBZ has) (VP (VBN undergone) (NP (DT a) (NN hysterectomy))))))))))))))))))))) (. .))))

advmod(important-6, Therefore-1)
nsubj(important-6, it-3)
xsubj(select-13, it-3)
cop(important-6, is-4)
advmod(important-6, critically-5)
root(ROOT-0, important-6)
prep_for(important-6, women-8)
amod(potential-11, childbearing-10)
prep_of(women-8, potential-11)
aux(select-13, to-12)
xcomp(important-6, select-13)
conj_and(select-13, commit-15)
aux(use-17, to-16)
xcomp(commit-15, use-17)
num(forms-19, 2-18)
dobj(use-17, forms-19)
prep_of(1-27, forms-19)
amod(contraception-22, effective-21)
prep_of(forms-19, contraception-22)
advmod(contraception-22, simultaneously-23)
advmod(1-27, at-25)
pobj(at-25, least-26)
nsubj(form-34, 1-27)
aux(form-34, must-30)
cop(form-34, be-31)
det(form-34, a-32)
amod(form-34, primary-33)
rcmod(forms-19, form-34)
mark(method-42, unless-36)
amod(abstinence-38, absolute-37)
nsubj(method-42, abstinence-38)
dep(method-42, is-39)
det(method-42, the-40)
amod(method-42, chosen-41)
advcl(form-34, method-42)
det(patient-46, the-45)
nsubj(undergone-48, patient-46)
aux(undergone-48, has-47)
conj_or(method-42, undergone-48)
det(hysterectomy-50, a-49)
dobj(undergone-48, hysterectomy-50)

@/NN Phenytoin/NN :/: Accutane/NN has/VBZ not/RB been/VBN shown/VBN to/TO alter/VB the/DT pharmacokinetics/NNS of/IN phenytoin/NN in/IN a/DT study/NN in/IN seven/CD healthy/JJ volunteers/NNS ./.

(ROOT (S1 (S (NP (NP (NN @) (NN Phenytoin)) (: :) (S (NP (NN Accutane)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB alter) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN phenytoin))) (PP (IN in) (NP (NP (DT a) (NN study)) (PP (IN in) (NP (CD seven) (JJ healthy) (NNS volunteers))))))))))))) (. .)))))

nn(Phenytoin-2, @-1)
root(ROOT-0, Phenytoin-2)
nsubjpass(shown-8, Accutane-4)
xsubj(alter-10, Accutane-4)
aux(shown-8, has-5)
neg(shown-8, not-6)
auxpass(shown-8, been-7)
dep(Phenytoin-2, shown-8)
aux(alter-10, to-9)
xcomp(shown-8, alter-10)
det(pharmacokinetics-12, the-11)
dobj(alter-10, pharmacokinetics-12)
prep_of(pharmacokinetics-12, phenytoin-14)
det(study-17, a-16)
prep_in(pharmacokinetics-12, study-17)
num(volunteers-21, seven-19)
amod(volunteers-21, healthy-20)
prep_in(study-17, volunteers-21)

These/DT results/NNS are/VBP consistent/JJ with/IN the/DT in/FW vitro/FW finding/NN that/IN neither/CC isotretinoin/NN nor/CC its/PRP$ metabolites/NNS induce/VBP or/CC inhibit/VBP the/DT activity/NN of/IN the/DT CYP/NN 2C9/NN human/JJ hepatic/JJ P450/NN enzyme/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS results)) (VP (VBP are) (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (ADJP (FW in) (FW vitro)) (NN finding)) (SBAR (IN that) (S (NP (CC neither) (NP (NN isotretinoin)) (CC nor) (NP (PRP$ its) (NNS metabolites))) (VP (VP (VBP induce)) (CC or) (VP (VBP inhibit) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT the) (NN CYP) (NN 2C9) (JJ human) (JJ hepatic) (NN P450) (NN enzyme))))))))))))) (. .))))

det(results-2, These-1)
nsubj(consistent-4, results-2)
cop(consistent-4, are-3)
root(ROOT-0, consistent-4)
det(finding-9, the-6)
nn(vitro-8, in-7)
amod(finding-9, vitro-8)
prep_with(consistent-4, finding-9)
complm(induce-16, that-10)
preconj(isotretinoin-12, neither-11)
nsubj(induce-16, isotretinoin-12)
poss(metabolites-15, its-14)
conj_nor(isotretinoin-12, metabolites-15)
dep(finding-9, induce-16)
conj_or(induce-16, inhibit-18)
det(activity-20, the-19)
dobj(inhibit-18, activity-20)
det(enzyme-28, the-22)
nn(enzyme-28, CYP-23)
nn(enzyme-28, 2C9-24)
amod(enzyme-28, human-25)
amod(enzyme-28, hepatic-26)
nn(enzyme-28, P450-27)
prep_of(activity-20, enzyme-28)

Phenytoin/NN is/VBZ known/VBN to/TO cause/VB osteomalacia/NN ./.

(ROOT (S1 (S (S (NP (NN Phenytoin)) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB cause) (NP (NN osteomalacia)))))))) (. .))))

nsubjpass(known-3, Phenytoin-1)
xsubj(cause-5, Phenytoin-1)
auxpass(known-3, is-2)
root(ROOT-0, known-3)
aux(cause-5, to-4)
xcomp(known-3, cause-5)
dobj(cause-5, osteomalacia-6)

No/DT formal/JJ clinical/JJ studies/NNS have/VBP been/VBN conducted/VBN to/TO assess/VB if/IN there/EX is/VBZ an/DT interactive/JJ effect/NN on/IN bone/NN loss/NN between/IN phenytoin/NN and/CC Accutane/NN ./.

(ROOT (S1 (S (S (NP (DT No) (JJ formal) (JJ clinical) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN conducted) (S (VP (TO to) (VP (VB assess) (SBAR (IN if) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT an) (JJ interactive) (NN effect)) (PP (IN on) (NP (NN bone) (NN loss))) (PP (IN between) (NP (NP (NN phenytoin)) (CC and) (NP (NN Accutane))))))))))))))) (. .))))

det(studies-4, No-1)
amod(studies-4, formal-2)
amod(studies-4, clinical-3)
nsubjpass(conducted-7, studies-4)
xsubj(assess-9, studies-4)
aux(conducted-7, have-5)
auxpass(conducted-7, been-6)
root(ROOT-0, conducted-7)
aux(assess-9, to-8)
xcomp(conducted-7, assess-9)
mark(is-12, if-10)
expl(is-12, there-11)
advcl(assess-9, is-12)
det(effect-15, an-13)
amod(effect-15, interactive-14)
nsubj(is-12, effect-15)
nn(loss-18, bone-17)
prep_on(effect-15, loss-18)
prep_between(effect-15, phenytoin-20)
conj_and(phenytoin-20, Accutane-22)

Therefore/RB ,/, caution/NN should/MD be/VB exercised/VBN when/WRB using/VBG these/DT drugs/NNS together/RB ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (VP (VBG using) (NP (DT these) (NNS drugs)) (ADVP (RB together))))))))) (. .))))

advmod(exercised-6, Therefore-1)
nsubjpass(exercised-6, caution-3)
aux(exercised-6, should-4)
auxpass(exercised-6, be-5)
root(ROOT-0, exercised-6)
advmod(using-8, when-7)
advcl(exercised-6, using-8)
det(drugs-10, these-9)
dobj(using-8, drugs-10)
advmod(using-8, together-11)

@/NN Systemic/JJ Corticosteroids/NNS :/: Systemic/JJ corticosteroids/NNS are/VBP known/VBN to/TO cause/VB osteoporosis/NN ./.

(ROOT (S1 (S (S (NP (NN @) (JJ Systemic) (NNS Corticosteroids)) (: :) (NP (JJ Systemic) (NNS corticosteroids)) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB cause) (NP (NN osteoporosis)))))))) (. .))))

nn(Corticosteroids-3, @-1)
amod(Corticosteroids-3, Systemic-2)
nsubjpass(known-8, Corticosteroids-3)
xsubj(cause-10, Corticosteroids-3)
amod(corticosteroids-6, Systemic-5)
nsubjpass(known-8, corticosteroids-6)
xsubj(cause-10, corticosteroids-6)
auxpass(known-8, are-7)
root(ROOT-0, known-8)
aux(cause-10, to-9)
xcomp(known-8, cause-10)
dobj(cause-10, osteoporosis-11)

No/DT formal/JJ clinical/JJ studies/NNS have/VBP been/VBN conducted/VBN to/TO assess/VB if/IN there/EX is/VBZ an/DT interactive/JJ effect/NN on/IN bone/NN loss/NN between/IN systemic/JJ corticosteroids/NNS and/CC Accutane/NN ./.

(ROOT (S1 (S (S (NP (DT No) (JJ formal) (JJ clinical) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN conducted) (S (VP (TO to) (VP (VB assess) (SBAR (IN if) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT an) (JJ interactive) (NN effect)) (PP (IN on) (NP (NN bone) (NN loss))) (PP (IN between) (NP (NP (JJ systemic) (NNS corticosteroids)) (CC and) (NP (NN Accutane))))))))))))))) (. .))))

det(studies-4, No-1)
amod(studies-4, formal-2)
amod(studies-4, clinical-3)
nsubjpass(conducted-7, studies-4)
xsubj(assess-9, studies-4)
aux(conducted-7, have-5)
auxpass(conducted-7, been-6)
root(ROOT-0, conducted-7)
aux(assess-9, to-8)
xcomp(conducted-7, assess-9)
mark(is-12, if-10)
expl(is-12, there-11)
advcl(assess-9, is-12)
det(effect-15, an-13)
amod(effect-15, interactive-14)
nsubj(is-12, effect-15)
nn(loss-18, bone-17)
prep_on(effect-15, loss-18)
amod(corticosteroids-21, systemic-20)
prep_between(effect-15, corticosteroids-21)
conj_and(corticosteroids-21, Accutane-23)

Therefore/RB ,/, caution/NN should/MD be/VB exercised/VBN when/WRB using/VBG these/DT drugs/NNS together/RB ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (VP (VBG using) (NP (DT these) (NNS drugs)) (ADVP (RB together))))))))) (. .))))

advmod(exercised-6, Therefore-1)
nsubjpass(exercised-6, caution-3)
aux(exercised-6, should-4)
auxpass(exercised-6, be-5)
root(ROOT-0, exercised-6)
advmod(using-8, when-7)
advcl(exercised-6, using-8)
det(drugs-10, these-9)
dobj(using-8, drugs-10)
advmod(using-8, together-11)

Prescribers/NNS are/VBP advised/VBN to/TO consult/VB the/DT package/JJ insert/NN of/IN medication/NN administered/VBN concomitantly/RB with/IN hormonal/JJ contraceptives/NNS ,/, since/IN some/DT medications/NNS may/MD decrease/VB the/DT effectiveness/NN of/IN these/DT birth/NN control/NN products/NNS ./.

(ROOT (S1 (S (S (NP (NNS Prescribers)) (VP (VBP are) (VP (VBN advised) (S (VP (TO to) (VP (VB consult) (NP (NP (DT the) (JJ package) (NN insert)) (PP (IN of) (NP (NP (NN medication)) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (JJ hormonal) (NNS contraceptives)))))))))) (, ,) (SBAR (IN since) (S (NP (DT some) (NNS medications)) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NN effectiveness)) (PP (IN of) (NP (DT these) (NN birth) (NN control) (NNS products))))))))))) (. .))))

nsubjpass(advised-3, Prescribers-1)
xsubj(consult-5, Prescribers-1)
auxpass(advised-3, are-2)
root(ROOT-0, advised-3)
aux(consult-5, to-4)
xcomp(advised-3, consult-5)
det(insert-8, the-6)
amod(insert-8, package-7)
dobj(consult-5, insert-8)
prep_of(insert-8, medication-10)
partmod(medication-10, administered-11)
advmod(administered-11, concomitantly-12)
amod(contraceptives-15, hormonal-14)
prep_with(administered-11, contraceptives-15)
mark(decrease-21, since-17)
det(medications-19, some-18)
nsubj(decrease-21, medications-19)
aux(decrease-21, may-20)
advcl(advised-3, decrease-21)
det(effectiveness-23, the-22)
dobj(decrease-21, effectiveness-23)
det(products-28, these-25)
nn(products-28, birth-26)
nn(products-28, control-27)
prep_of(effectiveness-23, products-28)

Accutane/JJ use/NN is/VBZ associated/VBN with/IN depression/NN in/IN some/DT patients/NNS ./.

(ROOT (S1 (S (S (NP (JJ Accutane) (NN use)) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (NN depression)) (PP (IN in) (NP (DT some) (NNS patients)))))))) (. .))))

amod(use-2, Accutane-1)
nsubjpass(associated-4, use-2)
auxpass(associated-4, is-3)
root(ROOT-0, associated-4)
prep_with(associated-4, depression-6)
det(patients-9, some-8)
prep_in(depression-6, patients-9)

Patients/NNS should/MD be/VB prospectively/RB cautioned/VBN not/RB to/TO self-medicate/VB with/IN the/DT herbal/JJ supplement/JJ St./NN John/NN @/NN s/NN Wort/NN because/IN a/DT possible/JJ interaction/NN has/VBZ been/VBN suggested/VBN with/IN hormonal/JJ contraceptives/NNS based/VBN on/IN reports/NNS of/IN breakthrough/JJ bleeding/JJ on/IN oral/JJ contraceptives/NNS shortly/RB after/IN starting/VBG St./NN Johns/NNP Wort/NNP ./.

(ROOT (S1 (S (S (NP (NNS Patients)) (VP (MD should) (VP (VB be) (ADVP (RB prospectively)) (VP (VBN cautioned) (S (VP (RB not) (TO to) (VP (VB self-medicate) (PP (IN with) (NP (DT the) (JJ herbal) (JJ supplement) (NN St.) (NN John) (NN @) (NN s) (NN Wort))) (SBAR (IN because) (S (NP (DT a) (JJ possible) (NN interaction)) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (PP (IN with) (NP (NP (JJ hormonal) (NNS contraceptives)) (VP (VBN based) (PP (IN on) (NP (NP (NNS reports)) (PP (IN of) (NP (JJ breakthrough) (JJ bleeding))))) (PP (IN on) (NP (NP (JJ oral) (NNS contraceptives)) (PP (ADVP (RB shortly)) (IN after) (S (VP (VBG starting) (NP (NN St.) (NP (NNP Johns) (NNP Wort))))))))))))))))))))))) (. .))))

nsubjpass(cautioned-5, Patients-1)
aux(cautioned-5, should-2)
auxpass(cautioned-5, be-3)
advmod(cautioned-5, prospectively-4)
root(ROOT-0, cautioned-5)
neg(self-medicate-8, not-6)
aux(self-medicate-8, to-7)
ccomp(cautioned-5, self-medicate-8)
xcomp(cautioned-5, self-medicate-8)
det(Wort-17, the-10)
amod(Wort-17, herbal-11)
amod(Wort-17, supplement-12)
nn(Wort-17, St.-13)
nn(Wort-17, John-14)
nn(Wort-17, @-15)
nn(Wort-17, s-16)
prep_with(self-medicate-8, Wort-17)
mark(suggested-24, because-18)
det(interaction-21, a-19)
amod(interaction-21, possible-20)
nsubjpass(suggested-24, interaction-21)
aux(suggested-24, has-22)
auxpass(suggested-24, been-23)
advcl(self-medicate-8, suggested-24)
amod(contraceptives-27, hormonal-26)
prep_with(suggested-24, contraceptives-27)
partmod(contraceptives-27, based-28)
prep_on(based-28, reports-30)
amod(bleeding-33, breakthrough-32)
prep_of(reports-30, bleeding-33)
amod(contraceptives-36, oral-35)
prep_on(based-28, contraceptives-36)
advmod(contraceptives-36, shortly-37)
prepc_after(contraceptives-36, starting-39)
dobj(starting-39, St.-40)
nn(Wort-42, Johns-41)
dep(St.-40, Wort-42)

Pregnancies/NNS have/VBP been/VBN reported/VBN by/IN users/NNS of/IN combined/JJ hormonal/JJ contraceptives/NNS who/WP also/RB used/VBD some/DT form/NN of/IN St./NN Johns/NNP Wort/NNP ./.

(ROOT (S1 (S (S (NP (NNS Pregnancies)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN by) (NP (NP (NNS users)) (PP (IN of) (NP (NP (JJ combined) (JJ hormonal) (NNS contraceptives)) (SBAR (WHNP (WP who)) (S (ADVP (RB also)) (VP (VBD used) (NP (NP (DT some) (NN form)) (PP (IN of) (NP (NN St.) (NNP Johns) (NNP Wort))))))))))))))) (. .))))

nsubjpass(reported-4, Pregnancies-1)
aux(reported-4, have-2)
auxpass(reported-4, been-3)
root(ROOT-0, reported-4)
agent(reported-4, users-6)
amod(contraceptives-10, combined-8)
amod(contraceptives-10, hormonal-9)
prep_of(users-6, contraceptives-10)
nsubj(used-13, contraceptives-10)
advmod(used-13, also-12)
rcmod(contraceptives-10, used-13)
det(form-15, some-14)
dobj(used-13, form-15)
nn(Wort-19, St.-17)
nn(Wort-19, Johns-18)
prep_of(form-15, Wort-19)

Laboratory/NN Tests/NNS Pregnancy/NN Test/NN Female/JJ patients/NNS of/IN childbearing/JJ potential/NN must/MD have/VB negative/JJ results/NNS from/IN 2/CD urine/NN or/CC serum/NN pregnancy/NN tests/NNS with/IN a/DT sensitivity/NN of/IN at/IN least/JJS 25/CD mIU/mL/NN before/IN receiving/VBG the/DT initial/JJ Accutane/NN prescription/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (NN Laboratory) (NNS Tests)) (NN Pregnancy) (NN Test)) (NP (JJ Female) (NNS patients))) (PP (IN of) (NP (JJ childbearing) (NN potential)))) (VP (MD must) (VP (VB have) (NP (NP (JJ negative) (NNS results)) (PP (IN from) (NP (NP (CD 2) (NN urine)) (CC or) (NP (NN serum) (NN pregnancy) (NNS tests)))) (PP (IN with) (NP (NP (DT a) (NN sensitivity)) (PP (IN of) (NP (QP (IN at) (JJS least) (CD 25)) (NN mIU/mL)))))) (PP (IN before) (S (VP (VBG receiving) (NP (DT the) (JJ initial) (NN Accutane) (NN prescription)))))))) (. .))))

nn(Tests-2, Laboratory-1)
nn(Test-4, Tests-2)
nn(Test-4, Pregnancy-3)
nsubj(have-11, Test-4)
amod(patients-6, Female-5)
dep(Test-4, patients-6)
amod(potential-9, childbearing-8)
prep_of(Test-4, potential-9)
aux(have-11, must-10)
root(ROOT-0, have-11)
amod(results-13, negative-12)
dobj(have-11, results-13)
num(urine-16, 2-15)
prep_from(results-13, urine-16)
nn(tests-20, serum-18)
nn(tests-20, pregnancy-19)
conj_or(urine-16, tests-20)
det(sensitivity-23, a-22)
prep_with(results-13, sensitivity-23)
quantmod(25-27, at-25)
mwe(at-25, least-26)
pobj(at-25, least-26)
num(mIU/mL-28, 25-27)
prep_of(sensitivity-23, mIU/mL-28)
prepc_before(have-11, receiving-30)
det(prescription-34, the-31)
amod(prescription-34, initial-32)
nn(prescription-34, Accutane-33)
dobj(receiving-30, prescription-34)

The/DT first/JJ test/NN is/VBZ obtained/VBN by/IN the/DT prescriber/NN when/WRB the/DT decision/NN is/VBZ made/VBN to/TO pursue/VBP qualification/NN of/IN the/DT patient/NN for/IN Accutane/NN (/-LRB- a/DT screening/NN test/NN )./NN

(ROOT (S1 (S (NP (DT The) (JJ first) (NN test)) (VP (VBZ is) (VP (VBN obtained) (PP (IN by) (NP (DT the) (NN prescriber))) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN decision)) (VP (VBZ is) (VP (VBN made) (S (VP (TO to) (VP (VP (VBP pursue) (NP (NP (NN qualification)) (PP (IN of) (NP (DT the) (NN patient))) (PP (IN for) (NP (NN Accutane))))) (-LRB- -LRB-) (NP (DT a) (NN screening) (NN test) (NN -RRB-.))))))))))))))

det(test-3, The-1)
amod(test-3, first-2)
nsubjpass(obtained-5, test-3)
auxpass(obtained-5, is-4)
root(ROOT-0, obtained-5)
det(prescriber-8, the-7)
agent(obtained-5, prescriber-8)
advmod(made-13, when-9)
det(decision-11, the-10)
nsubjpass(made-13, decision-11)
xsubj(pursue-15, decision-11)
auxpass(made-13, is-12)
advcl(obtained-5, made-13)
aux(pursue-15, to-14)
xcomp(made-13, pursue-15)
dobj(pursue-15, qualification-16)
det(patient-19, the-18)
prep_of(qualification-16, patient-19)
prep_for(qualification-16, Accutane-21)
det(-RRB-.-26, a-23)
nn(-RRB-.-26, screening-24)
nn(-RRB-.-26, test-25)
dobj(pursue-15, -RRB-.-26)

The/DT second/JJ pregnancy/NN test/NN (/-LRB- a/DT confirmation/NN test/NN )/-RRB- should/MD be/VB done/VBN during/IN the/DT first/JJ 5/CD days/NNS of/IN the/DT menstrual/JJ period/NN immediately/RB preceding/VBG the/DT beginning/NN of/IN Accutane/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ second) (NN pregnancy) (NN test)) (PRN (-LRB- -LRB-) (NP (DT a) (NN confirmation) (NN test)) (-RRB- -RRB-))) (VP (MD should) (VP (VB be) (VP (VBN done) (PP (IN during) (NP (NP (DT the) (JJ first) (CD 5) (NNS days)) (PP (IN of) (NP (NP (DT the) (JJ menstrual) (NN period)) (VP (ADVP (RB immediately)) (VBG preceding) (NP (NP (DT the) (NN beginning)) (PP (IN of) (NP (NN Accutane) (NN therapy))))))))))))) (. .))))

det(test-4, The-1)
amod(test-4, second-2)
nn(test-4, pregnancy-3)
nsubjpass(done-12, test-4)
det(test-8, a-6)
nn(test-8, confirmation-7)
appos(test-4, test-8)
aux(done-12, should-10)
auxpass(done-12, be-11)
root(ROOT-0, done-12)
det(days-17, the-14)
amod(days-17, first-15)
num(days-17, 5-16)
prep_during(done-12, days-17)
det(period-21, the-19)
amod(period-21, menstrual-20)
prep_of(days-17, period-21)
advmod(preceding-23, immediately-22)
partmod(period-21, preceding-23)
det(beginning-25, the-24)
dobj(preceding-23, beginning-25)
nn(therapy-28, Accutane-27)
prep_of(beginning-25, therapy-28)

After/IN consumption/NN of/IN alcohol/NN ,/, at/IN least/JJS 36/CD hours/NNS should/MD elapse/VB before/IN these/DT determinations/NNS are/VBP made/VBN ./.

(ROOT (S1 (S (S (PP (IN After) (NP (NP (NN consumption)) (PP (IN of) (NP (NN alcohol))))) (, ,) (NP (QP (IN at) (JJS least) (CD 36)) (NNS hours)) (VP (MD should) (VP (VB elapse) (SBAR (IN before) (S (NP (DT these) (NNS determinations)) (VP (VBP are) (VP (VBN made)))))))) (. .))))

prep_after(elapse-11, consumption-2)
prep_of(consumption-2, alcohol-4)
quantmod(36-8, at-6)
mwe(at-6, least-7)
pobj(at-6, least-7)
num(hours-9, 36-8)
nsubj(elapse-11, hours-9)
aux(elapse-11, should-10)
root(ROOT-0, elapse-11)
mark(made-16, before-12)
det(determinations-14, these-13)
nsubjpass(made-16, determinations-14)
auxpass(made-16, are-15)
advcl(elapse-11, made-16)

It/PRP is/VBZ recommended/VBN that/IN these/DT tests/NNS be/VB performed/VBN at/IN weekly/JJ or/CC biweekly/JJ intervals/NNS until/IN the/DT lipid/NN response/NN to/TO Accutane/NN is/VBZ established/VBN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (DT these) (NNS tests)) (VP (VB be) (VP (VBN performed) (PP (IN at) (NP (JJ weekly) (CC or) (JJ biweekly) (NNS intervals))) (SBAR (IN until) (S (NP (NP (DT the) (NN lipid) (NN response)) (PP (TO to) (NP (NN Accutane)))) (VP (VBZ is) (VP (VBN established)))))))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(performed-8, that-4)
det(tests-6, these-5)
nsubjpass(performed-8, tests-6)
auxpass(performed-8, be-7)
ccomp(recommended-3, performed-8)
amod(intervals-13, weekly-10)
conj_or(weekly-10, biweekly-12)
prep_at(performed-8, intervals-13)
mark(established-21, until-14)
det(response-17, the-15)
nn(response-17, lipid-16)
nsubjpass(established-21, response-17)
prep_to(response-17, Accutane-19)
auxpass(established-21, is-20)
advcl(performed-8, established-21)

The/DT incidence/NN of/IN hypertriglyceridemia/NNS is/VBZ 1/CD patient/NN in/IN 4/CD on/IN Accutane/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN incidence)) (PP (IN of) (NP (NNS hypertriglyceridemia)))) (VP (VBZ is) (NP (NP (CD 1) (NN patient)) (PP (IN in) (NP (CD 4))) (PP (IN on) (NP (NN Accutane) (NN therapy)))))) (. .))))

det(incidence-2, The-1)
nsubj(patient-7, incidence-2)
prep_of(incidence-2, hypertriglyceridemia-4)
cop(patient-7, is-5)
num(patient-7, 1-6)
root(ROOT-0, patient-7)
prep_in(patient-7, 4-9)
nn(therapy-12, Accutane-11)
prep_on(patient-7, therapy-12)

@/NN Liver/NN Function/NN Tests/NNS :/: Since/IN elevations/NNS of/IN liver/NN enzymes/NNS have/VBP been/VBN observed/VBN during/IN clinical/JJ trials/NNS ,/, and/CC hepatitis/NN has/VBZ been/VBN reported/VBN ,/, pretreatment/NN and/CC follow-up/JJ liver/NN function/NN tests/NNS should/MD be/VB performed/VBN at/IN weekly/JJ or/CC biweekly/JJ intervals/NNS until/IN the/DT response/NN to/TO Accutane/NN has/VBZ been/VBN established/VBN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN Liver) (NN Function) (NNS Tests)) (: :) (S (SBAR (IN Since) (S (S (NP (NP (NNS elevations)) (PP (IN of) (NP (NN liver) (NNS enzymes)))) (VP (VBP have) (VP (VBN been) (VP (VBN observed) (PP (IN during) (NP (JJ clinical) (NNS trials))))))) (, ,) (CC and) (S (NP (NN hepatitis)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported))))))) (, ,) (NP (NP (NN pretreatment)) (CC and) (NP (JJ follow-up) (NN liver) (NN function) (NNS tests))) (VP (MD should) (VP (VB be) (VP (VBN performed) (PP (IN at) (NP (ADJP (ADJP (JJ weekly)) (CC or) (ADJP (JJ biweekly))) (NNS intervals))) (SBAR (IN until) (S (NP (NP (DT the) (NN response)) (PP (TO to) (NP (NN Accutane)))) (VP (VBZ has) (VP (VBN been) (VP (VBN established)))))))))) (. .)))))

nn(Tests-4, @-1)
nn(Tests-4, Liver-2)
nn(Tests-4, Function-3)
root(ROOT-0, Tests-4)
mark(observed-13, Since-6)
nsubjpass(observed-13, elevations-7)
nn(enzymes-10, liver-9)
prep_of(elevations-7, enzymes-10)
aux(observed-13, have-11)
auxpass(observed-13, been-12)
advcl(performed-32, observed-13)
amod(trials-16, clinical-15)
prep_during(observed-13, trials-16)
nsubjpass(reported-22, hepatitis-19)
aux(reported-22, has-20)
auxpass(reported-22, been-21)
conj_and(observed-13, reported-22)
nsubjpass(performed-32, pretreatment-24)
amod(tests-29, follow-up-26)
nn(tests-29, liver-27)
nn(tests-29, function-28)
conj_and(pretreatment-24, tests-29)
aux(performed-32, should-30)
auxpass(performed-32, be-31)
dep(Tests-4, performed-32)
amod(intervals-37, weekly-34)
conj_or(weekly-34, biweekly-36)
prep_at(performed-32, intervals-37)
mark(established-45, until-38)
det(response-40, the-39)
nsubjpass(established-45, response-40)
prep_to(response-40, Accutane-42)
aux(established-45, has-43)
auxpass(established-45, been-44)
advcl(performed-32, established-45)

@/NN Glucose/NN :/: Some/DT patients/NNS receiving/VBG Accutane/NN have/VBP experienced/VBN problems/NNS in/IN the/DT control/NN of/IN their/PRP$ blood/NN sugar/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN Glucose)) (: :) (S (NP (NP (DT Some) (NNS patients)) (VP (VBG receiving) (NP (NN Accutane)))) (VP (VBP have) (VP (VBN experienced) (NP (NNS problems)) (PP (IN in) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (PRP$ their) (NN blood) (NN sugar)))))))) (. .)))))

nn(Glucose-2, @-1)
root(ROOT-0, Glucose-2)
det(patients-5, Some-4)
nsubj(experienced-9, patients-5)
partmod(patients-5, receiving-6)
dobj(receiving-6, Accutane-7)
aux(experienced-9, have-8)
dep(Glucose-2, experienced-9)
dobj(experienced-9, problems-10)
det(control-13, the-12)
prep_in(experienced-9, control-13)
poss(sugar-17, their-15)
nn(sugar-17, blood-16)
prep_of(control-13, sugar-17)

In/IN addition/NN ,/, new/JJ cases/NNS of/IN diabetes/NNS have/VBP been/VBN diagnosed/VBN during/IN Accutane/NN therapy/NN ,/, although/IN no/DT causal/JJ relationship/NN has/VBZ been/VBN established/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (JJ new) (NNS cases)) (PP (IN of) (NP (NNS diabetes)))) (VP (VBP have) (VP (VBN been) (VP (VBN diagnosed) (PP (IN during) (NP (NN Accutane) (NN therapy))) (, ,) (SBAR (IN although) (S (NP (DT no) (JJ causal) (NN relationship)) (VP (VBZ has) (VP (VBN been) (VP (VBN established)))))))))) (. .))))

prep_in(diagnosed-10, addition-2)
amod(cases-5, new-4)
nsubjpass(diagnosed-10, cases-5)
prep_of(cases-5, diabetes-7)
aux(diagnosed-10, have-8)
auxpass(diagnosed-10, been-9)
root(ROOT-0, diagnosed-10)
nn(therapy-13, Accutane-12)
prep_during(diagnosed-10, therapy-13)
mark(established-21, although-15)
det(relationship-18, no-16)
amod(relationship-18, causal-17)
nsubjpass(established-21, relationship-18)
aux(established-21, has-19)
auxpass(established-21, been-20)
advcl(diagnosed-10, established-21)

@/NN CPK/NN :/: Some/DT patients/NNS undergoing/VBG vigorous/JJ physical/JJ activity/NN while/IN on/IN Accutane/NN therapy/NN have/VBP experienced/VBN elevated/JJ CPK/NN levels/NNS ;/: ./.

(ROOT (S1 (S (NP (NP (NN @) (NN CPK)) (: :) (S (NP (NP (DT Some) (NNS patients)) (VP (VBG undergoing) (NP (JJ vigorous) (JJ physical) (NN activity)) (PP (IN while) (PP (IN on) (NP (NN Accutane) (NN therapy)))))) (VP (VBP have) (VP (VBN experienced) (NP (JJ elevated) (NN CPK) (NNS levels)))) (: ;)) (. .)))))

nn(CPK-2, @-1)
root(ROOT-0, CPK-2)
det(patients-5, Some-4)
nsubj(experienced-15, patients-5)
partmod(patients-5, undergoing-6)
amod(activity-9, vigorous-7)
amod(activity-9, physical-8)
dobj(undergoing-6, activity-9)
prep(undergoing-6, while-10)
pcomp(while-10, on-11)
nn(therapy-13, Accutane-12)
prep_on(while-10, therapy-13)
aux(experienced-15, have-14)
dep(CPK-2, experienced-15)
amod(levels-18, elevated-16)
nn(levels-18, CPK-17)
dobj(experienced-15, levels-18)

In/IN a/DT clinical/JJ trial/NN of/IN 217/CD pediatric/JJ patients/NNS (/-LRB- 12/CD to/TO 17/CD years/NNS )/-RRB- with/IN severe/JJ recalcitrant/JJ nodular/JJ acne/NN ,/, transient/JJ elevations/NNS in/IN CPK/NN were/VBD observed/VBN in/IN 12/CD %/NN of/IN patients/NNS ,/, including/VBG those/DT undergoing/VBG strenuous/JJ physical/JJ activity/NN in/IN association/NN with/IN reported/VBN musculoskeletal/JJ adverse/JJ events/NNS such/JJ as/IN back/RB pain/NN ,/, arthralgia/NN ,/, limb/NN injury/NN ,/, or/CC muscle/NN sprain/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (DT a) (JJ clinical) (NN trial)) (PP (IN of) (NP (NP (NP (CD 217) (JJ pediatric) (NNS patients)) (PRN (-LRB- -LRB-) (NP (QP (CD 12) (TO to) (CD 17)) (NNS years)) (-RRB- -RRB-))) (PP (IN with) (NP (JJ severe) (JJ recalcitrant) (JJ nodular) (NN acne))))))) (, ,) (NP (NP (JJ transient) (NNS elevations)) (PP (IN in) (NP (NN CPK)))) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (CD 12) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (, ,) (PP (VBG including) (NP (NP (DT those) (VBG undergoing) (JJ strenuous) (JJ physical) (NN activity)) (PP (IN in) (NP (NP (NN association)) (PP (IN with) (NP (NP (VBN reported) (JJ musculoskeletal) (JJ adverse) (NNS events)) (PP (JJ such) (IN as) (NP (RB back) (NP (NN pain)) (, ,) (NP (NN arthralgia)) (, ,) (NP (NN limb) (NN injury)) (, ,) (CC or) (NP (NN muscle) (NN sprain)))))))))))))))) (. .))))

det(trial-4, a-2)
amod(trial-4, clinical-3)
prep_in(observed-26, trial-4)
num(patients-8, 217-6)
amod(patients-8, pediatric-7)
prep_of(trial-4, patients-8)
number(17-12, 12-10)
dep(17-12, to-11)
num(years-13, 17-12)
appos(patients-8, years-13)
amod(acne-19, severe-16)
amod(acne-19, recalcitrant-17)
amod(acne-19, nodular-18)
prep_with(patients-8, acne-19)
amod(elevations-22, transient-21)
nsubjpass(observed-26, elevations-22)
prep_in(elevations-22, CPK-24)
auxpass(observed-26, were-25)
root(ROOT-0, observed-26)
num(%-29, 12-28)
prep_in(observed-26, %-29)
prep_of(%-29, patients-31)
det(activity-38, those-34)
amod(activity-38, undergoing-35)
amod(activity-38, strenuous-36)
amod(activity-38, physical-37)
prep_including(patients-31, activity-38)
prep_in(activity-38, association-40)
amod(events-45, reported-42)
amod(events-45, musculoskeletal-43)
amod(events-45, adverse-44)
prep_with(association-40, events-45)
advmod(pain-49, back-48)
prep_such_as(events-45, pain-49)
conj_or(pain-49, arthralgia-51)
nn(injury-54, limb-53)
conj_or(pain-49, injury-54)
nn(sprain-58, muscle-57)
conj_or(pain-49, sprain-58)

Nitroglycerin/NN :/: DynaCirc/NN @/NN (/-LRB- isradipine/NN )/-RRB- has/VBZ been/VBN safely/RB coadministered/VBN with/IN nitroglycerin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Nitroglycerin)) (: :) (NP (NP (NN DynaCirc) (NN @)) (PRN (-LRB- -LRB-) (NP (NN isradipine)) (-RRB- -RRB-)))) (VP (VBZ has) (VP (VBN been) (ADVP (RB safely)) (VP (VBN coadministered) (PP (IN with) (NP (NN nitroglycerin))))))) (. .))))

nsubjpass(coadministered-11, Nitroglycerin-1)
nn(@-4, DynaCirc-3)
dep(Nitroglycerin-1, @-4)
appos(@-4, isradipine-6)
aux(coadministered-11, has-8)
auxpass(coadministered-11, been-9)
advmod(coadministered-11, safely-10)
root(ROOT-0, coadministered-11)
prep_with(coadministered-11, nitroglycerin-13)

Hydrochlorothiazide/NN :/: A/DT study/NN in/IN normal/JJ healthy/JJ volunteers/NNS has/VBZ shown/VBN that/IN concomitant/JJ administration/NN of/IN DynaCirc/NN @/NN (/-LRB- isradipine/NN )/-RRB- and/CC hydrochlorothiazide/NN does/VBZ not/RB result/VB in/IN altered/JJ pharmacoktnetics/NNS of/IN either/DT drug/NN ./.

(ROOT (S1 (S (NP (NP (NN Hydrochlorothiazide)) (: :) (S (NP (NP (DT A) (NN study)) (PP (IN in) (NP (JJ normal) (JJ healthy) (NNS volunteers)))) (VP (VBZ has) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NP (NN DynaCirc) (NN @)) (PRN (-LRB- -LRB-) (NP (NN isradipine)) (-RRB- -RRB-))) (CC and) (NP (NN hydrochlorothiazide))))) (VP (VBZ does) (RB not) (VP (VB result) (PP (IN in) (NP (NP (JJ altered) (NNS pharmacoktnetics)) (PP (IN of) (NP (DT either) (NN drug)))))))))))) (. .)))))

root(ROOT-0, Hydrochlorothiazide-1)
det(study-4, A-3)
nsubj(shown-10, study-4)
amod(volunteers-8, normal-6)
amod(volunteers-8, healthy-7)
prep_in(study-4, volunteers-8)
aux(shown-10, has-9)
dep(Hydrochlorothiazide-1, shown-10)
complm(result-24, that-11)
amod(administration-13, concomitant-12)
nsubj(result-24, administration-13)
nn(@-16, DynaCirc-15)
prep_of(administration-13, @-16)
appos(@-16, isradipine-18)
conj_and(@-16, hydrochlorothiazide-21)
aux(result-24, does-22)
neg(result-24, not-23)
ccomp(shown-10, result-24)
amod(pharmacoktnetics-27, altered-26)
prep_in(result-24, pharmacoktnetics-27)
det(drug-30, either-29)
prep_of(pharmacoktnetics-27, drug-30)

In/IN a/DT study/NN in/IN hypertensive/JJ patients/NNS ,/, addition/NN of/IN isradipine/NN to/TO existing/NN hydrochlorothiazide/NN therapy/NN did/VBD not/RB result/VB in/IN any/DT unexpected/JJ adverse/JJ effects/NNS ,/, and/CC isradipine/NN had/VBD an/DT additional/JJ antihypertensive/JJ effect/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT a) (NN study)) (PP (IN in) (NP (JJ hypertensive) (NNS patients))))) (, ,) (S (NP (NP (NN addition)) (PP (IN of) (NP (NN isradipine))) (PP (TO to) (NP (NN existing) (NN hydrochlorothiazide) (NN therapy)))) (VP (VBD did) (RB not) (VP (VB result) (PP (IN in) (NP (DT any) (JJ unexpected) (JJ adverse) (NNS effects)))))) (, ,) (CC and) (S (NP (NN isradipine)) (VP (VBD had) (NP (DT an) (JJ additional) (JJ antihypertensive) (NN effect))))) (. .))))

det(study-3, a-2)
prep_in(result-17, study-3)
amod(patients-6, hypertensive-5)
prep_in(study-3, patients-6)
nsubj(result-17, addition-8)
prep_of(addition-8, isradipine-10)
nn(therapy-14, existing-12)
nn(therapy-14, hydrochlorothiazide-13)
prep_to(addition-8, therapy-14)
aux(result-17, did-15)
neg(result-17, not-16)
root(ROOT-0, result-17)
det(effects-22, any-19)
amod(effects-22, unexpected-20)
amod(effects-22, adverse-21)
prep_in(result-17, effects-22)
nsubj(had-26, isradipine-25)
conj_and(result-17, had-26)
det(effect-30, an-27)
amod(effect-30, additional-28)
amod(effect-30, antihypertensive-29)
dobj(had-26, effect-30)

Propranolol/NN :/: In/IN a/DT single/JJ dose/NN study/NN in/IN normal/JJ volunteers/NNS ,/, coadministration/NN of/IN propranolol/NN had/VBD a/DT small/JJ effect/NN on/IN the/DT rate/NN but/CC no/DT effect/NN on/IN the/DT extent/NN of/IN isradipine/NN bioavailability/NN ./.

(ROOT (S1 (S (NP (NP (NN Propranolol)) (: :) (S (PP (IN In) (NP (NP (DT a) (JJ single) (NN dose) (NN study)) (PP (IN in) (NP (JJ normal) (NNS volunteers))))) (, ,) (NP (NP (NN coadministration)) (PP (IN of) (NP (NN propranolol)))) (VP (VBD had) (NP (NP (NP (DT a) (JJ small) (NN effect)) (PP (IN on) (NP (DT the) (NN rate)))) (CC but) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN extent)) (PP (IN of) (NP (NN isradipine) (NN bioavailability))))))))) (. .)))))

root(ROOT-0, Propranolol-1)
det(study-7, a-4)
amod(study-7, single-5)
nn(study-7, dose-6)
prep_in(had-15, study-7)
amod(volunteers-10, normal-9)
prep_in(study-7, volunteers-10)
nsubj(had-15, coadministration-12)
prep_of(coadministration-12, propranolol-14)
dep(Propranolol-1, had-15)
det(effect-18, a-16)
amod(effect-18, small-17)
dobj(had-15, effect-18)
det(rate-21, the-20)
prep_on(effect-18, rate-21)
det(effect-24, no-23)
conj_but(effect-18, effect-24)
det(extent-27, the-26)
prep_on(effect-24, extent-27)
nn(bioavailability-30, isradipine-29)
prep_of(extent-27, bioavailability-30)

Significant/JJ increases/NNS In/IN AUC/NN (/-LRB- 27/CD %/NN )/-RRB- and/CC Cmax/NN (/-LRB- 58/CD %/NN )/-RRB- and/CC decreases/NNS in/IN tmax/NN (/-LRB- 23/CD %/NN )/-RRB- of/IN propranolol/NN were/VBD noted/VBN in/IN this/DT study/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Significant) (NNS increases)) (PP (IN In) (NP (NP (NP (NN AUC)) (PRN (-LRB- -LRB-) (NP (CD 27) (NN %)) (-RRB- -RRB-))) (CC and) (NP (NP (NN Cmax)) (PRN (-LRB- -LRB-) (NP (CD 58) (NN %)) (-RRB- -RRB-)))))) (CC and) (NP (NP (NNS decreases)) (PP (IN in) (NP (NP (NP (NN tmax)) (PRN (-LRB- -LRB-) (NP (CD 23) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (NN propranolol))))))) (VP (VBD were) (VP (VBN noted) (PP (IN in) (NP (DT this) (NN study)))))) (. .))))

amod(increases-2, Significant-1)
nsubjpass(noted-26, increases-2)
prep_in(increases-2, AUC-4)
num(%-7, 27-6)
appos(AUC-4, %-7)
conj_and(AUC-4, Cmax-10)
num(%-13, 58-12)
appos(Cmax-10, %-13)
conj_and(increases-2, decreases-16)
prep_in(decreases-16, tmax-18)
num(%-21, 23-20)
appos(tmax-18, %-21)
prep_of(tmax-18, propranolol-24)
auxpass(noted-26, were-25)
root(ROOT-0, noted-26)
det(study-29, this-28)
prep_in(noted-26, study-29)

However/RB ,/, concomitant/JJ administration/NN of/IN 5/CD mg/NN b.i.d./NNS isradipine/NN and/CC 40/CD mg/NN b.i.d./NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (CD 5) (NN mg) (NNS b.i.d.)) (NP (NP (NN isradipine)) (CC and) (NP (ADJP (CD 40) (NN mg)) (NN b.i.d.))))))) (. .))))

advmod(administration-4, However-1)
amod(administration-4, concomitant-3)
root(ROOT-0, administration-4)
num(b.i.d.-8, 5-6)
nn(b.i.d.-8, mg-7)
prep_of(administration-4, b.i.d.-8)
dep(b.i.d.-8, isradipine-9)
number(mg-12, 40-11)
amod(b.i.d.-13, mg-12)
conj_and(isradipine-9, b.i.d.-13)

propranolol/NN to/TO healthy/JJ volunteers/NNS under/IN steady-state/JJ conditions/NNS had/VBD no/DT relevant/JJ effect/NN on/IN either/DT drug/NN @/NN s/NN bioavailability/NN ,/, AUC/NN and/CC Cmax/NN ,/, differences/NNS were/VBD 20/CD %/NN between/IN isradipine/NN given/VBN singly/RB and/CC in/IN combination/NN with/IN propranolol/NN ,/, and/CC between/IN propranolol/NN given/VBN singly/RB and/CC in/IN combination/NN with/IN isradipine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN propranolol)) (PP (TO to) (NP (JJ healthy) (NNS volunteers))) (PP (IN under) (NP (JJ steady-state) (NNS conditions)))) (VP (VBD had) (NP (NP (NP (DT no) (JJ relevant) (NN effect)) (PP (IN on) (NP (DT either) (NN drug) (NN @) (NN s) (NN bioavailability)))) (, ,) (NP (NP (NN AUC)) (CC and) (NP (NN Cmax))) (, ,) (NP (NP (NNS differences)) (VP (VBD were) (NP (CD 20) (NN %)) (PP (PP (IN between) (NP (NP (NN isradipine)) (VP (VBN given) (UCP (ADVP (RB singly)) (CC and) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN propranolol))))))))) (, ,) (CC and) (PP (IN between) (NP (NP (NN propranolol)) (VP (VBN given) (UCP (ADVP (RB singly)) (CC and) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN isradipine))))))))))))))) (. .))))

nsubj(had-8, propranolol-1)
amod(volunteers-4, healthy-3)
prep_to(propranolol-1, volunteers-4)
amod(conditions-7, steady-state-6)
prep_under(propranolol-1, conditions-7)
root(ROOT-0, had-8)
det(effect-11, no-9)
amod(effect-11, relevant-10)
dobj(had-8, effect-11)
det(bioavailability-17, either-13)
nn(bioavailability-17, drug-14)
nn(bioavailability-17, @-15)
nn(bioavailability-17, s-16)
prep_on(effect-11, bioavailability-17)
appos(effect-11, AUC-19)
conj_and(AUC-19, Cmax-21)
appos(effect-11, differences-23)
cop(%-26, were-24)
num(%-26, 20-25)
partmod(differences-23, %-26)
prep_between(%-26, isradipine-28)
partmod(isradipine-28, given-29)
dep(given-29, singly-30)
conj_and(singly-30, in-32)
pobj(in-32, combination-33)
prep_with(combination-33, propranolol-35)
conj_and(isradipine-28, propranolol-39)
partmod(propranolol-39, given-40)
dep(given-40, singly-41)
conj_and(singly-41, in-43)
pobj(in-43, combination-44)
prep_with(combination-44, isradipine-46)

Cimetidine/NN :/: In/IN a/DT study/NN in/IN healthy/JJ volunteers/NNS ,/, a/DT one-week/JJ course/NN of/IN cimetidine/NN at/IN 400/CD mg/NN b.i.d./NN with/IN a/DT single/JJ 5/CD mg/NN dose/NN of/IN isradipine/NN on/IN the/DT sixth/JJ day/NN showed/VBD an/DT increase/NN in/IN isradipine/NN mean/JJ peak/NN plasma/NN concentrations/NNS (/-LRB- 36/CD %/NN )/-RRB- and/CC significant/JJ increase/NN in/IN area/NN under/IN the/DT curve/NN (/-LRB- 50%)./CD

(ROOT (S1 (S (NP (NP (NN Cimetidine)) (: :) (S (PP (IN In) (NP (NP (DT a) (NN study)) (PP (IN in) (NP (JJ healthy) (NNS volunteers))))) (, ,) (NP (NP (DT a) (JJ one-week) (NN course)) (PP (IN of) (NP (NP (NN cimetidine)) (PP (IN at) (NP (ADJP (CD 400) (NN mg)) (NN b.i.d.))) (PP (IN with) (NP (NP (DT a) (JJ single) (ADJP (CD 5) (NN mg)) (NN dose)) (PP (IN of) (NP (NN isradipine))) (PP (IN on) (NP (DT the) (JJ sixth) (NN day)))))))) (VP (VBD showed) (NP (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN isradipine) (JJ mean) (NN peak) (NN plasma) (NNS concentrations)) (PRN (-LRB- -LRB-) (NP (CD 36) (NN %)) (-RRB- -RRB-))))) (CC and) (NP (NP (JJ significant) (NN increase)) (PP (IN in) (NP (NP (NN area)) (PP (IN under) (NP (DT the) (NN curve))))))) (PRN (-LRB- -LRB-) (NP (CD 50%-RRB-.)))))))))

root(ROOT-0, Cimetidine-1)
det(study-5, a-4)
prep_in(showed-31, study-5)
amod(volunteers-8, healthy-7)
prep_in(study-5, volunteers-8)
det(course-12, a-10)
amod(course-12, one-week-11)
nsubj(showed-31, course-12)
prep_of(course-12, cimetidine-14)
number(mg-17, 400-16)
amod(b.i.d.-18, mg-17)
prep_at(cimetidine-14, b.i.d.-18)
det(dose-24, a-20)
amod(dose-24, single-21)
number(mg-23, 5-22)
amod(dose-24, mg-23)
prep_with(cimetidine-14, dose-24)
prep_of(dose-24, isradipine-26)
det(day-30, the-28)
amod(day-30, sixth-29)
prep_on(dose-24, day-30)
dep(Cimetidine-1, showed-31)
det(increase-33, an-32)
dobj(showed-31, increase-33)
nn(concentrations-39, isradipine-35)
amod(concentrations-39, mean-36)
nn(concentrations-39, peak-37)
nn(concentrations-39, plasma-38)
prep_in(increase-33, concentrations-39)
num(%-42, 36-41)
appos(concentrations-39, %-42)
amod(increase-46, significant-45)
conj_and(increase-33, increase-46)
prep_in(increase-46, area-48)
det(curve-51, the-50)
prep_under(area-48, curve-51)
dep(showed-31, 50%-RRB-.-53)

If/IN isradipine/NN therapy/NN is/VBZ initiated/VBN in/IN a/DT patient/NN currently/RB receiving/VBG cimetidine/NN careful/JJ monitoring/NN for/IN adverse/JJ reactions/NNS is/VBZ advised/JJ and/CC downward/JJ dose/NN adjustment/NN may/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (S (SBAR (IN If) (S (NP (NN isradipine) (NN therapy)) (VP (VBZ is) (VP (VBN initiated) (PP (IN in) (NP (NP (DT a) (NN patient)) (VP (ADVP (RB currently)) (VBG receiving) (NP (NP (NN cimetidine) (JJ careful) (NN monitoring)) (PP (IN for) (NP (JJ adverse) (NNS reactions))))))))))) (VP (VBZ is) (ADJP (JJ advised)))) (CC and) (S (NP (JJ downward) (NN dose) (NN adjustment)) (VP (MD may) (VP (VB be) (VP (VBN required)))))) (. .))))

mark(initiated-5, If-1)
nn(therapy-3, isradipine-2)
nsubjpass(initiated-5, therapy-3)
auxpass(initiated-5, is-4)
csubj(advised-18, initiated-5)
det(patient-8, a-7)
prep_in(initiated-5, patient-8)
advmod(receiving-10, currently-9)
partmod(patient-8, receiving-10)
nn(monitoring-13, cimetidine-11)
amod(monitoring-13, careful-12)
dobj(receiving-10, monitoring-13)
amod(reactions-16, adverse-15)
prep_for(monitoring-13, reactions-16)
cop(advised-18, is-17)
root(ROOT-0, advised-18)
amod(adjustment-22, downward-20)
nn(adjustment-22, dose-21)
nsubjpass(required-25, adjustment-22)
aux(required-25, may-23)
auxpass(required-25, be-24)
conj_and(advised-18, required-25)

Rifampicin/NN :/: In/IN a/DT study/NN in/IN healthy/JJ volunteers/NNS ,/, a/DT six-day/JJ course/NN of/IN rifampicin/NN at/IN 600/CD mg/day/NN followed/VBN by/IN a/DT single/JJ 5/CD mg/NN dose/NN of/IN isradipine/NN resulted/VBD in/IN a/DT reduction/NN in/IN isradipine/NN levels/NNS to/TO below/IN detectable/JJ limits/NNS ./.

(ROOT (S1 (S (NP (NP (NN Rifampicin)) (: :) (S (PP (IN In) (NP (NP (DT a) (NN study)) (PP (IN in) (NP (JJ healthy) (NNS volunteers))))) (, ,) (NP (NP (DT a) (JJ six-day) (NN course)) (PP (IN of) (NP (NN rifampicin))) (PP (IN at) (NP (NP (CD 600) (NN mg/day)) (VP (VBN followed) (PP (IN by) (NP (NP (DT a) (JJ single) (ADJP (CD 5) (NN mg)) (NN dose)) (PP (IN of) (NP (NN isradipine))))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NN isradipine) (NNS levels))) (PP (TO to)) (PP (IN below) (NP (JJ detectable) (NNS limits))))))) (. .)))))

root(ROOT-0, Rifampicin-1)
det(study-5, a-4)
prep_in(resulted-27, study-5)
amod(volunteers-8, healthy-7)
prep_in(study-5, volunteers-8)
det(course-12, a-10)
amod(course-12, six-day-11)
nsubj(resulted-27, course-12)
prep_of(course-12, rifampicin-14)
num(mg/day-17, 600-16)
prep_at(course-12, mg/day-17)
partmod(mg/day-17, followed-18)
det(dose-24, a-20)
amod(dose-24, single-21)
number(mg-23, 5-22)
amod(dose-24, mg-23)
agent(followed-18, dose-24)
prep_of(dose-24, isradipine-26)
dep(Rifampicin-1, resulted-27)
det(reduction-30, a-29)
prep_in(resulted-27, reduction-30)
nn(levels-33, isradipine-32)
prep_in(reduction-30, levels-33)
prep(reduction-30, to-34)
amod(limits-37, detectable-36)
prep_below(reduction-30, limits-37)

If/IN rifampicin/NN therapy/NN is/VBZ required/VBN ,/, isradipine/NN concentrations/NNS and/CC therapeutic/JJ effects/NNS are/VBP likely/JJ to/TO be/VB markedly/RB reduced/VBN or/CC abolished/VBN as/IN a/DT consequence/NN of/IN increased/VBN metabolism/NN and/CC higher/JJR clearance/NN of/IN isradipine/NN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN rifampicin) (NN therapy)) (VP (VBZ is) (VP (VBN required))))) (, ,) (NP (NP (NN isradipine) (NNS concentrations)) (CC and) (NP (JJ therapeutic) (NNS effects))) (VP (VBP are) (ADJP (JJ likely) (S (VP (TO to) (VP (VB be) (VP (ADVP (RB markedly)) (VP (VBN reduced)) (CC or) (VP (VBN abolished) (PP (IN as) (NP (NP (DT a) (NN consequence)) (PP (IN of) (NP (NP (VBN increased) (NN metabolism)) (CC and) (NP (NP (JJR higher) (NN clearance)) (PP (IN of) (NP (NN isradipine)))))))))))))))) (. .))))

mark(required-5, If-1)
nn(therapy-3, rifampicin-2)
nsubjpass(required-5, therapy-3)
auxpass(required-5, is-4)
advcl(likely-13, required-5)
nn(concentrations-8, isradipine-7)
nsubj(likely-13, concentrations-8)
amod(effects-11, therapeutic-10)
conj_and(concentrations-8, effects-11)
cop(likely-13, are-12)
root(ROOT-0, likely-13)
aux(reduced-17, to-14)
auxpass(reduced-17, be-15)
advmod(reduced-17, markedly-16)
xcomp(likely-13, reduced-17)
conj_or(reduced-17, abolished-19)
det(consequence-22, a-21)
prep_as(abolished-19, consequence-22)
amod(metabolism-25, increased-24)
prep_of(consequence-22, metabolism-25)
amod(clearance-28, higher-27)
conj_and(metabolism-25, clearance-28)
prep_of(clearance-28, isradipine-30)

Warfarin/NN :/: In/IN a/DT study/NN in/IN healthy/JJ volunteers/NNS ,/, no/DT clinically/RB relevant/JJ pharmacokinetic/JJ or/CC pharmacodynamic/JJ interaction/NN between/IN isradipine/NN and/CC racemic/JJ warfarin/NN was/VBD seen/VBN when/WRB two/CD single/JJ oral/JJ doses/NNS of/IN warfarin/NN (/-LRB- 0.7/CD mg/kg/NN body/NN weight/NN )/-RRB- were/VBD administered/VBN during/IN 11/CD days/NNS of/IN multipledose/NN treatment/NN with/IN 5/CD mg/NN b.i.d./NN isradipine/NN ./.

(ROOT (S1 (S (NP (NP (NN Warfarin)) (: :) (S (PP (IN In) (NP (NP (DT a) (NN study)) (PP (IN in) (NP (JJ healthy) (NNS volunteers))))) (, ,) (NP (NP (DT no) (ADJP (RB clinically) (JJ relevant)) (ADJP (ADJP (JJ pharmacokinetic)) (CC or) (ADJP (JJ pharmacodynamic))) (NN interaction)) (PP (IN between) (NP (NP (NN isradipine)) (CC and) (NP (JJ racemic) (NN warfarin))))) (VP (VBD was) (VP (VBN seen) (SBAR (WHADVP (WRB when)) (S (NP (NP (NP (CD two) (JJ single) (JJ oral) (NNS doses)) (PP (IN of) (NP (NN warfarin)))) (PRN (-LRB- -LRB-) (NP (CD 0.7) (NN mg/kg) (NN body) (NN weight)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN administered) (PP (IN during) (NP (NP (CD 11) (NNS days)) (PP (IN of) (NP (NP (NN multipledose) (NN treatment)) (PP (IN with) (NP (ADJP (CD 5) (NN mg)) (NN b.i.d.) (NN isradipine)))))))))))))) (. .)))))

root(ROOT-0, Warfarin-1)
det(study-5, a-4)
prep_in(seen-23, study-5)
amod(volunteers-8, healthy-7)
prep_in(study-5, volunteers-8)
det(interaction-16, no-10)
advmod(relevant-12, clinically-11)
amod(interaction-16, relevant-12)
amod(interaction-16, pharmacokinetic-13)
conj_or(pharmacokinetic-13, pharmacodynamic-15)
nsubjpass(seen-23, interaction-16)
prep_between(interaction-16, isradipine-18)
amod(warfarin-21, racemic-20)
conj_and(isradipine-18, warfarin-21)
auxpass(seen-23, was-22)
dep(Warfarin-1, seen-23)
advmod(administered-38, when-24)
num(doses-28, two-25)
amod(doses-28, single-26)
amod(doses-28, oral-27)
nsubjpass(administered-38, doses-28)
prep_of(doses-28, warfarin-30)
num(weight-35, 0.7-32)
nn(weight-35, mg/kg-33)
nn(weight-35, body-34)
appos(doses-28, weight-35)
auxpass(administered-38, were-37)
advcl(seen-23, administered-38)
num(days-41, 11-40)
prep_during(administered-38, days-41)
nn(treatment-44, multipledose-43)
prep_of(days-41, treatment-44)
number(mg-47, 5-46)
amod(isradipine-49, mg-47)
nn(isradipine-49, b.i.d.-48)
prep_with(treatment-44, isradipine-49)

Neither/CC racemic/JJ warfarin/NN nor/CC isradipine/NN binding/NN to/TO plasma/NN proteins/NNS in/FW vitro/FW was/VBD altered/VBN by/IN the/DT addition/NN of/IN the/DT other/JJ drug/NN ./.

(ROOT (S1 (S (S (NP (CC Neither) (NP (JJ racemic) (NN warfarin)) (CC nor) (NP (NP (NN isradipine) (NN binding)) (PP (TO to) (NP (NN plasma) (NNS proteins))) (ADVP (FW in) (FW vitro)))) (VP (VBD was) (VP (VBN altered) (PP (IN by) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (DT the) (JJ other) (NN drug)))))))) (. .))))

preconj(warfarin-3, Neither-1)
amod(warfarin-3, racemic-2)
nsubjpass(altered-13, warfarin-3)
nn(binding-6, isradipine-5)
conj_nor(warfarin-3, binding-6)
nn(proteins-9, plasma-8)
prep_to(binding-6, proteins-9)
nn(vitro-11, in-10)
advmod(binding-6, vitro-11)
auxpass(altered-13, was-12)
root(ROOT-0, altered-13)
det(addition-16, the-15)
agent(altered-13, addition-16)
det(drug-20, the-18)
amod(drug-20, other-19)
prep_of(addition-16, drug-20)

Digoxin/NN :/: The/DT concomitant/JJ administration/NN of/IN DynaCirc/NN @/NN (/-LRB- isradipine/NN )/-RRB- and/CC digoxin/NN in/IN a/DT single-dose/JJ pharmacokinetic/JJ study/NN did/VBD not/RB affect/VB renal/JJ ,/, nonrenal/JJ and/CC total/JJ body/NN clearance/NN of/IN digoxin/NN ./.

(ROOT (S1 (S (NP (NP (NN Digoxin)) (: :) (S (NP (NP (DT The) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NP (NN DynaCirc) (NN @)) (PRN (-LRB- -LRB-) (NP (NN isradipine)) (-RRB- -RRB-))) (CC and) (NP (NP (NN digoxin)) (PP (IN in) (NP (DT a) (JJ single-dose) (JJ pharmacokinetic) (NN study))))))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (ADJP (ADJP (JJ renal)) (, ,) (ADJP (JJ nonrenal)) (CC and) (ADJP (JJ total))) (NN body) (NN clearance)) (PP (IN of) (NP (NN digoxin))))))) (. .)))))

root(ROOT-0, Digoxin-1)
det(administration-5, The-3)
amod(administration-5, concomitant-4)
nsubj(affect-21, administration-5)
nn(@-8, DynaCirc-7)
prep_of(administration-5, @-8)
appos(@-8, isradipine-10)
conj_and(@-8, digoxin-13)
det(study-18, a-15)
amod(study-18, single-dose-16)
amod(study-18, pharmacokinetic-17)
prep_in(digoxin-13, study-18)
aux(affect-21, did-19)
neg(affect-21, not-20)
dep(Digoxin-1, affect-21)
amod(clearance-28, renal-22)
conj_and(renal-22, nonrenal-24)
conj_and(renal-22, total-26)
nn(clearance-28, body-27)
dobj(affect-21, clearance-28)
prep_of(clearance-28, digoxin-30)

Fentanyl/JJ Anesthesia/NN :/: Severe/JJ hypotension/NN has/VBZ been/VBN reported/VBN during/IN fentanyl/NN anesthesia/NN with/IN concomitant/JJ use/NN of/IN a/DT beta/NN blocker/NN and/CC a/DT calcium/NN channel/NN blocker/NN ./.

(ROOT (S1 (S (NP (NP (JJ Fentanyl) (NN Anesthesia)) (: :) (S (NP (JJ Severe) (NN hypotension)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN during) (NP (NP (NN fentanyl) (NN anesthesia)) (PP (IN with) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (DT a) (NN beta) (NN blocker)) (CC and) (NP (DT a) (NN calcium) (NN channel) (NN blocker)))))))))))) (. .)))))

amod(Anesthesia-2, Fentanyl-1)
root(ROOT-0, Anesthesia-2)
amod(hypotension-5, Severe-4)
nsubjpass(reported-8, hypotension-5)
aux(reported-8, has-6)
auxpass(reported-8, been-7)
dep(Anesthesia-2, reported-8)
nn(anesthesia-11, fentanyl-10)
prep_during(reported-8, anesthesia-11)
amod(use-14, concomitant-13)
prep_with(anesthesia-11, use-14)
det(blocker-18, a-16)
nn(blocker-18, beta-17)
prep_of(use-14, blocker-18)
det(blocker-23, a-20)
nn(blocker-23, calcium-21)
nn(blocker-23, channel-22)
conj_and(blocker-18, blocker-23)

Even/RB though/IN such/JJ interactions/NNS have/VBP not/RB been/VBN seen/VBN in/IN clinical/JJ studies/NNS with/IN DynaCirc/NN @/NN (/-LRB- isradipine/NN )/-RRB- ,/, an/DT increased/VBN volume/NN of/IN circulating/VBG fluids/NNS might/MD be/VB required/VBN if/IN such/PDT an/DT interaction/NN were/VBD to/TO occur/VB ./.

(ROOT (S1 (S (S (SBAR (RB Even) (IN though) (S (NP (JJ such) (NNS interactions)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN seen) (PP (IN in) (NP (NP (JJ clinical) (NNS studies)) (PP (IN with) (NP (NN DynaCirc) (NN @) (-LRB- -LRB-) (NN isradipine) (-RRB- -RRB-)))))))))) (, ,) (NP (NP (DT an) (VBN increased) (NN volume)) (PP (IN of) (NP (VBG circulating) (NNS fluids)))) (VP (MD might) (VP (VB be) (VP (VBN required) (SBAR (IN if) (S (NP (PDT such) (DT an) (NN interaction)) (VP (VBD were) (S (VP (TO to) (VP (VB occur))))))))))) (. .))))

advmod(seen-8, Even-1)
dep(seen-8, though-2)
amod(interactions-4, such-3)
nsubjpass(seen-8, interactions-4)
aux(seen-8, have-5)
neg(seen-8, not-6)
auxpass(seen-8, been-7)
advcl(required-27, seen-8)
amod(studies-11, clinical-10)
prep_in(seen-8, studies-11)
nn(isradipine-16, DynaCirc-13)
nn(isradipine-16, @-14)
prep_with(studies-11, isradipine-16)
det(volume-21, an-19)
amod(volume-21, increased-20)
nsubjpass(required-27, volume-21)
amod(fluids-24, circulating-23)
prep_of(volume-21, fluids-24)
aux(required-27, might-25)
auxpass(required-27, be-26)
root(ROOT-0, required-27)
mark(were-32, if-28)
predet(interaction-31, such-29)
det(interaction-31, an-30)
nsubj(were-32, interaction-31)
advcl(required-27, were-32)
aux(occur-34, to-33)
xcomp(were-32, occur-34)

Both/CC itraconazole/NN and/CC its/PRP$ major/JJ metabolite/NN ,/, hydroxyitraconazole/NN ,/, are/VBP inhibitors/NNS of/IN the/DT cytochrome/NN P450/NN 3A4/NN enzyme/NN system/NN ./.

(ROOT (S1 (S (S (NP (CC Both) (NP (NN itraconazole)) (CC and) (NP (NP (PRP$ its) (JJ major) (NN metabolite)) (, ,) (NP (NN hydroxyitraconazole)) (, ,))) (VP (VBP are) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (DT the) (NP (NN cytochrome) (NN P450) (NN 3A4)) (NN enzyme) (NN system)))))) (. .))))

preconj(itraconazole-2, Both-1)
nsubj(inhibitors-11, itraconazole-2)
poss(metabolite-6, its-4)
amod(metabolite-6, major-5)
conj_and(itraconazole-2, metabolite-6)
appos(metabolite-6, hydroxyitraconazole-8)
cop(inhibitors-11, are-10)
root(ROOT-0, inhibitors-11)
det(system-18, the-13)
nn(3A4-16, cytochrome-14)
nn(3A4-16, P450-15)
nn(system-18, 3A4-16)
nn(system-18, enzyme-17)
prep_of(inhibitors-11, system-18)

Coadministration/NN of/IN Itraconazole/NN and/CC drugs/NNS primarily/RB metabolized/VBN by/IN the/DT cytochrome/NN P450/NN 3A4/NN enzyme/NN system/NN may/MD result/VB in/IN increased/VBN plasma/NN concentrations/NNS of/IN the/DT drugs/NNS that/WDT could/MD increase/VB or/CC prolong/VB both/CC therapeutic/JJ and/CC adverse/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NP (NN Itraconazole)) (CC and) (NP (NNS drugs))) (VP (ADVP (RB primarily)) (VBN metabolized) (PP (IN by) (NP (DT the) (NP (NN cytochrome) (NN P450) (NN 3A4)) (NN enzyme) (NN system))))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (VBN increased) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (DT the) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VP (VB increase)) (CC or) (VP (VB prolong) (NP (ADJP (CC both) (ADJP (JJ therapeutic)) (CC and) (ADJP (JJ adverse))) (NNS effects)))))))))))))) (. .))))

nsubj(result-16, Coadministration-1)
prep_of(Coadministration-1, Itraconazole-3)
conj_and(Itraconazole-3, drugs-5)
advmod(metabolized-7, primarily-6)
partmod(Itraconazole-3, metabolized-7)
det(system-14, the-9)
nn(3A4-12, cytochrome-10)
nn(3A4-12, P450-11)
nn(system-14, 3A4-12)
nn(system-14, enzyme-13)
agent(metabolized-7, system-14)
aux(result-16, may-15)
root(ROOT-0, result-16)
amod(concentrations-20, increased-18)
nn(concentrations-20, plasma-19)
prep_in(result-16, concentrations-20)
det(drugs-23, the-22)
prep_of(concentrations-20, drugs-23)
nsubj(increase-26, drugs-23)
aux(increase-26, could-25)
rcmod(drugs-23, increase-26)
conj_or(increase-26, prolong-28)
preconj(therapeutic-30, both-29)
amod(effects-33, therapeutic-30)
conj_and(therapeutic-30, adverse-32)
dobj(prolong-28, effects-33)

Coadministration/NN of/IN terfenadine/NN with/IN Itraconazole/NN has/VBZ led/VBN to/TO elevated/JJ plasma/NN concentrations/NNS of/IN terfenadine/NN ,/, resulting/VBG in/IN rare/JJ instances/NNS of/IN life-/JJ threatening/NN cardiac/JJ dysrhythmias/NNS and/CC one/CD death/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN terfenadine))) (PP (IN with) (NP (NN Itraconazole)))) (VP (VBZ has) (VP (VBN led) (PP (TO to) (NP (NP (JJ elevated) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN terfenadine))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (JJ rare) (NNS instances)) (PP (IN of) (NP (NP (JJ life-) (NN threatening) (JJ cardiac) (NNS dysrhythmias)) (CC and) (NP (CD one) (NN death))))))))))) (. .))))

nsubj(led-7, Coadministration-1)
prep_of(Coadministration-1, terfenadine-3)
prep_with(Coadministration-1, Itraconazole-5)
aux(led-7, has-6)
root(ROOT-0, led-7)
amod(concentrations-11, elevated-9)
nn(concentrations-11, plasma-10)
prep_to(led-7, concentrations-11)
prep_of(concentrations-11, terfenadine-13)
xcomp(led-7, resulting-15)
amod(instances-18, rare-17)
prep_in(resulting-15, instances-18)
amod(dysrhythmias-23, life--20)
nn(dysrhythmias-23, threatening-21)
amod(dysrhythmias-23, cardiac-22)
prep_of(instances-18, dysrhythmias-23)
num(death-26, one-25)
conj_and(dysrhythmias-23, death-26)

Another/DT oral/JJ azole/JJ antifungal/JJ ,/, ketoconazole/NN ,/, inhibits/VBZ the/DT metabolism/NN of/IN astemizole/NN ,/, resulting/VBG in/IN elevated/JJ plasma/NN concentrations/NNS of/IN astemizole/NN and/CC its/PRP$ active/JJ metabolite/NN desmethylastermizole/NN which/WDT may/MD prolong/VB QT/VBG intervals/NNS ./.

(ROOT (S1 (S (S (NP (DT Another) (JJ oral) (JJ azole) (JJ antifungal) (, ,) (NP (NN ketoconazole)) (, ,)) (VP (VBZ inhibits) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN astemizole)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (JJ elevated) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (NN astemizole)) (CC and) (NP (PRP$ its) (JJ active) (NN metabolite)) (NP (NN desmethylastermizole)))) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB prolong) (NP (VBG QT) (NNS intervals)))))))))))) (. .))))

det(ketoconazole-6, Another-1)
amod(ketoconazole-6, oral-2)
amod(ketoconazole-6, azole-3)
amod(ketoconazole-6, antifungal-4)
nsubj(inhibits-8, ketoconazole-6)
root(ROOT-0, inhibits-8)
det(metabolism-10, the-9)
dobj(inhibits-8, metabolism-10)
prep_of(metabolism-10, astemizole-12)
partmod(inhibits-8, resulting-14)
xcomp(inhibits-8, resulting-14)
amod(concentrations-18, elevated-16)
nn(concentrations-18, plasma-17)
prep_in(resulting-14, concentrations-18)
nsubj(prolong-28, concentrations-18)
prep_of(concentrations-18, astemizole-20)
poss(metabolite-24, its-22)
amod(metabolite-24, active-23)
conj_and(astemizole-20, metabolite-24)
dep(astemizole-20, desmethylastermizole-25)
aux(prolong-28, may-27)
rcmod(concentrations-18, prolong-28)
amod(intervals-30, QT-29)
dobj(prolong-28, intervals-30)

In/FW vitro/FW data/NNS suggest/VBP that/IN itraconazole/NN ,/, when/WRB compared/VBN to/TO ketoconazole/NN ,/, has/VBZ a/DT less/RBR pronounced/JJ effect/NN on/IN the/DT biotransformation/NN system/NN responsible/JJ for/IN the/DT metabolism/NN of/IN astemizole/NN ./.

(ROOT (S1 (S (S (NP (FW In) (FW vitro) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN itraconazole)) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (TO to) (NP (NN ketoconazole)))))) (, ,) (VP (VBZ has) (NP (NP (DT a) (ADJP (RBR less) (JJ pronounced)) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN biotransformation) (NN system)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN astemizole)))))))))))))) (. .))))

nn(data-3, In-1)
nn(data-3, vitro-2)
nsubj(suggest-4, data-3)
root(ROOT-0, suggest-4)
complm(has-13, that-5)
nsubj(has-13, itraconazole-6)
advmod(compared-9, when-8)
advcl(has-13, compared-9)
prep_to(compared-9, ketoconazole-11)
ccomp(suggest-4, has-13)
det(effect-17, a-14)
advmod(pronounced-16, less-15)
amod(effect-17, pronounced-16)
dobj(has-13, effect-17)
det(system-21, the-19)
nn(system-21, biotransformation-20)
prep_on(effect-17, system-21)
amod(system-21, responsible-22)
det(metabolism-25, the-24)
prep_for(responsible-22, metabolism-25)
prep_of(metabolism-25, astemizole-27)

Based/VBN on/IN the/DT chemical/JJ resemblance/NN of/IN itraconazole/NN and/CC ketoconazole/NN ,/, coadministration/NN of/IN astemizole/NN with/IN itraconazole/NN is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (S (PP (VBN Based) (PP (IN on) (NP (NP (DT the) (JJ chemical) (NN resemblance)) (PP (IN of) (NP (NP (NN itraconazole)) (CC and) (NP (NN ketoconazole))))))) (, ,) (NP (NP (NN coadministration)) (PP (IN of) (NP (NN astemizole))) (PP (IN with) (NP (NN itraconazole)))) (VP (VBZ is) (VP (VBN contraindicated)))) (. .))))

prepc_based_on(contraindicated-17, on-2)
det(resemblance-5, the-3)
amod(resemblance-5, chemical-4)
pobj(contraindicated-17, resemblance-5)
prep_of(resemblance-5, itraconazole-7)
conj_and(itraconazole-7, ketoconazole-9)
nsubjpass(contraindicated-17, coadministration-11)
prep_of(coadministration-11, astemizole-13)
prep_with(coadministration-11, itraconazole-15)
auxpass(contraindicated-17, is-16)
root(ROOT-0, contraindicated-17)

Human/JJ pharmacokinetics/NNS data/NNS indicate/VBP that/IN oral/JJ ketoconazole/NN potently/RB inhibits/VBZ the/DT metabolism/NN of/IN cisapride/NN resulting/VBG in/IN an/DT eight-fold/JJ increase/NN in/IN the/DT mean/JJ AUC/NN of/IN cisapride/NN ./.

(ROOT (S1 (S (S (NP (JJ Human) (NNS pharmacokinetics) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (JJ oral) (NN ketoconazole)) (ADVP (RB potently)) (VP (VBZ inhibits) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NP (NN cisapride)) (VP (VBG resulting) (PP (IN in) (NP (NP (DT an) (JJ eight-fold) (NN increase)) (PP (IN in) (NP (NP (DT the) (JJ mean) (NN AUC)) (PP (IN of) (NP (NN cisapride)))))))))))))))) (. .))))

amod(data-3, Human-1)
nn(data-3, pharmacokinetics-2)
nsubj(indicate-4, data-3)
root(ROOT-0, indicate-4)
complm(inhibits-9, that-5)
amod(ketoconazole-7, oral-6)
nsubj(inhibits-9, ketoconazole-7)
advmod(inhibits-9, potently-8)
ccomp(indicate-4, inhibits-9)
det(metabolism-11, the-10)
dobj(inhibits-9, metabolism-11)
prep_of(metabolism-11, cisapride-13)
partmod(cisapride-13, resulting-14)
det(increase-18, an-16)
amod(increase-18, eight-fold-17)
prep_in(resulting-14, increase-18)
det(AUC-22, the-20)
amod(AUC-22, mean-21)
prep_in(increase-18, AUC-22)
prep_of(AUC-22, cisapride-24)

Data/NNS suggest/VBP that/IN coadministration/NN of/IN oral/JJ ketoconazole/NN and/CC cisapride/NN can/MD result/VB in/IN prolongation/NN of/IN the/DT QT/JJ interval/NN on/IN the/DT ECG/NN ./.

(ROOT (S1 (S (S (NP (NNS Data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (JJ oral) (NN ketoconazole)) (CC and) (NP (NN cisapride))))) (VP (MD can) (VP (VB result) (PP (IN in) (NP (NP (NN prolongation)) (PP (IN of) (NP (NP (DT the) (JJ QT) (NN interval)) (PP (IN on) (NP (DT the) (NN ECG))))))))))))) (. .))))

nsubj(suggest-2, Data-1)
root(ROOT-0, suggest-2)
complm(result-11, that-3)
nsubj(result-11, coadministration-4)
amod(ketoconazole-7, oral-6)
prep_of(coadministration-4, ketoconazole-7)
conj_and(ketoconazole-7, cisapride-9)
aux(result-11, can-10)
ccomp(suggest-2, result-11)
prep_in(result-11, prolongation-13)
det(interval-17, the-15)
amod(interval-17, QT-16)
prep_of(prolongation-13, interval-17)
det(ECG-20, the-19)
prep_on(interval-17, ECG-20)

In/FW vitro/FW data/NNS suggest/VBP that/IN itraconazole/NN also/RB markedly/RB inhibits/VBZ the/DT biotransformation/NN system/NN mainly/RB responsible/JJ for/IN the/DT metabolism/NN of/IN cisapride/NN ;/: ./.

(ROOT (S1 (S (S (NP (FW In) (FW vitro) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN itraconazole)) (ADVP (RB also)) (ADVP (RB markedly)) (VP (VBZ inhibits) (NP (NP (DT the) (NN biotransformation) (NN system)) (ADJP (RB mainly) (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN cisapride)))))))) (: ;))))) (. .))))

nn(data-3, In-1)
nn(data-3, vitro-2)
nsubj(suggest-4, data-3)
root(ROOT-0, suggest-4)
complm(inhibits-9, that-5)
nsubj(inhibits-9, itraconazole-6)
advmod(inhibits-9, also-7)
advmod(inhibits-9, markedly-8)
ccomp(suggest-4, inhibits-9)
det(system-12, the-10)
nn(system-12, biotransformation-11)
dobj(inhibits-9, system-12)
advmod(responsible-14, mainly-13)
amod(system-12, responsible-14)
det(metabolism-17, the-16)
prep_for(responsible-14, metabolism-17)
prep_of(metabolism-17, cisapride-19)

therefore/RB concomitant/JJ administration/NN of/IN Itraconazole/NN with/IN cisapride/NN is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (S (ADVP (RB therefore)) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN Itraconazole))) (PP (IN with) (NP (NN cisapride)))) (VP (VBZ is) (VP (VBN contraindicated)))) (. .))))

advmod(contraindicated-9, therefore-1)
amod(administration-3, concomitant-2)
nsubjpass(contraindicated-9, administration-3)
prep_of(administration-3, Itraconazole-5)
prep_with(administration-3, cisapride-7)
auxpass(contraindicated-9, is-8)
root(ROOT-0, contraindicated-9)

Coadministration/NN of/IN Itraconazole/NN with/IN oral/JJ midazolam/NN or/CC triazolam/NN has/VBZ resulted/VBD in/IN elevated/JJ plasma/NN concentrations/NNS of/IN the/DT latter/JJ two/CD drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN Itraconazole))) (PP (IN with) (NP (JJ oral) (NP (NN midazolam)) (CC or) (NP (NN triazolam))))) (VP (VBZ has) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ elevated) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (DT the) (JJ latter) (CD two) (NNS drugs)))))))) (. .))))

nsubj(resulted-10, Coadministration-1)
prep_of(Coadministration-1, Itraconazole-3)
amod(midazolam-6, oral-5)
prep_with(Coadministration-1, midazolam-6)
conj_or(midazolam-6, triazolam-8)
aux(resulted-10, has-9)
root(ROOT-0, resulted-10)
amod(concentrations-14, elevated-12)
nn(concentrations-14, plasma-13)
prep_in(resulted-10, concentrations-14)
det(drugs-19, the-16)
amod(drugs-19, latter-17)
num(drugs-19, two-18)
prep_of(concentrations-14, drugs-19)

This/DT may/MD potentiate/VB and/CC prolong/VB hypnotic/JJ and/CC sedative/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (MD may) (VP (VP (VB potentiate)) (CC and) (VP (VB prolong) (NP (ADJP (ADJP (JJ hypnotic)) (CC and) (ADJP (JJ sedative))) (NNS effects)))))) (. .))))

nsubj(potentiate-3, This-1)
aux(potentiate-3, may-2)
root(ROOT-0, potentiate-3)
conj_and(potentiate-3, prolong-5)
amod(effects-9, hypnotic-6)
conj_and(hypnotic-6, sedative-8)
dobj(prolong-5, effects-9)

These/DT agents/NNS should/MD not/RB be/VB used/VBN in/IN patients/NNS treated/VBN with/IN Itraconazole/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS agents)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NN Itraconazole)))))))))) (. .))))

det(agents-2, These-1)
nsubjpass(used-6, agents-2)
aux(used-6, should-3)
neg(used-6, not-4)
auxpass(used-6, be-5)
root(ROOT-0, used-6)
prep_in(used-6, patients-8)
partmod(patients-8, treated-9)
prep_with(treated-9, Itraconazole-11)

If/IN midazolam/NN is/VBZ administered/VBN parenterally/RB ,/, special/JJ precaution/NN is/VBZ required/VBN since/IN the/DT sedative/JJ effect/NN may/MD be/VB prolonged/JJ ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN midazolam)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB parenterally)))))) (, ,) (NP (JJ special) (NN precaution)) (VP (VBZ is) (VP (VBN required) (SBAR (IN since) (S (NP (DT the) (JJ sedative) (NN effect)) (VP (MD may) (VP (VB be) (ADJP (JJ prolonged))))))))) (. .))))

mark(administered-4, If-1)
nsubjpass(administered-4, midazolam-2)
auxpass(administered-4, is-3)
advcl(required-10, administered-4)
advmod(administered-4, parenterally-5)
amod(precaution-8, special-7)
nsubjpass(required-10, precaution-8)
auxpass(required-10, is-9)
root(ROOT-0, required-10)
mark(prolonged-17, since-11)
det(effect-14, the-12)
amod(effect-14, sedative-13)
nsubj(prolonged-17, effect-14)
aux(prolonged-17, may-15)
cop(prolonged-17, be-16)
advcl(required-10, prolonged-17)

Coadministration/NN of/IN Itraconazole/NN and/CC cyclosporine/NN ,/, tacrolimus/NN or/CC digoxin/NN has/VBZ led/VBN to/TO increased/VBN plasma/NN concentrations/NNS of/IN the/DT latter/JJ three/CD drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NN Itraconazole)) (CC and) (NP (NP (NN cyclosporine)) (, ,) (NP (NN tacrolimus)) (CC or) (NP (NN digoxin)))))) (VP (VBZ has) (VP (VBN led) (PP (TO to) (NP (NP (VBN increased) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (DT the) (JJ latter) (CD three) (NNS drugs)))))))) (. .))))

nsubj(led-11, Coadministration-1)
prep_of(Coadministration-1, Itraconazole-3)
conj_and(Itraconazole-3, cyclosporine-5)
conj_or(cyclosporine-5, tacrolimus-7)
conj_or(cyclosporine-5, digoxin-9)
aux(led-11, has-10)
root(ROOT-0, led-11)
amod(concentrations-15, increased-13)
nn(concentrations-15, plasma-14)
prep_to(led-11, concentrations-15)
det(drugs-20, the-17)
amod(drugs-20, latter-18)
num(drugs-20, three-19)
prep_of(concentrations-15, drugs-20)

Cyclosporine/NN ,/, tacrolimus/NN and/CC digoxin/NN concentrations/NNS should/MD be/VB monitored/VBN at/IN the/DT initiation/NN of/IN Itraconazole/NN therapy/NN and/CC frequently/RB thereafter/RB ,/, and/CC the/DT dose/NN of/IN these/DT three/CD drug/NN product/NN s/NNS adjusted/VBN appropriately/RB ./.

(ROOT (S1 (S (S (S (NP (NP (NN Cyclosporine)) (, ,) (NP (NN tacrolimus)) (CC and) (NP (NN digoxin) (NNS concentrations))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (PP (IN at) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (NP (NN Itraconazole) (NN therapy)) (CC and) (NP (RB frequently) (RB thereafter)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (DT these) (CD three) (NN drug) (NN product) (NNS s)))) (VP (VBN adjusted) (ADVP (RB appropriately))))) (. .))))

nsubjpass(monitored-9, Cyclosporine-1)
conj_and(Cyclosporine-1, tacrolimus-3)
nn(concentrations-6, digoxin-5)
conj_and(Cyclosporine-1, concentrations-6)
aux(monitored-9, should-7)
auxpass(monitored-9, be-8)
root(ROOT-0, monitored-9)
det(initiation-12, the-11)
prep_at(monitored-9, initiation-12)
nn(therapy-15, Itraconazole-14)
prep_of(initiation-12, therapy-15)
advmod(thereafter-18, frequently-17)
conj_and(therapy-15, thereafter-18)
det(dose-22, the-21)
nsubj(adjusted-29, dose-22)
det(s-28, these-24)
num(s-28, three-25)
nn(s-28, drug-26)
nn(s-28, product-27)
prep_of(dose-22, s-28)
conj_and(monitored-9, adjusted-29)
advmod(adjusted-29, appropriately-30)

There/EX have/VBP been/VBN rare/JJ reports/NNS of/IN rhabdomyolysis/NN involving/VBG renal/JJ transplant/NN patients/NNS receiving/VBG the/DT combination/NN of/IN Itraconazole/NN ,/, cyclosporine/NN ,/, and/CC the/DT HMG-CoA/NN reductase/NN inhibitors/NNS lovastatin/NN or/CC simvastatin/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (JJ rare) (NNS reports)) (PP (IN of) (NP (NN rhabdomyolysis))) (PP (VBG involving) (NP (NP (JJ renal) (NN transplant) (NNS patients)) (VP (VBG receiving) (NP (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NN Itraconazole)))) (, ,) (NP (NN cyclosporine)) (, ,) (CC and) (NP (NP (DT the) (NN HMG-CoA) (NN reductase) (NNS inhibitors)) (NP (NP (NN lovastatin)) (CC or) (NP (NN simvastatin)))))))))))) (. .))))

expl(reports-5, There-1)
aux(reports-5, have-2)
cop(reports-5, been-3)
amod(reports-5, rare-4)
root(ROOT-0, reports-5)
prep_of(reports-5, rhabdomyolysis-7)
amod(patients-11, renal-9)
nn(patients-11, transplant-10)
prep_involving(reports-5, patients-11)
partmod(patients-11, receiving-12)
det(combination-14, the-13)
dobj(receiving-12, combination-14)
prep_of(combination-14, Itraconazole-16)
conj_and(combination-14, cyclosporine-18)
det(inhibitors-24, the-21)
nn(inhibitors-24, HMG-CoA-22)
nn(inhibitors-24, reductase-23)
conj_and(combination-14, inhibitors-24)
dep(inhibitors-24, lovastatin-25)
conj_or(lovastatin-25, simvastatin-27)

Rhabdomyolysis/NN has/VBZ been/VBN observed/VBN in/IN patients/NNS receiving/VBG HMG-CoA/NN reductase/NN inhibitors/NNS administered/VBN alone/RB (/-LRB- at/IN recommended/VBN dosages/NNS )/-RRB- or/CC concomitantly/RB with/IN immunosuppressive/JJ drugs/NNS including/VBG cyclosporine/NN ./.

(ROOT (S1 (S (S (NP (NN Rhabdomyolysis)) (VP (VBZ has) (VP (VBN been) (VP (VBN observed) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN HMG-CoA) (NN reductase) (NNS inhibitors)) (VP (VBN administered) (ADVP (ADVP (ADVP (RB alone)) (PRN (-LRB- -LRB-) (PP (IN at) (NP (VBN recommended) (NNS dosages))) (-RRB- -RRB-))) (CC or) (ADVP (RB concomitantly))) (PP (IN with) (NP (NP (JJ immunosuppressive) (NNS drugs)) (PP (VBG including) (NP (NN cyclosporine)))))))))))))) (. .))))

nsubjpass(observed-4, Rhabdomyolysis-1)
aux(observed-4, has-2)
auxpass(observed-4, been-3)
root(ROOT-0, observed-4)
prep_in(observed-4, patients-6)
partmod(patients-6, receiving-7)
nn(inhibitors-10, HMG-CoA-8)
nn(inhibitors-10, reductase-9)
dobj(receiving-7, inhibitors-10)
partmod(inhibitors-10, administered-11)
advmod(administered-11, alone-12)
dep(alone-12, at-14)
amod(dosages-16, recommended-15)
pobj(at-14, dosages-16)
conj_or(alone-12, concomitantly-19)
amod(drugs-22, immunosuppressive-21)
prep_with(administered-11, drugs-22)
prep_including(drugs-22, cyclosporine-24)

When/WRB Itraconazole/NN was/VBD coadministered/VBN with/IN phenytoin/NN ,/, rifampin/NN ,/, or/CC H2antagonists/NN ,/, reduced/VBN plasma/NN concentrations/NNS of/IN itraconazole/NN were/VBD reported/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN Itraconazole)) (VP (VBD was) (VP (VBN coadministered) (PP (IN with) (NP (NP (NN phenytoin)) (, ,) (NP (NN rifampin)) (, ,) (CC or) (NP (NN H2antagonists)))))))) (, ,) (NP (NP (VBN reduced) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN itraconazole)))) (VP (VBD were) (VP (VBN reported)))) (. .))))

advmod(coadministered-4, When-1)
nsubjpass(coadministered-4, Itraconazole-2)
auxpass(coadministered-4, was-3)
advcl(reported-19, coadministered-4)
prep_with(coadministered-4, phenytoin-6)
conj_or(phenytoin-6, rifampin-8)
conj_or(phenytoin-6, H2antagonists-11)
amod(concentrations-15, reduced-13)
nn(concentrations-15, plasma-14)
nsubjpass(reported-19, concentrations-15)
prep_of(concentrations-15, itraconazole-17)
auxpass(reported-19, were-18)
root(ROOT-0, reported-19)

The/DT physician/NN is/VBZ advised/VBN to/TO monitor/VB the/DT plasma/NN concentrations/NNS of/IN itraconazole/NN when/WRB any/DT of/IN these/DT drugs/NNS is/VBZ taken/VBN concurrently/RB ,/, and/CC to/TO increase/VB the/DT dose/NN of/IN Itraconazole/NN if/IN necessary/JJ ./.

(ROOT (S1 (S (S (NP (DT The) (NN physician)) (VP (VBZ is) (VP (VBN advised) (S (VP (VP (TO to) (VP (VB monitor) (NP (NP (DT the) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN itraconazole)))) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT any)) (PP (IN of) (NP (DT these) (NNS drugs)))) (VP (VBZ is) (VP (VBN taken) (ADVP (RB concurrently)))))))) (, ,) (CC and) (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN Itraconazole)))) (SBAR (IN if) (FRAG (JJ necessary)))))))))) (. .))))

det(physician-2, The-1)
nsubjpass(advised-4, physician-2)
auxpass(advised-4, is-3)
root(ROOT-0, advised-4)
aux(monitor-6, to-5)
ccomp(advised-4, monitor-6)
det(concentrations-9, the-7)
nn(concentrations-9, plasma-8)
dobj(monitor-6, concentrations-9)
prep_of(concentrations-9, itraconazole-11)
advmod(taken-18, when-12)
nsubjpass(taken-18, any-13)
det(drugs-16, these-15)
prep_of(any-13, drugs-16)
auxpass(taken-18, is-17)
advcl(monitor-6, taken-18)
advmod(taken-18, concurrently-19)
aux(increase-23, to-22)
conj_and(monitor-6, increase-23)
det(dose-25, the-24)
dobj(increase-23, dose-25)
prep_of(dose-25, Itraconazole-27)
mark(necessary-29, if-28)
advcl(increase-23, necessary-29)

Although/IN no/DT studies/NNS have/VBP been/VBN conducted/VBN ,/, concomitant/JJ administration/NN of/IN Itraconazole/NN and/CC phenytoin/NN may/MD alter/VB the/DT metabolism/NN of/IN phenytoin/NN ;/: ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (DT no) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN conducted)))))) (, ,) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN Itraconazole)) (CC and) (NP (NN phenytoin))))) (VP (MD may) (VP (VB alter) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN phenytoin)))))) (: ;)) (. .))))

mark(conducted-6, Although-1)
det(studies-3, no-2)
nsubjpass(conducted-6, studies-3)
aux(conducted-6, have-4)
auxpass(conducted-6, been-5)
advcl(alter-15, conducted-6)
amod(administration-9, concomitant-8)
nsubj(alter-15, administration-9)
prep_of(administration-9, Itraconazole-11)
conj_and(Itraconazole-11, phenytoin-13)
aux(alter-15, may-14)
root(ROOT-0, alter-15)
det(metabolism-17, the-16)
dobj(alter-15, metabolism-17)
prep_of(metabolism-17, phenytoin-19)

therefore/RB ,/, plasma/NN concentrations/NNS of/IN phenytoin/NN should/MD also/RB be/VB monitored/VBN when/WRB it/PRP is/VBZ given/VBN concurrently/RB with/IN Itraconazole/NN ./.

(ROOT (S1 (S (S (ADVP (RB therefore)) (, ,) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN phenytoin)))) (VP (MD should) (ADVP (RB also)) (VP (VB be) (VP (VBN monitored) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN given) (ADVP (RB concurrently)) (PP (IN with) (NP (NN Itraconazole))))))))))) (. .))))

advmod(monitored-10, therefore-1)
nn(concentrations-4, plasma-3)
nsubjpass(monitored-10, concentrations-4)
prep_of(concentrations-4, phenytoin-6)
aux(monitored-10, should-7)
advmod(monitored-10, also-8)
auxpass(monitored-10, be-9)
root(ROOT-0, monitored-10)
advmod(given-14, when-11)
nsubjpass(given-14, it-12)
auxpass(given-14, is-13)
advcl(monitored-10, given-14)
advmod(given-14, concurrently-15)
prep_with(given-14, Itraconazole-17)

It/PRP has/VBZ been/VBN reported/VBN that/IN Itraconazole/NN enhances/VBZ the/DT anticoagulant/JJ effect/NN of/IN coumarin/JJ -like/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (SBAR (IN that) (S (NP (NN Itraconazole)) (VP (VBZ enhances) (NP (NP (DT the) (JJ anticoagulant) (NN effect)) (PP (IN of) (NP (JJ coumarin) (JJ -like) (NNS drugs))))))))))) (. .))))

nsubjpass(reported-4, It-1)
aux(reported-4, has-2)
auxpass(reported-4, been-3)
root(ROOT-0, reported-4)
complm(enhances-7, that-5)
nsubj(enhances-7, Itraconazole-6)
ccomp(reported-4, enhances-7)
det(effect-10, the-8)
amod(effect-10, anticoagulant-9)
dobj(enhances-7, effect-10)
amod(drugs-14, coumarin-12)
amod(drugs-14, -like-13)
prep_of(effect-10, drugs-14)

Therefore/RB ,/, prothrombin/NN time/NN should/MD be/VB carefully/RB monitored/VBN in/IN patients/NNS receiving/VBG Itraconazole/NN and/CC coumarin/JJ -like/JJ drugs/NNS simultaneously/RB ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NN prothrombin) (NN time)) (VP (MD should) (VP (VB be) (ADVP (RB carefully)) (VP (VBN monitored) (PP (IN in) (NP (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN Itraconazole)))) (CC and) (NP (JJ coumarin) (JJ -like) (NNS drugs)))) (ADVP (RB simultaneously)))))) (. .))))

advmod(monitored-8, Therefore-1)
nn(time-4, prothrombin-3)
nsubjpass(monitored-8, time-4)
aux(monitored-8, should-5)
auxpass(monitored-8, be-6)
advmod(monitored-8, carefully-7)
root(ROOT-0, monitored-8)
prep_in(monitored-8, patients-10)
partmod(patients-10, receiving-11)
dobj(receiving-11, Itraconazole-12)
amod(drugs-16, coumarin-14)
amod(drugs-16, -like-15)
conj_and(patients-10, drugs-16)
advmod(monitored-8, simultaneously-17)

Plasma/NN concentrations/NNS of/IN azole/JJ antifungal/JJ agents/NNS are/VBP reduced/VBN when/WRB given/VBN concurrently/RB with/IN isoniazid/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Plasma) (NNS concentrations)) (PP (IN of) (NP (JJ azole) (JJ antifungal) (NNS agents)))) (VP (VBP are) (VP (VBN reduced) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (ADVP (RB concurrently)) (PP (IN with) (NP (NN isoniazid))))))))) (. .))))

nn(concentrations-2, Plasma-1)
nsubjpass(reduced-8, concentrations-2)
amod(agents-6, azole-4)
amod(agents-6, antifungal-5)
prep_of(concentrations-2, agents-6)
auxpass(reduced-8, are-7)
root(ROOT-0, reduced-8)
advmod(given-10, when-9)
advcl(reduced-8, given-10)
advmod(given-10, concurrently-11)
prep_with(given-10, isoniazid-13)

Itraconazole/JJ plasma/NN concentrations/NNS should/MD be/VB monitored/VBN when/WRB Itraconazole/NN and/CC isoniazid/NN are/VBP coadministered/VBN ./.

(ROOT (S1 (S (S (NP (JJ Itraconazole) (NN plasma) (NNS concentrations)) (VP (MD should) (VP (VB be) (VP (VBN monitored))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN Itraconazole)) (CC and) (NP (NN isoniazid))) (VP (VBP are) (VP (VBN coadministered))))))) (. .))))

amod(concentrations-3, Itraconazole-1)
nn(concentrations-3, plasma-2)
nsubjpass(monitored-6, concentrations-3)
aux(monitored-6, should-4)
auxpass(monitored-6, be-5)
root(ROOT-0, monitored-6)
advmod(coadministered-12, when-7)
nsubjpass(coadministered-12, Itraconazole-8)
conj_and(Itraconazole-8, isoniazid-10)
auxpass(coadministered-12, are-11)
advcl(monitored-6, coadministered-12)

Severe/JJ hypoglycemia/NN has/VBZ been/VBN reported/VBN in/IN patients/NNS concomitantly/RB receiving/VBG azole/JJ antifungal/JJ agents/NNS and/CC oral/JJ hypoglycemic/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (JJ Severe) (NN hypoglycemia)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (ADVP (RB concomitantly)) (VBG receiving) (NP (NP (JJ azole) (JJ antifungal) (NNS agents)) (CC and) (NP (JJ oral) (JJ hypoglycemic) (NNS agents)))))))))) (. .))))

amod(hypoglycemia-2, Severe-1)
nsubjpass(reported-5, hypoglycemia-2)
aux(reported-5, has-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
prep_in(reported-5, patients-7)
advmod(receiving-9, concomitantly-8)
partmod(patients-7, receiving-9)
amod(agents-12, azole-10)
amod(agents-12, antifungal-11)
dobj(receiving-9, agents-12)
amod(agents-16, oral-14)
amod(agents-16, hypoglycemic-15)
conj_and(agents-12, agents-16)

Blood/NN glucose/NN concentrations/NNS should/MD be/VB carefully/RB monitored/VBN when/WRB Itraconazole/JJ and/CC oral/JJ hypoglycemic/JJ agents/NNS are/VBP coadministered/VBN ./.

(ROOT (S1 (S (S (NP (NN Blood) (NN glucose) (NNS concentrations)) (VP (MD should) (VP (VB be) (ADVP (RB carefully)) (VP (VBN monitored) (SBAR (WHADVP (WRB when)) (S (NP (ADJP (ADJP (JJ Itraconazole)) (CC and) (ADJP (JJ oral))) (JJ hypoglycemic) (NNS agents)) (VP (VBP are) (VP (VBN coadministered))))))))) (. .))))

nn(concentrations-3, Blood-1)
nn(concentrations-3, glucose-2)
nsubjpass(monitored-7, concentrations-3)
aux(monitored-7, should-4)
auxpass(monitored-7, be-5)
advmod(monitored-7, carefully-6)
root(ROOT-0, monitored-7)
advmod(coadministered-15, when-8)
amod(agents-13, Itraconazole-9)
conj_and(Itraconazole-9, oral-11)
amod(agents-13, hypoglycemic-12)
nsubjpass(coadministered-15, agents-13)
auxpass(coadministered-15, are-14)
advcl(monitored-7, coadministered-15)

Tinnitus/NN and/CC decreased/VBN hearing/NN have/VBP been/VBN reported/VBN in/IN patients/NNS concomitantly/RB receiving/VBG Itraconazole/NN and/CC quinidine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Tinnitus)) (CC and) (NP (VBN decreased) (NN hearing))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (ADVP (RB concomitantly)) (VBG receiving) (NP (NP (NN Itraconazole)) (CC and) (NP (NN quinidine)))))))))) (. .))))

nsubjpass(reported-7, Tinnitus-1)
amod(hearing-4, decreased-3)
conj_and(Tinnitus-1, hearing-4)
aux(reported-7, have-5)
auxpass(reported-7, been-6)
root(ROOT-0, reported-7)
prep_in(reported-7, patients-9)
advmod(receiving-11, concomitantly-10)
partmod(patients-9, receiving-11)
dobj(receiving-11, Itraconazole-12)
conj_and(Itraconazole-12, quinidine-14)

Edema/NN has/VBZ been/VBN reported/VBN in/IN patients/NNS concomitantly/RB receiving/VBG Itraconazole/NN and/CC dihydropyridine/NN calcium/NN channel/NN blockers/NNS ./.

(ROOT (S1 (S (S (NP (NN Edema)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NP (NNS patients)) (VP (ADVP (RB concomitantly)) (VBG receiving) (NP (NN Itraconazole)))) (CC and) (NP (NN dihydropyridine) (NN calcium) (NN channel) (NNS blockers)))))))) (. .))))

nsubjpass(reported-4, Edema-1)
aux(reported-4, has-2)
auxpass(reported-4, been-3)
root(ROOT-0, reported-4)
prep_in(reported-4, patients-6)
advmod(receiving-8, concomitantly-7)
partmod(patients-6, receiving-8)
dobj(receiving-8, Itraconazole-9)
nn(blockers-14, dihydropyridine-11)
nn(blockers-14, calcium-12)
nn(blockers-14, channel-13)
conj_and(patients-6, blockers-14)

The/DT results/NNS from/IN a/DT study/NN in/IN which/WDT eight/CD HIV-infected/JJ individuals/NNS were/VBD treated/VBN with/IN zidovudine/NN ,/, 8/CD +/-/CC 0.4/CD mg/kg/day/NN ,/, showed/VBD that/IN the/DT pharmacokinetics/NNS of/IN zidovudine/NN were/VBD not/RB affected/VBN during/IN concomitant/JJ administration/NN of/IN Itraconazole/NN ,/, 100/CD mg/NN b.i.d./NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS results)) (PP (IN from) (NP (NP (DT a) (NN study)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (CD eight) (JJ HIV-infected) (NNS individuals)) (VP (VBD were) (VP (VBN treated) (PP (IN with) (NP (NP (NN zidovudine)) (, ,) (NP (QP (CD 8) (CC +/-) (CD 0.4)) (NN mg/kg/day)) (, ,)))))))))) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN zidovudine)))) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN during) (NP (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN Itraconazole)))) (, ,) (NP (ADJP (CD 100) (NN mg)) (NN b.i.d.)))))))))) (. .))))

det(results-2, The-1)
nsubj(showed-21, results-2)
det(study-5, a-4)
prep_from(results-2, study-5)
rel(treated-12, which-7)
num(individuals-10, eight-8)
amod(individuals-10, HIV-infected-9)
nsubjpass(treated-12, individuals-10)
auxpass(treated-12, were-11)
rcmod(study-5, treated-12)
prep_with(treated-12, zidovudine-14)
num(mg/kg/day-19, 8-16)
conj_+/-(8-16, 0.4-18)
appos(zidovudine-14, mg/kg/day-19)
root(ROOT-0, showed-21)
complm(affected-29, that-22)
det(pharmacokinetics-24, the-23)
nsubjpass(affected-29, pharmacokinetics-24)
prep_of(pharmacokinetics-24, zidovudine-26)
auxpass(affected-29, were-27)
neg(affected-29, not-28)
ccomp(showed-21, affected-29)
amod(administration-32, concomitant-31)
prep_during(affected-29, administration-32)
prep_of(administration-32, Itraconazole-34)
number(mg-37, 100-36)
amod(b.i.d.-38, mg-37)
appos(administration-32, b.i.d.-38)

In/FW vitro/FW mixing/NN of/IN an/DT aminoglycoside/NN with/IN beta-lactamtype/JJ antibiotics/NNS (/-LRB- penicillins/NNS or/CC cephalosporins/NNS )/-RRB- may/MD result/VB in/IN a/DT significant/JJ mutual/JJ inactivation/NN ./.

(ROOT (S1 (S (S (NP (NP (ADJP (FW In) (FW vitro)) (NN mixing)) (PP (IN of) (NP (DT an) (NN aminoglycoside))) (PP (IN with) (NP (NP (JJ beta-lactamtype) (NNS antibiotics)) (PRN (-LRB- -LRB-) (NP (NP (NNS penicillins)) (CC or) (NP (NNS cephalosporins))) (-RRB- -RRB-))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (DT a) (JJ significant) (JJ mutual) (NN inactivation)))))) (. .))))

nn(vitro-2, In-1)
amod(mixing-3, vitro-2)
nsubj(result-16, mixing-3)
det(aminoglycoside-6, an-5)
prep_of(mixing-3, aminoglycoside-6)
amod(antibiotics-9, beta-lactamtype-8)
prep_with(mixing-3, antibiotics-9)
dep(antibiotics-9, penicillins-11)
conj_or(penicillins-11, cephalosporins-13)
aux(result-16, may-15)
root(ROOT-0, result-16)
det(inactivation-21, a-18)
amod(inactivation-21, significant-19)
amod(inactivation-21, mutual-20)
prep_in(result-16, inactivation-21)

Even/RB when/WRB an/DT aminoglycoside/NN and/CC a/DT penicillin/NN -type/JJ drug/NN are/VBP administered/VBN separately/RB by/IN different/JJ routes/NNS ,/, a/DT reduction/NN in/IN aminoglycoside/NN serum/NN half-life/NN or/CC serum/NN levels/NNS has/VBZ been/VBN reported/VBN in/IN patients/NNS with/IN impaired/JJ renal/JJ function/NN and/CC in/IN some/DT patients/NNS with/IN normal/JJ renal/JJ function/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (RB Even) (WRB when)) (S (NP (NP (DT an) (NN aminoglycoside)) (CC and) (NP (DT a) (NN penicillin) (JJ -type) (NN drug))) (VP (VBP are) (VP (VBN administered) (ADVP (RB separately)) (PP (IN by) (NP (JJ different) (NNS routes))))))) (, ,) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (NP (NN aminoglycoside) (NN serum) (NN half-life)) (CC or) (NP (NN serum) (NNS levels))))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ impaired) (JJ renal) (NN function))))) (CC and) (PP (IN in) (NP (NP (DT some) (NNS patients)) (PP (IN with) (NP (JJ normal) (JJ renal) (NN function)))))))))) (. .))))

advmod(when-2, Even-1)
advmod(administered-11, when-2)
det(aminoglycoside-4, an-3)
nsubjpass(administered-11, aminoglycoside-4)
det(drug-9, a-6)
nn(drug-9, penicillin-7)
amod(drug-9, -type-8)
conj_and(aminoglycoside-4, drug-9)
auxpass(administered-11, are-10)
advcl(reported-28, administered-11)
advmod(administered-11, separately-12)
amod(routes-15, different-14)
agent(administered-11, routes-15)
det(reduction-18, a-17)
nsubjpass(reported-28, reduction-18)
nn(half-life-22, aminoglycoside-20)
nn(half-life-22, serum-21)
prep_in(reduction-18, half-life-22)
nn(levels-25, serum-24)
conj_or(half-life-22, levels-25)
aux(reported-28, has-26)
auxpass(reported-28, been-27)
root(ROOT-0, reported-28)
prep_in(reported-28, patients-30)
amod(function-34, impaired-32)
amod(function-34, renal-33)
prep_with(patients-30, function-34)
det(patients-38, some-37)
conj_and(patients-30, patients-38)
amod(function-42, normal-40)
amod(function-42, renal-41)
prep_with(patients-38, function-42)

Usually/RB ,/, such/JJ inactivation/NN of/IN the/DT aminoglycoside/NN is/VBZ clinically/RB significant/JJ only/RB in/IN patients/NNS with/IN severely/RB impaired/JJ renal/JJ function/NN ../NN

(ROOT (S1 (S (ADVP (RB Usually)) (, ,) (NP (NP (JJ such) (NN inactivation)) (PP (IN of) (NP (DT the) (NN aminoglycoside)))) (VP (VBZ is) (ADJP (RB clinically) (JJ significant) (PP (ADVP (RB only)) (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (ADJP (RB severely) (JJ impaired)) (JJ renal) (NN function) (NN ..))))))))))

advmod(significant-10, Usually-1)
amod(inactivation-4, such-3)
nsubj(significant-10, inactivation-4)
det(aminoglycoside-7, the-6)
prep_of(inactivation-4, aminoglycoside-7)
cop(significant-10, is-8)
advmod(significant-10, clinically-9)
root(ROOT-0, significant-10)
advmod(significant-10, only-11)
prep_in(significant-10, patients-13)
advmod(impaired-16, severely-15)
amod(..-19, impaired-16)
amod(..-19, renal-17)
nn(..-19, function-18)
prep_with(patients-13, ..-19)

Prolonged/JJ recovery/NN time/NN may/MD occur/VB if/IN barbiturates/NNS and/or/CC narcotics/NNS are/VBP used/VBN concurrently/RB with/IN ketamine/NN ./.

(ROOT (S1 (S (S (NP (JJ Prolonged) (NN recovery) (NN time)) (VP (MD may) (VP (VB occur) (SBAR (IN if) (S (NP (NP (NNS barbiturates)) (CC and/or) (NP (NNS narcotics))) (VP (VBP are) (VP (VBN used) (ADVP (RB concurrently)) (PP (IN with) (NP (NN ketamine)))))))))) (. .))))

amod(time-3, Prolonged-1)
nn(time-3, recovery-2)
nsubj(occur-5, time-3)
aux(occur-5, may-4)
root(ROOT-0, occur-5)
mark(used-11, if-6)
nsubjpass(used-11, barbiturates-7)
conj_and/or(barbiturates-7, narcotics-9)
auxpass(used-11, are-10)
advcl(occur-5, used-11)
advmod(used-11, concurrently-12)
prep_with(used-11, ketamine-14)

Ketamine/NN is/VBZ clinically/RB compatible/JJ with/IN the/DT commonly/RB used/VBN general/JJ and/CC local/JJ anesthetic/JJ agents/NNS when/WRB an/DT adequate/JJ respiratory/JJ exchange/NN is/VBZ maintained/VBN ./.

(ROOT (S1 (S (S (NP (NN Ketamine)) (VP (VBZ is) (ADJP (RB clinically) (JJ compatible) (PP (IN with) (NP (DT the) (ADJP (RB commonly) (VBN used)) (ADJP (ADJP (JJ general)) (CC and) (ADJP (JJ local))) (JJ anesthetic) (NNS agents)))) (SBAR (WHADVP (WRB when)) (S (NP (DT an) (JJ adequate) (JJ respiratory) (NN exchange)) (VP (VBZ is) (VP (VBN maintained))))))) (. .))))

nsubj(compatible-4, Ketamine-1)
cop(compatible-4, is-2)
advmod(compatible-4, clinically-3)
root(ROOT-0, compatible-4)
det(agents-13, the-6)
advmod(used-8, commonly-7)
amod(agents-13, used-8)
amod(agents-13, general-9)
conj_and(general-9, local-11)
amod(agents-13, anesthetic-12)
prep_with(compatible-4, agents-13)
advmod(maintained-20, when-14)
det(exchange-18, an-15)
amod(exchange-18, adequate-16)
amod(exchange-18, respiratory-17)
nsubjpass(maintained-20, exchange-18)
auxpass(maintained-20, is-19)
advcl(compatible-4, maintained-20)

Ketoconazole/NN is/VBZ a/DT potent/JJ inhibitor/NN of/IN the/DT cytochrome/NN P450/NN 3A4/NN enzyme/NN system/NN ./.

(ROOT (S1 (S (S (NP (NN Ketoconazole)) (VP (VBZ is) (NP (NP (DT a) (JJ potent) (NN inhibitor)) (PP (IN of) (NP (DT the) (NP (NN cytochrome) (NN P450) (NN 3A4)) (NN enzyme) (NN system)))))) (. .))))

nsubj(inhibitor-5, Ketoconazole-1)
cop(inhibitor-5, is-2)
det(inhibitor-5, a-3)
amod(inhibitor-5, potent-4)
root(ROOT-0, inhibitor-5)
det(system-12, the-7)
nn(3A4-10, cytochrome-8)
nn(3A4-10, P450-9)
nn(system-12, 3A4-10)
nn(system-12, enzyme-11)
prep_of(inhibitor-5, system-12)

Coadministration/NN of/IN NIZORAL/JJ @/NN Tablets/NNS and/CC drugs/NNS primarily/RB metabolized/VBN by/IN the/DT cytochrome/NN P450/NN 3A4/NN enzyme/NN system/NN may/MD result/VB in/IN increased/VBN plasma/NN concentrations/NNS of/IN the/DT drugs/NNS that/WDT could/MD increase/VB or/CC prolong/VB both/CC therapeutic/JJ and/CC adverse/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NP (JJ NIZORAL) (NN @) (NNS Tablets)) (CC and) (NP (NNS drugs))) (VP (ADVP (RB primarily)) (VBN metabolized) (PP (IN by) (NP (DT the) (NP (NN cytochrome) (NN P450) (NN 3A4)) (NN enzyme) (NN system))))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (VBN increased) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (DT the) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VP (VB increase)) (CC or) (VP (VB prolong) (NP (ADJP (CC both) (ADJP (JJ therapeutic)) (CC and) (ADJP (JJ adverse))) (NNS effects)))))))))))))) (. .))))

nsubj(result-18, Coadministration-1)
amod(Tablets-5, NIZORAL-3)
nn(Tablets-5, @-4)
prep_of(Coadministration-1, Tablets-5)
conj_and(Tablets-5, drugs-7)
advmod(metabolized-9, primarily-8)
partmod(Tablets-5, metabolized-9)
det(system-16, the-11)
nn(3A4-14, cytochrome-12)
nn(3A4-14, P450-13)
nn(system-16, 3A4-14)
nn(system-16, enzyme-15)
agent(metabolized-9, system-16)
aux(result-18, may-17)
root(ROOT-0, result-18)
amod(concentrations-22, increased-20)
nn(concentrations-22, plasma-21)
prep_in(result-18, concentrations-22)
det(drugs-25, the-24)
prep_of(concentrations-22, drugs-25)
nsubj(increase-28, drugs-25)
aux(increase-28, could-27)
rcmod(drugs-25, increase-28)
conj_or(increase-28, prolong-30)
preconj(therapeutic-32, both-31)
amod(effects-35, therapeutic-32)
conj_and(therapeutic-32, adverse-34)
dobj(prolong-30, effects-35)

The/DT following/VBG drug/NN interactions/NNS have/VBP been/VBN identified/VBN involving/VBG NIZORAL/NN span/NN class=/IN c97/NN @/NN Tablets/NNS and/CC other/JJ drugs/NNS metabolized/VBN by/IN the/DT cytochrome/NN P450/NN 3A4/NN enzyme/NN system/NN :/: Ketoconazole/NN tablets/NNS inhibit/VBP the/DT metabolism/NN of/IN terfenadine/NN ,/, resulting/VBG in/IN an/DT increased/VBN plasma/NN concentration/NN of/IN terfenadine/NN and/CC a/DT delay/NN in/IN the/DT elimination/NN of/IN its/PRP$ acid/NN metabolite/NN ./.

(ROOT (S1 (S (S (NP (DT The) (VBG following) (NN drug) (NNS interactions)) (VP (VBP have) (VP (VBN been) (VP (VBN identified) (S (VP (VBG involving) (NP (NP (NN NIZORAL) (NN span)) (PP (IN class=) (NP (NP (NP (NN c97) (NN @) (NNS Tablets)) (CC and) (NP (JJ other) (NNS drugs))) (VP (VBN metabolized) (PP (IN by) (NP (NP (DT the) (NN cytochrome) (NN P450) (NN 3A4)) (NN enzyme) (NN system))))))))))))) (: :) (S (NP (NN Ketoconazole) (NNS tablets)) (VP (VBP inhibit) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN terfenadine)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (NP (DT an) (VBN increased) (NN plasma) (NN concentration)) (PP (IN of) (NP (NN terfenadine)))) (CC and) (NP (NP (DT a) (NN delay)) (PP (IN in) (NP (NP (DT the) (NN elimination)) (PP (IN of) (NP (PRP$ its) (NN acid) (NN metabolite)))))))))))) (. .))))

det(interactions-4, The-1)
amod(interactions-4, following-2)
nn(interactions-4, drug-3)
nsubjpass(identified-7, interactions-4)
aux(identified-7, have-5)
auxpass(identified-7, been-6)
root(ROOT-0, identified-7)
xcomp(identified-7, involving-8)
nn(span-10, NIZORAL-9)
dobj(involving-8, span-10)
nn(Tablets-14, c97-12)
nn(Tablets-14, @-13)
prep_class=(span-10, Tablets-14)
amod(drugs-17, other-16)
conj_and(Tablets-14, drugs-17)
partmod(Tablets-14, metabolized-18)
det(3A4-23, the-20)
nn(3A4-23, cytochrome-21)
nn(3A4-23, P450-22)
nn(system-25, 3A4-23)
nn(system-25, enzyme-24)
agent(metabolized-18, system-25)
nn(tablets-28, Ketoconazole-27)
nsubj(inhibit-29, tablets-28)
parataxis(identified-7, inhibit-29)
det(metabolism-31, the-30)
dobj(inhibit-29, metabolism-31)
prep_of(metabolism-31, terfenadine-33)
partmod(inhibit-29, resulting-35)
xcomp(inhibit-29, resulting-35)
det(concentration-40, an-37)
amod(concentration-40, increased-38)
nn(concentration-40, plasma-39)
prep_in(resulting-35, concentration-40)
prep_of(concentration-40, terfenadine-42)
det(delay-45, a-44)
conj_and(concentration-40, delay-45)
det(elimination-48, the-47)
prep_in(delay-45, elimination-48)
poss(metabolite-52, its-50)
nn(metabolite-52, acid-51)
prep_of(elimination-48, metabolite-52)

The/DT increased/VBN plasma/NN concentration/NN of/IN terfenadine/NN or/CC its/PRP$ metabolite/NN may/MD result/VB in/IN prolonged/JJ QT/VBG intervals/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (VBN increased) (NN plasma) (NN concentration)) (PP (IN of) (NP (NP (NN terfenadine)) (CC or) (NP (PRP$ its) (NN metabolite))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (JJ prolonged) (VBG QT) (NNS intervals)))))) (. .))))

det(concentration-4, The-1)
amod(concentration-4, increased-2)
nn(concentration-4, plasma-3)
nsubj(result-11, concentration-4)
prep_of(concentration-4, terfenadine-6)
poss(metabolite-9, its-8)
conj_or(terfenadine-6, metabolite-9)
aux(result-11, may-10)
root(ROOT-0, result-11)
amod(intervals-15, prolonged-13)
amod(intervals-15, QT-14)
prep_in(result-11, intervals-15)

Pharmacokinetic/JJ data/NNS indicate/VBP that/IN oral/JJ ketoconazole/NN inhibits/VBZ the/DT metabolism/NN of/IN astemizole/NN ,/, resulting/VBG in/IN elevated/JJ plasma/NN levels/NNS of/IN astemizole/NN and/CC its/PRP$ active/JJ metabolite/NN desmethylastemizole/NN which/WDT may/MD prolong/VB QT/VBG intervals/NNS ./.

(ROOT (S1 (S (S (NP (JJ Pharmacokinetic) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (JJ oral) (NN ketoconazole)) (VP (VBZ inhibits) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN astemizole)))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (JJ elevated) (NN plasma) (NNS levels)) (PP (IN of) (NP (NP (NN astemizole)) (CC and) (NP (PRP$ its) (JJ active) (NN metabolite)) (NP (NN desmethylastemizole)))) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB prolong) (NP (VBG QT) (NNS intervals))))))))))))))) (. .))))

amod(data-2, Pharmacokinetic-1)
nsubj(indicate-3, data-2)
root(ROOT-0, indicate-3)
complm(inhibits-7, that-4)
amod(ketoconazole-6, oral-5)
nsubj(inhibits-7, ketoconazole-6)
ccomp(indicate-3, inhibits-7)
det(metabolism-9, the-8)
dobj(inhibits-7, metabolism-9)
prep_of(metabolism-9, astemizole-11)
partmod(inhibits-7, resulting-13)
xcomp(inhibits-7, resulting-13)
amod(levels-17, elevated-15)
nn(levels-17, plasma-16)
prep_in(resulting-13, levels-17)
nsubj(prolong-27, levels-17)
prep_of(levels-17, astemizole-19)
poss(metabolite-23, its-21)
amod(metabolite-23, active-22)
conj_and(astemizole-19, metabolite-23)
dep(astemizole-19, desmethylastemizole-24)
aux(prolong-27, may-26)
rcmod(levels-17, prolong-27)
amod(intervals-29, QT-28)
dobj(prolong-27, intervals-29)

Coadministration/NN of/IN astemizole/NN with/IN ketoconazole/NN tablets/NNS is/VBZ therefore/RB contraindicated/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN astemizole))) (PP (IN with) (NP (NN ketoconazole) (NNS tablets)))) (VP (VBZ is) (ADVP (RB therefore)) (VP (VBN contraindicated)))) (. .))))

nsubjpass(contraindicated-9, Coadministration-1)
prep_of(Coadministration-1, astemizole-3)
nn(tablets-6, ketoconazole-5)
prep_with(Coadministration-1, tablets-6)
auxpass(contraindicated-9, is-7)
advmod(contraindicated-9, therefore-8)
root(ROOT-0, contraindicated-9)

Human/JJ pharmacokinetics/NNS data/NNS indicate/VBP that/IN oral/JJ ketoconazole/NN potently/RB inhibits/VBZ the/DT metabolism/NN of/IN cisapride/NN resulting/VBG in/IN a/DT mean/NN eight-fold/JJ increase/NN in/IN AUC/NN of/IN cisapride/NN ./.

(ROOT (S1 (S (S (NP (JJ Human) (NNS pharmacokinetics) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (JJ oral) (NN ketoconazole)) (ADVP (RB potently)) (VP (VBZ inhibits) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NP (NN cisapride)) (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (ADJP (NN mean) (JJ eight-fold)) (NN increase)) (PP (IN in) (NP (NP (NN AUC)) (PP (IN of) (NP (NN cisapride)))))))))))))))) (. .))))

amod(data-3, Human-1)
nn(data-3, pharmacokinetics-2)
nsubj(indicate-4, data-3)
root(ROOT-0, indicate-4)
complm(inhibits-9, that-5)
amod(ketoconazole-7, oral-6)
nsubj(inhibits-9, ketoconazole-7)
advmod(inhibits-9, potently-8)
ccomp(indicate-4, inhibits-9)
det(metabolism-11, the-10)
dobj(inhibits-9, metabolism-11)
prep_of(metabolism-11, cisapride-13)
partmod(cisapride-13, resulting-14)
det(increase-19, a-16)
dep(eight-fold-18, mean-17)
amod(increase-19, eight-fold-18)
prep_in(resulting-14, increase-19)
prep_in(increase-19, AUC-21)
prep_of(AUC-21, cisapride-23)

Data/NNS suggest/VBP that/IN coadministration/NN of/IN oral/JJ ketoconazole/NN and/CC cisapride/NN can/MD result/VB in/IN prolongation/NN of/IN the/DT QT/JJ interval/NN on/IN the/DT ECG/NN ./.

(ROOT (S1 (S (S (NP (NNS Data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (JJ oral) (NN ketoconazole)) (CC and) (NP (NN cisapride))))) (VP (MD can) (VP (VB result) (PP (IN in) (NP (NP (NN prolongation)) (PP (IN of) (NP (NP (DT the) (JJ QT) (NN interval)) (PP (IN on) (NP (DT the) (NN ECG))))))))))))) (. .))))

nsubj(suggest-2, Data-1)
root(ROOT-0, suggest-2)
complm(result-11, that-3)
nsubj(result-11, coadministration-4)
amod(ketoconazole-7, oral-6)
prep_of(coadministration-4, ketoconazole-7)
conj_and(ketoconazole-7, cisapride-9)
aux(result-11, can-10)
ccomp(suggest-2, result-11)
prep_in(result-11, prolongation-13)
det(interval-17, the-15)
amod(interval-17, QT-16)
prep_of(prolongation-13, interval-17)
det(ECG-20, the-19)
prep_on(interval-17, ECG-20)

Therefore/RB concomitant/JJ administration/NN of/IN ketoconazole/NN tablets/NNS with/IN cisapride/NN is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN ketoconazole) (NNS tablets))) (PP (IN with) (NP (NN cisapride)))) (VP (VBZ is) (VP (VBN contraindicated)))) (. .))))

advmod(contraindicated-10, Therefore-1)
amod(administration-3, concomitant-2)
nsubjpass(contraindicated-10, administration-3)
nn(tablets-6, ketoconazole-5)
prep_of(administration-3, tablets-6)
prep_with(administration-3, cisapride-8)
auxpass(contraindicated-10, is-9)
root(ROOT-0, contraindicated-10)

Ketoconazole/NN tablets/NNS may/MD alter/VB the/DT metabolism/NN of/IN cyclosporine/NN ,/, tacrolimus/NN ,/, and/CC methylprednisolone/NN ,/, resulting/VBG in/IN elevated/JJ plasma/NN concentrations/NNS of/IN the/DT latter/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NN Ketoconazole) (NNS tablets)) (VP (MD may) (VP (VB alter) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NP (NN cyclosporine)) (, ,) (NP (NN tacrolimus)) (, ,) (CC and) (NP (NN methylprednisolone))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (JJ elevated) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (DT the) (JJ latter) (NNS drugs)))))))))) (. .))))

nn(tablets-2, Ketoconazole-1)
nsubj(alter-4, tablets-2)
aux(alter-4, may-3)
root(ROOT-0, alter-4)
det(metabolism-6, the-5)
dobj(alter-4, metabolism-6)
prep_of(metabolism-6, cyclosporine-8)
conj_and(cyclosporine-8, tacrolimus-10)
conj_and(cyclosporine-8, methylprednisolone-13)
partmod(alter-4, resulting-15)
xcomp(alter-4, resulting-15)
amod(concentrations-19, elevated-17)
nn(concentrations-19, plasma-18)
prep_in(resulting-15, concentrations-19)
det(drugs-23, the-21)
amod(drugs-23, latter-22)
prep_of(concentrations-19, drugs-23)

Dosage/JJ adjustment/NN may/MD be/VB required/VBN if/IN cyclosporine/NN ,/, tacrolimus/NN ,/, or/CC methylprednisolone/NN are/VBP given/VBN concomitantly/RB with/IN NIZORAL/JJ @/NN Tablets/NNS ./.

(ROOT (S1 (S (S (NP (JJ Dosage) (NN adjustment)) (VP (MD may) (VP (VB be) (VP (VBN required) (SBAR (IN if) (S (NP (NP (NN cyclosporine)) (, ,) (NP (NN tacrolimus)) (, ,) (CC or) (NP (NN methylprednisolone))) (VP (VBP are) (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (JJ NIZORAL) (NN @) (NNS Tablets))))))))))) (. .))))

amod(adjustment-2, Dosage-1)
nsubjpass(required-5, adjustment-2)
aux(required-5, may-3)
auxpass(required-5, be-4)
root(ROOT-0, required-5)
mark(given-14, if-6)
nsubjpass(given-14, cyclosporine-7)
conj_or(cyclosporine-7, tacrolimus-9)
conj_or(cyclosporine-7, methylprednisolone-12)
auxpass(given-14, are-13)
advcl(required-5, given-14)
advmod(given-14, concomitantly-15)
amod(Tablets-19, NIZORAL-17)
nn(Tablets-19, @-18)
prep_with(given-14, Tablets-19)

Coadministration/NN of/IN NIZORAL/JJ @/NN Tablets/NNS with/IN midazolam/NN or/CC triazolam/NN has/VBZ resulted/VBD in/IN elevated/JJ plasma/NN concentrations/NNS of/IN the/DT latter/JJ two/CD drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (JJ NIZORAL) (NN @) (NNS Tablets))) (PP (IN with) (NP (NP (NN midazolam)) (CC or) (NP (NN triazolam))))) (VP (VBZ has) (VP (VBD resulted) (PP (IN in) (NP (NP (JJ elevated) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (DT the) (JJ latter) (CD two) (NNS drugs)))))))) (. .))))

nsubj(resulted-11, Coadministration-1)
amod(Tablets-5, NIZORAL-3)
nn(Tablets-5, @-4)
prep_of(Coadministration-1, Tablets-5)
prep_with(Coadministration-1, midazolam-7)
conj_or(midazolam-7, triazolam-9)
aux(resulted-11, has-10)
root(ROOT-0, resulted-11)
amod(concentrations-15, elevated-13)
nn(concentrations-15, plasma-14)
prep_in(resulted-11, concentrations-15)
det(drugs-20, the-17)
amod(drugs-20, latter-18)
num(drugs-20, two-19)
prep_of(concentrations-15, drugs-20)

This/DT may/MD potentiate/VB and/CC prolong/VB hypnotic/NN and/CC sedative/JJ effects/NNS ,/, especially/RB with/IN repeated/JJ dosing/NN or/CC chronic/JJ administration/NN of/IN these/DT agents/NNS ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (MD may) (VP (VP (VB potentiate)) (CC and) (VP (VB prolong) (NP (NP (NP (NN hypnotic)) (CC and) (NP (JJ sedative) (NNS effects))) (, ,) (ADVP (RB especially)) (PP (IN with) (NP (NP (NP (JJ repeated) (NN dosing)) (CC or) (NP (JJ chronic) (NN administration))) (PP (IN of) (NP (DT these) (NNS agents)))))))))) (. .))))

nsubj(potentiate-3, This-1)
aux(potentiate-3, may-2)
root(ROOT-0, potentiate-3)
conj_and(potentiate-3, prolong-5)
dobj(prolong-5, hypnotic-6)
amod(effects-9, sedative-8)
conj_and(hypnotic-6, effects-9)
advmod(hypnotic-6, especially-11)
amod(dosing-14, repeated-13)
prep_with(hypnotic-6, dosing-14)
amod(administration-17, chronic-16)
conj_or(dosing-14, administration-17)
det(agents-20, these-19)
prep_of(dosing-14, agents-20)

If/IN midazolam/NN is/VBZ administered/VBN parenterally/RB ,/, special/JJ precaution/NN is/VBZ required/VBN since/IN the/DT sedative/JJ effect/NN may/MD be/VB prolonged/JJ ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN midazolam)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB parenterally)))))) (, ,) (NP (JJ special) (NN precaution)) (VP (VBZ is) (VP (VBN required) (SBAR (IN since) (S (NP (DT the) (JJ sedative) (NN effect)) (VP (MD may) (VP (VB be) (ADJP (JJ prolonged))))))))) (. .))))

mark(administered-4, If-1)
nsubjpass(administered-4, midazolam-2)
auxpass(administered-4, is-3)
advcl(required-10, administered-4)
advmod(administered-4, parenterally-5)
amod(precaution-8, special-7)
nsubjpass(required-10, precaution-8)
auxpass(required-10, is-9)
root(ROOT-0, required-10)
mark(prolonged-17, since-11)
det(effect-14, the-12)
amod(effect-14, sedative-13)
nsubj(prolonged-17, effect-14)
aux(prolonged-17, may-15)
cop(prolonged-17, be-16)
advcl(required-10, prolonged-17)

Rare/JJ cases/NNS of/IN elevated/JJ plasma/NN concentrations/NNS of/IN digoxin/NN have/VBP been/VBN reported/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Rare) (NNS cases)) (PP (IN of) (NP (NP (JJ elevated) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN digoxin)))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported))))) (. .))))

amod(cases-2, Rare-1)
nsubjpass(reported-11, cases-2)
amod(concentrations-6, elevated-4)
nn(concentrations-6, plasma-5)
prep_of(cases-2, concentrations-6)
prep_of(concentrations-6, digoxin-8)
aux(reported-11, have-9)
auxpass(reported-11, been-10)
root(ROOT-0, reported-11)

It/PRP is/VBZ ,/, therefore/RB ,/, advisable/JJ to/TO monitor/VB digoxin/NN concentrations/NNS in/IN patients/NNS receiving/VBG ketoconazole/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (, ,) (ADVP (RB therefore)) (, ,) (ADJP (JJ advisable) (S (VP (TO to) (VP (VB monitor) (NP (NP (NN digoxin) (NNS concentrations)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN ketoconazole)))))))))))) (. .))))

nsubj(advisable-6, It-1)
cop(advisable-6, is-2)
advmod(advisable-6, therefore-4)
root(ROOT-0, advisable-6)
aux(monitor-8, to-7)
xcomp(advisable-6, monitor-8)
nn(concentrations-10, digoxin-9)
dobj(monitor-8, concentrations-10)
prep_in(concentrations-10, patients-12)
partmod(patients-12, receiving-13)
dobj(receiving-13, ketoconazole-14)

When/WRB taken/VBN orally/RB ,/, imidazole/JJ compounds/NNS like/IN ketoconazole/NN may/MD enhance/VB the/DT anticoagulant/JJ effect/NN of/IN coumarin/JJ -like/JJ drugs/NNS ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBN taken) (ADVP (RB orally))))) (, ,) (NP (NP (JJ imidazole) (NNS compounds)) (PP (IN like) (NP (NN ketoconazole)))) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (JJ anticoagulant) (NN effect)) (PP (IN of) (NP (JJ coumarin) (JJ -like) (NNS drugs))))))) (. .))))

advmod(taken-2, When-1)
advcl(enhance-10, taken-2)
advmod(taken-2, orally-3)
amod(compounds-6, imidazole-5)
nsubj(enhance-10, compounds-6)
prep_like(compounds-6, ketoconazole-8)
aux(enhance-10, may-9)
root(ROOT-0, enhance-10)
det(effect-13, the-11)
amod(effect-13, anticoagulant-12)
dobj(enhance-10, effect-13)
amod(drugs-17, coumarin-15)
amod(drugs-17, -like-16)
prep_of(effect-13, drugs-17)

In/IN simultaneous/JJ treatment/NN with/IN imidazole/JJ drugs/NNS and/CC coumarin/JJ drugs/NNS ,/, the/DT anticoagulant/JJ effect/NN should/MD be/VB carefully/RB titrated/VBN and/CC monitored/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (JJ simultaneous) (NN treatment)) (PP (IN with) (NP (NP (JJ imidazole) (NNS drugs)) (CC and) (NP (JJ coumarin) (NNS drugs)))))) (, ,) (NP (DT the) (JJ anticoagulant) (NN effect)) (VP (MD should) (VP (VB be) (ADVP (RB carefully)) (VP (VP (VBN titrated)) (CC and) (VP (VBN monitored)))))) (. .))))

amod(treatment-3, simultaneous-2)
prep_in(titrated-17, treatment-3)
amod(drugs-6, imidazole-5)
prep_with(treatment-3, drugs-6)
amod(drugs-9, coumarin-8)
conj_and(drugs-6, drugs-9)
det(effect-13, the-11)
amod(effect-13, anticoagulant-12)
nsubjpass(titrated-17, effect-13)
aux(titrated-17, should-14)
auxpass(titrated-17, be-15)
advmod(titrated-17, carefully-16)
root(ROOT-0, titrated-17)
conj_and(titrated-17, monitored-19)

Because/IN severe/JJ hypoglycemia/NN has/VBZ been/VBN reported/VBN in/IN patients/NNS concomitantly/RB receiving/VBG oral/JJ miconazole/NN (/-LRB- an/DT imidazole/NN )/-RRB- and/CC oral/JJ hypoglycemic/JJ agents/NNS ,/, such/PDT a/DT potential/JJ interaction/NN involving/VBG the/DT latter/JJ agents/NNS when/WRB used/VBN concomitantly/RB with/IN ketoconazole/NN tablets/NNS (/-LRB- an/DT imidazole/JJ )/-RRB- can/MD not/RB be/VB ruled/VBN out/RP ./.

(ROOT (S1 (S (SBAR (IN Because) (S (NP (JJ severe) (NN hypoglycemia)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (ADVP (RB concomitantly)) (VBG receiving) (NP (NP (NP (JJ oral) (NN miconazole)) (PRN (-LRB- -LRB-) (NP (DT an) (NN imidazole)) (-RRB- -RRB-))) (CC and) (NP (JJ oral) (JJ hypoglycemic) (NNS agents))))))))))) (, ,) (NP (NP (PDT such) (DT a) (JJ potential) (NN interaction)) (VP (VBG involving) (NP (NP (DT the) (JJ latter) (NNS agents)) (SBAR (WHADVP (WRB when)) (S (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NN ketoconazole) (NNS tablets)) (PRN (-LRB- -LRB-) (NP (DT an) (JJ imidazole)) (-RRB- -RRB-)))))))))) (VP (MD can) (RB not) (VP (VB be) (VP (VBN ruled) (PRT (RP out))))) (. .))))

mark(reported-6, Because-1)
amod(hypoglycemia-3, severe-2)
nsubjpass(reported-6, hypoglycemia-3)
aux(reported-6, has-4)
auxpass(reported-6, been-5)
advcl(ruled-43, reported-6)
prep_in(reported-6, patients-8)
advmod(receiving-10, concomitantly-9)
partmod(patients-8, receiving-10)
amod(miconazole-12, oral-11)
dobj(receiving-10, miconazole-12)
det(imidazole-15, an-14)
appos(miconazole-12, imidazole-15)
amod(agents-20, oral-18)
amod(agents-20, hypoglycemic-19)
conj_and(miconazole-12, agents-20)
predet(interaction-25, such-22)
det(interaction-25, a-23)
amod(interaction-25, potential-24)
nsubjpass(ruled-43, interaction-25)
partmod(interaction-25, involving-26)
det(agents-29, the-27)
amod(agents-29, latter-28)
dobj(involving-26, agents-29)
advmod(used-31, when-30)
dep(agents-29, used-31)
advmod(used-31, concomitantly-32)
nn(tablets-35, ketoconazole-34)
prep_with(used-31, tablets-35)
det(imidazole-38, an-37)
dep(tablets-35, imidazole-38)
aux(ruled-43, can-40)
neg(ruled-43, not-41)
auxpass(ruled-43, be-42)
root(ROOT-0, ruled-43)
prt(ruled-43, out-44)

Concomitant/JJ administration/NN of/IN ketoconazole/NN tablets/NNS with/IN phenytoin/NN may/MD alter/VB the/DT metabolism/NN of/IN one/CD or/CC both/DT of/IN the/DT drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NN ketoconazole) (NNS tablets))) (PP (IN with) (NP (NN phenytoin)))) (VP (MD may) (VP (VB alter) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NP (NP (CD one)) (CC or) (NP (DT both))) (PP (IN of) (NP (DT the) (NNS drugs))))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubj(alter-9, administration-2)
nn(tablets-5, ketoconazole-4)
prep_of(administration-2, tablets-5)
prep_with(administration-2, phenytoin-7)
aux(alter-9, may-8)
root(ROOT-0, alter-9)
det(metabolism-11, the-10)
dobj(alter-9, metabolism-11)
prep_of(metabolism-11, one-13)
conj_or(one-13, both-15)
det(drugs-18, the-17)
prep_of(one-13, drugs-18)

It/PRP is/VBZ suggested/VBN to/TO monitor/VB both/CC ketoconazole/NN and/CC phenytoin/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN suggested) (S (VP (TO to) (VP (VB monitor) (NP (CC both) (NP (NN ketoconazole)) (CC and) (NP (NN phenytoin))))))))) (. .))))

nsubjpass(suggested-3, It-1)
xsubj(monitor-5, It-1)
auxpass(suggested-3, is-2)
root(ROOT-0, suggested-3)
aux(monitor-5, to-4)
xcomp(suggested-3, monitor-5)
preconj(ketoconazole-7, both-6)
dobj(monitor-5, ketoconazole-7)
conj_and(ketoconazole-7, phenytoin-9)

Concomitant/JJ administration/NN of/IN rifampin/NN with/IN ketoconazole/NN tablets/NNS reduces/VBZ the/DT blood/NN levels/NNS of/IN the/DT latter/JJ ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NN rifampin))) (PP (IN with) (NP (NN ketoconazole) (NNS tablets)))) (VP (VBZ reduces) (NP (NP (DT the) (NN blood) (NNS levels)) (PP (IN of) (NP (DT the) (JJ latter)))))) (. .))))

amod(administration-2, Concomitant-1)
nsubj(reduces-8, administration-2)
prep_of(administration-2, rifampin-4)
nn(tablets-7, ketoconazole-6)
prep_with(administration-2, tablets-7)
root(ROOT-0, reduces-8)
det(levels-11, the-9)
nn(levels-11, blood-10)
dobj(reduces-8, levels-11)
det(latter-14, the-13)
prep_of(levels-11, latter-14)

INH/NN (/-LRB- Isoniazid/NN )/-RRB- is/VBZ also/RB reported/VBN to/TO affect/VB ketoconazole/NN concentrations/NNS adversely/RB ./.

(ROOT (S1 (S (S (NP (NP (NN INH)) (PRN (-LRB- -LRB-) (NP (NN Isoniazid)) (-RRB- -RRB-))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN reported) (S (VP (TO to) (VP (VB affect) (NP (NN ketoconazole) (NNS concentrations)) (ADVP (RB adversely)))))))) (. .))))

nsubjpass(reported-7, INH-1)
xsubj(affect-9, INH-1)
appos(INH-1, Isoniazid-3)
auxpass(reported-7, is-5)
advmod(reported-7, also-6)
root(ROOT-0, reported-7)
aux(affect-9, to-8)
xcomp(reported-7, affect-9)
nn(concentrations-11, ketoconazole-10)
dobj(affect-9, concentrations-11)
advmod(affect-9, adversely-12)

These/DT drugs/NNS should/MD not/RB be/VB given/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (DT These) (NNS drugs)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN given) (ADVP (RB concomitantly)))))) (. .))))

det(drugs-2, These-1)
nsubjpass(given-6, drugs-2)
aux(given-6, should-3)
neg(given-6, not-4)
auxpass(given-6, be-5)
root(ROOT-0, given-6)
advmod(given-6, concomitantly-7)

After/IN the/DT coadministration/NN of/IN 200/CD mg/NN oral/JJ ketoconazole/NN twice/RB daily/RB and/CC one/CD 20/CD mg/NN dose/NN of/IN loratadine/NN to/TO 11/CD subjects/NNS ,/, the/DT AUC/NN and/CC Cmax/NN of/IN loratadine/NN averaged/VBD 302/CD %/NN (/-LRB- @/NN 142/CD S.D./NN )/-RRB- and/CC 251/CD %/NN (/-LRB- @/NN 68/CD S.D./NN )/-RRB- ,/, respectively/RB ,/, of/IN those/DT obtained/VBN after/IN co-treatment/NN with/IN placebo/NN ./.

(ROOT (S1 (S (PP (IN After) (NP (NP (DT the) (NN coadministration)) (PP (IN of) (NP (NP (NP (ADJP (CD 200) (NN mg)) (JJ oral) (NN ketoconazole)) (ADVP (RB twice) (RB daily))) (CC and) (NP (NP (CD one) (ADJP (CD 20) (NN mg)) (NN dose)) (PP (IN of) (NP (NN loratadine))) (PP (TO to) (NP (CD 11) (NNS subjects)))))))) (, ,) (NP (NP (DT the) (NP (NN AUC)) (CC and) (NP (NN Cmax))) (PP (IN of) (NP (NN loratadine)))) (VP (VBD averaged) (NP (NP (NP (CD 302) (NN %)) (PRN (-LRB- -LRB-) (NP (NN @) (CD 142) (NN S.D.)) (-RRB- -RRB-))) (CC and) (NP (NP (CD 251) (NN %)) (PRN (-LRB- -LRB-) (NP (NN @) (CD 68) (NN S.D.)) (-RRB- -RRB-))) (, ,) (ADVP (RB respectively)) (, ,) (PP (IN of) (NP (NP (DT those)) (VP (VBN obtained) (PP (IN after) (NP (NP (NN co-treatment)) (PP (IN with) (NP (NN placebo)))))))))) (. .))))

det(coadministration-3, the-2)
prep_after(averaged-28, coadministration-3)
number(mg-6, 200-5)
amod(ketoconazole-8, mg-6)
amod(ketoconazole-8, oral-7)
prep_of(coadministration-3, ketoconazole-8)
advmod(daily-10, twice-9)
advmod(ketoconazole-8, daily-10)
num(dose-15, one-12)
number(mg-14, 20-13)
amod(dose-15, mg-14)
conj_and(ketoconazole-8, dose-15)
prep_of(dose-15, loratadine-17)
num(subjects-20, 11-19)
prep_to(dose-15, subjects-20)
dep(AUC-23, the-22)
nsubj(averaged-28, AUC-23)
conj_and(AUC-23, Cmax-25)
prep_of(AUC-23, loratadine-27)
root(ROOT-0, averaged-28)
num(%-30, 302-29)
dobj(averaged-28, %-30)
nn(S.D.-34, @-32)
num(S.D.-34, 142-33)
appos(%-30, S.D.-34)
num(%-38, 251-37)
conj_and(%-30, %-38)
nn(S.D.-42, @-40)
num(S.D.-42, 68-41)
appos(%-38, S.D.-42)
advmod(%-30, respectively-45)
conj_and(%-30, respectively-45)
conj_and(%-30, of-47)
prep_of(%-30, those-48)
partmod(those-48, obtained-49)
prep_after(obtained-49, co-treatment-51)
prep_with(co-treatment-51, placebo-53)

The/DT AUC/NN and/CC Cmax/NN of/IN descarboethoxyloratadine/NN ,/, an/DT active/JJ metabolite/NN ,/, averaged/VBD 155/CD %/NN (/-LRB- @/NN 27/CD S.D./NN )/-RRB- and/CC 141/CD %/NN (/-LRB- @/NN 35/CD S.D./NN )/-RRB- ,/, respectively/RB ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NP (NN AUC)) (CC and) (NP (NN Cmax))) (PP (IN of) (NP (NP (NN descarboethoxyloratadine)) (, ,) (NP (DT an) (JJ active) (NN metabolite)) (, ,)))) (VP (VBD averaged) (NP (NP (NP (CD 155) (NN %)) (PRN (-LRB- -LRB-) (NP (NN @) (CD 27) (NN S.D.)) (-RRB- -RRB-))) (CC and) (NP (NP (CD 141) (NN %)) (PRN (-LRB- -LRB-) (NP (NN @) (CD 35) (NN S.D.)) (-RRB- -RRB-))) (, ,) (ADVP (RB respectively))))) (. .))))

dep(AUC-2, The-1)
nsubj(averaged-12, AUC-2)
conj_and(AUC-2, Cmax-4)
prep_of(AUC-2, descarboethoxyloratadine-6)
det(metabolite-10, an-8)
amod(metabolite-10, active-9)
appos(descarboethoxyloratadine-6, metabolite-10)
root(ROOT-0, averaged-12)
num(%-14, 155-13)
dobj(averaged-12, %-14)
nn(S.D.-18, @-16)
num(S.D.-18, 27-17)
appos(%-14, S.D.-18)
num(%-22, 141-21)
conj_and(%-14, %-22)
nn(S.D.-26, @-24)
num(S.D.-26, 35-25)
appos(%-22, S.D.-26)
advmod(%-14, respectively-29)
conj_and(%-14, respectively-29)

Also/RB ,/, there/EX were/VBD no/DT clinically/RB significant/JJ differences/NNS in/IN adverse/JJ events/NNS when/WRB loratadine/NN was/VBD administered/VBN with/IN or/CC without/IN ketoconazole/NN ./.

(ROOT (S1 (S (S (ADVP (RB Also)) (, ,) (NP (EX there)) (VP (VBD were) (NP (NP (DT no) (ADJP (RB clinically) (JJ significant)) (NNS differences)) (PP (IN in) (NP (JJ adverse) (NNS events)))) (SBAR (WHADVP (WRB when)) (S (NP (NN loratadine)) (VP (VBD was) (VP (VBN administered) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NN ketoconazole)))))))))) (. .))))

advmod(were-4, Also-1)
expl(were-4, there-3)
root(ROOT-0, were-4)
det(differences-8, no-5)
advmod(significant-7, clinically-6)
amod(differences-8, significant-7)
nsubj(were-4, differences-8)
amod(events-11, adverse-10)
prep_in(differences-8, events-11)
advmod(administered-15, when-12)
nsubjpass(administered-15, loratadine-13)
auxpass(administered-15, was-14)
advcl(were-4, administered-15)
prep(administered-15, with-16)
conj_or(with-16, without-18)
pobj(without-18, ketoconazole-19)

Rare/JJ cases/NNS of/IN a/DT disulfiram/NN -like/JJ reaction/NN to/TO alcohol/NN have/VBP been/VBN reported/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Rare) (NNS cases)) (PP (IN of) (NP (NP (DT a) (ADJP (NN disulfiram) (JJ -like)) (NN reaction)) (PP (TO to) (NP (NN alcohol)))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported))))) (. .))))

amod(cases-2, Rare-1)
nsubjpass(reported-12, cases-2)
det(reaction-7, a-4)
dep(-like-6, disulfiram-5)
amod(reaction-7, -like-6)
prep_of(cases-2, reaction-7)
prep_to(reaction-7, alcohol-9)
aux(reported-12, have-10)
auxpass(reported-12, been-11)
root(ROOT-0, reported-12)

Cyclosporine/NN -/CC L-arginine/NN may/MD counteract/VB the/DT antinaturetic/JJ effect/NN of/IN cyclosporin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Cyclosporine)) (CC -) (NP (NN L-arginine))) (VP (MD may) (VP (VB counteract) (NP (NP (DT the) (JJ antinaturetic) (NN effect)) (PP (IN of) (NP (NN cyclosporin))))))) (. .))))

nsubj(counteract-5, Cyclosporine-1)
conj(Cyclosporine-1, L-arginine-3)
aux(counteract-5, may-4)
root(ROOT-0, counteract-5)
det(effect-8, the-6)
amod(effect-8, antinaturetic-7)
dobj(counteract-5, effect-8)
prep_of(effect-8, cyclosporin-10)

Ibuprofen/NN -/CC L-arginine/NN may/MD increase/VB the/DT absorption/NN of/IN ibuprofen/NN if/IN taken/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NP (NN Ibuprofen)) (CC -) (NP (NN L-arginine))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NN ibuprofen)))) (SBAR (IN if) (S (VP (VBN taken) (ADVP (RB concomitantly)))))))) (. .))))

nsubj(increase-5, Ibuprofen-1)
conj(Ibuprofen-1, L-arginine-3)
aux(increase-5, may-4)
root(ROOT-0, increase-5)
det(absorption-7, the-6)
dobj(increase-5, absorption-7)
prep_of(absorption-7, ibuprofen-9)
mark(taken-11, if-10)
advcl(increase-5, taken-11)
advmod(taken-11, concomitantly-12)

Organic/JJ nitrates/NNS -/: L-arginine/NN supplements/NNS theoretically/RB may/MD potentiate/VB the/DT effects/NNS of/IN organic/JJ nitrates/NNS if/IN taken/VBN concomitantly/RB ./.

(ROOT (S1 (S (NP (NP (JJ Organic) (NNS nitrates)) (: -) (S (NP (NN L-arginine) (NNS supplements)) (ADVP (RB theoretically)) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ organic) (NNS nitrates)))) (PP (IN if) (S (VP (VBN taken) (ADVP (RB concomitantly)))))))) (. .)))))

amod(nitrates-2, Organic-1)
root(ROOT-0, nitrates-2)
nn(supplements-5, L-arginine-4)
nsubj(potentiate-8, supplements-5)
advmod(potentiate-8, theoretically-6)
aux(potentiate-8, may-7)
dep(nitrates-2, potentiate-8)
det(effects-10, the-9)
dobj(potentiate-8, effects-10)
amod(nitrates-13, organic-12)
prep_of(effects-10, nitrates-13)
prepc_if(potentiate-8, taken-15)
advmod(taken-15, concomitantly-16)

Sildenafil/NN citrate/NN -/: Theoretically/RB ,/, L-/NN arginine/NN supplements/NNS taken/VBN concomitantly/RB with/IN sildenafil/NN citrate/NN ,/, may/MD potentiate/VB the/DT effects/NNS of/IN the/DT drug/NN ./.

(ROOT (S1 (S (NP (NP (NN Sildenafil) (NN citrate)) (: -) (S (ADVP (RB Theoretically)) (, ,) (NP (NP (NN L-) (NN arginine) (NNS supplements)) (VP (VBN taken) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN sildenafil) (NN citrate)))) (, ,)) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (DT the) (NN drug))))))) (. .)))))

nn(citrate-2, Sildenafil-1)
root(ROOT-0, citrate-2)
advmod(potentiate-16, Theoretically-4)
nn(supplements-8, L--6)
nn(supplements-8, arginine-7)
nsubj(potentiate-16, supplements-8)
partmod(supplements-8, taken-9)
advmod(taken-9, concomitantly-10)
nn(citrate-13, sildenafil-12)
prep_with(taken-9, citrate-13)
aux(potentiate-16, may-15)
dep(citrate-2, potentiate-16)
det(effects-18, the-17)
dobj(potentiate-16, effects-18)
det(drug-21, the-20)
prep_of(effects-18, drug-21)

No/DT drug/NN ,/, nutritional/JJ supplement/NN ,/, food/NN or/CC herb/NN interactions/NNS are/VBP known/VBN ./.

(ROOT (S1 (S (S (NP (DT No) (NP (NP (NN drug)) (, ,) (NP (JJ nutritional) (NN supplement)) (, ,) (NP (NN food)) (CC or) (NP (NN herb))) (NNS interactions)) (VP (VBP are) (VP (VBN known)))) (. .))))

det(interactions-10, No-1)
nn(interactions-10, drug-2)
amod(supplement-5, nutritional-4)
conj_or(drug-2, supplement-5)
conj_or(drug-2, food-7)
conj_or(drug-2, herb-9)
nsubjpass(known-12, interactions-10)
auxpass(known-12, are-11)
root(ROOT-0, known-12)

Interacts/VBZ with/IN valproic/JJ acid/NN ./.

(ROOT (S1 (S (S (VP (VBZ Interacts) (PP (IN with) (NP (JJ valproic) (NN acid))))) (. .))))

root(ROOT-0, Interacts-1)
amod(acid-4, valproic-3)
prep_with(Interacts-1, acid-4)

No/DT well-known/JJ drug/NN interactions/NNS with/IN glutamic/JJ acid/NN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (JJ well-known) (NN drug) (NNS interactions)) (PP (IN with) (NP (JJ glutamic) (NN acid))))) (. .))))

det(interactions-4, No-1)
amod(interactions-4, well-known-2)
nn(interactions-4, drug-3)
root(ROOT-0, interactions-4)
amod(acid-7, glutamic-6)
prep_with(interactions-4, acid-7)

Human/JJ growth/NN hormone/NN -/: Concomitant/JJ use/NN of/IN L-/NN glutamine/NN and/CC human/JJ growth/NN hormone/NN may/MD enhance/VB nutrient/JJ absorption/NN in/IN those/DT with/IN severe/JJ short/JJ bowel/NN syndrome/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Human) (NN growth) (NN hormone)) (: -) (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NN L-) (NN glutamine)))) (CC and) (NP (JJ human) (NN growth) (NN hormone))) (VP (MD may) (VP (VB enhance) (NP (JJ nutrient) (NN absorption)) (PP (IN in) (NP (NP (DT those)) (PP (IN with) (NP (JJ severe) (JJ short) (NN bowel) (NN syndrome)))))))) (. .))))

amod(hormone-3, Human-1)
nn(hormone-3, growth-2)
nsubj(enhance-15, hormone-3)
amod(use-6, Concomitant-5)
conj_and(hormone-3, use-6)
nn(glutamine-9, L--8)
prep_of(use-6, glutamine-9)
amod(hormone-13, human-11)
nn(hormone-13, growth-12)
conj_and(hormone-3, hormone-13)
aux(enhance-15, may-14)
root(ROOT-0, enhance-15)
amod(absorption-17, nutrient-16)
dobj(enhance-15, absorption-17)
prep_in(enhance-15, those-19)
amod(syndrome-24, severe-21)
amod(syndrome-24, short-22)
nn(syndrome-24, bowel-23)
prep_with(those-19, syndrome-24)

L-glutamine/NN has/VBZ orphan/NN drug/NN status/NN for/IN this/DT indication/NN ./.

(ROOT (S1 (S (S (NP (NN L-glutamine)) (VP (VBZ has) (NP (NN orphan) (NN drug) (NN status)) (PP (IN for) (NP (DT this) (NN indication))))) (. .))))

nsubj(has-2, L-glutamine-1)
root(ROOT-0, has-2)
nn(status-5, orphan-3)
nn(status-5, drug-4)
dobj(has-2, status-5)
det(indication-8, this-7)
prep_for(has-2, indication-8)

Indomethacin/NN -/: Concomitant/JJ use/NN of/IN L-/NN glutamine/NN and/CC indomethacin/NN may/MD ameliorate/VB increased/VBN intestinal/JJ permeability/NN caused/VBN by/IN indomethacin/NN ./.

(ROOT (S1 (S (NP (NP (NN Indomethacin)) (: -) (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NN L-) (NP (NP (NN glutamine)) (CC and) (NP (NN indomethacin)))))) (VP (MD may) (VP (VB ameliorate) (NP (NP (VBN increased) (JJ intestinal) (NN permeability)) (VP (VBN caused) (PP (IN by) (NP (NN indomethacin)))))))) (. .)))))

root(ROOT-0, Indomethacin-1)
amod(use-4, Concomitant-3)
nsubj(ameliorate-11, use-4)
prep_of(use-4, L--6)
dep(L--6, glutamine-7)
conj_and(glutamine-7, indomethacin-9)
aux(ameliorate-11, may-10)
dep(Indomethacin-1, ameliorate-11)
amod(permeability-14, increased-12)
amod(permeability-14, intestinal-13)
dobj(ameliorate-11, permeability-14)
partmod(permeability-14, caused-15)
agent(caused-15, indomethacin-17)

The/DT reported/VBN dose/NN used/VBN for/IN L-/NN glutamine/NN was/VBD 21/CD grams/NNS daily/RB taken/VBN in/IN divided/JJ doses/NNS three/CD times/NNS a/DT day/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (VBN reported) (NN dose)) (VP (VBN used) (PP (IN for) (NP (NN L-) (NN glutamine))))) (VP (VBD was) (ADVP (NP (CD 21) (NNS grams)) (RB daily)) (VP (VBN taken) (PP (IN in) (NP (NP (JJ divided) (NNS doses)) (NP (CD three) (NNS times) (NP (DT a) (NN day)))))))) (. .))))

det(dose-3, The-1)
amod(dose-3, reported-2)
nsubjpass(taken-12, dose-3)
partmod(dose-3, used-4)
nn(glutamine-7, L--6)
prep_for(used-4, glutamine-7)
auxpass(taken-12, was-8)
num(grams-10, 21-9)
npadvmod(daily-11, grams-10)
advmod(taken-12, daily-11)
root(ROOT-0, taken-12)
amod(doses-15, divided-14)
prep_in(taken-12, doses-15)
num(times-17, three-16)
dep(doses-15, times-17)
det(day-19, a-18)
dep(times-17, day-19)

Further/RB ,/, misoprostol/NN is/VBZ reported/VBN to/TO have/VB a/DT synergistic/JJ effect/NN with/IN this/DT combination/NN in/IN ameliorating/VBG intestinal/JJ permeability/NN ./.

(ROOT (S1 (S (S (ADVP (RB Further)) (, ,) (NP (NN misoprostol)) (VP (VBZ is) (VP (VBN reported) (S (VP (TO to) (VP (VB have) (NP (DT a) (JJ synergistic) (NN effect)) (PP (IN with) (NP (DT this) (NN combination))) (PP (IN in) (S (VP (VBG ameliorating) (NP (JJ intestinal) (NN permeability))))))))))) (. .))))

advmod(reported-5, Further-1)
nsubjpass(reported-5, misoprostol-3)
xsubj(have-7, misoprostol-3)
auxpass(reported-5, is-4)
root(ROOT-0, reported-5)
aux(have-7, to-6)
xcomp(reported-5, have-7)
det(effect-10, a-8)
amod(effect-10, synergistic-9)
dobj(have-7, effect-10)
det(combination-13, this-12)
prep_with(have-7, combination-13)
prepc_in(have-7, ameliorating-15)
amod(permeability-17, intestinal-16)
dobj(ameliorating-15, permeability-17)

Methotrexate/NN -/: There/EX is/VBZ one/CD report/NN that/IN methotrexate/NN may/MD decrease/VB the/DT possible/JJ effectiveness/NN of/IN supplemental/JJ L-/NN glutamine/NN for/IN chemotherapy-induced/JJ mucositis/NN ./.

(ROOT (S1 (S (NP (NP (NN Methotrexate)) (: -) (S (NP (EX There)) (VP (VBZ is) (NP (NP (CD one) (NN report)) (SBAR (IN that) (S (NP (NN methotrexate)) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (JJ possible) (NN effectiveness)) (PP (IN of) (NP (JJ supplemental) (NN L-) (NN glutamine))) (PP (IN for) (NP (JJ chemotherapy-induced) (NN mucositis))))))))))) (. .)))))

root(ROOT-0, Methotrexate-1)
expl(is-4, There-3)
dep(Methotrexate-1, is-4)
num(report-6, one-5)
nsubj(is-4, report-6)
complm(decrease-10, that-7)
nsubj(decrease-10, methotrexate-8)
aux(decrease-10, may-9)
dep(report-6, decrease-10)
det(effectiveness-13, the-11)
amod(effectiveness-13, possible-12)
dobj(decrease-10, effectiveness-13)
amod(glutamine-17, supplemental-15)
nn(glutamine-17, L--16)
prep_of(effectiveness-13, glutamine-17)
amod(mucositis-20, chemotherapy-induced-19)
prep_for(effectiveness-13, mucositis-20)

In/IN another/DT report/NN ,/, nine/CD patients/NNS with/IN breast/NN cancer/NN were/VBD reported/VBN to/TO have/VB decreased/VBN symptoms/NNS of/IN methotrexate-related/JJ toxicity/NN when/WRB given/VBN supplemental/JJ L-/NN glutamine/NN at/IN a/DT dose/NN of/IN 0.5/CD gram/kilogram/day/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (DT another) (NN report))) (, ,) (NP (NP (CD nine) (NNS patients)) (PP (IN with) (NP (NN breast) (NN cancer)))) (VP (VBD were) (VP (VBN reported) (S (VP (TO to) (VP (VB have) (NP (NP (VBN decreased) (NNS symptoms)) (PP (IN of) (NP (JJ methotrexate-related) (NN toxicity)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (NP (NP (JJ supplemental) (NN L-) (NN glutamine)) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (CD 0.5) (NN gram/kilogram/day))))))))))))))) (. .))))

det(report-3, another-2)
prep_in(reported-11, report-3)
num(patients-6, nine-5)
nsubjpass(reported-11, patients-6)
xsubj(have-13, patients-6)
nn(cancer-9, breast-8)
prep_with(patients-6, cancer-9)
auxpass(reported-11, were-10)
root(ROOT-0, reported-11)
aux(have-13, to-12)
xcomp(reported-11, have-13)
amod(symptoms-15, decreased-14)
dobj(have-13, symptoms-15)
amod(toxicity-18, methotrexate-related-17)
prep_of(symptoms-15, toxicity-18)
advmod(given-20, when-19)
advcl(have-13, given-20)
amod(glutamine-23, supplemental-21)
nn(glutamine-23, L--22)
dobj(given-20, glutamine-23)
det(dose-26, a-25)
prep_at(glutamine-23, dose-26)
num(gram/kilogram/day-29, 0.5-28)
prep_of(dose-26, gram/kilogram/day-29)

Paclitaxel/NN -/: In/IN one/CD report/NN ,/, L-glutamine/NN at/IN a/DT dose/NN of/IN 10/CD grams/NNS three/CD times/NNS daily/RB ,/, given/VBN 24/CD hours/NNS after/IN receiving/VBG paclitaxel/NN ,/, appeared/VBD to/TO prevent/VB the/DT development/NN of/IN myalgia/NN and/CC arthralgia/NN ,/, adverse/JJ reactions/NNS of/IN paclitaxel/NN ./.

(ROOT (S1 (S (NP (NP (NN Paclitaxel)) (: -) (S (PP (IN In) (NP (CD one) (NN report))) (, ,) (NP (NP (NN L-glutamine)) (PP (IN at) (NP (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (CD 10) (NNS grams))) (ADVP (NP (CD three) (NNS times)) (RB daily))) (, ,) (VP (VBN given) (PP (NP (CD 24) (NNS hours)) (IN after) (S (VP (VBG receiving) (NP (NN paclitaxel)))))) (, ,)))) (VP (VBD appeared) (S (VP (TO to) (VP (VB prevent) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NP (NN myalgia)) (CC and) (NP (NN arthralgia))) (, ,) (NP (NP (JJ adverse) (NNS reactions)) (PP (IN of) (NP (NN paclitaxel)))))))))))) (. .)))))

root(ROOT-0, Paclitaxel-1)
num(report-5, one-4)
prep_in(appeared-25, report-5)
nsubj(appeared-25, L-glutamine-7)
xsubj(prevent-27, L-glutamine-7)
det(dose-10, a-9)
prep_at(L-glutamine-7, dose-10)
num(grams-13, 10-12)
prep_of(dose-10, grams-13)
num(times-15, three-14)
npadvmod(daily-16, times-15)
advmod(dose-10, daily-16)
partmod(dose-10, given-18)
num(hours-20, 24-19)
npadvmod(given-18, hours-20)
prepc_after(given-18, receiving-22)
dobj(receiving-22, paclitaxel-23)
dep(Paclitaxel-1, appeared-25)
aux(prevent-27, to-26)
xcomp(appeared-25, prevent-27)
det(development-29, the-28)
dobj(prevent-27, development-29)
prep_of(development-29, myalgia-31)
conj_and(myalgia-31, arthralgia-33)
amod(reactions-36, adverse-35)
appos(myalgia-31, reactions-36)
prep_of(reactions-36, paclitaxel-38)

Concomitant/JJ use/NN of/IN calcium/NN supplements/NNS and/CC L-lysine/NN may/MD increase/VB calcium/NN absorption/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (NN calcium) (NNS supplements)) (CC and) (NP (NN L-lysine))))) (VP (MD may) (VP (VB increase) (NP (NN calcium) (NN absorption))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(increase-9, use-2)
nn(supplements-5, calcium-4)
prep_of(use-2, supplements-5)
conj_and(supplements-5, L-lysine-7)
aux(increase-9, may-8)
root(ROOT-0, increase-9)
nn(absorption-11, calcium-10)
dobj(increase-9, absorption-11)

Acetaminophen/NN and/CC methotrexate/NN -/CC L-methionine/NN may/MD decrease/VB hepatic/JJ toxicity/NN in/IN those/DT with/IN acetaminophen/NN overdosage/NN or/CC in/IN those/DT taking/VBG methotrexate/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Acetaminophen)) (CC and) (NP (NP (NN methotrexate)) (CC -) (NP (NN L-methionine)))) (VP (MD may) (VP (VB decrease) (NP (JJ hepatic) (NN toxicity)) (PP (IN in) (NP (NP (DT those)) (PP (PP (IN with) (NP (NN acetaminophen) (NN overdosage))) (CC or) (PP (IN in) (NP (NP (DT those)) (VP (VBG taking) (NP (NN methotrexate))))))))))) (. .))))

nsubj(decrease-7, Acetaminophen-1)
conj_and(Acetaminophen-1, methotrexate-3)
conj(methotrexate-3, L-methionine-5)
aux(decrease-7, may-6)
root(ROOT-0, decrease-7)
amod(toxicity-9, hepatic-8)
dobj(decrease-7, toxicity-9)
prep_in(decrease-7, those-11)
conj_or(those-11, those-11')
nn(overdosage-14, acetaminophen-13)
prep_with(those-11, overdosage-14)
prep_in(those-11', those-17)
partmod(those-17, taking-18)
dobj(taking-18, methotrexate-19)

Theoretically/RB ,/, it/PRP may/MD decrease/VB hepatic/JJ toxicity/NN in/IN the/DT case/NN of/IN other/JJ potential/JJ hepatotoxic/JJ drugs/NNS ,/, as/IN well/NN ./.

(ROOT (S1 (S (S (ADVP (RB Theoretically)) (, ,) (NP (PRP it)) (VP (MD may) (VP (VB decrease) (NP (JJ hepatic) (NN toxicity)) (PP (IN in) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NP (JJ other) (JJ potential) (JJ hepatotoxic) (NNS drugs)) (, ,) (PP (IN as) (NP (NN well)))))))))) (. .))))

advmod(decrease-5, Theoretically-1)
nsubj(decrease-5, it-3)
aux(decrease-5, may-4)
root(ROOT-0, decrease-5)
amod(toxicity-7, hepatic-6)
dobj(decrease-5, toxicity-7)
det(case-10, the-9)
prep_in(decrease-5, case-10)
amod(drugs-15, other-12)
amod(drugs-15, potential-13)
amod(drugs-15, hepatotoxic-14)
prep_of(case-10, drugs-15)
prep_as(drugs-15, well-18)

Gentamicin/NN -/CC Methionine/NN may/MD protect/VB against/IN the/DT ototoxic/JJ effects/NNS of/IN gentamicin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Gentamicin)) (CC -) (NP (NN Methionine))) (VP (MD may) (VP (VB protect) (PP (IN against) (NP (NP (DT the) (JJ ototoxic) (NNS effects)) (PP (IN of) (NP (NN gentamicin)))))))) (. .))))

nsubj(protect-5, Gentamicin-1)
conj(Gentamicin-1, Methionine-3)
aux(protect-5, may-4)
root(ROOT-0, protect-5)
det(effects-9, the-7)
amod(effects-9, ototoxic-8)
prep_against(protect-5, effects-9)
prep_of(effects-9, gentamicin-11)

Non-selective/JJ monoamine/NN oxidase/NN (/-LRB- MAO/NN )/-RRB- inhibitors/NNS -/: including/VBG phenelzine/NN sulfate/NN ,/, tranylcypromine/NN sulfate/NN and/CC pargyline/NN HC1/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Non-selective) (NN monoamine) (NN oxidase)) (PRN (-LRB- -LRB-) (NP (NN MAO)) (-RRB- -RRB-))) (NNS inhibitors)) (: -) (S (VP (VBG including) (NP (NP (NN phenelzine) (NN sulfate)) (, ,) (NP (NN tranylcypromine) (NN sulfate)) (CC and) (NP (NN pargyline) (NN HC1)))))) (. .))))

amod(oxidase-3, Non-selective-1)
nn(oxidase-3, monoamine-2)
nn(inhibitors-7, oxidase-3)
abbrev(oxidase-3, MAO-5)
dep(including-9, inhibitors-7)
root(ROOT-0, including-9)
nn(sulfate-11, phenelzine-10)
dobj(including-9, sulfate-11)
nn(sulfate-14, tranylcypromine-13)
conj_and(sulfate-11, sulfate-14)
nn(HC1-17, pargyline-16)
conj_and(sulfate-11, HC1-17)

Concomitant/JJ use/NN of/IN L-/NN phenylalanine/NN and/CC non-selective/JJ MAO/NN inhibitors/NNS may/MD cause/VB hypertension/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NP (NN L-) (NN phenylalanine)) (CC and) (NP (JJ non-selective) (NN MAO) (NNS inhibitors))))) (VP (MD may) (VP (VB cause) (NP (NN hypertension))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(cause-11, use-2)
nn(phenylalanine-5, L--4)
prep_of(use-2, phenylalanine-5)
amod(inhibitors-9, non-selective-7)
nn(inhibitors-9, MAO-8)
conj_and(phenylalanine-5, inhibitors-9)
aux(cause-11, may-10)
root(ROOT-0, cause-11)
dobj(cause-11, hypertension-12)

Selegiline/NN -/CC L-phenylalanine/NN and/CC the/DT selective/JJ MAO/NN inhibitor/NN selegiline/NN may/MD have/VB synergistic/JJ antidepressant/JJ activity/NN if/IN used/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Selegiline)) (CC -) (NP (NN L-phenylalanine))) (CC and) (NP (DT the) (JJ selective) (NN MAO) (NN inhibitor) (NN selegiline))) (VP (MD may) (VP (VB have) (NP (JJ synergistic) (JJ antidepressant) (NN activity)) (SBAR (IN if) (S (VP (VBN used) (ADVP (RB concomitantly)))))))) (. .))))

nsubj(have-11, Selegiline-1)
conj_and(Selegiline-1, L-phenylalanine-3)
det(selegiline-9, the-5)
amod(selegiline-9, selective-6)
nn(selegiline-9, MAO-7)
nn(selegiline-9, inhibitor-8)
conj_and(Selegiline-1, selegiline-9)
aux(have-11, may-10)
root(ROOT-0, have-11)
amod(activity-14, synergistic-12)
amod(activity-14, antidepressant-13)
dobj(have-11, activity-14)
mark(used-16, if-15)
advcl(have-11, used-16)
advmod(used-16, concomitantly-17)

Neuroleptic/JJ Drugs/NNS -/: L-phenylalanine/NN may/MD potentiate/VB the/DT tardive/JJ dyskinesia/NNS side/JJ reactions/NNS of/IN neuroleptic/JJ drugs/NNS if/IN used/VBN concomitantly/RB with/IN them/PRP ./.

(ROOT (S1 (S (NP (NP (JJ Neuroleptic) (NNS Drugs)) (: -) (S (NP (NN L-phenylalanine)) (VP (MD may) (VP (VB potentiate) (NP (NP (NP (DT the) (JJ tardive) (NNS dyskinesia)) (NP (JJ side) (NNS reactions))) (PP (IN of) (NP (JJ neuroleptic) (NNS drugs)))) (SBAR (IN if) (S (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (PRP them))))))))) (. .)))))

amod(Drugs-2, Neuroleptic-1)
root(ROOT-0, Drugs-2)
nsubj(potentiate-6, L-phenylalanine-4)
aux(potentiate-6, may-5)
dep(Drugs-2, potentiate-6)
det(dyskinesia-9, the-7)
amod(dyskinesia-9, tardive-8)
dobj(potentiate-6, dyskinesia-9)
amod(reactions-11, side-10)
dep(dyskinesia-9, reactions-11)
amod(drugs-14, neuroleptic-13)
prep_of(dyskinesia-9, drugs-14)
mark(used-16, if-15)
advcl(potentiate-6, used-16)
advmod(used-16, concomitantly-17)
prep_with(used-16, them-19)

Monoamine/NN oxidase/NN (/-LRB- MAO/NN )/-RRB- inhibitors/NNS such/JJ as/IN isocarboxazid/NN (/-LRB- e.g./FW ,/, Marplan/NN )/-RRB- ,/, phenelzine/NN (/-LRB- e.g./FW ,/, Nardil/NN )/-RRB- ,/, procarbazine/NN (/-LRB- e.g./FW ,/, Matulane/NN )/-RRB- ,/, selegiline/NN (/-LRB- e.g./FW ,/, Eldepryl/NN )/-RRB- ,/, and/CC tranylcypromine/NN (/-LRB- e.g./FW ,/, Parnate/NN )/-RRB- :/: Using/VBG these/DT medicines/NNS with/IN L-/NNP tryptophan/NN may/MD increase/VB the/DT chance/NN of/IN side/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (NP (NN Monoamine) (NN oxidase)) (PRN (-LRB- -LRB-) (NP (NN MAO)) (-RRB- -RRB-))) (NNS inhibitors)) (PP (JJ such) (IN as) (NP (NP (NP (NN isocarboxazid)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN Marplan)) (-RRB- -RRB-))) (, ,) (NP (NP (NN phenelzine)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN Nardil)) (-RRB- -RRB-))) (, ,) (NP (NP (NN procarbazine)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN Matulane)) (-RRB- -RRB-))) (, ,) (NP (NP (NN selegiline)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN Eldepryl)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN tranylcypromine)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN Parnate)) (-RRB- -RRB-))))) (: :)) (VP (VBG Using) (NP (NP (DT these) (NNS medicines)) (PP (IN with) (NP (NNP L-) (NN tryptophan)))))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN chance)) (PP (IN of) (NP (JJ side) (NNS effects))))))) (. .))))

nn(oxidase-2, Monoamine-1)
nn(inhibitors-6, oxidase-2)
abbrev(oxidase-2, MAO-4)
nsubj(increase-52, inhibitors-6)
prep_such_as(inhibitors-6, isocarboxazid-9)
dep(Marplan-13, e.g.-11)
appos(isocarboxazid-9, Marplan-13)
conj_and(isocarboxazid-9, phenelzine-16)
dep(Nardil-20, e.g.-18)
appos(phenelzine-16, Nardil-20)
conj_and(isocarboxazid-9, procarbazine-23)
dep(Matulane-27, e.g.-25)
appos(procarbazine-23, Matulane-27)
conj_and(isocarboxazid-9, selegiline-30)
dep(Eldepryl-34, e.g.-32)
appos(selegiline-30, Eldepryl-34)
conj_and(isocarboxazid-9, tranylcypromine-38)
dep(Parnate-42, e.g.-40)
appos(tranylcypromine-38, Parnate-42)
partmod(inhibitors-6, Using-45)
det(medicines-47, these-46)
dobj(Using-45, medicines-47)
nn(tryptophan-50, L--49)
prep_with(medicines-47, tryptophan-50)
aux(increase-52, may-51)
root(ROOT-0, increase-52)
det(chance-54, the-53)
dobj(increase-52, chance-54)
amod(effects-57, side-56)
prep_of(chance-54, effects-57)

Non-selective/JJ MAO/NN inhibitors/NNS including/VBG tranylcypromine/NN sulfate/NN ,/, phenelzine/NN sulfate/NN ,/, and/CC pargyline/NN HC1/NN :/: Concomitant/JJ use/NN of/IN L-/NNP tyrosine/NN and/CC non-selective/JJ MAO/NN inhibitors/NNS may/MD cause/VB hypertension/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Non-selective) (NN MAO) (NNS inhibitors)) (PP (VBG including) (NP (NP (NN tranylcypromine) (NN sulfate)) (, ,) (NP (NN phenelzine) (NN sulfate)) (, ,) (CC and) (NP (NN pargyline) (NN HC1))))) (: :) (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (NNP L-) (NN tyrosine)))) (CC and) (NP (JJ non-selective) (NN MAO) (NNS inhibitors))) (VP (MD may) (VP (VB cause) (NP (NN hypertension))))) (. .))))

amod(inhibitors-3, Non-selective-1)
nn(inhibitors-3, MAO-2)
nsubj(cause-25, inhibitors-3)
nn(sulfate-6, tranylcypromine-5)
prep_including(inhibitors-3, sulfate-6)
nn(sulfate-9, phenelzine-8)
conj_and(sulfate-6, sulfate-9)
nn(HC1-13, pargyline-12)
conj_and(sulfate-6, HC1-13)
amod(use-16, Concomitant-15)
conj_and(inhibitors-3, use-16)
nn(tyrosine-19, L--18)
prep_of(use-16, tyrosine-19)
amod(inhibitors-23, non-selective-21)
nn(inhibitors-23, MAO-22)
conj_and(inhibitors-3, inhibitors-23)
aux(cause-25, may-24)
root(ROOT-0, cause-25)
dobj(cause-25, hypertension-26)

In/IN one/CD survey/NN ,/, 2.3/CD %/NN of/IN patients/NNS taking/VBG labetalol/NN HCl/NN in/IN combination/NN with/IN tricyclic/JJ antidepressants/NNS experienced/VBN tremor/NN ,/, as/IN compared/VBN to/TO 0.7/CD %/NN reported/VBN to/TO occur/VB with/IN labetalol/NN HCl/NN alone/RB ./.

(ROOT (S1 (S (S (PP (IN In) (NP (CD one) (NN survey))) (, ,) (NP (NP (CD 2.3) (NN %)) (PP (IN of) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN labetalol) (NN HCl)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ tricyclic) (NNS antidepressants))))))))) (VP (VBN experienced) (NP (NN tremor)) (, ,) (SBAR (IN as) (S (VP (VBN compared) (PP (TO to) (NP (NP (CD 0.7) (NN %)) (VP (VBN reported) (S (VP (TO to) (VP (VB occur) (PP (IN with) (NP (NP (NN labetalol) (NN HCl)) (ADVP (RB alone))))))))))))))) (. .))))

num(survey-3, one-2)
prep_in(experienced-17, survey-3)
num(%-6, 2.3-5)
nsubj(experienced-17, %-6)
prep_of(%-6, patients-8)
partmod(patients-8, taking-9)
nn(HCl-11, labetalol-10)
dobj(taking-9, HCl-11)
prep_in(taking-9, combination-13)
amod(antidepressants-16, tricyclic-15)
prep_with(combination-13, antidepressants-16)
root(ROOT-0, experienced-17)
dobj(experienced-17, tremor-18)
mark(compared-21, as-20)
advcl(experienced-17, compared-21)
num(%-24, 0.7-23)
prep_to(compared-21, %-24)
xsubj(occur-27, %-24)
partmod(%-24, reported-25)
aux(occur-27, to-26)
xcomp(reported-25, occur-27)
nn(HCl-30, labetalol-29)
prep_with(occur-27, HCl-30)
advmod(HCl-30, alone-31)

Drugs/NNS possessing/VBG beta-blocking/JJ properties/NNS can/MD blunt/VB the/DT bronchodilator/NN effect/NN of/IN beta-receptor/NN agonist/NN drug/NN s/NN in/IN patients/NNS with/IN bronchospasm/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (VP (VBG possessing) (NP (JJ beta-blocking) (NNS properties)))) (VP (MD can) (VP (VB blunt) (NP (NP (DT the) (NN bronchodilator) (NN effect)) (PP (IN of) (NP (NN beta-receptor) (NN agonist) (NN drug) (NN s))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN bronchospasm)))))))) (: ;)) (. .))))

nsubj(blunt-6, Drugs-1)
partmod(Drugs-1, possessing-2)
amod(properties-4, beta-blocking-3)
dobj(possessing-2, properties-4)
aux(blunt-6, can-5)
root(ROOT-0, blunt-6)
det(effect-9, the-7)
nn(effect-9, bronchodilator-8)
dobj(blunt-6, effect-9)
nn(s-14, beta-receptor-11)
nn(s-14, agonist-12)
nn(s-14, drug-13)
prep_of(effect-9, s-14)
prep_in(effect-9, patients-16)
prep_with(patients-16, bronchospasm-18)

therefore/RB ,/, doses/NNS greater/JJR than/IN the/DT normal/JJ antiasthmatic/JJ dose/NN of/IN beta-agonist/NN bronchodilator/NN drugs/NNS may/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (ADVP (RB therefore)) (, ,) (NP (NP (NNS doses)) (ADJP (JJR greater) (PP (IN than) (NP (NP (DT the) (JJ normal) (JJ antiasthmatic) (NN dose)) (PP (IN of) (NP (NN beta-agonist) (NN bronchodilator) (NNS drugs))))))) (VP (MD may) (VP (VB be) (VP (VBN required))))) (. .))))

advmod(required-16, therefore-1)
nsubjpass(required-16, doses-3)
amod(doses-3, greater-4)
det(dose-9, the-6)
amod(dose-9, normal-7)
amod(dose-9, antiasthmatic-8)
prep_than(greater-4, dose-9)
nn(drugs-13, beta-agonist-11)
nn(drugs-13, bronchodilator-12)
prep_of(dose-9, drugs-13)
aux(required-16, may-14)
auxpass(required-16, be-15)
root(ROOT-0, required-16)

Cimetidine/NN has/VBZ been/VBN shown/VBN to/TO increase/VB the/DT bioavailability/NN of/IN labetalol/JJ HCl/NN ./.

(ROOT (S1 (S (S (NP (NN Cimetidine)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (JJ labetalol) (NN HCl))))))))))) (. .))))

nsubjpass(shown-4, Cimetidine-1)
xsubj(increase-6, Cimetidine-1)
aux(shown-4, has-2)
auxpass(shown-4, been-3)
root(ROOT-0, shown-4)
aux(increase-6, to-5)
xcomp(shown-4, increase-6)
det(bioavailability-8, the-7)
dobj(increase-6, bioavailability-8)
amod(HCl-11, labetalol-10)
prep_of(bioavailability-8, HCl-11)

Since/IN this/DT could/MD be/VB explained/VBN either/CC by/IN enhanced/VBN absorption/NN or/CC by/IN an/DT alteration/NN of/IN hepatic/JJ metabolism/NN of/IN labetalol/NN HCl/NN ,/, special/JJ care/NN should/MD be/VB used/VBN in/IN establishing/VBG the/DT dose/NN required/VBN for/IN blood/NN pressure/NN control/NN in/IN such/JJ patients/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (DT this)) (VP (MD could) (VP (VB be) (VP (VBN explained) (PP (CC either) (PP (IN by) (NP (VBN enhanced) (NN absorption))) (CC or) (PP (IN by) (NP (NP (DT an) (NN alteration)) (PP (IN of) (NP (NP (JJ hepatic) (NN metabolism)) (PP (IN of) (NP (NN labetalol) (NN HCl))))))))))))) (, ,) (NP (JJ special) (NN care)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN in) (S (VP (VBG establishing) (NP (NP (DT the) (NN dose)) (VP (VBN required) (PP (IN for) (NP (NP (NN blood) (NN pressure) (NN control)) (PP (IN in) (NP (JJ such) (NNS patients)))))))))))))) (. .))))

mark(explained-5, Since-1)
nsubjpass(explained-5, this-2)
aux(explained-5, could-3)
auxpass(explained-5, be-4)
advcl(used-25, explained-5)
preconj(explained-5, either-6)
amod(absorption-9, enhanced-8)
agent(explained-5, absorption-9)
det(alteration-13, an-12)
conj_or(absorption-9, alteration-13)
amod(metabolism-16, hepatic-15)
prep_of(alteration-13, metabolism-16)
nn(HCl-19, labetalol-18)
prep_of(metabolism-16, HCl-19)
amod(care-22, special-21)
nsubjpass(used-25, care-22)
aux(used-25, should-23)
auxpass(used-25, be-24)
root(ROOT-0, used-25)
prepc_in(used-25, establishing-27)
det(dose-29, the-28)
dobj(establishing-27, dose-29)
partmod(dose-29, required-30)
nn(control-34, blood-32)
nn(control-34, pressure-33)
prep_for(required-30, control-34)
amod(patients-37, such-36)
prep_in(control-34, patients-37)

Synergism/NN has/VBZ been/VBN shown/VBN between/IN halothane/NN anesthesia/NN and/CC intravenously/RB administered/VBN labetalol/NN HCl/NN ./.

(ROOT (S1 (S (S (NP (NN Synergism)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (PP (IN between) (NP (NP (NN halothane) (NN anesthesia)) (CC and) (NP (ADJP (RB intravenously) (VBN administered)) (NN labetalol) (NN HCl)))))))) (. .))))

nsubjpass(shown-4, Synergism-1)
aux(shown-4, has-2)
auxpass(shown-4, been-3)
root(ROOT-0, shown-4)
nn(anesthesia-7, halothane-6)
prep_between(shown-4, anesthesia-7)
advmod(administered-10, intravenously-9)
amod(HCl-12, administered-10)
nn(HCl-12, labetalol-11)
conj_and(anesthesia-7, HCl-12)

During/IN controlled/JJ hypotensive/JJ anesthesia/NN using/VBG labetalol/NN HCl/NN in/IN association/NN with/IN halothane/NN ,/, high/JJ concentrations/NNS (/-LRB- 3/CD %/NN or/CC above/JJ )/-RRB- of/IN halothane/NN should/MD not/RB be/VB used/VBN because/IN the/DT degree/NN of/IN hypotension/NN will/MD be/VB increased/VBN and/CC because/IN of/IN the/DT possibility/NN of/IN a/DT large/JJ reduction/NN in/IN cardiac/JJ output/NN and/CC an/DT increase/NN in/IN central/JJ venous/JJ pressure/NN ./.

(ROOT (S1 (S (S (PP (IN During) (NP (NP (JJ controlled) (JJ hypotensive) (NN anesthesia)) (VP (VBG using) (NP (NN labetalol) (NN HCl)) (PP (IN in) (NP (NP (NN association)) (PP (IN with) (NP (NN halothane)))))))) (, ,) (NP (NP (NP (JJ high) (NNS concentrations)) (PRN (-LRB- -LRB-) (NP (NP (CD 3) (NN %)) (CC or) (NP (JJ above))) (-RRB- -RRB-))) (PP (IN of) (NP (NN halothane)))) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (SBAR (IN because) (S (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NN hypotension)))) (VP (MD will) (VP (VB be) (VP (VBN increased) (CC and) (PP (IN because) (IN of) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (NP (DT a) (JJ large) (NN reduction)) (PP (IN in) (NP (JJ cardiac) (NN output)))) (CC and) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (JJ central) (JJ venous) (NN pressure))))))))))))))))) (. .))))

amod(anesthesia-4, controlled-2)
amod(anesthesia-4, hypotensive-3)
prep_during(used-26, anesthesia-4)
partmod(anesthesia-4, using-5)
nn(HCl-7, labetalol-6)
dobj(using-5, HCl-7)
prep_in(using-5, association-9)
prep_with(association-9, halothane-11)
amod(concentrations-14, high-13)
nsubjpass(used-26, concentrations-14)
num(%-17, 3-16)
dep(concentrations-14, %-17)
conj_or(%-17, above-19)
prep_of(concentrations-14, halothane-22)
aux(used-26, should-23)
neg(used-26, not-24)
auxpass(used-26, be-25)
root(ROOT-0, used-26)
mark(increased-34, because-27)
det(degree-29, the-28)
nsubjpass(increased-34, degree-29)
prep_of(degree-29, hypotension-31)
aux(increased-34, will-32)
auxpass(increased-34, be-33)
advcl(used-26, increased-34)
conj_and(increased-34, of-37)
det(possibility-39, the-38)
prep_because_of(increased-34, possibility-39)
det(reduction-43, a-41)
amod(reduction-43, large-42)
prep_of(possibility-39, reduction-43)
amod(output-46, cardiac-45)
prep_in(reduction-43, output-46)
det(increase-49, an-48)
conj_and(reduction-43, increase-49)
amod(pressure-53, central-51)
amod(pressure-53, venous-52)
prep_in(increase-49, pressure-53)

The/DT anesthesiologist/NN should/MD be/VB informed/VBN when/WRB a/DT patient/NN is/VBZ receiving/VBG labetalol/NN HCl/NN ./.

(ROOT (S1 (S (S (NP (DT The) (NN anesthesiologist)) (VP (MD should) (VP (VB be) (VP (VBN informed) (SBAR (WHADVP (WRB when)) (S (NP (DT a) (NN patient)) (VP (VBZ is) (VP (VBG receiving) (NP (NN labetalol) (NN HCl)))))))))) (. .))))

det(anesthesiologist-2, The-1)
nsubjpass(informed-5, anesthesiologist-2)
aux(informed-5, should-3)
auxpass(informed-5, be-4)
root(ROOT-0, informed-5)
advmod(receiving-10, when-6)
det(patient-8, a-7)
nsubj(receiving-10, patient-8)
aux(receiving-10, is-9)
advcl(informed-5, receiving-10)
nn(HCl-12, labetalol-11)
dobj(receiving-10, HCl-12)

Labetalol/NN HCl/NN blunts/VBZ the/DT reflex/NN tachycardia/NN produced/VBN by/IN nitroglycerin/NN without/IN prevent/VB ing/VBG its/PRP$ hypotensive/JJ effect/NN ./.

(ROOT (S1 (S (S (NP (NN Labetalol) (NN HCl)) (VP (VBZ blunts) (NP (NP (DT the) (NN reflex) (NN tachycardia)) (VP (VBN produced) (PP (IN by) (NP (NN nitroglycerin))) (PP (IN without) (S (NP (VB prevent)) (VP (VBG ing) (NP (PRP$ its) (JJ hypotensive) (NN effect))))))))) (. .))))

nn(HCl-2, Labetalol-1)
nsubj(blunts-3, HCl-2)
root(ROOT-0, blunts-3)
det(tachycardia-6, the-4)
nn(tachycardia-6, reflex-5)
dobj(blunts-3, tachycardia-6)
partmod(tachycardia-6, produced-7)
agent(produced-7, nitroglycerin-9)
nsubj(ing-12, prevent-11)
prepc_without(produced-7, ing-12)
poss(effect-15, its-13)
amod(effect-15, hypotensive-14)
dobj(ing-12, effect-15)

If/IN labetalol/NN HCl/NN is/VBZ used/VBN with/IN nitroglycerin/NN in/IN patients/NNS with/IN angina/NN pectoris/NNS ,/, additional/JJ antihypertensive/JJ effects/NNS may/MD occur/VB ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NN labetalol) (NN HCl)) (VP (VBZ is) (VP (VBN used) (PP (IN with) (NP (NN nitroglycerin))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN angina) (NNS pectoris))))))))) (, ,) (NP (JJ additional) (JJ antihypertensive) (NNS effects)) (VP (MD may) (VP (VB occur)))) (. .))))

mark(used-5, If-1)
nn(HCl-3, labetalol-2)
nsubjpass(used-5, HCl-3)
auxpass(used-5, is-4)
advcl(occur-18, used-5)
prep_with(used-5, nitroglycerin-7)
prep_in(used-5, patients-9)
nn(pectoris-12, angina-11)
prep_with(patients-9, pectoris-12)
amod(effects-16, additional-14)
amod(effects-16, antihypertensive-15)
nsubj(occur-18, effects-16)
aux(occur-18, may-17)
root(ROOT-0, occur-18)

Care/NN should/MD be/VB taken/VBN if/IN labetalol/NN is/VBZ used/VBN concomitantly/RB with/IN calcium/NN antagonist/NN s/NN of/IN the/DT verapamil/NN type/NN ./.

(ROOT (S1 (S (S (NP (NN Care)) (VP (MD should) (VP (VB be) (VP (VBN taken) (SBAR (IN if) (S (NP (NN labetalol)) (VP (VBZ is) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NN calcium) (NN antagonist) (NN s)) (PP (IN of) (NP (DT the) (NN verapamil) (NN type))))))))))))) (. .))))

nsubjpass(taken-4, Care-1)
aux(taken-4, should-2)
auxpass(taken-4, be-3)
root(ROOT-0, taken-4)
mark(used-8, if-5)
nsubjpass(used-8, labetalol-6)
auxpass(used-8, is-7)
advcl(taken-4, used-8)
advmod(used-8, concomitantly-9)
nn(s-13, calcium-11)
nn(s-13, antagonist-12)
prep_with(used-8, s-13)
det(type-17, the-15)
nn(type-17, verapamil-16)
prep_of(s-13, type-17)

Risk/NN of/IN Anaphylactic/JJ Reaction/NN :/: While/IN taking/VBG beta-blockers/NN ,/, patients/NNS with/IN a/DT history/NN of/IN severe/JJ anaphylactic/JJ reaction/NN to/TO a/DT variety/NN of/IN allergens/NNS may/MD be/VB more/RBR reactive/JJ to/TO repeated/JJ challenge/NN ,/, either/CC accidental/JJ ,/, diagnostic/JJ ,/, or/CC therapeutic/JJ ./.

(ROOT (S1 (S (NP (NP (NP (NN Risk)) (PP (IN of) (NP (JJ Anaphylactic) (NN Reaction)))) (: :) (S (SBAR (IN While) (S (VP (VBG taking) (NP (NN beta-blockers))))) (, ,) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (JJ severe) (JJ anaphylactic) (NN reaction)) (PP (TO to) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS allergens)))))))))) (VP (MD may) (VP (VB be) (ADJP (ADJP (RBR more) (JJ reactive) (PP (TO to) (NP (JJ repeated) (NN challenge)))) (, ,) (CC either) (ADJP (JJ accidental)) (, ,) (ADJP (JJ diagnostic)) (, ,) (CC or) (ADJP (JJ therapeutic)))))) (. .)))))

root(ROOT-0, Risk-1)
amod(Reaction-4, Anaphylactic-3)
prep_of(Risk-1, Reaction-4)
mark(taking-7, While-6)
advcl(reactive-26, taking-7)
dobj(taking-7, beta-blockers-8)
nsubj(reactive-26, patients-10)
det(history-13, a-12)
prep_with(patients-10, history-13)
amod(reaction-17, severe-15)
amod(reaction-17, anaphylactic-16)
prep_of(history-13, reaction-17)
det(variety-20, a-19)
prep_to(reaction-17, variety-20)
prep_of(variety-20, allergens-22)
aux(reactive-26, may-23)
cop(reactive-26, be-24)
advmod(reactive-26, more-25)
dep(Risk-1, reactive-26)
amod(challenge-29, repeated-28)
prep_to(reactive-26, challenge-29)
preconj(reactive-26, either-31)
conj_or(reactive-26, accidental-32)
conj_or(reactive-26, diagnostic-34)
conj_or(reactive-26, therapeutic-37)

Such/JJ patients/NNS may/MD be/VB unresponsive/JJ to/TO the/DT usual/JJ doses/NNS of/IN epinephrine/NN used/VBN to/TO treat/VB allergic/JJ reaction/NN ./.

(ROOT (S1 (S (S (NP (JJ Such) (NNS patients)) (VP (MD may) (VP (VB be) (ADJP (JJ unresponsive) (PP (TO to) (NP (NP (DT the) (JJ usual) (NNS doses)) (PP (IN of) (NP (NN epinephrine))) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (JJ allergic) (NN reaction)))))))))))) (. .))))

amod(patients-2, Such-1)
nsubj(unresponsive-5, patients-2)
aux(unresponsive-5, may-3)
cop(unresponsive-5, be-4)
root(ROOT-0, unresponsive-5)
det(doses-9, the-7)
amod(doses-9, usual-8)
prep_to(unresponsive-5, doses-9)
prep_of(doses-9, epinephrine-11)
partmod(doses-9, used-12)
aux(treat-14, to-13)
xcomp(used-12, treat-14)
amod(reaction-16, allergic-15)
dobj(treat-14, reaction-16)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: The/DT presence/NN of/IN labetalol/NN metabolites/NNS in/IN the/DT urine/NN may/MD result/VB in/IN falsely/RB elevated/JJ levels/NNS of/IN urinary/JJ catecholamines/NNS ,/, metanephrine/NN ,/, normetanephrine/NN and/CC vanillylmandelic/JJ acid/NN when/WRB measured/VBN by/IN fluorimetric/JJ or/CC photometric/JJ methods/NNS ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (NP (DT The) (NN presence)) (PP (IN of) (NP (NN labetalol) (NNS metabolites))) (PP (IN in) (NP (DT the) (NN urine)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (NP (ADJP (RB falsely) (JJ elevated)) (NNS levels)) (PP (IN of) (NP (JJ urinary) (NNS catecholamines)))) (, ,) (NP (NP (NN metanephrine)) (, ,) (NP (NN normetanephrine)) (CC and) (NP (JJ vanillylmandelic) (NN acid))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN measured) (PP (IN by) (NP (ADJP (ADJP (JJ fluorimetric)) (CC or) (ADJP (JJ photometric))) (NNS methods))))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
det(presence-7, The-6)
nsubj(result-15, presence-7)
nn(metabolites-10, labetalol-9)
prep_of(presence-7, metabolites-10)
det(urine-13, the-12)
prep_in(presence-7, urine-13)
aux(result-15, may-14)
dep(Interactions-4, result-15)
advmod(elevated-18, falsely-17)
amod(levels-19, elevated-18)
prep_in(result-15, levels-19)
amod(catecholamines-22, urinary-21)
prep_of(levels-19, catecholamines-22)
appos(levels-19, metanephrine-24)
conj_and(metanephrine-24, normetanephrine-26)
amod(acid-29, vanillylmandelic-28)
conj_and(metanephrine-24, acid-29)
advmod(measured-31, when-30)
advcl(result-15, measured-31)
amod(methods-36, fluorimetric-33)
conj_or(fluorimetric-33, photometric-35)
prep_by(measured-31, methods-36)

In/IN screening/JJ patients/NNS suspected/VBN of/IN having/VBG a/DT pheochromocytoma/NN and/CC being/VBG treated/VBN with/IN labetalol/NN HCl/NN ,/, a/DT specific/JJ method/NN ,/, such/JJ as/IN a/DT high/JJ performance/NN liquid/JJ chromatographic/JJ assay/NN with/IN solid/JJ phase/NN extraction/NN (/-LRB- e.g./FW ,/, J/NNP Chromatogr/NNP 385:241,1987/CD )/-RRB- should/MD be/VB employed/VBN in/IN determining/VBG levels/NNS of/IN catecholamines/NNS ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (JJ screening) (NNS patients)) (VP (VBN suspected) (PP (IN of) (S (VP (VP (VBG having) (NP (DT a) (NN pheochromocytoma))) (CC and) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NN labetalol) (NN HCl))))))))))) (, ,) (NP (NP (DT a) (JJ specific) (NN method)) (, ,) (ADJP (JJ such) (PP (IN as) (NP (NP (DT a) (JJ high) (NN performance) (JJ liquid) (JJ chromatographic) (NN assay)) (PP (IN with) (NP (NP (JJ solid) (NN phase) (NN extraction)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NNP J) (NNP Chromatogr) (CD 385:241,1987)) (-RRB- -RRB-)))))))) (VP (MD should) (VP (VB be) (VP (VBN employed) (PP (IN in) (S (VP (VBG determining) (NP (NP (NNS levels)) (PP (IN of) (NP (NNS catecholamines)))))))))) (. .))))

amod(patients-3, screening-2)
prep_in(employed-41, patients-3)
partmod(patients-3, suspected-4)
prepc_of(suspected-4, having-6)
det(pheochromocytoma-8, a-7)
dobj(having-6, pheochromocytoma-8)
auxpass(treated-11, being-10)
conj_and(having-6, treated-11)
nn(HCl-14, labetalol-13)
prep_with(treated-11, HCl-14)
det(method-18, a-16)
amod(method-18, specific-17)
nsubjpass(employed-41, method-18)
det(assay-27, a-22)
amod(assay-27, high-23)
nn(assay-27, performance-24)
amod(assay-27, liquid-25)
amod(assay-27, chromatographic-26)
prep_such_as(method-18, assay-27)
amod(extraction-31, solid-29)
nn(extraction-31, phase-30)
prep_with(assay-27, extraction-31)
dep(Chromatogr-36, e.g.-33)
nn(Chromatogr-36, J-35)
appos(extraction-31, Chromatogr-36)
num(Chromatogr-36, 385:241,1987-37)
aux(employed-41, should-39)
auxpass(employed-41, be-40)
root(ROOT-0, employed-41)
prepc_in(employed-41, determining-43)
dobj(determining-43, levels-44)
prep_of(levels-44, catecholamines-46)

Labetalol/NN HCl/NN has/VBZ also/RB been/VBN reported/VBN to/TO produce/VB a/DT false/JJ positive/JJ test/NN for/IN amphetamine/NN when/WRB screening/VBG urine/NN for/IN the/DT presence/NN of/IN drugs/NNS using/VBG the/DT commercially/RB available/JJ assay/NN methods/NNS Toxi-Lab/NN A/NN @/NN (/-LRB- thin-layer/NN chromatographic/JJ assay/NN )/-RRB- and/CC Emit-d.a.u./NN @/NN (/-LRB- radioenzymatic/JJ assay/NN )./CD

(ROOT (S1 (S (NP (NN Labetalol) (NN HCl)) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB produce) (NP (NP (DT a) (JJ false) (JJ positive) (NN test)) (PP (IN for) (NP (NN amphetamine)))) (SBAR (WHADVP (WRB when)) (S (VP (VBG screening) (NP (NN urine)) (PP (IN for) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (NNS drugs)) (VP (VBG using) (NP (NP (DT the) (ADJP (RB commercially) (JJ available)) (NN assay) (NNS methods) (NP (NP (NP (NN Toxi-Lab) (NN A) (NN @)) (PRN (-LRB- -LRB-) (NP (NN thin-layer) (JJ chromatographic) (NN assay)) (-RRB- -RRB-))) (CC and) (NP (NN Emit-d.a.u.) (NN @)))) (-LRB- -LRB-) (NP (JJ radioenzymatic) (NN assay) (CD -RRB-.))))))))))))))))))))

nn(HCl-2, Labetalol-1)
nsubjpass(reported-6, HCl-2)
xsubj(produce-8, HCl-2)
aux(reported-6, has-3)
advmod(reported-6, also-4)
auxpass(reported-6, been-5)
root(ROOT-0, reported-6)
aux(produce-8, to-7)
xcomp(reported-6, produce-8)
det(test-12, a-9)
amod(test-12, false-10)
amod(test-12, positive-11)
dobj(produce-8, test-12)
prep_for(test-12, amphetamine-14)
advmod(screening-16, when-15)
advcl(produce-8, screening-16)
dobj(screening-16, urine-17)
det(presence-20, the-19)
prep_for(screening-16, presence-20)
prep_of(presence-20, drugs-22)
partmod(drugs-22, using-23)
det(methods-28, the-24)
advmod(available-26, commercially-25)
amod(methods-28, available-26)
nn(methods-28, assay-27)
dobj(using-23, methods-28)
iobj(using-23, methods-28)
nn(@-31, Toxi-Lab-29)
nn(@-31, A-30)
dep(methods-28, @-31)
nn(assay-35, thin-layer-33)
amod(assay-35, chromatographic-34)
appos(@-31, assay-35)
nn(@-39, Emit-d.a.u.-38)
conj_and(@-31, @-39)
amod(assay-42, radioenzymatic-41)
dep(methods-28, assay-42)
num(assay-42, -RRB-.-43)

When/WRB patients/NNS being/VBG treated/VBN with/IN labetalol/NN have/VBP a/DT positive/JJ urine/NN test/NN for/IN amphetamine/NN using/VBG these/DT techniques/NNS confirmation/NN should/MD be/VB made/VBN by/IN using/VBG more/RBR specific/JJ methods/NNS such/JJ as/IN a/DT gas/NN chromatographic-mass/NN spectrometer/NN technique/NN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NP (NNS patients)) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NN labetalol)))))) (VP (VBP have) (NP (NP (DT a) (JJ positive) (NN urine) (NN test)) (PP (IN for) (NP (NP (NN amphetamine)) (VP (VBG using) (NP (DT these) (NNS techniques))))))))) (NP (NN confirmation)) (VP (MD should) (VP (VB be) (VP (VBN made) (PP (IN by) (S (VP (VBG using) (NP (ADJP (RBR more) (JJ specific)) (NP (NNS methods)) (PP (JJ such) (IN as) (NP (DT a) (NN gas) (NN chromatographic-mass) (NN spectrometer) (NN technique))))))))))) (. .))))

advmod(have-7, When-1)
nsubj(have-7, patients-2)
auxpass(treated-4, being-3)
partmod(patients-2, treated-4)
prep_with(treated-4, labetalol-6)
advcl(made-20, have-7)
det(test-11, a-8)
amod(test-11, positive-9)
nn(test-11, urine-10)
dobj(have-7, test-11)
prep_for(test-11, amphetamine-13)
partmod(amphetamine-13, using-14)
det(techniques-16, these-15)
dobj(using-14, techniques-16)
nsubjpass(made-20, confirmation-17)
aux(made-20, should-18)
auxpass(made-20, be-19)
root(ROOT-0, made-20)
agent(made-20, using-22)
advmod(specific-24, more-23)
amod(methods-25, specific-24)
dobj(using-22, methods-25)
det(technique-32, a-28)
nn(technique-32, gas-29)
nn(technique-32, chromatographic-mass-30)
nn(technique-32, spectrometer-31)
prep_such_as(methods-25, technique-32)

Results/NNS of/IN preliminary/JJ studies/NNS in/IN humans/NNS and/CC rats/NNS suggest/VBP that/IN nonabsorbable/JJ antacids/NNS given/VBN concurrently/RB with/IN lactulose/NN may/MD inhibit/VB the/DT desired/JJ lactulose/NN -induced/JJ drop/NN in/IN colonic/JJ pH/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Results)) (PP (IN of) (NP (NP (JJ preliminary) (NNS studies)) (PP (IN in) (NP (NP (NNS humans)) (CC and) (NP (NNS rats))))))) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ nonabsorbable) (NNS antacids)) (VP (VBN given) (ADVP (RB concurrently)) (PP (IN with) (NP (NN lactulose))))) (VP (MD may) (VP (VB inhibit) (NP (NP (DT the) (JJ desired) (NN lactulose) (JJ -induced) (NN drop)) (PP (IN in) (NP (JJ colonic) (NN pH)))))))))) (. .))))

nsubj(suggest-9, Results-1)
amod(studies-4, preliminary-3)
prep_of(Results-1, studies-4)
prep_in(studies-4, humans-6)
conj_and(humans-6, rats-8)
root(ROOT-0, suggest-9)
complm(inhibit-18, that-10)
amod(antacids-12, nonabsorbable-11)
nsubj(inhibit-18, antacids-12)
partmod(antacids-12, given-13)
advmod(given-13, concurrently-14)
prep_with(given-13, lactulose-16)
aux(inhibit-18, may-17)
ccomp(suggest-9, inhibit-18)
det(drop-23, the-19)
amod(drop-23, desired-20)
nn(drop-23, lactulose-21)
amod(drop-23, -induced-22)
dobj(inhibit-18, drop-23)
amod(pH-26, colonic-25)
prep_in(drop-23, pH-26)

Therefore/RB ,/, a/DT possible/JJ lack/NN of/IN desired/JJ effect/NN of/IN treatment/NN should/MD be/VB taken/VBN into/IN consideration/NN before/IN such/JJ drugs/NNS are/VBP given/VBN concomitantly/RB with/IN lactulose/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT a) (JJ possible) (NN lack)) (PP (IN of) (NP (NP (JJ desired) (NN effect)) (PP (IN of) (NP (NN treatment)))))) (VP (MD should) (VP (VB be) (VP (VBN taken) (PP (IN into) (NP (NN consideration))) (SBAR (IN before) (S (NP (JJ such) (NNS drugs)) (VP (VBP are) (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN lactulose))))))))))) (. .))))

advmod(taken-13, Therefore-1)
det(lack-5, a-3)
amod(lack-5, possible-4)
nsubjpass(taken-13, lack-5)
amod(effect-8, desired-7)
prep_of(lack-5, effect-8)
prep_of(effect-8, treatment-10)
aux(taken-13, should-11)
auxpass(taken-13, be-12)
root(ROOT-0, taken-13)
prep_into(taken-13, consideration-15)
mark(given-20, before-16)
amod(drugs-18, such-17)
nsubjpass(given-20, drugs-18)
auxpass(given-20, are-19)
advcl(taken-13, given-20)
advmod(given-20, concomitantly-21)
prep_with(given-20, lactulose-23)

Lamivudine/NN is/VBZ predominantly/RB eliminated/VBN in/IN the/DT urine/NN by/IN active/JJ organic/JJ cation/NN ic/NN secretion/NN ./.

(ROOT (S1 (S (S (NP (NN Lamivudine)) (VP (VBZ is) (ADVP (RB predominantly)) (VP (VBN eliminated) (PP (IN in) (NP (DT the) (NN urine))) (PP (IN by) (NP (JJ active) (JJ organic) (NN cation) (NN ic) (NN secretion)))))) (. .))))

nsubjpass(eliminated-4, Lamivudine-1)
auxpass(eliminated-4, is-2)
advmod(eliminated-4, predominantly-3)
root(ROOT-0, eliminated-4)
det(urine-7, the-6)
prep_in(eliminated-4, urine-7)
amod(secretion-13, active-9)
amod(secretion-13, organic-10)
nn(secretion-13, cation-11)
nn(secretion-13, ic-12)
agent(eliminated-4, secretion-13)

The/DT possibility/NN of/IN interactions/NNS with/IN other/JJ drugs/NNS administered/VBN concurrently/RB should/MD be/VB considered/VBN ,/, particularly/RB when/WRB their/PRP$ main/JJ route/NN of/IN elimination/NN is/VBZ active/JJ renal/JJ secretion/NN via/IN the/DT organic/JJ cationic/NN transport/NN system/NN (/-LRB- e.g./FW ,/, trimethoprim/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN possibility)) (PP (IN of) (NP (NP (NNS interactions)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (VP (VBN administered) (ADVP (RB concurrently)))))))) (VP (MD should) (VP (VB be) (VP (VBN considered) (, ,) (SBAR (WHADVP (RB particularly) (WRB when)) (S (NP (NP (PRP$ their) (JJ main) (NN route)) (PP (IN of) (NP (NN elimination)))) (VP (VBZ is) (NP (JJ active) (JJ renal) (NN secretion)) (PP (IN via) (NP (NP (DT the) (JJ organic) (NN cationic) (NN transport) (NN system)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN trimethoprim))) (-RRB- -RRB-))))))))))) (. .))))

det(possibility-2, The-1)
nsubjpass(considered-12, possibility-2)
prep_of(possibility-2, interactions-4)
amod(drugs-7, other-6)
prep_with(interactions-4, drugs-7)
partmod(drugs-7, administered-8)
advmod(administered-8, concurrently-9)
aux(considered-12, should-10)
auxpass(considered-12, be-11)
root(ROOT-0, considered-12)
advmod(when-15, particularly-14)
advmod(secretion-24, when-15)
poss(route-18, their-16)
amod(route-18, main-17)
nsubj(secretion-24, route-18)
prep_of(route-18, elimination-20)
cop(secretion-24, is-21)
amod(secretion-24, active-22)
amod(secretion-24, renal-23)
advcl(considered-12, secretion-24)
det(system-30, the-26)
amod(system-30, organic-27)
nn(system-30, cationic-28)
nn(system-30, transport-29)
prep_via(secretion-24, system-30)
dep(system-30, e.g.-32)
pobj(e.g.-32, trimethoprim-34)

TMP/NN 160/CD mg/SMX/NN 800/CD mg/NN once/IN daily/JJ has/VBZ been/VBN shown/VBN to/TO increase/VB lamivudine/NN exposure/NN (/-LRB- AUC/NN )/-RRB- by/IN 44/CD %./NN

(ROOT (S1 (S (NP (NP (NN TMP) (CD 160) (NN mg/SMX) (CD 800) (NN mg)) (PP (IN once) (NP (JJ daily)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB increase) (NP (NP (NN lamivudine) (NN exposure)) (PRN (-LRB- -LRB-) (NP (NN AUC)) (-RRB- -RRB-))) (PP (IN by) (NP (CD 44) (NN %.))))))))))))

nn(mg-5, TMP-1)
num(mg-5, 160-2)
nn(mg-5, mg/SMX-3)
num(mg-5, 800-4)
nsubjpass(shown-10, mg-5)
xsubj(increase-12, mg-5)
prep_once(mg-5, daily-7)
aux(shown-10, has-8)
auxpass(shown-10, been-9)
root(ROOT-0, shown-10)
aux(increase-12, to-11)
xcomp(shown-10, increase-12)
nn(exposure-14, lamivudine-13)
dobj(increase-12, exposure-14)
abbrev(exposure-14, AUC-16)
num(%.-20, 44-19)
prep_by(increase-12, %.-20)

No/DT change/NN in/IN dose/NN of/IN either/DT drug/NN is/VBZ recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (NN change)) (PP (IN in) (NP (NP (NN dose)) (PP (IN of) (NP (DT either) (NN drug)))))) (VP (VBZ is) (VP (VBN recommended)))) (. .))))

det(change-2, No-1)
nsubjpass(recommended-9, change-2)
prep_in(change-2, dose-4)
det(drug-7, either-6)
prep_of(dose-4, drug-7)
auxpass(recommended-9, is-8)
root(ROOT-0, recommended-9)

There/EX is/VBZ no/DT information/NN regarding/VBG the/DT effect/NN on/IN lamivudine/NN pharmacokinetics/NNS of/IN higher/JJR doses/NNS of/IN TMP/NN /SMX/NN such/JJ as/IN those/DT used/VBN to/TO treat/VB Pneumocystis/NN carinii/NN pneumonia/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT no) (NN information)) (PP (VBG regarding) (NP (NP (DT the) (NN effect)) (PP (IN on) (NP (NP (NN lamivudine) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (JJR higher) (NNS doses)) (PP (IN of) (NP (NN TMP) (NN /SMX))) (PP (JJ such) (IN as) (NP (NP (DT those)) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (NN Pneumocystis) (NN carinii) (NN pneumonia))))))))))))))))) (. .))))

expl(is-2, There-1)
root(ROOT-0, is-2)
det(information-4, no-3)
nsubj(is-2, information-4)
det(effect-7, the-6)
prep_regarding(information-4, effect-7)
nn(pharmacokinetics-10, lamivudine-9)
prep_on(effect-7, pharmacokinetics-10)
amod(doses-13, higher-12)
prep_of(pharmacokinetics-10, doses-13)
nn(/SMX-16, TMP-15)
prep_of(doses-13, /SMX-16)
prep_such_as(doses-13, those-19)
xsubj(treat-22, those-19)
partmod(those-19, used-20)
aux(treat-22, to-21)
xcomp(used-20, treat-22)
nn(pneumonia-25, Pneumocystis-23)
nn(pneumonia-25, carinii-24)
dobj(treat-22, pneumonia-25)

No/DT data/NNS are/VBP available/JJ regarding/VBG interactions/NNS with/IN other/JJ drugs/NNS that/WDT have/VBP renal/JJ clearance/NN mechanisms/NNS similar/JJ to/TO that/DT of/IN lamivudine/NN ./.

(ROOT (S1 (S (S (NP (DT No) (NNS data)) (VP (VBP are) (ADJP (JJ available) (PP (VBG regarding) (NP (NP (NNS interactions)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (NP (NP (JJ renal) (NN clearance) (NNS mechanisms)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (NN lamivudine))))))))))))))))) (. .))))

det(data-2, No-1)
nsubj(available-4, data-2)
cop(available-4, are-3)
root(ROOT-0, available-4)
prep_regarding(available-4, interactions-6)
amod(drugs-9, other-8)
prep_with(interactions-6, drugs-9)
nsubj(have-11, drugs-9)
rcmod(drugs-9, have-11)
amod(mechanisms-14, renal-12)
nn(mechanisms-14, clearance-13)
dobj(have-11, mechanisms-14)
amod(mechanisms-14, similar-15)
prep_to(similar-15, that-17)
prep_of(that-17, lamivudine-19)

Lamivudine/NN and/CC zalcitabine/NN may/MD inhibit/VB the/DT intracellular/JJ phosphorylation/NN of/IN one/CD another/DT ./.

(ROOT (S1 (S (S (NP (NP (NN Lamivudine)) (CC and) (NP (NN zalcitabine))) (VP (MD may) (VP (VB inhibit) (NP (NP (DT the) (JJ intracellular) (NN phosphorylation)) (PP (IN of) (NP (CD one) (DT another))))))) (. .))))

nsubj(inhibit-5, Lamivudine-1)
conj_and(Lamivudine-1, zalcitabine-3)
aux(inhibit-5, may-4)
root(ROOT-0, inhibit-5)
det(phosphorylation-8, the-6)
amod(phosphorylation-8, intracellular-7)
dobj(inhibit-5, phosphorylation-8)
prep_of(phosphorylation-8, one-10)
dep(one-10, another-11)

Therefore/RB ,/, use/NN of/IN lamivudine/NN in/IN combination/NN with/IN zalcitabine/NN is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN use)) (PP (IN of) (NP (NN lamivudine))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN zalcitabine)))))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

advmod(recommended-12, Therefore-1)
nsubjpass(recommended-12, use-3)
prep_of(use-3, lamivudine-5)
prep_in(use-3, combination-7)
prep_with(combination-7, zalcitabine-9)
auxpass(recommended-12, is-10)
neg(recommended-12, not-11)
root(ROOT-0, recommended-12)

Lansoprazole/NN is/VBZ metabolized/VBN through/IN the/DT cytochrome/NN P450/NN system/NN ,/, specifically/RB through/IN the/DT CYP3A/NN and/CC CYP2C19/NN isozymes/NNS ./.

(ROOT (S1 (S (S (NP (NN Lansoprazole)) (VP (VBZ is) (VP (VBN metabolized) (PP (IN through) (NP (DT the) (NN cytochrome) (NN P450) (NN system))) (, ,) (PP (ADVP (RB specifically)) (IN through) (NP (DT the) (NN CYP3A) (CC and) (NN CYP2C19) (NNS isozymes)))))) (. .))))

nsubjpass(metabolized-3, Lansoprazole-1)
auxpass(metabolized-3, is-2)
root(ROOT-0, metabolized-3)
det(system-8, the-5)
nn(system-8, cytochrome-6)
nn(system-8, P450-7)
prep_through(metabolized-3, system-8)
advmod(metabolized-3, specifically-10)
det(isozymes-16, the-12)
nn(isozymes-16, CYP3A-13)
conj_and(CYP3A-13, CYP2C19-15)
prep_through(metabolized-3, isozymes-16)

Studies/NNS have/VBP shown/VBN that/IN lansoprazole/NN does/VBZ not/RB have/VB clinically/RB significant/JJ interactions/NNS with/IN other/JJ drugs/NNS metabolized/VBN by/IN the/DT cytochrome/NN P450/NN system/NN ,/, such/JJ as/IN warfarin/NN ,/, antipyrine/NN ,/, indomethacin/NN ,/, ibuprofen/NN ,/, phenytoin/NN ,/, propranolol/NN ,/, prednisone/NN ,/, diazepam/NN ,/, clarithromycin/NN ,/, or/CC terfenadine/NN in/IN healthy/JJ subjects/NNS ./.

(ROOT (S1 (S (S (NP (NNS Studies)) (VP (VBP have) (VP (VBN shown) (PP (IN that) (S (NP (NN lansoprazole)) (VP (VBZ does) (RB not) (VP (VB have) (NP (NP (ADJP (RB clinically) (JJ significant)) (NNS interactions)) (PP (IN with) (NP (NP (NP (JJ other) (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (NN cytochrome) (NN P450) (NN system))))) (, ,) (PP (JJ such) (IN as) (NP (NP (NP (NN warfarin)) (, ,) (NP (NN antipyrine)) (, ,) (NP (NN indomethacin)) (, ,) (NP (NN ibuprofen)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN propranolol)) (, ,) (NP (NN prednisone)) (, ,) (NP (NN diazepam)) (, ,) (NP (NN clarithromycin)) (, ,) (CC or) (NP (NN terfenadine))) (PP (IN in) (NP (JJ healthy) (NNS subjects))))))))))))))) (. .))))

nsubj(shown-3, Studies-1)
aux(shown-3, have-2)
root(ROOT-0, shown-3)
nsubj(have-8, lansoprazole-5)
aux(have-8, does-6)
neg(have-8, not-7)
prepc_that(shown-3, have-8)
advmod(significant-10, clinically-9)
amod(interactions-11, significant-10)
dobj(have-8, interactions-11)
amod(drugs-14, other-13)
prep_with(interactions-11, drugs-14)
partmod(drugs-14, metabolized-15)
det(system-20, the-17)
nn(system-20, cytochrome-18)
nn(system-20, P450-19)
agent(metabolized-15, system-20)
prep_such_as(drugs-14, warfarin-24)
conj_or(warfarin-24, antipyrine-26)
conj_or(warfarin-24, indomethacin-28)
conj_or(warfarin-24, ibuprofen-30)
conj_or(warfarin-24, phenytoin-32)
conj_or(warfarin-24, propranolol-34)
conj_or(warfarin-24, prednisone-36)
conj_or(warfarin-24, diazepam-38)
conj_or(warfarin-24, clarithromycin-40)
conj_or(warfarin-24, terfenadine-43)
amod(subjects-46, healthy-45)
prep_in(warfarin-24, subjects-46)

These/DT compounds/NNS are/VBP metabolized/VBN through/IN various/JJ cytochrome/NN P450/NN isozymes/NNS including/VBG CYP1A2/NN ,/, CYP2C9/NN ,/, CYP2C19/NN ,/, CYP2D6/NN ,/, and/CC CYP3A/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS compounds)) (VP (VBP are) (VP (VBN metabolized) (PP (IN through) (NP (NP (JJ various) (NN cytochrome) (NN P450) (NNS isozymes)) (PP (VBG including) (NP (NP (NN CYP1A2)) (, ,) (NP (NN CYP2C9)) (, ,) (NP (NN CYP2C19)) (, ,) (NP (NN CYP2D6)) (, ,) (CC and) (NP (NN CYP3A))))))))) (. .))))

det(compounds-2, These-1)
nsubjpass(metabolized-4, compounds-2)
auxpass(metabolized-4, are-3)
root(ROOT-0, metabolized-4)
amod(isozymes-9, various-6)
nn(isozymes-9, cytochrome-7)
nn(isozymes-9, P450-8)
prep_through(metabolized-4, isozymes-9)
prep_including(isozymes-9, CYP1A2-11)
conj_and(CYP1A2-11, CYP2C9-13)
conj_and(CYP1A2-11, CYP2C19-15)
conj_and(CYP1A2-11, CYP2D6-17)
conj_and(CYP1A2-11, CYP3A-20)

When/WRB lansoprazole/NN was/VBD administered/VBN concomitantly/RB with/IN theophylline/NN (/-LRB- CYP1A2/NN ,/, CYP3A/NN )/-RRB- ,/, a/DT minor/JJ increase/NN (/-LRB- 10/CD %/NN )/-RRB- in/IN the/DT clearance/NN of/IN theophylline/NN was/VBD seen/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN lansoprazole)) (VP (VBD was) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NN theophylline)) (PRN (-LRB- -LRB-) (NP (NP (NN CYP1A2)) (, ,) (NP (NN CYP3A))) (-RRB- -RRB-)))))))) (, ,) (NP (NP (NP (DT a) (JJ minor) (NN increase)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN %)) (-RRB- -RRB-))) (PP (IN in) (NP (NP (DT the) (NN clearance)) (PP (IN of) (NP (NN theophylline)))))) (VP (VBD was) (VP (VBN seen)))) (. .))))

advmod(administered-4, When-1)
nsubjpass(administered-4, lansoprazole-2)
auxpass(administered-4, was-3)
advcl(seen-27, administered-4)
advmod(administered-4, concomitantly-5)
prep_with(administered-4, theophylline-7)
dep(theophylline-7, CYP1A2-9)
appos(CYP1A2-9, CYP3A-11)
det(increase-16, a-14)
amod(increase-16, minor-15)
nsubjpass(seen-27, increase-16)
num(%-19, 10-18)
appos(increase-16, %-19)
det(clearance-23, the-22)
prep_in(increase-16, clearance-23)
prep_of(clearance-23, theophylline-25)
auxpass(seen-27, was-26)
root(ROOT-0, seen-27)

Because/IN the/DT small/JJ magnitude/NN and/CC the/DT direction/NN of/IN the/DT effect/NN on/IN theophylline/NN clearance/NN ,/, this/DT interaction/NN is/VBZ unlikely/JJ to/TO be/VB clinical/JJ concern/NN ./.

(ROOT (S1 (S (S (PP (IN Because) (NP (NP (DT the) (JJ small) (NN magnitude)) (CC and) (NP (NP (DT the) (NN direction)) (PP (IN of) (NP (NP (DT the) (NN effect)) (PP (IN on) (NP (NN theophylline) (NN clearance)))))))) (, ,) (NP (DT this) (NN interaction)) (VP (VBZ is) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB be) (NP (JJ clinical) (NN concern)))))))) (. .))))

det(magnitude-4, the-2)
amod(magnitude-4, small-3)
prep_because(unlikely-18, magnitude-4)
det(direction-7, the-6)
conj_and(magnitude-4, direction-7)
det(effect-10, the-9)
prep_of(direction-7, effect-10)
nn(clearance-13, theophylline-12)
prep_on(effect-10, clearance-13)
det(interaction-16, this-15)
nsubj(unlikely-18, interaction-16)
cop(unlikely-18, is-17)
root(ROOT-0, unlikely-18)
aux(concern-22, to-19)
cop(concern-22, be-20)
amod(concern-22, clinical-21)
xcomp(unlikely-18, concern-22)

Nonetheless/RB ,/, individual/JJ patients/NNS may/MD require/VB additional/JJ titration/NN of/IN their/PRP$ theophylline/NN dosage/NN when/WRB lansoprazole/NN is/VBZ started/VBN or/CC stopped/VBN to/TO ensure/VB clinically/RB effective/JJ blood/NN levels/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Nonetheless)) (, ,) (NP (JJ individual) (NNS patients)) (VP (MD may) (VP (VB require) (NP (NP (JJ additional) (NN titration)) (PP (IN of) (NP (PRP$ their) (NN theophylline) (NN dosage)))) (SBAR (WHADVP (WRB when)) (S (NP (NN lansoprazole)) (VP (VBZ is) (VP (VP (VBN started)) (CC or) (VP (VBN stopped) (S (VP (TO to) (VP (VB ensure) (NP (ADJP (RB clinically) (JJ effective)) (NN blood) (NNS levels))))))))))))) (. .))))

advmod(require-6, Nonetheless-1)
amod(patients-4, individual-3)
nsubj(require-6, patients-4)
aux(require-6, may-5)
root(ROOT-0, require-6)
amod(titration-8, additional-7)
dobj(require-6, titration-8)
poss(dosage-12, their-10)
nn(dosage-12, theophylline-11)
prep_of(titration-8, dosage-12)
advmod(started-16, when-13)
nsubjpass(started-16, lansoprazole-14)
xsubj(ensure-20, lansoprazole-14)
auxpass(started-16, is-15)
advcl(require-6, started-16)
conj_or(started-16, stopped-18)
aux(ensure-20, to-19)
xcomp(stopped-18, ensure-20)
advmod(effective-22, clinically-21)
amod(levels-24, effective-22)
nn(levels-24, blood-23)
dobj(ensure-20, levels-24)

Lansoprazole/NN has/VBZ also/RB been/VBN shown/VBN to/TO have/VBP no/DT clinically/RB significant/JJ interaction/NN with/IN amoxicillin/NN ./.

(ROOT (S1 (S (S (NP (NN Lansoprazole)) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VBP have) (NP (NP (DT no) (ADJP (RB clinically) (JJ significant)) (NN interaction)) (PP (IN with) (NP (NN amoxicillin))))))))))) (. .))))

nsubjpass(shown-5, Lansoprazole-1)
xsubj(have-7, Lansoprazole-1)
aux(shown-5, has-2)
advmod(shown-5, also-3)
auxpass(shown-5, been-4)
root(ROOT-0, shown-5)
aux(have-7, to-6)
xcomp(shown-5, have-7)
det(interaction-11, no-8)
advmod(significant-10, clinically-9)
amod(interaction-11, significant-10)
dobj(have-7, interaction-11)
prep_with(interaction-11, amoxicillin-13)

In/IN a/DT single-dose/JJ crossover/NN study/NN examining/VBG lansoprazole/NN 30/CD mg/NN and/CC omeprazole/NN 20/CD mg/NN each/DT administered/VBN alone/RB and/CC concomitantly/RB with/IN sucralfate/NN 1/CD gram/NN ,/, absorption/NN of/IN the/DT proton/NN pump/NN inhibitors/NNS was/VBD delayed/VBN and/CC their/PRP$ bioavailability/NN was/VBD reduced/VBN by/IN 17/CD %/NN and/CC 16/CD %/NN ,/, respectively/RB ,/, when/WRB administered/VBN concomitantly/RB with/IN sucralfate/NN ./.

(ROOT (S1 (S (S (S (PP (IN In) (NP (NP (DT a) (JJ single-dose) (NN crossover) (NN study)) (VP (VBG examining) (NP (NP (NP (NN lansoprazole) (CD 30) (NN mg) (CC and) (NN omeprazole) (CD 20) (NN mg)) (NP (DT each))) (VP (VBN administered) (UCP (ADVP (RB alone)) (CC and) (PP (RB concomitantly) (IN with) (NP (NN sucralfate) (CD 1) (NN gram))))))))) (, ,) (NP (NP (NN absorption)) (PP (IN of) (NP (DT the) (NN proton) (NN pump) (NNS inhibitors)))) (VP (VBD was) (VP (VBN delayed)))) (CC and) (S (NP (PRP$ their) (NN bioavailability)) (VP (VBD was) (VP (VBN reduced) (PP (IN by) (NP (NP (CD 17) (NN %)) (CC and) (NP (CD 16) (NN %)) (, ,) (ADVP (RB respectively))))) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN sucralfate))))))))) (. .))))

det(study-5, a-2)
amod(study-5, single-dose-3)
nn(study-5, crossover-4)
prep_in(delayed-31, study-5)
partmod(study-5, examining-6)
nn(mg-9, lansoprazole-7)
num(mg-9, 30-8)
dobj(examining-6, mg-9)
nn(mg-13, omeprazole-11)
num(mg-13, 20-12)
conj_and(mg-9, mg-13)
dep(mg-9, each-14)
partmod(mg-9, administered-15)
dep(administered-15, alone-16)
advmod(with-19, concomitantly-18)
conj_and(alone-16, with-19)
nn(gram-22, sucralfate-20)
num(gram-22, 1-21)
pobj(with-19, gram-22)
nsubjpass(delayed-31, absorption-24)
det(inhibitors-29, the-26)
nn(inhibitors-29, proton-27)
nn(inhibitors-29, pump-28)
prep_of(absorption-24, inhibitors-29)
auxpass(delayed-31, was-30)
root(ROOT-0, delayed-31)
poss(bioavailability-34, their-33)
nsubjpass(reduced-36, bioavailability-34)
auxpass(reduced-36, was-35)
conj_and(delayed-31, reduced-36)
num(%-39, 17-38)
agent(reduced-36, %-39)
num(%-42, 16-41)
conj_and(%-39, %-42)
advmod(%-39, respectively-44)
conj_and(%-39, respectively-44)
advmod(administered-47, when-46)
advcl(reduced-36, administered-47)
advmod(administered-47, concomitantly-48)
prep_with(administered-47, sucralfate-50)

Therefore/RB ,/, proton/NN pump/NN inhibitors/NNS should/MD be/VB taken/VBN at/IN least/JJS 30/CD minutes/NNS prior/RB to/TO sucralfate/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NN proton) (NN pump) (NNS inhibitors)) (VP (MD should) (VP (VB be) (VP (VBN taken) (ADVP (NP (QP (IN at) (JJS least) (CD 30)) (NNS minutes)) (RB prior) (PP (TO to) (NP (NN sucralfate)))))))) (. .))))

advmod(taken-8, Therefore-1)
nn(inhibitors-5, proton-3)
nn(inhibitors-5, pump-4)
nsubjpass(taken-8, inhibitors-5)
aux(taken-8, should-6)
auxpass(taken-8, be-7)
root(ROOT-0, taken-8)
quantmod(30-11, at-9)
mwe(at-9, least-10)
pobj(at-9, least-10)
num(minutes-12, 30-11)
npadvmod(taken-8, minutes-12)
prep_prior_to(taken-8, sucralfate-15)

In/IN clinical/JJ trials/NNS ,/, antacids/NNS were/VBD administered/VBN concomitantly/RB with/IN lansoprazole/NN delayed-release/NN capsules/NNS ;/: ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ clinical) (NNS trials))) (, ,) (NP (NNS antacids)) (VP (VBD were) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN lansoprazole) (NN delayed-release) (NNS capsules))))) (: ;)) (. .))))

amod(trials-3, clinical-2)
prep_in(administered-7, trials-3)
nsubjpass(administered-7, antacids-5)
auxpass(administered-7, were-6)
root(ROOT-0, administered-7)
advmod(administered-7, concomitantly-8)
nn(capsules-12, lansoprazole-10)
nn(capsules-12, delayed-release-11)
prep_with(administered-7, capsules-12)

Lansoprazole/NN causes/VBZ a/DT profound/JJ and/CC long/JJ lasting/NN inhibition/NN of/IN gastric/JJ acid/NN secretion/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN Lansoprazole)) (VP (VBZ causes) (NP (NP (DT a) (ADJP (ADJP (JJ profound)) (CC and) (ADJP (JJ long))) (NN lasting) (NN inhibition)) (PP (IN of) (NP (JJ gastric) (NN acid) (NN secretion))))) (: ;)) (. .))))

nsubj(causes-2, Lansoprazole-1)
root(ROOT-0, causes-2)
det(inhibition-8, a-3)
amod(inhibition-8, profound-4)
conj_and(profound-4, long-6)
nn(inhibition-8, lasting-7)
dobj(causes-2, inhibition-8)
amod(secretion-12, gastric-10)
nn(secretion-12, acid-11)
prep_of(inhibition-8, secretion-12)

therefore/RB ,/, it/PRP is/VBZ theoretically/RB possible/JJ that/IN lansoprazole/NN may/MD interfere/VB with/IN the/DT absorption/NN of/IN drugs/NNS where/WRB gastric/JJ pH/NN is/VBZ an/DT important/JJ determinant/NN of/IN bioavailability/NN (/-LRB- e.g./FW ketoconazole/NN ,/, ampicillin/NN esters/NNS ,/, iron/NN salts/NNS ,/, digoxin/NN )/-RRB- ./.

(ROOT (S1 (S (S (ADVP (RB therefore)) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (RB theoretically) (JJ possible)) (SBAR (IN that) (S (NP (NN lansoprazole)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NP (NNS drugs)) (SBAR (WHADVP (WRB where)) (S (NP (JJ gastric) (NN pH)) (VP (VBZ is) (NP (NP (DT an) (JJ important) (NN determinant)) (PP (IN of) (NP (NP (NN bioavailability)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (NP (NN ketoconazole))) (, ,) (NP (NP (NN ampicillin) (NNS esters)) (, ,) (NP (NN iron) (NNS salts)) (, ,) (NP (NN digoxin))) (-RRB- -RRB-)))))))))))))))))) (. .))))

advmod(possible-6, therefore-1)
nsubj(possible-6, it-3)
cop(possible-6, is-4)
advmod(possible-6, theoretically-5)
root(ROOT-0, possible-6)
complm(interfere-10, that-7)
nsubj(interfere-10, lansoprazole-8)
aux(interfere-10, may-9)
ccomp(possible-6, interfere-10)
det(absorption-13, the-12)
prep_with(interfere-10, absorption-13)
prep_of(absorption-13, drugs-15)
advmod(determinant-22, where-16)
amod(pH-18, gastric-17)
nsubj(determinant-22, pH-18)
cop(determinant-22, is-19)
det(determinant-22, an-20)
amod(determinant-22, important-21)
rcmod(drugs-15, determinant-22)
prep_of(determinant-22, bioavailability-24)
dep(esters-30, e.g.-26)
pobj(e.g.-26, ketoconazole-27)
nn(esters-30, ampicillin-29)
dep(bioavailability-24, esters-30)
nn(salts-33, iron-32)
appos(esters-30, salts-33)
appos(esters-30, digoxin-35)

In/FW vitro/FW studies/NNS have/VBP shown/VBN that/IN precipitation/NN occurs/VBZ when/WRB eye/NN drops/NN containing/NN thimerosal/NNS are/VBP mixed/VBN with/IN latanoprost/NN ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NN precipitation)) (VP (VBZ occurs) (SBAR (WHADVP (WRB when)) (S (NP (NN eye) (NN drops) (NN containing) (NNS thimerosal)) (VP (VBP are) (VP (VBN mixed) (PP (IN with) (NP (NN latanoprost))))))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(shown-5, studies-3)
aux(shown-5, have-4)
root(ROOT-0, shown-5)
complm(occurs-8, that-6)
nsubj(occurs-8, precipitation-7)
ccomp(shown-5, occurs-8)
advmod(mixed-15, when-9)
nn(thimerosal-13, eye-10)
nn(thimerosal-13, drops-11)
nn(thimerosal-13, containing-12)
nsubjpass(mixed-15, thimerosal-13)
auxpass(mixed-15, are-14)
advcl(occurs-8, mixed-15)
prep_with(mixed-15, latanoprost-17)

If/IN such/JJ drugs/NNS are/VBP used/VBN they/PRP should/MD be/VB administered/VBN with/IN an/DT interval/NN of/IN at/IN least/JJS 5/CD minutes/NNS between/IN applications/NNS ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (JJ such) (NNS drugs)) (VP (VBP are) (VP (VBN used))))) (NP (PRP they)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (NP (DT an) (NN interval)) (PP (IN of) (NP (QP (IN at) (JJS least) (CD 5)) (NNS minutes))) (PP (IN between) (NP (NNS applications))))))))) (. .))))

mark(used-5, If-1)
amod(drugs-3, such-2)
nsubjpass(used-5, drugs-3)
auxpass(used-5, are-4)
advcl(administered-9, used-5)
nsubjpass(administered-9, they-6)
aux(administered-9, should-7)
auxpass(administered-9, be-8)
root(ROOT-0, administered-9)
det(interval-12, an-11)
prep_with(administered-9, interval-12)
quantmod(5-16, at-14)
mwe(at-14, least-15)
pobj(at-14, least-15)
num(minutes-17, 5-16)
prep_of(interval-12, minutes-17)
prep_between(interval-12, applications-19)

Results/NNS from/IN human/JJ in/FW vitro/FW metabolism/NN studies/NNS and/CC nonclinical/JJ studies/NNS show/VBP that/IN REVLIMID/JJ @/NN (/-LRB- lenalidomide/NN )/-RRB- is/VBZ neither/RB metabolized/VBN by/IN nor/CC inhibits/VBZ or/CC induces/VBZ the/DT cytochrome/NN P450/NN pathway/NN suggesting/VBG that/IN lenalidomide/NN is/VBZ not/RB likely/JJ to/TO cause/VB or/CC be/VB subject/JJ to/TO P450/NN -based/JJ metabolic/JJ drug/NN interactions/NNS in/IN man/NN ./.

(ROOT (S1 (S (NP (NP (NNS Results)) (PP (IN from) (NP (NP (JJ human) (ADJP (FW in) (FW vitro)) (NN metabolism) (NNS studies)) (CC and) (NP (JJ nonclinical) (NNS studies))))) (VP (VBP show) (SBAR (IN that) (S (NP (NP (JJ REVLIMID) (NN @)) (PRN (-LRB- -LRB-) (NP (NN lenalidomide)) (-RRB- -RRB-))) (VP (VBZ is) (ADVP (RB neither)) (VP (VBN metabolized) (SBAR (IN by) (S (CC nor) (VP (VP (VBZ inhibits)) (CC or) (VP (VBZ induces) (NP (NP (DT the) (NN cytochrome) (NN P450) (NN pathway)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NN lenalidomide)) (VP (VBZ is) (RB not) (ADJP (JJ likely) (S (VP (TO to) (VP (VP (VB cause)) (CC or) (VP (VB be) (ADJP (JJ subject) (PP (TO to) (NP (NP (NN P450) (JJ -based) (JJ metabolic) (NN drug) (NNS interactions)) (PP (IN in) (NP (NN man))))))))))))))))))))))))) (. .))))

nsubj(show-11, Results-1)
amod(studies-7, human-3)
nn(vitro-5, in-4)
amod(studies-7, vitro-5)
nn(studies-7, metabolism-6)
prep_from(Results-1, studies-7)
amod(studies-10, nonclinical-9)
conj_and(studies-7, studies-10)
root(ROOT-0, show-11)
complm(metabolized-20, that-12)
amod(@-14, REVLIMID-13)
nsubjpass(metabolized-20, @-14)
appos(@-14, lenalidomide-16)
auxpass(metabolized-20, is-18)
advmod(metabolized-20, neither-19)
ccomp(show-11, metabolized-20)
mark(inhibits-23, by-21)
advcl(metabolized-20, inhibits-23)
conj_or(inhibits-23, induces-25)
det(pathway-29, the-26)
nn(pathway-29, cytochrome-27)
nn(pathway-29, P450-28)
dobj(induces-25, pathway-29)
partmod(pathway-29, suggesting-30)
complm(likely-35, that-31)
nsubj(likely-35, lenalidomide-32)
cop(likely-35, is-33)
neg(likely-35, not-34)
ccomp(suggesting-30, likely-35)
aux(cause-37, to-36)
xcomp(likely-35, cause-37)
cop(subject-40, be-39)
conj_or(cause-37, subject-40)
nn(interactions-46, P450-42)
amod(interactions-46, -based-43)
amod(interactions-46, metabolic-44)
nn(interactions-46, drug-45)
prep_to(subject-40, interactions-46)
prep_in(interactions-46, man-48)

Co-administration/NN of/IN multiple/JJ doses/NNS of/IN 10/CD mg/NN of/IN lenalidomide/NN had/VBD no/DT effect/NN on/IN the/DT single/JJ dose/NN pharmacokinetics/NNS of/IN R-/NN and/CC S-/NN warfarin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NP (JJ multiple) (NNS doses)) (PP (IN of) (NP (NP (CD 10) (NN mg)) (PP (IN of) (NP (NN lenalidomide)))))))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NP (DT the) (JJ single) (NN dose)) (NP (NNS pharmacokinetics))) (PP (IN of) (NP (NP (NN R-)) (CC and) (NP (NN S-) (NN warfarin)))))))) (. .))))

nsubj(had-10, Co-administration-1)
amod(doses-4, multiple-3)
prep_of(Co-administration-1, doses-4)
num(mg-7, 10-6)
prep_of(doses-4, mg-7)
prep_of(mg-7, lenalidomide-9)
root(ROOT-0, had-10)
det(effect-12, no-11)
dobj(had-10, effect-12)
det(dose-16, the-14)
amod(dose-16, single-15)
prep_on(had-10, dose-16)
dep(dose-16, pharmacokinetics-17)
prep_of(dose-16, R--19)
nn(warfarin-22, S--21)
conj_and(R--19, warfarin-22)

Co-administration/NN of/IN single/JJ 25-mg/NN dose/NN warfarin/NN had/VBD no/DT effect/NN on/IN the/DT pharmacokinetics/NNS of/IN total/JJ lenalidomide/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (JJ single) (NN 25-mg) (NN dose) (NN warfarin)))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (JJ total) (NN lenalidomide))))))) (. .))))

nsubj(had-7, Co-administration-1)
amod(warfarin-6, single-3)
nn(warfarin-6, 25-mg-4)
nn(warfarin-6, dose-5)
prep_of(Co-administration-1, warfarin-6)
root(ROOT-0, had-7)
det(effect-9, no-8)
dobj(had-7, effect-9)
det(pharmacokinetics-12, the-11)
prep_on(had-7, pharmacokinetics-12)
amod(lenalidomide-15, total-14)
prep_of(pharmacokinetics-12, lenalidomide-15)

Expected/VBN changes/NNS in/IN laboratory/JJ assessments/NNS of/IN PT/NN and/CC INR/NN were/VBD observed/VBN after/IN warfarin/NN administration/NN ,/, but/CC these/DT changes/NNS were/VBD not/RB affected/VBN by/IN concomitant/JJ lenalidomide/NN administration/NN ./.

(ROOT (S1 (S (S (S (NP (NP (VBN Expected) (NNS changes)) (PP (IN in) (NP (NP (JJ laboratory) (NNS assessments)) (PP (IN of) (NP (NP (NN PT)) (CC and) (NP (NN INR))))))) (VP (VBD were) (VP (VBN observed) (PP (IN after) (NP (NN warfarin) (NN administration)))))) (, ,) (CC but) (S (NP (DT these) (NNS changes)) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN by) (NP (JJ concomitant) (NN lenalidomide) (NN administration))))))) (. .))))

amod(changes-2, Expected-1)
nsubjpass(observed-11, changes-2)
amod(assessments-5, laboratory-4)
prep_in(changes-2, assessments-5)
prep_of(assessments-5, PT-7)
conj_and(PT-7, INR-9)
auxpass(observed-11, were-10)
root(ROOT-0, observed-11)
nn(administration-14, warfarin-13)
prep_after(observed-11, administration-14)
det(changes-18, these-17)
nsubjpass(affected-21, changes-18)
auxpass(affected-21, were-19)
neg(affected-21, not-20)
conj_but(observed-11, affected-21)
amod(administration-25, concomitant-23)
nn(administration-25, lenalidomide-24)
agent(affected-21, administration-25)

Concomitant/JJ treatment/NN with/IN thrombolytic/JJ s/NNS (/-LRB- eg/NN ,/, rt-PA/NN or/CC streptokinase/NN )/-RRB- may/MD :/: -/TO increase/VB the/DT risk/NN of/IN bleeding/JJ complications/NNS -/CC considerably/RB enhance/VBP the/DT effect/NN of/IN REFLUDAN/NN on/IN aPTT/NN prolongation/NN ./.

(ROOT (S1 (S (NP (NP (JJ Concomitant) (NN treatment)) (PP (IN with) (NP (NP (JJ thrombolytic) (NNS s)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN rt-PA)) (CC or) (NP (NN streptokinase))) (-RRB- -RRB-))))) (MD may) (: :) (S (VP (TO -) (VP (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ bleeding) (NNS complications))))) (CC -) (ADVP (RB considerably)) (VP (VBP enhance) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN REFLUDAN))) (PP (IN on) (NP (NN aPTT) (NN prolongation)))))))) (. .))))

amod(treatment-2, Concomitant-1)
dep(increase-16, treatment-2)
amod(s-5, thrombolytic-4)
prep_with(treatment-2, s-5)
dep(s-5, eg-7)
conj_or(eg-7, rt-PA-9)
conj_or(eg-7, streptokinase-11)
dep(increase-16, may-13)
root(ROOT-0, increase-16)
det(risk-18, the-17)
dobj(increase-16, risk-18)
amod(complications-21, bleeding-20)
prep_of(risk-18, complications-21)
advmod(increase-16, considerably-23)
conj(increase-16, considerably-23)
conj(increase-16, enhance-24)
det(effect-26, the-25)
dobj(enhance-24, effect-26)
prep_of(effect-26, REFLUDAN-28)
nn(prolongation-31, aPTT-30)
prep_on(effect-26, prolongation-31)

Concomitant/JJ treatment/NN with/IN coumarin/JJ derivatives/NNS (/-LRB- vitamin/NN K/NN antagonists/NNS )/-RRB- and/CC drugs/NNS that/WDT affect/VBP platelet/NN function/NN may/MD also/RB increase/VB the/DT risk/NN of/IN bleeding/JJ ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN treatment)) (PP (IN with) (NP (NP (NP (JJ coumarin) (NNS derivatives)) (PRN (-LRB- -LRB-) (NP (NN vitamin) (NN K) (NNS antagonists)) (-RRB- -RRB-))) (CC and) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP affect) (NP (NN platelet) (NN function))))))))) (VP (MD may) (ADVP (RB also)) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (JJ bleeding))))))) (. .))))

amod(treatment-2, Concomitant-1)
nsubj(increase-19, treatment-2)
amod(derivatives-5, coumarin-4)
prep_with(treatment-2, derivatives-5)
nn(antagonists-9, vitamin-7)
nn(antagonists-9, K-8)
appos(derivatives-5, antagonists-9)
conj_and(derivatives-5, drugs-12)
nsubj(affect-14, drugs-12)
rcmod(drugs-12, affect-14)
nn(function-16, platelet-15)
dobj(affect-14, function-16)
aux(increase-19, may-17)
advmod(increase-19, also-18)
root(ROOT-0, increase-19)
det(risk-21, the-20)
dobj(increase-19, risk-21)
prep_of(risk-21, bleeding-23)

ERGAMISOL/NN @/NN (/-LRB- levamisole/NN hydrochloride/NN )/-RRB- has/VBZ been/VBN reported/VBN to/TO produce/VB ANTABUSE/NN -like/JJ side/JJ effects/NNS when/WRB given/VBN concomitantly/RB with/IN alcohol/NN ./.

(ROOT (S1 (S (S (NP (NP (NN ERGAMISOL) (NN @)) (PRN (-LRB- -LRB-) (NP (NN levamisole) (NN hydrochloride)) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB produce) (NP (ADJP (NN ANTABUSE) (JJ -like)) (JJ side) (NNS effects)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN alcohol))))))))))))) (. .))))

nn(@-2, ERGAMISOL-1)
nsubjpass(reported-9, @-2)
xsubj(produce-11, @-2)
nn(hydrochloride-5, levamisole-4)
appos(@-2, hydrochloride-5)
aux(reported-9, has-7)
auxpass(reported-9, been-8)
root(ROOT-0, reported-9)
aux(produce-11, to-10)
xcomp(reported-9, produce-11)
dep(-like-13, ANTABUSE-12)
amod(effects-15, -like-13)
amod(effects-15, side-14)
dobj(produce-11, effects-15)
advmod(given-17, when-16)
advcl(produce-11, given-17)
advmod(given-17, concomitantly-18)
prep_with(given-17, alcohol-20)

Concomitant/JJ administration/NN of/IN phenytoin/NN and/CC ERGAMISOL/NN @/NN plus/NN fluorouracil/NN has/VBZ lead/VB to/TO increased/VBN plasma/NN levels/NNS of/IN phenytoin/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN phenytoin)) (CC and) (NP (NN ERGAMISOL) (NN @) (NN plus) (NN fluorouracil))))) (VP (VBZ has) (VP (VB lead) (PP (TO to) (NP (NP (VBN increased) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN phenytoin)))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubj(lead-11, administration-2)
prep_of(administration-2, phenytoin-4)
nn(fluorouracil-9, ERGAMISOL-6)
nn(fluorouracil-9, @-7)
nn(fluorouracil-9, plus-8)
conj_and(phenytoin-4, fluorouracil-9)
aux(lead-11, has-10)
root(ROOT-0, lead-11)
amod(levels-15, increased-13)
nn(levels-15, plasma-14)
prep_to(lead-11, levels-15)
prep_of(levels-15, phenytoin-17)

The/DT physician/NN is/VBZ advised/VBN to/TO monitor/VB plasma/NN levels/NNS of/IN phenytoin/NN and/CC to/TO decrease/VB the/DT dose/NN if/IN necessary/JJ ./.

(ROOT (S1 (S (S (NP (DT The) (NN physician)) (VP (VBZ is) (VP (VBN advised) (S (VP (VP (TO to) (VP (VB monitor) (NP (NP (NN plasma) (NNS levels)) (PP (IN of) (NP (NN phenytoin)))))) (CC and) (VP (TO to) (VP (VB decrease) (NP (DT the) (NN dose) (SBAR (IN if) (FRAG (JJ necessary))))))))))) (. .))))

det(physician-2, The-1)
nsubjpass(advised-4, physician-2)
auxpass(advised-4, is-3)
root(ROOT-0, advised-4)
aux(monitor-6, to-5)
ccomp(advised-4, monitor-6)
nn(levels-8, plasma-7)
dobj(monitor-6, levels-8)
prep_of(levels-8, phenytoin-10)
aux(decrease-13, to-12)
conj_and(monitor-6, decrease-13)
det(dose-15, the-14)
dobj(decrease-13, dose-15)
mark(necessary-17, if-16)
ccomp(dose-15, necessary-17)

Because/IN of/IN reports/NNS of/IN prolongation/NN of/IN the/DT prothrombin/NN time/NN beyond/IN the/DT therapeutic/JJ range/NN in/IN patients/NNS taking/VBG concurrent/JJ levamisole/NN and/CC warfarin/NN sodium/NN ,/, it/PRP is/VBZ suggested/VBN that/IN the/DT prothrombin/NN time/NN be/VB monitored/VBN carefully/RB ,/, and/CC the/DT dose/NN of/IN warfarin/JJ sodium/NN or/CC other/JJ coumarin/JJ -like/JJ drugs/NNS should/MD be/VB adjusted/VBN accordingly/RB ,/, in/IN patients/NNS taking/VBG both/DT drugs/NNS ./.

(ROOT (S1 (S (PP (IN Because) (PP (IN of) (NP (NP (NNS reports)) (PP (IN of) (NP (NP (NN prolongation)) (PP (IN of) (NP (NP (DT the) (NN prothrombin) (NN time)) (PP (IN beyond) (NP (NP (DT the) (JJ therapeutic) (NN range)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (JJ concurrent) (NN levamisole)) (CC and) (NP (NN warfarin)) (NP (NN sodium))))))))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN suggested) (SBAR (IN that) (S (S (NP (DT the) (NN prothrombin) (NN time)) (VP (VB be) (VP (VBN monitored) (ADVP (RB carefully))))) (, ,) (CC and) (S (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NP (JJ warfarin) (NN sodium)) (CC or) (NP (JJ other) (JJ coumarin) (JJ -like) (NNS drugs))))) (VP (MD should) (VP (VB be) (VP (VBN adjusted) (ADVP (RB accordingly)) (, ,) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (DT both) (NNS drugs))))))))))))) (. .))))

prepc_because_of(suggested-25, of-2)
pobj(suggested-25, reports-3)
prep_of(reports-3, prolongation-5)
det(time-9, the-7)
nn(time-9, prothrombin-8)
prep_of(prolongation-5, time-9)
det(range-13, the-11)
amod(range-13, therapeutic-12)
prep_beyond(time-9, range-13)
prep_in(range-13, patients-15)
partmod(patients-15, taking-16)
amod(levamisole-18, concurrent-17)
dobj(taking-16, levamisole-18)
conj_and(levamisole-18, warfarin-20)
dobj(taking-16, sodium-21)
dep(levamisole-18, sodium-21)
nsubjpass(suggested-25, it-23)
auxpass(suggested-25, is-24)
root(ROOT-0, suggested-25)
complm(monitored-31, that-26)
det(time-29, the-27)
nn(time-29, prothrombin-28)
nsubjpass(monitored-31, time-29)
auxpass(monitored-31, be-30)
ccomp(suggested-25, monitored-31)
advmod(monitored-31, carefully-32)
det(dose-36, the-35)
nsubjpass(adjusted-47, dose-36)
amod(sodium-39, warfarin-38)
prep_of(dose-36, sodium-39)
amod(drugs-44, other-41)
amod(drugs-44, coumarin-42)
amod(drugs-44, -like-43)
conj_or(sodium-39, drugs-44)
aux(adjusted-47, should-45)
auxpass(adjusted-47, be-46)
conj_and(monitored-31, adjusted-47)
advmod(adjusted-47, accordingly-48)
prep_in(adjusted-47, patients-51)
partmod(patients-51, taking-52)
det(drugs-54, both-53)
dobj(taking-52, drugs-54)

Levetiracetam/NN and/CC its/PRP$ major/JJ metabolite/NN ,/, at/IN concentrations/NNS well/RB above/IN cmax/NN levels/NNS achieved/VBN within/IN the/DT therapeutic/JJ dose/NN range/NN ,/, are/VBP neither/CC inhibitors/NNS of/IN nor/CC high/JJ affinity/NN substrates/NNS for/IN human/JJ liver/NN cytochrome/NN P450/NN isoforms/NNS ,/, epoxide/NN hydrolase/NN or/CC UDP/NN -glucuronidation/NN enzymes/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Levetiracetam)) (CC and) (NP (PRP$ its) (JJ major) (NN metabolite))) (, ,) (PP (IN at) (NP (NP (NNS concentrations)) (PP (ADVP (RB well)) (IN above) (NP (NN cmax) (NNS levels))) (VP (VBN achieved) (PP (IN within) (NP (DT the) (JJ therapeutic) (NN dose) (NN range)))))) (, ,) (VP (VBP are) (NP (CC neither) (NP (NP (NNS inhibitors)) (PP (IN of))) (CC nor) (NP (NP (JJ high) (NN affinity) (NNS substrates)) (PP (IN for) (NP (NP (NP (JJ human) (NN liver) (NN cytochrome) (NN P450)) (NNS isoforms)) (, ,) (NP (NP (NN epoxide) (NN hydrolase)) (CC or) (NP (NN UDP) (NN -glucuronidation) (NNS enzymes))))))))) (. .))))

nsubj(inhibitors-22, Levetiracetam-1)
poss(metabolite-5, its-3)
amod(metabolite-5, major-4)
conj_and(Levetiracetam-1, metabolite-5)
prep_at(inhibitors-22, concentrations-8)
advmod(concentrations-8, well-9)
nn(levels-12, cmax-11)
prep_above(concentrations-8, levels-12)
partmod(concentrations-8, achieved-13)
det(range-18, the-15)
amod(range-18, therapeutic-16)
nn(range-18, dose-17)
prep_within(achieved-13, range-18)
cop(inhibitors-22, are-20)
preconj(inhibitors-22, neither-21)
root(ROOT-0, inhibitors-22)
prep(inhibitors-22, of-23)
amod(substrates-27, high-25)
nn(substrates-27, affinity-26)
conj_nor(inhibitors-22, substrates-27)
amod(P450-32, human-29)
nn(P450-32, liver-30)
nn(P450-32, cytochrome-31)
nn(isoforms-33, P450-32)
prep_for(substrates-27, isoforms-33)
nn(hydrolase-36, epoxide-35)
appos(isoforms-33, hydrolase-36)
nn(enzymes-40, UDP-38)
nn(enzymes-40, -glucuronidation-39)
conj_or(hydrolase-36, enzymes-40)

In/IN addition/NN ,/, levetiracetam/NN does/VBZ not/RB affect/VB the/DT in/FW vitro/FW glucuronidation/NN of/IN valproic/JJ acid/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NN levetiracetam)) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NP (DT the) (ADJP (FW in) (FW vitro)) (NN glucuronidation)) (PP (IN of) (NP (JJ valproic) (NN acid))))))) (. .))))

prep_in(affect-7, addition-2)
nsubj(affect-7, levetiracetam-4)
aux(affect-7, does-5)
neg(affect-7, not-6)
root(ROOT-0, affect-7)
det(glucuronidation-11, the-8)
nn(vitro-10, in-9)
amod(glucuronidation-11, vitro-10)
dobj(affect-7, glucuronidation-11)
amod(acid-14, valproic-13)
prep_of(glucuronidation-11, acid-14)

Levetiracetam/NN circulates/VBZ largely/RB unbound/JJ (/-LRB- 10/CD %/NN bound/JJ )/-RRB- to/TO plasma/NN proteins/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NN Levetiracetam)) (VP (VBZ circulates) (ADJP (RB largely) (JJ unbound) (PRN (-LRB- -LRB-) (ADJP (NP (CD 10) (NN %)) (JJ bound)) (-RRB- -RRB-)) (PP (TO to) (NP (NN plasma) (NNS proteins))))) (: ;)) (. .))))

nsubj(circulates-2, Levetiracetam-1)
root(ROOT-0, circulates-2)
advmod(unbound-4, largely-3)
acomp(circulates-2, unbound-4)
num(%-7, 10-6)
npadvmod(bound-8, %-7)
dep(unbound-4, bound-8)
nn(proteins-12, plasma-11)
prep_to(unbound-4, proteins-12)

clinically/RB significant/JJ interactions/NNS with/IN other/JJ drugs/NNS through/IN competition/NN for/IN protein/NN binding/NN sites/NNS are/VBP therefore/RB unlikely/JJ ./.

(ROOT (S1 (S (S (NP (NP (ADJP (RB clinically) (JJ significant)) (NNS interactions)) (PP (IN with) (NP (JJ other) (NNS drugs))) (PP (IN through) (NP (NP (NN competition)) (PP (IN for) (NP (NN protein) (NN binding) (NNS sites)))))) (VP (VBP are) (ADVP (RB therefore)) (ADJP (JJ unlikely)))) (. .))))

advmod(significant-2, clinically-1)
amod(interactions-3, significant-2)
nsubj(unlikely-15, interactions-3)
amod(drugs-6, other-5)
prep_with(interactions-3, drugs-6)
prep_through(interactions-3, competition-8)
nn(sites-12, protein-10)
nn(sites-12, binding-11)
prep_for(competition-8, sites-12)
cop(unlikely-15, are-13)
advmod(unlikely-15, therefore-14)
root(ROOT-0, unlikely-15)

Potential/JJ pharmacokinetic/JJ interactions/NNS were/VBD assessed/VBN in/IN clinical/JJ pharmacokinetic/JJ studies/NNS (/-LRB- phenytoin/NN ,/, valproate/NN ,/, oral/JJ contraceptive/NN ,/, digoxin/NN ,/, warfarin/NN ,/, probenecid/NN )/-RRB- and/CC through/IN pharmacokinetic/JJ screening/NN in/IN the/DT placebo-controlled/JJ clinical/JJ studies/NNS in/IN epilepsy/JJ patients/NNS ./.

(ROOT (S1 (S (S (NP (JJ Potential) (JJ pharmacokinetic) (NNS interactions)) (VP (VBD were) (VP (VBN assessed) (PP (PP (IN in) (NP (NP (JJ clinical) (JJ pharmacokinetic) (NNS studies)) (PRN (-LRB- -LRB-) (NP (NP (NN phenytoin)) (, ,) (NP (NN valproate)) (, ,) (NP (JJ oral) (NN contraceptive)) (, ,) (NP (NN digoxin)) (, ,) (NP (NN warfarin)) (, ,) (NP (NN probenecid))) (-RRB- -RRB-)))) (CC and) (PP (IN through) (NP (NP (JJ pharmacokinetic) (NN screening)) (PP (IN in) (NP (NP (DT the) (ADJP (JJ placebo-controlled) (JJ clinical)) (NNS studies)) (PP (IN in) (NP (JJ epilepsy) (NNS patients))))))))))) (. .))))

amod(interactions-3, Potential-1)
amod(interactions-3, pharmacokinetic-2)
nsubjpass(assessed-5, interactions-3)
auxpass(assessed-5, were-4)
root(ROOT-0, assessed-5)
conj_and(assessed-5, assessed-5')
amod(studies-9, clinical-7)
amod(studies-9, pharmacokinetic-8)
prep_in(assessed-5, studies-9)
dep(studies-9, phenytoin-11)
appos(phenytoin-11, valproate-13)
amod(contraceptive-16, oral-15)
appos(phenytoin-11, contraceptive-16)
appos(phenytoin-11, digoxin-18)
appos(phenytoin-11, warfarin-20)
appos(phenytoin-11, probenecid-22)
amod(screening-27, pharmacokinetic-26)
prep_through(assessed-5', screening-27)
det(studies-32, the-29)
amod(clinical-31, placebo-controlled-30)
amod(studies-32, clinical-31)
prep_in(screening-27, studies-32)
amod(patients-35, epilepsy-34)
prep_in(studies-32, patients-35)

Drug-Drug/JJ Interactions/NNS Between/IN Keppra/NN @/NN And/CC Other/JJ Antiepileptic/JJ Drugs/NNS (/-LRB- AEDs/NNS )/-RRB- Phenytoin/NN Keppra/NN @/NN (/-LRB- 3000/CD mg/NN daily/RB )/-RRB- had/VBD no/DT effect/NN on/IN the/DT pharmacokinetic/JJ disposition/NN of/IN phenytoin/NN in/IN patients/NNS with/IN refractory/JJ epilepsy/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Drug-Drug) (NNS Interactions)) (PP (IN Between) (NP (NP (NN Keppra) (NN @)) (CC And) (NP (NP (JJ Other) (JJ Antiepileptic) (NNS Drugs)) (PRN (-LRB- -LRB-) (NP (NNS AEDs)) (-RRB- -RRB-))) (NP (NP (NN Phenytoin) (NN Keppra) (NN @)) (PRN (-LRB- -LRB-) (NP (NP (CD 3000) (NN mg)) (ADVP (RB daily))) (-RRB- -RRB-)))))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (JJ pharmacokinetic) (NN disposition)) (PP (IN of) (NP (NP (NN phenytoin)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ refractory) (NN epilepsy))))))))))) (. .))))

amod(Interactions-2, Drug-Drug-1)
nsubj(had-21, Interactions-2)
nn(@-5, Keppra-4)
prep_between(Interactions-2, @-5)
amod(Drugs-9, Other-7)
amod(Drugs-9, Antiepileptic-8)
conj_and(@-5, Drugs-9)
appos(Drugs-9, AEDs-11)
nn(@-15, Phenytoin-13)
nn(@-15, Keppra-14)
dep(@-5, @-15)
num(mg-18, 3000-17)
dep(@-15, mg-18)
advmod(mg-18, daily-19)
root(ROOT-0, had-21)
det(effect-23, no-22)
dobj(had-21, effect-23)
det(disposition-27, the-25)
amod(disposition-27, pharmacokinetic-26)
prep_on(had-21, disposition-27)
prep_of(disposition-27, phenytoin-29)
prep_in(phenytoin-29, patients-31)
amod(epilepsy-34, refractory-33)
prep_with(patients-31, epilepsy-34)

Pharmacokinetics/NNS of/IN levetiracetam/NN were/VBD also/RB not/RB affected/VBN by/IN phenytoin/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Pharmacokinetics)) (PP (IN of) (NP (NN levetiracetam)))) (VP (VBD were) (ADVP (RB also)) (RB not) (VP (VBN affected) (PP (IN by) (NP (NN phenytoin)))))) (. .))))

nsubjpass(affected-7, Pharmacokinetics-1)
prep_of(Pharmacokinetics-1, levetiracetam-3)
auxpass(affected-7, were-4)
advmod(affected-7, also-5)
neg(affected-7, not-6)
root(ROOT-0, affected-7)
agent(affected-7, phenytoin-9)

Valproate/NN Keppra/NN @/NN (/-LRB- 1500/CD mg/NN twice/RB daily/RB )/-RRB- did/VBD not/RB alter/VB the/DT pharmacokinetics/NNS of/IN valproate/NN in/IN healthy/JJ volunteers/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Valproate) (NN Keppra) (NN @)) (PRN (-LRB- -LRB-) (NP (NP (CD 1500) (NN mg)) (ADVP (RB twice) (RB daily))) (-RRB- -RRB-))) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN valproate))) (PP (IN in) (NP (JJ healthy) (NNS volunteers))))))) (. .))))

nn(@-3, Valproate-1)
nn(@-3, Keppra-2)
nsubj(alter-12, @-3)
num(mg-6, 1500-5)
dep(@-3, mg-6)
advmod(daily-8, twice-7)
advmod(mg-6, daily-8)
aux(alter-12, did-10)
neg(alter-12, not-11)
root(ROOT-0, alter-12)
det(pharmacokinetics-14, the-13)
dobj(alter-12, pharmacokinetics-14)
prep_of(pharmacokinetics-14, valproate-16)
amod(volunteers-19, healthy-18)
prep_in(pharmacokinetics-14, volunteers-19)

Valproate/NN 500/CD mg/NN twice/RB daily/RB did/VBD not/RB modify/VB the/DT rate/NN or/CC extent/NN of/IN levetiracetam/NN absorption/NN or/CC its/PRP$ plasma/NN clearance/NN or/CC urinary/JJ excretion/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Valproate) (CD 500) (NN mg)) (ADVP (RB twice) (RB daily))) (VP (VBD did) (RB not) (VP (VB modify) (NP (NP (NP (DT the) (NP (NN rate)) (CC or) (NP (NN extent))) (PP (IN of) (NP (NN levetiracetam) (NN absorption)))) (CC or) (NP (NP (PRP$ its) (NN plasma) (NN clearance)) (CC or) (NP (JJ urinary) (NN excretion))))))) (. .))))

nn(mg-3, Valproate-1)
num(mg-3, 500-2)
nsubj(modify-8, mg-3)
advmod(daily-5, twice-4)
advmod(mg-3, daily-5)
aux(modify-8, did-6)
neg(modify-8, not-7)
root(ROOT-0, modify-8)
dep(rate-10, the-9)
dobj(modify-8, rate-10)
conj_or(rate-10, extent-12)
nn(absorption-15, levetiracetam-14)
prep_of(rate-10, absorption-15)
poss(clearance-19, its-17)
nn(clearance-19, plasma-18)
conj_or(rate-10, clearance-19)
amod(excretion-22, urinary-21)
conj_or(clearance-19, excretion-22)

There/EX also/RB was/VBD no/DT effect/NN on/IN exposure/NN to/TO and/CC the/DT excretion/NN of/IN the/DT primary/JJ metabolite/NN ,/, ucb/NN L057/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (ADVP (RB also)) (VP (VBD was) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN exposure)) (PP (TO to) (NP (NP (CC and) (DT the) (NN excretion)) (PP (IN of) (NP (NP (DT the) (JJ primary) (NN metabolite)) (, ,) (NP (NN ucb) (NN L057))))))))))) (. .))))

expl(was-3, There-1)
advmod(was-3, also-2)
root(ROOT-0, was-3)
det(effect-5, no-4)
nsubj(was-3, effect-5)
prep_on(effect-5, exposure-7)
cc(excretion-11, and-9)
det(excretion-11, the-10)
prep_to(exposure-7, excretion-11)
det(metabolite-15, the-13)
amod(metabolite-15, primary-14)
prep_of(excretion-11, metabolite-15)
nn(L057-18, ucb-17)
appos(metabolite-15, L057-18)

Potential/JJ drug/NN interactions/NNS between/IN Keppra/NN @/NN and/CC other/JJ AEDs/NNS (/-LRB- carbamazepine/NN ,/, gabapentin/NN ,/, lamotrigine/NN ,/, phenobarbital/NN ,/, phenytoin/NN ,/, primidone/NN and/CC valproate/NN )/-RRB- were/VBD also/RB assessed/VBN by/IN evaluating/VBG the/DT serum/NN concentrations/NNS of/IN levetiracetam/NN and/CC these/DT AEDs/NNS during/IN placebo-controlled/JJ clinical/JJ studies/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Potential) (NN drug) (NNS interactions)) (PP (IN between) (NP (NP (NN Keppra) (NN @)) (CC and) (NP (NP (JJ other) (NNS AEDs)) (PRN (-LRB- -LRB-) (NP (NP (NN carbamazepine)) (, ,) (NP (NN gabapentin)) (, ,) (NP (NN lamotrigine)) (, ,) (NP (NN phenobarbital)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN primidone)) (CC and) (NP (NN valproate))) (-RRB- -RRB-)))))) (VP (VBD were) (ADVP (RB also)) (VP (VBN assessed) (PP (IN by) (S (VP (VBG evaluating) (NP (NP (NP (DT the) (NN serum) (NNS concentrations)) (PP (IN of) (NP (NN levetiracetam)))) (CC and) (NP (DT these) (NNS AEDs))) (PP (IN during) (NP (ADJP (JJ placebo-controlled) (JJ clinical)) (NNS studies))))))))) (. .))))

amod(interactions-3, Potential-1)
nn(interactions-3, drug-2)
nsubjpass(assessed-27, interactions-3)
nn(@-6, Keppra-5)
prep_between(interactions-3, @-6)
amod(AEDs-9, other-8)
conj_and(@-6, AEDs-9)
dep(AEDs-9, carbamazepine-11)
conj_and(carbamazepine-11, gabapentin-13)
conj_and(carbamazepine-11, lamotrigine-15)
conj_and(carbamazepine-11, phenobarbital-17)
conj_and(carbamazepine-11, phenytoin-19)
conj_and(carbamazepine-11, primidone-21)
conj_and(carbamazepine-11, valproate-23)
auxpass(assessed-27, were-25)
advmod(assessed-27, also-26)
root(ROOT-0, assessed-27)
agent(assessed-27, evaluating-29)
det(concentrations-32, the-30)
nn(concentrations-32, serum-31)
dobj(evaluating-29, concentrations-32)
prep_of(concentrations-32, levetiracetam-34)
det(AEDs-37, these-36)
conj_and(concentrations-32, AEDs-37)
amod(clinical-40, placebo-controlled-39)
amod(studies-41, clinical-40)
prep_during(evaluating-29, studies-41)

These/DT data/NNS indicate/VBP that/IN levetiracetam/NN does/VBZ not/RB influence/VB the/DT plasma/NN concentration/NN of/IN other/JJ AEDs/NNS and/CC that/IN these/DT AEDs/NNS do/VBP not/RB influence/VB the/DT pharmacokinetics/NNS of/IN levetiracetam/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS data)) (VP (VBP indicate) (SBAR (SBAR (IN that) (S (NP (NN levetiracetam)) (VP (VBZ does) (RB not) (VP (VB influence) (NP (NP (DT the) (NN plasma) (NN concentration)) (PP (IN of) (NP (JJ other) (NNS AEDs)))))))) (CC and) (SBAR (IN that) (S (NP (DT these) (NNS AEDs)) (VP (VBP do) (RB not) (VP (VB influence) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN levetiracetam))))))))))) (. .))))

det(data-2, These-1)
nsubj(indicate-3, data-2)
root(ROOT-0, indicate-3)
complm(influence-8, that-4)
nsubj(influence-8, levetiracetam-5)
aux(influence-8, does-6)
neg(influence-8, not-7)
ccomp(indicate-3, influence-8)
det(concentration-11, the-9)
nn(concentration-11, plasma-10)
dobj(influence-8, concentration-11)
amod(AEDs-14, other-13)
prep_of(concentration-11, AEDs-14)
complm(influence-21, that-16)
det(AEDs-18, these-17)
nsubj(influence-21, AEDs-18)
aux(influence-21, do-19)
neg(influence-21, not-20)
conj_and(influence-8, influence-21)
det(pharmacokinetics-23, the-22)
dobj(influence-21, pharmacokinetics-23)
prep_of(pharmacokinetics-23, levetiracetam-25)

Effect/NN of/IN AEDs/NNS in/IN Pediatric/JJ Patients/NNS :/: There/EX was/VBD about/IN a/DT 22/CD %/NN increase/NN of/IN apparent/JJ total/JJ body/NN clearance/NN of/IN levetiracetam/NN when/WRB it/PRP was/VBD co-administered/VBN with/IN enzyme-inducing/JJ AEDs/NNS ./.

(ROOT (S1 (S (NP (NP (NN Effect)) (PP (IN of) (NP (NNS AEDs))) (PP (IN in) (NP (JJ Pediatric) (NNS Patients)))) (: :) (NP (EX There)) (VP (VBD was) (PP (IN about) (NP (NP (DT a) (ADJP (CD 22) (NN %)) (NN increase)) (PP (IN of) (NP (NP (JJ apparent) (JJ total) (NN body) (NN clearance)) (PP (IN of) (NP (NN levetiracetam))))))) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBD was) (VP (VBN co-administered) (PP (IN with) (NP (JJ enzyme-inducing) (NNS AEDs)))))))) (. .))))

nsubj(was-9, Effect-1)
prep_of(Effect-1, AEDs-3)
amod(Patients-6, Pediatric-5)
prep_in(Effect-1, Patients-6)
expl(was-9, There-8)
root(ROOT-0, was-9)
det(increase-14, a-11)
number(%-13, 22-12)
amod(increase-14, %-13)
prep_about(was-9, increase-14)
amod(clearance-19, apparent-16)
amod(clearance-19, total-17)
nn(clearance-19, body-18)
prep_of(increase-14, clearance-19)
prep_of(clearance-19, levetiracetam-21)
advmod(co-administered-25, when-22)
nsubjpass(co-administered-25, it-23)
auxpass(co-administered-25, was-24)
advcl(was-9, co-administered-25)
amod(AEDs-28, enzyme-inducing-27)
prep_with(co-administered-25, AEDs-28)

Dose/NN adjustment/NN is/VBZ not/RB recommended./NN Levetiracetam/NN had/VBD no/DT effect/NN on/IN plasma/NN concentrations/NNS of/IN carbamazepine/NN ,/, valproate/NN ,/, topiramate/NN ,/, or/CC lamotrigine/NN ./.

(ROOT (S1 (S (S (NP (NN Dose) (NN adjustment)) (VP (VBZ is) (RB not) (NP (NP (NN recommended.) (NN Levetiracetam)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (NN carbamazepine)) (, ,) (NP (NN valproate)) (, ,) (NP (NN topiramate)) (, ,) (CC or) (NP (NN lamotrigine)))))))))) (. .))))

nn(adjustment-2, Dose-1)
nsubj(Levetiracetam-6, adjustment-2)
cop(Levetiracetam-6, is-3)
neg(Levetiracetam-6, not-4)
nn(Levetiracetam-6, recommended.-5)
root(ROOT-0, Levetiracetam-6)
partmod(Levetiracetam-6, had-7)
det(effect-9, no-8)
dobj(had-7, effect-9)
nn(concentrations-12, plasma-11)
prep_on(had-7, concentrations-12)
prep_of(concentrations-12, carbamazepine-14)
conj_or(carbamazepine-14, valproate-16)
conj_or(carbamazepine-14, topiramate-18)
conj_or(carbamazepine-14, lamotrigine-21)

Other/JJ Drug/NN Interactions/NNS Oral/JJ Contraceptives/NNS Keppra/NNP @/NN (/-LRB- 500/CD mg/NN twice/RB daily/RB )/-RRB- did/VBD not/RB influence/VB the/DT pharmacokinetics/NNS of/IN an/DT oral/JJ contraceptive/NN containing/VBG 0.03/CD mg/NN ethinyl/NN estradiol/NN and/CC 0.15/CD mg/NN levonorgestrel/NN ,/, or/CC of/IN the/DT luteinizing/JJ hormone/NN and/CC progesterone/NN levels/NNS ,/, indicating/VBG that/IN impairment/NN of/IN contraceptive/JJ efficacy/NN is/VBZ unlikely/JJ ./.

(ROOT (S1 (S (S (NP (NP (JJ Other) (NN Drug) (NNS Interactions)) (JJ Oral) (NNS Contraceptives) (NP (NP (NNP Keppra) (NN @)) (PRN (-LRB- -LRB-) (NP (NP (CD 500) (NN mg)) (ADVP (RB twice) (RB daily))) (-RRB- -RRB-)))) (VP (VBD did) (RB not) (VP (VB influence) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (PP (IN of) (NP (NP (NP (DT an) (JJ oral) (NN contraceptive)) (VP (VBG containing) (NP (ADJP (CD 0.03) (NN mg)) (NN ethinyl) (NN estradiol)))) (CC and) (NP (ADJP (CD 0.15) (NN mg)) (NN levonorgestrel)))) (, ,) (CC or) (PP (IN of) (NP (NP (DT the) (JJ luteinizing) (NN hormone)) (CC and) (NP (NN progesterone) (NNS levels))))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (NN impairment)) (PP (IN of) (NP (JJ contraceptive) (NN efficacy)))) (VP (VBZ is) (ADJP (JJ unlikely))))))))) (. .))))

amod(Interactions-3, Other-1)
nn(Interactions-3, Drug-2)
nn(Contraceptives-5, Interactions-3)
amod(Contraceptives-5, Oral-4)
nsubj(influence-16, Contraceptives-5)
nn(@-7, Keppra-6)
dep(Contraceptives-5, @-7)
num(mg-10, 500-9)
dep(@-7, mg-10)
advmod(daily-12, twice-11)
advmod(mg-10, daily-12)
aux(influence-16, did-14)
neg(influence-16, not-15)
root(ROOT-0, influence-16)
det(pharmacokinetics-18, the-17)
dobj(influence-16, pharmacokinetics-18)
det(contraceptive-22, an-20)
amod(contraceptive-22, oral-21)
prep_of(pharmacokinetics-18, contraceptive-22)
partmod(contraceptive-22, containing-23)
number(mg-25, 0.03-24)
amod(estradiol-27, mg-25)
nn(estradiol-27, ethinyl-26)
dobj(containing-23, estradiol-27)
number(mg-30, 0.15-29)
amod(levonorgestrel-31, mg-30)
conj_and(contraceptive-22, levonorgestrel-31)
det(hormone-37, the-35)
amod(hormone-37, luteinizing-36)
conj_or(contraceptive-22, hormone-37)
nn(levels-40, progesterone-39)
conj_and(hormone-37, levels-40)
xcomp(influence-16, indicating-42)
complm(unlikely-49, that-43)
nsubj(unlikely-49, impairment-44)
amod(efficacy-47, contraceptive-46)
prep_of(impairment-44, efficacy-47)
cop(unlikely-49, is-48)
ccomp(indicating-42, unlikely-49)

Coadministration/NN of/IN this/DT oral/JJ contraceptive/NN did/VBD not/RB influence/VB the/DT pharmacokinetics/NNS of/IN levetiracetam/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (DT this) (JJ oral) (NN contraceptive)))) (VP (VBD did) (RB not) (VP (VB influence) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN levetiracetam))))))) (. .))))

nsubj(influence-8, Coadministration-1)
det(contraceptive-5, this-3)
amod(contraceptive-5, oral-4)
prep_of(Coadministration-1, contraceptive-5)
aux(influence-8, did-6)
neg(influence-8, not-7)
root(ROOT-0, influence-8)
det(pharmacokinetics-10, the-9)
dobj(influence-8, pharmacokinetics-10)
prep_of(pharmacokinetics-10, levetiracetam-12)

Digoxin/NN Keppra/NN @/NN (/-LRB- 1000/CD mg/NN twice/RB daily/RB )/-RRB- did/VBD not/RB influence/VB the/DT pharmacokinetics/NNS and/CC pharmacodynamics/NNS (/-LRB- ECG/NN )/-RRB- of/IN digoxin/NN given/VBN as/IN a/DT 0.25/CD mg/NN dose/NN every/DT day/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Digoxin) (NN Keppra) (NN @)) (PRN (-LRB- -LRB-) (NP (NP (CD 1000) (NN mg)) (ADVP (RB twice) (RB daily))) (-RRB- -RRB-))) (VP (VBD did) (RB not) (VP (VB influence) (NP (NP (NP (DT the) (NP (NNS pharmacokinetics)) (CC and) (NP (NNS pharmacodynamics))) (PRN (-LRB- -LRB-) (NP (NN ECG)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN digoxin)) (VP (VBN given) (PP (IN as) (NP (NP (DT a) (ADJP (CD 0.25) (NN mg)) (NN dose)) (VP (DT every) (NN day))))))))))) (. .))))

nn(@-3, Digoxin-1)
nn(@-3, Keppra-2)
nsubj(influence-12, @-3)
num(mg-6, 1000-5)
dep(@-3, mg-6)
advmod(daily-8, twice-7)
advmod(mg-6, daily-8)
aux(influence-12, did-10)
neg(influence-12, not-11)
root(ROOT-0, influence-12)
dep(pharmacokinetics-14, the-13)
dobj(influence-12, pharmacokinetics-14)
conj_and(pharmacokinetics-14, pharmacodynamics-16)
abbrev(pharmacokinetics-14, ECG-18)
prep_of(pharmacokinetics-14, digoxin-21)
partmod(digoxin-21, given-22)
det(dose-27, a-24)
number(mg-26, 0.25-25)
amod(dose-27, mg-26)
prep_as(given-22, dose-27)
dep(day-29, every-28)
dep(dose-27, day-29)

Coadministration/NN of/IN digoxin/NN did/VBD not/RB influence/VB the/DT pharmacokinetics/NNS of/IN levetiracetam/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN digoxin)))) (VP (VBD did) (RB not) (VP (VB influence) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN levetiracetam))))))) (. .))))

nsubj(influence-6, Coadministration-1)
prep_of(Coadministration-1, digoxin-3)
aux(influence-6, did-4)
neg(influence-6, not-5)
root(ROOT-0, influence-6)
det(pharmacokinetics-8, the-7)
dobj(influence-6, pharmacokinetics-8)
prep_of(pharmacokinetics-8, levetiracetam-10)

Warfarin/NN Keppra/NN @/NN (/-LRB- 1000/CD mg/NN twice/RB daily/RB )/-RRB- did/VBD not/RB influence/VB the/DT pharmacokinetics/NNS of/IN R/NN and/CC S/NN warfarin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Warfarin) (NN Keppra) (NN @)) (PRN (-LRB- -LRB-) (NP (NP (CD 1000) (NN mg)) (ADVP (RB twice) (RB daily))) (-RRB- -RRB-))) (VP (VBD did) (RB not) (VP (VB influence) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN R)) (CC and) (NP (NN S)) (NP (NN warfarin)))))))) (. .))))

nn(@-3, Warfarin-1)
nn(@-3, Keppra-2)
nsubj(influence-12, @-3)
num(mg-6, 1000-5)
dep(@-3, mg-6)
advmod(daily-8, twice-7)
advmod(mg-6, daily-8)
aux(influence-12, did-10)
neg(influence-12, not-11)
root(ROOT-0, influence-12)
det(pharmacokinetics-14, the-13)
dobj(influence-12, pharmacokinetics-14)
prep_of(pharmacokinetics-14, R-16)
conj_and(R-16, S-18)
dep(R-16, warfarin-19)

Prothrombin/NN time/NN was/VBD not/RB affected/VBN by/IN levetiracetam/NN ./.

(ROOT (S1 (S (S (NP (NN Prothrombin) (NN time)) (VP (VBD was) (RB not) (VP (VBN affected) (PP (IN by) (NP (NN levetiracetam)))))) (. .))))

nn(time-2, Prothrombin-1)
nsubjpass(affected-5, time-2)
auxpass(affected-5, was-3)
neg(affected-5, not-4)
root(ROOT-0, affected-5)
agent(affected-5, levetiracetam-7)

Coadministration/NN of/IN warfarin/NN did/VBD not/RB affect/VB the/DT pharmacokinetics/NNS of/IN levetiracetam/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN warfarin)))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN levetiracetam))))))) (. .))))

nsubj(affect-6, Coadministration-1)
prep_of(Coadministration-1, warfarin-3)
aux(affect-6, did-4)
neg(affect-6, not-5)
root(ROOT-0, affect-6)
det(pharmacokinetics-8, the-7)
dobj(affect-6, pharmacokinetics-8)
prep_of(pharmacokinetics-8, levetiracetam-10)

Probenecid/NN Probenecid/NN ,/, a/DT renal/JJ tubular/JJ secretion/NN blocking/NN agent/NN ,/, administered/VBN at/IN a/DT dose/NN of/IN 500/CD mg/NN four/CD times/NNS a/DT day/NN ,/, did/VBD not/RB change/VB the/DT pharmacokinetics/NNS of/IN levetiracetam/NN 1000/CD mg/NN twice/RB daily/RB ./.

(ROOT (S1 (S (S (NP (NP (NN Probenecid) (NN Probenecid)) (, ,) (NP (NP (DT a) (JJ renal) (JJ tubular) (NN secretion) (NN blocking) (NN agent)) (, ,) (VP (VBN administered) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (NP (CD 500) (NN mg)) (NP (NP (CD four) (NNS times)) (NP (DT a) (NN day))))))))) (, ,)) (VP (VBD did) (RB not) (VP (VB change) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN levetiracetam) (CD 1000) (NN mg)) (ADVP (RB twice) (RB daily)))))))) (. .))))

nn(Probenecid-2, Probenecid-1)
nsubj(change-25, Probenecid-2)
det(agent-9, a-4)
amod(agent-9, renal-5)
amod(agent-9, tubular-6)
nn(agent-9, secretion-7)
nn(agent-9, blocking-8)
appos(Probenecid-2, agent-9)
partmod(agent-9, administered-11)
det(dose-14, a-13)
prep_at(administered-11, dose-14)
num(mg-17, 500-16)
prep_of(dose-14, mg-17)
num(times-19, four-18)
dep(mg-17, times-19)
det(day-21, a-20)
dep(times-19, day-21)
aux(change-25, did-23)
neg(change-25, not-24)
root(ROOT-0, change-25)
det(pharmacokinetics-27, the-26)
dobj(change-25, pharmacokinetics-27)
nn(mg-31, levetiracetam-29)
num(mg-31, 1000-30)
prep_of(pharmacokinetics-27, mg-31)
advmod(daily-33, twice-32)
advmod(mg-31, daily-33)

Cssmax/NN of/IN the/DT metabolite/NN ,/, ucb/NN L057/NN ,/, was/VBD approximately/RB doubled/VBN in/IN the/DT presence/NN of/IN probenecid/NN while/IN the/DT fraction/NN of/IN drug/NN excreted/VBD unchanged/JJ in/IN the/DT urine/NN remained/VBD the/DT same/JJ ./.

(ROOT (S1 (S (S (NP (NP (NN Cssmax)) (PP (IN of) (NP (NP (DT the) (NN metabolite)) (, ,) (NP (NN ucb) (NN L057)) (, ,)))) (VP (VBD was) (RB approximately) (VP (VBN doubled) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN probenecid)))))) (SBAR (IN while) (S (NP (NP (DT the) (NN fraction)) (PP (IN of) (NP (NN drug)))) (VP (VBD excreted) (ADJP (JJ unchanged)) (PP (IN in) (NP (NP (DT the) (NN urine)) (VP (VBD remained) (NP (DT the) (JJ same)))))))))) (. .))))

nsubjpass(doubled-11, Cssmax-1)
det(metabolite-4, the-3)
prep_of(Cssmax-1, metabolite-4)
nn(L057-7, ucb-6)
appos(metabolite-4, L057-7)
auxpass(doubled-11, was-9)
advmod(doubled-11, approximately-10)
root(ROOT-0, doubled-11)
det(presence-14, the-13)
prep_in(doubled-11, presence-14)
prep_of(presence-14, probenecid-16)
mark(excreted-22, while-17)
det(fraction-19, the-18)
nsubj(excreted-22, fraction-19)
prep_of(fraction-19, drug-21)
advcl(doubled-11, excreted-22)
acomp(excreted-22, unchanged-23)
det(urine-26, the-25)
prep_in(excreted-22, urine-26)
cop(same-29, remained-27)
det(same-29, the-28)
partmod(urine-26, same-29)

Renal/JJ clearance/NN of/IN ucb/NN L057/NN in/IN the/DT presence/NN of/IN probenecid/NN decreased/VBD 60/CD %/NN ,/, probably/RB related/JJ to/TO competitive/JJ inhibition/NN of/IN tubular/JJ secretion/NN of/IN ucb/JJ L057/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Renal) (NN clearance)) (PP (IN of) (NP (NN ucb) (NN L057))) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN probenecid)))))) (VP (VBD decreased) (NP (NP (CD 60) (NN %)) (, ,) (ADJP (RB probably) (JJ related) (PP (TO to) (NP (NP (JJ competitive) (NN inhibition)) (PP (IN of) (NP (NP (JJ tubular) (NN secretion)) (PP (IN of) (NP (JJ ucb) (NN L057))))))))))) (. .))))

amod(clearance-2, Renal-1)
nsubj(decreased-11, clearance-2)
nn(L057-5, ucb-4)
prep_of(clearance-2, L057-5)
det(presence-8, the-7)
prep_in(clearance-2, presence-8)
prep_of(presence-8, probenecid-10)
root(ROOT-0, decreased-11)
num(%-13, 60-12)
dobj(decreased-11, %-13)
advmod(related-16, probably-15)
amod(%-13, related-16)
amod(inhibition-19, competitive-18)
prep_to(related-16, inhibition-19)
amod(secretion-22, tubular-21)
prep_of(inhibition-19, secretion-22)
amod(L057-25, ucb-24)
prep_of(secretion-22, L057-25)

The/DT effect/NN of/IN Keppra/NN @/NN on/IN probenecid/NN was/VBD not/RB studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN Keppra) (NN @))) (PP (IN on) (NP (NN probenecid)))) (VP (VBD was) (RB not) (VP (VBN studied)))) (. .))))

det(effect-2, The-1)
nsubjpass(studied-10, effect-2)
nn(@-5, Keppra-4)
prep_of(effect-2, @-5)
prep_on(effect-2, probenecid-7)
auxpass(studied-10, was-8)
neg(studied-10, not-9)
root(ROOT-0, studied-10)

Chirocaine/NN @/NN should/MD be/VB used/VBN with/IN caution/NN in/IN patients/NNS receiving/VBG other/JJ local/JJ anesthetics/NNS or/CC agents/NNS structurally/RB related/JJ to/TO amide-type/JJ local/JJ anesthetics/NNS since/IN the/DT toxic/JJ effects/NNS of/IN these/DT drugs/NNS could/MD be/VB additive/JJ ./.

(ROOT (S1 (S (S (NP (NN Chirocaine) (NN @)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NP (NN caution)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NP (JJ other) (JJ local) (NNS anesthetics)) (CC or) (NP (NNS agents))) (ADJP (RB structurally) (JJ related) (PP (TO to) (NP (JJ amide-type) (JJ local) (NNS anesthetics)))))))))) (SBAR (IN since) (S (NP (NP (DT the) (JJ toxic) (NNS effects)) (PP (IN of) (NP (DT these) (NNS drugs)))) (VP (MD could) (VP (VB be) (ADJP (JJ additive)))))))))) (. .))))

nn(@-2, Chirocaine-1)
nsubjpass(used-5, @-2)
aux(used-5, should-3)
auxpass(used-5, be-4)
root(ROOT-0, used-5)
prep_with(used-5, caution-7)
prep_in(caution-7, patients-9)
partmod(patients-9, receiving-10)
amod(anesthetics-13, other-11)
amod(anesthetics-13, local-12)
dobj(receiving-10, anesthetics-13)
conj_or(anesthetics-13, agents-15)
advmod(related-17, structurally-16)
amod(anesthetics-13, related-17)
amod(anesthetics-21, amide-type-19)
amod(anesthetics-21, local-20)
prep_to(related-17, anesthetics-21)
mark(additive-31, since-22)
det(effects-25, the-23)
amod(effects-25, toxic-24)
nsubj(additive-31, effects-25)
det(drugs-28, these-27)
prep_of(effects-25, drugs-28)
aux(additive-31, could-29)
cop(additive-31, be-30)
advcl(used-5, additive-31)

In/FW vitro/FW studies/NNS indicate/VBP CYP3A4/NN isoform/NN and/CC CYP1A2/NN isoform/NN mediate/VBP the/DT metabolism/NN of/IN levobupivacaine/NN to/TO desbutyl/NN levobupivacaine/NN and/CC 3-hydroxy/NN levobupivacaine/NN ,/, respectively/RB ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBP indicate) (S (NP (NP (NN CYP3A4) (NN isoform)) (CC and) (NP (NN CYP1A2) (NN isoform))) (VP (VBP mediate) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN levobupivacaine))) (PP (TO to) (NP (NP (NN desbutyl) (NN levobupivacaine)) (CC and) (NP (NN 3-hydroxy) (NN levobupivacaine))))) (, ,) (ADVP (RB respectively)))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(indicate-4, studies-3)
root(ROOT-0, indicate-4)
nn(isoform-6, CYP3A4-5)
nsubj(mediate-10, isoform-6)
nn(isoform-9, CYP1A2-8)
conj_and(isoform-6, isoform-9)
ccomp(indicate-4, mediate-10)
det(metabolism-12, the-11)
dobj(mediate-10, metabolism-12)
prep_of(metabolism-12, levobupivacaine-14)
nn(levobupivacaine-17, desbutyl-16)
prep_to(metabolism-12, levobupivacaine-17)
nn(levobupivacaine-20, 3-hydroxy-19)
conj_and(levobupivacaine-17, levobupivacaine-20)
advmod(mediate-10, respectively-22)

Thus/RB agents/NNS likely/RB to/TO be/VB concomitantly/RB administered/VBN with/IN Chirocaine/NN that/WDT are/VBP metabolized/VBN by/IN this/DT isoenzyme/NN family/NN may/MD potentially/RB interact/VB with/IN Chirocaine/NN ./.

(ROOT (S1 (S (S (ADVP (RB Thus)) (NP (NP (NNS agents)) (VP (ADVP (RB likely)) (TO to) (VP (VB be) (ADVP (RB concomitantly)) (VP (VBN administered) (PP (IN with) (NP (NP (NN Chirocaine)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN metabolized) (PP (IN by) (NP (DT this) (NN isoenzyme) (NN family))))))))))))) (VP (MD may) (ADVP (RB potentially)) (VP (VB interact) (PP (IN with) (NP (NN Chirocaine)))))) (. .))))

advmod(interact-19, Thus-1)
nsubj(interact-19, agents-2)
advmod(administered-7, likely-3)
aux(administered-7, to-4)
auxpass(administered-7, be-5)
advmod(administered-7, concomitantly-6)
dep(agents-2, administered-7)
prep_with(administered-7, Chirocaine-9)
nsubjpass(metabolized-12, Chirocaine-9)
auxpass(metabolized-12, are-11)
rcmod(Chirocaine-9, metabolized-12)
det(family-16, this-14)
nn(family-16, isoenzyme-15)
agent(metabolized-12, family-16)
aux(interact-19, may-17)
advmod(interact-19, potentially-18)
root(ROOT-0, interact-19)
prep_with(interact-19, Chirocaine-21)

Although/IN no/DT clinical/JJ studies/NNS have/VBP been/VBN conducted/VBN ,/, it/PRP is/VBZ likely/JJ that/IN the/DT metabolism/NN of/IN levobupivacaine/NN may/MD be/VB affected/VBN by/IN the/DT known/JJ CYP3A4/NN inducers/NNS (/-LRB- such/JJ as/IN phenytoin/NN ,/, phenobarbital/NN ,/, rifampin/NN )/-RRB- ,/, CYP3A4/JJ inhibitors/NNS (/-LRB- azole/JJ antimycotics/NNS e.g./FW ,/, ketoconazole/NN ;/: ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (DT no) (JJ clinical) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN conducted)))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ likely) (SBAR (IN that) (S (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN levobupivacaine)))) (VP (MD may) (VP (VB be) (VP (VBN affected) (PP (IN by) (NP (NP (NP (DT the) (JJ known) (NN CYP3A4) (NNS inducers)) (PRN (-LRB- -LRB-) (CONJP (JJ such) (IN as)) (NP (NP (NN phenytoin)) (, ,) (NP (NN phenobarbital)) (, ,) (NP (NN rifampin))) (-RRB- -RRB-))) (, ,) (NP (NP (JJ CYP3A4) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (JJ azole) (NNS antimycotics)) (PP (FW e.g.)))) (, ,) (NP (NN ketoconazole))))))))))) (: ;)) (. .))))

mark(conducted-7, Although-1)
det(studies-4, no-2)
amod(studies-4, clinical-3)
nsubjpass(conducted-7, studies-4)
aux(conducted-7, have-5)
auxpass(conducted-7, been-6)
advcl(likely-11, conducted-7)
nsubj(likely-11, it-9)
cop(likely-11, is-10)
root(ROOT-0, likely-11)
complm(affected-19, that-12)
det(metabolism-14, the-13)
nsubjpass(affected-19, metabolism-14)
prep_of(metabolism-14, levobupivacaine-16)
aux(affected-19, may-17)
auxpass(affected-19, be-18)
ccomp(likely-11, affected-19)
det(inducers-24, the-21)
amod(inducers-24, known-22)
nn(inducers-24, CYP3A4-23)
agent(affected-19, inducers-24)
dep(phenytoin-28, such-26)
dep(such-26, as-27)
dep(inducers-24, phenytoin-28)
appos(phenytoin-28, phenobarbital-30)
appos(phenytoin-28, rifampin-32)
amod(inhibitors-36, CYP3A4-35)
appos(inducers-24, inhibitors-36)
amod(antimycotics-39, azole-38)
dep(inhibitors-36, antimycotics-39)
dep(antimycotics-39, e.g.-40)
appos(inducers-24, ketoconazole-42)

certain/JJ protease/NN inhibitors/NNS e.g./FW ,/, ritanovir/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (JJ certain) (NN protease) (NNS inhibitors)) (PP (FW e.g.) (, ,) (NP (NN ritanovir))) (: ;))) (. .))))

amod(inhibitors-3, certain-1)
nn(inhibitors-3, protease-2)
root(ROOT-0, inhibitors-3)
prep(inhibitors-3, e.g.-4)
pobj(e.g.-4, ritanovir-6)

macrolide/NN antibiotics/NNS e.g./FW ,/, erythromycin/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN macrolide) (NNS antibiotics)) (NP (ADVP (FW e.g.)) (, ,) (NP (NN erythromycin) (: ;)))) (. .))))

nn(antibiotics-2, macrolide-1)
dep(erythromycin-5, antibiotics-2)
advmod(erythromycin-5, e.g.-3)
root(ROOT-0, erythromycin-5)

and/CC calcium/NN channel/NN antagonists/NNS e.g./FW ,/, verapamil/NN )/-RRB- ,/, CYP1A2/NN inducers/NNS (/-LRB- omeprazole/NN )/-RRB- and/CC CYP1A2/NN inhibitors/NNS (/-LRB- furafylline/NN and/CC clarithromycin/NN )/-RRB- ./.

(ROOT (S1 (S (NP (CC and) (NP (NP (NN calcium) (NN channel) (NNS antagonists)) (PRN (PP (FW e.g.) (, ,) (NP (NN verapamil))) (-RRB- -RRB-))) (, ,) (NP (NP (NN CYP1A2) (NNS inducers)) (PRN (-LRB- -LRB-) (NP (NN omeprazole)) (-RRB- -RRB-))) (CC and) (NP (NP (NN CYP1A2) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NP (NN furafylline)) (CC and) (NP (NN clarithromycin))) (-RRB- -RRB-))) (. .)))))

nn(antagonists-4, calcium-2)
nn(antagonists-4, channel-3)
root(ROOT-0, antagonists-4)
dep(antagonists-4, e.g.-5)
pobj(e.g.-5, verapamil-7)
nn(inducers-11, CYP1A2-10)
conj_and(antagonists-4, inducers-11)
appos(inducers-11, omeprazole-13)
nn(inhibitors-17, CYP1A2-16)
conj_and(antagonists-4, inhibitors-17)
dep(inhibitors-17, furafylline-19)
conj_and(furafylline-19, clarithromycin-21)

Dosage/NN adjustment/NN may/MD be/VB warranted/VBN when/WRB levobupivacaine/NN is/VBZ concurrently/RB administered/VBN with/IN CYP3A4/JJ inhibitors/NNS and/CC CYP1A2/NN inhibitors/NNS as/IN systemic/JJ levobupivacaine/NN levels/NNS may/MD rise/VB resulting/VBG in/IN toxicity/NN ./.

(ROOT (S1 (S (S (NP (NN Dosage) (NN adjustment)) (VP (MD may) (VP (VB be) (VP (VBN warranted) (SBAR (WHADVP (WRB when)) (S (NP (NN levobupivacaine)) (VP (VBZ is) (ADVP (RB concurrently)) (VP (VBN administered) (PP (IN with) (NP (NP (JJ CYP3A4) (NNS inhibitors)) (CC and) (NP (NN CYP1A2) (NNS inhibitors)))) (SBAR (IN as) (S (NP (JJ systemic) (NN levobupivacaine) (NNS levels)) (VP (MD may) (VP (VB rise) (S (VP (VBG resulting) (PP (IN in) (NP (NN toxicity))))))))))))))))) (. .))))

nn(adjustment-2, Dosage-1)
nsubjpass(warranted-5, adjustment-2)
aux(warranted-5, may-3)
auxpass(warranted-5, be-4)
root(ROOT-0, warranted-5)
advmod(administered-10, when-6)
nsubjpass(administered-10, levobupivacaine-7)
auxpass(administered-10, is-8)
advmod(administered-10, concurrently-9)
advcl(warranted-5, administered-10)
amod(inhibitors-13, CYP3A4-12)
prep_with(administered-10, inhibitors-13)
nn(inhibitors-16, CYP1A2-15)
conj_and(inhibitors-13, inhibitors-16)
mark(rise-22, as-17)
amod(levels-20, systemic-18)
nn(levels-20, levobupivacaine-19)
nsubj(rise-22, levels-20)
aux(rise-22, may-21)
advcl(administered-10, rise-22)
xcomp(rise-22, resulting-23)
prep_in(resulting-23, toxicity-25)

Specific/JJ drug/NN interaction/NN studies/NNS have/VBP not/RB been/VBN conducted/VBN with/IN Levofloxacin/NN ./.

(ROOT (S1 (S (S (NP (JJ Specific) (NN drug) (NN interaction) (NNS studies)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN conducted) (PP (IN with) (NP (NN Levofloxacin))))))) (. .))))

amod(studies-4, Specific-1)
nn(studies-4, drug-2)
nn(studies-4, interaction-3)
nsubjpass(conducted-8, studies-4)
aux(conducted-8, have-5)
neg(conducted-8, not-6)
auxpass(conducted-8, been-7)
root(ROOT-0, conducted-8)
prep_with(conducted-8, Levofloxacin-10)

However/RB ,/, the/DT systemic/JJ administration/NN of/IN some/DT quinolones/NNS has/VBZ been/VBN shown/VBN to/TO elevate/VBP plasma/NN concentrations/NNS of/IN theophylline/NN ,/, interfere/VB with/IN the/DT metabolism/NN of/IN caffeine/NN ,/, and/CC enhance/VB the/DT effects/NNS of/IN the/DT oral/JJ anticoagulant/NN warfarin/NN and/CC its/PRP$ derivatives/NNS ,/, and/CC has/VBZ been/VBN associated/VBN with/IN transient/JJ elevations/NNS in/IN serum/NN creatinine/NN in/IN patients/NNS receiving/VBG systemic/JJ cyclosporine/NN concomitantly/RB ./.

(ROOT (S1 (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (JJ systemic) (NN administration)) (PP (IN of) (NP (DT some) (NNS quinolones)))) (VP (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VP (VBP elevate) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN theophylline))))) (, ,) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN caffeine)))))) (, ,) (CC and) (VP (VB enhance) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (DT the) (JJ oral) (NN anticoagulant) (NN warfarin)) (CC and) (NP (PRP$ its) (NNS derivatives)))))))))))) (, ,) (CC and) (VP (VBZ has) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (JJ transient) (NNS elevations)) (PP (IN in) (NP (NP (NN serum) (NN creatinine)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ systemic) (NN cyclosporine))))))))) (ADVP (RB concomitantly)))))) (. .))))

advmod(shown-11, However-1)
det(administration-5, the-3)
amod(administration-5, systemic-4)
nsubjpass(shown-11, administration-5)
xsubj(elevate-13, administration-5)
det(quinolones-8, some-7)
prep_of(administration-5, quinolones-8)
aux(shown-11, has-9)
auxpass(shown-11, been-10)
root(ROOT-0, shown-11)
aux(elevate-13, to-12)
xcomp(shown-11, elevate-13)
nn(concentrations-15, plasma-14)
dobj(elevate-13, concentrations-15)
prep_of(concentrations-15, theophylline-17)
conj_and(elevate-13, interfere-19)
det(metabolism-22, the-21)
prep_with(interfere-19, metabolism-22)
prep_of(metabolism-22, caffeine-24)
conj_and(elevate-13, enhance-27)
det(effects-29, the-28)
dobj(enhance-27, effects-29)
det(warfarin-34, the-31)
amod(warfarin-34, oral-32)
nn(warfarin-34, anticoagulant-33)
prep_of(effects-29, warfarin-34)
poss(derivatives-37, its-36)
conj_and(warfarin-34, derivatives-37)
aux(associated-42, has-40)
auxpass(associated-42, been-41)
conj_and(shown-11, associated-42)
amod(elevations-45, transient-44)
prep_with(associated-42, elevations-45)
nn(creatinine-48, serum-47)
prep_in(elevations-45, creatinine-48)
prep_in(creatinine-48, patients-50)
partmod(patients-50, receiving-51)
amod(cyclosporine-53, systemic-52)
dobj(receiving-51, cyclosporine-53)
advmod(associated-42, concomitantly-54)

Interactions/NNS with/IN Other/JJ CNS/NN Agents/NNS :/: Concurrent/JJ use/NN of/IN Levo-Dromoran/NN with/IN all/DT central/JJ nervous/JJ system/NN depressants/NNS (/-LRB- eg/FW ,/, alcohol/NN ,/, sedatives/NNS ,/, hypnotics/NNS ,/, other/JJ opioids/NNS ,/, general/JJ anesthetics/NNS ,/, barbiturates/NNS ,/, tricyclic/JJ antidepressants/NNS ,/, phenothiazines/NNS ,/, tranquilizers/NNS ,/, skeletal/JJ muscle/NN relaxants/NNS and/CC antihistamines/NNS )/-RRB- may/MD result/VB in/IN additive/JJ central/JJ nervous/JJ system/NN depressant/NN effects/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NNS Interactions)) (PP (IN with) (NP (JJ Other) (NN CNS) (NNS Agents)))) (: :) (S (NP (NP (JJ Concurrent) (NN use)) (PP (IN of) (NP (NP (NN Levo-Dromoran)) (PP (IN with) (NP (NP (NP (DT all) (JJ central) (JJ nervous) (NN system)) (NNS depressants)) (PRN (-LRB- -LRB-) (PP (FW eg) (, ,) (NP (NN alcohol))) (, ,) (NP (NP (NNS sedatives)) (, ,) (NP (NNS hypnotics)) (, ,) (NP (JJ other) (NNS opioids)) (, ,) (NP (NP (JJ general) (NNS anesthetics)) (, ,) (NP (NNS barbiturates)) (, ,) (NP (JJ tricyclic) (NNS antidepressants)) (, ,) (NP (NNS phenothiazines)) (, ,) (NP (NNS tranquilizers)) (, ,) (NP (JJ skeletal) (NN muscle) (NNS relaxants)) (CC and) (NP (NNS antihistamines)))) (-RRB- -RRB-))))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (JJ additive) (JJ central) (JJ nervous) (NN system) (NN depressant) (NNS effects)))))) (. .)))))

root(ROOT-0, Interactions-1)
amod(Agents-5, Other-3)
nn(Agents-5, CNS-4)
prep_with(Interactions-1, Agents-5)
amod(use-8, Concurrent-7)
nsubj(result-48, use-8)
prep_of(use-8, Levo-Dromoran-10)
det(system-15, all-12)
amod(system-15, central-13)
amod(system-15, nervous-14)
nn(depressants-16, system-15)
prep_with(Levo-Dromoran-10, depressants-16)
dep(sedatives-22, eg-18)
pobj(eg-18, alcohol-20)
dep(depressants-16, sedatives-22)
appos(sedatives-22, hypnotics-24)
amod(opioids-27, other-26)
appos(sedatives-22, opioids-27)
amod(anesthetics-30, general-29)
appos(sedatives-22, anesthetics-30)
conj_and(anesthetics-30, barbiturates-32)
amod(antidepressants-35, tricyclic-34)
conj_and(anesthetics-30, antidepressants-35)
conj_and(anesthetics-30, phenothiazines-37)
conj_and(anesthetics-30, tranquilizers-39)
amod(relaxants-43, skeletal-41)
nn(relaxants-43, muscle-42)
conj_and(anesthetics-30, relaxants-43)
conj_and(anesthetics-30, antihistamines-45)
aux(result-48, may-47)
dep(Interactions-1, result-48)
amod(effects-55, additive-50)
amod(effects-55, central-51)
amod(effects-55, nervous-52)
nn(effects-55, system-53)
nn(effects-55, depressant-54)
prep_in(result-48, effects-55)

Although/IN no/DT interaction/NN between/IN MAO/NN inhibitors/NNS and/CC Levo-Dromoran/NN has/VBZ been/VBN observed/VBN ,/, it/PRP is/VBZ not/RB recommended/VBN for/IN use/NN with/IN MAO/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NP (DT no) (NN interaction)) (PP (IN between) (NP (NP (NN MAO) (NNS inhibitors)) (CC and) (NP (NN Levo-Dromoran))))) (VP (VBZ has) (VP (VBN been) (VP (VBN observed)))))) (, ,) (NP (PRP it)) (VP (VBZ is) (RB not) (VP (VBN recommended) (PP (IN for) (NP (NP (NN use)) (PP (IN with) (NP (NN MAO) (NNS inhibitors)))))))) (. .))))

mark(observed-11, Although-1)
det(interaction-3, no-2)
nsubjpass(observed-11, interaction-3)
nn(inhibitors-6, MAO-5)
prep_between(interaction-3, inhibitors-6)
conj_and(inhibitors-6, Levo-Dromoran-8)
aux(observed-11, has-9)
auxpass(observed-11, been-10)
advcl(recommended-16, observed-11)
nsubjpass(recommended-16, it-13)
auxpass(recommended-16, is-14)
neg(recommended-16, not-15)
root(ROOT-0, recommended-16)
prep_for(recommended-16, use-18)
nn(inhibitors-21, MAO-20)
prep_with(use-18, inhibitors-21)

Most/JJS cases/NNS of/IN serious/JJ or/CC fatal/JJ adverse/JJ events/NNS involving/VBG Levo-Dromoran/NN reported/VBN to/TO the/DT manufacturer/NN or/CC the/DT FDA/NN have/VBP involved/VBN either/CC the/DT administration/NN of/IN large/JJ initial/JJ doses/NNS or/CC too/RB frequent/JJ doses/NNS of/IN the/DT drug/NN to/TO nonopioid/JJ tolerant/JJ patients/NNS ,/, or/CC the/DT simultaneous/JJ administration/NN of/IN levorphanol/NN with/IN other/JJ drugs/NNS affecting/VBG respiration/NN ./.

(ROOT (S1 (S (S (NP (NP (JJS Most) (NNS cases)) (PP (IN of) (NP (NP (JJ serious) (CC or) (JJ fatal) (JJ adverse) (NNS events)) (VP (VBG involving) (NP (NP (NN Levo-Dromoran)) (VP (VBN reported) (PP (TO to) (NP (DT the) (NP (NN manufacturer)) (CC or) (NP (DT the) (NN FDA)))))))))) (VP (VBP have) (VP (VBN involved) (NP (CC either) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (NP (JJ large) (JJ initial) (NNS doses)) (CC or) (NP (ADJP (RB too) (JJ frequent)) (NNS doses))) (PP (IN of) (NP (DT the) (NN drug))))) (PP (TO to) (NP (JJ nonopioid) (JJ tolerant) (NNS patients)))) (, ,) (CC or) (NP (NP (DT the) (JJ simultaneous) (NN administration)) (PP (IN of) (NP (NP (NN levorphanol)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (VP (VBG affecting) (NP (NN respiration)))))))))))) (. .))))

amod(cases-2, Most-1)
nsubj(involved-19, cases-2)
amod(events-8, serious-4)
conj_or(serious-4, fatal-6)
amod(events-8, adverse-7)
prep_of(cases-2, events-8)
partmod(events-8, involving-9)
dobj(involving-9, Levo-Dromoran-10)
partmod(Levo-Dromoran-10, reported-11)
dep(manufacturer-14, the-13)
prep_to(reported-11, manufacturer-14)
det(FDA-17, the-16)
conj_or(manufacturer-14, FDA-17)
aux(involved-19, have-18)
root(ROOT-0, involved-19)
preconj(administration-22, either-20)
det(administration-22, the-21)
dobj(involved-19, administration-22)
amod(doses-26, large-24)
amod(doses-26, initial-25)
prep_of(administration-22, doses-26)
advmod(frequent-29, too-28)
amod(doses-30, frequent-29)
conj_or(doses-26, doses-30)
det(drug-33, the-32)
prep_of(doses-26, drug-33)
amod(patients-37, nonopioid-35)
amod(patients-37, tolerant-36)
prep_to(administration-22, patients-37)
det(administration-42, the-40)
amod(administration-42, simultaneous-41)
conj_or(administration-22, administration-42)
prep_of(administration-42, levorphanol-44)
amod(drugs-47, other-46)
prep_with(levorphanol-44, drugs-47)
partmod(drugs-47, affecting-48)
dobj(affecting-48, respiration-49)

The/DT initial/JJ dose/NN of/IN levorphanol/NN should/MD be/VB reduced/VBN by/IN approximately/RB 50/CD %/NN or/CC more/JJR when/WRB it/PRP is/VBZ given/VBN to/TO patients/NNS along/IN with/IN another/DT drug/NN affecting/VBG respiration/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ initial) (NN dose)) (PP (IN of) (NP (NN levorphanol)))) (VP (MD should) (VP (VB be) (VP (VBN reduced) (PP (IN by) (NP (NP (QP (RB approximately) (CD 50)) (NN %)) (CC or) (NP (JJR more)))) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN given) (PP (TO to) (NP (NNS patients))) (PP (IN along) (PP (IN with) (NP (NP (DT another) (NN drug)) (VP (VBG affecting) (NP (NN respiration)))))))))))))) (. .))))

det(dose-3, The-1)
amod(dose-3, initial-2)
nsubjpass(reduced-8, dose-3)
prep_of(dose-3, levorphanol-5)
aux(reduced-8, should-6)
auxpass(reduced-8, be-7)
root(ROOT-0, reduced-8)
quantmod(50-11, approximately-10)
num(%-12, 50-11)
agent(reduced-8, %-12)
conj_or(%-12, more-14)
advmod(given-18, when-15)
nsubjpass(given-18, it-16)
auxpass(given-18, is-17)
advcl(reduced-8, given-18)
prep_to(given-18, patients-20)
prepc_along_with(given-18, with-22)
det(drug-24, another-23)
pobj(given-18, drug-24)
partmod(drug-24, affecting-25)
dobj(affecting-25, respiration-26)

Interactions/NNS with/IN Mixed/JJ Agonist/NN /Antagonist/NN Opioid/NN Analgesics/NNS :/: Agonist/NN /antagonist/NN analgesics/NNS (/-LRB- eg/NN ,/, pentazocine/NN ,/, nalbuphine/NN ,/, butorphanol/NN ,/, dezocine/NN and/CC buprenorphine/NN )/-RRB- should/MD NOT/RB be/VB administered/VBN to/TO a/DT patient/NN who/WP has/VBZ received/VBN or/CC is/VBZ receiving/VBG a/DT course/NN of/IN therapy/NN with/IN a/DT pure/JJ agonist/NN opioid/NN analgesic/NN such/JJ as/IN Levo-Dromoran/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Interactions)) (PP (IN with) (NP (JJ Mixed) (NN Agonist) (NN /Antagonist) (NN Opioid) (NNS Analgesics)))) (: :) (S (NP (NP (NN Agonist) (NN /antagonist) (NNS analgesics)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN pentazocine)) (, ,) (NP (NN nalbuphine)) (, ,) (NP (NN butorphanol)) (, ,) (NP (NN dezocine)) (CC and) (NP (NN buprenorphine))) (-RRB- -RRB-))) (VP (MD should) (RB NOT) (VP (VB be) (VP (VBN administered) (PP (TO to) (NP (NP (DT a) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VP (VBZ has) (VP (VBN received))) (CC or) (VP (VBZ is) (VP (VBG receiving) (NP (NP (DT a) (NN course)) (PP (IN of) (NP (NN therapy)))) (PP (IN with) (NP (NP (DT a) (JJ pure) (NN agonist) (NN opioid) (NN analgesic)) (PP (JJ such) (IN as) (NP (NN Levo-Dromoran)))))))))))))))) (. .)))))

root(ROOT-0, Interactions-1)
amod(Analgesics-7, Mixed-3)
nn(Analgesics-7, Agonist-4)
nn(Analgesics-7, /Antagonist-5)
nn(Analgesics-7, Opioid-6)
prep_with(Interactions-1, Analgesics-7)
nn(analgesics-11, Agonist-9)
nn(analgesics-11, /antagonist-10)
nsubjpass(administered-28, analgesics-11)
dep(analgesics-11, eg-13)
conj_and(eg-13, pentazocine-15)
conj_and(eg-13, nalbuphine-17)
conj_and(eg-13, butorphanol-19)
conj_and(eg-13, dezocine-21)
conj_and(eg-13, buprenorphine-23)
aux(administered-28, should-25)
neg(administered-28, NOT-26)
auxpass(administered-28, be-27)
dep(Interactions-1, administered-28)
det(patient-31, a-30)
prep_to(administered-28, patient-31)
nsubj(received-34, patient-31)
aux(received-34, has-33)
rcmod(patient-31, received-34)
aux(receiving-37, is-36)
conj_or(received-34, receiving-37)
det(course-39, a-38)
dobj(receiving-37, course-39)
prep_of(course-39, therapy-41)
det(analgesic-47, a-43)
amod(analgesic-47, pure-44)
nn(analgesic-47, agonist-45)
nn(analgesic-47, opioid-46)
prep_with(receiving-37, analgesic-47)
prep_such_as(analgesic-47, Levo-Dromoran-50)

In/IN opioid/JJ -dependent/JJ patients/NNS ,/, mixed/JJ agonist/NN /antagonist/NN analgesics/NNS may/MD precipitate/VB withdrawal/NN symptoms/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ opioid) (JJ -dependent) (NNS patients))) (, ,) (NP (JJ mixed) (NN agonist) (NN /antagonist) (NNS analgesics)) (VP (MD may) (VP (VB precipitate) (NP (NN withdrawal) (NNS symptoms))))) (. .))))

amod(patients-4, opioid-2)
amod(patients-4, -dependent-3)
prep_in(precipitate-11, patients-4)
amod(analgesics-9, mixed-6)
nn(analgesics-9, agonist-7)
nn(analgesics-9, /antagonist-8)
nsubj(precipitate-11, analgesics-9)
aux(precipitate-11, may-10)
root(ROOT-0, precipitate-11)
nn(symptoms-13, withdrawal-12)
dobj(precipitate-11, symptoms-13)

No/DT Important/JJ Interactions/NNS To/TO Date/NN Levosimendan/NN does/VBZ not/RB have/VB clinically/RB important/JJ pharmacokinetic/JJ interactions/NNS with/IN captopril/NN ,/, beta-blockers/NN ,/, felodipine/NN ,/, digoxin/NN ,/, warfarin/NN ,/, isosorbide/NN mononitrate/NN ,/, carvedilol/NN ,/, ethanol/NN or/CC itraconazole/NN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (JJ Important) (NNS Interactions)) (PP (TO To) (NP (NN Date) (NN Levosimendan)))) (VP (VBZ does) (RB not) (VP (VB have) (NP (NP (NP (ADJP (RB clinically) (JJ important)) (JJ pharmacokinetic) (NNS interactions)) (PP (IN with) (NP (NN captopril)))) (, ,) (NP (NP (NN beta-blockers)) (, ,) (NP (NN felodipine)) (, ,) (NP (NN digoxin)) (, ,) (NP (NN warfarin)) (, ,) (NP (NN isosorbide) (NN mononitrate)) (, ,) (NP (NN carvedilol)) (, ,) (NP (NN ethanol)) (CC or) (NP (NN itraconazole))))))) (. .))))

det(Interactions-3, No-1)
amod(Interactions-3, Important-2)
nsubj(have-9, Interactions-3)
nn(Levosimendan-6, Date-5)
prep_to(Interactions-3, Levosimendan-6)
aux(have-9, does-7)
neg(have-9, not-8)
root(ROOT-0, have-9)
advmod(important-11, clinically-10)
amod(interactions-13, important-11)
amod(interactions-13, pharmacokinetic-12)
dobj(have-9, interactions-13)
prep_with(interactions-13, captopril-15)
appos(interactions-13, beta-blockers-17)
conj_or(beta-blockers-17, felodipine-19)
conj_or(beta-blockers-17, digoxin-21)
conj_or(beta-blockers-17, warfarin-23)
nn(mononitrate-26, isosorbide-25)
conj_or(beta-blockers-17, mononitrate-26)
conj_or(beta-blockers-17, carvedilol-28)
conj_or(beta-blockers-17, ethanol-30)
conj_or(beta-blockers-17, itraconazole-32)

The/DT magnitude/NN and/CC relative/JJ importance/NN of/IN the/DT effects/NNS noted/VBN below/IN are/VBP likely/JJ to/TO be/VB patient/NN specific/JJ and/CC may/MD vary/VB by/IN such/JJ factors/NNS as/IN age/NN ,/, gender/NN ,/, race/NN ,/, intercurrent/NN illnesses/NNS ,/, dose/NN of/IN either/DT agent/NN ,/, additional/JJ concomitant/JJ medications/NNS ,/, and/CC timing/NN of/IN drug/NN administration/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (DT The) (NN magnitude)) (CC and) (NP (JJ relative) (NN importance))) (PP (IN of) (NP (NP (DT the) (NNS effects)) (VP (VBN noted) (PP (IN below)))))) (VP (VBP are) (ADJP (JJ likely) (S (VP (VP (TO to) (VP (VB be) (ADJP (NN patient) (JJ specific)))) (CC and) (VP (MD may) (VP (VB vary) (PP (IN by) (NP (NP (JJ such) (NNS factors)) (PP (IN as) (NP (NP (NN age)) (, ,) (NP (NN gender)) (, ,) (NP (NN race)) (, ,) (NP (NN intercurrent) (NNS illnesses)) (, ,) (NP (NP (NN dose)) (PP (IN of) (NP (DT either) (NN agent)))) (, ,) (NP (JJ additional) (JJ concomitant) (NNS medications)) (, ,) (CC and) (NP (NP (NN timing)) (PP (IN of) (NP (NN drug) (NN administration))))))))))))))) (. .))))

det(magnitude-2, The-1)
nsubj(likely-12, magnitude-2)
amod(importance-5, relative-4)
conj_and(magnitude-2, importance-5)
det(effects-8, the-7)
prep_of(magnitude-2, effects-8)
partmod(effects-8, noted-9)
prep(noted-9, below-10)
cop(likely-12, are-11)
root(ROOT-0, likely-12)
aux(specific-16, to-13)
cop(specific-16, be-14)
dep(specific-16, patient-15)
dep(likely-12, specific-16)
aux(vary-19, may-18)
conj_and(specific-16, vary-19)
amod(factors-22, such-21)
prep_by(vary-19, factors-22)
prep_as(factors-22, age-24)
conj_and(age-24, gender-26)
conj_and(age-24, race-28)
nn(illnesses-31, intercurrent-30)
conj_and(age-24, illnesses-31)
conj_and(age-24, dose-33)
det(agent-36, either-35)
prep_of(dose-33, agent-36)
amod(medications-40, additional-38)
amod(medications-40, concomitant-39)
conj_and(age-24, medications-40)
conj_and(age-24, timing-43)
nn(administration-46, drug-45)
prep_of(timing-43, administration-46)

Any/DT agent/NN that/WDT alters/VBZ thyroid/NN hormone/NN synthesis/NN ,/, secretion/NN ,/, distribution/NN ,/, effect/NN on/IN target/NN tissues/NNS ,/, metabolism/NN ,/, or/CC elimination/NN may/MD alter/VB the/DT optimal/JJ therapeutic/JJ dose/NN of/IN levothyroxine/NN sodium/NN ./.

(ROOT (S1 (S (S (NP (NP (DT Any) (NN agent)) (SBAR (WHNP (WDT that)) (S (VP (VBZ alters) (NP (NP (NN thyroid) (NN hormone) (NN synthesis)) (, ,) (NP (NN secretion)) (, ,) (NP (NN distribution)) (, ,) (NP (NP (NN effect)) (PP (IN on) (NP (NN target) (NNS tissues)))) (, ,) (NP (NN metabolism)) (, ,) (CC or) (NP (NN elimination))))))) (VP (MD may) (VP (VB alter) (NP (NP (DT the) (JJ optimal) (JJ therapeutic) (NN dose)) (PP (IN of) (NP (NN levothyroxine) (NN sodium))))))) (. .))))

det(agent-2, Any-1)
nsubj(alters-4, agent-2)
nsubj(alter-23, agent-2)
rcmod(agent-2, alters-4)
nn(synthesis-7, thyroid-5)
nn(synthesis-7, hormone-6)
dobj(alters-4, synthesis-7)
conj_or(synthesis-7, secretion-9)
conj_or(synthesis-7, distribution-11)
conj_or(synthesis-7, effect-13)
nn(tissues-16, target-15)
prep_on(effect-13, tissues-16)
conj_or(synthesis-7, metabolism-18)
conj_or(synthesis-7, elimination-21)
aux(alter-23, may-22)
root(ROOT-0, alter-23)
det(dose-27, the-24)
amod(dose-27, optimal-25)
amod(dose-27, therapeutic-26)
dobj(alter-23, dose-27)
nn(sodium-30, levothyroxine-29)
prep_of(dose-27, sodium-30)

Levothyroxine/NN Sodium/NN Absorption/NN :/: The/DT following/JJ agents/NNS may/MD bind/VB and/CC decrease/VB absorption/NN of/IN levothyroxine/NN sodium/NN from/IN the/DT gastrointestinal/JJ tract/NN :/: aluminum/NN hydoxide/NN ,/, cholestyramine/NN resin/NN ,/, colestipol/NN hydrochloride/NN ,/, ferrous/JJ sulfate/NN ,/, sodium/NN polystyrene/NN sulfonate/NN ,/, soybean/NN flour/NN (/-LRB- e.g./FW ,/, infant/NN formula/NNS )/-RRB- ,/, sucralfate/NN ./.

(ROOT (S1 (S (NP (NP (NN Levothyroxine) (NN Sodium) (NN Absorption)) (: :) (S (NP (DT The) (JJ following) (NNS agents)) (VP (MD may) (VP (VP (VB bind)) (CC and) (VP (VB decrease) (NP (NP (NN absorption)) (PP (IN of) (NP (NN levothyroxine) (NN sodium))) (PP (IN from) (NP (DT the) (JJ gastrointestinal) (NN tract)))))))) (: :) (NP (NP (NP (NN aluminum) (NN hydoxide)) (, ,) (NP (NN cholestyramine) (NN resin)) (, ,) (NP (NN colestipol) (NN hydrochloride)) (, ,) (NP (JJ ferrous) (NN sulfate)) (, ,) (NP (NN sodium) (NN polystyrene) (NN sulfonate)) (, ,) (NP (NN soybean) (NN flour))) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN infant) (NNS formula)) (-RRB- -RRB-))) (, ,) (NP (NN sucralfate)) (. .)))))

nn(Absorption-3, Levothyroxine-1)
nn(Absorption-3, Sodium-2)
root(ROOT-0, Absorption-3)
det(agents-7, The-5)
amod(agents-7, following-6)
nsubj(bind-9, agents-7)
aux(bind-9, may-8)
dep(Absorption-3, bind-9)
conj_and(bind-9, decrease-11)
dobj(decrease-11, absorption-12)
nn(sodium-15, levothyroxine-14)
prep_of(absorption-12, sodium-15)
det(tract-19, the-17)
amod(tract-19, gastrointestinal-18)
prep_from(absorption-12, tract-19)
nn(hydoxide-22, aluminum-21)
dep(Absorption-3, hydoxide-22)
nn(resin-25, cholestyramine-24)
appos(hydoxide-22, resin-25)
nn(hydrochloride-28, colestipol-27)
appos(hydoxide-22, hydrochloride-28)
amod(sulfate-31, ferrous-30)
appos(hydoxide-22, sulfate-31)
nn(sulfonate-35, sodium-33)
nn(sulfonate-35, polystyrene-34)
appos(hydoxide-22, sulfonate-35)
nn(flour-38, soybean-37)
appos(hydoxide-22, flour-38)
dep(formula-43, e.g.-40)
nn(formula-43, infant-42)
appos(hydoxide-22, formula-43)
appos(Absorption-3, sucralfate-46)

Binding/VBG to/TO Serum/NN Proteins/NNS :/: The/DT following/VBG agents/NNS may/MD either/CC inhibit/VB levothyroxine/NN sodium/NN binding/NN to/TO serum/NN proteins/NNS or/CC alter/VB the/DT concentrations/NNS of/IN serum/NN binding/NN proteins/NNS :/: androgens/NNS and/CC related/JJ anabolic/JJ hormones/NNS ,/, asparaginase/NN ,/, clofibrate/NN ,/, estrogens/NNS and/CC estrogen-containing/JJ compounds/NNS ,/, 5-fluorouracil/NN ,/, furosemide/NN ,/, glucocorticoids/NNS ,/, meclofenamic/JJ acid/NN ,/, mefenamic/JJ acid/NN ,/, methadone/NN ,/, perphenazine/NN ,/, phenylbutazone/NN ,/, phenytoin/NN ,/, salicylates/NNS ,/, tamoxifen/NN ./.

(ROOT (S1 (S (S (VP (VBG Binding) (PP (TO to) (NP (NP (NN Serum) (NNS Proteins)) (: :) (S (NP (DT The) (VBG following) (NNS agents)) (VP (MD may) (VP (CC either) (VP (VB inhibit) (NP (NP (NN levothyroxine) (NN sodium) (NN binding)) (PP (TO to) (NP (NN serum) (NNS proteins))))) (CC or) (VP (VB alter) (NP (NP (DT the) (NNS concentrations)) (PP (IN of) (NP (NN serum) (NN binding) (NNS proteins)))))))) (: :) (NP (NNS androgens)) (CC and) (NP (NP (JJ related) (JJ anabolic) (NNS hormones)) (, ,) (NP (NN asparaginase)) (, ,) (NP (NN clofibrate)) (, ,) (NP (NNS estrogens)) (CC and) (NP (JJ estrogen-containing) (NNS compounds)) (, ,) (NP (NN 5-fluorouracil)) (, ,) (NP (NN furosemide)) (, ,) (NP (NNS glucocorticoids)) (, ,) (NP (JJ meclofenamic) (NN acid)) (, ,) (NP (JJ mefenamic) (NN acid)) (, ,) (NP (NN methadone)) (, ,) (NP (NN perphenazine)) (, ,) (NP (NN phenylbutazone)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NNS salicylates)) (, ,) (NP (NN tamoxifen))))))) (. .))))

root(ROOT-0, Binding-1)
nn(Proteins-4, Serum-3)
prep_to(Binding-1, Proteins-4)
det(agents-8, The-6)
amod(agents-8, following-7)
nsubj(inhibit-11, agents-8)
aux(inhibit-11, may-9)
preconj(inhibit-11, either-10)
conj_and(Proteins-4, inhibit-11)
nn(binding-14, levothyroxine-12)
nn(binding-14, sodium-13)
dobj(inhibit-11, binding-14)
nn(proteins-17, serum-16)
prep_to(binding-14, proteins-17)
conj_or(inhibit-11, alter-19)
det(concentrations-21, the-20)
dobj(alter-19, concentrations-21)
nn(proteins-25, serum-23)
nn(proteins-25, binding-24)
prep_of(concentrations-21, proteins-25)
conj_and(Proteins-4, androgens-27)
amod(hormones-31, related-29)
amod(hormones-31, anabolic-30)
conj_and(Proteins-4, hormones-31)
conj_and(hormones-31, asparaginase-33)
conj_and(hormones-31, clofibrate-35)
conj_and(hormones-31, estrogens-37)
amod(compounds-40, estrogen-containing-39)
conj_and(hormones-31, compounds-40)
conj_and(hormones-31, 5-fluorouracil-42)
conj_and(hormones-31, furosemide-44)
conj_and(hormones-31, glucocorticoids-46)
amod(acid-49, meclofenamic-48)
conj_and(hormones-31, acid-49)
amod(acid-52, mefenamic-51)
conj_and(hormones-31, acid-52)
conj_and(hormones-31, methadone-54)
conj_and(hormones-31, perphenazine-56)
conj_and(hormones-31, phenylbutazone-58)
conj_and(hormones-31, phenytoin-60)
conj_and(hormones-31, salicylates-62)
conj_and(hormones-31, tamoxifen-64)

Thyroid/NN Physiology/NN :/: The/DT following/VBG agents/NNS may/MD alter/VB thyroid/NN hormone/NN or/CC TSH/NN levels/NNS ,/, generally/RB by/IN effects/NNS on/IN thyroid/NN hormone/NN synthesis/NN ,/, secretion/NN ,/, distribution/NN ,/, metabolism/NN ,/, hormone/NN action/NN ,/, or/CC elimination/NN ,/, or/CC altered/JJ TSH/NN secretion/NN :/: aminoglutethimide/NN ,/, p-aminosalicylic/JJ acid/NN ,/, amiodarone/NN ,/, androgens/NNS and/CC related/JJ anabolic/JJ hormones/NNS ,/, complex/NN anions/NNS (/-LRB- thiocyanate/NN ,/, perchlorate/NN ,/, pertechnetate/NN )/-RRB- ,/, antithyroid/JJ drugs/NNS ,/, b-adrenergic/JJ blocking/NN agents/NNS ,/, carbamazepine/NN ,/, chloral/JJ hydrate/NN ,/, diazepam/NN ,/, dopamine/NN and/CC dopamine/NN agonists/NNS ,/, ethionamide/NN ,/, glucocorticoids/NNS ,/, heparin/NN ,/, hepatic/JJ enzyme/NN inducers/NNS ,/, insulin/NN ,/, iodinated/JJ cholestographic/JJ agents/NNS ,/, iodine-/JJ containing/VBG compounds/NNS ,/, levodopa/NN ,/, lovastatin/NN ,/, lithium/NN ,/, 6-mercaptopurine/NN ,/, metoclopramide/NN ,/, mitotane/NN ,/, nitroprusside/NN ,/, phenobarbital/NN ,/, phenytoin/NN ,/, resorcinol/JJ ,/, rifampin/NN ,/, somatostatin/NN analogs/NNS ,/, sulfonamides/NNS ,/, sulfonylureas/NN ,/, thiazide/NN diuretics/NNS ./.

(ROOT (S1 (S (NP (NP (NN Thyroid) (NN Physiology)) (: :) (S (NP (DT The) (VBG following) (NNS agents)) (VP (MD may) (VP (VB alter) (NP (NN thyroid) (NN hormone) (CC or) (NN TSH) (NNS levels)) (, ,) (ADVP (RB generally)) (PP (IN by) (NP (NP (NP (NP (NNS effects)) (PP (IN on) (NP (NN thyroid) (NN hormone) (NN synthesis)))) (, ,) (NP (NN secretion)) (, ,) (NP (NN distribution)) (, ,) (NP (NN metabolism)) (, ,) (NP (NN hormone) (NN action)) (, ,) (CC or) (NP (NN elimination)) (, ,) (CC or) (NP (JJ altered) (NN TSH) (NN secretion))) (: :) (NP (NP (NN aminoglutethimide)) (, ,) (NP (JJ p-aminosalicylic) (NN acid)) (, ,) (NP (NN amiodarone)) (, ,) (NP (NNS androgens)) (CC and) (NP (NP (JJ related) (JJ anabolic) (NNS hormones)) (, ,) (NP (NP (NN complex) (NNS anions)) (PRN (-LRB- -LRB-) (NP (NN thiocyanate)) (, ,) (NP (NN perchlorate)) (, ,) (NP (NN pertechnetate)) (-RRB- -RRB-) (, ,) (NP (JJ antithyroid) (NNS drugs)) (, ,) (NP (NP (NP (NP (NP (NP (NP (NP (NP (NP (JJ b-adrenergic) (NN blocking) (NNS agents)) (, ,) (NP (NN carbamazepine)) (, ,) (NP (NP (JJ chloral) (NN hydrate) (, ,) (NN diazepam) (, ,) (NN dopamine) (CC and) (NN dopamine) (NNS agonists)) (, ,) (NP (NN ethionamide)) (, ,) (NP (NNS glucocorticoids)) (, ,) (NP (NN heparin)) (, ,) (NP (JJ hepatic) (NN enzyme) (NNS inducers)) (, ,))) (NN insulin)) (, ,) (NP (JJ iodinated) (JJ cholestographic) (NNS agents)) (, ,)) (JJ iodine-)) (VP (VBG containing) (NP (NNS compounds)))) (, ,) (NP (NN levodopa)) (, ,) (NP (NN lovastatin)) (, ,) (NP (NN lithium)) (, ,) (NP (NN 6-mercaptopurine)) (, ,) (NP (NN metoclopramide)) (, ,) (NP (NN mitotane)) (, ,) (NP (NN nitroprusside)) (, ,) (NP (NN phenobarbital)) (, ,) (NP (NN phenytoin)) (, ,)) (ADJP (JJ resorcinol))) (, ,) (NP (NP (NN rifampin)) (, ,) (NP (NN somatostatin) (NNS analogs)) (, ,) (NP (NNS sulfonamides))) (, ,)) (NN sulfonylureas)))) (, ,) (NP (NN thiazide) (NNS diuretics))))))))) (. .)))))

nn(Physiology-2, Thyroid-1)
root(ROOT-0, Physiology-2)
det(agents-6, The-4)
amod(agents-6, following-5)
nsubj(alter-8, agents-6)
aux(alter-8, may-7)
dep(Physiology-2, alter-8)
nn(hormone-10, thyroid-9)
dobj(alter-8, hormone-10)
nn(levels-13, TSH-12)
conj_or(hormone-10, levels-13)
advmod(alter-8, generally-15)
prep_by(alter-8, effects-17)
nn(synthesis-21, thyroid-19)
nn(synthesis-21, hormone-20)
prep_on(effects-17, synthesis-21)
conj_or(effects-17, secretion-23)
conj_or(effects-17, distribution-25)
conj_or(effects-17, metabolism-27)
nn(action-30, hormone-29)
conj_or(effects-17, action-30)
conj_or(effects-17, elimination-33)
amod(secretion-38, altered-36)
nn(secretion-38, TSH-37)
conj_or(effects-17, secretion-38)
dep(effects-17, aminoglutethimide-40)
amod(acid-43, p-aminosalicylic-42)
conj_and(aminoglutethimide-40, acid-43)
conj_and(aminoglutethimide-40, amiodarone-45)
conj_and(aminoglutethimide-40, androgens-47)
amod(hormones-51, related-49)
amod(hormones-51, anabolic-50)
conj_and(aminoglutethimide-40, hormones-51)
nn(anions-54, complex-53)
appos(hormones-51, anions-54)
appos(anions-54, thiocyanate-56)
dep(thiocyanate-56, perchlorate-58)
dep(thiocyanate-56, pertechnetate-60)
amod(drugs-64, antithyroid-63)
dep(thiocyanate-56, drugs-64)
amod(agents-68, b-adrenergic-66)
nn(agents-68, blocking-67)
nn(insulin-92, agents-68)
appos(agents-68, carbamazepine-70)
amod(agonists-80, chloral-72)
nn(agonists-80, hydrate-73)
conj_and(hydrate-73, diazepam-75)
conj_and(hydrate-73, dopamine-77)
conj_and(hydrate-73, dopamine-79)
appos(agents-68, agonists-80)
appos(agonists-80, ethionamide-82)
appos(agonists-80, glucocorticoids-84)
appos(agonists-80, heparin-86)
amod(inducers-90, hepatic-88)
nn(inducers-90, enzyme-89)
appos(agonists-80, inducers-90)
nn(sulfonylureas-129, insulin-92)
amod(agents-96, iodinated-94)
amod(agents-96, cholestographic-95)
appos(insulin-92, agents-96)
amod(insulin-92, iodine--98)
partmod(insulin-92, containing-99)
dobj(containing-99, compounds-100)
appos(insulin-92, levodopa-102)
appos(insulin-92, lovastatin-104)
appos(insulin-92, lithium-106)
appos(insulin-92, 6-mercaptopurine-108)
appos(insulin-92, metoclopramide-110)
appos(insulin-92, mitotane-112)
appos(insulin-92, nitroprusside-114)
appos(insulin-92, phenobarbital-116)
appos(insulin-92, phenytoin-118)
amod(insulin-92, resorcinol-120)
appos(insulin-92, rifampin-122)
nn(analogs-125, somatostatin-124)
appos(rifampin-122, analogs-125)
appos(rifampin-122, sulfonamides-127)
dep(thiocyanate-56, sulfonylureas-129)
nn(diuretics-132, thiazide-131)
appos(hormones-51, diuretics-132)

Adrenocorticoids/NNS :/: Metabolic/JJ clearance/NN of/IN adrenocorticoids/NNS is/VBZ decreased/VBN in/IN hypothyroid/JJ patients/NNS and/CC increased/VBN in/IN hyperthyroid/JJ patients/NNS ,/, and/CC may/MD therefore/RB change/VB with/IN changing/VBG thyroid/NN status/NN ./.

(ROOT (S1 (S (NP (NP (NNS Adrenocorticoids)) (: :) (S (NP (NP (JJ Metabolic) (NN clearance)) (PP (IN of) (NP (NNS adrenocorticoids)))) (VP (VP (VBZ is) (VP (VP (VBN decreased) (PP (IN in) (NP (JJ hypothyroid) (NNS patients)))) (CC and) (VP (VBN increased) (PP (IN in) (NP (JJ hyperthyroid) (NNS patients)))))) (, ,) (CC and) (VP (MD may) (ADVP (RB therefore)) (VP (VB change) (PP (IN with) (S (VP (VBG changing) (NP (NN thyroid) (NN status))))))))) (. .)))))

root(ROOT-0, Adrenocorticoids-1)
amod(clearance-4, Metabolic-3)
nsubjpass(decreased-8, clearance-4)
prep_of(clearance-4, adrenocorticoids-6)
auxpass(decreased-8, is-7)
dep(Adrenocorticoids-1, decreased-8)
amod(patients-11, hypothyroid-10)
prep_in(decreased-8, patients-11)
conj_and(decreased-8, increased-13)
amod(patients-16, hyperthyroid-15)
prep_in(increased-13, patients-16)
aux(change-21, may-19)
advmod(change-21, therefore-20)
conj_and(decreased-8, change-21)
prepc_with(change-21, changing-23)
nn(status-25, thyroid-24)
dobj(changing-23, status-25)

Amiodarone/NN :/: Amiodarone/NN therapy/NN alone/RB can/MD cause/VB hypothyroidism/NN or/CC hyperthyroidism/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Amiodarone) (: :) (NN Amiodarone) (NN therapy)) (ADVP (RB alone))) (VP (MD can) (VP (VB cause) (NP (NP (NN hypothyroidism)) (CC or) (NP (NN hyperthyroidism)))))) (. .))))

nn(therapy-4, Amiodarone-1)
nn(therapy-4, Amiodarone-3)
nsubj(cause-7, therapy-4)
advmod(therapy-4, alone-5)
aux(cause-7, can-6)
root(ROOT-0, cause-7)
dobj(cause-7, hypothyroidism-8)
conj_or(hypothyroidism-8, hyperthyroidism-10)

Anticoagulants/NNS (/-LRB- Oral/JJ )/-RRB- :/: The/DT hypoprothrombinemic/JJ effect/NN of/IN anticoagulants/NNS may/MD be/VB potentiated/VBN ,/, apparently/RB by/IN increased/VBN catabloism/NN of/IN vitamin/NN K/NN -dependent/JJ clotting/NN factors/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NNS Anticoagulants)) (PRN (-LRB- -LRB-) (NP (JJ Oral)) (-RRB- -RRB-))) (: :) (S (NP (NP (DT The) (JJ hypoprothrombinemic) (NN effect)) (PP (IN of) (NP (NNS anticoagulants)))) (VP (MD may) (VP (VB be) (VP (VBN potentiated) (, ,) (ADVP (RB apparently)) (PP (IN by) (NP (NP (VBN increased) (NN catabloism)) (PP (IN of) (NP (ADJP (NN vitamin) (NN K) (JJ -dependent)) (NN clotting) (NNS factors))))))))) (. .)))))

root(ROOT-0, Anticoagulants-1)
dep(Anticoagulants-1, Oral-3)
det(effect-8, The-6)
amod(effect-8, hypoprothrombinemic-7)
nsubjpass(potentiated-13, effect-8)
prep_of(effect-8, anticoagulants-10)
aux(potentiated-13, may-11)
auxpass(potentiated-13, be-12)
dep(Anticoagulants-1, potentiated-13)
advmod(potentiated-13, apparently-15)
amod(catabloism-18, increased-17)
agent(potentiated-13, catabloism-18)
dep(-dependent-22, vitamin-20)
dep(-dependent-22, K-21)
amod(factors-24, -dependent-22)
nn(factors-24, clotting-23)
prep_of(catabloism-18, factors-24)

Antidiabetic/JJ Agents/NNS (/-LRB- Insulin/NN ,/, Sulfonylureas/NN )/-RRB- :/: Requirements/NNS for/IN insulin/NN or/CC oral/JJ antidiabetic/JJ agents/NNS may/MD be/VB reduced/VBN in/IN hypothyroid/JJ patients/NNS with/IN diabetes/NN mellitus/NN and/CC may/MD subsequently/RB increase/VB with/IN the/DT initiation/NN of/IN thyroid/NN hormone/NN replacement/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Antidiabetic) (NNS Agents)) (PRN (-LRB- -LRB-) (NP (NP (NN Insulin)) (, ,) (NP (NN Sulfonylureas))) (-RRB- -RRB-))) (: :) (NP (NP (NNS Requirements)) (PP (IN for) (NP (NP (NN insulin)) (CC or) (NP (JJ oral) (JJ antidiabetic) (NNS agents)))))) (VP (VP (MD may) (VP (VB be) (VP (VBN reduced) (PP (IN in) (NP (NP (JJ hypothyroid) (NNS patients)) (PP (IN with) (NP (NN diabetes) (NN mellitus)))))))) (CC and) (VP (MD may) (ADVP (RB subsequently)) (VP (VB increase) (PP (IN with) (NP (NP (DT the) (NN initiation)) (PP (IN of) (NP (NN thyroid) (NN hormone) (NN replacement) (NN therapy))))))))) (. .))))

amod(Agents-2, Antidiabetic-1)
nsubjpass(reduced-18, Agents-2)
dep(Agents-2, Insulin-4)
appos(Insulin-4, Sulfonylureas-6)
dep(Agents-2, Requirements-9)
prep_for(Requirements-9, insulin-11)
amod(agents-15, oral-13)
amod(agents-15, antidiabetic-14)
conj_or(insulin-11, agents-15)
aux(reduced-18, may-16)
auxpass(reduced-18, be-17)
root(ROOT-0, reduced-18)
amod(patients-21, hypothyroid-20)
prep_in(reduced-18, patients-21)
nn(mellitus-24, diabetes-23)
prep_with(patients-21, mellitus-24)
aux(increase-28, may-26)
advmod(increase-28, subsequently-27)
conj_and(reduced-18, increase-28)
det(initiation-31, the-30)
prep_with(increase-28, initiation-31)
nn(therapy-36, thyroid-33)
nn(therapy-36, hormone-34)
nn(therapy-36, replacement-35)
prep_of(initiation-31, therapy-36)

b-Adrenergic/JJ Blocking/NN Agents/NNS :/: Actions/NNS of/IN some/DT of/IN beta-blocking/JJ agent/NN s/NNS may/MD be/VB impaired/VBN when/WRB hypothyroid/JJ patients/NNS become/VBP euthyroid/JJ ./.

(ROOT (S1 (S (S (NP (NP (JJ b-Adrenergic) (NN Blocking) (NNS Agents)) (: :) (NP (NP (NNS Actions)) (PP (IN of) (NP (NP (DT some)) (PP (IN of) (NP (JJ beta-blocking) (NN agent) (NNS s))))))) (VP (MD may) (VP (VB be) (VP (VBN impaired) (SBAR (WHADVP (WRB when)) (S (NP (JJ hypothyroid) (NNS patients)) (VP (VBP become) (ADJP (JJ euthyroid))))))))) (. .))))

amod(Agents-3, b-Adrenergic-1)
nn(Agents-3, Blocking-2)
nsubjpass(impaired-14, Agents-3)
dep(Agents-3, Actions-5)
prep_of(Actions-5, some-7)
amod(s-11, beta-blocking-9)
nn(s-11, agent-10)
prep_of(some-7, s-11)
aux(impaired-14, may-12)
auxpass(impaired-14, be-13)
root(ROOT-0, impaired-14)
advmod(euthyroid-19, when-15)
amod(patients-17, hypothyroid-16)
nsubj(euthyroid-19, patients-17)
cop(euthyroid-19, become-18)
advcl(impaired-14, euthyroid-19)

Cytokines/NNS (/-LRB- interferon/NN ,/, interleukin/NN )/-RRB- :/: Cytokines/NNS have/VBP been/VBN reported/VBN to/TO induce/VB both/CC hyperthyroidism/NN and/CC hypothyroidism/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Cytokines)) (PRN (-LRB- -LRB-) (NP (NP (NN interferon)) (, ,) (NP (NN interleukin))) (-RRB- -RRB-))) (: :) (NP (NNS Cytokines))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB induce) (NP (CC both) (NP (NN hyperthyroidism)) (CC and) (NP (NN hypothyroidism)))))))))) (. .))))

nsubjpass(reported-11, Cytokines-1)
xsubj(induce-13, Cytokines-1)
dep(Cytokines-1, interferon-3)
appos(interferon-3, interleukin-5)
dep(Cytokines-1, Cytokines-8)
aux(reported-11, have-9)
auxpass(reported-11, been-10)
root(ROOT-0, reported-11)
aux(induce-13, to-12)
xcomp(reported-11, induce-13)
preconj(hyperthyroidism-15, both-14)
dobj(induce-13, hyperthyroidism-15)
conj_and(hyperthyroidism-15, hypothyroidism-17)

Digitalis/NN Glycosides/NNS :/: Therapeutic/JJ effects/NNS of/IN digitalis/NN glycosides/NNS may/MD be/VB reduced/VBN ./.

(ROOT (S1 (S (NP (NP (NN Digitalis) (NNS Glycosides)) (: :) (S (NP (NP (JJ Therapeutic) (NNS effects)) (PP (IN of) (NP (NN digitalis) (NNS glycosides)))) (VP (MD may) (VP (VB be) (VP (VBN reduced))))) (. .)))))

nn(Glycosides-2, Digitalis-1)
root(ROOT-0, Glycosides-2)
amod(effects-5, Therapeutic-4)
nsubjpass(reduced-11, effects-5)
nn(glycosides-8, digitalis-7)
prep_of(effects-5, glycosides-8)
aux(reduced-11, may-9)
auxpass(reduced-11, be-10)
dep(Glycosides-2, reduced-11)

Ketamine/NN :/: Marked/JJ hypertension/NN and/CC tachycardia/NN have/VBP been/VBN reported/VBN in/IN association/NN with/IN concomitant/JJ administration/NN of/IN levothyroxine/NN sodium/NN and/CC ketamine/NN ./.

(ROOT (S1 (S (NP (NP (NN Ketamine)) (: :) (S (NP (JJ Marked) (NP (NP (NN hypertension)) (CC and) (NP (NN tachycardia)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NN association)) (PP (IN with) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN levothyroxine) (NP (NP (NN sodium)) (CC and) (NP (NN ketamine))))))))))))) (. .)))))

root(ROOT-0, Ketamine-1)
amod(hypertension-4, Marked-3)
nsubjpass(reported-9, hypertension-4)
conj_and(hypertension-4, tachycardia-6)
aux(reported-9, have-7)
auxpass(reported-9, been-8)
dep(Ketamine-1, reported-9)
prep_in(reported-9, association-11)
amod(administration-14, concomitant-13)
prep_with(association-11, administration-14)
prep_of(administration-14, levothyroxine-16)
dep(levothyroxine-16, sodium-17)
conj_and(sodium-17, ketamine-19)

Maprotiline/NN :/: Risk/NN of/IN cardiac/JJ arrhythmias/NNS may/MD increase/VB ./.

(ROOT (S1 (S (S (NP (NP (NN Maprotiline) (: :) (NN Risk)) (PP (IN of) (NP (JJ cardiac) (NNS arrhythmias)))) (VP (MD may) (VP (VB increase)))) (. .))))

nn(Risk-3, Maprotiline-1)
nsubj(increase-8, Risk-3)
amod(arrhythmias-6, cardiac-5)
prep_of(Risk-3, arrhythmias-6)
aux(increase-8, may-7)
root(ROOT-0, increase-8)

Sodium/NN Iodide/NN (/-LRB- 123I/NN and/CC 131I/NN )/-RRB- ,/, Sodium/NN Pertechnetate/NN Tc99m/NN :/: Uptake/NN of/IN radiolabeled/VBN ions/NNS may/MD be/VB decreased/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Sodium) (NN Iodide)) (PRN (-LRB- -LRB-) (NP (NP (NN 123I)) (CC and) (NP (NN 131I))) (-RRB- -RRB-))) (, ,) (NP (NN Sodium) (NN Pertechnetate) (NN Tc99m)) (: :) (NP (NP (NN Uptake)) (PP (IN of) (NP (VBN radiolabeled) (NNS ions))))) (VP (MD may) (VP (VB be) (VP (VBN decreased))))) (. .))))

nn(Iodide-2, Sodium-1)
nsubjpass(decreased-19, Iodide-2)
dep(Iodide-2, 123I-4)
conj_and(123I-4, 131I-6)
nn(Tc99m-11, Sodium-9)
nn(Tc99m-11, Pertechnetate-10)
appos(Iodide-2, Tc99m-11)
dep(Iodide-2, Uptake-13)
amod(ions-16, radiolabeled-15)
prep_of(Uptake-13, ions-16)
aux(decreased-19, may-17)
auxpass(decreased-19, be-18)
root(ROOT-0, decreased-19)

Somatrem/NN //: Somatropin/NN :/: Excessive/JJ concurrent/JJ use/NN of/IN thyroid/NN hormone/NN may/MD accelerate/VB epiphyseal/JJ closure/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Somatrem)) (: /) (NP (NN Somatropin)) (: :) (NP (NP (JJ Excessive) (JJ concurrent) (NN use)) (PP (IN of) (NP (NN thyroid) (NN hormone))))) (VP (MD may) (VP (VB accelerate) (NP (JJ epiphyseal) (NN closure))))) (. .))))

nsubj(accelerate-12, Somatrem-1)
punct(Somatrem-1, /-2)
dep(Somatrem-1, Somatropin-3)
amod(use-7, Excessive-5)
amod(use-7, concurrent-6)
dep(Somatrem-1, use-7)
nn(hormone-10, thyroid-9)
prep_of(use-7, hormone-10)
aux(accelerate-12, may-11)
root(ROOT-0, accelerate-12)
amod(closure-14, epiphyseal-13)
dobj(accelerate-12, closure-14)

Untreated/JJ hypothyroidism/NN may/MD interfere/VB with/IN the/DT growth/NN response/NN to/TO somatrem/NN or/CC somatropin/NN ./.

(ROOT (S1 (S (S (NP (JJ Untreated) (NN hypothyroidism)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN growth) (NN response)) (PP (TO to) (NP (NP (NN somatrem)) (CC or) (NP (NN somatropin))))))))) (. .))))

amod(hypothyroidism-2, Untreated-1)
nsubj(interfere-4, hypothyroidism-2)
aux(interfere-4, may-3)
root(ROOT-0, interfere-4)
det(response-8, the-6)
nn(response-8, growth-7)
prep_with(interfere-4, response-8)
prep_to(response-8, somatrem-10)
conj_or(somatrem-10, somatropin-12)

Theophylline/NN :/: Theophylline/NN clearance/NN may/MD decrease/VB in/IN hypothyroid/JJ patients/NNS and/CC return/NN toward/IN normal/JJ when/WRB a/DT euthyroid/JJ state/NN is/VBZ achieved/VBN ./.

(ROOT (S1 (S (NP (NP (NN Theophylline)) (: :) (S (NP (NN Theophylline) (NN clearance)) (VP (MD may) (VP (VB decrease) (PP (IN in) (NP (NP (JJ hypothyroid) (NNS patients)) (CC and) (NP (NN return)))) (PP (IN toward) (NP (JJ normal)))) (SBAR (WHADVP (WRB when)) (S (NP (DT a) (JJ euthyroid) (NN state)) (VP (VBZ is) (VP (VBN achieved))))))) (. .)))))

root(ROOT-0, Theophylline-1)
nn(clearance-4, Theophylline-3)
nsubj(decrease-6, clearance-4)
aux(decrease-6, may-5)
dep(Theophylline-1, decrease-6)
amod(patients-9, hypothyroid-8)
prep_in(decrease-6, patients-9)
conj_and(patients-9, return-11)
prep_toward(decrease-6, normal-13)
advmod(achieved-19, when-14)
det(state-17, a-15)
amod(state-17, euthyroid-16)
nsubjpass(achieved-19, state-17)
auxpass(achieved-19, is-18)
advcl(decrease-6, achieved-19)

Tricyclic/JJ Antidepressants/NNS :/: Concurrent/JJ use/NN may/MD increase/VB the/DT therapeutic/JJ and/CC toxic/JJ effects/NNS of/IN both/DT drugs/NNS ,/, possibly/RB due/JJ to/TO increased/VBN catecholamine/NN sensitivity/NN ./.

(ROOT (S1 (S (NP (NP (JJ Tricyclic) (NNS Antidepressants)) (: :) (S (NP (JJ Concurrent) (NN use)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (ADJP (ADJP (JJ therapeutic)) (CC and) (ADJP (JJ toxic))) (NNS effects)) (PP (IN of) (NP (DT both) (NNS drugs)))) (, ,) (PP (ADVP (RB possibly)) (JJ due) (TO to) (NP (VBN increased) (NN catecholamine) (NN sensitivity)))))) (. .)))))

amod(Antidepressants-2, Tricyclic-1)
root(ROOT-0, Antidepressants-2)
amod(use-5, Concurrent-4)
nsubj(increase-7, use-5)
aux(increase-7, may-6)
dep(Antidepressants-2, increase-7)
det(effects-12, the-8)
amod(effects-12, therapeutic-9)
conj_and(therapeutic-9, toxic-11)
dobj(increase-7, effects-12)
det(drugs-15, both-14)
prep_of(effects-12, drugs-15)
advmod(increase-7, possibly-17)
amod(sensitivity-22, increased-20)
nn(sensitivity-22, catecholamine-21)
prep_due_to(increase-7, sensitivity-22)

Onset/NN of/IN action/NN of/IN tricyclics/NNS may/MD be/VB accelerated/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Onset)) (PP (IN of) (NP (NP (NN action)) (PP (IN of) (NP (NNS tricyclics)))))) (VP (MD may) (VP (VB be) (VP (VBN accelerated))))) (. .))))

nsubjpass(accelerated-8, Onset-1)
prep_of(Onset-1, action-3)
prep_of(action-3, tricyclics-5)
aux(accelerated-8, may-6)
auxpass(accelerated-8, be-7)
root(ROOT-0, accelerated-8)

Sympathomimetic/JJ Agents/NNS :/: Possible/JJ increased/VBN risk/NN of/IN coronary/JJ insufficiency/NN in/IN patients/NNS with/IN coronary/JJ artery/NN disease/NN ./.

(ROOT (S1 (S (NP (NP (JJ Sympathomimetic) (NNS Agents)) (: :) (NP (NP (JJ Possible) (VBN increased) (NN risk)) (PP (IN of) (NP (JJ coronary) (NN insufficiency))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ coronary) (NN artery) (NN disease)))))) (. .)))))

amod(Agents-2, Sympathomimetic-1)
root(ROOT-0, Agents-2)
amod(risk-6, Possible-4)
amod(risk-6, increased-5)
dep(Agents-2, risk-6)
amod(insufficiency-9, coronary-8)
prep_of(risk-6, insufficiency-9)
prep_in(risk-6, patients-11)
amod(disease-15, coronary-13)
nn(disease-15, artery-14)
prep_with(patients-11, disease-15)

The/DT administration/NN of/IN local/JJ anesthetic/JJ solutions/NNS containing/VBG epinephrine/NN or/CC norepinephrine/NN to/TO patients/NNS receiving/VBG monoamine/NN oxidase/NN inhibitors/NNS or/CC tricyclic/JJ antidepressants/NNS may/MD produce/VB severe/JJ ,/, prolonged/JJ hypertension/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NP (JJ local) (JJ anesthetic) (NNS solutions)) (VP (VBG containing) (NP (NP (NN epinephrine)) (CC or) (NP (NN norepinephrine))) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN monoamine) (NN oxidase) (NNS inhibitors)) (CC or) (NP (JJ tricyclic) (NNS antidepressants)))))))))) (VP (MD may) (VP (VB produce) (NP (ADJP (ADJP (JJ severe)) (, ,) (ADJP (JJ prolonged))) (NN hypertension))))) (. .))))

det(administration-2, The-1)
nsubj(produce-21, administration-2)
amod(solutions-6, local-4)
amod(solutions-6, anesthetic-5)
prep_of(administration-2, solutions-6)
partmod(solutions-6, containing-7)
dobj(containing-7, epinephrine-8)
conj_or(epinephrine-8, norepinephrine-10)
prep_to(containing-7, patients-12)
partmod(patients-12, receiving-13)
nn(inhibitors-16, monoamine-14)
nn(inhibitors-16, oxidase-15)
dobj(receiving-13, inhibitors-16)
amod(antidepressants-19, tricyclic-18)
conj_or(inhibitors-16, antidepressants-19)
aux(produce-21, may-20)
root(ROOT-0, produce-21)
amod(hypertension-25, severe-22)
dep(severe-22, prolonged-24)
dobj(produce-21, hypertension-25)

Phenothiazines/NNS and/CC butyrophenones/NNS may/MD reduce/VB or/CC reverse/VB the/DT pressor/JJ effect/NN of/IN epinephrine/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Phenothiazines)) (CC and) (NP (NNS butyrophenones))) (VP (MD may) (VP (VP (VB reduce)) (CC or) (VP (VB reverse) (NP (NP (DT the) (JJ pressor) (NN effect)) (PP (IN of) (NP (NN epinephrine)))))))) (. .))))

nsubj(reduce-5, Phenothiazines-1)
conj_and(Phenothiazines-1, butyrophenones-3)
aux(reduce-5, may-4)
root(ROOT-0, reduce-5)
conj_or(reduce-5, reverse-7)
det(effect-10, the-8)
amod(effect-10, pressor-9)
dobj(reverse-7, effect-10)
prep_of(effect-10, epinephrine-12)

Concurrent/JJ administration/NN of/IN vasopressor/JJ drugs/NNS (/-LRB- for/IN the/DT treatment/NN of/IN hypotension/NN related/JJ to/TO obstetric/JJ blocks/NNS )/-RRB- and/CC ergot-type/JJ oxytocic/JJ drugs/NNS may/MD cause/VB severe/JJ ,/, persistent/JJ hypertension/NN or/CC cerebrovascular/JJ accidents/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concurrent) (NN administration)) (PP (IN of) (NP (NP (NP (JJ vasopressor) (NNS drugs)) (PRN (-LRB- -LRB-) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN hypotension))) (ADJP (JJ related) (PP (TO to) (NP (JJ obstetric) (NNS blocks)))))) (-RRB- -RRB-))) (CC and) (NP (JJ ergot-type) (JJ oxytocic) (NNS drugs))))) (VP (MD may) (VP (VB cause) (NP (NP (JJ severe) (, ,) (JJ persistent) (NN hypertension)) (CC or) (NP (JJ cerebrovascular) (NN accidents)))))) (. .))))

amod(administration-2, Concurrent-1)
nsubj(cause-22, administration-2)
amod(drugs-5, vasopressor-4)
prep_of(administration-2, drugs-5)
dep(drugs-5, for-7)
det(treatment-9, the-8)
pobj(for-7, treatment-9)
prep_of(treatment-9, hypotension-11)
amod(treatment-9, related-12)
amod(blocks-15, obstetric-14)
prep_to(related-12, blocks-15)
amod(drugs-20, ergot-type-18)
amod(drugs-20, oxytocic-19)
conj_and(drugs-5, drugs-20)
aux(cause-22, may-21)
root(ROOT-0, cause-22)
amod(hypertension-26, severe-23)
amod(hypertension-26, persistent-25)
dobj(cause-22, hypertension-26)
amod(accidents-29, cerebrovascular-28)
conj_or(hypertension-26, accidents-29)

Lincomycin/NN has/VBZ been/VBN shown/VBN to/TO have/VBP neuromuscular/JJ blocking/NN properties/NNS that/WDT may/MD enhance/VB the/DT action/NN of/IN other/JJ neuromuscular/NN blocking/VBG agents/NNS ./.

(ROOT (S1 (S (S (NP (NN Lincomycin)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VBP have) (NP (NP (JJ neuromuscular) (NN blocking) (NNS properties)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (JJ other) (NN neuromuscular) (VBG blocking) (NNS agents)))))))))))))))) (. .))))

nsubjpass(shown-4, Lincomycin-1)
xsubj(have-6, Lincomycin-1)
aux(shown-4, has-2)
auxpass(shown-4, been-3)
root(ROOT-0, shown-4)
aux(have-6, to-5)
xcomp(shown-4, have-6)
amod(properties-9, neuromuscular-7)
nn(properties-9, blocking-8)
dobj(have-6, properties-9)
nsubj(enhance-12, properties-9)
aux(enhance-12, may-11)
rcmod(properties-9, enhance-12)
det(action-14, the-13)
dobj(enhance-12, action-14)
amod(agents-19, other-16)
nn(agents-19, neuromuscular-17)
amod(agents-19, blocking-18)
prep_of(action-14, agents-19)

Antagonism/NN between/IN lincomycin/NN and/CC erythromycin/NN in/IN vitro/FW has/VBZ been/VBN demonstrated/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Antagonism)) (PP (IN between) (NP (NP (NN lincomycin)) (CC and) (NP (NN erythromycin)))) (PP (IN in) (NP (FW vitro)))) (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated))))) (. .))))

nsubjpass(demonstrated-10, Antagonism-1)
prep_between(Antagonism-1, lincomycin-3)
conj_and(lincomycin-3, erythromycin-5)
prep_in(Antagonism-1, vitro-7)
aux(demonstrated-10, has-8)
auxpass(demonstrated-10, been-9)
root(ROOT-0, demonstrated-10)

Because/IN of/IN possible/JJ clinical/JJ significance/NN ,/, the/DT two/CD drugs/NNS should/MD not/RB be/VB administered/VBN concurrently/RB ./.

(ROOT (S1 (S (S (PP (IN Because) (PP (IN of) (NP (JJ possible) (JJ clinical) (NN significance)))) (, ,) (NP (DT the) (CD two) (NNS drugs)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (ADVP (RB concurrently)))))) (. .))))

prepc_because_of(administered-13, of-2)
amod(significance-5, possible-3)
amod(significance-5, clinical-4)
pobj(administered-13, significance-5)
det(drugs-9, the-7)
num(drugs-9, two-8)
nsubjpass(administered-13, drugs-9)
aux(administered-13, should-10)
neg(administered-13, not-11)
auxpass(administered-13, be-12)
root(ROOT-0, administered-13)
advmod(administered-13, concurrently-14)

Monoamine/NN Oxidase/NN Inhibition/NN :/: Linezolid/NN is/VBZ a/DT reversible/JJ ,/, nonselective/JJ inhibitor/NN of/IN monoamine/NN oxidase/NN ./.

(ROOT (S1 (S (NP (NP (NN Monoamine) (NN Oxidase) (NN Inhibition)) (: :) (S (NP (NN Linezolid)) (VP (VBZ is) (NP (NP (DT a) (ADJP (ADJP (JJ reversible)) (, ,) (ADJP (JJ nonselective))) (NN inhibitor)) (PP (IN of) (NP (NN monoamine) (NN oxidase)))))) (. .)))))

nn(Inhibition-3, Monoamine-1)
nn(Inhibition-3, Oxidase-2)
root(ROOT-0, Inhibition-3)
nsubj(inhibitor-11, Linezolid-5)
cop(inhibitor-11, is-6)
det(inhibitor-11, a-7)
amod(inhibitor-11, reversible-8)
dep(reversible-8, nonselective-10)
dep(Inhibition-3, inhibitor-11)
nn(oxidase-14, monoamine-13)
prep_of(inhibitor-11, oxidase-14)

Therefore/RB ,/, linezolid/NN has/VBZ the/DT potential/NN for/IN interaction/NN with/IN adrenergic/JJ and/CC serotonergic/JJ agents/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NN linezolid)) (VP (VBZ has) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (NN interaction)) (PP (IN with) (NP (ADJP (ADJP (JJ adrenergic)) (CC and) (ADJP (JJ serotonergic))) (NNS agents)))))))) (. .))))

advmod(has-4, Therefore-1)
nsubj(has-4, linezolid-3)
root(ROOT-0, has-4)
det(potential-6, the-5)
dobj(has-4, potential-6)
prep_for(potential-6, interaction-8)
amod(agents-13, adrenergic-10)
conj_and(adrenergic-10, serotonergic-12)
prep_with(interaction-8, agents-13)

Adrenergic/JJ Agents/NNS :/: Some/DT individuals/NNS receiving/VBG ZYVOX/NN may/MD experience/VBP a/DT reversible/JJ enhancement/NN of/IN the/DT pressor/JJ response/NN to/TO indirect-acting/JJ sympathomimetic/JJ agents/NNS ,/, vasopressor/NN or/CC dopaminergic/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Adrenergic) (NNS Agents)) (: :) (NP (NP (DT Some) (NNS individuals)) (VP (VBG receiving) (NP (NN ZYVOX))))) (VP (MD may) (VP (VBP experience) (NP (NP (DT a) (JJ reversible) (NN enhancement)) (PP (IN of) (NP (NP (DT the) (JJ pressor) (NN response)) (PP (TO to) (NP (NP (JJ indirect-acting) (JJ sympathomimetic) (NNS agents)) (, ,) (NP (NN vasopressor)) (CC or) (NP (JJ dopaminergic) (NNS agents)))))))))) (. .))))

amod(Agents-2, Adrenergic-1)
nsubj(experience-9, Agents-2)
det(individuals-5, Some-4)
dep(Agents-2, individuals-5)
partmod(individuals-5, receiving-6)
dobj(receiving-6, ZYVOX-7)
aux(experience-9, may-8)
root(ROOT-0, experience-9)
det(enhancement-12, a-10)
amod(enhancement-12, reversible-11)
dobj(experience-9, enhancement-12)
det(response-16, the-14)
amod(response-16, pressor-15)
prep_of(enhancement-12, response-16)
amod(agents-20, indirect-acting-18)
amod(agents-20, sympathomimetic-19)
prep_to(response-16, agents-20)
conj_or(agents-20, vasopressor-22)
amod(agents-25, dopaminergic-24)
conj_or(agents-20, agents-25)

Commonly/RB used/VBN drugs/NNS such/JJ as/IN phenylpropanolamine/NN and/CC pseudoephedrine/NN have/VBP been/VBN specifically/RB studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (ADJP (RB Commonly) (VBN used)) (NNS drugs)) (PP (JJ such) (IN as) (NP (NP (NN phenylpropanolamine)) (CC and) (NP (NN pseudoephedrine))))) (VP (VBP have) (VP (VBN been) (ADVP (RB specifically)) (VP (VBN studied))))) (. .))))

advmod(used-2, Commonly-1)
amod(drugs-3, used-2)
nsubjpass(studied-12, drugs-3)
prep_such_as(drugs-3, phenylpropanolamine-6)
conj_and(phenylpropanolamine-6, pseudoephedrine-8)
aux(studied-12, have-9)
auxpass(studied-12, been-10)
advmod(studied-12, specifically-11)
root(ROOT-0, studied-12)

Initial/JJ doses/NNS of/IN adrenergic/JJ agents/NNS ,/, such/JJ as/IN dopamine/NN or/CC epinephrine/NN ,/, should/MD be/VB reduced/VBN and/CC titrated/VBN to/TO achieve/VB the/DT desired/JJ response/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Initial) (NNS doses)) (PP (IN of) (NP (JJ adrenergic) (NNS agents))) (, ,) (PP (JJ such) (IN as) (NP (NP (NN dopamine)) (CC or) (NP (NN epinephrine)))) (, ,)) (VP (MD should) (VP (VB be) (VP (VP (VBN reduced)) (CC and) (VP (VBN titrated) (S (VP (TO to) (VP (VB achieve) (NP (DT the) (JJ desired) (NN response)))))))))) (. .))))

amod(doses-2, Initial-1)
nsubjpass(reduced-15, doses-2)
amod(agents-5, adrenergic-4)
prep_of(doses-2, agents-5)
prep_such_as(doses-2, dopamine-9)
conj_or(dopamine-9, epinephrine-11)
aux(reduced-15, should-13)
auxpass(reduced-15, be-14)
root(ROOT-0, reduced-15)
conj_and(reduced-15, titrated-17)
aux(achieve-19, to-18)
xcomp(titrated-17, achieve-19)
det(response-22, the-20)
amod(response-22, desired-21)
dobj(achieve-19, response-22)

Serotonergic/JJ Agents/NNS :/: Co-administration/NN of/IN linezolid/NN and/CC serotonergic/JJ agents/NNS was/VBD not/RB associated/VBN with/IN serotonin/NN syndrome/NN in/IN Phase/NN 1/CD ,/, 2/CD or/CC 3/CD studies/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Serotonergic) (NNS Agents)) (: :) (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NP (NN linezolid)) (CC and) (NP (JJ serotonergic) (NNS agents))))) (VP (VBD was) (RB not) (VP (VBN associated) (PP (IN with) (NP (NP (NP (NN serotonin) (NN syndrome)) (PP (IN in) (NP (NN Phase) (CD 1)))) (, ,) (NP (QP (CD 2) (CC or) (CD 3)) (NNS studies))))))) (. .)))))

amod(Agents-2, Serotonergic-1)
root(ROOT-0, Agents-2)
nsubjpass(associated-12, Co-administration-4)
prep_of(Co-administration-4, linezolid-6)
amod(agents-9, serotonergic-8)
conj_and(linezolid-6, agents-9)
auxpass(associated-12, was-10)
neg(associated-12, not-11)
dep(Agents-2, associated-12)
nn(syndrome-15, serotonin-14)
prep_with(associated-12, syndrome-15)
prep_in(syndrome-15, Phase-17)
num(Phase-17, 1-18)
num(studies-23, 2-20)
conj_or(2-20, 3-22)
appos(syndrome-15, studies-23)

Spontaneous/JJ reports/NNS of/IN serotonin/NN syndrome/NN associated/VBN with/IN co-administration/NN of/IN ZYVOX/NN and/CC serotonergic/JJ agents/NNS ,/, including/VBG antidepressants/NNS such/JJ as/IN selective/JJ serotonin/NN reuptake/NN inhibitors/NNS (/-LRB- SSRIs/NN )/-RRB- ,/, have/VBP been/VBN reported/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Spontaneous) (NNS reports)) (PP (IN of) (NP (NP (NN serotonin) (NN syndrome)) (VP (VBN associated) (PP (IN with) (NP (NP (NN co-administration)) (PP (IN of) (NP (NP (NN ZYVOX)) (CC and) (NP (NP (JJ serotonergic) (NNS agents)) (, ,) (PP (VBG including) (NP (NP (NNS antidepressants)) (PP (JJ such) (IN as) (NP (NP (JJ selective) (NN serotonin) (NN reuptake) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NN SSRIs)) (-RRB- -RRB-)))))) (, ,)))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN reported))))) (. .))))

amod(reports-2, Spontaneous-1)
nsubjpass(reported-29, reports-2)
nn(syndrome-5, serotonin-4)
prep_of(reports-2, syndrome-5)
partmod(syndrome-5, associated-6)
prep_with(associated-6, co-administration-8)
prep_of(co-administration-8, ZYVOX-10)
amod(agents-13, serotonergic-12)
conj_and(ZYVOX-10, agents-13)
prep_including(agents-13, antidepressants-16)
amod(inhibitors-22, selective-19)
nn(inhibitors-22, serotonin-20)
nn(inhibitors-22, reuptake-21)
prep_such_as(antidepressants-16, inhibitors-22)
abbrev(inhibitors-22, SSRIs-24)
aux(reported-29, have-27)
auxpass(reported-29, been-28)
root(ROOT-0, reported-29)

Patients/NNS who/WP are/VBP treated/VBN with/IN ZYVOX/JJ and/CC concomitant/JJ serotonergic/JJ agents/NNS should/MD be/VB closely/RB observed/VBN for/IN signs/NNS and/CC symptoms/NNS of/IN serotonin/NN syndrome/NN (/-LRB- e.g./FW ,/, cognitive/JJ dysfunction/NN ,/, hyperpyrexia/NN ,/, hyperreflexia/NN ,/, incoordination/NN )./NN

(ROOT (S1 (S (NP (NP (NNS Patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBN treated) (PP (IN with) (NP (ADJP (ADJP (JJ ZYVOX)) (CC and) (ADJP (JJ concomitant))) (JJ serotonergic) (NNS agents)))))))) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN observed) (PP (IN for) (NP (NP (NP (NNS signs)) (CC and) (NP (NNS symptoms))) (PP (IN of) (NP (NN serotonin) (NN syndrome)))))))) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NP (JJ cognitive) (NN dysfunction)) (, ,) (NP (NN hyperpyrexia)) (, ,) (NP (NN hyperreflexia)) (, ,) (NP (NN incoordination) (NN -RRB-.)))))))

nsubjpass(treated-4, Patients-1)
nsubjpass(observed-14, Patients-1)
auxpass(treated-4, are-3)
rcmod(Patients-1, treated-4)
amod(agents-10, ZYVOX-6)
conj_and(ZYVOX-6, concomitant-8)
amod(agents-10, serotonergic-9)
prep_with(treated-4, agents-10)
aux(observed-14, should-11)
auxpass(observed-14, be-12)
advmod(observed-14, closely-13)
root(ROOT-0, observed-14)
prep_for(observed-14, signs-16)
conj_and(signs-16, symptoms-18)
nn(syndrome-21, serotonin-20)
prep_of(signs-16, syndrome-21)
dep(dysfunction-26, e.g.-23)
amod(dysfunction-26, cognitive-25)
dep(observed-14, dysfunction-26)
appos(dysfunction-26, hyperpyrexia-28)
appos(dysfunction-26, hyperreflexia-30)
nn(-RRB-.-33, incoordination-32)
appos(dysfunction-26, -RRB-.-33)

If/IN any/DT signs/NNS or/CC symptoms/NNS occur/VBP physicians/NNS should/MD consider/VB discontinuation/NN of/IN either/CC one/CD or/CC both/DT agents/NNS (/-LRB- ZYVOX/NN or/CC concomitant/JJ serotonergic/JJ agents/NNS )/-RRB- ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NP (DT any) (NNS signs)) (CC or) (NP (NNS symptoms))) (VP (VBP occur)))) (NP (NNS physicians)) (VP (MD should) (VP (VB consider) (NP (NP (NN discontinuation)) (PP (IN of) (NP (CC either) (NP (CD one)) (CC or) (NP (DT both)) (NP (NP (NNS agents)) (PRN (-LRB- -LRB-) (NP (NP (NN ZYVOX)) (CC or) (NP (JJ concomitant) (JJ serotonergic) (NNS agents))) (-RRB- -RRB-))))))))) (. .))))

mark(occur-6, If-1)
det(signs-3, any-2)
nsubj(occur-6, signs-3)
conj_or(signs-3, symptoms-5)
advcl(consider-9, occur-6)
nsubj(consider-9, physicians-7)
aux(consider-9, should-8)
root(ROOT-0, consider-9)
dobj(consider-9, discontinuation-10)
preconj(one-13, either-12)
prep_of(discontinuation-10, one-13)
conj_or(one-13, both-15)
dep(one-13, agents-16)
dep(agents-16, ZYVOX-18)
amod(agents-22, concomitant-20)
amod(agents-22, serotonergic-21)
conj_or(ZYVOX-18, agents-22)

Oral/JJ Anticoagulants/NNS :/: Thyroid/NN hormones/NNS appear/VBP to/TO increase/VB catabolism/NN of/IN vitamin/NN K/NN -dependent/JJ clotting/NN factors/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Oral) (NNS Anticoagulants)) (: :) (S (NP (NN Thyroid) (NNS hormones)) (VP (VBP appear) (S (VP (TO to) (VP (VB increase) (NP (NP (NN catabolism)) (PP (IN of) (NP (ADJP (NN vitamin) (NN K) (JJ -dependent)) (NN clotting) (NNS factors))))))))) (. .)))))

amod(Anticoagulants-2, Oral-1)
root(ROOT-0, Anticoagulants-2)
nn(hormones-5, Thyroid-4)
nsubj(appear-6, hormones-5)
xsubj(increase-8, hormones-5)
dep(Anticoagulants-2, appear-6)
aux(increase-8, to-7)
xcomp(appear-6, increase-8)
dobj(increase-8, catabolism-9)
dep(-dependent-13, vitamin-11)
dep(-dependent-13, K-12)
amod(factors-15, -dependent-13)
nn(factors-15, clotting-14)
prep_of(catabolism-9, factors-15)

If/IN oral/JJ anticoagulants/NNS are/VBP also/RB being/VBG given/VBN ,/, compensatory/JJ increases/NNS in/IN clotting/JJ factor/NN synthesis/NN are/VBP impaired/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (JJ oral) (NNS anticoagulants)) (VP (VBP are) (ADVP (RB also)) (VP (VBG being) (VP (VBN given)))))) (, ,) (NP (NP (JJ compensatory) (NNS increases)) (PP (IN in) (NP (JJ clotting) (NN factor) (NN synthesis)))) (VP (VBP are) (VP (VBN impaired)))) (. .))))

mark(given-7, If-1)
amod(anticoagulants-3, oral-2)
nsubjpass(given-7, anticoagulants-3)
aux(given-7, are-4)
advmod(given-7, also-5)
auxpass(given-7, being-6)
advcl(impaired-16, given-7)
amod(increases-10, compensatory-9)
nsubjpass(impaired-16, increases-10)
amod(synthesis-14, clotting-12)
nn(synthesis-14, factor-13)
prep_in(increases-10, synthesis-14)
auxpass(impaired-16, are-15)
root(ROOT-0, impaired-16)

Patients/NNS stabilized/VBN on/IN oral/JJ anticoagulants/NNS who/WP are/VBP found/VBN to/TO require/VB thyroid/NN replacement/NN therapy/NN should/MD be/VB watched/VBD very/RB closely/RB when/WRB thyroid/NN is/VBZ started/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBN stabilized) (PP (IN on) (NP (NP (JJ oral) (NNS anticoagulants)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBN found) (S (VP (TO to) (VP (VB require) (NP (NN thyroid) (NN replacement) (NN therapy))))))))))))) (VP (MD should) (VP (VB be) (VP (VBD watched) (ADVP (RB very) (RB closely)) (SBAR (WHADVP (WRB when)) (S (NP (NN thyroid)) (VP (VBZ is) (VP (VBN started))))))))) (. .))))

nsubjpass(watched-16, Patients-1)
partmod(Patients-1, stabilized-2)
amod(anticoagulants-5, oral-4)
prep_on(stabilized-2, anticoagulants-5)
nsubjpass(found-8, anticoagulants-5)
auxpass(found-8, are-7)
rcmod(anticoagulants-5, found-8)
aux(require-10, to-9)
xcomp(found-8, require-10)
nn(therapy-13, thyroid-11)
nn(therapy-13, replacement-12)
dobj(require-10, therapy-13)
aux(watched-16, should-14)
auxpass(watched-16, be-15)
root(ROOT-0, watched-16)
advmod(closely-18, very-17)
advmod(watched-16, closely-18)
advmod(started-22, when-19)
nsubjpass(started-22, thyroid-20)
auxpass(started-22, is-21)
advcl(watched-16, started-22)

If/IN a/DT patient/NN is/VBZ truly/RB hypothyroid/JJ ,/, it/PRP is/VBZ likely/JJ that/IN a/DT reduction/NN in/IN anticoagulant/JJ dosage/NN will/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (DT a) (NN patient)) (VP (VBZ is) (ADJP (RB truly) (JJ hypothyroid))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ likely) (SBAR (IN that) (S (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (JJ anticoagulant) (NN dosage)))) (VP (MD will) (VP (VB be) (VP (VBN required))))))))) (. .))))

mark(hypothyroid-6, If-1)
det(patient-3, a-2)
nsubj(hypothyroid-6, patient-3)
cop(hypothyroid-6, is-4)
advmod(hypothyroid-6, truly-5)
advcl(likely-10, hypothyroid-6)
nsubj(likely-10, it-8)
cop(likely-10, is-9)
root(ROOT-0, likely-10)
complm(required-19, that-11)
det(reduction-13, a-12)
nsubjpass(required-19, reduction-13)
amod(dosage-16, anticoagulant-15)
prep_in(reduction-13, dosage-16)
aux(required-19, will-17)
auxpass(required-19, be-18)
ccomp(likely-10, required-19)

No/DT special/JJ precautions/NNS appear/VBP to/TO be/VB necessary/JJ when/WRB oral/JJ anticoagulant/NN therapy/NN is/VBZ begun/VBN in/IN a/DT patient/NN already/RB stabilized/VBN on/IN maintenance/NN thyroid/NN replacement/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (DT No) (JJ special) (NNS precautions)) (VP (VBP appear) (S (VP (TO to) (VP (VB be) (ADJP (JJ necessary))) (SBAR (WHADVP (WRB when)) (S (NP (JJ oral) (NN anticoagulant) (NN therapy)) (VP (VBZ is) (VP (VBN begun) (PP (IN in) (NP (NP (DT a) (NN patient)) (VP (ADVP (RB already)) (VBN stabilized) (PP (IN on) (NP (NN maintenance) (NN thyroid) (NN replacement) (NN therapy)))))))))))))) (. .))))

det(precautions-3, No-1)
amod(precautions-3, special-2)
nsubj(appear-4, precautions-3)
xsubj(necessary-7, precautions-3)
root(ROOT-0, appear-4)
aux(necessary-7, to-5)
cop(necessary-7, be-6)
xcomp(appear-4, necessary-7)
advmod(begun-13, when-8)
amod(therapy-11, oral-9)
nn(therapy-11, anticoagulant-10)
nsubjpass(begun-13, therapy-11)
auxpass(begun-13, is-12)
advcl(necessary-7, begun-13)
det(patient-16, a-15)
prep_in(begun-13, patient-16)
advmod(stabilized-18, already-17)
partmod(patient-16, stabilized-18)
nn(therapy-23, maintenance-20)
nn(therapy-23, thyroid-21)
nn(therapy-23, replacement-22)
prep_on(stabilized-18, therapy-23)

Insulin/NN or/CC Oral/JJ Hypoglycemics/NN :/: Initiating/VBG thyroid/NN replacement/NN therapy/NN may/MD cause/VB increases/NNS in/IN insulin/NN or/CC oral/JJ hypoglycemic/JJ requirements/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NN Insulin)) (CC or) (NP (JJ Oral) (NN Hypoglycemics))) (: :) (S (NP (VBG Initiating) (NN thyroid) (NN replacement) (NN therapy)) (VP (MD may) (VP (VB cause) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (NN insulin)) (CC or) (NP (JJ oral) (JJ hypoglycemic) (NNS requirements)))))))) (. .)))))

root(ROOT-0, Insulin-1)
amod(Hypoglycemics-4, Oral-3)
conj_or(Insulin-1, Hypoglycemics-4)
amod(therapy-9, Initiating-6)
nn(therapy-9, thyroid-7)
nn(therapy-9, replacement-8)
nsubj(cause-11, therapy-9)
aux(cause-11, may-10)
dep(Insulin-1, cause-11)
dobj(cause-11, increases-12)
prep_in(increases-12, insulin-14)
amod(requirements-18, oral-16)
amod(requirements-18, hypoglycemic-17)
conj_or(insulin-14, requirements-18)

The/DT effects/NNS seen/VBN are/VBP poorly/RB understood/VBN and/CC depend/VB upon/IN a/DT variety/NN of/IN factors/NNS such/JJ as/IN dose/NN and/CC type/NN of/IN thyroid/NN preparation/NN s/NNS and/CC endocrine/JJ status/NN of/IN the/DT patient/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS effects)) (VP (VBN seen))) (VP (VP (VBP are) (VP (ADVP (RB poorly)) (VBN understood))) (CC and) (VP (VB depend) (PP (IN upon) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (NNS factors)) (PP (JJ such) (IN as) (NP (NP (NP (NP (NP (NN dose)) (CC and) (NP (NN type))) (PP (IN of) (NP (NN thyroid) (NN preparation) (NNS s)))) (CC and) (NP (JJ endocrine) (NN status))) (PP (IN of) (NP (DT the) (NN patient)))))))))))) (. .))))

det(effects-2, The-1)
nsubjpass(understood-6, effects-2)
partmod(effects-2, seen-3)
auxpass(understood-6, are-4)
advmod(understood-6, poorly-5)
root(ROOT-0, understood-6)
conj_and(understood-6, depend-8)
det(variety-11, a-10)
prep_upon(depend-8, variety-11)
prep_of(variety-11, factors-13)
prep_such_as(factors-13, dose-16)
conj_and(dose-16, type-18)
nn(s-22, thyroid-20)
nn(s-22, preparation-21)
prep_of(dose-16, s-22)
amod(status-25, endocrine-24)
conj_and(dose-16, status-25)
det(patient-28, the-27)
prep_of(dose-16, patient-28)

Patients/NNS receiving/VBG insulin/NN or/CC oral/JJ hypoglycemics/NN should/MD be/VB closely/RB watched/VBD during/IN initiation/NN of/IN thyroid/NN replacement/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (NP (NN insulin)) (CC or) (NP (JJ oral) (NN hypoglycemics))))) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBD watched) (PP (IN during) (NP (NP (NN initiation)) (PP (IN of) (NP (NN thyroid) (NN replacement) (NN therapy))))))))) (. .))))

nsubjpass(watched-10, Patients-1)
partmod(Patients-1, receiving-2)
dobj(receiving-2, insulin-3)
amod(hypoglycemics-6, oral-5)
conj_or(insulin-3, hypoglycemics-6)
aux(watched-10, should-7)
auxpass(watched-10, be-8)
advmod(watched-10, closely-9)
root(ROOT-0, watched-10)
prep_during(watched-10, initiation-12)
nn(therapy-16, thyroid-14)
nn(therapy-16, replacement-15)
prep_of(initiation-12, therapy-16)

Cholestyramine/NN :/: Cholestyramine/NN binds/VBZ both/CC T4/NN and/CC T3/NN in/IN the/DT intestine/NN ,/, thus/RB impairing/VBG absorption/NN of/IN these/DT thyroid/NN hormones/NNS ./.

(ROOT (S1 (S (S (NP (NN Cholestyramine) (: :) (NN Cholestyramine)) (VP (VBZ binds) (NP (NP (CC both) (NP (NN T4)) (CC and) (NP (NN T3))) (PP (IN in) (NP (DT the) (NN intestine)))) (, ,) (S (ADVP (RB thus)) (VP (VBG impairing) (NP (NP (NN absorption)) (PP (IN of) (NP (DT these) (NN thyroid) (NNS hormones)))))))) (. .))))

nn(Cholestyramine-3, Cholestyramine-1)
nsubj(binds-4, Cholestyramine-3)
root(ROOT-0, binds-4)
preconj(T4-6, both-5)
dobj(binds-4, T4-6)
conj_and(T4-6, T3-8)
det(intestine-11, the-10)
prep_in(T4-6, intestine-11)
advmod(impairing-14, thus-13)
partmod(binds-4, impairing-14)
xcomp(binds-4, impairing-14)
dobj(impairing-14, absorption-15)
det(hormones-19, these-17)
nn(hormones-19, thyroid-18)
prep_of(absorption-15, hormones-19)

Therefore/RB ,/, 4/CD to/TO 5/CD hours/NNS should/MD elapse/VB between/IN administration/NN of/IN cholestyramine/NN and/CC thyroid/NN hormones/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (QP (CD 4) (TO to) (CD 5)) (NNS hours)) (VP (MD should) (VP (VB elapse) (PP (IN between) (NP (NP (NN administration)) (PP (IN of) (NP (NP (NN cholestyramine)) (CC and) (NP (NN thyroid) (NNS hormones))))))))) (. .))))

advmod(elapse-8, Therefore-1)
number(5-5, 4-3)
dep(5-5, to-4)
num(hours-6, 5-5)
nsubj(elapse-8, hours-6)
aux(elapse-8, should-7)
root(ROOT-0, elapse-8)
prep_between(elapse-8, administration-10)
prep_of(administration-10, cholestyramine-12)
nn(hormones-15, thyroid-14)
conj_and(cholestyramine-12, hormones-15)

Estrogen/NN ,/, Oral/JJ Contraceptives/NNS :/: Estrogens/NNS tend/VBP to/TO increase/VB serum/NN thyroxine-binding/NN globulin/NN (/-LRB- TBg)./NN

(ROOT (S1 (S (S (NP (NN Estrogen)) (, ,) (NP (JJ Oral) (NNS Contraceptives))) (: :) (S (NP (NNS Estrogens)) (VP (VBP tend) (S (VP (TO to) (VP (VB increase) (NP (NP (NN serum) (NN thyroxine-binding) (NN globulin)) (PRN (-LRB- -LRB-) (NP (NN TBg-RRB-.))))))))))))

dep(Contraceptives-4, Estrogen-1)
amod(Contraceptives-4, Oral-3)
root(ROOT-0, Contraceptives-4)
nsubj(tend-7, Estrogens-6)
xsubj(increase-9, Estrogens-6)
parataxis(Contraceptives-4, tend-7)
aux(increase-9, to-8)
xcomp(tend-7, increase-9)
nn(globulin-12, serum-10)
nn(globulin-12, thyroxine-binding-11)
dobj(increase-9, globulin-12)
dep(globulin-12, TBg-RRB-.-14)

In/IN a/DT patient/NN with/IN a/DT nonfunctioning/JJ thyroid/NN gland/NN who/WP is/VBZ receiving/VBG thyroid/NN replacement/NN therapy/NN ,/, free/JJ levothyroxine/NN may/MD be/VB decreased/VBN when/WRB estrogens/NNS are/VBP started/VBN thus/RB increasing/VBG thyroid/NN requirements/NNS ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT a) (NN patient)) (PP (IN with) (NP (NP (DT a) (JJ nonfunctioning) (NN thyroid) (NN gland)) (SBAR (WHNP (WP who)) (S (VP (VBZ is) (VP (VBG receiving) (NP (NN thyroid) (NN replacement) (NN therapy)))))))))) (, ,) (NP (JJ free) (NN levothyroxine)) (VP (MD may) (VP (VB be) (VP (VBN decreased) (SBAR (WHADVP (WRB when)) (S (NP (NNS estrogens)) (VP (VBP are) (VP (VBN started) (S (ADVP (RB thus)) (VP (VBG increasing) (NP (NN thyroid) (NNS requirements)))))))))))) (. .))))

det(patient-3, a-2)
prep_in(decreased-20, patient-3)
det(gland-8, a-5)
amod(gland-8, nonfunctioning-6)
nn(gland-8, thyroid-7)
prep_with(patient-3, gland-8)
nsubj(receiving-11, gland-8)
aux(receiving-11, is-10)
rcmod(gland-8, receiving-11)
nn(therapy-14, thyroid-12)
nn(therapy-14, replacement-13)
dobj(receiving-11, therapy-14)
amod(levothyroxine-17, free-16)
nsubjpass(decreased-20, levothyroxine-17)
aux(decreased-20, may-18)
auxpass(decreased-20, be-19)
root(ROOT-0, decreased-20)
advmod(started-24, when-21)
nsubjpass(started-24, estrogens-22)
auxpass(started-24, are-23)
advcl(decreased-20, started-24)
advmod(increasing-26, thus-25)
xcomp(started-24, increasing-26)
nn(requirements-28, thyroid-27)
dobj(increasing-26, requirements-28)

However/RB ,/, if/IN the/DT patients/NNS thyroid/NN gland/NN has/VBZ sufficient/JJ function/NN ,/, the/DT decreased/VBN free/JJ thyroxin/NN e/NN will/MD result/VB in/IN a/DT compensatory/JJ increase/NN in/IN thyroxin/NN e/NN output/NN by/IN the/DT thyroid/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (SBAR (IN if) (S (NP (DT the) (NNS patients) (NN thyroid) (NN gland)) (VP (VBZ has) (NP (JJ sufficient) (NN function))))) (, ,) (NP (DT the) (VBN decreased) (JJ free) (NN thyroxin) (NN e)) (VP (MD will) (VP (VB result) (PP (IN in) (NP (NP (DT a) (JJ compensatory) (NN increase)) (PP (IN in) (NP (NP (NN thyroxin) (NN e) (NN output)) (PP (IN by) (NP (DT the) (NN thyroid)))))))))) (. .))))

advmod(result-18, However-1)
mark(has-8, if-3)
det(gland-7, the-4)
nn(gland-7, patients-5)
nn(gland-7, thyroid-6)
nsubj(has-8, gland-7)
advcl(result-18, has-8)
amod(function-10, sufficient-9)
dobj(has-8, function-10)
det(e-16, the-12)
amod(e-16, decreased-13)
amod(e-16, free-14)
nn(e-16, thyroxin-15)
nsubj(result-18, e-16)
aux(result-18, will-17)
root(ROOT-0, result-18)
det(increase-22, a-20)
amod(increase-22, compensatory-21)
prep_in(result-18, increase-22)
nn(output-26, thyroxin-24)
nn(output-26, e-25)
prep_in(increase-22, output-26)
det(thyroid-29, the-28)
prep_by(output-26, thyroid-29)

Therefore/RB ,/, patients/NNS without/IN a/DT functioning/VBG thyroid/NN gland/NN who/WP are/VBP on/IN thyroid/NN replacement/NN therapy/NN may/MD need/VBP to/TO increase/VB their/PRP$ thyroid/NN dose/NN if/IN estrogens/NNS or/CC estrogen/NN -containing/JJ oral/JJ contraceptives/NNS are/VBP given/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NNS patients)) (PP (IN without) (NP (DT a) (VBG functioning) (NN thyroid) (NN gland))) (SBAR (WHNP (WP who)) (S (VP (VBP are) (PP (IN on) (NP (NN thyroid) (NN replacement) (NN therapy))))))) (VP (MD may) (VP (VBP need) (S (VP (TO to) (VP (VB increase) (NP (PRP$ their) (NN thyroid) (NN dose)) (SBAR (IN if) (S (NP (NP (NNS estrogens)) (CC or) (NP (ADJP (NN estrogen) (JJ -containing)) (JJ oral) (NNS contraceptives))) (VP (VBP are) (VP (VBN given))))))))))) (. .))))

advmod(need-16, Therefore-1)
nsubj(are-10, patients-3)
nsubj(need-16, patients-3)
xsubj(increase-18, patients-3)
det(gland-8, a-5)
amod(gland-8, functioning-6)
nn(gland-8, thyroid-7)
prep_without(patients-3, gland-8)
rcmod(patients-3, are-10)
nn(therapy-14, thyroid-12)
nn(therapy-14, replacement-13)
prep_on(are-10, therapy-14)
aux(need-16, may-15)
root(ROOT-0, need-16)
aux(increase-18, to-17)
xcomp(need-16, increase-18)
poss(dose-21, their-19)
nn(dose-21, thyroid-20)
dobj(increase-18, dose-21)
mark(given-30, if-22)
nsubjpass(given-30, estrogens-23)
dep(-containing-26, estrogen-25)
amod(contraceptives-28, -containing-26)
amod(contraceptives-28, oral-27)
conj_or(estrogens-23, contraceptives-28)
auxpass(given-30, are-29)
advcl(increase-18, given-30)

Tricyclic/JJ Antidepressants/NNS :/: Use/NN of/IN thyroid/NN products/NNS with/IN imipramine/NN and/CC other/JJ tricyclic/JJ antidepressants/NNS may/MD increase/VB receptor/NN sensitivity/NN and/CC enhance/VB antidepressant/JJ activity/NN transient/JJ cardiac/JJ arrhythmias/NNS have/VBP been/VBN observed/VBN ./.

(ROOT (S1 (S (S (NP (NP (JJ Tricyclic) (NNS Antidepressants)) (: :) (S (NP (NP (NN Use)) (PP (IN of) (NP (NN thyroid) (NNS products))) (PP (IN with) (NP (NP (NN imipramine)) (CC and) (NP (JJ other) (JJ tricyclic) (NNS antidepressants))))) (VP (MD may) (VP (VP (VP (VB increase) (NP (NN receptor) (NN sensitivity))) (CC and) (VP (VB enhance) (NP (JJ antidepressant) (NN activity)))) (NP (JJ transient) (JJ cardiac) (NNS arrhythmias)))))) (VP (VBP have) (VP (VBN been) (VP (VBN observed))))) (. .))))

amod(Antidepressants-2, Tricyclic-1)
nsubjpass(observed-27, Antidepressants-2)
nsubj(increase-15, Use-4)
nn(products-7, thyroid-6)
prep_of(Use-4, products-7)
prep_with(Use-4, imipramine-9)
amod(antidepressants-13, other-11)
amod(antidepressants-13, tricyclic-12)
conj_and(imipramine-9, antidepressants-13)
aux(increase-15, may-14)
dep(Antidepressants-2, increase-15)
nn(sensitivity-17, receptor-16)
dobj(increase-15, sensitivity-17)
conj_and(increase-15, enhance-19)
amod(activity-21, antidepressant-20)
dobj(enhance-19, activity-21)
amod(arrhythmias-24, transient-22)
amod(arrhythmias-24, cardiac-23)
dobj(increase-15, arrhythmias-24)
aux(observed-27, have-25)
auxpass(observed-27, been-26)
root(ROOT-0, observed-27)

Thyroid/NN hormone/NN activity/NN may/MD also/RB be/VB enhanced/VBN ./.

(ROOT (S1 (S (S (NP (NN Thyroid) (NN hormone) (NN activity)) (VP (MD may) (ADVP (RB also)) (VP (VB be) (VP (VBN enhanced))))) (. .))))

nn(activity-3, Thyroid-1)
nn(activity-3, hormone-2)
nsubjpass(enhanced-7, activity-3)
aux(enhanced-7, may-4)
advmod(enhanced-7, also-5)
auxpass(enhanced-7, be-6)
root(ROOT-0, enhanced-7)

Digitalis/NN :/: Thyroid/NN preparation/NN s/NNS may/MD potentiate/VB the/DT toxic/JJ effects/NNS of/IN digitalis/NN ./.

(ROOT (S1 (S (S (NP (NN Digitalis) (: :) (NN Thyroid) (NN preparation) (NNS s)) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (JJ toxic) (NNS effects)) (PP (IN of) (NP (NN digitalis))))))) (. .))))

nn(s-5, Digitalis-1)
nn(s-5, Thyroid-3)
nn(s-5, preparation-4)
nsubj(potentiate-7, s-5)
aux(potentiate-7, may-6)
root(ROOT-0, potentiate-7)
det(effects-10, the-8)
amod(effects-10, toxic-9)
dobj(potentiate-7, effects-10)
prep_of(effects-10, digitalis-12)

Thyroid/NN hormonal/JJ replacement/NN increases/VBZ metabolic/JJ rate/NN ,/, which/WDT requires/VBZ an/DT increase/NN in/IN digitalis/NN dosage/NN ./.

(ROOT (S1 (S (S (NP (NN Thyroid) (JJ hormonal) (NN replacement)) (VP (VBZ increases) (NP (NP (JJ metabolic) (NN rate)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ requires) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NN digitalis) (NN dosage)))))))))) (. .))))

nn(replacement-3, Thyroid-1)
amod(replacement-3, hormonal-2)
nsubj(increases-4, replacement-3)
root(ROOT-0, increases-4)
amod(rate-6, metabolic-5)
dobj(increases-4, rate-6)
nsubj(requires-9, rate-6)
rcmod(rate-6, requires-9)
det(increase-11, an-10)
dobj(requires-9, increase-11)
nn(dosage-14, digitalis-13)
prep_in(increase-11, dosage-14)

Ketamine/NN :/: When/WRB administered/VBN to/TO patients/NNS on/IN a/DT thyroid/NN preparation/NN ,/, this/DT parenteral/JJ anesthetic/NN may/MD cause/VB hypertension/NN and/CC tachycardia/NN ./.

(ROOT (S1 (S (NP (NP (NN Ketamine)) (: :) (S (SBAR (WHADVP (WRB When)) (S (VP (VBN administered) (PP (TO to) (NP (NNS patients))) (PP (IN on) (NP (DT a) (NN thyroid) (NN preparation)))))) (, ,) (NP (DT this) (JJ parenteral) (NN anesthetic)) (VP (MD may) (VP (VB cause) (NP (NP (NN hypertension)) (CC and) (NP (NN tachycardia)))))) (. .)))))

root(ROOT-0, Ketamine-1)
advmod(administered-4, When-3)
advcl(cause-16, administered-4)
prep_to(administered-4, patients-6)
det(preparation-10, a-8)
nn(preparation-10, thyroid-9)
prep_on(administered-4, preparation-10)
det(anesthetic-14, this-12)
amod(anesthetic-14, parenteral-13)
nsubj(cause-16, anesthetic-14)
aux(cause-16, may-15)
dep(Ketamine-1, cause-16)
dobj(cause-16, hypertension-17)
conj_and(hypertension-17, tachycardia-19)

Vasopressor/JJ s/NN :/: Thyroxine/NN increases/VBZ the/DT adrenergic/JJ effect/NN of/IN catecholamines/NNS such/JJ as/IN epinephrine/NN and/CC norepinephrine/NN ./.

(ROOT (S1 (S (S (NP (JJ Vasopressor) (NN s) (: :) (NN Thyroxine)) (VP (VBZ increases) (NP (NP (DT the) (JJ adrenergic) (NN effect)) (PP (IN of) (NP (NP (NNS catecholamines)) (PP (JJ such) (IN as) (NP (NP (NN epinephrine)) (CC and) (NP (NN norepinephrine))))))))) (. .))))

amod(Thyroxine-4, Vasopressor-1)
nn(Thyroxine-4, s-2)
nsubj(increases-5, Thyroxine-4)
root(ROOT-0, increases-5)
det(effect-8, the-6)
amod(effect-8, adrenergic-7)
dobj(increases-5, effect-8)
prep_of(effect-8, catecholamines-10)
prep_such_as(catecholamines-10, epinephrine-13)
conj_and(epinephrine-13, norepinephrine-15)

Therefore/RB ,/, injection/NN of/IN these/DT agents/NNS into/IN patients/NNS receiving/VBG thyroid/NN preparation/NN s/NNS increases/VBZ the/DT risk/NN of/IN precipitating/VBG coronary/JJ insufficiency/NN especially/RB in/IN patients/NNS with/IN coronary/JJ artery/NN disease/NN ./.

(ROOT (S1 (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN injection)) (PP (IN of) (NP (DT these) (NNS agents))) (PP (IN into) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN thyroid) (NN preparation) (NNS s)))))) (VP (VBZ increases) (NP (NP (DT the) (NN risk)) (PP (IN of) (S (VP (VBG precipitating) (NP (JJ coronary) (NN insufficiency)) (PP (ADVP (RB especially)) (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ coronary) (NN artery) (NN disease)))))))))) (. .))))

advmod(increases-13, Therefore-1)
nsubj(increases-13, injection-3)
det(agents-6, these-5)
prep_of(injection-3, agents-6)
prep_into(injection-3, patients-8)
partmod(patients-8, receiving-9)
nn(s-12, thyroid-10)
nn(s-12, preparation-11)
dobj(receiving-9, s-12)
root(ROOT-0, increases-13)
det(risk-15, the-14)
dobj(increases-13, risk-15)
prepc_of(risk-15, precipitating-17)
amod(insufficiency-19, coronary-18)
dobj(precipitating-17, insufficiency-19)
advmod(precipitating-17, especially-20)
prep_in(precipitating-17, patients-22)
amod(disease-26, coronary-24)
nn(disease-26, artery-25)
prep_with(patients-22, disease-26)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS The/DT following/JJ drugs/NNS or/CC moieties/NNS are/VBP known/VBN to/TO interfere/VB with/IN laboratory/NN tests/NNS performed/VBN in/IN patients/NNS on/IN thyroid/NN hormone/NN therapy/NN :/: androgens/NNS ,/, corticosteroids/NNS ,/, estrogens/NNS ,/, oral/JJ contraceptives/NNS containing/VBG estrogens/NNS ,/, iodine-containing/JJ preparations/NNS and/CC the/DT numerous/JJ preparations/NNS containing/VBG salicylates/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (NP (DT The) (NP (JJ following) (NNS drugs)) (CC or) (NP (NNS moieties)))) (VP (VBP are) (VP (VBN known) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (NP (NN laboratory) (NNS tests)) (VP (VBN performed) (PP (IN in) (NP (NP (NP (NNS patients)) (PP (IN on) (NP (NN thyroid) (NN hormone) (NN therapy)))) (: :) (NP (NP (NNS androgens)) (, ,) (NP (NNS corticosteroids)) (, ,) (NP (NNS estrogens)) (, ,) (NP (NP (JJ oral) (NNS contraceptives)) (VP (VBG containing) (NP (NNS estrogens)))) (, ,) (NP (JJ iodine-containing) (NNS preparations)) (CC and) (NP (NP (DT the) (JJ numerous) (NNS preparations)) (VP (VBG containing) (NP (NNS salicylates)))))))))))))))) (. .))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
nsubjpass(known-11, Interactions-4)
xsubj(interfere-13, Interactions-4)
dep(drugs-7, The-5)
amod(drugs-7, following-6)
dep(Interactions-4, drugs-7)
conj_or(drugs-7, moieties-9)
auxpass(known-11, are-10)
root(ROOT-0, known-11)
aux(interfere-13, to-12)
xcomp(known-11, interfere-13)
nn(tests-16, laboratory-15)
prep_with(interfere-13, tests-16)
partmod(tests-16, performed-17)
prep_in(performed-17, patients-19)
nn(therapy-23, thyroid-21)
nn(therapy-23, hormone-22)
prep_on(patients-19, therapy-23)
dep(patients-19, androgens-25)
conj_and(androgens-25, corticosteroids-27)
conj_and(androgens-25, estrogens-29)
amod(contraceptives-32, oral-31)
conj_and(androgens-25, contraceptives-32)
partmod(contraceptives-32, containing-33)
dobj(containing-33, estrogens-34)
amod(preparations-37, iodine-containing-36)
conj_and(androgens-25, preparations-37)
det(preparations-41, the-39)
amod(preparations-41, numerous-40)
conj_and(androgens-25, preparations-41)
partmod(preparations-41, containing-42)
dobj(containing-42, salicylates-43)

-/CC Changes/NNS in/IN TBg/NN concentration/NN should/MD be/VB taken/VBN into/IN consideration/NN in/IN the/DT interpretation/NN of/IN T4/NN and/CC T3/NN values/NNS ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NNS Changes)) (PP (IN in) (NP (NN TBg) (NN concentration)))) (VP (MD should) (VP (VB be) (VP (VBN taken) (PP (IN into) (NP (NN consideration))) (PP (IN in) (NP (NP (DT the) (NN interpretation)) (PP (IN of) (NP (NP (NP (NN T4)) (CC and) (NP (NN T3))) (NNS values))))))))) (. .))))

nsubjpass(taken-8, Changes-2)
nn(concentration-5, TBg-4)
prep_in(Changes-2, concentration-5)
aux(taken-8, should-6)
auxpass(taken-8, be-7)
root(ROOT-0, taken-8)
prep_into(taken-8, consideration-10)
det(interpretation-13, the-12)
prep_in(taken-8, interpretation-13)
nn(values-18, T4-15)
conj_and(T4-15, T3-17)
prep_of(interpretation-13, values-18)

Pregnancy/NN estrogens/NNS and/CC estrogen/NN -containing/JJ oral/JJ contraceptives/NNS increase/VBP TBg/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Pregnancy) (NNS estrogens)) (CC and) (NP (ADJP (NN estrogen) (JJ -containing)) (JJ oral) (NNS contraceptives))) (VP (VBP increase) (NP (NN TBg) (NNS concentrations)))) (. .))))

nn(estrogens-2, Pregnancy-1)
nsubj(increase-8, estrogens-2)
dep(-containing-5, estrogen-4)
amod(contraceptives-7, -containing-5)
amod(contraceptives-7, oral-6)
conj_and(estrogens-2, contraceptives-7)
root(ROOT-0, increase-8)
nn(concentrations-10, TBg-9)
dobj(increase-8, concentrations-10)

Decreases/NNS in/IN TBg/NN concentrations/NNS are/VBP observed/VBN in/IN nephrosis/NN ,/, acromegaly/NN and/CC after/IN androgen/NN or/CC corticosteroid/NN therapy/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Decreases)) (PP (IN in) (NP (NN TBg) (NNS concentrations)))) (VP (VBP are) (VP (VBN observed) (PP (PP (IN in) (NP (NP (NN nephrosis)) (, ,) (NP (NN acromegaly)))) (CC and) (PP (IN after) (NP (NP (NN androgen)) (CC or) (NP (NN corticosteroid) (NN therapy)))))))) (. .))))

nsubjpass(observed-6, Decreases-1)
nn(concentrations-4, TBg-3)
prep_in(Decreases-1, concentrations-4)
auxpass(observed-6, are-5)
root(ROOT-0, observed-6)
conj_and(observed-6, observed-6')
prep_in(observed-6, nephrosis-8)
appos(nephrosis-8, acromegaly-10)
prep_after(observed-6', androgen-13)
nn(therapy-16, corticosteroid-15)
conj_or(androgen-13, therapy-16)

Familial/JJ hyper-/JJ or/CC hypo-/JJ thyroxin/NN e-binding-globulinemias/NNS have/VBP been/VBN described/VBN ./.

(ROOT (S1 (S (S (NP (JJ Familial) (ADJP (ADJP (JJ hyper-)) (CC or) (ADJP (JJ hypo-))) (NN thyroxin) (NNS e-binding-globulinemias)) (VP (VBP have) (VP (VBN been) (VP (VBN described))))) (. .))))

amod(e-binding-globulinemias-6, Familial-1)
amod(e-binding-globulinemias-6, hyper--2)
conj_or(hyper--2, hypo--4)
nn(e-binding-globulinemias-6, thyroxin-5)
nsubjpass(described-9, e-binding-globulinemias-6)
aux(described-9, have-7)
auxpass(described-9, been-8)
root(ROOT-0, described-9)

The/DT binding/NN of/IN thyroxin/NN e/NN by/IN thyroxine-binding/JJ prealbumin/NN (/-LRB- TBPA/NN )/-RRB- is/VBZ inhibited/VBN by/IN salicylates/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN binding)) (PP (IN of) (NP (NN thyroxin) (NN e))) (PP (IN by) (NP (NP (JJ thyroxine-binding) (NN prealbumin)) (PRN (-LRB- -LRB-) (NP (NN TBPA)) (-RRB- -RRB-))))) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NNS salicylates)))))) (. .))))

det(binding-2, The-1)
nsubjpass(inhibited-13, binding-2)
nn(e-5, thyroxin-4)
prep_of(binding-2, e-5)
amod(prealbumin-8, thyroxine-binding-7)
prep_by(binding-2, prealbumin-8)
abbrev(prealbumin-8, TBPA-10)
auxpass(inhibited-13, is-12)
root(ROOT-0, inhibited-13)
agent(inhibited-13, salicylates-15)

-/CC Medicinal/NN or/CC dietary/NN iodine/NN interferes/VBZ with/IN all/DT in/FW vivo/FW tests/NNS of/IN radio-iodine/NN uptake/NN producing/VBG low/JJ uptakes/NNS which/WDT may/MD not/RB be/VB reflective/JJ of/IN a/DT true/JJ decrease/NN in/IN hormone/NN synthesis/NN ./.

(ROOT (S1 (S (S (NP (CC -) (NP (NN Medicinal)) (CC or) (NP (NN dietary) (NN iodine))) (VP (VBZ interferes) (PP (IN with) (NP (NP (DT all) (ADJP (FW in) (FW vivo)) (NNS tests)) (PP (IN of) (NP (NN radio-iodine) (NN uptake))) (VP (VBG producing) (NP (NP (JJ low) (NNS uptakes)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (RB not) (VP (VB be) (ADJP (JJ reflective) (PP (IN of) (NP (NP (DT a) (JJ true) (NN decrease)) (PP (IN in) (NP (NN hormone) (NN synthesis)))))))))))))))) (. .))))

nsubj(interferes-6, Medicinal-2)
nn(iodine-5, dietary-4)
conj_or(Medicinal-2, iodine-5)
root(ROOT-0, interferes-6)
det(tests-11, all-8)
nn(vivo-10, in-9)
amod(tests-11, vivo-10)
prep_with(interferes-6, tests-11)
nn(uptake-14, radio-iodine-13)
prep_of(tests-11, uptake-14)
partmod(tests-11, producing-15)
amod(uptakes-17, low-16)
dobj(producing-15, uptakes-17)
nsubj(reflective-22, uptakes-17)
aux(reflective-22, may-19)
neg(reflective-22, not-20)
cop(reflective-22, be-21)
rcmod(uptakes-17, reflective-22)
det(decrease-26, a-24)
amod(decrease-26, true-25)
prep_of(reflective-22, decrease-26)
nn(synthesis-29, hormone-28)
prep_in(decrease-26, synthesis-29)

Intracellular/JJ resistance/NN to/TO thyroid/NN hormone/NN is/VBZ quite/RB rare/JJ ./.

(ROOT (S1 (S (S (NP (NP (JJ Intracellular) (NN resistance)) (PP (TO to) (NP (NN thyroid) (NN hormone)))) (VP (VBZ is) (ADJP (RB quite) (JJ rare)))) (. .))))

amod(resistance-2, Intracellular-1)
nsubj(rare-8, resistance-2)
nn(hormone-5, thyroid-4)
prep_to(resistance-2, hormone-5)
cop(rare-8, is-6)
advmod(rare-8, quite-7)
root(ROOT-0, rare-8)

Urinary/JJ acidifying/JJ agents/NNS @/NN These/DT agents/NNS (/-LRB- ammonium/NN chloride/NN ,/, sodium/NN acid/NN phosphate/NN ,/, etc./NN )/-RRB- increase/VBP the/DT concentration/NN of/IN the/DT ionized/VBN species/NNS of/IN the/DT amphetamine/NN molecule/NN ,/, thereby/RB increasing/VBG urinary/JJ excretion/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Urinary) (JJ acidifying) (NNS agents)) (VP (NN @) (NP (NP (DT These) (NNS agents)) (PRN (-LRB- -LRB-) (NP (NP (NN ammonium) (NN chloride)) (, ,) (NP (NN sodium) (NN acid) (NN phosphate)) (, ,) (NP (NN etc.))) (-RRB- -RRB-))))) (VP (VBP increase) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (DT the) (VBN ionized) (NNS species))) (PP (IN of) (NP (DT the) (NN amphetamine) (NN molecule)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG increasing) (NP (JJ urinary) (NN excretion)))))) (. .))))

amod(agents-3, Urinary-1)
amod(agents-3, acidifying-2)
nsubj(increase-17, agents-3)
dep(agents-3, @-4)
det(agents-6, These-5)
dobj(@-4, agents-6)
nn(chloride-9, ammonium-8)
dep(agents-6, chloride-9)
nn(phosphate-13, sodium-11)
nn(phosphate-13, acid-12)
appos(chloride-9, phosphate-13)
appos(chloride-9, etc.-15)
root(ROOT-0, increase-17)
det(concentration-19, the-18)
dobj(increase-17, concentration-19)
det(species-23, the-21)
amod(species-23, ionized-22)
prep_of(concentration-19, species-23)
det(molecule-27, the-25)
nn(molecule-27, amphetamine-26)
prep_of(concentration-19, molecule-27)
advmod(increasing-30, thereby-29)
partmod(increase-17, increasing-30)
xcomp(increase-17, increasing-30)
amod(excretion-32, urinary-31)
dobj(increasing-30, excretion-32)

Both/CC groups/NNS of/IN agents/NNS lower/JJR blood/NN levels/NNS and/CC efficacy/NN of/IN amphetamines/NN ./.

(ROOT (S1 (S (S (NP (NP (CC Both) (NNS groups)) (PP (IN of) (NP (NNS agents)))) (VP (JJR lower) (NP (NP (NN blood) (NNS levels)) (CC and) (NP (NP (NN efficacy)) (PP (IN of) (NP (NN amphetamines))))))) (. .))))

dep(groups-2, Both-1)
nsubj(levels-7, groups-2)
prep_of(groups-2, agents-4)
dep(levels-7, lower-5)
nn(levels-7, blood-6)
root(ROOT-0, levels-7)
conj_and(levels-7, efficacy-9)
prep_of(efficacy-9, amphetamines-11)

Adrenergic/JJ blockers/NN @/NN Adrenergic/JJ blockers/NNS are/VBP inhibited/VBN by/IN amphetamines/NN ./.

(ROOT (S1 (S (S (NP (JJ Adrenergic) (NN blockers) (NN @) (JJ Adrenergic) (NNS blockers)) (VP (VBP are) (VP (VBN inhibited) (PP (IN by) (NP (NN amphetamines)))))) (. .))))

amod(blockers-5, Adrenergic-1)
nn(blockers-5, blockers-2)
nn(blockers-5, @-3)
amod(blockers-5, Adrenergic-4)
nsubjpass(inhibited-7, blockers-5)
auxpass(inhibited-7, are-6)
root(ROOT-0, inhibited-7)
agent(inhibited-7, amphetamines-9)

Antidepressants/NNS ,/, tricyclic/JJ @/NN Amphetamines/NN may/MD enhance/VB the/DT activity/NN of/IN tricyclic/JJ antidepressants/NNS or/CC sympathomimetic/JJ agents/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NNS Antidepressants)) (, ,) (NP (JJ tricyclic) (NN @) (NN Amphetamines)) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NP (JJ tricyclic) (NNS antidepressants)) (CC or) (NP (JJ sympathomimetic) (NNS agents))))))) (: ;)) (. .))))

nsubj(enhance-7, Antidepressants-1)
amod(Amphetamines-5, tricyclic-3)
nn(Amphetamines-5, @-4)
nsubj(enhance-7, Amphetamines-5)
aux(enhance-7, may-6)
root(ROOT-0, enhance-7)
det(activity-9, the-8)
dobj(enhance-7, activity-9)
amod(antidepressants-12, tricyclic-11)
prep_of(activity-9, antidepressants-12)
amod(agents-15, sympathomimetic-14)
conj_or(antidepressants-12, agents-15)

d-amphetamine/NN with/IN desipramine/NN or/CC protriptyline/NN and/CC possibly/RB other/JJ tricyclics/NNS cause/VBP striking/JJ and/CC sustained/JJ increases/NNS in/IN the/DT concentration/NN of/IN d-amphetamine/NN in/IN the/DT brain/NN ;/: ./.

(ROOT (S1 (S (S (NP (NP (NP (NN d-amphetamine)) (PP (IN with) (NP (NP (NN desipramine)) (CC or) (NP (NN protriptyline))))) (CC and) (ADVP (RB possibly)) (NP (JJ other) (NNS tricyclics))) (VP (VBP cause) (NP (NP (ADJP (ADJP (JJ striking)) (CC and) (ADJP (JJ sustained))) (NNS increases)) (PP (IN in) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NN d-amphetamine))) (PP (IN in) (NP (DT the) (NN brain))))))) (: ;)) (. .))))

nsubj(cause-10, d-amphetamine-1)
prep_with(d-amphetamine-1, desipramine-3)
conj_or(desipramine-3, protriptyline-5)
advmod(d-amphetamine-1, possibly-7)
conj_and(d-amphetamine-1, possibly-7)
amod(tricyclics-9, other-8)
conj_and(d-amphetamine-1, tricyclics-9)
root(ROOT-0, cause-10)
amod(increases-14, striking-11)
conj_and(striking-11, sustained-13)
dobj(cause-10, increases-14)
det(concentration-17, the-16)
prep_in(increases-14, concentration-17)
prep_of(concentration-17, d-amphetamine-19)
det(brain-22, the-21)
prep_in(concentration-17, brain-22)

MAO/NN inhibitors/NNS @/NN MAOI/NN antidepressants/NNS ,/, as/RB well/RB as/IN a/DT metabolite/NN of/IN furazolidone/NN ,/, slow/JJ amphetamine/NN metabolism/NN ./.

(ROOT (S1 (S (S (NP (NN MAO)) (VP (NNS inhibitors) (NP (NP (NN @) (NN MAOI) (NNS antidepressants)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NP (DT a) (NN metabolite)) (PP (IN of) (NP (NN furazolidone)))) (, ,) (NP (JJ slow) (NN amphetamine) (NN metabolism)))))) (. .))))

nsubj(inhibitors-2, MAO-1)
root(ROOT-0, inhibitors-2)
nn(antidepressants-5, @-3)
nn(antidepressants-5, MAOI-4)
dobj(inhibitors-2, antidepressants-5)
det(metabolite-11, a-10)
conj_and(antidepressants-5, metabolite-11)
prep_of(metabolite-11, furazolidone-13)
amod(metabolism-17, slow-15)
nn(metabolism-17, amphetamine-16)
appos(metabolite-11, metabolism-17)

This/DT slowing/NN potentiates/VBZ amphetamines/NN ,/, increasing/VBG their/PRP$ effect/NN on/IN the/DT release/NN of/IN norepinephrine/NN and/CC other/JJ monoamines/NNS from/IN adrenergic/JJ nerve/NN endings/NNS ;/: ./.

(ROOT (S1 (S (S (NP (DT This) (NN slowing)) (VP (VBZ potentiates) (NP (NN amphetamines)) (, ,) (S (VP (VBG increasing) (NP (NP (PRP$ their) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (NP (NN norepinephrine)) (CC and) (NP (JJ other) (NNS monoamines)))) (PP (IN from) (NP (JJ adrenergic) (NN nerve) (NNS endings))))))))) (: ;)) (. .))))

det(slowing-2, This-1)
nsubj(potentiates-3, slowing-2)
root(ROOT-0, potentiates-3)
dobj(potentiates-3, amphetamines-4)
partmod(potentiates-3, increasing-6)
xcomp(potentiates-3, increasing-6)
poss(effect-8, their-7)
dobj(increasing-6, effect-8)
det(release-11, the-10)
prep_on(effect-8, release-11)
prep_of(release-11, norepinephrine-13)
amod(monoamines-16, other-15)
conj_and(norepinephrine-13, monoamines-16)
amod(endings-20, adrenergic-18)
nn(endings-20, nerve-19)
prep_from(release-11, endings-20)

Antihistamines/NNS @/NN Amphetamines/NN may/MD counteract/VB the/DT sedative/JJ effect/NN of/IN antihistamines/NNS ./.

(ROOT (S1 (S (S (NP (NNS Antihistamines) (NN @) (NN Amphetamines)) (VP (MD may) (VP (VB counteract) (NP (NP (DT the) (JJ sedative) (NN effect)) (PP (IN of) (NP (NNS antihistamines))))))) (. .))))

nn(Amphetamines-3, Antihistamines-1)
nn(Amphetamines-3, @-2)
nsubj(counteract-5, Amphetamines-3)
aux(counteract-5, may-4)
root(ROOT-0, counteract-5)
det(effect-8, the-6)
amod(effect-8, sedative-7)
dobj(counteract-5, effect-8)
prep_of(effect-8, antihistamines-10)

Antihypertensives/NNS @/NN Amphetamines/NN may/MD antagonize/VB the/DT hypotensive/JJ effects/NNS of/IN antihypertensives/NNS ./.

(ROOT (S1 (S (S (NP (NNS Antihypertensives) (NN @) (NN Amphetamines)) (VP (MD may) (VP (VB antagonize) (NP (NP (DT the) (JJ hypotensive) (NNS effects)) (PP (IN of) (NP (NNS antihypertensives))))))) (. .))))

nn(Amphetamines-3, Antihypertensives-1)
nn(Amphetamines-3, @-2)
nsubj(antagonize-5, Amphetamines-3)
aux(antagonize-5, may-4)
root(ROOT-0, antagonize-5)
det(effects-8, the-6)
amod(effects-8, hypotensive-7)
dobj(antagonize-5, effects-8)
prep_of(effects-8, antihypertensives-10)

Chlorpromazine/NN @/NN Chlorpromazine/NN blocks/VBZ dopamine/NN and/CC norepinephrine/NN receptors/NNS ,/, thus/RB inhibiting/VBG the/DT central/JJ stimulant/JJ effects/NNS of/IN amphetamines/NN and/CC can/MD be/VB used/VBN to/TO treat/VB amphetamine/NN poisoning/NN ./.

(ROOT (S1 (S (S (NP (NN Chlorpromazine) (NN @) (NN Chlorpromazine)) (VP (VBZ blocks) (NP (NP (NP (NN dopamine)) (CC and) (NP (NN norepinephrine))) (NNS receptors)) (, ,) (S (ADVP (RB thus)) (VP (VP (VBG inhibiting) (NP (NP (DT the) (JJ central) (JJ stimulant) (NNS effects)) (PP (IN of) (NP (NN amphetamines))))) (CC and) (VP (MD can) (VP (VB be) (VP (VBN used) (S (VP (TO to) (VP (VB treat) (NP (NN amphetamine) (NN poisoning)))))))))))) (. .))))

nn(Chlorpromazine-3, Chlorpromazine-1)
nn(Chlorpromazine-3, @-2)
nsubj(blocks-4, Chlorpromazine-3)
root(ROOT-0, blocks-4)
nn(receptors-8, dopamine-5)
conj_and(dopamine-5, norepinephrine-7)
dobj(blocks-4, receptors-8)
advmod(inhibiting-11, thus-10)
dep(blocks-4, inhibiting-11)
det(effects-15, the-12)
amod(effects-15, central-13)
amod(effects-15, stimulant-14)
dobj(inhibiting-11, effects-15)
prep_of(effects-15, amphetamines-17)
aux(used-21, can-19)
auxpass(used-21, be-20)
conj_and(inhibiting-11, used-21)
aux(treat-23, to-22)
xcomp(used-21, treat-23)
nn(poisoning-25, amphetamine-24)
dobj(treat-23, poisoning-25)

Ethosuximide/NN @/NN Amphetamines/NN may/MD delay/VB intestinal/JJ absorption/NN of/IN ethosuximide/NN ./.

(ROOT (S1 (S (S (NP (NN Ethosuximide) (NN @) (NN Amphetamines)) (VP (MD may) (VP (VB delay) (NP (NP (JJ intestinal) (NN absorption)) (PP (IN of) (NP (NN ethosuximide))))))) (. .))))

nn(Amphetamines-3, Ethosuximide-1)
nn(Amphetamines-3, @-2)
nsubj(delay-5, Amphetamines-3)
aux(delay-5, may-4)
root(ROOT-0, delay-5)
amod(absorption-7, intestinal-6)
dobj(delay-5, absorption-7)
prep_of(absorption-7, ethosuximide-9)

Haloperidol/JJ @/NN Haloperidol/NN blocks/VBZ dopamine/NN receptors/NNS ,/, thus/RB inhibiting/VBG the/DT central/JJ stimulant/NN effects/NNS of/IN amphetamines/NN ./.

(ROOT (S1 (S (S (NP (JJ Haloperidol) (NN @) (NN Haloperidol)) (VP (VBZ blocks) (NP (NN dopamine) (NNS receptors)) (, ,) (S (ADVP (RB thus)) (VP (VBG inhibiting) (NP (NP (DT the) (JJ central) (NN stimulant) (NNS effects)) (PP (IN of) (NP (NN amphetamines)))))))) (. .))))

amod(Haloperidol-3, Haloperidol-1)
nn(Haloperidol-3, @-2)
nsubj(blocks-4, Haloperidol-3)
root(ROOT-0, blocks-4)
nn(receptors-6, dopamine-5)
dobj(blocks-4, receptors-6)
advmod(inhibiting-9, thus-8)
partmod(blocks-4, inhibiting-9)
xcomp(blocks-4, inhibiting-9)
det(effects-13, the-10)
amod(effects-13, central-11)
nn(effects-13, stimulant-12)
dobj(inhibiting-9, effects-13)
prep_of(effects-13, amphetamines-15)

Lithium/NN carbonate/NN @/NN The/DT anorectic/JJ and/CC stimulatory/JJ effects/NNS of/IN amphetamines/NN may/MD be/VB inhibited/VBN by/IN lithium/NN carbonate/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Lithium) (NN carbonate)) (VP (NN @) (NP (NP (DT The) (ADJP (ADJP (JJ anorectic)) (CC and) (ADJP (JJ stimulatory))) (NNS effects)) (PP (IN of) (NP (NN amphetamines)))))) (VP (MD may) (VP (VB be) (VP (VBN inhibited) (PP (IN by) (NP (NN lithium) (NN carbonate))))))) (. .))))

nn(carbonate-2, Lithium-1)
nsubjpass(inhibited-13, carbonate-2)
dep(carbonate-2, @-3)
det(effects-8, The-4)
amod(effects-8, anorectic-5)
conj_and(anorectic-5, stimulatory-7)
dobj(@-3, effects-8)
prep_of(effects-8, amphetamines-10)
aux(inhibited-13, may-11)
auxpass(inhibited-13, be-12)
root(ROOT-0, inhibited-13)
nn(carbonate-16, lithium-15)
agent(inhibited-13, carbonate-16)

Meperidine/NN @/NN Amphetamines/NNS potentiate/VB the/DT analgesic/JJ effect/NN of/IN meperidine/NN ./.

(ROOT (S1 (S (S (NP (NN Meperidine) (NN @) (NNS Amphetamines)) (VP (VB potentiate) (NP (NP (DT the) (JJ analgesic) (NN effect)) (PP (IN of) (NP (NN meperidine)))))) (. .))))

nn(Amphetamines-3, Meperidine-1)
nn(Amphetamines-3, @-2)
nsubj(potentiate-4, Amphetamines-3)
root(ROOT-0, potentiate-4)
det(effect-7, the-5)
amod(effect-7, analgesic-6)
dobj(potentiate-4, effect-7)
prep_of(effect-7, meperidine-9)

Methenamine/NN therapy/NN @/NN Urinary/JJ excretion/NN of/IN amphetamines/NN is/VBZ increased/VBN ,/, and/CC efficacy/NN is/VBZ reduced/VBN by/IN acidifying/VBG agents/NNS used/VBN in/IN methenamine/NN therapy/NN ./.

(ROOT (S1 (S (S (S (NP (NP (NN Methenamine) (NN therapy) (NN @) (JJ Urinary) (NN excretion)) (PP (IN of) (NP (NN amphetamines)))) (VP (VBZ is) (VP (VBN increased)))) (, ,) (CC and) (S (NP (NN efficacy)) (VP (VBZ is) (VP (VBN reduced) (PP (IN by) (S (VP (VBG acidifying) (NP (NP (NNS agents)) (VP (VBN used) (PP (IN in) (NP (NN methenamine) (NN therapy)))))))))))) (. .))))

nn(excretion-5, Methenamine-1)
nn(excretion-5, therapy-2)
nn(excretion-5, @-3)
amod(excretion-5, Urinary-4)
nsubjpass(increased-9, excretion-5)
prep_of(excretion-5, amphetamines-7)
auxpass(increased-9, is-8)
root(ROOT-0, increased-9)
nsubjpass(reduced-14, efficacy-12)
auxpass(reduced-14, is-13)
conj_and(increased-9, reduced-14)
agent(reduced-14, acidifying-16)
dobj(acidifying-16, agents-17)
partmod(agents-17, used-18)
nn(therapy-21, methenamine-20)
prep_in(used-18, therapy-21)

Norepinephrine/NN @/NN Amphetamines/NNS enhance/VBP the/DT adrenergic/JJ effect/NN of/IN norepinephrine/NN ./.

(ROOT (S1 (S (S (NP (NN Norepinephrine) (NN @) (NNS Amphetamines)) (VP (VBP enhance) (NP (NP (DT the) (JJ adrenergic) (NN effect)) (PP (IN of) (NP (NN norepinephrine)))))) (. .))))

nn(Amphetamines-3, Norepinephrine-1)
nn(Amphetamines-3, @-2)
nsubj(enhance-4, Amphetamines-3)
root(ROOT-0, enhance-4)
det(effect-7, the-5)
amod(effect-7, adrenergic-6)
dobj(enhance-4, effect-7)
prep_of(effect-7, norepinephrine-9)

Phenobarbital/JJ @/NN Amphetamines/NN may/MD delay/VB intestinal/JJ absorption/NN of/IN phenobarbital/NN ;/: ./.

(ROOT (S1 (S (S (NP (JJ Phenobarbital) (NN @) (NN Amphetamines)) (VP (MD may) (VP (VB delay) (NP (NP (JJ intestinal) (NN absorption)) (PP (IN of) (NP (NN phenobarbital)))))) (: ;)) (. .))))

amod(Amphetamines-3, Phenobarbital-1)
nn(Amphetamines-3, @-2)
nsubj(delay-5, Amphetamines-3)
aux(delay-5, may-4)
root(ROOT-0, delay-5)
amod(absorption-7, intestinal-6)
dobj(delay-5, absorption-7)
prep_of(absorption-7, phenobarbital-9)

co-administration/NN of/IN phenobarbital/NN may/MD produce/VB a/DT synergistic/JJ anticonvulsant/JJ action/NN ./.

(ROOT (S1 (S (S (NP (NP (NN co-administration)) (PP (IN of) (NP (NN phenobarbital)))) (VP (MD may) (VP (VB produce) (NP (DT a) (JJ synergistic) (JJ anticonvulsant) (NN action))))) (. .))))

nsubj(produce-5, co-administration-1)
prep_of(co-administration-1, phenobarbital-3)
aux(produce-5, may-4)
root(ROOT-0, produce-5)
det(action-9, a-6)
amod(action-9, synergistic-7)
amod(action-9, anticonvulsant-8)
dobj(produce-5, action-9)

Phenytoin/NN @/NN Amphetamines/NN may/MD delay/VB intestinal/JJ absorption/NN of/IN phenytoin/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN Phenytoin) (NN @) (NN Amphetamines)) (VP (MD may) (VP (VB delay) (NP (NP (JJ intestinal) (NN absorption)) (PP (IN of) (NP (NN phenytoin)))))) (: ;)) (. .))))

nn(Amphetamines-3, Phenytoin-1)
nn(Amphetamines-3, @-2)
nsubj(delay-5, Amphetamines-3)
aux(delay-5, may-4)
root(ROOT-0, delay-5)
amod(absorption-7, intestinal-6)
dobj(delay-5, absorption-7)
prep_of(absorption-7, phenytoin-9)

co-administration/NN of/IN phenytoin/NN may/MD produce/VB a/DT synergistic/JJ anticonvulsant/JJ action/NN ./.

(ROOT (S1 (S (S (NP (NP (NN co-administration)) (PP (IN of) (NP (NN phenytoin)))) (VP (MD may) (VP (VB produce) (NP (DT a) (JJ synergistic) (JJ anticonvulsant) (NN action))))) (. .))))

nsubj(produce-5, co-administration-1)
prep_of(co-administration-1, phenytoin-3)
aux(produce-5, may-4)
root(ROOT-0, produce-5)
det(action-9, a-6)
amod(action-9, synergistic-7)
amod(action-9, anticonvulsant-8)
dobj(produce-5, action-9)

Propoxyphene/NN @/NN In/IN cases/NNS of/IN propoxyphene/NN overdosage/NN ,/, amphetamine/NN CNS/NN stimulation/NN is/VBZ potentiated/VBN and/CC fatal/JJ convulsions/NNS can/MD occur/VB ./.

(ROOT (S1 (S (S (S (NP (NP (NN Propoxyphene) (NN @)) (PP (IN In) (NP (NP (NNS cases)) (PP (IN of) (NP (NP (NN propoxyphene) (NN overdosage)) (, ,) (NP (NN amphetamine) (NN CNS) (NN stimulation))))))) (VP (VBZ is) (VP (VBN potentiated)))) (CC and) (S (NP (JJ fatal) (NNS convulsions)) (VP (MD can) (VP (VB occur))))) (. .))))

nn(@-2, Propoxyphene-1)
nsubjpass(potentiated-13, @-2)
prep_in(@-2, cases-4)
nn(overdosage-7, propoxyphene-6)
prep_of(cases-4, overdosage-7)
nn(stimulation-11, amphetamine-9)
nn(stimulation-11, CNS-10)
appos(overdosage-7, stimulation-11)
auxpass(potentiated-13, is-12)
root(ROOT-0, potentiated-13)
amod(convulsions-16, fatal-15)
nsubj(occur-18, convulsions-16)
aux(occur-18, can-17)
conj_and(potentiated-13, occur-18)

Veratrum/NN alkaloids/NNS @/NN Amphetamines/NN inhibit/VBP the/DT hypotensive/JJ effect/NN of/IN veratrum/NN alkaloids/NNS ./.

(ROOT (S1 (S (S (NP (NN Veratrum) (NNS alkaloids) (NP (NN @) (NN Amphetamines))) (VP (VBP inhibit) (NP (NP (DT the) (JJ hypotensive) (NN effect)) (PP (IN of) (NP (NN veratrum) (NNS alkaloids)))))) (. .))))

nn(alkaloids-2, Veratrum-1)
nsubj(inhibit-5, alkaloids-2)
nn(Amphetamines-4, @-3)
dep(alkaloids-2, Amphetamines-4)
root(ROOT-0, inhibit-5)
det(effect-8, the-6)
amod(effect-8, hypotensive-7)
dobj(inhibit-5, effect-8)
nn(alkaloids-11, veratrum-10)
prep_of(effect-8, alkaloids-11)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: Amphetamines/NN can/MD cause/VB a/DT significant/JJ elevation/NN in/IN plasma/NN corticosteroid/NN levels/NNS ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (NP (NN Amphetamines)) (VP (MD can) (VP (VB cause) (NP (NP (DT a) (JJ significant) (NN elevation)) (PP (IN in) (NP (NN plasma) (NN corticosteroid) (NNS levels))))))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
nsubj(cause-8, Amphetamines-6)
aux(cause-8, can-7)
dep(Interactions-4, cause-8)
det(elevation-11, a-9)
amod(elevation-11, significant-10)
dobj(cause-8, elevation-11)
nn(levels-15, plasma-13)
nn(levels-15, corticosteroid-14)
prep_in(elevation-11, levels-15)

Amphetamines/NN may/MD interfere/VB with/IN urinary/JJ steroid/NN determinations/NNS ./.

(ROOT (S1 (S (S (NP (NN Amphetamines)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (JJ urinary) (NN steroid) (NNS determinations)))))) (. .))))

nsubj(interfere-3, Amphetamines-1)
aux(interfere-3, may-2)
root(ROOT-0, interfere-3)
amod(determinations-7, urinary-5)
nn(determinations-7, steroid-6)
prep_with(interfere-3, determinations-7)

Hypotension/NN -/: Patients/NNS on/IN Diuretic/JJ Therapy/NN :/: Patients/NNS on/IN diuretics/NN ,/, and/CC especially/RB those/DT in/IN whom/WP diuretic/JJ therapy/NN was/VBD recently/RB instituted/VBN ,/, may/MD occasionally/RB experience/VBP an/DT excessive/JJ reduction/NN of/IN blood/NN pressure/NN after/IN initiation/NN of/IN therapy/NN with/IN PRINIVIL/NN ./.

(ROOT (S1 (S (NP (NP (NN Hypotension)) (: -) (S (NP (NP (NP (NNS Patients)) (PP (IN on) (NP (JJ Diuretic) (NN Therapy)))) (: :) (NP (NP (NNS Patients)) (PP (IN on) (NP (NN diuretics)))) (, ,) (CC and) (ADVP (RB especially)) (NP (NP (DT those)) (SBAR (WHPP (IN in) (WHNP (WP whom))) (S (NP (JJ diuretic) (NN therapy)) (VP (VBD was) (ADVP (RB recently)) (VP (VBN instituted)))))) (, ,)) (VP (MD may) (ADVP (RB occasionally)) (VP (VBP experience) (NP (NP (DT an) (JJ excessive) (NN reduction)) (PP (IN of) (NP (NN blood) (NN pressure)))) (PP (IN after) (NP (NP (NN initiation)) (PP (IN of) (NP (NP (NN therapy)) (PP (IN with) (NP (NN PRINIVIL)))))))))) (. .)))))

root(ROOT-0, Hypotension-1)
nsubj(experience-25, Patients-3)
amod(Therapy-6, Diuretic-5)
prep_on(Patients-3, Therapy-6)
conj_and(Patients-3, Patients-8)
prep_on(Patients-8, diuretics-10)
advmod(Patients-3, especially-13)
conj_and(Patients-3, especially-13)
conj_and(Patients-3, those-14)
rel(instituted-21, whom-16)
amod(therapy-18, diuretic-17)
nsubjpass(instituted-21, therapy-18)
auxpass(instituted-21, was-19)
advmod(instituted-21, recently-20)
rcmod(those-14, instituted-21)
aux(experience-25, may-23)
advmod(experience-25, occasionally-24)
dep(Hypotension-1, experience-25)
det(reduction-28, an-26)
amod(reduction-28, excessive-27)
dobj(experience-25, reduction-28)
nn(pressure-31, blood-30)
prep_of(reduction-28, pressure-31)
prep_after(experience-25, initiation-33)
prep_of(initiation-33, therapy-35)
prep_with(therapy-35, PRINIVIL-37)

The/DT possibility/NN of/IN hypotensive/JJ effects/NNS with/IN PRINIVIL/NN can/MD be/VB minimized/VBN by/IN either/CC discontinuing/VBG the/DT diuretic/JJ or/CC increasing/VBG the/DT salt/NN intake/NN prior/JJ to/TO initiation/NN of/IN treatment/NN with/IN PRINIVIL/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN possibility)) (PP (IN of) (NP (NP (JJ hypotensive) (NNS effects)) (PP (IN with) (NP (NN PRINIVIL)))))) (VP (MD can) (VP (VB be) (VP (VBN minimized) (PP (IN by) (S (VP (CC either) (VP (VBG discontinuing) (NP (DT the) (JJ diuretic))) (CC or) (VP (VBG increasing) (NP (NP (DT the) (NN salt) (NN intake)) (ADJP (JJ prior) (PP (TO to) (NP (NP (NN initiation)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN with) (NP (NN PRINIVIL))))))))))))))))) (. .))))

det(possibility-2, The-1)
nsubjpass(minimized-10, possibility-2)
amod(effects-5, hypotensive-4)
prep_of(possibility-2, effects-5)
prep_with(effects-5, PRINIVIL-7)
aux(minimized-10, can-8)
auxpass(minimized-10, be-9)
root(ROOT-0, minimized-10)
preconj(discontinuing-13, either-12)
agent(minimized-10, discontinuing-13)
det(diuretic-15, the-14)
dobj(discontinuing-13, diuretic-15)
conj_or(discontinuing-13, increasing-17)
det(intake-20, the-18)
nn(intake-20, salt-19)
dobj(increasing-17, intake-20)
prep_prior_to(intake-20, initiation-23)
prep_of(initiation-23, treatment-25)
prep_with(treatment-25, PRINIVIL-27)

If/IN it/PRP is/VBZ necessary/JJ to/TO continue/VB the/DT diuretic/NN ,/, initiate/VB therapy/NN with/IN PRINIVIL/NN at/IN a/DT dose/NN of/IN 5/CD mg/NN daily/RB ,/, and/CC provide/VB close/JJ medical/JJ supervision/NN after/IN the/DT initial/JJ dose/NN until/IN blood/NN pressure/NN has/VBZ stabilized/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (PRP it)) (VP (VBZ is) (ADJP (JJ necessary) (S (VP (TO to) (VP (VP (VB continue) (NP (DT the) (NN diuretic))) (, ,) (VP (VB initiate) (NP (NP (NN therapy)) (PP (IN with) (NP (NN PRINIVIL)))) (PP (IN at) (NP (NP (DT a) (NN dose)) (PP (IN of) (NP (NP (CD 5) (NN mg)) (ADVP (RB daily))))))) (, ,) (CC and) (VP (VB provide) (NP (NP (JJ close) (JJ medical) (NN supervision)) (PP (IN after) (NP (NP (DT the) (JJ initial) (NN dose)) (PP (IN until) (NP (NN blood) (NN pressure)))))))))))))) (VP (VBZ has) (VP (VBN stabilized)))) (. .))))

mark(necessary-4, If-1)
nsubj(necessary-4, it-2)
cop(necessary-4, is-3)
csubj(stabilized-35, necessary-4)
aux(continue-6, to-5)
xcomp(necessary-4, continue-6)
det(diuretic-8, the-7)
dobj(continue-6, diuretic-8)
conj_and(continue-6, initiate-10)
dobj(initiate-10, therapy-11)
prep_with(therapy-11, PRINIVIL-13)
det(dose-16, a-15)
prep_at(initiate-10, dose-16)
num(mg-19, 5-18)
prep_of(dose-16, mg-19)
advmod(mg-19, daily-20)
conj_and(continue-6, provide-23)
amod(supervision-26, close-24)
amod(supervision-26, medical-25)
dobj(provide-23, supervision-26)
det(dose-30, the-28)
amod(dose-30, initial-29)
prep_after(supervision-26, dose-30)
nn(pressure-33, blood-32)
prep_until(dose-30, pressure-33)
aux(stabilized-35, has-34)
root(ROOT-0, stabilized-35)

When/WRB a/DT diuretic/NN is/VBZ added/VBN to/TO the/DT therapy/NN of/IN a/DT patient/NN receiving/VBG PRINIVIL/NN ,/, an/DT additional/JJ antihypertensive/JJ effect/NN is/VBZ usually/RB observed/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (DT a) (NN diuretic)) (VP (VBZ is) (VP (VBN added) (PP (TO to) (NP (NP (DT the) (NN therapy)) (PP (IN of) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN PRINIVIL))))))))))) (, ,) (NP (DT an) (JJ additional) (JJ antihypertensive) (NN effect)) (VP (VBZ is) (ADVP (RB usually)) (VP (VBN observed)))) (. .))))

advmod(added-5, When-1)
det(diuretic-3, a-2)
nsubjpass(added-5, diuretic-3)
auxpass(added-5, is-4)
advcl(observed-21, added-5)
det(therapy-8, the-7)
prep_to(added-5, therapy-8)
det(patient-11, a-10)
prep_of(therapy-8, patient-11)
partmod(patient-11, receiving-12)
dobj(receiving-12, PRINIVIL-13)
det(effect-18, an-15)
amod(effect-18, additional-16)
amod(effect-18, antihypertensive-17)
nsubjpass(observed-21, effect-18)
auxpass(observed-21, is-19)
advmod(observed-21, usually-20)
root(ROOT-0, observed-21)

Studies/NNS with/IN ACE/NN inhibitors/NNS in/IN combination/NN with/IN diuretics/NNS indicate/VBP that/IN the/DT dose/NN of/IN the/DT ACE/NN inhibitor/NN can/MD be/VB reduced/VBN when/WRB it/PRP is/VBZ given/VBN with/IN a/DT diuretic/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Studies)) (PP (IN with) (NP (NN ACE) (NNS inhibitors))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NNS diuretics)))))) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (DT the) (NN ACE) (NN inhibitor)))) (VP (MD can) (VP (VB be) (VP (VBN reduced))) (SBAR (WHADVP (WRB when)) (S (NP (PRP it)) (VP (VBZ is) (VP (VBN given) (PP (IN with) (NP (DT a) (NN diuretic)))))))))))) (. .))))

nsubj(indicate-9, Studies-1)
nn(inhibitors-4, ACE-3)
prep_with(Studies-1, inhibitors-4)
prep_in(Studies-1, combination-6)
prep_with(combination-6, diuretics-8)
root(ROOT-0, indicate-9)
complm(reduced-19, that-10)
det(dose-12, the-11)
nsubjpass(reduced-19, dose-12)
det(inhibitor-16, the-14)
nn(inhibitor-16, ACE-15)
prep_of(dose-12, inhibitor-16)
aux(reduced-19, can-17)
auxpass(reduced-19, be-18)
ccomp(indicate-9, reduced-19)
advmod(given-23, when-20)
nsubjpass(given-23, it-21)
auxpass(given-23, is-22)
advcl(reduced-19, given-23)
det(diuretic-26, a-25)
prep_with(given-23, diuretic-26)

Non-steroidal/JJ Anti-inflammatory/JJ Agents/NNS :/: In/IN some/DT patients/NNS with/IN compromised/VBN renal/JJ function/NN who/WP are/VBP being/VBG treated/VBN with/IN non-steroidal/JJ anti-inflammatory/JJ drugs/NNS ,/, the/DT co-administration/NN of/IN lisinopril/NN may/MD result/VB in/IN a/DT further/JJ deterioration/NN of/IN renal/JJ function/NN ./.

(ROOT (S1 (S (NP (NP (JJ Non-steroidal) (JJ Anti-inflammatory) (NNS Agents)) (: :) (S (PP (IN In) (NP (NP (DT some) (NNS patients)) (PP (IN with) (NP (VBN compromised) (JJ renal) (NN function))) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (JJ non-steroidal) (JJ anti-inflammatory) (NNS drugs)))))))))) (, ,) (NP (NP (DT the) (NN co-administration)) (PP (IN of) (NP (NN lisinopril)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT a) (JJ further) (NN deterioration)) (PP (IN of) (NP (JJ renal) (NN function)))))))) (. .)))))

amod(Agents-3, Non-steroidal-1)
amod(Agents-3, Anti-inflammatory-2)
root(ROOT-0, Agents-3)
det(patients-7, some-6)
nsubjpass(treated-15, patients-7)
prep_in(result-26, patients-7)
amod(function-11, compromised-9)
amod(function-11, renal-10)
prep_with(patients-7, function-11)
aux(treated-15, are-13)
auxpass(treated-15, being-14)
rcmod(patients-7, treated-15)
amod(drugs-19, non-steroidal-17)
amod(drugs-19, anti-inflammatory-18)
prep_with(treated-15, drugs-19)
det(co-administration-22, the-21)
nsubj(result-26, co-administration-22)
prep_of(co-administration-22, lisinopril-24)
aux(result-26, may-25)
dep(Agents-3, result-26)
det(deterioration-30, a-28)
amod(deterioration-30, further-29)
prep_in(result-26, deterioration-30)
amod(function-33, renal-32)
prep_of(deterioration-30, function-33)

Reports/NNS suggest/VBP that/IN NSAIDs/NNS may/MD diminish/VB the/DT antihypertensive/JJ effect/NN of/IN ACE/NN inhibitors/NNS ,/, including/VBG lisinopril/NN ./.

(ROOT (S1 (S (S (NP (NNS Reports)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS NSAIDs)) (VP (MD may) (VP (VB diminish) (NP (NP (DT the) (JJ antihypertensive) (NN effect)) (PP (IN of) (NP (NP (NN ACE) (NNS inhibitors)) (, ,) (PP (VBG including) (NP (NN lisinopril)))))))))))) (. .))))

nsubj(suggest-2, Reports-1)
root(ROOT-0, suggest-2)
complm(diminish-6, that-3)
nsubj(diminish-6, NSAIDs-4)
aux(diminish-6, may-5)
ccomp(suggest-2, diminish-6)
det(effect-9, the-7)
amod(effect-9, antihypertensive-8)
dobj(diminish-6, effect-9)
nn(inhibitors-12, ACE-11)
prep_of(effect-9, inhibitors-12)
prep_including(inhibitors-12, lisinopril-15)

This/DT interaction/NN should/MD be/VB given/VBN consideration/NN in/IN patients/NNS taking/VBG NSAIDs/NN concomitantly/RB with/IN ACE/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (DT This) (NN interaction)) (VP (MD should) (VP (VB be) (VP (VBN given) (NP (NP (NN consideration)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN NSAIDs)))))) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN ACE) (NNS inhibitors))))))) (. .))))

det(interaction-2, This-1)
nsubjpass(given-5, interaction-2)
aux(given-5, should-3)
auxpass(given-5, be-4)
root(ROOT-0, given-5)
dobj(given-5, consideration-6)
prep_in(consideration-6, patients-8)
partmod(patients-8, taking-9)
dobj(taking-9, NSAIDs-10)
advmod(given-5, concomitantly-11)
nn(inhibitors-14, ACE-13)
prep_with(given-5, inhibitors-14)

In/IN a/DT study/NN in/IN 36/CD patients/NNS with/IN mild/JJ to/TO moderate/JJ hypertension/NN where/WRB the/DT antihypertensive/JJ effects/NNS of/IN PRINIVIL/NN alone/RB were/VBD compared/VBN to/TO PRINIVIL/VB given/VBN concomitantly/RB with/IN indomethacin/NN ,/, the/DT use/NN of/IN indomethacin/NN was/VBD associated/VBN with/IN a/DT reduced/VBN antihypertensive/JJ effect/NN ,/, although/IN the/DT difference/NN between/IN the/DT two/CD regimens/NNS was/VBD not/RB significant/JJ ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (DT a) (NN study)) (PP (IN in) (NP (NP (CD 36) (NNS patients)) (PP (IN with) (NP (NP (ADJP (JJ mild) (TO to) (JJ moderate)) (NN hypertension)) (SBAR (WHADVP (WRB where)) (S (NP (NP (DT the) (JJ antihypertensive) (NNS effects)) (PP (IN of) (NP (NP (NN PRINIVIL)) (ADVP (RB alone))))) (VP (VBD were) (VP (VBN compared) (S (VP (TO to) (VP (VB PRINIVIL) (VP (VBN given) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN indomethacin))))))))))))))))) (, ,) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN indomethacin)))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (DT a) (VBN reduced) (JJ antihypertensive) (NN effect)))) (, ,) (SBAR (IN although) (S (NP (NP (DT the) (NN difference)) (PP (IN between) (NP (DT the) (CD two) (NNS regimens)))) (VP (VBD was) (RB not) (ADJP (JJ significant)))))) (. .))))

det(study-3, a-2)
prep_in(associated-33, study-3)
num(patients-6, 36-5)
prep_in(study-3, patients-6)
amod(moderate-10, mild-8)
dep(moderate-10, to-9)
amod(hypertension-11, moderate-10)
prep_with(patients-6, hypertension-11)
advmod(compared-20, where-12)
det(effects-15, the-13)
amod(effects-15, antihypertensive-14)
nsubjpass(compared-20, effects-15)
xsubj(PRINIVIL-22, effects-15)
prep_of(effects-15, PRINIVIL-17)
advmod(PRINIVIL-17, alone-18)
auxpass(compared-20, were-19)
rcmod(hypertension-11, compared-20)
aux(PRINIVIL-22, to-21)
xcomp(compared-20, PRINIVIL-22)
dep(PRINIVIL-22, given-23)
advmod(given-23, concomitantly-24)
prep_with(given-23, indomethacin-26)
det(use-29, the-28)
nsubjpass(associated-33, use-29)
prep_of(use-29, indomethacin-31)
auxpass(associated-33, was-32)
root(ROOT-0, associated-33)
det(effect-38, a-35)
amod(effect-38, reduced-36)
amod(effect-38, antihypertensive-37)
prep_with(associated-33, effect-38)
mark(significant-49, although-40)
det(difference-42, the-41)
nsubj(significant-49, difference-42)
det(regimens-46, the-44)
num(regimens-46, two-45)
prep_between(difference-42, regimens-46)
cop(significant-49, was-47)
neg(significant-49, not-48)
advcl(associated-33, significant-49)

Other/JJ Agents/NNS :/: PRINIVIL/NN has/VBZ been/VBN used/VBN concomitantly/RB with/IN nitrates/NNS and/or/CC digoxin/NN without/IN evidence/NN of/IN clinically/RB significant/JJ adverse/JJ interactions/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Other) (NNS Agents)) (: :) (S (NP (NN PRINIVIL)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NNS nitrates)) (CC and/or) (NP (NN digoxin)))) (PP (IN without) (NP (NP (NN evidence)) (PP (IN of) (NP (ADJP (RB clinically) (JJ significant)) (JJ adverse) (NNS interactions))))))))) (. .)))))

amod(Agents-2, Other-1)
root(ROOT-0, Agents-2)
nsubjpass(used-7, PRINIVIL-4)
aux(used-7, has-5)
auxpass(used-7, been-6)
dep(Agents-2, used-7)
advmod(used-7, concomitantly-8)
prep_with(used-7, nitrates-10)
conj_and/or(nitrates-10, digoxin-12)
prep_without(used-7, evidence-14)
advmod(significant-17, clinically-16)
amod(interactions-19, significant-17)
amod(interactions-19, adverse-18)
prep_of(evidence-14, interactions-19)

This/DT included/VBD post/JJ myocardial/JJ infarction/NN patients/NNS who/WP were/VBD receiving/VBG intravenous/JJ or/CC transdermal/JJ nitroglycerin/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (VBD included) (NP (NP (JJ post) (JJ myocardial) (NN infarction) (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBD were) (VP (VBG receiving) (NP (ADJP (ADJP (JJ intravenous)) (CC or) (ADJP (JJ transdermal))) (NN nitroglycerin))))))))) (. .))))

nsubj(included-2, This-1)
root(ROOT-0, included-2)
amod(patients-6, post-3)
amod(patients-6, myocardial-4)
nn(patients-6, infarction-5)
dobj(included-2, patients-6)
nsubj(receiving-9, patients-6)
aux(receiving-9, were-8)
rcmod(patients-6, receiving-9)
amod(nitroglycerin-13, intravenous-10)
conj_or(intravenous-10, transdermal-12)
dobj(receiving-9, nitroglycerin-13)

No/DT clinically/RB important/JJ pharmacokinetic/JJ interactions/NNS occurred/VBD when/WRB PRINIVIL/NN was/VBD used/VBN concomitantly/RB with/IN propranolol/NN or/CC hydrochlorothiazide/NN ./.

(ROOT (S1 (S (S (NP (DT No) (ADJP (RB clinically) (JJ important)) (JJ pharmacokinetic) (NNS interactions)) (VP (VBD occurred) (SBAR (WHADVP (WRB when)) (S (NP (NN PRINIVIL)) (VP (VBD was) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NN propranolol)) (CC or) (NP (NN hydrochlorothiazide)))))))))) (. .))))

det(interactions-5, No-1)
advmod(important-3, clinically-2)
amod(interactions-5, important-3)
amod(interactions-5, pharmacokinetic-4)
nsubj(occurred-6, interactions-5)
root(ROOT-0, occurred-6)
advmod(used-10, when-7)
nsubjpass(used-10, PRINIVIL-8)
auxpass(used-10, was-9)
advcl(occurred-6, used-10)
advmod(used-10, concomitantly-11)
prep_with(used-10, propranolol-13)
conj_or(propranolol-13, hydrochlorothiazide-15)

The/DT presence/NN of/IN food/NN in/IN the/DT stomach/NN does/VBZ not/RB alter/VB the/DT bioavailability/NN of/IN PRINIVIL/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN presence)) (PP (IN of) (NP (NN food))) (PP (IN in) (NP (DT the) (NN stomach)))) (VP (VBZ does) (RB not) (VP (VB alter) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (NN PRINIVIL))))))) (. .))))

det(presence-2, The-1)
nsubj(alter-10, presence-2)
prep_of(presence-2, food-4)
det(stomach-7, the-6)
prep_in(presence-2, stomach-7)
aux(alter-10, does-8)
neg(alter-10, not-9)
root(ROOT-0, alter-10)
det(bioavailability-12, the-11)
dobj(alter-10, bioavailability-12)
prep_of(bioavailability-12, PRINIVIL-14)

Agents/NNS Increasing/VBG Serum/NN Potassium/NN :/: PRINIVIL/NN attenuates/VBZ potassium/NN loss/NN caused/VBN by/IN thiazide-type/JJ diuretics/NN ./.

(ROOT (S1 (S (S (S (NP (NNS Agents)) (VP (VBG Increasing) (NP (NN Serum) (NN Potassium)))) (: :) (S (NP (NN PRINIVIL)) (VP (VBZ attenuates) (NP (NP (NN potassium) (NN loss)) (VP (VBN caused) (PP (IN by) (NP (JJ thiazide-type) (NN diuretics)))))))) (. .))))

nsubj(Increasing-2, Agents-1)
root(ROOT-0, Increasing-2)
nn(Potassium-4, Serum-3)
dobj(Increasing-2, Potassium-4)
nsubj(attenuates-7, PRINIVIL-6)
parataxis(Increasing-2, attenuates-7)
nn(loss-9, potassium-8)
dobj(attenuates-7, loss-9)
partmod(loss-9, caused-10)
amod(diuretics-13, thiazide-type-12)
agent(caused-10, diuretics-13)

Use/NN of/IN PRINIVIL/NN with/IN potassium-sparing/JJ diuretics/NNS (/-LRB- e.g./FW ,/, spironolactone/NN ,/, triamterene/NN ,/, or/CC amiloride/NN )/-RRB- ,/, potassium/NN supplement/NN s/NNS ,/, or/CC potassium-containing/JJ salt/NN substitutes/VBZ may/MD lead/VB to/TO significant/JJ increases/NNS in/IN serum/NN potassium/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Use)) (PP (IN of) (NP (NN PRINIVIL))) (PP (IN with) (NP (NP (NP (JJ potassium-sparing) (NNS diuretics)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN spironolactone)) (, ,) (NP (NN triamterene)) (, ,) (CC or) (NP (NN amiloride)))) (-RRB- -RRB-))) (, ,) (NP (NN potassium) (NN supplement) (NNS s)) (, ,) (CC or) (NP (JJ potassium-containing) (NN salt) (VBZ substitutes))))) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (JJ significant) (NNS increases)) (PP (IN in) (NP (NN serum) (NN potassium)))))))) (. .))))

nsubj(lead-27, Use-1)
prep_of(Use-1, PRINIVIL-3)
amod(diuretics-6, potassium-sparing-5)
prep_with(Use-1, diuretics-6)
dep(diuretics-6, e.g.-8)
pobj(e.g.-8, spironolactone-10)
conj_or(spironolactone-10, triamterene-12)
conj_or(spironolactone-10, amiloride-15)
nn(s-20, potassium-18)
nn(s-20, supplement-19)
conj_or(diuretics-6, s-20)
amod(salt-24, potassium-containing-23)
conj_or(diuretics-6, salt-24)
dep(salt-24, substitutes-25)
aux(lead-27, may-26)
root(ROOT-0, lead-27)
amod(increases-30, significant-29)
prep_to(lead-27, increases-30)
nn(potassium-33, serum-32)
prep_in(increases-30, potassium-33)

Potassium/NN sparing/NN agents/NNS should/MD generally/RB not/RB be/VB used/VBN in/IN patients/NNS with/IN heart/NN failure/NN who/WP are/VBP receiving/VBG PRINIVIL/NN ./.

(ROOT (S1 (S (S (NP (NN Potassium) (NN sparing) (NNS agents)) (VP (MD should) (ADVP (RB generally)) (RB not) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN heart) (NN failure))) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG receiving) (NP (NN PRINIVIL)))))))))))) (. .))))

nn(agents-3, Potassium-1)
nn(agents-3, sparing-2)
nsubjpass(used-8, agents-3)
aux(used-8, should-4)
advmod(used-8, generally-5)
neg(used-8, not-6)
auxpass(used-8, be-7)
root(ROOT-0, used-8)
prep_in(used-8, patients-10)
nsubj(receiving-16, patients-10)
nn(failure-13, heart-12)
prep_with(patients-10, failure-13)
aux(receiving-16, are-15)
rcmod(patients-10, receiving-16)
dobj(receiving-16, PRINIVIL-17)

Lithium/NN :/: Lithium/NN toxicity/NN has/VBZ been/VBN reported/VBN in/IN patients/NNS receiving/VBG lithium/NN concomitantly/RB with/IN drugs/NNS which/WDT cause/VBP elimination/NN of/IN sodium/NN ,/, including/VBG ACE/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Lithium)) (: :) (NP (NN Lithium) (NN toxicity))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN lithium)) (PP (ADVP (RB concomitantly)) (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT which)) (S (VP (VBP cause) (NP (NP (NN elimination)) (PP (IN of) (NP (NN sodium))))))) (, ,) (PP (VBG including) (NP (NN ACE) (NNS inhibitors))))))))))))) (. .))))

nsubjpass(reported-7, Lithium-1)
nn(toxicity-4, Lithium-3)
dep(Lithium-1, toxicity-4)
aux(reported-7, has-5)
auxpass(reported-7, been-6)
root(ROOT-0, reported-7)
prep_in(reported-7, patients-9)
partmod(patients-9, receiving-10)
dobj(receiving-10, lithium-11)
advmod(lithium-11, concomitantly-12)
prep_with(lithium-11, drugs-14)
nsubj(cause-16, drugs-14)
rcmod(drugs-14, cause-16)
dobj(cause-16, elimination-17)
prep_of(elimination-17, sodium-19)
nn(inhibitors-23, ACE-22)
prep_including(drugs-14, inhibitors-23)

Lithium/NN toxicity/NN was/VBD usually/RB reversible/JJ upon/IN discontinuation/NN of/IN lithium/NN and/CC the/DT ACE/NN inhibitor/NN ./.

(ROOT (S1 (S (S (NP (NN Lithium) (NN toxicity)) (VP (VBD was) (ADJP (RB usually) (JJ reversible) (PP (IN upon) (NP (NP (NN discontinuation)) (PP (IN of) (NP (NP (NN lithium)) (CC and) (NP (DT the) (NN ACE) (NN inhibitor))))))))) (. .))))

nn(toxicity-2, Lithium-1)
nsubj(reversible-5, toxicity-2)
cop(reversible-5, was-3)
advmod(reversible-5, usually-4)
root(ROOT-0, reversible-5)
prep_upon(reversible-5, discontinuation-7)
prep_of(discontinuation-7, lithium-9)
det(inhibitor-13, the-11)
nn(inhibitor-13, ACE-12)
conj_and(lithium-9, inhibitor-13)

It/PRP is/VBZ recommended/VBN that/IN serum/NN lithium/NN levels/NNS be/VB monitored/VBN frequently/RB if/IN PRINIVIL/NN is/VBZ administered/VBN concomitantly/RB with/IN lithium/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NN serum) (NN lithium) (NNS levels)) (VP (VB be) (VP (VBN monitored) (ADVP (RB frequently)) (SBAR (IN if) (S (NP (NN PRINIVIL)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN lithium)))))))))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(monitored-9, that-4)
nn(levels-7, serum-5)
nn(levels-7, lithium-6)
nsubjpass(monitored-9, levels-7)
auxpass(monitored-9, be-8)
ccomp(recommended-3, monitored-9)
advmod(monitored-9, frequently-10)
mark(administered-14, if-11)
nsubjpass(administered-14, PRINIVIL-12)
auxpass(administered-14, is-13)
advcl(monitored-9, administered-14)
advmod(administered-14, concomitantly-15)
prep_with(administered-14, lithium-17)

-/CC Lofexidine/NN may/MD enhance/VB the/DT CNS/NN depressive/JJ effects/NNS of/IN alcohol/NN ,/, barbiturates/NNS and/CC other/JJ sedatives/NNS ./.

(ROOT (S1 (S (S (CC -) (NP (NN Lofexidine)) (VP (MD may) (VP (VB enhance) (NP (NP (NP (DT the) (NN CNS) (JJ depressive) (NNS effects)) (PP (IN of) (NP (NN alcohol)))) (, ,) (NP (NP (NNS barbiturates)) (CC and) (NP (JJ other) (NNS sedatives))))))) (. .))))

nsubj(enhance-4, Lofexidine-2)
aux(enhance-4, may-3)
root(ROOT-0, enhance-4)
det(effects-8, the-5)
nn(effects-8, CNS-6)
amod(effects-8, depressive-7)
dobj(enhance-4, effects-8)
prep_of(effects-8, alcohol-10)
appos(effects-8, barbiturates-12)
amod(sedatives-15, other-14)
conj_and(barbiturates-12, sedatives-15)

-/CC Lofexidine/NN may/MD enhance/VB the/DT effects/NNS of/IN anti-hypertensive/JJ drug/NN therapy/NN ./.

(ROOT (S1 (S (S (CC -) (NP (NN Lofexidine)) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (JJ anti-hypertensive) (NN drug) (NN therapy))))))) (. .))))

nsubj(enhance-4, Lofexidine-2)
aux(enhance-4, may-3)
root(ROOT-0, enhance-4)
det(effects-6, the-5)
dobj(enhance-4, effects-6)
amod(therapy-10, anti-hypertensive-8)
nn(therapy-10, drug-9)
prep_of(effects-6, therapy-10)

-/CC Concomitant/JJ use/NN of/IN tricyclic/JJ antidepressants/NNS may/MD reduce/VB the/DT efficacy/NN of/IN lofexidine/NN ./.

(ROOT (S1 (S (S (NP (NP (CC -) (JJ Concomitant) (NN use)) (PP (IN of) (NP (JJ tricyclic) (NNS antidepressants)))) (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (NN lofexidine))))))) (. .))))

dep(use-3, Concomitant-2)
nsubj(reduce-8, use-3)
amod(antidepressants-6, tricyclic-5)
prep_of(use-3, antidepressants-6)
aux(reduce-8, may-7)
root(ROOT-0, reduce-8)
det(efficacy-10, the-9)
dobj(reduce-8, efficacy-10)
prep_of(efficacy-10, lofexidine-12)

Theophylline/NN :/: In/IN three/CD pharmacokinetic/JJ studies/NNS including/VBG 46/CD normal/JJ ,/, healthy/JJ subjects/NNS ,/, theophylline/NN clearance/NN and/CC concentration/NN were/VBD not/RB significantly/RB altered/VBN by/IN the/DT addition/NN of/IN lomefloxacin/NN ./.

(ROOT (S1 (S (S (NP (NN Theophylline)) (: :) (PP (IN In) (NP (NP (CD three) (JJ pharmacokinetic) (NNS studies)) (PP (VBG including) (NP (CD 46) (JJ normal) (, ,) (JJ healthy) (NNS subjects))))) (, ,) (NP (NP (NN theophylline) (NN clearance)) (CC and) (NP (NN concentration))) (VP (VBD were) (RB not) (ADVP (RB significantly)) (VP (VBN altered) (PP (IN by) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN lomefloxacin)))))))) (. .))))

nsubjpass(altered-21, Theophylline-1)
num(studies-6, three-4)
amod(studies-6, pharmacokinetic-5)
prep_in(altered-21, studies-6)
num(subjects-12, 46-8)
amod(subjects-12, normal-9)
amod(subjects-12, healthy-11)
prep_including(studies-6, subjects-12)
nn(clearance-15, theophylline-14)
nsubjpass(altered-21, clearance-15)
conj_and(clearance-15, concentration-17)
auxpass(altered-21, were-18)
neg(altered-21, not-19)
advmod(altered-21, significantly-20)
root(ROOT-0, altered-21)
det(addition-24, the-23)
agent(altered-21, addition-24)
prep_of(addition-24, lomefloxacin-26)

In/IN clinical/JJ studies/NNS where/WRB patients/NNS were/VBD on/IN chronic/JJ theophylline/NN therapy/NN ,/, lomefloxacin/NN had/VBD no/DT measurable/JJ effect/NN on/IN the/DT mean/JJ distribution/NN of/IN theophylline/NN concentrations/NNS or/CC the/DT mean/JJ estimates/NNS of/IN theophylline/NN clearance/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (JJ clinical) (NNS studies)) (SBAR (WHADVP (WRB where)) (S (NP (NNS patients)) (VP (VBD were) (PP (IN on) (NP (JJ chronic) (NN theophylline) (NN therapy)))))))) (, ,) (NP (NN lomefloxacin)) (VP (VBD had) (NP (DT no) (JJ measurable) (NN effect)) (PP (IN on) (NP (NP (DT the) (JJ mean) (NN distribution)) (PP (IN of) (NP (NP (NN theophylline) (NNS concentrations)) (CC or) (NP (NP (DT the) (JJ mean) (NNS estimates)) (PP (IN of) (NP (NN theophylline) (NN clearance)))))))))) (. .))))

amod(studies-3, clinical-2)
prep_in(had-13, studies-3)
advmod(were-6, where-4)
nsubj(were-6, patients-5)
rcmod(studies-3, were-6)
amod(therapy-10, chronic-8)
nn(therapy-10, theophylline-9)
prep_on(were-6, therapy-10)
nsubj(had-13, lomefloxacin-12)
root(ROOT-0, had-13)
det(effect-16, no-14)
amod(effect-16, measurable-15)
dobj(had-13, effect-16)
det(distribution-20, the-18)
amod(distribution-20, mean-19)
prep_on(had-13, distribution-20)
nn(concentrations-23, theophylline-22)
prep_of(distribution-20, concentrations-23)
det(estimates-27, the-25)
amod(estimates-27, mean-26)
conj_or(concentrations-23, estimates-27)
nn(clearance-30, theophylline-29)
prep_of(estimates-27, clearance-30)

Antacids/NNS and/CC sucralfate/NN :/: Sucralfate/NN and/CC antacids/NNS containing/VBG magnesium/NN or/CC aluminum/NN ,/, as/RB well/RB as/IN formulations/NNS containing/VBG divalent/NN and/CC trivalent/JJ cations/NNS such/JJ as/IN Videx/NN @/NN (/-LRB- didanosine/NN )/-RRB- ,/, chewable//NN buffer/NN ed/NN tablets/NNS or/CC the/DT pediatric/JJ powder/NN for/IN oral/JJ solution/NN can/MD form/VB chelation/NN complexes/NNS with/IN lomefloxacin/NN and/CC interfere/VB with/IN its/PRP$ bioavailability/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Antacids)) (CC and) (NP (NN sucralfate))) (: :) (S (NP (NP (NP (NN Sucralfate)) (CC and) (NP (NP (NP (NNS antacids)) (VP (VBG containing) (NP (NP (NN magnesium)) (CC or) (NP (NN aluminum))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NNS formulations)))) (VP (VBG containing) (NP (NP (NN divalent)) (CC and) (NP (NP (JJ trivalent) (NNS cations)) (PP (JJ such) (IN as) (NP (NP (NP (NN Videx) (NN @)) (PRN (-LRB- -LRB-) (NP (NN didanosine)) (-RRB- -RRB-))) (, ,) (NP (NN chewable/) (NN buffer) (NN ed) (NNS tablets)) (CC or) (NP (DT the) (JJ pediatric) (NN powder)))) (PP (IN for) (NP (JJ oral) (NN solution))))))) (VP (MD can) (VP (VP (VB form) (NP (NP (NN chelation) (NNS complexes)) (PP (IN with) (NP (NN lomefloxacin))))) (CC and) (VP (VB interfere) (PP (IN with) (NP (PRP$ its) (NN bioavailability))))))) (. .)))))

root(ROOT-0, Antacids-1)
conj_and(Antacids-1, sucralfate-3)
nsubj(form-42, Sucralfate-5)
conj_and(Sucralfate-5, antacids-7)
partmod(antacids-7, containing-8)
dobj(containing-8, magnesium-9)
conj_or(magnesium-9, aluminum-11)
conj_and(antacids-7, formulations-16)
partmod(Sucralfate-5, containing-17)
dobj(containing-17, divalent-18)
amod(cations-21, trivalent-20)
conj_and(divalent-18, cations-21)
nn(@-25, Videx-24)
prep_such_as(cations-21, @-25)
appos(@-25, didanosine-27)
nn(tablets-33, chewable/-30)
nn(tablets-33, buffer-31)
nn(tablets-33, ed-32)
conj_or(@-25, tablets-33)
det(powder-37, the-35)
amod(powder-37, pediatric-36)
conj_or(@-25, powder-37)
amod(solution-40, oral-39)
prep_for(cations-21, solution-40)
aux(form-42, can-41)
dep(Antacids-1, form-42)
nn(complexes-44, chelation-43)
dobj(form-42, complexes-44)
prep_with(complexes-44, lomefloxacin-46)
conj_and(form-42, interfere-48)
poss(bioavailability-51, its-50)
prep_with(interfere-48, bioavailability-51)

Sucralfate/NN administered/VBN 2/CD hours/NNS before/IN lomefloxacin/NN resulted/VBD in/IN a/DT slower/JJR absorption/NN (/-LRB- mean/NN C/NN max/NN decreased/VBD by/IN 30/CD %/NN and/CC mean/NN T/NN max/NN increased/VBN by/IN 1/CD hour/NN )/-RRB- and/CC a/DT lesser/JJR extent/NN of/IN absorption/NN (/-LRB- mean/JJ AUC/NN decreased/VBD by/IN approximately/RB 25/CD %)./NN

(ROOT (S1 (S (S (NP (NP (NN Sucralfate)) (VP (VBN administered) (NP (NP (CD 2) (NNS hours)) (PP (IN before) (NP (NN lomefloxacin)))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (JJR slower) (NN absorption)) (PRN (-LRB- -LRB-) (S (NP (NP (NN mean) (NN C) (NN max)) (VP (VBD decreased) (PP (IN by) (NP (NP (CD 30) (NN %)) (CC and) (NP (NN mean) (NN T) (NN max)))))) (VP (VBN increased) (PP (IN by) (NP (CD 1) (NN hour))))) (-RRB- -RRB-))) (CC and) (NP (NP (DT a) (JJR lesser) (NN extent)) (PP (IN of) (NP (NN absorption)))))))) (S (-LRB- -LRB-) (NP (JJ mean) (NN AUC)) (VP (VBD decreased) (PP (IN by) (NP (QP (RB approximately) (CD 25)) (NN %-RRB-.))))))))

nsubj(resulted-7, Sucralfate-1)
partmod(Sucralfate-1, administered-2)
num(hours-4, 2-3)
dobj(administered-2, hours-4)
prep_before(hours-4, lomefloxacin-6)
root(ROOT-0, resulted-7)
det(absorption-11, a-9)
amod(absorption-11, slower-10)
prep_in(resulted-7, absorption-11)
nn(max-15, mean-13)
nn(max-15, C-14)
nsubj(increased-24, max-15)
partmod(max-15, decreased-16)
num(%-19, 30-18)
agent(decreased-16, %-19)
nn(max-23, mean-21)
nn(max-23, T-22)
conj_and(%-19, max-23)
dep(absorption-11, increased-24)
num(hour-27, 1-26)
prep_by(increased-24, hour-27)
det(extent-32, a-30)
amod(extent-32, lesser-31)
conj_and(absorption-11, extent-32)
prep_of(extent-32, absorption-34)
amod(AUC-37, mean-36)
nsubj(decreased-38, AUC-37)
dep(resulted-7, decreased-38)
quantmod(25-41, approximately-40)
num(%-RRB-.-42, 25-41)
prep_by(decreased-38, %-RRB-.-42)

Magnesium/NN -/CC and/CC aluminum-containing/JJ antacids/NNS ,/, administered/VBN concomitantly/RB with/IN lomefloxacin/NN ,/, significantly/RB decreased/VBD the/DT bioavailability/NN (/-LRB- 48/CD %/NN )/-RRB- of/IN lomefloxacin/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Magnesium)) (CC -) (CC and) (NP (JJ aluminum-containing) (NNS antacids))) (, ,) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN lomefloxacin)))) (, ,)) (ADVP (RB significantly)) (VP (VBD decreased) (NP (NP (NP (DT the) (NN bioavailability)) (PRN (-LRB- -LRB-) (NP (CD 48) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (NN lomefloxacin)))))) (. .))))

nsubj(decreased-13, Magnesium-1)
conj_and(Magnesium-1, and-3)
amod(antacids-5, aluminum-containing-4)
conj_and(Magnesium-1, antacids-5)
partmod(Magnesium-1, administered-7)
advmod(administered-7, concomitantly-8)
prep_with(administered-7, lomefloxacin-10)
advmod(decreased-13, significantly-12)
root(ROOT-0, decreased-13)
det(bioavailability-15, the-14)
dobj(decreased-13, bioavailability-15)
num(%-18, 48-17)
appos(bioavailability-15, %-18)
prep_of(bioavailability-15, lomefloxacin-21)

Separating/VBG the/DT doses/NNS of/IN antacid/JJ and/CC lomefloxacin/NN minimizes/VBZ this/DT decrease/NN in/IN bioavailability/NN ;/: ./.

(ROOT (S1 (S (S (S (VP (VBG Separating) (NP (NP (DT the) (NNS doses)) (PP (IN of) (NP (NP (ADJP (JJ antacid))) (CC and) (NP (NN lomefloxacin))))))) (VP (VBZ minimizes) (NP (NP (DT this) (NN decrease)) (PP (IN in) (NP (NN bioavailability) (: ;)))))) (. .))))

csubj(minimizes-8, Separating-1)
det(doses-3, the-2)
dobj(Separating-1, doses-3)
prep_of(doses-3, antacid-5)
conj_and(antacid-5, lomefloxacin-7)
root(ROOT-0, minimizes-8)
det(decrease-10, this-9)
dobj(minimizes-8, decrease-10)
prep_in(decrease-10, bioavailability-12)

therefore/RB ,/, administration/NN of/IN these/DT agents/NNS should/MD precede/VBP lomefloxacin/NN dosing/NN by/IN 4/CD hours/NNS or/CC follow/VBP lomefloxacin/NN dosing/NN by/IN at/IN least/JJS 2/CD hours/NNS ./.

(ROOT (S1 (S (S (ADVP (RB therefore)) (, ,) (NP (NP (NN administration)) (PP (IN of) (NP (DT these) (NNS agents)))) (VP (MD should) (VP (VP (VBP precede) (NP (NN lomefloxacin) (NN dosing)) (PP (IN by) (NP (CD 4) (NNS hours)))) (CC or) (VP (VBP follow) (NP (NN lomefloxacin) (NN dosing)) (PP (IN by) (NP (QP (IN at) (JJS least) (CD 2)) (NNS hours))))))) (. .))))

advmod(precede-8, therefore-1)
nsubj(precede-8, administration-3)
det(agents-6, these-5)
prep_of(administration-3, agents-6)
aux(precede-8, should-7)
root(ROOT-0, precede-8)
nn(dosing-10, lomefloxacin-9)
dobj(precede-8, dosing-10)
num(hours-13, 4-12)
prep_by(precede-8, hours-13)
conj_or(precede-8, follow-15)
nn(dosing-17, lomefloxacin-16)
dobj(follow-15, dosing-17)
quantmod(2-21, at-19)
mwe(at-19, least-20)
pobj(at-19, least-20)
num(hours-22, 2-21)
prep_by(follow-15, hours-22)

Caffeine/NN :/: Two/CD hundred/CD mg/NN of/IN caffeine/NN (/-LRB- equivalent/JJ to/TO 1/CD to/TO 3/CD cups/NNS of/IN American/NNP coffee/NN )/-RRB- was/VBD administered/VBN to/TO 16/CD normal/JJ ,/, healthy/JJ volunteers/NNS who/WP had/VBD achieved/VBD steady-state/JJ blood/NN concentrations/NNS of/IN lomefloxacin/NN after/IN being/VBG dosed/VBN at/IN 400/CD mg/NN qd/NN ./.

(ROOT (S1 (S (NP (NP (NN Caffeine)) (: :) (S (NP (NP (NP (QP (CD Two) (CD hundred)) (NN mg)) (PP (IN of) (NP (NN caffeine)))) (PRN (-LRB- -LRB-) (ADJP (JJ equivalent) (PP (TO to) (NP (NP (QP (CD 1) (TO to) (CD 3)) (NNS cups)) (PP (IN of) (NP (NNP American) (NN coffee)))))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN administered) (PP (TO to) (NP (NP (CD 16) (ADJP (ADJP (JJ normal)) (, ,) (ADJP (JJ healthy))) (NNS volunteers)) (SBAR (WHNP (WP who)) (S (VP (VBD had) (VP (VBD achieved) (NP (NP (JJ steady-state) (NN blood) (NNS concentrations)) (PP (IN of) (NP (NN lomefloxacin)))) (PP (IN after) (S (VP (VBG being) (VP (VBN dosed) (PP (IN at) (NP (ADJP (CD 400) (NN mg)) (NN qd)))))))))))))))) (. .)))))

root(ROOT-0, Caffeine-1)
number(hundred-4, Two-3)
num(mg-5, hundred-4)
nsubjpass(administered-20, mg-5)
prep_of(mg-5, caffeine-7)
dep(mg-5, equivalent-9)
number(3-13, 1-11)
dep(3-13, to-12)
num(cups-14, 3-13)
prep_to(equivalent-9, cups-14)
nn(coffee-17, American-16)
prep_of(cups-14, coffee-17)
auxpass(administered-20, was-19)
dep(Caffeine-1, administered-20)
num(volunteers-26, 16-22)
amod(volunteers-26, normal-23)
dep(normal-23, healthy-25)
prep_to(administered-20, volunteers-26)
nsubj(achieved-29, volunteers-26)
aux(achieved-29, had-28)
rcmod(volunteers-26, achieved-29)
amod(concentrations-32, steady-state-30)
nn(concentrations-32, blood-31)
dobj(achieved-29, concentrations-32)
prep_of(concentrations-32, lomefloxacin-34)
auxpass(dosed-37, being-36)
prepc_after(achieved-29, dosed-37)
number(mg-40, 400-39)
amod(qd-41, mg-40)
prep_at(dosed-37, qd-41)

This/DT did/VBD not/RB result/VB in/IN any/DT statistically/RB or/CC clinically/RB relevant/JJ changes/NNS in/IN the/DT pharmacokinetic/JJ parameters/NNS of/IN either/CC caffeine/NN or/CC its/PRP$ major/JJ metabolite/NN ,/, paraxanthine/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (VBD did) (RB not) (VP (VB result) (PP (IN in) (NP (NP (DT any) (ADJP (ADVP (ADVP (RB statistically)) (CC or) (ADVP (RB clinically))) (JJ relevant)) (NNS changes)) (PP (IN in) (NP (NP (DT the) (JJ pharmacokinetic) (NNS parameters)) (PP (IN of) (NP (CC either) (NP (NN caffeine)) (CC or) (NP (NP (PRP$ its) (JJ major) (NN metabolite)) (, ,) (NP (NN paraxanthine)))))))))))) (. .))))

nsubj(result-4, This-1)
aux(result-4, did-2)
neg(result-4, not-3)
root(ROOT-0, result-4)
det(changes-11, any-6)
advmod(relevant-10, statistically-7)
conj_or(statistically-7, clinically-9)
amod(changes-11, relevant-10)
prep_in(result-4, changes-11)
det(parameters-15, the-13)
amod(parameters-15, pharmacokinetic-14)
prep_in(changes-11, parameters-15)
preconj(caffeine-18, either-17)
prep_of(parameters-15, caffeine-18)
poss(metabolite-22, its-20)
amod(metabolite-22, major-21)
conj_or(caffeine-18, metabolite-22)
appos(metabolite-22, paraxanthine-24)

No/DT data/NNS are/VBP available/JJ on/IN potential/JJ interactions/NNS in/IN individuals/NNS who/WP consume/VBD greater/JJR than/IN 200/CD mg/NN of/IN caffeine/NN per/IN day/NN or/CC in/IN those/DT ,/, such/JJ as/IN the/DT geriatric/JJ population/NN ,/, who/WP are/VBP generally/RB believed/VBN to/TO be/VB more/RBR susceptible/JJ to/TO the/DT development/NN of/IN drug-induced/JJ CNS-related/JJ adverse/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (DT No) (NNS data)) (VP (VBP are) (ADJP (JJ available) (PP (IN on) (NP (NP (JJ potential) (NNS interactions)) (PP (IN in) (NP (NP (NNS individuals)) (SBAR (WHNP (WP who)) (S (VP (VBD consume) (ADJP (ADJP (JJR greater)) (PP (IN than) (NP (NP (CD 200) (NN mg)) (PP (IN of) (NP (NN caffeine))) (PP (PP (IN per) (NP (NN day))) (CC or) (PP (IN in) (NP (DT those)))))))))) (, ,) (PP (JJ such) (IN as) (NP (DT the) (JJ geriatric) (NN population))) (, ,) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADVP (RB generally)) (VP (VBN believed) (S (VP (TO to) (VP (VB be) (ADJP (RBR more) (JJ susceptible) (PP (TO to) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ drug-induced) (JJ CNS-related) (JJ adverse) (NNS effects)))))))))))))))))))) (. .))))

det(data-2, No-1)
nsubj(available-4, data-2)
cop(available-4, are-3)
root(ROOT-0, available-4)
amod(interactions-7, potential-6)
prep_on(available-4, interactions-7)
prep_in(interactions-7, individuals-9)
nsubj(consume-11, individuals-9)
rcmod(individuals-9, consume-11)
acomp(consume-11, greater-12)
num(mg-15, 200-14)
prep_than(greater-12, mg-15)
conj_or(mg-15, mg-15')
prep_of(mg-15, caffeine-17)
prep_per(mg-15, day-19)
prep_in(mg-15', those-22)
det(population-28, the-26)
amod(population-28, geriatric-27)
prep_such_as(individuals-9, population-28)
nsubjpass(believed-33, who-30)
auxpass(believed-33, are-31)
advmod(believed-33, generally-32)
rcmod(individuals-9, believed-33)
aux(susceptible-37, to-34)
cop(susceptible-37, be-35)
advmod(susceptible-37, more-36)
xcomp(believed-33, susceptible-37)
det(development-40, the-39)
prep_to(susceptible-37, development-40)
amod(effects-45, drug-induced-42)
amod(effects-45, CNS-related-43)
amod(effects-45, adverse-44)
prep_of(development-40, effects-45)

Other/JJ quinolones/NNS have/VBP demonstrated/VBN moderate/JJ to/TO marked/JJ interference/NN with/IN the/DT metabolism/NN of/IN caffeine/NN ,/, resulting/VBG in/IN a/DT reduced/VBN clearance/NN ,/, a/DT prolongation/NN of/IN plasma/NN half-life/NN ,/, and/CC an/DT increase/NN in/IN symptoms/NNS that/WDT accompany/VBP high/JJ levels/NNS of/IN caffeine/NN ./.

(ROOT (S1 (S (S (NP (JJ Other) (NNS quinolones)) (VP (VBP have) (VP (VBN demonstrated) (ADJP (JJ moderate) (PP (TO to) (NP (NP (JJ marked) (NN interference)) (PP (IN with) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN caffeine))))) (, ,) (VP (VBG resulting) (PP (IN in) (NP (NP (DT a) (VBN reduced) (NN clearance)) (, ,) (NP (NP (DT a) (NN prolongation)) (PP (IN of) (NP (NN plasma) (NN half-life)))) (, ,) (CC and) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NNS symptoms)) (SBAR (WHNP (WDT that)) (S (VP (VBP accompany) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN caffeine))))))))))))))))))) (. .))))

amod(quinolones-2, Other-1)
nsubj(demonstrated-4, quinolones-2)
aux(demonstrated-4, have-3)
root(ROOT-0, demonstrated-4)
acomp(demonstrated-4, moderate-5)
amod(interference-8, marked-7)
prep_to(moderate-5, interference-8)
det(metabolism-11, the-10)
prep_with(interference-8, metabolism-11)
prep_of(metabolism-11, caffeine-13)
partmod(interference-8, resulting-15)
det(clearance-19, a-17)
amod(clearance-19, reduced-18)
prep_in(resulting-15, clearance-19)
det(prolongation-22, a-21)
conj_and(clearance-19, prolongation-22)
nn(half-life-25, plasma-24)
prep_of(prolongation-22, half-life-25)
det(increase-29, an-28)
conj_and(clearance-19, increase-29)
prep_in(increase-29, symptoms-31)
nsubj(accompany-33, symptoms-31)
rcmod(symptoms-31, accompany-33)
amod(levels-35, high-34)
dobj(accompany-33, levels-35)
prep_of(levels-35, caffeine-37)

Cimetidine/NN :/: Cimetidine/NN has/VBZ been/VBN demonstrated/VBN to/TO interfere/VB with/IN the/DT elimination/NN of/IN other/JJ quinolones/NNS ./.

(ROOT (S1 (S (S (NP (NN Cimetidine) (: :) (NN Cimetidine)) (VP (VBZ has) (VP (VBN been) (VP (VBN demonstrated) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN elimination)) (PP (IN of) (NP (JJ other) (NNS quinolones)))))))))))) (. .))))

nn(Cimetidine-3, Cimetidine-1)
nsubjpass(demonstrated-6, Cimetidine-3)
xsubj(interfere-8, Cimetidine-3)
aux(demonstrated-6, has-4)
auxpass(demonstrated-6, been-5)
root(ROOT-0, demonstrated-6)
aux(interfere-8, to-7)
xcomp(demonstrated-6, interfere-8)
det(elimination-11, the-10)
prep_with(interfere-8, elimination-11)
amod(quinolones-14, other-13)
prep_of(elimination-11, quinolones-14)

The/DT interaction/NN between/IN lomefloxacin/NN and/CC cimetidine/NN has/VBZ not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN interaction)) (PP (IN between) (NP (NP (NN lomefloxacin)) (CC and) (NP (NN cimetidine))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

det(interaction-2, The-1)
nsubjpass(studied-10, interaction-2)
prep_between(interaction-2, lomefloxacin-4)
conj_and(lomefloxacin-4, cimetidine-6)
aux(studied-10, has-7)
neg(studied-10, not-8)
auxpass(studied-10, been-9)
root(ROOT-0, studied-10)

Cyclosporine/NN :/: Elevated/JJ serum/NN levels/NNS of/IN cyclosporine/NN have/VBP been/VBN reported/VBN with/IN concomitant/JJ use/NN of/IN cyclosporine/NN with/IN other/JJ members/NNS of/IN the/DT quinolone/NN class/NN ./.

(ROOT (S1 (S (NP (NP (NN Cyclosporine)) (: :) (S (NP (NP (JJ Elevated) (NN serum) (NNS levels)) (PP (IN of) (NP (NN cyclosporine)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NN cyclosporine))) (PP (IN with) (NP (NP (JJ other) (NNS members)) (PP (IN of) (NP (DT the) (NN quinolone) (NN class))))))))))) (. .)))))

root(ROOT-0, Cyclosporine-1)
amod(levels-5, Elevated-3)
nn(levels-5, serum-4)
nsubjpass(reported-10, levels-5)
prep_of(levels-5, cyclosporine-7)
aux(reported-10, have-8)
auxpass(reported-10, been-9)
dep(Cyclosporine-1, reported-10)
amod(use-13, concomitant-12)
prep_with(reported-10, use-13)
prep_of(use-13, cyclosporine-15)
amod(members-18, other-17)
prep_with(use-13, members-18)
det(class-22, the-20)
nn(class-22, quinolone-21)
prep_of(members-18, class-22)

Interaction/NN between/IN lomefloxacin/NN and/CC cyclosporine/NN has/VBZ not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Interaction)) (PP (IN between) (NP (NP (NN lomefloxacin)) (CC and) (NP (NN cyclosporine))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

nsubjpass(studied-9, Interaction-1)
prep_between(Interaction-1, lomefloxacin-3)
conj_and(lomefloxacin-3, cyclosporine-5)
aux(studied-9, has-6)
neg(studied-9, not-7)
auxpass(studied-9, been-8)
root(ROOT-0, studied-9)

Omeprazole/NN :/: No/DT clinically/RB significant/JJ changes/NNS in/IN lomefloxacin/NN pharmacokinetics/NNS (/-LRB- AUC/NN ,/, C/NN max/NN ,/, or/CC T/NN max/NN )/-RRB- were/VBD observed/VBN when/WRB a/DT single/JJ dose/NN of/IN lomefloxacin/NN 400/CD mg/NN was/VBD given/VBN after/IN multiple/JJ doses/NNS of/IN omeprazole/NN (/-LRB- 20/CD mg/NN qd/NN )/-RRB- in/IN 13/CD healthy/JJ volunteers/NNS ./.

(ROOT (S1 (S (NP (NP (NN Omeprazole)) (: :) (S (NP (NP (DT No) (ADJP (RB clinically) (JJ significant)) (NNS changes)) (PP (IN in) (NP (NP (NN lomefloxacin) (NNS pharmacokinetics)) (PRN (-LRB- -LRB-) (NP (NP (NN AUC)) (, ,) (NP (NN C) (NN max)) (, ,) (CC or) (NP (NN T) (NN max))) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NN lomefloxacin) (CD 400) (NN mg)))) (VP (VBD was) (VP (VBN given) (PP (IN after) (NP (NP (JJ multiple) (NNS doses)) (PP (IN of) (NP (NP (NN omeprazole)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN mg) (NN qd)) (-RRB- -RRB-)))))) (PP (IN in) (NP (CD 13) (JJ healthy) (NNS volunteers)))))))))) (. .)))))

root(ROOT-0, Omeprazole-1)
det(changes-6, No-3)
advmod(significant-5, clinically-4)
amod(changes-6, significant-5)
nsubjpass(observed-21, changes-6)
nn(pharmacokinetics-9, lomefloxacin-8)
prep_in(changes-6, pharmacokinetics-9)
dep(pharmacokinetics-9, AUC-11)
nn(max-14, C-13)
conj_or(AUC-11, max-14)
nn(max-18, T-17)
conj_or(AUC-11, max-18)
auxpass(observed-21, were-20)
dep(Omeprazole-1, observed-21)
advmod(given-31, when-22)
det(dose-25, a-23)
amod(dose-25, single-24)
nsubjpass(given-31, dose-25)
nn(mg-29, lomefloxacin-27)
num(mg-29, 400-28)
prep_of(dose-25, mg-29)
auxpass(given-31, was-30)
advcl(observed-21, given-31)
amod(doses-34, multiple-33)
prep_after(given-31, doses-34)
prep_of(doses-34, omeprazole-36)
num(qd-40, 20-38)
nn(qd-40, mg-39)
appos(omeprazole-36, qd-40)
num(volunteers-45, 13-43)
amod(volunteers-45, healthy-44)
prep_in(given-31, volunteers-45)

Changes/NNS in/IN omeprazole/NN pharmacokinetics/NNS were/VBD not/RB studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Changes)) (PP (IN in) (NP (NN omeprazole) (NNS pharmacokinetics)))) (VP (VBD were) (RB not) (VP (VBN studied)))) (. .))))

nsubjpass(studied-7, Changes-1)
nn(pharmacokinetics-4, omeprazole-3)
prep_in(Changes-1, pharmacokinetics-4)
auxpass(studied-7, were-5)
neg(studied-7, not-6)
root(ROOT-0, studied-7)

Phenytoin/NN :/: No/DT significant/JJ differences/NNS were/VBD observed/VBN in/IN mean/JJ phenytoin/NN AUC/NN ,/, C/NN max/NN ,/, C/NN min/NN or/CC T/NN max/NN (/-LRB- although/IN C/NN max/NN increased/VBN by/IN 11/CD %/NN )/-RRB- when/WRB extended/JJ phenytoin/NN sodium/NN capsules/NNS (/-LRB- 100/CD mg/NN tid/NN )/-RRB- were/VBD coadministered/VBN with/IN lomefloxacin/NN (/-LRB- 400/CD mg/NN qd/NN )/-RRB- for/IN five/CD days/NNS in/IN 15/CD healthy/JJ males/NNS ./.

(ROOT (S1 (S (NP (NP (NN Phenytoin)) (: :) (S (NP (DT No) (JJ significant) (NNS differences)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (JJ mean) (NN phenytoin) (NN AUC)) (, ,) (NP (NN C) (NN max)) (, ,) (NP (NN C) (NN min)) (CC or) (NP (NN T) (NN max)))) (PRN (-LRB- -LRB-) (PP (IN although) (NP (NP (NN C) (NN max)) (VP (VBN increased) (PP (IN by) (NP (CD 11) (NN %)))))) (-RRB- -RRB-))) (SBAR (WHADVP (WRB when)) (S (NP (NP (JJ extended) (NN phenytoin) (NN sodium) (NNS capsules)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 100) (NN mg)) (NN tid)) (-RRB- -RRB-))) (VP (VBD were) (VP (VBN coadministered) (PP (IN with) (NP (NP (NP (NN lomefloxacin)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 400) (NN mg)) (NN qd)) (-RRB- -RRB-))) (PP (IN for) (NP (CD five) (NNS days))) (PP (IN in) (NP (CD 15) (JJ healthy) (NNS males))))))))))) (. .)))))

root(ROOT-0, Phenytoin-1)
det(differences-5, No-3)
amod(differences-5, significant-4)
nsubjpass(observed-7, differences-5)
auxpass(observed-7, were-6)
dep(Phenytoin-1, observed-7)
amod(AUC-11, mean-9)
nn(AUC-11, phenytoin-10)
prep_in(observed-7, AUC-11)
nn(max-14, C-13)
conj_or(AUC-11, max-14)
nn(min-17, C-16)
conj_or(AUC-11, min-17)
nn(max-20, T-19)
conj_or(AUC-11, max-20)
dep(observed-7, although-22)
nn(max-24, C-23)
pobj(although-22, max-24)
partmod(max-24, increased-25)
num(%-28, 11-27)
agent(increased-25, %-28)
advmod(coadministered-41, when-30)
amod(capsules-34, extended-31)
nn(capsules-34, phenytoin-32)
nn(capsules-34, sodium-33)
nsubjpass(coadministered-41, capsules-34)
number(mg-37, 100-36)
amod(tid-38, mg-37)
appos(capsules-34, tid-38)
auxpass(coadministered-41, were-40)
advcl(observed-7, coadministered-41)
prep_with(coadministered-41, lomefloxacin-43)
number(mg-46, 400-45)
amod(qd-47, mg-46)
appos(lomefloxacin-43, qd-47)
num(days-51, five-50)
prep_for(lomefloxacin-43, days-51)
num(males-55, 15-53)
amod(males-55, healthy-54)
prep_in(lomefloxacin-43, males-55)

Lomefloxacin/NN is/VBZ unlikely/JJ to/TO have/VB a/DT significant/JJ effect/NN on/IN phenytoin/NN metabolism/NN ./.

(ROOT (S1 (S (S (NP (NN Lomefloxacin)) (VP (VBZ is) (ADJP (JJ unlikely) (S (VP (TO to) (VP (VB have) (NP (DT a) (JJ significant) (NN effect)) (PP (IN on) (NP (NN phenytoin) (NN metabolism))))))))) (. .))))

nsubj(unlikely-3, Lomefloxacin-1)
cop(unlikely-3, is-2)
root(ROOT-0, unlikely-3)
aux(have-5, to-4)
xcomp(unlikely-3, have-5)
det(effect-8, a-6)
amod(effect-8, significant-7)
dobj(have-5, effect-8)
nn(metabolism-11, phenytoin-10)
prep_on(have-5, metabolism-11)

Probenecid/NN :/: Probenecid/NN slows/VBZ the/DT renal/JJ elimination/NN of/IN lome-floxacin/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Probenecid)) (: :) (NP (NN Probenecid))) (VP (VBZ slows) (NP (NP (DT the) (JJ renal) (NN elimination)) (PP (IN of) (NP (NN lome-floxacin)))))) (. .))))

nsubj(slows-4, Probenecid-1)
dep(Probenecid-1, Probenecid-3)
root(ROOT-0, slows-4)
det(elimination-7, the-5)
amod(elimination-7, renal-6)
dobj(slows-4, elimination-7)
prep_of(elimination-7, lome-floxacin-9)

An/DT increase/NN of/IN 63/CD %/NN in/IN the/DT mean/JJ AUC/NN and/CC increases/NNS of/IN 50/CD %/NN and/CC 4/CD %/NN ,/, respectively/RB ,/, in/IN the/DT mean/JJ T/NN max/NN and/CC mean/NN C/NN max/NN were/VBD noted/VBN in/IN 1/CD study/NN of/IN 6/CD individuals/NNS ./.

(ROOT (S1 (S (NP (NP (NP (DT An) (NN increase)) (PP (IN of) (NP (CD 63) (NN %))) (PP (IN in) (NP (DT the) (JJ mean) (NN AUC)))) (CC and) (NP (NP (NNS increases)) (PP (IN of) (NP (NP (CD 50) (NN %)) (CC and) (NP (CD 4) (NN %)) (, ,) (ADVP (RB respectively)) (, ,) (PP (IN in) (NP (NP (DT the) (JJ mean) (NN T) (NN max)) (CC and) (NP (NN mean) (NN C) (NN max)))))))) (VP (VBD were) (VP (VBN noted) (PP (IN in) (NP (NP (CD 1) (NN study)) (PP (IN of) (NP (CD 6) (NNS individuals))))))) (. .))))

det(increase-2, An-1)
nsubjpass(noted-31, increase-2)
num(%-5, 63-4)
prep_of(increase-2, %-5)
det(AUC-9, the-7)
amod(AUC-9, mean-8)
prep_in(increase-2, AUC-9)
conj_and(increase-2, increases-11)
num(%-14, 50-13)
prep_of(increases-11, %-14)
num(%-17, 4-16)
conj_and(%-14, %-17)
advmod(%-14, respectively-19)
conj_and(%-14, respectively-19)
conj_and(%-14, in-21)
det(max-25, the-22)
amod(max-25, mean-23)
nn(max-25, T-24)
prep_in(%-14, max-25)
nn(max-29, mean-27)
nn(max-29, C-28)
conj_and(max-25, max-29)
auxpass(noted-31, were-30)
root(ROOT-0, noted-31)
num(study-34, 1-33)
prep_in(noted-31, study-34)
num(individuals-37, 6-36)
prep_of(study-34, individuals-37)

Terfenadine/NN :/: No/DT clinically/RB significant/JJ changes/NNS occurred/VBD in/IN heart/NN rate/NN or/CC corrected/JJ QT/VBG intervals/NNS ,/, or/CC in/IN terfenadine/NN metabolite/NN or/CC lomefloxacin/NN pharmacokinetics/NNS ,/, during/IN concurrent/JJ administration/NN of/IN lomefloxacin/NN and/CC terfenadine/NN at/IN steady-state/NN in/IN 28/CD healthy/JJ males/NNS ./.

(ROOT (S1 (S (NP (NP (NN Terfenadine)) (: :) (S (NP (DT No) (ADJP (RB clinically) (JJ significant)) (NNS changes)) (VP (VBD occurred) (PP (PP (IN in) (NP (NP (NN heart) (NN rate)) (CC or) (NP (JJ corrected) (VBG QT) (NNS intervals)))) (, ,) (CC or) (PP (IN in) (NP (NP (NN terfenadine) (NN metabolite)) (CC or) (NP (NN lomefloxacin) (NNS pharmacokinetics))))) (, ,) (PP (IN during) (NP (NP (JJ concurrent) (NN administration)) (PP (IN of) (NP (NP (NN lomefloxacin)) (CC and) (NP (NN terfenadine)))) (PP (IN at) (NP (NP (NN steady-state)) (PP (IN in) (NP (CD 28) (JJ healthy) (NNS males))))))))) (. .)))))

root(ROOT-0, Terfenadine-1)
det(changes-6, No-3)
advmod(significant-5, clinically-4)
amod(changes-6, significant-5)
nsubj(occurred-7, changes-6)
dep(Terfenadine-1, occurred-7)
nn(rate-10, heart-9)
prep_in(occurred-7, rate-10)
amod(intervals-14, corrected-12)
amod(intervals-14, QT-13)
conj_or(rate-10, intervals-14)
nn(metabolite-19, terfenadine-18)
conj_or(rate-10, metabolite-19)
nn(pharmacokinetics-22, lomefloxacin-21)
conj_or(metabolite-19, pharmacokinetics-22)
amod(administration-26, concurrent-25)
prep_during(occurred-7, administration-26)
prep_of(administration-26, lomefloxacin-28)
conj_and(lomefloxacin-28, terfenadine-30)
prep_at(administration-26, steady-state-32)
num(males-36, 28-34)
amod(males-36, healthy-35)
prep_in(steady-state-32, males-36)

Warfarin/NN :/: Quinolones/NN may/MD enhance/VB the/DT effects/NNS of/IN the/DT oral/JJ anticoagulant/NN ,/, warfarin/NN ,/, or/CC its/PRP$ derivatives/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Warfarin)) (: :) (NP (NN Quinolones))) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (DT the) (JJ oral) (NN anticoagulant)) (, ,) (NP (NN warfarin)) (, ,) (CC or) (NP (PRP$ its) (NNS derivatives)))))))) (. .))))

nsubj(enhance-5, Warfarin-1)
dep(Warfarin-1, Quinolones-3)
aux(enhance-5, may-4)
root(ROOT-0, enhance-5)
det(effects-7, the-6)
dobj(enhance-5, effects-7)
det(anticoagulant-11, the-9)
amod(anticoagulant-11, oral-10)
prep_of(effects-7, anticoagulant-11)
conj_or(anticoagulant-11, warfarin-13)
poss(derivatives-17, its-16)
conj_or(anticoagulant-11, derivatives-17)

When/WRB these/DT products/NNS are/VBP administered/VBN concomitantly/RB ,/, prothrombin/NN or/CC other/JJ suitable/JJ coagulation/NN tests/NNS should/MD be/VB monitored/VBN closely/RB ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (DT these) (NNS products)) (VP (VBP are) (VP (VBN administered) (ADVP (RB concomitantly)))))) (, ,) (NP (NP (NN prothrombin)) (CC or) (NP (JJ other) (JJ suitable) (NN coagulation) (NNS tests))) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB closely)))))) (. .))))

advmod(administered-5, When-1)
det(products-3, these-2)
nsubjpass(administered-5, products-3)
auxpass(administered-5, are-4)
advcl(monitored-16, administered-5)
advmod(administered-5, concomitantly-6)
nsubjpass(monitored-16, prothrombin-8)
amod(tests-13, other-10)
amod(tests-13, suitable-11)
nn(tests-13, coagulation-12)
conj_or(prothrombin-8, tests-13)
aux(monitored-16, should-14)
auxpass(monitored-16, be-15)
root(ROOT-0, monitored-16)
advmod(monitored-16, closely-17)

However/RB ,/, no/DT clinically/RB or/CC statistically/RB significant/JJ differences/NNS in/IN prothrombin/NN time/NN ratio/NN or/CC warfarin/NN enantiomer/NN pharmacokinetics/NNS were/VBD observed/VBN in/IN a/DT small/JJ study/NN of/IN 7/CD healthy/JJ males/NNS who/WP received/VBD both/CC warfarin/NN and/CC lomefloxacin/NN under/IN steady-state/JJ conditions/NNS ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT no) (ADJP (RB clinically) (CC or) (ADJP (RB statistically) (JJ significant))) (NNS differences)) (PP (IN in) (NP (NP (NN prothrombin) (NN time) (NN ratio)) (CC or) (NP (NN warfarin) (NN enantiomer) (NNS pharmacokinetics))))) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (DT a) (JJ small) (NN study)) (PP (IN of) (NP (NP (CD 7) (JJ healthy) (NNS males)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (CC both) (NP (NN warfarin)) (CC and) (NP (NN lomefloxacin))) (PP (IN under) (NP (JJ steady-state) (NNS conditions))))))))))))) (. .))))

advmod(observed-18, However-1)
det(differences-8, no-3)
amod(differences-8, clinically-4)
advmod(significant-7, statistically-6)
conj_or(clinically-4, significant-7)
nsubjpass(observed-18, differences-8)
nn(ratio-12, prothrombin-10)
nn(ratio-12, time-11)
prep_in(differences-8, ratio-12)
nn(pharmacokinetics-16, warfarin-14)
nn(pharmacokinetics-16, enantiomer-15)
conj_or(ratio-12, pharmacokinetics-16)
auxpass(observed-18, were-17)
root(ROOT-0, observed-18)
det(study-22, a-20)
amod(study-22, small-21)
prep_in(observed-18, study-22)
num(males-26, 7-24)
amod(males-26, healthy-25)
prep_of(study-22, males-26)
nsubj(received-28, males-26)
rcmod(males-26, received-28)
preconj(warfarin-30, both-29)
dobj(received-28, warfarin-30)
conj_and(warfarin-30, lomefloxacin-32)
amod(conditions-35, steady-state-34)
prep_under(received-28, conditions-35)

There/EX was/VBD no/DT evidence/NN in/IN clinical/JJ trials/NNS of/IN drug/NN interactions/NNS with/IN concurrent/JJ medications/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBD was) (NP (DT no) (NN evidence)) (PP (IN in) (NP (NP (JJ clinical) (NNS trials)) (PP (IN of) (NP (NP (NN drug) (NNS interactions)) (PP (IN with) (NP (JJ concurrent) (NNS medications))))))))) (. .))))

expl(was-2, There-1)
root(ROOT-0, was-2)
det(evidence-4, no-3)
nsubj(was-2, evidence-4)
amod(trials-7, clinical-6)
prep_in(was-2, trials-7)
nn(interactions-10, drug-9)
prep_of(trials-7, interactions-10)
amod(medications-13, concurrent-12)
prep_with(interactions-10, medications-13)

Probenecid/NN :/: As/IN with/IN other/JJ b-lactam/NN antibiotics/NNS ,/, renal/JJ excretion/NN of/IN loracarbef/NN is/VBZ inhibited/VBN by/IN probenecid/NN and/CC resulted/VBD in/IN an/DT approximate/JJ 80/CD %/NN increase/NN in/IN the/DT AUC/NN for/IN loracarbef/NN ./.

(ROOT (S1 (S (NP (NP (NN Probenecid)) (: :) (S (PP (IN As) (PP (IN with) (NP (JJ other) (NN b-lactam) (NNS antibiotics)))) (, ,) (NP (NP (JJ renal) (NN excretion)) (PP (IN of) (NP (NN loracarbef)))) (VP (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NN probenecid))))) (CC and) (VP (VBD resulted) (PP (IN in) (NP (NP (DT an) (JJ approximate) (ADJP (CD 80) (NN %)) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN AUC)) (PP (IN for) (NP (NN loracarbef)))))))))) (. .)))))

root(ROOT-0, Probenecid-1)
prep(inhibited-14, As-3)
pcomp(As-3, with-4)
amod(antibiotics-7, other-5)
nn(antibiotics-7, b-lactam-6)
prep_with(As-3, antibiotics-7)
amod(excretion-10, renal-9)
nsubjpass(inhibited-14, excretion-10)
prep_of(excretion-10, loracarbef-12)
auxpass(inhibited-14, is-13)
dep(Probenecid-1, inhibited-14)
agent(inhibited-14, probenecid-16)
conj_and(inhibited-14, resulted-18)
det(increase-24, an-20)
amod(increase-24, approximate-21)
number(%-23, 80-22)
amod(increase-24, %-23)
prep_in(resulted-18, increase-24)
det(AUC-27, the-26)
prep_in(increase-24, AUC-27)
prep_for(AUC-27, loracarbef-29)

Loratadine/NN (/-LRB- 10/CD mg/NN once/RB daily/JJ )/-RRB- has/VBZ been/VBN coadministered/VBN with/IN therapeutic/JJ doses/NNS of/IN erythromycin/NN ,/, cimetidine/NN ,/, and/CC ketoconazole/NN in/IN controlled/JJ clinical/JJ pharmacology/NN studies/NNS in/IN adult/JJ volunteers/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Loratadine)) (PRN (-LRB- -LRB-) (NP (NP (CD 10) (NN mg)) (ADJP (RB once) (JJ daily))) (-RRB- -RRB-))) (VP (VBZ has) (VP (VBN been) (VP (VBN coadministered) (PP (IN with) (NP (NP (JJ therapeutic) (NNS doses)) (PP (IN of) (NP (NP (NP (NN erythromycin)) (, ,) (NP (NN cimetidine)) (, ,) (CC and) (NP (NN ketoconazole))) (PP (IN in) (NP (NP (JJ controlled) (JJ clinical) (NN pharmacology) (NNS studies)) (PP (IN in) (NP (JJ adult) (NNS volunteers))))))))))))) (. .))))

nsubjpass(coadministered-10, Loratadine-1)
num(mg-4, 10-3)
dep(Loratadine-1, mg-4)
advmod(daily-6, once-5)
amod(mg-4, daily-6)
aux(coadministered-10, has-8)
auxpass(coadministered-10, been-9)
root(ROOT-0, coadministered-10)
amod(doses-13, therapeutic-12)
prep_with(coadministered-10, doses-13)
prep_of(doses-13, erythromycin-15)
conj_and(erythromycin-15, cimetidine-17)
conj_and(erythromycin-15, ketoconazole-20)
amod(studies-25, controlled-22)
amod(studies-25, clinical-23)
nn(studies-25, pharmacology-24)
prep_in(erythromycin-15, studies-25)
amod(volunteers-28, adult-27)
prep_in(studies-25, volunteers-28)

Although/IN increased/VBN plasma/NN concentrations/NNS (/-LRB- AUC/NN 0-24/CD hrs/NNS )/-RRB- of/IN loratadine/NN and/or/CC descarboethoxyloratadine/NN were/VBD observed/VBN following/VBG coadministration/NN of/IN loratadine/NN with/IN each/DT of/IN these/DT drugs/NNS in/IN normal/JJ volunteers/NNS (/-LRB- n/NN =/JJ 24/CD in/IN each/DT study/NN )/-RRB- ,/, there/EX were/VBD no/DT clinically/RB relevant/JJ changes/NNS in/IN the/DT safety/NN profile/NN of/IN loratadine/NN ,/, as/IN assessed/VBN by/IN electrocardiographic/JJ parameters/NNS ,/, clinical/JJ laboratory/NN tests/NNS ,/, vital/JJ signs/NNS ,/, and/CC adverse/JJ events/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NP (NP (VBN increased) (NN plasma) (NNS concentrations)) (PRN (-LRB- -LRB-) (NP (NN AUC) (CD 0-24) (NNS hrs)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN loratadine)) (CC and/or) (NP (NN descarboethoxyloratadine))))) (VP (VBD were) (VP (VBN observed) (PP (VBG following) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NN loratadine)) (PP (IN with) (NP (NP (DT each)) (PP (IN of) (NP (DT these) (NNS drugs))))) (PP (IN in) (NP (NP (JJ normal) (NNS volunteers)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 24)) (PP (IN in) (NP (DT each) (NN study))) (-RRB- -RRB-)))))))))))) (, ,) (NP (EX there)) (VP (VBD were) (NP (DT no) (ADJP (RB clinically) (JJ relevant)) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NN safety) (NN profile)) (PP (IN of) (NP (NN loratadine))))) (, ,) (SBAR (IN as) (S (VP (VBN assessed) (PP (IN by) (NP (NP (JJ electrocardiographic) (NNS parameters)) (, ,) (NP (JJ clinical) (NN laboratory) (NNS tests)) (, ,) (NP (JJ vital) (NNS signs)) (, ,) (CC and) (NP (JJ adverse) (NNS events))))))))) (. .))))

mark(observed-15, Although-1)
amod(concentrations-4, increased-2)
nn(concentrations-4, plasma-3)
nsubjpass(observed-15, concentrations-4)
nn(hrs-8, AUC-6)
num(hrs-8, 0-24-7)
appos(concentrations-4, hrs-8)
prep_of(concentrations-4, loratadine-11)
conj_and/or(loratadine-11, descarboethoxyloratadine-13)
auxpass(observed-15, were-14)
advcl(were-38, observed-15)
prep_following(observed-15, coadministration-17)
prep_of(coadministration-17, loratadine-19)
prep_with(loratadine-19, each-21)
det(drugs-24, these-23)
prep_of(each-21, drugs-24)
amod(volunteers-27, normal-26)
prep_in(loratadine-19, volunteers-27)
dep(volunteers-27, n-29)
amod(n-29, =-30)
num(n-29, 24-31)
dep(n-29, in-32)
det(study-34, each-33)
pobj(in-32, study-34)
expl(were-38, there-37)
root(ROOT-0, were-38)
det(changes-42, no-39)
advmod(relevant-41, clinically-40)
amod(changes-42, relevant-41)
nsubj(were-38, changes-42)
det(profile-46, the-44)
nn(profile-46, safety-45)
prep_in(were-38, profile-46)
prep_of(profile-46, loratadine-48)
mark(assessed-51, as-50)
advcl(were-38, assessed-51)
amod(parameters-54, electrocardiographic-53)
prep_by(assessed-51, parameters-54)
amod(tests-58, clinical-56)
nn(tests-58, laboratory-57)
conj_and(parameters-54, tests-58)
amod(signs-61, vital-60)
conj_and(parameters-54, signs-61)
amod(events-65, adverse-64)
conj_and(parameters-54, events-65)

No/DT effects/NNS on/IN plasma/NN concentrations/NNS of/IN cimetidine/NN or/CC ketoconazole/NN were/VBD observed/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT No) (NNS effects)) (PP (IN on) (NP (NP (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (NN cimetidine)) (CC or) (NP (NN ketoconazole))))))) (VP (VBD were) (VP (VBN observed)))) (. .))))

det(effects-2, No-1)
nsubjpass(observed-11, effects-2)
nn(concentrations-5, plasma-4)
prep_on(effects-2, concentrations-5)
prep_of(concentrations-5, cimetidine-7)
conj_or(cimetidine-7, ketoconazole-9)
auxpass(observed-11, were-10)
root(ROOT-0, observed-11)

Plasma/NN concentrations/NNS (/-LRB- AUC/NN 0-24/NN hrs/NNS )/-RRB- of/IN erythromycin/NN decreased/VBD 15/CD %/NN with/IN coadministration/NN of/IN loratadine/NN relative/JJ to/TO that/DT observed/VBN with/IN erythromycin/NN alone/RB ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Plasma) (NNS concentrations)) (PRN (-LRB- -LRB-) (NP (NN AUC) (NN 0-24) (NNS hrs)) (-RRB- -RRB-))) (PP (IN of) (NP (NN erythromycin)))) (VP (VBD decreased) (NP (CD 15) (NN %)) (PP (IN with) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NN loratadine)) (ADJP (JJ relative) (PP (TO to) (NP (NP (DT that)) (VP (VBN observed) (PP (IN with) (NP (NP (NN erythromycin)) (ADVP (RB alone)))))))))))))) (. .))))

nn(concentrations-2, Plasma-1)
nsubj(decreased-10, concentrations-2)
nn(hrs-6, AUC-4)
nn(hrs-6, 0-24-5)
abbrev(concentrations-2, hrs-6)
prep_of(concentrations-2, erythromycin-9)
root(ROOT-0, decreased-10)
num(%-12, 15-11)
dobj(decreased-10, %-12)
prep_with(decreased-10, coadministration-14)
prep_of(coadministration-14, loratadine-16)
amod(loratadine-16, relative-17)
prep_to(relative-17, that-19)
partmod(that-19, observed-20)
prep_with(observed-20, erythromycin-22)
advmod(erythromycin-22, alone-23)

TABLE/NN 1/CD Effects/NNS on/IN Plasma/NN Concentrations/NNS (/-LRB- AUC/NN 0-24/CD hrs/NNS )/-RRB- of/IN Loratadine/NN and/CC Descarboethoxyloratadine/NN After/IN 10/CD Days/NNS of/IN Coadministration/NN (/-LRB- Loratadine/NN 10/CD mg/NN )/-RRB- in/IN Normal/JJ Volunteers/NNS ./.

(ROOT (S1 (S (NP (NP (NN TABLE) (CD 1) (NNS Effects)) (PP (IN on) (NP (NP (NP (NN Plasma) (NNS Concentrations)) (PRN (-LRB- -LRB-) (NP (NN AUC) (CD 0-24) (NNS hrs)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NP (NN Loratadine)) (CC and) (NP (NN Descarboethoxyloratadine))) (PP (IN After) (NP (NP (CD 10) (NNS Days)) (PP (IN of) (NP (NP (NN Coadministration)) (PRN (-LRB- -LRB-) (NP (NN Loratadine) (CD 10) (NN mg)) (-RRB- -RRB-)))))))))) (PP (IN in) (NP (JJ Normal) (NNS Volunteers))) (. .)))))

nn(Effects-3, TABLE-1)
num(Effects-3, 1-2)
root(ROOT-0, Effects-3)
nn(Concentrations-6, Plasma-5)
prep_on(Effects-3, Concentrations-6)
nn(hrs-10, AUC-8)
num(hrs-10, 0-24-9)
appos(Concentrations-6, hrs-10)
prep_of(Concentrations-6, Loratadine-13)
conj_and(Loratadine-13, Descarboethoxyloratadine-15)
num(Days-18, 10-17)
prep_after(Loratadine-13, Days-18)
prep_of(Days-18, Coadministration-20)
nn(mg-24, Loratadine-22)
num(mg-24, 10-23)
appos(Coadministration-20, mg-24)
amod(Volunteers-28, Normal-27)
prep_in(Effects-3, Volunteers-28)

@/NN Loratadine/NN Descarboethoxyloratadine/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN Loratadine) (NN Descarboethoxyloratadine)) (. .)))))

nn(Descarboethoxyloratadine-3, @-1)
nn(Descarboethoxyloratadine-3, Loratadine-2)
root(ROOT-0, Descarboethoxyloratadine-3)

There/EX does/VBZ not/RB appear/VB to/TO be/VB an/DT increase/NN in/IN adverse/JJ events/NNS in/IN subjects/NNS who/WP received/VBD oral/JJ contraceptives/NNS and/CC loratadine/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ does) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (JJ adverse) (NNS events)) (PP (IN in) (NP (NP (NNS subjects)) (SBAR (WHNP (WP who)) (S (VP (VBD received) (NP (NP (JJ oral) (NNS contraceptives)) (CC and) (NP (NN loratadine))))))))))))))))) (. .))))

expl(appear-4, There-1)
xsubj(increase-8, There-1)
aux(appear-4, does-2)
neg(appear-4, not-3)
root(ROOT-0, appear-4)
aux(increase-8, to-5)
cop(increase-8, be-6)
det(increase-8, an-7)
xcomp(appear-4, increase-8)
amod(events-11, adverse-10)
prep_in(increase-8, events-11)
prep_in(events-11, subjects-13)
nsubj(received-15, subjects-13)
rcmod(subjects-13, received-15)
amod(contraceptives-17, oral-16)
dobj(received-15, contraceptives-17)
conj_and(contraceptives-17, loratadine-19)

Tablets/NNS :/: The/DT benzodiazepines/NNS ,/, including/VBG lorazepam/NN ,/, produce/VBP CNS-depressant/JJ effects/NNS when/WRB administered/VBN with/IN such/JJ medications/NNS as/IN barbiturates/NNS or/CC alcohol/NN ./.

(ROOT (S1 (S (NP (NP (NNS Tablets)) (: :) (S (NP (NP (DT The) (NNS benzodiazepines)) (, ,) (PP (VBG including) (NP (NN lorazepam))) (, ,)) (VP (VBP produce) (NP (JJ CNS-depressant) (NNS effects)) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN with) (NP (NP (JJ such) (NNS medications)) (PP (IN as) (NP (NP (NNS barbiturates)) (CC or) (NP (NN alcohol))))))))))) (. .)))))

root(ROOT-0, Tablets-1)
det(benzodiazepines-4, The-3)
nsubj(produce-9, benzodiazepines-4)
prep_including(benzodiazepines-4, lorazepam-7)
dep(Tablets-1, produce-9)
amod(effects-11, CNS-depressant-10)
dobj(produce-9, effects-11)
advmod(administered-13, when-12)
advcl(produce-9, administered-13)
amod(medications-16, such-15)
prep_with(administered-13, medications-16)
prep_as(medications-16, barbiturates-18)
conj_or(barbiturates-18, alcohol-20)

Injection/NN :/: Lorazepam/NN injection/NN ,/, like/IN other/JJ injectable/JJ benzodiazepines/NNS ,/, produces/VBZ depression/NN of/IN the/DT central/JJ nervous/JJ system/NN when/WRB administered/VBN with/IN ethyl/NN alcohol/NN ,/, phenothiazines/NNS ,/, barbiturates/NNS ,/, MAO/NN inhibitors/NNS ,/, and/CC other/JJ antidepressants/NNS .When/JJ scopolamine/NN is/VBZ used/VBN concomitantly/RB with/IN injectable/JJ lorazepam/NNS ,/, an/DT increased/VBN incidence/NN of/IN sedation/NN ,/, hallucinations/NNS ,/, and/CC irrational/JJ behavior/NN has/VBZ been/VBN observed/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (NN Injection)) (: :) (S (NP (NN Lorazepam) (NN injection)) (, ,) (PP (IN like) (NP (JJ other) (JJ injectable) (NNS benzodiazepines))) (, ,) (VP (VBZ produces) (NP (NP (NN depression)) (PP (IN of) (NP (DT the) (JJ central) (JJ nervous) (NN system)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN with) (NP (NP (NN ethyl) (NN alcohol)) (, ,) (NP (NP (NNS phenothiazines)) (, ,) (NP (NNS barbiturates)) (, ,) (NP (NN MAO) (NNS inhibitors)) (, ,)) (CC and) (NP (JJ other) (NNS antidepressants)) (NP (JJ .When) (NN scopolamine)))))))))) (VP (VBZ is) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (JJ injectable) (NNS lorazepam)) (, ,) (NP (NP (DT an) (VBN increased) (NN incidence)) (PP (IN of) (NP (NN sedation)))) (, ,) (NP (NNS hallucinations))))))) (, ,) (CC and) (S (NP (JJ irrational) (NN behavior)) (VP (VBZ has) (VP (VBN been) (VP (VBN observed)))))) (. .))))

nsubjpass(used-37, Injection-1)
nn(injection-4, Lorazepam-3)
nsubj(produces-11, injection-4)
amod(benzodiazepines-9, other-7)
amod(benzodiazepines-9, injectable-8)
prep_like(produces-11, benzodiazepines-9)
dep(Injection-1, produces-11)
dobj(produces-11, depression-12)
det(system-17, the-14)
amod(system-17, central-15)
amod(system-17, nervous-16)
prep_of(depression-12, system-17)
advmod(administered-19, when-18)
advcl(produces-11, administered-19)
nn(alcohol-22, ethyl-21)
prep_with(administered-19, alcohol-22)
conj_and(alcohol-22, phenothiazines-24)
appos(phenothiazines-24, barbiturates-26)
nn(inhibitors-29, MAO-28)
appos(phenothiazines-24, inhibitors-29)
amod(antidepressants-33, other-32)
conj_and(alcohol-22, antidepressants-33)
amod(scopolamine-35, .When-34)
dep(alcohol-22, scopolamine-35)
auxpass(used-37, is-36)
root(ROOT-0, used-37)
advmod(used-37, concomitantly-38)
amod(lorazepam-41, injectable-40)
prep_with(used-37, lorazepam-41)
det(incidence-45, an-43)
amod(incidence-45, increased-44)
appos(lorazepam-41, incidence-45)
prep_of(incidence-45, sedation-47)
appos(lorazepam-41, hallucinations-49)
amod(behavior-53, irrational-52)
nsubjpass(observed-56, behavior-53)
aux(observed-56, has-54)
auxpass(observed-56, been-55)
conj_and(used-37, observed-56)

CYP3A4/NN Interactions/NNS ./.

(ROOT (S1 (S (S (NP (NN CYP3A4)) (VP (NNS Interactions))) (. .))))

nsubj(Interactions-2, CYP3A4-1)
root(ROOT-0, Interactions-2)

Lovastatin/NN is/VBZ metabolized/VBN by/IN CYP3A4/NN but/CC has/VBZ no/DT CYP3A4/JJ inhibitory/JJ activity/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN Lovastatin)) (VP (VP (VBZ is) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP3A4))))) (CC but) (VP (VBZ has) (NP (DT no) (JJ CYP3A4) (JJ inhibitory) (NN activity)))) (: ;)) (. .))))

nsubjpass(metabolized-3, Lovastatin-1)
auxpass(metabolized-3, is-2)
root(ROOT-0, metabolized-3)
agent(metabolized-3, CYP3A4-5)
conj_but(metabolized-3, has-7)
det(activity-11, no-8)
amod(activity-11, CYP3A4-9)
amod(activity-11, inhibitory-10)
dobj(has-7, activity-11)

therefore/RB it/PRP is/VBZ not/RB expected/VBN to/TO affect/VB the/DT plasma/NN concentrations/NNS of/IN other/JJ drugs/NNS metabolized/VBN by/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (ADVP (RB therefore)) (NP (PRP it)) (VP (VBZ is) (RB not) (VP (VBN expected) (S (VP (TO to) (VP (VB affect) (NP (NP (DT the) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (JJ other) (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (NN CYP3A4))))))))))))) (. .))))

advmod(expected-5, therefore-1)
nsubjpass(expected-5, it-2)
xsubj(affect-7, it-2)
auxpass(expected-5, is-3)
neg(expected-5, not-4)
root(ROOT-0, expected-5)
aux(affect-7, to-6)
xcomp(expected-5, affect-7)
det(concentrations-10, the-8)
nn(concentrations-10, plasma-9)
dobj(affect-7, concentrations-10)
amod(drugs-13, other-12)
prep_of(concentrations-10, drugs-13)
partmod(drugs-13, metabolized-14)
agent(metabolized-14, CYP3A4-16)

Potent/JJ inhibitors/NNS of/IN CYP3A4/NN (/-LRB- below/IN )/-RRB- increase/VBP the/DT risk/NN of/IN myopathy/NN by/IN reducing/VBG the/DT elimination/NN of/IN lovastatin/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Potent) (NNS inhibitors)) (PP (IN of) (NP (NN CYP3A4)))) (PRN (-LRB- -LRB-) (PP (IN below)) (-RRB- -RRB-))) (VP (VBP increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN myopathy)))) (PP (IN by) (S (VP (VBG reducing) (NP (NP (DT the) (NN elimination)) (PP (IN of) (NP (NN lovastatin))))))))) (. .))))

amod(inhibitors-2, Potent-1)
nsubj(increase-8, inhibitors-2)
prep_of(inhibitors-2, CYP3A4-4)
dep(inhibitors-2, below-6)
root(ROOT-0, increase-8)
det(risk-10, the-9)
dobj(increase-8, risk-10)
prep_of(risk-10, myopathy-12)
prepc_by(increase-8, reducing-14)
det(elimination-16, the-15)
dobj(reducing-14, elimination-16)
prep_of(elimination-16, lovastatin-18)

Itraconazole/NN Ketoconazole/NN Erythromycin/NN Clarithromycin/NN Telithromycin/NN HIV/NN protease/NN inhibitors/NNS Nefazodone/NN Cyclosporine/NN Large/JJ quantities/NNS of/IN grapefruit/NN juice/NN (/-LRB- 1/CD quart/NN daily/RB )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NP (NN Itraconazole) (NN Ketoconazole) (NN Erythromycin) (NN Clarithromycin) (NN Telithromycin)) (NN HIV) (NN protease) (NNS inhibitors)) (NP (NP (NN Nefazodone) (NN Cyclosporine) (JJ Large) (NNS quantities)) (PP (IN of) (NP (NP (NN grapefruit) (NN juice)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN quart) (RB daily)) (-RRB- -RRB-))))) (. .)))))

nn(Telithromycin-5, Itraconazole-1)
nn(Telithromycin-5, Ketoconazole-2)
nn(Telithromycin-5, Erythromycin-3)
nn(Telithromycin-5, Clarithromycin-4)
nn(inhibitors-8, Telithromycin-5)
nn(inhibitors-8, HIV-6)
nn(inhibitors-8, protease-7)
root(ROOT-0, inhibitors-8)
nn(quantities-12, Nefazodone-9)
nn(quantities-12, Cyclosporine-10)
amod(quantities-12, Large-11)
dep(inhibitors-8, quantities-12)
nn(juice-15, grapefruit-14)
prep_of(quantities-12, juice-15)
num(quart-18, 1-17)
appos(juice-15, quart-18)
advmod(quart-18, daily-19)

Interactions/NNS with/IN lipid-lowering/JJ drugs/NNS that/WDT can/MD cause/VB myopathy/NN when/WRB given/VBN alone/RB ./.

(ROOT (S1 (S (NP (NP (NNS Interactions)) (PP (IN with) (NP (NP (JJ lipid-lowering) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB cause) (NP (NN myopathy)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (ADVP (RB alone))))))))))) (. .)))))

root(ROOT-0, Interactions-1)
amod(drugs-4, lipid-lowering-3)
prep_with(Interactions-1, drugs-4)
nsubj(cause-7, drugs-4)
aux(cause-7, can-6)
rcmod(drugs-4, cause-7)
dobj(cause-7, myopathy-8)
advmod(given-10, when-9)
advcl(cause-7, given-10)
advmod(given-10, alone-11)

The/DT risk/NN of/IN myopathy/NN is/VBZ also/RB increased/VBN by/IN the/DT following/JJ lipid-lowering/JJ drugs/NNS that/WDT are/VBP not/RB potent/JJ CYP3A4/JJ inhibitors/NNS ,/, but/CC which/WDT can/MD cause/VB myopathy/NN when/WRB given/VBN alone/RB ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN risk)) (PP (IN of) (NP (NN myopathy)))) (VP (VBZ is) (ADVP (RB also)) (VP (VBN increased) (PP (IN by) (NP (NP (DT the) (JJ following) (JJ lipid-lowering) (NNS drugs)) (SBAR (SBAR (WHNP (WDT that)) (S (VP (VBP are) (RB not) (NP (JJ potent) (JJ CYP3A4) (NNS inhibitors))))) (, ,) (CC but) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB cause) (NP (NN myopathy)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (ADVP (RB alone))))))))))))))) (. .))))

det(risk-2, The-1)
nsubjpass(increased-7, risk-2)
prep_of(risk-2, myopathy-4)
auxpass(increased-7, is-5)
advmod(increased-7, also-6)
root(ROOT-0, increased-7)
det(drugs-12, the-9)
amod(drugs-12, following-10)
amod(drugs-12, lipid-lowering-11)
agent(increased-7, drugs-12)
nsubj(inhibitors-18, drugs-12)
nsubj(cause-23, drugs-12)
cop(inhibitors-18, are-14)
neg(inhibitors-18, not-15)
amod(inhibitors-18, potent-16)
amod(inhibitors-18, CYP3A4-17)
rcmod(drugs-12, inhibitors-18)
aux(cause-23, can-22)
conj_but(inhibitors-18, cause-23)
dobj(cause-23, myopathy-24)
advmod(given-26, when-25)
advcl(cause-23, given-26)
advmod(given-26, alone-27)

Gemfibrozil/NN :/: Other/JJ fibrates/NNS Niacin/NN (/-LRB- nicotinic/JJ acid/NN )/-RRB- (/-LRB- =1/CD g/day/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (NN Gemfibrozil)) (: :) (NP (NP (NP (JJ Other) (NNS fibrates) (NN Niacin)) (PRN (-LRB- -LRB-) (NP (JJ nicotinic) (NN acid)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (NP (CD =1) (NN g/day)) (-RRB- -RRB-))) (. .)))))

root(ROOT-0, Gemfibrozil-1)
amod(Niacin-5, Other-3)
nn(Niacin-5, fibrates-4)
dep(Gemfibrozil-1, Niacin-5)
amod(acid-8, nicotinic-7)
appos(Niacin-5, acid-8)
num(g/day-12, =1-11)
appos(Niacin-5, g/day-12)

Danazol/NN :/: The/DT risk/NN of/IN myopathy/rhabdomyolysis/NN is/VBZ increased/VBN by/IN concomitant/JJ administration/NN of/IN danazol/NN particularly/RB with/IN higher/JJR doses/NNS of/IN lovastatin/NN (/-LRB- see/VB WARNINGS/NNS ,/, Myopathy/Rhabdomyolysis/NNP )./CD

(ROOT (S1 (S (NP (NP (NN Danazol)) (: :) (S (NP (NP (DT The) (NN risk)) (PP (IN of) (NP (NN myopathy/rhabdomyolysis)))) (VP (VBZ is) (VP (VBN increased) (PP (IN by) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN danazol))))) (PP (ADVP (RB particularly)) (IN with) (NP (NP (JJR higher) (NNS doses)) (PP (IN of) (NP (NN lovastatin))))) (PRN (-LRB- -LRB-) (S (VP (VB see) (NP (NP (NNS WARNINGS)) (, ,) (NP (NNP Myopathy/Rhabdomyolysis) (CD -RRB-.)))))))))))))

root(ROOT-0, Danazol-1)
det(risk-4, The-3)
nsubjpass(increased-8, risk-4)
prep_of(risk-4, myopathy/rhabdomyolysis-6)
auxpass(increased-8, is-7)
dep(Danazol-1, increased-8)
amod(administration-11, concomitant-10)
agent(increased-8, administration-11)
prep_of(administration-11, danazol-13)
advmod(increased-8, particularly-14)
amod(doses-17, higher-16)
prep_with(increased-8, doses-17)
prep_of(doses-17, lovastatin-19)
parataxis(increased-8, see-21)
dobj(see-21, WARNINGS-22)
appos(WARNINGS-22, Myopathy/Rhabdomyolysis-24)
num(Myopathy/Rhabdomyolysis-24, -RRB-.-25)

Amiodarone/NN or/CC Verapamil/NN :/: The/DT risk/NN of/IN myopathy/rhabdomyolysis/NN is/VBZ increased/VBN when/WRB either/CC amiodarone/NN or/CC verapamil/NN is/VBZ used/VBN concomitantly/RB with/IN a/DT closely/RB related/JJ member/NN of/IN the/DT HMG-CoA/NN reductase/NN inhibitor/NN class/NN (/-LRB- see/VB WARNINGS/NNS ,/, Myopathy/Rhabdomyolysis/NN )./NN

(ROOT (S1 (S (NP (NP (NP (NN Amiodarone)) (CC or) (NP (NN Verapamil))) (: :) (S (NP (NP (DT The) (NN risk)) (PP (IN of) (NP (NN myopathy/rhabdomyolysis)))) (VP (VBZ is) (VP (VBN increased) (SBAR (WHADVP (WRB when)) (S (NP (CC either) (NP (NN amiodarone)) (CC or) (NP (NN verapamil))) (VP (VBZ is) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (NP (DT a) (ADJP (RB closely) (JJ related)) (NN member)) (PP (IN of) (NP (DT the) (NN HMG-CoA) (NN reductase) (NN inhibitor) (NN class) (S (-LRB- -LRB-) (VP (VB see) (NP (NNS WARNINGS))))))) (, ,) (NP (NN Myopathy/Rhabdomyolysis) (NN -RRB-.)))))))))))))))

root(ROOT-0, Amiodarone-1)
conj_or(Amiodarone-1, Verapamil-3)
det(risk-6, The-5)
nsubjpass(increased-10, risk-6)
prep_of(risk-6, myopathy/rhabdomyolysis-8)
auxpass(increased-10, is-9)
dep(Amiodarone-1, increased-10)
advmod(used-17, when-11)
preconj(amiodarone-13, either-12)
nsubjpass(used-17, amiodarone-13)
conj_or(amiodarone-13, verapamil-15)
auxpass(used-17, is-16)
advcl(increased-10, used-17)
advmod(used-17, concomitantly-18)
det(member-23, a-20)
advmod(related-22, closely-21)
amod(member-23, related-22)
prep_with(used-17, member-23)
det(class-29, the-25)
nn(class-29, HMG-CoA-26)
nn(class-29, reductase-27)
nn(class-29, inhibitor-28)
prep_of(member-23, class-29)
dep(class-29, see-31)
dobj(see-31, WARNINGS-32)
nn(-RRB-.-35, Myopathy/Rhabdomyolysis-34)
appos(member-23, -RRB-.-35)

Coumarin/NN Anticoagulant/NN s/NNS :/: In/IN a/DT small/JJ clinical/JJ trial/NN in/IN which/WDT lovastatin/NN was/VBD administered/VBN to/TO warfarin/JJ treated/JJ patients/NNS ,/, no/DT effect/NN on/IN prothrombin/NN time/NN was/VBD detected/VBN ./.

(ROOT (S1 (S (NP (NP (NN Coumarin) (NN Anticoagulant) (NNS s)) (: :) (S (PP (IN In) (NP (NP (DT a) (JJ small) (JJ clinical) (NN trial)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN lovastatin)) (VP (VBD was) (VP (VBN administered) (PP (TO to) (NP (JJ warfarin) (JJ treated) (NNS patients))))))))) (, ,) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NN prothrombin) (NN time)))) (VP (VBD was) (VP (VBN detected)))) (. .)))))

nn(s-3, Coumarin-1)
nn(s-3, Anticoagulant-2)
root(ROOT-0, s-3)
det(trial-9, a-6)
amod(trial-9, small-7)
amod(trial-9, clinical-8)
prep_in(detected-26, trial-9)
rel(administered-14, which-11)
nsubjpass(administered-14, lovastatin-12)
auxpass(administered-14, was-13)
rcmod(trial-9, administered-14)
amod(patients-18, warfarin-16)
amod(patients-18, treated-17)
prep_to(administered-14, patients-18)
det(effect-21, no-20)
nsubjpass(detected-26, effect-21)
nn(time-24, prothrombin-23)
prep_on(effect-21, time-24)
auxpass(detected-26, was-25)
dep(s-3, detected-26)

However/RB ,/, another/DT HMG-CoA/NN reductase/NN inhibitor/NN has/VBZ been/VBN found/VBN to/TO produce/VB a/DT less/JJR than/IN two-second/JJ increase/NN in/IN prothrombin/NN time/NN in/IN healthy/JJ volunteers/NNS receiving/VBG low/JJ doses/NNS of/IN warfarin/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (DT another) (NN HMG-CoA) (NN reductase) (NN inhibitor)) (VP (VBZ has) (VP (VBN been) (VP (VBN found) (S (VP (TO to) (VP (VB produce) (NP (NP (DT a) (ADJP (JJR less) (IN than) (JJ two-second)) (NN increase)) (PP (IN in) (NP (NN prothrombin) (NN time))) (PP (IN in) (NP (NP (JJ healthy) (NNS volunteers)) (VP (VBG receiving) (NP (NP (JJ low) (NNS doses)) (PP (IN of) (NP (NN warfarin))))))))))))))) (. .))))

advmod(found-9, However-1)
det(inhibitor-6, another-3)
nn(inhibitor-6, HMG-CoA-4)
nn(inhibitor-6, reductase-5)
nsubjpass(found-9, inhibitor-6)
xsubj(produce-11, inhibitor-6)
aux(found-9, has-7)
auxpass(found-9, been-8)
root(ROOT-0, found-9)
aux(produce-11, to-10)
xcomp(found-9, produce-11)
det(increase-16, a-12)
dep(two-second-15, less-13)
dep(two-second-15, than-14)
amod(increase-16, two-second-15)
dobj(produce-11, increase-16)
nn(time-19, prothrombin-18)
prep_in(increase-16, time-19)
amod(volunteers-22, healthy-21)
prep_in(increase-16, volunteers-22)
partmod(volunteers-22, receiving-23)
amod(doses-25, low-24)
dobj(receiving-23, doses-25)
prep_of(doses-25, warfarin-27)

Also/RB ,/, bleeding/JJ and/or/CC increased/VBN prothrombin/NN time/NN have/VBP been/VBN reported/VBN in/IN a/DT few/JJ patients/NNS taking/VBG coumarin/NN anticoagulant/NN s/NNS concomitantly/RB with/IN lovastatin/NN ./.

(ROOT (S1 (S (ADVP (RB Also)) (, ,) (NP (NP (ADJP (JJ bleeding))) (CC and/or) (NP (VBN increased) (NN prothrombin) (NN time))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN in) (NP (NP (DT a) (JJ few) (NNS patients)) (VP (VBG taking) (NP (NP (NN coumarin) (NN anticoagulant) (NNS s)) (PP (ADVP (RB concomitantly)) (IN with) (NP (NN lovastatin)))))))))) (. .))))

advmod(reported-10, Also-1)
nsubjpass(reported-10, bleeding-3)
amod(time-7, increased-5)
nn(time-7, prothrombin-6)
conj_and/or(bleeding-3, time-7)
aux(reported-10, have-8)
auxpass(reported-10, been-9)
root(ROOT-0, reported-10)
det(patients-14, a-12)
amod(patients-14, few-13)
prep_in(reported-10, patients-14)
partmod(patients-14, taking-15)
nn(s-18, coumarin-16)
nn(s-18, anticoagulant-17)
dobj(taking-15, s-18)
advmod(s-18, concomitantly-19)
prep_with(s-18, lovastatin-21)

It/PRP is/VBZ recommended/VBN that/IN in/IN patients/NNS taking/VBG anticoagulants/NNS ,/, prothrombin/NN time/NN be/VB determined/VBN before/IN starting/VBG lovastatin/NN and/CC frequently/RB enough/RB during/IN early/JJ therapy/NN to/TO insure/NN that/IN no/DT significant/JJ alteration/NN of/IN prothrombin/NN time/NN occurs/VBZ ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NNS anticoagulants))))) (, ,) (NP (NN prothrombin) (NN time)) (VP (VB be) (VP (VBN determined) (PP (IN before) (S (VP (VP (VBG starting) (NP (NN lovastatin))) (CC and) (ADVP (RB frequently)) (ADVP (RB enough)) (PP (IN during) (NP (NP (JJ early) (NN therapy)) (PP (TO to) (NP (NN insure))))) (SBAR (IN that) (S (NP (NP (DT no) (JJ significant) (NN alteration)) (PP (IN of) (NP (NN prothrombin) (NN time)))) (VP (VBZ occurs)))))))))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(determined-13, that-4)
prep_in(determined-13, patients-6)
partmod(patients-6, taking-7)
dobj(taking-7, anticoagulants-8)
nn(time-11, prothrombin-10)
nsubjpass(determined-13, time-11)
auxpass(determined-13, be-12)
ccomp(recommended-3, determined-13)
prepc_before(determined-13, starting-15)
dobj(starting-15, lovastatin-16)
advmod(starting-15, frequently-18)
conj_and(starting-15, frequently-18)
advmod(starting-15, enough-19)
conj_and(starting-15, enough-19)
amod(therapy-22, early-21)
prep_during(starting-15, therapy-22)
prep_to(therapy-22, insure-24)
dep(occurs-32, that-25)
det(alteration-28, no-26)
amod(alteration-28, significant-27)
nsubj(occurs-32, alteration-28)
nn(time-31, prothrombin-30)
prep_of(alteration-28, time-31)
ccomp(starting-15, occurs-32)

Once/IN a/DT stable/JJ prothrombin/NN time/NN has/VBZ been/VBN documented/VBN ,/, prothrombin/NN times/NNS can/MD be/VB monitored/VBN at/IN the/DT intervals/NNS usually/RB recommended/VBN for/IN patients/NNS on/IN coumarin/NN anticoagulant/NN s/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Once) (S (NP (DT a) (JJ stable) (NN prothrombin) (NN time)) (VP (VBZ has) (VP (VBN been) (VP (VBN documented)))))) (, ,) (NP (NN prothrombin) (NNS times)) (VP (MD can) (VP (VB be) (VP (VBN monitored) (PP (IN at) (NP (NP (DT the) (NNS intervals)) (VP (ADVP (RB usually)) (VBN recommended) (PP (IN for) (NP (NP (NNS patients)) (PP (IN on) (NP (NN coumarin) (NN anticoagulant) (NNS s)))))))))))) (. .))))

mark(documented-8, Once-1)
det(time-5, a-2)
amod(time-5, stable-3)
nn(time-5, prothrombin-4)
nsubjpass(documented-8, time-5)
aux(documented-8, has-6)
auxpass(documented-8, been-7)
advcl(monitored-14, documented-8)
nn(times-11, prothrombin-10)
nsubjpass(monitored-14, times-11)
aux(monitored-14, can-12)
auxpass(monitored-14, be-13)
root(ROOT-0, monitored-14)
det(intervals-17, the-16)
prep_at(monitored-14, intervals-17)
advmod(recommended-19, usually-18)
partmod(intervals-17, recommended-19)
prep_for(recommended-19, patients-21)
nn(s-25, coumarin-23)
nn(s-25, anticoagulant-24)
prep_on(patients-21, s-25)

If/IN the/DT dose/NN of/IN lovastatin/NN is/VBZ changed/VBN ,/, the/DT same/JJ procedure/NN should/MD be/VB repeated/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN lovastatin)))) (VP (VBZ is) (VP (VBN changed))))) (, ,) (NP (DT the) (JJ same) (NN procedure)) (VP (MD should) (VP (VB be) (VP (VBN repeated))))) (. .))))

mark(changed-7, If-1)
det(dose-3, the-2)
nsubjpass(changed-7, dose-3)
prep_of(dose-3, lovastatin-5)
auxpass(changed-7, is-6)
advcl(repeated-14, changed-7)
det(procedure-11, the-9)
amod(procedure-11, same-10)
nsubjpass(repeated-14, procedure-11)
aux(repeated-14, should-12)
auxpass(repeated-14, be-13)
root(ROOT-0, repeated-14)

Lovastatin/JJ therapy/NN has/VBZ not/RB been/VBN associated/VBN with/IN bleeding/JJ or/CC with/IN changes/NNS in/IN prothrombin/NN time/NN in/IN patients/NNS not/RB taking/VBG anticoagulants/NNS ./.

(ROOT (S1 (S (S (NP (JJ Lovastatin) (NN therapy)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN associated) (PP (PP (IN with) (NP (JJ bleeding))) (CC or) (PP (IN with) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NN prothrombin) (NN time)) (PP (IN in) (NP (NP (NNS patients)) (VP (RB not) (VBG taking) (NP (NNS anticoagulants)))))))))))))) (. .))))

amod(therapy-2, Lovastatin-1)
nsubjpass(associated-6, therapy-2)
aux(associated-6, has-3)
neg(associated-6, not-4)
auxpass(associated-6, been-5)
root(ROOT-0, associated-6)
prep_with(associated-6, bleeding-8)
conj_or(bleeding-8, changes-11)
nn(time-14, prothrombin-13)
prep_in(changes-11, time-14)
prep_in(time-14, patients-16)
neg(taking-18, not-17)
partmod(patients-16, taking-18)
dobj(taking-18, anticoagulants-19)

Propranolol/NN :/: In/IN normal/JJ volunteers/NNS ,/, there/EX was/VBD no/DT clinically/RB significant/JJ pharmacokinetic/JJ or/CC pharmacodynamic/JJ interaction/NN with/IN concomitant/JJ administration/NN of/IN single/JJ doses/NNS of/IN lovastatin/NN and/CC propranolol/NN ./.

(ROOT (S1 (S (NP (NP (NN Propranolol)) (: :) (S (PP (IN In) (NP (JJ normal) (NNS volunteers))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (ADJP (RB clinically) (JJ significant)) (ADJP (ADJP (JJ pharmacokinetic)) (CC or) (ADJP (JJ pharmacodynamic))) (NN interaction)) (PP (IN with) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (JJ single) (NNS doses)) (PP (IN of) (NP (NP (NN lovastatin)) (CC and) (NP (NN propranolol))))))))))) (. .)))))

root(ROOT-0, Propranolol-1)
amod(volunteers-5, normal-4)
prep_in(was-8, volunteers-5)
expl(was-8, there-7)
dep(Propranolol-1, was-8)
det(interaction-15, no-9)
advmod(significant-11, clinically-10)
amod(interaction-15, significant-11)
amod(interaction-15, pharmacokinetic-12)
conj_or(pharmacokinetic-12, pharmacodynamic-14)
nsubj(was-8, interaction-15)
amod(administration-18, concomitant-17)
prep_with(interaction-15, administration-18)
amod(doses-21, single-20)
prep_of(administration-18, doses-21)
prep_of(doses-21, lovastatin-23)
conj_and(lovastatin-23, propranolol-25)

Digoxin/NN :/: In/IN patients/NNS with/IN hypercholesterolemia/NN ,/, concomitant/JJ administration/NN of/IN lovastatin/NN and/CC digoxin/NN resulted/VBD in/IN no/DT effect/NN on/IN digoxin/NN plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Digoxin) (: :)) (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (NN hypercholesterolemia)))))) (, ,) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN lovastatin)) (CC and) (NP (NN digoxin))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NN digoxin) (NN plasma) (NNS concentrations))))))) (. .))))

nsubj(resulted-14, Digoxin-1)
prep_in(Digoxin-1, patients-4)
prep_with(patients-4, hypercholesterolemia-6)
amod(administration-9, concomitant-8)
nsubj(resulted-14, administration-9)
prep_of(administration-9, lovastatin-11)
conj_and(lovastatin-11, digoxin-13)
root(ROOT-0, resulted-14)
det(effect-17, no-16)
prep_in(resulted-14, effect-17)
nn(concentrations-21, digoxin-19)
nn(concentrations-21, plasma-20)
prep_on(effect-17, concentrations-21)

Oral/JJ Hypoglycemic/JJ Agents/NNS :/: In/IN pharmacokinetic/JJ studies/NNS of/IN MEVACOR/NN in/IN hypercholesterolemic/JJ noninsulin/NN dependent/JJ diabetic/JJ patients/NNS ,/, there/EX was/VBD no/DT drug/NN interaction/NN with/IN glipizide/NN or/CC with/IN chlorpropamide/NN ./.

(ROOT (S1 (S (NP (NP (JJ Oral) (JJ Hypoglycemic) (NNS Agents)) (: :) (S (PP (IN In) (NP (NP (JJ pharmacokinetic) (NNS studies)) (PP (IN of) (NP (NP (NN MEVACOR)) (PP (IN in) (NP (JJ hypercholesterolemic) (ADJP (NN noninsulin) (JJ dependent)) (JJ diabetic) (NNS patients))))))) (, ,) (NP (EX there)) (VP (VBD was) (NP (DT no) (NN drug) (NN interaction)) (PP (PP (IN with) (NP (NN glipizide))) (CC or) (PP (IN with) (NP (NN chlorpropamide)))))) (. .)))))

amod(Agents-3, Oral-1)
amod(Agents-3, Hypoglycemic-2)
root(ROOT-0, Agents-3)
amod(studies-7, pharmacokinetic-6)
prep_in(was-18, studies-7)
prep_of(studies-7, MEVACOR-9)
amod(patients-15, hypercholesterolemic-11)
dep(dependent-13, noninsulin-12)
amod(patients-15, dependent-13)
amod(patients-15, diabetic-14)
prep_in(MEVACOR-9, patients-15)
expl(was-18, there-17)
dep(Agents-3, was-18)
det(interaction-21, no-19)
nn(interaction-21, drug-20)
nsubj(was-18, interaction-21)
prep_with(was-18, glipizide-23)
conj_or(glipizide-23, chlorpropamide-26)

There/EX have/VBP been/VBN rare/JJ reports/NNS of/IN significant/JJ respiratory/JJ depression/NN ,/, stupor/NN and/or/CC hypotension/NN with/IN the/DT concomitant/JJ use/NN of/IN loxapine/NN and/CC lorazepam/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (JJ rare) (NNS reports)) (PP (IN of) (NP (NP (JJ significant) (JJ respiratory) (NN depression)) (, ,) (NP (NN stupor)) (CC and/or) (NP (NN hypotension)))) (PP (IN with) (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN loxapine)) (CC and) (NP (NN lorazepam)))))))))) (. .))))

expl(reports-5, There-1)
aux(reports-5, have-2)
cop(reports-5, been-3)
amod(reports-5, rare-4)
root(ROOT-0, reports-5)
amod(depression-9, significant-7)
amod(depression-9, respiratory-8)
prep_of(reports-5, depression-9)
conj_and/or(depression-9, stupor-11)
conj_and/or(depression-9, hypotension-13)
det(use-17, the-15)
amod(use-17, concomitant-16)
prep_with(reports-5, use-17)
prep_of(use-17, loxapine-19)
conj_and(loxapine-19, lorazepam-21)

The/DT risk/NN of/IN using/VBG loxapine/NN in/IN combination/NN with/IN CNS-active/JJ drugs/NNS has/VBZ not/RB been/VBN systematically/RB evaluated/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN risk)) (PP (IN of) (S (VP (VBG using) (NP (NN loxapine)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (JJ CNS-active) (NNS drugs))))))))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB systematically)) (VP (VBN evaluated))))) (. .))))

det(risk-2, The-1)
nsubjpass(evaluated-15, risk-2)
prepc_of(risk-2, using-4)
dobj(using-4, loxapine-5)
prep_in(using-4, combination-7)
amod(drugs-10, CNS-active-9)
prep_with(combination-7, drugs-10)
aux(evaluated-15, has-11)
neg(evaluated-15, not-12)
auxpass(evaluated-15, been-13)
advmod(evaluated-15, systematically-14)
root(ROOT-0, evaluated-15)

Therefore/RB ,/, caution/NN is/VBZ advised/VBN if/IN the/DT concomitant/JJ administration/NN of/IN loxapine/JJ and/CC CNS-active/JJ drugs/NNS is/VBZ required/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NN caution)) (VP (VBZ is) (VP (VBN advised) (SBAR (IN if) (S (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (ADJP (ADJP (JJ loxapine)) (CC and) (ADJP (JJ CNS-active))) (NNS drugs)))) (VP (VBZ is) (VP (VBN required)))))))) (. .))))

advmod(advised-5, Therefore-1)
nsubjpass(advised-5, caution-3)
auxpass(advised-5, is-4)
root(ROOT-0, advised-5)
mark(required-16, if-6)
det(administration-9, the-7)
amod(administration-9, concomitant-8)
nsubjpass(required-16, administration-9)
amod(drugs-14, loxapine-11)
conj_and(loxapine-11, CNS-active-13)
prep_of(administration-9, drugs-14)
auxpass(required-16, is-15)
advcl(advised-5, required-16)

The/DT absorption/NN of/IN lymecycline/NN may/MD be/VB affected/VBN by/IN the/DT simultaneous/JJ administration/NN of/IN indigestion/NN remedies/NNS ,/, iron/NN or/CC zinc/NN supplement/NN s/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN absorption)) (PP (IN of) (NP (NN lymecycline)))) (VP (MD may) (VP (VB be) (VP (VBN affected) (PP (IN by) (NP (NP (NP (DT the) (JJ simultaneous) (NN administration)) (PP (IN of) (NP (NN indigestion) (NNS remedies)))) (, ,) (NP (NN iron)) (CC or) (NP (NN zinc) (NN supplement) (NNS s)))))))) (. .))))

det(absorption-2, The-1)
nsubjpass(affected-7, absorption-2)
prep_of(absorption-2, lymecycline-4)
aux(affected-7, may-5)
auxpass(affected-7, be-6)
root(ROOT-0, affected-7)
det(administration-11, the-9)
amod(administration-11, simultaneous-10)
agent(affected-7, administration-11)
nn(remedies-14, indigestion-13)
prep_of(administration-11, remedies-14)
conj_or(administration-11, iron-16)
nn(s-20, zinc-18)
nn(s-20, supplement-19)
conj_or(administration-11, s-20)

Oral/JJ contraceptives/NNS may/MD be/VB less/RBR effective/JJ while/IN you/NN are/VBP taking/VBG lymecycline/NN ./.

(ROOT (S1 (S (S (NP (JJ Oral) (NNS contraceptives)) (VP (MD may) (VP (VB be) (ADJP (RBR less) (JJ effective)) (SBAR (IN while) (S (NP (NN you)) (VP (VBP are) (VP (VBG taking) (NP (NN lymecycline))))))))) (. .))))

amod(contraceptives-2, Oral-1)
nsubj(effective-6, contraceptives-2)
aux(effective-6, may-3)
cop(effective-6, be-4)
advmod(effective-6, less-5)
root(ROOT-0, effective-6)
mark(taking-10, while-7)
nsubj(taking-10, you-8)
aux(taking-10, are-9)
advcl(effective-6, taking-10)
dobj(taking-10, lymecycline-11)

Warfarin/NN Meclofenamate/NN sodium/NN enhances/VBZ the/DT effect/NN of/IN warfarin/NN ./.

(ROOT (S1 (S (S (NP (NN Warfarin) (NN Meclofenamate) (NN sodium)) (VP (VBZ enhances) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN warfarin)))))) (. .))))

nn(sodium-3, Warfarin-1)
nn(sodium-3, Meclofenamate-2)
nsubj(enhances-4, sodium-3)
root(ROOT-0, enhances-4)
det(effect-6, the-5)
dobj(enhances-4, effect-6)
prep_of(effect-6, warfarin-8)

Therefore/RB ,/, when/WRB meclofenamate/NN sodium/NN is/VBZ given/VBN to/TO a/DT patient/NN receiving/VBG warfarin/NN ,/, the/DT dosage/NN of/IN warfarin/NN should/MD be/VB reduced/VBN to/TO prevent/VB excessive/JJ prolongation/NN of/IN the/DT prothrombin/NN time/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NN meclofenamate) (NN sodium)) (VP (VBZ is) (VP (VBN given) (PP (TO to) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN warfarin))))))))) (, ,) (NP (NP (DT the) (NN dosage)) (PP (IN of) (NP (NN warfarin)))) (VP (MD should) (VP (VB be) (VP (VBN reduced) (S (VP (TO to) (VP (VB prevent) (NP (NP (JJ excessive) (NN prolongation)) (PP (IN of) (NP (DT the) (NN prothrombin) (NN time))))))))))) (. .))))

advmod(reduced-20, Therefore-1)
advmod(given-7, when-3)
nn(sodium-5, meclofenamate-4)
nsubjpass(given-7, sodium-5)
auxpass(given-7, is-6)
advcl(reduced-20, given-7)
det(patient-10, a-9)
prep_to(given-7, patient-10)
partmod(patient-10, receiving-11)
dobj(receiving-11, warfarin-12)
det(dosage-15, the-14)
nsubjpass(reduced-20, dosage-15)
prep_of(dosage-15, warfarin-17)
aux(reduced-20, should-18)
auxpass(reduced-20, be-19)
root(ROOT-0, reduced-20)
aux(prevent-22, to-21)
xcomp(reduced-20, prevent-22)
amod(prolongation-24, excessive-23)
dobj(prevent-22, prolongation-24)
det(time-28, the-26)
nn(time-28, prothrombin-27)
prep_of(prolongation-24, time-28)

Aspirin/NN Concurrent/JJ administration/NN of/IN aspirin/NN may/MD lower/JJR meclofenamate/NN sodium/NN plasma/NN levels/NNS ,/, possibly/RB by/IN competing/VBG for/IN protein/NN -binding/JJ sites/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Aspirin) (JJ Concurrent) (NN administration)) (PP (IN of) (NP (NN aspirin)))) (VP (MD may) (VP (JJR lower) (NP (NN meclofenamate) (NN sodium) (NN plasma) (NNS levels)) (, ,) (PP (ADVP (RB possibly)) (IN by) (S (VP (VBG competing) (PP (IN for) (NP (NN protein) (JJ -binding) (NNS sites))))))))) (. .))))

nn(administration-3, Aspirin-1)
amod(administration-3, Concurrent-2)
nsubj(levels-11, administration-3)
prep_of(administration-3, aspirin-5)
aux(levels-11, may-6)
dep(levels-11, lower-7)
nn(levels-11, meclofenamate-8)
nn(levels-11, sodium-9)
nn(levels-11, plasma-10)
root(ROOT-0, levels-11)
advmod(levels-11, possibly-13)
prepc_by(levels-11, competing-15)
nn(sites-19, protein-17)
amod(sites-19, -binding-18)
prep_for(competing-15, sites-19)

The/DT urinary/JJ excretion/NN of/IN meclofenamate/NN sodium/NN is/VBZ unaffected/VBN by/IN aspirin/NN ,/, indicating/VBG no/DT change/NN in/IN meclofenamate/NN sodium/NN absorption/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ urinary) (NN excretion)) (PP (IN of) (NP (NN meclofenamate) (NN sodium)))) (VP (VBZ is) (VP (VBN unaffected) (PP (IN by) (NP (NN aspirin))) (, ,) (S (VP (VBG indicating) (NP (NP (DT no) (NN change)) (PP (IN in) (NP (NN meclofenamate) (NN sodium) (NN absorption))))))))) (. .))))

det(excretion-3, The-1)
amod(excretion-3, urinary-2)
nsubjpass(unaffected-8, excretion-3)
nn(sodium-6, meclofenamate-5)
prep_of(excretion-3, sodium-6)
auxpass(unaffected-8, is-7)
root(ROOT-0, unaffected-8)
agent(unaffected-8, aspirin-10)
xcomp(unaffected-8, indicating-12)
det(change-14, no-13)
dobj(indicating-12, change-14)
nn(absorption-18, meclofenamate-16)
nn(absorption-18, sodium-17)
prep_in(change-14, absorption-18)

Meclofenamate/NN sodium/NN does/VBZ not/RB affect/VB serum/NN salicylate/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NN Meclofenamate) (NN sodium)) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NN serum) (NN salicylate) (NNS levels))))) (. .))))

nn(sodium-2, Meclofenamate-1)
nsubj(affect-5, sodium-2)
aux(affect-5, does-3)
neg(affect-5, not-4)
root(ROOT-0, affect-5)
nn(levels-8, serum-6)
nn(levels-8, salicylate-7)
dobj(affect-5, levels-8)

Greater/JJR fecal/NN blood/NN loss/NN results/VBZ from/IN concomitant/JJ administration/NN of/IN both/DT drugs/NNS than/IN from/IN either/DT drug/NN alone/RB ./.

(ROOT (S1 (S (S (NP (JJR Greater) (NN fecal) (NN blood) (NN loss)) (VP (VBZ results) (PP (IN from) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (DT both) (NNS drugs))) (PP (IN than) (PP (IN from) (NP (NP (DT either) (NN drug)) (ADVP (RB alone))))))))) (. .))))

amod(loss-4, Greater-1)
nn(loss-4, fecal-2)
nn(loss-4, blood-3)
nsubj(results-5, loss-4)
root(ROOT-0, results-5)
amod(administration-8, concomitant-7)
prep_from(results-5, administration-8)
det(drugs-11, both-10)
prep_of(administration-8, drugs-11)
prep(administration-8, than-12)
pcomp(than-12, from-13)
det(drug-15, either-14)
prep_from(than-12, drug-15)
advmod(drug-15, alone-16)

Propoxyphene/NN :/: The/DT concurrent/JJ administration/NN of/IN propoxyphene/NN hydrochloride/NN does/VBZ not/RB affect/VB the/DT bioavailability/NN of/IN meclofenamate/NN sodium/NN ./.

(ROOT (S1 (S (NP (NP (NN Propoxyphene)) (: :) (S (NP (NP (DT The) (JJ concurrent) (NN administration)) (PP (IN of) (NP (NN propoxyphene) (NN hydrochloride)))) (VP (VBZ does) (RB not) (VP (VB affect) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (NN meclofenamate) (NN sodium))))))) (. .)))))

root(ROOT-0, Propoxyphene-1)
det(administration-5, The-3)
amod(administration-5, concurrent-4)
nsubj(affect-11, administration-5)
nn(hydrochloride-8, propoxyphene-7)
prep_of(administration-5, hydrochloride-8)
aux(affect-11, does-9)
neg(affect-11, not-10)
dep(Propoxyphene-1, affect-11)
det(bioavailability-13, the-12)
dobj(affect-11, bioavailability-13)
nn(sodium-16, meclofenamate-15)
prep_of(bioavailability-13, sodium-16)

Antacids/NNS Concomitant/JJ administration/NN of/IN aluminum/NN and/CC magnesium/NN hydroxide/NN s/NNS does/VBZ not/RB interfere/VB with/IN absorption/NN of/IN meclofenamate/NN sodium/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Antacids)) (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN aluminum)) (CC and) (NP (NN magnesium) (NN hydroxide) (NNS s))))) (VP (VBZ does) (RB not) (VP (VB interfere) (PP (IN with) (NP (NP (NN absorption)) (PP (IN of) (NP (NN meclofenamate) (NN sodium)))))))) (. .))))

nn(administration-3, Antacids-1)
amod(administration-3, Concomitant-2)
nsubj(interfere-12, administration-3)
prep_of(administration-3, aluminum-5)
nn(s-9, magnesium-7)
nn(s-9, hydroxide-8)
conj_and(aluminum-5, s-9)
aux(interfere-12, does-10)
neg(interfere-12, not-11)
root(ROOT-0, interfere-12)
prep_with(interfere-12, absorption-14)
nn(sodium-17, meclofenamate-16)
prep_of(absorption-14, sodium-17)

Aspirin/NN :/: As/IN with/IN other/JJ NSAIDs/NNS ,/, concomitant/JJ administration/NN of/IN Ponstel/NN and/CC aspirin/NN is/VBZ not/RB generally/RB recommended/VBN because/IN of/IN the/DT potential/NN of/IN increased/VBN adverse/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NN Aspirin)) (: :) (PP (IN As) (PP (IN with) (NP (JJ other) (NNS NSAIDs)))) (, ,) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN Ponstel)) (CC and) (NP (NN aspirin))))) (VP (VBZ is) (RB not) (ADVP (RB generally)) (VP (VBN recommended) (PP (IN because) (IN of) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (VBN increased) (JJ adverse) (NNS effects)))))))) (. .))))

nsubjpass(recommended-17, Aspirin-1)
prep(recommended-17, As-3)
pcomp(As-3, with-4)
amod(NSAIDs-6, other-5)
prep_with(As-3, NSAIDs-6)
amod(administration-9, concomitant-8)
nsubjpass(recommended-17, administration-9)
prep_of(administration-9, Ponstel-11)
conj_and(Ponstel-11, aspirin-13)
auxpass(recommended-17, is-14)
neg(recommended-17, not-15)
advmod(recommended-17, generally-16)
root(ROOT-0, recommended-17)
det(potential-21, the-20)
prep_because_of(recommended-17, potential-21)
amod(effects-25, increased-23)
amod(effects-25, adverse-24)
prep_of(potential-21, effects-25)

Methotrexate/NN :/: NSAIDs/NNS have/VBP been/VBN reported/VBN to/TO competitively/RB inhibit/VB methotrexate/NN accumulation/NN in/IN rabbit/NN kidney/NN slices/NNS ./.

(ROOT (S1 (S (NP (NP (NN Methotrexate)) (: :) (S (NP (NNS NSAIDs)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (ADVP (RB competitively)) (VP (VB inhibit) (NP (NP (NN methotrexate) (NN accumulation)) (PP (IN in) (NP (NN rabbit) (NN kidney) (NNS slices))))))))))) (. .)))))

root(ROOT-0, Methotrexate-1)
nsubjpass(reported-6, NSAIDs-3)
xsubj(inhibit-9, NSAIDs-3)
aux(reported-6, have-4)
auxpass(reported-6, been-5)
dep(Methotrexate-1, reported-6)
aux(inhibit-9, to-7)
advmod(inhibit-9, competitively-8)
xcomp(reported-6, inhibit-9)
nn(accumulation-11, methotrexate-10)
dobj(inhibit-9, accumulation-11)
nn(slices-15, rabbit-13)
nn(slices-15, kidney-14)
prep_in(accumulation-11, slices-15)

This/DT may/MD indicate/VB that/IN they/PRP could/MD enhance/VB the/DT toxicity/NN of/IN methotrexate/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (MD may) (VP (VB indicate) (SBAR (IN that) (S (NP (PRP they)) (VP (MD could) (VP (VB enhance) (NP (NP (DT the) (NN toxicity)) (PP (IN of) (NP (NN methotrexate))))))))))) (. .))))

nsubj(indicate-3, This-1)
aux(indicate-3, may-2)
root(ROOT-0, indicate-3)
complm(enhance-7, that-4)
nsubj(enhance-7, they-5)
aux(enhance-7, could-6)
ccomp(indicate-3, enhance-7)
det(toxicity-9, the-8)
dobj(enhance-7, toxicity-9)
prep_of(toxicity-9, methotrexate-11)

Caution/NN should/MD be/VB used/VBN when/WRB NSAIDs/NNS are/VBP administered/VBN concomitantly/RB with/IN methotrexate/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN used))) (SBAR (WHADVP (WRB when)) (S (NP (NNS NSAIDs)) (VP (VBP are) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN methotrexate))))))))) (. .))))

nsubjpass(used-4, Caution-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
advmod(administered-8, when-5)
nsubjpass(administered-8, NSAIDs-6)
auxpass(administered-8, are-7)
advcl(used-4, administered-8)
advmod(administered-8, concomitantly-9)
prep_with(administered-8, methotrexate-11)

ACE/NN inhibitors/NNS :/: Reports/NNS suggest/VBP that/IN NSAIDs/NNS may/MD diminish/VB the/DT antihypertensive/JJ effect/NN of/IN ACE/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (NN ACE) (NNS inhibitors)) (: :) (NP (NNS Reports)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS NSAIDs)) (VP (MD may) (VP (VB diminish) (NP (NP (DT the) (JJ antihypertensive) (NN effect)) (PP (IN of) (NP (NN ACE) (NNS inhibitors)))))))))) (. .))))

nn(inhibitors-2, ACE-1)
nsubj(suggest-5, inhibitors-2)
nsubj(suggest-5, Reports-4)
root(ROOT-0, suggest-5)
complm(diminish-9, that-6)
nsubj(diminish-9, NSAIDs-7)
aux(diminish-9, may-8)
ccomp(suggest-5, diminish-9)
det(effect-12, the-10)
amod(effect-12, antihypertensive-11)
dobj(diminish-9, effect-12)
nn(inhibitors-15, ACE-14)
prep_of(effect-12, inhibitors-15)

This/DT interaction/NN should/MD be/VB given/VBN consideration/NN in/IN patients/NNS taking/VBG NSAIDs/NN concomitantly/RB with/IN ACE/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (DT This) (NN interaction)) (VP (MD should) (VP (VB be) (VP (VBN given) (NP (NP (NN consideration)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN NSAIDs)))))) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN ACE) (NNS inhibitors))))))) (. .))))

det(interaction-2, This-1)
nsubjpass(given-5, interaction-2)
aux(given-5, should-3)
auxpass(given-5, be-4)
root(ROOT-0, given-5)
dobj(given-5, consideration-6)
prep_in(consideration-6, patients-8)
partmod(patients-8, taking-9)
dobj(taking-9, NSAIDs-10)
advmod(given-5, concomitantly-11)
nn(inhibitors-14, ACE-13)
prep_with(given-5, inhibitors-14)

Furosemide/NN :/: Clinical/JJ studies/NNS ,/, as/RB well/RB as/IN post-marketing/JJ observations/NNS ,/, have/VBP shown/VBN that/IN NSAIDs/NNS can/MD reduce/VB the/DT natriuretic/JJ effect/NN of/IN furosemide/NN and/CC thiazides/NNS in/IN some/DT patients/NNS ./.

(ROOT (S1 (S (NP (NP (NN Furosemide)) (: :) (S (NP (NP (JJ Clinical) (NNS studies)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (JJ post-marketing) (NNS observations)) (, ,)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NNS NSAIDs)) (VP (MD can) (VP (VB reduce) (NP (NP (DT the) (JJ natriuretic) (NN effect)) (PP (IN of) (NP (NP (NN furosemide)) (CC and) (NP (NNS thiazides)))) (PP (IN in) (NP (DT some) (NNS patients))))))))))) (. .)))))

root(ROOT-0, Furosemide-1)
amod(studies-4, Clinical-3)
nsubj(shown-13, studies-4)
amod(observations-10, post-marketing-9)
conj_and(studies-4, observations-10)
aux(shown-13, have-12)
dep(Furosemide-1, shown-13)
complm(reduce-17, that-14)
nsubj(reduce-17, NSAIDs-15)
aux(reduce-17, can-16)
ccomp(shown-13, reduce-17)
det(effect-20, the-18)
amod(effect-20, natriuretic-19)
dobj(reduce-17, effect-20)
prep_of(effect-20, furosemide-22)
conj_and(furosemide-22, thiazides-24)
det(patients-27, some-26)
prep_in(effect-20, patients-27)

This/DT response/NN has/VBZ been/VBN attributed/VBN to/TO inhibition/NN of/IN renal/JJ prostaglandin/NN synthesis/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN response)) (VP (VBZ has) (VP (VBN been) (VP (VBN attributed) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ renal) (NN prostaglandin) (NN synthesis))))))))) (. .))))

det(response-2, This-1)
nsubjpass(attributed-5, response-2)
aux(attributed-5, has-3)
auxpass(attributed-5, been-4)
root(ROOT-0, attributed-5)
prep_to(attributed-5, inhibition-7)
amod(synthesis-11, renal-9)
nn(synthesis-11, prostaglandin-10)
prep_of(inhibition-7, synthesis-11)

During/IN concomitant/JJ therapy/NN of/IN Ponstel/NN with/IN furosemide/NN ,/, the/DT patient/NN should/MD be/VB observed/VBN closely/RB for/IN signs/NNS of/IN renal/JJ failure/NN ,/, as/RB well/RB as/IN to/TO assure/VB diuretic/JJ efficacy/NN ./.

(ROOT (S1 (S (S (PP (IN During) (NP (NP (JJ concomitant) (NN therapy)) (PP (IN of) (NP (NN Ponstel))) (PP (IN with) (NP (NN furosemide))))) (, ,) (NP (DT the) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB closely)) (PP (IN for) (NP (NP (NNS signs)) (PP (IN of) (NP (JJ renal) (NN failure))))) (, ,) (S (CONJP (RB as) (RB well) (IN as)) (VP (TO to) (VP (VB assure) (NP (JJ diuretic) (NN efficacy))))))))) (. .))))

amod(therapy-3, concomitant-2)
prep_during(observed-13, therapy-3)
prep_of(therapy-3, Ponstel-5)
prep_with(therapy-3, furosemide-7)
det(patient-10, the-9)
nsubjpass(observed-13, patient-10)
aux(observed-13, should-11)
auxpass(observed-13, be-12)
root(ROOT-0, observed-13)
advmod(observed-13, closely-14)
prep_for(observed-13, signs-16)
amod(failure-19, renal-18)
prep_of(signs-16, failure-19)
cc(assure-25, well-22)
aux(assure-25, to-24)
xcomp(observed-13, assure-25)
amod(efficacy-27, diuretic-26)
dobj(assure-25, efficacy-27)

Lithium/NN :/: NSAIDs/NNS have/VBP produced/VBN an/DT elevation/NN of/IN plasma/NN lithium/NN levels/NNS and/CC a/DT reduction/NN in/IN renal/JJ lithium/NN clearance/NN ./.

(ROOT (S1 (S (NP (NP (NN Lithium)) (: :) (S (NP (NNS NSAIDs)) (VP (VBP have) (VP (VBN produced) (NP (NP (NP (DT an) (NN elevation)) (PP (IN of) (NP (NN plasma) (NN lithium) (NNS levels)))) (CC and) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (JJ renal) (NN lithium) (NN clearance)))))))) (. .)))))

root(ROOT-0, Lithium-1)
nsubj(produced-5, NSAIDs-3)
aux(produced-5, have-4)
dep(Lithium-1, produced-5)
det(elevation-7, an-6)
dobj(produced-5, elevation-7)
nn(levels-11, plasma-9)
nn(levels-11, lithium-10)
prep_of(elevation-7, levels-11)
det(reduction-14, a-13)
conj_and(elevation-7, reduction-14)
amod(clearance-18, renal-16)
nn(clearance-18, lithium-17)
prep_in(reduction-14, clearance-18)

The/DT mean/JJ minimum/JJ lithium/NN concentration/NN increased/VBD 15/CD %/NN and/CC the/DT renal/JJ clearance/NN was/VBD decreased/VBN by/IN approximately/RB 20/CD %./NN

(ROOT (S1 (S (S (NP (DT The) (JJ mean) (JJ minimum) (NN lithium) (NN concentration)) (VP (VBD increased) (NP (CD 15) (NN %)))) (CC and) (S (NP (DT the) (JJ renal) (NN clearance)) (VP (VBD was) (VP (VBN decreased) (PP (IN by) (NP (QP (RB approximately) (CD 20)) (NN %.)))))))))

det(concentration-5, The-1)
amod(concentration-5, mean-2)
amod(concentration-5, minimum-3)
nn(concentration-5, lithium-4)
nsubj(increased-6, concentration-5)
root(ROOT-0, increased-6)
num(%-8, 15-7)
dobj(increased-6, %-8)
det(clearance-12, the-10)
amod(clearance-12, renal-11)
nsubjpass(decreased-14, clearance-12)
auxpass(decreased-14, was-13)
conj_and(increased-6, decreased-14)
quantmod(20-17, approximately-16)
num(%.-18, 20-17)
agent(decreased-14, %.-18)

These/DT effects/NNS have/VBP been/VBN attributed/VBN to/TO inhibition/NN of/IN renal/JJ prostaglandin/NN synthesis/NN by/IN the/DT NSAID/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS effects)) (VP (VBP have) (VP (VBN been) (VP (VBN attributed) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ renal) (NN prostaglandin) (NN synthesis))) (PP (IN by) (NP (DT the) (NN NSAID))))))))) (. .))))

det(effects-2, These-1)
nsubjpass(attributed-5, effects-2)
aux(attributed-5, have-3)
auxpass(attributed-5, been-4)
root(ROOT-0, attributed-5)
prep_to(attributed-5, inhibition-7)
amod(synthesis-11, renal-9)
nn(synthesis-11, prostaglandin-10)
prep_of(inhibition-7, synthesis-11)
det(NSAID-14, the-13)
prep_by(inhibition-7, NSAID-14)

Thus/RB ,/, when/WRB NSAIDs/NN and/CC lithium/NN are/VBP administered/VBN concurrently/RB ,/, subjects/NNS should/MD be/VB observed/VBN carefully/RB for/IN signs/NNS of/IN lithium/NN toxicity/NN ./.

(ROOT (S1 (S (S (ADVP (RB Thus)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN NSAIDs)) (CC and) (NP (NN lithium))) (VP (VBP are) (VP (VBN administered) (ADVP (RB concurrently)))))) (, ,) (NP (NNS subjects)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB carefully)) (PP (IN for) (NP (NP (NNS signs)) (PP (IN of) (NP (NN lithium) (NN toxicity))))))))) (. .))))

advmod(observed-14, Thus-1)
advmod(administered-8, when-3)
nsubjpass(administered-8, NSAIDs-4)
conj_and(NSAIDs-4, lithium-6)
auxpass(administered-8, are-7)
advcl(observed-14, administered-8)
advmod(administered-8, concurrently-9)
nsubjpass(observed-14, subjects-11)
aux(observed-14, should-12)
auxpass(observed-14, be-13)
root(ROOT-0, observed-14)
advmod(observed-14, carefully-15)
prep_for(observed-14, signs-17)
nn(toxicity-20, lithium-19)
prep_of(signs-17, toxicity-20)

Warfarin/NN :/: The/DT effects/NNS of/IN warfarin/NN and/CC NSAIDs/NN on/IN GI/JJ bleeding/JJ are/VBP synergistic/JJ ,/, such/JJ that/IN users/NNS of/IN both/DT drugs/NNS together/RB have/VBP a/DT risk/NN of/IN serious/JJ GI/JJ bleeding/JJ higher/JJR than/IN users/NNS of/IN either/DT drug/NN alone/RB ./.

(ROOT (S1 (S (NP (NP (NN Warfarin)) (: :) (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NP (NN warfarin)) (CC and) (NP (NN NSAIDs)))) (PP (IN on) (NP (JJ GI) (JJ bleeding)))) (VP (VBP are) (ADJP (JJ synergistic)) (, ,) (SBAR (JJ such) (IN that) (S (NP (NP (NNS users)) (PP (IN of) (NP (DT both) (NNS drugs)))) (ADVP (RB together)) (VP (VBP have) (NP (NP (DT a) (NN risk)) (PP (IN of) (NP (JJ serious) (JJ GI) (JJ bleeding))) (ADJP (ADJP (JJR higher)) (PP (IN than) (NP (NP (NNS users)) (PP (IN of) (NP (NP (DT either) (NN drug)) (ADVP (RB alone))))))))))))) (. .)))))

root(ROOT-0, Warfarin-1)
det(effects-4, The-3)
nsubj(synergistic-13, effects-4)
prep_of(effects-4, warfarin-6)
conj_and(warfarin-6, NSAIDs-8)
amod(bleeding-11, GI-10)
prep_on(effects-4, bleeding-11)
cop(synergistic-13, are-12)
dep(Warfarin-1, synergistic-13)
dep(have-22, such-15)
dep(have-22, that-16)
nsubj(have-22, users-17)
det(drugs-20, both-19)
prep_of(users-17, drugs-20)
advmod(have-22, together-21)
ccomp(synergistic-13, have-22)
det(risk-24, a-23)
dobj(have-22, risk-24)
amod(bleeding-28, serious-26)
amod(bleeding-28, GI-27)
prep_of(risk-24, bleeding-28)
amod(risk-24, higher-29)
prep_than(higher-29, users-31)
det(drug-34, either-33)
prep_of(users-31, drug-34)
advmod(drug-34, alone-35)

Antacids/NNS :/: In/IN a/DT single/JJ dose/NN study/NN (/-LRB- n=6/NN )/-RRB- ,/, ingestion/NN of/IN an/DT antacid/JJ containing/VBG 1.7-gram/NN of/IN magnesium/NN hydroxide/NN with/IN 500-mg/NN of/IN mefenamic/JJ acid/NN increased/VBD the/DT Cmax/NN and/CC AUC/NN of/IN mefenamic/JJ acid/NN by/IN 125/CD %/NN and/CC 36/CD %/NN ,/, respectively./IN @/NN A/NN number/NN of/IN compounds/NNS are/VBP inhibitors/NNS of/IN CYP2C9/NN including/VBG fluconazole/NN ,/, lovastatin/NN and/CC trimethoprim/NN ./.

(ROOT (S1 (S (NP (NP (NNS Antacids)) (: :) (S (PP (IN In) (NP (NP (DT a) (JJ single) (NN dose) (NN study)) (PRN (-LRB- -LRB-) (NP (NN n=6)) (-RRB- -RRB-)))) (, ,) (NP (NP (NN ingestion)) (PP (IN of) (NP (NP (DT an) (JJ antacid) (VBG containing) (NN 1.7-gram)) (PP (IN of) (NP (NP (NN magnesium) (NN hydroxide)) (PP (IN with) (NP (NP (NN 500-mg)) (PP (IN of) (NP (JJ mefenamic) (NN acid)))))))))) (VP (VBD increased) (NP (NP (DT the) (NP (NN Cmax)) (CC and) (NP (NN AUC))) (PP (IN of) (NP (JJ mefenamic) (NN acid)))) (PP (IN by) (NP (NP (CD 125) (NN %)) (CC and) (NP (CD 36) (NN %)))) (, ,) (SBAR (IN respectively.) (S (NP (NP (NN @) (NN A) (NN number)) (PP (IN of) (NP (NNS compounds)))) (VP (VBP are) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (NN CYP2C9))) (PP (VBG including) (NP (NP (NN fluconazole)) (, ,) (NP (NN lovastatin)) (CC and) (NP (NN trimethoprim)))))))))) (. .)))))

root(ROOT-0, Antacids-1)
det(study-7, a-4)
amod(study-7, single-5)
nn(study-7, dose-6)
prep_in(increased-26, study-7)
appos(study-7, n=6-9)
nsubj(increased-26, ingestion-12)
det(1.7-gram-17, an-14)
amod(1.7-gram-17, antacid-15)
amod(1.7-gram-17, containing-16)
prep_of(ingestion-12, 1.7-gram-17)
nn(hydroxide-20, magnesium-19)
prep_of(1.7-gram-17, hydroxide-20)
prep_with(hydroxide-20, 500-mg-22)
amod(acid-25, mefenamic-24)
prep_of(500-mg-22, acid-25)
dep(Antacids-1, increased-26)
dep(Cmax-28, the-27)
dobj(increased-26, Cmax-28)
conj_and(Cmax-28, AUC-30)
amod(acid-33, mefenamic-32)
prep_of(Cmax-28, acid-33)
num(%-36, 125-35)
prep_by(increased-26, %-36)
num(%-39, 36-38)
conj_and(%-36, %-39)
mark(inhibitors-48, respectively.-41)
nn(number-44, @-42)
nn(number-44, A-43)
nsubj(inhibitors-48, number-44)
prep_of(number-44, compounds-46)
cop(inhibitors-48, are-47)
advcl(increased-26, inhibitors-48)
prep_of(inhibitors-48, CYP2C9-50)
prep_including(inhibitors-48, fluconazole-52)
conj_and(fluconazole-52, lovastatin-54)
conj_and(fluconazole-52, trimethoprim-56)

Drug/NN interaction/NN studies/NNS of/IN mefenamic/JJ acid/NN and/CC these/DT compounds/NNS have/VBP not/RB been/VBN conducted/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN interaction) (NNS studies)) (PP (IN of) (NP (NP (JJ mefenamic) (NN acid)) (CC and) (NP (DT these) (NNS compounds))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN conducted))))) (. .))))

nn(studies-3, Drug-1)
nn(studies-3, interaction-2)
nsubjpass(conducted-13, studies-3)
amod(acid-6, mefenamic-5)
prep_of(studies-3, acid-6)
det(compounds-9, these-8)
conj_and(acid-6, compounds-9)
aux(conducted-13, have-10)
neg(conducted-13, not-11)
auxpass(conducted-13, been-12)
root(ROOT-0, conducted-13)

The/DT possibility/NN of/IN altered/JJ safety/NN and/CC efficacy/NN should/MD be/VB considered/VBN when/WRB Ponstel/NN is/VBZ used/VBN concomitantly/RB with/IN these/DT drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN possibility)) (PP (IN of) (NP (NP (JJ altered) (NN safety)) (CC and) (NP (NN efficacy))))) (VP (MD should) (VP (VB be) (VP (VBN considered) (SBAR (WHADVP (WRB when)) (S (NP (NN Ponstel)) (VP (VBZ is) (VP (VBN used) (ADVP (RB concomitantly)) (PP (IN with) (NP (DT these) (NNS drugs))))))))))) (. .))))

det(possibility-2, The-1)
nsubjpass(considered-10, possibility-2)
amod(safety-5, altered-4)
prep_of(possibility-2, safety-5)
conj_and(safety-5, efficacy-7)
aux(considered-10, should-8)
auxpass(considered-10, be-9)
root(ROOT-0, considered-10)
advmod(used-14, when-11)
nsubjpass(used-14, Ponstel-12)
auxpass(used-14, is-13)
advcl(considered-10, used-14)
advmod(used-14, concomitantly-15)
det(drugs-18, these-17)
prep_with(used-14, drugs-18)

Drug-drug/JJ interactions/NNS with/IN Mefloquine/NN have/VBP not/RB been/VBN explored/VBN in/IN detail/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Drug-drug) (NNS interactions)) (PP (IN with) (NP (NN Mefloquine)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN explored) (PP (IN in) (NP (NN detail))))))) (. .))))

amod(interactions-2, Drug-drug-1)
nsubjpass(explored-8, interactions-2)
prep_with(interactions-2, Mefloquine-4)
aux(explored-8, have-5)
neg(explored-8, not-6)
auxpass(explored-8, been-7)
root(ROOT-0, explored-8)
prep_in(explored-8, detail-10)

There/EX is/VBZ one/CD report/NN of/IN cardiopulmonary/NN arrest/NN ,/, with/IN full/JJ recovery/NN ,/, in/IN a/DT patient/NN who/WP was/VBD taking/VBG a/DT beta/NN blocker/NN (/-LRB- propranolol/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ is) (NP (NP (CD one) (NN report)) (PP (IN of) (NP (NN cardiopulmonary) (NN arrest)))) (, ,) (PP (IN with) (NP (JJ full) (NN recovery))) (, ,) (PP (IN in) (NP (NP (DT a) (NN patient)) (SBAR (WHNP (WP who)) (S (VP (VBD was) (VP (VBG taking) (NP (NP (DT a) (NN beta) (NN blocker)) (PRN (-LRB- -LRB-) (NP (NN propranolol)) (-RRB- -RRB-))))))))))) (. .))))

expl(is-2, There-1)
root(ROOT-0, is-2)
num(report-4, one-3)
nsubj(is-2, report-4)
nn(arrest-7, cardiopulmonary-6)
prep_of(report-4, arrest-7)
amod(recovery-11, full-10)
prep_with(is-2, recovery-11)
det(patient-15, a-14)
prep_in(is-2, patient-15)
nsubj(taking-18, patient-15)
aux(taking-18, was-17)
rcmod(patient-15, taking-18)
det(blocker-21, a-19)
nn(blocker-21, beta-20)
dobj(taking-18, blocker-21)
appos(blocker-21, propranolol-23)

The/DT benefits/NNS of/IN Mefloquine/NN therapy/NN should/MD be/VB weighed/VBN against/IN the/DT possibility/NN of/IN adverse/JJ effects/NNS in/IN patients/NNS with/IN cardiac/JJ disease/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS benefits)) (PP (IN of) (NP (NN Mefloquine) (NN therapy)))) (VP (MD should) (VP (VB be) (VP (VBN weighed) (PP (IN against) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (JJ adverse) (NNS effects)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ cardiac) (NN disease))))))))))))) (. .))))

det(benefits-2, The-1)
nsubjpass(weighed-8, benefits-2)
nn(therapy-5, Mefloquine-4)
prep_of(benefits-2, therapy-5)
aux(weighed-8, should-6)
auxpass(weighed-8, be-7)
root(ROOT-0, weighed-8)
det(possibility-11, the-10)
prep_against(weighed-8, possibility-11)
amod(effects-14, adverse-13)
prep_of(possibility-11, effects-14)
prep_in(effects-14, patients-16)
amod(disease-19, cardiac-18)
prep_with(patients-16, disease-19)

Because/IN of/IN the/DT danger/NN of/IN a/DT potentially/RB fatal/JJ prolongation/NN of/IN the/DT QTc/NN interval/NN ,/, halofantrine/NN must/MD not/RB be/VB given/VBN simultaneously/RB with/IN or/NN subsequent/JJ to/TO Mefloquine/NN ./.

(ROOT (S1 (S (S (PP (IN Because) (PP (IN of) (NP (NP (DT the) (NN danger)) (PP (IN of) (NP (NP (DT a) (ADJP (RB potentially) (JJ fatal)) (NN prolongation)) (PP (IN of) (NP (DT the) (NN QTc) (NN interval)))))))) (, ,) (NP (NN halofantrine)) (VP (MD must) (RB not) (VP (VB be) (VP (VBN given) (ADVP (RB simultaneously)) (PP (IN with) (NP (NP (NN or)) (ADJP (JJ subsequent) (PP (TO to) (NP (NN Mefloquine)))))))))) (. .))))

prepc_because_of(given-19, of-2)
det(danger-4, the-3)
pobj(given-19, danger-4)
det(prolongation-9, a-6)
advmod(fatal-8, potentially-7)
amod(prolongation-9, fatal-8)
prep_of(danger-4, prolongation-9)
det(interval-13, the-11)
nn(interval-13, QTc-12)
prep_of(prolongation-9, interval-13)
nsubjpass(given-19, halofantrine-15)
aux(given-19, must-16)
neg(given-19, not-17)
auxpass(given-19, be-18)
root(ROOT-0, given-19)
advmod(given-19, simultaneously-20)
prep_with(given-19, or-22)
prep_subsequent_to(or-22, Mefloquine-25)

Concomitant/JJ administration/NN of/IN Mefloquine/NN and/CC other/JJ related/JJ compounds/NNS (/-LRB- eg/NN ,/, quinine/NN ,/, quinidine/NN and/CC chloroquine/NN )/-RRB- may/MD produce/VB electrocardiographic/JJ abnormalities/NNS and/CC increase/VB the/DT risk/NN of/IN convulsions/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN Mefloquine)) (CC and) (NP (NP (JJ other) (JJ related) (NNS compounds)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NP (NN quinine)) (, ,) (NP (NN quinidine)) (CC and) (NP (NN chloroquine)))) (-RRB- -RRB-)))))) (VP (MD may) (VP (VP (VB produce) (NP (JJ electrocardiographic) (NNS abnormalities))) (CC and) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NNS convulsions)))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubj(produce-19, administration-2)
prep_of(administration-2, Mefloquine-4)
amod(compounds-8, other-6)
amod(compounds-8, related-7)
conj_and(Mefloquine-4, compounds-8)
dep(compounds-8, eg-10)
appos(eg-10, quinine-12)
conj_and(quinine-12, quinidine-14)
conj_and(quinine-12, chloroquine-16)
aux(produce-19, may-18)
root(ROOT-0, produce-19)
amod(abnormalities-21, electrocardiographic-20)
dobj(produce-19, abnormalities-21)
conj_and(produce-19, increase-23)
det(risk-25, the-24)
dobj(increase-23, risk-25)
prep_of(risk-25, convulsions-27)

If/IN these/DT drugs/NNS are/VBP to/TO be/VB used/VBN in/IN the/DT initial/JJ treatment/NN of/IN severe/JJ malaria/NN ,/, Mefloquine/NN administration/NN should/MD be/VB delayed/VBN at/IN least/JJS 12/CD hours/NNS after/IN the/DT last/JJ dose/NN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (DT these) (NNS drugs)) (VP (VBP are) (S (VP (TO to) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (DT the) (JJ initial) (NN treatment)) (PP (IN of) (NP (JJ severe) (NN malaria)))))))))))) (, ,) (NP (NN Mefloquine) (NN administration)) (VP (MD should) (VP (VB be) (VP (VBN delayed) (PP (NP (QP (IN at) (JJS least) (CD 12)) (NNS hours)) (IN after) (NP (DT the) (JJ last) (NN dose))))))) (. .))))

mark(are-4, If-1)
det(drugs-3, these-2)
nsubj(are-4, drugs-3)
xsubj(used-7, drugs-3)
advcl(delayed-20, are-4)
aux(used-7, to-5)
auxpass(used-7, be-6)
xcomp(are-4, used-7)
det(treatment-11, the-9)
amod(treatment-11, initial-10)
prep_in(used-7, treatment-11)
amod(malaria-14, severe-13)
prep_of(treatment-11, malaria-14)
nn(administration-17, Mefloquine-16)
nsubjpass(delayed-20, administration-17)
aux(delayed-20, should-18)
auxpass(delayed-20, be-19)
root(ROOT-0, delayed-20)
quantmod(12-23, at-21)
mwe(at-21, least-22)
pobj(at-21, least-22)
num(hours-24, 12-23)
npadvmod(delayed-20, hours-24)
det(dose-28, the-26)
amod(dose-28, last-27)
prep_after(delayed-20, dose-28)

There/EX is/VBZ evidence/NN that/IN the/DT use/NN of/IN halofantrine/NN after/IN Mefloquineuine/NN causes/VBZ a/DT significant/JJ lengthening/NN of/IN the/DT QTc/NN interval/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ is) (NP (NN evidence) (SBAR (IN that) (S (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN halofantrine))) (PP (IN after) (NP (NN Mefloquineuine)))) (VP (VBZ causes) (NP (NP (DT a) (JJ significant) (NN lengthening)) (PP (IN of) (NP (DT the) (NN QTc) (NN interval)))))))))) (. .))))

expl(is-2, There-1)
root(ROOT-0, is-2)
nsubj(is-2, evidence-3)
complm(causes-11, that-4)
det(use-6, the-5)
nsubj(causes-11, use-6)
prep_of(use-6, halofantrine-8)
prep_after(use-6, Mefloquineuine-10)
ccomp(evidence-3, causes-11)
det(lengthening-14, a-12)
amod(lengthening-14, significant-13)
dobj(causes-11, lengthening-14)
det(interval-18, the-16)
nn(interval-18, QTc-17)
prep_of(lengthening-14, interval-18)

This/DT appears/VBZ to/TO be/VB the/DT only/RB clinically/RB relevant/JJ interaction/NN of/IN this/DT kind/NN with/IN Mefloquine/NN ,/, although/IN theoretically/RB ,/, coadministration/NN of/IN other/JJ drugs/NNS known/VBN to/TO alter/VB cardiac/JJ conduction/NN (/-LRB- eg/NN ,/, anti-arrhythmic/JJ or/CC beta-adrenergic/JJ blocking/NN agents/NNS ,/, calcium/NN channel/NN blockers/NNS ,/, antihistamines/NNS or/CC H1-blocking/JJ agents/NNS ,/, tricyclic/JJ antidepressants/NNS and/CC phenothiazines/NNS )/-RRB- might/MD also/RB contribute/VB to/TO a/DT prolongation/NN of/IN the/DT QTc/NN interval/NN ./.

(ROOT (S1 (S (NP (DT This)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (NP (NP (DT the) (ADJP (RB only) (RB clinically) (JJ relevant)) (NN interaction)) (PP (IN of) (NP (DT this) (NN kind))) (PP (IN with) (NP (NN Mefloquine))))))) (, ,) (SBAR (IN although) (S (ADVP (RB theoretically)) (, ,) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (JJ other) (NNS drugs)) (VP (VBN known) (S (VP (TO to) (VP (VB alter) (NP (NP (JJ cardiac) (NN conduction)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NP (ADJP (ADJP (JJ anti-arrhythmic)) (CC or) (ADJP (JJ beta-adrenergic))) (NN blocking) (NNS agents)) (, ,) (NP (NN calcium) (NN channel) (NNS blockers)) (, ,) (NP (NNS antihistamines)) (CC or) (NP (NP (JJ H1-blocking) (NNS agents)) (, ,) (NP (JJ tricyclic) (NNS antidepressants)) (CC and) (NP (NNS phenothiazines))))) (-RRB- -RRB-)))))))))) (VP (MD might) (ADVP (RB also)) (VP (VB contribute) (PP (TO to) (NP (NP (DT a) (NN prolongation)) (PP (IN of) (NP (DT the) (NN QTc) (NN interval)))))))))) (. .))))

nsubj(appears-2, This-1)
xsubj(interaction-9, This-1)
root(ROOT-0, appears-2)
aux(interaction-9, to-3)
cop(interaction-9, be-4)
det(interaction-9, the-5)
advmod(relevant-8, only-6)
advmod(relevant-8, clinically-7)
amod(interaction-9, relevant-8)
xcomp(appears-2, interaction-9)
det(kind-12, this-11)
prep_of(interaction-9, kind-12)
prep_with(interaction-9, Mefloquine-14)
mark(contribute-53, although-16)
advmod(contribute-53, theoretically-17)
nsubj(contribute-53, coadministration-19)
amod(drugs-22, other-21)
prep_of(coadministration-19, drugs-22)
xsubj(alter-25, drugs-22)
partmod(drugs-22, known-23)
aux(alter-25, to-24)
xcomp(known-23, alter-25)
amod(conduction-27, cardiac-26)
dobj(alter-25, conduction-27)
dep(conduction-27, eg-29)
amod(agents-35, anti-arrhythmic-31)
conj_or(anti-arrhythmic-31, beta-adrenergic-33)
nn(agents-35, blocking-34)
appos(eg-29, agents-35)
nn(blockers-39, calcium-37)
nn(blockers-39, channel-38)
conj_or(agents-35, blockers-39)
conj_or(agents-35, antihistamines-41)
amod(agents-44, H1-blocking-43)
conj_or(agents-35, agents-44)
amod(antidepressants-47, tricyclic-46)
conj_and(agents-44, antidepressants-47)
conj_and(agents-44, phenothiazines-49)
aux(contribute-53, might-51)
advmod(contribute-53, also-52)
advcl(appears-2, contribute-53)
det(prolongation-56, a-55)
prep_to(contribute-53, prolongation-56)
det(interval-60, the-58)
nn(interval-60, QTc-59)
prep_of(prolongation-56, interval-60)

In/IN patients/NNS taking/VBG an/DT anticonvulsant/JJ (/-LRB- eg/NN ,/, valproic/JJ acid/NN ,/, carbamazepine/NN ,/, phenobarbital/NN or/CC phenytoin/NN )/-RRB- ,/, the/DT concomitant/JJ use/NN of/IN Mefloquine/NN may/MD reduce/VB seizure/JJ control/NN by/IN lowering/VBG the/DT plasma/NN levels/NNS of/IN the/DT anticonvulsant/JJ ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (DT an) (JJ anticonvulsant)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (JJ valproic) (NN acid)) (, ,) (NP (NN carbamazepine)) (, ,) (NP (NN phenobarbital)) (CC or) (NP (NN phenytoin))) (-RRB- -RRB-)))))) (, ,) (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (NN Mefloquine)))) (VP (MD may) (VP (VB reduce) (NP (JJ seizure) (NN control)) (PP (IN by) (S (VP (VBG lowering) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (DT the) (JJ anticonvulsant))))))))) (. .))))

prep_in(reduce-25, patients-2)
partmod(patients-2, taking-3)
det(anticonvulsant-5, an-4)
dobj(taking-3, anticonvulsant-5)
dep(anticonvulsant-5, eg-7)
amod(acid-10, valproic-9)
conj_or(eg-7, acid-10)
conj_or(eg-7, carbamazepine-12)
conj_or(eg-7, phenobarbital-14)
conj_or(eg-7, phenytoin-16)
det(use-21, the-19)
amod(use-21, concomitant-20)
nsubj(reduce-25, use-21)
prep_of(use-21, Mefloquine-23)
aux(reduce-25, may-24)
root(ROOT-0, reduce-25)
amod(control-27, seizure-26)
dobj(reduce-25, control-27)
prepc_by(reduce-25, lowering-29)
det(levels-32, the-30)
nn(levels-32, plasma-31)
dobj(lowering-29, levels-32)
det(anticonvulsant-35, the-34)
prep_of(levels-32, anticonvulsant-35)

Therefore/RB ,/, patients/NNS concurrently/RB taking/VBG antiseizure/NN medication/NN and/CC Mefloquine/NN should/MD have/VBP the/DT blood/NN level/NN of/IN their/PRP$ antiseizure/JJ medication/NN monitored/VBN and/CC the/DT dosage/NN adjusted/VBN appropriately/RB ./.

(ROOT (S1 (S (ADVP (RB Therefore)) (, ,) (NP (NP (NNS patients)) (VP (ADVP (RB concurrently)) (VBG taking) (NP (NP (NN antiseizure) (NN medication)) (CC and) (NP (NN Mefloquine))))) (VP (MD should) (VP (VBP have) (NP (NP (DT the) (NN blood) (NN level)) (PP (IN of) (NP (NP (NP (PRP$ their) (JJ antiseizure) (NN medication)) (VP (VBN monitored))) (CC and) (NP (NP (DT the) (NN dosage)) (VP (VBN adjusted) (ADVP (RB appropriately))))))))) (. .))))

advmod(have-11, Therefore-1)
nsubj(have-11, patients-3)
advmod(taking-5, concurrently-4)
partmod(patients-3, taking-5)
nn(medication-7, antiseizure-6)
dobj(taking-5, medication-7)
conj_and(medication-7, Mefloquine-9)
aux(have-11, should-10)
root(ROOT-0, have-11)
det(level-14, the-12)
nn(level-14, blood-13)
dobj(have-11, level-14)
poss(medication-18, their-16)
amod(medication-18, antiseizure-17)
prep_of(level-14, medication-18)
partmod(medication-18, monitored-19)
det(dosage-22, the-21)
conj_and(medication-18, dosage-22)
partmod(dosage-22, adjusted-23)
advmod(adjusted-23, appropriately-24)

When/WRB Mefloquine/NN is/VBZ taken/VBN concurrently/RB with/IN oral/JJ live/JJ typhoid/JJ vaccines/NNS ,/, attenuation/NN of/IN immunization/NN cannot/MD be/VB excluded/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN Mefloquine)) (VP (VBZ is) (VP (VBN taken) (ADVP (RB concurrently)) (PP (IN with) (NP (JJ oral) (JJ live) (JJ typhoid) (NNS vaccines))))))) (, ,) (NP (NP (NN attenuation)) (PP (IN of) (NP (NN immunization)))) (VP (MD cannot) (VP (VB be) (VP (VBN excluded))))) (. .))))

advmod(taken-4, When-1)
nsubjpass(taken-4, Mefloquine-2)
auxpass(taken-4, is-3)
advcl(cannot-15, taken-4)
advmod(taken-4, concurrently-5)
amod(vaccines-10, oral-7)
amod(vaccines-10, live-8)
amod(vaccines-10, typhoid-9)
prep_with(taken-4, vaccines-10)
nsubj(cannot-15, attenuation-12)
prep_of(attenuation-12, immunization-14)
root(ROOT-0, cannot-15)
auxpass(excluded-17, be-16)
dep(cannot-15, excluded-17)

Vaccinations/NNS with/IN attenuated/VBN live/JJ bacteria/NNS should/MD therefore/RB be/VB completed/VBN at/IN least/JJS 3/CD days/NNS before/IN the/DT first/JJ dose/NN of/IN Mefloquine/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Vaccinations)) (PP (IN with) (NP (VBN attenuated) (JJ live) (NNS bacteria)))) (VP (MD should) (ADVP (RB therefore)) (VP (VB be) (VP (VBN completed) (NP (QP (IN at) (JJS least) (CD 3)) (NNS days)) (PP (IN before) (NP (NP (DT the) (JJ first) (NN dose)) (PP (IN of) (NP (NN Mefloquine))))))))) (. .))))

nsubjpass(completed-9, Vaccinations-1)
amod(bacteria-5, attenuated-3)
amod(bacteria-5, live-4)
prep_with(Vaccinations-1, bacteria-5)
aux(completed-9, should-6)
advmod(completed-9, therefore-7)
auxpass(completed-9, be-8)
root(ROOT-0, completed-9)
quantmod(3-12, at-10)
mwe(at-10, least-11)
pobj(at-10, least-11)
num(days-13, 3-12)
tmod(completed-9, days-13)
det(dose-17, the-15)
amod(dose-17, first-16)
prep_before(completed-9, dose-17)
prep_of(dose-17, Mefloquine-19)

Nevertheless/RB ,/, the/DT effects/NNS of/IN Mefloquine/NN on/IN travelers/NNS receiving/VBG comedication/NN ,/, particularly/RB diabetics/NNS or/CC patients/NNS using/VBG anticoagulants/NNS ,/, should/MD be/VB checked/VBN before/IN departure/NN ./.

(ROOT (S1 (S (S (ADVP (RB Nevertheless)) (, ,) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN Mefloquine))) (PP (IN on) (NP (NP (NNS travelers)) (VP (VBG receiving) (NP (NP (NN comedication)) (, ,) (NP (ADVP (RB particularly)) (NP (NP (NNS diabetics)) (CC or) (NP (NP (NNS patients)) (VP (VBG using) (NP (NNS anticoagulants)))))) (, ,)))))) (VP (MD should) (VP (VB be) (VP (VBN checked) (PP (IN before) (NP (NN departure))))))) (. .))))

advmod(checked-21, Nevertheless-1)
det(effects-4, the-3)
nsubjpass(checked-21, effects-4)
prep_of(effects-4, Mefloquine-6)
prep_on(effects-4, travelers-8)
partmod(travelers-8, receiving-9)
dobj(receiving-9, comedication-10)
advmod(diabetics-13, particularly-12)
appos(comedication-10, diabetics-13)
conj_or(diabetics-13, patients-15)
partmod(patients-15, using-16)
dobj(using-16, anticoagulants-17)
aux(checked-21, should-19)
auxpass(checked-21, be-20)
root(ROOT-0, checked-21)
prep_before(checked-21, departure-23)

In/IN clinical/JJ trials/NNS ,/, the/DT concomitant/JJ administration/NN of/IN sulfadoxine/NN and/CC pyrimethamine/NN did/VBD not/RB alter/VB the/DT adverse/JJ reaction/NN profile/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ clinical) (NNS trials))) (, ,) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN sulfadoxine)) (CC and) (NP (NN pyrimethamine))))) (VP (VBD did) (RB not) (VP (VB alter) (NP (DT the) (JJ adverse) (NN reaction) (NN profile))))) (. .))))

amod(trials-3, clinical-2)
prep_in(alter-14, trials-3)
det(administration-7, the-5)
amod(administration-7, concomitant-6)
nsubj(alter-14, administration-7)
prep_of(administration-7, sulfadoxine-9)
conj_and(sulfadoxine-9, pyrimethamine-11)
aux(alter-14, did-12)
neg(alter-14, not-13)
root(ROOT-0, alter-14)
det(profile-18, the-15)
amod(profile-18, adverse-16)
nn(profile-18, reaction-17)
dobj(alter-14, profile-18)

Broad-Spectrum/NN Antibiotics-Broad-spectrum/NN antibiotics/NNS may/MD sterilize/VB the/DT bowel/NN and/CC decrease/VB the/DT vitamin/NN K/NN contribution/NN to/TO the/DT body/NN by/IN the/DT intestinal/JJ microflora/NNS ./.

(ROOT (S1 (S (S (NP (NN Broad-Spectrum) (NN Antibiotics-Broad-spectrum) (NNS antibiotics)) (VP (MD may) (VP (VP (VB sterilize) (NP (DT the) (NN bowel))) (CC and) (VP (VB decrease) (NP (NP (DT the) (NN vitamin) (NN K) (NN contribution)) (PP (TO to) (NP (DT the) (NN body))) (PP (IN by) (NP (DT the) (JJ intestinal) (NNS microflora)))))))) (. .))))

nn(antibiotics-3, Broad-Spectrum-1)
nn(antibiotics-3, Antibiotics-Broad-spectrum-2)
nsubj(sterilize-5, antibiotics-3)
aux(sterilize-5, may-4)
root(ROOT-0, sterilize-5)
det(bowel-7, the-6)
dobj(sterilize-5, bowel-7)
conj_and(sterilize-5, decrease-9)
det(contribution-13, the-10)
nn(contribution-13, vitamin-11)
nn(contribution-13, K-12)
dobj(decrease-9, contribution-13)
det(body-16, the-15)
prep_to(contribution-13, body-16)
det(microflora-20, the-18)
amod(microflora-20, intestinal-19)
prep_by(contribution-13, microflora-20)

Cephalosporins/NN -Cephalosporins/NNS containing/VBG side/JJ chains/NNS of/IN N-methylthiotetrazole/NN (/-LRB- cefmenoxime/NN ,/, cefoperazone/NN ,/, cefotetan/NN ,/, cefamandole/NN ,/, latamoxef/NN )/-RRB- or/CC methylthiadiazole/NN (/-LRB- cefazolin/NN )/-RRB- can/MD cause/VB vitamin/NN K/NN deficiency/NN and/CC hypoprothrombinemia/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Cephalosporins) (NNS -Cephalosporins)) (VP (VBG containing) (NP (NP (JJ side) (NNS chains)) (PP (IN of) (NP (NP (NP (NN N-methylthiotetrazole)) (PRN (-LRB- -LRB-) (NP (NP (NN cefmenoxime)) (, ,) (NP (NN cefoperazone)) (, ,) (NP (NN cefotetan)) (, ,) (NP (NN cefamandole)) (, ,) (NP (NN latamoxef))) (-RRB- -RRB-))) (CC or) (NP (NP (NN methylthiadiazole)) (PRN (-LRB- -LRB-) (NP (NN cefazolin)) (-RRB- -RRB-)))))))) (VP (MD can) (VP (VB cause) (NP (NP (NN vitamin) (NN K) (NN deficiency)) (CC and) (NP (NN hypoprothrombinemia)))))) (. .))))

nn(-Cephalosporins-2, Cephalosporins-1)
nsubj(cause-25, -Cephalosporins-2)
partmod(-Cephalosporins-2, containing-3)
amod(chains-5, side-4)
dobj(containing-3, chains-5)
prep_of(chains-5, N-methylthiotetrazole-7)
dep(N-methylthiotetrazole-7, cefmenoxime-9)
appos(cefmenoxime-9, cefoperazone-11)
appos(cefmenoxime-9, cefotetan-13)
appos(cefmenoxime-9, cefamandole-15)
appos(cefmenoxime-9, latamoxef-17)
conj_or(N-methylthiotetrazole-7, methylthiadiazole-20)
appos(methylthiadiazole-20, cefazolin-22)
aux(cause-25, can-24)
root(ROOT-0, cause-25)
nn(deficiency-28, vitamin-26)
nn(deficiency-28, K-27)
dobj(cause-25, deficiency-28)
conj_and(deficiency-28, hypoprothrombinemia-30)

These/DT cephalosporins/NNS are/VBP inhibitors/NNS of/IN hepatic/JJ vitamin/NN K/NN epoxide/NN reductase/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS cephalosporins)) (VP (VBP are) (NP (NP (NNS inhibitors)) (PP (IN of) (NP (JJ hepatic) (NN vitamin) (NN K) (NN epoxide) (NN reductase)))))) (. .))))

det(cephalosporins-2, These-1)
nsubj(inhibitors-4, cephalosporins-2)
cop(inhibitors-4, are-3)
root(ROOT-0, inhibitors-4)
amod(reductase-10, hepatic-6)
nn(reductase-10, vitamin-7)
nn(reductase-10, K-8)
nn(reductase-10, epoxide-9)
prep_of(inhibitors-4, reductase-10)

Cholestyramine/NN -Concomitant/JJ intake/NN of/IN cholestyramine/NN and/CC vitamin/NN K/NN may/MD reduce/VB the/DT absorption/NN of/IN vitamin/NN K/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Cholestyramine) (JJ -Concomitant) (NN intake)) (PP (IN of) (NP (NP (NN cholestyramine)) (CC and) (NP (NN vitamin) (NN K))))) (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NN vitamin) (NN K))))))) (. .))))

nn(intake-3, Cholestyramine-1)
amod(intake-3, -Concomitant-2)
nsubj(reduce-10, intake-3)
prep_of(intake-3, cholestyramine-5)
nn(K-8, vitamin-7)
conj_and(cholestyramine-5, K-8)
aux(reduce-10, may-9)
root(ROOT-0, reduce-10)
det(absorption-12, the-11)
dobj(reduce-10, absorption-12)
nn(K-15, vitamin-14)
prep_of(absorption-12, K-15)

Colestipol/JJ -Concomitant/JJ intake/NN of/IN colestipol/NN and/CC vitamin/NN K/NN may/MD reduce/VB the/DT absorption/NN of/IN vitamin/NN K/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Colestipol) (JJ -Concomitant) (NN intake)) (PP (IN of) (NP (NP (NN colestipol)) (CC and) (NP (NN vitamin) (NN K))))) (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NN vitamin) (NN K))))))) (. .))))

amod(intake-3, Colestipol-1)
amod(intake-3, -Concomitant-2)
nsubj(reduce-10, intake-3)
prep_of(intake-3, colestipol-5)
nn(K-8, vitamin-7)
conj_and(colestipol-5, K-8)
aux(reduce-10, may-9)
root(ROOT-0, reduce-10)
det(absorption-12, the-11)
dobj(reduce-10, absorption-12)
nn(K-15, vitamin-14)
prep_of(absorption-12, K-15)

Mineral/JJ Oil/NN -Concomitant/NN intake/NN of/IN mineral/JJ oil/NN and/CC vitamin/NN K/NN may/MD reduce/VB the/DT absorption/NN of/IN vitamin/NN K/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Mineral) (NN Oil) (NN -Concomitant) (NN intake)) (PP (IN of) (NP (NP (JJ mineral) (NN oil)) (CC and) (NP (NN vitamin) (NN K))))) (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NN vitamin) (NN K))))))) (. .))))

amod(intake-4, Mineral-1)
nn(intake-4, Oil-2)
nn(intake-4, -Concomitant-3)
nsubj(reduce-12, intake-4)
amod(oil-7, mineral-6)
prep_of(intake-4, oil-7)
nn(K-10, vitamin-9)
conj_and(oil-7, K-10)
aux(reduce-12, may-11)
root(ROOT-0, reduce-12)
det(absorption-14, the-13)
dobj(reduce-12, absorption-14)
nn(K-17, vitamin-16)
prep_of(absorption-14, K-17)

Orlistat/NN -Orlistat/NN may/MD decrease/VB the/DT absorption/NN of/IN vitamin/NN K/NN ./.

(ROOT (S1 (S (S (NP (NN Orlistat) (NN -Orlistat)) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NN absorption)) (PP (IN of) (NP (NN vitamin) (NN K))))))) (. .))))

nn(-Orlistat-2, Orlistat-1)
nsubj(decrease-4, -Orlistat-2)
aux(decrease-4, may-3)
root(ROOT-0, decrease-4)
det(absorption-6, the-5)
dobj(decrease-4, absorption-6)
nn(K-9, vitamin-8)
prep_of(absorption-6, K-9)

Salicylates/NNS -Salicylates/NNS in/IN large/JJ doses/NNS may/MD inhibit/VB vitamin/NN K/NN epoxide/NN reductase/NN resulting/VBG in/IN vitamin/NN K/NN deficiency/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Salicylates) (NNS -Salicylates)) (PP (IN in) (NP (JJ large) (NNS doses)))) (VP (MD may) (VP (VB inhibit) (NP (NP (NN vitamin) (NN K) (NN epoxide) (NN reductase)) (VP (VBG resulting) (PP (IN in) (NP (NN vitamin) (NN K) (NN deficiency)))))))) (. .))))

nn(-Salicylates-2, Salicylates-1)
nsubj(inhibit-7, -Salicylates-2)
amod(doses-5, large-4)
prep_in(-Salicylates-2, doses-5)
aux(inhibit-7, may-6)
root(ROOT-0, inhibit-7)
nn(reductase-11, vitamin-8)
nn(reductase-11, K-9)
nn(reductase-11, epoxide-10)
dobj(inhibit-7, reductase-11)
partmod(reductase-11, resulting-12)
nn(deficiency-16, vitamin-14)
nn(deficiency-16, K-15)
prep_in(resulting-12, deficiency-16)

Warfarin-/JJ Vitamin/NN K/NN can/MD antagonize/VB the/DT effect/NN of/IN warfarin/NN ./.

(ROOT (S1 (S (S (NP (JJ Warfarin-) (NN Vitamin) (NN K)) (VP (MD can) (VP (VB antagonize) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN warfarin))))))) (. .))))

amod(K-3, Warfarin--1)
nn(K-3, Vitamin-2)
nsubj(antagonize-5, K-3)
aux(antagonize-5, can-4)
root(ROOT-0, antagonize-5)
det(effect-7, the-6)
dobj(antagonize-5, effect-7)
prep_of(effect-7, warfarin-9)

Nabilone/NN should/MD be/VB administered/VBN with/IN caution/NN to/TO patients/NNS who/WP are/VBP taking/VBG other/JJ psychoactive/JJ drugs/NNS or/CC CNS/NN depressants/NNS ,/, including/VBG alcohol/NN ,/, barbiturates/NNS and/CC narcotic/JJ analgesics/NNS ,/, or/CC to/TO those/DT with/IN a/DT history/NN of/IN psychiatric/JJ disorder/NN (/-LRB- including/VBG manic-depressive/JJ illness/NN and/CC schizophrenia/NN )./CD

(ROOT (S1 (S (NP (NN Nabilone)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PP (IN with) (NP (NN caution))) (PP (PP (TO to) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG taking) (NP (NP (NP (JJ other) (JJ psychoactive) (NNS drugs)) (CC or) (NP (NN CNS) (NNS depressants))) (, ,) (PP (VBG including) (NP (NP (NN alcohol)) (, ,) (NP (NNS barbiturates)) (CC and) (NP (JJ narcotic) (NNS analgesics))))))))))) (, ,) (CC or) (PP (TO to) (NP (NP (DT those)) (PP (IN with) (NP (NP (DT a) (NN history)) (PP (IN of) (NP (NP (NP (JJ psychiatric) (NN disorder)) (PRN (-LRB- -LRB-) (NP (VBG including) (JJ manic-depressive) (NN illness)))) (CC and) (NP (NN schizophrenia) (CD -RRB-.)))))))))))))))

nsubjpass(administered-4, Nabilone-1)
aux(administered-4, should-2)
auxpass(administered-4, be-3)
root(ROOT-0, administered-4)
prep_with(administered-4, caution-6)
prep_to(administered-4, patients-8)
nsubj(taking-11, patients-8)
aux(taking-11, are-10)
rcmod(patients-8, taking-11)
amod(drugs-14, other-12)
amod(drugs-14, psychoactive-13)
dobj(taking-11, drugs-14)
nn(depressants-17, CNS-16)
conj_or(drugs-14, depressants-17)
prep_including(drugs-14, alcohol-20)
conj_and(alcohol-20, barbiturates-22)
amod(analgesics-25, narcotic-24)
conj_and(alcohol-20, analgesics-25)
conj_or(patients-8, those-29)
det(history-32, a-31)
prep_with(those-29, history-32)
amod(disorder-35, psychiatric-34)
prep_of(history-32, disorder-35)
amod(illness-39, including-37)
amod(illness-39, manic-depressive-38)
dep(disorder-35, illness-39)
conj_and(disorder-35, schizophrenia-41)
num(schizophrenia-41, -RRB-.-42)

Nabilone/NN has/VBZ been/VBN shown/VBN to/TO have/VB an/DT additive/JJ CNS/NN depressant/JJ effect/NN when/WRB given/VBN with/IN either/CC diazepam/NN ,/, secobarbitone/NN sodium/NN ,/, alcohol/NN or/CC codeine/NN ./.

(ROOT (S1 (S (S (NP (NN Nabilone)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB have) (NP (DT an) (JJ additive) (NN CNS) (JJ depressant) (NN effect)) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (PP (IN with) (NP (CC either) (NP (NN diazepam)) (, ,) (NP (NN secobarbitone) (NN sodium)) (, ,) (NP (NN alcohol)) (CC or) (NP (NN codeine)))))))))))))) (. .))))

nsubjpass(shown-4, Nabilone-1)
xsubj(have-6, Nabilone-1)
aux(shown-4, has-2)
auxpass(shown-4, been-3)
root(ROOT-0, shown-4)
aux(have-6, to-5)
xcomp(shown-4, have-6)
det(effect-11, an-7)
amod(effect-11, additive-8)
nn(effect-11, CNS-9)
amod(effect-11, depressant-10)
dobj(have-6, effect-11)
advmod(given-13, when-12)
advcl(have-6, given-13)
preconj(diazepam-16, either-15)
prep_with(given-13, diazepam-16)
nn(sodium-19, secobarbitone-18)
conj_or(diazepam-16, sodium-19)
conj_or(diazepam-16, alcohol-21)
conj_or(diazepam-16, codeine-23)

In/FW vitro/FW studies/NNS have/VBP shown/VBN that/IN ,/, because/IN of/IN its/PRP$ affinity/NN for/IN protein/NN ,/, 6MNA/NN may/MD displace/VB other/JJ protein/NN -bound/NN drugs/NNS from/IN their/PRP$ binding/VBG site/NN ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (, ,) (PP (IN because) (PP (IN of) (NP (NP (PRP$ its) (NN affinity)) (PP (IN for) (NP (NN protein)))))) (, ,) (NP (NN 6MNA)) (VP (MD may) (VP (VB displace) (NP (JJ other) (NN protein) (NN -bound) (NNS drugs)) (PP (IN from) (NP (PRP$ their) (VBG binding) (NN site)))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(shown-5, studies-3)
aux(shown-5, have-4)
root(ROOT-0, shown-5)
complm(displace-17, that-6)
prepc_because_of(displace-17, of-9)
poss(affinity-11, its-10)
pobj(displace-17, affinity-11)
prep_for(affinity-11, protein-13)
nsubj(displace-17, 6MNA-15)
aux(displace-17, may-16)
ccomp(shown-5, displace-17)
amod(drugs-21, other-18)
nn(drugs-21, protein-19)
nn(drugs-21, -bound-20)
dobj(displace-17, drugs-21)
poss(site-25, their-23)
amod(site-25, binding-24)
prep_from(displace-17, site-25)

Caution/NN should/MD be/VB exercised/VBN when/WRB administering/VBG nabumetone/NN with/IN warfarin/NN since/IN interactions/NNS have/VBP been/VBN seen/VBN with/IN other/JJ NSAIDs/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (SBAR (WHADVP (WRB when)) (S (VP (VBG administering) (NP (NN nabumetone)) (PP (IN with) (NP (NN warfarin))) (SBAR (IN since) (S (NP (NNS interactions)) (VP (VBP have) (VP (VBN been) (VP (VBN seen) (PP (IN with) (NP (JJ other) (NN NSAIDs))))))))))))))) (. .))))

nsubjpass(exercised-4, Caution-1)
aux(exercised-4, should-2)
auxpass(exercised-4, be-3)
root(ROOT-0, exercised-4)
advmod(administering-6, when-5)
advcl(exercised-4, administering-6)
dobj(administering-6, nabumetone-7)
prep_with(administering-6, warfarin-9)
mark(seen-14, since-10)
nsubjpass(seen-14, interactions-11)
aux(seen-14, have-12)
auxpass(seen-14, been-13)
advcl(administering-6, seen-14)
amod(NSAIDs-17, other-16)
prep_with(seen-14, NSAIDs-17)

Concomitant/JJ administration/NN of/IN an/DT aluminum-containing/JJ antacid/JJ had/VBD no/DT significant/JJ effect/NN in/IN the/DT bioavailability/NN of/IN 6MNA/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (DT an) (JJ aluminum-containing) (JJ antacid)))) (VP (VBD had) (NP (DT no) (JJ significant) (NN effect)) (PP (IN in) (NP (NP (DT the) (NN bioavailability)) (PP (IN of) (NP (NN 6MNA))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubj(had-7, administration-2)
det(antacid-6, an-4)
amod(antacid-6, aluminum-containing-5)
prep_of(administration-2, antacid-6)
root(ROOT-0, had-7)
det(effect-10, no-8)
amod(effect-10, significant-9)
dobj(had-7, effect-10)
det(bioavailability-13, the-12)
prep_in(had-7, bioavailability-13)
prep_of(bioavailability-13, 6MNA-15)

however/RB ,/, the/DT total/JJ amount/NN of/IN 6MNA/NN in/IN the/DT plasma/NN is/VBZ unchanged/JJ ./.

(ROOT (S1 (S (S (ADVP (RB however)) (, ,) (NP (NP (DT the) (JJ total) (NN amount)) (PP (IN of) (NP (NN 6MNA))) (PP (IN in) (NP (DT the) (NN plasma)))) (VP (VBZ is) (ADJP (JJ unchanged)))) (. .))))

advmod(unchanged-12, however-1)
det(amount-5, the-3)
amod(amount-5, total-4)
nsubj(unchanged-12, amount-5)
prep_of(amount-5, 6MNA-7)
det(plasma-10, the-9)
prep_in(amount-5, plasma-10)
cop(unchanged-12, is-11)
root(ROOT-0, unchanged-12)

No/DT pharmacokinetic-based/JJ drug-drug/JJ interaction/NN studies/NNS have/VBP been/VBN conducted/VBN with/IN SYNAREL/NN ./.

(ROOT (S1 (S (S (NP (DT No) (JJ pharmacokinetic-based) (JJ drug-drug) (NN interaction) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN conducted) (PP (IN with) (NP (NN SYNAREL))))))) (. .))))

det(studies-5, No-1)
amod(studies-5, pharmacokinetic-based-2)
amod(studies-5, drug-drug-3)
nn(studies-5, interaction-4)
nsubjpass(conducted-8, studies-5)
aux(conducted-8, have-6)
auxpass(conducted-8, been-7)
root(ROOT-0, conducted-8)
prep_with(conducted-8, SYNAREL-10)

However/RB ,/, because/IN nafarelin/NN acetate/NN is/VBZ a/DT peptide/NN that/WDT is/VBZ primarily/RB degraded/VBN by/IN peptidase/NN and/CC not/RB by/IN cytochrome/NN P-450/NN enzymes/NNS ,/, and/CC the/DT drug/NN is/VBZ only/RB about/RB 80/CD %/NN bound/VBD to/TO plasma/NN proteins/NNS at/IN 4/CD @/NN C/NN ,/, drug/NN interactions/NNS would/MD not/RB be/VB expected/VBN to/TO occur/VB ./.

(ROOT (S1 (S (ADVP (RB However)) (, ,) (SBAR (IN because) (S (S (NP (NN nafarelin) (NN acetate)) (VP (VBZ is) (NP (NP (DT a) (NN peptide)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADVP (RB primarily)) (VP (VBN degraded) (PP (PP (IN by) (NP (NN peptidase))) (CC and) (PP (RB not) (IN by) (NP (NP (NN cytochrome) (NN P-450)) (NNS enzymes))))))))))) (, ,) (CC and) (S (NP (DT the) (NN drug)) (VP (VBZ is) (ADVP (RB only)) (NP (NP (QP (RB about) (CD 80)) (NN %)) (VP (VBD bound) (PP (TO to) (NP (NN plasma) (NNS proteins))) (PP (IN at) (NP (CD 4) (NN @) (NN C))))))))) (, ,) (NP (NN drug) (NNS interactions)) (VP (MD would) (RB not) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB occur))))))) (. .))))

advmod(expected-44, However-1)
mark(peptide-8, because-3)
nn(acetate-5, nafarelin-4)
nsubj(peptide-8, acetate-5)
cop(peptide-8, is-6)
det(peptide-8, a-7)
nsubjpass(degraded-12, peptide-8)
advcl(expected-44, peptide-8)
auxpass(degraded-12, is-10)
advmod(degraded-12, primarily-11)
rcmod(peptide-8, degraded-12)
agent(degraded-12, peptidase-14)
neg(degraded-12, not-16)
nn(P-450-19, cytochrome-18)
nn(enzymes-20, P-450-19)
conj_and(peptidase-14, enzymes-20)
det(drug-24, the-23)
nsubj(%-29, drug-24)
cop(%-29, is-25)
advmod(%-29, only-26)
quantmod(80-28, about-27)
num(%-29, 80-28)
conj_and(peptide-8, %-29)
partmod(%-29, bound-30)
nn(proteins-33, plasma-32)
prep_to(bound-30, proteins-33)
num(C-37, 4-35)
nn(C-37, @-36)
prep_at(bound-30, C-37)
nn(interactions-40, drug-39)
nsubjpass(expected-44, interactions-40)
aux(expected-44, would-41)
neg(expected-44, not-42)
auxpass(expected-44, be-43)
root(ROOT-0, expected-44)
aux(occur-46, to-45)
xcomp(expected-44, occur-46)

Tetracycline/NN ,/, a/DT bacteriostat/NN ic/NN antibiotic/JJ ,/, may/MD antagonize/VB the/DT bactericidal/JJ effect/NN of/IN penicillin/NN and/CC concurrent/JJ use/NN of/IN these/DT drugs/NNS should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (NN Tetracycline)) (, ,) (NP (DT a) (NN bacteriostat) (NN ic) (JJ antibiotic)) (, ,)) (VP (MD may) (VP (VB antagonize) (NP (NP (DT the) (JJ bactericidal) (NN effect)) (PP (IN of) (NP (NN penicillin))))))) (CC and) (S (NP (NP (JJ concurrent) (NN use)) (PP (IN of) (NP (DT these) (NNS drugs)))) (VP (MD should) (VP (VB be) (VP (VBN avoided)))))) (. .))))

nsubj(antagonize-9, Tetracycline-1)
det(ic-5, a-3)
nn(ic-5, bacteriostat-4)
appos(Tetracycline-1, ic-5)
amod(ic-5, antibiotic-6)
aux(antagonize-9, may-8)
root(ROOT-0, antagonize-9)
det(effect-12, the-10)
amod(effect-12, bactericidal-11)
dobj(antagonize-9, effect-12)
prep_of(effect-12, penicillin-14)
amod(use-17, concurrent-16)
nsubjpass(avoided-23, use-17)
det(drugs-20, these-19)
prep_of(use-17, drugs-20)
aux(avoided-23, should-21)
auxpass(avoided-23, be-22)
conj_and(antagonize-9, avoided-23)

Studies/NNS to/TO evaluate/VB possible/JJ interactions/NNS between/IN REVIA/NNS and/CC drugs/NNS other/JJ than/IN opiates/NNS have/VBP not/RB been/VBN performed/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Studies)) (VP (TO to) (VP (VB evaluate) (NP (NP (NP (JJ possible) (NNS interactions)) (PP (IN between) (NP (NP (NNS REVIA)) (CC and) (NP (NNS drugs))))) (CONJP (JJ other) (IN than)) (NP (NNS opiates)))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN performed))))) (. .))))

nsubjpass(performed-16, Studies-1)
aux(evaluate-3, to-2)
dep(Studies-1, evaluate-3)
amod(interactions-5, possible-4)
dobj(evaluate-3, interactions-5)
prep_between(interactions-5, REVIA-7)
conj_and(REVIA-7, drugs-9)
conj_other(interactions-5, opiates-12)
aux(performed-16, have-13)
neg(performed-16, not-14)
auxpass(performed-16, been-15)
root(ROOT-0, performed-16)

Consequently/RB ,/, caution/NN is/VBZ advised/VBN if/IN the/DT concomitant/JJ administration/NN of/IN REVIA/NN and/CC other/JJ drugs/NNS is/VBZ required/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Consequently)) (, ,) (NP (NN caution)) (VP (VBZ is) (VP (VBN advised) (SBAR (IN if) (S (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN REVIA)) (CC and) (NP (JJ other) (NNS drugs))))) (VP (VBZ is) (VP (VBN required)))))))) (. .))))

advmod(advised-5, Consequently-1)
nsubjpass(advised-5, caution-3)
auxpass(advised-5, is-4)
root(ROOT-0, advised-5)
mark(required-16, if-6)
det(administration-9, the-7)
amod(administration-9, concomitant-8)
nsubjpass(required-16, administration-9)
prep_of(administration-9, REVIA-11)
amod(drugs-14, other-13)
conj_and(REVIA-11, drugs-14)
auxpass(required-16, is-15)
advcl(advised-5, required-16)

The/DT safety/NN and/CC efficacy/NN of/IN concomitant/JJ use/NN of/IN REVIA/NN and/CC disulfiram/NN is/VBZ unknown/JJ ,/, and/CC the/DT concomitant/JJ use/NN of/IN two/CD potentially/RB hepatotoxic/JJ medications/NNS is/VBZ not/RB ordinarily/RB recommended/VBN unless/IN the/DT probable/JJ benefits/NNS outweigh/VBP the/DT known/JJ risks/NNS ./.

(ROOT (S1 (S (S (S (NP (NP (DT The) (NP (NN safety)) (CC and) (NP (NN efficacy))) (PP (IN of) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NP (NN REVIA)) (CC and) (NP (NN disulfiram))))))) (VP (VBZ is) (ADJP (JJ unknown)))) (, ,) (CC and) (S (NP (NP (DT the) (JJ concomitant) (NN use)) (PP (IN of) (NP (CD two) (ADJP (RB potentially) (JJ hepatotoxic)) (NNS medications)))) (VP (VBZ is) (RB not) (ADVP (RB ordinarily)) (VP (VBN recommended) (SBAR (IN unless) (S (NP (DT the) (JJ probable) (NNS benefits)) (VP (VBP outweigh) (NP (DT the) (JJ known) (NNS risks))))))))) (. .))))

dep(safety-2, The-1)
nsubj(unknown-13, safety-2)
conj_and(safety-2, efficacy-4)
amod(use-7, concomitant-6)
prep_of(safety-2, use-7)
prep_of(use-7, REVIA-9)
conj_and(REVIA-9, disulfiram-11)
cop(unknown-13, is-12)
root(ROOT-0, unknown-13)
det(use-18, the-16)
amod(use-18, concomitant-17)
nsubjpass(recommended-27, use-18)
num(medications-23, two-20)
advmod(hepatotoxic-22, potentially-21)
amod(medications-23, hepatotoxic-22)
prep_of(use-18, medications-23)
auxpass(recommended-27, is-24)
neg(recommended-27, not-25)
advmod(recommended-27, ordinarily-26)
conj_and(unknown-13, recommended-27)
mark(outweigh-32, unless-28)
det(benefits-31, the-29)
amod(benefits-31, probable-30)
nsubj(outweigh-32, benefits-31)
advcl(recommended-27, outweigh-32)
det(risks-35, the-33)
amod(risks-35, known-34)
dobj(outweigh-32, risks-35)

Lethargy/NN and/CC somnolence/NN have/VBP been/VBN reported/VBN following/VBG doses/NNS of/IN REVIA/NN and/CC thioridazine/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Lethargy)) (CC and) (NP (NN somnolence))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (VBG following) (NP (NP (NNS doses)) (PP (IN of) (NP (NP (NN REVIA)) (CC and) (NP (NN thioridazine)))))))))) (. .))))

nsubjpass(reported-6, Lethargy-1)
conj_and(Lethargy-1, somnolence-3)
aux(reported-6, have-4)
auxpass(reported-6, been-5)
root(ROOT-0, reported-6)
prep_following(reported-6, doses-8)
prep_of(doses-8, REVIA-10)
conj_and(REVIA-10, thioridazine-12)

Patients/NNS taking/VBG REVIA/NN may/MD not/RB benefit/VB from/IN opioid/NN containing/NN medicines/NNS ,/, such/JJ as/IN cough/NN and/CC cold/JJ preparations/NNS ,/, antidiarrheal/JJ preparations/NNS ,/, and/CC opioid/JJ analgesics/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG taking) (NP (NN REVIA)))) (VP (MD may) (RB not) (VP (VB benefit) (PP (IN from) (NP (NP (NN opioid) (NN containing) (NNS medicines)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN cough)) (CC and) (NP (JJ cold) (NNS preparations)))) (, ,) (NP (JJ antidiarrheal) (NNS preparations)) (, ,) (CC and) (NP (ADJP (JJ opioid)) (NNS analgesics))))))) (. .))))

nsubj(benefit-6, Patients-1)
partmod(Patients-1, taking-2)
dobj(taking-2, REVIA-3)
aux(benefit-6, may-4)
neg(benefit-6, not-5)
root(ROOT-0, benefit-6)
nn(medicines-10, opioid-8)
nn(medicines-10, containing-9)
prep_from(benefit-6, medicines-10)
conj_and(medicines-10, as-13)
prep_such_as(medicines-10, cough-14)
amod(preparations-17, cold-16)
conj_and(cough-14, preparations-17)
amod(preparations-20, antidiarrheal-19)
conj_and(medicines-10, preparations-20)
amod(analgesics-24, opioid-23)
conj_and(medicines-10, analgesics-24)

In/IN an/DT emergency/NN situation/NN when/WRB opioid/NN analgesia/NN must/MD be/VB administered/VBN to/TO a/DT patient/NN receiving/VBG REVIA/NN ,/, the/DT amount/NN of/IN opioid/NN required/VBN may/MD be/VB greater/JJR than/IN usual/JJ ,/, and/CC the/DT resulting/VBG respiratory/JJ depression/NN may/MD be/VB deeper/JJR and/CC more/RBR prolonged/JJ ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (DT an) (NN emergency) (NN situation)) (SBAR (WHADVP (WRB when)) (S (NP (NN opioid) (NN analgesia)) (VP (MD must) (VP (VB be) (VP (VBN administered) (PP (TO to) (NP (NP (DT a) (NN patient)) (VP (VBG receiving) (NP (NN REVIA)))))))))))) (, ,) (S (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN opioid))) (VP (VBN required))) (VP (MD may) (VP (VB be) (ADJP (JJR greater) (PP (IN than) (NP (JJ usual))))))) (, ,) (CC and) (S (NP (DT the) (VBG resulting) (JJ respiratory) (NN depression)) (VP (MD may) (VP (VB be) (ADJP (ADJP (JJR deeper)) (CC and) (ADJP (RBR more) (JJ prolonged))))))) (. .))))

det(situation-4, an-2)
nn(situation-4, emergency-3)
tmod(administered-10, situation-4)
prep_in(greater-24, situation-4)
advmod(administered-10, when-5)
nn(analgesia-7, opioid-6)
nsubjpass(administered-10, analgesia-7)
aux(administered-10, must-8)
auxpass(administered-10, be-9)
dep(situation-4, administered-10)
det(patient-13, a-12)
prep_to(administered-10, patient-13)
partmod(patient-13, receiving-14)
dobj(receiving-14, REVIA-15)
det(amount-18, the-17)
nsubj(greater-24, amount-18)
prep_of(amount-18, opioid-20)
partmod(amount-18, required-21)
aux(greater-24, may-22)
cop(greater-24, be-23)
root(ROOT-0, greater-24)
prep_than(greater-24, usual-26)
det(depression-32, the-29)
amod(depression-32, resulting-30)
amod(depression-32, respiratory-31)
nsubj(deeper-35, depression-32)
aux(deeper-35, may-33)
cop(deeper-35, be-34)
conj_and(greater-24, deeper-35)
advmod(prolonged-38, more-37)
conj_and(deeper-35, prolonged-38)

The/DT use/NN of/IN NSAIDs/NN in/IN patients/NNS who/WP are/VBP receiving/VBG ACE/NN inhibitors/NNS may/MD potentiate/VB renal/JJ disease/NN states/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN use)) (PP (IN of) (NP (NN NSAIDs))) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (VP (VBG receiving) (NP (NN ACE) (NNS inhibitors))))))))) (VP (MD may) (VP (VB potentiate) (NP (JJ renal) (NN disease) (NNS states))))) (. .))))

det(use-2, The-1)
nsubj(potentiate-13, use-2)
prep_of(use-2, NSAIDs-4)
prep_in(use-2, patients-6)
nsubj(receiving-9, patients-6)
aux(receiving-9, are-8)
rcmod(patients-6, receiving-9)
nn(inhibitors-11, ACE-10)
dobj(receiving-9, inhibitors-11)
aux(potentiate-13, may-12)
root(ROOT-0, potentiate-13)
amod(states-16, renal-14)
nn(states-16, disease-15)
dobj(potentiate-13, states-16)

In/FW vitro/FW studies/NNS have/VBP shown/VBN that/IN naproxen/NN anion/NN ,/, because/IN of/IN its/PRP$ affinity/NN for/IN protein/NN ,/, may/MD displace/VB from/IN their/PRP$ binding/NN sites/NNS other/JJ drugs/NNS which/WDT are/VBP also/RB albumin/NN -bound/JJ ./.

(ROOT (S1 (S (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NN naproxen) (NN anion)) (, ,) (PP (IN because) (PP (IN of) (NP (NP (PRP$ its) (NN affinity)) (PP (IN for) (NP (NN protein)))))) (, ,) (VP (MD may) (VP (VB displace) (PP (IN from) (NP (PRP$ their) (NN binding) (NNS sites))) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADVP (RB also)) (ADJP (NN albumin) (JJ -bound))))))))))))) (. .))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(shown-5, studies-3)
aux(shown-5, have-4)
root(ROOT-0, shown-5)
complm(displace-18, that-6)
nn(anion-8, naproxen-7)
nsubj(displace-18, anion-8)
prepc_because_of(displace-18, of-11)
poss(affinity-13, its-12)
pobj(displace-18, affinity-13)
prep_for(affinity-13, protein-15)
aux(displace-18, may-17)
ccomp(shown-5, displace-18)
poss(sites-22, their-20)
nn(sites-22, binding-21)
prep_from(displace-18, sites-22)
amod(drugs-24, other-23)
dobj(displace-18, drugs-24)
nsubj(-bound-29, drugs-24)
cop(-bound-29, are-26)
advmod(-bound-29, also-27)
dep(-bound-29, albumin-28)
rcmod(drugs-24, -bound-29)

Theoretically/RB ,/, the/DT naproxen/NN anion/NN itself/PRP could/MD likewise/RB be/VB displaced/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Theoretically)) (, ,) (NP (DT the) (NN naproxen) (NN anion) (PRP itself)) (VP (MD could) (ADVP (RB likewise)) (VP (VB be) (VP (VBN displaced))))) (. .))))

advmod(displaced-10, Theoretically-1)
det(anion-5, the-3)
nn(anion-5, naproxen-4)
nsubjpass(displaced-10, anion-5)
dep(anion-5, itself-6)
aux(displaced-10, could-7)
advmod(displaced-10, likewise-8)
auxpass(displaced-10, be-9)
root(ROOT-0, displaced-10)

Short-term/JJ controlled/JJ studies/NNS failed/VBD to/TO show/VB that/IN taking/VBG the/DT drug/NN significantly/RB affects/VBZ prothrombin/NN times/NNS when/WRB administered/VBN to/TO individuals/NNS on/IN coumarin-type/JJ anticoagulants/NNS ./.

(ROOT (S1 (S (S (NP (JJ Short-term) (JJ controlled) (NNS studies)) (VP (VBD failed) (S (VP (TO to) (VP (VB show) (SBAR (IN that) (S (S (VP (VBG taking) (NP (DT the) (NN drug)))) (ADVP (RB significantly)) (VP (VBZ affects) (NP (NN prothrombin) (NNS times)) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (TO to) (NP (NP (NNS individuals)) (PP (IN on) (NP (JJ coumarin-type) (NNS anticoagulants)))))))))))))))) (. .))))

amod(studies-3, Short-term-1)
amod(studies-3, controlled-2)
nsubj(failed-4, studies-3)
xsubj(show-6, studies-3)
root(ROOT-0, failed-4)
aux(show-6, to-5)
xcomp(failed-4, show-6)
complm(affects-12, that-7)
csubj(affects-12, taking-8)
det(drug-10, the-9)
dobj(taking-8, drug-10)
advmod(affects-12, significantly-11)
ccomp(show-6, affects-12)
nn(times-14, prothrombin-13)
dobj(affects-12, times-14)
advmod(administered-16, when-15)
advcl(affects-12, administered-16)
prep_to(administered-16, individuals-18)
amod(anticoagulants-21, coumarin-type-20)
prep_on(individuals-18, anticoagulants-21)

Similarly/RB ,/, patients/NNS receiving/VBG the/DT drug/NN and/CC a/DT hydantoin/NN ,/, sulfonamide/NN or/CC sulfonylurea/NN should/MD be/VB observed/VBN for/IN signs/NNS of/IN toxicity/NN to/TO these/DT drugs/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Similarly)) (, ,) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (DT the) (NN drug)) (CC and) (NP (NP (DT a) (NN hydantoin)) (, ,) (NP (NN sulfonamide)) (CC or) (NP (NN sulfonylurea)))))) (VP (MD should) (VP (VB be) (VP (VBN observed) (PP (IN for) (NP (NP (NNS signs)) (PP (IN of) (NP (NP (NN toxicity)) (PP (TO to) (NP (DT these) (NNS drugs))))))))))) (. .))))

advmod(observed-16, Similarly-1)
nsubjpass(observed-16, patients-3)
partmod(patients-3, receiving-4)
det(drug-6, the-5)
dobj(receiving-4, drug-6)
det(hydantoin-9, a-8)
conj_and(drug-6, hydantoin-9)
conj_or(hydantoin-9, sulfonamide-11)
conj_or(hydantoin-9, sulfonylurea-13)
aux(observed-16, should-14)
auxpass(observed-16, be-15)
root(ROOT-0, observed-16)
prep_for(observed-16, signs-18)
prep_of(signs-18, toxicity-20)
det(drugs-23, these-22)
prep_to(toxicity-20, drugs-23)

Concomitant/JJ administration/NN of/IN naproxen/NN and/CC aspirin/NN is/VBZ not/RB recommended/VBN because/IN naproxen/NN is/VBZ displaced/VBN from/IN its/PRP$ binding/NN sites/NNS during/IN the/DT concomitant/JJ administration/NN of/IN aspirin/NN ,/, resulting/VBG in/IN lower/JJR plasma/NN concentrations/NNS and/CC peak/NN plasma/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN naproxen)) (CC and) (NP (NN aspirin))))) (VP (VBZ is) (RB not) (VP (VBN recommended) (SBAR (IN because) (S (NP (NN naproxen)) (VP (VBZ is) (VP (VBN displaced) (PP (IN from) (NP (PRP$ its) (NN binding) (NNS sites))) (PP (IN during) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NN aspirin)))))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (JJR lower) (NN plasma) (NNS concentrations)) (CC and) (NP (NN peak) (NN plasma) (NNS levels)))))))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubjpass(recommended-9, administration-2)
prep_of(administration-2, naproxen-4)
conj_and(naproxen-4, aspirin-6)
auxpass(recommended-9, is-7)
neg(recommended-9, not-8)
root(ROOT-0, recommended-9)
mark(displaced-13, because-10)
nsubjpass(displaced-13, naproxen-11)
auxpass(displaced-13, is-12)
advcl(recommended-9, displaced-13)
poss(sites-17, its-15)
nn(sites-17, binding-16)
prep_from(displaced-13, sites-17)
det(administration-21, the-19)
amod(administration-21, concomitant-20)
prep_during(displaced-13, administration-21)
prep_of(administration-21, aspirin-23)
xcomp(displaced-13, resulting-25)
amod(concentrations-29, lower-27)
nn(concentrations-29, plasma-28)
prep_in(resulting-25, concentrations-29)
nn(levels-33, peak-31)
nn(levels-33, plasma-32)
conj_and(concentrations-29, levels-33)

The/DT natriuretic/JJ effect/NN of/IN furosemide/NN has/VBZ been/VBN reported/VBN to/TO be/VB inhibited/VBN by/IN some/DT drugs/NNS of/IN this/DT class/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ natriuretic) (NN effect)) (PP (IN of) (NP (NN furosemide)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (VP (VBN inhibited) (PP (IN by) (NP (NP (DT some) (NNS drugs)) (PP (IN of) (NP (DT this) (NN class))))))))))))) (. .))))

det(effect-3, The-1)
amod(effect-3, natriuretic-2)
nsubjpass(reported-8, effect-3)
xsubj(inhibited-11, effect-3)
prep_of(effect-3, furosemide-5)
aux(reported-8, has-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
aux(inhibited-11, to-9)
auxpass(inhibited-11, be-10)
xcomp(reported-8, inhibited-11)
det(drugs-14, some-13)
agent(inhibited-11, drugs-14)
det(class-17, this-16)
prep_of(drugs-14, class-17)

Inhibition/NN of/IN renal/JJ lithium/NN clearance/NN leading/VBG to/TO increases/NNS in/IN plasma/NN lithium/NN concentrations/NNS has/VBZ also/RB been/VBN reported/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Inhibition)) (PP (IN of) (NP (NP (JJ renal) (NN lithium) (NN clearance)) (VP (VBG leading) (PP (TO to) (NP (NP (NNS increases)) (PP (IN in) (NP (NN plasma) (NN lithium) (NNS concentrations))))))))) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN reported))))) (. .))))

nsubjpass(reported-16, Inhibition-1)
amod(clearance-5, renal-3)
nn(clearance-5, lithium-4)
prep_of(Inhibition-1, clearance-5)
partmod(clearance-5, leading-6)
prep_to(leading-6, increases-8)
nn(concentrations-12, plasma-10)
nn(concentrations-12, lithium-11)
prep_in(increases-8, concentrations-12)
aux(reported-16, has-13)
advmod(reported-16, also-14)
auxpass(reported-16, been-15)
root(ROOT-0, reported-16)

Naproxen/NN and/CC other/JJ NSAIDs/NNS can/MD reduce/VB the/DT antihypertensive/JJ effect/NN of/IN propranolol/NN and/CC other/JJ beta-blockers/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Naproxen)) (CC and) (NP (JJ other) (NNS NSAIDs))) (VP (MD can) (VP (VB reduce) (NP (NP (DT the) (JJ antihypertensive) (NN effect)) (PP (IN of) (NP (NP (NN propranolol)) (CC and) (NP (JJ other) (NNS beta-blockers)))))))) (. .))))

nsubj(reduce-6, Naproxen-1)
amod(NSAIDs-4, other-3)
conj_and(Naproxen-1, NSAIDs-4)
aux(reduce-6, can-5)
root(ROOT-0, reduce-6)
det(effect-9, the-7)
amod(effect-9, antihypertensive-8)
dobj(reduce-6, effect-9)
prep_of(effect-9, propranolol-11)
amod(beta-blockers-14, other-13)
conj_and(propranolol-11, beta-blockers-14)

Probenecid/NN given/VBN concurrently/RB increases/VBZ naproxen/NN anion/NN plasma/NN levels/NNS and/CC extends/VBZ its/PRP$ plasma/NN half-life/NN significantly/RB ./.

(ROOT (S1 (S (S (NP (NP (NN Probenecid)) (VP (VBN given) (ADVP (RB concurrently)))) (VP (VP (VBZ increases) (NP (NN naproxen) (NN anion) (NN plasma) (NNS levels))) (CC and) (VP (VBZ extends) (NP (PRP$ its) (NN plasma) (NN half-life)) (ADVP (RB significantly))))) (. .))))

nsubj(increases-4, Probenecid-1)
partmod(Probenecid-1, given-2)
advmod(given-2, concurrently-3)
root(ROOT-0, increases-4)
nn(levels-8, naproxen-5)
nn(levels-8, anion-6)
nn(levels-8, plasma-7)
dobj(increases-4, levels-8)
conj_and(increases-4, extends-10)
poss(half-life-13, its-11)
nn(half-life-13, plasma-12)
dobj(extends-10, half-life-13)
advmod(extends-10, significantly-14)

Caution/NN should/MD be/VB used/VBN if/IN naproxen/NN is/VBZ administered/VBN concomitantly/RB with/IN methotrexate/NN ./.

(ROOT (S1 (S (S (NP (NN Caution)) (VP (MD should) (VP (VB be) (VP (VBN used) (SBAR (IN if) (S (NP (NN naproxen)) (VP (VBZ is) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN methotrexate))))))))))) (. .))))

nsubjpass(used-4, Caution-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
mark(administered-8, if-5)
nsubjpass(administered-8, naproxen-6)
auxpass(administered-8, is-7)
advcl(used-4, administered-8)
advmod(administered-8, concomitantly-9)
prep_with(administered-8, methotrexate-11)

Naproxen/NN ,/, naproxen/NN sodium/NN and/CC other/JJ NSAIDs/NNS have/VBP been/VBN reported/VBN to/TO reduce/VB the/DT tubular/JJ secretion/NN of/IN methotrexate/NN in/IN an/DT animal/JJ model/NN ,/, possibly/RB increasing/VBG the/DT toxicity/NN of/IN methotrexate/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Naproxen)) (, ,) (NP (NN naproxen) (NN sodium)) (CC and) (NP (JJ other) (NNS NSAIDs))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB reduce) (NP (NP (DT the) (JJ tubular) (NN secretion)) (PP (IN of) (NP (NN methotrexate))) (PP (IN in) (NP (DT an) (JJ animal) (NN model)))) (, ,) (S (ADVP (RB possibly)) (VP (VBG increasing) (NP (NP (DT the) (NN toxicity)) (PP (IN of) (NP (NN methotrexate))))))))))))) (. .))))

nsubjpass(reported-10, Naproxen-1)
xsubj(reduce-12, Naproxen-1)
nn(sodium-4, naproxen-3)
conj_and(Naproxen-1, sodium-4)
amod(NSAIDs-7, other-6)
conj_and(Naproxen-1, NSAIDs-7)
aux(reported-10, have-8)
auxpass(reported-10, been-9)
root(ROOT-0, reported-10)
aux(reduce-12, to-11)
xcomp(reported-10, reduce-12)
det(secretion-15, the-13)
amod(secretion-15, tubular-14)
dobj(reduce-12, secretion-15)
prep_of(secretion-15, methotrexate-17)
det(model-21, an-19)
amod(model-21, animal-20)
prep_in(secretion-15, model-21)
advmod(increasing-24, possibly-23)
partmod(reduce-12, increasing-24)
xcomp(reduce-12, increasing-24)
det(toxicity-26, the-25)
dobj(increasing-24, toxicity-26)
prep_of(toxicity-26, methotrexate-28)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS Naproxen/NN may/MD decrease/VB platelet/NN aggregation/NN and/CC prolong/VB bleeding/JJ time/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (NN Naproxen)) (VP (MD may) (VP (VP (VB decrease) (NP (NN platelet) (NN aggregation))) (CC and) (VP (VB prolong) (NP (JJ bleeding) (NN time)))))) (. .))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
nn(Naproxen-5, Interactions-4)
nsubj(decrease-7, Naproxen-5)
aux(decrease-7, may-6)
root(ROOT-0, decrease-7)
nn(aggregation-9, platelet-8)
dobj(decrease-7, aggregation-9)
conj_and(decrease-7, prolong-11)
amod(time-13, bleeding-12)
dobj(prolong-11, time-13)

The/DT administration/NN of/IN naproxen/NN may/MD result/VB in/IN increased/VBN urinary/JJ values/NNS for/IN 17-ketogenic/JJ steroids/NNS because/IN of/IN an/DT interaction/NN between/IN the/DT drug/NN and/or/CC its/PRP$ metabolites/NNS with/IN m-dinitrobenzene/NN used/VBN in/IN this/DT assay/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NN naproxen)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (VBN increased) (JJ urinary) (NNS values)) (PP (IN for) (NP (JJ 17-ketogenic) (NNS steroids))))) (PP (IN because) (IN of) (NP (NP (DT an) (NN interaction)) (PP (IN between) (NP (NP (DT the) (NN drug)) (CC and/or) (NP (PRP$ its) (NNS metabolites)))) (PP (IN with) (NP (NP (NN m-dinitrobenzene)) (VP (VBN used) (PP (IN in) (NP (DT this) (NN assay))))))))))) (. .))))

det(administration-2, The-1)
nsubj(result-6, administration-2)
prep_of(administration-2, naproxen-4)
aux(result-6, may-5)
root(ROOT-0, result-6)
amod(values-10, increased-8)
amod(values-10, urinary-9)
prep_in(result-6, values-10)
amod(steroids-13, 17-ketogenic-12)
prep_for(values-10, steroids-13)
det(interaction-17, an-16)
prep_because_of(result-6, interaction-17)
det(drug-20, the-19)
prep_between(interaction-17, drug-20)
poss(metabolites-23, its-22)
conj_and/or(drug-20, metabolites-23)
prep_with(interaction-17, m-dinitrobenzene-25)
partmod(m-dinitrobenzene-25, used-26)
det(assay-29, this-28)
prep_in(used-26, assay-29)

Although/IN 17-hydroxy-/JJ corticosteroid/NN measurements/NNS (/-LRB- Porter-Silber/NN test/NN )/-RRB- do/VBP not/RB appear/VB to/TO be/VB artifactually/RB altered/VBN ,/, it/PRP is/VBZ suggested/VBN that/IN therapy/NN with/IN naproxen/NN be/VB temporarily/RB discontinued/VBN 72/CD hours/NNS before/IN adrenal/JJ function/NN tests/NNS are/VBP performed/VBN if/IN the/DT Porter-Silber/NN test/NN is/VBZ to/TO be/VB used/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ 17-hydroxy-) (NN corticosteroid) (NNS measurements)) (PRN (-LRB- -LRB-) (NP (NN Porter-Silber) (NN test)) (-RRB- -RRB-))) (VP (VBP do) (RB not) (VP (VB appear) (S (VP (TO to) (VP (VB be) (ADVP (RB artifactually)) (VP (VBN altered))))))))) (, ,) (NP (PRP it)) (VP (VBZ is) (VP (VBN suggested) (SBAR (IN that) (S (NP (NP (NN therapy)) (PP (IN with) (NP (NN naproxen)))) (VP (VB be) (VP (ADVP (RB temporarily)) (VBN discontinued) (PP (NP (CD 72) (NNS hours)) (IN before) (NP (NP (JJ adrenal) (NN function) (NNS tests)) (VP (VBP are) (VP (VBN performed) (SBAR (IN if) (S (NP (DT the) (NN Porter-Silber) (NN test)) (VP (VBZ is) (S (VP (TO to) (VP (VB be) (VP (VBN used))))))))))))))))))) (. .))))

mark(appear-11, Although-1)
amod(measurements-4, 17-hydroxy--2)
nn(measurements-4, corticosteroid-3)
nsubj(appear-11, measurements-4)
xsubj(altered-15, measurements-4)
nn(test-7, Porter-Silber-6)
appos(measurements-4, test-7)
aux(appear-11, do-9)
neg(appear-11, not-10)
advcl(suggested-19, appear-11)
aux(altered-15, to-12)
auxpass(altered-15, be-13)
advmod(altered-15, artifactually-14)
xcomp(appear-11, altered-15)
nsubjpass(suggested-19, it-17)
auxpass(suggested-19, is-18)
root(ROOT-0, suggested-19)
complm(discontinued-26, that-20)
nsubjpass(discontinued-26, therapy-21)
prep_with(therapy-21, naproxen-23)
auxpass(discontinued-26, be-24)
advmod(discontinued-26, temporarily-25)
ccomp(suggested-19, discontinued-26)
num(hours-28, 72-27)
npadvmod(discontinued-26, hours-28)
amod(tests-32, adrenal-30)
nn(tests-32, function-31)
prep_before(discontinued-26, tests-32)
auxpass(performed-34, are-33)
dep(tests-32, performed-34)
mark(is-39, if-35)
det(test-38, the-36)
nn(test-38, Porter-Silber-37)
nsubj(is-39, test-38)
advcl(performed-34, is-39)
aux(used-42, to-40)
auxpass(used-42, be-41)
xcomp(is-39, used-42)

Naproxen/NN may/MD interfere/VB with/IN some/DT urinary/JJ assays/NNS of/IN 5-hydroxy/JJ indoleacetic/JJ acid/NN (/-LRB- 5HIAA)./NN

(ROOT (S1 (S (NP (NN Naproxen)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (DT some) (JJ urinary) (NNS assays)) (PP (IN of) (NP (JJ 5-hydroxy) (JJ indoleacetic) (NN acid))))) (-LRB- -LRB-) (NP (NN 5HIAA-RRB-.)))))))

nsubj(interfere-3, Naproxen-1)
aux(interfere-3, may-2)
root(ROOT-0, interfere-3)
det(assays-7, some-5)
amod(assays-7, urinary-6)
prep_with(interfere-3, assays-7)
amod(acid-11, 5-hydroxy-9)
amod(acid-11, indoleacetic-10)
prep_of(assays-7, acid-11)
dobj(interfere-3, 5HIAA-RRB-.-13)

Ergot-containing/JJ drugs/NNS have/VBP been/VBN reported/VBN to/TO cause/VB prolonged/JJ vasospastic/JJ reactions/NNS ./.

(ROOT (S1 (S (S (NP (JJ Ergot-containing) (NNS drugs)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB cause) (NP (JJ prolonged) (JJ vasospastic) (NNS reactions))))))))) (. .))))

amod(drugs-2, Ergot-containing-1)
nsubjpass(reported-5, drugs-2)
xsubj(cause-7, drugs-2)
aux(reported-5, have-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
aux(cause-7, to-6)
xcomp(reported-5, cause-7)
amod(reactions-10, prolonged-8)
amod(reactions-10, vasospastic-9)
dobj(cause-7, reactions-10)

Because/IN there/EX is/VBZ a/DT theoretical/JJ basis/NN that/IN these/DT effects/NNS may/MD be/VB additive/JJ ,/, use/NN of/IN ergotamine/JJ -containing/JJ or/CC ergot-type/JJ medications/NNS (/-LRB- like/IN dihydroergotamine/NN or/CC methysergide/NN )/-RRB- and/CC naratriptan/NN within/IN 24/CD hours/NNS is/VBZ contraindicated/VBN ./.

(ROOT (S1 (S (SBAR (IN Because) (S (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (JJ theoretical) (NN basis)) (SBAR (IN that) (S (NP (DT these) (NNS effects)) (VP (MD may) (VP (VB be) (ADJP (JJ additive)))))))))) (, ,) (NP (NP (NP (NN use)) (PP (IN of) (NP (NP (JJ ergotamine) (ADJP (ADJP (JJ -containing)) (CC or) (ADJP (JJ ergot-type))) (NNS medications)) (PRN (-LRB- -LRB-) (PP (IN like) (NP (NP (NN dihydroergotamine)) (CC or) (NP (NN methysergide)))) (-RRB- -RRB-))))) (CC and) (NP (NP (NN naratriptan)) (PP (IN within) (NP (CD 24) (NNS hours))))) (VP (VBZ is) (VP (VBN contraindicated))) (. .))))

mark(is-3, Because-1)
expl(is-3, there-2)
advcl(contraindicated-33, is-3)
det(basis-6, a-4)
amod(basis-6, theoretical-5)
nsubj(is-3, basis-6)
dobj(additive-12, basis-6)
complm(additive-12, that-7)
det(effects-9, these-8)
nsubj(additive-12, effects-9)
aux(additive-12, may-10)
cop(additive-12, be-11)
dep(basis-6, additive-12)
nsubjpass(contraindicated-33, use-14)
amod(medications-20, ergotamine-16)
amod(medications-20, -containing-17)
conj_or(-containing-17, ergot-type-19)
prep_of(use-14, medications-20)
dep(medications-20, like-22)
pobj(like-22, dihydroergotamine-23)
conj_or(dihydroergotamine-23, methysergide-25)
conj_and(use-14, naratriptan-28)
num(hours-31, 24-30)
prep_within(naratriptan-28, hours-31)
auxpass(contraindicated-33, is-32)
root(ROOT-0, contraindicated-33)

The/DT administration/NN of/IN naratriptan/NN with/IN other/JJ 5-HT1/NN agonists/NNS has/VBZ not/RB been/VBN evaluated/VBN in/IN migraine/NN patients/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN administration)) (PP (IN of) (NP (NN naratriptan))) (PP (IN with) (NP (JJ other) (NN 5-HT1) (NNS agonists)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN evaluated) (PP (IN in) (NP (NN migraine) (NNS patients))))))) (. .))))

det(administration-2, The-1)
nsubjpass(evaluated-12, administration-2)
prep_of(administration-2, naratriptan-4)
amod(agonists-8, other-6)
nn(agonists-8, 5-HT1-7)
prep_with(administration-2, agonists-8)
aux(evaluated-12, has-9)
neg(evaluated-12, not-10)
auxpass(evaluated-12, been-11)
root(ROOT-0, evaluated-12)
nn(patients-15, migraine-14)
prep_in(evaluated-12, patients-15)

Because/IN their/PRP$ vasospastic/JJ effects/NNS may/MD be/VB additive/JJ ,/, coadministration/NN of/IN naratriptan/NN and/CC other/JJ 5-HT1/NN agonists/NNS within/IN 24/CD hours/NNS of/IN each/DT other/JJ is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (PRP$ their) (JJ vasospastic) (NNS effects)) (VP (MD may) (VP (VB be) (ADJP (JJ additive)))))) (, ,) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NN naratriptan)) (CC and) (NP (JJ other) (NN 5-HT1) (NNS agonists)))) (PP (IN within) (NP (NP (CD 24) (NNS hours)) (PP (IN of) (NP (DT each) (JJ other)))))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

mark(additive-7, Because-1)
poss(effects-4, their-2)
amod(effects-4, vasospastic-3)
nsubj(additive-7, effects-4)
aux(additive-7, may-5)
cop(additive-7, be-6)
advcl(recommended-24, additive-7)
nsubjpass(recommended-24, coadministration-9)
prep_of(coadministration-9, naratriptan-11)
amod(agonists-15, other-13)
nn(agonists-15, 5-HT1-14)
conj_and(naratriptan-11, agonists-15)
num(hours-18, 24-17)
prep_within(coadministration-9, hours-18)
det(other-21, each-20)
prep_of(hours-18, other-21)
auxpass(recommended-24, is-22)
neg(recommended-24, not-23)
root(ROOT-0, recommended-24)

Selective/JJ serotonin/NN reuptake/NN inhibitors/NNS (/-LRB- SSRIs/NN )/-RRB- (/-LRB- e.g./FW ,/, fluoxetine/NN ,/, fluvoxamine/NN ,/, paroxetine/NN ,/, sertraline/NN )/-RRB- have/VBP been/VBN reported/VBN ,/, rarely/RB ,/, to/TO cause/VB weakness/NN ,/, hyperreflexia/NN ,/, and/CC incoordination/NN when/WRB coadministered/VBN with/IN 5-HTv/JJ agonists/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Selective) (NN serotonin) (NN reuptake) (NNS inhibitors)) (PRN (-LRB- -LRB-) (NP (NN SSRIs)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN fluoxetine)) (, ,) (NP (NN fluvoxamine)) (, ,) (NP (NN paroxetine)) (, ,) (NP (NN sertraline)))) (-RRB- -RRB-))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (, ,) (ADVP (RB rarely)) (, ,) (S (VP (TO to) (VP (VB cause) (NP (NP (NN weakness)) (, ,) (NP (NN hyperreflexia)) (, ,) (CC and) (NP (NN incoordination))) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (JJ 5-HTv) (NNS agonists))))))))))))) (. .))))

amod(inhibitors-4, Selective-1)
nn(inhibitors-4, serotonin-2)
nn(inhibitors-4, reuptake-3)
nsubjpass(reported-21, inhibitors-4)
xsubj(cause-26, inhibitors-4)
abbrev(inhibitors-4, SSRIs-6)
dep(inhibitors-4, e.g.-9)
pobj(e.g.-9, fluoxetine-11)
appos(fluoxetine-11, fluvoxamine-13)
appos(fluoxetine-11, paroxetine-15)
appos(fluoxetine-11, sertraline-17)
aux(reported-21, have-19)
auxpass(reported-21, been-20)
root(ROOT-0, reported-21)
advmod(reported-21, rarely-23)
aux(cause-26, to-25)
xcomp(reported-21, cause-26)
dobj(cause-26, weakness-27)
conj_and(weakness-27, hyperreflexia-29)
conj_and(weakness-27, incoordination-32)
advmod(coadministered-34, when-33)
advcl(cause-26, coadministered-34)
amod(agonists-37, 5-HTv-36)
prep_with(coadministered-34, agonists-37)

If/IN concomitant/JJ treatment/NN with/IN naratriptan/NN and/CC an/DT SSRI/NN is/VBZ clinically/RB warranted/VBN ,/, appropriate/JJ observation/NN of/IN the/DT patient/NN is/VBZ advised/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (NP (NP (JJ concomitant) (NN treatment)) (PP (IN with) (NP (NP (NN naratriptan)) (CC and) (NP (DT an) (NN SSRI))))) (VP (VBZ is) (ADVP (RB clinically)) (VP (VBN warranted))))) (, ,) (NP (NP (JJ appropriate) (NN observation)) (PP (IN of) (NP (DT the) (NN patient)))) (VP (VBZ is) (VP (VBN advised)))) (. .))))

mark(warranted-11, If-1)
amod(treatment-3, concomitant-2)
nsubjpass(warranted-11, treatment-3)
prep_with(treatment-3, naratriptan-5)
det(SSRI-8, an-7)
conj_and(naratriptan-5, SSRI-8)
auxpass(warranted-11, is-9)
advmod(warranted-11, clinically-10)
advcl(advised-19, warranted-11)
amod(observation-14, appropriate-13)
nsubjpass(advised-19, observation-14)
det(patient-17, the-16)
prep_of(observation-14, patient-17)
auxpass(advised-19, is-18)
root(ROOT-0, advised-19)

Drug/NN //: Laboratory/NN Test/NN Interactions/NNS AMERGE/NN Tablets/NNS are/VBP not/RB known/VBN to/TO interfere/VB with/IN commonly/RB employed/VBN clinical/JJ laboratory/NN tests/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (: /) (NN Laboratory) (NN Test) (NNS Interactions)) (VP (NN AMERGE) (NNS Tablets))) (VP (VBP are) (RB not) (VP (VBN known) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (ADJP (RB commonly) (VBN employed)) (JJ clinical) (NN laboratory) (NNS tests))))))))) (. .))))

nn(Interactions-5, Drug-1)
punct(Interactions-5, /-2)
nn(Interactions-5, Laboratory-3)
nn(Interactions-5, Test-4)
nsubjpass(known-10, Interactions-5)
xsubj(interfere-12, Interactions-5)
dep(Interactions-5, AMERGE-6)
dep(AMERGE-6, Tablets-7)
auxpass(known-10, are-8)
neg(known-10, not-9)
root(ROOT-0, known-10)
aux(interfere-12, to-11)
xcomp(known-10, interfere-12)
advmod(employed-15, commonly-14)
amod(tests-18, employed-15)
amod(tests-18, clinical-16)
nn(tests-18, laboratory-17)
prep_with(interfere-12, tests-18)

After/IN multiple/JJ dosing/NN ,/, interferon/NN beta-1a/NN (/-LRB- AVONEX/NN @/NN 30/CD mcg/NN IM/NN once/RB weekly/RB )/-RRB- reduced/VBD TYSABRI/NN @/NN clearance/NN by/IN approximately/RB 30/CD %./NN

(ROOT (S1 (S (PP (IN After) (NP (JJ multiple) (NN dosing))) (, ,) (NP (NP (NN interferon) (NN beta-1a)) (PRN (-LRB- -LRB-) (NP (NP (NN AVONEX) (NN @) (CD 30) (NN mcg) (NN IM)) (ADVP (RB once) (RB weekly))) (-RRB- -RRB-))) (VP (VBD reduced) (NP (NN TYSABRI) (NN @) (NN clearance)) (PP (IN by) (NP (QP (RB approximately) (CD 30)) (NN %.)))))))

amod(dosing-3, multiple-2)
prep_after(reduced-16, dosing-3)
nn(beta-1a-6, interferon-5)
nsubj(reduced-16, beta-1a-6)
nn(IM-12, AVONEX-8)
nn(IM-12, @-9)
num(IM-12, 30-10)
nn(IM-12, mcg-11)
dep(beta-1a-6, IM-12)
advmod(weekly-14, once-13)
advmod(IM-12, weekly-14)
root(ROOT-0, reduced-16)
nn(clearance-19, TYSABRI-17)
nn(clearance-19, @-18)
dobj(reduced-16, clearance-19)
quantmod(30-22, approximately-21)
num(%.-23, 30-22)
prep_by(reduced-16, %.-23)

Results/NNS of/IN studies/NNS in/IN multiple/JJ sclerosis/NN patients/NNS taking/VBG TYSABRI/NN @/NN and/CC concomitant/JJ interferon/NN beta-1a/NN (/-LRB- AVONEX/NN @/NN 30/CD mcg/NN IM/NN once/RB weekly/RB )/-RRB- or/CC glatiramer/NN acetate/NN were/VBD inconclusive/JJ with/IN regard/NN to/TO the/DT need/NN for/IN dose/NN adjustment/NN of/IN the/DT beta-interferon/NN or/CC glatiramer/NN acetate/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Results)) (PP (IN of) (NP (NP (NNS studies)) (PP (IN in) (NP (NP (NP (JJ multiple) (NN sclerosis)) (NNS patients)) (VP (VBG taking) (NP (NP (NP (NN TYSABRI) (NN @) (CC and) (JJ concomitant) (NN interferon) (NN beta-1a)) (PRN (-LRB- -LRB-) (NP (NP (NN AVONEX) (NN @) (CD 30) (NN mcg) (NN IM)) (ADVP (RB once) (RB weekly))) (-RRB- -RRB-))) (CC or) (NP (NN glatiramer) (NN acetate))))))))) (VP (VBD were) (ADJP (JJ inconclusive) (PP (IN with) (NP (NP (NN regard)) (PP (TO to) (NP (NP (DT the) (NN need)) (PP (IN for) (NP (NP (NN dose) (NN adjustment)) (PP (IN of) (NP (DT the) (NN beta-interferon) (CC or) (NN glatiramer) (NN acetate)))))))))))) (. .))))

nsubj(inconclusive-28, Results-1)
prep_of(Results-1, studies-3)
amod(sclerosis-6, multiple-5)
nn(patients-7, sclerosis-6)
prep_in(studies-3, patients-7)
partmod(patients-7, taking-8)
nn(@-10, TYSABRI-9)
dobj(taking-8, @-10)
amod(beta-1a-14, concomitant-12)
nn(beta-1a-14, interferon-13)
conj_and(@-10, beta-1a-14)
nn(IM-20, AVONEX-16)
nn(IM-20, @-17)
num(IM-20, 30-18)
nn(IM-20, mcg-19)
dep(@-10, IM-20)
advmod(weekly-22, once-21)
advmod(IM-20, weekly-22)
nn(acetate-26, glatiramer-25)
conj_or(@-10, acetate-26)
cop(inconclusive-28, were-27)
root(ROOT-0, inconclusive-28)
det(need-33, the-32)
prep_with_regard_to(inconclusive-28, need-33)
nn(adjustment-36, dose-35)
prep_for(need-33, adjustment-36)
det(acetate-42, the-38)
nn(acetate-42, beta-interferon-39)
conj_or(beta-interferon-39, glatiramer-41)
prep_of(adjustment-36, acetate-42)

Nelfinavir/NN is/VBZ an/DT inhibitor/NN of/IN CYP3A/NN (/-LRB- cytochrome/NN P450/NN 3A/NN )/-RRB- ./.

(ROOT (S1 (S (S (NP (NN Nelfinavir)) (VP (VBZ is) (NP (NP (NP (DT an) (NN inhibitor)) (PP (IN of) (NP (NN CYP3A)))) (PRN (-LRB- -LRB-) (NP (NN cytochrome) (NN P450) (NN 3A)) (-RRB- -RRB-))))) (. .))))

nsubj(inhibitor-4, Nelfinavir-1)
cop(inhibitor-4, is-2)
det(inhibitor-4, an-3)
root(ROOT-0, inhibitor-4)
prep_of(inhibitor-4, CYP3A-6)
nn(3A-10, cytochrome-8)
nn(3A-10, P450-9)
appos(inhibitor-4, 3A-10)

Coadministration/NN of/IN VIRACEPT/NN and/CC drugs/NNS primarily/RB metabolized/VBN by/IN CYP3A/NN (/-LRB- e.g./FW ,/, dihydropyridine/NN calcium/NN channel/NN blockers/NNS )/-RRB- may/MD result/VB in/IN increased/VBN plasma/NN concentrations/NNS of/IN the/DT other/JJ drug/NN that/WDT could/MD increase/VB or/CC prolong/VB both/DT its/PRP$ therapeutic/JJ and/CC adverse/JJ effects/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NN VIRACEPT)) (CC and) (NP (NP (NP (NNS drugs)) (VP (ADVP (RB primarily)) (VBN metabolized) (PP (IN by) (NP (NN CYP3A))))) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN dihydropyridine) (NN calcium) (NN channel) (NNS blockers)) (-RRB- -RRB-)))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (VBN increased) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (DT the) (JJ other) (NN drug)) (SBAR (WHNP (WDT that)) (S (VP (MD could) (VP (VP (VB increase)) (CC or) (VP (VB prolong) (NP (DT both) (PRP$ its) (ADJP (ADJP (JJ therapeutic)) (CC and) (ADJP (JJ adverse))) (NNS effects)))))))))))))) (. .))))

nsubj(result-19, Coadministration-1)
prep_of(Coadministration-1, VIRACEPT-3)
conj_and(VIRACEPT-3, drugs-5)
advmod(metabolized-7, primarily-6)
partmod(drugs-5, metabolized-7)
agent(metabolized-7, CYP3A-9)
dep(blockers-16, e.g.-11)
nn(blockers-16, dihydropyridine-13)
nn(blockers-16, calcium-14)
nn(blockers-16, channel-15)
appos(drugs-5, blockers-16)
aux(result-19, may-18)
root(ROOT-0, result-19)
amod(concentrations-23, increased-21)
nn(concentrations-23, plasma-22)
prep_in(result-19, concentrations-23)
det(drug-27, the-25)
amod(drug-27, other-26)
prep_of(concentrations-23, drug-27)
nsubj(increase-30, drug-27)
aux(increase-30, could-29)
rcmod(drug-27, increase-30)
conj_or(increase-30, prolong-32)
det(effects-38, both-33)
predet(effects-38, both-33)
poss(effects-38, its-34)
amod(effects-38, therapeutic-35)
conj_and(therapeutic-35, adverse-37)
dobj(prolong-32, effects-38)

Nelfinavir/NN is/VBZ metabolized/VBN in/IN proof/NN by/IN C.P.A./NN ./.

(ROOT (S1 (S (S (NP (NN Nelfinavir)) (VP (VBZ is) (VP (VBN metabolized) (PP (IN in) (NP (NN proof))) (PP (IN by) (NP (NN C.P.A.)))))) (. .))))

nsubjpass(metabolized-3, Nelfinavir-1)
auxpass(metabolized-3, is-2)
root(ROOT-0, metabolized-3)
prep_in(metabolized-3, proof-5)
agent(metabolized-3, C.P.A.-7)

Coadministration/NN of/IN VIRACEPT/NNS and/CC drugs/NNS that/WDT induce/VBP CYP3A/NN may/MD decrease/VB nelfinavir/NN plasma/NN concentrations/NNS and/CC reduce/VB its/PRP$ therapeutic/JJ effect/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NP (NNS VIRACEPT)) (CC and) (NP (NNS drugs))) (SBAR (WHNP (WDT that)) (S (VP (VBP induce) (NP (NN CYP3A)))))))) (VP (MD may) (VP (VP (VB decrease) (NP (NN nelfinavir) (NN plasma) (NNS concentrations))) (CC and) (VP (VB reduce) (NP (PRP$ its) (JJ therapeutic) (NN effect)))))) (. .))))

nsubj(decrease-10, Coadministration-1)
prep_of(Coadministration-1, VIRACEPT-3)
nsubj(induce-7, VIRACEPT-3)
conj_and(VIRACEPT-3, drugs-5)
rcmod(VIRACEPT-3, induce-7)
dobj(induce-7, CYP3A-8)
aux(decrease-10, may-9)
root(ROOT-0, decrease-10)
nn(concentrations-13, nelfinavir-11)
nn(concentrations-13, plasma-12)
dobj(decrease-10, concentrations-13)
conj_and(decrease-10, reduce-15)
poss(effect-18, its-16)
amod(effect-18, therapeutic-17)
dobj(reduce-15, effect-18)

Coadministration/NN of/IN VIRACEPT/NNS and/CC drugs/NNS that/WDT inhibit/VBP CYP3A/NN may/MD increase/VB nelfinavir/NN plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NP (NNS VIRACEPT)) (CC and) (NP (NNS drugs))) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (NN CYP3A)))))))) (VP (MD may) (VP (VB increase) (NP (NN nelfinavir) (NN plasma) (NNS concentrations))))) (. .))))

nsubj(increase-10, Coadministration-1)
prep_of(Coadministration-1, VIRACEPT-3)
nsubj(inhibit-7, VIRACEPT-3)
conj_and(VIRACEPT-3, drugs-5)
rcmod(VIRACEPT-3, inhibit-7)
dobj(inhibit-7, CYP3A-8)
aux(increase-10, may-9)
root(ROOT-0, increase-10)
nn(concentrations-13, nelfinavir-11)
nn(concentrations-13, plasma-12)
dobj(increase-10, concentrations-13)

Based/VBN on/IN known/JJ metabolic/JJ profiles/NNS ,/, clinically/RB significant/JJ drug/NN interactions/NNS are/VBP not/RB expected/VBN between/IN VIRACEPT/NN and/CC dapsone/NN ,/, trimethoprim/NN //: sulfamethoxazole/NN ,/, clarithromycin/NN ,/, erythromycin/NN ,/, itraconazole/NN or/CC fluconazole/NN ./.

(ROOT (S1 (S (PP (VBN Based) (PP (IN on) (NP (JJ known) (JJ metabolic) (NNS profiles)))) (, ,) (NP (ADJP (RB clinically) (JJ significant)) (NN drug) (NNS interactions)) (VP (VBP are) (RB not) (VP (VBN expected) (PP (IN between) (NP (NP (NN VIRACEPT)) (CC and) (NP (NN dapsone)) (, ,) (NP (NN trimethoprim)) (: /) (NP (NN sulfamethoxazole)) (, ,) (NP (NN clarithromycin)) (, ,) (NP (NN erythromycin)) (, ,) (NP (NP (NN itraconazole)) (CC or) (NP (NN fluconazole))))))) (. .))))

prepc_based_on(expected-13, on-2)
amod(profiles-5, known-3)
amod(profiles-5, metabolic-4)
pobj(expected-13, profiles-5)
advmod(significant-8, clinically-7)
amod(interactions-10, significant-8)
nn(interactions-10, drug-9)
nsubjpass(expected-13, interactions-10)
auxpass(expected-13, are-11)
neg(expected-13, not-12)
root(ROOT-0, expected-13)
prep_between(expected-13, VIRACEPT-15)
conj_and(VIRACEPT-15, dapsone-17)
conj_and(VIRACEPT-15, trimethoprim-19)
punct(VIRACEPT-15, /-20)
conj_and(VIRACEPT-15, sulfamethoxazole-21)
conj_and(VIRACEPT-15, clarithromycin-23)
conj_and(VIRACEPT-15, erythromycin-25)
conj_and(VIRACEPT-15, itraconazole-27)
conj_or(itraconazole-27, fluconazole-29)

Drugs/NNS That/WDT Should/MD Not/RB Be/VB Coadministered/VBN With/IN VIRACEPT/NN Antiarrhythmics/NNS :/: amiodarone/NN ,/, quinidine/NN Antihistamines/NNS :/: astemizole/NN ,/, terfenadine/NN Antimigraine/NN :/: ergot/NN derivatives/NNS Antimycobacterial/JJ agents/NNS :/: rifampin/NN Benzodiazepines/NN midazolam/NN ,/, triazolam/NN GI/NN motility/NN agents/NNS :/: cisapride/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT That)) (S (VP (MD Should) (RB Not) (VP (VB Be) (VP (VBN Coadministered) (PP (IN With) (NP (NN VIRACEPT) (NNS Antiarrhythmics))))))))) (: :) (NP (NP (NN amiodarone)) (, ,) (NP (NN quinidine) (NNS Antihistamines)) (: :) (NP (NN astemizole)) (, ,) (NP (NN terfenadine) (NN Antimigraine)) (: :) (NP (NP (NN ergot) (NNS derivatives)) (NP (JJ Antimycobacterial) (NNS agents))) (: :) (NP (NP (NN rifampin) (NN Benzodiazepines) (NN midazolam)) (, ,) (NP (NN triazolam) (NN GI) (NN motility) (NNS agents))) (: :) (NP (NN cisapride))) (. .)))))

root(ROOT-0, Drugs-1)
nsubjpass(Coadministered-6, Drugs-1)
aux(Coadministered-6, Should-3)
neg(Coadministered-6, Not-4)
auxpass(Coadministered-6, Be-5)
rcmod(Drugs-1, Coadministered-6)
nn(Antiarrhythmics-9, VIRACEPT-8)
prep_with(Coadministered-6, Antiarrhythmics-9)
dep(Drugs-1, amiodarone-11)
nn(Antihistamines-14, quinidine-13)
appos(amiodarone-11, Antihistamines-14)
dep(amiodarone-11, astemizole-16)
nn(Antimigraine-19, terfenadine-18)
appos(amiodarone-11, Antimigraine-19)
nn(derivatives-22, ergot-21)
dep(amiodarone-11, derivatives-22)
amod(agents-24, Antimycobacterial-23)
dep(derivatives-22, agents-24)
nn(midazolam-28, rifampin-26)
nn(midazolam-28, Benzodiazepines-27)
dep(amiodarone-11, midazolam-28)
nn(agents-33, triazolam-30)
nn(agents-33, GI-31)
nn(agents-33, motility-32)
appos(midazolam-28, agents-33)
dep(amiodarone-11, cisapride-35)

Drugs/NNS Which/WDT Require/VBP a/DT Dose/NN Reduction/NN When/WRB Coadminstered/VBN With/IN VIRACEPT/JJ Antimycobacterial/JJ agents/NNS :/: rifabutin/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT Which)) (S (VP (VBP Require) (NP (NP (DT a) (NN Dose) (NN Reduction)) (SBAR (WHADVP (WRB When)) (S (VP (VBN Coadminstered) (PP (IN With) (NP (JJ VIRACEPT) (JJ Antimycobacterial) (NNS agents))))))))))) (: :) (NP (NN rifabutin))) (. .))))

nsubj(Require-3, Drugs-1)
dep(rifabutin-14, Drugs-1)
rcmod(Drugs-1, Require-3)
det(Reduction-6, a-4)
nn(Reduction-6, Dose-5)
dobj(Require-3, Reduction-6)
advmod(Coadminstered-8, When-7)
dep(Reduction-6, Coadminstered-8)
amod(agents-12, VIRACEPT-10)
amod(agents-12, Antimycobacterial-11)
prep_with(Coadminstered-8, agents-12)
root(ROOT-0, rifabutin-14)

Other/JJ Potentially/RB Clinically/RB Significant/JJ Drug/NN Interactions/NNS With/IN VIRACEPT/NN */NN Anticonvulsants/NNS :/: carbamazepine/NN ,/, phenobarbital/NN ,/, phenytoin/NN May/MD decrease/VB nelfinavir/NN plasma/NN concentrations/NNS */NN */NN Anti-HIV/NN protease/NN inhibitors/NNS :/: indinavir/NN ,/, ritonavir/NN May/MD increase/VB nelfinavir/NN plasma/NN concentrations/NNS Oral/JJ contraceptives/NNS :/: ethinyl/NN estradiol/NN ,/, norethindrone/NN Plasma/NN concentrations/NNS may/MD be/VB decreased/VBN by/IN VIRACEPT/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Other) (ADJP (RB Potentially) (RB Clinically) (JJ Significant)) (NN Drug) (NNS Interactions)) (PP (IN With) (NP (NN VIRACEPT) (NN *) (NNS Anticonvulsants)))) (: :) (NP (NP (NN carbamazepine)) (, ,) (NP (NN phenobarbital)) (, ,) (NP (NN phenytoin)))) (VP (MD May) (VP (VB decrease) (NP (NN nelfinavir) (NN plasma) (NNS concentrations)) (S (NP (NP (NP (NN *) (NN *)) (NN Anti-HIV) (NN protease) (NNS inhibitors)) (: :) (NP (NP (NN indinavir)) (, ,) (NP (NN ritonavir)))) (VP (MD May) (VP (VP (VB increase) (NP (NN nelfinavir) (NN plasma) (NNS concentrations))) (NP (JJ Oral) (NNS contraceptives)))))))) (: :) (S (NP (NP (NP (NN ethinyl) (NN estradiol)) (, ,) (NP (NN norethindrone))) (NN Plasma) (NNS concentrations)) (VP (MD may) (VP (VB be) (VP (VBN decreased) (PP (IN by) (NP (NN VIRACEPT))))))) (. .))))

amod(Interactions-6, Other-1)
advmod(Significant-4, Potentially-2)
advmod(Significant-4, Clinically-3)
amod(Interactions-6, Significant-4)
nn(Interactions-6, Drug-5)
nsubj(decrease-18, Interactions-6)
nn(Anticonvulsants-10, VIRACEPT-8)
nn(Anticonvulsants-10, *-9)
prep_with(Interactions-6, Anticonvulsants-10)
dep(Interactions-6, carbamazepine-12)
appos(carbamazepine-12, phenobarbital-14)
appos(carbamazepine-12, phenytoin-16)
aux(decrease-18, May-17)
root(ROOT-0, decrease-18)
nn(concentrations-21, nelfinavir-19)
nn(concentrations-21, plasma-20)
dobj(decrease-18, concentrations-21)
nn(*-23, *-22)
nn(inhibitors-26, *-23)
nn(inhibitors-26, Anti-HIV-24)
nn(inhibitors-26, protease-25)
nsubj(increase-32, inhibitors-26)
dep(inhibitors-26, indinavir-28)
appos(indinavir-28, ritonavir-30)
aux(increase-32, May-31)
dep(decrease-18, increase-32)
nn(concentrations-35, nelfinavir-33)
nn(concentrations-35, plasma-34)
dobj(increase-32, concentrations-35)
amod(contraceptives-37, Oral-36)
dobj(increase-32, contraceptives-37)
nn(estradiol-40, ethinyl-39)
nn(concentrations-44, estradiol-40)
appos(estradiol-40, norethindrone-42)
nn(concentrations-44, Plasma-43)
nsubjpass(decreased-47, concentrations-44)
aux(decreased-47, may-45)
auxpass(decreased-47, be-46)
parataxis(decrease-18, decreased-47)
agent(decreased-47, VIRACEPT-49)

*/NNS :/: This/DT table/NN is/VBZ not/RB all/DT inclusive/JJ */NN */NN VIRACEPT/NN may/MD not/RB be/VB effective/JJ due/JJ to/TO decreased/VBN nelfinavir/NN plasma/NN concentrations/NNS in/IN patients/NNS taking/VBG these/DT agents/NNS concomitantly/RB ./.

(ROOT (S1 (S (NP (NP (NNS *)) (: :) (S (NP (DT This) (NN table)) (VP (VBZ is) (RB not) (NP (NP (DT all) (JJ inclusive) (NN *) (NN *) (NN VIRACEPT)) (VP (MD may) (RB not) (VP (VB be) (ADJP (JJ effective) (PP (JJ due) (TO to) (NP (NP (VBN decreased) (NN nelfinavir) (NN plasma) (NNS concentrations)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (DT these) (NNS agents))))))))))) (ADVP (RB concomitantly)))) (. .)))))

root(ROOT-0, *-1)
det(table-4, This-3)
nsubj(VIRACEPT-11, table-4)
cop(VIRACEPT-11, is-5)
neg(VIRACEPT-11, not-6)
det(VIRACEPT-11, all-7)
amod(VIRACEPT-11, inclusive-8)
nn(VIRACEPT-11, *-9)
nn(VIRACEPT-11, *-10)
dep(*-1, VIRACEPT-11)
aux(effective-15, may-12)
neg(effective-15, not-13)
cop(effective-15, be-14)
dep(VIRACEPT-11, effective-15)
amod(concentrations-21, decreased-18)
nn(concentrations-21, nelfinavir-19)
nn(concentrations-21, plasma-20)
prep_due_to(effective-15, concentrations-21)
prep_in(concentrations-21, patients-23)
partmod(patients-23, taking-24)
det(agents-26, these-25)
dobj(taking-24, agents-26)
advmod(VIRACEPT-11, concomitantly-27)

Antihistamines/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Antihistamines)) (. .)))))

root(ROOT-0, Antihistamines-1)

Terfenadine/NN :/: Administration/NN of/IN terfenadine/NN with/IN VIRACEPT/NN resulted/VBD in/IN the/DT appearance/NN of/IN unchanged/JJ terfenadine/NN in/IN plasma/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN Terfenadine)) (: :) (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN terfenadine))) (PP (IN with) (NP (NN VIRACEPT)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN appearance)) (PP (IN of) (NP (JJ unchanged) (NN terfenadine))) (PP (IN in) (NP (NN plasma)))))) (: ;)) (. .)))))

root(ROOT-0, Terfenadine-1)
nsubj(resulted-8, Administration-3)
prep_of(Administration-3, terfenadine-5)
prep_with(Administration-3, VIRACEPT-7)
dep(Terfenadine-1, resulted-8)
det(appearance-11, the-10)
prep_in(resulted-8, appearance-11)
amod(terfenadine-14, unchanged-13)
prep_of(appearance-11, terfenadine-14)
prep_in(appearance-11, plasma-16)

therefore/RB ,/, VIRACEPT/NN should/MD not/RB be/VB administered/VBN concurrently/RB with/IN terfenadine/NN because/IN of/IN the/DT potential/NN for/IN serious/JJ and/or/CC life-threatening/JJ cardiac/JJ arrhythmias/NNS ./.

(ROOT (S1 (S (S (ADVP (RB therefore)) (, ,) (NP (NN VIRACEPT)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (ADVP (RB concurrently)) (PP (IN with) (NP (NN terfenadine))) (PP (IN because) (IN of) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (ADJP (ADJP (JJ serious)) (CC and/or) (ADJP (JJ life-threatening))) (JJ cardiac) (NNS arrhythmias))))))))) (. .))))

advmod(administered-7, therefore-1)
nsubjpass(administered-7, VIRACEPT-3)
aux(administered-7, should-4)
neg(administered-7, not-5)
auxpass(administered-7, be-6)
root(ROOT-0, administered-7)
advmod(administered-7, concurrently-8)
prep_with(administered-7, terfenadine-10)
det(potential-14, the-13)
prep_because_of(administered-7, potential-14)
amod(arrhythmias-20, serious-16)
conj_and/or(serious-16, life-threatening-18)
amod(arrhythmias-20, cardiac-19)
prep_for(potential-14, arrhythmias-20)

Because/IN a/DT similar/JJ interaction/NN is/VBZ likely/JJ ,/, VIRACEPT/NN should/MD also/RB not/RB be/VB administered/VBN concurrently/RB with/IN astemizole/NN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (DT a) (JJ similar) (NN interaction)) (VP (VBZ is) (ADJP (JJ likely))))) (, ,) (NP (NN VIRACEPT)) (VP (MD should) (ADVP (RB also)) (RB not) (VP (VB be) (VP (VBN administered) (ADVP (RB concurrently)) (PP (IN with) (NP (NN astemizole))))))) (. .))))

mark(likely-6, Because-1)
det(interaction-4, a-2)
amod(interaction-4, similar-3)
nsubj(likely-6, interaction-4)
cop(likely-6, is-5)
advcl(administered-13, likely-6)
nsubjpass(administered-13, VIRACEPT-8)
aux(administered-13, should-9)
advmod(administered-13, also-10)
neg(administered-13, not-11)
auxpass(administered-13, be-12)
root(ROOT-0, administered-13)
advmod(administered-13, concurrently-14)
prep_with(administered-13, astemizole-16)

Anti-HIV/NN Protease/NN Inhibitors/NNS ./.

(ROOT (S1 (S (NP (NP (NN Anti-HIV) (NN Protease) (NNS Inhibitors)) (. .)))))

nn(Inhibitors-3, Anti-HIV-1)
nn(Inhibitors-3, Protease-2)
root(ROOT-0, Inhibitors-3)

Indinavir/NN :/: Coadministration/NN of/IN indinavir/NN with/IN VIRACEPT/NN resulted/VBD in/IN an/DT 83/CD %/NN increase/NN in/IN nelfinavir/NN plasma/NN AUC/NN and/CC a/DT 51/CD %/NN increase/NN in/IN indinavir/JJ plasma/NN A.C./NN ./.

(ROOT (S1 (S (NP (NP (NN Indinavir)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN indinavir))) (PP (IN with) (NP (NN VIRACEPT)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT an) (ADJP (CD 83) (NN %)) (NN increase)) (PP (IN in) (NP (NN nelfinavir) (NN plasma) (NN AUC)))) (CC and) (NP (NP (DT a) (ADJP (CD 51) (NN %)) (NN increase)) (PP (IN in) (NP (JJ indinavir) (NN plasma) (NN A.C.)))))))) (. .)))))

root(ROOT-0, Indinavir-1)
nsubj(resulted-8, Coadministration-3)
prep_of(Coadministration-3, indinavir-5)
prep_with(Coadministration-3, VIRACEPT-7)
dep(Indinavir-1, resulted-8)
det(increase-13, an-10)
number(%-12, 83-11)
amod(increase-13, %-12)
prep_in(resulted-8, increase-13)
nn(AUC-17, nelfinavir-15)
nn(AUC-17, plasma-16)
prep_in(increase-13, AUC-17)
det(increase-22, a-19)
number(%-21, 51-20)
amod(increase-22, %-21)
conj_and(increase-13, increase-22)
amod(A.C.-26, indinavir-24)
nn(A.C.-26, plasma-25)
prep_in(increase-22, A.C.-26)

Ritonavir/NN :/: Coadministration/NN of/IN ritonavir/NN with/IN VIRACEPT/NN resulted/VBD in/IN a/DT 152/CD %/NN increase/NN in/IN nelfinavir/NN plasma/NN AUC/NN and/CC very/RB little/JJ change/NN in/IN ritonavir/NN plasma/NN A.C./NN ./.

(ROOT (S1 (S (NP (NP (NN Ritonavir)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN ritonavir))) (PP (IN with) (NP (NN VIRACEPT)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (ADJP (CD 152) (NN %)) (NN increase)) (PP (IN in) (NP (NN nelfinavir) (NN plasma) (NN AUC)))) (CC and) (NP (NP (ADJP (RB very) (JJ little)) (NN change)) (PP (IN in) (NP (NN ritonavir) (NN plasma) (NN A.C.)))))))) (. .)))))

root(ROOT-0, Ritonavir-1)
nsubj(resulted-8, Coadministration-3)
prep_of(Coadministration-3, ritonavir-5)
prep_with(Coadministration-3, VIRACEPT-7)
dep(Ritonavir-1, resulted-8)
det(increase-13, a-10)
number(%-12, 152-11)
amod(increase-13, %-12)
prep_in(resulted-8, increase-13)
nn(AUC-17, nelfinavir-15)
nn(AUC-17, plasma-16)
prep_in(increase-13, AUC-17)
advmod(little-20, very-19)
amod(change-21, little-20)
conj_and(increase-13, change-21)
nn(A.C.-25, ritonavir-23)
nn(A.C.-25, plasma-24)
prep_in(change-21, A.C.-25)

Saquinavir/NN :/: Coadministration/NN of/IN saquinavir/NN (/-LRB- using/VBG an/DT experimental/JJ soft-/JJ gelatin/NN capsule/NN formulation/NN of/IN saquinavir/JJ 1200mg/NN )/-RRB- with/IN VIRACEPT/NN resulted/VBD in/IN an/DT 18/CD %/NN increase/NN in/IN nelfinavir/NN plasma/NN AUC/NN and/CC a/DT 4-fold/JJ increase/NN in/IN saquinavir/JJ plasma/NN A.C./NN ./.

(ROOT (S1 (S (NP (NP (NN Saquinavir)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN saquinavir))) (-LRB- -LRB-) (VP (VBG using) (NP (NP (DT an) (JJ experimental) (JJ soft-) (NN gelatin) (NN capsule) (NN formulation)) (PP (IN of) (NP (JJ saquinavir) (NN 1200mg))))) (-RRB- -RRB-) (PP (IN with) (NP (NN VIRACEPT)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT an) (ADJP (CD 18) (NN %)) (NN increase)) (PP (IN in) (NP (NN nelfinavir) (NN plasma) (NN AUC)))) (CC and) (NP (NP (DT a) (JJ 4-fold) (NN increase)) (PP (IN in) (NP (JJ saquinavir) (NN plasma) (NN A.C.)))))))) (. .)))))

root(ROOT-0, Saquinavir-1)
nsubj(resulted-20, Coadministration-3)
prep_of(Coadministration-3, saquinavir-5)
partmod(Coadministration-3, using-7)
det(formulation-13, an-8)
amod(formulation-13, experimental-9)
amod(formulation-13, soft--10)
nn(formulation-13, gelatin-11)
nn(formulation-13, capsule-12)
dobj(using-7, formulation-13)
amod(1200mg-16, saquinavir-15)
prep_of(formulation-13, 1200mg-16)
prep_with(Coadministration-3, VIRACEPT-19)
dep(Saquinavir-1, resulted-20)
det(increase-25, an-22)
number(%-24, 18-23)
amod(increase-25, %-24)
prep_in(resulted-20, increase-25)
nn(AUC-29, nelfinavir-27)
nn(AUC-29, plasma-28)
prep_in(increase-25, AUC-29)
det(increase-33, a-31)
amod(increase-33, 4-fold-32)
conj_and(increase-25, increase-33)
amod(A.C.-37, saquinavir-35)
nn(A.C.-37, plasma-36)
prep_in(increase-33, A.C.-37)

If/IN used/VBN in/IN combination/NN with/IN saquinavir/JJ hard/JJ gelatin/NN capsules/NNS at/IN the/DT recommended/VBN dose/NN of/IN 600/CD mg/NN tid/NN ,/, no/DT dose/NN adjustments/NNS are/VBP needed/VBN ./.

(ROOT (S1 (S (S (SBAR (IN If) (S (VP (VBN used) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NP (JJ saquinavir) (JJ hard) (NN gelatin) (NNS capsules)) (PP (IN at) (NP (NP (DT the) (VBN recommended) (NN dose)) (PP (IN of) (NP (ADJP (CD 600) (NN mg)) (NN tid)))))))))))) (, ,) (NP (DT no) (NN dose) (NNS adjustments)) (VP (VBP are) (VP (VBN needed)))) (. .))))

mark(used-2, If-1)
advcl(needed-23, used-2)
prep_in(used-2, combination-4)
amod(capsules-9, saquinavir-6)
amod(capsules-9, hard-7)
nn(capsules-9, gelatin-8)
prep_with(combination-4, capsules-9)
det(dose-13, the-11)
amod(dose-13, recommended-12)
prep_at(capsules-9, dose-13)
number(mg-16, 600-15)
amod(tid-17, mg-16)
prep_of(dose-13, tid-17)
det(adjustments-21, no-19)
nn(adjustments-21, dose-20)
nsubjpass(needed-23, adjustments-21)
auxpass(needed-23, are-22)
root(ROOT-0, needed-23)

Antifungal/JJ Agents/NNS ./.

(ROOT (S1 (S (S (NP (JJ Antifungal) (NNS Agents))) (. .))))

amod(Agents-2, Antifungal-1)
root(ROOT-0, Agents-2)

Ketoconazole/NN :/: Coadministration/NN of/IN ketoconazole/NN with/IN VIRACEPT/NN resulted/VBD in/IN a/DT 35/CD %/NN increase/NN in/IN nelfinavir/NN plasma/NN A.C./NN ./.

(ROOT (S1 (S (NP (NP (NN Ketoconazole)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN ketoconazole))) (PP (IN with) (NP (NN VIRACEPT)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (ADJP (CD 35) (NN %)) (NN increase)) (PP (IN in) (NP (NN nelfinavir) (NN plasma) (NN A.C.))))))) (. .)))))

root(ROOT-0, Ketoconazole-1)
nsubj(resulted-8, Coadministration-3)
prep_of(Coadministration-3, ketoconazole-5)
prep_with(Coadministration-3, VIRACEPT-7)
dep(Ketoconazole-1, resulted-8)
det(increase-13, a-10)
number(%-12, 35-11)
amod(increase-13, %-12)
prep_in(resulted-8, increase-13)
nn(A.C.-17, nelfinavir-15)
nn(A.C.-17, plasma-16)
prep_in(increase-13, A.C.-17)

This/DT change/NN was/VBD not/RB considered/VBN clinically/RB significant/JJ and/CC no/DT dose/NN adjustment/NN is/VBZ needed/VBN when/WRB ketoconazole/NN and/CC VIRACEPT/NN are/VBP coadministered/VBN ./.

(ROOT (S1 (S (S (S (NP (DT This) (NN change)) (VP (VBD was) (RB not) (VP (VBN considered) (ADJP (RB clinically) (JJ significant))))) (CC and) (S (NP (DT no) (NN dose) (NN adjustment)) (VP (VBZ is) (VP (VBN needed) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN ketoconazole)) (CC and) (NP (NN VIRACEPT))) (VP (VBP are) (VP (VBN coadministered))))))))) (. .))))

det(change-2, This-1)
nsubjpass(considered-5, change-2)
auxpass(considered-5, was-3)
neg(considered-5, not-4)
root(ROOT-0, considered-5)
advmod(significant-7, clinically-6)
acomp(considered-5, significant-7)
det(adjustment-11, no-9)
nn(adjustment-11, dose-10)
nsubjpass(needed-13, adjustment-11)
auxpass(needed-13, is-12)
conj_and(considered-5, needed-13)
advmod(coadministered-19, when-14)
nsubjpass(coadministered-19, ketoconazole-15)
conj_and(ketoconazole-15, VIRACEPT-17)
auxpass(coadministered-19, are-18)
advcl(needed-13, coadministered-19)

Anti-HIV/NN Reverse/NN Transcriptase/NN Inhibitors/NNS ./.

(ROOT (S1 (S (NP (NP (NN Anti-HIV) (NN Reverse) (NN Transcriptase) (NNS Inhibitors)) (. .)))))

nn(Inhibitors-4, Anti-HIV-1)
nn(Inhibitors-4, Reverse-2)
nn(Inhibitors-4, Transcriptase-3)
root(ROOT-0, Inhibitors-4)

Didanosine/NN :/: It/PRP is/VBZ recommended/VBN that/IN didanosine/NN be/VB administered/VBN on/IN an/DT empty/JJ stomach/NN ;/: ./.

(ROOT (S1 (S (NP (NP (NN Didanosine)) (: :) (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NN didanosine)) (VP (VB be) (VP (VBN administered) (PP (IN on) (NP (DT an) (JJ empty) (NN stomach))))))))) (: ;)) (. .)))))

root(ROOT-0, Didanosine-1)
nsubjpass(recommended-5, It-3)
auxpass(recommended-5, is-4)
dep(Didanosine-1, recommended-5)
complm(administered-9, that-6)
nsubjpass(administered-9, didanosine-7)
auxpass(administered-9, be-8)
ccomp(recommended-5, administered-9)
det(stomach-13, an-11)
amod(stomach-13, empty-12)
prep_on(administered-9, stomach-13)

therefore/RB ,/, nelfinavir/NN should/MD be/VB administered/VBN (/-LRB- with/IN food/NN )/-RRB- one/CD hour/NN after/IN or/CC more/JJR than/IN two/CD hours/NNS before/IN didanosine/NN ./.

(ROOT (S1 (S (S (ADVP (RB therefore)) (, ,) (NP (NN nelfinavir)) (VP (MD should) (VP (VB be) (VP (VBN administered) (PRN (-LRB- -LRB-) (PP (IN with) (NP (NN food))) (-RRB- -RRB-)) (PP (NP (CD one) (NN hour)) (IN after) (NP (NP (QP (CC or) (JJR more) (IN than) (CD two)) (NNS hours)) (PP (IN before) (NP (NN didanosine))))))))) (. .))))

advmod(administered-6, therefore-1)
nsubjpass(administered-6, nelfinavir-3)
aux(administered-6, should-4)
auxpass(administered-6, be-5)
root(ROOT-0, administered-6)
dep(administered-6, with-8)
pobj(with-8, food-9)
num(hour-12, one-11)
npadvmod(administered-6, hour-12)
cc(two-17, or-14)
quantmod(two-17, more-15)
quantmod(two-17, than-16)
num(hours-18, two-17)
prep_after(administered-6, hours-18)
prep_before(hours-18, didanosine-20)

Zidovudine/NN :/: Coadministration/NN of/IN zidovudine/NN and/CC lamivudine/NN with/IN VIRACEPT/NN resulted/VBD in/IN a/DT 35/CD %/NN decrease/NN in/IN zidovudine/JJ plasma/NN A.C./NN ./.

(ROOT (S1 (S (NP (NP (NN Zidovudine)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NN zidovudine)) (CC and) (NP (NN lamivudine)))) (PP (IN with) (NP (NN VIRACEPT)))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (ADJP (CD 35) (NN %)) (NN decrease)) (PP (IN in) (NP (JJ zidovudine) (NN plasma) (NN A.C.))))))) (. .)))))

root(ROOT-0, Zidovudine-1)
nsubj(resulted-10, Coadministration-3)
prep_of(Coadministration-3, zidovudine-5)
conj_and(zidovudine-5, lamivudine-7)
prep_with(Coadministration-3, VIRACEPT-9)
dep(Zidovudine-1, resulted-10)
det(decrease-15, a-12)
number(%-14, 35-13)
amod(decrease-15, %-14)
prep_in(resulted-10, decrease-15)
amod(A.C.-19, zidovudine-17)
nn(A.C.-19, plasma-18)
prep_in(decrease-15, A.C.-19)

A/DT dose/NN adjustment/NN is/VBZ not/RB needed/VBN when/WRB zidovudine/NN is/VBZ administered/VBN with/IN VIRACEPT/NN ./.

(ROOT (S1 (S (S (NP (DT A) (NN dose) (NN adjustment)) (VP (VBZ is) (RB not) (VP (VBN needed) (SBAR (WHADVP (WRB when)) (S (NP (NN zidovudine)) (VP (VBZ is) (VP (VBN administered) (PP (IN with) (NP (NN VIRACEPT)))))))))) (. .))))

det(adjustment-3, A-1)
nn(adjustment-3, dose-2)
nsubjpass(needed-6, adjustment-3)
auxpass(needed-6, is-4)
neg(needed-6, not-5)
root(ROOT-0, needed-6)
advmod(administered-10, when-7)
nsubjpass(administered-10, zidovudine-8)
auxpass(administered-10, is-9)
advcl(needed-6, administered-10)
prep_with(administered-10, VIRACEPT-12)

Little/JJ or/CC no/DT change/NN in/IN the/DT pharmacokinetics/NNS of/IN either/DT drug/NN was/VBD observed/VBN when/WRB VIRACEPT/NN was/VBD coadministered/VBN with/IN lamivudine/NN or/CC stavudine/NN ./.

(ROOT (S1 (S (S (NP (NP (ADJP (JJ Little))) (CC or) (NP (NP (DT no) (NN change)) (PP (IN in) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (DT either) (NN drug))))))) (VP (VBD was) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (NN VIRACEPT)) (VP (VBD was) (VP (VBN coadministered) (PP (IN with) (NP (NP (NN lamivudine)) (CC or) (NP (NN stavudine))))))))))) (. .))))

nsubjpass(observed-12, Little-1)
det(change-4, no-3)
conj_or(Little-1, change-4)
det(pharmacokinetics-7, the-6)
prep_in(change-4, pharmacokinetics-7)
det(drug-10, either-9)
prep_of(pharmacokinetics-7, drug-10)
auxpass(observed-12, was-11)
root(ROOT-0, observed-12)
advmod(coadministered-16, when-13)
nsubjpass(coadministered-16, VIRACEPT-14)
auxpass(coadministered-16, was-15)
advcl(observed-12, coadministered-16)
prep_with(coadministered-16, lamivudine-18)
conj_or(lamivudine-18, stavudine-20)

Antimycobacterial/JJ Agents/NNS ./.

(ROOT (S1 (S (S (NP (JJ Antimycobacterial) (NNS Agents))) (. .))))

amod(Agents-2, Antimycobacterial-1)
root(ROOT-0, Agents-2)

Rifabutin/NN :/: Coadministration/NN of/IN rifabutin/NN and/CC VIRACEPT/NN resulted/VBD in/IN a/DT 32/CD %/NN decrease/NN in/IN nelfinavir/NN plasma/NN AUC/NN and/CC a/DT 207/CD %/NN increase/NN in/IN rifabutin/NN plasma/NN A.C./NN ./.

(ROOT (S1 (S (NP (NP (NN Rifabutin)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NN rifabutin)) (CC and) (NP (NN VIRACEPT))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (ADJP (CD 32) (NN %)) (NN decrease)) (PP (IN in) (NP (NN nelfinavir) (NN plasma) (NN AUC)))) (CC and) (NP (NP (DT a) (ADJP (CD 207) (NN %)) (NN increase)) (PP (IN in) (NP (NN rifabutin) (NN plasma) (NN A.C.)))))))) (. .)))))

root(ROOT-0, Rifabutin-1)
nsubj(resulted-8, Coadministration-3)
prep_of(Coadministration-3, rifabutin-5)
conj_and(rifabutin-5, VIRACEPT-7)
dep(Rifabutin-1, resulted-8)
det(decrease-13, a-10)
number(%-12, 32-11)
amod(decrease-13, %-12)
prep_in(resulted-8, decrease-13)
nn(AUC-17, nelfinavir-15)
nn(AUC-17, plasma-16)
prep_in(decrease-13, AUC-17)
det(increase-22, a-19)
number(%-21, 207-20)
amod(increase-22, %-21)
conj_and(decrease-13, increase-22)
nn(A.C.-26, rifabutin-24)
nn(A.C.-26, plasma-25)
prep_in(increase-22, A.C.-26)

It/PRP is/VBZ recommended/VBN that/IN the/DT dose/NN of/IN rifabutin/NN be/VB reduced/VBN to/TO one-half/NN the/DT usual/JJ dose/NN when/WRB administered/VBN with/IN VIRACEPT/NN ./.

(ROOT (S1 (S (S (NP (PRP It)) (VP (VBZ is) (VP (VBN recommended) (SBAR (IN that) (S (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN rifabutin)))) (VP (VB be) (VP (VBN reduced) (PP (TO to) (NP (NN one-half) (NP (DT the) (JJ usual) (NN dose)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (IN with) (NP (NN VIRACEPT))))))))))))) (. .))))

nsubjpass(recommended-3, It-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
complm(reduced-10, that-4)
det(dose-6, the-5)
nsubjpass(reduced-10, dose-6)
prep_of(dose-6, rifabutin-8)
auxpass(reduced-10, be-9)
ccomp(recommended-3, reduced-10)
prep_to(reduced-10, one-half-12)
det(dose-15, the-13)
amod(dose-15, usual-14)
dep(one-half-12, dose-15)
advmod(administered-17, when-16)
advcl(reduced-10, administered-17)
prep_with(administered-17, VIRACEPT-19)

Rifampin/NN :/: Coadministration/NN of/IN rifampin/NN and/CC VIRACEPT/NN resulted/VBD in/IN an/DT 82/CD %/NN decrease/NN in/IN nelfinavir/NN plasma/NN A.C./NN ./.

(ROOT (S1 (S (NP (NP (NN Rifampin)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NN rifampin)) (CC and) (NP (NN VIRACEPT))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT an) (ADJP (CD 82) (NN %)) (NN decrease)) (PP (IN in) (NP (NN nelfinavir) (NN plasma) (NN A.C.))))))) (. .)))))

root(ROOT-0, Rifampin-1)
nsubj(resulted-8, Coadministration-3)
prep_of(Coadministration-3, rifampin-5)
conj_and(rifampin-5, VIRACEPT-7)
dep(Rifampin-1, resulted-8)
det(decrease-13, an-10)
number(%-12, 82-11)
amod(decrease-13, %-12)
prep_in(resulted-8, decrease-13)
nn(A.C.-17, nelfinavir-15)
nn(A.C.-17, plasma-16)
prep_in(decrease-13, A.C.-17)

VIRACEPT/NN and/CC rifampin/NN should/MD not/RB be/VB coadministered/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN VIRACEPT)) (CC and) (NP (NN rifampin))) (VP (MD should) (RB not) (VP (VB be) (VP (VBN coadministered))))) (. .))))

nsubjpass(coadministered-7, VIRACEPT-1)
conj_and(VIRACEPT-1, rifampin-3)
aux(coadministered-7, should-4)
neg(coadministered-7, not-5)
auxpass(coadministered-7, be-6)
root(ROOT-0, coadministered-7)

Oral/JJ Contraceptives/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Oral) (NNS Contraceptives)) (. .)))))

amod(Contraceptives-2, Oral-1)
root(ROOT-0, Contraceptives-2)

Ethinyl/NN Estradiol/NN and/CC Norethindrone/NN :/: Coadministration/NN of/IN VIRACEPT/NN with/IN OVCON-35/NN resulted/VBD in/IN a/DT 47/CD %/NN decrease/NN in/IN ethinyl/NN estradiol/NN and/CC an/DT 18/CD %/NN decrease/NN in/IN norethindrone/NN plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NN Ethinyl) (NN Estradiol)) (CC and) (NP (NN Norethindrone))) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN VIRACEPT))) (PP (IN with) (NP (NN OVCON-35)))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (ADJP (CD 47) (NN %)) (NN decrease)) (PP (IN in) (NP (NN ethinyl) (NN estradiol)))) (CC and) (NP (NP (DT an) (ADJP (CD 18) (NN %)) (NN decrease)) (PP (IN in) (NP (NN norethindrone) (NN plasma) (NNS concentrations)))))))) (. .)))))

nn(Estradiol-2, Ethinyl-1)
root(ROOT-0, Estradiol-2)
conj_and(Estradiol-2, Norethindrone-4)
nsubj(resulted-11, Coadministration-6)
prep_of(Coadministration-6, VIRACEPT-8)
prep_with(Coadministration-6, OVCON-35-10)
dep(Estradiol-2, resulted-11)
det(decrease-16, a-13)
number(%-15, 47-14)
amod(decrease-16, %-15)
prep_in(resulted-11, decrease-16)
nn(estradiol-19, ethinyl-18)
prep_in(decrease-16, estradiol-19)
det(decrease-24, an-21)
number(%-23, 18-22)
amod(decrease-24, %-23)
conj_and(decrease-16, decrease-24)
nn(concentrations-28, norethindrone-26)
nn(concentrations-28, plasma-27)
prep_in(decrease-24, concentrations-28)

Alternate/JJ or/CC additional/JJ contraceptive/NN measures/NNS should/MD be/VB used/VBN during/IN therapy/NN with/IN VIRACEPT/NN ./.

(ROOT (S1 (S (S (NP (JJ Alternate) (CC or) (JJ additional) (NN contraceptive) (NNS measures)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN during) (NP (NP (NN therapy)) (PP (IN with) (NP (NN VIRACEPT))))))))) (. .))))

amod(measures-5, Alternate-1)
conj_or(Alternate-1, additional-3)
nn(measures-5, contraceptive-4)
nsubjpass(used-8, measures-5)
aux(used-8, should-6)
auxpass(used-8, be-7)
root(ROOT-0, used-8)
prep_during(used-8, therapy-10)
prep_with(therapy-10, VIRACEPT-12)

Certain/JJ antibiotics/NNS ,/, especially/RB neomycin/NN ,/, streptomycin/NN and/CC kanamycin/NN ,/, have/VBP a/DT mild/JJ but/CC definite/JJ nondepolarizing/NN blocking/NN action/NN which/WDT may/MD accentuate/VB neuromuscular/JJ block/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Certain) (NNS antibiotics)) (, ,) (ADVP (RB especially)) (NP (NP (NN neomycin)) (, ,) (NP (NN streptomycin)) (CC and) (NP (NN kanamycin))) (, ,)) (VP (VBP have) (NP (NP (DT a) (ADJP (ADJP (JJ mild)) (CC but) (ADJP (JJ definite))) (NN nondepolarizing) (NN blocking) (NN action)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (VP (VB accentuate) (NP (JJ neuromuscular) (NN block))))))))) (. .))))

amod(antibiotics-2, Certain-1)
nsubj(have-11, antibiotics-2)
advmod(antibiotics-2, especially-4)
dep(antibiotics-2, neomycin-5)
conj_and(neomycin-5, streptomycin-7)
conj_and(neomycin-5, kanamycin-9)
root(ROOT-0, have-11)
det(action-18, a-12)
amod(action-18, mild-13)
conj_but(mild-13, definite-15)
nn(action-18, nondepolarizing-16)
nn(action-18, blocking-17)
dobj(have-11, action-18)
nsubj(accentuate-21, action-18)
aux(accentuate-21, may-20)
rcmod(action-18, accentuate-21)
amod(block-23, neuromuscular-22)
dobj(accentuate-21, block-23)

These/DT antibiotics/NNS should/MD be/VB used/VBN in/IN the/DT myasthenic/JJ patient/NN only/RB where/WRB definitely/RB indicated/VBN ,/, and/CC then/RB careful/JJ adjustment/NN should/MD be/VB made/VBN of/IN adjunctive/JJ anticholinesterase/NN dosage/NN ./.

(ROOT (S1 (S (S (S (NP (DT These) (NNS antibiotics)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (NP (DT the) (JJ myasthenic) (NN patient)) (SBAR (WHADVP (RB only) (WRB where)) (S (VP (ADVP (RB definitely)) (VBN indicated)))))))))) (, ,) (CC and) (S (NP (RB then) (JJ careful) (NN adjustment)) (VP (MD should) (VP (VB be) (VP (VBN made) (PP (IN of) (NP (JJ adjunctive) (NN anticholinesterase) (NN dosage)))))))) (. .))))

det(antibiotics-2, These-1)
nsubjpass(used-5, antibiotics-2)
aux(used-5, should-3)
auxpass(used-5, be-4)
root(ROOT-0, used-5)
det(patient-9, the-7)
amod(patient-9, myasthenic-8)
prep_in(used-5, patient-9)
advmod(where-11, only-10)
advmod(indicated-13, where-11)
advmod(indicated-13, definitely-12)
rcmod(patient-9, indicated-13)
advmod(adjustment-18, then-16)
amod(adjustment-18, careful-17)
nsubjpass(made-21, adjustment-18)
aux(made-21, should-19)
auxpass(made-21, be-20)
conj_and(used-5, made-21)
amod(dosage-25, adjunctive-23)
nn(dosage-25, anticholinesterase-24)
prep_of(made-21, dosage-25)

Local/JJ and/CC some/DT general/JJ anesthetics/NNS ,/, antiarrhythmic/JJ agent/NN s/NNS and/CC other/JJ drugs/NNS that/WDT interfere/VBP with/IN neuromuscular/JJ transmission/NN should/MD be/VB used/VBN cautiously/RB ,/, if/IN at/IN all/DT ,/, in/IN patients/NNS with/IN myasthenia/JJ gravis/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NP (NP (QP (JJ Local) (CC and) (DT some)) (JJ general) (NNS anesthetics)) (, ,) (NP (JJ antiarrhythmic) (NN agent) (NNS s)) (CC and) (NP (JJ other) (NNS drugs))) (SBAR (WHNP (WDT that)) (S (VP (VBP interfere) (PP (IN with) (NP (JJ neuromuscular) (NN transmission))))))) (VP (MD should) (VP (VB be) (VP (VBN used) (ADVP (RB cautiously)) (, ,) (ADVP (IN if) (IN at) (DT all)) (, ,) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ myasthenia) (NNS gravis)))))))) (: ;)) (. .))))

num(anesthetics-5, Local-1)
conj_and(Local-1, some-3)
quantmod(Local-1, some-3)
amod(anesthetics-5, general-4)
nsubj(interfere-14, anesthetics-5)
nsubjpass(used-20, anesthetics-5)
amod(s-9, antiarrhythmic-7)
nn(s-9, agent-8)
conj_and(anesthetics-5, s-9)
amod(drugs-12, other-11)
conj_and(anesthetics-5, drugs-12)
rcmod(anesthetics-5, interfere-14)
amod(transmission-17, neuromuscular-16)
prep_with(interfere-14, transmission-17)
aux(used-20, should-18)
auxpass(used-20, be-19)
root(ROOT-0, used-20)
advmod(used-20, cautiously-21)
advmod(used-20, if-23)
dep(if-23, at-24)
pobj(if-23, all-25)
prep_in(used-20, patients-28)
amod(gravis-31, myasthenia-30)
prep_with(patients-28, gravis-31)

the/DT dose/NN of/IN Prostigmin/NN may/MD have/VB to/TO be/VB increased/VBN accordingly/RB ./.

(ROOT (S1 (S (S (NP (NP (DT the) (NN dose)) (PP (IN of) (NP (NN Prostigmin)))) (VP (MD may) (VP (VB have) (S (VP (TO to) (VP (VB be) (VP (VBN increased) (ADVP (RB accordingly))))))))) (. .))))

det(dose-2, the-1)
nsubj(have-6, dose-2)
xsubj(increased-9, dose-2)
prep_of(dose-2, Prostigmin-4)
aux(have-6, may-5)
root(ROOT-0, have-6)
aux(increased-9, to-7)
auxpass(increased-9, be-8)
xcomp(have-6, increased-9)
advmod(increased-9, accordingly-10)

No/DT trials/NNS specifically/RB examining/VBG potential/JJ drug/NN interactions/NNS with/IN Natrecor/NN were/VBD conducted/VBN ,/, although/IN many/JJ concomitant/JJ drugs/NNS were/VBD used/VBN in/IN clinical/JJ trials/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT No) (NNS trials)) (VP (ADVP (RB specifically)) (VBG examining) (NP (NP (JJ potential) (NN drug) (NNS interactions)) (PP (IN with) (NP (NN Natrecor)))))) (VP (VBD were) (VP (VBN conducted)) (, ,) (SBAR (IN although) (S (NP (JJ many) (JJ concomitant) (NNS drugs)) (VP (VBD were) (VP (VBN used) (PP (IN in) (NP (JJ clinical) (NNS trials))))))))) (. .))))

det(trials-2, No-1)
nsubjpass(conducted-11, trials-2)
advmod(examining-4, specifically-3)
partmod(trials-2, examining-4)
amod(interactions-7, potential-5)
nn(interactions-7, drug-6)
dobj(examining-4, interactions-7)
prep_with(interactions-7, Natrecor-9)
auxpass(conducted-11, were-10)
root(ROOT-0, conducted-11)
mark(used-18, although-13)
amod(drugs-16, many-14)
amod(drugs-16, concomitant-15)
nsubjpass(used-18, drugs-16)
auxpass(used-18, were-17)
advcl(conducted-11, used-18)
amod(trials-21, clinical-20)
prep_in(used-18, trials-21)

No/DT drug/NN interactions/NNS were/VBD detected/VBN except/IN for/IN an/DT increase/NN in/IN symptomatic/JJ hypotension/NN in/IN patients/NNS receiving/VBG oral/JJ ACE/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (DT No) (NN drug) (NNS interactions)) (VP (VBD were) (VP (VBN detected) (PP (IN except) (PP (IN for) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (JJ symptomatic) (NN hypotension)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (JJ oral) (NN ACE) (NNS inhibitors))))))))))))) (. .))))

det(interactions-3, No-1)
nn(interactions-3, drug-2)
nsubjpass(detected-5, interactions-3)
auxpass(detected-5, were-4)
root(ROOT-0, detected-5)
prepc_except_for(detected-5, for-7)
det(increase-9, an-8)
pobj(detected-5, increase-9)
amod(hypotension-12, symptomatic-11)
prep_in(increase-9, hypotension-12)
prep_in(hypotension-12, patients-14)
partmod(patients-14, receiving-15)
amod(inhibitors-18, oral-16)
nn(inhibitors-18, ACE-17)
dobj(receiving-15, inhibitors-18)

The/DT co-administration/NN of/IN Natrecor/NN with/IN IV/NN vasodilators/NNS such/JJ as/IN nitroglycerin/NN ,/, nitroprusside/NN ,/, milrinone/NN ,/, or/CC IV/NN ACE/NN inhibitors/NNS has/VBZ not/RB been/VBN evaluated/VBN (/-LRB- these/DT drugs/NNS were/VBD not/RB co-administered/VBN with/IN Natrecor/NN in/IN clinical/JJ trials/NNS )./NN

(ROOT (S1 (S (S (NP (NP (DT The) (NN co-administration)) (PP (IN of) (NP (NN Natrecor))) (PP (IN with) (NP (NP (NN IV) (NNS vasodilators)) (PP (JJ such) (IN as) (NP (NP (NN nitroglycerin)) (, ,) (NP (NN nitroprusside)) (, ,) (NP (NN milrinone)) (, ,) (CC or) (NP (NN IV) (NN ACE) (NNS inhibitors))))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN evaluated))))) (S (-LRB- -LRB-) (NP (DT these) (NNS drugs)) (VP (VBD were) (RB not) (VP (VBN co-administered) (PP (IN with) (NP (NN Natrecor))) (PP (IN in) (NP (NP (JJ clinical) (NNS trials)) (NN -RRB-.)))))))))

det(co-administration-2, The-1)
nsubjpass(evaluated-23, co-administration-2)
prep_of(co-administration-2, Natrecor-4)
nn(vasodilators-7, IV-6)
prep_with(co-administration-2, vasodilators-7)
prep_such_as(vasodilators-7, nitroglycerin-10)
conj_or(nitroglycerin-10, nitroprusside-12)
conj_or(nitroglycerin-10, milrinone-14)
nn(inhibitors-19, IV-17)
nn(inhibitors-19, ACE-18)
conj_or(nitroglycerin-10, inhibitors-19)
aux(evaluated-23, has-20)
neg(evaluated-23, not-21)
auxpass(evaluated-23, been-22)
root(ROOT-0, evaluated-23)
det(drugs-26, these-25)
nsubjpass(co-administered-29, drugs-26)
auxpass(co-administered-29, were-27)
neg(co-administered-29, not-28)
dep(evaluated-23, co-administered-29)
prep_with(co-administered-29, Natrecor-31)
amod(trials-34, clinical-33)
nn(-RRB-.-35, trials-34)
prep_in(co-administered-29, -RRB-.-35)

Netilmicin/NN should/MD not/RB be/VB administered/VBN concomitantly/RB with/IN potent/JJ loop/NN diuretics/NNS such/JJ as/IN furosemide/NN and/CC ethacrynic/JJ acid/NN as/IN the/DT potential/NN for/IN ototoxicity/NN is/VBZ enhanced/VBN by/IN the/DT combination/NN ./.

(ROOT (S1 (S (S (NP (NN Netilmicin)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NP (JJ potent) (NN loop) (NNS diuretics)) (PP (JJ such) (IN as) (NP (NP (NN furosemide)) (CC and) (NP (JJ ethacrynic) (NN acid)))))) (SBAR (IN as) (S (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NN ototoxicity)))) (VP (VBZ is) (VP (VBN enhanced) (PP (IN by) (NP (DT the) (NN combination))))))))))) (. .))))

nsubjpass(administered-5, Netilmicin-1)
aux(administered-5, should-2)
neg(administered-5, not-3)
auxpass(administered-5, be-4)
root(ROOT-0, administered-5)
advmod(administered-5, concomitantly-6)
amod(diuretics-10, potent-8)
nn(diuretics-10, loop-9)
prep_with(administered-5, diuretics-10)
prep_such_as(diuretics-10, furosemide-13)
amod(acid-16, ethacrynic-15)
conj_and(furosemide-13, acid-16)
mark(enhanced-23, as-17)
det(potential-19, the-18)
nsubjpass(enhanced-23, potential-19)
prep_for(potential-19, ototoxicity-21)
auxpass(enhanced-23, is-22)
advcl(administered-5, enhanced-23)
det(combination-26, the-25)
agent(enhanced-23, combination-26)

Nevirapine/NN is/VBZ principally/RB metabolized/VBN by/IN the/DT liver/NN via/IN the/DT cytochrome/NN P450/NN isoenzymes/NNS ,/, 3A4/NN and/CC 2B6/NN ./.

(ROOT (S1 (S (S (NP (NN Nevirapine)) (VP (VBZ is) (ADVP (RB principally)) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (NN liver))) (PP (IN via) (NP (NP (DT the) (NN cytochrome) (NN P450) (NNS isoenzymes)) (, ,) (NP (NP (NN 3A4)) (CC and) (NP (NN 2B6)))))))) (. .))))

nsubjpass(metabolized-4, Nevirapine-1)
auxpass(metabolized-4, is-2)
advmod(metabolized-4, principally-3)
root(ROOT-0, metabolized-4)
det(liver-7, the-6)
agent(metabolized-4, liver-7)
det(isoenzymes-12, the-9)
nn(isoenzymes-12, cytochrome-10)
nn(isoenzymes-12, P450-11)
prep_via(metabolized-4, isoenzymes-12)
appos(isoenzymes-12, 3A4-14)
conj_and(3A4-14, 2B6-16)

Nevirapine/NN is/VBZ known/VBN to/TO be/VB an/DT inducer/NN of/IN these/DT enzymes/NNS ./.

(ROOT (S1 (S (S (NP (NN Nevirapine)) (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB be) (NP (NP (DT an) (NN inducer)) (PP (IN of) (NP (DT these) (NNS enzymes)))))))))) (. .))))

nsubjpass(known-3, Nevirapine-1)
xsubj(inducer-7, Nevirapine-1)
auxpass(known-3, is-2)
root(ROOT-0, known-3)
aux(inducer-7, to-4)
cop(inducer-7, be-5)
det(inducer-7, an-6)
xcomp(known-3, inducer-7)
det(enzymes-10, these-9)
prep_of(inducer-7, enzymes-10)

As/IN a/DT result/NN ,/, drugs/NNS that/WDT are/VBP metabolized/VBN by/IN these/DT enzyme/NN systems/NNS may/MD have/VBP lower/JJR than/IN expected/VBN plasma/NN levels/NNS when/WRB coadministered/VBN with/IN nevirapine/NN ./.

(ROOT (S1 (S (S (PP (IN As) (NP (DT a) (NN result))) (, ,) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN metabolized) (PP (IN by) (NP (DT these) (NN enzyme) (NNS systems)))))))) (VP (MD may) (VP (VBP have) (NP (JJR lower) (IN than) (VBN expected) (NN plasma) (NNS levels)) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NN nevirapine))))))))) (. .))))

det(result-3, a-2)
prep_as(have-14, result-3)
nsubjpass(metabolized-8, drugs-5)
nsubj(have-14, drugs-5)
auxpass(metabolized-8, are-7)
rcmod(drugs-5, metabolized-8)
det(systems-12, these-10)
nn(systems-12, enzyme-11)
agent(metabolized-8, systems-12)
aux(have-14, may-13)
root(ROOT-0, have-14)
amod(levels-19, lower-15)
amod(levels-19, than-16)
amod(levels-19, expected-17)
nn(levels-19, plasma-18)
dobj(have-14, levels-19)
advmod(coadministered-21, when-20)
advcl(have-14, coadministered-21)
prep_with(coadministered-21, nevirapine-23)

The/DT specific/JJ pharmacokinetic/JJ changes/NNS that/WDT occur/VBP with/IN co-administration/NN of/IN nevirapine/NN and/CC other/JJ drugs/NNS are/VBP listed/VBN in/IN CLINICAL/JJ PHARMACOLOGY/NN ,/, Table/NN 1/CD ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ specific) (JJ pharmacokinetic) (NNS changes)) (SBAR (WHNP (WDT that)) (S (VP (VBP occur) (PP (IN with) (NP (NP (NN co-administration)) (PP (IN of) (NP (NP (NN nevirapine)) (CC and) (NP (JJ other) (NNS drugs)))))))))) (VP (VBP are) (VP (VBN listed) (PP (IN in) (NP (NP (JJ CLINICAL) (NN PHARMACOLOGY)) (, ,) (NP (NN Table) (CD 1))))))) (. .))))

det(changes-4, The-1)
amod(changes-4, specific-2)
amod(changes-4, pharmacokinetic-3)
nsubj(occur-6, changes-4)
nsubjpass(listed-15, changes-4)
rcmod(changes-4, occur-6)
prep_with(occur-6, co-administration-8)
prep_of(co-administration-8, nevirapine-10)
amod(drugs-13, other-12)
conj_and(nevirapine-10, drugs-13)
auxpass(listed-15, are-14)
root(ROOT-0, listed-15)
amod(PHARMACOLOGY-18, CLINICAL-17)
prep_in(listed-15, PHARMACOLOGY-18)
appos(PHARMACOLOGY-18, Table-20)
num(Table-20, 1-21)

In/IN addition/NN to/TO established/JJ drug/NN interactions/NNS ,/, there/EX may/MD be/VB potential/JJ pharmacokinetic/JJ interactions/NNS between/IN nevirapine/NN and/CC other/JJ drug/NN classes/NNS that/WDT are/VBP metabolized/VBN by/IN the/DT cytochrome/NN P450/NN system/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NN addition) (TO to) (NP (JJ established) (NN drug) (NNS interactions))) (, ,) (NP (EX there)) (VP (MD may) (VP (VB be) (NP (NP (JJ potential) (JJ pharmacokinetic) (NNS interactions)) (PP (IN between) (NP (NP (NN nevirapine)) (CC and) (NP (JJ other) (NN drug) (NNS classes)))) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN metabolized) (PP (IN by) (NP (DT the) (NP (NN cytochrome) (NN P450)) (NN system))))))))))) (. .))))

amod(interactions-6, established-4)
nn(interactions-6, drug-5)
prep_in_addition_to(interactions-13, interactions-6)
expl(interactions-13, there-8)
aux(interactions-13, may-9)
cop(interactions-13, be-10)
amod(interactions-13, potential-11)
amod(interactions-13, pharmacokinetic-12)
root(ROOT-0, interactions-13)
nsubjpass(metabolized-22, interactions-13)
prep_between(interactions-13, nevirapine-15)
amod(classes-19, other-17)
nn(classes-19, drug-18)
conj_and(nevirapine-15, classes-19)
auxpass(metabolized-22, are-21)
rcmod(interactions-13, metabolized-22)
det(system-27, the-24)
nn(P450-26, cytochrome-25)
nn(system-27, P450-26)
agent(metabolized-22, system-27)

Although/IN specific/JJ drug/NN interaction/NN studies/NNS in/IN HIV-1/NN seropositive/JJ subjects/NNS have/VBP not/RB been/VBN conducted/VBN for/IN the/DT classes/NNS of/IN drugs/NNS listed/VBN in/IN Table/NN 4/CD ,/, additional/JJ clinical/JJ monitoring/NN may/MD be/VB warranted/VBN when/WRB co-administering/JJ these/DT drugs/NNS ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (NP (JJ specific) (NN drug) (NN interaction) (NNS studies)) (PP (IN in) (NP (NN HIV-1) (JJ seropositive) (NNS subjects)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN conducted) (PP (IN for) (NP (NP (DT the) (NNS classes)) (PP (IN of) (NP (NP (NNS drugs)) (VP (VBN listed) (PP (IN in) (NP (NN Table) (CD 4))))))))))))) (, ,) (NP (JJ additional) (JJ clinical) (NN monitoring)) (VP (MD may) (VP (VB be) (VP (VBN warranted) (SBAR (WHADVP (WRB when)) (S (VP (JJ co-administering) (NP (DT these) (NNS drugs))))))))) (. .))))

mark(conducted-13, Although-1)
amod(studies-5, specific-2)
nn(studies-5, drug-3)
nn(studies-5, interaction-4)
nsubjpass(conducted-13, studies-5)
nn(subjects-9, HIV-1-7)
amod(subjects-9, seropositive-8)
prep_in(studies-5, subjects-9)
aux(conducted-13, have-10)
neg(conducted-13, not-11)
auxpass(conducted-13, been-12)
advcl(warranted-29, conducted-13)
det(classes-16, the-15)
prep_for(conducted-13, classes-16)
prep_of(classes-16, drugs-18)
partmod(drugs-18, listed-19)
prep_in(listed-19, Table-21)
num(Table-21, 4-22)
amod(monitoring-26, additional-24)
amod(monitoring-26, clinical-25)
nsubjpass(warranted-29, monitoring-26)
aux(warranted-29, may-27)
auxpass(warranted-29, be-28)
root(ROOT-0, warranted-29)
advmod(co-administering-31, when-30)
advcl(warranted-29, co-administering-31)
det(drugs-33, these-32)
dobj(co-administering-31, drugs-33)

The/DT in/FW vitro/FW interaction/NN between/IN nevirapine/NN and/CC the/DT antithrombotic/JJ agent/NN warfarin/NN is/VBZ complex/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (ADJP (FW in) (FW vitro)) (NN interaction)) (PP (IN between) (NP (NP (NN nevirapine)) (CC and) (NP (DT the) (JJ antithrombotic) (NN agent) (NN warfarin))))) (VP (VBZ is) (NP (NN complex)))) (. .))))

det(interaction-4, The-1)
nn(vitro-3, in-2)
amod(interaction-4, vitro-3)
nsubj(complex-13, interaction-4)
prep_between(interaction-4, nevirapine-6)
det(warfarin-11, the-8)
amod(warfarin-11, antithrombotic-9)
nn(warfarin-11, agent-10)
conj_and(nevirapine-6, warfarin-11)
cop(complex-13, is-12)
root(ROOT-0, complex-13)

As/IN a/DT result/NN ,/, when/WRB giving/VBG these/DT drugs/NNS concomitantly/RB ,/, plasma/NN warfarin/NN levels/NNS may/MD change/VB with/IN the/DT potential/NN for/IN increases/NNS in/IN coagulation/NN time/NN ./.

(ROOT (S1 (S (S (PP (IN As) (NP (DT a) (NN result))) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBG giving) (NP (DT these) (NNS drugs)) (ADVP (RB concomitantly))))) (, ,) (NP (NN plasma) (NN warfarin) (NNS levels)) (VP (MD may) (VP (VB change) (PP (IN with) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (NNS increases)) (PP (IN in) (NP (NN coagulation) (NN time)))))))))) (. .))))

det(result-3, a-2)
prep_as(change-15, result-3)
advmod(giving-6, when-5)
advcl(change-15, giving-6)
det(drugs-8, these-7)
dobj(giving-6, drugs-8)
advmod(giving-6, concomitantly-9)
nn(levels-13, plasma-11)
nn(levels-13, warfarin-12)
nsubj(change-15, levels-13)
aux(change-15, may-14)
root(ROOT-0, change-15)
det(potential-18, the-17)
prep_with(change-15, potential-18)
prep_for(potential-18, increases-20)
nn(time-23, coagulation-22)
prep_in(increases-20, time-23)

When/WRB warfarin/NN is/VBZ co-administered/VBN with/IN nevirapine/NN ,/, anticoagulation/NN levels/NNS should/MD be/VB monitored/VBN frequently/RB ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NN warfarin)) (VP (VBZ is) (VP (VBN co-administered) (PP (IN with) (NP (NN nevirapine))))))) (, ,) (NP (NN anticoagulation) (NNS levels)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB frequently)))))) (. .))))

advmod(co-administered-4, When-1)
nsubjpass(co-administered-4, warfarin-2)
auxpass(co-administered-4, is-3)
advcl(monitored-12, co-administered-4)
prep_with(co-administered-4, nevirapine-6)
nn(levels-9, anticoagulation-8)
nsubjpass(monitored-12, levels-9)
aux(monitored-12, should-10)
auxpass(monitored-12, be-11)
root(ROOT-0, monitored-12)
advmod(monitored-12, frequently-13)

Drug/NN Name/NN ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN Name)) (. .)))))

nn(Name-2, Drug-1)
root(ROOT-0, Name-2)

Effect/NN on/IN Concentration/NN of/IN Nevirapine/NN or/CC Concomitant/JJ Drug/NN ./.

(ROOT (S1 (S (S (VP (NN Effect) (PP (IN on) (NP (NP (NN Concentration)) (PP (IN of) (NP (NP (NN Nevirapine)) (CC or) (NP (JJ Concomitant) (NN Drug)))))))) (. .))))

root(ROOT-0, Effect-1)
prep_on(Effect-1, Concentration-3)
prep_of(Concentration-3, Nevirapine-5)
amod(Drug-8, Concomitant-7)
conj_or(Nevirapine-5, Drug-8)

Clarithromycin/NN ./.

(ROOT (S1 (S (NP (NP (NN Clarithromycin)) (. .)))))

root(ROOT-0, Clarithromycin-1)

@/NN Clarithromycin/NN @/NN 14OH-/NN clarithromycin/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN Clarithromycin) (NN @) (NN 14OH-) (NN clarithromycin)) (. .)))))

nn(clarithromycin-5, @-1)
nn(clarithromycin-5, Clarithromycin-2)
nn(clarithromycin-5, @-3)
nn(clarithromycin-5, 14OH--4)
root(ROOT-0, clarithromycin-5)

Clarithromycin/NN exposure/NN was/VBD significantly/RB decreased/VBN by/IN nevirapine/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN Clarithromycin) (NN exposure)) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN decreased) (PP (IN by) (NP (NN nevirapine))))) (: ;)) (. .))))

nn(exposure-2, Clarithromycin-1)
nsubjpass(decreased-5, exposure-2)
auxpass(decreased-5, was-3)
advmod(decreased-5, significantly-4)
root(ROOT-0, decreased-5)
agent(decreased-5, nevirapine-7)

however/RB ,/, 14-OH/NN metabolite/NN concentrations/NNS were/VBD increased.Because/NN clarithromycin/NN active/JJ metabolite/NN has/VBZ reduced/VBN activity/NN against/IN Mycobacteriumavium-intracellulare/NN complex/NN ,/, overallactivity/NN against/IN this/DT pathogen/NN may/MD bealtered/JJ ./.

(ROOT (S1 (S (S (ADVP (RB however)) (, ,) (NP (NN 14-OH) (NN metabolite) (NNS concentrations)) (VP (VBD were) (NP (NP (NN increased.Because) (NN clarithromycin)) (S (NP (JJ active) (NN metabolite)) (VP (VBZ has) (NP (NP (VBN reduced) (NN activity)) (PP (IN against) (NP (NN Mycobacteriumavium-intracellulare) (NN complex)))) (, ,) (S (NP (NP (NN overallactivity)) (PP (IN against) (NP (DT this) (NN pathogen)))) (VP (MD may) (VP (JJ bealtered))))))))) (. .))))

advmod(clarithromycin-8, however-1)
nn(concentrations-5, 14-OH-3)
nn(concentrations-5, metabolite-4)
nsubj(clarithromycin-8, concentrations-5)
cop(clarithromycin-8, were-6)
nn(clarithromycin-8, increased.Because-7)
root(ROOT-0, clarithromycin-8)
amod(metabolite-10, active-9)
nsubj(has-11, metabolite-10)
dep(clarithromycin-8, has-11)
amod(activity-13, reduced-12)
dobj(has-11, activity-13)
nn(complex-16, Mycobacteriumavium-intracellulare-15)
prep_against(activity-13, complex-16)
nsubj(bealtered-23, overallactivity-18)
det(pathogen-21, this-20)
prep_against(overallactivity-18, pathogen-21)
aux(bealtered-23, may-22)
ccomp(has-11, bealtered-23)

Alternatives/NNS to/TO clarithromycin/NN ,/, such/JJ as/IN azithromycin/NN ,/, should/MD be/VB considered/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Alternatives)) (PP (TO to) (NP (NN clarithromycin))) (, ,) (PP (JJ such) (IN as) (NP (NN azithromycin))) (, ,)) (VP (MD should) (VP (VB be) (VP (VBN considered))))) (. .))))

nsubjpass(considered-11, Alternatives-1)
prep_to(Alternatives-1, clarithromycin-3)
prep_such_as(Alternatives-1, azithromycin-7)
aux(considered-11, should-9)
auxpass(considered-11, be-10)
root(ROOT-0, considered-11)

Efavirenz/NN ./.

(ROOT (S1 (S (NP (NP (NN Efavirenz)) (. .)))))

root(ROOT-0, Efavirenz-1)

@/NN Efavirenz/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN Efavirenz)) (. .)))))

nn(Efavirenz-2, @-1)
root(ROOT-0, Efavirenz-2)

Ethinyl/NN estradiol/NN and/CC Norethindrone/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN Ethinyl) (NN estradiol)) (CC and) (NP (NN Norethindrone))) (. .)))))

nn(estradiol-2, Ethinyl-1)
root(ROOT-0, estradiol-2)
conj_and(estradiol-2, Norethindrone-4)

@/NN Ethinyl/NN estradiol/NN span/VBP class=/NN c272/NN @/NN Norethindrone/NN ./.

(ROOT (S1 (S (S (NP (NN @) (NN Ethinyl) (NN estradiol)) (VP (VBP span) (NP (NN class=) (NN c272) (NN @) (NN Norethindrone)))) (. .))))

nn(estradiol-3, @-1)
nn(estradiol-3, Ethinyl-2)
nsubj(span-4, estradiol-3)
root(ROOT-0, span-4)
nn(Norethindrone-8, class=-5)
nn(Norethindrone-8, c272-6)
nn(Norethindrone-8, @-7)
dobj(span-4, Norethindrone-8)

Oral/JJ contraceptives/NNS and/CC other/JJ hormonalmethods/NNS of/IN birth/NN control/NN should/MD not/RB be/VB usedas/NN the/DT sole/JJ method/NN of/IN contraception/NN inwomen/CD taking/VBG nevirapine/NN ,/, since/IN nevirapinemay/NN lower/JJR the/DT plasma/NN levels/NNS of/IN thesemedications/NNS ./.

(ROOT (S1 (S (NP (NP (NP (JJ Oral) (NNS contraceptives)) (CC and) (NP (JJ other) (NNS hormonalmethods))) (PP (IN of) (NP (NN birth) (NN control)))) (VP (MD should) (RB not) (VP (VB be) (NN usedas) (NP (NP (DT the) (JJ sole) (NN method)) (PP (IN of) (NP (NP (NN contraception) (CD inwomen)) (VP (VBG taking) (NP (NN nevirapine)))))) (, ,) (SBAR (IN since) (S (NP (NN nevirapinemay)) (VP (JJR lower) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (NNS thesemedications))))))))) (. .))))

amod(contraceptives-2, Oral-1)
nsubj(method-15, contraceptives-2)
amod(hormonalmethods-5, other-4)
conj_and(contraceptives-2, hormonalmethods-5)
nn(control-8, birth-7)
prep_of(contraceptives-2, control-8)
aux(method-15, should-9)
neg(method-15, not-10)
cop(method-15, be-11)
dep(method-15, usedas-12)
det(method-15, the-13)
amod(method-15, sole-14)
root(ROOT-0, method-15)
prep_of(method-15, contraception-17)
num(contraception-17, inwomen-18)
partmod(contraception-17, taking-19)
dobj(taking-19, nevirapine-20)
mark(levels-27, since-22)
nsubj(levels-27, nevirapinemay-23)
dep(levels-27, lower-24)
det(levels-27, the-25)
nn(levels-27, plasma-26)
advcl(method-15, levels-27)
prep_of(levels-27, thesemedications-29)

Fluconazole/NN ./.

(ROOT (S1 (S (NP (NP (NN Fluconazole)) (. .)))))

root(ROOT-0, Fluconazole-1)

@/NN Nevirapine/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN Nevirapine)) (. .)))))

nn(Nevirapine-2, @-1)
root(ROOT-0, Nevirapine-2)

Because/IN of/IN the/DT risk/NN of/IN increased/VBN exposure/NN tonevirapine/NN ,/, caution/NN should/MD be/VB used/VBN inconcomitant/NN administration/NN ,/, and/CC patients/NNS should/MD be/VB monitored/VBN closely/RB for/IN nevirapine/NN -associated/JJ adverse/JJ events/NNS ./.

(ROOT (S1 (S (PP (IN Because) (PP (IN of) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (VBN increased) (NN exposure) (NN tonevirapine)))))) (, ,) (S (S (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN used) (NP (NN inconcomitant) (NN administration)))))) (, ,) (CC and) (S (NP (NNS patients)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB closely)) (PP (IN for) (NP (ADJP (NN nevirapine) (JJ -associated)) (JJ adverse) (NNS events)))))))) (. .))))

prepc_because_of(used-13, of-2)
det(risk-4, the-3)
pobj(used-13, risk-4)
amod(tonevirapine-8, increased-6)
nn(tonevirapine-8, exposure-7)
prep_of(risk-4, tonevirapine-8)
nsubjpass(used-13, caution-10)
aux(used-13, should-11)
auxpass(used-13, be-12)
root(ROOT-0, used-13)
nn(administration-15, inconcomitant-14)
dobj(used-13, administration-15)
nsubjpass(monitored-21, patients-18)
aux(monitored-21, should-19)
auxpass(monitored-21, be-20)
conj_and(used-13, monitored-21)
advmod(monitored-21, closely-22)
dep(-associated-25, nevirapine-24)
amod(events-27, -associated-25)
amod(events-27, adverse-26)
prep_for(monitored-21, events-27)

Indinavir/NN ./.

(ROOT (S1 (S (NP (NP (NN Indinavir)) (. .)))))

root(ROOT-0, Indinavir-1)

@/NN Indinavir/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN Indinavir)) (. .)))))

nn(Indinavir-2, @-1)
root(ROOT-0, Indinavir-2)

Appropriate/JJ doses/NNS for/IN this/DT combination/NN arenot/NN established/VBN ,/, but/CC an/DT increase/NN in/IN thedosage/NN of/IN indinavir/NN may/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (JJ Appropriate) (NNS doses)) (PP (IN for) (NP (DT this) (NN combination) (NN arenot)))) (VP (VBN established))) (, ,) (CC but) (S (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN thedosage)) (PP (IN of) (NP (NN indinavir)))))) (VP (MD may) (VP (VB be) (VP (VBN required)))))) (. .))))

amod(doses-2, Appropriate-1)
nsubj(established-7, doses-2)
det(arenot-6, this-4)
nn(arenot-6, combination-5)
prep_for(doses-2, arenot-6)
root(ROOT-0, established-7)
det(increase-11, an-10)
nsubjpass(required-18, increase-11)
prep_in(increase-11, thedosage-13)
prep_of(thedosage-13, indinavir-15)
aux(required-18, may-16)
auxpass(required-18, be-17)
conj_but(established-7, required-18)

Ketoconazole/NN ./.

(ROOT (S1 (S (NP (NP (NN Ketoconazole)) (. .)))))

root(ROOT-0, Ketoconazole-1)

@/NN Ketoconazole/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN Ketoconazole)) (. .)))))

nn(Ketoconazole-2, @-1)
root(ROOT-0, Ketoconazole-2)

Nevirapine/NN and/CC ketoconazole/NN should/MD not/RB beadministered/VB concomitantly/RB becausedecreases/NNS in/IN ketoconazole/NN plasmaconcentrations/NNS may/MD reduce/VB the/DT efficacy/NN of/IN the/DT drug/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Nevirapine)) (CC and) (NP (NN ketoconazole))) (VP (MD should) (RB not) (VP (VB beadministered) (ADVP (RB concomitantly)) (NP (NP (NNS becausedecreases)) (PP (IN in) (NP (NP (NN ketoconazole) (NNS plasmaconcentrations)) (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (DT the) (NN drug)))))))))))) (. .))))

nsubj(beadministered-6, Nevirapine-1)
conj_and(Nevirapine-1, ketoconazole-3)
aux(beadministered-6, should-4)
neg(beadministered-6, not-5)
root(ROOT-0, beadministered-6)
advmod(beadministered-6, concomitantly-7)
dobj(beadministered-6, becausedecreases-8)
nn(plasmaconcentrations-11, ketoconazole-10)
prep_in(becausedecreases-8, plasmaconcentrations-11)
aux(reduce-13, may-12)
dep(plasmaconcentrations-11, reduce-13)
det(efficacy-15, the-14)
dobj(reduce-13, efficacy-15)
det(drug-18, the-17)
prep_of(efficacy-15, drug-18)

Lopinavir/NN //: Ritonavir/NN ./.

(ROOT (S1 (S (S (NP (NN Lopinavir)) (: /) (NP (NN Ritonavir))) (. .))))

dep(Ritonavir-3, Lopinavir-1)
punct(Ritonavir-3, /-2)
root(ROOT-0, Ritonavir-3)

@/NN Lopinavir/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN Lopinavir)) (. .)))))

nn(Lopinavir-2, @-1)
root(ROOT-0, Lopinavir-2)

A/DT dose/NN increase/NN of/IN lopinavir/NN //: ritonavir/NN to/TO 533/133/CD mg/NN twice/RB daily/JJ with/IN food/NN isrecommended/VBN in/IN combination/NN with/IN nevirapine/NN ./.

(ROOT (S1 (S (NP (NP (NP (DT A) (NN dose) (NN increase)) (PP (IN of) (NP (NN lopinavir)))) (: /) (NP (NP (NN ritonavir) (TO to) (CD 533/133) (NN mg)) (ADJP (RB twice) (JJ daily) (PP (IN with) (NP (NP (NN food)) (VP (VBN isrecommended) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN nevirapine)))))))))) (. .)))))

det(increase-3, A-1)
nn(increase-3, dose-2)
root(ROOT-0, increase-3)
prep_of(increase-3, lopinavir-5)
punct(increase-3, /-6)
nn(mg-10, ritonavir-7)
dep(mg-10, to-8)
num(mg-10, 533/133-9)
dep(increase-3, mg-10)
advmod(daily-12, twice-11)
amod(mg-10, daily-12)
prep_with(daily-12, food-14)
partmod(food-14, isrecommended-15)
prep_in(isrecommended-15, combination-17)
prep_with(combination-17, nevirapine-19)

Methadone/NN ./.

(ROOT (S1 (S (NP (NP (NN Methadone)) (. .)))))

root(ROOT-0, Methadone-1)

Methadone/NN levels/NNS may/MD be/VB decreased/VBN ;/: increased/VBN dosages/NNS may/MD be/VB required/VBN toprevent/JJ symptoms/NNS of/IN opiate/NN withdrawal.Methadone/NN maintained/JJ patients/NNS beginningnevirapine/NN therapy/NN should/MD be/VB monitored/VBN forevidence/NN of/IN withdrawal/NN and/CC methadone/NN dose/NN should/MD be/VB adjusted/VBN accordingly/RB ./.

(ROOT (S1 (S (S (NP (NN Methadone) (NNS levels)) (VP (MD may) (VP (VB be) (VP (VBN decreased))))) (: ;) (S (NP (VBN increased) (NNS dosages)) (VP (MD may) (VP (VB be) (VP (VBN required) (NP (NP (JJ toprevent) (NNS symptoms)) (PP (IN of) (NP (NN opiate) (NN withdrawal.Methadone) (JJ maintained) (NNS patients))) (S (S (NP (NN beginningnevirapine) (NN therapy)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (NP (NP (NN forevidence)) (PP (IN of) (NP (NN withdrawal)))))))) (CC and) (S (NP (NN methadone) (NN dose)) (VP (MD should) (VP (VB be) (VP (VBN adjusted) (ADVP (RB accordingly)))))))))))) (. .))))

nn(levels-2, Methadone-1)
nsubjpass(decreased-5, levels-2)
aux(decreased-5, may-3)
auxpass(decreased-5, be-4)
root(ROOT-0, decreased-5)
amod(dosages-8, increased-7)
nsubjpass(required-11, dosages-8)
aux(required-11, may-9)
auxpass(required-11, be-10)
parataxis(decreased-5, required-11)
amod(symptoms-13, toprevent-12)
dobj(required-11, symptoms-13)
nn(patients-18, opiate-15)
nn(patients-18, withdrawal.Methadone-16)
amod(patients-18, maintained-17)
prep_of(symptoms-13, patients-18)
nn(therapy-20, beginningnevirapine-19)
nsubjpass(monitored-23, therapy-20)
aux(monitored-23, should-21)
auxpass(monitored-23, be-22)
dep(symptoms-13, monitored-23)
dobj(monitored-23, forevidence-24)
prep_of(forevidence-24, withdrawal-26)
nn(dose-29, methadone-28)
nsubjpass(adjusted-32, dose-29)
aux(adjusted-32, should-30)
auxpass(adjusted-32, be-31)
conj_and(monitored-23, adjusted-32)
advmod(adjusted-32, accordingly-33)

Nelfinavir/NN ./.

(ROOT (S1 (S (NP (NP (NN Nelfinavir)) (. .)))))

root(ROOT-0, Nelfinavir-1)

@/NN Nelfinavir/NN M8/NNP Metabolite/NN span/NN class=/NN c272/NN @/NN NelfinavirCmin/NN ?/.

(ROOT (S1 (S (S (NP (NN @) (NN Nelfinavir)) (NP (NNP M8) (NN Metabolite) (NN span) (NN class=) (NN c272) (NN @) (NN NelfinavirCmin))) (. ?))))

nn(Nelfinavir-2, @-1)
dep(NelfinavirCmin-9, Nelfinavir-2)
nn(NelfinavirCmin-9, M8-3)
nn(NelfinavirCmin-9, Metabolite-4)
nn(NelfinavirCmin-9, span-5)
nn(NelfinavirCmin-9, class=-6)
nn(NelfinavirCmin-9, c272-7)
nn(NelfinavirCmin-9, @-8)
root(ROOT-0, NelfinavirCmin-9)

The/DT appropriate/JJ dose/NN for/IN nelfinavir/NN incombination/NN with/IN nevirapine/NN ,/, with/IN respectto/NN safety/NN and/CC efficacy/NN ,/, has/VBZ not/RB been/VBN established/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ appropriate) (NN dose)) (PP (IN for) (NP (NP (NN nelfinavir) (NN incombination)) (PP (IN with) (NP (NN nevirapine))))) (, ,) (PP (IN with) (NP (NN respectto) (NP (NP (NN safety)) (CC and) (NP (NN efficacy))))) (, ,)) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN established))))) (. .))))

det(dose-3, The-1)
amod(dose-3, appropriate-2)
nsubjpass(established-19, dose-3)
nn(incombination-6, nelfinavir-5)
prep_for(dose-3, incombination-6)
prep_with(incombination-6, nevirapine-8)
prep_with(dose-3, respectto-11)
dep(respectto-11, safety-12)
conj_and(safety-12, efficacy-14)
aux(established-19, has-16)
neg(established-19, not-17)
auxpass(established-19, been-18)
root(ROOT-0, established-19)

Rifabutin/NN ./.

(ROOT (S1 (S (NP (NP (NN Rifabutin)) (. .)))))

root(ROOT-0, Rifabutin-1)

Rifabutin/NN and/CC its/PRP$ metabolite/NN concentrationswere/VBD moderately/RB increased/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Rifabutin)) (CC and) (NP (PRP$ its) (NN metabolite))) (VP (VBD concentrationswere) (ADVP (RB moderately)) (VP (VBN increased)))) (. .))))

nsubj(concentrationswere-5, Rifabutin-1)
poss(metabolite-4, its-3)
conj_and(Rifabutin-1, metabolite-4)
root(ROOT-0, concentrationswere-5)
advmod(concentrationswere-5, moderately-6)
dep(concentrationswere-5, increased-7)

Rifampin/NN ./.

(ROOT (S1 (S (NP (NP (NN Rifampin)) (. .)))))

root(ROOT-0, Rifampin-1)

@/NN Nevirapine/NN ./.

(ROOT (S1 (S (NP (NP (NN @) (NN Nevirapine)) (. .)))))

nn(Nevirapine-2, @-1)
root(ROOT-0, Nevirapine-2)

Nevirapine/NN and/CC rifampin/NN should/MD not/RB beadministered/VB concomitantly/RB becausedecreases/NNS in/IN nevirapine/NN plasmaconcentrations/NNS may/MD reduce/VB the/DT efficacy/NN ofthe/NN drug/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Nevirapine)) (CC and) (NP (NN rifampin))) (VP (MD should) (RB not) (VP (VB beadministered) (ADVP (RB concomitantly)) (NP (NP (NNS becausedecreases)) (PP (IN in) (NP (NN nevirapine))) (S (NP (NNS plasmaconcentrations)) (VP (MD may) (VP (VB reduce) (NP (DT the) (NN efficacy) (NN ofthe) (NN drug))))))))) (. .))))

nsubj(beadministered-6, Nevirapine-1)
conj_and(Nevirapine-1, rifampin-3)
aux(beadministered-6, should-4)
neg(beadministered-6, not-5)
root(ROOT-0, beadministered-6)
advmod(beadministered-6, concomitantly-7)
dobj(beadministered-6, becausedecreases-8)
prep_in(becausedecreases-8, nevirapine-10)
nsubj(reduce-13, plasmaconcentrations-11)
aux(reduce-13, may-12)
dep(becausedecreases-8, reduce-13)
det(drug-17, the-14)
nn(drug-17, efficacy-15)
nn(drug-17, ofthe-16)
dobj(reduce-13, drug-17)

Physicians/NNS needing/VBG to/TO treatpatients/NNS co-infected/VBN with/IN tuberculosis/NN andusing/VBG a/DT nevirapine/NN containing/VBG regimen/NN mayuse/NN rifabutin/NN instead/RB ./.

(ROOT (S1 (S (S (NP (NNS Physicians)) (VP (VBG needing) (PP (TO to) (NP (NP (NNS treatpatients)) (VP (VBN co-infected) (PP (IN with) (NP (NP (NN tuberculosis)) (VP (VBG andusing) (NP (NP (DT a) (NN nevirapine)) (VP (VBG containing) (NP (NP (NN regimen) (NN mayuse) (NN rifabutin)) (ADVP (RB instead))))))))))))) (. .))))

nsubj(needing-2, Physicians-1)
root(ROOT-0, needing-2)
prep_to(needing-2, treatpatients-4)
partmod(treatpatients-4, co-infected-5)
prep_with(co-infected-5, tuberculosis-7)
partmod(tuberculosis-7, andusing-8)
det(nevirapine-10, a-9)
dobj(andusing-8, nevirapine-10)
partmod(nevirapine-10, containing-11)
nn(rifabutin-14, regimen-12)
nn(rifabutin-14, mayuse-13)
dobj(containing-11, rifabutin-14)
advmod(rifabutin-14, instead-15)

Saquinavir/NN ./.

(ROOT (S1 (S (NP (NP (NN Saquinavir)) (. .)))))

root(ROOT-0, Saquinavir-1)

Appropriate/JJ doses/NNS for/IN this/DT combination/NN arenot/NN established/VBN ,/, but/CC an/DT increase/NN in/IN thedosage/NN of/IN saquinavir/NN may/MD be/VB required/VBN ./.

(ROOT (S1 (S (S (S (NP (NP (JJ Appropriate) (NNS doses)) (PP (IN for) (NP (DT this) (NN combination) (NN arenot)))) (VP (VBN established))) (, ,) (CC but) (S (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (NP (NN thedosage)) (PP (IN of) (NP (NN saquinavir)))))) (VP (MD may) (VP (VB be) (VP (VBN required)))))) (. .))))

amod(doses-2, Appropriate-1)
nsubj(established-7, doses-2)
det(arenot-6, this-4)
nn(arenot-6, combination-5)
prep_for(doses-2, arenot-6)
root(ROOT-0, established-7)
det(increase-11, an-10)
nsubjpass(required-18, increase-11)
prep_in(increase-11, thedosage-13)
prep_of(thedosage-13, saquinavir-15)
aux(required-18, may-16)
auxpass(required-18, be-17)
conj_but(established-7, required-18)

aBased/VBN on/IN reports/NNS of/IN narcotic/JJ withdrawal/NN syndrome/NN in/IN patients/NNS treated/VBN with/IN nevirapine/NN and/CC methadone/NN concurrently/RB ,/, and/CC evidence/NN of/IN decreased/VBN plasma/NN concentrations/NNS of/IN methadone/NN ./.

(ROOT (S1 (S (S (VP (VBN aBased) (PP (IN on) (NP (NP (NP (NNS reports)) (PP (IN of) (NP (NP (JJ narcotic) (NN withdrawal) (NN syndrome)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NP (NN nevirapine)) (CC and) (NP (NN methadone)))) (ADVP (RB concurrently)))))))) (, ,) (CC and) (NP (NP (NN evidence)) (PP (IN of) (NP (NP (VBN decreased) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN methadone)))))))))) (. .))))

root(ROOT-0, aBased-1)
prep_on(aBased-1, reports-3)
amod(syndrome-7, narcotic-5)
nn(syndrome-7, withdrawal-6)
prep_of(reports-3, syndrome-7)
prep_in(syndrome-7, patients-9)
partmod(patients-9, treated-10)
prep_with(treated-10, nevirapine-12)
conj_and(nevirapine-12, methadone-14)
advmod(treated-10, concurrently-15)
conj_and(reports-3, evidence-18)
amod(concentrations-22, decreased-20)
nn(concentrations-22, plasma-21)
prep_of(evidence-18, concentrations-22)
prep_of(concentrations-22, methadone-24)

Table/NN 4/CD @@@@@@@/IN Potential/JJ Drug/NN Interactions/NNS :/: Use/NN With/IN Caution/NN ,/, Dose/NN Adjustment/NN of/IN Co-administered/NN Drug/NN May/MD Be/VB Needed/VBN due/JJ to/TO Possible/JJ Decrease/NN in/IN Clinical/JJ Effect/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Table) (CD 4)) (PP (IN @@@@@@@) (NP (NP (JJ Potential) (NN Drug) (NNS Interactions)) (: :) (NP (NP (NN Use)) (PP (IN With) (NP (NN Caution)))) (, ,) (NP (NP (NN Dose) (NN Adjustment)) (PP (IN of) (NP (NP (NN Co-administered)) (NN Drug))))))) (VP (MD May) (VP (VB Be) (VP (VBN Needed) (PP (JJ due) (TO to) (NP (NP (JJ Possible) (NN Decrease)) (PP (IN in) (NP (JJ Clinical) (NN Effect))))))))) (. .))))

nsubjpass(Needed-19, Table-1)
num(Table-1, 4-2)
amod(Interactions-6, Potential-4)
nn(Interactions-6, Drug-5)
prep_@@@@@@@(Table-1, Interactions-6)
dep(Interactions-6, Use-8)
prep_with(Use-8, Caution-10)
nn(Adjustment-13, Dose-12)
appos(Interactions-6, Adjustment-13)
nn(Drug-16, Co-administered-15)
prep_of(Adjustment-13, Drug-16)
aux(Needed-19, May-17)
auxpass(Needed-19, Be-18)
root(ROOT-0, Needed-19)
amod(Decrease-23, Possible-22)
prep_due_to(Needed-19, Decrease-23)
amod(Effect-26, Clinical-25)
prep_in(Decrease-23, Effect-26)

Examples/NNS of/IN Drugs/NNS in/IN Which/WDT Plasma/NN Concentrations/NNS May/MD Be/VB Decreased/VBN By/IN Co-administration/NN With/IN Nevirapine/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Examples)) (PP (IN of) (NP (NP (NNS Drugs)) (SBAR (WHPP (IN in) (WHNP (WDT Which))) (S (NP (NN Plasma) (NNS Concentrations))))))) (VP (MD May) (VP (VB Be) (VP (VBN Decreased) (PP (IN By) (NP (NP (NN Co-administration)) (PP (IN With) (NP (NN Nevirapine))))))))) (. .))))

nsubjpass(Decreased-10, Examples-1)
prep_of(Examples-1, Drugs-3)
rel(Concentrations-7, Which-5)
nn(Concentrations-7, Plasma-6)
rcmod(Drugs-3, Concentrations-7)
aux(Decreased-10, May-8)
auxpass(Decreased-10, Be-9)
root(ROOT-0, Decreased-10)
agent(Decreased-10, Co-administration-12)
prep_with(Co-administration-12, Nevirapine-14)

Drug/NN Class/NN Examples/NNS of/IN Drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN Class) (NNS Examples)) (PP (IN of) (NP (NNS Drugs))))) (. .))))

nn(Examples-3, Drug-1)
nn(Examples-3, Class-2)
root(ROOT-0, Examples-3)
prep_of(Examples-3, Drugs-5)

Antiarrhythmics/NN ./.

(ROOT (S1 (S (NP (NP (NN Antiarrhythmics)) (. .)))))

root(ROOT-0, Antiarrhythmics-1)

Amiodarone/NN ,/, disopyramide/NN ,/, lidocaine/NN ./.

(ROOT (S1 (S (NP (NP (NN Amiodarone)) (, ,) (NP (NN disopyramide)) (, ,) (NP (NN lidocaine)) (. .)))))

root(ROOT-0, Amiodarone-1)
appos(Amiodarone-1, disopyramide-3)
appos(Amiodarone-1, lidocaine-5)

Anticonvulsants/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Anticonvulsants)) (. .)))))

root(ROOT-0, Anticonvulsants-1)

Carbamazepine/NN ,/, clonazepam/NN ,/, ethosuximide/NN ./.

(ROOT (S1 (S (NP (NP (NN Carbamazepine)) (, ,) (NP (NN clonazepam)) (, ,) (NP (NN ethosuximide)) (. .)))))

root(ROOT-0, Carbamazepine-1)
appos(Carbamazepine-1, clonazepam-3)
appos(Carbamazepine-1, ethosuximide-5)

Antifungals/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Antifungals)) (. .)))))

root(ROOT-0, Antifungals-1)

Itraconazole/NN ./.

(ROOT (S1 (S (NP (NP (NN Itraconazole)) (. .)))))

root(ROOT-0, Itraconazole-1)

Calcium/NN channel/NN blockers/NNS ./.

(ROOT (S1 (S (NP (NP (NN Calcium) (NN channel) (NNS blockers)) (. .)))))

nn(blockers-3, Calcium-1)
nn(blockers-3, channel-2)
root(ROOT-0, blockers-3)

Diltiazem/NN ,/, nifedipine/NN ,/, verapamil/NN ./.

(ROOT (S1 (S (NP (NP (NN Diltiazem)) (, ,) (NP (NN nifedipine)) (, ,) (NP (NN verapamil)) (. .)))))

root(ROOT-0, Diltiazem-1)
appos(Diltiazem-1, nifedipine-3)
appos(Diltiazem-1, verapamil-5)

Cyclophosphamide/NN ./.

(ROOT (S1 (S (NP (NP (NN Cyclophosphamide)) (. .)))))

root(ROOT-0, Cyclophosphamide-1)

Ergot/NN alkaloids/NNS ./.

(ROOT (S1 (S (NP (NP (NN Ergot) (NNS alkaloids)) (. .)))))

nn(alkaloids-2, Ergot-1)
root(ROOT-0, alkaloids-2)

Ergotamine/NN ./.

(ROOT (S1 (S (NP (NP (NN Ergotamine)) (. .)))))

root(ROOT-0, Ergotamine-1)

Immunosuppressants/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Immunosuppressants)) (. .)))))

root(ROOT-0, Immunosuppressants-1)

Cyclosporin/NN ,/, tacrolimus/NN ,/, sirolimus/NN ./.

(ROOT (S1 (S (NP (NP (NN Cyclosporin)) (, ,) (NP (NN tacrolimus)) (, ,) (NP (NN sirolimus)) (. .)))))

root(ROOT-0, Cyclosporin-1)
appos(Cyclosporin-1, tacrolimus-3)
appos(Cyclosporin-1, sirolimus-5)

Cisapride/NN ./.

(ROOT (S1 (S (NP (NP (NN Cisapride)) (. .)))))

root(ROOT-0, Cisapride-1)

Opiate/NN agonists/NNS ./.

(ROOT (S1 (S (S (NP (NN Opiate) (NNS agonists))) (. .))))

nn(agonists-2, Opiate-1)
root(ROOT-0, agonists-2)

Fentanyl/NN ./.

(ROOT (S1 (S (NP (NP (NN Fentanyl)) (. .)))))

root(ROOT-0, Fentanyl-1)

Examples/NNS of/IN Drugs/NNS in/IN Which/WDT Plasma/NN Concentrations/NNS May/MD Be/VB Increased/VBN By/IN Co-administration/NN With/IN Nevirapine/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Examples)) (PP (IN of) (NP (NP (NNS Drugs)) (SBAR (WHPP (IN in) (WHNP (WDT Which))) (S (NP (NN Plasma) (NNS Concentrations))))))) (VP (MD May) (VP (VB Be) (VP (VBN Increased) (PP (IN By) (NP (NP (NN Co-administration)) (PP (IN With) (NP (NN Nevirapine))))))))) (. .))))

nsubjpass(Increased-10, Examples-1)
prep_of(Examples-1, Drugs-3)
rel(Concentrations-7, Which-5)
nn(Concentrations-7, Plasma-6)
rcmod(Drugs-3, Concentrations-7)
aux(Increased-10, May-8)
auxpass(Increased-10, Be-9)
root(ROOT-0, Increased-10)
agent(Increased-10, Co-administration-12)
prep_with(Co-administration-12, Nevirapine-14)

Warfarin/NN ./.

(ROOT (S1 (S (NP (NP (NN Warfarin)) (. .)))))

root(ROOT-0, Warfarin-1)

Interactions/NNS for/IN Vitamin/NN B3/NN (/-LRB- Niacin/NN )/-RRB- :/: Antihypertensive/JJ Therapy/NN :/: Nicotinic/JJ acid/NN may/MD potentiate/VB the/DT effects/NNS of/IN ganglionic/JJ blocking/NN agents/NNS and/CC vasoactive/JJ drugs/NNS resulting/VBG in/IN postural/JJ hypotension/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NNS Interactions)) (PP (IN for) (NP (NP (NN Vitamin) (NN B3)) (PRN (-LRB- -LRB-) (NP (NN Niacin)) (-RRB- -RRB-))))) (: :) (NP (JJ Antihypertensive) (NN Therapy)) (: :) (NP (JJ Nicotinic) (NN acid))) (VP (MD may) (VP (VB potentiate) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ ganglionic) (NN blocking) (NNS agents)) (CC and) (NP (NP (JJ vasoactive) (NNS drugs)) (VP (VBG resulting) (PP (IN in) (NP (JJ postural) (NN hypotension))))))))))) (. .))))

nsubj(potentiate-15, Interactions-1)
nn(B3-4, Vitamin-3)
prep_for(Interactions-1, B3-4)
appos(B3-4, Niacin-6)
amod(Therapy-10, Antihypertensive-9)
dep(Interactions-1, Therapy-10)
amod(acid-13, Nicotinic-12)
dep(Interactions-1, acid-13)
aux(potentiate-15, may-14)
root(ROOT-0, potentiate-15)
det(effects-17, the-16)
dobj(potentiate-15, effects-17)
amod(agents-21, ganglionic-19)
nn(agents-21, blocking-20)
prep_of(effects-17, agents-21)
amod(drugs-24, vasoactive-23)
conj_and(agents-21, drugs-24)
partmod(drugs-24, resulting-25)
amod(hypotension-28, postural-27)
prep_in(resulting-25, hypotension-28)

Aspirin/NN :/: Concomitant/JJ aspirin/NN may/MD decrease/VB the/DT metabolic/JJ clearance/NN of/IN nicotinic/JJ acid/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Aspirin)) (: :) (NP (JJ Concomitant) (NN aspirin))) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (JJ metabolic) (NN clearance)) (PP (IN of) (NP (JJ nicotinic) (NN acid))))))) (. .))))

nsubj(decrease-6, Aspirin-1)
amod(aspirin-4, Concomitant-3)
dep(Aspirin-1, aspirin-4)
aux(decrease-6, may-5)
root(ROOT-0, decrease-6)
det(clearance-9, the-7)
amod(clearance-9, metabolic-8)
dobj(decrease-6, clearance-9)
amod(acid-12, nicotinic-11)
prep_of(clearance-9, acid-12)

Other/JJ :/: Concomitant/JJ alcohol/NN or/CC hot/JJ drinks/NNS may/MD increase/VB the/DT side/JJ effects/NNS of/IN flushing/NN and/CC pruritus/NN and/CC should/MD be/VB avoided/VBN at/IN the/DT time/NN of/IN drug/NN ingestion/NN ./.

(ROOT (S1 (S (S (NP (JJ Other) (: :) (NP (NP (JJ Concomitant) (NN alcohol)) (CC or) (NP (JJ hot) (NNS drinks)))) (VP (VP (MD may) (VP (VB increase) (NP (NP (DT the) (JJ side) (NNS effects)) (PP (IN of) (NP (NP (NN flushing)) (CC and) (NP (NN pruritus))))))) (CC and) (VP (MD should) (VP (VB be) (VP (VBN avoided) (PP (IN at) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (NN drug) (NN ingestion)))))))))) (. .))))

amod(alcohol-4, Other-1)
amod(alcohol-4, Concomitant-3)
nsubj(increase-9, alcohol-4)
amod(drinks-7, hot-6)
conj_or(alcohol-4, drinks-7)
aux(increase-9, may-8)
root(ROOT-0, increase-9)
det(effects-12, the-10)
amod(effects-12, side-11)
dobj(increase-9, effects-12)
prep_of(effects-12, flushing-14)
conj_and(flushing-14, pruritus-16)
aux(avoided-20, should-18)
auxpass(avoided-20, be-19)
conj_and(increase-9, avoided-20)
det(time-23, the-22)
prep_at(avoided-20, time-23)
nn(ingestion-26, drug-25)
prep_of(time-23, ingestion-26)

Beta-Blockers/NNS :/: In/IN controlled/JJ clinical/JJ studies/NNS ,/, adrenergic/JJ beta-receptor/JJ blockers/NNS have/VBP been/VBN frequently/RB administered/VBN concomitantly/RB with/IN nicardipine/CD HCl/NN ./.

(ROOT (S1 (S (NP (NP (NNS Beta-Blockers)) (: :) (S (PP (IN In) (NP (JJ controlled) (JJ clinical) (NNS studies))) (, ,) (NP (JJ adrenergic) (JJ beta-receptor) (NNS blockers)) (VP (VBP have) (VP (VBN been) (ADVP (RB frequently)) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (CD nicardipine) (NN HCl))))))) (. .)))))

root(ROOT-0, Beta-Blockers-1)
amod(studies-6, controlled-4)
amod(studies-6, clinical-5)
prep_in(administered-14, studies-6)
amod(blockers-10, adrenergic-8)
amod(blockers-10, beta-receptor-9)
nsubjpass(administered-14, blockers-10)
aux(administered-14, have-11)
auxpass(administered-14, been-12)
advmod(administered-14, frequently-13)
dep(Beta-Blockers-1, administered-14)
advmod(administered-14, concomitantly-15)
num(HCl-18, nicardipine-17)
prep_with(administered-14, HCl-18)

Cimetidine/NN Cimetidine/NN increases/VBZ nicardipine/NN HCl/NN plasma/NN levels/NNS ./.

(ROOT (S1 (S (S (NP (NN Cimetidine) (NN Cimetidine)) (VP (VBZ increases) (NP (NN nicardipine) (NN HCl) (NN plasma) (NNS levels)))) (. .))))

nn(Cimetidine-2, Cimetidine-1)
nsubj(increases-3, Cimetidine-2)
root(ROOT-0, increases-3)
nn(levels-7, nicardipine-4)
nn(levels-7, HCl-5)
nn(levels-7, plasma-6)
dobj(increases-3, levels-7)

Patients/NNS receiving/VBG the/DT two/CD drugs/NNS concomitantly/RB should/MD be/VB carefully/RB monitored/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG receiving) (NP (DT the) (CD two) (NNS drugs)))) (ADVP (RB concomitantly)) (VP (MD should) (VP (VB be) (ADVP (RB carefully)) (VP (VBN monitored))))) (. .))))

nsubjpass(monitored-10, Patients-1)
partmod(Patients-1, receiving-2)
det(drugs-5, the-3)
num(drugs-5, two-4)
dobj(receiving-2, drugs-5)
advmod(monitored-10, concomitantly-6)
aux(monitored-10, should-7)
auxpass(monitored-10, be-8)
advmod(monitored-10, carefully-9)
root(ROOT-0, monitored-10)

Digoxin/NN :/: Some/DT calcium/NN blockers/NNS may/MD increase/VB the/DT concentration/NN of/IN digitalis/NN preparation/NN s/NNS in/IN the/DT blood/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Digoxin)) (: :) (NP (DT Some) (NN calcium) (NNS blockers))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN concentration)) (PP (IN of) (NP (NP (NN digitalis) (NN preparation) (NNS s)) (PP (IN in) (NP (DT the) (NN blood))))))))) (. .))))

nsubj(increase-7, Digoxin-1)
det(blockers-5, Some-3)
nn(blockers-5, calcium-4)
dep(Digoxin-1, blockers-5)
aux(increase-7, may-6)
root(ROOT-0, increase-7)
det(concentration-9, the-8)
dobj(increase-7, concentration-9)
nn(s-13, digitalis-11)
nn(s-13, preparation-12)
prep_of(concentration-9, s-13)
det(blood-16, the-15)
prep_in(s-13, blood-16)

Nicardipine/NN HCl/NN usually/RB does/VBZ not/RB alter/VB the/DT plasma/NN levels/NNS of/IN digoxin/NN ,/, however/RB ,/, serum/NN digoxin/NN levels/NNS should/MD be/VB evaluated/VBN after/IN concomitant/JJ therapy/NN with/IN nicardipine/CD HCl/NN is/VBZ initiated/VBN ./.

(ROOT (S1 (S (S (S (NP (NN Nicardipine) (NN HCl)) (ADVP (RB usually)) (VP (VBZ does) (RB not) (VP (VB alter) (NP (NP (DT the) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN digoxin))))))) (, ,) (S (S (ADVP (RB however)) (, ,) (NP (NN serum) (NN digoxin) (NNS levels)) (VP (MD should) (VP (VB be) (VP (VBN evaluated) (PP (IN after) (NP (NP (JJ concomitant) (NN therapy)) (PP (IN with) (NP (CD nicardipine) (NN HCl))))))))) (VP (VBZ is) (VP (VBN initiated))))) (. .))))

nn(HCl-2, Nicardipine-1)
nsubj(alter-6, HCl-2)
advmod(alter-6, usually-3)
aux(alter-6, does-4)
neg(alter-6, not-5)
root(ROOT-0, alter-6)
det(levels-9, the-7)
nn(levels-9, plasma-8)
dobj(alter-6, levels-9)
prep_of(levels-9, digoxin-11)
advmod(evaluated-20, however-13)
nn(levels-17, serum-15)
nn(levels-17, digoxin-16)
nsubjpass(evaluated-20, levels-17)
aux(evaluated-20, should-18)
auxpass(evaluated-20, be-19)
csubjpass(initiated-28, evaluated-20)
amod(therapy-23, concomitant-22)
prep_after(evaluated-20, therapy-23)
num(HCl-26, nicardipine-25)
prep_with(therapy-23, HCl-26)
auxpass(initiated-28, is-27)
dep(alter-6, initiated-28)

Maalox/NN @/NN */NN Coadministration/NN of/IN Maalox/NN TC/NN had/VBD no/DT effect/NN on/IN nicardipine/CD HCl/NN absorption/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Maalox) (NN @) (NN *) (NN Coadministration)) (PP (IN of) (NP (NN Maalox) (NN TC)))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (CD nicardipine) (NN HCl) (NN absorption))))) (. .))))

nn(Coadministration-4, Maalox-1)
nn(Coadministration-4, @-2)
nn(Coadministration-4, *-3)
nsubj(had-8, Coadministration-4)
nn(TC-7, Maalox-6)
prep_of(Coadministration-4, TC-7)
root(ROOT-0, had-8)
det(effect-10, no-9)
dobj(had-8, effect-10)
num(absorption-14, nicardipine-12)
nn(absorption-14, HCl-13)
prep_on(had-8, absorption-14)

Fentanyl/JJ Anesthesia/NN Severe/JJ hypotension/NN has/VBZ been/VBN reported/VBN during/IN fentanyl/JJ anesthesia/NN with/IN concomitant/JJ use/NN of/IN a/DT beta-blocker/NN and/CC a/DT calcium/NN channel/NN blocker/NN ./.

(ROOT (S1 (S (S (NP (JJ Fentanyl) (NN Anesthesia) (JJ Severe) (NN hypotension)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN during) (NP (NP (JJ fentanyl) (NN anesthesia)) (PP (IN with) (NP (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (DT a) (NN beta-blocker)))) (CC and) (NP (DT a) (NN calcium) (NN channel) (NN blocker)))))))))) (. .))))

amod(hypotension-4, Fentanyl-1)
nn(hypotension-4, Anesthesia-2)
amod(hypotension-4, Severe-3)
nsubjpass(reported-7, hypotension-4)
aux(reported-7, has-5)
auxpass(reported-7, been-6)
root(ROOT-0, reported-7)
amod(anesthesia-10, fentanyl-9)
prep_during(reported-7, anesthesia-10)
amod(use-13, concomitant-12)
prep_with(anesthesia-10, use-13)
det(beta-blocker-16, a-15)
prep_of(use-13, beta-blocker-16)
det(blocker-21, a-18)
nn(blocker-21, calcium-19)
nn(blocker-21, channel-20)
conj_and(use-13, blocker-21)

Even/RB though/IN such/JJ interactions/NNS were/VBD not/RB seen/VBN during/IN clinical/JJ studies/NNS with/IN nicardipine/CD HCl/NN ,/, an/DT increased/VBN volume/NN of/IN circulating/JJ fluids/NNS might/MD be/VB required/VBN if/IN such/PDT an/DT interaction/NN were/VBD to/TO occur/VB ./.

(ROOT (S1 (S (S (SBAR (RB Even) (IN though) (S (NP (JJ such) (NNS interactions)) (VP (VBD were) (RB not) (VP (VBN seen) (PP (IN during) (NP (NP (JJ clinical) (NNS studies)) (PP (IN with) (NP (CD nicardipine) (NN HCl))))))))) (, ,) (NP (NP (DT an) (VBN increased) (NN volume)) (PP (IN of) (NP (JJ circulating) (NNS fluids)))) (VP (MD might) (VP (VB be) (VP (VBN required) (SBAR (IN if) (S (NP (PDT such) (DT an) (NN interaction)) (VP (VBD were) (S (VP (TO to) (VP (VB occur))))))))))) (. .))))

advmod(seen-7, Even-1)
dep(seen-7, though-2)
amod(interactions-4, such-3)
nsubjpass(seen-7, interactions-4)
auxpass(seen-7, were-5)
neg(seen-7, not-6)
advcl(required-23, seen-7)
amod(studies-10, clinical-9)
prep_during(seen-7, studies-10)
num(HCl-13, nicardipine-12)
prep_with(studies-10, HCl-13)
det(volume-17, an-15)
amod(volume-17, increased-16)
nsubjpass(required-23, volume-17)
amod(fluids-20, circulating-19)
prep_of(volume-17, fluids-20)
aux(required-23, might-21)
auxpass(required-23, be-22)
root(ROOT-0, required-23)
mark(were-28, if-24)
predet(interaction-27, such-25)
det(interaction-27, an-26)
nsubj(were-28, interaction-27)
advcl(required-23, were-28)
aux(occur-30, to-29)
xcomp(were-28, occur-30)

Cyclosporine/NN Concomitant/JJ administration/NN of/IN nicardipine/NN and/CC cyclosporine/NN levels/NNS ./.

(ROOT (S1 (S (NP (NP (NN Cyclosporine) (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NN nicardipine)) (CC and) (NP (NN cyclosporine) (NNS levels)))) (. .)))))

nn(administration-3, Cyclosporine-1)
amod(administration-3, Concomitant-2)
root(ROOT-0, administration-3)
prep_of(administration-3, nicardipine-5)
nn(levels-8, cyclosporine-7)
conj_and(nicardipine-5, levels-8)

Plasma/NN concentrations/NNS of/IN cyclosporine/NN should/MD therefore/RB be/VB closely/RB monitored/VBN ,/, and/CC its/PRP$ dosage/NN reduced/VBD accordingly/RB ,/, in/IN patients/NNS treated/VBN with/IN nicardipine/NN ./.

(ROOT (S1 (S (S (S (NP (NP (NN Plasma) (NNS concentrations)) (PP (IN of) (NP (NN cyclosporine)))) (VP (MD should) (ADVP (RB therefore)) (VP (VB be) (ADVP (RB closely)) (VP (VBN monitored))))) (, ,) (CC and) (S (NP (PRP$ its) (NN dosage)) (VP (VBD reduced) (ADVP (RB accordingly)) (, ,) (PP (IN in) (NP (NP (NNS patients)) (VP (VBN treated) (PP (IN with) (NP (NN nicardipine))))))))) (. .))))

nn(concentrations-2, Plasma-1)
nsubjpass(monitored-9, concentrations-2)
prep_of(concentrations-2, cyclosporine-4)
aux(monitored-9, should-5)
advmod(monitored-9, therefore-6)
auxpass(monitored-9, be-7)
advmod(monitored-9, closely-8)
root(ROOT-0, monitored-9)
poss(dosage-13, its-12)
nsubj(reduced-14, dosage-13)
conj_and(monitored-9, reduced-14)
advmod(reduced-14, accordingly-15)
prep_in(reduced-14, patients-18)
partmod(patients-18, treated-19)
prep_with(treated-19, nicardipine-21)

When/WRB therapeutic/JJ concentrations/NNS of/IN furosemide/NN ,/, propranolol/NN ,/, dipyridamole/NN ,/, warfarin/NN ,/, quinidine/NN ,/, or/CC naproxen/NN were/VBD added/VBN to/TO human/JJ plasma/NN (/-LRB- in/FW vitro/FW )/-RRB- ,/, the/DT plasma/NN protein/NN binding/NN of/IN nicardipine/CD HCl/NN was/VBD not/RB altered/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (NP (NP (JJ therapeutic) (NNS concentrations)) (PP (IN of) (NP (NP (NN furosemide)) (, ,) (NP (NN propranolol)) (, ,) (NP (NN dipyridamole)) (, ,) (NP (NN warfarin)) (, ,) (NP (NN quinidine)) (, ,) (CC or) (NP (NN naproxen))))) (VP (VBD were) (VP (VBN added) (PP (TO to) (NP (NP (JJ human) (NN plasma)) (PRN (-LRB- -LRB-) (NP (FW in) (FW vitro)) (-RRB- -RRB-)))))))) (, ,) (NP (NP (DT the) (NN plasma) (NN protein) (NN binding)) (PP (IN of) (NP (CD nicardipine) (NN HCl)))) (VP (VBD was) (RB not) (VP (VBN altered)))) (. .))))

advmod(added-18, When-1)
amod(concentrations-3, therapeutic-2)
nsubjpass(added-18, concentrations-3)
prep_of(concentrations-3, furosemide-5)
conj_or(furosemide-5, propranolol-7)
conj_or(furosemide-5, dipyridamole-9)
conj_or(furosemide-5, warfarin-11)
conj_or(furosemide-5, quinidine-13)
conj_or(furosemide-5, naproxen-16)
auxpass(added-18, were-17)
advcl(altered-36, added-18)
amod(plasma-21, human-20)
prep_to(added-18, plasma-21)
nn(vitro-24, in-23)
dep(plasma-21, vitro-24)
det(binding-30, the-27)
nn(binding-30, plasma-28)
nn(binding-30, protein-29)
nsubjpass(altered-36, binding-30)
num(HCl-33, nicardipine-32)
prep_of(binding-30, HCl-33)
auxpass(altered-36, was-34)
neg(altered-36, not-35)
root(ROOT-0, altered-36)

Physiological/JJ changes/NNS resulting/VBG from/IN smoking/NN cessation/NN ,/, with/IN or/CC without/IN nicotine/NN replacement/NN ,/, may/MD alter/VB the/DT pharmacokinetics/NNS of/IN certain/JJ concomitant/JJ medications/NNS ,/, such/JJ as/IN tricyclic/JJ antidepressants/NNS and/CC theophylline/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Physiological) (NNS changes)) (VP (VBG resulting) (PP (IN from) (NP (NN smoking) (NN cessation)))) (, ,) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NN nicotine) (NN replacement)))) (, ,)) (VP (MD may) (VP (VB alter) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (JJ certain) (JJ concomitant) (NNS medications)) (, ,) (PP (JJ such) (IN as) (NP (NP (JJ tricyclic) (NNS antidepressants)) (CC and) (NP (NN theophylline)))))))))) (. .))))

amod(changes-2, Physiological-1)
nsubj(alter-15, changes-2)
partmod(changes-2, resulting-3)
nn(cessation-6, smoking-5)
prep_from(resulting-3, cessation-6)
prep(changes-2, with-8)
conj_or(with-8, without-10)
nn(replacement-12, nicotine-11)
pobj(without-10, replacement-12)
aux(alter-15, may-14)
root(ROOT-0, alter-15)
det(pharmacokinetics-17, the-16)
dobj(alter-15, pharmacokinetics-17)
amod(medications-21, certain-19)
amod(medications-21, concomitant-20)
prep_of(pharmacokinetics-17, medications-21)
amod(antidepressants-26, tricyclic-25)
prep_such_as(medications-21, antidepressants-26)
conj_and(antidepressants-26, theophylline-28)

Doses/NNS of/IN these/DT and/CC perhaps/RB other/JJ medications/NNS may/MD need/VBP to/TO be/VB adjusted/VBN in/IN patients/NNS who/WP successfully/RB quit/VB smoking/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Doses)) (PP (IN of) (NP (ADJP (ADJP (DT these)) (CC and) (ADJP (ADVP (RB perhaps)) (JJ other))) (NNS medications)))) (VP (MD may) (VP (VBP need) (S (VP (TO to) (VP (VB be) (VP (VBN adjusted) (PP (IN in) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (ADVP (RB successfully)) (VP (VB quit) (NP (NN smoking)))))))))))))) (. .))))

nsubj(need-9, Doses-1)
xsubj(adjusted-12, Doses-1)
amod(medications-7, these-3)
advmod(other-6, perhaps-5)
conj_and(these-3, other-6)
prep_of(Doses-1, medications-7)
aux(need-9, may-8)
root(ROOT-0, need-9)
aux(adjusted-12, to-10)
auxpass(adjusted-12, be-11)
xcomp(need-9, adjusted-12)
prep_in(adjusted-12, patients-14)
nsubj(quit-17, patients-14)
advmod(quit-17, successfully-16)
rcmod(patients-14, quit-17)
dobj(quit-17, smoking-18)

In/FW vitro/FW ,/, nilutamide/NN has/VBZ been/VBN shown/VBN to/TO inhibit/VB the/DT activity/NN of/IN liver/NN cytochrome/NN P-450/NN isoenzymes/NNS and/CC therefore/RB ,/, may/MD reduce/VB the/DT metabolism/NN of/IN compounds/NNS requiring/VBG these/DT systems/NNS ./.

(ROOT (S1 (S (S (ADVP (FW In) (FW vitro)) (, ,) (NP (NN nilutamide)) (VP (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB inhibit) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (NN liver) (NN cytochrome) (NN P-450) (NNS isoenzymes)))))))))) (CC and) (VP (ADVP (RB therefore)) (, ,) (VP (MD may) (VP (VB reduce) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NP (NNS compounds)) (VP (VBG requiring) (NP (DT these) (NNS systems))))))))))) (. .))))

nn(vitro-2, In-1)
advmod(shown-7, vitro-2)
nsubjpass(shown-7, nilutamide-4)
xsubj(inhibit-9, nilutamide-4)
aux(shown-7, has-5)
auxpass(shown-7, been-6)
root(ROOT-0, shown-7)
aux(inhibit-9, to-8)
xcomp(shown-7, inhibit-9)
det(activity-11, the-10)
dobj(inhibit-9, activity-11)
nn(isoenzymes-16, liver-13)
nn(isoenzymes-16, cytochrome-14)
nn(isoenzymes-16, P-450-15)
prep_of(activity-11, isoenzymes-16)
advmod(reduce-21, therefore-18)
aux(reduce-21, may-20)
conj_and(shown-7, reduce-21)
det(metabolism-23, the-22)
dobj(reduce-21, metabolism-23)
prep_of(metabolism-23, compounds-25)
partmod(compounds-25, requiring-26)
det(systems-28, these-27)
dobj(requiring-26, systems-28)

Consequently/RB ,/, drugs/NNS with/IN a/DT low/JJ therapeutic/JJ margin/NN ,/, such/JJ as/IN vitamin/NN K/NN antagonists/NNS ,/, phenytoin/NN ,/, and/CC theophylline/NN ,/, could/MD have/VB a/DT delayed/VBN elimination/NN and/CC increases/NNS in/IN their/PRP$ serum/NN half-life/NN leading/VBG to/TO a/DT toxic/JJ level/NN ./.

(ROOT (S1 (S (S (ADVP (RB Consequently)) (, ,) (NP (NP (NNS drugs)) (PP (IN with) (NP (DT a) (JJ low) (JJ therapeutic) (NN margin))) (, ,) (PP (JJ such) (IN as) (NP (NP (NN vitamin) (NN K) (NNS antagonists)) (, ,) (NP (NP (NN phenytoin)) (, ,) (CC and) (NP (NN theophylline))))) (, ,)) (VP (MD could) (VP (VB have) (NP (NP (DT a) (VBN delayed) (NN elimination)) (CC and) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (PRP$ their) (NN serum) (NN half-life)) (VP (VBG leading) (PP (TO to) (NP (DT a) (JJ toxic) (NN level))))))))))) (. .))))

advmod(have-22, Consequently-1)
nsubj(have-22, drugs-3)
det(margin-8, a-5)
amod(margin-8, low-6)
amod(margin-8, therapeutic-7)
prep_with(drugs-3, margin-8)
nn(antagonists-14, vitamin-12)
nn(antagonists-14, K-13)
prep_such_as(drugs-3, antagonists-14)
appos(antagonists-14, phenytoin-16)
conj_and(phenytoin-16, theophylline-19)
aux(have-22, could-21)
root(ROOT-0, have-22)
det(elimination-25, a-23)
amod(elimination-25, delayed-24)
dobj(have-22, elimination-25)
conj_and(elimination-25, increases-27)
poss(half-life-31, their-29)
nn(half-life-31, serum-30)
prep_in(increases-27, half-life-31)
partmod(half-life-31, leading-32)
det(level-36, a-34)
amod(level-36, toxic-35)
prep_to(leading-32, level-36)

The/DT dosage/NN of/IN these/DT drugs/NNS or/CC others/NNS with/IN a/DT similar/JJ metabolism/NN may/MD need/VBP to/TO be/VB modified/VBN if/IN they/PRP are/VBP administered/VBN concomitantly/RB with/IN nilutamide/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN dosage)) (PP (IN of) (NP (NP (DT these) (NP (NNS drugs)) (CC or) (NP (NNS others))) (PP (IN with) (NP (DT a) (JJ similar) (NN metabolism)))))) (VP (MD may) (VP (VBP need) (S (VP (TO to) (VP (VB be) (VP (VBN modified) (SBAR (IN if) (S (NP (PRP they)) (VP (VBP are) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN nilutamide)))))))))))))) (. .))))

det(dosage-2, The-1)
nsubj(need-13, dosage-2)
xsubj(modified-16, dosage-2)
dep(drugs-5, these-4)
prep_of(dosage-2, drugs-5)
conj_or(drugs-5, others-7)
det(metabolism-11, a-9)
amod(metabolism-11, similar-10)
prep_with(drugs-5, metabolism-11)
aux(need-13, may-12)
root(ROOT-0, need-13)
aux(modified-16, to-14)
auxpass(modified-16, be-15)
xcomp(need-13, modified-16)
mark(administered-20, if-17)
nsubjpass(administered-20, they-18)
auxpass(administered-20, are-19)
advcl(modified-16, administered-20)
advmod(administered-20, concomitantly-21)
prep_with(administered-20, nilutamide-23)

For/IN example/NN ,/, when/WRB vitamin/NN K/NN antagonists/NNS are/VBP administered/VBN concomitantly/RB with/IN nilutamide/NN ,/, prothrombin/NN time/NN should/MD be/VB carefully/RB monitored/VBN and/CC if/IN necessary/JJ ,/, the/DT dosage/NN of/IN vitamin/NN K/NN antagonists/NNS should/MD be/VB reduced/VBN ./.

(ROOT (S1 (S (S (S (PP (IN For) (NP (NN example))) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NN vitamin) (NN K) (NNS antagonists)) (VP (VBP are) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN nilutamide))))))) (, ,) (NP (NN prothrombin) (NN time)) (VP (MD should) (VP (VB be) (ADVP (RB carefully)) (VP (VBN monitored))))) (CC and) (S (SBAR (IN if) (FRAG (JJ necessary))) (, ,) (NP (NP (DT the) (NN dosage)) (PP (IN of) (NP (NN vitamin) (NN K) (NNS antagonists)))) (VP (MD should) (VP (VB be) (VP (VBN reduced)))))) (. .))))

prep_for(monitored-19, example-2)
advmod(administered-9, when-4)
nn(antagonists-7, vitamin-5)
nn(antagonists-7, K-6)
nsubjpass(administered-9, antagonists-7)
auxpass(administered-9, are-8)
advcl(monitored-19, administered-9)
advmod(administered-9, concomitantly-10)
prep_with(administered-9, nilutamide-12)
nn(time-15, prothrombin-14)
nsubjpass(monitored-19, time-15)
aux(monitored-19, should-16)
auxpass(monitored-19, be-17)
advmod(monitored-19, carefully-18)
root(ROOT-0, monitored-19)
mark(necessary-22, if-21)
advcl(reduced-32, necessary-22)
det(dosage-25, the-24)
nsubjpass(reduced-32, dosage-25)
nn(antagonists-29, vitamin-27)
nn(antagonists-29, K-28)
prep_of(dosage-25, antagonists-29)
aux(reduced-32, should-30)
auxpass(reduced-32, be-31)
conj_and(monitored-19, reduced-32)

It/PRP is/VBZ possible/JJ that/IN the/DT cardiovascular/JJ action/NN of/IN other/JJ calcium/NN channel/NN blockers/NNS could/MD be/VB enhanced/VBN by/IN the/DT addition/NN of/IN Nimotop/NN @./NNS

(ROOT (S1 (S (NP (PRP It)) (VP (VBZ is) (ADJP (JJ possible)) (SBAR (IN that) (S (NP (NP (DT the) (JJ cardiovascular) (NN action)) (PP (IN of) (NP (JJ other) (NN calcium) (NN channel) (NNS blockers)))) (VP (MD could) (VP (VB be) (VP (VBN enhanced) (PP (IN by) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN Nimotop) (NNS @.))))))))))))))

nsubj(possible-3, It-1)
cop(possible-3, is-2)
root(ROOT-0, possible-3)
complm(enhanced-15, that-4)
det(action-7, the-5)
amod(action-7, cardiovascular-6)
nsubjpass(enhanced-15, action-7)
amod(blockers-12, other-9)
nn(blockers-12, calcium-10)
nn(blockers-12, channel-11)
prep_of(action-7, blockers-12)
aux(enhanced-15, could-13)
auxpass(enhanced-15, be-14)
ccomp(possible-3, enhanced-15)
det(addition-18, the-17)
agent(enhanced-15, addition-18)
nn(@.-21, Nimotop-20)
prep_of(addition-18, @.-21)

In/IN Europe/NN ,/, Nimotop/NN @/NN was/VBD observed/VBN to/TO occasionally/RB intensify/VB the/DT effect/NN of/IN antihypertensive/JJ compounds/NNS taken/VBN concomitantly/RB by/IN patients/NNS suffering/VBG from/IN hypertension/NN ;/: ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN Europe))) (, ,) (NP (NN Nimotop) (NN @)) (VP (VBD was) (VP (VBN observed) (S (VP (TO to) (ADVP (RB occasionally)) (VP (VB intensify) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (JJ antihypertensive) (NNS compounds)) (VP (VBN taken) (ADVP (RB concomitantly)) (PP (IN by) (NP (NP (NNS patients)) (VP (VBG suffering) (PP (IN from) (NP (NN hypertension))))))))))))))) (: ;)) (. .))))

prep_in(observed-7, Europe-2)
nn(@-5, Nimotop-4)
nsubjpass(observed-7, @-5)
xsubj(intensify-10, @-5)
auxpass(observed-7, was-6)
root(ROOT-0, observed-7)
aux(intensify-10, to-8)
advmod(intensify-10, occasionally-9)
xcomp(observed-7, intensify-10)
det(effect-12, the-11)
dobj(intensify-10, effect-12)
amod(compounds-15, antihypertensive-14)
prep_of(effect-12, compounds-15)
partmod(compounds-15, taken-16)
advmod(taken-16, concomitantly-17)
agent(taken-16, patients-19)
partmod(patients-19, suffering-20)
prep_from(suffering-20, hypertension-22)

A/DT study/NN in/IN eight/CD healthy/JJ volunteers/NNS has/VBZ shown/VBN a/DT 50/CD %/NN increase/NN in/IN mean/JJ peak/NN nimodipine/NN plasma/NN concentrations/NNS and/CC a/DT 90/CD %/NN increase/NN in/IN mean/NN area/NN under/IN the/DT curve/NN ,/, after/IN a/DT one/CD week/NN course/NN of/IN cimetidine/NN at/IN 1,000/CD mg/day/NN and/CC nimodipine/NN at/IN 90/CD mg/day/NN ./.

(ROOT (S1 (S (S (NP (NP (DT A) (NN study)) (PP (IN in) (NP (CD eight) (JJ healthy) (NNS volunteers)))) (VP (VBZ has) (VP (VBN shown) (NP (NP (NP (DT a) (ADJP (CD 50) (NN %)) (NN increase)) (PP (IN in) (NP (JJ mean) (NN peak) (NN nimodipine) (NN plasma) (NNS concentrations)))) (CC and) (NP (NP (DT a) (ADJP (CD 90) (NN %)) (NN increase)) (PP (IN in) (NP (NP (NN mean) (NN area)) (PP (IN under) (NP (DT the) (NN curve))))))) (, ,) (PP (IN after) (NP (NP (DT a) (CD one) (NN week) (NN course)) (PP (IN of) (NP (NP (NP (NN cimetidine)) (PP (IN at) (NP (CD 1,000) (NN mg/day)))) (CC and) (NP (NP (NN nimodipine)) (PP (IN at) (NP (CD 90) (NN mg/day))))))))))) (. .))))

det(study-2, A-1)
nsubj(shown-8, study-2)
num(volunteers-6, eight-4)
amod(volunteers-6, healthy-5)
prep_in(study-2, volunteers-6)
aux(shown-8, has-7)
root(ROOT-0, shown-8)
det(increase-12, a-9)
number(%-11, 50-10)
amod(increase-12, %-11)
dobj(shown-8, increase-12)
amod(concentrations-18, mean-14)
nn(concentrations-18, peak-15)
nn(concentrations-18, nimodipine-16)
nn(concentrations-18, plasma-17)
prep_in(increase-12, concentrations-18)
det(increase-23, a-20)
number(%-22, 90-21)
amod(increase-23, %-22)
conj_and(increase-12, increase-23)
nn(area-26, mean-25)
prep_in(increase-23, area-26)
det(curve-29, the-28)
prep_under(area-26, curve-29)
det(course-35, a-32)
num(course-35, one-33)
nn(course-35, week-34)
prep_after(shown-8, course-35)
prep_of(course-35, cimetidine-37)
num(mg/day-40, 1,000-39)
prep_at(cimetidine-37, mg/day-40)
conj_and(cimetidine-37, nimodipine-42)
num(mg/day-45, 90-44)
prep_at(nimodipine-42, mg/day-45)

This/DT effect/NN may/MD be/VB mediated/VBN by/IN the/DT known/JJ inhibition/NN of/IN hepatic/JJ cytochrome/NN P-/NN 450/CD by/IN cimetidine/NN ,/, which/WDT could/MD decrease/VB first/JJ pass/NN metabolism/NN of/IN nimodipine/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN effect)) (VP (MD may) (VP (VB be) (VP (VBN mediated) (PP (IN by) (NP (NP (DT the) (JJ known) (NN inhibition)) (PP (IN of) (NP (JJ hepatic) (NN cytochrome) (NN P-) (CD 450))) (PP (IN by) (NP (NP (NN cimetidine)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD could) (VP (VB decrease) (NP (NP (JJ first) (NN pass) (NN metabolism)) (PP (IN of) (NP (NN nimodipine)))))))))))))))) (. .))))

det(effect-2, This-1)
nsubjpass(mediated-5, effect-2)
aux(mediated-5, may-3)
auxpass(mediated-5, be-4)
root(ROOT-0, mediated-5)
det(inhibition-9, the-7)
amod(inhibition-9, known-8)
agent(mediated-5, inhibition-9)
amod(P--13, hepatic-11)
nn(P--13, cytochrome-12)
prep_of(inhibition-9, P--13)
num(P--13, 450-14)
prep_by(inhibition-9, cimetidine-16)
nsubj(decrease-20, cimetidine-16)
aux(decrease-20, could-19)
rcmod(cimetidine-16, decrease-20)
amod(metabolism-23, first-21)
nn(metabolism-23, pass-22)
dobj(decrease-20, metabolism-23)
prep_of(metabolism-23, nimodipine-25)

No/DT formal/JJ drug-interaction/NN studies/NNS have/VBP been/VBN performed/VBN ,/, and/CC a/DT clinically/RB significant/JJ interaction/NN with/IN other/JJ medications/NNS used/VBN in/IN the/DT treatment/NN of/IN hypoxic/JJ respiratory/JJ failure/NN cannot/MD be/VB excluded/VBN based/VBN on/IN the/DT available/JJ data/NNS ./.

(ROOT (S1 (S (S (S (NP (DT No) (JJ formal) (NN drug-interaction) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN performed))))) (, ,) (CC and) (S (NP (NP (DT a) (ADJP (RB clinically) (JJ significant)) (NN interaction)) (PP (IN with) (NP (NP (JJ other) (NNS medications)) (VP (VBN used) (PP (IN in) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (JJ hypoxic) (JJ respiratory) (NN failure))))))))) (VP (MD cannot) (VP (VB be) (VP (VBN excluded) (PP (VBN based) (PP (IN on) (NP (DT the) (JJ available) (NNS data))))))))) (. .))))

det(studies-4, No-1)
amod(studies-4, formal-2)
nn(studies-4, drug-interaction-3)
nsubjpass(performed-7, studies-4)
aux(performed-7, have-5)
auxpass(performed-7, been-6)
root(ROOT-0, performed-7)
det(interaction-13, a-10)
advmod(significant-12, clinically-11)
amod(interaction-13, significant-12)
nsubj(cannot-25, interaction-13)
amod(medications-16, other-15)
prep_with(interaction-13, medications-16)
partmod(medications-16, used-17)
det(treatment-20, the-19)
prep_in(used-17, treatment-20)
amod(failure-24, hypoxic-22)
amod(failure-24, respiratory-23)
prep_of(treatment-20, failure-24)
conj_and(performed-7, cannot-25)
auxpass(excluded-27, be-26)
dep(cannot-25, excluded-27)
prepc_based_on(excluded-27, on-29)
det(data-32, the-30)
amod(data-32, available-31)
pobj(excluded-27, data-32)

INOmax/NN has/VBZ been/VBN administered/VBN with/IN tolazoline/NN ,/, dopamine/NN ,/, dobutamine/NN ,/, steroids/NNS ,/, surfactant/NN ,/, and/CC high-frequency/VBP ventilation/NN ./.

(ROOT (S1 (S (S (NP (NN INOmax)) (VP (VBZ has) (VP (VBN been) (VP (VBN administered) (PP (IN with) (NP (NP (NN tolazoline)) (, ,) (NP (NN dopamine)) (, ,) (NP (NN dobutamine)) (, ,) (NP (NNS steroids)) (, ,) (NP (NN surfactant)) (, ,) (CC and) (NP (VBP high-frequency) (NN ventilation)))))))) (. .))))

nsubjpass(administered-4, INOmax-1)
aux(administered-4, has-2)
auxpass(administered-4, been-3)
root(ROOT-0, administered-4)
prep_with(administered-4, tolazoline-6)
conj_and(tolazoline-6, dopamine-8)
conj_and(tolazoline-6, dobutamine-10)
conj_and(tolazoline-6, steroids-12)
conj_and(tolazoline-6, surfactant-14)
dep(ventilation-18, high-frequency-17)
conj_and(tolazoline-6, ventilation-18)

Although/IN there/EX are/VBP no/DT study/NN data/NN to/TO evaluate/VB the/DT possibility/NN ,/, nitric/JJ oxide/NN donor/NN compounds/NNS ,/, including/VBG sodium/NN nitroprusside/NN and/CC nitroglycerin/NN ,/, may/MD have/VB an/DT additive/JJ effect/NN with/IN INOmax/NN on/IN the/DT risk/NN of/IN developing/VBG methemoglobinemia/NN ./.

(ROOT (S1 (S (SBAR (IN Although) (S (NP (EX there)) (VP (VBP are) (NP (DT no) (NN study) (NN data)) (S (VP (TO to) (VP (VB evaluate) (NP (DT the) (NN possibility)))))))) (, ,) (NP (NP (NP (JJ nitric) (NN oxide)) (NN donor) (NNS compounds)) (, ,) (PP (VBG including) (NP (NP (NN sodium) (NN nitroprusside)) (CC and) (NP (NN nitroglycerin)))) (, ,)) (VP (MD may) (VP (VB have) (NP (NP (DT an) (JJ additive) (NN effect)) (PP (IN with) (NP (NN INOmax))) (PP (IN on) (NP (NP (DT the) (NN risk)) (PP (IN of) (S (VP (VBG developing) (NP (NN methemoglobinemia)))))))))) (. .))))

mark(are-3, Although-1)
expl(are-3, there-2)
advcl(have-24, are-3)
det(data-6, no-4)
nn(data-6, study-5)
nsubj(are-3, data-6)
aux(evaluate-8, to-7)
xcomp(are-3, evaluate-8)
det(possibility-10, the-9)
dobj(evaluate-8, possibility-10)
amod(oxide-13, nitric-12)
nn(compounds-15, oxide-13)
nn(compounds-15, donor-14)
nsubj(have-24, compounds-15)
nn(nitroprusside-19, sodium-18)
prep_including(compounds-15, nitroprusside-19)
conj_and(nitroprusside-19, nitroglycerin-21)
aux(have-24, may-23)
root(ROOT-0, have-24)
det(effect-27, an-25)
amod(effect-27, additive-26)
dobj(have-24, effect-27)
prep_with(effect-27, INOmax-29)
det(risk-32, the-31)
prep_on(effect-27, risk-32)
prepc_of(risk-32, developing-34)
dobj(developing-34, methemoglobinemia-35)

An/DT association/NN between/IN prilocaine/NN and/CC an/DT increased/VBN risk/NN of/IN methaemoglobinaemia/NN ,/, particularly/RB in/IN infants/NNS ,/, has/VBZ specifically/RB been/VBN described/VBN in/IN a/DT literature/NN case/NN report/NN ./.

(ROOT (S1 (S (S (NP (NP (DT An) (NN association)) (PP (IN between) (NP (NP (NN prilocaine)) (CC and) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (NN methaemoglobinaemia)))))) (, ,) (ADVP (RB particularly)) (PP (IN in) (NP (NNS infants))) (, ,)) (VP (VBZ has) (ADVP (RB specifically)) (VP (VBN been) (VP (VBN described) (PP (IN in) (NP (DT a) (NN literature) (NN case) (NN report))))))) (. .))))

det(association-2, An-1)
nsubjpass(described-19, association-2)
prep_between(association-2, prilocaine-4)
det(risk-8, an-6)
amod(risk-8, increased-7)
conj_and(prilocaine-4, risk-8)
prep_of(risk-8, methaemoglobinaemia-10)
advmod(association-2, particularly-12)
prep_in(association-2, infants-14)
aux(described-19, has-16)
advmod(described-19, specifically-17)
auxpass(described-19, been-18)
root(ROOT-0, described-19)
det(report-24, a-21)
nn(report-24, literature-22)
nn(report-24, case-23)
prep_in(described-19, report-24)

This/DT risk/NN is/VBZ present/JJ whether/IN the/DT drugs/NNS are/VBP administered/VBN as/IN oral/JJ ,/, parenteral/JJ ,/, or/CC topical/JJ formulations/NNS ./.

(ROOT (S1 (S (S (NP (DT This) (NN risk)) (VP (VBZ is) (ADJP (JJ present)) (SBAR (IN whether) (S (NP (DT the) (NNS drugs)) (VP (VBP are) (VP (VBN administered) (PP (IN as) (NP (ADJP (ADJP (JJ oral)) (, ,) (ADJP (JJ parenteral)) (, ,) (CC or) (ADJP (JJ topical))) (NNS formulations))))))))) (. .))))

det(risk-2, This-1)
nsubj(present-4, risk-2)
cop(present-4, is-3)
root(ROOT-0, present-4)
complm(administered-9, whether-5)
det(drugs-7, the-6)
nsubjpass(administered-9, drugs-7)
auxpass(administered-9, are-8)
ccomp(present-4, administered-9)
amod(formulations-17, oral-11)
conj_or(oral-11, parenteral-13)
conj_or(oral-11, topical-16)
prep_as(administered-9, formulations-17)

Antacids/NNS containing/VBG magnesium/NN trisilicate/NN ,/, when/WRB administered/VBN concomitantly/RB with/IN nitrofurantoin/NN ,/, reduce/VBP both/CC the/DT rate/NN and/CC extent/NN of/IN absorption/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Antacids)) (VP (VBG containing) (NP (NN magnesium) (NN trisilicate))) (, ,) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN nitrofurantoin)))))) (, ,)) (VP (VBP reduce) (NP (NP (CC both) (DT the) (NP (NN rate)) (CC and) (NP (NN extent))) (PP (IN of) (NP (NN absorption)))))) (. .))))

nsubj(reduce-12, Antacids-1)
partmod(Antacids-1, containing-2)
nn(trisilicate-4, magnesium-3)
dobj(containing-2, trisilicate-4)
advmod(administered-7, when-6)
dep(Antacids-1, administered-7)
advmod(administered-7, concomitantly-8)
prep_with(administered-7, nitrofurantoin-10)
root(ROOT-0, reduce-12)
preconj(rate-15, both-13)
dep(rate-15, the-14)
dobj(reduce-12, rate-15)
conj_and(rate-15, extent-17)
prep_of(rate-15, absorption-19)

The/DT mechanism/NN for/IN this/DT interaction/NN probably/RB is/VBZ adsorption/NN of/IN nitrofurantoin/NN onto/IN the/DT surface/NN of/IN magnesium/NN trisilicate/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN mechanism)) (PP (IN for) (NP (DT this) (NN interaction)))) (ADVP (RB probably)) (VP (VBZ is) (NP (NP (NN adsorption)) (PP (IN of) (NP (NN nitrofurantoin))) (PP (IN onto) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (NN magnesium) (NN trisilicate)))))))) (. .))))

det(mechanism-2, The-1)
nsubj(adsorption-8, mechanism-2)
det(interaction-5, this-4)
prep_for(mechanism-2, interaction-5)
advmod(adsorption-8, probably-6)
cop(adsorption-8, is-7)
root(ROOT-0, adsorption-8)
prep_of(adsorption-8, nitrofurantoin-10)
det(surface-13, the-12)
prep_onto(adsorption-8, surface-13)
nn(trisilicate-16, magnesium-15)
prep_of(surface-13, trisilicate-16)

Uricosuric/JJ drugs/NNS ,/, such/JJ as/IN probenecid/NN and/CC sulfinpyrazone/NN ,/, can/MD inhibit/VB renal/JJ tubular/JJ secretion/NN of/IN nitrofurantoin/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Uricosuric) (NNS drugs)) (, ,) (PP (JJ such) (IN as) (NP (NP (NN probenecid)) (CC and) (NP (NN sulfinpyrazone)))) (, ,)) (VP (MD can) (VP (VB inhibit) (NP (NP (JJ renal) (JJ tubular) (NN secretion)) (PP (IN of) (NP (NN nitrofurantoin))))))) (. .))))

amod(drugs-2, Uricosuric-1)
nsubj(inhibit-11, drugs-2)
prep_such_as(drugs-2, probenecid-6)
conj_and(probenecid-6, sulfinpyrazone-8)
aux(inhibit-11, can-10)
root(ROOT-0, inhibit-11)
amod(secretion-14, renal-12)
amod(secretion-14, tubular-13)
dobj(inhibit-11, secretion-14)
prep_of(secretion-14, nitrofurantoin-16)

The/DT resulting/VBG increase/NN in/IN nitrofurantoin/NN serum/NN levels/NNS may/MD increase/VB toxicity/NN ,/, and/CC the/DT decreased/VBN urinary/JJ levels/NNS could/MD lessen/VB its/PRP$ efficacy/NN as/IN a/DT urinary/JJ tract/NN antibacterial/NN ./.

(ROOT (S1 (S (S (S (NP (NP (DT The) (VBG resulting) (NN increase)) (PP (IN in) (NP (NN nitrofurantoin) (NN serum) (NNS levels)))) (VP (MD may) (VP (VB increase) (NP (NN toxicity))))) (, ,) (CC and) (S (NP (DT the) (VBN decreased) (JJ urinary) (NNS levels)) (VP (MD could) (VP (VB lessen) (NP (PRP$ its) (NN efficacy)) (PP (IN as) (NP (DT a) (JJ urinary) (NN tract) (NN antibacterial))))))) (. .))))

det(increase-3, The-1)
amod(increase-3, resulting-2)
nsubj(increase-9, increase-3)
nn(levels-7, nitrofurantoin-5)
nn(levels-7, serum-6)
prep_in(increase-3, levels-7)
aux(increase-9, may-8)
root(ROOT-0, increase-9)
dobj(increase-9, toxicity-10)
det(levels-16, the-13)
amod(levels-16, decreased-14)
amod(levels-16, urinary-15)
nsubj(lessen-18, levels-16)
aux(lessen-18, could-17)
conj_and(increase-9, lessen-18)
poss(efficacy-20, its-19)
dobj(lessen-18, efficacy-20)
det(antibacterial-25, a-22)
amod(antibacterial-25, urinary-23)
nn(antibacterial-25, tract-24)
prep_as(lessen-18, antibacterial-25)

Drug/NN /Laboratory/NN Test/NN Interactions/NNS :/: As/IN a/DT result/NN of/IN the/DT presence/NN of/IN nitrofurantoin/NN ,/, a/DT false-positive/JJ reaction/NN for/IN glucose/NN in/IN the/DT urine/NN may/MD occur/VB ./.

(ROOT (S1 (S (NP (NP (NN Drug) (NN /Laboratory) (NN Test) (NNS Interactions)) (: :) (S (PP (IN As) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN nitrofurantoin))))))) (, ,) (NP (NP (DT a) (JJ false-positive) (NN reaction)) (PP (IN for) (NP (NN glucose))) (PP (IN in) (NP (DT the) (NN urine)))) (VP (MD may) (VP (VB occur)))) (. .)))))

nn(Interactions-4, Drug-1)
nn(Interactions-4, /Laboratory-2)
nn(Interactions-4, Test-3)
root(ROOT-0, Interactions-4)
det(result-8, a-7)
prep_as(occur-24, result-8)
det(presence-11, the-10)
prep_of(result-8, presence-11)
prep_of(presence-11, nitrofurantoin-13)
det(reaction-17, a-15)
amod(reaction-17, false-positive-16)
nsubj(occur-24, reaction-17)
prep_for(reaction-17, glucose-19)
det(urine-22, the-21)
prep_in(reaction-17, urine-22)
aux(occur-24, may-23)
dep(Interactions-4, occur-24)

This/DT has/VBZ been/VBN observed/VBN with/IN Benedict/NN @/NN s/NN and/CC Fehling/NN @/NN s/NN solutions/NNS but/CC not/RB with/IN the/DT glucose/NN enzymatic/JJ test/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (VBZ has) (VP (VBN been) (VP (VBN observed) (PP (PP (IN with) (NP (NP (NP (NN Benedict) (NN @) (NN s)) (CC and) (NP (NN Fehling) (NN @) (NN s))) (NNS solutions))) (CC but) (PP (RB not) (IN with) (NP (DT the) (NN glucose) (JJ enzymatic) (NN test)))))))) (. .))))

nsubjpass(observed-4, This-1)
aux(observed-4, has-2)
auxpass(observed-4, been-3)
root(ROOT-0, observed-4)
nn(s-8, Benedict-6)
nn(s-8, @-7)
nn(solutions-13, s-8)
nn(s-12, Fehling-10)
nn(s-12, @-11)
conj_and(s-8, s-12)
prep_with(observed-4, solutions-13)
neg(observed-4, not-15)
det(test-20, the-17)
nn(test-20, glucose-18)
amod(test-20, enzymatic-19)
conj_but(solutions-13, test-20)

The/DT vasodilating/JJ effects/NNS of/IN nitroglycerin/NN may/MD be/VB additive/JJ with/IN those/DT of/IN other/JJ vasodilators/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ vasodilating) (NNS effects)) (PP (IN of) (NP (NN nitroglycerin)))) (VP (MD may) (VP (VB be) (ADJP (JJ additive) (PP (IN with) (NP (NP (DT those)) (PP (IN of) (NP (JJ other) (NNS vasodilators))))))))) (. .))))

det(effects-3, The-1)
amod(effects-3, vasodilating-2)
nsubj(additive-8, effects-3)
prep_of(effects-3, nitroglycerin-5)
aux(additive-8, may-6)
cop(additive-8, be-7)
root(ROOT-0, additive-8)
prep_with(additive-8, those-10)
amod(vasodilators-13, other-12)
prep_of(those-10, vasodilators-13)

Alcohol/NN ,/, in/IN particular/JJ ,/, has/VBZ been/VBN found/VBN to/TO exhibit/VBP additive/JJ effects/NNS of/IN this/DT variety/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Alcohol)) (, ,) (PP (IN in) (NP (JJ particular))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN found) (S (VP (TO to) (VP (VBP exhibit) (NP (NP (JJ additive) (NNS effects)) (PP (IN of) (NP (DT this) (NN variety))))))))))) (. .))))

nsubjpass(found-8, Alcohol-1)
xsubj(exhibit-10, Alcohol-1)
prep_in(Alcohol-1, particular-4)
aux(found-8, has-6)
auxpass(found-8, been-7)
root(ROOT-0, found-8)
aux(exhibit-10, to-9)
xcomp(found-8, exhibit-10)
amod(effects-12, additive-11)
dobj(exhibit-10, effects-12)
det(variety-15, this-14)
prep_of(effects-12, variety-15)

Marked/JJ symptomatic/JJ orthostatic/JJ hypotension/NN has/VBZ been/VBN reported/VBN when/WRB calcium/NN channel/NN blockers/NNS and/CC organic/JJ nitrates/NNS were/VBD used/VBN in/IN combination/NN ./.

(ROOT (S1 (S (S (NP (JJ Marked) (JJ symptomatic) (JJ orthostatic) (NN hypotension)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN calcium) (NN channel) (NNS blockers)) (CC and) (NP (JJ organic) (NNS nitrates))) (VP (VBD were) (VP (VBN used) (PP (IN in) (NP (NN combination))))))))))) (. .))))

amod(hypotension-4, Marked-1)
amod(hypotension-4, symptomatic-2)
amod(hypotension-4, orthostatic-3)
nsubjpass(reported-7, hypotension-4)
aux(reported-7, has-5)
auxpass(reported-7, been-6)
root(ROOT-0, reported-7)
advmod(used-16, when-8)
nn(blockers-11, calcium-9)
nn(blockers-11, channel-10)
nsubjpass(used-16, blockers-11)
amod(nitrates-14, organic-13)
conj_and(blockers-11, nitrates-14)
auxpass(used-16, were-15)
advcl(reported-7, used-16)
prep_in(used-16, combination-18)

The/DT hypotensive/JJ effect/NN of/IN sodium/NN nitroprusside/NN is/VBZ augmented/VBN by/IN that/DT of/IN most/JJS other/JJ hypotensive/JJ drugs/NNS ,/, including/VBG ganglionic/NN blocking/NN agents/NNS ,/, negative/JJ inotropic/JJ agent/NN s/NNS ,/, and/CC inhaled/JJ anesthetics/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ hypotensive) (NN effect)) (PP (IN of) (NP (NN sodium) (NN nitroprusside)))) (VP (VBZ is) (VP (VBN augmented) (PP (IN by) (NP (NP (DT that)) (PP (IN of) (NP (NP (JJS most) (JJ other) (JJ hypotensive) (NNS drugs)) (, ,) (PP (VBG including) (NP (NP (NN ganglionic) (NN blocking) (NNS agents)) (, ,) (NP (JJ negative) (JJ inotropic) (NN agent) (NNS s)) (, ,) (CC and) (NP (JJ inhaled) (NNS anesthetics))))))))))) (. .))))

det(effect-3, The-1)
amod(effect-3, hypotensive-2)
nsubjpass(augmented-8, effect-3)
nn(nitroprusside-6, sodium-5)
prep_of(effect-3, nitroprusside-6)
auxpass(augmented-8, is-7)
root(ROOT-0, augmented-8)
agent(augmented-8, that-10)
amod(drugs-15, most-12)
amod(drugs-15, other-13)
amod(drugs-15, hypotensive-14)
prep_of(that-10, drugs-15)
nn(agents-20, ganglionic-18)
nn(agents-20, blocking-19)
prep_including(drugs-15, agents-20)
amod(s-25, negative-22)
amod(s-25, inotropic-23)
nn(s-25, agent-24)
conj_and(agents-20, s-25)
amod(anesthetics-29, inhaled-28)
conj_and(agents-20, anesthetics-29)

No/DT interactions/NNS have/VBP been/VBN observed/VBN between/IN nizatidine/NN and/CC theophylline/NN ,/, chlordiazepoxide/NN ,/, lorazepam/NN ,/, lidocaine/NN ,/, phenytoin/NN ,/, and/CC warfarin/NN ./.

(ROOT (S1 (S (S (NP (DT No) (NNS interactions)) (VP (VBP have) (VP (VBN been) (VP (VBN observed) (PP (IN between) (NP (NP (NN nizatidine)) (CC and) (NP (NN theophylline)) (, ,) (NP (NN chlordiazepoxide)) (, ,) (NP (NN lorazepam)) (, ,) (NP (NN lidocaine)) (, ,) (NP (NN phenytoin)) (, ,) (CC and) (NP (NN warfarin)))))))) (. .))))

det(interactions-2, No-1)
nsubjpass(observed-5, interactions-2)
aux(observed-5, have-3)
auxpass(observed-5, been-4)
root(ROOT-0, observed-5)
prep_between(observed-5, nizatidine-7)
conj_and(nizatidine-7, theophylline-9)
conj_and(nizatidine-7, chlordiazepoxide-11)
conj_and(nizatidine-7, lorazepam-13)
conj_and(nizatidine-7, lidocaine-15)
conj_and(nizatidine-7, phenytoin-17)
conj_and(nizatidine-7, warfarin-20)

Nizatidine/NN does/VBZ not/RB inhibit/VB the/DT cytochrome/NN P-450-linked/JJ drug/NN -metabolizing/NN enzyme/NN system/NN ;/: ./.

(ROOT (S1 (S (S (NP (NN Nizatidine)) (VP (VBZ does) (RB not) (VP (VB inhibit) (NP (DT the) (NN cytochrome) (JJ P-450-linked) (NN drug) (NN -metabolizing) (NN enzyme) (NN system)))) (: ;)) (. .))))

nsubj(inhibit-4, Nizatidine-1)
aux(inhibit-4, does-2)
neg(inhibit-4, not-3)
root(ROOT-0, inhibit-4)
det(system-11, the-5)
nn(system-11, cytochrome-6)
amod(system-11, P-450-linked-7)
nn(system-11, drug-8)
nn(system-11, -metabolizing-9)
nn(system-11, enzyme-10)
dobj(inhibit-4, system-11)

In/IN patients/NNS given/IN very/RB high/JJ doses/NNS (/-LRB- 3900/NN mg/NN )/-RRB- of/IN aspirin/NN daily/RB ,/, increases/NNS in/IN serum/NN salicylate/NN levels/NNS were/VBD seen/VBN when/WRB nizatidine/NN ,/, 150/CD mg/NN b.i.d./NN ,/, was/VBD administered/VBN concurrently/RB ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN given) (NP (NP (NP (ADJP (RB very) (JJ high)) (NNS doses)) (PRN (-LRB- -LRB-) (NP (NN 3900) (NN mg)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN aspirin)) (ADVP (RB daily)))))))) (, ,) (NP (NP (NNS increases)) (PP (IN in) (NP (NN serum) (NN salicylate) (NNS levels)))) (VP (VBD were) (VP (VBN seen) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN nizatidine)) (, ,) (NP (ADJP (CD 150) (NN mg)) (NN b.i.d.)) (, ,)) (VP (VBD was) (VP (VBN administered) (ADVP (RB concurrently))))))))) (. .))))

prep_in(seen-21, patients-2)
advmod(high-5, very-4)
amod(doses-6, high-5)
prep_given(patients-2, doses-6)
nn(mg-9, 3900-8)
appos(doses-6, mg-9)
prep_of(doses-6, aspirin-12)
advmod(aspirin-12, daily-13)
nsubjpass(seen-21, increases-15)
nn(levels-19, serum-17)
nn(levels-19, salicylate-18)
prep_in(increases-15, levels-19)
auxpass(seen-21, were-20)
root(ROOT-0, seen-21)
advmod(administered-30, when-22)
nsubjpass(administered-30, nizatidine-23)
number(mg-26, 150-25)
amod(b.i.d.-27, mg-26)
appos(nizatidine-23, b.i.d.-27)
auxpass(administered-30, was-29)
advcl(seen-21, administered-30)
advmod(administered-30, concurrently-31)

The/DT effectiveness/NN of/IN progestin/NN -only/NN pills/NNS is/VBZ reduced/VBN by/IN hepatic/JJ enzyme-inducing/JJ drugs/NNS such/JJ as/IN the/DT anticonvulsants/NNS phenytoin/NN ,/, carbamazepine/NN ,/, and/CC barbiturates/NNS ,/, and/CC the/DT antituberculosis/NN drug/NN rifampin/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effectiveness)) (PP (IN of) (NP (NN progestin) (NN -only) (NNS pills)))) (VP (VBZ is) (VP (VBN reduced) (PP (IN by) (NP (NP (JJ hepatic) (JJ enzyme-inducing) (NNS drugs)) (PP (JJ such) (IN as) (NP (DT the) (NNS anticonvulsants) (NP (NP (NN phenytoin)) (, ,) (NP (NN carbamazepine)) (, ,) (CC and) (NP (NNS barbiturates)) (, ,) (CC and) (NP (DT the) (NN antituberculosis) (NN drug) (NN rifampin)))))))))) (. .))))

det(effectiveness-2, The-1)
nsubjpass(reduced-8, effectiveness-2)
nn(pills-6, progestin-4)
nn(pills-6, -only-5)
prep_of(effectiveness-2, pills-6)
auxpass(reduced-8, is-7)
root(ROOT-0, reduced-8)
amod(drugs-12, hepatic-10)
amod(drugs-12, enzyme-inducing-11)
agent(reduced-8, drugs-12)
det(anticonvulsants-16, the-15)
prep_such_as(drugs-12, anticonvulsants-16)
dep(anticonvulsants-16, phenytoin-17)
conj_and(phenytoin-17, carbamazepine-19)
conj_and(phenytoin-17, barbiturates-22)
det(rifampin-28, the-25)
nn(rifampin-28, antituberculosis-26)
nn(rifampin-28, drug-27)
conj_and(phenytoin-17, rifampin-28)

Elevated/JJ plasma/NN levels/NNS of/IN theophylline/NN have/VBP been/VBN reported/VBN with/IN concomitant/JJ quinolone/NN use/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Elevated) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN theophylline)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (JJ concomitant) (NN quinolone) (NN use))))))) (. .))))

amod(levels-3, Elevated-1)
nn(levels-3, plasma-2)
nsubjpass(reported-8, levels-3)
prep_of(levels-3, theophylline-5)
aux(reported-8, have-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
amod(use-12, concomitant-10)
nn(use-12, quinolone-11)
prep_with(reported-8, use-12)

There/EX have/VBP been/VBN reports/NNS of/IN theophylline/NN -related/JJ side/JJ effects/NNS in/IN patients/NNS on/IN concomitant/JJ therapy/NN with/IN norfloxacin/NN and/CC theophylline/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (NP (NP (NNS reports)) (PP (IN of) (NP (NP (NN theophylline) (JJ -related) (JJ side) (NNS effects)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN on) (NP (NP (JJ concomitant) (NN therapy)) (PP (IN with) (NP (NP (NN norfloxacin)) (CC and) (NP (NN theophylline)))))))))))))) (. .))))

expl(reports-4, There-1)
aux(reports-4, have-2)
cop(reports-4, been-3)
root(ROOT-0, reports-4)
nn(effects-9, theophylline-6)
amod(effects-9, -related-7)
amod(effects-9, side-8)
prep_of(reports-4, effects-9)
prep_in(effects-9, patients-11)
amod(therapy-14, concomitant-13)
prep_on(patients-11, therapy-14)
prep_with(therapy-14, norfloxacin-16)
conj_and(norfloxacin-16, theophylline-18)

Therefore/RB ,/, monitoring/NN of/IN theophylline/NN plasma/NN levels/NNS should/MD be/VB considered/VBN and/CC dosage/NN of/IN theophylline/NN adjusted/VBN as/IN required/VBN ./.

(ROOT (S1 (S (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN monitoring)) (PP (IN of) (NP (NN theophylline) (NN plasma) (NNS levels)))) (VP (MD should) (VP (VB be) (VP (VBN considered))))) (CC and) (S (NP (NP (NN dosage)) (PP (IN of) (NP (NN theophylline)))) (VP (VBN adjusted) (PP (IN as) (NP (VBN required)))))) (. .))))

advmod(considered-10, Therefore-1)
nsubjpass(considered-10, monitoring-3)
nn(levels-7, theophylline-5)
nn(levels-7, plasma-6)
prep_of(monitoring-3, levels-7)
aux(considered-10, should-8)
auxpass(considered-10, be-9)
root(ROOT-0, considered-10)
nsubj(adjusted-15, dosage-12)
prep_of(dosage-12, theophylline-14)
conj_and(considered-10, adjusted-15)
prep_as(adjusted-15, required-17)

Elevated/JJ serum/NN levels/NNS of/IN cyclosporine/NN have/VBP been/VBN reported/VBN with/IN concomitant/JJ use/NN of/IN cyclosporine/NN with/IN norfloxacin/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Elevated) (NN serum) (NNS levels)) (PP (IN of) (NP (NN cyclosporine)))) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN with) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NN cyclosporine))) (PP (IN with) (NP (NN norfloxacin))))))))) (. .))))

amod(levels-3, Elevated-1)
nn(levels-3, serum-2)
nsubjpass(reported-8, levels-3)
prep_of(levels-3, cyclosporine-5)
aux(reported-8, have-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
amod(use-11, concomitant-10)
prep_with(reported-8, use-11)
prep_of(use-11, cyclosporine-13)
prep_with(use-11, norfloxacin-15)

Therefore/RB ,/, cyclosporine/NN serum/NN levels/NNS should/MD be/VB monitored/VBN and/CC appropriate/JJ cyclosporine/NN dosage/NN adjustments/NNS made/VBD when/WRB these/DT drugs/NNS are/VBP used/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (S (ADVP (RB Therefore)) (, ,) (NP (NN cyclosporine) (NN serum) (NNS levels)) (VP (MD should) (VP (VB be) (VP (VBN monitored))))) (CC and) (S (NP (JJ appropriate) (NN cyclosporine) (NN dosage) (NNS adjustments)) (VP (VBD made) (SBAR (WHADVP (WRB when)) (S (NP (DT these) (NNS drugs)) (VP (VBP are) (VP (VBN used) (ADVP (RB concomitantly))))))))) (. .))))

advmod(monitored-8, Therefore-1)
nn(levels-5, cyclosporine-3)
nn(levels-5, serum-4)
nsubjpass(monitored-8, levels-5)
aux(monitored-8, should-6)
auxpass(monitored-8, be-7)
root(ROOT-0, monitored-8)
amod(adjustments-13, appropriate-10)
nn(adjustments-13, cyclosporine-11)
nn(adjustments-13, dosage-12)
nsubj(made-14, adjustments-13)
conj_and(monitored-8, made-14)
advmod(used-19, when-15)
det(drugs-17, these-16)
nsubjpass(used-19, drugs-17)
auxpass(used-19, are-18)
advcl(made-14, used-19)
advmod(used-19, concomitantly-20)

Quinolones/NNS ,/, including/VBG norfloxacin/NN ,/, may/MD enhance/VB the/DT effects/NNS of/IN oral/JJ anticoagulants/NNS ,/, including/VBG warfarin/NN or/CC its/PRP$ derivatives/NNS or/CC similar/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Quinolones)) (, ,) (PP (VBG including) (NP (NN norfloxacin))) (, ,)) (VP (MD may) (VP (VB enhance) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (JJ oral) (NNS anticoagulants)) (, ,) (PP (VBG including) (NP (NP (NN warfarin)) (CC or) (NP (NP (PRP$ its) (NNS derivatives)) (CC or) (NP (JJ similar) (NNS agents))))))))))) (. .))))

nsubj(enhance-7, Quinolones-1)
prep_including(Quinolones-1, norfloxacin-4)
aux(enhance-7, may-6)
root(ROOT-0, enhance-7)
det(effects-9, the-8)
dobj(enhance-7, effects-9)
amod(anticoagulants-12, oral-11)
prep_of(effects-9, anticoagulants-12)
prep_including(anticoagulants-12, warfarin-15)
poss(derivatives-18, its-17)
conj_or(warfarin-15, derivatives-18)
amod(agents-21, similar-20)
conj_or(derivatives-18, agents-21)

The/DT concomitant/JJ administration/NN of/IN quinolones/NNS including/VBG norfloxacin/NN with/IN glyburide/NN (/-LRB- a/DT sulfonylurea/NN agent/NN )/-RRB- has/VBZ ,/, on/IN rare/JJ occasions/NNS ,/, resulted/VBD in/IN severe/JJ hypoglycemia/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NNS quinolones)) (PP (VBG including) (NP (NP (NN norfloxacin)) (PP (IN with) (NP (NP (NN glyburide)) (PRN (-LRB- -LRB-) (NP (DT a) (NN sulfonylurea) (NN agent)) (-RRB- -RRB-))))))))) (VP (VBZ has) (, ,) (PP (IN on) (NP (JJ rare) (NNS occasions))) (, ,) (VP (VBD resulted) (PP (IN in) (NP (JJ severe) (NN hypoglycemia)))))) (. .))))

det(administration-3, The-1)
amod(administration-3, concomitant-2)
nsubj(resulted-21, administration-3)
prep_of(administration-3, quinolones-5)
prep_including(quinolones-5, norfloxacin-7)
prep_with(norfloxacin-7, glyburide-9)
det(agent-13, a-11)
nn(agent-13, sulfonylurea-12)
appos(glyburide-9, agent-13)
aux(resulted-21, has-15)
amod(occasions-19, rare-18)
prep_on(resulted-21, occasions-19)
root(ROOT-0, resulted-21)
amod(hypoglycemia-24, severe-23)
prep_in(resulted-21, hypoglycemia-24)

Diminished/VBN urinary/JJ excretion/NN of/IN norfloxacin/NN has/VBZ been/VBN reported/VBN during/IN the/DT concomitant/JJ administration/NN of/IN probenecid/NN and/CC norfloxacin/NN ./.

(ROOT (S1 (S (S (NP (NP (VBN Diminished) (JJ urinary) (NN excretion)) (PP (IN of) (NP (NN norfloxacin)))) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (PP (IN during) (NP (NP (DT the) (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN probenecid)) (CC and) (NP (NN norfloxacin)))))))))) (. .))))

amod(excretion-3, Diminished-1)
amod(excretion-3, urinary-2)
nsubjpass(reported-8, excretion-3)
prep_of(excretion-3, norfloxacin-5)
aux(reported-8, has-6)
auxpass(reported-8, been-7)
root(ROOT-0, reported-8)
det(administration-12, the-10)
amod(administration-12, concomitant-11)
prep_during(reported-8, administration-12)
prep_of(administration-12, probenecid-14)
conj_and(probenecid-14, norfloxacin-16)

The/DT concomitant/JJ use/NN of/IN nitrofurantoin/NN is/VBZ not/RB recommended/VBN since/IN nitrofurantoin/NN may/MD antagonize/VB the/DT antibacterial/JJ effect/NN of/IN Norfloxacin/NN in/IN the/DT urinary/JJ tract/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ concomitant) (NN use)) (PP (IN of) (NP (NN nitrofurantoin)))) (VP (VBZ is) (RB not) (VP (VBN recommended) (SBAR (IN since) (S (NP (NN nitrofurantoin)) (VP (MD may) (VP (VB antagonize) (NP (NP (DT the) (JJ antibacterial) (NN effect)) (PP (IN of) (NP (NN Norfloxacin))) (PP (IN in) (NP (DT the) (JJ urinary) (NN tract))))))))))) (. .))))

det(use-3, The-1)
amod(use-3, concomitant-2)
nsubjpass(recommended-8, use-3)
prep_of(use-3, nitrofurantoin-5)
auxpass(recommended-8, is-6)
neg(recommended-8, not-7)
root(ROOT-0, recommended-8)
mark(antagonize-12, since-9)
nsubj(antagonize-12, nitrofurantoin-10)
aux(antagonize-12, may-11)
advcl(recommended-8, antagonize-12)
det(effect-15, the-13)
amod(effect-15, antibacterial-14)
dobj(antagonize-12, effect-15)
prep_of(effect-15, Norfloxacin-17)
det(tract-21, the-19)
amod(tract-21, urinary-20)
prep_in(effect-15, tract-21)

Multivitamins/NNS ,/, or/CC other/JJ products/NNS containing/VBG iron/NN or/CC zinc/NN ,/, antacids/NNS or/CC sucralfate/NN should/MD not/RB be/VB administered/VBN concomitantly/RB with/IN ,/, or/CC within/IN 2/CD hours/NNS of/IN ,/, the/DT administration/NN of/IN norfloxacin/NN ,/, because/IN they/PRP may/MD interfere/VB with/IN absorption/NN resulting/VBG in/IN lower/JJR serum/NN and/CC urine/NN levels/NNS of/IN norfloxacin/NN ./.

(ROOT (S1 (S (NP (NP (NNS Multivitamins)) (, ,) (CC or) (NP (NP (JJ other) (NNS products)) (VP (VBG containing) (NP (NP (NN iron)) (CC or) (NP (NN zinc))))) (, ,) (NP (NNS antacids)) (CC or) (NP (NN sucralfate))) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (PP (IN with)) (, ,) (CC or) (PP (IN within) (NP (NP (NP (CD 2) (NNS hours)) (PP (IN of))) (, ,) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NN norfloxacin))))))) (, ,) (SBAR (IN because) (S (NP (PRP they)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (NN absorption)) (VP (VBG resulting) (PP (IN in) (NP (NP (JJR lower) (NN serum) (CC and) (NN urine) (NNS levels)) (PP (IN of) (NP (NN norfloxacin))))))))))))))) (. .))))

nsubjpass(administered-17, Multivitamins-1)
amod(products-5, other-4)
conj_or(Multivitamins-1, products-5)
partmod(products-5, containing-6)
dobj(containing-6, iron-7)
conj_or(iron-7, zinc-9)
conj_or(Multivitamins-1, antacids-11)
conj_or(Multivitamins-1, sucralfate-13)
aux(administered-17, should-14)
neg(administered-17, not-15)
auxpass(administered-17, be-16)
root(ROOT-0, administered-17)
advmod(administered-17, concomitantly-18)
prep(administered-17, with-19)
conj_or(with-19, within-22)
num(hours-24, 2-23)
pobj(within-22, hours-24)
prep(hours-24, of-25)
det(administration-28, the-27)
appos(hours-24, administration-28)
prep_of(administration-28, norfloxacin-30)
mark(interfere-35, because-32)
nsubj(interfere-35, they-33)
aux(interfere-35, may-34)
advcl(administered-17, interfere-35)
prep_with(interfere-35, absorption-37)
partmod(absorption-37, resulting-38)
amod(serum-41, lower-40)
prep_in(resulting-38, serum-41)
nn(levels-44, urine-43)
conj_and(serum-41, levels-44)
prep_of(serum-41, norfloxacin-46)

Videx/NN (/-LRB- Didanosine/NN )/-RRB- chewable//NN buffer/NN ed/NN tablets/NNS or/CC the/DT pediatric/JJ powder/NN for/IN oral/JJ solution/NN should/MD not/RB be/VB administered/VBN concomitantly/RB with/IN ,/, or/CC within/IN 2/CD hours/NNS of/IN ,/, the/DT administration/NN of/IN norfloxacin/NN ,/, because/IN these/DT products/NNS may/MD interfere/VB with/IN absorption/NN resulting/VBG in/IN lower/JJR serum/NN and/CC urine/NN levels/NNS of/IN norfloxacin/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN Videx) (-LRB- -LRB-) (NN Didanosine) (-RRB- -RRB-) (NN chewable/) (NN buffer) (NN ed) (NNS tablets)) (CC or) (NP (DT the) (JJ pediatric) (NN powder))) (PP (IN for) (NP (JJ oral) (NN solution)))) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (PP (IN with)) (, ,) (CC or) (PP (IN within) (NP (NP (CD 2) (NNS hours) (IN of)) (, ,) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NN norfloxacin))))))) (, ,) (SBAR (IN because) (S (NP (DT these) (NNS products)) (VP (MD may) (VP (VB interfere) (PP (IN with) (NP (NP (NN absorption)) (VP (VBG resulting) (PP (IN in) (NP (NP (JJR lower) (NN serum) (CC and) (NN urine) (NNS levels)) (PP (IN of) (NP (NN norfloxacin))))))))))))))) (. .))))

nn(tablets-8, Videx-1)
nn(tablets-8, Didanosine-3)
nn(tablets-8, chewable/-5)
nn(tablets-8, buffer-6)
nn(tablets-8, ed-7)
nsubjpass(administered-19, tablets-8)
det(powder-12, the-10)
amod(powder-12, pediatric-11)
conj_or(tablets-8, powder-12)
amod(solution-15, oral-14)
prep_for(tablets-8, solution-15)
aux(administered-19, should-16)
neg(administered-19, not-17)
auxpass(administered-19, be-18)
root(ROOT-0, administered-19)
advmod(administered-19, concomitantly-20)
prep(administered-19, with-21)
conj_or(with-21, within-24)
num(hours-26, 2-25)
pobj(within-24, hours-26)
amod(hours-26, of-27)
det(administration-30, the-29)
appos(hours-26, administration-30)
prep_of(administration-30, norfloxacin-32)
mark(interfere-38, because-34)
det(products-36, these-35)
nsubj(interfere-38, products-36)
aux(interfere-38, may-37)
advcl(administered-19, interfere-38)
prep_with(interfere-38, absorption-40)
partmod(absorption-40, resulting-41)
amod(serum-44, lower-43)
prep_in(resulting-41, serum-44)
nn(levels-47, urine-46)
conj_and(serum-44, levels-47)
prep_of(serum-44, norfloxacin-49)

Some/DT quinolones/NNS have/VBP also/RB been/VBN shown/VBN to/TO interfere/VB with/IN the/DT metabolism/NN of/IN caffeine/NN ./.

(ROOT (S1 (S (S (NP (DT Some) (NNS quinolones)) (VP (VBP have) (ADVP (RB also)) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB interfere) (PP (IN with) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN caffeine)))))))))))) (. .))))

det(quinolones-2, Some-1)
nsubjpass(shown-6, quinolones-2)
xsubj(interfere-8, quinolones-2)
aux(shown-6, have-3)
advmod(shown-6, also-4)
auxpass(shown-6, been-5)
root(ROOT-0, shown-6)
aux(interfere-8, to-7)
xcomp(shown-6, interfere-8)
det(metabolism-11, the-10)
prep_with(interfere-8, metabolism-11)
prep_of(metabolism-11, caffeine-13)

This/DT may/MD lead/VB to/TO reduced/VBN clearance/NN of/IN caffeine/NN and/CC a/DT prolongation/NN of/IN its/PRP$ plasma/NN half-life/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (NP (VBN reduced) (NN clearance)) (PP (IN of) (NP (NN caffeine)))) (CC and) (NP (NP (DT a) (NN prolongation)) (PP (IN of) (NP (PRP$ its) (NN plasma) (NN half-life))))))))) (. .))))

nsubj(lead-3, This-1)
aux(lead-3, may-2)
root(ROOT-0, lead-3)
amod(clearance-6, reduced-5)
prep_to(lead-3, clearance-6)
prep_of(clearance-6, caffeine-8)
det(prolongation-11, a-10)
conj_and(clearance-6, prolongation-11)
poss(half-life-15, its-13)
nn(half-life-15, plasma-14)
prep_of(prolongation-11, half-life-15)

Reduced/VBN efficacy/NN and/CC increased/VBN incidence/NN of/IN breakthrough/JJ bleeding/JJ and/CC menstrual/JJ irregularities/NNS have/VBP been/VBN associated/VBN with/IN concomitant/JJ use/NN of/IN rifampin/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (VBN Reduced) (NN efficacy)) (CC and) (NP (VBN increased) (NN incidence))) (PP (IN of) (NP (JJ breakthrough) (JJ bleeding)))) (CC and) (NP (JJ menstrual) (NNS irregularities))) (VP (VBP have) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NN rifampin))))))))) (. .))))

amod(efficacy-2, Reduced-1)
nsubjpass(associated-14, efficacy-2)
amod(incidence-5, increased-4)
conj_and(efficacy-2, incidence-5)
amod(bleeding-8, breakthrough-7)
prep_of(efficacy-2, bleeding-8)
amod(irregularities-11, menstrual-10)
conj_and(efficacy-2, irregularities-11)
aux(associated-14, have-12)
auxpass(associated-14, been-13)
root(ROOT-0, associated-14)
amod(use-17, concomitant-16)
prep_with(associated-14, use-17)
prep_of(use-17, rifampin-19)

A/DT similar/JJ association/NN ,/, though/RB less/RBR marked/JJ ,/, has/VBZ been/VBN suggested/VBN with/IN barbiturates/NNS ,/, phenylbutazone/NN ,/, phenytoin/NN sodium/NN ,/, carbamazepine/NN ,/, griseofulvin/NN ,/, topiramate/NN ,/, and/CC possibly/RB with/IN ampicillin/NN and/CC tetracyclines/NN 72/CD ./.

(ROOT (S1 (S (S (NP (NP (DT A) (JJ similar) (NN association)) (, ,) (ADJP (RB though) (RBR less) (JJ marked)) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (PP (IN with) (NP (NP (NNS barbiturates)) (, ,) (NP (NP (NN phenylbutazone)) (, ,) (NP (NN phenytoin) (NN sodium)) (, ,) (NP (NN carbamazepine)) (, ,) (NP (NN griseofulvin)) (, ,) (NP (NN topiramate)) (, ,) (CC and) (ADVP (RB possibly)) (PP (IN with) (NP (NP (NN ampicillin)) (CC and) (NP (NN tetracyclines) (CD 72))))))))))) (. .))))

det(association-3, A-1)
amod(association-3, similar-2)
nsubjpass(suggested-11, association-3)
advmod(marked-7, though-5)
advmod(marked-7, less-6)
amod(association-3, marked-7)
aux(suggested-11, has-9)
auxpass(suggested-11, been-10)
root(ROOT-0, suggested-11)
prep_with(suggested-11, barbiturates-13)
appos(barbiturates-13, phenylbutazone-15)
nn(sodium-18, phenytoin-17)
appos(phenylbutazone-15, sodium-18)
appos(phenylbutazone-15, carbamazepine-20)
appos(phenylbutazone-15, griseofulvin-22)
appos(phenylbutazone-15, topiramate-24)
conj_and(phenylbutazone-15, possibly-27)
prep_with(possibly-27, ampicillin-29)
conj_and(ampicillin-29, tetracyclines-31)
num(tetracyclines-31, 72-32)

A/DT possible/JJ interaction/NN has/VBZ been/VBN suggested/VBN with/IN hormonal/JJ contraceptives/NNS and/CC the/DT herbal/JJ supplement/NN St./NN Johns/NNP Wort/NNP based/VBN on/IN some/DT reports/NNS of/IN oral/JJ contraceptive/JJ users/NNS experiencing/VBG breakthrough/JJ bleeding/JJ shortly/RB after/IN starting/VBG St./NN Johns/NNP Wort/NNP ./.

(ROOT (S1 (S (S (NP (DT A) (JJ possible) (NN interaction)) (VP (VBZ has) (VP (VBN been) (VP (VBN suggested) (PP (IN with) (NP (NP (NP (JJ hormonal) (NNS contraceptives)) (CC and) (NP (DT the) (JJ herbal) (NN supplement) (NN St.)) (NP (NNP Johns) (NNP Wort))) (VP (VBN based) (PP (IN on) (NP (NP (DT some) (NNS reports)) (PP (IN of) (NP (NP (JJ oral) (JJ contraceptive) (NNS users)) (VP (VBG experiencing) (NP (NP (JJ breakthrough) (JJ bleeding)) (CONJP (RB shortly) (IN after)) (NP (VBG starting) (NN St.)) (NP (NNP Johns) (NNP Wort))))))))))))))) (. .))))

det(interaction-3, A-1)
amod(interaction-3, possible-2)
nsubjpass(suggested-6, interaction-3)
aux(suggested-6, has-4)
auxpass(suggested-6, been-5)
root(ROOT-0, suggested-6)
amod(contraceptives-9, hormonal-8)
prep_with(suggested-6, contraceptives-9)
det(St.-14, the-11)
amod(St.-14, herbal-12)
nn(St.-14, supplement-13)
conj_and(contraceptives-9, St.-14)
nn(Wort-16, Johns-15)
dep(contraceptives-9, Wort-16)
partmod(contraceptives-9, based-17)
det(reports-20, some-19)
prep_on(based-17, reports-20)
amod(users-24, oral-22)
amod(users-24, contraceptive-23)
prep_of(reports-20, users-24)
partmod(users-24, experiencing-25)
amod(bleeding-27, breakthrough-26)
dobj(experiencing-25, bleeding-27)
amod(St.-31, starting-30)
conj_shortly(bleeding-27, St.-31)
nn(Wort-33, Johns-32)
dobj(experiencing-25, Wort-33)
dep(bleeding-27, Wort-33)

Pregnancies/NNS have/VBP been/VBN reported/VBN by/IN users/NNS of/IN combined/JJ hormonal/JJ contraceptives/NNS who/WP also/RB used/VBD some/DT form/NN of/IN St./NN Johns/NNP Wort/NNP ./.

(ROOT (S1 (S (S (NP (NNS Pregnancies)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (PP (IN by) (NP (NP (NNS users)) (PP (IN of) (NP (NP (JJ combined) (JJ hormonal) (NNS contraceptives)) (SBAR (WHNP (WP who)) (S (ADVP (RB also)) (VP (VBD used) (NP (NP (DT some) (NN form)) (PP (IN of) (NP (NN St.) (NNP Johns) (NNP Wort))))))))))))))) (. .))))

nsubjpass(reported-4, Pregnancies-1)
aux(reported-4, have-2)
auxpass(reported-4, been-3)
root(ROOT-0, reported-4)
agent(reported-4, users-6)
amod(contraceptives-10, combined-8)
amod(contraceptives-10, hormonal-9)
prep_of(users-6, contraceptives-10)
nsubj(used-13, contraceptives-10)
advmod(used-13, also-12)
rcmod(contraceptives-10, used-13)
det(form-15, some-14)
dobj(used-13, form-15)
nn(Wort-19, St.-17)
nn(Wort-19, Johns-18)
prep_of(form-15, Wort-19)

Healthcare/NN prescribers/NNS are/VBP advised/VBN to/TO consult/VB the/DT package/JJ inserts/NNS of/IN medication/NN administered/VBN concomitantly/RB with/IN oral/JJ contraceptives/NNS ./.

(ROOT (S1 (S (S (NP (NN Healthcare) (NNS prescribers)) (VP (VBP are) (VP (VBN advised) (S (VP (TO to) (VP (VB consult) (NP (NP (DT the) (JJ package) (NNS inserts)) (PP (IN of) (NP (NP (NN medication)) (VP (VBN administered) (ADVP (RB concomitantly)) (PP (IN with) (NP (JJ oral) (NNS contraceptives))))))))))))) (. .))))

nn(prescribers-2, Healthcare-1)
nsubjpass(advised-4, prescribers-2)
xsubj(consult-6, prescribers-2)
auxpass(advised-4, are-3)
root(ROOT-0, advised-4)
aux(consult-6, to-5)
xcomp(advised-4, consult-6)
det(inserts-9, the-7)
amod(inserts-9, package-8)
dobj(consult-6, inserts-9)
prep_of(inserts-9, medication-11)
partmod(medication-11, administered-12)
advmod(administered-12, concomitantly-13)
amod(contraceptives-16, oral-15)
prep_with(administered-12, contraceptives-16)

Steady-state/JJ serum/NN concentrations/NNS of/IN tricyclic/JJ antidepressants/NNS are/VBP reported/VBN to/TO fluctuate/VB significantly/RB when/WRB cimetidine/NN is/VBZ either/CC added/VBN or/CC deleted/VBN from/IN the/DT drug/NN regimen/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Steady-state) (NN serum) (NNS concentrations)) (PP (IN of) (NP (JJ tricyclic) (NNS antidepressants)))) (VP (VBP are) (VP (VBN reported) (S (VP (TO to) (VP (VB fluctuate) (ADVP (RB significantly)) (SBAR (WHADVP (WRB when)) (S (NP (NN cimetidine)) (VP (VBZ is) (VP (CC either) (VP (VBN added)) (CC or) (VP (VBN deleted) (PP (IN from) (NP (DT the) (NN drug) (NN regimen)))))))))))))) (. .))))

amod(concentrations-3, Steady-state-1)
nn(concentrations-3, serum-2)
nsubjpass(reported-8, concentrations-3)
xsubj(fluctuate-10, concentrations-3)
amod(antidepressants-6, tricyclic-5)
prep_of(concentrations-3, antidepressants-6)
auxpass(reported-8, are-7)
root(ROOT-0, reported-8)
aux(fluctuate-10, to-9)
xcomp(reported-8, fluctuate-10)
advmod(fluctuate-10, significantly-11)
advmod(added-16, when-12)
nsubjpass(added-16, cimetidine-13)
auxpass(added-16, is-14)
preconj(added-16, either-15)
advcl(fluctuate-10, added-16)
conj_or(added-16, deleted-18)
det(regimen-22, the-20)
nn(regimen-22, drug-21)
prep_from(deleted-18, regimen-22)

Serious/JJ anticholinergic/JJ symptoms/NNS (/-LRB- severe/JJ dry/JJ mouth/NN ,/, urinary/JJ retention/NN ,/, blurred/JJ vision/NN )/-RRB- have/VBP been/VBN associated/VBN with/IN elevations/NNS in/IN the/DT serum/NN levels/NNS of/IN tricyclic/JJ antidepressants/NNS when/WRB cimetidine/NN is/VBZ added/VBN to/TO the/DT drug/NN regimen/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Serious) (JJ anticholinergic) (NNS symptoms)) (PRN (-LRB- -LRB-) (NP (NP (JJ severe) (JJ dry) (NN mouth)) (, ,) (NP (JJ urinary) (NN retention)) (, ,) (NP (JJ blurred) (NN vision))) (-RRB- -RRB-))) (VP (VBP have) (VP (VBN been) (VP (VBN associated) (PP (IN with) (NP (NP (NNS elevations)) (PP (IN in) (NP (NP (DT the) (NN serum) (NNS levels)) (PP (IN of) (NP (JJ tricyclic) (NNS antidepressants))))))) (SBAR (WHADVP (WRB when)) (S (NP (NN cimetidine)) (VP (VBZ is) (VP (VBN added) (PP (TO to) (NP (DT the) (NN drug) (NN regimen))))))))))) (. .))))

amod(symptoms-3, Serious-1)
amod(symptoms-3, anticholinergic-2)
nsubjpass(associated-17, symptoms-3)
amod(mouth-7, severe-5)
amod(mouth-7, dry-6)
dep(symptoms-3, mouth-7)
amod(retention-10, urinary-9)
appos(mouth-7, retention-10)
amod(vision-13, blurred-12)
appos(mouth-7, vision-13)
aux(associated-17, have-15)
auxpass(associated-17, been-16)
root(ROOT-0, associated-17)
prep_with(associated-17, elevations-19)
det(levels-23, the-21)
nn(levels-23, serum-22)
prep_in(elevations-19, levels-23)
amod(antidepressants-26, tricyclic-25)
prep_of(levels-23, antidepressants-26)
advmod(added-30, when-27)
nsubjpass(added-30, cimetidine-28)
auxpass(added-30, is-29)
advcl(associated-17, added-30)
det(regimen-34, the-32)
nn(regimen-34, drug-33)
prep_to(added-30, regimen-34)

In/IN addition/NN ,/, higher-than/JJ expected/VBN steady-state/NN serum/NN concentrations/NNS of/IN tricyclic/JJ antidepressants/NNS have/VBP been/VBN observed/VBN when/WRB therapy/NN is/VBZ initiated/VBN in/IN patients/NNS already/RB taking/VBG cimetidine/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (JJ higher-than) (VBN expected) (NN steady-state) (NN serum) (NNS concentrations)) (PP (IN of) (NP (JJ tricyclic) (NNS antidepressants)))) (VP (VBP have) (VP (VBN been) (VP (VBN observed) (SBAR (WHADVP (WRB when)) (S (NP (NN therapy)) (VP (VBZ is) (VP (VBN initiated) (PP (IN in) (NP (NP (NNS patients)) (VP (ADVP (RB already)) (VBG taking) (NP (NN cimetidine))))))))))))) (. .))))

prep_in(observed-14, addition-2)
amod(concentrations-8, higher-than-4)
amod(concentrations-8, expected-5)
nn(concentrations-8, steady-state-6)
nn(concentrations-8, serum-7)
nsubjpass(observed-14, concentrations-8)
amod(antidepressants-11, tricyclic-10)
prep_of(concentrations-8, antidepressants-11)
aux(observed-14, have-12)
auxpass(observed-14, been-13)
root(ROOT-0, observed-14)
advmod(initiated-18, when-15)
nsubjpass(initiated-18, therapy-16)
auxpass(initiated-18, is-17)
advcl(observed-14, initiated-18)
prep_in(initiated-18, patients-20)
advmod(taking-22, already-21)
partmod(patients-20, taking-22)
dobj(taking-22, cimetidine-23)

In/IN well-controlled/JJ patients/NNS undergoing/VBG concurrent/JJ therapy/NN with/IN cimetidine/NN ,/, a/DT decrease/NN in/IN the/DT steady-state/JJ serum/NN concentrations/NNS of/IN tricyclic/JJ antidepressants/NNS may/MD occur/VB when/WRB cime-tidine/NN therapy/NN is/VBZ discontinued/VBN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (JJ well-controlled) (NNS patients)) (VP (VBG undergoing) (NP (JJ concurrent) (NN therapy)) (PP (IN with) (NP (NN cimetidine)))))) (, ,) (NP (NP (DT a) (NN decrease)) (PP (IN in) (NP (NP (DT the) (JJ steady-state) (NN serum) (NNS concentrations)) (PP (IN of) (NP (JJ tricyclic) (NNS antidepressants)))))) (VP (MD may) (VP (VB occur) (SBAR (WHADVP (WRB when)) (S (NP (NN cime-tidine) (NN therapy)) (VP (VBZ is) (VP (VBN discontinued)))))))) (. .))))

amod(patients-3, well-controlled-2)
prep_in(occur-21, patients-3)
partmod(patients-3, undergoing-4)
amod(therapy-6, concurrent-5)
dobj(undergoing-4, therapy-6)
prep_with(undergoing-4, cimetidine-8)
det(decrease-11, a-10)
nsubj(occur-21, decrease-11)
det(concentrations-16, the-13)
amod(concentrations-16, steady-state-14)
nn(concentrations-16, serum-15)
prep_in(decrease-11, concentrations-16)
amod(antidepressants-19, tricyclic-18)
prep_of(concentrations-16, antidepressants-19)
aux(occur-21, may-20)
root(ROOT-0, occur-21)
advmod(discontinued-26, when-22)
nn(therapy-24, cime-tidine-23)
nsubjpass(discontinued-26, therapy-24)
auxpass(discontinued-26, is-25)
advcl(occur-21, discontinued-26)

The/DT therapeutic/JJ efficacy/NN of/IN tricyclic/JJ antidepressants/NNS may/MD be/VB compromised/VBN in/IN these/DT patients/NNS when/WRB cimetidine/NN is/VBZ discontinued/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ therapeutic) (NN efficacy)) (PP (IN of) (NP (JJ tricyclic) (NNS antidepressants)))) (VP (MD may) (VP (VB be) (VP (VBN compromised) (PP (IN in) (NP (DT these) (NNS patients))) (SBAR (WHADVP (WRB when)) (S (NP (NN cimetidine)) (VP (VBZ is) (VP (VBN discontinued))))))))) (. .))))

det(efficacy-3, The-1)
amod(efficacy-3, therapeutic-2)
nsubjpass(compromised-9, efficacy-3)
amod(antidepressants-6, tricyclic-5)
prep_of(efficacy-3, antidepressants-6)
aux(compromised-9, may-7)
auxpass(compromised-9, be-8)
root(ROOT-0, compromised-9)
det(patients-12, these-11)
prep_in(compromised-9, patients-12)
advmod(discontinued-16, when-13)
nsubjpass(discontinued-16, cimetidine-14)
auxpass(discontinued-16, is-15)
advcl(compromised-9, discontinued-16)

Several/JJ of/IN the/DT tricyclic/JJ antidepressants/NNS have/VBP been/VBN cited/VBN in/IN these/DT reports/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Several)) (PP (IN of) (NP (DT the) (JJ tricyclic) (NNS antidepressants)))) (VP (VBP have) (VP (VBN been) (VP (VBN cited) (PP (IN in) (NP (DT these) (NNS reports))))))) (. .))))

nsubjpass(cited-8, Several-1)
det(antidepressants-5, the-3)
amod(antidepressants-5, tricyclic-4)
prep_of(Several-1, antidepressants-5)
aux(cited-8, have-6)
auxpass(cited-8, been-7)
root(ROOT-0, cited-8)
det(reports-11, these-10)
prep_in(cited-8, reports-11)

There/EX have/VBP been/VBN greater/JJR than/IN 2-fold/JJ increases/NNS in/IN previously/RB stable/JJ plasma/NN levels/NNS of/IN other/JJ antidepressants/NNS ,/, including/VBG nortriptyline/NN ,/, when/WRB fluoxetine/NN hydrochloride/NN has/VBZ been/VBN administered/VBN in/IN combination/NN with/IN these/DT agents/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP have) (VP (VBN been) (ADJP (ADJP (JJR greater)) (PP (IN than) (NP (NP (JJ 2-fold) (NNS increases)) (PP (IN in) (NP (NP (ADJP (RB previously) (JJ stable)) (NN plasma) (NNS levels)) (PP (IN of) (NP (NP (JJ other) (NNS antidepressants)) (, ,) (PP (VBG including) (NP (NN nortriptyline))) (, ,)))))))) (SBAR (WHADVP (WRB when)) (S (NP (NN fluoxetine) (NN hydrochloride)) (VP (VBZ has) (VP (VBN been) (VP (VBN administered) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (DT these) (NNS agents))))))))))))) (. .))))

expl(greater-4, There-1)
aux(greater-4, have-2)
cop(greater-4, been-3)
root(ROOT-0, greater-4)
amod(increases-7, 2-fold-6)
prep_than(greater-4, increases-7)
advmod(stable-10, previously-9)
amod(levels-12, stable-10)
nn(levels-12, plasma-11)
prep_in(increases-7, levels-12)
amod(antidepressants-15, other-14)
prep_of(levels-12, antidepressants-15)
prep_including(antidepressants-15, nortriptyline-18)
advmod(administered-25, when-20)
nn(hydrochloride-22, fluoxetine-21)
nsubjpass(administered-25, hydrochloride-22)
aux(administered-25, has-23)
auxpass(administered-25, been-24)
advcl(greater-4, administered-25)
prep_in(administered-25, combination-27)
det(agents-30, these-29)
prep_with(combination-27, agents-30)

Fluoxetine/NN and/CC its/PRP$ active/JJ metabolite/NN ,/, norfluoxe-tine/NN ,/, have/VBP long/JJ half-lives/NNS (/-LRB- 4/CD to/TO 16/CD days/NNS for/IN norfluoxetine/NN )/-RRB- ,/, that/WDT may/MD affect/VB strategies/NNS during/IN conversion/NN from/IN one/CD drug/NN to/TO the/DT other/JJ ./.

(ROOT (S1 (S (S (NP (NP (NN Fluoxetine)) (CC and) (NP (NP (PRP$ its) (JJ active) (NN metabolite)) (, ,) (NP (NN norfluoxe-tine)) (, ,))) (VP (VBP have) (NP (NP (NP (JJ long) (NNS half-lives)) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 4) (TO to) (CD 16)) (NNS days)) (PP (IN for) (NP (NN norfluoxetine)))) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB affect) (NP (NNS strategies)) (PP (IN during) (NP (NP (NN conversion)) (PP (IN from) (NP (CD one) (NN drug))) (PP (TO to) (NP (DT the) (JJ other)))))))))))) (. .))))

nsubj(have-9, Fluoxetine-1)
poss(metabolite-5, its-3)
amod(metabolite-5, active-4)
conj_and(Fluoxetine-1, metabolite-5)
appos(metabolite-5, norfluoxe-tine-7)
root(ROOT-0, have-9)
amod(half-lives-11, long-10)
dobj(have-9, half-lives-11)
nsubj(affect-23, half-lives-11)
number(16-15, 4-13)
dep(16-15, to-14)
num(days-16, 16-15)
dep(half-lives-11, days-16)
prep_for(days-16, norfluoxetine-18)
aux(affect-23, may-22)
rcmod(half-lives-11, affect-23)
dobj(affect-23, strategies-24)
prep_during(affect-23, conversion-26)
num(drug-29, one-28)
prep_from(conversion-26, drug-29)
det(other-32, the-31)
prep_to(conversion-26, other-32)

Administration/NN of/IN reserpine/NN during/IN therapy/NN with/IN a/DT tricyclic/JJ antidepressant/JJ has/VBZ been/VBN shown/VBN to/TO produce/VB a/DT @/NN stimulating/NN @/NN effect/NN in/IN some/DT depressed/JJ patients/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Administration)) (PP (IN of) (NP (NN reserpine))) (PP (IN during) (NP (NN therapy))) (PP (IN with) (NP (DT a) (JJ tricyclic) (JJ antidepressant)))) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB produce) (NP (DT a) (NN @) (NN stimulating) (NN @) (NN effect)) (PP (IN in) (NP (DT some) (JJ depressed) (NNS patients)))))))))) (. .))))

nsubjpass(shown-12, Administration-1)
xsubj(produce-14, Administration-1)
prep_of(Administration-1, reserpine-3)
prep_during(Administration-1, therapy-5)
det(antidepressant-9, a-7)
amod(antidepressant-9, tricyclic-8)
prep_with(Administration-1, antidepressant-9)
aux(shown-12, has-10)
auxpass(shown-12, been-11)
root(ROOT-0, shown-12)
aux(produce-14, to-13)
xcomp(shown-12, produce-14)
det(effect-19, a-15)
nn(effect-19, @-16)
nn(effect-19, stimulating-17)
nn(effect-19, @-18)
dobj(produce-14, effect-19)
det(patients-23, some-21)
amod(patients-23, depressed-22)
prep_in(produce-14, patients-23)

Close/JJ supervision/NN and/CC careful/JJ adjustment/NN of/IN the/DT dosage/NN are/VBP required/VBN when/WRB nortriptyline/NN hydrochloride/NN is/VBZ used/VBN with/IN other/JJ anticholinergic/JJ drugs/NNS or/CC sympathomimetic/JJ drugs/NNS ./.

(ROOT (S1 (S (S (NP (NP (NP (JJ Close) (NN supervision)) (CC and) (NP (JJ careful) (NN adjustment))) (PP (IN of) (NP (DT the) (NN dosage)))) (VP (VBP are) (VP (VBN required) (SBAR (WHADVP (WRB when)) (S (NP (NN nortriptyline) (NN hydrochloride)) (VP (VBZ is) (VP (VBN used) (PP (IN with) (NP (NP (JJ other) (JJ anticholinergic) (NNS drugs)) (CC or) (NP (JJ sympathomimetic) (NNS drugs))))))))))) (. .))))

amod(supervision-2, Close-1)
nsubjpass(required-10, supervision-2)
amod(adjustment-5, careful-4)
conj_and(supervision-2, adjustment-5)
det(dosage-8, the-7)
prep_of(supervision-2, dosage-8)
auxpass(required-10, are-9)
root(ROOT-0, required-10)
advmod(used-15, when-11)
nn(hydrochloride-13, nortriptyline-12)
nsubjpass(used-15, hydrochloride-13)
auxpass(used-15, is-14)
advcl(required-10, used-15)
amod(drugs-19, other-17)
amod(drugs-19, anticholinergic-18)
prep_with(used-15, drugs-19)
amod(drugs-22, sympathomimetic-21)
conj_or(drugs-19, drugs-22)

The/DT patient/NN should/MD be/VB informed/VBN that/IN the/DT response/NN to/TO alcohol/NN may/MD be/VB exaggerated/VBN ./.

(ROOT (S1 (S (S (NP (DT The) (NN patient)) (VP (MD should) (VP (VB be) (VP (VBN informed) (SBAR (IN that) (S (NP (NP (DT the) (NN response)) (PP (TO to) (NP (NN alcohol)))) (VP (MD may) (VP (VB be) (VP (VBN exaggerated)))))))))) (. .))))

det(patient-2, The-1)
nsubjpass(informed-5, patient-2)
aux(informed-5, should-3)
auxpass(informed-5, be-4)
root(ROOT-0, informed-5)
complm(exaggerated-13, that-6)
det(response-8, the-7)
nsubjpass(exaggerated-13, response-8)
prep_to(response-8, alcohol-10)
aux(exaggerated-13, may-11)
auxpass(exaggerated-13, be-12)
ccomp(informed-5, exaggerated-13)

Drugs/NNS Metabolized/VBN by/IN P450IID6/NN @/NN A/DT subset/NN (/-LRB- 3/CD %/NN to/TO 10/CD %/NN )/-RRB- of/IN the/DT population/NN has/VBZ reduced/VBN activity/NN of/IN certain/JJ drug/NN metabolizing/NN enzymes/NNS such/JJ as/IN the/DT cytochrome/NN P450/NN isoenzyme/NN P450IID6/NN ./.

(ROOT (S1 (S (S (NP (NNS Drugs)) (VP (VBN Metabolized) (PP (IN by) (NP (NP (NN P450IID6) (NN @)) (S (NP (NP (NP (DT A) (NN subset)) (PRN (-LRB- -LRB-) (NP (CD 3) (NN %) (TO to) (CD 10) (NN %)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN population)))) (VP (VBZ has) (NP (NP (VBN reduced) (NN activity)) (PP (IN of) (NP (NP (JJ certain) (NN drug) (NN metabolizing) (NNS enzymes)) (PP (JJ such) (IN as) (NP (DT the) (NN cytochrome) (NN P450) (NN isoenzyme) (NN P450IID6)))))))))))) (. .))))

nsubj(Metabolized-2, Drugs-1)
root(ROOT-0, Metabolized-2)
nn(@-5, P450IID6-4)
prep_by(Metabolized-2, @-5)
det(subset-7, A-6)
nsubj(has-18, subset-7)
num(%-13, 3-9)
nn(%-13, %-10)
dep(%-13, to-11)
num(%-13, 10-12)
appos(subset-7, %-13)
det(population-17, the-16)
prep_of(subset-7, population-17)
dep(@-5, has-18)
amod(activity-20, reduced-19)
dobj(has-18, activity-20)
amod(enzymes-25, certain-22)
nn(enzymes-25, drug-23)
nn(enzymes-25, metabolizing-24)
prep_of(activity-20, enzymes-25)
det(P450IID6-32, the-28)
nn(P450IID6-32, cytochrome-29)
nn(P450IID6-32, P450-30)
nn(P450IID6-32, isoenzyme-31)
prep_such_as(enzymes-25, P450IID6-32)

Such/JJ individuals/NNS are/VBP referred/VBN to/TO as/IN @/NN poor/JJ metabolizers/NN @/NN of/IN drugs/NNS such/JJ as/IN debrisoquin/NN ,/, dextromethorphan/NN ,/, and/CC the/DT tricyclic/JJ antidepressants/NNS ./.

(ROOT (S1 (S (S (NP (JJ Such) (NNS individuals)) (VP (VBP are) (VP (VBN referred) (PP (TO to)) (PP (IN as) (NP (NP (NN @) (JJ poor) (NN metabolizers) (NN @)) (PP (IN of) (NP (NP (NNS drugs)) (PP (JJ such) (IN as) (NP (NP (NN debrisoquin)) (, ,) (NP (NN dextromethorphan)) (, ,) (CC and) (NP (DT the) (JJ tricyclic) (NNS antidepressants))))))))))) (. .))))

amod(individuals-2, Such-1)
nsubjpass(referred-4, individuals-2)
auxpass(referred-4, are-3)
root(ROOT-0, referred-4)
prep(referred-4, to-5)
nn(@-10, @-7)
amod(@-10, poor-8)
nn(@-10, metabolizers-9)
prep_as(referred-4, @-10)
prep_of(@-10, drugs-12)
prep_such_as(drugs-12, debrisoquin-15)
conj_and(debrisoquin-15, dextromethorphan-17)
det(antidepressants-22, the-20)
amod(antidepressants-22, tricyclic-21)
conj_and(debrisoquin-15, antidepressants-22)

These/DT individuals/NNS may/MD have/VBP higher/JJR than/IN expected/VBN plasma/NN concentrations/NNS of/IN tricyclic/JJ antidepressants/NNS when/WRB given/VBN usual/JJ doses/NNS ./.

(ROOT (S1 (S (S (NP (DT These) (NNS individuals)) (VP (MD may) (VP (VBP have) (NP (NP (JJR higher) (IN than) (VBN expected) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (JJ tricyclic) (NNS antidepressants)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (NP (JJ usual) (NNS doses)))))))) (. .))))

det(individuals-2, These-1)
nsubj(have-4, individuals-2)
aux(have-4, may-3)
root(ROOT-0, have-4)
amod(concentrations-9, higher-5)
amod(concentrations-9, than-6)
amod(concentrations-9, expected-7)
nn(concentrations-9, plasma-8)
dobj(have-4, concentrations-9)
amod(antidepressants-12, tricyclic-11)
prep_of(concentrations-9, antidepressants-12)
advmod(given-14, when-13)
advcl(have-4, given-14)
amod(doses-16, usual-15)
dobj(given-14, doses-16)

In/IN addition/NN ,/, certain/JJ drugs/NNS that/WDT are/VBP metabolized/VBN by/IN this/DT isoenzyme/NN ,/, including/VBG many/JJ antidepressants/NNS (/-LRB- tricyclic/JJ antidepressants/NNS ,/, selective/JJ serotonin/NN reuptake/NN inhibitors/NNS ,/, and/CC others/NNS )/-RRB- ,/, may/MD inhibit/VB the/DT activity/NN of/IN this/DT isoenzyme/NN ,/, and/CC thus/RB may/MD make/VB normal/JJ metab-olizers/NNS resemble/VBP poor/JJ metabolizers/NNS with/IN regard/NN to/TO concomitant/JJ therapy/NN with/IN other/JJ drugs/NNS metabolized/VBN by/IN this/DT enzyme/NN system/NN ,/, leading/VBG to/TO drug/NN interactions/NNS ./.

(ROOT (S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NP (JJ certain) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN metabolized) (PP (IN by) (NP (DT this) (NN isoenzyme)))))))) (, ,) (PP (VBG including) (NP (NP (JJ many) (NNS antidepressants)) (PRN (-LRB- -LRB-) (NP (NP (JJ tricyclic) (NNS antidepressants)) (, ,) (NP (JJ selective) (NN serotonin) (NN reuptake) (NNS inhibitors)) (, ,) (CC and) (NP (NNS others))) (-RRB- -RRB-)))) (, ,)) (VP (VP (MD may) (VP (VB inhibit) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT this) (NN isoenzyme)))))) (, ,) (CC and) (ADVP (RB thus)) (VP (MD may) (VP (VB make) (S (NP (JJ normal) (NNS metab-olizers)) (VP (VBP resemble) (NP (JJ poor) (NNS metabolizers)) (PP (IN with) (NP (NP (NN regard)) (PP (TO to) (NP (NP (JJ concomitant) (NN therapy)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (DT this) (NN enzyme) (NN system)))))))))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NN drug) (NNS interactions)))))))))) (. .))))

prep_in(inhibit-30, addition-2)
amod(drugs-5, certain-4)
nsubjpass(metabolized-8, drugs-5)
nsubj(inhibit-30, drugs-5)
auxpass(metabolized-8, are-7)
rcmod(drugs-5, metabolized-8)
det(isoenzyme-11, this-10)
agent(metabolized-8, isoenzyme-11)
amod(antidepressants-15, many-14)
prep_including(drugs-5, antidepressants-15)
amod(antidepressants-18, tricyclic-17)
dep(antidepressants-15, antidepressants-18)
amod(inhibitors-23, selective-20)
nn(inhibitors-23, serotonin-21)
nn(inhibitors-23, reuptake-22)
conj_and(antidepressants-18, inhibitors-23)
conj_and(antidepressants-18, others-26)
aux(inhibit-30, may-29)
root(ROOT-0, inhibit-30)
det(activity-32, the-31)
dobj(inhibit-30, activity-32)
det(isoenzyme-35, this-34)
prep_of(activity-32, isoenzyme-35)
advmod(inhibit-30, thus-38)
conj_and(inhibit-30, thus-38)
aux(make-40, may-39)
conj_and(inhibit-30, make-40)
amod(metab-olizers-42, normal-41)
nsubj(metabolizers-45, metab-olizers-42)
cop(metabolizers-45, resemble-43)
amod(metabolizers-45, poor-44)
ccomp(make-40, metabolizers-45)
amod(therapy-50, concomitant-49)
prep_with_regard_to(metabolizers-45, therapy-50)
amod(drugs-53, other-52)
prep_with(therapy-50, drugs-53)
partmod(drugs-53, metabolized-54)
det(system-58, this-56)
nn(system-58, enzyme-57)
agent(metabolized-54, system-58)
partmod(metabolizers-45, leading-60)
xcomp(metabolizers-45, leading-60)
nn(interactions-63, drug-62)
prep_to(leading-60, interactions-63)

Concomitant/JJ use/NN of/IN tricyclic/JJ antidepressants/NNS with/IN other/JJ drugs/NNS metabolized/VBN by/IN cytochrome/NN P450IID6/NN may/MD require/VB lower/JJR doses/NNS than/IN usually/RB prescribed/VBN for/IN either/CC the/DT tricyclic/JJ antidepressant/JJ or/CC the/DT other/JJ drug/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN use)) (PP (IN of) (NP (JJ tricyclic) (NNS antidepressants))) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (NN cytochrome) (NN P450IID6))))))) (VP (MD may) (VP (VB require) (NP (NP (JJR lower) (NNS doses)) (VP (ADVP (IN than) (RB usually)) (VBN prescribed) (PP (IN for) (NP (CC either) (NP (DT the) (JJ tricyclic) (JJ antidepressant)) (CC or) (NP (DT the) (JJ other) (NN drug))))))))) (. .))))

amod(use-2, Concomitant-1)
nsubj(require-14, use-2)
amod(antidepressants-5, tricyclic-4)
prep_of(use-2, antidepressants-5)
amod(drugs-8, other-7)
prep_with(use-2, drugs-8)
partmod(drugs-8, metabolized-9)
nn(P450IID6-12, cytochrome-11)
agent(metabolized-9, P450IID6-12)
aux(require-14, may-13)
root(ROOT-0, require-14)
amod(doses-16, lower-15)
dobj(require-14, doses-16)
advmod(prescribed-19, than-17)
advmod(than-17, usually-18)
partmod(doses-16, prescribed-19)
preconj(antidepressant-24, either-21)
det(antidepressant-24, the-22)
amod(antidepressant-24, tricyclic-23)
prep_for(prescribed-19, antidepressant-24)
det(drug-28, the-26)
amod(drug-28, other-27)
conj_or(antidepressant-24, drug-28)

Therefore/RB ,/, co-administration/NN of/IN tricyclic/JJ antidepressants/NNS with/IN other/JJ drugs/NNS that/WDT are/VBP metabolized/VBN by/IN this/DT isoenzyme/NN ,/, including/VBG other/JJ antidepressants/NNS ,/, phenothiazines/NNS ,/, carbamazepine/NN ,/, and/CC Type/NN 1C/NN antiarrhythmics/NNS (/-LRB- eg/NN ,/, propafenone/NN ,/, flecainide/NN ,/, and/CC encainide/NN )/-RRB- ,/, or/CC that/WDT inhibit/VBP this/DT enzyme/NN (/-LRB- eg/NN ,/, quinidine/NN )/-RRB- ,/, should/MD be/VB approached/VBN with/IN caution/NN ./.

(ROOT (S1 (S (ADVP (RB Therefore)) (, ,) (NP (NP (NN co-administration)) (PP (IN of) (NP (JJ tricyclic) (NNS antidepressants))) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (SBAR (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN metabolized) (PP (IN by) (NP (DT this) (NN isoenzyme))) (, ,) (PP (VBG including) (NP (NP (JJ other) (NNS antidepressants)) (, ,) (NP (NNS phenothiazines)) (, ,) (NP (NN carbamazepine)) (, ,) (CC and) (NP (NP (NN Type) (NN 1C) (NNS antiarrhythmics)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN propafenone)) (, ,) (NP (NN flecainide)) (, ,) (CC and) (NP (NN encainide))) (-RRB- -RRB-))))))))) (, ,) (CC or) (SBAR (WHNP (WDT that)) (S (VP (VBP inhibit) (NP (NP (DT this) (NN enzyme)) (PRN (-LRB- -LRB-) (NP (NP (NN eg)) (, ,) (NP (NN quinidine))) (-RRB- -RRB-)))))))))) (, ,) (VP (MD should) (VP (VB be) (VP (VBN approached) (PP (IN with) (NP (NN caution)))))) (. .))))

advmod(approached-53, Therefore-1)
nsubjpass(approached-53, co-administration-3)
amod(antidepressants-6, tricyclic-5)
prep_of(co-administration-3, antidepressants-6)
amod(drugs-9, other-8)
prep_with(co-administration-3, drugs-9)
nsubjpass(metabolized-12, drugs-9)
nsubj(inhibit-42, drugs-9)
auxpass(metabolized-12, are-11)
rcmod(drugs-9, metabolized-12)
det(isoenzyme-15, this-14)
agent(metabolized-12, isoenzyme-15)
amod(antidepressants-19, other-18)
prep_including(metabolized-12, antidepressants-19)
conj_and(antidepressants-19, phenothiazines-21)
conj_and(antidepressants-19, carbamazepine-23)
nn(antiarrhythmics-28, Type-26)
nn(antiarrhythmics-28, 1C-27)
conj_and(antidepressants-19, antiarrhythmics-28)
dep(antiarrhythmics-28, eg-30)
conj_and(eg-30, propafenone-32)
conj_and(eg-30, flecainide-34)
conj_and(eg-30, encainide-37)
conj_or(metabolized-12, inhibit-42)
det(enzyme-44, this-43)
dobj(inhibit-42, enzyme-44)
dep(enzyme-44, eg-46)
appos(eg-46, quinidine-48)
aux(approached-53, should-51)
auxpass(approached-53, be-52)
root(ROOT-0, approached-53)
prep_with(approached-53, caution-55)

Treatment/NN with/IN PEGASYS/NN once/RB weekly/RB for/IN 4/CD weeks/NNS in/IN healthy/JJ subjects/NNS was/VBD associated/VBN with/IN an/DT inhibition/NN of/IN P450/NN 1A2/NN and/CC a/DT 25/CD %/NN increase/NN in/IN theophylline/NN AUC/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Treatment)) (PP (IN with) (NP (NN PEGASYS))) (PP (ADVP (RB once) (RB weekly)) (IN for) (NP (NP (CD 4) (NNS weeks)) (PP (IN in) (NP (JJ healthy) (NNS subjects)))))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT an) (NN inhibition)) (PP (IN of) (NP (NN P450) (NN 1A2)))) (CC and) (NP (NP (DT a) (ADJP (CD 25) (NN %)) (NN increase)) (PP (IN in) (NP (NN theophylline) (NN AUC))))))))) (. .))))

nsubjpass(associated-13, Treatment-1)
prep_with(Treatment-1, PEGASYS-3)
advmod(weekly-5, once-4)
advmod(Treatment-1, weekly-5)
num(weeks-8, 4-7)
prep_for(Treatment-1, weeks-8)
amod(subjects-11, healthy-10)
prep_in(weeks-8, subjects-11)
auxpass(associated-13, was-12)
root(ROOT-0, associated-13)
det(inhibition-16, an-15)
prep_with(associated-13, inhibition-16)
nn(1A2-19, P450-18)
prep_of(inhibition-16, 1A2-19)
det(increase-24, a-21)
number(%-23, 25-22)
amod(increase-24, %-23)
conj_and(inhibition-16, increase-24)
nn(AUC-27, theophylline-26)
prep_in(increase-24, AUC-27)

Theophylline/NN serum/NN levels/NNS should/MD be/VB monitored/VBN and/CC appropriate/JJ dose/NN adjustments/NNS considered/VBN for/IN patients/NNS given/IN both/CC theophylline/NN and/CC PEGASYS/NN ./.

(ROOT (S1 (S (S (S (NP (NN Theophylline) (NN serum) (NNS levels)) (VP (MD should) (VP (VB be) (VP (VBN monitored))))) (CC and) (S (NP (JJ appropriate) (NN dose) (NNS adjustments)) (VP (VBN considered) (PP (IN for) (NP (NP (NNS patients)) (PP (IN given) (NP (CC both) (NP (NN theophylline)) (CC and) (NP (NN PEGASYS))))))))) (. .))))

nn(levels-3, Theophylline-1)
nn(levels-3, serum-2)
nsubjpass(monitored-6, levels-3)
aux(monitored-6, should-4)
auxpass(monitored-6, be-5)
root(ROOT-0, monitored-6)
amod(adjustments-10, appropriate-8)
nn(adjustments-10, dose-9)
nsubj(considered-11, adjustments-10)
conj_and(monitored-6, considered-11)
prep_for(considered-11, patients-13)
preconj(theophylline-16, both-15)
prep_given(patients-13, theophylline-16)
conj_and(theophylline-16, PEGASYS-18)

There/EX was/VBD no/DT effect/NN on/IN the/DT pharmacokinetics/NNS of/IN representative/JJ drugs/NNS metabolized/VBN by/IN CYP/NN 2C9/NN ,/, CYP/NN 2C19/NN ,/, CYP/NN 2D6/NN or/CC CYP/NN 3A4/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (JJ representative) (NNS drugs)) (VP (VBN metabolized) (PP (IN by) (NP (NP (NN CYP) (NN 2C9)) (, ,) (NP (NN CYP) (NN 2C19)) (, ,) (NP (NN CYP) (NN 2D6)) (CC or) (NP (NN CYP) (NN 3A4)))))))))))) (. .))))

expl(was-2, There-1)
root(ROOT-0, was-2)
det(effect-4, no-3)
nsubj(was-2, effect-4)
det(pharmacokinetics-7, the-6)
prep_on(effect-4, pharmacokinetics-7)
amod(drugs-10, representative-9)
prep_of(pharmacokinetics-7, drugs-10)
partmod(drugs-10, metabolized-11)
nn(2C9-14, CYP-13)
agent(metabolized-11, 2C9-14)
nn(2C19-17, CYP-16)
conj_or(2C9-14, 2C19-17)
nn(2D6-20, CYP-19)
conj_or(2C9-14, 2D6-20)
nn(3A4-23, CYP-22)
conj_or(2C9-14, 3A4-23)

In/IN patients/NNS with/IN chronic/JJ hepatitis/NN C/NN treated/VBN with/IN PEGASYS/NN in/IN combination/NN with/IN COPEGUS/NN ,/, PEGASYS/NN treatment/NN did/VBD not/RB affect/VB ribavirin/NN distribution/NN or/CC clearance/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ chronic) (NN hepatitis) (NN C))) (VP (VBN treated) (PP (IN with) (NP (NN PEGASYS))) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN COPEGUS)))))))) (, ,) (NP (NN PEGASYS) (NN treatment)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (NN ribavirin) (NN distribution)) (CC or) (NP (NN clearance)))))) (. .))))

prep_in(affect-19, patients-2)
amod(C-6, chronic-4)
nn(C-6, hepatitis-5)
prep_with(patients-2, C-6)
partmod(patients-2, treated-7)
prep_with(treated-7, PEGASYS-9)
prep_in(treated-7, combination-11)
prep_with(combination-11, COPEGUS-13)
nn(treatment-16, PEGASYS-15)
nsubj(affect-19, treatment-16)
aux(affect-19, did-17)
neg(affect-19, not-18)
root(ROOT-0, affect-19)
nn(distribution-21, ribavirin-20)
dobj(affect-19, distribution-21)
conj_or(distribution-21, clearance-23)

Nucleoside/NN Analogues/NNS Didanosine/NN Co-administration/NN of/IN COPEGUS/NN and/CC didanosine/NN is/VBZ not/RB recommended/VBN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Nucleoside) (NNS Analogues)) (NN Didanosine) (NN Co-administration)) (PP (IN of) (NP (NP (NN COPEGUS)) (CC and) (NP (NN didanosine))))) (VP (VBZ is) (RB not) (VP (VBN recommended)))) (. .))))

nn(Analogues-2, Nucleoside-1)
nn(Co-administration-4, Analogues-2)
nn(Co-administration-4, Didanosine-3)
nsubjpass(recommended-11, Co-administration-4)
prep_of(Co-administration-4, COPEGUS-6)
conj_and(COPEGUS-6, didanosine-8)
auxpass(recommended-11, is-9)
neg(recommended-11, not-10)
root(ROOT-0, recommended-11)

Stavudine/NN and/CC Zidovudine/NN Ribavirin/NN can/MD antagonize/VB the/DT in/FW vitro/FW antiviral/JJ activity/NN of/IN stavudine/NN and/CC zidovudine/NN against/IN HIV/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Stavudine)) (CC and) (NP (NN Zidovudine) (NN Ribavirin))) (VP (MD can) (VP (VB antagonize) (NP (NP (DT the) (ADJP (FW in) (FW vitro)) (JJ antiviral) (NN activity)) (PP (IN of) (NP (NP (NN stavudine)) (CC and) (NP (NN zidovudine)))) (PP (IN against) (NP (NN HIV))))))) (. .))))

nsubj(antagonize-6, Stavudine-1)
nn(Ribavirin-4, Zidovudine-3)
conj_and(Stavudine-1, Ribavirin-4)
aux(antagonize-6, can-5)
root(ROOT-0, antagonize-6)
det(activity-11, the-7)
nn(vitro-9, in-8)
amod(activity-11, vitro-9)
amod(activity-11, antiviral-10)
dobj(antagonize-6, activity-11)
prep_of(activity-11, stavudine-13)
conj_and(stavudine-13, zidovudine-15)
prep_against(activity-11, HIV-17)

Therefore/RB ,/, concomitant/JJ use/NN of/IN ribavirin/NN with/IN either/DT of/IN these/DT drugs/NNS should/MD be/VB avoided/VBN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (JJ concomitant) (NN use)) (PP (IN of) (NP (NN ribavirin))) (PP (IN with) (NP (NP (DT either)) (PP (IN of) (NP (DT these) (NNS drugs)))))) (VP (MD should) (VP (VB be) (VP (VBN avoided))))) (. .))))

advmod(avoided-14, Therefore-1)
amod(use-4, concomitant-3)
nsubjpass(avoided-14, use-4)
prep_of(use-4, ribavirin-6)
prep_with(use-4, either-8)
det(drugs-11, these-10)
prep_of(either-8, drugs-11)
aux(avoided-14, should-12)
auxpass(avoided-14, be-13)
root(ROOT-0, avoided-14)

Carcinogenesis/NN ,/, Mutagenesis/NN ,/, Impairment/NN of/IN Fertility/NN Carcinogenesis/NN PEGASYS/NN has/VBZ not/RB been/VBN tested/VBN for/IN its/PRP$ carcinogenic/JJ potential/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Carcinogenesis)) (, ,) (NP (NN Mutagenesis)) (, ,) (NP (NN Impairment))) (PP (IN of) (NP (NN Fertility) (NN Carcinogenesis) (NN PEGASYS)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN tested) (PP (IN for) (NP (PRP$ its) (JJ carcinogenic) (NN potential))))))) (. .))))

nsubjpass(tested-13, Carcinogenesis-1)
appos(Carcinogenesis-1, Mutagenesis-3)
appos(Carcinogenesis-1, Impairment-5)
nn(PEGASYS-9, Fertility-7)
nn(PEGASYS-9, Carcinogenesis-8)
prep_of(Carcinogenesis-1, PEGASYS-9)
aux(tested-13, has-10)
neg(tested-13, not-11)
auxpass(tested-13, been-12)
root(ROOT-0, tested-13)
poss(potential-17, its-15)
amod(potential-17, carcinogenic-16)
prep_for(tested-13, potential-17)

Mutagenesis/NN PEGASYS/NN did/VBD not/RB cause/VB DNA/NN damage/NN when/WRB tested/VBN in/IN the/DT Ame/NN s/NN bacterial/JJ mutagenicity/NN assay/NN and/CC in/IN the/DT in/FW vitro/FW chromosomal/NN aberration/NN assay/NN in/IN human/JJ lymphocytes/NNS ,/, either/CC in/IN the/DT presence/NN or/CC absence/NN of/IN metabolic/JJ activation/NN ./.

(ROOT (S1 (S (S (NP (NN Mutagenesis) (NN PEGASYS)) (VP (VBD did) (RB not) (VP (VB cause) (NP (NN DNA) (NN damage)) (SBAR (WHADVP (WRB when)) (S (VP (VBN tested) (PP (PP (IN in) (NP (DT the) (NN Ame) (NN s) (JJ bacterial) (NN mutagenicity) (NN assay))) (CC and) (PP (IN in) (NP (NP (DT the) (ADJP (FW in) (FW vitro)) (NN chromosomal) (NN aberration) (NN assay)) (PP (IN in) (NP (JJ human) (NNS lymphocytes))))) (, ,) (CC either) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC or) (NP (NN absence))) (PP (IN of) (NP (JJ metabolic) (NN activation)))))))))))) (. .))))

nn(PEGASYS-2, Mutagenesis-1)
nsubj(cause-5, PEGASYS-2)
aux(cause-5, did-3)
neg(cause-5, not-4)
root(ROOT-0, cause-5)
nn(damage-7, DNA-6)
dobj(cause-5, damage-7)
advmod(tested-9, when-8)
advcl(cause-5, tested-9)
det(assay-16, the-11)
nn(assay-16, Ame-12)
nn(assay-16, s-13)
amod(assay-16, bacterial-14)
nn(assay-16, mutagenicity-15)
prep_in(tested-9, assay-16)
det(assay-24, the-19)
nn(vitro-21, in-20)
amod(assay-24, vitro-21)
nn(assay-24, chromosomal-22)
nn(assay-24, aberration-23)
conj_and(assay-16, assay-24)
amod(lymphocytes-27, human-26)
prep_in(assay-24, lymphocytes-27)
dep(tested-9, either-29)
dep(presence-32, the-31)
conj_and(assay-16, presence-32)
conj_or(presence-32, absence-34)
amod(activation-37, metabolic-36)
prep_of(presence-32, activation-37)

Use/NN With/IN Ribavirin/NN Ribavirin/NN is/VBZ genotoxic/JJ and/CC mutagenic/JJ ./.

(ROOT (S1 (S (S (NP (NP (NN Use)) (PP (IN With) (NP (NN Ribavirin) (NN Ribavirin)))) (VP (VBZ is) (ADJP (ADJP (JJ genotoxic)) (CC and) (ADJP (JJ mutagenic))))) (. .))))

nsubj(genotoxic-6, Use-1)
nn(Ribavirin-4, Ribavirin-3)
prep_with(Use-1, Ribavirin-4)
cop(genotoxic-6, is-5)
root(ROOT-0, genotoxic-6)
conj_and(genotoxic-6, mutagenic-8)

The/DT carcinogenic/JJ potential/NN of/IN ribavirin/NN has/VBZ not/RB been/VBN fully/RB determined/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (JJ carcinogenic) (NN potential)) (PP (IN of) (NP (NN ribavirin)))) (VP (VBZ has) (RB not) (VP (VBN been) (ADVP (RB fully)) (VP (VBN determined))))) (. .))))

det(potential-3, The-1)
amod(potential-3, carcinogenic-2)
nsubjpass(determined-10, potential-3)
prep_of(potential-3, ribavirin-5)
aux(determined-10, has-6)
neg(determined-10, not-7)
auxpass(determined-10, been-8)
advmod(determined-10, fully-9)
root(ROOT-0, determined-10)

In/IN a/DT p53/NN (/-LRB- +/-/CC )/-RRB- mouse/NN carcinogenicity/NN study/NN at/IN doses/NNS up/RP to/TO the/DT maximum/JJ tolerated/VBN dose/NN of/IN 100/CD mg/kg/day/NN ribavirin/NN was/VBD not/RB oncogenic/JJ ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NP (NP (DT a) (NN p53)) (-LRB- -LRB-) (CC +/-) (-RRB- -RRB-)) (NN mouse) (NN carcinogenicity) (NN study)) (PP (IN at) (NP (NP (NNS doses)) (PP (RP up) (TO to) (NP (NP (DT the) (JJ maximum) (VBN tolerated) (NN dose)) (PP (IN of) (NP (ADJP (CD 100) (NN mg/kg/day)) (NN ribavirin))))))))) (VP (VBD was) (RB not) (ADJP (JJ oncogenic)))) (. .))))

det(p53-3, a-2)
nn(study-9, p53-3)
cc(p53-3, +/--5)
nn(study-9, mouse-7)
nn(study-9, carcinogenicity-8)
prep_in(oncogenic-24, study-9)
prep_at(study-9, doses-11)
dep(doses-11, up-12)
det(dose-17, the-14)
amod(dose-17, maximum-15)
amod(dose-17, tolerated-16)
prep_to(doses-11, dose-17)
number(mg/kg/day-20, 100-19)
amod(ribavirin-21, mg/kg/day-20)
prep_of(dose-17, ribavirin-21)
cop(oncogenic-24, was-22)
neg(oncogenic-24, not-23)
root(ROOT-0, oncogenic-24)

However/RB ,/, on/IN a/DT body/NN surface/NN area/NN basis/NN ,/, this/DT dose/NN was/VBD 0.5/CD times/NNS maximum/JJ recommended/VBN human/JJ 24-hour/JJ dose/NN of/IN ribavirin/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (PP (IN on) (NP (NP (DT a) (NN body) (NN surface) (NN area)) (NN basis))) (, ,) (NP (DT this) (NN dose)) (VP (VBD was) (NP (NP (CD 0.5) (NNS times) (JJ maximum) (VBN recommended) (JJ human) (JJ 24-hour) (NN dose)) (PP (IN of) (NP (NN ribavirin)))))) (. .))))

advmod(dose-19, However-1)
det(area-7, a-4)
nn(area-7, body-5)
nn(area-7, surface-6)
nn(basis-8, area-7)
prep_on(dose-19, basis-8)
det(dose-11, this-10)
nsubj(dose-19, dose-11)
cop(dose-19, was-12)
num(dose-19, 0.5-13)
nn(dose-19, times-14)
amod(dose-19, maximum-15)
amod(dose-19, recommended-16)
amod(dose-19, human-17)
amod(dose-19, 24-hour-18)
root(ROOT-0, dose-19)
prep_of(dose-19, ribavirin-21)

A/DT study/NN in/IN rats/NNS to/TO assess/VB the/DT carcinogenic/JJ potential/NN of/IN ribavirin/NN is/VBZ ongoing/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT A) (NN study)) (PP (IN in) (NP (NNS rats))) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (JJ carcinogenic) (NN potential)) (PP (IN of) (NP (NN ribavirin)))))))) (VP (VBZ is) (ADJP (JJ ongoing)))) (. .))))

det(study-2, A-1)
nsubj(ongoing-13, study-2)
prep_in(study-2, rats-4)
aux(assess-6, to-5)
infmod(study-2, assess-6)
det(potential-9, the-7)
amod(potential-9, carcinogenic-8)
dobj(assess-6, potential-9)
prep_of(potential-9, ribavirin-11)
cop(ongoing-13, is-12)
root(ROOT-0, ongoing-13)

Mutagenesis/NN Impairment/NN of/IN Fertility/NN PEGASYS/NN may/MD impair/VB fertility/NN in/IN women/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Mutagenesis) (NN Impairment)) (PP (IN of) (NP (NN Fertility) (NN PEGASYS)))) (VP (MD may) (VP (VB impair) (NP (NP (NN fertility)) (PP (IN in) (NP (NNS women))))))) (. .))))

nn(Impairment-2, Mutagenesis-1)
nsubj(impair-7, Impairment-2)
nn(PEGASYS-5, Fertility-4)
prep_of(Impairment-2, PEGASYS-5)
aux(impair-7, may-6)
root(ROOT-0, impair-7)
dobj(impair-7, fertility-8)
prep_in(fertility-8, women-10)

Prolonged/JJ menstrual/JJ cycles/NNS and/or/CC amenorrhea/NN were/VBD observed/VBN in/IN female/JJ cynomolgus/NN monkeys/NNS given/VBN sc/NN injections/NNS of/IN 600/CD m/NN g/kg/dose/NN (/-LRB- 7200/CD m/NN g/m2/dose/NN )/-RRB- of/IN PEGASYS/NN every/DT other/JJ day/NN for/IN one/CD month/NN ,/, at/IN approximately/RB 180/CD times/NNS the/DT recommended/VBN weekly/JJ human/JJ dose/NN for/IN a/DT 60/CD kg/NN person/NN (/-LRB- based/VBN on/IN body/NN surface/NN area/NN )./CD

(ROOT (S1 (S (S (NP (NP (JJ Prolonged) (JJ menstrual) (NNS cycles)) (CC and/or) (NP (NN amenorrhea))) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (JJ female) (NN cynomolgus) (NNS monkeys)) (VP (VBN given) (NP (NP (NN sc) (NNS injections)) (PP (IN of) (NP (NP (ADJP (CD 600) (NN m)) (NN g/kg/dose)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 7200) (NN m)) (NN g/m2/dose)) (-RRB- -RRB-)))) (PP (IN of) (NP (NN PEGASYS)))) (PP (NP (DT every) (JJ other) (NN day)) (IN for) (NP (CD one) (NN month)))))) (, ,) (PP (IN at) (NP (QP (RB approximately) (CD 180)) (NNS times)))))) (NP (NP (DT the) (VBN recommended) (JJ weekly) (JJ human) (NN dose)) (PP (IN for) (NP (DT a) (ADJP (CD 60) (NN kg)) (NN person))) (-LRB- -LRB-) (VP (VBN based) (PP (IN on) (NP (NN body) (NN surface) (NN area) (CD -RRB-.))))))))

amod(cycles-3, Prolonged-1)
amod(cycles-3, menstrual-2)
nsubjpass(observed-7, cycles-3)
conj_and/or(cycles-3, amenorrhea-5)
auxpass(observed-7, were-6)
root(ROOT-0, observed-7)
amod(monkeys-11, female-9)
nn(monkeys-11, cynomolgus-10)
prep_in(observed-7, monkeys-11)
partmod(monkeys-11, given-12)
nn(injections-14, sc-13)
dobj(given-12, injections-14)
number(m-17, 600-16)
amod(g/kg/dose-18, m-17)
prep_of(injections-14, g/kg/dose-18)
number(m-21, 7200-20)
amod(g/m2/dose-22, m-21)
appos(g/kg/dose-18, g/m2/dose-22)
prep_of(injections-14, PEGASYS-25)
det(day-28, every-26)
amod(day-28, other-27)
npadvmod(given-12, day-28)
num(month-31, one-30)
prep_for(given-12, month-31)
quantmod(180-35, approximately-34)
num(times-36, 180-35)
prep_at(observed-7, times-36)
det(dose-41, the-37)
amod(dose-41, recommended-38)
amod(dose-41, weekly-39)
amod(dose-41, human-40)
dep(observed-7, dose-41)
det(person-46, a-43)
number(kg-45, 60-44)
amod(person-46, kg-45)
prep_for(dose-41, person-46)
partmod(dose-41, based-48)
nn(area-52, body-50)
nn(area-52, surface-51)
prep_on(based-48, area-52)
num(area-52, -RRB-.-53)

Menstrual/JJ cycle/NN irregularities/NNS were/VBD accompanied/VBN by/IN both/CC a/DT decrease/NN and/CC delay/NN in/IN the/DT peak/JJ 17b/NN -/CC estradiol/NN and/CC progesterone/NN levels/NNS following/VBG administration/NN of/IN PEGASYS/NN to/TO female/JJ monkeys/NNS ./.

(ROOT (S1 (S (S (NP (JJ Menstrual) (NN cycle) (NNS irregularities)) (VP (VBD were) (VP (VBN accompanied) (PP (IN by) (NP (CC both) (NP (NP (NP (DT a) (NN decrease)) (CC and) (NP (NN delay))) (PP (IN in) (NP (DT the) (JJ peak) (NN 17b)))) (CC -) (NP (NP (NP (NP (NN estradiol)) (CC and) (NP (NN progesterone))) (NNS levels)) (PP (VBG following) (NP (NP (NN administration)) (PP (IN of) (NP (NN PEGASYS))) (PP (TO to) (NP (JJ female) (NNS monkeys))))))))))) (. .))))

amod(irregularities-3, Menstrual-1)
nn(irregularities-3, cycle-2)
nsubjpass(accompanied-5, irregularities-3)
auxpass(accompanied-5, were-4)
root(ROOT-0, accompanied-5)
preconj(decrease-9, both-7)
det(decrease-9, a-8)
agent(accompanied-5, decrease-9)
conj_and(decrease-9, delay-11)
det(17b-15, the-13)
amod(17b-15, peak-14)
prep_in(decrease-9, 17b-15)
nn(levels-20, estradiol-17)
conj_and(estradiol-17, progesterone-19)
conj_and(decrease-9, levels-20)
prep_following(levels-20, administration-22)
prep_of(administration-22, PEGASYS-24)
amod(monkeys-27, female-26)
prep_to(administration-22, monkeys-27)

Every/DT other/JJ day/NN dosing/NN with/IN 100m/CD g/kg/NN (/-LRB- 1200m/CD g/m2/NN )/-RRB- PEGASYS/NN (/-LRB- equivalent/JJ to/TO approximately/RB 30/CD times/NNS the/DT recommended/VBN human/JJ dose/NN )/-RRB- had/VBD no/DT effects/NNS on/IN cycle/NN duration/NN or/CC reproductive/JJ hormone/NN status/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (DT Every) (JJ other) (NN day)) (NN dosing)) (PP (IN with) (NP (NP (NP (CD 100m) (NN g/kg)) (PRN (-LRB- -LRB-) (NP (CD 1200m) (NN g/m2)) (-RRB- -RRB-))) (NP (NP (NN PEGASYS)) (PRN (-LRB- -LRB-) (NP (ADJP (JJ equivalent) (PP (TO to) (NP (QP (RB approximately) (CD 30)) (NNS times)))) (NP (DT the) (VBN recommended) (JJ human) (NN dose))) (-RRB- -RRB-)))))) (VP (VBD had) (NP (NP (DT no) (NNS effects)) (PP (IN on) (NP (NP (NN cycle) (NN duration)) (CC or) (NP (JJ reproductive) (NN hormone) (NN status))))))) (. .))))

det(day-3, Every-1)
amod(day-3, other-2)
nn(dosing-4, day-3)
nsubj(had-24, dosing-4)
num(g/kg-7, 100m-6)
prep_with(dosing-4, g/kg-7)
num(g/m2-10, 1200m-9)
appos(g/kg-7, g/m2-10)
dep(g/kg-7, PEGASYS-12)
amod(dose-22, equivalent-14)
quantmod(30-17, approximately-16)
num(times-18, 30-17)
prep_to(equivalent-14, times-18)
det(dose-22, the-19)
amod(dose-22, recommended-20)
amod(dose-22, human-21)
dep(PEGASYS-12, dose-22)
root(ROOT-0, had-24)
det(effects-26, no-25)
dobj(had-24, effects-26)
nn(duration-29, cycle-28)
prep_on(effects-26, duration-29)
amod(status-33, reproductive-31)
nn(status-33, hormone-32)
conj_or(duration-29, status-33)

The/DT effects/NNS of/IN PEGASYS/NN on/IN male/JJ fertility/NN have/VBP not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS effects)) (PP (IN of) (NP (NN PEGASYS))) (PP (IN on) (NP (JJ male) (NN fertility)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

det(effects-2, The-1)
nsubjpass(studied-11, effects-2)
prep_of(effects-2, PEGASYS-4)
amod(fertility-7, male-6)
prep_on(effects-2, fertility-7)
aux(studied-11, have-8)
neg(studied-11, not-9)
auxpass(studied-11, been-10)
root(ROOT-0, studied-11)

However/RB ,/, no/DT adverse/JJ effects/NNS on/IN fertility/NN were/VBD observed/VBN in/IN male/JJ Rhesus/NN monkeys/NNS treated/VBN with/IN non-/JJ pegylated/JJ interferon/NN alfa-2a/NN for/IN 5/CD months/NNS at/IN doses/NNS up/RP to/TO 25/CD x/CC 106/CD IU/kg/day/NN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT no) (JJ adverse) (NNS effects)) (PP (IN on) (NP (NN fertility)))) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (JJ male) (NN Rhesus) (NNS monkeys)) (VP (VBN treated) (PP (IN with) (NP (NP (JJ non-) (JJ pegylated) (NN interferon) (NN alfa-2a)) (PP (IN for) (NP (CD 5) (NNS months))) (PP (IN at) (NP (NP (NNS doses)) (PP (RP up) (TO to) (NP (QP (CD 25) (CC x) (CD 106)) (NN IU/kg/day))))))))))))) (. .))))

advmod(observed-9, However-1)
det(effects-5, no-3)
amod(effects-5, adverse-4)
nsubjpass(observed-9, effects-5)
prep_on(effects-5, fertility-7)
auxpass(observed-9, were-8)
root(ROOT-0, observed-9)
amod(monkeys-13, male-11)
nn(monkeys-13, Rhesus-12)
prep_in(observed-9, monkeys-13)
partmod(monkeys-13, treated-14)
amod(alfa-2a-19, non--16)
amod(alfa-2a-19, pegylated-17)
nn(alfa-2a-19, interferon-18)
prep_with(treated-14, alfa-2a-19)
num(months-22, 5-21)
prep_for(alfa-2a-19, months-22)
prep_at(alfa-2a-19, doses-24)
dep(doses-24, up-25)
num(IU/kg/day-30, 25-27)
conj_x(25-27, 106-29)
prep_to(doses-24, IU/kg/day-30)

Pregnancy/NN Pregnancy/NN :/: Category/NN C/NN PEGASYS/NN has/VBZ not/RB been/VBN studied/VBN for/IN its/PRP$ teratogenic/JJ effect/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Pregnancy) (NN Pregnancy)) (: :) (NP (NN Category) (NN C) (NN PEGASYS))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied) (PP (IN for) (NP (PRP$ its) (JJ teratogenic) (NN effect))))))) (. .))))

nn(Pregnancy-2, Pregnancy-1)
nsubjpass(studied-10, Pregnancy-2)
nn(PEGASYS-6, Category-4)
nn(PEGASYS-6, C-5)
dep(Pregnancy-2, PEGASYS-6)
aux(studied-10, has-7)
neg(studied-10, not-8)
auxpass(studied-10, been-9)
root(ROOT-0, studied-10)
poss(effect-14, its-12)
amod(effect-14, teratogenic-13)
prep_for(studied-10, effect-14)

Non-/JJ pegylated/JJ interferon/NN alfa-2a/NN treatment/NN of/IN pregnant/JJ Rhesus/NN monkeys/NNS at/IN approximately/RB 20/CD to/TO 500/CD times/NNS the/DT human/JJ weekly/JJ dose/NN resulted/VBD in/IN a/DT statistically/RB significant/JJ increase/NN in/IN abortions/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Non-) (JJ pegylated) (NN interferon) (NN alfa-2a) (NN treatment)) (PP (IN of) (NP (JJ pregnant) (NN Rhesus) (NNS monkeys))) (PP (IN at) (NP (QP (RB approximately) (CD 20) (TO to) (CD 500) (NNS times)) (NP (DT the) (JJ human) (JJ weekly) (NN dose))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (ADJP (RB statistically) (JJ significant)) (NN increase)) (PP (IN in) (NP (NNS abortions))))))) (. .))))

amod(treatment-5, Non--1)
amod(treatment-5, pegylated-2)
nn(treatment-5, interferon-3)
nn(treatment-5, alfa-2a-4)
nsubj(resulted-20, treatment-5)
amod(monkeys-9, pregnant-7)
nn(monkeys-9, Rhesus-8)
prep_of(treatment-5, monkeys-9)
quantmod(times-15, approximately-11)
number(times-15, 20-12)
dep(times-15, to-13)
number(times-15, 500-14)
num(dose-19, times-15)
det(dose-19, the-16)
amod(dose-19, human-17)
amod(dose-19, weekly-18)
prep_at(treatment-5, dose-19)
root(ROOT-0, resulted-20)
det(increase-25, a-22)
advmod(significant-24, statistically-23)
amod(increase-25, significant-24)
prep_in(resulted-20, increase-25)
prep_in(increase-25, abortions-27)

No/DT teratogenic/JJ effects/NNS were/VBD seen/VBN in/IN the/DT offspring/JJ deliver/VB ed/NN at/IN term/NN ./.

(ROOT (S1 (S (S (NP (DT No) (JJ teratogenic) (NNS effects)) (VP (VBD were) (VP (VBN seen) (PP (IN in) (NP (NP (DT the) (JJ offspring)) (VP (VB deliver) (NP (NN ed)) (PP (IN at) (NP (NN term))))))))) (. .))))

det(effects-3, No-1)
amod(effects-3, teratogenic-2)
nsubjpass(seen-5, effects-3)
auxpass(seen-5, were-4)
root(ROOT-0, seen-5)
det(offspring-8, the-7)
prep_in(seen-5, offspring-8)
dep(offspring-8, deliver-9)
dobj(deliver-9, ed-10)
prep_at(deliver-9, term-12)

PEGASYS/NN should/MD be/VB assumed/VBN to/TO have/VB abortifacient/JJ potential/NN ./.

(ROOT (S1 (S (S (NP (NN PEGASYS)) (VP (MD should) (VP (VB be) (VP (VBN assumed) (S (VP (TO to) (VP (VB have) (NP (JJ abortifacient) (NN potential))))))))) (. .))))

nsubjpass(assumed-4, PEGASYS-1)
aux(assumed-4, should-2)
auxpass(assumed-4, be-3)
root(ROOT-0, assumed-4)
aux(have-6, to-5)
xcomp(assumed-4, have-6)
amod(potential-8, abortifacient-7)
dobj(have-6, potential-8)

There/EX are/VBP no/DT adequate/JJ and/CC well-controlled/JJ studies/NNS of/IN PEGASYS/NN in/IN pregnant/JJ women/NNS ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBP are) (NP (NP (DT no) (ADJP (ADJP (JJ adequate)) (CC and) (ADJP (JJ well-controlled))) (NNS studies)) (PP (IN of) (NP (NN PEGASYS))) (PP (IN in) (NP (JJ pregnant) (NNS women)))))) (. .))))

expl(are-2, There-1)
root(ROOT-0, are-2)
det(studies-7, no-3)
amod(studies-7, adequate-4)
conj_and(adequate-4, well-controlled-6)
nsubj(are-2, studies-7)
prep_of(studies-7, PEGASYS-9)
amod(women-12, pregnant-11)
prep_in(studies-7, women-12)

PEGASYS/NN is/VBZ to/TO be/VB used/VBN during/IN pregnancy/NN only/RB if/IN the/DT potential/JJ benefit/NN justifies/VBZ the/DT potential/JJ risk/NN to/TO the/DT fetus/NN ./.

(ROOT (S1 (S (S (NP (NN PEGASYS)) (VP (VBZ is) (S (VP (TO to) (VP (VB be) (VP (VBN used) (PP (IN during) (NP (NN pregnancy))) (SBAR (RB only) (IN if) (S (NP (DT the) (JJ potential) (NN benefit)) (VP (VBZ justifies) (NP (NP (DT the) (JJ potential) (NN risk)) (PP (TO to) (NP (DT the) (NN fetus))))))))))))) (. .))))

nsubj(is-2, PEGASYS-1)
xsubj(used-5, PEGASYS-1)
root(ROOT-0, is-2)
aux(used-5, to-3)
auxpass(used-5, be-4)
xcomp(is-2, used-5)
prep_during(used-5, pregnancy-7)
advmod(justifies-13, only-8)
dep(justifies-13, if-9)
det(benefit-12, the-10)
amod(benefit-12, potential-11)
nsubj(justifies-13, benefit-12)
ccomp(used-5, justifies-13)
det(risk-16, the-14)
amod(risk-16, potential-15)
dobj(justifies-13, risk-16)
det(fetus-19, the-18)
prep_to(risk-16, fetus-19)

PEGASYS/NN is/VBZ recommended/VBN for/IN use/NN in/IN women/NNS of/IN childbearing/JJ potential/NN only/RB when/WRB they/PRP are/VBP using/VBG effective/JJ contraception/NN during/IN therapy/NN ./.

(ROOT (S1 (S (S (NP (NN PEGASYS)) (VP (VBZ is) (VP (VBN recommended) (PP (IN for) (NP (NP (NN use)) (PP (IN in) (NP (NP (NNS women)) (PP (IN of) (NP (JJ childbearing) (NN potential))))))) (SBAR (WHADVP (RB only) (WRB when)) (S (NP (PRP they)) (VP (VBP are) (VP (VBG using) (NP (JJ effective) (NN contraception)) (PP (IN during) (NP (NN therapy)))))))))) (. .))))

nsubjpass(recommended-3, PEGASYS-1)
auxpass(recommended-3, is-2)
root(ROOT-0, recommended-3)
prep_for(recommended-3, use-5)
prep_in(use-5, women-7)
amod(potential-10, childbearing-9)
prep_of(women-7, potential-10)
advmod(when-12, only-11)
advmod(using-15, when-12)
nsubj(using-15, they-13)
aux(using-15, are-14)
advcl(recommended-3, using-15)
amod(contraception-17, effective-16)
dobj(using-15, contraception-17)
prep_during(using-15, therapy-19)

Pregnancy/NN :/: Category/NN X/NN :/: Use/NN With/IN Ribavirin/NN (/-LRB- see/VB CONTRAINDICATIONS/NNS )/-RRB- Significant/JJ teratogenic/JJ and/or/CC embryocidal/JJ effects/NNS have/VBP been/VBN demonstrated/VBN in/IN all/DT animal/JJ species/NNS exposed/VBN to/TO ribavirin/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NP (NN Pregnancy)) (: :) (NP (NN Category) (NN X)) (: :) (NP (NP (NN Use)) (PP (IN With) (NP (NN Ribavirin))))) (PRN (-LRB- -LRB-) (VP (VB see) (NP (NNS CONTRAINDICATIONS))) (-RRB- -RRB-))) (JJ Significant) (ADJP (ADJP (JJ teratogenic)) (CC and/or) (ADJP (JJ embryocidal))) (NNS effects)) (VP (VBP have) (VP (VBN been) (VP (VBN demonstrated) (PP (IN in) (NP (NP (DT all) (JJ animal) (NNS species)) (VP (VBN exposed) (PP (TO to) (NP (NN ribavirin)))))))))) (. .))))

nn(effects-17, Pregnancy-1)
nn(X-4, Category-3)
dep(Pregnancy-1, X-4)
dep(Pregnancy-1, Use-6)
prep_with(Use-6, Ribavirin-8)
dep(Pregnancy-1, see-10)
dobj(see-10, CONTRAINDICATIONS-11)
amod(effects-17, Significant-13)
amod(effects-17, teratogenic-14)
conj_and/or(teratogenic-14, embryocidal-16)
nsubjpass(demonstrated-20, effects-17)
aux(demonstrated-20, have-18)
auxpass(demonstrated-20, been-19)
root(ROOT-0, demonstrated-20)
det(species-24, all-22)
amod(species-24, animal-23)
prep_in(demonstrated-20, species-24)
partmod(species-24, exposed-25)
prep_to(exposed-25, ribavirin-27)

COPEGUS/JJ therapy/NN is/VBZ contraindicated/VBN in/IN women/NNS who/WP are/VBP pregnant/JJ and/CC in/IN the/DT male/JJ partners/NNS of/IN women/NNS who/WP are/VBP pregnant/JJ ./.

(ROOT (S1 (S (S (NP (JJ COPEGUS) (NN therapy)) (VP (VBZ is) (VP (VBN contraindicated) (PP (PP (IN in) (NP (NP (NNS women)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADJP (JJ pregnant))))))) (CC and) (PP (IN in) (NP (NP (DT the) (JJ male) (NNS partners)) (PP (IN of) (NP (NP (NNS women)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADJP (JJ pregnant))))))))))))) (. .))))

amod(therapy-2, COPEGUS-1)
nsubjpass(contraindicated-4, therapy-2)
auxpass(contraindicated-4, is-3)
root(ROOT-0, contraindicated-4)
prep_in(contraindicated-4, women-6)
nsubj(pregnant-9, women-6)
cop(pregnant-9, are-8)
rcmod(women-6, pregnant-9)
det(partners-14, the-12)
amod(partners-14, male-13)
conj_and(women-6, partners-14)
prep_of(partners-14, women-16)
nsubj(pregnant-19, women-16)
cop(pregnant-19, are-18)
rcmod(women-16, pregnant-19)

If/IN pregnancy/NN occurs/VBZ in/IN a/DT patient/NN or/CC partner/NN of/IN a/DT patient/NN during/IN treatment/NN or/CC during/IN the/DT 6/CD months/NNS after/IN treatment/NN cessation/NN ,/, such/JJ cases/NNS should/MD be/VB reported/VBN to/TO the/DT COPEGUS/NN Pregnancy/NN Registry/NN at/IN 1-800-526-6367/NN ./.

(ROOT (S1 (S (SBAR (IN If) (S (NP (NN pregnancy)) (VP (VBZ occurs) (PP (IN in) (NP (NP (DT a) (NN patient) (CC or) (NN partner)) (PP (IN of) (NP (DT a) (NN patient))))) (PP (PP (IN during) (NP (NN treatment))) (CC or) (PP (IN during) (NP (NP (DT the) (CD 6) (NNS months)) (PP (IN after) (NP (NN treatment) (NN cessation))))))))) (, ,) (NP (JJ such) (NNS cases)) (VP (MD should) (VP (VB be) (VP (VBN reported) (PP (TO to) (NP (DT the) (NN COPEGUS) (NN Pregnancy) (NN Registry))) (PP (IN at) (NP (NN 1-800-526-6367)))))) (. .))))

mark(occurs-3, If-1)
nsubj(occurs-3, pregnancy-2)
advcl(reported-27, occurs-3)
det(patient-6, a-5)
prep_in(occurs-3, patient-6)
conj_or(patient-6, partner-8)
det(patient-11, a-10)
prep_of(patient-6, patient-11)
prep_during(occurs-3, treatment-13)
det(months-18, the-16)
num(months-18, 6-17)
conj_or(treatment-13, months-18)
nn(cessation-21, treatment-20)
prep_after(months-18, cessation-21)
amod(cases-24, such-23)
nsubjpass(reported-27, cases-24)
aux(reported-27, should-25)
auxpass(reported-27, be-26)
root(ROOT-0, reported-27)
det(Registry-32, the-29)
nn(Registry-32, COPEGUS-30)
nn(Registry-32, Pregnancy-31)
prep_to(reported-27, Registry-32)
prep_at(reported-27, 1-800-526-6367-34)

Nursing/VBG Mothers/NNS :/: It/PRP is/VBZ not/RB known/VBN whether/IN peginterferon/NN or/CC ribavirin/NN or/CC its/PRP$ components/NNS are/VBP excreted/VBN in/IN human/JJ milk/NN ./.

(ROOT (S1 (S (S (S (VP (VBG Nursing) (NP (NNS Mothers)))) (: :) (S (NP (PRP It)) (VP (VBZ is) (RB not) (VP (VBN known) (SBAR (IN whether) (S (NP (NP (NP (NN peginterferon)) (CC or) (NP (NN ribavirin))) (CC or) (NP (PRP$ its) (NNS components))) (VP (VBP are) (VP (VBN excreted) (PP (IN in) (NP (JJ human) (NN milk))))))))))) (. .))))

root(ROOT-0, Nursing-1)
dobj(Nursing-1, Mothers-2)
nsubjpass(known-7, It-4)
auxpass(known-7, is-5)
neg(known-7, not-6)
parataxis(Nursing-1, known-7)
complm(excreted-16, whether-8)
nsubjpass(excreted-16, peginterferon-9)
conj_or(peginterferon-9, ribavirin-11)
poss(components-14, its-13)
conj_or(peginterferon-9, components-14)
auxpass(excreted-16, are-15)
ccomp(known-7, excreted-16)
amod(milk-19, human-18)
prep_in(excreted-16, milk-19)

The/DT effect/NN of/IN orally/RB ingested/VBN peginterferon/NN or/CC ribavirin/NN from/IN breast/NN milk/NN on/IN the/DT nursing/JJ infant/NN has/VBZ not/RB been/VBN evaluated/VBN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NP (ADJP (RB orally) (VBN ingested)) (NP (NP (NN peginterferon)) (CC or) (NP (NN ribavirin)))) (PP (IN from) (NP (NN breast) (NN milk))))) (PP (IN on) (NP (DT the) (JJ nursing) (NN infant)))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN evaluated))))) (. .))))

det(effect-2, The-1)
nsubjpass(evaluated-19, effect-2)
advmod(ingested-5, orally-4)
amod(peginterferon-6, ingested-5)
prep_of(effect-2, peginterferon-6)
conj_or(peginterferon-6, ribavirin-8)
nn(milk-11, breast-10)
prep_from(peginterferon-6, milk-11)
det(infant-15, the-13)
amod(infant-15, nursing-14)
prep_on(effect-2, infant-15)
aux(evaluated-19, has-16)
neg(evaluated-19, not-17)
auxpass(evaluated-19, been-18)
root(ROOT-0, evaluated-19)

Because/IN of/IN the/DT potential/NN for/IN adverse/JJ reactions/NNS from/IN the/DT drugs/NNS in/IN nursing/JJ infants/NNS ,/, a/DT decision/NN must/MD be/VB made/VBN whether/IN to/TO discontinue/VBP nursing/VBG or/CC discontinue/NN PEGASYS/NN and/CC COPEGUS/NN treatment/NN ./.

(ROOT (S1 (S (PP (IN Because) (PP (IN of) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (JJ adverse) (NNS reactions)) (PP (IN from) (NP (NP (DT the) (NNS drugs)) (PP (IN in) (NP (JJ nursing) (NNS infants)))))))))) (, ,) (NP (DT a) (NN decision)) (VP (MD must) (VP (VB be) (VP (VBN made) (SBAR (IN whether) (S (VP (TO to) (VP (VBP discontinue) (PP (VBG nursing) (NP (CC or) (NP (NN discontinue) (NN PEGASYS)) (CC and) (NP (NN COPEGUS) (NN treatment))))))))))) (. .))))

prepc_because_of(made-19, of-2)
det(potential-4, the-3)
pobj(made-19, potential-4)
amod(reactions-7, adverse-6)
prep_for(potential-4, reactions-7)
det(drugs-10, the-9)
prep_from(reactions-7, drugs-10)
amod(infants-13, nursing-12)
prep_in(drugs-10, infants-13)
det(decision-16, a-15)
nsubjpass(made-19, decision-16)
aux(made-19, must-17)
auxpass(made-19, be-18)
root(ROOT-0, made-19)
complm(discontinue-22, whether-20)
aux(discontinue-22, to-21)
ccomp(made-19, discontinue-22)
nn(PEGASYS-26, discontinue-25)
prep_nursing(discontinue-22, PEGASYS-26)
nn(treatment-29, COPEGUS-28)
conj_and(PEGASYS-26, treatment-29)

Pediatric/JJ Use/NN :/: The/DT safety/NN and/CC effectiveness/NN of/IN PEGASYS/NN ,/, alone/RB or/CC in/IN combination/NN with/IN COPEGUS/NN in/IN patients/NNS below/IN the/DT age/NN of/IN 18/CD years/NNS have/VBP not/RB been/VBN established/VBN ./.

(ROOT (S1 (S (NP (NP (JJ Pediatric) (NN Use)) (: :) (S (NP (NP (DT The) (NP (NN safety)) (CC and) (NP (NN effectiveness))) (PP (IN of) (NP (NP (NN PEGASYS)) (, ,) (UCP (ADVP (RB alone)) (CC or) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN COPEGUS)))))))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN below) (NP (NP (DT the) (NN age)) (PP (IN of) (NP (CD 18) (NNS years)))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN established))))) (. .)))))

amod(Use-2, Pediatric-1)
root(ROOT-0, Use-2)
dep(safety-5, The-4)
nsubjpass(established-28, safety-5)
conj_and(safety-5, effectiveness-7)
prep_of(safety-5, PEGASYS-9)
dep(PEGASYS-9, alone-11)
conj_or(alone-11, in-13)
pobj(in-13, combination-14)
prep_with(combination-14, COPEGUS-16)
prep_in(safety-5, patients-18)
det(age-21, the-20)
prep_below(patients-18, age-21)
num(years-24, 18-23)
prep_of(age-21, years-24)
aux(established-28, have-25)
neg(established-28, not-26)
auxpass(established-28, been-27)
dep(Use-2, established-28)

PEGASYS/NN contains/VBZ benzyl/NN alcohol/NN ./.

(ROOT (S1 (S (S (NP (NN PEGASYS)) (VP (VBZ contains) (NP (NN benzyl) (NN alcohol)))) (. .))))

nsubj(contains-2, PEGASYS-1)
root(ROOT-0, contains-2)
nn(alcohol-4, benzyl-3)
dobj(contains-2, alcohol-4)

Benzyl/JJ alcohol/NN has/VBZ been/VBN reported/VBN to/TO be/VB associated/VBN with/IN an/DT increased/VBN incidence/NN of/IN neurological/JJ and/CC other/JJ complications/NNS in/IN neonates/NNS and/CC infants/NNS ,/, which/WDT are/VBP sometimes/RB fatal/JJ ./.

(ROOT (S1 (S (S (NP (JJ Benzyl) (NN alcohol)) (VP (VBZ has) (VP (VBN been) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (VBN increased) (NN incidence)) (PP (IN of) (NP (JJ neurological) (CC and) (JJ other) (NNS complications))) (PP (IN in) (NP (NP (NNS neonates)) (CC and) (NP (NNS infants)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP are) (ADVP (RB sometimes)) (ADJP (JJ fatal))))))))))))))) (. .))))

amod(alcohol-2, Benzyl-1)
nsubjpass(reported-5, alcohol-2)
xsubj(associated-8, alcohol-2)
aux(reported-5, has-3)
auxpass(reported-5, been-4)
root(ROOT-0, reported-5)
aux(associated-8, to-6)
auxpass(associated-8, be-7)
xcomp(reported-5, associated-8)
det(incidence-12, an-10)
amod(incidence-12, increased-11)
prep_with(associated-8, incidence-12)
amod(complications-17, neurological-14)
conj_and(neurological-14, other-16)
prep_of(incidence-12, complications-17)
prep_in(incidence-12, neonates-19)
conj_and(neonates-19, infants-21)
nsubj(fatal-26, which-23)
cop(fatal-26, are-24)
advmod(fatal-26, sometimes-25)
rcmod(incidence-12, fatal-26)

Clinical/JJ studies/NNS of/IN PEGASYS/NN alone/RB or/CC in/IN combination/NN with/IN COPEGUS/NNS did/VBD not/RB include/VB sufficient/JJ numbers/NNS of/IN subjects/NNS aged/JJ 65/CD or/CC over/IN to/TO determine/VB whether/IN they/PRP respond/VBP differently/RB from/IN younger/JJR subjects/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Clinical) (NNS studies)) (PP (IN of) (NP (NP (NN PEGASYS)) (UCP (ADVP (RB alone)) (CC or) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NNS COPEGUS))))))))) (VP (VBD did) (RB not) (VP (VB include) (NP (NP (JJ sufficient) (NNS numbers)) (PP (PP (IN of) (NP (NP (NNS subjects)) (ADJP (JJ aged) (NP (CD 65))))) (CC or) (PP (IN over) (S (VP (TO to) (VP (VB determine) (SBAR (IN whether) (S (NP (PRP they)) (VP (VBP respond) (ADVP (RB differently)) (PP (IN from) (NP (JJR younger) (NNS subjects))))))))))))))) (. .))))

amod(studies-2, Clinical-1)
nsubj(include-13, studies-2)
prep_of(studies-2, PEGASYS-4)
dep(PEGASYS-4, alone-5)
conj_or(alone-5, in-7)
pobj(in-7, combination-8)
prep_with(combination-8, COPEGUS-10)
aux(include-13, did-11)
neg(include-13, not-12)
root(ROOT-0, include-13)
amod(numbers-15, sufficient-14)
dobj(include-13, numbers-15)
conj_or(numbers-15, numbers-15')
prep_of(numbers-15, subjects-17)
amod(subjects-17, aged-18)
dep(aged-18, 65-19)
aux(determine-23, to-22)
prepc_over(numbers-15', determine-23)
complm(respond-26, whether-24)
nsubj(respond-26, they-25)
ccomp(determine-23, respond-26)
advmod(respond-26, differently-27)
amod(subjects-30, younger-29)
prep_from(respond-26, subjects-30)

Adverse/JJ reactions/NNS related/JJ to/TO alpha/NN interferon/NN s/NN ,/, such/JJ as/IN CNS/NN ,/, cardiac/JJ ,/, and/CC systemic/JJ (/-LRB- eg/FW ,/, flu-like/JJ )/-RRB- effects/NNS may/MD be/VB more/RBR severe/JJ in/IN the/DT elderly/JJ and/CC caution/NN should/MD be/VB exercised/VBN in/IN the/DT use/NN of/IN PEGASYS/NN in/IN this/DT population/NN ./.

(ROOT (S1 (S (S (S (NP (NP (JJ Adverse) (NNS reactions)) (ADJP (JJ related) (PP (TO to) (NP (NP (NN alpha) (NN interferon) (NN s)) (, ,) (NP (NP (ADJP (JJ such) (PP (IN as) (NP (NN CNS))))) (, ,) (NP (ADJP (JJ cardiac))) (, ,) (CC and) (NP (ADJP (ADJP (JJ systemic)) (PRN (-LRB- -LRB-) (PP (FW eg)) (, ,) (ADJP (JJ flu-like)) (-RRB- -RRB-))) (NNS effects))))))) (VP (MD may) (VP (VB be) (ADJP (RBR more) (JJ severe)) (PP (IN in) (NP (DT the) (JJ elderly)))))) (CC and) (S (NP (NN caution)) (VP (MD should) (VP (VB be) (VP (VBN exercised) (PP (IN in) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NN PEGASYS)) (PP (IN in) (NP (DT this) (NN population)))))))))))) (. .))))

amod(reactions-2, Adverse-1)
nsubj(severe-26, reactions-2)
amod(reactions-2, related-3)
nn(s-7, alpha-5)
nn(s-7, interferon-6)
prep_to(related-3, s-7)
appos(s-7, such-9)
prep_as(such-9, CNS-11)
conj_and(such-9, cardiac-13)
amod(effects-22, systemic-16)
dep(flu-like-20, eg-18)
dep(systemic-16, flu-like-20)
conj_and(such-9, effects-22)
aux(severe-26, may-23)
cop(severe-26, be-24)
advmod(severe-26, more-25)
root(ROOT-0, severe-26)
det(elderly-29, the-28)
prep_in(severe-26, elderly-29)
nsubjpass(exercised-34, caution-31)
aux(exercised-34, should-32)
auxpass(exercised-34, be-33)
conj_and(severe-26, exercised-34)
det(use-37, the-36)
prep_in(exercised-34, use-37)
prep_of(use-37, PEGASYS-39)
det(population-42, this-41)
prep_in(PEGASYS-39, population-42)

PEGASYS/NN and/CC COPEGUS/NN are/VBP excreted/VBN by/IN the/DT kidney/NN ,/, and/CC the/DT risk/NN of/IN toxic/JJ reactions/NNS to/TO this/DT therapy/NN may/MD be/VB greater/JJR in/IN patients/NNS with/IN impaired/JJ renal/JJ function/NN ./.

(ROOT (S1 (S (S (S (NP (NP (NN PEGASYS)) (CC and) (NP (NN COPEGUS))) (VP (VBP are) (VP (VBN excreted) (PP (IN by) (NP (DT the) (NN kidney)))))) (, ,) (CC and) (S (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NP (JJ toxic) (NNS reactions)) (PP (TO to) (NP (DT this) (NN therapy)))))) (VP (MD may) (VP (VB be) (ADJP (JJR greater) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (JJ impaired) (JJ renal) (NN function)))))))))) (. .))))

nsubjpass(excreted-5, PEGASYS-1)
conj_and(PEGASYS-1, COPEGUS-3)
auxpass(excreted-5, are-4)
root(ROOT-0, excreted-5)
det(kidney-8, the-7)
agent(excreted-5, kidney-8)
det(risk-12, the-11)
nsubj(greater-21, risk-12)
amod(reactions-15, toxic-14)
prep_of(risk-12, reactions-15)
det(therapy-18, this-17)
prep_to(reactions-15, therapy-18)
aux(greater-21, may-19)
cop(greater-21, be-20)
conj_and(excreted-5, greater-21)
prep_in(greater-21, patients-23)
amod(function-27, impaired-25)
amod(function-27, renal-26)
prep_with(patients-23, function-27)

PEGASYS/NN should/MD be/VB used/VBN with/IN caution/NN in/IN patients/NNS with/IN creatinine/NN clearance/NN 50/CD mL/min/NN and/CC COPEGUS/NN should/MD not/RB be/VB administered/VBN to/TO patients/NNS with/IN creatinine/NN clearance/NN 50/CD mL/min/NN ./.

(ROOT (S1 (S (S (S (NP (NN PEGASYS)) (VP (MD should) (VP (VB be) (VP (VBN used) (PP (IN with) (NP (NN caution))) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN creatinine) (NN clearance) (CD 50) (NN mL/min))))))))) (CC and) (S (NP (NN COPEGUS)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN administered) (PP (TO to) (NP (NP (NNS patients)) (PP (IN with) (NP (NN creatinine) (NN clearance) (CD 50) (NN mL/min)))))))))) (. .))))

nsubjpass(used-4, PEGASYS-1)
aux(used-4, should-2)
auxpass(used-4, be-3)
root(ROOT-0, used-4)
prep_with(used-4, caution-6)
prep_in(used-4, patients-8)
nn(mL/min-13, creatinine-10)
nn(mL/min-13, clearance-11)
num(mL/min-13, 50-12)
prep_with(patients-8, mL/min-13)
nsubjpass(administered-19, COPEGUS-15)
aux(administered-19, should-16)
neg(administered-19, not-17)
auxpass(administered-19, be-18)
conj_and(used-4, administered-19)
prep_to(administered-19, patients-21)
nn(mL/min-26, creatinine-23)
nn(mL/min-26, clearance-24)
num(mL/min-26, 50-25)
prep_with(patients-21, mL/min-26)

Phenothiazines/NNS -/CC Taking/VBG piperazine/NN and/CC a/DT phenothiazine/JJ together/RB may/MD increase/VB the/DT risk/NN of/IN convulsions/NN (/-LRB- seizures)./NN

(ROOT (S1 (S (S (NP (NNS Phenothiazines)) (CC -) (VP (VBG Taking) (NP (NP (NN piperazine)) (CC and) (NP (DT a) (JJ phenothiazine))))) (ADVP (RB together)) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN convulsions)))) (PRN (-LRB- -LRB-) (NP (NN seizures-RRB-.))))))))

csubj(increase-10, Phenothiazines-1)
conj(Phenothiazines-1, Taking-3)
dobj(Taking-3, piperazine-4)
det(phenothiazine-7, a-6)
conj_and(piperazine-4, phenothiazine-7)
advmod(increase-10, together-8)
aux(increase-10, may-9)
root(ROOT-0, increase-10)
det(risk-12, the-11)
dobj(increase-10, risk-12)
prep_of(risk-12, convulsions-14)
dep(increase-10, seizures-RRB-.-16)

Pyrantel/NNP (/-LRB- e.g./FW ,/, Antiminth/NNP )/-RRB- -/: Taking/VBG piperazine/NN and/CC pyrantel/NN together/RB may/MD decrease/VB the/DT effects/NNS of/IN piperazine/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNP Pyrantel)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NNP Antiminth)) (-RRB- -RRB-))) (: -) (S (S (VP (VBG Taking) (NP (NP (NN piperazine)) (CC and) (NP (NN pyrantel))))) (ADVP (RB together)) (VP (MD may) (VP (VB decrease) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NN piperazine))))))) (. .)))))

root(ROOT-0, Pyrantel-1)
dep(Antiminth-5, e.g.-3)
appos(Pyrantel-1, Antiminth-5)
csubj(decrease-14, Taking-8)
dobj(Taking-8, piperazine-9)
conj_and(piperazine-9, pyrantel-11)
advmod(decrease-14, together-12)
aux(decrease-14, may-13)
dep(Pyrantel-1, decrease-14)
det(effects-16, the-15)
dobj(decrease-14, effects-16)
prep_of(effects-16, piperazine-18)

ACE/NN inhibitors/NNS :/: Reports/NNS suggest/VBP that/IN NSAIDs/NNS may/MD diminish/VB the/DT antihypertensive/JJ effect/NN of/IN Angiotensin/NN Converting/NN Enzyme/NN (/-LRB- ACE/NN )/-RRB- inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (NN ACE) (NNS inhibitors)) (: :) (NP (NNS Reports)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS NSAIDs)) (VP (MD may) (VP (VB diminish) (NP (NP (DT the) (JJ antihypertensive) (NN effect)) (PP (IN of) (NP (NP (NP (NN Angiotensin) (NN Converting) (NN Enzyme)) (PRN (-LRB- -LRB-) (NP (NN ACE)) (-RRB- -RRB-))) (NNS inhibitors)))))))))) (. .))))

nn(inhibitors-2, ACE-1)
nsubj(suggest-5, inhibitors-2)
nsubj(suggest-5, Reports-4)
root(ROOT-0, suggest-5)
complm(diminish-9, that-6)
nsubj(diminish-9, NSAIDs-7)
aux(diminish-9, may-8)
ccomp(suggest-5, diminish-9)
det(effect-12, the-10)
amod(effect-12, antihypertensive-11)
dobj(diminish-9, effect-12)
nn(Enzyme-16, Angiotensin-14)
nn(Enzyme-16, Converting-15)
nn(inhibitors-20, Enzyme-16)
abbrev(Enzyme-16, ACE-18)
prep_of(effect-12, inhibitors-20)

In/IN patients/NNS with/IN mild/JJ to/TO moderate/JJ hypertension/NN ,/, administration/NN of/IN 25/CD mg/NN daily/RB of/IN VIOXX/NN with/IN the/DT ACE/NN inhibitor/NN benazepril/NN ,/, 10/CD to/TO 40/CD mg/NN for/IN 4/CD weeks/NNS ,/, was/VBD associated/VBN with/IN an/DT average/JJ increase/NN in/IN mean/JJ arterial/JJ pressure/NN of/IN about/RB 3/CD mm/NN Hg/NN compared/VBN to/TO ACE/NN inhibitor/NN alone/RB ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (S (ADJP (JJ mild) (PP (TO to) (NP (NP (JJ moderate) (NN hypertension)) (, ,) (NP (NP (NN administration)) (PP (IN of) (NP (NP (CD 25) (NN mg) (RB daily)) (PP (IN of) (NP (NP (NN VIOXX)) (PP (IN with) (NP (DT the) (NN ACE) (NN inhibitor) (NN benazepril)))))))) (, ,) (NP (NP (QP (CD 10) (TO to) (CD 40)) (NN mg)) (PP (IN for) (NP (CD 4) (NNS weeks)))) (, ,)))))))) (VP (VBD was) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (JJ average) (NN increase)) (PP (IN in) (NP (NP (JJ mean) (JJ arterial) (NN pressure)) (PP (IN of) (NP (ADJP (QP (RB about) (CD 3)) (NN mm)) (NN Hg))) (PP (VBN compared) (PP (TO to) (NP (NP (NN ACE) (NN inhibitor)) (ADVP (RB alone)))))))))))) (. .))))

prep_in(associated-31, patients-2)
prepc_with(patients-2, mild-4)
amod(hypertension-7, moderate-6)
prep_to(mild-4, hypertension-7)
appos(hypertension-7, administration-9)
num(mg-12, 25-11)
prep_of(administration-9, mg-12)
advmod(mg-12, daily-13)
prep_of(mg-12, VIOXX-15)
det(benazepril-20, the-17)
nn(benazepril-20, ACE-18)
nn(benazepril-20, inhibitor-19)
prep_with(VIOXX-15, benazepril-20)
number(40-24, 10-22)
dep(40-24, to-23)
num(mg-25, 40-24)
appos(hypertension-7, mg-25)
num(weeks-28, 4-27)
prep_for(mg-25, weeks-28)
auxpass(associated-31, was-30)
root(ROOT-0, associated-31)
det(increase-35, an-33)
amod(increase-35, average-34)
prep_with(associated-31, increase-35)
amod(pressure-39, mean-37)
amod(pressure-39, arterial-38)
prep_in(increase-35, pressure-39)
quantmod(3-42, about-41)
dep(mm-43, 3-42)
dep(Hg-44, mm-43)
prep_of(pressure-39, Hg-44)
prepc_compared_to(pressure-39, to-46)
nn(inhibitor-48, ACE-47)
pobj(pressure-39, inhibitor-48)
advmod(inhibitor-48, alone-49)

This/DT interaction/NN should/MD be/VB given/VBN consideration/NN in/IN patients/NNS taking/VBG VIOXX/NN concomitantly/RB with/IN ACE/NN inhibitors/NNS ./.

(ROOT (S1 (S (S (NP (DT This) (NN interaction)) (VP (MD should) (VP (VB be) (VP (VBN given) (NP (NP (NN consideration)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN VIOXX)))))) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN ACE) (NNS inhibitors))))))) (. .))))

det(interaction-2, This-1)
nsubjpass(given-5, interaction-2)
aux(given-5, should-3)
auxpass(given-5, be-4)
root(ROOT-0, given-5)
dobj(given-5, consideration-6)
prep_in(consideration-6, patients-8)
partmod(patients-8, taking-9)
dobj(taking-9, VIOXX-10)
advmod(given-5, concomitantly-11)
nn(inhibitors-14, ACE-13)
prep_with(given-5, inhibitors-14)

Aspirin/NN Concomitant/JJ administration/NN of/IN low-dose/JJ aspirin/NN with/IN VIOXX/NN may/MD result/VB in/IN an/DT increased/VBN rate/NN of/IN GI/NN ulceration/NN or/CC other/JJ complications/NNS ,/, compared/VBN to/TO use/NN of/IN VIOXX/NN alone/RB ./.

(ROOT (S1 (S (S (NP (NP (NN Aspirin) (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (JJ low-dose) (NN aspirin)) (PP (IN with) (NP (NN VIOXX)))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT an) (VBN increased) (NN rate)) (PP (IN of) (NP (NP (NN GI) (NN ulceration)) (CC or) (NP (JJ other) (NNS complications)))))) (, ,) (S (VP (VBN compared) (PP (TO to) (NP (NP (NN use)) (PP (IN of) (NP (NP (NN VIOXX)) (ADVP (RB alone))))))))))) (. .))))

nn(administration-3, Aspirin-1)
amod(administration-3, Concomitant-2)
nsubj(result-10, administration-3)
amod(aspirin-6, low-dose-5)
prep_of(administration-3, aspirin-6)
prep_with(aspirin-6, VIOXX-8)
aux(result-10, may-9)
root(ROOT-0, result-10)
det(rate-14, an-12)
amod(rate-14, increased-13)
prep_in(result-10, rate-14)
nn(ulceration-17, GI-16)
prep_of(rate-14, ulceration-17)
amod(complications-20, other-19)
conj_or(ulceration-17, complications-20)
prep_compared_to(result-10, use-24)
prep_of(use-24, VIOXX-26)
advmod(VIOXX-26, alone-27)

In/IN a/DT 12-week/JJ endoscopy/NN study/NN conducted/VBN in/IN OA/JJ patients/NNS there/EX was/VBD no/DT difference/NN in/IN the/DT cumulative/JJ incidence/NN of/IN endoscopic/JJ gastroduodenal/JJ ulcers/NNS in/IN patients/NNS taking/VBG low-dose/JJ (/-LRB- 81/CD mg/NN )/-RRB- enteric/JJ coated/JJ aspirin/NN plus/CC VIOXX/NN 25/CD mg/NN daily/RB ,/, as/IN compared/VBN to/TO those/DT taking/VBG ibuprofen/NN 2400/CD mg/NN daily/RB alone/RB ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (DT a) (JJ 12-week) (NN endoscopy) (NN study)) (VP (VBN conducted) (PP (IN in) (NP (JJ OA) (NNS patients)))))) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (NN difference)) (PP (IN in) (NP (NP (DT the) (JJ cumulative) (NN incidence)) (PP (IN of) (NP (JJ endoscopic) (JJ gastroduodenal) (NNS ulcers))))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (JJ low-dose) (PRN (-LRB- -LRB-) (NP (CD 81) (NN mg)) (-RRB- -RRB-)) (JJ enteric) (NP (NP (JJ coated) (NN aspirin)) (CC plus) (NP (NP (NN VIOXX) (CD 25) (NN mg)) (ADVP (RB daily))))))))) (, ,) (SBAR (IN as) (S (VP (VBN compared) (PP (TO to) (NP (NP (DT those)) (VP (VBG taking) (NP (NP (NN ibuprofen) (CD 2400) (NN mg) (RB daily)) (ADVP (RB alone)))))))))) (. .))))

det(study-5, a-2)
amod(study-5, 12-week-3)
nn(study-5, endoscopy-4)
prep_in(was-11, study-5)
partmod(study-5, conducted-6)
amod(patients-9, OA-8)
prep_in(conducted-6, patients-9)
expl(was-11, there-10)
root(ROOT-0, was-11)
det(difference-13, no-12)
nsubj(was-11, difference-13)
det(incidence-17, the-15)
amod(incidence-17, cumulative-16)
prep_in(difference-13, incidence-17)
amod(ulcers-21, endoscopic-19)
amod(ulcers-21, gastroduodenal-20)
prep_of(incidence-17, ulcers-21)
prep_in(difference-13, patients-23)
partmod(patients-23, taking-24)
amod(aspirin-32, low-dose-25)
num(mg-28, 81-27)
appos(aspirin-32, mg-28)
amod(aspirin-32, enteric-30)
amod(aspirin-32, coated-31)
dobj(taking-24, aspirin-32)
nn(mg-36, VIOXX-34)
num(mg-36, 25-35)
conj_plus(aspirin-32, mg-36)
advmod(mg-36, daily-37)
mark(compared-40, as-39)
advcl(was-11, compared-40)
prep_to(compared-40, those-42)
partmod(those-42, taking-43)
nn(mg-46, ibuprofen-44)
num(mg-46, 2400-45)
dobj(taking-43, mg-46)
advmod(mg-46, daily-47)
advmod(mg-46, alone-48)

Patients/NNS taking/VBG low-dose/JJ aspirin/NN plus/CC ibuprofen/NN were/VBD not/RB studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (VBG taking) (NP (JJ low-dose) (NP (NN aspirin)) (CC plus) (NP (NN ibuprofen))))) (VP (VBD were) (RB not) (VP (VBN studied)))) (. .))))

nsubjpass(studied-9, Patients-1)
partmod(Patients-1, taking-2)
amod(aspirin-4, low-dose-3)
dobj(taking-2, aspirin-4)
conj_plus(aspirin-4, ibuprofen-6)
auxpass(studied-9, were-7)
neg(studied-9, not-8)
root(ROOT-0, studied-9)

At/IN steady/JJ state/NN ,/, VIOXX/NN 50/CD mg/NN once/RB daily/RB had/VBD no/DT effect/NN on/IN the/DT anti-platelet/JJ activity/NN of/IN low-dose/JJ (/-LRB- 81/CD mg/NN once/RB daily/JJ )/-RRB- aspirin/NN ,/, as/IN assessed/VBN by/IN ex/FW vivo/FW platelet/NN aggregation/NN and/CC serum/NN TXB2/NN generation/NN in/IN clotting/JJ blood/NN ./.

(ROOT (S1 (S (PP (IN At) (NP (JJ steady) (NN state))) (, ,) (NP (NP (NN VIOXX) (CD 50) (NN mg)) (ADVP (RB once) (RB daily))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (JJ anti-platelet) (NN activity)) (PP (IN of) (NP (ADJP (ADJP (JJ low-dose)) (PRN (-LRB- -LRB-) (NP (NP (CD 81) (NN mg)) (ADJP (RB once) (JJ daily))) (-RRB- -RRB-))) (NN aspirin))))) (, ,) (SBAR (IN as) (S (VP (VBN assessed) (PP (IN by) (NP (NP (NP (ADJP (FW ex) (FW vivo)) (NN platelet) (NN aggregation)) (CC and) (NP (NN serum) (NN TXB2) (NN generation))) (PP (IN in) (NP (JJ clotting) (NN blood))))))))) (. .))))

amod(state-3, steady-2)
prep_at(had-10, state-3)
nn(mg-7, VIOXX-5)
num(mg-7, 50-6)
nsubj(had-10, mg-7)
advmod(daily-9, once-8)
advmod(mg-7, daily-9)
root(ROOT-0, had-10)
det(effect-12, no-11)
dobj(had-10, effect-12)
det(activity-16, the-14)
amod(activity-16, anti-platelet-15)
prep_on(had-10, activity-16)
amod(aspirin-25, low-dose-18)
num(mg-21, 81-20)
dep(low-dose-18, mg-21)
advmod(daily-23, once-22)
amod(mg-21, daily-23)
prep_of(activity-16, aspirin-25)
mark(assessed-28, as-27)
advcl(had-10, assessed-28)
nn(vivo-31, ex-30)
amod(aggregation-33, vivo-31)
nn(aggregation-33, platelet-32)
prep_by(assessed-28, aggregation-33)
nn(generation-37, serum-35)
nn(generation-37, TXB2-36)
conj_and(aggregation-33, generation-37)
amod(blood-40, clotting-39)
prep_in(aggregation-33, blood-40)

Because/IN of/IN its/PRP$ lack/NN of/IN platelet/NN effects/NNS ,/, VIOXX/NN is/VBZ not/RB a/DT substitute/VB for/IN aspirin/NN for/IN cardiovascular/JJ prophylaxis/NNS ./.

(ROOT (S1 (S (S (PP (IN Because) (IN of) (NP (NP (PRP$ its) (NN lack)) (PP (IN of) (NP (NN platelet) (NNS effects))))) (, ,) (NP (NN VIOXX)) (VP (VBZ is) (RB not) (VP (DT a) (VP (VB substitute) (PP (IN for) (NP (NN aspirin))) (PP (IN for) (NP (JJ cardiovascular) (NNS prophylaxis))))))) (. .))))

poss(lack-4, its-3)
prep_because_of(substitute-13, lack-4)
nn(effects-7, platelet-6)
prep_of(lack-4, effects-7)
nsubj(substitute-13, VIOXX-9)
aux(substitute-13, is-10)
neg(substitute-13, not-11)
dep(substitute-13, a-12)
root(ROOT-0, substitute-13)
prep_for(substitute-13, aspirin-15)
amod(prophylaxis-18, cardiovascular-17)
prep_for(substitute-13, prophylaxis-18)

Therefore/RB ,/, in/IN patients/NNS taking/VBG VIOXX/NN ,/, antiplatelet/NN therapies/NNS should/MD not/RB be/VB discontinued/VBN and/CC should/MD be/VB considered/VBN in/IN patients/NNS with/IN an/DT indication/NN for/IN cardiovascular/JJ prophylaxis/NNS ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN VIOXX))))) (, ,) (NP (NN antiplatelet) (NNS therapies)) (VP (VP (MD should) (RB not) (VP (VB be) (VP (VBN discontinued)))) (CC and) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT an) (NN indication)) (PP (IN for) (NP (JJ cardiovascular) (NNS prophylaxis)))))))))))) (. .))))

advmod(discontinued-13, Therefore-1)
prep_in(discontinued-13, patients-4)
partmod(patients-4, taking-5)
dobj(taking-5, VIOXX-6)
nn(therapies-9, antiplatelet-8)
nsubjpass(discontinued-13, therapies-9)
aux(discontinued-13, should-10)
neg(discontinued-13, not-11)
auxpass(discontinued-13, be-12)
root(ROOT-0, discontinued-13)
aux(considered-17, should-15)
auxpass(considered-17, be-16)
conj_and(discontinued-13, considered-17)
prep_in(considered-17, patients-19)
det(indication-22, an-21)
prep_with(patients-19, indication-22)
amod(prophylaxis-25, cardiovascular-24)
prep_for(indication-22, prophylaxis-25)

Prospective/JJ ,/, long-term/JJ studies/NNS on/IN concomitant/JJ administration/NN of/IN VIOXX/NN and/CC aspirin/NN have/VBP not/RB been/VBN conducted/VBN ./.

(ROOT (S1 (S (S (NP (NP (ADJP (ADJP (JJ Prospective)) (, ,) (ADJP (JJ long-term))) (NNS studies)) (PP (IN on) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN VIOXX)) (CC and) (NP (NN aspirin))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN conducted))))) (. .))))

amod(studies-4, Prospective-1)
dep(Prospective-1, long-term-3)
nsubjpass(conducted-15, studies-4)
amod(administration-7, concomitant-6)
prep_on(studies-4, administration-7)
prep_of(administration-7, VIOXX-9)
conj_and(VIOXX-9, aspirin-11)
aux(conducted-15, have-12)
neg(conducted-15, not-13)
auxpass(conducted-15, been-14)
root(ROOT-0, conducted-15)

Cimetidine/NN Co-administration/NN with/IN high/JJ doses/NNS of/IN cimetidine/NN [800/CD mg/NN twice/RB daily/RB ]/-RRB- increased/VBD the/DT Cmax/NN of/IN rofecoxib/NN by/IN 21/CD %/NN ,/, the/DT AUC0-120hr/NN by/IN 23/CD %/NN and/CC the/DT t1/NN /2/CD by/IN 15/CD %./NN

(ROOT (S1 (S (S (NP (NP (NN Cimetidine) (NN Co-administration)) (PP (IN with) (NP (NP (JJ high) (NNS doses)) (PRN (PP (IN of) (NP (NN cimetidine))) (NP (NP (CD -LSB-800) (NN mg)) (ADVP (RB twice) (RB daily))) (-RRB- -RSB-))))) (VP (VBD increased) (NP (NP (DT the) (NN Cmax)) (PP (IN of) (NP (NN rofecoxib)))) (PP (IN by) (NP (CD 21) (NN %))))) (, ,) (NP (NP (DT the) (NN AUC0-120hr)) (PP (IN by) (NP (NP (CD 23) (NN %)) (CC and) (NP (DT the) (NP (NN t1) (CD /2))))) (PP (IN by) (NP (CD 15) (NN %.)))))))

nn(Co-administration-2, Cimetidine-1)
nsubj(increased-13, Co-administration-2)
amod(doses-5, high-4)
prep_with(Co-administration-2, doses-5)
dep(mg-9, of-6)
pobj(of-6, cimetidine-7)
num(mg-9, -LSB-800-8)
dep(doses-5, mg-9)
advmod(daily-11, twice-10)
advmod(mg-9, daily-11)
punct(mg-9, -RSB--12)
root(ROOT-0, increased-13)
det(Cmax-15, the-14)
dobj(increased-13, Cmax-15)
prep_of(Cmax-15, rofecoxib-17)
num(%-20, 21-19)
prep_by(increased-13, %-20)
det(AUC0-120hr-23, the-22)
dep(increased-13, AUC0-120hr-23)
num(%-26, 23-25)
prep_by(AUC0-120hr-23, %-26)
det(t1-29, the-28)
conj_and(%-26, t1-29)
num(t1-29, /2-30)
num(%.-33, 15-32)
prep_by(AUC0-120hr-23, %.-33)

Digoxin/NN Rofecoxib/NN 75/CD mg/NN once/RB daily/RB for/IN 11/CD days/NNS does/VBZ not/RB alter/VB the/DT plasma/NN concentration/NN profile/NN or/CC renal/JJ elimination/NN of/IN digoxin/NN after/IN a/DT single/JJ 0.5/CD mg/NN oral/JJ dose/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Digoxin) (NN Rofecoxib) (CD 75) (NN mg)) (ADVP (RB once) (RB daily) (PP (IN for) (NP (CD 11) (NNS days))))) (VP (VBZ does) (RB not) (VP (VB alter) (NP (NP (DT the) (NN plasma) (NN concentration) (NN profile)) (CC or) (NP (NP (JJ renal) (NN elimination)) (PP (IN of) (NP (NN digoxin))))) (PP (IN after) (NP (DT a) (JJ single) (ADJP (CD 0.5) (NN mg)) (JJ oral) (NN dose)))))) (. .))))

nn(mg-4, Digoxin-1)
nn(mg-4, Rofecoxib-2)
num(mg-4, 75-3)
nsubj(alter-12, mg-4)
advmod(daily-6, once-5)
advmod(mg-4, daily-6)
num(days-9, 11-8)
prep_for(daily-6, days-9)
aux(alter-12, does-10)
neg(alter-12, not-11)
root(ROOT-0, alter-12)
det(profile-16, the-13)
nn(profile-16, plasma-14)
nn(profile-16, concentration-15)
dobj(alter-12, profile-16)
amod(elimination-19, renal-18)
conj_or(profile-16, elimination-19)
prep_of(elimination-19, digoxin-21)
det(dose-28, a-23)
amod(dose-28, single-24)
number(mg-26, 0.5-25)
amod(dose-28, mg-26)
amod(dose-28, oral-27)
prep_after(alter-12, dose-28)

Furosemide/JJ Clinical/JJ studies/NNS ,/, as/RB well/RB as/IN post-marketing/JJ observations/NNS ,/, have/VBP shown/VBN that/IN NSAIDs/NNS can/MD reduce/VB the/DT natriuretic/JJ effect/NN of/IN furosemide/NN and/CC thiazides/NNS in/IN some/DT patients/NNS ./.

(ROOT (S1 (S (S (NP (NP (JJ Furosemide) (JJ Clinical) (NNS studies)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (JJ post-marketing) (NNS observations)) (, ,)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NNS NSAIDs)) (VP (MD can) (VP (VB reduce) (NP (NP (DT the) (JJ natriuretic) (NN effect)) (PP (IN of) (NP (NP (NN furosemide)) (CC and) (NP (NNS thiazides)))) (PP (IN in) (NP (DT some) (NNS patients))))))))))) (. .))))

amod(studies-3, Furosemide-1)
amod(studies-3, Clinical-2)
nsubj(shown-12, studies-3)
amod(observations-9, post-marketing-8)
conj_and(studies-3, observations-9)
aux(shown-12, have-11)
root(ROOT-0, shown-12)
complm(reduce-16, that-13)
nsubj(reduce-16, NSAIDs-14)
aux(reduce-16, can-15)
ccomp(shown-12, reduce-16)
det(effect-19, the-17)
amod(effect-19, natriuretic-18)
dobj(reduce-16, effect-19)
prep_of(effect-19, furosemide-21)
conj_and(furosemide-21, thiazides-23)
det(patients-26, some-25)
prep_in(effect-19, patients-26)

This/DT response/NN has/VBZ been/VBN attributed/VBN to/TO inhibition/NN of/IN renal/JJ prostaglandin/NN synthesis/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN response)) (VP (VBZ has) (VP (VBN been) (VP (VBN attributed) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ renal) (NN prostaglandin) (NN synthesis))))))))) (. .))))

det(response-2, This-1)
nsubjpass(attributed-5, response-2)
aux(attributed-5, has-3)
auxpass(attributed-5, been-4)
root(ROOT-0, attributed-5)
prep_to(attributed-5, inhibition-7)
amod(synthesis-11, renal-9)
nn(synthesis-11, prostaglandin-10)
prep_of(inhibition-7, synthesis-11)

Ketoconazole/NN Ketoconazole/NN 400/CD mg/NN daily/RB did/VBD not/RB have/VB any/DT clinically/RB important/JJ effect/NN on/IN the/DT pharmacokinetics/NNS of/IN rofecoxib/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Ketoconazole) (NN Ketoconazole) (CD 400) (NN mg)) (ADVP (RB daily))) (VP (VBD did) (RB not) (VP (VB have) (NP (DT any) (ADJP (RB clinically) (JJ important)) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN rofecoxib)))))))) (. .))))

nn(mg-4, Ketoconazole-1)
nn(mg-4, Ketoconazole-2)
num(mg-4, 400-3)
nsubj(have-8, mg-4)
advmod(mg-4, daily-5)
aux(have-8, did-6)
neg(have-8, not-7)
root(ROOT-0, have-8)
det(effect-12, any-9)
advmod(important-11, clinically-10)
amod(effect-12, important-11)
dobj(have-8, effect-12)
det(pharmacokinetics-15, the-14)
prep_on(have-8, pharmacokinetics-15)
prep_of(pharmacokinetics-15, rofecoxib-17)

Lithium/NN NSAIDs/NNS have/VBP produced/VBN an/DT elevation/NN of/IN plasma/NN lithium/NN levels/NNS and/CC a/DT reduction/NN in/IN renal/JJ lithium/NN clearance/NN ./.

(ROOT (S1 (S (S (NP (NN Lithium) (NNS NSAIDs)) (VP (VBP have) (VP (VBN produced) (NP (NP (NP (DT an) (NN elevation)) (PP (IN of) (NP (NN plasma) (NN lithium) (NNS levels)))) (CC and) (NP (NP (DT a) (NN reduction)) (PP (IN in) (NP (JJ renal) (NN lithium) (NN clearance)))))))) (. .))))

nn(NSAIDs-2, Lithium-1)
nsubj(produced-4, NSAIDs-2)
aux(produced-4, have-3)
root(ROOT-0, produced-4)
det(elevation-6, an-5)
dobj(produced-4, elevation-6)
nn(levels-10, plasma-8)
nn(levels-10, lithium-9)
prep_of(elevation-6, levels-10)
det(reduction-13, a-12)
conj_and(elevation-6, reduction-13)
amod(clearance-17, renal-15)
nn(clearance-17, lithium-16)
prep_in(reduction-13, clearance-17)

Thus/RB ,/, when/WRB VIOXX/NN and/CC lithium/NN are/VBP administered/VBN concurrently/RB ,/, subjects/NNS should/MD be/VB observed/VBN carefully/RB for/IN signs/NNS of/IN lithium/NN toxicity/NN ./.

(ROOT (S1 (S (S (ADVP (RB Thus)) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN VIOXX)) (CC and) (NP (NN lithium))) (VP (VBP are) (VP (VBN administered) (ADVP (RB concurrently)))))) (, ,) (NP (NNS subjects)) (VP (MD should) (VP (VB be) (VP (VBN observed) (ADVP (RB carefully)) (PP (IN for) (NP (NP (NNS signs)) (PP (IN of) (NP (NN lithium) (NN toxicity))))))))) (. .))))

advmod(observed-14, Thus-1)
advmod(administered-8, when-3)
nsubjpass(administered-8, VIOXX-4)
conj_and(VIOXX-4, lithium-6)
auxpass(administered-8, are-7)
advcl(observed-14, administered-8)
advmod(administered-8, concurrently-9)
nsubjpass(observed-14, subjects-11)
aux(observed-14, should-12)
auxpass(observed-14, be-13)
root(ROOT-0, observed-14)
advmod(observed-14, carefully-15)
prep_for(observed-14, signs-17)
nn(toxicity-20, lithium-19)
prep_of(signs-17, toxicity-20)

Methotrexate/NN VIOXX/NN 12.5/CD ,/, 25/CD ,/, and/CC 50/CD mg/NN ,/, each/DT dose/NN administered/VBN once/RB daily/RB for/IN 7/CD days/NNS ,/, had/VBD no/DT effect/NN on/IN the/DT plasma/NN concentration/NN of/IN methotrexate/NN as/IN measured/VBN by/IN AUC0-24hr/NN in/IN patients/NNS receiving/VBG single/JJ weekly/JJ methotrexate/NN doses/NNS of/IN 7.5/CD to/TO 20/CD mg/NN for/IN rheumatoid/JJ arthritis/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Methotrexate) (NN VIOXX)) (ADJP (QP (CD 12.5) (, ,) (CD 25) (, ,) (CC and) (CD 50)) (NN mg))) (, ,) (NP (NP (DT each) (NN dose)) (VP (VBN administered) (ADVP (RB once) (RB daily)) (PP (IN for) (NP (CD 7) (NNS days))))) (, ,)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN plasma) (NN concentration)) (PP (IN of) (NP (NN methotrexate))))) (SBAR (IN as) (S (VP (VBN measured) (PP (IN by) (NP (NP (NN AUC0-24hr)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (JJ single) (JJ weekly) (NN methotrexate) (NNS doses)) (PP (IN of) (NP (QP (CD 7.5) (TO to) (CD 20)) (NN mg)))) (PP (IN for) (NP (JJ rheumatoid) (NN arthritis))))))))))))) (. .))))

nn(VIOXX-2, Methotrexate-1)
nsubj(had-20, VIOXX-2)
dep(mg-9, 12.5-3)
number(12.5-3, 25-5)
conj_and(12.5-3, 50-8)
dep(VIOXX-2, mg-9)
det(dose-12, each-11)
appos(VIOXX-2, dose-12)
partmod(dose-12, administered-13)
advmod(daily-15, once-14)
advmod(administered-13, daily-15)
num(days-18, 7-17)
prep_for(administered-13, days-18)
root(ROOT-0, had-20)
det(effect-22, no-21)
dobj(had-20, effect-22)
det(concentration-26, the-24)
nn(concentration-26, plasma-25)
prep_on(had-20, concentration-26)
prep_of(concentration-26, methotrexate-28)
mark(measured-30, as-29)
advcl(had-20, measured-30)
prep_by(measured-30, AUC0-24hr-32)
prep_in(AUC0-24hr-32, patients-34)
partmod(patients-34, receiving-35)
amod(doses-39, single-36)
amod(doses-39, weekly-37)
nn(doses-39, methotrexate-38)
dobj(receiving-35, doses-39)
number(20-43, 7.5-41)
dep(20-43, to-42)
num(mg-44, 20-43)
prep_of(doses-39, mg-44)
amod(arthritis-47, rheumatoid-46)
prep_for(receiving-35, arthritis-47)

At/IN higher/JJR than/IN recommended/VBN doses/NNS ,/, VIOXX/NN 75/CD mg/NN administered/VBN once/RB daily/RB for/IN 10/CD days/NNS increased/VBD plasma/NN concentrations/NNS by/IN 23/CD %/NN as/IN measured/VBN by/IN AUC0-24hr/NN in/IN patients/NNS receiving/VBG methotrexate/NN 7.5/CD to/TO 15/CD mg/week/NN for/IN rheumatoid/JJ arthritis/NN ./.

(ROOT (S1 (S (S (PP (IN At) (NP (JJR higher) (IN than) (VBN recommended) (NNS doses))) (, ,) (NP (NP (NN VIOXX) (CD 75) (NN mg)) (VP (VBN administered) (ADVP (RB once) (RB daily)) (PP (IN for) (NP (CD 10) (NNS days))))) (VP (VBD increased) (NP (NN plasma) (NNS concentrations)) (PP (IN by) (NP (CD 23) (NN %))) (SBAR (IN as) (S (VP (VBN measured) (PP (IN by) (NP (NP (NN AUC0-24hr)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NP (NN methotrexate)) (NP (CD 7.5) (TO to) (CD 15) (NN mg/week))) (PP (IN for) (NP (JJ rheumatoid) (NN arthritis)))))))))))))) (. .))))

amod(doses-5, higher-2)
amod(doses-5, than-3)
amod(doses-5, recommended-4)
prep_at(increased-16, doses-5)
nn(mg-9, VIOXX-7)
num(mg-9, 75-8)
nsubj(increased-16, mg-9)
partmod(mg-9, administered-10)
advmod(daily-12, once-11)
advmod(administered-10, daily-12)
num(days-15, 10-14)
prep_for(administered-10, days-15)
root(ROOT-0, increased-16)
nn(concentrations-18, plasma-17)
dobj(increased-16, concentrations-18)
num(%-21, 23-20)
prep_by(increased-16, %-21)
mark(measured-23, as-22)
advcl(increased-16, measured-23)
prep_by(measured-23, AUC0-24hr-25)
prep_in(AUC0-24hr-25, patients-27)
partmod(patients-27, receiving-28)
dobj(receiving-28, methotrexate-29)
num(mg/week-33, 7.5-30)
dep(mg/week-33, to-31)
num(mg/week-33, 15-32)
dep(methotrexate-29, mg/week-33)
amod(arthritis-36, rheumatoid-35)
prep_for(methotrexate-29, arthritis-36)

At/IN 24/CD hours/NNS postdose/NN ,/, a/DT similar/JJ proportion/NN of/IN patients/NNS treated/VBN with/IN methotrexate/NN alone/RB (/-LRB- 94/CD %/NN )/-RRB- and/CC subsequently/RB treated/VBN with/IN methotrexate/NN co-administered/VBN with/IN 75/CD mg/NN of/IN rofecoxib/NN (/-LRB- 88/CD %/NN )/-RRB- had/VBD methotrexate/NN plasma/NN concentrations/NNS below/IN the/DT measurable/JJ limit/NN (/-LRB- 5/CD ng/mL/NN )./CD

(ROOT (S1 (S (PP (IN At) (NP (CD 24) (NNS hours) (NN postdose))) (, ,) (NP (NP (DT a) (JJ similar) (NN proportion)) (PP (IN of) (NP (NP (NNS patients)) (VP (VP (VBN treated) (PP (IN with) (NP (NN methotrexate))) (ADVP (ADVP (RB alone)) (PRN (-LRB- -LRB-) (NP (CD 94) (NN %)) (-RRB- -RRB-)))) (CC and) (VP (ADVP (RB subsequently)) (VBN treated) (PP (IN with) (NP (NN methotrexate))) (PP (VBN co-administered) (PP (IN with) (NP (NP (CD 75) (NN mg)) (PP (IN of) (NP (NP (NN rofecoxib)) (PRN (-LRB- -LRB-) (NP (CD 88) (NN %)) (-RRB- -RRB-)))))))))))) (VP (VBD had) (NP (NN methotrexate) (NN plasma) (NNS concentrations)) (PP (IN below) (NP (NP (DT the) (JJ measurable) (NN limit)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN ng/mL) (CD -RRB-.)))))))))

num(postdose-4, 24-2)
nn(postdose-4, hours-3)
prep_at(had-34, postdose-4)
det(proportion-8, a-6)
amod(proportion-8, similar-7)
nsubj(had-34, proportion-8)
prep_of(proportion-8, patients-10)
dep(patients-10, treated-11)
prep_with(treated-11, methotrexate-13)
advmod(treated-11, alone-14)
num(%-17, 94-16)
dep(alone-14, %-17)
advmod(treated-21, subsequently-20)
conj_and(treated-11, treated-21)
prep_with(treated-21, methotrexate-23)
prep(treated-21, co-administered-24)
pcomp(co-administered-24, with-25)
num(mg-27, 75-26)
prep_with(co-administered-24, mg-27)
prep_of(mg-27, rofecoxib-29)
num(%-32, 88-31)
appos(rofecoxib-29, %-32)
root(ROOT-0, had-34)
nn(concentrations-37, methotrexate-35)
nn(concentrations-37, plasma-36)
dobj(had-34, concentrations-37)
det(limit-41, the-39)
amod(limit-41, measurable-40)
prep_below(had-34, limit-41)
num(ng/mL-44, 5-43)
dep(limit-41, ng/mL-44)
num(ng/mL-44, -RRB-.-45)

Standard/JJ monitoring/NN of/IN methotrexate-related/JJ toxicity/NN should/MD be/VB continued/VBN if/IN VIOXX/NN and/CC methotrexate/NN are/VBP administered/VBN concomitantly/RB ./.

(ROOT (S1 (S (S (NP (NP (JJ Standard) (NN monitoring)) (PP (IN of) (NP (JJ methotrexate-related) (NN toxicity)))) (VP (MD should) (VP (VB be) (VP (VBN continued) (SBAR (IN if) (S (NP (NP (NN VIOXX)) (CC and) (NP (NN methotrexate))) (VP (VBP are) (VP (VBN administered) (ADVP (RB concomitantly)))))))))) (. .))))

amod(monitoring-2, Standard-1)
nsubjpass(continued-8, monitoring-2)
amod(toxicity-5, methotrexate-related-4)
prep_of(monitoring-2, toxicity-5)
aux(continued-8, should-6)
auxpass(continued-8, be-7)
root(ROOT-0, continued-8)
mark(administered-14, if-9)
nsubjpass(administered-14, VIOXX-10)
conj_and(VIOXX-10, methotrexate-12)
auxpass(administered-14, are-13)
advcl(continued-8, administered-14)
advmod(administered-14, concomitantly-15)

Oral/JJ Contraceptives/NN Rofecoxib/NN did/VBD not/RB have/VB any/DT clinically/RB important/JJ effect/NN on/IN the/DT pharmacokinetics/NNS of/IN ethinyl/NN estradiol/NN and/CC norethindrone/NN ./.

(ROOT (S1 (S (S (NP (JJ Oral) (NN Contraceptives) (NN Rofecoxib)) (VP (VBD did) (RB not) (VP (VB have) (NP (DT any) (ADJP (RB clinically) (JJ important)) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN ethinyl) (NN estradiol)) (CC and) (NP (NN norethindrone))))))))) (. .))))

amod(Rofecoxib-3, Oral-1)
nn(Rofecoxib-3, Contraceptives-2)
nsubj(have-6, Rofecoxib-3)
aux(have-6, did-4)
neg(have-6, not-5)
root(ROOT-0, have-6)
det(effect-10, any-7)
advmod(important-9, clinically-8)
amod(effect-10, important-9)
dobj(have-6, effect-10)
det(pharmacokinetics-13, the-12)
prep_on(have-6, pharmacokinetics-13)
nn(estradiol-16, ethinyl-15)
prep_of(pharmacokinetics-13, estradiol-16)
conj_and(estradiol-16, norethindrone-18)

Prednisone/NN //: prednisolone/NN Rofecoxib/NN did/VBD not/RB have/VB any/DT clinically/RB important/JJ effect/NN on/IN the/DT pharmacokinetics/NNS of/IN prednisolone/NN or/CC prednisone/NN ./.

(ROOT (S1 (S (S (NP (NN Prednisone) (: /) (NN prednisolone) (NN Rofecoxib)) (VP (VBD did) (RB not) (VP (VB have) (NP (DT any) (ADJP (RB clinically) (JJ important)) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN prednisolone)) (CC or) (NP (NN prednisone))))))))) (. .))))

nn(Rofecoxib-4, Prednisone-1)
punct(Rofecoxib-4, /-2)
nn(Rofecoxib-4, prednisolone-3)
nsubj(have-7, Rofecoxib-4)
aux(have-7, did-5)
neg(have-7, not-6)
root(ROOT-0, have-7)
det(effect-11, any-8)
advmod(important-10, clinically-9)
amod(effect-11, important-10)
dobj(have-7, effect-11)
det(pharmacokinetics-14, the-13)
prep_on(have-7, pharmacokinetics-14)
prep_of(pharmacokinetics-14, prednisolone-16)
conj_or(prednisolone-16, prednisone-18)

Rifampin/NN Co-administration/NN of/IN VIOXX/NN with/IN rifampin/NN 600/CD mg/NN daily/RB ,/, a/DT potent/JJ inducer/NN of/IN hepatic/JJ metabolism/NN ,/, produced/VBD an/DT approximate/JJ 50/CD %/NN decrease/NN in/IN rofecoxib/NN plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Rifampin) (NN Co-administration)) (PP (IN of) (NP (NN VIOXX))) (PP (IN with) (NP (NP (NP (NN rifampin) (CD 600) (NN mg)) (ADVP (RB daily))) (, ,) (NP (NP (DT a) (JJ potent) (NN inducer)) (PP (IN of) (NP (JJ hepatic) (NN metabolism)))) (, ,)))) (VP (VBD produced) (NP (NP (DT an) (JJ approximate) (ADJP (CD 50) (NN %)) (NN decrease)) (PP (IN in) (NP (NN rofecoxib) (NN plasma) (NNS concentrations)))))) (. .))))

nn(Co-administration-2, Rifampin-1)
nsubj(produced-18, Co-administration-2)
prep_of(Co-administration-2, VIOXX-4)
nn(mg-8, rifampin-6)
num(mg-8, 600-7)
prep_with(Co-administration-2, mg-8)
advmod(mg-8, daily-9)
det(inducer-13, a-11)
amod(inducer-13, potent-12)
appos(mg-8, inducer-13)
amod(metabolism-16, hepatic-15)
prep_of(inducer-13, metabolism-16)
root(ROOT-0, produced-18)
det(decrease-23, an-19)
amod(decrease-23, approximate-20)
number(%-22, 50-21)
amod(decrease-23, %-22)
dobj(produced-18, decrease-23)
nn(concentrations-27, rofecoxib-25)
nn(concentrations-27, plasma-26)
prep_in(decrease-23, concentrations-27)

Therefore/RB ,/, a/DT starting/VBG daily/JJ dose/NN of/IN 25/CD mg/NN of/IN VIOXX/NN should/MD be/VB considered/VBN for/IN the/DT treatment/NN of/IN osteoarthritis/NN when/WRB VIOXX/NN is/VBZ co-administered/VBN with/IN potent/JJ inducers/NNS of/IN hepatic/JJ metabolism/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (DT a) (VBG starting) (JJ daily) (NN dose)) (PP (IN of) (NP (NP (CD 25) (NN mg)) (PP (IN of) (NP (NN VIOXX)))))) (VP (MD should) (VP (VB be) (VP (VBN considered) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN osteoarthritis))))) (SBAR (WHADVP (WRB when)) (S (NP (NN VIOXX)) (VP (VBZ is) (VP (VBN co-administered) (PP (IN with) (NP (NP (JJ potent) (NNS inducers)) (PP (IN of) (NP (JJ hepatic) (NN metabolism))))))))))))) (. .))))

advmod(considered-14, Therefore-1)
det(dose-6, a-3)
amod(dose-6, starting-4)
amod(dose-6, daily-5)
nsubjpass(considered-14, dose-6)
num(mg-9, 25-8)
prep_of(dose-6, mg-9)
prep_of(mg-9, VIOXX-11)
aux(considered-14, should-12)
auxpass(considered-14, be-13)
root(ROOT-0, considered-14)
det(treatment-17, the-16)
prep_for(considered-14, treatment-17)
prep_of(treatment-17, osteoarthritis-19)
advmod(co-administered-23, when-20)
nsubjpass(co-administered-23, VIOXX-21)
auxpass(co-administered-23, is-22)
advcl(considered-14, co-administered-23)
amod(inducers-26, potent-25)
prep_with(co-administered-23, inducers-26)
amod(metabolism-29, hepatic-28)
prep_of(inducers-26, metabolism-29)

Theophylline/NN VIOXX/NN 12.5/CD ,/, 25/CD ,/, and/CC 50/CD mg/NN administered/VBN once/RB daily/RB for/IN 7/CD days/NNS increased/VBD plasma/NN theophylline/NN concentrations/NNS (/-LRB- AUC/NN (/-LRB- 0-/CD @/NN )/-RRB- )/-RRB- by/IN 38/CD to/TO 60/CD %/NN in/IN healthy/JJ subjects/NNS administered/VBN a/DT single/JJ 300-mg/JJ dose/NN of/IN theophylline/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Theophylline) (NN VIOXX) (QP (CD 12.5) (, ,) (CD 25) (, ,) (CC and) (CD 50)) (NN mg)) (VP (VBN administered) (ADVP (RB once) (RB daily)) (PP (IN for) (NP (CD 7) (NNS days))))) (VP (VBD increased) (NP (NP (NN plasma) (NN theophylline) (NNS concentrations)) (PRN (-LRB- -LRB-) (NP (NP (NN AUC)) (PRN (-LRB- -LRB-) (NP (CD 0-) (NN @)) (-RRB- -RRB-))) (-RRB- -RRB-))) (PP (IN by) (NP (NP (QP (CD 38) (TO to) (CD 60)) (NN %)) (PP (IN in) (NP (NP (JJ healthy) (NNS subjects)) (VP (VBN administered) (NP (NP (DT a) (JJ single) (JJ 300-mg) (NN dose)) (PP (IN of) (NP (NN theophylline))))))))))) (. .))))

nn(mg-9, Theophylline-1)
nn(mg-9, VIOXX-2)
num(mg-9, 12.5-3)
number(12.5-3, 25-5)
conj_and(12.5-3, 50-8)
nsubj(increased-16, mg-9)
partmod(mg-9, administered-10)
advmod(daily-12, once-11)
advmod(administered-10, daily-12)
num(days-15, 7-14)
prep_for(administered-10, days-15)
root(ROOT-0, increased-16)
nn(concentrations-19, plasma-17)
nn(concentrations-19, theophylline-18)
dobj(increased-16, concentrations-19)
dep(concentrations-19, AUC-21)
num(@-24, 0--23)
appos(AUC-21, @-24)
number(60-30, 38-28)
dep(60-30, to-29)
num(%-31, 60-30)
prep_by(increased-16, %-31)
amod(subjects-34, healthy-33)
prep_in(%-31, subjects-34)
partmod(subjects-34, administered-35)
det(dose-39, a-36)
amod(dose-39, single-37)
amod(dose-39, 300-mg-38)
dobj(administered-35, dose-39)
prep_of(dose-39, theophylline-41)

Adequate/JJ monitoring/NN of/IN theophylline/NN plasma/NN concentrations/NNS should/MD be/VB considered/VBN when/WRB therapy/NN with/IN VIOXX/NN is/VBZ initiated/VBN or/CC changed/VBN in/IN patients/NNS receiving/VBG theophylline/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Adequate) (NN monitoring)) (PP (IN of) (NP (NN theophylline) (NN plasma) (NNS concentrations)))) (VP (MD should) (VP (VB be) (VP (VBN considered) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN therapy)) (PP (IN with) (NP (NN VIOXX)))) (VP (VBZ is) (VP (VP (VBN initiated)) (CC or) (VP (VBN changed) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN theophylline)))))))))))))) (. .))))

amod(monitoring-2, Adequate-1)
nsubjpass(considered-9, monitoring-2)
nn(concentrations-6, theophylline-4)
nn(concentrations-6, plasma-5)
prep_of(monitoring-2, concentrations-6)
aux(considered-9, should-7)
auxpass(considered-9, be-8)
root(ROOT-0, considered-9)
advmod(initiated-15, when-10)
nsubjpass(initiated-15, therapy-11)
prep_with(therapy-11, VIOXX-13)
auxpass(initiated-15, is-14)
advcl(considered-9, initiated-15)
conj_or(initiated-15, changed-17)
prep_in(changed-17, patients-19)
partmod(patients-19, receiving-20)
dobj(receiving-20, theophylline-21)

These/DT data/NNS suggest/VBP that/IN rofecoxib/NN may/MD produce/VB a/DT modest/JJ inhibition/NN of/IN cytochrome/NN P450/NN (/-LRB- CYP/NN )/-RRB- 1A2/NN ./.

(ROOT (S1 (S (S (NP (DT These) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN rofecoxib)) (VP (MD may) (VP (VB produce) (NP (NP (DT a) (JJ modest) (NN inhibition)) (PP (IN of) (NP (NP (NP (NN cytochrome) (NN P450)) (PRN (-LRB- -LRB-) (NP (NN CYP)) (-RRB- -RRB-))) (NN 1A2)))))))))) (. .))))

det(data-2, These-1)
nsubj(suggest-3, data-2)
root(ROOT-0, suggest-3)
complm(produce-7, that-4)
nsubj(produce-7, rofecoxib-5)
aux(produce-7, may-6)
ccomp(suggest-3, produce-7)
det(inhibition-10, a-8)
amod(inhibition-10, modest-9)
dobj(produce-7, inhibition-10)
nn(P450-13, cytochrome-12)
nn(1A2-17, P450-13)
abbrev(P450-13, CYP-15)
prep_of(inhibition-10, 1A2-17)

Therefore/RB ,/, there/EX is/VBZ a/DT potential/NN for/IN an/DT interaction/NN with/IN other/JJ drugs/NNS that/WDT are/VBP metabolized/VBN by/IN CYP/VBG 1A2/NN (/-LRB- e.g./FW ,/, amitriptyline/NN ,/, tacrine/NN ,/, and/CC zileuton/NN )/-RRB- ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (EX there)) (VP (VBZ is) (NP (NP (DT a) (NN potential)) (PP (IN for) (NP (NP (DT an) (NN interaction)) (PP (IN with) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN metabolized) (PP (IN by) (S (VP (VBG CYP) (NP (NP (NN 1A2)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NP (NN amitriptyline)) (, ,) (NP (NN tacrine)) (, ,) (CC and) (NP (NN zileuton)))) (-RRB- -RRB-))))))))))))))))) (. .))))

advmod(is-4, Therefore-1)
expl(is-4, there-3)
root(ROOT-0, is-4)
det(potential-6, a-5)
nsubj(is-4, potential-6)
det(interaction-9, an-8)
prep_for(potential-6, interaction-9)
amod(drugs-12, other-11)
prep_with(interaction-9, drugs-12)
nsubjpass(metabolized-15, drugs-12)
auxpass(metabolized-15, are-14)
rcmod(drugs-12, metabolized-15)
agent(metabolized-15, CYP-17)
dobj(CYP-17, 1A2-18)
dep(1A2-18, e.g.-20)
pobj(e.g.-20, amitriptyline-22)
conj_and(amitriptyline-22, tacrine-24)
conj_and(amitriptyline-22, zileuton-27)

Warfarin/NN Anticoagulant/NN activity/NN should/MD be/VB monitored/VBN ,/, particularly/RB in/IN the/DT first/JJ few/JJ days/NNS after/IN initiating/VBG or/CC changing/VBG VIOXX/NN therapy/NN in/IN patients/NNS receiving/VBG warfarin/JJ or/CC similar/JJ agents/NNS ,/, since/IN these/DT patients/NNS are/VBP at/IN an/DT increased/VBN risk/NN of/IN bleeding/JJ complications/NNS ./.

(ROOT (S1 (S (S (NP (NN Warfarin) (NN Anticoagulant) (NN activity)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (, ,) (PP (ADVP (RB particularly)) (IN in) (NP (NP (DT the) (JJ first) (JJ few) (NNS days)) (PP (IN after) (S (VP (VP (VBG initiating)) (CC or) (VP (VBG changing) (NP (NP (NN VIOXX) (NN therapy)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (ADJP (ADJP (JJ warfarin)) (CC or) (ADJP (JJ similar))) (NNS agents)))))))))))) (, ,) (SBAR (IN since) (S (NP (DT these) (NNS patients)) (VP (VBP are) (PP (IN at) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (JJ bleeding) (NNS complications)))))))))))) (. .))))

nn(activity-3, Warfarin-1)
nn(activity-3, Anticoagulant-2)
nsubjpass(monitored-6, activity-3)
aux(monitored-6, should-4)
auxpass(monitored-6, be-5)
root(ROOT-0, monitored-6)
advmod(monitored-6, particularly-8)
det(days-13, the-10)
amod(days-13, first-11)
amod(days-13, few-12)
prep_in(monitored-6, days-13)
prepc_after(days-13, initiating-15)
conj_or(initiating-15, changing-17)
nn(therapy-19, VIOXX-18)
dobj(changing-17, therapy-19)
prep_in(therapy-19, patients-21)
partmod(patients-21, receiving-22)
amod(agents-26, warfarin-23)
conj_or(warfarin-23, similar-25)
dobj(receiving-22, agents-26)
mark(are-31, since-28)
det(patients-30, these-29)
nsubj(are-31, patients-30)
advcl(monitored-6, are-31)
det(risk-35, an-33)
amod(risk-35, increased-34)
prep_at(are-31, risk-35)
amod(complications-38, bleeding-37)
prep_of(risk-35, complications-38)

In/IN single/JJ and/CC multiple/JJ dose/NN studies/NNS in/IN healthy/JJ subjects/NNS receiving/VBG both/CC warfarin/NN and/CC rofecoxib/NN ,/, prothrombin/NN time/NN (/-LRB- measured/VBN as/IN INR/NN )/-RRB- was/VBD increased/VBN by/IN approximately/RB 8/CD %/NN to/TO 11/CD %./NN

(ROOT (S1 (S (PP (IN In) (NP (NP (ADJP (ADJP (JJ single)) (CC and) (ADJP (JJ multiple))) (NN dose) (NNS studies)) (PP (IN in) (NP (NP (JJ healthy) (NNS subjects)) (VP (VBG receiving) (NP (CC both) (NP (NN warfarin)) (CC and) (NP (NN rofecoxib)))))))) (, ,) (NP (NP (NN prothrombin) (NN time)) (PRN (-LRB- -LRB-) (VP (VBN measured) (PP (IN as) (NP (NN INR)))) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN increased) (PP (IN by) (NP (QP (RB approximately) (CD 8)) (NN %))) (PP (TO to) (NP (CD 11) (NN %.))))))))

amod(studies-6, single-2)
conj_and(single-2, multiple-4)
nn(studies-6, dose-5)
prep_in(increased-24, studies-6)
amod(subjects-9, healthy-8)
prep_in(studies-6, subjects-9)
partmod(subjects-9, receiving-10)
preconj(warfarin-12, both-11)
dobj(receiving-10, warfarin-12)
conj_and(warfarin-12, rofecoxib-14)
nn(time-17, prothrombin-16)
nsubjpass(increased-24, time-17)
dep(time-17, measured-19)
prep_as(measured-19, INR-21)
auxpass(increased-24, was-23)
root(ROOT-0, increased-24)
quantmod(8-27, approximately-26)
num(%-28, 8-27)
agent(increased-24, %-28)
num(%.-31, 11-30)
prep_to(increased-24, %.-31)

In/IN post-marketing/JJ experience/VBP ,/, bleeding/JJ events/NNS have/VBP been/VBN reported/VBN ,/, predominantly/RB in/IN the/DT elderly/JJ ,/, in/IN association/NN with/IN increases/NNS in/IN prothrombin/NN time/NN in/IN patients/NNS receiving/VBG VIOXX/NN concurrently/RB with/IN warfarin/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (JJ post-marketing) (VBP experience))) (, ,) (NP (JJ bleeding) (NNS events)) (VP (VBP have) (VP (VBN been) (VP (VBN reported) (, ,) (PP (ADVP (RB predominantly)) (IN in) (NP (DT the) (JJ elderly))) (, ,) (PP (IN in) (NP (NP (NN association)) (PP (IN with) (NP (NP (NNS increases)) (PP (IN in) (NP (NP (NN prothrombin) (NN time)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NP (NN VIOXX)) (PP (ADVP (RB concurrently)) (IN with) (NP (NN warfarin))))))))))))))))) (. .))))

prep_in(reported-9, post-marketing-2)
dep(post-marketing-2, experience-3)
amod(events-6, bleeding-5)
nsubjpass(reported-9, events-6)
aux(reported-9, have-7)
auxpass(reported-9, been-8)
root(ROOT-0, reported-9)
advmod(reported-9, predominantly-11)
det(elderly-14, the-13)
prep_in(reported-9, elderly-14)
prep_in(reported-9, association-17)
prep_with(association-17, increases-19)
nn(time-22, prothrombin-21)
prep_in(increases-19, time-22)
prep_in(time-22, patients-24)
partmod(patients-24, receiving-25)
dobj(receiving-25, VIOXX-26)
advmod(VIOXX-26, concurrently-27)
prep_with(VIOXX-26, warfarin-29)

Several/JJ drug/NN interaction/NN studies/NNS have/VBP been/VBN completed/VBN with/IN both/CC INVIRASE/NN and/CC FORTOVASE/NN ./.

(ROOT (S1 (S (S (NP (JJ Several) (NN drug) (NN interaction) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN completed) (PP (IN with) (NP (CC both) (NP (NN INVIRASE)) (CC and) (NP (NN FORTOVASE)))))))) (. .))))

amod(studies-4, Several-1)
nn(studies-4, drug-2)
nn(studies-4, interaction-3)
nsubjpass(completed-7, studies-4)
aux(completed-7, have-5)
auxpass(completed-7, been-6)
root(ROOT-0, completed-7)
preconj(INVIRASE-10, both-9)
prep_with(completed-7, INVIRASE-10)
conj_and(INVIRASE-10, FORTOVASE-12)

Observations/NNS from/IN drug/NN interaction/NN studies/NNS with/IN FORTOVASE/NN may/MD not/RB be/VB predictive/JJ for/IN INVIRASE/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Observations)) (PP (IN from) (NP (NP (NN drug) (NN interaction) (NNS studies)) (PP (IN with) (NP (NN FORTOVASE)))))) (VP (MD may) (RB not) (VP (VB be) (ADJP (JJ predictive) (PP (IN for) (NP (NN INVIRASE))))))) (. .))))

nsubj(predictive-11, Observations-1)
nn(studies-5, drug-3)
nn(studies-5, interaction-4)
prep_from(Observations-1, studies-5)
prep_with(studies-5, FORTOVASE-7)
aux(predictive-11, may-8)
neg(predictive-11, not-9)
cop(predictive-11, be-10)
root(ROOT-0, predictive-11)
prep_for(predictive-11, INVIRASE-13)

Because/IN ritonavir/NN is/VBZ coadministered/JJ ,/, prescribers/NNS should/MD also/RB refer/VBP to/TO the/DT prescribing/JJ information/NN for/IN ritonavir/NN regarding/VBG drug/NN interactions/NNS associated/VBN with/IN this/DT agent/NN ./.

(ROOT (S1 (S (S (SBAR (IN Because) (S (NP (NN ritonavir)) (VP (VBZ is) (ADJP (JJ coadministered))))) (, ,) (NP (NNS prescribers)) (VP (MD should) (ADVP (RB also)) (VP (VBP refer) (PP (TO to) (NP (NP (DT the) (JJ prescribing) (NN information)) (PP (IN for) (NP (NN ritonavir))) (PP (VBG regarding) (NP (NP (NN drug) (NNS interactions)) (VP (VBN associated) (PP (IN with) (NP (DT this) (NN agent))))))))))) (. .))))

mark(coadministered-4, Because-1)
nsubj(coadministered-4, ritonavir-2)
cop(coadministered-4, is-3)
advcl(refer-9, coadministered-4)
nsubj(refer-9, prescribers-6)
aux(refer-9, should-7)
advmod(refer-9, also-8)
root(ROOT-0, refer-9)
det(information-13, the-11)
amod(information-13, prescribing-12)
prep_to(refer-9, information-13)
prep_for(information-13, ritonavir-15)
nn(interactions-18, drug-17)
prep_regarding(information-13, interactions-18)
partmod(interactions-18, associated-19)
det(agent-22, this-21)
prep_with(associated-19, agent-22)

The/DT metabolism/NN of/IN saquinavir/NN is/VBZ mediated/VBN by/IN cytochrome/NN P450/NN ,/, with/IN the/DT specific/JJ isoenzyme/NN CYP3A4/NN responsible/JJ for/IN 90/CD %/NN of/IN the/DT hepatic/JJ metabolism/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN metabolism)) (PP (IN of) (NP (NN saquinavir)))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (NN cytochrome) (NN P450))) (, ,) (PP (IN with) (NP (NP (DT the) (JJ specific) (NN isoenzyme) (NN CYP3A4)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (CD 90) (NN %)) (PP (IN of) (NP (DT the) (JJ hepatic) (NN metabolism))))))))))) (. .))))

det(metabolism-2, The-1)
nsubjpass(mediated-6, metabolism-2)
prep_of(metabolism-2, saquinavir-4)
auxpass(mediated-6, is-5)
root(ROOT-0, mediated-6)
nn(P450-9, cytochrome-8)
agent(mediated-6, P450-9)
det(CYP3A4-15, the-12)
amod(CYP3A4-15, specific-13)
nn(CYP3A4-15, isoenzyme-14)
prep_with(mediated-6, CYP3A4-15)
amod(CYP3A4-15, responsible-16)
num(%-19, 90-18)
prep_for(responsible-16, %-19)
det(metabolism-23, the-21)
amod(metabolism-23, hepatic-22)
prep_of(%-19, metabolism-23)

Additionally/RB ,/, saquinavir/NN is/VBZ a/DT substrate/NN for/IN P-/NN Glycoprotein/NN (/-LRB- Pgp)./NNP

(ROOT (S1 (S (ADVP (RB Additionally)) (, ,) (NP (NN saquinavir)) (VP (VBZ is) (NP (NP (DT a) (NN substrate)) (PP (IN for) (NP (NN P-) (NN Glycoprotein))))) (PRN (-LRB- -LRB-) (NP (NNP Pgp-RRB-.))))))

advmod(substrate-6, Additionally-1)
nsubj(substrate-6, saquinavir-3)
cop(substrate-6, is-4)
det(substrate-6, a-5)
root(ROOT-0, substrate-6)
nn(Glycoprotein-9, P--8)
prep_for(substrate-6, Glycoprotein-9)
dep(substrate-6, Pgp-RRB-.-11)

Therefore/RB ,/, drugs/NNS that/WDT affect/VBP CYP3A4/NN and/or/CC Pgp/NN ,/, may/MD modify/VB the/DT pharmacokinetics/NNS of/IN saquinavir/NN ./.

(ROOT (S1 (S (S (ADVP (RB Therefore)) (, ,) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP affect) (NP (NP (NN CYP3A4)) (CC and/or) (NP (NN Pgp))))))) (, ,) (VP (MD may) (VP (VB modify) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN saquinavir))))))) (. .))))

advmod(modify-11, Therefore-1)
nsubj(affect-5, drugs-3)
nsubj(modify-11, drugs-3)
rcmod(drugs-3, affect-5)
dobj(affect-5, CYP3A4-6)
conj_and/or(CYP3A4-6, Pgp-8)
aux(modify-11, may-10)
root(ROOT-0, modify-11)
det(pharmacokinetics-13, the-12)
dobj(modify-11, pharmacokinetics-13)
prep_of(pharmacokinetics-13, saquinavir-15)

Similarly/RB ,/, saquinavir/NN might/MD also/RB modify/VB the/DT pharmacokinetics/NNS of/IN other/JJ drugs/NNS that/WDT are/VBP substrates/NNS for/IN CYP3A4/NN or/CC Pgp/NN ./.

(ROOT (S1 (S (S (ADVP (RB Similarly)) (, ,) (NP (NN saquinavir)) (VP (MD might) (ADVP (RB also)) (VP (VB modify) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (JJ other) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (NNS substrates)) (PP (IN for) (NP (NP (NN CYP3A4)) (CC or) (NP (NN Pgp)))))))))))))) (. .))))

advmod(modify-6, Similarly-1)
nsubj(modify-6, saquinavir-3)
aux(modify-6, might-4)
advmod(modify-6, also-5)
root(ROOT-0, modify-6)
det(pharmacokinetics-8, the-7)
dobj(modify-6, pharmacokinetics-8)
amod(drugs-11, other-10)
prep_of(pharmacokinetics-8, drugs-11)
nsubj(substrates-14, drugs-11)
cop(substrates-14, are-13)
rcmod(drugs-11, substrates-14)
prep_for(substrates-14, CYP3A4-16)
conj_or(CYP3A4-16, Pgp-18)

Drugs/NNS that/WDT are/VBP contraindicated/VBN specifically/RB due/JJ to/TO the/DT expected/VBN magnitude/NN of/IN interaction/NN and/CC potential/NN for/IN serious/JJ adverse/JJ events/NNS are/VBP listed/JJ CONTRAINDICATIONS/NNS ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN contraindicated) (PP (ADVP (RB specifically)) (JJ due) (TO to) (NP (NP (DT the) (VBN expected) (NN magnitude)) (PP (IN of) (NP (NP (NN interaction)) (CC and) (NP (NN potential)))) (PP (IN for) (NP (JJ serious) (JJ adverse) (NNS events)))))))))) (VP (VBP are) (NP (JJ listed) (NNS CONTRAINDICATIONS)))) (. .))))

nsubjpass(contraindicated-4, Drugs-1)
nsubj(CONTRAINDICATIONS-21, Drugs-1)
auxpass(contraindicated-4, are-3)
rcmod(Drugs-1, contraindicated-4)
advmod(contraindicated-4, specifically-5)
det(magnitude-10, the-8)
amod(magnitude-10, expected-9)
prep_due_to(contraindicated-4, magnitude-10)
prep_of(magnitude-10, interaction-12)
conj_and(interaction-12, potential-14)
amod(events-18, serious-16)
amod(events-18, adverse-17)
prep_for(magnitude-10, events-18)
cop(CONTRAINDICATIONS-21, are-19)
amod(CONTRAINDICATIONS-21, listed-20)
root(ROOT-0, CONTRAINDICATIONS-21)

Additional/JJ drugs/NNS that/WDT are/VBP not/RB recommended/VBN for/IN coadministration/NN with/IN INVIRASE/NN and/CC ritonavir/NN are/VBP included/VBN below/IN ./.

(ROOT (S1 (S (S (NP (NP (JJ Additional) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (RB not) (VP (VBN recommended) (PP (IN for) (NP (NP (NN coadministration)) (PP (IN with) (NP (NP (NN INVIRASE)) (CC and) (NP (NN ritonavir))))))))))) (VP (VBP are) (VP (VBN included) (PP (IN below))))) (. .))))

amod(drugs-2, Additional-1)
nsubjpass(recommended-6, drugs-2)
nsubjpass(included-14, drugs-2)
auxpass(recommended-6, are-4)
neg(recommended-6, not-5)
rcmod(drugs-2, recommended-6)
prep_for(recommended-6, coadministration-8)
prep_with(coadministration-8, INVIRASE-10)
conj_and(INVIRASE-10, ritonavir-12)
auxpass(included-14, are-13)
root(ROOT-0, included-14)
prep(included-14, below-15)

When/WRB coadministering/VBG INVIRASE/NN //: ritonavir/NN with/IN any/DT agent/NN having/VBG a/DT narrow/JJ therapeutic/JJ margin/NN ,/, such/JJ as/IN anticoagulants/NNS ,/, anticonvulsants/NNS ,/, and/CC antiarrhythmics/NNS ,/, special/JJ attention/NN is/VBZ warranted/VBN ./.

(ROOT (S1 (S (S (SBAR (WHADVP (WRB When)) (S (VP (VBG coadministering) (NP (NP (NN INVIRASE)) (: /) (NP (NN ritonavir))) (PP (IN with) (S (NP (DT any) (NN agent)) (VP (VBG having) (NP (DT a) (JJ narrow) (JJ therapeutic) (NN margin)) (, ,) (PP (JJ such) (IN as) (NP (NP (NNS anticoagulants)) (, ,) (NP (NNS anticonvulsants)) (, ,) (CC and) (NP (NNS antiarrhythmics)))))))))) (, ,) (NP (JJ special) (NN attention)) (VP (VBZ is) (VP (VBN warranted)))) (. .))))

advmod(coadministering-2, When-1)
advcl(warranted-27, coadministering-2)
dobj(coadministering-2, INVIRASE-3)
punct(INVIRASE-3, /-4)
dep(INVIRASE-3, ritonavir-5)
det(agent-8, any-7)
nsubj(having-9, agent-8)
prepc_with(coadministering-2, having-9)
det(margin-13, a-10)
amod(margin-13, narrow-11)
amod(margin-13, therapeutic-12)
dobj(having-9, margin-13)
prep_such_as(having-9, anticoagulants-17)
conj_and(anticoagulants-17, anticonvulsants-19)
conj_and(anticoagulants-17, antiarrhythmics-22)
amod(attention-25, special-24)
nsubjpass(warranted-27, attention-25)
auxpass(warranted-27, is-26)
root(ROOT-0, warranted-27)

Drugs/NNS That/WDT Should/MD Not/RB Be/VB Coadministered/VBN With/IN INVIRASE/NN //: Ritonavir/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT That)) (S (VP (MD Should) (RB Not) (VP (VB Be) (VP (VBN Coadministered) (PP (IN With) (NP (NN INVIRASE))))))))) (: /) (NP (NN Ritonavir))) (. .))))

nsubjpass(Coadministered-6, Drugs-1)
dep(Ritonavir-10, Drugs-1)
aux(Coadministered-6, Should-3)
neg(Coadministered-6, Not-4)
auxpass(Coadministered-6, Be-5)
rcmod(Drugs-1, Coadministered-6)
prep_with(Coadministered-6, INVIRASE-8)
punct(Ritonavir-10, /-9)
root(ROOT-0, Ritonavir-10)

Drug/NN Class/NN :/: Drug/NN Name/NN Clinical/JJ Comment/NN ./.

(ROOT (S1 (S (S (NP (NN Drug) (NN Class)) (: :) (NP (NN Drug) (NN Name) (JJ Clinical) (NN Comment))) (. .))))

nn(Class-2, Drug-1)
dep(Comment-7, Class-2)
nn(Comment-7, Drug-4)
nn(Comment-7, Name-5)
amod(Comment-7, Clinical-6)
root(ROOT-0, Comment-7)

Antiarrhythmics/NN :/: Amiodarone/NN ,/, bepridil/NN ,/, flecainide/NN ,/, propafenone/NN ,/, quinidine/NN CONTRAINDICATED/VBN due/JJ to/TO potential/NN for/IN serious/JJ and/or/CC life-threatening/JJ reactions/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Antiarrhythmics)) (: :) (NP (NP (NN Amiodarone)) (, ,) (NP (NN bepridil)) (, ,) (NP (NN flecainide)) (, ,) (NP (NN propafenone)) (, ,) (NP (NN quinidine)))) (VP (VBN CONTRAINDICATED) (PP (JJ due) (TO to) (NP (NP (NN potential)) (PP (IN for) (NP (ADJP (ADJP (JJ serious)) (CC and/or) (ADJP (JJ life-threatening))) (NNS reactions))))))) (. .))))

nsubj(CONTRAINDICATED-12, Antiarrhythmics-1)
dep(Antiarrhythmics-1, Amiodarone-3)
appos(Amiodarone-3, bepridil-5)
appos(Amiodarone-3, flecainide-7)
appos(Amiodarone-3, propafenone-9)
appos(Amiodarone-3, quinidine-11)
root(ROOT-0, CONTRAINDICATED-12)
prep_due_to(CONTRAINDICATED-12, potential-15)
amod(reactions-20, serious-17)
conj_and/or(serious-17, life-threatening-19)
prep_for(potential-15, reactions-20)

Antihistamines/NNS :/: astemizole/NN */NN ,/, terfenadine/NN */NN CONTRAINDICATED/VBN due/JJ to/TO potential/NN for/IN serious/JJ and/or/CC life-threatening/JJ cardiac/JJ arrhythmias/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Antihistamines)) (: :) (S (NP (NN astemizole) (NN *) (, ,) (NN terfenadine) (NN *)) (VP (VBN CONTRAINDICATED) (PP (JJ due) (TO to) (NP (NP (NN potential)) (PP (IN for) (NP (ADJP (ADJP (JJ serious)) (CC and/or) (ADJP (JJ life-threatening))) (JJ cardiac) (NNS arrhythmias))))))) (. .)))))

root(ROOT-0, Antihistamines-1)
nn(*-7, astemizole-3)
nn(*-7, *-4)
dep(*-7, terfenadine-6)
nsubj(CONTRAINDICATED-8, *-7)
dep(Antihistamines-1, CONTRAINDICATED-8)
prep_due_to(CONTRAINDICATED-8, potential-11)
amod(arrhythmias-17, serious-13)
conj_and/or(serious-13, life-threatening-15)
amod(arrhythmias-17, cardiac-16)
prep_for(potential-11, arrhythmias-17)

Ergot/NN Derivatives/NNS :/: Dihydroergotamine/NN ,/, ergonovine/NN ,/, ergotamine/NN ,/, methylergonovine/NN CONTRAINDICATED/VBN due/JJ to/TO potential/NN for/IN serious/JJ and/CC life-threatening/JJ reactions/NNS such/JJ as/IN acute/JJ ergot/NN toxicity/NN characterized/VBN by/IN peripheral/JJ vasospasm/NN and/CC ischemia/NN of/IN the/DT extremities/NNS and/CC other/JJ tissues/NNS ./.

(ROOT (S1 (S (NP (NP (NN Ergot) (NNS Derivatives)) (: :) (S (NP (NP (NN Dihydroergotamine)) (, ,) (NP (NN ergonovine)) (, ,) (NP (NN ergotamine)) (, ,) (NP (NN methylergonovine))) (VP (VBN CONTRAINDICATED) (PP (JJ due) (TO to) (NP (NP (NN potential)) (PP (IN for) (NP (NP (ADJP (ADJP (JJ serious)) (CC and) (ADJP (JJ life-threatening))) (NNS reactions)) (PP (JJ such) (IN as) (NP (NP (JJ acute) (NN ergot) (NN toxicity)) (VP (VBN characterized) (PP (IN by) (NP (NP (NP (JJ peripheral) (NN vasospasm)) (CC and) (NP (NN ischemia))) (PP (IN of) (NP (NP (DT the) (NNS extremities)) (CC and) (NP (JJ other) (NNS tissues))))))))))))))) (. .)))))

nn(Derivatives-2, Ergot-1)
root(ROOT-0, Derivatives-2)
nsubj(CONTRAINDICATED-11, Dihydroergotamine-4)
appos(Dihydroergotamine-4, ergonovine-6)
appos(Dihydroergotamine-4, ergotamine-8)
appos(Dihydroergotamine-4, methylergonovine-10)
dep(Derivatives-2, CONTRAINDICATED-11)
prep_due_to(CONTRAINDICATED-11, potential-14)
amod(reactions-19, serious-16)
conj_and(serious-16, life-threatening-18)
prep_for(potential-14, reactions-19)
amod(toxicity-24, acute-22)
nn(toxicity-24, ergot-23)
prep_such_as(reactions-19, toxicity-24)
partmod(toxicity-24, characterized-25)
amod(vasospasm-28, peripheral-27)
agent(characterized-25, vasospasm-28)
conj_and(vasospasm-28, ischemia-30)
det(extremities-33, the-32)
prep_of(vasospasm-28, extremities-33)
amod(tissues-36, other-35)
conj_and(extremities-33, tissues-36)

Antimycobacterial/JJ Agents/NNS :/: rifampin/NN CONTRAINDICATED/VBN since/IN the/DT coadministration/NN of/IN this/DT product/NN with/IN saquinavir/NN in/IN an/DT antiretroviral/JJ regimen/NN reduces/VBZ the/DT plasma/NN concentrations/NNS of/IN saquinavir/NN ./.

(ROOT (S1 (S (NP (NP (JJ Antimycobacterial) (NNS Agents)) (: :) (S (NP (NN rifampin)) (VP (VBN CONTRAINDICATED) (SBAR (IN since) (S (NP (NP (DT the) (NN coadministration)) (PP (IN of) (NP (DT this) (NN product))) (PP (IN with) (NP (NP (NN saquinavir)) (PP (IN in) (NP (DT an) (JJ antiretroviral) (NN regimen)))))) (VP (VBZ reduces) (NP (NP (DT the) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN saquinavir))))))))) (. .)))))

amod(Agents-2, Antimycobacterial-1)
root(ROOT-0, Agents-2)
nsubj(CONTRAINDICATED-5, rifampin-4)
dep(Agents-2, CONTRAINDICATED-5)
mark(reduces-18, since-6)
det(coadministration-8, the-7)
nsubj(reduces-18, coadministration-8)
det(product-11, this-10)
prep_of(coadministration-8, product-11)
prep_with(coadministration-8, saquinavir-13)
det(regimen-17, an-15)
amod(regimen-17, antiretroviral-16)
prep_in(saquinavir-13, regimen-17)
advcl(CONTRAINDICATED-5, reduces-18)
det(concentrations-21, the-19)
nn(concentrations-21, plasma-20)
dobj(reduces-18, concentrations-21)
prep_of(concentrations-21, saquinavir-23)

Garlic/JJ Cap/NN sules/NN Garlic/NN capsules/NNS should/MD not/RB be/VB used/VBN while/IN taking/VBG saquinavir/NN (/-LRB- FORTOVASE/NN )/-RRB- as/IN the/DT sole/JJ protease/NN inhibitor/NN due/JJ to/TO the/DT risk/NN of/IN decreased/VBN saquinavir/JJ plasma/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (JJ Garlic) (NN Cap) (NN sules) (NN Garlic) (NNS capsules)) (VP (MD should) (RB not) (VP (VB be) (VP (VBN used) (SBAR (IN while) (S (VP (VBG taking) (NP (NP (NN saquinavir)) (PRN (-LRB- -LRB-) (NP (NN FORTOVASE)) (-RRB- -RRB-))) (PP (IN as) (NP (NP (DT the) (JJ sole) (NN protease) (NN inhibitor)) (ADJP (JJ due) (PP (TO to) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (VBN decreased) (JJ saquinavir) (NN plasma) (NNS concentrations))))))))))))))) (. .))))

amod(capsules-5, Garlic-1)
nn(capsules-5, Cap-2)
nn(capsules-5, sules-3)
nn(capsules-5, Garlic-4)
nsubjpass(used-9, capsules-5)
aux(used-9, should-6)
neg(used-9, not-7)
auxpass(used-9, be-8)
root(ROOT-0, used-9)
mark(taking-11, while-10)
advcl(used-9, taking-11)
dobj(taking-11, saquinavir-12)
abbrev(saquinavir-12, FORTOVASE-14)
det(inhibitor-20, the-17)
amod(inhibitor-20, sole-18)
nn(inhibitor-20, protease-19)
prep_as(taking-11, inhibitor-20)
det(risk-24, the-23)
prep_due_to(inhibitor-20, risk-24)
amod(concentrations-29, decreased-26)
amod(concentrations-29, saquinavir-27)
nn(concentrations-29, plasma-28)
prep_of(risk-24, concentrations-29)

No/DT data/NNS are/VBP available/JJ for/IN the/DT coadministration/NN of/IN INVIRASE/NN //: ritonavir/NN or/CC FORTOVASE/NN //: ritonavir/NN and/CC garlic/NN capsules/NNS ./.

(ROOT (S1 (S (S (NP (DT No) (NNS data)) (VP (VBP are) (ADJP (JJ available) (PP (IN for) (NP (NP (DT the) (NN coadministration)) (PP (IN of) (NP (NP (NN INVIRASE)) (: /) (NP (NP (NN ritonavir)) (CC or) (NP (NN FORTOVASE))) (: /) (NP (NP (NP (NN ritonavir)) (CC and) (NP (NN garlic))) (NNS capsules))))))))) (. .))))

det(data-2, No-1)
nsubj(available-4, data-2)
cop(available-4, are-3)
root(ROOT-0, available-4)
det(coadministration-7, the-6)
prep_for(available-4, coadministration-7)
prep_of(coadministration-7, INVIRASE-9)
punct(INVIRASE-9, /-10)
dep(INVIRASE-9, ritonavir-11)
conj_or(ritonavir-11, FORTOVASE-13)
punct(INVIRASE-9, /-14)
nn(capsules-18, ritonavir-15)
conj_and(ritonavir-15, garlic-17)
dep(INVIRASE-9, capsules-18)

GI/NN Motility/NN Agent/NN :/: cisapride/NN */VBD CONTRAINDICATED/VBN due/JJ to/TO potential/NN for/IN serious/JJ and/or/CC life-threatening/JJ reactions/NNS such/JJ as/IN cardiac/JJ arrhythmias/NNS ./.

(ROOT (S1 (S (NP (NP (NN GI) (NN Motility) (NN Agent)) (: :) (S (NP (NN cisapride)) (VP (VBD *) (VP (VBN CONTRAINDICATED) (PP (JJ due) (TO to) (NP (NP (NN potential)) (PP (IN for) (NP (NP (ADJP (ADJP (JJ serious)) (CC and/or) (ADJP (JJ life-threatening))) (NNS reactions)) (PP (JJ such) (IN as) (NP (JJ cardiac) (NNS arrhythmias)))))))))) (. .)))))

nn(Agent-3, GI-1)
nn(Agent-3, Motility-2)
root(ROOT-0, Agent-3)
nsubj(*-6, cisapride-5)
dep(Agent-3, *-6)
dep(*-6, CONTRAINDICATED-7)
prep_due_to(CONTRAINDICATED-7, potential-10)
amod(reactions-15, serious-12)
conj_and/or(serious-12, life-threatening-14)
prep_for(potential-10, reactions-15)
amod(arrhythmias-19, cardiac-18)
prep_such_as(reactions-15, arrhythmias-19)

Herbal/JJ Products/NNS :/: St./NN John/NN @/NN s/NN wort/NN (/-LRB- hypericum/NN perforatum/NN )/-RRB- WARNING/NN coadministration/NN may/MD lead/VB to/TO loss/NN of/IN virologic/JJ response/NN and/CC possible/JJ resistance/NN to/TO INVIRASE/NN or/CC to/TO the/DT class/NN of/IN protease/NN inhibitors/NNS ./.

(ROOT (S1 (S (NP (NP (JJ Herbal) (NNS Products)) (: :) (S (NP (NN St.) (NN John) (NN @) (NN s) (NN wort) (-LRB- -LRB-) (NN hypericum) (NN perforatum) (-RRB- -RRB-) (NN WARNING) (NN coadministration)) (VP (MD may) (VP (VB lead) (PP (TO to) (NP (NP (NN loss)) (PP (IN of) (NP (NP (JJ virologic) (NN response)) (CC and) (NP (JJ possible) (NN resistance)))))) (PP (PP (TO to) (NP (NN INVIRASE))) (CC or) (PP (TO to) (NP (NP (DT the) (NN class)) (PP (IN of) (NP (NN protease) (NNS inhibitors))))))))) (. .)))))

amod(Products-2, Herbal-1)
root(ROOT-0, Products-2)
nn(coadministration-14, St.-4)
nn(coadministration-14, John-5)
nn(coadministration-14, @-6)
nn(coadministration-14, s-7)
nn(coadministration-14, wort-8)
nn(coadministration-14, hypericum-10)
nn(coadministration-14, perforatum-11)
nn(coadministration-14, WARNING-13)
nsubj(lead-16, coadministration-14)
aux(lead-16, may-15)
dep(Products-2, lead-16)
prep_to(lead-16, loss-18)
amod(response-21, virologic-20)
prep_of(loss-18, response-21)
amod(resistance-24, possible-23)
conj_and(response-21, resistance-24)
prep_to(lead-16, INVIRASE-26)
det(class-30, the-29)
conj_or(INVIRASE-26, class-30)
nn(inhibitors-33, protease-32)
prep_of(class-30, inhibitors-33)

HMG-CoA/NN Reductase/NN Inhibitors/NNS :/: lovastatin/NN ,/, simvastatin/NN WARNING/NN potential/NN for/IN serious/JJ reactions/NNS such/JJ as/IN risk/NN of/IN myopathy/NN including/VBG rhabdomyolysis/NN ./.

(ROOT (S1 (S (NP (NP (NN HMG-CoA) (NN Reductase) (NNS Inhibitors)) (: :) (NP (NP (NN lovastatin)) (, ,) (NP (NP (NN simvastatin) (NN WARNING) (NN potential)) (PP (IN for) (NP (NP (JJ serious) (NNS reactions)) (PP (JJ such) (IN as) (NP (NP (NN risk)) (PP (IN of) (NP (NN myopathy))) (PP (VBG including) (NP (NN rhabdomyolysis))))))))) (. .)))))

nn(Inhibitors-3, HMG-CoA-1)
nn(Inhibitors-3, Reductase-2)
root(ROOT-0, Inhibitors-3)
dep(Inhibitors-3, lovastatin-5)
nn(potential-9, simvastatin-7)
nn(potential-9, WARNING-8)
appos(lovastatin-5, potential-9)
amod(reactions-12, serious-11)
prep_for(potential-9, reactions-12)
prep_such_as(reactions-12, risk-15)
prep_of(risk-15, myopathy-17)
prep_including(risk-15, rhabdomyolysis-19)

Sedatives/NNS //: Hypnotics/NN :/: triazolam/NN ,/, midazolam/NN CONTRAINDICATED/VBN due/JJ to/TO potential/NN for/IN serious/JJ and/or/CC life-threatening/JJ reactions/NNS such/JJ as/IN prolonged/JJ or/CC increased/VBN sedation/NN or/CC respiratory/JJ depression/NN ./.

(ROOT (S1 (S (NP (NP (NNS Sedatives)) (: /) (NP (NN Hypnotics)) (: :) (NP (NP (NN triazolam)) (, ,) (NP (NP (NN midazolam)) (VP (VBN CONTRAINDICATED) (PP (JJ due) (TO to) (NP (NP (NN potential)) (PP (IN for) (NP (NP (ADJP (ADJP (JJ serious)) (CC and/or) (ADJP (JJ life-threatening))) (NNS reactions)) (PP (JJ such) (IN as) (NP (NP (ADJP (ADJP (JJ prolonged)) (CC or) (ADJP (VBN increased))) (NN sedation)) (CC or) (NP (JJ respiratory) (NN depression))))))))))) (. .)))))

root(ROOT-0, Sedatives-1)
punct(Sedatives-1, /-2)
dep(Sedatives-1, Hypnotics-3)
dep(Sedatives-1, triazolam-5)
appos(triazolam-5, midazolam-7)
partmod(midazolam-7, CONTRAINDICATED-8)
prep_due_to(CONTRAINDICATED-8, potential-11)
amod(reactions-16, serious-13)
conj_and/or(serious-13, life-threatening-15)
prep_for(potential-11, reactions-16)
amod(sedation-22, prolonged-19)
conj_or(prolonged-19, increased-21)
prep_such_as(reactions-16, sedation-22)
amod(depression-25, respiratory-24)
conj_or(sedation-22, depression-25)

Drugs/NNS That/DT Are/VBP Mainly/RB Metabolized/VBN by/IN CYP3A4/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (NP (DT That))) (VP (VBP Are) (ADVP (RB Mainly)) (VP (VBN Metabolized) (PP (IN by) (NP (NN CYP3A4)))))) (. .))))

nsubjpass(Metabolized-5, Drugs-1)
dep(Drugs-1, That-2)
auxpass(Metabolized-5, Are-3)
advmod(Metabolized-5, Mainly-4)
root(ROOT-0, Metabolized-5)
agent(Metabolized-5, CYP3A4-7)

Although/IN specific/JJ studies/NNS have/VBP not/RB been/VBN performed/VBN ,/, coadministration/NN with/IN drugs/NNS that/WDT are/VBP mainly/RB metabolized/VBN by/IN CYP3A4/NN (/-LRB- eg/NN ,/, calcium/NN channel/NN blockers/NNS ,/, dapsone/NN ,/, disopyramide/NN ,/, quinine/NN ,/, amiodarone/NN ,/, quinidine/NN ,/, warfarin/NN ,/, tacrolimus/NN ,/, cyclosporine/NN ,/, ergot/NN derivatives/NNS ,/, pimozide/NN ,/, carbamazepine/NN ,/, fentanyl/NN ,/, alfentanyl/NN ,/, alprazolam/NN ,/, and/CC triazolam/NN )/-RRB- may/MD have/VBP elevated/JJ plasma/NN concentrations/NNS when/WRB coadministered/VBN with/IN saquinavir/NN ;/: ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (JJ specific) (NNS studies)) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN performed)))))) (, ,) (NP (NP (NN coadministration)) (PP (IN with) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB mainly)) (VP (VBN metabolized) (PP (IN by) (NP (NP (NN CYP3A4)) (PRN (-LRB- -LRB-) (NP (NN eg)) (, ,) (NP (NP (NP (NP (NN calcium) (NN channel) (NNS blockers)) (, ,) (NP (NN dapsone)) (, ,) (NP (NN disopyramide)) (, ,) (NP (NN quinine)) (, ,) (NP (NN amiodarone)) (, ,)) (NN quinidine)) (, ,) (NP (NN warfarin)) (, ,) (NP (NN tacrolimus)) (, ,) (NP (NN cyclosporine)) (, ,) (NP (NN ergot) (NNS derivatives)) (, ,) (NP (NN pimozide)) (, ,) (NP (NN carbamazepine)) (, ,) (NP (NN fentanyl)) (, ,) (NP (NN alfentanyl)) (, ,) (NP (NN alprazolam)) (, ,) (CC and) (NP (NN triazolam))) (-RRB- -RRB-))))))))))) (VP (MD may) (VP (VBP have) (NP (JJ elevated) (NN plasma) (NNS concentrations)) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NN saquinavir)))))))) (: ;)) (. .))))

mark(performed-7, Although-1)
amod(studies-3, specific-2)
nsubjpass(performed-7, studies-3)
aux(performed-7, have-4)
neg(performed-7, not-5)
auxpass(performed-7, been-6)
advcl(have-58, performed-7)
nsubj(have-58, coadministration-9)
prep_with(coadministration-9, drugs-11)
nsubjpass(metabolized-15, drugs-11)
auxpass(metabolized-15, are-13)
advmod(metabolized-15, mainly-14)
rcmod(drugs-11, metabolized-15)
agent(metabolized-15, CYP3A4-17)
dep(CYP3A4-17, eg-19)
nn(blockers-23, calcium-21)
nn(blockers-23, channel-22)
nn(quinidine-33, blockers-23)
appos(blockers-23, dapsone-25)
appos(blockers-23, disopyramide-27)
appos(blockers-23, quinine-29)
appos(blockers-23, amiodarone-31)
dep(eg-19, quinidine-33)
conj_and(quinidine-33, warfarin-35)
conj_and(quinidine-33, tacrolimus-37)
conj_and(quinidine-33, cyclosporine-39)
nn(derivatives-42, ergot-41)
conj_and(quinidine-33, derivatives-42)
conj_and(quinidine-33, pimozide-44)
conj_and(quinidine-33, carbamazepine-46)
conj_and(quinidine-33, fentanyl-48)
conj_and(quinidine-33, alfentanyl-50)
conj_and(quinidine-33, alprazolam-52)
conj_and(quinidine-33, triazolam-55)
aux(have-58, may-57)
root(ROOT-0, have-58)
amod(concentrations-61, elevated-59)
nn(concentrations-61, plasma-60)
dobj(have-58, concentrations-61)
advmod(coadministered-63, when-62)
advcl(have-58, coadministered-63)
prep_with(coadministered-63, saquinavir-65)

Since/IN INVIRASE/NN is/VBZ coadministered/VBN with/IN ritonavir/NN ,/, the/DT ritonavir/NN label/VB should/MD be/VB reviewed/VBN for/IN additional/JJ drugs/NNS that/WDT should/MD not/RB be/VB coadministered/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Since) (S (NP (NN INVIRASE)) (VP (VBZ is) (VP (VBN coadministered) (PP (IN with) (NP (NN ritonavir))))))) (, ,) (NP (NP (DT the) (NN ritonavir)) (VP (VB label))) (VP (MD should) (VP (VB be) (VP (VBN reviewed) (PP (IN for) (NP (NP (JJ additional) (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD should) (RB not) (VP (VB be) (VP (VBN coadministered)))))))))))) (. .))))

mark(coadministered-4, Since-1)
nsubjpass(coadministered-4, INVIRASE-2)
auxpass(coadministered-4, is-3)
advcl(reviewed-13, coadministered-4)
prep_with(coadministered-4, ritonavir-6)
det(ritonavir-9, the-8)
nsubjpass(reviewed-13, ritonavir-9)
dep(ritonavir-9, label-10)
aux(reviewed-13, should-11)
auxpass(reviewed-13, be-12)
root(ROOT-0, reviewed-13)
amod(drugs-16, additional-15)
prep_for(reviewed-13, drugs-16)
nsubjpass(coadministered-21, drugs-16)
aux(coadministered-21, should-18)
neg(coadministered-21, not-19)
auxpass(coadministered-21, be-20)
rcmod(drugs-16, coadministered-21)

Inducers/NNS of/IN CYP3A4/NN ./.

(ROOT (S1 (S (NP (NP (NNS Inducers)) (PP (IN of) (NP (NN CYP3A4))) (. .)))))

root(ROOT-0, Inducers-1)
prep_of(Inducers-1, CYP3A4-3)

Coadministration/NN with/IN compounds/NNS that/WDT are/VBP potent/JJ inducers/NNS of/IN CYP3A4/NN (/-LRB- eg/NN ,/, phenobarbital/NN ,/, phenytoin/NN ,/, dexamethasone/NN ,/, carbamazepine/NN )/-RRB- may/MD result/VB in/IN decreased/VBN plasma/NN levels/NNS of/IN saquinavir/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN with) (NP (NP (NNS compounds)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (NP (NP (JJ potent) (NNS inducers)) (PP (IN of) (NP (NN CYP3A4)))) (PRN (-LRB- -LRB-) (NP (NN eg)) (, ,) (NP (NP (NN phenobarbital)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN dexamethasone)) (, ,) (NP (NN carbamazepine))) (-RRB- -RRB-)))))))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (VBN decreased) (NN plasma) (NNS levels)) (PP (IN of) (NP (NN saquinavir)))))))) (. .))))

nsubj(result-22, Coadministration-1)
prep_with(Coadministration-1, compounds-3)
nsubj(inducers-7, compounds-3)
cop(inducers-7, are-5)
amod(inducers-7, potent-6)
rcmod(compounds-3, inducers-7)
prep_of(inducers-7, CYP3A4-9)
dep(inducers-7, eg-11)
dep(eg-11, phenobarbital-13)
appos(phenobarbital-13, phenytoin-15)
appos(phenobarbital-13, dexamethasone-17)
appos(phenobarbital-13, carbamazepine-19)
aux(result-22, may-21)
root(ROOT-0, result-22)
amod(levels-26, decreased-24)
nn(levels-26, plasma-25)
prep_in(result-22, levels-26)
prep_of(levels-26, saquinavir-28)

Sulfacetamide/NN preparation/NN s/NNS are/VBP incompatible/JJ with/IN silver/NN preparation/NN s/NNS ./.

(ROOT (S1 (S (S (NP (NN Sulfacetamide) (NN preparation) (NNS s)) (VP (VBP are) (ADJP (JJ incompatible) (PP (IN with) (NP (NN silver) (NN preparation) (NNS s)))))) (. .))))

nn(s-3, Sulfacetamide-1)
nn(s-3, preparation-2)
nsubj(incompatible-5, s-3)
cop(incompatible-5, are-4)
root(ROOT-0, incompatible-5)
nn(s-9, silver-7)
nn(s-9, preparation-8)
prep_with(incompatible-5, s-9)

Sulfapyridine/NN may/MD interact/VB with/IN any/DT of/IN the/DT following/NN :/: -/: Acetaminophen/NN (/-LRB- e.g./FW ,/, Tylenol/NN )/-RRB- (/-LRB- with/IN long-term/JJ ,/, high-dose/JJ use/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NN Sulfapyridine)) (VP (MD may) (VP (VB interact) (PP (IN with) (NP (NP (DT any)) (PP (IN of) (NP (NP (NP (DT the) (NN following)) (: :)) (: -) (NP (NP (NN Acetaminophen)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN Tylenol)) (-RRB- -RRB-))))))) (PRN (-LRB- -LRB-) (PP (IN with) (NP (ADJP (ADJP (JJ long-term)) (, ,) (ADJP (JJ high-dose))) (NN use))) (-RRB- -RRB-)) (CC or)))) (. .))))

nsubj(interact-3, Sulfapyridine-1)
aux(interact-3, may-2)
root(ROOT-0, interact-3)
prep_with(interact-3, any-5)
det(following-8, the-7)
prep_of(any-5, following-8)
dep(following-8, Acetaminophen-11)
dep(Tylenol-15, e.g.-13)
appos(Acetaminophen-11, Tylenol-15)
dep(interact-3, with-18)
amod(use-22, long-term-19)
dep(long-term-19, high-dose-21)
pobj(with-18, use-22)
cc(interact-3, or-24)

-/CC Amiodarone/NN (/-LRB- e.g./FW ,/, Cordarone/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Amiodarone)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Cordarone))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Amiodarone-2)
dep(Amiodarone-2, e.g.-4)
pobj(e.g.-4, Cordarone-6)
root(ROOT-0, or-8)

-/: Anabolic/JJ steroids/NNS (/-LRB- nandrolone/NN [e.g./NN ,/, Anabolin/NN ]/-RRB- ,/, oxandrolone/NN [e.g./NN ,/, Anavar/NNP ]/-RRB- ,/, oxymetholone/NN [e.g./NN ,/, Anadrol/NNP ]/-RRB- ,/, stanozolol/NNP [e.g./NNP ,/, Winstrol/NNP ]/-RRB- )/-RRB- or/CC ./.

(ROOT (S1 (S (S (PRN (: -) (NP (NP (JJ Anabolic) (NNS steroids)) (PRN (-LRB- -LRB-) (NP (NP (NN nandrolone) (NN -LSB-e.g.)) (, ,) (NP (NN Anabolin))) (-RRB- -RSB-))) (, ,) (FRAG (NP (NN oxandrolone) (NN -LSB-e.g.)) (, ,) (NP (NNP Anavar) (-RRB- -RSB-)) (, ,) (NP (NN oxymetholone) (NN -LSB-e.g.)) (, ,) (NP (NNP Anadrol) (-RRB- -RSB-)) (, ,) (NP (NNP stanozolol) (NNP -LSB-e.g.) (, ,) (NNP Winstrol)) (-RRB- -RSB-)) (-RRB- -RRB-)) (CC or)) (. .))))

amod(steroids-3, Anabolic-2)
dep(or-29, steroids-3)
nn(-LSB-e.g.-6, nandrolone-5)
dep(steroids-3, -LSB-e.g.-6)
appos(-LSB-e.g.-6, Anabolin-8)
punct(-LSB-e.g.-6, -RSB--9)
nn(-LSB-e.g.-12, oxandrolone-11)
dep(steroids-3, -LSB-e.g.-12)
dep(-LSB-e.g.-12, Anavar-14)
punct(Anavar-14, -RSB--15)
nn(-LSB-e.g.-18, oxymetholone-17)
dep(-LSB-e.g.-12, -LSB-e.g.-18)
dep(-LSB-e.g.-12, Anadrol-20)
punct(Anadrol-20, -RSB--21)
nn(Winstrol-26, stanozolol-23)
nn(Winstrol-26, -LSB-e.g.-24)
dep(-LSB-e.g.-12, Winstrol-26)
punct(-LSB-e.g.-12, -RSB--27)
root(ROOT-0, or-29)

-/CC Androgens/NNS (/-LRB- male/JJ hormones/NNS )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NNS Androgens)) (PRN (-LRB- -LRB-) (NP (JJ male) (NNS hormones)) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-7, Androgens-2)
amod(hormones-5, male-4)
appos(Androgens-2, hormones-5)
root(ROOT-0, or-7)

-/TO Antithyroid/JJ agents/NNS (/-LRB- medicine/NN for/IN overactive/JJ thyroid/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (PP (TO -) (NP (JJ Antithyroid) (NNS agents))) (PRN (-LRB- -LRB-) (NP (NN medicine)) (PP (IN for) (NP (JJ overactive) (NN thyroid))) (-RRB- -RRB-)) (CC or)) (. .))))

amod(agents-3, Antithyroid-2)
dep(or-10, agents-3)
dep(or-10, medicine-5)
dep(medicine-5, for-6)
amod(thyroid-8, overactive-7)
pobj(for-6, thyroid-8)
root(ROOT-0, or-10)

-/CC Carbamazepine/NN (/-LRB- e.g./FW ,/, Tegretol/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Carbamazepine)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Tegretol))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Carbamazepine-2)
dep(Carbamazepine-2, e.g.-4)
pobj(e.g.-4, Tegretol-6)
root(ROOT-0, or-8)

-/CC Carmustine/NN (/-LRB- e.g./FW ,/, BiCNU/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Carmustine)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN BiCNU))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Carmustine-2)
dep(Carmustine-2, e.g.-4)
pobj(e.g.-4, BiCNU-6)
root(ROOT-0, or-8)

-/CC Chloroquine/NN (/-LRB- e.g./FW ,/, Aralen/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Chloroquine)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Aralen))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Chloroquine-2)
dep(Chloroquine-2, e.g.-4)
pobj(e.g.-4, Aralen-6)
root(ROOT-0, or-8)

-/CC Dantrolene/NN (/-LRB- e.g./FW ,/, Dantrium/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Dantrolene)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Dantrium))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Dantrolene-2)
dep(Dantrolene-2, e.g.-4)
pobj(e.g.-4, Dantrium-6)
root(ROOT-0, or-8)

-/CC Daunorubicin/NN (/-LRB- e.g./FW ,/, Cerubidine/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Daunorubicin)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Cerubidine))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Daunorubicin-2)
dep(Daunorubicin-2, e.g.-4)
pobj(e.g.-4, Cerubidine-6)
root(ROOT-0, or-8)

-/CC Disulfiram/NN (/-LRB- e.g./FW ,/, Antabuse/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Disulfiram)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN Antabuse)) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Disulfiram-2)
dep(Antabuse-6, e.g.-4)
appos(Disulfiram-2, Antabuse-6)
root(ROOT-0, or-8)

-/CC Divalproex/NN (/-LRB- e.g./FW ,/, Depakote/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Divalproex)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Depakote))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Divalproex-2)
dep(Divalproex-2, e.g.-4)
pobj(e.g.-4, Depakote-6)
root(ROOT-0, or-8)

-/CC Estrogens/NNS (/-LRB- female/NN hormones/NNS )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NNS Estrogens)) (PRN (-LRB- -LRB-) (NP (NN female) (NNS hormones)) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-7, Estrogens-2)
nn(hormones-5, female-4)
appos(Estrogens-2, hormones-5)
root(ROOT-0, or-7)

-/CC Etretinate/NN (/-LRB- e.g./FW ,/, Tegison/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Etretinate)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Tegison))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Etretinate-2)
dep(Etretinate-2, e.g.-4)
pobj(e.g.-4, Tegison-6)
root(ROOT-0, or-8)

-/CC Gold/NN salt/NN s/NNS (/-LRB- medicine/NN for/IN arthritis/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Gold) (NN salt) (NNS s)) (PRN (-LRB- -LRB-) (NP (NN medicine)) (PP (IN for) (NP (NN arthritis))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

nn(s-4, Gold-2)
nn(s-4, salt-3)
dep(or-10, s-4)
dep(s-4, medicine-6)
dep(medicine-6, for-7)
pobj(for-7, arthritis-8)
root(ROOT-0, or-10)

-/CC Hydroxychloroquine/NN (/-LRB- e.g./FW ,/, Plaquenil/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Hydroxychloroquine)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Plaquenil))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Hydroxychloroquine-2)
dep(Hydroxychloroquine-2, e.g.-4)
pobj(e.g.-4, Plaquenil-6)
root(ROOT-0, or-8)

-/CC Mercaptopurine/NN (/-LRB- e.g./FW ,/, Purinethol/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Mercaptopurine)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Purinethol))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Mercaptopurine-2)
dep(Mercaptopurine-2, e.g.-4)
pobj(e.g.-4, Purinethol-6)
root(ROOT-0, or-8)

-/CC Naltrexone/NN (/-LRB- e.g./FW ,/, Trexan/NN )/-RRB- (/-LRB- with/IN long-term/JJ ,/, high-dose/JJ use/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (NP (NP (NP (NP (CC -) (NN Naltrexone)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN Trexan)) (-RRB- -RRB-))) (PRN (-LRB- -LRB-) (PP (IN with) (NP (ADJP (ADJP (JJ long-term)) (, ,) (ADJP (JJ high-dose))) (NN use))) (-RRB- -RRB-))) (CC or) (. .)))))

root(ROOT-0, Naltrexone-2)
dep(Trexan-6, e.g.-4)
appos(Naltrexone-2, Trexan-6)
dep(Naltrexone-2, with-9)
amod(use-13, long-term-10)
dep(long-term-10, high-dose-12)
pobj(with-9, use-13)
cc(Naltrexone-2, or-15)

-/CC Oral/JJ contraceptives/NNS (/-LRB- birth/NN control/NN pills/NNS )/-RRB- containing/VBG estrogen/NN or/NN ./.

(ROOT (S1 (S (S (CC -) (NP (NP (JJ Oral) (NNS contraceptives)) (PRN (-LRB- -LRB-) (NP (NN birth) (NN control) (NNS pills)) (-RRB- -RRB-))) (VP (VBG containing) (NP (NN estrogen) (NN or)))) (. .))))

amod(contraceptives-3, Oral-2)
nsubj(containing-9, contraceptives-3)
nn(pills-7, birth-5)
nn(pills-7, control-6)
appos(contraceptives-3, pills-7)
root(ROOT-0, containing-9)
nn(or-11, estrogen-10)
dobj(containing-9, or-11)

-/TO Other/JJ anti-infectives/NNS by/IN mouth/NN or/CC by/IN injection/NN (/-LRB- medicine/NN for/IN infection/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (PP (TO -) (NP (NP (JJ Other) (NNS anti-infectives)) (PP (PP (IN by) (NP (NN mouth))) (CC or) (PP (IN by) (NP (NN injection)))))) (PRN (-LRB- -LRB-) (NP (NN medicine)) (PP (IN for) (NP (NN infection))) (-RRB- -RRB-)) (CC or)) (. .))))

amod(anti-infectives-3, Other-2)
dep(or-14, anti-infectives-3)
prep_by(anti-infectives-3, mouth-5)
conj_or(mouth-5, injection-8)
dep(or-14, medicine-10)
dep(medicine-10, for-11)
pobj(for-11, infection-12)
root(ROOT-0, or-14)

-/CC Phenothiazines/NNS (/-LRB- acetophenazine/NN [e.g./NN ,/, Tindal/NNP ]/-RRB- ,/, chlorpromazine/NN [e.g./NN ,/, Thorazine/NN ]/-RRB- ,/, fluphenazine/NN [e.g./NN ,/, Prolixin/NN ]/-RRB- ,/, mesoridazine/NN [e.g./NN ,/, Serentil/NN ]/-RRB- ,/, perphenazine/NN [e.g./NN ,/, Trilafon/NNP ]/-RRB- ,/, prochlorperazine/NN [e.g./NN ,/, Compazine/NN ]/-RRB- ,/, promazine/NN [e.g./NN ,/, Sparine/NN ]/-RRB- ,/, promethazine/NN [e.g./NN ,/, Phenergan/NNP ]/-RRB- ,/, thioridazine/NN [e.g./NN ,/, Mellaril/NN ]/-RRB- ,/, trifluoperazine/NN [e.g./NN ,/, Stelazine/NN ]/-RRB- ,/, triflupromazine/NN [e.g./NN ,/, Vesprin/NN ]/-RRB- ,/, trimeprazine/NN [e.g./NN ,/, Temaril/NN ]/-RRB- )/-RRB- or/CC ./.

(ROOT (S1 (S (CC -) (NNS Phenothiazines) (-LRB- -LRB-) (NN acetophenazine) (NN -LSB-e.g.) (, ,) (NNP Tindal) (-RRB- -RSB-) (, ,) (NN chlorpromazine) (NN -LSB-e.g.) (, ,) (NN Thorazine) (-RRB- -RSB-) (, ,) (NN fluphenazine) (NN -LSB-e.g.) (, ,) (NN Prolixin) (-RRB- -RSB-) (, ,) (NN mesoridazine) (NN -LSB-e.g.) (, ,) (NN Serentil) (-RRB- -RSB-) (, ,) (NN perphenazine) (NN -LSB-e.g.) (, ,) (NNP Trilafon) (-RRB- -RSB-) (, ,) (NN prochlorperazine) (NN -LSB-e.g.) (, ,) (NN Compazine) (-RRB- -RSB-) (, ,) (NN promazine) (NN -LSB-e.g.) (, ,) (NN Sparine) (-RRB- -RSB-) (, ,) (NN promethazine) (NN -LSB-e.g.) (, ,) (NNP Phenergan) (-RRB- -RSB-) (, ,) (NN thioridazine) (NN -LSB-e.g.) (, ,) (NN Mellaril) (-RRB- -RSB-) (, ,) (NN trifluoperazine) (NN -LSB-e.g.) (, ,) (NN Stelazine) (-RRB- -RSB-) (, ,) (NN triflupromazine) (NN -LSB-e.g.) (, ,) (NN Vesprin) (-RRB- -RSB-) (, ,) (NN trimeprazine) (NN -LSB-e.g.) (, ,) (NN Temaril) (-RRB- -RSB-) (-RRB- -RRB-) (CC or) (. .))))

dep(-LSB-e.g.-71, Phenothiazines-2)
conj_or(-LSB-e.g.-71, acetophenazine-4)
dep(-LSB-e.g.-71, -LSB-e.g.-5)
conj_or(-LSB-e.g.-71, Tindal-7)
punct(-LSB-e.g.-71, -RSB--8)
conj_or(-LSB-e.g.-71, chlorpromazine-10)
dep(-LSB-e.g.-71, -LSB-e.g.-11)
conj_or(-LSB-e.g.-71, Thorazine-13)
punct(-LSB-e.g.-71, -RSB--14)
conj_or(-LSB-e.g.-71, fluphenazine-16)
dep(-LSB-e.g.-71, -LSB-e.g.-17)
conj_or(-LSB-e.g.-71, Prolixin-19)
punct(-LSB-e.g.-71, -RSB--20)
conj_or(-LSB-e.g.-71, mesoridazine-22)
dep(-LSB-e.g.-71, -LSB-e.g.-23)
conj_or(-LSB-e.g.-71, Serentil-25)
punct(-LSB-e.g.-71, -RSB--26)
conj_or(-LSB-e.g.-71, perphenazine-28)
dep(-LSB-e.g.-71, -LSB-e.g.-29)
conj_or(-LSB-e.g.-71, Trilafon-31)
punct(-LSB-e.g.-71, -RSB--32)
conj_or(-LSB-e.g.-71, prochlorperazine-34)
dep(-LSB-e.g.-71, -LSB-e.g.-35)
conj_or(-LSB-e.g.-71, Compazine-37)
punct(-LSB-e.g.-71, -RSB--38)
conj_or(-LSB-e.g.-71, promazine-40)
dep(-LSB-e.g.-71, -LSB-e.g.-41)
conj_or(-LSB-e.g.-71, Sparine-43)
punct(-LSB-e.g.-71, -RSB--44)
conj_or(-LSB-e.g.-71, promethazine-46)
dep(-LSB-e.g.-71, -LSB-e.g.-47)
conj_or(-LSB-e.g.-71, Phenergan-49)
punct(-LSB-e.g.-71, -RSB--50)
conj_or(-LSB-e.g.-71, thioridazine-52)
dep(-LSB-e.g.-71, -LSB-e.g.-53)
conj_or(-LSB-e.g.-71, Mellaril-55)
punct(-LSB-e.g.-71, -RSB--56)
conj_or(-LSB-e.g.-71, trifluoperazine-58)
dep(-LSB-e.g.-71, -LSB-e.g.-59)
conj_or(-LSB-e.g.-71, Stelazine-61)
punct(-LSB-e.g.-71, -RSB--62)
conj_or(-LSB-e.g.-71, triflupromazine-64)
dep(-LSB-e.g.-71, -LSB-e.g.-65)
conj_or(-LSB-e.g.-71, Vesprin-67)
punct(-LSB-e.g.-71, -RSB--68)
conj_or(-LSB-e.g.-71, trimeprazine-70)
root(ROOT-0, -LSB-e.g.-71)
conj_or(-LSB-e.g.-71, Temaril-73)
punct(-LSB-e.g.-71, -RSB--74)

-/CC Plicamycin/NN (/-LRB- e.g./FW ,/, Mithracin/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Plicamycin)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Mithracin))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Plicamycin-2)
dep(Plicamycin-2, e.g.-4)
pobj(e.g.-4, Mithracin-6)
root(ROOT-0, or-8)

-/CC Valproic/JJ acid/NN (/-LRB- e.g./FW ,/, Depakene/NN )/-RRB- @/NN Use/NN of/IN sulfapyridine/NN with/IN these/DT medicines/NNS may/MD increase/VB the/DT chance/NN of/IN side/JJ effects/NNS affecting/VBG the/DT liver/NN ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NP (NP (JJ Valproic) (NN acid)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN Depakene)) (-RRB- -RRB-))) (NN @) (NN Use)) (PP (IN of) (NP (NN sulfapyridine))) (PP (IN with) (NP (DT these) (NNS medicines)))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN chance)) (PP (IN of) (NP (NP (JJ side) (NNS effects)) (VP (VBG affecting) (NP (DT the) (NN liver))))))))) (. .))))

amod(acid-3, Valproic-2)
nn(Use-10, acid-3)
dep(Depakene-7, e.g.-5)
appos(acid-3, Depakene-7)
nn(Use-10, @-9)
nsubj(increase-17, Use-10)
prep_of(Use-10, sulfapyridine-12)
det(medicines-15, these-14)
prep_with(Use-10, medicines-15)
aux(increase-17, may-16)
root(ROOT-0, increase-17)
det(chance-19, the-18)
dobj(increase-17, chance-19)
amod(effects-22, side-21)
prep_of(chance-19, effects-22)
partmod(effects-22, affecting-23)
det(liver-25, the-24)
dobj(affecting-23, liver-25)

-/CC Acetohydroxamic/JJ acid/NN (/-LRB- e.g./FW ,/, Lithostat/NN )/-RRB- or/NN ./.

(ROOT (S1 (S (NP (NP (CC -) (NP (NP (JJ Acetohydroxamic) (NN acid)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN Lithostat)) (-RRB- -RRB-))) (NN or)) (. .)))))

amod(acid-3, Acetohydroxamic-2)
nn(or-9, acid-3)
dep(Lithostat-7, e.g.-5)
appos(acid-3, Lithostat-7)
root(ROOT-0, or-9)

-/CC Dapsone/NN or/NN ./.

(ROOT (S1 (S (S (CC -) (NP (NN Dapsone) (NN or))) (. .))))

nn(or-3, Dapsone-2)
root(ROOT-0, or-3)

-/CC Furazolidone/NN (/-LRB- e.g./FW ,/, Furoxone/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Furazolidone)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Furoxone))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Furazolidone-2)
dep(Furazolidone-2, e.g.-4)
pobj(e.g.-4, Furoxone-6)
root(ROOT-0, or-8)

-/CC Nitrofurantoin/NN (/-LRB- e.g./FW ,/, Furadantin/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Nitrofurantoin)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Furadantin))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Nitrofurantoin-2)
dep(Nitrofurantoin-2, e.g.-4)
pobj(e.g.-4, Furadantin-6)
root(ROOT-0, or-8)

-/CC Primaquine/NN or/NN ./.

(ROOT (S1 (S (S (CC -) (NP (NN Primaquine) (NN or))) (. .))))

nn(or-3, Primaquine-2)
root(ROOT-0, or-3)

-/CC Procainamide/NN (/-LRB- e.g./FW ,/, Pronestyl/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Procainamide)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Pronestyl))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Procainamide-2)
dep(Procainamide-2, e.g.-4)
pobj(e.g.-4, Pronestyl-6)
root(ROOT-0, or-8)

-/CC Quinidine/NN (/-LRB- e.g./FW ,/, Quinidex/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Quinidine)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Quinidex))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Quinidine-2)
dep(Quinidine-2, e.g.-4)
pobj(e.g.-4, Quinidex-6)
root(ROOT-0, or-8)

-/CC Quinine/NN (/-LRB- e.g./FW ,/, Quinamm/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Quinine)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Quinamm))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Quinine-2)
dep(Quinine-2, e.g.-4)
pobj(e.g.-4, Quinamm-6)
root(ROOT-0, or-8)

-/CC Sulfoxone/NN (/-LRB- e.g./FW ,/, Diasone/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Sulfoxone)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Diasone))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Sulfoxone-2)
dep(Sulfoxone-2, e.g.-4)
pobj(e.g.-4, Diasone-6)
root(ROOT-0, or-8)

-/CC Vitamin/NN K/NN (/-LRB- e.g./FW ,/, AquaMEPHYTON/NNP ,/, Synkayvite/NNP )/-RRB- @/NN Use/NN of/IN sulfapyridine/NN with/IN these/DT medicines/NNS may/MD increase/VB the/DT chance/NN of/IN side/JJ effects/NNS affecting/VBG the/DT blood/NN ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NP (NP (NN Vitamin) (NN K)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NNP AquaMEPHYTON) (, ,) (NNP Synkayvite)) (-RRB- -RRB-))) (NN @) (NN Use)) (PP (IN of) (NP (NP (NN sulfapyridine)) (PP (IN with) (NP (DT these) (NNS medicines)))))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN chance)) (PP (IN of) (NP (NP (JJ side) (NNS effects)) (VP (VBG affecting) (NP (DT the) (NN blood))))))))) (. .))))

nn(K-3, Vitamin-2)
nn(Use-12, K-3)
dep(Synkayvite-9, e.g.-5)
nn(Synkayvite-9, AquaMEPHYTON-7)
appos(K-3, Synkayvite-9)
nn(Use-12, @-11)
nsubj(increase-19, Use-12)
prep_of(Use-12, sulfapyridine-14)
det(medicines-17, these-16)
prep_with(sulfapyridine-14, medicines-17)
aux(increase-19, may-18)
root(ROOT-0, increase-19)
det(chance-21, the-20)
dobj(increase-19, chance-21)
amod(effects-24, side-23)
prep_of(chance-21, effects-24)
partmod(effects-24, affecting-25)
det(blood-27, the-26)
dobj(affecting-25, blood-27)

-/CC Anticoagulants/NNS (/-LRB- blood/NN thinner/NN s/NNS )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NNS Anticoagulants)) (PRN (-LRB- -LRB-) (NP (NN blood) (NN thinner) (NNS s)) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Anticoagulants-2)
nn(s-6, blood-4)
nn(s-6, thinner-5)
appos(Anticoagulants-2, s-6)
root(ROOT-0, or-8)

-/CC Ethotoin/NN (/-LRB- e.g./FW ,/, Peganone/NN )/-RRB- or/CC ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NN Ethotoin)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (NN Peganone))) (-RRB- -RRB-))) (NP (CC or))) (. .))))

dep(or-8, Ethotoin-2)
dep(Ethotoin-2, e.g.-4)
pobj(e.g.-4, Peganone-6)
root(ROOT-0, or-8)

-/CC Mephenytoin/NNP (/-LRB- e.g./FW ,/, Mesantoin/NNP )/-RRB- @/NN Use/NN of/IN sulfapyridine/NN with/IN these/DT medicines/NNS may/MD increase/VB the/DT chance/NN of/IN side/JJ effects/NNS of/IN these/DT medicines/NNS ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NP (NP (NNP Mephenytoin)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NNP Mesantoin)) (-RRB- -RRB-))) (NN @) (NN Use)) (PP (IN of) (NP (NN sulfapyridine))) (PP (IN with) (NP (DT these) (NNS medicines)))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN chance)) (PP (IN of) (NP (NP (JJ side) (NNS effects)) (PP (IN of) (NP (DT these) (NNS medicines))))))))) (. .))))

nn(Use-9, Mephenytoin-2)
dep(Mesantoin-6, e.g.-4)
appos(Mephenytoin-2, Mesantoin-6)
nn(Use-9, @-8)
nsubj(increase-16, Use-9)
prep_of(Use-9, sulfapyridine-11)
det(medicines-14, these-13)
prep_with(Use-9, medicines-14)
aux(increase-16, may-15)
root(ROOT-0, increase-16)
det(chance-18, the-17)
dobj(increase-16, chance-18)
amod(effects-21, side-20)
prep_of(chance-18, effects-21)
det(medicines-24, these-23)
prep_of(effects-21, medicines-24)

-/TO Antidiabetics/NN ,/, oral/JJ (/-LRB- diabetes/NN medicine/NN you/VBN take/VB by/IN mouth/NN )/-RRB- @/NN Use/NN of/IN oral/JJ antidiabetics/NNS with/IN sulfapyridine/NN may/MD increase/VB the/DT chance/NN of/IN side/JJ effects/NNS affecting/VBG the/DT blood/NN and/or/CC the/DT side/JJ effects/NNS or/CC oral/JJ antidiabetics/NNS ./.

(ROOT (S1 (S (PP (TO -) (NP (NN Antidiabetics))) (, ,) (NP (NP (ADJP (ADJP (JJ oral)) (PRN (-LRB- -LRB-) (S (NP (NN diabetes) (NN medicine)) (VP (VBN you) (VP (VB take) (PP (IN by) (NP (NN mouth)))))) (-RRB- -RRB-))) (NN @) (NN Use)) (PP (IN of) (NP (NP (JJ oral) (NNS antidiabetics)) (PP (IN with) (NP (NN sulfapyridine)))))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN chance)) (PP (IN of) (NP (NP (JJ side) (NNS effects)) (VP (VBG affecting) (NP (NP (DT the) (NN blood)) (CC and/or) (NP (NP (DT the) (JJ side) (NNS effects)) (CC or) (NP (JJ oral) (NNS antidiabetics)))))))))) (. .))))

prep(increase-21, Antidiabetics-2)
amod(Use-14, oral-4)
nn(medicine-7, diabetes-6)
nsubj(you-8, medicine-7)
dep(oral-4, you-8)
dep(you-8, take-9)
prep_by(take-9, mouth-11)
nn(Use-14, @-13)
nsubj(increase-21, Use-14)
amod(antidiabetics-17, oral-16)
prep_of(Use-14, antidiabetics-17)
prep_with(antidiabetics-17, sulfapyridine-19)
aux(increase-21, may-20)
root(ROOT-0, increase-21)
det(chance-23, the-22)
dobj(increase-21, chance-23)
amod(effects-26, side-25)
prep_of(chance-23, effects-26)
partmod(effects-26, affecting-27)
det(blood-29, the-28)
dobj(affecting-27, blood-29)
det(effects-33, the-31)
amod(effects-33, side-32)
conj_and/or(blood-29, effects-33)
amod(antidiabetics-36, oral-35)
conj_or(effects-33, antidiabetics-36)

-/CC Methotrexate/NN (/-LRB- e.g./FW ,/, Mexate/NN )/-RRB- @/NN Use/NN of/IN methotrexate/NN with/IN sulfapyridine/NN may/MD increase/VB the/DT chance/NN of/IN side/JJ effects/NNS affecting/VBG the/DT liver/NN and/or/CC the/DT side/JJ effects/NNS of/IN methotrexate/NN ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NP (NP (NN Methotrexate)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN Mexate)) (-RRB- -RRB-))) (NN @) (NN Use)) (PP (IN of) (NP (NN methotrexate))) (PP (IN with) (NP (NN sulfapyridine)))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN chance)) (PP (IN of) (NP (NP (NP (JJ side) (NNS effects)) (VP (VBG affecting) (NP (DT the) (NN liver)))) (CC and/or) (NP (NP (DT the) (JJ side) (NNS effects)) (PP (IN of) (NP (NN methotrexate)))))))))) (. .))))

nn(Use-9, Methotrexate-2)
dep(Mexate-6, e.g.-4)
appos(Methotrexate-2, Mexate-6)
nn(Use-9, @-8)
nsubj(increase-15, Use-9)
prep_of(Use-9, methotrexate-11)
prep_with(Use-9, sulfapyridine-13)
aux(increase-15, may-14)
root(ROOT-0, increase-15)
det(chance-17, the-16)
dobj(increase-15, chance-17)
amod(effects-20, side-19)
prep_of(chance-17, effects-20)
partmod(effects-20, affecting-21)
det(liver-23, the-22)
dobj(affecting-21, liver-23)
det(effects-27, the-25)
amod(effects-27, side-26)
conj_and/or(effects-20, effects-27)
prep_of(effects-27, methotrexate-29)

-/CC Methyldopa/NN (/-LRB- e.g./FW ,/, Aldomet/NN )/-RRB- @/NN Use/NN of/IN methyldopa/NN with/IN sulfapyridine/NN may/MD increase/VB the/DT chance/NN of/IN side/JJ effects/NNS affecting/VBG the/DT liver/NN and/or/CC the/DT blood/NN ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NP (NP (NN Methyldopa)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN Aldomet)) (-RRB- -RRB-))) (NN @) (NN Use)) (PP (IN of) (NP (NP (NN methyldopa)) (PP (IN with) (NP (NN sulfapyridine)))))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN chance)) (PP (IN of) (NP (JJ side) (NNS effects)))) (PP (VBG affecting) (NP (DT the) (NP (NP (NN liver)) (CC and/or) (NP (DT the) (NN blood)))))))) (. .))))

nn(Use-9, Methyldopa-2)
dep(Aldomet-6, e.g.-4)
appos(Methyldopa-2, Aldomet-6)
nn(Use-9, @-8)
nsubj(increase-15, Use-9)
prep_of(Use-9, methyldopa-11)
prep_with(methyldopa-11, sulfapyridine-13)
aux(increase-15, may-14)
root(ROOT-0, increase-15)
det(chance-17, the-16)
dobj(increase-15, chance-17)
amod(effects-20, side-19)
prep_of(chance-17, effects-20)
det(liver-23, the-22)
prep_affecting(increase-15, liver-23)
det(blood-26, the-25)
conj_and/or(liver-23, blood-26)

-/CC Phenytoin/NN (/-LRB- e.g./FW ,/, Dilantin/NN )/-RRB- @/NN Use/NN of/IN phenytoin/NN with/IN sulfapyridine/NN may/MD increase/VB the/DT chance/NN of/IN side/JJ effects/NNS affecting/VBG the/DT liver/NN and/or/CC the/DT side/JJ effects/NNS of/IN phenytoin/NN ./.

(ROOT (S1 (S (S (NP (NP (CC -) (NP (NP (NN Phenytoin)) (PRN (-LRB- -LRB-) (PP (FW e.g.)) (, ,) (NP (NN Dilantin)) (-RRB- -RRB-))) (NN @) (NN Use)) (PP (IN of) (NP (NN phenytoin))) (PP (IN with) (NP (NN sulfapyridine)))) (VP (MD may) (VP (VB increase) (NP (NP (DT the) (NN chance)) (PP (IN of) (NP (NP (NP (JJ side) (NNS effects)) (VP (VBG affecting) (NP (DT the) (NN liver)))) (CC and/or) (NP (NP (DT the) (JJ side) (NNS effects)) (PP (IN of) (NP (NN phenytoin)))))))))) (. .))))

nn(Use-9, Phenytoin-2)
dep(Dilantin-6, e.g.-4)
appos(Phenytoin-2, Dilantin-6)
nn(Use-9, @-8)
nsubj(increase-15, Use-9)
prep_of(Use-9, phenytoin-11)
prep_with(Use-9, sulfapyridine-13)
aux(increase-15, may-14)
root(ROOT-0, increase-15)
det(chance-17, the-16)
dobj(increase-15, chance-17)
amod(effects-20, side-19)
prep_of(chance-17, effects-20)
partmod(effects-20, affecting-21)
det(liver-23, the-22)
dobj(affecting-21, liver-23)
det(effects-27, the-25)
amod(effects-27, side-26)
conj_and/or(effects-20, effects-27)
prep_of(effects-27, phenytoin-29)

In/IN evaluating/VBG the/DT potential/NN for/IN interactions/NNS among/IN co-administered/NN antiepilepsy/NN drugs/NNS (/-LRB- AEDs/NNS )/-RRB- ,/, whether/IN or/CC not/RB an/DT AED/NN induces/VBZ or/CC does/VBZ not/RB induce/VB metabolic/JJ enzymes/NNS is/VBZ an/DT important/JJ consideration/NN ./.

(ROOT (S1 (S (S (PP (IN In) (S (VP (VBG evaluating) (NP (NP (DT the) (NN potential)) (PP (IN for) (NP (NP (NNS interactions)) (PP (IN among) (NP (NP (NN co-administered) (NN antiepilepsy) (NNS drugs)) (PRN (-LRB- -LRB-) (NP (NNS AEDs)) (-RRB- -RRB-)))))))))) (, ,) (SBAR (IN whether) (CC or) (RB not) (S (NP (DT an) (NN AED)) (VP (VP (VBZ induces)) (CC or) (VP (VBZ does) (RB not) (VP (VB induce) (NP (JJ metabolic) (NNS enzymes))))))) (VP (VBZ is) (NP (DT an) (JJ important) (NN consideration)))) (. .))))

prepc_in(consideration-30, evaluating-2)
det(potential-4, the-3)
dobj(evaluating-2, potential-4)
prep_for(potential-4, interactions-6)
nn(drugs-10, co-administered-8)
nn(drugs-10, antiepilepsy-9)
prep_among(interactions-6, drugs-10)
appos(drugs-10, AEDs-12)
dep(induces-20, whether-15)
conj_or(induces-20, not-17)
det(AED-19, an-18)
nsubj(induces-20, AED-19)
csubj(consideration-30, induces-20)
aux(induce-24, does-22)
neg(induce-24, not-23)
conj_or(induces-20, induce-24)
amod(enzymes-26, metabolic-25)
dobj(induce-24, enzymes-26)
cop(consideration-30, is-27)
det(consideration-30, an-28)
amod(consideration-30, important-29)
root(ROOT-0, consideration-30)

Phenytoin/NN ,/, phenobarbital/NN and/CC carbamazepine/NN are/VBP ge/NN nerally/RB classified/VBN as/IN enzyme/NN inducers/NNS ;/: ./.

(ROOT (S1 (S (S (NP (NP (NN Phenytoin)) (, ,) (NP (NN phenobarbital)) (CC and) (NP (NN carbamazepine))) (VP (VBP are) (ADVP (NN ge) (RB nerally)) (VP (VBN classified) (PP (IN as) (NP (NN enzyme) (NNS inducers))))) (: ;)) (. .))))

nsubjpass(classified-9, Phenytoin-1)
conj_and(Phenytoin-1, phenobarbital-3)
conj_and(Phenytoin-1, carbamazepine-5)
auxpass(classified-9, are-6)
dep(nerally-8, ge-7)
advmod(classified-9, nerally-8)
root(ROOT-0, classified-9)
nn(inducers-12, enzyme-11)
prep_as(classified-9, inducers-12)

valproate/NN and/CC gabapentin/NN are/VBP not/RB ./.

(ROOT (S1 (S (S (NP (NP (NN valproate)) (CC and) (NP (NN gabapentin))) (VP (VBP are) (RB not))) (. .))))

nsubj(are-4, valproate-1)
conj_and(valproate-1, gabapentin-3)
root(ROOT-0, are-4)
neg(are-4, not-5)

GABITRIL/NN is/VBZ considered/VBN to/TO be/VB a/DT non-enzyme/JJ inducing/NN AED/NN ./.

(ROOT (S1 (S (S (NP (NN GABITRIL)) (VP (VBZ is) (VP (VBN considered) (S (VP (TO to) (VP (VB be) (NP (DT a) (JJ non-enzyme) (NN inducing) (NN AED)))))))) (. .))))

nsubjpass(considered-3, GABITRIL-1)
xsubj(AED-9, GABITRIL-1)
auxpass(considered-3, is-2)
root(ROOT-0, considered-3)
aux(AED-9, to-4)
cop(AED-9, be-5)
det(AED-9, a-6)
amod(AED-9, non-enzyme-7)
nn(AED-9, inducing-8)
xcomp(considered-3, AED-9)

Effects/NNS of/IN GABITRIL/NN on/IN other/JJ Antiepilepsy/NN Drugs/NNS (/-LRB- AEDs/NNS )/-RRB- :/: Phenytoin/NN :/: Tiagabine/NN had/VBD no/DT effect/NN on/IN the/DT steady-state/JJ plasma/NN concentrations/NNS of/IN phenytoin/NN in/IN patients/NNS with/IN epilepsy/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Effects)) (PP (IN of) (NP (NN GABITRIL))) (PP (IN on) (NP (NP (NP (JJ other) (NN Antiepilepsy) (NNS Drugs)) (PRN (-LRB- -LRB-) (NP (NNS AEDs)) (-RRB- -RRB-))) (: :) (NP (NN Phenytoin)) (: :) (NP (NN Tiagabine))))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (DT the) (JJ steady-state) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NP (NN phenytoin)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN epilepsy))))))))))) (. .))))

nsubj(had-15, Effects-1)
prep_of(Effects-1, GABITRIL-3)
amod(Drugs-7, other-5)
nn(Drugs-7, Antiepilepsy-6)
prep_on(Effects-1, Drugs-7)
appos(Drugs-7, AEDs-9)
dep(Drugs-7, Phenytoin-12)
dep(Drugs-7, Tiagabine-14)
root(ROOT-0, had-15)
det(effect-17, no-16)
dobj(had-15, effect-17)
det(concentrations-22, the-19)
amod(concentrations-22, steady-state-20)
nn(concentrations-22, plasma-21)
prep_on(had-15, concentrations-22)
prep_of(concentrations-22, phenytoin-24)
prep_in(phenytoin-24, patients-26)
prep_with(patients-26, epilepsy-28)

Carbamazepine/NN :/: Tiagabine/NN had/VBD no/DT effect/NN on/IN the/DT steady-state/JJ plasma/NN concentrations/NNS of/IN carbamazepine/NN or/CC its/PRP$ epoxide/NN metabolite/NN in/IN patients/NNS with/IN epilepsy/NN ./.

(ROOT (S1 (S (NP (NP (NN Carbamazepine)) (: :) (S (NP (NN Tiagabine)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NP (DT the) (JJ steady-state) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN carbamazepine)))) (CC or) (NP (NP (PRP$ its) (NN epoxide) (NN metabolite)) (PP (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN epilepsy)))))))))) (. .)))))

root(ROOT-0, Carbamazepine-1)
nsubj(had-4, Tiagabine-3)
dep(Carbamazepine-1, had-4)
det(effect-6, no-5)
dobj(had-4, effect-6)
det(concentrations-11, the-8)
amod(concentrations-11, steady-state-9)
nn(concentrations-11, plasma-10)
prep_on(had-4, concentrations-11)
prep_of(concentrations-11, carbamazepine-13)
poss(metabolite-17, its-15)
nn(metabolite-17, epoxide-16)
conj_or(concentrations-11, metabolite-17)
prep_in(metabolite-17, patients-19)
prep_with(patients-19, epilepsy-21)

Valproate/NN :/: Tiagabine/NN causes/VBZ a/DT slight/JJ decrease/NN (/-LRB- about/RB 10/CD %/NN )/-RRB- in/IN steady-state/JJ valproate/NN concentrations/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Valproate)) (: :) (NP (NN Tiagabine))) (VP (VBZ causes) (NP (NP (DT a) (JJ slight) (NN decrease)) (PRN (-LRB- -LRB-) (NP (QP (RB about) (CD 10)) (NN %)) (-RRB- -RRB-))) (PP (IN in) (NP (JJ steady-state) (NN valproate) (NNS concentrations))))) (. .))))

nsubj(causes-4, Valproate-1)
dep(Valproate-1, Tiagabine-3)
root(ROOT-0, causes-4)
det(decrease-7, a-5)
amod(decrease-7, slight-6)
dobj(causes-4, decrease-7)
quantmod(10-10, about-9)
num(%-11, 10-10)
appos(decrease-7, %-11)
amod(concentrations-16, steady-state-14)
nn(concentrations-16, valproate-15)
prep_in(causes-4, concentrations-16)

Phenobarbital/NN or/CC Primidone/NN :/: No/DT formal/JJ pharmacokinetic/JJ studies/NNS have/VBP been/VBN performed/VBN examining/VBG the/DT addition/NN of/IN tiagabine/NN to/TO regimens/NNS containing/VBG phenobarbital/NN or/CC primidone/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN Phenobarbital)) (CC or) (NP (NN Primidone))) (: :) (S (NP (DT No) (JJ formal) (JJ pharmacokinetic) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN performed) (S (VP (VBG examining) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NN tiagabine))) (PP (TO to) (NP (NP (NNS regimens)) (VP (VBG containing) (NP (NP (NN phenobarbital)) (CC or) (NP (NN primidone))))))))))))) (. .)))))

root(ROOT-0, Phenobarbital-1)
conj_or(Phenobarbital-1, Primidone-3)
det(studies-8, No-5)
amod(studies-8, formal-6)
amod(studies-8, pharmacokinetic-7)
nsubjpass(performed-11, studies-8)
aux(performed-11, have-9)
auxpass(performed-11, been-10)
dep(Phenobarbital-1, performed-11)
xcomp(performed-11, examining-12)
det(addition-14, the-13)
dobj(examining-12, addition-14)
prep_of(addition-14, tiagabine-16)
prep_to(addition-14, regimens-18)
partmod(regimens-18, containing-19)
dobj(containing-19, phenobarbital-20)
conj_or(phenobarbital-20, primidone-22)

The/DT addition/NN of/IN tiagabine/NN in/IN a/DT limited/JJ number/NN of/IN patients/NNS in/IN three/CD well-controlled/JJ studies/NNS caused/VBD no/DT systematic/JJ changes/NNS in/IN phenobarbital/NN or/CC primidone/NN concentrations/NNS when/WRB compared/VBN to/TO placebo/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN addition)) (PP (IN of) (NP (NN tiagabine))) (PP (IN in) (NP (NP (DT a) (JJ limited) (NN number)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN in) (NP (CD three) (JJ well-controlled) (NNS studies)))))))) (VP (VBD caused) (NP (DT no) (JJ systematic) (NNS changes)) (PP (IN in) (NP (NP (NP (NN phenobarbital)) (CC or) (NP (NN primidone))) (NNS concentrations))) (SBAR (WHADVP (WRB when)) (S (VP (VBN compared) (PP (TO to) (NP (NN placebo)))))))) (. .))))

det(addition-2, The-1)
nsubj(caused-15, addition-2)
prep_of(addition-2, tiagabine-4)
det(number-8, a-6)
amod(number-8, limited-7)
prep_in(addition-2, number-8)
prep_of(number-8, patients-10)
num(studies-14, three-12)
amod(studies-14, well-controlled-13)
prep_in(patients-10, studies-14)
root(ROOT-0, caused-15)
det(changes-18, no-16)
amod(changes-18, systematic-17)
dobj(caused-15, changes-18)
nn(concentrations-23, phenobarbital-20)
conj_or(phenobarbital-20, primidone-22)
prep_in(caused-15, concentrations-23)
advmod(compared-25, when-24)
advcl(caused-15, compared-25)
prep_to(compared-25, placebo-27)

Effects/NNS of/IN other/JJ Antiepilepsy/NN Drugs/NNS (/-LRB- AEDs/NNS )/-RRB- on/IN GABITRIL/NN :/: Carbamazepine/NN :/: Population/NN pharmacokinetic/JJ analyses/NNS indicate/VBP that/IN tiagabine/NN clearance/NN is/VBZ 60/CD %/NN greater/JJR in/IN patients/NNS taking/VBG carbamazepine/NN with/IN or/CC without/IN other/JJ enzyme-/JJ inducing/NN AEDs/NNS ./.

(ROOT (S1 (S (NP (NP (NNS Effects)) (PP (IN of) (NP (NP (JJ other) (NN Antiepilepsy) (NNS Drugs)) (PRN (-LRB- -LRB-) (NP (NNS AEDs)) (-RRB- -RRB-)))) (PP (IN on) (NP (NN GABITRIL)))) (: :) (NP (NP (NN Carbamazepine)) (: :) (S (NP (NN Population) (JJ pharmacokinetic) (NNS analyses)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN tiagabine) (NN clearance)) (VP (VBZ is) (ADJP (NP (CD 60) (NN %)) (JJR greater) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN carbamazepine)) (PP (IN with) (CC or) (PP (IN without) (NP (JJ other) (JJ enzyme-) (NN inducing) (NNS AEDs))))))))))))) (. .)))))

dep(Carbamazepine-12, Effects-1)
amod(Drugs-5, other-3)
nn(Drugs-5, Antiepilepsy-4)
prep_of(Effects-1, Drugs-5)
appos(Drugs-5, AEDs-7)
prep_on(Effects-1, GABITRIL-10)
root(ROOT-0, Carbamazepine-12)
nn(analyses-16, Population-14)
amod(analyses-16, pharmacokinetic-15)
nsubj(indicate-17, analyses-16)
dep(Carbamazepine-12, indicate-17)
complm(greater-24, that-18)
nn(clearance-20, tiagabine-19)
nsubj(greater-24, clearance-20)
cop(greater-24, is-21)
num(%-23, 60-22)
npadvmod(greater-24, %-23)
ccomp(indicate-17, greater-24)
prep_in(greater-24, patients-26)
partmod(patients-26, taking-27)
dobj(taking-27, carbamazepine-28)
prep(taking-27, with-29)
conj_or(with-29, without-31)
amod(AEDs-35, other-32)
amod(AEDs-35, enzyme--33)
nn(AEDs-35, inducing-34)
pobj(without-31, AEDs-35)

Phenytoin/NN :/: Population/NN pharmacokinetic/JJ analyses/NNS indicate/VBP that/IN tiagabine/NN clearance/NN is/VBZ 60/CD %/NN greater/JJR in/IN patients/NNS taking/VBG phenytoin/NN with/IN or/CC without/IN other/JJ enzyme-/JJ inducing/VBG AEDs/NNS ./.

(ROOT (S1 (S (NP (NP (NN Phenytoin)) (: :) (S (NP (NN Population) (JJ pharmacokinetic) (NNS analyses)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN tiagabine) (NN clearance)) (VP (VBZ is) (ADJP (NP (CD 60) (NN %)) (JJR greater) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (NN phenytoin)) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (JJ other) (JJ enzyme-) (VBG inducing) (NNS AEDs)))))))))))))) (. .)))))

root(ROOT-0, Phenytoin-1)
nn(analyses-5, Population-3)
amod(analyses-5, pharmacokinetic-4)
nsubj(indicate-6, analyses-5)
dep(Phenytoin-1, indicate-6)
complm(greater-13, that-7)
nn(clearance-9, tiagabine-8)
nsubj(greater-13, clearance-9)
cop(greater-13, is-10)
num(%-12, 60-11)
npadvmod(greater-13, %-12)
ccomp(indicate-6, greater-13)
prep_in(greater-13, patients-15)
partmod(patients-15, taking-16)
dobj(taking-16, phenytoin-17)
prep(phenytoin-17, with-18)
conj_or(with-18, without-20)
amod(AEDs-24, other-21)
amod(AEDs-24, enzyme--22)
amod(AEDs-24, inducing-23)
pobj(without-20, AEDs-24)

Phenobarbital/NN (/-LRB- Primidone/NN )/-RRB- :/: Population/NN pharmacokinetic/JJ analyses/NNS indicate/VBP that/IN tiagabine/NN clearance/NN is/VBZ 60/CD %/NN greater/JJR in/IN patients/NNS taking/VBG phenobarbital/NN (/-LRB- primidone/NN )/-RRB- with/IN or/CC without/IN other/JJ enzyme-inducing/JJ AEDs/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NN Phenobarbital)) (PRN (-LRB- -LRB-) (NP (NN Primidone)) (-RRB- -RRB-))) (: :) (S (NP (NN Population) (JJ pharmacokinetic) (NNS analyses)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN tiagabine) (NN clearance)) (VP (VBZ is) (ADJP (NP (CD 60) (NN %)) (JJR greater) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (NN phenobarbital)) (PRN (-LRB- -LRB-) (NP (NN primidone)) (-RRB- -RRB-))) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (JJ other) (JJ enzyme-inducing) (NNS AEDs))))))))))))) (. .)))))

root(ROOT-0, Phenobarbital-1)
appos(Phenobarbital-1, Primidone-3)
nn(analyses-8, Population-6)
amod(analyses-8, pharmacokinetic-7)
nsubj(indicate-9, analyses-8)
dep(Phenobarbital-1, indicate-9)
complm(greater-16, that-10)
nn(clearance-12, tiagabine-11)
nsubj(greater-16, clearance-12)
cop(greater-16, is-13)
num(%-15, 60-14)
npadvmod(greater-16, %-15)
ccomp(indicate-9, greater-16)
prep_in(greater-16, patients-18)
partmod(patients-18, taking-19)
dobj(taking-19, phenobarbital-20)
appos(phenobarbital-20, primidone-22)
prep(taking-19, with-24)
conj_or(with-24, without-26)
amod(AEDs-29, other-27)
amod(AEDs-29, enzyme-inducing-28)
pobj(without-26, AEDs-29)

Valproate/NN :/: The/DT addition/NN of/IN tiagabine/NN to/TO patients/NNS taking/VBG valproate/NN chronically/RB had/VBD no/DT effect/NN on/IN tiagabine/NN pharmacokinetics/NNS ,/, but/CC valproate/NN significantly/RB decreased/VBD tiagabine/NN binding/NN in/FW vitro/FW from/IN 96.3/CD to/TO 94.8/CD %/NN ,/, which/WDT resulted/VBD in/IN an/DT increase/NN of/IN approximately/RB 40/CD %/NN in/IN the/DT free/JJ tiagabine/NN concentration/NN ./.

(ROOT (S1 (S (NP (NP (NN Valproate)) (: :) (S (S (NP (NP (DT The) (NN addition)) (PP (IN of) (NP (NN tiagabine))) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN valproate)))))) (ADVP (RB chronically)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NN tiagabine) (NNS pharmacokinetics))))) (, ,) (CC but) (S (NP (NN valproate)) (ADVP (RB significantly)) (VP (VBD decreased) (NP (NN tiagabine) (NN binding)) (ADVP (FW in) (FW vitro)) (PP (IN from) (NP (NP (QP (CD 96.3) (TO to) (CD 94.8)) (NN %)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD resulted) (PP (IN in) (NP (NP (DT an) (NN increase)) (PP (IN of) (NP (QP (RB approximately) (CD 40)) (NN %))) (PP (IN in) (NP (DT the) (JJ free) (NN tiagabine) (NN concentration))))))))))))) (. .)))))

root(ROOT-0, Valproate-1)
det(addition-4, The-3)
nsubj(had-12, addition-4)
prep_of(addition-4, tiagabine-6)
prep_to(addition-4, patients-8)
partmod(patients-8, taking-9)
dobj(taking-9, valproate-10)
advmod(had-12, chronically-11)
dep(Valproate-1, had-12)
det(effect-14, no-13)
dobj(had-12, effect-14)
nn(pharmacokinetics-17, tiagabine-16)
prep_on(had-12, pharmacokinetics-17)
nsubj(decreased-22, valproate-20)
advmod(decreased-22, significantly-21)
conj_but(had-12, decreased-22)
nn(binding-24, tiagabine-23)
dobj(decreased-22, binding-24)
nn(vitro-26, in-25)
advmod(decreased-22, vitro-26)
number(94.8-30, 96.3-28)
dep(94.8-30, to-29)
num(%-31, 94.8-30)
prep_from(decreased-22, %-31)
nsubj(resulted-34, %-31)
rcmod(%-31, resulted-34)
det(increase-37, an-36)
prep_in(resulted-34, increase-37)
quantmod(40-40, approximately-39)
num(%-41, 40-40)
prep_of(increase-37, %-41)
det(concentration-46, the-43)
amod(concentration-46, free-44)
nn(concentration-46, tiagabine-45)
prep_in(increase-37, concentration-46)

Interaction/NN of/IN GABITRIL/NN with/IN Other/JJ Drugs/NNS :/: Cimetidine/NN :/: Co-administration/NN of/IN cimetidine/NN (/-LRB- 800/CD mg/day/NN )/-RRB- to/TO patients/NNS taking/VBG tiagabine/NN chronically/RB had/VBD no/DT effect/NN on/IN tiagabine/NN pharmacokinetics/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NN Interaction)) (PP (IN of) (NP (NN GABITRIL))) (PP (IN with) (NP (JJ Other) (NNS Drugs)))) (: :) (NP (NN Cimetidine)) (: :) (S (NP (NP (NN Co-administration)) (PP (IN of) (NP (NP (NN cimetidine)) (PRN (-LRB- -LRB-) (NP (CD 800) (NN mg/day)) (-RRB- -RRB-)))) (PP (TO to) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN tiagabine)))))) (ADVP (RB chronically)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NN tiagabine) (NNS pharmacokinetics))))) (. .)))))

root(ROOT-0, Interaction-1)
prep_of(Interaction-1, GABITRIL-3)
amod(Drugs-6, Other-5)
prep_with(Interaction-1, Drugs-6)
dep(Interaction-1, Cimetidine-8)
nsubj(had-22, Co-administration-10)
prep_of(Co-administration-10, cimetidine-12)
num(mg/day-15, 800-14)
appos(cimetidine-12, mg/day-15)
prep_to(Co-administration-10, patients-18)
partmod(patients-18, taking-19)
dobj(taking-19, tiagabine-20)
advmod(had-22, chronically-21)
dep(Interaction-1, had-22)
det(effect-24, no-23)
dobj(had-22, effect-24)
nn(pharmacokinetics-27, tiagabine-26)
prep_on(had-22, pharmacokinetics-27)

Theophylline/NN :/: A/DT single/JJ 10/CD mg/NN dose/NN of/IN tiagabine/NN did/VBD not/RB affect/VB the/DT pharmacokinetics/NNS of/IN theophylline/NN at/IN steady/JJ state/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Theophylline)) (: :) (NP (NP (DT A) (JJ single) (ADJP (CD 10) (NN mg)) (NN dose)) (PP (IN of) (NP (NN tiagabine))))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN theophylline))) (PP (IN at) (NP (JJ steady) (NN state))))))) (. .))))

nsubj(affect-12, Theophylline-1)
det(dose-7, A-3)
amod(dose-7, single-4)
number(mg-6, 10-5)
amod(dose-7, mg-6)
dep(Theophylline-1, dose-7)
prep_of(dose-7, tiagabine-9)
aux(affect-12, did-10)
neg(affect-12, not-11)
root(ROOT-0, affect-12)
det(pharmacokinetics-14, the-13)
dobj(affect-12, pharmacokinetics-14)
prep_of(pharmacokinetics-14, theophylline-16)
amod(state-19, steady-18)
prep_at(pharmacokinetics-14, state-19)

Warfarin/NN :/: No/DT significant/JJ differences/NNS were/VBD observed/VBN in/IN the/DT steady-state/JJ pharmacokinetics/NNS of/IN R-/NN warfarin/NN or/CC S-/NN warfarin/NN with/IN the/DT addition/NN of/IN tiagabine/NN given/VBN as/IN a/DT single/JJ dose/NN ./.

(ROOT (S1 (S (NP (NP (NN Warfarin)) (: :) (S (NP (DT No) (JJ significant) (NNS differences)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (JJ steady-state) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NN R-) (NN warfarin)) (CC or) (NP (NN S-) (NN warfarin)))) (PP (IN with) (NP (NP (DT the) (NN addition)) (PP (IN of) (NP (NP (NN tiagabine)) (VP (VBN given) (PP (IN as) (NP (DT a) (JJ single) (NN dose))))))))))))) (. .)))))

root(ROOT-0, Warfarin-1)
det(differences-5, No-3)
amod(differences-5, significant-4)
nsubjpass(observed-7, differences-5)
auxpass(observed-7, were-6)
dep(Warfarin-1, observed-7)
det(pharmacokinetics-11, the-9)
amod(pharmacokinetics-11, steady-state-10)
prep_in(observed-7, pharmacokinetics-11)
nn(warfarin-14, R--13)
prep_of(pharmacokinetics-11, warfarin-14)
nn(warfarin-17, S--16)
conj_or(warfarin-14, warfarin-17)
det(addition-20, the-19)
prep_with(pharmacokinetics-11, addition-20)
prep_of(addition-20, tiagabine-22)
partmod(tiagabine-22, given-23)
det(dose-27, a-25)
amod(dose-27, single-26)
prep_as(given-23, dose-27)

Prothrombin/NN times/NNS were/VBD not/RB affected/VBN by/IN tiagabine/NN ./.

(ROOT (S1 (S (S (NP (NN Prothrombin) (NNS times)) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN by) (NP (NN tiagabine)))))) (. .))))

nn(times-2, Prothrombin-1)
nsubjpass(affected-5, times-2)
auxpass(affected-5, were-3)
neg(affected-5, not-4)
root(ROOT-0, affected-5)
agent(affected-5, tiagabine-7)

Digoxin/NN :/: Concomitant/JJ administration/NN of/IN tiagabine/NN did/VBD not/RB affect/VB the/DT steady-state/JJ pharmacokinetics/NNS of/IN digoxin/NN or/CC the/DT mean/JJ daily/JJ trough/NN serum/NN level/NN of/IN digoxin/NN ./.

(ROOT (S1 (S (NP (NP (NN Digoxin)) (: :) (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NN tiagabine)))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (NP (DT the) (JJ steady-state) (NNS pharmacokinetics)) (PP (IN of) (NP (NN digoxin)))) (CC or) (NP (NP (DT the) (JJ mean) (JJ daily) (NN trough) (NN serum) (NN level)) (PP (IN of) (NP (NN digoxin)))))))) (. .)))))

root(ROOT-0, Digoxin-1)
amod(administration-4, Concomitant-3)
nsubj(affect-9, administration-4)
prep_of(administration-4, tiagabine-6)
aux(affect-9, did-7)
neg(affect-9, not-8)
dep(Digoxin-1, affect-9)
det(pharmacokinetics-12, the-10)
amod(pharmacokinetics-12, steady-state-11)
dobj(affect-9, pharmacokinetics-12)
prep_of(pharmacokinetics-12, digoxin-14)
det(level-21, the-16)
amod(level-21, mean-17)
amod(level-21, daily-18)
nn(level-21, trough-19)
nn(level-21, serum-20)
conj_or(pharmacokinetics-12, level-21)
prep_of(level-21, digoxin-23)

Ethanol/NN or/CC Triazolam/NN :/: No/DT significant/JJ differences/NNS were/VBD observed/VBN in/IN the/DT pharmacokinetics/NNS of/IN triazolam/NN (/-LRB- 0.125/CD mg/NN )/-RRB- and/CC tiagabine/NN (/-LRB- 10/CD mg/NN )/-RRB- when/WRB given/VBN together/RB as/IN a/DT single/JJ dose/NN ./.

(ROOT (S1 (S (NP (NP (NP (NN Ethanol)) (CC or) (NP (NN Triazolam))) (: :) (S (NP (DT No) (JJ significant) (NNS differences)) (VP (VBD were) (VP (VBN observed) (PP (IN in) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NP (NN triazolam)) (PRN (-LRB- -LRB-) (NP (CD 0.125) (NN mg)) (-RRB- -RRB-))) (CC and) (NP (NP (NN tiagabine)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN mg)) (-RRB- -RRB-))))))) (SBAR (WHADVP (WRB when)) (S (VP (VBN given) (ADVP (RB together)) (PP (IN as) (NP (DT a) (JJ single) (NN dose))))))))) (. .)))))

root(ROOT-0, Ethanol-1)
conj_or(Ethanol-1, Triazolam-3)
det(differences-7, No-5)
amod(differences-7, significant-6)
nsubjpass(observed-9, differences-7)
auxpass(observed-9, were-8)
dep(Ethanol-1, observed-9)
det(pharmacokinetics-12, the-11)
prep_in(observed-9, pharmacokinetics-12)
prep_of(pharmacokinetics-12, triazolam-14)
num(mg-17, 0.125-16)
appos(triazolam-14, mg-17)
conj_and(triazolam-14, tiagabine-20)
num(mg-23, 10-22)
appos(tiagabine-20, mg-23)
advmod(given-26, when-25)
advcl(observed-9, given-26)
advmod(given-26, together-27)
det(dose-31, a-29)
amod(dose-31, single-30)
prep_as(given-26, dose-31)

The/DT pharmacokinetics/NNS of/IN ethanol/NN were/VBD not/RB affected/VBN by/IN multiple-dose/JJ administration/NN of/IN tiagabine/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS pharmacokinetics)) (PP (IN of) (NP (NN ethanol)))) (VP (VBD were) (RB not) (VP (VBN affected) (PP (IN by) (NP (NP (JJ multiple-dose) (NN administration)) (PP (IN of) (NP (NN tiagabine)))))))) (. .))))

det(pharmacokinetics-2, The-1)
nsubjpass(affected-7, pharmacokinetics-2)
prep_of(pharmacokinetics-2, ethanol-4)
auxpass(affected-7, were-5)
neg(affected-7, not-6)
root(ROOT-0, affected-7)
amod(administration-10, multiple-dose-9)
agent(affected-7, administration-10)
prep_of(administration-10, tiagabine-12)

Tiagabine/NN has/VBZ shown/VBN no/DT clinically/RB important/JJ potentiation/NN of/IN the/DT pharmacodynamic/JJ effects/NNS of/IN triazo/NN lam/NN or/CC alcohol/NN ./.

(ROOT (S1 (S (S (NP (NN Tiagabine)) (VP (VBZ has) (VP (VBN shown) (NP (NP (DT no) (ADJP (RB clinically) (JJ important)) (NN potentiation)) (PP (IN of) (NP (NP (DT the) (JJ pharmacodynamic) (NNS effects)) (PP (IN of) (NP (NP (NN triazo)) (NP (NN lam)) (CC or) (NP (NN alcohol)))))))))) (. .))))

nsubj(shown-3, Tiagabine-1)
aux(shown-3, has-2)
root(ROOT-0, shown-3)
det(potentiation-7, no-4)
advmod(important-6, clinically-5)
amod(potentiation-7, important-6)
dobj(shown-3, potentiation-7)
det(effects-11, the-9)
amod(effects-11, pharmacodynamic-10)
prep_of(potentiation-7, effects-11)
prep_of(effects-11, triazo-13)
dep(triazo-13, lam-14)
conj_or(triazo-13, alcohol-16)

Because/IN of/IN the/DT possible/JJ additive/JJ effects/NNS of/IN drugs/NNS that/WDT may/MD depress/VB the/DT nervous/JJ system/NN ,/, ethanol/NN or/CC triazolam/NN should/MD be/VB used/VBN cautiously/RB in/IN combination/NN with/IN tiagabine/NN ./.

(ROOT (S1 (S (S (PP (IN Because) (PP (IN of) (NP (NP (DT the) (JJ possible) (JJ additive) (NNS effects)) (PP (IN of) (NP (NP (NNS drugs)) (SBAR (WHNP (WDT that)) (S (VP (MD may) (VP (VB depress) (NP (DT the) (JJ nervous) (NN system))))))))))) (, ,) (NP (NP (NN ethanol)) (CC or) (NP (NN triazolam))) (VP (MD should) (VP (VB be) (VP (VBN used) (ADVP (RB cautiously)) (PP (IN in) (NP (NP (NN combination)) (PP (IN with) (NP (NN tiagabine))))))))) (. .))))

prepc_because_of(used-21, of-2)
det(effects-6, the-3)
amod(effects-6, possible-4)
amod(effects-6, additive-5)
pobj(used-21, effects-6)
prep_of(effects-6, drugs-8)
nsubj(depress-11, drugs-8)
aux(depress-11, may-10)
rcmod(drugs-8, depress-11)
det(system-14, the-12)
amod(system-14, nervous-13)
dobj(depress-11, system-14)
nsubjpass(used-21, ethanol-16)
conj_or(ethanol-16, triazolam-18)
aux(used-21, should-19)
auxpass(used-21, be-20)
root(ROOT-0, used-21)
advmod(used-21, cautiously-22)
prep_in(used-21, combination-24)
prep_with(combination-24, tiagabine-26)

Oral/JJ Contraceptives/NNS :/: Multiple/JJ dose/NN administration/NN of/IN tiagabine/NN (/-LRB- 8/CD mg/day/NN monotherapy/NN )/-RRB- did/VBD not/RB alter/VB the/DT pharmacokinetics/NNS of/IN oral/JJ contraceptives/NNS in/IN healthy/JJ women/NNS of/IN childbearing/JJ age/NN ./.

(ROOT (S1 (S (NP (NP (JJ Oral) (NNS Contraceptives)) (: :) (S (NP (NP (JJ Multiple) (NN dose) (NN administration)) (PP (IN of) (NP (NP (NN tiagabine)) (PRN (-LRB- -LRB-) (NP (CD 8) (NN mg/day) (NN monotherapy)) (-RRB- -RRB-))))) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (JJ oral) (NNS contraceptives))) (PP (IN in) (NP (NP (JJ healthy) (NNS women)) (PP (IN of) (NP (JJ childbearing) (NN age))))))))) (. .)))))

amod(Contraceptives-2, Oral-1)
root(ROOT-0, Contraceptives-2)
amod(administration-6, Multiple-4)
nn(administration-6, dose-5)
nsubj(alter-16, administration-6)
prep_of(administration-6, tiagabine-8)
num(monotherapy-12, 8-10)
nn(monotherapy-12, mg/day-11)
appos(tiagabine-8, monotherapy-12)
aux(alter-16, did-14)
neg(alter-16, not-15)
dep(Contraceptives-2, alter-16)
det(pharmacokinetics-18, the-17)
dobj(alter-16, pharmacokinetics-18)
amod(contraceptives-21, oral-20)
prep_of(pharmacokinetics-18, contraceptives-21)
amod(women-24, healthy-23)
prep_in(pharmacokinetics-18, women-24)
amod(age-27, childbearing-26)
prep_of(women-24, age-27)

Antipyrine/NN :/: Antipyrine/NN pharmacokinetics/NNS were/VBD not/RB significantly/RB different/JJ before/IN and/CC after/IN tiagabine/NN multiple-dose/NN regimens/NNS ./.

(ROOT (S1 (S (S (NP (NN Antipyrine) (: :) (NN Antipyrine) (NNS pharmacokinetics)) (VP (VBD were) (RB not) (ADJP (RB significantly) (JJ different)) (PP (PP (IN before)) (CC and) (PP (IN after) (NP (NN tiagabine) (NN multiple-dose) (NNS regimens)))))) (. .))))

nn(pharmacokinetics-4, Antipyrine-1)
nn(pharmacokinetics-4, Antipyrine-3)
nsubj(different-8, pharmacokinetics-4)
cop(different-8, were-5)
neg(different-8, not-6)
advmod(different-8, significantly-7)
root(ROOT-0, different-8)
prep(different-8, before-9)
conj_and(before-9, after-11)
nn(regimens-14, tiagabine-12)
nn(regimens-14, multiple-dose-13)
pobj(after-11, regimens-14)

This/DT indicates/VBZ that/IN tiagabine/NN does/VBZ not/RB cause/VB induction/NN or/CC inhibition/NN of/IN the/DT hepatic/JJ microsomal/JJ enzyme/NN systems/NNS responsible/JJ for/IN the/DT metabolism/NN of/IN antipyrine/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (VBZ indicates) (SBAR (IN that) (S (NP (NN tiagabine)) (VP (VBZ does) (RB not) (VP (VB cause) (NP (NP (NP (NN induction)) (CC or) (NP (NN inhibition))) (PP (IN of) (NP (NP (DT the) (JJ hepatic) (JJ microsomal) (NN enzyme) (NNS systems)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NN antipyrine))))))))))))))) (. .))))

nsubj(indicates-2, This-1)
root(ROOT-0, indicates-2)
complm(cause-7, that-3)
nsubj(cause-7, tiagabine-4)
aux(cause-7, does-5)
neg(cause-7, not-6)
ccomp(indicates-2, cause-7)
dobj(cause-7, induction-8)
conj_or(induction-8, inhibition-10)
det(systems-16, the-12)
amod(systems-16, hepatic-13)
amod(systems-16, microsomal-14)
nn(systems-16, enzyme-15)
prep_of(induction-8, systems-16)
amod(systems-16, responsible-17)
det(metabolism-20, the-19)
prep_for(responsible-17, metabolism-20)
prep_of(metabolism-20, antipyrine-22)

Interaction/NN of/IN GABITRIL/NN with/IN Highly/RB Protein/NN Bound/JJ Drugs/NNS :/: In/FW vitro/FW data/NNS showed/VBD that/IN tiagabine/NN is/VBZ 96/CD %/NN bound/VBD to/TO human/JJ plasma/NN protein/NN and/CC therefore/RB has/VBZ the/DT potential/NN to/TO interact/VB with/IN other/JJ highly/RB protein/NN bound/JJ compounds/NNS ./.

(ROOT (S1 (S (NP (NP (NN Interaction)) (PP (IN of) (NP (NN GABITRIL))) (PP (IN with) (NP (NP (ADJP (RB Highly) (NN Protein) (JJ Bound)) (NNS Drugs)) (: :) (NP (ADJP (FW In) (FW vitro)) (NNS data))))) (VP (VBD showed) (SBAR (IN that) (S (NP (NN tiagabine)) (VP (VP (VBZ is) (NP (NP (CD 96) (NN %)) (VP (VBD bound) (PP (TO to) (NP (JJ human) (NN plasma) (NN protein)))))) (CC and) (ADVP (RB therefore)) (VP (VBZ has) (NP (DT the) (NN potential) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (JJ other) (ADJP (RB highly) (NN protein) (JJ bound)) (NNS compounds)))))))))))) (. .))))

nsubj(showed-13, Interaction-1)
prep_of(Interaction-1, GABITRIL-3)
advmod(Bound-7, Highly-5)
dep(Bound-7, Protein-6)
amod(Drugs-8, Bound-7)
prep_with(Interaction-1, Drugs-8)
nn(vitro-11, In-10)
amod(data-12, vitro-11)
dep(Drugs-8, data-12)
root(ROOT-0, showed-13)
complm(%-18, that-14)
nsubj(%-18, tiagabine-15)
cop(%-18, is-16)
num(%-18, 96-17)
ccomp(showed-13, %-18)
partmod(%-18, bound-19)
amod(protein-23, human-21)
nn(protein-23, plasma-22)
prep_to(bound-19, protein-23)
advmod(%-18, therefore-25)
conj_and(%-18, therefore-25)
conj_and(%-18, has-26)
det(potential-28, the-27)
dobj(has-26, potential-28)
aux(interact-30, to-29)
infmod(potential-28, interact-30)
amod(compounds-36, other-32)
advmod(bound-35, highly-33)
dep(bound-35, protein-34)
amod(compounds-36, bound-35)
prep_with(interact-30, compounds-36)

Such/PDT an/DT interaction/NN can/MD potentially/RB lead/VB to/TO higher/JJR free/JJ fractions/NNS of/IN either/CC tiagabine/NN or/CC the/DT competing/VBG drug/NN ./.

(ROOT (S1 (S (S (NP (PDT Such) (DT an) (NN interaction)) (VP (MD can) (ADVP (RB potentially)) (VP (VB lead) (PP (TO to) (NP (NP (JJR higher) (JJ free) (NNS fractions)) (PP (IN of) (NP (CC either) (NP (NN tiagabine)) (CC or) (NP (DT the) (VBG competing) (NN drug))))))))) (. .))))

predet(interaction-3, Such-1)
det(interaction-3, an-2)
nsubj(lead-6, interaction-3)
aux(lead-6, can-4)
advmod(lead-6, potentially-5)
root(ROOT-0, lead-6)
amod(fractions-10, higher-8)
amod(fractions-10, free-9)
prep_to(lead-6, fractions-10)
preconj(tiagabine-13, either-12)
prep_of(fractions-10, tiagabine-13)
det(drug-17, the-15)
amod(drug-17, competing-16)
conj_or(tiagabine-13, drug-17)

The/DT drug/NN interaction/NN studies/NNS with/IN valdecoxib/NN were/VBD performed/VBN both/CC with/IN valdecoxib/NN and/CC a/DT rapidly/RB hydrolyzed/JJ intravenous/JJ prodrug/NN form/VBP ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN drug) (NN interaction) (NNS studies)) (PP (IN with) (NP (NN valdecoxib)))) (VP (VBD were) (VP (VP (VBN performed)) (CC both) (SBAR (IN with) (S (NP (NP (NN valdecoxib)) (CC and) (NP (DT a) (ADJP (RB rapidly) (JJ hydrolyzed)) (JJ intravenous) (NN prodrug))) (VP (VBP form))))))) (. .))))

det(studies-4, The-1)
nn(studies-4, drug-2)
nn(studies-4, interaction-3)
nsubjpass(performed-8, studies-4)
prep_with(studies-4, valdecoxib-6)
auxpass(performed-8, were-7)
root(ROOT-0, performed-8)
dep(performed-8, both-9)
mark(form-18, with-10)
nsubj(form-18, valdecoxib-11)
det(prodrug-17, a-13)
advmod(hydrolyzed-15, rapidly-14)
amod(prodrug-17, hydrolyzed-15)
amod(prodrug-17, intravenous-16)
conj_and(valdecoxib-11, prodrug-17)
advcl(performed-8, form-18)
conj(performed-8, form-18)

The/DT results/NNS from/IN trials/NNS using/VBG the/DT intravenous/JJ prodrug/NN are/VBP reported/VBN in/IN this/DT section/NN as/IN they/PRP relate/VB to/TO the/DT role/NN of/IN valdecoxib/NN in/IN drug/NN interactions/NNS ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NNS results)) (PP (IN from) (NP (NP (NNS trials)) (VP (VBG using) (NP (DT the) (JJ intravenous) (NN prodrug)))))) (VP (VBP are) (VP (VBN reported) (PP (IN in) (NP (DT this) (NN section))) (SBAR (IN as) (S (NP (PRP they)) (VP (VB relate) (PP (TO to) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN valdecoxib))) (PP (IN in) (NP (NN drug) (NNS interactions))))))))))) (. .))))

det(results-2, The-1)
nsubjpass(reported-10, results-2)
prep_from(results-2, trials-4)
partmod(trials-4, using-5)
det(prodrug-8, the-6)
amod(prodrug-8, intravenous-7)
dobj(using-5, prodrug-8)
auxpass(reported-10, are-9)
root(ROOT-0, reported-10)
det(section-13, this-12)
prep_in(reported-10, section-13)
mark(relate-16, as-14)
nsubj(relate-16, they-15)
advcl(reported-10, relate-16)
det(role-19, the-18)
prep_to(relate-16, role-19)
prep_of(role-19, valdecoxib-21)
nn(interactions-24, drug-23)
prep_in(role-19, interactions-24)

General/JJ :/: In/IN humans/NNS ,/, valdecoxib/NN metabolism/NN is/VBZ predominantly/RB mediated/VBN via/IN CYP/VBG 3A4/NN and/CC 2C9/NN with/IN glucuronidation/NN being/VBG a/DT further/JJ (/-LRB- 20/CD %/NN )/-RRB- route/NN of/IN metabolism/NN ./.

(ROOT (S1 (S (S (NP (JJ General)) (: :) (PP (IN In) (NP (NNS humans))) (, ,) (NP (NN valdecoxib) (NN metabolism)) (VP (VBZ is) (ADVP (RB predominantly)) (VP (VBN mediated) (PP (IN via) (S (VP (VBG CYP) (NP (NP (NN 3A4)) (CC and) (NP (NN 2C9))) (PP (IN with) (S (NP (NN glucuronidation)) (VP (VBG being) (NP (NP (DT a) (ADJP (ADJP (JJ further)) (PRN (-LRB- -LRB-) (NP (CD 20) (NN %)) (-RRB- -RRB-))) (NN route)) (PP (IN of) (NP (NN metabolism))))))))))))) (. .))))

nsubjpass(mediated-10, General-1)
prep_in(mediated-10, humans-4)
nn(metabolism-7, valdecoxib-6)
nsubjpass(mediated-10, metabolism-7)
auxpass(mediated-10, is-8)
advmod(mediated-10, predominantly-9)
root(ROOT-0, mediated-10)
prepc_via(mediated-10, CYP-12)
dobj(CYP-12, 3A4-13)
conj_and(3A4-13, 2C9-15)
nsubj(route-25, glucuronidation-17)
cop(route-25, being-18)
det(route-25, a-19)
amod(route-25, further-20)
num(%-23, 20-22)
dep(further-20, %-23)
prepc_with(CYP-12, route-25)
prep_of(route-25, metabolism-27)

In/FW vitro/FW studies/NNS indicate/VBP that/IN valdecoxib/NN is/VBZ a/DT moderate/JJ inhibitor/NN of/IN CYP/NN 2C19/NN (/-LRB- IC50/NN =/JJ 6/CD @/NN g/mL/NN or/CC 19/CD @/NN M/NN )/-RRB- and/CC 2C9/NN (/-LRB- IC50/NN =/JJ 13/CD @/NN g/mL/NN or/CC 41/CD @/NN M/NN )/-RRB- ,/, and/CC a/DT weak/JJ inhibitor/NN of/IN CYP/NN 2D6/NN (/-LRB- IC50/NN =/JJ 31/CD @/NN g/mL/NN or/CC 100/CD @/NN M/NN )/-RRB- and/CC 3A4/NN (/-LRB- IC50/NN =/JJ 44/CD @/NN g/mL/NN or/CC 141/CD @/NN M/NN )/-RRB- ../NN

(ROOT (S1 (S (NP (ADJP (FW In) (FW vitro)) (NNS studies)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN valdecoxib)) (VP (VBZ is) (NP (NP (NP (NP (DT a) (JJ moderate) (NN inhibitor)) (PP (IN of) (NP (NP (NP (NN CYP) (NN 2C19)) (PRN (-LRB- -LRB-) (S (NP (NN IC50)) (VP (JJ =) (NP (NP (NP (CD 6)) (NP (NN @) (NN g/mL))) (CC or) (NP (CD 19)) (NP (NN @) (NN M))))) (-RRB- -RRB-))) (CC and) (NP (NN 2C9))))) (PRN (-LRB- -LRB-) (NP (NP (NN IC50)) (ADJP (JJ =) (NP (CD 13) (NN @) (NN g/mL) (CC or) (CD 41) (NN @) (NN M)))) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NP (NP (NP (DT a) (JJ weak) (NN inhibitor)) (PP (IN of) (NP (NN CYP) (NN 2D6)))) (PRN (-LRB- -LRB-) (NP (NP (NN IC50)) (ADJP (JJ =) (NP (NP (ADJP (CD 31) (NN @)) (NN g/mL)) (CC or) (NP (ADJP (CD 100) (NN @)) (NN M))))) (-RRB- -RRB-))) (CC and) (NP (NN 3A4))) (PRN (-LRB- -LRB-) (NP (NP (NN IC50)) (ADJP (JJ =) (NP (CD 44) (NN @) (NN g/mL) (CC or) (CD 141) (NN @) (NN M)))) (-RRB- -RRB-))) (NP (NN ..))))))))))

nn(vitro-2, In-1)
amod(studies-3, vitro-2)
nsubj(indicate-4, studies-3)
root(ROOT-0, indicate-4)
complm(inhibitor-10, that-5)
nsubj(inhibitor-10, valdecoxib-6)
cop(inhibitor-10, is-7)
det(inhibitor-10, a-8)
amod(inhibitor-10, moderate-9)
ccomp(indicate-4, inhibitor-10)
nn(2C19-13, CYP-12)
prep_of(inhibitor-10, 2C19-13)
nsubj(=-16, IC50-15)
dep(2C19-13, =-16)
dobj(=-16, 6-17)
nn(g/mL-19, @-18)
dep(6-17, g/mL-19)
conj_or(6-17, 19-21)
nn(M-23, @-22)
dobj(=-16, M-23)
dep(6-17, M-23)
conj_and(2C19-13, 2C9-26)
dep(inhibitor-10, IC50-28)
amod(IC50-28, =-29)
num(g/mL-32, 13-30)
nn(g/mL-32, @-31)
dep(=-29, g/mL-32)
num(M-36, 41-34)
nn(M-36, @-35)
conj_or(g/mL-32, M-36)
det(inhibitor-42, a-40)
amod(inhibitor-42, weak-41)
conj_and(inhibitor-10, inhibitor-42)
nn(2D6-45, CYP-44)
prep_of(inhibitor-42, 2D6-45)
dep(inhibitor-42, IC50-47)
amod(IC50-47, =-48)
number(@-50, 31-49)
amod(g/mL-51, @-50)
dep(=-48, g/mL-51)
number(@-54, 100-53)
amod(M-55, @-54)
conj_or(g/mL-51, M-55)
conj_and(inhibitor-42, 3A4-58)
dep(inhibitor-42, IC50-60)
amod(IC50-60, =-61)
num(g/mL-64, 44-62)
nn(g/mL-64, @-63)
dep(=-61, g/mL-64)
num(M-68, 141-66)
nn(M-68, @-67)
conj_or(g/mL-64, M-68)
dep(inhibitor-10, ..-70)

Aspirin/NN :/: Concomitant/JJ administration/NN of/IN aspirin/NN with/IN valdecoxib/NN may/MD result/VB in/IN an/DT increased/VBN risk/NN of/IN GI/NN ulceration/NN and/CC complications/NNS compared/VBN to/TO valdecoxib/NN alone/RB ./.

(ROOT (S1 (S (NP (NP (NN Aspirin)) (: :) (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NN aspirin))) (PP (IN with) (NP (NN valdecoxib)))) (VP (MD may) (VP (VB result) (PP (IN in) (NP (NP (DT an) (VBN increased) (NN risk)) (PP (IN of) (NP (NP (NN GI) (NN ulceration)) (CC and) (NP (NNS complications)))))) (PP (VBN compared) (PP (TO to) (NP (NP (NN valdecoxib)) (ADVP (RB alone)))))))) (. .)))))

root(ROOT-0, Aspirin-1)
amod(administration-4, Concomitant-3)
nsubj(result-10, administration-4)
prep_of(administration-4, aspirin-6)
prep_with(administration-4, valdecoxib-8)
aux(result-10, may-9)
dep(Aspirin-1, result-10)
det(risk-14, an-12)
amod(risk-14, increased-13)
prep_in(result-10, risk-14)
nn(ulceration-17, GI-16)
prep_of(risk-14, ulceration-17)
conj_and(ulceration-17, complications-19)
prepc_compared_to(result-10, to-21)
pobj(result-10, valdecoxib-22)
advmod(valdecoxib-22, alone-23)

Because/IN of/IN its/PRP$ lack/NN of/IN anti-platelet/JJ effect/NN valdecoxib/NN is/VBZ not/RB a/DT substitute/VB for/IN aspirin/NN for/IN cardiovascular/JJ prophylaxis/NNS ./.

(ROOT (S1 (S (S (PP (IN Because) (IN of) (NP (NP (PRP$ its) (NN lack)) (PP (IN of) (NP (JJ anti-platelet) (NN effect) (NN valdecoxib))))) (VP (VBZ is) (RB not) (VP (DT a) (VP (VB substitute) (PP (IN for) (NP (NN aspirin))) (PP (IN for) (NP (JJ cardiovascular) (NNS prophylaxis))))))) (. .))))

poss(lack-4, its-3)
prep_because_of(substitute-12, lack-4)
amod(valdecoxib-8, anti-platelet-6)
nn(valdecoxib-8, effect-7)
prep_of(lack-4, valdecoxib-8)
aux(substitute-12, is-9)
neg(substitute-12, not-10)
dep(substitute-12, a-11)
root(ROOT-0, substitute-12)
prep_for(substitute-12, aspirin-14)
amod(prophylaxis-17, cardiovascular-16)
prep_for(substitute-12, prophylaxis-17)

In/IN a/DT parallel/JJ group/NN drug/NN interaction/NN study/NN comparing/VBG the/DT intravenous/JJ prodrug/NN form/NN of/IN valdecoxib/NN at/IN 40/CD mg/NN BID/JJ (/-LRB- n=10/NN )/-RRB- vs/CC placebo/NN (/-LRB- n=9/NN )/-RRB- ,/, valdecoxib/NN had/VBD no/DT effect/NN on/IN in/FW vitro/FW aspirin/NN -mediated/JJ inhibition/NN of/IN arachidonate/NN -/: or/CC collagen/NN -stimulated/JJ platelet/NN aggregation/NN ./.

(ROOT (S1 (S (PP (IN In) (NP (NP (DT a) (JJ parallel) (NN group) (NN drug) (NN interaction) (NN study)) (VP (VBG comparing) (NP (NP (DT the) (JJ intravenous) (NN prodrug) (NN form)) (PP (IN of) (NP (NN valdecoxib)))) (PP (IN at) (NP (NP (NP (NP (CD 40) (NN mg) (JJ BID)) (PRN (-LRB- -LRB-) (NP (NN n=10)) (-RRB- -RRB-))) (CC vs) (NP (NN placebo))) (PRN (-LRB- -LRB-) (NP (NN n=9)) (-RRB- -RRB-))))))) (, ,) (NP (NN valdecoxib)) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (ADJP (NP (ADJP (FW in) (FW vitro)) (NN aspirin)) (JJ -mediated)) (NN inhibition)) (PP (IN of) (NP (NP (NN arachidonate)) (: -) (CC or) (NP (NN collagen)) (NP (JJ -stimulated) (NN platelet) (NN aggregation))))))) (. .))))

det(study-7, a-2)
amod(study-7, parallel-3)
nn(study-7, group-4)
nn(study-7, drug-5)
nn(study-7, interaction-6)
prep_in(had-29, study-7)
partmod(study-7, comparing-8)
det(form-12, the-9)
amod(form-12, intravenous-10)
nn(form-12, prodrug-11)
dobj(comparing-8, form-12)
prep_of(form-12, valdecoxib-14)
num(mg-17, 40-16)
prep_at(comparing-8, mg-17)
amod(mg-17, BID-18)
appos(mg-17, n=10-20)
conj_vs(mg-17, placebo-23)
appos(mg-17, n=9-25)
nsubj(had-29, valdecoxib-28)
root(ROOT-0, had-29)
det(effect-31, no-30)
dobj(had-29, effect-31)
nn(vitro-34, in-33)
amod(aspirin-35, vitro-34)
npadvmod(-mediated-36, aspirin-35)
amod(inhibition-37, -mediated-36)
prep_on(had-29, inhibition-37)
prep_of(inhibition-37, arachidonate-39)
conj_or(arachidonate-39, collagen-42)
amod(aggregation-45, -stimulated-43)
nn(aggregation-45, platelet-44)
dep(arachidonate-39, aggregation-45)

Methotrexate/NN :/: Valdecoxib/NN 10/CD mg/NN BID/NN did/VBD not/RB show/VB a/DT significant/JJ effect/NN on/IN the/DT plasma/NN exposure/NN or/CC renal/JJ clearance/NN of/IN methotrexate/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Methotrexate)) (: :) (NP (NN Valdecoxib) (CD 10) (NN mg))) (NN BID)) (VP (VBD did) (RB not) (VP (VB show) (NP (NP (DT a) (JJ significant) (NN effect)) (PP (IN on) (NP (NP (DT the) (NN plasma) (NN exposure)) (CC or) (NP (NP (JJ renal) (NN clearance)) (PP (IN of) (NP (NN methotrexate)))))))))) (. .))))

nn(BID-6, Methotrexate-1)
nn(mg-5, Valdecoxib-3)
num(mg-5, 10-4)
dep(Methotrexate-1, mg-5)
nsubj(show-9, BID-6)
aux(show-9, did-7)
neg(show-9, not-8)
root(ROOT-0, show-9)
det(effect-12, a-10)
amod(effect-12, significant-11)
dobj(show-9, effect-12)
det(exposure-16, the-14)
nn(exposure-16, plasma-15)
prep_on(effect-12, exposure-16)
amod(clearance-19, renal-18)
conj_or(exposure-16, clearance-19)
prep_of(clearance-19, methotrexate-21)

ACE-inhibitors/NNS :/: Reports/NNS suggest/VBP that/IN NSAIDs/NNS may/MD diminish/VB the/DT antihypertensive/JJ effect/NN of/IN ACE-inhibitors/NNS ./.

(ROOT (S1 (S (NP (NP (NNS ACE-inhibitors)) (: :) (S (NP (NNS Reports)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NNS NSAIDs)) (VP (MD may) (VP (VB diminish) (NP (NP (DT the) (JJ antihypertensive) (NN effect)) (PP (IN of) (NP (NNS ACE-inhibitors)))))))))) (. .)))))

root(ROOT-0, ACE-inhibitors-1)
nsubj(suggest-4, Reports-3)
dep(ACE-inhibitors-1, suggest-4)
complm(diminish-8, that-5)
nsubj(diminish-8, NSAIDs-6)
aux(diminish-8, may-7)
ccomp(suggest-4, diminish-8)
det(effect-11, the-9)
amod(effect-11, antihypertensive-10)
dobj(diminish-8, effect-11)
prep_of(effect-11, ACE-inhibitors-13)

This/DT interaction/NN should/MD be/VB given/VBN consideration/NN in/IN patients/NNS taking/VBG BEXTRA/NN concomitantly/RB with/IN ACE-inhibitors/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN interaction)) (VP (MD should) (VP (VB be) (VP (VBN given) (NP (NP (NN consideration)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NN BEXTRA)))))) (ADVP (RB concomitantly)) (PP (IN with) (NP (NN ACE-inhibitors))))))) (. .))))

det(interaction-2, This-1)
nsubjpass(given-5, interaction-2)
aux(given-5, should-3)
auxpass(given-5, be-4)
root(ROOT-0, given-5)
dobj(given-5, consideration-6)
prep_in(consideration-6, patients-8)
partmod(patients-8, taking-9)
dobj(taking-9, BEXTRA-10)
advmod(given-5, concomitantly-11)
prep_with(given-5, ACE-inhibitors-13)

Furosemide/NN :/: Clinical/JJ studies/NNS ,/, as/RB well/RB as/IN post-marketing/JJ observations/NNS ,/, have/VBP shown/VBN that/IN NSAIDs/NNS can/MD reduce/VB the/DT natriuretic/JJ effect/NN of/IN furosemide/NN and/CC thiazides/NNS in/IN some/DT patients/NNS ./.

(ROOT (S1 (S (NP (NP (NN Furosemide)) (: :) (S (NP (NP (JJ Clinical) (NNS studies)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (JJ post-marketing) (NNS observations)) (, ,)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NNS NSAIDs)) (VP (MD can) (VP (VB reduce) (NP (NP (DT the) (JJ natriuretic) (NN effect)) (PP (IN of) (NP (NP (NN furosemide)) (CC and) (NP (NNS thiazides)))) (PP (IN in) (NP (DT some) (NNS patients))))))))))) (. .)))))

root(ROOT-0, Furosemide-1)
amod(studies-4, Clinical-3)
nsubj(shown-13, studies-4)
amod(observations-10, post-marketing-9)
conj_and(studies-4, observations-10)
aux(shown-13, have-12)
dep(Furosemide-1, shown-13)
complm(reduce-17, that-14)
nsubj(reduce-17, NSAIDs-15)
aux(reduce-17, can-16)
ccomp(shown-13, reduce-17)
det(effect-20, the-18)
amod(effect-20, natriuretic-19)
dobj(reduce-17, effect-20)
prep_of(effect-20, furosemide-22)
conj_and(furosemide-22, thiazides-24)
det(patients-27, some-26)
prep_in(effect-20, patients-27)

This/DT response/NN has/VBZ been/VBN attributed/VBN to/TO inhibition/NN of/IN renal/JJ prostaglandin/NN synthesis/NN ./.

(ROOT (S1 (S (S (NP (DT This) (NN response)) (VP (VBZ has) (VP (VBN been) (VP (VBN attributed) (PP (TO to) (NP (NP (NN inhibition)) (PP (IN of) (NP (JJ renal) (NN prostaglandin) (NN synthesis))))))))) (. .))))

det(response-2, This-1)
nsubjpass(attributed-5, response-2)
aux(attributed-5, has-3)
auxpass(attributed-5, been-4)
root(ROOT-0, attributed-5)
prep_to(attributed-5, inhibition-7)
amod(synthesis-11, renal-9)
nn(synthesis-11, prostaglandin-10)
prep_of(inhibition-7, synthesis-11)

Anticonvulsants/NNS (/-LRB- Phenytoin/NN )/-RRB- :/: Steady/JJ state/NN plasma/NN exposure/NN (/-LRB- AUC/NN )/-RRB- of/IN valdecoxib/NN (/-LRB- 40/CD mg/NN BID/JJ for/IN 12/CD days/NNS )/-RRB- was/VBD decreased/VBN by/IN 27/CD %/NN when/WRB co-administered/VBN with/IN multiple/JJ doses/NNS (/-LRB- 300/CD mg/NN QD/NN for/IN 12/CD days/NNS )/-RRB- of/IN phenytoin/NN (/-LRB- a/DT CYP/JJ 3A4/NN inducer/NN )./CD

(ROOT (S1 (S (NP (NP (NP (NNS Anticonvulsants)) (PRN (-LRB- -LRB-) (NP (NN Phenytoin)) (-RRB- -RRB-))) (: :) (S (NP (NP (NP (JJ Steady) (NN state) (NN plasma) (NN exposure)) (PRN (-LRB- -LRB-) (NP (NN AUC)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN valdecoxib)) (PRN (-LRB- -LRB-) (NP (NP (CD 40) (NN mg)) (ADJP (JJ BID) (PP (IN for) (NP (CD 12) (NNS days))))) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN decreased) (PP (IN by) (NP (CD 27) (NN %))) (SBAR (WHADVP (WRB when)) (S (VP (VBN co-administered) (PP (IN with) (NP (NP (NP (JJ multiple) (NNS doses)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 300) (NN mg)) (NN QD)) (PP (IN for) (NP (CD 12) (NNS days)))) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN phenytoin)) (-LRB- -LRB-) (NP (DT a) (JJ CYP) (NN 3A4) (NN inducer) (CD -RRB-.))))))))))))))))

root(ROOT-0, Anticonvulsants-1)
appos(Anticonvulsants-1, Phenytoin-3)
amod(exposure-9, Steady-6)
nn(exposure-9, state-7)
nn(exposure-9, plasma-8)
nsubjpass(decreased-24, exposure-9)
abbrev(exposure-9, AUC-11)
prep_of(exposure-9, valdecoxib-14)
num(mg-17, 40-16)
dep(valdecoxib-14, mg-17)
amod(mg-17, BID-18)
num(days-21, 12-20)
prep_for(BID-18, days-21)
auxpass(decreased-24, was-23)
dep(Anticonvulsants-1, decreased-24)
num(%-27, 27-26)
agent(decreased-24, %-27)
advmod(co-administered-29, when-28)
advcl(decreased-24, co-administered-29)
amod(doses-32, multiple-31)
prep_with(co-administered-29, doses-32)
number(mg-35, 300-34)
amod(QD-36, mg-35)
dep(doses-32, QD-36)
num(days-39, 12-38)
prep_for(QD-36, days-39)
prep_of(doses-32, phenytoin-42)
det(inducer-47, a-44)
amod(inducer-47, CYP-45)
nn(inducer-47, 3A4-46)
dep(phenytoin-42, inducer-47)
num(inducer-47, -RRB-.-48)

Patients/NNS already/RB stabilized/VBN on/IN valdecoxib/NN should/MD be/VB closely/RB monitored/VBN for/IN loss/NN of/IN symptom/JJ control/NN with/IN phenytoin/NN coadministration/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Patients)) (VP (ADVP (RB already)) (VBN stabilized) (PP (IN on) (NP (NN valdecoxib))))) (VP (MD should) (VP (VB be) (ADVP (RB closely)) (VP (VBN monitored) (PP (IN for) (NP (NP (NN loss)) (PP (IN of) (NP (JJ symptom) (NN control))) (PP (IN with) (NP (NN phenytoin) (NN coadministration))))))))) (. .))))

nsubjpass(monitored-9, Patients-1)
advmod(stabilized-3, already-2)
partmod(Patients-1, stabilized-3)
prep_on(stabilized-3, valdecoxib-5)
aux(monitored-9, should-6)
auxpass(monitored-9, be-7)
advmod(monitored-9, closely-8)
root(ROOT-0, monitored-9)
prep_for(monitored-9, loss-11)
amod(control-14, symptom-13)
prep_of(loss-11, control-14)
nn(coadministration-17, phenytoin-16)
prep_with(loss-11, coadministration-17)

Valdecoxib/NN did/VBD not/RB have/VB a/DT statistically/RB significant/JJ effect/NN on/IN the/DT pharmacokinetics/NNS of/IN phenytoin/NN (/-LRB- a/DT CYP/JJ 2C9/NN and/CC CYP/NN 2C19/NN substrate/NN )./NN

(ROOT (S1 (S (NP (NN Valdecoxib)) (VP (VBD did) (RB not) (VP (VB have) (NP (NP (DT a) (ADJP (RB statistically) (JJ significant)) (NN effect)) (PP (IN on) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN phenytoin)))))) (PRN (-LRB- -LRB-) (NP (NP (DT a) (JJ CYP) (NN 2C9)) (CC and) (NP (NN CYP) (NN 2C19) (NN substrate) (NN -RRB-.)))))))))

nsubj(have-4, Valdecoxib-1)
aux(have-4, did-2)
neg(have-4, not-3)
root(ROOT-0, have-4)
det(effect-8, a-5)
advmod(significant-7, statistically-6)
amod(effect-8, significant-7)
dobj(have-4, effect-8)
det(pharmacokinetics-11, the-10)
prep_on(effect-8, pharmacokinetics-11)
prep_of(pharmacokinetics-11, phenytoin-13)
det(2C9-17, a-15)
amod(2C9-17, CYP-16)
dep(have-4, 2C9-17)
nn(-RRB-.-22, CYP-19)
nn(-RRB-.-22, 2C19-20)
nn(-RRB-.-22, substrate-21)
conj_and(2C9-17, -RRB-.-22)

Drug/NN interaction/NN studies/NNS with/IN other/JJ anticonvulsants/NNS have/VBP not/RB been/VBN conducted/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Drug) (NN interaction) (NNS studies)) (PP (IN with) (NP (JJ other) (NNS anticonvulsants)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN conducted))))) (. .))))

nn(studies-3, Drug-1)
nn(studies-3, interaction-2)
nsubjpass(conducted-10, studies-3)
amod(anticonvulsants-6, other-5)
prep_with(studies-3, anticonvulsants-6)
aux(conducted-10, have-7)
neg(conducted-10, not-8)
auxpass(conducted-10, been-9)
root(ROOT-0, conducted-10)

Routine/JJ monitoring/NN should/MD be/VB performed/VBN when/WRB therapy/NN with/IN BEXTRA/NN is/VBZ either/CC initiated/JJ or/CC discontinued/VBN in/IN patients/NNS on/IN anticonvulsant/JJ therapy/NN ./.

(ROOT (S1 (S (S (NP (JJ Routine) (NN monitoring)) (VP (MD should) (VP (VB be) (VP (VBN performed))) (SBAR (WHADVP (WRB when)) (S (NP (NP (NN therapy)) (PP (IN with) (NP (NN BEXTRA)))) (VP (VBZ is) (UCP (CC either) (ADJP (JJ initiated)) (CC or) (VP (VBN discontinued) (PP (IN in) (NP (NP (NNS patients)) (PP (IN on) (NP (JJ anticonvulsant) (NN therapy)))))))))))) (. .))))

amod(monitoring-2, Routine-1)
nsubjpass(performed-5, monitoring-2)
aux(performed-5, should-3)
auxpass(performed-5, be-4)
root(ROOT-0, performed-5)
advmod(is-10, when-6)
nsubj(is-10, therapy-7)
prep_with(therapy-7, BEXTRA-9)
advcl(performed-5, is-10)
dep(is-10, either-11)
dep(either-11, initiated-12)
conj_or(either-11, discontinued-14)
prep_in(discontinued-14, patients-16)
amod(therapy-19, anticonvulsant-18)
prep_on(patients-16, therapy-19)

Dextromethorphan/NN :/: Dextromethorphan/NN is/VBZ primarily/RB metabolized/VBN by/IN CYP/NN 2D6/NN and/CC to/TO a/DT lesser/JJR extent/NN by/IN 3A4/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Dextromethorphan)) (: :) (NP (NN Dextromethorphan))) (VP (VBZ is) (VP (VP (ADVP (RB primarily)) (VBN metabolized) (PP (IN by) (NP (NN CYP) (NN 2D6)))) (CC and) (VP (PP (TO to) (NP (DT a) (JJR lesser) (NN extent))) (PP (IN by) (NP (NN 3A4))))))) (. .))))

nsubjpass(metabolized-6, Dextromethorphan-1)
dep(Dextromethorphan-1, Dextromethorphan-3)
auxpass(metabolized-6, is-4)
advmod(metabolized-6, primarily-5)
root(ROOT-0, metabolized-6)
nn(2D6-9, CYP-8)
agent(metabolized-6, 2D6-9)
conj_and(metabolized-6, to-11)
det(extent-14, a-12)
amod(extent-14, lesser-13)
pobj(to-11, extent-14)
prep_by(to-11, 3A4-16)

Coadministration/NN with/IN valdecoxib/NN (/-LRB- 40/CD mg/NN BID/JJ for/IN 7/CD days/NNS )/-RRB- resulted/VBD in/IN a/DT significant/JJ increase/NN in/IN dextromethorphan/NN plasma/NN levels/NNS suggesting/VBG that/IN ,/, at/IN these/DT doses/NNS ,/, valdecoxib/NN is/VBZ a/DT weak/JJ inhibitor/NN of/IN 2D6/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN with) (NP (NP (NN valdecoxib)) (PRN (-LRB- -LRB-) (NP (NP (CD 40) (NN mg)) (ADJP (JJ BID) (PP (IN for) (NP (CD 7) (NNS days))))) (-RRB- -RRB-))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (NN dextromethorphan) (NN plasma) (NNS levels))))) (S (VP (VBG suggesting) (SBAR (IN that) (S (, ,) (PP (IN at) (NP (DT these) (NNS doses))) (, ,) (NP (NN valdecoxib)) (VP (VBZ is) (NP (NP (DT a) (JJ weak) (NN inhibitor)) (PP (IN of) (NP (NN 2D6))))))))))) (. .))))

nsubj(resulted-12, Coadministration-1)
prep_with(Coadministration-1, valdecoxib-3)
num(mg-6, 40-5)
dep(valdecoxib-3, mg-6)
amod(mg-6, BID-7)
num(days-10, 7-9)
prep_for(BID-7, days-10)
root(ROOT-0, resulted-12)
det(increase-16, a-14)
amod(increase-16, significant-15)
prep_in(resulted-12, increase-16)
nn(levels-20, dextromethorphan-18)
nn(levels-20, plasma-19)
prep_in(increase-16, levels-20)
xcomp(resulted-12, suggesting-21)
complm(inhibitor-32, that-22)
det(doses-26, these-25)
prep_at(inhibitor-32, doses-26)
nsubj(inhibitor-32, valdecoxib-28)
cop(inhibitor-32, is-29)
det(inhibitor-32, a-30)
amod(inhibitor-32, weak-31)
ccomp(suggesting-21, inhibitor-32)
prep_of(inhibitor-32, 2D6-34)

Even/RB so/RB dextromethorphan/NN plasma/NN concentrations/NNS in/IN the/DT presence/NN of/IN high/JJ doses/NNS of/IN valdecoxib/NN were/VBD almost/RB 5-fold/RB lower/JJR than/IN those/DT seen/VBN in/IN CYP/NN 2D6/NN poor/JJ metabolizers/NNS suggesting/VBG that/IN dose/NN adjustment/NN is/VBZ not/RB necessary/JJ ./.

(ROOT (S1 (S (S (ADVP (RB Even) (RB so)) (NP (NP (NN dextromethorphan) (NN plasma) (NNS concentrations)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (JJ high) (NNS doses)) (PP (IN of) (NP (NN valdecoxib)))))))) (VP (VBD were) (ADJP (ADJP (ADVP (RB almost) (RB 5-fold)) (JJR lower)) (PP (IN than) (NP (NP (DT those)) (VP (VBN seen) (PP (IN in) (NP (NP (NP (NN CYP) (NN 2D6)) (JJ poor) (NNS metabolizers)) (VP (VBG suggesting) (SBAR (IN that) (S (NP (NN dose) (NN adjustment)) (VP (VBZ is) (RB not) (ADJP (JJ necessary)))))))))))))) (. .))))

advmod(so-2, Even-1)
advmod(lower-17, so-2)
nn(concentrations-5, dextromethorphan-3)
nn(concentrations-5, plasma-4)
nsubj(lower-17, concentrations-5)
det(presence-8, the-7)
prep_in(concentrations-5, presence-8)
amod(doses-11, high-10)
prep_of(presence-8, doses-11)
prep_of(doses-11, valdecoxib-13)
cop(lower-17, were-14)
advmod(5-fold-16, almost-15)
advmod(lower-17, 5-fold-16)
root(ROOT-0, lower-17)
prep_than(lower-17, those-19)
partmod(those-19, seen-20)
nn(2D6-23, CYP-22)
nn(metabolizers-25, 2D6-23)
amod(metabolizers-25, poor-24)
prep_in(seen-20, metabolizers-25)
partmod(metabolizers-25, suggesting-26)
complm(necessary-32, that-27)
nn(adjustment-29, dose-28)
nsubj(necessary-32, adjustment-29)
cop(necessary-32, is-30)
neg(necessary-32, not-31)
ccomp(suggesting-26, necessary-32)

Lithium/NN :/: Valdecoxib/NN 40/CD mg/NN BID/NN for/IN 7/CD days/NNS produced/VBD significant/JJ decreases/NNS in/IN lithium/NN serum/NN clearance/NN (/-LRB- 25/CD %/NN )/-RRB- and/CC renal/JJ clearance/NN (/-LRB- 30/CD %/NN )/-RRB- with/IN a/DT 34/CD %/NN higher/JJR serum/NN exposure/NN compared/VBN to/TO lithium/NN alone/RB ./.

(ROOT (S1 (S (S (NP (NP (NN Lithium)) (: :) (NP (NP (NP (NN Valdecoxib) (CD 40) (NN mg)) (NN BID)) (PP (IN for) (NP (CD 7) (NNS days))))) (VP (VBD produced) (NP (NP (JJ significant) (NNS decreases)) (PP (IN in) (NP (NP (NP (NN lithium) (NN serum) (NN clearance)) (PRN (-LRB- -LRB-) (NP (CD 25) (NN %)) (-RRB- -RRB-))) (CC and) (NP (NP (JJ renal) (NN clearance)) (PRN (-LRB- -LRB-) (NP (CD 30) (NN %)) (-RRB- -RRB-)))))) (PP (IN with) (NP (NP (DT a) (ADJP (NP (CD 34) (NN %)) (JJR higher)) (NN serum) (NN exposure)) (PP (VBN compared) (PP (TO to) (NP (NP (NN lithium)) (ADVP (RB alone))))))))) (. .))))

nsubj(produced-10, Lithium-1)
nn(mg-5, Valdecoxib-3)
num(mg-5, 40-4)
nn(BID-6, mg-5)
dep(Lithium-1, BID-6)
num(days-9, 7-8)
prep_for(BID-6, days-9)
root(ROOT-0, produced-10)
amod(decreases-12, significant-11)
dobj(produced-10, decreases-12)
nn(clearance-16, lithium-14)
nn(clearance-16, serum-15)
prep_in(decreases-12, clearance-16)
num(%-19, 25-18)
appos(clearance-16, %-19)
amod(clearance-23, renal-22)
conj_and(clearance-16, clearance-23)
num(%-26, 30-25)
appos(clearance-23, %-26)
det(exposure-34, a-29)
num(%-31, 34-30)
npadvmod(higher-32, %-31)
amod(exposure-34, higher-32)
nn(exposure-34, serum-33)
prep_with(produced-10, exposure-34)
prepc_compared_to(exposure-34, to-36)
pobj(exposure-34, lithium-37)
advmod(lithium-37, alone-38)

Lithium/JJ serum/NN concentrations/NNS should/MD be/VB monitored/VBN closely/RB when/WRB initiating/VBG or/CC changing/VBG therapy/NN with/IN BEXTRA/NN in/IN patients/NNS receiving/VBG lithium/NN ./.

(ROOT (S1 (S (S (NP (JJ Lithium) (NN serum) (NNS concentrations)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (ADVP (RB closely)) (SBAR (WHADVP (WRB when)) (S (VP (VP (VBG initiating)) (CC or) (VP (VBG changing) (NP (NP (NN therapy)) (PP (IN with) (NP (NN BEXTRA))) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (NN lithium)))))))))))))) (. .))))

amod(concentrations-3, Lithium-1)
nn(concentrations-3, serum-2)
nsubjpass(monitored-6, concentrations-3)
aux(monitored-6, should-4)
auxpass(monitored-6, be-5)
root(ROOT-0, monitored-6)
advmod(monitored-6, closely-7)
advmod(initiating-9, when-8)
advcl(monitored-6, initiating-9)
conj_or(initiating-9, changing-11)
dobj(changing-11, therapy-12)
prep_with(therapy-12, BEXTRA-14)
prep_in(therapy-12, patients-16)
partmod(patients-16, receiving-17)
dobj(receiving-17, lithium-18)

Lithium/NN carbonate/NN (/-LRB- 450/CD mg/NN BID/JJ for/IN 7/CD days/NNS )/-RRB- had/VBD no/DT effect/NN on/IN valdecoxib/NN pharmacokinetics/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Lithium) (NN carbonate)) (PRN (-LRB- -LRB-) (NP (NP (CD 450) (NN mg)) (ADJP (JJ BID) (PP (IN for) (NP (CD 7) (NNS days))))) (-RRB- -RRB-))) (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NN valdecoxib) (NNS pharmacokinetics))))) (. .))))

nn(carbonate-2, Lithium-1)
nsubj(had-11, carbonate-2)
num(mg-5, 450-4)
dep(carbonate-2, mg-5)
amod(mg-5, BID-6)
num(days-9, 7-8)
prep_for(BID-6, days-9)
root(ROOT-0, had-11)
det(effect-13, no-12)
dobj(had-11, effect-13)
nn(pharmacokinetics-16, valdecoxib-15)
prep_on(had-11, pharmacokinetics-16)

Warfarin/NN :/: The/DT effect/NN of/IN valdecoxib/NN on/IN the/DT anticoagulant/JJ effect/NN of/IN warfarin/NN (/-LRB- 1/CD -/CC 8/CD mg/day/NN )/-RRB- was/VBD studied/VBN in/IN healthy/JJ subjects/NNS by/IN coadministration/NN of/IN BEXTRA/NN 40/CD mg/NN BID/NN for/IN 7/CD days/NNS ./.

(ROOT (S1 (S (NP (NP (NN Warfarin)) (: :) (S (NP (NP (DT The) (NN effect)) (PP (IN of) (NP (NN valdecoxib))) (PP (IN on) (NP (NP (DT the) (JJ anticoagulant) (NN effect)) (PP (IN of) (NP (NP (NN warfarin)) (PRN (-LRB- -LRB-) (NP (CD 1) (CC -) (CD 8) (NN mg/day)) (-RRB- -RRB-))))))) (VP (VBD was) (VP (VBN studied) (PP (IN in) (NP (JJ healthy) (NNS subjects))) (PP (IN by) (NP (NP (NN coadministration)) (PP (IN of) (NP (NN BEXTRA) (CD 40) (NN mg) (NN BID))))) (PP (IN for) (NP (CD 7) (NNS days)))))) (. .)))))

root(ROOT-0, Warfarin-1)
det(effect-4, The-3)
nsubjpass(studied-20, effect-4)
prep_of(effect-4, valdecoxib-6)
det(effect-10, the-8)
amod(effect-10, anticoagulant-9)
prep_on(effect-4, effect-10)
prep_of(effect-10, warfarin-12)
nn(mg/day-17, 1-14)
conj(1-14, 8-16)
appos(warfarin-12, mg/day-17)
auxpass(studied-20, was-19)
dep(Warfarin-1, studied-20)
amod(subjects-23, healthy-22)
prep_in(studied-20, subjects-23)
agent(studied-20, coadministration-25)
nn(BID-30, BEXTRA-27)
num(BID-30, 40-28)
nn(BID-30, mg-29)
prep_of(coadministration-25, BID-30)
num(days-33, 7-32)
prep_for(studied-20, days-33)

Valdecoxib/NN caused/VBD a/DT statistically/RB significant/JJ increase/NN in/IN plasma/NN exposures/NNS of/IN R-/NN warfarin/NN and/CC S-/NN warfarin/NN (/-LRB- 12/CD %/NN and/CC 15/CD %/NN ,/, respectively/RB )/-RRB- ,/, and/CC in/IN the/DT pharmacodynamic/JJ effects/NNS (/-LRB- prothrombin/NN time/NN ,/, measured/VBN as/IN INR/NN )/-RRB- of/IN warfarin/NN ./.

(ROOT (S1 (S (S (NP (NN Valdecoxib)) (VP (VBD caused) (NP (NP (NP (DT a) (ADJP (RB statistically) (JJ significant)) (NN increase)) (PP (IN in) (NP (NP (NN plasma) (NNS exposures)) (PP (IN of) (NP (NN R-) (NN warfarin)))))) (CC and) (NP (NP (NN S-) (NN warfarin)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 12) (NN %)) (CC and) (NP (CD 15) (NN %))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-)))) (, ,) (CC and) (PP (IN in) (NP (NP (NP (DT the) (JJ pharmacodynamic) (NNS effects)) (PRN (-LRB- -LRB-) (NP (NP (NN prothrombin) (NN time)) (, ,) (VP (VBN measured) (PP (IN as) (NP (NN INR))))) (-RRB- -RRB-))) (PP (IN of) (NP (NN warfarin))))))) (. .))))

nsubj(caused-2, Valdecoxib-1)
root(ROOT-0, caused-2)
det(increase-6, a-3)
advmod(significant-5, statistically-4)
amod(increase-6, significant-5)
dobj(caused-2, increase-6)
nn(exposures-9, plasma-8)
prep_in(increase-6, exposures-9)
nn(warfarin-12, R--11)
prep_of(exposures-9, warfarin-12)
nn(warfarin-15, S--14)
conj_and(increase-6, warfarin-15)
num(%-18, 12-17)
dep(warfarin-15, %-18)
num(%-21, 15-20)
conj_and(%-18, %-21)
advmod(%-18, respectively-23)
conj_and(caused-2, in-27)
det(effects-30, the-28)
amod(effects-30, pharmacodynamic-29)
prep_in(caused-2, effects-30)
nn(time-33, prothrombin-32)
dep(effects-30, time-33)
partmod(time-33, measured-35)
prep_as(measured-35, INR-37)
prep_of(effects-30, warfarin-40)

While/IN mean/NN INR/NN values/NNS were/VBD only/RB slightly/RB increased/VBN with/IN coadministration/NN of/IN valdecoxib/NN ,/, the/DT day-to-day/JJ variability/NN in/IN individual/JJ INR/NN values/NNS was/VBD increased/VBN ./.

(ROOT (S1 (S (S (SBAR (IN While) (S (NP (NN mean) (NN INR) (NNS values)) (VP (VBD were) (ADVP (RB only) (RB slightly)) (VP (VBN increased) (PP (IN with) (NP (NP (NN coadministration)) (PP (IN of) (NP (NN valdecoxib))))))))) (, ,) (NP (NP (DT the) (JJ day-to-day) (NN variability)) (PP (IN in) (NP (JJ individual) (NN INR) (NNS values)))) (VP (VBD was) (VP (VBN increased)))) (. .))))

mark(increased-8, While-1)
nn(values-4, mean-2)
nn(values-4, INR-3)
nsubjpass(increased-8, values-4)
auxpass(increased-8, were-5)
advmod(slightly-7, only-6)
advmod(increased-8, slightly-7)
advcl(increased-22, increased-8)
prep_with(increased-8, coadministration-10)
prep_of(coadministration-10, valdecoxib-12)
det(variability-16, the-14)
amod(variability-16, day-to-day-15)
nsubjpass(increased-22, variability-16)
amod(values-20, individual-18)
nn(values-20, INR-19)
prep_in(variability-16, values-20)
auxpass(increased-22, was-21)
root(ROOT-0, increased-22)

Anticoagulant/NN therapy/NN should/MD be/VB monitored/VBN ,/, particularly/RB during/IN the/DT first/JJ few/JJ weeks/NNS ,/, after/IN initiating/VBG therapy/NN with/IN BEXTRA/NN in/IN patients/NNS receiving/VBG warfarin/JJ or/CC similar/JJ agents/NNS ./.

(ROOT (S1 (S (S (NP (NN Anticoagulant) (NN therapy)) (VP (MD should) (VP (VB be) (VP (VBN monitored) (, ,) (PP (ADVP (RB particularly)) (IN during) (NP (DT the) (JJ first) (JJ few) (NNS weeks))) (, ,) (PP (IN after) (S (VP (VBG initiating) (NP (NP (NN therapy)) (PP (IN with) (NP (NP (NN BEXTRA)) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG receiving) (NP (ADJP (ADJP (JJ warfarin)) (CC or) (ADJP (JJ similar))) (NNS agents))))))))))))))) (. .))))

nn(therapy-2, Anticoagulant-1)
nsubjpass(monitored-5, therapy-2)
aux(monitored-5, should-3)
auxpass(monitored-5, be-4)
root(ROOT-0, monitored-5)
advmod(monitored-5, particularly-7)
det(weeks-12, the-9)
amod(weeks-12, first-10)
amod(weeks-12, few-11)
prep_during(monitored-5, weeks-12)
prepc_after(monitored-5, initiating-15)
dobj(initiating-15, therapy-16)
prep_with(therapy-16, BEXTRA-18)
prep_in(BEXTRA-18, patients-20)
partmod(patients-20, receiving-21)
amod(agents-25, warfarin-22)
conj_or(warfarin-22, similar-24)
dobj(receiving-21, agents-25)

Fluconazole/NN and/CC Ketoconazole/NN :/: Ketoconazole/NN and/CC fluconazole/NN are/VBP predominantly/RB CYP/JJ 3A4/NN and/CC 2C9/NN inhibitors/NNS ,/, respectively/RB ./.

(ROOT (S1 (S (NP (NP (NP (NN Fluconazole)) (CC and) (NP (NN Ketoconazole))) (: :) (S (NP (NP (NN Ketoconazole)) (CC and) (NP (NN fluconazole))) (VP (VBP are) (NP (ADJP (RB predominantly) (JJ CYP)) (NP (NP (NN 3A4)) (CC and) (NP (NN 2C9))) (NNS inhibitors)) (, ,) (ADVP (RB respectively)))) (. .)))))

root(ROOT-0, Fluconazole-1)
conj_and(Fluconazole-1, Ketoconazole-3)
nsubj(inhibitors-14, Ketoconazole-5)
conj_and(Ketoconazole-5, fluconazole-7)
cop(inhibitors-14, are-8)
advmod(CYP-10, predominantly-9)
amod(inhibitors-14, CYP-10)
nn(inhibitors-14, 3A4-11)
conj_and(3A4-11, 2C9-13)
dep(Fluconazole-1, inhibitors-14)
advmod(inhibitors-14, respectively-16)

Concomitant/JJ single/JJ dose/NN administration/NN of/IN valdecoxib/NN 20/CD mg/NN with/IN multiple/JJ doses/NNS of/IN ketoconazole/NN and/CC fluconazole/NN produced/VBD a/DT significant/JJ increase/NN in/IN exposure/NN of/IN valdecoxib/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (JJ single) (NN dose) (NN administration)) (PP (IN of) (NP (NN valdecoxib) (CD 20) (NN mg))) (PP (IN with) (NP (NP (JJ multiple) (NNS doses)) (PP (IN of) (NP (NP (NN ketoconazole)) (CC and) (NP (NN fluconazole))))))) (VP (VBD produced) (NP (NP (DT a) (JJ significant) (NN increase)) (PP (IN in) (NP (NP (NN exposure)) (PP (IN of) (NP (NN valdecoxib)))))))) (. .))))

amod(administration-4, Concomitant-1)
amod(administration-4, single-2)
nn(administration-4, dose-3)
nsubj(produced-16, administration-4)
nn(mg-8, valdecoxib-6)
num(mg-8, 20-7)
prep_of(administration-4, mg-8)
amod(doses-11, multiple-10)
prep_with(administration-4, doses-11)
prep_of(doses-11, ketoconazole-13)
conj_and(ketoconazole-13, fluconazole-15)
root(ROOT-0, produced-16)
det(increase-19, a-17)
amod(increase-19, significant-18)
dobj(produced-16, increase-19)
prep_in(increase-19, exposure-21)
prep_of(exposure-21, valdecoxib-23)

Plasma/NN exposure/NN (/-LRB- AUC/NN )/-RRB- to/TO valdecoxib/NN was/VBD increased/VBN 62/CD %/NN when/WRB coadministered/VBN with/IN fluconazole/NN and/CC 38/CD %/NN when/WRB coadministered/VBN with/IN ketoconazole/NN ./.

(ROOT (S1 (S (S (NP (NP (NP (NN Plasma) (NN exposure)) (PRN (-LRB- -LRB-) (NP (NN AUC)) (-RRB- -RRB-))) (PP (TO to) (NP (NN valdecoxib)))) (VP (VBD was) (VP (VBN increased) (NP (NP (NP (CD 62) (NN %)) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NN fluconazole))))))) (CC and) (NP (NP (CD 38) (NN %)) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NN ketoconazole))))))))))) (. .))))

nn(exposure-2, Plasma-1)
nsubjpass(increased-9, exposure-2)
abbrev(exposure-2, AUC-4)
prep_to(exposure-2, valdecoxib-7)
auxpass(increased-9, was-8)
root(ROOT-0, increased-9)
num(%-11, 62-10)
dobj(increased-9, %-11)
advmod(coadministered-13, when-12)
dep(%-11, coadministered-13)
prep_with(coadministered-13, fluconazole-15)
num(%-18, 38-17)
conj_and(%-11, %-18)
advmod(coadministered-20, when-19)
dep(%-18, coadministered-20)
prep_with(coadministered-20, ketoconazole-22)

Glyburide/NN :/: Glyburide/NN is/VBZ a/DT CYP/NN 2C9/NN substrate/NN ./.

(ROOT (S1 (S (S (NP (NN Glyburide)) (: :) (S (NP (NN Glyburide)) (VP (VBZ is) (NP (DT a) (NN CYP) (NN 2C9) (NN substrate))))) (. .))))

dep(substrate-8, Glyburide-1)
nsubj(substrate-8, Glyburide-3)
cop(substrate-8, is-4)
det(substrate-8, a-5)
nn(substrate-8, CYP-6)
nn(substrate-8, 2C9-7)
root(ROOT-0, substrate-8)

Coadministration/NN of/IN valdecoxib/NN (/-LRB- 10/CD mg/NN BID/NN for/IN 7/CD days/NNS )/-RRB- with/IN glyburide/NN (/-LRB- 5/CD mg/NN QD/NN or/CC 10/CD mg/NN BID/NN )/-RRB- did/VBD not/RB affect/VB the/DT pharmacokinetics/NNS (/-LRB- exposure/NN )/-RRB- of/IN glyburide/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NN valdecoxib)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 10) (NN mg)) (NN BID)) (PP (IN for) (NP (CD 7) (NNS days)))) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (NN glyburide)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 5) (NN mg)) (NN QD)) (CC or) (NP (ADJP (CD 10) (NN mg)) (NN BID))) (-RRB- -RRB-))))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (NP (DT the) (NNS pharmacokinetics)) (PRN (-LRB- -LRB-) (NP (NN exposure)) (-RRB- -RRB-))) (PP (IN of) (NP (NN glyburide))))))) (. .))))

nsubj(affect-25, Coadministration-1)
prep_of(Coadministration-1, valdecoxib-3)
number(mg-6, 10-5)
amod(BID-7, mg-6)
dep(valdecoxib-3, BID-7)
num(days-10, 7-9)
prep_for(BID-7, days-10)
prep_with(Coadministration-1, glyburide-13)
number(mg-16, 5-15)
amod(QD-17, mg-16)
dep(glyburide-13, QD-17)
number(mg-20, 10-19)
amod(BID-21, mg-20)
conj_or(QD-17, BID-21)
aux(affect-25, did-23)
neg(affect-25, not-24)
root(ROOT-0, affect-25)
det(pharmacokinetics-27, the-26)
dobj(affect-25, pharmacokinetics-27)
appos(pharmacokinetics-27, exposure-29)
prep_of(pharmacokinetics-27, glyburide-32)

Coadministration/NN of/IN valdecoxib/NN (/-LRB- 40/CD mg/NN BID/JJ (/-LRB- day/NN 1/CD )/-RRB- and/CC 40/CD mg/NN QD/NN (/-LRB- days/NNS 2-7/CD )/-RRB- )/-RRB- with/IN glyburide/NN (/-LRB- 5/CD mg/NN QD/NN )/-RRB- did/VBD not/RB affect/VB either/CC the/DT pharmacokinetics/NNS (/-LRB- exposure/NN )/-RRB- or/CC the/DT pharmacodynamics/NNS (/-LRB- blood/NN glucose/NN and/CC insulin/NN levels/NNS )/-RRB- of/IN glyburide/NN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NN valdecoxib)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 40) (NN mg) (JJ BID)) (PRN (-LRB- -LRB-) (NP (NN day) (CD 1)) (-RRB- -RRB-))) (CC and) (NP (NP (ADJP (CD 40) (NN mg)) (NN QD)) (PRN (-LRB- -LRB-) (NP (NNS days) (NP (CD 2-7))) (-RRB- -RRB-)))) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (NN glyburide)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 5) (NN mg)) (NN QD)) (-RRB- -RRB-))))) (VP (VBD did) (RB not) (VP (VB affect) (NP (CC either) (NP (NP (DT the) (NNS pharmacokinetics)) (PRN (-LRB- -LRB-) (NP (NN exposure)) (-RRB- -RRB-))) (CC or) (NP (NP (NP (DT the) (NNS pharmacodynamics)) (PRN (-LRB- -LRB-) (NP (NP (NN blood) (NN glucose)) (CC and) (NP (NN insulin) (NNS levels))) (-RRB- -RRB-))) (PP (IN of) (NP (NN glyburide)))))))) (. .))))

nsubj(affect-30, Coadministration-1)
prep_of(Coadministration-1, valdecoxib-3)
num(mg-6, 40-5)
dep(valdecoxib-3, mg-6)
amod(mg-6, BID-7)
appos(mg-6, day-9)
num(day-9, 1-10)
number(mg-14, 40-13)
amod(QD-15, mg-14)
conj_and(mg-6, QD-15)
appos(QD-15, days-17)
dep(days-17, 2-7-18)
prep_with(Coadministration-1, glyburide-22)
number(mg-25, 5-24)
amod(QD-26, mg-25)
appos(glyburide-22, QD-26)
aux(affect-30, did-28)
neg(affect-30, not-29)
root(ROOT-0, affect-30)
preconj(pharmacokinetics-33, either-31)
det(pharmacokinetics-33, the-32)
dobj(affect-30, pharmacokinetics-33)
appos(pharmacokinetics-33, exposure-35)
det(pharmacodynamics-39, the-38)
conj_or(pharmacokinetics-33, pharmacodynamics-39)
nn(glucose-42, blood-41)
dep(pharmacodynamics-39, glucose-42)
nn(levels-45, insulin-44)
conj_and(glucose-42, levels-45)
prep_of(pharmacodynamics-39, glyburide-48)

Coadministration/NN of/IN valdecoxib/NN (/-LRB- 40/CD mg/NN BID/JJ (/-LRB- day/NN 1/CD )/-RRB- and/CC 40/CD mg/NN QD/NN (/-LRB- days/NNS 2-7/CD )/-RRB- )/-RRB- with/IN glyburide/NN (/-LRB- 10/CD mg/NN glyburide/NN BID/NN )/-RRB- resulted/VBD in/IN 21/CD %/NN increase/NN in/IN glyburide/NN AUC0-12/CD and/CC a/DT 16/CD %/NN increase/NN in/IN glyburide/NN Cmax/NN leading/VBG to/TO a/DT 16/CD %/NN decrease/NN in/IN glucose/NN AUC0-24/CD ./.

(ROOT (S1 (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NN valdecoxib)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 40) (NN mg) (JJ BID)) (PRN (-LRB- -LRB-) (NP (NN day) (CD 1)) (-RRB- -RRB-))) (CC and) (NP (NP (ADJP (CD 40) (NN mg)) (NN QD)) (PRN (-LRB- -LRB-) (NP (NNS days) (NP (CD 2-7))) (-RRB- -RRB-)))) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (NN glyburide)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 10) (NN mg)) (NN glyburide) (NN BID)) (-RRB- -RRB-))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (ADJP (CD 21) (NN %)) (NN increase)) (PP (IN in) (NP (NN glyburide) (CD AUC0-12)))) (CC and) (NP (NP (DT a) (CD 16) (NN %) (NN increase)) (PP (IN in) (NP (NP (NN glyburide) (NN Cmax)) (VP (VBG leading) (PP (TO to) (NP (NP (DT a) (ADJP (CD 16) (NN %)) (NN decrease)) (PP (IN in) (NP (NN glucose) (CD AUC0-24)))))))))))) (. .))))

nsubj(resulted-29, Coadministration-1)
prep_of(Coadministration-1, valdecoxib-3)
num(mg-6, 40-5)
dep(valdecoxib-3, mg-6)
amod(mg-6, BID-7)
appos(mg-6, day-9)
num(day-9, 1-10)
number(mg-14, 40-13)
amod(QD-15, mg-14)
conj_and(mg-6, QD-15)
appos(QD-15, days-17)
dep(days-17, 2-7-18)
prep_with(Coadministration-1, glyburide-22)
number(mg-25, 10-24)
amod(BID-27, mg-25)
nn(BID-27, glyburide-26)
appos(glyburide-22, BID-27)
root(ROOT-0, resulted-29)
number(%-32, 21-31)
amod(increase-33, %-32)
prep_in(resulted-29, increase-33)
prep_in(increase-33, glyburide-35)
num(glyburide-35, AUC0-12-36)
det(increase-41, a-38)
num(increase-41, 16-39)
nn(increase-41, %-40)
conj_and(increase-33, increase-41)
nn(Cmax-44, glyburide-43)
prep_in(increase-41, Cmax-44)
partmod(Cmax-44, leading-45)
det(decrease-50, a-47)
number(%-49, 16-48)
amod(decrease-50, %-49)
prep_to(leading-45, decrease-50)
prep_in(decrease-50, glucose-52)
num(glucose-52, AUC0-24-53)

Insulin/NN parameters/NNS were/VBD not/RB affected/VBN ./.

(ROOT (S1 (S (S (NP (NN Insulin) (NNS parameters)) (VP (VBD were) (RB not) (VP (VBN affected)))) (. .))))

nn(parameters-2, Insulin-1)
nsubjpass(affected-5, parameters-2)
auxpass(affected-5, were-3)
neg(affected-5, not-4)
root(ROOT-0, affected-5)

Because/IN changes/NNS in/IN glucose/NN concentrations/NNS with/IN valdecoxib/NN coadministration/NN were/VBD within/IN the/DT normal/JJ variability/NN and/CC individual/JJ glucose/NN concentrations/NNS were/VBD above/RB or/CC near/IN 70/CD mg/dL/NN ,/, dose/NN adjustment/NN for/IN glyburide/NN (/-LRB- 5/CD mg/NN QD/NN and/CC 10/CD mg/NN BID/NN )/-RRB- with/IN valdecoxib/NN coadministration/NN (/-LRB- up/RB to/TO 40/CD mg/NN QD/NN )/-RRB- is/VBZ not/RB indicated/VBN ./.

(ROOT (S1 (S (SBAR (IN Because) (S (S (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NN glucose) (NNS concentrations)) (PP (IN with) (NP (NN valdecoxib) (NN coadministration)))))) (VP (VBD were) (PP (IN within) (NP (DT the) (JJ normal) (NN variability))))) (CC and) (S (NP (JJ individual) (NN glucose) (NNS concentrations)) (VP (VBD were) (UCP (ADVP (RB above)) (CC or) (PP (IN near) (NP (CD 70) (NN mg/dL)))))))) (, ,) (NP (NP (NN dose) (NN adjustment)) (PP (IN for) (NP (NP (NN glyburide)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 5) (NN mg)) (NN QD)) (CC and) (NP (ADJP (CD 10) (NN mg)) (NN BID))) (-RRB- -RRB-)))) (PP (IN with) (NP (NP (NN valdecoxib) (NN coadministration)) (PRN (-LRB- -LRB-) (NP (QP (RB up) (TO to) (CD 40)) (NN mg) (NN QD)) (-RRB- -RRB-))))) (VP (VBZ is) (RB not) (VP (VBN indicated))) (. .))))

mark(were-9, Because-1)
nsubj(were-9, changes-2)
nn(concentrations-5, glucose-4)
prep_in(changes-2, concentrations-5)
nn(coadministration-8, valdecoxib-7)
prep_with(concentrations-5, coadministration-8)
advcl(indicated-50, were-9)
det(variability-13, the-11)
amod(variability-13, normal-12)
prep_within(were-9, variability-13)
amod(concentrations-17, individual-15)
nn(concentrations-17, glucose-16)
nsubj(were-18, concentrations-17)
conj_and(were-9, were-18)
dep(were-18, above-19)
conj_or(above-19, near-21)
num(mg/dL-23, 70-22)
pobj(near-21, mg/dL-23)
nn(adjustment-26, dose-25)
nsubjpass(indicated-50, adjustment-26)
prep_for(adjustment-26, glyburide-28)
number(mg-31, 5-30)
amod(QD-32, mg-31)
dep(glyburide-28, QD-32)
number(mg-35, 10-34)
amod(BID-36, mg-35)
conj_and(QD-32, BID-36)
nn(coadministration-40, valdecoxib-39)
prep_with(adjustment-26, coadministration-40)
quantmod(40-44, up-42)
dep(40-44, to-43)
num(QD-46, 40-44)
nn(QD-46, mg-45)
appos(coadministration-40, QD-46)
auxpass(indicated-50, is-48)
neg(indicated-50, not-49)
root(ROOT-0, indicated-50)

Coadministration/NN of/IN glyburide/NN with/IN doses/NNS higher/JJR than/IN 40/CD mg/NN valdecoxib/NN (/-LRB- e.g./FW ,/, 40/CD mg/NN BID/NN )/-RRB- have/VBP not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN glyburide))) (PP (IN with) (NP (NP (NNS doses)) (ADJP (JJR higher) (PP (IN than) (NP (NP (ADJP (CD 40) (NN mg)) (NN valdecoxib)) (PRN (-LRB- -LRB-) (PP (FW e.g.) (, ,) (NP (ADJP (CD 40) (NN mg)) (NN BID))) (-RRB- -RRB-)))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

nsubjpass(studied-21, Coadministration-1)
prep_of(Coadministration-1, glyburide-3)
prep_with(Coadministration-1, doses-5)
amod(doses-5, higher-6)
number(mg-9, 40-8)
amod(valdecoxib-10, mg-9)
prep_than(higher-6, valdecoxib-10)
dep(valdecoxib-10, e.g.-12)
number(mg-15, 40-14)
amod(BID-16, mg-15)
pobj(e.g.-12, BID-16)
aux(studied-21, have-18)
neg(studied-21, not-19)
auxpass(studied-21, been-20)
root(ROOT-0, studied-21)

Omeprazole/NN :/: Omeprazole/NN is/VBZ a/DT CYP/JJ 3A4/NN substrate/NN and/CC CYP/NN 2C19/NN substrate/NN and/CC inhibitor/NN ./.

(ROOT (S1 (S (NP (NP (NN Omeprazole)) (: :) (S (NP (NN Omeprazole)) (VP (VBZ is) (NP (NP (DT a) (JJ CYP) (NN 3A4) (NN substrate)) (CC and) (NP (NP (NN CYP) (NN 2C19) (NN substrate)) (CC and) (NP (NN inhibitor)))))) (. .)))))

root(ROOT-0, Omeprazole-1)
nsubj(substrate-8, Omeprazole-3)
cop(substrate-8, is-4)
det(substrate-8, a-5)
amod(substrate-8, CYP-6)
nn(substrate-8, 3A4-7)
dep(Omeprazole-1, substrate-8)
nn(substrate-12, CYP-10)
nn(substrate-12, 2C19-11)
conj_and(substrate-8, substrate-12)
conj_and(substrate-12, inhibitor-14)

Valdecoxib/NN steady/JJ state/NN plasma/NN concentrations/NNS (/-LRB- 40/CD mg/NN BID/JJ )/-RRB- were/VBD not/RB affected/VBN significantly/RB with/IN multiple/JJ doses/NNS of/IN omeprazole/NN (/-LRB- 40/CD mg/NN QD/NN )./NN

(ROOT (S1 (S (NP (NP (NN Valdecoxib) (JJ steady) (NN state) (NN plasma) (NNS concentrations)) (PRN (-LRB- -LRB-) (NP (CD 40) (NN mg) (JJ BID)) (-RRB- -RRB-))) (VP (VBD were) (RB not) (VP (VBN affected) (ADVP (RB significantly)) (PP (IN with) (NP (NP (JJ multiple) (NNS doses)) (PP (IN of) (NP (NN omeprazole))))) (-LRB- -LRB-) (NP (ADJP (CD 40) (NN mg)) (NN QD) (NN -RRB-.)))))))

nn(concentrations-5, Valdecoxib-1)
amod(concentrations-5, steady-2)
nn(concentrations-5, state-3)
nn(concentrations-5, plasma-4)
nsubjpass(affected-13, concentrations-5)
num(mg-8, 40-7)
appos(concentrations-5, mg-8)
amod(mg-8, BID-9)
auxpass(affected-13, were-11)
neg(affected-13, not-12)
root(ROOT-0, affected-13)
advmod(affected-13, significantly-14)
amod(doses-17, multiple-16)
prep_with(affected-13, doses-17)
prep_of(doses-17, omeprazole-19)
number(mg-22, 40-21)
amod(-RRB-.-24, mg-22)
nn(-RRB-.-24, QD-23)
dobj(affected-13, -RRB-.-24)

Coadministration/NN with/IN valdecoxib/NN increased/VBN exposure/NN of/IN omeprazole/NN (/-LRB- AUC/NN )/-RRB- by/IN 46/CD %./NN

(ROOT (S1 (S (NP (NP (NN Coadministration)) (PP (IN with) (NP (NP (NP (NN valdecoxib)) (VBN increased) (NN exposure)) (PP (IN of) (NP (NP (NN omeprazole)) (PRN (-LRB- -LRB-) (NP (NN AUC)) (-RRB- -RRB-)))))) (PP (IN by) (NP (CD 46) (NN %.)))))))

root(ROOT-0, Coadministration-1)
nn(exposure-5, valdecoxib-3)
amod(exposure-5, increased-4)
prep_with(Coadministration-1, exposure-5)
prep_of(exposure-5, omeprazole-7)
abbrev(omeprazole-7, AUC-9)
num(%.-13, 46-12)
prep_by(Coadministration-1, %.-13)

Drugs/NNS whose/WP$ absorption/NN is/VBZ sensitive/JJ to/TO pH/NN may/MD be/VB negatively/RB impacted/VBN by/IN concomitant/JJ administration/NN of/IN omeprazole/NN and/CC valdecoxib/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WP$ whose) (NN absorption)) (S (VP (VBZ is) (ADJP (JJ sensitive) (PP (TO to) (NP (NN pH)))))))) (VP (MD may) (VP (VB be) (ADVP (RB negatively)) (VP (VBN impacted) (PP (IN by) (NP (NP (JJ concomitant) (NN administration)) (PP (IN of) (NP (NP (NN omeprazole)) (CC and) (NP (NN valdecoxib)))))))))) (. .))))

poss(absorption-3, Drugs-1)
nsubjpass(impacted-11, Drugs-1)
nsubj(sensitive-5, absorption-3)
cop(sensitive-5, is-4)
rcmod(Drugs-1, sensitive-5)
prep_to(sensitive-5, pH-7)
aux(impacted-11, may-8)
auxpass(impacted-11, be-9)
advmod(impacted-11, negatively-10)
root(ROOT-0, impacted-11)
amod(administration-14, concomitant-13)
agent(impacted-11, administration-14)
prep_of(administration-14, omeprazole-16)
conj_and(omeprazole-16, valdecoxib-18)

However/RB ,/, because/IN higher/JJR doses/NNS (/-LRB- up/RB to/TO 360/CD mg/NN QD/NN )/-RRB- of/IN omeprazole/NN are/VBP tolerated/VBN in/IN Zollinger-Ellison/NN (/-LRB- ZE/NN )/-RRB- patients/NNS ,/, no/DT dose/NN adjustment/NN for/IN omeprazole/NN is/VBZ recommended/VBN at/IN current/JJ doses/NNS ./.

(ROOT (S1 (S (ADVP (RB However)) (, ,) (SBAR (IN because) (S (NP (NP (NP (JJR higher) (NNS doses)) (PRN (-LRB- -LRB-) (NP (QP (RB up) (TO to) (CD 360)) (NN mg) (NN QD)) (-RRB- -RRB-))) (PP (IN of) (NP (NN omeprazole)))) (VP (VBP are) (VP (VBN tolerated) (PP (IN in) (NP (NP (NP (NN Zollinger-Ellison)) (PRN (-LRB- -LRB-) (NP (NN ZE)) (-RRB- -RRB-))) (NNS patients))))))) (, ,) (NP (NP (DT no) (NN dose) (NN adjustment)) (PP (IN for) (NP (NN omeprazole)))) (VP (VBZ is) (VP (VBN recommended) (PP (IN at) (NP (JJ current) (NNS doses))))) (. .))))

advmod(recommended-30, However-1)
mark(tolerated-16, because-3)
amod(doses-5, higher-4)
nsubjpass(tolerated-16, doses-5)
quantmod(360-9, up-7)
dep(360-9, to-8)
num(QD-11, 360-9)
nn(QD-11, mg-10)
appos(doses-5, QD-11)
prep_of(doses-5, omeprazole-14)
auxpass(tolerated-16, are-15)
advcl(recommended-30, tolerated-16)
nn(patients-22, Zollinger-Ellison-18)
abbrev(Zollinger-Ellison-18, ZE-20)
prep_in(tolerated-16, patients-22)
det(adjustment-26, no-24)
nn(adjustment-26, dose-25)
nsubjpass(recommended-30, adjustment-26)
prep_for(adjustment-26, omeprazole-28)
auxpass(recommended-30, is-29)
root(ROOT-0, recommended-30)
amod(doses-33, current-32)
prep_at(recommended-30, doses-33)

Coadministration/NN of/IN valdecoxib/NN with/IN doses/NNS higher/JJR than/IN 40/CD mg/NN QD/NN omeprazole/NN has/VBZ not/RB been/VBN studied/VBN ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NN valdecoxib))) (PP (IN with) (NP (NP (NNS doses)) (ADJP (JJR higher) (PP (IN than) (NP (ADJP (CD 40) (NN mg)) (NN QD) (NN omeprazole))))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN studied))))) (. .))))

nsubjpass(studied-15, Coadministration-1)
prep_of(Coadministration-1, valdecoxib-3)
prep_with(Coadministration-1, doses-5)
amod(doses-5, higher-6)
number(mg-9, 40-8)
amod(omeprazole-11, mg-9)
nn(omeprazole-11, QD-10)
prep_than(higher-6, omeprazole-11)
aux(studied-15, has-12)
neg(studied-15, not-13)
auxpass(studied-15, been-14)
root(ROOT-0, studied-15)

Oral/JJ Contraceptives/NNS :/: Valdecoxib/NN (/-LRB- 40/CD mg/NN BID/NN )/-RRB- did/VBD not/RB induce/VB the/DT metabolism/NN of/IN the/DT combination/NN oral/JJ contraceptive/JJ norethindrone//NN ethinyl/NN estradiol/NN (/-LRB- 1/CD mg/NN /35/NN mcg/NN combination/NN ,/, Ortho-Novum/NN 1/35/CD @/NN )/-RRB- ./.

(ROOT (S1 (S (NP (NP (JJ Oral) (NNS Contraceptives)) (: :) (S (NP (NP (NN Valdecoxib)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 40) (NN mg)) (NN BID)) (-RRB- -RRB-))) (VP (VBD did) (RB not) (VP (VB induce) (NP (NP (DT the) (NN metabolism)) (PP (IN of) (NP (NP (DT the) (NN combination) (JJ oral) (JJ contraceptive) (NN norethindrone/) (NN ethinyl) (NN estradiol)) (PRN (-LRB- -LRB-) (FRAG (NP (ADJP (CD 1) (NN mg)) (NN /35) (NN mcg) (NN combination)) (, ,) (NP (NN Ortho-Novum) (CD 1/35) (NN @))) (-RRB- -RRB-)))))))) (. .)))))

amod(Contraceptives-2, Oral-1)
root(ROOT-0, Contraceptives-2)
nsubj(induce-12, Valdecoxib-4)
number(mg-7, 40-6)
amod(BID-8, mg-7)
appos(Valdecoxib-4, BID-8)
aux(induce-12, did-10)
neg(induce-12, not-11)
dep(Contraceptives-2, induce-12)
det(metabolism-14, the-13)
dobj(induce-12, metabolism-14)
det(estradiol-22, the-16)
nn(estradiol-22, combination-17)
amod(estradiol-22, oral-18)
amod(estradiol-22, contraceptive-19)
nn(estradiol-22, norethindrone/-20)
nn(estradiol-22, ethinyl-21)
prep_of(metabolism-14, estradiol-22)
number(mg-25, 1-24)
amod(combination-28, mg-25)
nn(combination-28, /35-26)
nn(combination-28, mcg-27)
dep(estradiol-22, combination-28)
nn(@-32, Ortho-Novum-30)
num(@-32, 1/35-31)
dep(combination-28, @-32)

Coadministration/NN of/IN valdecoxib/NN and/CC Ortho-Novum/NN 1/35/NN @/NN increased/VBD the/DT exposure/NN of/IN norethindrone/NN and/CC ethinyl/NN estradiol/NN by/IN 20/CD %/NN and/CC 34/CD %/NN ,/, respectively/RB ./.

(ROOT (S1 (S (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NN valdecoxib)) (CC and) (NP (NN Ortho-Novum) (NN 1/35) (NN @))))) (VP (VBD increased) (NP (NP (DT the) (NN exposure)) (PP (IN of) (NP (NP (NN norethindrone)) (CC and) (NP (NN ethinyl) (NN estradiol))))) (PP (IN by) (NP (NP (CD 20) (NN %)) (CC and) (NP (CD 34) (NN %)) (, ,) (ADVP (RB respectively)))))) (. .))))

nsubj(increased-8, Coadministration-1)
prep_of(Coadministration-1, valdecoxib-3)
nn(@-7, Ortho-Novum-5)
nn(@-7, 1/35-6)
conj_and(valdecoxib-3, @-7)
root(ROOT-0, increased-8)
det(exposure-10, the-9)
dobj(increased-8, exposure-10)
prep_of(exposure-10, norethindrone-12)
nn(estradiol-15, ethinyl-14)
conj_and(norethindrone-12, estradiol-15)
num(%-18, 20-17)
prep_by(increased-8, %-18)
num(%-21, 34-20)
conj_and(%-18, %-21)
advmod(%-18, respectively-23)
conj_and(%-18, respectively-23)

Although/IN there/EX is/VBZ little/JJ risk/NN for/IN loss/NN of/IN contraceptive/JJ efficacy/NN ,/, the/DT clinical/JJ significance/NN of/IN these/DT increased/VBN exposures/NNS in/IN terms/NNS of/IN safety/NN is/VBZ not/RB known/VBN ./.

(ROOT (S1 (S (S (SBAR (IN Although) (S (NP (EX there)) (VP (VBZ is) (NP (NP (JJ little) (NN risk)) (PP (IN for) (NP (NP (NN loss)) (PP (IN of) (NP (JJ contraceptive) (NN efficacy))))))))) (, ,) (NP (NP (DT the) (JJ clinical) (NN significance)) (PP (IN of) (NP (DT these) (VBN increased) (NNS exposures))) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NN safety)))))) (VP (VBZ is) (RB not) (VP (VBN known)))) (. .))))

mark(is-3, Although-1)
expl(is-3, there-2)
advcl(known-25, is-3)
amod(risk-5, little-4)
nsubj(is-3, risk-5)
prep_for(risk-5, loss-7)
amod(efficacy-10, contraceptive-9)
prep_of(loss-7, efficacy-10)
det(significance-14, the-12)
amod(significance-14, clinical-13)
nsubjpass(known-25, significance-14)
det(exposures-18, these-16)
amod(exposures-18, increased-17)
prep_of(significance-14, exposures-18)
prep_in(significance-14, terms-20)
prep_of(terms-20, safety-22)
auxpass(known-25, is-23)
neg(known-25, not-24)
root(ROOT-0, known-25)

These/DT increased/VBN exposures/NNS of/IN norethindrone/NN and/CC ethinyl/NN estradiol/NN should/MD be/VB taken/VBN into/IN consideration/NN when/WRB selecting/VBG an/DT oral/JJ contraceptive/NN for/IN women/NNS taking/VBG valdecoxib/NN ./.

(ROOT (S1 (S (S (NP (NP (DT These) (VBN increased) (NNS exposures)) (PP (IN of) (NP (NP (NN norethindrone)) (CC and) (NP (NN ethinyl) (NN estradiol))))) (VP (MD should) (VP (VB be) (VP (VBN taken) (PP (IN into) (NP (NN consideration))) (SBAR (WHADVP (WRB when)) (S (VP (VBG selecting) (NP (NP (DT an) (JJ oral) (NN contraceptive)) (PP (IN for) (NP (NP (NNS women)) (VP (VBG taking) (NP (NN valdecoxib))))))))))))) (. .))))

det(exposures-3, These-1)
amod(exposures-3, increased-2)
nsubjpass(taken-11, exposures-3)
prep_of(exposures-3, norethindrone-5)
nn(estradiol-8, ethinyl-7)
conj_and(norethindrone-5, estradiol-8)
aux(taken-11, should-9)
auxpass(taken-11, be-10)
root(ROOT-0, taken-11)
prep_into(taken-11, consideration-13)
advmod(selecting-15, when-14)
advcl(taken-11, selecting-15)
det(contraceptive-18, an-16)
amod(contraceptive-18, oral-17)
dobj(selecting-15, contraceptive-18)
prep_for(contraceptive-18, women-20)
partmod(women-20, taking-21)
dobj(taking-21, valdecoxib-22)

Diazepam/NN :/: Diazepam/NN (/-LRB- Valium/NN )/-RRB- is/VBZ a/DT CYP/NN 3A4/NN and/CC CYP/NN 2C19/NN substrate/NN ./.

(ROOT (S1 (S (NP (NP (NN Diazepam)) (: :) (S (NP (NP (NN Diazepam)) (PRN (-LRB- -LRB-) (NP (NN Valium)) (-RRB- -RRB-))) (VP (VBZ is) (NP (DT a) (NN CYP) (NN 3A4) (CC and) (NN CYP) (NN 2C19) (NN substrate)))) (. .)))))

root(ROOT-0, Diazepam-1)
nsubj(3A4-10, Diazepam-3)
appos(Diazepam-3, Valium-5)
cop(3A4-10, is-7)
det(3A4-10, a-8)
nn(3A4-10, CYP-9)
dep(Diazepam-1, 3A4-10)
nn(substrate-14, CYP-12)
nn(substrate-14, 2C19-13)
conj_and(3A4-10, substrate-14)

Plasma/NN exposure/NN of/IN diazepam/NN (/-LRB- 10/CD mg/NN BID/NN )/-RRB- was/VBD increased/VBN by/IN 28/CD %/NN following/VBG administration/NN of/IN valdecoxib/NN (/-LRB- 40/CD mg/NN BID/NN )/-RRB- for/IN 12/CD days/NNS ,/, while/IN plasma/NN exposure/NN of/IN valdecoxib/NN (/-LRB- 40/CD mg/NN BID/NN )/-RRB- was/VBD not/RB substantially/RB increased/VBN following/VBG administration/NN of/IN diazepam/NN (/-LRB- 10/CD mg/NN BID/NN )/-RRB- for/IN 12/CD days/NNS ./.

(ROOT (S1 (S (S (NP (NP (NN Plasma) (NN exposure)) (PP (IN of) (NP (NP (NN diazepam)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 10) (NN mg)) (NN BID)) (-RRB- -RRB-))))) (VP (VBD was) (VP (VBN increased) (PP (IN by) (NP (CD 28) (NN %))) (PP (VBG following) (NP (NP (NN administration)) (PP (IN of) (NP (NP (NN valdecoxib)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 40) (NN mg)) (NN BID)) (-RRB- -RRB-)))) (PP (IN for) (NP (CD 12) (NNS days)))))) (, ,) (SBAR (IN while) (S (NP (NP (NN plasma) (NN exposure)) (PP (IN of) (NP (NP (NN valdecoxib)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 40) (NN mg)) (NN BID)) (-RRB- -RRB-))))) (VP (VBD was) (RB not) (ADVP (RB substantially)) (VP (VBN increased) (PP (VBG following) (NP (NP (NN administration)) (PP (IN of) (NP (NP (NP (NN diazepam)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 10) (NN mg)) (NN BID)) (-RRB- -RRB-))) (PP (IN for) (NP (CD 12) (NNS days))))))))))))) (. .))))

nn(exposure-2, Plasma-1)
nsubjpass(increased-11, exposure-2)
prep_of(exposure-2, diazepam-4)
number(mg-7, 10-6)
amod(BID-8, mg-7)
appos(diazepam-4, BID-8)
auxpass(increased-11, was-10)
root(ROOT-0, increased-11)
num(%-14, 28-13)
agent(increased-11, %-14)
prep_following(increased-11, administration-16)
prep_of(administration-16, valdecoxib-18)
number(mg-21, 40-20)
amod(BID-22, mg-21)
appos(valdecoxib-18, BID-22)
num(days-26, 12-25)
prep_for(administration-16, days-26)
mark(increased-41, while-28)
nn(exposure-30, plasma-29)
nsubjpass(increased-41, exposure-30)
prep_of(exposure-30, valdecoxib-32)
number(mg-35, 40-34)
amod(BID-36, mg-35)
appos(valdecoxib-32, BID-36)
auxpass(increased-41, was-38)
neg(increased-41, not-39)
advmod(increased-41, substantially-40)
advcl(increased-11, increased-41)
prep_following(increased-41, administration-43)
prep_of(administration-43, diazepam-45)
number(mg-48, 10-47)
amod(BID-49, mg-48)
appos(diazepam-45, BID-49)
num(days-53, 12-52)
prep_for(diazepam-45, days-53)

Although/IN the/DT magnitude/NN of/IN changes/NNS in/IN diazepam/NN plasma/NN exposure/NN when/WRB coadministered/VBN with/IN valdecoxib/NN were/VBD not/RB sufficient/JJ to/TO warrant/VBP dosage/NN adjustments/NNS ,/, patients/NNS may/MD experience/VBP enhanced/VBN sedative/JJ side/JJ effects/NNS caused/VBN by/IN increased/VBN exposure/NN of/IN diazepam/NN under/IN this/DT circumstance/NN ./.

(ROOT (S1 (S (SBAR (IN Although) (S (NP (NP (DT the) (NN magnitude)) (PP (IN of) (NP (NP (NNS changes)) (PP (IN in) (NP (NP (NN diazepam) (NN plasma) (NN exposure)) (SBAR (WHADVP (WRB when)) (S (VP (VBN coadministered) (PP (IN with) (NP (NN valdecoxib))))))))))) (VP (VBD were) (RB not) (ADJP (JJ sufficient) (S (VP (TO to) (VP (VBP warrant) (NP (NN dosage) (NNS adjustments))))))))) (, ,) (NP (NNS patients)) (VP (MD may) (VP (VBP experience) (NP (NP (VBN enhanced) (JJ sedative) (JJ side) (NNS effects)) (VP (VBN caused) (PP (IN by) (NP (NP (VBN increased) (NN exposure)) (PP (IN of) (NP (NN diazepam))) (PP (IN under) (NP (DT this) (NN circumstance))))))))) (. .))))

mark(sufficient-16, Although-1)
det(magnitude-3, the-2)
nsubj(sufficient-16, magnitude-3)
prep_of(magnitude-3, changes-5)
nn(exposure-9, diazepam-7)
nn(exposure-9, plasma-8)
prep_in(changes-5, exposure-9)
advmod(coadministered-11, when-10)
dep(exposure-9, coadministered-11)
prep_with(coadministered-11, valdecoxib-13)
cop(sufficient-16, were-14)
neg(sufficient-16, not-15)
advcl(experience-24, sufficient-16)
aux(warrant-18, to-17)
xcomp(sufficient-16, warrant-18)
nn(adjustments-20, dosage-19)
dobj(warrant-18, adjustments-20)
nsubj(experience-24, patients-22)
aux(experience-24, may-23)
root(ROOT-0, experience-24)
amod(effects-28, enhanced-25)
amod(effects-28, sedative-26)
amod(effects-28, side-27)
dobj(experience-24, effects-28)
partmod(effects-28, caused-29)
amod(exposure-32, increased-31)
agent(caused-29, exposure-32)
prep_of(exposure-32, diazepam-34)
det(circumstance-37, this-36)
prep_under(exposure-32, circumstance-37)

As/IN with/IN all/DT drugs/NNS ,/, the/DT potential/NN exists/VBZ for/IN interaction/NN with/IN other/JJ drugs/NNS by/IN a/DT variety/NN of/IN mechanisms/NNS ./.

(ROOT (S1 (S (S (PP (IN As) (PP (IN with) (NP (DT all) (NNS drugs)))) (, ,) (NP (DT the) (NN potential)) (VP (VBZ exists) (PP (IN for) (NP (NP (NN interaction)) (PP (IN with) (NP (JJ other) (NNS drugs))))) (PP (IN by) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS mechanisms))))))) (. .))))

prep(exists-8, As-1)
pcomp(As-1, with-2)
det(drugs-4, all-3)
prep_with(As-1, drugs-4)
det(potential-7, the-6)
nsubj(exists-8, potential-7)
root(ROOT-0, exists-8)
prep_for(exists-8, interaction-10)
amod(drugs-13, other-12)
prep_with(interaction-10, drugs-13)
det(variety-16, a-15)
prep_by(exists-8, variety-16)
prep_of(variety-16, mechanisms-18)

CNS-Active/JJ Drugs/NNS Ethanol/NN :/: Sonata/NN 10/CD mg/NN potentiated/VBD the/DT CNS-impairing/JJ effects/NNS of/IN ethanol/NN 0.75/CD g/kg/NN on/IN balance/NN testing/NN and/CC reaction/NN time/NN for/IN 1/CD hour/NN after/IN ethanol/NN administration/NN and/CC on/IN the/DT digit/JJ symbol/NN substitution/NN test/NN (/-LRB- DSST/NN )/-RRB- ,/, symbol/NN copying/NN test/NN ,/, and/CC the/DT variability/NN component/NN of/IN the/DT divided/JJ attention/NN test/VB for/IN 2.5/CD hours/NNS after/IN ethanol/NN administration/NN ./.

(ROOT (S1 (S (NP (NP (JJ CNS-Active) (NNS Drugs) (NN Ethanol)) (: :) (S (NP (NN Sonata) (CD 10) (NN mg)) (VP (VBD potentiated) (NP (NP (DT the) (JJ CNS-impairing) (NNS effects)) (PP (IN of) (NP (NN ethanol) (CD 0.75) (NN g/kg))) (PP (PP (IN on) (NP (NP (NP (NN balance) (NN testing)) (CC and) (NP (NN reaction) (NN time))) (PP (IN for) (NP (CD 1) (NN hour))) (PP (IN after) (NP (NN ethanol) (NN administration))))) (CC and) (PP (IN on) (NP (NP (NP (DT the) (JJ digit) (NN symbol) (NN substitution) (NN test)) (PRN (-LRB- -LRB-) (NP (NN DSST)) (-RRB- -RRB-))) (, ,) (NP (NN symbol) (NN copying) (NN test)) (, ,) (CC and) (NP (NP (DT the) (NN variability) (NN component)) (PP (IN of) (NP (NP (DT the) (JJ divided) (NN attention)) (VP (VB test) (PP (IN for) (NP (NP (CD 2.5) (NNS hours)) (PP (IN after) (NP (NN ethanol) (NN administration))))))))))))))) (. .)))))

amod(Ethanol-3, CNS-Active-1)
nn(Ethanol-3, Drugs-2)
root(ROOT-0, Ethanol-3)
nn(mg-7, Sonata-5)
num(mg-7, 10-6)
nsubj(potentiated-8, mg-7)
dep(Ethanol-3, potentiated-8)
det(effects-11, the-9)
amod(effects-11, CNS-impairing-10)
dobj(potentiated-8, effects-11)
nn(g/kg-15, ethanol-13)
num(g/kg-15, 0.75-14)
prep_of(effects-11, g/kg-15)
nn(testing-18, balance-17)
prep_on(effects-11, testing-18)
nn(time-21, reaction-20)
conj_and(testing-18, time-21)
num(hour-24, 1-23)
prep_for(testing-18, hour-24)
nn(administration-27, ethanol-26)
prep_after(testing-18, administration-27)
det(test-34, the-30)
amod(test-34, digit-31)
nn(test-34, symbol-32)
nn(test-34, substitution-33)
conj_and(testing-18, test-34)
abbrev(test-34, DSST-36)
nn(test-41, symbol-39)
nn(test-41, copying-40)
conj_and(test-34, test-41)
det(component-46, the-44)
nn(component-46, variability-45)
conj_and(test-34, component-46)
det(attention-50, the-48)
amod(attention-50, divided-49)
prep_of(component-46, attention-50)
dep(attention-50, test-51)
num(hours-54, 2.5-53)
prep_for(test-51, hours-54)
nn(administration-57, ethanol-56)
prep_after(hours-54, administration-57)

zaleplon/NN did/VBD not/RB affect/VB the/DT pharmacokinetics/NNS of/IN ethanol/NN ./.

(ROOT (S1 (S (S (NP (NN zaleplon)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN ethanol))))))) (. .))))

nsubj(affect-4, zaleplon-1)
aux(affect-4, did-2)
neg(affect-4, not-3)
root(ROOT-0, affect-4)
det(pharmacokinetics-6, the-5)
dobj(affect-4, pharmacokinetics-6)
prep_of(pharmacokinetics-6, ethanol-8)

Imipramine/NN :/: Coadministration/NN of/IN single/JJ doses/NNS of/IN Sonata/NN 20/CD mg/NN and/CC imipramine/NN 75/CD mg/NN produced/VBD additive/JJ effects/NNS on/IN decreased/VBN alertness/NN and/CC impaired/JJ psychomotor/NN performance/NN for/IN 2/CD to/TO 4/CD hours/NNS after/IN administration/NN ./.

(ROOT (S1 (S (NP (NP (NN Imipramine)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (JJ single) (NNS doses)) (PP (IN of) (NP (NP (NN Sonata) (CD 20) (NN mg)) (CC and) (NP (NN imipramine) (CD 75) (NN mg))))))) (VP (VBD produced) (NP (NP (JJ additive) (NNS effects)) (PP (IN on) (NP (NP (VBN decreased) (NN alertness)) (CC and) (NP (JJ impaired) (NN psychomotor) (NN performance)))) (PP (IN for) (NP (QP (CD 2) (TO to) (CD 4)) (NNS hours)))) (PP (IN after) (NP (NN administration))))) (. .)))))

root(ROOT-0, Imipramine-1)
nsubj(produced-15, Coadministration-3)
amod(doses-6, single-5)
prep_of(Coadministration-3, doses-6)
nn(mg-10, Sonata-8)
num(mg-10, 20-9)
prep_of(doses-6, mg-10)
nn(mg-14, imipramine-12)
num(mg-14, 75-13)
conj_and(mg-10, mg-14)
dep(Imipramine-1, produced-15)
amod(effects-17, additive-16)
dobj(produced-15, effects-17)
amod(alertness-20, decreased-19)
prep_on(effects-17, alertness-20)
amod(performance-24, impaired-22)
nn(performance-24, psychomotor-23)
conj_and(alertness-20, performance-24)
number(4-28, 2-26)
dep(4-28, to-27)
num(hours-29, 4-28)
prep_for(effects-17, hours-29)
prep_after(produced-15, administration-31)

The/DT interaction/NN was/VBD pharmacodynamic/JJ with/IN no/DT alteration/NN of/IN the/DT pharmacokinetics/NNS of/IN either/DT drug/NN ./.

(ROOT (S1 (S (S (NP (DT The) (NN interaction)) (VP (VBD was) (ADJP (JJ pharmacodynamic) (PP (IN with) (NP (NP (DT no) (NN alteration)) (PP (IN of) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (DT either) (NN drug)))))))))) (. .))))

det(interaction-2, The-1)
nsubj(pharmacodynamic-4, interaction-2)
cop(pharmacodynamic-4, was-3)
root(ROOT-0, pharmacodynamic-4)
det(alteration-7, no-6)
prep_with(pharmacodynamic-4, alteration-7)
det(pharmacokinetics-10, the-9)
prep_of(alteration-7, pharmacokinetics-10)
det(drug-13, either-12)
prep_of(pharmacokinetics-10, drug-13)

Paroxetine/NN :/: Coadministration/NN of/IN a/DT single/JJ dose/NN of/IN Sonata/NN 20/CD mg/NN and/CC paroxetine/NN 20/CD mg/NN daily/RB for/IN 7/CD days/NNS did/VBD not/RB produce/VB any/DT interaction/NN on/IN psychomotor/NN performance/NN ./.

(ROOT (S1 (S (NP (NP (NN Paroxetine)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NP (NN Sonata) (CD 20) (NN mg)) (CC and) (NP (NP (NN paroxetine) (CD 20) (NN mg)) (ADVP (RB daily)) (PP (IN for) (NP (CD 7) (NNS days))))))))) (VP (VBD did) (RB not) (VP (VB produce) (NP (NP (DT any) (NN interaction)) (PP (IN on) (NP (NN psychomotor) (NN performance))))))) (. .)))))

root(ROOT-0, Paroxetine-1)
nsubj(produce-22, Coadministration-3)
det(dose-7, a-5)
amod(dose-7, single-6)
prep_of(Coadministration-3, dose-7)
nn(mg-11, Sonata-9)
num(mg-11, 20-10)
prep_of(dose-7, mg-11)
nn(mg-15, paroxetine-13)
num(mg-15, 20-14)
conj_and(mg-11, mg-15)
advmod(mg-15, daily-16)
num(days-19, 7-18)
prep_for(mg-15, days-19)
aux(produce-22, did-20)
neg(produce-22, not-21)
dep(Paroxetine-1, produce-22)
det(interaction-24, any-23)
dobj(produce-22, interaction-24)
nn(performance-27, psychomotor-26)
prep_on(interaction-24, performance-27)

Additionally/RB ,/, paroxetine/NN did/VBD not/RB alter/VB the/DT pharmacokinetics/NNS of/IN Sonata/NN ,/, reflecting/VBG the/DT absence/NN of/IN a/DT role/NN of/IN CYP2D6/NN in/IN zaleplon/NN @/NN s/NN metabolism/NN ./.

(ROOT (S1 (S (S (ADVP (RB Additionally)) (, ,) (NP (NN paroxetine)) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NN Sonata)))) (, ,) (S (VP (VBG reflecting) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NP (DT a) (NN role)) (PP (IN of) (NP (NN CYP2D6))) (PP (IN in) (NP (NN zaleplon) (NN @) (NN s) (NN metabolism))))))))))) (. .))))

advmod(alter-6, Additionally-1)
nsubj(alter-6, paroxetine-3)
aux(alter-6, did-4)
neg(alter-6, not-5)
root(ROOT-0, alter-6)
det(pharmacokinetics-8, the-7)
dobj(alter-6, pharmacokinetics-8)
prep_of(pharmacokinetics-8, Sonata-10)
partmod(alter-6, reflecting-12)
xcomp(alter-6, reflecting-12)
det(absence-14, the-13)
dobj(reflecting-12, absence-14)
det(role-17, a-16)
prep_of(absence-14, role-17)
prep_of(role-17, CYP2D6-19)
nn(metabolism-24, zaleplon-21)
nn(metabolism-24, @-22)
nn(metabolism-24, s-23)
prep_in(role-17, metabolism-24)

Thioridazine/NN :/: Coadministration/NN of/IN single/JJ doses/NNS of/IN Sonata/NN 20/CD mg/NN and/CC thioridazine/NN 50/CD mg/NN produced/VBD additive/JJ effects/NNS on/IN decreased/VBN alertness/NN and/CC impaired/JJ psychomotor/NN performance/NN for/IN 2/CD to/TO 4/CD hours/NNS after/IN administration/NN ./.

(ROOT (S1 (S (NP (NP (NN Thioridazine)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (JJ single) (NNS doses)) (PP (IN of) (NP (NP (NN Sonata) (CD 20) (NN mg)) (CC and) (NP (NN thioridazine) (CD 50) (NN mg))))))) (VP (VBD produced) (NP (NP (JJ additive) (NNS effects)) (PP (IN on) (NP (NP (VBN decreased) (NN alertness)) (CC and) (NP (JJ impaired) (NN psychomotor) (NN performance)))) (PP (IN for) (NP (QP (CD 2) (TO to) (CD 4)) (NNS hours)))) (PP (IN after) (NP (NN administration))))) (. .)))))

root(ROOT-0, Thioridazine-1)
nsubj(produced-15, Coadministration-3)
amod(doses-6, single-5)
prep_of(Coadministration-3, doses-6)
nn(mg-10, Sonata-8)
num(mg-10, 20-9)
prep_of(doses-6, mg-10)
nn(mg-14, thioridazine-12)
num(mg-14, 50-13)
conj_and(mg-10, mg-14)
dep(Thioridazine-1, produced-15)
amod(effects-17, additive-16)
dobj(produced-15, effects-17)
amod(alertness-20, decreased-19)
prep_on(effects-17, alertness-20)
amod(performance-24, impaired-22)
nn(performance-24, psychomotor-23)
conj_and(alertness-20, performance-24)
number(4-28, 2-26)
dep(4-28, to-27)
num(hours-29, 4-28)
prep_for(effects-17, hours-29)
prep_after(produced-15, administration-31)

The/DT interaction/NN was/VBD pharmacodynamic/JJ with/IN no/DT alteration/NN of/IN the/DT pharmacokinetics/NNS of/IN either/DT drug/NN ./.

(ROOT (S1 (S (S (NP (DT The) (NN interaction)) (VP (VBD was) (ADJP (JJ pharmacodynamic) (PP (IN with) (NP (NP (DT no) (NN alteration)) (PP (IN of) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (DT either) (NN drug)))))))))) (. .))))

det(interaction-2, The-1)
nsubj(pharmacodynamic-4, interaction-2)
cop(pharmacodynamic-4, was-3)
root(ROOT-0, pharmacodynamic-4)
det(alteration-7, no-6)
prep_with(pharmacodynamic-4, alteration-7)
det(pharmacokinetics-10, the-9)
prep_of(alteration-7, pharmacokinetics-10)
det(drug-13, either-12)
prep_of(pharmacokinetics-10, drug-13)

Venlafaxine/NN :/: Coadministration/NN of/IN a/DT single/JJ dose/NN of/IN zaleplon/NN 10/CD mg/NN and/CC multiple/JJ doses/NNS of/IN venlafaxine/NN ER/NN (/-LRB- extended/JJ release/NN )/-RRB- 150/CD mg/NN did/VBD not/RB result/VB in/IN any/DT significant/JJ changes/NNS in/IN the/DT pharmacokinetics/NNS of/IN either/CC zaleplon/NN or/CC venlafaxine/NN ./.

(ROOT (S1 (S (NP (NP (NN Venlafaxine)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NP (NN zaleplon) (CD 10) (NN mg)) (CC and) (NP (NP (NP (JJ multiple) (NNS doses)) (PP (IN of) (NP (NN venlafaxine) (NN ER)))) (PRN (-LRB- -LRB-) (NP (JJ extended) (NN release)) (-RRB- -RRB-))) (NP (CD 150) (NN mg))))))) (VP (VBD did) (RB not) (VP (VB result) (PP (IN in) (NP (NP (DT any) (JJ significant) (NNS changes)) (PP (IN in) (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (CC either) (NP (NN zaleplon)) (CC or) (NP (NN venlafaxine))))))))))) (. .)))))

root(ROOT-0, Venlafaxine-1)
nsubj(result-26, Coadministration-3)
det(dose-7, a-5)
amod(dose-7, single-6)
prep_of(Coadministration-3, dose-7)
nn(mg-11, zaleplon-9)
num(mg-11, 10-10)
prep_of(dose-7, mg-11)
amod(doses-14, multiple-13)
conj_and(mg-11, doses-14)
nn(ER-17, venlafaxine-16)
prep_of(doses-14, ER-17)
amod(release-20, extended-19)
appos(doses-14, release-20)
num(mg-23, 150-22)
dep(mg-11, mg-23)
aux(result-26, did-24)
neg(result-26, not-25)
dep(Venlafaxine-1, result-26)
det(changes-30, any-28)
amod(changes-30, significant-29)
prep_in(result-26, changes-30)
det(pharmacokinetics-33, the-32)
prep_in(changes-30, pharmacokinetics-33)
preconj(zaleplon-36, either-35)
prep_of(pharmacokinetics-33, zaleplon-36)
conj_or(zaleplon-36, venlafaxine-38)

In/IN addition/NN ,/, there/EX was/VBD no/DT pharmacodynamic/JJ interaction/NN as/IN a/DT result/NN of/IN coadministration/NN of/IN zaleplon/NN and/CC venlafaxine/NN ER/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (EX there)) (VP (VBD was) (NP (DT no) (JJ pharmacodynamic) (NN interaction)) (PP (IN as) (NP (NP (DT a) (NN result)) (PP (IN of) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NN zaleplon)) (CC and) (NP (NN venlafaxine) (NN ER)))))))))) (. .))))

prep_in(was-5, addition-2)
expl(was-5, there-4)
root(ROOT-0, was-5)
det(interaction-8, no-6)
amod(interaction-8, pharmacodynamic-7)
nsubj(was-5, interaction-8)
det(result-11, a-10)
prep_as(was-5, result-11)
prep_of(result-11, coadministration-13)
prep_of(coadministration-13, zaleplon-15)
nn(ER-18, venlafaxine-17)
conj_and(zaleplon-15, ER-18)

Promethazine/NN :/: Coadministration/NN of/IN a/DT single/JJ dose/NN of/IN zaleplon/NN and/CC promethazine/NN (/-LRB- 10/CD and/CC 25/CD mg/NN ,/, respectively/RB )/-RRB- resulted/VBD in/IN a/DT 15/CD %/NN decrease/NN in/IN maximal/JJ plasma/NN concentrations/NNS of/IN zaleplon/NN ,/, but/CC no/DT change/NN in/IN the/DT area/NN under/IN the/DT plasma/NN concentration-time/NN curve/NN ./.

(ROOT (S1 (S (NP (NP (NN Promethazine)) (: :) (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (NP (DT a) (JJ single) (NN dose)) (PP (IN of) (NP (NP (NN zaleplon)) (CC and) (NP (NN promethazine))))) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 10) (CC and) (CD 25)) (NN mg)) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))))) (VP (VBD resulted) (PP (IN in) (NP (NP (NP (DT a) (ADJP (CD 15) (NN %)) (NN decrease)) (PP (IN in) (NP (NP (JJ maximal) (NN plasma) (NNS concentrations)) (PP (IN of) (NP (NN zaleplon)))))) (, ,) (CC but) (NP (NP (DT no) (NN change)) (PP (IN in) (NP (NP (DT the) (NN area)) (PP (IN under) (NP (DT the) (NN plasma) (NN concentration-time) (NN curve)))))))))) (. .)))))

root(ROOT-0, Promethazine-1)
nsubj(resulted-20, Coadministration-3)
det(dose-7, a-5)
amod(dose-7, single-6)
prep_of(Coadministration-3, dose-7)
prep_of(dose-7, zaleplon-9)
conj_and(zaleplon-9, promethazine-11)
num(mg-16, 10-13)
conj_and(10-13, 25-15)
dep(dose-7, mg-16)
advmod(mg-16, respectively-18)
dep(Promethazine-1, resulted-20)
det(decrease-25, a-22)
number(%-24, 15-23)
amod(decrease-25, %-24)
prep_in(resulted-20, decrease-25)
amod(concentrations-29, maximal-27)
nn(concentrations-29, plasma-28)
prep_in(decrease-25, concentrations-29)
prep_of(concentrations-29, zaleplon-31)
det(change-35, no-34)
conj_but(decrease-25, change-35)
det(area-38, the-37)
prep_in(change-35, area-38)
det(curve-43, the-40)
nn(curve-43, plasma-41)
nn(curve-43, concentration-time-42)
prep_under(area-38, curve-43)

However/RB ,/, the/DT pharmacodynamics/NNS of/IN coadministration/NN of/IN zaleplon/NN and/CC promethazine/NN have/VBP not/RB been/VBN evaluated/VBN ./.

(ROOT (S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (DT the) (NNS pharmacodynamics)) (PP (IN of) (NP (NP (NN coadministration)) (PP (IN of) (NP (NP (NN zaleplon)) (CC and) (NP (NN promethazine))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN evaluated))))) (. .))))

advmod(evaluated-14, However-1)
det(pharmacodynamics-4, the-3)
nsubjpass(evaluated-14, pharmacodynamics-4)
prep_of(pharmacodynamics-4, coadministration-6)
prep_of(coadministration-6, zaleplon-8)
conj_and(zaleplon-8, promethazine-10)
aux(evaluated-14, have-11)
neg(evaluated-14, not-12)
auxpass(evaluated-14, been-13)
root(ROOT-0, evaluated-14)

Drugs/NNS That/WDT Induce/VBP CYP3A4/NN Rifampin/NN :/: CYP3A4/NN is/VBZ ordinarily/RB a/DT minor/JJ metabolizing/NN enzyme/NN of/IN zaleplon/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT That)) (S (VP (VBP Induce) (NP (NN CYP3A4) (NN Rifampin)))))) (: :) (S (NP (NN CYP3A4)) (VP (VBZ is) (ADVP (RB ordinarily)) (NP (NP (DT a) (JJ minor) (NN metabolizing) (NN enzyme)) (PP (IN of) (NP (NN zaleplon)))))) (. .)))))

root(ROOT-0, Drugs-1)
nsubj(Induce-3, Drugs-1)
rcmod(Drugs-1, Induce-3)
nn(Rifampin-5, CYP3A4-4)
dobj(Induce-3, Rifampin-5)
nsubj(enzyme-13, CYP3A4-7)
cop(enzyme-13, is-8)
advmod(enzyme-13, ordinarily-9)
det(enzyme-13, a-10)
amod(enzyme-13, minor-11)
nn(enzyme-13, metabolizing-12)
dep(Drugs-1, enzyme-13)
prep_of(enzyme-13, zaleplon-15)

Multiple-dose/JJ administration/NN of/IN the/DT potent/JJ CYP3A4/NN inducer/NN rifampin/NN (/-LRB- 600/CD mg/NN every/DT 24/CD hours/NNS ,/, q24h/NN ,/, for/IN 14/CD days/NNS )/-RRB- ,/, however/RB ,/, reduced/VBD zaleplon/NN Cmax/NN and/CC AUC/NN by/IN approximately/RB 80/CD %./NN

(ROOT (S1 (S (NP (NP (JJ Multiple-dose) (NN administration)) (PP (IN of) (NP (NP (DT the) (JJ potent) (NN CYP3A4) (NN inducer) (NN rifampin)) (PRN (-LRB- -LRB-) (NP (NP (CD 600) (NN mg) (NP (DT every) (CD 24) (NNS hours)) (, ,) (NP (NN q24h)) (, ,)) (PP (IN for) (NP (CD 14) (NNS days)))) (-RRB- -RRB-))))) (, ,) (ADVP (RB however)) (, ,) (VP (VBD reduced) (NP (NP (NN zaleplon) (NN Cmax)) (CC and) (NP (NN AUC))) (PP (IN by) (NP (QP (RB approximately) (CD 80)) (NN %.)))))))

amod(administration-2, Multiple-dose-1)
nsubj(reduced-25, administration-2)
det(rifampin-8, the-4)
amod(rifampin-8, potent-5)
nn(rifampin-8, CYP3A4-6)
nn(rifampin-8, inducer-7)
prep_of(administration-2, rifampin-8)
num(mg-11, 600-10)
dep(rifampin-8, mg-11)
det(hours-14, every-12)
num(hours-14, 24-13)
dep(mg-11, hours-14)
appos(mg-11, q24h-16)
num(days-20, 14-19)
prep_for(mg-11, days-20)
advmod(reduced-25, however-23)
root(ROOT-0, reduced-25)
nn(Cmax-27, zaleplon-26)
dobj(reduced-25, Cmax-27)
conj_and(Cmax-27, AUC-29)
quantmod(80-32, approximately-31)
num(%.-33, 80-32)
prep_by(reduced-25, %.-33)

The/DT coadministration/NN of/IN a/DT potent/JJ CYP3A4/NN enzyme/NN inducer/NN ,/, although/IN not/RB posing/VBG a/DT safety/NN concern/NN ,/, thus/RB could/MD lead/VB to/TO ineffectiveness/NN of/IN zaleplon/NN ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN coadministration)) (PP (IN of) (NP (DT a) (JJ potent) (NN CYP3A4) (NN enzyme) (NN inducer)))) (, ,) (SBAR (IN although) (S (VP (RB not) (VBG posing) (NP (DT a) (NN safety) (NN concern))))) (, ,) (ADVP (RB thus)) (VP (MD could) (VP (VB lead) (PP (TO to) (NP (NP (NN ineffectiveness)) (PP (IN of) (NP (NN zaleplon)))))))) (. .))))

det(coadministration-2, The-1)
nsubj(lead-19, coadministration-2)
det(inducer-8, a-4)
amod(inducer-8, potent-5)
nn(inducer-8, CYP3A4-6)
nn(inducer-8, enzyme-7)
prep_of(coadministration-2, inducer-8)
mark(posing-12, although-10)
neg(posing-12, not-11)
dep(lead-19, posing-12)
det(concern-15, a-13)
nn(concern-15, safety-14)
dobj(posing-12, concern-15)
advmod(lead-19, thus-17)
aux(lead-19, could-18)
root(ROOT-0, lead-19)
prep_to(lead-19, ineffectiveness-21)
prep_of(ineffectiveness-21, zaleplon-23)

An/DT alternative/JJ non-CYP3A4/NN substrate/NN hypnotic/JJ agent/NN may/MD be/VB considered/VBN in/IN patients/NNS taking/VBG CYP3A4/JJ inducers/NNS such/JJ as/IN rifampin/NN ,/, phenytoin/NN ,/, carbamazepine/NN ,/, and/CC phenobarbital/NN ./.

(ROOT (S1 (S (S (NP (DT An) (JJ alternative) (NN non-CYP3A4) (NN substrate) (JJ hypnotic) (NN agent)) (VP (MD may) (VP (VB be) (VP (VBN considered) (PP (IN in) (NP (NP (NNS patients)) (VP (VBG taking) (NP (NP (JJ CYP3A4) (NNS inducers)) (PP (JJ such) (IN as) (NP (NP (NN rifampin)) (, ,) (NP (NN phenytoin)) (, ,) (NP (NN carbamazepine)) (, ,) (CC and) (NP (NN phenobarbital)))))))))))) (. .))))

det(agent-6, An-1)
amod(agent-6, alternative-2)
nn(agent-6, non-CYP3A4-3)
nn(agent-6, substrate-4)
amod(agent-6, hypnotic-5)
nsubjpass(considered-9, agent-6)
aux(considered-9, may-7)
auxpass(considered-9, be-8)
root(ROOT-0, considered-9)
prep_in(considered-9, patients-11)
partmod(patients-11, taking-12)
amod(inducers-14, CYP3A4-13)
dobj(taking-12, inducers-14)
prep_such_as(inducers-14, rifampin-17)
conj_and(rifampin-17, phenytoin-19)
conj_and(rifampin-17, carbamazepine-21)
conj_and(rifampin-17, phenobarbital-24)

Drugs/NNS That/WDT Inhibit/VBP CYP3A4/NN CYP3A4/NN is/VBZ a/DT minor/JJ metabolic/JJ pathway/NN for/IN the/DT elimination/NN of/IN zaleplon/NN because/IN the/DT sum/NN of/IN desethylzaleplon/NN (/-LRB- formed/VBN via/IN CYP3A4/NN in/FW vitro/FW )/-RRB- and/CC its/PRP$ metabolites/NNS ,/, 5-oxo-desethylzaleplon/NN and/CC 5-oxo-desethylzaleplon/NN glucuronide/NN ,/, account/VBP for/IN only/RB 9/CD %/NN of/IN the/DT urinary/JJ recovery/NN of/IN a/DT zaleplon/NN dose/NN ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT That)) (S (VP (VBP Inhibit) (NP (NN CYP3A4) (NN CYP3A4)))))) (VP (VBZ is) (NP (NP (DT a) (JJ minor) (JJ metabolic) (NN pathway)) (PP (IN for) (NP (NP (DT the) (NN elimination)) (PP (IN of) (NP (NN zaleplon)))))) (SBAR (IN because) (S (NP (NP (NP (DT the) (NN sum)) (PP (IN of) (NP (NP (NN desethylzaleplon)) (-LRB- -LRB-) (VP (VBN formed) (PP (IN via) (NP (NN CYP3A4))) (ADVP (FW in) (FW vitro))) (-RRB- -RRB-)))) (CC and) (NP (NP (PRP$ its) (NNS metabolites)) (, ,) (NP (NP (NN 5-oxo-desethylzaleplon)) (CC and) (NP (NN 5-oxo-desethylzaleplon) (NN glucuronide))) (, ,))) (VP (VBP account) (PP (IN for) (NP (NP (QP (RB only) (CD 9)) (NN %)) (PP (IN of) (NP (NP (DT the) (JJ urinary) (NN recovery)) (PP (IN of) (NP (DT a) (NN zaleplon) (NN dose)))))))))))) (. .))))

nsubj(Inhibit-3, Drugs-1)
nsubj(pathway-10, Drugs-1)
rcmod(Drugs-1, Inhibit-3)
nn(CYP3A4-5, CYP3A4-4)
dobj(Inhibit-3, CYP3A4-5)
cop(pathway-10, is-6)
det(pathway-10, a-7)
amod(pathway-10, minor-8)
amod(pathway-10, metabolic-9)
root(ROOT-0, pathway-10)
det(elimination-13, the-12)
prep_for(pathway-10, elimination-13)
prep_of(elimination-13, zaleplon-15)
mark(account-37, because-16)
det(sum-18, the-17)
nsubj(account-37, sum-18)
prep_of(sum-18, desethylzaleplon-20)
partmod(desethylzaleplon-20, formed-22)
prep_via(formed-22, CYP3A4-24)
nn(vitro-26, in-25)
advmod(formed-22, vitro-26)
poss(metabolites-30, its-29)
conj_and(sum-18, metabolites-30)
appos(metabolites-30, 5-oxo-desethylzaleplon-32)
nn(glucuronide-35, 5-oxo-desethylzaleplon-34)
conj_and(5-oxo-desethylzaleplon-32, glucuronide-35)
advcl(pathway-10, account-37)
quantmod(9-40, only-39)
num(%-41, 9-40)
prep_for(account-37, %-41)
det(recovery-45, the-43)
amod(recovery-45, urinary-44)
prep_of(%-41, recovery-45)
det(dose-49, a-47)
nn(dose-49, zaleplon-48)
prep_of(recovery-45, dose-49)

Coadministration/NN of/IN single/JJ ,/, oral/JJ doses/NNS of/IN zaleplon/NN with/IN erythromycin/NN (/-LRB- 10/CD mg/NN and/CC 800/CD mg/NN ,/, respectively/RB )/-RRB- ,/, a/DT strong/JJ ,/, selective/JJ CYP3A4/NN inhibitor/NN produced/VBD a/DT 34/CD %/NN increase/NN in/IN zaleplon/NN s/NN maximal/JJ plasma/NN concentrations/NNS and/CC a/DT 20/CD %/NN increase/NN in/IN the/DT area/NN under/IN the/DT plasma/NN concentration-time/NN curve/NN ./.

(ROOT (S1 (S (NP (NP (NN Coadministration)) (PP (IN of) (NP (NP (ADJP (ADJP (JJ single)) (, ,) (ADJP (JJ oral))) (NNS doses)) (PP (IN of) (NP (NN zaleplon))))) (PP (IN with) (NP (NP (NP (NN erythromycin)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 10) (NN mg)) (CC and) (NP (CD 800) (NN mg))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))) (, ,) (NP (DT a) (ADJP (ADJP (JJ strong)) (, ,) (ADJP (JJ selective))) (NN CYP3A4) (NN inhibitor))))) (VP (VBD produced) (NP (NP (NP (DT a) (ADJP (CD 34) (NN %)) (NN increase)) (PP (IN in) (NP (NN zaleplon) (NN s) (JJ maximal) (NN plasma) (NNS concentrations)))) (CC and) (NP (NP (DT a) (ADJP (CD 20) (NN %)) (NN increase)) (PP (IN in) (NP (NP (DT the) (NN area)) (PP (IN under) (NP (DT the) (NN plasma) (NN concentration-time) (NN curve)))))))) (. .))))

nsubj(produced-27, Coadministration-1)
amod(doses-6, single-3)
dep(single-3, oral-5)
prep_of(Coadministration-1, doses-6)
prep_of(doses-6, zaleplon-8)
prep_with(Coadministration-1, erythromycin-10)
num(mg-13, 10-12)
dep(erythromycin-10, mg-13)
num(mg-16, 800-15)
conj_and(mg-13, mg-16)
advmod(mg-13, respectively-18)
det(inhibitor-26, a-21)
amod(inhibitor-26, strong-22)
dep(strong-22, selective-24)
nn(inhibitor-26, CYP3A4-25)
appos(erythromycin-10, inhibitor-26)
root(ROOT-0, produced-27)
det(increase-31, a-28)
number(%-30, 34-29)
amod(increase-31, %-30)
dobj(produced-27, increase-31)
nn(concentrations-37, zaleplon-33)
nn(concentrations-37, s-34)
amod(concentrations-37, maximal-35)
nn(concentrations-37, plasma-36)
prep_in(increase-31, concentrations-37)
det(increase-42, a-39)
number(%-41, 20-40)
amod(increase-42, %-41)
conj_and(increase-31, increase-42)
det(area-45, the-44)
prep_in(increase-42, area-45)
det(curve-50, the-47)
nn(curve-50, plasma-48)
nn(curve-50, concentration-time-49)
prep_under(area-45, curve-50)

The/DT magnitude/NN of/IN interaction/NN with/IN multiple/JJ doses/NNS of/IN erythromycin/NN is/VBZ unknown/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT The) (NN magnitude)) (PP (IN of) (NP (NP (NN interaction)) (PP (IN with) (NP (NP (JJ multiple) (NNS doses)) (PP (IN of) (NP (NN erythromycin)))))))) (VP (VBZ is) (ADJP (JJ unknown)))) (. .))))

det(magnitude-2, The-1)
nsubj(unknown-11, magnitude-2)
prep_of(magnitude-2, interaction-4)
amod(doses-7, multiple-6)
prep_with(interaction-4, doses-7)
prep_of(doses-7, erythromycin-9)
cop(unknown-11, is-10)
root(ROOT-0, unknown-11)

Other/JJ strong/JJ selective/JJ CYP3A4/JJ inhibitors/NNS such/JJ as/IN ketoconazole/NN can/MD also/RB be/VB expected/VBN to/TO increase/VB the/DT exposure/NN of/IN zaleplon/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Other) (JJ strong) (JJ selective) (JJ CYP3A4) (NNS inhibitors)) (PP (JJ such) (IN as) (NP (NN ketoconazole)))) (VP (MD can) (ADVP (RB also)) (VP (VB be) (VP (VBN expected) (S (VP (TO to) (VP (VB increase) (NP (NP (DT the) (NN exposure)) (PP (IN of) (NP (NN zaleplon))))))))))) (. .))))

amod(inhibitors-5, Other-1)
amod(inhibitors-5, strong-2)
amod(inhibitors-5, selective-3)
amod(inhibitors-5, CYP3A4-4)
nsubjpass(expected-12, inhibitors-5)
prep_such_as(inhibitors-5, ketoconazole-8)
aux(expected-12, can-9)
advmod(expected-12, also-10)
auxpass(expected-12, be-11)
root(ROOT-0, expected-12)
aux(increase-14, to-13)
xcomp(expected-12, increase-14)
det(exposure-16, the-15)
dobj(increase-14, exposure-16)
prep_of(exposure-16, zaleplon-18)

A/DT routine/JJ dosage/NN adjustment/NN of/IN zaleplon/NN is/VBZ not/RB considered/VBN necessary/JJ ./.

(ROOT (S1 (S (S (NP (NP (DT A) (JJ routine) (NN dosage) (NN adjustment)) (PP (IN of) (NP (NN zaleplon)))) (VP (VBZ is) (RB not) (VP (VBN considered) (ADJP (JJ necessary))))) (. .))))

det(adjustment-4, A-1)
amod(adjustment-4, routine-2)
nn(adjustment-4, dosage-3)
nsubjpass(considered-9, adjustment-4)
prep_of(adjustment-4, zaleplon-6)
auxpass(considered-9, is-7)
neg(considered-9, not-8)
root(ROOT-0, considered-9)
acomp(considered-9, necessary-10)

Drugs/NNS That/WDT Inhibit/VBP Aldehyde/NN Oxidase/NN :/: The/DT aldehyde/NN oxidase/NN enzyme/NN system/NN is/VBZ less/RBR well/RB studied/VBN than/IN the/DT cytochrome/NN P450/NN enzyme/NN system/NN ./.

(ROOT (S1 (S (NP (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT That)) (S (VP (VBP Inhibit) (NP (NN Aldehyde) (NN Oxidase)))))) (: :) (S (NP (DT The) (NN aldehyde) (NN oxidase) (NN enzyme) (NN system)) (VP (VBZ is) (ADVP (RBR less) (RB well)) (VP (VBN studied) (PP (IN than) (NP (DT the) (NN cytochrome) (NN P450) (NN enzyme) (NN system)))))) (. .)))))

root(ROOT-0, Drugs-1)
nsubj(Inhibit-3, Drugs-1)
rcmod(Drugs-1, Inhibit-3)
nn(Oxidase-5, Aldehyde-4)
dobj(Inhibit-3, Oxidase-5)
det(system-11, The-7)
nn(system-11, aldehyde-8)
nn(system-11, oxidase-9)
nn(system-11, enzyme-10)
nsubjpass(studied-15, system-11)
auxpass(studied-15, is-12)
advmod(well-14, less-13)
advmod(studied-15, well-14)
dep(Drugs-1, studied-15)
det(system-21, the-17)
nn(system-21, cytochrome-18)
nn(system-21, P450-19)
nn(system-21, enzyme-20)
prep_than(studied-15, system-21)

Diphenhydramine/NN :/: Diphenhydramine/NN is/VBZ reported/VBN to/TO be/VB a/DT weak/JJ inhibitor/NN of/IN aldehyde/NN oxidase/NN in/IN rat/NN liver/NN ,/, but/CC its/PRP$ inhibitory/JJ effects/NNS in/IN human/JJ liver/NN are/VBP not/RB known/VBN ./.

(ROOT (S1 (S (NP (NP (NN Diphenhydramine)) (: :) (S (S (NP (NN Diphenhydramine)) (VP (VBZ is) (VP (VBN reported) (S (VP (TO to) (VP (VB be) (NP (NP (DT a) (JJ weak) (NN inhibitor)) (PP (IN of) (NP (NN aldehyde) (NN oxidase))) (PP (IN in) (NP (NN rat) (NN liver)))))))))) (, ,) (CC but) (S (NP (NP (PRP$ its) (JJ inhibitory) (NNS effects)) (PP (IN in) (NP (JJ human) (NN liver)))) (VP (VBP are) (RB not) (VP (VBN known))))) (. .)))))

root(ROOT-0, Diphenhydramine-1)
nsubjpass(reported-5, Diphenhydramine-3)
xsubj(inhibitor-10, Diphenhydramine-3)
auxpass(reported-5, is-4)
dep(Diphenhydramine-1, reported-5)
aux(inhibitor-10, to-6)
cop(inhibitor-10, be-7)
det(inhibitor-10, a-8)
amod(inhibitor-10, weak-9)
xcomp(reported-5, inhibitor-10)
nn(oxidase-13, aldehyde-12)
prep_of(inhibitor-10, oxidase-13)
nn(liver-16, rat-15)
prep_in(inhibitor-10, liver-16)
poss(effects-21, its-19)
amod(effects-21, inhibitory-20)
nsubjpass(known-27, effects-21)
amod(liver-24, human-23)
prep_in(effects-21, liver-24)
auxpass(known-27, are-25)
neg(known-27, not-26)
conj_but(reported-5, known-27)

There/EX is/VBZ no/DT pharmacokinetic/JJ interaction/NN between/IN zaleplon/NN and/CC diphenhydramine/NN following/VBG the/DT administration/NN of/IN a/DT single/JJ dose/NN (/-LRB- 10/CD mg/NN and/CC 50/CD mg/NN ,/, respectively/RB )/-RRB- of/IN each/DT drug/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBZ is) (NP (NP (DT no) (JJ pharmacokinetic) (NN interaction)) (PP (IN between) (NP (NP (NP (NN zaleplon)) (CC and) (NP (NN diphenhydramine))) (PP (VBG following) (NP (NP (DT the) (NN administration)) (PP (IN of) (NP (NP (NP (DT a) (JJ single) (NN dose)) (PRN (-LRB- -LRB-) (NP (NP (CD 10) (NN mg) (CC and) (NP (CD 50) (NN mg))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))) (PP (IN of) (NP (DT each) (NN drug)))))))))))) (. .))))

expl(is-2, There-1)
root(ROOT-0, is-2)
det(interaction-5, no-3)
amod(interaction-5, pharmacokinetic-4)
nsubj(is-2, interaction-5)
prep_between(interaction-5, zaleplon-7)
conj_and(zaleplon-7, diphenhydramine-9)
det(administration-12, the-11)
prep_following(zaleplon-7, administration-12)
det(dose-16, a-14)
amod(dose-16, single-15)
prep_of(administration-12, dose-16)
num(mg-19, 10-18)
dep(dose-16, mg-19)
num(mg-22, 50-21)
conj_and(mg-19, mg-22)
advmod(mg-19, respectively-24)
det(drug-28, each-27)
prep_of(dose-16, drug-28)

Drugs/NNS That/IN Inhibit/VBP Both/DT Aldehyde/NN Oxidase/NN and/CC CYP3A4/NN Cimetidine/NN :/: Cimetidine/NN inhibits/VBZ both/CC aldehyde/NN oxidase/NN (/-LRB- in/FW vitro/FW )/-RRB- and/CC CYP3A4/NN (/-LRB- in/FW vitro/FW and/CC in/FW vivo/FW )/-RRB- ,/, the/DT primary/JJ and/CC secondary/JJ enzymes/NNS ,/, respectively/RB ,/, responsible/JJ for/IN zaleplon/NN metabolism/NN ./.

(ROOT (S1 (S (NP (NP (NP (NP (NNS Drugs)) (SBAR (IN That) (S (VP (VBP Inhibit) (NP (DT Both) (NN Aldehyde) (NN Oxidase)))))) (CC and) (NP (NN CYP3A4) (NN Cimetidine))) (: :) (S (NP (NN Cimetidine)) (VP (VBZ inhibits) (NP (CC both) (NP (NP (NN aldehyde) (NN oxidase)) (PRN (-LRB- -LRB-) (NP (FW in) (FW vitro)) (-RRB- -RRB-))) (CC and) (NP (NN CYP3A4))) (PRN (-LRB- -LRB-) (NP (NP (FW in) (FW vitro)) (CC and) (NP (FW in) (FW vivo))) (-RRB- -RRB-)) (, ,) (NP (NP (DT the) (ADJP (ADJP (JJ primary)) (CC and) (ADJP (JJ secondary))) (NNS enzymes)) (, ,) (ADVP (RB respectively)) (, ,) (ADJP (JJ responsible) (PP (IN for) (NP (NN zaleplon) (NN metabolism))))))) (. .)))))

root(ROOT-0, Drugs-1)
complm(Inhibit-3, That-2)
dep(Drugs-1, Inhibit-3)
det(Oxidase-6, Both-4)
nn(Oxidase-6, Aldehyde-5)
dobj(Inhibit-3, Oxidase-6)
nn(Cimetidine-9, CYP3A4-8)
conj_and(Drugs-1, Cimetidine-9)
nsubj(inhibits-12, Cimetidine-11)
dep(Drugs-1, inhibits-12)
preconj(oxidase-15, both-13)
nn(oxidase-15, aldehyde-14)
dobj(inhibits-12, oxidase-15)
nn(vitro-18, in-17)
dep(oxidase-15, vitro-18)
conj_and(oxidase-15, CYP3A4-21)
nn(vitro-24, in-23)
dep(inhibits-12, vitro-24)
nn(vivo-27, in-26)
conj_and(vitro-24, vivo-27)
det(enzymes-34, the-30)
amod(enzymes-34, primary-31)
conj_and(primary-31, secondary-33)
dobj(inhibits-12, enzymes-34)
advmod(enzymes-34, respectively-36)
amod(enzymes-34, responsible-38)
nn(metabolism-41, zaleplon-40)
prep_for(responsible-38, metabolism-41)

Concomitant/JJ administration/NN of/IN Sonata/NN (/-LRB- 10/CD mg/NN )/-RRB- and/CC cimetidine/NN (/-LRB- 800/CD mg/NN )/-RRB- produced/VBD an/DT 85/CD %/NN increase/NN in/IN the/DT mean/JJ Cmax/NN and/CC AUC/NN of/IN zaleplon/NN ./.

(ROOT (S1 (S (S (NP (NP (JJ Concomitant) (NN administration)) (PP (IN of) (NP (NP (NP (NN Sonata)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN mg)) (-RRB- -RRB-))) (CC and) (NP (NP (NN cimetidine)) (PRN (-LRB- -LRB-) (NP (CD 800) (NN mg)) (-RRB- -RRB-)))))) (VP (VBD produced) (NP (NP (DT an) (ADJP (CD 85) (NN %)) (NN increase)) (PP (IN in) (NP (NP (DT the) (NP (JJ mean) (NN Cmax)) (CC and) (NP (NN AUC))) (PP (IN of) (NP (NN zaleplon)))))))) (. .))))

amod(administration-2, Concomitant-1)
nsubj(produced-15, administration-2)
prep_of(administration-2, Sonata-4)
num(mg-7, 10-6)
appos(Sonata-4, mg-7)
conj_and(Sonata-4, cimetidine-10)
num(mg-13, 800-12)
appos(cimetidine-10, mg-13)
root(ROOT-0, produced-15)
det(increase-19, an-16)
number(%-18, 85-17)
amod(increase-19, %-18)
dobj(produced-15, increase-19)
dep(Cmax-23, the-21)
amod(Cmax-23, mean-22)
prep_in(increase-19, Cmax-23)
conj_and(Cmax-23, AUC-25)
prep_of(Cmax-23, zaleplon-27)

An/DT initial/JJ dose/NN of/IN 5/CD mg/NN should/MD be/VB given/VBN to/TO patients/NNS who/WP are/VBP concomitantly/RB being/VBG treated/VBN with/IN cimetidine/NN ./.

(ROOT (S1 (S (S (NP (NP (DT An) (JJ initial) (NN dose)) (PP (IN of) (NP (CD 5) (NN mg)))) (VP (MD should) (VP (VB be) (VP (VBN given) (PP (TO to) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (VBP are) (ADVP (RB concomitantly)) (VP (VBG being) (VP (VBN treated) (PP (IN with) (NP (NN cimetidine)))))))))))))) (. .))))

det(dose-3, An-1)
amod(dose-3, initial-2)
nsubjpass(given-9, dose-3)
num(mg-6, 5-5)
prep_of(dose-3, mg-6)
aux(given-9, should-7)
auxpass(given-9, be-8)
root(ROOT-0, given-9)
prep_to(given-9, patients-11)
nsubjpass(treated-16, patients-11)
aux(treated-16, are-13)
advmod(treated-16, concomitantly-14)
auxpass(treated-16, being-15)
rcmod(patients-11, treated-16)
prep_with(treated-16, cimetidine-18)

Drugs/NNS Highly/RB Bound/VBN to/TO Plasma/NN Protein/NN Zaleplon/NN is/VBZ not/RB highly/RB bound/VBN to/TO plasma/NN proteins/NNS (/-LRB- fraction/NN bound/JJ 60/CD %/NN span/NN class=/NN c104/CD @/NN 15/CD %/NN )/-RRB- ;/: ./.

(ROOT (S1 (S (S (NP (NP (NNS Drugs)) (VP (ADVP (RB Highly)) (VBN Bound) (PP (TO to) (NP (NN Plasma) (NN Protein) (NN Zaleplon))))) (VP (VBZ is) (RB not) (ADVP (RB highly)) (VP (VBN bound) (PP (TO to) (NP (NN plasma) (NNS proteins))) (PRN (-LRB- -LRB-) (NP (NN fraction) (JJ bound) (CD 60) (NN %) (NN span) (NN class=) (CD c104) (NN @) (CD 15) (NN %)) (-RRB- -RRB-)))) (: ;)) (. .))))

nsubjpass(bound-11, Drugs-1)
advmod(Bound-3, Highly-2)
partmod(Drugs-1, Bound-3)
nn(Zaleplon-7, Plasma-5)
nn(Zaleplon-7, Protein-6)
prep_to(Bound-3, Zaleplon-7)
auxpass(bound-11, is-8)
neg(bound-11, not-9)
advmod(bound-11, highly-10)
root(ROOT-0, bound-11)
nn(proteins-14, plasma-13)
prep_to(bound-11, proteins-14)
nn(%-25, fraction-16)
amod(%-25, bound-17)
num(%-25, 60-18)
nn(%-25, %-19)
nn(%-25, span-20)
nn(%-25, class=-21)
num(%-25, c104-22)
nn(%-25, @-23)
num(%-25, 15-24)
dep(bound-11, %-25)

therefore/RB ,/, the/DT disposition/NN of/IN zaleplon/NN is/VBZ not/RB expected/VBN to/TO be/VB sensitive/JJ to/TO alterations/NNS in/IN protein/NN binding/NN ./.

(ROOT (S1 (S (S (ADVP (RB therefore)) (, ,) (NP (NP (DT the) (NN disposition)) (PP (IN of) (NP (NN zaleplon)))) (VP (VBZ is) (RB not) (VP (VBN expected) (S (VP (TO to) (VP (VB be) (ADJP (JJ sensitive) (PP (TO to) (NP (NP (NNS alterations)) (PP (IN in) (NP (NN protein) (NN binding)))))))))))) (. .))))

advmod(expected-9, therefore-1)
det(disposition-4, the-3)
nsubjpass(expected-9, disposition-4)
xsubj(sensitive-12, disposition-4)
prep_of(disposition-4, zaleplon-6)
auxpass(expected-9, is-7)
neg(expected-9, not-8)
root(ROOT-0, expected-9)
aux(sensitive-12, to-10)
cop(sensitive-12, be-11)
xcomp(expected-9, sensitive-12)
prep_to(sensitive-12, alterations-14)
nn(binding-17, protein-16)
prep_in(alterations-14, binding-17)

In/IN addition/NN ,/, administration/NN of/IN Sonata/NN to/TO a/DT patient/NN taking/VBG another/DT drug/NN that/WDT is/VBZ highly/RB protein/NN bound/VBN should/MD not/RB cause/VB transient/JJ increase/NN in/IN free/JJ concentrations/NNS of/IN the/DT other/JJ drug/NN ./.

(ROOT (S1 (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN administration)) (PP (IN of) (NP (NN Sonata))) (PP (TO to) (NP (NP (DT a) (NN patient)) (VP (VBG taking) (NP (NP (DT another) (NN drug)) (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (ADVP (RB highly)) (VP (NN protein) (VBN bound)))))))))) (VP (MD should) (RB not) (VP (VB cause) (NP (NP (JJ transient) (NN increase)) (PP (IN in) (NP (NP (JJ free) (NNS concentrations)) (PP (IN of) (NP (DT the) (JJ other) (NN drug))))))))) (. .))))

prep_in(cause-20, addition-2)
nsubj(cause-20, administration-4)
prep_of(administration-4, Sonata-6)
det(patient-9, a-8)
prep_to(administration-4, patient-9)
partmod(patient-9, taking-10)
det(drug-12, another-11)
dobj(taking-10, drug-12)
nsubjpass(bound-17, drug-12)
auxpass(bound-17, is-14)
advmod(bound-17, highly-15)
dep(bound-17, protein-16)
rcmod(drug-12, bound-17)
aux(cause-20, should-18)
neg(cause-20, not-19)
root(ROOT-0, cause-20)
amod(increase-22, transient-21)
dobj(cause-20, increase-22)
amod(concentrations-25, free-24)
prep_in(increase-22, concentrations-25)
det(drug-29, the-27)
amod(drug-29, other-28)
prep_of(concentrations-25, drug-29)

Drugs/NNS with/IN a/DT Narrow/JJ Therapeutic/JJ Index/NN Digoxin/NN :/: Sonata/NN (/-LRB- 10/CD mg/NN )/-RRB- did/VBD not/RB affect/VB the/DT pharmacokinetic/JJ or/CC pharmacodynamic/JJ profile/NN of/IN digoxin/NN (/-LRB- 0.375/CD mg/NN q24h/NN for/IN 8/CD days/NNS )./JJ

(ROOT (S1 (S (NP (NP (NNS Drugs)) (PP (IN with) (NP (NP (DT a) (JJ Narrow) (JJ Therapeutic) (NN Index) (NN Digoxin)) (: :) (NP (NP (NN Sonata)) (PRN (-LRB- -LRB-) (NP (CD 10) (NN mg)) (-RRB- -RRB-)))))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (DT the) (ADJP (ADJP (JJ pharmacokinetic)) (CC or) (ADJP (JJ pharmacodynamic))) (NN profile)) (PP (IN of) (NP (NN digoxin)))))) (PRN (-LRB- -LRB-) (NP (CD 0.375) (NN mg) (NN q24h)) (PP (IN for) (NP (CD 8) (NNS days) (JJ -RRB-.)))))))

nsubj(affect-16, Drugs-1)
det(Digoxin-7, a-3)
amod(Digoxin-7, Narrow-4)
amod(Digoxin-7, Therapeutic-5)
nn(Digoxin-7, Index-6)
prep_with(Drugs-1, Digoxin-7)
dep(Digoxin-7, Sonata-9)
num(mg-12, 10-11)
appos(Sonata-9, mg-12)
aux(affect-16, did-14)
neg(affect-16, not-15)
root(ROOT-0, affect-16)
det(profile-21, the-17)
amod(profile-21, pharmacokinetic-18)
conj_or(pharmacokinetic-18, pharmacodynamic-20)
dobj(affect-16, profile-21)
prep_of(profile-21, digoxin-23)
num(q24h-27, 0.375-25)
nn(q24h-27, mg-26)
dep(affect-16, q24h-27)
dep(q24h-27, for-28)
num(days-30, 8-29)
pobj(for-28, days-30)
amod(days-30, -RRB-.-31)

Warfarin/NN :/: Multiple/JJ oral/JJ doses/NNS of/IN Sonata/NN (/-LRB- 20/CD mg/NN q24h/NN for/IN 13/CD days/NNS )/-RRB- did/VBD not/RB affect/VB the/DT pharmacokinetics/NNS of/IN warfarin/NN (/-LRB- R+/JJ )/-RRB- -/: or/CC (/-LRB- S-/NN )/-RRB- -/CC enantiomer/NN s/NNS or/CC the/DT pharmacodynamics/NNS (/-LRB- prothrombin/NN time/NN )/-RRB- following/VBG a/DT single/JJ 25-mg/JJ oral/JJ dose/NN of/IN warfarin/NN ./.

(ROOT (S1 (S (NP (NP (NN Warfarin)) (: :) (S (NP (NP (JJ Multiple) (JJ oral) (NNS doses)) (PP (IN of) (NP (NP (NN Sonata)) (PRN (-LRB- -LRB-) (NP (NP (ADJP (CD 20) (NN mg)) (NN q24h)) (PP (IN for) (NP (CD 13) (NNS days)))) (-RRB- -RRB-))))) (VP (VBD did) (RB not) (VP (VB affect) (NP (NP (NP (DT the) (NNS pharmacokinetics)) (PP (IN of) (NP (NP (NP (NN warfarin)) (PRN (-LRB- -LRB-) (NP (JJ R+)) (-RRB- -RRB-)) (: -) (CC or) (PRN (-LRB- -LRB-) (NP (NN S-)) (-RRB- -RRB-))) (CC -) (NP (NN enantiomer) (NNS s))))) (CC or) (NP (NP (NP (DT the) (NNS pharmacodynamics)) (PRN (-LRB- -LRB-) (NP (NN prothrombin) (NN time)) (-RRB- -RRB-))) (PP (VBG following) (NP (NP (DT a) (JJ single) (JJ 25-mg) (JJ oral) (NN dose)) (PP (IN of) (NP (NN warfarin)))))))))) (. .)))))

root(ROOT-0, Warfarin-1)
amod(doses-5, Multiple-3)
amod(doses-5, oral-4)
nsubj(affect-18, doses-5)
prep_of(doses-5, Sonata-7)
number(mg-10, 20-9)
amod(q24h-11, mg-10)
dep(Sonata-7, q24h-11)
num(days-14, 13-13)
prep_for(q24h-11, days-14)
aux(affect-18, did-16)
neg(affect-18, not-17)
dep(Warfarin-1, affect-18)
det(pharmacokinetics-20, the-19)
dobj(affect-18, pharmacokinetics-20)
prep_of(pharmacokinetics-20, warfarin-22)
dep(warfarin-22, R+-24)
appos(warfarin-22, S--29)
nn(s-33, enantiomer-32)
conj_or(warfarin-22, s-33)
det(pharmacodynamics-36, the-35)
conj_or(pharmacokinetics-20, pharmacodynamics-36)
nn(time-39, prothrombin-38)
appos(pharmacodynamics-36, time-39)
det(dose-46, a-42)
amod(dose-46, single-43)
amod(dose-46, 25-mg-44)
amod(dose-46, oral-45)
prep_following(pharmacodynamics-36, dose-46)
prep_of(dose-46, warfarin-48)

Drugs/NNS That/WDT Alter/VBP Renal/JJ Excretion/NN Ibuprofen/NN :/: Ibuprofen/NN is/VBZ known/VBN to/TO affect/VB renal/JJ function/NN and/CC ,/, consequently/RB ,/, alter/VB the/DT renal/JJ excretion/NN of/IN other/JJ drugs/NNS ./.

(ROOT (S1 (S (NP (NP (NP (NNS Drugs)) (SBAR (WHNP (WDT That)) (S (VP (VBP Alter) (NP (JJ Renal) (NN Excretion) (NN Ibuprofen)))))) (: :) (NP (NP (NN Ibuprofen)) (VP (VBZ is) (VP (VBN known) (S (VP (VP (TO to) (VP (VB affect) (NP (JJ renal) (NN function)))) (CC and) (, ,) (ADVP (RB consequently)) (, ,) (VP (VB alter) (NP (NP (DT the) (JJ renal) (NN excretion)) (PP (IN of) (NP (JJ other) (NNS drugs)))))))))) (. .)))))

root(ROOT-0, Drugs-1)
nsubj(Alter-3, Drugs-1)
rcmod(Drugs-1, Alter-3)
amod(Ibuprofen-6, Renal-4)
nn(Ibuprofen-6, Excretion-5)
dobj(Alter-3, Ibuprofen-6)
dep(Drugs-1, Ibuprofen-8)
auxpass(known-10, is-9)
dep(Ibuprofen-8, known-10)
aux(affect-12, to-11)
ccomp(known-10, affect-12)
amod(function-14, renal-13)
dobj(affect-12, function-14)
advmod(affect-12, consequently-17)
conj_and(affect-12, consequently-17)
conj_and(affect-12, alter-19)
det(excretion-22, the-20)
amod(excretion-22, renal-21)
dobj(alter-19, excretion-22)
amod(drugs-25, other-24)
prep_of(excretion-22, drugs-25)

There/EX was/VBD no/DT apparent/JJ pharmacokinetic/JJ interaction/NN between/IN zaleplon/NN and/CC ibuprofen/NN following/VBG single/JJ dose/NN administration/NN (/-LRB- 10/CD mg/NN and/CC 600/CD mg/NN ,/, respectively/RB )/-RRB- of/IN each/DT drug/NN ./.

(ROOT (S1 (S (S (NP (EX There)) (VP (VBD was) (NP (NP (DT no) (JJ apparent) (JJ pharmacokinetic) (NN interaction)) (PP (IN between) (NP (NP (NN zaleplon)) (CC and) (NP (NN ibuprofen))))) (PP (VBG following) (NP (NP (NP (JJ single) (NN dose) (NN administration)) (PRN (-LRB- -LRB-) (NP (NP (NP (CD 10) (NN mg)) (CC and) (NP (CD 600) (NN mg))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))) (PP (IN of) (NP (DT each) (NN drug))))))) (. .))))

expl(was-2, There-1)
root(ROOT-0, was-2)
det(interaction-6, no-3)
amod(interaction-6, apparent-4)
amod(interaction-6, pharmacokinetic-5)
nsubj(was-2, interaction-6)
prep_between(interaction-6, zaleplon-8)
conj_and(zaleplon-8, ibuprofen-10)
amod(administration-14, single-12)
nn(administration-14, dose-13)
prep_following(was-2, administration-14)
num(mg-17, 10-16)
dep(administration-14, mg-17)
num(mg-20, 600-19)
conj_and(mg-17, mg-20)
advmod(mg-17, respectively-22)
det(drug-26, each-25)
prep_of(administration-14, drug-26)

This/DT was/VBD expected/VBN because/IN zaleplon/NN is/VBZ primarily/RB metabolized/VBN and/CC renal/JJ excretion/NN of/IN unchanged/JJ zaleplon/NN accounts/VBZ for/IN less/JJR than/IN 1/CD %/NN of/IN the/DT administered/VBN dose/NN ./.

(ROOT (S1 (S (S (NP (DT This)) (VP (VBD was) (VP (VBN expected) (SBAR (IN because) (S (S (NP (NN zaleplon)) (VP (VBZ is) (ADVP (RB primarily)) (VP (VBN metabolized)))) (CC and) (S (NP (NP (JJ renal) (NN excretion)) (PP (IN of) (NP (JJ unchanged) (NN zaleplon)))) (VP (VBZ accounts) (PP (IN for) (NP (NP (QP (JJR less) (IN than) (CD 1)) (NN %)) (PP (IN of) (NP (DT the) (VBN administered) (NN dose)))))))))))) (. .))))

nsubjpass(expected-3, This-1)
auxpass(expected-3, was-2)
root(ROOT-0, expected-3)
mark(metabolized-8, because-4)
nsubjpass(metabolized-8, zaleplon-5)
auxpass(metabolized-8, is-6)
advmod(metabolized-8, primarily-7)
advcl(expected-3, metabolized-8)
amod(excretion-11, renal-10)
nsubj(accounts-15, excretion-11)
amod(zaleplon-14, unchanged-13)
prep_of(excretion-11, zaleplon-14)
conj_and(metabolized-8, accounts-15)
mwe(than-18, less-17)
quantmod(1-19, than-18)
num(%-20, 1-19)
prep_for(accounts-15, %-20)
det(dose-24, the-22)
amod(dose-24, administered-23)
prep_of(%-20, dose-24)

